3792|Natriuretic Agents|natriuretic agents|mesh-ancestor
153828427|NCT01242449|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153828428|NCT01242449|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153828429|NCT01242449|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153828430|NCT01242449|Tubulin Modulators|tubulin modulators|mesh-ancestor
153828431|NCT01242449|Antimitotic Agents|antimitotic agents|mesh-ancestor
153828432|NCT01242449|Mitosis Modulators|mitosis modulators|mesh-ancestor
153828433|NCT01242449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153368441|NCT02183792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153368442|NCT02183792|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
153368443|NCT00363519|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
153368444|NCT00363519|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153368445|NCT00363519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153368446|NCT00363519|Incretins|incretins|mesh-ancestor
153368464|NCT01124786|Gemcitabine|gemcitabine|mesh-list
153368465|NCT01124786|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153368466|NCT01124786|Antimetabolites|antimetabolites|mesh-ancestor
153368467|NCT01124786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153368468|NCT01124786|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153461391|NCT05598606|Zoledronic Acid|zoledronic acid|mesh-list
153461392|NCT05598606|Denosumab|denosumab|mesh-list
153461393|NCT05598606|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153461394|NCT05598606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153368469|NCT01125098|Amoxicillin|amoxicillin|mesh-list
153368470|NCT01125098|Clavulanic Acid|clavulanic acid|mesh-list
153368471|NCT01125098|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
153368472|NCT01125098|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153368473|NCT01125098|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153368474|NCT01125098|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
153368475|NCT01125098|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153368476|NCT01125098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153368477|NCT02478489|Naltrexone|naltrexone|mesh-list
153368478|NCT02478489|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
153368479|NCT02478489|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
153828452|NCT00484133|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
153828461|NCT00484133|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
153828462|NCT00484133|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
153828463|NCT00484133|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153828464|NCT00484341|Doxorubicin|doxorubicin|mesh-list
153828465|NCT00484341|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153828466|NCT00484341|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153828467|NCT00484341|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153828468|NCT00484341|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153368535|NCT02481219|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153368536|NCT02481219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153368537|NCT02481219|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153368538|NCT02481219|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153368539|NCT02481219|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
153368540|NCT02481219|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153368541|NCT02481219|Cathartics|cathartics|mesh-ancestor
153368542|NCT02481219|Laxatives|laxatives|mesh-ancestor
153368544|NCT02481297|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153368545|NCT02481297|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153732023|NCT00140309|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153732024|NCT00140309|Antimetabolites|antimetabolites|mesh-ancestor
153828522|NCT04514796|Adalimumab|adalimumab|mesh-list
153360084|NCT01269047|Exenatide|exenatide|mesh-list
153464789|NCT00038610|Dermatologic Agents|dermatologic agents|mesh-ancestor
153828523|NCT04514796|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
153828524|NCT04514796|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153828525|NCT04514796|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153828526|NCT00488969|Morphine|morphine|mesh-list
153828527|NCT00488969|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153828528|NCT00488969|Narcotics|narcotics|mesh-ancestor
153828529|NCT00488969|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153828530|NCT00488969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153828531|NCT00488969|Analgesics|analgesics|mesh-ancestor
153828532|NCT00488969|Sensory System Agents|sensory system agents|mesh-ancestor
153828533|NCT00488969|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153464884|NCT02091882|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
153828534|NCT00484692|Bupropion|bupropion|mesh-list
153828535|NCT00484692|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
153828536|NCT00484692|Antidepressive Agents|antidepressive agents|mesh-ancestor
153828537|NCT00484692|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153828538|NCT00484692|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
153828546|NCT00484692|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153828549|NCT00484731|Anesthetics, Local|anesthetics, local|mesh-ancestor
153828550|NCT00484731|Anesthetics|anesthetics|mesh-ancestor
153828551|NCT00484731|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153828552|NCT00484731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153828553|NCT00484731|Sensory System Agents|sensory system agents|mesh-ancestor
153828554|NCT00484731|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153828555|NCT00484484|Ketamine|ketamine|mesh-list
153368563|NCT01165112|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153368564|NCT01165112|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153368565|NCT01165112|Immunologic Factors|immunologic factors|mesh-ancestor
153368566|NCT01165112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153368567|NCT01165112|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153368568|NCT01165112|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153368569|NCT01165112|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153368570|NCT01165112|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153368571|NCT01165112|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153828718|NCT00485030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153828719|NCT00485030|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153828720|NCT00485030|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153828802|NCT00485342|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153828803|NCT00485342|Antiviral Agents|antiviral agents|mesh-ancestor
153828804|NCT00485342|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153828805|NCT00485342|Antimetabolites|antimetabolites|mesh-ancestor
153828806|NCT00485342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153828807|NCT00485342|Immunologic Factors|immunologic factors|mesh-ancestor
153368820|NCT01137890|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153368986|NCT02570139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153368988|NCT02410200|Dermatologic Agents|dermatologic agents|mesh-ancestor
153368989|NCT02410200|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153829041|NCT00490373|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153829042|NCT00490373|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153829043|NCT00485823|Olanzapine|olanzapine|mesh-list
153829044|NCT00485823|Antiemetics|antiemetics|mesh-ancestor
153369110|NCT01144442|Tubulin Modulators|tubulin modulators|mesh-ancestor
153369111|NCT01144442|Antimitotic Agents|antimitotic agents|mesh-ancestor
153829134|NCT00486005|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
153829135|NCT00486005|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153829136|NCT00486005|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153829181|NCT04511715|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153829182|NCT04511715|Growth Substances|growth substances|mesh-ancestor
153829183|NCT04511715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153829184|NCT04511715|Growth Inhibitors|growth inhibitors|mesh-ancestor
153829186|NCT00486317|Salmon calcitonin|salmon calcitonin|mesh-list
153829187|NCT00486317|Calcitonin Gene-Related Peptide|calcitonin gene-related peptide|mesh-list
153829188|NCT00486317|Katacalcin|katacalcin|mesh-list
153829423|NCT02275962|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153829424|NCT02275962|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153829425|NCT02275962|Leprostatic Agents|leprostatic agents|mesh-ancestor
153829426|NCT02275962|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153829427|NCT02275962|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153829428|NCT02275962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153829493|NCT01300546|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153829494|NCT01300546|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153829495|NCT01300546|Gout Suppressants|gout suppressants|mesh-ancestor
153369775|NCT05655273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153369777|NCT05624151|Dexmedetomidine|dexmedetomidine|mesh-list
153830119|NCT04516278|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153370185|NCT02678182|Trastuzumab|trastuzumab|mesh-list
153370186|NCT02678182|Durvalumab|durvalumab|mesh-list
153370187|NCT02678182|Ramucirumab|ramucirumab|mesh-list
153370458|NCT04055649|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153370459|NCT04055649|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153370460|NCT04055649|Tubulin Modulators|tubulin modulators|mesh-ancestor
153370461|NCT04055649|Antimitotic Agents|antimitotic agents|mesh-ancestor
153370462|NCT04055649|Mitosis Modulators|mitosis modulators|mesh-ancestor
153830413|NCT00497237|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153830414|NCT00497237|Respiratory System Agents|respiratory system agents|mesh-ancestor
153830415|NCT00497237|Dermatologic Agents|dermatologic agents|mesh-ancestor
153830416|NCT00497237|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
153830417|NCT00497237|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
153830418|NCT00497237|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
153464908|NCT00253890|Antidepressive Agents|antidepressive agents|mesh-ancestor
153830419|NCT00497237|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153830420|NCT00497237|Adrenergic Agents|adrenergic agents|mesh-ancestor
153830421|NCT00497237|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153830481|NCT00507195|Anesthetics|anesthetics|mesh-ancestor
153830489|NCT00507195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153830490|NCT00507195|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153830491|NCT00507195|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
153830492|NCT00497471|Pyrimethamine|pyrimethamine|mesh-list
153830493|NCT00497471|Dapsone|dapsone|mesh-list
153830494|NCT00497471|Antimalarials|antimalarials|mesh-ancestor
153830495|NCT00497471|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153830551|NCT05149560|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
153830552|NCT05149560|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
153830553|NCT05149560|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
153830554|NCT05149560|Purinergic Agents|purinergic agents|mesh-ancestor
153830555|NCT05149560|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153830556|NCT05149560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153830557|NCT05149560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153830558|NCT00494897|Cytarabine|cytarabine|mesh-list
153830590|NCT00494897|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153830591|NCT00494897|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153830592|NCT00494897|Tubulin Modulators|tubulin modulators|mesh-ancestor
153830593|NCT00494897|Antimitotic Agents|antimitotic agents|mesh-ancestor
153830594|NCT00494897|Mitosis Modulators|mitosis modulators|mesh-ancestor
153830595|NCT00494897|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153830596|NCT00494897|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153830597|NCT00494897|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153830599|NCT00497744|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153830643|NCT05143125|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153830659|NCT00498251|Albuterol|albuterol|mesh-list
153830660|NCT00498251|Ipratropium|ipratropium|mesh-list
153830661|NCT00498251|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153830662|NCT00498251|Autonomic Agents|autonomic agents|mesh-ancestor
153830663|NCT00498251|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153830664|NCT00498251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153465101|NCT00091260|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153370725|NCT01229462|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153370726|NCT01229462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153370727|NCT01229462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153370728|NCT01229462|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153370729|NCT01229462|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153370730|NCT01229462|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
153370731|NCT01229462|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153370732|NCT01229462|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153370733|NCT01292642|Nicotine|nicotine|mesh-list
153370734|NCT01292642|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
153370735|NCT01292642|Autonomic Agents|autonomic agents|mesh-ancestor
153370736|NCT01292642|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153370737|NCT01292642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153370738|NCT01292642|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
153370739|NCT01292642|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
153370740|NCT01292642|Cholinergic Agents|cholinergic agents|mesh-ancestor
153370741|NCT01292642|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153370742|NCT01292642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153370743|NCT01231334|Clindamycin|clindamycin|mesh-list
153370744|NCT01231334|Clindamycin palmitate|clindamycin palmitate|mesh-list
153370745|NCT01231334|Clindamycin phosphate|clindamycin phosphate|mesh-list
153370746|NCT01231334|Dapsone|dapsone|mesh-list
153370747|NCT01231334|Adapalene|adapalene|mesh-list
153370748|NCT01231334|Benzoyl Peroxide|benzoyl peroxide|mesh-list
153370749|NCT01231334|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153370750|NCT01231334|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153830708|NCT00498680|Sildenafil Citrate|sildenafil citrate|mesh-list
153830709|NCT00498680|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
153830744|NCT05145543|Levobupivacaine|levobupivacaine|mesh-list
153830745|NCT05145543|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153830746|NCT05145543|Antiemetics|antiemetics|mesh-ancestor
153830747|NCT05145543|Autonomic Agents|autonomic agents|mesh-ancestor
153830748|NCT05145543|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153830749|NCT05145543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153830750|NCT05145543|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153830751|NCT05145543|Glucocorticoids|glucocorticoids|mesh-ancestor
153830752|NCT05145543|Hormones|hormones|mesh-ancestor
153830753|NCT05145543|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153370788|NCT03009500|Sensory System Agents|sensory system agents|mesh-ancestor
153370789|NCT03009500|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153465230|NCT00195624|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153465231|NCT00195702|Adalimumab|adalimumab|mesh-list
153465235|NCT00197184|Vaccines|vaccines|mesh-list
153465282|NCT00205374|Antiviral Agents|antiviral agents|mesh-ancestor
153813665|NCT00436722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153813666|NCT00436722|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153813667|NCT00334880|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
153465283|NCT00205374|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153465286|NCT00103194|Lapatinib|lapatinib|mesh-list
153830754|NCT05145543|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153370818|NCT01715207|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
153370819|NCT01715207|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
153370820|NCT01715207|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
153370821|NCT01715207|Adrenergic Agents|adrenergic agents|mesh-ancestor
153370822|NCT01715207|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153370823|NCT01716221|Dexetimide|dexetimide|mesh-list
153370824|NCT01716221|Bupropion|bupropion|mesh-list
153461395|NCT04400916|Tranexamic Acid|tranexamic acid|mesh-list
153461396|NCT04400916|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
153461397|NCT04400916|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153370826|NCT01716221|Escitalopram|escitalopram|mesh-list
153370827|NCT01716221|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
153370828|NCT01716221|Antidepressive Agents|antidepressive agents|mesh-ancestor
153830791|NCT00498992|Sensory System Agents|sensory system agents|mesh-ancestor
153830845|NCT00503477|Cediranib|cediranib|mesh-list
153830846|NCT00503477|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153830847|NCT00503477|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153830848|NCT00503477|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153830849|NCT00503477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153830850|NCT05144295|Lactulose|lactulose|mesh-list
153370888|NCT01231412|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153370889|NCT01231412|Antimetabolites|antimetabolites|mesh-ancestor
153370890|NCT01231412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153370891|NCT01231412|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153370892|NCT01231412|Immunologic Factors|immunologic factors|mesh-ancestor
153370893|NCT01231412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153370894|NCT01231412|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153370895|NCT01231412|Antifungal Agents|antifungal agents|mesh-ancestor
153370896|NCT01231412|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153370897|NCT01231412|Dermatologic Agents|dermatologic agents|mesh-ancestor
153370898|NCT01231412|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153370899|NCT01231412|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
153370900|NCT01231412|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153370901|NCT01231412|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
153370902|NCT01231412|Antitubercular Agents|antitubercular agents|mesh-ancestor
153370903|NCT01231412|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153830889|NCT00503516|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
153830934|NCT01246817|MTOR Inhibitors|mtor inhibitors|mesh-list
153370975|NCT01234766|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153370976|NCT01234766|Alkylating Agents|alkylating agents|mesh-ancestor
153465458|NCT00225498|Risperidone|risperidone|mesh-list
153370977|NCT01234766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153370978|NCT01234922|Losartan|losartan|mesh-list
153370979|NCT01234922|Ramipril|ramipril|mesh-list
153370980|NCT01234922|Lisinopril|lisinopril|mesh-list
153370981|NCT01234922|Benazepril|benazepril|mesh-list
153370982|NCT01234922|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153370998|NCT01337336|Cholinergic Antagonists|cholinergic antagonists|mesh-list
153370999|NCT01337336|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153371000|NCT01337336|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153371001|NCT01337336|Autonomic Agents|autonomic agents|mesh-ancestor
153371002|NCT01337336|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153371003|NCT01337336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153371004|NCT01337336|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153371005|NCT01337336|Respiratory System Agents|respiratory system agents|mesh-ancestor
153371006|NCT01337336|Dermatologic Agents|dermatologic agents|mesh-ancestor
153371007|NCT01337336|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
153371008|NCT01337336|Parasympatholytics|parasympatholytics|mesh-ancestor
153371009|NCT01337336|Cholinergic Agents|cholinergic agents|mesh-ancestor
153371010|NCT01337336|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153371011|NCT01337336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153371012|NCT01337336|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
153371013|NCT01337336|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
153371014|NCT01337336|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153371015|NCT01337336|Adrenergic Agents|adrenergic agents|mesh-ancestor
153371016|NCT01239212|Levetiracetam|levetiracetam|mesh-list
153371017|NCT01239212|Anticonvulsants|anticonvulsants|mesh-ancestor
153830966|NCT00499577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153830968|NCT02274740|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153830969|NCT02274740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153830970|NCT00499733|Cyclophosphamide|cyclophosphamide|mesh-list
153830971|NCT00499733|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153465742|NCT04226352|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153461403|NCT03832452|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153461404|NCT03832452|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153461405|NCT03832452|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153461406|NCT03832452|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153461407|NCT03832452|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153830974|NCT00499733|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153830975|NCT00499733|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153830976|NCT00499733|Alkylating Agents|alkylating agents|mesh-ancestor
153371052|NCT02597907|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
153371058|NCT02600325|Grazoprevir|grazoprevir|mesh-list
153830983|NCT06155760|Glucocorticoids|glucocorticoids|mesh-ancestor
153830984|NCT06155760|Hormones|hormones|mesh-ancestor
153830985|NCT06155760|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153830986|NCT06155760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153830987|NCT06155760|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153830988|NCT06155760|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153831022|NCT06154590|Antimetabolites|antimetabolites|mesh-ancestor
153831023|NCT06154590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153831024|NCT06154590|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153831025|NCT06154590|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153371071|NCT02600715|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153371072|NCT02600715|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
153371073|NCT02600715|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
153371100|NCT00365313|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153384587|NCT02338362|Xhance|xhance|mesh-list
153371101|NCT00365313|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153371102|NCT00365313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153371103|NCT00365313|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
153371104|NCT00365313|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153371105|NCT00365313|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
153371106|NCT02605395|Rabeprazole|rabeprazole|mesh-list
153831026|NCT06154590|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153831027|NCT06154590|Immunologic Factors|immunologic factors|mesh-ancestor
153831028|NCT06154590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153831029|NCT06154590|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
153831030|NCT06154590|Hormone Antagonists|hormone antagonists|mesh-ancestor
153461408|NCT03832452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153465914|NCT00135798|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153461409|NCT03832452|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153461410|NCT03832452|Antiviral Agents|antiviral agents|mesh-ancestor
153461412|NCT04279938|Pembrolizumab|pembrolizumab|mesh-list
153461413|NCT04279938|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153831035|NCT06154590|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153831036|NCT06154590|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153831037|NCT06154590|Alkylating Agents|alkylating agents|mesh-ancestor
153371118|NCT04343001|Sensory System Agents|sensory system agents|mesh-ancestor
153371119|NCT04343001|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153371120|NCT04343001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153371121|NCT04343001|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153371122|NCT04343001|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153371123|NCT04343001|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153371124|NCT04343001|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153371155|NCT04743063|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
153371156|NCT04743063|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
153371157|NCT04743063|Protease Inhibitors|protease inhibitors|mesh-ancestor
153371158|NCT04743063|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153371177|NCT01740713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153371179|NCT02613117|Tin Fluorides|tin fluorides|mesh-list
153371180|NCT02613117|Cariostatic Agents|cariostatic agents|mesh-ancestor
153371181|NCT02613117|Protective Agents|protective agents|mesh-ancestor
153831133|NCT05915104|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153831135|NCT05893225|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153831136|NCT05893225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153831137|NCT05851508|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
153831138|NCT05851508|Methylprednisolone|methylprednisolone|mesh-list
153831139|NCT05851508|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
153831140|NCT05851508|Prednisolone|prednisolone|mesh-list
153831141|NCT05851508|Prednisolone acetate|prednisolone acetate|mesh-list
153831142|NCT05851508|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
153831143|NCT05851508|Prednisolone phosphate|prednisolone phosphate|mesh-list
153371260|NCT01243580|Contraceptives, Oral|contraceptives, oral|mesh-list
153371261|NCT01243580|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153371262|NCT01243580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153831211|NCT05638633|Prednisolone acetate|prednisolone acetate|mesh-list
153831212|NCT05638633|Corticosterone|corticosterone|mesh-list
153819970|NCT00431171|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153819971|NCT00431171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153819972|NCT00431210|Immunomodulating Agents|immunomodulating agents|mesh-list
153819973|NCT00431210|Immunologic Factors|immunologic factors|mesh-ancestor
153831213|NCT05638633|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
153466169|NCT00344370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153466173|NCT00344682|Memantine|memantine|mesh-list
153831214|NCT05638633|Prednisolone phosphate|prednisolone phosphate|mesh-list
153831220|NCT05638633|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153831226|NCT05638633|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153371334|NCT01307462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153371336|NCT05731089|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153371337|NCT05731089|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153371338|NCT05731089|Growth Substances|growth substances|mesh-ancestor
153371339|NCT05731089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153371340|NCT05731089|Growth Inhibitors|growth inhibitors|mesh-ancestor
153371341|NCT05731089|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153371343|NCT01307618|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153371344|NCT01307618|Immunologic Factors|immunologic factors|mesh-ancestor
153371363|NCT05730777|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153371364|NCT05730777|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153371365|NCT05730777|Tubulin Modulators|tubulin modulators|mesh-ancestor
153371366|NCT05730777|Antimitotic Agents|antimitotic agents|mesh-ancestor
153371367|NCT05730777|Mitosis Modulators|mitosis modulators|mesh-ancestor
153371368|NCT05730777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153371369|NCT04425239|Leucovorin|leucovorin|mesh-list
153371370|NCT04425239|Folic Acid|folic acid|mesh-list
153371371|NCT04425239|Fluorouracil|fluorouracil|mesh-list
153371372|NCT04425239|Irinotecan|irinotecan|mesh-list
153371373|NCT04425239|Panitumumab|panitumumab|mesh-list
153831293|NCT05194488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153466338|NCT00354978|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153831294|NCT05194488|Cholinergic Agents|cholinergic agents|mesh-ancestor
153831295|NCT05194488|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153831296|NCT05194488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153831297|NCT05194488|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
153831298|NCT05194488|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153831437|NCT04942626|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
153831438|NCT04942626|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153831439|NCT04942626|Antimetabolites|antimetabolites|mesh-ancestor
153831440|NCT04942626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153831441|NCT04942626|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153831442|NCT04942626|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153831443|NCT04893174|Hyaluronic Acid|hyaluronic acid|mesh-list
153831444|NCT04893174|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153831445|NCT04893174|Immunologic Factors|immunologic factors|mesh-ancestor
153831446|NCT04893174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153371534|NCT05081193|Anabolic Agents|anabolic agents|mesh-ancestor
153371536|NCT01349972|Daunorubicin|daunorubicin|mesh-list
153371569|NCT01748045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153371570|NCT01748045|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153371571|NCT01748045|Respiratory System Agents|respiratory system agents|mesh-ancestor
153371572|NCT01748045|Free Radical Scavengers|free radical scavengers|mesh-ancestor
153371573|NCT01748045|Antioxidants|antioxidants|mesh-ancestor
153371574|NCT01748045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153371575|NCT01748045|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153831523|NCT04484337|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-list
153371604|NCT01248416|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153371605|NCT01248416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153371614|NCT01749293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153831550|NCT04473053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153831551|NCT04473053|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
153831552|NCT04473053|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
153831553|NCT04473053|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
153831554|NCT04473053|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153466605|NCT00313560|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153466606|NCT00314106|Aldesleukin|aldesleukin|mesh-list
153831555|NCT04473053|Immunologic Factors|immunologic factors|mesh-ancestor
153831556|NCT04455750|Leuprolide|leuprolide|mesh-list
153831557|NCT04455750|Goserelin|goserelin|mesh-list
153831558|NCT04455750|Rucaparib|rucaparib|mesh-list
153831559|NCT04455750|Fertility Agents, Female|fertility agents, female|mesh-ancestor
153831560|NCT04455750|Fertility Agents|fertility agents|mesh-ancestor
153831622|NCT04177095|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153831623|NCT04177095|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153831624|NCT04158050|Omalizumab|omalizumab|mesh-list
153831625|NCT04158050|Antibodies|antibodies|mesh-list
153831626|NCT04158050|Immunologic Factors|immunologic factors|mesh-ancestor
153831660|NCT04083183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153371731|NCT01250834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153371732|NCT04387695|Sorafenib|sorafenib|mesh-list
153371733|NCT04387695|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153371735|NCT04387695|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153371736|NCT04387695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153371737|NCT01354652|Lamivudine|lamivudine|mesh-list
153371738|NCT01354652|Entecavir|entecavir|mesh-list
153371739|NCT01354652|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153371740|NCT01354652|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153384710|NCT01831232|Cytarabine|cytarabine|mesh-list
153371741|NCT01354652|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153371742|NCT01354652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153371743|NCT01354652|Antiviral Agents|antiviral agents|mesh-ancestor
153371744|NCT01354652|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153371745|NCT01354652|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153466741|NCT00400686|Epoetin Alfa|epoetin alfa|mesh-list
153371746|NCT01354652|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153371747|NCT01753739|Bepotastine besilate|bepotastine besilate|mesh-list
153371748|NCT01753739|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
153371750|NCT01250990|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153371751|NCT01250990|Antimetabolites|antimetabolites|mesh-ancestor
153371752|NCT01250990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153371753|NCT01250990|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153371754|NCT01250990|Vasodilator Agents|vasodilator agents|mesh-ancestor
153371755|NCT01250990|Vitamin B Complex|vitamin b complex|mesh-ancestor
153371756|NCT01250990|Vitamins|vitamins|mesh-ancestor
153371757|NCT01250990|Micronutrients|micronutrients|mesh-ancestor
153371758|NCT01250990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153371759|NCT02990975|Ketamine|ketamine|mesh-list
153371760|NCT02990975|Analgesics|analgesics|mesh-ancestor
153371761|NCT02990975|Sensory System Agents|sensory system agents|mesh-ancestor
153831704|NCT04052334|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153831705|NCT04052334|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153831726|NCT03871361|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153831727|NCT03871361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153831728|NCT03871361|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153831730|NCT03871361|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153831756|NCT03559413|Immunomodulating Agents|immunomodulating agents|mesh-ancestor
153831757|NCT03559413|Immunologic Factors|immunologic factors|mesh-ancestor
153831758|NCT03559413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153831759|NCT03559413|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153831760|NCT03559413|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153831761|NCT03559413|Interferon Inducers|interferon inducers|mesh-ancestor
153831763|NCT03467867|Venetoclax|venetoclax|mesh-list
153371817|NCT02242409|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
153371818|NCT02242409|Gemcitabine|gemcitabine|mesh-list
153466831|NCT00381810|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153466832|NCT00381810|Anesthetics, Local|anesthetics, local|mesh-ancestor
153371819|NCT02242409|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153371820|NCT02242409|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153371854|NCT04246619|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153371855|NCT04246619|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
153371856|NCT04246619|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153371857|NCT04246619|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153371858|NCT04246619|Antidepressive Agents|antidepressive agents|mesh-ancestor
153371859|NCT04246619|Dopamine Agents|dopamine agents|mesh-ancestor
153371860|NCT01757561|Propofol|propofol|mesh-list
153371861|NCT01757561|Sevoflurane|sevoflurane|mesh-list
153371862|NCT01757561|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153371863|NCT01757561|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153831806|NCT03215706|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153831807|NCT03215706|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153831808|NCT03215706|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153831809|NCT03215706|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153831810|NCT03215706|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153831811|NCT03214354|Sirolimus|sirolimus|mesh-list
153831812|NCT03214354|Alemtuzumab|alemtuzumab|mesh-list
153831813|NCT03214354|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153831862|NCT02872116|Leucovorin|leucovorin|mesh-list
153831871|NCT02872116|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153831872|NCT02872116|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153831874|NCT02872116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153831875|NCT02872116|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153831876|NCT02872116|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153831877|NCT02872116|Antidotes|antidotes|mesh-ancestor
153831878|NCT02872116|Protective Agents|protective agents|mesh-ancestor
153831879|NCT02872116|Vitamin B Complex|vitamin b complex|mesh-ancestor
153831880|NCT02872116|Vitamins|vitamins|mesh-ancestor
153831881|NCT02872116|Micronutrients|micronutrients|mesh-ancestor
153467069|NCT00412074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153467070|NCT00412074|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153831882|NCT02867384|Obinutuzumab|obinutuzumab|mesh-list
153831883|NCT02867384|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153831884|NCT02867384|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153831885|NCT02852486|Pioglitazone|pioglitazone|mesh-list
153831886|NCT02852486|Imatinib Mesylate|imatinib mesylate|mesh-list
153371931|NCT01251536|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153371932|NCT01251536|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153371933|NCT02620683|Lidocaine|lidocaine|mesh-list
153371934|NCT02620683|Anesthetics, Local|anesthetics, local|mesh-ancestor
153831887|NCT02852486|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153831888|NCT02852486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153831916|NCT02363374|Vitamin B Complex|vitamin b complex|mesh-ancestor
153371960|NCT01355588|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153371962|NCT01355588|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153371963|NCT01355588|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153371964|NCT01355588|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153371965|NCT01355588|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153371966|NCT02621619|Acetaminophen|acetaminophen|mesh-list
153371967|NCT02621619|Hydromorphone|hydromorphone|mesh-list
153371968|NCT02621619|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153371969|NCT02621619|Analgesics|analgesics|mesh-ancestor
153371970|NCT02621619|Sensory System Agents|sensory system agents|mesh-ancestor
153371971|NCT02621619|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153371972|NCT02621619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153371973|NCT02621619|Antipyretics|antipyretics|mesh-ancestor
153372008|NCT02623803|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153372009|NCT02623803|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153372010|NCT02623803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153832050|NCT00732212|Coagulants|coagulants|mesh-ancestor
153832051|NCT00592280|Pancrelipase|pancrelipase|mesh-list
153832052|NCT00592280|Pancreatin|pancreatin|mesh-list
153832053|NCT00592280|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153832054|NCT00589875|Valacyclovir|valacyclovir|mesh-list
153832055|NCT00589875|Temozolomide|temozolomide|mesh-list
153832056|NCT00589875|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153832057|NCT00589875|Alkylating Agents|alkylating agents|mesh-ancestor
153372099|NCT01322048|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153372100|NCT01322048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153372101|NCT01322048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153832071|NCT00503594|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153832072|NCT00503594|Antimetabolites|antimetabolites|mesh-ancestor
153832073|NCT00503594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153832074|NCT00503594|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153832075|NCT00503594|Dermatologic Agents|dermatologic agents|mesh-ancestor
153832076|NCT00503594|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153832077|NCT00503594|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153832136|NCT00506727|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
153819974|NCT00431210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153819975|NCT00431249|Cilostazol|cilostazol|mesh-list
153819976|NCT00431249|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153819977|NCT00431249|Autonomic Agents|autonomic agents|mesh-ancestor
153819978|NCT00431249|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153819979|NCT00431249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153819980|NCT00431249|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153819981|NCT00431249|Respiratory System Agents|respiratory system agents|mesh-ancestor
153819982|NCT00431249|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153819983|NCT00431249|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153819984|NCT00431249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153819985|NCT00431249|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153819986|NCT00431249|Vasodilator Agents|vasodilator agents|mesh-ancestor
153819987|NCT00431249|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
153819988|NCT00431249|Protective Agents|protective agents|mesh-ancestor
153372184|NCT03684785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153372187|NCT01364558|Anticonvulsants|anticonvulsants|mesh-ancestor
153372188|NCT01364558|Antiemetics|antiemetics|mesh-ancestor
153372189|NCT01364558|Autonomic Agents|autonomic agents|mesh-ancestor
153372190|NCT01364558|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153372191|NCT01364558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153372192|NCT01364558|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153372193|NCT01364558|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153372194|NCT01364558|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153372195|NCT01364558|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
153832139|NCT00506727|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153832143|NCT00506727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153832144|NCT00506727|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
153467534|NCT00538824|Hormones|hormones|mesh-ancestor
153467620|NCT03117660|Vitamin A|vitamin a|mesh-list
153832146|NCT00506727|Autonomic Agents|autonomic agents|mesh-ancestor
153832147|NCT00506727|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153832148|NCT00506727|Dopamine Agents|dopamine agents|mesh-ancestor
153832149|NCT00506727|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
153832171|NCT03458247|Abiraterone Acetate|abiraterone acetate|mesh-list
153832172|NCT03458247|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153832173|NCT03458247|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153832174|NCT03458247|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153415262|NCT00367471|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153372251|NCT01260662|Sensory System Agents|sensory system agents|mesh-ancestor
153372252|NCT01260662|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153372253|NCT01260662|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
153372254|NCT01260662|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
153372255|NCT01260662|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
153372256|NCT01260662|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153819989|NCT00431249|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
153819990|NCT00431249|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
153819991|NCT00431249|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153372263|NCT02327117|Coagulants|coagulants|mesh-ancestor
153372264|NCT01365650|Fluticasone|fluticasone|mesh-list
153372265|NCT01365650|Xhance|xhance|mesh-list
153372266|NCT01365650|Ketorolac|ketorolac|mesh-list
153832201|NCT00507585|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153832203|NCT00507585|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153467778|NCT00449046|Autonomic Agents|autonomic agents|mesh-ancestor
153832204|NCT00507585|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153832205|NCT00507585|Growth Substances|growth substances|mesh-ancestor
153832206|NCT00507585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153832207|NCT00507585|Growth Inhibitors|growth inhibitors|mesh-ancestor
153832208|NCT00507585|Antimetabolites|antimetabolites|mesh-ancestor
153832209|NCT00507585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153832210|NCT00507585|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153832211|NCT00507585|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153832212|NCT00507585|Immunologic Factors|immunologic factors|mesh-ancestor
153832213|NCT00507585|Antidotes|antidotes|mesh-ancestor
153832214|NCT00507585|Protective Agents|protective agents|mesh-ancestor
153832215|NCT00507585|Vitamin B Complex|vitamin b complex|mesh-ancestor
153832216|NCT00507585|Vitamins|vitamins|mesh-ancestor
153832217|NCT00507585|Micronutrients|micronutrients|mesh-ancestor
153832218|NCT01247714|Phentermine|phentermine|mesh-list
153832219|NCT01247714|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
153832220|NCT01247714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153832221|NCT01247714|Appetite Depressants|appetite depressants|mesh-ancestor
153372268|NCT01365650|Phenylephrine|phenylephrine|mesh-list
153372269|NCT01365650|Oxymetazoline|oxymetazoline|mesh-list
153372270|NCT01365650|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153372271|NCT01365650|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153372272|NCT01365650|Autonomic Agents|autonomic agents|mesh-ancestor
153372274|NCT01365650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153372288|NCT01365650|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153372289|NCT01365650|Adrenergic Agents|adrenergic agents|mesh-ancestor
153372290|NCT01365650|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153372291|NCT01365650|Sympathomimetics|sympathomimetics|mesh-ancestor
153372292|NCT01365650|Nasal Decongestants|nasal decongestants|mesh-ancestor
153372293|NCT01365650|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
153372294|NCT01365650|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
153372296|NCT01365650|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
153372297|NCT01365650|Protective Agents|protective agents|mesh-ancestor
153832255|NCT00508326|Mitosis Modulators|mitosis modulators|mesh-ancestor
153832256|NCT00508326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153832258|NCT00507858|Pemetrexed|pemetrexed|mesh-list
153372365|NCT05167643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153372366|NCT05167643|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
153372367|NCT05167643|Hormone Antagonists|hormone antagonists|mesh-ancestor
153372386|NCT01366976|Analgesics|analgesics|mesh-ancestor
153372387|NCT01366976|Sensory System Agents|sensory system agents|mesh-ancestor
153372388|NCT01366976|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153832346|NCT02954484|Analgesics|analgesics|mesh-ancestor
153832347|NCT02954484|Sensory System Agents|sensory system agents|mesh-ancestor
153832348|NCT02954484|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153832349|NCT02954484|Anesthetics, Local|anesthetics, local|mesh-ancestor
153832350|NCT02954484|Anesthetics|anesthetics|mesh-ancestor
153832351|NCT02954484|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153832352|NCT02954484|Antipyretics|antipyretics|mesh-ancestor
153832353|NCT02954484|Anticonvulsants|anticonvulsants|mesh-ancestor
153832354|NCT02954484|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153832355|NCT02954484|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153832356|NCT02954484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153372437|NCT01778465|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153372438|NCT01778465|Antifungal Agents|antifungal agents|mesh-ancestor
153372439|NCT01778465|Keratolytic Agents|keratolytic agents|mesh-ancestor
153372440|NCT01778465|Dermatologic Agents|dermatologic agents|mesh-ancestor
153372508|NCT01783847|Hormones|hormones|mesh-ancestor
153372509|NCT01783847|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153372510|NCT01783847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153372511|NCT01783847|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153372512|NCT01783847|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153372513|NCT01783847|Antiemetics|antiemetics|mesh-ancestor
153372514|NCT01783847|Autonomic Agents|autonomic agents|mesh-ancestor
153372515|NCT01783847|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153832460|NCT02274974|Anesthetics|anesthetics|mesh-list
153832461|NCT02274974|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153832462|NCT02274974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153832463|NCT02274974|Sensory System Agents|sensory system agents|mesh-ancestor
153832464|NCT02274974|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153832465|NCT02274974|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153832466|NCT02274974|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
153832467|NCT02274974|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153832468|NCT02274974|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153832469|NCT02274974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153832470|NCT02274974|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153832475|NCT02274974|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153832476|NCT02274974|Autonomic Agents|autonomic agents|mesh-ancestor
153832477|NCT02274974|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153832478|NCT02274974|Respiratory System Agents|respiratory system agents|mesh-ancestor
153832479|NCT02274974|Mydriatics|mydriatics|mesh-ancestor
153832480|NCT02274974|Sympathomimetics|sympathomimetics|mesh-ancestor
153372563|NCT02382575|Immunologic Factors|immunologic factors|mesh-ancestor
153372564|NCT02382575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153372565|NCT02382575|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153468176|NCT02128230|Glucocorticoids|glucocorticoids|mesh-ancestor
153372566|NCT02382575|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153372567|NCT02382575|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153372568|NCT02382575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153372570|NCT01807871|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
153372571|NCT01807871|Autonomic Agents|autonomic agents|mesh-ancestor
153832509|NCT00509613|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153832510|NCT00509613|Immunologic Factors|immunologic factors|mesh-ancestor
153832511|NCT00509613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153832512|NCT00501410|Leucovorin|leucovorin|mesh-list
153832513|NCT00501410|Fluorouracil|fluorouracil|mesh-list
153832514|NCT00501410|Oxaliplatin|oxaliplatin|mesh-list
153832515|NCT00501410|Cetuximab|cetuximab|mesh-list
153832528|NCT00501410|Micronutrients|micronutrients|mesh-ancestor
153832553|NCT00508911|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
153832555|NCT02955719|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
153832556|NCT02955719|Antidepressive Agents|antidepressive agents|mesh-ancestor
153832557|NCT02955719|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153832558|NCT02955719|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
153832559|NCT02955719|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153832560|NCT02955719|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153832561|NCT02955719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153832562|NCT02955719|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153832563|NCT02955719|Serotonin Agents|serotonin agents|mesh-ancestor
153372624|NCT01267136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153832572|NCT02955524|Anesthetics, Local|anesthetics, local|mesh-ancestor
153832573|NCT02955524|Anesthetics|anesthetics|mesh-ancestor
153832574|NCT02955524|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153832575|NCT02955524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153468357|NCT06297915|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153832576|NCT02955524|Sensory System Agents|sensory system agents|mesh-ancestor
153832577|NCT02955524|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153832578|NCT02955524|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153832579|NCT02955524|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
153832580|NCT02955524|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153372662|NCT01371110|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153372663|NCT01371110|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153372664|NCT01371110|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153372665|NCT01371110|GABA Modulators|gaba modulators|mesh-ancestor
153372666|NCT01371110|GABA Agents|gaba agents|mesh-ancestor
153372667|NCT01791491|Abatacept|abatacept|mesh-list
153372668|NCT01791491|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153372669|NCT01791491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153832621|NCT02952573|Autonomic Agents|autonomic agents|mesh-ancestor
153832622|NCT02952573|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153832623|NCT02952573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153832624|NCT02952573|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153832625|NCT02952573|Glucocorticoids|glucocorticoids|mesh-ancestor
153832627|NCT02952573|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153832628|NCT02952573|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153832629|NCT02952573|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153832630|NCT02952573|Protease Inhibitors|protease inhibitors|mesh-ancestor
153832631|NCT02952573|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153832632|NCT02952573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153832633|NCT00501722|Satavaptan|satavaptan|mesh-list
153372720|NCT01373450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153372721|NCT01373450|Incretins|incretins|mesh-ancestor
153372722|NCT01373450|Hormones|hormones|mesh-ancestor
153832640|NCT01248611|Narcotics|narcotics|mesh-ancestor
153832672|NCT00501839|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
153819992|NCT00470886|Telmisartan|telmisartan|mesh-list
153819993|NCT00470886|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153819999|NCT00431522|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153820000|NCT00431522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153832719|NCT00502034|Interferons|interferons|mesh-list
153832720|NCT00502034|Interferon-alpha|interferon-alpha|mesh-list
153832721|NCT00502034|Interferon alpha-2|interferon alpha-2|mesh-list
153832722|NCT00502034|Interleukin-2|interleukin-2|mesh-list
153832723|NCT00502034|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153832724|NCT00502034|Antiviral Agents|antiviral agents|mesh-ancestor
153372799|NCT01812005|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153372801|NCT01812005|Immunologic Factors|immunologic factors|mesh-ancestor
153372802|NCT01812005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153372803|NCT01812005|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153372804|NCT01332578|Acetaminophen|acetaminophen|mesh-list
153372805|NCT01332578|Ascorbic Acid|ascorbic acid|mesh-list
153372806|NCT01332578|Phenylephrine|phenylephrine|mesh-list
153372807|NCT01332578|Oxymetazoline|oxymetazoline|mesh-list
153372808|NCT01332578|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153372809|NCT01332578|Analgesics|analgesics|mesh-ancestor
153372810|NCT01332578|Sensory System Agents|sensory system agents|mesh-ancestor
153372811|NCT01332578|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153372812|NCT01332578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153372813|NCT01332578|Antipyretics|antipyretics|mesh-ancestor
153372814|NCT01332578|Antioxidants|antioxidants|mesh-ancestor
153372815|NCT01332578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153372816|NCT01332578|Protective Agents|protective agents|mesh-ancestor
153372817|NCT01332578|Vitamins|vitamins|mesh-ancestor
153468813|NCT06018623|Anesthetics|anesthetics|mesh-list
153372818|NCT01332578|Micronutrients|micronutrients|mesh-ancestor
153832778|NCT01248923|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153832779|NCT01248923|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153372862|NCT01734161|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153372863|NCT01734161|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153832827|NCT00502268|Ergocalciferols|ergocalciferols|mesh-list
153832828|NCT00502268|Vitamins|vitamins|mesh-ancestor
153832861|NCT02952807|Oxytocics|oxytocics|mesh-ancestor
153832862|NCT02275130|Calcium, Dietary|calcium, dietary|mesh-list
153832863|NCT02275130|Calcium|calcium|mesh-list
153832864|NCT02275130|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153832865|NCT02275130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153372943|NCT01378988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153372945|NCT01335620|Emtricitabine|emtricitabine|mesh-list
153372946|NCT01335620|Raltegravir Potassium|raltegravir potassium|mesh-list
153372947|NCT01335620|Antiviral Agents|antiviral agents|mesh-ancestor
153372948|NCT01335620|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153832900|NCT01249430|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153832901|NCT01249430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153832902|NCT01249430|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153832903|NCT01249430|Antimetabolites|antimetabolites|mesh-ancestor
153832904|NCT01249430|Antiviral Agents|antiviral agents|mesh-ancestor
153832905|NCT01249430|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153832906|NCT01249430|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153832907|NCT01249430|Immunologic Factors|immunologic factors|mesh-ancestor
153832908|NCT01249430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153832909|NCT01249430|Analgesics|analgesics|mesh-ancestor
153832910|NCT01249430|Sensory System Agents|sensory system agents|mesh-ancestor
153832911|NCT01249430|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153832912|NCT02952963|Chenodeoxycholic Acid|chenodeoxycholic acid|mesh-list
153832913|NCT02952963|Colesevelam Hydrochloride|colesevelam hydrochloride|mesh-list
153832914|NCT02952963|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153468978|NCT05742438|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
153468980|NCT05742438|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153832915|NCT02952963|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153832916|NCT02952963|Antimetabolites|antimetabolites|mesh-ancestor
153832917|NCT02952963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153833030|NCT00511446|Antimitotic Agents|antimitotic agents|mesh-ancestor
153373111|NCT02023593|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153373112|NCT02023593|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153833072|NCT02951754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153833073|NCT02951754|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
153833074|NCT02951754|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153833075|NCT02951754|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153833076|NCT02951754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153373154|NCT02685267|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153373175|NCT00368121|Autonomic Agents|autonomic agents|mesh-ancestor
153833131|NCT00513162|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153833132|NCT00513162|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153833133|NCT00513162|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153833134|NCT00513162|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153833153|NCT00512265|Respiratory System Agents|respiratory system agents|mesh-ancestor
153833168|NCT00513396|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153833169|NCT01249274|Progesterone|progesterone|mesh-list
153833170|NCT01249274|Progestins|progestins|mesh-ancestor
153833171|NCT01249274|Hormones|hormones|mesh-ancestor
153833188|NCT00504959|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153373281|NCT01547741|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153373282|NCT01547741|Alkylating Agents|alkylating agents|mesh-ancestor
153373283|NCT01547741|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153833239|NCT00513786|Mitosis Modulators|mitosis modulators|mesh-ancestor
153373288|NCT01390064|Monatide (IMS 3015)|monatide (ims 3015)|mesh-list
153373289|NCT01390064|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153373290|NCT01390064|Immunologic Factors|immunologic factors|mesh-ancestor
153373291|NCT01390064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153373293|NCT01473368|Clavulanic Acid|clavulanic acid|mesh-list
153373314|NCT01391312|Cholinergic Agents|cholinergic agents|mesh-ancestor
153373315|NCT01391312|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153373316|NCT01391312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153373318|NCT01391312|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153373319|NCT03008252|Caseins|caseins|mesh-list
153373320|NCT03008252|Chelating Agents|chelating agents|mesh-ancestor
153373321|NCT03008252|Sequestering Agents|sequestering agents|mesh-ancestor
153833263|NCT00513864|Codeine|codeine|mesh-list
153833264|NCT00513864|Dextromethorphan|dextromethorphan|mesh-list
153833265|NCT00513864|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153833266|NCT00513864|Narcotics|narcotics|mesh-ancestor
153833267|NCT00513864|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153833268|NCT00513864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153833269|NCT00513864|Analgesics|analgesics|mesh-ancestor
153833288|NCT00512928|Vitamin K|vitamin k|mesh-list
153833289|NCT00512928|Acenocoumarol|acenocoumarol|mesh-list
153833290|NCT00512928|Menaquinone 7|menaquinone 7|mesh-list
153833291|NCT00512928|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
153833292|NCT00512928|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153833293|NCT00512928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153833294|NCT00512928|Hemostatics|hemostatics|mesh-ancestor
153833295|NCT00512928|Coagulants|coagulants|mesh-ancestor
153833296|NCT00512928|Vitamins|vitamins|mesh-ancestor
153833297|NCT00512928|Micronutrients|micronutrients|mesh-ancestor
153833298|NCT00512928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153833299|NCT00512928|Anticoagulants|anticoagulants|mesh-ancestor
153833300|NCT00505154|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
153833301|NCT00505154|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153833302|NCT00505154|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153833332|NCT00513981|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153373373|NCT02249663|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153833453|NCT01243268|Telmisartan amlodipine combination|telmisartan amlodipine combination|mesh-list
153833454|NCT01243268|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153833455|NCT01243268|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
153833456|NCT01243268|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
153833475|NCT00515151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153833476|NCT01241786|Lenalidomide|lenalidomide|mesh-list
153833477|NCT01241786|Azacitidine|azacitidine|mesh-list
153373517|NCT02698215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153373518|NCT02698215|Sensory System Agents|sensory system agents|mesh-ancestor
153373538|NCT04172961|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
153373539|NCT04172961|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
153461736|NCT03193866|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
153833499|NCT01241318|Disinfectants|disinfectants|mesh-ancestor
153833500|NCT01241318|Dermatologic Agents|dermatologic agents|mesh-ancestor
153833501|NCT00514488|Imatinib Mesylate|imatinib mesylate|mesh-list
153833502|NCT00514488|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153833503|NCT00514488|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153833504|NCT00514488|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153469118|NCT05555615|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
153833505|NCT00514488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153833506|NCT00514488|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153833530|NCT02950623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153833531|NCT02950623|Dermatologic Agents|dermatologic agents|mesh-ancestor
153833532|NCT02950623|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
153833533|NCT00516009|Dexamethasone|dexamethasone|mesh-list
153833534|NCT00516009|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153833535|NCT00516009|Antiemetics|antiemetics|mesh-ancestor
153833536|NCT00516009|Autonomic Agents|autonomic agents|mesh-ancestor
153373574|NCT02701257|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153373575|NCT02701257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153373576|NCT02701257|Incretins|incretins|mesh-ancestor
153373577|NCT01836029|Carboplatin|carboplatin|mesh-list
153373578|NCT01836029|Fluorouracil|fluorouracil|mesh-list
153373579|NCT01836029|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153373580|NCT01836029|Antimetabolites|antimetabolites|mesh-ancestor
153373581|NCT01836029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153373582|NCT01836029|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153373583|NCT01836029|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153373584|NCT01836029|Immunologic Factors|immunologic factors|mesh-ancestor
153373585|NCT01836029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153373586|NCT02703909|Rocuronium|rocuronium|mesh-list
153626847|NCT02019329|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
153626848|NCT02019329|Dopamine Agents|dopamine agents|mesh-ancestor
153626849|NCT02019355|Fluorouracil|fluorouracil|mesh-list
153373587|NCT02703909|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
153373588|NCT02703909|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
153373589|NCT02703909|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
153373590|NCT02703909|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153373637|NCT03349281|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153373638|NCT03349281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153373639|NCT03349281|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153373640|NCT03349281|Glucocorticoids|glucocorticoids|mesh-ancestor
153833592|NCT01244828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153833593|NCT01244828|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153833594|NCT00504192|Gemcitabine|gemcitabine|mesh-list
153833595|NCT00504192|Oxaliplatin|oxaliplatin|mesh-list
153833596|NCT00504192|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153833597|NCT00504192|Antimetabolites|antimetabolites|mesh-ancestor
153833598|NCT00504192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153833599|NCT00504192|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153833600|NCT01243346|Crenolanib|crenolanib|mesh-list
153833601|NCT01243346|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153833602|NCT01249443|Paclitaxel|paclitaxel|mesh-list
153833603|NCT01249443|Carboplatin|carboplatin|mesh-list
153627000|NCT02020200|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153833604|NCT01249443|Vorinostat|vorinostat|mesh-list
153833605|NCT01249443|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153833606|NCT01249443|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153833607|NCT01249443|Tubulin Modulators|tubulin modulators|mesh-ancestor
153833608|NCT01249443|Antimitotic Agents|antimitotic agents|mesh-ancestor
153833609|NCT01249443|Mitosis Modulators|mitosis modulators|mesh-ancestor
153833610|NCT01249443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153833640|NCT00516282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153373680|NCT03206151|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153373681|NCT03206151|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153373682|NCT03206151|Antidotes|antidotes|mesh-ancestor
153373683|NCT03206151|Protective Agents|protective agents|mesh-ancestor
153373684|NCT03206151|Vitamin B Complex|vitamin b complex|mesh-ancestor
153627097|NCT02021097|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153627098|NCT02021097|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
153373686|NCT03206151|Micronutrients|micronutrients|mesh-ancestor
153833641|NCT00516282|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153833642|NCT01249521|Bevacizumab|bevacizumab|mesh-list
153833644|NCT01249521|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153833645|NCT01249521|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153833646|NCT01249521|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153373716|NCT04795583|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153373717|NCT04795583|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153373719|NCT02722239|Dapagliflozin|dapagliflozin|mesh-list
153373720|NCT02722239|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153373721|NCT02722239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153627099|NCT02021097|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
153373722|NCT02722239|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
153373723|NCT02722239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153373724|NCT02578641|Carboplatin|carboplatin|mesh-list
153373725|NCT02578641|Gemcitabine|gemcitabine|mesh-list
153373726|NCT02578641|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153373727|NCT02578641|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153373728|NCT02578641|Antimetabolites|antimetabolites|mesh-ancestor
153833678|NCT01244256|Clotrimazole|clotrimazole|mesh-list
153373759|NCT01848041|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153373760|NCT01848041|Adrenergic Agents|adrenergic agents|mesh-ancestor
153627265|NCT02022293|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153627266|NCT02022293|Antimetabolites|antimetabolites|mesh-ancestor
153627267|NCT02022293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153627268|NCT02022293|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153627271|NCT02022358|Leucovorin|leucovorin|mesh-list
153373761|NCT01848041|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153373762|NCT01848041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153373763|NCT01848041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153373764|NCT01848041|Sympathomimetics|sympathomimetics|mesh-ancestor
153373765|NCT01848041|Autonomic Agents|autonomic agents|mesh-ancestor
153373766|NCT01848041|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153373767|NCT01848041|Nasal Decongestants|nasal decongestants|mesh-ancestor
153373768|NCT01848041|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
153833717|NCT01249404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153833735|NCT04519385|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153833736|NCT04519385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153833737|NCT04519385|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153833738|NCT04519385|Glucocorticoids|glucocorticoids|mesh-ancestor
153373815|NCT02724423|Anesthetics, General|anesthetics, general|mesh-ancestor
153373816|NCT02724423|Anesthetics|anesthetics|mesh-ancestor
153373817|NCT02724423|GABA Modulators|gaba modulators|mesh-ancestor
153373818|NCT02724423|GABA Agents|gaba agents|mesh-ancestor
153373819|NCT02724423|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153627452|NCT02023359|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153373820|NCT02724423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153373821|NCT02989259|Apatinib|apatinib|mesh-list
153373822|NCT02989259|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153373823|NCT02989259|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153373824|NCT02989259|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153373849|NCT01852019|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
153373902|NCT02401230|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153373903|NCT02401230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153373904|NCT02401230|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153627691|NCT02024659|Budesonide|budesonide|mesh-list
153373905|NCT02401230|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153373906|NCT01854359|Idebenone|idebenone|mesh-list
153373907|NCT01854359|Antioxidants|antioxidants|mesh-ancestor
153373908|NCT01854359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153373909|NCT01854359|Protective Agents|protective agents|mesh-ancestor
153373910|NCT01854359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153373911|NCT01854593|Bevacizumab|bevacizumab|mesh-list
153373930|NCT02734953|Respiratory System Agents|respiratory system agents|mesh-ancestor
153627850|NCT02025608|Dexpramipexole|dexpramipexole|mesh-list
153627851|NCT02025608|Antioxidants|antioxidants|mesh-ancestor
153373931|NCT02734953|Free Radical Scavengers|free radical scavengers|mesh-ancestor
153373932|NCT02734953|Antioxidants|antioxidants|mesh-ancestor
153373933|NCT02734953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153373934|NCT02734953|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153373935|NCT02734953|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
153373936|NCT02734953|Vasodilator Agents|vasodilator agents|mesh-ancestor
153373937|NCT02734953|Gasotransmitters|gasotransmitters|mesh-ancestor
153373938|NCT02734953|Protective Agents|protective agents|mesh-ancestor
153373939|NCT02428608|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
153627996|NCT02026492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153627997|NCT02026505|Bortezomib|bortezomib|mesh-list
153373940|NCT02428608|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
153373941|NCT02428608|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153373942|NCT02428608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153833874|NCT01246206|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153833875|NCT01246206|Immunologic Factors|immunologic factors|mesh-ancestor
153833876|NCT01246206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153833877|NCT01246206|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
153833878|NCT01246206|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153833879|NCT01246206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153833880|NCT04510610|Decitabine|decitabine|mesh-list
153833891|NCT01246011|Protease Inhibitors|protease inhibitors|mesh-ancestor
153833892|NCT01246011|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153628208|NCT02027792|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153628209|NCT02027792|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153833893|NCT01246011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153833894|NCT01246011|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153833895|NCT01244490|Guanfacine|guanfacine|mesh-list
153833896|NCT01244490|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
153833897|NCT01244490|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
153833898|NCT01244490|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153833904|NCT01244490|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153833905|NCT01244490|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
153833943|NCT00516438|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
153833944|NCT00516438|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153373993|NCT01421186|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153374015|NCT01860521|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153374016|NCT01860521|Narcotics|narcotics|mesh-ancestor
153374017|NCT01860521|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153628333|NCT02028598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153374018|NCT01860521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153374019|NCT01860521|Analgesics|analgesics|mesh-ancestor
153833961|NCT02950155|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153833962|NCT00516672|Lapatinib|lapatinib|mesh-list
153833963|NCT00516672|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153833964|NCT00516672|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153833965|NCT00516672|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153628334|NCT02028598|Vasodilator Agents|vasodilator agents|mesh-ancestor
153628335|NCT02028598|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
153833966|NCT00516672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153833967|NCT00516672|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153833968|NCT00516711|Sevoflurane|sevoflurane|mesh-list
153833969|NCT00516711|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153833970|NCT00516711|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
153833971|NCT00516711|Anesthetics, General|anesthetics, general|mesh-ancestor
153833972|NCT00516711|Anesthetics|anesthetics|mesh-ancestor
153374061|NCT01485380|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153834026|NCT02950038|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153834028|NCT04510220|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153834029|NCT02949648|Nicotine|nicotine|mesh-list
153834030|NCT02949648|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
153834031|NCT02949648|Autonomic Agents|autonomic agents|mesh-ancestor
153834032|NCT02949648|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153834033|NCT02949648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153834034|NCT02949648|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
153834035|NCT02949648|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
153834036|NCT02949648|Cholinergic Agents|cholinergic agents|mesh-ancestor
153628489|NCT02029573|Alkylating Agents|alkylating agents|mesh-ancestor
153628490|NCT02029573|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153834037|NCT02949648|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153834046|NCT04510337|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153834047|NCT04510337|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153834049|NCT04510337|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153374126|NCT01422434|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153374127|NCT01861457|Anti-Infective Agents, Local|anti-infective agents, local|mesh-list
153374128|NCT01861457|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153374130|NCT02270255|Ropivacaine|ropivacaine|mesh-list
153374131|NCT02270255|Anesthetics, Local|anesthetics, local|mesh-ancestor
153834052|NCT04510337|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153834053|NCT04510337|Tocolytic Agents|tocolytic agents|mesh-ancestor
153834054|NCT04510337|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153834055|NCT04510337|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
153628567|NCT02029950|Idarubicin|idarubicin|mesh-list
153628568|NCT02029950|Etoposide phosphate|etoposide phosphate|mesh-list
153834056|NCT04510337|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
153834057|NCT04510337|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
153834059|NCT02949765|Trace Elements|trace elements|mesh-ancestor
153834060|NCT02949765|Micronutrients|micronutrients|mesh-ancestor
153834061|NCT02949765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153834062|NCT04518176|Oxytocin|oxytocin|mesh-list
153834063|NCT04518176|Oxytocics|oxytocics|mesh-ancestor
153834064|NCT04518176|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153834065|NCT04518176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153834066|NCT00516945|Lamivudine|lamivudine|mesh-list
153834067|NCT00516945|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153374133|NCT02270255|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153374134|NCT02270255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153374135|NCT02270255|Sensory System Agents|sensory system agents|mesh-ancestor
153374136|NCT02270255|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153374137|NCT02270255|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153374138|NCT02270255|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
153374139|NCT02270255|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153628681|NCT02034253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153374140|NCT02270255|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153374141|NCT02270255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153374142|NCT02651259|Vitamins|vitamins|mesh-list
153374143|NCT02651259|Pyridoxine|pyridoxine|mesh-list
153374144|NCT02651259|Pyridoxal|pyridoxal|mesh-list
153374152|NCT02651259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153374153|NCT02651259|Antitubercular Agents|antitubercular agents|mesh-ancestor
153374154|NCT02651259|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153374155|NCT02651259|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153374156|NCT02651259|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
153374158|NCT02651259|Antimetabolites|antimetabolites|mesh-ancestor
153374159|NCT02651259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153374160|NCT02651259|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153628837|NCT02040441|Natriuretic Agents|natriuretic agents|mesh-ancestor
153628838|NCT02040454|Paclitaxel|paclitaxel|mesh-list
153628839|NCT02040454|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153628840|NCT02040454|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153374161|NCT02651259|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
153374162|NCT02651259|Leprostatic Agents|leprostatic agents|mesh-ancestor
153374163|NCT02651259|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153374164|NCT02271425|Evacetrapib|evacetrapib|mesh-list
153834079|NCT02275598|Immunoconjugates|immunoconjugates|mesh-ancestor
153834080|NCT02275598|Immunologic Factors|immunologic factors|mesh-ancestor
153834081|NCT02275598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153834083|NCT00517062|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153834084|NCT00517062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153834085|NCT00517179|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
153834086|NCT00517179|Vasodilator Agents|vasodilator agents|mesh-ancestor
153834087|NCT00517179|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
153834088|NCT00517179|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
153834089|NCT00517179|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153834090|NCT00517179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153834091|NCT00517179|Urological Agents|urological agents|mesh-ancestor
153834092|NCT00517218|Oblimersen|oblimersen|mesh-list
153834093|NCT00517218|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153834094|NCT00506207|Oxaliplatin|oxaliplatin|mesh-list
153834095|NCT00506207|Irinotecan|irinotecan|mesh-list
153834096|NCT00506207|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153834097|NCT00506207|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
153834098|NCT00506207|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153834099|NCT00506207|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153834100|NCT00506207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153834101|NCT00517257|Atorvastatin|atorvastatin|mesh-list
153834102|NCT00517257|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153834103|NCT00517257|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153834104|NCT00517257|Antimetabolites|antimetabolites|mesh-ancestor
153834105|NCT00517257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153834106|NCT00517257|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153834107|NCT00517257|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
153834108|NCT00517257|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153834109|NCT00506246|Propofol|propofol|mesh-list
153628975|NCT02041117|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153834110|NCT00506246|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153374165|NCT02271425|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153374166|NCT02271425|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153374167|NCT02271425|Antimetabolites|antimetabolites|mesh-ancestor
153374168|NCT02271425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153374189|NCT02651415|Protease Inhibitors|protease inhibitors|mesh-ancestor
153374190|NCT02651415|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153374191|NCT02651415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153374192|NCT02651415|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153374193|NCT00555425|Buprenorphine|buprenorphine|mesh-list
153374194|NCT00555425|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
153374195|NCT00555425|Naloxone|naloxone|mesh-list
153834111|NCT00506246|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153834112|NCT00506246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153834113|NCT00506246|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153834114|NCT00506246|Anesthetics, General|anesthetics, general|mesh-ancestor
153834115|NCT00506246|Anesthetics|anesthetics|mesh-ancestor
153834116|NCT01243242|Metadoxine|metadoxine|mesh-list
153834117|NCT01243242|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
153834123|NCT04517201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153834124|NCT01241292|Elotuzumab|elotuzumab|mesh-list
153834125|NCT01241292|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153834126|NCT00517725|Carvedilol|carvedilol|mesh-list
153834127|NCT00517725|Nebivolol|nebivolol|mesh-list
153834128|NCT00517725|Bisoprolol|bisoprolol|mesh-list
153834129|NCT00517725|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
153834130|NCT00517725|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
153834131|NCT00517725|Adrenergic Agents|adrenergic agents|mesh-ancestor
153834132|NCT00517725|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153629132|NCT02042690|Hormones|hormones|mesh-ancestor
153629134|NCT02042690|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153834133|NCT00517725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153834134|NCT00517725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153834135|NCT00517725|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153834136|NCT00517725|Antioxidants|antioxidants|mesh-ancestor
153834137|NCT00517725|Protective Agents|protective agents|mesh-ancestor
153834138|NCT00517725|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153834139|NCT00517725|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153834140|NCT00517725|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153834141|NCT00517725|Vasodilator Agents|vasodilator agents|mesh-ancestor
153834142|NCT00517725|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
153834143|NCT00517725|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
153834144|NCT00517725|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
153834145|NCT00517725|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
153834146|NCT00517725|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153834147|NCT00517725|Sympatholytics|sympatholytics|mesh-ancestor
153629238|NCT02043886|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153629239|NCT02043886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153834148|NCT00517725|Autonomic Agents|autonomic agents|mesh-ancestor
153834149|NCT00517725|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153834150|NCT00517725|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
153834151|NCT01240863|Hydrocodone|hydrocodone|mesh-list
153834152|NCT01240863|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153834153|NCT01240863|Narcotics|narcotics|mesh-ancestor
153374208|NCT04338633|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153374210|NCT04338633|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153374211|NCT01488188|Vaccines|vaccines|mesh-list
153374212|NCT01488188|Immunologic Factors|immunologic factors|mesh-ancestor
153629319|NCT02044250|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153374213|NCT01488188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153374214|NCT01489670|Bimatoprost|bimatoprost|mesh-list
153374215|NCT01489670|Ophthalmic Solutions|ophthalmic solutions|mesh-list
153374216|NCT01489670|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
153374217|NCT01489670|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153374218|NCT01427504|Etravirine|etravirine|mesh-list
153374219|NCT01427504|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153374220|NCT01427504|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153374221|NCT01427504|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153374222|NCT01427504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153374223|NCT01427504|Antiviral Agents|antiviral agents|mesh-ancestor
153374224|NCT01427504|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153629449|NCT02045368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153374225|NCT02265965|Nitroglycerin|nitroglycerin|mesh-list
153374226|NCT02265965|Vasodilator Agents|vasodilator agents|mesh-ancestor
153374228|NCT03021083|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153374229|NCT03021083|Narcotics|narcotics|mesh-ancestor
153374230|NCT03021083|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153374231|NCT03021083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153374232|NCT03021083|Analgesics|analgesics|mesh-ancestor
153374233|NCT03021083|Sensory System Agents|sensory system agents|mesh-ancestor
153374234|NCT03021083|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153374235|NCT03021083|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153374236|NCT03021083|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153374237|NCT03021083|Anesthetics, General|anesthetics, general|mesh-ancestor
153374238|NCT03021083|Anesthetics|anesthetics|mesh-ancestor
153374239|NCT03000257|Venetoclax|venetoclax|mesh-list
153374240|NCT03000257|Rovalpituzumab tesirine|rovalpituzumab tesirine|mesh-list
153374241|NCT03000257|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153834159|NCT01240863|Antitussive Agents|antitussive agents|mesh-ancestor
153834160|NCT01240863|Respiratory System Agents|respiratory system agents|mesh-ancestor
153834161|NCT01240746|Vaccines|vaccines|mesh-list
153834162|NCT01240746|Immunologic Factors|immunologic factors|mesh-ancestor
153834163|NCT01240746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153834164|NCT01240590|Cisplatin|cisplatin|mesh-list
153834165|NCT01240590|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153834166|NCT01240200|Insulin Glargine|insulin glargine|mesh-list
153834167|NCT01240200|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153834168|NCT01240200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153834169|NCT00504543|Everolimus|everolimus|mesh-list
153834170|NCT00504543|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153834171|NCT00504543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153834172|NCT00504543|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153629753|NCT02047019|Vasodilator Agents|vasodilator agents|mesh-ancestor
153834173|NCT00504543|Immunologic Factors|immunologic factors|mesh-ancestor
153834174|NCT00504543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153834175|NCT00504543|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
153834176|NCT00504543|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153834177|NCT00504543|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153834178|NCT02949843|Pembrolizumab|pembrolizumab|mesh-list
153834179|NCT02949843|Nivolumab|nivolumab|mesh-list
153834180|NCT02949843|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-list
153834181|NCT02949843|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153834182|NCT02949843|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153834183|NCT02949843|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153834184|NCT02949843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153834185|NCT02949843|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153834186|NCT02949843|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153834187|NCT00517764|Citalopram|citalopram|mesh-list
153834188|NCT00517764|Escitalopram|escitalopram|mesh-list
153834189|NCT00517764|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
153374243|NCT03000257|Immunologic Factors|immunologic factors|mesh-ancestor
153374244|NCT03000257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153374245|NCT02945813|Metformin|metformin|mesh-list
153374246|NCT02945813|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153374247|NCT02945813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153374257|NCT05442801|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153374258|NCT05442801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153374259|NCT05442801|Parasympatholytics|parasympatholytics|mesh-ancestor
153374260|NCT05339373|Aceclofenac|aceclofenac|mesh-list
153374261|NCT05339373|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153374263|NCT05339373|Analgesics|analgesics|mesh-ancestor
153374264|NCT05339373|Sensory System Agents|sensory system agents|mesh-ancestor
153374265|NCT05339373|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153374266|NCT05339373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153374267|NCT05339373|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153374268|NCT05339373|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153374270|NCT05439993|Tepotinib|tepotinib|mesh-list
153374271|NCT05439993|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153629851|NCT00005823|Antiviral Agents|antiviral agents|mesh-ancestor
153374272|NCT05439993|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153374273|NCT05439993|Tubulin Modulators|tubulin modulators|mesh-ancestor
153374274|NCT05439993|Antimitotic Agents|antimitotic agents|mesh-ancestor
153834190|NCT00517764|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153834191|NCT00517764|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153834192|NCT00517764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153834193|NCT00517764|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153834194|NCT00517764|Serotonin Agents|serotonin agents|mesh-ancestor
153834195|NCT00517764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153834196|NCT00517764|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
153834197|NCT00517764|Antidepressive Agents|antidepressive agents|mesh-ancestor
153834198|NCT00517764|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153834199|NCT00517803|Micronutrients|micronutrients|mesh-list
153834200|NCT00517803|Trace Elements|trace elements|mesh-list
153834201|NCT00517803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153834202|NCT04516304|Equol|equol|mesh-list
153834203|NCT04516304|Phytoestrogens|phytoestrogens|mesh-ancestor
153834204|NCT04516304|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
153834205|NCT04516304|Estrogens|estrogens|mesh-ancestor
153834206|NCT04516304|Hormones|hormones|mesh-ancestor
153834207|NCT04516304|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153834208|NCT04516304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153834209|NCT01242930|Niacinamide|niacinamide|mesh-list
153834210|NCT01242930|Lenalidomide|lenalidomide|mesh-list
153834211|NCT01242930|Imetelstat|imetelstat|mesh-list
153834212|NCT01242930|Motesanib diphosphate|motesanib diphosphate|mesh-list
153834213|NCT01242930|Immunologic Factors|immunologic factors|mesh-ancestor
153834214|NCT01242930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153834215|NCT01242930|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153834216|NCT01242930|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153834217|NCT01242930|Growth Substances|growth substances|mesh-ancestor
153834218|NCT01242930|Growth Inhibitors|growth inhibitors|mesh-ancestor
153834219|NCT01242930|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153834220|NCT01242930|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153374276|NCT05439993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153374277|NCT00554099|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
153461414|NCT04279938|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153629901|NCT00005850|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153461415|NCT04279938|Immunologic Factors|immunologic factors|mesh-ancestor
153629935|NCT00005862|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153461416|NCT04279938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153461417|NCT04279938|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153461418|NCT04279938|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153461419|NCT04279938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153374303|NCT00553319|Adderall|adderall|mesh-list
153374304|NCT00553319|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
153374305|NCT00553319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153374306|NCT00553319|Sympathomimetics|sympathomimetics|mesh-ancestor
153374307|NCT00553319|Autonomic Agents|autonomic agents|mesh-ancestor
153374308|NCT00553319|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153374309|NCT00553319|Dopamine Agents|dopamine agents|mesh-ancestor
153374310|NCT00553319|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153374311|NCT00553319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153374312|NCT00553319|Adrenergic Agents|adrenergic agents|mesh-ancestor
153834242|NCT01240629|Doxorubicin|doxorubicin|mesh-list
153834243|NCT01240629|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
153834244|NCT01240629|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153834245|NCT01240629|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153630011|NCT00005892|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153630012|NCT00005892|Immunologic Factors|immunologic factors|mesh-ancestor
153630013|NCT00005892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153834246|NCT01240629|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153834247|NCT01240629|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153834248|NCT01240629|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153834249|NCT01240629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153834250|NCT00518232|Methylphenidate|methylphenidate|mesh-list
153834251|NCT00518232|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
153834252|NCT00518232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153834253|NCT00518232|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
153834254|NCT00518232|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153834255|NCT00518232|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153834256|NCT00518232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153834257|NCT00518232|Dopamine Agents|dopamine agents|mesh-ancestor
153834258|NCT00518232|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153834259|NCT00505505|Insulin|insulin|mesh-list
153834260|NCT00505505|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
153834261|NCT00505505|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153834262|NCT00505505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153834263|NCT00518271|Sirolimus|sirolimus|mesh-list
153834264|NCT00518271|Tacrolimus|tacrolimus|mesh-list
153461420|NCT05686434|Osimertinib|osimertinib|mesh-list
153461421|NCT05686434|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153461422|NCT05686434|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153461423|NCT05686434|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153461424|NCT05686434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153461425|NCT05686434|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153461426|NCT03338244|Azithromycin|azithromycin|mesh-list
153461427|NCT03338244|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153834287|NCT00518466|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
153834288|NCT00518466|Appetite Depressants|appetite depressants|mesh-ancestor
153461446|NCT03082092|Protective Agents|protective agents|mesh-ancestor
153630176|NCT00005949|Antiviral Agents|antiviral agents|mesh-ancestor
153461447|NCT03082092|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153461448|NCT03082092|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153461449|NCT04401852|Magnesium Sulfate|magnesium sulfate|mesh-list
153834290|NCT00518466|Sympathomimetics|sympathomimetics|mesh-ancestor
153834291|NCT00518466|Autonomic Agents|autonomic agents|mesh-ancestor
153834292|NCT00518466|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153834293|NCT00518466|Adrenergic Agents|adrenergic agents|mesh-ancestor
153834294|NCT00518466|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153834295|NCT00518466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153834297|NCT00518583|Doxorubicin|doxorubicin|mesh-list
153834298|NCT00518583|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
153834299|NCT00518583|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153374354|NCT02676375|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
153374355|NCT02676375|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153374356|NCT02676375|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153374357|NCT02676375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153374358|NCT02676375|Dopamine Agents|dopamine agents|mesh-ancestor
153374359|NCT02676375|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153374360|NCT02676375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153374361|NCT02676375|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
153374362|NCT02676375|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153374363|NCT02676375|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153374364|NCT01871441|Mycophenolic Acid|mycophenolic acid|mesh-list
153374365|NCT01871441|Cyclophosphamide|cyclophosphamide|mesh-list
153374367|NCT01871441|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153374368|NCT01871441|Immunologic Factors|immunologic factors|mesh-ancestor
153374369|NCT01871441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153374370|NCT01871441|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153374371|NCT01871441|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153374372|NCT01871441|Alkylating Agents|alkylating agents|mesh-ancestor
153374373|NCT01871441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153630272|NCT00005976|Carboplatin|carboplatin|mesh-list
153834310|NCT00519753|Travoprost|travoprost|mesh-list
153834311|NCT00519753|Ophthalmic Solutions|ophthalmic solutions|mesh-list
153834312|NCT00519753|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
153834313|NCT00519753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153834314|NCT00519753|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
153834315|NCT00519753|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
153834316|NCT00519753|Adrenergic Agents|adrenergic agents|mesh-ancestor
153834317|NCT00519753|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153834318|NCT00519753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153834319|NCT00519753|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153834320|NCT00519753|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153820003|NCT00431522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153820004|NCT00431522|Antimanic Agents|antimanic agents|mesh-ancestor
153820005|NCT00431522|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153820006|NCT00431522|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153820007|NCT00431522|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153820009|NCT00462111|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153820010|NCT00462111|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153820011|NCT00462111|Analgesics|analgesics|mesh-ancestor
153820012|NCT00462111|Sensory System Agents|sensory system agents|mesh-ancestor
153374385|NCT04338711|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153374387|NCT04338711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153374389|NCT01874951|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
153374390|NCT01874951|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
153374391|NCT01874951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153374392|NCT01874951|Sensory System Agents|sensory system agents|mesh-ancestor
153374393|NCT01874951|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153374394|NCT04739241|Insulin|insulin|mesh-list
153374395|NCT04739241|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
153374396|NCT04739241|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153820013|NCT00462111|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153820014|NCT00462111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153820015|NCT00462111|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153820029|NCT00431561|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153820030|NCT00462189|Immunotoxin HA22|immunotoxin ha22|mesh-list
153820031|NCT00462189|Immunotoxins|immunotoxins|mesh-list
153820032|NCT00462189|Immunoconjugates|immunoconjugates|mesh-ancestor
153820033|NCT00462189|Immunologic Factors|immunologic factors|mesh-ancestor
153820034|NCT00462189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153820035|NCT00462189|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153820036|NCT00431678|Moxifloxacin|moxifloxacin|mesh-list
153820037|NCT00431678|Levofloxacin|levofloxacin|mesh-list
153820038|NCT00431678|Ceftriaxone|ceftriaxone|mesh-list
153820039|NCT00431678|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
153834348|NCT04514588|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
153834349|NCT04514588|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153834350|NCT04514588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153834351|NCT04514588|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
153834352|NCT04514588|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
153834353|NCT04514588|Purinergic Agents|purinergic agents|mesh-ancestor
153834354|NCT04514588|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153374411|NCT03024437|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153374413|NCT01489826|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153374414|NCT01489826|Antiemetics|antiemetics|mesh-ancestor
153374415|NCT01489826|Autonomic Agents|autonomic agents|mesh-ancestor
153374416|NCT01489826|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153374417|NCT01489826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153374418|NCT01489826|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153374419|NCT01489826|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
153374420|NCT01489826|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
153374421|NCT01489826|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153374422|NCT01489826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153374423|NCT01489826|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
153820046|NCT00431678|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153820047|NCT00431678|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
153820048|NCT00431678|Contraceptive Agents|contraceptive agents|mesh-ancestor
153820049|NCT00431678|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153630668|NCT05597163|Cholinergic Agents|cholinergic agents|mesh-ancestor
153820050|NCT00431678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153820051|NCT00431678|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
153820052|NCT00431678|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
153820053|NCT00431678|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
153820054|NCT00431678|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
153820055|NCT00431678|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
153820056|NCT00431678|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153374432|NCT02677701|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153374433|NCT02677701|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153374434|NCT01543178|Rifaximin|rifaximin|mesh-list
153374435|NCT01543178|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153374436|NCT01543178|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153374437|NCT01543178|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153374438|NCT01649856|Rituximab|rituximab|mesh-list
153374439|NCT01649856|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153374440|NCT01649856|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153374441|NCT01649856|Immunologic Factors|immunologic factors|mesh-ancestor
153374442|NCT01649856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153374443|NCT01649856|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153374444|NCT01543568|Aflibercept|aflibercept|mesh-list
153374445|NCT01543568|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153374446|NCT01543568|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153374447|NCT01543568|Growth Substances|growth substances|mesh-ancestor
153374448|NCT01543568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153374449|NCT01543568|Growth Inhibitors|growth inhibitors|mesh-ancestor
153820065|NCT00471042|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153820066|NCT00471042|Narcotics|narcotics|mesh-ancestor
153820067|NCT00471042|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153820068|NCT00471042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153820069|NCT00471042|Analgesics|analgesics|mesh-ancestor
153820070|NCT00471042|Sensory System Agents|sensory system agents|mesh-ancestor
153820071|NCT00471042|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153834388|NCT00518895|Alkylating Agents|alkylating agents|mesh-ancestor
153834389|NCT00518895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153834390|NCT00518895|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153834391|NCT02954978|Nilotinib|nilotinib|mesh-list
153834392|NCT02954978|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153374450|NCT01543568|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153374451|NCT02681757|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
153374452|NCT02681757|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153374453|NCT02375724|Bromides|bromides|mesh-list
153374454|NCT02375724|Anticonvulsants|anticonvulsants|mesh-ancestor
153374455|NCT02398188|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
153374456|NCT02398188|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153374457|NCT02398188|Autonomic Agents|autonomic agents|mesh-ancestor
153374458|NCT02398188|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153374459|NCT02398188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153374460|NCT02398188|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153374461|NCT02398188|Respiratory System Agents|respiratory system agents|mesh-ancestor
153374462|NCT02398188|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
153374463|NCT02398188|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
153404700|NCT03228017|Antipyretics|antipyretics|mesh-ancestor
153374477|NCT02424630|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153374478|NCT02397408|Choline|choline|mesh-list
153374479|NCT02397408|Lipotropic Agents|lipotropic agents|mesh-ancestor
153374480|NCT02397408|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153834414|NCT00519012|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
153834416|NCT00519012|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153834417|NCT00519012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153834418|NCT00519012|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153834419|NCT00519012|Serotonin Agents|serotonin agents|mesh-ancestor
153630947|NCT00006066|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153630948|NCT00006066|Antiviral Agents|antiviral agents|mesh-ancestor
153630950|NCT00006072|Rituximab|rituximab|mesh-list
153834420|NCT00519012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153374482|NCT02397408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153374483|NCT02397408|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153374484|NCT02397408|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153374485|NCT02397408|Nootropic Agents|nootropic agents|mesh-ancestor
153374486|NCT02397096|Ritonavir|ritonavir|mesh-list
153374487|NCT02397096|HIV Protease Inhibitors|hiv protease inhibitors|mesh-list
153374488|NCT02397096|Tenofovir|tenofovir|mesh-list
153374489|NCT02397096|Lamivudine|lamivudine|mesh-list
153374490|NCT02397096|Cobicistat|cobicistat|mesh-list
153374491|NCT02397096|Elvitegravir|elvitegravir|mesh-list
153374492|NCT02397096|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-list
153374493|NCT02397096|Protease Inhibitors|protease inhibitors|mesh-list
153374494|NCT02397096|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
153374495|NCT02397096|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153374496|NCT02397096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153374497|NCT02397096|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153834421|NCT00519012|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
153834422|NCT00519012|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
153834423|NCT00519012|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153834424|NCT00519012|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153834446|NCT00520338|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153834447|NCT00520338|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
153834448|NCT00520338|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153834456|NCT00519051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153834457|NCT00519051|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153834458|NCT00519051|Serotonin Agents|serotonin agents|mesh-ancestor
153834459|NCT00519051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153374524|NCT00367965|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153374525|NCT00367965|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153631079|NCT00006126|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153631080|NCT00006126|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153374526|NCT00367965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153374527|NCT02683161|Varenicline|varenicline|mesh-list
153374528|NCT02683161|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
153374529|NCT02683161|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
153374530|NCT02683161|Cholinergic Agents|cholinergic agents|mesh-ancestor
153374531|NCT02683161|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153374532|NCT02683161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153374533|NCT02683161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153374534|NCT02683707|Lidocaine|lidocaine|mesh-list
153374535|NCT02683707|Midazolam|midazolam|mesh-list
153374536|NCT02683707|Fentanyl|fentanyl|mesh-list
153374537|NCT02683707|Anesthetics, Local|anesthetics, local|mesh-ancestor
153374538|NCT02683707|Anesthetics|anesthetics|mesh-ancestor
153374539|NCT02683707|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153374540|NCT02683707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153374541|NCT02683707|Sensory System Agents|sensory system agents|mesh-ancestor
153374542|NCT02683707|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153374543|NCT02683707|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153374544|NCT02683707|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
153374545|NCT02683707|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153374546|NCT02683707|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153374547|NCT02683707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153374548|NCT02683707|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153374549|NCT02683707|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153374550|NCT02683707|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153374551|NCT02683707|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153834462|NCT00519051|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
153834463|NCT00519051|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153834465|NCT02275832|Minoxidil|minoxidil|mesh-list
153834466|NCT02275832|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153834467|NCT02275832|Vasodilator Agents|vasodilator agents|mesh-ancestor
153834468|NCT00519207|Lidocaine|lidocaine|mesh-list
153834469|NCT00519207|Anesthetics, Local|anesthetics, local|mesh-ancestor
153834470|NCT00519207|Anesthetics|anesthetics|mesh-ancestor
153834471|NCT00519207|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153834472|NCT00519207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153834473|NCT00519207|Sensory System Agents|sensory system agents|mesh-ancestor
153834474|NCT00519207|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153834475|NCT00519207|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153834476|NCT00519207|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
153834477|NCT00519207|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153834478|NCT00519207|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153834487|NCT02590094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153834488|NCT02590094|Growth Inhibitors|growth inhibitors|mesh-ancestor
153374559|NCT02683707|Narcotics|narcotics|mesh-ancestor
153834501|NCT02949258|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153834508|NCT04514081|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153834510|NCT04514081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153374577|NCT02371980|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153374578|NCT02867865|Gemcitabine|gemcitabine|mesh-list
153374579|NCT02867865|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153374580|NCT02867865|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153374581|NCT02867865|Antimetabolites|antimetabolites|mesh-ancestor
153631262|NCT00006246|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153631263|NCT00006246|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153374582|NCT02867865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153374583|NCT05447949|Levobupivacaine|levobupivacaine|mesh-list
153374584|NCT05447949|Anesthetics, Local|anesthetics, local|mesh-ancestor
153374585|NCT05447949|Anesthetics|anesthetics|mesh-ancestor
153374586|NCT05447949|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153374587|NCT05447949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153374588|NCT05447949|Sensory System Agents|sensory system agents|mesh-ancestor
153374589|NCT05447949|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153374590|NCT05447871|Bupivacaine|bupivacaine|mesh-list
153374591|NCT05447871|Anesthetics, Local|anesthetics, local|mesh-ancestor
153374592|NCT05447871|Anesthetics|anesthetics|mesh-ancestor
153374593|NCT05447871|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153374594|NCT05447871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153374595|NCT05447871|Sensory System Agents|sensory system agents|mesh-ancestor
153374596|NCT05447871|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153374597|NCT00369447|Nimotuzumab|nimotuzumab|mesh-list
153374598|NCT00369447|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153374599|NCT00369447|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153374600|NCT04772235|Osimertinib|osimertinib|mesh-list
153631373|NCT00006279|Nevirapine|nevirapine|mesh-list
153631374|NCT00006279|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153374601|NCT04772235|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153374602|NCT04772235|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153374603|NCT04772235|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153374604|NCT04772235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153374605|NCT04772235|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153834511|NCT04514081|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153834512|NCT04514081|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153834513|NCT00519246|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-list
153834514|NCT00519246|Analgesics, Opioid|analgesics, opioid|mesh-list
153834515|NCT00519246|Narcotics|narcotics|mesh-ancestor
153834516|NCT00519246|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153834517|NCT00519246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153834518|NCT00519246|Analgesics|analgesics|mesh-ancestor
153834519|NCT00519246|Sensory System Agents|sensory system agents|mesh-ancestor
153834521|NCT00519246|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153834522|NCT00519246|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153834523|NCT00519246|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153834525|NCT00519987|Analgesics|analgesics|mesh-ancestor
153834526|NCT00519987|Sensory System Agents|sensory system agents|mesh-ancestor
153631547|NCT00005857|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153631553|NCT00005860|Leucovorin|leucovorin|mesh-list
153374627|NCT00369837|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153374628|NCT00369837|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153834540|NCT00519324|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153834541|NCT00519324|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153834543|NCT00519324|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153834544|NCT00519324|Immunologic Factors|immunologic factors|mesh-ancestor
153834545|NCT00519324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153834546|NCT00519324|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153834547|NCT00520650|Aripiprazole|aripiprazole|mesh-list
153834548|NCT00520650|Antidepressive Agents|antidepressive agents|mesh-ancestor
153834549|NCT00520650|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153834550|NCT00520650|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153834551|NCT00520650|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153834552|NCT00520650|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153374633|NCT05449899|Busulfan|busulfan|mesh-list
153374634|NCT05449899|Fludarabine|fludarabine|mesh-list
153374635|NCT05449899|Decitabine|decitabine|mesh-list
153374636|NCT05449899|Lenograstim|lenograstim|mesh-list
153374637|NCT05449899|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153374638|NCT05449899|Immunologic Factors|immunologic factors|mesh-ancestor
153374639|NCT05449899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153374640|NCT05449899|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153374641|NCT05449899|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153374642|NCT05449899|Alkylating Agents|alkylating agents|mesh-ancestor
153374643|NCT05449899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153374644|NCT05449899|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153374645|NCT05449899|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153374646|NCT05449899|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153374647|NCT05449899|Antimetabolites|antimetabolites|mesh-ancestor
153834565|NCT00519363|Atorvastatin|atorvastatin|mesh-list
153834566|NCT00519363|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153834567|NCT00519363|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153834568|NCT00519363|Antimetabolites|antimetabolites|mesh-ancestor
153834569|NCT00519363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153834570|NCT00519363|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153834571|NCT00519363|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
153834572|NCT00519363|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153834574|NCT00519480|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153834575|NCT00519480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153834576|NCT02955056|Teriparatide|teriparatide|mesh-list
153631710|NCT00386503|Antiviral Agents|antiviral agents|mesh-ancestor
153834577|NCT02955056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153834578|NCT02955056|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153834579|NCT02955056|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153834581|NCT02954939|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153834582|NCT02954939|Glucocorticoids|glucocorticoids|mesh-ancestor
153834583|NCT02954939|Hormones|hormones|mesh-ancestor
153834584|NCT02954939|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153374668|NCT01546454|Contraceptive Agents|contraceptive agents|mesh-ancestor
153374669|NCT01546454|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153374670|NCT01546454|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
153374671|NCT01546454|Progestins|progestins|mesh-ancestor
153374672|NCT01546454|Fertility Agents, Female|fertility agents, female|mesh-ancestor
153374673|NCT01546454|Fertility Agents|fertility agents|mesh-ancestor
153374674|NCT01546454|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153374675|NCT01546454|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153374676|NCT01546454|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
153374677|NCT01546454|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
153374678|NCT01546454|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
153374679|NCT01546454|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
153374680|NCT00368901|Darbepoetin alfa|darbepoetin alfa|mesh-list
153374681|NCT00368901|Hematinics|hematinics|mesh-ancestor
153374682|NCT05430867|Memantine|memantine|mesh-list
153374683|NCT05430867|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
153631780|NCT00005938|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153374684|NCT05430867|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
153374685|NCT05430867|Dopamine Agents|dopamine agents|mesh-ancestor
153834630|NCT04513340|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
153834631|NCT04513340|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
153834633|NCT04513340|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153834634|NCT04513340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153834635|NCT04513340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153834636|NCT04513340|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
153834637|NCT04513340|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153834638|NCT04513379|Efavirenz|efavirenz|mesh-list
153834639|NCT04513379|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153834640|NCT04513379|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153374732|NCT01493180|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
153374733|NCT01493180|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153834642|NCT04513379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153834643|NCT04513379|Antiviral Agents|antiviral agents|mesh-ancestor
153834644|NCT04513379|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153834645|NCT04513379|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
153834646|NCT04513379|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153834647|NCT04513379|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
153834648|NCT04513379|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
153834649|NCT04513379|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
153834650|NCT04513379|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
153834651|NCT00521157|Naltrexone|naltrexone|mesh-list
153834652|NCT00521157|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
153834653|NCT00521157|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
153834654|NCT00521157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153834655|NCT00521157|Sensory System Agents|sensory system agents|mesh-ancestor
153834656|NCT00521157|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153834657|NCT00505817|Leuprolide|leuprolide|mesh-list
153834658|NCT00505817|Cetrorelix|cetrorelix|mesh-list
153834660|NCT00505817|Fertility Agents|fertility agents|mesh-ancestor
153374753|NCT01431014|Hormones|hormones|mesh-ancestor
153374754|NCT01431014|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153374755|NCT01431014|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153374756|NCT01431014|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153374757|NCT01431014|Protease Inhibitors|protease inhibitors|mesh-ancestor
153374758|NCT01431014|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153374759|NCT01431014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153374760|NCT01431170|Trimethoprim|trimethoprim|mesh-list
153374761|NCT01431170|Polymyxins|polymyxins|mesh-list
153374762|NCT01431170|Polymyxin B|polymyxin b|mesh-list
153374763|NCT01431170|Besifloxacin|besifloxacin|mesh-list
153374764|NCT01431170|Fluoroquinolones|fluoroquinolones|mesh-list
153374765|NCT01431170|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
153374766|NCT01431170|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153374767|NCT01431170|Antimalarials|antimalarials|mesh-ancestor
153374768|NCT01431170|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153374769|NCT01431170|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153374770|NCT01431170|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153374771|NCT01431170|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153834661|NCT00505817|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153834662|NCT00505817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153834663|NCT00505817|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153834664|NCT00505817|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153834665|NCT00505817|Hormone Antagonists|hormone antagonists|mesh-ancestor
153834666|NCT00505817|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153834667|NCT00521430|Cyclosporine|cyclosporine|mesh-list
153834668|NCT00521430|Methylprednisolone|methylprednisolone|mesh-list
153834669|NCT00521430|Methotrexate|methotrexate|mesh-list
153834670|NCT00521430|Fludarabine phosphate|fludarabine phosphate|mesh-list
153834671|NCT00521430|Fludarabine|fludarabine|mesh-list
153834673|NCT00521430|Cyclosporins|cyclosporins|mesh-list
153834674|NCT00521430|Antilymphocyte Serum|antilymphocyte serum|mesh-list
153834675|NCT00521430|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
153834676|NCT00521430|Abortifacient Agents|abortifacient agents|mesh-ancestor
153834677|NCT00521430|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153834678|NCT00521430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153834679|NCT00521430|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153834680|NCT00521430|Antimetabolites|antimetabolites|mesh-ancestor
153632049|NCT00006007|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153632099|NCT00006019|Antimetabolites|antimetabolites|mesh-ancestor
153834681|NCT00521430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153834682|NCT00521430|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153834683|NCT00521430|Dermatologic Agents|dermatologic agents|mesh-ancestor
153834684|NCT00521430|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153834685|NCT00521430|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153834686|NCT00521430|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153834687|NCT00521430|Immunologic Factors|immunologic factors|mesh-ancestor
153834688|NCT00521430|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153834689|NCT00521430|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153834690|NCT00521430|Antifungal Agents|antifungal agents|mesh-ancestor
153834691|NCT00521430|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153834692|NCT00521430|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
153834693|NCT00521430|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153834694|NCT00521430|Antiemetics|antiemetics|mesh-ancestor
153834695|NCT00521430|Autonomic Agents|autonomic agents|mesh-ancestor
153834696|NCT00521430|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153834697|NCT00521430|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153374777|NCT01431170|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153374780|NCT01431170|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153374781|NCT05448183|Gemcitabine|gemcitabine|mesh-list
153374782|NCT05448183|Oxaliplatin|oxaliplatin|mesh-list
153632212|NCT00006363|Antiviral Agents|antiviral agents|mesh-ancestor
153374783|NCT05448183|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153374784|NCT05448183|Antimetabolites|antimetabolites|mesh-ancestor
153374785|NCT05448183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153374786|NCT05448183|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153374788|NCT04732455|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
153374789|NCT04732455|Anesthetics, Local|anesthetics, local|mesh-ancestor
153374790|NCT04732455|Anesthetics|anesthetics|mesh-ancestor
153374791|NCT04732455|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153374792|NCT04732455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153374793|NCT04732455|Sensory System Agents|sensory system agents|mesh-ancestor
153374794|NCT04732455|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153374795|NCT04732455|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153374796|NCT04732455|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
153374797|NCT04732455|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153374798|NCT04732455|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153374799|NCT04732455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153374801|NCT04732455|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153834733|NCT05146778|Adrenergic Agents|adrenergic agents|mesh-ancestor
153834734|NCT05146778|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153834736|NCT05146778|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153834737|NCT05146778|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153834738|NCT05146778|Anesthetics, General|anesthetics, general|mesh-ancestor
153834739|NCT00505700|Cytarabine|cytarabine|mesh-list
153834740|NCT00505700|Bortezomib|bortezomib|mesh-list
153834741|NCT00505700|Idarubicin|idarubicin|mesh-list
153834742|NCT00505700|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153834743|NCT00505700|Antimetabolites|antimetabolites|mesh-ancestor
153834744|NCT00505700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153834745|NCT00505700|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153834747|NCT00505700|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153834748|NCT00505700|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153834749|NCT00505700|Immunologic Factors|immunologic factors|mesh-ancestor
153834750|NCT00505700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153834751|NCT00505700|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153834752|NCT00505700|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153834753|NCT00505700|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153834754|NCT00505700|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153374825|NCT01431794|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153374826|NCT01431794|Tubulin Modulators|tubulin modulators|mesh-ancestor
153374827|NCT01431794|Antimitotic Agents|antimitotic agents|mesh-ancestor
153374828|NCT01431794|Mitosis Modulators|mitosis modulators|mesh-ancestor
153374829|NCT01431794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153374830|NCT01431794|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153374831|NCT01431794|Antimetabolites|antimetabolites|mesh-ancestor
153374832|NCT01497860|Vinorelbine|vinorelbine|mesh-list
153374833|NCT01497860|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153374834|NCT01497860|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153374835|NCT01497860|Tubulin Modulators|tubulin modulators|mesh-ancestor
153374836|NCT01497860|Antimitotic Agents|antimitotic agents|mesh-ancestor
153374837|NCT01497860|Mitosis Modulators|mitosis modulators|mesh-ancestor
153374838|NCT01497860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153374839|NCT02213900|Haloperidol|haloperidol|mesh-list
153374840|NCT02213900|Haloperidol decanoate|haloperidol decanoate|mesh-list
153374841|NCT02213900|Antiemetics|antiemetics|mesh-ancestor
153374842|NCT02213900|Autonomic Agents|autonomic agents|mesh-ancestor
153374845|NCT02213900|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153834785|NCT00523185|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153834786|NCT00523185|GABA Modulators|gaba modulators|mesh-ancestor
153834787|NCT00523185|GABA Agents|gaba agents|mesh-ancestor
153834788|NCT00523185|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153834789|NCT00523185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153834790|NCT00523185|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153834791|NCT00523185|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
153834792|NCT00523185|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
153834793|NCT00523185|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153834794|NCT00523185|Anesthetics, General|anesthetics, general|mesh-ancestor
153834795|NCT00523185|Anesthetics|anesthetics|mesh-ancestor
153834796|NCT04512404|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-list
153834803|NCT04693962|Mitogens|mitogens|mesh-list
153834821|NCT00521742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153834822|NCT00521781|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
153834823|NCT00521781|Leuprolide|leuprolide|mesh-list
153834824|NCT00521781|Bicalutamide|bicalutamide|mesh-list
153834825|NCT00521781|Androgens|androgens|mesh-list
153374896|NCT01551056|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
153374897|NCT01551056|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
153374898|NCT01551056|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
153374899|NCT01551056|Histamine Antagonists|histamine antagonists|mesh-ancestor
153374900|NCT01551056|Histamine Agents|histamine agents|mesh-ancestor
153374901|NCT01551056|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153374902|NCT01551056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153374903|NCT01551056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153374904|NCT05227131|Capecitabine|capecitabine|mesh-list
153374905|NCT05227131|Tucatinib|tucatinib|mesh-list
153374906|NCT05227131|Margetuximab|margetuximab|mesh-list
153374907|NCT05227131|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153374908|NCT05227131|Antimetabolites|antimetabolites|mesh-ancestor
153374909|NCT05227131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153374910|NCT05227131|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153374911|NCT05227131|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153834879|NCT00523458|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153374948|NCT02688309|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153374949|NCT02688309|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153374958|NCT00370851|Growth Inhibitors|growth inhibitors|mesh-ancestor
153374959|NCT05124171|Vaccines|vaccines|mesh-list
153374960|NCT05124171|Immunologic Factors|immunologic factors|mesh-ancestor
153374961|NCT05124171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153374962|NCT00370305|Rosiglitazone|rosiglitazone|mesh-list
153374963|NCT00370305|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153374964|NCT00370305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153374965|NCT00371007|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
153374966|NCT00371007|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153374967|NCT00371007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153374968|NCT00371007|Incretins|incretins|mesh-ancestor
153374969|NCT00371007|Hormones|hormones|mesh-ancestor
153374970|NCT00371007|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153374971|NCT00371007|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
153374972|NCT00371007|Protease Inhibitors|protease inhibitors|mesh-ancestor
153632406|NCT05546320|Sympatholytics|sympatholytics|mesh-ancestor
153632412|NCT05535595|Perindopril|perindopril|mesh-list
153374973|NCT00371007|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153834880|NCT00523458|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153834881|NCT00523458|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153834882|NCT00523458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153834883|NCT00523458|Antiviral Agents|antiviral agents|mesh-ancestor
153834884|NCT00523458|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153834885|NCT00523458|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
153834886|NCT00523458|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153834887|NCT00523458|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
153834888|NCT00523458|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
153834904|NCT00507065|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
153834905|NCT00507065|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153374974|NCT00371007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153374986|NCT00552617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153374987|NCT00552617|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
153632447|NCT05285683|Carbidopa|carbidopa|mesh-list
153632449|NCT05285683|Methylphenidate|methylphenidate|mesh-list
153374988|NCT00552617|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
153374989|NCT00552617|Cholinergic Agents|cholinergic agents|mesh-ancestor
153374990|NCT00552617|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153374991|NCT00552617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153374992|NCT02421120|Tazobactam|tazobactam|mesh-list
153374993|NCT02421120|Ceftolozane|ceftolozane|mesh-list
153834906|NCT00507065|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153834907|NCT00507065|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
153834908|NCT00522132|Artesunate|artesunate|mesh-list
153834909|NCT00522132|Antimalarials|antimalarials|mesh-ancestor
153834910|NCT00522132|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153834911|NCT00522132|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153834912|NCT00522132|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153834913|NCT00522132|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153834914|NCT00522132|Antiviral Agents|antiviral agents|mesh-ancestor
153834915|NCT00522132|Schistosomicides|schistosomicides|mesh-ancestor
153834916|NCT00522132|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
153834917|NCT00522132|Anthelmintics|anthelmintics|mesh-ancestor
153834918|NCT00522210|Insulin|insulin|mesh-list
153834919|NCT00522210|Isophane Insulin, Human|isophane insulin, human|mesh-list
153834920|NCT00522210|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153834922|NCT00522249|Interferons|interferons|mesh-list
153834933|NCT00522249|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153834934|NCT00522249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153834935|NCT00522249|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153834936|NCT00522249|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153834937|NCT00522249|Growth Substances|growth substances|mesh-ancestor
153834938|NCT00522249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153834939|NCT00522249|Growth Inhibitors|growth inhibitors|mesh-ancestor
153834940|NCT00522249|Immunologic Factors|immunologic factors|mesh-ancestor
153834941|NCT05148767|Irinotecan|irinotecan|mesh-list
153834942|NCT05148767|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
153834943|NCT05148767|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153834944|NCT05148767|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153632670|NCT02890069|Panobinostat|panobinostat|mesh-list
153632671|NCT02890069|Spartalizumab|spartalizumab|mesh-list
153632672|NCT02890069|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
153834945|NCT05148767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153834946|NCT05148767|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153834947|NCT00523692|Etanercept|etanercept|mesh-list
153834948|NCT00523692|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
153834949|NCT00523692|Methylprednisolone|methylprednisolone|mesh-list
153375014|NCT02420262|Liraglutide|liraglutide|mesh-list
153375015|NCT02420262|Xultophy|xultophy|mesh-list
153375016|NCT02420262|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153375017|NCT02420262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153834951|NCT00523692|Prednisolone|prednisolone|mesh-list
153834952|NCT00523692|Prednisolone acetate|prednisolone acetate|mesh-list
153834953|NCT00523692|Methotrexate|methotrexate|mesh-list
153834954|NCT00523692|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
153834955|NCT00523692|Prednisolone phosphate|prednisolone phosphate|mesh-list
153834956|NCT00523692|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
153834957|NCT00523692|Abortifacient Agents|abortifacient agents|mesh-ancestor
153834958|NCT00523692|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153632787|NCT00006708|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153632788|NCT00006708|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153834959|NCT00523692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153834960|NCT00523692|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153834961|NCT00523692|Antimetabolites|antimetabolites|mesh-ancestor
153834962|NCT00523692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153834963|NCT00523692|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153834964|NCT00523692|Dermatologic Agents|dermatologic agents|mesh-ancestor
153375034|NCT00369993|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
153375035|NCT00369993|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
153375045|NCT00552305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153375047|NCT01854255|Doxorubicin|doxorubicin|mesh-list
153375048|NCT01854255|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
153375049|NCT01854255|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153375050|NCT01854255|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153375051|NCT01854255|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153375052|NCT01854255|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153375053|NCT01854255|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153375054|NCT01854255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153375055|NCT01555281|Nelfinavir|nelfinavir|mesh-list
153834967|NCT00523692|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153834968|NCT00523692|Immunologic Factors|immunologic factors|mesh-ancestor
153834969|NCT00523692|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153834970|NCT00523692|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153834971|NCT00523692|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153834972|NCT00523692|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153834973|NCT00523692|Analgesics|analgesics|mesh-ancestor
153834974|NCT00523692|Sensory System Agents|sensory system agents|mesh-ancestor
153834975|NCT00523692|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153834976|NCT00523692|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153834977|NCT00523692|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153632951|NCT00006055|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153834978|NCT00523692|Antiemetics|antiemetics|mesh-ancestor
153834979|NCT00523692|Autonomic Agents|autonomic agents|mesh-ancestor
153834980|NCT00523692|Glucocorticoids|glucocorticoids|mesh-ancestor
153834981|NCT00523692|Hormones|hormones|mesh-ancestor
153834982|NCT00523692|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153834983|NCT00523692|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
153820080|NCT00462540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153820081|NCT00462540|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153820082|NCT00462540|Respiratory System Agents|respiratory system agents|mesh-ancestor
153834986|NCT05148689|Phenylephrine|phenylephrine|mesh-list
153834987|NCT05148689|Oxymetazoline|oxymetazoline|mesh-list
153834988|NCT05148689|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153834990|NCT05148689|Adrenergic Agents|adrenergic agents|mesh-ancestor
153375057|NCT01555281|Lenalidomide|lenalidomide|mesh-list
153375058|NCT01555281|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153375059|NCT01555281|Antiemetics|antiemetics|mesh-ancestor
153375060|NCT01555281|Autonomic Agents|autonomic agents|mesh-ancestor
153375061|NCT01555281|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153375062|NCT01555281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153375066|NCT01555281|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153375067|NCT01555281|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153375068|NCT01555281|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153375069|NCT01555281|Immunologic Factors|immunologic factors|mesh-ancestor
153375070|NCT01555281|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153375071|NCT01555281|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153375072|NCT01555281|Growth Substances|growth substances|mesh-ancestor
153375073|NCT01555281|Growth Inhibitors|growth inhibitors|mesh-ancestor
153375074|NCT01555281|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
153375075|NCT01555281|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
153375076|NCT01555281|Protease Inhibitors|protease inhibitors|mesh-ancestor
153375077|NCT01555281|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153375078|NCT01555281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153375079|NCT01555281|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153375080|NCT01555281|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153375081|NCT01555281|Antiviral Agents|antiviral agents|mesh-ancestor
153375082|NCT01555281|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153375083|NCT00370539|Triamcinolone|triamcinolone|mesh-list
153375084|NCT00370539|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
153375085|NCT00370539|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
153375086|NCT00370539|Bevacizumab|bevacizumab|mesh-list
153375087|NCT00370539|Verteporfin|verteporfin|mesh-list
153375088|NCT00370539|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
153632996|NCT00006088|Mitosis Modulators|mitosis modulators|mesh-ancestor
153633000|NCT00006094|Fluorouracil|fluorouracil|mesh-list
153375089|NCT00370539|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153835011|NCT00522444|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153835012|NCT00522444|Anticonvulsants|anticonvulsants|mesh-ancestor
153820084|NCT00462540|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
153820085|NCT00462540|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153820086|NCT00462540|Adrenergic Agents|adrenergic agents|mesh-ancestor
153835013|NCT00522444|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153835014|NCT00522444|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153835015|NCT00522444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153835016|NCT00522444|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153835017|NCT00522444|Tocolytic Agents|tocolytic agents|mesh-ancestor
153633058|NCT00006112|Levoleucovorin|levoleucovorin|mesh-list
153633059|NCT00006112|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153835018|NCT00522444|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153835019|NCT05148143|Raltitrexed|raltitrexed|mesh-list
153835020|NCT05148143|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153835021|NCT05148143|Antimetabolites|antimetabolites|mesh-ancestor
153835022|NCT05148143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153835023|NCT05148143|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153835024|NCT05148143|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153375092|NCT00370539|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153375094|NCT00370539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153375095|NCT00370539|Growth Inhibitors|growth inhibitors|mesh-ancestor
153375096|NCT00370539|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153375097|NCT00370539|Glucocorticoids|glucocorticoids|mesh-ancestor
153375098|NCT00370539|Hormones|hormones|mesh-ancestor
153375109|NCT03996057|Estrogens|estrogens|mesh-list
153375110|NCT03996057|Hormones|hormones|mesh-ancestor
153375111|NCT03996057|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153835025|NCT05148143|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153835026|NCT00523887|Fentanyl|fentanyl|mesh-list
153835027|NCT00523887|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153835028|NCT00523887|Narcotics|narcotics|mesh-ancestor
153835029|NCT00523887|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153835030|NCT00523887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153835031|NCT00523887|Analgesics|analgesics|mesh-ancestor
153835032|NCT00523887|Sensory System Agents|sensory system agents|mesh-ancestor
153835033|NCT00523887|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153835034|NCT00523887|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153835035|NCT00523887|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153835036|NCT00523887|Anesthetics, General|anesthetics, general|mesh-ancestor
153835037|NCT00523887|Anesthetics|anesthetics|mesh-ancestor
153820087|NCT00462540|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153820088|NCT00462540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153820089|NCT00462540|Anticonvulsants|anticonvulsants|mesh-ancestor
153820090|NCT00462540|Tocolytic Agents|tocolytic agents|mesh-ancestor
153820091|NCT00462540|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153835039|NCT05145218|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153835040|NCT05145218|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153835041|NCT05145218|Tubulin Modulators|tubulin modulators|mesh-ancestor
153835042|NCT05145218|Antimitotic Agents|antimitotic agents|mesh-ancestor
153835043|NCT05145218|Mitosis Modulators|mitosis modulators|mesh-ancestor
153835044|NCT05145218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153835045|NCT00523926|Bedaquiline|bedaquiline|mesh-list
153375112|NCT03996057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153375113|NCT03996057|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
153375114|NCT03996057|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153375115|NCT03996057|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153375116|NCT03150875|Docetaxel|docetaxel|mesh-list
153375117|NCT03150875|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153375118|NCT03150875|Tubulin Modulators|tubulin modulators|mesh-ancestor
153375126|NCT04880889|Pantothenic Acid|pantothenic acid|mesh-list
153375127|NCT04880889|Thiamine|thiamine|mesh-list
153633405|NCT00007527|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153633452|NCT00006292|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153375128|NCT04880889|Vitamin B Complex|vitamin b complex|mesh-ancestor
153375129|NCT04880889|Vitamins|vitamins|mesh-ancestor
153375130|NCT04880889|Micronutrients|micronutrients|mesh-ancestor
153375131|NCT04880889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153375132|NCT03833427|Pembrolizumab|pembrolizumab|mesh-list
153375133|NCT03833427|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153375134|NCT03833427|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153375139|NCT04849377|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153375150|NCT04802031|Immunologic Factors|immunologic factors|mesh-ancestor
153375151|NCT04802031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153835072|NCT05142098|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153835074|NCT05142098|Sensory System Agents|sensory system agents|mesh-ancestor
153835075|NCT05142098|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153835076|NCT05142098|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153835077|NCT05142098|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153835078|NCT05142098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153835079|NCT00523965|Amphotericin B|amphotericin b|mesh-list
153835080|NCT00523965|Paromomycin|paromomycin|mesh-list
153835081|NCT00523965|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
153835082|NCT00523965|Miltefosine|miltefosine|mesh-list
153835083|NCT00523965|Amphotericin B, deoxycholate drug combination|amphotericin b, deoxycholate drug combination|mesh-list
153835084|NCT00523965|Deoxycholic Acid|deoxycholic acid|mesh-list
153835085|NCT00523965|Amebicides|amebicides|mesh-ancestor
153835086|NCT00523965|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153835087|NCT00523965|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153375152|NCT05454345|Moxifloxacin|moxifloxacin|mesh-list
153375153|NCT05454345|Rifampin|rifampin|mesh-list
153375154|NCT05454345|Isoniazid|isoniazid|mesh-list
153375155|NCT05454345|Pyrazinamide|pyrazinamide|mesh-list
153375156|NCT05454345|Ethambutol|ethambutol|mesh-list
153375157|NCT05454345|Rifapentine|rifapentine|mesh-list
153375175|NCT05454345|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
153375176|NCT05454345|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
153835098|NCT05141669|Immunologic Factors|immunologic factors|mesh-ancestor
153820092|NCT00462540|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
153820093|NCT00462540|Cholinergic Agents|cholinergic agents|mesh-ancestor
153461507|NCT04400136|Dexlansoprazole|dexlansoprazole|mesh-list
153461508|NCT04400136|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
153633567|NCT00006349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153633568|NCT00006349|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
153461509|NCT04400136|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153461510|NCT04400136|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
153461511|NCT04400136|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153461512|NCT04400136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153461513|NCT04857840|Firibastat|firibastat|mesh-list
153461514|NCT04857840|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153461515|NCT04582968|Capecitabine|capecitabine|mesh-list
153461516|NCT04582968|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153461517|NCT04582968|Antimetabolites|antimetabolites|mesh-ancestor
153835109|NCT05148377|Anticoagulants|anticoagulants|mesh-ancestor
153835110|NCT05148377|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153835111|NCT05148377|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153835112|NCT05148377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153835113|NCT00524160|Fentanyl|fentanyl|mesh-list
153835114|NCT00524160|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153375180|NCT04459611|Paclitaxel|paclitaxel|mesh-list
153375181|NCT04459611|Carboplatin|carboplatin|mesh-list
153375182|NCT04459611|Pemetrexed|pemetrexed|mesh-list
153375183|NCT04459611|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
153375184|NCT04459611|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153375185|NCT04459611|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153375186|NCT04459611|Tubulin Modulators|tubulin modulators|mesh-ancestor
153375187|NCT04459611|Antimitotic Agents|antimitotic agents|mesh-ancestor
153375188|NCT04459611|Mitosis Modulators|mitosis modulators|mesh-ancestor
153375189|NCT04459611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153375190|NCT04459611|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153375191|NCT04459611|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153375192|NCT04459611|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153375193|NCT00370617|Metformin|metformin|mesh-list
153633630|NCT00006364|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153375194|NCT00370617|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153375195|NCT00370617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153375196|NCT01553708|Sulfadiazine|sulfadiazine|mesh-list
153375197|NCT01553708|Silver Sulfadiazine|silver sulfadiazine|mesh-list
153375198|NCT01553708|Mitogens|mitogens|mesh-list
153375199|NCT01553708|Mitosis Modulators|mitosis modulators|mesh-ancestor
153375200|NCT01553708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153375201|NCT01553708|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153375202|NCT01553708|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153375203|NCT01553708|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153375204|NCT01553708|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153835127|NCT00524199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153835128|NCT00523068|Tolterodine Tartrate|tolterodine tartrate|mesh-list
153835129|NCT00523068|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
153835130|NCT00523068|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
153835131|NCT00523068|Cholinergic Agents|cholinergic agents|mesh-ancestor
153835134|NCT00523068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153375243|NCT02347332|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153375245|NCT01502306|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
153375246|NCT01502306|Autonomic Agents|autonomic agents|mesh-ancestor
153375247|NCT01502306|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153375248|NCT01502306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153375249|NCT01502306|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
153375250|NCT01502306|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
153375251|NCT01502306|Cholinergic Agents|cholinergic agents|mesh-ancestor
153375252|NCT01502306|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153375253|NCT01502306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153375254|NCT03325959|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
153375255|NCT03325959|Analgesics|analgesics|mesh-ancestor
153375256|NCT03325959|Sensory System Agents|sensory system agents|mesh-ancestor
153835165|NCT02947932|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153835166|NCT02947932|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153633716|NCT00007995|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153633717|NCT00007995|Immunologic Factors|immunologic factors|mesh-ancestor
153835167|NCT02947932|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153835168|NCT02947932|Gout Suppressants|gout suppressants|mesh-ancestor
153835169|NCT02947932|Tocolytic Agents|tocolytic agents|mesh-ancestor
153835170|NCT02947932|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153835171|NCT02947932|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153835172|NCT02947893|Nilotinib|nilotinib|mesh-list
153835173|NCT02947893|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153835174|NCT02947893|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153375275|NCT05451381|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153375276|NCT05451381|Analgesics|analgesics|mesh-ancestor
153375277|NCT05451381|Sensory System Agents|sensory system agents|mesh-ancestor
153375278|NCT05451381|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153835206|NCT00524706|Vitamins|vitamins|mesh-ancestor
153835207|NCT00524706|Micronutrients|micronutrients|mesh-ancestor
153835208|NCT00507143|Irinotecan|irinotecan|mesh-list
153835209|NCT00507143|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
153835210|NCT00507143|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153835211|NCT00507143|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153835212|NCT00507143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153835213|NCT00507143|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153835214|NCT00525993|Etoricoxib|etoricoxib|mesh-list
153375279|NCT05451381|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
153375280|NCT05451381|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153375282|NCT05451381|Adrenergic Agents|adrenergic agents|mesh-ancestor
153375283|NCT05451381|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153375284|NCT05451381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153375285|NCT05451381|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153633810|NCT00006427|Analgesics|analgesics|mesh-ancestor
153375286|NCT05451381|Anesthetics, General|anesthetics, general|mesh-ancestor
153375287|NCT05451381|Anesthetics|anesthetics|mesh-ancestor
153375288|NCT05450913|Lidocaine|lidocaine|mesh-list
153375289|NCT05450913|Anesthetics, Local|anesthetics, local|mesh-list
153375290|NCT05450913|Anesthetics|anesthetics|mesh-list
153375291|NCT05450913|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153375292|NCT05450913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153375293|NCT05450913|Sensory System Agents|sensory system agents|mesh-ancestor
153375294|NCT05450913|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153375295|NCT05450913|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153375296|NCT05450913|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
153375297|NCT05450913|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153375298|NCT05450913|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153781775|NCT04559308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153405000|NCT05715788|Antioxidants|antioxidants|mesh-ancestor
153835237|NCT02947815|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
153835238|NCT02947815|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
153375302|NCT02215070|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153375303|NCT02215070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153375304|NCT04000737|Sorafenib|sorafenib|mesh-list
153375305|NCT04000737|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153375306|NCT04000737|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153375307|NCT04000737|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153375308|NCT04000737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153375309|NCT02347098|Atorvastatin|atorvastatin|mesh-list
153375310|NCT02347098|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-list
153375311|NCT02347098|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153375312|NCT02347098|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153375313|NCT02347098|Antimetabolites|antimetabolites|mesh-ancestor
153375314|NCT02347098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153375315|NCT02347098|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153820095|NCT04703465|Antiviral Agents|antiviral agents|mesh-ancestor
153820096|NCT04703465|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153820097|NCT04703465|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153820098|NCT04703465|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153820099|NCT04703465|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153820100|NCT04703465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153820101|NCT04703465|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153820102|NCT04703465|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153820103|NCT00471159|Docetaxel|docetaxel|mesh-list
153820104|NCT00471159|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153633887|NCT00006451|Methotrexate|methotrexate|mesh-list
153820105|NCT00471159|Tubulin Modulators|tubulin modulators|mesh-ancestor
153375316|NCT02347098|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153375318|NCT03708237|Ropinirole|ropinirole|mesh-list
153375319|NCT03708237|Analgesics|analgesics|mesh-ancestor
153375320|NCT03708237|Sensory System Agents|sensory system agents|mesh-ancestor
153375321|NCT03708237|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153375322|NCT03708237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153835239|NCT02947815|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153835253|NCT00507221|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153835254|NCT00507221|Tubulin Modulators|tubulin modulators|mesh-ancestor
153835255|NCT00507221|Antimitotic Agents|antimitotic agents|mesh-ancestor
153835256|NCT00507221|Mitosis Modulators|mitosis modulators|mesh-ancestor
153835257|NCT00507221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153835258|NCT00507221|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153835259|NCT02947737|Gentamicins|gentamicins|mesh-list
153835260|NCT02947737|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153375323|NCT03708237|Anticonvulsants|anticonvulsants|mesh-ancestor
153375324|NCT03708237|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153375325|NCT03708237|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153375326|NCT03708237|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153375327|NCT03708237|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153633963|NCT00008268|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153375328|NCT03708237|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
153375329|NCT03708237|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
153375330|NCT03708237|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153375331|NCT03708237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153375332|NCT03708237|Antimanic Agents|antimanic agents|mesh-ancestor
153375333|NCT03708237|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
153375334|NCT03708237|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
153375335|NCT03708237|Dopamine Agonists|dopamine agonists|mesh-ancestor
153375336|NCT03708237|Dopamine Agents|dopamine agents|mesh-ancestor
153835269|NCT05146895|Immunologic Factors|immunologic factors|mesh-ancestor
153375337|NCT01556594|Glucagon|glucagon|mesh-list
153375364|NCT01440764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153375365|NCT01440764|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
153375366|NCT01440764|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153375367|NCT01440764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153375368|NCT01557452|Givinostat hydrochloride|givinostat hydrochloride|mesh-list
153375369|NCT01557452|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
153375370|NCT01557452|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153375371|NCT01557452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153375372|NCT05283837|Pertuzumab|pertuzumab|mesh-list
153375373|NCT05283837|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153375374|NCT05283837|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153375375|NCT02209610|Fentanyl|fentanyl|mesh-list
153375376|NCT02209610|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153375377|NCT02209610|Narcotics|narcotics|mesh-ancestor
153375378|NCT02209610|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153375379|NCT02209610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153835296|NCT05145608|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153835297|NCT05145608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153835298|NCT05145608|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153835299|NCT05145608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153835314|NCT02946294|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153835316|NCT02946294|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153835317|NCT02946294|Adrenergic Agents|adrenergic agents|mesh-ancestor
153375380|NCT02209610|Analgesics|analgesics|mesh-ancestor
153375381|NCT02209610|Sensory System Agents|sensory system agents|mesh-ancestor
153375382|NCT02209610|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153634225|NCT00007813|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153375383|NCT02209610|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153375384|NCT02209610|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153375385|NCT02209610|Anesthetics, General|anesthetics, general|mesh-ancestor
153375400|NCT01558700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153375401|NCT01558700|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153375402|NCT01558700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153375404|NCT01558700|Sensory System Agents|sensory system agents|mesh-ancestor
153375405|NCT01558700|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153375406|NCT01558700|Antidepressive Agents|antidepressive agents|mesh-ancestor
153375407|NCT01558700|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153375408|NCT01558700|Dopamine Agents|dopamine agents|mesh-ancestor
153375409|NCT02757105|Ondansetron|ondansetron|mesh-list
153375410|NCT02757105|Antiemetics|antiemetics|mesh-ancestor
153375411|NCT02757105|Autonomic Agents|autonomic agents|mesh-ancestor
153375412|NCT02757105|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153375413|NCT02757105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153375414|NCT02757105|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153375415|NCT02757105|Antipruritics|antipruritics|mesh-ancestor
153375416|NCT02757105|Dermatologic Agents|dermatologic agents|mesh-ancestor
153375417|NCT02757105|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
153375418|NCT02757105|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153375419|NCT02757105|Serotonin Agents|serotonin agents|mesh-ancestor
153375420|NCT02757105|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153375421|NCT02757105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153375422|NCT05083845|Anesthetics|anesthetics|mesh-list
153375423|NCT05083845|Anesthetics, Local|anesthetics, local|mesh-list
153375424|NCT05083845|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153375425|NCT05083845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153375426|NCT05083845|Sensory System Agents|sensory system agents|mesh-ancestor
153375427|NCT05083845|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153375428|NCT00371553|Sunitinib|sunitinib|mesh-list
153835338|NCT00525096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153835339|NCT00525096|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153835340|NCT00525096|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153835341|NCT00525096|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
153835342|NCT00525096|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153835343|NCT00525096|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153835344|NCT00525096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153835345|NCT00525096|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153835364|NCT00525252|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
153835365|NCT00525252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153835366|NCT00525252|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
153375430|NCT00371553|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153375432|NCT00371553|Growth Substances|growth substances|mesh-ancestor
153375433|NCT00371553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153375434|NCT00371553|Growth Inhibitors|growth inhibitors|mesh-ancestor
153375435|NCT00371553|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153375436|NCT00371553|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153375437|NCT00371553|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153375439|NCT01507220|Bupivacaine|bupivacaine|mesh-list
153375440|NCT01507220|Anesthetics, Local|anesthetics, local|mesh-ancestor
153375441|NCT01507220|Anesthetics|anesthetics|mesh-ancestor
153375442|NCT01507220|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153375443|NCT01507220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153375444|NCT01507220|Sensory System Agents|sensory system agents|mesh-ancestor
153375445|NCT01507220|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153375446|NCT01507220|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153375447|NCT01507220|Narcotics|narcotics|mesh-ancestor
153375448|NCT01507220|Analgesics|analgesics|mesh-ancestor
153375449|NCT01509404|Valganciclovir|valganciclovir|mesh-list
153375450|NCT01509404|Antiviral Agents|antiviral agents|mesh-ancestor
153375451|NCT01509404|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153375452|NCT01562132|Fluconazole|fluconazole|mesh-list
153375453|NCT01562132|Flucytosine|flucytosine|mesh-list
153375459|NCT01562132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153375460|NCT01562132|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153634460|NCT05637073|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
153634461|NCT05637073|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
153634462|NCT05637073|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
153634525|NCT00000145|Zinc|zinc|mesh-list
153820106|NCT00471159|Antimitotic Agents|antimitotic agents|mesh-ancestor
153820107|NCT00471159|Mitosis Modulators|mitosis modulators|mesh-ancestor
153820108|NCT00471159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153820109|NCT00462618|Quetiapine Fumarate|quetiapine fumarate|mesh-list
153375462|NCT01562132|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153375463|NCT01562132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153375464|NCT01562132|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
153375465|NCT01562132|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
153375466|NCT01562132|Antimetabolites|antimetabolites|mesh-ancestor
153375467|NCT02762331|Ascorbic Acid|ascorbic acid|mesh-list
153375469|NCT02762331|Micronutrients|micronutrients|mesh-ancestor
153375470|NCT02762331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153375471|NCT02762331|Antioxidants|antioxidants|mesh-ancestor
153375472|NCT02762331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153375473|NCT02762331|Protective Agents|protective agents|mesh-ancestor
153375474|NCT02762799|Lenograstim|lenograstim|mesh-list
153375475|NCT02762799|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153375476|NCT02762799|Immunologic Factors|immunologic factors|mesh-ancestor
153375477|NCT02762799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153375478|NCT01447706|Paclitaxel|paclitaxel|mesh-list
153375479|NCT01447706|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153375480|NCT01447706|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153375481|NCT01447706|Tubulin Modulators|tubulin modulators|mesh-ancestor
153375482|NCT01447706|Antimitotic Agents|antimitotic agents|mesh-ancestor
153375483|NCT01447706|Mitosis Modulators|mitosis modulators|mesh-ancestor
153375484|NCT01447706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153375485|NCT01509638|Bupivacaine|bupivacaine|mesh-list
153375486|NCT01509638|Anesthetics, Local|anesthetics, local|mesh-ancestor
153835394|NCT02947269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153835416|NCT00526305|Antiemetics|antiemetics|mesh-ancestor
153835417|NCT00526305|Autonomic Agents|autonomic agents|mesh-ancestor
153835418|NCT00526305|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153835419|NCT00526305|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153835420|NCT00526305|Glucocorticoids|glucocorticoids|mesh-ancestor
153835421|NCT00526305|Hormones|hormones|mesh-ancestor
153835422|NCT00526305|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153835423|NCT00526305|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153835424|NCT00526305|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153634575|NCT00000175|Testosterone|testosterone|mesh-list
153634576|NCT00000175|Estrogens|estrogens|mesh-list
153634577|NCT00000175|Androgens|androgens|mesh-ancestor
153634578|NCT00000175|Hormones|hormones|mesh-ancestor
153634579|NCT00000175|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153634580|NCT00000175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153634581|NCT00000187|Ritanserin|ritanserin|mesh-list
153634582|NCT00000187|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153634583|NCT00000187|Serotonin Agents|serotonin agents|mesh-ancestor
153634584|NCT00000187|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153634585|NCT00000187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153634636|NCT00000421|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153634637|NCT00000421|Glucocorticoids|glucocorticoids|mesh-ancestor
153634638|NCT00000421|Hormones|hormones|mesh-ancestor
153634644|NCT00000427|Hormones|hormones|mesh-list
153375488|NCT01509638|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153375489|NCT01509638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153375490|NCT01509638|Sensory System Agents|sensory system agents|mesh-ancestor
153375491|NCT01509638|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153375492|NCT04336917|Lidocaine|lidocaine|mesh-list
153375494|NCT04336917|Anesthetics, Local|anesthetics, local|mesh-list
153375495|NCT04336917|Anesthetics|anesthetics|mesh-list
153375496|NCT04336917|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153375497|NCT04336917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153375498|NCT04336917|Sensory System Agents|sensory system agents|mesh-ancestor
153375499|NCT04336917|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153375500|NCT04336917|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153375501|NCT04336917|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
153375502|NCT04336917|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153375503|NCT04336917|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153375504|NCT04336917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153375505|NCT01448486|Raltegravir Potassium|raltegravir potassium|mesh-list
153835425|NCT00526305|Tubulin Modulators|tubulin modulators|mesh-ancestor
153835426|NCT00526305|Antimitotic Agents|antimitotic agents|mesh-ancestor
153835427|NCT00526305|Mitosis Modulators|mitosis modulators|mesh-ancestor
153835428|NCT00526305|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153835429|NCT00526305|Antimetabolites|antimetabolites|mesh-ancestor
153634645|NCT00000427|Parathyroid Hormone|parathyroid hormone|mesh-list
153634646|NCT00000427|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153634650|NCT00000457|Bupropion|bupropion|mesh-list
153835430|NCT00526305|Antiviral Agents|antiviral agents|mesh-ancestor
153835431|NCT00526305|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153835432|NCT00526305|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153835433|NCT00526305|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153835434|NCT00526305|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153835441|NCT02276768|Parasympatholytics|parasympatholytics|mesh-ancestor
153835442|NCT02276768|Autonomic Agents|autonomic agents|mesh-ancestor
153835443|NCT02276768|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153835444|NCT02276768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153835445|NCT00526383|Antidepressive Agents|antidepressive agents|mesh-list
153835446|NCT00526383|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-list
153835447|NCT00526383|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153835449|NCT05147753|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153835450|NCT00525408|Docetaxel|docetaxel|mesh-list
153835451|NCT00525408|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153835452|NCT00525408|Tubulin Modulators|tubulin modulators|mesh-ancestor
153835453|NCT00525408|Antimitotic Agents|antimitotic agents|mesh-ancestor
153835454|NCT00525408|Mitosis Modulators|mitosis modulators|mesh-ancestor
153835455|NCT00525408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153835456|NCT00525447|Dexamethasone|dexamethasone|mesh-list
153835457|NCT00525447|Lenalidomide|lenalidomide|mesh-list
153835458|NCT00525447|Dacetuzumab|dacetuzumab|mesh-list
153835459|NCT00525447|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153835460|NCT00525447|Antiemetics|antiemetics|mesh-ancestor
153835461|NCT00525447|Autonomic Agents|autonomic agents|mesh-ancestor
153835462|NCT00525447|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153835463|NCT00525447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153835464|NCT00525447|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153835465|NCT00525447|Glucocorticoids|glucocorticoids|mesh-ancestor
153835466|NCT00525447|Hormones|hormones|mesh-ancestor
153835467|NCT00525447|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153835468|NCT00525447|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153835477|NCT00525486|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153835479|NCT00525486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153375539|NCT02770365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153375540|NCT02770365|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
153375541|NCT02770365|Contraceptive Agents|contraceptive agents|mesh-ancestor
153375542|NCT02770365|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153375543|NCT02770365|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
153375544|NCT02770521|Insulin Lispro|insulin lispro|mesh-list
153375545|NCT02770521|Treprostinil|treprostinil|mesh-list
153375546|NCT02770521|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153375547|NCT02770521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153375548|NCT02770521|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153375550|NCT02346240|Certolizumab Pegol|certolizumab pegol|mesh-list
153375551|NCT02346240|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153375552|NCT02346240|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153375553|NCT02346240|Analgesics|analgesics|mesh-ancestor
153375554|NCT02346240|Sensory System Agents|sensory system agents|mesh-ancestor
153375555|NCT02346240|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153375556|NCT02346240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153375557|NCT02346240|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153375558|NCT02346240|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153375559|NCT02346240|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153375560|NCT02346240|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153375561|NCT02346240|Immunologic Factors|immunologic factors|mesh-ancestor
153375562|NCT02346240|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
153375563|NCT01511978|Amifampridine|amifampridine|mesh-list
153375564|NCT01511978|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
153375565|NCT01511978|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153375566|NCT01511978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153835480|NCT00525486|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153835481|NCT00525486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153835482|NCT00525486|Vasodilator Agents|vasodilator agents|mesh-ancestor
153835483|NCT00525486|Tocolytic Agents|tocolytic agents|mesh-ancestor
153835504|NCT00525564|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153835505|NCT00525564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153835506|NCT00525642|Cyclophosphamide|cyclophosphamide|mesh-list
153375567|NCT01511978|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
153375568|NCT01511978|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153375569|NCT01511978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153375571|NCT02772783|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
153375572|NCT02772783|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153375573|NCT02772783|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153375582|NCT05349045|Growth Substances|growth substances|mesh-ancestor
153375583|NCT05349045|Growth Inhibitors|growth inhibitors|mesh-ancestor
153375584|NCT05349045|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153375585|NCT02392104|Warfarin|warfarin|mesh-list
153375586|NCT02392104|Anticoagulants|anticoagulants|mesh-ancestor
153375587|NCT04336605|Analgesics|analgesics|mesh-list
153375588|NCT04336605|Sensory System Agents|sensory system agents|mesh-ancestor
153375589|NCT04336605|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153375590|NCT04336605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153375591|NCT01450826|Ondansetron|ondansetron|mesh-list
153375592|NCT01450826|Aprepitant|aprepitant|mesh-list
153375593|NCT01450826|Antiemetics|antiemetics|mesh-ancestor
153835507|NCT00525642|Docetaxel|docetaxel|mesh-list
153835508|NCT00525642|Doxorubicin|doxorubicin|mesh-list
153835509|NCT00525642|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
153835510|NCT00525642|Epirubicin|epirubicin|mesh-list
153835511|NCT00525642|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153835512|NCT00525642|Immunologic Factors|immunologic factors|mesh-ancestor
153835513|NCT00525642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153835514|NCT00525642|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153835515|NCT00525642|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153835516|NCT00525642|Alkylating Agents|alkylating agents|mesh-ancestor
153835517|NCT00525642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153835518|NCT00525642|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153835519|NCT00525642|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153835520|NCT00525642|Tubulin Modulators|tubulin modulators|mesh-ancestor
153461534|NCT03227562|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153634879|NCT00000556|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153461535|NCT03227562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153634880|NCT00000556|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
153634941|NCT00000586|Antisickling Agents|antisickling agents|mesh-ancestor
153634942|NCT00000586|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153634943|NCT00000586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153634944|NCT00000586|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153634945|NCT00000595|Deferoxamine|deferoxamine|mesh-list
153461536|NCT03227562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153461537|NCT03227562|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153461538|NCT03227562|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153835522|NCT00525642|Mitosis Modulators|mitosis modulators|mesh-ancestor
153835523|NCT00525642|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153835524|NCT00525642|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153835525|NCT00525642|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153835526|NCT00525642|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153835527|NCT00525681|Cyclosporine|cyclosporine|mesh-list
153835528|NCT00525681|Tacrolimus|tacrolimus|mesh-list
153835529|NCT00525681|Cyclosporins|cyclosporins|mesh-list
153835530|NCT00525681|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153835531|NCT00525681|Immunologic Factors|immunologic factors|mesh-ancestor
153835532|NCT00525681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153835533|NCT00525681|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
153835534|NCT00525681|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153835535|NCT00525681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153835536|NCT00525681|Antifungal Agents|antifungal agents|mesh-ancestor
153835537|NCT00525681|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153835538|NCT00525681|Dermatologic Agents|dermatologic agents|mesh-ancestor
153835539|NCT00525681|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153835540|NCT03456635|Anti-Infective Agents|anti-infective agents|mesh-list
153835541|NCT03456635|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
153835542|NCT02945982|Entecavir|entecavir|mesh-list
153835543|NCT02945982|Carvedilol|carvedilol|mesh-list
153835544|NCT02945982|Antiviral Agents|antiviral agents|mesh-ancestor
153835545|NCT02945982|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153835546|NCT02945982|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
153835547|NCT02945982|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
153835556|NCT02945982|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153375616|NCT05349825|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153375617|NCT05349825|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153375618|NCT05349825|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
153375623|NCT01451996|Dermatologic Agents|dermatologic agents|mesh-ancestor
153375624|NCT01451996|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
153375625|NCT01451996|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
153375627|NCT01451996|Histamine Antagonists|histamine antagonists|mesh-ancestor
153375628|NCT01451996|Histamine Agents|histamine agents|mesh-ancestor
153375629|NCT01451996|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153375630|NCT01451996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153635078|NCT00000688|Ganciclovir|ganciclovir|mesh-list
153375631|NCT01451996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153375632|NCT01512446|Alendronate|alendronate|mesh-list
153375633|NCT01512446|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153375634|NCT01512446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153375635|NCT04334967|Ascorbic Acid|ascorbic acid|mesh-list
153375636|NCT04334967|Hydroxychloroquine|hydroxychloroquine|mesh-list
153375638|NCT04334967|Micronutrients|micronutrients|mesh-ancestor
153375639|NCT04334967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153375640|NCT04334967|Antimalarials|antimalarials|mesh-ancestor
153375641|NCT04334967|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153375642|NCT04334967|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153375643|NCT04334967|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153375644|NCT04334967|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153835557|NCT02945982|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153835558|NCT02945982|Vasodilator Agents|vasodilator agents|mesh-ancestor
153835559|NCT02945982|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
153835560|NCT02945982|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
153835561|NCT02954393|Amoxicillin|amoxicillin|mesh-list
153835562|NCT02954393|Metronidazole|metronidazole|mesh-list
153835563|NCT02954393|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153835564|NCT02954393|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153835565|NCT02954393|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153835566|NCT02954393|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153635251|NCT00000799|Uricosuric Agents|uricosuric agents|mesh-ancestor
153635252|NCT00000799|Gout Suppressants|gout suppressants|mesh-ancestor
153635253|NCT00000799|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153635254|NCT00000799|Antiviral Agents|antiviral agents|mesh-ancestor
153635255|NCT00000799|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153635256|NCT00000799|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153635257|NCT00000799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153635258|NCT00000817|Amitriptyline|amitriptyline|mesh-list
153635260|NCT00000817|Antidepressive Agents|antidepressive agents|mesh-ancestor
153835567|NCT02954276|Sumatriptan|sumatriptan|mesh-list
153835568|NCT02954276|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
153835569|NCT02954276|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
153375651|NCT04335123|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153375652|NCT04335123|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
153375653|NCT04335123|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
153375654|NCT04335123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153375655|NCT02742987|Clopidogrel|clopidogrel|mesh-list
153375656|NCT02742987|Ticagrelor|ticagrelor|mesh-list
153375657|NCT02742987|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153375658|NCT02742987|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
153375659|NCT02742987|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
153375660|NCT02742987|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
153375661|NCT02742987|Purinergic Agents|purinergic agents|mesh-ancestor
153375662|NCT02742987|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153375663|NCT02742987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153835584|NCT00526617|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
153835585|NCT00526617|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153835586|NCT00507845|Felodipine|felodipine|mesh-list
153835587|NCT00507845|Ramipril|ramipril|mesh-list
153835588|NCT00507845|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
153835589|NCT00507845|Protease Inhibitors|protease inhibitors|mesh-ancestor
153835590|NCT00507845|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153835591|NCT00507845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153635323|NCT00000859|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
153635324|NCT00000859|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153835592|NCT00507845|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153835593|NCT00507845|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153835594|NCT00507845|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153835595|NCT00507845|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153375676|NCT05450055|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153375677|NCT05450055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153375678|NCT02743377|Rolipram|rolipram|mesh-list
153375679|NCT02743377|Antidepressive Agents|antidepressive agents|mesh-ancestor
153375680|NCT02743377|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153375681|NCT02743377|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
153375682|NCT02743377|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
153375683|NCT02743377|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153375684|NCT02743377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153375685|NCT05437965|Glucocorticoids|glucocorticoids|mesh-list
153835606|NCT00507962|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153835607|NCT00507962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153835608|NCT00508040|Interferons|interferons|mesh-list
153835609|NCT00508040|Interferon-alpha|interferon-alpha|mesh-list
153835610|NCT00508040|Interferon alpha-2|interferon alpha-2|mesh-list
153835611|NCT00508040|Prednisone|prednisone|mesh-list
153835612|NCT00508040|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153635411|NCT00000904|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
153835613|NCT00508040|Glucocorticoids|glucocorticoids|mesh-ancestor
153835614|NCT00508040|Hormones|hormones|mesh-ancestor
153835615|NCT00508040|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153835616|NCT00508040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153835617|NCT00508040|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153835618|NCT00508040|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153835619|NCT00508040|Antiviral Agents|antiviral agents|mesh-ancestor
153835620|NCT00508040|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153835621|NCT00508040|Immunologic Factors|immunologic factors|mesh-ancestor
153835622|NCT00508664|Docetaxel|docetaxel|mesh-list
153835623|NCT00508664|Fluorouracil|fluorouracil|mesh-list
153835624|NCT00508664|Cetuximab|cetuximab|mesh-list
153835625|NCT00508664|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153835626|NCT00508664|Tubulin Modulators|tubulin modulators|mesh-ancestor
153835627|NCT00508664|Antimitotic Agents|antimitotic agents|mesh-ancestor
153835628|NCT00508664|Mitosis Modulators|mitosis modulators|mesh-ancestor
153835629|NCT00508664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153375686|NCT05437965|Immunosuppressive Agents|immunosuppressive agents|mesh-list
153375693|NCT00372099|Calcitonin Gene-Related Peptide|calcitonin gene-related peptide|mesh-list
153375694|NCT00372099|Katacalcin|katacalcin|mesh-list
153635523|NCT00000643|Antidotes|antidotes|mesh-ancestor
153375695|NCT00372099|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153375696|NCT00372099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153375697|NCT00372099|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153375699|NCT02748525|Cholecystokinin|cholecystokinin|mesh-list
153375700|NCT02748525|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
153375701|NCT02748525|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153375702|NCT01454414|Permethrin|permethrin|mesh-list
153375703|NCT01454414|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153375704|NCT01454414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153375705|NCT04335513|Insulin|insulin|mesh-list
153375708|NCT01568528|Oxytocin|oxytocin|mesh-list
153835670|NCT02953847|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
153835671|NCT02953847|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
153835672|NCT02953847|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
153835673|NCT02953847|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
153835674|NCT02953847|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153375741|NCT04737837|Anticonvulsants|anticonvulsants|mesh-ancestor
153375742|NCT04737837|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
153375743|NCT04737837|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153375744|NCT04737837|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153375745|NCT04737837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153375746|NCT05456763|Butyric Acid|butyric acid|mesh-list
153635688|NCT00001048|Zidovudine|zidovudine|mesh-list
153635689|NCT00001048|Didanosine|didanosine|mesh-list
153635691|NCT00001048|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153635692|NCT00001048|Antimetabolites|antimetabolites|mesh-ancestor
153375747|NCT05456763|Histamine Antagonists|histamine antagonists|mesh-ancestor
153375748|NCT05456763|Histamine Agents|histamine agents|mesh-ancestor
153375749|NCT05456763|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153375750|NCT05456763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153375751|NCT05456763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153375752|NCT02973711|Nilotinib|nilotinib|mesh-list
153375753|NCT02973711|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153375754|NCT02973711|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153375755|NCT02973711|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153835675|NCT02953847|Antimetabolites|antimetabolites|mesh-ancestor
153835676|NCT02953847|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153835677|NCT00526695|Sevoflurane|sevoflurane|mesh-list
153835678|NCT00526695|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153375770|NCT00372645|Micronutrients|micronutrients|mesh-ancestor
153375771|NCT00372645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153375772|NCT00372723|Infliximab|infliximab|mesh-list
153375773|NCT00372723|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
153375774|NCT00372723|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153375775|NCT00372723|Dermatologic Agents|dermatologic agents|mesh-ancestor
153375776|NCT00372723|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153375777|NCT00372723|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153835700|NCT00508859|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153835701|NCT00508859|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
153835702|NCT00508859|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153835703|NCT00508859|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153835704|NCT00508859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153835705|NCT00508859|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153835706|NCT00508859|Serotonin Agents|serotonin agents|mesh-ancestor
153835707|NCT00508859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153835708|NCT00508898|Calcitriol|calcitriol|mesh-list
153835709|NCT00508898|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153835710|NCT00508898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153835734|NCT00510419|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
153835735|NCT00510419|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
153835736|NCT00510419|Serotonin Agents|serotonin agents|mesh-ancestor
153635830|NCT00001180|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153635833|NCT00389272|Ibuprofen|ibuprofen|mesh-list
153635861|NCT00000114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153635862|NCT00000114|Antioxidants|antioxidants|mesh-ancestor
153635863|NCT00000114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153635864|NCT00000114|Protective Agents|protective agents|mesh-ancestor
153635865|NCT00001261|gamma-Globulins|gamma-globulins|mesh-list
153635866|NCT00001261|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
153635867|NCT00001261|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
153635868|NCT00001261|Immunologic Factors|immunologic factors|mesh-ancestor
153835737|NCT00510419|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153835738|NCT00510419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153835739|NCT00510419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153375799|NCT05455359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153375807|NCT00373503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153375808|NCT00373503|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153375809|NCT00373503|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153375810|NCT00373503|Analgesics|analgesics|mesh-ancestor
153375811|NCT00373503|Sensory System Agents|sensory system agents|mesh-ancestor
153375812|NCT00373503|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153375813|NCT00373503|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
153375814|NCT00373503|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
153375815|NCT00373503|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153375816|NCT00373503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153375817|NCT00373503|Hormones|hormones|mesh-ancestor
153375818|NCT00373503|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153375819|NCT00373503|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153375820|NCT00373503|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
153375821|NCT00373503|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
153375822|NCT00373503|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153375823|NCT00373503|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153375824|NCT00373503|Adrenergic Agents|adrenergic agents|mesh-ancestor
153375825|NCT01515176|Ofatumumab|ofatumumab|mesh-list
153375826|NCT01515176|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
153375827|NCT01515176|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153375828|NCT01515176|Immunologic Factors|immunologic factors|mesh-ancestor
153835740|NCT00510536|Acetaminophen|acetaminophen|mesh-list
153835741|NCT00510536|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153835742|NCT00510536|Analgesics|analgesics|mesh-ancestor
153835743|NCT00510536|Sensory System Agents|sensory system agents|mesh-ancestor
153835751|NCT03458715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153835752|NCT03458715|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153835753|NCT03458715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153835754|NCT03458715|Incretins|incretins|mesh-ancestor
153835755|NCT03458715|Hormones|hormones|mesh-ancestor
153835756|NCT03458715|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153835757|NCT03458715|Protease Inhibitors|protease inhibitors|mesh-ancestor
153835758|NCT03458715|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153835759|NCT00510614|Tinidazole|tinidazole|mesh-list
153835760|NCT00510614|Alkylating Agents|alkylating agents|mesh-ancestor
153835761|NCT00510614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153835762|NCT00510614|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153835763|NCT00510614|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153835764|NCT00510614|Antitrichomonal Agents|antitrichomonal agents|mesh-ancestor
153835765|NCT00510614|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153375841|NCT01515566|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153375843|NCT01515566|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153375844|NCT01515566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153375845|NCT01515566|Analgesics|analgesics|mesh-ancestor
153375846|NCT01515566|Sensory System Agents|sensory system agents|mesh-ancestor
153375847|NCT01515566|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153375848|NCT01515566|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153375849|NCT01515566|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153375850|NCT01515566|Anesthetics, General|anesthetics, general|mesh-ancestor
153835769|NCT00508976|Anesthetics, Local|anesthetics, local|mesh-ancestor
153636115|NCT00001741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153835770|NCT00508976|Anesthetics|anesthetics|mesh-ancestor
153835771|NCT00508976|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153835780|NCT00509015|Artesunate|artesunate|mesh-list
153375867|NCT05440968|Analgesics|analgesics|mesh-ancestor
153375868|NCT05440968|Sensory System Agents|sensory system agents|mesh-ancestor
153375869|NCT05440968|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153375870|NCT05440968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153375871|NCT05440968|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153375872|NCT05440968|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153375873|NCT01516424|Risperidone|risperidone|mesh-list
153375874|NCT01516424|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153375875|NCT01516424|Serotonin Agents|serotonin agents|mesh-ancestor
153835791|NCT00509015|Schistosomicides|schistosomicides|mesh-ancestor
153835792|NCT00509015|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
153835793|NCT00509015|Anthelmintics|anthelmintics|mesh-ancestor
153835794|NCT00509015|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153835795|NCT00509015|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153835796|NCT00509015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153636238|NCT00000369|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153636239|NCT00000369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153636240|NCT00000369|Antimanic Agents|antimanic agents|mesh-ancestor
153636241|NCT00000369|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153636242|NCT00000369|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153636243|NCT00000369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153636244|NCT00000375|Nortriptyline|nortriptyline|mesh-list
153835797|NCT00509015|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
153835798|NCT00528060|Ritonavir|ritonavir|mesh-list
153835799|NCT00528060|Atazanavir Sulfate|atazanavir sulfate|mesh-list
153835800|NCT00528060|Tenofovir|tenofovir|mesh-list
153835801|NCT00528060|Emtricitabine|emtricitabine|mesh-list
153835802|NCT00528060|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
153835803|NCT00528060|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
153835804|NCT00528060|Protease Inhibitors|protease inhibitors|mesh-ancestor
153835805|NCT00528060|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153835806|NCT00528060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153835807|NCT00528060|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153835813|NCT00528060|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153835819|NCT00527085|Hormone Antagonists|hormone antagonists|mesh-ancestor
153835820|NCT00527085|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153835821|NCT00509327|Bisacodyl|bisacodyl|mesh-list
153835822|NCT00509327|Cathartics|cathartics|mesh-ancestor
153835823|NCT00509327|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153835824|NCT00509327|Laxatives|laxatives|mesh-ancestor
153835825|NCT00509405|Potassium Citrate|potassium citrate|mesh-list
153835826|NCT00509405|Diuretics|diuretics|mesh-ancestor
153835827|NCT00509405|Natriuretic Agents|natriuretic agents|mesh-ancestor
153835828|NCT00509405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153835829|NCT00509405|Expectorants|expectorants|mesh-ancestor
153835830|NCT00509405|Respiratory System Agents|respiratory system agents|mesh-ancestor
153835831|NCT00509561|Capecitabine|capecitabine|mesh-list
153636313|NCT00000381|Antidepressive Agents|antidepressive agents|mesh-ancestor
153636314|NCT00000381|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153636315|NCT00000381|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
153636316|NCT00000381|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153835832|NCT00509561|Cetuximab|cetuximab|mesh-list
153835833|NCT00509561|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153636317|NCT00000381|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153835834|NCT00509561|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153835835|NCT00509561|Antimetabolites|antimetabolites|mesh-ancestor
153835836|NCT00509561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153835837|NCT00509561|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153835838|NCT00509639|Metronidazole|metronidazole|mesh-list
153835839|NCT00509639|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153835840|NCT00509639|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153835841|NCT00509639|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153375923|NCT01468532|Antimitotic Agents|antimitotic agents|mesh-ancestor
153375924|NCT01468532|Mitosis Modulators|mitosis modulators|mesh-ancestor
153375925|NCT01468532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153375926|NCT01468532|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153375927|NCT01468532|Glucocorticoids|glucocorticoids|mesh-ancestor
153375929|NCT01468532|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153375930|NCT01468532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153375931|NCT01468532|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153375933|NCT01469234|Fexofenadine|fexofenadine|mesh-list
153375934|NCT01469234|Terfenadine|terfenadine|mesh-list
153375935|NCT01469234|Antipruritics|antipruritics|mesh-ancestor
153835850|NCT00528177|Sensory System Agents|sensory system agents|mesh-ancestor
153835863|NCT00528216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153835865|NCT00528255|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
153835866|NCT00528255|Abortifacient Agents|abortifacient agents|mesh-ancestor
153835867|NCT00528255|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153835868|NCT00528255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153375945|NCT06196021|Hyaluronic Acid|hyaluronic acid|mesh-list
153375946|NCT06196021|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153375947|NCT06196021|Immunologic Factors|immunologic factors|mesh-ancestor
153636414|NCT02972476|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
153636415|NCT02972476|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153636416|NCT02972476|Adrenergic Agents|adrenergic agents|mesh-ancestor
153636417|NCT02972476|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153375948|NCT06196021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153375949|NCT06196021|Viscosupplements|viscosupplements|mesh-ancestor
153375950|NCT06196021|Protective Agents|protective agents|mesh-ancestor
153375951|NCT06195670|Capecitabine|capecitabine|mesh-list
153375952|NCT06195670|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153375953|NCT06195670|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153375954|NCT06195670|Antimetabolites|antimetabolites|mesh-ancestor
153375955|NCT06195670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153375957|NCT06195306|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
153375959|NCT06195306|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153375961|NCT06195306|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153375962|NCT06195306|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153835875|NCT02953106|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153835876|NCT02953106|Autonomic Agents|autonomic agents|mesh-ancestor
153835877|NCT02953106|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153835881|NCT02953106|Dermatologic Agents|dermatologic agents|mesh-ancestor
153835882|NCT02953106|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
153835883|NCT02953106|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
153835884|NCT02953106|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153835885|NCT02953106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153835886|NCT02953106|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
153835887|NCT02953106|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
153835888|NCT02953106|Histamine Antagonists|histamine antagonists|mesh-ancestor
153835889|NCT02953106|Histamine Agents|histamine agents|mesh-ancestor
153835890|NCT02953106|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153835891|NCT02952989|Pembrolizumab|pembrolizumab|mesh-list
153835892|NCT02952989|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153835893|NCT02952989|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153835894|NCT02952989|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153835895|NCT02952989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153835896|NCT00510926|Imatinib Mesylate|imatinib mesylate|mesh-list
153835897|NCT00510926|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153835898|NCT00510926|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153636479|NCT00000504|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153835899|NCT00510926|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153375973|NCT06195254|Immunologic Factors|immunologic factors|mesh-ancestor
153375974|NCT06195254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153375975|NCT06195137|Thioctic Acid|thioctic acid|mesh-list
153375976|NCT06195137|Caffeine|caffeine|mesh-list
153375977|NCT06195137|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
153375978|NCT06195137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153375979|NCT06195137|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
153375980|NCT06195137|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153375981|NCT06195137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153375982|NCT06195137|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
153375983|NCT06195137|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
153835900|NCT00510926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153835901|NCT00510926|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153835902|NCT00509834|Lactoferrin|lactoferrin|mesh-list
153835903|NCT00509834|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153835904|NCT03459404|Sufentanil|sufentanil|mesh-list
153835905|NCT03459404|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153835906|NCT03459404|Narcotics|narcotics|mesh-ancestor
153835907|NCT03459404|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153835908|NCT03459404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153835909|NCT03459404|Analgesics|analgesics|mesh-ancestor
153835910|NCT03459404|Sensory System Agents|sensory system agents|mesh-ancestor
153835911|NCT03459404|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153835912|NCT03459404|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153835913|NCT03459404|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153835914|NCT03459404|Anesthetics, General|anesthetics, general|mesh-ancestor
153835915|NCT03459404|Anesthetics|anesthetics|mesh-ancestor
153835916|NCT00527202|Botulinum Toxins|botulinum toxins|mesh-list
153835917|NCT00527202|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
153835918|NCT00527202|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
153835919|NCT00527202|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
153835920|NCT00527202|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153376000|NCT06194851|Oxytocin|oxytocin|mesh-list
153376001|NCT06194851|Oxytocics|oxytocics|mesh-ancestor
153636581|NCT00000525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153376002|NCT06194851|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153376003|NCT06194851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153376004|NCT06194734|Docetaxel|docetaxel|mesh-list
153376005|NCT06194734|Irinotecan|irinotecan|mesh-list
153376006|NCT06194734|Tegafur|tegafur|mesh-list
153376007|NCT06194734|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153376008|NCT06194734|Tubulin Modulators|tubulin modulators|mesh-ancestor
153376009|NCT06194734|Antimitotic Agents|antimitotic agents|mesh-ancestor
153376010|NCT06194734|Mitosis Modulators|mitosis modulators|mesh-ancestor
153835921|NCT00527202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153835935|NCT00509990|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153835937|NCT00509990|Analgesics|analgesics|mesh-ancestor
153636705|NCT04650880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153835938|NCT00509990|Sensory System Agents|sensory system agents|mesh-ancestor
153835939|NCT00509990|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153835940|NCT00509990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153835941|NCT00509990|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153835942|NCT00509990|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153835943|NCT00509990|Dermatologic Agents|dermatologic agents|mesh-ancestor
153835944|NCT00509990|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153636706|NCT04650880|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153636707|NCT04601077|Nitric Oxide|nitric oxide|mesh-list
153636748|NCT00000639|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
153636749|NCT00000639|Flucytosine|flucytosine|mesh-list
153636750|NCT00000639|Antifungal Agents|antifungal agents|mesh-ancestor
153636751|NCT00000639|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153636752|NCT00000639|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
153636753|NCT00000639|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153636754|NCT00000639|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153636756|NCT00000639|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153376011|NCT06194734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153376013|NCT06194734|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153376014|NCT06194734|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153376015|NCT06194734|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153376016|NCT06194734|Antimetabolites|antimetabolites|mesh-ancestor
153376017|NCT06194721|Anesthetics|anesthetics|mesh-list
153376018|NCT06194721|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153376019|NCT06194721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153376020|NCT06194656|Cetuximab|cetuximab|mesh-list
153376021|NCT06194656|Antibodies|antibodies|mesh-list
153376022|NCT06194656|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
153376023|NCT06194656|Immunologic Factors|immunologic factors|mesh-ancestor
153376024|NCT06194656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153376025|NCT06194656|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153376026|NCT06194656|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153376027|NCT06194617|Anticoagulants|anticoagulants|mesh-list
153376028|NCT06194214|Digoxin|digoxin|mesh-list
153376029|NCT06194214|Pirtobrutinib|pirtobrutinib|mesh-list
153376030|NCT06194214|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153376031|NCT06194214|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
153835959|NCT03459833|Viscosupplements|viscosupplements|mesh-ancestor
153835960|NCT03459833|Protective Agents|protective agents|mesh-ancestor
153835961|NCT05648487|Antibodies|antibodies|mesh-list
153835962|NCT05648487|Immunologic Factors|immunologic factors|mesh-ancestor
153835963|NCT05648487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153835964|NCT00511121|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
153835965|NCT00511121|Imatinib Mesylate|imatinib mesylate|mesh-list
153835966|NCT00511121|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153835967|NCT00511121|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153835968|NCT00511121|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153835969|NCT00511121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153835970|NCT00511121|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153835971|NCT00511121|Antiviral Agents|antiviral agents|mesh-ancestor
153636869|NCT04321954|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153636871|NCT00000675|CD4 Immunoadhesins|cd4 immunoadhesins|mesh-list
153835972|NCT00511121|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153835973|NCT04692051|Paclitaxel|paclitaxel|mesh-list
153835974|NCT04692051|Cisplatin|cisplatin|mesh-list
153835975|NCT04692051|Gemcitabine|gemcitabine|mesh-list
153835976|NCT04692051|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153835977|NCT04692051|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153835978|NCT04692051|Tubulin Modulators|tubulin modulators|mesh-ancestor
153835979|NCT04692051|Antimitotic Agents|antimitotic agents|mesh-ancestor
153835980|NCT04692051|Mitosis Modulators|mitosis modulators|mesh-ancestor
153835981|NCT04692051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153835982|NCT04692051|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153835983|NCT04692051|Antimetabolites|antimetabolites|mesh-ancestor
153835984|NCT00528723|Albuterol|albuterol|mesh-list
153835985|NCT00528723|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153835986|NCT00528723|Autonomic Agents|autonomic agents|mesh-ancestor
153835987|NCT00528723|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153835988|NCT00528723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153835989|NCT00528723|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153835990|NCT00528723|Respiratory System Agents|respiratory system agents|mesh-ancestor
153835991|NCT00528723|Tocolytic Agents|tocolytic agents|mesh-ancestor
153835992|NCT00528723|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153835993|NCT00528723|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
153835994|NCT00528723|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
153835995|NCT00528723|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153376074|NCT06191133|Antimetabolites|antimetabolites|mesh-ancestor
153376075|NCT06191133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153636942|NCT00000687|Antiviral Agents|antiviral agents|mesh-ancestor
153376076|NCT06191133|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153376077|NCT06190951|Pembrolizumab|pembrolizumab|mesh-list
153376078|NCT06190951|Cemiplimab|cemiplimab|mesh-list
153376079|NCT06190951|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153376080|NCT06190951|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153376081|NCT06190951|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153376082|NCT06190951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153376083|NCT06190912|Bryostatin 1|bryostatin 1|mesh-list
153376084|NCT06190912|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153376085|NCT06190912|Immunologic Factors|immunologic factors|mesh-ancestor
153376086|NCT06190912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153376087|NCT06190912|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153376088|NCT06190899|Gedatolisib|gedatolisib|mesh-list
153376089|NCT06190899|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153376090|NCT06190899|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153637094|NCT04020172|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
153637095|NCT04020172|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153376091|NCT06190899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153835998|NCT00528723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153835999|NCT00510107|Oxaliplatin|oxaliplatin|mesh-list
153836000|NCT00510107|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153836002|NCT01580514|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
153836003|NCT01580514|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153836004|NCT01580514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153836005|NCT01580514|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
153836006|NCT01580514|Incretins|incretins|mesh-ancestor
153836007|NCT01580514|Hormones|hormones|mesh-ancestor
153836008|NCT01580514|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153836009|NCT00528918|Insulin glulisine|insulin glulisine|mesh-list
153836010|NCT00528918|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153836012|NCT00515190|Oxaliplatin|oxaliplatin|mesh-list
153836023|NCT02953184|Cyclophosphamide|cyclophosphamide|mesh-list
153836024|NCT02953184|Docetaxel|docetaxel|mesh-list
153836025|NCT02953184|Doxorubicin|doxorubicin|mesh-list
153376093|NCT06190782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153376094|NCT06190782|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153376095|NCT06190782|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153836027|NCT02953184|Dexrazoxane|dexrazoxane|mesh-list
153836028|NCT02953184|Razoxane|razoxane|mesh-list
153836029|NCT02953184|Pirarubicin|pirarubicin|mesh-list
153836030|NCT02953184|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153836031|NCT02953184|Immunologic Factors|immunologic factors|mesh-ancestor
153637324|NCT00000870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153836032|NCT02953184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153836033|NCT02953184|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153836034|NCT02953184|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153836035|NCT02953184|Alkylating Agents|alkylating agents|mesh-ancestor
153836036|NCT02953184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153836037|NCT02953184|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153836038|NCT02953184|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153836039|NCT02953184|Micronutrients|micronutrients|mesh-ancestor
153836040|NCT02953184|Tubulin Modulators|tubulin modulators|mesh-ancestor
153836041|NCT02953184|Antimitotic Agents|antimitotic agents|mesh-ancestor
153836042|NCT02953184|Mitosis Modulators|mitosis modulators|mesh-ancestor
153836043|NCT02953184|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153836044|NCT02953184|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153836058|NCT00515229|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
153836059|NCT00515229|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153836060|NCT00515229|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153836061|NCT00515229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153836062|NCT00515229|Adrenergic Agents|adrenergic agents|mesh-ancestor
153836063|NCT00515229|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153836064|NCT00511316|Montelukast|montelukast|mesh-list
153836065|NCT00511316|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153836066|NCT00511316|Respiratory System Agents|respiratory system agents|mesh-ancestor
153836067|NCT00511316|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
153836068|NCT00511316|Hormone Antagonists|hormone antagonists|mesh-ancestor
153836069|NCT00511316|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153836070|NCT00511316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153376140|NCT06190483|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153376141|NCT06190483|Anticonvulsants|anticonvulsants|mesh-ancestor
153376150|NCT06190483|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153376151|NCT06190483|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153376152|NCT06190483|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153637436|NCT00000903|Protease Inhibitors|protease inhibitors|mesh-ancestor
153376153|NCT06190483|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153376154|NCT06190483|Anesthetics, General|anesthetics, general|mesh-ancestor
153376155|NCT06190483|Anesthetics|anesthetics|mesh-ancestor
153376156|NCT06190483|GABA Modulators|gaba modulators|mesh-ancestor
153376157|NCT06190483|GABA Agents|gaba agents|mesh-ancestor
153376158|NCT06190483|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153376159|NCT06190457|Rituximab|rituximab|mesh-list
153376160|NCT06190457|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153376161|NCT06190457|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153376162|NCT06190457|Immunologic Factors|immunologic factors|mesh-ancestor
153376163|NCT06190457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153376164|NCT06190457|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153376165|NCT06190405|Chrysarobin|chrysarobin|mesh-list
153836082|NCT00529269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153836083|NCT00515268|6-((3-((dimethylamino)carbonyl)phenyl)sulfonyl)-8-methyl-4-((3-methyloxyphenyl)amino)-3-quinolinecarboxamide|6-((3-((dimethylamino)carbonyl)phenyl)sulfonyl)-8-methyl-4-((3-methyloxyphenyl)amino)-3-quinolinecarboxamide|mesh-list
153836084|NCT00515268|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
153836085|NCT00515268|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
153836087|NCT00515268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153836088|NCT01356966|Folic Acid|folic acid|mesh-list
153836089|NCT01356966|Hematinics|hematinics|mesh-ancestor
153836090|NCT01356966|Vitamin B Complex|vitamin b complex|mesh-ancestor
153836091|NCT01356966|Vitamins|vitamins|mesh-ancestor
153836092|NCT01356966|Micronutrients|micronutrients|mesh-ancestor
153637536|NCT00000999|Zidovudine|zidovudine|mesh-list
153836093|NCT01356966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153836094|NCT02944734|Amlodipine|amlodipine|mesh-list
153836095|NCT02944734|Candesartan|candesartan|mesh-list
153376167|NCT06190405|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153376168|NCT06190405|Analgesics|analgesics|mesh-ancestor
153376169|NCT06190405|Sensory System Agents|sensory system agents|mesh-ancestor
153376170|NCT06190405|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153376171|NCT06190405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153376188|NCT06190158|Captopril|captopril|mesh-list
153836111|NCT00510263|Prednisolone acetate|prednisolone acetate|mesh-list
153836112|NCT00510263|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
153836113|NCT00510263|Prednisolone phosphate|prednisolone phosphate|mesh-list
153836114|NCT00510263|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153836115|NCT00510263|Glucocorticoids|glucocorticoids|mesh-ancestor
153836116|NCT00510263|Hormones|hormones|mesh-ancestor
153836117|NCT00510263|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153836118|NCT00510263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153836119|NCT00510263|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153836120|NCT00510263|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153836121|NCT00510263|Antiemetics|antiemetics|mesh-ancestor
153836122|NCT00510263|Autonomic Agents|autonomic agents|mesh-ancestor
153836123|NCT00510263|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153376198|NCT06190158|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153376199|NCT06190158|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153376200|NCT06190158|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153637600|NCT00391144|Hormones|hormones|mesh-ancestor
153376201|NCT06190158|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
153376202|NCT06190158|Protease Inhibitors|protease inhibitors|mesh-ancestor
153376203|NCT06190158|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153376207|NCT06190145|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153376208|NCT06190145|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153376210|NCT06190145|Sensory System Agents|sensory system agents|mesh-ancestor
153376211|NCT06190145|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153376212|NCT06190145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153376213|NCT06190145|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153376214|NCT06190145|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153376215|NCT06190145|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153376216|NCT06190145|Immunologic Factors|immunologic factors|mesh-ancestor
153376218|NCT06190132|Analgesics|analgesics|mesh-ancestor
153376219|NCT06190132|Sensory System Agents|sensory system agents|mesh-ancestor
153376220|NCT06190132|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153836128|NCT00510263|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153836129|NCT00511628|Risperidone|risperidone|mesh-list
153836130|NCT00511628|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153836131|NCT00511628|Serotonin Agents|serotonin agents|mesh-ancestor
153836132|NCT00511628|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153836133|NCT00511628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153836134|NCT00511628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153836135|NCT00511628|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153836136|NCT00511628|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153836137|NCT00511628|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153836138|NCT00511628|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153836139|NCT00511628|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
153836140|NCT00511628|Dopamine Agents|dopamine agents|mesh-ancestor
153836141|NCT00529425|Ropivacaine|ropivacaine|mesh-list
153836142|NCT00529425|Anesthetics, Local|anesthetics, local|mesh-ancestor
153836143|NCT00529425|Anesthetics|anesthetics|mesh-ancestor
153836144|NCT00529425|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153637702|NCT00005831|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153637703|NCT00005831|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153637704|NCT00005831|Tubulin Modulators|tubulin modulators|mesh-ancestor
153637705|NCT00005831|Antimitotic Agents|antimitotic agents|mesh-ancestor
153637706|NCT00005831|Mitosis Modulators|mitosis modulators|mesh-ancestor
153637707|NCT00005831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153637708|NCT00005831|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153637709|NCT00005831|Antimetabolites|antimetabolites|mesh-ancestor
153637710|NCT00005831|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153637711|NCT00005834|Thalidomide|thalidomide|mesh-list
153637712|NCT00005834|Dexamethasone|dexamethasone|mesh-list
153637713|NCT00005834|Cyclophosphamide|cyclophosphamide|mesh-list
153637714|NCT00005834|Etoposide|etoposide|mesh-list
153637715|NCT00005834|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153637744|NCT00001029|Zidovudine|zidovudine|mesh-list
153836145|NCT00529425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153836146|NCT00529425|Sensory System Agents|sensory system agents|mesh-ancestor
153836147|NCT00529425|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153836148|NCT02950935|Progesterone|progesterone|mesh-list
153836149|NCT02950935|Progestins|progestins|mesh-ancestor
153836150|NCT02950935|Hormones|hormones|mesh-ancestor
153836151|NCT02950935|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153836152|NCT02950935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153836153|NCT00529620|Pyrimethamine|pyrimethamine|mesh-list
153836154|NCT00529620|Piperaquine|piperaquine|mesh-list
153836155|NCT00529620|Sulfadoxine|sulfadoxine|mesh-list
153376228|NCT06190132|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
153376229|NCT06190132|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153376230|NCT06190132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153376231|NCT06190132|Antimanic Agents|antimanic agents|mesh-ancestor
153376232|NCT06190106|Psychotropic Drugs|psychotropic drugs|mesh-list
153376247|NCT06188026|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
153376248|NCT06188026|Contraceptive Agents|contraceptive agents|mesh-ancestor
153376249|NCT06188026|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153376250|NCT06188026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153376251|NCT06188026|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
153376252|NCT06188026|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
153376253|NCT06188026|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
153376254|NCT06188026|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
153836156|NCT00529620|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
153836157|NCT00529620|Amodiaquine|amodiaquine|mesh-list
153836158|NCT00529620|Artenimol|artenimol|mesh-list
153836159|NCT00529620|Sulfalene|sulfalene|mesh-list
153836160|NCT00529620|Antimalarials|antimalarials|mesh-ancestor
153836161|NCT00529620|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153836162|NCT00529620|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153836163|NCT00529620|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153836164|NCT00529620|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153836165|NCT00529620|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153836166|NCT00529620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153836167|NCT00529620|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
153836168|NCT00512993|Zoledronic Acid|zoledronic acid|mesh-list
153836169|NCT00512993|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153836170|NCT00512993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153836171|NCT00513032|Methylene Blue|methylene blue|mesh-list
153836172|NCT00513032|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153836174|NCT00513110|Caffeine|caffeine|mesh-list
153836198|NCT00511823|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153836199|NCT00511823|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153836200|NCT00511823|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
153836201|NCT00511823|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153836202|NCT00511823|Serotonin Agents|serotonin agents|mesh-ancestor
153637745|NCT00001029|Didanosine|didanosine|mesh-list
153836203|NCT00511823|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153376278|NCT06184633|Semaglutide|semaglutide|mesh-list
153376279|NCT06184633|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
153376280|NCT06184633|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153376281|NCT06184633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153376282|NCT06184581|Lamotrigine|lamotrigine|mesh-list
153376283|NCT06184581|Lithium Carbonate|lithium carbonate|mesh-list
153376284|NCT06184581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153376285|NCT06184581|Antidepressive Agents|antidepressive agents|mesh-ancestor
153376286|NCT06184581|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153376287|NCT06184581|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153376288|NCT06184581|Antimanic Agents|antimanic agents|mesh-ancestor
153376289|NCT06184581|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153376290|NCT06184581|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153376291|NCT06184581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153376292|NCT06184581|Anticonvulsants|anticonvulsants|mesh-ancestor
153376293|NCT06184581|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153376294|NCT06184581|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153637781|NCT00005843|Tipifarnib|tipifarnib|mesh-list
153637782|NCT00005843|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153637783|NCT00005849|Paclitaxel|paclitaxel|mesh-list
153376295|NCT06184581|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153376296|NCT06184581|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153376297|NCT06184581|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153376298|NCT06178640|Simvastatin|simvastatin|mesh-list
153376299|NCT06178640|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153376300|NCT06178640|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153376301|NCT06178640|Antimetabolites|antimetabolites|mesh-ancestor
153376302|NCT06178640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153376303|NCT06178640|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153836208|NCT00515736|Thiamine|thiamine|mesh-list
153836210|NCT00515736|Selenium|selenium|mesh-list
153836211|NCT00515736|Micronutrients|micronutrients|mesh-ancestor
153836212|NCT00515736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153836213|NCT00515736|Trace Elements|trace elements|mesh-ancestor
153836214|NCT00515736|Antioxidants|antioxidants|mesh-ancestor
153836215|NCT00515736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153836216|NCT00515736|Protective Agents|protective agents|mesh-ancestor
153836217|NCT00515736|Vitamin B Complex|vitamin b complex|mesh-ancestor
153836218|NCT00511940|Acamprosate|acamprosate|mesh-list
153836219|NCT00511940|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
153836220|NCT00513149|Clopidogrel|clopidogrel|mesh-list
153836221|NCT00513149|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153836222|NCT00513149|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
153836223|NCT00513149|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
153637899|NCT00001086|Efavirenz|efavirenz|mesh-list
153836224|NCT00513149|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
153836225|NCT00513149|Purinergic Agents|purinergic agents|mesh-ancestor
153836226|NCT00513149|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153836227|NCT00513149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153836228|NCT00513149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153836229|NCT02944227|Ranibizumab|ranibizumab|mesh-list
153836230|NCT02944227|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153836231|NCT02944227|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153836232|NCT02944227|Growth Substances|growth substances|mesh-ancestor
153836233|NCT02944227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153836234|NCT02944227|Growth Inhibitors|growth inhibitors|mesh-ancestor
153836235|NCT02944227|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153836236|NCT00513188|Leucovorin|leucovorin|mesh-list
153836237|NCT00513188|Cytarabine|cytarabine|mesh-list
153836238|NCT00513188|Prednisone|prednisone|mesh-list
153836239|NCT00513188|Cyclophosphamide|cyclophosphamide|mesh-list
153836240|NCT00513188|Doxorubicin|doxorubicin|mesh-list
153836241|NCT00513188|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
153836242|NCT00513188|Methotrexate|methotrexate|mesh-list
153836243|NCT00513188|Vincristine|vincristine|mesh-list
153836244|NCT00513188|Denileukin diftitox|denileukin diftitox|mesh-list
153836245|NCT00513188|Levoleucovorin|levoleucovorin|mesh-list
153836246|NCT00513188|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153376327|NCT06132685|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153376329|NCT06132685|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153836255|NCT00513188|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153836256|NCT00513188|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153836257|NCT00513188|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153836258|NCT00513188|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153836259|NCT00513188|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153836262|NCT00513188|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153836263|NCT00513188|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153836264|NCT00513188|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
153376337|NCT06113913|Dermatologic Agents|dermatologic agents|mesh-ancestor
153376338|NCT06113913|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153376339|NCT06113913|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153376341|NCT06104449|Hydrocortisone|hydrocortisone|mesh-list
153376342|NCT06104449|Fludrocortisone|fludrocortisone|mesh-list
153637909|NCT00001086|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153376343|NCT06104449|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153637910|NCT00001086|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
153637911|NCT00001086|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
153637912|NCT00001086|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
153376344|NCT06104449|Antiemetics|antiemetics|mesh-ancestor
153376345|NCT06104449|Autonomic Agents|autonomic agents|mesh-ancestor
153376346|NCT06104449|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153820113|NCT00462618|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153820114|NCT00462618|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153820115|NCT00462618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153820116|NCT00431795|Doxorubicin|doxorubicin|mesh-list
153820117|NCT00431795|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
153820118|NCT00431795|Epirubicin|epirubicin|mesh-list
153836268|NCT00513188|Antimetabolites|antimetabolites|mesh-ancestor
153836269|NCT00513188|Dermatologic Agents|dermatologic agents|mesh-ancestor
153836270|NCT00513188|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153836271|NCT00513188|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153836272|NCT00513188|Antiviral Agents|antiviral agents|mesh-ancestor
153836273|NCT00513188|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153836274|NCT00513188|Antidotes|antidotes|mesh-ancestor
153836275|NCT00513188|Protective Agents|protective agents|mesh-ancestor
153836276|NCT00513188|Vitamin B Complex|vitamin b complex|mesh-ancestor
153836277|NCT00513188|Vitamins|vitamins|mesh-ancestor
153836278|NCT00513188|Micronutrients|micronutrients|mesh-ancestor
153836279|NCT00513188|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153836280|NCT00513188|Tubulin Modulators|tubulin modulators|mesh-ancestor
153836281|NCT00513188|Antimitotic Agents|antimitotic agents|mesh-ancestor
153836282|NCT00513188|Mitosis Modulators|mitosis modulators|mesh-ancestor
153836283|NCT00513266|Leucovorin|leucovorin|mesh-list
153836284|NCT00513266|Bevacizumab|bevacizumab|mesh-list
153836285|NCT00513266|Cetuximab|cetuximab|mesh-list
153836286|NCT00513266|Fluorouracil|fluorouracil|mesh-list
153836287|NCT00513266|Oxaliplatin|oxaliplatin|mesh-list
153836288|NCT00513266|Irinotecan|irinotecan|mesh-list
153836289|NCT00513266|Calcium|calcium|mesh-list
153836291|NCT00513266|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153376363|NCT06061575|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153376364|NCT06061575|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153376365|NCT06061575|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153376366|NCT06061575|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153376367|NCT06061575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153376369|NCT06060405|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153376370|NCT06060405|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153376371|NCT06035874|8-hydroxy-2,2,14,14-tetramethylpentadecanedioic acid|8-hydroxy-2,2,14,14-tetramethylpentadecanedioic acid|mesh-list
153376372|NCT06035874|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153376373|NCT06035874|Antimetabolites|antimetabolites|mesh-ancestor
153376374|NCT06035874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153376375|NCT06035874|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153376376|NCT06035874|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153376377|NCT06035874|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153376378|NCT06035874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153836293|NCT00513266|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153836294|NCT00513266|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153836295|NCT00513266|Growth Substances|growth substances|mesh-ancestor
153836296|NCT00513266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153836297|NCT00513266|Growth Inhibitors|growth inhibitors|mesh-ancestor
153836298|NCT00513266|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153836299|NCT00513266|Antimetabolites|antimetabolites|mesh-ancestor
153836300|NCT00513266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153376394|NCT06023329|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153376396|NCT06023329|Sensory System Agents|sensory system agents|mesh-ancestor
153376397|NCT06023329|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153376398|NCT06008860|Azelastine|azelastine|mesh-list
153376399|NCT06008860|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153376400|NCT06008860|Autonomic Agents|autonomic agents|mesh-ancestor
153376401|NCT06008860|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153376402|NCT06008860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153637987|NCT00005867|Sensory System Agents|sensory system agents|mesh-ancestor
153637990|NCT00005870|Mitomycins|mitomycins|mesh-list
153376403|NCT06008860|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153376413|NCT06008860|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153376414|NCT06008821|Epinephrine|epinephrine|mesh-list
153376415|NCT06008821|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153376416|NCT06008821|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153836315|NCT00513383|Fluorouracil|fluorouracil|mesh-list
153836316|NCT00513383|Panitumumab|panitumumab|mesh-list
153836317|NCT00513383|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153836318|NCT00513383|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153836319|NCT00513383|Tubulin Modulators|tubulin modulators|mesh-ancestor
153836320|NCT00513383|Antimitotic Agents|antimitotic agents|mesh-ancestor
153836321|NCT00513383|Mitosis Modulators|mitosis modulators|mesh-ancestor
153836322|NCT00513383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153836323|NCT00513383|Antimetabolites|antimetabolites|mesh-ancestor
153836324|NCT00513383|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153836325|NCT00513383|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153836326|NCT00513383|Immunologic Factors|immunologic factors|mesh-ancestor
153836327|NCT00513383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153836328|NCT00513383|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153836329|NCT00515892|Immunotoxin HA22|immunotoxin ha22|mesh-list
153836330|NCT00515892|Antibodies|antibodies|mesh-list
153836331|NCT00515892|Immunoglobulins|immunoglobulins|mesh-list
153836332|NCT00515892|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
153836333|NCT00515892|Immunotoxins|immunotoxins|mesh-list
153836334|NCT00515892|Immunologic Factors|immunologic factors|mesh-ancestor
153376417|NCT06008821|Adrenergic Agents|adrenergic agents|mesh-ancestor
153376418|NCT06008821|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153376419|NCT06008821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153376420|NCT06008821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153376421|NCT06008821|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
153376422|NCT06008821|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153376423|NCT06008821|Autonomic Agents|autonomic agents|mesh-ancestor
153376424|NCT06008821|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153376425|NCT06008821|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153376426|NCT06008821|Respiratory System Agents|respiratory system agents|mesh-ancestor
153376427|NCT06008821|Mydriatics|mydriatics|mesh-ancestor
153376428|NCT06008821|Sympathomimetics|sympathomimetics|mesh-ancestor
153376429|NCT06008821|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
153376430|NCT06001658|Gemcitabine|gemcitabine|mesh-list
153376431|NCT06001658|Pembrolizumab|pembrolizumab|mesh-list
153376432|NCT06001658|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153376433|NCT06001658|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153376435|NCT06001658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153836360|NCT00513656|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153836361|NCT00513656|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
153836363|NCT00530127|Iron Chelating Agents|iron chelating agents|mesh-ancestor
153836364|NCT00530127|Chelating Agents|chelating agents|mesh-ancestor
153836365|NCT00530127|Sequestering Agents|sequestering agents|mesh-ancestor
153836366|NCT00530127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153836367|NCT04691934|Anesthetics|anesthetics|mesh-list
153836368|NCT04691934|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153836369|NCT04691934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153836370|NCT00512057|Allopurinol|allopurinol|mesh-list
153836371|NCT00512057|Antimetabolites|antimetabolites|mesh-ancestor
153836372|NCT00512057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153376440|NCT05980559|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153376441|NCT05980559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153376442|NCT05980559|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
153376443|NCT05980559|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153376444|NCT05980559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153376445|NCT05980559|Cholinergic Agents|cholinergic agents|mesh-ancestor
153376446|NCT05980559|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153376447|NCT05950945|Trastuzumab|trastuzumab|mesh-list
153376448|NCT05950945|Trastuzumab deruxtecan|trastuzumab deruxtecan|mesh-list
153376449|NCT05950945|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153376450|NCT05950945|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153376451|NCT05950945|Immunoconjugates|immunoconjugates|mesh-ancestor
153376452|NCT05950945|Immunologic Factors|immunologic factors|mesh-ancestor
153376453|NCT05950945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153376473|NCT05947448|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153376474|NCT05947448|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153376475|NCT05947448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153376476|NCT05947448|Vasodilator Agents|vasodilator agents|mesh-ancestor
153376477|NCT05947448|Tocolytic Agents|tocolytic agents|mesh-ancestor
153376478|NCT05947448|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153376479|NCT05947448|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
153376480|NCT05947448|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
153376481|NCT05938608|Primaquine|primaquine|mesh-list
153376482|NCT05938608|Antimalarials|antimalarials|mesh-ancestor
153836400|NCT00512291|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153836401|NCT00512291|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153836402|NCT00512291|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153836403|NCT00512291|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153836404|NCT00512291|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153836405|NCT00512291|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
153836406|NCT00512291|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153836407|NCT00512291|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153836408|NCT00512291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153836409|NCT00512291|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153836410|NCT00512291|Serotonin Agents|serotonin agents|mesh-ancestor
153836411|NCT00512291|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
153836412|NCT00512291|Antidepressive Agents|antidepressive agents|mesh-ancestor
153836413|NCT00512291|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
153836414|NCT00512291|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153836415|NCT00512291|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153836416|NCT00514163|Gemcitabine|gemcitabine|mesh-list
153376484|NCT05938608|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153376498|NCT05934448|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153376499|NCT05934448|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153638122|NCT00001146|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153376500|NCT05926804|Amoxicillin|amoxicillin|mesh-list
153376501|NCT05926804|Metronidazole|metronidazole|mesh-list
153376502|NCT05926804|Clarithromycin|clarithromycin|mesh-list
153376503|NCT05926804|Lansoprazole|lansoprazole|mesh-list
153376504|NCT05926804|Dexlansoprazole|dexlansoprazole|mesh-list
153376505|NCT05926804|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153376506|NCT05926804|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153376507|NCT05926804|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153376508|NCT05926804|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153376509|NCT05926804|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
153836430|NCT00530361|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
153836431|NCT00530361|Natriuretic Agents|natriuretic agents|mesh-ancestor
153836432|NCT00530361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153836433|NCT00512408|Testosterone|testosterone|mesh-list
153836434|NCT00512408|Androgens|androgens|mesh-ancestor
153836435|NCT00512408|Hormones|hormones|mesh-ancestor
153836436|NCT00512408|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153836437|NCT00512408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153836438|NCT00530400|Cefuroxime|cefuroxime|mesh-list
153836439|NCT00530400|Cefuroxime axetil|cefuroxime axetil|mesh-list
153376510|NCT05926804|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153376511|NCT05926804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153638188|NCT00005891|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153638189|NCT00009880|Paclitaxel|paclitaxel|mesh-list
153376512|NCT05926804|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
153376513|NCT05926804|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153376514|NCT05926804|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
153376515|NCT05926804|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153376516|NCT05926804|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
153376517|NCT05861336|Paclitaxel|paclitaxel|mesh-list
153376518|NCT05861336|Gemcitabine|gemcitabine|mesh-list
153376519|NCT05861336|Losartan|losartan|mesh-list
153376520|NCT05861336|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153376521|NCT05861336|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153376522|NCT05861336|Tubulin Modulators|tubulin modulators|mesh-ancestor
153376523|NCT05861336|Antimitotic Agents|antimitotic agents|mesh-ancestor
153376524|NCT05861336|Mitosis Modulators|mitosis modulators|mesh-ancestor
153376526|NCT05861336|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153376528|NCT05861336|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153376529|NCT05861336|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153376530|NCT05861336|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
153376531|NCT05861336|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
153376532|NCT05833763|Obinutuzumab|obinutuzumab|mesh-list
153376533|NCT05833763|Pirtobrutinib|pirtobrutinib|mesh-list
153376534|NCT05833763|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153638248|NCT00009997|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153836450|NCT00530478|Donepezil|donepezil|mesh-list
153836451|NCT00530478|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
153836452|NCT00530478|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153836453|NCT00530478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153836454|NCT00530478|Cholinergic Agents|cholinergic agents|mesh-ancestor
153836455|NCT00530478|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153836456|NCT00530478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153836457|NCT00530478|Nootropic Agents|nootropic agents|mesh-ancestor
153836458|NCT00530556|Zolpidem|zolpidem|mesh-list
153836459|NCT00530556|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
153836460|NCT00530556|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153836461|NCT00530556|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153836462|NCT00530556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153836463|NCT00530556|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
153836464|NCT00530556|GABA Agonists|gaba agonists|mesh-ancestor
153836465|NCT00530556|GABA Agents|gaba agents|mesh-ancestor
153376562|NCT05819619|Antipruritics|antipruritics|mesh-ancestor
153376563|NCT05819619|Dermatologic Agents|dermatologic agents|mesh-ancestor
153376564|NCT05819619|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
153376565|NCT05819619|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153376566|NCT05819619|Serotonin Agents|serotonin agents|mesh-ancestor
153836472|NCT00530595|Valsartan|valsartan|mesh-list
153836473|NCT00530595|Candesartan|candesartan|mesh-list
153836474|NCT00530595|Candesartan cilexetil|candesartan cilexetil|mesh-list
153836475|NCT00530595|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153638326|NCT00010231|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153836476|NCT00530595|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
153836477|NCT00530595|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
153836478|NCT00530595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153836479|NCT00530595|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153836480|NCT02943759|Chlorhexidine|chlorhexidine|mesh-list
153836481|NCT02943759|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
153836482|NCT02943759|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
153836483|NCT02943759|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153836484|NCT02943759|Disinfectants|disinfectants|mesh-ancestor
153836485|NCT02943759|Dermatologic Agents|dermatologic agents|mesh-ancestor
153836486|NCT02944110|Glucagon|glucagon|mesh-list
153836487|NCT02944110|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153836488|NCT02944110|Hormones|hormones|mesh-ancestor
153836489|NCT02944110|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153836490|NCT02944110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153836491|NCT02951975|Dexamethasone|dexamethasone|mesh-list
153836493|NCT02951975|Antiemetics|antiemetics|mesh-ancestor
153376589|NCT05766267|Isoniazid|isoniazid|mesh-list
153376590|NCT05766267|Pyrazinamide|pyrazinamide|mesh-list
153376591|NCT05766267|Ethambutol|ethambutol|mesh-list
153376592|NCT05766267|Rifabutin|rifabutin|mesh-list
153376593|NCT05766267|Bedaquiline|bedaquiline|mesh-list
153376594|NCT05766267|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153376595|NCT05766267|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153376596|NCT05766267|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153376597|NCT05766267|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153376599|NCT05766267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153376600|NCT05766267|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153376601|NCT05766267|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
153376602|NCT05766267|Antitubercular Agents|antitubercular agents|mesh-ancestor
153376603|NCT05766267|Leprostatic Agents|leprostatic agents|mesh-ancestor
153376604|NCT05766267|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153376605|NCT05766267|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
153836497|NCT02951975|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153836498|NCT02951975|Glucocorticoids|glucocorticoids|mesh-ancestor
153836499|NCT02951975|Hormones|hormones|mesh-ancestor
153836500|NCT02951975|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153836501|NCT02951975|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153836502|NCT02951975|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153836503|NCT00514397|Temozolomide|temozolomide|mesh-list
153836504|NCT00514397|Motexafin gadolinium|motexafin gadolinium|mesh-list
153836505|NCT00514397|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153836506|NCT00514397|Alkylating Agents|alkylating agents|mesh-ancestor
153836507|NCT00514397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153836511|NCT02943603|Pembrolizumab|pembrolizumab|mesh-list
153836524|NCT00531687|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153836525|NCT00531687|Antimetabolites|antimetabolites|mesh-ancestor
153836526|NCT00514475|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
153836527|NCT00514475|Immunologic Factors|immunologic factors|mesh-ancestor
153836528|NCT00514475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153836529|NCT00512681|Oxaliplatin|oxaliplatin|mesh-list
153836530|NCT00512681|Irinotecan|irinotecan|mesh-list
153836531|NCT00512681|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153836532|NCT00512681|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
153836533|NCT00512681|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153376607|NCT05766267|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
153376608|NCT05766267|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
153376609|NCT05766267|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
153376610|NCT05766267|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
153376611|NCT05766267|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
153376612|NCT05766267|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153376613|NCT05766267|Antimetabolites|antimetabolites|mesh-ancestor
153376614|NCT05766267|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153376615|NCT05765266|Methylprednisolone|methylprednisolone|mesh-list
153376616|NCT05765266|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
153376617|NCT05765266|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
153376629|NCT05765266|Hormones|hormones|mesh-ancestor
153836545|NCT00530868|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
153836546|NCT00530868|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153836547|NCT00530868|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153836548|NCT00530868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153836549|NCT00530868|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
153836550|NCT00530868|Hormone Antagonists|hormone antagonists|mesh-ancestor
153638659|NCT00001287|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
153638660|NCT00001287|Antibodies|antibodies|mesh-list
153836551|NCT00530868|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153836552|NCT00530907|Bevacizumab|bevacizumab|mesh-list
153836553|NCT00530907|Valproic Acid|valproic acid|mesh-list
153836554|NCT00530907|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153836555|NCT00530907|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153836556|NCT00530907|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153836557|NCT00530907|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153836558|NCT00530907|Growth Substances|growth substances|mesh-ancestor
153836559|NCT00530907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153836560|NCT00530907|Growth Inhibitors|growth inhibitors|mesh-ancestor
153836561|NCT00530907|Anticonvulsants|anticonvulsants|mesh-ancestor
153836562|NCT00530907|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153836563|NCT00530907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153376640|NCT05735431|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153376641|NCT05735431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153376642|NCT05735431|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153376643|NCT05735431|Respiratory System Agents|respiratory system agents|mesh-ancestor
153376644|NCT05735431|Dermatologic Agents|dermatologic agents|mesh-ancestor
153376645|NCT05735431|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
153376646|NCT05735431|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
153376647|NCT05735431|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
153376648|NCT05735431|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153836583|NCT00514670|Disinfectants|disinfectants|mesh-ancestor
153836584|NCT00531063|Everolimus|everolimus|mesh-list
153836585|NCT00531063|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
153836586|NCT00531063|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153836587|NCT00531063|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153836588|NCT00531063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153836589|NCT00531063|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153376675|NCT05721235|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153376676|NCT05721235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153638764|NCT00014092|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153638765|NCT00014092|Antiviral Agents|antiviral agents|mesh-ancestor
153638766|NCT00014092|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153376677|NCT05721235|Dopamine Agents|dopamine agents|mesh-ancestor
153376678|NCT05721235|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153376679|NCT05703672|Varenicline|varenicline|mesh-list
153376680|NCT05703672|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
153376681|NCT05703672|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
153376682|NCT05703672|Cholinergic Agents|cholinergic agents|mesh-ancestor
153376683|NCT05703672|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153376684|NCT05703672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153376685|NCT05703672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153376686|NCT05699473|Calcium, Dietary|calcium, dietary|mesh-list
153376687|NCT05699473|Tetrahydrofolates|tetrahydrofolates|mesh-list
153376689|NCT05699473|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153376690|NCT05699473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153376691|NCT05699473|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153376692|NCT05699473|Vitamin B Complex|vitamin b complex|mesh-ancestor
153376693|NCT05699473|Vitamins|vitamins|mesh-ancestor
153376694|NCT05699473|Micronutrients|micronutrients|mesh-ancestor
153836591|NCT00531063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153836610|NCT02943369|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
153638805|NCT00014248|Adenosine|adenosine|mesh-list
153836611|NCT02943369|Purinergic Agents|purinergic agents|mesh-ancestor
153836612|NCT02943369|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153376705|NCT05689671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153376706|NCT05689671|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153376707|NCT05689671|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153376708|NCT05689671|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153376709|NCT05689671|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153376710|NCT05689671|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153376711|NCT05688475|Dexamethasone|dexamethasone|mesh-list
153376712|NCT05688475|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153376713|NCT05688475|Antiemetics|antiemetics|mesh-ancestor
153376714|NCT05688475|Autonomic Agents|autonomic agents|mesh-ancestor
153376715|NCT05688475|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153376716|NCT05688475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153376717|NCT05688475|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153836633|NCT04695509|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153836634|NCT04695509|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153836635|NCT04695509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153836636|NCT04695509|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153836637|NCT04695509|Anesthetics, General|anesthetics, general|mesh-ancestor
153836639|NCT02943135|Lidocaine|lidocaine|mesh-list
153836641|NCT02943135|Anesthetics|anesthetics|mesh-ancestor
153376718|NCT05688475|Glucocorticoids|glucocorticoids|mesh-ancestor
153376768|NCT05640180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153836676|NCT02943252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153836677|NCT02943252|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153836678|NCT02943252|Antimetabolites|antimetabolites|mesh-ancestor
153836680|NCT00514982|Infliximab|infliximab|mesh-list
153836681|NCT00514982|Mesalamine|mesalamine|mesh-list
153836682|NCT00514982|Mercaptopurine|mercaptopurine|mesh-list
153836683|NCT00514982|Tacrolimus|tacrolimus|mesh-list
153836684|NCT00514982|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153836685|NCT00514982|Immunologic Factors|immunologic factors|mesh-ancestor
153836686|NCT00514982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153376795|NCT05610085|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
153376797|NCT05592678|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
153376798|NCT05592678|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153376799|NCT05592678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153376800|NCT05592678|Cholinergic Agents|cholinergic agents|mesh-ancestor
153376801|NCT05592678|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153376802|NCT05592678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153376803|NCT05592678|Nootropic Agents|nootropic agents|mesh-ancestor
153376804|NCT05590221|Cyclophosphamide|cyclophosphamide|mesh-list
153638857|NCT00014404|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153638858|NCT00014404|Analgesics|analgesics|mesh-ancestor
153638859|NCT00014404|Sensory System Agents|sensory system agents|mesh-ancestor
153638860|NCT00014404|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153638861|NCT00014404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153638863|NCT00014404|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153638864|NCT00014404|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
153376805|NCT05590221|Fludarabine|fludarabine|mesh-list
153376806|NCT05590221|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153376807|NCT05590221|Immunologic Factors|immunologic factors|mesh-ancestor
153836710|NCT00531999|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153376822|NCT05586802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153376823|NCT05586802|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153376824|NCT05586802|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153376825|NCT05586802|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
153376827|NCT05586802|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
153376828|NCT05586802|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153376829|NCT05586802|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153376830|NCT05586802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153376831|NCT05586802|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
153376832|NCT05586802|Hormone Antagonists|hormone antagonists|mesh-ancestor
153836736|NCT05319912|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153836737|NCT05319912|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153836738|NCT05319912|Growth Substances|growth substances|mesh-ancestor
153836739|NCT05319912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153836740|NCT05319912|Growth Inhibitors|growth inhibitors|mesh-ancestor
153836741|NCT05319912|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153836742|NCT05319912|Trace Elements|trace elements|mesh-ancestor
153836743|NCT05319912|Micronutrients|micronutrients|mesh-ancestor
153836744|NCT00515138|Rituximab|rituximab|mesh-list
153836745|NCT00515138|Carboplatin|carboplatin|mesh-list
153836746|NCT00515138|Etoposide|etoposide|mesh-list
153836747|NCT00515138|Bortezomib|bortezomib|mesh-list
153836748|NCT00515138|Ifosfamide|ifosfamide|mesh-list
153638891|NCT00014638|Hormone Antagonists|hormone antagonists|mesh-ancestor
153638892|NCT00014638|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153638893|NCT00014638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153638894|NCT00001341|Raltitrexed|raltitrexed|mesh-list
153638895|NCT00001341|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153638896|NCT00001341|Antimetabolites|antimetabolites|mesh-ancestor
153836749|NCT00515138|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153836750|NCT00515138|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153836751|NCT00515138|Immunologic Factors|immunologic factors|mesh-ancestor
153836752|NCT00515138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153836753|NCT00515138|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153836754|NCT00515138|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153836755|NCT00515138|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153836756|NCT00515138|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153376839|NCT05583474|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
153376840|NCT05583474|Adrenergic Agents|adrenergic agents|mesh-ancestor
153376841|NCT05583474|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153376842|NCT05583474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153376843|NCT05583474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153376844|NCT05583474|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153376845|NCT05583474|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153376846|NCT05583474|Sympatholytics|sympatholytics|mesh-ancestor
153376847|NCT05583474|Autonomic Agents|autonomic agents|mesh-ancestor
153376848|NCT05583474|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153376849|NCT05571878|Insulin Lispro|insulin lispro|mesh-list
153376850|NCT05571878|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153376851|NCT05571878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153376852|NCT05570409|Mycophenolic Acid|mycophenolic acid|mesh-list
153376853|NCT05570409|Prednisolone|prednisolone|mesh-list
153376854|NCT05570409|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
153376855|NCT05570409|Methylprednisolone|methylprednisolone|mesh-list
153376856|NCT05570409|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
153376857|NCT05570409|Prednisolone acetate|prednisolone acetate|mesh-list
153376858|NCT05570409|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
153376859|NCT05570409|Prednisolone phosphate|prednisolone phosphate|mesh-list
153376860|NCT05570409|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153638946|NCT00005987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153638947|NCT00005987|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153376861|NCT05570409|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153376862|NCT05570409|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
153376863|NCT05570409|Antitubercular Agents|antitubercular agents|mesh-ancestor
153376864|NCT05570409|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153376865|NCT05570409|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153376866|NCT05570409|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153376867|NCT05570409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153836762|NCT00515255|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153376868|NCT05570409|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153836763|NCT00515255|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153836785|NCT00516152|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153836786|NCT00516152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153836787|NCT00516152|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153836788|NCT00516152|Antimetabolites|antimetabolites|mesh-ancestor
153836789|NCT00516152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153836790|NCT00516152|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153836791|NCT00516152|Dermatologic Agents|dermatologic agents|mesh-ancestor
153836792|NCT00516152|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153376877|NCT05570409|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153376878|NCT05570409|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
153376879|NCT05570409|Protective Agents|protective agents|mesh-ancestor
153376881|NCT05562973|Hallucinogens|hallucinogens|mesh-ancestor
153376882|NCT05562973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153836799|NCT00516152|Alkylating Agents|alkylating agents|mesh-ancestor
153836800|NCT00516152|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153836801|NCT00516152|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153836802|NCT00516191|Doxorubicin|doxorubicin|mesh-list
153836803|NCT00516191|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
153836804|NCT00516191|Bortezomib|bortezomib|mesh-list
153836805|NCT00516191|Melphalan|melphalan|mesh-list
153836806|NCT00516191|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153836807|NCT00516191|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153836808|NCT00516191|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153836809|NCT00516191|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153836810|NCT00516191|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153376883|NCT05562973|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153376884|NCT05559931|N,N-Dimethyltryptamine|n,n-dimethyltryptamine|mesh-list
153376885|NCT05559931|Hallucinogens|hallucinogens|mesh-ancestor
153376886|NCT05559931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153639008|NCT00001344|Narcotics|narcotics|mesh-ancestor
153376887|NCT05559931|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153376888|NCT05559931|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153376889|NCT05559931|Serotonin Agents|serotonin agents|mesh-ancestor
153376890|NCT05559931|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153376891|NCT05559931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153376905|NCT05498272|Leuprolide|leuprolide|mesh-list
153376906|NCT05498272|Goserelin|goserelin|mesh-list
153376907|NCT05498272|Triptorelin Pamoate|triptorelin pamoate|mesh-list
153376908|NCT05498272|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
153376909|NCT05498272|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153376910|NCT05498272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153376911|NCT05498272|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153376912|NCT05498272|Fertility Agents, Female|fertility agents, female|mesh-ancestor
153836811|NCT00516191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153836812|NCT00516191|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153836813|NCT00516191|Alkylating Agents|alkylating agents|mesh-ancestor
153836814|NCT00516191|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153836818|NCT00515450|Immunoglobulins|immunoglobulins|mesh-list
153836830|NCT00515489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153836831|NCT00515489|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153836832|NCT00515489|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153836833|NCT00515489|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153836834|NCT00515489|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153836835|NCT00515489|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
153836836|NCT00515489|Dopamine Agents|dopamine agents|mesh-ancestor
153836837|NCT02941575|Methamphetamine|methamphetamine|mesh-list
153836838|NCT02941575|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
153836839|NCT02941575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153376913|NCT05498272|Fertility Agents|fertility agents|mesh-ancestor
153376914|NCT05498272|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153376915|NCT05498272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153376916|NCT05498272|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153376917|NCT05498272|Luteolytic Agents|luteolytic agents|mesh-ancestor
153376918|NCT05498272|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
153376919|NCT05498272|Contraceptive Agents|contraceptive agents|mesh-ancestor
153639047|NCT00015067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153639052|NCT00015067|Dopamine Agents|dopamine agents|mesh-ancestor
153376920|NCT05498272|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
153732041|NCT00140465|Clopidogrel|clopidogrel|mesh-list
153836849|NCT02941575|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153836850|NCT02941575|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
153836851|NCT02941731|Oseltamivir|oseltamivir|mesh-list
153836852|NCT02941731|Antiviral Agents|antiviral agents|mesh-ancestor
153836853|NCT02941731|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153836854|NCT02941731|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153836855|NCT02941731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153836857|NCT02951039|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
153836858|NCT02951039|Antithrombins|antithrombins|mesh-ancestor
153836859|NCT02951039|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
153836860|NCT02951039|Protease Inhibitors|protease inhibitors|mesh-ancestor
153836861|NCT02951039|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153836862|NCT02951039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153836863|NCT02951039|Anticoagulants|anticoagulants|mesh-ancestor
153836864|NCT02951117|Dexamethasone|dexamethasone|mesh-list
153836865|NCT02951117|Venetoclax|venetoclax|mesh-list
153836866|NCT02951117|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153836867|NCT02951117|Antiemetics|antiemetics|mesh-ancestor
153836868|NCT02951117|Autonomic Agents|autonomic agents|mesh-ancestor
153639063|NCT00015106|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153639064|NCT00015106|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153836869|NCT02951117|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153836870|NCT02951117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153836871|NCT02951117|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153836872|NCT02951117|Glucocorticoids|glucocorticoids|mesh-ancestor
153836873|NCT02951117|Hormones|hormones|mesh-ancestor
153836874|NCT02951117|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153836875|NCT02951117|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153376950|NCT05455697|Immunoglobulins|immunoglobulins|mesh-list
153376951|NCT05455697|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
153376952|NCT05455697|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153376953|NCT05455697|Immunologic Factors|immunologic factors|mesh-ancestor
153376965|NCT05455697|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153376966|NCT05455697|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153376967|NCT05455697|Glucocorticoids|glucocorticoids|mesh-ancestor
153376968|NCT05455697|Hormones|hormones|mesh-ancestor
153376969|NCT05455697|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153376970|NCT05455697|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153836911|NCT05317611|Antipruritics|antipruritics|mesh-ancestor
153836912|NCT05317611|Dermatologic Agents|dermatologic agents|mesh-ancestor
153639148|NCT00006002|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153639149|NCT00006002|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153639150|NCT00006002|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153639152|NCT00001365|Dextromethorphan|dextromethorphan|mesh-list
153639153|NCT00001365|Antitussive Agents|antitussive agents|mesh-ancestor
153639154|NCT00001365|Respiratory System Agents|respiratory system agents|mesh-ancestor
153639155|NCT00001365|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
153639160|NCT00001365|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153836913|NCT05317611|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
153836914|NCT05317611|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153836915|NCT05317611|Serotonin Agents|serotonin agents|mesh-ancestor
153836916|NCT05317611|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153836917|NCT05317611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153836918|NCT05317572|Morphine|morphine|mesh-list
153836919|NCT05317572|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153836920|NCT05317572|Narcotics|narcotics|mesh-ancestor
153836921|NCT05317572|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153836922|NCT05317572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153836923|NCT05317572|Analgesics|analgesics|mesh-ancestor
153836924|NCT05317572|Sensory System Agents|sensory system agents|mesh-ancestor
153639178|NCT00006005|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153639179|NCT00006005|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153639180|NCT00006005|Growth Substances|growth substances|mesh-ancestor
153639181|NCT00006005|Growth Inhibitors|growth inhibitors|mesh-ancestor
153376997|NCT05443971|Immunologic Factors|immunologic factors|mesh-ancestor
153376998|NCT05443971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153377000|NCT05418868|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
153377001|NCT05418868|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
153377004|NCT05418868|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153836942|NCT00516425|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153377018|NCT05406583|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153377019|NCT05406583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153377020|NCT05406583|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153377021|NCT05406583|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153377022|NCT05406583|Antiviral Agents|antiviral agents|mesh-ancestor
153377023|NCT05406583|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153377024|NCT05382559|Cetuximab|cetuximab|mesh-list
153377025|NCT05382559|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153639241|NCT00016198|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153639242|NCT00016198|Immunologic Factors|immunologic factors|mesh-ancestor
153639243|NCT00016198|Antidotes|antidotes|mesh-ancestor
153639244|NCT00016198|Protective Agents|protective agents|mesh-ancestor
153639245|NCT00016198|Vitamin B Complex|vitamin b complex|mesh-ancestor
153639246|NCT00016198|Vitamins|vitamins|mesh-ancestor
153639247|NCT00016198|Micronutrients|micronutrients|mesh-ancestor
153377026|NCT05382559|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153377027|NCT05377242|Curcumin|curcumin|mesh-list
153836975|NCT02949752|Dopamine Agents|dopamine agents|mesh-ancestor
153836976|NCT02949752|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153836977|NCT02949752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153377053|NCT05359211|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153377054|NCT05351541|Zolpidem|zolpidem|mesh-list
153377055|NCT05351541|Modafinil|modafinil|mesh-list
153377056|NCT05351541|Psilocybin|psilocybin|mesh-list
153377057|NCT05351541|N,N-Dimethyltryptamine|n,n-dimethyltryptamine|mesh-list
153377058|NCT05351541|Hallucinogens|hallucinogens|mesh-ancestor
153377059|NCT05351541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153377060|NCT05351541|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153377061|NCT05351541|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
153377063|NCT05351541|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
153377064|NCT05351541|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
153377065|NCT05351541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153377066|NCT05351541|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
153377067|NCT05351541|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153377068|NCT05351541|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153377069|NCT05351541|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
153377070|NCT05351541|GABA Agonists|gaba agonists|mesh-ancestor
153377071|NCT05351541|GABA Agents|gaba agents|mesh-ancestor
153377072|NCT05351541|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153377073|NCT05351541|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153377074|NCT05351541|Serotonin Agents|serotonin agents|mesh-ancestor
153377075|NCT05351541|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
153377076|NCT05327699|Ketamine|ketamine|mesh-list
153377077|NCT05327699|Analgesics|analgesics|mesh-ancestor
153837002|NCT02941224|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153837003|NCT02941224|Antifungal Agents|antifungal agents|mesh-ancestor
153837004|NCT02941224|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153377080|NCT05327699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153377081|NCT05327699|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
153377082|NCT05327699|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153377083|NCT05327699|Anesthetics, General|anesthetics, general|mesh-ancestor
153377084|NCT05327699|Anesthetics|anesthetics|mesh-ancestor
153377085|NCT05327699|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153377086|NCT05327699|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
153377087|NCT05327699|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
153377088|NCT05327699|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153377089|NCT05327699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153639329|NCT00006023|Antimetabolites|antimetabolites|mesh-ancestor
153639330|NCT00006023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153639331|NCT00006023|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153639332|NCT00016588|Tenofovir|tenofovir|mesh-list
153377090|NCT05298592|Paclitaxel|paclitaxel|mesh-list
153377091|NCT05298592|Carboplatin|carboplatin|mesh-list
153377092|NCT05298592|Nivolumab|nivolumab|mesh-list
153377116|NCT05257824|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153377117|NCT05257824|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153377118|NCT05257824|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153377119|NCT05257824|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153377120|NCT05257824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153377121|NCT05257824|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153377122|NCT05257824|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153377123|NCT05257824|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153377124|NCT05257824|Antipyretics|antipyretics|mesh-ancestor
153377125|NCT05257824|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
153377126|NCT05257824|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
153377127|NCT05257824|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
153377128|NCT05257824|Purinergic Agents|purinergic agents|mesh-ancestor
153377129|NCT05257824|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153377130|NCT05251948|Capecitabine|capecitabine|mesh-list
153377131|NCT05251948|Oxaliplatin|oxaliplatin|mesh-list
153377132|NCT05251948|Atezolizumab|atezolizumab|mesh-list
153377133|NCT05251948|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153639446|NCT00017095|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153639447|NCT00017095|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153639448|NCT00017095|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153639449|NCT00017095|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153639450|NCT00006029|Gemcitabine|gemcitabine|mesh-list
153639451|NCT00006029|Doxorubicin|doxorubicin|mesh-list
153639452|NCT00006029|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
153639453|NCT00006029|Vinorelbine|vinorelbine|mesh-list
153639454|NCT00006029|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153639455|NCT00006029|Antimetabolites|antimetabolites|mesh-ancestor
153377134|NCT05251948|Antimetabolites|antimetabolites|mesh-ancestor
153639456|NCT00006029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153639457|NCT00006029|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153639458|NCT00006029|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153639459|NCT00006029|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153639460|NCT00006029|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153639461|NCT00006029|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153639462|NCT00006029|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153639463|NCT00006029|Tubulin Modulators|tubulin modulators|mesh-ancestor
153639464|NCT00006029|Antimitotic Agents|antimitotic agents|mesh-ancestor
153639465|NCT00006029|Mitosis Modulators|mitosis modulators|mesh-ancestor
153639466|NCT00371059|Memantine|memantine|mesh-list
153639467|NCT00371059|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
153639468|NCT00371059|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
153361726|NCT00882206|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
153837051|NCT00518297|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
153837052|NCT00518297|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153837053|NCT00518297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153837056|NCT00518297|Protease Inhibitors|protease inhibitors|mesh-ancestor
153837070|NCT00516971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153837071|NCT00518570|Levetiracetam|levetiracetam|mesh-list
153837072|NCT00518570|Anticonvulsants|anticonvulsants|mesh-ancestor
153837073|NCT00518570|Nootropic Agents|nootropic agents|mesh-ancestor
153837074|NCT03458208|Metformin|metformin|mesh-list
153837075|NCT03458208|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153837076|NCT03458208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153837077|NCT00517283|Exenatide|exenatide|mesh-list
153837078|NCT00517283|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
153837079|NCT00517283|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153837080|NCT00517283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153837081|NCT00517283|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
153837082|NCT00517283|Incretins|incretins|mesh-ancestor
153837083|NCT00517283|Hormones|hormones|mesh-ancestor
153377157|NCT05221502|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153377158|NCT05209152|Azacitidine|azacitidine|mesh-list
153377159|NCT05209152|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153377160|NCT05209152|Antimetabolites|antimetabolites|mesh-ancestor
153377161|NCT05209152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153377162|NCT05209152|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153377163|NCT05209152|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153377164|NCT05184712|Carboplatin|carboplatin|mesh-list
153377165|NCT05184712|Pemetrexed|pemetrexed|mesh-list
153377166|NCT05184712|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153377167|NCT05184712|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153639469|NCT00371059|Dopamine Agents|dopamine agents|mesh-ancestor
153639470|NCT00371059|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153639472|NCT00371059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153377168|NCT05184712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153377169|NCT05184712|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153377170|NCT05184712|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153377171|NCT05171686|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
153377172|NCT05171686|Chlorthalidone|chlorthalidone|mesh-list
153377173|NCT05171686|Torsemide|torsemide|mesh-list
153377174|NCT05171686|Furosemide|furosemide|mesh-list
153377175|NCT05171686|Bumetanide|bumetanide|mesh-list
153377176|NCT05171686|Diuretics|diuretics|mesh-list
153377177|NCT05171686|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153377178|NCT05171686|Natriuretic Agents|natriuretic agents|mesh-ancestor
153377179|NCT05171686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153377180|NCT05171686|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
153377181|NCT05171686|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153377182|NCT05171686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153377183|NCT05171686|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
153377184|NCT05168202|Azacitidine|azacitidine|mesh-list
153837084|NCT00517283|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153837085|NCT02940912|Apomorphine|apomorphine|mesh-list
153837086|NCT02940912|Emetics|emetics|mesh-ancestor
153837087|NCT02940912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153837088|NCT02940912|Autonomic Agents|autonomic agents|mesh-ancestor
153837089|NCT02940912|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153837090|NCT02940912|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153837091|NCT02940912|Dopamine Agonists|dopamine agonists|mesh-ancestor
153837092|NCT02940912|Dopamine Agents|dopamine agents|mesh-ancestor
153837093|NCT02940912|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153639566|NCT00006038|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153639567|NCT00006038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153639606|NCT00017329|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153639607|NCT00017368|Cyclophosphamide|cyclophosphamide|mesh-list
153639608|NCT00017368|Melphalan|melphalan|mesh-list
153639609|NCT00017368|Ifosfamide|ifosfamide|mesh-list
153639610|NCT00017368|Thiotepa|thiotepa|mesh-list
153639611|NCT00017368|Carboplatin|carboplatin|mesh-list
153639612|NCT00017368|Doxorubicin|doxorubicin|mesh-list
153837094|NCT02940912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153837095|NCT00517322|Ramipril|ramipril|mesh-list
153837096|NCT00517322|Irbesartan|irbesartan|mesh-list
153837097|NCT00517322|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
153837098|NCT00517322|Protease Inhibitors|protease inhibitors|mesh-ancestor
153837099|NCT00517322|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153837100|NCT00517322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153837101|NCT00517322|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153837102|NCT00517322|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
153377203|NCT05139420|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153377204|NCT05139420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153377207|NCT05100017|Parasympatholytics|parasympatholytics|mesh-ancestor
153377208|NCT05100017|Autonomic Agents|autonomic agents|mesh-ancestor
153377209|NCT05100017|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153377210|NCT05100017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153377211|NCT05100017|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
153377212|NCT05100017|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
153377213|NCT05100017|Cholinergic Agents|cholinergic agents|mesh-ancestor
153639689|NCT00017641|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153377214|NCT05100017|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153377215|NCT05100017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153377216|NCT05100017|Urological Agents|urological agents|mesh-ancestor
153377217|NCT05100017|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
153639691|NCT00017680|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153639692|NCT00017680|Alkylating Agents|alkylating agents|mesh-ancestor
153639693|NCT00017680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153639694|NCT00017680|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153639695|NCT00017680|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153639696|NCT00017680|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153639697|NCT00017680|Immunologic Factors|immunologic factors|mesh-ancestor
153639698|NCT00017680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153639699|NCT00017719|Lamivudine|lamivudine|mesh-list
153639700|NCT00017719|Zidovudine|zidovudine|mesh-list
153639701|NCT00017719|Nevirapine|nevirapine|mesh-list
153639702|NCT00017719|Lamivudine, zidovudine drug combination|lamivudine, zidovudine drug combination|mesh-list
153639703|NCT00017719|Nelfinavir|nelfinavir|mesh-list
153639704|NCT00017719|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153639707|NCT00017719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153639708|NCT00017719|Antiviral Agents|antiviral agents|mesh-ancestor
153639709|NCT00017719|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153377218|NCT05100017|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
153377219|NCT05081492|Antibodies|antibodies|mesh-list
153377220|NCT05081492|Immunoglobulins|immunoglobulins|mesh-list
153377221|NCT05081492|Immunologic Factors|immunologic factors|mesh-ancestor
153377222|NCT05081492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153377223|NCT05081102|Ibuprofen|ibuprofen|mesh-list
153377224|NCT05081102|Oxycodone|oxycodone|mesh-list
153377225|NCT05081102|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153377226|NCT05081102|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153377227|NCT05081102|Analgesics|analgesics|mesh-ancestor
153837133|NCT00518765|Aliskiren|aliskiren|mesh-list
153837157|NCT02940756|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
153837158|NCT02940756|Anthelmintics|anthelmintics|mesh-ancestor
153377233|NCT05081102|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153377235|NCT05081102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153377236|NCT05081102|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153377237|NCT05081102|Narcotics|narcotics|mesh-ancestor
153377238|NCT05081102|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153377239|NCT05057806|Empagliflozin|empagliflozin|mesh-list
153377240|NCT05057806|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
153639719|NCT00001542|Antifungal Agents|antifungal agents|mesh-ancestor
153639767|NCT00017992|Protease Inhibitors|protease inhibitors|mesh-ancestor
153639768|NCT00017992|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153639769|NCT00017992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153639770|NCT00017992|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153639771|NCT00017992|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153639772|NCT00017992|Antiviral Agents|antiviral agents|mesh-ancestor
153639773|NCT00017992|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153639774|NCT00017992|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
153639775|NCT00017992|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153639776|NCT00017992|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153639777|NCT00017992|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153639784|NCT00018148|Nicotine|nicotine|mesh-list
153639827|NCT00018187|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153377241|NCT05057806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153377242|NCT05057806|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153377243|NCT05057806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153377244|NCT05053334|Omalizumab|omalizumab|mesh-list
153377245|NCT05053334|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
153377246|NCT05053334|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153377247|NCT05053334|Respiratory System Agents|respiratory system agents|mesh-ancestor
153377248|NCT05045443|Curcumin|curcumin|mesh-list
153377249|NCT05045443|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153377250|NCT05045443|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153377251|NCT05045443|Analgesics|analgesics|mesh-ancestor
153377252|NCT05045443|Sensory System Agents|sensory system agents|mesh-ancestor
153377253|NCT05045443|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153377254|NCT05045443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153377255|NCT05045443|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153377256|NCT05045443|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153377257|NCT05045443|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153377258|NCT05045443|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153377259|NCT05045443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153377260|NCT05036408|Coal Tar|coal tar|mesh-list
153377261|NCT05036408|Keratolytic Agents|keratolytic agents|mesh-ancestor
153837159|NCT02939547|Betadex|betadex|mesh-list
153837160|NCT02939547|Sequestering Agents|sequestering agents|mesh-ancestor
153837161|NCT02939547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153837162|NCT02941068|Fluconazole|fluconazole|mesh-list
153639853|NCT00018460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153639854|NCT00386750|Lumefantrine|lumefantrine|mesh-list
153639855|NCT00386750|Artemether|artemether|mesh-list
153639874|NCT00001596|Pirfenidone|pirfenidone|mesh-list
153837163|NCT02941068|Caspofungin|caspofungin|mesh-list
153837164|NCT02941068|Antifungal Agents|antifungal agents|mesh-ancestor
153837165|NCT02941068|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153837166|NCT02941068|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
153837167|NCT02941068|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153837168|NCT02941068|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153837169|NCT02941068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153837181|NCT00517946|Cetirizine|cetirizine|mesh-list
153377288|NCT04931017|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153377289|NCT04931017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153639930|NCT05573386|Immunologic Factors|immunologic factors|mesh-ancestor
153377290|NCT04926948|Immunomodulating Agents|immunomodulating agents|mesh-list
153377291|NCT04926948|Immunologic Factors|immunologic factors|mesh-ancestor
153377292|NCT04926948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153377293|NCT04919564|Furosemide|furosemide|mesh-list
153377294|NCT04919564|Diuretics|diuretics|mesh-ancestor
153377295|NCT04919564|Natriuretic Agents|natriuretic agents|mesh-ancestor
153377296|NCT04919564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153377297|NCT04919564|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
153639931|NCT05573386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153639932|NCT00001656|Olanzapine|olanzapine|mesh-list
153639933|NCT00001656|Clozapine|clozapine|mesh-list
153639934|NCT00001656|Antiemetics|antiemetics|mesh-ancestor
153639935|NCT00001656|Autonomic Agents|autonomic agents|mesh-ancestor
153377298|NCT04919564|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153377299|NCT04919564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153377300|NCT04908800|Itraconazole|itraconazole|mesh-list
153837216|NCT04690920|Remdesivir|remdesivir|mesh-list
153377326|NCT04894864|Analgesics|analgesics|mesh-ancestor
153377327|NCT04894864|Sensory System Agents|sensory system agents|mesh-ancestor
153377328|NCT04894864|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153377329|NCT04855383|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
153377330|NCT04855383|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153377331|NCT04855383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153377333|NCT04831320|Nivolumab|nivolumab|mesh-list
153377334|NCT04831320|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153837229|NCT02939235|Ticagrelor|ticagrelor|mesh-list
153837230|NCT02939235|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153837231|NCT02939235|Narcotics|narcotics|mesh-ancestor
153837232|NCT02939235|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153837233|NCT02939235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153837234|NCT02939235|Analgesics|analgesics|mesh-ancestor
153837235|NCT02939235|Sensory System Agents|sensory system agents|mesh-ancestor
153837236|NCT02939235|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153837239|NCT02939235|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
153837241|NCT02939235|Purinergic Agents|purinergic agents|mesh-ancestor
153837242|NCT02939235|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153837243|NCT02939235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153837244|NCT02939235|Antiemetics|antiemetics|mesh-ancestor
153837245|NCT02939235|Autonomic Agents|autonomic agents|mesh-ancestor
153820119|NCT00431795|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153820120|NCT00431795|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153820121|NCT00431795|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153820122|NCT00431795|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153820123|NCT00431795|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153820124|NCT00431795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153820125|NCT00462657|Dimercaprol|dimercaprol|mesh-list
153820126|NCT00462657|Chelating Agents|chelating agents|mesh-ancestor
153820127|NCT00462657|Sequestering Agents|sequestering agents|mesh-ancestor
153639995|NCT05419921|Anesthetics, Local|anesthetics, local|mesh-ancestor
153639996|NCT05419921|Anesthetics|anesthetics|mesh-ancestor
153639997|NCT05419921|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153639998|NCT05419921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153639999|NCT05419921|Sensory System Agents|sensory system agents|mesh-ancestor
153640000|NCT05419921|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153640007|NCT00386828|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153640008|NCT00386828|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153820128|NCT00462657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153837246|NCT02939235|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153837247|NCT02939235|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
153837248|NCT02939235|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
153837249|NCT02939235|Dopamine Agents|dopamine agents|mesh-ancestor
153837250|NCT00518141|Aspirin|aspirin|mesh-list
153837251|NCT00518141|Salicylic Acid|salicylic acid|mesh-list
153837252|NCT00518141|Salicylates|salicylates|mesh-list
153837253|NCT00518141|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153837254|NCT00518141|Antifungal Agents|antifungal agents|mesh-ancestor
153837255|NCT00518141|Keratolytic Agents|keratolytic agents|mesh-ancestor
153837256|NCT00518141|Dermatologic Agents|dermatologic agents|mesh-ancestor
153837257|NCT00518141|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153837258|NCT00518141|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153837259|NCT00518141|Analgesics|analgesics|mesh-ancestor
153837260|NCT00518141|Sensory System Agents|sensory system agents|mesh-ancestor
153837261|NCT00518141|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153837262|NCT00518141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153377335|NCT04831320|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153640017|NCT00001725|Respiratory System Agents|respiratory system agents|mesh-ancestor
153640018|NCT00001725|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
153640019|NCT00001725|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
153640020|NCT00001725|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153640021|NCT00001725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153640024|NCT00001725|Narcotics|narcotics|mesh-ancestor
153377336|NCT04831320|Tubulin Modulators|tubulin modulators|mesh-ancestor
153377337|NCT04831320|Antimitotic Agents|antimitotic agents|mesh-ancestor
153377338|NCT04831320|Mitosis Modulators|mitosis modulators|mesh-ancestor
153377339|NCT04831320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153377340|NCT04831320|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153377341|NCT04831320|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153377343|NCT04792073|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153377344|NCT04792073|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153377345|NCT04791943|Melatonin|melatonin|mesh-list
153377346|NCT04791943|Antioxidants|antioxidants|mesh-ancestor
153377347|NCT04791943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153377348|NCT04791943|Protective Agents|protective agents|mesh-ancestor
153377349|NCT04791943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153377350|NCT04791943|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153377351|NCT04776018|Daratumumab|daratumumab|mesh-list
153377352|NCT04776018|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153377353|NCT04763759|Antibodies|antibodies|mesh-list
153377354|NCT04763759|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
153377364|NCT04678401|Fludarabine|fludarabine|mesh-list
153377365|NCT04678401|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153837263|NCT00518141|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153837264|NCT00518141|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153837269|NCT00518141|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153837270|NCT00518141|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153837271|NCT00518141|Antipyretics|antipyretics|mesh-ancestor
153837272|NCT02938962|Tranexamic Acid|tranexamic acid|mesh-list
153837273|NCT02938962|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
153837274|NCT02938962|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153837275|NCT02938962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153640063|NCT00392275|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153640065|NCT00001749|Cyclosporine|cyclosporine|mesh-list
153837276|NCT02938962|Hemostatics|hemostatics|mesh-ancestor
153837277|NCT02938962|Coagulants|coagulants|mesh-ancestor
153837278|NCT00519701|Hydroxyurea|hydroxyurea|mesh-list
153837279|NCT00519701|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153837280|NCT00519701|Antisickling Agents|antisickling agents|mesh-ancestor
153837281|NCT00519701|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153837282|NCT00519701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153837283|NCT00519701|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153837284|NCT04691076|Fentanyl|fentanyl|mesh-list
153837285|NCT04691076|Propofol|propofol|mesh-list
153837286|NCT04691076|Esketamine|esketamine|mesh-list
153837287|NCT04691076|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153837288|NCT04691076|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153837289|NCT04691076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153837290|NCT04691076|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153837291|NCT04691076|Anesthetics, General|anesthetics, general|mesh-ancestor
153837292|NCT04691076|Anesthetics|anesthetics|mesh-ancestor
153377366|NCT04678401|Immunologic Factors|immunologic factors|mesh-ancestor
153377367|NCT04678401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153377377|NCT04659044|Antibodies|antibodies|mesh-list
153377378|NCT04659044|Immunoglobulins|immunoglobulins|mesh-list
153377379|NCT04659044|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
153377380|NCT04659044|Immunoconjugates|immunoconjugates|mesh-list
153377381|NCT04659044|Polatuzumab vedotin|polatuzumab vedotin|mesh-list
153377382|NCT04659044|Immunologic Factors|immunologic factors|mesh-ancestor
153377383|NCT04659044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153377384|NCT04659044|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153377385|NCT04659044|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153377386|NCT04657081|Venetoclax|venetoclax|mesh-list
153377387|NCT04657081|Decitabine|decitabine|mesh-list
153640100|NCT00001758|Antitubercular Agents|antitubercular agents|mesh-ancestor
153640101|NCT00001758|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153640102|NCT00001758|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
153377388|NCT04657081|Decitabine and cedazuridine drug combination|decitabine and cedazuridine drug combination|mesh-list
153377389|NCT04657081|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153377390|NCT04657081|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153377391|NCT04657081|Antimetabolites|antimetabolites|mesh-ancestor
153377392|NCT04657081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153837293|NCT04691076|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153837294|NCT04691076|Narcotics|narcotics|mesh-ancestor
153837295|NCT04691076|Analgesics|analgesics|mesh-ancestor
153837296|NCT04691076|Sensory System Agents|sensory system agents|mesh-ancestor
153837297|NCT04691076|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153837298|NCT04691076|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153837299|NCT04691076|Antidepressive Agents|antidepressive agents|mesh-ancestor
153837300|NCT04691076|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153781776|NCT04559308|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153837303|NCT02949206|Coagulants|coagulants|mesh-ancestor
153837304|NCT05108454|Micronutrients|micronutrients|mesh-list
153837305|NCT05108454|Trace Elements|trace elements|mesh-list
153837306|NCT05108454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153837307|NCT02940561|Methotrexate|methotrexate|mesh-list
153837308|NCT02940561|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
153837309|NCT02940561|Abortifacient Agents|abortifacient agents|mesh-ancestor
153837310|NCT02940561|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153837311|NCT02940561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153837312|NCT02940561|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153837313|NCT02940561|Antimetabolites|antimetabolites|mesh-ancestor
153837314|NCT02940561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153837315|NCT02940561|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153837316|NCT02940561|Dermatologic Agents|dermatologic agents|mesh-ancestor
153837317|NCT02940561|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153837318|NCT02940561|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153837319|NCT02940561|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153640155|NCT00386867|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
153837320|NCT02940561|Immunologic Factors|immunologic factors|mesh-ancestor
153377393|NCT04657081|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153377394|NCT04653246|Dexamethasone|dexamethasone|mesh-list
153377395|NCT04653246|Lenalidomide|lenalidomide|mesh-list
153377396|NCT04653246|Bortezomib|bortezomib|mesh-list
153377397|NCT04653246|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153837334|NCT02940405|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153837335|NCT02940405|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153837336|NCT02940405|Analgesics|analgesics|mesh-ancestor
153837337|NCT02940405|Sensory System Agents|sensory system agents|mesh-ancestor
153837338|NCT02940405|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153837339|NCT02940405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153837340|NCT02940405|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153837341|NCT02940405|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153837342|NCT02940405|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153837343|NCT02940405|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153837346|NCT02940444|Anticoagulants|anticoagulants|mesh-ancestor
153377473|NCT04425902|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153377474|NCT04425902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153377475|NCT04425902|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153377476|NCT04425902|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153377477|NCT04425902|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153837388|NCT02940483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153837389|NCT02940483|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153837390|NCT02940483|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153837392|NCT04974684|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
153837393|NCT04974684|Antithrombins|antithrombins|mesh-ancestor
153837394|NCT04974684|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
153837395|NCT04974684|Protease Inhibitors|protease inhibitors|mesh-ancestor
153837396|NCT04974684|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153837397|NCT04974684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153837398|NCT04974684|Anticoagulants|anticoagulants|mesh-ancestor
153837399|NCT00520091|Celecoxib|celecoxib|mesh-list
153837400|NCT00520091|Irinotecan|irinotecan|mesh-list
153837401|NCT00520091|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153837402|NCT00520091|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
153837403|NCT00520091|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153837404|NCT00520091|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153377479|NCT04425902|Anesthetics, General|anesthetics, general|mesh-ancestor
153377480|NCT04425902|Anesthetics|anesthetics|mesh-ancestor
153377481|NCT04425902|GABA Modulators|gaba modulators|mesh-ancestor
153377482|NCT04425902|GABA Agents|gaba agents|mesh-ancestor
153377483|NCT04425902|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153377484|NCT04425902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153377485|NCT04425902|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
153377486|NCT04425902|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
153377487|NCT04425902|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153377488|NCT04425902|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
153837418|NCT00520169|Sensory System Agents|sensory system agents|mesh-ancestor
153837419|NCT00520169|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153837420|NCT00520169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153377494|NCT04425902|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153377495|NCT04425902|Respiratory System Agents|respiratory system agents|mesh-ancestor
153377496|NCT04425902|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
153377497|NCT04425902|Hormone Antagonists|hormone antagonists|mesh-ancestor
153377498|NCT04425902|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153377499|NCT04425902|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
153377500|NCT04425902|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
153377501|NCT04425902|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153377502|NCT04425902|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153377503|NCT04425902|Sympatholytics|sympatholytics|mesh-ancestor
153377504|NCT04425902|Autonomic Agents|autonomic agents|mesh-ancestor
153377505|NCT04425902|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153377506|NCT04425902|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
153377507|NCT04425902|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
153377508|NCT04425902|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
153377509|NCT04425902|Adrenergic Agents|adrenergic agents|mesh-ancestor
153837429|NCT00520169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153377534|NCT04413799|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153377535|NCT04413799|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153377536|NCT04413799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153377537|NCT04413799|Analgesics|analgesics|mesh-ancestor
153732060|NCT01247701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153732061|NCT01247701|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153837438|NCT00520247|Protease Inhibitors|protease inhibitors|mesh-ancestor
153837439|NCT00520247|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153837440|NCT00520247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153837441|NCT00520247|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153837442|NCT02949050|Immunomodulating Agents|immunomodulating agents|mesh-list
153837443|NCT02949050|Immunologic Factors|immunologic factors|mesh-ancestor
153837444|NCT02949050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153837445|NCT00520325|Lectins|lectins|mesh-list
153837446|NCT00520325|Agglutinins|agglutinins|mesh-ancestor
153837447|NCT00520325|Immunologic Factors|immunologic factors|mesh-ancestor
153837448|NCT00520325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153837449|NCT00520325|Coagulants|coagulants|mesh-ancestor
153837450|NCT00520442|Ibuprofen|ibuprofen|mesh-list
153837451|NCT00520442|Codeine|codeine|mesh-list
153837454|NCT00520442|Analgesics|analgesics|mesh-ancestor
153837476|NCT02939898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153837478|NCT02939898|Hormone Antagonists|hormone antagonists|mesh-ancestor
153640321|NCT03958123|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
153837479|NCT02939898|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153837480|NCT02939898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153837481|NCT00520754|Levocetirizine|levocetirizine|mesh-list
153837482|NCT00520754|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
153837483|NCT00520754|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
153837484|NCT00520754|Histamine Antagonists|histamine antagonists|mesh-ancestor
153837485|NCT00520754|Histamine Agents|histamine agents|mesh-ancestor
153837486|NCT00520754|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153837487|NCT00520754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153837488|NCT00520754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153837489|NCT02277132|Sildenafil Citrate|sildenafil citrate|mesh-list
153837490|NCT02277132|Vasodilator Agents|vasodilator agents|mesh-ancestor
153837491|NCT02277132|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
153837492|NCT02277132|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
153837493|NCT02277132|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153837494|NCT02277132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153837495|NCT02277132|Urological Agents|urological agents|mesh-ancestor
153377572|NCT04270747|Aflibercept|aflibercept|mesh-list
153377573|NCT04270747|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153377574|NCT04270747|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153377575|NCT04270747|Growth Substances|growth substances|mesh-ancestor
153377576|NCT04270747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153377577|NCT04270747|Growth Inhibitors|growth inhibitors|mesh-ancestor
153377578|NCT04270747|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153377579|NCT04269213|Cytarabine|cytarabine|mesh-list
153377580|NCT04269213|Daunorubicin|daunorubicin|mesh-list
153377581|NCT04269213|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153377582|NCT04269213|Antimetabolites|antimetabolites|mesh-ancestor
153377583|NCT04269213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153377584|NCT04269213|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153377585|NCT04269213|Antiviral Agents|antiviral agents|mesh-ancestor
153377586|NCT04269213|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153377587|NCT04269213|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153377588|NCT04269213|Immunologic Factors|immunologic factors|mesh-ancestor
153377589|NCT04269213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153377590|NCT04269213|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153377591|NCT04269213|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153377592|NCT04269213|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153377593|NCT04269213|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153377594|NCT04249362|Durvalumab|durvalumab|mesh-list
153377595|NCT04249362|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153377596|NCT04249362|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153377597|NCT04231877|Prednisone|prednisone|mesh-list
153377598|NCT04231877|Cortisone|cortisone|mesh-list
153377599|NCT04231877|Cyclophosphamide|cyclophosphamide|mesh-list
153377600|NCT04231877|Rituximab|rituximab|mesh-list
153640361|NCT05206175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153377601|NCT04231877|Doxorubicin|doxorubicin|mesh-list
153640362|NCT05206175|Adrenergic Agents|adrenergic agents|mesh-ancestor
153640363|NCT05206175|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
153640364|NCT05206175|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153640365|NCT05206175|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153640366|NCT05206175|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
153640367|NCT00392899|Tegafur|tegafur|mesh-list
153640368|NCT00392899|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153640369|NCT00392899|Antimetabolites|antimetabolites|mesh-ancestor
153640370|NCT00392899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153377602|NCT04231877|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
153377603|NCT04231877|Etoposide|etoposide|mesh-list
153837504|NCT00520949|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
153837505|NCT00520949|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153837508|NCT00520949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153837510|NCT00520949|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
153837511|NCT00520949|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
153837512|NCT00520949|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
153837513|NCT00520949|Antitrichomonal Agents|antitrichomonal agents|mesh-ancestor
153837514|NCT00520949|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153837515|NCT00520949|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153837516|NCT00520949|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
153837517|NCT02938260|Metoprolol|metoprolol|mesh-list
153837518|NCT02938260|Diltiazem|diltiazem|mesh-list
153837519|NCT02938260|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153837520|NCT02938260|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153837521|NCT02938260|Sympatholytics|sympatholytics|mesh-ancestor
153837522|NCT02938260|Autonomic Agents|autonomic agents|mesh-ancestor
153837523|NCT02938260|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153837524|NCT02938260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153837525|NCT02938260|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
153837526|NCT02938260|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
153377604|NCT04231877|Daunorubicin|daunorubicin|mesh-list
153377605|NCT04231877|Podophyllotoxin|podophyllotoxin|mesh-list
153377606|NCT04231877|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
153377608|NCT04231877|Immunoglobulins|immunoglobulins|mesh-list
153377609|NCT04231877|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
153377610|NCT04231877|Lenograstim|lenograstim|mesh-list
153377611|NCT04231877|Immunoconjugates|immunoconjugates|mesh-list
153377612|NCT04231877|Polatuzumab vedotin|polatuzumab vedotin|mesh-list
153377613|NCT04231877|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153377614|NCT04231877|Immunologic Factors|immunologic factors|mesh-ancestor
153377615|NCT04231877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153377616|NCT04231877|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153377617|NCT04231877|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153837538|NCT02938182|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
153377618|NCT04231877|Alkylating Agents|alkylating agents|mesh-ancestor
153377619|NCT04231877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153377620|NCT04231877|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153377621|NCT04231877|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153377622|NCT04231877|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153377623|NCT04231877|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153377624|NCT04231877|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153377625|NCT04231877|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153377626|NCT04231877|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153377627|NCT04231877|Glucocorticoids|glucocorticoids|mesh-ancestor
153377628|NCT04231877|Hormones|hormones|mesh-ancestor
153640377|NCT00392938|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153640418|NCT03152149|Cholinergic Agents|cholinergic agents|mesh-ancestor
153377629|NCT04231877|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153377630|NCT04231877|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153377631|NCT04231877|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153377632|NCT04231877|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153377633|NCT04231877|Keratolytic Agents|keratolytic agents|mesh-ancestor
153377634|NCT04231877|Dermatologic Agents|dermatologic agents|mesh-ancestor
153377635|NCT04231877|Tubulin Modulators|tubulin modulators|mesh-ancestor
153377636|NCT04231877|Antimitotic Agents|antimitotic agents|mesh-ancestor
153377637|NCT04231877|Mitosis Modulators|mitosis modulators|mesh-ancestor
153377638|NCT04224636|Bevacizumab|bevacizumab|mesh-list
153377639|NCT04224636|Atezolizumab|atezolizumab|mesh-list
153377640|NCT04224636|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153377673|NCT04094298|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153377675|NCT04094298|Hormones|hormones|mesh-ancestor
153377676|NCT04094298|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153377677|NCT04094298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153377678|NCT04094298|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153377679|NCT04094298|Immunologic Factors|immunologic factors|mesh-ancestor
153377680|NCT04083950|Aspirin|aspirin|mesh-list
153377681|NCT04083950|Vaccines|vaccines|mesh-list
153377682|NCT04083950|Immunologic Factors|immunologic factors|mesh-ancestor
153377683|NCT04083950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153377684|NCT04083950|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153377685|NCT04083950|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153377687|NCT04083950|Sensory System Agents|sensory system agents|mesh-ancestor
153377688|NCT04083950|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153377689|NCT04083950|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153377690|NCT04083950|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153377691|NCT04083950|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153837588|NCT02931357|Anesthetics|anesthetics|mesh-ancestor
153377695|NCT04083950|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153377698|NCT04056455|Mobocertinib|mobocertinib|mesh-list
153377699|NCT04056455|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153377700|NCT04056455|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153377701|NCT04056455|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153377702|NCT04056455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153377703|NCT04046887|Paclitaxel|paclitaxel|mesh-list
153377704|NCT04046887|Gemcitabine|gemcitabine|mesh-list
153377706|NCT04046887|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153377707|NCT04046887|Tubulin Modulators|tubulin modulators|mesh-ancestor
153377708|NCT04046887|Antimitotic Agents|antimitotic agents|mesh-ancestor
153377709|NCT04046887|Mitosis Modulators|mitosis modulators|mesh-ancestor
153377710|NCT04046887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153640484|NCT00387374|Immunoglobulins|immunoglobulins|mesh-list
153640485|NCT00387374|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
153640486|NCT00387374|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153640487|NCT00387374|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153640488|NCT00387374|Tubulin Modulators|tubulin modulators|mesh-ancestor
153640489|NCT00387374|Antimitotic Agents|antimitotic agents|mesh-ancestor
153640490|NCT00387374|Mitosis Modulators|mitosis modulators|mesh-ancestor
153640492|NCT00387374|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153377711|NCT04046887|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153377712|NCT04046887|Antimetabolites|antimetabolites|mesh-ancestor
153377713|NCT04045431|Hylan|hylan|mesh-list
153377714|NCT04045431|Viscosupplements|viscosupplements|mesh-ancestor
153377715|NCT04045431|Protective Agents|protective agents|mesh-ancestor
153377716|NCT04045431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153377717|NCT04036448|Lenalidomide|lenalidomide|mesh-list
153377718|NCT04036448|Immunologic Factors|immunologic factors|mesh-ancestor
153377719|NCT04036448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153377720|NCT04036448|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153377721|NCT04036448|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153377722|NCT04036448|Growth Substances|growth substances|mesh-ancestor
153377723|NCT04036448|Growth Inhibitors|growth inhibitors|mesh-ancestor
153377724|NCT04036448|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153377725|NCT04030052|Factor VIII|factor viii|mesh-list
153377726|NCT04030052|Coagulants|coagulants|mesh-ancestor
153837628|NCT02948348|Antimetabolites|antimetabolites|mesh-ancestor
153837629|NCT02948348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153837630|NCT02948348|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153837631|NCT02948348|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153837632|NCT02948348|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153837633|NCT04693910|Hormones|hormones|mesh-list
153837634|NCT04693910|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153837635|NCT04693910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153837636|NCT00522158|Atorvastatin|atorvastatin|mesh-list
153837637|NCT00522158|Simvastatin|simvastatin|mesh-list
153732064|NCT01247701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153837638|NCT00522158|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153837639|NCT00522158|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153837641|NCT00522158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153837642|NCT00522158|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153837643|NCT00522158|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
153837644|NCT00522158|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153837645|NCT02931123|Rifaximin|rifaximin|mesh-list
153837646|NCT02931123|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153837647|NCT02931123|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153837648|NCT02931123|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153377727|NCT04021043|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
153377728|NCT04021043|Nivolumab|nivolumab|mesh-list
153377729|NCT04021043|Ipilimumab|ipilimumab|mesh-list
153377730|NCT04021043|Antibodies|antibodies|mesh-list
153377731|NCT04021043|Immunoglobulins|immunoglobulins|mesh-list
153377732|NCT04021043|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
153377733|NCT04021043|Immunologic Factors|immunologic factors|mesh-ancestor
153377734|NCT04021043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153377735|NCT04021043|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153640540|NCT03151096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153640541|NCT03151096|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
153640542|NCT03151096|Dermatologic Agents|dermatologic agents|mesh-ancestor
153640543|NCT03906539|Atorvastatin|atorvastatin|mesh-list
153640544|NCT03906539|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153640545|NCT03906539|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153640546|NCT03906539|Antimetabolites|antimetabolites|mesh-ancestor
153640551|NCT00389688|Pemetrexed|pemetrexed|mesh-list
153377736|NCT04021043|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153377737|NCT04021043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153377738|NCT04012073|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-list
153377739|NCT04012073|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
153377749|NCT04007289|Anticoagulants|anticoagulants|mesh-ancestor
153837650|NCT02936934|Oxycodone|oxycodone|mesh-list
153837651|NCT02936934|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153837652|NCT02936934|Narcotics|narcotics|mesh-ancestor
153837653|NCT02936934|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153837654|NCT02936934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153837655|NCT02936934|Analgesics|analgesics|mesh-ancestor
153837656|NCT02936934|Sensory System Agents|sensory system agents|mesh-ancestor
153837657|NCT02936934|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153837658|NCT00522470|Rosiglitazone|rosiglitazone|mesh-list
153837659|NCT00522470|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153837660|NCT00522470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153837661|NCT00522509|Floxuridine|floxuridine|mesh-list
153837662|NCT00522509|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153837663|NCT00522509|Antimetabolites|antimetabolites|mesh-ancestor
153837664|NCT00522509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153837665|NCT00522509|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153837666|NCT00522587|Remifentanil|remifentanil|mesh-list
153837667|NCT00522587|Sevoflurane|sevoflurane|mesh-list
153837668|NCT00522587|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153837669|NCT00522587|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
153837670|NCT00522587|Anesthetics, General|anesthetics, general|mesh-ancestor
153837671|NCT00522587|Anesthetics|anesthetics|mesh-ancestor
153837672|NCT00522587|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153837673|NCT00522587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153837674|NCT00522587|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153837675|NCT00522587|Narcotics|narcotics|mesh-ancestor
153837676|NCT00522587|Analgesics|analgesics|mesh-ancestor
153837677|NCT00522587|Sensory System Agents|sensory system agents|mesh-ancestor
153837678|NCT00522587|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153837679|NCT00522665|Irinotecan|irinotecan|mesh-list
153837680|NCT00522665|Cetuximab|cetuximab|mesh-list
153837681|NCT00522665|Everolimus|everolimus|mesh-list
153837682|NCT00522665|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
153837683|NCT00522665|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153837684|NCT00522665|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153377782|NCT03850418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153377783|NCT03850418|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153377784|NCT03850418|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153377785|NCT03850366|Cyclophosphamide|cyclophosphamide|mesh-list
153377787|NCT03850366|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153377788|NCT03850366|Immunologic Factors|immunologic factors|mesh-ancestor
153377789|NCT03850366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153377790|NCT03850366|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153377791|NCT03850366|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153377792|NCT03850366|Alkylating Agents|alkylating agents|mesh-ancestor
153377793|NCT03850366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153377794|NCT03850366|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153377795|NCT03850366|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153377796|NCT03797001|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
153377797|NCT03797001|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153377798|NCT03754049|Dexamethasone|dexamethasone|mesh-list
153377799|NCT03754049|Dexamethasone acetate|dexamethasone acetate|mesh-list
153377800|NCT03754049|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
153377801|NCT03754049|BB 1101|bb 1101|mesh-list
153377802|NCT03754049|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153377803|NCT03754049|Antiemetics|antiemetics|mesh-ancestor
153377805|NCT03754049|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153377806|NCT03754049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153377807|NCT03754049|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153377808|NCT03754049|Glucocorticoids|glucocorticoids|mesh-ancestor
153837703|NCT02937012|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153837704|NCT00522782|Budesonide|budesonide|mesh-list
153837705|NCT00522782|Nitric Oxide|nitric oxide|mesh-list
153837706|NCT00522782|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153837707|NCT00522782|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153837708|NCT00522782|Autonomic Agents|autonomic agents|mesh-ancestor
153837709|NCT00522782|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153837710|NCT00522782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153837711|NCT00522782|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153837712|NCT00522782|Respiratory System Agents|respiratory system agents|mesh-ancestor
153837713|NCT00522782|Glucocorticoids|glucocorticoids|mesh-ancestor
153837714|NCT00522782|Hormones|hormones|mesh-ancestor
153837715|NCT00522782|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153837716|NCT00522782|Free Radical Scavengers|free radical scavengers|mesh-ancestor
153837717|NCT00522782|Antioxidants|antioxidants|mesh-ancestor
153837718|NCT00522782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153837726|NCT00522821|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
153837728|NCT00522821|gamma-Globulins|gamma-globulins|mesh-list
153837729|NCT00522821|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
153837730|NCT00522821|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153377810|NCT03754049|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153377811|NCT03754049|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153377812|NCT03754049|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153377813|NCT03754049|Protease Inhibitors|protease inhibitors|mesh-ancestor
153377814|NCT03754049|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153640728|NCT01807429|Anesthetics|anesthetics|mesh-ancestor
153640759|NCT01349803|Adrenergic Agents|adrenergic agents|mesh-ancestor
153640760|NCT01349803|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153640761|NCT01349803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153640762|NCT01807000|Prucalopride|prucalopride|mesh-list
153640763|NCT01807000|Laxatives|laxatives|mesh-ancestor
153640764|NCT01807000|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153640765|NCT01807000|Serotonin 5-HT4 Receptor Agonists|serotonin 5-ht4 receptor agonists|mesh-ancestor
153640766|NCT01807000|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
153640767|NCT01807000|Serotonin Agents|serotonin agents|mesh-ancestor
153377815|NCT03754049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153377816|NCT03747939|Thalidomide|thalidomide|mesh-list
153377817|NCT03747939|Apremilast|apremilast|mesh-list
153377818|NCT03747939|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153377819|NCT03747939|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153837731|NCT00522821|Immunologic Factors|immunologic factors|mesh-ancestor
153837732|NCT00522821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153837734|NCT02936895|Cholecalciferol|cholecalciferol|mesh-list
153837735|NCT02936895|Vitamins|vitamins|mesh-ancestor
153837736|NCT02936895|Micronutrients|micronutrients|mesh-ancestor
153837737|NCT02936895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153837738|NCT02936895|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153837739|NCT02936895|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153837740|NCT00522938|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
153837741|NCT00522938|Tosedostat|tosedostat|mesh-list
153837742|NCT00522938|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153377831|NCT03747939|Immunologic Factors|immunologic factors|mesh-ancestor
153377832|NCT03747939|Leprostatic Agents|leprostatic agents|mesh-ancestor
153377833|NCT03747939|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153377834|NCT03747939|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153377835|NCT03747939|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153377836|NCT03747939|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153377837|NCT03747939|Growth Substances|growth substances|mesh-ancestor
153377838|NCT03747939|Growth Inhibitors|growth inhibitors|mesh-ancestor
153377839|NCT03747939|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153377840|NCT03702725|Dexamethasone|dexamethasone|mesh-list
153377841|NCT03702725|Lenalidomide|lenalidomide|mesh-list
153377842|NCT03702725|Ibrutinib|ibrutinib|mesh-list
153377843|NCT03702725|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153377844|NCT03702725|Antiemetics|antiemetics|mesh-ancestor
153377845|NCT03702725|Autonomic Agents|autonomic agents|mesh-ancestor
153377846|NCT03702725|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153377847|NCT03702725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153377848|NCT03702725|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153377849|NCT03702725|Glucocorticoids|glucocorticoids|mesh-ancestor
153377850|NCT03702725|Hormones|hormones|mesh-ancestor
153837753|NCT04694105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153837754|NCT04694105|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153461550|NCT04278378|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
153461551|NCT04278378|Dermatologic Agents|dermatologic agents|mesh-ancestor
153461552|NCT04785924|Imipenem|imipenem|mesh-list
153837755|NCT04694105|Glucocorticoids|glucocorticoids|mesh-ancestor
153837756|NCT04694105|Hormones|hormones|mesh-ancestor
153837757|NCT04694105|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153837758|NCT04694105|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153837759|NCT04694105|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153837760|NCT04694105|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153837761|NCT04694105|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153837762|NCT04694105|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153837763|NCT04694105|Analgesics|analgesics|mesh-ancestor
153837764|NCT04694105|Sensory System Agents|sensory system agents|mesh-ancestor
153377853|NCT03702725|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153377854|NCT03702725|Immunologic Factors|immunologic factors|mesh-ancestor
153377855|NCT03702725|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153377856|NCT03702725|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153377857|NCT03702725|Growth Substances|growth substances|mesh-ancestor
153377858|NCT03702725|Growth Inhibitors|growth inhibitors|mesh-ancestor
153377859|NCT03702725|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153377860|NCT03702725|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153377861|NCT03702725|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153377862|NCT03702725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153377864|NCT03671811|Megestrol Acetate|megestrol acetate|mesh-list
153377865|NCT03671811|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
153377866|NCT03671811|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
153377867|NCT03671811|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
153377868|NCT03671811|Contraceptive Agents|contraceptive agents|mesh-ancestor
153377869|NCT03671811|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153377870|NCT03671811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153377871|NCT03671811|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
153377872|NCT03671811|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
153377873|NCT03671811|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153837773|NCT02930733|Anesthetics|anesthetics|mesh-ancestor
153837774|NCT02930733|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153837783|NCT00523055|Sensory System Agents|sensory system agents|mesh-ancestor
153837784|NCT00523055|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153837785|NCT00523055|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153837786|NCT00523055|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
153837787|NCT00523055|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153377879|NCT03652961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153377880|NCT03652961|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153377881|NCT03652961|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153377882|NCT03652961|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153377884|NCT03652961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153377885|NCT03652961|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153377886|NCT03646617|Nivolumab|nivolumab|mesh-list
153377887|NCT03646617|Ipilimumab|ipilimumab|mesh-list
153377888|NCT03646617|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153377889|NCT03646617|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153377890|NCT03646617|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153640800|NCT05517291|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153377891|NCT03646617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153377892|NCT03625349|omega-N-Methylarginine|omega-n-methylarginine|mesh-list
153377893|NCT03625349|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153377894|NCT03625349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153377895|NCT03624517|Octreotide|octreotide|mesh-list
153837796|NCT00523289|Sensory System Agents|sensory system agents|mesh-ancestor
153837797|NCT00523289|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153837798|NCT00524381|Etanercept|etanercept|mesh-list
153837799|NCT00524381|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153837800|NCT00524381|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153377909|NCT03590821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153377910|NCT03590821|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153377911|NCT03590821|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153837820|NCT00523406|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153837821|NCT00523406|Glucocorticoids|glucocorticoids|mesh-ancestor
153837822|NCT00523406|Hormones|hormones|mesh-ancestor
153837823|NCT00523406|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153837824|NCT00523406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153837825|NCT00524615|Spironolactone|spironolactone|mesh-list
153837826|NCT00524615|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
153837827|NCT00524615|Hormone Antagonists|hormone antagonists|mesh-ancestor
153837828|NCT00524615|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153837829|NCT00524615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153837830|NCT00524615|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
153837831|NCT00524615|Diuretics|diuretics|mesh-ancestor
153640922|NCT01466101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153837832|NCT00524615|Natriuretic Agents|natriuretic agents|mesh-ancestor
153732066|NCT01247701|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153837847|NCT02948075|Carboplatin|carboplatin|mesh-list
153837848|NCT02948075|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153377926|NCT03535727|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153377927|NCT03535727|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153377928|NCT03535727|Tubulin Modulators|tubulin modulators|mesh-ancestor
153377929|NCT03535727|Antimitotic Agents|antimitotic agents|mesh-ancestor
153377930|NCT03535727|Mitosis Modulators|mitosis modulators|mesh-ancestor
153377931|NCT03535727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153377932|NCT03535727|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153640923|NCT01466101|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153640924|NCT01466101|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153640925|NCT01466101|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153640926|NCT01466101|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153640927|NCT01466101|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153640977|NCT05393505|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
153377933|NCT03535727|Antimetabolites|antimetabolites|mesh-ancestor
153377934|NCT03535727|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
153377935|NCT03535727|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153377936|NCT03535727|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153377937|NCT03514368|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
153377938|NCT03514368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153377944|NCT03502577|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153377945|NCT03502577|Immunologic Factors|immunologic factors|mesh-ancestor
153377946|NCT03502577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153377947|NCT03502577|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153377948|NCT03502577|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153377949|NCT03502577|Alkylating Agents|alkylating agents|mesh-ancestor
153377950|NCT03502577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153837849|NCT02948075|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153837850|NCT02948075|Tubulin Modulators|tubulin modulators|mesh-ancestor
153837851|NCT02948075|Antimitotic Agents|antimitotic agents|mesh-ancestor
153837852|NCT02948075|Mitosis Modulators|mitosis modulators|mesh-ancestor
153837853|NCT02948075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153837854|NCT02930811|Sildenafil Citrate|sildenafil citrate|mesh-list
153837855|NCT02930811|Vasodilator Agents|vasodilator agents|mesh-ancestor
153837856|NCT02930811|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
153837857|NCT02930811|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
153837858|NCT02930811|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153837859|NCT02930811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153837860|NCT02930811|Urological Agents|urological agents|mesh-ancestor
153837863|NCT02947880|Natriuretic Agents|natriuretic agents|mesh-ancestor
153837864|NCT02947880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153837865|NCT02947880|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
153837866|NCT02947880|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153837867|NCT02947880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153837868|NCT00523757|Spironolactone|spironolactone|mesh-list
153641036|NCT00393679|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153641037|NCT00393679|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153641038|NCT00393679|Antiviral Agents|antiviral agents|mesh-ancestor
153641039|NCT00393679|Schistosomicides|schistosomicides|mesh-ancestor
153837869|NCT00523757|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
153837884|NCT00524693|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
153837885|NCT00524693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153837886|NCT02931201|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
153837887|NCT02931201|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
153837888|NCT02931201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153837889|NCT02936427|Dexamethasone|dexamethasone|mesh-list
153837890|NCT02936427|Dexamethasone acetate|dexamethasone acetate|mesh-list
153377988|NCT03341078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153377989|NCT03341078|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153837894|NCT02936427|Antiemetics|antiemetics|mesh-ancestor
153837895|NCT02936427|Autonomic Agents|autonomic agents|mesh-ancestor
153837896|NCT02936427|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153837897|NCT02936427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153837898|NCT02936427|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153837899|NCT02936427|Glucocorticoids|glucocorticoids|mesh-ancestor
153837901|NCT02936427|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153837902|NCT02936427|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153837903|NCT02936427|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153837904|NCT02936427|Protease Inhibitors|protease inhibitors|mesh-ancestor
153837905|NCT02936427|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153837906|NCT02936427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153837907|NCT00523913|Rosiglitazone|rosiglitazone|mesh-list
153837908|NCT00523913|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153837909|NCT00523913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153837910|NCT02947763|Metronidazole|metronidazole|mesh-list
153377999|NCT03313778|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153378000|NCT03313778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153378002|NCT03300427|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
153641093|NCT00847678|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153378004|NCT03300427|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
153378005|NCT03300427|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
153378006|NCT03300427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153378007|NCT03299049|Rilpivirine|rilpivirine|mesh-list
153837912|NCT02947763|Minocycline|minocycline|mesh-list
153461553|NCT04785924|Relebactam|relebactam|mesh-list
153461554|NCT04785924|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153461555|NCT04785924|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153461556|NCT04785924|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
153837913|NCT02947763|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153837914|NCT02947763|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153837915|NCT02947763|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153837916|NCT02947763|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153837917|NCT02947763|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153837918|NCT02947763|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153837919|NCT02947763|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153837920|NCT02947763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153837921|NCT02947763|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153837922|NCT02947763|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
153837923|NCT02947763|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153837924|NCT00523952|Tacrolimus|tacrolimus|mesh-list
153837925|NCT00523952|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153837926|NCT00523952|Immunologic Factors|immunologic factors|mesh-ancestor
153837927|NCT00523952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153837928|NCT00523952|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
153837929|NCT00523952|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153837930|NCT00523952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153378009|NCT03299049|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153378010|NCT03299049|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153378011|NCT03299049|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153378012|NCT03299049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153378013|NCT03299049|Antiviral Agents|antiviral agents|mesh-ancestor
153378022|NCT03247413|Dexamethasone|dexamethasone|mesh-list
153378023|NCT03247413|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153378024|NCT03247413|Antiemetics|antiemetics|mesh-ancestor
153378025|NCT03247413|Autonomic Agents|autonomic agents|mesh-ancestor
153378026|NCT03247413|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153378027|NCT03247413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153378028|NCT03247413|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153378029|NCT03247413|Glucocorticoids|glucocorticoids|mesh-ancestor
153378030|NCT03247413|Hormones|hormones|mesh-ancestor
153378031|NCT03247413|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153378032|NCT03247413|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153378033|NCT03247413|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153378035|NCT03222531|Sofosbuvir-velpatasvir drug combination|sofosbuvir-velpatasvir drug combination|mesh-list
153378036|NCT03222531|Velpatasvir|velpatasvir|mesh-list
153378037|NCT03222531|Antiviral Agents|antiviral agents|mesh-ancestor
153378038|NCT03222531|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153378039|NCT03206203|Carboplatin|carboplatin|mesh-list
153378040|NCT03206203|Atezolizumab|atezolizumab|mesh-list
153837931|NCT00524069|Bevacizumab|bevacizumab|mesh-list
153837932|NCT00524069|Gemcitabine|gemcitabine|mesh-list
153837933|NCT00524069|Capecitabine|capecitabine|mesh-list
153837934|NCT00524069|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153837935|NCT00524069|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153837936|NCT00524069|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153837937|NCT00524069|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153837938|NCT00524069|Growth Substances|growth substances|mesh-ancestor
153837939|NCT00524069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153837940|NCT00524069|Growth Inhibitors|growth inhibitors|mesh-ancestor
153837941|NCT00524069|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153837942|NCT00524069|Antimetabolites|antimetabolites|mesh-ancestor
153837943|NCT00524069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153837944|NCT00524810|Docetaxel|docetaxel|mesh-list
153837945|NCT00524810|Doxorubicin|doxorubicin|mesh-list
153837946|NCT00524810|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
153837947|NCT00524810|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153837948|NCT00524810|Tubulin Modulators|tubulin modulators|mesh-ancestor
153837949|NCT00524810|Antimitotic Agents|antimitotic agents|mesh-ancestor
153837950|NCT00524810|Mitosis Modulators|mitosis modulators|mesh-ancestor
153837951|NCT00524810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153837952|NCT00524810|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153837953|NCT00524810|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153837954|NCT00524810|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153837955|NCT00524810|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153837956|NCT00524849|Zoledronic Acid|zoledronic acid|mesh-list
153837957|NCT00524849|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153837958|NCT00524849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153837959|NCT00524927|Methoxyflurane|methoxyflurane|mesh-list
153837960|NCT00524927|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
153461557|NCT04785924|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153461558|NCT04785924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153461559|NCT04451772|Upadacitinib|upadacitinib|mesh-list
153461560|NCT04451772|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
153837961|NCT00524927|Anesthetics, General|anesthetics, general|mesh-ancestor
153837962|NCT00524927|Anesthetics|anesthetics|mesh-ancestor
153837963|NCT00524927|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153378041|NCT03206203|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153378042|NCT03206203|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153378043|NCT03206203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153378044|NCT03206203|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153378046|NCT03188796|Cholecalciferol|cholecalciferol|mesh-list
153378047|NCT03188796|Vitamins|vitamins|mesh-ancestor
153378048|NCT03188796|Micronutrients|micronutrients|mesh-ancestor
153378049|NCT03188796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153378060|NCT03167905|Entonox|entonox|mesh-list
153378061|NCT03167905|Anesthetics, Local|anesthetics, local|mesh-ancestor
153378062|NCT03167905|Anesthetics|anesthetics|mesh-ancestor
153378063|NCT03167905|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153378064|NCT03167905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153837964|NCT00524927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153837965|NCT00524966|Hemostatics|hemostatics|mesh-list
153837966|NCT00524966|Coagulants|coagulants|mesh-ancestor
153837967|NCT02276846|Paclitaxel|paclitaxel|mesh-list
153837968|NCT02276846|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153837969|NCT02276846|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153837970|NCT02276846|Tubulin Modulators|tubulin modulators|mesh-ancestor
153837971|NCT02276846|Antimitotic Agents|antimitotic agents|mesh-ancestor
153837972|NCT02276846|Mitosis Modulators|mitosis modulators|mesh-ancestor
153837973|NCT02276846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153837974|NCT02935725|Ketamine|ketamine|mesh-list
153837975|NCT02935725|Analgesics|analgesics|mesh-ancestor
153641302|NCT03620942|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153641359|NCT00276835|Genistein|genistein|mesh-list
153837976|NCT02935725|Sensory System Agents|sensory system agents|mesh-ancestor
153837977|NCT02935725|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153837978|NCT02935725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153820895|NCT04702334|Lidocaine|lidocaine|mesh-list
153378068|NCT03167905|Narcotics|narcotics|mesh-ancestor
153378069|NCT03167905|Analgesics|analgesics|mesh-ancestor
153378070|NCT03167905|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153378071|NCT03167905|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153378072|NCT03167905|Anesthetics, General|anesthetics, general|mesh-ancestor
153378073|NCT03167905|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
153378074|NCT03167905|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153378075|NCT03167905|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
153837987|NCT02935725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153837989|NCT02935764|Fluorouracil|fluorouracil|mesh-list
153837990|NCT02935764|Irinotecan|irinotecan|mesh-list
153837991|NCT02935764|Antimetabolites|antimetabolites|mesh-ancestor
153837992|NCT02935764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153837993|NCT02935764|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153837994|NCT02935764|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153837995|NCT02935764|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153837996|NCT02935764|Immunologic Factors|immunologic factors|mesh-ancestor
153837997|NCT02935764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153837998|NCT02935764|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
153837999|NCT02935764|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153838000|NCT02935764|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153838001|NCT02935764|Antidotes|antidotes|mesh-ancestor
153838008|NCT02935998|Serotonin Agents|serotonin agents|mesh-ancestor
153838009|NCT02935998|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153838010|NCT02935998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153838011|NCT02935998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153838012|NCT02935998|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153838013|NCT02935998|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153838014|NCT02935998|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153838015|NCT02935998|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153838016|NCT02935998|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
153838017|NCT02935998|Dopamine Agents|dopamine agents|mesh-ancestor
153838018|NCT02930109|Cytarabine|cytarabine|mesh-list
153838019|NCT02930109|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153838020|NCT02930109|Antimetabolites|antimetabolites|mesh-ancestor
153838021|NCT02930109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153838022|NCT02930109|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153838023|NCT02930109|Antiviral Agents|antiviral agents|mesh-ancestor
153838024|NCT02930109|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153838025|NCT02930109|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153838026|NCT02930109|Immunologic Factors|immunologic factors|mesh-ancestor
153838027|NCT02930109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153838028|NCT00524186|Leucovorin|leucovorin|mesh-list
153838029|NCT00524186|Fluorouracil|fluorouracil|mesh-list
153838030|NCT00524186|Irinotecan|irinotecan|mesh-list
153378141|NCT02838420|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153378142|NCT02838420|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153378143|NCT02838420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153378144|NCT02838420|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153378146|NCT02757859|Pancreatin|pancreatin|mesh-list
153378147|NCT02757859|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153378148|NCT02719613|Dexamethasone|dexamethasone|mesh-list
153378149|NCT02719613|Dexamethasone acetate|dexamethasone acetate|mesh-list
153378150|NCT02719613|Nivolumab|nivolumab|mesh-list
153378151|NCT02719613|Lenalidomide|lenalidomide|mesh-list
153378152|NCT02719613|Bortezomib|bortezomib|mesh-list
153378153|NCT02719613|Pomalidomide|pomalidomide|mesh-list
153378154|NCT02719613|Elotuzumab|elotuzumab|mesh-list
153378155|NCT02719613|BB 1101|bb 1101|mesh-list
153378156|NCT02719613|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153378157|NCT02719613|Antiemetics|antiemetics|mesh-ancestor
153378158|NCT02719613|Autonomic Agents|autonomic agents|mesh-ancestor
153378159|NCT02719613|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153378160|NCT02719613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153378161|NCT02719613|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153838096|NCT00525239|Atazanavir Sulfate|atazanavir sulfate|mesh-list
153838097|NCT00525239|Efavirenz|efavirenz|mesh-list
153838098|NCT00525239|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
153838099|NCT00525239|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
153838100|NCT00525239|Protease Inhibitors|protease inhibitors|mesh-ancestor
153838101|NCT00525239|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153838102|NCT00525239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153838103|NCT00525239|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153838104|NCT00525239|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153838105|NCT00525239|Antiviral Agents|antiviral agents|mesh-ancestor
153838106|NCT00525239|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153838107|NCT00525239|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
153838108|NCT00525239|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153838109|NCT00525239|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153838110|NCT00525239|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153641515|NCT00276250|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153838111|NCT00525239|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
153838112|NCT00525239|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
153838113|NCT00525239|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
153838114|NCT00525239|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
153838115|NCT00525239|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
153838121|NCT02947334|Antimetabolites|antimetabolites|mesh-ancestor
153838122|NCT02947334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153838123|NCT02947334|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153838125|NCT00525278|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
153838126|NCT00525278|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
153838127|NCT00525278|Histamine Antagonists|histamine antagonists|mesh-ancestor
153838128|NCT00525278|Histamine Agents|histamine agents|mesh-ancestor
153838129|NCT00525278|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153838130|NCT00525278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153838131|NCT00525278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153838132|NCT02929719|Dapsone|dapsone|mesh-list
153838133|NCT02929719|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153838134|NCT02929719|Antimalarials|antimalarials|mesh-ancestor
153838135|NCT02929719|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153838136|NCT02929719|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153838137|NCT02929719|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153838138|NCT02929719|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153838139|NCT02929719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153838140|NCT02929719|Leprostatic Agents|leprostatic agents|mesh-ancestor
153838141|NCT02929719|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153838142|NCT02929524|Ketamine|ketamine|mesh-list
153838143|NCT02929524|Analgesics|analgesics|mesh-ancestor
153838144|NCT02929524|Sensory System Agents|sensory system agents|mesh-ancestor
153838145|NCT02929524|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153838146|NCT02929524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153838147|NCT02929524|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
153838148|NCT02929524|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153838149|NCT02929524|Anesthetics, General|anesthetics, general|mesh-ancestor
153838175|NCT00526175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153838176|NCT00526175|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153838177|NCT00526175|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153838178|NCT00526175|Alkylating Agents|alkylating agents|mesh-ancestor
153838179|NCT00526175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153378278|NCT02192398|Guanfacine|guanfacine|mesh-list
153378279|NCT02192398|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153378280|NCT02192398|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
153378281|NCT02192398|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153378282|NCT02192398|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153378283|NCT02192398|Adrenergic Agents|adrenergic agents|mesh-ancestor
153378284|NCT02192398|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153378285|NCT02192398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153378286|NCT02192398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153378288|NCT02069730|Androgen Antagonists|androgen antagonists|mesh-list
153378289|NCT02069730|Hormones|hormones|mesh-ancestor
153838190|NCT00526175|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153838192|NCT00526175|Dermatologic Agents|dermatologic agents|mesh-ancestor
153838193|NCT00526175|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153838194|NCT00526175|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153838195|NCT00526175|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153838196|NCT00526175|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153378308|NCT02037048|Antimetabolites|antimetabolites|mesh-ancestor
153378309|NCT02037048|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153378310|NCT02037048|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153378311|NCT02037048|Immunologic Factors|immunologic factors|mesh-ancestor
153378312|NCT02037048|Antidotes|antidotes|mesh-ancestor
153378313|NCT02037048|Protective Agents|protective agents|mesh-ancestor
153378314|NCT02037048|Vitamin B Complex|vitamin b complex|mesh-ancestor
153378315|NCT02037048|Vitamins|vitamins|mesh-ancestor
153378316|NCT02037048|Micronutrients|micronutrients|mesh-ancestor
153378317|NCT01979367|Analgesics|analgesics|mesh-list
153838219|NCT02929563|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153838220|NCT02929563|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
153838221|NCT02929563|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153838222|NCT02929563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153838223|NCT00525551|Acetylcysteine|acetylcysteine|mesh-list
153838224|NCT00525551|N-monoacetylcystine|n-monoacetylcystine|mesh-list
153838225|NCT00525551|Antiviral Agents|antiviral agents|mesh-ancestor
153838226|NCT00525551|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153838227|NCT00525551|Expectorants|expectorants|mesh-ancestor
153838228|NCT00525551|Respiratory System Agents|respiratory system agents|mesh-ancestor
153838229|NCT00525551|Free Radical Scavengers|free radical scavengers|mesh-ancestor
153838230|NCT00525551|Antioxidants|antioxidants|mesh-ancestor
153838231|NCT00525551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153838232|NCT00525551|Protective Agents|protective agents|mesh-ancestor
153838233|NCT00525551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153378318|NCT01979367|Sensory System Agents|sensory system agents|mesh-ancestor
153838277|NCT02946437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153838278|NCT02946437|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153838279|NCT02946437|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
153838280|NCT02946632|Metformin|metformin|mesh-list
153838281|NCT02946632|Dapagliflozin|dapagliflozin|mesh-list
153838282|NCT02946632|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
153838283|NCT02946632|Glimepiride|glimepiride|mesh-list
153641654|NCT04574245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153378374|NCT01606878|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153378375|NCT01606878|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153378376|NCT01606878|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153378377|NCT01606878|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153378378|NCT01606878|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153378379|NCT01606878|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153378380|NCT01606878|Tubulin Modulators|tubulin modulators|mesh-ancestor
153378381|NCT01606878|Antimitotic Agents|antimitotic agents|mesh-ancestor
153378382|NCT01606878|Mitosis Modulators|mitosis modulators|mesh-ancestor
153378383|NCT01606878|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
153378384|NCT01606878|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153378385|NCT01606878|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
153378386|NCT01606878|Protective Agents|protective agents|mesh-ancestor
153378387|NCT01175356|Vitamin A|vitamin a|mesh-list
153378388|NCT01175356|Cyclophosphamide|cyclophosphamide|mesh-list
153378389|NCT01175356|Melphalan|melphalan|mesh-list
153378390|NCT01175356|Busulfan|busulfan|mesh-list
153378391|NCT01175356|Mechlorethamine|mechlorethamine|mesh-list
153378392|NCT01175356|Nitrogen Mustard Compounds|nitrogen mustard compounds|mesh-list
153378393|NCT01175356|Cisplatin|cisplatin|mesh-list
153838309|NCT02929212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153838310|NCT02929212|Antipyretics|antipyretics|mesh-ancestor
153838311|NCT02929251|Adalimumab|adalimumab|mesh-list
153838312|NCT02929251|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
153838327|NCT02929095|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153378414|NCT01175356|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153378415|NCT01175356|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153378416|NCT01175356|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153378417|NCT01175356|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153378418|NCT01175356|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153378419|NCT01175356|Tubulin Modulators|tubulin modulators|mesh-ancestor
153378420|NCT01175356|Antimitotic Agents|antimitotic agents|mesh-ancestor
153378421|NCT01175356|Mitosis Modulators|mitosis modulators|mesh-ancestor
153378422|NCT01175356|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
153378423|NCT01175356|Keratolytic Agents|keratolytic agents|mesh-ancestor
153378424|NCT01175356|Dermatologic Agents|dermatologic agents|mesh-ancestor
153378425|NCT01175356|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
153378426|NCT01151605|Insulin|insulin|mesh-list
153378427|NCT01151605|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
153378428|NCT01151605|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153378429|NCT01151605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153838343|NCT02928861|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
153838344|NCT02928861|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
153838345|NCT02928861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153838346|NCT00525668|Epigallocatechin gallate|epigallocatechin gallate|mesh-list
153838347|NCT00525668|Antioxidants|antioxidants|mesh-ancestor
153641769|NCT02490241|Antimanic Agents|antimanic agents|mesh-ancestor
153641770|NCT02490241|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153838348|NCT00525668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153838349|NCT00525668|Protective Agents|protective agents|mesh-ancestor
153838350|NCT00525668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153838351|NCT00525668|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
153838352|NCT00525668|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
153838353|NCT00525668|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153838354|NCT00525668|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
153838355|NCT00525707|Tezosentan|tezosentan|mesh-list
153838356|NCT00525707|Vasodilator Agents|vasodilator agents|mesh-ancestor
153838357|NCT00526214|Celecoxib|celecoxib|mesh-list
153838358|NCT00526214|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153838359|NCT00526214|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153838360|NCT00526214|Analgesics|analgesics|mesh-ancestor
153838361|NCT00526214|Sensory System Agents|sensory system agents|mesh-ancestor
153378488|NCT00295893|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153378489|NCT00295893|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153378490|NCT00295893|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153378491|NCT00295893|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153838383|NCT02946944|Antithrombins|antithrombins|mesh-ancestor
153838384|NCT02946944|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
153838385|NCT02946944|Protease Inhibitors|protease inhibitors|mesh-ancestor
153838386|NCT02946944|Anticoagulants|anticoagulants|mesh-ancestor
153838387|NCT02947061|Docetaxel|docetaxel|mesh-list
153838388|NCT02947061|Capecitabine|capecitabine|mesh-list
153838389|NCT02947061|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153838390|NCT02947061|Tubulin Modulators|tubulin modulators|mesh-ancestor
153838391|NCT02947061|Antimitotic Agents|antimitotic agents|mesh-ancestor
153838392|NCT02947061|Mitosis Modulators|mitosis modulators|mesh-ancestor
153838393|NCT02947061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153838444|NCT00526409|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153838445|NCT00526409|Antiviral Agents|antiviral agents|mesh-ancestor
153838446|NCT00526409|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153378554|NCT01470170|Alfentanil|alfentanil|mesh-list
153378555|NCT01470170|Propofol|propofol|mesh-list
153378556|NCT01470170|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153378557|NCT01470170|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153378558|NCT01470170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153378559|NCT01470170|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153378560|NCT01470170|Anesthetics, General|anesthetics, general|mesh-ancestor
153838449|NCT00526409|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153838450|NCT00526448|Ribavirin|ribavirin|mesh-list
153838451|NCT00526448|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
153838452|NCT00526448|Antimetabolites|antimetabolites|mesh-ancestor
153838453|NCT00526448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153838454|NCT00526448|Antiviral Agents|antiviral agents|mesh-ancestor
153838455|NCT00526448|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153838456|NCT02946671|Nivolumab|nivolumab|mesh-list
153838457|NCT02946671|Mogamulizumab|mogamulizumab|mesh-list
153838486|NCT02945163|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153838487|NCT02945163|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
153378591|NCT05037825|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153378593|NCT01573052|Chlordiazepoxide|chlordiazepoxide|mesh-list
153378594|NCT01573052|Gabapentin|gabapentin|mesh-list
153378595|NCT01573052|Analgesics|analgesics|mesh-ancestor
153378596|NCT01573052|Sensory System Agents|sensory system agents|mesh-ancestor
153378597|NCT01573052|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153378598|NCT01573052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153378599|NCT01573052|Anticonvulsants|anticonvulsants|mesh-ancestor
153378600|NCT01573052|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153378601|NCT01573052|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153378602|NCT01573052|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153378603|NCT01573052|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153378604|NCT01573052|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
153378628|NCT01472432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153378629|NCT01524302|Levofloxacin|levofloxacin|mesh-list
153378649|NCT02802111|Tocolytic Agents|tocolytic agents|mesh-ancestor
153378650|NCT02802111|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153378651|NCT02802111|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
153378652|NCT02802111|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
153378653|NCT02802111|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153378654|NCT02802111|Adrenergic Agents|adrenergic agents|mesh-ancestor
153378655|NCT02802111|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153378656|NCT02802111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153378657|NCT01576874|Oxytocin|oxytocin|mesh-list
153378658|NCT01576874|Oxytocics|oxytocics|mesh-ancestor
153378659|NCT01576874|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153378661|NCT01576952|Bromfenac|bromfenac|mesh-list
153838536|NCT00526877|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153838537|NCT00526877|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153838538|NCT00526877|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
153838539|NCT00526877|Dopamine Agents|dopamine agents|mesh-ancestor
153838540|NCT02927496|Doxycycline|doxycycline|mesh-list
153838541|NCT02927496|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153838542|NCT02927496|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153838543|NCT02927496|Antimalarials|antimalarials|mesh-ancestor
153838544|NCT02927496|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153838545|NCT02927496|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153838546|NCT02927535|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-list
153838547|NCT02927535|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153838548|NCT00527033|Mirabegron|mirabegron|mesh-list
153838564|NCT02924922|Mannitol|mannitol|mesh-list
153838570|NCT04692896|Anesthetics, Local|anesthetics, local|mesh-ancestor
153838571|NCT04692896|Anesthetics|anesthetics|mesh-ancestor
153838572|NCT04692896|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153838573|NCT04692896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153838574|NCT04692896|Sensory System Agents|sensory system agents|mesh-ancestor
153838575|NCT04692896|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153838576|NCT04692896|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153838577|NCT04692896|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
153838578|NCT04692896|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153378672|NCT01577966|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153378673|NCT01577966|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153378674|NCT01577966|Analgesics|analgesics|mesh-ancestor
153378675|NCT01577966|Sensory System Agents|sensory system agents|mesh-ancestor
153378676|NCT01577966|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153378677|NCT01577966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153378678|NCT01577966|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153378679|NCT01577966|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153378680|NCT01577966|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153378681|NCT02345226|Efavirenz, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|efavirenz, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
153378682|NCT02345226|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153378683|NCT02345226|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153378684|NCT02345226|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153378685|NCT02345226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153378686|NCT02345226|Antiviral Agents|antiviral agents|mesh-ancestor
153360895|NCT01376297|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
153838602|NCT02925000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153838603|NCT02926989|Plasma-lyte 148|plasma-lyte 148|mesh-list
153838604|NCT02926989|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
153378699|NCT01528592|Carbidopa|carbidopa|mesh-list
153378700|NCT01528592|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
153378701|NCT01528592|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
153378702|NCT01528592|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
153378703|NCT01528592|Dopamine Agents|dopamine agents|mesh-ancestor
153378704|NCT01528592|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153378705|NCT01528592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153378706|NCT01528592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153378707|NCT01528592|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
153378708|NCT01528592|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153378709|NCT01528592|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153378710|NCT01528592|Immunologic Factors|immunologic factors|mesh-ancestor
153378711|NCT01528592|Dopamine Agonists|dopamine agonists|mesh-ancestor
153378712|NCT01578278|Fluticasone|fluticasone|mesh-list
153378713|NCT01578278|Xhance|xhance|mesh-list
153378714|NCT01578278|Bepotastine besilate|bepotastine besilate|mesh-list
153378716|NCT01578278|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153378717|NCT01578278|Autonomic Agents|autonomic agents|mesh-ancestor
153378752|NCT02806869|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153378753|NCT02806869|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153378754|NCT02806869|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153838655|NCT00528359|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153838656|NCT00528359|Serotonin Agents|serotonin agents|mesh-ancestor
153838657|NCT00528359|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153838658|NCT00528359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153378756|NCT02806869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153378757|NCT03910101|Botulinum Toxins|botulinum toxins|mesh-list
153378758|NCT03910101|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
153378759|NCT03910101|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153378760|NCT03910101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153378761|NCT03910101|Cholinergic Agents|cholinergic agents|mesh-ancestor
153378762|NCT03910101|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153378763|NCT03910101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153642088|NCT00085228|Docetaxel|docetaxel|mesh-list
153378764|NCT02813265|Loteprednol Etabonate|loteprednol etabonate|mesh-list
153378765|NCT02813265|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
153378766|NCT05564858|Antibodies|antibodies|mesh-list
153378768|NCT05564858|Immunoconjugates|immunoconjugates|mesh-list
153378841|NCT02818569|Sensory System Agents|sensory system agents|mesh-ancestor
153838725|NCT00528515|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153838726|NCT00528515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153838727|NCT00528515|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153838728|NCT00528515|Anesthetics, General|anesthetics, general|mesh-ancestor
153838729|NCT00528515|Anesthetics|anesthetics|mesh-ancestor
153838730|NCT00528515|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
153838731|NCT02923986|Dasatinib|dasatinib|mesh-list
153838732|NCT02923986|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153838733|NCT02923986|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153838734|NCT02923986|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153838735|NCT02923986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153838736|NCT02923986|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153838737|NCT02926248|Colchicine|colchicine|mesh-list
153838738|NCT02926248|Gout Suppressants|gout suppressants|mesh-ancestor
153838739|NCT02926248|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153838740|NCT02926248|Tubulin Modulators|tubulin modulators|mesh-ancestor
153838741|NCT02926248|Antimitotic Agents|antimitotic agents|mesh-ancestor
153838742|NCT02926248|Mitosis Modulators|mitosis modulators|mesh-ancestor
153838743|NCT02926248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153378842|NCT02818569|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153378857|NCT03581409|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153838766|NCT02926170|Antithrombins|antithrombins|mesh-ancestor
153838767|NCT02926170|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
153838768|NCT02926170|Protease Inhibitors|protease inhibitors|mesh-ancestor
153838777|NCT04691687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153838778|NCT04691687|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
153838779|NCT04691687|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153838780|NCT04691687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153838781|NCT02923869|Bupivacaine|bupivacaine|mesh-list
153838782|NCT02923869|Levobupivacaine|levobupivacaine|mesh-list
153378900|NCT03510741|Expectorants|expectorants|mesh-ancestor
153838784|NCT02923869|Anesthetics|anesthetics|mesh-ancestor
153838785|NCT02923869|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153838786|NCT02923869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153838787|NCT02923869|Sensory System Agents|sensory system agents|mesh-ancestor
153838788|NCT02923869|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153838789|NCT02923791|Lenograstim|lenograstim|mesh-list
153838790|NCT02923791|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153838791|NCT02923791|Immunologic Factors|immunologic factors|mesh-ancestor
153642119|NCT00085345|Alkylating Agents|alkylating agents|mesh-ancestor
153642121|NCT00085345|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153838792|NCT02923791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153838795|NCT00527540|Interferon-alpha|interferon-alpha|mesh-list
153838796|NCT00527540|Interferon alpha-2|interferon alpha-2|mesh-list
153838797|NCT00527540|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
153378923|NCT02901249|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153378924|NCT02901249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153378925|NCT02901249|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153378926|NCT02901249|Serotonin Agents|serotonin agents|mesh-ancestor
153838804|NCT00527540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153838805|NCT02926053|Cyclophosphamide|cyclophosphamide|mesh-list
153838806|NCT02926053|Fludarabine|fludarabine|mesh-list
153838807|NCT02926053|Interleukin-2|interleukin-2|mesh-list
153838808|NCT02926053|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153838809|NCT02926053|Immunologic Factors|immunologic factors|mesh-ancestor
153838810|NCT02926053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153838811|NCT02926053|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153838812|NCT02926053|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153838813|NCT02926053|Alkylating Agents|alkylating agents|mesh-ancestor
153838814|NCT02926053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153838815|NCT02926053|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153838816|NCT02926053|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153838817|NCT02926053|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153838818|NCT02926053|Analgesics|analgesics|mesh-ancestor
153838819|NCT02926053|Sensory System Agents|sensory system agents|mesh-ancestor
153838820|NCT02926053|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153838821|NCT00527657|Thalidomide|thalidomide|mesh-list
153838822|NCT00527657|Temozolomide|temozolomide|mesh-list
153838823|NCT00527657|Lomustine|lomustine|mesh-list
153838824|NCT00527657|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153838825|NCT00527657|Alkylating Agents|alkylating agents|mesh-ancestor
153838826|NCT00527657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153838827|NCT00527657|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153838828|NCT00527657|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153838829|NCT00527657|Immunologic Factors|immunologic factors|mesh-ancestor
153378939|NCT00373815|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153378940|NCT00373815|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153378941|NCT00373815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153378942|NCT00373815|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153378943|NCT00373815|Immunologic Factors|immunologic factors|mesh-ancestor
153378956|NCT00373893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153838830|NCT00527657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153838831|NCT00527657|Leprostatic Agents|leprostatic agents|mesh-ancestor
153838832|NCT00527657|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153838833|NCT00527657|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153838834|NCT00527657|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153838835|NCT00527657|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153838836|NCT00527657|Growth Substances|growth substances|mesh-ancestor
153838837|NCT00527657|Growth Inhibitors|growth inhibitors|mesh-ancestor
153838838|NCT00528983|Azacitidine|azacitidine|mesh-list
153838840|NCT00528983|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153838841|NCT00528983|Antimetabolites|antimetabolites|mesh-ancestor
153838842|NCT00528983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153838843|NCT00528983|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153838844|NCT00528983|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153838845|NCT00529022|Carboplatin|carboplatin|mesh-list
153838846|NCT00529022|Azacitidine|azacitidine|mesh-list
153838847|NCT00529022|Valproic Acid|valproic acid|mesh-list
153838848|NCT00529022|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153838849|NCT00529022|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153838850|NCT00529022|Antimetabolites|antimetabolites|mesh-ancestor
153838851|NCT00529022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153838853|NCT00529022|Anticonvulsants|anticonvulsants|mesh-ancestor
153461561|NCT04451772|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153461562|NCT04451772|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153838854|NCT00529022|GABA Agents|gaba agents|mesh-ancestor
153838855|NCT00529022|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153838856|NCT00529022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153838857|NCT00529022|Antimanic Agents|antimanic agents|mesh-ancestor
153838858|NCT00529022|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153838859|NCT00529022|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153838860|NCT00529022|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153838861|NCT02923557|Pirarubicin|pirarubicin|mesh-list
153378958|NCT00373893|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153378959|NCT00373893|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153838875|NCT02925975|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153838876|NCT02925975|Vasodilator Agents|vasodilator agents|mesh-ancestor
153378973|NCT02977299|Dopamine Agents|dopamine agents|mesh-ancestor
153378974|NCT02977299|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153378975|NCT02977299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153378976|NCT02977299|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
153378978|NCT02977299|Serotonin Agents|serotonin agents|mesh-ancestor
153838892|NCT02945033|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153838894|NCT02945033|Antipyretics|antipyretics|mesh-ancestor
153838895|NCT00529295|Misoprostol|misoprostol|mesh-list
153838896|NCT00529295|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
153838897|NCT00529295|Abortifacient Agents|abortifacient agents|mesh-ancestor
153838898|NCT00529295|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153838899|NCT00529295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153838900|NCT00529295|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
153838901|NCT00529295|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153838902|NCT00529295|Oxytocics|oxytocics|mesh-ancestor
153838903|NCT02922933|Entinostat|entinostat|mesh-list
153838904|NCT02922933|Omeprazole|omeprazole|mesh-list
153838905|NCT02922933|Famotidine|famotidine|mesh-list
153838906|NCT02922933|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
153838907|NCT02922933|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153838908|NCT02922933|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
153838909|NCT02922933|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153838910|NCT02922933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153838911|NCT02922933|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
153838912|NCT02922933|Histamine Antagonists|histamine antagonists|mesh-ancestor
153838913|NCT02922933|Histamine Agents|histamine agents|mesh-ancestor
153838914|NCT02922933|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153838915|NCT02922933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153838916|NCT02922933|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153838917|NCT02922933|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
153379011|NCT02904915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153379012|NCT02907489|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
153379013|NCT02907489|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
153379014|NCT02907489|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153379015|NCT01535924|Gemcitabine|gemcitabine|mesh-list
153379016|NCT01535924|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
153379018|NCT01535924|Antimetabolites|antimetabolites|mesh-ancestor
153379019|NCT01535924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153379020|NCT01535924|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153379021|NCT01535924|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153379022|NCT01535924|Alkylating Agents|alkylating agents|mesh-ancestor
153379023|NCT02909439|Neostigmine|neostigmine|mesh-list
153379024|NCT02909439|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
153379025|NCT02909439|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153379026|NCT02909439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153379027|NCT02909439|Cholinergic Agents|cholinergic agents|mesh-ancestor
153379028|NCT02909439|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153379029|NCT02909439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153379030|NCT02909439|Parasympathomimetics|parasympathomimetics|mesh-ancestor
153379031|NCT02909439|Autonomic Agents|autonomic agents|mesh-ancestor
153379032|NCT02909439|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153379033|NCT01536938|Calcitriol|calcitriol|mesh-list
153379034|NCT01536938|Betamethasone|betamethasone|mesh-list
153379035|NCT01536938|Betamethasone Valerate|betamethasone valerate|mesh-list
153379038|NCT01536938|Calcipotriene|calcipotriene|mesh-list
153838943|NCT00529880|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153838944|NCT00529880|Immunologic Factors|immunologic factors|mesh-ancestor
153838945|NCT00529880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153838946|NCT00529880|Antiviral Agents|antiviral agents|mesh-ancestor
153838947|NCT00529880|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153838948|NCT02925702|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
153838949|NCT02925702|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153838951|NCT00531089|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153838952|NCT00531089|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153838953|NCT00531089|Immunologic Factors|immunologic factors|mesh-ancestor
153838954|NCT00531089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153838955|NCT00531089|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153838956|NCT02922699|Omeprazole|omeprazole|mesh-list
153379047|NCT01536938|Dermatologic Agents|dermatologic agents|mesh-ancestor
153379048|NCT01536938|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153379049|NCT01536938|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
153379050|NCT01536938|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153379051|NCT01536938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153379059|NCT01588418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153379060|NCT01588418|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
153379061|NCT01588418|Incretins|incretins|mesh-ancestor
153379062|NCT01588418|Hormones|hormones|mesh-ancestor
153379063|NCT01588418|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153379064|NCT03007160|Potassium Citrate|potassium citrate|mesh-list
153379065|NCT03007160|Diuretics|diuretics|mesh-ancestor
153379068|NCT03007160|Expectorants|expectorants|mesh-ancestor
153838969|NCT02922660|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153838970|NCT02922660|Anesthetics, General|anesthetics, general|mesh-ancestor
153838971|NCT02922660|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153838972|NCT02922660|Narcotics|narcotics|mesh-ancestor
153838973|NCT02922660|Analgesics|analgesics|mesh-ancestor
153838974|NCT02922660|Sensory System Agents|sensory system agents|mesh-ancestor
153838975|NCT02922660|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153838976|NCT02922660|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
153838977|NCT02922465|Clopidogrel|clopidogrel|mesh-list
153838978|NCT02922465|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153838979|NCT02922465|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
153838980|NCT02922465|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
153838981|NCT02922465|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
153838982|NCT02922465|Purinergic Agents|purinergic agents|mesh-ancestor
153838983|NCT02922465|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153838984|NCT02922465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153379076|NCT03007004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153379077|NCT03007004|Cholinergic Agents|cholinergic agents|mesh-ancestor
153379078|NCT03007004|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153642398|NCT00087256|Analgesics|analgesics|mesh-ancestor
153642399|NCT00087256|Sensory System Agents|sensory system agents|mesh-ancestor
153642400|NCT00087256|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153642401|NCT00087256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153642402|NCT00087256|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153642403|NCT00087256|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153642404|NCT00087256|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
153379079|NCT03007004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153379080|NCT03007004|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
153838991|NCT02944292|Anesthetics, General|anesthetics, general|mesh-ancestor
153838992|NCT02944292|Anesthetics|anesthetics|mesh-ancestor
153838993|NCT02922426|Olanzapine|olanzapine|mesh-list
153838994|NCT02922426|Antiemetics|antiemetics|mesh-ancestor
153838995|NCT02922426|Autonomic Agents|autonomic agents|mesh-ancestor
153838996|NCT02922426|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153838997|NCT02922426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153838998|NCT02922426|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153838999|NCT02922426|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153839000|NCT02922426|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153839001|NCT02922426|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153839002|NCT02922426|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153839003|NCT02922426|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
153839004|NCT02922426|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153839005|NCT02922426|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153839006|NCT02922426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153839007|NCT02922426|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153839008|NCT02922426|Serotonin Agents|serotonin agents|mesh-ancestor
153839009|NCT00531128|Gamma-sitosterol|gamma-sitosterol|mesh-list
153839010|NCT00531128|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153839011|NCT00531128|Antimetabolites|antimetabolites|mesh-ancestor
153839012|NCT00531128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153379106|NCT02914509|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153379107|NCT02840097|Tranexamic Acid|tranexamic acid|mesh-list
153379108|NCT02840097|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
153379110|NCT02840097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153379125|NCT02988089|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
153379126|NCT02988089|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153379127|NCT02988089|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153379128|NCT02988089|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153379129|NCT02988089|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
153379130|NCT02988089|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153379131|NCT02988089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153839014|NCT02925351|Clofarabine|clofarabine|mesh-list
153839015|NCT02925351|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153839017|NCT02925351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153839018|NCT02925351|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153839020|NCT00531167|Adefovir|adefovir|mesh-list
153839021|NCT00531167|Entecavir|entecavir|mesh-list
153839022|NCT00531167|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153839023|NCT00531167|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153839024|NCT00531167|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153839025|NCT00531167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153839026|NCT00531167|Antiviral Agents|antiviral agents|mesh-ancestor
153839027|NCT00531167|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153839028|NCT00531167|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153839029|NCT00531167|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153839030|NCT02944214|Febuxostat|febuxostat|mesh-list
153839031|NCT02944214|Benzbromarone|benzbromarone|mesh-list
153839032|NCT02944214|Gout Suppressants|gout suppressants|mesh-ancestor
153839033|NCT02944214|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153839036|NCT02922075|Chlorhexidine|chlorhexidine|mesh-list
153839043|NCT02922348|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
153839044|NCT02922348|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
153839045|NCT02922348|Ethinyl Estradiol|ethinyl estradiol|mesh-list
153839046|NCT02922348|Medroxyprogesterone|medroxyprogesterone|mesh-list
153839047|NCT02922348|Norgestimate|norgestimate|mesh-list
153839048|NCT02922348|Contraceptive Agents|contraceptive agents|mesh-list
153839049|NCT02922348|Contraceptives, Oral|contraceptives, oral|mesh-list
153839050|NCT02922348|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-list
153839051|NCT02922348|Hormones|hormones|mesh-list
153839052|NCT02922348|Estradiol|estradiol|mesh-list
153839053|NCT02922348|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
153839054|NCT02922348|Progestins|progestins|mesh-list
153839055|NCT02922348|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153839056|NCT02922348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153839057|NCT02922348|Estrogens|estrogens|mesh-ancestor
153839058|NCT02922348|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
153839059|NCT02922348|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153839060|NCT02922348|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
153839061|NCT02922348|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
153839062|NCT02922348|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
153839063|NCT00527501|Travoprost|travoprost|mesh-list
153839064|NCT00527501|Brinzolamide|brinzolamide|mesh-list
153839065|NCT00527501|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153839066|NCT00527501|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
153839067|NCT00527501|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153839068|NCT00527501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153839069|NCT02922387|Varenicline|varenicline|mesh-list
153839070|NCT02922387|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
153839071|NCT02922387|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
153379196|NCT00551291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153379197|NCT00551291|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153839072|NCT02922387|Cholinergic Agents|cholinergic agents|mesh-ancestor
153839073|NCT02922387|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153839074|NCT02922387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153839075|NCT02922387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153839076|NCT00531323|Etravirine|etravirine|mesh-list
153839077|NCT00531323|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153839078|NCT00531323|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153642533|NCT00088075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153839079|NCT00531323|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153839080|NCT00531323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153839081|NCT00531323|Antiviral Agents|antiviral agents|mesh-ancestor
153839082|NCT00531323|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153839083|NCT00531362|Aspirin|aspirin|mesh-list
153839084|NCT00531362|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153839085|NCT00531362|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153839086|NCT00531362|Analgesics|analgesics|mesh-ancestor
153839087|NCT00531362|Sensory System Agents|sensory system agents|mesh-ancestor
153839088|NCT00531362|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153839089|NCT00531362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153839090|NCT00531362|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153379226|NCT01593722|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
153839100|NCT00531401|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153839101|NCT00531401|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153839102|NCT00531401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153839103|NCT00531440|Everolimus|everolimus|mesh-list
153839104|NCT00531440|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
153839105|NCT00531440|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153839106|NCT00531440|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153839107|NCT00531440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153839108|NCT00531440|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153839109|NCT00531440|Immunologic Factors|immunologic factors|mesh-ancestor
153839110|NCT00531440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153839111|NCT00531440|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153839112|NCT02944526|Ropivacaine|ropivacaine|mesh-list
153839113|NCT02944526|Anesthetics, Local|anesthetics, local|mesh-ancestor
153839114|NCT02944526|Anesthetics|anesthetics|mesh-ancestor
153839115|NCT02944526|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153839116|NCT02944526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153839117|NCT02944526|Sensory System Agents|sensory system agents|mesh-ancestor
153379252|NCT01595516|Kininogens|kininogens|mesh-list
153379253|NCT01595516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153379254|NCT01595516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153379255|NCT01595516|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153379256|NCT01595516|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153379257|NCT01595516|Sympatholytics|sympatholytics|mesh-ancestor
153379258|NCT01595516|Autonomic Agents|autonomic agents|mesh-ancestor
153642603|NCT00088543|Immunologic Factors|immunologic factors|mesh-ancestor
153379259|NCT01595516|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153379261|NCT01595516|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
153379262|NCT01595516|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
153379263|NCT01595516|Adrenergic Agents|adrenergic agents|mesh-ancestor
153379264|NCT01595516|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153379265|NCT01595516|Vasodilator Agents|vasodilator agents|mesh-ancestor
153379266|NCT01595516|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
153379273|NCT01596842|Vitamin D|vitamin d|mesh-list
153379284|NCT02218190|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153379285|NCT03006614|Cisplatin|cisplatin|mesh-list
153379286|NCT03006614|Gemcitabine|gemcitabine|mesh-list
153379287|NCT03006614|Docetaxel|docetaxel|mesh-list
153379288|NCT03006614|Capecitabine|capecitabine|mesh-list
153379289|NCT03006614|Trastuzumab|trastuzumab|mesh-list
153379290|NCT03006614|Vinorelbine|vinorelbine|mesh-list
153379291|NCT03006614|Epirubicin|epirubicin|mesh-list
153379292|NCT03006614|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153379293|NCT03006614|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153379294|NCT03006614|Antimetabolites|antimetabolites|mesh-ancestor
153379295|NCT03006614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153379296|NCT03006614|Tubulin Modulators|tubulin modulators|mesh-ancestor
153379297|NCT03006614|Antimitotic Agents|antimitotic agents|mesh-ancestor
153379298|NCT03006614|Mitosis Modulators|mitosis modulators|mesh-ancestor
153379299|NCT03006614|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153379300|NCT03006614|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153379301|NCT03006614|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153379302|NCT03006614|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153379303|NCT03006614|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153379304|NCT03006614|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153379305|NCT03001466|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
153379306|NCT03001466|Ophthalmic Solutions|ophthalmic solutions|mesh-list
153379307|NCT03006380|Oxytocin|oxytocin|mesh-list
153379308|NCT03006380|Oxytocics|oxytocics|mesh-ancestor
153379311|NCT02981030|Misoprostol|misoprostol|mesh-list
153839177|NCT00531557|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
153839178|NCT00531557|Protease Inhibitors|protease inhibitors|mesh-ancestor
153839179|NCT00531557|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153839181|NCT00531557|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153839199|NCT02943707|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
153839200|NCT02943707|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153839201|NCT00531635|Mycophenolic Acid|mycophenolic acid|mesh-list
153839202|NCT00531635|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153839203|NCT00531635|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153839204|NCT00531635|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
153839205|NCT00531635|Antitubercular Agents|antitubercular agents|mesh-ancestor
153839206|NCT00531635|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153839207|NCT00531635|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153839208|NCT00531635|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153839209|NCT00531635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153839210|NCT02917551|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
153839211|NCT02917551|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
153839212|NCT02917551|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153839213|NCT02917551|Antitubercular Agents|antitubercular agents|mesh-ancestor
153839214|NCT00531674|Tocopherols|tocopherols|mesh-list
153839215|NCT00531674|Antioxidants|antioxidants|mesh-ancestor
153839216|NCT00531674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153379319|NCT02981030|Oxytocics|oxytocics|mesh-ancestor
153379320|NCT02981030|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
153379321|NCT02981030|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
153379322|NCT02981030|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
153379323|NCT02981030|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
153379324|NCT02981030|Contraceptive Agents|contraceptive agents|mesh-ancestor
153379325|NCT02981030|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
153379326|NCT02981030|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
153379327|NCT02981030|Hormone Antagonists|hormone antagonists|mesh-ancestor
153379328|NCT02981030|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153379329|NCT02981030|Luteolytic Agents|luteolytic agents|mesh-ancestor
153379330|NCT02981030|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
153379331|NCT02981030|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
153379332|NCT03006146|Molgramostim|molgramostim|mesh-list
153379333|NCT03006146|Sargramostim|sargramostim|mesh-list
153379340|NCT00551213|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153732074|NCT00140543|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153732075|NCT00140543|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153379342|NCT00551213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153379343|NCT00551213|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153379344|NCT00551213|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
153839217|NCT00531674|Protective Agents|protective agents|mesh-ancestor
153839218|NCT00531674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153839220|NCT00531674|Micronutrients|micronutrients|mesh-ancestor
153839221|NCT00530972|Ribavirin|ribavirin|mesh-list
153839222|NCT00530972|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
153839223|NCT00530972|Antimetabolites|antimetabolites|mesh-ancestor
153379376|NCT03000218|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
153379377|NCT03000218|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153379378|NCT03010683|Metformin|metformin|mesh-list
153379379|NCT03010683|Liraglutide|liraglutide|mesh-list
153379380|NCT03010683|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153642723|NCT00089167|Hormones|hormones|mesh-ancestor
153379381|NCT03010683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153379382|NCT03010683|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
153379383|NCT03010683|Incretins|incretins|mesh-ancestor
153379384|NCT03010683|Hormones|hormones|mesh-ancestor
153379385|NCT03010683|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153379386|NCT04877678|Bepotastine besilate|bepotastine besilate|mesh-list
153379387|NCT04877678|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
153379388|NCT02918097|Risperidone|risperidone|mesh-list
153379389|NCT02918097|Lithium Carbonate|lithium carbonate|mesh-list
153379390|NCT02918097|Sertraline|sertraline|mesh-list
153379391|NCT02918097|Nortriptyline|nortriptyline|mesh-list
153379392|NCT02918097|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153379393|NCT02918097|Serotonin Agents|serotonin agents|mesh-ancestor
153379394|NCT02918097|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153379395|NCT02918097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153379396|NCT02918097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153379397|NCT02918097|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153839293|NCT00531986|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153839294|NCT00531986|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
153839295|NCT00531986|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153839296|NCT02920827|Dapivirine|dapivirine|mesh-list
153839297|NCT02920827|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153839298|NCT02920827|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153839299|NCT02920827|Antiviral Agents|antiviral agents|mesh-ancestor
153839300|NCT02920827|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153839301|NCT02920905|Lidocaine|lidocaine|mesh-list
153839302|NCT02920905|Atracurium|atracurium|mesh-list
153839303|NCT02920905|Anesthetics, Local|anesthetics, local|mesh-ancestor
153839304|NCT02920905|Anesthetics|anesthetics|mesh-ancestor
153379405|NCT02918097|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153379406|NCT02918097|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153379411|NCT02918097|Adrenergic Agents|adrenergic agents|mesh-ancestor
153379412|NCT05408585|Anesthetics|anesthetics|mesh-list
153379413|NCT05408585|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153379414|NCT05408585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153379416|NCT02999204|Cholecalciferol|cholecalciferol|mesh-list
153379417|NCT02999204|Vitamins|vitamins|mesh-ancestor
153379418|NCT02999204|Micronutrients|micronutrients|mesh-ancestor
153379419|NCT02999204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153379420|NCT02999204|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153379421|NCT02999204|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153379422|NCT03012477|Adavosertib|adavosertib|mesh-list
153379423|NCT03012477|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153379424|NCT03012477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153379425|NCT02919111|Edetic Acid|edetic acid|mesh-list
153379426|NCT02919111|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
153379427|NCT02919111|Chelating Agents|chelating agents|mesh-ancestor
153379428|NCT02919111|Sequestering Agents|sequestering agents|mesh-ancestor
153379429|NCT02919111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153379430|NCT02919111|Anticoagulants|anticoagulants|mesh-ancestor
153839311|NCT02920905|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153839312|NCT02920905|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153839313|NCT02920905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153839314|NCT02920905|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
153839315|NCT02920905|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
153839316|NCT02920905|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
153839317|NCT02920905|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
153839318|NCT02920905|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
153839319|NCT02920905|Cholinergic Agents|cholinergic agents|mesh-ancestor
153839320|NCT02920905|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153839321|NCT02917200|Moxifloxacin|moxifloxacin|mesh-list
153839322|NCT02917200|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153839323|NCT02917200|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153839324|NCT02917200|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153839325|NCT02917200|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153839326|NCT02917200|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153839327|NCT02917200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153839328|NCT02917200|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153839342|NCT02917005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153839343|NCT02917005|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
153839344|NCT02917005|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153839345|NCT02917005|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
153839346|NCT02917005|Hormone Antagonists|hormone antagonists|mesh-ancestor
153839347|NCT02917005|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153839348|NCT02917005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153839349|NCT02917005|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153839350|NCT02942810|Cefepime|cefepime|mesh-list
153839351|NCT02942810|Cefepime-zidebactam|cefepime-zidebactam|mesh-list
153839352|NCT02942810|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153839353|NCT02942810|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153839354|NCT02920710|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
153839355|NCT02920710|Hormones|hormones|mesh-ancestor
153642916|NCT00089869|Serotonin Agents|serotonin agents|mesh-ancestor
153839356|NCT02920710|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153839357|NCT02920710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153839358|NCT02941913|Palonosetron|palonosetron|mesh-list
153839359|NCT02941913|Antiemetics|antiemetics|mesh-ancestor
153839360|NCT02941913|Autonomic Agents|autonomic agents|mesh-ancestor
153839361|NCT02941913|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153379497|NCT02247362|Immunologic Factors|immunologic factors|mesh-ancestor
153379498|NCT02247362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153379499|NCT02247362|Agglutinins|agglutinins|mesh-ancestor
153379500|NCT02247362|Coagulants|coagulants|mesh-ancestor
153379501|NCT02920749|Anesthetics|anesthetics|mesh-list
153379502|NCT02920749|Propofol|propofol|mesh-list
153379503|NCT02920749|Sevoflurane|sevoflurane|mesh-list
153379504|NCT02920749|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153379505|NCT02920749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153379506|NCT02920749|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153379507|NCT02920749|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153379508|NCT02920749|Anesthetics, General|anesthetics, general|mesh-ancestor
153379509|NCT02920749|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153379510|NCT02920749|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
153379511|NCT02248142|Pramipexole|pramipexole|mesh-list
153379512|NCT02248142|Dexpramipexole|dexpramipexole|mesh-list
153379513|NCT02248142|Antioxidants|antioxidants|mesh-ancestor
153379514|NCT02248142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153379515|NCT02248142|Protective Agents|protective agents|mesh-ancestor
153379516|NCT02248142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153379517|NCT02248142|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
153379518|NCT02248142|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
153379521|NCT02248142|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153379522|NCT04667780|Colchicine|colchicine|mesh-list
153379523|NCT04667780|Gout Suppressants|gout suppressants|mesh-ancestor
153379524|NCT04667780|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153379525|NCT04667780|Tubulin Modulators|tubulin modulators|mesh-ancestor
153379526|NCT04667780|Antimitotic Agents|antimitotic agents|mesh-ancestor
153839386|NCT02942732|Vitamins|vitamins|mesh-ancestor
153839407|NCT02920359|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153839409|NCT02916654|Trace Elements|trace elements|mesh-ancestor
153839410|NCT02916654|Micronutrients|micronutrients|mesh-ancestor
153839411|NCT02916654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153839412|NCT02941562|Leucovorin|leucovorin|mesh-list
153839413|NCT02941562|Fluorouracil|fluorouracil|mesh-list
153839414|NCT02941562|Oxaliplatin|oxaliplatin|mesh-list
153839415|NCT02941562|Antimetabolites|antimetabolites|mesh-ancestor
153839416|NCT02941562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153839417|NCT02941562|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153839418|NCT02941562|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153642954|NCT00006185|Rosiglitazone|rosiglitazone|mesh-list
153642955|NCT00006185|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153642956|NCT00006185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153642957|NCT00091039|Metronidazole|metronidazole|mesh-list
153642958|NCT00091039|Paclitaxel|paclitaxel|mesh-list
153642959|NCT00091039|Carboplatin|carboplatin|mesh-list
153642960|NCT00091039|Vaccines|vaccines|mesh-list
153642961|NCT00091039|Adjuvants, Vaccine|adjuvants, vaccine|mesh-list
153642962|NCT00091039|Immunologic Factors|immunologic factors|mesh-ancestor
153642963|NCT00091039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153643001|NCT00091234|Immunologic Factors|immunologic factors|mesh-ancestor
153643002|NCT00091234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153839419|NCT02941562|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153839420|NCT02941562|Immunologic Factors|immunologic factors|mesh-ancestor
153839421|NCT02941562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153839422|NCT02941562|Antidotes|antidotes|mesh-ancestor
153839423|NCT02941562|Protective Agents|protective agents|mesh-ancestor
153379527|NCT04667780|Mitosis Modulators|mitosis modulators|mesh-ancestor
153379528|NCT04667780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153379529|NCT04667780|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153379531|NCT02248220|Dexpramipexole|dexpramipexole|mesh-list
153379532|NCT02248220|Antioxidants|antioxidants|mesh-ancestor
153379533|NCT02248220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153379534|NCT02248220|Protective Agents|protective agents|mesh-ancestor
153379535|NCT02248220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153379536|NCT02248220|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
153379537|NCT02248220|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
153379538|NCT02248220|Dopamine Agonists|dopamine agonists|mesh-ancestor
153379539|NCT02248220|Dopamine Agents|dopamine agents|mesh-ancestor
153379540|NCT02248220|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153379541|NCT02921061|Cytarabine|cytarabine|mesh-list
153379542|NCT02921061|Decitabine|decitabine|mesh-list
153379543|NCT02921061|2-chloro-3'-deoxyadenosine|2-chloro-3'-deoxyadenosine|mesh-list
153643012|NCT00091312|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153643013|NCT00091312|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153643014|NCT00091312|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153643015|NCT00091312|Immunologic Factors|immunologic factors|mesh-ancestor
153643016|NCT00091312|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
153643017|NCT00091312|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153643018|NCT00091312|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153643019|NCT00091312|Antidotes|antidotes|mesh-ancestor
153643020|NCT00091312|Protective Agents|protective agents|mesh-ancestor
153643021|NCT00091312|Vitamin B Complex|vitamin b complex|mesh-ancestor
153643022|NCT00091312|Vitamins|vitamins|mesh-ancestor
153379544|NCT02921061|Mitoxantrone|mitoxantrone|mesh-list
153379545|NCT02921061|Cladribine|cladribine|mesh-list
153379546|NCT02921061|Lenograstim|lenograstim|mesh-list
153379547|NCT02921061|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153379548|NCT02921061|Antimetabolites|antimetabolites|mesh-ancestor
153379551|NCT02921061|Antiviral Agents|antiviral agents|mesh-ancestor
153379552|NCT02921061|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153379553|NCT02921061|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153379554|NCT02921061|Immunologic Factors|immunologic factors|mesh-ancestor
153379555|NCT02921061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153379556|NCT02921061|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153379557|NCT02921061|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153839426|NCT02941562|Micronutrients|micronutrients|mesh-ancestor
153839427|NCT02942888|Niacinamide|niacinamide|mesh-list
153839429|NCT02942888|Nicotinic Acids|nicotinic acids|mesh-list
153839430|NCT02942888|Vitamin B Complex|vitamin b complex|mesh-ancestor
153839431|NCT02942888|Vitamins|vitamins|mesh-ancestor
153839432|NCT02942888|Micronutrients|micronutrients|mesh-ancestor
153839433|NCT02942888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153839434|NCT02942888|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153839435|NCT02942888|Antimetabolites|antimetabolites|mesh-ancestor
153839436|NCT02942888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153839437|NCT02942888|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153839438|NCT02942888|Vasodilator Agents|vasodilator agents|mesh-ancestor
153839439|NCT02916420|Dexamethasone|dexamethasone|mesh-list
153839440|NCT02916420|Pomalidomide|pomalidomide|mesh-list
153839441|NCT02916420|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153839442|NCT02916420|Antiemetics|antiemetics|mesh-ancestor
153839443|NCT02916420|Autonomic Agents|autonomic agents|mesh-ancestor
153839444|NCT02916420|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153839445|NCT02916420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153839446|NCT02916420|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153839447|NCT02916420|Glucocorticoids|glucocorticoids|mesh-ancestor
153839448|NCT02916420|Hormones|hormones|mesh-ancestor
153839466|NCT03458468|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
153379570|NCT02281409|Mogamulizumab|mogamulizumab|mesh-list
153379571|NCT02281409|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153379572|NCT02859441|Ranibizumab|ranibizumab|mesh-list
153379574|NCT02859441|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153379575|NCT02859441|Growth Substances|growth substances|mesh-ancestor
153379576|NCT02859441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153379577|NCT02859441|Growth Inhibitors|growth inhibitors|mesh-ancestor
153379578|NCT02859441|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153379579|NCT01880099|Galantamine|galantamine|mesh-list
153379580|NCT01880099|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-list
153379581|NCT01880099|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153379582|NCT01880099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153379583|NCT01880099|Cholinergic Agents|cholinergic agents|mesh-ancestor
153379584|NCT01880099|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153379585|NCT01880099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153379586|NCT01880099|Parasympathomimetics|parasympathomimetics|mesh-ancestor
153379587|NCT01880099|Autonomic Agents|autonomic agents|mesh-ancestor
153643061|NCT00006200|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153643062|NCT00006200|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153643063|NCT00006200|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153643064|NCT00006200|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153643065|NCT00006200|Growth Substances|growth substances|mesh-ancestor
153643066|NCT00006200|Growth Inhibitors|growth inhibitors|mesh-ancestor
153643067|NCT00006200|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153379588|NCT01880099|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153379589|NCT01880099|Nootropic Agents|nootropic agents|mesh-ancestor
153379590|NCT04287803|Methoxyflurane|methoxyflurane|mesh-list
153379602|NCT02860845|Antifungal Agents|antifungal agents|mesh-list
153379603|NCT02860845|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153379604|NCT02860845|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
153379605|NCT02860845|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153379618|NCT03003884|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153379619|NCT03003884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153379620|NCT03003884|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153379621|NCT03003884|Anesthetics, General|anesthetics, general|mesh-ancestor
153379622|NCT03003884|Anesthetics|anesthetics|mesh-ancestor
153379623|NCT02248454|Insulin Lispro|insulin lispro|mesh-list
153379624|NCT02248454|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153379625|NCT02248454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153379626|NCT01881113|Cetirizine|cetirizine|mesh-list
153379627|NCT01881113|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
153379628|NCT01881113|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
153379629|NCT01881113|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
153379630|NCT01881113|Histamine Antagonists|histamine antagonists|mesh-ancestor
153379631|NCT01881113|Histamine Agents|histamine agents|mesh-ancestor
153839496|NCT02941016|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
153643070|NCT00006200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153643071|NCT00006203|Naltrexone|naltrexone|mesh-list
153643072|NCT00006203|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
153643073|NCT00006203|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
153643074|NCT00006203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153643075|NCT00006203|Sensory System Agents|sensory system agents|mesh-ancestor
153643076|NCT00006203|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153643077|NCT00091624|Lenalidomide|lenalidomide|mesh-list
153643078|NCT00091624|Immunologic Factors|immunologic factors|mesh-ancestor
153643079|NCT00091624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153839497|NCT02941016|Protease Inhibitors|protease inhibitors|mesh-ancestor
153643080|NCT00091624|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153643081|NCT00091624|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153839498|NCT02941016|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153839499|NCT02941016|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153379644|NCT02987699|Leucovorin|leucovorin|mesh-list
153839542|NCT02940821|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153839543|NCT02941601|Carboplatin|carboplatin|mesh-list
153839544|NCT02941601|Gemcitabine|gemcitabine|mesh-list
153839545|NCT02941601|Necitumumab|necitumumab|mesh-list
153839546|NCT02941601|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153839547|NCT02941601|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153379652|NCT02987699|Vitamin B Complex|vitamin b complex|mesh-ancestor
153379653|NCT02987699|Vitamins|vitamins|mesh-ancestor
153379654|NCT02987699|Micronutrients|micronutrients|mesh-ancestor
153379655|NCT02987699|Antimetabolites|antimetabolites|mesh-ancestor
153379656|NCT02987699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153379657|NCT02987699|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153379658|NCT02987699|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153379659|NCT02987699|Immunologic Factors|immunologic factors|mesh-ancestor
153379660|NCT03003728|Melphalan|melphalan|mesh-list
153379661|NCT03003728|Elotuzumab|elotuzumab|mesh-list
153379662|NCT03003728|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153379663|NCT03003728|Alkylating Agents|alkylating agents|mesh-ancestor
153379664|NCT03003728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153379665|NCT03003728|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153379666|NCT03003728|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153379667|NCT03003728|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153379668|NCT03003728|Immunologic Factors|immunologic factors|mesh-ancestor
153379669|NCT03003728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153379670|NCT05672810|Fibrin fragment D|fibrin fragment d|mesh-list
153379671|NCT05672810|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
153379672|NCT05672810|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153379673|NCT05672810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153379674|NCT05672810|Hemostatics|hemostatics|mesh-ancestor
153379675|NCT05672810|Coagulants|coagulants|mesh-ancestor
153379676|NCT00559247|Asunaprevir|asunaprevir|mesh-list
153379677|NCT00559247|Protease Inhibitors|protease inhibitors|mesh-ancestor
153379678|NCT00559247|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153379679|NCT00559247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153379680|NCT03003416|Dexamethasone|dexamethasone|mesh-list
153379681|NCT03003416|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153379682|NCT03003416|Antiemetics|antiemetics|mesh-ancestor
153839548|NCT02941601|Antimetabolites|antimetabolites|mesh-ancestor
153839549|NCT02941601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153839550|NCT02941601|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153839551|NCT03160638|Azithromycin|azithromycin|mesh-list
153839552|NCT03160638|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153839553|NCT03160638|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153839554|NCT02919462|Cisplatin|cisplatin|mesh-list
153643106|NCT00091741|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153643107|NCT00091741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153643108|NCT00091741|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153643109|NCT00091741|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153643110|NCT00091741|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153839555|NCT02919462|Pemetrexed|pemetrexed|mesh-list
153839556|NCT02919462|Vinorelbine|vinorelbine|mesh-list
153839557|NCT02919462|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153839558|NCT02919462|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153839559|NCT02919462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153379704|NCT02988869|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153379705|NCT02988869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153379706|NCT02988869|Parasympatholytics|parasympatholytics|mesh-ancestor
153379707|NCT02988869|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
153379708|NCT02988869|Cholinergic Agents|cholinergic agents|mesh-ancestor
153379709|NCT03028467|Folic Acid|folic acid|mesh-list
153379710|NCT03028467|Methotrexate|methotrexate|mesh-list
153379711|NCT03028467|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
153379712|NCT03028467|Abortifacient Agents|abortifacient agents|mesh-ancestor
153379713|NCT03028467|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153379714|NCT03028467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153379715|NCT03028467|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153379716|NCT03028467|Antimetabolites|antimetabolites|mesh-ancestor
153379717|NCT03028467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153379718|NCT03028467|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153379719|NCT03028467|Dermatologic Agents|dermatologic agents|mesh-ancestor
153379720|NCT03028467|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153379721|NCT03028467|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153379722|NCT03028467|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153379723|NCT03028467|Immunologic Factors|immunologic factors|mesh-ancestor
153379724|NCT03028467|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153379725|NCT03028467|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153379726|NCT03028467|Hematinics|hematinics|mesh-ancestor
153379727|NCT03028467|Vitamin B Complex|vitamin b complex|mesh-ancestor
153839594|NCT06026163|Caffeine citrate|caffeine citrate|mesh-list
153839595|NCT06026163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153839596|NCT06026163|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
153839608|NCT06025916|Hemostatics|hemostatics|mesh-ancestor
153379739|NCT02223260|Anticoagulants|anticoagulants|mesh-ancestor
153379740|NCT02863263|Povidone-Iodine|povidone-iodine|mesh-list
153379742|NCT02863263|Plasma Substitutes|plasma substitutes|mesh-ancestor
153379743|NCT02863263|Blood Substitutes|blood substitutes|mesh-ancestor
153379744|NCT02863263|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
153379745|NCT02863263|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153379746|NCT02223338|Ciprofloxacin|ciprofloxacin|mesh-list
153379747|NCT02223338|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153379748|NCT02223338|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153379749|NCT02223338|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153379750|NCT02223338|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153379751|NCT02223338|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153379752|NCT02223338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153379753|NCT02223338|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153379754|NCT02223338|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
153643208|NCT00092365|Celecoxib|celecoxib|mesh-list
153379755|NCT02223338|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153379756|NCT01887587|Dexamethasone|dexamethasone|mesh-list
153379757|NCT01887587|Doxorubicin|doxorubicin|mesh-list
153379758|NCT01887587|Vincristine|vincristine|mesh-list
153379759|NCT01887587|Ixazomib|ixazomib|mesh-list
153379760|NCT01887587|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153379761|NCT01887587|Antiemetics|antiemetics|mesh-ancestor
153839658|NCT06025474|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
153839659|NCT06025474|Vortioxetine|vortioxetine|mesh-list
153839660|NCT06025474|Citalopram|citalopram|mesh-list
153839661|NCT06025474|Sertraline|sertraline|mesh-list
153839662|NCT06025474|Paroxetine|paroxetine|mesh-list
153839663|NCT06025474|Escitalopram|escitalopram|mesh-list
153839664|NCT06025474|Analgesics|analgesics|mesh-ancestor
153839665|NCT06025474|Sensory System Agents|sensory system agents|mesh-ancestor
153839666|NCT06025474|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153839667|NCT06025474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153839668|NCT06025474|Anticonvulsants|anticonvulsants|mesh-ancestor
153839669|NCT06025474|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153839670|NCT06025474|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153839671|NCT06025474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153839672|NCT06025474|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153839673|NCT06025474|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153839674|NCT06025474|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153839675|NCT06025474|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153839677|NCT06025474|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
153839678|NCT06025474|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153379780|NCT01887587|Protease Inhibitors|protease inhibitors|mesh-ancestor
153379781|NCT03029091|Losartan|losartan|mesh-list
153379782|NCT03029091|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153379783|NCT03029091|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153643292|NCT00387608|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153643293|NCT00093613|Sorafenib|sorafenib|mesh-list
153643294|NCT00093613|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153643296|NCT00093613|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153379784|NCT03029091|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
153379785|NCT03029091|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
153379786|NCT03029091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153379787|NCT02997410|Salicylic Acid|salicylic acid|mesh-list
153379788|NCT02997410|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153379789|NCT02997410|Antifungal Agents|antifungal agents|mesh-ancestor
153379804|NCT00374205|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
153379805|NCT00374205|Anthelmintics|anthelmintics|mesh-ancestor
153379806|NCT02248844|Botulinum Toxins|botulinum toxins|mesh-list
153379807|NCT02248844|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
153379808|NCT02248844|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
153379809|NCT02248844|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
153379810|NCT02248844|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153379811|NCT02248844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153379812|NCT02248844|Cholinergic Agents|cholinergic agents|mesh-ancestor
153379813|NCT02248844|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153379814|NCT02248844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153379815|NCT02248844|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
153379816|NCT02248844|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153839681|NCT06025474|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
153839682|NCT06025474|Antidepressive Agents|antidepressive agents|mesh-ancestor
153839692|NCT06025409|Leuprolide|leuprolide|mesh-list
153379828|NCT03029715|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
153379829|NCT03029715|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153379831|NCT03029715|Adrenergic Agents|adrenergic agents|mesh-ancestor
153379832|NCT03029715|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153379833|NCT03029715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153379834|NCT03029715|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153379835|NCT03029715|Anesthetics, General|anesthetics, general|mesh-ancestor
153379836|NCT03029715|Anesthetics|anesthetics|mesh-ancestor
153379837|NCT03029715|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153379838|NCT03029715|Narcotics|narcotics|mesh-ancestor
153379839|NCT03029715|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
153379840|NCT00555035|Dolutegravir|dolutegravir|mesh-list
153379841|NCT00555035|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
153379842|NCT00555035|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
153379843|NCT00555035|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153379844|NCT00555035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153379845|NCT00555035|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153379846|NCT00555035|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153839746|NCT06024915|Rifampin|rifampin|mesh-list
153379880|NCT01891331|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
153379881|NCT01891331|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153379882|NCT01891331|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153379883|NCT01891331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153379884|NCT01891331|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153379885|NCT01891331|Hormone Antagonists|hormone antagonists|mesh-ancestor
153643390|NCT00094120|Growth Substances|growth substances|mesh-ancestor
153643391|NCT00094120|Growth Inhibitors|growth inhibitors|mesh-ancestor
153643392|NCT00006245|Paclitaxel|paclitaxel|mesh-list
153643393|NCT00006245|Alvocidib|alvocidib|mesh-list
153643394|NCT00006245|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153643395|NCT00006245|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153643396|NCT00006245|Tubulin Modulators|tubulin modulators|mesh-ancestor
153643397|NCT00006245|Antimitotic Agents|antimitotic agents|mesh-ancestor
153643398|NCT00006245|Mitosis Modulators|mitosis modulators|mesh-ancestor
153643399|NCT00006245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153643405|NCT00094315|Cocaine|cocaine|mesh-list
153379886|NCT01891331|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153839759|NCT06024915|Antitubercular Agents|antitubercular agents|mesh-ancestor
153839760|NCT06024915|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153839761|NCT06024915|Leprostatic Agents|leprostatic agents|mesh-ancestor
153839762|NCT06024915|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153839763|NCT06024915|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
153839764|NCT06024915|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
153839769|NCT06024746|Empagliflozin|empagliflozin|mesh-list
153379914|NCT03022097|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153379915|NCT03022097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153379916|NCT03022097|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153379917|NCT03022097|Respiratory System Agents|respiratory system agents|mesh-ancestor
153379918|NCT03022097|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
153379919|NCT03022097|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
153839788|NCT06024252|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153839789|NCT06024252|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153839790|NCT06024252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153839791|NCT06024213|Methylene Blue|methylene blue|mesh-list
153839792|NCT06024213|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153643407|NCT00094315|Anesthetics|anesthetics|mesh-ancestor
153643436|NCT00094432|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
153839793|NCT06024213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153839794|NCT06023459|Buprenorphine|buprenorphine|mesh-list
153839795|NCT06023459|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
153839842|NCT06022939|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153839843|NCT06022939|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153839848|NCT06022939|Glucocorticoids|glucocorticoids|mesh-ancestor
153379953|NCT02328755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153379954|NCT02328755|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153379956|NCT02328755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153379957|NCT02328755|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153379958|NCT02328755|Dermatologic Agents|dermatologic agents|mesh-ancestor
153379959|NCT02328755|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153379960|NCT02328755|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153379961|NCT02328755|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153379962|NCT02328755|Immunologic Factors|immunologic factors|mesh-ancestor
153379963|NCT02328755|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153379964|NCT02328755|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153379965|NCT02328755|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
153379966|NCT02870283|Carbamazepine|carbamazepine|mesh-list
153379967|NCT02870283|Valproic Acid|valproic acid|mesh-list
153379968|NCT02870283|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153379969|NCT02870283|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153379971|NCT02870283|Antimanic Agents|antimanic agents|mesh-ancestor
153839889|NCT06019741|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153839890|NCT06019741|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153839891|NCT06019741|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153839892|NCT06019741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153839893|NCT06019741|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153839894|NCT06019741|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153643567|NCT00095251|Antiemetics|antiemetics|mesh-ancestor
153643568|NCT00095251|Autonomic Agents|autonomic agents|mesh-ancestor
153839895|NCT06019741|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153839897|NCT06019741|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
153839898|NCT06019741|Antithrombins|antithrombins|mesh-ancestor
153839899|NCT06019741|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
153380004|NCT03040011|Glucocorticoids|glucocorticoids|mesh-ancestor
153380005|NCT03040011|Hormones|hormones|mesh-ancestor
153380006|NCT03040011|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153380007|NCT03040011|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153380008|NCT03040011|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153380009|NCT03040011|Anesthetics, Local|anesthetics, local|mesh-ancestor
153380010|NCT03040011|Anesthetics|anesthetics|mesh-ancestor
153380011|NCT03040011|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153380012|NCT03040011|Sensory System Agents|sensory system agents|mesh-ancestor
153380013|NCT02225132|Hydroxyurea|hydroxyurea|mesh-list
153380014|NCT02225132|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153380015|NCT02225132|Antisickling Agents|antisickling agents|mesh-ancestor
153380016|NCT02225132|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153380017|NCT02225132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153380019|NCT03040479|Lasmiditan|lasmiditan|mesh-list
153839905|NCT06016218|Simvastatin|simvastatin|mesh-list
153732086|NCT00154791|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153732087|NCT00140582|Rituximab|rituximab|mesh-list
153732088|NCT00140582|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153732089|NCT00140582|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153732090|NCT00140582|Immunologic Factors|immunologic factors|mesh-ancestor
153732091|NCT00140582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153732092|NCT00140582|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153732093|NCT00154869|Ribavirin|ribavirin|mesh-list
153732094|NCT00154869|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
153839906|NCT06016218|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153839907|NCT06016218|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153839908|NCT06016218|Antimetabolites|antimetabolites|mesh-ancestor
153839909|NCT06016218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153839910|NCT06016218|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153839911|NCT06016218|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
153839912|NCT06016218|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153839913|NCT06013618|Irinotecan|irinotecan|mesh-list
153839914|NCT06013618|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-list
153380062|NCT02994602|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153380063|NCT02994602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153380064|NCT02994602|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
153380065|NCT02994602|Contraceptive Agents|contraceptive agents|mesh-ancestor
153380066|NCT02994602|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153380068|NCT03297710|Trifluridine|trifluridine|mesh-list
153839931|NCT06012734|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153839932|NCT06012734|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153839933|NCT06009991|Propofol|propofol|mesh-list
153839934|NCT06009991|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153839935|NCT06009991|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153732095|NCT00154869|Antimetabolites|antimetabolites|mesh-ancestor
153732096|NCT00154869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153732097|NCT00154869|Antiviral Agents|antiviral agents|mesh-ancestor
153392609|NCT04699383|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153839936|NCT06009991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153839937|NCT06009991|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153839938|NCT06009991|Anesthetics, General|anesthetics, general|mesh-ancestor
153839939|NCT06009991|Anesthetics|anesthetics|mesh-ancestor
153839940|NCT06008405|Azacitidine|azacitidine|mesh-list
153839941|NCT06008405|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153839942|NCT06008405|Antimetabolites|antimetabolites|mesh-ancestor
153839943|NCT06008405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153839944|NCT06008405|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153380074|NCT04350671|Ritonavir|ritonavir|mesh-list
153380075|NCT04350671|Lopinavir|lopinavir|mesh-list
153380076|NCT04350671|Interferon-beta|interferon-beta|mesh-list
153380077|NCT04350671|Interferon beta-1a|interferon beta-1a|mesh-list
153380078|NCT04350671|Hydroxychloroquine|hydroxychloroquine|mesh-list
153380079|NCT04350671|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153380080|NCT04350671|Antiviral Agents|antiviral agents|mesh-ancestor
153380081|NCT04350671|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153380082|NCT04350671|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
153380083|NCT04350671|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
153380084|NCT04350671|Protease Inhibitors|protease inhibitors|mesh-ancestor
153380085|NCT04350671|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153380086|NCT04350671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153380087|NCT04350671|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153380088|NCT04350671|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153380089|NCT04350671|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
153380090|NCT04350671|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153380091|NCT04350671|Antimalarials|antimalarials|mesh-ancestor
153380092|NCT04350671|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153839992|NCT05982392|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153839993|NCT05982392|Gout Suppressants|gout suppressants|mesh-ancestor
153839994|NCT05982392|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153839995|NCT05982392|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153643843|NCT00097045|Interferons|interferons|mesh-list
153643844|NCT00097045|Ribavirin|ribavirin|mesh-list
153643845|NCT00097045|Interferon omega 1|interferon omega 1|mesh-list
153643846|NCT00097045|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153839996|NCT05982392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153839998|NCT05971810|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
153839999|NCT05971810|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153380114|NCT03045861|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153380115|NCT03045861|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
153380116|NCT03045861|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153380117|NCT03045861|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153380118|NCT03045861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153380120|NCT02249078|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153380121|NCT01903265|Cyclobenzaprine|cyclobenzaprine|mesh-list
153380122|NCT01903265|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
153840038|NCT05924321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153840040|NCT05917275|Amlodipine|amlodipine|mesh-list
153840041|NCT05917275|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
153840042|NCT05917275|Olmesartan|olmesartan|mesh-list
153840043|NCT05917275|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
153840044|NCT05917275|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153380174|NCT03686657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153380176|NCT03686657|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
153380177|NCT03686657|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
153380178|NCT02476058|Diphenhydramine|diphenhydramine|mesh-list
153380179|NCT02476058|Promethazine|promethazine|mesh-list
153380180|NCT02476058|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
153380181|NCT02476058|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153380182|NCT02476058|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153380183|NCT02476058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153380184|NCT02476058|Anesthetics, Local|anesthetics, local|mesh-ancestor
153380185|NCT02476058|Anesthetics|anesthetics|mesh-ancestor
153380186|NCT02476058|Sensory System Agents|sensory system agents|mesh-ancestor
153380187|NCT02476058|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153380188|NCT02476058|Antiemetics|antiemetics|mesh-ancestor
153380189|NCT02476058|Autonomic Agents|autonomic agents|mesh-ancestor
153380190|NCT02476058|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153380191|NCT02476058|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
153380192|NCT02476058|Histamine Antagonists|histamine antagonists|mesh-ancestor
153380193|NCT02476058|Histamine Agents|histamine agents|mesh-ancestor
153380194|NCT02476058|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153380195|NCT02476058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153840091|NCT05896007|Antimetabolites|antimetabolites|mesh-ancestor
153840092|NCT05896007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153840093|NCT05896007|Dermatologic Agents|dermatologic agents|mesh-ancestor
153840094|NCT05896007|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153840095|NCT05896007|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153840096|NCT05896007|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153840097|NCT05896007|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153840098|NCT05896007|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153840099|NCT05896007|Alkylating Agents|alkylating agents|mesh-ancestor
153840100|NCT05896007|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153643887|NCT00097318|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153643893|NCT00097435|Ribavirin|ribavirin|mesh-list
153840101|NCT05896007|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153840103|NCT05891132|Prilocaine|prilocaine|mesh-list
153840104|NCT05891132|Lidocaine, Prilocaine Drug Combination|lidocaine, prilocaine drug combination|mesh-list
153380208|NCT02071394|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153380209|NCT02071394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153380211|NCT01911065|Immunologic Factors|immunologic factors|mesh-ancestor
153380212|NCT01911065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153380213|NCT02995772|Tamoxifen|tamoxifen|mesh-list
153380214|NCT02995772|Fluorouracil|fluorouracil|mesh-list
153380215|NCT02995772|Letrozole|letrozole|mesh-list
153380216|NCT02995772|Anastrozole|anastrozole|mesh-list
153380217|NCT02995772|Exemestane|exemestane|mesh-list
153732098|NCT00154869|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153732099|NCT00140660|Rituximab|rituximab|mesh-list
153380218|NCT02995772|Aromatase Inhibitors|aromatase inhibitors|mesh-list
153380219|NCT02995772|Antimetabolites|antimetabolites|mesh-ancestor
153380220|NCT02995772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153380221|NCT02995772|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153380222|NCT02995772|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153380223|NCT02995772|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153380224|NCT02995772|Immunologic Factors|immunologic factors|mesh-ancestor
153380226|NCT02995772|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153380236|NCT02227316|Ibuprofen|ibuprofen|mesh-list
153380237|NCT02227316|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153380238|NCT02227316|Analgesics|analgesics|mesh-ancestor
153840105|NCT05891132|Anesthetics|anesthetics|mesh-list
153840106|NCT05891132|Anesthetics, Local|anesthetics, local|mesh-ancestor
153840107|NCT05891132|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153840108|NCT05891132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153840109|NCT05891132|Sensory System Agents|sensory system agents|mesh-ancestor
153840110|NCT05891132|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153840111|NCT05891132|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153840112|NCT05891132|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
153840113|NCT05891132|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153840114|NCT05891132|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153840115|NCT05891132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153643933|NCT00400387|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
153840116|NCT05891132|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
153840117|NCT05890638|Albuterol|albuterol|mesh-list
153840118|NCT05890638|Ipratropium|ipratropium|mesh-list
153840119|NCT05890638|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153840120|NCT05890638|Autonomic Agents|autonomic agents|mesh-ancestor
153840121|NCT05890638|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153840122|NCT05890638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153840123|NCT05890638|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153840124|NCT05890638|Respiratory System Agents|respiratory system agents|mesh-ancestor
153840125|NCT05890638|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
153840126|NCT05890638|Cholinergic Agents|cholinergic agents|mesh-ancestor
153840127|NCT05890638|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153840128|NCT05890638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153840129|NCT05890638|Tocolytic Agents|tocolytic agents|mesh-ancestor
153840130|NCT05890638|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153840131|NCT05890638|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
153380246|NCT02227316|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153380247|NCT02227316|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153380248|NCT02227316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153380250|NCT00555971|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
153380251|NCT00555971|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153380252|NCT00555971|Respiratory System Agents|respiratory system agents|mesh-ancestor
153380253|NCT02943213|Chlorpromazine|chlorpromazine|mesh-list
153380254|NCT02943213|Antiemetics|antiemetics|mesh-ancestor
153380255|NCT02943213|Autonomic Agents|autonomic agents|mesh-ancestor
153380256|NCT02943213|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153380257|NCT02943213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153380258|NCT02943213|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153380259|NCT02943213|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153380260|NCT02943213|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153380261|NCT02943213|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153380262|NCT02943213|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153380263|NCT02943213|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
153380264|NCT02943213|Dopamine Agents|dopamine agents|mesh-ancestor
153380265|NCT02943213|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153380266|NCT02943213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153643979|NCT00097942|Dopamine Agents|dopamine agents|mesh-ancestor
153643980|NCT00097942|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153644029|NCT00098683|Protective Agents|protective agents|mesh-ancestor
153644030|NCT00098683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153380267|NCT02249234|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
153380268|NCT02249234|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
153380269|NCT02249234|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153840134|NCT05890638|Adrenergic Agents|adrenergic agents|mesh-ancestor
153840135|NCT05885503|Aflibercept|aflibercept|mesh-list
153840136|NCT05885503|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153840137|NCT05885503|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153840138|NCT05885503|Growth Substances|growth substances|mesh-ancestor
153840139|NCT05885503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153840140|NCT05885503|Growth Inhibitors|growth inhibitors|mesh-ancestor
153840142|NCT05876949|Denosumab|denosumab|mesh-list
153380275|NCT02249234|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153380277|NCT01338740|Infliximab|infliximab|mesh-list
153380278|NCT01338740|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
153380279|NCT01338740|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153380280|NCT01338740|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153380281|NCT01338740|Dermatologic Agents|dermatologic agents|mesh-ancestor
153380282|NCT01338740|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153380283|NCT02944461|Dapsone|dapsone|mesh-list
153380284|NCT02944461|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153380285|NCT02944461|Antimalarials|antimalarials|mesh-ancestor
153380286|NCT02944461|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153380287|NCT02944461|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153380288|NCT02944461|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153380289|NCT02944461|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153380290|NCT02944461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153380291|NCT02944461|Leprostatic Agents|leprostatic agents|mesh-ancestor
153380292|NCT02944461|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153380293|NCT05376722|Prednisone|prednisone|mesh-list
153380294|NCT05376722|Pamiparib|pamiparib|mesh-list
153380295|NCT05376722|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153380296|NCT05376722|Glucocorticoids|glucocorticoids|mesh-ancestor
153380297|NCT05376722|Hormones|hormones|mesh-ancestor
153380298|NCT05376722|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153380299|NCT05376722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153380300|NCT05376722|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153461563|NCT04451772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153461564|NCT04451772|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153461565|NCT03831984|Bromfenac|bromfenac|mesh-list
153461566|NCT03831984|Hyaluronic Acid|hyaluronic acid|mesh-list
153461567|NCT03831984|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153461568|NCT03831984|Immunologic Factors|immunologic factors|mesh-ancestor
153461569|NCT03831984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153380301|NCT05376722|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153380303|NCT05376722|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153840164|NCT05839899|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
153840165|NCT05839899|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
153840166|NCT05839899|Hormone Antagonists|hormone antagonists|mesh-ancestor
153840167|NCT05839899|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153840168|NCT05839899|Luteolytic Agents|luteolytic agents|mesh-ancestor
153840169|NCT05839899|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
153840170|NCT05839899|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
153840172|NCT05838560|Quercetin|quercetin|mesh-list
153840173|NCT05838560|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153840174|NCT05838560|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153840175|NCT05838560|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153840176|NCT05838560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153840177|NCT05838560|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153840178|NCT05838560|Antioxidants|antioxidants|mesh-ancestor
153840187|NCT05835011|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153840188|NCT05835011|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153840189|NCT05834569|Acetaminophen|acetaminophen|mesh-list
153840190|NCT05834569|Ibuprofen|ibuprofen|mesh-list
153840191|NCT05834569|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153840192|NCT05834569|Analgesics|analgesics|mesh-ancestor
153840193|NCT05834569|Sensory System Agents|sensory system agents|mesh-ancestor
153840194|NCT05834569|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153840195|NCT05834569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153840196|NCT05834569|Antipyretics|antipyretics|mesh-ancestor
153840199|NCT05834569|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153380320|NCT03111381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153380322|NCT02946489|Analgesics|analgesics|mesh-ancestor
153380323|NCT02946489|Sensory System Agents|sensory system agents|mesh-ancestor
153380324|NCT02946489|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153380325|NCT02946489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153380326|NCT02946489|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
153380327|NCT02946489|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153380328|NCT02946489|Anesthetics, General|anesthetics, general|mesh-ancestor
153380329|NCT02946489|Anesthetics|anesthetics|mesh-ancestor
153380330|NCT02946489|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153380331|NCT02946489|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
153380332|NCT02946489|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
153380333|NCT02946489|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153380334|NCT02946489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153380335|NCT02227706|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
153380336|NCT02227706|Hemostatics|hemostatics|mesh-ancestor
153380337|NCT02227706|Coagulants|coagulants|mesh-ancestor
153840204|NCT05831683|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153840205|NCT05831683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153840206|NCT05820347|Rocuronium|rocuronium|mesh-list
153840207|NCT05820347|Succinylcholine|succinylcholine|mesh-list
153840208|NCT05820347|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
153840237|NCT05681377|GABA Agents|gaba agents|mesh-ancestor
153840238|NCT05681377|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153840239|NCT05681377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153840240|NCT05661279|Anesthetics|anesthetics|mesh-list
153840241|NCT05661279|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153840242|NCT05661279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153840243|NCT05660681|Glycerol|glycerol|mesh-list
153840244|NCT05660681|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
153840245|NCT05660681|Protective Agents|protective agents|mesh-ancestor
153840246|NCT05660681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153840247|NCT05642923|Thiamine|thiamine|mesh-list
153840248|NCT05642923|Vitamins|vitamins|mesh-ancestor
153840249|NCT05642923|Micronutrients|micronutrients|mesh-ancestor
153840250|NCT05642923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153380358|NCT01930487|Antioxidants|antioxidants|mesh-list
153380359|NCT01930487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153380360|NCT01930487|Protective Agents|protective agents|mesh-ancestor
153380361|NCT01930487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153380362|NCT03063255|Anesthetics|anesthetics|mesh-list
153644159|NCT00099775|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153644163|NCT00099892|Vildagliptin|vildagliptin|mesh-list
153380363|NCT03063255|Mepivacaine|mepivacaine|mesh-list
153380364|NCT03063255|Rocuronium|rocuronium|mesh-list
153380365|NCT03063255|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153380366|NCT03063255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153380367|NCT03063255|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
153380368|NCT03063255|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
153380369|NCT03063255|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
153380370|NCT03063255|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153380371|NCT03063255|Anesthetics, Local|anesthetics, local|mesh-ancestor
153380372|NCT03063255|Sensory System Agents|sensory system agents|mesh-ancestor
153380376|NCT03115827|Carbidopa|carbidopa|mesh-list
153380388|NCT01915823|Azelastine|azelastine|mesh-list
153380389|NCT01915823|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153380390|NCT01915823|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153380391|NCT01915823|Autonomic Agents|autonomic agents|mesh-ancestor
153840251|NCT05642923|Vitamin B Complex|vitamin b complex|mesh-ancestor
153840252|NCT05641363|Ketorolac|ketorolac|mesh-list
153840253|NCT05641363|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
153840254|NCT05641363|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153840255|NCT05641363|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153840256|NCT05641363|Analgesics|analgesics|mesh-ancestor
153840257|NCT05641363|Sensory System Agents|sensory system agents|mesh-ancestor
153840258|NCT05641363|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153840259|NCT05641363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153840260|NCT05641363|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153840261|NCT05641363|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153840262|NCT05641363|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153840263|NCT05641363|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153840264|NCT05641363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153840265|NCT05595083|Dexmedetomidine|dexmedetomidine|mesh-list
153840266|NCT05595083|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153840267|NCT05595083|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153840268|NCT05595083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153840269|NCT05595083|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153840270|NCT05595083|Analgesics|analgesics|mesh-ancestor
153840271|NCT05595083|Sensory System Agents|sensory system agents|mesh-ancestor
153840272|NCT05595083|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153380400|NCT01915823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153380401|NCT01915823|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
153380402|NCT01915823|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
153380403|NCT01915823|Histamine Antagonists|histamine antagonists|mesh-ancestor
153380405|NCT01915823|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153380407|NCT01916681|Oxytocin|oxytocin|mesh-list
153380408|NCT01916681|Oxytocics|oxytocics|mesh-ancestor
153380409|NCT01916681|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153380410|NCT01916681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153380411|NCT01916681|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
153380412|NCT01916681|Abortifacient Agents|abortifacient agents|mesh-ancestor
153380413|NCT01916681|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
153380414|NCT01916681|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153380415|NCT05735951|Stiripentol|stiripentol|mesh-list
153380416|NCT05735951|Anticonvulsants|anticonvulsants|mesh-ancestor
153380417|NCT01917773|Octreotide|octreotide|mesh-list
153380418|NCT01917773|Bisacodyl|bisacodyl|mesh-list
153380419|NCT01917773|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153380420|NCT01917773|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153380421|NCT01917773|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153380422|NCT01917773|Cathartics|cathartics|mesh-ancestor
153380423|NCT01917773|Laxatives|laxatives|mesh-ancestor
153840315|NCT05474846|Melatonin|melatonin|mesh-list
153840316|NCT05474846|Methylphenidate|methylphenidate|mesh-list
153840317|NCT05474846|Antioxidants|antioxidants|mesh-ancestor
153840318|NCT05474846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153840319|NCT05474846|Protective Agents|protective agents|mesh-ancestor
153840320|NCT05474846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153840321|NCT05474846|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153840322|NCT05474846|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
153840323|NCT05474846|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
153840324|NCT05474846|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153840325|NCT05474846|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153840326|NCT05474846|Dopamine Agents|dopamine agents|mesh-ancestor
153840327|NCT05474846|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153840328|NCT05385432|Mycophenolic Acid|mycophenolic acid|mesh-list
153840329|NCT05385432|Tacrolimus|tacrolimus|mesh-list
153840330|NCT05385432|Antilymphocyte Serum|antilymphocyte serum|mesh-list
153380442|NCT03074409|Oxytocin|oxytocin|mesh-list
153380443|NCT03074409|Oxytocics|oxytocics|mesh-ancestor
153380444|NCT03074409|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153732115|NCT02964572|Empagliflozin|empagliflozin|mesh-list
153732116|NCT02964572|Glimepiride|glimepiride|mesh-list
153380445|NCT03074409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153380446|NCT02955147|Prednisone|prednisone|mesh-list
153380447|NCT02955147|Ustekinumab|ustekinumab|mesh-list
153380448|NCT02955147|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153380449|NCT02955147|Glucocorticoids|glucocorticoids|mesh-ancestor
153380450|NCT02955147|Hormones|hormones|mesh-ancestor
153644376|NCT00101062|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
153644377|NCT00101062|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153380451|NCT02955147|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153461570|NCT03831984|Viscosupplements|viscosupplements|mesh-ancestor
153461571|NCT03831984|Protective Agents|protective agents|mesh-ancestor
153461572|NCT03831984|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153820130|NCT00431990|Bortezomib|bortezomib|mesh-list
153820131|NCT00431990|Romidepsin|romidepsin|mesh-list
153820132|NCT00431990|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153820133|NCT00431990|Antiemetics|antiemetics|mesh-ancestor
153820134|NCT00431990|Autonomic Agents|autonomic agents|mesh-ancestor
153820135|NCT00431990|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153820136|NCT00431990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153820137|NCT00431990|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153820138|NCT00431990|Glucocorticoids|glucocorticoids|mesh-ancestor
153820140|NCT00431990|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153820141|NCT00431990|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153461573|NCT03831984|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153461574|NCT03831984|Analgesics|analgesics|mesh-ancestor
153461579|NCT02084706|Triamcinolone|triamcinolone|mesh-list
153820143|NCT00431990|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153820144|NCT00431990|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
153820145|NCT00431990|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153380452|NCT02955147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153380453|NCT02955147|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153380454|NCT02955147|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153380455|NCT02955147|Dermatologic Agents|dermatologic agents|mesh-ancestor
153380456|NCT03119181|Lidocaine|lidocaine|mesh-list
153380457|NCT03119181|Epinephrine|epinephrine|mesh-list
153380458|NCT03119181|Racepinephrine|racepinephrine|mesh-list
153380459|NCT03119181|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
153380460|NCT03119181|Epinephryl borate|epinephryl borate|mesh-list
153380461|NCT03119181|Anesthetics, Local|anesthetics, local|mesh-ancestor
153380462|NCT03119181|Anesthetics|anesthetics|mesh-ancestor
153380463|NCT03119181|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153644484|NCT00101569|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153644485|NCT00101569|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153644486|NCT00101569|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153644487|NCT00101569|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153644506|NCT00101764|Hormones|hormones|mesh-ancestor
153644535|NCT00102154|Analgesics|analgesics|mesh-ancestor
153644536|NCT00102154|Sensory System Agents|sensory system agents|mesh-ancestor
153644537|NCT00102154|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153644539|NCT00102154|Anticonvulsants|anticonvulsants|mesh-ancestor
153380464|NCT03119181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153380465|NCT03119181|Sensory System Agents|sensory system agents|mesh-ancestor
153380466|NCT03119181|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153380467|NCT03119181|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153380468|NCT03119181|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
153380469|NCT03119181|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153840331|NCT05385432|Basiliximab|basiliximab|mesh-list
153840332|NCT05385432|Immunosuppressive Agents|immunosuppressive agents|mesh-list
153840333|NCT05385432|Thymoglobulin|thymoglobulin|mesh-list
153840334|NCT05385432|Immunologic Factors|immunologic factors|mesh-ancestor
153840335|NCT05385432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153840336|NCT05385432|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
153840337|NCT05385432|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153840338|NCT05385432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153840339|NCT05385432|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153840340|NCT05385432|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153840341|NCT05385432|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
153840342|NCT05385432|Antitubercular Agents|antitubercular agents|mesh-ancestor
153840358|NCT05304273|Mifepristone|mifepristone|mesh-list
153840359|NCT05304273|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153840360|NCT05304273|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
153840361|NCT05304273|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153840362|NCT05304273|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153840363|NCT05304273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153840364|NCT05304273|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
153840365|NCT05304273|Hormone Antagonists|hormone antagonists|mesh-ancestor
153840366|NCT05304273|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153840367|NCT05304273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153840368|NCT05304273|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
153840369|NCT05304273|Abortifacient Agents|abortifacient agents|mesh-ancestor
153840370|NCT05304273|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153840371|NCT05304273|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
153840372|NCT05304273|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153822866|NCT03278652|Analgesics|analgesics|mesh-list
153840373|NCT05304273|Oxytocics|oxytocics|mesh-ancestor
153840374|NCT05304273|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
153840375|NCT05304273|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
153380488|NCT01691534|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153380489|NCT01691534|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153392794|NCT05738564|Autonomic Agents|autonomic agents|mesh-ancestor
153380490|NCT01691534|Leprostatic Agents|leprostatic agents|mesh-ancestor
153380492|NCT01691690|Dexamethasone|dexamethasone|mesh-list
153380493|NCT01691690|Midazolam|midazolam|mesh-list
153380494|NCT01691690|Morphine|morphine|mesh-list
153840379|NCT05304273|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
153840380|NCT05304273|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
153840381|NCT05304273|Luteolytic Agents|luteolytic agents|mesh-ancestor
153840382|NCT05304273|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
153840383|NCT05304273|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
153840385|NCT05303805|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153840386|NCT05303805|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
153840387|NCT05303805|Anesthetics, General|anesthetics, general|mesh-ancestor
153840388|NCT05303805|Anesthetics|anesthetics|mesh-ancestor
153840389|NCT05303805|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153380548|NCT02283827|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
153380549|NCT01626092|Cyclosporine|cyclosporine|mesh-list
153380550|NCT01626092|Mycophenolic Acid|mycophenolic acid|mesh-list
153380551|NCT01626092|Melphalan|melphalan|mesh-list
153380552|NCT01626092|Alemtuzumab|alemtuzumab|mesh-list
153380553|NCT01626092|Clofarabine|clofarabine|mesh-list
153380554|NCT01626092|Cyclosporins|cyclosporins|mesh-list
153380555|NCT01626092|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153380556|NCT01626092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153644599|NCT00006428|Adrenergic Agents|adrenergic agents|mesh-ancestor
153380557|NCT01626092|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153380558|NCT01626092|Immunologic Factors|immunologic factors|mesh-ancestor
153380559|NCT01626092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153380560|NCT01626092|Antifungal Agents|antifungal agents|mesh-ancestor
153380561|NCT01626092|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153380562|NCT01626092|Dermatologic Agents|dermatologic agents|mesh-ancestor
153380563|NCT01626092|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153380564|NCT01626092|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
153380565|NCT01626092|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153380566|NCT01626092|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153380567|NCT01626092|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
153840425|NCT05223478|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
153840426|NCT05223478|Adrenergic Agents|adrenergic agents|mesh-ancestor
153840427|NCT05223478|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153840428|NCT05223478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153840429|NCT05223478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153840430|NCT05223478|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153840431|NCT05206084|Sirolimus|sirolimus|mesh-list
153840432|NCT05206084|Everolimus|everolimus|mesh-list
153840433|NCT05206084|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
153840434|NCT05206084|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153840435|NCT05206084|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153840437|NCT05206084|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153840449|NCT05205499|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153840450|NCT05205499|Antifungal Agents|antifungal agents|mesh-ancestor
153840451|NCT05205499|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153840452|NCT05205499|Immunologic Factors|immunologic factors|mesh-ancestor
153840453|NCT05205499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153840454|NCT05177510|Mifepristone|mifepristone|mesh-list
153840455|NCT05177510|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
153840456|NCT05177510|Abortifacient Agents|abortifacient agents|mesh-ancestor
153840457|NCT05177510|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153840458|NCT05177510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153644664|NCT00006443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153644665|NCT00006443|Antiviral Agents|antiviral agents|mesh-ancestor
153644666|NCT00006443|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153644683|NCT00103051|Gefitinib|gefitinib|mesh-list
153840459|NCT05177510|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
153840460|NCT05177510|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
153840461|NCT05177510|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
153840462|NCT05177510|Contraceptive Agents|contraceptive agents|mesh-ancestor
153840463|NCT05177510|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
153840464|NCT05177510|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
153840465|NCT05177510|Hormone Antagonists|hormone antagonists|mesh-ancestor
153840466|NCT05177510|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153840467|NCT05177510|Luteolytic Agents|luteolytic agents|mesh-ancestor
153380590|NCT00374985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153380592|NCT01695668|Cyclosporine|cyclosporine|mesh-list
153380593|NCT01695668|Cyclosporins|cyclosporins|mesh-list
153380594|NCT01695668|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153380595|NCT01695668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153380596|NCT01695668|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153380597|NCT01695668|Immunologic Factors|immunologic factors|mesh-ancestor
153380598|NCT01695668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153380599|NCT01695668|Antifungal Agents|antifungal agents|mesh-ancestor
153380600|NCT01695668|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153380601|NCT01695668|Dermatologic Agents|dermatologic agents|mesh-ancestor
153380602|NCT01695668|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153380603|NCT01695668|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
153380604|NCT01695668|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
153380605|NCT03270020|Denosumab|denosumab|mesh-list
153644700|NCT00103246|Silicon|silicon|mesh-list
153644701|NCT00103246|Silicon phthalocyanine|silicon phthalocyanine|mesh-list
153644702|NCT00103246|Trace Elements|trace elements|mesh-ancestor
153644703|NCT00103246|Micronutrients|micronutrients|mesh-ancestor
153644704|NCT00103246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153380611|NCT01921751|Capecitabine|capecitabine|mesh-list
153380612|NCT01921751|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153380613|NCT01921751|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153380614|NCT01921751|Tubulin Modulators|tubulin modulators|mesh-ancestor
153380615|NCT01921751|Antimitotic Agents|antimitotic agents|mesh-ancestor
153380616|NCT01921751|Mitosis Modulators|mitosis modulators|mesh-ancestor
153380617|NCT01921751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153380618|NCT01921751|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153380619|NCT01921751|Antimetabolites|antimetabolites|mesh-ancestor
153840469|NCT05177510|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
153840470|NCT05168475|Infliximab|infliximab|mesh-list
153840471|NCT05168475|Rituximab|rituximab|mesh-list
153840472|NCT05168475|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153840473|NCT05168475|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153840474|NCT05168475|Immunologic Factors|immunologic factors|mesh-ancestor
153840475|NCT05168475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153840497|NCT05149287|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
153644743|NCT00103753|Sequestering Agents|sequestering agents|mesh-ancestor
153644744|NCT00103753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153644745|NCT00006452|Motexafin gadolinium|motexafin gadolinium|mesh-list
153644746|NCT00006452|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153644747|NCT00006452|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
153644748|NCT00006452|Dermatologic Agents|dermatologic agents|mesh-ancestor
153644749|NCT00103792|Mycophenolic Acid|mycophenolic acid|mesh-list
153840498|NCT05149287|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153840499|NCT05149287|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153840500|NCT05149287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153840501|NCT05149287|Third Generation Cephalosporins|third generation cephalosporins|mesh-ancestor
153380621|NCT02958345|Immunologic Factors|immunologic factors|mesh-ancestor
153380622|NCT02958345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153380623|NCT01629134|Hyaluronic Acid|hyaluronic acid|mesh-list
153380624|NCT01629134|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153380625|NCT01629134|Immunologic Factors|immunologic factors|mesh-ancestor
153380646|NCT01696760|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153380648|NCT01696760|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153840504|NCT05149287|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153840505|NCT05136443|Loteprednol Etabonate|loteprednol etabonate|mesh-list
153840506|NCT05136443|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
153840507|NCT05133297|Tofacitinib|tofacitinib|mesh-list
153840508|NCT05133297|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
153840509|NCT05133297|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153840510|NCT05133297|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153840511|NCT05133297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153840512|NCT05132088|Semaglutide|semaglutide|mesh-list
153840513|NCT05132088|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
153840514|NCT05132088|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153840515|NCT05132088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153840516|NCT05117398|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
153840517|NCT05117398|Dalbavancin|dalbavancin|mesh-list
153840518|NCT05117398|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
153840519|NCT05117398|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153840520|NCT05117398|Antitubercular Agents|antitubercular agents|mesh-ancestor
153840521|NCT05110781|Atezolizumab|atezolizumab|mesh-list
153840522|NCT05110781|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
153840523|NCT05110781|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153840524|NCT05110781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153380671|NCT01924871|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153380672|NCT01924871|Narcotics|narcotics|mesh-ancestor
153380673|NCT01924871|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153380674|NCT01924871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153380675|NCT01924871|Analgesics|analgesics|mesh-ancestor
153380676|NCT01924871|Sensory System Agents|sensory system agents|mesh-ancestor
153644878|NCT02972268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153644879|NCT02972268|Urological Agents|urological agents|mesh-ancestor
153644880|NCT02972268|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
153644881|NCT02972268|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
153822956|NCT00480363|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153822957|NCT00480363|Glucocorticoids|glucocorticoids|mesh-ancestor
153822958|NCT00480363|Hormones|hormones|mesh-ancestor
153822959|NCT00480363|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153380677|NCT01924871|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153380678|NCT01924871|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
153380679|NCT01924871|Anesthetics, General|anesthetics, general|mesh-ancestor
153380680|NCT01924871|Anesthetics|anesthetics|mesh-ancestor
153380681|NCT01698710|Paclitaxel|paclitaxel|mesh-list
153380682|NCT01698710|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
153380683|NCT01698710|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153380684|NCT01698710|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153380685|NCT01698710|Tubulin Modulators|tubulin modulators|mesh-ancestor
153380710|NCT01938989|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
153380712|NCT01938989|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153380713|NCT01939301|Nitric Oxide|nitric oxide|mesh-list
153380714|NCT01939301|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153380715|NCT01939301|Autonomic Agents|autonomic agents|mesh-ancestor
153380716|NCT01939301|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153380717|NCT01939301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153380718|NCT01939301|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153380719|NCT01939301|Respiratory System Agents|respiratory system agents|mesh-ancestor
153380720|NCT01939301|Free Radical Scavengers|free radical scavengers|mesh-ancestor
153380721|NCT01939301|Antioxidants|antioxidants|mesh-ancestor
153380722|NCT01939301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153380723|NCT01939301|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153380724|NCT01939301|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
153380725|NCT01939301|Vasodilator Agents|vasodilator agents|mesh-ancestor
153732120|NCT02964572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153380726|NCT01939301|Gasotransmitters|gasotransmitters|mesh-ancestor
153380727|NCT01939301|Protective Agents|protective agents|mesh-ancestor
153380730|NCT03078075|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
153380731|NCT03078075|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
153380732|NCT03078075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153840580|NCT05065190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153840582|NCT05027048|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153840583|NCT05027048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153840584|NCT05014776|Pembrolizumab|pembrolizumab|mesh-list
153840585|NCT05014776|Ipilimumab|ipilimumab|mesh-list
153840586|NCT05014776|Tadalafil|tadalafil|mesh-list
153840587|NCT05014776|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153840588|NCT05014776|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153840589|NCT05014776|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153840590|NCT05014776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153840591|NCT05014776|Vasodilator Agents|vasodilator agents|mesh-ancestor
153840592|NCT05014776|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
153840593|NCT05014776|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
153840594|NCT05014776|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153840595|NCT05014776|Urological Agents|urological agents|mesh-ancestor
153840596|NCT05013216|Poly ICLC|poly iclc|mesh-list
153840597|NCT05013216|Interferon Inducers|interferon inducers|mesh-ancestor
153644882|NCT02972268|Cholinergic Agents|cholinergic agents|mesh-ancestor
153644884|NCT00104806|Vitamin D|vitamin d|mesh-list
153644905|NCT00006464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153822966|NCT00480363|Growth Inhibitors|growth inhibitors|mesh-ancestor
153840598|NCT05013216|Immunologic Factors|immunologic factors|mesh-ancestor
153840599|NCT05013216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153840600|NCT05005312|Ritonavir|ritonavir|mesh-list
153840601|NCT05005312|Nirmatrelvir|nirmatrelvir|mesh-list
153840602|NCT05005312|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
153840603|NCT05005312|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
153840604|NCT05005312|Protease Inhibitors|protease inhibitors|mesh-ancestor
153840605|NCT05005312|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153840606|NCT05005312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153380740|NCT03078075|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153380741|NCT03078075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153380742|NCT03078075|Dopamine Agents|dopamine agents|mesh-ancestor
153380743|NCT03078075|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153380744|NCT03078075|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
153380745|NCT03078075|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153380746|NCT03078075|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153380747|NCT01926977|Ranibizumab|ranibizumab|mesh-list
153380748|NCT01926977|Aflibercept|aflibercept|mesh-list
153380749|NCT01926977|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153380750|NCT01926977|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153380751|NCT01926977|Growth Substances|growth substances|mesh-ancestor
153380752|NCT01926977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153380753|NCT01926977|Growth Inhibitors|growth inhibitors|mesh-ancestor
153380754|NCT01926977|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153380755|NCT01928693|Moxifloxacin|moxifloxacin|mesh-list
153380756|NCT01928693|Gatifloxacin|gatifloxacin|mesh-list
153380757|NCT01928693|Besifloxacin|besifloxacin|mesh-list
153380758|NCT01928693|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
153380759|NCT01928693|Ophthalmic Solutions|ophthalmic solutions|mesh-list
153380760|NCT01928693|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
153380761|NCT01928693|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153380762|NCT01928693|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153380763|NCT01928693|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153380775|NCT01928849|Valproic Acid|valproic acid|mesh-list
153392923|NCT04595565|Antimetabolites|antimetabolites|mesh-ancestor
153840619|NCT05001984|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
153840620|NCT05001984|Protease Inhibitors|protease inhibitors|mesh-ancestor
153840621|NCT05001984|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153840622|NCT05001984|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153840624|NCT04988945|Tremelimumab|tremelimumab|mesh-list
153840625|NCT04988945|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153840626|NCT04988945|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153840627|NCT04956692|Paclitaxel|paclitaxel|mesh-list
153840628|NCT04956692|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
153840629|NCT04956692|Carboplatin|carboplatin|mesh-list
153840630|NCT04956692|Pembrolizumab|pembrolizumab|mesh-list
153840631|NCT04956692|Pemetrexed|pemetrexed|mesh-list
153840632|NCT04956692|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153840633|NCT04956692|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153840634|NCT04956692|Tubulin Modulators|tubulin modulators|mesh-ancestor
153644907|NCT00104845|Immunologic Factors|immunologic factors|mesh-ancestor
153644908|NCT00104845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153840635|NCT04956692|Antimitotic Agents|antimitotic agents|mesh-ancestor
153840636|NCT04956692|Mitosis Modulators|mitosis modulators|mesh-ancestor
153840637|NCT04956692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153840638|NCT04956692|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153840639|NCT04956692|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153840640|NCT04956692|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153840641|NCT04956692|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153840642|NCT04956692|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153840643|NCT04946305|Lutetium Lu 177 dotatate|lutetium lu 177 dotatate|mesh-list
153840644|NCT04946305|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
153840645|NCT04946305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153840646|NCT04943588|Antibodies|antibodies|mesh-list
153840647|NCT04943588|Hepatitis C Antibodies|hepatitis c antibodies|mesh-list
153840648|NCT04943588|Immunologic Factors|immunologic factors|mesh-ancestor
153840649|NCT04943588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153840650|NCT04889066|Durvalumab|durvalumab|mesh-list
153840651|NCT04889066|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153840652|NCT04889066|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153840653|NCT04883528|Valsartan|valsartan|mesh-list
153840654|NCT04883528|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
153840655|NCT04883528|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153380783|NCT01928849|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153380784|NCT01928849|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153380785|NCT01928849|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153380786|NCT01631552|Sacituzumab govitecan|sacituzumab govitecan|mesh-list
153380787|NCT01631552|Immunoconjugates|immunoconjugates|mesh-ancestor
153380788|NCT01631552|Immunologic Factors|immunologic factors|mesh-ancestor
153380789|NCT01631552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153380790|NCT03081117|Insulin|insulin|mesh-list
153380791|NCT03081117|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153380792|NCT03081117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153380793|NCT01944293|Midazolam|midazolam|mesh-list
153380794|NCT01944293|Ketamine|ketamine|mesh-list
153380795|NCT01944293|Analgesics|analgesics|mesh-ancestor
153380796|NCT01944293|Sensory System Agents|sensory system agents|mesh-ancestor
153380797|NCT01944293|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153380798|NCT01944293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153380799|NCT01944293|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
153380800|NCT01944293|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153380801|NCT01944293|Anesthetics, General|anesthetics, general|mesh-ancestor
153380802|NCT01944293|Anesthetics|anesthetics|mesh-ancestor
153380803|NCT01944293|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153380804|NCT01944293|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
153380805|NCT01944293|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
153380806|NCT01944293|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153380807|NCT01944293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153380808|NCT01944293|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153392941|NCT04230681|Sensory System Agents|sensory system agents|mesh-ancestor
153380809|NCT01944293|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153380810|NCT01944293|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153380811|NCT01944293|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153840678|NCT04824911|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153840679|NCT04824911|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153840680|NCT04824911|Antipyretics|antipyretics|mesh-ancestor
153840681|NCT04824911|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153840682|NCT04824911|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153840683|NCT04824911|Antimetabolites|antimetabolites|mesh-ancestor
153644931|NCT00006470|Vaccines|vaccines|mesh-list
153840684|NCT04824911|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153840685|NCT04824911|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
153840686|NCT04824911|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
153840687|NCT04824911|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
153840688|NCT04824911|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
153840689|NCT04824911|Purinergic Agents|purinergic agents|mesh-ancestor
153840690|NCT04824911|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153840691|NCT04818489|Colchicine|colchicine|mesh-list
153840692|NCT04818489|Gout Suppressants|gout suppressants|mesh-ancestor
153840693|NCT04818489|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153380812|NCT01944293|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153380813|NCT01944293|GABA Modulators|gaba modulators|mesh-ancestor
153380814|NCT01944293|GABA Agents|gaba agents|mesh-ancestor
153380815|NCT01944371|Disulfiram|disulfiram|mesh-list
153380816|NCT01944371|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
153380817|NCT01944371|Acetaldehyde Dehydrogenase Inhibitors|acetaldehyde dehydrogenase inhibitors|mesh-ancestor
153380818|NCT01944371|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153380819|NCT01944371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153380820|NCT02343120|Zanubrutinib|zanubrutinib|mesh-list
153380821|NCT02343120|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153380822|NCT02343120|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153380823|NCT02343120|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153380824|NCT02343120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153380825|NCT02343120|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153380826|NCT01631630|Pioglitazone|pioglitazone|mesh-list
153380827|NCT01631630|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153380828|NCT01631630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153380829|NCT03837860|Oxycodone|oxycodone|mesh-list
153380830|NCT03837860|Risperidone|risperidone|mesh-list
153380831|NCT03837860|Ziprasidone|ziprasidone|mesh-list
153380832|NCT03837860|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153380833|NCT03837860|Narcotics|narcotics|mesh-ancestor
153380834|NCT03837860|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153380835|NCT03837860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153380836|NCT03837860|Analgesics|analgesics|mesh-ancestor
153380837|NCT03837860|Sensory System Agents|sensory system agents|mesh-ancestor
153380838|NCT03837860|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153380839|NCT03837860|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153380840|NCT03837860|Serotonin Agents|serotonin agents|mesh-ancestor
153840697|NCT04818489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153840698|NCT04818489|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153840700|NCT04803474|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153840701|NCT04803474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153645019|NCT00106054|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
153840702|NCT04780659|Vaccines|vaccines|mesh-list
153840703|NCT04780659|Immunologic Factors|immunologic factors|mesh-ancestor
153840704|NCT04780659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153840705|NCT04768023|Vitamin D|vitamin d|mesh-list
153840706|NCT04768023|Vitamins|vitamins|mesh-ancestor
153840707|NCT04768023|Micronutrients|micronutrients|mesh-ancestor
153840708|NCT04768023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153840709|NCT04768023|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153840710|NCT04753879|Paclitaxel|paclitaxel|mesh-list
153840711|NCT04753879|Gemcitabine|gemcitabine|mesh-list
153840712|NCT04753879|Pembrolizumab|pembrolizumab|mesh-list
153840713|NCT04753879|Capecitabine|capecitabine|mesh-list
153840714|NCT04753879|Irinotecan|irinotecan|mesh-list
153840715|NCT04753879|Olaparib|olaparib|mesh-list
153840716|NCT04753879|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153840717|NCT04753879|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153840718|NCT04753879|Tubulin Modulators|tubulin modulators|mesh-ancestor
153840719|NCT04753879|Antimitotic Agents|antimitotic agents|mesh-ancestor
153840720|NCT04753879|Mitosis Modulators|mitosis modulators|mesh-ancestor
153840721|NCT04753879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153840722|NCT04753879|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153840723|NCT04753879|Antimetabolites|antimetabolites|mesh-ancestor
153840724|NCT04753879|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153380849|NCT02289989|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153380850|NCT03076112|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
153380851|NCT03076112|Ipragliflozin|ipragliflozin|mesh-list
153380852|NCT03076112|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153380853|NCT03076112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153380854|NCT03076112|Incretins|incretins|mesh-ancestor
153380855|NCT03076112|Hormones|hormones|mesh-ancestor
153380856|NCT03076112|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153380857|NCT03076112|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
153380858|NCT03076112|Protease Inhibitors|protease inhibitors|mesh-ancestor
153380859|NCT03076112|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153380860|NCT03076112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153380861|NCT03076112|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
153380863|NCT03129945|Nifedipine|nifedipine|mesh-list
153380864|NCT03129945|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153380865|NCT03129945|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153380866|NCT03129945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153645077|NCT00006485|Alvocidib|alvocidib|mesh-list
153645078|NCT00006485|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
153645079|NCT00006485|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153645080|NCT00006485|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153645081|NCT00006485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153645082|NCT00006485|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153645083|NCT00006485|Growth Inhibitors|growth inhibitors|mesh-ancestor
153645084|NCT00006485|Growth Substances|growth substances|mesh-ancestor
153823058|NCT04700709|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153823059|NCT04700709|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
153823060|NCT04700709|Antitubercular Agents|antitubercular agents|mesh-ancestor
153823061|NCT04700709|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153823062|NCT04700709|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153823063|NCT04700709|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153823064|NCT04700709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153823065|NCT04700709|Antifungal Agents|antifungal agents|mesh-ancestor
153380867|NCT03129945|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153380868|NCT03129945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153380869|NCT03129945|Vasodilator Agents|vasodilator agents|mesh-ancestor
153380870|NCT03129945|Tocolytic Agents|tocolytic agents|mesh-ancestor
153380871|NCT03129945|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153380872|NCT03129945|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153380873|NCT03129945|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153732121|NCT02964572|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153732122|NCT02964572|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153380874|NCT03129945|Analgesics|analgesics|mesh-ancestor
153380892|NCT03093207|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153380893|NCT03093207|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153380894|NCT03093207|Analgesics|analgesics|mesh-ancestor
153380895|NCT03093207|Sensory System Agents|sensory system agents|mesh-ancestor
153380896|NCT03093207|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153380897|NCT03093207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153380898|NCT03093207|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153380899|NCT03093207|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153380900|NCT03093207|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153380901|NCT03093207|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153380905|NCT03093207|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153840758|NCT04675827|Tubulin Modulators|tubulin modulators|mesh-ancestor
153840759|NCT04675827|Antimitotic Agents|antimitotic agents|mesh-ancestor
153840760|NCT04675827|Mitosis Modulators|mitosis modulators|mesh-ancestor
153645085|NCT00006485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153645086|NCT00006485|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153645087|NCT00106522|Methotrexate|methotrexate|mesh-list
153645088|NCT00106522|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
153645089|NCT00106522|Abortifacient Agents|abortifacient agents|mesh-ancestor
153645090|NCT00106522|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153645093|NCT00106522|Antimetabolites|antimetabolites|mesh-ancestor
153645119|NCT00401206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153645120|NCT00401206|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153645121|NCT00401206|Analgesics|analgesics|mesh-ancestor
153823068|NCT04700709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153823069|NCT04698317|Mitogens|mitogens|mesh-list
153823070|NCT04698317|Mitosis Modulators|mitosis modulators|mesh-ancestor
153823071|NCT04698317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153823072|NCT04700475|Citric Acid|citric acid|mesh-list
153823073|NCT04700475|Sodium Citrate|sodium citrate|mesh-list
153823074|NCT04700475|Anticoagulants|anticoagulants|mesh-ancestor
153431790|NCT05832489|Methylphenidate|methylphenidate|mesh-list
153840761|NCT04675827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153840762|NCT04675827|Immunotoxins|immunotoxins|mesh-ancestor
153840763|NCT04675827|Immunoconjugates|immunoconjugates|mesh-ancestor
153840764|NCT04675827|Immunologic Factors|immunologic factors|mesh-ancestor
153840765|NCT04675827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153840766|NCT04623944|Cytarabine|cytarabine|mesh-list
153840767|NCT04623944|Cyclophosphamide|cyclophosphamide|mesh-list
153840768|NCT04623944|Fludarabine|fludarabine|mesh-list
153840769|NCT04623944|Decitabine|decitabine|mesh-list
153820146|NCT00431990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153820147|NCT00462696|Docetaxel|docetaxel|mesh-list
153820148|NCT00462696|Epirubicin|epirubicin|mesh-list
153820149|NCT00462696|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153820150|NCT00462696|Tubulin Modulators|tubulin modulators|mesh-ancestor
153840786|NCT04590937|Furosemide|furosemide|mesh-list
153840787|NCT04590937|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
153840788|NCT04590937|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153840790|NCT04590937|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153840791|NCT04590937|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153840792|NCT04590937|Antimetabolites|antimetabolites|mesh-ancestor
153645122|NCT00401206|Sensory System Agents|sensory system agents|mesh-ancestor
153645123|NCT00401206|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153645124|NCT00401206|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
153645125|NCT00401206|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153645126|NCT00401206|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153645127|NCT00401206|Adrenergic Agents|adrenergic agents|mesh-ancestor
153645128|NCT00401206|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153645129|NCT00401206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153645130|NCT00401323|Docetaxel|docetaxel|mesh-list
153645131|NCT00401323|Fluorouracil|fluorouracil|mesh-list
153645132|NCT00401323|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153840793|NCT04590937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153840794|NCT04590937|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153840795|NCT04590937|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
153840796|NCT04590937|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153840798|NCT04590937|Natriuretic Agents|natriuretic agents|mesh-ancestor
153820151|NCT00462696|Antimitotic Agents|antimitotic agents|mesh-ancestor
153820152|NCT00462696|Mitosis Modulators|mitosis modulators|mesh-ancestor
153820153|NCT00462696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153820154|NCT00462696|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153820155|NCT00462696|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153840799|NCT04590937|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
153840800|NCT04590937|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153840801|NCT04590937|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153840802|NCT04590937|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
153840803|NCT04590937|Protective Agents|protective agents|mesh-ancestor
153840804|NCT04563923|Avdoralimab|avdoralimab|mesh-list
153840805|NCT04563923|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153840806|NCT04563923|Antiviral Agents|antiviral agents|mesh-ancestor
153840807|NCT04563923|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153840808|NCT04562558|Leucovorin|leucovorin|mesh-list
153380929|NCT02342886|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153380930|NCT02342886|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153380931|NCT02342886|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153380932|NCT02342886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153380933|NCT02342886|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153380934|NCT02342886|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
153380935|NCT02342886|Antitubercular Agents|antitubercular agents|mesh-ancestor
153380936|NCT02342886|Leprostatic Agents|leprostatic agents|mesh-ancestor
153380937|NCT02342886|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153645257|NCT00107731|Anticonvulsants|anticonvulsants|mesh-ancestor
153645258|NCT00107731|GABA Agents|gaba agents|mesh-ancestor
153645259|NCT00107731|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153645260|NCT04712396|Itraconazole|itraconazole|mesh-list
153645261|NCT04712396|Antifungal Agents|antifungal agents|mesh-ancestor
153645288|NCT00006656|Alkylating Agents|alkylating agents|mesh-ancestor
153840809|NCT04562558|Dactinomycin|dactinomycin|mesh-list
153840810|NCT04562558|Methotrexate|methotrexate|mesh-list
153380992|NCT01647932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153380994|NCT02366130|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
153380995|NCT02366130|Hormones|hormones|mesh-list
153840839|NCT04560673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153840840|NCT04560673|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153840841|NCT04560673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153840842|NCT04560673|Analgesics|analgesics|mesh-ancestor
153840843|NCT04560673|Sensory System Agents|sensory system agents|mesh-ancestor
153840844|NCT04560673|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153840845|NCT04560673|Antidepressive Agents|antidepressive agents|mesh-ancestor
153840846|NCT04560673|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153840847|NCT04560673|Dopamine Agents|dopamine agents|mesh-ancestor
153840866|NCT04528329|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153840867|NCT04528329|Antiemetics|antiemetics|mesh-ancestor
153840868|NCT04528329|Autonomic Agents|autonomic agents|mesh-ancestor
153840869|NCT04528329|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153840870|NCT04528329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153840871|NCT04528329|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153840872|NCT04528329|Glucocorticoids|glucocorticoids|mesh-ancestor
153840874|NCT04528329|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153380996|NCT02366130|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153380997|NCT02366130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153380998|NCT02366130|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153380999|NCT02366130|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153381000|NCT01635062|Calcitriol|calcitriol|mesh-list
153381001|NCT01635062|Dihydroxycholecalciferols|dihydroxycholecalciferols|mesh-list
153381002|NCT01635062|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153381003|NCT01635062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153645355|NCT00108394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153645356|NCT00108511|Gemfibrozil|gemfibrozil|mesh-list
153645357|NCT00108511|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153645415|NCT00108979|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153645416|NCT00108979|Serotonin Agents|serotonin agents|mesh-ancestor
153645417|NCT00108979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153645418|NCT03608397|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
153645419|NCT03608397|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
153645420|NCT03608397|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
153645421|NCT03608397|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153645422|NCT03608397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153645423|NCT03608397|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
153645424|NCT03608397|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153645476|NCT00006968|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153645477|NCT00006968|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
153645480|NCT00109408|Methotrexate|methotrexate|mesh-list
153381004|NCT01635062|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
153381005|NCT01635062|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153381006|NCT01635062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153381007|NCT01635062|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
153381008|NCT01635062|Vitamins|vitamins|mesh-ancestor
153381009|NCT01635062|Micronutrients|micronutrients|mesh-ancestor
153381010|NCT01635062|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153381011|NCT01637090|Everolimus|everolimus|mesh-list
153381012|NCT01637090|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
153381013|NCT01637090|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153381014|NCT01637090|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153381015|NCT01637090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153393068|NCT02259517|Dopamine Agents|dopamine agents|mesh-ancestor
153840875|NCT04528329|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153840876|NCT04528329|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153840877|NCT04528329|Protease Inhibitors|protease inhibitors|mesh-ancestor
153840878|NCT04528329|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153840881|NCT04526288|Daunorubicin|daunorubicin|mesh-list
153840891|NCT04526288|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153840892|NCT04526288|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153840893|NCT04526288|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153840894|NCT04526288|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153840896|NCT04495608|Antifungal Agents|antifungal agents|mesh-ancestor
153381016|NCT01637090|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153381017|NCT01637090|Immunologic Factors|immunologic factors|mesh-ancestor
153381018|NCT01637090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153645482|NCT00109408|Abortifacient Agents|abortifacient agents|mesh-ancestor
153645483|NCT00109408|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153645484|NCT00109408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153645485|NCT00109408|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153645486|NCT00109408|Antimetabolites|antimetabolites|mesh-ancestor
153645487|NCT00109408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153645488|NCT00109408|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153645489|NCT00109408|Dermatologic Agents|dermatologic agents|mesh-ancestor
153645490|NCT00109408|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153645491|NCT00109408|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153645492|NCT00109408|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153645496|NCT00109564|Acetylcholine|acetylcholine|mesh-list
153381019|NCT01637090|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153381021|NCT02389452|Viscosupplements|viscosupplements|mesh-ancestor
153381022|NCT02389452|Protective Agents|protective agents|mesh-ancestor
153381023|NCT02389452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153381024|NCT02365584|Lanreotide|lanreotide|mesh-list
153381025|NCT02365584|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153381026|NCT02342418|Tedizolid|tedizolid|mesh-list
153381027|NCT02342418|Tedizolid phosphate|tedizolid phosphate|mesh-list
153381028|NCT02342418|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153381029|NCT02342418|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153381030|NCT05727449|Anesthetics|anesthetics|mesh-list
153381031|NCT05727449|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153381032|NCT05727449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153381033|NCT03102645|Imipramine|imipramine|mesh-list
153381034|NCT03102645|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
153381035|NCT03102645|Antidepressive Agents|antidepressive agents|mesh-ancestor
153381036|NCT03102645|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153381037|NCT03102645|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
153381038|NCT03102645|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153381041|NCT03102645|Adrenergic Agents|adrenergic agents|mesh-ancestor
153840915|NCT04478838|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153840916|NCT04478838|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153840917|NCT04478838|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153840918|NCT04478838|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153840919|NCT04478838|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
153840920|NCT04478838|Dopamine Agents|dopamine agents|mesh-ancestor
153840921|NCT04478838|Antiemetics|antiemetics|mesh-ancestor
153840922|NCT04478838|Autonomic Agents|autonomic agents|mesh-ancestor
153840923|NCT04478838|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153840924|NCT04478838|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153840925|NCT04478838|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
153820156|NCT00462696|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153820157|NCT00462696|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153820158|NCT00462813|3,3'-diindolylmethane|3,3'-diindolylmethane|mesh-list
153820159|NCT00462813|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
153820160|NCT00462813|Protective Agents|protective agents|mesh-ancestor
153820161|NCT00462813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153840926|NCT04478838|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153840927|NCT04478838|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153840928|NCT04446416|Bevacizumab|bevacizumab|mesh-list
153840929|NCT04446416|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153840930|NCT04446416|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153840931|NCT04446416|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153840932|NCT04446416|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153381054|NCT02287415|Eslicarbazepine acetate|eslicarbazepine acetate|mesh-list
153381055|NCT02287415|Warfarin|warfarin|mesh-list
153381056|NCT02287415|Anticoagulants|anticoagulants|mesh-ancestor
153381057|NCT02287415|Anticonvulsants|anticonvulsants|mesh-ancestor
153381058|NCT02287415|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
153381059|NCT02287415|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153381060|NCT02287415|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153381061|NCT02287415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153381062|NCT02312934|Nicotine|nicotine|mesh-list
153381063|NCT02312934|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
153381064|NCT02312934|Autonomic Agents|autonomic agents|mesh-ancestor
153381065|NCT02312934|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153381066|NCT02312934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153381067|NCT02312934|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
153381068|NCT02312934|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
153645516|NCT00109798|Alkylating Agents|alkylating agents|mesh-ancestor
153645517|NCT00109798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153645518|NCT00109798|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153381069|NCT02312934|Cholinergic Agents|cholinergic agents|mesh-ancestor
153381070|NCT02312934|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153381071|NCT02312934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153840947|NCT04421378|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153840948|NCT04421378|Alkylating Agents|alkylating agents|mesh-ancestor
153840949|NCT04421378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153840950|NCT04409600|Botulinum Toxins|botulinum toxins|mesh-list
153840951|NCT04409600|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
153840952|NCT04409600|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153840953|NCT04409600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153840954|NCT04409600|Cholinergic Agents|cholinergic agents|mesh-ancestor
153840955|NCT04409600|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153840956|NCT04409600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153840958|NCT04322305|Analgesics|analgesics|mesh-ancestor
153840959|NCT04322305|Sensory System Agents|sensory system agents|mesh-ancestor
153840960|NCT04322305|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153840961|NCT04322305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153840962|NCT04322305|Anticonvulsants|anticonvulsants|mesh-ancestor
153840963|NCT04322305|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153840964|NCT04322305|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153840965|NCT04322305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153840966|NCT04322305|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153840967|NCT04322305|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153840968|NCT04322305|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153840969|NCT04322305|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153840970|NCT04322305|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153381116|NCT02978157|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
153381117|NCT02978157|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153840976|NCT04305158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153840977|NCT04305158|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153840979|NCT04305158|Sensory System Agents|sensory system agents|mesh-ancestor
153840980|NCT04305158|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153840981|NCT04301778|Durvalumab|durvalumab|mesh-list
153840982|NCT04301778|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153840983|NCT04301778|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153645584|NCT00007202|Stavudine|stavudine|mesh-list
153645585|NCT00007202|Didanosine|didanosine|mesh-list
153645586|NCT00007202|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
153645587|NCT00007202|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
153645588|NCT00007202|Protease Inhibitors|protease inhibitors|mesh-ancestor
153645589|NCT00007202|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153645591|NCT00007202|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153645620|NCT00388193|Immunologic Factors|immunologic factors|mesh-ancestor
153645621|NCT00388193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153645622|NCT00388193|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153645623|NCT00110695|Paclitaxel|paclitaxel|mesh-list
153645624|NCT00110695|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
153363161|NCT03219710|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
153363162|NCT03219710|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153840984|NCT04291209|Acetylcysteine|acetylcysteine|mesh-list
153840985|NCT04291209|N-monoacetylcystine|n-monoacetylcystine|mesh-list
153840986|NCT04291209|Antiviral Agents|antiviral agents|mesh-ancestor
153840987|NCT04291209|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153840988|NCT04291209|Expectorants|expectorants|mesh-ancestor
153840989|NCT04291209|Respiratory System Agents|respiratory system agents|mesh-ancestor
153840990|NCT04291209|Free Radical Scavengers|free radical scavengers|mesh-ancestor
153840991|NCT04291209|Antioxidants|antioxidants|mesh-ancestor
153840992|NCT04291209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153840993|NCT04291209|Protective Agents|protective agents|mesh-ancestor
153840994|NCT04291209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153840995|NCT04291209|Antidotes|antidotes|mesh-ancestor
153840996|NCT04256824|Triclosan|triclosan|mesh-list
153840997|NCT04256824|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
153840998|NCT04256824|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153840999|NCT04256824|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
153841000|NCT04256824|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153841001|NCT04256824|Antimetabolites|antimetabolites|mesh-ancestor
153841002|NCT04256824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153841003|NCT04256824|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153841004|NCT04256213|Nivolumab|nivolumab|mesh-list
153841027|NCT04231448|Alkylating Agents|alkylating agents|mesh-ancestor
153841028|NCT04231448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153841029|NCT04231448|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153645625|NCT00110695|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153418611|NCT02941640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153645626|NCT00110695|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153645627|NCT00110695|Tubulin Modulators|tubulin modulators|mesh-ancestor
153645628|NCT00110695|Antimitotic Agents|antimitotic agents|mesh-ancestor
153645629|NCT00110695|Mitosis Modulators|mitosis modulators|mesh-ancestor
153381150|NCT03140631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153381151|NCT03140631|Coagulants|coagulants|mesh-ancestor
153381152|NCT04420260|Adjuvants, Immunologic|adjuvants, immunologic|mesh-list
153381153|NCT04420260|Immunologic Factors|immunologic factors|mesh-ancestor
153381154|NCT04420260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153381156|NCT00422643|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153381157|NCT00422643|Immunologic Factors|immunologic factors|mesh-ancestor
153381158|NCT00422643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153381159|NCT00422643|Viscosupplements|viscosupplements|mesh-ancestor
153381160|NCT00422643|Protective Agents|protective agents|mesh-ancestor
153381161|NCT05405907|Hemostatics|hemostatics|mesh-list
153381162|NCT05405907|Coagulants|coagulants|mesh-ancestor
153381163|NCT01706588|Diclofenac|diclofenac|mesh-list
153381164|NCT01706588|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153381165|NCT01706588|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153381166|NCT01706588|Analgesics|analgesics|mesh-ancestor
153381167|NCT01706588|Sensory System Agents|sensory system agents|mesh-ancestor
153381168|NCT01706588|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153381169|NCT01706588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153381170|NCT01706588|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153841047|NCT04224051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153841048|NCT04209114|Nivolumab|nivolumab|mesh-list
153841049|NCT04209114|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153841050|NCT04209114|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153841051|NCT04209114|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153841052|NCT04209114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153841053|NCT04176978|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
153841054|NCT04176978|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153841055|NCT04176978|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153841056|NCT04176978|Antimetabolites|antimetabolites|mesh-ancestor
153645758|NCT00111631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153645760|NCT00111670|Protease Inhibitors|protease inhibitors|mesh-ancestor
153645809|NCT00111943|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153645820|NCT00401635|Carboplatin|carboplatin|mesh-list
153841057|NCT04176978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153841058|NCT04176978|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153381183|NCT01602692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153381184|NCT01602692|Sensory System Agents|sensory system agents|mesh-ancestor
153381185|NCT01602692|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153381186|NCT01602692|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153381187|NCT01602692|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
153381188|NCT01602692|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153645824|NCT00401635|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153381189|NCT01602692|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153381190|NCT01602692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153381191|NCT01602692|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153381192|NCT01602692|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153381193|NCT01602692|Adrenergic Agents|adrenergic agents|mesh-ancestor
153841069|NCT04152941|Olaparib|olaparib|mesh-list
153841070|NCT04152941|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
153841071|NCT04152941|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153841072|NCT04152941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153841073|NCT04152941|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153841074|NCT04150900|Pembrolizumab|pembrolizumab|mesh-list
153841075|NCT04150900|Bavituximab|bavituximab|mesh-list
153841076|NCT04150900|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153841077|NCT04150900|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153841078|NCT04150900|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153841079|NCT04150900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153841080|NCT04124965|Rozanolixizumab|rozanolixizumab|mesh-list
153841081|NCT04124965|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153841082|NCT04124965|Immunologic Factors|immunologic factors|mesh-ancestor
153841083|NCT04124965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153841084|NCT04116073|Antibodies|antibodies|mesh-list
153841085|NCT04116073|Immunologic Factors|immunologic factors|mesh-ancestor
153841086|NCT04116073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153841087|NCT04022967|Ritonavir|ritonavir|mesh-list
153841088|NCT04022967|Atazanavir Sulfate|atazanavir sulfate|mesh-list
153841089|NCT04022967|Tenofovir|tenofovir|mesh-list
153841090|NCT04022967|Lamivudine|lamivudine|mesh-list
153841091|NCT04022967|Dolutegravir|dolutegravir|mesh-list
153841092|NCT04022967|Efavirenz|efavirenz|mesh-list
153645825|NCT00401635|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153645826|NCT00401635|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153645827|NCT00401635|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153645828|NCT00401635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153645829|NCT00401674|Paclitaxel|paclitaxel|mesh-list
153645830|NCT00401674|Carboplatin|carboplatin|mesh-list
153645831|NCT00401674|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153645832|NCT00401674|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153645833|NCT00401674|Tubulin Modulators|tubulin modulators|mesh-ancestor
153645853|NCT00007358|Hormones|hormones|mesh-ancestor
153645858|NCT00112138|Analgesics|analgesics|mesh-ancestor
153645859|NCT00112138|Sensory System Agents|sensory system agents|mesh-ancestor
153645860|NCT00112138|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153841093|NCT04022967|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
153841094|NCT04022967|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
153841095|NCT04022967|Protease Inhibitors|protease inhibitors|mesh-ancestor
153841096|NCT04022967|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153841097|NCT04022967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153841098|NCT04022967|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153841099|NCT04022967|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153841100|NCT04022967|Antiviral Agents|antiviral agents|mesh-ancestor
153841101|NCT04022967|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153841102|NCT04022967|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
153381234|NCT01706666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153381235|NCT01706666|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153381236|NCT01706666|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153381237|NCT01706666|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153381238|NCT01706666|Antiemetics|antiemetics|mesh-ancestor
153381239|NCT01706666|Autonomic Agents|autonomic agents|mesh-ancestor
153381240|NCT01706666|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153381241|NCT01706666|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153381242|NCT01706666|Glucocorticoids|glucocorticoids|mesh-ancestor
153381243|NCT01706666|Hormones|hormones|mesh-ancestor
153381244|NCT01706666|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153381245|NCT01706666|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153381246|NCT01706666|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153381247|NCT01706666|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153381248|NCT01706666|Growth Substances|growth substances|mesh-ancestor
153381249|NCT01706666|Growth Inhibitors|growth inhibitors|mesh-ancestor
153381250|NCT03149991|Ketamine|ketamine|mesh-list
153381251|NCT03149991|Brexpiprazole|brexpiprazole|mesh-list
153381252|NCT03149991|Analgesics|analgesics|mesh-ancestor
153381253|NCT03149991|Sensory System Agents|sensory system agents|mesh-ancestor
153381254|NCT03149991|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153381255|NCT03149991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153381256|NCT03149991|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
153381257|NCT03149991|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153381258|NCT03149991|Anesthetics, General|anesthetics, general|mesh-ancestor
153381259|NCT03149991|Anesthetics|anesthetics|mesh-ancestor
153381260|NCT03149991|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153381261|NCT03149991|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
153841104|NCT04022967|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153841105|NCT04022967|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153841106|NCT04022967|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
153841107|NCT04022967|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
153841108|NCT04022967|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
153841109|NCT04022967|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
153841110|NCT04022967|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
153841118|NCT03998813|Anesthetics, Local|anesthetics, local|mesh-ancestor
153841119|NCT03998813|Anesthetics|anesthetics|mesh-ancestor
153841120|NCT03998813|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153841121|NCT03998813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153645871|NCT00112138|Antimanic Agents|antimanic agents|mesh-ancestor
153645872|NCT03330639|Capsaicin|capsaicin|mesh-list
153645873|NCT03330639|Antipruritics|antipruritics|mesh-ancestor
153645874|NCT03330639|Dermatologic Agents|dermatologic agents|mesh-ancestor
153645916|NCT00007592|Natriuretic Agents|natriuretic agents|mesh-ancestor
153645917|NCT00007592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153645918|NCT00007592|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
153645919|NCT00007592|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153841122|NCT03998813|Sensory System Agents|sensory system agents|mesh-ancestor
153841123|NCT03998813|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153732123|NCT02964572|Immunologic Factors|immunologic factors|mesh-ancestor
153732124|NCT00162201|Abatacept|abatacept|mesh-list
153841124|NCT03991091|Oxytocin|oxytocin|mesh-list
153841125|NCT03991091|Oxytocics|oxytocics|mesh-ancestor
153841126|NCT03991091|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153841127|NCT03991091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153841128|NCT03971422|Rozanolixizumab|rozanolixizumab|mesh-list
153841129|NCT03971422|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153841130|NCT03971422|Immunologic Factors|immunologic factors|mesh-ancestor
153841131|NCT03971422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153841132|NCT03945656|Insulin|insulin|mesh-list
153841133|NCT03945656|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
153841134|NCT03945656|Insulin Glargine|insulin glargine|mesh-list
153841135|NCT03945656|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153841136|NCT03945656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153841137|NCT03927079|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
153381262|NCT03149991|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
153381263|NCT03149991|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153381264|NCT03149991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153381265|NCT03149991|Serotonin Agents|serotonin agents|mesh-ancestor
153381266|NCT03149991|Dopamine Agonists|dopamine agonists|mesh-ancestor
153381267|NCT03149991|Dopamine Agents|dopamine agents|mesh-ancestor
153381268|NCT05704439|Antihypertensive Agents|antihypertensive agents|mesh-list
153381269|NCT05400993|Cyclophosphamide|cyclophosphamide|mesh-list
153381271|NCT05400993|Epirubicin|epirubicin|mesh-list
153381272|NCT05400993|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153381273|NCT05400993|Immunologic Factors|immunologic factors|mesh-ancestor
153381274|NCT05400993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153381275|NCT05400993|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153381276|NCT05400993|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153381277|NCT05400993|Alkylating Agents|alkylating agents|mesh-ancestor
153381278|NCT05400993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153381279|NCT05400993|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153381280|NCT05400993|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153381281|NCT05400993|Tubulin Modulators|tubulin modulators|mesh-ancestor
153381282|NCT05400993|Antimitotic Agents|antimitotic agents|mesh-ancestor
153381283|NCT05400993|Mitosis Modulators|mitosis modulators|mesh-ancestor
153381284|NCT05400993|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153381285|NCT05400993|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153381286|NCT05400993|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153381287|NCT05400993|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153381288|NCT01605890|Tenofovir|tenofovir|mesh-list
153381289|NCT01605890|Emtricitabine|emtricitabine|mesh-list
153381290|NCT01605890|Raltegravir Potassium|raltegravir potassium|mesh-list
153645980|NCT00112684|Growth Inhibitors|growth inhibitors|mesh-ancestor
153645981|NCT00112684|Growth Substances|growth substances|mesh-ancestor
153645982|NCT00112684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153645983|NCT00112684|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153645984|NCT00112684|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153645985|NCT00112684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153381291|NCT01605890|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
153381292|NCT01605890|Antiviral Agents|antiviral agents|mesh-ancestor
153381293|NCT01605890|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153381294|NCT01605890|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153381295|NCT01605890|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153381296|NCT01605890|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153841138|NCT03927079|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
153841157|NCT03822962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153841158|NCT03822962|Antipyretics|antipyretics|mesh-ancestor
153841159|NCT03822962|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153841160|NCT03822962|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153841161|NCT03822962|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153732125|NCT00162201|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153732126|NCT00162201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153569158|NCT04560725|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153732127|NCT00162201|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153732128|NCT00162201|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153732129|NCT00162201|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153732130|NCT00162201|Immunologic Factors|immunologic factors|mesh-ancestor
153732131|NCT00162201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153841162|NCT03822962|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153841163|NCT03822962|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153841164|NCT03822962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153841165|NCT03806387|Alemtuzumab|alemtuzumab|mesh-list
153841166|NCT03806387|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153381326|NCT05738993|Pertuzumab|pertuzumab|mesh-list
153381329|NCT01709474|Vitamin D|vitamin d|mesh-list
153841177|NCT03770260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153841178|NCT03762850|Dapagliflozin|dapagliflozin|mesh-list
153841179|NCT03762850|Irbesartan|irbesartan|mesh-list
153841180|NCT03762850|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
153841181|NCT03762850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153841182|NCT03762850|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153841183|NCT03762850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153841184|NCT03762850|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153841185|NCT03762850|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
153841186|NCT03762850|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
153841187|NCT03759093|Thalidomide|thalidomide|mesh-list
153841188|NCT03759093|Dexamethasone|dexamethasone|mesh-list
153841189|NCT03759093|Dexamethasone acetate|dexamethasone acetate|mesh-list
153841190|NCT03759093|Cyclophosphamide|cyclophosphamide|mesh-list
153841191|NCT03759093|Lenalidomide|lenalidomide|mesh-list
153841193|NCT03759093|BB 1101|bb 1101|mesh-list
153841194|NCT03759093|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153841195|NCT03759093|Immunologic Factors|immunologic factors|mesh-ancestor
153841196|NCT03759093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153841197|NCT03759093|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153381355|NCT02331095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153381357|NCT02331095|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
153381358|NCT02331095|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153646043|NCT00007787|Tacrolimus|tacrolimus|mesh-list
153646044|NCT00007787|Cyclosporins|cyclosporins|mesh-list
153381359|NCT02331095|Anticoagulants|anticoagulants|mesh-ancestor
153381360|NCT02331095|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
153381361|NCT02331095|Antithrombins|antithrombins|mesh-ancestor
153381362|NCT02331095|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
153381363|NCT02331095|Protease Inhibitors|protease inhibitors|mesh-ancestor
153381364|NCT01640834|Glucagon|glucagon|mesh-list
153381365|NCT01640834|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153381366|NCT01640834|Hormones|hormones|mesh-ancestor
153381367|NCT01640834|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153381368|NCT01640834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153381370|NCT03029273|Fludarabine|fludarabine|mesh-list
153381371|NCT03029273|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153381372|NCT03029273|Immunologic Factors|immunologic factors|mesh-ancestor
153381373|NCT03029273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153381374|NCT03029273|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153381375|NCT03029273|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153841225|NCT03756961|Propofol|propofol|mesh-list
153381376|NCT03029273|Alkylating Agents|alkylating agents|mesh-ancestor
153841226|NCT03756961|Desflurane|desflurane|mesh-list
153841227|NCT03756961|Esketamine|esketamine|mesh-list
153841228|NCT03756961|Anesthetics, Local|anesthetics, local|mesh-ancestor
153841229|NCT03756961|Anesthetics|anesthetics|mesh-ancestor
153841230|NCT03756961|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153841231|NCT03756961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153841232|NCT03756961|Sensory System Agents|sensory system agents|mesh-ancestor
153841233|NCT03756961|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153841234|NCT03756961|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153841235|NCT03756961|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
153841245|NCT03756961|Adrenergic Agents|adrenergic agents|mesh-ancestor
153841246|NCT03756961|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153841247|NCT03756961|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153841248|NCT03756961|Anesthetics, General|anesthetics, general|mesh-ancestor
153841249|NCT03756961|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153841251|NCT03756961|Antidepressive Agents|antidepressive agents|mesh-ancestor
153841252|NCT03756961|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153841253|NCT03756961|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
153841254|NCT03737110|Rilonacept|rilonacept|mesh-list
153841255|NCT03737110|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153841256|NCT03735901|Levodopa|levodopa|mesh-list
153841257|NCT03735901|Carbidopa|carbidopa|mesh-list
153841258|NCT03735901|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
153841259|NCT03735901|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
153841260|NCT03735901|Dopamine Agents|dopamine agents|mesh-ancestor
153841261|NCT03735901|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153841262|NCT03735901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153841263|NCT03735901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153841264|NCT03735901|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
153841265|NCT03735901|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153841266|NCT03723590|Hyaluronic Acid|hyaluronic acid|mesh-list
153841267|NCT03723590|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153841268|NCT03723590|Immunologic Factors|immunologic factors|mesh-ancestor
153841269|NCT03723590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153381391|NCT05738681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153381392|NCT05738681|Protective Agents|protective agents|mesh-ancestor
153381393|NCT05738681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153841272|NCT03710122|Vancomycin|vancomycin|mesh-list
153841273|NCT03710122|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153841274|NCT03710122|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153841275|NCT03698669|Analgesics, Opioid|analgesics, opioid|mesh-list
153841276|NCT03698669|Narcotics|narcotics|mesh-ancestor
153841277|NCT03698669|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153841278|NCT03698669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153841279|NCT03698669|Analgesics|analgesics|mesh-ancestor
153841280|NCT03698669|Sensory System Agents|sensory system agents|mesh-ancestor
153841281|NCT03698669|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153841282|NCT03691077|Ocrelizumab|ocrelizumab|mesh-list
153841283|NCT03691077|Immunologic Factors|immunologic factors|mesh-ancestor
153841284|NCT03691077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153841285|NCT03625648|Pentoxifylline|pentoxifylline|mesh-list
153841286|NCT03625648|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
153841287|NCT03625648|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153841288|NCT03625648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153841289|NCT03625648|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153841290|NCT03625648|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
153841291|NCT03625648|Protective Agents|protective agents|mesh-ancestor
153841292|NCT03625648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153841293|NCT03625648|Vasodilator Agents|vasodilator agents|mesh-ancestor
153841314|NCT03587740|Mitosis Modulators|mitosis modulators|mesh-ancestor
153381436|NCT05259995|Adrenergic Agents|adrenergic agents|mesh-ancestor
153381437|NCT05259995|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153381438|NCT05259995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153381439|NCT05259995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153381440|NCT05259995|Sympathomimetics|sympathomimetics|mesh-ancestor
153381441|NCT05259995|Autonomic Agents|autonomic agents|mesh-ancestor
153381442|NCT05259995|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153381443|NCT05259995|Nasal Decongestants|nasal decongestants|mesh-ancestor
153381444|NCT05259995|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
153381445|NCT05259995|Respiratory System Agents|respiratory system agents|mesh-ancestor
153381446|NCT03028883|Buprenorphine|buprenorphine|mesh-list
153381447|NCT03028883|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153381448|NCT03028883|Narcotics|narcotics|mesh-ancestor
153381449|NCT03028883|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153381450|NCT03028883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153381451|NCT03028883|Analgesics|analgesics|mesh-ancestor
153381452|NCT03028883|Sensory System Agents|sensory system agents|mesh-ancestor
153381453|NCT03028883|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153841315|NCT03587740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153841316|NCT03586999|Prednisolone|prednisolone|mesh-list
153841317|NCT03586999|Cyclophosphamide|cyclophosphamide|mesh-list
153841319|NCT03586999|Etoposide|etoposide|mesh-list
153841320|NCT03586999|Vincristine|vincristine|mesh-list
153841321|NCT03586999|Doxorubicin|doxorubicin|mesh-list
153841322|NCT03586999|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
153841323|NCT03586999|Prednisolone phosphate|prednisolone phosphate|mesh-list
153646058|NCT00390897|Antiviral Agents|antiviral agents|mesh-ancestor
153646059|NCT00390897|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153646060|NCT00113347|Docetaxel|docetaxel|mesh-list
153646099|NCT00007826|Antacids|antacids|mesh-ancestor
153841324|NCT03586999|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153841325|NCT03586999|Immunologic Factors|immunologic factors|mesh-ancestor
153841326|NCT03586999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153841327|NCT03586999|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153381468|NCT02986685|Autonomic Agents|autonomic agents|mesh-ancestor
153381469|NCT02986685|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153381482|NCT01611662|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153381484|NCT01611662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153381485|NCT05200481|Carboplatin|carboplatin|mesh-list
153381486|NCT05200481|Pemetrexed|pemetrexed|mesh-list
153381487|NCT05200481|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153381488|NCT05200481|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153381491|NCT05200481|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153381493|NCT01646762|Paclitaxel|paclitaxel|mesh-list
153381494|NCT01646762|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
153381495|NCT01646762|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153381496|NCT01646762|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153381497|NCT01646762|Tubulin Modulators|tubulin modulators|mesh-ancestor
153381498|NCT01646762|Antimitotic Agents|antimitotic agents|mesh-ancestor
153381499|NCT01646762|Mitosis Modulators|mitosis modulators|mesh-ancestor
153381500|NCT01646762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153381501|NCT04997525|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
153381502|NCT04997525|Estradiol|estradiol|mesh-list
153381503|NCT04997525|Progesterone|progesterone|mesh-list
153381504|NCT04997525|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
153381505|NCT04997525|Estrogens|estrogens|mesh-ancestor
153381506|NCT04997525|Hormones|hormones|mesh-ancestor
153381508|NCT04997525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153841353|NCT03537495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153841354|NCT03518606|Durvalumab|durvalumab|mesh-list
153841355|NCT03518606|Vinorelbine|vinorelbine|mesh-list
153841356|NCT03518606|Tremelimumab|tremelimumab|mesh-list
153841357|NCT03518606|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153841358|NCT03518606|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153841359|NCT03518606|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153841360|NCT03518606|Tubulin Modulators|tubulin modulators|mesh-ancestor
153841361|NCT03518606|Antimitotic Agents|antimitotic agents|mesh-ancestor
153841362|NCT03518606|Mitosis Modulators|mitosis modulators|mesh-ancestor
153841363|NCT03518606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153841380|NCT03390296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153841381|NCT03390296|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153841382|NCT03390296|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153841384|NCT03390296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153841385|NCT03390296|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153841386|NCT03390296|Immunotoxins|immunotoxins|mesh-ancestor
153841387|NCT03390296|Immunoconjugates|immunoconjugates|mesh-ancestor
153841388|NCT03390296|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153841389|NCT03386240|Triclosan|triclosan|mesh-list
153732133|NCT01248247|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
153841390|NCT03386240|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
153646100|NCT00007826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153646101|NCT00007826|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153823355|NCT00443937|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153823356|NCT00443937|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153823357|NCT00443937|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
153823358|NCT00443937|Antitubercular Agents|antitubercular agents|mesh-ancestor
153823359|NCT00443937|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153841391|NCT03386240|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153841392|NCT03386240|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
153841393|NCT03386240|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153841394|NCT03386240|Antimetabolites|antimetabolites|mesh-ancestor
153381518|NCT01619774|Dabrafenib|dabrafenib|mesh-list
153381519|NCT01619774|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153381520|NCT01619774|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153381521|NCT01619774|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153820162|NCT00462813|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153820163|NCT01052012|Bupivacaine|bupivacaine|mesh-list
153820164|NCT01052012|Anesthetics, Local|anesthetics, local|mesh-ancestor
153820165|NCT01052012|Anesthetics|anesthetics|mesh-ancestor
153461591|NCT02084706|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
153381522|NCT01619774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153381524|NCT01651442|Trazodone|trazodone|mesh-list
153381525|NCT01651442|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
153381526|NCT01651442|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153381527|NCT01651442|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153381528|NCT01651442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153381545|NCT04868045|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153381546|NCT04868045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153841395|NCT03386240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153841396|NCT03386240|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153841397|NCT03338387|Acipimox|acipimox|mesh-list
153841398|NCT03338387|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153841399|NCT03338387|Antimetabolites|antimetabolites|mesh-ancestor
153841400|NCT03338387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153841401|NCT03338387|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153841402|NCT03334253|Atropine|atropine|mesh-list
153841403|NCT03334253|Ophthalmic Solutions|ophthalmic solutions|mesh-list
153841404|NCT03334253|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153841405|NCT03334253|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153841406|NCT03334253|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153841407|NCT03334253|Autonomic Agents|autonomic agents|mesh-ancestor
153841408|NCT03334253|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153841409|NCT03334253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153841410|NCT03334253|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153841411|NCT03334253|Respiratory System Agents|respiratory system agents|mesh-ancestor
153841412|NCT03334253|Mydriatics|mydriatics|mesh-ancestor
153841413|NCT03334253|Parasympatholytics|parasympatholytics|mesh-ancestor
153841427|NCT03304080|Trastuzumab|trastuzumab|mesh-list
153841428|NCT03304080|Pertuzumab|pertuzumab|mesh-list
153841429|NCT03304080|Palbociclib|palbociclib|mesh-list
153841430|NCT03304080|Anastrozole|anastrozole|mesh-list
153841431|NCT03304080|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153646102|NCT00007865|Rituximab|rituximab|mesh-list
153841432|NCT03304080|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153841433|NCT03304080|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153381558|NCT01658228|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
153381560|NCT01658228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153381561|NCT01658228|Cholinergic Agents|cholinergic agents|mesh-ancestor
153381562|NCT01658228|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153381563|NCT01658228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153381564|NCT01658228|Nootropic Agents|nootropic agents|mesh-ancestor
153381565|NCT01658228|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
153381566|NCT01658228|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153381567|NCT01658228|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153381568|NCT01658228|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
153381569|NCT01658228|Antidepressive Agents|antidepressive agents|mesh-ancestor
153381570|NCT01658228|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153732134|NCT01248247|Sorafenib|sorafenib|mesh-list
153393363|NCT04349930|Cannabidiol|cannabidiol|mesh-list
153381571|NCT01658228|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
153381572|NCT01658228|Serotonin Agents|serotonin agents|mesh-ancestor
153381574|NCT05709938|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
153381575|NCT05709938|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153381576|NCT05709938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153381577|NCT01659866|Ciprofloxacin|ciprofloxacin|mesh-list
153381578|NCT01659866|Gentamicins|gentamicins|mesh-list
153381579|NCT01659866|Ceftriaxone|ceftriaxone|mesh-list
153841443|NCT03275506|Bevacizumab|bevacizumab|mesh-list
153841444|NCT03275506|Pembrolizumab|pembrolizumab|mesh-list
153841445|NCT03275506|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153841446|NCT03275506|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153841447|NCT03275506|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153841448|NCT03275506|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153841449|NCT03275506|Growth Substances|growth substances|mesh-ancestor
153841450|NCT03275506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153841451|NCT03275506|Growth Inhibitors|growth inhibitors|mesh-ancestor
153841452|NCT03275506|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153841453|NCT03275506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153841454|NCT03267680|Indomethacin|indomethacin|mesh-list
153841455|NCT03267680|Cyclophosphamide|cyclophosphamide|mesh-list
153841456|NCT03267680|Omeprazole|omeprazole|mesh-list
153841457|NCT03267680|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153841458|NCT03267680|Immunologic Factors|immunologic factors|mesh-ancestor
153841459|NCT03267680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153841460|NCT03267680|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153841461|NCT03267680|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153841462|NCT03267680|Alkylating Agents|alkylating agents|mesh-ancestor
153841463|NCT03267680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153841464|NCT03267680|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153841465|NCT03267680|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153841466|NCT03267680|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
153841467|NCT03267680|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153841468|NCT03267680|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
153841469|NCT03267680|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153841470|NCT03267680|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153841471|NCT03267680|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153841472|NCT03267680|Analgesics|analgesics|mesh-ancestor
153841473|NCT03267680|Sensory System Agents|sensory system agents|mesh-ancestor
153841474|NCT03267680|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153841476|NCT03267680|Gout Suppressants|gout suppressants|mesh-ancestor
153381600|NCT01659866|Antimalarials|antimalarials|mesh-ancestor
153381607|NCT02249702|Docetaxel|docetaxel|mesh-list
153381608|NCT02249702|Trabectedin|trabectedin|mesh-list
153381609|NCT02249702|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153823435|NCT00444249|Dipivefrin|dipivefrin|mesh-list
153381610|NCT02249702|Antimetabolites|antimetabolites|mesh-ancestor
153381611|NCT02249702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153381612|NCT02249702|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153381613|NCT02249702|Tubulin Modulators|tubulin modulators|mesh-ancestor
153732135|NCT01248247|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153381614|NCT02249702|Antimitotic Agents|antimitotic agents|mesh-ancestor
153381615|NCT02249702|Mitosis Modulators|mitosis modulators|mesh-ancestor
153381616|NCT02249702|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153381617|NCT02249702|Alkylating Agents|alkylating agents|mesh-ancestor
153381618|NCT02947529|Tranexamic Acid|tranexamic acid|mesh-list
153381619|NCT02947529|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
153381620|NCT02947529|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153381621|NCT02947529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153381622|NCT02947529|Hemostatics|hemostatics|mesh-ancestor
153381623|NCT02947529|Coagulants|coagulants|mesh-ancestor
153381624|NCT01660802|Dexamethasone|dexamethasone|mesh-list
153381625|NCT01660802|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153381626|NCT01660802|Antiemetics|antiemetics|mesh-ancestor
153381627|NCT01660802|Autonomic Agents|autonomic agents|mesh-ancestor
153381628|NCT01660802|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153381629|NCT01660802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153381630|NCT01660802|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153381631|NCT01660802|Glucocorticoids|glucocorticoids|mesh-ancestor
153381632|NCT01660802|Hormones|hormones|mesh-ancestor
153381633|NCT01660802|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153381634|NCT01660802|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153841477|NCT03267680|Tocolytic Agents|tocolytic agents|mesh-ancestor
153841478|NCT03267680|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153841479|NCT03267680|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153841480|NCT03249870|Inotuzumab Ozogamicin|inotuzumab ozogamicin|mesh-list
153841490|NCT03235739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153841491|NCT03235739|Sensory System Agents|sensory system agents|mesh-ancestor
153841492|NCT03235739|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153841493|NCT03210688|Alfacalcidol|alfacalcidol|mesh-list
153841494|NCT03210688|Hydroxycholecalciferols|hydroxycholecalciferols|mesh-list
153841496|NCT03210688|Prednisolone|prednisolone|mesh-list
153841497|NCT03210688|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153841498|NCT03210688|Glucocorticoids|glucocorticoids|mesh-ancestor
153841499|NCT03210688|Hormones|hormones|mesh-ancestor
153841500|NCT03210688|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153841501|NCT03210688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153841502|NCT03210688|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153841503|NCT03210688|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153841504|NCT03210688|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153841505|NCT03210688|Vitamins|vitamins|mesh-ancestor
153841506|NCT03210688|Micronutrients|micronutrients|mesh-ancestor
153841507|NCT03109795|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
153841508|NCT03109795|Clonidine|clonidine|mesh-list
153841509|NCT03109795|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153841510|NCT03109795|Diuretics|diuretics|mesh-ancestor
153841511|NCT03109795|Natriuretic Agents|natriuretic agents|mesh-ancestor
153841512|NCT03109795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153841513|NCT03109795|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
153841514|NCT03109795|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153841515|NCT03109795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153381640|NCT01661114|Fluorouracil|fluorouracil|mesh-list
153381641|NCT01661114|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153381642|NCT01661114|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153381643|NCT01661114|Antimetabolites|antimetabolites|mesh-ancestor
153381644|NCT01661114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153381645|NCT01661114|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153381646|NCT01661114|Immunologic Factors|immunologic factors|mesh-ancestor
153381657|NCT02987829|Androgen Receptor Antagonists|androgen receptor antagonists|mesh-list
153381658|NCT02987829|Androgen Antagonists|androgen antagonists|mesh-ancestor
153381659|NCT02987829|Hormone Antagonists|hormone antagonists|mesh-ancestor
153455665|NCT05367960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153381660|NCT02987829|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153381661|NCT02987829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153841517|NCT03109795|Sensory System Agents|sensory system agents|mesh-ancestor
153841518|NCT03109795|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153841519|NCT03109795|Sympatholytics|sympatholytics|mesh-ancestor
153841520|NCT03109795|Autonomic Agents|autonomic agents|mesh-ancestor
153841521|NCT03109795|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
153841522|NCT03109795|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153841523|NCT03109795|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153841524|NCT03109795|Adrenergic Agents|adrenergic agents|mesh-ancestor
153841525|NCT03109795|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153841526|NCT02980510|Leucovorin|leucovorin|mesh-list
153841527|NCT02980510|Folic Acid|folic acid|mesh-list
153841547|NCT02980510|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153841548|NCT02980510|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153841549|NCT02980510|Immunologic Factors|immunologic factors|mesh-ancestor
153841550|NCT02971956|Pembrolizumab|pembrolizumab|mesh-list
153841551|NCT02971956|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153841552|NCT02971956|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153841553|NCT02971956|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153841554|NCT02971956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153841555|NCT02967289|Irinotecan|irinotecan|mesh-list
153841556|NCT02967289|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
153841557|NCT02967289|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153841558|NCT02967289|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153841559|NCT02967289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153841560|NCT02967289|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153841561|NCT02939742|Betamethasone|betamethasone|mesh-list
153381719|NCT01662908|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153381720|NCT01662908|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153381721|NCT01662908|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153381722|NCT01662908|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
153381724|NCT01662908|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
153381725|NCT01662908|Protease Inhibitors|protease inhibitors|mesh-ancestor
153646113|NCT00007865|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153381726|NCT01662908|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153381727|NCT00375297|Sildenafil Citrate|sildenafil citrate|mesh-list
153381728|NCT00375297|Vasodilator Agents|vasodilator agents|mesh-ancestor
153381729|NCT00375297|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
153381730|NCT00375297|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
153381731|NCT00375297|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153381732|NCT00375297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153381733|NCT00375297|Urological Agents|urological agents|mesh-ancestor
153841604|NCT02719314|Methylprednisolone|methylprednisolone|mesh-list
153841605|NCT02719314|Glucocorticoids|glucocorticoids|mesh-list
153841606|NCT02719314|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153841607|NCT02719314|Antiemetics|antiemetics|mesh-ancestor
153841608|NCT02719314|Autonomic Agents|autonomic agents|mesh-ancestor
153841609|NCT02719314|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153841610|NCT02719314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153841611|NCT02719314|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153841613|NCT02719314|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153841614|NCT02719314|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
153841615|NCT02719314|Protective Agents|protective agents|mesh-ancestor
153841616|NCT02598362|Ciprofloxacin|ciprofloxacin|mesh-list
153381738|NCT02234570|Antinematodal Agents|antinematodal agents|mesh-ancestor
153381739|NCT04525599|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
153381740|NCT04525599|Immunologic Factors|immunologic factors|mesh-ancestor
153841632|NCT02585388|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153841633|NCT02585388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153841634|NCT02585388|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
153841635|NCT02585388|Hormone Antagonists|hormone antagonists|mesh-ancestor
153841636|NCT02585388|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153841637|NCT02585388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153381760|NCT04348695|Antimetabolites|antimetabolites|mesh-ancestor
153381761|NCT04348695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153381762|NCT04348695|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153381763|NCT04348695|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
153381764|NCT04348695|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153381772|NCT04316871|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153381773|NCT05364567|Vitamin D|vitamin d|mesh-list
153381774|NCT05364567|Cholecalciferol|cholecalciferol|mesh-list
153381775|NCT05364567|Vitamins|vitamins|mesh-ancestor
153381776|NCT05364567|Micronutrients|micronutrients|mesh-ancestor
153646147|NCT03272295|Cathartics|cathartics|mesh-ancestor
153646148|NCT03272295|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153646149|NCT03272295|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153646150|NCT00007904|Tamoxifen|tamoxifen|mesh-list
153646151|NCT00007904|Paclitaxel|paclitaxel|mesh-list
153646152|NCT00007904|Cyclophosphamide|cyclophosphamide|mesh-list
153646153|NCT00007904|Doxorubicin|doxorubicin|mesh-list
153381777|NCT05364567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153381778|NCT05364567|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153841662|NCT02579161|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153841663|NCT02579161|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153841664|NCT02579161|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153841665|NCT02579161|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153841666|NCT02579161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153841667|NCT02579161|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153841668|NCT02579161|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
153841669|NCT02579161|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153841670|NCT02579161|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
153841671|NCT02579161|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153841672|NCT02568124|Tranexamic Acid|tranexamic acid|mesh-list
153841673|NCT02568124|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
153841674|NCT02568124|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153841675|NCT02568124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153841676|NCT02568124|Hemostatics|hemostatics|mesh-ancestor
153841677|NCT02568124|Coagulants|coagulants|mesh-ancestor
153841678|NCT02535533|Selenium|selenium|mesh-list
153841679|NCT02535533|Axitinib|axitinib|mesh-list
153841680|NCT02535533|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153381801|NCT01665950|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153381802|NCT01665950|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153381819|NCT01667978|Antiviral Agents|antiviral agents|mesh-ancestor
153381820|NCT01667978|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153381821|NCT01667978|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
153381822|NCT01667978|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153381823|NCT01667978|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
153381824|NCT01667978|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
153381825|NCT01667978|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
153381826|NCT01667978|Contraceptive Agents|contraceptive agents|mesh-ancestor
153381827|NCT01667978|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153646156|NCT00007904|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153646157|NCT00007904|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153646158|NCT00007904|Tubulin Modulators|tubulin modulators|mesh-ancestor
153646159|NCT00007904|Antimitotic Agents|antimitotic agents|mesh-ancestor
153646212|NCT00007982|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153646213|NCT00007982|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153646214|NCT00007982|Alkylating Agents|alkylating agents|mesh-ancestor
153646215|NCT00007982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153823563|NCT00495339|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
153823564|NCT00495339|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153363521|NCT01837628|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153363522|NCT01837628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153363524|NCT01837628|Dermatologic Agents|dermatologic agents|mesh-ancestor
153363525|NCT01462877|Fenofibrate|fenofibrate|mesh-list
153363526|NCT01462877|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153363527|NCT01462877|Antimetabolites|antimetabolites|mesh-ancestor
153363528|NCT01462877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153381828|NCT01667978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153381829|NCT01667978|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
153381831|NCT03282669|Morphine|morphine|mesh-list
153841681|NCT02535533|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153841682|NCT02535533|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153841683|NCT02535533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153841684|NCT02535533|Antioxidants|antioxidants|mesh-ancestor
153841685|NCT02535533|Protective Agents|protective agents|mesh-ancestor
153841686|NCT02535533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153841687|NCT02535533|Trace Elements|trace elements|mesh-ancestor
153841688|NCT02535533|Micronutrients|micronutrients|mesh-ancestor
153841698|NCT02498912|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153841699|NCT02498912|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153841700|NCT02431897|Estrogens|estrogens|mesh-list
153841701|NCT02431897|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
153841702|NCT02431897|Hormones|hormones|mesh-ancestor
153841703|NCT02431897|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153841704|NCT02431897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153841705|NCT02427841|Paclitaxel|paclitaxel|mesh-list
153841706|NCT02427841|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
153841707|NCT02427841|Gemcitabine|gemcitabine|mesh-list
153841708|NCT02427841|Fluorouracil|fluorouracil|mesh-list
153841709|NCT02427841|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153841710|NCT02427841|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153841713|NCT02427841|Mitosis Modulators|mitosis modulators|mesh-ancestor
153841714|NCT02427841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153841715|NCT02427841|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153841716|NCT02427841|Antimetabolites|antimetabolites|mesh-ancestor
153841717|NCT02427841|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153841718|NCT02427841|Immunologic Factors|immunologic factors|mesh-ancestor
153381860|NCT01668836|Antioxidants|antioxidants|mesh-ancestor
153381861|NCT01668836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153381862|NCT01668836|Protective Agents|protective agents|mesh-ancestor
153381863|NCT01668836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153381864|NCT01668836|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153381865|NCT01668836|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153381866|NCT03744663|Buprenorphine|buprenorphine|mesh-list
153381867|NCT03744663|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
153381868|NCT03744663|Naloxone|naloxone|mesh-list
153732141|NCT00140894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153732142|NCT00140894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153732143|NCT00140894|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153732144|NCT00140894|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
153841724|NCT02425566|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153841725|NCT02425566|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153841726|NCT02425566|Ganglionic Blockers|ganglionic blockers|mesh-ancestor
153841727|NCT02425566|Autonomic Agents|autonomic agents|mesh-ancestor
153841728|NCT02425566|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153841729|NCT02425566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153841730|NCT02425566|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
153841731|NCT02425566|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
153841732|NCT02425566|Cholinergic Agents|cholinergic agents|mesh-ancestor
153841733|NCT02425566|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153841734|NCT02425566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153841735|NCT02386735|Prednisone|prednisone|mesh-list
153841736|NCT02386735|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153841737|NCT02386735|Glucocorticoids|glucocorticoids|mesh-ancestor
153841738|NCT02386735|Hormones|hormones|mesh-ancestor
153841739|NCT02386735|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153841740|NCT02386735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153823565|NCT00460148|Ropinirole|ropinirole|mesh-list
153823566|NCT00460148|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
153823567|NCT00460148|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
153823568|NCT00460148|Dopamine Agonists|dopamine agonists|mesh-ancestor
153841741|NCT02386735|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153841742|NCT02386735|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153841743|NCT02383251|Paclitaxel|paclitaxel|mesh-list
153841744|NCT02383251|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153841750|NCT02348216|Cyclophosphamide|cyclophosphamide|mesh-list
153841751|NCT02348216|Fludarabine|fludarabine|mesh-list
153381869|NCT03744663|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153381870|NCT03744663|Narcotics|narcotics|mesh-ancestor
153381871|NCT03744663|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153381872|NCT03744663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153381873|NCT03744663|Analgesics|analgesics|mesh-ancestor
153381874|NCT03744663|Sensory System Agents|sensory system agents|mesh-ancestor
153381875|NCT03744663|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153381876|NCT03744663|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
153381877|NCT01669538|Galantamine|galantamine|mesh-list
153381878|NCT01669538|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
153381879|NCT01669538|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153381880|NCT01669538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153381881|NCT01669538|Cholinergic Agents|cholinergic agents|mesh-ancestor
153381882|NCT01669538|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153381883|NCT01669538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153381884|NCT01669538|Parasympathomimetics|parasympathomimetics|mesh-ancestor
153381885|NCT01669538|Autonomic Agents|autonomic agents|mesh-ancestor
153381886|NCT01669538|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153381887|NCT01669538|Nootropic Agents|nootropic agents|mesh-ancestor
153381889|NCT00375375|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153381890|NCT04333095|Bupivacaine|bupivacaine|mesh-list
153381891|NCT04333095|Anesthetics, Local|anesthetics, local|mesh-ancestor
153381892|NCT04333095|Anesthetics|anesthetics|mesh-ancestor
153381893|NCT04333095|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153381894|NCT04333095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153381895|NCT04333095|Sensory System Agents|sensory system agents|mesh-ancestor
153381896|NCT04333095|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153381898|NCT00375687|Luteolytic Agents|luteolytic agents|mesh-ancestor
153381899|NCT00375687|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
153381900|NCT00375687|Contraceptive Agents|contraceptive agents|mesh-ancestor
153381901|NCT00375687|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153381902|NCT00375687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153841752|NCT02348216|Axicabtagene ciloleucel|axicabtagene ciloleucel|mesh-list
153841753|NCT02348216|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153841755|NCT02348216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153841756|NCT02348216|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153841757|NCT02348216|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153841758|NCT02348216|Alkylating Agents|alkylating agents|mesh-ancestor
153841759|NCT02348216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153841760|NCT02348216|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153841761|NCT02348216|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153841762|NCT02348216|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153841763|NCT02204683|Aflibercept|aflibercept|mesh-list
153841764|NCT02204683|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153841765|NCT02204683|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153841766|NCT02204683|Growth Substances|growth substances|mesh-ancestor
153841768|NCT02204683|Growth Inhibitors|growth inhibitors|mesh-ancestor
153381917|NCT01673828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153381918|NCT05325099|Azacitidine|azacitidine|mesh-list
153381919|NCT05325099|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153381920|NCT05325099|Antimetabolites|antimetabolites|mesh-ancestor
153381921|NCT05325099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153381922|NCT05325099|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153381923|NCT05325099|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153381924|NCT02296775|Rituximab|rituximab|mesh-list
153381925|NCT02296775|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153381926|NCT02296775|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153381927|NCT02296775|Immunologic Factors|immunologic factors|mesh-ancestor
153381928|NCT02296775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153646216|NCT00007982|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153646217|NCT00007982|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153646218|NCT00007982|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153381929|NCT02296775|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153381930|NCT01675778|Hydromorphone|hydromorphone|mesh-list
153381931|NCT01675778|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153381932|NCT01675778|Narcotics|narcotics|mesh-ancestor
153381933|NCT01675778|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153381934|NCT01675778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153381935|NCT01675778|Analgesics|analgesics|mesh-ancestor
153381936|NCT01675778|Sensory System Agents|sensory system agents|mesh-ancestor
153381937|NCT01675778|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153381938|NCT04736589|Sirolimus|sirolimus|mesh-list
153381939|NCT04736589|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153381940|NCT04736589|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153841798|NCT01906814|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153381945|NCT04736589|Immunologic Factors|immunologic factors|mesh-ancestor
153381946|NCT04736589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153381947|NCT05201859|Capecitabine|capecitabine|mesh-list
153381948|NCT05201859|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153381949|NCT05201859|Antimetabolites|antimetabolites|mesh-ancestor
153381950|NCT05201859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153381951|NCT05201859|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153381953|NCT02594111|Gout Suppressants|gout suppressants|mesh-ancestor
153381954|NCT02594111|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153381955|NCT02594111|Tubulin Modulators|tubulin modulators|mesh-ancestor
153381956|NCT02594111|Antimitotic Agents|antimitotic agents|mesh-ancestor
153381957|NCT02594111|Mitosis Modulators|mitosis modulators|mesh-ancestor
153381958|NCT02594111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153381959|NCT02594111|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153381960|NCT03186261|Chlorhexidine|chlorhexidine|mesh-list
153381961|NCT03186261|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
153381962|NCT03186261|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
153381963|NCT03186261|Fluorides|fluorides|mesh-list
153381964|NCT03186261|Cariostatic Agents|cariostatic agents|mesh-ancestor
153381965|NCT03186261|Protective Agents|protective agents|mesh-ancestor
153381977|NCT02986607|Parathyroid Hormone|parathyroid hormone|mesh-list
153381978|NCT02986607|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153381979|NCT02986607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153381980|NCT01678976|Eslicarbazepine acetate|eslicarbazepine acetate|mesh-list
153381981|NCT01678976|Oxcarbazepine|oxcarbazepine|mesh-list
153381982|NCT01678976|Anticonvulsants|anticonvulsants|mesh-ancestor
153381983|NCT01678976|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
153381984|NCT01678976|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153381985|NCT01678976|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153381986|NCT01678976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153381987|NCT01678976|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
153381988|NCT01678976|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
153381989|NCT02249936|Omeprazole|omeprazole|mesh-list
153381990|NCT02249936|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
153381991|NCT02249936|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153381992|NCT02249936|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
153381993|NCT02249936|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153381994|NCT02249936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153381995|NCT03190005|Clopidogrel|clopidogrel|mesh-list
153381996|NCT03190005|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153381997|NCT03190005|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
153382004|NCT01461915|Paclitaxel|paclitaxel|mesh-list
153382013|NCT01461915|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153382014|NCT01461915|Antimetabolites|antimetabolites|mesh-ancestor
153382015|NCT01461915|Anticoagulants|anticoagulants|mesh-ancestor
153382016|NCT01461915|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153382017|NCT01461915|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153382018|NCT01682642|Goserelin|goserelin|mesh-list
153382019|NCT01682642|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153382020|NCT01682642|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153382021|NCT01683422|Gemcitabine|gemcitabine|mesh-list
153382022|NCT01683422|Capecitabine|capecitabine|mesh-list
153382023|NCT01683422|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
153382024|NCT01683422|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153382025|NCT01683422|Antimetabolites|antimetabolites|mesh-ancestor
153393708|NCT00002973|Melphalan|melphalan|mesh-list
153646219|NCT00007982|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153646220|NCT00007982|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153646221|NCT00007982|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153841891|NCT01431326|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153841892|NCT01431326|Analgesics|analgesics|mesh-ancestor
153841893|NCT01431326|Sensory System Agents|sensory system agents|mesh-ancestor
153841894|NCT01431326|Anticoagulants|anticoagulants|mesh-ancestor
153841895|NCT01431326|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153841896|NCT01431326|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153841897|NCT01431326|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
153841898|NCT01431326|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
153841899|NCT01431326|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
153841900|NCT01431326|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153841901|NCT01431326|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153841902|NCT01431326|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153841903|NCT01431326|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
153841904|NCT01431326|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153382037|NCT05066061|Analgesics|analgesics|mesh-list
153382040|NCT05066061|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153382041|NCT05066061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153382042|NCT05066061|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153382043|NCT05066061|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153382044|NCT05066061|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153382045|NCT03197025|Aldesleukin|aldesleukin|mesh-list
153382046|NCT03197025|Interleukin-2|interleukin-2|mesh-list
153382047|NCT03197025|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153382048|NCT03197025|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153382049|NCT03197025|Analgesics|analgesics|mesh-ancestor
153382050|NCT03197025|Sensory System Agents|sensory system agents|mesh-ancestor
153382051|NCT03197025|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153382052|NCT03197025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153382053|NCT03197025|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153382054|NCT03197025|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153382055|NCT03197025|Antiviral Agents|antiviral agents|mesh-ancestor
153382056|NCT03197025|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153382057|NCT02249546|Amoxicillin|amoxicillin|mesh-list
153382058|NCT02249546|Clarithromycin|clarithromycin|mesh-list
153382059|NCT02249546|Acetylcysteine|acetylcysteine|mesh-list
153382060|NCT02249546|N-monoacetylcystine|n-monoacetylcystine|mesh-list
153382061|NCT02249546|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153382062|NCT02249546|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153841910|NCT01431326|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153841911|NCT01431326|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153841912|NCT01431326|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153841913|NCT01431326|Vasodilator Agents|vasodilator agents|mesh-ancestor
153841914|NCT01431326|Tocolytic Agents|tocolytic agents|mesh-ancestor
153841915|NCT01431326|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153841916|NCT01431326|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
153841917|NCT01431326|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153841918|NCT01431326|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153841919|NCT01431326|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153841920|NCT01431326|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
153841921|NCT01431326|Dopamine Agents|dopamine agents|mesh-ancestor
153841925|NCT01431326|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153841926|NCT01431326|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
153841927|NCT01431326|GABA Agonists|gaba agonists|mesh-ancestor
153841928|NCT01431326|GABA Agents|gaba agents|mesh-ancestor
153841929|NCT01431326|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153841930|NCT01431326|Serotonin Agents|serotonin agents|mesh-ancestor
153841931|NCT01431326|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153455666|NCT05330884|BCG Vaccine|bcg vaccine|mesh-list
153646222|NCT00114205|Docetaxel|docetaxel|mesh-list
153841932|NCT01431326|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
153841933|NCT01431326|Chelating Agents|chelating agents|mesh-ancestor
153841934|NCT01431326|Sequestering Agents|sequestering agents|mesh-ancestor
153841935|NCT01431326|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
153841936|NCT01431326|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
153841937|NCT01431326|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
153841938|NCT01431326|Adrenergic Agents|adrenergic agents|mesh-ancestor
153841939|NCT01431326|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
153841940|NCT01431326|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
153841941|NCT01431326|GABA Antagonists|gaba antagonists|mesh-ancestor
153841942|NCT01431326|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
153841943|NCT01431326|Sympathomimetics|sympathomimetics|mesh-ancestor
153841944|NCT01431326|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
153382068|NCT02249546|Antiviral Agents|antiviral agents|mesh-ancestor
153841958|NCT01303679|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153841959|NCT01303679|Tubulin Modulators|tubulin modulators|mesh-ancestor
153841960|NCT01303679|Antimitotic Agents|antimitotic agents|mesh-ancestor
153841961|NCT01303679|Mitosis Modulators|mitosis modulators|mesh-ancestor
153841962|NCT01303679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153841967|NCT01303679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153841968|NCT01303679|Growth Inhibitors|growth inhibitors|mesh-ancestor
153841969|NCT01303679|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
153841970|NCT01303679|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153841971|NCT01303679|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153841972|NCT01303679|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
153841973|NCT01303679|Hormone Antagonists|hormone antagonists|mesh-ancestor
153841974|NCT01303679|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153841975|NCT01298713|Tamoxifen|tamoxifen|mesh-list
153841976|NCT01298713|Everolimus|everolimus|mesh-list
153841977|NCT01298713|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
153841978|NCT01298713|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153841979|NCT01298713|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153841980|NCT01298713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153841981|NCT01298713|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153841982|NCT01298713|Immunologic Factors|immunologic factors|mesh-ancestor
153841983|NCT01298713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153841984|NCT01298713|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153382125|NCT03978767|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153382126|NCT03978767|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153382127|NCT03978767|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153382128|NCT03978767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153382129|NCT03978767|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153382130|NCT03978767|Narcotics|narcotics|mesh-ancestor
153382131|NCT03978767|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153382132|NCT04436133|Vaccines|vaccines|mesh-list
153382133|NCT04436133|Immunologic Factors|immunologic factors|mesh-ancestor
153382134|NCT04436133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153382135|NCT01685996|Zonisamide|zonisamide|mesh-list
153382136|NCT01685996|Anticonvulsants|anticonvulsants|mesh-ancestor
153382137|NCT01685996|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153382138|NCT01685996|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153382139|NCT01685996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153382140|NCT01685996|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153382141|NCT01685996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153382142|NCT03207399|Sofosbuvir-velpatasvir drug combination|sofosbuvir-velpatasvir drug combination|mesh-list
153382143|NCT03207399|Antiviral Agents|antiviral agents|mesh-ancestor
153382144|NCT03207399|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153382145|NCT02196155|Cortisone|cortisone|mesh-list
153382146|NCT02196155|Botulinum Toxins|botulinum toxins|mesh-list
153842004|NCT01191697|Antimetabolites|antimetabolites|mesh-ancestor
153842005|NCT01191697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153842006|NCT01189643|Bevacizumab|bevacizumab|mesh-list
153382149|NCT02196155|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
153363702|NCT01830218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153823714|NCT00105482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153823715|NCT00105482|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
153823718|NCT00496002|Adefovir|adefovir|mesh-list
153382150|NCT02196155|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153382151|NCT02196155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153382153|NCT02196155|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153382154|NCT02196155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153382155|NCT02196155|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153382156|NCT02196155|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
153382157|NCT02196155|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153382158|NCT02175173|Rufinamide|rufinamide|mesh-list
153382159|NCT02175173|Anticonvulsants|anticonvulsants|mesh-ancestor
153382160|NCT02175173|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
153382161|NCT02175173|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153382162|NCT02175173|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153382163|NCT02175173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153382164|NCT04121403|Rituximab|rituximab|mesh-list
153382165|NCT04121403|Cladribine|cladribine|mesh-list
153382166|NCT04121403|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153382167|NCT04121403|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153382168|NCT04121403|Immunologic Factors|immunologic factors|mesh-ancestor
153382169|NCT04121403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153382170|NCT04121403|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153382171|NCT04121403|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153382172|NCT03224403|Acetaminophen|acetaminophen|mesh-list
153382173|NCT03224403|Ibuprofen|ibuprofen|mesh-list
153382174|NCT03224403|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153382175|NCT03224403|Analgesics|analgesics|mesh-ancestor
153382176|NCT03224403|Sensory System Agents|sensory system agents|mesh-ancestor
153382177|NCT03224403|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153382178|NCT03224403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153382179|NCT03224403|Antipyretics|antipyretics|mesh-ancestor
153393823|NCT00003081|Alkylating Agents|alkylating agents|mesh-ancestor
153842033|NCT01044745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153842040|NCT01044745|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153842041|NCT01044745|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153842042|NCT01044745|Antimetabolites|antimetabolites|mesh-ancestor
153842043|NCT01044745|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
153842044|NCT01044745|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153842045|NCT01044745|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153842046|NCT01044745|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
153842047|NCT01044745|Antitubercular Agents|antitubercular agents|mesh-ancestor
153842048|NCT01044745|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153842049|NCT01044745|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153842051|NCT00990275|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
153842052|NCT00990275|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153842053|NCT00990275|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153842054|NCT00990275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153842055|NCT02941328|Pyridostigmine Bromide|pyridostigmine bromide|mesh-list
153842056|NCT02941328|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
153842057|NCT02941328|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153842058|NCT02941328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153842059|NCT02941328|Cholinergic Agents|cholinergic agents|mesh-ancestor
153842060|NCT02941328|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153842061|NCT02941328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153842062|NCT02915796|Lenograstim|lenograstim|mesh-list
153842063|NCT02915796|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153842064|NCT02915796|Immunologic Factors|immunologic factors|mesh-ancestor
153382180|NCT03224403|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153382181|NCT03224403|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153382182|NCT03224403|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153382183|NCT03224403|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153382184|NCT03224403|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153382185|NCT03224403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153382187|NCT02334059|Analgesics|analgesics|mesh-ancestor
153382196|NCT02334059|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
153382197|NCT02334059|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
153382198|NCT02334059|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153382199|NCT02334059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153382201|NCT04501523|Tislelizumab|tislelizumab|mesh-list
153382202|NCT04501523|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153382203|NCT04501523|Antimetabolites|antimetabolites|mesh-ancestor
153382204|NCT04501523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153382205|NCT04501523|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153382206|NCT04501523|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153382207|NCT04499573|Cytarabine|cytarabine|mesh-list
153382208|NCT04499573|Dexamethasone|dexamethasone|mesh-list
153382209|NCT04499573|Cyclophosphamide|cyclophosphamide|mesh-list
153382210|NCT04499573|Fludarabine|fludarabine|mesh-list
153382211|NCT04499573|Etoposide|etoposide|mesh-list
153382212|NCT04499573|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153382213|NCT04499573|Immunologic Factors|immunologic factors|mesh-ancestor
153382214|NCT04499573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153382215|NCT04499573|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153842099|NCT02915172|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153842100|NCT02915172|Antimetabolites|antimetabolites|mesh-ancestor
153382229|NCT04499573|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153382230|NCT04499573|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153382231|NCT04499573|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153382232|NCT04499573|Antimetabolites|antimetabolites|mesh-ancestor
153382233|NCT04499573|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153382234|NCT04499573|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153382235|NCT04499573|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153382236|NCT04499573|Antiviral Agents|antiviral agents|mesh-ancestor
153382237|NCT04499573|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153382238|NCT03425097|Fexofenadine|fexofenadine|mesh-list
153382239|NCT03425097|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
153382240|NCT03425097|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
153382241|NCT03425097|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
153382242|NCT03425097|Histamine Antagonists|histamine antagonists|mesh-ancestor
153382243|NCT03425097|Histamine Agents|histamine agents|mesh-ancestor
153382244|NCT03425097|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153382245|NCT03425097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153382246|NCT03425097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153842102|NCT02915172|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153842103|NCT02915172|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153842138|NCT02918760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153842139|NCT02918760|Anticonvulsants|anticonvulsants|mesh-ancestor
153842140|NCT02918760|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153842141|NCT02918760|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153842142|NCT02918760|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153842143|NCT02918760|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153842144|NCT02918760|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
153382261|NCT01769027|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153382262|NCT01769027|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
153455668|NCT05330884|Immunologic Factors|immunologic factors|mesh-ancestor
153382263|NCT01769027|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153382264|NCT01769027|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153382265|NCT01769027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153382266|NCT01769027|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153382267|NCT01769027|Serotonin Agents|serotonin agents|mesh-ancestor
153382268|NCT01769027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153382270|NCT04706637|Dapagliflozin|dapagliflozin|mesh-list
153382271|NCT04706637|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
153842157|NCT03458078|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153842158|NCT03458078|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153842159|NCT03458078|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153842160|NCT03458078|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153842161|NCT03458078|Anesthetics, General|anesthetics, general|mesh-ancestor
153842162|NCT03458078|Anesthetics|anesthetics|mesh-ancestor
153393880|NCT00003099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153842163|NCT03458078|GABA Modulators|gaba modulators|mesh-ancestor
153842164|NCT03458078|GABA Agents|gaba agents|mesh-ancestor
153842165|NCT03458078|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153842166|NCT03458078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153842167|NCT03458078|Analgesics|analgesics|mesh-ancestor
153842171|NCT03458078|Anticonvulsants|anticonvulsants|mesh-ancestor
153842172|NCT03458078|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153842173|NCT03458078|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153842174|NCT03458078|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153842175|NCT03458078|Tocolytic Agents|tocolytic agents|mesh-ancestor
153842176|NCT03458078|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153842178|NCT04690556|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153382296|NCT02299349|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153382297|NCT02299349|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153382309|NCT03296163|Paclitaxel|paclitaxel|mesh-list
153842184|NCT01294579|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
153842186|NCT01294579|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153842187|NCT01294579|Alkylating Agents|alkylating agents|mesh-ancestor
153842188|NCT01294579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153842189|NCT01294579|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153842190|NCT02914626|Ranibizumab|ranibizumab|mesh-list
153842191|NCT02914626|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153842192|NCT02914626|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153842193|NCT02914626|Growth Substances|growth substances|mesh-ancestor
153842194|NCT02914626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153646279|NCT00114556|Zoledronic Acid|zoledronic acid|mesh-list
153646280|NCT00114556|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153646281|NCT00114556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153646282|NCT00008021|Cyclosporine|cyclosporine|mesh-list
153646334|NCT00008060|Micronutrients|micronutrients|mesh-ancestor
153646335|NCT00114868|Vitamins|vitamins|mesh-list
153646336|NCT00114868|Vitamin A|vitamin a|mesh-list
153646337|NCT00114868|Retinol palmitate|retinol palmitate|mesh-list
153646338|NCT00114868|Micronutrients|micronutrients|mesh-ancestor
153646339|NCT00114868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153646402|NCT00115102|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153646403|NCT00115102|Anesthetics, General|anesthetics, general|mesh-ancestor
153646404|NCT00115102|Anesthetics|anesthetics|mesh-ancestor
153646405|NCT00115102|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153646406|NCT00115102|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
153646407|NCT00115102|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
153646408|NCT00115102|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153646409|NCT00115102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153646410|NCT00115102|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153646464|NCT00115492|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
153646465|NCT00115492|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153842195|NCT02914626|Growth Inhibitors|growth inhibitors|mesh-ancestor
153842196|NCT02914626|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153842197|NCT02918331|Dexamethasone|dexamethasone|mesh-list
153842198|NCT02918331|Lenalidomide|lenalidomide|mesh-list
153842199|NCT02918331|Daratumumab|daratumumab|mesh-list
153842200|NCT02918331|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153842201|NCT02918331|Antiemetics|antiemetics|mesh-ancestor
153842202|NCT02918331|Autonomic Agents|autonomic agents|mesh-ancestor
153842203|NCT02918331|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153842204|NCT02918331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153842205|NCT02918331|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153842206|NCT02918331|Glucocorticoids|glucocorticoids|mesh-ancestor
153842207|NCT02918331|Hormones|hormones|mesh-ancestor
153382354|NCT03226899|Mitosis Modulators|mitosis modulators|mesh-ancestor
153382355|NCT03226899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153382356|NCT03226899|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153382357|NCT03226899|Antimetabolites|antimetabolites|mesh-ancestor
153382358|NCT03226899|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153382359|NCT03226899|Free Radical Scavengers|free radical scavengers|mesh-ancestor
153382360|NCT03226899|Antioxidants|antioxidants|mesh-ancestor
153382361|NCT03226899|Protective Agents|protective agents|mesh-ancestor
153382362|NCT03226899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153842223|NCT01294462|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
153382363|NCT03226899|Uricosuric Agents|uricosuric agents|mesh-ancestor
153382364|NCT01990703|Levonorgestrel|levonorgestrel|mesh-list
153382365|NCT01990703|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
153842224|NCT01294462|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
153842225|NCT01294462|Purinergic Agents|purinergic agents|mesh-ancestor
153842226|NCT01294462|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153842270|NCT04817033|Adrenergic Agents|adrenergic agents|mesh-ancestor
153382391|NCT03440229|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153382393|NCT01963091|Oxytocics|oxytocics|mesh-ancestor
153382394|NCT01963091|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153382395|NCT01963091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153382396|NCT02306759|Ketamine|ketamine|mesh-list
153382397|NCT02306759|Analgesics|analgesics|mesh-ancestor
153382398|NCT02306759|Sensory System Agents|sensory system agents|mesh-ancestor
153382399|NCT02306759|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153382400|NCT02306759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153382401|NCT02306759|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
153382402|NCT02306759|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153382403|NCT02306759|Anesthetics, General|anesthetics, general|mesh-ancestor
153382404|NCT02306759|Anesthetics|anesthetics|mesh-ancestor
153382405|NCT02306759|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153382406|NCT02306759|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
153382407|NCT02306759|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
153382408|NCT02306759|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153842300|NCT02938286|Sympathomimetics|sympathomimetics|mesh-ancestor
153842301|NCT02938286|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
153842302|NCT02938286|Anesthetics, Local|anesthetics, local|mesh-ancestor
153842303|NCT02938286|Anesthetics|anesthetics|mesh-ancestor
153842304|NCT02938286|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153842305|NCT02938286|Sensory System Agents|sensory system agents|mesh-ancestor
153842306|NCT01292239|Ribavirin|ribavirin|mesh-list
153842307|NCT01292239|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
153842308|NCT01292239|Simeprevir|simeprevir|mesh-list
153842309|NCT01292239|Antimetabolites|antimetabolites|mesh-ancestor
153842310|NCT01292239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153842311|NCT01292239|Antiviral Agents|antiviral agents|mesh-ancestor
153732147|NCT00140894|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153842312|NCT01292239|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153842313|NCT01292239|Protease Inhibitors|protease inhibitors|mesh-ancestor
153842314|NCT01292239|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153842315|NCT05600179|Dexamethasone|dexamethasone|mesh-list
153842316|NCT05600179|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153842317|NCT05600179|Antiemetics|antiemetics|mesh-ancestor
153842318|NCT05600179|Autonomic Agents|autonomic agents|mesh-ancestor
153382437|NCT01688102|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153382438|NCT01994993|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
153382439|NCT01994993|Metronidazole|metronidazole|mesh-list
153382440|NCT01994993|Clindamycin|clindamycin|mesh-list
153842325|NCT05600179|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153842326|NCT05600179|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153842328|NCT02937662|Cyclophosphamide|cyclophosphamide|mesh-list
153842329|NCT02937662|Idarubicin|idarubicin|mesh-list
153842330|NCT02937662|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153842331|NCT02937662|Immunologic Factors|immunologic factors|mesh-ancestor
153842332|NCT02937662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153842333|NCT02937662|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153842334|NCT02937662|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153842335|NCT02937662|Alkylating Agents|alkylating agents|mesh-ancestor
153842336|NCT02937662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153842337|NCT02937662|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153842338|NCT02937662|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153842339|NCT02937662|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153842340|NCT02937662|Antimetabolites|antimetabolites|mesh-ancestor
153842341|NCT02937662|Antiviral Agents|antiviral agents|mesh-ancestor
153842342|NCT02937662|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153646619|NCT00008450|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153646620|NCT00008489|Didanosine|didanosine|mesh-list
153646621|NCT00008489|Antimetabolites|antimetabolites|mesh-ancestor
153646622|NCT00008489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153646629|NCT00008489|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153646630|NCT00116350|Misoprostol|misoprostol|mesh-list
153646631|NCT00116350|Oxytocin|oxytocin|mesh-list
153646632|NCT00116350|Oxytocics|oxytocics|mesh-ancestor
153842343|NCT02937662|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153842344|NCT02937662|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153842345|NCT02937662|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153842346|NCT02937662|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153842347|NCT01290757|Dabigatran|dabigatran|mesh-list
153842348|NCT01290757|Antithrombins|antithrombins|mesh-ancestor
153842349|NCT01290757|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
153842350|NCT01290757|Protease Inhibitors|protease inhibitors|mesh-ancestor
153842351|NCT01290757|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153842352|NCT01290757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153842353|NCT01290757|Anticoagulants|anticoagulants|mesh-ancestor
153382489|NCT04436744|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153382490|NCT04436744|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153382492|NCT04436744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153382493|NCT04436744|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153382494|NCT04436744|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
153382495|NCT04436744|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153382496|NCT04436744|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
153382497|NCT04436744|Hormone Antagonists|hormone antagonists|mesh-ancestor
153382498|NCT04436744|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153382499|NCT04436744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153382500|NCT01963793|Aprepitant|aprepitant|mesh-list
153382501|NCT01963793|Fosaprepitant|fosaprepitant|mesh-list
153382502|NCT01963793|Antiemetics|antiemetics|mesh-ancestor
153382503|NCT01963793|Autonomic Agents|autonomic agents|mesh-ancestor
153382504|NCT01963793|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153382505|NCT01963793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153382506|NCT01963793|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153382507|NCT01963793|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
153382508|NCT01963793|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153823881|NCT00496665|Immunologic Factors|immunologic factors|mesh-ancestor
153646642|NCT00116389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153646643|NCT00116389|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153646644|NCT00116467|Vaccines|vaccines|mesh-list
153646645|NCT00116467|Immunologic Factors|immunologic factors|mesh-ancestor
153646646|NCT00116467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153646647|NCT00008528|Enfuvirtide|enfuvirtide|mesh-list
153363860|NCT01720940|Vancomycin|vancomycin|mesh-list
153382509|NCT01963793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153382510|NCT03449433|Insulin|insulin|mesh-list
153382511|NCT03449433|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
153842367|NCT01290718|Antimetabolites|antimetabolites|mesh-ancestor
153382512|NCT03449433|Insulin Aspart|insulin aspart|mesh-list
153842389|NCT02937779|Antiviral Agents|antiviral agents|mesh-ancestor
153842390|NCT02937779|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153842391|NCT02937779|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153842392|NCT02937779|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153842393|NCT02937779|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153842394|NCT02937779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153842395|NCT02937779|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153842396|NCT02937779|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153842397|NCT01290679|Ribavirin|ribavirin|mesh-list
153842398|NCT01290679|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
153842399|NCT01290679|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
153842400|NCT01290679|Simeprevir|simeprevir|mesh-list
153842401|NCT01290679|Antimetabolites|antimetabolites|mesh-ancestor
153842402|NCT01290679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153732149|NCT00140894|Analgesics|analgesics|mesh-ancestor
153394000|NCT00003141|Thiotepa|thiotepa|mesh-list
153842403|NCT01290679|Antiviral Agents|antiviral agents|mesh-ancestor
153842404|NCT01290679|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153842405|NCT01290679|Protease Inhibitors|protease inhibitors|mesh-ancestor
153842407|NCT03457389|Cabergoline|cabergoline|mesh-list
153842408|NCT03457389|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
153842409|NCT03457389|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
153842410|NCT03457389|Dopamine Agonists|dopamine agonists|mesh-ancestor
153842411|NCT03457389|Dopamine Agents|dopamine agents|mesh-ancestor
153842412|NCT03457389|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153382530|NCT01996943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153382531|NCT04812626|Triamcinolone|triamcinolone|mesh-list
153382532|NCT04812626|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
153382533|NCT04812626|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
153382534|NCT04812626|Fluorouracil|fluorouracil|mesh-list
153842423|NCT02890186|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153842424|NCT02890186|Narcotics|narcotics|mesh-ancestor
153842425|NCT02890186|Analgesics|analgesics|mesh-ancestor
153842426|NCT02890186|Sensory System Agents|sensory system agents|mesh-ancestor
153842427|NCT02890186|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153842428|NCT02909751|Tocotrienols|tocotrienols|mesh-list
153842430|NCT02909751|Tocopherols|tocopherols|mesh-list
153842431|NCT02909751|Docetaxel|docetaxel|mesh-list
153842432|NCT02909751|Cyclophosphamide|cyclophosphamide|mesh-list
153842433|NCT02909751|Trastuzumab|trastuzumab|mesh-list
153842434|NCT02909751|Epirubicin|epirubicin|mesh-list
153842435|NCT02909751|Pertuzumab|pertuzumab|mesh-list
153842436|NCT02909751|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153842437|NCT02909751|Tubulin Modulators|tubulin modulators|mesh-ancestor
153646652|NCT00008528|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153646653|NCT00008528|Antiviral Agents|antiviral agents|mesh-ancestor
153646654|NCT00008528|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153646655|NCT00116506|Bevacizumab|bevacizumab|mesh-list
153646656|NCT00116506|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
153823902|NCT00496704|Antimetabolites|antimetabolites|mesh-ancestor
153823903|NCT00496704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153823904|NCT00496704|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153823906|NCT00591916|Hyaluronic Acid|hyaluronic acid|mesh-list
153842438|NCT02909751|Antimitotic Agents|antimitotic agents|mesh-ancestor
153842439|NCT02909751|Mitosis Modulators|mitosis modulators|mesh-ancestor
153842440|NCT02909751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153842441|NCT02909751|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153842442|NCT02909751|Immunologic Factors|immunologic factors|mesh-ancestor
153842443|NCT02909751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153842444|NCT02909751|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153842445|NCT02909751|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153842446|NCT02909751|Alkylating Agents|alkylating agents|mesh-ancestor
153842447|NCT02909751|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153842448|NCT02909751|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153842449|NCT02909751|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153842450|NCT02909751|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153842451|NCT02909751|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153842452|NCT02909751|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153842455|NCT02909751|Vitamins|vitamins|mesh-ancestor
153382607|NCT02986451|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153382609|NCT02986451|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153382610|NCT02986451|Immunologic Factors|immunologic factors|mesh-ancestor
153461593|NCT02084706|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153382611|NCT02986451|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153382612|NCT02986451|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153382613|NCT02986451|Growth Substances|growth substances|mesh-ancestor
153382614|NCT02986451|Growth Inhibitors|growth inhibitors|mesh-ancestor
153382615|NCT02986451|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153382616|NCT02986451|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153382617|NCT02986451|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
153382618|NCT02986451|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153382619|NCT02986451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153382620|NCT02986451|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
153842482|NCT01290601|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153842483|NCT01290601|Antimalarials|antimalarials|mesh-ancestor
153842484|NCT01290601|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153842485|NCT01290601|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153842486|NCT01290601|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153842487|NCT01290601|Analgesics|analgesics|mesh-ancestor
153842488|NCT01290601|Sensory System Agents|sensory system agents|mesh-ancestor
153842489|NCT01290601|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153646657|NCT00116506|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153646672|NCT00116623|Magnesium Sulfate|magnesium sulfate|mesh-list
153646673|NCT00116623|Analgesics|analgesics|mesh-ancestor
153646674|NCT00116623|Sensory System Agents|sensory system agents|mesh-ancestor
153646675|NCT00116623|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153646676|NCT00116623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153646677|NCT00116623|Anesthetics|anesthetics|mesh-ancestor
153646678|NCT00116623|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153646679|NCT00116623|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153646680|NCT00116623|Anticonvulsants|anticonvulsants|mesh-ancestor
153646740|NCT02752815|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153646741|NCT02752815|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153646742|NCT02752815|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153646743|NCT02752815|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153646744|NCT00116935|Imatinib Mesylate|imatinib mesylate|mesh-list
153646745|NCT00116935|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153842490|NCT01290601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153842491|NCT01290601|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153842492|NCT01290601|Filaricides|filaricides|mesh-ancestor
153842493|NCT01290601|Antinematodal Agents|antinematodal agents|mesh-ancestor
153842494|NCT01290601|Anthelmintics|anthelmintics|mesh-ancestor
153842495|NCT02978391|Epinephrine|epinephrine|mesh-list
153842496|NCT02978391|Hemostatics|hemostatics|mesh-list
153842497|NCT02978391|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153842498|NCT02978391|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153842499|NCT02978391|Adrenergic Agents|adrenergic agents|mesh-ancestor
153842500|NCT02978391|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153842501|NCT02978391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153891021|NCT01029652|Immunologic Factors|immunologic factors|mesh-ancestor
153646746|NCT00116935|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153646747|NCT00116935|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153646748|NCT00116935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153646749|NCT00116935|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153646750|NCT00388388|Losartan|losartan|mesh-list
153646751|NCT00388388|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
153646752|NCT00388388|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153646753|NCT00388388|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153646754|NCT00388388|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
153646755|NCT00388388|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
153646756|NCT00388388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153646762|NCT00117013|Topotecan|topotecan|mesh-list
153646796|NCT00388427|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153646797|NCT00388427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153646798|NCT00117364|Sacchachitin|sacchachitin|mesh-list
153646799|NCT00117364|Antioxidants|antioxidants|mesh-ancestor
153646800|NCT00117364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153646801|NCT00117364|Protective Agents|protective agents|mesh-ancestor
153646802|NCT00117364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153646803|NCT00117403|Vitamins|vitamins|mesh-list
153646804|NCT00117403|Vitamin E|vitamin e|mesh-list
153842502|NCT02978391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153842503|NCT02978391|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
153842512|NCT02978391|Coagulants|coagulants|mesh-ancestor
153842513|NCT01290094|Ibandronic Acid|ibandronic acid|mesh-list
153842514|NCT01290094|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153842515|NCT01290094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153842516|NCT04688346|Epinephrine|epinephrine|mesh-list
153842517|NCT04688346|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153842518|NCT04688346|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153842519|NCT04688346|Adrenergic Agents|adrenergic agents|mesh-ancestor
153842520|NCT04688346|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153842521|NCT04688346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153842522|NCT04688346|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153842523|NCT04688346|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
153842524|NCT04688346|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153842525|NCT04688346|Autonomic Agents|autonomic agents|mesh-ancestor
153646919|NCT00118183|Mitosis Modulators|mitosis modulators|mesh-ancestor
153646920|NCT00118183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153646921|NCT00390975|Tegaserod|tegaserod|mesh-list
153646922|NCT00390975|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
153646923|NCT00390975|Serotonin Agents|serotonin agents|mesh-ancestor
153646924|NCT00390975|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153646925|NCT00390975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153646926|NCT00390975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153646927|NCT00118222|Dihematoporphyrin Ether|dihematoporphyrin ether|mesh-list
153646929|NCT00118222|Ether|ether|mesh-list
153842526|NCT04688346|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153842527|NCT04688346|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153842528|NCT04688346|Respiratory System Agents|respiratory system agents|mesh-ancestor
153382641|NCT03307005|GABA Agonists|gaba agonists|mesh-ancestor
153382642|NCT03307005|GABA Agents|gaba agents|mesh-ancestor
153382643|NCT03307005|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153382644|NCT03307005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153382645|NCT02005601|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
153382646|NCT02005601|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
153382647|NCT02005601|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153382648|NCT02005601|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153382649|NCT02005601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153382650|NCT02005601|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153382652|NCT02005601|Analgesics|analgesics|mesh-ancestor
153382664|NCT02007863|Immunologic Factors|immunologic factors|mesh-ancestor
153382665|NCT02007863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153382666|NCT02007863|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153382667|NCT02007863|Alkylating Agents|alkylating agents|mesh-ancestor
153382668|NCT02007863|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153382669|NCT03460899|Hypoglycemic Agents|hypoglycemic agents|mesh-list
153382670|NCT03460899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153382672|NCT02305277|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
153382673|NCT02305277|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153382674|NCT02305277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153842529|NCT04688346|Mydriatics|mydriatics|mesh-ancestor
153842530|NCT04688346|Sympathomimetics|sympathomimetics|mesh-ancestor
153842531|NCT04688346|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
153842532|NCT01289821|Leucovorin|leucovorin|mesh-list
153842533|NCT01289821|Folic Acid|folic acid|mesh-list
153842534|NCT01289821|Oxaliplatin|oxaliplatin|mesh-list
153842535|NCT01289821|Levoleucovorin|levoleucovorin|mesh-list
153842536|NCT01289821|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153842537|NCT01289821|Antidotes|antidotes|mesh-ancestor
153842538|NCT01289821|Protective Agents|protective agents|mesh-ancestor
153842539|NCT01289821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153842540|NCT01289821|Vitamin B Complex|vitamin b complex|mesh-ancestor
153842541|NCT01289821|Vitamins|vitamins|mesh-ancestor
153842542|NCT01289821|Micronutrients|micronutrients|mesh-ancestor
153842543|NCT01289821|Hematinics|hematinics|mesh-ancestor
153842544|NCT02913768|Ondansetron|ondansetron|mesh-list
153842545|NCT02913768|Antiemetics|antiemetics|mesh-ancestor
153842546|NCT02913768|Autonomic Agents|autonomic agents|mesh-ancestor
153842547|NCT02913768|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153842548|NCT02913768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153842549|NCT02913768|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153842565|NCT01289782|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153842566|NCT02913417|Nivolumab|nivolumab|mesh-list
153842567|NCT02913417|Ipilimumab|ipilimumab|mesh-list
153842568|NCT02913417|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153842569|NCT02913417|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153382676|NCT02305277|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
153382678|NCT03309657|Ceftolozane|ceftolozane|mesh-list
153382679|NCT03309657|Ceftolozane, tazobactam drug combination|ceftolozane, tazobactam drug combination|mesh-list
153382680|NCT03309657|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153382681|NCT03309657|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153382682|NCT03309657|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
153382683|NCT03309657|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153382684|NCT03309657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153647040|NCT00119119|Tocotrienols|tocotrienols|mesh-list
153382685|NCT03309657|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
153382686|NCT03463161|Pembrolizumab|pembrolizumab|mesh-list
153382687|NCT03463161|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153382688|NCT03463161|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153382689|NCT03463161|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153382690|NCT03463161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153382691|NCT03467685|Anesthetics|anesthetics|mesh-list
153382692|NCT03467685|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153382693|NCT03467685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153382694|NCT03468075|Ascorbic Acid|ascorbic acid|mesh-list
153382695|NCT03468075|Gemcitabine|gemcitabine|mesh-list
153382696|NCT03468075|Vitamins|vitamins|mesh-ancestor
153842581|NCT02913573|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153842582|NCT02913573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153842583|NCT02913573|Sensory System Agents|sensory system agents|mesh-ancestor
153842584|NCT02913573|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153842586|NCT01289353|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153842587|NCT02913300|Lidocaine|lidocaine|mesh-list
153842588|NCT02913300|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
153842589|NCT02913300|Anesthetics, Local|anesthetics, local|mesh-ancestor
153842590|NCT02913300|Anesthetics|anesthetics|mesh-ancestor
153842591|NCT02913300|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153842592|NCT02913300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153842593|NCT02913300|Sensory System Agents|sensory system agents|mesh-ancestor
153842594|NCT02913300|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153842595|NCT02913300|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153842596|NCT02913300|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
153842597|NCT02913300|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153842598|NCT02913300|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153842599|NCT02913300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153394083|NCT05635903|Anesthetics|anesthetics|mesh-ancestor
153842600|NCT02936375|Cyclophosphamide|cyclophosphamide|mesh-list
153842601|NCT02936375|Azathioprine|azathioprine|mesh-list
153842602|NCT02936375|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153842603|NCT02936375|Immunologic Factors|immunologic factors|mesh-ancestor
153842604|NCT02936375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153842605|NCT02936375|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153842606|NCT02936375|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153842607|NCT02936375|Alkylating Agents|alkylating agents|mesh-ancestor
153842608|NCT02936375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153382718|NCT02067416|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153382730|NCT03258645|Protease Inhibitors|protease inhibitors|mesh-ancestor
153382731|NCT03258645|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153382732|NCT03258645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153382733|NCT03258645|Anticoagulants|anticoagulants|mesh-ancestor
153382734|NCT03482583|Nicotine|nicotine|mesh-list
153382735|NCT03482583|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
153382736|NCT03482583|Autonomic Agents|autonomic agents|mesh-ancestor
153382737|NCT03482583|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153842609|NCT02936375|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153842610|NCT02936375|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153842611|NCT02936375|Antimetabolites|antimetabolites|mesh-ancestor
153842612|NCT02936375|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153842613|NCT02913690|Vitamin E|vitamin e|mesh-list
153842614|NCT02913690|Vitamins|vitamins|mesh-ancestor
153842615|NCT02913690|Micronutrients|micronutrients|mesh-ancestor
153842616|NCT02913690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153842617|NCT02913690|Antioxidants|antioxidants|mesh-ancestor
153842618|NCT02913690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153842619|NCT02913690|Protective Agents|protective agents|mesh-ancestor
153842620|NCT01289119|Metformin|metformin|mesh-list
153842621|NCT01289119|Pioglitazone|pioglitazone|mesh-list
153842622|NCT01289119|Alogliptin|alogliptin|mesh-list
153647070|NCT00119587|Hematinics|hematinics|mesh-ancestor
153647080|NCT00119704|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153647081|NCT00119704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153647082|NCT00119704|Cholinergic Agents|cholinergic agents|mesh-ancestor
153842623|NCT01289119|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153842656|NCT02935790|Ipilimumab|ipilimumab|mesh-list
153842657|NCT02935790|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153842658|NCT02935790|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153842659|NCT02935790|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153842660|NCT02935790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153842661|NCT02912637|Xenon|xenon|mesh-list
153842662|NCT02912637|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
153842664|NCT02912637|Anesthetics|anesthetics|mesh-ancestor
153382772|NCT02057939|Androgens|androgens|mesh-list
153382773|NCT02057939|Fertility Agents, Female|fertility agents, female|mesh-ancestor
153382774|NCT02057939|Fertility Agents|fertility agents|mesh-ancestor
153382775|NCT02057939|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153382776|NCT02057939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153382777|NCT02057939|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153382778|NCT02057939|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153382779|NCT02057939|Hormones|hormones|mesh-ancestor
153382780|NCT02057939|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153382781|NCT03496467|Nepafenac|nepafenac|mesh-list
153382782|NCT03496467|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153382783|NCT03496467|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153382784|NCT03496467|Analgesics|analgesics|mesh-ancestor
153382785|NCT03496467|Sensory System Agents|sensory system agents|mesh-ancestor
153382786|NCT03496467|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153382787|NCT03496467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153382788|NCT03496467|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153382789|NCT03496467|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153382790|NCT02058251|Oxytocin|oxytocin|mesh-list
153382791|NCT02058251|Oxytocics|oxytocics|mesh-ancestor
153382794|NCT03329937|Niraparib|niraparib|mesh-list
153842680|NCT02912910|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153842681|NCT02912910|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153842682|NCT02912910|Sympathomimetics|sympathomimetics|mesh-ancestor
153842683|NCT02912910|Autonomic Agents|autonomic agents|mesh-ancestor
153842684|NCT02912910|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153842685|NCT02912910|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
153842686|NCT02912910|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
153842687|NCT02935829|Locust bean gum|locust bean gum|mesh-list
153842688|NCT02935829|Antidiarrheals|antidiarrheals|mesh-ancestor
153842689|NCT02935829|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153842690|NCT02912754|Ibrutinib|ibrutinib|mesh-list
153842691|NCT02912754|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153842692|NCT02912754|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153842693|NCT02912754|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153842694|NCT02912754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153842695|NCT02912676|Methotrexate|methotrexate|mesh-list
153842696|NCT02912676|Mercaptopurine|mercaptopurine|mesh-list
153842697|NCT02912676|Thioguanine|thioguanine|mesh-list
153842698|NCT02912676|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
153842699|NCT02912676|Abortifacient Agents|abortifacient agents|mesh-ancestor
153394146|NCT01755169|Anesthetics|anesthetics|mesh-ancestor
153382854|NCT01982123|Technetium Tc 99m Aggregated Albumin|technetium tc 99m aggregated albumin|mesh-list
153382855|NCT01982123|Antidotes|antidotes|mesh-ancestor
153842716|NCT02935985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153842717|NCT02935985|Hemostatics|hemostatics|mesh-ancestor
153382856|NCT01982123|Protective Agents|protective agents|mesh-ancestor
153382857|NCT01982123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153382858|NCT01982123|Chelating Agents|chelating agents|mesh-ancestor
153842718|NCT02935985|Coagulants|coagulants|mesh-ancestor
153842719|NCT02912169|Anesthetics|anesthetics|mesh-list
153842720|NCT02912169|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153842721|NCT02912169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153842722|NCT02912520|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
153842723|NCT02912520|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153842724|NCT02935959|Midazolam|midazolam|mesh-list
153842725|NCT02935959|Dexmedetomidine|dexmedetomidine|mesh-list
153842726|NCT02935959|Ketamine|ketamine|mesh-list
153842727|NCT02935959|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153842728|NCT02935959|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153842729|NCT02935959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153842730|NCT02935959|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153842731|NCT02935959|Analgesics|analgesics|mesh-ancestor
153842732|NCT02935959|Sensory System Agents|sensory system agents|mesh-ancestor
153842733|NCT02935959|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153842734|NCT02935959|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
153842735|NCT02935959|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153842736|NCT02935959|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153842737|NCT02935959|Adrenergic Agents|adrenergic agents|mesh-ancestor
153842738|NCT02935959|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153842739|NCT02935959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153382874|NCT02396147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153382875|NCT01713608|Artefenomel|artefenomel|mesh-list
153382876|NCT01713608|Antimalarials|antimalarials|mesh-ancestor
153382877|NCT01713608|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153382878|NCT01713608|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153382879|NCT01713608|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153382881|NCT02018627|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
153461594|NCT02084706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153461595|NCT02084706|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153382882|NCT02018627|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153382883|NCT02018627|Hormones|hormones|mesh-ancestor
153382884|NCT02018627|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153382885|NCT02018627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153382886|NCT02018627|Incretins|incretins|mesh-ancestor
153382887|NCT04413344|Bromocriptine|bromocriptine|mesh-list
153382888|NCT04413344|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
153382889|NCT04413344|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
153382890|NCT04413344|Hormone Antagonists|hormone antagonists|mesh-ancestor
153382891|NCT04413344|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153732150|NCT00140894|Sensory System Agents|sensory system agents|mesh-ancestor
153732151|NCT00140894|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153382892|NCT04413344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153382893|NCT04413344|Dopamine Agonists|dopamine agonists|mesh-ancestor
153382894|NCT04413344|Dopamine Agents|dopamine agents|mesh-ancestor
153382895|NCT04413344|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153382896|NCT04413344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153842799|NCT02935010|Natriuretic Agents|natriuretic agents|mesh-ancestor
153842800|NCT02935010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153842801|NCT02935010|Expectorants|expectorants|mesh-ancestor
153842802|NCT02935010|Respiratory System Agents|respiratory system agents|mesh-ancestor
153842803|NCT02935530|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
153842805|NCT02935530|Dalteparin|dalteparin|mesh-list
153842806|NCT02935530|Argatroban|argatroban|mesh-list
153842807|NCT02935530|Anticoagulants|anticoagulants|mesh-ancestor
153842808|NCT02935530|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153842809|NCT02935530|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153842855|NCT02934035|Sensory System Agents|sensory system agents|mesh-ancestor
153842856|NCT02934035|Dopamine Agents|dopamine agents|mesh-ancestor
153842964|NCT02933099|Palonosetron|palonosetron|mesh-list
153383100|NCT01744574|Hormones|hormones|mesh-ancestor
153383101|NCT01744574|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153383102|NCT01744574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153383103|NCT01744730|Clindamycin|clindamycin|mesh-list
153383104|NCT01744730|Clindamycin palmitate|clindamycin palmitate|mesh-list
153383105|NCT01744730|Clindamycin phosphate|clindamycin phosphate|mesh-list
153383106|NCT01744730|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153383107|NCT01744730|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153842997|NCT02911350|Antimitotic Agents|antimitotic agents|mesh-ancestor
153842998|NCT02911350|Mitosis Modulators|mitosis modulators|mesh-ancestor
153842999|NCT02911350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153843000|NCT02911350|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153843001|NCT02911350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153843002|NCT02932397|Propofol|propofol|mesh-list
153843003|NCT02932397|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153843004|NCT02932397|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153843005|NCT02932397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153843007|NCT02932397|Anesthetics, General|anesthetics, general|mesh-ancestor
153843008|NCT02932397|Anesthetics|anesthetics|mesh-ancestor
153843009|NCT02911272|Oxytocin|oxytocin|mesh-list
153843010|NCT02911272|Oxytocics|oxytocics|mesh-ancestor
153843011|NCT02911272|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153843012|NCT02911272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153843013|NCT02932436|Empagliflozin|empagliflozin|mesh-list
153647086|NCT00119704|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153647087|NCT00120055|Atorvastatin|atorvastatin|mesh-list
153647089|NCT00120055|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153843014|NCT02932436|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
153843015|NCT02932436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153843016|NCT02932436|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153843017|NCT02932436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153461597|NCT02084706|Hormones|hormones|mesh-ancestor
153461598|NCT02084706|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153461599|NCT02084706|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153461600|NCT02084706|Immunologic Factors|immunologic factors|mesh-ancestor
153461601|NCT02084706|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153461602|NCT04433988|Pentoxifylline|pentoxifylline|mesh-list
153461603|NCT04433988|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
153843018|NCT02932007|Chloroquine|chloroquine|mesh-list
153843019|NCT02932007|Chloroquine diphosphate|chloroquine diphosphate|mesh-list
153843020|NCT02932007|Amebicides|amebicides|mesh-ancestor
153843024|NCT02932007|Antimalarials|antimalarials|mesh-ancestor
153843025|NCT02932007|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153383160|NCT01723514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153383162|NCT01723514|Sensory System Agents|sensory system agents|mesh-ancestor
153383163|NCT01723514|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153383164|NCT01723514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153383165|NCT02044367|Dabigatran|dabigatran|mesh-list
153383166|NCT02044367|Antithrombins|antithrombins|mesh-ancestor
153383167|NCT02044367|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
153383206|NCT01747850|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153843112|NCT01287520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153843114|NCT01287520|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153843115|NCT01287520|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
153843116|NCT01287520|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153843117|NCT01287520|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
153843118|NCT01287520|Histamine Antagonists|histamine antagonists|mesh-ancestor
153843119|NCT01287520|Histamine Agents|histamine agents|mesh-ancestor
153843120|NCT01287520|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153843163|NCT04137770|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153843164|NCT04137770|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153843165|NCT04137770|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153843166|NCT04137770|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153843169|NCT01286740|Antiviral Agents|antiviral agents|mesh-ancestor
153843206|NCT05590936|Ondansetron|ondansetron|mesh-list
153843207|NCT05590936|Dimenhydrinate|dimenhydrinate|mesh-list
153843208|NCT05590936|Antiemetics|antiemetics|mesh-ancestor
153843209|NCT05590936|Autonomic Agents|autonomic agents|mesh-ancestor
153843210|NCT05590936|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153843211|NCT05590936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153843212|NCT05590936|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153843213|NCT05590936|Antipruritics|antipruritics|mesh-ancestor
153843214|NCT05590936|Dermatologic Agents|dermatologic agents|mesh-ancestor
153843215|NCT05590936|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
153843293|NCT02665143|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153843294|NCT02665143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153843295|NCT00532272|Letrozole|letrozole|mesh-list
153383396|NCT01749956|Leucovorin|leucovorin|mesh-list
153383397|NCT01749956|Fluorouracil|fluorouracil|mesh-list
153383398|NCT01749956|Oxaliplatin|oxaliplatin|mesh-list
153383399|NCT01749956|Aflibercept|aflibercept|mesh-list
153383400|NCT01749956|Antimetabolites|antimetabolites|mesh-ancestor
153383401|NCT01749956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153383402|NCT01749956|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153383403|NCT01749956|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153843336|NCT02922491|Vitamin E|vitamin e|mesh-list
153383456|NCT03711188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153383457|NCT02366663|Cytarabine|cytarabine|mesh-list
153383458|NCT02366663|Rituximab|rituximab|mesh-list
153383459|NCT02366663|Etoposide|etoposide|mesh-list
153383460|NCT02366663|Melphalan|melphalan|mesh-list
153383461|NCT02366663|Carmustine|carmustine|mesh-list
153383462|NCT02366663|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153647145|NCT00120367|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153647148|NCT00120367|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153383463|NCT02366663|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153843348|NCT02921984|Pemetrexed|pemetrexed|mesh-list
153843349|NCT02921984|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153843350|NCT02921984|Tubulin Modulators|tubulin modulators|mesh-ancestor
153843351|NCT02921984|Antimitotic Agents|antimitotic agents|mesh-ancestor
153843352|NCT02921984|Mitosis Modulators|mitosis modulators|mesh-ancestor
153843353|NCT02921984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153843354|NCT02921984|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153843355|NCT02921984|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153394239|NCT01764607|Sirolimus|sirolimus|mesh-list
153843356|NCT02921984|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153843357|NCT01285609|Paclitaxel|paclitaxel|mesh-list
153843358|NCT01285609|Carboplatin|carboplatin|mesh-list
153843359|NCT01285609|Ipilimumab|ipilimumab|mesh-list
153843361|NCT01285609|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153843397|NCT02932722|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153843398|NCT02932722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153843399|NCT02932722|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153843400|NCT02932722|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153843401|NCT02932722|Anesthetics, General|anesthetics, general|mesh-ancestor
153843402|NCT02932722|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153843403|NCT02932722|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
153843405|NCT02932761|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153843406|NCT02932761|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153843407|NCT01283971|Adalimumab|adalimumab|mesh-list
153843408|NCT01283971|Methotrexate|methotrexate|mesh-list
153843409|NCT01283971|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
153843410|NCT01283971|Abortifacient Agents|abortifacient agents|mesh-ancestor
153843411|NCT01283971|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153383544|NCT02373137|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153383545|NCT02373137|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153383546|NCT02373137|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
153383547|NCT02373137|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153383548|NCT02373371|Methyl 5-aminolevulinate|methyl 5-aminolevulinate|mesh-list
153383549|NCT02373371|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
153383550|NCT02373371|Dermatologic Agents|dermatologic agents|mesh-ancestor
153383551|NCT00354653|Lamivudine|lamivudine|mesh-list
153383552|NCT00354653|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153383553|NCT00354653|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153383554|NCT00354653|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153383555|NCT00354653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153843422|NCT01283971|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153843423|NCT01283971|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153843425|NCT01283971|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153843426|NCT02921360|Aspirin|aspirin|mesh-list
153843427|NCT02921360|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153383574|NCT00354809|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153383575|NCT00354809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153843479|NCT02921165|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153843480|NCT02921165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153843513|NCT01283464|Tretinoin|tretinoin|mesh-list
153383617|NCT03211286|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
153383618|NCT03211286|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153383619|NCT03211286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153383621|NCT03211286|Coagulants|coagulants|mesh-ancestor
153383622|NCT01763606|Aspirin|aspirin|mesh-list
153383623|NCT01763606|Enoxaparin|enoxaparin|mesh-list
153383624|NCT01763606|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153383625|NCT01763606|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153383626|NCT01763606|Analgesics|analgesics|mesh-ancestor
153383627|NCT01763606|Sensory System Agents|sensory system agents|mesh-ancestor
153383628|NCT01763606|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153647156|NCT00120484|Vitamin B 12|vitamin b 12|mesh-list
153843527|NCT01282801|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
153843528|NCT01282801|Antidepressive Agents|antidepressive agents|mesh-ancestor
153843529|NCT01282801|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153843530|NCT00532350|Tiotropium Bromide|tiotropium bromide|mesh-list
153843531|NCT00532350|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153843532|NCT00532350|Autonomic Agents|autonomic agents|mesh-ancestor
153843533|NCT00532350|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153843534|NCT00532350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153843535|NCT00532350|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153843536|NCT00532350|Respiratory System Agents|respiratory system agents|mesh-ancestor
153383686|NCT01768520|Sensory System Agents|sensory system agents|mesh-ancestor
153383687|NCT01768520|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153383688|NCT01768520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153383689|NCT01768520|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153383690|NCT01768520|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153383691|NCT01768520|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
153383692|NCT01768520|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153843588|NCT05466708|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153843589|NCT02920502|Cholecalciferol|cholecalciferol|mesh-list
153843590|NCT02920502|Vitamin D|vitamin d|mesh-list
153843591|NCT02920502|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153843592|NCT02920502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153843593|NCT02920502|Vitamins|vitamins|mesh-ancestor
153843594|NCT02920502|Micronutrients|micronutrients|mesh-ancestor
153843598|NCT01282216|Immunologic Factors|immunologic factors|mesh-ancestor
153843599|NCT01282216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153843600|NCT01281865|Everolimus|everolimus|mesh-list
153843601|NCT01281865|Imatinib Mesylate|imatinib mesylate|mesh-list
153843602|NCT01281865|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
153383732|NCT02239874|Cholecalciferol|cholecalciferol|mesh-list
153383733|NCT02239874|Vitamins|vitamins|mesh-list
153383734|NCT02239874|Micronutrients|micronutrients|mesh-ancestor
153383735|NCT02239874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153383736|NCT02239874|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153383737|NCT02239874|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153383738|NCT01771952|Hyaluronic Acid|hyaluronic acid|mesh-list
153383739|NCT01771952|Hylan|hylan|mesh-list
153383740|NCT01771952|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153843603|NCT01281865|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153843604|NCT01281865|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153843646|NCT01280968|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
153843647|NCT01280968|Autonomic Agents|autonomic agents|mesh-ancestor
153843648|NCT01280968|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153843649|NCT01280968|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
153843650|NCT01280968|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
153843651|NCT01280968|Cholinergic Agents|cholinergic agents|mesh-ancestor
153843652|NCT01280968|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153843653|NCT01280968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153843654|NCT01280968|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153843655|NCT01280968|Antacids|antacids|mesh-ancestor
153843656|NCT01280968|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153843657|NCT02920385|Semaglutide|semaglutide|mesh-list
153843658|NCT02920385|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
153843659|NCT02920385|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153843660|NCT02920385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153843661|NCT02932020|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
153843662|NCT02932020|Methylprednisolone|methylprednisolone|mesh-list
153843663|NCT02932020|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
153843664|NCT02932020|Prednisolone|prednisolone|mesh-list
153843665|NCT02932020|Prednisolone acetate|prednisolone acetate|mesh-list
153843666|NCT02932020|Bupivacaine|bupivacaine|mesh-list
153843667|NCT02932020|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
153843668|NCT02932020|Prednisolone phosphate|prednisolone phosphate|mesh-list
153843774|NCT02919605|Antifungal Agents|antifungal agents|mesh-ancestor
153843775|NCT02919605|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153843776|NCT02919605|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153843777|NCT02919605|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153843778|NCT02919605|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
153843779|NCT00532428|Raloxifene Hydrochloride|raloxifene hydrochloride|mesh-list
153843780|NCT00532428|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
153843781|NCT00532428|Hormone Antagonists|hormone antagonists|mesh-ancestor
153843782|NCT00532428|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153843783|NCT00532428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153843784|NCT00532428|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
153843785|NCT00532428|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
153843786|NCT00532428|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153383921|NCT01787006|Antimetabolites|antimetabolites|mesh-ancestor
153383922|NCT01787006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153383923|NCT01787006|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153383924|NCT01787006|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153383925|NCT01787006|Immunologic Factors|immunologic factors|mesh-ancestor
153843827|NCT02919371|Growth Inhibitors|growth inhibitors|mesh-ancestor
153843828|NCT02919371|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153843829|NCT02919371|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153843830|NCT02919371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153843831|NCT04736901|Enoxaparin|enoxaparin|mesh-list
153843832|NCT04736901|Rivaroxaban|rivaroxaban|mesh-list
153843833|NCT04736901|Apixaban|apixaban|mesh-list
153843928|NCT02918747|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153384062|NCT01877642|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153384063|NCT01877642|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153384064|NCT01877642|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153384094|NCT03500289|Analgesics|analgesics|mesh-ancestor
153384095|NCT03500289|Sensory System Agents|sensory system agents|mesh-ancestor
153384096|NCT03500289|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153384097|NCT03500289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153384098|NCT03500289|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
153384099|NCT03500289|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153843997|NCT00532623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153843998|NCT00532623|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153843999|NCT00532623|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153844000|NCT00532623|Tubulin Modulators|tubulin modulators|mesh-ancestor
153844001|NCT00532623|Antimitotic Agents|antimitotic agents|mesh-ancestor
153844002|NCT00532623|Mitosis Modulators|mitosis modulators|mesh-ancestor
153844004|NCT00532662|Analgesics|analgesics|mesh-ancestor
153844005|NCT00532662|Sensory System Agents|sensory system agents|mesh-ancestor
153844006|NCT00532662|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153844007|NCT00532662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153844008|NCT00532662|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
153844009|NCT00532662|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153844010|NCT00532662|Anesthetics, General|anesthetics, general|mesh-ancestor
153844011|NCT00532662|Anesthetics|anesthetics|mesh-ancestor
153844012|NCT00532662|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153844014|NCT00532662|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
153384157|NCT01798316|Sensory System Agents|sensory system agents|mesh-ancestor
153384158|NCT01798316|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153732158|NCT00155064|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
153394329|NCT01771627|Varenicline|varenicline|mesh-list
153384159|NCT01798316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153384160|NCT01798316|Antipyretics|antipyretics|mesh-ancestor
153384161|NCT03883763|Bupivacaine|bupivacaine|mesh-list
153384162|NCT03883763|Anesthetics, Local|anesthetics, local|mesh-ancestor
153384163|NCT03883763|Anesthetics|anesthetics|mesh-ancestor
153384170|NCT01798394|Hormones|hormones|mesh-ancestor
153844034|NCT00533676|Nasal Decongestants|nasal decongestants|mesh-ancestor
153844035|NCT00533676|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
153844036|NCT00533676|Respiratory System Agents|respiratory system agents|mesh-ancestor
153844037|NCT05467319|Iron isomaltoside 1000|iron isomaltoside 1000|mesh-list
153844038|NCT05467319|Hematinics|hematinics|mesh-ancestor
153844039|NCT04484610|Analgesics, Opioid|analgesics, opioid|mesh-list
153844040|NCT04484610|Narcotics|narcotics|mesh-ancestor
153844041|NCT04484610|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153844042|NCT04484610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153844043|NCT04484610|Analgesics|analgesics|mesh-ancestor
153844044|NCT04484610|Sensory System Agents|sensory system agents|mesh-ancestor
153844045|NCT04484610|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153844046|NCT05466149|Aflutinib|aflutinib|mesh-list
153384183|NCT00357305|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153384184|NCT00357305|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153384185|NCT00357305|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153844082|NCT00532454|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153844083|NCT00532454|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153844090|NCT01275625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153844092|NCT01275625|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153844093|NCT01275625|Antiviral Agents|antiviral agents|mesh-ancestor
153844094|NCT01275625|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153844126|NCT00533637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153844127|NCT05466695|Sildenafil Citrate|sildenafil citrate|mesh-list
153844128|NCT05466695|Tadalafil|tadalafil|mesh-list
153844129|NCT05466695|Vasodilator Agents|vasodilator agents|mesh-ancestor
153844130|NCT05466695|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
153844131|NCT05466695|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
153844132|NCT05466695|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153844133|NCT05466695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153844134|NCT05466695|Urological Agents|urological agents|mesh-ancestor
153844181|NCT00534183|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153844182|NCT00534183|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
153844183|NCT00534183|Dopamine Agents|dopamine agents|mesh-ancestor
153844184|NCT00534183|Antiemetics|antiemetics|mesh-ancestor
153844185|NCT00534183|Autonomic Agents|autonomic agents|mesh-ancestor
153844186|NCT00534183|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153844187|NCT00534183|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153844188|NCT00534183|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
153844189|NCT00534183|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153844190|NCT00534183|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153844191|NCT00534183|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
153844192|NCT00532727|Carboplatin|carboplatin|mesh-list
153844193|NCT00532727|Docetaxel|docetaxel|mesh-list
153844194|NCT00532727|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153844195|NCT00532727|Tubulin Modulators|tubulin modulators|mesh-ancestor
153384323|NCT00376311|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153384324|NCT00376311|Vasodilator Agents|vasodilator agents|mesh-ancestor
153384325|NCT03511521|Insulin|insulin|mesh-list
153384326|NCT03511521|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
153384327|NCT03511521|Insulin Aspart|insulin aspart|mesh-list
153384328|NCT03511521|Insulin, Isophane|insulin, isophane|mesh-list
153384329|NCT03511521|Isophane Insulin, Human|isophane insulin, human|mesh-list
153384330|NCT03511521|Isophane insulin, beef|isophane insulin, beef|mesh-list
153384331|NCT03511521|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153384332|NCT03511521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153384333|NCT00376077|Methylprednisolone|methylprednisolone|mesh-list
153384334|NCT00376077|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
153384335|NCT00376077|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
153384336|NCT00376077|gamma-Globulins|gamma-globulins|mesh-list
153732159|NCT00155064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153394366|NCT01777945|Docetaxel|docetaxel|mesh-list
153384337|NCT00376077|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
153384338|NCT00376077|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153384339|NCT00376077|Antiemetics|antiemetics|mesh-ancestor
153384340|NCT00376077|Autonomic Agents|autonomic agents|mesh-ancestor
153844240|NCT05209035|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153844241|NCT05209035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153844242|NCT05209035|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153844243|NCT05209035|Serotonin Agents|serotonin agents|mesh-ancestor
153844244|NCT05209035|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
153844245|NCT05209035|Antidepressive Agents|antidepressive agents|mesh-ancestor
153844246|NCT00534261|Interferons|interferons|mesh-list
153844247|NCT00534261|Interferon-beta|interferon-beta|mesh-list
153844248|NCT00534261|Interferon beta-1a|interferon beta-1a|mesh-list
153844249|NCT00534261|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153844279|NCT05152004|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
153844280|NCT05152004|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153384389|NCT03530631|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
153384390|NCT03530631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153384391|NCT03350217|Hydroxyethyl Starch Derivatives|hydroxyethyl starch derivatives|mesh-list
153384392|NCT03350217|Plasma Substitutes|plasma substitutes|mesh-ancestor
153384393|NCT03350217|Blood Substitutes|blood substitutes|mesh-ancestor
153384394|NCT03351933|Immunoglobulins|immunoglobulins|mesh-list
153384395|NCT03351933|Antibodies|antibodies|mesh-list
153844294|NCT00534378|Midazolam|midazolam|mesh-list
153844295|NCT00534378|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153844296|NCT00534378|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153844297|NCT00534378|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153844298|NCT00534378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153844299|NCT00534378|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153844300|NCT00534378|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153844301|NCT00534378|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153844302|NCT00534378|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153844374|NCT00534651|Analgesics|analgesics|mesh-ancestor
153844375|NCT00534651|Sensory System Agents|sensory system agents|mesh-ancestor
153844376|NCT00534651|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153844377|NCT00534651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153844378|NCT00534651|Antipyretics|antipyretics|mesh-ancestor
153844379|NCT05080959|Ropivacaine|ropivacaine|mesh-list
153844380|NCT05080959|Anesthetics, Local|anesthetics, local|mesh-ancestor
153384482|NCT03541941|Anesthetics, Local|anesthetics, local|mesh-ancestor
153384483|NCT03541941|Anesthetics|anesthetics|mesh-ancestor
153384484|NCT03541941|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153844525|NCT00535808|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153844526|NCT00535808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153844527|NCT00535808|Vasodilator Agents|vasodilator agents|mesh-ancestor
153844528|NCT00535808|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153384623|NCT05327660|Gasotransmitters|gasotransmitters|mesh-ancestor
153384624|NCT05327660|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153384625|NCT05327660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153384626|NCT01822886|Gemcitabine|gemcitabine|mesh-list
153384627|NCT01822886|Romidepsin|romidepsin|mesh-list
153384628|NCT01822886|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153384629|NCT01822886|Antimetabolites|antimetabolites|mesh-ancestor
153384630|NCT01822886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153844568|NCT04910100|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153844569|NCT04910100|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153844570|NCT04910100|Vasodilator Agents|vasodilator agents|mesh-ancestor
153844571|NCT04910100|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
153844572|NCT04910100|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
153384668|NCT05327582|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153384669|NCT05327582|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153384670|NCT02271698|Dexamethasone|dexamethasone|mesh-list
153844605|NCT01606384|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
153844606|NCT01606384|Natriuretic Agents|natriuretic agents|mesh-ancestor
153844607|NCT01606384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153844608|NCT01606462|Oxytocin|oxytocin|mesh-list
153844609|NCT01606462|Oxytocics|oxytocics|mesh-ancestor
153844610|NCT01606462|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153844611|NCT01606462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153844612|NCT01606540|Ibuprofen|ibuprofen|mesh-list
153844613|NCT01606540|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153384709|NCT01830842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153384711|NCT01831232|Idarubicin|idarubicin|mesh-list
153384712|NCT01831232|Pravastatin|pravastatin|mesh-list
153384713|NCT01831232|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153384714|NCT01831232|Antimetabolites|antimetabolites|mesh-ancestor
153384721|NCT01831232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153384722|NCT01831232|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153844756|NCT05469386|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
153844757|NCT05469386|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153844758|NCT05469386|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153844858|NCT00595972|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153844859|NCT00595972|Growth Substances|growth substances|mesh-ancestor
153844860|NCT00595972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153844861|NCT00595972|Growth Inhibitors|growth inhibitors|mesh-ancestor
153844862|NCT00595972|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153844863|NCT00596050|Lidocaine|lidocaine|mesh-list
153844864|NCT00596050|Midazolam|midazolam|mesh-list
153844865|NCT00596050|Fentanyl|fentanyl|mesh-list
153844866|NCT00596050|Ketamine|ketamine|mesh-list
153844867|NCT00596050|Etomidate|etomidate|mesh-list
153844868|NCT00596050|Anesthetics, Local|anesthetics, local|mesh-ancestor
153844869|NCT00596050|Anesthetics|anesthetics|mesh-ancestor
153844870|NCT00596050|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153385004|NCT00558896|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153385005|NCT00558896|Growth Substances|growth substances|mesh-ancestor
153385006|NCT00558896|Growth Inhibitors|growth inhibitors|mesh-ancestor
153385007|NCT01857362|Nitisinone|nitisinone|mesh-list
153844906|NCT00596206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153844908|NCT00596206|Immunologic Factors|immunologic factors|mesh-ancestor
153844909|NCT00596206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153844910|NCT00624130|Drospirenone and ethinyl estradiol combination|drospirenone and ethinyl estradiol combination|mesh-list
153844911|NCT00624130|Dacuronium|dacuronium|mesh-list
153844973|NCT05312866|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153844974|NCT05312866|Sensory System Agents|sensory system agents|mesh-ancestor
153844975|NCT05312866|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153844976|NCT05312866|Narcotics|narcotics|mesh-ancestor
153844977|NCT05312866|Analgesics|analgesics|mesh-ancestor
153844978|NCT05312866|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153844979|NCT05312866|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153844980|NCT05312866|Anesthetics, General|anesthetics, general|mesh-ancestor
153844981|NCT05312866|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153844982|NCT05312866|Antipyretics|antipyretics|mesh-ancestor
153844983|NCT05312866|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153844984|NCT05312866|Anticonvulsants|anticonvulsants|mesh-ancestor
153844985|NCT05312866|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153845012|NCT00597064|Prednisone|prednisone|mesh-list
153845013|NCT00597064|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153385114|NCT04203225|Anesthetics, Local|anesthetics, local|mesh-ancestor
153385115|NCT04203225|Anesthetics|anesthetics|mesh-ancestor
153385116|NCT04203225|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153385117|NCT04203225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153385118|NCT04203225|Sensory System Agents|sensory system agents|mesh-ancestor
153385120|NCT04203225|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153845038|NCT05470764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153845039|NCT05470764|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153845040|NCT05470764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153845045|NCT05470764|Diuretics|diuretics|mesh-ancestor
153845046|NCT05470764|Natriuretic Agents|natriuretic agents|mesh-ancestor
153385180|NCT03701061|Immunologic Factors|immunologic factors|mesh-ancestor
153385181|NCT03701061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153385182|NCT03705273|Dexamethasone|dexamethasone|mesh-list
153385183|NCT03705273|Dexamethasone acetate|dexamethasone acetate|mesh-list
153385184|NCT03705273|BB 1101|bb 1101|mesh-list
153845084|NCT05467826|Antimetabolites|antimetabolites|mesh-ancestor
153845085|NCT05467826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153845086|NCT05467826|Antiviral Agents|antiviral agents|mesh-ancestor
153385185|NCT03705273|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153385186|NCT03705273|Antiemetics|antiemetics|mesh-ancestor
153385187|NCT03705273|Autonomic Agents|autonomic agents|mesh-ancestor
153385188|NCT03705273|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153385217|NCT04173429|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153385218|NCT04173429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153845087|NCT05467826|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153845089|NCT00598156|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
153845090|NCT00598156|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153845091|NCT00598156|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153845092|NCT00598156|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153845093|NCT00598156|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153845094|NCT00598156|Growth Substances|growth substances|mesh-ancestor
153845095|NCT00598156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153385229|NCT04167189|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
153385230|NCT04167189|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153385231|NCT04167189|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153385232|NCT04167189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153385233|NCT03929367|Oxytocin|oxytocin|mesh-list
153845139|NCT02891785|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153845140|NCT02891785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153845141|NCT00598858|Prednisone|prednisone|mesh-list
153845142|NCT00598858|Cortisone|cortisone|mesh-list
153845143|NCT00598858|Docetaxel|docetaxel|mesh-list
153845144|NCT00598858|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153845145|NCT00598858|Tubulin Modulators|tubulin modulators|mesh-ancestor
153845146|NCT00598858|Antimitotic Agents|antimitotic agents|mesh-ancestor
153845147|NCT00598858|Mitosis Modulators|mitosis modulators|mesh-ancestor
153845148|NCT00598858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153385273|NCT00556322|Docetaxel|docetaxel|mesh-list
153385274|NCT00556322|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153385275|NCT00556322|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153385276|NCT00556322|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153385277|NCT00556322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153385278|NCT00556322|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153385279|NCT00556322|Tubulin Modulators|tubulin modulators|mesh-ancestor
153385280|NCT00556322|Antimitotic Agents|antimitotic agents|mesh-ancestor
153385281|NCT00556322|Mitosis Modulators|mitosis modulators|mesh-ancestor
153845263|NCT05312346|Micronutrients|micronutrients|mesh-ancestor
153845264|NCT05312346|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153845265|NCT05568563|Ethyl Chloride|ethyl chloride|mesh-list
153845266|NCT05568563|Anesthetics, Local|anesthetics, local|mesh-ancestor
153845267|NCT05568563|Anesthetics|anesthetics|mesh-ancestor
153845268|NCT05568563|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153845269|NCT05568563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153845270|NCT05568563|Sensory System Agents|sensory system agents|mesh-ancestor
153845271|NCT05568563|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153845272|NCT00536861|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
153845273|NCT00536861|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153845274|NCT00536861|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153845275|NCT00536861|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153845276|NCT00536861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153845277|NCT00536861|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153845278|NCT05469984|Gentamicins|gentamicins|mesh-list
153845279|NCT05469984|Ampicillin|ampicillin|mesh-list
153845280|NCT05469984|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153845281|NCT05469984|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153845282|NCT05469984|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
153845283|NCT05469984|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153845284|NCT05469984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153845285|NCT05312190|Progesterone|progesterone|mesh-list
153845286|NCT05312190|Progestins|progestins|mesh-ancestor
153845287|NCT05312190|Hormones|hormones|mesh-ancestor
153845288|NCT05312190|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153845360|NCT01313884|Temozolomide|temozolomide|mesh-list
153845361|NCT01313884|Doxorubicin|doxorubicin|mesh-list
153845362|NCT01313884|Irinotecan|irinotecan|mesh-list
153845363|NCT01313884|Vincristine|vincristine|mesh-list
153385504|NCT00552344|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153385505|NCT00552344|Immunologic Factors|immunologic factors|mesh-ancestor
153385506|NCT00552344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153385507|NCT00552344|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153385573|NCT00553202|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153385574|NCT00553202|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153385575|NCT00553202|Alkylating Agents|alkylating agents|mesh-ancestor
153385576|NCT00553202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153385577|NCT00553202|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153385578|NCT00553202|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153385579|NCT00553202|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
153385580|NCT00553202|Abortifacient Agents|abortifacient agents|mesh-ancestor
153385581|NCT00553202|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153385651|NCT03250520|Sunscreening Agents|sunscreening agents|mesh-ancestor
153385652|NCT03250520|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
153385653|NCT03250520|Protective Agents|protective agents|mesh-ancestor
153385654|NCT03250520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153385655|NCT03250520|Dermatologic Agents|dermatologic agents|mesh-ancestor
153385656|NCT03250520|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
153385658|NCT03847389|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153385659|NCT03847389|Glucocorticoids|glucocorticoids|mesh-ancestor
153845541|NCT00552656|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153845542|NCT00552656|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153845543|NCT00552656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153845545|NCT01824537|Immunologic Factors|immunologic factors|mesh-ancestor
153845546|NCT01824537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153845547|NCT04863339|Tranexamic Acid|tranexamic acid|mesh-list
153385661|NCT03847389|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153385662|NCT03847389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153385663|NCT02351934|Celecoxib|celecoxib|mesh-list
153647266|NCT00121381|Tacrolimus|tacrolimus|mesh-list
153647267|NCT00121381|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153647268|NCT00121381|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153647269|NCT00121381|Analgesics|analgesics|mesh-ancestor
153647270|NCT00121381|Sensory System Agents|sensory system agents|mesh-ancestor
153647271|NCT00121381|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153385664|NCT02351934|Furosemide|furosemide|mesh-list
153385665|NCT02351934|Gabapentin|gabapentin|mesh-list
153385666|NCT02351934|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153385667|NCT02351934|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153385668|NCT02351934|Analgesics|analgesics|mesh-ancestor
153385669|NCT02351934|Sensory System Agents|sensory system agents|mesh-ancestor
153385670|NCT02351934|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153385671|NCT02351934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153385672|NCT02351934|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153385673|NCT02351934|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153385674|NCT02351934|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
153385718|NCT04763408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153385720|NCT03825939|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
153385733|NCT00551642|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153385734|NCT00551642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153385735|NCT00551642|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153385736|NCT00551642|Respiratory System Agents|respiratory system agents|mesh-ancestor
153845627|NCT04687878|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
153845628|NCT04687878|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153845629|NCT04687878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153845630|NCT01256671|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
153385765|NCT04004481|Analgesics|analgesics|mesh-ancestor
153385766|NCT04004481|Sensory System Agents|sensory system agents|mesh-ancestor
153385767|NCT04004481|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153385768|NCT03997851|Acetaminophen|acetaminophen|mesh-list
153385769|NCT03997851|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153385770|NCT03997851|Analgesics|analgesics|mesh-ancestor
153385771|NCT03997851|Sensory System Agents|sensory system agents|mesh-ancestor
153385772|NCT03997851|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153385773|NCT03997851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153385774|NCT03997851|Antipyretics|antipyretics|mesh-ancestor
153385776|NCT03989427|Sodium Fluoride|sodium fluoride|mesh-list
153385777|NCT03989427|Cariostatic Agents|cariostatic agents|mesh-ancestor
153385778|NCT03989427|Protective Agents|protective agents|mesh-ancestor
153385779|NCT03989427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153845729|NCT01254604|Timolol|timolol|mesh-list
153845763|NCT05414058|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153845764|NCT05414058|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153385878|NCT01507233|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153385879|NCT01507233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153385880|NCT01507233|Sensory System Agents|sensory system agents|mesh-ancestor
153385881|NCT01507233|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153385882|NCT01507233|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153385883|NCT01507233|Narcotics|narcotics|mesh-ancestor
153385884|NCT01507233|Analgesics|analgesics|mesh-ancestor
153385886|NCT02301390|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153385887|NCT02301390|Vasodilator Agents|vasodilator agents|mesh-ancestor
153385888|NCT02301390|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
153385889|NCT02301390|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153845819|NCT04319770|Viscosupplements|viscosupplements|mesh-ancestor
153845820|NCT04319770|Protective Agents|protective agents|mesh-ancestor
153845821|NCT01253200|Acifluorfen|acifluorfen|mesh-list
153845822|NCT01253200|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153845823|NCT01253200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153845824|NCT04515901|Lidocaine|lidocaine|mesh-list
153845825|NCT04515901|Anesthetics, Local|anesthetics, local|mesh-ancestor
153845826|NCT04515901|Anesthetics|anesthetics|mesh-ancestor
153845827|NCT04515901|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153845828|NCT04515901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153845829|NCT04515901|Sensory System Agents|sensory system agents|mesh-ancestor
153845830|NCT04515901|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153845831|NCT04515901|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153385979|NCT01394211|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153455669|NCT05330884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153647273|NCT00121381|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153385980|NCT01394211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153386033|NCT01882868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153386034|NCT01882868|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153386035|NCT01882868|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153386036|NCT01882868|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153386037|NCT01882868|Growth Substances|growth substances|mesh-ancestor
153386038|NCT01882868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153386039|NCT01882868|Growth Inhibitors|growth inhibitors|mesh-ancestor
153386041|NCT01882868|Protective Agents|protective agents|mesh-ancestor
153386042|NCT01882868|Vitamin B Complex|vitamin b complex|mesh-ancestor
153845923|NCT01199978|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
153845924|NCT01199978|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
153845925|NCT01199978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153845927|NCT00532116|Antidepressive Agents|antidepressive agents|mesh-ancestor
153845928|NCT00532116|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153845929|NCT00532116|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
153845930|NCT00532116|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
153732161|NCT00155064|Protease Inhibitors|protease inhibitors|mesh-ancestor
153845931|NCT00532116|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
153845932|NCT00532116|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153845933|NCT00532116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153845934|NCT00532116|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
153845935|NCT00532116|Protective Agents|protective agents|mesh-ancestor
153845936|NCT00532116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153845938|NCT04283513|Antimetabolites|antimetabolites|mesh-ancestor
153845958|NCT03910998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153845959|NCT04685148|Estradiol|estradiol|mesh-list
153845960|NCT04685148|Estrogens|estrogens|mesh-ancestor
153845961|NCT04685148|Hormones|hormones|mesh-ancestor
153386099|NCT01309581|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
153386100|NCT01309581|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
153386101|NCT01309581|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153386102|NCT01309581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153386104|NCT05289050|Esketamine|esketamine|mesh-list
153386105|NCT05289050|Analgesics|analgesics|mesh-ancestor
153386106|NCT05289050|Sensory System Agents|sensory system agents|mesh-ancestor
153386107|NCT05289050|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153386111|NCT05289050|Anesthetics, General|anesthetics, general|mesh-ancestor
153846073|NCT00537888|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
153386225|NCT02299206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153386227|NCT02640573|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153386228|NCT02640573|Antisickling Agents|antisickling agents|mesh-ancestor
153386229|NCT02640573|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153386230|NCT02640573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153386231|NCT02640573|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153386232|NCT02298192|Liraglutide|liraglutide|mesh-list
153386233|NCT02298192|Xultophy|xultophy|mesh-list
153386234|NCT02298192|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153386235|NCT02298192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153386236|NCT02298192|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
153846106|NCT01246960|Fluorouracil|fluorouracil|mesh-list
153846107|NCT01246960|Oxaliplatin|oxaliplatin|mesh-list
153846108|NCT01246960|Ramucirumab|ramucirumab|mesh-list
153846109|NCT01246960|Antimetabolites|antimetabolites|mesh-ancestor
153846110|NCT01246960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153846111|NCT01246960|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153846112|NCT01246960|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153846113|NCT01246960|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153846116|NCT01246960|Antidotes|antidotes|mesh-ancestor
153846193|NCT03736616|Rituximab|rituximab|mesh-list
153846194|NCT03736616|Carboplatin|carboplatin|mesh-list
153846195|NCT03736616|Etoposide|etoposide|mesh-list
153846196|NCT03736616|Melphalan|melphalan|mesh-list
153846197|NCT03736616|Ifosfamide|ifosfamide|mesh-list
153846198|NCT03736616|Carmustine|carmustine|mesh-list
153846199|NCT03736616|Acalabrutinib|acalabrutinib|mesh-list
153455670|NCT05289349|Propofol|propofol|mesh-list
153647390|NCT02013492|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153846200|NCT03736616|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153846201|NCT03736616|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153846202|NCT03736616|Immunologic Factors|immunologic factors|mesh-ancestor
153846215|NCT03736616|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153846217|NCT03736616|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153846218|NCT03736616|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153846219|NCT03736616|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153846220|NCT03718403|Theophylline|theophylline|mesh-list
153846221|NCT03718403|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153846222|NCT03718403|Autonomic Agents|autonomic agents|mesh-ancestor
153846223|NCT03718403|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153846224|NCT03718403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153846225|NCT03718403|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153846226|NCT03718403|Respiratory System Agents|respiratory system agents|mesh-ancestor
153386344|NCT01118013|Dermatologic Agents|dermatologic agents|mesh-ancestor
153386345|NCT01118013|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153386346|NCT01118013|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153386347|NCT01118013|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153386348|NCT01118013|Immunologic Factors|immunologic factors|mesh-ancestor
153386349|NCT01118013|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153386350|NCT01118013|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153386351|NCT01118013|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
153386352|NCT01118013|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153386354|NCT01118013|Antitubercular Agents|antitubercular agents|mesh-ancestor
153846237|NCT00537966|Tenofovir|tenofovir|mesh-list
153846238|NCT00537966|Lamivudine|lamivudine|mesh-list
153846239|NCT00537966|Emtricitabine|emtricitabine|mesh-list
153846240|NCT00537966|Raltegravir Potassium|raltegravir potassium|mesh-list
153846241|NCT00537966|Dolutegravir|dolutegravir|mesh-list
153846242|NCT00537966|Abacavir|abacavir|mesh-list
153846243|NCT00537966|Cobicistat|cobicistat|mesh-list
153846244|NCT00537966|Rilpivirine|rilpivirine|mesh-list
153846245|NCT00537966|Elvitegravir|elvitegravir|mesh-list
153846246|NCT00537966|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
153846247|NCT00537966|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
153846248|NCT00537966|Protease Inhibitors|protease inhibitors|mesh-ancestor
153846249|NCT00537966|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153846274|NCT00538005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153846276|NCT00538005|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153846277|NCT00538005|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153846278|NCT00538005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153846279|NCT03610412|Magnesium Oxide|magnesium oxide|mesh-list
153846280|NCT03610412|Antacids|antacids|mesh-ancestor
153846281|NCT03610412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153846282|NCT03610412|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153846283|NCT00538044|Simvastatin|simvastatin|mesh-list
153846284|NCT00538044|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153846285|NCT00538044|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153846286|NCT00538044|Antimetabolites|antimetabolites|mesh-ancestor
153386403|NCT02277548|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153386404|NCT02277548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153732164|NCT02483260|Antimetabolites|antimetabolites|mesh-ancestor
153386405|NCT02277548|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153386406|NCT02277548|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153386407|NCT02277548|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153386409|NCT02277548|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153846300|NCT00545493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153846302|NCT01266460|Immunologic Factors|immunologic factors|mesh-ancestor
153846303|NCT01266460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153846304|NCT05119257|Antibodies|antibodies|mesh-list
153846305|NCT05119257|Antibodies, Bispecific|antibodies, bispecific|mesh-list
153846306|NCT05119257|Immunologic Factors|immunologic factors|mesh-ancestor
153846307|NCT05119257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153386452|NCT02379585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153386453|NCT02379585|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153386455|NCT02379585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153386456|NCT02379585|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153386457|NCT02379585|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153386458|NCT02379585|Alkylating Agents|alkylating agents|mesh-ancestor
153386459|NCT02379585|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153386460|NCT02379585|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153386461|NCT02379585|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153386462|NCT02379585|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153386463|NCT02379585|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153361031|NCT02155010|Anesthetics|anesthetics|mesh-ancestor
153455671|NCT05289349|Sevoflurane|sevoflurane|mesh-list
153647458|NCT00122629|Antimetabolites|antimetabolites|mesh-ancestor
153647459|NCT00122629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153647460|NCT00122629|Immunologic Factors|immunologic factors|mesh-ancestor
153647461|NCT00122629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153647462|NCT00122629|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
153647463|NCT00122629|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
153647464|NCT00122629|Dopamine Agents|dopamine agents|mesh-ancestor
153647465|NCT00122629|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153647520|NCT00129142|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153647521|NCT00129142|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153647522|NCT00129142|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
153647523|NCT00129142|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
153647524|NCT00129142|Hormone Antagonists|hormone antagonists|mesh-ancestor
153647525|NCT00129142|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153647526|NCT00129142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153647527|NCT00129142|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153846412|NCT01265056|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
153846414|NCT01265056|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153846415|NCT01265056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153846416|NCT01265056|Antimanic Agents|antimanic agents|mesh-ancestor
153846418|NCT02942498|Vitamin E|vitamin e|mesh-list
153846419|NCT02942498|Micronutrients|micronutrients|mesh-ancestor
153846420|NCT02942498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153846421|NCT02942498|Antioxidants|antioxidants|mesh-ancestor
153846422|NCT02942498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153846423|NCT02942498|Protective Agents|protective agents|mesh-ancestor
153846424|NCT00545961|Amoxicillin|amoxicillin|mesh-list
153846425|NCT00545961|Clavulanic Acid|clavulanic acid|mesh-list
153846426|NCT00545961|Clavulanic Acids|clavulanic acids|mesh-list
153846460|NCT02889367|Odalasvir|odalasvir|mesh-list
153846461|NCT02889367|Antiviral Agents|antiviral agents|mesh-ancestor
153846462|NCT02889367|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153846463|NCT00546039|Genistein|genistein|mesh-list
153846464|NCT00546039|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
153846465|NCT00546039|Protective Agents|protective agents|mesh-ancestor
153846466|NCT00546039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153846467|NCT00546039|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153846468|NCT00546039|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153846469|NCT00546039|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153846470|NCT00546039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153846471|NCT00546039|Phytoestrogens|phytoestrogens|mesh-ancestor
153846472|NCT00546039|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
153846473|NCT00546039|Estrogens|estrogens|mesh-ancestor
153386679|NCT00832299|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153386680|NCT00832299|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153386681|NCT00832299|Immunologic Factors|immunologic factors|mesh-ancestor
153386682|NCT00832299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153386683|NCT00832299|Antidotes|antidotes|mesh-ancestor
153386710|NCT03723447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153386711|NCT03723447|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
153386712|NCT03723447|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153386713|NCT03723447|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153386714|NCT03723447|Respiratory System Agents|respiratory system agents|mesh-ancestor
153386715|NCT03723447|Mydriatics|mydriatics|mesh-ancestor
153386716|NCT03723447|Sympathomimetics|sympathomimetics|mesh-ancestor
153386717|NCT03723447|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
153386718|NCT00836355|Minocycline|minocycline|mesh-list
153386719|NCT00836355|Enoxaparin|enoxaparin|mesh-list
153386720|NCT00836355|Anticoagulants|anticoagulants|mesh-ancestor
153386721|NCT00836355|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153846573|NCT00539448|Insulin|insulin|mesh-list
153846574|NCT00539448|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
153846575|NCT00539448|Insulin Glargine|insulin glargine|mesh-list
153846576|NCT00539448|Insulin glulisine|insulin glulisine|mesh-list
153846577|NCT00539448|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153846578|NCT00539448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153846579|NCT01808456|Vaccines|vaccines|mesh-list
153846580|NCT01808456|Immunologic Factors|immunologic factors|mesh-ancestor
153846581|NCT01808456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153386742|NCT00823095|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153386743|NCT00823095|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
153386744|NCT00823095|Vasodilator Agents|vasodilator agents|mesh-ancestor
153386745|NCT00823095|Gasotransmitters|gasotransmitters|mesh-ancestor
153386746|NCT00823095|Protective Agents|protective agents|mesh-ancestor
153846630|NCT00539799|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153846631|NCT00945152|Vancomycin|vancomycin|mesh-list
153647636|NCT00009204|Serotonin Agents|serotonin agents|mesh-ancestor
153846632|NCT00945152|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153846633|NCT00945152|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153846634|NCT00546507|Celecoxib|celecoxib|mesh-list
153846635|NCT00546507|Diclofenac|diclofenac|mesh-list
153846636|NCT00546507|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153386747|NCT00803283|Morphine|morphine|mesh-list
153386748|NCT00803283|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153386749|NCT00803283|Narcotics|narcotics|mesh-ancestor
153386750|NCT00803283|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153386751|NCT00803283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153386752|NCT00803283|Analgesics|analgesics|mesh-ancestor
153386753|NCT00803283|Sensory System Agents|sensory system agents|mesh-ancestor
153386754|NCT00803283|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153386755|NCT00799773|Rituximab|rituximab|mesh-list
153386756|NCT00799773|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153386757|NCT00799773|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153386758|NCT00799773|Immunologic Factors|immunologic factors|mesh-ancestor
153386759|NCT00799773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153846671|NCT00659711|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
153846673|NCT00659711|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153846674|NCT00659711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153846675|NCT02581007|Cyclophosphamide|cyclophosphamide|mesh-list
153846676|NCT02581007|Melphalan|melphalan|mesh-list
153846677|NCT02581007|Fludarabine|fludarabine|mesh-list
153846678|NCT02581007|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153846679|NCT02581007|Immunologic Factors|immunologic factors|mesh-ancestor
153846680|NCT02581007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153846681|NCT02581007|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153846682|NCT02581007|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153846683|NCT02581007|Alkylating Agents|alkylating agents|mesh-ancestor
153386810|NCT00684255|Fludarabine|fludarabine|mesh-list
153386811|NCT00684255|Busulfan|busulfan|mesh-list
153386812|NCT00684255|Alemtuzumab|alemtuzumab|mesh-list
153386813|NCT00684255|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153386814|NCT00684255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153386815|NCT00684255|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153386816|NCT00684255|Immunologic Factors|immunologic factors|mesh-ancestor
153386817|NCT00684255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153386818|NCT00684255|Alkylating Agents|alkylating agents|mesh-ancestor
153386819|NCT00684255|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153386820|NCT00684255|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153386843|NCT00642603|Growth Substances|growth substances|mesh-ancestor
153386844|NCT00642603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153386846|NCT00642603|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153386847|NCT00642603|Antimetabolites|antimetabolites|mesh-ancestor
153386848|NCT00642603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153386849|NCT00642603|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
153386850|NCT00642603|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153386851|NCT00642603|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153386852|NCT01841931|Buprenorphine|buprenorphine|mesh-list
153386853|NCT01841931|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
153386854|NCT01841931|Naloxone|naloxone|mesh-list
153386855|NCT01841931|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153386856|NCT01841931|Narcotics|narcotics|mesh-ancestor
153846769|NCT00547170|Antimalarials|antimalarials|mesh-ancestor
153846770|NCT00547170|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153846771|NCT00547170|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153846772|NCT00547209|Nitrous Oxide|nitrous oxide|mesh-list
153846773|NCT00547209|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
153846774|NCT00547209|Anesthetics, General|anesthetics, general|mesh-ancestor
153846775|NCT00547209|Anesthetics|anesthetics|mesh-ancestor
153846776|NCT00547209|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153846777|NCT00547209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153386889|NCT00422955|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153386890|NCT00422955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153846820|NCT00547443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153846821|NCT00547443|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153846822|NCT00547443|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153846823|NCT00547560|Begacestat|begacestat|mesh-list
153846824|NCT00547560|Gamma Secretase Inhibitors and Modulators|gamma secretase inhibitors and modulators|mesh-ancestor
153846825|NCT00547560|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153846826|NCT00547560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153846827|NCT00547599|Tadalafil|tadalafil|mesh-list
153846828|NCT00547599|Vasodilator Agents|vasodilator agents|mesh-ancestor
153846829|NCT00547599|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
153846830|NCT00547599|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
153846831|NCT00547599|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153846832|NCT00547599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153846833|NCT00547599|Urological Agents|urological agents|mesh-ancestor
153846834|NCT02908763|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
153846835|NCT02908763|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
153846836|NCT02908763|Antiviral Agents|antiviral agents|mesh-ancestor
153846837|NCT02908763|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153846838|NCT02908412|Bupivacaine|bupivacaine|mesh-list
153846839|NCT02908412|Anesthetics, Local|anesthetics, local|mesh-ancestor
153386952|NCT01673061|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153386953|NCT01673061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153386983|NCT01598025|Fludarabine phosphate|fludarabine phosphate|mesh-list
153386984|NCT01598025|Melphalan|melphalan|mesh-list
153386985|NCT01598025|Thiotepa|thiotepa|mesh-list
153386986|NCT01598025|Antilymphocyte Serum|antilymphocyte serum|mesh-list
153386987|NCT01598025|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153846840|NCT02908412|Anesthetics|anesthetics|mesh-ancestor
153846841|NCT02908412|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153846842|NCT02908412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153846843|NCT02908412|Sensory System Agents|sensory system agents|mesh-ancestor
153846872|NCT03809442|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153846874|NCT03809442|Sensory System Agents|sensory system agents|mesh-ancestor
153846875|NCT03809442|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
153846876|NCT03809442|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153386988|NCT01598025|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153386989|NCT01598025|Antimetabolites|antimetabolites|mesh-ancestor
153386990|NCT01598025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153386991|NCT01598025|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153386992|NCT01598025|Immunologic Factors|immunologic factors|mesh-ancestor
153386993|NCT01598025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153386994|NCT01598025|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153386995|NCT01598025|Alkylating Agents|alkylating agents|mesh-ancestor
153386996|NCT01598025|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153386998|NCT01587963|Antioxidants|antioxidants|mesh-ancestor
153386999|NCT01587963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153387000|NCT01587963|Protective Agents|protective agents|mesh-ancestor
153387001|NCT01587963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153387002|NCT01587963|Vitamins|vitamins|mesh-ancestor
153387003|NCT01587963|Micronutrients|micronutrients|mesh-ancestor
153387004|NCT01648751|Estrogens|estrogens|mesh-list
153387005|NCT01648751|Hormones|hormones|mesh-ancestor
153387007|NCT01648751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153846919|NCT00534807|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
153846920|NCT00534807|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
153846922|NCT00534846|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153846923|NCT00534846|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153387035|NCT01549977|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153387036|NCT00357617|Celecoxib|celecoxib|mesh-list
153387037|NCT00357617|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153387038|NCT00357617|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153387039|NCT00357617|Analgesics|analgesics|mesh-ancestor
153387040|NCT00357617|Sensory System Agents|sensory system agents|mesh-ancestor
153387041|NCT00357617|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153387042|NCT00357617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153387043|NCT00357617|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153387044|NCT00357617|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153387045|NCT00357617|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
153387046|NCT00357617|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153387047|NCT00357617|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153846938|NCT00548067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153846939|NCT00548067|Vasodilator Agents|vasodilator agents|mesh-ancestor
153387093|NCT01534143|Fludarabine|fludarabine|mesh-list
153387094|NCT01534143|Fludarabine phosphate|fludarabine phosphate|mesh-list
153387095|NCT01534143|Bortezomib|bortezomib|mesh-list
153387096|NCT01534143|Busulfan|busulfan|mesh-list
153387097|NCT01534143|Tacrolimus|tacrolimus|mesh-list
153387098|NCT01534143|Thymoglobulin|thymoglobulin|mesh-list
153387099|NCT01534143|Antilymphocyte Serum|antilymphocyte serum|mesh-list
153387100|NCT01534143|Immunoglobulins|immunoglobulins|mesh-list
153387101|NCT01534143|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153387102|NCT01534143|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153387103|NCT01534143|Antimetabolites|antimetabolites|mesh-ancestor
153387104|NCT01534143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153387105|NCT01534143|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153387106|NCT01534143|Immunologic Factors|immunologic factors|mesh-ancestor
153387107|NCT01534143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153387108|NCT01534143|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
153387109|NCT01534143|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153387110|NCT01534143|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153387111|NCT01534143|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153387112|NCT01534143|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153387113|NCT01534143|Antifungal Agents|antifungal agents|mesh-ancestor
153387114|NCT01534143|Alkylating Agents|alkylating agents|mesh-ancestor
153387115|NCT01534143|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153846968|NCT02907593|Budesonide|budesonide|mesh-list
153846969|NCT02907593|Calfactant|calfactant|mesh-list
153846970|NCT02907593|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153387124|NCT01692171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153387125|NCT05723315|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
153387126|NCT05723315|Natriuretic Agents|natriuretic agents|mesh-ancestor
153387127|NCT05723315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153387128|NCT00570531|Paclitaxel|paclitaxel|mesh-list
153387129|NCT00570531|Bevacizumab|bevacizumab|mesh-list
153387130|NCT00570531|Fluorouracil|fluorouracil|mesh-list
153387131|NCT00570531|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153387132|NCT00570531|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153387133|NCT00570531|Tubulin Modulators|tubulin modulators|mesh-ancestor
153387134|NCT00570531|Antimitotic Agents|antimitotic agents|mesh-ancestor
153387135|NCT00570531|Mitosis Modulators|mitosis modulators|mesh-ancestor
153387136|NCT00570531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153387137|NCT00570531|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153387140|NCT00570531|Growth Substances|growth substances|mesh-ancestor
153847073|NCT01262677|Pregabalin|pregabalin|mesh-list
153847074|NCT01262677|Analgesics|analgesics|mesh-ancestor
153847075|NCT01262677|Sensory System Agents|sensory system agents|mesh-ancestor
153847076|NCT01262677|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153847077|NCT01262677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153847078|NCT01262677|Anticonvulsants|anticonvulsants|mesh-ancestor
153847079|NCT01262677|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153847080|NCT01262677|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153847081|NCT01262677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153847082|NCT01262677|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153847083|NCT01262677|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153847084|NCT01262677|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153847085|NCT01262677|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153847086|NCT01262677|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153847087|NCT02899364|Sodium thiosulfate|sodium thiosulfate|mesh-list
153847088|NCT02899364|Antidotes|antidotes|mesh-ancestor
153847089|NCT02899364|Protective Agents|protective agents|mesh-ancestor
153847090|NCT02899364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153847091|NCT02899364|Antioxidants|antioxidants|mesh-ancestor
153847092|NCT02899364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153847093|NCT02899364|Antitubercular Agents|antitubercular agents|mesh-ancestor
153847094|NCT02899364|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153847095|NCT02899364|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153847096|NCT02899364|Chelating Agents|chelating agents|mesh-ancestor
153847097|NCT02899364|Sequestering Agents|sequestering agents|mesh-ancestor
153781777|NCT04559308|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153847098|NCT04206865|Valsartan|valsartan|mesh-list
153847099|NCT04206865|Vasodilator Agents|vasodilator agents|mesh-list
153847100|NCT04206865|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
153847101|NCT04206865|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153847102|NCT04206865|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
153847110|NCT01262638|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153387233|NCT02973399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153387234|NCT02224729|Dexamethasone|dexamethasone|mesh-list
153387235|NCT02224729|Bortezomib|bortezomib|mesh-list
153387236|NCT02224729|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
153387237|NCT02224729|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153387238|NCT02224729|Antiemetics|antiemetics|mesh-ancestor
153387239|NCT02224729|Autonomic Agents|autonomic agents|mesh-ancestor
153387240|NCT02224729|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153387241|NCT02224729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153387242|NCT02224729|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153387243|NCT02224729|Glucocorticoids|glucocorticoids|mesh-ancestor
153387244|NCT02224729|Hormones|hormones|mesh-ancestor
153387245|NCT02224729|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153387246|NCT02224729|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153387247|NCT02224729|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153387248|NCT02224729|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153387249|NCT02224729|Alkylating Agents|alkylating agents|mesh-ancestor
153387250|NCT02224729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153387251|NCT00305643|Celecoxib|celecoxib|mesh-list
153387252|NCT00305643|Capecitabine|capecitabine|mesh-list
153387253|NCT00305643|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153847117|NCT00535119|Paclitaxel|paclitaxel|mesh-list
153847123|NCT00535119|Tubulin Modulators|tubulin modulators|mesh-ancestor
153847124|NCT00535119|Antimitotic Agents|antimitotic agents|mesh-ancestor
153387262|NCT00305643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153387263|NCT00305643|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153387264|NCT00305643|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153387265|NCT00305643|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
153387266|NCT00305643|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153387267|NCT00305643|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153387268|NCT03004105|Durvalumab|durvalumab|mesh-list
153387269|NCT03004105|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153387270|NCT03004105|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153387271|NCT00271011|Irinotecan|irinotecan|mesh-list
153387272|NCT00271011|Cetuximab|cetuximab|mesh-list
153387273|NCT00271011|Mitomycins|mitomycins|mesh-list
153387274|NCT00271011|Mitomycin|mitomycin|mesh-list
153387275|NCT00271011|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
153387276|NCT00271011|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153387277|NCT00271011|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153387278|NCT00271011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153387279|NCT00271011|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153387280|NCT00271011|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153387281|NCT00271011|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153387282|NCT00271011|Alkylating Agents|alkylating agents|mesh-ancestor
153387283|NCT00271011|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153387284|NCT03312530|Atezolizumab|atezolizumab|mesh-list
153387285|NCT03312530|Venetoclax|venetoclax|mesh-list
153387286|NCT03312530|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153847174|NCT04043494|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153847175|NCT04043494|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153847176|NCT04043494|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
153847177|NCT04043494|Abortifacient Agents|abortifacient agents|mesh-ancestor
153847178|NCT04043494|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153847179|NCT04043494|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153847180|NCT04043494|Antimetabolites|antimetabolites|mesh-ancestor
153847181|NCT04043494|Dermatologic Agents|dermatologic agents|mesh-ancestor
153847182|NCT04043494|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153847185|NCT04043494|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153847186|NCT04043494|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153847187|NCT04043494|Tubulin Modulators|tubulin modulators|mesh-ancestor
153847188|NCT04043494|Antimitotic Agents|antimitotic agents|mesh-ancestor
153847189|NCT04043494|Mitosis Modulators|mitosis modulators|mesh-ancestor
153847191|NCT02899286|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153847192|NCT04322422|Montelukast|montelukast|mesh-list
153847193|NCT04322422|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153847194|NCT04322422|Respiratory System Agents|respiratory system agents|mesh-ancestor
153847195|NCT04322422|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
153847196|NCT04322422|Hormone Antagonists|hormone antagonists|mesh-ancestor
153847197|NCT04322422|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153847198|NCT04322422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153847199|NCT04322422|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
153847203|NCT02899169|Hydroxyurea|hydroxyurea|mesh-list
153847204|NCT02899169|Arsenic Trioxide|arsenic trioxide|mesh-list
153847205|NCT02899169|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153847206|NCT02899169|Keratolytic Agents|keratolytic agents|mesh-ancestor
153847207|NCT02899169|Dermatologic Agents|dermatologic agents|mesh-ancestor
153847208|NCT02899169|Antisickling Agents|antisickling agents|mesh-ancestor
153847209|NCT02899169|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153847210|NCT02899169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153847211|NCT02899169|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153847212|NCT00548964|Ketamine|ketamine|mesh-list
153847213|NCT00548964|Lithium Carbonate|lithium carbonate|mesh-list
153847214|NCT00548964|Analgesics|analgesics|mesh-ancestor
153847215|NCT00548964|Sensory System Agents|sensory system agents|mesh-ancestor
153847216|NCT00548964|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153847217|NCT00548964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153847218|NCT00548964|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
153847219|NCT00548964|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153847220|NCT00548964|Anesthetics, General|anesthetics, general|mesh-ancestor
153847249|NCT00549120|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153847250|NCT00549120|Autonomic Agents|autonomic agents|mesh-ancestor
153847251|NCT00549120|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153847252|NCT00549120|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153847253|NCT00549120|Respiratory System Agents|respiratory system agents|mesh-ancestor
153387365|NCT00357851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153387366|NCT00358319|Valproic Acid|valproic acid|mesh-list
153387367|NCT00358319|Anticonvulsants|anticonvulsants|mesh-ancestor
153387368|NCT00358319|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153387369|NCT00358319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153387370|NCT00358319|GABA Agents|gaba agents|mesh-ancestor
153387371|NCT00358319|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153387372|NCT00358319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153387373|NCT00358319|Antimanic Agents|antimanic agents|mesh-ancestor
153387374|NCT00358319|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153387375|NCT00358319|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153387376|NCT00358319|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153387377|NCT05663801|Magnesium Sulfate|magnesium sulfate|mesh-list
153387378|NCT05663801|Ketamine|ketamine|mesh-list
153387379|NCT05663801|Bupivacaine|bupivacaine|mesh-list
153387380|NCT05663801|Anesthetics, Local|anesthetics, local|mesh-ancestor
153387381|NCT05663801|Anesthetics|anesthetics|mesh-ancestor
153387382|NCT05663801|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153387383|NCT05663801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153387384|NCT05663801|Sensory System Agents|sensory system agents|mesh-ancestor
153387385|NCT05663801|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153387386|NCT05663801|Analgesics|analgesics|mesh-ancestor
153387387|NCT05663801|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
153387388|NCT05663801|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153387389|NCT05663801|Anesthetics, General|anesthetics, general|mesh-ancestor
153387390|NCT05663801|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
153387391|NCT05663801|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
153847254|NCT00549120|Tocolytic Agents|tocolytic agents|mesh-ancestor
153387408|NCT00000117|Antibodies|antibodies|mesh-list
153847255|NCT00549120|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153847256|NCT00549120|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
153847257|NCT00549120|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
153847258|NCT00549120|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153847259|NCT00549120|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
153847260|NCT00549120|Cholinergic Agents|cholinergic agents|mesh-ancestor
153847261|NCT04680884|Antifungal Agents|antifungal agents|mesh-list
153847262|NCT04680884|Clotrimazole|clotrimazole|mesh-list
153847263|NCT04680884|Miconazole|miconazole|mesh-list
153847264|NCT04680884|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153847279|NCT00535470|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153847280|NCT00535470|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153847282|NCT00535509|Docetaxel|docetaxel|mesh-list
153847283|NCT00535509|Trastuzumab|trastuzumab|mesh-list
153847284|NCT00535509|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153647717|NCT00009672|Morphine|morphine|mesh-list
153847285|NCT00535509|Tubulin Modulators|tubulin modulators|mesh-ancestor
153847286|NCT00535509|Antimitotic Agents|antimitotic agents|mesh-ancestor
153847287|NCT00535509|Mitosis Modulators|mitosis modulators|mesh-ancestor
153847288|NCT00535509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153847289|NCT00535509|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153847290|NCT01262365|Epratuzumab|epratuzumab|mesh-list
153847291|NCT01262365|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153847292|NCT01262365|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153387419|NCT00380133|Hormones|hormones|mesh-ancestor
153387420|NCT00380133|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153387421|NCT00380133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153387422|NCT00380133|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153387423|NCT00380133|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153387425|NCT02959229|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153387426|NCT02953665|Liraglutide|liraglutide|mesh-list
153387427|NCT02953665|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
153387428|NCT02953665|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153387429|NCT02953665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153387430|NCT02953665|Incretins|incretins|mesh-ancestor
153387431|NCT02953665|Hormones|hormones|mesh-ancestor
153387432|NCT02953665|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153847328|NCT04680962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153387463|NCT00000207|Narcotics|narcotics|mesh-ancestor
153387464|NCT00000207|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153387465|NCT00000207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153387466|NCT00000207|Analgesics|analgesics|mesh-ancestor
153387467|NCT00000207|Sensory System Agents|sensory system agents|mesh-ancestor
153387468|NCT00000207|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153387469|NCT00000207|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
153387470|NCT02295774|Methylene Blue|methylene blue|mesh-list
153387471|NCT02295774|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153387473|NCT01807611|Mycophenolic Acid|mycophenolic acid|mesh-list
153847375|NCT04321642|Anesthetics, General|anesthetics, general|mesh-ancestor
153847376|NCT04321642|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153847377|NCT04321642|Analgesics|analgesics|mesh-ancestor
153847378|NCT04321642|Sensory System Agents|sensory system agents|mesh-ancestor
153847379|NCT04321642|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153847380|NCT02897219|Ipragliflozin|ipragliflozin|mesh-list
153847381|NCT02897219|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153847382|NCT02897219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153847383|NCT02897219|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
153847384|NCT02897219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153732170|NCT00140933|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153732171|NCT00140933|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153847385|NCT04321720|Mechlorethamine|mechlorethamine|mesh-list
153847386|NCT04321720|Alkylating Agents|alkylating agents|mesh-ancestor
153847387|NCT04321720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153387501|NCT02977949|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
153387502|NCT02977949|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
153387503|NCT02977949|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153387505|NCT02294682|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153387506|NCT02294682|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153387507|NCT02294682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153387508|NCT02294682|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153387509|NCT01692717|Losartan|losartan|mesh-list
153387510|NCT01692717|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
153387511|NCT01692717|Atorvastatin|atorvastatin|mesh-list
153387512|NCT01692717|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153387513|NCT01692717|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153387514|NCT01692717|Antimetabolites|antimetabolites|mesh-ancestor
153387515|NCT01692717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153847427|NCT00549666|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
153847440|NCT00551577|Docetaxel|docetaxel|mesh-list
153847441|NCT00551577|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153847442|NCT00551577|Tubulin Modulators|tubulin modulators|mesh-ancestor
153847443|NCT00551577|Antimitotic Agents|antimitotic agents|mesh-ancestor
153847444|NCT00551577|Mitosis Modulators|mitosis modulators|mesh-ancestor
153847445|NCT00551577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153847446|NCT04321096|Camostat|camostat|mesh-list
153847447|NCT04321096|Protease Inhibitors|protease inhibitors|mesh-ancestor
153847448|NCT04321096|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153847449|NCT04321096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153847450|NCT04321096|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
153847451|NCT04321096|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
153847452|NCT03556696|Remifentanil|remifentanil|mesh-list
153847453|NCT03556696|Propofol|propofol|mesh-list
153847454|NCT03556696|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153847455|NCT03556696|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153847456|NCT03556696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153847457|NCT03556696|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153847481|NCT00551733|Carboplatin|carboplatin|mesh-list
153847482|NCT00551733|Paclitaxel poliglumex|paclitaxel poliglumex|mesh-list
153847483|NCT00551733|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153847484|NCT00551733|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153847485|NCT00551733|Tubulin Modulators|tubulin modulators|mesh-ancestor
153847486|NCT00551733|Antimitotic Agents|antimitotic agents|mesh-ancestor
153847487|NCT00551733|Mitosis Modulators|mitosis modulators|mesh-ancestor
153847488|NCT00551733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153847504|NCT04922424|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
153847505|NCT04922424|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153847506|NCT00553748|Alovudine|alovudine|mesh-list
153847507|NCT00553748|Antiviral Agents|antiviral agents|mesh-ancestor
153847508|NCT00553748|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153847509|NCT00551850|MP 412|mp 412|mesh-list
153847510|NCT00551850|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153847511|NCT00551850|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153847512|NCT00551850|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153847513|NCT00551850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153847514|NCT00550095|Valsartan|valsartan|mesh-list
153847515|NCT00550095|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153847516|NCT00550095|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
153847517|NCT00550095|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
153847518|NCT00550095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153387654|NCT02322216|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
153387655|NCT02322216|Histamine Antagonists|histamine antagonists|mesh-ancestor
153387657|NCT02322216|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153387658|NCT02322216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153387659|NCT03447639|Povidone-Iodine|povidone-iodine|mesh-list
153387660|NCT03447639|Povidone|povidone|mesh-list
153387661|NCT03447639|Plasma Substitutes|plasma substitutes|mesh-ancestor
153387662|NCT03447639|Blood Substitutes|blood substitutes|mesh-ancestor
153387663|NCT03447639|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
153387664|NCT03447639|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153387665|NCT03425799|Tranexamic Acid|tranexamic acid|mesh-list
153387666|NCT03425799|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
153387667|NCT03425799|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153387668|NCT03425799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153387669|NCT03425799|Hemostatics|hemostatics|mesh-ancestor
153387670|NCT03425799|Coagulants|coagulants|mesh-ancestor
153847555|NCT04902495|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153847557|NCT02895659|Epinephrine|epinephrine|mesh-list
153387679|NCT03360903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153647718|NCT00009672|Nortriptyline|nortriptyline|mesh-list
153647719|NCT00009672|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153647727|NCT00009672|Antidepressive Agents|antidepressive agents|mesh-ancestor
153647728|NCT00009672|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153647729|NCT00009672|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
153647730|NCT00009672|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153889885|NCT01263483|Micronutrients|micronutrients|mesh-ancestor
153889886|NCT01011049|Vaccines|vaccines|mesh-list
153889887|NCT01011049|Immunologic Factors|immunologic factors|mesh-ancestor
153647731|NCT00009672|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153647733|NCT00009672|Adrenergic Agents|adrenergic agents|mesh-ancestor
153387680|NCT03360903|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
153387681|NCT03360903|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
153387682|NCT03360903|Purinergic Agents|purinergic agents|mesh-ancestor
153387683|NCT03360903|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153387684|NCT00000231|Buprenorphine|buprenorphine|mesh-list
153387685|NCT00000231|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153387686|NCT00000231|Narcotics|narcotics|mesh-ancestor
153387687|NCT00000231|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153387688|NCT00000231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153387689|NCT00000231|Analgesics|analgesics|mesh-ancestor
153387690|NCT00000231|Sensory System Agents|sensory system agents|mesh-ancestor
153387691|NCT00000231|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153387692|NCT00000231|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
153387694|NCT00000237|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153387696|NCT00000237|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153387697|NCT00000237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153847580|NCT00552201|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153847581|NCT00552201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153847582|NCT03391882|Apomorphine|apomorphine|mesh-list
153847583|NCT03391882|Emetics|emetics|mesh-ancestor
153847584|NCT03391882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153847585|NCT03391882|Autonomic Agents|autonomic agents|mesh-ancestor
153847586|NCT03391882|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153847587|NCT03391882|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153847588|NCT03391882|Dopamine Agonists|dopamine agonists|mesh-ancestor
153847589|NCT03391882|Dopamine Agents|dopamine agents|mesh-ancestor
153847590|NCT03391882|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153847591|NCT03391882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153847592|NCT00550329|Glipizide|glipizide|mesh-list
153387742|NCT00000261|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153387743|NCT00000261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153387744|NCT00000261|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153387745|NCT00000261|Analgesics|analgesics|mesh-ancestor
153387746|NCT00000261|Sensory System Agents|sensory system agents|mesh-ancestor
153387747|NCT00000261|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153847604|NCT00550563|Vitamin D|vitamin d|mesh-list
153387748|NCT00000801|Cytarabine|cytarabine|mesh-list
153387749|NCT00000801|Dexamethasone|dexamethasone|mesh-list
153387750|NCT00000801|Cyclophosphamide|cyclophosphamide|mesh-list
153387751|NCT00000801|Doxorubicin|doxorubicin|mesh-list
153387752|NCT00000801|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
153387753|NCT00000801|Vincristine|vincristine|mesh-list
153387754|NCT00000801|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153387755|NCT00000801|Immunologic Factors|immunologic factors|mesh-ancestor
153387756|NCT00000801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153387757|NCT00000801|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153387758|NCT00000801|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153847630|NCT02895113|Sensory System Agents|sensory system agents|mesh-ancestor
153847631|NCT02895113|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153847632|NCT02895113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153847633|NCT02895113|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153847634|NCT02895113|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153847635|NCT02895113|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153847636|NCT02895113|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153847637|NCT02895113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153847638|NCT02895113|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153847639|NCT02895113|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153847640|NCT02895113|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153387763|NCT00000801|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153387764|NCT00000801|Antiemetics|antiemetics|mesh-ancestor
153387765|NCT00000801|Autonomic Agents|autonomic agents|mesh-ancestor
153387766|NCT00000801|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153387767|NCT00000801|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153387768|NCT00000801|Glucocorticoids|glucocorticoids|mesh-ancestor
153387770|NCT00000801|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153387771|NCT00000801|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153847643|NCT00552630|Antidotes|antidotes|mesh-ancestor
153847644|NCT00552630|Protective Agents|protective agents|mesh-ancestor
153847645|NCT00552630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153847646|NCT00552630|Chelating Agents|chelating agents|mesh-ancestor
153847647|NCT00552630|Sequestering Agents|sequestering agents|mesh-ancestor
153847648|NCT00552630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153847649|NCT00552630|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153387805|NCT00001677|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
153387806|NCT00001677|Abortifacient Agents|abortifacient agents|mesh-ancestor
153387807|NCT00001677|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153387808|NCT00001677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153387809|NCT00001677|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153387810|NCT00001677|Antimetabolites|antimetabolites|mesh-ancestor
153387811|NCT00001677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153387812|NCT00001677|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153387813|NCT00001677|Dermatologic Agents|dermatologic agents|mesh-ancestor
153387814|NCT00001677|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153387815|NCT00001677|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153387816|NCT00001677|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153387818|NCT00001677|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153387819|NCT00001677|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153387820|NCT00001689|Vincristine|vincristine|mesh-list
153387821|NCT00001689|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153387822|NCT00001689|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153387823|NCT00001689|Tubulin Modulators|tubulin modulators|mesh-ancestor
153387824|NCT00001689|Antimitotic Agents|antimitotic agents|mesh-ancestor
153387825|NCT00001689|Mitosis Modulators|mitosis modulators|mesh-ancestor
153387826|NCT00001689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153387827|NCT00001713|Heparin|heparin|mesh-list
153847730|NCT02895074|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
153387850|NCT00000273|Anesthetics|anesthetics|mesh-ancestor
153387851|NCT00000273|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
153387852|NCT00000273|Antitussive Agents|antitussive agents|mesh-ancestor
153387853|NCT00000273|Respiratory System Agents|respiratory system agents|mesh-ancestor
153387854|NCT00000819|Prednisone|prednisone|mesh-list
153387855|NCT00000819|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153387856|NCT00000819|Glucocorticoids|glucocorticoids|mesh-ancestor
153387857|NCT00000819|Hormones|hormones|mesh-ancestor
153387858|NCT00000819|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153387859|NCT00000819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153387860|NCT00000819|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153387861|NCT00000819|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153387862|NCT00000279|Clonidine|clonidine|mesh-list
153387863|NCT00000279|Analgesics|analgesics|mesh-ancestor
153387864|NCT00000279|Sensory System Agents|sensory system agents|mesh-ancestor
153387865|NCT00000279|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153387866|NCT00000279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153387867|NCT00000279|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153387868|NCT00000279|Sympatholytics|sympatholytics|mesh-ancestor
153387869|NCT00000279|Autonomic Agents|autonomic agents|mesh-ancestor
153387870|NCT00000279|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
153387871|NCT00000279|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153387872|NCT00000279|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153387873|NCT00000279|Adrenergic Agents|adrenergic agents|mesh-ancestor
153847739|NCT02894918|Antiviral Agents|antiviral agents|mesh-ancestor
153847740|NCT02894918|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153847741|NCT00551109|SA 4503|sa 4503|mesh-list
153847742|NCT00551109|Nootropic Agents|nootropic agents|mesh-ancestor
153847743|NCT00551265|Cyclophosphamide|cyclophosphamide|mesh-list
153847744|NCT00551265|Oregovomab|oregovomab|mesh-list
153847746|NCT00551265|Antibodies|antibodies|mesh-list
153847761|NCT02894606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153847762|NCT02894606|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153847763|NCT00551343|Exenatide|exenatide|mesh-list
153847764|NCT00551343|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
153847765|NCT00551343|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153847766|NCT00551343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153847767|NCT00551343|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
153847768|NCT00551343|Incretins|incretins|mesh-ancestor
153847769|NCT00551343|Hormones|hormones|mesh-ancestor
153847770|NCT00551343|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153847771|NCT00551382|Montelukast|montelukast|mesh-list
153387890|NCT00001737|Cyclosporine|cyclosporine|mesh-list
153387891|NCT00001737|Cyclosporins|cyclosporins|mesh-list
153387892|NCT00001737|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153387893|NCT00001737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153387894|NCT00001737|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153847773|NCT00551382|Respiratory System Agents|respiratory system agents|mesh-ancestor
153847774|NCT00551382|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
153847775|NCT00551382|Hormone Antagonists|hormone antagonists|mesh-ancestor
153847776|NCT00551382|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153847777|NCT00551382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153847778|NCT00551382|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
153847779|NCT00551382|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
153847780|NCT00551382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153847782|NCT02894684|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153847783|NCT02894684|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153847784|NCT02894645|Cytarabine|cytarabine|mesh-list
153387956|NCT00000297|Autonomic Agents|autonomic agents|mesh-ancestor
153847823|NCT02894645|Dermatologic Agents|dermatologic agents|mesh-ancestor
153847824|NCT02894645|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153847825|NCT02894645|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153847827|NCT02894645|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153847828|NCT02894645|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153847829|NCT02894645|Tubulin Modulators|tubulin modulators|mesh-ancestor
153847830|NCT02894645|Antimitotic Agents|antimitotic agents|mesh-ancestor
153847831|NCT02894645|Mitosis Modulators|mitosis modulators|mesh-ancestor
153847832|NCT00552747|Fenofibrate|fenofibrate|mesh-list
153847833|NCT00552747|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153847834|NCT00552747|Antimetabolites|antimetabolites|mesh-ancestor
153847835|NCT00552747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153847836|NCT00552747|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153847837|NCT05427617|Fulvestrant|fulvestrant|mesh-list
153847838|NCT05427617|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-list
153847839|NCT05427617|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153847840|NCT05427617|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153847841|NCT05427617|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
153847842|NCT05427617|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
153847843|NCT05427617|Hormone Antagonists|hormone antagonists|mesh-ancestor
153387961|NCT00359879|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
153387962|NCT00359879|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153387963|NCT00359879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153387964|NCT00359879|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
153387965|NCT00359879|Incretins|incretins|mesh-ancestor
153388020|NCT00000885|Abacavir|abacavir|mesh-list
153388021|NCT00000885|Didanosine|didanosine|mesh-list
153388022|NCT00000885|Stavudine|stavudine|mesh-list
153388023|NCT00000885|Adefovir|adefovir|mesh-list
153388024|NCT00000885|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
153388025|NCT00000885|Nelfinavir|nelfinavir|mesh-list
153388026|NCT00000885|Indinavir|indinavir|mesh-list
153388027|NCT00000885|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153388028|NCT00000885|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153388029|NCT00000885|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153732172|NCT00140933|Analgesics|analgesics|mesh-ancestor
153732173|NCT00140933|Sensory System Agents|sensory system agents|mesh-ancestor
153388030|NCT00000885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153847904|NCT01260922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153847905|NCT01260922|Cholinergic Agents|cholinergic agents|mesh-ancestor
153847906|NCT01260922|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153847907|NCT01260922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153847908|NCT01260922|Nootropic Agents|nootropic agents|mesh-ancestor
153847909|NCT01212094|Rituximab|rituximab|mesh-list
153847910|NCT01212094|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153847911|NCT01212094|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153847912|NCT01212094|Immunologic Factors|immunologic factors|mesh-ancestor
153388034|NCT00000885|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153388036|NCT00000885|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
153388037|NCT00000885|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153388038|NCT00000885|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
153388039|NCT00000885|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
153388079|NCT00000921|Glucocorticoids|glucocorticoids|mesh-ancestor
153847972|NCT04152980|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153847973|NCT04152980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153847974|NCT04152980|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153847975|NCT04152980|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
153847976|NCT04152980|Protective Agents|protective agents|mesh-ancestor
153847977|NCT04152980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153847978|NCT04152980|Vasodilator Agents|vasodilator agents|mesh-ancestor
153847979|NCT04152980|Free Radical Scavengers|free radical scavengers|mesh-ancestor
153847980|NCT04152980|Antioxidants|antioxidants|mesh-ancestor
153847981|NCT01232452|Pemetrexed|pemetrexed|mesh-list
153847982|NCT01232452|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153847983|NCT01232452|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153847984|NCT01232452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153847985|NCT01232452|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153847986|NCT01232452|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153847987|NCT01211197|Metformin|metformin|mesh-list
153847988|NCT01211197|Empagliflozin|empagliflozin|mesh-list
153847989|NCT01211197|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153847990|NCT01211197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153847991|NCT01211197|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
153847992|NCT01211197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153847993|NCT00553137|Fluconazole|fluconazole|mesh-list
153847994|NCT00553137|Antifungal Agents|antifungal agents|mesh-ancestor
153847995|NCT00553137|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153847996|NCT00553137|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
153847997|NCT00553137|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153847998|NCT00553137|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153388139|NCT00000963|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153388140|NCT00000963|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153388141|NCT00000963|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153388142|NCT00000963|Antiviral Agents|antiviral agents|mesh-ancestor
153388143|NCT00000963|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153388154|NCT00001893|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153388155|NCT00001893|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153388156|NCT00001893|Analgesics|analgesics|mesh-ancestor
153848003|NCT00553137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153848004|NCT00553137|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
153388157|NCT00001893|Sensory System Agents|sensory system agents|mesh-ancestor
153388165|NCT00000981|Fiacitabine|fiacitabine|mesh-list
153848005|NCT00553137|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
153848006|NCT04090775|Cyclophosphamide|cyclophosphamide|mesh-list
153848008|NCT04090775|Ipilimumab|ipilimumab|mesh-list
153848009|NCT04090775|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153848010|NCT04090775|Immunologic Factors|immunologic factors|mesh-ancestor
153848011|NCT04090775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153848012|NCT04090775|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153848013|NCT04090775|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153848014|NCT04090775|Alkylating Agents|alkylating agents|mesh-ancestor
153848015|NCT04090775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153848016|NCT04090775|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153848017|NCT04090775|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153848018|NCT04090775|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153848019|NCT04090775|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153848020|NCT01232296|Sorafenib|sorafenib|mesh-list
153848021|NCT01232296|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153848022|NCT01232296|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153848025|NCT04041011|Fluzoparib|fluzoparib|mesh-list
153848047|NCT01231555|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
153848082|NCT03850535|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153848083|NCT03850535|Antiviral Agents|antiviral agents|mesh-ancestor
153848084|NCT03850535|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153848085|NCT03850535|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153388236|NCT00359177|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
153388237|NCT00359177|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153388238|NCT00359177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153388240|NCT00001017|Amphotericin B|amphotericin b|mesh-list
153388241|NCT00001017|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
153388242|NCT00001017|Antifungal Agents|antifungal agents|mesh-ancestor
153388243|NCT00001017|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153388244|NCT00001017|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
153388245|NCT00001017|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153388246|NCT00001017|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153388247|NCT00001017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153388248|NCT00001017|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153388249|NCT00001017|Hormone Antagonists|hormone antagonists|mesh-ancestor
153848094|NCT05255367|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153848095|NCT05255367|Disinfectants|disinfectants|mesh-ancestor
153848096|NCT05255367|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
153848097|NCT05255367|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
153848098|NCT03653000|Anesthetics|anesthetics|mesh-list
153848099|NCT03653000|Anesthetics, Local|anesthetics, local|mesh-list
153848100|NCT03653000|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153848101|NCT03653000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153848102|NCT03653000|Sensory System Agents|sensory system agents|mesh-ancestor
153848103|NCT03653000|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153848104|NCT03639389|Morphine|morphine|mesh-list
153848105|NCT03639389|Analgesics|analgesics|mesh-list
153848106|NCT03639389|Bupivacaine|bupivacaine|mesh-list
153848107|NCT03639389|Anesthetics, Local|anesthetics, local|mesh-ancestor
153848108|NCT03639389|Anesthetics|anesthetics|mesh-ancestor
153848109|NCT03639389|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153361081|NCT01380197|Sensory System Agents|sensory system agents|mesh-ancestor
153361083|NCT00862784|Leucovorin|leucovorin|mesh-list
153848110|NCT03639389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153848111|NCT03639389|Sensory System Agents|sensory system agents|mesh-ancestor
153848112|NCT03639389|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153848113|NCT03639389|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153848133|NCT03570983|Antiviral Agents|antiviral agents|mesh-ancestor
153848134|NCT03570983|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153848135|NCT03570983|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153848136|NCT03570983|Immunologic Factors|immunologic factors|mesh-ancestor
153848137|NCT03570983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153848138|NCT03570983|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153848139|NCT03570983|Alkylating Agents|alkylating agents|mesh-ancestor
153848140|NCT03570983|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153848141|NCT03570983|Gout Suppressants|gout suppressants|mesh-ancestor
153848142|NCT03570983|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153388270|NCT00001965|Antifungal Agents|antifungal agents|mesh-ancestor
153388271|NCT00001965|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153388272|NCT00001965|Dermatologic Agents|dermatologic agents|mesh-ancestor
153388273|NCT00001965|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153388274|NCT00001965|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
153388275|NCT00001023|Azithromycin|azithromycin|mesh-list
153388276|NCT00001023|Clarithromycin|clarithromycin|mesh-list
153388277|NCT00001023|Rifabutin|rifabutin|mesh-list
153388278|NCT00001023|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153388279|NCT00001023|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153388280|NCT00001023|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
153388281|NCT00001023|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153388282|NCT00001023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153388283|NCT00001023|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
153388284|NCT00001023|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153388299|NCT00001035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153388300|NCT00001035|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153388301|NCT00001035|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153388302|NCT00001035|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153848192|NCT05093205|Midazolam|midazolam|mesh-list
153848193|NCT05093205|Atorvastatin|atorvastatin|mesh-list
153848194|NCT05093205|Levonorgestrel|levonorgestrel|mesh-list
153848195|NCT05093205|Ethinyl Estradiol|ethinyl estradiol|mesh-list
153848196|NCT05093205|Estradiol|estradiol|mesh-list
153732174|NCT00140933|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153732175|NCT00140933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153732176|NCT00140933|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153732177|NCT00140933|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153732178|NCT00140933|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153732179|NCT00140933|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153732180|NCT00140933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153732181|NCT00140933|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
153732182|NCT04515628|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
153732184|NCT04515628|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153732185|NCT04515628|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153732186|NCT04515628|Antimetabolites|antimetabolites|mesh-ancestor
153732187|NCT04515628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153732188|NCT04515628|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153732189|NCT04515628|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
153732190|NCT04515628|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153732191|NCT04515628|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153732192|NCT00407043|Loteprednol Etabonate|loteprednol etabonate|mesh-list
153732193|NCT00407043|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
153365558|NCT00928694|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153361104|NCT00862784|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153361105|NCT00862784|Growth Substances|growth substances|mesh-ancestor
153361107|NCT00864032|Sorafenib|sorafenib|mesh-list
153388332|NCT00001989|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153388333|NCT00001989|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153388334|NCT00001989|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
153388335|NCT00001989|Abortifacient Agents|abortifacient agents|mesh-ancestor
153388336|NCT00001989|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153388337|NCT00001989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153388338|NCT00001989|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153388339|NCT00001989|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153388340|NCT00001059|Doxorubicin|doxorubicin|mesh-list
153388341|NCT00001059|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
153388342|NCT00001059|Bleomycin|bleomycin|mesh-list
153388343|NCT00001059|Vincristine|vincristine|mesh-list
153388344|NCT00001059|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153388345|NCT00001059|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153388346|NCT00001059|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153388347|NCT00001059|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153848204|NCT05093205|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153388348|NCT00001059|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153388354|NCT00001065|Amphotericin B|amphotericin b|mesh-list
153820182|NCT00471393|Dimethyl Sulfoxide|dimethyl sulfoxide|mesh-list
153820183|NCT00471393|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153820184|NCT00471393|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153820185|NCT00471393|Analgesics|analgesics|mesh-ancestor
153820186|NCT00471393|Sensory System Agents|sensory system agents|mesh-ancestor
153848205|NCT05093205|Anesthetics, General|anesthetics, general|mesh-ancestor
153848206|NCT05093205|Anesthetics|anesthetics|mesh-ancestor
153848207|NCT05093205|GABA Modulators|gaba modulators|mesh-ancestor
153848208|NCT05093205|GABA Agents|gaba agents|mesh-ancestor
153732197|NCT00141011|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153732198|NCT00141011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153732199|NCT00504946|Cholecalciferol|cholecalciferol|mesh-list
153732200|NCT00504946|Vitamin D|vitamin d|mesh-list
153732202|NCT00504946|Budesonide|budesonide|mesh-list
153732203|NCT00504946|Montelukast|montelukast|mesh-list
153732204|NCT00504946|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153848209|NCT05093205|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153848210|NCT05093205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153848235|NCT02623751|Hormone Antagonists|hormone antagonists|mesh-ancestor
153848236|NCT02623751|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153848237|NCT02623751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153848238|NCT02623751|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
153848240|NCT02469155|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153848241|NCT02469155|Serotonin Agents|serotonin agents|mesh-ancestor
153848242|NCT02469155|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153848243|NCT02469155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153848244|NCT02469155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153848245|NCT02469155|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153848246|NCT02469155|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153848247|NCT02469155|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153848248|NCT02469155|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153848249|NCT02469155|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
153848250|NCT02469155|Dopamine Agents|dopamine agents|mesh-ancestor
153848251|NCT02465606|Triamcinolone|triamcinolone|mesh-list
153848252|NCT02465606|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
153848253|NCT02465606|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
153848255|NCT02465606|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
153848256|NCT02465606|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153848257|NCT02465606|Glucocorticoids|glucocorticoids|mesh-ancestor
153848258|NCT02465606|Hormones|hormones|mesh-ancestor
153388387|NCT00002007|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153848262|NCT02465606|Immunologic Factors|immunologic factors|mesh-ancestor
153848263|NCT02465606|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153848264|NCT02465606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153848266|NCT05080530|Cholecalciferol|cholecalciferol|mesh-list
153848267|NCT05080530|Vitamins|vitamins|mesh-ancestor
153848268|NCT05080530|Micronutrients|micronutrients|mesh-ancestor
153848269|NCT05080530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153848270|NCT05080530|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153848271|NCT05080530|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153848272|NCT00554177|Mifepristone|mifepristone|mesh-list
153848273|NCT00554177|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
153848274|NCT00554177|Abortifacient Agents|abortifacient agents|mesh-ancestor
153848275|NCT00554177|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153848276|NCT00554177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153848277|NCT00554177|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
153848278|NCT00554177|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
153848279|NCT00554177|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
153848280|NCT00554177|Contraceptive Agents|contraceptive agents|mesh-ancestor
153848281|NCT00554177|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
153848282|NCT00554177|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
153848283|NCT00554177|Hormone Antagonists|hormone antagonists|mesh-ancestor
153848284|NCT00554177|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153848285|NCT00554177|Luteolytic Agents|luteolytic agents|mesh-ancestor
153732212|NCT00504946|Respiratory System Agents|respiratory system agents|mesh-ancestor
153732213|NCT00504946|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
153732214|NCT00504946|Hormone Antagonists|hormone antagonists|mesh-ancestor
153732215|NCT00504946|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
153732216|NCT00504946|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
153732217|NCT00504946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153732218|NCT00504946|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153732219|NCT00504946|Autonomic Agents|autonomic agents|mesh-ancestor
153732220|NCT00504946|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153732221|NCT00504946|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153732223|NCT00504946|Micronutrients|micronutrients|mesh-ancestor
153732224|NCT00504946|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153388453|NCT00001101|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153388454|NCT00001101|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153388455|NCT00001101|Antimalarials|antimalarials|mesh-ancestor
153388456|NCT00001101|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153388457|NCT00001101|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153388458|NCT00001101|Third Generation Cephalosporins|third generation cephalosporins|mesh-ancestor
153388459|NCT00001101|Beta Lactam Antibiotics|beta lactam antibiotics|mesh-ancestor
153388460|NCT00001107|Fluconazole|fluconazole|mesh-list
153388461|NCT00001107|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
153388462|NCT00001107|Antifungal Agents|antifungal agents|mesh-ancestor
153388463|NCT00001107|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153388464|NCT00001107|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
153388465|NCT00001107|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153732231|NCT00141050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153732233|NCT00141050|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153732234|NCT04511416|Metformin|metformin|mesh-list
153732235|NCT04511416|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153732236|NCT04511416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153732237|NCT00407082|Fluocinolone Acetonide|fluocinolone acetonide|mesh-list
153732238|NCT00407082|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153732239|NCT00407082|Glucocorticoids|glucocorticoids|mesh-ancestor
153732240|NCT00407082|Hormones|hormones|mesh-ancestor
153732241|NCT00407082|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153732242|NCT00407082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153732243|NCT00141089|Tegaserod|tegaserod|mesh-list
153848339|NCT04684017|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153848340|NCT04684017|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153848341|NCT04684017|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153848342|NCT04684017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153848343|NCT00554450|Dapagliflozin|dapagliflozin|mesh-list
153848344|NCT00554450|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
153848345|NCT00554450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153848346|NCT00554450|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153848347|NCT00554450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153848348|NCT00553020|Insulin Glargine|insulin glargine|mesh-list
153820187|NCT00471393|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153820188|NCT00471393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153461604|NCT04433988|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153461605|NCT04433988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153461606|NCT04433988|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153461607|NCT04433988|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
153461609|NCT04433988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153461610|NCT04433988|Vasodilator Agents|vasodilator agents|mesh-ancestor
153848349|NCT00553020|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153848350|NCT00553020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153848352|NCT00554528|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153848353|NCT00554528|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153848354|NCT00554528|Analgesics|analgesics|mesh-ancestor
153848355|NCT00554528|Sensory System Agents|sensory system agents|mesh-ancestor
153848356|NCT00554528|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153388490|NCT00002025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153388492|NCT00001131|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153388493|NCT00001131|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153388494|NCT00001131|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153388495|NCT00001131|Antiviral Agents|antiviral agents|mesh-ancestor
153388496|NCT00001131|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153388497|NCT00001155|Cyclophosphamide|cyclophosphamide|mesh-list
153388498|NCT00001155|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153388499|NCT00001155|Immunologic Factors|immunologic factors|mesh-ancestor
153388500|NCT00001155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153388501|NCT00001155|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153388502|NCT00001155|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153848368|NCT04683198|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153848369|NCT04683198|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153732246|NCT00141089|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153732247|NCT00141089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153732248|NCT00141089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153732249|NCT00407121|Bevacizumab|bevacizumab|mesh-list
153732250|NCT00407121|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153732251|NCT00407121|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153821193|NCT04701710|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153821194|NCT00437606|Ethanol|ethanol|mesh-list
153821195|NCT00437606|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
153821196|NCT00437606|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153821197|NCT00437606|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153821198|NCT00437606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153732252|NCT00407121|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153732253|NCT00407121|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153732254|NCT00407121|Growth Substances|growth substances|mesh-ancestor
153732255|NCT00407121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153732256|NCT00407121|Growth Inhibitors|growth inhibitors|mesh-ancestor
153732258|NCT00141167|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
153732259|NCT00141167|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
153732260|NCT00141167|Cholinergic Agents|cholinergic agents|mesh-ancestor
153395084|NCT02537873|Cocaine|cocaine|mesh-list
153848370|NCT04683198|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153848371|NCT04683198|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153388539|NCT00001209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153388541|NCT00001209|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153388542|NCT00001209|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153388543|NCT00001209|Tubulin Modulators|tubulin modulators|mesh-ancestor
153388544|NCT00001209|Antimitotic Agents|antimitotic agents|mesh-ancestor
153388545|NCT00001209|Mitosis Modulators|mitosis modulators|mesh-ancestor
153388546|NCT00001209|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153388547|NCT00001209|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153848406|NCT02324309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153848407|NCT02306291|Cytarabine|cytarabine|mesh-list
153848408|NCT02306291|Etoposide|etoposide|mesh-list
153848409|NCT02306291|Mitoxantrone|mitoxantrone|mesh-list
153848410|NCT02306291|Idarubicin|idarubicin|mesh-list
153848411|NCT02306291|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153848412|NCT02306291|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153848413|NCT02306291|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153848414|NCT02306291|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153388552|NCT00002049|Immunologic Factors|immunologic factors|mesh-ancestor
153388584|NCT00002055|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153732262|NCT00141167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153732263|NCT00141167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153732265|NCT00141206|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
153732266|NCT00141206|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
153732267|NCT00141206|Cholinergic Agents|cholinergic agents|mesh-ancestor
153732268|NCT00141206|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153732269|NCT00141206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153732270|NCT00141206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153732271|NCT00141245|Pregabalin|pregabalin|mesh-list
153732272|NCT00141245|Analgesics|analgesics|mesh-ancestor
153732273|NCT00141245|Sensory System Agents|sensory system agents|mesh-ancestor
153732274|NCT00141245|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153732275|NCT00141245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153732277|NCT00141245|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153732278|NCT00141245|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153732279|NCT00141245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153732280|NCT00141245|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153732281|NCT00141245|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153732282|NCT00141245|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153732283|NCT00141245|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153732284|NCT00141245|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153732285|NCT00141362|Pregabalin|pregabalin|mesh-list
153732286|NCT00141362|Analgesics|analgesics|mesh-ancestor
153732287|NCT00141362|Sensory System Agents|sensory system agents|mesh-ancestor
153732288|NCT00141362|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153395098|NCT02537951|Lidocaine|lidocaine|mesh-list
153388585|NCT00002055|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153388586|NCT00002055|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
153388587|NCT05031455|Aspirin|aspirin|mesh-list
153848415|NCT02306291|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153848416|NCT02306291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153848417|NCT02306291|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153848423|NCT02306291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153848424|NCT02306291|Analgesics|analgesics|mesh-ancestor
153848425|NCT02306291|Sensory System Agents|sensory system agents|mesh-ancestor
153848426|NCT02306291|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153848427|NCT02306291|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153848428|NCT02302079|Ranibizumab|ranibizumab|mesh-list
153848431|NCT02302079|Growth Substances|growth substances|mesh-ancestor
153848432|NCT02302079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153848433|NCT02302079|Growth Inhibitors|growth inhibitors|mesh-ancestor
153848434|NCT02302079|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153848436|NCT01210495|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153848437|NCT01210495|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153848438|NCT01210495|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153848439|NCT01210495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153848440|NCT02289716|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
153388596|NCT05031455|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153388597|NCT05031455|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153388598|NCT05031455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153388599|NCT05031455|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153388600|NCT05031455|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153388601|NCT05031455|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153388602|NCT05031455|Antipyretics|antipyretics|mesh-ancestor
153388603|NCT05029973|Bevacizumab|bevacizumab|mesh-list
153388604|NCT05029973|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153388605|NCT05029973|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153848521|NCT02221232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153388662|NCT00002079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153388663|NCT00002079|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153388664|NCT00002079|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153388665|NCT00002079|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153388666|NCT00002079|Antiviral Agents|antiviral agents|mesh-ancestor
153388667|NCT00002079|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153388668|NCT00002079|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153388669|NCT00002079|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153388670|NCT00002079|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
153388671|NCT00002079|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153388672|NCT00002079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153388674|NCT00002085|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153781778|NCT04559308|Alkylating Agents|alkylating agents|mesh-ancestor
153461621|NCT04344678|Sildenafil Citrate|sildenafil citrate|mesh-list
153461622|NCT04344678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153461623|NCT04344678|Vasodilator Agents|vasodilator agents|mesh-ancestor
153461624|NCT04344678|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
153461625|NCT04344678|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
153461626|NCT04344678|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153461627|NCT04344678|Urological Agents|urological agents|mesh-ancestor
153732289|NCT00141362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153732290|NCT00141362|Anticonvulsants|anticonvulsants|mesh-ancestor
153732291|NCT00141362|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153732292|NCT00141362|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153732293|NCT00141362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153732294|NCT00141362|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153732295|NCT00141362|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153732296|NCT00141362|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153388675|NCT00002085|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153388677|NCT00001383|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153388678|NCT00001383|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153388679|NCT00001383|Tubulin Modulators|tubulin modulators|mesh-ancestor
153388680|NCT00001383|Antimitotic Agents|antimitotic agents|mesh-ancestor
153388681|NCT00001383|Mitosis Modulators|mitosis modulators|mesh-ancestor
153388682|NCT00001383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153388683|NCT00002091|Pentoxifylline|pentoxifylline|mesh-list
153388684|NCT00002091|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
153388685|NCT00002091|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153388686|NCT00002091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153388687|NCT00002091|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153388688|NCT00002091|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
153388689|NCT00002091|Protective Agents|protective agents|mesh-ancestor
153388690|NCT00002091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153388691|NCT00002091|Vasodilator Agents|vasodilator agents|mesh-ancestor
153388692|NCT00002091|Free Radical Scavengers|free radical scavengers|mesh-ancestor
153388693|NCT00002091|Antioxidants|antioxidants|mesh-ancestor
153848522|NCT02221232|Disinfectants|disinfectants|mesh-ancestor
153848547|NCT01210222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153848548|NCT01210222|Growth Inhibitors|growth inhibitors|mesh-ancestor
153848562|NCT01209949|Sensory System Agents|sensory system agents|mesh-ancestor
153848563|NCT01209949|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153388704|NCT00002097|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153388705|NCT00002097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153388706|NCT00001431|Gemcitabine|gemcitabine|mesh-list
153388707|NCT00001431|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153388708|NCT00001431|Antimetabolites|antimetabolites|mesh-ancestor
153388709|NCT00001431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153388710|NCT00001431|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153388711|NCT00002103|Leucovorin|leucovorin|mesh-list
153388712|NCT00002103|Trimetrexate|trimetrexate|mesh-list
153388713|NCT00002103|Calcium|calcium|mesh-list
153388714|NCT00002103|Levoleucovorin|levoleucovorin|mesh-list
153848565|NCT01209949|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153848566|NCT01209949|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153848567|NCT04831593|Anesthetics|anesthetics|mesh-list
153848568|NCT04831593|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153848569|NCT04831593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153848570|NCT04667897|Ranibizumab|ranibizumab|mesh-list
153848571|NCT04667897|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153848572|NCT04667897|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153848573|NCT04667897|Growth Substances|growth substances|mesh-ancestor
153848574|NCT04667897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153848577|NCT01209832|Midazolam|midazolam|mesh-list
153848578|NCT01209832|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153848579|NCT01209832|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153848580|NCT01209832|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153848581|NCT01209832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153848582|NCT01209832|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153848583|NCT01209832|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153848584|NCT01209832|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153388742|NCT00360191|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153388743|NCT00360191|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153388744|NCT00360191|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153388745|NCT00360191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153388750|NCT00360191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153388751|NCT00001443|Indinavir|indinavir|mesh-list
153647800|NCT00009750|Antifungal Agents|antifungal agents|mesh-ancestor
153388752|NCT00001443|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
153388753|NCT00001443|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
153388754|NCT00001443|Protease Inhibitors|protease inhibitors|mesh-ancestor
153388755|NCT00001443|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153388756|NCT00001443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153388757|NCT00001443|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153388758|NCT00001443|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153388759|NCT00001443|Antiviral Agents|antiviral agents|mesh-ancestor
153388760|NCT00001443|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153388761|NCT00001449|Leucovorin|leucovorin|mesh-list
153388762|NCT00001449|Gemcitabine|gemcitabine|mesh-list
153388763|NCT00001449|Floxuridine|floxuridine|mesh-list
153388764|NCT00001449|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153388765|NCT00001449|Antimetabolites|antimetabolites|mesh-ancestor
153388766|NCT00001449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153388767|NCT00001449|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153388768|NCT00001449|Antidotes|antidotes|mesh-ancestor
153848595|NCT04667819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153848596|NCT04667819|Viscosupplements|viscosupplements|mesh-ancestor
153848597|NCT04667819|Protective Agents|protective agents|mesh-ancestor
153848598|NCT04683159|Brimonidine Tartrate|brimonidine tartrate|mesh-list
153848599|NCT04683159|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153848600|NCT04683159|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
153848601|NCT04683159|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153848602|NCT04683159|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153848603|NCT04683159|Adrenergic Agents|adrenergic agents|mesh-ancestor
153848604|NCT04683159|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153388771|NCT00001449|Vitamin B Complex|vitamin b complex|mesh-ancestor
153388773|NCT00001449|Micronutrients|micronutrients|mesh-ancestor
153388774|NCT00002109|Zidovudine|zidovudine|mesh-list
153388775|NCT00002109|Didanosine|didanosine|mesh-list
153388786|NCT00002109|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153361224|NCT00825266|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153388787|NCT00002109|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153388788|NCT00002109|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153388789|NCT00002109|Immunologic Factors|immunologic factors|mesh-ancestor
153388790|NCT00002109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153388791|NCT00359567|Palonosetron|palonosetron|mesh-list
153388792|NCT00359567|Granisetron|granisetron|mesh-list
153848647|NCT01230814|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153388794|NCT00359567|Autonomic Agents|autonomic agents|mesh-ancestor
153388795|NCT00359567|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153388796|NCT00359567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153388797|NCT00359567|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153388798|NCT00359567|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
153388799|NCT00359567|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153388801|NCT00359567|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153848651|NCT01230814|Hormone Antagonists|hormone antagonists|mesh-ancestor
153848652|NCT01230814|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153848653|NCT01230814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153848654|NCT01230814|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
153848655|NCT01230814|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
153848656|NCT01230814|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
153848657|NCT01230307|Vitamin D|vitamin d|mesh-list
153848658|NCT01230307|Cholecalciferol|cholecalciferol|mesh-list
153848659|NCT01230307|Vitamins|vitamins|mesh-ancestor
153848660|NCT01230307|Micronutrients|micronutrients|mesh-ancestor
153848661|NCT01230307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153388837|NCT00001569|Mitosis Modulators|mitosis modulators|mesh-ancestor
153388838|NCT00001569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153388848|NCT00002127|Thalidomide|thalidomide|mesh-list
153848675|NCT00556634|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153848676|NCT00556634|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
153848677|NCT00556634|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153848685|NCT01209520|Cisplatin|cisplatin|mesh-list
153647922|NCT00019786|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153647923|NCT00019786|Alkylating Agents|alkylating agents|mesh-ancestor
153647924|NCT00019786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153647925|NCT00019786|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153848686|NCT01209520|Carboplatin|carboplatin|mesh-list
153848709|NCT04805541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153848711|NCT04784754|Antioxidants|antioxidants|mesh-ancestor
153848712|NCT04784754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153848713|NCT04784754|Protective Agents|protective agents|mesh-ancestor
153848714|NCT04784754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153848715|NCT04784754|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153848717|NCT04666805|Toremifene|toremifene|mesh-list
153848718|NCT04666805|Letrozole|letrozole|mesh-list
153848719|NCT04666805|Anastrozole|anastrozole|mesh-list
153848720|NCT04666805|Exemestane|exemestane|mesh-list
153848721|NCT04666805|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153848722|NCT04666805|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
153848723|NCT04666805|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153848724|NCT04666805|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153848725|NCT04666805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153848726|NCT04666805|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
153848727|NCT04666805|Hormone Antagonists|hormone antagonists|mesh-ancestor
153848728|NCT04666805|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153848729|NCT04666805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153848730|NCT04666805|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153388877|NCT00380913|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153388878|NCT00380913|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153388879|NCT00380913|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153388880|NCT00380913|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153388881|NCT00380913|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153388882|NCT00002133|Itraconazole|itraconazole|mesh-list
153388883|NCT00002133|Antifungal Agents|antifungal agents|mesh-ancestor
153388884|NCT00002133|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153388898|NCT00001629|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
153388899|NCT00001629|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
153388900|NCT00001629|Protease Inhibitors|protease inhibitors|mesh-ancestor
153388901|NCT00001629|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153388904|NCT00002139|Azithromycin|azithromycin|mesh-list
153848732|NCT04666805|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
153848733|NCT04666805|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153848734|NCT04721457|Povidone-Iodine|povidone-iodine|mesh-list
153848735|NCT04721457|Listerine|listerine|mesh-list
153848736|NCT04721457|Hydrogen Peroxide|hydrogen peroxide|mesh-list
153848737|NCT04721457|Cetylpyridinium|cetylpyridinium|mesh-list
153848738|NCT04721457|Sodium Hypochlorite|sodium hypochlorite|mesh-list
153848740|NCT04721457|Povidone|povidone|mesh-list
153848741|NCT04721457|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
153848742|NCT04721457|Sodium Fluoride|sodium fluoride|mesh-list
153848743|NCT04721457|Plasma Substitutes|plasma substitutes|mesh-ancestor
153732297|NCT00141362|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153732298|NCT00141362|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153732299|NCT00155259|Docetaxel|docetaxel|mesh-list
153732300|NCT00155259|Capecitabine|capecitabine|mesh-list
153732301|NCT00155259|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153732302|NCT00155259|Tubulin Modulators|tubulin modulators|mesh-ancestor
153732303|NCT00155259|Antimitotic Agents|antimitotic agents|mesh-ancestor
153732304|NCT00155259|Mitosis Modulators|mitosis modulators|mesh-ancestor
153732305|NCT00155259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153732306|NCT00155259|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153732307|NCT00155259|Antimetabolites|antimetabolites|mesh-ancestor
153732308|NCT00141401|Pregabalin|pregabalin|mesh-list
153732309|NCT00141401|Analgesics|analgesics|mesh-ancestor
153732310|NCT00141401|Sensory System Agents|sensory system agents|mesh-ancestor
153732311|NCT00141401|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153732312|NCT00141401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153732313|NCT00141401|Anticonvulsants|anticonvulsants|mesh-ancestor
153732314|NCT00141401|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153732315|NCT00141401|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153732316|NCT00141401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153732317|NCT00141401|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153732318|NCT00141401|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153732319|NCT00141401|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153848745|NCT04721457|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
153848746|NCT04721457|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153848747|NCT04721457|Cariostatic Agents|cariostatic agents|mesh-ancestor
153848748|NCT04721457|Protective Agents|protective agents|mesh-ancestor
153848749|NCT04721457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153848750|NCT04721457|Disinfectants|disinfectants|mesh-ancestor
153848751|NCT04665986|Docetaxel|docetaxel|mesh-list
153848752|NCT04665986|Vinorelbine|vinorelbine|mesh-list
153848753|NCT04665986|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153848754|NCT04665986|Tubulin Modulators|tubulin modulators|mesh-ancestor
153848755|NCT04665986|Antimitotic Agents|antimitotic agents|mesh-ancestor
153848756|NCT04665986|Mitosis Modulators|mitosis modulators|mesh-ancestor
153848757|NCT04665986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153732327|NCT00505102|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153732328|NCT00505102|Immunologic Factors|immunologic factors|mesh-ancestor
153732329|NCT00505102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153732330|NCT00505102|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153732331|NCT00404378|Ketoconazole|ketoconazole|mesh-list
153732332|NCT00404378|Casopitant|casopitant|mesh-list
153732333|NCT00404378|Antifungal Agents|antifungal agents|mesh-ancestor
153732334|NCT00404378|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153848758|NCT04665986|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153848759|NCT04638309|Azacitidine|azacitidine|mesh-list
153848760|NCT04638309|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153848761|NCT04638309|Antimetabolites|antimetabolites|mesh-ancestor
153848762|NCT04638309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153848763|NCT04638309|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153848764|NCT04638309|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153848765|NCT04665830|Evolocumab|evolocumab|mesh-list
153848766|NCT04665830|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
153848767|NCT04665830|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153821294|NCT00437996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153821295|NCT00437996|Anesthetics, Local|anesthetics, local|mesh-ancestor
153821296|NCT04701242|Ezetimibe|ezetimibe|mesh-list
153821299|NCT04701242|Antimetabolites|antimetabolites|mesh-ancestor
153848770|NCT04665830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153848790|NCT04683237|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
153848791|NCT04683237|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153848792|NCT04683237|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153848793|NCT04683237|Appetite Stimulants|appetite stimulants|mesh-ancestor
153848794|NCT04683237|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
153848795|NCT04665362|Apatinib|apatinib|mesh-list
153848796|NCT04665362|Antibodies|antibodies|mesh-list
153848797|NCT04665362|Immunologic Factors|immunologic factors|mesh-ancestor
153848798|NCT04665362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153848799|NCT04665362|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153848800|NCT04665362|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153848826|NCT00557102|Antimetabolites|antimetabolites|mesh-ancestor
153848827|NCT00557102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153848828|NCT00557102|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153848829|NCT00557102|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153848830|NCT00557102|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153848831|NCT00557102|Immunologic Factors|immunologic factors|mesh-ancestor
153848832|NCT00557102|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
153848833|NCT00557102|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153848834|NCT00557102|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153848835|NCT00557102|Antidotes|antidotes|mesh-ancestor
153848836|NCT00557102|Protective Agents|protective agents|mesh-ancestor
153848837|NCT00557102|Vitamin B Complex|vitamin b complex|mesh-ancestor
153848838|NCT00557102|Vitamins|vitamins|mesh-ancestor
153848839|NCT00557102|Micronutrients|micronutrients|mesh-ancestor
153848840|NCT00557102|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153388982|NCT00002163|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153461628|NCT03249558|Morphine|morphine|mesh-list
153461629|NCT03249558|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
153461630|NCT03249558|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153461631|NCT03249558|Narcotics|narcotics|mesh-ancestor
153461632|NCT03249558|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153461633|NCT03249558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153461634|NCT03249558|Analgesics|analgesics|mesh-ancestor
153461635|NCT03249558|Sensory System Agents|sensory system agents|mesh-ancestor
153461636|NCT03249558|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153461637|NCT03249558|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
153647926|NCT00019786|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153647927|NCT00019786|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153388983|NCT00002163|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153388984|NCT00002325|Fluconazole|fluconazole|mesh-list
153388985|NCT00002325|Antifungal Agents|antifungal agents|mesh-ancestor
153388986|NCT00002325|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153388987|NCT00002325|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
153388988|NCT00002325|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153388989|NCT00002325|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153388990|NCT00002325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153388991|NCT00002325|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153388992|NCT00002325|Hormone Antagonists|hormone antagonists|mesh-ancestor
153389012|NCT00002337|Immunologic Factors|immunologic factors|mesh-ancestor
153389013|NCT00002337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153389014|NCT00002337|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153389015|NCT00002337|Antiviral Agents|antiviral agents|mesh-ancestor
153389016|NCT00002337|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153848841|NCT01209286|Blinatumomab|blinatumomab|mesh-list
153848842|NCT01209286|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153848843|NCT04663763|Capecitabine|capecitabine|mesh-list
153732335|NCT00404378|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
153732336|NCT00404378|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153732337|NCT00404378|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153732338|NCT00404378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153732339|NCT00404378|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153732340|NCT00404378|Hormone Antagonists|hormone antagonists|mesh-ancestor
153732341|NCT00404378|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153732342|NCT00404378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153732343|NCT00404378|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
153732344|NCT00404378|Antiemetics|antiemetics|mesh-ancestor
153848844|NCT04663763|Oxaliplatin|oxaliplatin|mesh-list
153848858|NCT04351737|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
153848859|NCT04351737|Prednisolone phosphate|prednisolone phosphate|mesh-list
153848860|NCT04351737|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153848861|NCT04351737|Antiemetics|antiemetics|mesh-ancestor
153848862|NCT04351737|Autonomic Agents|autonomic agents|mesh-ancestor
153848863|NCT04351737|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153848864|NCT04351737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153848865|NCT04351737|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153848866|NCT04351737|Glucocorticoids|glucocorticoids|mesh-ancestor
153848867|NCT04351737|Hormones|hormones|mesh-ancestor
153848868|NCT04351737|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153848891|NCT04662866|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153848892|NCT04662866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153389033|NCT02293902|Methotrexate|methotrexate|mesh-list
153389034|NCT02293902|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
153389035|NCT02293902|Abortifacient Agents|abortifacient agents|mesh-ancestor
153389036|NCT02293902|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153389037|NCT02293902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153389038|NCT02293902|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153389039|NCT02293902|Antimetabolites|antimetabolites|mesh-ancestor
153389040|NCT02293902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153389041|NCT02293902|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153389042|NCT02293902|Dermatologic Agents|dermatologic agents|mesh-ancestor
153389043|NCT02293902|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153389044|NCT02293902|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153389045|NCT02293902|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153389046|NCT02293902|Immunologic Factors|immunologic factors|mesh-ancestor
153389047|NCT02293902|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153389048|NCT02293902|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153389049|NCT02293902|Hematinics|hematinics|mesh-ancestor
153389050|NCT02293902|Vitamin B Complex|vitamin b complex|mesh-ancestor
153389051|NCT02293902|Vitamins|vitamins|mesh-ancestor
153389052|NCT02293902|Micronutrients|micronutrients|mesh-ancestor
153732348|NCT00404378|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
153732349|NCT00404378|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153732351|NCT04511728|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153732352|NCT04511728|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153732353|NCT04511728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153732354|NCT04511728|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153732355|NCT04511728|Anesthetics, General|anesthetics, general|mesh-ancestor
153732356|NCT04511728|Anesthetics|anesthetics|mesh-ancestor
153732357|NCT00162318|Cetuximab|cetuximab|mesh-list
153732358|NCT00162318|Gefitinib|gefitinib|mesh-list
153732359|NCT00162318|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153365982|NCT01652495|Prednisolone|prednisolone|mesh-list
153732360|NCT00162318|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153732361|NCT00162318|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153732362|NCT00162318|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153732363|NCT00162318|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153732364|NCT00162318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153848909|NCT03986424|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
153848910|NCT03986424|Dopamine Agents|dopamine agents|mesh-ancestor
153848911|NCT03986424|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153848912|NCT03986424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153848913|NCT03986424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153848914|NCT03986424|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
153848915|NCT03986424|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
153848916|NCT00557180|Beclomethasone|beclomethasone|mesh-list
153848917|NCT00557180|Bromides|bromides|mesh-list
153389060|NCT00002349|Antimetabolites|antimetabolites|mesh-ancestor
153389061|NCT00002349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153389062|NCT00002349|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153389063|NCT00002349|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153389064|NCT00002349|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153389065|NCT00002349|Antiviral Agents|antiviral agents|mesh-ancestor
153389100|NCT00002181|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153389101|NCT00002181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153389103|NCT00002367|Zidovudine|zidovudine|mesh-list
153848930|NCT00557180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153848931|NCT00557180|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
153848932|NCT00557180|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
153848933|NCT00557180|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153848934|NCT00557180|Adrenergic Agents|adrenergic agents|mesh-ancestor
153732367|NCT00404417|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
153732368|NCT00404417|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
153732369|NCT00404417|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153732370|NCT00404417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153732371|NCT00404417|Cholinergic Agents|cholinergic agents|mesh-ancestor
153732372|NCT00404417|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153848935|NCT00557180|Anticonvulsants|anticonvulsants|mesh-ancestor
153848936|NCT00557180|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153848937|NCT00557180|Glucocorticoids|glucocorticoids|mesh-ancestor
153848939|NCT00557180|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153848940|NCT00557219|Fenoldopam|fenoldopam|mesh-list
153848941|NCT00557219|Ketanserin|ketanserin|mesh-list
153848942|NCT00557219|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153848962|NCT03798405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153848963|NCT03798405|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153848965|NCT04661696|Carboplatin|carboplatin|mesh-list
153848966|NCT04661696|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153848967|NCT04661696|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153848968|NCT04661696|Tubulin Modulators|tubulin modulators|mesh-ancestor
153848969|NCT04661696|Antimitotic Agents|antimitotic agents|mesh-ancestor
153848970|NCT04661696|Mitosis Modulators|mitosis modulators|mesh-ancestor
153848972|NCT06087289|Carboplatin|carboplatin|mesh-list
153389126|NCT00002379|Zidovudine|zidovudine|mesh-list
153389127|NCT00002379|Stavudine|stavudine|mesh-list
153389128|NCT00002379|Adefovir|adefovir|mesh-list
153389129|NCT00002379|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
153389130|NCT00002379|Indinavir|indinavir|mesh-list
153389131|NCT00002379|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153389132|NCT00002379|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153389133|NCT00002379|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153389134|NCT00002379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153389135|NCT00002379|Antiviral Agents|antiviral agents|mesh-ancestor
153389136|NCT00002379|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153389137|NCT00002379|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153389138|NCT00002379|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153389161|NCT00002193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153389162|NCT00002193|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153647934|NCT00019825|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153647935|NCT00019825|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153647936|NCT00019864|Leucovorin|leucovorin|mesh-list
153389163|NCT00002193|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153389164|NCT00002193|Antiviral Agents|antiviral agents|mesh-ancestor
153389165|NCT00002391|Lamivudine|lamivudine|mesh-list
153389166|NCT00002391|Zidovudine|zidovudine|mesh-list
153389167|NCT00002391|Abacavir|abacavir|mesh-list
153389168|NCT00002391|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153389169|NCT00002391|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153848993|NCT06087211|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153848994|NCT06087211|Tocolytic Agents|tocolytic agents|mesh-ancestor
153848995|NCT06087211|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153848996|NCT06087055|Ritonavir|ritonavir|mesh-list
153848997|NCT06087055|Itraconazole|itraconazole|mesh-list
153848998|NCT06087055|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
153389180|NCT00002199|Lamivudine, zidovudine drug combination|lamivudine, zidovudine drug combination|mesh-list
153732391|NCT00404534|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153732392|NCT00404534|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
153732393|NCT00404534|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153732394|NCT00404534|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
153732395|NCT00404534|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153395368|NCT02504723|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153389182|NCT00002199|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153389183|NCT00002199|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153389217|NCT00002205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153389218|NCT00002205|Antiviral Agents|antiviral agents|mesh-ancestor
153389219|NCT00002205|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153389220|NCT00002205|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153849074|NCT06085417|Magnesium Sulfate|magnesium sulfate|mesh-list
153389222|NCT00002205|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
153389223|NCT00002205|Antitubercular Agents|antitubercular agents|mesh-ancestor
153389224|NCT00002205|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153389225|NCT00002205|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
153389226|NCT00002205|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
153389227|NCT00002205|Protease Inhibitors|protease inhibitors|mesh-ancestor
153389251|NCT00002409|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153361333|NCT00872534|Analgesics|analgesics|mesh-ancestor
153361334|NCT00872534|Sensory System Agents|sensory system agents|mesh-ancestor
153361335|NCT00872534|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153361336|NCT00872534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153361337|NCT00872534|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153361338|NCT00872534|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153361339|NCT00872534|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153361340|NCT00872534|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153821360|NCT00438152|Protease Inhibitors|protease inhibitors|mesh-ancestor
153389252|NCT00002409|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153389253|NCT00002409|Antimetabolites|antimetabolites|mesh-ancestor
153389254|NCT00002211|Nelfinavir|nelfinavir|mesh-list
153389255|NCT00002211|Didanosine|didanosine|mesh-list
153389256|NCT00002211|Stavudine|stavudine|mesh-list
153389257|NCT00002211|Delavirdine|delavirdine|mesh-list
153389258|NCT00002211|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
153389259|NCT00002211|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
153389260|NCT00002211|Protease Inhibitors|protease inhibitors|mesh-ancestor
153389261|NCT00002211|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153389319|NCT00002223|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
153389320|NCT00002223|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
153389321|NCT00002223|Protease Inhibitors|protease inhibitors|mesh-ancestor
153732396|NCT00404534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153732397|NCT00404534|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
153732398|NCT00404534|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
153732399|NCT00404534|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153732400|NCT00505258|Ceftobiprole|ceftobiprole|mesh-list
153732401|NCT00505258|Ceftobiprole medocaril|ceftobiprole medocaril|mesh-list
153732402|NCT00505258|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153732403|NCT00505258|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153732404|NCT00162396|Albuterol|albuterol|mesh-list
153732405|NCT00162396|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153732406|NCT00162396|Autonomic Agents|autonomic agents|mesh-ancestor
153732407|NCT00162396|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153732408|NCT00162396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153732409|NCT00162396|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153732410|NCT00162396|Respiratory System Agents|respiratory system agents|mesh-ancestor
153849161|NCT06077981|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153849162|NCT06077981|Immunologic Factors|immunologic factors|mesh-ancestor
153849163|NCT06077981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153849164|NCT06077981|Viscosupplements|viscosupplements|mesh-ancestor
153849165|NCT06077981|Protective Agents|protective agents|mesh-ancestor
153849166|NCT06076668|Dexmedetomidine|dexmedetomidine|mesh-list
153849167|NCT06076668|Melatonin|melatonin|mesh-list
153849168|NCT06076668|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153849169|NCT06076668|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153849170|NCT06076668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153849171|NCT06076668|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153849172|NCT06076668|Analgesics|analgesics|mesh-ancestor
153849173|NCT06076668|Sensory System Agents|sensory system agents|mesh-ancestor
153849174|NCT06076668|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153849175|NCT06076668|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
153849176|NCT06076668|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153849177|NCT06076668|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153849178|NCT06076668|Adrenergic Agents|adrenergic agents|mesh-ancestor
153849179|NCT06076668|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153849180|NCT06076668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153849181|NCT06076668|Antioxidants|antioxidants|mesh-ancestor
153849182|NCT06076668|Protective Agents|protective agents|mesh-ancestor
153849183|NCT06072521|Lactoferrin|lactoferrin|mesh-list
153732413|NCT00162396|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
153732414|NCT00162396|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
153732416|NCT00162396|Adrenergic Agents|adrenergic agents|mesh-ancestor
153569469|NCT03511118|Sympathomimetics|sympathomimetics|mesh-ancestor
153389371|NCT00002235|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153389372|NCT00002235|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153389373|NCT00002235|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153389392|NCT00002463|Procarbazine|procarbazine|mesh-list
153389393|NCT00002463|Mechlorethamine|mechlorethamine|mesh-list
153389394|NCT00002463|Calcium|calcium|mesh-list
153389395|NCT00002463|Levoleucovorin|levoleucovorin|mesh-list
153389396|NCT00002463|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153389397|NCT00002463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153389398|NCT00002463|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153389399|NCT00002463|Glucocorticoids|glucocorticoids|mesh-ancestor
153389400|NCT00002463|Hormones|hormones|mesh-ancestor
153389401|NCT00002463|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153389402|NCT00002463|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153389403|NCT00002463|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153389404|NCT00002463|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
153389427|NCT00002463|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153389428|NCT00002247|Ganciclovir|ganciclovir|mesh-list
153389429|NCT00002247|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
153389430|NCT00002247|Antiviral Agents|antiviral agents|mesh-ancestor
153389431|NCT00002247|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153389432|NCT00002247|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153389433|NCT00002247|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153389434|NCT00002247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153389435|NCT00002475|Interferons|interferons|mesh-list
153389436|NCT00002475|Interferon-alpha|interferon-alpha|mesh-list
153389437|NCT00002475|Interferon-gamma|interferon-gamma|mesh-list
153389438|NCT00002475|Cyclophosphamide|cyclophosphamide|mesh-list
153389439|NCT00002475|Vaccines|vaccines|mesh-list
153389440|NCT00002475|Sargramostim|sargramostim|mesh-list
153389441|NCT00002475|Immunologic Factors|immunologic factors|mesh-ancestor
153389442|NCT00002475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153389554|NCT00002499|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153389555|NCT00002499|Antiviral Agents|antiviral agents|mesh-ancestor
153389556|NCT00002499|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153389557|NCT00002499|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153389558|NCT00002499|Tubulin Modulators|tubulin modulators|mesh-ancestor
153389559|NCT00002499|Antimitotic Agents|antimitotic agents|mesh-ancestor
153389560|NCT00002499|Mitosis Modulators|mitosis modulators|mesh-ancestor
153389561|NCT00002499|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153389562|NCT00002499|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153389563|NCT00002499|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153389565|NCT00002505|Interferon-gamma|interferon-gamma|mesh-list
153826103|NCT00601315|Clarithromycin|clarithromycin|mesh-list
153389566|NCT00002505|Vaccines|vaccines|mesh-list
153389567|NCT00002505|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153389568|NCT00002505|Antiviral Agents|antiviral agents|mesh-ancestor
153389569|NCT00002505|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153849380|NCT05419362|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153849381|NCT05419362|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153849382|NCT05359731|Dexamethasone|dexamethasone|mesh-list
153849383|NCT05359731|Bupivacaine|bupivacaine|mesh-list
153849384|NCT05359731|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153849385|NCT05359731|Antiemetics|antiemetics|mesh-ancestor
153849414|NCT05341817|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153849415|NCT05341817|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153389570|NCT00002505|Immunologic Factors|immunologic factors|mesh-ancestor
153389571|NCT00002505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153389572|NCT00002265|Zalcitabine|zalcitabine|mesh-list
153389573|NCT00002265|Antimetabolites|antimetabolites|mesh-ancestor
153849416|NCT05341817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153389574|NCT00002265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153389575|NCT00002265|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153389576|NCT00002265|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153389577|NCT00002265|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153389578|NCT00002265|Antiviral Agents|antiviral agents|mesh-ancestor
153389579|NCT00002265|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153389580|NCT00002265|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153389581|NCT00002265|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153389584|NCT00002271|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153389585|NCT00002517|Cytarabine|cytarabine|mesh-list
153849426|NCT05341817|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
153849427|NCT05341817|Contraceptive Agents|contraceptive agents|mesh-ancestor
153849428|NCT05341817|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
153849429|NCT05341817|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
153849430|NCT05341817|Luteolytic Agents|luteolytic agents|mesh-ancestor
153849431|NCT05341817|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
153849432|NCT05341817|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
153849433|NCT05290090|Rituximab|rituximab|mesh-list
153849434|NCT05290090|Lenalidomide|lenalidomide|mesh-list
153849435|NCT05290090|Zanubrutinib|zanubrutinib|mesh-list
153849436|NCT05290090|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153849437|NCT05290090|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153849438|NCT05290090|Immunologic Factors|immunologic factors|mesh-ancestor
153389643|NCT00002523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153389645|NCT00002523|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153389646|NCT00002523|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153389647|NCT00002523|Immunologic Factors|immunologic factors|mesh-ancestor
153389648|NCT00002523|Antidotes|antidotes|mesh-ancestor
153389649|NCT00002523|Protective Agents|protective agents|mesh-ancestor
153389650|NCT00002523|Vitamin B Complex|vitamin b complex|mesh-ancestor
153389651|NCT00002523|Vitamins|vitamins|mesh-ancestor
153389679|NCT00002217|Lamivudine|lamivudine|mesh-list
153389680|NCT00002217|Zidovudine|zidovudine|mesh-list
153389681|NCT00002217|Abacavir|abacavir|mesh-list
153389682|NCT00002217|Lamivudine, zidovudine drug combination|lamivudine, zidovudine drug combination|mesh-list
153389683|NCT00002217|Amprenavir|amprenavir|mesh-list
153389684|NCT00002217|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153389685|NCT00002217|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153361370|NCT01507103|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153361371|NCT01507103|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153361372|NCT01507103|Alkylating Agents|alkylating agents|mesh-ancestor
153361373|NCT01507103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153361374|NCT01507103|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153361376|NCT02480010|Pertuzumab|pertuzumab|mesh-list
153389686|NCT00002217|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153389687|NCT00002217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153389688|NCT00002217|Antiviral Agents|antiviral agents|mesh-ancestor
153389689|NCT00002217|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153389690|NCT00002217|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153732421|NCT04518982|Lenalidomide|lenalidomide|mesh-list
153732422|NCT04518982|Immunologic Factors|immunologic factors|mesh-ancestor
153732423|NCT04518982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153732424|NCT04518982|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153732425|NCT04518982|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153732426|NCT04518982|Growth Substances|growth substances|mesh-ancestor
153732427|NCT04518982|Growth Inhibitors|growth inhibitors|mesh-ancestor
153732428|NCT04518982|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153732429|NCT00155376|Morphine|morphine|mesh-list
153732430|NCT00155376|Glucagon|glucagon|mesh-list
153732431|NCT00155376|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153732432|NCT00155376|Narcotics|narcotics|mesh-ancestor
153732433|NCT00155376|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153732434|NCT00155376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153732435|NCT00155376|Analgesics|analgesics|mesh-ancestor
153732436|NCT00155376|Sensory System Agents|sensory system agents|mesh-ancestor
153732437|NCT00155376|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153732438|NCT00155376|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153732439|NCT00155376|Hormones|hormones|mesh-ancestor
153732440|NCT00155376|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153732441|NCT00141557|Methyltestosterone|methyltestosterone|mesh-list
153732442|NCT00141557|Estrogens|estrogens|mesh-list
153732443|NCT00141557|Estrogens, Esterified (USP)|estrogens, esterified (usp)|mesh-list
153732444|NCT00141557|Estrone|estrone|mesh-list
153732445|NCT00141557|Testosterone|testosterone|mesh-list
153732446|NCT00141557|Testosterone undecanoate|testosterone undecanoate|mesh-list
153732447|NCT00141557|Testosterone enanthate|testosterone enanthate|mesh-list
153732448|NCT00141557|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
153389705|NCT00002283|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153849621|NCT04592809|Ketamine|ketamine|mesh-list
153849622|NCT04592809|Analgesics|analgesics|mesh-ancestor
153849623|NCT04592809|Sensory System Agents|sensory system agents|mesh-ancestor
153849624|NCT04592809|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153849625|NCT04592809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153849626|NCT04592809|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
153732449|NCT00141557|Hormones|hormones|mesh-ancestor
153389787|NCT00002547|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153389808|NCT00002553|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153389809|NCT00002553|Alkylating Agents|alkylating agents|mesh-ancestor
153389810|NCT00002553|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153389811|NCT00002553|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153389812|NCT00002553|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153389813|NCT00002553|Trace Elements|trace elements|mesh-ancestor
153389814|NCT00002553|Micronutrients|micronutrients|mesh-ancestor
153389815|NCT00002559|Paclitaxel|paclitaxel|mesh-list
153389816|NCT00002559|Ifosfamide|ifosfamide|mesh-list
153389817|NCT00002559|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153389818|NCT00002559|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153389819|NCT00002559|Tubulin Modulators|tubulin modulators|mesh-ancestor
153389820|NCT00002559|Antimitotic Agents|antimitotic agents|mesh-ancestor
153389821|NCT00002559|Mitosis Modulators|mitosis modulators|mesh-ancestor
153389846|NCT00002565|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153389847|NCT00002565|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153389848|NCT00002565|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153389849|NCT00002565|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153389850|NCT00002565|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153389851|NCT00002565|Glucocorticoids|glucocorticoids|mesh-ancestor
153389852|NCT00002565|Hormones|hormones|mesh-ancestor
153389853|NCT00002565|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153389854|NCT00002565|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153361405|NCT01507181|Anesthetics, General|anesthetics, general|mesh-ancestor
153389856|NCT00002565|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153389857|NCT00002565|Antimetabolites|antimetabolites|mesh-ancestor
153389858|NCT00002565|Antiviral Agents|antiviral agents|mesh-ancestor
153389859|NCT00002565|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153389860|NCT00002565|Tubulin Modulators|tubulin modulators|mesh-ancestor
153389861|NCT00002565|Antimitotic Agents|antimitotic agents|mesh-ancestor
153389862|NCT00002565|Mitosis Modulators|mitosis modulators|mesh-ancestor
153389863|NCT00002565|Antiemetics|antiemetics|mesh-ancestor
153389864|NCT00002565|Autonomic Agents|autonomic agents|mesh-ancestor
153389865|NCT00002565|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153389866|NCT00002565|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153389867|NCT00002565|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
153389868|NCT00002565|Protective Agents|protective agents|mesh-ancestor
153849702|NCT04169191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153849703|NCT04169191|Vasodilator Agents|vasodilator agents|mesh-ancestor
153849704|NCT04169191|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
153389902|NCT00002571|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153389903|NCT00002571|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
153389904|NCT00002571|Abortifacient Agents|abortifacient agents|mesh-ancestor
153389905|NCT00002571|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153389906|NCT00002571|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153389907|NCT00002571|Antimetabolites|antimetabolites|mesh-ancestor
153389908|NCT00002571|Dermatologic Agents|dermatologic agents|mesh-ancestor
153389909|NCT00002571|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153389910|NCT00002571|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153389911|NCT00002571|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153389912|NCT00002571|Antiviral Agents|antiviral agents|mesh-ancestor
153389913|NCT00002571|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153389914|NCT00002571|Antidotes|antidotes|mesh-ancestor
153389915|NCT00002571|Protective Agents|protective agents|mesh-ancestor
153849738|NCT04108481|Autonomic Agents|autonomic agents|mesh-ancestor
153849739|NCT04108481|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153849740|NCT04108481|Dopamine Agents|dopamine agents|mesh-ancestor
153849741|NCT04108481|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153849749|NCT04073303|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
153849750|NCT04073303|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
153732450|NCT00141557|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153647950|NCT00019864|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153647951|NCT00019864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153647952|NCT00019864|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
153647953|NCT00019864|Abortifacient Agents|abortifacient agents|mesh-ancestor
153647954|NCT00019864|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153647955|NCT00019864|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153647956|NCT00019864|Antimetabolites|antimetabolites|mesh-ancestor
153647957|NCT00019864|Dermatologic Agents|dermatologic agents|mesh-ancestor
153647958|NCT00019864|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153647959|NCT00019864|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153732451|NCT00141557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153732452|NCT00141557|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153732453|NCT00141557|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153732454|NCT00141557|Anabolic Agents|anabolic agents|mesh-ancestor
153732455|NCT00141557|Androgens|androgens|mesh-ancestor
153821496|NCT00438737|Micronutrients|micronutrients|mesh-ancestor
153821497|NCT00438776|Olanzapine|olanzapine|mesh-list
153821498|NCT00438776|Antiemetics|antiemetics|mesh-ancestor
153821499|NCT00438776|Autonomic Agents|autonomic agents|mesh-ancestor
153821500|NCT00438776|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153361448|NCT00878228|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153361449|NCT00878228|Serotonin Agents|serotonin agents|mesh-ancestor
153361450|NCT00878228|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153361451|NCT00878228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153361452|NCT01391273|Bimatoprost|bimatoprost|mesh-list
153361453|NCT01391273|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
153361454|NCT01391273|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153361455|NCT01429259|Meropenem|meropenem|mesh-list
153361456|NCT01429259|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153361457|NCT01429259|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153732456|NCT00162474|Phenytoin|phenytoin|mesh-list
153732457|NCT00162474|Warfarin|warfarin|mesh-list
153732458|NCT00162474|Anticoagulants|anticoagulants|mesh-ancestor
153732459|NCT00162474|Anticonvulsants|anticonvulsants|mesh-ancestor
153732460|NCT00162474|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
153732461|NCT00162474|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153732462|NCT00162474|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153732463|NCT00162474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153732464|NCT00162474|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
153732465|NCT00162474|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
153732466|NCT04518553|Antiviral Agents|antiviral agents|mesh-list
153732467|NCT04518553|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153732468|NCT00505336|Eplerenone|eplerenone|mesh-list
153732469|NCT00505336|Atorvastatin|atorvastatin|mesh-list
153732470|NCT00505336|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153732471|NCT00505336|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153389920|NCT00002571|Antimitotic Agents|antimitotic agents|mesh-ancestor
153389921|NCT00002571|Mitosis Modulators|mitosis modulators|mesh-ancestor
153389922|NCT00002571|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
153389923|NCT00002571|Antimalarials|antimalarials|mesh-ancestor
153389924|NCT00002571|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153389925|NCT00002571|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153389926|NCT00002571|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
153389927|NCT00002571|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
153389928|NCT00002571|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153389929|NCT00002571|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153389950|NCT02223871|Lumefantrine|lumefantrine|mesh-list
153389951|NCT02223871|Artemether|artemether|mesh-list
153389952|NCT02223871|Primaquine|primaquine|mesh-list
153389953|NCT02223871|Antimalarials|antimalarials|mesh-ancestor
153389954|NCT02223871|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153389955|NCT02223871|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153389956|NCT02223871|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153389965|NCT00002595|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153389966|NCT03004339|Betamethasone|betamethasone|mesh-list
153389967|NCT03004339|Betamethasone Valerate|betamethasone valerate|mesh-list
153389968|NCT03004339|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
153389969|NCT03004339|Betamethasone benzoate|betamethasone benzoate|mesh-list
153389970|NCT03004339|Calcipotriene|calcipotriene|mesh-list
153389971|NCT03004339|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
153389972|NCT03004339|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153389973|NCT03004339|Glucocorticoids|glucocorticoids|mesh-ancestor
153389974|NCT03004339|Hormones|hormones|mesh-ancestor
153389975|NCT03004339|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153849796|NCT03949673|Gout Suppressants|gout suppressants|mesh-ancestor
153849798|NCT03919955|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
153849799|NCT03919955|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
153648010|NCT00009984|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153648011|NCT00009984|Antimetabolites|antimetabolites|mesh-ancestor
153648012|NCT00009984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153648014|NCT00009984|Immunologic Factors|immunologic factors|mesh-ancestor
153849800|NCT03919955|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153849801|NCT03919955|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153849802|NCT03919955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153849803|NCT03919955|Adrenergic Agents|adrenergic agents|mesh-ancestor
153389976|NCT03004339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153389977|NCT03004339|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153389981|NCT00002619|Thiotepa|thiotepa|mesh-list
153849891|NCT03386539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153849892|NCT03386539|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
153849893|NCT03386539|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153849894|NCT03386539|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153849895|NCT03386539|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153849896|NCT03386539|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
153849897|NCT03386539|Antitubercular Agents|antitubercular agents|mesh-ancestor
153849898|NCT03386539|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153390075|NCT05806723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153390076|NCT05806723|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153390077|NCT05806723|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
153390079|NCT05806697|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
153390080|NCT05806697|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
153390081|NCT05806697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153390083|NCT05806671|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153390084|NCT05806671|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153849903|NCT03304821|Immunologic Factors|immunologic factors|mesh-ancestor
153849904|NCT03304821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153849907|NCT03267121|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153849908|NCT03267121|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153849909|NCT03267121|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153849910|NCT03267121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153849911|NCT03267121|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153849912|NCT03267121|Antimetabolites|antimetabolites|mesh-ancestor
153849913|NCT03253679|Adavosertib|adavosertib|mesh-list
153849914|NCT03253679|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153849915|NCT03253679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153849916|NCT03095352|Carboplatin|carboplatin|mesh-list
153849917|NCT03095352|Pembrolizumab|pembrolizumab|mesh-list
153390119|NCT05806307|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153390120|NCT05806307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153390121|NCT05806307|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
153390122|NCT05806307|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153390123|NCT05806307|Autonomic Agents|autonomic agents|mesh-ancestor
153390124|NCT05806307|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153390125|NCT05806307|Respiratory System Agents|respiratory system agents|mesh-ancestor
153390126|NCT05806307|Mydriatics|mydriatics|mesh-ancestor
153390127|NCT05806307|Sympathomimetics|sympathomimetics|mesh-ancestor
153390128|NCT05806307|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
153390129|NCT05806307|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
153390130|NCT05806307|Abortifacient Agents|abortifacient agents|mesh-ancestor
153390131|NCT05806307|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
153390132|NCT05806307|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153390133|NCT05806307|Hemostatics|hemostatics|mesh-ancestor
153390134|NCT05806307|Coagulants|coagulants|mesh-ancestor
153390135|NCT05806307|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
153390136|NCT05806307|Natriuretic Agents|natriuretic agents|mesh-ancestor
153390137|NCT05806047|Fulvestrant|fulvestrant|mesh-list
153390138|NCT05806047|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153390139|NCT05806047|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153390140|NCT05806047|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
153390141|NCT05806047|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
153390142|NCT05806047|Hormone Antagonists|hormone antagonists|mesh-ancestor
153849958|NCT02899728|Podophyllotoxin|podophyllotoxin|mesh-list
153849959|NCT02899728|Cediranib|cediranib|mesh-list
153390181|NCT05804747|Antithrombins|antithrombins|mesh-ancestor
153390182|NCT05804747|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
153390183|NCT05804747|Protease Inhibitors|protease inhibitors|mesh-ancestor
153390184|NCT05804747|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153390185|NCT05804747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153390186|NCT05804747|Anticoagulants|anticoagulants|mesh-ancestor
153390187|NCT05800938|Isosorbide|isosorbide|mesh-list
153390188|NCT05800938|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
153390189|NCT05800938|Diuretics|diuretics|mesh-ancestor
153390190|NCT05800938|Natriuretic Agents|natriuretic agents|mesh-ancestor
153390191|NCT05800938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153390192|NCT05797935|Dapagliflozin|dapagliflozin|mesh-list
153390193|NCT05797935|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
153390194|NCT05797935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153390195|NCT05797935|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153390196|NCT05797935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153390197|NCT05775237|Vitamins|vitamins|mesh-list
153390198|NCT05775237|Ascorbic Acid|ascorbic acid|mesh-list
153390199|NCT05775237|Curcumin|curcumin|mesh-list
153390200|NCT05775237|Micronutrients|micronutrients|mesh-ancestor
153390201|NCT05775237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153390202|NCT05775237|Antioxidants|antioxidants|mesh-ancestor
153390203|NCT05775237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153849998|NCT02543268|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153849999|NCT02500797|Nivolumab|nivolumab|mesh-list
153390225|NCT05751044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153390226|NCT05751044|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153390227|NCT05751044|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153850051|NCT02005471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153850053|NCT01933932|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153850054|NCT01933932|Tubulin Modulators|tubulin modulators|mesh-ancestor
153850055|NCT01933932|Antimitotic Agents|antimitotic agents|mesh-ancestor
153850056|NCT01933932|Mitosis Modulators|mitosis modulators|mesh-ancestor
153850057|NCT01933932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153850059|NCT01711658|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153850060|NCT01711658|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153850061|NCT01711658|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153850062|NCT01711658|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153850063|NCT01711658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153850064|NCT01622868|Lapatinib|lapatinib|mesh-list
153850065|NCT01622868|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153850066|NCT01622868|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153850067|NCT01622868|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153850068|NCT01622868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153850069|NCT01622868|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153850070|NCT01518556|Idarubicin|idarubicin|mesh-list
153850071|NCT01518556|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153850072|NCT01518556|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153850073|NCT01518556|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153850074|NCT01518556|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153850075|NCT01518556|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153850076|NCT01518556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153850077|NCT00317720|Trastuzumab|trastuzumab|mesh-list
153850078|NCT00317720|Everolimus|everolimus|mesh-list
153850079|NCT00317720|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153850080|NCT00317720|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153850081|NCT00317720|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
153850082|NCT00317720|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153732472|NCT00505336|Antimetabolites|antimetabolites|mesh-ancestor
153732473|NCT00505336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153732474|NCT00505336|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153732475|NCT00505336|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
153395648|NCT02578901|Tranexamic Acid|tranexamic acid|mesh-list
153850083|NCT00317720|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153850084|NCT00317720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153850085|NCT00317720|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153850086|NCT00317720|Immunologic Factors|immunologic factors|mesh-ancestor
153850087|NCT00317720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153390279|NCT05511870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153390280|NCT05511870|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153390281|NCT05511870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153390283|NCT05492851|Viscosupplements|viscosupplements|mesh-ancestor
153390284|NCT05492851|Protective Agents|protective agents|mesh-ancestor
153390285|NCT05492851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153390286|NCT05423535|Fibrin Foam|fibrin foam|mesh-list
153390287|NCT05423535|Hemostatics|hemostatics|mesh-ancestor
153390288|NCT05423535|Coagulants|coagulants|mesh-ancestor
153390289|NCT05414409|Metformin|metformin|mesh-list
153850092|NCT00540072|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153850139|NCT01207687|Immunoglobulins|immunoglobulins|mesh-list
153850140|NCT01207687|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
153850141|NCT01207687|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153850142|NCT01207687|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153390321|NCT05161156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153390322|NCT05161156|Anticonvulsants|anticonvulsants|mesh-ancestor
153390323|NCT05132101|Palbociclib|palbociclib|mesh-list
153390324|NCT05132101|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153390325|NCT05132101|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153390326|NCT05132101|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153390327|NCT05132101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153390328|NCT05062395|Deoxyglucose|deoxyglucose|mesh-list
153395675|NCT04743011|Heparin|heparin|mesh-list
153390329|NCT05062395|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
153390330|NCT05062395|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
153390331|NCT05062395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153390332|NCT05062395|Antimetabolites|antimetabolites|mesh-ancestor
153390333|NCT05062395|Antiviral Agents|antiviral agents|mesh-ancestor
153390334|NCT05062395|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153390335|NCT05045950|Memantine|memantine|mesh-list
153390336|NCT05045950|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
153390337|NCT05045950|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
153390338|NCT05045950|Dopamine Agents|dopamine agents|mesh-ancestor
153390339|NCT05045950|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153390340|NCT05045950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153390341|NCT05045950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153390342|NCT05045950|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
153390343|NCT05045950|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
153850150|NCT01207453|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
153850151|NCT01207453|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153850152|NCT01207453|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153850153|NCT01207453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153850154|NCT01207453|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153850155|NCT01207453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153850156|NCT01207453|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153850157|NCT01207453|Analgesics|analgesics|mesh-ancestor
153850158|NCT01207453|Sensory System Agents|sensory system agents|mesh-ancestor
153850159|NCT01207453|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153850160|NCT01207453|Antidepressive Agents|antidepressive agents|mesh-ancestor
153850161|NCT01207453|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153850162|NCT00540345|Interferons|interferons|mesh-list
153850163|NCT00540345|Ribavirin|ribavirin|mesh-list
153850164|NCT00540345|Interferon-alpha|interferon-alpha|mesh-list
153850165|NCT00540345|Interferon alpha-2|interferon alpha-2|mesh-list
153390362|NCT04704050|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153390363|NCT04669210|Mycophenolic Acid|mycophenolic acid|mesh-list
153390364|NCT04669210|Tacrolimus|tacrolimus|mesh-list
153390365|NCT04669210|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153390366|NCT04669210|Immunologic Factors|immunologic factors|mesh-ancestor
153390367|NCT04669210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153850166|NCT00540345|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
153850167|NCT00540345|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153850168|NCT00540345|Antiviral Agents|antiviral agents|mesh-ancestor
153850169|NCT00540345|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153850170|NCT00540345|Antimetabolites|antimetabolites|mesh-ancestor
153648016|NCT00009984|Leprostatic Agents|leprostatic agents|mesh-ancestor
153648017|NCT00009984|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153648018|NCT00009984|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153648019|NCT00009984|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153648020|NCT00009984|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153648021|NCT00009984|Growth Substances|growth substances|mesh-ancestor
153648023|NCT00020332|Docetaxel|docetaxel|mesh-list
153850171|NCT00540345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153850172|NCT00540345|Immunologic Factors|immunologic factors|mesh-ancestor
153850173|NCT00540345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153850174|NCT01207414|Iloperidone|iloperidone|mesh-list
153850191|NCT04659551|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153850192|NCT04659551|Alkylating Agents|alkylating agents|mesh-ancestor
153850193|NCT04659551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153850194|NCT04659551|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153850195|NCT04659551|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153850196|NCT04659551|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153850197|NCT04659551|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153850205|NCT04659551|Hormone Antagonists|hormone antagonists|mesh-ancestor
153850206|NCT04659551|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153850207|NCT04659551|Luteolytic Agents|luteolytic agents|mesh-ancestor
153850209|NCT04659551|Contraceptive Agents|contraceptive agents|mesh-ancestor
153390406|NCT04578600|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153390408|NCT04389177|Cisplatin|cisplatin|mesh-list
153390409|NCT04389177|Pembrolizumab|pembrolizumab|mesh-list
153390410|NCT04389177|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153390411|NCT04389177|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153390412|NCT04389177|Tubulin Modulators|tubulin modulators|mesh-ancestor
153390432|NCT04341545|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153390433|NCT04341545|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153390434|NCT04341545|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
153390435|NCT04341545|Hormone Antagonists|hormone antagonists|mesh-ancestor
153390436|NCT04341545|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153390437|NCT04341545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153390439|NCT04219722|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153390440|NCT04219722|Immunologic Factors|immunologic factors|mesh-ancestor
153390441|NCT04219722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153390442|NCT04219722|Viscosupplements|viscosupplements|mesh-ancestor
153390443|NCT04219722|Protective Agents|protective agents|mesh-ancestor
153390444|NCT04186299|Clonidine|clonidine|mesh-list
153390445|NCT04186299|Epinephrine|epinephrine|mesh-list
153390446|NCT04186299|Carticaine|carticaine|mesh-list
153390447|NCT04186299|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153390448|NCT04186299|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153850273|NCT04658732|Antimanic Agents|antimanic agents|mesh-ancestor
153850274|NCT04658732|GABA Modulators|gaba modulators|mesh-ancestor
153850275|NCT04658732|GABA Agents|gaba agents|mesh-ancestor
153850276|NCT00540696|Darbepoetin alfa|darbepoetin alfa|mesh-list
153850277|NCT00540696|Hematinics|hematinics|mesh-ancestor
153850278|NCT04658420|Ketamine|ketamine|mesh-list
153850279|NCT04658420|Analgesics|analgesics|mesh-ancestor
153850280|NCT04658420|Sensory System Agents|sensory system agents|mesh-ancestor
153850281|NCT04658420|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153850282|NCT04658420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153850283|NCT04658420|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
153850284|NCT04658420|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153850285|NCT04658420|Anesthetics, General|anesthetics, general|mesh-ancestor
153850286|NCT04658420|Anesthetics|anesthetics|mesh-ancestor
153850287|NCT04658420|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153850288|NCT04658420|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
153850289|NCT04658420|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
153850290|NCT04658420|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153850291|NCT04658420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153850292|NCT00540891|Alfuzosin|alfuzosin|mesh-list
153850293|NCT00540891|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
153850294|NCT00540891|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
153850295|NCT00540891|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
153850296|NCT00540891|Adrenergic Agents|adrenergic agents|mesh-ancestor
153850297|NCT00540891|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153850298|NCT00540891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153390491|NCT03767933|Acetaminophen|acetaminophen|mesh-list
153390492|NCT03767933|Ibuprofen|ibuprofen|mesh-list
153390493|NCT03767933|Hydromorphone|hydromorphone|mesh-list
153648065|NCT00020488|Leucovorin|leucovorin|mesh-list
153732486|NCT04518202|Anesthetics, Local|anesthetics, local|mesh-ancestor
153732487|NCT04518202|Anesthetics|anesthetics|mesh-ancestor
153732488|NCT04518202|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153732489|NCT04518202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153732490|NCT04518202|Sensory System Agents|sensory system agents|mesh-ancestor
153732491|NCT04518202|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153732492|NCT04518202|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153732493|NCT04518202|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
153732494|NCT04518202|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153732495|NCT04518202|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153732496|NCT04518202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153732497|NCT04517890|Lidocaine|lidocaine|mesh-list
153732498|NCT04517890|Anesthetics, Local|anesthetics, local|mesh-ancestor
153732499|NCT04517890|Anesthetics|anesthetics|mesh-ancestor
153732500|NCT04517890|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153732501|NCT04517890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153732502|NCT04517890|Sensory System Agents|sensory system agents|mesh-ancestor
153390500|NCT03767933|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153390501|NCT03767933|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153390502|NCT03767933|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153390503|NCT03767933|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153390504|NCT03767933|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153850303|NCT04658225|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153850304|NCT04658225|Disinfectants|disinfectants|mesh-ancestor
153850305|NCT00540930|Ranibizumab|ranibizumab|mesh-list
153850306|NCT00540930|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153850307|NCT00540930|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153850308|NCT00540930|Growth Substances|growth substances|mesh-ancestor
153850336|NCT00541086|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
153850337|NCT00541086|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
153850338|NCT00541086|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153850339|NCT04657484|Prednisolone|prednisolone|mesh-list
153850347|NCT04657484|Glucocorticoids|glucocorticoids|mesh-ancestor
153850348|NCT04657484|Hormones|hormones|mesh-ancestor
153850349|NCT04657484|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153850350|NCT04657484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153850351|NCT04657484|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153850352|NCT04657484|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153850353|NCT04657484|Antiemetics|antiemetics|mesh-ancestor
153850354|NCT04657484|Autonomic Agents|autonomic agents|mesh-ancestor
153914610|NCT00930046|Anesthetics, Local|anesthetics, local|mesh-ancestor
153390535|NCT03555916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153390536|NCT03555916|Cholinergic Agents|cholinergic agents|mesh-ancestor
153390537|NCT03555916|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153390538|NCT03474497|Pembrolizumab|pembrolizumab|mesh-list
153390539|NCT03474497|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153390540|NCT03474497|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153390541|NCT03474497|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153390542|NCT03474497|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153390543|NCT03395223|Methylene Blue|methylene blue|mesh-list
153390544|NCT03395223|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153390545|NCT03395223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153390546|NCT03289650|Tacrolimus|tacrolimus|mesh-list
153390547|NCT03289650|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153390548|NCT03289650|Immunologic Factors|immunologic factors|mesh-ancestor
153390549|NCT03289650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153390550|NCT03289650|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
153390553|NCT03192397|Mycophenolic Acid|mycophenolic acid|mesh-list
153390584|NCT02975492|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153390585|NCT02867267|Thymalfasin|thymalfasin|mesh-list
153390586|NCT02867267|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153390587|NCT02867267|Immunologic Factors|immunologic factors|mesh-ancestor
153850375|NCT00541125|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153850376|NCT00541125|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153850377|NCT00541125|Immunologic Factors|immunologic factors|mesh-ancestor
153850378|NCT00541125|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
153850379|NCT00541125|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153850380|NCT00541125|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153850381|NCT00541125|Antidotes|antidotes|mesh-ancestor
153850382|NCT00541125|Protective Agents|protective agents|mesh-ancestor
153850383|NCT00541125|Vitamin B Complex|vitamin b complex|mesh-ancestor
153850384|NCT00541125|Vitamins|vitamins|mesh-ancestor
153850385|NCT00541125|Micronutrients|micronutrients|mesh-ancestor
153850386|NCT00541164|Ubiquinone|ubiquinone|mesh-list
153850387|NCT00541164|Coenzyme Q10|coenzyme q10|mesh-list
153850388|NCT00541164|Micronutrients|micronutrients|mesh-ancestor
153850389|NCT00541164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153850390|NCT00541164|Vitamins|vitamins|mesh-ancestor
153850391|NCT00541281|Prednisone|prednisone|mesh-list
153850392|NCT00541281|Docetaxel|docetaxel|mesh-list
153850393|NCT00541281|Estramustine|estramustine|mesh-list
153850394|NCT00541281|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153850395|NCT00541281|Tubulin Modulators|tubulin modulators|mesh-ancestor
153850396|NCT00541281|Antimitotic Agents|antimitotic agents|mesh-ancestor
153850397|NCT00541281|Mitosis Modulators|mitosis modulators|mesh-ancestor
153850399|NCT00541281|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153390599|NCT02821832|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153390600|NCT02821832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153390601|NCT02821832|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
153390602|NCT02821832|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
153390603|NCT02821832|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
153390604|NCT02821832|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
153390605|NCT02821832|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
153850418|NCT04657172|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153850419|NCT04657172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153850421|NCT04657172|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
153850422|NCT04657172|Cholinergic Agents|cholinergic agents|mesh-ancestor
153850423|NCT04657172|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153850424|NCT04657172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153850425|NCT03199794|Factor VIII|factor viii|mesh-list
153850426|NCT03199794|Coagulants|coagulants|mesh-ancestor
153850427|NCT00541359|Bortezomib|bortezomib|mesh-list
153850428|NCT00541359|Topotecan|topotecan|mesh-list
153850429|NCT00541359|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153850430|NCT00541359|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
153850431|NCT00541359|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153850432|NCT00541359|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153850433|NCT00541359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153850434|NCT03096249|Oxytocin|oxytocin|mesh-list
153850435|NCT03096249|Oxytocics|oxytocics|mesh-ancestor
153850436|NCT03096249|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153850437|NCT03096249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153850438|NCT04656665|Aspirin|aspirin|mesh-list
153850439|NCT04656665|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153850440|NCT04656665|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153390655|NCT01370811|Oxybutynin|oxybutynin|mesh-list
153390656|NCT01370811|Analgesics|analgesics|mesh-ancestor
153390657|NCT01370811|Sensory System Agents|sensory system agents|mesh-ancestor
153390658|NCT01370811|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153390659|NCT01370811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153390660|NCT01370811|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153390661|NCT01370811|Sympatholytics|sympatholytics|mesh-ancestor
153390662|NCT01370811|Autonomic Agents|autonomic agents|mesh-ancestor
153390663|NCT01370811|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
153390664|NCT01370811|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153390665|NCT01370811|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153850451|NCT04656665|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153850452|NCT04656665|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153850453|NCT04656665|Antipyretics|antipyretics|mesh-ancestor
153850454|NCT03014622|Botulinum Toxins|botulinum toxins|mesh-list
153850455|NCT03014622|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
153850456|NCT03014622|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
153850457|NCT03014622|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
153850458|NCT03014622|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153850459|NCT03014622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153850460|NCT03014622|Cholinergic Agents|cholinergic agents|mesh-ancestor
153850461|NCT03014622|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153850463|NCT03014622|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
153850464|NCT03014622|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153850466|NCT04655807|Ustekinumab|ustekinumab|mesh-list
153850467|NCT04655807|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
153850468|NCT04655807|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153850469|NCT04655807|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153850470|NCT04655807|Dermatologic Agents|dermatologic agents|mesh-ancestor
153850471|NCT04655417|Sodium Tetradecyl Sulfate|sodium tetradecyl sulfate|mesh-list
153850472|NCT04655417|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
153461638|NCT03249558|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153820189|NCT00471393|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153820190|NCT00471393|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153820191|NCT00471393|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153820192|NCT00471393|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153820193|NCT00471393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153820194|NCT00471393|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
153820195|NCT00471393|Protective Agents|protective agents|mesh-ancestor
153361654|NCT04382300|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153850473|NCT04655417|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
153850474|NCT00541515|Insulin|insulin|mesh-list
153850475|NCT00541515|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153850476|NCT00541515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153850477|NCT04655729|Infliximab|infliximab|mesh-list
153850478|NCT04655729|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
153850479|NCT04655729|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153850480|NCT04655729|Dermatologic Agents|dermatologic agents|mesh-ancestor
153850481|NCT04655729|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153850482|NCT04655729|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153850483|NCT00541554|Aripiprazole|aripiprazole|mesh-list
153850484|NCT00541554|Antidepressive Agents|antidepressive agents|mesh-ancestor
153850485|NCT00541554|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153390666|NCT01370811|Adrenergic Agents|adrenergic agents|mesh-ancestor
153390667|NCT01370811|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153390668|NCT01370811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153390669|NCT01370811|Parasympatholytics|parasympatholytics|mesh-ancestor
153390670|NCT01370811|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
153390671|NCT01370811|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
153390672|NCT01370811|Cholinergic Agents|cholinergic agents|mesh-ancestor
153390673|NCT01370811|Urological Agents|urological agents|mesh-ancestor
153390676|NCT01323569|Nabiximols|nabiximols|mesh-list
153850499|NCT00541554|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
153850501|NCT04655183|Niraparib|niraparib|mesh-list
153395989|NCT02604173|Diuretics|diuretics|mesh-ancestor
153850502|NCT04655183|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
153850503|NCT04655183|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153850504|NCT04655183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153850505|NCT04655183|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153850506|NCT00541710|Genistein|genistein|mesh-list
153850507|NCT00541710|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
153850508|NCT00541710|Protective Agents|protective agents|mesh-ancestor
153850509|NCT00541710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153850510|NCT00541710|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153850525|NCT04654676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153850527|NCT00541905|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
153850528|NCT00541905|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153850529|NCT00541905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153850530|NCT00541905|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
153850531|NCT00541905|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153914611|NCT00930046|Anesthetics|anesthetics|mesh-ancestor
153390714|NCT01323465|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153390715|NCT01323465|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153390716|NCT01323465|Hormone Antagonists|hormone antagonists|mesh-ancestor
153390717|NCT01323465|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153390718|NCT01323465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153821699|NCT00476424|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153390719|NCT01323465|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
153390720|NCT01323465|Analgesics|analgesics|mesh-ancestor
153390721|NCT01323465|Sensory System Agents|sensory system agents|mesh-ancestor
153390722|NCT01323465|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153390723|NCT01322464|Nabiximols|nabiximols|mesh-list
153390724|NCT01322464|Analgesics|analgesics|mesh-ancestor
153390725|NCT01322464|Sensory System Agents|sensory system agents|mesh-ancestor
153390726|NCT01322464|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153648070|NCT00020488|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153390727|NCT01322464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153390728|NCT01322139|Moxifloxacin|moxifloxacin|mesh-list
153390729|NCT01322139|Nabiximols|nabiximols|mesh-list
153390730|NCT01322139|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
153390731|NCT01322139|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153390732|NCT01322139|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153390733|NCT01322139|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153648110|NCT00020566|Alkylating Agents|alkylating agents|mesh-ancestor
153648111|NCT00020566|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153648112|NCT00020566|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153648113|NCT00020566|Immunologic Factors|immunologic factors|mesh-ancestor
153648114|NCT00020566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153648115|NCT00020566|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153648164|NCT00020839|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153648165|NCT00010140|Tamoxifen|tamoxifen|mesh-list
153648166|NCT00010140|Docetaxel|docetaxel|mesh-list
153648167|NCT00010140|Epirubicin|epirubicin|mesh-list
153648168|NCT00010140|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153648169|NCT00010140|Tubulin Modulators|tubulin modulators|mesh-ancestor
153648170|NCT00010140|Antimitotic Agents|antimitotic agents|mesh-ancestor
153648171|NCT00010140|Mitosis Modulators|mitosis modulators|mesh-ancestor
153648172|NCT00010140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153648173|NCT00010140|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153648174|NCT00010140|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153648175|NCT00010140|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153648176|NCT00010140|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153390734|NCT01322139|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153390735|NCT01322139|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153390736|NCT01322139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153850532|NCT00541905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153850533|NCT00541905|Cholinergic Agents|cholinergic agents|mesh-ancestor
153850534|NCT00541905|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153850535|NCT00542022|Oxymetazoline|oxymetazoline|mesh-list
153850536|NCT00542022|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153850537|NCT00542022|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153850538|NCT00542022|Adrenergic Agents|adrenergic agents|mesh-ancestor
153850539|NCT00542022|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153850540|NCT00542022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153850541|NCT00542022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153850542|NCT00542022|Sympathomimetics|sympathomimetics|mesh-ancestor
153850543|NCT00542022|Autonomic Agents|autonomic agents|mesh-ancestor
153850558|NCT00542139|Respiratory System Agents|respiratory system agents|mesh-ancestor
153850570|NCT03454841|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
153850571|NCT03454841|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
153850572|NCT03454841|Purinergic Agents|purinergic agents|mesh-ancestor
153850573|NCT03454841|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153850574|NCT03454841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153850575|NCT03454841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153850576|NCT04653506|Acetaminophen|acetaminophen|mesh-list
153850577|NCT04653506|Ibuprofen|ibuprofen|mesh-list
153850578|NCT04653506|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153850579|NCT04653506|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153850580|NCT04653506|Analgesics|analgesics|mesh-ancestor
153850581|NCT04653506|Sensory System Agents|sensory system agents|mesh-ancestor
153390762|NCT00885326|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153390763|NCT00885326|Alkylating Agents|alkylating agents|mesh-ancestor
153390764|NCT00885326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153390765|NCT00885326|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153390766|NCT00885326|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153390767|NCT00885326|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153390768|NCT00885326|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153390769|NCT00885326|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153390770|NCT00885326|Growth Substances|growth substances|mesh-ancestor
153390771|NCT00885326|Growth Inhibitors|growth inhibitors|mesh-ancestor
153390772|NCT00885326|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153390774|NCT00606138|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153390775|NCT00606138|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153390776|NCT00606138|Growth Substances|growth substances|mesh-ancestor
153850603|NCT04653623|Hemostatics|hemostatics|mesh-ancestor
153850609|NCT04653779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153850610|NCT00542607|Levocetirizine|levocetirizine|mesh-list
153850611|NCT00542607|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
153850612|NCT00542607|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
153850613|NCT00542607|Histamine Antagonists|histamine antagonists|mesh-ancestor
153850614|NCT00542607|Histamine Agents|histamine agents|mesh-ancestor
153850615|NCT00542607|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153850616|NCT00542607|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153850617|NCT00542607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153850618|NCT04685031|Clobetasol|clobetasol|mesh-list
153850619|NCT04685031|Nitroglycerin|nitroglycerin|mesh-list
153850620|NCT04685031|Vasodilator Agents|vasodilator agents|mesh-ancestor
153850621|NCT04685031|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153850622|NCT04685031|Glucocorticoids|glucocorticoids|mesh-ancestor
153850623|NCT04685031|Hormones|hormones|mesh-ancestor
153850624|NCT04685031|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153850625|NCT04685031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153850626|NCT00542763|Mycophenolic Acid|mycophenolic acid|mesh-list
153850627|NCT00542763|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153850628|NCT00542763|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153850629|NCT00542763|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
153850630|NCT00542763|Antitubercular Agents|antitubercular agents|mesh-ancestor
153850631|NCT00542763|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153850632|NCT00542763|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153850633|NCT00542763|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153850634|NCT00542763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153850635|NCT01854684|Temoporfin|temoporfin|mesh-list
153850636|NCT01854684|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153850637|NCT01854684|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
153850638|NCT01854684|Dermatologic Agents|dermatologic agents|mesh-ancestor
153850639|NCT00542802|Carbamazepine|carbamazepine|mesh-list
153850640|NCT00542802|Levetiracetam|levetiracetam|mesh-list
153390821|NCT00002643|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
153390822|NCT00002643|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
153390823|NCT00002643|Protective Agents|protective agents|mesh-ancestor
153390824|NCT00002643|Trace Elements|trace elements|mesh-ancestor
153820196|NCT00471393|Free Radical Scavengers|free radical scavengers|mesh-ancestor
153390830|NCT00002649|Interleukin-2|interleukin-2|mesh-list
153390831|NCT00002649|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153390832|NCT00002649|Immunologic Factors|immunologic factors|mesh-ancestor
153390833|NCT00002649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153390834|NCT00002649|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153390843|NCT00002649|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153390844|NCT00002649|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153390845|NCT00002649|Analgesics|analgesics|mesh-ancestor
153390846|NCT00002649|Sensory System Agents|sensory system agents|mesh-ancestor
153850641|NCT00542802|Anticonvulsants|anticonvulsants|mesh-ancestor
153850642|NCT00542802|Nootropic Agents|nootropic agents|mesh-ancestor
153850643|NCT00542802|Antimanic Agents|antimanic agents|mesh-ancestor
153850644|NCT00542802|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153850645|NCT00542802|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153850646|NCT00542802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153850647|NCT00542802|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153850648|NCT00542802|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153850649|NCT00542802|Analgesics|analgesics|mesh-ancestor
153850650|NCT00542802|Sensory System Agents|sensory system agents|mesh-ancestor
153850651|NCT00542802|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153850652|NCT00542802|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153850653|NCT00542802|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153850654|NCT00542802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153850655|NCT00542802|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
153820197|NCT00471393|Antioxidants|antioxidants|mesh-ancestor
153820198|NCT00432068|Octreotide|octreotide|mesh-list
153820199|NCT00432068|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153820200|NCT00432068|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153820201|NCT00432068|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153820202|NCT03273231|Ketamine|ketamine|mesh-list
153820203|NCT03273231|Analgesics|analgesics|mesh-ancestor
153820204|NCT03273231|Sensory System Agents|sensory system agents|mesh-ancestor
153820205|NCT03273231|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153820206|NCT03273231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153820207|NCT03273231|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
153820208|NCT03273231|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153820209|NCT03273231|Anesthetics, General|anesthetics, general|mesh-ancestor
153820210|NCT03273231|Anesthetics|anesthetics|mesh-ancestor
153850656|NCT00542802|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
153850657|NCT04652648|Hydroxychloroquine|hydroxychloroquine|mesh-list
153850658|NCT04652648|Antimalarials|antimalarials|mesh-ancestor
153850659|NCT04652648|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153850660|NCT04652648|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153850661|NCT04652648|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153850662|NCT04652648|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153850663|NCT04652648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153850664|NCT04652648|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153850665|NCT00542841|Hydrocortisone|hydrocortisone|mesh-list
153850666|NCT00542841|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153850667|NCT04652492|Tislelizumab|tislelizumab|mesh-list
153850668|NCT04652492|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153850669|NCT04652492|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153850670|NCT00543075|Oblimersen|oblimersen|mesh-list
153850671|NCT00543075|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153850672|NCT00543114|Rituximab|rituximab|mesh-list
153850673|NCT00543114|Fludarabine|fludarabine|mesh-list
153850674|NCT00543114|Lenalidomide|lenalidomide|mesh-list
153850675|NCT00543114|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153850676|NCT00543114|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153850677|NCT00543114|Immunologic Factors|immunologic factors|mesh-ancestor
153850678|NCT00543114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153850679|NCT00543114|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153850680|NCT00543114|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153850681|NCT00543114|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153850682|NCT00543114|Growth Substances|growth substances|mesh-ancestor
153850683|NCT00543114|Growth Inhibitors|growth inhibitors|mesh-ancestor
153850684|NCT03454724|Sirolimus|sirolimus|mesh-list
153850685|NCT03454724|Everolimus|everolimus|mesh-list
153850686|NCT03454724|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
153850687|NCT03454724|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153850688|NCT03454724|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153850689|NCT03454724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153850690|NCT03454724|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153390881|NCT02249299|Sensory System Agents|sensory system agents|mesh-ancestor
153390882|NCT02249299|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153390883|NCT02249299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153390884|NCT00002679|Tamoxifen|tamoxifen|mesh-list
153390885|NCT00002679|Paclitaxel|paclitaxel|mesh-list
153390886|NCT00002679|Cyclophosphamide|cyclophosphamide|mesh-list
153390887|NCT00002679|Doxorubicin|doxorubicin|mesh-list
153390888|NCT00002679|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
153390889|NCT00002679|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153850710|NCT00557843|Anesthetics, Local|anesthetics, local|mesh-ancestor
153850711|NCT00557843|Anesthetics|anesthetics|mesh-ancestor
153850712|NCT00557843|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153390894|NCT00002679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153390895|NCT00002679|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153732517|NCT00141596|Acid Sensing Ion Channel Blockers|acid sensing ion channel blockers|mesh-ancestor
153390905|NCT00002679|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153390906|NCT00002679|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
153390907|NCT00002679|Hormone Antagonists|hormone antagonists|mesh-ancestor
153390908|NCT00002679|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153390909|NCT00002679|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153390910|NCT00002679|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
153390911|NCT00002679|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
153390912|NCT00002679|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153390915|NCT00002691|Dexamethasone|dexamethasone|mesh-list
153390916|NCT00002691|Cyclophosphamide|cyclophosphamide|mesh-list
153390917|NCT00002691|Methotrexate|methotrexate|mesh-list
153390918|NCT00002691|Etoposide|etoposide|mesh-list
153390919|NCT00002691|Vincristine|vincristine|mesh-list
153390920|NCT00002691|Daunorubicin|daunorubicin|mesh-list
153390921|NCT00002691|Asparaginase|asparaginase|mesh-list
153850717|NCT04651556|Ketorolac|ketorolac|mesh-list
153850724|NCT04651556|Sensory System Agents|sensory system agents|mesh-ancestor
153850725|NCT04651556|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153850726|NCT04651556|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153850727|NCT04651556|Analgesics|analgesics|mesh-ancestor
153850728|NCT04651556|Antipyretics|antipyretics|mesh-ancestor
153850729|NCT04651556|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153850730|NCT04651556|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153850731|NCT04651556|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153850732|NCT04651556|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153850733|NCT04651556|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153850734|NCT04651556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153850735|NCT04651556|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153850736|NCT04651556|Anticonvulsants|anticonvulsants|mesh-ancestor
153850737|NCT04651556|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153850738|NCT04651556|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153850739|NCT04651556|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153850740|NCT04651556|Tocolytic Agents|tocolytic agents|mesh-ancestor
153390927|NCT00002691|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153390928|NCT00002691|Alkylating Agents|alkylating agents|mesh-ancestor
153390945|NCT00002691|Antimetabolites|antimetabolites|mesh-ancestor
153390946|NCT00002691|Dermatologic Agents|dermatologic agents|mesh-ancestor
153850746|NCT04651049|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153850747|NCT04651049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153850748|NCT04651049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153850749|NCT04651049|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153850750|NCT04651049|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153850751|NCT04651049|Vasodilator Agents|vasodilator agents|mesh-ancestor
153850752|NCT04651205|Thiamine|thiamine|mesh-list
153850753|NCT04651205|Vitamins|vitamins|mesh-ancestor
153850754|NCT04651205|Micronutrients|micronutrients|mesh-ancestor
153850755|NCT04651205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153850756|NCT04651205|Vitamin B Complex|vitamin b complex|mesh-ancestor
153850759|NCT03456648|Antithrombins|antithrombins|mesh-ancestor
153850760|NCT03456648|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
153390950|NCT00002691|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153732527|NCT02275663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153732529|NCT02275663|Immunologic Factors|immunologic factors|mesh-ancestor
153732530|NCT02275663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153732531|NCT02275663|Antiviral Agents|antiviral agents|mesh-ancestor
153732532|NCT02275663|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153732533|NCT02275663|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153732534|NCT02275702|Dexamethasone|dexamethasone|mesh-list
153732535|NCT02275702|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153732536|NCT02275702|Antiemetics|antiemetics|mesh-ancestor
153732537|NCT02275702|Autonomic Agents|autonomic agents|mesh-ancestor
153396219|NCT01848067|Prednisone|prednisone|mesh-list
153390951|NCT00002691|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153390952|NCT00002691|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153390953|NCT00002691|Antiviral Agents|antiviral agents|mesh-ancestor
153390954|NCT00002691|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153390955|NCT00002691|Antidotes|antidotes|mesh-ancestor
153390956|NCT00002691|Protective Agents|protective agents|mesh-ancestor
153390957|NCT00002691|Vitamin B Complex|vitamin b complex|mesh-ancestor
153390958|NCT00002691|Vitamins|vitamins|mesh-ancestor
153390959|NCT00002691|Micronutrients|micronutrients|mesh-ancestor
153390960|NCT00002691|Tubulin Modulators|tubulin modulators|mesh-ancestor
153390961|NCT00002691|Antimitotic Agents|antimitotic agents|mesh-ancestor
153390962|NCT00002691|Mitosis Modulators|mitosis modulators|mesh-ancestor
153390967|NCT04054115|Urological Agents|urological agents|mesh-ancestor
153390968|NCT00002697|Carboplatin|carboplatin|mesh-list
153390969|NCT00002697|Etoposide|etoposide|mesh-list
153390970|NCT00002697|Ifosfamide|ifosfamide|mesh-list
153390971|NCT00002697|Sargramostim|sargramostim|mesh-list
153390972|NCT00002697|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153390973|NCT00002697|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153390974|NCT00002697|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153390975|NCT00002697|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153390976|NCT00002697|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153390977|NCT00002697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153850781|NCT00557921|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153850782|NCT00557921|Antipyretics|antipyretics|mesh-ancestor
153850783|NCT00557921|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
153850784|NCT00557921|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
153850785|NCT00557921|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
153390989|NCT00002715|Mechlorethamine|mechlorethamine|mesh-list
153390990|NCT00002715|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153390991|NCT00002715|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153390992|NCT00002715|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153390993|NCT00002715|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153390994|NCT00002715|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153850796|NCT02324283|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153850797|NCT02324283|Anesthetics, General|anesthetics, general|mesh-ancestor
153850798|NCT02324283|Anesthetics|anesthetics|mesh-ancestor
153850799|NCT02324283|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
153850800|NCT00557960|Amphetamine|amphetamine|mesh-list
153850803|NCT00557960|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
153850804|NCT00557960|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153850805|NCT00557960|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153850806|NCT00557960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153850808|NCT00557960|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153850809|NCT00557960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153850810|NCT00557960|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
153390995|NCT00002715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153390996|NCT00002715|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153390997|NCT00002715|Glucocorticoids|glucocorticoids|mesh-ancestor
153390998|NCT00002715|Hormones|hormones|mesh-ancestor
153390999|NCT00002715|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153391000|NCT00002715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153391001|NCT00002715|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153391002|NCT00002715|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153391003|NCT00002715|Tubulin Modulators|tubulin modulators|mesh-ancestor
153391004|NCT00002715|Antimitotic Agents|antimitotic agents|mesh-ancestor
153391005|NCT00002715|Mitosis Modulators|mitosis modulators|mesh-ancestor
153391006|NCT00002715|Alkylating Agents|alkylating agents|mesh-ancestor
153391007|NCT00002715|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153391008|NCT02976467|Fulacimstat|fulacimstat|mesh-list
153391009|NCT02976467|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153391011|NCT02981095|Bupivacaine|bupivacaine|mesh-list
153732554|NCT04517227|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153732555|NCT00141713|Etanercept|etanercept|mesh-list
153732556|NCT00141713|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153732557|NCT00141713|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153732558|NCT00141713|Analgesics|analgesics|mesh-ancestor
153732559|NCT00141713|Sensory System Agents|sensory system agents|mesh-ancestor
153732560|NCT00141713|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153732561|NCT00141713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153732562|NCT00141713|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153732563|NCT00141713|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153732564|NCT00141713|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153732565|NCT00141713|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153732566|NCT00141713|Immunologic Factors|immunologic factors|mesh-ancestor
153732568|NCT04517188|Povidone-Iodine|povidone-iodine|mesh-list
153732569|NCT04517188|Povidone|povidone|mesh-list
153732570|NCT04517188|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
153732571|NCT04517188|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153732572|NCT04517188|Trace Elements|trace elements|mesh-ancestor
153732573|NCT04517188|Micronutrients|micronutrients|mesh-ancestor
153850830|NCT00543504|Bevacizumab|bevacizumab|mesh-list
153850831|NCT00543504|Trastuzumab|trastuzumab|mesh-list
153850832|NCT00543504|Cetuximab|cetuximab|mesh-list
153850833|NCT00543504|Sunitinib|sunitinib|mesh-list
153850834|NCT00543504|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
153850835|NCT00543504|Sorafenib|sorafenib|mesh-list
153850836|NCT00543504|Lapatinib|lapatinib|mesh-list
153850837|NCT00543504|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153850838|NCT00543504|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153391045|NCT01625455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153391046|NCT01625455|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153391047|NCT01625455|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
153391048|NCT01625455|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153391049|NCT01625455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153391050|NCT05751681|Cetrorelix|cetrorelix|mesh-list
153391051|NCT05751681|Dydrogesterone|dydrogesterone|mesh-list
153391052|NCT05751681|Progestins|progestins|mesh-list
153391053|NCT05751681|Fertility Agents, Female|fertility agents, female|mesh-ancestor
153391054|NCT05751681|Fertility Agents|fertility agents|mesh-ancestor
153391055|NCT05751681|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153391056|NCT05751681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153391057|NCT05751681|Hormone Antagonists|hormone antagonists|mesh-ancestor
153391058|NCT05751681|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153391059|NCT05751681|Hormones|hormones|mesh-ancestor
153391060|NCT02976623|Metronidazole|metronidazole|mesh-list
153850845|NCT00543504|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153850846|NCT00543504|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153850847|NCT00543504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153850848|NCT00543933|Nitric Oxide|nitric oxide|mesh-list
153850849|NCT00543933|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153850850|NCT00543933|Autonomic Agents|autonomic agents|mesh-ancestor
153850851|NCT00543933|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153850852|NCT00543933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153850856|NCT00543933|Antioxidants|antioxidants|mesh-ancestor
153850877|NCT00544011|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153391061|NCT02976623|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153391062|NCT02976623|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153391063|NCT02976623|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153391064|NCT02976623|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153391066|NCT00002733|Interferon-alpha|interferon-alpha|mesh-list
153391067|NCT00002733|Aldesleukin|aldesleukin|mesh-list
153391068|NCT00002733|Cimetidine|cimetidine|mesh-list
153391069|NCT00002733|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153391070|NCT00002733|Antiviral Agents|antiviral agents|mesh-ancestor
153391071|NCT00002733|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153391072|NCT00002733|Immunologic Factors|immunologic factors|mesh-ancestor
153391073|NCT00002733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153391074|NCT00002733|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153391075|NCT00002733|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153391080|NCT00002733|Histamine Agents|histamine agents|mesh-ancestor
153391081|NCT00002733|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153391082|NCT00002733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153391083|NCT00002733|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
153391084|NCT00002733|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153391085|NCT00002733|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153391086|NCT01625923|Olanzapine|olanzapine|mesh-list
153391087|NCT01625923|Antiemetics|antiemetics|mesh-ancestor
153391088|NCT01625923|Autonomic Agents|autonomic agents|mesh-ancestor
153391089|NCT01625923|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153391090|NCT01625923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153391091|NCT01625923|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153391092|NCT01625923|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153850878|NCT00544011|Immunologic Factors|immunologic factors|mesh-ancestor
153850909|NCT02909088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153850911|NCT04649645|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
153850912|NCT04649645|Autonomic Agents|autonomic agents|mesh-ancestor
153850913|NCT04649645|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153850914|NCT04649645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153850915|NCT04649645|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
153850916|NCT04649645|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
153850917|NCT04649645|Cholinergic Agents|cholinergic agents|mesh-ancestor
153850918|NCT04649645|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153850919|NCT04649645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153850920|NCT00544128|Ritonavir|ritonavir|mesh-list
153391105|NCT00002751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153391106|NCT00002757|Cytarabine|cytarabine|mesh-list
153391107|NCT00002757|Prednisone|prednisone|mesh-list
153391108|NCT00002757|Prednisolone|prednisolone|mesh-list
153391109|NCT00002757|Hydrocortisone|hydrocortisone|mesh-list
153391110|NCT00002757|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
153391111|NCT00002757|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
153391112|NCT00002757|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
153391113|NCT00002757|Cyclophosphamide|cyclophosphamide|mesh-list
153391114|NCT00002757|Doxorubicin|doxorubicin|mesh-list
153391115|NCT00002757|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
153391116|NCT00002757|Methotrexate|methotrexate|mesh-list
153391117|NCT00002757|Etoposide|etoposide|mesh-list
153391118|NCT00002757|Vincristine|vincristine|mesh-list
153391119|NCT00002757|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153391120|NCT00002757|Immunologic Factors|immunologic factors|mesh-ancestor
153391121|NCT00002757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153391122|NCT00002757|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153391123|NCT00002757|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153391124|NCT00002757|Alkylating Agents|alkylating agents|mesh-ancestor
153391125|NCT00002757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153391126|NCT00002757|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153821824|NCT03279536|Hematinics|hematinics|mesh-ancestor
153391127|NCT00002757|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153850926|NCT00544128|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
153850927|NCT00544128|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
153850928|NCT00544128|Protease Inhibitors|protease inhibitors|mesh-ancestor
153850929|NCT00544128|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153850930|NCT00544128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153850931|NCT00544128|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153850932|NCT00544128|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153850933|NCT00544128|Antiviral Agents|antiviral agents|mesh-ancestor
153732596|NCT00141791|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153732597|NCT00141791|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153732598|NCT00141791|Analgesics|analgesics|mesh-ancestor
153732599|NCT00141791|Sensory System Agents|sensory system agents|mesh-ancestor
153732600|NCT00141791|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153732601|NCT00141791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153732602|NCT00141791|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153732603|NCT00141791|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153732604|NCT00141791|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153732605|NCT00141791|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153732606|NCT00141791|Immunologic Factors|immunologic factors|mesh-ancestor
153732607|NCT04516603|4-Aminopyridine|4-aminopyridine|mesh-list
153732608|NCT04516603|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
153732609|NCT04516603|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153391140|NCT00002757|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153391141|NCT00002757|Antimetabolites|antimetabolites|mesh-ancestor
153391142|NCT00002757|Dermatologic Agents|dermatologic agents|mesh-ancestor
153391143|NCT00002757|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153391144|NCT00002757|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153391145|NCT00002757|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153391147|NCT00002757|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153391148|NCT00002757|Tubulin Modulators|tubulin modulators|mesh-ancestor
153391149|NCT00002757|Antimitotic Agents|antimitotic agents|mesh-ancestor
153850960|NCT01239745|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
153850961|NCT01239745|Hormone Antagonists|hormone antagonists|mesh-ancestor
153850962|NCT01239745|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153850963|NCT01239745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153850965|NCT01239472|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
153391152|NCT00002763|Interferon-alpha|interferon-alpha|mesh-list
153391153|NCT00002763|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153391154|NCT00002763|Antiviral Agents|antiviral agents|mesh-ancestor
153391155|NCT00002763|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153391156|NCT00002763|Immunologic Factors|immunologic factors|mesh-ancestor
153391157|NCT00002763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153391158|NCT00002775|Docetaxel|docetaxel|mesh-list
153391159|NCT00002775|Estramustine|estramustine|mesh-list
153391160|NCT00002775|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153391161|NCT00002775|Tubulin Modulators|tubulin modulators|mesh-ancestor
153391162|NCT00002775|Antimitotic Agents|antimitotic agents|mesh-ancestor
153391163|NCT00002775|Mitosis Modulators|mitosis modulators|mesh-ancestor
153391164|NCT00002775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153850976|NCT00544284|Alkylating Agents|alkylating agents|mesh-ancestor
153391210|NCT00002793|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153391211|NCT00002793|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153391212|NCT00002793|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153850988|NCT02888275|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153850989|NCT02888275|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153850990|NCT02888275|Adrenergic Agents|adrenergic agents|mesh-ancestor
153850991|NCT02888275|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153850992|NCT02888275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153850993|NCT03456531|Aspirin|aspirin|mesh-list
153850994|NCT03456531|Analgesics|analgesics|mesh-list
153850995|NCT03456531|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153850999|NCT03456531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153851000|NCT03456531|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153851001|NCT03456531|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153851002|NCT03456531|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153851003|NCT03456531|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153851004|NCT03456531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153851005|NCT03456531|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153851006|NCT03456531|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153851007|NCT03456531|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153851008|NCT03456531|Antipyretics|antipyretics|mesh-ancestor
153851009|NCT02909049|Midazolam|midazolam|mesh-list
153851010|NCT02909049|Ketamine|ketamine|mesh-list
153851011|NCT02909049|Mepivacaine|mepivacaine|mesh-list
153851012|NCT02909049|Analgesics|analgesics|mesh-ancestor
153851013|NCT02909049|Sensory System Agents|sensory system agents|mesh-ancestor
153851014|NCT02909049|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153851015|NCT02909049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153851016|NCT02909049|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
153851017|NCT02909049|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153851018|NCT02909049|Anesthetics, General|anesthetics, general|mesh-ancestor
153851019|NCT02909049|Anesthetics|anesthetics|mesh-ancestor
153851020|NCT02909049|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153851021|NCT02909049|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
153851022|NCT02909049|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
153648329|NCT00000134|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
153851023|NCT02909049|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153851024|NCT02909049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153851025|NCT02909049|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153391216|NCT00002793|Vitamin B Complex|vitamin b complex|mesh-ancestor
153391218|NCT00002793|Micronutrients|micronutrients|mesh-ancestor
153391219|NCT01632709|Bupivacaine|bupivacaine|mesh-list
153391220|NCT01632709|Anesthetics, Local|anesthetics, local|mesh-ancestor
153391221|NCT01632709|Anesthetics|anesthetics|mesh-ancestor
153391222|NCT01632709|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153391223|NCT01632709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153391224|NCT01632709|Sensory System Agents|sensory system agents|mesh-ancestor
153391225|NCT01632709|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153391226|NCT05751291|Bupivacaine|bupivacaine|mesh-list
153391227|NCT05751291|Anesthetics, Local|anesthetics, local|mesh-ancestor
153391228|NCT05751291|Anesthetics|anesthetics|mesh-ancestor
153391229|NCT05751291|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153391230|NCT05751291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153391231|NCT05751291|Sensory System Agents|sensory system agents|mesh-ancestor
153391232|NCT05751291|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153391234|NCT01634191|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153391235|NCT01634191|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153391236|NCT01634191|Analgesics|analgesics|mesh-ancestor
153391237|NCT01634191|Sensory System Agents|sensory system agents|mesh-ancestor
153851026|NCT02909049|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153851027|NCT02909049|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153851028|NCT02909049|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153851029|NCT02909049|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153851030|NCT02909049|GABA Modulators|gaba modulators|mesh-ancestor
153851031|NCT02909049|GABA Agents|gaba agents|mesh-ancestor
153851032|NCT02909049|Anesthetics, Local|anesthetics, local|mesh-ancestor
153851033|NCT01229449|Acetaminophen|acetaminophen|mesh-list
153851034|NCT01229449|Ibuprofen|ibuprofen|mesh-list
153851035|NCT01229449|Codeine|codeine|mesh-list
153851036|NCT01229449|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153851037|NCT01229449|Analgesics|analgesics|mesh-ancestor
153851038|NCT01229449|Sensory System Agents|sensory system agents|mesh-ancestor
153851039|NCT01229449|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153851041|NCT01229449|Antipyretics|antipyretics|mesh-ancestor
153851042|NCT01229449|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153851043|NCT01229449|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153851044|NCT01229449|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153851045|NCT01229449|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153851046|NCT01229449|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153851047|NCT01229449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153851048|NCT01229449|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153851058|NCT01238575|Adrenergic Agents|adrenergic agents|mesh-ancestor
153851059|NCT01238575|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153851060|NCT01238575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153851061|NCT01238575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153851063|NCT06022419|Cysteine Proteinase Inhibitors|cysteine proteinase inhibitors|mesh-ancestor
153851064|NCT06022419|Protease Inhibitors|protease inhibitors|mesh-ancestor
153851065|NCT06022419|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153851066|NCT06022419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153851067|NCT06022276|Nimotuzumab|nimotuzumab|mesh-list
153851068|NCT06022276|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153851069|NCT06022276|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153851071|NCT06022237|Cholecalciferol|cholecalciferol|mesh-list
153851072|NCT06022237|Ibandronic Acid|ibandronic acid|mesh-list
153851073|NCT06022237|Calcium|calcium|mesh-list
153851074|NCT06022237|Vitamins|vitamins|mesh-ancestor
153851075|NCT06022237|Micronutrients|micronutrients|mesh-ancestor
153851079|NCT06022198|Dimercaprol|dimercaprol|mesh-list
153391296|NCT00361517|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153391297|NCT00361517|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153391298|NCT00361517|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153391299|NCT00361517|Antifungal Agents|antifungal agents|mesh-ancestor
153391300|NCT00361517|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
153391301|NCT00361517|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153391302|NCT05447507|Dexmedetomidine|dexmedetomidine|mesh-list
153851082|NCT06022198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153851083|NCT06021951|8-hydroxy-2,2,14,14-tetramethylpentadecanedioic acid|8-hydroxy-2,2,14,14-tetramethylpentadecanedioic acid|mesh-list
153851085|NCT06021951|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153851086|NCT06021951|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153851087|NCT06021951|Antimetabolites|antimetabolites|mesh-ancestor
153851088|NCT06021951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153851089|NCT06021951|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153851090|NCT06021951|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153851091|NCT06021951|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153851092|NCT06021951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153851093|NCT06021912|Immunomodulating Agents|immunomodulating agents|mesh-list
153851094|NCT06021912|Immunologic Factors|immunologic factors|mesh-ancestor
153851095|NCT06021912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153851096|NCT06021847|Chlorhexidine|chlorhexidine|mesh-list
153851097|NCT06021847|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
153851098|NCT06021847|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153851099|NCT06021847|Disinfectants|disinfectants|mesh-ancestor
153851100|NCT06021756|Ketamine|ketamine|mesh-list
153851101|NCT06021756|Analgesics|analgesics|mesh-ancestor
153851102|NCT06021756|Sensory System Agents|sensory system agents|mesh-ancestor
153851103|NCT06021756|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153391313|NCT05447507|Adrenergic Agents|adrenergic agents|mesh-ancestor
153391314|NCT05447507|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153391315|NCT05447507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153391316|NCT01635439|Dinoprostone|dinoprostone|mesh-list
153391317|NCT01635439|Oxytocics|oxytocics|mesh-ancestor
153391318|NCT01635439|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153391319|NCT01635439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153391320|NCT01636063|Misoprostol|misoprostol|mesh-list
153391321|NCT01636063|Mifepristone|mifepristone|mesh-list
153391322|NCT01636063|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
153732621|NCT00505492|Carboplatin|carboplatin|mesh-list
153396547|NCT01930747|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
153391323|NCT01636063|Abortifacient Agents|abortifacient agents|mesh-ancestor
153391324|NCT01636063|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153391325|NCT01636063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153391326|NCT01636063|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
153391327|NCT01636063|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153851116|NCT06021717|Analgesics|analgesics|mesh-ancestor
153851117|NCT06021717|Sensory System Agents|sensory system agents|mesh-ancestor
153851118|NCT06021717|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153851119|NCT06021717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153851120|NCT06021717|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
153851121|NCT06021717|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153851122|NCT06021717|Anesthetics, General|anesthetics, general|mesh-ancestor
153851123|NCT06021717|Anesthetics|anesthetics|mesh-ancestor
153851124|NCT06021717|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153851125|NCT06021717|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
153851126|NCT06021717|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
153851145|NCT06021522|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153851146|NCT06021522|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
153851147|NCT06021522|Dopamine Agents|dopamine agents|mesh-ancestor
153851148|NCT06021522|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153851149|NCT06021522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153851150|NCT06021210|Letermovir|letermovir|mesh-list
153851151|NCT06021210|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
153851152|NCT06021210|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153851153|NCT06021210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153851154|NCT06021210|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153851155|NCT06021210|Antiviral Agents|antiviral agents|mesh-ancestor
153851156|NCT06021210|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153851157|NCT06021119|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
153391352|NCT05749575|Mitosis Modulators|mitosis modulators|mesh-ancestor
153391353|NCT05749575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153391354|NCT05623761|Fluorides|fluorides|mesh-list
153391355|NCT05623761|Cariostatic Agents|cariostatic agents|mesh-ancestor
153391356|NCT05623761|Protective Agents|protective agents|mesh-ancestor
153391357|NCT05623761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153391358|NCT00361985|Esomeprazole|esomeprazole|mesh-list
153391359|NCT00361985|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
153391360|NCT00361985|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153391361|NCT00361985|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
153391362|NCT00361985|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153391363|NCT00361985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153391364|NCT00362063|Hormones|hormones|mesh-list
153391365|NCT00362063|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153391366|NCT00362063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153391367|NCT00382239|Exenatide|exenatide|mesh-list
153391368|NCT00382239|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
153851168|NCT06021015|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153851169|NCT06020989|Carboplatin|carboplatin|mesh-list
153851170|NCT06020989|Pemetrexed|pemetrexed|mesh-list
153851171|NCT06020989|Lazertinib|lazertinib|mesh-list
153851172|NCT06020989|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153851173|NCT06020989|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153851174|NCT06020989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153851175|NCT06020989|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153851176|NCT06020989|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153851177|NCT06020989|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153851178|NCT06020885|Immunomodulating Agents|immunomodulating agents|mesh-list
153851179|NCT06020885|Immunologic Factors|immunologic factors|mesh-ancestor
153851180|NCT06020885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153851181|NCT06020833|Tretinoin|tretinoin|mesh-list
153851182|NCT06020833|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153851183|NCT06020833|Keratolytic Agents|keratolytic agents|mesh-ancestor
153851184|NCT06020833|Dermatologic Agents|dermatologic agents|mesh-ancestor
153851185|NCT06020716|Amoxicillin|amoxicillin|mesh-list
153851186|NCT06020716|Clavulanic Acid|clavulanic acid|mesh-list
153851187|NCT06020716|Clavulanic Acids|clavulanic acids|mesh-list
153851188|NCT06020716|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
153851189|NCT06020716|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153851190|NCT06020716|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153851191|NCT06020716|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
153851192|NCT06020716|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153851193|NCT06020716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153851194|NCT06009185|Zamicastat|zamicastat|mesh-list
153851195|NCT06009185|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153851196|NCT06009185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153851197|NCT06004739|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
153851198|NCT06004739|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
153851199|NCT06004739|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153851200|NCT06004739|Antitubercular Agents|antitubercular agents|mesh-ancestor
153851201|NCT05989217|Salicylic Acid|salicylic acid|mesh-list
153361889|NCT01432145|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153851203|NCT05989217|Antifungal Agents|antifungal agents|mesh-ancestor
153851204|NCT05989217|Keratolytic Agents|keratolytic agents|mesh-ancestor
153851205|NCT05989217|Dermatologic Agents|dermatologic agents|mesh-ancestor
153851206|NCT05975580|Topiramate|topiramate|mesh-list
153851207|NCT05975580|Phentermine|phentermine|mesh-list
153732647|NCT04516174|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153732648|NCT04516174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153732649|NCT04516174|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153732650|NCT04516174|Analgesics|analgesics|mesh-ancestor
153732651|NCT04516174|Sensory System Agents|sensory system agents|mesh-ancestor
153732652|NCT04516174|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153732653|NCT04516174|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
153732654|NCT04516174|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153732655|NCT04516174|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153396607|NCT04507841|Niraparib|niraparib|mesh-list
153391400|NCT00382083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153391402|NCT00382083|Analgesics|analgesics|mesh-ancestor
153391403|NCT00382083|Antipyretics|antipyretics|mesh-ancestor
153391404|NCT00382083|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153391405|NCT00382083|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153391443|NCT01642147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153391444|NCT04584749|Lidocaine|lidocaine|mesh-list
153391445|NCT04584749|Anesthetics, Local|anesthetics, local|mesh-ancestor
153391446|NCT04584749|Anesthetics|anesthetics|mesh-ancestor
153391447|NCT04584749|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153391448|NCT04584749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153391449|NCT04584749|Sensory System Agents|sensory system agents|mesh-ancestor
153391450|NCT04584749|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153851226|NCT05963347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153851227|NCT05963347|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153391456|NCT01644331|Tolvaptan|tolvaptan|mesh-list
153851228|NCT05963347|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153851229|NCT05963347|Alkylating Agents|alkylating agents|mesh-ancestor
153851230|NCT05963347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153851231|NCT05963347|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153851232|NCT05963347|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153851233|NCT05963347|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153851234|NCT05963347|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153851235|NCT05963347|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153851236|NCT05963347|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153851237|NCT05963347|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153851238|NCT05963347|Glucocorticoids|glucocorticoids|mesh-ancestor
153851239|NCT05963347|Hormones|hormones|mesh-ancestor
153851240|NCT05963347|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153851241|NCT05963347|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153851242|NCT05963347|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153851243|NCT05963347|Tubulin Modulators|tubulin modulators|mesh-ancestor
153851244|NCT05963347|Antimitotic Agents|antimitotic agents|mesh-ancestor
153851245|NCT05963347|Mitosis Modulators|mitosis modulators|mesh-ancestor
153851246|NCT05857748|Lifitegrast|lifitegrast|mesh-list
153851247|NCT05857748|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
153851248|NCT05857748|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
153851258|NCT05847517|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
153851259|NCT05847517|Adrenergic Agents|adrenergic agents|mesh-ancestor
153851260|NCT05847517|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153851261|NCT05847517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153851262|NCT05797623|Cyclosporine|cyclosporine|mesh-list
153851264|NCT05797623|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153914612|NCT00930046|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153391458|NCT01644331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153391459|NCT01644331|Natriuretic Agents|natriuretic agents|mesh-ancestor
153391460|NCT01644331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153391461|NCT00362141|Levetiracetam|levetiracetam|mesh-list
153391462|NCT00362141|Anticonvulsants|anticonvulsants|mesh-ancestor
153391463|NCT00362141|Nootropic Agents|nootropic agents|mesh-ancestor
153391464|NCT05733897|Hydroxychloroquine|hydroxychloroquine|mesh-list
153391465|NCT05733897|Antimalarials|antimalarials|mesh-ancestor
153391466|NCT05733897|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153391467|NCT05733897|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153391468|NCT05733897|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153391469|NCT05733897|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153391470|NCT05733897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153391471|NCT05733897|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153391472|NCT01646671|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
153391473|NCT01646671|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
153391475|NCT03561259|Vorinostat|vorinostat|mesh-list
153851275|NCT05746065|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153851276|NCT05746065|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153851277|NCT05746065|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153851278|NCT05746065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153851279|NCT05746065|Antiviral Agents|antiviral agents|mesh-ancestor
153851297|NCT05708989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153851298|NCT05708989|Anesthetics, Local|anesthetics, local|mesh-ancestor
153851299|NCT05708989|Anesthetics|anesthetics|mesh-ancestor
153851300|NCT05669833|Golimumab|golimumab|mesh-list
153851301|NCT05669833|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
153851302|NCT05669833|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153851303|NCT05669833|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153391512|NCT01651351|Alpha 1-Antitrypsin|alpha 1-antitrypsin|mesh-list
153391513|NCT01651351|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153391514|NCT01651351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153391515|NCT01651351|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
153391516|NCT01651351|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
153391518|NCT03762317|Analgesics|analgesics|mesh-ancestor
153391519|NCT03762317|Sensory System Agents|sensory system agents|mesh-ancestor
153391520|NCT03762317|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153391521|NCT03762317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153461741|NCT04195776|Tenofovir|tenofovir|mesh-list
153391541|NCT03002545|Cathartics|cathartics|mesh-ancestor
153391542|NCT03002545|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153391543|NCT04517747|Ramucirumab|ramucirumab|mesh-list
153391544|NCT04517747|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153391545|NCT04517747|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153391546|NCT04517747|Growth Substances|growth substances|mesh-ancestor
153391547|NCT04517747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153391548|NCT04517747|Growth Inhibitors|growth inhibitors|mesh-ancestor
153391549|NCT04517747|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153391550|NCT02219581|Dexamethasone|dexamethasone|mesh-list
153391551|NCT02219581|Dexamethasone acetate|dexamethasone acetate|mesh-list
153391552|NCT02219581|BB 1101|bb 1101|mesh-list
153391553|NCT02219581|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153391554|NCT02219581|Antiemetics|antiemetics|mesh-ancestor
153391555|NCT02219581|Autonomic Agents|autonomic agents|mesh-ancestor
153391556|NCT02219581|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153461742|NCT04195776|Antiviral Agents|antiviral agents|mesh-ancestor
153851330|NCT05591755|Ketotifen|ketotifen|mesh-list
153851331|NCT05591755|Brimonidine Tartrate|brimonidine tartrate|mesh-list
153851332|NCT05591755|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
153851333|NCT05591755|Ophthalmic Solutions|ophthalmic solutions|mesh-list
153851334|NCT05591755|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153851335|NCT05591755|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
153851336|NCT05591755|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153851351|NCT05585229|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153851353|NCT05579730|Brimonidine Tartrate|brimonidine tartrate|mesh-list
153851354|NCT05579730|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
153851355|NCT05579730|Ophthalmic Solutions|ophthalmic solutions|mesh-list
153851356|NCT05579730|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153851357|NCT05579730|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
153851358|NCT05579730|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153391570|NCT01912274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153391571|NCT01912274|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153391572|NCT01912274|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153391573|NCT01654861|Ascorbic Acid|ascorbic acid|mesh-list
153391574|NCT01654861|Gemcitabine|gemcitabine|mesh-list
153391575|NCT01654861|Vitamins|vitamins|mesh-ancestor
153391576|NCT01654861|Micronutrients|micronutrients|mesh-ancestor
153391577|NCT01654861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153391578|NCT01654861|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153391579|NCT01654861|Antimetabolites|antimetabolites|mesh-ancestor
153391580|NCT01654861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153391581|NCT01654861|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153391582|NCT01654861|Antioxidants|antioxidants|mesh-ancestor
153391583|NCT01654861|Protective Agents|protective agents|mesh-ancestor
153391584|NCT05184777|Estradiol|estradiol|mesh-list
153391585|NCT05184777|Progesterone|progesterone|mesh-list
153391586|NCT05184777|Estrogens|estrogens|mesh-ancestor
153851361|NCT05579730|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153851362|NCT05579730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153851363|NCT05579730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153851364|NCT05579730|Antipruritics|antipruritics|mesh-ancestor
153851365|NCT05579730|Dermatologic Agents|dermatologic agents|mesh-ancestor
153851366|NCT05579730|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
153851367|NCT05579730|Histamine Antagonists|histamine antagonists|mesh-ancestor
153851368|NCT05579730|Histamine Agents|histamine agents|mesh-ancestor
153732668|NCT04515979|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153361944|NCT05946135|Lansoprazole|lansoprazole|mesh-list
153391595|NCT01912352|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153391596|NCT01912352|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153391597|NCT01912352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153391598|NCT01912352|Dopamine Agents|dopamine agents|mesh-ancestor
153391599|NCT01912352|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153391600|NCT02975843|Beclomethasone|beclomethasone|mesh-list
153391601|NCT02975843|Glycopyrrolate|glycopyrrolate|mesh-list
153391602|NCT02975843|Formoterol Fumarate|formoterol fumarate|mesh-list
153391603|NCT02975843|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153391604|NCT02975843|Autonomic Agents|autonomic agents|mesh-ancestor
153391605|NCT02975843|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153391606|NCT02975843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153391607|NCT02975843|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153391608|NCT02975843|Respiratory System Agents|respiratory system agents|mesh-ancestor
153391609|NCT02975843|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
153391610|NCT02975843|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
153391611|NCT02975843|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153391612|NCT02975843|Adrenergic Agents|adrenergic agents|mesh-ancestor
153391613|NCT02975843|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153391614|NCT02975843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153391615|NCT02975843|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153851390|NCT05473715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153851391|NCT05473715|Growth Inhibitors|growth inhibitors|mesh-ancestor
153851392|NCT05473715|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153851393|NCT05403450|Decitabine|decitabine|mesh-list
153648468|NCT00022126|Abortifacient Agents|abortifacient agents|mesh-ancestor
153648469|NCT00022126|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153851394|NCT05403450|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153851395|NCT05403450|Antimetabolites|antimetabolites|mesh-ancestor
153851396|NCT05403450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153851397|NCT05403450|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153851398|NCT05403450|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153851399|NCT05338619|Lazertinib|lazertinib|mesh-list
153851400|NCT05338619|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153851401|NCT05338619|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153851402|NCT05338619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153851404|NCT05320380|Prednisolone|prednisolone|mesh-list
153851405|NCT05320380|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
153851406|NCT05320380|Methylprednisolone|methylprednisolone|mesh-list
153851415|NCT05320380|Fludarabine phosphate|fludarabine phosphate|mesh-list
153851417|NCT05320380|Daunorubicin|daunorubicin|mesh-list
153851418|NCT05320380|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
153851419|NCT05320380|Prednisolone phosphate|prednisolone phosphate|mesh-list
153851420|NCT05320380|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
153851421|NCT05320380|Abortifacient Agents|abortifacient agents|mesh-ancestor
153851422|NCT05320380|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153851423|NCT05320380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153851429|NCT05320380|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153851430|NCT05320380|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153851431|NCT05320380|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153851432|NCT05320380|Immunologic Factors|immunologic factors|mesh-ancestor
153851433|NCT05320380|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153391629|NCT01655563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153391630|NCT01655719|Pioglitazone|pioglitazone|mesh-list
153391631|NCT01655719|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153391632|NCT01655719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153391634|NCT05735756|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
153391635|NCT05735756|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153391636|NCT05735756|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153391637|NCT05735756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153391638|NCT05735756|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153391639|NCT05735756|Serotonin Agents|serotonin agents|mesh-ancestor
153391640|NCT05735756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153391641|NCT05735756|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
153391642|NCT05735756|Antidepressive Agents|antidepressive agents|mesh-ancestor
153391643|NCT05735756|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153391644|NCT01936844|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
153391646|NCT02987348|Insulin|insulin|mesh-list
153391662|NCT01656031|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153851434|NCT05320380|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153851440|NCT05320380|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153851441|NCT05320380|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153851442|NCT05320380|Antiemetics|antiemetics|mesh-ancestor
153851443|NCT05320380|Autonomic Agents|autonomic agents|mesh-ancestor
153851444|NCT05320380|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153851445|NCT05320380|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153851446|NCT05320380|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
153851447|NCT05320380|Protective Agents|protective agents|mesh-ancestor
153851448|NCT05320380|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153851449|NCT05320380|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153851450|NCT05320380|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153851451|NCT05124275|Pilocarpine|pilocarpine|mesh-list
153851452|NCT05124275|Miotics|miotics|mesh-ancestor
153851453|NCT05124275|Autonomic Agents|autonomic agents|mesh-ancestor
153851454|NCT05124275|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153851455|NCT05124275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153851456|NCT05124275|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
153851457|NCT05124275|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
153820211|NCT03273231|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153648475|NCT00022126|Antiviral Agents|antiviral agents|mesh-ancestor
153820212|NCT03273231|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
153820213|NCT03273231|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
153820214|NCT03273231|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153820215|NCT03273231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153820216|NCT00432146|Lugol's solution|lugol's solution|mesh-list
153820217|NCT00432146|Hemostatics|hemostatics|mesh-ancestor
153820218|NCT00432146|Coagulants|coagulants|mesh-ancestor
153851458|NCT05124275|Cholinergic Agents|cholinergic agents|mesh-ancestor
153851459|NCT05124275|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153851460|NCT05124275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153851461|NCT05033054|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
153851462|NCT05033054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153851463|NCT05033054|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153851464|NCT05033054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153851465|NCT05009927|Imatinib Mesylate|imatinib mesylate|mesh-list
153391664|NCT01656031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153391665|NCT01656031|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153391666|NCT01656031|Antiviral Agents|antiviral agents|mesh-ancestor
153391667|NCT01656031|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153391668|NCT01656031|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153391669|NCT01656031|Immunologic Factors|immunologic factors|mesh-ancestor
153391670|NCT01656031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153391671|NCT01656187|Memantine|memantine|mesh-list
153391672|NCT01656187|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
153391673|NCT01656187|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
153391674|NCT01656187|Dopamine Agents|dopamine agents|mesh-ancestor
153391675|NCT01656187|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153391676|NCT01656187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153391677|NCT01656187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153391678|NCT01656187|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
153391699|NCT01662115|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153732672|NCT00505531|Narcotics|narcotics|mesh-ancestor
153732673|NCT00505531|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153732674|NCT00505531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153391700|NCT01662115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153391701|NCT01662115|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
153391702|NCT01662115|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
153391703|NCT01662115|Cholinergic Agents|cholinergic agents|mesh-ancestor
153391704|NCT01662115|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153391721|NCT00000309|Risperidone|risperidone|mesh-list
153391722|NCT00000309|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153391723|NCT00000309|Serotonin Agents|serotonin agents|mesh-ancestor
153391724|NCT00000309|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153461743|NCT04195776|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153851494|NCT04902261|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153851495|NCT04841434|Methotrexate|methotrexate|mesh-list
153851496|NCT04841434|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
153851497|NCT04841434|Abortifacient Agents|abortifacient agents|mesh-ancestor
153851498|NCT04841434|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153851499|NCT04841434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153851500|NCT04841434|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153851501|NCT04841434|Antimetabolites|antimetabolites|mesh-ancestor
153851505|NCT04841434|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153851506|NCT04841434|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153851507|NCT04841434|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153851508|NCT04841434|Immunologic Factors|immunologic factors|mesh-ancestor
153851509|NCT04841434|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153851510|NCT04841434|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153851511|NCT04838301|Pregnanolone|pregnanolone|mesh-list
153851512|NCT04838301|Anesthetics|anesthetics|mesh-ancestor
153851513|NCT04838301|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153851514|NCT04838301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153851515|NCT04817189|Dexamethasone|dexamethasone|mesh-list
153851516|NCT04817189|Ondansetron|ondansetron|mesh-list
153851517|NCT04817189|Palonosetron|palonosetron|mesh-list
153851518|NCT04817189|Granisetron|granisetron|mesh-list
153851519|NCT04817189|Tropisetron|tropisetron|mesh-list
153851520|NCT04817189|Dolasetron|dolasetron|mesh-list
153851521|NCT04817189|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153851522|NCT04817189|Antiemetics|antiemetics|mesh-ancestor
153851523|NCT04817189|Autonomic Agents|autonomic agents|mesh-ancestor
153851524|NCT04817189|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153851525|NCT04817189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153391725|NCT00000309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153391726|NCT00000309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153391727|NCT00000309|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153391728|NCT00000309|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153391737|NCT00000315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153391739|NCT00000315|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153391740|NCT00000315|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
153391741|NCT00000315|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
153391742|NCT00000315|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153391743|NCT00000315|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153361980|NCT05945979|Vitamins|vitamins|mesh-ancestor
153391744|NCT00000315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153391745|NCT00000315|Dopamine Agents|dopamine agents|mesh-ancestor
153391746|NCT00000315|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153391747|NCT00000321|Desipramine|desipramine|mesh-list
153851526|NCT04817189|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153851527|NCT04817189|Glucocorticoids|glucocorticoids|mesh-ancestor
153851528|NCT04817189|Hormones|hormones|mesh-ancestor
153851529|NCT04817189|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153851530|NCT04817189|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153851531|NCT04817189|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153851532|NCT04817189|Antipruritics|antipruritics|mesh-ancestor
153851533|NCT04817189|Dermatologic Agents|dermatologic agents|mesh-ancestor
153851534|NCT04817189|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
153851535|NCT04817189|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153851536|NCT04817189|Serotonin Agents|serotonin agents|mesh-ancestor
153851537|NCT04817189|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153851538|NCT04817189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153851539|NCT04724837|Dapagliflozin|dapagliflozin|mesh-list
153851540|NCT04724837|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
153851541|NCT04724837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153851542|NCT04724837|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153851543|NCT04724837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153851544|NCT04603001|Azacitidine|azacitidine|mesh-list
153851545|NCT04603001|Venetoclax|venetoclax|mesh-list
153851546|NCT04603001|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153851547|NCT04603001|Antimetabolites|antimetabolites|mesh-ancestor
153851548|NCT04603001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153391748|NCT00000321|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
153391749|NCT00000321|Antidepressive Agents|antidepressive agents|mesh-ancestor
153391764|NCT01940276|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153391765|NCT01940276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153851551|NCT04588922|Azacitidine|azacitidine|mesh-list
153851552|NCT04588922|Venetoclax|venetoclax|mesh-list
153851553|NCT04588922|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153851554|NCT04588922|Antimetabolites|antimetabolites|mesh-ancestor
153851555|NCT04588922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153851556|NCT04588922|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153851557|NCT04588922|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153851558|NCT04576364|Magnesium Sulfate|magnesium sulfate|mesh-list
153851559|NCT04576364|Analgesics|analgesics|mesh-ancestor
153851560|NCT04576364|Sensory System Agents|sensory system agents|mesh-ancestor
153851561|NCT04576364|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153851562|NCT04576364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153851563|NCT04576364|Anesthetics|anesthetics|mesh-ancestor
153851564|NCT04576364|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153851565|NCT04576364|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153851566|NCT04576364|Anticonvulsants|anticonvulsants|mesh-ancestor
153851567|NCT04576364|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153391783|NCT01919216|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153391784|NCT01919216|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153851572|NCT04576364|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153851576|NCT04538976|Sildenafil Citrate|sildenafil citrate|mesh-list
153851577|NCT04538976|Vasodilator Agents|vasodilator agents|mesh-ancestor
153851578|NCT04538976|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
153851579|NCT04538976|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
153851580|NCT04538976|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153851581|NCT04538976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153851582|NCT04538976|Urological Agents|urological agents|mesh-ancestor
153851583|NCT04522544|Durvalumab|durvalumab|mesh-list
153851584|NCT04522544|Tremelimumab|tremelimumab|mesh-list
153851585|NCT04522544|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153851586|NCT04522544|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153732686|NCT00505531|Histamine Antagonists|histamine antagonists|mesh-ancestor
153391785|NCT01919216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153391786|NCT01919216|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153391801|NCT01940510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153391802|NCT01940510|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
153391803|NCT01940510|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
153391804|NCT01940510|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
153391805|NCT01940510|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
153391806|NCT01940510|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
153391807|NCT01940510|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
153391809|NCT01940510|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153391810|NCT00380289|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
153391811|NCT00380289|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
153391812|NCT00380289|Adrenergic Agents|adrenergic agents|mesh-ancestor
153391813|NCT00380289|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153851587|NCT04521686|Gemcitabine|gemcitabine|mesh-list
153851588|NCT04521686|Durvalumab|durvalumab|mesh-list
153851589|NCT04521686|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153851590|NCT04521686|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153851591|NCT04521686|Antimetabolites|antimetabolites|mesh-ancestor
153851592|NCT04521686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153851593|NCT04521686|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153851594|NCT04431635|Rituximab|rituximab|mesh-list
153851602|NCT04431635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153851603|NCT04324307|Paclitaxel|paclitaxel|mesh-list
153851604|NCT04324307|Gemcitabine|gemcitabine|mesh-list
153851605|NCT04324307|Fluorouracil|fluorouracil|mesh-list
153851606|NCT04324307|Oxaliplatin|oxaliplatin|mesh-list
153851607|NCT04324307|Irinotecan|irinotecan|mesh-list
153851608|NCT04324307|Folfirinox|folfirinox|mesh-list
153851609|NCT04324307|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153851610|NCT04324307|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153851611|NCT04324307|Tubulin Modulators|tubulin modulators|mesh-ancestor
153851612|NCT04324307|Antimitotic Agents|antimitotic agents|mesh-ancestor
153851613|NCT04324307|Mitosis Modulators|mitosis modulators|mesh-ancestor
153851614|NCT04324307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153851615|NCT04324307|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153851616|NCT04324307|Antimetabolites|antimetabolites|mesh-ancestor
153851617|NCT04324307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153851618|NCT04324307|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153851619|NCT04324307|Immunologic Factors|immunologic factors|mesh-ancestor
153391817|NCT05364645|Pemetrexed|pemetrexed|mesh-list
153391818|NCT05364645|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153391819|NCT05364645|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153391820|NCT05364645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153391821|NCT05364645|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153391822|NCT05364645|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153391823|NCT01919450|Regadenoson|regadenoson|mesh-list
153391824|NCT01919450|Adenosine A2 Receptor Agonists|adenosine a2 receptor agonists|mesh-ancestor
153391825|NCT01919450|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
153362008|NCT05944107|Heparin|heparin|mesh-list
153391829|NCT01919450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153391830|NCT01919450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153391831|NCT01602679|Progesterone|progesterone|mesh-list
153391832|NCT01602679|Progestins|progestins|mesh-ancestor
153391833|NCT01602679|Hormones|hormones|mesh-ancestor
153391834|NCT01602679|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153391835|NCT01602679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153391836|NCT01919606|Bupivacaine|bupivacaine|mesh-list
153391837|NCT01919606|Anesthetics, Local|anesthetics, local|mesh-ancestor
153391838|NCT01919606|Anesthetics|anesthetics|mesh-ancestor
153391839|NCT01919606|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153391840|NCT01919606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153391841|NCT01919606|Sensory System Agents|sensory system agents|mesh-ancestor
153851645|NCT04174170|Dopamine Agonists|dopamine agonists|mesh-ancestor
153851646|NCT04174170|Dopamine Agents|dopamine agents|mesh-ancestor
153851647|NCT04172779|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
153851648|NCT04172779|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153851649|NCT04172779|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153851650|NCT04172779|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153851651|NCT04172779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153851652|NCT04172779|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153851653|NCT04146298|Cyclophosphamide|cyclophosphamide|mesh-list
153851654|NCT04146298|Fludarabine|fludarabine|mesh-list
153851655|NCT04146298|Antibodies|antibodies|mesh-list
153851656|NCT04146298|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
153851657|NCT04146298|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153851658|NCT04146298|Immunologic Factors|immunologic factors|mesh-ancestor
153851659|NCT04146298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153851660|NCT04146298|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153851661|NCT04146298|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153851662|NCT04146298|Alkylating Agents|alkylating agents|mesh-ancestor
153822051|NCT02957162|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
153851663|NCT04146298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153851664|NCT04146298|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153391867|NCT01667029|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153391868|NCT01667029|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153391869|NCT01943864|Trametinib|trametinib|mesh-list
153391870|NCT01943864|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153391871|NCT01943864|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153391872|NCT01943864|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153391873|NCT01943864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153391874|NCT01607203|Triptorelin Pamoate|triptorelin pamoate|mesh-list
153391875|NCT01607203|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
153391876|NCT01607203|Luteolytic Agents|luteolytic agents|mesh-ancestor
153391877|NCT01607203|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
153391878|NCT01607203|Contraceptive Agents|contraceptive agents|mesh-ancestor
153391879|NCT01607203|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153391880|NCT01607203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153391881|NCT01607203|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
153391882|NCT01607203|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153391883|NCT01607203|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153391884|NCT00000333|Benztropine|benztropine|mesh-list
153391885|NCT00000333|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
153391886|NCT00000333|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
153391887|NCT00000333|Parasympatholytics|parasympatholytics|mesh-ancestor
153391888|NCT00000333|Autonomic Agents|autonomic agents|mesh-ancestor
153391889|NCT00000333|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153391890|NCT00000333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153391891|NCT00000333|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
153851665|NCT04146298|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153851666|NCT04124614|Sertraline|sertraline|mesh-list
153851667|NCT04124614|Brexpiprazole|brexpiprazole|mesh-list
153851668|NCT04124614|Antidepressive Agents|antidepressive agents|mesh-ancestor
153851669|NCT04124614|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153851670|NCT04124614|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
153851671|NCT04124614|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153732690|NCT00505531|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
153851675|NCT04124614|Serotonin Agents|serotonin agents|mesh-ancestor
153851676|NCT04124614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153851677|NCT04124614|Dopamine Agonists|dopamine agonists|mesh-ancestor
153851678|NCT04124614|Dopamine Agents|dopamine agents|mesh-ancestor
153851679|NCT03953131|1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid|1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid|mesh-list
153851680|NCT03953131|Chelating Agents|chelating agents|mesh-ancestor
153851681|NCT03953131|Sequestering Agents|sequestering agents|mesh-ancestor
153822088|NCT00477126|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
153822089|NCT00477126|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
153822090|NCT00477126|Protease Inhibitors|protease inhibitors|mesh-ancestor
153822091|NCT00477126|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153822092|NCT00477126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153822093|NCT00477126|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153822094|NCT00477126|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153822095|NCT00477126|Antiviral Agents|antiviral agents|mesh-ancestor
153822096|NCT00477126|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153822097|NCT00477126|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
153822098|NCT00477126|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153822099|NCT03279341|Prucalopride|prucalopride|mesh-list
153822100|NCT03279341|Bisacodyl|bisacodyl|mesh-list
153820219|NCT00432302|Sagopilone|sagopilone|mesh-list
153820220|NCT00432302|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153820221|NCT00463008|Methotrexate|methotrexate|mesh-list
153851700|NCT03889795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153391915|NCT00000345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153391917|NCT00000345|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153822101|NCT03279341|Laxatives|laxatives|mesh-ancestor
153820222|NCT00463008|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
153820223|NCT00463008|Abortifacient Agents|abortifacient agents|mesh-ancestor
153820224|NCT00463008|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153820225|NCT00463008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153820226|NCT00463008|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153820227|NCT00463008|Antimetabolites|antimetabolites|mesh-ancestor
153461645|NCT03246828|Gliclazide|gliclazide|mesh-list
153461646|NCT03246828|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153461647|NCT03246828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153461648|NCT04316442|Immunoconjugates|immunoconjugates|mesh-list
153391923|NCT00000345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153391924|NCT00000357|Buprenorphine|buprenorphine|mesh-list
153391925|NCT00000357|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153391926|NCT00000357|Narcotics|narcotics|mesh-ancestor
153391927|NCT00000357|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153391928|NCT00000357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153391929|NCT00000357|Analgesics|analgesics|mesh-ancestor
153391930|NCT00000357|Sensory System Agents|sensory system agents|mesh-ancestor
153391931|NCT00000357|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153391932|NCT00000357|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
153391933|NCT01922336|Infliximab|infliximab|mesh-list
153391934|NCT01922336|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
153391935|NCT01922336|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153362079|NCT05820841|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153362080|NCT05820841|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153362081|NCT05820841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153362082|NCT05820841|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153362083|NCT05806567|Belumosudil|belumosudil|mesh-list
153362084|NCT05806567|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153362085|NCT05806567|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153362086|NCT05806567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153362087|NCT05731518|Irinotecan|irinotecan|mesh-list
153362088|NCT05731518|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
153362089|NCT05731518|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153362090|NCT05731518|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153362091|NCT05731518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153391937|NCT01922336|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153391938|NCT01922336|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153851707|NCT03808025|Analgesics, Opioid|analgesics, opioid|mesh-list
153851708|NCT03808025|Narcotics|narcotics|mesh-ancestor
153851709|NCT03808025|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153851710|NCT03808025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153851711|NCT03808025|Analgesics|analgesics|mesh-ancestor
153851712|NCT03808025|Sensory System Agents|sensory system agents|mesh-ancestor
153851713|NCT03808025|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153851714|NCT03802084|Imatinib Mesylate|imatinib mesylate|mesh-list
153851715|NCT03802084|Vactosertib|vactosertib|mesh-list
153851716|NCT03802084|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153851717|NCT03802084|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153851718|NCT03802084|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153851719|NCT03802084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153851720|NCT03802084|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153851721|NCT03777462|Paclitaxel|paclitaxel|mesh-list
153851724|NCT03777462|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153851725|NCT03777462|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153851726|NCT03777462|Tubulin Modulators|tubulin modulators|mesh-ancestor
153851727|NCT03777462|Antimitotic Agents|antimitotic agents|mesh-ancestor
153851728|NCT03777462|Mitosis Modulators|mitosis modulators|mesh-ancestor
153851729|NCT03777462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153851730|NCT03777462|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153851731|NCT03777462|Antimetabolites|antimetabolites|mesh-ancestor
153851732|NCT03745326|Aldesleukin|aldesleukin|mesh-list
153851733|NCT03745326|Cyclophosphamide|cyclophosphamide|mesh-list
153851734|NCT03745326|Fludarabine|fludarabine|mesh-list
153851735|NCT03745326|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153851736|NCT03745326|Immunologic Factors|immunologic factors|mesh-ancestor
153851738|NCT03745326|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153851739|NCT03745326|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153851740|NCT03745326|Alkylating Agents|alkylating agents|mesh-ancestor
153851741|NCT03745326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153391939|NCT04330755|Magnesium Sulfate|magnesium sulfate|mesh-list
153391940|NCT04330755|Simendan|simendan|mesh-list
153391941|NCT04330755|Analgesics|analgesics|mesh-ancestor
153391942|NCT04330755|Sensory System Agents|sensory system agents|mesh-ancestor
153391943|NCT04330755|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153391944|NCT04330755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153391945|NCT04330755|Anesthetics|anesthetics|mesh-ancestor
153391946|NCT04330755|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153391947|NCT04330755|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153391948|NCT04330755|Anticonvulsants|anticonvulsants|mesh-ancestor
153391949|NCT04330755|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153391950|NCT04330755|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153391951|NCT04330755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153391952|NCT04330755|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153391953|NCT04330755|Tocolytic Agents|tocolytic agents|mesh-ancestor
153391954|NCT04330755|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153391955|NCT04330755|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
153391956|NCT04330755|Vasodilator Agents|vasodilator agents|mesh-ancestor
153391957|NCT04330755|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
153391958|NCT04330755|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
153391959|NCT04330755|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153391960|NCT04330755|Protective Agents|protective agents|mesh-ancestor
153391961|NCT01608295|Paroxetine|paroxetine|mesh-list
153391962|NCT01608295|Antidepressive Agents|antidepressive agents|mesh-list
153391963|NCT01608295|Vilazodone Hydrochloride|vilazodone hydrochloride|mesh-list
153391964|NCT01608295|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
153391965|NCT01608295|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153391966|NCT01608295|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153391967|NCT01608295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153391968|NCT01608295|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153851747|NCT03745326|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153851748|NCT03730181|Isoniazid|isoniazid|mesh-list
153851749|NCT03730181|Rifapentine|rifapentine|mesh-list
153851750|NCT03730181|Antitubercular Agents|antitubercular agents|mesh-ancestor
153851751|NCT03730181|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153851752|NCT03730181|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153851753|NCT03730181|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
153851754|NCT03730181|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153851762|NCT03674671|Sensory System Agents|sensory system agents|mesh-ancestor
153851763|NCT03674671|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153851764|NCT03674671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153851765|NCT03674671|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
153851766|NCT03674671|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153851767|NCT03674671|Anesthetics, General|anesthetics, general|mesh-ancestor
153851768|NCT03674671|Anesthetics|anesthetics|mesh-ancestor
153851769|NCT03674671|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153851770|NCT03674671|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
153851771|NCT03674671|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
153851772|NCT03674671|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153851773|NCT03674671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153851774|NCT03668119|Nivolumab|nivolumab|mesh-list
153851775|NCT03668119|Ipilimumab|ipilimumab|mesh-list
153391972|NCT01608295|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153391973|NCT01608295|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
153391974|NCT01608295|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153391975|NCT01608295|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153391976|NCT01608295|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
153391977|NCT01608295|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
153391979|NCT04713189|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153391980|NCT04713189|Narcotics|narcotics|mesh-ancestor
153391981|NCT04713189|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153391982|NCT04713189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153391983|NCT04713189|Analgesics|analgesics|mesh-ancestor
153391984|NCT04713189|Sensory System Agents|sensory system agents|mesh-ancestor
153391985|NCT04713189|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153391988|NCT04713189|Anesthetics, General|anesthetics, general|mesh-ancestor
153362132|NCT05531942|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153392008|NCT00000429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153851776|NCT03668119|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153851777|NCT03668119|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153851778|NCT03668119|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153851779|NCT03668119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153851780|NCT03659799|Insulin|insulin|mesh-list
153851781|NCT03659799|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
153851782|NCT03659799|Insulin Aspart|insulin aspart|mesh-list
153851783|NCT03659799|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153851784|NCT03659799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153851785|NCT03653364|Baloxavir|baloxavir|mesh-list
153851786|NCT03653364|Antiviral Agents|antiviral agents|mesh-ancestor
153851800|NCT03624244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153851801|NCT03620019|Denosumab|denosumab|mesh-list
153851802|NCT03620019|Pembrolizumab|pembrolizumab|mesh-list
153851803|NCT03620019|Nivolumab|nivolumab|mesh-list
153851804|NCT03620019|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153851805|NCT03620019|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153851806|NCT03620019|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153851807|NCT03620019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153851808|NCT03620019|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153851809|NCT03620019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153851810|NCT03591770|Vaccines|vaccines|mesh-list
153851811|NCT03591770|Immunologic Factors|immunologic factors|mesh-ancestor
153851812|NCT03591770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153392010|NCT00000429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153392011|NCT00000429|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153392012|NCT01673191|Dexamethasone|dexamethasone|mesh-list
153392013|NCT01673191|Prednisolone acetate|prednisolone acetate|mesh-list
153392014|NCT01673191|Ophthalmic Solutions|ophthalmic solutions|mesh-list
153392015|NCT01673191|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153392016|NCT01673191|Antiemetics|antiemetics|mesh-ancestor
153392017|NCT01673191|Autonomic Agents|autonomic agents|mesh-ancestor
153362133|NCT05531942|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153392020|NCT01673191|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153392021|NCT01673191|Glucocorticoids|glucocorticoids|mesh-ancestor
153392023|NCT01673191|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153392024|NCT01673191|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153392025|NCT01673191|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153392026|NCT01673191|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
153392027|NCT01925144|Omeprazole|omeprazole|mesh-list
153392028|NCT01925144|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
153392029|NCT01925144|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153392030|NCT01925144|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
153392031|NCT01925144|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153392032|NCT01925144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153392033|NCT00000441|Carbamazepine|carbamazepine|mesh-list
153392034|NCT00000441|Lorazepam|lorazepam|mesh-list
153392035|NCT00000441|Anticonvulsants|anticonvulsants|mesh-ancestor
153392036|NCT00000441|Antiemetics|antiemetics|mesh-ancestor
153392037|NCT00000441|Autonomic Agents|autonomic agents|mesh-ancestor
153392040|NCT00000441|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153851813|NCT03559647|Atezolizumab|atezolizumab|mesh-list
153851814|NCT03559647|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153851815|NCT03559647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153851816|NCT03559647|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153851817|NCT03559647|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153851821|NCT03321734|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
153851822|NCT03321734|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153851823|NCT03321734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153851824|NCT03321734|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
153851825|NCT03321734|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
153851826|NCT03321734|Purinergic Agents|purinergic agents|mesh-ancestor
153851827|NCT03321734|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153851828|NCT03261830|Clindamycin|clindamycin|mesh-list
153851829|NCT03261830|Clindamycin palmitate|clindamycin palmitate|mesh-list
153851830|NCT03261830|Clindamycin phosphate|clindamycin phosphate|mesh-list
153822169|NCT00477711|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153362158|NCT05422664|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153851832|NCT03261830|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153851833|NCT03261830|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153851834|NCT03261830|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
153851835|NCT03261830|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153851836|NCT03261830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153851837|NCT03064568|Misoprostol|misoprostol|mesh-list
153732704|NCT00162669|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153732705|NCT00162669|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153732706|NCT00162669|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153732707|NCT00162669|Growth Substances|growth substances|mesh-ancestor
153732708|NCT00162669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153732709|NCT00162669|Growth Inhibitors|growth inhibitors|mesh-ancestor
153732710|NCT00141947|Bexarotene|bexarotene|mesh-list
153732711|NCT00141947|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153732712|NCT04514770|Misoprostol|misoprostol|mesh-list
153732713|NCT04514770|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
153732714|NCT04514770|Abortifacient Agents|abortifacient agents|mesh-ancestor
153732715|NCT04514770|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153851838|NCT03064568|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
153851839|NCT03064568|Abortifacient Agents|abortifacient agents|mesh-ancestor
153851840|NCT03064568|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153851841|NCT03064568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153851842|NCT03064568|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
153851843|NCT03064568|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153851844|NCT03064568|Oxytocics|oxytocics|mesh-ancestor
153851845|NCT02691078|Octreotide|octreotide|mesh-list
153851846|NCT02691078|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153851847|NCT02691078|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153851848|NCT02691078|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153851849|NCT02549573|Apomorphine|apomorphine|mesh-list
153851850|NCT02549573|Emetics|emetics|mesh-ancestor
153851851|NCT02549573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153851852|NCT02549573|Autonomic Agents|autonomic agents|mesh-ancestor
153851853|NCT02549573|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153851854|NCT02549573|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153851855|NCT02549573|Dopamine Agonists|dopamine agonists|mesh-ancestor
153392055|NCT00000441|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153392056|NCT00000441|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
153392057|NCT00000441|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
153392058|NCT00000447|Naltrexone|naltrexone|mesh-list
153392059|NCT00000447|Nicotine|nicotine|mesh-list
153392060|NCT00000447|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
153392061|NCT00000447|Autonomic Agents|autonomic agents|mesh-ancestor
153392062|NCT00000447|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153392063|NCT00000447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153392064|NCT00000447|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
153392065|NCT00000447|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
153392066|NCT00000447|Cholinergic Agents|cholinergic agents|mesh-ancestor
153392067|NCT00000447|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153392068|NCT00000447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153392069|NCT00000447|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
153392070|NCT00000447|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
153392071|NCT00000447|Sensory System Agents|sensory system agents|mesh-ancestor
153392072|NCT01927718|Thalidomide|thalidomide|mesh-list
153392073|NCT01927718|Lenalidomide|lenalidomide|mesh-list
153392074|NCT01927718|Immunologic Factors|immunologic factors|mesh-ancestor
153392075|NCT01927718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153392076|NCT01927718|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153392077|NCT01927718|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153392078|NCT01927718|Growth Substances|growth substances|mesh-ancestor
153392079|NCT01927718|Growth Inhibitors|growth inhibitors|mesh-ancestor
153392080|NCT01927718|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153392081|NCT01927718|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153392082|NCT01927718|Leprostatic Agents|leprostatic agents|mesh-ancestor
153851868|NCT02542657|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153851869|NCT02542657|Glucocorticoids|glucocorticoids|mesh-ancestor
153851870|NCT02542657|Hormones|hormones|mesh-ancestor
153851871|NCT02542657|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153851872|NCT02542657|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153851874|NCT02542657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153362188|NCT04981041|Ticagrelor|ticagrelor|mesh-list
153851875|NCT02542657|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153851876|NCT02542657|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153851877|NCT02542657|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
153851878|NCT02542657|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153851879|NCT02542657|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
153851880|NCT02542657|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153851881|NCT02542657|Immunologic Factors|immunologic factors|mesh-ancestor
153851882|NCT02542657|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153851883|NCT02542657|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153851884|NCT02542657|Growth Substances|growth substances|mesh-ancestor
153392083|NCT01927718|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153392084|NCT01927718|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153392085|NCT01948310|Ranolazine|ranolazine|mesh-list
153392086|NCT01948310|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153392087|NCT01948310|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153392088|NCT01948310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153392089|NCT01948388|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
153392090|NCT01948388|Hormones|hormones|mesh-ancestor
153392091|NCT01948388|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153392092|NCT01948388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153851908|NCT01789879|Efavirenz|efavirenz|mesh-list
153392106|NCT05295537|Hematinics|hematinics|mesh-ancestor
153392107|NCT02287376|Diclofenac|diclofenac|mesh-list
153392108|NCT02287376|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153392109|NCT02287376|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153392110|NCT02287376|Analgesics|analgesics|mesh-ancestor
153392111|NCT02287376|Sensory System Agents|sensory system agents|mesh-ancestor
153392112|NCT02287376|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153392113|NCT02287376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153392114|NCT02287376|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153392115|NCT02287376|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153392116|NCT02287376|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153392117|NCT02287376|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153392118|NCT02287376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153392120|NCT01928186|Antiviral Agents|antiviral agents|mesh-ancestor
153392121|NCT01928186|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153392122|NCT01611571|Teriparatide|teriparatide|mesh-list
153392123|NCT01611571|Risedronic Acid|risedronic acid|mesh-list
153392124|NCT01611571|Etidronic Acid|etidronic acid|mesh-list
153392125|NCT01611571|Parathyroid Hormone|parathyroid hormone|mesh-list
153392126|NCT01611571|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153392127|NCT01611571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153851909|NCT01789879|Nevirapine|nevirapine|mesh-list
153851910|NCT01789879|Levonorgestrel|levonorgestrel|mesh-list
153851911|NCT01789879|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153851912|NCT01789879|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153851913|NCT01789879|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153851914|NCT01789879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153851915|NCT01789879|Antiviral Agents|antiviral agents|mesh-ancestor
153851916|NCT01789879|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153851917|NCT01789879|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
153851918|NCT01789879|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153732718|NCT04514770|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153732719|NCT04514770|Oxytocics|oxytocics|mesh-ancestor
153732721|NCT00141986|Ergocalciferols|ergocalciferols|mesh-list
153822227|NCT00442676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153851920|NCT01789879|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
153851921|NCT01789879|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
153851922|NCT01789879|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
153851923|NCT01789879|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
153851924|NCT01789879|Contraceptive Agents|contraceptive agents|mesh-ancestor
153851925|NCT01789879|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153851926|NCT01789879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153851927|NCT01789879|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
153851928|NCT01789879|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
153851929|NCT01789879|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
153851930|NCT01789879|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153851931|NCT01789879|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153851932|NCT01772563|Itraconazole|itraconazole|mesh-list
153392134|NCT00000477|Dihydromevinolin|dihydromevinolin|mesh-list
153392135|NCT00000477|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153392136|NCT00000477|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153392137|NCT00000477|Antimetabolites|antimetabolites|mesh-ancestor
153392138|NCT00000477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153392139|NCT00000477|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153392140|NCT00000477|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
153392141|NCT00000477|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153392142|NCT00000483|Niacin|niacin|mesh-list
153392146|NCT00000483|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153392148|NCT00000483|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153392149|NCT00000483|Antimetabolites|antimetabolites|mesh-ancestor
153392150|NCT00000483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153392151|NCT00000483|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153392152|NCT00000483|Vasodilator Agents|vasodilator agents|mesh-ancestor
153392154|NCT00000483|Vitamins|vitamins|mesh-ancestor
153392155|NCT00000483|Micronutrients|micronutrients|mesh-ancestor
153392156|NCT00000483|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153392157|NCT00000507|Streptokinase|streptokinase|mesh-list
153392158|NCT00000507|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153392159|NCT00000507|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153392160|NCT00000507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153392161|NCT00380445|Vildagliptin|vildagliptin|mesh-list
153392162|NCT00380445|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153648518|NCT00388739|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153392163|NCT00380445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153392164|NCT00380445|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
153851933|NCT01772563|Antifungal Agents|antifungal agents|mesh-ancestor
153851934|NCT01772563|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153392165|NCT00380445|Protease Inhibitors|protease inhibitors|mesh-ancestor
153392166|NCT00380445|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153392168|NCT01950260|Hormones|hormones|mesh-list
153851935|NCT01772563|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
153851936|NCT01772563|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153851937|NCT01772563|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153851938|NCT01772563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153851939|NCT01772563|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153851940|NCT01772563|Hormone Antagonists|hormone antagonists|mesh-ancestor
153851941|NCT01772563|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153851942|NCT01772563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153851943|NCT01772563|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
153851944|NCT01316523|Rituximab|rituximab|mesh-list
153851945|NCT01316523|Lenalidomide|lenalidomide|mesh-list
153851946|NCT01316523|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153851947|NCT01316523|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153851948|NCT01316523|Immunologic Factors|immunologic factors|mesh-ancestor
153851949|NCT01316523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153851950|NCT01316523|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153851951|NCT01316523|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153851952|NCT01316523|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153851966|NCT00848328|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153851967|NCT00848328|Immunologic Factors|immunologic factors|mesh-ancestor
153851968|NCT00848328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153851969|NCT00848328|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153851970|NCT00848328|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153392172|NCT01676311|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
153392173|NCT01676311|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153392174|NCT01676311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153392175|NCT01676311|Cholinergic Agents|cholinergic agents|mesh-ancestor
153392176|NCT01676311|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153392177|NCT01676311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153392178|NCT01676311|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
153392179|NCT01676311|Protective Agents|protective agents|mesh-ancestor
153392180|NCT01951118|Donepezil|donepezil|mesh-list
153392200|NCT01951820|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153392201|NCT01951820|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153392202|NCT01951820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153851971|NCT00848328|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153851972|NCT00848328|Growth Substances|growth substances|mesh-ancestor
153851973|NCT00848328|Growth Inhibitors|growth inhibitors|mesh-ancestor
153851974|NCT01237951|Dexamethasone|dexamethasone|mesh-list
153851975|NCT01237951|Gemcitabine|gemcitabine|mesh-list
153851976|NCT01237951|Melphalan|melphalan|mesh-list
153851977|NCT01237951|Busulfan|busulfan|mesh-list
153851978|NCT01237951|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153851979|NCT01237951|Antiemetics|antiemetics|mesh-ancestor
153851980|NCT01237951|Autonomic Agents|autonomic agents|mesh-ancestor
153851981|NCT01237951|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153851982|NCT01237951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153851983|NCT01237951|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153851984|NCT01237951|Glucocorticoids|glucocorticoids|mesh-ancestor
153851985|NCT01237951|Hormones|hormones|mesh-ancestor
153851986|NCT01237951|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153851987|NCT01237951|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153851988|NCT01237951|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153851989|NCT01237951|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153851990|NCT01237951|Antimetabolites|antimetabolites|mesh-ancestor
153851991|NCT01237951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153851992|NCT01237951|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153851993|NCT01237951|Alkylating Agents|alkylating agents|mesh-ancestor
153852004|NCT00544362|Cetuximab|cetuximab|mesh-list
153362239|NCT04512365|Sensory System Agents|sensory system agents|mesh-ancestor
153362240|NCT04512365|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153392227|NCT00000513|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153852006|NCT00544362|Antimetabolites|antimetabolites|mesh-ancestor
153852007|NCT00544362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153852008|NCT00544362|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153852009|NCT00544362|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153852010|NCT00544362|Immunologic Factors|immunologic factors|mesh-ancestor
153852011|NCT00544362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153852022|NCT00544518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153852023|NCT00544518|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153852024|NCT00544518|Antimetabolites|antimetabolites|mesh-ancestor
153852025|NCT00544518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153852026|NCT00544518|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153852027|NCT00544518|Appetite Depressants|appetite depressants|mesh-ancestor
153852028|NCT00544518|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
153392228|NCT00000513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153392229|NCT00000513|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
153392230|NCT00000513|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
153392231|NCT00000513|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
153392232|NCT00000513|Adrenergic Agents|adrenergic agents|mesh-ancestor
153392233|NCT00000513|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153392234|NCT00000513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153392235|NCT00000513|Diuretics|diuretics|mesh-ancestor
153392236|NCT00000513|Natriuretic Agents|natriuretic agents|mesh-ancestor
153392237|NCT00000513|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
153392238|NCT00000513|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153392239|NCT00000543|Calcium|calcium|mesh-list
153392240|NCT00000543|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153392241|NCT00000543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153392242|NCT00000549|Hormones|hormones|mesh-list
153362241|NCT04512365|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
153852037|NCT00544596|Acetic Acid|acetic acid|mesh-list
153852039|NCT00544596|Etoposide phosphate|etoposide phosphate|mesh-list
153852040|NCT00544596|Retinol acetate|retinol acetate|mesh-list
153852041|NCT00544596|Gossypol acetic acid|gossypol acetic acid|mesh-list
153852042|NCT00544596|Gossypol|gossypol|mesh-list
153852043|NCT00544596|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153852044|NCT00544596|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153852045|NCT00544596|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153852046|NCT00544596|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153852047|NCT00544596|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153852048|NCT00544596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153852049|NCT00544596|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153392257|NCT00000585|Penicillins|penicillins|mesh-list
153392258|NCT00000585|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153392259|NCT00000585|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153392260|NCT01701115|Bupivacaine|bupivacaine|mesh-list
153392261|NCT01701115|Anesthetics, Local|anesthetics, local|mesh-list
153392262|NCT01701115|Mepivacaine|mepivacaine|mesh-list
153392263|NCT01701115|Anesthetics|anesthetics|mesh-list
153392264|NCT01701115|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153392265|NCT01701115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153392266|NCT01701115|Sensory System Agents|sensory system agents|mesh-ancestor
153392267|NCT01701115|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153392268|NCT00000597|Nandrolone Decanoate|nandrolone decanoate|mesh-list
153392269|NCT00000597|Nandrolone|nandrolone|mesh-list
153392270|NCT00000597|Nandrolone phenpropionate|nandrolone phenpropionate|mesh-list
153392271|NCT00000597|Antilymphocyte Serum|antilymphocyte serum|mesh-list
153392272|NCT00000597|Androgens|androgens|mesh-ancestor
153392273|NCT00000597|Hormones|hormones|mesh-ancestor
153392274|NCT00000597|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153392275|NCT00000597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153852054|NCT00544596|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
153852055|NCT00544596|Protective Agents|protective agents|mesh-ancestor
153852056|NCT00544596|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
153852057|NCT00544596|Contraceptive Agents|contraceptive agents|mesh-ancestor
153852058|NCT00544596|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153852059|NCT00544596|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
153852060|NCT00544596|Spermatocidal Agents|spermatocidal agents|mesh-ancestor
153852061|NCT00544596|Antispermatogenic Agents|antispermatogenic agents|mesh-ancestor
153852063|NCT02908191|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
153852065|NCT02908191|Antiviral Agents|antiviral agents|mesh-ancestor
153852066|NCT02908191|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153852067|NCT02908191|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153852068|NCT02908191|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153852069|NCT02908191|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153852070|NCT02908191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153852071|NCT02908191|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153852072|NCT02908191|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153852073|NCT00544791|Melatonin|melatonin|mesh-list
153852074|NCT00544791|Antioxidants|antioxidants|mesh-ancestor
153852075|NCT00544791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153852076|NCT00544791|Protective Agents|protective agents|mesh-ancestor
153852077|NCT00544791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153392278|NCT00000597|Immunologic Factors|immunologic factors|mesh-ancestor
153392286|NCT01621009|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153392287|NCT01621009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153392288|NCT01621009|Dopamine Agents|dopamine agents|mesh-ancestor
153392289|NCT01621009|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153392290|NCT01621009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153392291|NCT01621009|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
153392292|NCT01621009|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153392293|NCT01621009|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153392295|NCT04830969|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
153392296|NCT04830969|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
153392297|NCT04830969|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153392298|NCT04830969|Disinfectants|disinfectants|mesh-ancestor
153392299|NCT04830969|Dermatologic Agents|dermatologic agents|mesh-ancestor
153392300|NCT01683331|Insulin|insulin|mesh-list
153392301|NCT01683331|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153392302|NCT01683331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153392303|NCT02986880|Botulinum Toxins|botulinum toxins|mesh-list
153852091|NCT04647773|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153852092|NCT04647773|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153852093|NCT01237678|Carboplatin|carboplatin|mesh-list
153852094|NCT01237678|Etoposide|etoposide|mesh-list
153852095|NCT01237678|Lorvotuzumab mertansine|lorvotuzumab mertansine|mesh-list
153852096|NCT01237678|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153852097|NCT01237678|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153852098|NCT01237678|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153852099|NCT01237678|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153852100|NCT01237678|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153852101|NCT01237678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153852102|NCT01237678|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153392304|NCT02986880|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
153392305|NCT02986880|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
153392306|NCT02986880|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
153392307|NCT02986880|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153392308|NCT02986880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153392309|NCT02986880|Cholinergic Agents|cholinergic agents|mesh-ancestor
153392310|NCT02986880|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153392311|NCT02986880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153392312|NCT02986880|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
153392313|NCT02986880|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153392314|NCT02290106|Pitavastatin|pitavastatin|mesh-list
153392315|NCT02290106|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
153392316|NCT02290106|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153732746|NCT04514419|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153732747|NCT04514419|Tubulin Modulators|tubulin modulators|mesh-ancestor
153732748|NCT04514419|Antimitotic Agents|antimitotic agents|mesh-ancestor
153732749|NCT04514419|Mitosis Modulators|mitosis modulators|mesh-ancestor
153732750|NCT04514419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153732751|NCT04514419|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153732752|NCT00142025|Oxcarbazepine|oxcarbazepine|mesh-list
153732753|NCT00142025|Anticonvulsants|anticonvulsants|mesh-ancestor
153732754|NCT00142025|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
153732755|NCT00142025|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153732756|NCT00142025|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153732757|NCT00142025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153732758|NCT00142025|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
153392320|NCT02290106|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153392321|NCT02290106|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153392323|NCT00000621|Isotretinoin|isotretinoin|mesh-list
153392324|NCT00000621|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153392325|NCT00000621|Keratolytic Agents|keratolytic agents|mesh-ancestor
153392326|NCT00000621|Dermatologic Agents|dermatologic agents|mesh-ancestor
153392327|NCT04818957|Vitamin D|vitamin d|mesh-list
153392328|NCT04818957|Cholecalciferol|cholecalciferol|mesh-list
153392329|NCT04818957|Vitamins|vitamins|mesh-ancestor
153392342|NCT01621477|Antilymphocyte Serum|antilymphocyte serum|mesh-list
153392343|NCT01621477|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153392344|NCT01621477|Immunologic Factors|immunologic factors|mesh-ancestor
153392345|NCT01621477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153392346|NCT01621477|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153392347|NCT01621477|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153392348|NCT01621477|Alkylating Agents|alkylating agents|mesh-ancestor
153392349|NCT01621477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153392350|NCT01621477|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153392351|NCT01621477|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153392352|NCT01621477|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153392353|NCT01621477|Antimetabolites|antimetabolites|mesh-ancestor
153392354|NCT01621477|Antiviral Agents|antiviral agents|mesh-ancestor
153392355|NCT01621477|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153392356|NCT01621477|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
153392357|NCT01621477|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153392358|NCT01621477|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153392359|NCT01621477|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
153392360|NCT01621477|Antitubercular Agents|antitubercular agents|mesh-ancestor
153392361|NCT01621477|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153392362|NCT01621477|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153852134|NCT01237327|Megestrol|megestrol|mesh-list
153852135|NCT01237327|Megestrol Acetate|megestrol acetate|mesh-list
153852136|NCT01237327|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153852137|NCT01237327|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
153852138|NCT01237327|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153392371|NCT00000627|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153392372|NCT00000627|Hormone Antagonists|hormone antagonists|mesh-ancestor
153392373|NCT00000627|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153392374|NCT00000627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153392375|NCT00000627|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
153392376|NCT00000627|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
153392377|NCT00000633|Vaccines|vaccines|mesh-list
153392378|NCT00000633|Immunologic Factors|immunologic factors|mesh-ancestor
153392379|NCT00000633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153392380|NCT01621633|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
153392381|NCT01621633|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
153392382|NCT01621633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153392383|NCT05479214|Metformin|metformin|mesh-list
153852159|NCT02907021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153852160|NCT02907021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153852161|NCT01237054|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
153852162|NCT01237054|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
153392407|NCT01701505|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153392408|NCT01701505|Adrenergic Agents|adrenergic agents|mesh-ancestor
153392409|NCT01701505|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153392410|NCT01701505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153392411|NCT01701505|Sympathomimetics|sympathomimetics|mesh-ancestor
153392412|NCT01701505|Autonomic Agents|autonomic agents|mesh-ancestor
153392413|NCT01701505|Nasal Decongestants|nasal decongestants|mesh-ancestor
153392414|NCT01701505|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
153392415|NCT01701505|Respiratory System Agents|respiratory system agents|mesh-ancestor
153392416|NCT01701505|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
153392417|NCT01701505|Mydriatics|mydriatics|mesh-ancestor
153392419|NCT01701505|Protective Agents|protective agents|mesh-ancestor
153852182|NCT04647344|Antimitotic Agents|antimitotic agents|mesh-ancestor
153852183|NCT04647344|Mitosis Modulators|mitosis modulators|mesh-ancestor
153852184|NCT04647344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153852185|NCT04647344|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153852186|NCT04647344|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153852187|NCT04647344|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153852188|NCT02906748|Parathyroid Hormone|parathyroid hormone|mesh-list
153852189|NCT02906748|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153362328|NCT03911414|Inositol|inositol|mesh-list
153852190|NCT02906748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153852191|NCT02907957|Anesthetics|anesthetics|mesh-list
153852192|NCT02907957|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153852193|NCT02907957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153852194|NCT04646876|Magnesium Sulfate|magnesium sulfate|mesh-list
153852195|NCT04646876|Analgesics|analgesics|mesh-ancestor
153852196|NCT04646876|Sensory System Agents|sensory system agents|mesh-ancestor
153852197|NCT04646876|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153852198|NCT04646876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153852199|NCT04646876|Anesthetics|anesthetics|mesh-ancestor
153852200|NCT04646876|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153852201|NCT04646876|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153852213|NCT02908035|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153852214|NCT02908035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153852215|NCT02908035|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153852216|NCT02908035|Immunologic Factors|immunologic factors|mesh-ancestor
153852217|NCT02908035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153852218|NCT02908035|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153852219|NCT02908035|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153852220|NCT02908035|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153392425|NCT00000669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153392427|NCT00000669|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153392428|NCT00000669|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153392429|NCT00000669|Antiviral Agents|antiviral agents|mesh-ancestor
153392430|NCT00000669|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153392431|NCT00000669|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153392432|NCT00000669|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153392433|NCT01622257|Metformin|metformin|mesh-list
153392434|NCT01622257|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153392435|NCT01622257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153852221|NCT02908035|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153852222|NCT02908035|Antifungal Agents|antifungal agents|mesh-ancestor
153852223|NCT04646759|Capecitabine|capecitabine|mesh-list
153852224|NCT04646759|Fulvestrant|fulvestrant|mesh-list
153852225|NCT04646759|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153852226|NCT04646759|Antimetabolites|antimetabolites|mesh-ancestor
153852237|NCT02906514|Blood Substitutes|blood substitutes|mesh-ancestor
153852241|NCT04646135|Autonomic Agents|autonomic agents|mesh-ancestor
153852242|NCT04646135|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153392505|NCT00000723|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153852292|NCT06237569|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153852293|NCT06237569|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153852295|NCT06237569|GABA Agents|gaba agents|mesh-ancestor
153852296|NCT06237478|Glycopyrrolate|glycopyrrolate|mesh-list
153852297|NCT06237478|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153852298|NCT06237478|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
153852299|NCT06237478|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
153852300|NCT06237478|Cholinergic Agents|cholinergic agents|mesh-ancestor
153852301|NCT06237478|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153852302|NCT06237478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153392506|NCT00000723|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153392507|NCT00000723|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
153392508|NCT00000723|Abortifacient Agents|abortifacient agents|mesh-ancestor
153392509|NCT00000723|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153392510|NCT00000723|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153392511|NCT00000723|Antimetabolites|antimetabolites|mesh-ancestor
153392512|NCT00000723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153392513|NCT00000723|Dermatologic Agents|dermatologic agents|mesh-ancestor
153392522|NCT00000723|Vitamin B Complex|vitamin b complex|mesh-ancestor
153852362|NCT06236789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153852363|NCT06236789|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153852364|NCT06236672|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-list
153852365|NCT06236672|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153852366|NCT06236672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153852367|NCT06236555|Adenosine|adenosine|mesh-list
153852368|NCT06236555|Dinoprost|dinoprost|mesh-list
153461649|NCT04316442|Immunologic Factors|immunologic factors|mesh-ancestor
153461650|NCT04316442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153461651|NCT03204396|Dulaglutide|dulaglutide|mesh-list
153461652|NCT03204396|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
153461653|NCT03204396|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153461654|NCT03204396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153461655|NCT03174132|Lidocaine|lidocaine|mesh-list
153852369|NCT06236555|Dinoprost tromethamine|dinoprost tromethamine|mesh-list
153852370|NCT06236555|Analgesics|analgesics|mesh-ancestor
153852371|NCT06236555|Sensory System Agents|sensory system agents|mesh-ancestor
153392574|NCT03438773|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
153392575|NCT03438773|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153392576|NCT03438773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153392577|NCT02974985|Hyaluronic Acid|hyaluronic acid|mesh-list
153392578|NCT02974985|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153392579|NCT02974985|Immunologic Factors|immunologic factors|mesh-ancestor
153392580|NCT02974985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153392581|NCT02974985|Viscosupplements|viscosupplements|mesh-ancestor
153392582|NCT02974985|Protective Agents|protective agents|mesh-ancestor
153392583|NCT01704781|Lenalidomide|lenalidomide|mesh-list
153392584|NCT01704781|Immunologic Factors|immunologic factors|mesh-ancestor
153392585|NCT01704781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153392586|NCT01704781|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153392587|NCT01704781|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153392588|NCT01704781|Growth Substances|growth substances|mesh-ancestor
153392591|NCT02288156|Capsaicin|capsaicin|mesh-list
153362374|NCT03456700|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153392613|NCT04699383|Anthelmintics|anthelmintics|mesh-ancestor
153392614|NCT05423132|Ropivacaine|ropivacaine|mesh-list
153392615|NCT05423132|Anesthetics, Local|anesthetics, local|mesh-ancestor
153392616|NCT05423132|Anesthetics|anesthetics|mesh-ancestor
153392617|NCT05423132|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153392618|NCT05423132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153392619|NCT05423132|Sensory System Agents|sensory system agents|mesh-ancestor
153732822|NCT00505882|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153732823|NCT00505882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153732824|NCT00142337|Zidovudine|zidovudine|mesh-list
153732825|NCT00142337|Didanosine|didanosine|mesh-list
153732826|NCT00142337|Antimetabolites|antimetabolites|mesh-ancestor
153732827|NCT00142337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153732828|NCT00142337|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153732829|NCT00142337|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153732830|NCT00142337|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153732831|NCT00142337|Antiviral Agents|antiviral agents|mesh-ancestor
153397705|NCT05364515|Clobetasol|clobetasol|mesh-list
153392627|NCT02975219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153392628|NCT02975219|Growth Inhibitors|growth inhibitors|mesh-ancestor
153392629|NCT01686451|Simvastatin|simvastatin|mesh-list
153392630|NCT01686451|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153392631|NCT01686451|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153392632|NCT01686451|Antimetabolites|antimetabolites|mesh-ancestor
153392633|NCT01686451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153392634|NCT01686451|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153392635|NCT01686451|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
153392636|NCT01686451|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153362375|NCT03456700|Antifungal Agents|antifungal agents|mesh-ancestor
153362376|NCT03456700|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153362377|NCT03456700|Immunologic Factors|immunologic factors|mesh-ancestor
153362378|NCT03456700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153392637|NCT00361751|Fenofibrate|fenofibrate|mesh-list
153392638|NCT00361751|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153392639|NCT00361751|Antimetabolites|antimetabolites|mesh-ancestor
153392640|NCT00361751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153392641|NCT00361751|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153392643|NCT05681702|Clopidogrel|clopidogrel|mesh-list
153392644|NCT05681702|Ticagrelor|ticagrelor|mesh-list
153392645|NCT05681702|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
153852420|NCT06236152|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153852421|NCT06236139|Cyclophosphamide|cyclophosphamide|mesh-list
153852422|NCT06236139|Fludarabine|fludarabine|mesh-list
153852423|NCT06236139|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153852424|NCT06236139|Immunologic Factors|immunologic factors|mesh-ancestor
153852425|NCT06236139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153852426|NCT06236139|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153852427|NCT06236139|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153852428|NCT06236139|Alkylating Agents|alkylating agents|mesh-ancestor
153852429|NCT06236139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153852430|NCT06236139|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153852431|NCT06236139|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153852432|NCT06236126|Lidocaine|lidocaine|mesh-list
153852433|NCT06236126|Anesthetics, Local|anesthetics, local|mesh-ancestor
153852434|NCT06236126|Anesthetics|anesthetics|mesh-ancestor
153852435|NCT06236126|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153852436|NCT06236126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153852437|NCT06236126|Sensory System Agents|sensory system agents|mesh-ancestor
153852438|NCT06236126|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153852451|NCT06236061|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153852471|NCT06235931|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153852472|NCT06235931|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153392682|NCT03668951|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153392683|NCT03668951|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153392684|NCT03668951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153392685|NCT03668951|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153852474|NCT06235931|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
153852486|NCT06235918|Mitosis Modulators|mitosis modulators|mesh-ancestor
153852487|NCT06235918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153852488|NCT06235918|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153852489|NCT06235749|Calcium|calcium|mesh-list
153392700|NCT04889703|Dermatologic Agents|dermatologic agents|mesh-ancestor
153392701|NCT04889703|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153392702|NCT04889703|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153392703|NCT04889703|Analgesics|analgesics|mesh-ancestor
153392704|NCT04889703|Sensory System Agents|sensory system agents|mesh-ancestor
153392705|NCT04889703|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153392706|NCT04889703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153392707|NCT04889703|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153392708|NCT04889703|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153392709|NCT04889703|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153392710|NCT04889703|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153392711|NCT04889703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153392712|NCT00421811|Melphalan|melphalan|mesh-list
153392713|NCT00421811|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153392733|NCT01706263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153392734|NCT01706263|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153392735|NCT01706263|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153392736|NCT01706263|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153852518|NCT06235320|Analgesics|analgesics|mesh-ancestor
153852519|NCT06235320|Sensory System Agents|sensory system agents|mesh-ancestor
153852520|NCT06235320|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153852521|NCT06235320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153852522|NCT06235320|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153852523|NCT06235320|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153852524|NCT06235320|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153852525|NCT06235320|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153852526|NCT06235320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153852527|NCT06235320|Antipyretics|antipyretics|mesh-ancestor
153852528|NCT06233357|Casirivimab and imdevimab drug combination|casirivimab and imdevimab drug combination|mesh-list
153852529|NCT06233357|Antiviral Agents|antiviral agents|mesh-ancestor
153852530|NCT06233357|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153852531|NCT06232759|Tislelizumab|tislelizumab|mesh-list
153852532|NCT06232759|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153852533|NCT06232759|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153392744|NCT04342247|Testosterone|testosterone|mesh-list
153392745|NCT04342247|Testosterone undecanoate|testosterone undecanoate|mesh-list
153392746|NCT04342247|Testosterone enanthate|testosterone enanthate|mesh-list
153392747|NCT04342247|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153392748|NCT04342247|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153392749|NCT04342247|Anabolic Agents|anabolic agents|mesh-ancestor
153852580|NCT06207305|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153852581|NCT06207305|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153852582|NCT06207305|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
153392816|NCT05738408|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
153392817|NCT05738408|Autonomic Agents|autonomic agents|mesh-ancestor
153392818|NCT05738408|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153392819|NCT05738408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153392820|NCT05738408|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
153392821|NCT05738408|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
153392822|NCT05738408|Cholinergic Agents|cholinergic agents|mesh-ancestor
153392823|NCT05738408|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153392824|NCT05738408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153392827|NCT01352117|Efavirenz|efavirenz|mesh-list
153392828|NCT01352117|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
153392829|NCT01352117|Efavirenz, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|efavirenz, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
153852625|NCT06151652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153852626|NCT06151652|Protective Agents|protective agents|mesh-ancestor
153852627|NCT06151652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153852628|NCT06151652|Vitamin B Complex|vitamin b complex|mesh-ancestor
153852629|NCT06151652|Vitamins|vitamins|mesh-ancestor
153392842|NCT01352117|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153732948|NCT00506194|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153732949|NCT00506194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153392843|NCT01352117|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
153392844|NCT01352117|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153392845|NCT01352117|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
153392846|NCT01352117|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
153392847|NCT01352117|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
153392848|NCT01352117|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
153392849|NCT03379207|Dimercaprol|dimercaprol|mesh-list
153392850|NCT03379207|Chelating Agents|chelating agents|mesh-ancestor
153392851|NCT03379207|Sequestering Agents|sequestering agents|mesh-ancestor
153392852|NCT03379207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153392853|NCT02974439|Amlodipine|amlodipine|mesh-list
153392854|NCT02974439|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153392855|NCT02974439|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153392856|NCT02974439|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153392857|NCT02974439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153392858|NCT02974439|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153392859|NCT02974439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153392860|NCT02974439|Vasodilator Agents|vasodilator agents|mesh-ancestor
153392862|NCT03340727|Caffeine citrate|caffeine citrate|mesh-list
153392863|NCT03340727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153392864|NCT03340727|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
153392865|NCT03340727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153392870|NCT03340727|Purinergic Agents|purinergic agents|mesh-ancestor
153392871|NCT03340727|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153392872|NCT01707043|Calcitriol|calcitriol|mesh-list
153392873|NCT01707043|Betamethasone|betamethasone|mesh-list
153392874|NCT01707043|Betamethasone Valerate|betamethasone valerate|mesh-list
153392875|NCT01707043|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
153392876|NCT01707043|Betamethasone benzoate|betamethasone benzoate|mesh-list
153392877|NCT01707043|Calcipotriene|calcipotriene|mesh-list
153392878|NCT01707043|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
153392879|NCT01707043|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153392880|NCT01707043|Glucocorticoids|glucocorticoids|mesh-ancestor
153392881|NCT01707043|Hormones|hormones|mesh-ancestor
153392907|NCT03634917|Calcium, Dietary|calcium, dietary|mesh-list
153392908|NCT03634917|Acamprosate|acamprosate|mesh-list
153392909|NCT03634917|Calcium Carbonate|calcium carbonate|mesh-list
153392910|NCT03634917|Calcium|calcium|mesh-list
153392911|NCT03634917|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153392912|NCT03634917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153392913|NCT03634917|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153392914|NCT03634917|Antacids|antacids|mesh-ancestor
153392915|NCT03634917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153392916|NCT03634917|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153392917|NCT03634917|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
153392918|NCT04595565|Carboplatin|carboplatin|mesh-list
153392919|NCT04595565|Capecitabine|capecitabine|mesh-list
153392920|NCT04595565|Sacituzumab govitecan|sacituzumab govitecan|mesh-list
153392921|NCT04595565|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153392922|NCT04595565|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153852708|NCT06126952|Histamine Antagonists|histamine antagonists|mesh-ancestor
153852709|NCT06126952|Histamine Agents|histamine agents|mesh-ancestor
153392924|NCT04595565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153392925|NCT04595565|Immunoconjugates|immunoconjugates|mesh-ancestor
153392932|NCT02284880|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153852710|NCT06126952|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153852711|NCT06126952|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153852712|NCT06126952|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153852714|NCT06126952|Sensory System Agents|sensory system agents|mesh-ancestor
153852715|NCT06126952|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153852716|NCT06104540|Petrolatum|petrolatum|mesh-list
153852717|NCT06104540|Emollients|emollients|mesh-ancestor
153852718|NCT06104540|Dermatologic Agents|dermatologic agents|mesh-ancestor
153852719|NCT06096116|Antithrombins|antithrombins|mesh-list
153852720|NCT06096116|Antithrombin III|antithrombin iii|mesh-list
153852721|NCT06096116|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
153852722|NCT06096116|Protease Inhibitors|protease inhibitors|mesh-ancestor
153852723|NCT06096116|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153732962|NCT00406731|omega-N-Methylarginine|omega-n-methylarginine|mesh-list
153732963|NCT00406731|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153852724|NCT06096116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153852725|NCT06096116|Anticoagulants|anticoagulants|mesh-ancestor
153852726|NCT06092879|Asciminib|asciminib|mesh-list
153852727|NCT06092879|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153852728|NCT06092879|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153392966|NCT05033756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153392967|NCT05033756|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
153392968|NCT05033756|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153392970|NCT03522077|Coagulants|coagulants|mesh-ancestor
153392971|NCT02980562|Bisacodyl|bisacodyl|mesh-list
153392972|NCT02980562|Cathartics|cathartics|mesh-ancestor
153392973|NCT02980562|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153392974|NCT02980562|Laxatives|laxatives|mesh-ancestor
153392975|NCT03266393|Tacrolimus|tacrolimus|mesh-list
153392976|NCT03266393|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153392977|NCT03266393|Immunologic Factors|immunologic factors|mesh-ancestor
153852729|NCT06092879|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153852730|NCT06092879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153852751|NCT06040255|Prednisone|prednisone|mesh-list
153852752|NCT06040255|Methylprednisolone|methylprednisolone|mesh-list
153852753|NCT06040255|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
153852754|NCT06040255|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
153852755|NCT06040255|Prednisolone|prednisolone|mesh-list
153852756|NCT06040255|Prednisolone acetate|prednisolone acetate|mesh-list
153852757|NCT06040255|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
153852758|NCT06040255|Prednisolone phosphate|prednisolone phosphate|mesh-list
153852759|NCT06040255|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153852760|NCT06040255|Glucocorticoids|glucocorticoids|mesh-ancestor
153852761|NCT06040255|Hormones|hormones|mesh-ancestor
153852762|NCT06040255|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153392985|NCT00421967|Racepinephrine|racepinephrine|mesh-list
153392986|NCT00421967|Ropivacaine|ropivacaine|mesh-list
153392987|NCT00421967|Epinephryl borate|epinephryl borate|mesh-list
153392988|NCT00421967|Anesthetics, Local|anesthetics, local|mesh-ancestor
153392989|NCT00421967|Anesthetics|anesthetics|mesh-ancestor
153392990|NCT00421967|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153392991|NCT00421967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153852818|NCT05909683|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
153852819|NCT05888922|Minoxidil|minoxidil|mesh-list
153852820|NCT05888922|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153393033|NCT00362531|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153393034|NCT00362531|Glucocorticoids|glucocorticoids|mesh-ancestor
153393035|NCT00362531|Hormones|hormones|mesh-ancestor
153393036|NCT00362531|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153393052|NCT04330677|Hormones|hormones|mesh-ancestor
153852825|NCT05872425|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
153852826|NCT05872425|Hormone Antagonists|hormone antagonists|mesh-ancestor
153852827|NCT05872425|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153852828|NCT05872425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153852829|NCT05872425|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
153852831|NCT05872425|Natriuretic Agents|natriuretic agents|mesh-ancestor
153852832|NCT05872425|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
153852833|NCT05872425|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
153733002|NCT00142961|Adrenergic Agents|adrenergic agents|mesh-ancestor
153733003|NCT00142961|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153733004|NCT00142961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153733006|NCT00163254|Anticoagulants|anticoagulants|mesh-ancestor
153733007|NCT00163254|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153733008|NCT00143000|Ribavirin|ribavirin|mesh-list
153733009|NCT00143000|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
153733010|NCT00143000|Antimetabolites|antimetabolites|mesh-ancestor
153733011|NCT00143000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153733012|NCT00143000|Antiviral Agents|antiviral agents|mesh-ancestor
153733013|NCT00143000|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153852858|NCT05822076|Anesthetics, Local|anesthetics, local|mesh-ancestor
153852859|NCT05822076|Anesthetics|anesthetics|mesh-ancestor
153852860|NCT05822076|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153393071|NCT02259517|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
153393072|NCT02259517|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153393073|NCT02259517|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153393074|NCT02259517|Adrenergic Agents|adrenergic agents|mesh-ancestor
153393075|NCT04358588|Nitric Oxide|nitric oxide|mesh-list
153393076|NCT04358588|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153393077|NCT04358588|Autonomic Agents|autonomic agents|mesh-ancestor
153852879|NCT05776979|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153852880|NCT05776979|Growth Substances|growth substances|mesh-ancestor
153852881|NCT05776979|Growth Inhibitors|growth inhibitors|mesh-ancestor
153852882|NCT05776979|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153852883|NCT05767671|Dimercaprol|dimercaprol|mesh-list
153852884|NCT05767671|Chelating Agents|chelating agents|mesh-ancestor
153852885|NCT05767671|Sequestering Agents|sequestering agents|mesh-ancestor
153852886|NCT05767671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153852887|NCT05689372|Semaglutide|semaglutide|mesh-list
153393098|NCT03166761|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153393099|NCT03166761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153393100|NCT03166761|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153393101|NCT03166761|Glucocorticoids|glucocorticoids|mesh-ancestor
153393102|NCT03166761|Hormones|hormones|mesh-ancestor
153393103|NCT03166761|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153393104|NCT03166761|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153393105|NCT03166761|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153393106|NCT03166761|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153393107|NCT03166761|Immunologic Factors|immunologic factors|mesh-ancestor
153393108|NCT03166761|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153393109|NCT03166761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153393110|NCT04195256|Dexmedetomidine|dexmedetomidine|mesh-list
153393111|NCT04195256|Ketamine|ketamine|mesh-list
153393112|NCT04195256|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153852888|NCT05689372|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
153393149|NCT01710787|Sensory System Agents|sensory system agents|mesh-ancestor
153393150|NCT01710787|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153393151|NCT01710787|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153393152|NCT01710787|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153393153|NCT01710787|Adrenergic Agents|adrenergic agents|mesh-ancestor
153393154|NCT01710787|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153393155|NCT01710787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153393156|NCT01710787|Sympathomimetics|sympathomimetics|mesh-ancestor
153393157|NCT01710787|Autonomic Agents|autonomic agents|mesh-ancestor
153393158|NCT01710787|Nasal Decongestants|nasal decongestants|mesh-ancestor
153393159|NCT01710787|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
153393160|NCT01710787|Respiratory System Agents|respiratory system agents|mesh-ancestor
153393161|NCT01710787|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
153852930|NCT05670509|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153852931|NCT05670509|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153852932|NCT05670509|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153852933|NCT05670509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153852934|NCT05670509|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153852935|NCT05670509|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153852942|NCT05670509|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153852943|NCT05670509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153852945|NCT05631236|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
153852946|NCT05631236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153852947|NCT05631236|Sympathomimetics|sympathomimetics|mesh-ancestor
153393194|NCT04826588|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
153393196|NCT04826588|Prednisolone acetate|prednisolone acetate|mesh-list
153393197|NCT04826588|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
153393198|NCT04826588|Prednisolone phosphate|prednisolone phosphate|mesh-list
153393199|NCT04826588|Immunoglobulins|immunoglobulins|mesh-list
153393200|NCT04826588|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153393205|NCT04826588|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153393206|NCT04826588|Glucocorticoids|glucocorticoids|mesh-ancestor
153393208|NCT04826588|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153393209|NCT04826588|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
153393210|NCT04826588|Protective Agents|protective agents|mesh-ancestor
153393211|NCT04826588|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153393212|NCT04826588|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153393213|NCT04826588|Immunologic Factors|immunologic factors|mesh-ancestor
153393214|NCT01719367|Atenolol|atenolol|mesh-list
153393215|NCT01719367|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153393216|NCT01719367|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153393217|NCT01719367|Sympatholytics|sympatholytics|mesh-ancestor
153393218|NCT01719367|Autonomic Agents|autonomic agents|mesh-ancestor
153393223|NCT01719367|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
153393224|NCT01719367|Adrenergic Agents|adrenergic agents|mesh-ancestor
153393225|NCT01719367|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153393226|NCT01719367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153393228|NCT02276040|Anesthetics, Local|anesthetics, local|mesh-ancestor
153393229|NCT02276040|Anesthetics|anesthetics|mesh-ancestor
153393230|NCT02276040|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153393231|NCT02276040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153822672|NCT00445055|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153393242|NCT02250703|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153393243|NCT02250703|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
153393244|NCT02250703|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153393245|NCT02250703|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153393246|NCT02250703|Adrenergic Agents|adrenergic agents|mesh-ancestor
153393247|NCT02250703|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153393248|NCT02250703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153393249|NCT02250703|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153393250|NCT02250703|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153393251|NCT02250703|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153393252|NCT02250703|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153393253|NCT02250703|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153393254|NCT02250703|Anesthetics, General|anesthetics, general|mesh-ancestor
153393255|NCT02250703|Anesthetics|anesthetics|mesh-ancestor
153393256|NCT02250703|GABA Modulators|gaba modulators|mesh-ancestor
153393257|NCT02250703|GABA Agents|gaba agents|mesh-ancestor
153393258|NCT02314728|Misoprostol|misoprostol|mesh-list
153393259|NCT02314728|Oxytocin|oxytocin|mesh-list
153393260|NCT02314728|Oxytocics|oxytocics|mesh-ancestor
153393261|NCT02314728|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153393262|NCT02314728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153853027|NCT05468892|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153853028|NCT05468892|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153853029|NCT05468892|Antimetabolites|antimetabolites|mesh-ancestor
153853030|NCT05468892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153853031|NCT05468892|Antiviral Agents|antiviral agents|mesh-ancestor
153853032|NCT05468892|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153853033|NCT05382208|Doxycycline|doxycycline|mesh-list
153853034|NCT05382208|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153853035|NCT05382208|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153853036|NCT05382208|Antimalarials|antimalarials|mesh-ancestor
153853037|NCT05382208|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153853038|NCT05382208|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153362622|NCT02966912|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153362623|NCT01437605|Poly I-C|poly i-c|mesh-list
153853040|NCT05354102|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153853041|NCT05354102|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153853042|NCT05354102|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153853043|NCT05354102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153853044|NCT05351489|Dexmedetomidine|dexmedetomidine|mesh-list
153853045|NCT05351489|Bupivacaine|bupivacaine|mesh-list
153853046|NCT05351489|Anesthetics, Local|anesthetics, local|mesh-ancestor
153853047|NCT05351489|Anesthetics|anesthetics|mesh-ancestor
153853048|NCT05351489|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153853049|NCT05351489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153853050|NCT05351489|Sensory System Agents|sensory system agents|mesh-ancestor
153853051|NCT05351489|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153853052|NCT05351489|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153853053|NCT05351489|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153393266|NCT02314728|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153393267|NCT03135860|Nitric Oxide|nitric oxide|mesh-list
153393268|NCT03135860|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153393269|NCT03135860|Autonomic Agents|autonomic agents|mesh-ancestor
153393278|NCT03135860|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
153393280|NCT03135860|Gasotransmitters|gasotransmitters|mesh-ancestor
153393281|NCT03135860|Protective Agents|protective agents|mesh-ancestor
153393282|NCT02275338|Lanreotide|lanreotide|mesh-list
153393283|NCT02275338|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153393284|NCT01646268|Rotigotine|rotigotine|mesh-list
153393285|NCT01646268|Dopamine Agonists|dopamine agonists|mesh-ancestor
153393286|NCT01646268|Dopamine Agents|dopamine agents|mesh-ancestor
153393287|NCT01646268|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153393298|NCT01722487|Chlorambucil|chlorambucil|mesh-list
153733083|NCT00143234|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153733084|NCT00143234|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153733085|NCT00143234|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153733086|NCT00143234|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153733087|NCT00143234|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153733088|NCT00143234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153733089|NCT00143234|Vasodilator Agents|vasodilator agents|mesh-ancestor
153733091|NCT00163488|Glucocorticoids|glucocorticoids|mesh-ancestor
153733092|NCT00163488|Hormones|hormones|mesh-ancestor
153733093|NCT00163488|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153733095|NCT00163488|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
153853076|NCT05342974|Oxytocics|oxytocics|mesh-ancestor
153853077|NCT05338320|Fentanyl|fentanyl|mesh-list
153853078|NCT05338320|Morphine|morphine|mesh-list
153853079|NCT05338320|Anesthetics|anesthetics|mesh-ancestor
153853080|NCT05338320|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153853081|NCT05338320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153853082|NCT05338320|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153853083|NCT05338320|Narcotics|narcotics|mesh-ancestor
153853084|NCT05338320|Analgesics|analgesics|mesh-ancestor
153853090|NCT05335629|Dapagliflozin|dapagliflozin|mesh-list
153853091|NCT05335629|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
153853133|NCT05266937|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153853134|NCT05266937|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153853135|NCT05266937|Tubulin Modulators|tubulin modulators|mesh-ancestor
153853136|NCT05266937|Antimitotic Agents|antimitotic agents|mesh-ancestor
153853137|NCT05266937|Mitosis Modulators|mitosis modulators|mesh-ancestor
153853138|NCT05266937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153853139|NCT05266937|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153853140|NCT05266937|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153853141|NCT05176626|Phentermine|phentermine|mesh-list
153853142|NCT05176626|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
153853143|NCT05176626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153853144|NCT05176626|Appetite Depressants|appetite depressants|mesh-ancestor
153853145|NCT05176626|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
153393358|NCT02318654|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153393359|NCT02318654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153393360|NCT02318654|Sensory System Agents|sensory system agents|mesh-ancestor
153393361|NCT02318654|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153393362|NCT02318654|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
153393364|NCT04349930|Anticonvulsants|anticonvulsants|mesh-ancestor
153393365|NCT02303990|Pembrolizumab|pembrolizumab|mesh-list
153393366|NCT02303990|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153393367|NCT02303990|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153393368|NCT02303990|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153393369|NCT02303990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153393370|NCT01727089|Bevacizumab|bevacizumab|mesh-list
153393371|NCT01727089|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
153393372|NCT01727089|Endothelial Growth Factors|endothelial growth factors|mesh-list
153393374|NCT01727089|Immunoglobulins|immunoglobulins|mesh-list
153853146|NCT05176626|Sympathomimetics|sympathomimetics|mesh-ancestor
153853147|NCT05176626|Autonomic Agents|autonomic agents|mesh-ancestor
153393395|NCT01727791|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153393396|NCT01727791|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153393397|NCT01727791|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153393398|NCT01728337|Botulinum Toxins|botulinum toxins|mesh-list
153393399|NCT01728337|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
153393400|NCT01728337|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
153393401|NCT01728337|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
153393402|NCT01728337|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153393403|NCT01728337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153393404|NCT01728337|Cholinergic Agents|cholinergic agents|mesh-ancestor
153393405|NCT01728337|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153393406|NCT01728337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153393407|NCT01728337|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
153393412|NCT02247193|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
153393413|NCT02247193|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153393414|NCT02247193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153393415|NCT02247193|Cholinergic Agents|cholinergic agents|mesh-ancestor
153393492|NCT03990363|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153853257|NCT04844866|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153853258|NCT04844866|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153853259|NCT04844866|Immunologic Factors|immunologic factors|mesh-ancestor
153853260|NCT04844866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153853261|NCT04844866|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153853262|NCT04844866|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153853263|NCT04844866|Antimetabolites|antimetabolites|mesh-ancestor
153393504|NCT00002913|Topotecan|topotecan|mesh-list
153393505|NCT00002913|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153393506|NCT00002913|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153393507|NCT00002913|Tubulin Modulators|tubulin modulators|mesh-ancestor
153393508|NCT00002913|Antimitotic Agents|antimitotic agents|mesh-ancestor
153393509|NCT00002913|Mitosis Modulators|mitosis modulators|mesh-ancestor
153393510|NCT00002913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153853276|NCT04810572|Antioxidants|antioxidants|mesh-ancestor
153853277|NCT04810572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153853278|NCT04810572|Protective Agents|protective agents|mesh-ancestor
153853279|NCT04810572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153853280|NCT04800471|Insulin|insulin|mesh-list
153853281|NCT04800471|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153853282|NCT04800471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153853283|NCT04789837|Cilostazol|cilostazol|mesh-list
153853284|NCT04789837|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153853285|NCT04789837|Autonomic Agents|autonomic agents|mesh-ancestor
153853286|NCT04789837|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153853301|NCT04772196|Cholecalciferol|cholecalciferol|mesh-list
153853302|NCT04772196|Vitamins|vitamins|mesh-ancestor
153853303|NCT04772196|Micronutrients|micronutrients|mesh-ancestor
153853304|NCT04772196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153853305|NCT04772196|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153853306|NCT04772196|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153853307|NCT04761848|Cilostazol|cilostazol|mesh-list
153853308|NCT04761848|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153393530|NCT00002919|Dermatologic Agents|dermatologic agents|mesh-ancestor
153853317|NCT04761848|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153853318|NCT04761848|Vasodilator Agents|vasodilator agents|mesh-ancestor
153393558|NCT00383799|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153393559|NCT00383799|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
153393560|NCT00383799|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153393561|NCT00383799|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153393562|NCT00383799|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
153822760|NCT03279120|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153822761|NCT03279120|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
153822762|NCT03279120|Contraceptive Agents|contraceptive agents|mesh-ancestor
153822763|NCT03279120|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153822764|NCT03279120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153822765|NCT03279120|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
153822766|NCT03279120|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
153822767|NCT03279120|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
153822768|NCT00479934|Imatinib Mesylate|imatinib mesylate|mesh-list
153822769|NCT00479934|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153822770|NCT00479934|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153822771|NCT00479934|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153822772|NCT00479934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153822774|NCT00442182|Givinostat hydrochloride|givinostat hydrochloride|mesh-list
153393564|NCT00383799|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
153393565|NCT00383799|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
153393567|NCT04545541|Calcium heparin|calcium heparin|mesh-list
153393568|NCT04545541|Anticoagulants|anticoagulants|mesh-ancestor
153393569|NCT04545541|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153393570|NCT04545541|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153393571|NCT04545541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153393573|NCT00002925|Etoposide|etoposide|mesh-list
153393574|NCT00002925|Daunorubicin|daunorubicin|mesh-list
153393575|NCT00002925|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153393576|NCT00002925|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153393577|NCT00002925|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153393578|NCT00002925|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153393579|NCT00002925|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153393580|NCT00002925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153393581|NCT00002925|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153393582|NCT00002925|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153853330|NCT04757571|Serotonin Agents|serotonin agents|mesh-ancestor
153393604|NCT00002943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153393605|NCT00002943|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153853365|NCT04722575|Atezolizumab|atezolizumab|mesh-list
153853366|NCT04722575|Vemurafenib|vemurafenib|mesh-list
153853367|NCT04722575|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153853368|NCT04722575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153853369|NCT04722575|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153853370|NCT04722575|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153393628|NCT05315557|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153393629|NCT00002955|Leucovorin|leucovorin|mesh-list
153393630|NCT00002955|Trimetrexate|trimetrexate|mesh-list
153393631|NCT00002955|Fluorouracil|fluorouracil|mesh-list
153393632|NCT00002955|Calcium|calcium|mesh-list
153393633|NCT00002955|Levoleucovorin|levoleucovorin|mesh-list
153393634|NCT00002955|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153393635|NCT00002955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153393636|NCT00002955|Antimetabolites|antimetabolites|mesh-ancestor
153393637|NCT00002955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153853389|NCT04634071|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153853390|NCT04634071|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153853391|NCT04634071|Dopamine Agents|dopamine agents|mesh-ancestor
153853392|NCT04634071|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
153853393|NCT04634071|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153853394|NCT04634071|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153853395|NCT04632433|Cemiplimab|cemiplimab|mesh-list
153853396|NCT04632433|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153853397|NCT04632433|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153853398|NCT04601532|Sulfadiazine|sulfadiazine|mesh-list
153853399|NCT04601532|Silver Sulfadiazine|silver sulfadiazine|mesh-list
153853400|NCT04601532|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153853401|NCT04601532|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153853402|NCT04601532|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153853403|NCT04601532|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153362762|NCT03215498|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
153853453|NCT04410341|Escitalopram|escitalopram|mesh-list
153853454|NCT04410341|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
153853455|NCT04410341|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153853456|NCT04410341|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153853457|NCT04410341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153853458|NCT04410341|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153853459|NCT04410341|Serotonin Agents|serotonin agents|mesh-ancestor
153853460|NCT04410341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153853461|NCT04410341|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153853462|NCT04410341|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
153853463|NCT04410341|Protease Inhibitors|protease inhibitors|mesh-ancestor
153853464|NCT04410341|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153853465|NCT04377386|Vitamin D|vitamin d|mesh-list
153853466|NCT04377386|Ergocalciferols|ergocalciferols|mesh-list
153853467|NCT04377386|Cholecalciferol|cholecalciferol|mesh-list
153853468|NCT04377386|Vitamins|vitamins|mesh-list
153853469|NCT04377386|Micronutrients|micronutrients|mesh-ancestor
153393777|NCT00003039|Alvocidib|alvocidib|mesh-list
153393781|NCT00003039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153393782|NCT00003039|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153393783|NCT00003039|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153393784|NCT00003039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153393785|NCT00003063|Leucovorin|leucovorin|mesh-list
153393786|NCT00003063|Interferons|interferons|mesh-list
153393787|NCT00003063|Interferon-alpha|interferon-alpha|mesh-list
153393788|NCT00003063|Levamisole|levamisole|mesh-list
153393789|NCT00003063|Fluorouracil|fluorouracil|mesh-list
153393790|NCT00003063|Calcium|calcium|mesh-list
153393791|NCT00003063|Levoleucovorin|levoleucovorin|mesh-list
153853563|NCT03959176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153853564|NCT03959176|Sympathomimetics|sympathomimetics|mesh-ancestor
153853565|NCT03959176|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
153853566|NCT03959176|Nasal Decongestants|nasal decongestants|mesh-ancestor
153853567|NCT03959176|Respiratory System Agents|respiratory system agents|mesh-ancestor
153393792|NCT00003063|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153853568|NCT03959176|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
153393850|NCT00003087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153393851|NCT00003093|Cyclophosphamide|cyclophosphamide|mesh-list
153393852|NCT00003093|Carboplatin|carboplatin|mesh-list
153393853|NCT00003093|Doxorubicin|doxorubicin|mesh-list
153393854|NCT00003093|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
153393855|NCT00003093|Etoposide|etoposide|mesh-list
153393856|NCT00003093|Molgramostim|molgramostim|mesh-list
153393857|NCT00003093|Lenograstim|lenograstim|mesh-list
153393858|NCT00003093|Sargramostim|sargramostim|mesh-list
153393859|NCT00003093|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153393860|NCT00003093|Immunologic Factors|immunologic factors|mesh-ancestor
153393861|NCT00003093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153853626|NCT03611868|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153853627|NCT03611868|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153853633|NCT03563716|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153853634|NCT03563716|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153853635|NCT03521154|Osimertinib|osimertinib|mesh-list
153822818|NCT03278808|Azithromycin|azithromycin|mesh-list
153822819|NCT03278808|Chloroquine|chloroquine|mesh-list
153822820|NCT03278808|Chloroquine diphosphate|chloroquine diphosphate|mesh-list
153822821|NCT03278808|Atovaquone|atovaquone|mesh-list
153822822|NCT03278808|Proguanil|proguanil|mesh-list
153822823|NCT03278808|Atovaquone, proguanil drug combination|atovaquone, proguanil drug combination|mesh-list
153822824|NCT03278808|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153822825|NCT03278808|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153822826|NCT03278808|Amebicides|amebicides|mesh-ancestor
153822827|NCT03278808|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153822828|NCT03278808|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153853636|NCT03521154|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153853637|NCT03521154|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153393862|NCT00003093|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153393863|NCT00003093|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153393864|NCT00003093|Alkylating Agents|alkylating agents|mesh-ancestor
153393865|NCT00003093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153393866|NCT00003093|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153393867|NCT00003093|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153393868|NCT00003093|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153393869|NCT00003093|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153393870|NCT00003093|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153393871|NCT00003093|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153393872|NCT00003093|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153393873|NCT00003093|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153393875|NCT00003099|Fenretinide|fenretinide|mesh-list
153393876|NCT00003099|Retinamide|retinamide|mesh-list
153393877|NCT00003099|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
153853638|NCT03521154|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153853639|NCT03521154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153853640|NCT03521154|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153853641|NCT03486301|Pembrolizumab|pembrolizumab|mesh-list
153853642|NCT03486301|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153853690|NCT03238196|Palbociclib|palbociclib|mesh-list
153853691|NCT03238196|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153853692|NCT03238196|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153853693|NCT03238196|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
153853721|NCT03057431|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
153393950|NCT03962725|Ketamine|ketamine|mesh-list
153393951|NCT03962725|Propofol|propofol|mesh-list
153393952|NCT03962725|Anesthetics|anesthetics|mesh-list
153393953|NCT03962725|Rocuronium|rocuronium|mesh-list
153393954|NCT03962725|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-list
153393955|NCT03962725|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153393956|NCT03962725|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153393957|NCT03962725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153393958|NCT03962725|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153393959|NCT03962725|Analgesics|analgesics|mesh-ancestor
153393960|NCT03962725|Sensory System Agents|sensory system agents|mesh-ancestor
153393961|NCT03962725|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153393962|NCT03962725|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
153393984|NCT02210559|Antimetabolites|antimetabolites|mesh-ancestor
153393985|NCT00003135|Doxorubicin|doxorubicin|mesh-list
153393986|NCT00003135|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
153393987|NCT00003135|Fluorouracil|fluorouracil|mesh-list
153393988|NCT00003135|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153853734|NCT03020199|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153853735|NCT03020199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153393990|NCT00003135|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153393991|NCT00003135|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153393992|NCT00003135|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153393993|NCT00003135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153393994|NCT00003135|Antimetabolites|antimetabolites|mesh-ancestor
153393995|NCT00003135|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153393996|NCT00003135|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153393997|NCT00003135|Immunologic Factors|immunologic factors|mesh-ancestor
153733181|NCT00143702|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153733183|NCT00143702|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153362822|NCT00895934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153733186|NCT00143702|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153733187|NCT00143702|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153733188|NCT00143702|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153733189|NCT00143702|Vitamin B Complex|vitamin b complex|mesh-ancestor
153733190|NCT00143702|Vitamins|vitamins|mesh-ancestor
153733191|NCT00143702|Micronutrients|micronutrients|mesh-ancestor
153733192|NCT00143702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153733193|NCT00143702|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
153733194|NCT00143702|Dermatologic Agents|dermatologic agents|mesh-ancestor
153733195|NCT00156078|Pregabalin|pregabalin|mesh-list
153733196|NCT00156078|Analgesics|analgesics|mesh-ancestor
153733197|NCT00156078|Sensory System Agents|sensory system agents|mesh-ancestor
153733198|NCT00156078|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153733199|NCT00156078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153393998|NCT00003135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153393999|NCT00003141|Cyclophosphamide|cyclophosphamide|mesh-list
153394001|NCT00003141|Cisplatin|cisplatin|mesh-list
153394002|NCT00003141|Carboplatin|carboplatin|mesh-list
153394003|NCT00003141|Etoposide|etoposide|mesh-list
153394004|NCT00003141|Vincristine|vincristine|mesh-list
153394005|NCT00003141|Lenograstim|lenograstim|mesh-list
153394006|NCT00003141|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153394007|NCT00003141|Immunologic Factors|immunologic factors|mesh-ancestor
153394008|NCT00003141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153394009|NCT00003141|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153853765|NCT02939573|Azathioprine|azathioprine|mesh-list
153853766|NCT02939573|Gout Suppressants|gout suppressants|mesh-ancestor
153853767|NCT02939573|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153853768|NCT02939573|Tubulin Modulators|tubulin modulators|mesh-ancestor
153853769|NCT02939573|Antimitotic Agents|antimitotic agents|mesh-ancestor
153853777|NCT02939573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153853778|NCT02939573|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153853779|NCT02939573|Antimalarials|antimalarials|mesh-ancestor
153853782|NCT02939573|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153853783|NCT02939573|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153853784|NCT02939573|Leprostatic Agents|leprostatic agents|mesh-ancestor
153853785|NCT02939573|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153853786|NCT02925416|Oritavancin|oritavancin|mesh-list
153853787|NCT02925416|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153853788|NCT02925416|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153853789|NCT02705196|Paclitaxel|paclitaxel|mesh-list
153853813|NCT02646475|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
153394043|NCT01743859|Lenalidomide|lenalidomide|mesh-list
153394044|NCT01743859|Azacitidine|azacitidine|mesh-list
153394045|NCT01743859|Immunologic Factors|immunologic factors|mesh-ancestor
153394046|NCT01743859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153394047|NCT01743859|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153394048|NCT01743859|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153394049|NCT01743859|Growth Substances|growth substances|mesh-ancestor
153394050|NCT01743859|Growth Inhibitors|growth inhibitors|mesh-ancestor
153394051|NCT01743859|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153394052|NCT01743859|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153394053|NCT01743859|Antimetabolites|antimetabolites|mesh-ancestor
153394104|NCT01754389|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
153394112|NCT01754389|Dermatologic Agents|dermatologic agents|mesh-ancestor
153394113|NCT01754389|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153394114|NCT01754389|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153394115|NCT01754389|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153394116|NCT01754389|Immunologic Factors|immunologic factors|mesh-ancestor
153394117|NCT01754389|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153853885|NCT01988883|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
153853886|NCT01988883|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
153853887|NCT01988883|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
153853888|NCT01988883|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
153394118|NCT01754389|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153394119|NCT01754389|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
153733227|NCT00143780|Immunologic Factors|immunologic factors|mesh-ancestor
153733228|NCT00143780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153733229|NCT02276365|Pioglitazone|pioglitazone|mesh-list
153733230|NCT02276365|Empagliflozin|empagliflozin|mesh-list
153733231|NCT02276365|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153733232|NCT02276365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153733233|NCT02276365|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
153733234|NCT02276365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153733235|NCT05145634|Anticoagulants|anticoagulants|mesh-list
153853889|NCT01955499|Lenalidomide|lenalidomide|mesh-list
153853891|NCT01955499|Immunologic Factors|immunologic factors|mesh-ancestor
153362867|NCT01447511|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
153362868|NCT01447511|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
153394168|NCT04172701|Muscarinic Antagonists|muscarinic antagonists|mesh-list
153853911|NCT01829568|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153853912|NCT01829568|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153853913|NCT01829568|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153853939|NCT01509742|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
153853940|NCT01509742|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153853941|NCT01509742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153853942|NCT01509742|Incretins|incretins|mesh-ancestor
153853943|NCT01509742|Hormones|hormones|mesh-ancestor
153853944|NCT01509742|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153853945|NCT01186328|Cytarabine|cytarabine|mesh-list
153853946|NCT01186328|Prednisone|prednisone|mesh-list
153853947|NCT01186328|Hydrocortisone|hydrocortisone|mesh-list
153853948|NCT01186328|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
153853949|NCT01186328|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
153853950|NCT01186328|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
153853951|NCT01186328|Cortisone|cortisone|mesh-list
153853952|NCT01186328|Doxorubicin|doxorubicin|mesh-list
153853953|NCT01186328|Methotrexate|methotrexate|mesh-list
153853954|NCT01186328|Vincristine|vincristine|mesh-list
153853955|NCT01186328|Asparaginase|asparaginase|mesh-list
153853956|NCT01186328|Pegaspargase|pegaspargase|mesh-list
153394186|NCT04062097|Vitamins|vitamins|mesh-ancestor
153394187|NCT04062097|Micronutrients|micronutrients|mesh-ancestor
153394188|NCT04062097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153394189|NCT04062097|Antithrombins|antithrombins|mesh-ancestor
153394190|NCT04062097|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
153394191|NCT04062097|Protease Inhibitors|protease inhibitors|mesh-ancestor
153394192|NCT04062097|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153394193|NCT04062097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153394194|NCT04062097|Anticoagulants|anticoagulants|mesh-ancestor
153394195|NCT04062097|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
153394196|NCT04062097|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153853967|NCT01186328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153853968|NCT01186328|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153853969|NCT01186328|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
153853970|NCT01186328|Abortifacient Agents|abortifacient agents|mesh-ancestor
153394202|NCT04005079|Ofloxacin|ofloxacin|mesh-list
153394203|NCT04005079|Prednisolone|prednisolone|mesh-list
153394204|NCT04005079|Pilocarpine|pilocarpine|mesh-list
153394205|NCT04005079|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153394206|NCT04005079|Glucocorticoids|glucocorticoids|mesh-ancestor
153394207|NCT04005079|Hormones|hormones|mesh-ancestor
153394208|NCT04005079|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153394209|NCT04005079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153394210|NCT04005079|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153853971|NCT01186328|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153853972|NCT01186328|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153853973|NCT01186328|Antimetabolites|antimetabolites|mesh-ancestor
153853974|NCT01186328|Dermatologic Agents|dermatologic agents|mesh-ancestor
153394223|NCT04005079|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153394224|NCT04005079|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153394225|NCT04005079|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153394226|NCT04005079|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
153394227|NCT04005079|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153394229|NCT01762501|Azilsartan medoxomil|azilsartan medoxomil|mesh-list
153394230|NCT01762501|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153394231|NCT01762501|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153394232|NCT01762501|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153394233|NCT01762501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153854006|NCT01054196|Growth Inhibitors|growth inhibitors|mesh-ancestor
153854007|NCT01054196|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153394238|NCT01762501|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
153394240|NCT01764607|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153394241|NCT01764607|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153394242|NCT01764607|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153362885|NCT01831622|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153394246|NCT01764607|Immunologic Factors|immunologic factors|mesh-ancestor
153394247|NCT01764607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153394248|NCT01764685|Topiramate|topiramate|mesh-list
153394249|NCT01764685|Anticonvulsants|anticonvulsants|mesh-ancestor
153394250|NCT01764685|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153394251|NCT01764685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153394252|NCT05115409|Rituximab|rituximab|mesh-list
153394253|NCT05115409|Antibodies|antibodies|mesh-list
153854018|NCT01041508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153854020|NCT01041508|Immunologic Factors|immunologic factors|mesh-ancestor
153854021|NCT01041508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153854022|NCT01041508|Antifungal Agents|antifungal agents|mesh-ancestor
153854023|NCT01041508|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153854024|NCT01041508|Dermatologic Agents|dermatologic agents|mesh-ancestor
153854025|NCT01041508|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153854026|NCT01041508|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
153854027|NCT01041508|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153854028|NCT01041508|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153854029|NCT01041508|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
153854030|NCT01041508|Antitubercular Agents|antitubercular agents|mesh-ancestor
153854031|NCT01041508|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153394264|NCT01766713|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153394265|NCT01767103|Deferiprone|deferiprone|mesh-list
153394266|NCT01767103|Iron Chelating Agents|iron chelating agents|mesh-ancestor
153394267|NCT01767103|Chelating Agents|chelating agents|mesh-ancestor
153394268|NCT01767103|Sequestering Agents|sequestering agents|mesh-ancestor
153394293|NCT01769209|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153394294|NCT01769209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153394296|NCT01769209|Abortifacient Agents|abortifacient agents|mesh-ancestor
153394356|NCT04350931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153394358|NCT01673867|Nivolumab|nivolumab|mesh-list
153394359|NCT01673867|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153394360|NCT01673867|Tubulin Modulators|tubulin modulators|mesh-ancestor
153394361|NCT01673867|Antimitotic Agents|antimitotic agents|mesh-ancestor
153854119|NCT04682184|Adrenergic Agents|adrenergic agents|mesh-ancestor
153854120|NCT04682184|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153854121|NCT04682184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153854122|NCT04682184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153854123|NCT04682184|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153854124|NCT04682184|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153854125|NCT04682184|Vasodilator Agents|vasodilator agents|mesh-ancestor
153854126|NCT04682184|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153854127|NCT04682184|Autonomic Agents|autonomic agents|mesh-ancestor
153854128|NCT04682184|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153394362|NCT01673867|Mitosis Modulators|mitosis modulators|mesh-ancestor
153394363|NCT01673867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153854162|NCT00558662|Coccidiostats|coccidiostats|mesh-ancestor
153854163|NCT00558662|Proton Ionophores|proton ionophores|mesh-ancestor
153854164|NCT00558662|Uncoupling Agents|uncoupling agents|mesh-ancestor
153854165|NCT00558662|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153854166|NCT00558662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153854167|NCT00558662|Ionophores|ionophores|mesh-ancestor
153854168|NCT00558662|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153394450|NCT02041533|Nivolumab|nivolumab|mesh-list
153394451|NCT02041533|Pemetrexed|pemetrexed|mesh-list
153854220|NCT04681911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153394452|NCT02041533|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153394453|NCT02041533|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153394455|NCT02041533|Antimitotic Agents|antimitotic agents|mesh-ancestor
153394456|NCT02041533|Mitosis Modulators|mitosis modulators|mesh-ancestor
153394457|NCT02041533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153394458|NCT02041533|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153394459|NCT02041533|Antimetabolites|antimetabolites|mesh-ancestor
153394460|NCT02041533|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153394461|NCT02041533|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153394462|NCT02041533|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153394463|NCT02041533|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153394464|NCT02041533|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153394465|NCT02260531|Trastuzumab|trastuzumab|mesh-list
153394466|NCT02260531|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153394467|NCT02260531|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153648717|NCT00394966|Rolapitant|rolapitant|mesh-list
153394468|NCT02458235|Azacitidine|azacitidine|mesh-list
153854225|NCT02905734|Nicotine|nicotine|mesh-list
153854226|NCT02905734|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
153854227|NCT02905734|Autonomic Agents|autonomic agents|mesh-ancestor
153854228|NCT02905734|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153854229|NCT02905734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153822953|NCT00480363|Autonomic Agents|autonomic agents|mesh-ancestor
153854230|NCT02905734|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
153854231|NCT02905734|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
153854232|NCT02905734|Cholinergic Agents|cholinergic agents|mesh-ancestor
153854233|NCT02905734|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153854234|NCT02905734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153854235|NCT04644185|Myeloma Proteins|myeloma proteins|mesh-list
153854236|NCT04644185|Paraproteins|paraproteins|mesh-list
153854237|NCT04644185|Immunologic Factors|immunologic factors|mesh-ancestor
153854238|NCT04644185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153854239|NCT02905461|Contraceptive Agents|contraceptive agents|mesh-list
153854240|NCT02905461|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153854241|NCT02905461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153854242|NCT02905305|Dexamethasone|dexamethasone|mesh-list
153854243|NCT02905305|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153854244|NCT02905305|Antiemetics|antiemetics|mesh-ancestor
153854245|NCT02905305|Autonomic Agents|autonomic agents|mesh-ancestor
153854246|NCT02905305|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153394493|NCT02115997|Antiemetics|antiemetics|mesh-ancestor
153394494|NCT02115997|Autonomic Agents|autonomic agents|mesh-ancestor
153394495|NCT02115997|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153394496|NCT02115997|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153394497|NCT02115997|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
153394498|NCT02115997|Protective Agents|protective agents|mesh-ancestor
153394499|NCT01805323|Dexamethasone|dexamethasone|mesh-list
153394500|NCT01805323|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153394501|NCT01805323|Antiemetics|antiemetics|mesh-ancestor
153394502|NCT01805323|Autonomic Agents|autonomic agents|mesh-ancestor
153394503|NCT01805323|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153394504|NCT01805323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153394505|NCT01805323|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153854249|NCT02905305|Glucocorticoids|glucocorticoids|mesh-ancestor
153854250|NCT02905305|Hormones|hormones|mesh-ancestor
153854251|NCT02905305|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153854252|NCT02905305|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153854253|NCT02905305|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153854254|NCT02899182|Nitrous Oxide|nitrous oxide|mesh-list
153854255|NCT02899182|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
153854257|NCT02899182|Anesthetics|anesthetics|mesh-ancestor
153394508|NCT01805323|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153394509|NCT01805323|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153394510|NCT01805323|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153394511|NCT01641055|Caseins|caseins|mesh-list
153394512|NCT01641055|Chelating Agents|chelating agents|mesh-ancestor
153394513|NCT01641055|Sequestering Agents|sequestering agents|mesh-ancestor
153394514|NCT01641055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153394515|NCT01788631|Regadenoson|regadenoson|mesh-list
153394516|NCT01788631|Adenosine A2 Receptor Agonists|adenosine a2 receptor agonists|mesh-ancestor
153394517|NCT01788631|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
153394518|NCT01788631|Purinergic Agonists|purinergic agonists|mesh-ancestor
153394519|NCT01788631|Purinergic Agents|purinergic agents|mesh-ancestor
153394520|NCT01788631|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153394521|NCT01788631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153394522|NCT01788631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153394523|NCT00907283|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
153394524|NCT00907283|Deferiprone|deferiprone|mesh-list
153394525|NCT00907283|Iron Chelating Agents|iron chelating agents|mesh-ancestor
153394526|NCT00907283|Chelating Agents|chelating agents|mesh-ancestor
153394527|NCT00907283|Sequestering Agents|sequestering agents|mesh-ancestor
153394528|NCT00907283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153394529|NCT01789255|Cyclosporine|cyclosporine|mesh-list
153394530|NCT01789255|Methotrexate|methotrexate|mesh-list
153394531|NCT01789255|Vorinostat|vorinostat|mesh-list
153394532|NCT01789255|Tacrolimus|tacrolimus|mesh-list
153394533|NCT01789255|Cyclosporins|cyclosporins|mesh-list
153854291|NCT04643132|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153854292|NCT04643132|Anesthetics, General|anesthetics, general|mesh-ancestor
153394538|NCT01789255|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153394539|NCT01789255|Antimetabolites|antimetabolites|mesh-ancestor
153394540|NCT01789255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153394541|NCT01789255|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153394554|NCT02464163|Agglutinins|agglutinins|mesh-ancestor
153394555|NCT02464163|Immunologic Factors|immunologic factors|mesh-ancestor
153394556|NCT02464163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153394557|NCT02464163|Coagulants|coagulants|mesh-ancestor
153854318|NCT00559169|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153854319|NCT00559169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153854321|NCT04642664|Apatinib|apatinib|mesh-list
153854322|NCT04642664|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153854323|NCT04642664|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153854324|NCT04642664|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153394572|NCT02694809|Estrogens|estrogens|mesh-list
153394573|NCT02694809|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
153394574|NCT02694809|Hormones|hormones|mesh-ancestor
153394575|NCT02694809|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153394576|NCT02694809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153394577|NCT02694809|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
153394578|NCT02694809|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
153394579|NCT02694809|Hormone Antagonists|hormone antagonists|mesh-ancestor
153394580|NCT02694809|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153394581|NCT00362687|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
153394582|NCT00362687|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153394583|NCT00362687|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153854341|NCT02904564|Antimetabolites|antimetabolites|mesh-ancestor
153854365|NCT04640870|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153854366|NCT02897934|Bupivacaine|bupivacaine|mesh-list
153854367|NCT02897934|Anesthetics, Local|anesthetics, local|mesh-ancestor
153854368|NCT02897934|Anesthetics|anesthetics|mesh-ancestor
153854369|NCT02897934|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153854370|NCT02897934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153394603|NCT02469701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153854373|NCT04640129|Interferons|interferons|mesh-list
153854374|NCT04640129|Tenofovir|tenofovir|mesh-list
153854375|NCT04640129|Interferon-alpha|interferon-alpha|mesh-list
153854376|NCT04640129|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153854377|NCT04640129|Antiviral Agents|antiviral agents|mesh-ancestor
153854378|NCT04640129|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153854379|NCT04640129|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153854380|NCT04640129|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153854381|NCT04640129|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153854382|NCT04640129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153854383|NCT04640129|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153854384|NCT04640129|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153854385|NCT04640129|Immunologic Factors|immunologic factors|mesh-ancestor
153854386|NCT04640129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153854387|NCT02898012|Bevacizumab|bevacizumab|mesh-list
153854444|NCT00559481|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153854446|NCT00559481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153854447|NCT00559481|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153854448|NCT00559481|Hormone Antagonists|hormone antagonists|mesh-ancestor
153854449|NCT00559481|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
153854450|NCT02897856|Midazolam|midazolam|mesh-list
153394686|NCT02471651|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153394687|NCT02477423|Gentamicins|gentamicins|mesh-list
153394688|NCT02477423|Ampicillin|ampicillin|mesh-list
153394689|NCT02477423|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153394690|NCT02477423|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153394691|NCT02477423|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
153854451|NCT02897856|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153854452|NCT02897856|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153854453|NCT02897856|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153854454|NCT02897856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153854455|NCT02897856|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153854464|NCT02897856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153854465|NCT01236118|Ixekizumab|ixekizumab|mesh-list
153854466|NCT01236118|Dermatologic Agents|dermatologic agents|mesh-ancestor
153854467|NCT04206631|Doxycycline|doxycycline|mesh-list
153854468|NCT04206631|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153854469|NCT04206631|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153854470|NCT04206631|Antimalarials|antimalarials|mesh-ancestor
153854471|NCT04206631|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153854472|NCT04206631|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153854473|NCT04639817|Levofloxacin|levofloxacin|mesh-list
153854474|NCT04639817|Trimethoprim|trimethoprim|mesh-list
153394733|NCT04744571|Sympatholytics|sympatholytics|mesh-ancestor
153854485|NCT04639817|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
153854486|NCT04639817|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153854487|NCT04639817|Antimalarials|antimalarials|mesh-ancestor
153854488|NCT04639817|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153854489|NCT04639817|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153854490|NCT04639817|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153854491|NCT04639817|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
153854492|NCT04639817|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
153854493|NCT01236001|Lacosamide|lacosamide|mesh-list
153362936|NCT01831700|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153362937|NCT01831700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153362938|NCT01831700|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
153362939|NCT01831700|Protease Inhibitors|protease inhibitors|mesh-ancestor
153362940|NCT01831700|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153854494|NCT01236001|Anticonvulsants|anticonvulsants|mesh-ancestor
153854495|NCT01236001|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
153854496|NCT01236001|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153854497|NCT01236001|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153394734|NCT04744571|Autonomic Agents|autonomic agents|mesh-ancestor
153394735|NCT04744571|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
153394736|NCT04744571|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
153394737|NCT04744571|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
153394738|NCT04744571|Adrenergic Agents|adrenergic agents|mesh-ancestor
153394739|NCT00363155|KRN 7000|krn 7000|mesh-list
153394740|NCT00363155|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153394741|NCT00363155|Immunologic Factors|immunologic factors|mesh-ancestor
153394742|NCT00363155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153394743|NCT00363155|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153854505|NCT01229254|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
153394753|NCT02257957|Ophthalmic Solutions|ophthalmic solutions|mesh-list
153394755|NCT02257957|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
153394756|NCT02257957|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153394757|NCT02257957|Immunologic Factors|immunologic factors|mesh-ancestor
153394769|NCT02525549|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153394771|NCT02525549|Analgesics|analgesics|mesh-ancestor
153394775|NCT02525549|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153394777|NCT01878799|Sofosbuvir|sofosbuvir|mesh-list
153394778|NCT01878799|Ledipasvir|ledipasvir|mesh-list
153394779|NCT01878799|Antiviral Agents|antiviral agents|mesh-ancestor
153394780|NCT01878799|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153394781|NCT02527265|Insulin|insulin|mesh-list
153394782|NCT02527265|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153394783|NCT02527265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153394784|NCT01879345|Eslicarbazepine acetate|eslicarbazepine acetate|mesh-list
153394785|NCT01879345|Anticonvulsants|anticonvulsants|mesh-ancestor
153394787|NCT01879345|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153394794|NCT01804075|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153394810|NCT02530151|Morphine|morphine|mesh-list
153394811|NCT02530151|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153394812|NCT02530151|Narcotics|narcotics|mesh-ancestor
153394813|NCT02530151|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153394814|NCT02530151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153394815|NCT02530151|Analgesics|analgesics|mesh-ancestor
153854554|NCT00559676|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153854555|NCT00559676|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153854556|NCT00559676|Antidotes|antidotes|mesh-ancestor
153854557|NCT00559676|Protective Agents|protective agents|mesh-ancestor
153854558|NCT00559676|Vitamin B Complex|vitamin b complex|mesh-ancestor
153854559|NCT00559676|Vitamins|vitamins|mesh-ancestor
153854560|NCT00559676|Micronutrients|micronutrients|mesh-ancestor
153854561|NCT04639271|Trastuzumab|trastuzumab|mesh-list
153854562|NCT04639271|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
153854563|NCT04639271|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153854564|NCT04639271|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153362969|NCT02504268|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153362970|NCT02504268|Immunologic Factors|immunologic factors|mesh-ancestor
153362971|NCT02504268|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153362972|NCT02504268|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153362973|NCT02504268|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153362974|NCT02504268|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153362975|NCT00904826|Eculizumab|eculizumab|mesh-list
153362976|NCT00904826|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
153362977|NCT00904826|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153362978|NCT00904826|Immunologic Factors|immunologic factors|mesh-ancestor
153362979|NCT00904826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153362980|NCT05311514|Ophthalmic Solutions|ophthalmic solutions|mesh-list
153362981|NCT05311514|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
153362982|NCT01448525|Bimatoprost|bimatoprost|mesh-list
153362983|NCT01448525|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
153362984|NCT01448525|Ophthalmic Solutions|ophthalmic solutions|mesh-list
153854599|NCT01235689|Antimetabolites|antimetabolites|mesh-ancestor
153854600|NCT01235689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153854601|NCT01235689|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153854602|NCT01235689|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153854603|NCT01235689|Immunologic Factors|immunologic factors|mesh-ancestor
153854604|NCT04680819|Propolis|propolis|mesh-list
153854605|NCT04680819|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153854606|NCT02896842|Imatinib Mesylate|imatinib mesylate|mesh-list
153854607|NCT02896842|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153854608|NCT02896842|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153854609|NCT02896842|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153854610|NCT02896842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153854611|NCT02896842|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153854612|NCT00559715|Bevacizumab|bevacizumab|mesh-list
153394852|NCT02531321|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
153394853|NCT02531321|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
153394854|NCT01805089|Melatonin|melatonin|mesh-list
153394882|NCT02419547|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153394883|NCT02419547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153394884|NCT02419547|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153394885|NCT02419547|Anesthetics, General|anesthetics, general|mesh-ancestor
153394887|NCT02419547|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153394888|NCT02419547|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153854643|NCT00553683|Immunologic Factors|immunologic factors|mesh-ancestor
153854644|NCT00553683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153854645|NCT00553683|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153854646|NCT00553683|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153854647|NCT00553683|Alkylating Agents|alkylating agents|mesh-ancestor
153854648|NCT00553683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153854649|NCT00553683|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153854650|NCT00553683|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153823042|NCT00443235|Growth Inhibitors|growth inhibitors|mesh-ancestor
153823043|NCT04700943|Anesthetics|anesthetics|mesh-list
153823044|NCT04700943|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153823045|NCT04700943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153823046|NCT00456248|Ribavirin|ribavirin|mesh-list
153823047|NCT00456248|Interferon alfacon-1|interferon alfacon-1|mesh-list
153363020|NCT02476422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153394901|NCT02419547|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
153394902|NCT02533427|Ethinyl Estradiol|ethinyl estradiol|mesh-list
153394903|NCT02533427|Norgestimate|norgestimate|mesh-list
153394904|NCT02533427|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
153394905|NCT02533427|Estradiol|estradiol|mesh-list
153394906|NCT02533427|Estrogens|estrogens|mesh-ancestor
153394907|NCT02533427|Hormones|hormones|mesh-ancestor
153394908|NCT02533427|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153854652|NCT01229176|Vaccines|vaccines|mesh-list
153854682|NCT01235338|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
153854683|NCT01235338|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
153854684|NCT01235338|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
153854685|NCT01235338|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153394927|NCT02533505|Formoterol Fumarate|formoterol fumarate|mesh-list
153394928|NCT02533505|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153394929|NCT02533505|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153394930|NCT02533505|Autonomic Agents|autonomic agents|mesh-ancestor
153394931|NCT02533505|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153394932|NCT02533505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153394933|NCT02533505|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153394934|NCT02533505|Respiratory System Agents|respiratory system agents|mesh-ancestor
153394935|NCT02533505|Glucocorticoids|glucocorticoids|mesh-ancestor
153394936|NCT02533505|Hormones|hormones|mesh-ancestor
153854739|NCT02895672|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153854740|NCT02895672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153854741|NCT02895672|Incretins|incretins|mesh-ancestor
153854742|NCT02895672|Hormones|hormones|mesh-ancestor
153854743|NCT02895672|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153854744|NCT02895672|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
153854745|NCT01227967|Ribavirin|ribavirin|mesh-list
153854746|NCT01227967|Oseltamivir|oseltamivir|mesh-list
153854750|NCT01227967|Antiviral Agents|antiviral agents|mesh-ancestor
153394992|NCT05324995|Sympathomimetics|sympathomimetics|mesh-ancestor
153394993|NCT05324995|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
153394994|NCT05324995|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153394995|NCT05324995|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153394996|NCT05324995|Analgesics|analgesics|mesh-ancestor
153394997|NCT05324995|Sensory System Agents|sensory system agents|mesh-ancestor
153394998|NCT05324995|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153394999|NCT05324995|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153395000|NCT05324995|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
153395001|NCT05324995|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153395002|NCT05324995|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153395003|NCT05318521|Ibuprofen|ibuprofen|mesh-list
153395008|NCT05318521|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153395013|NCT05318521|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153395014|NCT05318521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153395015|NCT02420873|Maytansine|maytansine|mesh-list
153395016|NCT02420873|Lorvotuzumab mertansine|lorvotuzumab mertansine|mesh-list
153395017|NCT02420873|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153363050|NCT01832870|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153363052|NCT01553201|Botulinum Toxins|botulinum toxins|mesh-list
153395039|NCT02267083|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153395040|NCT02267083|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153395041|NCT02267083|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153395042|NCT02267083|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153395043|NCT02267083|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153395044|NCT02267083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153395045|NCT02535611|Memantine|memantine|mesh-list
153395046|NCT02535611|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
153395047|NCT02535611|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
153395048|NCT02535611|Dopamine Agents|dopamine agents|mesh-ancestor
153395049|NCT02535611|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153395050|NCT02535611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153395051|NCT02535611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153395052|NCT02535611|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
153395053|NCT02535611|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
153395054|NCT01823497|Morphine|morphine|mesh-list
153395055|NCT01823497|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153854796|NCT00560300|Vitamin D|vitamin d|mesh-list
153854877|NCT01227577|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153854878|NCT01227577|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153854879|NCT01227577|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153854880|NCT01227577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153854882|NCT00624676|Benzoic Acid|benzoic acid|mesh-list
153854883|NCT00624676|Salicylates|salicylates|mesh-list
153854898|NCT00624676|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153854899|NCT00624676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153854900|NCT05655715|Nivolumab|nivolumab|mesh-list
153854901|NCT05655715|Ipilimumab|ipilimumab|mesh-list
153854902|NCT05655715|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153854903|NCT05655715|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153854904|NCT05655715|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153854905|NCT05655715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153854906|NCT04317235|Ropivacaine|ropivacaine|mesh-list
153854907|NCT04317235|Anesthetics, Local|anesthetics, local|mesh-ancestor
153854908|NCT04317235|Anesthetics|anesthetics|mesh-ancestor
153854909|NCT04317235|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153854913|NCT00560690|Metformin|metformin|mesh-list
153395187|NCT02431637|Piperaquine|piperaquine|mesh-list
153395188|NCT02431637|Antimalarials|antimalarials|mesh-ancestor
153395189|NCT02431637|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153395190|NCT02431637|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153395191|NCT02431637|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153395192|NCT02545907|Thalidomide|thalidomide|mesh-list
153395193|NCT02545907|Dexamethasone|dexamethasone|mesh-list
153395194|NCT02545907|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153395195|NCT02545907|Antiemetics|antiemetics|mesh-ancestor
153395196|NCT02545907|Autonomic Agents|autonomic agents|mesh-ancestor
153395197|NCT02545907|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153395198|NCT02545907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153395199|NCT02545907|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153395200|NCT02545907|Glucocorticoids|glucocorticoids|mesh-ancestor
153395201|NCT02545907|Hormones|hormones|mesh-ancestor
153395202|NCT02545907|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153395203|NCT02545907|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153395204|NCT02545907|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153395205|NCT02545907|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153395206|NCT02545907|Immunologic Factors|immunologic factors|mesh-ancestor
153395207|NCT02545907|Leprostatic Agents|leprostatic agents|mesh-ancestor
153395208|NCT02545907|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153395209|NCT02545907|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153395210|NCT02545907|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153395211|NCT02545907|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153395212|NCT02545907|Growth Substances|growth substances|mesh-ancestor
153395213|NCT02545907|Growth Inhibitors|growth inhibitors|mesh-ancestor
153395214|NCT02495831|Diclofenac|diclofenac|mesh-list
153854951|NCT04633850|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153395215|NCT02495831|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153854953|NCT04633850|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153363096|NCT01533077|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153854966|NCT05427942|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
153854967|NCT05427942|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153854968|NCT05427942|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153854969|NCT05427903|Epinephrine|epinephrine|mesh-list
153854970|NCT05427903|Anesthetics|anesthetics|mesh-list
153854971|NCT05427903|Carticaine|carticaine|mesh-list
153854972|NCT05427903|Anesthetics, Local|anesthetics, local|mesh-list
153854973|NCT05427903|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153854993|NCT05427747|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153854994|NCT05427747|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153854995|NCT00445406|Bevacizumab|bevacizumab|mesh-list
153395229|NCT02498483|Sensory System Agents|sensory system agents|mesh-ancestor
153395230|NCT02498483|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153395231|NCT02498483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153395232|NCT02498483|Antipyretics|antipyretics|mesh-ancestor
153395233|NCT02547623|Dexamethasone|dexamethasone|mesh-list
153395234|NCT02547623|Prednisolone|prednisolone|mesh-list
153395235|NCT02547623|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153395236|NCT02547623|Antiemetics|antiemetics|mesh-ancestor
153395237|NCT02547623|Autonomic Agents|autonomic agents|mesh-ancestor
153395246|NCT02547779|Plasma-lyte 148|plasma-lyte 148|mesh-list
153395247|NCT02547779|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
153395248|NCT02547779|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
153395249|NCT00559585|Abatacept|abatacept|mesh-list
153395250|NCT00559585|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153395251|NCT00559585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153395252|NCT00559585|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153395258|NCT01824901|Docetaxel|docetaxel|mesh-list
153395259|NCT01824901|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153395260|NCT01824901|Tubulin Modulators|tubulin modulators|mesh-ancestor
153395261|NCT01824901|Antimitotic Agents|antimitotic agents|mesh-ancestor
153395262|NCT01824901|Mitosis Modulators|mitosis modulators|mesh-ancestor
153395263|NCT01824901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153855035|NCT00445796|Antimalarials|antimalarials|mesh-ancestor
153855036|NCT00445796|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153855037|NCT00445796|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153855038|NCT00445796|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153855039|NCT00445796|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153395271|NCT04969627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153395272|NCT04969627|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
153395273|NCT04969627|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
153395275|NCT04969627|Hormones|hormones|mesh-ancestor
153395276|NCT04969627|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153395277|NCT04953325|Vaccines|vaccines|mesh-list
153395278|NCT04953325|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
153395279|NCT04953325|Immunologic Factors|immunologic factors|mesh-ancestor
153395280|NCT04953325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153395281|NCT01826851|Bupivacaine|bupivacaine|mesh-list
153855047|NCT01225822|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153855048|NCT01225822|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153855049|NCT01225822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153855050|NCT01225822|Antithrombins|antithrombins|mesh-ancestor
153855051|NCT01225822|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
153855052|NCT01225822|Protease Inhibitors|protease inhibitors|mesh-ancestor
153855053|NCT01225822|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153733309|NCT00144209|Protective Agents|protective agents|mesh-ancestor
153855055|NCT00445874|Antipruritics|antipruritics|mesh-ancestor
153855067|NCT01225549|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153855068|NCT01225549|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153395310|NCT02434523|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153395312|NCT02434523|Sensory System Agents|sensory system agents|mesh-ancestor
153395313|NCT02434523|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153395314|NCT02434523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153395315|NCT02434523|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
153395316|NCT02434523|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153395317|NCT02434523|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153395318|NCT02434523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153395319|NCT02434523|Adrenergic Agents|adrenergic agents|mesh-ancestor
153395320|NCT02434523|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153395321|NCT02501135|Bupivacaine|bupivacaine|mesh-list
153395322|NCT02501135|Ropivacaine|ropivacaine|mesh-list
153395323|NCT02501135|Anesthetics, Local|anesthetics, local|mesh-ancestor
153395324|NCT02501135|Anesthetics|anesthetics|mesh-ancestor
153395325|NCT02501135|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153395326|NCT02501135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153395327|NCT02501135|Sensory System Agents|sensory system agents|mesh-ancestor
153395328|NCT02501135|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153395329|NCT02550743|Capecitabine|capecitabine|mesh-list
153855070|NCT01225549|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153855071|NCT01225549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153855072|NCT01225549|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153855073|NCT01225549|Respiratory System Agents|respiratory system agents|mesh-ancestor
153855074|NCT01225549|Glucocorticoids|glucocorticoids|mesh-ancestor
153855075|NCT01225549|Hormones|hormones|mesh-ancestor
153855076|NCT01225549|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153855077|NCT05469685|Amoxicillin|amoxicillin|mesh-list
153363131|NCT03219788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153363133|NCT03219788|Sensory System Agents|sensory system agents|mesh-ancestor
153363135|NCT03219710|Dexamethasone|dexamethasone|mesh-list
153395383|NCT02439281|Anesthetics|anesthetics|mesh-ancestor
153395384|NCT02439281|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153855159|NCT02902302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153855160|NCT02902302|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153855161|NCT02902302|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153855162|NCT02902302|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153855163|NCT02902302|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153855164|NCT02902302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153855165|NCT01223365|Hydrocodone|hydrocodone|mesh-list
153855166|NCT01223365|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153855167|NCT01223365|Narcotics|narcotics|mesh-ancestor
153855168|NCT01223365|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153855169|NCT01223365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153855170|NCT01223365|Analgesics|analgesics|mesh-ancestor
153855171|NCT01223365|Sensory System Agents|sensory system agents|mesh-ancestor
153855172|NCT01223365|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153855173|NCT01223365|Antitussive Agents|antitussive agents|mesh-ancestor
153855174|NCT01223365|Respiratory System Agents|respiratory system agents|mesh-ancestor
153855175|NCT02956811|Dapagliflozin|dapagliflozin|mesh-list
153395407|NCT02505269|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153395408|NCT02505269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153395409|NCT02505269|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153395410|NCT02505269|Alkylating Agents|alkylating agents|mesh-ancestor
153395411|NCT02505269|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153395412|NCT02505269|Immunotoxins|immunotoxins|mesh-ancestor
153395413|NCT02505269|Immunoconjugates|immunoconjugates|mesh-ancestor
153395437|NCT02506673|GABA Agents|gaba agents|mesh-ancestor
153395438|NCT02506673|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153395439|NCT02506673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153395440|NCT02508077|Calcium, Dietary|calcium, dietary|mesh-list
153395441|NCT02508077|Leucovorin|leucovorin|mesh-list
153395442|NCT02508077|Folic Acid|folic acid|mesh-list
153395443|NCT02508077|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
153395444|NCT02508077|Panitumumab|panitumumab|mesh-list
153395445|NCT02508077|Fluorouracil|fluorouracil|mesh-list
153395446|NCT02508077|Irinotecan|irinotecan|mesh-list
153395447|NCT02508077|Camptothecin|camptothecin|mesh-list
153395448|NCT02508077|Antibodies|antibodies|mesh-list
153395449|NCT02508077|Immunoglobulins|immunoglobulins|mesh-list
153395450|NCT02508077|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
153395451|NCT02508077|Calcium|calcium|mesh-list
153855206|NCT04317157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153855207|NCT04317157|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
153855208|NCT04317157|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
153855209|NCT04317157|Purinergic Agents|purinergic agents|mesh-ancestor
153855210|NCT04317157|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153855211|NCT04317079|3,4-dihydroxyphenylethanol|3,4-dihydroxyphenylethanol|mesh-list
153855212|NCT04317079|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153855213|NCT04317079|Antioxidants|antioxidants|mesh-ancestor
153855214|NCT04317079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153855215|NCT04317079|Protective Agents|protective agents|mesh-ancestor
153855216|NCT04317079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153855217|NCT04317079|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153855219|NCT03277430|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153855220|NCT03277430|Immunologic Factors|immunologic factors|mesh-ancestor
153855221|NCT03277430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153855222|NCT03277430|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
153855223|NCT03277430|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153395457|NCT02508077|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153395458|NCT02508077|Antimetabolites|antimetabolites|mesh-ancestor
153395459|NCT02508077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153363146|NCT03219710|Hormones|hormones|mesh-ancestor
153395461|NCT02508077|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153395462|NCT02508077|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
153395463|NCT02508077|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153855228|NCT04699214|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153855229|NCT04699214|Growth Substances|growth substances|mesh-ancestor
153855230|NCT04699214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153855231|NCT04699214|Growth Inhibitors|growth inhibitors|mesh-ancestor
153855232|NCT04699214|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153855233|NCT02902380|Dexmedetomidine|dexmedetomidine|mesh-list
153855234|NCT02902380|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153855235|NCT02902380|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153855236|NCT02902380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153395471|NCT02508077|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153395472|NCT00558259|Dabigatran|dabigatran|mesh-list
153395473|NCT00558259|Antithrombins|antithrombins|mesh-ancestor
153395474|NCT00558259|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
153395475|NCT00558259|Protease Inhibitors|protease inhibitors|mesh-ancestor
153395476|NCT00558259|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153395477|NCT00558259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153855242|NCT02902380|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153855243|NCT02902380|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153855244|NCT02902380|Adrenergic Agents|adrenergic agents|mesh-ancestor
153855245|NCT02902380|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153855271|NCT03277079|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153855272|NCT03277079|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153855273|NCT03277079|Antimetabolites|antimetabolites|mesh-ancestor
153395511|NCT02561897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153395515|NCT02512679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153395516|NCT02512679|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153395517|NCT02512679|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153855278|NCT01220557|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153855279|NCT01220557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153855280|NCT04317001|Modafinil|modafinil|mesh-list
153855281|NCT04317001|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
153855282|NCT04317001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153855283|NCT04317001|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
153855284|NCT04317001|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
153395523|NCT02562521|Varenicline|varenicline|mesh-list
153395524|NCT02562521|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
153395525|NCT02562521|Autonomic Agents|autonomic agents|mesh-ancestor
153395526|NCT02562521|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153395527|NCT02562521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153395528|NCT02562521|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
153395529|NCT02562521|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
153395530|NCT02562521|Cholinergic Agents|cholinergic agents|mesh-ancestor
153395531|NCT02562521|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153395532|NCT02562521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153395533|NCT02562755|Sorafenib|sorafenib|mesh-list
153395534|NCT02562755|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153855318|NCT01220167|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153855319|NCT01220167|Antipruritics|antipruritics|mesh-ancestor
153395583|NCT02569541|Fusidic Acid|fusidic acid|mesh-list
153395585|NCT02569541|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153395586|NCT02569541|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
153855322|NCT01220167|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153855323|NCT01220167|Serotonin Agents|serotonin agents|mesh-ancestor
153855324|NCT01220167|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153855325|NCT01220167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153855326|NCT00447239|Insulin|insulin|mesh-list
153855327|NCT00447239|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153855328|NCT00447239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153855329|NCT05425914|Vitamin D|vitamin d|mesh-list
153855330|NCT05425914|Lubricant Eye Drops|lubricant eye drops|mesh-list
153855331|NCT05425914|Vitamins|vitamins|mesh-ancestor
153855332|NCT05425914|Micronutrients|micronutrients|mesh-ancestor
153855333|NCT05425914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153855334|NCT05425914|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153855335|NCT05425914|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
153855336|NCT05425914|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
153855337|NCT00447356|Interferons|interferons|mesh-list
153855338|NCT00447356|Interferon-alpha|interferon-alpha|mesh-list
153855339|NCT00447356|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153855340|NCT00447356|Antiviral Agents|antiviral agents|mesh-ancestor
153855341|NCT00447356|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153855342|NCT00447356|Immunologic Factors|immunologic factors|mesh-ancestor
153855343|NCT00447356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153855384|NCT03455322|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
153855386|NCT05425368|Cariostatic Agents|cariostatic agents|mesh-ancestor
153855387|NCT05425368|Protective Agents|protective agents|mesh-ancestor
153855388|NCT05425368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153855389|NCT00447863|Levonorgestrel|levonorgestrel|mesh-list
153855390|NCT00447863|Ethinyl Estradiol|ethinyl estradiol|mesh-list
153855391|NCT00447863|Estradiol|estradiol|mesh-list
153855392|NCT00447863|Estrogens|estrogens|mesh-ancestor
153855393|NCT00447863|Hormones|hormones|mesh-ancestor
153855394|NCT00447863|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153855395|NCT00447863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153855396|NCT00447863|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
153855397|NCT00447863|Contraceptive Agents|contraceptive agents|mesh-ancestor
153855398|NCT00447863|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153855399|NCT00447863|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
153855400|NCT00447863|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
153855401|NCT00447863|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
153855402|NCT00447863|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
153855403|NCT00448097|Docetaxel|docetaxel|mesh-list
153855404|NCT00448097|Cetuximab|cetuximab|mesh-list
153855405|NCT00448097|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153855406|NCT00448097|Tubulin Modulators|tubulin modulators|mesh-ancestor
153855419|NCT00448292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153855421|NCT02901561|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
153855422|NCT02901561|Abortifacient Agents|abortifacient agents|mesh-ancestor
153395681|NCT04743011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153395682|NCT03528941|Lamivudine|lamivudine|mesh-list
153395683|NCT03528941|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153395684|NCT03528941|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153395685|NCT03528941|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153395686|NCT03528941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153395687|NCT03528941|Antiviral Agents|antiviral agents|mesh-ancestor
153395688|NCT03528941|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153395689|NCT03528941|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153395690|NCT03528941|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153395691|NCT01836133|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
153395692|NCT01836133|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153395693|NCT01836133|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153855448|NCT03276689|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153855449|NCT03276689|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153855450|NCT03276689|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
153855451|NCT03276689|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153855452|NCT03276689|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153855453|NCT03276689|Antidepressive Agents|antidepressive agents|mesh-ancestor
153855454|NCT03276689|Dopamine Agents|dopamine agents|mesh-ancestor
153855455|NCT01220128|Paclitaxel|paclitaxel|mesh-list
153855456|NCT01220128|Docetaxel|docetaxel|mesh-list
153855457|NCT01220128|Cyclophosphamide|cyclophosphamide|mesh-list
153855458|NCT01220128|Carboplatin|carboplatin|mesh-list
153363194|NCT03219554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153395736|NCT02289690|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153395737|NCT02289690|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153395738|NCT02289690|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153395740|NCT02289690|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
153395742|NCT02268955|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153395743|NCT02268955|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153395744|NCT02268955|Analgesics|analgesics|mesh-ancestor
153395745|NCT02268955|Sensory System Agents|sensory system agents|mesh-ancestor
153395746|NCT02268955|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153395747|NCT02268955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153395748|NCT02268955|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153855482|NCT01220128|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153855483|NCT01220128|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153855484|NCT01220128|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153855485|NCT01220128|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
153855486|NCT01220128|Hormone Antagonists|hormone antagonists|mesh-ancestor
153855487|NCT01220128|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153855488|NCT04698941|Paclitaxel|paclitaxel|mesh-list
153855489|NCT04698941|Simvastatin|simvastatin|mesh-list
153855490|NCT04698941|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153855491|NCT04698941|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153855492|NCT04698941|Tubulin Modulators|tubulin modulators|mesh-ancestor
153855493|NCT04698941|Antimitotic Agents|antimitotic agents|mesh-ancestor
153855494|NCT04698941|Mitosis Modulators|mitosis modulators|mesh-ancestor
153855495|NCT04698941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153855496|NCT04698941|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153855497|NCT04698941|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153855498|NCT04698941|Antimetabolites|antimetabolites|mesh-ancestor
153855499|NCT04698941|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153363195|NCT01554371|Cyclophosphamide|cyclophosphamide|mesh-list
153855515|NCT02901288|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
153855516|NCT02901288|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153855517|NCT02901288|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
153855518|NCT02901288|Antitubercular Agents|antitubercular agents|mesh-ancestor
153855519|NCT02901288|Leprostatic Agents|leprostatic agents|mesh-ancestor
153395752|NCT02268955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153395753|NCT02585843|Spironolactone|spironolactone|mesh-list
153395754|NCT02585843|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
153395755|NCT02585843|Hormone Antagonists|hormone antagonists|mesh-ancestor
153395756|NCT02585843|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153395757|NCT02585843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153395758|NCT02585843|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
153395759|NCT02585843|Diuretics|diuretics|mesh-ancestor
153395760|NCT02585843|Natriuretic Agents|natriuretic agents|mesh-ancestor
153395761|NCT01838317|Pioglitazone|pioglitazone|mesh-list
153395762|NCT01838317|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153395763|NCT01838317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153395764|NCT05249231|Fluorides|fluorides|mesh-list
153395765|NCT05249231|Cariostatic Agents|cariostatic agents|mesh-ancestor
153395766|NCT05249231|Protective Agents|protective agents|mesh-ancestor
153395767|NCT05249231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153395768|NCT05249153|Sufentanil|sufentanil|mesh-list
153395769|NCT05249153|Dexmedetomidine|dexmedetomidine|mesh-list
153395770|NCT05249153|Dsuvia|dsuvia|mesh-list
153395771|NCT05249153|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153395772|NCT05249153|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153395773|NCT05249153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153395774|NCT05249153|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153395775|NCT05249153|Analgesics|analgesics|mesh-ancestor
153395776|NCT05249153|Sensory System Agents|sensory system agents|mesh-ancestor
153855531|NCT00448643|Cisplatin|cisplatin|mesh-list
153855532|NCT00448643|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153855533|NCT05424393|Etanercept|etanercept|mesh-list
153855555|NCT01219933|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
153855556|NCT01219933|Prednisolone|prednisolone|mesh-list
153855557|NCT01219933|Prednisolone acetate|prednisolone acetate|mesh-list
153855558|NCT01219933|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
153855559|NCT01219933|Prednisolone phosphate|prednisolone phosphate|mesh-list
153855560|NCT01219933|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153855561|NCT01219933|Antiemetics|antiemetics|mesh-ancestor
153855562|NCT01219933|Autonomic Agents|autonomic agents|mesh-ancestor
153855563|NCT01219933|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153855564|NCT01219933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153855565|NCT01219933|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153855566|NCT01219933|Glucocorticoids|glucocorticoids|mesh-ancestor
153855568|NCT01219933|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153395802|NCT02271217|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
153395803|NCT02271217|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153395804|NCT02271217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153395805|NCT02989519|Progesterone|progesterone|mesh-list
153395806|NCT02989519|Dydrogesterone|dydrogesterone|mesh-list
153395807|NCT02989519|Progestins|progestins|mesh-ancestor
153395808|NCT02989519|Hormones|hormones|mesh-ancestor
153395809|NCT02989519|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153395810|NCT02989519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153395811|NCT02429375|Brentuximab Vedotin|brentuximab vedotin|mesh-list
153395812|NCT02429375|Mocetinostat|mocetinostat|mesh-list
153395813|NCT02429375|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153395814|NCT02429375|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153395815|NCT02429375|Immunotoxins|immunotoxins|mesh-ancestor
153395816|NCT02429375|Immunoconjugates|immunoconjugates|mesh-ancestor
153395817|NCT02429375|Immunologic Factors|immunologic factors|mesh-ancestor
153395818|NCT02429375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153395819|NCT02429375|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
153855579|NCT05368441|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153855585|NCT05368441|GABA Agents|gaba agents|mesh-ancestor
153855586|NCT05368441|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153855587|NCT05368441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153855588|NCT04316845|Technetium Tc 99m Sestamibi|technetium tc 99m sestamibi|mesh-list
153855589|NCT04316845|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
153855590|NCT04316845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153855591|NCT01218802|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
153395825|NCT02289456|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153395826|NCT02289456|Tubulin Modulators|tubulin modulators|mesh-ancestor
153395827|NCT02289456|Antimitotic Agents|antimitotic agents|mesh-ancestor
153395828|NCT02289456|Mitosis Modulators|mitosis modulators|mesh-ancestor
153395829|NCT02289456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153395830|NCT02589977|Regadenoson|regadenoson|mesh-list
153395831|NCT02589977|Adenosine A2 Receptor Agonists|adenosine a2 receptor agonists|mesh-ancestor
153395832|NCT02589977|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
153395833|NCT02589977|Purinergic Agonists|purinergic agonists|mesh-ancestor
153395834|NCT02589977|Purinergic Agents|purinergic agents|mesh-ancestor
153395835|NCT02589977|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153395836|NCT02589977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153395837|NCT02589977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153395838|NCT02274948|Metformin|metformin|mesh-list
153395839|NCT02274948|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153395840|NCT02274948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153395841|NCT02274792|Etanercept|etanercept|mesh-list
153395842|NCT02274792|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153395843|NCT02274792|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153395844|NCT02274792|Analgesics|analgesics|mesh-ancestor
153395845|NCT02274792|Sensory System Agents|sensory system agents|mesh-ancestor
153395846|NCT02274792|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153363266|NCT03218852|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153855625|NCT00449501|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153855626|NCT00449501|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
153855627|NCT00449501|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
153855629|NCT00449501|Adrenergic Agents|adrenergic agents|mesh-ancestor
153855630|NCT00449501|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153855631|NCT00449501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153855632|NCT02900820|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
153855633|NCT02900820|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
153855634|NCT02900820|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153855635|NCT02900820|Antitubercular Agents|antitubercular agents|mesh-ancestor
153855636|NCT01188772|Sofosbuvir|sofosbuvir|mesh-list
153855637|NCT01188772|Antiviral Agents|antiviral agents|mesh-ancestor
153855638|NCT01188772|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153855639|NCT01188655|Etanercept|etanercept|mesh-list
153395872|NCT02592629|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153395873|NCT02592629|Immunologic Factors|immunologic factors|mesh-ancestor
153395875|NCT02596451|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153395876|NCT02596451|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153395877|NCT02596451|Analgesics|analgesics|mesh-ancestor
153395878|NCT02596451|Sensory System Agents|sensory system agents|mesh-ancestor
153395879|NCT02596451|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153395880|NCT02596451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153395881|NCT02596451|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153395903|NCT02597543|Regadenoson|regadenoson|mesh-list
153363272|NCT03218852|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153395926|NCT02599649|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153395928|NCT01840345|N-monoacetylcystine|n-monoacetylcystine|mesh-list
153395929|NCT01840345|Antiviral Agents|antiviral agents|mesh-ancestor
153395931|NCT01840345|Expectorants|expectorants|mesh-ancestor
153395932|NCT01840345|Respiratory System Agents|respiratory system agents|mesh-ancestor
153395933|NCT01840345|Free Radical Scavengers|free radical scavengers|mesh-ancestor
153395934|NCT01840345|Antioxidants|antioxidants|mesh-ancestor
153395935|NCT01840345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153395936|NCT01840345|Protective Agents|protective agents|mesh-ancestor
153395937|NCT01840345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153395938|NCT01840345|Antidotes|antidotes|mesh-ancestor
153395939|NCT00364481|Omeprazole|omeprazole|mesh-list
153395940|NCT00364481|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
153395941|NCT00364481|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153855674|NCT01188538|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153855675|NCT01188538|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153855676|NCT01188538|Dermatologic Agents|dermatologic agents|mesh-ancestor
153855677|NCT00449657|Paclitaxel|paclitaxel|mesh-list
153855678|NCT00449657|Carboplatin|carboplatin|mesh-list
153855679|NCT00449657|Gemcitabine|gemcitabine|mesh-list
153855680|NCT00449657|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153855681|NCT00449657|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153855682|NCT00449657|Tubulin Modulators|tubulin modulators|mesh-ancestor
153855683|NCT00449657|Antimitotic Agents|antimitotic agents|mesh-ancestor
153855684|NCT00449657|Mitosis Modulators|mitosis modulators|mesh-ancestor
153855685|NCT00449657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153855686|NCT00449657|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153855687|NCT00449657|Antimetabolites|antimetabolites|mesh-ancestor
153855688|NCT04318444|Hydroxychloroquine|hydroxychloroquine|mesh-list
153395959|NCT00553267|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
153395960|NCT00553267|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
153395961|NCT00364559|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
153855718|NCT00449774|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153855725|NCT02900742|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153855727|NCT02900742|Antimitotic Agents|antimitotic agents|mesh-ancestor
153855728|NCT02900742|Mitosis Modulators|mitosis modulators|mesh-ancestor
153855729|NCT02900742|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153855730|NCT02900742|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153855731|NCT02900742|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153855732|NCT00449813|Pantoprazole|pantoprazole|mesh-list
153855733|NCT00449813|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
153855734|NCT00449813|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153855735|NCT00449813|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
153855736|NCT00449813|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153855737|NCT00449813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153855738|NCT01218100|Lisinopril|lisinopril|mesh-list
153855739|NCT01218100|Nebivolol|nebivolol|mesh-list
153855740|NCT01218100|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
153855741|NCT01218100|Protease Inhibitors|protease inhibitors|mesh-ancestor
153396002|NCT00365339|Aripiprazole|aripiprazole|mesh-list
153396003|NCT00365339|Famotidine|famotidine|mesh-list
153396004|NCT00365339|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
153396005|NCT00365339|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
153396006|NCT00365339|Protease Inhibitors|protease inhibitors|mesh-ancestor
153396007|NCT00365339|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153396008|NCT00365339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153396009|NCT00365339|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153396010|NCT00365339|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153396012|NCT00365339|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153396013|NCT00365339|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
153396014|NCT00365339|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153396015|NCT00365339|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153396016|NCT00365339|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153396017|NCT00365339|Antidepressive Agents|antidepressive agents|mesh-ancestor
153396018|NCT00365339|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153396019|NCT00365339|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153396020|NCT00365339|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153396021|NCT00365339|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153855764|NCT00450008|Leprostatic Agents|leprostatic agents|mesh-ancestor
153855765|NCT00450008|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153855766|NCT00450008|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153855767|NCT00450008|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153855768|NCT00450008|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153855769|NCT00450008|Growth Substances|growth substances|mesh-ancestor
153855770|NCT00450008|Growth Inhibitors|growth inhibitors|mesh-ancestor
153855771|NCT02900469|Denosumab|denosumab|mesh-list
153855772|NCT02900469|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153855773|NCT02900469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153855774|NCT00450086|Budesonide|budesonide|mesh-list
153855775|NCT00450086|Mesalamine|mesalamine|mesh-list
153396039|NCT02815033|Lipotropic Agents|lipotropic agents|mesh-ancestor
153396040|NCT02815033|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153396041|NCT02815033|Antimetabolites|antimetabolites|mesh-ancestor
153396042|NCT02815033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153396043|NCT02815033|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153396044|NCT02815033|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153396045|NCT02815033|Nootropic Agents|nootropic agents|mesh-ancestor
153396046|NCT00366119|Ramipril|ramipril|mesh-list
153396047|NCT00366119|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
153396048|NCT00366119|Protease Inhibitors|protease inhibitors|mesh-ancestor
153396049|NCT00366119|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153396050|NCT00366119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153855814|NCT00450164|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
153855815|NCT00450164|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
153855817|NCT00450164|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153855818|NCT00450164|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
153855819|NCT00450164|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153855820|NCT00450164|Sympatholytics|sympatholytics|mesh-ancestor
153855821|NCT00450164|Autonomic Agents|autonomic agents|mesh-ancestor
153855822|NCT00450164|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153855823|NCT02900430|Antifungal Agents|antifungal agents|mesh-list
153855824|NCT02900430|Clotrimazole|clotrimazole|mesh-list
153855825|NCT02900430|Miconazole|miconazole|mesh-list
153396083|NCT02605187|Anticonvulsants|anticonvulsants|mesh-ancestor
153396084|NCT02605187|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153396085|NCT02605187|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153396086|NCT02605187|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153396090|NCT02605187|Antimanic Agents|antimanic agents|mesh-ancestor
153855831|NCT02900430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153855832|NCT02900430|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153855833|NCT02900430|Hormone Antagonists|hormone antagonists|mesh-ancestor
153855834|NCT02900430|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153855851|NCT00450203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153855852|NCT00450203|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153855853|NCT00450203|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153396125|NCT01642212|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153396126|NCT01642212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153396128|NCT01642212|Respiratory System Agents|respiratory system agents|mesh-ancestor
153396129|NCT01642212|Glucocorticoids|glucocorticoids|mesh-ancestor
153396131|NCT01642212|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153396132|NCT05649618|Cyclophosphamide|cyclophosphamide|mesh-list
153396133|NCT05649618|Fludarabine|fludarabine|mesh-list
153396134|NCT05649618|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153396135|NCT05649618|Immunologic Factors|immunologic factors|mesh-ancestor
153855884|NCT00450515|Capecitabine|capecitabine|mesh-list
153855885|NCT00450515|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153855886|NCT00450515|Antimetabolites|antimetabolites|mesh-ancestor
153855887|NCT00450515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153855888|NCT00450515|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153855889|NCT00450827|Bevacizumab|bevacizumab|mesh-list
153855891|NCT00450827|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
153855892|NCT00450827|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153855893|NCT00450827|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153855894|NCT00450827|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153855895|NCT00450827|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153855896|NCT00450827|Growth Substances|growth substances|mesh-ancestor
153855897|NCT00450827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153855898|NCT00450827|Growth Inhibitors|growth inhibitors|mesh-ancestor
153855899|NCT00450827|Immunologic Factors|immunologic factors|mesh-ancestor
153855900|NCT00450944|Immunotoxins|immunotoxins|mesh-list
153855901|NCT00450944|Immunoconjugates|immunoconjugates|mesh-ancestor
153855902|NCT00450944|Immunologic Factors|immunologic factors|mesh-ancestor
153855903|NCT00450944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153855905|NCT00451061|Alfuzosin|alfuzosin|mesh-list
153855906|NCT00451061|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
153855907|NCT00451061|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
153855908|NCT00451061|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
153855909|NCT00451061|Adrenergic Agents|adrenergic agents|mesh-ancestor
153855910|NCT00451061|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153396147|NCT00552175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153396148|NCT00552175|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153396160|NCT01644474|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153396161|NCT01644474|Antimetabolites|antimetabolites|mesh-ancestor
153396162|NCT01644474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153396163|NCT01644474|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153396164|NCT01644474|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
153396165|NCT01644474|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
153396166|NCT01644474|Protease Inhibitors|protease inhibitors|mesh-ancestor
153396167|NCT01644474|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153396168|NCT01644474|Immunologic Factors|immunologic factors|mesh-ancestor
153396169|NCT01644474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153396170|NCT02989129|Quercetin|quercetin|mesh-list
153396171|NCT02989129|Antioxidants|antioxidants|mesh-ancestor
153855927|NCT04341441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153855928|NCT04341441|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153855929|NCT01187953|Tacrolimus|tacrolimus|mesh-list
153855930|NCT01187953|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153855931|NCT01187953|Immunologic Factors|immunologic factors|mesh-ancestor
153855932|NCT01187953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153855933|NCT01187953|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
153855934|NCT01187953|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153855985|NCT01186939|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153396223|NCT01848067|Hormones|hormones|mesh-ancestor
153396224|NCT01848067|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153396225|NCT01848067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153396226|NCT01848067|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153396227|NCT01848067|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153396228|NCT01848067|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153363340|NCT03217448|Warfarin|warfarin|mesh-list
153396240|NCT00364871|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
153396241|NCT00364871|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
153396242|NCT00364871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153396243|NCT00364871|Sensory System Agents|sensory system agents|mesh-ancestor
153396244|NCT00364871|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153396245|NCT00364871|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
153396246|NCT00364871|Antidepressive Agents|antidepressive agents|mesh-ancestor
153396247|NCT00364871|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153396248|NCT00364871|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
153856007|NCT02930954|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153856008|NCT02930954|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153856009|NCT02930954|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153856010|NCT02930954|Growth Substances|growth substances|mesh-ancestor
153856011|NCT02930954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153856012|NCT02930954|Growth Inhibitors|growth inhibitors|mesh-ancestor
153856021|NCT04117659|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-list
153856022|NCT04117659|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
153856023|NCT04117659|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153856024|NCT04117659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153856025|NCT02930057|Betamethasone|betamethasone|mesh-list
153856026|NCT02930057|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153856027|NCT02930057|Glucocorticoids|glucocorticoids|mesh-ancestor
153856028|NCT02930057|Hormones|hormones|mesh-ancestor
153856029|NCT02930057|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153396264|NCT00551161|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
153396265|NCT00551161|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
153396266|NCT00550771|Paclitaxel|paclitaxel|mesh-list
153396308|NCT00550537|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
153396309|NCT00550537|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153396310|NCT00550537|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153396311|NCT00550537|Tubulin Modulators|tubulin modulators|mesh-ancestor
153396312|NCT00550537|Antimitotic Agents|antimitotic agents|mesh-ancestor
153396313|NCT00550537|Mitosis Modulators|mitosis modulators|mesh-ancestor
153396314|NCT00550537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153396315|NCT00550537|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153396317|NCT00550537|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153396318|NCT00550537|Growth Substances|growth substances|mesh-ancestor
153396319|NCT00550537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153396320|NCT00550537|Growth Inhibitors|growth inhibitors|mesh-ancestor
153396321|NCT00550537|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153396322|NCT00550537|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153396323|NCT00550537|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153396324|NCT04801043|Imipenem|imipenem|mesh-list
153396325|NCT04801043|Cilastatin|cilastatin|mesh-list
153396326|NCT04801043|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153856066|NCT00624325|Immunologic Factors|immunologic factors|mesh-ancestor
153396327|NCT04801043|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153733316|NCT05149339|Vitamins|vitamins|mesh-ancestor
153856121|NCT02928419|Growth Substances|growth substances|mesh-ancestor
153856122|NCT02928419|Growth Inhibitors|growth inhibitors|mesh-ancestor
153856123|NCT02928419|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153856124|NCT02928614|Liraglutide|liraglutide|mesh-list
153856125|NCT02928614|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
153856126|NCT02928614|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153856127|NCT02928614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153856128|NCT02928614|Incretins|incretins|mesh-ancestor
153856129|NCT02928614|Hormones|hormones|mesh-ancestor
153856154|NCT02928575|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153856155|NCT02928575|Growth Substances|growth substances|mesh-ancestor
153856156|NCT02928575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153856157|NCT02928575|Growth Inhibitors|growth inhibitors|mesh-ancestor
153396397|NCT02265913|Acyclovir|acyclovir|mesh-list
153396398|NCT02265913|Antiviral Agents|antiviral agents|mesh-ancestor
153396399|NCT02265913|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153396400|NCT02624843|Ethanol|ethanol|mesh-list
153396401|NCT02624843|Benzyl Alcohol|benzyl alcohol|mesh-list
153396402|NCT02624843|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
153396403|NCT02624843|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153396404|NCT02624843|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153396405|NCT02624843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153396406|NCT02624843|Anesthetics, Local|anesthetics, local|mesh-ancestor
153396407|NCT02624843|Anesthetics|anesthetics|mesh-ancestor
153396408|NCT02624843|Sensory System Agents|sensory system agents|mesh-ancestor
153396409|NCT02624843|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153396410|NCT02279641|Allopurinol|allopurinol|mesh-list
153396411|NCT02279641|Verinurad|verinurad|mesh-list
153396412|NCT02279641|Antimetabolites|antimetabolites|mesh-ancestor
153396413|NCT02279641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153396414|NCT02279641|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153396415|NCT02279641|Gout Suppressants|gout suppressants|mesh-ancestor
153856166|NCT02927951|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153856167|NCT02927951|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153856168|NCT02927951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153856169|NCT02927951|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153363392|NCT00895232|Iron|iron|mesh-list
153856170|NCT02927951|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153856171|NCT02927951|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153856172|NCT02927951|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153856173|NCT02927951|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153856174|NCT02927405|Gabapentin|gabapentin|mesh-list
153396429|NCT00553657|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153396430|NCT00553657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153396431|NCT00553657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153396432|NCT00553657|Urological Agents|urological agents|mesh-ancestor
153396433|NCT04992143|Sorafenib|sorafenib|mesh-list
153396434|NCT04992143|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153856201|NCT02926976|Risperidone|risperidone|mesh-list
153856202|NCT02926976|Aripiprazole|aripiprazole|mesh-list
153396443|NCT04485065|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153396444|NCT03769129|Pembrolizumab|pembrolizumab|mesh-list
153396445|NCT03769129|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153396446|NCT03769129|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153396447|NCT03769129|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153856203|NCT02926976|Clozapine|clozapine|mesh-list
153856204|NCT02926976|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153856205|NCT02926976|Serotonin Agents|serotonin agents|mesh-ancestor
153856206|NCT02926976|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153856207|NCT02926976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153856208|NCT02926976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153856209|NCT02926976|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153856210|NCT02926976|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153856211|NCT02926976|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153856212|NCT02926976|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153856213|NCT02926976|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
153856214|NCT02926976|Dopamine Agents|dopamine agents|mesh-ancestor
153856258|NCT04798287|Golimumab|golimumab|mesh-list
153856259|NCT04798287|Certolizumab Pegol|certolizumab pegol|mesh-list
153856260|NCT04798287|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-list
153396499|NCT01871077|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153396500|NCT01871077|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153396501|NCT01871077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153396502|NCT01874119|Fosaprepitant|fosaprepitant|mesh-list
153396503|NCT01874119|Aprepitant|aprepitant|mesh-list
153396504|NCT01874119|Antiemetics|antiemetics|mesh-ancestor
153396505|NCT01874119|Autonomic Agents|autonomic agents|mesh-ancestor
153396506|NCT01874119|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153396507|NCT01874119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153396508|NCT01874119|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153396509|NCT01874119|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
153396510|NCT01874119|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153856261|NCT04798287|Etanercept|etanercept|mesh-list
153856262|NCT04798287|Tofacitinib|tofacitinib|mesh-list
153856263|NCT04798287|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153733319|NCT00148005|Cholinergic Antagonists|cholinergic antagonists|mesh-list
153856264|NCT04798287|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153856265|NCT04798287|Dermatologic Agents|dermatologic agents|mesh-ancestor
153856266|NCT04798287|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153856267|NCT04798287|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153856268|NCT04798287|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153856269|NCT04798287|Analgesics|analgesics|mesh-ancestor
153856270|NCT04798287|Sensory System Agents|sensory system agents|mesh-ancestor
153856271|NCT04798287|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153856272|NCT04798287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153856273|NCT04798287|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153396511|NCT01874119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153396512|NCT02823145|Fenfluramine|fenfluramine|mesh-list
153396513|NCT02823145|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
153396514|NCT02823145|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153363403|NCT03211052|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153363404|NCT03211052|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153396515|NCT02823145|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153396516|NCT02823145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153396517|NCT02823145|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153856278|NCT04798287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153856279|NCT04689191|Vaccines|vaccines|mesh-list
153856280|NCT04689191|Immunologic Factors|immunologic factors|mesh-ancestor
153856281|NCT04689191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153856282|NCT02925299|Insulin|insulin|mesh-list
153856283|NCT02925299|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153396546|NCT01930747|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
153396548|NCT01930747|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153396549|NCT01930747|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153396550|NCT01930747|Narcotics|narcotics|mesh-ancestor
153396551|NCT01930747|Analgesics|analgesics|mesh-ancestor
153396552|NCT01930747|Sensory System Agents|sensory system agents|mesh-ancestor
153396553|NCT01931527|Rasburicase|rasburicase|mesh-list
153396554|NCT01931527|Gout Suppressants|gout suppressants|mesh-ancestor
153396555|NCT01931527|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153396556|NCT02639429|Misoprostol|misoprostol|mesh-list
153396557|NCT02639429|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
153396558|NCT02639429|Abortifacient Agents|abortifacient agents|mesh-ancestor
153396559|NCT02639429|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153396560|NCT02639429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153396561|NCT02639429|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
153396562|NCT02639429|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153396563|NCT02639429|Oxytocics|oxytocics|mesh-ancestor
153396611|NCT04507841|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153396666|NCT01643928|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153396667|NCT01643928|Immunologic Factors|immunologic factors|mesh-ancestor
153396668|NCT01643928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153396669|NCT01643928|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153396670|NCT03750071|Avelumab|avelumab|mesh-list
153396671|NCT03750071|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153856420|NCT01228656|Sensory System Agents|sensory system agents|mesh-ancestor
153856421|NCT01228656|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153856422|NCT01228656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153856423|NCT01228656|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153856424|NCT01228656|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153856425|NCT01228656|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153856426|NCT01228656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153856427|NCT02125266|Methotrexate|methotrexate|mesh-list
153733321|NCT00148005|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153399940|NCT01981772|Sensory System Agents|sensory system agents|mesh-ancestor
153856428|NCT02125266|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
153856429|NCT02125266|Abortifacient Agents|abortifacient agents|mesh-ancestor
153856430|NCT02125266|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153856431|NCT02125266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153856432|NCT02125266|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153856433|NCT02125266|Antimetabolites|antimetabolites|mesh-ancestor
153823445|NCT00459407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153823446|NCT00459407|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
153823447|NCT00459407|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
153823448|NCT00459407|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153823449|NCT00459407|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
153856434|NCT02125266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153856435|NCT02125266|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153856436|NCT02125266|Dermatologic Agents|dermatologic agents|mesh-ancestor
153856437|NCT02125266|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153856438|NCT02125266|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153856439|NCT02125266|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153856440|NCT02125266|Immunologic Factors|immunologic factors|mesh-ancestor
153856441|NCT02125266|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153396684|NCT05588531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153396685|NCT05588297|Bevacizumab|bevacizumab|mesh-list
153396686|NCT05588297|Nivolumab|nivolumab|mesh-list
153396687|NCT05588297|Capecitabine|capecitabine|mesh-list
153396688|NCT05588297|Oxaliplatin|oxaliplatin|mesh-list
153396689|NCT05588297|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153856447|NCT02116998|Antacids|antacids|mesh-ancestor
153856448|NCT02116998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153856449|NCT02116998|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153856450|NCT02110368|Methyltestosterone|methyltestosterone|mesh-list
153856451|NCT02110368|Testosterone|testosterone|mesh-list
153856452|NCT02110368|Testosterone undecanoate|testosterone undecanoate|mesh-list
153856453|NCT02110368|Testosterone enanthate|testosterone enanthate|mesh-list
153856454|NCT02110368|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
153856455|NCT02110368|Androgens|androgens|mesh-ancestor
153856456|NCT02110368|Hormones|hormones|mesh-ancestor
153856457|NCT02110368|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153856458|NCT02110368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153856459|NCT02110368|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153856460|NCT02110368|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153856461|NCT02110368|Anabolic Agents|anabolic agents|mesh-ancestor
153856462|NCT02916485|Sirolimus|sirolimus|mesh-list
153856463|NCT02916485|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153856464|NCT02916485|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153856465|NCT02916485|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153856466|NCT02916485|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153856467|NCT02916485|Antifungal Agents|antifungal agents|mesh-ancestor
153396749|NCT00367211|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153396750|NCT00367211|Gout Suppressants|gout suppressants|mesh-ancestor
153856499|NCT02916251|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153856500|NCT02916251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153856501|NCT02916251|Incretins|incretins|mesh-ancestor
153856502|NCT02106546|Paclitaxel|paclitaxel|mesh-list
153856503|NCT02106546|Carboplatin|carboplatin|mesh-list
153856504|NCT02106546|Veliparib|veliparib|mesh-list
153856505|NCT02106546|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153856517|NCT02916173|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153856518|NCT02916134|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
153856519|NCT02916134|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153856520|NCT02104245|Ciprofloxacin|ciprofloxacin|mesh-list
153396763|NCT02646449|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153396764|NCT02646449|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
153396765|NCT02646449|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
153396766|NCT02646449|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
153396767|NCT02646449|Adrenergic Agents|adrenergic agents|mesh-ancestor
153396768|NCT02646449|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
153396769|NCT02646449|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153396770|NCT02646449|Serotonin Agents|serotonin agents|mesh-ancestor
153396771|NCT02646449|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
153396772|NCT04339361|Lidocaine|lidocaine|mesh-list
153396773|NCT04339361|Dinoprostone|dinoprostone|mesh-list
153396774|NCT04339361|Anesthetics, Local|anesthetics, local|mesh-ancestor
153396775|NCT04339361|Anesthetics|anesthetics|mesh-ancestor
153396776|NCT04339361|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153396782|NCT04339361|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153396783|NCT04339361|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153396784|NCT04339361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153363452|NCT01561703|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
153363453|NCT01561703|Third Generation Cephalosporins|third generation cephalosporins|mesh-ancestor
153363454|NCT01561703|Beta Lactam Antibiotics|beta lactam antibiotics|mesh-ancestor
153396801|NCT03081143|Paclitaxel|paclitaxel|mesh-list
153396802|NCT03081143|Ramucirumab|ramucirumab|mesh-list
153396803|NCT03081143|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153396804|NCT03081143|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153396805|NCT03081143|Tubulin Modulators|tubulin modulators|mesh-ancestor
153396806|NCT03081143|Antimitotic Agents|antimitotic agents|mesh-ancestor
153396807|NCT03081143|Mitosis Modulators|mitosis modulators|mesh-ancestor
153396808|NCT03081143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153396809|NCT03081143|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153396810|NCT03081143|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153396811|NCT03081143|Growth Substances|growth substances|mesh-ancestor
153396812|NCT03081143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153856555|NCT01699464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153856556|NCT01699464|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
153856557|NCT01699464|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
153856558|NCT01699464|Adrenergic Agents|adrenergic agents|mesh-ancestor
153856559|NCT01699464|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153856560|NCT01699464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153856561|NCT01699464|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153856562|NCT01699464|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153856563|NCT04688645|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
153856564|NCT02104050|Dapansutrile|dapansutrile|mesh-list
153856565|NCT02104050|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153856566|NCT01694277|Sunitinib|sunitinib|mesh-list
153856567|NCT01694277|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153856568|NCT01694277|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153856569|NCT01694277|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153856570|NCT01694277|Growth Substances|growth substances|mesh-ancestor
153856603|NCT01666977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153823488|NCT00488436|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
153823489|NCT00459719|Tacrolimus|tacrolimus|mesh-list
153823490|NCT00459719|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153856604|NCT01666977|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153856605|NCT01666977|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153856606|NCT01666977|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153856607|NCT01666977|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153856608|NCT01666977|Growth Substances|growth substances|mesh-ancestor
153396847|NCT02659787|Analgesics|analgesics|mesh-ancestor
153396848|NCT02659787|Sensory System Agents|sensory system agents|mesh-ancestor
153396849|NCT02659787|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153396850|NCT02659787|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
153396851|NCT05044871|Paclitaxel|paclitaxel|mesh-list
153396852|NCT05044871|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
153396853|NCT05044871|Bevacizumab|bevacizumab|mesh-list
153396854|NCT05044871|Tislelizumab|tislelizumab|mesh-list
153396855|NCT05044871|Pamiparib|pamiparib|mesh-list
153396856|NCT05044871|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153856635|NCT01661166|Cholinergic Agents|cholinergic agents|mesh-ancestor
153856636|NCT01661166|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153856637|NCT01661166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153856638|NCT01661166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153856639|NCT01661166|Urological Agents|urological agents|mesh-ancestor
153856640|NCT02915042|Dexmedetomidine|dexmedetomidine|mesh-list
153396881|NCT02350517|Endostar protein|endostar protein|mesh-list
153396882|NCT02350517|Endostatins|endostatins|mesh-list
153396883|NCT02350517|Nedaplatin|nedaplatin|mesh-list
153396884|NCT02350517|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153396885|NCT02350517|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153363464|NCT02501928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153363465|NCT02501928|Urological Agents|urological agents|mesh-ancestor
153363466|NCT01462253|Cyclophosphamide|cyclophosphamide|mesh-list
153363467|NCT01462253|Clofarabine|clofarabine|mesh-list
153363468|NCT01462253|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153396895|NCT02270736|Botulinum Toxins|botulinum toxins|mesh-list
153396896|NCT02270736|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
153396897|NCT02270736|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
153396898|NCT02270736|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
153856652|NCT02915042|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153856653|NCT02915042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153856654|NCT01658826|Valacyclovir|valacyclovir|mesh-list
153856656|NCT01658826|Antiviral Agents|antiviral agents|mesh-ancestor
153856671|NCT01643226|Micronutrients|micronutrients|mesh-ancestor
153856672|NCT01643226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153856673|NCT01643226|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
153363479|NCT01837394|Acetaminophen|acetaminophen|mesh-list
153363480|NCT01837394|Morphine|morphine|mesh-list
153363481|NCT01837394|Ondansetron|ondansetron|mesh-list
153363482|NCT01837394|Metoclopramide|metoclopramide|mesh-list
153396986|NCT02692391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153396987|NCT02696291|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
153396989|NCT02682563|Gliclazide|gliclazide|mesh-list
153396990|NCT02682563|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
153396991|NCT02682563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153396993|NCT02682563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153396994|NCT02697071|Ketamine|ketamine|mesh-list
153396995|NCT02697071|Analgesics|analgesics|mesh-ancestor
153396996|NCT02697071|Sensory System Agents|sensory system agents|mesh-ancestor
153396997|NCT02697071|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153396998|NCT02697071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153396999|NCT02697071|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
153397000|NCT02697071|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153397001|NCT02697071|Anesthetics, General|anesthetics, general|mesh-ancestor
153397002|NCT02697071|Anesthetics|anesthetics|mesh-ancestor
153397003|NCT02697071|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153397004|NCT02697071|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
153397005|NCT02697071|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
153397006|NCT02697071|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153397007|NCT02697071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153856849|NCT02044341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153856851|NCT02044341|Anesthetics|anesthetics|mesh-ancestor
153856852|NCT02044341|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153856854|NCT02044341|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153856855|NCT00555399|Temozolomide|temozolomide|mesh-list
153397094|NCT02705807|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153397095|NCT02705807|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153397096|NCT02705807|Vasodilator Agents|vasodilator agents|mesh-ancestor
153397097|NCT01643772|Oxycodone|oxycodone|mesh-list
153397098|NCT01643772|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153397099|NCT01643772|Narcotics|narcotics|mesh-ancestor
153397105|NCT02707523|Azithromycin|azithromycin|mesh-list
153397106|NCT02707523|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153397107|NCT02707523|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153397108|NCT02712047|Fluticasone|fluticasone|mesh-list
153856856|NCT00555399|Vorinostat|vorinostat|mesh-list
153856857|NCT00555399|Isotretinoin|isotretinoin|mesh-list
153856858|NCT00555399|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153856859|NCT00555399|Alkylating Agents|alkylating agents|mesh-ancestor
153856860|NCT00555399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153856861|NCT00555399|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153856862|NCT00555399|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
153856863|NCT00555399|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153856864|NCT00555399|Dermatologic Agents|dermatologic agents|mesh-ancestor
153856865|NCT02912663|Magnesium Sulfate|magnesium sulfate|mesh-list
153856866|NCT02912663|Verapamil|verapamil|mesh-list
153856867|NCT02912663|Analgesics|analgesics|mesh-ancestor
153856868|NCT02912663|Sensory System Agents|sensory system agents|mesh-ancestor
153856869|NCT02912663|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153856870|NCT02912663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153856871|NCT02912663|Anesthetics|anesthetics|mesh-ancestor
153856872|NCT02912663|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153856873|NCT02912663|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153856874|NCT02912663|Anticonvulsants|anticonvulsants|mesh-ancestor
153856875|NCT02912663|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153856876|NCT02912663|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153856877|NCT02912663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153856878|NCT02912663|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153856879|NCT02912663|Tocolytic Agents|tocolytic agents|mesh-ancestor
153856880|NCT02912663|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153856881|NCT02912663|Vasodilator Agents|vasodilator agents|mesh-ancestor
153856886|NCT02894151|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
153856887|NCT02894151|Contraceptive Agents|contraceptive agents|mesh-ancestor
153856888|NCT02894151|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153856889|NCT02894151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153856890|NCT02894151|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
153856891|NCT02894151|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
153856892|NCT02894151|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
153856893|NCT02894151|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153397137|NCT05215925|Pemetrexed|pemetrexed|mesh-list
153397138|NCT05215925|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153397139|NCT05215925|Tubulin Modulators|tubulin modulators|mesh-ancestor
153397140|NCT05215925|Antimitotic Agents|antimitotic agents|mesh-ancestor
153397149|NCT05159687|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153397150|NCT05159687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153856898|NCT02912702|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
153856899|NCT02912702|Etoposide|etoposide|mesh-list
153856900|NCT02912702|Etoposide phosphate|etoposide phosphate|mesh-list
153856901|NCT02912702|Pegaspargase|pegaspargase|mesh-list
153856902|NCT02912702|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153856903|NCT02912702|Antiemetics|antiemetics|mesh-ancestor
153856904|NCT02912702|Autonomic Agents|autonomic agents|mesh-ancestor
153856905|NCT02912702|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153856906|NCT02912702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153856907|NCT02912702|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153914635|NCT04712071|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153856910|NCT02912702|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153856911|NCT02912702|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153856913|NCT02912702|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153856914|NCT02912702|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153856940|NCT02912156|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153856941|NCT02912156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153856942|NCT02912156|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
153856944|NCT03455049|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153856945|NCT03455049|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153856946|NCT03455049|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153856948|NCT03455049|Sensory System Agents|sensory system agents|mesh-ancestor
153856949|NCT03455049|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153856950|NCT03455049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153856951|NCT03455049|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153397196|NCT05109143|Gout Suppressants|gout suppressants|mesh-ancestor
153397197|NCT05109143|Tocolytic Agents|tocolytic agents|mesh-ancestor
153397198|NCT05109143|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153397199|NCT05109143|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153397200|NCT05109143|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153397201|NCT05109143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153397202|NCT03614663|Cannabidiol|cannabidiol|mesh-list
153397203|NCT03614663|Anticonvulsants|anticonvulsants|mesh-ancestor
153397204|NCT00085735|Cyclophosphamide|cyclophosphamide|mesh-list
153397205|NCT00085735|Lomustine|lomustine|mesh-list
153397251|NCT02726789|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153397276|NCT00368303|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
153397278|NCT00368303|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153397279|NCT00368303|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
153397280|NCT00368303|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153397281|NCT00368303|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153397282|NCT00368381|Hydrocortisone|hydrocortisone|mesh-list
153397283|NCT00368381|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153397284|NCT02734355|Amlodipine|amlodipine|mesh-list
153397285|NCT02734355|Telmisartan|telmisartan|mesh-list
153397286|NCT02734355|Telmisartan amlodipine combination|telmisartan amlodipine combination|mesh-list
153857028|NCT02911298|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153857029|NCT02911298|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153857030|NCT02911298|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153857032|NCT01983306|Guanylyl Cyclase C Agonists|guanylyl cyclase c agonists|mesh-ancestor
153857033|NCT01983306|Enzyme Activators|enzyme activators|mesh-ancestor
153857034|NCT01983306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153857035|NCT01983306|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153857036|NCT01982175|Alemtuzumab|alemtuzumab|mesh-list
153857037|NCT01982175|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153857044|NCT01973049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153857045|NCT01973049|Antiviral Agents|antiviral agents|mesh-ancestor
153857046|NCT01973049|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153857047|NCT01973049|Protease Inhibitors|protease inhibitors|mesh-ancestor
153857048|NCT01973049|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153857049|NCT01185964|Doxorubicin|doxorubicin|mesh-list
153857051|NCT01185964|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153857052|NCT01185964|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153857053|NCT01185964|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153397298|NCT00369395|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153397299|NCT00369395|Growth Substances|growth substances|mesh-ancestor
153397331|NCT02711735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153397332|NCT05445011|Cyclophosphamide|cyclophosphamide|mesh-list
153397333|NCT05445011|Fludarabine|fludarabine|mesh-list
153397334|NCT05445011|Fludarabine phosphate|fludarabine phosphate|mesh-list
153857080|NCT02910518|Calcium heparin|calcium heparin|mesh-list
153857082|NCT02910518|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153857083|NCT02910518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153857084|NCT02910518|Anticoagulants|anticoagulants|mesh-ancestor
153857085|NCT02910518|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153857086|NCT02910518|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153857087|NCT02910518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153857088|NCT02910518|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153857089|NCT02910518|Hormones|hormones|mesh-ancestor
153857090|NCT02910518|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153857091|NCT01217437|Bevacizumab|bevacizumab|mesh-list
153857092|NCT01217437|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
153397335|NCT05445011|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153397336|NCT05445011|Immunologic Factors|immunologic factors|mesh-ancestor
153397337|NCT05445011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153397338|NCT05445011|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153397339|NCT05445011|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153397340|NCT05445011|Alkylating Agents|alkylating agents|mesh-ancestor
153397341|NCT05445011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153857094|NCT01217437|Temozolomide|temozolomide|mesh-list
153857095|NCT01217437|Camptothecin|camptothecin|mesh-list
153857096|NCT01217437|Endothelial Growth Factors|endothelial growth factors|mesh-list
153857097|NCT01217437|Antibodies|antibodies|mesh-list
153857098|NCT01217437|Immunoglobulins|immunoglobulins|mesh-list
153857099|NCT01217437|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
153857100|NCT01217437|Immunoglobulin G|immunoglobulin g|mesh-list
153857101|NCT01217437|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153857102|NCT01217437|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153857103|NCT01217437|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153857104|NCT01217437|Growth Substances|growth substances|mesh-ancestor
153857105|NCT01217437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153397346|NCT04744181|Folic Acid|folic acid|mesh-list
153397347|NCT04744181|Vitamin B Complex|vitamin b complex|mesh-list
153397348|NCT04744181|Vitamins|vitamins|mesh-ancestor
153397349|NCT04744181|Micronutrients|micronutrients|mesh-ancestor
153397350|NCT04744181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153397351|NCT04744181|Hematinics|hematinics|mesh-ancestor
153397352|NCT00619931|APD791|apd791|mesh-list
153397353|NCT00619931|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
153441406|NCT00004885|Antimetabolites|antimetabolites|mesh-ancestor
153397354|NCT00619931|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153397355|NCT00619931|Serotonin Agents|serotonin agents|mesh-ancestor
153397387|NCT01889797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153397388|NCT01889797|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153397389|NCT00369551|Paclitaxel|paclitaxel|mesh-list
153397390|NCT00369551|Bevacizumab|bevacizumab|mesh-list
153397391|NCT00369551|Carboplatin|carboplatin|mesh-list
153397392|NCT00369551|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
153397393|NCT00369551|Antibodies|antibodies|mesh-list
153397394|NCT00369551|Immunoglobulins|immunoglobulins|mesh-list
153397395|NCT00369551|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
153397396|NCT00369551|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153397397|NCT00369551|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153397398|NCT00369551|Tubulin Modulators|tubulin modulators|mesh-ancestor
153397399|NCT00369551|Antimitotic Agents|antimitotic agents|mesh-ancestor
153397400|NCT00369551|Mitosis Modulators|mitosis modulators|mesh-ancestor
153397401|NCT00369551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153397402|NCT00369551|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153397403|NCT00369551|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153857200|NCT06226506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153857201|NCT06226506|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153857202|NCT06226506|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
153857203|NCT06226506|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153857204|NCT06226506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153857205|NCT06226363|Antibodies|antibodies|mesh-list
153397447|NCT00370799|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153397448|NCT00370799|Respiratory System Agents|respiratory system agents|mesh-ancestor
153397449|NCT02661971|Leucovorin|leucovorin|mesh-list
153397450|NCT02661971|Docetaxel|docetaxel|mesh-list
153397451|NCT02661971|Fluorouracil|fluorouracil|mesh-list
153397452|NCT02661971|Oxaliplatin|oxaliplatin|mesh-list
153397453|NCT02661971|Ramucirumab|ramucirumab|mesh-list
153857214|NCT06225895|Anesthetics, Local|anesthetics, local|mesh-ancestor
153857215|NCT06225895|Anesthetics|anesthetics|mesh-ancestor
153857216|NCT06225895|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153857217|NCT06225895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153857249|NCT06224855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153857251|NCT06224725|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153857252|NCT06224725|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153857253|NCT06224725|Analgesics|analgesics|mesh-ancestor
153397499|NCT00369863|Hormones|hormones|mesh-ancestor
153397500|NCT00369863|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153397501|NCT00369863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153397502|NCT00369863|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153397503|NCT00369863|Immunologic Factors|immunologic factors|mesh-ancestor
153823598|NCT00460382|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153363555|NCT01839890|Tubulin Modulators|tubulin modulators|mesh-ancestor
153363556|NCT01839890|Antimitotic Agents|antimitotic agents|mesh-ancestor
153363557|NCT01839890|Mitosis Modulators|mitosis modulators|mesh-ancestor
153363558|NCT01839890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153363559|NCT02205983|Acetaminophen|acetaminophen|mesh-list
153363560|NCT02205983|Hydromorphone|hydromorphone|mesh-list
153363561|NCT02205983|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153363562|NCT02205983|Analgesics|analgesics|mesh-ancestor
153363563|NCT02205983|Sensory System Agents|sensory system agents|mesh-ancestor
153363564|NCT02205983|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153363565|NCT02205983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153363566|NCT02205983|Antipyretics|antipyretics|mesh-ancestor
153397504|NCT00369863|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153397505|NCT00369863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153397506|NCT01890343|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
153397507|NCT01890343|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
153397508|NCT01890343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153397510|NCT02588027|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153397511|NCT02588027|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153397512|NCT02588027|Analgesics|analgesics|mesh-ancestor
153397548|NCT05431673|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
153397549|NCT05431673|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
153397550|NCT05431673|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
153397551|NCT05431673|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
153397552|NCT01951651|Exenatide|exenatide|mesh-list
153397553|NCT01951651|Glipizide|glipizide|mesh-list
153397554|NCT01951651|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
153397555|NCT01951651|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153397556|NCT01951651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153397557|NCT01951651|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
153397558|NCT01951651|Incretins|incretins|mesh-ancestor
153397559|NCT01951651|Hormones|hormones|mesh-ancestor
153857309|NCT06199466|Antimetabolites|antimetabolites|mesh-ancestor
153857310|NCT06199297|Bevacizumab|bevacizumab|mesh-list
153857311|NCT06199297|Atezolizumab|atezolizumab|mesh-list
153857312|NCT06199297|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153857313|NCT06199297|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153857314|NCT06199297|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153857315|NCT06199297|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153857316|NCT06199297|Growth Substances|growth substances|mesh-ancestor
153857317|NCT06199297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153857318|NCT06199297|Growth Inhibitors|growth inhibitors|mesh-ancestor
153857319|NCT06199297|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153857320|NCT06199297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153857359|NCT05919472|Immunologic Factors|immunologic factors|mesh-ancestor
153857360|NCT05919472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153857361|NCT05919472|Trace Elements|trace elements|mesh-ancestor
153363574|NCT03210038|Anesthetics|anesthetics|mesh-ancestor
153857363|NCT05918094|Fluorouracil|fluorouracil|mesh-list
153857364|NCT05918094|Antimetabolites|antimetabolites|mesh-ancestor
153857365|NCT05918094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153857366|NCT05918094|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153857367|NCT05918094|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153857368|NCT05918094|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153397613|NCT01951963|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
153397614|NCT01951963|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153397615|NCT01951963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153397616|NCT01951963|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153397617|NCT01951963|Narcotics|narcotics|mesh-ancestor
153397619|NCT02377271|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153397620|NCT02377271|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
153397621|NCT02377271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153397622|NCT01894555|Aspirin|aspirin|mesh-list
153397623|NCT01894555|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153397624|NCT01894555|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153397625|NCT01894555|Analgesics|analgesics|mesh-ancestor
153397626|NCT01894555|Sensory System Agents|sensory system agents|mesh-ancestor
153397627|NCT01894555|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153397628|NCT01894555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153397629|NCT01894555|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153397630|NCT01894555|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153857369|NCT05918094|Immunologic Factors|immunologic factors|mesh-ancestor
153857370|NCT05918094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153857371|NCT05900245|Propofol|propofol|mesh-list
153857372|NCT05900245|Anesthetics|anesthetics|mesh-list
153857373|NCT05900245|Succinylcholine|succinylcholine|mesh-list
153857374|NCT05900245|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153397647|NCT02028221|Metformin|metformin|mesh-list
153397698|NCT04359953|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153397699|NCT04359953|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153857423|NCT05746897|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153857424|NCT05746897|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153857425|NCT05746897|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153857426|NCT05746897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153857427|NCT05741060|Equol|equol|mesh-list
153857446|NCT05721144|Vasodilator Agents|vasodilator agents|mesh-ancestor
153857447|NCT05721144|Gasotransmitters|gasotransmitters|mesh-ancestor
153857448|NCT05721144|Protective Agents|protective agents|mesh-ancestor
153857449|NCT05708859|Tirzepatide|tirzepatide|mesh-list
153857450|NCT05708859|Incretins|incretins|mesh-ancestor
153857451|NCT05708859|Hormones|hormones|mesh-ancestor
153857452|NCT05708859|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153397700|NCT04359953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153397701|NCT04359953|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153397702|NCT04359953|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153397703|NCT04359953|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
153397704|NCT04359953|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
153397733|NCT00371111|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153397734|NCT00371111|Growth Substances|growth substances|mesh-ancestor
153397735|NCT00371111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153397736|NCT00371111|Growth Inhibitors|growth inhibitors|mesh-ancestor
153397737|NCT00371111|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153857483|NCT05446870|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153857484|NCT05446870|Growth Substances|growth substances|mesh-ancestor
153857485|NCT05446870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153857486|NCT05446870|Growth Inhibitors|growth inhibitors|mesh-ancestor
153857487|NCT05446870|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153857488|NCT05442515|Cyclophosphamide|cyclophosphamide|mesh-list
153857489|NCT05442515|Fludarabine|fludarabine|mesh-list
153857490|NCT05442515|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153857491|NCT05442515|Immunologic Factors|immunologic factors|mesh-ancestor
153857492|NCT05442515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153857493|NCT05442515|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153857494|NCT05442515|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153857495|NCT05442515|Alkylating Agents|alkylating agents|mesh-ancestor
153857496|NCT05442515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153857497|NCT05442515|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153857498|NCT05442515|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153397745|NCT05454683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153857517|NCT05232708|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
153857518|NCT05232708|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153857519|NCT05232708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153857521|NCT05230758|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153857522|NCT05230758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153857523|NCT05222828|Mepivacaine|mepivacaine|mesh-list
153857524|NCT05222828|Anesthetics, Local|anesthetics, local|mesh-ancestor
153857525|NCT05222828|Anesthetics|anesthetics|mesh-ancestor
153397773|NCT05451719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153397774|NCT05451719|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153397775|NCT01955629|Capecitabine|capecitabine|mesh-list
153397776|NCT01955629|Oxaliplatin|oxaliplatin|mesh-list
153397777|NCT01955629|Aflibercept|aflibercept|mesh-list
153363637|NCT03213158|Ixazomib|ixazomib|mesh-list
153363642|NCT02498418|Rifaximin|rifaximin|mesh-list
153397778|NCT01955629|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153397780|NCT01955629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153397781|NCT01955629|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153397782|NCT01955629|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153397783|NCT01955629|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153397784|NCT01955629|Growth Substances|growth substances|mesh-ancestor
153857526|NCT05222828|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153857527|NCT05222828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153400385|NCT02040116|Rituximab|rituximab|mesh-list
153857528|NCT05222828|Sensory System Agents|sensory system agents|mesh-ancestor
153857529|NCT05222828|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153857530|NCT05212246|Imiquimod|imiquimod|mesh-list
153857531|NCT05212246|Toll-Like Receptor Agonists|toll-like receptor agonists|mesh-ancestor
153857532|NCT05212246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153857533|NCT05212246|Immunomodulating Agents|immunomodulating agents|mesh-ancestor
153857534|NCT05212246|Immunologic Factors|immunologic factors|mesh-ancestor
153857535|NCT05212246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153857536|NCT05212246|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153857537|NCT05212246|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153857538|NCT05212246|Interferon Inducers|interferon inducers|mesh-ancestor
153857539|NCT05206500|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
153857540|NCT05206500|Amoxicillin|amoxicillin|mesh-list
153857541|NCT05206500|Metronidazole|metronidazole|mesh-list
153857542|NCT05206500|Clindamycin|clindamycin|mesh-list
153857543|NCT05206500|Linezolid|linezolid|mesh-list
153857544|NCT05206500|Tetracycline|tetracycline|mesh-list
153857545|NCT05206500|Penicillins|penicillins|mesh-list
153857546|NCT05206500|Ampicillin|ampicillin|mesh-list
153857547|NCT05206500|Fosfomycin|fosfomycin|mesh-list
153857548|NCT05206500|Nitrofurantoin|nitrofurantoin|mesh-list
153397814|NCT05448989|Autonomic Agents|autonomic agents|mesh-ancestor
153397815|NCT05448989|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153397816|NCT05448989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153857550|NCT05206500|Fluoroquinolones|fluoroquinolones|mesh-list
153857551|NCT05206500|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153363673|NCT01724606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153857553|NCT05206500|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153857554|NCT05206500|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
153857555|NCT05206500|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153857570|NCT05065411|Exemestane|exemestane|mesh-list
153857571|NCT05065411|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
153857572|NCT05065411|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153857573|NCT05065411|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153857574|NCT05065411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153857575|NCT05065411|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153857576|NCT05065411|Immunologic Factors|immunologic factors|mesh-ancestor
153857584|NCT05065411|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
153857585|NCT05065411|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153857586|NCT05017545|Abatacept|abatacept|mesh-list
153857587|NCT05017545|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153857588|NCT05017545|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153857589|NCT05017545|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153857590|NCT05017545|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153857591|NCT05017545|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153857592|NCT05017545|Immunologic Factors|immunologic factors|mesh-ancestor
153857593|NCT05017545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153857594|NCT05017545|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153857595|NCT04989816|Trastuzumab|trastuzumab|mesh-list
153857596|NCT04989816|Trastuzumab deruxtecan|trastuzumab deruxtecan|mesh-list
153857597|NCT04989816|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153397846|NCT00370019|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
153397847|NCT00370019|Contraceptive Agents|contraceptive agents|mesh-ancestor
153397848|NCT00370019|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153397849|NCT00370019|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
153397865|NCT04969211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153857598|NCT04989816|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153857599|NCT04989816|Immunoconjugates|immunoconjugates|mesh-ancestor
153857600|NCT04989816|Immunologic Factors|immunologic factors|mesh-ancestor
153363674|NCT03219164|Aztreonam|aztreonam|mesh-list
153363677|NCT01720238|Lamivudine|lamivudine|mesh-list
153857601|NCT04989816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153857603|NCT04989699|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153857604|NCT04989699|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153857605|NCT04989699|Growth Substances|growth substances|mesh-ancestor
153857606|NCT04989699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153857607|NCT04989699|Growth Inhibitors|growth inhibitors|mesh-ancestor
153857608|NCT04989699|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153857610|NCT04965493|Venetoclax|venetoclax|mesh-list
153857611|NCT04965493|Pirtobrutinib|pirtobrutinib|mesh-list
153857612|NCT04965493|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153857613|NCT04965493|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153857614|NCT04965493|Immunologic Factors|immunologic factors|mesh-ancestor
153857615|NCT04965493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153857616|NCT04965493|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153857617|NCT04965493|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153857618|NCT04965493|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153857619|NCT04965493|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153857641|NCT04892017|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153857642|NCT04892017|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153857643|NCT04892017|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153857644|NCT04892017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153397893|NCT03029533|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153397894|NCT03029533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153397898|NCT04921007|Anesthetics, Local|anesthetics, local|mesh-ancestor
153857722|NCT04700124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153857723|NCT04700124|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153857724|NCT04700124|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153857726|NCT04681677|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153857727|NCT04681677|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153857728|NCT04681677|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153857729|NCT04681677|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153857730|NCT04681677|Growth Substances|growth substances|mesh-ancestor
153857731|NCT04681677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153857732|NCT04681677|Growth Inhibitors|growth inhibitors|mesh-ancestor
153857733|NCT04674813|Cyclophosphamide|cyclophosphamide|mesh-list
153397987|NCT01910311|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
153397988|NCT01910311|Antitubercular Agents|antitubercular agents|mesh-ancestor
153397989|NCT01910311|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153397990|NCT01910311|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153397991|NCT01910311|Leprostatic Agents|leprostatic agents|mesh-ancestor
153397992|NCT01910311|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153397993|NCT01910311|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153397994|NCT01910311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153397995|NCT01910311|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
153397996|NCT01910311|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
153397997|NCT01910311|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
153857745|NCT04662515|Warfarin|warfarin|mesh-list
153857753|NCT04662515|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
153857754|NCT04662515|Protease Inhibitors|protease inhibitors|mesh-ancestor
153857755|NCT04662515|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153857756|NCT04662515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153857758|NCT04626518|Lenvatinib|lenvatinib|mesh-list
153857759|NCT04626518|Belzutifan|belzutifan|mesh-list
153857760|NCT04626518|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153857761|NCT04626518|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153857762|NCT04626518|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153857763|NCT04626518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153857764|NCT04626518|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153857765|NCT04626518|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153857766|NCT04510506|Pancrelipase|pancrelipase|mesh-list
153857767|NCT04510506|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153857768|NCT04463368|Nivolumab|nivolumab|mesh-list
153857769|NCT04463368|Ipilimumab|ipilimumab|mesh-list
153398020|NCT04403711|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153398021|NCT04403711|Adrenergic Agents|adrenergic agents|mesh-ancestor
153398022|NCT04403711|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153648765|NCT00000173|Vitamin E|vitamin e|mesh-list
153398023|NCT04403711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153398024|NCT01911169|Vitamin D|vitamin d|mesh-list
153398025|NCT01911169|Cholecalciferol|cholecalciferol|mesh-list
153398026|NCT01911169|Vitamins|vitamins|mesh-list
153398027|NCT01911169|Micronutrients|micronutrients|mesh-ancestor
153398028|NCT01911169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153398029|NCT01911169|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153398030|NCT01911169|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153398031|NCT04403087|Trimebutine|trimebutine|mesh-list
153398032|NCT04403087|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153398042|NCT04748887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153398043|NCT01916629|Sunscreening Agents|sunscreening agents|mesh-list
153398044|NCT01916629|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
153398045|NCT01916629|Protective Agents|protective agents|mesh-ancestor
153857783|NCT04421963|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153857784|NCT04330664|Adagrasib|adagrasib|mesh-list
153857785|NCT04330664|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153398047|NCT01916629|Dermatologic Agents|dermatologic agents|mesh-ancestor
153398049|NCT01916941|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153398050|NCT01916941|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
153398051|NCT01916941|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
153398052|NCT01916941|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
153398053|NCT01916941|Adrenergic Agents|adrenergic agents|mesh-ancestor
153398054|NCT01916941|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153398055|NCT01916941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153398056|NCT01916941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153398058|NCT04768985|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153398059|NCT04768985|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153398060|NCT04768985|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153398061|NCT04768985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153857794|NCT04303169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153857795|NCT04303169|Keratolytic Agents|keratolytic agents|mesh-ancestor
153857796|NCT04303169|Dermatologic Agents|dermatologic agents|mesh-ancestor
153857797|NCT04242329|Immunomodulating Agents|immunomodulating agents|mesh-list
153857798|NCT04242329|Immunologic Factors|immunologic factors|mesh-ancestor
153857799|NCT04242329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153857800|NCT04239625|Vitamin A|vitamin a|mesh-list
153857801|NCT04239625|Retinol acetate|retinol acetate|mesh-list
153857802|NCT04239625|Vitamins|vitamins|mesh-ancestor
153857803|NCT04239625|Micronutrients|micronutrients|mesh-ancestor
153857804|NCT04239625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153857805|NCT04239625|Protective Agents|protective agents|mesh-ancestor
153857806|NCT04239625|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
153857807|NCT04239625|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153857808|NCT04239625|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153857809|NCT04239625|Immunologic Factors|immunologic factors|mesh-ancestor
153857810|NCT04234360|Prednisone|prednisone|mesh-list
153857811|NCT04234360|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153398065|NCT04210037|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153398066|NCT04210037|Tubulin Modulators|tubulin modulators|mesh-ancestor
153398067|NCT04210037|Antimitotic Agents|antimitotic agents|mesh-ancestor
153398068|NCT04210037|Mitosis Modulators|mitosis modulators|mesh-ancestor
153398069|NCT04210037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153398070|NCT00371501|Aspirin|aspirin|mesh-list
153398071|NCT00371501|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
153398072|NCT00371501|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153398073|NCT00371501|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153398074|NCT00371501|Analgesics|analgesics|mesh-ancestor
153398075|NCT00371501|Sensory System Agents|sensory system agents|mesh-ancestor
153398082|NCT00371501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153398083|NCT00371501|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153398085|NCT00371501|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153398086|NCT00371501|Antipyretics|antipyretics|mesh-ancestor
153398087|NCT00371501|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153398088|NCT00371501|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153398089|NCT00371501|Antimetabolites|antimetabolites|mesh-ancestor
153398090|NCT00371501|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153857812|NCT04234360|Glucocorticoids|glucocorticoids|mesh-ancestor
153857813|NCT04234360|Hormones|hormones|mesh-ancestor
153857814|NCT04234360|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153857815|NCT04234360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153857816|NCT04234360|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153857817|NCT04234360|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153857818|NCT04211961|Scopolamine|scopolamine|mesh-list
153857819|NCT04211961|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
153857820|NCT04211961|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153857821|NCT04211961|Antiemetics|antiemetics|mesh-ancestor
153857822|NCT04211961|Autonomic Agents|autonomic agents|mesh-ancestor
153857823|NCT04211961|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153857830|NCT04211961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153857831|NCT04211961|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
153857832|NCT04211961|Parasympatholytics|parasympatholytics|mesh-ancestor
153857834|NCT04206787|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153857835|NCT04206787|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153857836|NCT04206787|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153857837|NCT04206787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153857838|NCT04206787|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153857839|NCT04137380|Mirikizumab|mirikizumab|mesh-list
153398091|NCT00371501|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
153398092|NCT03251651|Dexmedetomidine|dexmedetomidine|mesh-list
153398093|NCT03251651|Propofol|propofol|mesh-list
153398094|NCT03251651|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153398095|NCT03251651|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153398096|NCT03251651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153398097|NCT03251651|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153398098|NCT03251651|Analgesics|analgesics|mesh-ancestor
153398099|NCT03251651|Sensory System Agents|sensory system agents|mesh-ancestor
153398100|NCT03251651|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153857847|NCT04137380|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153857848|NCT04137380|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
153857849|NCT04137380|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153857850|NCT04075292|Rituximab|rituximab|mesh-list
153398101|NCT03251651|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
153398102|NCT03251651|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153398103|NCT03251651|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153398104|NCT03251651|Adrenergic Agents|adrenergic agents|mesh-ancestor
153398105|NCT03251651|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153398106|NCT03251651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153398107|NCT03251651|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153398108|NCT03251651|Anesthetics, General|anesthetics, general|mesh-ancestor
153398109|NCT03251651|Anesthetics|anesthetics|mesh-ancestor
153398110|NCT05738707|Vaccines|vaccines|mesh-list
153857851|NCT04075292|Acalabrutinib|acalabrutinib|mesh-list
153857852|NCT04075292|Chlorambucil|chlorambucil|mesh-list
153823833|NCT00461825|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
153857854|NCT04075292|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153857855|NCT04075292|Immunologic Factors|immunologic factors|mesh-ancestor
153857856|NCT04075292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153857857|NCT04075292|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153857858|NCT04075292|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153857859|NCT04075292|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153857860|NCT04075292|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153398111|NCT05738707|Immunologic Factors|immunologic factors|mesh-ancestor
153857862|NCT04075292|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153857863|NCT04075292|Alkylating Agents|alkylating agents|mesh-ancestor
153857865|NCT03944941|Avelumab|avelumab|mesh-list
153857866|NCT03944941|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153857867|NCT03944941|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153857868|NCT03919929|Semaglutide|semaglutide|mesh-list
153857869|NCT03919929|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-list
153857870|NCT03919929|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153857871|NCT03919929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153857872|NCT03843008|Melatonin|melatonin|mesh-list
153857873|NCT03843008|Antioxidants|antioxidants|mesh-ancestor
153857874|NCT03843008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153648873|NCT00000179|Serotonin Agents|serotonin agents|mesh-ancestor
153857875|NCT03843008|Protective Agents|protective agents|mesh-ancestor
153857876|NCT03843008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153398130|NCT05349071|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153398131|NCT05349071|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
153398132|NCT05349071|Protective Agents|protective agents|mesh-ancestor
153398133|NCT05349071|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153398134|NCT05349071|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153398160|NCT05738317|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153398162|NCT05738317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153857907|NCT03613532|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153857908|NCT03613532|Alkylating Agents|alkylating agents|mesh-ancestor
153857909|NCT03613532|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153857910|NCT03613532|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153857911|NCT03605927|Sirolimus|sirolimus|mesh-list
153857912|NCT03605927|Tacrolimus|tacrolimus|mesh-list
153857913|NCT03605927|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153857914|NCT03605927|Immunologic Factors|immunologic factors|mesh-ancestor
153857915|NCT03605927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153857916|NCT03605927|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
153857917|NCT03605927|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153857918|NCT03605927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153857919|NCT03605927|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153398185|NCT02287909|Purinergic Agents|purinergic agents|mesh-ancestor
153398186|NCT02287909|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153398204|NCT02833805|Immunologic Factors|immunologic factors|mesh-ancestor
153398205|NCT02833805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153398206|NCT02833805|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153398207|NCT02833805|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153857942|NCT03504241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153857956|NCT03326596|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153857957|NCT03326596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153398208|NCT02833805|Alkylating Agents|alkylating agents|mesh-ancestor
153398210|NCT02833805|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153398228|NCT04768465|Prednisone|prednisone|mesh-list
153398229|NCT04768465|Bromides|bromides|mesh-list
153398230|NCT04768465|Tacrolimus|tacrolimus|mesh-list
153398231|NCT04768465|Pyridostigmine Bromide|pyridostigmine bromide|mesh-list
153398232|NCT04768465|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153398233|NCT04768465|Glucocorticoids|glucocorticoids|mesh-ancestor
153857958|NCT03326596|Hemostatics|hemostatics|mesh-ancestor
153857959|NCT03326596|Coagulants|coagulants|mesh-ancestor
153857960|NCT03224767|Vemurafenib|vemurafenib|mesh-list
153857961|NCT03224767|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153857962|NCT03224767|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153857963|NCT03224767|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153857964|NCT03224767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153857965|NCT03173950|Nivolumab|nivolumab|mesh-list
153857966|NCT03173950|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153857967|NCT03173950|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153857968|NCT03173950|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153857969|NCT03173950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153857970|NCT03142893|Ketoconazole|ketoconazole|mesh-list
153857971|NCT03142893|Dexamethasone|dexamethasone|mesh-list
153857972|NCT03142893|Dexamethasone acetate|dexamethasone acetate|mesh-list
153857973|NCT03142893|Hydrocortisone|hydrocortisone|mesh-list
153857974|NCT03142893|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
153857975|NCT03142893|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
153857976|NCT03142893|Hormones|hormones|mesh-list
153857977|NCT03142893|Cosyntropin|cosyntropin|mesh-list
153857978|NCT03142893|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
153857979|NCT03142893|BB 1101|bb 1101|mesh-list
153398241|NCT04768465|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
153398243|NCT04768465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153398251|NCT01614665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153398252|NCT01614665|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
153398253|NCT01614665|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153398254|NCT01614665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153398255|NCT00371735|Artesunate|artesunate|mesh-list
153398256|NCT00371735|Dapsone|dapsone|mesh-list
153398257|NCT00371735|Chlorproguanil|chlorproguanil|mesh-list
153398258|NCT00371735|Proguanil|proguanil|mesh-list
153398259|NCT00371735|Antimalarials|antimalarials|mesh-ancestor
153398260|NCT00371735|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153398261|NCT00371735|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153398262|NCT00371735|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153858011|NCT02927301|Atezolizumab|atezolizumab|mesh-list
153398265|NCT00371735|Schistosomicides|schistosomicides|mesh-ancestor
153398266|NCT00371735|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
153398267|NCT00371735|Anthelmintics|anthelmintics|mesh-ancestor
153398268|NCT00371735|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153398269|NCT00371735|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153398270|NCT00371735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153398271|NCT00371735|Leprostatic Agents|leprostatic agents|mesh-ancestor
153398272|NCT00371735|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153398273|NCT00371735|Antimetabolites|antimetabolites|mesh-ancestor
153398274|NCT05417659|Niacin|niacin|mesh-list
153398275|NCT05417659|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153858024|NCT02892123|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153858025|NCT02892123|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153363838|NCT04379492|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153363839|NCT04379492|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153858026|NCT02892123|Tubulin Modulators|tubulin modulators|mesh-ancestor
153858027|NCT02892123|Antimitotic Agents|antimitotic agents|mesh-ancestor
153858028|NCT02892123|Mitosis Modulators|mitosis modulators|mesh-ancestor
153858029|NCT02892123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153858030|NCT02892123|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153858031|NCT02892123|Antimetabolites|antimetabolites|mesh-ancestor
153858032|NCT02892123|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153858033|NCT02892123|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153858034|NCT02659930|Doxorubicin|doxorubicin|mesh-list
153858040|NCT02659930|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153858041|NCT02659930|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153398297|NCT02767271|Luliconazole|luliconazole|mesh-list
153398298|NCT02767271|Antifungal Agents|antifungal agents|mesh-ancestor
153398299|NCT02767271|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153398300|NCT05647993|Azithromycin|azithromycin|mesh-list
153398301|NCT05647993|Cefazolin|cefazolin|mesh-list
153398302|NCT05647993|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153398312|NCT02741687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153398314|NCT02741687|Hormones|hormones|mesh-ancestor
153398315|NCT02741687|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153398316|NCT02741687|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
153398317|NCT02741687|Protease Inhibitors|protease inhibitors|mesh-ancestor
153398318|NCT02741687|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153398319|NCT02741687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153398320|NCT05361499|Amoxicillin|amoxicillin|mesh-list
153398321|NCT05361499|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153398322|NCT05361499|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153398324|NCT04337099|TEMPO|tempo|mesh-list
153858042|NCT02659930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153858043|NCT02659930|Immunologic Factors|immunologic factors|mesh-ancestor
153858044|NCT02659930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153858045|NCT02659930|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153858051|NCT02611037|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153858052|NCT02611037|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153858054|NCT02611037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153858055|NCT02611037|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
153858056|NCT02611037|Abortifacient Agents|abortifacient agents|mesh-ancestor
153398326|NCT04337099|Antioxidants|antioxidants|mesh-ancestor
153398327|NCT04337099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153398328|NCT04337099|Protective Agents|protective agents|mesh-ancestor
153398329|NCT04337099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153398330|NCT04337099|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
153398331|NCT04337099|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153398332|NCT04337099|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
153398333|NCT04337099|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
153398334|NCT05627791|Oxytocin|oxytocin|mesh-list
153398335|NCT05627791|Oxytocics|oxytocics|mesh-ancestor
153398336|NCT05627791|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153398337|NCT05627791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153398338|NCT04337879|Oxaliplatin|oxaliplatin|mesh-list
153398339|NCT04337879|Irinotecan|irinotecan|mesh-list
153858081|NCT02402660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153398340|NCT04337879|Calcium|calcium|mesh-list
153398341|NCT04337879|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153398342|NCT04337879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153398343|NCT04337879|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153398344|NCT04337879|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
153398345|NCT04337879|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153398346|NCT04337879|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153398347|NCT04337879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153398348|NCT02745353|Naloxegol|naloxegol|mesh-list
153398353|NCT04778839|Paclitaxel|paclitaxel|mesh-list
153398416|NCT02295553|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
153398417|NCT02295553|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
153398418|NCT02295553|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153398419|NCT02295553|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153398420|NCT02296099|Bupivacaine|bupivacaine|mesh-list
153398421|NCT02296099|Anesthetics, Local|anesthetics, local|mesh-ancestor
153398422|NCT02296099|Anesthetics|anesthetics|mesh-ancestor
153398423|NCT02296099|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153398424|NCT02296099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153858136|NCT01566695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153858137|NCT01566695|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153858138|NCT01566695|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153858139|NCT01081951|Paclitaxel|paclitaxel|mesh-list
153858140|NCT01081951|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
153858141|NCT01081951|Carboplatin|carboplatin|mesh-list
153858142|NCT01081951|Olaparib|olaparib|mesh-list
153858143|NCT01081951|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153858144|NCT01081951|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153858145|NCT01081951|Tubulin Modulators|tubulin modulators|mesh-ancestor
153858146|NCT01081951|Antimitotic Agents|antimitotic agents|mesh-ancestor
153858157|NCT00736385|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153858158|NCT00736385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153858160|NCT00392327|Cyclophosphamide|cyclophosphamide|mesh-list
153858161|NCT00392327|Cisplatin|cisplatin|mesh-list
153858162|NCT00392327|Carboplatin|carboplatin|mesh-list
153858163|NCT00392327|Vincristine|vincristine|mesh-list
153858164|NCT00392327|Tretinoin|tretinoin|mesh-list
153858165|NCT00392327|Isotretinoin|isotretinoin|mesh-list
153858166|NCT00392327|Lenograstim|lenograstim|mesh-list
153858167|NCT00392327|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153858168|NCT00392327|Immunologic Factors|immunologic factors|mesh-ancestor
153398425|NCT02296099|Sensory System Agents|sensory system agents|mesh-ancestor
153398426|NCT02296099|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153398427|NCT05455073|Folic Acid|folic acid|mesh-list
153398428|NCT05455073|Hematinics|hematinics|mesh-ancestor
153398429|NCT05455073|Vitamin B Complex|vitamin b complex|mesh-ancestor
153398430|NCT05455073|Vitamins|vitamins|mesh-ancestor
153398431|NCT05455073|Micronutrients|micronutrients|mesh-ancestor
153398432|NCT05455073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153398433|NCT04334993|Blinatumomab|blinatumomab|mesh-list
153398434|NCT04334993|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153398435|NCT05349929|Ibuprofen|ibuprofen|mesh-list
153398436|NCT05349929|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153398437|NCT05349929|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153398438|NCT05349929|Analgesics|analgesics|mesh-ancestor
153398439|NCT05349929|Sensory System Agents|sensory system agents|mesh-ancestor
153398440|NCT05349929|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153398441|NCT05349929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153398442|NCT05349929|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153398443|NCT05349929|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153398444|NCT05349929|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153398445|NCT05349929|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153398446|NCT05349929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153398447|NCT04757675|Dexmedetomidine|dexmedetomidine|mesh-list
153398448|NCT04757675|Ketamine|ketamine|mesh-list
153398449|NCT04757675|Esketamine|esketamine|mesh-list
153733351|NCT02954692|Metformin|metformin|mesh-list
153398450|NCT04757675|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153398451|NCT04757675|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153398452|NCT04757675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153398453|NCT04757675|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153398455|NCT04757675|Sensory System Agents|sensory system agents|mesh-ancestor
153398459|NCT04757675|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153858169|NCT00392327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153858170|NCT00392327|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153858171|NCT00392327|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153858172|NCT00392327|Alkylating Agents|alkylating agents|mesh-ancestor
153858173|NCT00392327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153858174|NCT00392327|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153858175|NCT00392327|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153858176|NCT00392327|Vitamins|vitamins|mesh-ancestor
153858177|NCT00392327|Micronutrients|micronutrients|mesh-ancestor
153858178|NCT00392327|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153858179|NCT00392327|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153858191|NCT00357565|Cyclosporins|cyclosporins|mesh-list
153858192|NCT00357565|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153858193|NCT00357565|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153858194|NCT00357565|Antimetabolites|antimetabolites|mesh-ancestor
153858195|NCT00357565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153858196|NCT00357565|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153858197|NCT00357565|Immunologic Factors|immunologic factors|mesh-ancestor
153858198|NCT00357565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153858199|NCT00357565|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153858200|NCT00357565|Antifungal Agents|antifungal agents|mesh-ancestor
153858201|NCT00357565|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153858202|NCT00357565|Dermatologic Agents|dermatologic agents|mesh-ancestor
153858203|NCT00357565|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153858204|NCT00357565|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
153858205|NCT00357565|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153858206|NCT00357565|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
153858207|NCT00357565|Antitubercular Agents|antitubercular agents|mesh-ancestor
153858208|NCT00357565|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153858209|NCT00357565|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153398476|NCT05288075|Cholinergic Agents|cholinergic agents|mesh-ancestor
153398477|NCT05288075|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153398478|NCT05288075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153398479|NCT05288075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153398480|NCT05288075|Antidotes|antidotes|mesh-ancestor
153398481|NCT05288075|Protective Agents|protective agents|mesh-ancestor
153398482|NCT05272787|Sunscreening Agents|sunscreening agents|mesh-list
153398483|NCT05272787|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
153398484|NCT05272787|Protective Agents|protective agents|mesh-ancestor
153398485|NCT05272787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153398486|NCT05272787|Dermatologic Agents|dermatologic agents|mesh-ancestor
153398487|NCT05145569|Paclitaxel|paclitaxel|mesh-list
153398488|NCT05145569|Carboplatin|carboplatin|mesh-list
153398489|NCT05145569|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153398490|NCT05145569|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153823895|NCT00496665|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153823896|NCT00496665|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153823897|NCT00496665|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153823898|NCT00496704|Gemcitabine|gemcitabine|mesh-list
153823899|NCT00496704|Capecitabine|capecitabine|mesh-list
153823900|NCT00496704|Oxaliplatin|oxaliplatin|mesh-list
153823901|NCT00496704|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153398497|NCT03763175|Dihydromevinolin|dihydromevinolin|mesh-list
153398498|NCT03763175|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153398499|NCT03763175|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153858231|NCT04676997|Paclitaxel|paclitaxel|mesh-list
153858232|NCT04676997|Cyclophosphamide|cyclophosphamide|mesh-list
153858233|NCT04676997|Epirubicin|epirubicin|mesh-list
153858234|NCT04676997|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153858235|NCT04676997|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153858236|NCT04676997|Tubulin Modulators|tubulin modulators|mesh-ancestor
153858237|NCT04676997|Antimitotic Agents|antimitotic agents|mesh-ancestor
153858238|NCT04676997|Mitosis Modulators|mitosis modulators|mesh-ancestor
153858239|NCT04676997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153858240|NCT04676997|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153858241|NCT04676997|Immunologic Factors|immunologic factors|mesh-ancestor
153858242|NCT04676997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153398500|NCT03763175|Antimetabolites|antimetabolites|mesh-ancestor
153398501|NCT03763175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153398502|NCT03763175|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153398503|NCT03763175|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
153398504|NCT03763175|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153398505|NCT04365049|Paclitaxel|paclitaxel|mesh-list
153398506|NCT04365049|Gemcitabine|gemcitabine|mesh-list
153398507|NCT04365049|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153398508|NCT04365049|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153398509|NCT04365049|Tubulin Modulators|tubulin modulators|mesh-ancestor
153398510|NCT04365049|Antimitotic Agents|antimitotic agents|mesh-ancestor
153398511|NCT04365049|Mitosis Modulators|mitosis modulators|mesh-ancestor
153398512|NCT04365049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153858295|NCT00555594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153858297|NCT02910050|Letrozole|letrozole|mesh-list
153858298|NCT02910050|Anastrozole|anastrozole|mesh-list
153858299|NCT02910050|Exemestane|exemestane|mesh-list
153858300|NCT02910050|Bicalutamide|bicalutamide|mesh-list
153823913|NCT00591916|Protective Agents|protective agents|mesh-ancestor
153823915|NCT00462215|Immunologic Factors|immunologic factors|mesh-ancestor
153823916|NCT00462215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153823917|NCT00462371|Insulin|insulin|mesh-list
153823918|NCT00462371|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153823919|NCT00462371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153823920|NCT00497016|Atorvastatin|atorvastatin|mesh-list
153823921|NCT00497016|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153858301|NCT02910050|Aromatase Inhibitors|aromatase inhibitors|mesh-list
153398559|NCT02990845|Fertility Agents, Female|fertility agents, female|mesh-ancestor
153398560|NCT02990845|Fertility Agents|fertility agents|mesh-ancestor
153398561|NCT02990845|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153398562|NCT02990845|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153398563|NCT01987219|Bromides|bromides|mesh-list
153398564|NCT01987219|Albuterol|albuterol|mesh-list
153398565|NCT01987219|Ipratropium|ipratropium|mesh-list
153398566|NCT01987219|Anticonvulsants|anticonvulsants|mesh-ancestor
153398567|NCT01987219|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153398568|NCT01987219|Autonomic Agents|autonomic agents|mesh-ancestor
153398569|NCT01987219|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153398570|NCT01987219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153398571|NCT01987219|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153398572|NCT01987219|Respiratory System Agents|respiratory system agents|mesh-ancestor
153398573|NCT01987219|Tocolytic Agents|tocolytic agents|mesh-ancestor
153398574|NCT01987219|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153398575|NCT01987219|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
153398576|NCT01987219|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
153398577|NCT01987219|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153398578|NCT01987219|Adrenergic Agents|adrenergic agents|mesh-ancestor
153858302|NCT02910050|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153858303|NCT02910050|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153858304|NCT02910050|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153858305|NCT02910050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153858306|NCT02910050|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
153858307|NCT02910050|Hormone Antagonists|hormone antagonists|mesh-ancestor
153858308|NCT02910050|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153858310|NCT02910050|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153858311|NCT02910050|Androgen Antagonists|androgen antagonists|mesh-ancestor
153858312|NCT02909933|Metformin|metformin|mesh-list
153858313|NCT02909933|Liraglutide|liraglutide|mesh-list
153858323|NCT02910245|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153398583|NCT04265053|Ketorolac|ketorolac|mesh-list
153398584|NCT04265053|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
153398585|NCT04265053|Estradiol|estradiol|mesh-list
153398586|NCT04265053|Testosterone|testosterone|mesh-list
153398587|NCT04265053|Ganirelix|ganirelix|mesh-list
153398588|NCT04265053|Estrogens|estrogens|mesh-ancestor
153398589|NCT04265053|Hormones|hormones|mesh-ancestor
153398590|NCT04265053|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153398591|NCT04265053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153398592|NCT04265053|Androgens|androgens|mesh-ancestor
153398593|NCT04265053|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153398594|NCT04265053|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153398595|NCT04265053|Analgesics|analgesics|mesh-ancestor
153398596|NCT04265053|Sensory System Agents|sensory system agents|mesh-ancestor
153398597|NCT04265053|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153398598|NCT04265053|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153398599|NCT04265053|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153398600|NCT04265053|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153398601|NCT04265053|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153398602|NCT04265053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153398603|NCT04265053|Hormone Antagonists|hormone antagonists|mesh-ancestor
153858324|NCT02910245|Glucocorticoids|glucocorticoids|mesh-ancestor
153858325|NCT02910245|Hormones|hormones|mesh-ancestor
153858326|NCT02910245|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153858327|NCT02910245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153648885|NCT00023725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153648886|NCT00391404|Alendronate|alendronate|mesh-list
153858328|NCT02910245|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153858329|NCT02910245|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153858330|NCT02910245|Antimetabolites|antimetabolites|mesh-ancestor
153858331|NCT02910245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153858332|NCT02910245|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153858333|NCT02910245|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153858334|NCT02910245|Immunologic Factors|immunologic factors|mesh-ancestor
153858335|NCT02910245|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153858336|NCT02910245|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153858337|NCT02910245|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153858338|NCT02910245|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153858339|NCT02910245|Analgesics|analgesics|mesh-ancestor
153858340|NCT02910245|Sensory System Agents|sensory system agents|mesh-ancestor
153858341|NCT02910245|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153858342|NCT02910245|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153398606|NCT04332497|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153398607|NCT04332497|Narcotics|narcotics|mesh-ancestor
153398608|NCT04332497|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153398609|NCT04332497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153398610|NCT04332497|Analgesics|analgesics|mesh-ancestor
153398611|NCT04332497|Sensory System Agents|sensory system agents|mesh-ancestor
153398612|NCT04332497|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153398613|NCT04332497|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153398620|NCT04332497|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153398621|NCT04332497|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153398622|NCT04332497|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153398623|NCT04332497|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153398625|NCT04258397|Analgesics|analgesics|mesh-ancestor
153858343|NCT01185340|Serotonin|serotonin|mesh-list
153858344|NCT01185340|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-list
153858345|NCT01185340|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
153858346|NCT01185340|Serotonin Agents|serotonin agents|mesh-ancestor
153858347|NCT01185340|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153823933|NCT00222872|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153858348|NCT01185340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153858349|NCT01185340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153858350|NCT01185340|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153858351|NCT01185340|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153858352|NCT01959282|Niacinamide|niacinamide|mesh-list
153858353|NCT01959282|Peficitinib|peficitinib|mesh-list
153858354|NCT01959282|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153858355|NCT01959282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153858356|NCT01959282|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153858357|NCT01959282|Immunologic Factors|immunologic factors|mesh-ancestor
153858358|NCT01959282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153858359|NCT01959282|Vitamin B Complex|vitamin b complex|mesh-ancestor
153858360|NCT01959282|Vitamins|vitamins|mesh-ancestor
153858361|NCT01959282|Micronutrients|micronutrients|mesh-ancestor
153858362|NCT01185301|Adalimumab|adalimumab|mesh-list
153858363|NCT01185301|Methotrexate|methotrexate|mesh-list
153398626|NCT04258397|Sensory System Agents|sensory system agents|mesh-ancestor
153398627|NCT04258397|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153398628|NCT04258397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153398629|NCT04258397|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153398630|NCT04258397|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153398631|NCT04258397|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153398632|NCT04258397|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153398633|NCT04258397|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153858373|NCT01185301|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153823968|NCT00462995|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153823969|NCT00462995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153823970|NCT00462995|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153398659|NCT00373373|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153398660|NCT00373373|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153398661|NCT00373373|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153398662|NCT00373373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153398664|NCT00373451|Calcium heparin|calcium heparin|mesh-list
153398665|NCT00373451|Bivalirudin|bivalirudin|mesh-list
153398666|NCT00373451|Abciximab|abciximab|mesh-list
153398667|NCT00373451|Anticoagulants|anticoagulants|mesh-ancestor
153398668|NCT00373451|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153398669|NCT00373451|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153398670|NCT00373451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153398671|NCT00373451|Antithrombins|antithrombins|mesh-ancestor
153398672|NCT00373451|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
153398673|NCT00373451|Protease Inhibitors|protease inhibitors|mesh-ancestor
153858379|NCT01185301|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
153858380|NCT01185301|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153858381|NCT04675008|Dacomitinib|dacomitinib|mesh-list
153858382|NCT04675008|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153858383|NCT04675008|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153398710|NCT01993849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153398711|NCT01993849|Antidotes|antidotes|mesh-ancestor
153398712|NCT02778113|Glucagon|glucagon|mesh-list
153398713|NCT02778113|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
153398714|NCT02778113|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153398715|NCT02778113|Hormones|hormones|mesh-ancestor
153398716|NCT02778113|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153398717|NCT02778113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153398718|NCT02778113|Incretins|incretins|mesh-ancestor
153398719|NCT04982237|Paclitaxel|paclitaxel|mesh-list
153398720|NCT04982237|Bevacizumab|bevacizumab|mesh-list
153398721|NCT04982237|Carboplatin|carboplatin|mesh-list
153398722|NCT04982237|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153398723|NCT04982237|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153398724|NCT04982237|Tubulin Modulators|tubulin modulators|mesh-ancestor
153398725|NCT04982237|Antimitotic Agents|antimitotic agents|mesh-ancestor
153398726|NCT04982237|Mitosis Modulators|mitosis modulators|mesh-ancestor
153398727|NCT04982237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153398728|NCT04982237|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153858457|NCT00555867|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153858458|NCT00555867|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153398732|NCT04982237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153398733|NCT04982237|Growth Inhibitors|growth inhibitors|mesh-ancestor
153398736|NCT02316379|Xenon|xenon|mesh-list
153858476|NCT00555984|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153858477|NCT00555984|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
153858478|NCT00555984|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153858479|NCT00555984|Narcotics|narcotics|mesh-ancestor
153858480|NCT00555984|Analgesics|analgesics|mesh-ancestor
153858481|NCT00555984|Sensory System Agents|sensory system agents|mesh-ancestor
153858482|NCT00555984|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153858483|NCT03457337|Gefitinib|gefitinib|mesh-list
153858484|NCT03457337|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153858485|NCT03457337|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153858486|NCT03457337|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153858487|NCT03457337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153858488|NCT03457337|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153858489|NCT01908738|Lidocaine|lidocaine|mesh-list
153858490|NCT01908738|Anesthetics, Local|anesthetics, local|mesh-ancestor
153858491|NCT01908738|Anesthetics|anesthetics|mesh-ancestor
153858492|NCT01908738|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153858493|NCT01908738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153398760|NCT01997515|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153398761|NCT01997515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153398762|NCT01997905|Protein S|protein s|mesh-list
153398763|NCT01997905|Anticoagulants|anticoagulants|mesh-ancestor
153398764|NCT02788019|Ropivacaine|ropivacaine|mesh-list
153398765|NCT02788019|Anesthetics, Local|anesthetics, local|mesh-ancestor
153398766|NCT02788019|Anesthetics|anesthetics|mesh-ancestor
153398767|NCT02788019|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153398777|NCT02789033|Isosorbide Dinitrate|isosorbide dinitrate|mesh-list
153398778|NCT02789033|Isosorbide-5-mononitrate|isosorbide-5-mononitrate|mesh-list
153398779|NCT02789033|Chitosan|chitosan|mesh-list
153398780|NCT02789033|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
153858509|NCT01902381|Antioxidants|antioxidants|mesh-ancestor
153858510|NCT01902381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153858511|NCT01902381|Protective Agents|protective agents|mesh-ancestor
153858512|NCT01902381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153858513|NCT01902381|Vitamin B Complex|vitamin b complex|mesh-ancestor
153398782|NCT02789033|Natriuretic Agents|natriuretic agents|mesh-ancestor
153398783|NCT02789033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153398784|NCT02789033|Vasodilator Agents|vasodilator agents|mesh-ancestor
153398785|NCT02789033|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
153398786|NCT02789033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153398787|NCT02789033|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153398788|NCT02789033|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153398789|NCT02789033|Antimetabolites|antimetabolites|mesh-ancestor
153398790|NCT02789033|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153398791|NCT02789033|Chelating Agents|chelating agents|mesh-ancestor
153398792|NCT02789033|Sequestering Agents|sequestering agents|mesh-ancestor
153398793|NCT02789033|Hemostatics|hemostatics|mesh-ancestor
153398794|NCT02789033|Coagulants|coagulants|mesh-ancestor
153398796|NCT00372827|Brinzolamide|brinzolamide|mesh-list
153398797|NCT00372827|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153398798|NCT00372827|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
153398799|NCT00372827|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153364051|NCT01723202|Trametinib|trametinib|mesh-list
153364052|NCT01723202|Dabrafenib|dabrafenib|mesh-list
153364053|NCT01723202|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153364054|NCT01723202|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153398817|NCT02882633|Anesthetics, Local|anesthetics, local|mesh-ancestor
153398818|NCT02882633|Anesthetics|anesthetics|mesh-ancestor
153398819|NCT02882633|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153398820|NCT02882633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153398821|NCT02882633|Sensory System Agents|sensory system agents|mesh-ancestor
153398822|NCT02882633|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153398823|NCT00373607|Artesunate|artesunate|mesh-list
153398824|NCT00373607|Piperaquine|piperaquine|mesh-list
153398825|NCT00373607|Mefloquine|mefloquine|mesh-list
153398826|NCT00373607|Antimalarials|antimalarials|mesh-ancestor
153398827|NCT00373607|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153858541|NCT02277197|Cetuximab|cetuximab|mesh-list
153364063|NCT03830216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153364064|NCT01726946|Ribavirin|ribavirin|mesh-list
153364065|NCT01726946|Antimetabolites|antimetabolites|mesh-ancestor
153364066|NCT01726946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153364067|NCT01726946|Antiviral Agents|antiviral agents|mesh-ancestor
153858567|NCT04673214|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153858568|NCT00556023|Gemcitabine|gemcitabine|mesh-list
153858569|NCT00556023|Tremelimumab|tremelimumab|mesh-list
153858570|NCT00556023|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153858571|NCT00556023|Antimetabolites|antimetabolites|mesh-ancestor
153858572|NCT00556023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153858573|NCT00556023|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153858574|NCT05011214|Ketamine|ketamine|mesh-list
153858575|NCT05011214|Sevoflurane|sevoflurane|mesh-list
153858576|NCT05011214|Esketamine|esketamine|mesh-list
153858577|NCT05011214|Analgesics|analgesics|mesh-ancestor
153858578|NCT05011214|Sensory System Agents|sensory system agents|mesh-ancestor
153858583|NCT05011214|Anesthetics, General|anesthetics, general|mesh-ancestor
153398889|NCT02895035|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153398890|NCT02895035|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153858605|NCT04672707|Bromhexine|bromhexine|mesh-list
153858606|NCT04672707|Expectorants|expectorants|mesh-ancestor
153858618|NCT04932083|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153858619|NCT04932083|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153858621|NCT04932083|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153858622|NCT04932083|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153398891|NCT02895035|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
153398892|NCT02895035|Nasal Decongestants|nasal decongestants|mesh-ancestor
153398893|NCT02895035|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
153398894|NCT02895035|Protective Agents|protective agents|mesh-ancestor
153398896|NCT02802449|Ergocalciferols|ergocalciferols|mesh-list
153398897|NCT02802449|Cholecalciferol|cholecalciferol|mesh-list
153398898|NCT02802449|Calcifediol|calcifediol|mesh-list
153398899|NCT02802449|Hydroxycholecalciferols|hydroxycholecalciferols|mesh-list
153398900|NCT02802449|Vitamins|vitamins|mesh-list
153398913|NCT02803229|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153398914|NCT02803229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153398915|NCT02803229|Adrenergic Agents|adrenergic agents|mesh-ancestor
153858623|NCT04932083|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153858624|NCT04932083|Anesthetics, General|anesthetics, general|mesh-ancestor
153858625|NCT04932083|GABA Modulators|gaba modulators|mesh-ancestor
153858626|NCT04932083|GABA Agents|gaba agents|mesh-ancestor
153858627|NCT04932083|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153858628|NCT04932083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153858629|NCT04932083|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153858630|NCT04932083|Narcotics|narcotics|mesh-ancestor
153858631|NCT04932083|Analgesics|analgesics|mesh-ancestor
153858632|NCT01825980|Ritonavir|ritonavir|mesh-list
153858633|NCT01825980|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
153824122|NCT00463736|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153824123|NCT00463736|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153398925|NCT01938001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153398926|NCT01938001|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153398927|NCT01938001|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153398928|NCT01938001|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153398929|NCT01938001|Growth Substances|growth substances|mesh-ancestor
153398930|NCT01938001|Growth Inhibitors|growth inhibitors|mesh-ancestor
153398931|NCT02805179|Temozolomide|temozolomide|mesh-list
153398932|NCT02805179|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153398933|NCT02805179|Alkylating Agents|alkylating agents|mesh-ancestor
153398934|NCT02805179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153398935|NCT02805179|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153398936|NCT02896595|Anesthetics|anesthetics|mesh-list
153398937|NCT02896595|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153398938|NCT02896595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153398939|NCT02003911|Azithromycin|azithromycin|mesh-list
153398940|NCT02003911|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153398941|NCT02003911|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153398942|NCT04147351|Bevacizumab|bevacizumab|mesh-list
153398943|NCT04147351|Atezolizumab|atezolizumab|mesh-list
153398944|NCT04147351|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153858647|NCT01655225|Pemetrexed|pemetrexed|mesh-list
153858648|NCT01655225|Letrozole|letrozole|mesh-list
153858649|NCT01655225|Fulvestrant|fulvestrant|mesh-list
153858650|NCT01655225|Midazolam|midazolam|mesh-list
153858651|NCT01655225|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153858652|NCT01655225|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153858673|NCT01655225|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153858674|NCT01655225|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153858675|NCT01655225|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
153398945|NCT04147351|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153398951|NCT04147351|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153398952|NCT04147351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153398953|NCT02004613|Dexmedetomidine|dexmedetomidine|mesh-list
153398954|NCT02004613|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153398955|NCT02004613|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153398956|NCT02004613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153858708|NCT04607252|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
153858709|NCT04607252|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
153858710|NCT04607252|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153858711|NCT04607252|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153858712|NCT04607252|Appetite Stimulants|appetite stimulants|mesh-ancestor
153858713|NCT04607252|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
153858715|NCT01782729|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153398984|NCT02896907|Calcium, Dietary|calcium, dietary|mesh-list
153398985|NCT02896907|Vitamins|vitamins|mesh-list
153398986|NCT02896907|Leucovorin|leucovorin|mesh-list
153398987|NCT02896907|Ascorbic Acid|ascorbic acid|mesh-list
153398988|NCT02896907|Tetrahydrofolates|tetrahydrofolates|mesh-list
153398989|NCT02896907|Formyltetrahydrofolates|formyltetrahydrofolates|mesh-list
153398990|NCT02896907|Fluorouracil|fluorouracil|mesh-list
153398991|NCT02896907|Oxaliplatin|oxaliplatin|mesh-list
153398992|NCT02896907|Irinotecan|irinotecan|mesh-list
153398993|NCT02896907|Camptothecin|camptothecin|mesh-list
153398994|NCT02896907|Calcium|calcium|mesh-list
153398995|NCT02896907|Levoleucovorin|levoleucovorin|mesh-list
153399008|NCT02896907|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153399010|NCT02896907|Protective Agents|protective agents|mesh-ancestor
153399011|NCT02896907|Vitamin B Complex|vitamin b complex|mesh-ancestor
153399012|NCT02896907|Antioxidants|antioxidants|mesh-ancestor
153399013|NCT02896907|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153399014|NCT02005549|Bevacizumab|bevacizumab|mesh-list
153399015|NCT02005549|Docetaxel|docetaxel|mesh-list
153399016|NCT02005549|Capecitabine|capecitabine|mesh-list
153399017|NCT02005549|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153399018|NCT02005549|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153399019|NCT02005549|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153399020|NCT02005549|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153399021|NCT02005549|Growth Substances|growth substances|mesh-ancestor
153399022|NCT02005549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153399023|NCT02005549|Growth Inhibitors|growth inhibitors|mesh-ancestor
153399024|NCT02005549|Tubulin Modulators|tubulin modulators|mesh-ancestor
153399025|NCT02005549|Antimitotic Agents|antimitotic agents|mesh-ancestor
153399044|NCT04492358|Prednisone|prednisone|mesh-list
153399045|NCT04492358|Colchicine|colchicine|mesh-list
153399046|NCT04492358|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153399047|NCT04492358|Glucocorticoids|glucocorticoids|mesh-ancestor
153399048|NCT04492358|Hormones|hormones|mesh-ancestor
153399051|NCT04492358|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153399052|NCT04492358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153399053|NCT04492358|Gout Suppressants|gout suppressants|mesh-ancestor
153399054|NCT04492358|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153399055|NCT04492358|Tubulin Modulators|tubulin modulators|mesh-ancestor
153858755|NCT04671420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153858756|NCT04671420|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153858757|NCT04573556|Lemborexant|lemborexant|mesh-list
153364162|NCT03007121|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153364163|NCT03007121|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153364164|NCT03007121|Anesthetics, General|anesthetics, general|mesh-ancestor
153364165|NCT01725152|Ganaxolone|ganaxolone|mesh-list
153364166|NCT01725152|Neurosteroids|neurosteroids|mesh-ancestor
153364167|NCT01725152|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153364168|NCT01725152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153364169|NCT01725152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153364170|NCT01725152|GABA Modulators|gaba modulators|mesh-ancestor
153364171|NCT01725152|GABA Agents|gaba agents|mesh-ancestor
153858775|NCT01779453|Antimetabolites|antimetabolites|mesh-ancestor
153858776|NCT01779453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153399058|NCT04492358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153399060|NCT01066663|Antimalarials|antimalarials|mesh-ancestor
153824200|NCT00497562|Antidepressive Agents|antidepressive agents|mesh-ancestor
153824201|NCT00497562|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153824202|NCT00497562|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
153858813|NCT04670601|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153858814|NCT04670601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153858815|NCT04670601|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153858816|NCT04670601|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153858817|NCT04670601|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153858818|NCT04670601|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153858819|NCT04670601|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153858820|NCT04670601|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153858821|NCT04670601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153858822|NCT04670913|Apatinib|apatinib|mesh-list
153858823|NCT04670913|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153858824|NCT04670913|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153399099|NCT03417986|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153399104|NCT04349228|Hydroxychloroquine|hydroxychloroquine|mesh-list
153399105|NCT04349228|Antimalarials|antimalarials|mesh-ancestor
153399106|NCT04349228|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153399107|NCT04349228|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153399108|NCT04349228|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153399109|NCT04349228|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153824209|NCT00497601|Amphotericin B|amphotericin b|mesh-list
153824210|NCT00497601|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
153824211|NCT00497601|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
153824212|NCT00497601|Amebicides|amebicides|mesh-ancestor
153824213|NCT00497601|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153399170|NCT01988246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153399171|NCT01988246|Growth Inhibitors|growth inhibitors|mesh-ancestor
153399172|NCT01988246|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153399174|NCT01990898|Cyclosporins|cyclosporins|mesh-list
153399175|NCT01990898|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153399176|NCT01990898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153399177|NCT01990898|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153399178|NCT01990898|Immunologic Factors|immunologic factors|mesh-ancestor
153399179|NCT01990898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153399180|NCT01990898|Antifungal Agents|antifungal agents|mesh-ancestor
153399181|NCT01990898|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153399182|NCT01990898|Dermatologic Agents|dermatologic agents|mesh-ancestor
153399183|NCT01990898|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153399184|NCT01990898|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
153399186|NCT01960387|Clofarabine|clofarabine|mesh-list
153399187|NCT01960387|Antimetabolites|antimetabolites|mesh-list
153399188|NCT01960387|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153399191|NCT01960387|Antiviral Agents|antiviral agents|mesh-ancestor
153364201|NCT03006809|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153364202|NCT03006809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153364203|NCT01580423|Aprepitant|aprepitant|mesh-list
153364204|NCT01580423|Antiemetics|antiemetics|mesh-ancestor
153364205|NCT01580423|Autonomic Agents|autonomic agents|mesh-ancestor
153364206|NCT01580423|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153364207|NCT01580423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153364208|NCT01580423|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153364209|NCT01580423|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
153364210|NCT01580423|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153399194|NCT01960387|Immunologic Factors|immunologic factors|mesh-ancestor
153399195|NCT01960387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153399197|NCT02823431|Anesthetics, Local|anesthetics, local|mesh-ancestor
153399198|NCT02823431|Anesthetics|anesthetics|mesh-ancestor
153399199|NCT02823431|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153399200|NCT02823431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153399201|NCT02823431|Sensory System Agents|sensory system agents|mesh-ancestor
153399202|NCT02823431|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153399203|NCT02823431|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153399204|NCT02823431|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
153399205|NCT02823431|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153399209|NCT02824913|Ophthalmic Solutions|ophthalmic solutions|mesh-list
153858926|NCT00532142|Glucocorticoids|glucocorticoids|mesh-ancestor
153858927|NCT00532142|Hormones|hormones|mesh-ancestor
153858928|NCT00532142|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153858929|NCT00532142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153858931|NCT00533312|Niacinamide|niacinamide|mesh-list
153858932|NCT00533312|Nicotinic Acids|nicotinic acids|mesh-list
153858933|NCT00533312|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153858934|NCT00533312|Antimetabolites|antimetabolites|mesh-ancestor
153858935|NCT00533312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153858936|NCT00533312|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153858937|NCT00533312|Vasodilator Agents|vasodilator agents|mesh-ancestor
153858938|NCT00533312|Vitamin B Complex|vitamin b complex|mesh-ancestor
153858939|NCT00533312|Vitamins|vitamins|mesh-ancestor
153858940|NCT00533312|Micronutrients|micronutrients|mesh-ancestor
153858941|NCT00533312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153858942|NCT00533390|Efavirenz|efavirenz|mesh-list
153858943|NCT00533390|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153858944|NCT00533390|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153858945|NCT00533390|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153858946|NCT00533390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153858947|NCT00533390|Antiviral Agents|antiviral agents|mesh-ancestor
153858948|NCT00533390|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153858949|NCT00533390|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
153858950|NCT00533390|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153399228|NCT02059070|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153399229|NCT01962961|Acetylcysteine|acetylcysteine|mesh-list
153399230|NCT01962961|N-monoacetylcystine|n-monoacetylcystine|mesh-list
153399231|NCT01962961|Antiviral Agents|antiviral agents|mesh-ancestor
153399232|NCT01962961|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153399233|NCT01962961|Expectorants|expectorants|mesh-ancestor
153399234|NCT01962961|Respiratory System Agents|respiratory system agents|mesh-ancestor
153399235|NCT01962961|Free Radical Scavengers|free radical scavengers|mesh-ancestor
153399236|NCT01962961|Antioxidants|antioxidants|mesh-ancestor
153399237|NCT01962961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153399238|NCT01962961|Protective Agents|protective agents|mesh-ancestor
153399239|NCT01962961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153399240|NCT01962961|Antidotes|antidotes|mesh-ancestor
153399241|NCT03010631|Lubiprostone|lubiprostone|mesh-list
153399242|NCT03010631|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
153399243|NCT03010631|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153399244|NCT03010631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153824247|NCT00490854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153824248|NCT00490854|Heparin Antagonists|heparin antagonists|mesh-ancestor
153824249|NCT00490854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153824250|NCT00490854|Coagulants|coagulants|mesh-ancestor
153824251|NCT00490893|Insulin Detemir|insulin detemir|mesh-list
153824252|NCT00490893|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153824253|NCT00490893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153824254|NCT03272126|Vitamin D|vitamin d|mesh-list
153824255|NCT03272126|Vitamins|vitamins|mesh-ancestor
153824256|NCT03272126|Micronutrients|micronutrients|mesh-ancestor
153824257|NCT03272126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153824258|NCT03272126|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153824259|NCT00491049|Levofloxacin|levofloxacin|mesh-list
153824260|NCT00491049|Ophthalmic Solutions|ophthalmic solutions|mesh-list
153824261|NCT00491049|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
153824262|NCT00491049|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
153648895|NCT00000191|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153858968|NCT04668456|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153858969|NCT04668456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153858970|NCT04668456|Sensory System Agents|sensory system agents|mesh-ancestor
153399286|NCT02913521|Diclofenac|diclofenac|mesh-list
153399287|NCT02913521|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153399288|NCT02913521|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153399289|NCT02913521|Analgesics|analgesics|mesh-ancestor
153399290|NCT02913521|Sensory System Agents|sensory system agents|mesh-ancestor
153399291|NCT02913521|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153399292|NCT02913521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153399293|NCT02913521|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153399294|NCT02913521|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153399295|NCT02913521|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153399296|NCT02913521|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153399297|NCT02913521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153399298|NCT01969201|Hormones|hormones|mesh-list
153399299|NCT01969201|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153399300|NCT01969201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153399301|NCT01962428|Ticagrelor|ticagrelor|mesh-list
153399302|NCT01962428|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153399303|NCT01962428|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
153858996|NCT00556413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153858997|NCT00556413|Antimetabolites|antimetabolites|mesh-ancestor
153858998|NCT00556413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153858999|NCT00556413|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153859000|NCT00556413|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153859001|NCT00556413|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153859002|NCT00556413|Immunologic Factors|immunologic factors|mesh-ancestor
153859003|NCT00556413|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
153364231|NCT03001193|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153824264|NCT00491049|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153824265|NCT00491049|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153824266|NCT00491049|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153824267|NCT00491049|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153824268|NCT00491049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153824269|NCT00491049|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153824270|NCT00491049|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
153859004|NCT00556413|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153859005|NCT00556413|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153859006|NCT00556413|Antidotes|antidotes|mesh-ancestor
153859007|NCT00556413|Protective Agents|protective agents|mesh-ancestor
153859008|NCT00556413|Vitamin B Complex|vitamin b complex|mesh-ancestor
153859009|NCT00556413|Vitamins|vitamins|mesh-ancestor
153859010|NCT00556413|Micronutrients|micronutrients|mesh-ancestor
153859011|NCT00556413|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153859012|NCT04668690|Mitoxantrone|mitoxantrone|mesh-list
153859013|NCT04668690|Analgesics|analgesics|mesh-ancestor
153859014|NCT04668690|Sensory System Agents|sensory system agents|mesh-ancestor
153859015|NCT04668690|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153859016|NCT04668690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153859017|NCT04668690|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153859018|NCT04668690|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153859019|NCT04668690|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153859020|NCT04668690|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153859021|NCT04668690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153859022|NCT00533585|Paclitaxel|paclitaxel|mesh-list
153824288|NCT00497913|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153824289|NCT00497913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153824290|NCT00497913|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
153824291|NCT00497913|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153824292|NCT03272321|Oxytocin|oxytocin|mesh-list
153824293|NCT03272321|Oxytocics|oxytocics|mesh-ancestor
153859035|NCT00533585|Growth Substances|growth substances|mesh-ancestor
153859036|NCT00533585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153859037|NCT00533585|Growth Inhibitors|growth inhibitors|mesh-ancestor
153859038|NCT00533585|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153859039|NCT00533585|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153859040|NCT04659057|Lidocaine|lidocaine|mesh-list
153859041|NCT04659057|Dexmedetomidine|dexmedetomidine|mesh-list
153859042|NCT04659057|Anesthetics, Local|anesthetics, local|mesh-ancestor
153859043|NCT04659057|Anesthetics|anesthetics|mesh-ancestor
153859044|NCT04659057|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153859045|NCT04659057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153859046|NCT04659057|Sensory System Agents|sensory system agents|mesh-ancestor
153399326|NCT01969435|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153399327|NCT01969435|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153399328|NCT01969435|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153399329|NCT01969435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153399337|NCT01969435|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153399338|NCT01969435|Alkylating Agents|alkylating agents|mesh-ancestor
153399339|NCT01969435|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153859047|NCT04659057|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153859048|NCT04659057|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153859049|NCT04659057|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
153859050|NCT04659057|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153859051|NCT04659057|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153859052|NCT04659057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153859053|NCT04659057|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153824295|NCT03272321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153824296|NCT00491127|Dexamethasone|dexamethasone|mesh-list
153824297|NCT00491127|Gemcitabine|gemcitabine|mesh-list
153824298|NCT00491127|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153824299|NCT00491127|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153824300|NCT00491127|Antiemetics|antiemetics|mesh-ancestor
153859057|NCT04659057|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153859058|NCT04659057|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153859059|NCT04659057|Adrenergic Agents|adrenergic agents|mesh-ancestor
153859060|NCT04659057|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153859061|NCT00533741|Aluminum Hydroxide|aluminum hydroxide|mesh-list
153859062|NCT00533741|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153399342|NCT01965002|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153399343|NCT01965002|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153399344|NCT01965002|Analgesics|analgesics|mesh-ancestor
153399345|NCT01965002|Sensory System Agents|sensory system agents|mesh-ancestor
153399346|NCT01965002|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153399347|NCT01965002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153399348|NCT01965002|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153399349|NCT01965002|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153399350|NCT01965002|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153399351|NCT01965002|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153859083|NCT04658355|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
153859084|NCT04658355|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153859085|NCT04658355|Disinfectants|disinfectants|mesh-ancestor
153859086|NCT04658355|Dermatologic Agents|dermatologic agents|mesh-ancestor
153399366|NCT01969747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153399367|NCT02002832|Risperidone|risperidone|mesh-list
153859087|NCT04658355|Plasma Substitutes|plasma substitutes|mesh-ancestor
153733371|NCT00506974|Sodium Oxybate|sodium oxybate|mesh-list
153859102|NCT00533936|Immunologic Factors|immunologic factors|mesh-ancestor
153399380|NCT02002832|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
153399381|NCT02002832|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
153399382|NCT02002832|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
153399383|NCT02002832|Adrenergic Agents|adrenergic agents|mesh-ancestor
153399384|NCT02002832|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
153399385|NCT02002832|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
153399386|NCT01966718|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
153399387|NCT01966718|Hormones|hormones|mesh-ancestor
153399388|NCT01966718|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153399389|NCT01966718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153399390|NCT02308501|Alcaftadine|alcaftadine|mesh-list
153399391|NCT02308501|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
153399392|NCT02308501|Histamine Antagonists|histamine antagonists|mesh-ancestor
153399393|NCT02308501|Histamine Agents|histamine agents|mesh-ancestor
153399394|NCT02308501|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153648900|NCT00000191|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153399395|NCT02308501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153399396|NCT02308501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153399397|NCT02006108|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
153824315|NCT00491166|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153824316|NCT00491166|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153824317|NCT00491166|Analgesics|analgesics|mesh-ancestor
153824318|NCT00491166|Sensory System Agents|sensory system agents|mesh-ancestor
153824319|NCT00491166|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153824320|NCT00491166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153824321|NCT00491166|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153824322|NCT00491166|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153824323|NCT03273062|Tolcapone|tolcapone|mesh-list
153824324|NCT03273062|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
153399415|NCT02008682|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
153399416|NCT02008682|Liraglutide|liraglutide|mesh-list
153399417|NCT02008682|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153399418|NCT02008682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153399419|NCT02008682|Incretins|incretins|mesh-ancestor
153399420|NCT02008682|Hormones|hormones|mesh-ancestor
153399421|NCT02008682|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153399422|NCT02008682|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
153399423|NCT02008682|Protease Inhibitors|protease inhibitors|mesh-ancestor
153364312|NCT03405194|Antiviral Agents|antiviral agents|mesh-ancestor
153364313|NCT03405194|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153364314|NCT03405194|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
153364315|NCT03405194|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153859156|NCT00534287|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153859157|NCT00534287|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153733372|NCT00506974|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153733373|NCT00506974|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153733374|NCT00506974|Anesthetics, General|anesthetics, general|mesh-ancestor
153733375|NCT00506974|Anesthetics|anesthetics|mesh-ancestor
153733376|NCT00506974|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153859158|NCT00534287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153859159|NCT00534287|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153859160|NCT00534287|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
153859161|NCT00534287|Contraceptive Agents|contraceptive agents|mesh-ancestor
153399439|NCT00373919|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153399440|NCT00373919|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153399441|NCT00373919|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153399442|NCT00373919|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
153399443|NCT00373919|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153399444|NCT00373919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153399445|NCT02916407|Sevoflurane|sevoflurane|mesh-list
153399446|NCT02916407|Desflurane|desflurane|mesh-list
153399447|NCT02916407|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153399448|NCT02916407|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
153399449|NCT02916407|Anesthetics, General|anesthetics, general|mesh-ancestor
153399450|NCT02916407|Anesthetics|anesthetics|mesh-ancestor
153824350|NCT01327612|Oxaliplatin|oxaliplatin|mesh-list
153824351|NCT01327612|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153824352|NCT01327612|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153824353|NCT01327612|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153824354|NCT01327612|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153824355|NCT01327612|Growth Substances|growth substances|mesh-ancestor
153824356|NCT01327612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153824357|NCT01327612|Growth Inhibitors|growth inhibitors|mesh-ancestor
153824358|NCT01327612|Antimetabolites|antimetabolites|mesh-ancestor
153824359|NCT01327612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153824362|NCT01327612|Immunologic Factors|immunologic factors|mesh-ancestor
153399470|NCT02012192|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153399471|NCT02012192|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153859162|NCT00534287|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153859163|NCT00534287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153859164|NCT00534287|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
153859165|NCT00534287|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
153859166|NCT00534287|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
153859167|NCT04168502|Gemtuzumab|gemtuzumab|mesh-list
153859175|NCT01215916|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153859176|NCT01215916|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153859177|NCT01215916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153859178|NCT01215916|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153859179|NCT01215916|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153859180|NCT01184872|Vancomycin|vancomycin|mesh-list
153859181|NCT01184872|Penicillins|penicillins|mesh-list
153859182|NCT01184872|Daptomycin|daptomycin|mesh-list
153399499|NCT02014363|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153859204|NCT00556959|Analgesics|analgesics|mesh-ancestor
153859205|NCT00556959|Sensory System Agents|sensory system agents|mesh-ancestor
153859206|NCT00556959|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153859207|NCT00556959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153859208|NCT00556959|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153859209|NCT00556959|Sympatholytics|sympatholytics|mesh-ancestor
153859210|NCT00556959|Autonomic Agents|autonomic agents|mesh-ancestor
153859211|NCT00556959|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
153859212|NCT00556959|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153859213|NCT00556959|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153859214|NCT00556959|Adrenergic Agents|adrenergic agents|mesh-ancestor
153859215|NCT00556959|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153859216|NCT00556959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153859217|NCT01184326|Everolimus|everolimus|mesh-list
153859218|NCT01184326|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
153859228|NCT01215253|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153859229|NCT01215253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153859230|NCT01184053|Arsenic Trioxide|arsenic trioxide|mesh-list
153859231|NCT01184053|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153859232|NCT03813875|Midazolam|midazolam|mesh-list
153859233|NCT03813875|Fentanyl|fentanyl|mesh-list
153859234|NCT03813875|Alfentanil|alfentanil|mesh-list
153859235|NCT03813875|Propofol|propofol|mesh-list
153859236|NCT03813875|Sevoflurane|sevoflurane|mesh-list
153859237|NCT03813875|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153859238|NCT03813875|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153399520|NCT02012348|Benzalkonium Compounds|benzalkonium compounds|mesh-list
153399521|NCT02012348|Triclocarban|triclocarban|mesh-list
153399522|NCT02012348|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153399523|NCT02012348|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
153399524|NCT02834663|Ranibizumab|ranibizumab|mesh-list
153399525|NCT02834663|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153399526|NCT02834663|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153399531|NCT01973036|Oxytocin|oxytocin|mesh-list
153824367|NCT01327612|Micronutrients|micronutrients|mesh-ancestor
153824368|NCT01243281|Entecavir|entecavir|mesh-list
153824369|NCT01243281|Antiviral Agents|antiviral agents|mesh-ancestor
153824370|NCT01243281|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153824371|NCT00464399|Everolimus|everolimus|mesh-list
153824372|NCT00464399|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
153824373|NCT00464399|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153824374|NCT00464399|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153859240|NCT03813875|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153859241|NCT03813875|Anesthetics, General|anesthetics, general|mesh-ancestor
153859242|NCT03813875|Anesthetics|anesthetics|mesh-ancestor
153859243|NCT03813875|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153859244|NCT03813875|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153859245|NCT03813875|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153859246|NCT03813875|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153859247|NCT03813875|GABA Modulators|gaba modulators|mesh-ancestor
153859248|NCT03813875|GABA Agents|gaba agents|mesh-ancestor
153859249|NCT03813875|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153859250|NCT03813875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153859251|NCT03813875|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153859252|NCT03813875|Narcotics|narcotics|mesh-ancestor
153859253|NCT03813875|Analgesics|analgesics|mesh-ancestor
153859254|NCT03813875|Sensory System Agents|sensory system agents|mesh-ancestor
153859255|NCT03813875|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153859256|NCT03813875|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153859257|NCT03813875|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
153364367|NCT01045694|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153364368|NCT01045694|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
153824375|NCT00464399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153824376|NCT00464399|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153824377|NCT00464399|Immunologic Factors|immunologic factors|mesh-ancestor
153824378|NCT00464399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153824379|NCT00464399|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153824380|NCT04132882|Sodium thiosulfate|sodium thiosulfate|mesh-list
153824381|NCT04132882|Antidotes|antidotes|mesh-ancestor
153824382|NCT04132882|Protective Agents|protective agents|mesh-ancestor
153824383|NCT04132882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153824384|NCT04132882|Antioxidants|antioxidants|mesh-ancestor
153824385|NCT04132882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153824386|NCT04132882|Antitubercular Agents|antitubercular agents|mesh-ancestor
153824387|NCT04132882|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153824388|NCT04132882|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153859275|NCT04665141|Respiratory System Agents|respiratory system agents|mesh-ancestor
153859276|NCT04665063|Cyclophosphamide|cyclophosphamide|mesh-list
153399551|NCT02923895|Fluorides|fluorides|mesh-list
153399552|NCT02923895|Tin Fluorides|tin fluorides|mesh-list
153399553|NCT02923895|Fluorophosphate|fluorophosphate|mesh-list
153399571|NCT02839889|Naloxegol|naloxegol|mesh-list
153859303|NCT01215097|Linagliptin|linagliptin|mesh-list
153859304|NCT01215097|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153399590|NCT01973335|Bumetanide|bumetanide|mesh-list
153399591|NCT01973335|Diuretics|diuretics|mesh-list
153399592|NCT01973335|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-list
153399593|NCT01973335|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
153399594|NCT01973335|Hormone Antagonists|hormone antagonists|mesh-ancestor
153399595|NCT01973335|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153399596|NCT01973335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153399597|NCT01973335|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
153399598|NCT01973335|Natriuretic Agents|natriuretic agents|mesh-ancestor
153399599|NCT01973335|Anticonvulsants|anticonvulsants|mesh-ancestor
153399606|NCT01973413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153399607|NCT02021461|Eslicarbazepine acetate|eslicarbazepine acetate|mesh-list
153399608|NCT02021461|Anticonvulsants|anticonvulsants|mesh-ancestor
153399609|NCT02021461|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
153399610|NCT02021461|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153399611|NCT02021461|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153399612|NCT02021461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153399613|NCT02929667|Fluoxetine|fluoxetine|mesh-list
153399614|NCT02929667|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
153399615|NCT02929667|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153399616|NCT02929667|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153399618|NCT02929667|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153824405|NCT01243359|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153824406|NCT01243359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153824407|NCT00498342|Acetylcysteine|acetylcysteine|mesh-list
153824408|NCT00498342|N-monoacetylcystine|n-monoacetylcystine|mesh-list
153824409|NCT00498342|Antiviral Agents|antiviral agents|mesh-ancestor
153824410|NCT00498342|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153824411|NCT00498342|Expectorants|expectorants|mesh-ancestor
153824412|NCT00498342|Respiratory System Agents|respiratory system agents|mesh-ancestor
153824413|NCT00498342|Free Radical Scavengers|free radical scavengers|mesh-ancestor
153824414|NCT00498342|Antioxidants|antioxidants|mesh-ancestor
153824415|NCT00498342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153859326|NCT04664010|Ascorbic Acid|ascorbic acid|mesh-list
153859327|NCT04664010|Interferons|interferons|mesh-list
153859328|NCT04664010|Ribavirin|ribavirin|mesh-list
153859329|NCT04664010|Interferon-alpha|interferon-alpha|mesh-list
153859330|NCT04664010|Interferon-alfa-1b|interferon-alfa-1b|mesh-list
153859331|NCT04664010|Micronutrients|micronutrients|mesh-ancestor
153859332|NCT04664010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153364404|NCT01586975|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153364405|NCT03000413|Fentanyl|fentanyl|mesh-list
153364406|NCT03000413|Ketamine|ketamine|mesh-list
153364407|NCT03000413|Analgesics|analgesics|mesh-ancestor
153859365|NCT04663386|Respiratory System Agents|respiratory system agents|mesh-ancestor
153364408|NCT03000413|Sensory System Agents|sensory system agents|mesh-ancestor
153364409|NCT03000413|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153364410|NCT03000413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153903287|NCT01212588|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
153364411|NCT03000413|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
153364412|NCT03000413|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153364413|NCT03000413|Anesthetics, General|anesthetics, general|mesh-ancestor
153859367|NCT04663386|Hormones|hormones|mesh-ancestor
153859368|NCT04663386|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153859369|NCT04663386|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
153859370|NCT04663386|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
153859371|NCT04663386|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153859372|NCT04663386|Adrenergic Agents|adrenergic agents|mesh-ancestor
153859383|NCT04663269|Hormones|hormones|mesh-ancestor
153824434|NCT00591994|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
153824435|NCT00591994|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
153824436|NCT00591994|Dopamine Agonists|dopamine agonists|mesh-ancestor
153824437|NCT00591994|Dopamine Agents|dopamine agents|mesh-ancestor
153824438|NCT00591994|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153824439|NCT00591994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153859385|NCT04663269|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153859386|NCT04663269|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153859387|NCT03303339|Cytarabine|cytarabine|mesh-list
153859388|NCT03303339|Decitabine|decitabine|mesh-list
153859389|NCT03303339|Onvansertib|onvansertib|mesh-list
153859390|NCT03303339|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153859391|NCT03303339|Antimetabolites|antimetabolites|mesh-ancestor
153859392|NCT03303339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153859393|NCT03303339|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153859394|NCT03303339|Antiviral Agents|antiviral agents|mesh-ancestor
153859395|NCT03303339|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153859396|NCT03303339|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153859397|NCT03303339|Immunologic Factors|immunologic factors|mesh-ancestor
153859398|NCT03303339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153859399|NCT03303339|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153859400|NCT03303339|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153859401|NCT03422471|Hypoglycemic Agents|hypoglycemic agents|mesh-list
153859402|NCT03422471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153859403|NCT03299946|Nivolumab|nivolumab|mesh-list
153859408|NCT00535340|Amibegron|amibegron|mesh-list
153364434|NCT01588457|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153364435|NCT01588457|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153364436|NCT01588457|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153364437|NCT01588457|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153364438|NCT01588457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153364439|NCT01588457|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153399712|NCT02938949|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153399713|NCT02938949|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153399714|NCT02938949|Antimetabolites|antimetabolites|mesh-ancestor
153859414|NCT00535340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153859415|NCT00535340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153859416|NCT00535340|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
153859417|NCT00535379|Sunitinib|sunitinib|mesh-list
153859418|NCT00535379|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153859419|NCT00535379|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153859420|NCT00535379|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153859421|NCT00535379|Growth Substances|growth substances|mesh-ancestor
153859422|NCT00535379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153859423|NCT00535379|Growth Inhibitors|growth inhibitors|mesh-ancestor
153859424|NCT00535379|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153859425|NCT00535379|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153859445|NCT04679064|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153859446|NCT04679064|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153859447|NCT04679064|Tubulin Modulators|tubulin modulators|mesh-ancestor
153859448|NCT04679064|Antimitotic Agents|antimitotic agents|mesh-ancestor
153859449|NCT04679064|Mitosis Modulators|mitosis modulators|mesh-ancestor
153859450|NCT04679064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153859451|NCT04679064|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153859452|NCT04679064|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153859453|NCT04679064|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153824469|NCT01327573|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
153824470|NCT01327573|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153824471|NCT01327573|Immunologic Factors|immunologic factors|mesh-ancestor
153824472|NCT01327573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153824473|NCT02893384|Anesthetics|anesthetics|mesh-list
153824474|NCT02893384|Anesthetics, Local|anesthetics, local|mesh-list
153824475|NCT02893384|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153824476|NCT02893384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153824477|NCT02893384|Sensory System Agents|sensory system agents|mesh-ancestor
153824478|NCT02893384|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153824479|NCT02893228|Levobupivacaine|levobupivacaine|mesh-list
153824480|NCT02893228|Anesthetics, Local|anesthetics, local|mesh-ancestor
153364448|NCT01588457|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153364449|NCT03005639|Vemurafenib|vemurafenib|mesh-list
153859454|NCT04679064|Growth Substances|growth substances|mesh-ancestor
153364450|NCT03005639|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153364451|NCT03005639|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153364452|NCT03005639|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153364453|NCT03005639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153364454|NCT01590875|Adenosine|adenosine|mesh-list
153364455|NCT01590875|Analgesics|analgesics|mesh-ancestor
153364456|NCT01590875|Sensory System Agents|sensory system agents|mesh-ancestor
153364457|NCT01590875|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153364458|NCT01590875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153364459|NCT01590875|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153364460|NCT01590875|Vasodilator Agents|vasodilator agents|mesh-ancestor
153364461|NCT01590875|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
153364462|NCT01590875|Purinergic Agonists|purinergic agonists|mesh-ancestor
153859455|NCT04679064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153859456|NCT04679064|Growth Inhibitors|growth inhibitors|mesh-ancestor
153859457|NCT04679064|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153859458|NCT04679064|Antimetabolites|antimetabolites|mesh-ancestor
153859459|NCT04679064|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153859460|NCT04679064|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153824481|NCT02893228|Anesthetics|anesthetics|mesh-ancestor
153824482|NCT02893228|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153824483|NCT02893228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153824484|NCT02893228|Sensory System Agents|sensory system agents|mesh-ancestor
153824485|NCT02893228|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153824486|NCT00498537|Spironolactone|spironolactone|mesh-list
153824487|NCT00498537|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
153824488|NCT00498537|Hormone Antagonists|hormone antagonists|mesh-ancestor
153824489|NCT00498537|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153824490|NCT00498537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153824491|NCT00498537|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
153824492|NCT00498537|Diuretics|diuretics|mesh-ancestor
153824493|NCT00498537|Natriuretic Agents|natriuretic agents|mesh-ancestor
153824494|NCT00491478|Sertraline|sertraline|mesh-list
153824495|NCT00491478|Antidepressive Agents|antidepressive agents|mesh-ancestor
153859519|NCT03245021|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153859520|NCT03245021|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153364471|NCT01725230|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153364472|NCT01725230|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153364473|NCT01725230|Antimetabolites|antimetabolites|mesh-ancestor
153364474|NCT01725230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153364475|NCT01725230|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153364476|NCT01725230|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
153399846|NCT02344316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153399847|NCT02344316|Protective Agents|protective agents|mesh-ancestor
153399848|NCT02344316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153399849|NCT02344316|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153399850|NCT02344628|Azithromycin|azithromycin|mesh-list
153399851|NCT02344628|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153399852|NCT02344628|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153399853|NCT02345486|Plasma-lyte 148|plasma-lyte 148|mesh-list
153399854|NCT02345486|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
153399855|NCT02345486|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
153399856|NCT02019758|Fluticasone|fluticasone|mesh-list
153399858|NCT02019758|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153399859|NCT02019758|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153399860|NCT02019758|Autonomic Agents|autonomic agents|mesh-ancestor
153399861|NCT02019758|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153399862|NCT02019758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153399863|NCT02019758|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153399864|NCT02019758|Respiratory System Agents|respiratory system agents|mesh-ancestor
153399865|NCT02019758|Dermatologic Agents|dermatologic agents|mesh-ancestor
153399866|NCT02019758|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
153824496|NCT00491478|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153824497|NCT00491478|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
153824498|NCT00491478|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153824499|NCT00491478|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153824500|NCT00491478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153824501|NCT00491478|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153824502|NCT00491478|Serotonin Agents|serotonin agents|mesh-ancestor
153824503|NCT00491478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153824504|NCT00491517|Sirolimus|sirolimus|mesh-list
153824505|NCT00491517|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153824506|NCT00491517|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153824507|NCT00491517|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153824508|NCT00491517|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153399884|NCT01980589|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153399885|NCT01980589|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153399886|NCT01980589|Glucocorticoids|glucocorticoids|mesh-ancestor
153399888|NCT01980589|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153399922|NCT01982695|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153399923|NCT01982695|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
153399924|NCT01982695|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
153399925|NCT01982695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153859622|NCT00538148|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153859647|NCT04661709|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153859648|NCT04661709|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153399926|NCT01982695|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
153399927|NCT01982695|Protease Inhibitors|protease inhibitors|mesh-ancestor
153399928|NCT01982695|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153399929|NCT01982695|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
153399930|NCT01982695|Protective Agents|protective agents|mesh-ancestor
153399931|NCT01982695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153399933|NCT01981772|Epinephrine|epinephrine|mesh-list
153399934|NCT01981772|Racepinephrine|racepinephrine|mesh-list
153399935|NCT01981772|Epinephryl borate|epinephryl borate|mesh-list
153399936|NCT01981772|Anesthetics, Local|anesthetics, local|mesh-ancestor
153859658|NCT04661709|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153859659|NCT04661709|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153859660|NCT04661709|Antipyretics|antipyretics|mesh-ancestor
153399939|NCT01981772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153399941|NCT01981772|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153399942|NCT01981772|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153399943|NCT01981772|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
153824510|NCT00491517|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153824511|NCT00491517|Immunologic Factors|immunologic factors|mesh-ancestor
153824512|NCT00491517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153824513|NCT00464789|Bazedoxifene|bazedoxifene|mesh-list
153824514|NCT00464789|Estrogens|estrogens|mesh-list
153824515|NCT00464789|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
153824516|NCT00464789|Hormones|hormones|mesh-ancestor
153455672|NCT05289349|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153824517|NCT00464789|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153859676|NCT04661709|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
153859677|NCT04661709|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
153859678|NCT04661709|Adrenergic Agents|adrenergic agents|mesh-ancestor
153399958|NCT01981772|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
153399959|NCT01982240|Bisacodyl|bisacodyl|mesh-list
153399960|NCT01982240|Plecanatide|plecanatide|mesh-list
153399961|NCT01982240|Cathartics|cathartics|mesh-ancestor
153399962|NCT01982240|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153399963|NCT01982240|Laxatives|laxatives|mesh-ancestor
153399964|NCT01982240|Guanylyl Cyclase C Agonists|guanylyl cyclase c agonists|mesh-ancestor
153399965|NCT01982240|Enzyme Activators|enzyme activators|mesh-ancestor
153399966|NCT01982240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153399967|NCT02029495|Brodalumab|brodalumab|mesh-list
153399968|NCT02029495|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
153399969|NCT02029495|Dermatologic Agents|dermatologic agents|mesh-ancestor
153399970|NCT02029495|Immunologic Factors|immunologic factors|mesh-ancestor
153399971|NCT02029495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153399972|NCT01985425|Colchicine|colchicine|mesh-list
153399973|NCT01985425|Gout Suppressants|gout suppressants|mesh-ancestor
153399974|NCT01985425|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153859699|NCT00538265|Antitubercular Agents|antitubercular agents|mesh-ancestor
153859700|NCT00538265|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153859701|NCT00538265|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153859702|NCT02462811|Acetaminophen|acetaminophen|mesh-list
153859703|NCT02462811|Promethazine|promethazine|mesh-list
153859704|NCT02462811|Diphenhydramine|diphenhydramine|mesh-list
153859705|NCT02462811|Hydrocodone|hydrocodone|mesh-list
153859706|NCT02462811|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153859707|NCT02462811|Analgesics|analgesics|mesh-ancestor
153859708|NCT02462811|Sensory System Agents|sensory system agents|mesh-ancestor
153859709|NCT02462811|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153859710|NCT02462811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153859711|NCT02462811|Antipyretics|antipyretics|mesh-ancestor
153859712|NCT02462811|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153399992|NCT01985581|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153399993|NCT01985581|Adrenergic Agents|adrenergic agents|mesh-ancestor
153399994|NCT01985581|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153399995|NCT01985581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153399996|NCT01985581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153399997|NCT02024204|Fluticasone|fluticasone|mesh-list
153399999|NCT02024204|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
153820233|NCT00463008|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153820234|NCT00463008|Immunologic Factors|immunologic factors|mesh-ancestor
153820235|NCT00463008|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153820236|NCT00463008|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153820237|NCT00463086|Isoniazid|isoniazid|mesh-list
153820238|NCT00463086|Antitubercular Agents|antitubercular agents|mesh-ancestor
153820239|NCT00463086|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153820240|NCT00463086|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153824522|NCT00464789|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153824523|NCT00467012|Paclitaxel|paclitaxel|mesh-list
153824524|NCT00467012|Bevacizumab|bevacizumab|mesh-list
153824525|NCT00467012|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153824526|NCT00467012|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153824527|NCT00467012|Tubulin Modulators|tubulin modulators|mesh-ancestor
153824528|NCT00467012|Antimitotic Agents|antimitotic agents|mesh-ancestor
153824529|NCT00467012|Mitosis Modulators|mitosis modulators|mesh-ancestor
153824530|NCT00467012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153824531|NCT00467012|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153400000|NCT02024204|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
153400001|NCT02024204|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153400002|NCT02024204|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153400003|NCT02024204|Autonomic Agents|autonomic agents|mesh-ancestor
153456225|NCT03386929|Axitinib|axitinib|mesh-list
153400004|NCT02024204|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153400005|NCT02024204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153859728|NCT02462811|Anesthetics|anesthetics|mesh-ancestor
153824541|NCT03272867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153400051|NCT01986361|Sensory System Agents|sensory system agents|mesh-ancestor
153400052|NCT01986361|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153400053|NCT01986361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153400054|NCT01986361|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153400055|NCT01986361|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153400056|NCT01986361|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153400057|NCT01986361|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153400058|NCT01986361|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153400059|NCT01986361|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153400060|NCT01986361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153400061|NCT01983020|Lidocaine|lidocaine|mesh-list
153400069|NCT01983020|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153400070|NCT01983020|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
153400071|NCT01983020|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153400072|NCT01983020|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153400073|NCT01983020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153400074|NCT01983020|Analgesics|analgesics|mesh-ancestor
153400075|NCT01983020|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
153400076|NCT01983020|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153400077|NCT01983020|Anesthetics, General|anesthetics, general|mesh-ancestor
153400078|NCT01983020|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
153824546|NCT01327495|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
153824548|NCT01327495|Androgens|androgens|mesh-ancestor
153824549|NCT01327495|Hormones|hormones|mesh-ancestor
153824550|NCT01327495|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153824551|NCT01327495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153364517|NCT03005717|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153364518|NCT03005717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153364520|NCT03005483|Analgesics|analgesics|mesh-ancestor
153364521|NCT03005483|Sensory System Agents|sensory system agents|mesh-ancestor
153364522|NCT03005483|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153364523|NCT03005483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153400079|NCT01983020|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
153400080|NCT01983020|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153400081|NCT02058511|Anesthetics|anesthetics|mesh-list
153859767|NCT00538499|Bupivacaine|bupivacaine|mesh-list
153859768|NCT00538499|Anesthetics, Local|anesthetics, local|mesh-ancestor
153859769|NCT00538499|Anesthetics|anesthetics|mesh-ancestor
153859770|NCT00538499|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153859771|NCT00538499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153859772|NCT00538499|Sensory System Agents|sensory system agents|mesh-ancestor
153859773|NCT00538499|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153859774|NCT00538499|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153859775|NCT00538499|Narcotics|narcotics|mesh-ancestor
153824554|NCT01327495|Anabolic Agents|anabolic agents|mesh-ancestor
153400083|NCT02058511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153400084|NCT01983566|Omeprazole|omeprazole|mesh-list
153400085|NCT01983566|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
153400086|NCT01983566|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153400087|NCT01983566|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
153400088|NCT01983566|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153400089|NCT01983566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153400090|NCT01983878|Ramucirumab|ramucirumab|mesh-list
153400091|NCT01983878|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153400092|NCT01983878|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153859803|NCT00538655|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
153859804|NCT00538655|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
153859805|NCT00538655|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
153859806|NCT00538655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153859807|NCT00538694|Daptomycin|daptomycin|mesh-list
153859808|NCT00538694|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153859809|NCT00538694|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153859810|NCT02436096|Cyclobenzaprine|cyclobenzaprine|mesh-list
153859811|NCT02436096|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
153859812|NCT02436096|Antidepressive Agents|antidepressive agents|mesh-ancestor
153859813|NCT02436096|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153859814|NCT02436096|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
153859815|NCT02436096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153859816|NCT02436096|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
153859817|NCT02436096|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153859818|NCT02436096|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153859819|NCT02436096|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153859820|NCT00538811|Interferons|interferons|mesh-list
153859821|NCT00538811|Ribavirin|ribavirin|mesh-list
153859822|NCT00538811|Interferon-alpha|interferon-alpha|mesh-list
153859823|NCT00538811|Interferon alpha-2|interferon alpha-2|mesh-list
153859824|NCT00538811|Interferon-gamma|interferon-gamma|mesh-list
153400133|NCT02354378|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153859855|NCT00538889|Citalopram|citalopram|mesh-list
153400136|NCT02354378|Analgesics|analgesics|mesh-ancestor
153400137|NCT02354378|Sensory System Agents|sensory system agents|mesh-ancestor
153400138|NCT02354378|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153400139|NCT02354378|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
153400140|NCT02354378|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153400141|NCT02354378|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153400142|NCT02354378|Adrenergic Agents|adrenergic agents|mesh-ancestor
153400143|NCT02354378|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153400144|NCT02354378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153400146|NCT02059213|Leuprolide|leuprolide|mesh-list
153400147|NCT02059213|Goserelin|goserelin|mesh-list
153400148|NCT02059213|Bicalutamide|bicalutamide|mesh-list
153400149|NCT02059213|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153400150|NCT02059213|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153400151|NCT02059213|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153817001|NCT00427388|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153400152|NCT02059213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153400153|NCT02059213|Fertility Agents, Female|fertility agents, female|mesh-ancestor
153400154|NCT02059213|Fertility Agents|fertility agents|mesh-ancestor
153400155|NCT02059213|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153859856|NCT00538889|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
153859857|NCT00538889|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153859858|NCT00538889|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153859859|NCT00538889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153859860|NCT00538889|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153824565|NCT00491634|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153824566|NCT01327339|Ropinirole|ropinirole|mesh-list
153824567|NCT01327339|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
153824568|NCT01327339|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
153824569|NCT01327339|Dopamine Agonists|dopamine agonists|mesh-ancestor
153824570|NCT01327339|Dopamine Agents|dopamine agents|mesh-ancestor
153824571|NCT01327339|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153824572|NCT01327339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153824573|NCT01327339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153824574|NCT01327300|Mesalamine|mesalamine|mesh-list
153824575|NCT01327300|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153824576|NCT01327300|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153824577|NCT01327300|Analgesics|analgesics|mesh-ancestor
153400165|NCT02037061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153400166|NCT02037061|Sensory System Agents|sensory system agents|mesh-ancestor
153400167|NCT02037061|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153400168|NCT02354534|Artesunate|artesunate|mesh-list
153400169|NCT02354534|Antimalarials|antimalarials|mesh-ancestor
153400170|NCT02354534|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153400171|NCT02354534|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153400172|NCT02354534|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153400173|NCT02354534|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153400174|NCT02354534|Antiviral Agents|antiviral agents|mesh-ancestor
153859882|NCT00539123|Buprenorphine|buprenorphine|mesh-list
153364558|NCT03005171|Anesthetics|anesthetics|mesh-ancestor
153364559|NCT03005171|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153364560|NCT03005171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153364561|NCT03005171|Sensory System Agents|sensory system agents|mesh-ancestor
153364562|NCT03005171|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153859905|NCT00539396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153859906|NCT00539435|Insulin|insulin|mesh-list
153859907|NCT00539435|Insulin Aspart|insulin aspart|mesh-list
153859908|NCT00539435|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153859909|NCT00539435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153859910|NCT00539630|Docetaxel|docetaxel|mesh-list
153859911|NCT00539630|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153859912|NCT00539630|Tubulin Modulators|tubulin modulators|mesh-ancestor
153859913|NCT00539630|Antimitotic Agents|antimitotic agents|mesh-ancestor
153400203|NCT02061397|Immunologic Factors|immunologic factors|mesh-ancestor
153400204|NCT02061397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153400205|NCT02061397|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153400206|NCT02061397|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153400207|NCT02061397|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153859923|NCT00539669|Docetaxel|docetaxel|mesh-list
153824589|NCT00467207|Cholinergic Agents|cholinergic agents|mesh-ancestor
153824590|NCT00467207|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153824594|NCT00592111|Prednisone|prednisone|mesh-list
153400249|NCT02403830|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153400250|NCT02403830|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
153400251|NCT02403830|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
153400252|NCT02403830|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
153400253|NCT02403830|Purinergic Agents|purinergic agents|mesh-ancestor
153400254|NCT02403830|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153455673|NCT05289349|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153400255|NCT02403830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153400256|NCT02403830|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
153400257|NCT02036840|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
153859938|NCT00554424|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153859939|NCT00554424|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153859940|NCT00554424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153859941|NCT04660305|Insulin Aspart|insulin aspart|mesh-list
153859942|NCT04660305|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153859943|NCT04660305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153824600|NCT00592111|Bleomycin|bleomycin|mesh-list
153859984|NCT00540137|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153859985|NCT00540137|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153859986|NCT00540137|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153859987|NCT00540137|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
153400293|NCT02877485|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153400294|NCT02877485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153400295|NCT00374387|NuvaRing|nuvaring|mesh-list
153400296|NCT00374387|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
153400297|NCT00374387|Contraceptive Agents|contraceptive agents|mesh-ancestor
153400298|NCT00374387|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153400299|NCT00374387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153400300|NCT03023891|Prednisone|prednisone|mesh-list
153400306|NCT03023891|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153400307|NCT03023891|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153400308|NCT03028025|Hemostatics|hemostatics|mesh-list
153400309|NCT03028025|Coagulants|coagulants|mesh-ancestor
153400310|NCT02955329|Nicotine|nicotine|mesh-list
153400311|NCT02955329|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
153400312|NCT02955329|Autonomic Agents|autonomic agents|mesh-ancestor
153400313|NCT02955329|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153400314|NCT02955329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153400315|NCT02955329|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
153400316|NCT02955329|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
153400317|NCT02955329|Cholinergic Agents|cholinergic agents|mesh-ancestor
153400318|NCT02955329|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153400327|NCT02359058|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153400328|NCT02359058|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153400329|NCT02359058|Growth Substances|growth substances|mesh-ancestor
153400330|NCT02359058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153400331|NCT02359058|Growth Inhibitors|growth inhibitors|mesh-ancestor
153400332|NCT02404610|Propofol|propofol|mesh-list
153400333|NCT02404610|Hypnotics and Sedatives|hypnotics and sedatives|mesh-list
153400334|NCT02404610|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153400335|NCT02404610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153400336|NCT02404610|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153400337|NCT02404610|Anesthetics, General|anesthetics, general|mesh-ancestor
153400338|NCT02404610|Anesthetics|anesthetics|mesh-ancestor
153400339|NCT03110003|Bupivacaine|bupivacaine|mesh-list
153400340|NCT03110003|Anesthetics, Local|anesthetics, local|mesh-ancestor
153400341|NCT03110003|Anesthetics|anesthetics|mesh-ancestor
153400342|NCT03110003|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153400343|NCT03110003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153400344|NCT03110003|Sensory System Agents|sensory system agents|mesh-ancestor
153824606|NCT00592111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153824607|NCT00592111|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153824608|NCT00592111|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153824609|NCT00592111|Alkylating Agents|alkylating agents|mesh-ancestor
153824610|NCT00592111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153824611|NCT00592111|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153364597|NCT03004625|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153364599|NCT03404024|Mitosis Modulators|mitosis modulators|mesh-ancestor
153364600|NCT03404024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153364601|NCT01725542|Ribavirin|ribavirin|mesh-list
153364602|NCT01725542|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
153400345|NCT03110003|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153400346|NCT03114995|Tirofiban|tirofiban|mesh-list
153400347|NCT03114995|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153400348|NCT03114995|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153860030|NCT04659915|Glucocorticoids|glucocorticoids|mesh-ancestor
153860031|NCT04659915|Hormones|hormones|mesh-ancestor
153860032|NCT04659915|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153860033|NCT04659915|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153860034|NCT04659915|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153860035|NCT00557427|Fluoxetine|fluoxetine|mesh-list
153860036|NCT00557427|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
153860037|NCT00557427|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153860038|NCT00557427|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153860039|NCT00557427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153649101|NCT00024310|Antimetabolites|antimetabolites|mesh-ancestor
153860040|NCT00557427|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153860041|NCT00557427|Serotonin Agents|serotonin agents|mesh-ancestor
153860042|NCT00557427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153860044|NCT00557427|Antidepressive Agents|antidepressive agents|mesh-ancestor
153400361|NCT02959853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153400363|NCT00374465|Carvedilol|carvedilol|mesh-list
153400364|NCT00374465|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
153400365|NCT00374465|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
153400367|NCT00374465|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153400368|NCT00374465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153400369|NCT00374465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153400370|NCT00374465|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153400371|NCT00374465|Antioxidants|antioxidants|mesh-ancestor
153400372|NCT00374465|Protective Agents|protective agents|mesh-ancestor
153400373|NCT00374465|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153400374|NCT00374465|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153400375|NCT00374465|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153400376|NCT00374465|Vasodilator Agents|vasodilator agents|mesh-ancestor
153400377|NCT00374465|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
153400378|NCT00374465|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
153400379|NCT00374465|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153860059|NCT00540800|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153860060|NCT00540800|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153860061|NCT00540800|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153860062|NCT00540800|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153860063|NCT00540956|Cytarabine|cytarabine|mesh-list
153860064|NCT00540956|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153860065|NCT00540956|Antimetabolites|antimetabolites|mesh-ancestor
153860066|NCT00540956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153860067|NCT00540956|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153824637|NCT00592306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153824639|NCT00467246|Insulin Detemir|insulin detemir|mesh-list
153860089|NCT00541112|Oxaliplatin|oxaliplatin|mesh-list
153860090|NCT00541112|Cetuximab|cetuximab|mesh-list
153860091|NCT00541112|Calcium|calcium|mesh-list
153400380|NCT02039726|Quizartinib|quizartinib|mesh-list
153400383|NCT02039726|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153400384|NCT02039726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153400386|NCT02040116|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153400387|NCT02040116|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153400388|NCT02040116|Immunologic Factors|immunologic factors|mesh-ancestor
153400389|NCT02040116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153400390|NCT02040116|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153400391|NCT02360774|Canagliflozin|canagliflozin|mesh-list
153400392|NCT02360774|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
153400393|NCT02360774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153400394|NCT02360774|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153400395|NCT02360774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153400396|NCT02361476|Clonidine|clonidine|mesh-list
153400397|NCT02361476|Analgesics|analgesics|mesh-ancestor
153400398|NCT02361476|Sensory System Agents|sensory system agents|mesh-ancestor
153400399|NCT02361476|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153400400|NCT02361476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153400401|NCT02361476|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153400402|NCT02361476|Sympatholytics|sympatholytics|mesh-ancestor
153400403|NCT02361476|Autonomic Agents|autonomic agents|mesh-ancestor
153400404|NCT02361476|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
153400405|NCT02361476|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153400406|NCT02361476|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153400407|NCT02361476|Adrenergic Agents|adrenergic agents|mesh-ancestor
153400408|NCT02361476|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153400410|NCT02363270|Ketamine|ketamine|mesh-list
153860101|NCT00541112|Antidotes|antidotes|mesh-ancestor
153400411|NCT02363270|Analgesics|analgesics|mesh-ancestor
153860102|NCT00541112|Protective Agents|protective agents|mesh-ancestor
153860103|NCT00541112|Vitamin B Complex|vitamin b complex|mesh-ancestor
153860104|NCT00541112|Vitamins|vitamins|mesh-ancestor
153860105|NCT00541112|Micronutrients|micronutrients|mesh-ancestor
153860106|NCT00541112|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153860107|NCT04659525|Ezetimibe|ezetimibe|mesh-list
153860108|NCT04659525|Evolocumab|evolocumab|mesh-list
153860109|NCT04659525|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153860110|NCT04659525|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153860111|NCT04659525|Antimetabolites|antimetabolites|mesh-ancestor
153860112|NCT04659525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153860113|NCT04659525|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153860114|NCT04659525|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
153860115|NCT04659525|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
153860116|NCT04659525|Protease Inhibitors|protease inhibitors|mesh-ancestor
153860117|NCT04659525|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153860118|NCT02333643|Digoxin|digoxin|mesh-list
153860119|NCT02333643|Furosemide|furosemide|mesh-list
153860120|NCT02333643|Diuretics|diuretics|mesh-ancestor
153860121|NCT02333643|Natriuretic Agents|natriuretic agents|mesh-ancestor
153860122|NCT02333643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153860123|NCT02333643|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
153860124|NCT02333643|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153860125|NCT02333643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153860126|NCT02333643|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153860136|NCT00541463|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153860137|NCT00541463|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153860143|NCT02324985|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153860144|NCT02324985|Analgesics|analgesics|mesh-ancestor
153860145|NCT02324985|Sensory System Agents|sensory system agents|mesh-ancestor
153824653|NCT00491712|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153824654|NCT00491712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153824656|NCT02893111|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153824657|NCT04328272|Azithromycin|azithromycin|mesh-list
153824658|NCT04328272|Hydroxychloroquine|hydroxychloroquine|mesh-list
153824659|NCT04328272|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153824660|NCT04328272|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153824661|NCT04328272|Antimalarials|antimalarials|mesh-ancestor
153400447|NCT02410382|Glucocorticoids|glucocorticoids|mesh-ancestor
153400448|NCT02410382|Hormones|hormones|mesh-ancestor
153400449|NCT02410382|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153400450|NCT02410382|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153400451|NCT02410382|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153400458|NCT03038867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153400459|NCT03038867|Analgesics|analgesics|mesh-ancestor
153400460|NCT03038867|Sensory System Agents|sensory system agents|mesh-ancestor
153400461|NCT03038867|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153400462|NCT03038867|Antidepressive Agents|antidepressive agents|mesh-ancestor
153860151|NCT02324985|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153860152|NCT02324985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153860154|NCT04659642|Dexmedetomidine|dexmedetomidine|mesh-list
153400468|NCT03119831|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
153400469|NCT03119831|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153400470|NCT03119831|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153400471|NCT03119831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153400472|NCT03119831|Disinfectants|disinfectants|mesh-ancestor
153400473|NCT03119831|Dermatologic Agents|dermatologic agents|mesh-ancestor
153400474|NCT02965781|Squaric acid dibutyl ester|squaric acid dibutyl ester|mesh-list
153400475|NCT02965781|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153400476|NCT02965781|Immunologic Factors|immunologic factors|mesh-ancestor
153400477|NCT02965781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153400479|NCT03124121|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
153860188|NCT00541853|Candesartan|candesartan|mesh-list
153860189|NCT00541853|Candesartan cilexetil|candesartan cilexetil|mesh-list
153860190|NCT00541853|Cilnidipine|cilnidipine|mesh-list
153400480|NCT03124121|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153400481|NCT03124121|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153400482|NCT03124121|Immunologic Factors|immunologic factors|mesh-ancestor
153400483|NCT03124121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153400484|NCT03042299|Azilsartan medoxomil|azilsartan medoxomil|mesh-list
153400485|NCT03042299|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
153400486|NCT03042299|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
153400487|NCT03042299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153820094|NCT04703465|Tenofovir|tenofovir|mesh-list
153400489|NCT00374699|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153400490|NCT00374777|Nitrazepam|nitrazepam|mesh-list
153400491|NCT00374777|Zolpidem|zolpidem|mesh-list
153400492|NCT00374777|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
153400493|NCT00374777|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153824682|NCT03272009|Interferon alpha-2|interferon alpha-2|mesh-list
153824683|NCT03272009|Entecavir|entecavir|mesh-list
153824684|NCT03272009|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
153824685|NCT03272009|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153649326|NCT00025402|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153824686|NCT03272009|Antiviral Agents|antiviral agents|mesh-ancestor
153824687|NCT03272009|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153824688|NCT03272009|Immunologic Factors|immunologic factors|mesh-ancestor
153824689|NCT03272009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153824690|NCT00498888|Tolterodine Tartrate|tolterodine tartrate|mesh-list
153824691|NCT00498888|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
153824692|NCT00498888|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
153400511|NCT02044796|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153400512|NCT02044796|Antimetabolites|antimetabolites|mesh-ancestor
153400513|NCT02044796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153400514|NCT02044796|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153400515|NCT02044796|Antiviral Agents|antiviral agents|mesh-ancestor
153400516|NCT02044796|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153400517|NCT02044796|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153400518|NCT02044796|Immunologic Factors|immunologic factors|mesh-ancestor
153400519|NCT02044796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153400520|NCT02044796|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153400539|NCT03127943|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
153400540|NCT03127943|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153400541|NCT03127943|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153400542|NCT03127943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153400543|NCT03048383|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
153400544|NCT03048383|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
153400545|NCT03048383|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
153400546|NCT03048383|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153400547|NCT03048383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153400548|NCT03048383|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
153400549|NCT03048383|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153402533|NCT05114460|Naloxone|naloxone|mesh-list
153860230|NCT00542126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153860231|NCT00542126|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
153860232|NCT00542126|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153860233|NCT00542126|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153860234|NCT00542165|Alfuzosin|alfuzosin|mesh-list
153860235|NCT00542165|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
153860236|NCT00542165|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
153860237|NCT00542165|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
153860238|NCT00542165|Adrenergic Agents|adrenergic agents|mesh-ancestor
153860239|NCT00542165|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153860240|NCT00542165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153860241|NCT00542165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153860242|NCT00542165|Urological Agents|urological agents|mesh-ancestor
153860243|NCT00542243|Finasteride|finasteride|mesh-list
153860244|NCT00542243|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
153860245|NCT00542243|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153860246|NCT00542243|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153860247|NCT00542243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153860248|NCT00542243|Hormone Antagonists|hormone antagonists|mesh-ancestor
153400553|NCT02045264|Icatibant|icatibant|mesh-list
153400554|NCT02045264|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153400555|NCT02045264|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153400556|NCT02045264|Analgesics|analgesics|mesh-ancestor
153400557|NCT02045264|Sensory System Agents|sensory system agents|mesh-ancestor
153400558|NCT02045264|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153400559|NCT02045264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153649436|NCT00025597|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
153649437|NCT00025597|Etoposide|etoposide|mesh-list
153649438|NCT00025597|Vincristine|vincristine|mesh-list
153649439|NCT00025597|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153649440|NCT00025597|Immunologic Factors|immunologic factors|mesh-ancestor
153400560|NCT02045264|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153400561|NCT02045264|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153400562|NCT02045264|Bradykinin B2 Receptor Antagonists|bradykinin b2 receptor antagonists|mesh-ancestor
153400563|NCT02045264|Bradykinin Receptor Antagonists|bradykinin receptor antagonists|mesh-ancestor
153400564|NCT02045264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153400565|NCT02045264|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
153400566|NCT02045264|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153400567|NCT02045264|Immunologic Factors|immunologic factors|mesh-ancestor
153400568|NCT02975297|Exenatide|exenatide|mesh-list
153400569|NCT02975297|Nicotine|nicotine|mesh-list
153400570|NCT02975297|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
153400571|NCT02975297|Autonomic Agents|autonomic agents|mesh-ancestor
153400572|NCT02975297|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153400573|NCT02975297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153400574|NCT02975297|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
153400575|NCT02975297|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
153400576|NCT02975297|Cholinergic Agents|cholinergic agents|mesh-ancestor
153400577|NCT02975297|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153400578|NCT02975297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153400579|NCT02975297|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
153400580|NCT02975297|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153400581|NCT02975297|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
153400584|NCT02975297|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153860254|NCT00542399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153860255|NCT00542555|Naproxen|naproxen|mesh-list
153860256|NCT00542555|Naproxen-n-butyl nitrate|naproxen-n-butyl nitrate|mesh-list
153824725|NCT00491985|Vaccines|vaccines|mesh-list
153364725|NCT02462928|Growth Inhibitors|growth inhibitors|mesh-ancestor
153364726|NCT02462928|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153364727|NCT03002831|Tegafur|tegafur|mesh-list
153860257|NCT00542555|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153860258|NCT00542555|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153860259|NCT00542555|Analgesics|analgesics|mesh-ancestor
153860260|NCT00542555|Sensory System Agents|sensory system agents|mesh-ancestor
153860261|NCT00542555|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153860269|NCT00542555|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
153860270|NCT00542711|Curcumin|curcumin|mesh-list
153860271|NCT00542711|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153860272|NCT00542711|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153860273|NCT00542711|Analgesics|analgesics|mesh-ancestor
153860274|NCT00542711|Sensory System Agents|sensory system agents|mesh-ancestor
153860275|NCT00542711|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153860276|NCT00542711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153860277|NCT00542711|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153860278|NCT00542711|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153860279|NCT00542711|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153860280|NCT00542711|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153860281|NCT00542711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153860282|NCT00542984|Teriparatide|teriparatide|mesh-list
153860283|NCT00542984|Calcitonin|calcitonin|mesh-list
153860284|NCT00542984|Salmon calcitonin|salmon calcitonin|mesh-list
153860285|NCT00542984|Calcitonin Gene-Related Peptide|calcitonin gene-related peptide|mesh-list
153400607|NCT00374855|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
153400608|NCT00374855|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153400610|NCT00374855|Natriuretic Agents|natriuretic agents|mesh-ancestor
153400611|NCT00374855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153400612|NCT00374855|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
153400613|NCT00374855|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153400614|NCT00374855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153400615|NCT02412644|Apremilast|apremilast|mesh-list
153400616|NCT02412644|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153400617|NCT02412644|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153649449|NCT00025597|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153649450|NCT00025597|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153649451|NCT00025597|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153649494|NCT00025636|Antiviral Agents|antiviral agents|mesh-ancestor
153649495|NCT00025636|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153400618|NCT02412644|Analgesics|analgesics|mesh-ancestor
153400619|NCT02412644|Sensory System Agents|sensory system agents|mesh-ancestor
153400620|NCT02412644|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153400621|NCT02412644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153400622|NCT02412644|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153400623|NCT02412644|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153860291|NCT02257983|Ubiquinone|ubiquinone|mesh-list
153860303|NCT04648917|Caffeic acid|caffeic acid|mesh-list
153860304|NCT04648917|Antioxidants|antioxidants|mesh-ancestor
153860305|NCT04648917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153860315|NCT00543218|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153860317|NCT00543218|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153860318|NCT00543218|Vasodilator Agents|vasodilator agents|mesh-ancestor
153860319|NCT02252835|Colchicine|colchicine|mesh-list
153860320|NCT02252835|Febuxostat|febuxostat|mesh-list
153860321|NCT02252835|Gout Suppressants|gout suppressants|mesh-ancestor
153860322|NCT02252835|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153860323|NCT02252835|Tubulin Modulators|tubulin modulators|mesh-ancestor
153860324|NCT02252835|Antimitotic Agents|antimitotic agents|mesh-ancestor
153860325|NCT02252835|Mitosis Modulators|mitosis modulators|mesh-ancestor
153400633|NCT04737473|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153400634|NCT04737473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153400635|NCT02369900|Esmolol|esmolol|mesh-list
153400636|NCT02369900|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
153400637|NCT02369900|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
153400638|NCT02369900|Adrenergic Agents|adrenergic agents|mesh-ancestor
153400639|NCT02369900|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153400640|NCT02369900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153400641|NCT02369900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153860329|NCT03456752|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153860330|NCT03456752|Antiemetics|antiemetics|mesh-ancestor
153860331|NCT03456752|Autonomic Agents|autonomic agents|mesh-ancestor
153860332|NCT03456752|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153860340|NCT03456713|Mirikizumab|mirikizumab|mesh-list
153860341|NCT03456713|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153860342|NCT03456713|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153860343|NCT03456713|Analgesics|analgesics|mesh-ancestor
153860344|NCT03456713|Sensory System Agents|sensory system agents|mesh-ancestor
153860345|NCT03456713|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153860346|NCT03456713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153860347|NCT03456713|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153400642|NCT02369900|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
153400643|NCT03054857|Dexmedetomidine|dexmedetomidine|mesh-list
153400644|NCT03054857|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153400645|NCT03054857|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153400646|NCT03054857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153400647|NCT03054857|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153400648|NCT03054857|Analgesics|analgesics|mesh-ancestor
153400649|NCT03054857|Sensory System Agents|sensory system agents|mesh-ancestor
153400650|NCT03054857|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153824788|NCT00492219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153824789|NCT00492219|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
153824790|NCT00492219|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153824791|NCT00492219|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153824792|NCT00465257|Artesunate|artesunate|mesh-list
153824793|NCT00465257|Amodiaquine|amodiaquine|mesh-list
153824794|NCT00465257|Antimalarials|antimalarials|mesh-ancestor
153824795|NCT00465257|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153860350|NCT03456713|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153860351|NCT04648137|N-Methyl-3,4-methylenedioxyamphetamine|n-methyl-3,4-methylenedioxyamphetamine|mesh-list
153860352|NCT04648137|Hallucinogens|hallucinogens|mesh-ancestor
153860353|NCT04648137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153860354|NCT04648137|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153860355|NCT04648137|Serotonin Agents|serotonin agents|mesh-ancestor
153860356|NCT04648137|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153860357|NCT04648137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153860358|NCT04648137|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
153860359|NCT04648137|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153860360|NCT04648137|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153860361|NCT04648137|Adrenergic Agents|adrenergic agents|mesh-ancestor
153860362|NCT04648332|Bupivacaine|bupivacaine|mesh-list
153400657|NCT02414204|Sildenafil Citrate|sildenafil citrate|mesh-list
153400658|NCT02414204|Vasodilator Agents|vasodilator agents|mesh-ancestor
153860531|NCT01191268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153860532|NCT01191268|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
153860534|NCT04647552|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153400910|NCT02044393|Itraconazole|itraconazole|mesh-list
153400911|NCT02044393|Antifungal Agents|antifungal agents|mesh-ancestor
153400912|NCT02044393|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153400913|NCT02044393|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
153400914|NCT02044393|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153400915|NCT02044393|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153400916|NCT02044393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153401057|NCT02065687|Mitosis Modulators|mitosis modulators|mesh-ancestor
153401058|NCT02065687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153401059|NCT02065687|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153401060|NCT02065687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153401062|NCT03096353|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
153401063|NCT03096353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153401064|NCT03096353|Sensory System Agents|sensory system agents|mesh-ancestor
153401065|NCT03096353|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153401066|NCT03098615|Efinaconazole|efinaconazole|mesh-list
153860809|NCT04968899|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153860810|NCT04968899|Glucocorticoids|glucocorticoids|mesh-ancestor
153860812|NCT04968899|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153860813|NCT04968899|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153860814|NCT04968899|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153860815|NCT04968899|Immunologic Factors|immunologic factors|mesh-ancestor
153860816|NCT04965818|Futibatinib|futibatinib|mesh-list
153860817|NCT04965818|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153860818|NCT04941105|Evolocumab|evolocumab|mesh-list
153860819|NCT04941105|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
153860820|NCT04941105|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153860821|NCT04941105|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153860822|NCT04941105|Antimetabolites|antimetabolites|mesh-ancestor
153860823|NCT04941105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153860824|NCT04941105|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
153401177|NCT02393378|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153401178|NCT02393378|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153401179|NCT02393378|Immunologic Factors|immunologic factors|mesh-ancestor
153401180|NCT02393378|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153401181|NCT02393378|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153401182|NCT02393378|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
153860936|NCT04609176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153860937|NCT04562090|Mirabegron|mirabegron|mesh-list
153860938|NCT04562090|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
153860939|NCT04562090|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
153860940|NCT04562090|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153860941|NCT04562090|Adrenergic Agents|adrenergic agents|mesh-ancestor
153401250|NCT05423834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153401252|NCT05423834|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153401253|NCT03103061|Regadenoson|regadenoson|mesh-list
153401254|NCT03103061|Adenosine A2 Receptor Agonists|adenosine a2 receptor agonists|mesh-ancestor
153401255|NCT03103061|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
153401256|NCT03103061|Purinergic Agonists|purinergic agonists|mesh-ancestor
153401257|NCT03103061|Purinergic Agents|purinergic agents|mesh-ancestor
153401258|NCT03103061|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153401259|NCT03103061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153401260|NCT03103061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153401262|NCT03105479|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153401263|NCT03105479|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153401264|NCT00355862|Cyclosporine|cyclosporine|mesh-list
153401265|NCT00355862|Sirolimus|sirolimus|mesh-list
153861053|NCT03433807|Idebenone|idebenone|mesh-list
153861054|NCT03433807|Antioxidants|antioxidants|mesh-ancestor
153861055|NCT03433807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153861056|NCT03433807|Protective Agents|protective agents|mesh-ancestor
153824804|NCT04130776|Coagulants|coagulants|mesh-ancestor
153824805|NCT04130776|Fertility Agents, Male|fertility agents, male|mesh-ancestor
153824806|NCT04130776|Fertility Agents|fertility agents|mesh-ancestor
153861061|NCT03416179|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153861062|NCT03416179|Antimetabolites|antimetabolites|mesh-ancestor
153401374|NCT02051335|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
153401375|NCT02051335|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
153401376|NCT02051335|Parasympatholytics|parasympatholytics|mesh-ancestor
153401377|NCT03290027|Tazarotene|tazarotene|mesh-list
153401378|NCT03290027|Dermatologic Agents|dermatologic agents|mesh-ancestor
153401379|NCT03290027|Keratolytic Agents|keratolytic agents|mesh-ancestor
153861130|NCT01792934|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153861132|NCT01792934|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153861133|NCT01792934|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153401487|NCT04736381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153401488|NCT04736381|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153401490|NCT03302741|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
153401491|NCT03302741|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153401492|NCT03302741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153401493|NCT03302741|Cholinergic Agents|cholinergic agents|mesh-ancestor
153401494|NCT03302741|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153824817|NCT02955810|Daratumumab|daratumumab|mesh-list
153861483|NCT00548483|Autonomic Agents|autonomic agents|mesh-ancestor
153401836|NCT05987696|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153401837|NCT05987696|Immunologic Factors|immunologic factors|mesh-ancestor
153401838|NCT05987696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153401871|NCT05986968|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153401873|NCT05986968|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153401874|NCT05986968|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153401875|NCT05986968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153861558|NCT00560586|Autonomic Agents|autonomic agents|mesh-ancestor
153861559|NCT00560586|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153861560|NCT00560586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153861561|NCT00560586|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153861562|NCT00560586|Respiratory System Agents|respiratory system agents|mesh-ancestor
153861563|NCT00560586|Glucocorticoids|glucocorticoids|mesh-ancestor
153861564|NCT00560586|Hormones|hormones|mesh-ancestor
153861565|NCT00560586|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153861566|NCT00549068|Risedronic Acid|risedronic acid|mesh-list
153861567|NCT00549068|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153401895|NCT05986201|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
153861710|NCT00550199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153861711|NCT00550199|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153861712|NCT00550199|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
153861713|NCT00550199|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153861714|NCT04643301|Liraglutide|liraglutide|mesh-list
153861715|NCT04643301|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
153402085|NCT05814640|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153402086|NCT05814640|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153402244|NCT05529147|Antihypertensive Agents|antihypertensive agents|mesh-list
153402245|NCT05526690|Metformin|metformin|mesh-list
153402246|NCT05526690|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153402247|NCT05526690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153402248|NCT05526430|Harmine|harmine|mesh-list
153402249|NCT05526430|Hallucinogens|hallucinogens|mesh-ancestor
153402586|NCT05074589|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153402647|NCT05049616|Protease Inhibitors|protease inhibitors|mesh-ancestor
153402648|NCT05049616|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153824838|NCT00465296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153824839|NCT00492414|Paroxetine|paroxetine|mesh-list
153824840|NCT00492414|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
153824841|NCT00492414|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153824842|NCT00492414|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153824843|NCT00492414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153824844|NCT00492414|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153824845|NCT00492414|Serotonin Agents|serotonin agents|mesh-ancestor
153824846|NCT00492414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153824847|NCT00492414|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
153824848|NCT00492414|Antidepressive Agents|antidepressive agents|mesh-ancestor
153824849|NCT00492414|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153402649|NCT05049213|Povidone-Iodine|povidone-iodine|mesh-list
153402651|NCT05049213|Plasma Substitutes|plasma substitutes|mesh-ancestor
153402652|NCT05049213|Blood Substitutes|blood substitutes|mesh-ancestor
153402653|NCT05049213|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
153402654|NCT05049213|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153402655|NCT05025605|Dexmedetomidine|dexmedetomidine|mesh-list
153402656|NCT05025605|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153402657|NCT05025605|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153402658|NCT05025605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153402829|NCT04760626|Insulin|insulin|mesh-list
153824852|NCT00492414|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153824853|NCT01243632|Gemcitabine|gemcitabine|mesh-list
153649499|NCT00025675|Gefitinib|gefitinib|mesh-list
153824854|NCT01243632|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153364819|NCT03401606|Analgesics|analgesics|mesh-ancestor
153364820|NCT03401606|Sensory System Agents|sensory system agents|mesh-ancestor
153364821|NCT03401606|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153364822|NCT03401606|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
153364823|NCT03401606|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153364824|NCT03401606|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153364825|NCT03401606|Adrenergic Agents|adrenergic agents|mesh-ancestor
153364826|NCT03401606|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153364827|NCT03401606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153862776|NCT02900729|Natriuretic Agents|natriuretic agents|mesh-ancestor
153862777|NCT02900729|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
153862778|NCT01190410|Certolizumab Pegol|certolizumab pegol|mesh-list
153862779|NCT01190410|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
153862780|NCT01190410|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153862781|NCT01190410|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153862782|NCT01190410|Immunologic Factors|immunologic factors|mesh-ancestor
153862804|NCT04621110|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153862805|NCT04621110|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153862806|NCT04621110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153862807|NCT04621110|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153862808|NCT04621110|Analgesics|analgesics|mesh-ancestor
153862809|NCT04621110|Sensory System Agents|sensory system agents|mesh-ancestor
153862810|NCT04621110|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153862811|NCT04621110|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
153403176|NCT04139304|Glucocorticoids|glucocorticoids|mesh-ancestor
153403249|NCT04043195|Ipilimumab|ipilimumab|mesh-list
153403250|NCT04043195|Oxaliplatin|oxaliplatin|mesh-list
153403251|NCT04043195|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153403252|NCT04043195|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153403253|NCT04043195|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153403254|NCT04043195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153403255|NCT04038255|Nicotine|nicotine|mesh-list
153403256|NCT04038255|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
153403257|NCT04038255|Autonomic Agents|autonomic agents|mesh-ancestor
153403258|NCT04038255|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153403259|NCT04038255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153403260|NCT04038255|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
153403261|NCT04038255|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
153403262|NCT04038255|Cholinergic Agents|cholinergic agents|mesh-ancestor
153403263|NCT04038255|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153403264|NCT04038255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153403265|NCT04031729|Aspirin|aspirin|mesh-list
153403266|NCT04031729|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153403267|NCT04031729|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153403268|NCT04031729|Analgesics|analgesics|mesh-ancestor
153403269|NCT04031729|Sensory System Agents|sensory system agents|mesh-ancestor
153403270|NCT04031729|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153862879|NCT04619862|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153403302|NCT04014387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153403304|NCT04005053|Acetylcysteine|acetylcysteine|mesh-list
153403305|NCT04005053|N-monoacetylcystine|n-monoacetylcystine|mesh-list
153403306|NCT04005053|Antiviral Agents|antiviral agents|mesh-ancestor
153403407|NCT03719326|Tubulin Modulators|tubulin modulators|mesh-ancestor
153403408|NCT03719326|Antimitotic Agents|antimitotic agents|mesh-ancestor
153403409|NCT03719326|Mitosis Modulators|mitosis modulators|mesh-ancestor
153403410|NCT03719326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153403411|NCT03719326|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153824856|NCT01243632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153364854|NCT03401372|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153364855|NCT03401372|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153364856|NCT03401372|Alkylating Agents|alkylating agents|mesh-ancestor
153364857|NCT03401372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153364858|NCT03401372|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153364859|NCT03401372|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153364860|NCT03401372|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153364861|NCT03401372|Antiemetics|antiemetics|mesh-ancestor
153364862|NCT03401372|Autonomic Agents|autonomic agents|mesh-ancestor
153364863|NCT03401372|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153824873|NCT00592579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153824874|NCT00592618|Acetylcysteine|acetylcysteine|mesh-list
153824875|NCT00592618|N-monoacetylcystine|n-monoacetylcystine|mesh-list
153824876|NCT00592618|Antiviral Agents|antiviral agents|mesh-ancestor
153824877|NCT00592618|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153403412|NCT03719326|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153403413|NCT03719326|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153403414|NCT03719326|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153863044|NCT04618497|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153863045|NCT04618497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153863046|NCT04618497|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153863047|NCT04618497|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153863048|NCT04618497|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153863049|NCT04618497|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153863083|NCT04618107|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153863084|NCT04618107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153863086|NCT05423015|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153863087|NCT04618146|Morphine|morphine|mesh-list
153863106|NCT05421962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153863107|NCT05421962|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
153863108|NCT05421962|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153863109|NCT05421962|Anesthetics, General|anesthetics, general|mesh-ancestor
153863110|NCT05421962|Anesthetics|anesthetics|mesh-ancestor
153863111|NCT05421962|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153863145|NCT05419583|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
153863146|NCT05419583|Protease Inhibitors|protease inhibitors|mesh-ancestor
153863147|NCT05419583|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153863148|NCT05419583|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153863149|NCT05419583|Antimetabolites|antimetabolites|mesh-ancestor
153863150|NCT05419583|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153863151|NCT05387408|Analgesics, Opioid|analgesics, opioid|mesh-list
153863152|NCT05387408|Narcotics|narcotics|mesh-ancestor
153403545|NCT03474198|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
153403546|NCT03474198|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
153403547|NCT03474198|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
153863154|NCT05387408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153863155|NCT05387408|Analgesics|analgesics|mesh-ancestor
153863156|NCT05387408|Sensory System Agents|sensory system agents|mesh-ancestor
153863157|NCT05387408|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153863158|NCT05376761|Dexmedetomidine|dexmedetomidine|mesh-list
153863159|NCT05376761|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153863160|NCT05376761|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153863161|NCT05376761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153403549|NCT03474198|Antimetabolites|antimetabolites|mesh-ancestor
153403588|NCT03342027|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153403613|NCT03192995|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
153403614|NCT03192995|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153403615|NCT03192995|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153403616|NCT03192995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153403680|NCT03035331|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153403681|NCT03035331|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153403682|NCT03035331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153403684|NCT02944500|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
153403685|NCT02944500|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153403754|NCT02684227|Paclitaxel|paclitaxel|mesh-list
153403755|NCT02684227|Carboplatin|carboplatin|mesh-list
153403756|NCT02684227|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
153403757|NCT02684227|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153733399|NCT00507091|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153403758|NCT02684227|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153403759|NCT02684227|Tubulin Modulators|tubulin modulators|mesh-ancestor
153403760|NCT02684227|Antimitotic Agents|antimitotic agents|mesh-ancestor
153403761|NCT02684227|Mitosis Modulators|mitosis modulators|mesh-ancestor
153403762|NCT02684227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153403763|NCT02623972|Cyclophosphamide|cyclophosphamide|mesh-list
153403764|NCT02623972|Doxorubicin|doxorubicin|mesh-list
153403765|NCT02623972|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
153403766|NCT02623972|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153403767|NCT02623972|Immunologic Factors|immunologic factors|mesh-ancestor
153403768|NCT02623972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153403769|NCT02623972|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153824902|NCT01245543|Antimitotic Agents|antimitotic agents|mesh-ancestor
153824903|NCT01245543|Mitosis Modulators|mitosis modulators|mesh-ancestor
153824904|NCT01245543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153824905|NCT00592930|Olanzapine|olanzapine|mesh-list
153824906|NCT00592930|Antiemetics|antiemetics|mesh-ancestor
153824907|NCT00592930|Autonomic Agents|autonomic agents|mesh-ancestor
153824908|NCT00592930|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153824909|NCT00592930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153824910|NCT00592930|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153824911|NCT00592930|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153403770|NCT02623972|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153403771|NCT02623972|Alkylating Agents|alkylating agents|mesh-ancestor
153403772|NCT02623972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153403773|NCT02623972|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153403774|NCT02623972|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153403775|NCT02623972|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153403776|NCT02623972|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153863397|NCT04615611|Albuterol|albuterol|mesh-list
153863398|NCT04615611|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153863399|NCT04615611|Autonomic Agents|autonomic agents|mesh-ancestor
153863400|NCT04615611|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153863401|NCT04615611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153863444|NCT04613700|Hormones|hormones|mesh-ancestor
153863471|NCT00563472|Desogestrel|desogestrel|mesh-list
153863472|NCT00563472|Progesterone|progesterone|mesh-list
153863473|NCT00563472|Progestins|progestins|mesh-ancestor
153863474|NCT00563472|Hormones|hormones|mesh-ancestor
153863475|NCT00563472|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153863476|NCT00563472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153863477|NCT00563472|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
153863478|NCT00563472|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
153863479|NCT00563472|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
153863480|NCT00563472|Contraceptive Agents|contraceptive agents|mesh-ancestor
153863481|NCT00563472|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153863483|NCT00563472|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
153863484|NCT04679597|Capecitabine|capecitabine|mesh-list
153863485|NCT04679597|Oxaliplatin|oxaliplatin|mesh-list
153863486|NCT04679597|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153863487|NCT04679597|Antimetabolites|antimetabolites|mesh-ancestor
153863488|NCT04679597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153403863|NCT02389036|Beta Lactam Antibiotics|beta lactam antibiotics|mesh-ancestor
153403865|NCT02389036|Ionophores|ionophores|mesh-ancestor
153403866|NCT02389036|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153403867|NCT02369523|Bupivacaine|bupivacaine|mesh-list
153403868|NCT02369523|Ropivacaine|ropivacaine|mesh-list
153403869|NCT02369523|Anesthetics, Local|anesthetics, local|mesh-ancestor
153403870|NCT02369523|Anesthetics|anesthetics|mesh-ancestor
153403871|NCT02369523|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153403872|NCT02369523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153403873|NCT02369523|Sensory System Agents|sensory system agents|mesh-ancestor
153403874|NCT02369523|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153403875|NCT02339064|Apomorphine|apomorphine|mesh-list
153403876|NCT02339064|Emetics|emetics|mesh-ancestor
153403877|NCT02339064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153403878|NCT02339064|Autonomic Agents|autonomic agents|mesh-ancestor
153403879|NCT02339064|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153403880|NCT02339064|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153403881|NCT02339064|Dopamine Agonists|dopamine agonists|mesh-ancestor
153403882|NCT02339064|Dopamine Agents|dopamine agents|mesh-ancestor
153403883|NCT02339064|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153403885|NCT02277717|Trastuzumab|trastuzumab|mesh-list
153824916|NCT00592930|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153824917|NCT00592930|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153824918|NCT00592930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153824919|NCT00592930|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153824920|NCT00592930|Serotonin Agents|serotonin agents|mesh-ancestor
153824921|NCT00592969|Metformin|metformin|mesh-list
153824922|NCT00592969|Insulin Aspart|insulin aspart|mesh-list
153824923|NCT00592969|Biphasic Insulins|biphasic insulins|mesh-list
153403886|NCT02277717|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153403887|NCT02277717|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153403888|NCT02207712|Ranibizumab|ranibizumab|mesh-list
153403889|NCT02207712|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153403890|NCT02207712|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153403891|NCT02207712|Growth Substances|growth substances|mesh-ancestor
153863505|NCT04612998|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153863506|NCT04612998|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153863507|NCT04612998|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153863508|NCT04612998|Autonomic Agents|autonomic agents|mesh-ancestor
153863509|NCT04612998|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153863510|NCT04612998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153863511|NCT04612998|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153863512|NCT04612998|Respiratory System Agents|respiratory system agents|mesh-ancestor
153863513|NCT04612998|Mydriatics|mydriatics|mesh-ancestor
153863514|NCT04612998|Parasympatholytics|parasympatholytics|mesh-ancestor
153863515|NCT04612998|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
153863516|NCT04612998|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
153863517|NCT04612998|Cholinergic Agents|cholinergic agents|mesh-ancestor
153863518|NCT04612998|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153863519|NCT04612998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153863520|NCT04612998|Antiemetics|antiemetics|mesh-ancestor
153863558|NCT04612803|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153863559|NCT04612803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153863560|NCT04612803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153863562|NCT02204345|Carboplatin|carboplatin|mesh-list
153863563|NCT02204345|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153403983|NCT01726582|Vitamin B Complex|vitamin b complex|mesh-ancestor
153403987|NCT01687127|Vitamin B Complex|vitamin b complex|mesh-list
153403989|NCT01687127|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153863617|NCT00560898|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
153403999|NCT01565200|Immunoconjugates|immunoconjugates|mesh-ancestor
153404000|NCT01565200|Immunologic Factors|immunologic factors|mesh-ancestor
153404001|NCT01565200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153404002|NCT01565200|Tubulin Modulators|tubulin modulators|mesh-ancestor
153404003|NCT01565200|Antimitotic Agents|antimitotic agents|mesh-ancestor
153404004|NCT01565200|Mitosis Modulators|mitosis modulators|mesh-ancestor
153824935|NCT00593008|Sirolimus|sirolimus|mesh-list
153824936|NCT00593008|Gemcitabine|gemcitabine|mesh-list
153824937|NCT00593008|Temsirolimus|temsirolimus|mesh-list
153824938|NCT00593008|MTOR Inhibitors|mtor inhibitors|mesh-list
153824939|NCT00593008|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153824940|NCT00593008|Antimetabolites|antimetabolites|mesh-ancestor
153404017|NCT01476787|Growth Inhibitors|growth inhibitors|mesh-ancestor
153404018|NCT01476787|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153404019|NCT01476787|Alkylating Agents|alkylating agents|mesh-ancestor
153404020|NCT01476787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153404022|NCT01059786|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
153404023|NCT01059786|Pentostatin|pentostatin|mesh-list
153404024|NCT01059786|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153404025|NCT01059786|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153404026|NCT01059786|Immunologic Factors|immunologic factors|mesh-ancestor
153404027|NCT01059786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153404030|NCT01059786|Alkylating Agents|alkylating agents|mesh-ancestor
153824941|NCT00593008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153824942|NCT00593008|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153364906|NCT04716335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153364907|NCT02221349|Listerine|listerine|mesh-list
153364908|NCT02221349|Fluorides|fluorides|mesh-list
153364909|NCT02221349|Sodium Fluoride|sodium fluoride|mesh-list
153364910|NCT02221349|Tin Fluorides|tin fluorides|mesh-list
153364911|NCT02221349|Cariostatic Agents|cariostatic agents|mesh-ancestor
153364912|NCT02221349|Protective Agents|protective agents|mesh-ancestor
153364913|NCT02221349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153364914|NCT02221349|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
153364915|NCT02221349|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153364916|NCT02461758|Vaccines|vaccines|mesh-list
153863644|NCT04611711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153863645|NCT04611711|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153863646|NCT04611711|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153863647|NCT04632537|BCG Vaccine|bcg vaccine|mesh-list
153863648|NCT04632537|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153863649|NCT04632537|Immunologic Factors|immunologic factors|mesh-ancestor
153863650|NCT04632537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153863651|NCT02092922|Filanesib|filanesib|mesh-list
153863652|NCT02092922|Lenograstim|lenograstim|mesh-list
153863653|NCT02092922|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153863654|NCT02092922|Immunologic Factors|immunologic factors|mesh-ancestor
153404036|NCT00871065|Sildenafil Citrate|sildenafil citrate|mesh-list
153404056|NCT00786682|Docetaxel|docetaxel|mesh-list
153404061|NCT00786682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153404062|NCT00786682|Antimalarials|antimalarials|mesh-ancestor
153404063|NCT00786682|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153404064|NCT00786682|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153863678|NCT02081300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153364945|NCT02461134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153863765|NCT02026349|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153404147|NCT00118131|Docetaxel|docetaxel|mesh-list
153404148|NCT00118131|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153404149|NCT00118131|Tubulin Modulators|tubulin modulators|mesh-ancestor
153404150|NCT00118131|Antimitotic Agents|antimitotic agents|mesh-ancestor
153404151|NCT00118131|Mitosis Modulators|mitosis modulators|mesh-ancestor
153404152|NCT00118131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153364960|NCT02223065|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
153364961|NCT02223065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153364962|NCT02223065|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153364963|NCT02223065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153364964|NCT02223065|Incretins|incretins|mesh-ancestor
153364965|NCT02223065|Hormones|hormones|mesh-ancestor
153364966|NCT02223065|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153364967|NCT02223065|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
153364968|NCT02223065|Protease Inhibitors|protease inhibitors|mesh-ancestor
153364969|NCT02223065|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153364970|NCT04366232|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
153863805|NCT01998035|Antimetabolites|antimetabolites|mesh-ancestor
153404231|NCT03838484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153404234|NCT03838484|Cholinergic Agents|cholinergic agents|mesh-ancestor
153404235|NCT03838484|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153404236|NCT03838484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153404237|NCT05721872|Arsenic Trioxide|arsenic trioxide|mesh-list
153404238|NCT05721872|Isoascorbic acid|isoascorbic acid|mesh-list
153404239|NCT05721872|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153404240|NCT05721872|Antioxidants|antioxidants|mesh-ancestor
153404241|NCT05721872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153824994|NCT05653453|Tubulin Modulators|tubulin modulators|mesh-ancestor
153824995|NCT05653453|Antimitotic Agents|antimitotic agents|mesh-ancestor
153824996|NCT05653453|Mitosis Modulators|mitosis modulators|mesh-ancestor
153824997|NCT05653453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153824998|NCT05653453|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153364982|NCT02241278|Anesthetics|anesthetics|mesh-ancestor
153825007|NCT00468182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153825008|NCT00468182|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153825009|NCT05649163|Disitamab vedotin|disitamab vedotin|mesh-list
153825010|NCT05649163|Immunoconjugates|immunoconjugates|mesh-ancestor
153825011|NCT05649163|Immunologic Factors|immunologic factors|mesh-ancestor
153825012|NCT05649163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153825013|NCT00465452|Dopamine|dopamine|mesh-list
153825014|NCT00465452|Dopamine Agonists|dopamine agonists|mesh-list
153825015|NCT00465452|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
153825016|NCT00465452|Sympathomimetics|sympathomimetics|mesh-ancestor
153825017|NCT00465452|Autonomic Agents|autonomic agents|mesh-ancestor
153825018|NCT00465452|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153825019|NCT00465452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153404255|NCT03216356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153404256|NCT02411929|Ertugliflozin|ertugliflozin|mesh-list
153404257|NCT02411929|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
153404258|NCT02411929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153404259|NCT02411929|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153404260|NCT02411929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153404262|NCT00356954|Antioxidants|antioxidants|mesh-ancestor
153404263|NCT00356954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153364996|NCT04347512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153364997|NCT04347512|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153364998|NCT02460978|Dapagliflozin|dapagliflozin|mesh-list
153364999|NCT02460978|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
153365000|NCT02460978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153365001|NCT02460978|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153365002|NCT02460978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153365003|NCT04372316|Vitamin B 12|vitamin b 12|mesh-list
153365004|NCT04372316|Vitamin B Complex|vitamin b complex|mesh-ancestor
153365005|NCT04372316|Vitamins|vitamins|mesh-ancestor
153825030|NCT01379521|Immunologic Factors|immunologic factors|mesh-ancestor
153825031|NCT01379521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153825032|NCT01379521|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153825033|NCT00468260|Epothilone B|epothilone b|mesh-list
153825034|NCT00468260|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153825035|NCT00468260|Tubulin Modulators|tubulin modulators|mesh-ancestor
153825036|NCT00468260|Antimitotic Agents|antimitotic agents|mesh-ancestor
153404374|NCT01349192|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153404375|NCT01349192|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153404376|NCT01349192|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153404377|NCT01349192|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
153404378|NCT01349192|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
153404379|NCT01349192|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153404380|NCT01349192|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
153404381|NCT02362321|Dexamethasone|dexamethasone|mesh-list
153404382|NCT02362321|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153863987|NCT01941836|8-hydroxy-2,2,14,14-tetramethylpentadecanedioic acid|8-hydroxy-2,2,14,14-tetramethylpentadecanedioic acid|mesh-list
153863989|NCT01941836|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153863990|NCT01941836|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153863991|NCT01941836|Antimetabolites|antimetabolites|mesh-ancestor
153863992|NCT01941836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153863993|NCT01941836|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153863994|NCT01941836|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153863995|NCT01941836|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153863996|NCT01941836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153404386|NCT02362321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153404387|NCT02362321|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153404388|NCT02362321|Glucocorticoids|glucocorticoids|mesh-ancestor
153404389|NCT02362321|Hormones|hormones|mesh-ancestor
153404390|NCT02362321|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153404391|NCT02362321|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153404392|NCT02362321|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153404393|NCT00354991|Losartan|losartan|mesh-list
153404394|NCT00354991|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
153404395|NCT00354991|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153404396|NCT00354991|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153404397|NCT00354991|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
153404398|NCT00354991|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
153404401|NCT00354991|Natriuretic Agents|natriuretic agents|mesh-ancestor
153404402|NCT00354991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153404403|NCT00354991|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
153864004|NCT01163851|Antimetabolites|antimetabolites|mesh-ancestor
153864005|NCT01163851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153864006|NCT01163851|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153864007|NCT01917383|Timolol|timolol|mesh-list
153864008|NCT01917383|Latanoprost|latanoprost|mesh-list
153864009|NCT01917383|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
153864010|NCT01917383|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
153864011|NCT01917383|Adrenergic Agents|adrenergic agents|mesh-ancestor
153825049|NCT00465608|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
153825050|NCT00465608|Adrenergic Agents|adrenergic agents|mesh-ancestor
153825051|NCT00465608|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153825052|NCT00465608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153365016|NCT02241356|Sympathomimetics|sympathomimetics|mesh-ancestor
153365017|NCT02241356|Autonomic Agents|autonomic agents|mesh-ancestor
153365018|NCT02241356|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153365019|NCT02241356|Dopamine Agents|dopamine agents|mesh-ancestor
153365020|NCT02241356|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153365021|NCT02241356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153365022|NCT02241356|Adrenergic Agents|adrenergic agents|mesh-ancestor
153864012|NCT01917383|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153864013|NCT01917383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153864014|NCT01917383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153864015|NCT01917383|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153864016|NCT01917383|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153404644|NCT05419297|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153404645|NCT05419297|Narcotics|narcotics|mesh-ancestor
153404658|NCT03226457|Diuretics|diuretics|mesh-ancestor
153404659|NCT03226457|Natriuretic Agents|natriuretic agents|mesh-ancestor
153404660|NCT03226457|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
153825054|NCT00465608|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153825055|NCT00465608|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153825056|NCT00465608|Vasodilator Agents|vasodilator agents|mesh-ancestor
153825058|NCT01371877|Ergocalciferols|ergocalciferols|mesh-list
153825059|NCT01371877|Cholecalciferol|cholecalciferol|mesh-list
153825060|NCT01371877|Vitamins|vitamins|mesh-list
153365023|NCT02241356|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
153365024|NCT02241356|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153365025|NCT02241356|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153365026|NCT02241356|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
153365027|NCT04365686|Propofol|propofol|mesh-list
153365028|NCT04365686|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153365029|NCT04365686|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153365030|NCT04365686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153365031|NCT04365686|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153864263|NCT01758458|Aldesleukin|aldesleukin|mesh-list
153864264|NCT01758458|Interferon-beta|interferon-beta|mesh-list
153864265|NCT01758458|Interleukin-2|interleukin-2|mesh-list
153864266|NCT01758458|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153864267|NCT01758458|Antiviral Agents|antiviral agents|mesh-ancestor
153404694|NCT03228017|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153404695|NCT03228017|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153404696|NCT03228017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153404697|NCT03228017|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153404698|NCT03228017|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153404699|NCT03228017|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153404701|NCT03228017|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153404702|NCT03228017|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153404703|NCT03228017|Antimetabolites|antimetabolites|mesh-ancestor
153404704|NCT03228017|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153404705|NCT03228017|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
153404706|NCT00355927|Propofol|propofol|mesh-list
153404707|NCT00355927|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153461665|NCT03174132|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153825061|NCT01371877|Micronutrients|micronutrients|mesh-ancestor
153825062|NCT01371877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153825063|NCT01371877|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153825064|NCT01371877|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153825065|NCT01245816|Eflornithine|eflornithine|mesh-list
153825066|NCT01245816|Sulindac|sulindac|mesh-list
153825067|NCT01245816|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153825068|NCT01245816|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
153825069|NCT01245816|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153825070|NCT01245816|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153825071|NCT01245816|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153365033|NCT04365686|Anesthetics|anesthetics|mesh-ancestor
153365034|NCT02241590|Entecavir|entecavir|mesh-list
153404717|NCT00357422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153404759|NCT00003183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153404760|NCT00003183|Analgesics|analgesics|mesh-ancestor
153404761|NCT00003183|Sensory System Agents|sensory system agents|mesh-ancestor
153404762|NCT00003183|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153404763|NCT00003183|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153404764|NCT00003183|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153404765|NCT00003183|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153404766|NCT00003183|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153404767|NCT00003183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153404768|NCT02979223|Ascorbic Acid|ascorbic acid|mesh-list
153404769|NCT02979223|Magnesium citrate|magnesium citrate|mesh-list
153404770|NCT02979223|Picosulfate sodium|picosulfate sodium|mesh-list
153461666|NCT03174132|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153461667|NCT03174132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153461668|NCT03174132|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153461669|NCT03174132|Immunologic Factors|immunologic factors|mesh-ancestor
153864364|NCT01698281|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153864365|NCT01698281|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153864366|NCT01698281|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153864367|NCT01698281|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153864368|NCT01698281|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153864369|NCT01698281|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153864370|NCT01698281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153864372|NCT00565461|Immunologic Factors|immunologic factors|mesh-ancestor
153864373|NCT00565461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153864374|NCT01858883|Paclitaxel|paclitaxel|mesh-list
153864375|NCT01858883|Gemcitabine|gemcitabine|mesh-list
153404771|NCT02979223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153404773|NCT02979223|Protective Agents|protective agents|mesh-ancestor
153404774|NCT02979223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153404775|NCT02979223|Vitamins|vitamins|mesh-ancestor
153404824|NCT05716256|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
153404825|NCT05716256|Protease Inhibitors|protease inhibitors|mesh-ancestor
153404826|NCT05716256|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153404827|NCT05716256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153864422|NCT01658501|Hormones|hormones|mesh-ancestor
153864423|NCT01658501|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153864424|NCT01651871|Cetirizine|cetirizine|mesh-list
153864425|NCT01651871|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
153825098|NCT00492687|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153825099|NCT01371838|Ceftriaxone|ceftriaxone|mesh-list
153825100|NCT01371838|Ceftaroline|ceftaroline|mesh-list
153825101|NCT01371838|Third Generation Cephalosporins|third generation cephalosporins|mesh-ancestor
153864426|NCT01651871|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
153864427|NCT01651871|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
153864428|NCT01651871|Histamine Antagonists|histamine antagonists|mesh-ancestor
153864429|NCT01651871|Histamine Agents|histamine agents|mesh-ancestor
153864430|NCT01651871|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153404829|NCT00356083|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153404830|NCT00356083|Narcotics|narcotics|mesh-ancestor
153404831|NCT00356083|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153864431|NCT01651871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153864432|NCT01651871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153864433|NCT04608006|Fentanyl|fentanyl|mesh-list
153864434|NCT04608006|Bupivacaine|bupivacaine|mesh-list
153864435|NCT04608006|Anesthetics, Local|anesthetics, local|mesh-ancestor
153864436|NCT04608006|Anesthetics|anesthetics|mesh-ancestor
153404867|NCT00003207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153864470|NCT01632137|Antioxidants|antioxidants|mesh-ancestor
153864471|NCT01632137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153864472|NCT01632137|Protective Agents|protective agents|mesh-ancestor
153864473|NCT01632137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153864474|NCT01632137|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153864475|NCT00565539|Interferons|interferons|mesh-list
153864476|NCT00565539|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153864477|NCT00565539|Antiviral Agents|antiviral agents|mesh-ancestor
153864480|NCT04599699|Hormones|hormones|mesh-ancestor
153864499|NCT01303796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153864500|NCT01303796|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153864501|NCT01303796|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153864502|NCT04598880|Magnesium citrate|magnesium citrate|mesh-list
153864503|NCT04598880|Picosulfate sodium|picosulfate sodium|mesh-list
153864504|NCT04598880|Cathartics|cathartics|mesh-ancestor
153864505|NCT04598880|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153864506|NCT00564564|Quetiapine Fumarate|quetiapine fumarate|mesh-list
153864507|NCT00564564|Clomipramine|clomipramine|mesh-list
153864508|NCT00564564|Antidepressive Agents|antidepressive agents|mesh-ancestor
153864509|NCT00564564|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153864510|NCT00564564|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153864511|NCT00564564|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153864512|NCT00564564|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153864513|NCT00564564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153864514|NCT00564564|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
153864515|NCT00564564|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
153864516|NCT00564564|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153404946|NCT00003399|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153404947|NCT00003399|Tubulin Modulators|tubulin modulators|mesh-ancestor
153404948|NCT00003399|Antimitotic Agents|antimitotic agents|mesh-ancestor
153404949|NCT00003399|Mitosis Modulators|mitosis modulators|mesh-ancestor
153404950|NCT00003399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153864531|NCT00565656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153864532|NCT00565656|Growth Inhibitors|growth inhibitors|mesh-ancestor
153864533|NCT00564603|Dexamethasone|dexamethasone|mesh-list
153864534|NCT00564603|Dexamethasone acetate|dexamethasone acetate|mesh-list
153864535|NCT00564603|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
153864536|NCT00564603|BB 1101|bb 1101|mesh-list
153404955|NCT00003399|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153404956|NCT00003399|Alkylating Agents|alkylating agents|mesh-ancestor
153404957|NCT00003399|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153404958|NCT00003399|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153404959|NCT00003399|Antiemetics|antiemetics|mesh-ancestor
153404960|NCT00003399|Autonomic Agents|autonomic agents|mesh-ancestor
153404961|NCT00003399|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153864554|NCT00555347|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
153864555|NCT00555347|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
153864556|NCT00555347|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
153864557|NCT00555347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153864558|NCT00564642|Acetylcysteine|acetylcysteine|mesh-list
153864559|NCT00564642|N-monoacetylcystine|n-monoacetylcystine|mesh-list
153864560|NCT00564642|Antiviral Agents|antiviral agents|mesh-ancestor
153864561|NCT00564642|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153864562|NCT00564642|Expectorants|expectorants|mesh-ancestor
153864563|NCT00564642|Respiratory System Agents|respiratory system agents|mesh-ancestor
153864564|NCT00564642|Free Radical Scavengers|free radical scavengers|mesh-ancestor
153864565|NCT00564642|Antioxidants|antioxidants|mesh-ancestor
153404991|NCT00003219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153404993|NCT05715788|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153404994|NCT05715788|Autonomic Agents|autonomic agents|mesh-ancestor
153404995|NCT05715788|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153404996|NCT05715788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153404997|NCT05715788|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153404998|NCT05715788|Respiratory System Agents|respiratory system agents|mesh-ancestor
153404999|NCT05715788|Free Radical Scavengers|free radical scavengers|mesh-ancestor
153405001|NCT05715788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153405002|NCT05715788|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153405004|NCT05715788|Vasodilator Agents|vasodilator agents|mesh-ancestor
153405110|NCT03384329|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153405112|NCT03443063|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
153405113|NCT03443063|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153405114|NCT03443063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153405115|NCT03443063|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
153405116|NCT03443063|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153405117|NCT03443063|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153405118|NCT03443063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153405119|NCT03256253|Pregabalin|pregabalin|mesh-list
153405120|NCT03256253|Analgesics|analgesics|mesh-ancestor
153405121|NCT03256253|Sensory System Agents|sensory system agents|mesh-ancestor
153365136|NCT02242370|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153864738|NCT01161472|GABA Agents|gaba agents|mesh-ancestor
153864739|NCT01161472|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153864740|NCT01161472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153864741|NCT01161472|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
153864742|NCT01161472|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
153405148|NCT01238211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153405149|NCT01238211|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153405150|NCT01238211|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153405151|NCT01238211|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153405152|NCT01238211|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153405153|NCT01238211|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153405154|NCT01238211|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153405155|NCT04735445|Liver Extracts|liver extracts|mesh-list
153405156|NCT04735445|Hematinics|hematinics|mesh-ancestor
153405157|NCT00003231|Docetaxel|docetaxel|mesh-list
153405158|NCT00003231|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153405159|NCT00003231|Tubulin Modulators|tubulin modulators|mesh-ancestor
153405160|NCT00003231|Antimitotic Agents|antimitotic agents|mesh-ancestor
153405161|NCT00003231|Mitosis Modulators|mitosis modulators|mesh-ancestor
153405162|NCT00003231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153405163|NCT00003405|Interferons|interferons|mesh-list
153405164|NCT00003405|Cytarabine|cytarabine|mesh-list
153864743|NCT01161472|Cholinergic Agents|cholinergic agents|mesh-ancestor
153864744|NCT01161472|Urological Agents|urological agents|mesh-ancestor
153864745|NCT04675385|Hyaluronic Acid|hyaluronic acid|mesh-list
153864746|NCT04675385|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153864747|NCT04675385|Immunologic Factors|immunologic factors|mesh-ancestor
153864748|NCT04675385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153864749|NCT04675385|Viscosupplements|viscosupplements|mesh-ancestor
153864750|NCT04675385|Protective Agents|protective agents|mesh-ancestor
153864751|NCT04598061|Dexmedetomidine|dexmedetomidine|mesh-list
153864815|NCT00566124|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153864816|NCT00566124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153864817|NCT01159912|Fluticasone|fluticasone|mesh-list
153405223|NCT04344158|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153405224|NCT04344158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153405225|NCT00003249|Ketoconazole|ketoconazole|mesh-list
153405226|NCT00003249|Carboxyamido-triazole|carboxyamido-triazole|mesh-list
153405227|NCT00003249|Antifungal Agents|antifungal agents|mesh-ancestor
153405228|NCT00003249|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153405254|NCT03269435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153405255|NCT03269435|Sensory System Agents|sensory system agents|mesh-ancestor
153864849|NCT04631822|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153864851|NCT04605705|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153864852|NCT04605705|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153405265|NCT00003261|Zidovudine|zidovudine|mesh-list
153405467|NCT05445440|Sulfasalazine|sulfasalazine|mesh-list
153405468|NCT05445440|Methotrexate|methotrexate|mesh-list
153865044|NCT01157182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153865045|NCT01157182|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
153865046|NCT01157182|Contraceptive Agents|contraceptive agents|mesh-ancestor
153865047|NCT01157182|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153865048|NCT01157182|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
153865049|NCT01157182|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
153865050|NCT01157182|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
153865141|NCT01155661|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-list
153865142|NCT01155661|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
153865143|NCT01155661|Serotonin Agents|serotonin agents|mesh-ancestor
153405554|NCT00360386|Purinergic Agents|purinergic agents|mesh-ancestor
153865161|NCT00565188|Purinergic Agents|purinergic agents|mesh-ancestor
153865162|NCT00565188|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153865163|NCT00565188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153865166|NCT04603833|Tubulin Modulators|tubulin modulators|mesh-ancestor
153865167|NCT04603833|Antimitotic Agents|antimitotic agents|mesh-ancestor
153865168|NCT04603833|Mitosis Modulators|mitosis modulators|mesh-ancestor
153865169|NCT04603833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153865170|NCT04603872|Dasatinib|dasatinib|mesh-list
153405582|NCT04343768|Interferon beta-1a|interferon beta-1a|mesh-list
153405583|NCT04343768|Hydroxychloroquine|hydroxychloroquine|mesh-list
153405584|NCT04343768|Interferon beta-1b|interferon beta-1b|mesh-list
153405585|NCT04343768|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153405586|NCT04343768|Antiviral Agents|antiviral agents|mesh-ancestor
153865227|NCT04626752|Alkylating Agents|alkylating agents|mesh-ancestor
153865228|NCT04626752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153865229|NCT04626752|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153865230|NCT04626752|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153865231|NCT01155466|Rasagiline|rasagiline|mesh-list
153865232|NCT01155466|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
153865233|NCT01155466|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153865234|NCT01155466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153865235|NCT01155466|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
153865260|NCT00565227|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
153865261|NCT00565227|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153865326|NCT04601142|Protective Agents|protective agents|mesh-ancestor
153865327|NCT04601142|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153865328|NCT04601142|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153865329|NCT04625543|Paclitaxel|paclitaxel|mesh-list
153865330|NCT04625543|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
153865331|NCT04625543|Cisplatin|cisplatin|mesh-list
153865332|NCT04625543|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153865333|NCT04625543|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153865334|NCT04625543|Tubulin Modulators|tubulin modulators|mesh-ancestor
153865335|NCT04625543|Antimitotic Agents|antimitotic agents|mesh-ancestor
153865336|NCT04625543|Mitosis Modulators|mitosis modulators|mesh-ancestor
153405814|NCT05918133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153405816|NCT05918107|Pemetrexed|pemetrexed|mesh-list
153405817|NCT05918107|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153405818|NCT05918107|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153405819|NCT05918107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153865406|NCT00567177|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
153865407|NCT00567216|Nadolol|nadolol|mesh-list
153865408|NCT00567216|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
153865409|NCT00567216|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
153405820|NCT05918107|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153405821|NCT05918107|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153405822|NCT05897268|Lenvatinib|lenvatinib|mesh-list
153405823|NCT05897268|Tislelizumab|tislelizumab|mesh-list
153405824|NCT05897268|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153405825|NCT05897268|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153405826|NCT05897268|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153405827|NCT05897268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153405828|NCT05897268|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153405829|NCT05895019|Propofol|propofol|mesh-list
153405830|NCT05895019|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153405831|NCT05895019|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153405832|NCT05895019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153405833|NCT05895019|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153405834|NCT05895019|Anesthetics, General|anesthetics, general|mesh-ancestor
153405835|NCT05895019|Anesthetics|anesthetics|mesh-ancestor
153405836|NCT05893056|Lenvatinib|lenvatinib|mesh-list
153405837|NCT05893056|Tislelizumab|tislelizumab|mesh-list
153405838|NCT05893056|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153405840|NCT05893056|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153865535|NCT00562289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153865536|NCT00562289|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153865537|NCT00562289|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153865538|NCT00562289|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153865539|NCT00562289|Antipyretics|antipyretics|mesh-ancestor
153865542|NCT00562289|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
153365376|NCT01632995|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153365378|NCT01632995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153365379|NCT01632995|Antiviral Agents|antiviral agents|mesh-ancestor
153865618|NCT04622618|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153865619|NCT04622618|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153865620|NCT04622618|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
153406080|NCT05457998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153406083|NCT05438316|Protease Inhibitors|protease inhibitors|mesh-ancestor
153825418|NCT01243788|Respiratory System Agents|respiratory system agents|mesh-ancestor
153825419|NCT01243788|Dermatologic Agents|dermatologic agents|mesh-ancestor
153825420|NCT01243788|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
153825421|NCT01243788|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
153825422|NCT01243788|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
153825423|NCT01243788|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153825424|NCT01243788|Adrenergic Agents|adrenergic agents|mesh-ancestor
153825425|NCT01243788|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153865703|NCT04621487|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153865704|NCT04621487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153865705|NCT04621487|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
153865706|NCT04621487|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153406190|NCT05213676|Free Radical Scavengers|free radical scavengers|mesh-ancestor
153406192|NCT05213676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153406193|NCT05213676|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153733413|NCT05148910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153365407|NCT02224313|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153365408|NCT02224313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153365409|NCT02224313|Progestins|progestins|mesh-ancestor
153365410|NCT04362410|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
153365411|NCT04362410|Immunologic Factors|immunologic factors|mesh-ancestor
153365412|NCT04362410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153669901|NCT00846326|Xhance|xhance|mesh-list
153365413|NCT02460198|Pembrolizumab|pembrolizumab|mesh-list
153365414|NCT02460198|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153365415|NCT02460198|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153365416|NCT02460198|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153365417|NCT02460198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153365419|NCT01633853|Ergocalciferols|ergocalciferols|mesh-list
153365420|NCT01633853|Cholecalciferol|cholecalciferol|mesh-list
153865830|NCT04588389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153865831|NCT00637234|Oxcarbazepine|oxcarbazepine|mesh-list
153865935|NCT00562835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153865936|NCT00562835|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153865937|NCT00562835|Antiemetics|antiemetics|mesh-ancestor
153865938|NCT00562835|Autonomic Agents|autonomic agents|mesh-ancestor
153865939|NCT00562835|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153865940|NCT00562835|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153865941|NCT00562835|Glucocorticoids|glucocorticoids|mesh-ancestor
153865942|NCT00562835|Hormones|hormones|mesh-ancestor
153865943|NCT00562835|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153865944|NCT00562835|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
153865945|NCT00562835|Protective Agents|protective agents|mesh-ancestor
153865946|NCT00562835|Vitamin B Complex|vitamin b complex|mesh-ancestor
153865947|NCT00568737|Drotrecogin alfa activated|drotrecogin alfa activated|mesh-list
153406416|NCT04562792|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153406417|NCT04562792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153406418|NCT04544813|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
153406419|NCT04544813|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153406420|NCT04501367|Dexamethasone|dexamethasone|mesh-list
153406423|NCT04501367|BB 1101|bb 1101|mesh-list
153406427|NCT04501367|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153406428|NCT04501367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153406429|NCT04501367|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153406430|NCT04501367|Glucocorticoids|glucocorticoids|mesh-ancestor
153406431|NCT04501367|Hormones|hormones|mesh-ancestor
153406432|NCT04501367|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153406433|NCT04501367|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153866005|NCT04586361|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153406457|NCT04427293|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153406458|NCT04427293|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153406460|NCT04391842|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153406461|NCT04391842|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153406462|NCT04391842|Analgesics|analgesics|mesh-ancestor
153406463|NCT04391842|Sensory System Agents|sensory system agents|mesh-ancestor
153406464|NCT04391842|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153406465|NCT04391842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153406466|NCT04391842|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153406467|NCT04391842|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153406468|NCT04391842|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153406469|NCT04391842|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153406470|NCT04391842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153406471|NCT04383262|Fosamprenavir|fosamprenavir|mesh-list
153406472|NCT04383262|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
153403864|NCT02389036|Antifungal Agents|antifungal agents|mesh-ancestor
153406473|NCT04383262|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
153406474|NCT04383262|Protease Inhibitors|protease inhibitors|mesh-ancestor
153406475|NCT04383262|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153406476|NCT04383262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153406477|NCT04383262|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153406478|NCT04383262|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153866043|NCT04618601|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
153866045|NCT04618601|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153866046|NCT04618601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153866049|NCT04618601|Natriuretic Agents|natriuretic agents|mesh-ancestor
153866050|NCT00567918|Tacrolimus|tacrolimus|mesh-list
153866051|NCT00567918|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153866052|NCT00567918|Immunologic Factors|immunologic factors|mesh-ancestor
153866053|NCT00567918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153866054|NCT00567918|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
153866055|NCT00567918|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153866056|NCT00567918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153866057|NCT00569712|Budesonide|budesonide|mesh-list
153866058|NCT00569712|Formoterol Fumarate|formoterol fumarate|mesh-list
153866059|NCT00569712|Dimercaprol|dimercaprol|mesh-list
153406487|NCT04360681|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
153406488|NCT04360681|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153406489|NCT04360681|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153406490|NCT04360681|Adrenergic Agents|adrenergic agents|mesh-ancestor
153406491|NCT04360681|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153406516|NCT04328844|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153406517|NCT04327024|Allopurinol|allopurinol|mesh-list
153406518|NCT04327024|Verinurad|verinurad|mesh-list
153406519|NCT04327024|Antimetabolites|antimetabolites|mesh-ancestor
153406520|NCT04327024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153866060|NCT00569712|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153866061|NCT00569712|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153866062|NCT00569712|Autonomic Agents|autonomic agents|mesh-ancestor
153866063|NCT00569712|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153406530|NCT04315272|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153406531|NCT04304352|Cyclophosphamide|cyclophosphamide|mesh-list
153406532|NCT04304352|Capecitabine|capecitabine|mesh-list
153406533|NCT04304352|Vinorelbine|vinorelbine|mesh-list
153406534|NCT04304352|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153406535|NCT04304352|Immunologic Factors|immunologic factors|mesh-ancestor
153406536|NCT04304352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153406537|NCT04304352|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153406538|NCT04304352|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153406539|NCT04304352|Alkylating Agents|alkylating agents|mesh-ancestor
153406540|NCT04304352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153406541|NCT04304352|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153406542|NCT04304352|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153406543|NCT04304352|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153403897|NCT02187991|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153406544|NCT04304352|Antimetabolites|antimetabolites|mesh-ancestor
153406545|NCT04304352|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153866099|NCT00567957|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153866100|NCT00567957|Narcotics|narcotics|mesh-ancestor
153866101|NCT00567957|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153866102|NCT00567957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153365507|NCT01869413|Hemostatics|hemostatics|mesh-ancestor
153365508|NCT01869413|Coagulants|coagulants|mesh-ancestor
153365509|NCT02982512|Dexmedetomidine|dexmedetomidine|mesh-list
153365510|NCT02982512|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153365511|NCT02982512|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153365512|NCT02982512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153365513|NCT02982512|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153365514|NCT02982512|Analgesics|analgesics|mesh-ancestor
153825519|NCT00469586|Insulin|insulin|mesh-list
153825520|NCT00469586|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
153825521|NCT00469586|Metformin|metformin|mesh-list
153825522|NCT00469586|Glimepiride|glimepiride|mesh-list
153825523|NCT00469586|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153825524|NCT00469586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153825525|NCT00469586|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153825526|NCT00469586|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153866112|NCT02940002|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153866113|NCT02940002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153825538|NCT00493428|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
153866168|NCT00570219|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153866169|NCT00570219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153866170|NCT00570219|GABA Agents|gaba agents|mesh-ancestor
153866171|NCT00570219|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153866172|NCT00570219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153866173|NCT00570219|Antimanic Agents|antimanic agents|mesh-ancestor
153406605|NCT04268121|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153406606|NCT04268121|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153406607|NCT04268121|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153406608|NCT04268121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153406610|NCT04252612|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153406611|NCT04252612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153406612|NCT04251156|Semaglutide|semaglutide|mesh-list
153406613|NCT04251156|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
153406614|NCT04251156|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153406615|NCT04251156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153406616|NCT04210505|Povidone-Iodine|povidone-iodine|mesh-list
153406618|NCT04210505|Plasma Substitutes|plasma substitutes|mesh-ancestor
153406619|NCT04210505|Blood Substitutes|blood substitutes|mesh-ancestor
153406620|NCT04210505|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
153406621|NCT04210505|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153825550|NCT01342510|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153825551|NCT01342510|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153825552|NCT01342510|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
153825553|NCT01342510|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153825554|NCT01342510|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153825555|NCT01342510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153866190|NCT00568074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153866192|NCT00568113|N-monoacetylcystine|n-monoacetylcystine|mesh-list
153866197|NCT00568113|Free Radical Scavengers|free radical scavengers|mesh-ancestor
153866198|NCT00568113|Antioxidants|antioxidants|mesh-ancestor
153866199|NCT00568113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153866200|NCT00568113|Protective Agents|protective agents|mesh-ancestor
153406712|NCT03935893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153406714|NCT03935893|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153365571|NCT02451696|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153365572|NCT02451696|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153365573|NCT02451696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153365574|NCT02451696|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153866275|NCT00563108|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153866276|NCT00563108|Immunologic Factors|immunologic factors|mesh-ancestor
153866277|NCT00563108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153866278|NCT00570882|Sunitinib|sunitinib|mesh-list
153825586|NCT00469703|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153825588|NCT00469703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153825589|NCT00469703|Leprostatic Agents|leprostatic agents|mesh-ancestor
153825590|NCT00469703|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153825591|NCT00469703|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153825592|NCT00469703|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153866441|NCT04613180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153866442|NCT04613180|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
153866443|NCT04613180|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
153866444|NCT04613180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153866446|NCT00571935|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
153866447|NCT00571935|Insulin Aspart|insulin aspart|mesh-list
153866448|NCT00571935|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153866449|NCT00571935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153866450|NCT04612634|Vaccines|vaccines|mesh-list
153866451|NCT04612634|Immunologic Factors|immunologic factors|mesh-ancestor
153866452|NCT04612634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153866453|NCT04580199|Ethanol|ethanol|mesh-list
153866454|NCT04580199|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
153866455|NCT04580199|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153866458|NCT00568347|Fluticasone|fluticasone|mesh-list
153365595|NCT02459418|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153365596|NCT02459418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153649623|NCT00026416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153649624|NCT00026416|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153649625|NCT00026416|Leprostatic Agents|leprostatic agents|mesh-ancestor
153365597|NCT04361318|Hydroxychloroquine|hydroxychloroquine|mesh-list
153365598|NCT04361318|Nitazoxanide|nitazoxanide|mesh-list
153365599|NCT04361318|Antimalarials|antimalarials|mesh-ancestor
153365600|NCT04361318|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153825609|NCT01244100|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153825611|NCT01244100|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153825612|NCT01244100|Antipyretics|antipyretics|mesh-ancestor
153407411|NCT00665600|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153407412|NCT00665600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153407413|NCT00665600|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153407414|NCT00665600|Respiratory System Agents|respiratory system agents|mesh-ancestor
153866954|NCT00577161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153867119|NCT00578370|Respiratory System Agents|respiratory system agents|mesh-ancestor
153867121|NCT04593836|Menthol|menthol|mesh-list
153867122|NCT04593836|Antipruritics|antipruritics|mesh-ancestor
153867123|NCT04593836|Dermatologic Agents|dermatologic agents|mesh-ancestor
153867124|NCT04593836|Antiemetics|antiemetics|mesh-ancestor
153867125|NCT04593836|Autonomic Agents|autonomic agents|mesh-ancestor
153867126|NCT04593836|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153867127|NCT04593836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153867128|NCT04593836|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153867129|NCT04593836|Parasympatholytics|parasympatholytics|mesh-ancestor
153867130|NCT04593524|Vitamin D|vitamin d|mesh-list
153867131|NCT04593524|Vitamins|vitamins|mesh-ancestor
153867132|NCT04593524|Micronutrients|micronutrients|mesh-ancestor
153867133|NCT04593524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153867135|NCT00578526|Sunitinib|sunitinib|mesh-list
153867245|NCT04591535|Dopamine Agonists|dopamine agonists|mesh-ancestor
153867246|NCT00580242|Lenalidomide|lenalidomide|mesh-list
153867247|NCT00580242|Bortezomib|bortezomib|mesh-list
153867248|NCT00580242|Immunologic Factors|immunologic factors|mesh-ancestor
153867249|NCT00580242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153407715|NCT00003389|Immunologic Factors|immunologic factors|mesh-ancestor
153407716|NCT00003389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153407717|NCT00003389|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153407718|NCT00003389|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153407719|NCT00003389|Alkylating Agents|alkylating agents|mesh-ancestor
153407720|NCT00003389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153867257|NCT04591457|Insulin Glargine|insulin glargine|mesh-list
153867258|NCT04591457|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153867259|NCT04591457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153867260|NCT00580320|Bortezomib|bortezomib|mesh-list
153867261|NCT00580320|Dacarbazine|dacarbazine|mesh-list
153867262|NCT00580320|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153867263|NCT00580320|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153867264|NCT00580320|Alkylating Agents|alkylating agents|mesh-ancestor
153867265|NCT00580320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153867266|NCT00580359|Capecitabine|capecitabine|mesh-list
153867292|NCT04590638|Racepinephrine|racepinephrine|mesh-list
153407759|NCT00002525|Protective Agents|protective agents|mesh-ancestor
153407760|NCT00002525|Vitamin B Complex|vitamin b complex|mesh-ancestor
153407761|NCT00002525|Vitamins|vitamins|mesh-ancestor
153407762|NCT00002525|Micronutrients|micronutrients|mesh-ancestor
153407763|NCT05475522|Aminolevulinic Acid|aminolevulinic acid|mesh-list
153407764|NCT05475522|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
153407765|NCT05475522|Dermatologic Agents|dermatologic agents|mesh-ancestor
153407766|NCT02259348|Aldesleukin|aldesleukin|mesh-list
153407768|NCT02259348|Melphalan|melphalan|mesh-list
153407769|NCT02259348|Mechlorethamine|mechlorethamine|mesh-list
153407770|NCT02259348|Thiotepa|thiotepa|mesh-list
153407771|NCT02259348|Rituximab|rituximab|mesh-list
153407772|NCT02259348|Fludarabine|fludarabine|mesh-list
153407774|NCT02259348|Interleukin-2|interleukin-2|mesh-list
153407775|NCT02259348|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153407776|NCT02259348|Immunologic Factors|immunologic factors|mesh-ancestor
153407777|NCT02259348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153407778|NCT02259348|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153407779|NCT02259348|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153407780|NCT02259348|Alkylating Agents|alkylating agents|mesh-ancestor
153407781|NCT02259348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153407782|NCT02259348|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153407783|NCT02259348|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153407801|NCT00357019|Respiratory System Agents|respiratory system agents|mesh-ancestor
153407802|NCT00357019|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
153407803|NCT00357019|Histamine Antagonists|histamine antagonists|mesh-ancestor
153407804|NCT00357019|Histamine Agents|histamine agents|mesh-ancestor
153407805|NCT00357019|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153407806|NCT00357019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153407807|NCT00357019|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
153407808|NCT00357019|Protective Agents|protective agents|mesh-ancestor
153407809|NCT00357019|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
153407810|NCT03994705|Cyclophosphamide|cyclophosphamide|mesh-list
153407811|NCT03994705|Fludarabine|fludarabine|mesh-list
153407812|NCT03994705|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153407813|NCT03994705|Immunologic Factors|immunologic factors|mesh-ancestor
153407823|NCT03587207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153407824|NCT03592121|Phenylephrine|phenylephrine|mesh-list
153407825|NCT03592121|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
153407826|NCT03592121|Mydriatics|mydriatics|mesh-ancestor
153404021|NCT01059786|Rituximab|rituximab|mesh-list
153407827|NCT03592121|Autonomic Agents|autonomic agents|mesh-ancestor
153407828|NCT03592121|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153407831|NCT03592121|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
153407832|NCT03592121|Nasal Decongestants|nasal decongestants|mesh-ancestor
153407833|NCT03592121|Respiratory System Agents|respiratory system agents|mesh-ancestor
153867412|NCT04577430|Dexmedetomidine|dexmedetomidine|mesh-list
153867413|NCT04577430|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153867414|NCT04577430|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153867415|NCT04577430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153867416|NCT04577430|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153867417|NCT04577430|Analgesics|analgesics|mesh-ancestor
153867418|NCT04577430|Sensory System Agents|sensory system agents|mesh-ancestor
153867419|NCT04577430|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153867420|NCT04577430|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
153867421|NCT04577430|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153867422|NCT04577430|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153867423|NCT04577430|Adrenergic Agents|adrenergic agents|mesh-ancestor
153867424|NCT04577430|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153407898|NCT03472469|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153407900|NCT03472469|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
153407901|NCT03472469|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
153407941|NCT02258334|Immunologic Factors|immunologic factors|mesh-ancestor
153408100|NCT04439396|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153408101|NCT04439396|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153408102|NCT04439396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153408442|NCT02976116|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153408444|NCT01600716|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
153408445|NCT01600716|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
153408446|NCT01600716|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
153408447|NCT01600716|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153408448|NCT01600716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153867987|NCT00570440|Ethinyl Estradiol|ethinyl estradiol|mesh-list
153867988|NCT00570440|Contraceptive Agents|contraceptive agents|mesh-list
153867989|NCT00570440|Contraceptives, Oral|contraceptives, oral|mesh-list
153867990|NCT00570440|Estradiol|estradiol|mesh-list
153867991|NCT00570440|Estrogens|estrogens|mesh-ancestor
153867992|NCT00570440|Hormones|hormones|mesh-ancestor
153825678|NCT00474890|Sympathomimetics|sympathomimetics|mesh-ancestor
153461671|NCT03174132|Protective Agents|protective agents|mesh-ancestor
153461672|NCT03818802|Niacinamide|niacinamide|mesh-list
153461674|NCT03818802|Nicotinic Acids|nicotinic acids|mesh-list
153461675|NCT03818802|Vitamin B Complex|vitamin b complex|mesh-ancestor
153461676|NCT03818802|Vitamins|vitamins|mesh-ancestor
153461677|NCT03818802|Micronutrients|micronutrients|mesh-ancestor
153461678|NCT03818802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153461679|NCT03818802|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153461680|NCT03818802|Antimetabolites|antimetabolites|mesh-ancestor
153409053|NCT04256603|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
153649677|NCT00027079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153649678|NCT00011778|Bortezomib|bortezomib|mesh-list
153649679|NCT00011778|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153649680|NCT00000425|Acetaminophen|acetaminophen|mesh-list
153649681|NCT00000425|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
153670529|NCT00129740|Nilotinib|nilotinib|mesh-list
153409054|NCT04256603|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153409055|NCT04256603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153409056|NCT04256603|Antimanic Agents|antimanic agents|mesh-ancestor
153868574|NCT00586833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153868576|NCT00575354|Sevoflurane|sevoflurane|mesh-list
153868577|NCT00575354|Isoflurane|isoflurane|mesh-list
153868578|NCT00575354|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153868579|NCT00575354|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
153868580|NCT00575354|Anesthetics, General|anesthetics, general|mesh-ancestor
153868581|NCT00575354|Anesthetics|anesthetics|mesh-ancestor
153868582|NCT00575354|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153868583|NCT00575354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153868584|NCT00586911|Betaine|betaine|mesh-list
153868585|NCT00586911|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153868586|NCT00586911|Lipotropic Agents|lipotropic agents|mesh-ancestor
153409092|NCT03127592|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153409093|NCT03127592|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153409094|NCT03127592|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
153409095|NCT03127592|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153409096|NCT03127592|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153409172|NCT01152541|Dextrans|dextrans|mesh-list
153409173|NCT01152541|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
153409174|NCT01152541|Vitamin B Complex|vitamin b complex|mesh-ancestor
153409175|NCT01152541|Vitamins|vitamins|mesh-ancestor
153409176|NCT01152541|Micronutrients|micronutrients|mesh-ancestor
153409177|NCT01152541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153409260|NCT05716945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153409261|NCT05716945|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153409262|NCT05716945|Glucocorticoids|glucocorticoids|mesh-ancestor
153409263|NCT05716945|Hormones|hormones|mesh-ancestor
153409264|NCT05716945|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153409265|NCT05716945|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153825726|NCT00501267|Autonomic Agents|autonomic agents|mesh-ancestor
153461681|NCT03818802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153461682|NCT03818802|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153461683|NCT03818802|Vasodilator Agents|vasodilator agents|mesh-ancestor
153461684|NCT04398108|Margetuximab|margetuximab|mesh-list
153461685|NCT04398108|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153409677|NCT02976727|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153409678|NCT02976727|Sensory System Agents|sensory system agents|mesh-ancestor
153409679|NCT02976727|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153409680|NCT02976727|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153409681|NCT02976727|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
153409682|NCT02976727|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153409683|NCT02976727|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153409684|NCT02976727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153409685|NCT02976727|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153409686|NCT02976727|Dermatologic Agents|dermatologic agents|mesh-ancestor
153409687|NCT02976727|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
153409688|NCT02977117|Dialysis Solutions|dialysis solutions|mesh-list
153409689|NCT02977117|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
153869164|NCT04607447|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153869165|NCT04607447|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153409711|NCT00360763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153409713|NCT04010305|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153409714|NCT04010305|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153409715|NCT04010305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153409716|NCT04010305|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153409717|NCT04010305|Analgesics|analgesics|mesh-ancestor
153409718|NCT04010305|Sensory System Agents|sensory system agents|mesh-ancestor
153409748|NCT04730635|Cholinergic Agents|cholinergic agents|mesh-ancestor
153869240|NCT00564707|Cholinergic Agents|cholinergic agents|mesh-ancestor
153869241|NCT00564707|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153461686|NCT01625286|Paclitaxel|paclitaxel|mesh-list
153461687|NCT01625286|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
153869282|NCT00564824|Purinergic Agents|purinergic agents|mesh-ancestor
153409850|NCT05444101|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
153869356|NCT00590694|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153869357|NCT00565175|Famotidine|famotidine|mesh-list
153869358|NCT00565175|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
153869359|NCT00565175|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153869360|NCT00565175|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
153869361|NCT00565175|Histamine Antagonists|histamine antagonists|mesh-ancestor
153869362|NCT00565175|Histamine Agents|histamine agents|mesh-ancestor
153869363|NCT00565175|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153869364|NCT00565175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153869365|NCT00565175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153409936|NCT01634100|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
153409937|NCT01634100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153869400|NCT00476151|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153869401|NCT00476151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153869402|NCT00476151|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
153869403|NCT00476151|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153869404|NCT00476151|Anesthetics, General|anesthetics, general|mesh-ancestor
153869405|NCT00476151|Anesthetics|anesthetics|mesh-ancestor
153869406|NCT00476151|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153869407|NCT00476151|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
153869408|NCT00476151|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
153869409|NCT00476151|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153869410|NCT00476151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153365790|NCT01605539|Anticonvulsants|anticonvulsants|mesh-ancestor
153365791|NCT02458638|Atezolizumab|atezolizumab|mesh-list
153365792|NCT02458638|Antibodies|antibodies|mesh-list
153365793|NCT02458638|Immunologic Factors|immunologic factors|mesh-ancestor
153365794|NCT02458638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153365795|NCT02458638|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153365796|NCT02458638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153869412|NCT00476151|Antidepressive Agents|antidepressive agents|mesh-ancestor
153869413|NCT00476151|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153869414|NCT00476151|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153869415|NCT00476151|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
153869416|NCT00476151|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153869417|NCT00476151|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153869418|NCT00476151|Adrenergic Agents|adrenergic agents|mesh-ancestor
153869420|NCT04603664|Cysteine Proteinase Inhibitors|cysteine proteinase inhibitors|mesh-ancestor
153869421|NCT04603664|Protease Inhibitors|protease inhibitors|mesh-ancestor
153869422|NCT04603664|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153869423|NCT04603664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153869424|NCT00474903|Aspirin|aspirin|mesh-list
153869425|NCT00474903|Esomeprazole|esomeprazole|mesh-list
153869426|NCT00474903|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
153869427|NCT00474903|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153869428|NCT00474903|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
153869429|NCT00474903|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153869430|NCT00474903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153869431|NCT00474903|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153869432|NCT00474903|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153869433|NCT00474903|Analgesics|analgesics|mesh-ancestor
153869434|NCT00474903|Sensory System Agents|sensory system agents|mesh-ancestor
153869436|NCT00474903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153869493|NCT00565253|Autonomic Agents|autonomic agents|mesh-ancestor
153410023|NCT00003423|Cyclophosphamide|cyclophosphamide|mesh-list
153410024|NCT00003423|Methotrexate|methotrexate|mesh-list
153410025|NCT00003423|Etoposide|etoposide|mesh-list
153461688|NCT01625286|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153461689|NCT01625286|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153461690|NCT01625286|Tubulin Modulators|tubulin modulators|mesh-ancestor
153461691|NCT01625286|Antimitotic Agents|antimitotic agents|mesh-ancestor
153461692|NCT01625286|Mitosis Modulators|mitosis modulators|mesh-ancestor
153461693|NCT01625286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153461694|NCT05158062|Paclitaxel|paclitaxel|mesh-list
153461695|NCT05158062|Docetaxel|docetaxel|mesh-list
153461696|NCT05158062|Bevacizumab|bevacizumab|mesh-list
153461697|NCT05158062|Carboplatin|carboplatin|mesh-list
153820244|NCT00463086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153820245|NCT00463086|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153820247|NCT02957435|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
153820248|NCT02957435|Hormone Antagonists|hormone antagonists|mesh-ancestor
153820249|NCT02957435|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153870023|NCT01089504|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
153649689|NCT00000425|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153649690|NCT00000428|Amitriptyline|amitriptyline|mesh-list
153649692|NCT00000428|Antidepressive Agents|antidepressive agents|mesh-ancestor
153870024|NCT01089504|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153870025|NCT01089504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153870026|NCT01089504|GABA Modulators|gaba modulators|mesh-ancestor
153410591|NCT00003543|Antimetabolites|antimetabolites|mesh-ancestor
153410592|NCT00003543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153410593|NCT00003543|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153410594|NCT00003543|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153410595|NCT00003543|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153410610|NCT00003549|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153410612|NCT00003549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153410613|NCT00003549|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153410614|NCT00003549|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153825851|NCT00600145|Histamine Antagonists|histamine antagonists|mesh-ancestor
153825852|NCT00600145|Histamine Agents|histamine agents|mesh-ancestor
153825853|NCT00600145|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153825854|NCT00600145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153825855|NCT00600145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153825856|NCT00600145|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153825857|NCT00600145|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153825858|NCT00600145|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153825859|NCT00600145|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
153410619|NCT00003549|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153410620|NCT00003549|Dermatologic Agents|dermatologic agents|mesh-ancestor
153410621|NCT00003549|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153410622|NCT00003549|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153410623|NCT00003549|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153410624|NCT00002883|Fluorouracil|fluorouracil|mesh-list
153410625|NCT00002883|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153870027|NCT01089504|GABA Agents|gaba agents|mesh-ancestor
153870028|NCT01089504|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
153410626|NCT00002883|Antimetabolites|antimetabolites|mesh-ancestor
153870029|NCT01089504|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
153870030|NCT01089504|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
153870031|NCT03452696|Calcium|calcium|mesh-list
153870032|NCT03452696|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153870033|NCT03452696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153870034|NCT01088997|Milrinone|milrinone|mesh-list
153870035|NCT01088997|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
153870036|NCT01088997|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153870037|NCT01088997|Vasodilator Agents|vasodilator agents|mesh-ancestor
153870038|NCT01088997|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
153870039|NCT01088997|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
153825860|NCT00600145|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
153410860|NCT00003597|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153410861|NCT00003597|Alkylating Agents|alkylating agents|mesh-ancestor
153410862|NCT00003597|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153410876|NCT00004005|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153410877|NCT00004005|Immunologic Factors|immunologic factors|mesh-ancestor
153410878|NCT00004005|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
153410879|NCT00004005|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153410880|NCT00004005|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153410881|NCT00004005|Antidotes|antidotes|mesh-ancestor
153870294|NCT01083810|Ritonavir|ritonavir|mesh-list
153870518|NCT01086267|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153870519|NCT00590915|Asparaginase|asparaginase|mesh-list
153411106|NCT00004071|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153411191|NCT00004107|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
153411192|NCT00004107|Immunologic Factors|immunologic factors|mesh-ancestor
153411258|NCT00005013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153411259|NCT00005013|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153649725|NCT00000461|Niacin|niacin|mesh-list
153411260|NCT00005013|Serotonin Agents|serotonin agents|mesh-ancestor
153411261|NCT00005013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153411326|NCT00003687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153411328|NCT00003693|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153870793|NCT03453164|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153870794|NCT03453164|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153870795|NCT03453164|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153870796|NCT03453164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153870798|NCT03450434|Glutarimide|glutarimide|mesh-list
153411420|NCT00003621|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153411421|NCT00003621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153411422|NCT00003621|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153411423|NCT00003621|Alkylating Agents|alkylating agents|mesh-ancestor
153411424|NCT00385359|Albuterol|albuterol|mesh-list
153411425|NCT00385359|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153411426|NCT00385359|Autonomic Agents|autonomic agents|mesh-ancestor
153411427|NCT00385359|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153411428|NCT00385359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153870872|NCT00195494|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153870874|NCT00195494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153870875|NCT00195494|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153411555|NCT00003741|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
153411556|NCT00003741|Immunologic Factors|immunologic factors|mesh-ancestor
153871027|NCT00191789|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153871028|NCT00191789|Antimetabolites|antimetabolites|mesh-ancestor
153871029|NCT00191789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153411636|NCT00004323|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153411637|NCT00004323|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153411638|NCT00004323|Glucocorticoids|glucocorticoids|mesh-ancestor
153411639|NCT00004323|Hormones|hormones|mesh-ancestor
153411640|NCT00004323|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153411641|NCT00004323|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
153411642|NCT00004323|Protective Agents|protective agents|mesh-ancestor
153411643|NCT00003753|Dexamethasone|dexamethasone|mesh-list
153871035|NCT00191282|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
153871036|NCT00191282|Insulin Glargine|insulin glargine|mesh-list
153871037|NCT00191282|Insulin Lispro|insulin lispro|mesh-list
153871038|NCT00191282|Isophane Insulin, Human|isophane insulin, human|mesh-list
153871039|NCT00191282|Insulin, Isophane|insulin, isophane|mesh-list
153871040|NCT00191282|Isophane insulin, beef|isophane insulin, beef|mesh-list
153411677|NCT00003765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153411678|NCT00003765|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153411679|NCT00003765|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153411680|NCT00003771|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
153411681|NCT00003771|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
153411682|NCT00003771|Norethindrone|norethindrone|mesh-list
153411683|NCT00003771|Norethindrone Acetate|norethindrone acetate|mesh-list
153411684|NCT00003771|Estradiol|estradiol|mesh-list
153411685|NCT00003771|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
153411686|NCT00003771|Estrogens|estrogens|mesh-ancestor
153411687|NCT00003771|Hormones|hormones|mesh-ancestor
153411688|NCT00003771|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153411689|NCT00003771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153411690|NCT00003771|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
153871065|NCT00198107|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153871066|NCT00198107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153871068|NCT00198107|Dopamine Agents|dopamine agents|mesh-ancestor
153871069|NCT00198107|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153871071|NCT00198107|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
153365948|NCT02237417|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
153365949|NCT02237417|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153365950|NCT02237417|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
153365951|NCT02237417|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
153871072|NCT00198107|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
153871073|NCT00198107|Serotonin Agents|serotonin agents|mesh-ancestor
153871074|NCT00198107|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
153871075|NCT00198107|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153871076|NCT00198107|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
153871077|NCT00198107|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
153871078|NCT00198107|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
153871079|NCT00198107|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153871080|NCT00198107|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
153871081|NCT00198107|Antitubercular Agents|antitubercular agents|mesh-ancestor
153871082|NCT00198107|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153871083|NCT00198107|Antimetabolites|antimetabolites|mesh-ancestor
153871084|NCT00179660|Lenalidomide|lenalidomide|mesh-list
153871085|NCT00179660|Immunologic Factors|immunologic factors|mesh-ancestor
153871086|NCT00179660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153871087|NCT00179660|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153871088|NCT00179660|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153871089|NCT00179660|Growth Substances|growth substances|mesh-ancestor
153871090|NCT00179660|Growth Inhibitors|growth inhibitors|mesh-ancestor
153871091|NCT00179660|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153411700|NCT00004401|Immunoglobulins|immunoglobulins|mesh-list
153411701|NCT00004401|Antibodies|antibodies|mesh-list
153411702|NCT00004401|gamma-Globulins|gamma-globulins|mesh-list
153411704|NCT00004401|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
153411705|NCT00004401|Immunologic Factors|immunologic factors|mesh-ancestor
153411706|NCT00004401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153411708|NCT00003783|Cytarabine|cytarabine|mesh-list
153411709|NCT00003783|Dexamethasone|dexamethasone|mesh-list
153411710|NCT00003783|Prednisone|prednisone|mesh-list
153411711|NCT00003783|Cyclophosphamide|cyclophosphamide|mesh-list
153411712|NCT00003783|Methotrexate|methotrexate|mesh-list
153871096|NCT00178256|Antimitotic Agents|antimitotic agents|mesh-ancestor
153871099|NCT02211222|Lenvatinib|lenvatinib|mesh-list
153871106|NCT00177164|Aripiprazole|aripiprazole|mesh-list
153871107|NCT00177164|Quetiapine Fumarate|quetiapine fumarate|mesh-list
153871108|NCT00177164|Ziprasidone|ziprasidone|mesh-list
153871109|NCT00177164|Antipsychotic Agents|antipsychotic agents|mesh-list
153871110|NCT00177164|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153871111|NCT00177164|Serotonin Agents|serotonin agents|mesh-ancestor
153871112|NCT00177164|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153411738|NCT00003783|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
153411739|NCT00003783|Abortifacient Agents|abortifacient agents|mesh-ancestor
153411740|NCT00003783|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153411741|NCT00003783|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153411742|NCT00003783|Antimetabolites|antimetabolites|mesh-ancestor
153411743|NCT00003783|Dermatologic Agents|dermatologic agents|mesh-ancestor
153411744|NCT00003783|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153411745|NCT00003783|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153411746|NCT00003783|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153411747|NCT00003783|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153411748|NCT00003783|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153411749|NCT00003783|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153411750|NCT00003783|Antiviral Agents|antiviral agents|mesh-ancestor
153411751|NCT00003783|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153411753|NCT00003783|Protective Agents|protective agents|mesh-ancestor
153871113|NCT00177164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153871114|NCT00177164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153871115|NCT00177164|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153871116|NCT00177164|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153871117|NCT00177164|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153871118|NCT00177164|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
153871119|NCT00177164|Dopamine Agents|dopamine agents|mesh-ancestor
153820250|NCT02957435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153820251|NCT02957435|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
153820252|NCT02957435|Diuretics|diuretics|mesh-ancestor
153820253|NCT02957435|Natriuretic Agents|natriuretic agents|mesh-ancestor
153871127|NCT00177164|Antidepressive Agents|antidepressive agents|mesh-ancestor
153871139|NCT04559841|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
153411754|NCT00003783|Vitamin B Complex|vitamin b complex|mesh-ancestor
153411755|NCT00003783|Vitamins|vitamins|mesh-ancestor
153411756|NCT00003783|Micronutrients|micronutrients|mesh-ancestor
153411757|NCT00003783|Tubulin Modulators|tubulin modulators|mesh-ancestor
153411758|NCT00003783|Antimitotic Agents|antimitotic agents|mesh-ancestor
153411759|NCT00003783|Mitosis Modulators|mitosis modulators|mesh-ancestor
153411760|NCT00003783|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153411761|NCT00003789|Melphalan|melphalan|mesh-list
153411762|NCT00003789|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153411763|NCT00003789|Alkylating Agents|alkylating agents|mesh-ancestor
153411764|NCT00003789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153411765|NCT00003789|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153649726|NCT00000461|Pravastatin|pravastatin|mesh-list
153649727|NCT00000461|Gemfibrozil|gemfibrozil|mesh-list
153411766|NCT00003789|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153411767|NCT00003789|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153411768|NCT00003789|Immunologic Factors|immunologic factors|mesh-ancestor
153411771|NCT00004407|Antibodies|antibodies|mesh-list
153411772|NCT00004407|gamma-Globulins|gamma-globulins|mesh-list
153411773|NCT00004407|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
153411774|NCT00004407|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
153411775|NCT00004407|Immunologic Factors|immunologic factors|mesh-ancestor
153365997|NCT01652495|Hormones|hormones|mesh-ancestor
153820254|NCT02957435|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153820255|NCT00471471|Sargramostim|sargramostim|mesh-list
153820256|NCT00471471|Immunologic Factors|immunologic factors|mesh-ancestor
153820257|NCT00471471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153820258|NCT02273492|Aspirin, Dipyridamole Drug Combination|aspirin, dipyridamole drug combination|mesh-list
153820259|NCT02273492|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153411776|NCT00004407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153411777|NCT00004419|Mitogens|mitogens|mesh-list
153411778|NCT00004419|Mitosis Modulators|mitosis modulators|mesh-ancestor
153411779|NCT00004419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153411780|NCT00004431|Baclofen|baclofen|mesh-list
153411781|NCT00004431|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
153871142|NCT02489942|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
153871143|NCT02489942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153871144|NCT02489942|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153871145|NCT02489942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153871146|NCT04559568|Midazolam|midazolam|mesh-list
153871147|NCT04559568|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153871148|NCT04559568|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153871149|NCT04559568|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153871150|NCT04559568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153871151|NCT04559568|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153871152|NCT04559568|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153871153|NCT04559568|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153871154|NCT04559568|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153871155|NCT04559568|Anesthetics, General|anesthetics, general|mesh-ancestor
153871156|NCT04559568|Anesthetics|anesthetics|mesh-ancestor
153871157|NCT04559568|GABA Modulators|gaba modulators|mesh-ancestor
153871158|NCT04559568|GABA Agents|gaba agents|mesh-ancestor
153871159|NCT04559568|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153871160|NCT04559568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153871184|NCT00176462|Autonomic Agents|autonomic agents|mesh-ancestor
153871185|NCT00176462|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153871186|NCT00176462|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153871187|NCT00176462|Glucocorticoids|glucocorticoids|mesh-ancestor
153871188|NCT00176462|Hormones|hormones|mesh-ancestor
153871189|NCT00176462|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153411802|NCT00384969|Immunologic Factors|immunologic factors|mesh-ancestor
153411818|NCT00385437|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
153411819|NCT00385437|Adrenergic Agents|adrenergic agents|mesh-ancestor
153411820|NCT00385437|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
153411821|NCT00385437|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153871210|NCT00176462|Mitosis Modulators|mitosis modulators|mesh-ancestor
153411822|NCT00385437|Serotonin Agents|serotonin agents|mesh-ancestor
153411823|NCT00385437|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
153411824|NCT00004467|Acetylcysteine|acetylcysteine|mesh-list
153411825|NCT00004467|N-monoacetylcystine|n-monoacetylcystine|mesh-list
153411826|NCT00004467|Antiviral Agents|antiviral agents|mesh-ancestor
153411827|NCT00004467|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153871214|NCT00175019|Allopurinol|allopurinol|mesh-list
153871215|NCT00175019|Febuxostat|febuxostat|mesh-list
153871216|NCT00175019|Antimetabolites|antimetabolites|mesh-ancestor
153871217|NCT00175019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153871232|NCT00171704|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153871233|NCT00171704|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153871234|NCT00171704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153871235|NCT00171704|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
153871236|NCT00171704|Hormone Antagonists|hormone antagonists|mesh-ancestor
153366007|NCT00935792|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
153366008|NCT00935792|Alemtuzumab|alemtuzumab|mesh-list
153366009|NCT00935792|Everolimus|everolimus|mesh-list
153366010|NCT00935792|Antibodies|antibodies|mesh-list
153366011|NCT00935792|Immunoglobulins|immunoglobulins|mesh-list
153366012|NCT00935792|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
153366013|NCT00935792|Immunologic Factors|immunologic factors|mesh-ancestor
153366016|NCT00935792|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
153871237|NCT00171704|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153411851|NCT00004485|Cyclosporins|cyclosporins|mesh-list
153411852|NCT00004485|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153411853|NCT00004485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153411854|NCT00004485|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153411855|NCT00004485|Immunologic Factors|immunologic factors|mesh-ancestor
153411856|NCT00004485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153411857|NCT00004485|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153411858|NCT00004485|Antifungal Agents|antifungal agents|mesh-ancestor
153411859|NCT00004485|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153411860|NCT00004485|Dermatologic Agents|dermatologic agents|mesh-ancestor
153411861|NCT00004485|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153411862|NCT00004485|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
153411863|NCT00004485|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153411864|NCT00004485|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
153411865|NCT00004485|Antitubercular Agents|antitubercular agents|mesh-ancestor
153411866|NCT00004485|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153411867|NCT00385125|Rituximab|rituximab|mesh-list
153411868|NCT00385125|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
153411869|NCT00385125|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153411870|NCT00385125|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153411871|NCT00385125|Immunologic Factors|immunologic factors|mesh-ancestor
153411872|NCT00385125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153411873|NCT00385125|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153411874|NCT00385125|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153411875|NCT00385125|Alkylating Agents|alkylating agents|mesh-ancestor
153871251|NCT00171314|Hormone Antagonists|hormone antagonists|mesh-ancestor
153871252|NCT00171314|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153871253|NCT00171314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153871254|NCT00171314|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153871255|NCT00171158|Imatinib Mesylate|imatinib mesylate|mesh-list
153871256|NCT00171158|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153871257|NCT00171158|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153871258|NCT00171158|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153871259|NCT00171158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153871260|NCT00171158|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153871261|NCT00170846|Everolimus|everolimus|mesh-list
153871262|NCT00170846|Azathioprine|azathioprine|mesh-list
153411876|NCT00385125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153411877|NCT00003819|Keyhole-limpet hemocyanin|keyhole-limpet hemocyanin|mesh-list
153411878|NCT00003819|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153411879|NCT00003819|Immunologic Factors|immunologic factors|mesh-ancestor
153411880|NCT00003819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153411881|NCT00003825|Pentosan Sulfuric Polyester|pentosan sulfuric polyester|mesh-list
153411882|NCT00003825|Anticoagulants|anticoagulants|mesh-ancestor
153411883|NCT00004551|Nicotine|nicotine|mesh-list
153411884|NCT00004551|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
153411885|NCT00004551|Autonomic Agents|autonomic agents|mesh-ancestor
153411886|NCT00004551|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153411887|NCT00004551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153411888|NCT00004551|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
153411889|NCT00004551|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
153411890|NCT00004551|Cholinergic Agents|cholinergic agents|mesh-ancestor
153411891|NCT00004551|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153411892|NCT00004551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153411893|NCT02678312|Enalapril|enalapril|mesh-list
153411894|NCT02678312|Enalaprilat|enalaprilat|mesh-list
153411895|NCT02678312|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
153411896|NCT02678312|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
153411897|NCT02678312|Protease Inhibitors|protease inhibitors|mesh-ancestor
153411898|NCT02678312|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153411899|NCT02678312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153411900|NCT02678312|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153411901|NCT02678312|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
153411902|NCT00003843|Irinotecan|irinotecan|mesh-list
153826059|NCT00475397|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
153871272|NCT00170846|Antimetabolites|antimetabolites|mesh-ancestor
153871273|NCT00170846|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153871274|NCT00170846|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153871276|NCT04562103|Ropivacaine|ropivacaine|mesh-list
153871277|NCT04562103|Anesthetics, Local|anesthetics, local|mesh-ancestor
153871278|NCT04562103|Anesthetics|anesthetics|mesh-ancestor
153871279|NCT04562103|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153871280|NCT04562103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153871281|NCT04562103|Sensory System Agents|sensory system agents|mesh-ancestor
153871282|NCT04562103|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153871283|NCT04562103|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153871284|NCT04562103|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153871285|NCT04562103|Adrenergic Agents|adrenergic agents|mesh-ancestor
153871286|NCT04562103|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153871287|NCT04562103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153871288|NCT04562103|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
153871289|NCT04562103|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153411903|NCT00003843|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
153411904|NCT00003843|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153411905|NCT00003843|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153411906|NCT00003843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153411907|NCT00003843|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153411909|NCT00003849|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153411910|NCT00003849|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153411911|NCT00003849|Immunologic Factors|immunologic factors|mesh-ancestor
153411912|NCT00003849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153411913|NCT00003849|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153411914|NCT00004575|Miconazole|miconazole|mesh-list
153411918|NCT00004575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153411919|NCT00004575|Antifungal Agents|antifungal agents|mesh-ancestor
153411920|NCT00004575|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153411921|NCT00004575|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
153411922|NCT00004575|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153411923|NCT00004575|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153411930|NCT00004575|Cysteine Proteinase Inhibitors|cysteine proteinase inhibitors|mesh-ancestor
153411932|NCT00004581|Ritonavir|ritonavir|mesh-list
153411933|NCT00004581|Lopinavir|lopinavir|mesh-list
153411934|NCT00004581|Nevirapine|nevirapine|mesh-list
153411935|NCT00004581|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
153411936|NCT00004581|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
153411937|NCT00004581|Protease Inhibitors|protease inhibitors|mesh-ancestor
153411938|NCT00004581|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153411939|NCT00004581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153411940|NCT00004581|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153411941|NCT00004581|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153411942|NCT00004581|Antiviral Agents|antiviral agents|mesh-ancestor
153411943|NCT00004581|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153411944|NCT00004581|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
153411945|NCT00004581|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153411946|NCT00004581|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153411947|NCT00004581|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153411948|NCT00004581|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
153411949|NCT00004581|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
153411950|NCT00004257|Fluorouracil|fluorouracil|mesh-list
153411951|NCT00004257|Oxaliplatin|oxaliplatin|mesh-list
153411952|NCT00004257|Antimetabolites|antimetabolites|mesh-ancestor
153871381|NCT00477386|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153871382|NCT00477269|Imatinib Mesylate|imatinib mesylate|mesh-list
153871383|NCT00477269|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153871384|NCT00477269|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153871385|NCT00477269|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153871387|NCT00477269|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153871400|NCT00476996|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153871401|NCT00476996|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153412016|NCT00004689|Thioacetazone|thioacetazone|mesh-list
153412017|NCT00004689|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153412018|NCT00004689|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153412019|NCT00004689|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
153412020|NCT00004689|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153412021|NCT00004689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153412022|NCT00004689|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
153871416|NCT00475865|Glatiramer Acetate|glatiramer acetate|mesh-list
153871417|NCT00475865|(T,G)-A-L|(t,g)-a-l|mesh-list
153871418|NCT00475865|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153412031|NCT00004689|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
153412032|NCT00004689|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
153412033|NCT00004689|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
153412034|NCT00004695|Interleukin-2|interleukin-2|mesh-list
153412035|NCT00004695|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153412036|NCT00004695|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153412037|NCT00004695|Analgesics|analgesics|mesh-ancestor
153412038|NCT00004695|Sensory System Agents|sensory system agents|mesh-ancestor
153412039|NCT00004695|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153412040|NCT00004695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153412041|NCT00004731|Ubiquinone|ubiquinone|mesh-list
153412042|NCT00004731|Coenzyme Q10|coenzyme q10|mesh-list
153412043|NCT00004731|Micronutrients|micronutrients|mesh-ancestor
153871454|NCT00474929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153412068|NCT00003909|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153412069|NCT00003909|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
153412070|NCT00003909|Dermatologic Agents|dermatologic agents|mesh-ancestor
153412071|NCT00004767|Sodium Benzoate|sodium benzoate|mesh-list
153412072|NCT00004767|4-phenylbutyric acid|4-phenylbutyric acid|mesh-list
153412073|NCT00004767|Phenylacetic acid|phenylacetic acid|mesh-list
153412074|NCT00004767|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153412075|NCT00004767|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153412076|NCT00004767|Antimetabolites|antimetabolites|mesh-ancestor
153412077|NCT00004767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153412078|NCT00004767|Antifungal Agents|antifungal agents|mesh-ancestor
153871465|NCT00474383|Abiraterone Acetate|abiraterone acetate|mesh-list
153871466|NCT00474383|Glucocorticoids|glucocorticoids|mesh-list
153871467|NCT00474383|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153871468|NCT00474383|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153871469|NCT00474383|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153871470|NCT00474383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153871471|NCT00474383|Hormone Antagonists|hormone antagonists|mesh-ancestor
153871472|NCT00474383|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153871473|NCT00474383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153412090|NCT00004785|Autonomic Agents|autonomic agents|mesh-ancestor
153412091|NCT00004785|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153412092|NCT00004785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153412093|NCT00004785|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153412094|NCT00004785|Glucocorticoids|glucocorticoids|mesh-ancestor
153412095|NCT00004785|Hormones|hormones|mesh-ancestor
153412096|NCT00004785|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153412097|NCT00004785|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153412098|NCT00004785|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153412099|NCT00004785|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
153412100|NCT00004785|Protective Agents|protective agents|mesh-ancestor
153412101|NCT00004815|Hormones|hormones|mesh-list
153412102|NCT00004815|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153412103|NCT00004815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153412104|NCT02279823|Minoxidil|minoxidil|mesh-list
153412105|NCT02279823|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
153412106|NCT02279823|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153412107|NCT02279823|Vasodilator Agents|vasodilator agents|mesh-ancestor
153412108|NCT04040361|Pembrolizumab|pembrolizumab|mesh-list
153412109|NCT04040361|Ramucirumab|ramucirumab|mesh-list
153871474|NCT00474383|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153871475|NCT00474383|Hormones|hormones|mesh-ancestor
153871476|NCT00472199|Pramipexole|pramipexole|mesh-list
153871477|NCT00472199|Dexpramipexole|dexpramipexole|mesh-list
153412114|NCT04040361|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153412115|NCT04040361|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153412116|NCT04040361|Growth Substances|growth substances|mesh-ancestor
153412117|NCT04040361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153412118|NCT04040361|Growth Inhibitors|growth inhibitors|mesh-ancestor
153412120|NCT00386061|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
153412121|NCT00386061|Cannabinoid Receptor Antagonists|cannabinoid receptor antagonists|mesh-ancestor
153412123|NCT00386061|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153871496|NCT00470834|Dutasteride|dutasteride|mesh-list
153871518|NCT02212431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153871520|NCT00470093|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153871521|NCT00470093|Antiviral Agents|antiviral agents|mesh-ancestor
153871522|NCT00470093|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153871523|NCT00470054|Dasatinib|dasatinib|mesh-list
153871524|NCT00470054|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153871525|NCT00470054|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153871526|NCT00470054|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153412142|NCT00005577|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153412144|NCT00005583|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
153412145|NCT00005583|Epirubicin|epirubicin|mesh-list
153412146|NCT00005583|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153412147|NCT00005583|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153412148|NCT00005583|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153412149|NCT00005583|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153412150|NCT00005583|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153412151|NCT00005583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153412152|NCT00005589|Cytarabine|cytarabine|mesh-list
153412153|NCT00005589|Cyclophosphamide|cyclophosphamide|mesh-list
153412154|NCT00005589|Melphalan|melphalan|mesh-list
153412155|NCT00005589|Carmustine|carmustine|mesh-list
153412156|NCT00005589|Rituximab|rituximab|mesh-list
153412157|NCT00005589|Etoposide|etoposide|mesh-list
153412158|NCT00005589|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153412159|NCT00005589|Immunologic Factors|immunologic factors|mesh-ancestor
153412160|NCT00005589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153871565|NCT00474188|Lenalidomide|lenalidomide|mesh-list
153871566|NCT00474188|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153871567|NCT00474188|Antiemetics|antiemetics|mesh-ancestor
153871568|NCT00474188|Autonomic Agents|autonomic agents|mesh-ancestor
153871586|NCT01089647|Autonomic Agents|autonomic agents|mesh-ancestor
153412208|NCT00005607|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153412209|NCT00005607|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153412210|NCT00005607|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153412211|NCT00005607|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153412212|NCT00005607|Immunologic Factors|immunologic factors|mesh-ancestor
153412213|NCT00005607|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
153412214|NCT00005607|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153412215|NCT00005607|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153412216|NCT00005607|Antidotes|antidotes|mesh-ancestor
153412217|NCT00005607|Protective Agents|protective agents|mesh-ancestor
153412218|NCT00005607|Vitamin B Complex|vitamin b complex|mesh-ancestor
153412220|NCT00005607|Micronutrients|micronutrients|mesh-ancestor
153412221|NCT00005613|Cyclophosphamide|cyclophosphamide|mesh-list
153412222|NCT00005613|Carmustine|carmustine|mesh-list
153412223|NCT00005613|Etoposide|etoposide|mesh-list
153412224|NCT00005613|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153412225|NCT00005613|Immunologic Factors|immunologic factors|mesh-ancestor
153412226|NCT00005613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153412227|NCT00005613|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153412228|NCT00005613|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153412229|NCT00005613|Alkylating Agents|alkylating agents|mesh-ancestor
153871587|NCT01089647|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153826184|NCT00470405|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153826185|NCT00601978|Levodopa|levodopa|mesh-list
153826186|NCT00601978|Carbidopa|carbidopa|mesh-list
153826187|NCT00601978|Entacapone|entacapone|mesh-list
153826188|NCT00601978|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
153826189|NCT00601978|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
153826190|NCT00601978|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
153871625|NCT01089413|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153871626|NCT01089413|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153871627|NCT01089413|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153871628|NCT01089413|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153871629|NCT01089413|Growth Substances|growth substances|mesh-ancestor
153871630|NCT01089413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153871631|NCT01089413|Growth Inhibitors|growth inhibitors|mesh-ancestor
153871632|NCT02212782|Linagliptin|linagliptin|mesh-list
153871633|NCT02212782|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153871634|NCT02212782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153871635|NCT02212782|Incretins|incretins|mesh-ancestor
153871636|NCT02212782|Hormones|hormones|mesh-ancestor
153412260|NCT00005637|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153366203|NCT01620047|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153366204|NCT01620047|Narcotics|narcotics|mesh-ancestor
153366205|NCT01620047|Analgesics|analgesics|mesh-ancestor
153366206|NCT01620047|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153366207|NCT01620047|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153412290|NCT00005673|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153412291|NCT03390673|Bevacizumab|bevacizumab|mesh-list
153412292|NCT03390673|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153412293|NCT03390673|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153412294|NCT03390673|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153412295|NCT03390673|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153412296|NCT03390673|Growth Substances|growth substances|mesh-ancestor
153412297|NCT03390673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153871653|NCT02212821|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153871654|NCT02212821|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
153871655|NCT02212821|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153871656|NCT02212821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153871658|NCT01088243|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153871659|NCT01088243|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153871660|NCT01088243|Analgesics|analgesics|mesh-ancestor
153871661|NCT01088243|Sensory System Agents|sensory system agents|mesh-ancestor
153871662|NCT01088243|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153871663|NCT01088243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153871664|NCT01088243|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153871665|NCT01088243|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153871684|NCT01088048|Chlorambucil|chlorambucil|mesh-list
153871706|NCT01087970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153412331|NCT00005793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153412332|NCT00005793|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153412333|NCT00005793|Antimetabolites|antimetabolites|mesh-ancestor
153412334|NCT00005793|Antiviral Agents|antiviral agents|mesh-ancestor
153412335|NCT00005793|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153412336|NCT00005793|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153412337|NCT00005793|Immunologic Factors|immunologic factors|mesh-ancestor
153412338|NCT00005793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153412339|NCT00005793|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153412340|NCT00005793|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
153412341|NCT00005799|Cyclosporine|cyclosporine|mesh-list
153412342|NCT00005799|Mycophenolic Acid|mycophenolic acid|mesh-list
153412343|NCT00005799|Fludarabine|fludarabine|mesh-list
153412344|NCT00005799|Fludarabine phosphate|fludarabine phosphate|mesh-list
153412345|NCT00005799|Cyclosporins|cyclosporins|mesh-list
153412346|NCT00005799|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153871707|NCT01087970|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153871708|NCT01087970|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153871709|NCT01087970|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153871710|NCT01087814|Efavirenz|efavirenz|mesh-list
153871711|NCT01087814|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153871712|NCT01087814|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153871713|NCT01087814|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153871714|NCT01087814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153871715|NCT01087814|Antiviral Agents|antiviral agents|mesh-ancestor
153871716|NCT01087814|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153366241|NCT00939536|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
153366242|NCT00939536|GABA Agonists|gaba agonists|mesh-ancestor
153366243|NCT00939536|GABA Agents|gaba agents|mesh-ancestor
153366244|NCT00939536|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153366245|NCT00939536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153366246|NCT02982122|Vasoconstrictor Agents|vasoconstrictor agents|mesh-list
153366247|NCT04358354|Fluorouracil|fluorouracil|mesh-list
153826234|NCT00602095|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
153826235|NCT00602095|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153826236|NCT00602095|Oxytocics|oxytocics|mesh-ancestor
153871758|NCT01086410|Respiratory System Agents|respiratory system agents|mesh-ancestor
153871760|NCT01086410|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
153871761|NCT01086410|Glucocorticoids|glucocorticoids|mesh-ancestor
153871762|NCT01086410|Hormones|hormones|mesh-ancestor
153871763|NCT01086410|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153871764|NCT01086410|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153871817|NCT01085045|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
153871818|NCT01085045|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
153412482|NCT02420210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153412483|NCT02420210|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153871848|NCT01084655|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153871850|NCT01084655|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153871851|NCT04552431|Ciprofloxacin|ciprofloxacin|mesh-list
153871852|NCT04552431|Tamsulosin|tamsulosin|mesh-list
153871853|NCT04552431|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153871854|NCT04552431|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153871855|NCT04552431|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153871856|NCT04552431|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153412534|NCT01789333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153412535|NCT01789333|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
153412536|NCT01789333|Dermatologic Agents|dermatologic agents|mesh-ancestor
153412537|NCT02524106|Bococizumab|bococizumab|mesh-list
153412538|NCT02524106|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153412539|NCT02524106|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153412540|NCT02524106|Antimetabolites|antimetabolites|mesh-ancestor
153871896|NCT00179010|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153871897|NCT00179010|Vasodilator Agents|vasodilator agents|mesh-ancestor
153871898|NCT00179010|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
153871899|NCT00179010|Purinergic Agonists|purinergic agonists|mesh-ancestor
153871900|NCT00179010|Purinergic Agents|purinergic agents|mesh-ancestor
153871901|NCT00179010|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153871902|NCT00179010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153871903|NCT01083602|Dexamethasone|dexamethasone|mesh-list
153871904|NCT01083602|Bortezomib|bortezomib|mesh-list
153871905|NCT01083602|Panobinostat|panobinostat|mesh-list
153871923|NCT00178464|Analgesics|analgesics|mesh-ancestor
153871924|NCT00178464|Sensory System Agents|sensory system agents|mesh-ancestor
153871940|NCT04671914|Viscosupplements|viscosupplements|mesh-ancestor
153871941|NCT04671914|Protective Agents|protective agents|mesh-ancestor
153871943|NCT01083485|Naloxone|naloxone|mesh-list
153871944|NCT01083485|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153871945|NCT01083485|Narcotics|narcotics|mesh-ancestor
153871946|NCT01083485|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153871947|NCT01083485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153826265|NCT00502164|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153826266|NCT00502164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153826267|NCT00470522|Folic Acid|folic acid|mesh-list
153826268|NCT00470522|Methotrexate|methotrexate|mesh-list
153826269|NCT00470522|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
153826270|NCT00470522|Abortifacient Agents|abortifacient agents|mesh-ancestor
153826271|NCT00470522|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153826272|NCT00470522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153412665|NCT02420041|Anesthetics|anesthetics|mesh-ancestor
153412666|NCT02420041|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153872018|NCT00177216|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153872019|NCT00177216|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153872020|NCT00177216|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
153872021|NCT00177216|GABA Agonists|gaba agonists|mesh-ancestor
153872022|NCT00177216|GABA Agents|gaba agents|mesh-ancestor
153872023|NCT01081769|Paliperidone Palmitate|paliperidone palmitate|mesh-list
153872024|NCT01081769|Antipsychotic Agents|antipsychotic agents|mesh-list
153872025|NCT01081769|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153872026|NCT01081769|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153872027|NCT01081769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153872028|NCT01081769|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153872030|NCT01081769|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153366277|NCT04354376|Telmisartan|telmisartan|mesh-list
153366278|NCT04354376|1,4-dihydropyridine|1,4-dihydropyridine|mesh-list
153366279|NCT04354376|Diuretics|diuretics|mesh-list
153366280|NCT04354376|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-list
153412750|NCT00363337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153412751|NCT00363337|Dopamine Agonists|dopamine agonists|mesh-ancestor
153412752|NCT00363337|Dopamine Agents|dopamine agents|mesh-ancestor
153872099|NCT04571489|Antimetabolites|antimetabolites|mesh-ancestor
153872115|NCT01080131|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
153872116|NCT01080131|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153826290|NCT01244178|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153826291|NCT01244178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153826292|NCT00470561|Aspirin|aspirin|mesh-list
153826293|NCT00470561|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153826294|NCT00470561|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153826295|NCT00470561|Analgesics|analgesics|mesh-ancestor
153826296|NCT00470561|Sensory System Agents|sensory system agents|mesh-ancestor
153366281|NCT04354376|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-list
153366282|NCT04354376|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153366283|NCT04354376|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
153412813|NCT02453581|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153412814|NCT02453581|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153412816|NCT02533466|Listerine|listerine|mesh-list
153412855|NCT02437669|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153412856|NCT02437669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153412857|NCT02437669|Analgesics|analgesics|mesh-ancestor
153412858|NCT02437669|Sensory System Agents|sensory system agents|mesh-ancestor
153412859|NCT02437669|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153412860|NCT02430818|Ketamine|ketamine|mesh-list
153412861|NCT02430818|Morphine|morphine|mesh-list
153412862|NCT02430818|Analgesics|analgesics|mesh-ancestor
153412863|NCT02430818|Sensory System Agents|sensory system agents|mesh-ancestor
153412864|NCT02430818|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153412865|NCT02430818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153412866|NCT02430818|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
153412867|NCT02430818|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153412868|NCT02430818|Anesthetics, General|anesthetics, general|mesh-ancestor
153872214|NCT00479856|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153872215|NCT00479856|Tubulin Modulators|tubulin modulators|mesh-ancestor
153872216|NCT00479856|Antimitotic Agents|antimitotic agents|mesh-ancestor
153872217|NCT00479856|Mitosis Modulators|mitosis modulators|mesh-ancestor
153872218|NCT00479856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153872219|NCT00479856|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153872220|NCT00479856|Antimetabolites|antimetabolites|mesh-ancestor
153872221|NCT00479856|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153872222|NCT00479856|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153872223|NCT00479856|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153872224|NCT04997759|Neostigmine|neostigmine|mesh-list
153872225|NCT04997759|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
153872238|NCT04991948|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153872239|NCT04991948|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153872240|NCT04991948|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153872241|NCT04991948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153412881|NCT02455453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153412882|NCT02533934|Ledipasvir, sofosbuvir drug combination|ledipasvir, sofosbuvir drug combination|mesh-list
153412883|NCT02533934|Antiviral Agents|antiviral agents|mesh-ancestor
153412884|NCT02533934|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153412885|NCT02519023|Acetaminophen|acetaminophen|mesh-list
153412887|NCT02519023|Epinephrine|epinephrine|mesh-list
153412888|NCT02519023|Oxycodone|oxycodone|mesh-list
153412889|NCT02519023|Bupivacaine|bupivacaine|mesh-list
153412890|NCT02519023|Anesthetics, Local|anesthetics, local|mesh-ancestor
153412891|NCT02519023|Anesthetics|anesthetics|mesh-ancestor
153412892|NCT02519023|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153412893|NCT02519023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153412894|NCT02519023|Sensory System Agents|sensory system agents|mesh-ancestor
153872242|NCT04990778|Venetoclax|venetoclax|mesh-list
153872243|NCT04990778|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153872244|NCT00479388|Niacin|niacin|mesh-list
153872245|NCT00479388|Atorvastatin|atorvastatin|mesh-list
153872246|NCT00479388|Simvastatin|simvastatin|mesh-list
153872247|NCT00479388|Calcium|calcium|mesh-list
153872248|NCT00479388|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153872249|NCT00479388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153872250|NCT00479388|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153872251|NCT00479388|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153872252|NCT00479388|Antimetabolites|antimetabolites|mesh-ancestor
153412922|NCT02497040|Anesthetics|anesthetics|mesh-ancestor
153412923|NCT02497040|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153412924|NCT02497040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153412925|NCT02497040|Sensory System Agents|sensory system agents|mesh-ancestor
153872255|NCT00479388|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
153872256|NCT00479388|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153872257|NCT00479388|Vasodilator Agents|vasodilator agents|mesh-ancestor
153872258|NCT00479388|Vitamin B Complex|vitamin b complex|mesh-ancestor
153872259|NCT00479388|Vitamins|vitamins|mesh-ancestor
153872260|NCT00479388|Micronutrients|micronutrients|mesh-ancestor
153872261|NCT00479232|Decitabine|decitabine|mesh-list
153872262|NCT00479232|Vorinostat|vorinostat|mesh-list
153872263|NCT00479232|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153872264|NCT00479232|Antimetabolites|antimetabolites|mesh-ancestor
153872265|NCT00479232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153872266|NCT00479232|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153872267|NCT00479232|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153412932|NCT02523235|Sensory System Agents|sensory system agents|mesh-ancestor
153412933|NCT02523235|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153817710|NCT06140966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153412935|NCT02498522|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153412936|NCT02498522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153412937|NCT02919787|Irinotecan|irinotecan|mesh-list
153412938|NCT02919787|Fluorouracil|fluorouracil|mesh-list
153412939|NCT02919787|Oxaliplatin|oxaliplatin|mesh-list
153412940|NCT02919787|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
153412941|NCT02919787|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153412942|NCT02919787|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153412943|NCT02919787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153412944|NCT02919787|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153412945|NCT02919787|Antimetabolites|antimetabolites|mesh-ancestor
153412946|NCT02919787|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153412947|NCT02919787|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153412948|NCT02919787|Immunologic Factors|immunologic factors|mesh-ancestor
153412949|NCT02919787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153412950|NCT02459275|Metoclopramide|metoclopramide|mesh-list
153412951|NCT02459275|Antiemetics|antiemetics|mesh-ancestor
153872287|NCT00556127|Lenograstim|lenograstim|mesh-list
153872288|NCT00556127|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153872289|NCT00556127|Immunologic Factors|immunologic factors|mesh-ancestor
153872290|NCT00556127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153872291|NCT00556127|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153872292|NCT00556127|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153872293|NCT00556127|Alkylating Agents|alkylating agents|mesh-ancestor
153872294|NCT00556127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153872295|NCT00556127|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153412965|NCT02524561|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153412966|NCT02524561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153412967|NCT02524561|Progestins|progestins|mesh-ancestor
153412968|NCT02431598|Gadolinium 1,4,7,10-tetraazacyclododecane-N,N',N'',N'''-tetraacetate|gadolinium 1,4,7,10-tetraazacyclododecane-n,n',n'',n'''-tetraacetate|mesh-list
153412969|NCT02431598|Chelating Agents|chelating agents|mesh-ancestor
153412970|NCT02431598|Sequestering Agents|sequestering agents|mesh-ancestor
153412971|NCT02431598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153412972|NCT04743739|Cyclosporine|cyclosporine|mesh-list
153412977|NCT04743739|Immunologic Factors|immunologic factors|mesh-ancestor
153826359|NCT00476099|Respiratory System Agents|respiratory system agents|mesh-ancestor
153412978|NCT04743739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153872311|NCT00556127|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153412983|NCT04743739|Antifungal Agents|antifungal agents|mesh-ancestor
153412984|NCT04743739|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153412985|NCT04743739|Dermatologic Agents|dermatologic agents|mesh-ancestor
153412986|NCT04743739|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
153872338|NCT00478608|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153872339|NCT00478608|Antifungal Agents|antifungal agents|mesh-ancestor
153872340|NCT00478608|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153872341|NCT00478608|Immunologic Factors|immunologic factors|mesh-ancestor
153872342|NCT00478608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153872343|NCT00478140|Trastuzumab|trastuzumab|mesh-list
153872344|NCT00478140|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153872345|NCT00478140|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153872346|NCT00478023|Morphine|morphine|mesh-list
153872351|NCT00478023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153872352|NCT00478023|Analgesics|analgesics|mesh-ancestor
153872353|NCT00478023|Sensory System Agents|sensory system agents|mesh-ancestor
153872354|NCT00478023|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153872355|NCT00478023|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
153872356|NCT00478023|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153872357|NCT00478023|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153872359|NCT00478023|Adrenergic Agents|adrenergic agents|mesh-ancestor
153413033|NCT02535806|Antiemetics|antiemetics|mesh-ancestor
153413034|NCT02535806|Autonomic Agents|autonomic agents|mesh-ancestor
153413035|NCT02535806|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153413036|NCT02535806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153413037|NCT02535806|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153413038|NCT02535806|Glucocorticoids|glucocorticoids|mesh-ancestor
153413039|NCT02535806|Hormones|hormones|mesh-ancestor
153413040|NCT02535806|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153413041|NCT02535806|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153413042|NCT02535806|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153413043|NCT02535806|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
153872381|NCT00477672|Pimavanserin|pimavanserin|mesh-list
153872382|NCT00477672|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
153872383|NCT00477672|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
153872384|NCT00477672|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153872385|NCT00477672|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153872386|NCT00477672|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153872387|NCT00477672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153872388|NCT00477672|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153413048|NCT02535806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153413049|NCT02535806|Dermatologic Agents|dermatologic agents|mesh-ancestor
153413050|NCT02535806|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153413051|NCT02535806|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153872406|NCT00477633|Estrogens|estrogens|mesh-ancestor
153872407|NCT00477633|Hormones|hormones|mesh-ancestor
153872408|NCT00477633|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153872409|NCT00477633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153872410|NCT00477633|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
153649731|NCT00000461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153872411|NCT00477633|Contraceptive Agents|contraceptive agents|mesh-ancestor
153872412|NCT00477633|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153872413|NCT00477633|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
153872414|NCT00477633|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
153872415|NCT00477633|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
153872416|NCT00477633|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
153872417|NCT04541823|Propofol|propofol|mesh-list
153413084|NCT02464033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153413085|NCT02464033|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153872430|NCT00556361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153872431|NCT00556361|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
153872432|NCT00556361|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153872433|NCT00556361|Anesthetics, General|anesthetics, general|mesh-ancestor
153872434|NCT00556361|Anesthetics|anesthetics|mesh-ancestor
153872435|NCT00556361|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153872436|NCT00556361|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
153872437|NCT00556361|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
153872438|NCT00556361|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153872439|NCT00556361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153413108|NCT02432456|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153413109|NCT02432456|Anesthetics, General|anesthetics, general|mesh-ancestor
153413110|NCT02432456|Anesthetics|anesthetics|mesh-ancestor
153413111|NCT02432456|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153413112|NCT02432456|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
153413113|NCT02432456|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
153413115|NCT02432456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153413116|NCT02432456|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153413117|NCT02432456|Antipyretics|antipyretics|mesh-ancestor
153413118|NCT02432456|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153413119|NCT02432456|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153413120|NCT02432456|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153413121|NCT02432456|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153413122|NCT02432456|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153413123|NCT02432456|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
153872464|NCT04541277|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153872465|NCT04541277|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153872466|NCT04541277|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153872467|NCT04541277|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153872468|NCT04540926|Cyclosporine|cyclosporine|mesh-list
153872469|NCT04540926|Cyclosporins|cyclosporins|mesh-list
153872470|NCT04540926|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153872471|NCT04540926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153872472|NCT04540926|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153872483|NCT04540965|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
153413165|NCT02464657|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153872510|NCT04570592|Serotonin Agents|serotonin agents|mesh-ancestor
153872511|NCT04570592|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153872512|NCT04570592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153872513|NCT02215395|Ethinyl Estradiol|ethinyl estradiol|mesh-list
153872514|NCT02215395|Contraceptive Agents|contraceptive agents|mesh-list
153872515|NCT02215395|Estradiol|estradiol|mesh-list
153872516|NCT02215395|Estrogens|estrogens|mesh-ancestor
153872517|NCT02215395|Hormones|hormones|mesh-ancestor
153872518|NCT02215395|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153872519|NCT02215395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153872520|NCT02215395|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
153413166|NCT02464657|Antimetabolites|antimetabolites|mesh-ancestor
153413167|NCT02464657|Antiviral Agents|antiviral agents|mesh-ancestor
153413168|NCT02464657|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153413169|NCT02464657|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153413170|NCT02464657|Immunologic Factors|immunologic factors|mesh-ancestor
153413171|NCT02464657|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
153413172|NCT02464657|Protective Agents|protective agents|mesh-ancestor
153872525|NCT02215434|Methyltestosterone|methyltestosterone|mesh-list
153872526|NCT02215434|Testosterone|testosterone|mesh-list
153872527|NCT02215434|Testosterone undecanoate|testosterone undecanoate|mesh-list
153872528|NCT02215434|Testosterone enanthate|testosterone enanthate|mesh-list
153872529|NCT02215434|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
153872530|NCT02215434|Androgens|androgens|mesh-ancestor
153413205|NCT02436668|Tubulin Modulators|tubulin modulators|mesh-ancestor
153413223|NCT02506634|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
153413224|NCT02506634|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153872580|NCT02214498|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
153413229|NCT02541422|N-monoacetylcystine|n-monoacetylcystine|mesh-list
153413230|NCT02541422|Antiviral Agents|antiviral agents|mesh-ancestor
153413231|NCT02541422|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153413232|NCT02541422|Expectorants|expectorants|mesh-ancestor
153413233|NCT02541422|Respiratory System Agents|respiratory system agents|mesh-ancestor
153413234|NCT02541422|Free Radical Scavengers|free radical scavengers|mesh-ancestor
153413235|NCT02541422|Antioxidants|antioxidants|mesh-ancestor
153413236|NCT02541422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153413237|NCT02541422|Protective Agents|protective agents|mesh-ancestor
153413238|NCT02541422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153413239|NCT02541422|Antidotes|antidotes|mesh-ancestor
153413240|NCT02439164|Midazolam|midazolam|mesh-list
153413241|NCT02439164|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153413242|NCT02439164|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153413243|NCT02439164|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153413244|NCT02439164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153413245|NCT02439164|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153413247|NCT02439164|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153413248|NCT02439164|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153413249|NCT02439164|Anesthetics, General|anesthetics, general|mesh-ancestor
153413250|NCT02439164|Anesthetics|anesthetics|mesh-ancestor
153872599|NCT04560218|Oxytocics|oxytocics|mesh-ancestor
153872600|NCT05135104|Palbociclib|palbociclib|mesh-list
153872601|NCT05135104|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153872602|NCT05135104|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153872603|NCT05135104|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153872604|NCT05135104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153872625|NCT04559165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153872626|NCT04559165|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153872627|NCT04559165|Chelating Agents|chelating agents|mesh-ancestor
153872628|NCT04559165|Sequestering Agents|sequestering agents|mesh-ancestor
153872629|NCT04559165|Hemostatics|hemostatics|mesh-ancestor
153872630|NCT04559165|Coagulants|coagulants|mesh-ancestor
153872631|NCT04312048|Isosorbide|isosorbide|mesh-list
153872632|NCT04312048|Isosorbide Dinitrate|isosorbide dinitrate|mesh-list
153872633|NCT04312048|Isosorbide-5-mononitrate|isosorbide-5-mononitrate|mesh-list
153872634|NCT04312048|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
153872635|NCT04312048|Diuretics|diuretics|mesh-ancestor
153872636|NCT04312048|Natriuretic Agents|natriuretic agents|mesh-ancestor
153872637|NCT04312048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153872638|NCT04312048|Vasodilator Agents|vasodilator agents|mesh-ancestor
153872639|NCT04312048|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
153872640|NCT04312048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153872641|NCT04311697|Phentolamine|phentolamine|mesh-list
153413312|NCT02551094|Gout Suppressants|gout suppressants|mesh-ancestor
153413313|NCT02551094|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153413314|NCT02551094|Tubulin Modulators|tubulin modulators|mesh-ancestor
153413315|NCT02551094|Antimitotic Agents|antimitotic agents|mesh-ancestor
153413316|NCT02551094|Mitosis Modulators|mitosis modulators|mesh-ancestor
153413317|NCT02551094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153413318|NCT02551094|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153413319|NCT02513498|Ixazomib|ixazomib|mesh-list
153413320|NCT02513498|Glycine|glycine|mesh-list
153872651|NCT04311697|Vasodilator Agents|vasodilator agents|mesh-ancestor
153872652|NCT04311697|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
153872653|NCT04311697|Protective Agents|protective agents|mesh-ancestor
153872654|NCT00575861|Zileuton|zileuton|mesh-list
153577522|NCT01718327|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153577523|NCT01718327|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153577524|NCT01718327|Growth Substances|growth substances|mesh-ancestor
153577525|NCT01718327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153577526|NCT01718327|Growth Inhibitors|growth inhibitors|mesh-ancestor
153577527|NCT01718327|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153577528|NCT01718327|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153577529|NCT01718327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153577530|NCT01718340|Metformin|metformin|mesh-list
153577531|NCT01718340|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153577532|NCT01718340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153577533|NCT01718366|Vitamin D|vitamin d|mesh-list
153872655|NCT00575861|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153872656|NCT00575861|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153872657|NCT00575861|Analgesics|analgesics|mesh-ancestor
153872658|NCT00575861|Sensory System Agents|sensory system agents|mesh-ancestor
153872659|NCT00575861|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153872660|NCT00575861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153872661|NCT00575861|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153872662|NCT00575861|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153872663|NCT00575861|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
153872664|NCT00575861|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153872665|NCT00575861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153872666|NCT00575861|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
153872667|NCT00575861|Hormone Antagonists|hormone antagonists|mesh-ancestor
153413321|NCT02513498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153413322|NCT02513498|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153413323|NCT02513498|Protease Inhibitors|protease inhibitors|mesh-ancestor
153413324|NCT02513498|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153413325|NCT02513498|Glycine Agents|glycine agents|mesh-ancestor
153413326|NCT02513498|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153413327|NCT02513498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153413328|NCT04787354|Capecitabine|capecitabine|mesh-list
153413329|NCT04787354|Oxaliplatin|oxaliplatin|mesh-list
153413330|NCT04787354|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153413331|NCT04787354|Antimetabolites|antimetabolites|mesh-ancestor
153413332|NCT04787354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153413333|NCT04787354|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153366447|NCT03034382|Sympathomimetics|sympathomimetics|mesh-ancestor
153366448|NCT03034382|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
153366449|NCT01664741|Nicotine|nicotine|mesh-list
153366450|NCT01664741|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
153366451|NCT01664741|Autonomic Agents|autonomic agents|mesh-ancestor
153872703|NCT02882737|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153872705|NCT02882737|Incretins|incretins|mesh-ancestor
153872707|NCT02211950|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
153872708|NCT02211950|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153872709|NCT02211950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153872710|NCT02211950|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153413383|NCT04186286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153413384|NCT04186286|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153413385|NCT04186286|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153413386|NCT04186286|Vasodilator Agents|vasodilator agents|mesh-ancestor
153413388|NCT04341038|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
153413389|NCT04341038|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
153872711|NCT02211950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153872712|NCT04538820|Dexamethasone|dexamethasone|mesh-list
153872713|NCT04538820|Dexamethasone acetate|dexamethasone acetate|mesh-list
153872714|NCT04538820|BB 1101|bb 1101|mesh-list
153872715|NCT04538820|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153872716|NCT04538820|Antiemetics|antiemetics|mesh-ancestor
153872717|NCT04538820|Autonomic Agents|autonomic agents|mesh-ancestor
153872718|NCT04538820|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153872719|NCT04538820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153872720|NCT04538820|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153872721|NCT04538820|Glucocorticoids|glucocorticoids|mesh-ancestor
153872722|NCT04538820|Hormones|hormones|mesh-ancestor
153872723|NCT04538820|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153872724|NCT04538820|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153872725|NCT04538820|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153872726|NCT04538820|Protease Inhibitors|protease inhibitors|mesh-ancestor
153872727|NCT04538820|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153872728|NCT04538820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153872729|NCT00575978|Hydralazine|hydralazine|mesh-list
153872730|NCT00575978|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153872731|NCT00575978|Vasodilator Agents|vasodilator agents|mesh-ancestor
153872732|NCT04546347|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
153872733|NCT02882932|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
153872734|NCT04539054|Caffeine|caffeine|mesh-list
153577534|NCT01718366|Azacitidine|azacitidine|mesh-list
153413390|NCT04341038|Prednisolone|prednisolone|mesh-list
153413391|NCT04341038|Prednisolone acetate|prednisolone acetate|mesh-list
153413392|NCT04341038|Tacrolimus|tacrolimus|mesh-list
153413393|NCT04341038|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
153413394|NCT04341038|Prednisolone phosphate|prednisolone phosphate|mesh-list
153413395|NCT04341038|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153413396|NCT04341038|Immunologic Factors|immunologic factors|mesh-ancestor
153872736|NCT04539054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153872738|NCT04539054|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153872739|NCT04539054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153872740|NCT04539054|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
153872741|NCT04539054|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
153872742|NCT04539054|Purinergic Agents|purinergic agents|mesh-ancestor
153872743|NCT04539054|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153872744|NCT00576017|Fentanyl|fentanyl|mesh-list
153872745|NCT00576017|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153872746|NCT00576017|Narcotics|narcotics|mesh-ancestor
153872747|NCT00576017|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153872748|NCT00576017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153872749|NCT00576017|Analgesics|analgesics|mesh-ancestor
153872750|NCT00576017|Sensory System Agents|sensory system agents|mesh-ancestor
153872751|NCT00576017|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153872752|NCT00576017|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153872753|NCT00576017|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153872754|NCT00576017|Anesthetics, General|anesthetics, general|mesh-ancestor
153872755|NCT00576017|Anesthetics|anesthetics|mesh-ancestor
153872756|NCT04558697|Tea Tree Oil|tea tree oil|mesh-list
153872757|NCT04558697|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
153872758|NCT04558697|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153413415|NCT02561702|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
153413416|NCT02561702|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153404653|NCT03226457|Furosemide|furosemide|mesh-list
153413417|NCT02561702|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153413418|NCT02561702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153413419|NCT02563496|Chloroquine|chloroquine|mesh-list
153413420|NCT02563496|Tafenoquine|tafenoquine|mesh-list
153413421|NCT02563496|Amebicides|amebicides|mesh-ancestor
153577535|NCT01718366|Deferasirox|deferasirox|mesh-list
153577536|NCT01718366|Vitamins|vitamins|mesh-ancestor
153577537|NCT01718366|Micronutrients|micronutrients|mesh-ancestor
153366487|NCT03030716|Procyanidin|procyanidin|mesh-list
153413422|NCT02563496|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153872766|NCT02278458|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153872767|NCT02278458|Antimetabolites|antimetabolites|mesh-ancestor
153872768|NCT02278458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153872769|NCT02278458|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153872771|NCT01128595|Xhance|xhance|mesh-list
153872772|NCT01128595|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153872773|NCT01128595|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153872774|NCT01128595|Autonomic Agents|autonomic agents|mesh-ancestor
153413444|NCT02541409|Interferon-alpha|interferon-alpha|mesh-list
153413447|NCT02541409|Sofosbuvir|sofosbuvir|mesh-list
153872775|NCT01128595|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153872776|NCT01128595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153872777|NCT01128595|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153872778|NCT01128595|Respiratory System Agents|respiratory system agents|mesh-ancestor
153872779|NCT01128595|Dermatologic Agents|dermatologic agents|mesh-ancestor
153872780|NCT01128595|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
153872781|NCT01129336|Zoledronic Acid|zoledronic acid|mesh-list
153872782|NCT01129336|Diphosphonates|diphosphonates|mesh-list
153413477|NCT02541565|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153413479|NCT02541565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153413480|NCT02541565|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153413481|NCT02541565|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153413482|NCT02541565|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153872823|NCT04558463|Antiviral Agents|antiviral agents|mesh-ancestor
153872824|NCT04558463|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153872825|NCT04558463|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153872826|NCT04558463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153872827|NCT01126879|Genistein|genistein|mesh-list
153872828|NCT01126879|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
153872829|NCT01126879|Protective Agents|protective agents|mesh-ancestor
153872830|NCT01126879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153872831|NCT01126879|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153872832|NCT01126879|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153872833|NCT01126879|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153577538|NCT01718366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153577539|NCT01718366|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153872834|NCT01126879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153872835|NCT01126879|Phytoestrogens|phytoestrogens|mesh-ancestor
153872847|NCT04311658|Vasodilator Agents|vasodilator agents|mesh-ancestor
153872848|NCT04311658|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
153872849|NCT04311658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153872850|NCT02882308|Durvalumab|durvalumab|mesh-list
153872851|NCT02882308|Olaparib|olaparib|mesh-list
153872852|NCT02882308|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153872853|NCT02882308|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153872854|NCT02882308|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
153872855|NCT02882308|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153872856|NCT02882308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153872857|NCT00625456|Molgramostim|molgramostim|mesh-list
153872858|NCT00625456|Sargramostim|sargramostim|mesh-list
153872859|NCT00625456|Immunologic Factors|immunologic factors|mesh-ancestor
153872860|NCT00625456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153872861|NCT00625456|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153872862|NCT04539444|Tislelizumab|tislelizumab|mesh-list
153872863|NCT04539444|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
153413525|NCT00364052|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153413527|NCT00364052|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153872878|NCT00576329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153872879|NCT02882581|Metformin|metformin|mesh-list
153872880|NCT02882581|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153872881|NCT02882581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153872882|NCT02882347|Somatostatin|somatostatin|mesh-list
153872883|NCT02882347|Hormones|hormones|mesh-ancestor
153413566|NCT05247554|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153413567|NCT05247554|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153413568|NCT05247554|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153413569|NCT05247554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153413570|NCT05247554|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153413573|NCT02596022|Sensory System Agents|sensory system agents|mesh-ancestor
153413574|NCT02596022|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153413575|NCT02596022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153413576|NCT02596022|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
153413577|NCT02596022|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153872917|NCT02212067|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
153872918|NCT02212067|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153872919|NCT02212067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153872920|NCT02278575|Antithrombins|antithrombins|mesh-list
153413582|NCT02596022|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
153413583|NCT02596022|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153413584|NCT02596022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153413585|NCT00364442|Fluticasone|fluticasone|mesh-list
153413586|NCT00364442|Xhance|xhance|mesh-list
153413587|NCT00364442|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
153413588|NCT00364442|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153413589|NCT00364442|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153413590|NCT00364442|Autonomic Agents|autonomic agents|mesh-ancestor
153413591|NCT00364442|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153413592|NCT00364442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153413593|NCT00364442|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153413594|NCT00364442|Respiratory System Agents|respiratory system agents|mesh-ancestor
153413595|NCT00364442|Dermatologic Agents|dermatologic agents|mesh-ancestor
153413596|NCT00364442|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
153413597|NCT00364442|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
153413598|NCT00364442|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
153577540|NCT01718366|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153577541|NCT01718366|Antimetabolites|antimetabolites|mesh-ancestor
153817711|NCT06140966|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153817712|NCT06140966|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153413599|NCT00364442|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153413600|NCT00364442|Adrenergic Agents|adrenergic agents|mesh-ancestor
153413601|NCT00364442|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153413602|NCT00364442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153413604|NCT05371574|Analgesics|analgesics|mesh-ancestor
153413605|NCT05371574|Sensory System Agents|sensory system agents|mesh-ancestor
153413606|NCT05371574|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153872937|NCT04558268|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153872938|NCT04558268|Glucocorticoids|glucocorticoids|mesh-ancestor
153872940|NCT04558268|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153872941|NCT04558268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153872942|NCT04558268|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153872943|NCT04558268|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153872944|NCT04558268|Progestins|progestins|mesh-ancestor
153872945|NCT04558268|Hematinics|hematinics|mesh-ancestor
153872946|NCT04558268|Vitamin B Complex|vitamin b complex|mesh-ancestor
153872947|NCT04558268|Vitamins|vitamins|mesh-ancestor
153872948|NCT04558268|Micronutrients|micronutrients|mesh-ancestor
153872949|NCT01125514|Furosemide|furosemide|mesh-list
153872950|NCT01125514|Aliskiren|aliskiren|mesh-list
153872951|NCT01125514|Diuretics|diuretics|mesh-ancestor
153872952|NCT01125514|Natriuretic Agents|natriuretic agents|mesh-ancestor
153872953|NCT01125514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153413612|NCT05371574|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153413613|NCT05371574|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153413614|NCT05371574|Adrenergic Agents|adrenergic agents|mesh-ancestor
153413615|NCT05371574|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153413616|NCT05371574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153413617|NCT05371340|Quercetin|quercetin|mesh-list
153413618|NCT05371340|Antioxidants|antioxidants|mesh-ancestor
153817713|NCT06140966|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153817714|NCT06140966|Antiemetics|antiemetics|mesh-ancestor
153817715|NCT06140966|Autonomic Agents|autonomic agents|mesh-ancestor
153817716|NCT06140966|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153817717|NCT06140966|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153817718|NCT06140966|Glucocorticoids|glucocorticoids|mesh-ancestor
153817719|NCT06140966|Hormones|hormones|mesh-ancestor
153817720|NCT06140966|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153817721|NCT06140966|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153459083|NCT05353062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153577542|NCT01718366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153577543|NCT01718366|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153577545|NCT01718366|Iron Chelating Agents|iron chelating agents|mesh-ancestor
153577547|NCT01718366|Sequestering Agents|sequestering agents|mesh-ancestor
153577548|NCT01718379|Lenalidomide|lenalidomide|mesh-list
153413619|NCT05371340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153413621|NCT05371340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153413622|NCT02601170|Hyaluronic Acid|hyaluronic acid|mesh-list
153413623|NCT02601170|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153413624|NCT02601170|Immunologic Factors|immunologic factors|mesh-ancestor
153413625|NCT02601170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153413626|NCT02601170|Viscosupplements|viscosupplements|mesh-ancestor
153413627|NCT02601170|Protective Agents|protective agents|mesh-ancestor
153413628|NCT00366002|Darifenacin|darifenacin|mesh-list
153413629|NCT00366002|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
153872983|NCT04538391|Anesthetics|anesthetics|mesh-ancestor
153872984|NCT04538391|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153872985|NCT04538391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153872986|NCT04538391|Sensory System Agents|sensory system agents|mesh-ancestor
153872987|NCT04538391|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153872988|NCT04545801|Ketamine|ketamine|mesh-list
153872989|NCT04545801|Analgesics|analgesics|mesh-ancestor
153872990|NCT04545801|Sensory System Agents|sensory system agents|mesh-ancestor
153872991|NCT04545801|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153872992|NCT04545801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153872993|NCT04545801|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
153872994|NCT04545801|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153872995|NCT04545801|Anesthetics, General|anesthetics, general|mesh-ancestor
153872996|NCT04545801|Anesthetics|anesthetics|mesh-ancestor
153872997|NCT04545801|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153872998|NCT04545801|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
153872999|NCT04545801|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
153873000|NCT04545801|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153413661|NCT05365880|Sensory System Agents|sensory system agents|mesh-ancestor
153413662|NCT05365880|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153873010|NCT00576602|Hematinics|hematinics|mesh-ancestor
153873011|NCT02212223|Vitamin D|vitamin d|mesh-list
153873012|NCT02212223|Cholecalciferol|cholecalciferol|mesh-list
153873013|NCT02212223|Vitamins|vitamins|mesh-ancestor
153873014|NCT02212223|Micronutrients|micronutrients|mesh-ancestor
153873015|NCT02212223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153873016|NCT02212223|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153873017|NCT02212223|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153873018|NCT00637585|Fexofenadine|fexofenadine|mesh-list
153873019|NCT00637585|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
153873020|NCT00637585|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
153873021|NCT00637585|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
153873022|NCT00637585|Histamine Antagonists|histamine antagonists|mesh-ancestor
153873023|NCT00637585|Histamine Agents|histamine agents|mesh-ancestor
153873024|NCT00637585|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153873025|NCT00637585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153873026|NCT00637585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153873027|NCT02214810|Bupivacaine|bupivacaine|mesh-list
153873028|NCT02214810|Anesthetics, Local|anesthetics, local|mesh-ancestor
153873029|NCT02214810|Anesthetics|anesthetics|mesh-ancestor
153873030|NCT02214810|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153873031|NCT02214810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153873032|NCT02214810|Sensory System Agents|sensory system agents|mesh-ancestor
153873033|NCT02214810|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153873034|NCT01125046|Bevacizumab|bevacizumab|mesh-list
153873065|NCT04545450|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153873067|NCT04545450|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153404712|NCT00355927|Anesthetics|anesthetics|mesh-ancestor
153873068|NCT04545450|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153873069|NCT04545450|Anabolic Agents|anabolic agents|mesh-ancestor
153873070|NCT04545450|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
153873071|NCT04545450|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153873072|NCT04545450|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153873073|NCT04545450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153873074|NCT04545450|Hormone Antagonists|hormone antagonists|mesh-ancestor
153873075|NCT04579133|Durvalumab|durvalumab|mesh-list
153826535|NCT01324141|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
153413735|NCT05731778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153413736|NCT05731778|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
153413737|NCT05731778|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153413738|NCT05477264|Tislelizumab|tislelizumab|mesh-list
153413739|NCT05477264|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153413740|NCT05477264|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153413741|NCT00422318|Benzbromarone|benzbromarone|mesh-list
153413742|NCT00422318|Uricosuric Agents|uricosuric agents|mesh-ancestor
153413743|NCT00422318|Gout Suppressants|gout suppressants|mesh-ancestor
153413744|NCT00422318|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153413745|NCT00364754|Tesmilifene|tesmilifene|mesh-list
153413746|NCT00364754|Histamine Antagonists|histamine antagonists|mesh-ancestor
153413747|NCT00364754|Histamine Agents|histamine agents|mesh-ancestor
153873077|NCT04579133|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153873078|NCT04579133|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153873079|NCT04579133|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
153873080|NCT04579133|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153873081|NCT04579133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153873082|NCT00576914|Endostatins|endostatins|mesh-list
153873083|NCT00576914|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153873084|NCT00576914|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153873085|NCT00576914|Growth Substances|growth substances|mesh-ancestor
153873086|NCT00576914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153873087|NCT00576914|Growth Inhibitors|growth inhibitors|mesh-ancestor
153873088|NCT00576914|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153366551|NCT03030560|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153873113|NCT01124617|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153873114|NCT01124617|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153873115|NCT01124617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153873116|NCT01124617|Adrenergic Agents|adrenergic agents|mesh-ancestor
153873117|NCT01124617|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153873118|NCT04205890|Ketamine|ketamine|mesh-list
153873119|NCT04205890|Analgesics|analgesics|mesh-ancestor
153873120|NCT04205890|Sensory System Agents|sensory system agents|mesh-ancestor
153873121|NCT04205890|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153873131|NCT04205890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153873132|NCT00577109|Leucovorin|leucovorin|mesh-list
153873133|NCT00577109|Bevacizumab|bevacizumab|mesh-list
153873134|NCT00577109|Cetuximab|cetuximab|mesh-list
153873135|NCT00577109|Irinotecan|irinotecan|mesh-list
153873136|NCT00577109|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153873138|NCT00577109|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153873139|NCT00577109|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153873140|NCT00577109|Growth Substances|growth substances|mesh-ancestor
153873141|NCT00577109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153873142|NCT00577109|Growth Inhibitors|growth inhibitors|mesh-ancestor
153873143|NCT00577109|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
153413905|NCT05068232|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153413906|NCT05068232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153413907|NCT05068232|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153413909|NCT04326764|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153413910|NCT04326764|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
153413911|NCT04326764|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153413912|NCT04326764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153413913|NCT02628236|Aminolevulinic Acid|aminolevulinic acid|mesh-list
153413914|NCT02628236|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
153413915|NCT02628236|Dermatologic Agents|dermatologic agents|mesh-ancestor
153413917|NCT02629094|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
153413918|NCT02629094|Hormone Antagonists|hormone antagonists|mesh-ancestor
153413919|NCT02629094|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153413920|NCT02629094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153413921|NCT02629094|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
153413922|NCT02629094|Diuretics|diuretics|mesh-ancestor
153873247|NCT00577694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153873248|NCT00577694|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153873249|NCT00577694|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153873250|NCT00577694|Immunotoxins|immunotoxins|mesh-ancestor
153873251|NCT00577694|Immunoconjugates|immunoconjugates|mesh-ancestor
153873252|NCT00577694|Immunologic Factors|immunologic factors|mesh-ancestor
153873253|NCT00577694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153873254|NCT04537533|Tranexamic Acid|tranexamic acid|mesh-list
153873255|NCT04537533|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
153873256|NCT04537533|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153873257|NCT04537533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153873258|NCT04537533|Hemostatics|hemostatics|mesh-ancestor
153873259|NCT04537533|Coagulants|coagulants|mesh-ancestor
153873260|NCT02216058|Sirolimus|sirolimus|mesh-list
153873261|NCT02216058|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153873262|NCT02216058|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153873263|NCT02216058|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153873264|NCT02216058|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153826569|NCT00494598|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153404772|NCT02979223|Antioxidants|antioxidants|mesh-ancestor
153873265|NCT02216058|Antifungal Agents|antifungal agents|mesh-ancestor
153873266|NCT02216058|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153873267|NCT02216058|Immunologic Factors|immunologic factors|mesh-ancestor
153873268|NCT02216058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153873269|NCT00577850|Alendronate|alendronate|mesh-list
153873270|NCT00577850|Risedronic Acid|risedronic acid|mesh-list
153413933|NCT04289792|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153649816|NCT00000464|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
153413934|NCT04289792|Tubulin Modulators|tubulin modulators|mesh-ancestor
153413935|NCT04289792|Antimitotic Agents|antimitotic agents|mesh-ancestor
153413936|NCT04289792|Mitosis Modulators|mitosis modulators|mesh-ancestor
153413937|NCT04289792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153413938|NCT04289792|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153413939|NCT04289792|Antimetabolites|antimetabolites|mesh-ancestor
153413940|NCT02631590|Gemcitabine|gemcitabine|mesh-list
153413941|NCT02631590|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153413942|NCT02631590|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153413943|NCT02631590|Antimetabolites|antimetabolites|mesh-ancestor
153413944|NCT02631590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153413945|NCT02253654|Epoetin Alfa|epoetin alfa|mesh-list
153413946|NCT02253654|Hematinics|hematinics|mesh-ancestor
153873283|NCT00577967|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153873284|NCT00577967|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153873285|NCT00577967|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153873286|NCT00577967|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153873287|NCT00577967|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
153873288|NCT00577967|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
153873289|NCT00577967|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153873290|NCT00577967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153873291|NCT00577967|Antimanic Agents|antimanic agents|mesh-ancestor
153413957|NCT02706847|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153413958|NCT02706847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153413959|NCT02706847|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153413960|NCT02470741|Letrozole|letrozole|mesh-list
153413966|NCT02470741|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
153413967|NCT02470741|Hormone Antagonists|hormone antagonists|mesh-ancestor
153413968|NCT02470741|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153413969|NCT02470741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153413971|NCT02544607|Analgesics|analgesics|mesh-ancestor
153413972|NCT02544607|Sensory System Agents|sensory system agents|mesh-ancestor
153413973|NCT02544607|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153873319|NCT04537065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153873321|NCT04544163|Magnesium Sulfate|magnesium sulfate|mesh-list
153873322|NCT04544163|Fentanyl|fentanyl|mesh-list
153873323|NCT04544163|Anesthetics, Local|anesthetics, local|mesh-ancestor
153414013|NCT02624479|Protective Agents|protective agents|mesh-ancestor
153414014|NCT02624479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153414015|NCT02624479|Antioxidants|antioxidants|mesh-ancestor
153414016|NCT02624479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153414017|NCT02624479|Antitubercular Agents|antitubercular agents|mesh-ancestor
153414018|NCT02624479|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153414019|NCT02624479|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153414020|NCT02624479|Chelating Agents|chelating agents|mesh-ancestor
153414021|NCT02624479|Sequestering Agents|sequestering agents|mesh-ancestor
153414022|NCT02472223|Povidone-Iodine|povidone-iodine|mesh-list
153414023|NCT02472223|Povidone|povidone|mesh-list
153414024|NCT02472223|Lubricant Eye Drops|lubricant eye drops|mesh-list
153414025|NCT02472223|Plasma Substitutes|plasma substitutes|mesh-ancestor
153414026|NCT02472223|Blood Substitutes|blood substitutes|mesh-ancestor
153414027|NCT02472223|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
153414028|NCT02472223|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153414029|NCT02472223|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
153414030|NCT02472223|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
153414031|NCT02247960|Ciprofloxacin|ciprofloxacin|mesh-list
153414032|NCT02247960|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153414033|NCT02247960|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153826597|NCT00471809|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153826598|NCT00471809|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153826599|NCT00471809|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153826601|NCT00471809|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
153577549|NCT01718379|Immunologic Factors|immunologic factors|mesh-ancestor
153366616|NCT03017222|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153414034|NCT02247960|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153414036|NCT02247960|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153873368|NCT04536831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153873369|NCT04536831|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153873370|NCT04536831|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153873372|NCT02214966|Ramipril|ramipril|mesh-list
153873373|NCT02214966|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153414038|NCT02247960|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153414039|NCT02247960|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
153414040|NCT02247960|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153414041|NCT02473783|Sertraline|sertraline|mesh-list
153414042|NCT02473783|Antidepressive Agents|antidepressive agents|mesh-ancestor
153414043|NCT02473783|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153414044|NCT02473783|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
153414045|NCT02473783|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153414046|NCT02473783|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153414048|NCT02473783|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153873520|NCT04542252|Dermatologic Agents|dermatologic agents|mesh-ancestor
153873521|NCT04542252|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153873522|NCT04542252|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
153873523|NCT04532775|Methylprednisolone|methylprednisolone|mesh-list
153873524|NCT04532775|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
153873525|NCT04532775|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
153873526|NCT04532775|Prednisolone|prednisolone|mesh-list
153873527|NCT04532775|Prednisolone acetate|prednisolone acetate|mesh-list
153873528|NCT04532775|Magnesium Sulfate|magnesium sulfate|mesh-list
153873529|NCT04532775|Bupivacaine|bupivacaine|mesh-list
153873530|NCT04532775|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
153873531|NCT04532775|Prednisolone phosphate|prednisolone phosphate|mesh-list
153873532|NCT04532775|Anesthetics, Local|anesthetics, local|mesh-ancestor
153873533|NCT04532775|Anesthetics|anesthetics|mesh-ancestor
153873534|NCT04532775|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153873541|NCT04532775|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153873543|NCT04532775|Hormones|hormones|mesh-ancestor
153873544|NCT04532775|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153404805|NCT00376493|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153873545|NCT04532775|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
153873546|NCT04532775|Protective Agents|protective agents|mesh-ancestor
153873547|NCT04532775|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153873548|NCT04532775|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153873549|NCT04532775|Analgesics|analgesics|mesh-ancestor
153414286|NCT03551210|Levofloxacin|levofloxacin|mesh-list
153414287|NCT03551210|Ofloxacin|ofloxacin|mesh-list
153873613|NCT02217189|Astringents|astringents|mesh-ancestor
153873614|NCT02217189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153873615|NCT02217189|Dermatologic Agents|dermatologic agents|mesh-ancestor
153873616|NCT00579956|Meropenem|meropenem|mesh-list
153873617|NCT00579956|Ceftazidime|ceftazidime|mesh-list
153873618|NCT00579956|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153873619|NCT00579956|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153873620|NCT00579956|Third Generation Cephalosporins|third generation cephalosporins|mesh-ancestor
153873621|NCT00579956|Beta Lactam Antibiotics|beta lactam antibiotics|mesh-ancestor
153873622|NCT04555304|Paclitaxel|paclitaxel|mesh-list
153873623|NCT04555304|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
153873624|NCT04555304|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153873625|NCT04555304|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153873626|NCT04555304|Tubulin Modulators|tubulin modulators|mesh-ancestor
153873627|NCT04555304|Antimitotic Agents|antimitotic agents|mesh-ancestor
153873628|NCT04555304|Mitosis Modulators|mitosis modulators|mesh-ancestor
153873629|NCT04555304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153873630|NCT04531800|Mitogens|mitogens|mesh-list
153873631|NCT04531800|Mitosis Modulators|mitosis modulators|mesh-ancestor
153414302|NCT02482675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153414303|NCT00364195|Tesmilifene|tesmilifene|mesh-list
153414304|NCT00364195|Histamine Antagonists|histamine antagonists|mesh-ancestor
153414305|NCT00364195|Histamine Agents|histamine agents|mesh-ancestor
153414306|NCT00364195|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153414307|NCT00364195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153649855|NCT00027664|Thalidomide|thalidomide|mesh-list
153414308|NCT00364195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153414342|NCT03678428|Vitamins|vitamins|mesh-ancestor
153366689|NCT03023306|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153366690|NCT05710367|Dapagliflozin|dapagliflozin|mesh-list
153873666|NCT00580112|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153873667|NCT00580112|Glucocorticoids|glucocorticoids|mesh-ancestor
153873668|NCT00580112|Hormones|hormones|mesh-ancestor
153873698|NCT00580190|Alprazolam|alprazolam|mesh-list
153873699|NCT00580190|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153414366|NCT02577991|Hormones|hormones|mesh-ancestor
153873700|NCT00580190|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153873701|NCT00580190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153873702|NCT00580190|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153873703|NCT00580190|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153873704|NCT00580190|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153873779|NCT00580619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153873780|NCT00580619|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153873781|NCT00580619|Sympatholytics|sympatholytics|mesh-ancestor
153873782|NCT00580619|Autonomic Agents|autonomic agents|mesh-ancestor
153873783|NCT00580619|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153873784|NCT00580619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153873785|NCT00580619|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
153873786|NCT00580619|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153414474|NCT02587117|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153414475|NCT02587117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153414476|NCT02587117|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153414479|NCT02587117|Antioxidants|antioxidants|mesh-ancestor
153873787|NCT00580619|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153873788|NCT00580619|Adrenergic Agents|adrenergic agents|mesh-ancestor
153873789|NCT00580619|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153873790|NCT00580619|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153873827|NCT02217852|Natriuretic Agents|natriuretic agents|mesh-ancestor
153873828|NCT02217852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153873829|NCT02217852|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
153873830|NCT02217852|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153873831|NCT02217852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153873832|NCT02217852|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
153873833|NCT02217852|Protease Inhibitors|protease inhibitors|mesh-ancestor
153873835|NCT02217852|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153873836|NCT02217852|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153873837|NCT02217852|Vasodilator Agents|vasodilator agents|mesh-ancestor
153873839|NCT02217930|Levonadifloxacin|levonadifloxacin|mesh-list
153873840|NCT02217930|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153873841|NCT02217930|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153873842|NCT02217930|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153873843|NCT02217930|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153873844|NCT02217930|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153873845|NCT02217930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153873846|NCT02217930|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153873847|NCT02217930|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
153873848|NCT04577846|Cephalexin|cephalexin|mesh-list
153414556|NCT04001881|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153414557|NCT04001881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153414559|NCT03019640|Rituximab|rituximab|mesh-list
153414560|NCT03019640|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
153414561|NCT03019640|Etoposide|etoposide|mesh-list
153414562|NCT03019640|Lenalidomide|lenalidomide|mesh-list
153414563|NCT03019640|Etoposide phosphate|etoposide phosphate|mesh-list
153873864|NCT00580814|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
153873890|NCT04577885|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153873892|NCT04577885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153873893|NCT04577885|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
153873894|NCT04577885|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
153873895|NCT04577885|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
153873896|NCT04577885|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
153873909|NCT00580931|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153873910|NCT00580931|Vasodilator Agents|vasodilator agents|mesh-ancestor
153873911|NCT01120093|Bromides|bromides|mesh-list
153873912|NCT01120093|Formoterol Fumarate|formoterol fumarate|mesh-list
153873913|NCT01120093|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153873914|NCT01120093|Autonomic Agents|autonomic agents|mesh-ancestor
153873915|NCT01120093|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153873933|NCT00581009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153873934|NCT00581009|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153873935|NCT00581009|Serotonin Agents|serotonin agents|mesh-ancestor
153873936|NCT00581009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153873937|NCT00581009|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153873938|NCT00581009|Antimanic Agents|antimanic agents|mesh-ancestor
153873939|NCT00581009|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153873940|NCT00581009|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153873941|NCT02218359|Amikacin|amikacin|mesh-list
153873942|NCT02218359|Fosfomycin|fosfomycin|mesh-list
153873972|NCT02218671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153873973|NCT01119937|Glycopyrrolate|glycopyrrolate|mesh-list
153873974|NCT01119937|Tiotropium Bromide|tiotropium bromide|mesh-list
153873975|NCT01119937|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153873976|NCT01119937|Autonomic Agents|autonomic agents|mesh-ancestor
153873977|NCT01119937|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153873978|NCT01119937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153366725|NCT01680653|Glucagon|glucagon|mesh-list
153414708|NCT02240628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153414709|NCT02589067|Chlorhexidine|chlorhexidine|mesh-list
153414710|NCT02589067|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
153414711|NCT02589067|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
153414712|NCT02589067|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153414713|NCT02589067|Disinfectants|disinfectants|mesh-ancestor
153874018|NCT02882230|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153874020|NCT02882230|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153874021|NCT02882230|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153874022|NCT02882230|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153874023|NCT01119625|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
153874024|NCT01119625|Immunologic Factors|immunologic factors|mesh-ancestor
153874025|NCT01119625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153874026|NCT02218827|Loteprednol Etabonate|loteprednol etabonate|mesh-list
153874027|NCT02218827|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
153414719|NCT02207400|Sodium Fluoride|sodium fluoride|mesh-list
153414720|NCT02207400|Cariostatic Agents|cariostatic agents|mesh-ancestor
153414721|NCT02207400|Protective Agents|protective agents|mesh-ancestor
153414722|NCT02207400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153414723|NCT02207400|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
153874042|NCT01118962|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
153874043|NCT01118962|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153874044|NCT01118962|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153874045|NCT01118962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153414739|NCT02589847|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153414740|NCT02589847|Antitubercular Agents|antitubercular agents|mesh-ancestor
153414741|NCT02592421|Dapagliflozin|dapagliflozin|mesh-list
153414742|NCT02592421|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
153414743|NCT02592421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153414744|NCT02592421|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153414745|NCT02592421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153414746|NCT02512783|Lidocaine|lidocaine|mesh-list
153414747|NCT02512783|Propofol|propofol|mesh-list
153414748|NCT02512783|Anesthetics, Local|anesthetics, local|mesh-ancestor
153414749|NCT02512783|Anesthetics|anesthetics|mesh-ancestor
153577550|NCT01718379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153414750|NCT02512783|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153414751|NCT02512783|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153414752|NCT02512783|Sensory System Agents|sensory system agents|mesh-ancestor
153414753|NCT02512783|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153414754|NCT02512783|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153414755|NCT02512783|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
153414756|NCT02512783|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153414757|NCT02512783|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153414758|NCT02512783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153874059|NCT05092984|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
153874061|NCT05092984|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153874062|NCT05092984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153874063|NCT05092984|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
153874064|NCT05092984|Diuretics|diuretics|mesh-ancestor
153874065|NCT05092984|Natriuretic Agents|natriuretic agents|mesh-ancestor
153874066|NCT02213159|Dexmedetomidine|dexmedetomidine|mesh-list
153874067|NCT02213159|Morphine|morphine|mesh-list
153874068|NCT02213159|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153874069|NCT02213159|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153874070|NCT02213159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153874080|NCT02213159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153874082|NCT02213159|Narcotics|narcotics|mesh-ancestor
153874083|NCT01118455|Anticonvulsants|anticonvulsants|mesh-list
153874084|NCT02219100|Mifepristone|mifepristone|mesh-list
153874085|NCT02219100|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
153874086|NCT02219100|Abortifacient Agents|abortifacient agents|mesh-ancestor
153874087|NCT02219100|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153874112|NCT02219178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153874113|NCT02219178|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153874161|NCT02219412|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153874163|NCT02219412|Analgesics|analgesics|mesh-ancestor
153874164|NCT02219412|Sensory System Agents|sensory system agents|mesh-ancestor
153874165|NCT02219412|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153874166|NCT02219412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153874168|NCT02219412|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153874169|NCT02219412|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153414867|NCT02600767|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
153414868|NCT02600767|Antimalarials|antimalarials|mesh-ancestor
153414869|NCT02600767|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153414870|NCT02600767|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153414871|NCT02600767|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153414872|NCT00365287|Cyclosporine|cyclosporine|mesh-list
153414873|NCT00365287|Mycophenolic Acid|mycophenolic acid|mesh-list
153414888|NCT00365287|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153414889|NCT00365287|Antimetabolites|antimetabolites|mesh-ancestor
153414890|NCT00365287|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153414891|NCT00365287|Antifungal Agents|antifungal agents|mesh-ancestor
153414892|NCT00365287|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153414893|NCT00365287|Dermatologic Agents|dermatologic agents|mesh-ancestor
153414894|NCT00365287|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
153414895|NCT00365287|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153874278|NCT01117987|Imatinib Mesylate|imatinib mesylate|mesh-list
153388843|NCT00001587|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153388844|NCT00001587|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153391256|NCT04266197|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153391257|NCT04266197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153391258|NCT04266197|Urological Agents|urological agents|mesh-ancestor
153391259|NCT05669313|Rivaroxaban|rivaroxaban|mesh-list
153391260|NCT05669313|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
153391261|NCT05669313|Antithrombins|antithrombins|mesh-ancestor
153391262|NCT05669313|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
153396100|NCT02989207|Alkylating Agents|alkylating agents|mesh-ancestor
153396101|NCT02989207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153396102|NCT02989207|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153396103|NCT02989207|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153396104|NCT01843621|Vaccines|vaccines|mesh-list
153396105|NCT01843621|Immunologic Factors|immunologic factors|mesh-ancestor
153396106|NCT01843621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153396107|NCT02608229|Paclitaxel|paclitaxel|mesh-list
153396108|NCT02608229|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
153396109|NCT02608229|Gemcitabine|gemcitabine|mesh-list
153402588|NCT05074589|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153402589|NCT05074589|Immunologic Factors|immunologic factors|mesh-ancestor
153402590|NCT05074589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153402591|NCT05074589|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
153402592|NCT05074589|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153402593|NCT05074589|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153402594|NCT05074589|Antidotes|antidotes|mesh-ancestor
153402595|NCT05074589|Protective Agents|protective agents|mesh-ancestor
153402596|NCT05074589|Vitamin B Complex|vitamin b complex|mesh-ancestor
153402597|NCT05074589|Vitamins|vitamins|mesh-ancestor
153402598|NCT05074589|Micronutrients|micronutrients|mesh-ancestor
153402599|NCT05061654|Tazobactam|tazobactam|mesh-list
153649870|NCT00027703|Gemcitabine|gemcitabine|mesh-list
153402601|NCT05061654|Ceftolozane, tazobactam drug combination|ceftolozane, tazobactam drug combination|mesh-list
153404620|NCT03226223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153404621|NCT03226223|Sympathomimetics|sympathomimetics|mesh-ancestor
153404622|NCT03226223|Autonomic Agents|autonomic agents|mesh-ancestor
153404623|NCT03226223|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153404624|NCT03226223|Dopamine Agents|dopamine agents|mesh-ancestor
153404625|NCT03226223|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153404626|NCT03226223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153404627|NCT03226223|Adrenergic Agents|adrenergic agents|mesh-ancestor
153404628|NCT03226223|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
153404629|NCT03226223|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153404630|NCT03226223|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153404631|NCT03226223|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
153404632|NCT05620771|Bevacizumab|bevacizumab|mesh-list
153404633|NCT05620771|Atezolizumab|atezolizumab|mesh-list
153404634|NCT05620771|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153404635|NCT05620771|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153404636|NCT05620771|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153404637|NCT05620771|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153404739|NCT00376337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153405178|NCT00003405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153405197|NCT00003243|Aldesleukin|aldesleukin|mesh-list
153405631|NCT05924893|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
153405681|NCT05922800|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
153405682|NCT05922800|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153405683|NCT05922800|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153405684|NCT05922800|Antimetabolites|antimetabolites|mesh-ancestor
153405685|NCT05922800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153405686|NCT05922800|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153405687|NCT05922696|Vitamin D|vitamin d|mesh-list
153405688|NCT05922696|Cholecalciferol|cholecalciferol|mesh-list
153405689|NCT05922696|Vitamins|vitamins|mesh-ancestor
153405032|NCT03252353|Octreotide|octreotide|mesh-list
153405690|NCT05922696|Micronutrients|micronutrients|mesh-ancestor
153405691|NCT05922696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153405692|NCT05922696|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153405693|NCT05922696|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153405712|NCT05922384|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153405713|NCT05922384|Immunologic Factors|immunologic factors|mesh-ancestor
153405714|NCT05922384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153405715|NCT05922358|Anti-Allergic Agents|anti-allergic agents|mesh-list
153405716|NCT05922345|Docetaxel|docetaxel|mesh-list
153405717|NCT05922345|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153405718|NCT05922345|Tubulin Modulators|tubulin modulators|mesh-ancestor
153405719|NCT05922345|Antimitotic Agents|antimitotic agents|mesh-ancestor
153405720|NCT05922345|Mitosis Modulators|mitosis modulators|mesh-ancestor
153405721|NCT05922345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153405722|NCT05922306|Interferons|interferons|mesh-list
153366842|NCT01685411|Allopurinol|allopurinol|mesh-list
153366843|NCT01685411|Levetiracetam|levetiracetam|mesh-list
153366844|NCT01685411|Tacrolimus|tacrolimus|mesh-list
153366845|NCT01685411|Antilymphocyte Serum|antilymphocyte serum|mesh-list
153366846|NCT01685411|Lenograstim|lenograstim|mesh-list
153366847|NCT01685411|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153366848|NCT01685411|Immunologic Factors|immunologic factors|mesh-ancestor
153366849|NCT01685411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153366850|NCT01685411|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153366851|NCT01685411|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153577551|NCT01718379|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153405726|NCT05922306|Antiviral Agents|antiviral agents|mesh-ancestor
153405727|NCT05922306|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153405728|NCT05922306|Immunologic Factors|immunologic factors|mesh-ancestor
153405791|NCT05920538|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153405792|NCT05920538|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153405793|NCT05920538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153405794|NCT05920538|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153405795|NCT05920538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153405796|NCT05920538|Vasodilator Agents|vasodilator agents|mesh-ancestor
153405797|NCT05920187|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
153405798|NCT05919992|Hydrocortisone|hydrocortisone|mesh-list
153405799|NCT05919992|Metyrapone|metyrapone|mesh-list
153405800|NCT05919992|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153405801|NCT05919992|Antimetabolites|antimetabolites|mesh-ancestor
153405802|NCT05919992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153405803|NCT05919992|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153405804|NCT05919966|Chlorhexidine|chlorhexidine|mesh-list
153405805|NCT05919966|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
153407341|NCT01084083|Paclitaxel|paclitaxel|mesh-list
153407456|NCT00330564|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153407457|NCT00330564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153407579|NCT00070291|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153407580|NCT00070291|Immunologic Factors|immunologic factors|mesh-ancestor
153407581|NCT00070291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153407582|NCT00070291|Antifungal Agents|antifungal agents|mesh-ancestor
153407583|NCT00070291|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153407584|NCT00070291|Dermatologic Agents|dermatologic agents|mesh-ancestor
153407585|NCT00070291|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153405051|NCT00358358|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153407586|NCT00070291|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
153407587|NCT00064350|Sorafenib|sorafenib|mesh-list
153407588|NCT00064350|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153407589|NCT00064350|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153407590|NCT00064350|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153407591|NCT00064350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153407592|NCT00060346|Prednisone|prednisone|mesh-list
153407593|NCT00060346|Cyclophosphamide|cyclophosphamide|mesh-list
153407594|NCT00060346|Rituximab|rituximab|mesh-list
153407595|NCT00060346|Doxorubicin|doxorubicin|mesh-list
153407596|NCT00060346|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
153407705|NCT00003389|Doxorubicin|doxorubicin|mesh-list
153407706|NCT00003389|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
153407707|NCT00003389|Etoposide|etoposide|mesh-list
153407708|NCT00003389|Vincristine|vincristine|mesh-list
153407709|NCT00003389|Etoposide phosphate|etoposide phosphate|mesh-list
153407710|NCT00003389|Bleomycin|bleomycin|mesh-list
153407711|NCT00003389|Vinblastine|vinblastine|mesh-list
153407712|NCT00003389|Podophyllotoxin|podophyllotoxin|mesh-list
153407713|NCT00003389|Imidazole|imidazole|mesh-list
153408153|NCT04342910|Tubulin Modulators|tubulin modulators|mesh-ancestor
153408154|NCT04342910|Antimitotic Agents|antimitotic agents|mesh-ancestor
153408155|NCT04342910|Mitosis Modulators|mitosis modulators|mesh-ancestor
153408283|NCT04243616|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153408284|NCT04243616|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153409486|NCT00608972|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153409487|NCT00608972|Growth Substances|growth substances|mesh-ancestor
153409488|NCT00608972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153409489|NCT00608972|Growth Inhibitors|growth inhibitors|mesh-ancestor
153409491|NCT02729714|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
153409492|NCT02729714|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153409493|NCT02729714|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153409494|NCT02729714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153409495|NCT02729714|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
153409496|NCT02729714|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153409531|NCT05648058|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
153409532|NCT05648058|Histamine Antagonists|histamine antagonists|mesh-ancestor
153409533|NCT05648058|Histamine Agents|histamine agents|mesh-ancestor
153409534|NCT05648058|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153409535|NCT05648058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153409536|NCT05648058|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
153409537|NCT05648058|Antipruritics|antipruritics|mesh-ancestor
153409814|NCT00362089|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153409815|NCT00362089|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153409816|NCT00362089|Analgesics|analgesics|mesh-ancestor
153409817|NCT00362089|Sensory System Agents|sensory system agents|mesh-ancestor
153409989|NCT00589316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153409991|NCT00589316|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153409992|NCT00589316|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153410016|NCT00003417|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153410017|NCT00003417|Alkylating Agents|alkylating agents|mesh-ancestor
153410018|NCT00003417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153405081|NCT02265510|Hormones|hormones|mesh-ancestor
153410019|NCT00003417|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153410020|NCT00003423|Cytarabine|cytarabine|mesh-list
153410087|NCT00003273|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153410088|NCT00003273|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153410090|NCT00003273|Dermatologic Agents|dermatologic agents|mesh-ancestor
153410091|NCT00003273|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153410092|NCT00003273|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153410093|NCT00003273|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153410094|NCT00003273|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153410095|NCT00003273|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153410096|NCT00003273|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153410097|NCT00003273|Antidotes|antidotes|mesh-ancestor
153410098|NCT00003273|Protective Agents|protective agents|mesh-ancestor
153410099|NCT00003273|Vitamin B Complex|vitamin b complex|mesh-ancestor
153410100|NCT00003273|Vitamins|vitamins|mesh-ancestor
153410101|NCT00003273|Micronutrients|micronutrients|mesh-ancestor
153410102|NCT00003273|Tubulin Modulators|tubulin modulators|mesh-ancestor
153411797|NCT00384969|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153411798|NCT00384969|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153411799|NCT00384969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153411800|NCT00384969|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
153411801|NCT00384969|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153412298|NCT03390673|Growth Inhibitors|growth inhibitors|mesh-ancestor
153412384|NCT01689987|Cyclophosphamide|cyclophosphamide|mesh-list
153412385|NCT01689987|Ichthammol|ichthammol|mesh-list
153412386|NCT01689987|BB 1101|bb 1101|mesh-list
153412387|NCT01689987|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153412388|NCT01689987|Immunologic Factors|immunologic factors|mesh-ancestor
153412389|NCT01689987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153412390|NCT01689987|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153412391|NCT01689987|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153412392|NCT01689987|Alkylating Agents|alkylating agents|mesh-ancestor
153412393|NCT01689987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153412394|NCT01689987|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153783612|NCT00236561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153412420|NCT01680939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153412422|NCT01680939|Sensory System Agents|sensory system agents|mesh-ancestor
153412423|NCT01680939|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153412424|NCT01680939|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153412425|NCT01680939|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153412426|NCT01680939|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153412427|NCT01680939|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153412428|NCT01680939|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153412429|NCT01680939|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153412430|NCT01680939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153412431|NCT01689597|Morphine|morphine|mesh-list
153412432|NCT01689597|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153412433|NCT01689597|Narcotics|narcotics|mesh-ancestor
153412434|NCT01689597|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153412435|NCT01689597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153412436|NCT01689597|Analgesics|analgesics|mesh-ancestor
153412437|NCT01689597|Sensory System Agents|sensory system agents|mesh-ancestor
153412438|NCT01689597|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153412440|NCT02483000|Cytarabine|cytarabine|mesh-list
153412493|NCT04829799|Ketorolac|ketorolac|mesh-list
153412494|NCT04829799|Lidocaine|lidocaine|mesh-list
153412495|NCT04829799|Phenylephrine|phenylephrine|mesh-list
153413203|NCT02436668|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153413260|NCT05078606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153413500|NCT04707950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153413501|NCT04707950|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
153413502|NCT04707950|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153413503|NCT04707950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153413526|NCT00364052|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153413528|NCT00364052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153413529|NCT02582840|Dapagliflozin|dapagliflozin|mesh-list
153413530|NCT02582840|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
153413531|NCT02582840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153413532|NCT02582840|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153413533|NCT02582840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153783613|NCT00236561|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153783614|NCT00236561|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153413534|NCT00364988|Pioglitazone|pioglitazone|mesh-list
153413536|NCT00364988|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153413537|NCT00364988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153413538|NCT00364988|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153413539|NCT00364988|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153413540|NCT00364988|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
153674588|NCT00054522|Micronutrients|micronutrients|mesh-ancestor
153413704|NCT00365612|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153413705|NCT00365612|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
153366945|NCT02485158|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153366946|NCT02485158|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
153366947|NCT02485158|Hallucinogens|hallucinogens|mesh-ancestor
153366948|NCT02485158|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153366949|NCT02485158|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153366950|NCT02485158|Analgesics|analgesics|mesh-ancestor
153366951|NCT02485158|Sensory System Agents|sensory system agents|mesh-ancestor
153366952|NCT02485158|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
153366953|NCT02485158|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
153577552|NCT01718379|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153577553|NCT01718379|Growth Substances|growth substances|mesh-ancestor
153577554|NCT01718379|Growth Inhibitors|growth inhibitors|mesh-ancestor
153577555|NCT01718379|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153577556|NCT01718496|Morphine|morphine|mesh-list
153577557|NCT01718496|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153577558|NCT01718496|Narcotics|narcotics|mesh-ancestor
153577559|NCT01718496|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153413841|NCT00851136|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153413842|NCT00851136|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153413843|NCT00851136|Growth Substances|growth substances|mesh-ancestor
153413844|NCT00851136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153413845|NCT00851136|Growth Inhibitors|growth inhibitors|mesh-ancestor
153413867|NCT02620904|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
153413868|NCT02620904|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
153413871|NCT00300768|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153413872|NCT00300768|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153413873|NCT00300768|Anthelmintics|anthelmintics|mesh-ancestor
153413874|NCT00300768|Antinematodal Agents|antinematodal agents|mesh-ancestor
153413898|NCT05068232|Carboplatin|carboplatin|mesh-list
153413899|NCT05068232|Etoposide|etoposide|mesh-list
153413900|NCT05068232|Durvalumab|durvalumab|mesh-list
153413981|NCT02544607|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
153413982|NCT02544607|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153413983|NCT02544607|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153413985|NCT00363571|Anticonvulsants|anticonvulsants|mesh-ancestor
153413986|NCT00363571|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
153413987|NCT00363571|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153413988|NCT00363571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153413989|NCT00363571|Diuretics|diuretics|mesh-ancestor
153413990|NCT00363571|Natriuretic Agents|natriuretic agents|mesh-ancestor
153413991|NCT00363571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153413992|NCT04744675|Triamcinolone|triamcinolone|mesh-list
153413993|NCT04744675|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
153413994|NCT04744675|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
153413995|NCT04744675|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
153413996|NCT04744675|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153413997|NCT04744675|Glucocorticoids|glucocorticoids|mesh-ancestor
153413998|NCT04744675|Hormones|hormones|mesh-ancestor
153413999|NCT04744675|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153414073|NCT00366938|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153414387|NCT04341727|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153414388|NCT04341727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153414389|NCT04341727|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153414411|NCT00367094|Protease Inhibitors|protease inhibitors|mesh-ancestor
153414412|NCT00367094|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153414414|NCT02581111|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
153414415|NCT02581111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153414416|NCT02581111|Sensory System Agents|sensory system agents|mesh-ancestor
153414417|NCT02581111|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153414418|NCT05587400|Dobutamine|dobutamine|mesh-list
153414419|NCT05587400|Nitric Oxide|nitric oxide|mesh-list
153414420|NCT05587400|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153414421|NCT05587400|Autonomic Agents|autonomic agents|mesh-ancestor
153414422|NCT05587400|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153414423|NCT05587400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153414424|NCT05587400|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153414425|NCT05587400|Respiratory System Agents|respiratory system agents|mesh-ancestor
153414426|NCT05587400|Free Radical Scavengers|free radical scavengers|mesh-ancestor
153414427|NCT05587400|Antioxidants|antioxidants|mesh-ancestor
153414428|NCT05587400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153414429|NCT05587400|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153414924|NCT02611765|Penicillin G|penicillin g|mesh-list
153414925|NCT02611765|Penicillin G Benzathine|penicillin g benzathine|mesh-list
153414926|NCT02611765|Penicillin G Procaine|penicillin g procaine|mesh-list
153414927|NCT02611765|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153414928|NCT02611765|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153414929|NCT02616523|Lidocaine|lidocaine|mesh-list
153416079|NCT02722837|Sofosbuvir-velpatasvir drug combination|sofosbuvir-velpatasvir drug combination|mesh-list
153416081|NCT02722837|Antiviral Agents|antiviral agents|mesh-ancestor
153416082|NCT02722837|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153416083|NCT02710526|Buprenorphine|buprenorphine|mesh-list
153815029|NCT00344669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153416084|NCT02710526|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153416086|NCT02710526|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153416087|NCT02710526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153416088|NCT02710526|Analgesics|analgesics|mesh-ancestor
153416089|NCT02710526|Sensory System Agents|sensory system agents|mesh-ancestor
153416090|NCT02710526|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153416091|NCT02710526|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
153416092|NCT02664961|Bevacizumab|bevacizumab|mesh-list
153416109|NCT02713178|Anesthetics|anesthetics|mesh-ancestor
153416110|NCT02713178|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153416111|NCT02713178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153416112|NCT02713178|Sensory System Agents|sensory system agents|mesh-ancestor
153416113|NCT02713178|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153416114|NCT04048850|Grazoprevir|grazoprevir|mesh-list
153416115|NCT04048850|Elbasvir-grazoprevir drug combination|elbasvir-grazoprevir drug combination|mesh-list
153416116|NCT04048850|Antiviral Agents|antiviral agents|mesh-ancestor
153416117|NCT04048850|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153416139|NCT02730247|Ramucirumab|ramucirumab|mesh-list
153416140|NCT02730247|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153416141|NCT02730247|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153416142|NCT02730247|Tubulin Modulators|tubulin modulators|mesh-ancestor
153416143|NCT02730247|Antimitotic Agents|antimitotic agents|mesh-ancestor
153416144|NCT02730247|Mitosis Modulators|mitosis modulators|mesh-ancestor
153416145|NCT02730247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153416146|NCT02730247|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153826980|NCT01247337|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153416147|NCT02730247|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153416512|NCT00368498|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153416514|NCT05172817|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
153416515|NCT05172817|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153416516|NCT05172817|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153416517|NCT00961142|Fludarabine|fludarabine|mesh-list
153416518|NCT00961142|Melphalan|melphalan|mesh-list
153416519|NCT00961142|Thiotepa|thiotepa|mesh-list
153416520|NCT00961142|Thymoglobulin|thymoglobulin|mesh-list
153416576|NCT04338919|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153416577|NCT04338919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153416875|NCT05202158|Gentamicins|gentamicins|mesh-list
153416876|NCT05202158|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153416877|NCT05202158|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153416878|NCT05202158|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
153416879|NCT05202158|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153417019|NCT05453552|Immunologic Factors|immunologic factors|mesh-ancestor
153417020|NCT05453552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153417021|NCT05453552|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153417108|NCT00370760|Hormones|hormones|mesh-ancestor
153415244|NCT00367393|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153417129|NCT05203562|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153417130|NCT05203562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153417131|NCT04766762|Flunarizine|flunarizine|mesh-list
153417132|NCT04766762|Anticonvulsants|anticonvulsants|mesh-ancestor
153417133|NCT04766762|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153417134|NCT04766762|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153417135|NCT04766762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153417136|NCT04766762|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153417159|NCT02737891|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153417160|NCT02737891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153417161|NCT02196558|Quetmolimab|quetmolimab|mesh-list
153367004|NCT03018626|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153417162|NCT02196558|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153417163|NCT04809662|Imiquimod|imiquimod|mesh-list
153417164|NCT04809662|Toll-Like Receptor Agonists|toll-like receptor agonists|mesh-ancestor
153417165|NCT04809662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153417166|NCT04809662|Immunomodulating Agents|immunomodulating agents|mesh-ancestor
153417167|NCT04809662|Immunologic Factors|immunologic factors|mesh-ancestor
153417168|NCT04809662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153417169|NCT04809662|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153417170|NCT04809662|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153417171|NCT04809662|Interferon Inducers|interferon inducers|mesh-ancestor
153417172|NCT02196324|Serlopitant|serlopitant|mesh-list
153417173|NCT02196324|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
153417174|NCT02196324|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153417175|NCT02196324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153417176|NCT02196324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153417177|NCT05450419|Vitamin D|vitamin d|mesh-list
153417178|NCT05450419|Cholecalciferol|cholecalciferol|mesh-list
153417179|NCT05450419|Vitamins|vitamins|mesh-ancestor
153417310|NCT05057689|Fentanyl|fentanyl|mesh-list
153417311|NCT05057689|Dexmedetomidine|dexmedetomidine|mesh-list
153417312|NCT05057689|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153417315|NCT05057689|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153417439|NCT02753881|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153417440|NCT02753881|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153417441|NCT02753881|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153417442|NCT02753881|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153417443|NCT02753881|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153417455|NCT05348096|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153417456|NCT05348096|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153417457|NCT05348096|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153417458|NCT05348096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153417459|NCT04337606|Decitabine|decitabine|mesh-list
153417460|NCT04337606|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153417461|NCT04337606|Antimetabolites|antimetabolites|mesh-ancestor
153417462|NCT04337606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153417463|NCT04337606|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153417464|NCT04337606|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153417465|NCT01190306|Riboflavin|riboflavin|mesh-list
153417466|NCT01190306|Vitamin B Complex|vitamin b complex|mesh-ancestor
153417467|NCT01190306|Vitamins|vitamins|mesh-ancestor
153417468|NCT01190306|Micronutrients|micronutrients|mesh-ancestor
153417469|NCT01190306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153417470|NCT01190306|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
153417516|NCT02194062|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153417517|NCT02194062|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153417518|NCT02194062|Autonomic Agents|autonomic agents|mesh-ancestor
153417614|NCT02766517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153405222|NCT04344158|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153417615|NCT05348239|Copper|copper|mesh-list
153417616|NCT05348239|Chlorophyllin|chlorophyllin|mesh-list
153417617|NCT05348239|Trace Elements|trace elements|mesh-ancestor
153417618|NCT05348239|Micronutrients|micronutrients|mesh-ancestor
153417619|NCT05348239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153417756|NCT04507022|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153417757|NCT04507022|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
153417758|NCT04507022|Progestins|progestins|mesh-ancestor
153417759|NCT04507022|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153417760|NCT04507022|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153417761|NCT04507022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153417762|NCT04507022|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
153417763|NCT04507022|Hormone Antagonists|hormone antagonists|mesh-ancestor
153417813|NCT00371995|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153417814|NCT00371995|Antifungal Agents|antifungal agents|mesh-ancestor
153417815|NCT00371995|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153417816|NCT00372307|Pimecrolimus|pimecrolimus|mesh-list
153417817|NCT00372307|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153417818|NCT00372307|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153417819|NCT00372307|Analgesics|analgesics|mesh-ancestor
153417912|NCT04737655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153417913|NCT04737655|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153417914|NCT04737655|Respiratory System Agents|respiratory system agents|mesh-ancestor
153417915|NCT04737655|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
153417916|NCT04737655|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
153417917|NCT04737655|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153417918|NCT04737655|Adrenergic Agents|adrenergic agents|mesh-ancestor
153417919|NCT04737655|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153367056|NCT00979940|Atorvastatin|atorvastatin|mesh-list
153367057|NCT00979940|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153367058|NCT00979940|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153417920|NCT04737655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153418880|NCT05829148|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153418881|NCT05829148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153418882|NCT05829148|Anticonvulsants|anticonvulsants|mesh-ancestor
153418883|NCT05829148|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153418884|NCT05829148|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153418885|NCT05829148|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153418886|NCT05829148|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153418887|NCT05829148|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153418888|NCT05829148|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153418889|NCT05829148|Antioxidants|antioxidants|mesh-ancestor
153418890|NCT05829148|Protective Agents|protective agents|mesh-ancestor
153418891|NCT05829057|Interleukin-2|interleukin-2|mesh-list
153418892|NCT05829057|Antibodies|antibodies|mesh-list
153418893|NCT05829057|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
153418894|NCT05829057|Immunologic Factors|immunologic factors|mesh-ancestor
153418895|NCT05829057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153418896|NCT05829057|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153418897|NCT05829057|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153418898|NCT05829057|Analgesics|analgesics|mesh-ancestor
153418899|NCT05829057|Sensory System Agents|sensory system agents|mesh-ancestor
153418900|NCT05829057|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153418901|NCT05828550|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
153418902|NCT05828550|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153418903|NCT05828381|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
153418904|NCT05828381|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153418905|NCT05828199|Dexmedetomidine|dexmedetomidine|mesh-list
153420414|NCT02867605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153783623|NCT02215330|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
153420415|NCT02867605|Viscosupplements|viscosupplements|mesh-ancestor
153420416|NCT02867605|Protective Agents|protective agents|mesh-ancestor
153367101|NCT00982592|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153420647|NCT03795350|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
153422381|NCT04008030|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153422383|NCT04008030|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
153422384|NCT04008030|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153422385|NCT04008030|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153422386|NCT04008030|Antidotes|antidotes|mesh-ancestor
153423730|NCT02176356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153423732|NCT02176356|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153423733|NCT02176356|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153423764|NCT02136576|Sodium Fluoride|sodium fluoride|mesh-list
153423765|NCT02136576|Cariostatic Agents|cariostatic agents|mesh-ancestor
153424000|NCT04713956|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153424001|NCT04713956|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153424002|NCT04713956|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153424003|NCT04713956|Antimetabolites|antimetabolites|mesh-ancestor
153424004|NCT04713956|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153424005|NCT04713956|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153424007|NCT04425746|Dermatologic Agents|dermatologic agents|mesh-ancestor
153424009|NCT04392362|Analgesics|analgesics|mesh-ancestor
153424694|NCT03232892|Trametinib|trametinib|mesh-list
153424701|NCT03510481|Antimalarials|antimalarials|mesh-ancestor
153424702|NCT03510481|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153424703|NCT03510481|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153424704|NCT03510481|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153424705|NCT03109418|Ketamine|ketamine|mesh-list
153424706|NCT03109418|Analgesics|analgesics|mesh-ancestor
153424707|NCT03109418|Sensory System Agents|sensory system agents|mesh-ancestor
153424708|NCT03109418|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153424709|NCT03109418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153424710|NCT03109418|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
153424711|NCT03109418|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153424712|NCT03109418|Anesthetics, General|anesthetics, general|mesh-ancestor
153424713|NCT03109418|Anesthetics|anesthetics|mesh-ancestor
153424714|NCT03109418|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153424715|NCT03109418|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
153424716|NCT03109418|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
153424717|NCT03109418|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153424718|NCT03109418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153424719|NCT03404167|Zoliflodacin|zoliflodacin|mesh-list
153424720|NCT03404167|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153424721|NCT03404167|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153424722|NCT03404167|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153424723|NCT03404167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153424725|NCT03771560|Leucovorin|leucovorin|mesh-list
153424726|NCT03771560|Folic Acid|folic acid|mesh-list
153424737|NCT03767738|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153424742|NCT02973620|Simendan|simendan|mesh-list
153424755|NCT05313386|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153424757|NCT05313386|Sensory System Agents|sensory system agents|mesh-ancestor
153424792|NCT03405259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153424793|NCT03513757|Lidocaine|lidocaine|mesh-list
153424794|NCT03513757|Glycopyrrolate|glycopyrrolate|mesh-list
153424795|NCT03513757|Dexmedetomidine|dexmedetomidine|mesh-list
153424796|NCT03513757|Nitrous Oxide|nitrous oxide|mesh-list
153424797|NCT03513757|Propofol|propofol|mesh-list
153424798|NCT03513757|Sevoflurane|sevoflurane|mesh-list
153424799|NCT03513757|Anesthetics, Local|anesthetics, local|mesh-ancestor
153424800|NCT03513757|Anesthetics|anesthetics|mesh-ancestor
153424820|NCT03513757|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153424822|NCT03513757|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153424823|NCT03513757|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
153424824|NCT03513757|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
153424825|NCT03513757|Cholinergic Agents|cholinergic agents|mesh-ancestor
153424826|NCT03760640|Insulin Lispro|insulin lispro|mesh-list
153424827|NCT03760640|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153424828|NCT03760640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153424829|NCT03275623|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
153424830|NCT03275623|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153424831|NCT03756038|Lorazepam|lorazepam|mesh-list
153424832|NCT03756038|Anticonvulsants|anticonvulsants|mesh-ancestor
153424833|NCT03756038|Antiemetics|antiemetics|mesh-ancestor
153424834|NCT03756038|Autonomic Agents|autonomic agents|mesh-ancestor
153424835|NCT03756038|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153424836|NCT03756038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153424837|NCT03756038|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153424838|NCT03756038|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153424839|NCT03756038|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153424840|NCT03756038|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153424841|NCT03756038|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153424842|NCT03756038|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153424843|NCT03756038|GABA Modulators|gaba modulators|mesh-ancestor
153424844|NCT03756038|GABA Agents|gaba agents|mesh-ancestor
153424845|NCT03756038|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153424877|NCT02934932|Dopamine Agents|dopamine agents|mesh-ancestor
153424878|NCT03415243|Acetaminophen|acetaminophen|mesh-list
153783628|NCT02278510|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
153424883|NCT03415243|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153424884|NCT03415243|Analgesics|analgesics|mesh-ancestor
153424885|NCT03415243|Sensory System Agents|sensory system agents|mesh-ancestor
153424886|NCT03415243|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153424887|NCT03415243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153424888|NCT03415243|Antipyretics|antipyretics|mesh-ancestor
153424889|NCT03415243|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
153424890|NCT03415243|Mydriatics|mydriatics|mesh-ancestor
153424891|NCT03415243|Autonomic Agents|autonomic agents|mesh-ancestor
153424893|NCT03415243|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
153424894|NCT03415243|Nasal Decongestants|nasal decongestants|mesh-ancestor
153424895|NCT03415243|Respiratory System Agents|respiratory system agents|mesh-ancestor
153424896|NCT03415243|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
153424897|NCT03415243|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153424898|NCT03415243|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153424899|NCT03415243|Adrenergic Agents|adrenergic agents|mesh-ancestor
153424900|NCT03415243|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153424901|NCT03415243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153424902|NCT03415243|Protective Agents|protective agents|mesh-ancestor
153424903|NCT03415243|Antitussive Agents|antitussive agents|mesh-ancestor
153424904|NCT03415243|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
153424905|NCT03415243|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
153424906|NCT03415243|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153424907|NCT03415243|Narcotics|narcotics|mesh-ancestor
153424939|NCT03742154|Varenicline|varenicline|mesh-list
153424940|NCT03742154|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
153424941|NCT03742154|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
153424942|NCT03742154|Cholinergic Agents|cholinergic agents|mesh-ancestor
153424943|NCT03742154|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153424944|NCT03742154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153424945|NCT03742154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153817722|NCT06140966|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153817723|NCT06140966|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153817724|NCT06140966|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153817725|NCT06140966|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153424947|NCT02734940|Fentanyl|fentanyl|mesh-list
153424948|NCT02734940|Ketamine|ketamine|mesh-list
153424949|NCT02734940|Dexmedetomidine|dexmedetomidine|mesh-list
153424950|NCT02734940|Morphine|morphine|mesh-list
153424951|NCT02734940|Anesthetics, Local|anesthetics, local|mesh-ancestor
153424952|NCT02734940|Anesthetics|anesthetics|mesh-ancestor
153424953|NCT02734940|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153424954|NCT02734940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153424955|NCT02734940|Sensory System Agents|sensory system agents|mesh-ancestor
153424956|NCT02734940|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153424957|NCT02734940|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153424958|NCT02734940|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
153424959|NCT02734940|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153424960|NCT02734940|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153424961|NCT02734940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153424962|NCT02734940|Analgesics|analgesics|mesh-ancestor
153424963|NCT02734940|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
153424964|NCT02734940|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153424965|NCT02734940|Anesthetics, General|anesthetics, general|mesh-ancestor
153424966|NCT02734940|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
153424968|NCT02734940|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153424969|NCT02734940|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153424970|NCT02734940|Narcotics|narcotics|mesh-ancestor
153424971|NCT02734940|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153425020|NCT02614586|Dermatologic Agents|dermatologic agents|mesh-ancestor
153425021|NCT02614586|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
153425022|NCT02614586|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153425023|NCT02614586|Serotonin Agents|serotonin agents|mesh-ancestor
153425024|NCT02614586|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153425025|NCT02614586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153425569|NCT00791336|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153425570|NCT00791336|Antiviral Agents|antiviral agents|mesh-ancestor
153425571|NCT00791336|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153425572|NCT00771602|Rituximab|rituximab|mesh-list
153425573|NCT00771602|Alemtuzumab|alemtuzumab|mesh-list
153425574|NCT00771602|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153425575|NCT00771602|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153425600|NCT05080556|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153405307|NCT04412863|Interferons|interferons|mesh-list
153425602|NCT01797380|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
153425603|NCT01797380|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153425604|NCT01797380|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153425605|NCT01797380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153425606|NCT01797380|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153425607|NCT01797380|Serotonin Agents|serotonin agents|mesh-ancestor
153425608|NCT01797380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153425609|NCT00732680|Botulinum Toxins|botulinum toxins|mesh-list
153425610|NCT00732680|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
153425611|NCT00732680|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
153425612|NCT00732680|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
153425613|NCT00732680|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153425614|NCT00732680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153426711|NCT00000914|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153426712|NCT00000914|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153426713|NCT00000914|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153426714|NCT00000914|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
153367214|NCT02447250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153367215|NCT02447250|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153367216|NCT02447250|Respiratory System Agents|respiratory system agents|mesh-ancestor
153367217|NCT02447250|Tocolytic Agents|tocolytic agents|mesh-ancestor
153367218|NCT02447250|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153367220|NCT02447250|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
153426715|NCT00000914|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
153426716|NCT00000914|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
153426717|NCT00000914|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
153426959|NCT00001016|Antidotes|antidotes|mesh-ancestor
153426960|NCT00001016|Protective Agents|protective agents|mesh-ancestor
153426961|NCT00001016|Vitamin B Complex|vitamin b complex|mesh-ancestor
153426962|NCT00001016|Vitamins|vitamins|mesh-ancestor
153427858|NCT04713254|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153427859|NCT04713254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153427860|NCT04713254|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
153427861|NCT04713254|Antidepressive Agents|antidepressive agents|mesh-ancestor
153427862|NCT04713254|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
153428035|NCT00000698|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153428036|NCT00000698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153428038|NCT03764449|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
153428039|NCT03764449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153428040|NCT03764449|Natriuretic Agents|natriuretic agents|mesh-ancestor
153428041|NCT03764449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153428042|NCT00002180|Tenofovir|tenofovir|mesh-list
153428043|NCT00002180|Antiviral Agents|antiviral agents|mesh-ancestor
153428831|NCT00002456|Dermatologic Agents|dermatologic agents|mesh-ancestor
153428833|NCT00002456|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153428834|NCT00002456|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153429377|NCT00002630|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153429378|NCT00002630|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153429424|NCT01434745|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
153429427|NCT01401049|Propofol|propofol|mesh-list
153429428|NCT01401049|Fospropofol|fospropofol|mesh-list
153783630|NCT02278510|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153429429|NCT01401049|Anesthetics, Local|anesthetics, local|mesh-ancestor
153429430|NCT01401049|Anesthetics|anesthetics|mesh-ancestor
153429431|NCT01401049|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153429432|NCT01401049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153432230|NCT05116293|Anesthetics|anesthetics|mesh-ancestor
153432231|NCT05116293|GABA Modulators|gaba modulators|mesh-ancestor
153432268|NCT05113251|Immunoconjugates|immunoconjugates|mesh-ancestor
153432269|NCT05087914|Naproxen|naproxen|mesh-list
153432270|NCT05087914|Levodopa|levodopa|mesh-list
153432271|NCT05087914|Carbidopa|carbidopa|mesh-list
153432272|NCT05087914|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
153432273|NCT05087914|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153432274|NCT05087914|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153432331|NCT05044429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153432332|NCT05039619|Acetaminophen|acetaminophen|mesh-list
153432333|NCT05039619|Diphenhydramine|diphenhydramine|mesh-list
153432334|NCT05039619|Promethazine|promethazine|mesh-list
153432335|NCT05039619|Mycophenolic Acid|mycophenolic acid|mesh-list
153432337|NCT05039619|Methylprednisolone|methylprednisolone|mesh-list
153432338|NCT05039619|Obinutuzumab|obinutuzumab|mesh-list
153432339|NCT05039619|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153649974|NCT00012051|Antiemetics|antiemetics|mesh-ancestor
153432340|NCT05039619|Glucocorticoids|glucocorticoids|mesh-ancestor
153432493|NCT04755283|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
153432494|NCT04755283|Antithrombins|antithrombins|mesh-ancestor
153367256|NCT04200066|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
153783631|NCT02278510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153432495|NCT04755283|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
153432496|NCT04755283|Protease Inhibitors|protease inhibitors|mesh-ancestor
153432497|NCT04755283|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153433135|NCT02301286|Analgesics|analgesics|mesh-ancestor
153433136|NCT02301286|Sensory System Agents|sensory system agents|mesh-ancestor
153433137|NCT02301286|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153433138|NCT02301286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153433139|NCT02301286|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153433170|NCT02216838|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153433171|NCT02081378|Imatinib Mesylate|imatinib mesylate|mesh-list
153433173|NCT02081378|Nilotinib|nilotinib|mesh-list
153433174|NCT02081378|Asciminib|asciminib|mesh-list
153433175|NCT02081378|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153433451|NCT00000469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153433452|NCT00000469|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153433453|NCT00000469|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153433454|NCT00000469|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153433455|NCT00000469|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153433456|NCT00000469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153433457|NCT00000469|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153433458|NCT00000469|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153433459|NCT00000469|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153433460|NCT00000469|Antipyretics|antipyretics|mesh-ancestor
153827274|NCT01315249|Respiratory System Agents|respiratory system agents|mesh-ancestor
153827275|NCT01315249|Dermatologic Agents|dermatologic agents|mesh-ancestor
153827276|NCT01315249|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
153827277|NCT01315249|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
153827278|NCT01315249|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
153577560|NCT01718496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153577562|NCT01718496|Sensory System Agents|sensory system agents|mesh-ancestor
153577563|NCT01718496|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153577565|NCT01718587|Antiviral Agents|antiviral agents|mesh-list
153577566|NCT01718587|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153577567|NCT01718587|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153577568|NCT01718587|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153577569|NCT01718587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153577570|NCT01718587|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153577571|NCT01718587|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153577572|NCT01718587|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153577573|NCT01718613|Vasopressins|vasopressins|mesh-list
153577574|NCT01718613|Arginine Vasopressin|arginine vasopressin|mesh-list
153577575|NCT01718613|Norepinephrine|norepinephrine|mesh-list
153433463|NCT00000469|Antimetabolites|antimetabolites|mesh-ancestor
153433464|NCT00000469|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153433465|NCT00000469|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
153433466|NCT00000889|Aldesleukin|aldesleukin|mesh-list
153433707|NCT00000979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153433708|NCT00000979|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153783635|NCT04545892|Dermatologic Agents|dermatologic agents|mesh-ancestor
153433709|NCT00000979|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153461764|NCT04130802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153433933|NCT00001057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153433934|NCT00001057|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153433935|NCT00001057|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153433937|NCT00001057|Antiviral Agents|antiviral agents|mesh-ancestor
153433938|NCT00001057|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153433939|NCT00001057|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153783636|NCT04545892|Sensory System Agents|sensory system agents|mesh-ancestor
153783637|NCT04545892|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153434032|NCT00002323|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153434033|NCT00002323|Antiviral Agents|antiviral agents|mesh-ancestor
153434034|NCT00002323|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153434035|NCT00002323|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153434036|NCT00002323|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153434067|NCT00001891|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153434068|NCT00001891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153434069|NCT00001891|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
153434070|NCT00001891|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
153434071|NCT00001891|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153434072|NCT00001891|Adrenergic Agents|adrenergic agents|mesh-ancestor
153434073|NCT00001891|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153415246|NCT00367393|Dermatologic Agents|dermatologic agents|mesh-ancestor
153434158|NCT00001963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153434307|NCT00002047|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153434308|NCT00002047|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153434309|NCT00002047|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153434342|NCT00002401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153434344|NCT00002401|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153434345|NCT00002401|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153434346|NCT00002401|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153434347|NCT00002401|Antimetabolites|antimetabolites|mesh-ancestor
153434348|NCT00002401|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
153434349|NCT00002401|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
153434350|NCT00002401|Protease Inhibitors|protease inhibitors|mesh-ancestor
153434351|NCT00002407|Lamivudine|lamivudine|mesh-list
153434352|NCT00002407|Nevirapine|nevirapine|mesh-list
153434353|NCT00002407|Didanosine|didanosine|mesh-list
153434354|NCT00002407|Stavudine|stavudine|mesh-list
153434355|NCT00002407|Indinavir|indinavir|mesh-list
153434356|NCT00002407|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153434387|NCT00002419|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153434388|NCT00002419|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
153434389|NCT00002419|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153434390|NCT00002419|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
153783638|NCT04545892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153434391|NCT00002419|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
153434392|NCT00002419|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
153434393|NCT00002419|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
153434394|NCT00002419|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153434395|NCT00002419|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153434396|NCT00002419|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
153434397|NCT00002419|Antitubercular Agents|antitubercular agents|mesh-ancestor
153434578|NCT00002461|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153434579|NCT00002461|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153783639|NCT02214706|Sirolimus|sirolimus|mesh-list
153434580|NCT00002461|Alkylating Agents|alkylating agents|mesh-ancestor
153434581|NCT00002461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153434582|NCT00002461|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153434583|NCT00002461|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153434584|NCT00002461|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153434585|NCT00002461|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153434586|NCT00002461|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153434587|NCT00002461|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153434673|NCT00002155|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
153434674|NCT00002155|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
153434675|NCT00002155|Protease Inhibitors|protease inhibitors|mesh-ancestor
153434676|NCT00003038|Suramin|suramin|mesh-list
153434677|NCT00003038|Doxorubicin|doxorubicin|mesh-list
153434678|NCT00003038|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
153434679|NCT00003038|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153434680|NCT00003038|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153434681|NCT00003038|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153434682|NCT00003038|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153434683|NCT00003038|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153434684|NCT00003038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153434685|NCT00003038|Antinematodal Agents|antinematodal agents|mesh-ancestor
153434686|NCT00003038|Anthelmintics|anthelmintics|mesh-ancestor
153434687|NCT00003038|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153434688|NCT00003038|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153434689|NCT00003038|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
153434690|NCT00003038|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153434691|NCT00003044|Cisplatin|cisplatin|mesh-list
153434692|NCT00003044|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153434693|NCT00002161|Adefovir|adefovir|mesh-list
153435143|NCT00002239|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
153435144|NCT00002239|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
153435145|NCT00002239|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
153435146|NCT00002239|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
153435147|NCT00002239|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
153435148|NCT00002239|Antitubercular Agents|antitubercular agents|mesh-ancestor
153435149|NCT00002239|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153435152|NCT00383474|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153435411|NCT00002263|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153435412|NCT00002263|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153435413|NCT00002263|Immunologic Factors|immunologic factors|mesh-ancestor
153435414|NCT00002263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153435415|NCT00002816|Leucovorin|leucovorin|mesh-list
153435416|NCT00002816|Cobalt|cobalt|mesh-list
153435481|NCT00002269|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153435482|NCT00002269|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153435483|NCT00002269|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153435484|NCT00002275|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
153435485|NCT00002275|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
153435486|NCT00002275|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
153435518|NCT05751421|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153435519|NCT05751421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153435520|NCT05751421|Sensory System Agents|sensory system agents|mesh-ancestor
153827343|NCT01313728|Dapsone|dapsone|mesh-list
153577576|NCT01718613|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153577577|NCT01718613|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153577578|NCT01718613|Adrenergic Agents|adrenergic agents|mesh-ancestor
153577579|NCT01718613|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153577580|NCT01718613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153577581|NCT01718613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153577582|NCT01718613|Sympathomimetics|sympathomimetics|mesh-ancestor
153577583|NCT01718613|Autonomic Agents|autonomic agents|mesh-ancestor
153577584|NCT01718613|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153817726|NCT06140966|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153817727|NCT06140966|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153817728|NCT06140966|Growth Substances|growth substances|mesh-ancestor
153817729|NCT06140966|Growth Inhibitors|growth inhibitors|mesh-ancestor
153817730|NCT06140966|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153817731|NCT06139107|Letrozole|letrozole|mesh-list
153817732|NCT06139107|Aromatase Inhibitors|aromatase inhibitors|mesh-list
153817733|NCT06139107|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153817734|NCT06139107|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153817735|NCT06139107|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153435521|NCT05751421|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153435522|NCT05751421|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153435523|NCT05751421|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153435524|NCT05751421|Analgesics|analgesics|mesh-ancestor
153435525|NCT05751421|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153435526|NCT05751421|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153435527|NCT05751421|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
153435528|NCT05751421|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153435529|NCT05751421|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153435530|NCT05751421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153435531|NCT00002822|Cyclophosphamide|cyclophosphamide|mesh-list
153435532|NCT00002822|Ifosfamide|ifosfamide|mesh-list
153435533|NCT00002822|Carboplatin|carboplatin|mesh-list
153435534|NCT00002822|Doxorubicin|doxorubicin|mesh-list
153435557|NCT00002281|Antimetabolites|antimetabolites|mesh-ancestor
153405384|NCT03465787|Dopamine Agents|dopamine agents|mesh-ancestor
153435558|NCT00002281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153815034|NCT04715165|Anesthetics|anesthetics|mesh-ancestor
153435580|NCT00002828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153435581|NCT00002828|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153435582|NCT00002828|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153435583|NCT00002828|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153435584|NCT00002828|Immunologic Factors|immunologic factors|mesh-ancestor
153435585|NCT00002828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153435586|NCT00002828|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153435587|NCT00002828|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153435588|NCT00003410|Motexafin gadolinium|motexafin gadolinium|mesh-list
153435622|NCT00002557|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
153435624|NCT00002557|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153435625|NCT00002557|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153435626|NCT00002557|Antimetabolites|antimetabolites|mesh-ancestor
153435627|NCT00002557|Dermatologic Agents|dermatologic agents|mesh-ancestor
153435628|NCT00002557|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153435629|NCT00002557|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153435630|NCT00002557|Immunologic Factors|immunologic factors|mesh-ancestor
153817736|NCT06139107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153817737|NCT06139107|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
153817738|NCT06139107|Hormone Antagonists|hormone antagonists|mesh-ancestor
153435632|NCT00002557|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153435633|NCT00002557|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153435634|NCT00002557|Antidotes|antidotes|mesh-ancestor
153435635|NCT00002557|Protective Agents|protective agents|mesh-ancestor
153435636|NCT00002557|Vitamin B Complex|vitamin b complex|mesh-ancestor
153435637|NCT00002557|Vitamins|vitamins|mesh-ancestor
153435638|NCT00002557|Micronutrients|micronutrients|mesh-ancestor
153435639|NCT00003158|Paclitaxel|paclitaxel|mesh-list
153435640|NCT00003158|Etoposide|etoposide|mesh-list
153435641|NCT00003158|Carboplatin|carboplatin|mesh-list
153435642|NCT00003158|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153435643|NCT00003158|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153435644|NCT00003158|Tubulin Modulators|tubulin modulators|mesh-ancestor
153435645|NCT00003158|Antimitotic Agents|antimitotic agents|mesh-ancestor
153435646|NCT00003158|Mitosis Modulators|mitosis modulators|mesh-ancestor
153415247|NCT00367393|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153435693|NCT00002840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153435694|NCT00002840|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153435695|NCT00002840|Alkylating Agents|alkylating agents|mesh-ancestor
153435696|NCT00002846|Aldesleukin|aldesleukin|mesh-list
153435697|NCT00002846|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153435698|NCT00002846|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153435699|NCT00002846|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153435700|NCT00002846|Antiviral Agents|antiviral agents|mesh-ancestor
153435701|NCT00002846|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153435702|NCT05720767|Itraconazole|itraconazole|mesh-list
153435730|NCT05751031|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153435731|NCT05751031|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
153435732|NCT05751031|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
153435745|NCT00003422|Calcium|calcium|mesh-list
153435746|NCT00003422|Levoleucovorin|levoleucovorin|mesh-list
153827376|NCT00481442|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
153827377|NCT00481442|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153827378|NCT00481442|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153827379|NCT00481442|Adrenergic Agents|adrenergic agents|mesh-ancestor
153827380|NCT00481442|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153435747|NCT00003422|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153435748|NCT00003422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153435749|NCT00003422|Antimetabolites|antimetabolites|mesh-ancestor
153435750|NCT00003422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153435751|NCT00003422|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153435752|NCT00003422|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153435753|NCT00003422|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153435754|NCT00003422|Immunologic Factors|immunologic factors|mesh-ancestor
153435786|NCT00002864|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
153435787|NCT00002864|Hormone Antagonists|hormone antagonists|mesh-ancestor
153435788|NCT00002864|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153435789|NCT00002864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153435790|NCT00002864|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153435791|NCT00002864|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153435792|NCT00002864|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
153435793|NCT00002864|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
153435794|NCT00002864|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153435795|NCT00002864|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153435833|NCT00002581|Dermatologic Agents|dermatologic agents|mesh-ancestor
153435834|NCT00002581|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153435835|NCT00002581|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153435836|NCT00002581|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153435837|NCT00002581|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
153435838|NCT00002581|Hormone Antagonists|hormone antagonists|mesh-ancestor
153435839|NCT00002581|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153435840|NCT00002581|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153435841|NCT00002581|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
153435842|NCT00002581|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
153435843|NCT00002581|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153367435|NCT01005290|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153435852|NCT00002587|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153435853|NCT00002587|Tubulin Modulators|tubulin modulators|mesh-ancestor
153435854|NCT00002587|Antimitotic Agents|antimitotic agents|mesh-ancestor
153435855|NCT00002587|Mitosis Modulators|mitosis modulators|mesh-ancestor
153435856|NCT00002587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153435896|NCT00003194|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153435897|NCT00003194|Immunologic Factors|immunologic factors|mesh-ancestor
153435898|NCT00003194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153435899|NCT00003194|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153435900|NCT00003194|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153435901|NCT00003194|Alkylating Agents|alkylating agents|mesh-ancestor
153435902|NCT00003194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153435903|NCT00003194|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153435904|NCT00003194|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153435905|NCT00003194|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153435906|NCT00003194|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153435907|NCT00003194|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153435908|NCT00003194|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153435909|NCT00003194|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
153435910|NCT00002882|Interferons|interferons|mesh-list
153435911|NCT00002882|Interferon-alpha|interferon-alpha|mesh-list
153435912|NCT00002882|Interferon alpha-2|interferon alpha-2|mesh-list
153435913|NCT00002882|Aldesleukin|aldesleukin|mesh-list
153435915|NCT00002882|Interleukin-2|interleukin-2|mesh-list
153435916|NCT00002882|Dacarbazine|dacarbazine|mesh-list
153435917|NCT00002882|Vinblastine|vinblastine|mesh-list
153435918|NCT00002882|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153435919|NCT00002882|Antiviral Agents|antiviral agents|mesh-ancestor
153435992|NCT00002599|Micronutrients|micronutrients|mesh-ancestor
153436005|NCT00003200|Antimitotic Agents|antimitotic agents|mesh-ancestor
153436006|NCT00003200|Mitosis Modulators|mitosis modulators|mesh-ancestor
153436007|NCT00003200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153436009|NCT00003446|Trimetrexate|trimetrexate|mesh-list
153436178|NCT00003242|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153436179|NCT00003242|Immunologic Factors|immunologic factors|mesh-ancestor
153436180|NCT00003242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153436182|NCT05664061|Xhance|xhance|mesh-list
153436183|NCT05664061|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
153436184|NCT05664061|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
153436185|NCT05664061|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153436186|NCT05664061|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153436187|NCT05664061|Autonomic Agents|autonomic agents|mesh-ancestor
153436188|NCT05664061|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153783644|NCT02214706|Antifungal Agents|antifungal agents|mesh-ancestor
153783645|NCT02214706|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153436189|NCT05664061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153436190|NCT05664061|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153436191|NCT05664061|Respiratory System Agents|respiratory system agents|mesh-ancestor
153436192|NCT05664061|Dermatologic Agents|dermatologic agents|mesh-ancestor
153436193|NCT05664061|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
153436194|NCT05664061|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
153436195|NCT05664061|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
153436196|NCT05664061|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153436197|NCT05664061|Adrenergic Agents|adrenergic agents|mesh-ancestor
153436198|NCT05664061|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153436199|NCT05664061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153436200|NCT05664061|Glucocorticoids|glucocorticoids|mesh-ancestor
153436201|NCT05664061|Hormones|hormones|mesh-ancestor
153461765|NCT04130802|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153436250|NCT00003992|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153436282|NCT00002653|Hormones|hormones|mesh-ancestor
153436288|NCT00003254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153436290|NCT00003254|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153436291|NCT00003254|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153436292|NCT00003254|Immunologic Factors|immunologic factors|mesh-ancestor
153436293|NCT00003254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153436344|NCT00002665|Levoleucovorin|levoleucovorin|mesh-list
153436345|NCT00002665|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153436346|NCT00002665|Immunologic Factors|immunologic factors|mesh-ancestor
153436347|NCT00002665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153436348|NCT00002665|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153436349|NCT00002665|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153436350|NCT00002665|Alkylating Agents|alkylating agents|mesh-ancestor
153436351|NCT00002665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153436352|NCT00002665|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153436353|NCT00002665|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153436354|NCT00002665|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153436355|NCT00002665|Antiemetics|antiemetics|mesh-ancestor
153436356|NCT00002665|Autonomic Agents|autonomic agents|mesh-ancestor
153436357|NCT00002665|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153436358|NCT00002665|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153436359|NCT00002665|Glucocorticoids|glucocorticoids|mesh-ancestor
153436393|NCT00003536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153436394|NCT00003536|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153436396|NCT00003536|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153436397|NCT00003536|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153436398|NCT00003536|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153436399|NCT00003536|Immunologic Factors|immunologic factors|mesh-ancestor
153436400|NCT00003536|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153436414|NCT00004010|Etoposide|etoposide|mesh-list
153436415|NCT00004010|Vincristine|vincristine|mesh-list
153436416|NCT00004010|Bleomycin|bleomycin|mesh-list
153436417|NCT00004010|Vinblastine|vinblastine|mesh-list
153436418|NCT00004010|Procarbazine|procarbazine|mesh-list
153436419|NCT00004010|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153436420|NCT00004010|Immunologic Factors|immunologic factors|mesh-ancestor
153436421|NCT00004010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153436422|NCT00004010|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153436455|NCT00004022|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153436456|NCT00381901|Trastuzumab|trastuzumab|mesh-list
153436457|NCT00381901|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153436458|NCT00381901|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153436459|NCT00003278|Dexamethasone|dexamethasone|mesh-list
153436460|NCT00003278|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153436461|NCT00003278|Antiemetics|antiemetics|mesh-ancestor
153436513|NCT00384410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153436514|NCT00384410|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153436515|NCT00384410|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153436516|NCT00384410|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153436517|NCT00384410|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153436518|NCT00384410|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153436519|NCT00004040|Interferons|interferons|mesh-list
153436550|NCT00003572|Mycophenolic Acid|mycophenolic acid|mesh-list
153436551|NCT00003572|Tacrolimus|tacrolimus|mesh-list
153436552|NCT00003572|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153436553|NCT00003572|Immunologic Factors|immunologic factors|mesh-ancestor
153436554|NCT00003572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153436555|NCT00003572|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
153436556|NCT00003572|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153436557|NCT00003572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153436611|NCT00003578|Melphalan|melphalan|mesh-list
153436612|NCT00003578|Carmustine|carmustine|mesh-list
153436613|NCT00003578|Doxorubicin|doxorubicin|mesh-list
153436630|NCT00003578|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153436631|NCT00003578|Glucocorticoids|glucocorticoids|mesh-ancestor
153436639|NCT00003578|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153436640|NCT00003578|Tubulin Modulators|tubulin modulators|mesh-ancestor
153436641|NCT00003578|Antimitotic Agents|antimitotic agents|mesh-ancestor
153436642|NCT00003578|Mitosis Modulators|mitosis modulators|mesh-ancestor
153436671|NCT00002701|Immunologic Factors|immunologic factors|mesh-ancestor
153436672|NCT00002701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153436673|NCT00002701|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153436674|NCT00002701|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153436741|NCT00002707|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
153650018|NCT00000479|Aspirin|aspirin|mesh-list
153436742|NCT00002707|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
153436743|NCT00002707|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153436745|NCT00003596|Mitomycins|mitomycins|mesh-list
153436746|NCT00003596|Mitomycin|mitomycin|mesh-list
153436747|NCT00003596|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153436748|NCT00003596|Antimetabolites|antimetabolites|mesh-ancestor
153436819|NCT04609423|Micronutrients|micronutrients|mesh-ancestor
153436820|NCT04609423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153436821|NCT04609423|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153436945|NCT00003638|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153436946|NCT00003638|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153436947|NCT00003638|Alkylating Agents|alkylating agents|mesh-ancestor
153436948|NCT00003638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153436949|NCT00003638|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153436950|NCT00003638|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153436951|NCT00003638|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153436953|NCT00004142|Floxuridine|floxuridine|mesh-list
153436954|NCT00004142|Antimetabolites|antimetabolites|mesh-ancestor
153437001|NCT00003650|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153437002|NCT00003650|Antimetabolites|antimetabolites|mesh-ancestor
153437003|NCT00003650|Dermatologic Agents|dermatologic agents|mesh-ancestor
153437004|NCT00003650|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153437005|NCT00003650|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153437006|NCT00003650|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153437007|NCT00003650|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153459101|NCT03152370|Antimetabolites|antimetabolites|mesh-ancestor
153367514|NCT02170532|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153405450|NCT00356473|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153437008|NCT00003650|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153437009|NCT00003650|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153437010|NCT00003650|Antiviral Agents|antiviral agents|mesh-ancestor
153437011|NCT00003650|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153437012|NCT00003650|Tubulin Modulators|tubulin modulators|mesh-ancestor
153437013|NCT00003650|Antimitotic Agents|antimitotic agents|mesh-ancestor
153437048|NCT00002755|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153437050|NCT00002755|Hormone Antagonists|hormone antagonists|mesh-ancestor
153437051|NCT00002755|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153437052|NCT00002755|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153437053|NCT00002755|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
153437054|NCT00002755|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
153437055|NCT00002755|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153437088|NCT00382135|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
153437089|NCT00382135|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
153437090|NCT00382135|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153437091|NCT00382135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153437092|NCT00382135|Urological Agents|urological agents|mesh-ancestor
153437094|NCT00003662|Methylprednisolone|methylprednisolone|mesh-list
153437095|NCT00003662|Cyclophosphamide|cyclophosphamide|mesh-list
153437097|NCT00003662|Busulfan|busulfan|mesh-list
153437098|NCT00003662|Cyclosporins|cyclosporins|mesh-list
153437099|NCT00003662|Antilymphocyte Serum|antilymphocyte serum|mesh-list
153437100|NCT00003662|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153437101|NCT00003662|Immunologic Factors|immunologic factors|mesh-ancestor
153437149|NCT00002773|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153437150|NCT00002773|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153437152|NCT00002773|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153437153|NCT00004160|Paclitaxel|paclitaxel|mesh-list
153437216|NCT00003680|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153437217|NCT00003680|Dermatologic Agents|dermatologic agents|mesh-ancestor
153437218|NCT00003680|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153437219|NCT00003680|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153437220|NCT00003680|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153437221|NCT00003680|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
153437222|NCT00003680|Hormone Antagonists|hormone antagonists|mesh-ancestor
153437223|NCT00003680|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153437224|NCT00003680|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153437225|NCT00003680|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
153437226|NCT00003680|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
153437227|NCT00003680|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153437254|NCT00002785|Alkylating Agents|alkylating agents|mesh-ancestor
153437276|NCT00002785|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153437277|NCT00002785|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153437278|NCT00002785|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153437279|NCT00002785|Antiviral Agents|antiviral agents|mesh-ancestor
153437280|NCT00002785|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153437281|NCT00002785|Antidotes|antidotes|mesh-ancestor
153437282|NCT00002785|Protective Agents|protective agents|mesh-ancestor
153437283|NCT00002785|Vitamin B Complex|vitamin b complex|mesh-ancestor
153437284|NCT00002785|Vitamins|vitamins|mesh-ancestor
153437285|NCT00002785|Micronutrients|micronutrients|mesh-ancestor
153437286|NCT00002785|Tubulin Modulators|tubulin modulators|mesh-ancestor
153437287|NCT00002785|Antimitotic Agents|antimitotic agents|mesh-ancestor
153437288|NCT00002785|Mitosis Modulators|mitosis modulators|mesh-ancestor
153437289|NCT00002785|Antifungal Agents|antifungal agents|mesh-ancestor
153437290|NCT00002785|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
153437291|NCT00002785|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
153459102|NCT03152370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153459103|NCT03152370|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153459104|NCT03152370|Antidotes|antidotes|mesh-ancestor
153459105|NCT03152370|Protective Agents|protective agents|mesh-ancestor
153459106|NCT03152370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153459107|NCT03152370|Vitamin B Complex|vitamin b complex|mesh-ancestor
153459108|NCT03152370|Vitamins|vitamins|mesh-ancestor
153459109|NCT03152370|Micronutrients|micronutrients|mesh-ancestor
153459110|NCT03152370|Hematinics|hematinics|mesh-ancestor
153459111|NCT02187120|Tranexamic Acid|tranexamic acid|mesh-list
153459112|NCT02187120|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
153577586|NCT01718613|Hemostatics|hemostatics|mesh-ancestor
153577587|NCT01718613|Coagulants|coagulants|mesh-ancestor
153577588|NCT01718613|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
153577589|NCT01718613|Natriuretic Agents|natriuretic agents|mesh-ancestor
153577590|NCT01718626|Docetaxel|docetaxel|mesh-list
153577591|NCT01718626|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153437292|NCT00002785|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153437293|NCT00002785|Trace Elements|trace elements|mesh-ancestor
153437294|NCT00004184|Aluminum Hydroxide|aluminum hydroxide|mesh-list
153437295|NCT00004184|Antibodies|antibodies|mesh-list
153437296|NCT00004184|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
153437297|NCT00004184|Sargramostim|sargramostim|mesh-list
153437298|NCT00004184|Aluminum sulfate|aluminum sulfate|mesh-list
153437299|NCT00004184|Immunologic Factors|immunologic factors|mesh-ancestor
153437300|NCT00004184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153437301|NCT00004184|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153437303|NCT00004184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153437304|NCT00004184|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153437305|NCT00003386|Paclitaxel|paclitaxel|mesh-list
153437306|NCT00003386|Cyclophosphamide|cyclophosphamide|mesh-list
153437400|NCT00003686|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
153437401|NCT00003686|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
153437402|NCT00003686|Cholinergic Agents|cholinergic agents|mesh-ancestor
153437551|NCT00003728|Mercaptopurine|mercaptopurine|mesh-list
153437552|NCT00003728|Mitoxantrone|mitoxantrone|mesh-list
153437553|NCT00003728|Thioguanine|thioguanine|mesh-list
153437554|NCT00003728|Vindesine|vindesine|mesh-list
153437555|NCT00003728|Levoleucovorin|levoleucovorin|mesh-list
153437556|NCT00003728|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153437579|NCT00003728|Abortifacient Agents|abortifacient agents|mesh-ancestor
153437580|NCT00003728|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153437581|NCT00003728|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153437582|NCT00003728|Antimetabolites|antimetabolites|mesh-ancestor
153650086|NCT00395551|Ranibizumab|ranibizumab|mesh-list
153437583|NCT00003728|Dermatologic Agents|dermatologic agents|mesh-ancestor
153437584|NCT00003728|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153437679|NCT00004904|Hormones|hormones|mesh-ancestor
153437775|NCT00003776|Levoleucovorin|levoleucovorin|mesh-list
153437776|NCT00003776|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153437777|NCT00003776|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153437778|NCT00003776|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153437779|NCT00003776|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153437780|NCT00003776|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153437781|NCT00003776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153437782|NCT00003776|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153437783|NCT00003776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153437784|NCT00003776|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
153437785|NCT00003776|Abortifacient Agents|abortifacient agents|mesh-ancestor
153437786|NCT00003776|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153437838|NCT00004346|Cathartics|cathartics|mesh-ancestor
153437839|NCT00004346|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153437840|NCT00384800|Thalidomide|thalidomide|mesh-list
153437876|NCT02972762|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153437877|NCT02972762|Anesthetics, General|anesthetics, general|mesh-ancestor
153437879|NCT00004358|Calcitonin|calcitonin|mesh-list
153437880|NCT00004358|Salmon calcitonin|salmon calcitonin|mesh-list
153437881|NCT00004358|Calcitonin Gene-Related Peptide|calcitonin gene-related peptide|mesh-list
153437882|NCT00004358|Katacalcin|katacalcin|mesh-list
153437909|NCT00005000|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
153437910|NCT00005000|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153437911|NCT00005000|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
153437912|NCT00005000|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
153437913|NCT00005000|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
153437914|NCT00005000|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
153437915|NCT00005000|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
153437916|NCT00005000|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
153437917|NCT00005000|Protease Inhibitors|protease inhibitors|mesh-ancestor
153437918|NCT00005000|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153437919|NCT00005000|Immunologic Factors|immunologic factors|mesh-ancestor
153437920|NCT00005000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153437921|NCT00004376|Guanfacine|guanfacine|mesh-list
153577592|NCT01718626|Tubulin Modulators|tubulin modulators|mesh-ancestor
153577593|NCT01718626|Antimitotic Agents|antimitotic agents|mesh-ancestor
153577594|NCT01718626|Mitosis Modulators|mitosis modulators|mesh-ancestor
153577595|NCT01718626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153367572|NCT01062230|Bortezomib|bortezomib|mesh-list
153437922|NCT00004376|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153437923|NCT00004376|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
153437924|NCT00004376|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153783652|NCT00236639|Topiramate|topiramate|mesh-list
153783653|NCT00236639|Anticonvulsants|anticonvulsants|mesh-ancestor
153437925|NCT00004376|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153437926|NCT00004376|Adrenergic Agents|adrenergic agents|mesh-ancestor
153437927|NCT00004376|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153437928|NCT00004376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153437929|NCT00004376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153437930|NCT00005006|Alendronate|alendronate|mesh-list
153437931|NCT00005006|Teriparatide|teriparatide|mesh-list
153437932|NCT00005006|Hormones|hormones|mesh-list
153437933|NCT00005006|Parathyroid Hormone|parathyroid hormone|mesh-list
153437968|NCT00005018|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153438094|NCT00004436|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153438095|NCT00004436|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153438096|NCT00004436|Fertility Agents, Female|fertility agents, female|mesh-ancestor
153438098|NCT00004436|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153438099|NCT00005042|Semaxinib|semaxinib|mesh-list
153438100|NCT00005042|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153438135|NCT00003860|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153438136|NCT00003860|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153438137|NCT00003860|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153438138|NCT00003860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153438139|NCT00003860|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153438140|NCT00003860|Alkylating Agents|alkylating agents|mesh-ancestor
153438141|NCT00005048|Paclitaxel|paclitaxel|mesh-list
153438251|NCT00003920|Immunologic Factors|immunologic factors|mesh-ancestor
153438252|NCT00003920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153438253|NCT00003920|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153438254|NCT00003920|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153438261|NCT00003920|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
153438262|NCT00003926|Melphalan|melphalan|mesh-list
153438263|NCT00003926|Busulfan|busulfan|mesh-list
153438295|NCT00005090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153438296|NCT00005090|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153438297|NCT00005090|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153438298|NCT00005090|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153438299|NCT00005090|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153438300|NCT00005090|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153438301|NCT00005090|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153438302|NCT00005090|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153438303|NCT00005090|Tubulin Modulators|tubulin modulators|mesh-ancestor
153438304|NCT00005090|Antimitotic Agents|antimitotic agents|mesh-ancestor
153438305|NCT00005090|Mitosis Modulators|mitosis modulators|mesh-ancestor
153438306|NCT00004580|Ritonavir|ritonavir|mesh-list
153438307|NCT00004580|Lopinavir|lopinavir|mesh-list
153438308|NCT00004580|Nevirapine|nevirapine|mesh-list
153438309|NCT00004580|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
153438310|NCT00004580|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
153438311|NCT00004580|Protease Inhibitors|protease inhibitors|mesh-ancestor
153438337|NCT00004646|Hormones|hormones|mesh-ancestor
153438338|NCT00004646|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153438339|NCT00004646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153438340|NCT00004646|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153438341|NCT00004646|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153438342|NCT00005108|Estradiol|estradiol|mesh-list
153438343|NCT00005108|Progesterone|progesterone|mesh-list
153438344|NCT00005108|Estrogens|estrogens|mesh-ancestor
153438345|NCT00005108|Hormones|hormones|mesh-ancestor
153827586|NCT00482222|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153827587|NCT00482222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153827589|NCT00482222|Antimetabolites|antimetabolites|mesh-ancestor
153577596|NCT01718652|Canagliflozin|canagliflozin|mesh-list
153577597|NCT01718652|Cyclosporine|cyclosporine|mesh-list
153577598|NCT01718652|Cyclosporins|cyclosporins|mesh-list
153577599|NCT01718652|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153577600|NCT01718652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153577601|NCT01718652|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153577602|NCT01718652|Immunologic Factors|immunologic factors|mesh-ancestor
153577603|NCT01718652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153577604|NCT01718652|Antifungal Agents|antifungal agents|mesh-ancestor
153577605|NCT01718652|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153577606|NCT01718652|Dermatologic Agents|dermatologic agents|mesh-ancestor
153577607|NCT01718652|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153577608|NCT01718652|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
153438347|NCT00005108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153438406|NCT00004730|Magnesium Sulfate|magnesium sulfate|mesh-list
153405543|NCT02259582|Pemetrexed|pemetrexed|mesh-list
153438407|NCT00004730|Analgesics|analgesics|mesh-ancestor
153438429|NCT00004736|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153438430|NCT00004736|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153783655|NCT00236639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153438432|NCT00004736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153438433|NCT00004736|Antiviral Agents|antiviral agents|mesh-ancestor
153438434|NCT00004736|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153438435|NCT00004736|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153438503|NCT00004772|Immunologic Factors|immunologic factors|mesh-ancestor
153438504|NCT00004772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153438505|NCT04712929|Fluconazole|fluconazole|mesh-list
153438506|NCT04712929|Antifungal Agents|antifungal agents|mesh-ancestor
153438593|NCT00005612|Cyclophosphamide|cyclophosphamide|mesh-list
153438594|NCT00005612|Carboplatin|carboplatin|mesh-list
153438595|NCT00005612|Topotecan|topotecan|mesh-list
153415248|NCT00367393|Immunologic Factors|immunologic factors|mesh-ancestor
153438644|NCT00005642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153438645|NCT00005642|Growth Inhibitors|growth inhibitors|mesh-ancestor
153650128|NCT00028327|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153438646|NCT00005642|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153438647|NCT00005642|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153438648|NCT00005642|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153438649|NCT00005642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153438650|NCT00005648|Gemcitabine|gemcitabine|mesh-list
153438651|NCT00005648|Tipifarnib|tipifarnib|mesh-list
153438652|NCT00005648|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153438653|NCT00005648|Antimetabolites|antimetabolites|mesh-ancestor
153438739|NCT00005774|Respiratory System Agents|respiratory system agents|mesh-ancestor
153438740|NCT00005786|Arsenic Trioxide|arsenic trioxide|mesh-list
153438741|NCT00005786|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153438742|NCT00005792|Etoposide|etoposide|mesh-list
153438743|NCT00005792|Melphalan|melphalan|mesh-list
153438744|NCT00005792|Topotecan|topotecan|mesh-list
153438745|NCT00005792|Etoposide phosphate|etoposide phosphate|mesh-list
153438746|NCT00005792|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153438747|NCT00005792|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153438748|NCT00005792|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153438749|NCT00005792|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153438750|NCT00005792|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153438751|NCT00005792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153438789|NCT00385970|Antidotes|antidotes|mesh-ancestor
153438790|NCT00385970|Protective Agents|protective agents|mesh-ancestor
153438859|NCT04568876|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153438860|NCT04568876|Antiviral Agents|antiviral agents|mesh-ancestor
153438861|NCT04568876|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153438862|NCT04568876|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
153438863|NCT04568876|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
153438983|NCT04330495|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153438984|NCT04330495|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153438985|NCT04330495|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153438986|NCT04330495|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153438987|NCT04330495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153438988|NCT04330495|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153439052|NCT04123717|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153439053|NCT04123717|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153439054|NCT04123717|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153439083|NCT04330027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153439085|NCT00002893|Fluorouracil|fluorouracil|mesh-list
153439086|NCT00002893|Raltitrexed|raltitrexed|mesh-list
153439088|NCT00002893|Levoleucovorin|levoleucovorin|mesh-list
153439089|NCT00002893|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153439236|NCT03693781|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153577609|NCT01718652|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
153577610|NCT01718652|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153577611|NCT01718678|Melatonin|melatonin|mesh-list
153577612|NCT01718678|Antioxidants|antioxidants|mesh-ancestor
153577613|NCT01718678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153459121|NCT01674738|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153577616|NCT01718678|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153577618|NCT01718717|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153577619|NCT01718717|Narcotics|narcotics|mesh-ancestor
153577620|NCT01718717|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153577621|NCT01718717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153577622|NCT01718717|Analgesics|analgesics|mesh-ancestor
153577623|NCT01718717|Sensory System Agents|sensory system agents|mesh-ancestor
153577624|NCT01718717|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153577625|NCT01718808|Capecitabine|capecitabine|mesh-list
153577626|NCT01718808|Cetuximab|cetuximab|mesh-list
153439237|NCT03693781|Tubulin Modulators|tubulin modulators|mesh-ancestor
153439238|NCT03693781|Antimitotic Agents|antimitotic agents|mesh-ancestor
153439239|NCT03693781|Mitosis Modulators|mitosis modulators|mesh-ancestor
153439240|NCT03693781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153439241|NCT03693781|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153439299|NCT00003397|Glucocorticoids|glucocorticoids|mesh-ancestor
153439300|NCT00003397|Hormones|hormones|mesh-ancestor
153439301|NCT00003397|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153650136|NCT00028327|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
153439333|NCT00002989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153439335|NCT00002989|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153439336|NCT00002989|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153439337|NCT00002989|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153439338|NCT00002989|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153439339|NCT00002989|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153439340|NCT00002995|Dactinomycin|dactinomycin|mesh-list
153439341|NCT00002995|Cyclophosphamide|cyclophosphamide|mesh-list
153439342|NCT00002995|Vincristine|vincristine|mesh-list
153827637|NCT00482261|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153827638|NCT00482261|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153827639|NCT00482261|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153827640|NCT00482261|Analgesics|analgesics|mesh-ancestor
153827641|NCT00482261|Sensory System Agents|sensory system agents|mesh-ancestor
153827642|NCT00482261|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153827643|NCT00482261|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153827644|NCT00482261|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153367634|NCT02416908|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153367635|NCT02416908|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153367636|NCT01070810|Thiamine|thiamine|mesh-list
153367637|NCT01070810|Vitamin B Complex|vitamin b complex|mesh-ancestor
153367638|NCT01070810|Vitamins|vitamins|mesh-ancestor
153367639|NCT01070810|Micronutrients|micronutrients|mesh-ancestor
153577627|NCT01718808|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153577628|NCT01718808|Antimetabolites|antimetabolites|mesh-ancestor
153577629|NCT01718808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153577630|NCT01718808|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153577631|NCT01718808|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153577632|NCT01718834|Vaccines|vaccines|mesh-list
153577633|NCT01718834|Immunologic Factors|immunologic factors|mesh-ancestor
153577634|NCT01718834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153577635|NCT01718899|Lenalidomide|lenalidomide|mesh-list
153577636|NCT01718899|Immunologic Factors|immunologic factors|mesh-ancestor
153577637|NCT01718899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153577638|NCT01718899|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153577639|NCT01718899|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153367644|NCT01071044|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
153439343|NCT00002995|Sargramostim|sargramostim|mesh-list
153783662|NCT00269334|Citalopram|citalopram|mesh-list
153815035|NCT04715165|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153439344|NCT00002995|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153439345|NCT00002995|Immunologic Factors|immunologic factors|mesh-ancestor
153439346|NCT00002995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153439347|NCT00002995|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153439348|NCT00002995|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153439380|NCT00003001|Micronutrients|micronutrients|mesh-ancestor
153439381|NCT00003421|Prednisolone|prednisolone|mesh-list
153439382|NCT00003421|Doxorubicin|doxorubicin|mesh-list
153439601|NCT00003517|Fertility Agents|fertility agents|mesh-ancestor
153439602|NCT00003517|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153439603|NCT00003517|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153439604|NCT00003517|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153439605|NCT00003517|Hormone Antagonists|hormone antagonists|mesh-ancestor
153439606|NCT00003037|Gemcitabine|gemcitabine|mesh-list
153439607|NCT00003037|Docetaxel|docetaxel|mesh-list
153439608|NCT00003037|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153439638|NCT00383929|Candesartan cilexetil|candesartan cilexetil|mesh-list
153439639|NCT00383929|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153439640|NCT00383929|Diuretics|diuretics|mesh-ancestor
153439641|NCT00383929|Natriuretic Agents|natriuretic agents|mesh-ancestor
153439642|NCT00383929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153439731|NCT00002827|Mitosis Modulators|mitosis modulators|mesh-ancestor
153439732|NCT00002827|Trace Elements|trace elements|mesh-ancestor
153439733|NCT00002827|Micronutrients|micronutrients|mesh-ancestor
153439734|NCT00002827|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
153439735|NCT00002827|Protective Agents|protective agents|mesh-ancestor
153439736|NCT00384475|Ciclesonide|ciclesonide|mesh-list
153439737|NCT00384475|Glucocorticoids|glucocorticoids|mesh-ancestor
153439738|NCT00384475|Hormones|hormones|mesh-ancestor
153439739|NCT00384475|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153439740|NCT00384475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153439741|NCT00384475|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
153439835|NCT00003577|Epirubicin|epirubicin|mesh-list
153439836|NCT00003577|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153650144|NCT00028366|Tenofovir|tenofovir|mesh-list
153439837|NCT00003577|Immunologic Factors|immunologic factors|mesh-ancestor
153439838|NCT00003577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153439839|NCT00003577|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153439840|NCT00003577|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153439841|NCT00003577|Alkylating Agents|alkylating agents|mesh-ancestor
153439842|NCT00003577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153439843|NCT00003577|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153439844|NCT00003577|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153439846|NCT00003577|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153439847|NCT00003577|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
153439848|NCT00003577|Abortifacient Agents|abortifacient agents|mesh-ancestor
153827645|NCT00482261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153827646|NCT00482261|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153827647|NCT00482261|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153827648|NCT00482261|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153827649|NCT00482261|Antipyretics|antipyretics|mesh-ancestor
153827650|NCT00482261|Immunologic Factors|immunologic factors|mesh-ancestor
153827651|NCT00482261|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153827652|NCT00482261|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153827653|NCT00482261|Growth Substances|growth substances|mesh-ancestor
153827654|NCT00482261|Growth Inhibitors|growth inhibitors|mesh-ancestor
153827655|NCT04518618|Fentanyl|fentanyl|mesh-list
153577640|NCT01718899|Growth Substances|growth substances|mesh-ancestor
153577641|NCT01718899|Growth Inhibitors|growth inhibitors|mesh-ancestor
153577643|NCT01718912|Metronidazole|metronidazole|mesh-list
153577644|NCT01718912|Nystatin|nystatin|mesh-list
153577645|NCT01718912|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153577646|NCT01718912|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153577647|NCT01718912|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153577648|NCT01718912|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153577649|NCT01718912|Antifungal Agents|antifungal agents|mesh-ancestor
153577650|NCT01718912|Ionophores|ionophores|mesh-ancestor
153577651|NCT01718912|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153439873|NCT00003583|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
153439874|NCT00003583|Protective Agents|protective agents|mesh-ancestor
153439955|NCT00002869|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153439956|NCT00002869|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153439958|NCT00002869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153439959|NCT00002869|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153439960|NCT00002869|Immunologic Factors|immunologic factors|mesh-ancestor
153439961|NCT00002869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153439962|NCT00002869|Antisickling Agents|antisickling agents|mesh-ancestor
153439963|NCT00002869|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153439964|NCT00002869|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153439965|NCT00002875|Cyclophosphamide|cyclophosphamide|mesh-list
153439966|NCT00002875|Lomustine|lomustine|mesh-list
153439967|NCT00002875|Cisplatin|cisplatin|mesh-list
153439969|NCT00002875|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153439970|NCT00002875|Immunologic Factors|immunologic factors|mesh-ancestor
153439971|NCT00002875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153439972|NCT00002875|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153439973|NCT00002875|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153439974|NCT00002875|Alkylating Agents|alkylating agents|mesh-ancestor
153439975|NCT00002875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153439976|NCT00002875|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153439977|NCT00002875|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153439978|NCT00002875|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153439979|NCT00002875|Tubulin Modulators|tubulin modulators|mesh-ancestor
153439980|NCT00002875|Antimitotic Agents|antimitotic agents|mesh-ancestor
153439981|NCT00002875|Mitosis Modulators|mitosis modulators|mesh-ancestor
153440056|NCT00002887|Vinblastine|vinblastine|mesh-list
153440058|NCT00002887|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153440059|NCT00002887|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153440060|NCT00002887|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153783664|NCT00269334|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153440061|NCT00002887|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153440062|NCT00002887|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153440063|NCT00002887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153440064|NCT00002887|Tubulin Modulators|tubulin modulators|mesh-ancestor
153440166|NCT00003955|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153440167|NCT00003955|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153440168|NCT00003955|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153440169|NCT00003955|Tubulin Modulators|tubulin modulators|mesh-ancestor
153440170|NCT00003955|Antimitotic Agents|antimitotic agents|mesh-ancestor
153440171|NCT00003955|Mitosis Modulators|mitosis modulators|mesh-ancestor
153440172|NCT00003955|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153440173|NCT00003955|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153440174|NCT00003955|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153440175|NCT00003955|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
153440208|NCT00003961|Immunologic Factors|immunologic factors|mesh-ancestor
153440209|NCT00003961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153440210|NCT00003661|Cyclosporine|cyclosporine|mesh-list
153440211|NCT00003661|Methylprednisolone|methylprednisolone|mesh-list
153440213|NCT00003661|Busulfan|busulfan|mesh-list
153440701|NCT00003187|Methylprednisolone|methylprednisolone|mesh-list
153440702|NCT00003187|Cyclophosphamide|cyclophosphamide|mesh-list
153440703|NCT00003187|Methotrexate|methotrexate|mesh-list
153440704|NCT00003187|Cyclosporins|cyclosporins|mesh-list
153440705|NCT00003187|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153440706|NCT00003187|Immunologic Factors|immunologic factors|mesh-ancestor
153440707|NCT00003187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153440708|NCT00003187|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153440792|NCT00004141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153440793|NCT00004141|Immunologic Factors|immunologic factors|mesh-ancestor
153440794|NCT00004141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153440795|NCT02972905|Nemiralisib|nemiralisib|mesh-list
153440796|NCT02972905|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153440797|NCT02972905|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153577652|NCT01718912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153577653|NCT01718951|Pamidronate|pamidronate|mesh-list
153577654|NCT01718951|Golimumab|golimumab|mesh-list
153577655|NCT01718951|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
153577656|NCT01718951|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153577657|NCT01718951|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153577658|NCT01718951|Immunologic Factors|immunologic factors|mesh-ancestor
153577665|NCT01718964|Natriuretic Agents|natriuretic agents|mesh-ancestor
153817739|NCT06139107|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153817740|NCT06139107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153817745|NCT06136455|Listerine|listerine|mesh-list
153817746|NCT06136455|Sodium Fluoride|sodium fluoride|mesh-list
153817747|NCT06136455|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
153817748|NCT06136455|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153817749|NCT06136455|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153817750|NCT06136455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153817751|NCT06136455|Cariostatic Agents|cariostatic agents|mesh-ancestor
153817752|NCT06136455|Protective Agents|protective agents|mesh-ancestor
153440798|NCT02972905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153440799|NCT00003799|Leucovorin|leucovorin|mesh-list
153440800|NCT00003799|Fluorouracil|fluorouracil|mesh-list
153440801|NCT00003799|Oxaliplatin|oxaliplatin|mesh-list
153440802|NCT00003799|Calcium|calcium|mesh-list
153440933|NCT00003217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153441289|NCT00004855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153441292|NCT00004855|Antiviral Agents|antiviral agents|mesh-ancestor
153441293|NCT00004855|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153441294|NCT00004855|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
153441295|NCT00004855|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153441296|NCT00004855|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153650178|NCT00012207|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153441297|NCT00004855|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153441298|NCT00004855|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
153441299|NCT00004855|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
153441559|NCT00004999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153827693|NCT01311505|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
153827694|NCT01311505|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
153827695|NCT01311505|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
153827696|NCT01311505|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153827697|NCT01311505|Antimetabolites|antimetabolites|mesh-ancestor
153827698|NCT01311505|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153827699|NCT01240538|Cyclophosphamide|cyclophosphamide|mesh-list
153827700|NCT01240538|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153827701|NCT01240538|Immunologic Factors|immunologic factors|mesh-ancestor
153827702|NCT01240538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153827709|NCT01310803|Valrubicin|valrubicin|mesh-list
153441560|NCT00004999|Antiviral Agents|antiviral agents|mesh-ancestor
153441561|NCT00004999|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153441562|NCT00004999|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153441563|NCT00004999|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153441564|NCT00004999|Antimetabolites|antimetabolites|mesh-ancestor
153441565|NCT00004999|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
153441632|NCT00004399|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153441633|NCT00004399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153441634|NCT00004399|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153441635|NCT00004399|Tocolytic Agents|tocolytic agents|mesh-ancestor
153441636|NCT00004399|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153441637|NCT00004399|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153441638|NCT00004399|Vasodilator Agents|vasodilator agents|mesh-ancestor
153441639|NCT00004423|Aminosalicylic Acid|aminosalicylic acid|mesh-list
153441866|NCT00004567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153441868|NCT00005113|Sirolimus|sirolimus|mesh-list
153441869|NCT00005113|Tacrolimus|tacrolimus|mesh-list
153441870|NCT00005113|Cyclosporins|cyclosporins|mesh-list
153441871|NCT00005113|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153441872|NCT00005113|Immunologic Factors|immunologic factors|mesh-ancestor
153442114|NCT00385645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153442115|NCT00385645|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153442116|NCT00385645|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153442117|NCT00385645|Antiviral Agents|antiviral agents|mesh-ancestor
153442118|NCT00385645|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153827711|NCT01310803|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153827712|NCT01310803|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153827713|NCT01310803|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153827714|NCT01310803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153367705|NCT01076504|Carboplatin|carboplatin|mesh-list
153442120|NCT00385645|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153442122|NCT00385957|Lamivudine|lamivudine|mesh-list
153442123|NCT00385957|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153442124|NCT00385957|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153442125|NCT00385957|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153442126|NCT00385957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153442127|NCT00385957|Antiviral Agents|antiviral agents|mesh-ancestor
153650188|NCT00028483|Docetaxel|docetaxel|mesh-list
153442128|NCT00385957|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153783667|NCT00269334|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153442159|NCT00005791|Irinotecan|irinotecan|mesh-list
153442160|NCT00005791|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153442161|NCT00005791|Antimetabolites|antimetabolites|mesh-ancestor
153783668|NCT00269334|Serotonin Agents|serotonin agents|mesh-ancestor
153442162|NCT00005791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153442163|NCT00005791|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153442624|NCT02116530|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153367727|NCT02174432|Sensory System Agents|sensory system agents|mesh-ancestor
153367728|NCT02174432|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153367729|NCT02176382|Zoledronic Acid|zoledronic acid|mesh-list
153367730|NCT02176382|Denosumab|denosumab|mesh-list
153367731|NCT02176382|Teriparatide|teriparatide|mesh-list
153367732|NCT02176382|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153367733|NCT02176382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153367734|NCT02176382|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153367735|NCT01077596|Bupropion|bupropion|mesh-list
153367736|NCT01077596|Antidepressive Agents|antidepressive agents|mesh-list
153367738|NCT01077596|Serotonin|serotonin|mesh-list
153827715|NCT04518540|Thioctic Acid|thioctic acid|mesh-list
153827716|NCT04518540|Antioxidants|antioxidants|mesh-ancestor
153827717|NCT04518540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153442625|NCT02116530|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153783669|NCT00269334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153815036|NCT04715165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153442626|NCT02116530|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153442627|NCT02116530|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153442628|NCT02116530|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153442629|NCT02116530|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153442630|NCT02116530|Antipruritics|antipruritics|mesh-ancestor
153442631|NCT02116530|Dermatologic Agents|dermatologic agents|mesh-ancestor
153442632|NCT02116530|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
153442633|NCT02116530|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153442634|NCT02116530|Serotonin Agents|serotonin agents|mesh-ancestor
153442635|NCT02116530|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153442636|NCT02116530|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153442637|NCT02116530|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153442664|NCT04730856|Anticoagulants|anticoagulants|mesh-ancestor
153442856|NCT01624194|Oxytocics|oxytocics|mesh-ancestor
153442857|NCT01624194|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153442858|NCT01624194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153442859|NCT02079636|Gemcitabine|gemcitabine|mesh-list
153442860|NCT02079636|Pembrolizumab|pembrolizumab|mesh-list
153442861|NCT02079636|Pemetrexed|pemetrexed|mesh-list
153442961|NCT02062632|Antidepressive Agents|antidepressive agents|mesh-ancestor
153442962|NCT02062632|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153442963|NCT02062632|Histamine Antagonists|histamine antagonists|mesh-ancestor
153442964|NCT02062632|Histamine Agents|histamine agents|mesh-ancestor
153442965|NCT02062632|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153442966|NCT02062632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153443016|NCT02021292|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
153443017|NCT02021292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153443054|NCT02019420|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153443055|NCT02019420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153443091|NCT04720716|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153443092|NCT04720716|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153443093|NCT04720716|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153443094|NCT04720716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153443095|NCT02039778|Temozolomide|temozolomide|mesh-list
153443096|NCT02039778|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153443097|NCT02039778|Alkylating Agents|alkylating agents|mesh-ancestor
153650227|NCT00028600|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153443098|NCT02039778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153443579|NCT01996332|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153443580|NCT01996332|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153443581|NCT01996332|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153443582|NCT01996332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153443583|NCT01996332|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153443584|NCT01987596|Lenograstim|lenograstim|mesh-list
153443585|NCT01987596|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153443586|NCT01987596|Immunologic Factors|immunologic factors|mesh-ancestor
153443587|NCT01987596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153443589|NCT01964898|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
153443590|NCT01964898|Autonomic Agents|autonomic agents|mesh-ancestor
153443591|NCT01964898|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153443592|NCT01964898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153443593|NCT01964898|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
153443594|NCT01964898|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
153443595|NCT01964898|Cholinergic Agents|cholinergic agents|mesh-ancestor
153367759|NCT02740868|Anesthetics, General|anesthetics, general|mesh-ancestor
153367760|NCT02740868|Anesthetics|anesthetics|mesh-ancestor
153367761|NCT02740868|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153367762|NCT02740868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153367763|NCT02414958|Empagliflozin|empagliflozin|mesh-list
153367764|NCT02414958|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
153367766|NCT02414958|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153817753|NCT06133699|Methylene Blue|methylene blue|mesh-list
153817754|NCT06133699|Radiopharmaceuticals|radiopharmaceuticals|mesh-list
153817755|NCT06133699|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153817756|NCT06133699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153817757|NCT06117969|Tibolone|tibolone|mesh-list
153817758|NCT06117969|Androgen Antagonists|androgen antagonists|mesh-ancestor
153459122|NCT01674738|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153459123|NCT01674738|Growth Substances|growth substances|mesh-ancestor
153443597|NCT01964898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153443598|NCT01964352|Tiotropium Bromide|tiotropium bromide|mesh-list
153443599|NCT01964352|Olodaterol|olodaterol|mesh-list
153443600|NCT01964352|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153443813|NCT01939002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153443814|NCT01939002|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153815037|NCT04715165|Sensory System Agents|sensory system agents|mesh-ancestor
153443815|NCT01939002|Gout Suppressants|gout suppressants|mesh-ancestor
153443816|NCT01939002|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153443849|NCT01980888|Immunologic Factors|immunologic factors|mesh-ancestor
153443850|NCT01980888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153443851|NCT01980888|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153443852|NCT01980888|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153444408|NCT01133639|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153444409|NCT01133639|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153444410|NCT01133639|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153444411|NCT01133639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153444412|NCT00378911|Sunitinib|sunitinib|mesh-list
153444413|NCT00378911|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153444414|NCT00378911|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153444415|NCT00378911|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153444416|NCT00378911|Growth Substances|growth substances|mesh-ancestor
153444417|NCT00378911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153444418|NCT00378911|Growth Inhibitors|growth inhibitors|mesh-ancestor
153444419|NCT00378911|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153444420|NCT00378911|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153444447|NCT02499887|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153444448|NCT02499887|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153444465|NCT02504099|Protease Inhibitors|protease inhibitors|mesh-ancestor
153444466|NCT02504099|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153444467|NCT02504099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153444666|NCT00850421|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
153444667|NCT00850421|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
153444668|NCT00850421|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153444669|NCT00850421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153444670|NCT00850421|Cholinergic Agents|cholinergic agents|mesh-ancestor
153444671|NCT00850421|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153444672|NCT00850421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153444673|NCT00850421|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
153445062|NCT00546455|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153445063|NCT00546455|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
153445064|NCT00546455|Protective Agents|protective agents|mesh-ancestor
153445065|NCT00546455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153445066|NCT00000737|Megestrol|megestrol|mesh-list
153445067|NCT00000737|Megestrol Acetate|megestrol acetate|mesh-list
153445068|NCT00000737|Dronabinol|dronabinol|mesh-list
153445278|NCT00281879|Autonomic Agents|autonomic agents|mesh-ancestor
153445279|NCT00281879|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153445280|NCT00281879|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153445281|NCT00281879|Glucocorticoids|glucocorticoids|mesh-ancestor
153367800|NCT03015818|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153367801|NCT03015818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153367802|NCT03015818|Cariostatic Agents|cariostatic agents|mesh-ancestor
153367803|NCT03015818|Protective Agents|protective agents|mesh-ancestor
153367804|NCT01080248|Gemcitabine|gemcitabine|mesh-list
153367805|NCT01080248|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153367806|NCT01080248|Antimetabolites|antimetabolites|mesh-ancestor
153367807|NCT01080248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153367808|NCT01080248|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153367809|NCT02452476|Poractant alfa|poractant alfa|mesh-list
153367810|NCT02452476|Pulmonary Surfactants|pulmonary surfactants|mesh-ancestor
153367811|NCT02452476|Respiratory System Agents|respiratory system agents|mesh-ancestor
153367812|NCT01082588|Pravastatin|pravastatin|mesh-list
153445283|NCT00281879|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153445284|NCT00281879|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
153445285|NCT00281879|Protective Agents|protective agents|mesh-ancestor
153445287|NCT00000809|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153445288|NCT00000809|Immunologic Factors|immunologic factors|mesh-ancestor
153445289|NCT00000809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153445290|NCT00000809|Antacids|antacids|mesh-ancestor
153445291|NCT00000809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153445292|NCT00000809|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153445293|NCT00240227|Prazosin|prazosin|mesh-list
153445294|NCT00240227|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153445295|NCT00240227|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
153445326|NCT00000839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153445328|NCT00000839|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153445329|NCT00000839|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153445330|NCT00000839|Antiviral Agents|antiviral agents|mesh-ancestor
153445426|NCT00000887|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153445579|NCT00000239|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
153445580|NCT00000245|Desipramine|desipramine|mesh-list
153445705|NCT00001061|Ganciclovir|ganciclovir|mesh-list
153445770|NCT00000293|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
153650286|NCT00028756|Antimetabolites|antimetabolites|mesh-ancestor
153445771|NCT00000293|Antidepressive Agents|antidepressive agents|mesh-ancestor
153445772|NCT00000293|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153445773|NCT00000293|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
153445774|NCT00000293|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153446122|NCT00000623|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153446124|NCT00000623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153446125|NCT00000623|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153446126|NCT00000623|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153446127|NCT00000623|Vasodilator Agents|vasodilator agents|mesh-ancestor
153446128|NCT00000623|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
153446129|NCT00000623|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
153446130|NCT00000623|Urological Agents|urological agents|mesh-ancestor
153459124|NCT01674738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153459125|NCT01674738|Growth Inhibitors|growth inhibitors|mesh-ancestor
153827815|NCT00482976|Ruboxistaurin|ruboxistaurin|mesh-list
153446131|NCT00000623|Iron Chelating Agents|iron chelating agents|mesh-ancestor
153446132|NCT00000623|Chelating Agents|chelating agents|mesh-ancestor
153446133|NCT00000623|Sequestering Agents|sequestering agents|mesh-ancestor
153446134|NCT00000623|Siderophores|siderophores|mesh-ancestor
153446136|NCT00001991|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153446137|NCT00001991|Antimalarials|antimalarials|mesh-ancestor
153446140|NCT00001991|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153446141|NCT00001991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153446143|NCT00001997|Didanosine|didanosine|mesh-list
153446144|NCT00001997|Interleukin-2|interleukin-2|mesh-list
153446145|NCT00001997|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153446146|NCT00001997|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153446825|NCT00002435|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153446826|NCT00002447|Ritonavir|ritonavir|mesh-list
153447008|NCT00002501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153447009|NCT00002501|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153447010|NCT00002501|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153447012|NCT00002147|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
153447013|NCT00002147|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153447014|NCT00002147|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153447015|NCT00002147|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153447016|NCT00002147|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153447017|NCT00002147|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153450898|NCT04649060|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153450899|NCT04649060|Alkylating Agents|alkylating agents|mesh-ancestor
153450900|NCT04649060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153450901|NCT04649060|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153450902|NCT04649060|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153450903|NCT04649060|Immunologic Factors|immunologic factors|mesh-ancestor
153450904|NCT04608487|Cyclophosphamide|cyclophosphamide|mesh-list
153450905|NCT04608487|Fludarabine|fludarabine|mesh-list
153450906|NCT04608487|Axicabtagene ciloleucel|axicabtagene ciloleucel|mesh-list
153450907|NCT04608487|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153450908|NCT04608487|Immunologic Factors|immunologic factors|mesh-ancestor
153451144|NCT03737604|Sensory System Agents|sensory system agents|mesh-ancestor
153451145|NCT03737604|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153459126|NCT01674738|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153451147|NCT03676504|Fludarabine|fludarabine|mesh-list
153451182|NCT03563690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153451183|NCT03557008|Metronidazole|metronidazole|mesh-list
153451185|NCT03557008|Neomycin|neomycin|mesh-list
153451186|NCT03557008|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153451187|NCT03557008|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153451235|NCT02333370|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
153451236|NCT02333370|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
153451237|NCT02333370|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153451238|NCT02333370|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
153451239|NCT02303444|Sorafenib|sorafenib|mesh-list
153451240|NCT02303444|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153650401|NCT00029380|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153452487|NCT01803282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153452489|NCT01803282|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153452490|NCT01803282|Antimetabolites|antimetabolites|mesh-ancestor
153452491|NCT01803282|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
153452492|NCT01803282|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153452493|NCT01803282|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153452494|NCT01803282|Antidotes|antidotes|mesh-ancestor
153452495|NCT01803282|Protective Agents|protective agents|mesh-ancestor
153452496|NCT01803282|Vitamin B Complex|vitamin b complex|mesh-ancestor
153452497|NCT01803282|Vitamins|vitamins|mesh-ancestor
153452498|NCT01803282|Micronutrients|micronutrients|mesh-ancestor
153452499|NCT01803282|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153452532|NCT01844700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153452534|NCT01844700|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153452535|NCT01844700|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153452536|NCT01844700|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153452537|NCT01844700|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153453259|NCT01778010|Anesthetics, Local|anesthetics, local|mesh-ancestor
153453260|NCT01778010|Anesthetics|anesthetics|mesh-ancestor
153827828|NCT00481013|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153453261|NCT01778010|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153453262|NCT01778010|Sensory System Agents|sensory system agents|mesh-ancestor
153453263|NCT01778010|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153453264|NCT01778010|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
153453265|NCT01778010|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
153453266|NCT01778010|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153453267|NCT01778010|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153453268|NCT01778010|Dopamine Agents|dopamine agents|mesh-ancestor
153453269|NCT01778010|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153453271|NCT01777854|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
153453272|NCT01777854|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153453273|NCT01777854|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
153453274|NCT01777854|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153453275|NCT01777854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153453276|NCT01777620|Botulinum Toxins|botulinum toxins|mesh-list
153453277|NCT01777620|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
153453278|NCT01777620|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
153453279|NCT01777620|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
153453280|NCT01777620|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153453281|NCT01777620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153453282|NCT01777620|Cholinergic Agents|cholinergic agents|mesh-ancestor
153453283|NCT01777620|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153453284|NCT01777620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153453285|NCT01777620|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
153453286|NCT01777620|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153453287|NCT01777542|Insulin|insulin|mesh-list
153453288|NCT01777542|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
153453289|NCT01777542|Mitogens|mitogens|mesh-list
153453290|NCT01777542|Mecasermin|mecasermin|mesh-list
153453291|NCT01777542|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153453292|NCT01777542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153453293|NCT01777542|Mitosis Modulators|mitosis modulators|mesh-ancestor
153454096|NCT01681212|Alkylating Agents|alkylating agents|mesh-ancestor
153454097|NCT01687296|Fluticasone|fluticasone|mesh-list
153454099|NCT01687296|Prednisone|prednisone|mesh-list
153454100|NCT01687296|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
153454101|NCT01687296|Albuterol|albuterol|mesh-list
153454102|NCT01687296|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153454153|NCT01568034|Levodopa|levodopa|mesh-list
153454154|NCT01568034|Carbidopa|carbidopa|mesh-list
153454155|NCT01568034|Opicapone|opicapone|mesh-list
153454156|NCT01568034|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
153454157|NCT01568034|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
153454158|NCT01568034|Dopamine Agents|dopamine agents|mesh-ancestor
153454159|NCT01568034|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153454160|NCT01568034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153454161|NCT01568034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153454324|NCT03027960|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153454325|NCT03027960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153454326|NCT01539642|Sufentanil|sufentanil|mesh-list
153454327|NCT01539642|Dsuvia|dsuvia|mesh-list
153454328|NCT01539642|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153454329|NCT01539642|Narcotics|narcotics|mesh-ancestor
153454597|NCT03028428|Immunologic Factors|immunologic factors|mesh-ancestor
153454598|NCT03028428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153454599|NCT03028428|Viscosupplements|viscosupplements|mesh-ancestor
153454600|NCT03028428|Protective Agents|protective agents|mesh-ancestor
153454775|NCT01547598|Bimatoprost|bimatoprost|mesh-list
153454781|NCT01547598|Adrenergic Agents|adrenergic agents|mesh-ancestor
153454782|NCT01547598|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153454783|NCT01547598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153454784|NCT01547598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153454810|NCT01524198|Autonomic Agents|autonomic agents|mesh-ancestor
153454811|NCT01524198|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153454812|NCT01524198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153454813|NCT01524198|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153454814|NCT01524198|Respiratory System Agents|respiratory system agents|mesh-ancestor
153454817|NCT01524198|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153454818|NCT01523886|Rocuronium|rocuronium|mesh-list
153454819|NCT01523886|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
153454820|NCT01523886|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
153454821|NCT01523886|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
153454822|NCT01523886|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153454823|NCT01523886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153454824|NCT01546038|Cytarabine|cytarabine|mesh-list
153454825|NCT01546038|Decitabine|decitabine|mesh-list
153454826|NCT01546038|Daunorubicin|daunorubicin|mesh-list
153454948|NCT01516008|Analgesics|analgesics|mesh-ancestor
153456111|NCT03725059|Antimitotic Agents|antimitotic agents|mesh-ancestor
153456112|NCT03725059|Mitosis Modulators|mitosis modulators|mesh-ancestor
153456474|NCT01453374|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
153456475|NCT01453374|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
153456476|NCT01453374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153456477|NCT01453374|Sensory System Agents|sensory system agents|mesh-ancestor
153456478|NCT01453374|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153456791|NCT03026244|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153456792|NCT03026244|Chelating Agents|chelating agents|mesh-ancestor
153456793|NCT03026244|Sequestering Agents|sequestering agents|mesh-ancestor
153456853|NCT01439568|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153456854|NCT01439568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153456855|NCT01469052|Axitinib|axitinib|mesh-list
153456856|NCT01469052|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153456857|NCT01469052|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153456858|NCT01469052|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153456859|NCT01469052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153456860|NCT01468818|Cyclophosphamide|cyclophosphamide|mesh-list
153456911|NCT01441440|Antidepressive Agents|antidepressive agents|mesh-ancestor
153456979|NCT01466790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153456981|NCT01466790|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153456982|NCT01466790|Protease Inhibitors|protease inhibitors|mesh-ancestor
153456983|NCT01466790|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153456984|NCT01418352|Aripiprazole|aripiprazole|mesh-list
153456985|NCT01418352|Antidepressive Agents|antidepressive agents|mesh-ancestor
153456986|NCT01418352|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153456987|NCT01418352|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153456988|NCT01418352|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153457256|NCT01402284|Dexamethasone|dexamethasone|mesh-list
153457257|NCT01402284|Lenalidomide|lenalidomide|mesh-list
153457258|NCT01402284|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153457259|NCT01402284|Antiemetics|antiemetics|mesh-ancestor
153457260|NCT01402284|Autonomic Agents|autonomic agents|mesh-ancestor
153457753|NCT04326738|Anesthetics|anesthetics|mesh-ancestor
153457759|NCT04347486|Neostigmine|neostigmine|mesh-list
153457760|NCT04347486|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153457761|NCT04347486|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153457762|NCT04347486|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153457763|NCT04347486|Autonomic Agents|autonomic agents|mesh-ancestor
153650465|NCT00012519|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153457821|NCT05631678|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
153457822|NCT05631678|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
153457823|NCT05631678|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
153457824|NCT05631678|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
153457837|NCT04008264|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153457839|NCT04008264|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
153457840|NCT04008264|Cholinergic Agents|cholinergic agents|mesh-ancestor
153457841|NCT04008264|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153457842|NCT04008264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153457843|NCT04008264|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
153457873|NCT03986970|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153457874|NCT03594396|Durvalumab|durvalumab|mesh-list
153457875|NCT03594396|Olaparib|olaparib|mesh-list
153457876|NCT03594396|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153457877|NCT03594396|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153457878|NCT03594396|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
153457879|NCT03594396|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153457880|NCT03594396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153367880|NCT01085006|Hemostatics|hemostatics|mesh-ancestor
153367881|NCT01085006|Coagulants|coagulants|mesh-ancestor
153367882|NCT01085786|Amoxicillin|amoxicillin|mesh-list
153367883|NCT01085786|Metronidazole|metronidazole|mesh-list
153367884|NCT01085786|Clarithromycin|clarithromycin|mesh-list
153367885|NCT01085786|Esomeprazole|esomeprazole|mesh-list
153367886|NCT01085786|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153459127|NCT01674738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153459128|NCT01674738|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153459129|NCT01674738|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153459130|NCT01675206|Vitamin K|vitamin k|mesh-list
153459131|NCT01675206|Vitamin K 2|vitamin k 2|mesh-list
153459132|NCT01675206|Vitamins|vitamins|mesh-ancestor
153459133|NCT01675206|Micronutrients|micronutrients|mesh-ancestor
153459134|NCT01675206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153459135|NCT01675206|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
153577666|NCT01718964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153577667|NCT01718964|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153577668|NCT01719042|Ondansetron|ondansetron|mesh-list
153577669|NCT01719042|Antiemetics|antiemetics|mesh-ancestor
153457883|NCT03594240|Vitamins|vitamins|mesh-ancestor
153457884|NCT03594240|Micronutrients|micronutrients|mesh-ancestor
153457885|NCT03594240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153457886|NCT03594240|Hematinics|hematinics|mesh-ancestor
153457887|NCT03598374|Folic Acid|folic acid|mesh-list
153457888|NCT03598374|Vitamin B Complex|vitamin b complex|mesh-list
153457889|NCT03598374|Inositol|inositol|mesh-list
153457890|NCT03598374|Hematinics|hematinics|mesh-ancestor
153457891|NCT03598374|Vitamins|vitamins|mesh-ancestor
153457892|NCT03598374|Micronutrients|micronutrients|mesh-ancestor
153457912|NCT00217464|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
153457914|NCT00217464|Hormone Antagonists|hormone antagonists|mesh-ancestor
153457915|NCT00217464|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153457916|NCT00217464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153457917|NCT03597282|Nivolumab|nivolumab|mesh-list
153457918|NCT03597282|Ipilimumab|ipilimumab|mesh-list
153457919|NCT03597282|Poly ICLC|poly iclc|mesh-list
153457920|NCT03597282|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153457921|NCT03597282|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153457922|NCT03597282|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153457923|NCT03597282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153457924|NCT03597282|Interferon Inducers|interferon inducers|mesh-ancestor
153457925|NCT03597282|Immunologic Factors|immunologic factors|mesh-ancestor
153457926|NCT03597282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153457927|NCT03593304|Vitamins|vitamins|mesh-list
153457928|NCT03593304|Vitamin B 12|vitamin b 12|mesh-list
153457929|NCT03593304|Pyridoxine|pyridoxine|mesh-list
153457930|NCT03593304|Pyridoxal|pyridoxal|mesh-list
153457931|NCT03593304|Vitamin B 6|vitamin b 6|mesh-list
153457932|NCT03593304|Vitamin B Complex|vitamin b complex|mesh-list
153457933|NCT03593304|Micronutrients|micronutrients|mesh-ancestor
153650520|NCT00012558|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153457934|NCT03593304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153457935|NCT00211536|Insulin|insulin|mesh-list
153457936|NCT00211536|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
153405877|NCT05857514|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153457939|NCT03596970|Everolimus|everolimus|mesh-list
153458062|NCT03023436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153458063|NCT04195074|Tenofovir|tenofovir|mesh-list
153458064|NCT04195074|Entecavir|entecavir|mesh-list
153458065|NCT04195074|Antiviral Agents|antiviral agents|mesh-ancestor
153458066|NCT04195074|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153458067|NCT04195074|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153458068|NCT04195074|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153458069|NCT04195074|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153458070|NCT04195074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153458163|NCT03023358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153458164|NCT03023358|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153458571|NCT03588936|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153458572|NCT03588936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153458574|NCT03022500|Tremelimumab|tremelimumab|mesh-list
153458575|NCT03022500|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153458576|NCT03022500|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153458577|NCT04148898|Bevacizumab|bevacizumab|mesh-list
153458578|NCT04148898|Osimertinib|osimertinib|mesh-list
153458579|NCT04148898|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153458580|NCT04148898|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153458581|NCT04148898|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153459213|NCT01675986|Dermatologic Agents|dermatologic agents|mesh-ancestor
153459798|NCT05990192|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153459799|NCT05990192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153459800|NCT05990192|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153827888|NCT04325191|Melatonin|melatonin|mesh-list
153827889|NCT04325191|Antioxidants|antioxidants|mesh-ancestor
153827890|NCT04325191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153827891|NCT04325191|Protective Agents|protective agents|mesh-ancestor
153827892|NCT04325191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153827893|NCT04325191|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153827894|NCT04517292|Cisplatin|cisplatin|mesh-list
153827895|NCT04517292|Gemcitabine|gemcitabine|mesh-list
153827900|NCT00482846|Melphalan|melphalan|mesh-list
153577670|NCT01719042|Autonomic Agents|autonomic agents|mesh-ancestor
153459804|NCT05972512|Micronutrients|micronutrients|mesh-ancestor
153459805|NCT05972512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153460047|NCT04865419|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153460048|NCT04865419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153460070|NCT04796194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153460071|NCT04739865|Psilocybin|psilocybin|mesh-list
153460072|NCT04739865|Hallucinogens|hallucinogens|mesh-ancestor
153460073|NCT04739865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153460074|NCT04739865|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153460075|NCT04638465|Cisplatin|cisplatin|mesh-list
153460076|NCT04638465|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153460077|NCT04630522|Vitamin D|vitamin d|mesh-list
153460078|NCT04630522|Calcium, Dietary|calcium, dietary|mesh-list
153460079|NCT04630522|Calcium|calcium|mesh-list
153460080|NCT04630522|Vitamins|vitamins|mesh-ancestor
153460081|NCT04630522|Micronutrients|micronutrients|mesh-ancestor
153460141|NCT04533997|Diuretics|diuretics|mesh-ancestor
153577728|NCT01719588|Analgesics|analgesics|mesh-ancestor
153577729|NCT01719588|Sensory System Agents|sensory system agents|mesh-ancestor
153359766|NCT04199117|Cholinergic Agents|cholinergic agents|mesh-ancestor
153359767|NCT04199117|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153359768|NCT04199117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153359769|NCT04185402|Azithromycin|azithromycin|mesh-list
153359770|NCT04185402|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153359771|NCT04185402|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153650527|NCT00012558|GABA Agents|gaba agents|mesh-ancestor
153813280|NCT00333086|Hormone Antagonists|hormone antagonists|mesh-ancestor
153813281|NCT00333086|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153813282|NCT00333086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153813283|NCT00333125|Timolol|timolol|mesh-list
153813284|NCT00333125|Travoprost|travoprost|mesh-list
153813285|NCT00333125|Dorzolamide|dorzolamide|mesh-list
153813286|NCT00333125|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
153813287|NCT00333125|Ophthalmic Solutions|ophthalmic solutions|mesh-list
153813288|NCT00333125|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
153813289|NCT00333125|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
153813290|NCT00333125|Adrenergic Agents|adrenergic agents|mesh-ancestor
153813291|NCT00333125|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153813292|NCT00333125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153359775|NCT04112641|Vitamin B Complex|vitamin b complex|mesh-ancestor
153359776|NCT04112641|Vitamins|vitamins|mesh-ancestor
153359777|NCT04112641|Micronutrients|micronutrients|mesh-ancestor
153359778|NCT04112641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153359779|NCT04112641|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153359780|NCT04112641|Antimetabolites|antimetabolites|mesh-ancestor
153359781|NCT04112641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153359782|NCT04112641|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153359783|NCT04112641|Vasodilator Agents|vasodilator agents|mesh-ancestor
153359784|NCT04074967|Nivolumab|nivolumab|mesh-list
153359791|NCT03973268|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
153359792|NCT03973268|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153359793|NCT03973268|Immunologic Factors|immunologic factors|mesh-ancestor
153359794|NCT03973268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153359795|NCT03947827|Minocycline|minocycline|mesh-list
153359796|NCT03947827|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153813300|NCT00333164|Autonomic Agents|autonomic agents|mesh-ancestor
153359869|NCT03396601|Analgesics|analgesics|mesh-ancestor
153359870|NCT03396601|Sensory System Agents|sensory system agents|mesh-ancestor
153359871|NCT03396601|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153813580|NCT00436293|Docetaxel|docetaxel|mesh-list
153360037|NCT01268111|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153360038|NCT01349231|Ketamine|ketamine|mesh-list
153360039|NCT01349231|Analgesics|analgesics|mesh-ancestor
153461874|NCT05248932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153462682|NCT04123392|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153360074|NCT01321151|Protective Agents|protective agents|mesh-ancestor
153463262|NCT01455246|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153463263|NCT01455246|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153463623|NCT05586750|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153463815|NCT02983422|Aminophylline|aminophylline|mesh-list
153463816|NCT02983422|Furosemide|furosemide|mesh-list
153463818|NCT02983422|Autonomic Agents|autonomic agents|mesh-ancestor
153464019|NCT02442180|Lenograstim|lenograstim|mesh-list
153464406|NCT01895400|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153464407|NCT01895400|Autonomic Agents|autonomic agents|mesh-ancestor
153464754|NCT00038610|Cytarabine|cytarabine|mesh-list
153464948|NCT00255684|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153465192|NCT04118556|Antifungal Agents|antifungal agents|mesh-ancestor
153465301|NCT00208026|Dermatologic Agents|dermatologic agents|mesh-ancestor
153465421|NCT00223704|Bradykinin Receptor Antagonists|bradykinin receptor antagonists|mesh-ancestor
153465422|NCT00223704|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
153465514|NCT00114114|Goserelin|goserelin|mesh-list
153465634|NCT00234078|Protective Agents|protective agents|mesh-ancestor
153465962|NCT00142116|Immunologic Factors|immunologic factors|mesh-ancestor
153466111|NCT00330876|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153466112|NCT00330876|Antimetabolites|antimetabolites|mesh-ancestor
153466202|NCT01791114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153466351|NCT00354978|Protective Agents|protective agents|mesh-ancestor
153466352|NCT00354978|Vitamin B Complex|vitamin b complex|mesh-ancestor
153466575|NCT00365274|Hormones|hormones|mesh-ancestor
153467017|NCT00385008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153467217|NCT00528450|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153467218|NCT00528450|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153467326|NCT00486018|Ranibizumab|ranibizumab|mesh-list
153467327|NCT00486018|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153467328|NCT00486018|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153467461|NCT00431184|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153467581|NCT00439296|Cyclophosphamide|cyclophosphamide|mesh-list
153467734|NCT02115048|Letrozole|letrozole|mesh-list
153468086|NCT01797900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153468087|NCT03572790|Prucalopride|prucalopride|mesh-list
153468218|NCT03172416|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153468292|NCT06298383|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153468387|NCT06297681|Autonomic Agents|autonomic agents|mesh-ancestor
153468388|NCT06297681|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153468389|NCT06297681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153468391|NCT06297681|Glucocorticoids|glucocorticoids|mesh-ancestor
153468499|NCT06293417|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-list
153468500|NCT06293417|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153468501|NCT06293417|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153468502|NCT06293417|Antimetabolites|antimetabolites|mesh-ancestor
153468503|NCT06293417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153468504|NCT06293417|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153468505|NCT06293417|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153813741|NCT04716179|Hormones|hormones|mesh-list
153468506|NCT06292546|Amoxicillin|amoxicillin|mesh-list
153468609|NCT06261827|Antioxidants|antioxidants|mesh-ancestor
153469010|NCT05691478|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153469011|NCT05691478|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153469012|NCT05691478|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153469013|NCT05691478|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153469014|NCT05691478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153469015|NCT05691478|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
153469016|NCT05691478|Abortifacient Agents|abortifacient agents|mesh-ancestor
153469030|NCT05671081|Narcotics|narcotics|mesh-list
153469031|NCT05671081|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153627125|NCT02021214|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153627211|NCT02021851|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153627213|NCT02021851|Protease Inhibitors|protease inhibitors|mesh-ancestor
153627341|NCT02022527|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153627344|NCT02022527|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153627429|NCT02023086|Mydriatics|mydriatics|mesh-list
153627430|NCT02023086|Autonomic Agents|autonomic agents|mesh-ancestor
153628639|NCT02032043|Mitosis Modulators|mitosis modulators|mesh-ancestor
153628987|NCT02041338|Paclitaxel|paclitaxel|mesh-list
153629084|NCT02042482|Ubiquinone|ubiquinone|mesh-list
153629180|NCT02043223|Vitamins|vitamins|mesh-list
153629470|NCT02045667|Mexiletine|mexiletine|mesh-list
153629564|NCT02046109|Disinfectants|disinfectants|mesh-ancestor
153629565|NCT02046187|Temozolomide|temozolomide|mesh-list
153629643|NCT02046551|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153629878|NCT00005838|Vinorelbine|vinorelbine|mesh-list
153629879|NCT00005838|Carboplatin|carboplatin|mesh-list
153630330|NCT00005988|Leucovorin|leucovorin|mesh-list
153630413|NCT00006006|Interferon-alpha|interferon-alpha|mesh-list
153630414|NCT00006006|Thalidomide|thalidomide|mesh-list
153630607|NCT00386841|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153630694|NCT03940131|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153630822|NCT02373813|Folic Acid|folic acid|mesh-list
153650592|NCT00030004|GABA Agents|gaba agents|mesh-ancestor
153650593|NCT00030004|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153630885|NCT00006048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153631018|NCT00006114|Vinorelbine|vinorelbine|mesh-list
153631019|NCT00006114|Mitoxantrone|mitoxantrone|mesh-list
153631020|NCT00006114|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153631021|NCT00006114|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153631022|NCT00006114|Tubulin Modulators|tubulin modulators|mesh-ancestor
153631023|NCT00006114|Antimitotic Agents|antimitotic agents|mesh-ancestor
153631024|NCT00006114|Mitosis Modulators|mitosis modulators|mesh-ancestor
153631475|NCT00005836|Oxaliplatin|oxaliplatin|mesh-list
153631730|NCT00006345|Glucocorticoids|glucocorticoids|mesh-ancestor
153632068|NCT00006013|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153632269|NCT00006381|Celecoxib|celecoxib|mesh-list
153632373|NCT05552404|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153632602|NCT00006468|Antidotes|antidotes|mesh-ancestor
153632707|NCT00006486|Carboxyamido-triazole|carboxyamido-triazole|mesh-list
153632933|NCT00006055|Cyclosporine|cyclosporine|mesh-list
153633075|NCT00006112|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153633197|NCT00006190|Efavirenz|efavirenz|mesh-list
153633409|NCT00007527|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153633501|NCT00006325|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
153633793|NCT00006397|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153633908|NCT00006451|Antifungal Agents|antifungal agents|mesh-ancestor
153634015|NCT00006469|Mitosis Modulators|mitosis modulators|mesh-ancestor
153634113|NCT00006799|Megestrol|megestrol|mesh-list
153634114|NCT00006799|Megestrol Acetate|megestrol acetate|mesh-list
153634509|NCT00000136|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153634610|NCT00000214|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153634768|NCT00000499|Diuretics|diuretics|mesh-ancestor
153634769|NCT00000499|Natriuretic Agents|natriuretic agents|mesh-ancestor
153634913|NCT00000559|Hormones|hormones|mesh-list
153634987|NCT00000640|Sulfamethoxazole|sulfamethoxazole|mesh-list
153635002|NCT00000646|Pentoxifylline|pentoxifylline|mesh-list
153635081|NCT00000688|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153635169|NCT00000751|Antimetabolites|antimetabolites|mesh-ancestor
153635280|NCT00000826|Dapsone|dapsone|mesh-list
153635402|NCT00000904|polysaccharide-K|polysaccharide-k|mesh-list
153635403|NCT00000904|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153635541|NCT00000970|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153635542|NCT00000970|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153635630|NCT00001033|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153635747|NCT00001084|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
153635780|NCT00001105|Antibodies|antibodies|mesh-list
153635880|NCT00001267|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153636067|NCT00001693|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153636168|NCT05640817|Antioxidants|antioxidants|mesh-ancestor
153636435|NCT05349838|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153636437|NCT05349838|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153636440|NCT05305456|Vitamins|vitamins|mesh-list
153636547|NCT00000522|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
153636548|NCT00000522|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
153636648|NCT00000576|Respiratory System Agents|respiratory system agents|mesh-ancestor
153636738|NCT04547530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153636740|NCT00000612|Estrogens|estrogens|mesh-list
153636848|NCT00000666|Pyrimethamine|pyrimethamine|mesh-list
153637100|NCT00000747|Nevirapine|nevirapine|mesh-list
153637186|NCT00390598|Laxatives|laxatives|mesh-ancestor
153637187|NCT00390598|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153637188|NCT00000816|Trimethoprim|trimethoprim|mesh-list
153637375|NCT00000888|Ritonavir|ritonavir|mesh-list
153637521|NCT00000975|Hormone Antagonists|hormone antagonists|mesh-ancestor
153637525|NCT00000978|Zidovudine|zidovudine|mesh-list
153637816|NCT00005852|Immunologic Factors|immunologic factors|mesh-ancestor
153638045|NCT00001119|Antiviral Agents|antiviral agents|mesh-ancestor
153638046|NCT00001119|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153638302|NCT00010192|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153638385|NCT00001191|Omeprazole|omeprazole|mesh-list
153638529|NCT00005945|Mercaptopurine|mercaptopurine|mesh-list
153638648|NCT00012688|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153638799|NCT00014209|Hormones|hormones|mesh-ancestor
153638834|NCT00014287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153638835|NCT00014287|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153639012|NCT00001344|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153639013|NCT00014989|Magnesium Sulfate|magnesium sulfate|mesh-list
153639014|NCT00014989|Analgesics|analgesics|mesh-ancestor
153639115|NCT00015691|Metformin|metformin|mesh-list
153639262|NCT00016276|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153639394|NCT00386672|Ergocalciferols|ergocalciferols|mesh-list
153639513|NCT04734418|Adrenergic Agents|adrenergic agents|mesh-ancestor
153639514|NCT04734418|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153650638|NCT00030121|Cardiodilatin|cardiodilatin|mesh-list
153639625|NCT00017368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153639748|NCT00017758|Antiviral Agents|antiviral agents|mesh-ancestor
153639865|NCT00001575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153640082|NCT00001758|Efavirenz|efavirenz|mesh-list
153640083|NCT00001758|Abacavir|abacavir|mesh-list
153640084|NCT00001758|Amprenavir|amprenavir|mesh-list
153640118|NCT05620628|Durvalumab|durvalumab|mesh-list
153640304|NCT05411861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153640305|NCT03958513|Bupivacaine|bupivacaine|mesh-list
153640443|NCT03151720|Loratadine|loratadine|mesh-list
153640553|NCT00389688|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153640555|NCT00389688|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153640643|NCT04796831|Quizartinib|quizartinib|mesh-list
153640753|NCT01349803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153640969|NCT01465828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153641114|NCT00847366|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153641311|NCT03620942|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153641312|NCT03620942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153641539|NCT00276133|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153641690|NCT04554862|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153641789|NCT00006047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153641870|NCT00084058|Ritonavir|ritonavir|mesh-list
153641871|NCT00084058|Lopinavir|lopinavir|mesh-list
153641872|NCT00084058|Saquinavir|saquinavir|mesh-list
153641980|NCT00084604|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
153642249|NCT00086203|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153642250|NCT00006095|Irinotecan|irinotecan|mesh-list
153642359|NCT00086944|Alkylating Agents|alkylating agents|mesh-ancestor
153642509|NCT00087880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153642510|NCT00087880|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
153642511|NCT00087880|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153642512|NCT00087880|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153642514|NCT00088036|Antiemetics|antiemetics|mesh-ancestor
153642515|NCT00088036|Autonomic Agents|autonomic agents|mesh-ancestor
153642516|NCT00088036|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153642517|NCT00088036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153642518|NCT00088036|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153642519|NCT00088036|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153642589|NCT00088504|Antiviral Agents|antiviral agents|mesh-ancestor
153642590|NCT00088504|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153642767|NCT00423826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153642768|NCT00423826|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153642866|NCT00089440|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153642997|NCT00091234|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153643360|NCT00093925|Clevidipine|clevidipine|mesh-list
153643361|NCT00093925|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153643368|NCT00006239|Tretinoin|tretinoin|mesh-list
153643474|NCT00094627|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153643590|NCT00095329|Antifungal Agents|antifungal agents|mesh-ancestor
153643799|NCT00006299|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153643800|NCT00006299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153643801|NCT00006299|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153643802|NCT00006299|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153643803|NCT00006299|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
153643804|NCT00006299|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153643967|NCT00097825|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153644068|NCT00387920|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153644178|NCT00099970|Volociximab|volociximab|mesh-list
153644288|NCT00006377|Paclitaxel|paclitaxel|mesh-list
153644400|NCT00101179|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-list
153644401|NCT00101179|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153644402|NCT00101179|Antimetabolites|antimetabolites|mesh-ancestor
153644406|NCT00400777|Amlodipine|amlodipine|mesh-list
153644499|NCT00101569|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
153644611|NCT00102700|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153644994|NCT00006479|Calcium|calcium|mesh-list
153644995|NCT00006479|Levoleucovorin|levoleucovorin|mesh-list
153645004|NCT00006479|Antidotes|antidotes|mesh-ancestor
153645298|NCT00006695|Iodine|iodine|mesh-list
153645327|NCT00108238|Estradiol|estradiol|mesh-list
153645408|NCT00006890|Growth Substances|growth substances|mesh-ancestor
153645544|NCT00109993|Glucocorticoids|glucocorticoids|mesh-ancestor
153645855|NCT00007358|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153646069|NCT00113347|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153646181|NCT00113815|Topiramate|topiramate|mesh-list
153646374|NCT00008177|Antimetabolites|antimetabolites|mesh-ancestor
153646458|NCT00115414|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153646556|NCT00008294|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153646557|NCT00008294|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153646700|NCT02909322|Hydromorphone|hydromorphone|mesh-list
153646701|NCT02909322|Bupivacaine|bupivacaine|mesh-list
153646792|NCT00388427|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153646891|NCT00118066|Vitamins|vitamins|mesh-ancestor
153646892|NCT00118066|Micronutrients|micronutrients|mesh-ancestor
153647122|NCT00402181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153647123|NCT00402181|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153647329|NCT04705948|Analgesics|analgesics|mesh-ancestor
153647336|NCT04705948|Anesthetics|anesthetics|mesh-ancestor
153647409|NCT00122473|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153647602|NCT00128635|Immunologic Factors|immunologic factors|mesh-ancestor
153647745|NCT00018733|Serotonin Agents|serotonin agents|mesh-ancestor
153647825|NCT00019123|Growth Inhibitors|growth inhibitors|mesh-ancestor
153647914|NCT00019669|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153648125|NCT00010062|Immunologic Factors|immunologic factors|mesh-ancestor
153648126|NCT00010062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153648241|NCT00021073|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
153648362|NCT00021814|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
153648707|NCT00023218|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153648995|NCT00023998|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153648996|NCT00023998|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153649002|NCT00023998|Antidotes|antidotes|mesh-ancestor
153649109|NCT00024349|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153649110|NCT00024349|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153649219|NCT00000368|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
153649220|NCT00000368|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153649221|NCT00000368|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153649222|NCT00025168|Gemcitabine|gemcitabine|mesh-list
153649373|NCT00000395|Antimetabolites|antimetabolites|mesh-ancestor
153649593|NCT00026338|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153649747|NCT00027508|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153649925|NCT00011973|Fenretinide|fenretinide|mesh-list
153650041|NCT00028132|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153650044|NCT00028132|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153650162|NCT00012207|Aldesleukin|aldesleukin|mesh-list
153650297|NCT00028756|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153650602|NCT00030082|Immunologic Factors|immunologic factors|mesh-ancestor
153650717|NCT00030589|Bexarotene|bexarotene|mesh-list
153650820|NCT00012909|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153650901|NCT00031720|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
153651021|NCT00032110|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
153651246|NCT00000620|Chlorthalidone|chlorthalidone|mesh-list
153651247|NCT00000620|Diltiazem|diltiazem|mesh-list
153651248|NCT00000620|Benazepril|benazepril|mesh-list
153651396|NCT00033592|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
153651650|NCT00396487|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153651766|NCT00034801|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153651876|NCT00014235|Antitubercular Agents|antitubercular agents|mesh-ancestor
153651877|NCT00014235|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153651878|NCT00000710|Didanosine|didanosine|mesh-list
153651879|NCT00000710|Antimetabolites|antimetabolites|mesh-ancestor
153651883|NCT00000710|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153651991|NCT00014352|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153651992|NCT00014352|Tubulin Modulators|tubulin modulators|mesh-ancestor
153652105|NCT00035464|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153489188|NCT03179436|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153652221|NCT00035893|Poly I-C|poly i-c|mesh-list
153652325|NCT00000794|Protective Agents|protective agents|mesh-ancestor
153652431|NCT00000851|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153652550|NCT00037102|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153652665|NCT00037609|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153652666|NCT00037609|Analgesics|analgesics|mesh-ancestor
153652843|NCT00396721|Sirolimus|sirolimus|mesh-list
153652861|NCT00000965|Zidovudine|zidovudine|mesh-list
153652957|NCT05195242|Antiemetics|antiemetics|mesh-ancestor
153652958|NCT05195242|Autonomic Agents|autonomic agents|mesh-ancestor
153652959|NCT05195242|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153653061|NCT00001007|Antiviral Agents|antiviral agents|mesh-ancestor
153653062|NCT00001007|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153653148|NCT00001040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153653375|NCT00016263|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153653477|NCT00016380|Autonomic Agents|autonomic agents|mesh-ancestor
153653671|NCT00038935|Factor VIII|factor viii|mesh-list
153653786|NCT00039481|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153654009|NCT00040690|Protective Agents|protective agents|mesh-ancestor
153654112|NCT00041431|Hormones|hormones|mesh-list
153654200|NCT00001457|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153654201|NCT00001457|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153654295|NCT00042562|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153491436|NCT02767128|Anticoagulants|anticoagulants|mesh-ancestor
153654485|NCT00043342|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153654682|NCT00044473|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153654930|NCT00045448|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153655235|NCT00001766|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153655352|NCT00047242|7-hydroxystaurosporine|7-hydroxystaurosporine|mesh-list
153492352|NCT03308942|Niraparib|niraparib|mesh-list
153655490|NCT05641337|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
153655597|NCT00049114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153655598|NCT00049114|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153655600|NCT00049114|Alkylating Agents|alkylating agents|mesh-ancestor
153655704|NCT00049777|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153655827|NCT00050674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153655828|NCT00050713|Sirolimus|sirolimus|mesh-list
153655976|NCT00052000|Antibodies|antibodies|mesh-list
153656244|NCT00053833|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153656431|NCT00055120|Emtricitabine|emtricitabine|mesh-list
153656582|NCT00055978|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153656692|NCT05410197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153656787|NCT00058006|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153656878|NCT00058474|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153656879|NCT00058474|Antimetabolites|antimetabolites|mesh-ancestor
153656883|NCT00058474|Immunologic Factors|immunologic factors|mesh-ancestor
153656985|NCT00059878|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
153656986|NCT00059878|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153656987|NCT00059878|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153656988|NCT00059878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153656989|NCT00059878|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153656990|NCT00059878|Hormone Antagonists|hormone antagonists|mesh-ancestor
153656991|NCT00059878|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153656992|NCT00059878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153656993|NCT00059878|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
153656994|NCT00059917|Camptothecin|camptothecin|mesh-list
153656995|NCT00059917|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153657054|NCT00398515|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153657169|NCT00060931|Protective Agents|protective agents|mesh-ancestor
153657496|NCT06138132|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153657621|NCT05820763|Dexamethasone|dexamethasone|mesh-list
153657728|NCT05655013|Zoledronic Acid|zoledronic acid|mesh-list
153657729|NCT05655013|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153657897|NCT05279833|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153657898|NCT05279833|Sympatholytics|sympatholytics|mesh-ancestor
153657899|NCT05279833|Autonomic Agents|autonomic agents|mesh-ancestor
153657991|NCT05062356|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153658221|NCT04508400|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153658222|NCT04508400|Serotonin Agents|serotonin agents|mesh-ancestor
153658223|NCT04508400|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153658298|NCT04240054|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153658299|NCT04240054|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153658300|NCT04235114|Nimotuzumab|nimotuzumab|mesh-list
153658301|NCT04235114|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153658302|NCT04235114|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153495271|NCT00000282|Pemoline|pemoline|mesh-list
153658303|NCT04222504|Tenofovir|tenofovir|mesh-list
153658304|NCT04222504|Emtricitabine|emtricitabine|mesh-list
153658305|NCT04222504|Antiviral Agents|antiviral agents|mesh-ancestor
153658378|NCT04169828|Antiemetics|antiemetics|mesh-ancestor
153658379|NCT04169828|Autonomic Agents|autonomic agents|mesh-ancestor
153658476|NCT03698162|Growth Substances|growth substances|mesh-ancestor
153658477|NCT03698162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153658557|NCT03420521|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153753742|NCT00177567|Antidepressive Agents|antidepressive agents|mesh-ancestor
153590872|NCT01815892|Furosemide|furosemide|mesh-list
153754058|NCT00178035|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
153754059|NCT00178035|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153754060|NCT00178035|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153754061|NCT02904538|Dexamethasone|dexamethasone|mesh-list
153754062|NCT02904538|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153754063|NCT02904538|Antiemetics|antiemetics|mesh-ancestor
153591211|NCT01818648|Exenatide|exenatide|mesh-list
153754064|NCT02904538|Autonomic Agents|autonomic agents|mesh-ancestor
153754065|NCT02904538|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153754066|NCT02904538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153754067|NCT02904538|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153754114|NCT00553423|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153754115|NCT02904304|Ibuprofen|ibuprofen|mesh-list
153754116|NCT02904304|Phenylephrine|phenylephrine|mesh-list
153754117|NCT02904304|Oxymetazoline|oxymetazoline|mesh-list
153754118|NCT02904304|Desloratadine|desloratadine|mesh-list
153754119|NCT02904304|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153754120|NCT02904304|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153754121|NCT02904304|Analgesics|analgesics|mesh-ancestor
153754402|NCT05622201|Immunologic Factors|immunologic factors|mesh-ancestor
153754730|NCT03854370|Blood Substitutes|blood substitutes|mesh-ancestor
153754731|NCT03729349|Golimumab|golimumab|mesh-list
153754732|NCT03729349|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
153754733|NCT03729349|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153754734|NCT03729349|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153754735|NCT03729349|Immunologic Factors|immunologic factors|mesh-ancestor
153754737|NCT03535298|Interferons|interferons|mesh-list
153754814|NCT03215693|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153754815|NCT03215693|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153754816|NCT03215693|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153754817|NCT03215693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153754819|NCT03187106|Cephalexin|cephalexin|mesh-list
153754820|NCT03187106|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153754821|NCT03187106|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153754822|NCT03187106|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153754823|NCT03187106|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153754824|NCT03159702|Fludarabine|fludarabine|mesh-list
153754825|NCT03159702|Melphalan|melphalan|mesh-list
153754826|NCT03159702|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153754827|NCT03159702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153754881|NCT02222155|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153754972|NCT00168506|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-list
153754976|NCT00168506|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153755050|NCT02902432|Growth Substances|growth substances|mesh-ancestor
153755051|NCT02902432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153755182|NCT00169130|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153755183|NCT00169130|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153755277|NCT02898376|Vitamin E|vitamin e|mesh-list
153755365|NCT02897830|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153755366|NCT02897830|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153755463|NCT02896621|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153755464|NCT02896621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153755465|NCT02896621|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153755466|NCT02896621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153755467|NCT02896621|Vasodilator Agents|vasodilator agents|mesh-ancestor
153755468|NCT02896621|Diuretics|diuretics|mesh-ancestor
153755469|NCT02896621|Natriuretic Agents|natriuretic agents|mesh-ancestor
153755470|NCT02896621|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
153755471|NCT02896621|Acid Sensing Ion Channel Blockers|acid sensing ion channel blockers|mesh-ancestor
153755472|NCT02896621|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153755540|NCT00169988|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
153755541|NCT00169988|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153755542|NCT00169988|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153755544|NCT02895529|Caspofungin|caspofungin|mesh-list
153755545|NCT02895529|Antifungal Agents|antifungal agents|mesh-ancestor
153755546|NCT02895529|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153755547|NCT02895529|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
153755549|NCT02895529|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153755617|NCT05423821|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153755618|NCT05423821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153755619|NCT00170378|Enoxaparin|enoxaparin|mesh-list
153755620|NCT00170378|Anticoagulants|anticoagulants|mesh-ancestor
153755621|NCT00170378|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153755622|NCT00170378|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153755623|NCT00170378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153755624|NCT00179244|Bupropion|bupropion|mesh-list
153755625|NCT00179244|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
153755626|NCT00179244|Antidepressive Agents|antidepressive agents|mesh-ancestor
153755627|NCT00179244|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153755628|NCT00179244|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
153755629|NCT00179244|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153755630|NCT00179244|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153755632|NCT00179244|Dopamine Agents|dopamine agents|mesh-ancestor
153755685|NCT05420350|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
153755686|NCT05420350|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153755687|NCT05420350|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153755688|NCT05420350|Anticonvulsants|anticonvulsants|mesh-ancestor
153755689|NCT05420350|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153755690|NCT05420350|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153755691|NCT05420350|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153755692|NCT05420350|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153755693|NCT05420350|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153755709|NCT02885272|Deoxyglucose|deoxyglucose|mesh-list
153755760|NCT00170768|Autonomic Agents|autonomic agents|mesh-ancestor
153755806|NCT00170924|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
153755807|NCT00170924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153755808|NCT01356940|4-Aminopyridine|4-aminopyridine|mesh-list
153755817|NCT00170963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153755818|NCT00170963|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153755819|NCT00170963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153755820|NCT00170963|Vasodilator Agents|vasodilator agents|mesh-ancestor
153755821|NCT00170963|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
153755822|NCT00170963|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
153755824|NCT02492776|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
153755825|NCT02492776|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153755826|NCT02492776|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
153755827|NCT02492776|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153755828|NCT02492776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153755829|NCT00171041|Valsartan|valsartan|mesh-list
153755830|NCT00171041|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153755831|NCT00171041|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
153755832|NCT00171041|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
153755833|NCT00171041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153755834|NCT05392699|Interleukin-12|interleukin-12|mesh-list
153755835|NCT05392699|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153755836|NCT05392699|Immunologic Factors|immunologic factors|mesh-ancestor
153755837|NCT05392699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153755838|NCT05392699|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153755839|NCT05392699|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153755840|NCT05392699|Growth Substances|growth substances|mesh-ancestor
153755841|NCT05392699|Growth Inhibitors|growth inhibitors|mesh-ancestor
153755847|NCT00171080|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
153755849|NCT02229877|Omeprazole|omeprazole|mesh-list
153755972|NCT00197340|Anesthetics|anesthetics|mesh-ancestor
153755973|NCT00197340|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153755974|NCT00197340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153755975|NCT00197340|Sensory System Agents|sensory system agents|mesh-ancestor
153755976|NCT00197340|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153755978|NCT00171587|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153755979|NCT00171587|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153755980|NCT00171587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153755982|NCT00171626|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153756058|NCT00197418|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
153756059|NCT00171821|Deferasirox|deferasirox|mesh-list
153756060|NCT00171821|Iron Chelating Agents|iron chelating agents|mesh-ancestor
153756061|NCT00171821|Chelating Agents|chelating agents|mesh-ancestor
153756062|NCT00171821|Sequestering Agents|sequestering agents|mesh-ancestor
153756063|NCT00171821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153756064|NCT05054023|Piroxicam|piroxicam|mesh-list
153756065|NCT05054023|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153756066|NCT05054023|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153756176|NCT00197613|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
153756178|NCT00180024|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153756179|NCT00180024|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
153756180|NCT00180024|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
153756181|NCT00180024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153756182|NCT00172055|Zoledronic Acid|zoledronic acid|mesh-list
153756183|NCT00172055|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153756184|NCT00172055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153756185|NCT04934449|Salicylic Acid|salicylic acid|mesh-list
153756186|NCT04934449|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153756187|NCT04934449|Antifungal Agents|antifungal agents|mesh-ancestor
153756188|NCT04934449|Keratolytic Agents|keratolytic agents|mesh-ancestor
153756189|NCT04934449|Dermatologic Agents|dermatologic agents|mesh-ancestor
153756190|NCT03455179|Methamphetamine|methamphetamine|mesh-list
153756192|NCT03455179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153756198|NCT03455179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153756199|NCT03455179|Adrenergic Agents|adrenergic agents|mesh-ancestor
153756200|NCT03455179|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
153756201|NCT03455179|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153756203|NCT03455179|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
153756230|NCT00172172|Parathyroid Hormone|parathyroid hormone|mesh-list
153756231|NCT00172172|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153756232|NCT00172172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153756233|NCT02908711|Ropivacaine|ropivacaine|mesh-list
153756234|NCT02908711|Anesthetics, Local|anesthetics, local|mesh-ancestor
153756235|NCT02908711|Anesthetics|anesthetics|mesh-ancestor
153756236|NCT02908711|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153756237|NCT02908711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153756322|NCT00198120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153756324|NCT00198159|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153756325|NCT00198159|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153756326|NCT00198159|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153756327|NCT00198159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153756328|NCT00198159|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153756329|NCT02907307|Clotrimazole|clotrimazole|mesh-list
153756330|NCT02907307|Miconazole|miconazole|mesh-list
153756494|NCT00203073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153756698|NCT00410631|Topotecan|topotecan|mesh-list
153756786|NCT00198627|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153756886|NCT00407849|Immunologic Factors|immunologic factors|mesh-ancestor
153756987|NCT01756339|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153756988|NCT01756339|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153757063|NCT00203736|Antimalarials|antimalarials|mesh-ancestor
153757159|NCT00174473|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153757160|NCT00174473|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
153757161|NCT00174473|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153757162|NCT00174473|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153757163|NCT00174473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153757164|NCT00174473|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153757165|NCT00174473|Hormone Antagonists|hormone antagonists|mesh-ancestor
153650745|NCT00030784|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153650746|NCT00030784|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153650749|NCT00030784|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153757166|NCT00174473|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153757389|NCT00712582|Analgesics|analgesics|mesh-ancestor
153757641|NCT00175643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153757878|NCT00176618|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153757952|NCT00554242|Vitamins|vitamins|mesh-ancestor
153757953|NCT00554242|Micronutrients|micronutrients|mesh-ancestor
153757954|NCT00554242|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153757955|NCT00554242|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153757956|NCT00176735|Capecitabine|capecitabine|mesh-list
153757957|NCT00176735|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153757958|NCT00176735|Antimetabolites|antimetabolites|mesh-ancestor
153757959|NCT00176735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153757960|NCT00176735|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153757961|NCT00410943|Hydromorphone|hydromorphone|mesh-list
153757962|NCT00410943|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153757963|NCT00410943|Narcotics|narcotics|mesh-ancestor
153758010|NCT00410982|Immunologic Factors|immunologic factors|mesh-ancestor
153758011|NCT00410982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153758012|NCT00410982|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153758013|NCT00410982|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153758015|NCT00410982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153758016|NCT00410982|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153758017|NCT00410982|Alkylating Agents|alkylating agents|mesh-ancestor
153758018|NCT00410982|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153758020|NCT02372578|Pregabalin|pregabalin|mesh-list
153758079|NCT02335918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153758166|NCT04677985|Sensory System Agents|sensory system agents|mesh-ancestor
153758176|NCT00554632|Ortho Evra|ortho evra|mesh-list
153816187|NCT00352313|Carboplatin|carboplatin|mesh-list
153816188|NCT00352313|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153758490|NCT00200694|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
153758491|NCT00200694|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153758492|NCT00200694|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
153758494|NCT00200694|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153758495|NCT00557713|Bevacizumab|bevacizumab|mesh-list
153758496|NCT00557713|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153758497|NCT00557713|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153758498|NCT00557713|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153758499|NCT00557713|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153758516|NCT00178100|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153758597|NCT00205725|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153758658|NCT00206154|Hormones|hormones|mesh-ancestor
153758659|NCT00206154|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153758660|NCT00206154|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
153758661|NCT00206154|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
153758662|NCT00206154|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153758663|NCT00206154|Adrenergic Agents|adrenergic agents|mesh-ancestor
153758664|NCT00206154|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153758665|NCT00206154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153759068|NCT00179699|Immunologic Factors|immunologic factors|mesh-ancestor
153759573|NCT00578149|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153759574|NCT00578149|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153759863|NCT04576975|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
153760025|NCT00187746|Adefovir|adefovir|mesh-list
153760146|NCT00584662|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
153760147|NCT00584662|Mydriatics|mydriatics|mesh-ancestor
153760148|NCT00584662|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
153760149|NCT00584662|Protective Agents|protective agents|mesh-ancestor
153760151|NCT00584779|Analgesics|analgesics|mesh-ancestor
153650800|NCT00031057|Vitamin B Complex|vitamin b complex|mesh-ancestor
153650801|NCT00031057|Vitamins|vitamins|mesh-ancestor
153650802|NCT00031057|Micronutrients|micronutrients|mesh-ancestor
153650803|NCT00031057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153650804|NCT00031057|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
153650805|NCT00031057|Dermatologic Agents|dermatologic agents|mesh-ancestor
153760152|NCT00584779|Sensory System Agents|sensory system agents|mesh-ancestor
153760153|NCT00584779|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153760154|NCT00584779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153760479|NCT00588133|Hemostatics|hemostatics|mesh-ancestor
153760512|NCT00209742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153760513|NCT00209742|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153760644|NCT00588913|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153760645|NCT00588913|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153760646|NCT00588913|Antiviral Agents|antiviral agents|mesh-ancestor
153760647|NCT00588913|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153760648|NCT00588913|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153760649|NCT00588913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153760650|NCT00182741|Calcitriol|calcitriol|mesh-list
153760651|NCT00182741|Prednisone|prednisone|mesh-list
153760652|NCT00182741|Mitoxantrone|mitoxantrone|mesh-list
153760653|NCT00182741|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153760654|NCT00182741|Glucocorticoids|glucocorticoids|mesh-ancestor
153760655|NCT00182741|Hormones|hormones|mesh-ancestor
153760656|NCT00182741|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153760657|NCT00182741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153760658|NCT00182741|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153760809|NCT00590785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153761056|NCT00408785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153761422|NCT00185159|Olmesartan|olmesartan|mesh-list
153762017|NCT00212589|Folic Acid|folic acid|mesh-list
153762748|NCT06116240|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153763042|NCT06317870|Narcotics|narcotics|mesh-ancestor
153763263|NCT06316570|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153763514|NCT06200467|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153763778|NCT06059391|Vaccines|vaccines|mesh-list
153763779|NCT06059391|Lenograstim|lenograstim|mesh-list
153763780|NCT06059391|Immunologic Factors|immunologic factors|mesh-ancestor
153763783|NCT06050252|Cisplatin|cisplatin|mesh-list
153764161|NCT05679401|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153764162|NCT05661552|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
153764403|NCT05321602|Paliperidone Palmitate|paliperidone palmitate|mesh-list
153764450|NCT05265299|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153764453|NCT05203172|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153764454|NCT05203172|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153764455|NCT05202353|Semaglutide|semaglutide|mesh-list
153764456|NCT05202353|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
153764457|NCT05202353|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153764458|NCT05202353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153764459|NCT05179421|Oxytocin|oxytocin|mesh-list
153764460|NCT05179421|Oxytocics|oxytocics|mesh-ancestor
153764461|NCT05179421|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153764462|NCT05179421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153764463|NCT05170334|Belinostat|belinostat|mesh-list
153764464|NCT05170334|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153764466|NCT05170334|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153764509|NCT05078866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153764511|NCT05070403|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153764512|NCT05070403|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153764550|NCT05014282|Autonomic Agents|autonomic agents|mesh-ancestor
153764736|NCT04614311|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
153764971|NCT04336189|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153765791|NCT04677114|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153765792|NCT04677114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153766158|NCT02595866|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153766855|NCT00221871|Anesthetics, General|anesthetics, general|mesh-ancestor
153457585|NCT01381692|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153457586|NCT01381692|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153457587|NCT01381692|Glucocorticoids|glucocorticoids|mesh-ancestor
153767443|NCT00409643|Amlodipine|amlodipine|mesh-list
153767940|NCT00206778|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153768228|NCT00195299|Sirolimus|sirolimus|mesh-list
153768229|NCT00195299|Temsirolimus|temsirolimus|mesh-list
153769069|NCT00208533|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
153769293|NCT00227136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153769294|NCT00227136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153769295|NCT00203957|Istradefylline|istradefylline|mesh-list
153769296|NCT00203957|Adenosine A2 Receptor Antagonists|adenosine a2 receptor antagonists|mesh-ancestor
153769812|NCT00478426|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153769813|NCT00478426|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153770012|NCT00232089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153770013|NCT00232089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153770014|NCT00205166|Caffeine|caffeine|mesh-list
153770015|NCT00205166|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
153770016|NCT00205166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153770017|NCT00205166|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
153770018|NCT00205166|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153770020|NCT00205166|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
153770243|NCT00206219|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153770494|NCT00233025|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153770538|NCT00207779|Heparin|heparin|mesh-list
153770775|NCT01084603|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153770825|NCT00237393|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153771097|NCT00234390|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153771098|NCT00234390|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153771099|NCT00234390|Autonomic Agents|autonomic agents|mesh-ancestor
153771100|NCT00234390|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153771101|NCT00234390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153771102|NCT00234390|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153771118|NCT00209612|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153771119|NCT00209612|Tubulin Modulators|tubulin modulators|mesh-ancestor
153771120|NCT00209612|Antimitotic Agents|antimitotic agents|mesh-ancestor
153771121|NCT00209612|Mitosis Modulators|mitosis modulators|mesh-ancestor
153771187|NCT01081132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153771189|NCT00234468|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153771190|NCT00234468|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153771191|NCT00234468|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153771192|NCT00234468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153771193|NCT00234468|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153771194|NCT01080625|Phenylephrine|phenylephrine|mesh-list
153771195|NCT01080625|Epinephrine|epinephrine|mesh-list
153771196|NCT01080625|Oxymetazoline|oxymetazoline|mesh-list
153771197|NCT01080625|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153771198|NCT01080625|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153771199|NCT01080625|Adrenergic Agents|adrenergic agents|mesh-ancestor
153771200|NCT01080625|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153771201|NCT01080625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153771202|NCT01080625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153771203|NCT01080625|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
153771204|NCT01080625|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153771305|NCT01086748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153771306|NCT01086748|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153771307|NCT01086748|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153771308|NCT01086748|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153771309|NCT01086748|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153771310|NCT01086748|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
153771311|NCT01086748|Dopamine Agents|dopamine agents|mesh-ancestor
153771313|NCT00237705|Antiemetics|antiemetics|mesh-ancestor
153771314|NCT00237705|Autonomic Agents|autonomic agents|mesh-ancestor
153771315|NCT00237705|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153771316|NCT00237705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153771317|NCT00237705|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153781972|NCT04557397|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
153781973|NCT04557397|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
153781974|NCT04557397|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
153781975|NCT04557202|Tamsulosin|tamsulosin|mesh-list
153781976|NCT04557202|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
153781977|NCT04557202|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
153781978|NCT04557202|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
153781979|NCT04557202|Adrenergic Agents|adrenergic agents|mesh-ancestor
153771323|NCT00209885|Lidocaine|lidocaine|mesh-list
153771324|NCT00209885|Droperidol|droperidol|mesh-list
153771325|NCT00209885|Ketamine|ketamine|mesh-list
153771326|NCT00209885|Gabapentin|gabapentin|mesh-list
153771327|NCT00209885|Esketamine|esketamine|mesh-list
153771328|NCT00209885|Anesthetics, Local|anesthetics, local|mesh-ancestor
153771329|NCT00209885|Anesthetics|anesthetics|mesh-ancestor
153771371|NCT00209924|Gaboxadol|gaboxadol|mesh-list
153771372|NCT00209924|Analgesics|analgesics|mesh-ancestor
153771373|NCT00209924|Sensory System Agents|sensory system agents|mesh-ancestor
153771374|NCT00209924|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153771375|NCT00209924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153771425|NCT04991662|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153771426|NCT04991662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153771427|NCT04991662|Sympathomimetics|sympathomimetics|mesh-ancestor
153771428|NCT04991662|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
153771429|NCT04991662|Nasal Decongestants|nasal decongestants|mesh-ancestor
153771430|NCT04991662|Respiratory System Agents|respiratory system agents|mesh-ancestor
153771431|NCT04991662|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
153771432|NCT04991662|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153771433|NCT04991662|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153771434|NCT04991662|Adrenergic Agents|adrenergic agents|mesh-ancestor
153771487|NCT00210314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153771488|NCT00210314|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153771489|NCT00210314|Antimetabolites|antimetabolites|mesh-ancestor
153771490|NCT00210314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153771491|NCT00210314|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153771492|NCT00210314|Dermatologic Agents|dermatologic agents|mesh-ancestor
153771493|NCT00210314|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153771494|NCT00210314|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153771495|NCT00210314|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153771496|NCT00210314|Immunologic Factors|immunologic factors|mesh-ancestor
153771497|NCT00210314|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153771498|NCT00210314|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153771499|NCT00210314|Antiviral Agents|antiviral agents|mesh-ancestor
153771557|NCT00210548|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
153771988|NCT00238407|Tubulin Modulators|tubulin modulators|mesh-ancestor
153772225|NCT00238953|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
153772226|NCT00238953|Antitubercular Agents|antitubercular agents|mesh-ancestor
153772539|NCT00222573|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
153772735|NCT00214058|Carboplatin|carboplatin|mesh-list
153772736|NCT00214058|Docetaxel|docetaxel|mesh-list
153773013|NCT00240747|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153773014|NCT00240747|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
153816255|NCT00352859|Sorafenib|sorafenib|mesh-list
153816256|NCT00352859|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153816257|NCT00352859|Antimetabolites|antimetabolites|mesh-ancestor
153816258|NCT00352859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153773015|NCT00240747|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153773017|NCT00215384|Formoterol Fumarate|formoterol fumarate|mesh-list
153773254|NCT00240942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153773474|NCT00244959|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153773475|NCT00244959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153773477|NCT00244998|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153773478|NCT00244998|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153773479|NCT00244998|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
153773480|NCT00244998|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
153773481|NCT00244998|Hormone Antagonists|hormone antagonists|mesh-ancestor
153773482|NCT00244998|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153773483|NCT00244998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153773532|NCT00216632|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153773533|NCT00216632|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153773534|NCT00216632|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
153773535|NCT00216632|Dopamine Agents|dopamine agents|mesh-ancestor
153773536|NCT04662736|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
153773537|NCT04662736|Tedizolid|tedizolid|mesh-list
153773538|NCT04662736|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153773603|NCT00557206|Docetaxel|docetaxel|mesh-list
153773604|NCT00557206|Oxaliplatin|oxaliplatin|mesh-list
153773605|NCT00557206|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153773606|NCT00557206|Tubulin Modulators|tubulin modulators|mesh-ancestor
153773607|NCT00557206|Antimitotic Agents|antimitotic agents|mesh-ancestor
153773608|NCT00557206|Mitosis Modulators|mitosis modulators|mesh-ancestor
153773609|NCT00557206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153773610|NCT00241371|Clofarabine|clofarabine|mesh-list
153773611|NCT00241371|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153773727|NCT00558220|Immunologic Factors|immunologic factors|mesh-ancestor
153773728|NCT00558220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153773729|NCT00217295|Topiramate|topiramate|mesh-list
153773730|NCT00217295|Anticonvulsants|anticonvulsants|mesh-ancestor
153773731|NCT00217295|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153773732|NCT00217295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153773898|NCT04645303|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153773899|NCT04645303|Viscosupplements|viscosupplements|mesh-ancestor
153773900|NCT04645303|Protective Agents|protective agents|mesh-ancestor
153773901|NCT00217607|Paclitaxel|paclitaxel|mesh-list
153773902|NCT00217607|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153773903|NCT00217607|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153774123|NCT00218621|Narcotics|narcotics|mesh-ancestor
153774126|NCT00218621|Analgesics|analgesics|mesh-ancestor
153774277|NCT00246363|Silymarin|silymarin|mesh-list
153774478|NCT04626193|Amoxicillin|amoxicillin|mesh-list
153774771|NCT00220298|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
153775071|NCT04616872|Antimetabolites|antimetabolites|mesh-ancestor
153775072|NCT04616872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153775073|NCT04616872|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153775074|NCT04616872|Dermatologic Agents|dermatologic agents|mesh-ancestor
153775382|NCT06167057|Alkylating Agents|alkylating agents|mesh-ancestor
153775675|NCT05221645|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153775978|NCT04283604|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
153775979|NCT04283604|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153776035|NCT04144933|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153776036|NCT04144933|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153776037|NCT04144933|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153776038|NCT04144933|Antimanic Agents|antimanic agents|mesh-ancestor
153776039|NCT04144933|Antipruritics|antipruritics|mesh-ancestor
153776040|NCT04144933|Dermatologic Agents|dermatologic agents|mesh-ancestor
153776041|NCT04144933|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
153776042|NCT04144933|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153776043|NCT04144933|Serotonin Agents|serotonin agents|mesh-ancestor
153776044|NCT04144933|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153776045|NCT04144933|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153776046|NCT04144933|Tocolytic Agents|tocolytic agents|mesh-ancestor
153776103|NCT03949855|Immunologic Factors|immunologic factors|mesh-ancestor
153776104|NCT03949855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153776105|NCT03949855|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153776106|NCT03949855|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153776107|NCT03920267|Deucravacitinib|deucravacitinib|mesh-list
153776108|NCT03920267|Dermatologic Agents|dermatologic agents|mesh-ancestor
153776109|NCT03920267|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153650984|NCT00031954|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153650985|NCT00031954|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153650986|NCT00031954|Tubulin Modulators|tubulin modulators|mesh-ancestor
153776171|NCT03770416|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153776172|NCT03770416|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153776174|NCT03631043|Vaccines|vaccines|mesh-list
153776175|NCT03631043|Immunologic Factors|immunologic factors|mesh-ancestor
153776176|NCT03631043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153776177|NCT03631043|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153776182|NCT03609580|Tamsulosin|tamsulosin|mesh-list
153776322|NCT03069638|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153776323|NCT03069638|Analgesics|analgesics|mesh-ancestor
153776324|NCT03069638|Sensory System Agents|sensory system agents|mesh-ancestor
153776325|NCT03069638|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153776326|NCT03069638|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
153776362|NCT02910531|Vitamin B Complex|vitamin b complex|mesh-ancestor
153776363|NCT02910531|Vitamins|vitamins|mesh-ancestor
153776364|NCT02910531|Micronutrients|micronutrients|mesh-ancestor
153776365|NCT02883062|Paclitaxel|paclitaxel|mesh-list
153776366|NCT02883062|Carboplatin|carboplatin|mesh-list
153776367|NCT02883062|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
153776368|NCT02883062|Atezolizumab|atezolizumab|mesh-list
153776433|NCT02626338|Idarubicin|idarubicin|mesh-list
153776622|NCT01674140|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
153776626|NCT01674140|Fertility Agents|fertility agents|mesh-ancestor
153777722|NCT00414921|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153777727|NCT00414921|Analgesics|analgesics|mesh-ancestor
153778130|NCT00253305|Naftifine|naftifine|mesh-list
153778316|NCT04587115|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153778317|NCT04587115|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
153778318|NCT04587115|Dopamine Agents|dopamine agents|mesh-ancestor
153779065|NCT00571246|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153779066|NCT00254631|Oxycodone|oxycodone|mesh-list
153779067|NCT00254631|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153779068|NCT00254631|Narcotics|narcotics|mesh-ancestor
153779069|NCT00254631|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153779070|NCT00254631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153779071|NCT00254631|Analgesics|analgesics|mesh-ancestor
153779074|NCT00571285|Vitamin D|vitamin d|mesh-list
153779378|NCT00573547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153779379|NCT00573547|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
153779380|NCT00573547|Antidepressive Agents|antidepressive agents|mesh-ancestor
153779381|NCT00573547|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153779382|NCT00573547|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
153779385|NCT00573664|Gabapentin|gabapentin|mesh-list
153779402|NCT00573742|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153779403|NCT00573742|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
153779404|NCT00573742|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
153779405|NCT00573742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153779407|NCT00254865|Norelgestromin|norelgestromin|mesh-list
153779408|NCT00254865|Contraceptive Agents|contraceptive agents|mesh-list
153779409|NCT00254865|Estradiol|estradiol|mesh-list
153779410|NCT00254865|Estrogens|estrogens|mesh-ancestor
153779411|NCT00254865|Hormones|hormones|mesh-ancestor
153779412|NCT00254865|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153779961|NCT00226694|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153779962|NCT00255996|Linezolid|linezolid|mesh-list
153779963|NCT00255996|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153780010|NCT00227357|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
153780011|NCT00227357|Naloxone|naloxone|mesh-list
153780012|NCT00227357|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153780013|NCT00227357|Narcotics|narcotics|mesh-ancestor
153780014|NCT00227357|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153780015|NCT00227357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153780016|NCT00227357|Analgesics|analgesics|mesh-ancestor
153780017|NCT00227357|Sensory System Agents|sensory system agents|mesh-ancestor
153780019|NCT00227357|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
153780181|NCT00256542|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153780403|NCT00414024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153780404|NCT00256893|Ropinirole|ropinirole|mesh-list
153780405|NCT00256893|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
153780406|NCT00256893|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
153780407|NCT00256893|Dopamine Agonists|dopamine agonists|mesh-ancestor
153650992|NCT00031993|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
153650993|NCT00031993|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153679837|NCT00211120|Hematinics|hematinics|mesh-ancestor
153780408|NCT00256893|Dopamine Agents|dopamine agents|mesh-ancestor
153780409|NCT00256893|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153780410|NCT00256893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153780411|NCT00256893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153780412|NCT00229385|Ziprasidone|ziprasidone|mesh-list
153780413|NCT00229385|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153780414|NCT00229385|Serotonin Agents|serotonin agents|mesh-ancestor
153780415|NCT00229385|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153780416|NCT00229385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153780450|NCT00236223|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153780451|NCT00236223|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153780452|NCT00236223|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153780453|NCT00236223|Antimanic Agents|antimanic agents|mesh-ancestor
153780454|NCT00229424|Famotidine|famotidine|mesh-list
153780455|NCT00229424|Lafutidine|lafutidine|mesh-list
153780456|NCT00229424|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
153780457|NCT00229424|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153780458|NCT00229424|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
153780459|NCT00229424|Histamine Antagonists|histamine antagonists|mesh-ancestor
153780460|NCT00229424|Histamine Agents|histamine agents|mesh-ancestor
153780461|NCT00229424|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153780464|NCT00256932|Alvimopan|alvimopan|mesh-list
153780515|NCT00229697|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
153617701|NCT04883749|Acalabrutinib|acalabrutinib|mesh-list
153780516|NCT00229697|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
153780517|NCT00229697|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153780584|NCT00236457|Dopamine Agents|dopamine agents|mesh-ancestor
153780586|NCT00236496|Anticonvulsants|anticonvulsants|mesh-ancestor
153780587|NCT00236496|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153780588|NCT00236496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153780589|NCT00199277|Iron|iron|mesh-list
153780590|NCT00199277|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
153780750|NCT00236730|Anticonvulsants|anticonvulsants|mesh-ancestor
153780892|NCT00257751|Protease Inhibitors|protease inhibitors|mesh-ancestor
153780893|NCT00257751|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153780894|NCT00257751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153780895|NCT00179413|Interferons|interferons|mesh-list
153781023|NCT00200525|Emetics|emetics|mesh-ancestor
153781123|NCT00258336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153781124|NCT00258336|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153781125|NCT00171925|Vitamin D|vitamin d|mesh-list
153781127|NCT00171925|Calcium|calcium|mesh-list
153781221|NCT00201695|Arsenic Trioxide|arsenic trioxide|mesh-list
153781320|NCT00258843|Vaccines|vaccines|mesh-list
153781425|NCT00476554|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153457635|NCT01380990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153457656|NCT00214968|Modafinil|modafinil|mesh-list
153566786|NCT06233266|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153566787|NCT06233266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153566788|NCT06233266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153566789|NCT06233240|Metformin|metformin|mesh-list
153457674|NCT03592212|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153457675|NCT03592212|Adrenergic Agents|adrenergic agents|mesh-ancestor
153457676|NCT03592212|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153566790|NCT06233240|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
153566791|NCT06233240|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153566793|NCT06233240|Incretins|incretins|mesh-ancestor
153566888|NCT06233032|Sympathomimetics|sympathomimetics|mesh-ancestor
153566889|NCT06233032|Autonomic Agents|autonomic agents|mesh-ancestor
153566890|NCT06233032|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
153566891|NCT06233019|Salicylic Acid|salicylic acid|mesh-list
153566892|NCT06233019|Salicylates|salicylates|mesh-list
153566893|NCT06233019|Glycolic acid|glycolic acid|mesh-list
153566894|NCT06233019|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153566949|NCT06232694|Antiviral Agents|antiviral agents|mesh-ancestor
153566950|NCT06232694|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153566951|NCT06232694|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153566952|NCT06232694|Immunologic Factors|immunologic factors|mesh-ancestor
153566953|NCT06232694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153566954|NCT06232694|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153566955|NCT06232694|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153566956|NCT06232694|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153566957|NCT06232694|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153566958|NCT06232642|Iron|iron|mesh-list
153566959|NCT06232642|Hydroxocobalamin|hydroxocobalamin|mesh-list
153566960|NCT06232642|Vitamin B 12|vitamin b 12|mesh-list
153816347|NCT00353561|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153567089|NCT06080399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153567154|NCT05902169|Lomustine|lomustine|mesh-list
153567194|NCT05840952|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153567250|NCT05773664|Hormones|hormones|mesh-ancestor
153567251|NCT05773664|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153567252|NCT05773664|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153567253|NCT05773664|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153567254|NCT05773664|Protease Inhibitors|protease inhibitors|mesh-ancestor
153567255|NCT05773664|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153567256|NCT05773664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153567257|NCT05773664|Dermatologic Agents|dermatologic agents|mesh-ancestor
153567258|NCT05773053|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
153567259|NCT05773053|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
153567260|NCT05773053|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
153567261|NCT05773053|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153567262|NCT05773053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153567263|NCT05773053|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
153567264|NCT05773053|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153567265|NCT05773053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153567266|NCT05773053|Cholinergic Agents|cholinergic agents|mesh-ancestor
153567267|NCT05773053|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153567268|NCT05746039|Semaglutide|semaglutide|mesh-list
153567270|NCT05746039|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153781600|NCT00231023|Immunologic Factors|immunologic factors|mesh-ancestor
153567368|NCT05640778|Aromatase Inhibitors|aromatase inhibitors|mesh-list
153567369|NCT05640778|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153567521|NCT05388669|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153567523|NCT05388669|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153567824|NCT04870203|Adalimumab|adalimumab|mesh-list
153567925|NCT04682366|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153568180|NCT04245085|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153568372|NCT03508232|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153568726|NCT01680549|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153568819|NCT00401167|Dopamine Agents|dopamine agents|mesh-ancestor
153569248|NCT04339062|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153569379|NCT03511118|Bupropion|bupropion|mesh-list
153569380|NCT03511118|Sertraline|sertraline|mesh-list
153569474|NCT03511118|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
153569476|NCT03445858|Decitabine|decitabine|mesh-list
153569477|NCT03445858|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153569478|NCT03445858|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153569479|NCT03445858|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153569480|NCT03445858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153569481|NCT03445858|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153569482|NCT03445858|Antimetabolites|antimetabolites|mesh-ancestor
153816436|NCT00458328|Z 338|z 338|mesh-list
153569549|NCT03120780|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153569550|NCT03120780|Narcotics|narcotics|mesh-ancestor
153569551|NCT03120780|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153569681|NCT02306954|Antiviral Agents|antiviral agents|mesh-ancestor
153569774|NCT01686386|Dexamethasone|dexamethasone|mesh-list
153569891|NCT01690221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153570031|NCT01690598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153570032|NCT01690598|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153570033|NCT01690598|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
153570034|NCT01690637|Oseltamivir|oseltamivir|mesh-list
153570035|NCT01690637|Antiviral Agents|antiviral agents|mesh-ancestor
153570108|NCT01690884|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153651003|NCT00000575|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153570109|NCT01690884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153570111|NCT01690962|Hydroxocobalamin|hydroxocobalamin|mesh-list
153570112|NCT01690962|Vitamin B 12|vitamin b 12|mesh-list
153570255|NCT01692210|Analgesics|analgesics|mesh-ancestor
153570299|NCT01692808|Ergocalciferols|ergocalciferols|mesh-list
153570300|NCT01692808|Cholecalciferol|cholecalciferol|mesh-list
153570301|NCT01692808|Vitamins|vitamins|mesh-list
153570302|NCT01692808|Micronutrients|micronutrients|mesh-ancestor
153570561|NCT05291052|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153816501|NCT00458523|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153570670|NCT05291793|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153570671|NCT05291793|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153570672|NCT05291793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153570689|NCT05294887|Autonomic Agents|autonomic agents|mesh-ancestor
153570690|NCT05294887|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153570691|NCT05294887|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
153570692|NCT05294887|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153570693|NCT05294887|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153570694|NCT05294887|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153570695|NCT05294887|Vasodilator Agents|vasodilator agents|mesh-ancestor
153570696|NCT05294822|Insulin|insulin|mesh-list
153570755|NCT05294393|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153570756|NCT05293977|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
153570757|NCT05293977|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153570758|NCT05293704|Mizoribine|mizoribine|mesh-list
153570760|NCT05293704|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153816553|NCT00458718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153816555|NCT00458718|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153816557|NCT00467181|Fenoldopam|fenoldopam|mesh-list
153570883|NCT05267938|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
153571027|NCT05189444|Antacids|antacids|mesh-ancestor
153571126|NCT04975802|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153816599|NCT00426023|Dermatologic Agents|dermatologic agents|mesh-ancestor
153571166|NCT04871425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153571326|NCT04464577|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
153458007|NCT03591744|Autonomic Agents|autonomic agents|mesh-ancestor
153458008|NCT03591744|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153458009|NCT03591744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153458010|NCT03591744|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153458011|NCT03591744|Glucocorticoids|glucocorticoids|mesh-ancestor
153458012|NCT03591744|Hormones|hormones|mesh-ancestor
153458013|NCT03591744|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153571584|NCT05801900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153571585|NCT05801900|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153458040|NCT04196946|Anesthetics|anesthetics|mesh-ancestor
153458041|NCT03023904|Nivolumab|nivolumab|mesh-list
153458042|NCT03023904|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153458043|NCT03023904|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153458044|NCT03023904|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153458045|NCT03023904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153571682|NCT05800197|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153571775|NCT05611229|Pembrolizumab|pembrolizumab|mesh-list
153571807|NCT05521984|Dapagliflozin|dapagliflozin|mesh-list
153571808|NCT05521984|Carmustine|carmustine|mesh-list
153571809|NCT05521984|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
153571810|NCT05521984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153458088|NCT04194684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153458089|NCT04194294|Lidocaine|lidocaine|mesh-list
153458090|NCT04194294|Anesthetics, Local|anesthetics, local|mesh-ancestor
153458091|NCT04194294|Anesthetics|anesthetics|mesh-ancestor
153571882|NCT05003648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153571883|NCT05003648|Protective Agents|protective agents|mesh-ancestor
153571884|NCT05003648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153571885|NCT05003648|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
153571886|NCT05003648|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
153571931|NCT04717908|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
153816732|NCT03271905|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153816733|NCT03271905|Autonomic Agents|autonomic agents|mesh-ancestor
153816734|NCT03271905|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153816735|NCT03271905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153816736|NCT03271905|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153816737|NCT03271905|Respiratory System Agents|respiratory system agents|mesh-ancestor
153816738|NCT03271905|Tocolytic Agents|tocolytic agents|mesh-ancestor
153572034|NCT03769285|Niacinamide|niacinamide|mesh-list
153572235|NCT01819064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153458102|NCT04029090|Free Radical Scavengers|free radical scavengers|mesh-ancestor
153458103|NCT04029090|Antioxidants|antioxidants|mesh-ancestor
153458104|NCT04029090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153458105|NCT04029090|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
153458106|NCT04029090|Protective Agents|protective agents|mesh-ancestor
153458107|NCT04029090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153458108|NCT04193982|Vitamin E|vitamin e|mesh-list
153458109|NCT04193982|Vitamins|vitamins|mesh-ancestor
153458110|NCT04193982|Micronutrients|micronutrients|mesh-ancestor
153458111|NCT04193982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153572424|NCT03651102|Immunologic Factors|immunologic factors|mesh-ancestor
153572425|NCT03651102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153572426|NCT03651102|Leprostatic Agents|leprostatic agents|mesh-ancestor
153572427|NCT03651102|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153572428|NCT03651102|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153572429|NCT03651102|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153572430|NCT03651102|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153572431|NCT03651102|Growth Substances|growth substances|mesh-ancestor
153572432|NCT03651102|Growth Inhibitors|growth inhibitors|mesh-ancestor
153572476|NCT03569475|Sensory System Agents|sensory system agents|mesh-ancestor
153572477|NCT03569475|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153572479|NCT03546556|Dideoxynucleosides|dideoxynucleosides|mesh-list
153572480|NCT03546556|Antiviral Agents|antiviral agents|mesh-ancestor
153572481|NCT03546556|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153572482|NCT03546556|Antimetabolites|antimetabolites|mesh-ancestor
153572483|NCT03546556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153572484|NCT03546556|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153572485|NCT03546556|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153572486|NCT03546556|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153572487|NCT03533712|Folic Acid|folic acid|mesh-list
153572488|NCT03533712|Hematinics|hematinics|mesh-ancestor
153572512|NCT03518242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153572513|NCT03518242|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153572602|NCT05438108|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153572603|NCT05438108|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153572604|NCT05438108|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153572605|NCT05438108|Growth Substances|growth substances|mesh-ancestor
153572606|NCT05438108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153572607|NCT05438108|Growth Inhibitors|growth inhibitors|mesh-ancestor
153572608|NCT05437783|Azithromycin|azithromycin|mesh-list
153572609|NCT05437783|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153572610|NCT05437783|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153572611|NCT05437718|Ropivacaine|ropivacaine|mesh-list
153572647|NCT05437432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153572648|NCT05437432|Adrenergic Agents|adrenergic agents|mesh-ancestor
153572649|NCT05437432|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
153572650|NCT05437432|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153572651|NCT05437432|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153572652|NCT05437432|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
153572653|NCT05437432|Antidepressive Agents|antidepressive agents|mesh-ancestor
153572654|NCT05437432|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153572655|NCT05437432|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153572656|NCT05437432|Antimanic Agents|antimanic agents|mesh-ancestor
153572657|NCT05437432|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153572658|NCT05437432|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153572659|NCT05437224|Ambrisentan|ambrisentan|mesh-list
153572718|NCT04312009|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
153572719|NCT04312009|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
153572720|NCT04312009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153572721|NCT04100096|Brexpiprazole|brexpiprazole|mesh-list
153572722|NCT04100096|Serotonin Agents|serotonin agents|mesh-ancestor
153572723|NCT04100096|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153572724|NCT04100096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153572725|NCT04100096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153572726|NCT04100096|Dopamine Agonists|dopamine agonists|mesh-ancestor
153572727|NCT04100096|Dopamine Agents|dopamine agents|mesh-ancestor
153572728|NCT03850483|PF-06700841|pf-06700841|mesh-list
153572729|NCT03850483|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153572730|NCT03850483|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153572732|NCT03563742|Tenofovir|tenofovir|mesh-list
153572800|NCT02203773|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153572801|NCT02203773|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153572802|NCT02203773|Antifungal Agents|antifungal agents|mesh-ancestor
153572897|NCT03056014|N-monoacetylcystine|n-monoacetylcystine|mesh-list
153572898|NCT03056014|Antiviral Agents|antiviral agents|mesh-ancestor
153572899|NCT03056014|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153572900|NCT03056014|Expectorants|expectorants|mesh-ancestor
153572901|NCT03056014|Respiratory System Agents|respiratory system agents|mesh-ancestor
153458149|NCT04027530|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153573020|NCT02787551|rGLP-1 protein|rglp-1 protein|mesh-list
153573021|NCT02787551|Hypoglycemic Agents|hypoglycemic agents|mesh-list
153816807|NCT00426608|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153816808|NCT00426608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153816809|NCT00426608|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153816810|NCT00426608|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153816811|NCT00426608|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153816812|NCT00426608|GABA Modulators|gaba modulators|mesh-ancestor
153816813|NCT00426608|GABA Agents|gaba agents|mesh-ancestor
153816814|NCT00426608|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153816815|NCT00426608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153573182|NCT02363998|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153573183|NCT02363998|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
153573184|NCT02363998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153573185|NCT02363998|Sensory System Agents|sensory system agents|mesh-ancestor
153573186|NCT02363998|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153573187|NCT02363998|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
153573188|NCT02363998|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153573189|NCT02363998|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153573190|NCT02363998|Adrenergic Agents|adrenergic agents|mesh-ancestor
153573191|NCT02363998|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153573192|NCT02363998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153573193|NCT02363998|Analgesics|analgesics|mesh-ancestor
153573194|NCT02363998|Sympatholytics|sympatholytics|mesh-ancestor
153573195|NCT02363998|Autonomic Agents|autonomic agents|mesh-ancestor
153573196|NCT02353728|Nilotinib|nilotinib|mesh-list
153573197|NCT02353728|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153573198|NCT02353728|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153573199|NCT02353728|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153573200|NCT02353728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153573202|NCT02325466|Ticagrelor|ticagrelor|mesh-list
153573203|NCT02325466|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153573204|NCT02325466|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153573205|NCT02325466|Analgesics|analgesics|mesh-ancestor
153573217|NCT02325466|Antipyretics|antipyretics|mesh-ancestor
153816824|NCT00426647|Analgesics|analgesics|mesh-ancestor
153816825|NCT00426647|Sensory System Agents|sensory system agents|mesh-ancestor
153816826|NCT00426647|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153816827|NCT00426647|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
153816828|NCT00459615|Artesunate|artesunate|mesh-list
153816829|NCT00459615|Antimalarials|antimalarials|mesh-ancestor
153573365|NCT01817426|Infliximab|infliximab|mesh-list
153573366|NCT01817426|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
153573367|NCT01817426|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153458182|NCT04192812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153458183|NCT04192812|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153458184|NCT04192812|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153458185|NCT04407000|Favipiravir|favipiravir|mesh-list
153573368|NCT01817426|Dermatologic Agents|dermatologic agents|mesh-ancestor
153573369|NCT01817426|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153573370|NCT01817426|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153573371|NCT01741103|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
153781611|NCT00231140|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153573372|NCT01741103|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153573373|NCT01741103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153573374|NCT01741103|Incretins|incretins|mesh-ancestor
153573375|NCT01741103|Hormones|hormones|mesh-ancestor
153573416|NCT01414777|Dermatologic Agents|dermatologic agents|mesh-ancestor
153573417|NCT01414777|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
153573418|NCT01414777|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153573419|NCT01414777|Serotonin Agents|serotonin agents|mesh-ancestor
153573420|NCT01414777|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153573421|NCT01414777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153573422|NCT01411241|Vaccines|vaccines|mesh-list
153573423|NCT01411241|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
153573424|NCT01411241|Immunologic Factors|immunologic factors|mesh-ancestor
153573425|NCT01411241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153573426|NCT01380938|Ribavirin|ribavirin|mesh-list
153573427|NCT01380938|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
153573428|NCT01380938|Interferon-alpha|interferon-alpha|mesh-list
153573459|NCT01150045|Leucovorin|leucovorin|mesh-list
153573554|NCT00579527|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153573555|NCT00579527|Glucocorticoids|glucocorticoids|mesh-ancestor
153573556|NCT00579527|Hormones|hormones|mesh-ancestor
153573557|NCT00579527|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153573603|NCT01694134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153573604|NCT01694134|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153573605|NCT01694134|Antiemetics|antiemetics|mesh-ancestor
153573606|NCT01694134|Autonomic Agents|autonomic agents|mesh-ancestor
153573607|NCT01694134|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153573608|NCT01694134|Glucocorticoids|glucocorticoids|mesh-ancestor
153573610|NCT01694134|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153573611|NCT01694134|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
153573612|NCT01694134|Protective Agents|protective agents|mesh-ancestor
153816846|NCT00468351|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153816847|NCT00468351|Growth Substances|growth substances|mesh-ancestor
153816848|NCT00468351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153816849|NCT00468351|Growth Inhibitors|growth inhibitors|mesh-ancestor
153816850|NCT00468351|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153816851|NCT00468351|Glucocorticoids|glucocorticoids|mesh-ancestor
153816852|NCT00468351|Hormones|hormones|mesh-ancestor
153816853|NCT00468351|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153573676|NCT01694693|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153573677|NCT01694693|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153573679|NCT01694693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153573680|NCT01694693|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153573681|NCT01694732|Varenicline|varenicline|mesh-list
153573682|NCT01694732|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
153573683|NCT01694732|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
153573688|NCT01694797|Metoprolol|metoprolol|mesh-list
153573720|NCT01695109|Liraglutide|liraglutide|mesh-list
153573771|NCT01695356|Protective Agents|protective agents|mesh-ancestor
153573772|NCT01695356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153573773|NCT01695356|Dermatologic Agents|dermatologic agents|mesh-ancestor
153573774|NCT01695356|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
153573775|NCT01695460|Cholecalciferol|cholecalciferol|mesh-list
153458231|NCT03023982|Bupivacaine|bupivacaine|mesh-list
153458232|NCT03023982|Anesthetics, Local|anesthetics, local|mesh-ancestor
153458233|NCT03023982|Anesthetics|anesthetics|mesh-ancestor
153458234|NCT03023982|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153458235|NCT03023982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153458236|NCT03023982|Sensory System Agents|sensory system agents|mesh-ancestor
153458237|NCT03023982|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153458238|NCT03023982|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153458239|NCT03023982|Narcotics|narcotics|mesh-ancestor
153458240|NCT03023982|Analgesics|analgesics|mesh-ancestor
153458241|NCT04192110|Diuretics|diuretics|mesh-list
153458242|NCT04192110|Natriuretic Agents|natriuretic agents|mesh-ancestor
153458243|NCT04192110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153458244|NCT04025736|Tranexamic Acid|tranexamic acid|mesh-list
153458245|NCT04025736|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
153458250|NCT04190160|Xultophy|xultophy|mesh-list
153816893|NCT01057433|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
153573835|NCT01696409|Vitamin D|vitamin d|mesh-list
153573836|NCT01696409|Ergocalciferols|ergocalciferols|mesh-list
153573837|NCT01696409|Cholecalciferol|cholecalciferol|mesh-list
153573838|NCT01696409|Vitamins|vitamins|mesh-list
153573839|NCT01696409|Micronutrients|micronutrients|mesh-ancestor
153573840|NCT01696409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153458275|NCT04024800|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153458276|NCT04024800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153458279|NCT04406610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153573871|NCT01696552|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
153458288|NCT04023630|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153458289|NCT04023630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153458290|NCT04023630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153458291|NCT04023630|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
153458292|NCT04023630|Antithrombins|antithrombins|mesh-ancestor
153458293|NCT04023630|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
153458294|NCT04023630|Protease Inhibitors|protease inhibitors|mesh-ancestor
153458295|NCT04023630|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153458296|NCT04023630|Anticoagulants|anticoagulants|mesh-ancestor
153458297|NCT04199754|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
153458298|NCT04022304|Isophane Insulin, Human|isophane insulin, human|mesh-list
153458299|NCT04022304|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153573981|NCT01697098|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153573982|NCT01697098|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153573983|NCT01697098|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153573984|NCT01697098|Protease Inhibitors|protease inhibitors|mesh-ancestor
153573985|NCT01697098|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153574066|NCT01697631|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
153816975|NCT00427310|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153816976|NCT00427310|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153816977|NCT00427310|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153816978|NCT00427310|Immunologic Factors|immunologic factors|mesh-ancestor
153816979|NCT00427310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153816980|NCT00427310|Anticoagulants|anticoagulants|mesh-ancestor
153816981|NCT00427310|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153574067|NCT01697631|Insulin Aspart|insulin aspart|mesh-list
153574105|NCT01697787|Artemether|artemether|mesh-list
153574106|NCT01697787|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
153574107|NCT01697787|Amodiaquine|amodiaquine|mesh-list
153574108|NCT01697787|Antimalarials|antimalarials|mesh-ancestor
153574109|NCT01697787|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153574110|NCT01697787|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153574111|NCT01697787|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153574112|NCT01697787|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153574163|NCT01698476|4-phenylbutyric acid|4-phenylbutyric acid|mesh-list
153574164|NCT01698476|Vitamins|vitamins|mesh-ancestor
153574165|NCT01698476|Micronutrients|micronutrients|mesh-ancestor
153574166|NCT01698476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153574167|NCT01698476|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153574168|NCT01698476|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153574169|NCT01698476|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153574170|NCT01698541|Tacrolimus|tacrolimus|mesh-list
153574218|NCT01698697|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153574219|NCT01698697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153574220|NCT01698723|Ribavirin|ribavirin|mesh-list
153574221|NCT01698723|Antimetabolites|antimetabolites|mesh-ancestor
153817007|NCT04704947|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
153817008|NCT04704947|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-list
153817009|NCT04704947|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153817010|NCT04704947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153574222|NCT01698723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153574224|NCT01698723|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153574225|NCT01698749|Dexamethasone|dexamethasone|mesh-list
153574226|NCT01698749|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153574227|NCT01698749|Antiemetics|antiemetics|mesh-ancestor
153574228|NCT01698749|Autonomic Agents|autonomic agents|mesh-ancestor
153574229|NCT01698749|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153574230|NCT01698749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153574231|NCT01698749|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153574232|NCT01698749|Glucocorticoids|glucocorticoids|mesh-ancestor
153574233|NCT01698749|Hormones|hormones|mesh-ancestor
153574251|NCT01698788|Protease Inhibitors|protease inhibitors|mesh-ancestor
153574252|NCT01698788|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153574253|NCT01698788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153574254|NCT01698931|Glyburide|glyburide|mesh-list
153574255|NCT01698931|Repaglinide|repaglinide|mesh-list
153574256|NCT01698931|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153574257|NCT01698931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153574258|NCT01699113|Rabeprazole|rabeprazole|mesh-list
153574301|NCT01699360|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153817020|NCT00427466|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153817021|NCT00427505|Deferasirox|deferasirox|mesh-list
153817022|NCT00427505|Iron Chelating Agents|iron chelating agents|mesh-ancestor
153574302|NCT01699360|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153574303|NCT01699360|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153574304|NCT01699360|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153574305|NCT01699412|Dexamethasone|dexamethasone|mesh-list
153574307|NCT01699412|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153574308|NCT01699412|Antiemetics|antiemetics|mesh-ancestor
153574309|NCT01699412|Autonomic Agents|autonomic agents|mesh-ancestor
153574310|NCT01699412|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153574311|NCT01699412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153574331|NCT01699490|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
153574332|NCT01699490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153574333|NCT01699490|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
153574381|NCT01699724|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153574382|NCT01699724|Serotonin Agents|serotonin agents|mesh-ancestor
153574383|NCT01699724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153574384|NCT01699776|Digoxin|digoxin|mesh-list
153574385|NCT01699776|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153574386|NCT01699776|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
153574387|NCT01699776|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153574388|NCT01699776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153574389|NCT01699776|Protective Agents|protective agents|mesh-ancestor
153574390|NCT01699776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153574391|NCT01699802|Anesthetics|anesthetics|mesh-list
153574392|NCT01699802|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153574393|NCT01699802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153574394|NCT01699828|Buspirone|buspirone|mesh-list
153574395|NCT01699828|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153574396|NCT01699828|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153574397|NCT01699828|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153574398|NCT01699828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153574399|NCT01699828|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153574400|NCT01699828|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
153574401|NCT01699828|Serotonin Agents|serotonin agents|mesh-ancestor
153574402|NCT01699828|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153574403|NCT01699828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153574432|NCT01699997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153574433|NCT01700010|Paclitaxel|paclitaxel|mesh-list
153574434|NCT01700010|Lapatinib|lapatinib|mesh-list
153574435|NCT01700010|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153574436|NCT01700010|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153574437|NCT01700010|Tubulin Modulators|tubulin modulators|mesh-ancestor
153574438|NCT01700010|Antimitotic Agents|antimitotic agents|mesh-ancestor
153574439|NCT01700010|Mitosis Modulators|mitosis modulators|mesh-ancestor
153817050|NCT00469131|Mycophenolic Acid|mycophenolic acid|mesh-list
153817051|NCT00469131|Tacrolimus|tacrolimus|mesh-list
153817052|NCT00469131|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153817053|NCT00469131|Immunologic Factors|immunologic factors|mesh-ancestor
153817054|NCT00469131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153817055|NCT00469131|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
153817056|NCT00469131|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153817057|NCT00469131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153574548|NCT01700751|Immunologic Factors|immunologic factors|mesh-ancestor
153574549|NCT01700751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153574551|NCT01700790|Lopinavir|lopinavir|mesh-list
153574552|NCT01700790|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
153574553|NCT01700790|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
153574554|NCT01700790|Protease Inhibitors|protease inhibitors|mesh-ancestor
153574555|NCT01700790|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153574556|NCT01700790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153574557|NCT01700790|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153574558|NCT01700790|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153574559|NCT01700790|Antiviral Agents|antiviral agents|mesh-ancestor
153817074|NCT00428168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153574638|NCT01701323|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153574647|NCT01701336|Cloricromen|cloricromen|mesh-list
153574740|NCT01701843|Respiratory System Agents|respiratory system agents|mesh-ancestor
153574742|NCT01701856|Interferon-beta|interferon-beta|mesh-list
153574743|NCT01701856|Interferon beta-1b|interferon beta-1b|mesh-list
153574744|NCT01701856|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153574745|NCT01701856|Antiviral Agents|antiviral agents|mesh-ancestor
153574746|NCT01701856|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153574747|NCT01701856|Immunologic Factors|immunologic factors|mesh-ancestor
153574757|NCT01701882|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153574810|NCT01702129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153574811|NCT01702129|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153574812|NCT01702181|Tacrolimus|tacrolimus|mesh-list
153817092|NCT00460473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153817093|NCT00460473|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153817094|NCT00460473|Analgesics|analgesics|mesh-ancestor
153817095|NCT00460473|Sensory System Agents|sensory system agents|mesh-ancestor
153817096|NCT00460473|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153817097|NCT00460473|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
153817099|NCT00460473|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153574862|NCT01702623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153574863|NCT01702623|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
153574869|NCT01702636|Hemostatics|hemostatics|mesh-ancestor
153458484|NCT05581992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153458485|NCT05581992|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153574904|NCT01702714|Antimitotic Agents|antimitotic agents|mesh-ancestor
153574905|NCT01702714|Mitosis Modulators|mitosis modulators|mesh-ancestor
153574906|NCT01702714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153574907|NCT01702714|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153574909|NCT01702792|Monatide (IMS 3015)|monatide (ims 3015)|mesh-list
153574910|NCT01702792|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153574911|NCT01702792|Immunologic Factors|immunologic factors|mesh-ancestor
153574914|NCT01702857|Vaccines|vaccines|mesh-list
153574986|NCT01703364|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153574987|NCT01703364|Growth Substances|growth substances|mesh-ancestor
153574988|NCT01703364|Growth Inhibitors|growth inhibitors|mesh-ancestor
153574989|NCT01703364|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153574990|NCT01703390|Cetuximab|cetuximab|mesh-list
153574991|NCT01703390|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153574992|NCT01703390|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153574993|NCT01703468|Oxcarbazepine|oxcarbazepine|mesh-list
153575067|NCT01703910|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153575068|NCT01703910|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153575069|NCT01703910|Tubulin Modulators|tubulin modulators|mesh-ancestor
153575070|NCT01703910|Antimitotic Agents|antimitotic agents|mesh-ancestor
153575071|NCT01703910|Mitosis Modulators|mitosis modulators|mesh-ancestor
153575072|NCT01703910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153575073|NCT01703910|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153575074|NCT01703910|Antimetabolites|antimetabolites|mesh-ancestor
153817118|NCT00428558|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153817119|NCT00428558|Antiviral Agents|antiviral agents|mesh-ancestor
153817120|NCT00428558|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153458488|NCT03020940|Cefuroxime|cefuroxime|mesh-list
153575177|NCT01704638|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
153458497|NCT03645408|Incretins|incretins|mesh-ancestor
153575251|NCT01704898|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153575252|NCT01704898|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153575253|NCT01704898|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153575254|NCT01704898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153575255|NCT01704898|Antiviral Agents|antiviral agents|mesh-ancestor
153575256|NCT01704898|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153575257|NCT01704898|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
153575277|NCT01705223|Vaccines|vaccines|mesh-list
153575278|NCT01705223|Immunologic Factors|immunologic factors|mesh-ancestor
153575279|NCT01705223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153575280|NCT01705249|Norethindrone|norethindrone|mesh-list
153575281|NCT01705249|Norethindrone Acetate|norethindrone acetate|mesh-list
153575282|NCT01705249|Estradiol|estradiol|mesh-list
153575283|NCT01705249|Estrogens|estrogens|mesh-ancestor
153575326|NCT01705392|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
153575362|NCT01705483|Mitosis Modulators|mitosis modulators|mesh-ancestor
153575363|NCT01705483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153575364|NCT01705639|Melatonin|melatonin|mesh-list
153575365|NCT01705639|Antioxidants|antioxidants|mesh-ancestor
153575366|NCT01705639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153575367|NCT01705639|Protective Agents|protective agents|mesh-ancestor
153575368|NCT01705639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153575369|NCT01705639|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153575445|NCT01706354|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153575446|NCT01706367|Vaccines|vaccines|mesh-list
153575447|NCT01706367|Immunologic Factors|immunologic factors|mesh-ancestor
153575523|NCT01707082|Anesthetics|anesthetics|mesh-ancestor
153458613|NCT04148820|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
153458614|NCT04148820|Protease Inhibitors|protease inhibitors|mesh-ancestor
153458615|NCT04148820|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153458616|NCT03941496|Azacitidine|azacitidine|mesh-list
153458617|NCT03941496|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153575609|NCT01707407|Hormone Antagonists|hormone antagonists|mesh-ancestor
153575610|NCT01707407|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153458641|NCT03580980|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153458643|NCT03580980|Anesthetics, Local|anesthetics, local|mesh-ancestor
153458644|NCT03587220|Lidocaine|lidocaine|mesh-list
153575649|NCT01707732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153575650|NCT01707745|Bevacizumab|bevacizumab|mesh-list
153575651|NCT01707745|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153575652|NCT01707745|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153575653|NCT01707745|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153575654|NCT01707745|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153575685|NCT01707940|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153575686|NCT01707940|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
153575687|NCT01707940|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153575688|NCT01707940|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153575689|NCT01707940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153575690|NCT01707940|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153575691|NCT01707940|Hormone Antagonists|hormone antagonists|mesh-ancestor
153817278|NCT06189404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153458656|NCT03587220|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153458657|NCT03587220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153458658|NCT03587220|Antipruritics|antipruritics|mesh-ancestor
153458659|NCT03587220|Dermatologic Agents|dermatologic agents|mesh-ancestor
153458660|NCT03587220|Histamine Agonists|histamine agonists|mesh-ancestor
153458661|NCT03587220|Histamine Agents|histamine agents|mesh-ancestor
153458662|NCT03587220|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153458663|NCT03586908|Ophthalmic Solutions|ophthalmic solutions|mesh-list
153575717|NCT01708239|Fibrin fragment D|fibrin fragment d|mesh-list
153575767|NCT01708447|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153575768|NCT01708447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153575769|NCT01708616|Risperidone|risperidone|mesh-list
153575770|NCT01708616|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153575771|NCT01708616|Serotonin Agents|serotonin agents|mesh-ancestor
153575772|NCT01708616|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153575773|NCT01708616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153575774|NCT01708616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153575775|NCT01708616|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153575776|NCT01708616|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153575777|NCT01708616|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153575778|NCT01708616|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153575779|NCT01708616|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
153575863|NCT01709019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153575864|NCT01709071|Vaccines|vaccines|mesh-list
153575865|NCT01709071|Immunologic Factors|immunologic factors|mesh-ancestor
153575866|NCT01709071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153575867|NCT01709370|Letrozole|letrozole|mesh-list
153575868|NCT01709370|Palbociclib|palbociclib|mesh-list
153575869|NCT01709370|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153575870|NCT01709370|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
153575871|NCT01709370|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153575872|NCT01709370|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153575873|NCT01709370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153575874|NCT01709370|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
153575875|NCT01709370|Hormone Antagonists|hormone antagonists|mesh-ancestor
153575876|NCT01709370|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153575877|NCT01709370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153575878|NCT01709370|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153575879|NCT01709630|Magnesium Sulfate|magnesium sulfate|mesh-list
153575880|NCT01709630|Analgesics|analgesics|mesh-ancestor
153575881|NCT01709630|Sensory System Agents|sensory system agents|mesh-ancestor
153575882|NCT01709630|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153575883|NCT01709630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153575894|NCT01709656|Celecoxib|celecoxib|mesh-list
153575896|NCT01709656|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153575897|NCT01709656|Analgesics|analgesics|mesh-ancestor
153575898|NCT01709656|Sensory System Agents|sensory system agents|mesh-ancestor
153575907|NCT01709682|Amiodarone|amiodarone|mesh-list
153575933|NCT01709760|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
153575934|NCT01709760|Abortifacient Agents|abortifacient agents|mesh-ancestor
153575935|NCT01709760|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153575936|NCT01709760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153575937|NCT01709760|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153575938|NCT01709760|Antimetabolites|antimetabolites|mesh-ancestor
153575939|NCT01709760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153575940|NCT01709760|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153575968|NCT01709994|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153575970|NCT01709994|Analgesics|analgesics|mesh-ancestor
153575971|NCT01709994|Sensory System Agents|sensory system agents|mesh-ancestor
153575972|NCT01709994|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153575973|NCT01709994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153575974|NCT01709994|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153575975|NCT01709994|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153575976|NCT01709994|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153575977|NCT01709994|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153575978|NCT01709994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153575982|NCT01709994|Antipyretics|antipyretics|mesh-ancestor
153576008|NCT01710163|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153576009|NCT01710163|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153576010|NCT01710163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153576011|NCT01710163|Dopamine Agonists|dopamine agonists|mesh-ancestor
153576012|NCT01710163|Dopamine Agents|dopamine agents|mesh-ancestor
153576013|NCT01710163|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153576014|NCT01710163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153576015|NCT01710163|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
153576016|NCT01710163|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
153576017|NCT01710163|Serotonin Agents|serotonin agents|mesh-ancestor
153576018|NCT01710163|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
153576049|NCT01710384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153576050|NCT01710384|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153576051|NCT01710384|Respiratory System Agents|respiratory system agents|mesh-ancestor
153576052|NCT01710462|Domperidone|domperidone|mesh-list
153576053|NCT01710462|Pantoprazole|pantoprazole|mesh-list
153576054|NCT01710462|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
153576055|NCT01710462|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153576056|NCT01710462|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
153817352|NCT06188468|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
153576090|NCT01710566|Abortifacient Agents|abortifacient agents|mesh-ancestor
153576091|NCT01710566|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
153576092|NCT01710566|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153576093|NCT01710592|Docetaxel|docetaxel|mesh-list
153576094|NCT01710592|Capecitabine|capecitabine|mesh-list
153576095|NCT01710592|Oxaliplatin|oxaliplatin|mesh-list
153576096|NCT01710592|Epirubicin|epirubicin|mesh-list
153576097|NCT01710592|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153576098|NCT01710592|Tubulin Modulators|tubulin modulators|mesh-ancestor
153576099|NCT01710592|Antimitotic Agents|antimitotic agents|mesh-ancestor
153576169|NCT01710904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153576170|NCT01710904|Analgesics|analgesics|mesh-ancestor
153576171|NCT01710904|Sensory System Agents|sensory system agents|mesh-ancestor
153576172|NCT01710904|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153576173|NCT01710904|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
153576174|NCT01710995|Omeprazole, sodium bicarbonate drug combination|omeprazole, sodium bicarbonate drug combination|mesh-list
153576175|NCT01710995|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
153576176|NCT01710995|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153817368|NCT06188390|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153817369|NCT06188390|Immunologic Factors|immunologic factors|mesh-ancestor
153817370|NCT06188390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153817372|NCT06188390|Protective Agents|protective agents|mesh-ancestor
153817373|NCT06188325|Eliglustat|eliglustat|mesh-list
153817374|NCT06188325|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153817375|NCT06188325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153817376|NCT06188221|Lidocaine|lidocaine|mesh-list
153817377|NCT06188221|Anesthetics, Local|anesthetics, local|mesh-ancestor
153817378|NCT06188221|Anesthetics|anesthetics|mesh-ancestor
153576223|NCT01711320|Omeprazole|omeprazole|mesh-list
153576242|NCT01711437|Antioxidants|antioxidants|mesh-ancestor
153576243|NCT01711437|Protective Agents|protective agents|mesh-ancestor
153576244|NCT01711437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153576246|NCT01711437|Micronutrients|micronutrients|mesh-ancestor
153576247|NCT01711437|Antifoaming Agents|antifoaming agents|mesh-ancestor
153576248|NCT01711437|Emollients|emollients|mesh-ancestor
153576249|NCT01711437|Dermatologic Agents|dermatologic agents|mesh-ancestor
153576250|NCT01711437|Cathartics|cathartics|mesh-ancestor
153576251|NCT01711437|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153576252|NCT01711437|Antacids|antacids|mesh-ancestor
153817383|NCT06188221|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153817384|NCT06188221|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
153817385|NCT06188221|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153817386|NCT06188221|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153817387|NCT06188221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153817389|NCT06188208|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153576314|NCT01711567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153576315|NCT01711567|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153576316|NCT01711567|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153576317|NCT01711593|Dimercaprol|dimercaprol|mesh-list
153576318|NCT01711593|Chelating Agents|chelating agents|mesh-ancestor
153576319|NCT01711593|Sequestering Agents|sequestering agents|mesh-ancestor
153576320|NCT01711593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153576321|NCT01711671|Dexamethasone|dexamethasone|mesh-list
153576348|NCT01711723|Phospholipase A2 Inhibitors|phospholipase a2 inhibitors|mesh-ancestor
153576349|NCT01711723|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153576350|NCT01711723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153576351|NCT01711749|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
153576352|NCT01711749|Calcium|calcium|mesh-list
153576353|NCT01711749|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153576354|NCT01711749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153458789|NCT03155568|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153458791|NCT03155646|Dexmedetomidine|dexmedetomidine|mesh-list
153458792|NCT03155646|Levobupivacaine|levobupivacaine|mesh-list
153458793|NCT03155646|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153458794|NCT03155646|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153458795|NCT03155646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153458796|NCT03155646|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153458797|NCT03155646|Analgesics|analgesics|mesh-ancestor
153458798|NCT03155646|Sensory System Agents|sensory system agents|mesh-ancestor
153576421|NCT01712126|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153576422|NCT01712126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153576423|NCT01712126|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
153576424|NCT01712126|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
153576425|NCT01712139|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
153576426|NCT01712139|Irbesartan|irbesartan|mesh-list
153576427|NCT01712139|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153576428|NCT01712139|Diuretics|diuretics|mesh-ancestor
153576429|NCT01712139|Natriuretic Agents|natriuretic agents|mesh-ancestor
153576430|NCT01712139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153817426|NCT06188052|Hemostatics|hemostatics|mesh-ancestor
153817427|NCT06188052|Coagulants|coagulants|mesh-ancestor
153817428|NCT06187987|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
153817429|NCT06187987|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153458804|NCT03155646|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153458805|NCT03155646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153458806|NCT03155646|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153576459|NCT01712321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153576460|NCT01712321|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153576461|NCT01712321|Serotonin Agents|serotonin agents|mesh-ancestor
153576465|NCT01712347|Bevacizumab|bevacizumab|mesh-list
153576522|NCT01712828|Immunologic Factors|immunologic factors|mesh-ancestor
153576523|NCT01712828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153781625|NCT00266448|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
153576524|NCT01712828|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153576525|NCT01712828|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153576526|NCT01712828|Growth Substances|growth substances|mesh-ancestor
153576527|NCT01712828|Growth Inhibitors|growth inhibitors|mesh-ancestor
153576528|NCT01712828|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153576529|NCT01712828|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153576530|NCT01712828|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153576559|NCT01712828|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153576560|NCT01712828|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153576561|NCT01712828|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
153576562|NCT01712828|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
153576604|NCT01713101|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
153681356|NCT00073827|Albuterol|albuterol|mesh-list
153576605|NCT01713101|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153576606|NCT01713101|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153576607|NCT01713101|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153576608|NCT01713101|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153576609|NCT01713101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153576610|NCT01713127|Remifentanil|remifentanil|mesh-list
153576611|NCT01713127|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153576612|NCT01713127|Narcotics|narcotics|mesh-ancestor
153576646|NCT01713309|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153576647|NCT01713309|Immunologic Factors|immunologic factors|mesh-ancestor
153576648|NCT01713309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153576649|NCT01713361|Enoxaparin|enoxaparin|mesh-list
153576650|NCT01713361|Anticoagulants|anticoagulants|mesh-ancestor
153817460|NCT06187584|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
153817461|NCT06187584|Hydrocodone|hydrocodone|mesh-list
153817462|NCT06187584|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153817463|NCT06187584|Analgesics|analgesics|mesh-ancestor
153576671|NCT01713426|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153576672|NCT01713426|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153576673|NCT01713426|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153576674|NCT01713426|Antipruritics|antipruritics|mesh-ancestor
153576675|NCT01713426|Dermatologic Agents|dermatologic agents|mesh-ancestor
153576676|NCT01713556|Propranolol|propranolol|mesh-list
153576677|NCT01713556|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
153576716|NCT01713803|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153817489|NCT06187506|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153817490|NCT06187493|Dapagliflozin|dapagliflozin|mesh-list
153817491|NCT06187493|Empagliflozin|empagliflozin|mesh-list
153817492|NCT06187493|Enalapril|enalapril|mesh-list
153817493|NCT06187493|Lisinopril|lisinopril|mesh-list
153817494|NCT06187493|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
153817495|NCT06187493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153817502|NCT06187493|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
153817503|NCT06187493|Protective Agents|protective agents|mesh-ancestor
153817504|NCT06187441|Dexamethasone|dexamethasone|mesh-list
153817505|NCT06187441|Lenalidomide|lenalidomide|mesh-list
153817506|NCT06187441|Daratumumab|daratumumab|mesh-list
153817507|NCT06187441|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153817508|NCT06187441|Antiemetics|antiemetics|mesh-ancestor
153576739|NCT01714011|Antidepressive Agents|antidepressive agents|mesh-ancestor
153576756|NCT01714037|Gemcitabine|gemcitabine|mesh-list
153576770|NCT01714089|Interferon-beta|interferon-beta|mesh-list
153576771|NCT01714089|Interferon beta-1a|interferon beta-1a|mesh-list
153576772|NCT01714089|RNS60|rns60|mesh-list
153576773|NCT01714089|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153576774|NCT01714089|Antiviral Agents|antiviral agents|mesh-ancestor
153576775|NCT01714089|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153576776|NCT01714089|Immunologic Factors|immunologic factors|mesh-ancestor
153576777|NCT01714089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153576821|NCT01714154|Antiviral Agents|antiviral agents|mesh-ancestor
153576822|NCT01714154|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153576823|NCT01714154|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
153576824|NCT01714154|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153576825|NCT01714193|Canagliflozin|canagliflozin|mesh-list
153576826|NCT01714193|Contraceptive Agents|contraceptive agents|mesh-list
153576827|NCT01714193|Contraceptives, Oral|contraceptives, oral|mesh-list
153576828|NCT01714193|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153576829|NCT01714193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153576830|NCT01714193|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
153576831|NCT01714193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153576832|NCT01714193|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153576833|NCT01714193|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
153576874|NCT01714414|Lamivudine|lamivudine|mesh-list
153576875|NCT01714414|Zidovudine|zidovudine|mesh-list
153576876|NCT01714414|Efavirenz|efavirenz|mesh-list
153576877|NCT01714414|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153817532|NCT06187090|Antiviral Agents|antiviral agents|mesh-ancestor
153817533|NCT06187090|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153817534|NCT06187090|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
153817536|NCT06187090|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153576920|NCT01714570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153576922|NCT01714596|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153576923|NCT01714648|Triptorelin Pamoate|triptorelin pamoate|mesh-list
153576924|NCT01714648|Luteolytic Agents|luteolytic agents|mesh-ancestor
153576925|NCT01714648|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
153576926|NCT01714648|Contraceptive Agents|contraceptive agents|mesh-ancestor
153576927|NCT01714648|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153817549|NCT06186921|Bupivacaine|bupivacaine|mesh-list
153817550|NCT06186921|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153817551|NCT06186921|Antiemetics|antiemetics|mesh-ancestor
153576955|NCT01714817|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153576956|NCT01714817|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153576957|NCT01714817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153576958|NCT01714817|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153576959|NCT01714817|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153576960|NCT01714817|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153576991|NCT01714960|Ophthalmic Solutions|ophthalmic solutions|mesh-list
153576992|NCT01714960|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
153576993|NCT01715077|Ipilimumab|ipilimumab|mesh-list
153576994|NCT01715077|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153576995|NCT01715077|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153576996|NCT01715077|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153576997|NCT01715077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153576998|NCT01715090|Insulin|insulin|mesh-list
153577037|NCT01715311|Respiratory System Agents|respiratory system agents|mesh-ancestor
153577038|NCT01715311|Parasympatholytics|parasympatholytics|mesh-ancestor
153577039|NCT01715311|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
153577040|NCT01715311|Cholinergic Agents|cholinergic agents|mesh-ancestor
153577041|NCT01715311|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153577042|NCT01715311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153577043|NCT01715363|Leucovorin|leucovorin|mesh-list
153577044|NCT01715363|Folic Acid|folic acid|mesh-list
153577045|NCT01715363|Oxaliplatin|oxaliplatin|mesh-list
153577046|NCT01715363|Levoleucovorin|levoleucovorin|mesh-list
153577047|NCT01715363|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153577048|NCT01715363|Antidotes|antidotes|mesh-ancestor
153458953|NCT01671774|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153458955|NCT01671774|Sensory System Agents|sensory system agents|mesh-ancestor
153458956|NCT01671774|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153458957|NCT01671774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153458958|NCT01671774|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153458959|NCT01671852|Mometasone Furoate|mometasone furoate|mesh-list
153458960|NCT01671852|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153458961|NCT01671852|Dermatologic Agents|dermatologic agents|mesh-ancestor
153577134|NCT01715701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153817603|NCT06186596|Hormones|hormones|mesh-ancestor
153577187|NCT01716377|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
153577188|NCT01716377|Antidepressive Agents|antidepressive agents|mesh-ancestor
153577189|NCT01716377|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153577190|NCT01716416|Cetuximab|cetuximab|mesh-list
153577191|NCT01716416|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153577192|NCT01716416|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153577194|NCT01716442|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153577195|NCT01716442|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153577196|NCT01716442|Immunologic Factors|immunologic factors|mesh-ancestor
153577197|NCT01716442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153577198|NCT01716442|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153577199|NCT01716572|Erythromycin|erythromycin|mesh-list
153577200|NCT01716572|Erythromycin Estolate|erythromycin estolate|mesh-list
153577201|NCT01716572|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
153817613|NCT06186388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153817614|NCT06186388|Protective Agents|protective agents|mesh-ancestor
153817615|NCT06186388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153817616|NCT06186219|Rituximab|rituximab|mesh-list
153817617|NCT06186219|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153817618|NCT06186219|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153817619|NCT06186219|Immunologic Factors|immunologic factors|mesh-ancestor
153817620|NCT06186219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153817621|NCT06186219|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153817622|NCT06185179|Metformin|metformin|mesh-list
153459004|NCT03153072|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
153651081|NCT00000596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153651083|NCT00000596|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153651084|NCT00000596|Alkylating Agents|alkylating agents|mesh-ancestor
153459005|NCT03153072|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
153459006|NCT03153072|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
153459007|NCT01673724|Pramipexole|pramipexole|mesh-list
153459008|NCT01673724|Bromocriptine|bromocriptine|mesh-list
153459009|NCT01673724|Dexpramipexole|dexpramipexole|mesh-list
153577259|NCT01716689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153577260|NCT01716689|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153577261|NCT01716689|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153577262|NCT01716767|Analgesics|analgesics|mesh-list
153577263|NCT01716767|Menthol|menthol|mesh-list
153577296|NCT01717118|Immunologic Factors|immunologic factors|mesh-ancestor
153577297|NCT01717118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153577298|NCT01717157|Fentanyl|fentanyl|mesh-list
153577299|NCT01717157|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153577300|NCT01717157|Narcotics|narcotics|mesh-ancestor
153577301|NCT01717157|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153577302|NCT01717157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153577303|NCT01717157|Analgesics|analgesics|mesh-ancestor
153817638|NCT06182267|Fluorides|fluorides|mesh-list
153817639|NCT06182267|Sodium Fluoride|sodium fluoride|mesh-list
153817640|NCT06182267|Cariostatic Agents|cariostatic agents|mesh-ancestor
153817641|NCT06182267|Protective Agents|protective agents|mesh-ancestor
153817642|NCT06182267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153817643|NCT06182267|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
153577319|NCT01717222|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153577320|NCT01717222|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153577321|NCT01717222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153577322|NCT01717235|Ropinirole|ropinirole|mesh-list
153577323|NCT01717235|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
153577324|NCT01717235|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
153577325|NCT01717235|Dopamine Agonists|dopamine agonists|mesh-ancestor
153577326|NCT01717235|Dopamine Agents|dopamine agents|mesh-ancestor
153577330|NCT01717300|Oxazolidinones|oxazolidinones|mesh-list
153459042|NCT03378102|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153459043|NCT03032328|Vitamin D|vitamin d|mesh-list
153459044|NCT03032328|Vitamins|vitamins|mesh-ancestor
153577338|NCT01717300|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
153577339|NCT01717300|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153577341|NCT01717404|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153577342|NCT01717404|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
153577343|NCT01717404|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153577344|NCT01717404|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153577345|NCT01717404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153577349|NCT01717599|Analgesics|analgesics|mesh-ancestor
153817678|NCT06165900|Tubulin Modulators|tubulin modulators|mesh-ancestor
153459046|NCT03032328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153459047|NCT03032328|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153459048|NCT04747392|Teriparatide|teriparatide|mesh-list
153459049|NCT04747392|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153459050|NCT04747392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153577395|NCT01717807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153577397|NCT01717846|Abatacept|abatacept|mesh-list
153577398|NCT01717846|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153577414|NCT01717911|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
153577415|NCT01717911|Protease Inhibitors|protease inhibitors|mesh-ancestor
153577417|NCT01717911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153577418|NCT01717950|Aluminum Hydroxide|aluminum hydroxide|mesh-list
153577419|NCT01717950|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153577420|NCT01717950|Immunologic Factors|immunologic factors|mesh-ancestor
153577421|NCT01717950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153577423|NCT01717950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153577455|NCT01718093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153577456|NCT01718223|Temoporfin|temoporfin|mesh-list
153577457|NCT01718223|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153577458|NCT01718223|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
153577459|NCT01718223|Dermatologic Agents|dermatologic agents|mesh-ancestor
153577460|NCT01718236|Rocuronium|rocuronium|mesh-list
153577461|NCT01718236|Succinylcholine|succinylcholine|mesh-list
153577462|NCT01718236|Neostigmine|neostigmine|mesh-list
153577463|NCT01718236|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
153577464|NCT01718236|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
153817696|NCT06140966|Dexamethasone|dexamethasone|mesh-list
153817697|NCT06140966|Cyclophosphamide|cyclophosphamide|mesh-list
153817698|NCT06140966|Melphalan|melphalan|mesh-list
153817699|NCT06140966|Etoposide|etoposide|mesh-list
153817700|NCT06140966|Lenalidomide|lenalidomide|mesh-list
153817701|NCT06140966|Bortezomib|bortezomib|mesh-list
153817702|NCT06140966|Epirubicin|epirubicin|mesh-list
153817703|NCT06140966|Daratumumab|daratumumab|mesh-list
153817704|NCT06140966|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153817705|NCT06140966|Immunologic Factors|immunologic factors|mesh-ancestor
153577506|NCT01718314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153577507|NCT01718314|Sensory System Agents|sensory system agents|mesh-ancestor
153577508|NCT01718314|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153577509|NCT01718314|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153577510|NCT01718314|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
153577511|NCT01718314|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153577512|NCT01718314|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153577513|NCT01718314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153577514|NCT01718314|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
153459084|NCT05353062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153459085|NCT05353062|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
153459086|NCT05353062|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153459087|NCT05353062|Autonomic Agents|autonomic agents|mesh-ancestor
153459088|NCT05353062|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153459089|NCT05353062|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153459090|NCT05353062|Respiratory System Agents|respiratory system agents|mesh-ancestor
153459091|NCT05353062|Mydriatics|mydriatics|mesh-ancestor
153459092|NCT05353062|Sympathomimetics|sympathomimetics|mesh-ancestor
153459093|NCT05353062|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
153459094|NCT05353062|Coagulants|coagulants|mesh-ancestor
153459095|NCT03152370|Leucovorin|leucovorin|mesh-list
153459096|NCT03152370|Folic Acid|folic acid|mesh-list
153459097|NCT03152370|Capecitabine|capecitabine|mesh-list
153459098|NCT03152370|Oxaliplatin|oxaliplatin|mesh-list
153459099|NCT03152370|Levoleucovorin|levoleucovorin|mesh-list
153459100|NCT03152370|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153577546|NCT01718366|Chelating Agents|chelating agents|mesh-ancestor
153577561|NCT01718496|Analgesics|analgesics|mesh-ancestor
153577614|NCT01718678|Protective Agents|protective agents|mesh-ancestor
153577615|NCT01718678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153459113|NCT02187120|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153459114|NCT02187120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153459115|NCT02187120|Hemostatics|hemostatics|mesh-ancestor
153459116|NCT02187120|Coagulants|coagulants|mesh-ancestor
153459120|NCT01674738|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153577617|NCT01718717|Morphine|morphine|mesh-list
153577659|NCT01718951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153577660|NCT01718951|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153577661|NCT01718964|Hydrocortisone|hydrocortisone|mesh-list
153577662|NCT01718964|Mannitol|mannitol|mesh-list
153577663|NCT01718964|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
153577664|NCT01718964|Diuretics|diuretics|mesh-ancestor
153817744|NCT06136455|Ethanol|ethanol|mesh-list
153459137|NCT01675206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153459138|NCT01675206|Hemostatics|hemostatics|mesh-ancestor
153459139|NCT01675206|Coagulants|coagulants|mesh-ancestor
153459140|NCT03150576|Paclitaxel|paclitaxel|mesh-list
153459142|NCT03150576|Olaparib|olaparib|mesh-list
153459143|NCT03150576|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153459144|NCT03150576|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153459145|NCT03150576|Tubulin Modulators|tubulin modulators|mesh-ancestor
153577738|NCT01719601|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153577739|NCT01719601|Narcotics|narcotics|mesh-ancestor
153577742|NCT01719601|Analgesics|analgesics|mesh-ancestor
153459159|NCT04747080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153459160|NCT04747080|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153459162|NCT04747080|Hormones|hormones|mesh-ancestor
153820699|NCT00434135|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153577776|NCT01719705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153577777|NCT01719705|Anticonvulsants|anticonvulsants|mesh-ancestor
153577778|NCT01719705|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153577779|NCT01719705|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153577782|NCT01719705|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153577814|NCT01719835|Tubulin Modulators|tubulin modulators|mesh-ancestor
153577815|NCT01719835|Antimitotic Agents|antimitotic agents|mesh-ancestor
153577816|NCT01719835|Mitosis Modulators|mitosis modulators|mesh-ancestor
153577817|NCT01719835|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153577819|NCT01719835|Autonomic Agents|autonomic agents|mesh-ancestor
153577820|NCT01719835|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153577821|NCT01719835|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153577822|NCT01719835|Glucocorticoids|glucocorticoids|mesh-ancestor
153681912|NCT00126451|Vorinostat|vorinostat|mesh-list
153577823|NCT01719835|Hormones|hormones|mesh-ancestor
153459181|NCT01675362|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153577885|NCT01720537|Immunologic Factors|immunologic factors|mesh-ancestor
153817821|NCT06005480|Anesthetics|anesthetics|mesh-ancestor
153577956|NCT01724892|Antiemetics|antiemetics|mesh-ancestor
153577957|NCT01724892|Autonomic Agents|autonomic agents|mesh-ancestor
153577958|NCT01724892|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153577959|NCT01724892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153577960|NCT01724892|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153577961|NCT01724892|Glucocorticoids|glucocorticoids|mesh-ancestor
153577962|NCT01724892|Hormones|hormones|mesh-ancestor
153577963|NCT01724892|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153817855|NCT05987956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153817856|NCT05981118|Betamethasone|betamethasone|mesh-list
153817857|NCT05981118|Betamethasone Valerate|betamethasone valerate|mesh-list
153817858|NCT05981118|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
153817859|NCT05981118|Betamethasone benzoate|betamethasone benzoate|mesh-list
153817860|NCT05981118|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
153817861|NCT05981118|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153817863|NCT05981118|Hormones|hormones|mesh-ancestor
153578022|NCT01729195|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153578023|NCT01729195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153578024|NCT01729195|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153578025|NCT01729195|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
153578026|NCT01729195|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153578027|NCT01730014|Insulin Glargine|insulin glargine|mesh-list
153578028|NCT01730014|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153578029|NCT01730014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153817869|NCT05956769|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
153817870|NCT05956769|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153817871|NCT05956769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153817872|NCT05956769|Hemostatics|hemostatics|mesh-ancestor
153817873|NCT05956769|Coagulants|coagulants|mesh-ancestor
153578075|NCT01730326|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153578076|NCT01730417|3-Iodobenzylguanidine|3-iodobenzylguanidine|mesh-list
153578103|NCT01726400|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153578104|NCT01726400|Antiviral Agents|antiviral agents|mesh-ancestor
153578105|NCT01726400|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153578106|NCT01726400|Antimetabolites|antimetabolites|mesh-ancestor
153578107|NCT01726400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153578108|NCT01726400|Immunologic Factors|immunologic factors|mesh-ancestor
153578109|NCT01726400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153578110|NCT01730612|Histamine|histamine|mesh-list
153578111|NCT01730612|Glycine|glycine|mesh-list
153578112|NCT01730612|Histamine Agonists|histamine agonists|mesh-ancestor
153817896|NCT05859477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153578184|NCT01731067|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153578185|NCT01731067|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153578186|NCT01731067|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153578187|NCT01731067|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
153578188|NCT01731067|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
153578189|NCT01731067|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
153578190|NCT01731067|Histamine Antagonists|histamine antagonists|mesh-ancestor
153578191|NCT01731067|Histamine Agents|histamine agents|mesh-ancestor
153578194|NCT01731132|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
153578195|NCT01731132|Contraceptive Agents|contraceptive agents|mesh-ancestor
153578196|NCT01731132|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153459291|NCT04763616|Cemiplimab|cemiplimab|mesh-list
153459292|NCT04763616|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153459293|NCT04763616|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153459294|NCT03652974|Valproic Acid|valproic acid|mesh-list
153459295|NCT03652974|Clozapine|clozapine|mesh-list
153459296|NCT03652974|Amisulpride|amisulpride|mesh-list
153459297|NCT03652974|Anticonvulsants|anticonvulsants|mesh-ancestor
153459298|NCT03652974|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153459299|NCT03652974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153459300|NCT03652974|GABA Agents|gaba agents|mesh-ancestor
153459301|NCT03652974|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153459302|NCT03652974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153459304|NCT03652974|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153578197|NCT01731132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153817918|NCT05823480|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153578257|NCT01731340|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153578259|NCT01731431|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153578260|NCT01731431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153578261|NCT01731457|Etanercept|etanercept|mesh-list
153578262|NCT01731457|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153459323|NCT03642210|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153459324|NCT03642210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153459325|NCT03642210|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
153459326|NCT03642210|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
153817937|NCT05768711|Venetoclax|venetoclax|mesh-list
153817952|NCT05756621|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153578346|NCT01731795|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153578347|NCT01731795|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153578348|NCT01731795|Protease Inhibitors|protease inhibitors|mesh-ancestor
153578349|NCT01731795|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153578350|NCT01731795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153459335|NCT02082678|Dermatologic Agents|dermatologic agents|mesh-ancestor
153459336|NCT02082678|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
153459337|NCT02082678|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153459338|NCT02082678|Serotonin Agents|serotonin agents|mesh-ancestor
153459339|NCT02082678|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153578378|NCT01732094|Luteolytic Agents|luteolytic agents|mesh-ancestor
153578379|NCT01732094|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
153578380|NCT01732094|Contraceptive Agents|contraceptive agents|mesh-ancestor
153578900|NCT01736020|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153578901|NCT01736020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153578976|NCT01736514|Febuxostat|febuxostat|mesh-list
153579081|NCT01737203|Vasodilator Agents|vasodilator agents|mesh-ancestor
153579884|NCT01742689|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
153579886|NCT01742689|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153580329|NCT01744964|Apomorphine|apomorphine|mesh-list
153580330|NCT01744964|Emetics|emetics|mesh-ancestor
153580706|NCT01747226|Cariostatic Agents|cariostatic agents|mesh-ancestor
153581156|NCT01749384|Immunoglobulins|immunoglobulins|mesh-list
153582093|NCT04518306|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
153582095|NCT04450212|Vitamins|vitamins|mesh-ancestor
153582096|NCT04450212|Micronutrients|micronutrients|mesh-ancestor
153582097|NCT04450212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153582098|NCT04450212|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
153582158|NCT04307134|Inotuzumab Ozogamicin|inotuzumab ozogamicin|mesh-list
153582919|NCT01751854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153582922|NCT01751854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153582923|NCT01751919|Imatinib Mesylate|imatinib mesylate|mesh-list
153582924|NCT01751919|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153582925|NCT01751919|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153582926|NCT01751919|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153583447|NCT01755845|Mitosis Modulators|mitosis modulators|mesh-ancestor
153583795|NCT01757769|Silodosin|silodosin|mesh-list
153584282|NCT01760330|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153584283|NCT01760330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153585250|NCT01765829|Pimozide|pimozide|mesh-list
153585684|NCT01768299|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
153585685|NCT01768299|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153586005|NCT01769768|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
153586245|NCT01770964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153586666|NCT01774396|Anesthetics, Local|anesthetics, local|mesh-ancestor
153586938|NCT01777087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153587114|NCT01778686|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153587324|NCT01780051|Metformin|metformin|mesh-list
153587325|NCT01780051|Repaglinide|repaglinide|mesh-list
153587519|NCT01781377|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
153587520|NCT01781377|Dopamine Agents|dopamine agents|mesh-ancestor
153587521|NCT01781377|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153587522|NCT01781377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153587523|NCT01781442|Sirolimus|sirolimus|mesh-list
153587524|NCT01781442|Temsirolimus|temsirolimus|mesh-list
153587536|NCT01781442|Antifungal Agents|antifungal agents|mesh-ancestor
153587537|NCT01781507|Cetirizine|cetirizine|mesh-list
153587781|NCT01783756|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153587848|NCT01784250|Sensory System Agents|sensory system agents|mesh-ancestor
153588009|NCT01785290|Haloperidol|haloperidol|mesh-list
153588010|NCT01785290|Haloperidol decanoate|haloperidol decanoate|mesh-list
153588011|NCT01785290|Antiemetics|antiemetics|mesh-ancestor
153588012|NCT01785290|Autonomic Agents|autonomic agents|mesh-ancestor
153588013|NCT01785290|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153459361|NCT00003816|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153459362|NCT00003816|Immunologic Factors|immunologic factors|mesh-ancestor
153588325|NCT01787357|Moxifloxacin|moxifloxacin|mesh-list
153588475|NCT01788462|Tesamorelin|tesamorelin|mesh-list
153588930|NCT01798446|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153589205|NCT01801774|Hormones|hormones|mesh-ancestor
153589206|NCT01801774|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153589207|NCT01801774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153589208|NCT01801774|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153589210|NCT01801774|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153459363|NCT00003816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153459364|NCT00003816|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153459365|NCT00003816|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153459366|NCT00003816|Alkylating Agents|alkylating agents|mesh-ancestor
153589570|NCT01804595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153589793|NCT01808898|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153590194|NCT01812096|Bortezomib|bortezomib|mesh-list
153590435|NCT01813552|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153590436|NCT01813552|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
153590437|NCT01813552|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153590438|NCT01813552|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
153590439|NCT01813565|Hyaluronic Acid|hyaluronic acid|mesh-list
153590440|NCT01813565|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153590441|NCT01813565|Immunologic Factors|immunologic factors|mesh-ancestor
153590442|NCT01813565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153590464|NCT01813617|Abortifacient Agents|abortifacient agents|mesh-ancestor
153590465|NCT01813617|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153590466|NCT01813617|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153590467|NCT01813617|Antimetabolites|antimetabolites|mesh-ancestor
153590468|NCT01813617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153590469|NCT01813617|Dermatologic Agents|dermatologic agents|mesh-ancestor
153590470|NCT01813617|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153590471|NCT01813617|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153590472|NCT01813617|Immunologic Factors|immunologic factors|mesh-ancestor
153590473|NCT01813617|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153590528|NCT01813955|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
153818007|NCT05698407|Narcotics|narcotics|mesh-ancestor
153590529|NCT01813955|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153590530|NCT01813955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153590531|NCT01813955|Vasodilator Agents|vasodilator agents|mesh-ancestor
153590532|NCT01813955|Urological Agents|urological agents|mesh-ancestor
153590533|NCT01813981|Caffeine|caffeine|mesh-list
153590534|NCT01813981|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
153590535|NCT01813981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153590536|NCT01813981|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
153590537|NCT01813981|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153590538|NCT01813981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153590539|NCT01813981|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
153818015|NCT05690087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153818016|NCT05690087|Sensory System Agents|sensory system agents|mesh-ancestor
153818017|NCT05690087|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153818018|NCT05690087|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153818019|NCT05690087|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
153818020|NCT05690087|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153818021|NCT05690087|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153590638|NCT01814423|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153590639|NCT01814423|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153590640|NCT01814423|Antimalarials|antimalarials|mesh-ancestor
153590641|NCT01814423|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153590642|NCT01814423|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153590643|NCT01814423|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153590645|NCT01814423|Sensory System Agents|sensory system agents|mesh-ancestor
153590646|NCT01814423|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153781707|NCT04561336|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153590647|NCT01814423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153590648|NCT01814423|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153590649|NCT01814423|Filaricides|filaricides|mesh-ancestor
153590650|NCT01814423|Antinematodal Agents|antinematodal agents|mesh-ancestor
153590653|NCT01814449|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153818034|NCT05676112|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153818035|NCT05676112|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153818036|NCT05676112|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153818037|NCT05668650|Pembrolizumab|pembrolizumab|mesh-list
153818038|NCT05668650|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153818039|NCT05668650|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153818040|NCT05668650|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153459414|NCT03826992|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153459415|NCT03826992|Antimetabolites|antimetabolites|mesh-ancestor
153459416|NCT03826992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153459417|NCT03826992|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153459418|NCT03826992|Antiviral Agents|antiviral agents|mesh-ancestor
153590675|NCT01814475|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153590714|NCT01814618|Autonomic Agents|autonomic agents|mesh-ancestor
153590715|NCT01814618|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153590716|NCT01814618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153590717|NCT01814618|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153590718|NCT01814618|Respiratory System Agents|respiratory system agents|mesh-ancestor
153590719|NCT01814618|Glucocorticoids|glucocorticoids|mesh-ancestor
153590720|NCT01814618|Hormones|hormones|mesh-ancestor
153590721|NCT01814618|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153590722|NCT01814683|Primaquine|primaquine|mesh-list
153590723|NCT01814683|Antimalarials|antimalarials|mesh-ancestor
153459424|NCT03826992|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153459425|NCT03826992|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153459426|NCT03826992|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153459428|NCT00004092|Cyclophosphamide|cyclophosphamide|mesh-list
153459429|NCT00004092|Carboplatin|carboplatin|mesh-list
153459430|NCT00004092|Doxorubicin|doxorubicin|mesh-list
153459431|NCT00004092|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
153590764|NCT01814865|Hormones|hormones|mesh-ancestor
153590775|NCT01814891|Vitamin A|vitamin a|mesh-list
153590863|NCT01815541|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153590865|NCT01815658|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
153590866|NCT01815658|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153590867|NCT01815723|Dimethyl Fumarate|dimethyl fumarate|mesh-list
153590868|NCT01815723|Dermatologic Agents|dermatologic agents|mesh-ancestor
153590869|NCT01815723|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153590870|NCT01815723|Immunologic Factors|immunologic factors|mesh-ancestor
153370715|NCT02980757|Gliclazide|gliclazide|mesh-list
153590871|NCT01815723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153459474|NCT03825198|Glucocorticoids|glucocorticoids|mesh-ancestor
153459475|NCT03825198|Hormones|hormones|mesh-ancestor
153590873|NCT01815892|Diuretics|diuretics|mesh-ancestor
153590874|NCT01815892|Natriuretic Agents|natriuretic agents|mesh-ancestor
153590879|NCT01815944|Ropivacaine|ropivacaine|mesh-list
153590897|NCT01816035|Mitosis Modulators|mitosis modulators|mesh-ancestor
153590898|NCT01816035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153590899|NCT01816035|Immunotoxins|immunotoxins|mesh-ancestor
153590900|NCT01816035|Immunologic Factors|immunologic factors|mesh-ancestor
153590901|NCT01816035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153590902|NCT01816191|Diltiazem|diltiazem|mesh-list
153590903|NCT01816191|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153590904|NCT01816191|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153590905|NCT01816191|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153590906|NCT01816191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153590951|NCT01816490|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153590952|NCT01816490|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153590953|NCT01816490|Protective Agents|protective agents|mesh-ancestor
153590954|NCT01816490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153590956|NCT01816529|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153590957|NCT01816529|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153590958|NCT01816529|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153590959|NCT01816529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153590962|NCT01816529|Vasodilator Agents|vasodilator agents|mesh-ancestor
153591003|NCT01816646|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153591004|NCT01816646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153591006|NCT01816659|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153591007|NCT01816659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153591008|NCT01816789|Buserelin|buserelin|mesh-list
153591009|NCT01816789|Fertility Agents, Female|fertility agents, female|mesh-ancestor
153591010|NCT01816789|Fertility Agents|fertility agents|mesh-ancestor
153591028|NCT01816997|Pravastatin|pravastatin|mesh-list
153591029|NCT01816997|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153591030|NCT01816997|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153591031|NCT01816997|Antimetabolites|antimetabolites|mesh-ancestor
153591032|NCT01816997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153591033|NCT01816997|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153591034|NCT01816997|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
153591035|NCT01816997|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153591036|NCT01817023|Cisplatin|cisplatin|mesh-list
153591086|NCT01817322|Protective Agents|protective agents|mesh-ancestor
153591087|NCT01817322|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153591088|NCT01817322|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153591089|NCT01817322|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153591090|NCT01817322|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
153591091|NCT01817322|Antitubercular Agents|antitubercular agents|mesh-ancestor
153591092|NCT01817322|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153591094|NCT01817322|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153591164|NCT01817803|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
153591166|NCT01817816|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
153591167|NCT01817816|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
153591213|NCT01818648|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153591214|NCT01818648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153591215|NCT01818648|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
153591216|NCT01818648|Incretins|incretins|mesh-ancestor
153591217|NCT01818648|Hormones|hormones|mesh-ancestor
153591218|NCT01818648|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153591219|NCT01818713|Doxorubicin|doxorubicin|mesh-list
153459519|NCT06125834|Tubulin Modulators|tubulin modulators|mesh-ancestor
153459521|NCT06125834|Mitosis Modulators|mitosis modulators|mesh-ancestor
153459522|NCT06125834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153459523|NCT06125834|Immunotoxins|immunotoxins|mesh-ancestor
153459524|NCT06125834|Immunoconjugates|immunoconjugates|mesh-ancestor
153591220|NCT01818713|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
153818137|NCT05571644|Micronutrients|micronutrients|mesh-ancestor
153818138|NCT05545137|Fosfomycin|fosfomycin|mesh-list
153818139|NCT05545137|Amdinocillin Pivoxil|amdinocillin pivoxil|mesh-list
153818140|NCT05545137|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153818141|NCT05545137|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153818142|NCT05545137|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
153818149|NCT05539027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153818150|NCT05511246|Ethanol|ethanol|mesh-list
153818151|NCT05511246|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
153818154|NCT05511246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153591338|NCT01819285|Hormones|hormones|mesh-ancestor
153591379|NCT01819649|Selenium|selenium|mesh-list
153591435|NCT01819870|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
153591437|NCT01819961|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
153591438|NCT01819961|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
153591439|NCT01819961|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
153591440|NCT01819961|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
153591441|NCT01820026|Amoxicillin|amoxicillin|mesh-list
153591442|NCT01820026|Azithromycin|azithromycin|mesh-list
153591443|NCT01820026|Vancomycin|vancomycin|mesh-list
153591444|NCT01820026|Imipenem|imipenem|mesh-list
153818182|NCT05411497|Immunologic Factors|immunologic factors|mesh-ancestor
153818183|NCT05411497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153818184|NCT05411497|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153818185|NCT05411497|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153591446|NCT01820026|Cefotaxime|cefotaxime|mesh-list
153818196|NCT05351385|Dimercaprol|dimercaprol|mesh-list
153818197|NCT05351385|Chelating Agents|chelating agents|mesh-ancestor
153591481|NCT01820312|Paclitaxel|paclitaxel|mesh-list
153591521|NCT01820455|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153591522|NCT01820455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153459605|NCT06124560|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
153459606|NCT06124560|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153459607|NCT06124560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153459608|NCT06124560|Incretins|incretins|mesh-ancestor
153459609|NCT06124560|Hormones|hormones|mesh-ancestor
153459612|NCT06124560|Protease Inhibitors|protease inhibitors|mesh-ancestor
153818234|NCT05175131|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153818235|NCT05175131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153818236|NCT05162976|Nivolumab|nivolumab|mesh-list
153459616|NCT06124547|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
153591568|NCT01820897|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
153591570|NCT01820897|Antimalarials|antimalarials|mesh-ancestor
153591596|NCT01821001|Dopamine Agonists|dopamine agonists|mesh-ancestor
153591597|NCT01821001|Dopamine Agents|dopamine agents|mesh-ancestor
153591598|NCT01821001|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153591599|NCT01821001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153591600|NCT01821027|Canagliflozin|canagliflozin|mesh-list
153591601|NCT01821027|Simvastatin|simvastatin|mesh-list
153591602|NCT01821027|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153591603|NCT01821027|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153591604|NCT01821027|Antimetabolites|antimetabolites|mesh-ancestor
153591605|NCT01821027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153818285|NCT05081609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153459668|NCT06123884|Growth Substances|growth substances|mesh-ancestor
153459669|NCT06123884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153459670|NCT06123884|Growth Inhibitors|growth inhibitors|mesh-ancestor
153459671|NCT06123884|Immunologic Factors|immunologic factors|mesh-ancestor
153459673|NCT06123702|Anticonvulsants|anticonvulsants|mesh-ancestor
153591619|NCT01821040|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153591620|NCT01821066|Tamoxifen|tamoxifen|mesh-list
153591621|NCT01821066|Palbociclib|palbociclib|mesh-list
153591622|NCT01821066|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
153591623|NCT01821066|Hormone Antagonists|hormone antagonists|mesh-ancestor
153591624|NCT01821066|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153591625|NCT01821066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153591626|NCT01821066|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153591627|NCT01821066|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153591634|NCT01821170|Methylphenidate|methylphenidate|mesh-list
153591640|NCT01821170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153591641|NCT01821170|Dopamine Agents|dopamine agents|mesh-ancestor
153591642|NCT01821170|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153591643|NCT01821235|Gabapentin|gabapentin|mesh-list
153591644|NCT01821235|Analgesics|analgesics|mesh-ancestor
153591645|NCT01821235|Sensory System Agents|sensory system agents|mesh-ancestor
153591646|NCT01821235|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153591647|NCT01821235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153591685|NCT01821404|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153591798|NCT01822405|Tocotrienols|tocotrienols|mesh-list
153591799|NCT01822405|alpha-Tocopherol|alpha-tocopherol|mesh-list
153591800|NCT01822405|Pentoxifylline|pentoxifylline|mesh-list
153591860|NCT01822639|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
153591861|NCT01822639|Protease Inhibitors|protease inhibitors|mesh-ancestor
153591862|NCT01822730|Risperidone|risperidone|mesh-list
153591863|NCT01822730|Paliperidone Palmitate|paliperidone palmitate|mesh-list
153591864|NCT01822730|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153591865|NCT01822730|Serotonin Agents|serotonin agents|mesh-ancestor
153591866|NCT01822730|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153591869|NCT01822730|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153591921|NCT01822509|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153591922|NCT01822509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153591923|NCT01823042|Azathioprine|azathioprine|mesh-list
153591924|NCT01823042|Antimetabolites|antimetabolites|mesh-ancestor
153591925|NCT01823042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153591926|NCT01823042|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153591927|NCT01823042|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153591928|NCT01823042|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153591929|NCT01823042|Immunologic Factors|immunologic factors|mesh-ancestor
153591930|NCT01823042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153591931|NCT01823042|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153591932|NCT01823081|Bevacizumab|bevacizumab|mesh-list
153591933|NCT01823081|Fasudil|fasudil|mesh-list
153591934|NCT01823081|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153591935|NCT01823081|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153591936|NCT01823081|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153591937|NCT01823081|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153591938|NCT01823081|Growth Substances|growth substances|mesh-ancestor
153591939|NCT01823081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153591940|NCT01823081|Growth Inhibitors|growth inhibitors|mesh-ancestor
153591941|NCT01823081|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153591942|NCT01823081|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153591943|NCT01823081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153591944|NCT01823081|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153818314|NCT05041062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153818316|NCT05040126|Bedaquiline|bedaquiline|mesh-list
153818317|NCT05040126|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153818318|NCT05040126|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153818319|NCT05040126|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
153592008|NCT01823809|Purinergic Agents|purinergic agents|mesh-ancestor
153592011|NCT01823965|Ranibizumab|ranibizumab|mesh-list
153818330|NCT04973345|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153818331|NCT04973345|Autonomic Agents|autonomic agents|mesh-ancestor
153818332|NCT04973345|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153818333|NCT04973345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153818334|NCT04973345|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153818335|NCT04973345|Respiratory System Agents|respiratory system agents|mesh-ancestor
153818336|NCT04973345|Sympathomimetics|sympathomimetics|mesh-ancestor
153818337|NCT04973345|Tocolytic Agents|tocolytic agents|mesh-ancestor
153818338|NCT04973345|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153818339|NCT04973345|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
153818340|NCT04973345|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
153818341|NCT04973345|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153592099|NCT01824524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153592101|NCT01824524|Sensory System Agents|sensory system agents|mesh-ancestor
153592102|NCT01824524|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153459735|NCT06119893|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153459736|NCT06119893|Glucocorticoids|glucocorticoids|mesh-ancestor
153459737|NCT06119893|Hormones|hormones|mesh-ancestor
153459738|NCT06119893|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153459739|NCT06119893|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153459740|NCT06119893|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153459741|NCT06118619|Interferons|interferons|mesh-list
153592114|NCT01824758|Rocuronium|rocuronium|mesh-list
153592115|NCT01824758|Esmolol|esmolol|mesh-list
153592116|NCT01824758|Anesthetics, Local|anesthetics, local|mesh-ancestor
153818346|NCT04967417|Carboplatin|carboplatin|mesh-list
153459757|NCT06067438|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153459758|NCT06067438|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153459759|NCT06067438|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
153459760|NCT06067438|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153459761|NCT06067438|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153459762|NCT06067438|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
153592192|NCT01825083|Ketamine|ketamine|mesh-list
153818369|NCT04939662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153592395|NCT01827020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153459823|NCT05876390|Analgesics|analgesics|mesh-ancestor
153459824|NCT05876390|Sensory System Agents|sensory system agents|mesh-ancestor
153459825|NCT05876390|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153459826|NCT05876390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153459828|NCT05786768|Rituximab|rituximab|mesh-list
153459829|NCT05786768|Obinutuzumab|obinutuzumab|mesh-list
153459830|NCT05786768|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153459854|NCT05734508|Smallpox and monkeypox vaccine modified vaccinia ankara-bavarian nordic|smallpox and monkeypox vaccine modified vaccinia ankara-bavarian nordic|mesh-list
153459855|NCT05734508|Antiviral Agents|antiviral agents|mesh-ancestor
153459856|NCT05734508|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153459857|NCT05700448|Gemcitabine|gemcitabine|mesh-list
153459858|NCT05700448|Oxaliplatin|oxaliplatin|mesh-list
153459859|NCT05700448|Pegaspargase|pegaspargase|mesh-list
153459860|NCT05700448|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153592506|NCT01827540|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
153592507|NCT01827540|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153592508|NCT01827540|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153592509|NCT01827540|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153592551|NCT01827865|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153592553|NCT01827865|Analgesics|analgesics|mesh-ancestor
153592554|NCT01827865|Sensory System Agents|sensory system agents|mesh-ancestor
153818456|NCT04589754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153818457|NCT04572165|Semaglutide|semaglutide|mesh-list
153818458|NCT04572165|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
153459880|NCT05566054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153459881|NCT05566054|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153459882|NCT05566054|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153459883|NCT05552001|Sacituzumab govitecan|sacituzumab govitecan|mesh-list
153459885|NCT05552001|Immunologic Factors|immunologic factors|mesh-ancestor
153592576|NCT01827878|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
153592577|NCT01827878|Protective Agents|protective agents|mesh-ancestor
153592578|NCT01828125|Hypoglycemic Agents|hypoglycemic agents|mesh-list
153592579|NCT01828125|Glucagon|glucagon|mesh-list
153592580|NCT01828125|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153592581|NCT01828125|Hormones|hormones|mesh-ancestor
153592624|NCT01828385|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153592626|NCT01828437|Prednisolone|prednisolone|mesh-list
153592627|NCT01828437|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
153592628|NCT01828437|Methylprednisolone|methylprednisolone|mesh-list
153592629|NCT01828437|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
153592630|NCT01828437|Prednisolone acetate|prednisolone acetate|mesh-list
153592631|NCT01828437|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
153592632|NCT01828437|Prednisolone phosphate|prednisolone phosphate|mesh-list
153592633|NCT01828437|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153592634|NCT01828437|Glucocorticoids|glucocorticoids|mesh-ancestor
153592635|NCT01828437|Hormones|hormones|mesh-ancestor
153592672|NCT01828606|Ionophores|ionophores|mesh-ancestor
153592673|NCT01828606|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153459898|NCT05482542|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153459899|NCT05482542|Alkylating Agents|alkylating agents|mesh-ancestor
153592732|NCT01829334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153592734|NCT01829334|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153592744|NCT01829659|Ticagrelor|ticagrelor|mesh-list
153592848|NCT01830530|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153592849|NCT01830530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153592850|NCT01830530|Vasodilator Agents|vasodilator agents|mesh-ancestor
153592851|NCT01830530|Tocolytic Agents|tocolytic agents|mesh-ancestor
153592852|NCT01830530|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153592853|NCT01830907|Vitamins|vitamins|mesh-list
153592876|NCT01832350|Respiratory System Agents|respiratory system agents|mesh-ancestor
153592877|NCT01832350|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
153592878|NCT01832350|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
153592925|NCT01834820|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153592926|NCT01834820|Adrenergic Agents|adrenergic agents|mesh-ancestor
153592927|NCT01834820|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153592928|NCT01834820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153592929|NCT01834820|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
153592930|NCT01834820|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153592931|NCT01834820|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153592932|NCT01834820|Respiratory System Agents|respiratory system agents|mesh-ancestor
153592933|NCT01834820|Mydriatics|mydriatics|mesh-ancestor
153592934|NCT01834820|Sympathomimetics|sympathomimetics|mesh-ancestor
153592936|NCT01835197|Abrocitinib|abrocitinib|mesh-list
153592990|NCT01837290|Analgesics|analgesics|mesh-ancestor
153592991|NCT01837290|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
153592992|NCT01837290|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153592993|NCT01837290|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153592994|NCT01837290|Adrenergic Agents|adrenergic agents|mesh-ancestor
153592995|NCT01837290|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153592996|NCT01837290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153818500|NCT04532372|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153818501|NCT04532372|Immunologic Factors|immunologic factors|mesh-ancestor
153818502|NCT04532372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153459915|NCT05391828|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
153459916|NCT05391828|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153459917|NCT05391828|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
153459918|NCT05391828|Histamine Antagonists|histamine antagonists|mesh-ancestor
153593024|NCT01837446|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153593025|NCT01837446|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153593026|NCT01837446|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
153372895|NCT02641353|Apremilast|apremilast|mesh-list
153593076|NCT01840254|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153593077|NCT01840254|Analgesics|analgesics|mesh-ancestor
153593078|NCT01840254|Sensory System Agents|sensory system agents|mesh-ancestor
153593079|NCT01840254|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153593080|NCT01840254|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
153593081|NCT01840254|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153593083|NCT01840254|Adrenergic Agents|adrenergic agents|mesh-ancestor
153593084|NCT01840254|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153593085|NCT01840254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153818514|NCT04429542|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153818515|NCT04429542|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153818516|NCT04429542|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153818517|NCT04429542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153593164|NCT01841112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153593166|NCT01841125|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
153593251|NCT01841463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153593386|NCT01842321|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153459927|NCT05390736|Vitamins|vitamins|mesh-ancestor
153459928|NCT05390736|Micronutrients|micronutrients|mesh-ancestor
153459929|NCT05390736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153459930|NCT05390736|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153459931|NCT05380856|Neurotransmitter Agents|neurotransmitter agents|mesh-list
153459932|NCT05380856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153593387|NCT01842321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153593388|NCT01842321|Hormone Antagonists|hormone antagonists|mesh-ancestor
153593389|NCT01842321|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153593390|NCT01842321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153593391|NCT01842321|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153593392|NCT01842373|Lidocaine|lidocaine|mesh-list
153593393|NCT01842373|Tetracaine|tetracaine|mesh-list
153593394|NCT01842373|Benzocaine|benzocaine|mesh-list
153593395|NCT01842373|Anesthetics, Local|anesthetics, local|mesh-ancestor
153593396|NCT01842373|Anesthetics|anesthetics|mesh-ancestor
153593408|NCT01842516|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153593409|NCT01842516|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153459953|NCT05335148|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153459954|NCT05299931|Ustekinumab|ustekinumab|mesh-list
153459955|NCT05299931|Dermatologic Agents|dermatologic agents|mesh-ancestor
153459956|NCT05216432|Fulvestrant|fulvestrant|mesh-list
153459957|NCT05216432|Palbociclib|palbociclib|mesh-list
153459958|NCT05216432|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153593456|NCT01843075|Liraglutide|liraglutide|mesh-list
153593457|NCT01843075|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
153593458|NCT01843075|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153593507|NCT01843179|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153593508|NCT01843179|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153593509|NCT01843179|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153593510|NCT01843179|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153593511|NCT01843179|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153593512|NCT01843257|Ethanol|ethanol|mesh-list
153593513|NCT01843257|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
153593514|NCT01843257|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153593515|NCT01843257|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153593544|NCT01843309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153593545|NCT01843309|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
153593547|NCT01843309|Natriuretic Agents|natriuretic agents|mesh-ancestor
153593548|NCT01843439|Pyridoxine|pyridoxine|mesh-list
153593597|NCT01843829|Oxaliplatin|oxaliplatin|mesh-list
153593598|NCT01843829|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153593599|NCT01843829|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153593600|NCT01843829|Tubulin Modulators|tubulin modulators|mesh-ancestor
153593601|NCT01843829|Antimitotic Agents|antimitotic agents|mesh-ancestor
153593602|NCT01843829|Mitosis Modulators|mitosis modulators|mesh-ancestor
153593603|NCT01843829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153593604|NCT01843829|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153593605|NCT01843829|Antimetabolites|antimetabolites|mesh-ancestor
153593606|NCT01843868|Prednisolone|prednisolone|mesh-list
153593607|NCT01843868|Cyclophosphamide|cyclophosphamide|mesh-list
153593608|NCT01843868|Doxorubicin|doxorubicin|mesh-list
153593699|NCT01844323|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153593700|NCT01844323|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153593701|NCT01844323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153593702|NCT01844401|Albuterol|albuterol|mesh-list
153593703|NCT01844401|Procaterol|procaterol|mesh-list
153593704|NCT01844401|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153593705|NCT01844401|Autonomic Agents|autonomic agents|mesh-ancestor
153593708|NCT01844401|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153593744|NCT01844648|Autonomic Agents|autonomic agents|mesh-ancestor
153593745|NCT01844648|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153593746|NCT01844648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153593750|NCT01844648|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153593751|NCT01844648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153593752|NCT01844674|Vemurafenib|vemurafenib|mesh-list
153593753|NCT01844674|Tizanidine|tizanidine|mesh-list
153593754|NCT01844674|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153593756|NCT01844674|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153818610|NCT04175431|Hormone Antagonists|hormone antagonists|mesh-ancestor
153818611|NCT04175431|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153818612|NCT04115163|Paclitaxel|paclitaxel|mesh-list
153818613|NCT04115163|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
153818614|NCT04115163|Gemcitabine|gemcitabine|mesh-list
153818615|NCT04115163|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153818616|NCT04115163|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153818617|NCT04115163|Tubulin Modulators|tubulin modulators|mesh-ancestor
153818618|NCT04115163|Antimitotic Agents|antimitotic agents|mesh-ancestor
153818619|NCT04115163|Mitosis Modulators|mitosis modulators|mesh-ancestor
153818620|NCT04115163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153818622|NCT04115163|Antimetabolites|antimetabolites|mesh-ancestor
153593827|NCT01845142|Micronutrients|micronutrients|mesh-ancestor
153593828|NCT01845142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153593829|NCT01845142|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153593830|NCT01845142|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153593831|NCT01845194|Metoprolol|metoprolol|mesh-list
153593832|NCT01845194|Talinolol|talinolol|mesh-list
153593833|NCT01845194|Torsemide|torsemide|mesh-list
153593834|NCT01845194|Midazolam|midazolam|mesh-list
153593835|NCT01845194|Codeine|codeine|mesh-list
153593836|NCT01845194|Caffeine|caffeine|mesh-list
153593837|NCT01845194|Pravastatin|pravastatin|mesh-list
153593838|NCT01845194|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153593839|NCT01845194|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153593840|NCT01845194|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153593841|NCT01845194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153593842|NCT01845194|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153593843|NCT01845194|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153593844|NCT01845194|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153593941|NCT01845532|Anesthetics|anesthetics|mesh-ancestor
153594078|NCT01846832|Immunologic Factors|immunologic factors|mesh-ancestor
153594079|NCT01846832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153594080|NCT01846832|Protease Inhibitors|protease inhibitors|mesh-ancestor
153594081|NCT01846832|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153594082|NCT01846962|Fluticasone|fluticasone|mesh-list
153594083|NCT01846962|Budesonide|budesonide|mesh-list
153594084|NCT01846962|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153594085|NCT01846962|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153594086|NCT01846962|Autonomic Agents|autonomic agents|mesh-ancestor
153594087|NCT01846962|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153594088|NCT01846962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153594116|NCT01847157|Anesthetics|anesthetics|mesh-list
153594117|NCT01847157|Prilocaine|prilocaine|mesh-list
153594118|NCT01847157|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153594119|NCT01847157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153594120|NCT01847157|Anesthetics, Local|anesthetics, local|mesh-ancestor
153594121|NCT01847157|Sensory System Agents|sensory system agents|mesh-ancestor
153594122|NCT01847157|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153594123|NCT01847235|Temozolomide|temozolomide|mesh-list
153594124|NCT01847235|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153594149|NCT01847456|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153594150|NCT01847456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153594151|NCT01847495|Irinotecan|irinotecan|mesh-list
153594158|NCT01847521|Antioxidants|antioxidants|mesh-ancestor
153594283|NCT01848236|Ergocalciferols|ergocalciferols|mesh-list
153594284|NCT01848236|Cholecalciferol|cholecalciferol|mesh-list
153594285|NCT01848236|Vitamins|vitamins|mesh-list
153594349|NCT01848743|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153814335|NCT00338546|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153594355|NCT01848769|Beclomethasone|beclomethasone|mesh-list
153594584|NCT01850680|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153594679|NCT01851408|Temsirolimus|temsirolimus|mesh-list
153594680|NCT01851408|MTOR Inhibitors|mtor inhibitors|mesh-list
153594681|NCT01851408|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153594682|NCT01851408|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153818742|NCT03880019|Olaparib|olaparib|mesh-list
153594708|NCT01851473|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
153594709|NCT01851473|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153594710|NCT01851473|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153594711|NCT01851473|Dopamine Agents|dopamine agents|mesh-ancestor
153594712|NCT01851473|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153594713|NCT01851473|Antimalarials|antimalarials|mesh-ancestor
153594714|NCT01851473|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153594715|NCT01851473|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153594716|NCT01851473|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153594717|NCT01851473|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
153594718|NCT01851473|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
153594719|NCT01851473|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153594720|NCT01851473|Analgesics|analgesics|mesh-ancestor
153594721|NCT01851486|Clonidine|clonidine|mesh-list
153594722|NCT01851486|Naloxone|naloxone|mesh-list
153594723|NCT01851486|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
153594724|NCT01851486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153594725|NCT01851486|Sensory System Agents|sensory system agents|mesh-ancestor
153594726|NCT01851486|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153594727|NCT01851486|Analgesics|analgesics|mesh-ancestor
153594752|NCT01851681|Amoxicillin|amoxicillin|mesh-list
153818775|NCT03864419|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153818776|NCT03864419|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153818777|NCT03864419|Glucocorticoids|glucocorticoids|mesh-ancestor
153460178|NCT04294576|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153460179|NCT04294576|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153460180|NCT04294576|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153460181|NCT04294576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153460182|NCT04274361|Ketamine|ketamine|mesh-list
153460183|NCT04274361|Analgesics|analgesics|mesh-ancestor
153460184|NCT04274361|Sensory System Agents|sensory system agents|mesh-ancestor
153594925|NCT01852903|Micronutrients|micronutrients|mesh-ancestor
153594954|NCT01853111|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153594955|NCT01853306|Veliparib|veliparib|mesh-list
153460195|NCT04274361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153460196|NCT04218825|Mechlorethamine|mechlorethamine|mesh-list
153460197|NCT04218825|Alkylating Agents|alkylating agents|mesh-ancestor
153460198|NCT04218825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153460199|NCT04218825|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153460200|NCT04218825|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153595000|NCT01853787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153595001|NCT01853787|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153595002|NCT01853787|Respiratory System Agents|respiratory system agents|mesh-ancestor
153595003|NCT01853787|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
153595004|NCT01853787|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
153595005|NCT01853787|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153595006|NCT01853787|Adrenergic Agents|adrenergic agents|mesh-ancestor
153595007|NCT01853787|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153595034|NCT01853956|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153595035|NCT01853956|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153595036|NCT01853956|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153595037|NCT01853956|GABA Modulators|gaba modulators|mesh-ancestor
153595038|NCT01853956|GABA Agents|gaba agents|mesh-ancestor
153595039|NCT01853956|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153595040|NCT01853956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153595041|NCT01854021|Anesthetics|anesthetics|mesh-list
153818816|NCT03809793|Acipimox|acipimox|mesh-list
153595061|NCT01854086|Diphosphonates|diphosphonates|mesh-list
153595062|NCT01854086|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153595063|NCT01854086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153595065|NCT01854203|Gemcitabine|gemcitabine|mesh-list
153595066|NCT01854203|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153595067|NCT01854203|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153595068|NCT01854203|Antimetabolites|antimetabolites|mesh-ancestor
153595069|NCT01854203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153595071|NCT01854216|Dopamine Agonists|dopamine agonists|mesh-ancestor
153595072|NCT01854216|Dopamine Agents|dopamine agents|mesh-ancestor
153595073|NCT01854216|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153595074|NCT01854216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153595075|NCT01854216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153595076|NCT01854411|Analgesics|analgesics|mesh-list
153595108|NCT01854489|Antitubercular Agents|antitubercular agents|mesh-ancestor
153595109|NCT01854489|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153595110|NCT01854489|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153595111|NCT01854489|Leprostatic Agents|leprostatic agents|mesh-ancestor
153595112|NCT01854489|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153595113|NCT01854489|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153595114|NCT01854489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153595115|NCT01854489|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
153460218|NCT04198727|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153460219|NCT04198727|Antimetabolites|antimetabolites|mesh-ancestor
153460220|NCT04198727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153460221|NCT04198727|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153460222|NCT04128072|Mogamulizumab|mogamulizumab|mesh-list
153460223|NCT04128072|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153460224|NCT04095364|Paclitaxel|paclitaxel|mesh-list
153460225|NCT04095364|Carboplatin|carboplatin|mesh-list
153595152|NCT01854606|Immunologic Factors|immunologic factors|mesh-ancestor
153595153|NCT01854606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153595154|NCT01854606|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153595155|NCT01854619|Anti-Infective Agents|anti-infective agents|mesh-list
153595156|NCT01854619|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
153595177|NCT01854762|Antiviral Agents|antiviral agents|mesh-ancestor
153595178|NCT01854762|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153595179|NCT01854762|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
153595180|NCT01854762|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153595181|NCT01854762|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
153595182|NCT01854762|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
153595183|NCT01854970|Esomeprazole|esomeprazole|mesh-list
153595184|NCT01854970|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
153595189|NCT01855009|Calcium, Dietary|calcium, dietary|mesh-list
153595216|NCT01855061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153595217|NCT01855100|Rivaroxaban|rivaroxaban|mesh-list
153595218|NCT01855100|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
153595219|NCT01855100|Antithrombins|antithrombins|mesh-ancestor
153595220|NCT01855100|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
153595221|NCT01855100|Protease Inhibitors|protease inhibitors|mesh-ancestor
153595222|NCT01855100|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153595223|NCT01855100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153595224|NCT01855100|Anticoagulants|anticoagulants|mesh-ancestor
153595225|NCT01855139|Rivaroxaban|rivaroxaban|mesh-list
153595226|NCT01855139|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
153595227|NCT01855139|Antithrombins|antithrombins|mesh-ancestor
153595263|NCT01855490|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153595264|NCT01855490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153595265|NCT01855490|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
153595266|NCT01855490|Incretins|incretins|mesh-ancestor
153595267|NCT01855490|Hormones|hormones|mesh-ancestor
153595268|NCT01855490|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153595269|NCT01855516|Heparin|heparin|mesh-list
153595270|NCT01855516|Anticoagulants|anticoagulants|mesh-ancestor
153595271|NCT01855516|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153595308|NCT01855581|Propofol|propofol|mesh-list
153595309|NCT01855581|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153595310|NCT01855581|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153460251|NCT03969420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153460252|NCT03969420|Growth Inhibitors|growth inhibitors|mesh-ancestor
153460253|NCT03969420|Growth Substances|growth substances|mesh-ancestor
153460255|NCT03969420|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153460256|NCT03921242|Metformin|metformin|mesh-list
153460257|NCT03921242|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
153595311|NCT01855581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153595312|NCT01855581|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153595313|NCT01855581|Anesthetics, General|anesthetics, general|mesh-ancestor
153595342|NCT01855724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153595343|NCT01855724|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153595344|NCT01855737|Warfarin|warfarin|mesh-list
153595345|NCT01855737|Anticoagulants|anticoagulants|mesh-ancestor
153595346|NCT01855763|Insulin|insulin|mesh-list
153595347|NCT01855763|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
153595348|NCT01855763|Metformin|metformin|mesh-list
153595349|NCT01855763|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153460261|NCT03921242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153460262|NCT03921242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153460263|NCT03921242|Protease Inhibitors|protease inhibitors|mesh-ancestor
153595389|NCT01856101|Immunologic Factors|immunologic factors|mesh-ancestor
153595390|NCT01856101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153595391|NCT01856127|Sertraline|sertraline|mesh-list
153595392|NCT01856127|Vilazodone Hydrochloride|vilazodone hydrochloride|mesh-list
153595435|NCT01856374|Sirolimus|sirolimus|mesh-list
153595436|NCT01856374|Everolimus|everolimus|mesh-list
153595437|NCT01856374|Atorvastatin|atorvastatin|mesh-list
153595438|NCT01856374|Pravastatin|pravastatin|mesh-list
153595439|NCT01856374|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153595440|NCT01856374|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153595441|NCT01856374|Antimetabolites|antimetabolites|mesh-ancestor
153595442|NCT01856374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153595443|NCT01856374|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153595444|NCT01856374|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
153595445|NCT01856374|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153460267|NCT03914443|Nivolumab|nivolumab|mesh-list
153460268|NCT03914443|Fluorouracil|fluorouracil|mesh-list
153595474|NCT01856556|Glycine Agents|glycine agents|mesh-ancestor
153595475|NCT01856556|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153595476|NCT01856556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153595477|NCT01856556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153595478|NCT01856621|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
153818881|NCT03598270|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
153818882|NCT03598270|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153818883|NCT03598270|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153818884|NCT03598270|Tubulin Modulators|tubulin modulators|mesh-ancestor
153818885|NCT03598270|Antimitotic Agents|antimitotic agents|mesh-ancestor
153818886|NCT03598270|Mitosis Modulators|mitosis modulators|mesh-ancestor
153818887|NCT03598270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153818888|NCT03598270|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153818889|NCT03598270|Antimetabolites|antimetabolites|mesh-ancestor
153595512|NCT01856946|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153595514|NCT01856959|Albuterol|albuterol|mesh-list
153595515|NCT01856959|Analgesics|analgesics|mesh-ancestor
153460301|NCT03716349|Anesthetics, Local|anesthetics, local|mesh-list
153595531|NCT01856959|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153595532|NCT01856959|Respiratory System Agents|respiratory system agents|mesh-ancestor
153595533|NCT01856959|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
153595534|NCT01856959|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
153595535|NCT01856959|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153595536|NCT01856959|Adrenergic Agents|adrenergic agents|mesh-ancestor
153595538|NCT01856985|Misoprostol|misoprostol|mesh-list
153818890|NCT03598270|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153818891|NCT03598270|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153818892|NCT03598270|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153818893|NCT03598270|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153595653|NCT01857479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153595717|NCT01857804|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
153595718|NCT01857804|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153595719|NCT01857804|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
153595720|NCT01857804|Disinfectants|disinfectants|mesh-ancestor
153595721|NCT01857804|Dermatologic Agents|dermatologic agents|mesh-ancestor
153595722|NCT01857817|Etodolac|etodolac|mesh-list
153595723|NCT01857817|Propranolol|propranolol|mesh-list
153595724|NCT01857817|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
153595725|NCT01857817|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
153595776|NCT01857895|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153595778|NCT01857921|Atorvastatin|atorvastatin|mesh-list
153595779|NCT01857921|Pravastatin|pravastatin|mesh-list
153595780|NCT01857921|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153595781|NCT01857921|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153595782|NCT01857921|Antimetabolites|antimetabolites|mesh-ancestor
153595783|NCT01857921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153595784|NCT01857921|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153595785|NCT01857921|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
153595786|NCT01857921|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153595788|NCT01857999|Losartan|losartan|mesh-list
153595884|NCT01858155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153595885|NCT01858155|Protective Agents|protective agents|mesh-ancestor
153595886|NCT01858155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153595887|NCT01858155|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153814337|NCT00338546|Adrenergic Agents|adrenergic agents|mesh-ancestor
153814338|NCT00338546|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153818917|NCT03517969|Mitosis Modulators|mitosis modulators|mesh-ancestor
153818918|NCT03517969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153818919|NCT03517722|Ustekinumab|ustekinumab|mesh-list
153818920|NCT03517722|Dermatologic Agents|dermatologic agents|mesh-ancestor
153460337|NCT03677141|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153460338|NCT03677141|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153460339|NCT03677141|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153460340|NCT03677141|Glucocorticoids|glucocorticoids|mesh-ancestor
153460341|NCT03677141|Hormones|hormones|mesh-ancestor
153460342|NCT03677141|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153460343|NCT03677141|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153595912|NCT01858402|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153595913|NCT01858402|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153595914|NCT01858402|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153595915|NCT01858441|Abiraterone Acetate|abiraterone acetate|mesh-list
153595916|NCT01858441|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153595977|NCT01858623|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
153595978|NCT01858623|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153595980|NCT01858649|Oxaliplatin|oxaliplatin|mesh-list
153595981|NCT01858649|Irinotecan|irinotecan|mesh-list
153595982|NCT01858649|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153595983|NCT01858649|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153595984|NCT01858649|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153595985|NCT01858649|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153596024|NCT01858870|Anticonvulsants|anticonvulsants|mesh-ancestor
153596025|NCT01858870|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
153596026|NCT01858870|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153596027|NCT01858870|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153818968|NCT03414502|Leflunomide|leflunomide|mesh-list
153818969|NCT03414502|Tofacitinib|tofacitinib|mesh-list
153818970|NCT03414502|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153818971|NCT03414502|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153818972|NCT03414502|Immunologic Factors|immunologic factors|mesh-ancestor
153818973|NCT03414502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153818974|NCT03414502|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153596052|NCT01859234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153596053|NCT01859377|Ibuprofen|ibuprofen|mesh-list
153596054|NCT01859377|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153596055|NCT01859377|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153596056|NCT01859377|Analgesics|analgesics|mesh-ancestor
153596057|NCT01859377|Sensory System Agents|sensory system agents|mesh-ancestor
153596058|NCT01859377|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153596059|NCT01859377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153596060|NCT01859377|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153596061|NCT01859377|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153596062|NCT01859377|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153596063|NCT01859377|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153596064|NCT01859377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153818987|NCT03414502|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153818988|NCT03414502|Antimalarials|antimalarials|mesh-ancestor
153818989|NCT03414502|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153818990|NCT03414502|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153818991|NCT03414502|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153818992|NCT03414502|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153818993|NCT03414502|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153818994|NCT03414502|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153818995|NCT03414502|Analgesics|analgesics|mesh-ancestor
153818996|NCT03414502|Sensory System Agents|sensory system agents|mesh-ancestor
153818997|NCT03414502|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153818998|NCT03414502|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153596122|NCT01859728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153596123|NCT01859728|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
153596124|NCT01859728|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153596125|NCT01859728|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153596126|NCT01859754|gamma-Globulins|gamma-globulins|mesh-list
153596127|NCT01859754|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
153596128|NCT01859754|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
153596129|NCT01859754|Immunologic Factors|immunologic factors|mesh-ancestor
153596130|NCT01859754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153596131|NCT01860014|Poractant alfa|poractant alfa|mesh-list
153596133|NCT01860014|Pulmonary Surfactants|pulmonary surfactants|mesh-ancestor
153596134|NCT01860014|Respiratory System Agents|respiratory system agents|mesh-ancestor
153596135|NCT01860066|Fluticasone|fluticasone|mesh-list
153596136|NCT01860066|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
153596137|NCT01860066|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
153596138|NCT01860066|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153596139|NCT01860066|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153596140|NCT01860066|Autonomic Agents|autonomic agents|mesh-ancestor
153596158|NCT01860105|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153596159|NCT01860105|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
153596166|NCT01860144|Bevacizumab|bevacizumab|mesh-list
153820704|NCT00434135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153596191|NCT01860196|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153596193|NCT01860235|Benzocaine|benzocaine|mesh-list
153596194|NCT01860235|Anesthetics, Local|anesthetics, local|mesh-list
153596195|NCT01860235|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153596196|NCT01860235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153596197|NCT01860235|Sensory System Agents|sensory system agents|mesh-ancestor
153596198|NCT01860235|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153596242|NCT01860625|Nootropic Agents|nootropic agents|mesh-ancestor
153596243|NCT01860638|Bevacizumab|bevacizumab|mesh-list
153596244|NCT01860638|Temozolomide|temozolomide|mesh-list
153596245|NCT01860638|Lomustine|lomustine|mesh-list
153596246|NCT01860638|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153460438|NCT03384836|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153460439|NCT03384836|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153460441|NCT03336333|Rituximab|rituximab|mesh-list
153460442|NCT03336333|Venetoclax|venetoclax|mesh-list
153460443|NCT03336333|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
153460444|NCT03336333|Zanubrutinib|zanubrutinib|mesh-list
153460445|NCT03336333|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153596303|NCT01860781|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
153460460|NCT03240068|Vasodilator Agents|vasodilator agents|mesh-ancestor
153460461|NCT03240068|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
153596363|NCT01861223|Nimotuzumab|nimotuzumab|mesh-list
153596364|NCT01861223|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153596365|NCT01861223|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153596366|NCT01861223|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153596367|NCT01861223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153596368|NCT01861223|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153596369|NCT01861223|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153596370|NCT01861340|Dexamethasone|dexamethasone|mesh-list
153596371|NCT01861340|Lenalidomide|lenalidomide|mesh-list
153596372|NCT01861340|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153460487|NCT03033342|Omeprazole|omeprazole|mesh-list
153460488|NCT03033342|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
153460489|NCT03033342|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153460490|NCT03033342|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
153819074|NCT03258593|Anesthetics|anesthetics|mesh-ancestor
153819075|NCT03258593|Antiemetics|antiemetics|mesh-ancestor
153819076|NCT03258593|Autonomic Agents|autonomic agents|mesh-ancestor
153596452|NCT01862081|Docetaxel|docetaxel|mesh-list
153596453|NCT01862081|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153596454|NCT01862081|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153596455|NCT01862081|Tubulin Modulators|tubulin modulators|mesh-ancestor
153596456|NCT01862081|Antimitotic Agents|antimitotic agents|mesh-ancestor
153596457|NCT01862081|Mitosis Modulators|mitosis modulators|mesh-ancestor
153596458|NCT01862081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153596459|NCT01862120|Interleukin-2|interleukin-2|mesh-list
153596462|NCT01862120|Analgesics|analgesics|mesh-ancestor
153460512|NCT02957968|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153460513|NCT02957968|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153460514|NCT02957968|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153460515|NCT02957968|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153596494|NCT01862497|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
153596496|NCT01862497|Adrenergic Agents|adrenergic agents|mesh-ancestor
153596497|NCT01862497|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153596500|NCT01862497|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153819127|NCT03125928|Tubulin Modulators|tubulin modulators|mesh-ancestor
153596560|NCT01863069|Interferon beta-1a|interferon beta-1a|mesh-list
153596561|NCT01863069|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153596562|NCT01863069|Antiviral Agents|antiviral agents|mesh-ancestor
153596563|NCT01863069|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153596616|NCT01863251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153596710|NCT01863654|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153596827|NCT01864265|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153596950|NCT01865331|Insulin Aspart|insulin aspart|mesh-list
153596951|NCT01865331|Insulin, Long-Acting|insulin, long-acting|mesh-list
153596952|NCT01865331|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153596953|NCT01865331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153596954|NCT01865500|Prednisolone|prednisolone|mesh-list
153596956|NCT01865500|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153596957|NCT01865500|Glucocorticoids|glucocorticoids|mesh-ancestor
153596958|NCT01865500|Hormones|hormones|mesh-ancestor
153596959|NCT01865500|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153596960|NCT01865500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153596961|NCT01865500|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153596962|NCT01865500|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153596963|NCT01865500|Autonomic Agents|autonomic agents|mesh-ancestor
153596964|NCT01865500|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153596965|NCT01865500|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153596966|NCT01865500|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153596967|NCT01865500|Respiratory System Agents|respiratory system agents|mesh-ancestor
153596968|NCT01865630|Etanercept|etanercept|mesh-list
153596970|NCT01865630|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153597000|NCT01865916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153597001|NCT01865916|Protective Agents|protective agents|mesh-ancestor
153819221|NCT02737046|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153819222|NCT02737046|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153819223|NCT02737046|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153819224|NCT02737046|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153819225|NCT02737046|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153819226|NCT02737046|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
153460645|NCT00716976|Sequestering Agents|sequestering agents|mesh-ancestor
153460646|NCT00634634|Sorafenib|sorafenib|mesh-list
153597026|NCT01866059|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153597027|NCT01866059|Dopamine Agents|dopamine agents|mesh-ancestor
153597028|NCT01866059|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153597029|NCT01866059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153597030|NCT01866059|Adrenergic Agents|adrenergic agents|mesh-ancestor
153597031|NCT01866059|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
153597032|NCT01866059|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153597033|NCT01866059|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153597034|NCT01866059|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
153597035|NCT01866241|Misoprostol|misoprostol|mesh-list
153597067|NCT01866488|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
153597074|NCT01866514|Lidocaine|lidocaine|mesh-list
153597142|NCT01867255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153597143|NCT01867255|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
153460657|NCT00634634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153460658|NCT00509353|Irinotecan|irinotecan|mesh-list
153460659|NCT00509353|Vincristine|vincristine|mesh-list
153460660|NCT00509353|3-Iodobenzylguanidine|3-iodobenzylguanidine|mesh-list
153460661|NCT00509353|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
153460662|NCT00509353|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153460663|NCT00509353|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153460664|NCT00509353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153460665|NCT00509353|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153597181|NCT01867502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153597182|NCT01867502|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
153597183|NCT01867502|Protease Inhibitors|protease inhibitors|mesh-ancestor
153597270|NCT01868113|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153597271|NCT01868113|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153597272|NCT01868113|Autonomic Agents|autonomic agents|mesh-ancestor
153597273|NCT01868113|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153597274|NCT01868113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153597275|NCT01868113|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153597276|NCT01868113|Respiratory System Agents|respiratory system agents|mesh-ancestor
153597277|NCT01868113|Dermatologic Agents|dermatologic agents|mesh-ancestor
153597311|NCT01868555|Insulin Aspart|insulin aspart|mesh-list
153597312|NCT01868555|Insulin, Long-Acting|insulin, long-acting|mesh-list
153597313|NCT01868555|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
153597314|NCT01868555|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153597315|NCT01868555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153597316|NCT01868568|Insulin|insulin|mesh-list
153597380|NCT01869010|Antiviral Agents|antiviral agents|mesh-ancestor
153597381|NCT01869010|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153597385|NCT01869010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153597386|NCT01869010|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153597387|NCT01869010|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153597388|NCT01869023|Gemcitabine|gemcitabine|mesh-list
153597389|NCT01869023|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153597390|NCT01869023|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153597391|NCT01869023|Antimetabolites|antimetabolites|mesh-ancestor
153597392|NCT01869023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153597393|NCT01869036|Morphine|morphine|mesh-list
153597394|NCT01869036|Anesthetics|anesthetics|mesh-list
153781721|NCT00266643|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153597395|NCT01869036|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153597396|NCT01869036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153597397|NCT01869036|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153597398|NCT01869036|Narcotics|narcotics|mesh-ancestor
153819296|NCT02446964|Tacrolimus|tacrolimus|mesh-list
153819297|NCT02446964|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153819298|NCT02446964|Immunologic Factors|immunologic factors|mesh-ancestor
153819299|NCT02446964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153819300|NCT02446964|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153819301|NCT02446964|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153819302|NCT02446964|Alkylating Agents|alkylating agents|mesh-ancestor
153819303|NCT02446964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153819304|NCT02446964|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153597474|NCT01869803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153597475|NCT01869803|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153597476|NCT01869881|Sarpogrelate|sarpogrelate|mesh-list
153597477|NCT01869881|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153597478|NCT01869881|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153597479|NCT01869881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153597480|NCT01869881|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153597481|NCT01869881|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153819312|NCT02446964|Antitubercular Agents|antitubercular agents|mesh-ancestor
153819313|NCT02446964|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153597570|NCT01870128|Antimetabolites|antimetabolites|mesh-ancestor
153819347|NCT02228681|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153597604|NCT01870219|Ketamine|ketamine|mesh-list
153597647|NCT01870440|Dexamethasone acetate|dexamethasone acetate|mesh-list
153597718|NCT01870674|YH12852|yh12852|mesh-list
153460805|NCT03524508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153460806|NCT03524508|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
153597750|NCT01870908|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
153597751|NCT01870908|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153597752|NCT01870908|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153597753|NCT01870986|Adalimumab|adalimumab|mesh-list
153597757|NCT01871129|Dexmedetomidine|dexmedetomidine|mesh-list
153819403|NCT01938261|Acetaminophen|acetaminophen|mesh-list
153597837|NCT01871662|Immunologic Factors|immunologic factors|mesh-ancestor
153597838|NCT01871662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153597839|NCT01871662|Antioxidants|antioxidants|mesh-ancestor
153597840|NCT01871662|Protective Agents|protective agents|mesh-ancestor
153597841|NCT01871662|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153597846|NCT01871675|Immunologic Factors|immunologic factors|mesh-ancestor
153597889|NCT01871701|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153597890|NCT01871701|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153597891|NCT01871740|Folic Acid|folic acid|mesh-list
153597892|NCT01871740|Enalapril|enalapril|mesh-list
153597893|NCT01871740|Enalaprilat|enalaprilat|mesh-list
153597894|NCT01871740|Maleic acid|maleic acid|mesh-list
153597895|NCT01871740|Hematinics|hematinics|mesh-ancestor
153819446|NCT01263769|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153819447|NCT01263769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153460842|NCT00089778|Interleukin-2|interleukin-2|mesh-list
153460843|NCT00089778|Mitogens|mitogens|mesh-list
153460844|NCT00089778|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153460845|NCT00089778|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153460846|NCT00089778|Analgesics|analgesics|mesh-ancestor
153460847|NCT00089778|Sensory System Agents|sensory system agents|mesh-ancestor
153460848|NCT00089778|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153819449|NCT01154764|Antifungal Agents|antifungal agents|mesh-ancestor
153819450|NCT01154764|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153819451|NCT01154764|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
153819452|NCT01154764|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153819453|NCT01154764|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153819454|NCT01154764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153819455|NCT01154764|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153819456|NCT01154764|Hormone Antagonists|hormone antagonists|mesh-ancestor
153819460|NCT01035983|Frovatriptan|frovatriptan|mesh-list
153819468|NCT01004978|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
153597938|NCT01871857|Sympathomimetics|sympathomimetics|mesh-ancestor
153597939|NCT01871857|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
153597940|NCT01871922|Atropine|atropine|mesh-list
153819472|NCT01004978|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153598057|NCT01872442|Interferon alpha-2|interferon alpha-2|mesh-list
153598058|NCT01872442|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
153598059|NCT01872442|Dasatinib|dasatinib|mesh-list
153598060|NCT01872442|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153598061|NCT01872442|Antiviral Agents|antiviral agents|mesh-ancestor
153598062|NCT01872442|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153460895|NCT00088374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153460896|NCT00087594|Ribavirin|ribavirin|mesh-list
153460897|NCT00087594|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
153598094|NCT01872494|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153598095|NCT01872494|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153598096|NCT01872494|Narcotics|narcotics|mesh-ancestor
153598097|NCT01872494|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153598098|NCT01872494|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
153460919|NCT03768960|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153460920|NCT00087126|Topotecan|topotecan|mesh-list
153460921|NCT00087126|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
153460922|NCT00087126|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153460923|NCT00087126|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153460924|NCT00087126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153460925|NCT00087126|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153598165|NCT01872858|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
153598166|NCT01872858|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
153598167|NCT01872871|Acetaminophen|acetaminophen|mesh-list
153598168|NCT01872871|Anesthetics|anesthetics|mesh-list
153598169|NCT01872871|Anesthetics, Local|anesthetics, local|mesh-list
153598170|NCT01872871|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153598172|NCT01872871|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153598207|NCT01872962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153598208|NCT01872988|Tenofovir|tenofovir|mesh-list
153598209|NCT01872988|Antiviral Agents|antiviral agents|mesh-ancestor
153598210|NCT01872988|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153598211|NCT01872988|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153598212|NCT01872988|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153598213|NCT01872988|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153598214|NCT01872988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153460946|NCT00085566|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153460947|NCT00085566|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153598263|NCT05855616|Disinfectants|disinfectants|mesh-ancestor
153598264|NCT05855590|Tranexamic Acid|tranexamic acid|mesh-list
153598265|NCT05855590|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
153598266|NCT05855590|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153598267|NCT05855590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153598268|NCT05855590|Hemostatics|hemostatics|mesh-ancestor
153598269|NCT05855590|Coagulants|coagulants|mesh-ancestor
153598270|NCT05855486|Ophthalmic Solutions|ophthalmic solutions|mesh-list
153598271|NCT05855486|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
153598272|NCT05855187|Modafinil|modafinil|mesh-list
153598273|NCT05855187|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
153598274|NCT05855187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153598275|NCT05855187|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
153598276|NCT05855187|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
153598277|NCT05855187|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
153598278|NCT05855187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153598279|NCT05855070|Verapamil|verapamil|mesh-list
153598280|NCT05855070|Hyaluronic Acid|hyaluronic acid|mesh-list
153598281|NCT05855070|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153598282|NCT05855070|Immunologic Factors|immunologic factors|mesh-ancestor
153598283|NCT05855070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153819542|NCT00671008|Insulin Aspart|insulin aspart|mesh-list
153819543|NCT00671008|Insulin Detemir|insulin detemir|mesh-list
153819544|NCT00671008|Biphasic Insulins|biphasic insulins|mesh-list
153819545|NCT00671008|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
153819546|NCT00671008|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153819547|NCT00671008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153598341|NCT05854082|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
153598342|NCT05854082|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153598343|NCT05854082|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153598344|NCT05854082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153598345|NCT05853965|Venetoclax|venetoclax|mesh-list
153598346|NCT05853965|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153598347|NCT05853718|Tenofovir|tenofovir|mesh-list
153598348|NCT05853718|Antiviral Agents|antiviral agents|mesh-ancestor
153598415|NCT05815602|Parasympatholytics|parasympatholytics|mesh-ancestor
153598416|NCT05815602|Autonomic Agents|autonomic agents|mesh-ancestor
153598417|NCT05815602|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153598418|NCT05755737|Ondansetron|ondansetron|mesh-list
153598419|NCT05755737|Antiemetics|antiemetics|mesh-ancestor
153598420|NCT05755737|Autonomic Agents|autonomic agents|mesh-ancestor
153598421|NCT05755737|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153598422|NCT05755737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153598610|NCT05225363|Alkylating Agents|alkylating agents|mesh-ancestor
153598611|NCT05225363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153598612|NCT05225363|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153598613|NCT05225363|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153598614|NCT05221229|Liraglutide|liraglutide|mesh-list
153598615|NCT05221229|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
153598616|NCT05221229|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153598617|NCT05221229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153598618|NCT05221229|Incretins|incretins|mesh-ancestor
153598619|NCT05221229|Hormones|hormones|mesh-ancestor
153598642|NCT05073822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153598643|NCT05073822|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
153598644|NCT05073822|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153598645|NCT05073822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153598646|NCT05073822|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153598647|NCT05073822|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153598648|NCT05073822|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
153598649|NCT05073822|Antitubercular Agents|antitubercular agents|mesh-ancestor
153598650|NCT05073822|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153598651|NCT05073822|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153598652|NCT05047952|Vortioxetine|vortioxetine|mesh-list
153598670|NCT05001828|Venetoclax|venetoclax|mesh-list
153598694|NCT04917484|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153819573|NCT00585559|Antidotes|antidotes|mesh-ancestor
153819574|NCT00486356|Carboplatin|carboplatin|mesh-list
153819575|NCT00486356|Capecitabine|capecitabine|mesh-list
153819576|NCT00486356|Epirubicin|epirubicin|mesh-list
153819577|NCT00486356|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153819578|NCT00486356|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153819579|NCT00486356|Antimetabolites|antimetabolites|mesh-ancestor
153819580|NCT00486356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153598724|NCT04782180|Emtricitabine tenofovir alafenamide|emtricitabine tenofovir alafenamide|mesh-list
153598726|NCT04782180|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153598727|NCT04782180|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153598728|NCT04782180|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153598729|NCT04782180|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153598730|NCT04782180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153598731|NCT04782180|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153598784|NCT04717362|Testosterone|testosterone|mesh-list
153598785|NCT04717362|Testosterone undecanoate|testosterone undecanoate|mesh-list
153598786|NCT04717362|Testosterone enanthate|testosterone enanthate|mesh-list
153598787|NCT04717362|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153598788|NCT04717362|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153598789|NCT04717362|Anabolic Agents|anabolic agents|mesh-ancestor
153598790|NCT04717362|Hormones|hormones|mesh-ancestor
153598791|NCT04717362|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153598792|NCT04717362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153598793|NCT04717362|Androgens|androgens|mesh-ancestor
153598849|NCT04041050|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
153598850|NCT04041050|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153598851|NCT04041050|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153598852|NCT04041050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153819588|NCT00475514|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153819589|NCT00475514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153819590|NCT00475514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153819591|NCT00447382|Insulin|insulin|mesh-list
153819592|NCT00447382|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
153598878|NCT03899857|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153598879|NCT03899857|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153598880|NCT03899857|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153598881|NCT03899857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153598882|NCT03871491|Azithromycin|azithromycin|mesh-list
153598883|NCT03871491|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153598884|NCT03871491|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153598885|NCT03839914|Vancomycin|vancomycin|mesh-list
153598919|NCT03664687|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153598920|NCT03664687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153598921|NCT03663504|Metronidazole|metronidazole|mesh-list
153598922|NCT03663504|Neomycin|neomycin|mesh-list
153598923|NCT03663504|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153598924|NCT03663504|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153598925|NCT03663504|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153598926|NCT03663504|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153598927|NCT03663504|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
153598928|NCT03663504|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153598929|NCT03663504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153598930|NCT03654066|Botulinum Toxins|botulinum toxins|mesh-list
153598931|NCT03654066|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
153598932|NCT03654066|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
153598933|NCT03654066|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
153598934|NCT03654066|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153598936|NCT03654066|Cholinergic Agents|cholinergic agents|mesh-ancestor
153598949|NCT03404596|Autonomic Agents|autonomic agents|mesh-ancestor
153598950|NCT03404596|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153598951|NCT03404596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153598952|NCT03404596|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
153598953|NCT03404596|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
153598954|NCT03404596|Cholinergic Agents|cholinergic agents|mesh-ancestor
153598955|NCT03404596|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153598957|NCT03340220|Itraconazole|itraconazole|mesh-list
153599009|NCT02573324|Alkylating Agents|alkylating agents|mesh-ancestor
153599010|NCT02573324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153599011|NCT02573324|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153599012|NCT02573324|Immunoconjugates|immunoconjugates|mesh-ancestor
153599013|NCT02573324|Immunologic Factors|immunologic factors|mesh-ancestor
153599014|NCT02573324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153599015|NCT02553642|Nivolumab|nivolumab|mesh-list
153599016|NCT02553642|Ipilimumab|ipilimumab|mesh-list
153599017|NCT02553642|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153599018|NCT02553642|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153599228|NCT01873768|Aminocaproic Acid|aminocaproic acid|mesh-list
153599229|NCT01873768|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
153599230|NCT01873768|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153599231|NCT01873768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153599232|NCT01873768|Hemostatics|hemostatics|mesh-ancestor
153599233|NCT01873768|Coagulants|coagulants|mesh-ancestor
153599234|NCT01873807|Cyclophosphamide|cyclophosphamide|mesh-list
153599287|NCT01874080|Saxagliptin|saxagliptin|mesh-list
153599288|NCT01874080|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153599290|NCT01874080|Incretins|incretins|mesh-ancestor
153599473|NCT01875822|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153599474|NCT01875822|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153599475|NCT01875822|Analgesics|analgesics|mesh-ancestor
153599476|NCT01875822|Sensory System Agents|sensory system agents|mesh-ancestor
153599477|NCT01875822|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153599478|NCT01875822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153599479|NCT01875822|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153599480|NCT01875822|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153599481|NCT01875822|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153599484|NCT01875926|Gontivimab|gontivimab|mesh-list
153599540|NCT01876121|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
153599541|NCT01876121|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153599542|NCT01876121|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153599543|NCT01876121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153599544|NCT01876186|Solifenacin Succinate|solifenacin succinate|mesh-list
153599545|NCT01876186|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
153599546|NCT01876186|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
153599599|NCT01876563|Vitamins|vitamins|mesh-ancestor
153599600|NCT01876563|Micronutrients|micronutrients|mesh-ancestor
153599601|NCT01876563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153599603|NCT01876615|Diclofenac|diclofenac|mesh-list
153599758|NCT01878136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153599759|NCT01878188|BCG Vaccine|bcg vaccine|mesh-list
153599760|NCT01878188|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153461015|NCT00083616|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153599761|NCT01878188|Immunologic Factors|immunologic factors|mesh-ancestor
153599762|NCT01878188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153599764|NCT01878201|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153599765|NCT01878201|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
153599932|NCT01879358|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153599933|NCT01879358|Immunologic Factors|immunologic factors|mesh-ancestor
153599934|NCT01879358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153599935|NCT01879423|Lamotrigine|lamotrigine|mesh-list
153599936|NCT01879423|Anticonvulsants|anticonvulsants|mesh-list
153599937|NCT01879423|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153599938|NCT01879423|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153599939|NCT01879423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153599940|NCT01879423|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153599941|NCT01879423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153599942|NCT01879423|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153599943|NCT01879423|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153599944|NCT01879423|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153599945|NCT01879423|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153599946|NCT01879423|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153599947|NCT01879488|Edetic Acid|edetic acid|mesh-list
153599948|NCT01879488|Pentetic Acid|pentetic acid|mesh-list
153600032|NCT01880307|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153600033|NCT01880307|Glucocorticoids|glucocorticoids|mesh-ancestor
153600034|NCT01880307|Hormones|hormones|mesh-ancestor
153600035|NCT01880307|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153600036|NCT01880307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153600037|NCT01880307|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153600038|NCT01880307|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153600039|NCT01880307|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153600040|NCT01880307|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
153600041|NCT01880307|Dermatologic Agents|dermatologic agents|mesh-ancestor
153600042|NCT01880307|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153600043|NCT01880307|Antimetabolites|antimetabolites|mesh-ancestor
153600044|NCT01880307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153600045|NCT01880307|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153600046|NCT01880307|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153461018|NCT00083226|Bortezomib|bortezomib|mesh-list
153461019|NCT00083226|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153461020|NCT00083226|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153461021|NCT00083226|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153461022|NCT00083226|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153461023|NCT00083226|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153461024|NCT00083226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153461025|NCT00082758|Interleukin-2|interleukin-2|mesh-list
153461026|NCT00082758|Denileukin diftitox|denileukin diftitox|mesh-list
153461027|NCT00082758|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153600369|NCT01883323|Sensory System Agents|sensory system agents|mesh-ancestor
153600370|NCT01883323|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153600371|NCT01883323|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153600372|NCT01883323|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153600373|NCT01883323|Antiviral Agents|antiviral agents|mesh-ancestor
153600811|NCT01886638|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153600812|NCT01886638|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153600813|NCT01886638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153600814|NCT01886638|Antiviral Agents|antiviral agents|mesh-ancestor
153600815|NCT01886638|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153600816|NCT01886638|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153600867|NCT01887223|Adrenergic Agents|adrenergic agents|mesh-ancestor
153600868|NCT01887223|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153600869|NCT01887223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153600870|NCT01887223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153600871|NCT01887223|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
153600872|NCT01887223|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
153601127|NCT01888302|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153601128|NCT01888302|Immunologic Factors|immunologic factors|mesh-ancestor
153601129|NCT01888302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153601130|NCT01888328|Isotretinoin|isotretinoin|mesh-list
153601131|NCT01888328|Dermatologic Agents|dermatologic agents|mesh-ancestor
153601133|NCT01888341|Dermatologic Agents|dermatologic agents|mesh-ancestor
153601134|NCT01888354|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
153601135|NCT01888354|Hormones|hormones|mesh-ancestor
153601136|NCT01888354|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153601137|NCT01888354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153601138|NCT01888393|Ivacaftor|ivacaftor|mesh-list
153601139|NCT01888393|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
153601144|NCT01888458|Micafungin|micafungin|mesh-list
153601169|NCT01888562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153601170|NCT01888562|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153601171|NCT01888575|Aspirin|aspirin|mesh-list
153601172|NCT01888575|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153601173|NCT01888575|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153601174|NCT01888575|Analgesics|analgesics|mesh-ancestor
153601175|NCT01888575|Sensory System Agents|sensory system agents|mesh-ancestor
153601176|NCT01888575|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153601177|NCT01888575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153601178|NCT01888575|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153601300|NCT01888978|Immunologic Factors|immunologic factors|mesh-ancestor
153601353|NCT01889290|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
153601354|NCT01889290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153601355|NCT01889290|Sensory System Agents|sensory system agents|mesh-ancestor
153601356|NCT01889290|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153601357|NCT01889368|Grape Seed Extract|grape seed extract|mesh-list
153601358|NCT01889368|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153601360|NCT01889368|Antioxidants|antioxidants|mesh-ancestor
153601688|NCT01900106|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
153601689|NCT01900106|Protease Inhibitors|protease inhibitors|mesh-ancestor
153601690|NCT01900106|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153601692|NCT01900106|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153601729|NCT01900327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153601730|NCT01900327|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153601732|NCT01900405|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153601733|NCT01900405|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153601734|NCT01900405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153601735|NCT01900405|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153601736|NCT01900405|Analgesics|analgesics|mesh-ancestor
153601737|NCT01900405|Sensory System Agents|sensory system agents|mesh-ancestor
153601738|NCT01900405|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153601739|NCT01900405|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
153601975|NCT01901601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153601977|NCT01901640|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
153601978|NCT01901640|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
153601979|NCT01901640|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153601980|NCT01901640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153601981|NCT01901666|Hormones|hormones|mesh-list
153601982|NCT01901666|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153601983|NCT01901666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153601984|NCT01901692|Sorafenib|sorafenib|mesh-list
153601985|NCT01901692|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153601986|NCT01901692|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153601987|NCT01901692|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153601988|NCT01901692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153601989|NCT01902017|Ketotifen|ketotifen|mesh-list
153601990|NCT01902017|Antipruritics|antipruritics|mesh-ancestor
153602192|NCT01902862|Rituximab|rituximab|mesh-list
153602210|NCT01903057|Ivermectin|ivermectin|mesh-list
153602211|NCT01903057|Albendazole|albendazole|mesh-list
153602212|NCT01903057|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153602213|NCT01903057|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153602214|NCT01903057|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153602215|NCT01903057|Anthelmintics|anthelmintics|mesh-ancestor
153602216|NCT01903057|Anticestodal Agents|anticestodal agents|mesh-ancestor
153602217|NCT01903057|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
153602218|NCT01903057|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153602219|NCT01903057|Tubulin Modulators|tubulin modulators|mesh-ancestor
153602220|NCT01903057|Antimitotic Agents|antimitotic agents|mesh-ancestor
153602274|NCT01903278|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
153461035|NCT03438318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153461036|NCT03438318|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153461037|NCT03438318|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153819613|NCT00226421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153819615|NCT00226421|Sensory System Agents|sensory system agents|mesh-ancestor
153819616|NCT00226421|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153819618|NCT00226395|Oxymorphone|oxymorphone|mesh-list
153602762|NCT01907204|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
153602763|NCT01907204|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
153602829|NCT01907529|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153602830|NCT01907529|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153602831|NCT01907529|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153602832|NCT01907529|Growth Substances|growth substances|mesh-ancestor
153602833|NCT01907529|Growth Inhibitors|growth inhibitors|mesh-ancestor
153602943|NCT01908114|Vaccines|vaccines|mesh-list
153602944|NCT01908114|Immunologic Factors|immunologic factors|mesh-ancestor
153602945|NCT01908114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153602946|NCT01908257|Lesinurad|lesinurad|mesh-list
153602981|NCT01908296|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153602982|NCT01908296|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
153602984|NCT01908322|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153602985|NCT01908322|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153603292|NCT01910480|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153603293|NCT01910480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153603294|NCT01910480|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
153603295|NCT01910506|Verinurad|verinurad|mesh-list
153603353|NCT01910883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153603354|NCT01910883|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153603355|NCT01910883|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153603610|NCT01912586|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
153603611|NCT01912586|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
153603612|NCT01912586|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153603614|NCT01912586|Urological Agents|urological agents|mesh-ancestor
153603664|NCT01912755|Adrenergic Agents|adrenergic agents|mesh-ancestor
153603665|NCT01912755|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153603666|NCT01912755|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
153603667|NCT01912755|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153603668|NCT01912755|Autonomic Agents|autonomic agents|mesh-ancestor
153603669|NCT01912755|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153603670|NCT01912755|Respiratory System Agents|respiratory system agents|mesh-ancestor
153603671|NCT01912755|Mydriatics|mydriatics|mesh-ancestor
153603672|NCT01912755|Sympathomimetics|sympathomimetics|mesh-ancestor
153603673|NCT01912755|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
153603674|NCT01912820|Quercetin|quercetin|mesh-list
153603675|NCT01912820|Antioxidants|antioxidants|mesh-ancestor
153603676|NCT01912820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153603677|NCT01912820|Protective Agents|protective agents|mesh-ancestor
153603679|NCT01912898|Vitamin D|vitamin d|mesh-list
153603845|NCT01914133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153603846|NCT01914133|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153603847|NCT01914133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153603848|NCT01914146|Insulin|insulin|mesh-list
153603849|NCT01914146|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
153603850|NCT01914146|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153603851|NCT01914146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153603852|NCT01914211|Tranexamic Acid|tranexamic acid|mesh-list
153603853|NCT01914211|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
153603854|NCT01914211|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153604153|NCT01916252|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153604154|NCT01916252|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153604155|NCT01916252|Immunologic Factors|immunologic factors|mesh-ancestor
153604156|NCT01916252|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153604157|NCT01916252|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153604158|NCT01916252|Growth Substances|growth substances|mesh-ancestor
153604159|NCT01916252|Growth Inhibitors|growth inhibitors|mesh-ancestor
153604160|NCT01916252|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153604161|NCT01916252|Alkylating Agents|alkylating agents|mesh-ancestor
153604163|NCT01916252|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153604209|NCT01916642|Anesthetics, Local|anesthetics, local|mesh-ancestor
153604210|NCT01916642|Anesthetics|anesthetics|mesh-ancestor
153604415|NCT01917578|Antimitotic Agents|antimitotic agents|mesh-ancestor
153604416|NCT01917578|Mitosis Modulators|mitosis modulators|mesh-ancestor
153604417|NCT01917578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153604418|NCT01917578|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153604419|NCT01917578|Immunologic Factors|immunologic factors|mesh-ancestor
153604420|NCT01917578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153604421|NCT01917578|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153604422|NCT01917578|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153604423|NCT01917578|Alkylating Agents|alkylating agents|mesh-ancestor
153604424|NCT01917578|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153604425|NCT01917578|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153604426|NCT01917578|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153604440|NCT01917708|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153604441|NCT01917708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153604442|NCT01917708|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153604629|NCT01918813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153604631|NCT01918852|Capecitabine|capecitabine|mesh-list
153604632|NCT01918852|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153604633|NCT01918852|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153604634|NCT01918852|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153604635|NCT01918852|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153604636|NCT01918852|Growth Substances|growth substances|mesh-ancestor
153604637|NCT01918852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153604954|NCT01927640|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153604955|NCT01927640|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
153604956|NCT01927640|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153604957|NCT01927640|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153604958|NCT01927640|Adrenergic Agents|adrenergic agents|mesh-ancestor
153604959|NCT01927640|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153604960|NCT01927640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153604961|NCT01927640|Anesthetics, Local|anesthetics, local|mesh-ancestor
153604981|NCT01928407|Darunavir|darunavir|mesh-list
153604995|NCT01929486|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153604996|NCT01929590|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
153604997|NCT01929590|Laxatives|laxatives|mesh-ancestor
153461059|NCT04402320|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153461060|NCT04402320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153461061|NCT03436056|Pembrolizumab|pembrolizumab|mesh-list
153461062|NCT03436056|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153461063|NCT03436056|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153461064|NCT03436056|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153605011|NCT01930019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153605012|NCT01930201|Anesthetics|anesthetics|mesh-list
153605015|NCT01930292|Paclitaxel|paclitaxel|mesh-list
153605259|NCT01931410|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
153605260|NCT01931410|Abortifacient Agents|abortifacient agents|mesh-ancestor
153605287|NCT01931592|Colistin|colistin|mesh-list
153605323|NCT01931787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153605324|NCT01931787|Vitamin B Complex|vitamin b complex|mesh-ancestor
153605325|NCT01931787|Vitamins|vitamins|mesh-ancestor
153605326|NCT01931787|Micronutrients|micronutrients|mesh-ancestor
153605327|NCT01931982|Liraglutide|liraglutide|mesh-list
153605328|NCT01931982|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
153605329|NCT01931982|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153605424|NCT01932385|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153605425|NCT01932385|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153605426|NCT01932385|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153605427|NCT01932385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153605428|NCT01932424|Propofol|propofol|mesh-list
153605429|NCT01932424|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153605430|NCT01932424|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153605431|NCT01932424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153605432|NCT01932424|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153605433|NCT01932424|Anesthetics, General|anesthetics, general|mesh-ancestor
153605434|NCT01932424|Anesthetics|anesthetics|mesh-ancestor
153605435|NCT01932450|Antihypertensive Agents|antihypertensive agents|mesh-list
153605436|NCT01932502|Clobazam|clobazam|mesh-list
153605437|NCT01932502|Anticonvulsants|anticonvulsants|mesh-ancestor
153605438|NCT01932502|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153605439|NCT01932502|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153605440|NCT01932502|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153605475|NCT01932554|Analgesics|analgesics|mesh-ancestor
153605476|NCT01932554|Sensory System Agents|sensory system agents|mesh-ancestor
153605477|NCT01932554|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153605478|NCT01932554|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153605479|NCT01932554|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153605480|NCT01932554|Anesthetics, General|anesthetics, general|mesh-ancestor
153605481|NCT01932554|Anesthetics|anesthetics|mesh-ancestor
153605482|NCT01932554|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153605483|NCT01932554|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153605484|NCT01932554|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153605485|NCT01932554|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153605486|NCT01932554|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153605487|NCT01932554|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153605488|NCT01932554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153605542|NCT01933152|Ranibizumab|ranibizumab|mesh-list
153605684|NCT01934569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153605685|NCT01934569|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153605686|NCT01934569|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153605687|NCT01934569|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153605688|NCT01934569|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153605689|NCT01934569|Anesthetics, General|anesthetics, general|mesh-ancestor
153605690|NCT01934569|Anesthetics|anesthetics|mesh-ancestor
153605691|NCT01934569|GABA Modulators|gaba modulators|mesh-ancestor
153605692|NCT01934569|GABA Agents|gaba agents|mesh-ancestor
153605735|NCT01934777|Antioxidants|antioxidants|mesh-ancestor
153606047|NCT01936064|Alkylating Agents|alkylating agents|mesh-ancestor
153606048|NCT01936064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153606049|NCT01936064|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153606050|NCT01936064|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153606051|NCT01936064|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153606052|NCT01936064|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153606053|NCT01936064|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153606054|NCT01936064|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153606056|NCT01936090|Melphalan|melphalan|mesh-list
153606057|NCT01936090|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153606058|NCT01936090|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153606059|NCT01936090|Alkylating Agents|alkylating agents|mesh-ancestor
153606060|NCT01936090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153606297|NCT06037135|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153606298|NCT06037135|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153606299|NCT06037135|Adrenergic Agents|adrenergic agents|mesh-ancestor
153606300|NCT06037135|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153606301|NCT06037135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153606319|NCT05900401|Cyclophosphamide|cyclophosphamide|mesh-list
153606320|NCT05900401|Rituximab|rituximab|mesh-list
153606321|NCT05900401|Fludarabine|fludarabine|mesh-list
153606648|NCT05224336|Micronutrients|micronutrients|mesh-ancestor
153606649|NCT05224336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153606650|NCT05224336|Hallucinogens|hallucinogens|mesh-ancestor
153606651|NCT05224336|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153606652|NCT05133804|Methylphenidate|methylphenidate|mesh-list
153606653|NCT05133804|Reboxetine|reboxetine|mesh-list
153606654|NCT05133804|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
153606655|NCT05133804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153606656|NCT05133804|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
153606666|NCT05109364|Terazosin|terazosin|mesh-list
153606940|NCT04460352|Antimetabolites|antimetabolites|mesh-ancestor
153606941|NCT04460352|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153606942|NCT04460352|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153606943|NCT04460352|Immunologic Factors|immunologic factors|mesh-ancestor
153606944|NCT04460352|Antidotes|antidotes|mesh-ancestor
153606945|NCT04460352|Protective Agents|protective agents|mesh-ancestor
153606946|NCT04460352|Vitamin B Complex|vitamin b complex|mesh-ancestor
153606947|NCT04460352|Vitamins|vitamins|mesh-ancestor
153606948|NCT04460352|Micronutrients|micronutrients|mesh-ancestor
153606949|NCT04419181|Carboplatin|carboplatin|mesh-list
153819655|NCT00066703|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
153819656|NCT00066703|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153819657|NCT00066703|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153606950|NCT04419181|Docetaxel|docetaxel|mesh-list
153607149|NCT04066114|Mycophenolic Acid|mycophenolic acid|mesh-list
153607150|NCT04066114|Prednisone|prednisone|mesh-list
153607151|NCT04066114|Methylprednisolone|methylprednisolone|mesh-list
153607152|NCT04066114|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
153607153|NCT04066114|Everolimus|everolimus|mesh-list
153607213|NCT03875092|Mitosis Modulators|mitosis modulators|mesh-ancestor
153607214|NCT03875092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153607215|NCT03875092|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153607216|NCT03875092|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153607217|NCT03862833|Zoledronic Acid|zoledronic acid|mesh-list
153607493|NCT01993810|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153607494|NCT01993810|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153607498|NCT01993810|Immunologic Factors|immunologic factors|mesh-ancestor
153607527|NCT01919619|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153607528|NCT01919619|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153607529|NCT01919619|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153607530|NCT01919619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153607531|NCT01918527|Capecitabine|capecitabine|mesh-list
153607532|NCT01918527|Oxaliplatin|oxaliplatin|mesh-list
153607533|NCT01918527|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153607534|NCT01918527|Antimetabolites|antimetabolites|mesh-ancestor
153607536|NCT01918527|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153781744|NCT04559425|BB 1101|bb 1101|mesh-list
153607591|NCT01529593|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153607766|NCT01936636|Sensory System Agents|sensory system agents|mesh-ancestor
153607767|NCT01936636|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153607768|NCT01936636|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153607769|NCT01936636|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153607771|NCT01936636|Anesthetics|anesthetics|mesh-ancestor
153607772|NCT01936805|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
153607773|NCT01936805|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153608056|NCT01938729|Antiemetics|antiemetics|mesh-ancestor
153608057|NCT01938729|Autonomic Agents|autonomic agents|mesh-ancestor
153608060|NCT01938729|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153608074|NCT01938755|Sensory System Agents|sensory system agents|mesh-ancestor
153608075|NCT01938755|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153608077|NCT01938781|Antiviral Agents|antiviral agents|mesh-ancestor
153608078|NCT01938781|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153608079|NCT01938820|Entecavir|entecavir|mesh-list
153608080|NCT01938820|Antiviral Agents|antiviral agents|mesh-ancestor
153608081|NCT01938820|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153608082|NCT01938859|Quetiapine Fumarate|quetiapine fumarate|mesh-list
153608083|NCT01938859|Antidepressive Agents|antidepressive agents|mesh-ancestor
153608084|NCT01938859|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153608085|NCT01938859|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153608086|NCT01938859|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153608087|NCT01938859|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153608088|NCT01938859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153608089|NCT01938872|Paclitaxel|paclitaxel|mesh-list
153608254|NCT01939639|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153608255|NCT01939639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153608256|NCT01939691|Prednisolone|prednisolone|mesh-list
153608257|NCT01939691|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
153608258|NCT01939691|Methylprednisolone|methylprednisolone|mesh-list
153608259|NCT01939691|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
153608260|NCT01939691|Prednisolone acetate|prednisolone acetate|mesh-list
153608261|NCT01939691|Nepafenac|nepafenac|mesh-list
153608262|NCT01939691|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
153608263|NCT01939691|Prednisolone phosphate|prednisolone phosphate|mesh-list
153608264|NCT01939691|Difluprednate|difluprednate|mesh-list
153608483|NCT01940978|Histamine Antagonists|histamine antagonists|mesh-ancestor
153608484|NCT01940978|Histamine Agents|histamine agents|mesh-ancestor
153608485|NCT01940978|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153608486|NCT01940978|Serotonin Agents|serotonin agents|mesh-ancestor
153608487|NCT01940978|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
153608488|NCT01941004|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
153608489|NCT01941004|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
153608491|NCT01941004|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153608546|NCT01941264|Lumefantrine|lumefantrine|mesh-list
153608547|NCT01941264|Artemether|artemether|mesh-list
153608548|NCT01941264|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
153608549|NCT01941264|Antimalarials|antimalarials|mesh-ancestor
153608550|NCT01941264|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153608551|NCT01941264|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153608552|NCT01941264|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153608553|NCT01941316|Irinotecan|irinotecan|mesh-list
153608554|NCT01941316|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
153608555|NCT01941316|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153608556|NCT01941316|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153608557|NCT01941316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153608558|NCT01941316|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153608559|NCT01941329|Ranibizumab|ranibizumab|mesh-list
153608560|NCT01941329|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153651101|NCT00000599|Niacin|niacin|mesh-list
153608561|NCT01941329|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153608562|NCT01941329|Growth Substances|growth substances|mesh-ancestor
153608563|NCT01941329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153608564|NCT01941329|Growth Inhibitors|growth inhibitors|mesh-ancestor
153608565|NCT01941329|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153651142|NCT00032890|Analgesics|analgesics|mesh-ancestor
153608657|NCT01941966|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153608658|NCT01941979|Leucovorin|leucovorin|mesh-list
153608659|NCT01941979|Capecitabine|capecitabine|mesh-list
153608660|NCT01941979|Oxaliplatin|oxaliplatin|mesh-list
153608661|NCT01941979|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153608662|NCT01941979|Antimetabolites|antimetabolites|mesh-ancestor
153608663|NCT01941979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153608664|NCT01941979|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153608665|NCT01941979|Antidotes|antidotes|mesh-ancestor
153608720|NCT01942187|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153608792|NCT01942551|Tadalafil|tadalafil|mesh-list
153609066|NCT01944683|GABA Modulators|gaba modulators|mesh-ancestor
153609067|NCT01944683|GABA Agents|gaba agents|mesh-ancestor
153609070|NCT01944735|Mannitol|mannitol|mesh-list
153609108|NCT01945099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153609109|NCT01945268|Vaccines|vaccines|mesh-list
153609110|NCT01945268|Immunologic Factors|immunologic factors|mesh-ancestor
153609111|NCT01945268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153609112|NCT01945437|Magnesium Sulfate|magnesium sulfate|mesh-list
153609113|NCT01945437|Analgesics|analgesics|mesh-ancestor
153609114|NCT01945437|Sensory System Agents|sensory system agents|mesh-ancestor
153609345|NCT04411953|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153609346|NCT04411953|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153609347|NCT04411953|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153609348|NCT04411953|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
153609349|NCT04411953|Dopamine Agents|dopamine agents|mesh-ancestor
153609350|NCT04411953|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153609351|NCT04411953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153609352|NCT04411953|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
153609353|NCT04411953|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
153609354|NCT04411953|Parasympatholytics|parasympatholytics|mesh-ancestor
153609355|NCT04411953|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
153609356|NCT04411953|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
153609357|NCT04411953|Cholinergic Agents|cholinergic agents|mesh-ancestor
153609358|NCT04411953|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
153609664|NCT04475016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153609665|NCT04475016|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153609723|NCT03568604|Immunologic Factors|immunologic factors|mesh-ancestor
153609724|NCT03568604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153609726|NCT03539055|Antithrombins|antithrombins|mesh-ancestor
153609727|NCT03539055|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
153609728|NCT03539055|Protease Inhibitors|protease inhibitors|mesh-ancestor
153609729|NCT03539055|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153609730|NCT03539055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153609731|NCT03539055|Anticoagulants|anticoagulants|mesh-ancestor
153609732|NCT03485534|Tenofovir|tenofovir|mesh-list
153610013|NCT04636034|Anesthetics|anesthetics|mesh-list
153610014|NCT04636034|Anesthetics, Local|anesthetics, local|mesh-list
153610015|NCT04636034|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153610016|NCT04636034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153610017|NCT04636034|Sensory System Agents|sensory system agents|mesh-ancestor
153610033|NCT04350593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153610034|NCT04350593|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153610035|NCT04350593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153610036|NCT04222283|Emtricitabine|emtricitabine|mesh-list
153610045|NCT04070352|Fidaxomicin|fidaxomicin|mesh-list
153610195|NCT02900560|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153610196|NCT02900560|Antimetabolites|antimetabolites|mesh-ancestor
153610197|NCT02900560|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153610199|NCT02877550|Obinutuzumab|obinutuzumab|mesh-list
153610200|NCT02877550|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153610201|NCT02877550|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153610202|NCT02775812|Pembrolizumab|pembrolizumab|mesh-list
153610203|NCT02775812|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153610204|NCT02775812|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153610205|NCT02775812|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153610206|NCT02775812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153610207|NCT02679170|Crizotinib|crizotinib|mesh-list
153610208|NCT02679170|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153610365|NCT01946399|Glucocorticoids|glucocorticoids|mesh-ancestor
153610366|NCT01946399|Hormones|hormones|mesh-ancestor
153610367|NCT01946399|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153610368|NCT01946399|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153610369|NCT01946399|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153610370|NCT01946555|Fentanyl|fentanyl|mesh-list
153610371|NCT01946555|Morphine|morphine|mesh-list
153610372|NCT01946555|Oxycodone|oxycodone|mesh-list
153610374|NCT01946555|Methadone|methadone|mesh-list
153610424|NCT01946620|Respiratory System Agents|respiratory system agents|mesh-ancestor
153610425|NCT01946620|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
153610426|NCT01946620|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
153610427|NCT01946620|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153610428|NCT01946620|Adrenergic Agents|adrenergic agents|mesh-ancestor
153610429|NCT01946620|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153819660|NCT00066703|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
153819661|NCT00066703|Contraceptive Agents|contraceptive agents|mesh-ancestor
153819662|NCT00066703|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153819663|NCT00066703|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
153819664|NCT00066690|Tamoxifen|tamoxifen|mesh-list
153819665|NCT00066690|Triptorelin Pamoate|triptorelin pamoate|mesh-list
153819666|NCT00066690|Exemestane|exemestane|mesh-list
153819667|NCT00066690|Tryptophan|tryptophan|mesh-list
153819668|NCT00066690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153819669|NCT00066690|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153610549|NCT01947777|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
153610551|NCT01947790|Pioglitazone|pioglitazone|mesh-list
153610552|NCT01947790|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153610553|NCT01947790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153610554|NCT01947803|Paliperidone Palmitate|paliperidone palmitate|mesh-list
153610597|NCT01947985|Antithrombins|antithrombins|mesh-ancestor
153610598|NCT01947985|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
153610599|NCT01947985|Protease Inhibitors|protease inhibitors|mesh-ancestor
153610602|NCT01947985|Anticoagulants|anticoagulants|mesh-ancestor
153610917|NCT01950000|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153610918|NCT01950000|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153610919|NCT01950000|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153610922|NCT01950182|Tamoxifen|tamoxifen|mesh-list
153610982|NCT01950507|Respiratory System Agents|respiratory system agents|mesh-ancestor
153610983|NCT01950507|Glucocorticoids|glucocorticoids|mesh-ancestor
153610984|NCT01950507|Hormones|hormones|mesh-ancestor
153610985|NCT01950507|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153610986|NCT01950507|Antifungal Agents|antifungal agents|mesh-ancestor
153610987|NCT01950507|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153610988|NCT01950507|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
153610989|NCT01950507|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153610990|NCT01950507|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153610993|NCT01950507|Hormone Antagonists|hormone antagonists|mesh-ancestor
153611160|NCT01951560|GABA Agents|gaba agents|mesh-ancestor
153611161|NCT01951560|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153611162|NCT01951560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153611163|NCT01951560|Antimanic Agents|antimanic agents|mesh-ancestor
153611164|NCT01951560|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153611165|NCT01951560|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153611166|NCT01951560|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153611167|NCT01951599|Osimertinib|osimertinib|mesh-list
153611168|NCT01951599|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153611169|NCT01951599|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153611170|NCT01951599|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153611171|NCT01951599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153611173|NCT01951677|Aluminum Hydroxide|aluminum hydroxide|mesh-list
153611409|NCT05875285|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153611410|NCT05875285|Antimetabolites|antimetabolites|mesh-ancestor
153611411|NCT05875285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153611453|NCT05874778|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153611454|NCT05874778|Tubulin Modulators|tubulin modulators|mesh-ancestor
153611455|NCT05874778|Antimitotic Agents|antimitotic agents|mesh-ancestor
153611456|NCT05874778|Mitosis Modulators|mitosis modulators|mesh-ancestor
153611457|NCT05874778|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153611458|NCT05874778|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153611459|NCT05874778|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153611460|NCT05874778|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153611461|NCT05874778|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153611697|NCT04966546|Dopamine Agents|dopamine agents|mesh-ancestor
153611698|NCT04966546|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153611699|NCT04966546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153611700|NCT04966546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153611701|NCT04966546|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
153611702|NCT04966546|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
153611703|NCT04853446|Dexamethasone|dexamethasone|mesh-list
153611704|NCT04853446|Dexamethasone acetate|dexamethasone acetate|mesh-list
153611755|NCT04660760|Growth Substances|growth substances|mesh-ancestor
153611760|NCT04507217|Carboplatin|carboplatin|mesh-list
153612042|NCT02333565|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153612043|NCT02278185|Leuprolide|leuprolide|mesh-list
153612044|NCT02278185|Goserelin|goserelin|mesh-list
153612075|NCT02177695|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
153612077|NCT02177695|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153612078|NCT02177695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153612079|NCT02177695|Dermatologic Agents|dermatologic agents|mesh-ancestor
153612080|NCT02177695|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153612081|NCT02177695|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153612082|NCT02177695|Immunologic Factors|immunologic factors|mesh-ancestor
153612083|NCT02177695|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153612084|NCT02177695|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153612085|NCT02177695|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153612086|NCT02177695|Tubulin Modulators|tubulin modulators|mesh-ancestor
153612087|NCT02177695|Antimitotic Agents|antimitotic agents|mesh-ancestor
153612088|NCT02177695|Mitosis Modulators|mitosis modulators|mesh-ancestor
153612200|NCT01953172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153612202|NCT01953172|Micronutrients|micronutrients|mesh-ancestor
153612243|NCT01953536|Vitamin B Complex|vitamin b complex|mesh-ancestor
153612245|NCT01953536|Micronutrients|micronutrients|mesh-ancestor
153612246|NCT01953536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153612247|NCT01953679|Ulipristal acetate|ulipristal acetate|mesh-list
153612248|NCT01953679|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
153612249|NCT01953679|Contraceptive Agents|contraceptive agents|mesh-ancestor
153612501|NCT01954784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153612502|NCT01954784|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153612503|NCT01954784|Immunologic Factors|immunologic factors|mesh-ancestor
153612504|NCT01954784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153612505|NCT01954784|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153612506|NCT01954784|Antifungal Agents|antifungal agents|mesh-ancestor
153612507|NCT01954784|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153612508|NCT01954784|Dermatologic Agents|dermatologic agents|mesh-ancestor
153612542|NCT01955070|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153612543|NCT01955070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153612544|NCT01955135|Ketamine|ketamine|mesh-list
153612545|NCT01955135|Propofol|propofol|mesh-list
153612546|NCT01955135|Sevoflurane|sevoflurane|mesh-list
153612552|NCT01955135|Anesthetics|anesthetics|mesh-ancestor
153612710|NCT01955759|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
153612711|NCT01955759|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153612712|NCT01955759|Sympatholytics|sympatholytics|mesh-ancestor
153612713|NCT01955759|Autonomic Agents|autonomic agents|mesh-ancestor
153612714|NCT01955759|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153612715|NCT01955759|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
153612716|NCT01955824|Lidocaine|lidocaine|mesh-list
153612717|NCT01955824|Anesthetics, Local|anesthetics, local|mesh-ancestor
153613103|NCT01959061|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153613156|NCT01959191|Purinergic Agents|purinergic agents|mesh-ancestor
153613157|NCT01959191|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153613158|NCT01959386|Trastuzumab|trastuzumab|mesh-list
153613159|NCT01959386|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153613160|NCT01959386|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153613161|NCT01959399|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
153613485|NCT01962181|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153613486|NCT01962285|Propofol|propofol|mesh-list
153613487|NCT01962285|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153613488|NCT01962285|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153613535|NCT01963039|Protective Agents|protective agents|mesh-ancestor
153613536|NCT01963039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153613537|NCT01963182|Irinotecan|irinotecan|mesh-list
153613538|NCT01963182|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
153613539|NCT01963182|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153613540|NCT01963182|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153651148|NCT00032890|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
153651150|NCT00032890|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153613541|NCT01963182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153613542|NCT01963182|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153613543|NCT01963221|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
153613544|NCT01963221|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
153613545|NCT01963221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153613717|NCT01964040|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153613718|NCT01964040|Analgesics|analgesics|mesh-ancestor
153613719|NCT01964040|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
153613720|NCT01964040|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153613772|NCT01964248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153613773|NCT01964248|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
153613775|NCT01964287|Paclitaxel|paclitaxel|mesh-list
153613776|NCT01964287|Gemcitabine|gemcitabine|mesh-list
153613777|NCT01964287|Oxaliplatin|oxaliplatin|mesh-list
153613778|NCT01964287|Irinotecan|irinotecan|mesh-list
153613779|NCT01964287|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
153614095|NCT01966172|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153614096|NCT01966172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153614097|NCT01966172|Analgesics|analgesics|mesh-ancestor
153614098|NCT01966172|Sensory System Agents|sensory system agents|mesh-ancestor
153614099|NCT01966172|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153614100|NCT01966172|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153614101|NCT01966172|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153614102|NCT01966172|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153614103|NCT01966172|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153614104|NCT01966172|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153614105|NCT01966172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153614106|NCT01966172|Antipyretics|antipyretics|mesh-ancestor
153614107|NCT01966172|Anticonvulsants|anticonvulsants|mesh-ancestor
153614151|NCT01966484|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153614152|NCT01966484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153614153|NCT01966484|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
153614272|NCT01967368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153614273|NCT01967381|Methamphetamine|methamphetamine|mesh-list
153614274|NCT01967381|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
153614275|NCT01967381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153614276|NCT01967381|Sympathomimetics|sympathomimetics|mesh-ancestor
153614277|NCT01967381|Autonomic Agents|autonomic agents|mesh-ancestor
153614323|NCT01967524|Anesthetics|anesthetics|mesh-ancestor
153614324|NCT01967524|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153614325|NCT01967524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153614490|NCT01968577|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153614492|NCT01968616|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153614493|NCT01968616|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153614551|NCT01969019|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
153614553|NCT01969019|Prednisolone acetate|prednisolone acetate|mesh-list
153614554|NCT01969019|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
153614555|NCT01969019|Prednisolone phosphate|prednisolone phosphate|mesh-list
153614556|NCT01969019|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153614558|NCT01969019|Hormones|hormones|mesh-ancestor
153614559|NCT01969019|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153614560|NCT01969019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153614561|NCT01969019|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153614562|NCT01969019|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153614563|NCT01969019|Antiemetics|antiemetics|mesh-ancestor
153614564|NCT01969019|Autonomic Agents|autonomic agents|mesh-ancestor
153614565|NCT01969019|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153614566|NCT01969019|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153614567|NCT01969019|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
153614733|NCT01969955|Antimitotic Agents|antimitotic agents|mesh-ancestor
153614734|NCT01969955|Mitosis Modulators|mitosis modulators|mesh-ancestor
153614735|NCT01969955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153614737|NCT01970046|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153614738|NCT01970046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153614739|NCT01970059|Metoprolol|metoprolol|mesh-list
153614740|NCT01970059|Carvedilol|carvedilol|mesh-list
153614741|NCT01970059|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153614742|NCT01970059|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153814356|NCT00338624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153814357|NCT00338624|Urological Agents|urological agents|mesh-ancestor
153614743|NCT01970059|Sympatholytics|sympatholytics|mesh-ancestor
153614744|NCT01970059|Autonomic Agents|autonomic agents|mesh-ancestor
153614959|NCT01971658|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153614960|NCT01971658|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153614961|NCT01971658|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153614962|NCT01971658|Growth Substances|growth substances|mesh-ancestor
153614963|NCT01971658|Growth Inhibitors|growth inhibitors|mesh-ancestor
153614964|NCT01971684|Mycophenolic Acid|mycophenolic acid|mesh-list
153614966|NCT01971684|Mercaptopurine|mercaptopurine|mesh-list
153614967|NCT01971684|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153614968|NCT01971684|Immunologic Factors|immunologic factors|mesh-ancestor
153614969|NCT01971684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153615018|NCT01972230|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153615057|NCT01972490|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153615058|NCT01972490|Growth Substances|growth substances|mesh-ancestor
153615059|NCT01972490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153615111|NCT01972984|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153615120|NCT01973010|Ibuprofen|ibuprofen|mesh-list
153615573|NCT01976078|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
153615574|NCT01976078|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153615575|NCT01976078|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
153615576|NCT01976078|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153615577|NCT01976078|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
153615578|NCT01976078|Histamine Antagonists|histamine antagonists|mesh-ancestor
153615579|NCT01976078|Histamine Agents|histamine agents|mesh-ancestor
153615580|NCT01976143|Etirinotecan pegol|etirinotecan pegol|mesh-list
153615581|NCT01976143|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153615582|NCT01976143|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153615583|NCT01976143|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153615584|NCT01976143|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153364640|NCT05014919|Vortioxetine|vortioxetine|mesh-list
153364943|NCT02461134|Ponesimod|ponesimod|mesh-list
153365308|NCT02244632|Irinotecan|irinotecan|mesh-list
153365911|NCT02229461|Aspirin|aspirin|mesh-list
153367332|NCT01031498|Antipruritics|antipruritics|mesh-ancestor
153367757|NCT02740868|Xenon|xenon|mesh-list
153392861|NCT03340727|Caffeine|caffeine|mesh-list
153819678|NCT00066690|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
153461131|NCT01679106|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153461132|NCT01679106|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153461134|NCT01679106|Anesthetics, General|anesthetics, general|mesh-ancestor
153819783|NCT00430118|Autonomic Agents|autonomic agents|mesh-ancestor
153819784|NCT00430118|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153819785|NCT00430118|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153819786|NCT00430118|Glucocorticoids|glucocorticoids|mesh-ancestor
153461186|NCT01679574|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153461187|NCT01679574|Fertility Agents, Female|fertility agents, female|mesh-ancestor
153461188|NCT01679574|Fertility Agents|fertility agents|mesh-ancestor
153461189|NCT01679574|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153461190|NCT01679574|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
153461191|NCT01679574|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
153461193|NCT01679652|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153461194|NCT01679652|Vasodilator Agents|vasodilator agents|mesh-ancestor
153461195|NCT01679652|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
153461196|NCT01679652|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
153819795|NCT00430118|Abortifacient Agents|abortifacient agents|mesh-ancestor
153819796|NCT00430118|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153819797|NCT00430118|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153819798|NCT00430118|Antimetabolites|antimetabolites|mesh-ancestor
153819799|NCT00430118|Dermatologic Agents|dermatologic agents|mesh-ancestor
153461200|NCT01679652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153461201|NCT01679652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153461202|NCT04761744|Nivolumab|nivolumab|mesh-list
153461203|NCT04761744|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153461204|NCT04761744|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153461205|NCT04761744|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153461206|NCT04761744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153819816|NCT00461565|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
153819817|NCT00461565|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
153819818|NCT00461565|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153819819|NCT00461565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153814359|NCT00338780|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153819820|NCT00461565|Urological Agents|urological agents|mesh-ancestor
153819822|NCT00430196|Analgesics|analgesics|mesh-ancestor
153819823|NCT00430196|Sensory System Agents|sensory system agents|mesh-ancestor
153461243|NCT03088254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153461244|NCT03088254|Vasodilator Agents|vasodilator agents|mesh-ancestor
153461245|NCT03088254|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153461246|NCT03088254|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153461247|NCT03088254|Antimetabolites|antimetabolites|mesh-ancestor
153461248|NCT03088254|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153461249|NCT03088254|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
153819875|NCT00430547|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153819898|NCT00461799|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153819899|NCT00430664|Povidone-Iodine|povidone-iodine|mesh-list
153819923|NCT03271164|Antioxidants|antioxidants|mesh-ancestor
153819924|NCT03271164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153819925|NCT03271164|Protective Agents|protective agents|mesh-ancestor
153819926|NCT00430898|Basiliximab|basiliximab|mesh-list
153819927|NCT00430898|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153819928|NCT00430898|Immunologic Factors|immunologic factors|mesh-ancestor
153819969|NCT00431171|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153461377|NCT05345574|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153461378|NCT05345574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153461379|NCT05345574|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153461380|NCT05345574|Analgesics|analgesics|mesh-ancestor
153461381|NCT05345574|Sensory System Agents|sensory system agents|mesh-ancestor
153461382|NCT05345574|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153461383|NCT05345574|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
153461429|NCT03082092|Methylprednisolone|methylprednisolone|mesh-list
153461430|NCT03082092|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
153461431|NCT03082092|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
153461432|NCT03082092|Prednisolone|prednisolone|mesh-list
153461433|NCT03082092|Prednisolone acetate|prednisolone acetate|mesh-list
153461434|NCT03082092|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
153461435|NCT03082092|Prednisolone phosphate|prednisolone phosphate|mesh-list
153461436|NCT03082092|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153461437|NCT03082092|Antiemetics|antiemetics|mesh-ancestor
153461438|NCT03082092|Autonomic Agents|autonomic agents|mesh-ancestor
153461439|NCT03082092|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153461440|NCT03082092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153461441|NCT03082092|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153461442|NCT03082092|Glucocorticoids|glucocorticoids|mesh-ancestor
153461443|NCT03082092|Hormones|hormones|mesh-ancestor
153461444|NCT03082092|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153461445|NCT03082092|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
153820008|NCT00462111|Indomethacin|indomethacin|mesh-list
153820016|NCT00462111|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153820017|NCT00462111|Gout Suppressants|gout suppressants|mesh-ancestor
153820018|NCT00462111|Tocolytic Agents|tocolytic agents|mesh-ancestor
153820019|NCT00462111|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153820020|NCT00462111|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153820021|NCT00462111|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153820022|NCT00462111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153820023|NCT00431561|Temozolomide|temozolomide|mesh-list
153820025|NCT00431561|Trabedersen|trabedersen|mesh-list
153820026|NCT00431561|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153820027|NCT00431561|Alkylating Agents|alkylating agents|mesh-ancestor
153820028|NCT00431561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153461468|NCT03082482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153820072|NCT00471042|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
153820073|NCT00462540|Bromides|bromides|mesh-list
153820074|NCT00462540|Albuterol|albuterol|mesh-list
153820075|NCT00462540|Formoterol Fumarate|formoterol fumarate|mesh-list
153820076|NCT00462540|Ipratropium|ipratropium|mesh-list
153820077|NCT00462540|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153820078|NCT00462540|Autonomic Agents|autonomic agents|mesh-ancestor
153820079|NCT00462540|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153461492|NCT03081702|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
153461493|NCT04399434|Insulin|insulin|mesh-list
153461494|NCT04399434|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153461495|NCT04399434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153461496|NCT04760574|Testosterone|testosterone|mesh-list
153461497|NCT04760574|Androgens|androgens|mesh-ancestor
153461498|NCT04760574|Hormones|hormones|mesh-ancestor
153461499|NCT04760574|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153814361|NCT00338780|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153461530|NCT03261570|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153461531|NCT03227562|Risperidone|risperidone|mesh-list
153820166|NCT01052012|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153820167|NCT01052012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153820168|NCT01052012|Sensory System Agents|sensory system agents|mesh-ancestor
153820169|NCT01052012|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153820170|NCT00462852|Gemcitabine|gemcitabine|mesh-list
153820172|NCT00462852|Tinzaparin|tinzaparin|mesh-list
153461588|NCT02084706|Sensory System Agents|sensory system agents|mesh-ancestor
153461589|NCT02084706|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153461590|NCT02084706|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153461592|NCT02084706|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153820175|NCT00462852|Antimetabolites|antimetabolites|mesh-ancestor
153820176|NCT00462852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153820177|NCT00462852|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153820178|NCT00462852|Anticoagulants|anticoagulants|mesh-ancestor
153820179|NCT00462852|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153820180|NCT00462852|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153820181|NCT00471393|Diclofenac|diclofenac|mesh-list
153461664|NCT03174132|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
153360267|NCT01355705|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153360268|NCT01355705|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153360269|NCT01355705|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153360270|NCT01355705|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153360271|NCT01355705|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153360272|NCT01355705|Antipyretics|antipyretics|mesh-ancestor
153360273|NCT01355705|Immunologic Factors|immunologic factors|mesh-ancestor
153360274|NCT01355705|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153360275|NCT01355705|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153360276|NCT01355705|Growth Substances|growth substances|mesh-ancestor
153360277|NCT01355705|Growth Inhibitors|growth inhibitors|mesh-ancestor
153820289|NCT00432575|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
153820290|NCT00432575|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153820291|NCT00432575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153820292|NCT00432575|Hormones|hormones|mesh-ancestor
153820293|NCT00432575|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153820294|NCT00432575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153820295|NCT00432614|Escitalopram|escitalopram|mesh-list
153820296|NCT00432614|Amibegron|amibegron|mesh-list
153820297|NCT00432614|Amibegron hydrochloride|amibegron hydrochloride|mesh-list
153820298|NCT00432614|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
153820299|NCT00432614|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153820300|NCT00432614|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153820301|NCT00432614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153820320|NCT00471588|Antioxidants|antioxidants|mesh-ancestor
153820321|NCT00471588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153820322|NCT00471588|Protective Agents|protective agents|mesh-ancestor
153820323|NCT00471588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153820324|NCT00471588|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
153820325|NCT00471588|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
153820326|NCT00471588|Dopamine Agonists|dopamine agonists|mesh-ancestor
153360305|NCT05089526|Fentanyl|fentanyl|mesh-list
153360316|NCT05089526|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153360317|NCT05089526|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153360318|NCT05089526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153360319|NCT05089526|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153360322|NCT05089526|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
153360323|NCT05089526|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153360324|NCT05089526|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153360325|NCT05089526|Adrenergic Agents|adrenergic agents|mesh-ancestor
153360326|NCT05089526|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153360333|NCT05089526|Narcotics|narcotics|mesh-ancestor
153820355|NCT00432887|Purinergic Agents|purinergic agents|mesh-ancestor
153651158|NCT00032929|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153651159|NCT00032929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153820356|NCT00432887|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153820357|NCT00471744|Levetiracetam|levetiracetam|mesh-list
153820358|NCT00471744|Sulthiame|sulthiame|mesh-list
153820359|NCT00471744|Anticonvulsants|anticonvulsants|mesh-ancestor
153820360|NCT00471744|Nootropic Agents|nootropic agents|mesh-ancestor
153820361|NCT00471783|Chlorhexidine|chlorhexidine|mesh-list
153820362|NCT00471783|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
153360375|NCT00806078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153360376|NCT00806078|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
153360377|NCT00806078|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153360378|NCT00806078|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153360380|NCT00806078|Sensory System Agents|sensory system agents|mesh-ancestor
153360382|NCT00806234|Olanzapine|olanzapine|mesh-list
153360383|NCT00806234|Risperidone|risperidone|mesh-list
153360384|NCT00806234|Aripiprazole|aripiprazole|mesh-list
153820406|NCT00471900|Immunologic Factors|immunologic factors|mesh-ancestor
153820407|NCT00471900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153820408|NCT01051661|Vaccines|vaccines|mesh-list
153820409|NCT01051661|Immunologic Factors|immunologic factors|mesh-ancestor
153820410|NCT01051661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153820411|NCT01051466|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
153820412|NCT01051466|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
153820413|NCT01051466|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153820414|NCT01051466|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153820415|NCT01051466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153820416|NCT01051466|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153820433|NCT00433121|Serotonin Agents|serotonin agents|mesh-ancestor
153820434|NCT00433121|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153820435|NCT00433121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153820436|NCT00433121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153820437|NCT00433121|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153360415|NCT00806234|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
153360416|NCT00806234|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
153360417|NCT00806234|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
153360418|NCT00806234|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
153820438|NCT00433121|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153820439|NCT00433121|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153820440|NCT00433121|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153820441|NCT00433121|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
153820442|NCT00433121|Dopamine Agents|dopamine agents|mesh-ancestor
153820443|NCT00433121|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
153820444|NCT00433121|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153820445|NCT00433121|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153820446|NCT00433121|Autonomic Agents|autonomic agents|mesh-ancestor
153820472|NCT00591526|Immunologic Factors|immunologic factors|mesh-ancestor
153360450|NCT00811850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153360451|NCT00811850|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153360497|NCT00845000|Dopamine Agents|dopamine agents|mesh-ancestor
153360498|NCT00845000|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153360499|NCT00845000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153820549|NCT00433784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153360531|NCT01330355|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153360532|NCT01330355|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153360533|NCT01330355|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153360534|NCT01330355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153360535|NCT01330355|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153360536|NCT02193815|Calcitriol|calcitriol|mesh-list
153820555|NCT00464256|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153820556|NCT00464256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153820558|NCT00464256|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153820559|NCT00464256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153820560|NCT00433823|Atorvastatin|atorvastatin|mesh-list
153820561|NCT00433823|Ezetimibe|ezetimibe|mesh-list
153820562|NCT00433823|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153651196|NCT00033085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153360568|NCT01331213|Analgesics|analgesics|mesh-ancestor
153360569|NCT01331213|Sensory System Agents|sensory system agents|mesh-ancestor
153360570|NCT01331213|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153360571|NCT01331213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153360572|NCT01331213|Anticonvulsants|anticonvulsants|mesh-ancestor
153360573|NCT01331213|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153360574|NCT01331213|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153820611|NCT00106028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153820612|NCT00106028|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153820613|NCT00464451|Dexmedetomidine|dexmedetomidine|mesh-list
153820614|NCT00464451|Chloral Hydrate|chloral hydrate|mesh-list
153820615|NCT00464451|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153820616|NCT00464451|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153820617|NCT00464451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153360600|NCT01277159|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153360601|NCT01277159|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153820638|NCT00433979|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153820639|NCT01050764|Vidarabine|vidarabine|mesh-list
153820640|NCT01050764|Fludarabine|fludarabine|mesh-list
153820641|NCT01050764|Fludarabine phosphate|fludarabine phosphate|mesh-list
153820642|NCT01050764|Melphalan|melphalan|mesh-list
153820643|NCT01050764|Thiotepa|thiotepa|mesh-list
153820644|NCT01050764|Thymoglobulin|thymoglobulin|mesh-list
153820645|NCT01050764|Antilymphocyte Serum|antilymphocyte serum|mesh-list
153820646|NCT01050764|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153820647|NCT01050764|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153820648|NCT01050764|Antimetabolites|antimetabolites|mesh-ancestor
153820649|NCT01050764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153360632|NCT01332461|Dermatologic Agents|dermatologic agents|mesh-ancestor
153360633|NCT01332461|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
153820656|NCT01050764|Alkylating Agents|alkylating agents|mesh-ancestor
153820657|NCT01050764|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153820659|NCT00434096|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
153820660|NCT00434096|Cannabinoid Receptor Antagonists|cannabinoid receptor antagonists|mesh-ancestor
153820661|NCT00434096|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
153360643|NCT01279187|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153820671|NCT01050569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153360654|NCT03608696|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153360655|NCT03608696|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
153360656|NCT01334723|Finasteride|finasteride|mesh-list
153820676|NCT01050569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153820677|NCT04702490|Empagliflozin|empagliflozin|mesh-list
153360670|NCT04311710|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153360671|NCT04311710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153360672|NCT01402427|Verapamil|verapamil|mesh-list
153360673|NCT01402427|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153360674|NCT01402427|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153360675|NCT01402427|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153360676|NCT01402427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153502208|NCT01278342|Dopamine Agonists|dopamine agonists|mesh-ancestor
153520684|NCT05735639|Apixaban|apixaban|mesh-list
153520685|NCT05735639|Enoxaparin sodium|enoxaparin sodium|mesh-list
153520686|NCT05735639|Dabigatran|dabigatran|mesh-list
153523518|NCT03613792|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153523519|NCT03613792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153523521|NCT03613792|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153489494|NCT04320342|Bromides|bromides|mesh-list
153489495|NCT04320342|Formoterol Fumarate|formoterol fumarate|mesh-list
153489496|NCT04320342|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153489497|NCT04320342|Autonomic Agents|autonomic agents|mesh-ancestor
153489498|NCT04320342|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153489499|NCT04320342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153489500|NCT04320342|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153489501|NCT04320342|Respiratory System Agents|respiratory system agents|mesh-ancestor
153489502|NCT04320342|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
153489503|NCT04320342|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
153489511|NCT04320342|Hormones|hormones|mesh-ancestor
153489553|NCT03937986|Dopamine Agents|dopamine agents|mesh-ancestor
153489554|NCT03937986|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153489555|NCT03937986|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
153489556|NCT03937986|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153489557|NCT03937986|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
153489620|NCT02420652|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153814364|NCT00338780|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153489621|NCT02420652|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153489622|NCT02420652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153489623|NCT02420652|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153489624|NCT02420652|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153489686|NCT00596154|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153489687|NCT00596154|Tubulin Modulators|tubulin modulators|mesh-ancestor
153489688|NCT00596154|Antimitotic Agents|antimitotic agents|mesh-ancestor
153489689|NCT00596154|Mitosis Modulators|mitosis modulators|mesh-ancestor
153489690|NCT00596154|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153489691|NCT00281658|Paclitaxel|paclitaxel|mesh-list
153489756|NCT02431572|Immunomodulating Agents|immunomodulating agents|mesh-list
153489757|NCT02431572|Immunologic Factors|immunologic factors|mesh-ancestor
153489758|NCT02431572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153489759|NCT02431650|Primaquine|primaquine|mesh-list
153489760|NCT02431650|Antimalarials|antimalarials|mesh-ancestor
153489761|NCT02431650|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153489762|NCT02431650|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153489763|NCT02431650|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153489764|NCT02437344|Naltrexone|naltrexone|mesh-list
153489765|NCT02437344|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
153489824|NCT02462148|Sympathomimetics|sympathomimetics|mesh-ancestor
153489825|NCT02462148|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
153489826|NCT02462382|Ropivacaine|ropivacaine|mesh-list
153489827|NCT02462382|Anesthetics, Local|anesthetics, local|mesh-ancestor
153489828|NCT02462382|Anesthetics|anesthetics|mesh-ancestor
153489829|NCT02462382|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153489830|NCT02462382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153489831|NCT02462382|Sensory System Agents|sensory system agents|mesh-ancestor
153489832|NCT02462382|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153489833|NCT02464176|Dexamethasone|dexamethasone|mesh-list
153489834|NCT02464176|Dexamethasone acetate|dexamethasone acetate|mesh-list
153489835|NCT02464176|Epinephrine|epinephrine|mesh-list
153489836|NCT02464176|Bupivacaine|bupivacaine|mesh-list
153489837|NCT02464176|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
153489884|NCT02472522|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153489885|NCT02472522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153489957|NCT02491788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153490029|NCT02515890|Sensory System Agents|sensory system agents|mesh-ancestor
153490030|NCT02515890|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153490031|NCT02515890|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
153490032|NCT02515890|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153490098|NCT02529072|Vaccines|vaccines|mesh-list
153490099|NCT02529072|Immunologic Factors|immunologic factors|mesh-ancestor
153490100|NCT02529072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153490174|NCT02542410|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
153490246|NCT02562066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153490247|NCT02562924|Prednisone|prednisone|mesh-list
153490320|NCT02582970|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153490394|NCT02108496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153490472|NCT03560466|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153490545|NCT05419674|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
153490547|NCT05386524|Bevacizumab|bevacizumab|mesh-list
153490548|NCT05386524|Doxorubicin|doxorubicin|mesh-list
153490621|NCT02960646|Cyclophosphamide|cyclophosphamide|mesh-list
153490691|NCT02624700|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153490693|NCT02631954|Voriconazole|voriconazole|mesh-list
153490763|NCT05510856|Antimanic Agents|antimanic agents|mesh-ancestor
153490835|NCT02653560|Chelating Agents|chelating agents|mesh-ancestor
153490912|NCT02655354|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
153490982|NCT02673372|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153490983|NCT02673372|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
153527475|NCT01471847|Capecitabine|capecitabine|mesh-list
153490984|NCT02673372|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
153490985|NCT02673372|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153490986|NCT02673372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153490987|NCT02673372|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153491050|NCT02709018|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
153491051|NCT02709018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153491052|NCT02713230|Bupivacaine|bupivacaine|mesh-list
153491053|NCT02713230|Anesthetics, Local|anesthetics, local|mesh-ancestor
153491054|NCT02713230|Anesthetics|anesthetics|mesh-ancestor
153527600|NCT01472406|Pancrelipase|pancrelipase|mesh-list
153491056|NCT02713230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153491057|NCT02713230|Sensory System Agents|sensory system agents|mesh-ancestor
153814365|NCT00338780|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153491058|NCT02713230|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153491059|NCT02713698|Propofol|propofol|mesh-list
153491060|NCT02713698|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153491110|NCT02726178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153491111|NCT02726178|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153491112|NCT02726178|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153491113|NCT02726178|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153491114|NCT02726178|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153491115|NCT02726178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153491117|NCT02733588|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
153491118|NCT02733588|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153491119|NCT02733588|Hormones|hormones|mesh-ancestor
153491120|NCT02733588|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153491121|NCT02733588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153491122|NCT02733588|Incretins|incretins|mesh-ancestor
153491123|NCT02737332|Abiraterone Acetate|abiraterone acetate|mesh-list
153491124|NCT02737332|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153491125|NCT02737332|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153491126|NCT02737332|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153491127|NCT02737332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153491128|NCT02737332|Hormone Antagonists|hormone antagonists|mesh-ancestor
153491129|NCT02737332|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153781835|NCT00231998|Dermatologic Agents|dermatologic agents|mesh-ancestor
153491161|NCT05266404|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
153527874|NCT01474902|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153491162|NCT05266404|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
153491169|NCT05266404|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
153491171|NCT05266404|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153491173|NCT05063604|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
153491174|NCT05063604|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153491197|NCT05452434|Mirabegron|mirabegron|mesh-list
153491219|NCT05447364|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153491291|NCT03703206|Anesthetics|anesthetics|mesh-list
153491292|NCT03703206|Anesthetics, Local|anesthetics, local|mesh-list
153491295|NCT03703206|Sensory System Agents|sensory system agents|mesh-ancestor
153491364|NCT03121716|Antimetabolites|antimetabolites|mesh-ancestor
153491365|NCT03121716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153491366|NCT03121716|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153491367|NCT02714634|Hydroxychloroquine|hydroxychloroquine|mesh-list
153491368|NCT02714634|Sulfasalazine|sulfasalazine|mesh-list
153491369|NCT02714634|Methotrexate|methotrexate|mesh-list
153527993|NCT01475760|Chitosan|chitosan|mesh-list
153491371|NCT02714634|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
153491372|NCT02714634|Abortifacient Agents|abortifacient agents|mesh-ancestor
153491373|NCT02714634|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153491374|NCT02714634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153491375|NCT02714634|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153491376|NCT02714634|Antimetabolites|antimetabolites|mesh-ancestor
153491377|NCT02714634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153491378|NCT02714634|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153491379|NCT02714634|Dermatologic Agents|dermatologic agents|mesh-ancestor
153491380|NCT02714634|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153491421|NCT02747628|Antioxidants|antioxidants|mesh-ancestor
153491422|NCT02747628|Protective Agents|protective agents|mesh-ancestor
153491423|NCT02747628|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153491424|NCT02754570|Pilocarpine|pilocarpine|mesh-list
153491425|NCT02754570|Miotics|miotics|mesh-ancestor
153491426|NCT02754570|Autonomic Agents|autonomic agents|mesh-ancestor
153491427|NCT02754570|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153491428|NCT02754570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153491429|NCT02754570|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
153491430|NCT02754570|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
153528116|NCT01476488|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153491488|NCT02775240|Sensory System Agents|sensory system agents|mesh-ancestor
153491489|NCT02775240|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153491490|NCT02775240|Antiviral Agents|antiviral agents|mesh-ancestor
153491491|NCT02775240|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153491492|NCT02777268|Hydrocortisone|hydrocortisone|mesh-list
153491493|NCT02777268|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153491494|NCT05350020|Hydrocortisone|hydrocortisone|mesh-list
153491495|NCT05350020|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
153491496|NCT05350020|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
153491497|NCT05350020|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
153491498|NCT05350020|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153491553|NCT05273814|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153491554|NCT05273814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153491555|NCT05273814|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153491556|NCT05273814|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153491557|NCT04784208|Hormones|hormones|mesh-list
153491558|NCT04784208|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153491560|NCT04024878|Nivolumab|nivolumab|mesh-list
153491609|NCT06085079|Dermatologic Agents|dermatologic agents|mesh-ancestor
153491610|NCT06084858|Dialysis Solutions|dialysis solutions|mesh-list
153491611|NCT06084858|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
153491612|NCT06084819|Cytarabine|cytarabine|mesh-list
153491613|NCT06084819|Azacitidine|azacitidine|mesh-list
153491614|NCT06084819|Venetoclax|venetoclax|mesh-list
153491615|NCT06084819|Aclacinomycins|aclacinomycins|mesh-list
153491616|NCT06084819|Lenograstim|lenograstim|mesh-list
153491617|NCT06084819|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153491618|NCT06084819|Antimetabolites|antimetabolites|mesh-ancestor
153528170|NCT01476813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153491619|NCT06084819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153491620|NCT06084819|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153491621|NCT06084819|Antiviral Agents|antiviral agents|mesh-ancestor
153491622|NCT06084819|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153491624|NCT06084819|Immunologic Factors|immunologic factors|mesh-ancestor
153491672|NCT06084507|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153491673|NCT06084507|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
153491674|NCT06084507|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153491675|NCT06084156|Metformin|metformin|mesh-list
153491676|NCT06084156|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153491744|NCT06082232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153491745|NCT06082232|Sensory System Agents|sensory system agents|mesh-ancestor
153491894|NCT05384821|Temozolomide|temozolomide|mesh-list
153491973|NCT05032183|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153491974|NCT05032183|Immunologic Factors|immunologic factors|mesh-ancestor
153491976|NCT05032183|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153492044|NCT04984317|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153492045|NCT04984317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153492047|NCT04984317|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153492048|NCT04977479|Vaccines|vaccines|mesh-list
153492049|NCT04977479|Immunologic Factors|immunologic factors|mesh-ancestor
153492051|NCT04947189|Dexamethasone|dexamethasone|mesh-list
153492118|NCT04520503|Anesthetics, General|anesthetics, general|mesh-ancestor
153492191|NCT04172259|Docetaxel|docetaxel|mesh-list
153492192|NCT04172259|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
153492194|NCT04172259|Doxorubicin|doxorubicin|mesh-list
153492265|NCT03751436|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153492266|NCT03735875|Venetoclax|venetoclax|mesh-list
153492267|NCT03735875|Quizartinib|quizartinib|mesh-list
153492268|NCT03735875|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153492269|NCT03735875|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153492273|NCT03629327|Aspirin|aspirin|mesh-list
153492331|NCT03350516|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153492333|NCT03350516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153492334|NCT03350516|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153492335|NCT03348670|Prednisone|prednisone|mesh-list
153492336|NCT03348670|Abiraterone Acetate|abiraterone acetate|mesh-list
153492337|NCT03348670|Relugolix|relugolix|mesh-list
153492338|NCT03348670|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153492398|NCT03166644|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153492400|NCT03166644|Anesthetics|anesthetics|mesh-ancestor
153492401|NCT02998528|Paclitaxel|paclitaxel|mesh-list
153492402|NCT02998528|Vinorelbine|vinorelbine|mesh-list
153492403|NCT02998528|Docetaxel|docetaxel|mesh-list
153492404|NCT02998528|Carboplatin|carboplatin|mesh-list
153492405|NCT02998528|Gemcitabine|gemcitabine|mesh-list
153492406|NCT02998528|Nivolumab|nivolumab|mesh-list
153492407|NCT02998528|Pemetrexed|pemetrexed|mesh-list
153492408|NCT02998528|Ipilimumab|ipilimumab|mesh-list
153492409|NCT02998528|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153492410|NCT02998528|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153492538|NCT00942331|Growth Substances|growth substances|mesh-ancestor
153492611|NCT00076310|Mitosis Modulators|mitosis modulators|mesh-ancestor
153492687|NCT00800514|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153492761|NCT02835846|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153492762|NCT02835846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153492764|NCT02844582|Cortisone|cortisone|mesh-list
153492765|NCT02844582|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153492832|NCT02865720|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
153492833|NCT02865720|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153492904|NCT02902770|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153492905|NCT02902770|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153492906|NCT02902770|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153492907|NCT02902770|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153492908|NCT02907918|Trastuzumab|trastuzumab|mesh-list
153492909|NCT02907918|Letrozole|letrozole|mesh-list
153492910|NCT02907918|Palbociclib|palbociclib|mesh-list
153492972|NCT02913924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153528600|NCT01479244|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153492973|NCT02913924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153493044|NCT02956044|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153493045|NCT02956044|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
153493047|NCT02956044|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153493113|NCT02970162|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
153493114|NCT02970162|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153493115|NCT02970162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153493117|NCT02970552|Progestins|progestins|mesh-ancestor
153493119|NCT02970552|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153493120|NCT02970552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153493121|NCT02978508|Permethrin|permethrin|mesh-list
153493122|NCT02978508|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153493123|NCT02978508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153493124|NCT02881008|Entecavir|entecavir|mesh-list
153493175|NCT03020004|Ribavirin|ribavirin|mesh-list
153493176|NCT03020004|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
153493177|NCT03020004|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
153493189|NCT03020082|Ritonavir|ritonavir|mesh-list
153493249|NCT03044418|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153493250|NCT03044418|Anesthetics, General|anesthetics, general|mesh-ancestor
153493251|NCT03048006|Gadolinium 1,4,7,10-tetraazacyclododecane-N,N',N'',N'''-tetraacetate|gadolinium 1,4,7,10-tetraazacyclododecane-n,n',n'',n'''-tetraacetate|mesh-list
153493252|NCT03048006|Chelating Agents|chelating agents|mesh-ancestor
153493253|NCT03048006|Sequestering Agents|sequestering agents|mesh-ancestor
153493254|NCT03048006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153493255|NCT03051672|Pembrolizumab|pembrolizumab|mesh-list
153493256|NCT03051672|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153528883|NCT01481194|Bortezomib|bortezomib|mesh-list
153493257|NCT03051672|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153493258|NCT03051672|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153493314|NCT03070470|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153493315|NCT03070470|Amebicides|amebicides|mesh-ancestor
153493386|NCT03107754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153493387|NCT03107754|Sensory System Agents|sensory system agents|mesh-ancestor
153493457|NCT04589364|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
153493458|NCT04589364|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153493459|NCT04473924|Mycophenolic Acid|mycophenolic acid|mesh-list
153493460|NCT04473924|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153493461|NCT04473924|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153493462|NCT04473924|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
153493463|NCT04473924|Antitubercular Agents|antitubercular agents|mesh-ancestor
153493464|NCT04473924|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153493465|NCT04473924|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153493468|NCT04131192|Gemcitabine|gemcitabine|mesh-list
153493522|NCT00151398|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
153493523|NCT00151398|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153651203|NCT00033085|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153651204|NCT00033085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153889914|NCT01003639|Ibuprofen|ibuprofen|mesh-list
153889915|NCT01003639|Naproxen|naproxen|mesh-list
153889916|NCT01003639|Acetazolamide|acetazolamide|mesh-list
153889917|NCT01003639|Codeine|codeine|mesh-list
153651205|NCT00033163|Tenofovir|tenofovir|mesh-list
153651206|NCT00033163|Adefovir|adefovir|mesh-list
153814369|NCT00451620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153493524|NCT00151398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153493525|NCT00151398|Cholinergic Agents|cholinergic agents|mesh-ancestor
153493526|NCT00151398|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153493527|NCT00151398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153493528|NCT00151398|Nootropic Agents|nootropic agents|mesh-ancestor
153493529|NCT03181308|Nivolumab|nivolumab|mesh-list
153493589|NCT03223272|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153493659|NCT03301272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153493660|NCT03301272|Cholinergic Agents|cholinergic agents|mesh-ancestor
153493732|NCT03395886|Dexmedetomidine|dexmedetomidine|mesh-list
153493806|NCT03459612|Dermatologic Agents|dermatologic agents|mesh-ancestor
153493882|NCT03541356|Dopamine Agents|dopamine agents|mesh-ancestor
153493883|NCT03541356|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153493885|NCT03541356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153529282|NCT01484145|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153493952|NCT03674970|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
153494029|NCT04399980|Mavrilimumab|mavrilimumab|mesh-list
153494030|NCT04399980|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153494104|NCT03962634|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153494177|NCT03806556|Hemostatics|hemostatics|mesh-ancestor
153494178|NCT03806556|Coagulants|coagulants|mesh-ancestor
153494179|NCT03812328|Enoxaparin|enoxaparin|mesh-list
153494180|NCT03812328|Anticoagulants|anticoagulants|mesh-ancestor
153494181|NCT03812328|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153494182|NCT03812328|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153494183|NCT03812328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153494184|NCT03805386|Analgesics, Opioid|analgesics, opioid|mesh-list
153529479|NCT01485679|Deoxyglucose|deoxyglucose|mesh-list
153494185|NCT03805386|Narcotics|narcotics|mesh-ancestor
153651207|NCT00033163|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
153651208|NCT00033163|Antiviral Agents|antiviral agents|mesh-ancestor
153651216|NCT00033241|Gemcitabine|gemcitabine|mesh-list
153651258|NCT00000620|Terazosin|terazosin|mesh-list
153651259|NCT00000620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153651260|NCT00000620|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153651261|NCT00000620|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153494186|NCT03805386|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153494244|NCT03042780|Immunologic Factors|immunologic factors|mesh-ancestor
153494245|NCT03042780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153494246|NCT03042780|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153494247|NCT02985840|Dexamethasone|dexamethasone|mesh-list
153494248|NCT02985840|Ondansetron|ondansetron|mesh-list
153494249|NCT02985840|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153494250|NCT02985840|Antiemetics|antiemetics|mesh-ancestor
153494251|NCT02985840|Autonomic Agents|autonomic agents|mesh-ancestor
153494252|NCT02985840|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153494253|NCT02985840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153494254|NCT02985840|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153494306|NCT02587650|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153494307|NCT02587650|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153494381|NCT02345772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153494451|NCT01846182|Pregabalin|pregabalin|mesh-list
153494525|NCT01602198|Cholinergic Agents|cholinergic agents|mesh-ancestor
153494599|NCT01292070|Histamine Agonists|histamine agonists|mesh-ancestor
153494600|NCT01292070|Histamine Agents|histamine agents|mesh-ancestor
153494601|NCT01292070|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153494602|NCT01292070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153494604|NCT01284504|Celecoxib|celecoxib|mesh-list
153494669|NCT01115244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153494670|NCT01115244|Leprostatic Agents|leprostatic agents|mesh-ancestor
153529859|NCT01487421|Insulin Detemir|insulin detemir|mesh-list
153494671|NCT01115244|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153494673|NCT01031550|Isoflurane|isoflurane|mesh-list
153494674|NCT01031550|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153494675|NCT01031550|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153494676|NCT01031550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153494677|NCT01031550|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153494678|NCT01031550|Anesthetics, General|anesthetics, general|mesh-ancestor
153494679|NCT01031550|Anesthetics|anesthetics|mesh-ancestor
153494680|NCT01031550|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
153494730|NCT00811590|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153530101|NCT01489072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153494731|NCT00811590|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153494732|NCT00811590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153494733|NCT00811590|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153494734|NCT00811590|Immunologic Factors|immunologic factors|mesh-ancestor
153494735|NCT00811590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153494799|NCT00676026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153494866|NCT00570258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153494867|NCT00568698|Hydroxyurea|hydroxyurea|mesh-list
153494940|NCT03472872|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153495014|NCT00145704|Vitamin D|vitamin d|mesh-list
153495015|NCT00145704|Ergocalciferols|ergocalciferols|mesh-list
153495016|NCT00145704|Cholecalciferol|cholecalciferol|mesh-list
153495087|NCT02595996|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
153495088|NCT02595996|Adrenergic Agents|adrenergic agents|mesh-ancestor
153495158|NCT00000192|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153495235|NCT00000264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153495236|NCT00000264|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
153495237|NCT00000264|Anesthetics, General|anesthetics, general|mesh-ancestor
153495238|NCT00000264|Anesthetics|anesthetics|mesh-ancestor
153495239|NCT00000264|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153495240|NCT00000264|Analgesics|analgesics|mesh-ancestor
153495241|NCT00000264|Sensory System Agents|sensory system agents|mesh-ancestor
153495242|NCT00000264|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153495243|NCT00000270|Cocaine|cocaine|mesh-list
153495244|NCT00000270|Anesthetics, Local|anesthetics, local|mesh-ancestor
153495245|NCT00000270|Anesthetics|anesthetics|mesh-ancestor
153891328|NCT06055101|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153495246|NCT00000270|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153495247|NCT00000270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153495248|NCT00000270|Sensory System Agents|sensory system agents|mesh-ancestor
153495249|NCT00000270|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153495257|NCT00000276|Bupropion|bupropion|mesh-list
153495292|NCT00000306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153495293|NCT00000306|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
153495294|NCT00000306|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153495295|NCT00000306|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153495296|NCT00000306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153495297|NCT00000306|Dopamine Agents|dopamine agents|mesh-ancestor
153495298|NCT00000306|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153495299|NCT00000318|Buprenorphine|buprenorphine|mesh-list
153495300|NCT00000318|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153495301|NCT00000318|Narcotics|narcotics|mesh-ancestor
153495302|NCT00000318|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153495354|NCT00000354|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153495355|NCT00000354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153495356|NCT00000372|Cycloserine|cycloserine|mesh-list
153495357|NCT00000372|Clozapine|clozapine|mesh-list
153495425|NCT00000510|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153495426|NCT00000510|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153495497|NCT00000660|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153651326|NCT00033319|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153651327|NCT00033319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153651328|NCT00033319|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153651329|NCT00033319|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153651330|NCT00033319|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153651331|NCT00033319|Antipyretics|antipyretics|mesh-ancestor
153651332|NCT00033358|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
153651333|NCT00033358|Ethinyl Estradiol|ethinyl estradiol|mesh-list
153651334|NCT00033358|Medroxyprogesterone|medroxyprogesterone|mesh-list
153651337|NCT00033358|Estrogens|estrogens|mesh-ancestor
153651338|NCT00033358|Hormones|hormones|mesh-ancestor
153891340|NCT06054789|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
153891341|NCT06054789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153891342|NCT06054321|Dexetimide|dexetimide|mesh-list
153891343|NCT06054321|Aripiprazole|aripiprazole|mesh-list
153495498|NCT00000660|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153781846|NCT00266838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153495499|NCT00000660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153495500|NCT00000702|Zidovudine|zidovudine|mesh-list
153495501|NCT00000702|Antimetabolites|antimetabolites|mesh-ancestor
153495502|NCT00000702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153495503|NCT00000702|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153495505|NCT00000702|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153495562|NCT00000738|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153495563|NCT00000738|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153530447|NCT01490411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153530448|NCT01490437|Dexamethasone|dexamethasone|mesh-list
153495564|NCT00000738|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153495565|NCT00000738|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153495566|NCT00000738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153495567|NCT00000738|Vasodilator Agents|vasodilator agents|mesh-ancestor
153495569|NCT00000750|Antimetabolites|antimetabolites|mesh-ancestor
153651339|NCT00033358|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153495570|NCT00000750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153495571|NCT00000750|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153495572|NCT00000750|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153495573|NCT00000750|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153438556|NCT00004814|Glatiramer Acetate|glatiramer acetate|mesh-list
153495574|NCT00000750|Antiviral Agents|antiviral agents|mesh-ancestor
153495575|NCT00000750|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153495576|NCT00000750|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153495577|NCT00000750|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153495579|NCT00000804|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
153495580|NCT00000804|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
153495581|NCT00000804|Protease Inhibitors|protease inhibitors|mesh-ancestor
153495582|NCT00000804|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153495583|NCT00000804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153495584|NCT00000804|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153495585|NCT00000804|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153495586|NCT00000804|Antiviral Agents|antiviral agents|mesh-ancestor
153495587|NCT00000804|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153495588|NCT00000810|Zidovudine|zidovudine|mesh-list
153495589|NCT00000810|Didanosine|didanosine|mesh-list
153495590|NCT00000810|Delavirdine|delavirdine|mesh-list
153495591|NCT00000810|Antimetabolites|antimetabolites|mesh-ancestor
153495593|NCT00000810|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153495605|NCT00000834|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153495606|NCT00000834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153495677|NCT00000912|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153495678|NCT00000918|Ritonavir|ritonavir|mesh-list
153495679|NCT00000918|Indinavir|indinavir|mesh-list
153495751|NCT00000942|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153495752|NCT00000942|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
153495753|NCT00000942|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
153495754|NCT00000948|Aldesleukin|aldesleukin|mesh-list
153495755|NCT00000948|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153495756|NCT00000948|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153495757|NCT00000948|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153495758|NCT00000948|Antiviral Agents|antiviral agents|mesh-ancestor
153889918|NCT01003639|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153495759|NCT00000948|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153889919|NCT01003639|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153889920|NCT01003639|Analgesics|analgesics|mesh-ancestor
153889921|NCT01003639|Sensory System Agents|sensory system agents|mesh-ancestor
153889922|NCT01003639|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153889923|NCT01003639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153889924|NCT01003639|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153889925|NCT01003639|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153651415|NCT00013689|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153651416|NCT00013689|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153891375|NCT06054321|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
153891376|NCT06054321|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
153891377|NCT06054321|Histamine Antagonists|histamine antagonists|mesh-ancestor
153891378|NCT06054321|Histamine Agents|histamine agents|mesh-ancestor
153495760|NCT00000954|Didanosine|didanosine|mesh-list
153495761|NCT00000954|Zalcitabine|zalcitabine|mesh-list
153495762|NCT00000954|Doxorubicin|doxorubicin|mesh-list
153495816|NCT00001044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153495963|NCT00001680|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153495974|NCT00001698|Ketorolac|ketorolac|mesh-list
153496032|NCT00001854|Ribavirin|ribavirin|mesh-list
153496105|NCT00002034|Ganciclovir|ganciclovir|mesh-list
153496187|NCT00002082|Azithromycin|azithromycin|mesh-list
153496252|NCT00002130|Vesnarinone|vesnarinone|mesh-list
153496257|NCT00002130|Antiviral Agents|antiviral agents|mesh-ancestor
153496325|NCT00002178|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153496326|NCT00002178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153496327|NCT00002178|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153496328|NCT00002178|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153496396|NCT00002208|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153496398|NCT00002208|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153496544|NCT00002322|Antiviral Agents|antiviral agents|mesh-ancestor
153496545|NCT00002322|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153496546|NCT00002322|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153496547|NCT00002322|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153496548|NCT00002328|Azithromycin|azithromycin|mesh-list
153496549|NCT00002328|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153496614|NCT00002370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153496615|NCT00002370|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153496616|NCT00002370|Hormone Antagonists|hormone antagonists|mesh-ancestor
153496617|NCT00002370|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153496618|NCT00002370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153496619|NCT00002370|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
153496622|NCT00002376|Stavudine|stavudine|mesh-list
153496682|NCT00002406|Protease Inhibitors|protease inhibitors|mesh-ancestor
153496757|NCT00002436|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153496829|NCT00002466|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153496830|NCT00002466|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153496978|NCT00002550|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153497053|NCT00002580|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
153497129|NCT00002604|Carmustine|carmustine|mesh-list
153497130|NCT00002604|O(6)-benzylguanine|o(6)-benzylguanine|mesh-list
153531196|NCT01495169|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153497131|NCT00002604|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153497132|NCT00002604|Alkylating Agents|alkylating agents|mesh-ancestor
153497133|NCT00002604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153497134|NCT00002604|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153497135|NCT00002604|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153497136|NCT00002610|Dactinomycin|dactinomycin|mesh-list
153497137|NCT00002610|Cyclophosphamide|cyclophosphamide|mesh-list
153497138|NCT00002610|Carboplatin|carboplatin|mesh-list
153497139|NCT00002610|Doxorubicin|doxorubicin|mesh-list
153497140|NCT00002610|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
153497141|NCT00002610|Etoposide|etoposide|mesh-list
153497142|NCT00002610|Vincristine|vincristine|mesh-list
153497143|NCT00002610|Lenograstim|lenograstim|mesh-list
153497144|NCT00002610|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153497166|NCT00002616|Aldesleukin|aldesleukin|mesh-list
153497191|NCT00002634|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153497192|NCT00002634|Immunologic Factors|immunologic factors|mesh-ancestor
153497193|NCT00002634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153497265|NCT00002664|Immunologic Factors|immunologic factors|mesh-ancestor
153497267|NCT00002664|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153497341|NCT00002688|Etoposide|etoposide|mesh-list
153497342|NCT00002688|Mitoxantrone|mitoxantrone|mesh-list
153651417|NCT00013689|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153497343|NCT00002688|Cyclosporins|cyclosporins|mesh-list
153497344|NCT00002688|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153497345|NCT00002688|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153497358|NCT00002688|Analgesics|analgesics|mesh-ancestor
153497414|NCT00002700|Vitamin B Complex|vitamin b complex|mesh-ancestor
153497415|NCT00002700|Vitamins|vitamins|mesh-ancestor
153497489|NCT00002748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153531355|NCT01496105|Lidocaine|lidocaine|mesh-list
153497490|NCT00002748|Immunologic Factors|immunologic factors|mesh-ancestor
153497491|NCT00002754|Antibodies|antibodies|mesh-list
153497492|NCT00002754|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
153497493|NCT00002754|Immunologic Factors|immunologic factors|mesh-ancestor
153497494|NCT00002754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153497495|NCT00002760|Ketoconazole|ketoconazole|mesh-list
153497496|NCT00002760|Hydrocortisone|hydrocortisone|mesh-list
153497497|NCT00002760|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
153497498|NCT00002760|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
153497499|NCT00002760|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
153497500|NCT00002760|Androgen Antagonists|androgen antagonists|mesh-list
153497501|NCT00002760|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153497502|NCT00002760|Antifungal Agents|antifungal agents|mesh-ancestor
153497503|NCT00002760|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153497549|NCT00002784|Cyclophosphamide|cyclophosphamide|mesh-list
153497622|NCT05751252|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153497623|NCT05751252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153531458|NCT01496742|Bevacizumab|bevacizumab|mesh-list
153497692|NCT05360628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153497763|NCT03846570|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153497769|NCT03846570|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153497913|NCT00002838|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153497914|NCT00002838|Immunologic Factors|immunologic factors|mesh-ancestor
153497985|NCT00002904|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153497986|NCT00002928|Paclitaxel|paclitaxel|mesh-list
153498011|NCT00002964|Trioxsalen|trioxsalen|mesh-list
153498058|NCT00002982|Antiviral Agents|antiviral agents|mesh-ancestor
153498135|NCT00003060|Cyclosporins|cyclosporins|mesh-list
153498136|NCT00003060|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153498207|NCT00003084|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153498282|NCT00003150|Vincristine|vincristine|mesh-list
153498283|NCT00003150|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153498357|NCT00003204|Rituximab|rituximab|mesh-list
153498358|NCT00003204|Fludarabine|fludarabine|mesh-list
153498359|NCT00003204|Fludarabine phosphate|fludarabine phosphate|mesh-list
153498360|NCT00003204|Vincristine|vincristine|mesh-list
153498361|NCT00003204|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153498427|NCT00003252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153498428|NCT00003264|Gemcitabine|gemcitabine|mesh-list
153498429|NCT00003264|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153498430|NCT00003264|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153498431|NCT00003264|Antimetabolites|antimetabolites|mesh-ancestor
153498432|NCT00003264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153498433|NCT00003276|Irinotecan|irinotecan|mesh-list
153498434|NCT00003276|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
153498435|NCT00003276|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153498436|NCT00003276|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153498437|NCT00003276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153498438|NCT00003276|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153498439|NCT00003288|Cyclophosphamide|cyclophosphamide|mesh-list
153498440|NCT00003288|Tirapazamine|tirapazamine|mesh-list
153498441|NCT00003288|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153498442|NCT00003288|Immunologic Factors|immunologic factors|mesh-ancestor
153498444|NCT00003288|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153498483|NCT00003336|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153498484|NCT00003336|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153498485|NCT00003336|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153498487|NCT00003336|Autonomic Agents|autonomic agents|mesh-ancestor
153498488|NCT00003336|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153498489|NCT00003336|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153498490|NCT00003336|Glucocorticoids|glucocorticoids|mesh-ancestor
153498491|NCT00003336|Hormones|hormones|mesh-ancestor
153498493|NCT00003336|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
153498549|NCT00003396|Immunologic Factors|immunologic factors|mesh-ancestor
153498550|NCT00003396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153531963|NCT01499875|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153498554|NCT00003396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153498556|NCT00003396|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153498557|NCT00003402|Dexamethasone|dexamethasone|mesh-list
153498558|NCT00003402|Paclitaxel|paclitaxel|mesh-list
153498559|NCT00003402|Etoposide|etoposide|mesh-list
153498560|NCT00003402|Cyclophosphamide|cyclophosphamide|mesh-list
153498561|NCT00003402|Melphalan|melphalan|mesh-list
153651532|NCT00034177|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153651533|NCT00034177|Tubulin Modulators|tubulin modulators|mesh-ancestor
153651534|NCT00034177|Antimitotic Agents|antimitotic agents|mesh-ancestor
153651535|NCT00034177|Mitosis Modulators|mitosis modulators|mesh-ancestor
153651536|NCT00034177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153651537|NCT00389129|Aspirin|aspirin|mesh-list
153498562|NCT00003402|Carmustine|carmustine|mesh-list
153498563|NCT00003402|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153498564|NCT00003402|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153498565|NCT00003402|Tubulin Modulators|tubulin modulators|mesh-ancestor
153498566|NCT00003402|Antimitotic Agents|antimitotic agents|mesh-ancestor
153498609|NCT00003414|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153498683|NCT00003564|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153498759|NCT00003612|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153498760|NCT00003624|Paclitaxel|paclitaxel|mesh-list
153498830|NCT00003696|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
153498904|NCT00003792|Lenograstim|lenograstim|mesh-list
153498992|NCT00003858|Mitoxantrone|mitoxantrone|mesh-list
153499052|NCT00003894|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153499053|NCT00003900|Docetaxel|docetaxel|mesh-list
153499054|NCT00003900|Irinotecan|irinotecan|mesh-list
153499055|NCT00003900|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153499056|NCT00003900|Tubulin Modulators|tubulin modulators|mesh-ancestor
153499057|NCT00003900|Antimitotic Agents|antimitotic agents|mesh-ancestor
153499058|NCT00003900|Mitosis Modulators|mitosis modulators|mesh-ancestor
153499120|NCT00003954|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153499270|NCT00004074|Interleukin-12|interleukin-12|mesh-list
153499346|NCT00004128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153499363|NCT00004158|Melphalan|melphalan|mesh-list
153499422|NCT00004188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153499423|NCT00004188|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153499424|NCT00004188|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153499425|NCT00004188|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153651591|NCT00014001|Antiemetics|antiemetics|mesh-ancestor
153499426|NCT00004188|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153499492|NCT00004218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153499493|NCT00004218|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153499494|NCT00004218|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153499495|NCT00004218|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153499496|NCT00004218|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153499497|NCT00004218|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153499498|NCT00004218|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153499499|NCT00004218|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153499500|NCT00004218|Antimetabolites|antimetabolites|mesh-ancestor
153499501|NCT00004218|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153499502|NCT00004218|Tubulin Modulators|tubulin modulators|mesh-ancestor
153499503|NCT00004218|Antimitotic Agents|antimitotic agents|mesh-ancestor
153499504|NCT00004218|Mitosis Modulators|mitosis modulators|mesh-ancestor
153499505|NCT00004218|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153499506|NCT00004218|Glucocorticoids|glucocorticoids|mesh-ancestor
153499508|NCT00004218|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153499509|NCT00004218|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153499547|NCT00004248|Aldesleukin|aldesleukin|mesh-list
153499548|NCT00004248|Doxorubicin|doxorubicin|mesh-list
153499549|NCT00004248|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
153499550|NCT00004248|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153499551|NCT00004248|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153499552|NCT00004248|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153499553|NCT00004248|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153499554|NCT00004248|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153532634|NCT01502943|Antimetabolites|antimetabolites|mesh-ancestor
153499555|NCT00004248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153499556|NCT00004248|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153499557|NCT00004248|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153499558|NCT00004248|Antiviral Agents|antiviral agents|mesh-ancestor
153499559|NCT00004248|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153499560|NCT00004254|Raltitrexed|raltitrexed|mesh-list
153499561|NCT00004254|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153499562|NCT00004254|Antimetabolites|antimetabolites|mesh-ancestor
153499563|NCT00004254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153499564|NCT00004254|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153499565|NCT00004254|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153499566|NCT00004254|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153499568|NCT00004260|Interleukin-12|interleukin-12|mesh-list
153499569|NCT00004260|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153499570|NCT00004260|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153499571|NCT00004260|Immunologic Factors|immunologic factors|mesh-ancestor
153651627|NCT02971540|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153651628|NCT02971540|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153651629|NCT02971540|Antipyretics|antipyretics|mesh-ancestor
153651630|NCT00034489|Gemcitabine|gemcitabine|mesh-list
153651631|NCT00034489|Pemetrexed|pemetrexed|mesh-list
153651632|NCT00034489|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153651680|NCT00014040|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153651681|NCT00014040|Respiratory System Agents|respiratory system agents|mesh-ancestor
153651682|NCT00014040|Free Radical Scavengers|free radical scavengers|mesh-ancestor
153499572|NCT00004260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153499573|NCT00004260|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153499574|NCT00004260|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153499575|NCT00004260|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153499576|NCT00004260|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153499577|NCT00004260|Growth Substances|growth substances|mesh-ancestor
153499593|NCT00004266|Vasodilator Agents|vasodilator agents|mesh-ancestor
153499594|NCT00004266|Tocolytic Agents|tocolytic agents|mesh-ancestor
153499595|NCT00004266|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153499596|NCT00004266|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
153499597|NCT00004266|Protease Inhibitors|protease inhibitors|mesh-ancestor
153499598|NCT00004266|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153499599|NCT00004266|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
153499600|NCT00004266|Protective Agents|protective agents|mesh-ancestor
153499660|NCT00004404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153499661|NCT00004404|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
153499662|NCT00004404|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
153499663|NCT00004410|Ursodoxicoltaurine|ursodoxicoltaurine|mesh-list
153499664|NCT00004410|Antiviral Agents|antiviral agents|mesh-ancestor
153532933|NCT01504126|Propranolol|propranolol|mesh-list
153499665|NCT00004410|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153651696|NCT00034528|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153651697|NCT00034528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153651698|NCT00034528|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153651699|NCT00034528|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153651700|NCT00034528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153651701|NCT00034528|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153651702|NCT00034528|Immunologic Factors|immunologic factors|mesh-ancestor
153651703|NCT00034528|Alkylating Agents|alkylating agents|mesh-ancestor
153651706|NCT00000677|Sch 39304|sch 39304|mesh-list
153499666|NCT00004410|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
153499667|NCT00004410|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153499668|NCT00004416|Botulinum Toxins|botulinum toxins|mesh-list
153499669|NCT00004416|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
153499670|NCT00004416|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
153499671|NCT00004416|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
153499672|NCT00004416|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153499673|NCT00004416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153499674|NCT00004416|Cholinergic Agents|cholinergic agents|mesh-ancestor
153499675|NCT00004416|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153499676|NCT00004416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153499677|NCT00004416|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
153499678|NCT00004416|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153499679|NCT00004422|Immunoglobulins|immunoglobulins|mesh-list
153499680|NCT00004422|Antibodies|antibodies|mesh-list
153499681|NCT00004422|gamma-Globulins|gamma-globulins|mesh-list
153499682|NCT00004422|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
153499709|NCT00004446|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
153499710|NCT00004446|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153499711|NCT00004446|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153499712|NCT00004464|Cyclophosphamide|cyclophosphamide|mesh-list
153499713|NCT00004464|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153499714|NCT00004464|Immunologic Factors|immunologic factors|mesh-ancestor
153499715|NCT00004464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153499716|NCT00004464|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153533121|NCT01505049|Vaccines|vaccines|mesh-list
153651799|NCT00000689|Vincristine|vincristine|mesh-list
153651800|NCT00000689|Bleomycin|bleomycin|mesh-list
153651801|NCT00000689|Sargramostim|sargramostim|mesh-list
153651802|NCT00000689|Levoleucovorin|levoleucovorin|mesh-list
153651845|NCT00034879|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153651846|NCT00034879|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153651847|NCT00034879|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153651848|NCT00034879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153651850|NCT00000707|Pentamidine|pentamidine|mesh-list
153651851|NCT00000707|Antifungal Agents|antifungal agents|mesh-ancestor
153651852|NCT00000707|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153651853|NCT00000707|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153651854|NCT00000707|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153651855|NCT00000707|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
153499717|NCT00004464|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153533328|NCT01506024|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153499718|NCT00004464|Alkylating Agents|alkylating agents|mesh-ancestor
153499719|NCT00004464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153499720|NCT00004464|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153499721|NCT00004464|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153499722|NCT00004482|Cyclosporine|cyclosporine|mesh-list
153499723|NCT00004482|Prednisone|prednisone|mesh-list
153499724|NCT00004482|Methylprednisolone|methylprednisolone|mesh-list
153499725|NCT00004482|Cyclosporins|cyclosporins|mesh-list
153499726|NCT00004482|Muromonab-CD3|muromonab-cd3|mesh-list
153499727|NCT00004482|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153499728|NCT00004482|Glucocorticoids|glucocorticoids|mesh-ancestor
153499729|NCT00004482|Hormones|hormones|mesh-ancestor
153499730|NCT00004482|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153499731|NCT00004482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153499761|NCT00004488|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153499762|NCT00004554|Naltrexone|naltrexone|mesh-list
153499763|NCT00004554|Sertraline|sertraline|mesh-list
153499764|NCT00004554|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
153499765|NCT00004554|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
153499766|NCT00004554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153651857|NCT00014235|Mycophenolic Acid|mycophenolic acid|mesh-list
153651858|NCT00014235|Fludarabine|fludarabine|mesh-list
153651859|NCT00014235|Fludarabine phosphate|fludarabine phosphate|mesh-list
153651860|NCT00014235|Cyclosporins|cyclosporins|mesh-list
153499767|NCT00004554|Sensory System Agents|sensory system agents|mesh-ancestor
153499768|NCT00004554|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153499769|NCT00004554|Antidepressive Agents|antidepressive agents|mesh-ancestor
153499770|NCT00004554|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153499771|NCT00004554|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
153499772|NCT00004554|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153499773|NCT00004554|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153499774|NCT00004554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153499775|NCT00004554|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153499777|NCT00004578|Ritonavir|ritonavir|mesh-list
153499778|NCT00004578|Lopinavir|lopinavir|mesh-list
153499779|NCT00004578|Lamivudine|lamivudine|mesh-list
153499780|NCT00004578|Stavudine|stavudine|mesh-list
153499781|NCT00004578|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
153499782|NCT00004578|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
153499783|NCT00004578|Protease Inhibitors|protease inhibitors|mesh-ancestor
153499784|NCT00004578|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153499785|NCT00004578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153499786|NCT00004578|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153499787|NCT00004578|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153499788|NCT00004578|Antiviral Agents|antiviral agents|mesh-ancestor
153499789|NCT00004578|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153499790|NCT00004578|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
153651961|NCT00035074|Immunologic Factors|immunologic factors|mesh-ancestor
153651962|NCT00035074|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153651963|NCT00035074|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153651964|NCT00035113|Epothilones|epothilones|mesh-list
153651965|NCT00035113|Epothilone B|epothilone b|mesh-list
153651966|NCT00035113|Tubulin Modulators|tubulin modulators|mesh-ancestor
153651967|NCT00035113|Antimitotic Agents|antimitotic agents|mesh-ancestor
153651968|NCT00035113|Mitosis Modulators|mitosis modulators|mesh-ancestor
153651969|NCT00035113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153651970|NCT00035113|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153651971|NCT00000722|Pentamidine|pentamidine|mesh-list
153651972|NCT00000722|Antifungal Agents|antifungal agents|mesh-ancestor
153651973|NCT00000722|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153651974|NCT00000722|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153499791|NCT00004578|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153499804|NCT00004650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153499805|NCT00004650|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
153499806|NCT00004650|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
153499807|NCT00004650|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
153499808|NCT00004650|Contraceptive Agents|contraceptive agents|mesh-ancestor
153499809|NCT00004650|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153499810|NCT00004650|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
153499811|NCT00004650|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
153499812|NCT00004650|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
153499813|NCT00004650|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153499814|NCT00004650|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153499815|NCT00004662|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
153499816|NCT00004662|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153499817|NCT00004662|Immunologic Factors|immunologic factors|mesh-ancestor
153499818|NCT00004662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153499819|NCT00004686|Prednisone|prednisone|mesh-list
153499820|NCT00004686|Methotrexate|methotrexate|mesh-list
153499821|NCT00004686|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153499822|NCT00004686|Glucocorticoids|glucocorticoids|mesh-ancestor
153499823|NCT00004686|Hormones|hormones|mesh-ancestor
153499824|NCT00004686|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153499825|NCT00004686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153652019|NCT00035191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153652020|NCT00035191|Parasympathomimetics|parasympathomimetics|mesh-ancestor
153652066|NCT00035425|Linezolid|linezolid|mesh-list
153499826|NCT00004686|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153499830|NCT00004686|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153499831|NCT00004686|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153499832|NCT00004686|Antimetabolites|antimetabolites|mesh-ancestor
153499833|NCT00004686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153499834|NCT00004686|Dermatologic Agents|dermatologic agents|mesh-ancestor
153499835|NCT00004686|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153499836|NCT00004686|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153499837|NCT00004686|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153499838|NCT00004686|Immunologic Factors|immunologic factors|mesh-ancestor
153360686|NCT01365611|Autonomic Agents|autonomic agents|mesh-ancestor
153820680|NCT04702490|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153499839|NCT00004686|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153499840|NCT00004686|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153499841|NCT00004728|Aspirin|aspirin|mesh-list
153499842|NCT00004728|Warfarin|warfarin|mesh-list
153499843|NCT00004728|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153499844|NCT00004728|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153499845|NCT00004728|Analgesics|analgesics|mesh-ancestor
153499846|NCT00004728|Sensory System Agents|sensory system agents|mesh-ancestor
153499847|NCT00004728|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153499848|NCT00004728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153499849|NCT00004728|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153499850|NCT00004728|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153499851|NCT00004728|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153499852|NCT00004728|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153499853|NCT00004728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153499854|NCT00004728|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153499855|NCT00004728|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153499856|NCT00004728|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153499857|NCT00004728|Antipyretics|antipyretics|mesh-ancestor
153499858|NCT00004728|Anticoagulants|anticoagulants|mesh-ancestor
153499859|NCT00004734|Folic Acid|folic acid|mesh-list
153499860|NCT00004734|Pyridoxine|pyridoxine|mesh-list
153499861|NCT00004734|Vitamin B 12|vitamin b 12|mesh-list
153499862|NCT00004734|Hydroxocobalamin|hydroxocobalamin|mesh-list
153499863|NCT00004734|Hematinics|hematinics|mesh-ancestor
153499864|NCT00004734|Vitamin B Complex|vitamin b complex|mesh-ancestor
153499865|NCT00004734|Vitamins|vitamins|mesh-ancestor
153499866|NCT00004734|Micronutrients|micronutrients|mesh-ancestor
153499867|NCT00004734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153499868|NCT00004740|Isoniazid|isoniazid|mesh-list
153499869|NCT00004740|Antitubercular Agents|antitubercular agents|mesh-ancestor
153499870|NCT00004740|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153499871|NCT00004740|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153499872|NCT00004740|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
153499873|NCT00004740|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153499874|NCT00004740|Antimetabolites|antimetabolites|mesh-ancestor
153499875|NCT00004740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153652090|NCT00000752|Nasal Decongestants|nasal decongestants|mesh-ancestor
153652118|NCT00014469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153652119|NCT00014469|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153652120|NCT00014469|Antimetabolites|antimetabolites|mesh-ancestor
153652121|NCT00014469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153652122|NCT00014469|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153652123|NCT00014469|Dermatologic Agents|dermatologic agents|mesh-ancestor
153652124|NCT00014469|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153432577|NCT04472598|Navitoclax|navitoclax|mesh-list
153499877|NCT00004758|Pyridoxine|pyridoxine|mesh-list
153499880|NCT00004758|Nitrazepam|nitrazepam|mesh-list
153499881|NCT00004758|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
153499882|NCT00004758|Anticonvulsants|anticonvulsants|mesh-ancestor
153499883|NCT00004758|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153499884|NCT00004758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153499885|NCT00004758|GABA Agents|gaba agents|mesh-ancestor
153499886|NCT00004758|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153499887|NCT00004758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153499888|NCT00004758|Antimanic Agents|antimanic agents|mesh-ancestor
153499889|NCT00004758|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153499890|NCT00004758|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153499891|NCT00004758|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153499892|NCT00004758|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153499893|NCT00004758|Analgesics|analgesics|mesh-ancestor
153499894|NCT00004758|Sensory System Agents|sensory system agents|mesh-ancestor
153499895|NCT00004758|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153652130|NCT00014469|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
153652131|NCT00014469|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153652132|NCT00014469|Alkylating Agents|alkylating agents|mesh-ancestor
153652133|NCT00014469|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153652134|NCT00000755|Zidovudine|zidovudine|mesh-list
153652135|NCT00000755|Antimetabolites|antimetabolites|mesh-ancestor
153652136|NCT00000755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153889937|NCT01003639|Natriuretic Agents|natriuretic agents|mesh-ancestor
153889938|NCT01003639|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153889939|NCT01003639|Narcotics|narcotics|mesh-ancestor
153652137|NCT00000755|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153499896|NCT00004758|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153499897|NCT00004758|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153499898|NCT00004758|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
153499899|NCT00004758|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
153499900|NCT00004758|Vitamin B Complex|vitamin b complex|mesh-ancestor
153499901|NCT00004758|Vitamins|vitamins|mesh-ancestor
153534081|NCT01509300|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153499902|NCT00004758|Micronutrients|micronutrients|mesh-ancestor
153499904|NCT00004758|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153499905|NCT00004758|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153499906|NCT00004758|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153499907|NCT00004758|GABA Modulators|gaba modulators|mesh-ancestor
153499908|NCT00004770|Thioctic Acid|thioctic acid|mesh-list
153499909|NCT00004770|Antioxidants|antioxidants|mesh-ancestor
153499911|NCT00004770|Protective Agents|protective agents|mesh-ancestor
153499924|NCT00004794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153499925|NCT00004800|Vaccines|vaccines|mesh-list
153499926|NCT00004800|Immunologic Factors|immunologic factors|mesh-ancestor
153499927|NCT00004800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153499928|NCT00004842|Budesonide|budesonide|mesh-list
153499929|NCT00004842|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153499930|NCT00004842|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153499931|NCT00004842|Autonomic Agents|autonomic agents|mesh-ancestor
153499932|NCT00004842|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153499933|NCT00004842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153499934|NCT00004842|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153652186|NCT00014586|Androgen Antagonists|androgen antagonists|mesh-ancestor
153499935|NCT00004842|Respiratory System Agents|respiratory system agents|mesh-ancestor
153499936|NCT00004842|Glucocorticoids|glucocorticoids|mesh-ancestor
153652222|NCT00035893|Antiviral Agents|antiviral agents|mesh-ancestor
153652223|NCT00035893|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153652224|NCT00035893|Interferon Inducers|interferon inducers|mesh-ancestor
153652225|NCT00035893|Immunologic Factors|immunologic factors|mesh-ancestor
153652226|NCT00035893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153652227|NCT00035971|Alendronate|alendronate|mesh-list
153652228|NCT00035971|Raloxifene Hydrochloride|raloxifene hydrochloride|mesh-list
153652229|NCT00035971|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153652230|NCT00035971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153652231|NCT00035971|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
153652232|NCT00035971|Hormone Antagonists|hormone antagonists|mesh-ancestor
153652233|NCT00035971|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153652234|NCT00035971|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
153652235|NCT00035971|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
153652280|NCT00036127|Dopamine Agents|dopamine agents|mesh-ancestor
153499937|NCT00004842|Hormones|hormones|mesh-ancestor
153499938|NCT00004842|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153499939|NCT00004854|Carvedilol|carvedilol|mesh-list
153499940|NCT00004854|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
153499941|NCT00004854|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
153499942|NCT00004854|Adrenergic Agents|adrenergic agents|mesh-ancestor
153534533|NCT01511757|Hormone Antagonists|hormone antagonists|mesh-ancestor
153499943|NCT00004854|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153499944|NCT00004854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153499945|NCT00004854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153499946|NCT00004854|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153499948|NCT00004854|Protective Agents|protective agents|mesh-ancestor
153499949|NCT00004854|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153499970|NCT00004878|Fludarabine phosphate|fludarabine phosphate|mesh-list
153499971|NCT00004878|Fludarabine|fludarabine|mesh-list
153499972|NCT00004878|Idarubicin|idarubicin|mesh-list
153499973|NCT00004878|Tacrolimus|tacrolimus|mesh-list
153499974|NCT00004878|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
153652287|NCT00036127|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153652288|NCT00036127|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
153652289|NCT00036127|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
153652290|NCT00000788|Fluconazole|fluconazole|mesh-list
153652291|NCT00000788|Methadone|methadone|mesh-list
153652292|NCT00000788|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153652293|NCT00000788|Narcotics|narcotics|mesh-ancestor
153652294|NCT00000788|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153652296|NCT00000788|Analgesics|analgesics|mesh-ancestor
153652337|NCT00000794|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153652338|NCT00000794|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153652340|NCT00000794|Coccidiostats|coccidiostats|mesh-ancestor
153499975|NCT00004878|Abortifacient Agents|abortifacient agents|mesh-ancestor
153499976|NCT00004878|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153499977|NCT00004878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153499978|NCT00004878|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153499979|NCT00004878|Antimetabolites|antimetabolites|mesh-ancestor
153499980|NCT00004878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153499981|NCT00004878|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153499982|NCT00004878|Dermatologic Agents|dermatologic agents|mesh-ancestor
153499983|NCT00004878|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153499984|NCT00004878|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153499985|NCT00004878|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153499986|NCT00004878|Immunologic Factors|immunologic factors|mesh-ancestor
153499987|NCT00004878|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153499988|NCT00004878|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153499989|NCT00004878|Antiviral Agents|antiviral agents|mesh-ancestor
153499990|NCT00004878|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153535126|NCT01514942|Folic Acid|folic acid|mesh-list
153499991|NCT00004878|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
153499992|NCT00004878|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153499993|NCT00004878|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153499994|NCT00004878|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153499995|NCT00004884|Gemcitabine|gemcitabine|mesh-list
153499996|NCT00004884|Docetaxel|docetaxel|mesh-list
153500019|NCT00004926|Ro 23-7553|ro 23-7553|mesh-list
153500020|NCT00004926|Vitamins|vitamins|mesh-ancestor
153500021|NCT00004926|Micronutrients|micronutrients|mesh-ancestor
153500022|NCT00004926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153500023|NCT00004926|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153500024|NCT00004926|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153500025|NCT00004926|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153500026|NCT00004932|Imatinib Mesylate|imatinib mesylate|mesh-list
153500027|NCT00004932|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153500028|NCT00004932|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153500029|NCT00004932|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153500030|NCT00004932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153535220|NCT01515592|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153500031|NCT00004932|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153500033|NCT00004938|Antifungal Agents|antifungal agents|mesh-ancestor
153500034|NCT00004938|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153500035|NCT00004938|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
153500036|NCT00004938|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153431005|NCT04099303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153431006|NCT00379951|Ertapenem|ertapenem|mesh-list
153431007|NCT00379951|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153431008|NCT00379951|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153431009|NCT00000337|Selegiline|selegiline|mesh-list
153431010|NCT00000337|Antidepressive Agents|antidepressive agents|mesh-ancestor
153431011|NCT00000337|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153652391|NCT00036400|Epoetin Alfa|epoetin alfa|mesh-list
153652392|NCT00036400|Hematinics|hematinics|mesh-ancestor
153652393|NCT00036439|Infliximab|infliximab|mesh-list
153652394|NCT00036439|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
153652395|NCT00036439|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153500037|NCT00004938|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153500038|NCT00004938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153500039|NCT00004938|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153500040|NCT00004938|Hormone Antagonists|hormone antagonists|mesh-ancestor
153500041|NCT00004938|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153500042|NCT00004938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153500043|NCT00004938|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
153500045|NCT00004986|Nitazoxanide|nitazoxanide|mesh-list
153500065|NCT00004998|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
153500066|NCT00004998|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
153500068|NCT00005010|Irbesartan|irbesartan|mesh-list
153500069|NCT00005010|Pravastatin|pravastatin|mesh-list
153500070|NCT00005010|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153500071|NCT00005010|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153500072|NCT00005010|Antimetabolites|antimetabolites|mesh-ancestor
153500073|NCT00005010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153500075|NCT00005010|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
153500076|NCT00005010|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153500077|NCT00005010|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153500078|NCT00005010|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
153500079|NCT00005010|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
153500080|NCT00005022|Etoposide|etoposide|mesh-list
153500081|NCT00005022|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153500082|NCT00005022|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153500083|NCT00005022|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153500084|NCT00005022|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153500085|NCT00005022|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153500117|NCT00005076|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153500118|NCT00005076|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153500119|NCT00005076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153500120|NCT00005076|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153500121|NCT00005076|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153500122|NCT00005088|Cisplatin|cisplatin|mesh-list
153500123|NCT00005088|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153500124|NCT00005094|Celecoxib|celecoxib|mesh-list
153500125|NCT00005094|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153500126|NCT00005094|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153500127|NCT00005094|Analgesics|analgesics|mesh-ancestor
153500128|NCT00005094|Sensory System Agents|sensory system agents|mesh-ancestor
153500129|NCT00005094|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153500130|NCT00005094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153500131|NCT00005094|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153500132|NCT00005094|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153500133|NCT00005094|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
153500134|NCT00005094|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153500135|NCT00005094|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153500136|NCT00005094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153500137|NCT00005106|Lamivudine|lamivudine|mesh-list
153500138|NCT00005106|Zidovudine|zidovudine|mesh-list
153500139|NCT00005106|Abacavir|abacavir|mesh-list
153500140|NCT00005106|Stavudine|stavudine|mesh-list
153500141|NCT00005106|Lamivudine, zidovudine drug combination|lamivudine, zidovudine drug combination|mesh-list
153500142|NCT00005106|Nelfinavir|nelfinavir|mesh-list
153535871|NCT01518725|Vitamin D|vitamin d|mesh-list
153500144|NCT00005106|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153500145|NCT00005106|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153500146|NCT00005106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153500147|NCT00005106|Antiviral Agents|antiviral agents|mesh-ancestor
153500148|NCT00005106|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153500159|NCT00005118|Protease Inhibitors|protease inhibitors|mesh-ancestor
153500160|NCT00005118|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153500161|NCT00005118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153500162|NCT00005118|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153443169|NCT02057250|Sulfasalazine|sulfasalazine|mesh-list
153500163|NCT00005118|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153500164|NCT00005118|Antiviral Agents|antiviral agents|mesh-ancestor
153500165|NCT00005118|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153500166|NCT00005118|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
153500167|NCT00005118|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153500168|NCT00005520|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
153500169|NCT00005520|Candesartan|candesartan|mesh-list
153500170|NCT00005520|Candesartan cilexetil|candesartan cilexetil|mesh-list
153500171|NCT00005520|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153500172|NCT00005520|Diuretics|diuretics|mesh-ancestor
153500173|NCT00005520|Natriuretic Agents|natriuretic agents|mesh-ancestor
153500174|NCT00005520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153500175|NCT00005520|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
153500176|NCT00005520|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153500177|NCT00005520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153500178|NCT00005520|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
153500179|NCT00005520|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
153500180|NCT00005574|Gentamicins|gentamicins|mesh-list
153500181|NCT00005574|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153500182|NCT00005574|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153500183|NCT00005574|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
153500186|NCT00005580|Fludarabine|fludarabine|mesh-list
153500204|NCT00005586|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153536077|NCT01520077|Ezetimibe, Simvastatin Drug Combination|ezetimibe, simvastatin drug combination|mesh-list
153500205|NCT00005586|Immunologic Factors|immunologic factors|mesh-ancestor
153500206|NCT00005586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153500207|NCT00005586|Antidotes|antidotes|mesh-ancestor
153500208|NCT00005586|Protective Agents|protective agents|mesh-ancestor
153500209|NCT00005586|Vitamin B Complex|vitamin b complex|mesh-ancestor
153500210|NCT00005586|Vitamins|vitamins|mesh-ancestor
153500211|NCT00005586|Micronutrients|micronutrients|mesh-ancestor
153500212|NCT00005592|Rituximab|rituximab|mesh-list
153500213|NCT00005592|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
153500214|NCT00005592|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153500215|NCT00005592|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153500216|NCT00005592|Immunologic Factors|immunologic factors|mesh-ancestor
153500217|NCT00005592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153500218|NCT00005592|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153500219|NCT00005598|Azacitidine|azacitidine|mesh-list
153500221|NCT00005598|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153500222|NCT00005598|Antimetabolites|antimetabolites|mesh-ancestor
153500223|NCT00005598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153500224|NCT00005598|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153500225|NCT00005598|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153500226|NCT00005598|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
153500257|NCT00005622|Immunologic Factors|immunologic factors|mesh-ancestor
153500258|NCT00005622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153500259|NCT00005622|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153500260|NCT00005622|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153500261|NCT00005622|Alkylating Agents|alkylating agents|mesh-ancestor
153536361|NCT01521962|Alogliptin|alogliptin|mesh-list
153652457|NCT00000857|Growth Inhibitors|growth inhibitors|mesh-ancestor
153652458|NCT00000857|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153500262|NCT00005622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153500263|NCT00005622|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153500264|NCT00005622|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153500266|NCT00005634|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153500267|NCT00005634|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
153500268|NCT00005634|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153500269|NCT00005634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153500270|NCT00005640|Technetium Tc 99m Sulfur Colloid|technetium tc 99m sulfur colloid|mesh-list
153500271|NCT00005640|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
153500272|NCT00005640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153500274|NCT00005646|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153500275|NCT00005646|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153500276|NCT00005646|Tubulin Modulators|tubulin modulators|mesh-ancestor
153500277|NCT00005646|Antimitotic Agents|antimitotic agents|mesh-ancestor
153500278|NCT00005646|Mitosis Modulators|mitosis modulators|mesh-ancestor
153500279|NCT00005646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153500280|NCT00005652|Rituximab|rituximab|mesh-list
153500281|NCT00005652|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153500305|NCT00005802|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
153500306|NCT00005802|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
153500307|NCT00005802|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
153500308|NCT00005802|Methotrexate|methotrexate|mesh-list
153500309|NCT00005802|Fludarabine phosphate|fludarabine phosphate|mesh-list
153500310|NCT00005802|Fludarabine|fludarabine|mesh-list
153500311|NCT00005802|Etoposide|etoposide|mesh-list
153500312|NCT00005802|Mitoxantrone|mitoxantrone|mesh-list
153443318|NCT01363440|Aflibercept|aflibercept|mesh-list
153536641|NCT01523379|Parecoxib|parecoxib|mesh-list
153500313|NCT00005802|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
153500314|NCT00005802|Abortifacient Agents|abortifacient agents|mesh-ancestor
153500315|NCT00005802|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153500316|NCT00005802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153500324|NCT00005802|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153500325|NCT00005802|Immunologic Factors|immunologic factors|mesh-ancestor
153500326|NCT00005802|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153500357|NCT00355290|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
153500358|NCT00355290|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153500359|NCT00355290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153500360|NCT00355290|Hemostatics|hemostatics|mesh-ancestor
153500361|NCT00355290|Coagulants|coagulants|mesh-ancestor
153500362|NCT00355446|Bimatoprost|bimatoprost|mesh-list
153500363|NCT00355446|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153500364|NCT00355524|Ritonavir|ritonavir|mesh-list
153500365|NCT00355524|Darunavir|darunavir|mesh-list
153500366|NCT00355524|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
153500367|NCT00355524|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
153500368|NCT00355524|Protease Inhibitors|protease inhibitors|mesh-ancestor
153500369|NCT00355524|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153500370|NCT00355524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153500371|NCT00355524|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153500372|NCT00355524|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153652524|NCT00000869|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153652525|NCT00000869|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153652529|NCT00037102|Interferons|interferons|mesh-list
153500373|NCT00355524|Antiviral Agents|antiviral agents|mesh-ancestor
153500374|NCT00355524|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153500375|NCT00355524|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
153500376|NCT00355524|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153500377|NCT00355602|Metronidazole|metronidazole|mesh-list
153500378|NCT00355602|Vancomycin|vancomycin|mesh-list
153500379|NCT00355602|Clarithromycin|clarithromycin|mesh-list
153500380|NCT00355602|Doxycycline|doxycycline|mesh-list
153500381|NCT00355602|Ciprofloxacin|ciprofloxacin|mesh-list
153500382|NCT00355602|Rifaximin|rifaximin|mesh-list
153500383|NCT00355602|Cefuroxime|cefuroxime|mesh-list
153500384|NCT00355602|Neomycin|neomycin|mesh-list
153536935|NCT01524861|Antioxidants|antioxidants|mesh-ancestor
153500385|NCT00355602|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
153500386|NCT00355602|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
153500387|NCT00355602|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153500402|NCT00355602|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
153500403|NCT00355602|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
153500404|NCT00356070|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
153500405|NCT00356070|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
153500406|NCT00356070|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153500407|NCT00356070|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153500408|NCT00356070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153500409|NCT00356070|Adrenergic Agents|adrenergic agents|mesh-ancestor
153537111|NCT05891262|Ethinyl Estradiol|ethinyl estradiol|mesh-list
153500410|NCT00356070|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153500411|NCT00356070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153500413|NCT00356226|Analgesics|analgesics|mesh-ancestor
153500414|NCT00356226|Sensory System Agents|sensory system agents|mesh-ancestor
153500415|NCT00356226|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153500416|NCT00356226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153500417|NCT00356226|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153500418|NCT00356226|Sympatholytics|sympatholytics|mesh-ancestor
153500419|NCT00356226|Autonomic Agents|autonomic agents|mesh-ancestor
153500420|NCT00356226|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
153500421|NCT00356226|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153500422|NCT00356226|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153500423|NCT00356226|Adrenergic Agents|adrenergic agents|mesh-ancestor
153500424|NCT00356226|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153500425|NCT00356226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153500426|NCT00356460|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
153500427|NCT00356460|Antibodies|antibodies|mesh-list
153500428|NCT00356460|Immunoglobulins|immunoglobulins|mesh-list
153500445|NCT00356616|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153500446|NCT00356772|Azithromycin|azithromycin|mesh-list
153500447|NCT00356772|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153889943|NCT01003249|Baclofen|baclofen|mesh-list
153500448|NCT00356772|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153652539|NCT00037102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153652540|NCT00037102|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153652541|NCT00037102|Dermatologic Agents|dermatologic agents|mesh-ancestor
153652561|NCT00037180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153652562|NCT00037180|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153814402|NCT00338936|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
153891621|NCT05809700|Protective Agents|protective agents|mesh-ancestor
153891622|NCT05773092|Osimertinib|osimertinib|mesh-list
153891623|NCT05773092|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153891624|NCT05773092|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153891625|NCT05773092|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153500449|NCT00356850|Azithromycin|azithromycin|mesh-list
153500450|NCT00356850|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153500451|NCT00356850|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153500452|NCT00356928|Cyclophosphamide|cyclophosphamide|mesh-list
153500453|NCT00356928|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153500454|NCT00356928|Immunologic Factors|immunologic factors|mesh-ancestor
153537701|NCT01415882|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153500455|NCT00356928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153500456|NCT00356928|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153500457|NCT00356928|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153500458|NCT00356928|Alkylating Agents|alkylating agents|mesh-ancestor
153500459|NCT00356928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153500460|NCT00356928|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153500461|NCT00356928|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153500462|NCT00357084|Prednisone|prednisone|mesh-list
153500463|NCT00357084|Methylprednisolone|methylprednisolone|mesh-list
153500464|NCT00357084|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
153500465|NCT00357084|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
153500466|NCT00357084|Prednisolone|prednisolone|mesh-list
153500467|NCT00357084|Prednisolone acetate|prednisolone acetate|mesh-list
153500468|NCT00357084|Methotrexate|methotrexate|mesh-list
153500469|NCT00357084|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
153500470|NCT00357084|Prednisolone phosphate|prednisolone phosphate|mesh-list
153500471|NCT00357084|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153500472|NCT00357084|Glucocorticoids|glucocorticoids|mesh-ancestor
153500473|NCT00357084|Hormones|hormones|mesh-ancestor
153500474|NCT00357084|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153500475|NCT00357084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153500476|NCT00357084|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153500477|NCT00357084|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153500478|NCT00357084|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
153500479|NCT00357084|Abortifacient Agents|abortifacient agents|mesh-ancestor
153500480|NCT00357084|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153500482|NCT00357084|Antimetabolites|antimetabolites|mesh-ancestor
153500483|NCT00357084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153500484|NCT00357084|Dermatologic Agents|dermatologic agents|mesh-ancestor
153500485|NCT00357084|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153500486|NCT00357084|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153500487|NCT00357084|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153500488|NCT00357084|Immunologic Factors|immunologic factors|mesh-ancestor
153500489|NCT00357084|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153500490|NCT00357084|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153538641|NCT01529190|Pregabalin|pregabalin|mesh-list
153500491|NCT00357084|Antiemetics|antiemetics|mesh-ancestor
153500492|NCT00357084|Autonomic Agents|autonomic agents|mesh-ancestor
153500493|NCT00357084|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153500494|NCT00357084|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153652563|NCT00037180|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153500495|NCT00357084|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
153652564|NCT00037180|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153652565|NCT00037180|Immunologic Factors|immunologic factors|mesh-ancestor
153652566|NCT00037180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153500496|NCT00357084|Protective Agents|protective agents|mesh-ancestor
153500498|NCT00357240|Atazanavir Sulfate|atazanavir sulfate|mesh-list
153500499|NCT00357240|Omeprazole|omeprazole|mesh-list
153500500|NCT00357240|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
153500501|NCT00357240|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
153500502|NCT00357240|Protease Inhibitors|protease inhibitors|mesh-ancestor
153500503|NCT00357240|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153500504|NCT00357240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153500505|NCT00357240|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153500506|NCT00357240|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153500507|NCT00357240|Antiviral Agents|antiviral agents|mesh-ancestor
153500508|NCT00357240|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153500509|NCT00357240|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
153500510|NCT00357240|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153538863|NCT01530230|Oxytocin|oxytocin|mesh-list
153538864|NCT01530230|Oxytocics|oxytocics|mesh-ancestor
153500511|NCT00357240|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
153500512|NCT00357240|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153500513|NCT00357240|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
153500514|NCT00357318|Bevacizumab|bevacizumab|mesh-list
153500516|NCT00357318|Sunitinib|sunitinib|mesh-list
153500524|NCT00357318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153500525|NCT00357318|Growth Inhibitors|growth inhibitors|mesh-ancestor
153500526|NCT00357318|Immunologic Factors|immunologic factors|mesh-ancestor
153538924|NCT01530503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153500527|NCT00357318|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153500528|NCT00357318|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153500529|NCT00357318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153500530|NCT00357474|Ethanol|ethanol|mesh-list
153500531|NCT00357474|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
153500532|NCT00357474|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153500533|NCT00357474|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153538927|NCT01530503|Alkylating Agents|alkylating agents|mesh-ancestor
153500534|NCT00357474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153500535|NCT00357630|Gemcitabine|gemcitabine|mesh-list
153500536|NCT00357630|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153500537|NCT00357630|Antimetabolites|antimetabolites|mesh-ancestor
153500538|NCT00357630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153500539|NCT00357630|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153500540|NCT00357708|Decitabine|decitabine|mesh-list
153500541|NCT00357708|Azacitidine|azacitidine|mesh-list
153500542|NCT00357708|Vorinostat|vorinostat|mesh-list
153500543|NCT00357708|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153500544|NCT00357708|Antimetabolites|antimetabolites|mesh-ancestor
153500545|NCT00357708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153500546|NCT00357708|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153500547|NCT00357708|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153500548|NCT00357708|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
153500549|NCT00357864|Carbachol|carbachol|mesh-list
153500551|NCT00357864|Miotics|miotics|mesh-ancestor
153500552|NCT00357864|Autonomic Agents|autonomic agents|mesh-ancestor
153500553|NCT00357864|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153500554|NCT00357864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153500555|NCT00357864|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
153500556|NCT00357864|Cholinergic Agents|cholinergic agents|mesh-ancestor
153500565|NCT00357942|Narcotics|narcotics|mesh-ancestor
153500566|NCT00357942|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153500567|NCT00357942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153500568|NCT00357942|Analgesics|analgesics|mesh-ancestor
153500569|NCT00357942|Sensory System Agents|sensory system agents|mesh-ancestor
153500570|NCT00357942|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153500571|NCT00358020|Thalidomide|thalidomide|mesh-list
153500572|NCT00358020|Bortezomib|bortezomib|mesh-list
153500573|NCT00358020|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153500574|NCT00358020|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153500575|NCT00358020|Immunologic Factors|immunologic factors|mesh-ancestor
153500576|NCT00358020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153500577|NCT00358020|Leprostatic Agents|leprostatic agents|mesh-ancestor
153500578|NCT00358020|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153500579|NCT00358020|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153539364|NCT01533220|Pheniramine|pheniramine|mesh-list
153500580|NCT00358020|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153500581|NCT00358020|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153500582|NCT00358020|Growth Substances|growth substances|mesh-ancestor
153500583|NCT00358020|Growth Inhibitors|growth inhibitors|mesh-ancestor
153500584|NCT00358176|Risedronic Acid|risedronic acid|mesh-list
153500585|NCT00358176|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153500586|NCT00358176|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153500587|NCT00358176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153500588|NCT00358176|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153500589|NCT00358176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153500590|NCT00358176|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153500591|NCT00358410|Casopitant|casopitant|mesh-list
153500592|NCT00358410|Antiemetics|antiemetics|mesh-ancestor
153539520|NCT01533870|Rifampin|rifampin|mesh-list
153500608|NCT00358488|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
153500609|NCT00358488|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
153500610|NCT00358488|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153500611|NCT00358488|Adrenergic Agents|adrenergic agents|mesh-ancestor
153500612|NCT00358488|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153500613|NCT00358488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153500614|NCT00358488|Tocolytic Agents|tocolytic agents|mesh-ancestor
153500615|NCT00358488|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153539643|NCT01534806|Ketorolac|ketorolac|mesh-list
153500616|NCT00358566|Gemcitabine|gemcitabine|mesh-list
153500617|NCT00358566|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153500618|NCT00358566|Antimetabolites|antimetabolites|mesh-ancestor
153500619|NCT00358566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153500620|NCT00358566|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153500621|NCT00359112|Metformin|metformin|mesh-list
153500622|NCT00359112|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153500623|NCT00359112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153500624|NCT00359190|Lapatinib|lapatinib|mesh-list
153500625|NCT00359190|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153500626|NCT00359190|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153500627|NCT00359190|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153500628|NCT00359190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153500629|NCT00359190|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153539805|NCT01535768|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153500630|NCT00359658|Cyclosporine|cyclosporine|mesh-list
153500631|NCT00359658|Prednisolone|prednisolone|mesh-list
153500633|NCT00359658|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153500634|NCT00359658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153500653|NCT00359814|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153500654|NCT00359814|Immunologic Factors|immunologic factors|mesh-ancestor
153500655|NCT00359814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153500656|NCT00359814|Antifungal Agents|antifungal agents|mesh-ancestor
153500657|NCT00359814|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153500658|NCT00359814|Dermatologic Agents|dermatologic agents|mesh-ancestor
153500659|NCT00359814|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153500660|NCT00359814|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
153500661|NCT00359892|Obatoclax|obatoclax|mesh-list
153500662|NCT00359892|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153500663|NCT00359892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153500664|NCT00359970|Azithromycin|azithromycin|mesh-list
153500665|NCT00359970|Loperamide|loperamide|mesh-list
153500666|NCT00359970|Antidiarrheals|antidiarrheals|mesh-list
153500667|NCT00359970|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153500668|NCT00359970|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153500669|NCT00359970|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153500670|NCT00360048|Oxytocin|oxytocin|mesh-list
153500671|NCT00360048|Oxytocics|oxytocics|mesh-ancestor
153500672|NCT00360048|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153500673|NCT00360048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153500674|NCT00360438|Rasburicase|rasburicase|mesh-list
153500675|NCT00360438|Gout Suppressants|gout suppressants|mesh-ancestor
153500676|NCT00360438|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153500677|NCT00360594|Acamprosate|acamprosate|mesh-list
153500678|NCT00360594|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
153500679|NCT00360750|Cytarabine|cytarabine|mesh-list
153500680|NCT00360750|Carboplatin|carboplatin|mesh-list
153652621|NCT00037531|Immunologic Factors|immunologic factors|mesh-ancestor
153652622|NCT00037531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153652624|NCT00037570|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
153652625|NCT00037570|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153652626|NCT00037570|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
153500681|NCT00360750|Etoposide|etoposide|mesh-list
153500682|NCT00360750|Vincristine|vincristine|mesh-list
153500683|NCT00360750|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153500684|NCT00360750|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153781866|NCT02212210|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153500699|NCT00360984|Insulin|insulin|mesh-list
153500700|NCT00360984|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
153500701|NCT00360984|Insulin Glargine|insulin glargine|mesh-list
153500702|NCT00360984|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153500703|NCT00360984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153500704|NCT00361452|Epinephrine|epinephrine|mesh-list
153500705|NCT00361452|Albuterol|albuterol|mesh-list
153500706|NCT00361452|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153500707|NCT00361452|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153540268|NCT01538459|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153500708|NCT00361452|Adrenergic Agents|adrenergic agents|mesh-ancestor
153500709|NCT00361452|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153500710|NCT00361452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153500711|NCT00361452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153500712|NCT00361452|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
153500713|NCT00361452|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153500714|NCT00361452|Autonomic Agents|autonomic agents|mesh-ancestor
153540416|NCT01538953|Eusol|eusol|mesh-list
153500715|NCT00361452|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153500716|NCT00361452|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153500717|NCT00361452|Respiratory System Agents|respiratory system agents|mesh-ancestor
153500718|NCT00361452|Mydriatics|mydriatics|mesh-ancestor
153500719|NCT00361452|Sympathomimetics|sympathomimetics|mesh-ancestor
153500720|NCT00361452|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
153500721|NCT00361452|Tocolytic Agents|tocolytic agents|mesh-ancestor
153500722|NCT00361452|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153500723|NCT00361452|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
153500724|NCT00361686|Tramadol|tramadol|mesh-list
153500725|NCT00361686|Remifentanil|remifentanil|mesh-list
153500726|NCT00361686|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153540436|NCT01539044|Mydriatics|mydriatics|mesh-ancestor
153540446|NCT01539174|Prednisone|prednisone|mesh-list
153500727|NCT00361686|Narcotics|narcotics|mesh-ancestor
153500728|NCT00361686|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153500730|NCT00361686|Analgesics|analgesics|mesh-ancestor
153500743|NCT00361998|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153500744|NCT00361998|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153500745|NCT00362310|Indinavir|indinavir|mesh-list
153500746|NCT00362310|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
153500747|NCT00362310|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
153889951|NCT01003249|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153652627|NCT00037570|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153652628|NCT00037570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153652629|NCT00000899|Lamivudine|lamivudine|mesh-list
153652630|NCT00000899|Stavudine|stavudine|mesh-list
153652631|NCT00000899|Nelfinavir|nelfinavir|mesh-list
153500748|NCT00362310|Protease Inhibitors|protease inhibitors|mesh-ancestor
153500749|NCT00362310|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153500750|NCT00362310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153500751|NCT00362310|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153540663|NCT01540500|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153500752|NCT00362310|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153500753|NCT00362310|Antiviral Agents|antiviral agents|mesh-ancestor
153500754|NCT00362310|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153500755|NCT00362544|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
153500756|NCT00362544|Antifungal Agents|antifungal agents|mesh-ancestor
153500757|NCT00362544|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153500758|NCT00362544|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153500759|NCT00362544|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153500761|NCT00362700|Antiviral Agents|antiviral agents|mesh-ancestor
153500762|NCT00362700|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153500764|NCT00362778|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153500765|NCT00362778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153500766|NCT00362934|Atorvastatin|atorvastatin|mesh-list
153500767|NCT00362934|Simvastatin|simvastatin|mesh-list
153500768|NCT00362934|Fenofibrate|fenofibrate|mesh-list
153500769|NCT00362934|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153540863|NCT01541332|Hormones|hormones|mesh-ancestor
153500770|NCT00362934|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153500771|NCT00362934|Antimetabolites|antimetabolites|mesh-ancestor
153500772|NCT00362934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153500776|NCT00363090|Prednisone|prednisone|mesh-list
153500791|NCT00363090|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153500792|NCT00363090|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153500793|NCT00363090|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153500794|NCT00363090|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153500795|NCT00363090|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153500796|NCT00363090|Glucocorticoids|glucocorticoids|mesh-ancestor
153500797|NCT00363090|Hormones|hormones|mesh-ancestor
153541214|NCT01543724|Antidepressive Agents|antidepressive agents|mesh-ancestor
153500798|NCT00363090|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153500799|NCT00363090|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153541371|NCT01544634|Beclomethasone|beclomethasone|mesh-list
153500800|NCT00363090|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153500801|NCT00363090|Tubulin Modulators|tubulin modulators|mesh-ancestor
153500802|NCT00363090|Antimitotic Agents|antimitotic agents|mesh-ancestor
153500803|NCT00363090|Mitosis Modulators|mitosis modulators|mesh-ancestor
153500804|NCT00363090|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153500805|NCT00363792|Nitroglycerin|nitroglycerin|mesh-list
153500806|NCT00363792|Vasodilator Agents|vasodilator agents|mesh-ancestor
153500807|NCT00363948|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
153500808|NCT00363948|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153500809|NCT00363948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153500810|NCT00363948|Incretins|incretins|mesh-ancestor
153500811|NCT00363948|Hormones|hormones|mesh-ancestor
153500812|NCT00363948|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153500813|NCT00363948|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
153500814|NCT00363948|Protease Inhibitors|protease inhibitors|mesh-ancestor
153652678|NCT00037804|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153652679|NCT00037882|Interferons|interferons|mesh-list
153652680|NCT00037882|Interferon-alpha|interferon-alpha|mesh-list
153652681|NCT00037882|Interferon alpha-2|interferon alpha-2|mesh-list
153652682|NCT00037882|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
153652683|NCT00037882|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153652684|NCT00037882|Antiviral Agents|antiviral agents|mesh-ancestor
153891649|NCT05613842|Copper|copper|mesh-list
153500815|NCT00363948|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153500816|NCT00363948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153500817|NCT00364026|Darusentan|darusentan|mesh-list
153500818|NCT00364026|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
153500819|NCT00364026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153500820|NCT00364260|Epoetin Alfa|epoetin alfa|mesh-list
153500821|NCT00364260|Hematinics|hematinics|mesh-ancestor
153500822|NCT00364572|Etanercept|etanercept|mesh-list
153500823|NCT00364572|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153500824|NCT00364572|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153500826|NCT00364572|Sensory System Agents|sensory system agents|mesh-ancestor
153500828|NCT00364572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153500829|NCT00364572|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153500830|NCT00364572|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153500831|NCT00364572|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153500832|NCT00364572|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153500833|NCT00364572|Immunologic Factors|immunologic factors|mesh-ancestor
153500834|NCT00364806|Metoclopramide|metoclopramide|mesh-list
153500835|NCT00364806|Prochlorperazine|prochlorperazine|mesh-list
153500836|NCT00364806|Antiemetics|antiemetics|mesh-ancestor
153500837|NCT00364806|Autonomic Agents|autonomic agents|mesh-ancestor
153500838|NCT00364806|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153500839|NCT00364806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153543140|NCT05846867|Oxaliplatin|oxaliplatin|mesh-list
153543141|NCT05846867|Irinotecan|irinotecan|mesh-list
153543339|NCT05813158|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153500840|NCT00364806|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153500841|NCT00364806|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
153500842|NCT00364806|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
153500843|NCT00364806|Dopamine Agents|dopamine agents|mesh-ancestor
153500844|NCT00364806|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153500845|NCT00364806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153544258|NCT01557114|Ipilimumab|ipilimumab|mesh-list
153500847|NCT00364806|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153500848|NCT00364806|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153500849|NCT00364806|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153544889|NCT04298853|Analgesics|analgesics|mesh-ancestor
153619276|NCT01983761|Vidarabine|vidarabine|mesh-list
153619966|NCT01988298|Antipyretics|antipyretics|mesh-ancestor
153500852|NCT00365040|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153500853|NCT00365040|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153500854|NCT00365040|Alkylating Agents|alkylating agents|mesh-ancestor
153621996|NCT02002260|Contraceptive Agents|contraceptive agents|mesh-list
153500855|NCT00365040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153622432|NCT02005575|Sensory System Agents|sensory system agents|mesh-ancestor
153500856|NCT00365040|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153652688|NCT00037999|Testosterone|testosterone|mesh-list
153652689|NCT00037999|Androgens|androgens|mesh-ancestor
153652690|NCT00037999|Hormones|hormones|mesh-ancestor
153652691|NCT00037999|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153652692|NCT00037999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153652693|NCT00038077|Metoprolol|metoprolol|mesh-list
153652694|NCT00038077|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153652695|NCT00038077|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153652696|NCT00038077|Sympatholytics|sympatholytics|mesh-ancestor
153652697|NCT00038077|Autonomic Agents|autonomic agents|mesh-ancestor
153652698|NCT00038077|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153652706|NCT00038116|Dopamine|dopamine|mesh-list
153623032|NCT05501886|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153500857|NCT00365040|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153623617|NCT04396990|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153623881|NCT03956056|Poly ICLC|poly iclc|mesh-list
153624289|NCT02253316|Ixazomib|ixazomib|mesh-list
153500859|NCT00365586|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153500869|NCT00365586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153500870|NCT00365742|Simvastatin|simvastatin|mesh-list
153500871|NCT00365742|Red yeast rice|red yeast rice|mesh-list
153500872|NCT00365742|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153500873|NCT00365742|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153500874|NCT00365742|Antimetabolites|antimetabolites|mesh-ancestor
153500875|NCT00365742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153500876|NCT00365742|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153452558|NCT01844076|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153452559|NCT01844076|Antinematodal Agents|antinematodal agents|mesh-ancestor
153452560|NCT01844076|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153910859|NCT02776189|GABA Modulators|gaba modulators|mesh-ancestor
153452578|NCT01799226|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153452579|NCT01799226|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
153452580|NCT01799226|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153452582|NCT01799226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153452583|NCT01799226|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153452584|NCT01798056|Vaccines|vaccines|mesh-list
153452585|NCT01798056|Immunologic Factors|immunologic factors|mesh-ancestor
153452586|NCT01798056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153452587|NCT01824342|Denosumab|denosumab|mesh-list
153452590|NCT01823328|Ketamine|ketamine|mesh-list
153452594|NCT01823328|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153452595|NCT01823328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153452596|NCT01823328|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
153452597|NCT01823328|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153452598|NCT01823328|Anesthetics, General|anesthetics, general|mesh-ancestor
153452599|NCT01823328|Anesthetics|anesthetics|mesh-ancestor
153452600|NCT01823328|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153452601|NCT01823328|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
153500877|NCT00365742|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
153500878|NCT00365742|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153500879|NCT00365820|Tegaserod|tegaserod|mesh-list
153500880|NCT00365820|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
153500881|NCT00365820|Serotonin Agents|serotonin agents|mesh-ancestor
153910944|NCT02776813|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153910945|NCT02776813|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153910946|NCT02776813|Immunologic Factors|immunologic factors|mesh-ancestor
153452665|NCT01794780|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153452666|NCT01794780|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
153452667|NCT01794780|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
153452668|NCT01794780|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153452669|NCT01794780|Adrenergic Agents|adrenergic agents|mesh-ancestor
153452670|NCT01794780|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153452671|NCT01794780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153452672|NCT01794780|Parasympatholytics|parasympatholytics|mesh-ancestor
153452673|NCT01794780|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
153452674|NCT01794780|Cholinergic Agents|cholinergic agents|mesh-ancestor
153452739|NCT01818258|Antiviral Agents|antiviral agents|mesh-ancestor
153500882|NCT00365820|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153911117|NCT02767219|Fluorouracil|fluorouracil|mesh-list
153452841|NCT01790568|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153452842|NCT01790568|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153452843|NCT01790568|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
153652709|NCT00038116|Autonomic Agents|autonomic agents|mesh-ancestor
153652710|NCT00038116|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153652711|NCT00038116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153432715|NCT03683251|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153432717|NCT03683251|Growth Substances|growth substances|mesh-ancestor
153452844|NCT01790568|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
153452845|NCT01836198|Clarithromycin|clarithromycin|mesh-list
153452846|NCT01836198|Ketoconazole|ketoconazole|mesh-list
153452847|NCT01836198|Gemfibrozil|gemfibrozil|mesh-list
153911131|NCT02767219|Hormones|hormones|mesh-ancestor
153452907|NCT01814748|Metformin|metformin|mesh-list
153500883|NCT00365820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153500884|NCT00365820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153500885|NCT00365898|Hydromorphone|hydromorphone|mesh-list
153911271|NCT02770729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153911272|NCT02770729|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
153911273|NCT02770729|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
153911274|NCT02770729|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
153911275|NCT02770105|Caffeine|caffeine|mesh-list
153911276|NCT02770105|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
153911277|NCT02770105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153911278|NCT02770105|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
153911285|NCT02769793|Levodopa|levodopa|mesh-list
153500887|NCT00365898|Narcotics|narcotics|mesh-ancestor
153500888|NCT00365898|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153500889|NCT00365898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153500890|NCT00365898|Analgesics|analgesics|mesh-ancestor
153500891|NCT00365898|Sensory System Agents|sensory system agents|mesh-ancestor
153911336|NCT02770261|Candesartan|candesartan|mesh-list
153500892|NCT00365898|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153911427|NCT02768077|Antioxidants|antioxidants|mesh-ancestor
153911429|NCT02768077|Protective Agents|protective agents|mesh-ancestor
153500893|NCT00366600|Neratinib|neratinib|mesh-list
153500894|NCT00366600|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153500895|NCT00366600|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153500896|NCT00366600|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153500897|NCT00366600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153500898|NCT00366834|Dexamethasone|dexamethasone|mesh-list
153500899|NCT00366834|Dexamethasone acetate|dexamethasone acetate|mesh-list
153500911|NCT00366834|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153500912|NCT00366834|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153500913|NCT00366834|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153500914|NCT00366834|Protease Inhibitors|protease inhibitors|mesh-ancestor
153500915|NCT00366834|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153500916|NCT00366834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153500917|NCT00366834|Antipruritics|antipruritics|mesh-ancestor
153500918|NCT00366834|Dermatologic Agents|dermatologic agents|mesh-ancestor
153500919|NCT00366834|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
153500920|NCT00366834|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153500921|NCT00366834|Serotonin Agents|serotonin agents|mesh-ancestor
153500922|NCT00366834|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153500923|NCT00366834|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
153500925|NCT00367068|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
153500926|NCT00367068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153911662|NCT04222855|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153911663|NCT04222855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153911664|NCT04222855|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153911665|NCT04222855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153453395|NCT01732458|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
153453396|NCT01708902|Metformin|metformin|mesh-list
153453397|NCT01708902|Linagliptin|linagliptin|mesh-list
153453398|NCT01708902|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153453399|NCT01708902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153453400|NCT01708902|Incretins|incretins|mesh-ancestor
153453401|NCT01708902|Hormones|hormones|mesh-ancestor
153453403|NCT01708902|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
153500927|NCT00367068|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
153500928|NCT00367068|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153500929|NCT00367068|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
153500930|NCT00367068|GABA Agonists|gaba agonists|mesh-ancestor
153500931|NCT00367068|GABA Agents|gaba agents|mesh-ancestor
153500932|NCT00367068|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153500934|NCT00367302|Buprenorphine|buprenorphine|mesh-list
153911684|NCT04268602|Anesthetics, Local|anesthetics, local|mesh-list
153500961|NCT00367614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153500963|NCT00368160|Zopiclone|zopiclone|mesh-list
153500964|NCT00368160|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153500965|NCT00368160|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153500966|NCT00368160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153500967|NCT00368238|Aspirin|aspirin|mesh-list
153500968|NCT00368238|Epoetin Alfa|epoetin alfa|mesh-list
153500969|NCT00368238|Clopidogrel|clopidogrel|mesh-list
153500970|NCT00368238|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153500971|NCT00368238|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153911729|NCT00061282|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
153911730|NCT04268524|Miltefosine|miltefosine|mesh-list
153911731|NCT04268524|Antifungal Agents|antifungal agents|mesh-ancestor
153911732|NCT04268524|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153911733|NCT04268524|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153911734|NCT04268524|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153911735|NCT04268524|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153911737|NCT02855632|Progesterone|progesterone|mesh-list
153911738|NCT02855632|Lenograstim|lenograstim|mesh-list
153911739|NCT02855632|Estrogens|estrogens|mesh-list
153911740|NCT02855632|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153911741|NCT02855632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153911742|NCT02855632|Progestins|progestins|mesh-ancestor
153911743|NCT02855632|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153500972|NCT00368238|Analgesics|analgesics|mesh-ancestor
153500973|NCT00368238|Sensory System Agents|sensory system agents|mesh-ancestor
153500974|NCT00368238|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153500975|NCT00368238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153500976|NCT00368238|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153500977|NCT00368238|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153500978|NCT00368238|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153500979|NCT00368238|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153500980|NCT00368238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153911937|NCT04315974|Protease Inhibitors|protease inhibitors|mesh-ancestor
153500981|NCT00368238|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153500982|NCT00368238|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153500983|NCT00368238|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153781868|NCT02212210|Autonomic Agents|autonomic agents|mesh-ancestor
153912016|NCT01189890|Immunologic Factors|immunologic factors|mesh-ancestor
153912054|NCT00938860|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153912055|NCT00938860|Immunologic Factors|immunologic factors|mesh-ancestor
153912056|NCT00938860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153912057|NCT00938860|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
153912058|NCT00938860|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153912059|NCT00938860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153912060|NCT00938860|Antifungal Agents|antifungal agents|mesh-ancestor
153912061|NCT00938860|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153912062|NCT00938860|Dermatologic Agents|dermatologic agents|mesh-ancestor
153912063|NCT00938860|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153453803|NCT01721070|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153453804|NCT01721070|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153453805|NCT01721070|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153453806|NCT01721070|Anesthetics, General|anesthetics, general|mesh-ancestor
153453807|NCT01721070|Anesthetics|anesthetics|mesh-ancestor
153453808|NCT01721070|Antifungal Agents|antifungal agents|mesh-ancestor
153500985|NCT00368238|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
153500986|NCT00368238|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
153912130|NCT00937768|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153912131|NCT00937768|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153912132|NCT00631228|Everolimus|everolimus|mesh-list
153912133|NCT00631228|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
153912134|NCT00631228|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153912135|NCT00631228|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153912136|NCT00631228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153453874|NCT01717638|Vaccines|vaccines|mesh-list
153453875|NCT01717638|Immunologic Factors|immunologic factors|mesh-ancestor
153453876|NCT01717638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153453877|NCT01745094|Solifenacin Succinate|solifenacin succinate|mesh-list
153912158|NCT05380960|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153912159|NCT05380960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153912160|NCT05380960|Hemostatics|hemostatics|mesh-ancestor
153912161|NCT05380960|Coagulants|coagulants|mesh-ancestor
153912162|NCT00604630|Epoetin Alfa|epoetin alfa|mesh-list
153912163|NCT00604630|Hematinics|hematinics|mesh-ancestor
153912164|NCT01189266|Vorinostat|vorinostat|mesh-list
153453903|NCT01742286|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153453904|NCT01742286|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153453905|NCT01742286|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153453906|NCT01742286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153453907|NCT01742286|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153465221|NCT00195624|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153453908|NCT01716234|Posaconazole|posaconazole|mesh-list
153500987|NCT00368238|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
153500988|NCT00368238|Purinergic Agents|purinergic agents|mesh-ancestor
153500989|NCT00368238|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153501005|NCT00368862|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
153652752|NCT00038272|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153501006|NCT00368862|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153501007|NCT00368862|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153501008|NCT00368862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153501009|NCT00368862|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153501010|NCT00368862|Serotonin Agents|serotonin agents|mesh-ancestor
153501011|NCT00368862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153501012|NCT00368862|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
153501013|NCT00368862|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
153501014|NCT00368862|Dopamine Agents|dopamine agents|mesh-ancestor
153501015|NCT00368862|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
153501016|NCT00368862|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
153501017|NCT00369018|Aminolevulinic Acid|aminolevulinic acid|mesh-list
153912234|NCT00949702|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153912235|NCT00949702|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153912236|NCT00949702|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153912237|NCT00949702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153912238|NCT01034631|Everolimus|everolimus|mesh-list
153912239|NCT01034631|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
153453978|NCT01695954|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
153453979|NCT01695954|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
153912257|NCT01227668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153501018|NCT00369018|Methyl 5-aminolevulinate|methyl 5-aminolevulinate|mesh-list
153501019|NCT00369018|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
153501020|NCT00369018|Dermatologic Agents|dermatologic agents|mesh-ancestor
153501022|NCT00369096|Anticoagulants|anticoagulants|mesh-ancestor
153501023|NCT00369174|Rosiglitazone|rosiglitazone|mesh-list
153501024|NCT00369174|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153501025|NCT00369174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153501026|NCT00369252|Nimotuzumab|nimotuzumab|mesh-list
153501027|NCT00369252|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153501028|NCT00369252|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153501056|NCT00370266|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153501057|NCT00370266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153501058|NCT00370422|Triamcinolone|triamcinolone|mesh-list
153501059|NCT00370422|Bevacizumab|bevacizumab|mesh-list
153501060|NCT00370422|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153501061|NCT00370422|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153501062|NCT00370422|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153912352|NCT01160640|Ceftriaxone|ceftriaxone|mesh-list
153912353|NCT01160640|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153912354|NCT01160640|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153912355|NCT01160640|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153912356|NCT01160640|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153912357|NCT01160640|Antimalarials|antimalarials|mesh-ancestor
153501063|NCT00370422|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153501064|NCT00370422|Growth Substances|growth substances|mesh-ancestor
153501065|NCT00370422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153501066|NCT00370422|Growth Inhibitors|growth inhibitors|mesh-ancestor
153501067|NCT00370422|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153501069|NCT00370422|Hormones|hormones|mesh-ancestor
153912429|NCT04625725|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153501070|NCT00370422|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153501071|NCT00370500|Quetiapine Fumarate|quetiapine fumarate|mesh-list
153501072|NCT00370500|Antidepressive Agents|antidepressive agents|mesh-ancestor
153501073|NCT00370500|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153501074|NCT00370500|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153501075|NCT00370500|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153501076|NCT00370500|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153501077|NCT00370500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153501078|NCT00370656|Pregabalin|pregabalin|mesh-list
153501079|NCT00370656|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
153501080|NCT00370656|Amitriptyline|amitriptyline|mesh-list
153501081|NCT00370656|Analgesics|analgesics|mesh-ancestor
153501082|NCT00370656|Sensory System Agents|sensory system agents|mesh-ancestor
153501083|NCT00370656|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153501084|NCT00370656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153501086|NCT00370656|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153501098|NCT00370656|Dopamine Agents|dopamine agents|mesh-ancestor
153501099|NCT00370656|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
153501100|NCT00370656|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153501101|NCT00370656|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
153501102|NCT00370656|Adrenergic Agents|adrenergic agents|mesh-ancestor
153501103|NCT00370734|Botulinum Toxins|botulinum toxins|mesh-list
153501104|NCT00370734|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
153501105|NCT00370734|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
153912584|NCT01179672|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153454336|NCT01539642|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153454337|NCT01539642|Anesthetics, General|anesthetics, general|mesh-ancestor
153454338|NCT01539642|Anesthetics|anesthetics|mesh-ancestor
153454339|NCT01538472|Cytarabine|cytarabine|mesh-list
153454340|NCT01538472|Rituximab|rituximab|mesh-list
153454341|NCT01538472|Melphalan|melphalan|mesh-list
153454342|NCT01538472|Carmustine|carmustine|mesh-list
153454343|NCT01538472|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
153454344|NCT01538472|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153454345|NCT01538472|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153454346|NCT01538472|Immunologic Factors|immunologic factors|mesh-ancestor
153454347|NCT01538472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153454348|NCT01538472|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153454349|NCT01538472|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153454351|NCT01538472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153454352|NCT01538472|Antiviral Agents|antiviral agents|mesh-ancestor
153454353|NCT01538472|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153454354|NCT01538472|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153454356|NCT01538472|Alkylating Agents|alkylating agents|mesh-ancestor
153501106|NCT00370734|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
153501107|NCT00370734|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153501108|NCT00370734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153501109|NCT00370734|Cholinergic Agents|cholinergic agents|mesh-ancestor
153501120|NCT00371124|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
153454448|NCT01559454|Narcotics|narcotics|mesh-ancestor
153501121|NCT00371124|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153501122|NCT00371124|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153501123|NCT00371124|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153501124|NCT00371124|Autonomic Agents|autonomic agents|mesh-ancestor
153501125|NCT00371124|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153501126|NCT00371124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153501127|NCT00371124|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153652872|NCT00015054|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
153652873|NCT00015054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153652874|NCT00015054|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
153652875|NCT00015054|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153652876|NCT00015054|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153891690|NCT05477004|Ketamine|ketamine|mesh-list
153891691|NCT05477004|Analgesics|analgesics|mesh-ancestor
153891692|NCT05477004|Sensory System Agents|sensory system agents|mesh-ancestor
153891693|NCT05477004|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153891698|NCT05477004|Anesthetics|anesthetics|mesh-ancestor
153501128|NCT00371124|Respiratory System Agents|respiratory system agents|mesh-ancestor
153501129|NCT00371124|Mydriatics|mydriatics|mesh-ancestor
153501130|NCT00371124|Parasympatholytics|parasympatholytics|mesh-ancestor
153501131|NCT00371124|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
153501132|NCT00371124|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
153501137|NCT00371592|Antiviral Agents|antiviral agents|mesh-ancestor
153501138|NCT00371592|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153501139|NCT00371904|Rituximab|rituximab|mesh-list
153454741|NCT01525602|Mitosis Modulators|mitosis modulators|mesh-ancestor
153912965|NCT02695381|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
153912966|NCT02695381|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153912967|NCT02695381|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153912968|NCT02746783|Vaccines|vaccines|mesh-list
153912969|NCT02746783|Immunologic Factors|immunologic factors|mesh-ancestor
153912970|NCT02746783|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153912971|NCT02747953|Afatinib|afatinib|mesh-list
153912972|NCT02747953|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153912973|NCT02747953|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153912974|NCT02747953|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153912975|NCT02747953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153912976|NCT02747953|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153912977|NCT02655523|Dexamethasone|dexamethasone|mesh-list
153912978|NCT02655523|Triamcinolone|triamcinolone|mesh-list
153912979|NCT02655523|Bupivacaine|bupivacaine|mesh-list
153912980|NCT02655523|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153912981|NCT02655523|Antiemetics|antiemetics|mesh-ancestor
153912982|NCT02655523|Autonomic Agents|autonomic agents|mesh-ancestor
153912983|NCT02655523|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153454742|NCT01525602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153454743|NCT01549002|Fentanyl|fentanyl|mesh-list
153454744|NCT01549002|Morphine|morphine|mesh-list
153454745|NCT01549002|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153454746|NCT01549002|Narcotics|narcotics|mesh-ancestor
153454747|NCT01549002|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153454748|NCT01549002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153454749|NCT01549002|Analgesics|analgesics|mesh-ancestor
153454755|NCT01549002|Anesthetics|anesthetics|mesh-ancestor
153454806|NCT01524978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153454807|NCT01524198|Budesonide|budesonide|mesh-list
153454808|NCT01524198|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153454809|NCT01524198|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153913026|NCT02281981|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153913027|NCT02281981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153501140|NCT00371904|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153652877|NCT00015054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153501141|NCT00371904|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153501142|NCT00371904|Immunologic Factors|immunologic factors|mesh-ancestor
153501143|NCT00371904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153652878|NCT00015054|Dopamine Agents|dopamine agents|mesh-ancestor
153501144|NCT00371904|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153501145|NCT00372138|Thrombin|thrombin|mesh-list
153501146|NCT00372138|Hemostatics|hemostatics|mesh-ancestor
153501147|NCT00372138|Coagulants|coagulants|mesh-ancestor
153501148|NCT00372216|Clopidogrel|clopidogrel|mesh-list
153501149|NCT00372216|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153913076|NCT00636259|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153913077|NCT02736019|Celecoxib|celecoxib|mesh-list
153913078|NCT02736019|Tramadol|tramadol|mesh-list
153913079|NCT02736019|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153913080|NCT02736019|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153913081|NCT02736019|Analgesics|analgesics|mesh-ancestor
153913082|NCT02736019|Sensory System Agents|sensory system agents|mesh-ancestor
153913083|NCT02736019|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153913084|NCT02736019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153913085|NCT02736019|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153913086|NCT02736019|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153913087|NCT02736019|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
153913088|NCT02736019|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153913089|NCT02736019|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153454849|NCT01571232|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153454850|NCT01571232|Antiemetics|antiemetics|mesh-ancestor
153454851|NCT01571232|Autonomic Agents|autonomic agents|mesh-ancestor
153454852|NCT01571232|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153454853|NCT01571232|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153454854|NCT01571232|Glucocorticoids|glucocorticoids|mesh-ancestor
153454856|NCT01571232|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153454857|NCT01571232|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153454859|NCT01522950|Nebivolol|nebivolol|mesh-list
153454860|NCT01522950|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153454861|NCT01522950|Vasodilator Agents|vasodilator agents|mesh-ancestor
153454862|NCT01522950|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
153454863|NCT01522950|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
153454864|NCT01522950|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153454865|NCT01522950|Adrenergic Agents|adrenergic agents|mesh-ancestor
153454866|NCT01522950|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153454872|NCT01522950|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153454873|NCT01522950|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
153913090|NCT02736019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153913091|NCT02736019|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153913092|NCT02736019|Narcotics|narcotics|mesh-ancestor
153913093|NCT02736019|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153913094|NCT05595889|Irinotecan|irinotecan|mesh-list
153913095|NCT05595889|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
153913096|NCT05595889|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153913097|NCT05595889|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153913098|NCT05595889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153913099|NCT05595889|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153913100|NCT02735395|Amoxicillin|amoxicillin|mesh-list
153913101|NCT02735395|Metronidazole|metronidazole|mesh-list
153913106|NCT02741947|Levodopa|levodopa|mesh-list
153501151|NCT00372216|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
153501152|NCT00372216|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
153501153|NCT00372216|Purinergic Agents|purinergic agents|mesh-ancestor
153501154|NCT00372216|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153501155|NCT00372216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153501156|NCT00372216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153501158|NCT00372294|Clindamycin palmitate|clindamycin palmitate|mesh-list
153501159|NCT00372294|Clindamycin phosphate|clindamycin phosphate|mesh-list
153501160|NCT00372294|Sulfadiazine|sulfadiazine|mesh-list
153501161|NCT00372294|Pyrimethamine|pyrimethamine|mesh-list
153501162|NCT00372294|Dexamethasone|dexamethasone|mesh-list
153501163|NCT00372294|Prednisolone|prednisolone|mesh-list
153501164|NCT00372294|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153501165|NCT00372294|Antiemetics|antiemetics|mesh-ancestor
153913114|NCT02741947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153913115|NCT02741947|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153913116|NCT02740933|Demeclocycline|demeclocycline|mesh-list
153913117|NCT02740933|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153913118|NCT02740933|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153913119|NCT02739685|Everolimus|everolimus|mesh-list
153913120|NCT02739685|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
153913121|NCT02739685|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153913122|NCT02739685|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153913123|NCT02739685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153913124|NCT02739685|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153913125|NCT02739685|Immunologic Factors|immunologic factors|mesh-ancestor
153913126|NCT02739685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153913127|NCT02739685|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153913128|NCT02735317|Vitamin B 12|vitamin b 12|mesh-list
153913129|NCT02735317|Hydroxocobalamin|hydroxocobalamin|mesh-list
153917977|NCT04263844|Anesthetics|anesthetics|mesh-ancestor
153913136|NCT02735317|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153913137|NCT02735317|Antiemetics|antiemetics|mesh-ancestor
153913138|NCT02735317|Autonomic Agents|autonomic agents|mesh-ancestor
153913139|NCT02735317|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153913140|NCT02735317|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153913141|NCT02735317|Glucocorticoids|glucocorticoids|mesh-ancestor
153913142|NCT02735317|Hormones|hormones|mesh-ancestor
153913143|NCT02735317|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153913144|NCT02735317|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153913145|NCT02735317|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153913146|NCT02735317|Vitamin B Complex|vitamin b complex|mesh-ancestor
153913147|NCT02735317|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153913148|NCT02735317|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153913152|NCT02735317|Hematinics|hematinics|mesh-ancestor
153454936|NCT01517412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153501166|NCT00372294|Autonomic Agents|autonomic agents|mesh-ancestor
153913192|NCT02745925|Sensory System Agents|sensory system agents|mesh-ancestor
153501167|NCT00372294|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153455025|NCT01519518|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153455068|NCT01510158|Antimetabolites|antimetabolites|mesh-ancestor
153913281|NCT02743663|Albuterol|albuterol|mesh-list
153913329|NCT02730949|Vitamin B Complex|vitamin b complex|mesh-ancestor
153913330|NCT02730949|Vitamins|vitamins|mesh-ancestor
153913331|NCT02730949|Micronutrients|micronutrients|mesh-ancestor
153913332|NCT02730949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153913333|NCT04205929|Curcumin|curcumin|mesh-list
153913334|NCT04205929|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153913335|NCT04205929|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153913336|NCT04205929|Analgesics|analgesics|mesh-ancestor
153913352|NCT02730481|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153913353|NCT02730481|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153913354|NCT02730481|Tubulin Modulators|tubulin modulators|mesh-ancestor
153913355|NCT02730481|Antimitotic Agents|antimitotic agents|mesh-ancestor
153913356|NCT02730481|Mitosis Modulators|mitosis modulators|mesh-ancestor
153913357|NCT02730481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153913359|NCT02730091|Vinorelbine|vinorelbine|mesh-list
153913360|NCT02730091|Anastrozole|anastrozole|mesh-list
153913361|NCT02730091|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153913362|NCT02730091|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
153913363|NCT02730091|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153455162|NCT02985372|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153455163|NCT02985372|Immunologic Factors|immunologic factors|mesh-ancestor
153455164|NCT02985372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153913370|NCT02730091|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153913371|NCT02730091|Tubulin Modulators|tubulin modulators|mesh-ancestor
153653033|NCT00001004|Interferons|interferons|mesh-list
153913372|NCT02730091|Antimitotic Agents|antimitotic agents|mesh-ancestor
153913373|NCT02730091|Mitosis Modulators|mitosis modulators|mesh-ancestor
153913374|NCT02730091|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153913375|NCT02742805|Vitamin D|vitamin d|mesh-list
153913376|NCT02742805|Ergocalciferols|ergocalciferols|mesh-list
153913377|NCT02742805|Cholecalciferol|cholecalciferol|mesh-list
153913378|NCT02742805|Vitamins|vitamins|mesh-list
153913379|NCT02742805|Omalizumab|omalizumab|mesh-list
153501169|NCT00372294|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153501181|NCT00372294|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153501182|NCT00372294|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153501183|NCT00372294|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153501189|NCT00372372|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153501190|NCT00372372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153501191|NCT00372372|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153501192|NCT00372762|Furosemide|furosemide|mesh-list
153501193|NCT00372762|Bumetanide|bumetanide|mesh-list
153501194|NCT00372762|Diuretics|diuretics|mesh-ancestor
153913401|NCT02732197|Anesthetics, General|anesthetics, general|mesh-ancestor
153913402|NCT02732197|Anesthetics|anesthetics|mesh-ancestor
153913403|NCT02732197|GABA Modulators|gaba modulators|mesh-ancestor
153913404|NCT02732197|GABA Agents|gaba agents|mesh-ancestor
153913405|NCT02732197|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153913406|NCT02732197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153913407|NCT02729935|Parecoxib|parecoxib|mesh-list
153913408|NCT02729935|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
153913409|NCT02729935|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153913410|NCT02729935|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153913411|NCT02729935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153913412|NCT02729935|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153913413|NCT02729935|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153913414|NCT02729935|Analgesics|analgesics|mesh-ancestor
153913415|NCT02729935|Sensory System Agents|sensory system agents|mesh-ancestor
153913416|NCT02729935|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153913417|NCT02729935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153913418|NCT02729935|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153913419|NCT02729935|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153913420|NCT02729467|Itraconazole|itraconazole|mesh-list
153913421|NCT02729467|Rifampin|rifampin|mesh-list
153913422|NCT02729467|Antifungal Agents|antifungal agents|mesh-ancestor
153653041|NCT04896541|Cilgavimab and tixagevimab drug combination|cilgavimab and tixagevimab drug combination|mesh-list
153653042|NCT04896541|Antiviral Agents|antiviral agents|mesh-ancestor
153653043|NCT04896541|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153653044|NCT00396760|Tranexamic Acid|tranexamic acid|mesh-list
153653045|NCT00396760|Aprotinin|aprotinin|mesh-list
153653046|NCT00396760|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
153653047|NCT00396760|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153653048|NCT00396760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153653049|NCT00396760|Hemostatics|hemostatics|mesh-ancestor
153653050|NCT00396760|Coagulants|coagulants|mesh-ancestor
153653090|NCT00001010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153653093|NCT00001010|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153913423|NCT02729467|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153913424|NCT02729467|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
153913427|NCT02729467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153913428|NCT02729467|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153913429|NCT02729467|Hormone Antagonists|hormone antagonists|mesh-ancestor
153913430|NCT02729467|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153913431|NCT02729467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153913432|NCT02729467|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
153913433|NCT02729467|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
153501196|NCT00372762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153501197|NCT00372762|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
153501198|NCT00372762|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153501199|NCT00372762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153501200|NCT00373464|Etoricoxib|etoricoxib|mesh-list
153501201|NCT00373464|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153501202|NCT00373464|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153501203|NCT00373464|Analgesics|analgesics|mesh-ancestor
153501204|NCT00373464|Sensory System Agents|sensory system agents|mesh-ancestor
153913441|NCT02729467|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
153913442|NCT02729467|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
153913443|NCT02729467|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
153913444|NCT02727205|Rotigotine|rotigotine|mesh-list
153913445|NCT02727205|Dopamine Agonists|dopamine agonists|mesh-ancestor
153913446|NCT02727205|Dopamine Agents|dopamine agents|mesh-ancestor
153913447|NCT02727205|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153913448|NCT02727205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153913449|NCT02727205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153913450|NCT02721433|Denosumab|denosumab|mesh-list
153913451|NCT02721433|Zoledronic Acid|zoledronic acid|mesh-list
153913452|NCT02721433|Pamidronate|pamidronate|mesh-list
153913453|NCT02721433|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153501205|NCT00373464|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153913465|NCT02721043|Interferon Inducers|interferon inducers|mesh-ancestor
153653097|NCT00001010|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153653098|NCT00001013|Leucovorin|leucovorin|mesh-list
153653099|NCT00001013|Trimethoprim|trimethoprim|mesh-list
153653100|NCT00001013|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
153653101|NCT00001013|Sulfamethoxazole|sulfamethoxazole|mesh-list
153653153|NCT00001040|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153653154|NCT00001040|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153653155|NCT00001040|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153653156|NCT00001040|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
153653157|NCT00001040|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
153653158|NCT00001040|Protease Inhibitors|protease inhibitors|mesh-ancestor
153432778|NCT03641755|Sapacitabine|sapacitabine|mesh-list
153501206|NCT00373464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153501207|NCT00373464|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153501208|NCT00373464|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153501209|NCT00373464|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
153501210|NCT00373464|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153501211|NCT00373464|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153501212|NCT00373464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153501213|NCT00373620|Paclitaxel|paclitaxel|mesh-list
153501216|NCT00373620|Tubulin Modulators|tubulin modulators|mesh-ancestor
153501217|NCT00373620|Antimitotic Agents|antimitotic agents|mesh-ancestor
153501218|NCT00373620|Mitosis Modulators|mitosis modulators|mesh-ancestor
153501219|NCT00373620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153501220|NCT00373776|Miltefosine|miltefosine|mesh-list
153501221|NCT00373776|Antifungal Agents|antifungal agents|mesh-ancestor
153913506|NCT02728453|Empagliflozin|empagliflozin|mesh-list
153501222|NCT00373776|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153913535|NCT02694289|Metformin|metformin|mesh-list
153913574|NCT02719015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153913575|NCT02725489|Durvalumab|durvalumab|mesh-list
153913576|NCT02725489|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153913578|NCT02718547|Timolol|timolol|mesh-list
153913579|NCT02718547|Brimonidine Tartrate|brimonidine tartrate|mesh-list
153913580|NCT02718547|Ophthalmic Solutions|ophthalmic solutions|mesh-list
153913581|NCT02718547|Brimonidine Tartrate, Timolol Maleate Drug Combination|brimonidine tartrate, timolol maleate drug combination|mesh-list
153653161|NCT00015873|Cytarabine|cytarabine|mesh-list
153653162|NCT00015873|Prednisolone|prednisolone|mesh-list
153653163|NCT00015873|Methotrexate|methotrexate|mesh-list
153653164|NCT00015873|Mercaptopurine|mercaptopurine|mesh-list
153653165|NCT00015873|Vincristine|vincristine|mesh-list
153653166|NCT00015873|Asparaginase|asparaginase|mesh-list
153653167|NCT00015873|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
153653168|NCT00015873|Abortifacient Agents|abortifacient agents|mesh-ancestor
153653169|NCT00015873|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153653170|NCT00015873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153653172|NCT00015873|Antimetabolites|antimetabolites|mesh-ancestor
153913582|NCT02718547|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
153913583|NCT02718547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153913584|NCT02718547|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
153913585|NCT02718547|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
153913586|NCT02718547|Adrenergic Agents|adrenergic agents|mesh-ancestor
153913587|NCT02718547|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153501223|NCT00373776|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153501224|NCT00373776|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153501225|NCT00373776|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153501226|NCT00374478|Scopolamine|scopolamine|mesh-list
153501227|NCT00374478|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
153501228|NCT00374478|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153501229|NCT00374478|Antiemetics|antiemetics|mesh-ancestor
153501230|NCT00374478|Autonomic Agents|autonomic agents|mesh-ancestor
153820687|NCT00464763|Analgesics|analgesics|mesh-ancestor
153467598|NCT00439296|Antiemetics|antiemetics|mesh-ancestor
153913599|NCT02725099|Purinergic Agents|purinergic agents|mesh-ancestor
153913600|NCT02725099|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153913601|NCT02725099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153913602|NCT02725099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153913603|NCT01225211|Ivacaftor|ivacaftor|mesh-list
153913604|NCT01225211|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
153913605|NCT01225211|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153913606|NCT01225211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153913607|NCT02685709|Octreotide|octreotide|mesh-list
153913608|NCT02685709|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153913609|NCT02685709|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153913610|NCT02685709|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153913611|NCT02265367|Milnacipran|milnacipran|mesh-list
153913612|NCT02265367|Levomilnacipran|levomilnacipran|mesh-list
153913613|NCT02265367|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
153913614|NCT02265367|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153913615|NCT02265367|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153913616|NCT02265367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153913617|NCT02265367|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153501231|NCT00374478|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153653199|NCT00015912|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153653200|NCT00015912|Immunologic Factors|immunologic factors|mesh-ancestor
153653209|NCT03668431|Trametinib|trametinib|mesh-list
153501232|NCT00374478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153501233|NCT00374478|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153501234|NCT00374478|Mydriatics|mydriatics|mesh-ancestor
153501235|NCT00374478|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
153501236|NCT00374478|Cholinergic Agents|cholinergic agents|mesh-ancestor
153501237|NCT00374478|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153501238|NCT00374478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153501239|NCT00374478|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
153501240|NCT00374478|Parasympatholytics|parasympatholytics|mesh-ancestor
153913618|NCT02265367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153913619|NCT02265367|Antidepressive Agents|antidepressive agents|mesh-ancestor
153913620|NCT02265367|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153913621|NCT02265367|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153913623|NCT02265367|Sensory System Agents|sensory system agents|mesh-ancestor
153913624|NCT02265367|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153913625|NCT02718469|Vaccines|vaccines|mesh-list
153913626|NCT02718469|Immunologic Factors|immunologic factors|mesh-ancestor
153913627|NCT02718469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153913628|NCT02716285|Peppermint oil|peppermint oil|mesh-list
153913629|NCT02716285|Antiemetics|antiemetics|mesh-ancestor
153913630|NCT02716285|Autonomic Agents|autonomic agents|mesh-ancestor
153913631|NCT02716285|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153913632|NCT02716285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153913633|NCT02716285|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153913634|NCT02716285|Parasympatholytics|parasympatholytics|mesh-ancestor
153653257|NCT00001076|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153653258|NCT00001076|Interferon Inducers|interferon inducers|mesh-ancestor
153653259|NCT00001076|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
153653260|NCT00001076|Protective Agents|protective agents|mesh-ancestor
153913635|NCT01224821|Tositumomab I-131|tositumomab i-131|mesh-list
153913636|NCT01224821|Antibodies|antibodies|mesh-list
153913637|NCT01224821|Immunologic Factors|immunologic factors|mesh-ancestor
153501242|NCT00373542|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
153913696|NCT02724163|Daunorubicin|daunorubicin|mesh-list
153913697|NCT02724163|Mitoxantrone|mitoxantrone|mesh-list
153913698|NCT02724163|Gemtuzumab|gemtuzumab|mesh-list
153913699|NCT02724163|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153913700|NCT02724163|Immunologic Factors|immunologic factors|mesh-ancestor
153913701|NCT02724163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153913702|NCT02724163|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153913703|NCT02724163|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153913704|NCT02724163|Alkylating Agents|alkylating agents|mesh-ancestor
153913705|NCT02724163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153913718|NCT02724163|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153913719|NCT02724163|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153913720|NCT02724163|Immunotoxins|immunotoxins|mesh-ancestor
153913721|NCT02724163|Immunoconjugates|immunoconjugates|mesh-ancestor
153913722|NCT02723461|Oxytocin|oxytocin|mesh-list
153913723|NCT02723461|Oxytocics|oxytocics|mesh-ancestor
153913724|NCT02723461|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153913726|NCT02715193|Volagidemab|volagidemab|mesh-list
153501243|NCT00373542|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
153501244|NCT00373542|Dopamine Agonists|dopamine agonists|mesh-ancestor
153501245|NCT00373542|Dopamine Agents|dopamine agents|mesh-ancestor
153501246|NCT00373542|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153501263|NCT00376272|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
153501271|NCT00376428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153501274|NCT00376584|Antimetabolites|antimetabolites|mesh-ancestor
153913772|NCT02723383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153913773|NCT02723383|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
153913774|NCT02723383|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153913775|NCT02723383|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
153913776|NCT02723383|GABA Agonists|gaba agonists|mesh-ancestor
153913777|NCT02723383|GABA Agents|gaba agents|mesh-ancestor
153913778|NCT02723383|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153913779|NCT02723383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153455549|NCT05824806|Hyaluronic Acid|hyaluronic acid|mesh-list
153455550|NCT05824806|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153455551|NCT05824806|Immunologic Factors|immunologic factors|mesh-ancestor
153455552|NCT05824806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153455554|NCT05824806|Protective Agents|protective agents|mesh-ancestor
153455555|NCT05786365|Ketamine|ketamine|mesh-list
153455556|NCT05786365|Analgesics|analgesics|mesh-ancestor
153455557|NCT05786365|Sensory System Agents|sensory system agents|mesh-ancestor
153653443|NCT00016341|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153653444|NCT00016341|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153653445|NCT00016341|Tubulin Modulators|tubulin modulators|mesh-ancestor
153653504|NCT00001202|Diuretics|diuretics|mesh-ancestor
153455558|NCT05786365|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153455559|NCT05786365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153455560|NCT05786365|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
153913780|NCT05269537|Ephedrine|ephedrine|mesh-list
153913781|NCT05269537|Fentanyl|fentanyl|mesh-list
153913782|NCT05269537|Bupivacaine|bupivacaine|mesh-list
153913783|NCT05269537|Oxytocin|oxytocin|mesh-list
153913784|NCT05269537|Anesthetics, Local|anesthetics, local|mesh-ancestor
153913785|NCT05269537|Anesthetics|anesthetics|mesh-ancestor
153913786|NCT05269537|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153913787|NCT05269537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153913788|NCT05269537|Sensory System Agents|sensory system agents|mesh-ancestor
153913789|NCT05269537|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153913791|NCT05269537|Narcotics|narcotics|mesh-ancestor
153913792|NCT05269537|Analgesics|analgesics|mesh-ancestor
153455561|NCT05786365|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153455562|NCT05786365|Anesthetics, General|anesthetics, general|mesh-ancestor
153455576|NCT05763953|Etripamil|etripamil|mesh-list
153913806|NCT01222715|Cyclophosphamide|cyclophosphamide|mesh-list
153467956|NCT00524472|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
153913807|NCT01222715|Bevacizumab|bevacizumab|mesh-list
153913808|NCT01222715|Temsirolimus|temsirolimus|mesh-list
153913809|NCT01222715|Vinorelbine|vinorelbine|mesh-list
153913810|NCT01222715|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
153455577|NCT05763953|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153455578|NCT05763953|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153501275|NCT00376584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153501276|NCT00376584|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153501277|NCT00376584|Vasodilator Agents|vasodilator agents|mesh-ancestor
153501278|NCT00376584|Vitamin B Complex|vitamin b complex|mesh-ancestor
153501279|NCT00376584|Vitamins|vitamins|mesh-ancestor
153501280|NCT00376584|Micronutrients|micronutrients|mesh-ancestor
153501281|NCT00376584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153501282|NCT00376662|Etidronic Acid|etidronic acid|mesh-list
153501283|NCT00376662|Hormones|hormones|mesh-list
153913822|NCT01222715|Alkylating Agents|alkylating agents|mesh-ancestor
153913823|NCT01222715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153913824|NCT01222715|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153913825|NCT01222715|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153455591|NCT05757063|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
153455592|NCT05757063|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153455594|NCT05757063|Adrenergic Agents|adrenergic agents|mesh-ancestor
153455595|NCT05757063|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153455596|NCT05757063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153455597|NCT05757063|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153455598|NCT05757063|Anesthetics, General|anesthetics, general|mesh-ancestor
153455599|NCT05757063|Anesthetics|anesthetics|mesh-ancestor
153455600|NCT05755035|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
153455601|NCT05755035|Immunoglobulins|immunoglobulins|mesh-list
153455602|NCT05755035|Antibodies|antibodies|mesh-list
153455603|NCT05755035|gamma-Globulins|gamma-globulins|mesh-list
153455604|NCT05755035|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
153455605|NCT05755035|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
153455606|NCT05755035|Immunoglobulin G|immunoglobulin g|mesh-list
153455607|NCT05755035|Immunologic Factors|immunologic factors|mesh-ancestor
153455608|NCT05755035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153455609|NCT05731895|BI 425809|bi 425809|mesh-list
153455610|NCT05731895|Nootropic Agents|nootropic agents|mesh-ancestor
153455611|NCT05660213|Bevacizumab|bevacizumab|mesh-list
153913826|NCT01222715|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153913827|NCT01222715|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153913842|NCT02723071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153913843|NCT02722759|Chrysarobin|chrysarobin|mesh-list
153913844|NCT02722759|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154157517|NCT05639751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154157518|NCT05634707|Temozolomide|temozolomide|mesh-list
154157519|NCT05634707|Fluoxetine|fluoxetine|mesh-list
154157520|NCT05634707|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154157521|NCT05634707|Alkylating Agents|alkylating agents|mesh-ancestor
154157522|NCT05634707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154157523|NCT05634707|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154157524|NCT05634707|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
154157525|NCT05634707|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154157526|NCT05634707|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154157527|NCT05634707|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154157528|NCT05634707|Serotonin Agents|serotonin agents|mesh-ancestor
154157529|NCT05634707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154157530|NCT05634707|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
154157544|NCT05633667|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154157545|NCT05633667|Tubulin Modulators|tubulin modulators|mesh-ancestor
154157546|NCT05633667|Antimitotic Agents|antimitotic agents|mesh-ancestor
154157547|NCT05633667|Mitosis Modulators|mitosis modulators|mesh-ancestor
154157548|NCT05633667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153653626|NCT00016926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153653627|NCT00016926|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153653628|NCT00038545|Paclitaxel|paclitaxel|mesh-list
153653629|NCT00038545|Topotecan|topotecan|mesh-list
153653630|NCT00038545|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153653631|NCT00038545|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153653632|NCT00038545|Tubulin Modulators|tubulin modulators|mesh-ancestor
154157549|NCT05633667|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154157550|NCT05633667|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154157551|NCT05633667|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154157552|NCT05633667|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154157553|NCT05633667|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154157554|NCT05633667|Immunoconjugates|immunoconjugates|mesh-ancestor
154157555|NCT05633667|Immunologic Factors|immunologic factors|mesh-ancestor
154157556|NCT05633667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154157557|NCT05607342|SR 142801|sr 142801|mesh-list
154157558|NCT05607342|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154157559|NCT05607342|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154157560|NCT05607342|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154157561|NCT05607342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154157562|NCT05607342|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154157563|NCT05606965|Vaccines|vaccines|mesh-list
154157564|NCT05606965|Immunologic Factors|immunologic factors|mesh-ancestor
154157565|NCT05606965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154157566|NCT05583227|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154157567|NCT05583227|Immunologic Factors|immunologic factors|mesh-ancestor
154157568|NCT05583227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154157569|NCT05565378|Pembrolizumab|pembrolizumab|mesh-list
154157570|NCT05565378|Dostarlimab|dostarlimab|mesh-list
154157571|NCT05565378|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154157572|NCT05565378|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154157573|NCT05565378|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154157574|NCT05565378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154157586|NCT05555862|Artenimol|artenimol|mesh-list
154157587|NCT05555862|Artemisinins|artemisinins|mesh-list
154157588|NCT05555862|Artemisinin|artemisinin|mesh-list
154157589|NCT05555862|Antimalarials|antimalarials|mesh-ancestor
154157590|NCT05555862|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154157591|NCT05555862|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154157592|NCT05555862|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154157593|NCT05555862|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154157594|NCT05555862|Antiviral Agents|antiviral agents|mesh-ancestor
154157595|NCT05555862|Schistosomicides|schistosomicides|mesh-ancestor
154157596|NCT05555862|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
154157597|NCT05555862|Anthelmintics|anthelmintics|mesh-ancestor
154157598|NCT05555251|Trastuzumab|trastuzumab|mesh-list
154157599|NCT05555251|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154157600|NCT05555251|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154157601|NCT05550064|Contraceptive Agents|contraceptive agents|mesh-list
154157602|NCT05550064|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154157603|NCT05550064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154157604|NCT05546580|Gilteritinib|gilteritinib|mesh-list
154157605|NCT05546580|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154157606|NCT05546580|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154157607|NCT05546580|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154157608|NCT05546580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154157609|NCT05534620|Fludarabine|fludarabine|mesh-list
154157610|NCT05534620|Treosulfan|treosulfan|mesh-list
154157611|NCT05534620|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154157612|NCT05534620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154157613|NCT05534620|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154157635|NCT05498480|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154157636|NCT05498480|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154157637|NCT05498480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154157638|NCT05485051|Chlorhexidine|chlorhexidine|mesh-list
154157639|NCT05485051|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
154157640|NCT05485051|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154157641|NCT05485051|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154157642|NCT05485051|Disinfectants|disinfectants|mesh-ancestor
154157643|NCT05485051|Dermatologic Agents|dermatologic agents|mesh-ancestor
154157644|NCT05483010|Atorvastatin|atorvastatin|mesh-list
154157645|NCT05483010|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
154157646|NCT05483010|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154157647|NCT05483010|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154157648|NCT05483010|Antimetabolites|antimetabolites|mesh-ancestor
154157649|NCT05483010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154157650|NCT05483010|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154157693|NCT05481970|Narcotics|narcotics|mesh-ancestor
154157694|NCT05481970|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154157695|NCT05477875|Acetaminophen|acetaminophen|mesh-list
154157697|NCT05477875|Codeine|codeine|mesh-list
154157698|NCT05477875|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154157699|NCT05477875|Analgesics|analgesics|mesh-ancestor
154157700|NCT05477875|Sensory System Agents|sensory system agents|mesh-ancestor
154157701|NCT05477875|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154157702|NCT05477875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154157703|NCT05477875|Antipyretics|antipyretics|mesh-ancestor
154157704|NCT05477875|Hallucinogens|hallucinogens|mesh-ancestor
154157705|NCT05477875|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154157706|NCT05477875|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
154157707|NCT05477875|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
154157708|NCT05477875|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154157709|NCT05477875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154157710|NCT05477875|Hormones|hormones|mesh-ancestor
154157711|NCT05477875|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154157712|NCT05477875|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154157713|NCT05477875|Narcotics|narcotics|mesh-ancestor
154157714|NCT05477875|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154157715|NCT05477875|Antitussive Agents|antitussive agents|mesh-ancestor
154157716|NCT05477875|Respiratory System Agents|respiratory system agents|mesh-ancestor
154157717|NCT05459701|Dapagliflozin|dapagliflozin|mesh-list
154157742|NCT05377905|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154157743|NCT05377905|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154157744|NCT05377905|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154157745|NCT05377905|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154157746|NCT05377905|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154157747|NCT05377905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154157748|NCT05377658|Paclitaxel|paclitaxel|mesh-list
154157749|NCT05377658|Carboplatin|carboplatin|mesh-list
154157750|NCT05377658|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
154157751|NCT05377658|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154157752|NCT05377658|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154157753|NCT05377658|Tubulin Modulators|tubulin modulators|mesh-ancestor
153653861|NCT00039988|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154157754|NCT05377658|Antimitotic Agents|antimitotic agents|mesh-ancestor
154157755|NCT05377658|Mitosis Modulators|mitosis modulators|mesh-ancestor
154157756|NCT05377658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154157757|NCT05319015|Pembrolizumab|pembrolizumab|mesh-list
154157758|NCT05319015|Lenvatinib|lenvatinib|mesh-list
154157759|NCT05319015|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154157760|NCT05319015|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154157761|NCT05319015|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154157762|NCT05319015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154157763|NCT05319015|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154157764|NCT05319015|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154157765|NCT05312892|Amlodipine|amlodipine|mesh-list
154157766|NCT05312892|Antihypertensive Agents|antihypertensive agents|mesh-list
154157767|NCT05312892|Moxonidine|moxonidine|mesh-list
154157768|NCT05312892|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154157769|NCT05312892|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154157770|NCT05312892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154157771|NCT05312892|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154157772|NCT05312892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154157773|NCT05312892|Vasodilator Agents|vasodilator agents|mesh-ancestor
154157783|NCT05288062|Antiemetics|antiemetics|mesh-ancestor
154157784|NCT05288062|Autonomic Agents|autonomic agents|mesh-ancestor
154157785|NCT05288062|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154157786|NCT05288062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154157787|NCT05288062|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154157788|NCT05288062|Glucocorticoids|glucocorticoids|mesh-ancestor
154157789|NCT05288062|Hormones|hormones|mesh-ancestor
154157790|NCT05288062|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154157791|NCT05288062|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154157792|NCT05288062|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154157793|NCT05288062|Protease Inhibitors|protease inhibitors|mesh-ancestor
154157794|NCT05288062|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154157795|NCT05288062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154157796|NCT05288062|Immunologic Factors|immunologic factors|mesh-ancestor
154157797|NCT05288062|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154157798|NCT05288062|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154157799|NCT05288062|Growth Substances|growth substances|mesh-ancestor
154157800|NCT05288062|Growth Inhibitors|growth inhibitors|mesh-ancestor
154157801|NCT05288062|Dermatologic Agents|dermatologic agents|mesh-ancestor
154157802|NCT05283226|Paclitaxel|paclitaxel|mesh-list
154157803|NCT05283226|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154157837|NCT05232825|Desloratadine|desloratadine|mesh-list
154157838|NCT05232825|Ocrelizumab|ocrelizumab|mesh-list
154157839|NCT05232825|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154157840|NCT05232825|Antiemetics|antiemetics|mesh-ancestor
154157841|NCT05232825|Autonomic Agents|autonomic agents|mesh-ancestor
154157842|NCT05232825|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154157843|NCT05232825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154157844|NCT05232825|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154157845|NCT05232825|Glucocorticoids|glucocorticoids|mesh-ancestor
154157846|NCT05232825|Hormones|hormones|mesh-ancestor
154157847|NCT05232825|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154157848|NCT05232825|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154157849|NCT05232825|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154157850|NCT05232825|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
154157851|NCT05232825|Protective Agents|protective agents|mesh-ancestor
154157852|NCT05232825|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
154157853|NCT05232825|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154157854|NCT05232825|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154157855|NCT05232825|Anesthetics, Local|anesthetics, local|mesh-ancestor
154157856|NCT05232825|Anesthetics|anesthetics|mesh-ancestor
154157857|NCT05232825|Sensory System Agents|sensory system agents|mesh-ancestor
154157858|NCT05232825|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
153653871|NCT00039988|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153653872|NCT00040027|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
153653873|NCT00040027|Interferon-alpha|interferon-alpha|mesh-list
153653874|NCT00040027|Thymalfasin|thymalfasin|mesh-list
153653875|NCT00040027|Antiviral Agents|antiviral agents|mesh-ancestor
154157859|NCT05232825|Histamine Antagonists|histamine antagonists|mesh-ancestor
154157860|NCT05232825|Histamine Agents|histamine agents|mesh-ancestor
154157861|NCT05232825|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154157862|NCT05232825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154157863|NCT05232825|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154157864|NCT05232825|Antipruritics|antipruritics|mesh-ancestor
154157865|NCT05232825|Dermatologic Agents|dermatologic agents|mesh-ancestor
154157866|NCT05232825|Immunologic Factors|immunologic factors|mesh-ancestor
154157867|NCT05232825|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154157868|NCT05232825|Cholinergic Agents|cholinergic agents|mesh-ancestor
154157877|NCT05223335|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154157878|NCT05223335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154157879|NCT05223335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154157880|NCT05219799|Propranolol|propranolol|mesh-list
154157881|NCT05219799|Phentolamine|phentolamine|mesh-list
154157882|NCT05219799|Isoproterenol|isoproterenol|mesh-list
154157883|NCT05219799|Norepinephrine|norepinephrine|mesh-list
154157884|NCT05219799|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
154157885|NCT05219799|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154157886|NCT05219799|Adrenergic Agents|adrenergic agents|mesh-ancestor
154157887|NCT05219799|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154157888|NCT05219799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154157889|NCT05219799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154157890|NCT05219799|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154157891|NCT05219799|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154157892|NCT05219799|Vasodilator Agents|vasodilator agents|mesh-ancestor
154157893|NCT05219799|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154157894|NCT05219799|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154157895|NCT05219799|Sympathomimetics|sympathomimetics|mesh-ancestor
154157896|NCT05219799|Autonomic Agents|autonomic agents|mesh-ancestor
154157897|NCT05219799|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154157898|NCT05219799|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154157899|NCT05219799|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
154157900|NCT05219799|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154157901|NCT05219799|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154157902|NCT05219799|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154157903|NCT05219799|Respiratory System Agents|respiratory system agents|mesh-ancestor
154157904|NCT05219799|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
154157905|NCT05219799|Protective Agents|protective agents|mesh-ancestor
154157906|NCT05219513|Obinutuzumab|obinutuzumab|mesh-list
154157907|NCT05219513|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154157921|NCT05203822|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154157922|NCT05203822|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
154157923|NCT05203822|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154157924|NCT05203822|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154157925|NCT05203822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153653882|NCT00001343|Hormones|hormones|mesh-ancestor
154157926|NCT05203822|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153653884|NCT00001343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154157927|NCT05203822|Hormone Antagonists|hormone antagonists|mesh-ancestor
154157928|NCT05203822|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154157929|NCT05203822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154157930|NCT05203822|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154157931|NCT05203822|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154157932|NCT05180825|Trametinib|trametinib|mesh-list
154157933|NCT05180825|Vinblastine|vinblastine|mesh-list
154157934|NCT05180825|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154157935|NCT05180825|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154157936|NCT05180825|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154157937|NCT05180825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154157938|NCT05180825|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154157939|NCT05180825|Tubulin Modulators|tubulin modulators|mesh-ancestor
154157940|NCT05180825|Antimitotic Agents|antimitotic agents|mesh-ancestor
154157941|NCT05180825|Mitosis Modulators|mitosis modulators|mesh-ancestor
154157942|NCT05174312|Diuretics|diuretics|mesh-list
154157943|NCT05174312|Natriuretic Agents|natriuretic agents|mesh-ancestor
154157944|NCT05174312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154157945|NCT05157581|Methoxsalen|methoxsalen|mesh-list
154157946|NCT05157581|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
154157947|NCT05157581|Dermatologic Agents|dermatologic agents|mesh-ancestor
154157948|NCT05140148|Amantadine|amantadine|mesh-list
154157949|NCT05140148|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
154157950|NCT05140148|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
154157951|NCT05140148|Antiviral Agents|antiviral agents|mesh-ancestor
154157988|NCT05088356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154157989|NCT05088356|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154157990|NCT05088356|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154157991|NCT05088356|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154157992|NCT05088356|Antimetabolites|antimetabolites|mesh-ancestor
154157993|NCT05088356|Antiviral Agents|antiviral agents|mesh-ancestor
154157994|NCT05088356|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154157995|NCT05088356|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154157996|NCT05088356|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
154157997|NCT05088356|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154157998|NCT05088356|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154157999|NCT05088356|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
154158000|NCT05088356|Antitubercular Agents|antitubercular agents|mesh-ancestor
154158001|NCT05088356|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154158002|NCT05088356|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154158003|NCT05088356|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154158015|NCT05022810|Acetaminophen|acetaminophen|mesh-list
154158016|NCT05022810|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154158017|NCT05022810|Analgesics|analgesics|mesh-ancestor
154158018|NCT05022810|Sensory System Agents|sensory system agents|mesh-ancestor
154158019|NCT05022810|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153653902|NCT00040105|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154158020|NCT05022810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154158021|NCT05022810|Antipyretics|antipyretics|mesh-ancestor
154158036|NCT04990323|Cyclophosphamide|cyclophosphamide|mesh-list
154158037|NCT04990323|Busulfan|busulfan|mesh-list
154158038|NCT04990323|Thiotepa|thiotepa|mesh-list
154158039|NCT04990323|Fludarabine|fludarabine|mesh-list
154158041|NCT04990323|Clofarabine|clofarabine|mesh-list
154158042|NCT04990323|Tacrolimus|tacrolimus|mesh-list
154158043|NCT04990323|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153646490|NCT02993406|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153646491|NCT02993406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153646492|NCT00115531|Vaccines|vaccines|mesh-list
153646493|NCT00115531|Immunologic Factors|immunologic factors|mesh-ancestor
153646494|NCT00115531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153646495|NCT00115570|Insulin|insulin|mesh-list
154158044|NCT04990323|Immunologic Factors|immunologic factors|mesh-ancestor
154158045|NCT04990323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154158046|NCT04990323|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154158047|NCT04990323|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154158048|NCT04990323|Alkylating Agents|alkylating agents|mesh-ancestor
154158049|NCT04990323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154158050|NCT04990323|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154158051|NCT04990323|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154158052|NCT04990323|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154158053|NCT04990323|Antimetabolites|antimetabolites|mesh-ancestor
154158054|NCT04990323|Antiviral Agents|antiviral agents|mesh-ancestor
154158055|NCT04990323|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154158056|NCT04990323|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
154158057|NCT04990323|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154158058|NCT04975997|Dexamethasone|dexamethasone|mesh-list
154158104|NCT04914234|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154158105|NCT04914234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154158106|NCT04913311|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
154158107|NCT04913311|Dimercaprol|dimercaprol|mesh-list
154158108|NCT04913311|Chelating Agents|chelating agents|mesh-ancestor
154158109|NCT04913311|Sequestering Agents|sequestering agents|mesh-ancestor
154158110|NCT04913311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154158111|NCT04913311|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154158112|NCT04913311|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154158113|NCT04913220|Cemiplimab|cemiplimab|mesh-list
153538411|NCT01527968|Tranexamic Acid|tranexamic acid|mesh-list
154158119|NCT04904588|Busulfan|busulfan|mesh-list
154158169|NCT04884035|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154158170|NCT04884035|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154158171|NCT04884035|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154158172|NCT04884035|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154158173|NCT04884035|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154158174|NCT04884035|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154158175|NCT04884035|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154158176|NCT04884035|Glucocorticoids|glucocorticoids|mesh-ancestor
154158177|NCT04884035|Hormones|hormones|mesh-ancestor
154158178|NCT04884035|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154158179|NCT04884035|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154158180|NCT04884035|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154158181|NCT04884035|Tubulin Modulators|tubulin modulators|mesh-ancestor
154158182|NCT04884035|Antimitotic Agents|antimitotic agents|mesh-ancestor
154158183|NCT04884035|Mitosis Modulators|mitosis modulators|mesh-ancestor
154158184|NCT04884035|Immunoconjugates|immunoconjugates|mesh-ancestor
154158185|NCT04853758|Valsartan|valsartan|mesh-list
154158186|NCT04853758|Enalapril|enalapril|mesh-list
154158187|NCT04853758|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
153803578|NCT00290264|Budesonide|budesonide|mesh-list
154158188|NCT04853758|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
154158189|NCT04853758|Enzyme Inhibitors|enzyme inhibitors|mesh-list
153538485|NCT01528540|Pregabalin|pregabalin|mesh-list
153490996|NCT02684136|Suvorexant|suvorexant|mesh-list
154158190|NCT04853758|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154158191|NCT04853758|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
154158192|NCT04853758|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
154158193|NCT04853758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154158195|NCT04835805|Nivolumab|nivolumab|mesh-list
154158196|NCT04835805|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154158197|NCT04835805|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154158198|NCT04835805|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154158199|NCT04835805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154158200|NCT04819269|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
154158201|NCT04819269|Ophthalmic Solutions|ophthalmic solutions|mesh-list
154158206|NCT04792502|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154158207|NCT04792502|Growth Substances|growth substances|mesh-ancestor
154158208|NCT04792502|Growth Inhibitors|growth inhibitors|mesh-ancestor
153654100|NCT00017394|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153654101|NCT00017394|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153654102|NCT00017394|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153654103|NCT00017394|Growth Substances|growth substances|mesh-ancestor
153654145|NCT00041704|Anidulafungin|anidulafungin|mesh-list
154158209|NCT04792502|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154158210|NCT04791969|Naltrexone|naltrexone|mesh-list
154158211|NCT04791969|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
154158212|NCT04791969|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
154158213|NCT04791969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154158214|NCT04791969|Sensory System Agents|sensory system agents|mesh-ancestor
154158215|NCT04791969|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154158216|NCT04789304|Midazolam|midazolam|mesh-list
154158217|NCT04789304|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154158218|NCT04789304|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154158219|NCT04789304|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154158220|NCT04789304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154158221|NCT04789304|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154158222|NCT04789304|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154158223|NCT04789304|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154158224|NCT04789304|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154158225|NCT04789304|Anesthetics, General|anesthetics, general|mesh-ancestor
154158226|NCT04789304|Anesthetics|anesthetics|mesh-ancestor
154158227|NCT04789304|GABA Modulators|gaba modulators|mesh-ancestor
154158228|NCT04789304|GABA Agents|gaba agents|mesh-ancestor
154158229|NCT04789304|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154158230|NCT04789304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154158231|NCT04772079|Deucravacitinib|deucravacitinib|mesh-list
154158232|NCT04772079|Dermatologic Agents|dermatologic agents|mesh-ancestor
154158233|NCT04772079|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154158234|NCT04772079|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154158235|NCT04772079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154158236|NCT04756063|Ascorbic Acid|ascorbic acid|mesh-list
154158237|NCT04756063|Vitamins|vitamins|mesh-ancestor
154158238|NCT04756063|Micronutrients|micronutrients|mesh-ancestor
154158239|NCT04756063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154158240|NCT04756063|Antioxidants|antioxidants|mesh-ancestor
154158241|NCT04756063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154158244|NCT04747314|Aripiprazole|aripiprazole|mesh-list
154158245|NCT04747314|Mirtazapine|mirtazapine|mesh-list
154158246|NCT04747314|Bupropion|bupropion|mesh-list
154158247|NCT04747314|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
154158248|NCT04747314|Sertraline|sertraline|mesh-list
154158249|NCT04747314|Antidepressive Agents|antidepressive agents|mesh-list
154158250|NCT04747314|Escitalopram|escitalopram|mesh-list
154158251|NCT04747314|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
154158252|NCT04747314|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154158253|NCT04747314|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154158254|NCT04747314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154158255|NCT04747314|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154158256|NCT04747314|Serotonin Agents|serotonin agents|mesh-ancestor
154158257|NCT04747314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154158258|NCT04747314|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154158259|NCT04747314|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
154158260|NCT04747314|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154158261|NCT04747314|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
154158262|NCT04747314|Dopamine Agents|dopamine agents|mesh-ancestor
154158267|NCT04747314|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154158268|NCT04747314|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154158269|NCT04747314|Dopamine Agonists|dopamine agonists|mesh-ancestor
154158270|NCT04747314|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
154158271|NCT04747314|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
154158272|NCT04747314|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
154158273|NCT04747314|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154158274|NCT04747314|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
154158296|NCT04725656|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
154158298|NCT04725656|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154158299|NCT04725656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154158300|NCT04725656|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
154158301|NCT04725656|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
154158302|NCT04725656|Cholinergic Agents|cholinergic agents|mesh-ancestor
154158303|NCT04725656|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154158304|NCT04725656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154158305|NCT04712097|Rituximab|rituximab|mesh-list
154158306|NCT04712097|Lenalidomide|lenalidomide|mesh-list
154158307|NCT04712097|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154158308|NCT04712097|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154158309|NCT04712097|Immunologic Factors|immunologic factors|mesh-ancestor
154158310|NCT04712097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154158311|NCT04712097|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154158312|NCT04712097|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154158313|NCT04712097|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154158314|NCT04712097|Growth Substances|growth substances|mesh-ancestor
154158315|NCT04712097|Growth Inhibitors|growth inhibitors|mesh-ancestor
154158316|NCT04704934|Paclitaxel|paclitaxel|mesh-list
154158317|NCT04704934|Trastuzumab|trastuzumab|mesh-list
154158318|NCT04704934|Ramucirumab|ramucirumab|mesh-list
154158319|NCT04704934|Trastuzumab deruxtecan|trastuzumab deruxtecan|mesh-list
154158320|NCT04704934|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154158321|NCT04704934|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154158322|NCT04704934|Tubulin Modulators|tubulin modulators|mesh-ancestor
154158323|NCT04704934|Antimitotic Agents|antimitotic agents|mesh-ancestor
154158324|NCT04704934|Mitosis Modulators|mitosis modulators|mesh-ancestor
154158325|NCT04704934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154158326|NCT04704934|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154158327|NCT04704934|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154158328|NCT04704934|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154158329|NCT04704934|Growth Substances|growth substances|mesh-ancestor
154158330|NCT04704934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154158331|NCT04704934|Growth Inhibitors|growth inhibitors|mesh-ancestor
154158332|NCT04704934|Immunoconjugates|immunoconjugates|mesh-ancestor
154158363|NCT04678336|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154158365|NCT04678336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154158366|NCT04678336|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154158367|NCT04678336|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154158368|NCT04660344|Atezolizumab|atezolizumab|mesh-list
154158369|NCT04660344|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154158370|NCT04660344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154158371|NCT04660344|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154158372|NCT04660344|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154158373|NCT04624113|Pembrolizumab|pembrolizumab|mesh-list
154158374|NCT04624113|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154158375|NCT04624113|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154158376|NCT04624113|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154158377|NCT04624113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154158378|NCT04612556|Vaccines|vaccines|mesh-list
154158379|NCT04612556|Immunologic Factors|immunologic factors|mesh-ancestor
154158380|NCT04612556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154158381|NCT04607733|Mirikizumab|mirikizumab|mesh-list
154158382|NCT04607733|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154158383|NCT04607733|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154158384|NCT04607733|Analgesics|analgesics|mesh-ancestor
154158385|NCT04607733|Sensory System Agents|sensory system agents|mesh-ancestor
154158386|NCT04607733|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154158387|NCT04607733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154158388|NCT04607733|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154158389|NCT04607733|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154158390|NCT04607733|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154158391|NCT04607733|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154158392|NCT04585035|Pembrolizumab|pembrolizumab|mesh-list
154158393|NCT04585035|Cetuximab|cetuximab|mesh-list
154158394|NCT04585035|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154158395|NCT04585035|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154158396|NCT04585035|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154158398|NCT04581408|Ivacaftor|ivacaftor|mesh-list
154158400|NCT04581408|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154158401|NCT04581408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154158402|NCT04560998|Semaglutide|semaglutide|mesh-list
154158403|NCT04560998|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
154158404|NCT04560998|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154158405|NCT04560998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153654532|NCT00043654|Abortifacient Agents|abortifacient agents|mesh-ancestor
154158406|NCT04557735|Ravulizumab|ravulizumab|mesh-list
154158407|NCT04557735|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
154158408|NCT04557735|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154158409|NCT04557735|Immunologic Factors|immunologic factors|mesh-ancestor
154158410|NCT04557735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154158412|NCT04549467|Lamivudine|lamivudine|mesh-list
154158413|NCT04549467|Emtricitabine|emtricitabine|mesh-list
154158414|NCT04549467|Dolutegravir|dolutegravir|mesh-list
154158415|NCT04549467|Antiviral Agents|antiviral agents|mesh-ancestor
154158416|NCT04549467|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154158417|NCT04549467|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
154158418|NCT04549467|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154158419|NCT04549467|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154158420|NCT04549467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154158421|NCT04549467|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154158422|NCT04549467|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154158423|NCT04549467|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
154158424|NCT04549467|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
154158425|NCT04545242|Dexamethasone|dexamethasone|mesh-list
154158426|NCT04545242|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154158427|NCT04545242|Antiemetics|antiemetics|mesh-ancestor
154158428|NCT04545242|Autonomic Agents|autonomic agents|mesh-ancestor
154158429|NCT04545242|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154158430|NCT04545242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154158431|NCT04545242|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154158432|NCT04545242|Glucocorticoids|glucocorticoids|mesh-ancestor
154158433|NCT04545242|Hormones|hormones|mesh-ancestor
154158440|NCT04491136|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
154158441|NCT04491136|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
153654564|NCT00043810|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154158442|NCT04491136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154158443|NCT04487067|Bevacizumab|bevacizumab|mesh-list
154158444|NCT04487067|Atezolizumab|atezolizumab|mesh-list
154158445|NCT04487067|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154158446|NCT04487067|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154158447|NCT04487067|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154158448|NCT04487067|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154158449|NCT04487067|Growth Substances|growth substances|mesh-ancestor
154158450|NCT04487067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154158451|NCT04487067|Growth Inhibitors|growth inhibitors|mesh-ancestor
154158452|NCT04487067|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154158453|NCT04487067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154158454|NCT04485104|Cannabidiol|cannabidiol|mesh-list
154158455|NCT04485104|Anticonvulsants|anticonvulsants|mesh-ancestor
154158456|NCT04473820|Lidocaine|lidocaine|mesh-list
154158457|NCT04473820|Prilocaine|prilocaine|mesh-list
154158458|NCT04473820|Lidocaine, Prilocaine Drug Combination|lidocaine, prilocaine drug combination|mesh-list
154158459|NCT04473820|Anesthetics, Local|anesthetics, local|mesh-ancestor
154158460|NCT04473820|Anesthetics|anesthetics|mesh-ancestor
154158461|NCT04473820|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154158462|NCT04473820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154158463|NCT04473820|Sensory System Agents|sensory system agents|mesh-ancestor
154158464|NCT04473820|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154158465|NCT04473820|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154158466|NCT04473820|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154158467|NCT04473820|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154158468|NCT04473820|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154158469|NCT04473820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154158470|NCT04473820|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
154158471|NCT04447027|Dexamethasone|dexamethasone|mesh-list
154158479|NCT04447027|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154158480|NCT04447027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153482051|NCT01390818|Elafin|elafin|mesh-list
154158482|NCT04447027|Glucocorticoids|glucocorticoids|mesh-ancestor
154158483|NCT04447027|Hormones|hormones|mesh-ancestor
154158484|NCT04447027|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154158485|NCT04447027|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154158486|NCT04447027|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154158487|NCT04447027|Immunologic Factors|immunologic factors|mesh-ancestor
154158488|NCT04447027|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154158489|NCT04447027|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154158490|NCT04447027|Growth Substances|growth substances|mesh-ancestor
154158491|NCT04447027|Growth Inhibitors|growth inhibitors|mesh-ancestor
154158492|NCT04447027|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154158494|NCT04447027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154158540|NCT04384692|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154158541|NCT04384692|Immunologic Factors|immunologic factors|mesh-ancestor
154158542|NCT04384692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154158543|NCT04384692|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154158544|NCT04384692|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154158545|NCT04384692|Alkylating Agents|alkylating agents|mesh-ancestor
154158546|NCT04384692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154158547|NCT04384692|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154158548|NCT04384692|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154158549|NCT04384692|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
153654731|NCT00397501|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154158550|NCT04384692|Abortifacient Agents|abortifacient agents|mesh-ancestor
154158551|NCT04384692|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154158552|NCT04384692|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154158553|NCT04384692|Antimetabolites|antimetabolites|mesh-ancestor
154158554|NCT04384692|Dermatologic Agents|dermatologic agents|mesh-ancestor
154158555|NCT04384692|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154158556|NCT04384692|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154158557|NCT04384692|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154158558|NCT04384692|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
154158594|NCT04311632|Immunologic Factors|immunologic factors|mesh-ancestor
154158595|NCT04311632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154158596|NCT04311632|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
154158597|NCT04311632|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154158598|NCT04311632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154158599|NCT04311632|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154158600|NCT04311632|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154158601|NCT04311632|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
154158602|NCT04311632|Antitubercular Agents|antitubercular agents|mesh-ancestor
153654786|NCT00044707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154158603|NCT04311632|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154158604|NCT04311632|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154158605|NCT04213885|Riboflavin|riboflavin|mesh-list
154158606|NCT04213885|Vitamin B Complex|vitamin b complex|mesh-ancestor
154158607|NCT04213885|Vitamins|vitamins|mesh-ancestor
154158608|NCT04213885|Micronutrients|micronutrients|mesh-ancestor
154158609|NCT04213885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154158610|NCT04213885|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
154158611|NCT04213885|Dermatologic Agents|dermatologic agents|mesh-ancestor
154158612|NCT04203160|Cisplatin|cisplatin|mesh-list
154158613|NCT04203160|Gemcitabine|gemcitabine|mesh-list
154158614|NCT04203160|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154158615|NCT04203160|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154158616|NCT04203160|Antimetabolites|antimetabolites|mesh-ancestor
154158617|NCT04203160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154158618|NCT04187053|Methylene Blue|methylene blue|mesh-list
154158619|NCT04187053|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154158620|NCT04187053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154158621|NCT04098744|Artesunate|artesunate|mesh-list
154158622|NCT04098744|Artemisinins|artemisinins|mesh-list
154158623|NCT04098744|Artemisinin|artemisinin|mesh-list
154158624|NCT04098744|Antimalarials|antimalarials|mesh-ancestor
154158625|NCT04098744|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154158626|NCT04098744|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154158627|NCT04098744|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154158628|NCT04098744|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154158629|NCT04098744|Antiviral Agents|antiviral agents|mesh-ancestor
154158630|NCT04098744|Schistosomicides|schistosomicides|mesh-ancestor
154158631|NCT04098744|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
153646496|NCT00115570|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
153646497|NCT00115570|Insulin Glargine|insulin glargine|mesh-list
154158632|NCT04098744|Anthelmintics|anthelmintics|mesh-ancestor
154158633|NCT04095689|Docetaxel|docetaxel|mesh-list
154158634|NCT04095689|Pembrolizumab|pembrolizumab|mesh-list
154158635|NCT04095689|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154158636|NCT04095689|Tubulin Modulators|tubulin modulators|mesh-ancestor
154158637|NCT04095689|Antimitotic Agents|antimitotic agents|mesh-ancestor
154158638|NCT04095689|Mitosis Modulators|mitosis modulators|mesh-ancestor
154158639|NCT04095689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154158640|NCT04095689|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154158641|NCT04095689|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154158642|NCT04086485|Olaparib|olaparib|mesh-list
154158643|NCT04086485|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
154158644|NCT04086485|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154158645|NCT04086485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154158646|NCT04086485|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154158647|NCT04080531|Vaccines|vaccines|mesh-list
154158648|NCT04080531|Immunologic Factors|immunologic factors|mesh-ancestor
154158649|NCT04080531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154158650|NCT04067011|Doxycycline|doxycycline|mesh-list
154158651|NCT04067011|Ciprofloxacin|ciprofloxacin|mesh-list
154158652|NCT04067011|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154158653|NCT04067011|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154158654|NCT04067011|Antimalarials|antimalarials|mesh-ancestor
154158655|NCT04067011|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154158656|NCT04067011|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154158657|NCT04067011|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154158658|NCT04067011|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154158659|NCT04067011|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154158660|NCT04067011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154158661|NCT04067011|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154158662|NCT04067011|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
154158663|NCT04067011|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154158664|NCT04053634|Benralizumab|benralizumab|mesh-list
154158665|NCT04053634|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154158666|NCT04053634|Respiratory System Agents|respiratory system agents|mesh-ancestor
154158667|NCT04047797|Rituximab|rituximab|mesh-list
154158671|NCT04047797|Immunoglobulins|immunoglobulins|mesh-list
154158672|NCT04047797|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154158674|NCT04047797|Immunologic Factors|immunologic factors|mesh-ancestor
154158675|NCT04047797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154158676|NCT04047797|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154158677|NCT04047797|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154158678|NCT04047797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154158679|NCT04047797|Protease Inhibitors|protease inhibitors|mesh-ancestor
154158680|NCT04047797|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154158681|NCT04047797|Glycine Agents|glycine agents|mesh-ancestor
154158682|NCT04047797|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154158683|NCT04002401|Cyclophosphamide|cyclophosphamide|mesh-list
154158684|NCT04002401|Rituximab|rituximab|mesh-list
154158685|NCT04002401|Fludarabine|fludarabine|mesh-list
154158686|NCT04002401|Axicabtagene ciloleucel|axicabtagene ciloleucel|mesh-list
154158687|NCT04002401|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154158688|NCT04002401|Immunologic Factors|immunologic factors|mesh-ancestor
154158689|NCT04002401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154158690|NCT04002401|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154158691|NCT04002401|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154158692|NCT04002401|Alkylating Agents|alkylating agents|mesh-ancestor
154158693|NCT04002401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154158694|NCT04002401|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154158695|NCT04002401|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154158696|NCT04002401|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154158697|NCT03997448|Pembrolizumab|pembrolizumab|mesh-list
154158718|NCT03964090|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154158719|NCT03964090|Dermatologic Agents|dermatologic agents|mesh-ancestor
154158720|NCT03964090|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154158721|NCT03964090|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154158722|NCT03964090|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154158723|NCT03964090|Immunologic Factors|immunologic factors|mesh-ancestor
154158724|NCT03964090|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154158725|NCT03964090|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154158726|NCT03964090|Antiviral Agents|antiviral agents|mesh-ancestor
154158727|NCT03964090|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154158728|NCT03964090|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154158729|NCT03964090|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154158730|NCT03964090|Antifungal Agents|antifungal agents|mesh-ancestor
154158731|NCT03941093|Leucovorin|leucovorin|mesh-list
154158732|NCT03941093|Paclitaxel|paclitaxel|mesh-list
154158733|NCT03941093|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
154158734|NCT03941093|Gemcitabine|gemcitabine|mesh-list
154158735|NCT03941093|Irinotecan|irinotecan|mesh-list
154158736|NCT03941093|Fluorouracil|fluorouracil|mesh-list
154158737|NCT03941093|Folfirinox|folfirinox|mesh-list
154158738|NCT03941093|Levoleucovorin|levoleucovorin|mesh-list
154158739|NCT03941093|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154158740|NCT03941093|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154158741|NCT03941093|Tubulin Modulators|tubulin modulators|mesh-ancestor
154158742|NCT03941093|Antimitotic Agents|antimitotic agents|mesh-ancestor
154158743|NCT03941093|Mitosis Modulators|mitosis modulators|mesh-ancestor
154158744|NCT03941093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154158745|NCT03941093|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154158746|NCT03941093|Antimetabolites|antimetabolites|mesh-ancestor
154158747|NCT03941093|Antidotes|antidotes|mesh-ancestor
154158748|NCT03941093|Protective Agents|protective agents|mesh-ancestor
154158749|NCT03941093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154158750|NCT03941093|Vitamin B Complex|vitamin b complex|mesh-ancestor
154158751|NCT03941093|Vitamins|vitamins|mesh-ancestor
154158752|NCT03941093|Micronutrients|micronutrients|mesh-ancestor
154158764|NCT03920007|Glucocorticoids|glucocorticoids|mesh-ancestor
154158765|NCT03920007|Hormones|hormones|mesh-ancestor
154158766|NCT03920007|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154158767|NCT03920007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154158768|NCT03920007|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154158769|NCT03920007|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154158770|NCT03920007|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
154158771|NCT03920007|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154158772|NCT03920007|Antimalarials|antimalarials|mesh-ancestor
154158773|NCT03920007|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154158774|NCT03920007|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154158775|NCT03920007|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154158776|NCT03920007|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154158777|NCT03920007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154158821|NCT03845166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154158822|NCT03845166|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154158823|NCT03845166|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154158825|NCT03840967|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
154158826|NCT03840967|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154158827|NCT03840967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154158828|NCT03840967|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154158829|NCT03825757|Aspirin|aspirin|mesh-list
154158884|NCT03768349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154158885|NCT03761173|Anticoagulants|anticoagulants|mesh-list
154158886|NCT03711448|Prednisone|prednisone|mesh-list
154158887|NCT03711448|Ustekinumab|ustekinumab|mesh-list
154158888|NCT03711448|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154158889|NCT03711448|Glucocorticoids|glucocorticoids|mesh-ancestor
154158890|NCT03711448|Hormones|hormones|mesh-ancestor
154158891|NCT03711448|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154158892|NCT03711448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154158893|NCT03711448|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154158894|NCT03711448|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154158895|NCT03711448|Dermatologic Agents|dermatologic agents|mesh-ancestor
154158896|NCT03646123|Doxorubicin|doxorubicin|mesh-list
154158897|NCT03646123|Nivolumab|nivolumab|mesh-list
154158898|NCT03646123|Dacarbazine|dacarbazine|mesh-list
154158899|NCT03646123|Brentuximab Vedotin|brentuximab vedotin|mesh-list
154158942|NCT03568630|Analgesics|analgesics|mesh-ancestor
154158943|NCT03568630|Sensory System Agents|sensory system agents|mesh-ancestor
154158944|NCT03568630|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154158945|NCT03568630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154158946|NCT03568630|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154158947|NCT03568630|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154158948|NCT03554317|Nivolumab|nivolumab|mesh-list
154158949|NCT03554317|Methyltestosterone|methyltestosterone|mesh-list
154158950|NCT03554317|Testosterone|testosterone|mesh-list
154158951|NCT03554317|Testosterone undecanoate|testosterone undecanoate|mesh-list
154158952|NCT03554317|Testosterone enanthate|testosterone enanthate|mesh-list
154159003|NCT03374670|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154159004|NCT03374670|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154159005|NCT03374670|Growth Substances|growth substances|mesh-ancestor
154159006|NCT03374670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154159007|NCT03374670|Growth Inhibitors|growth inhibitors|mesh-ancestor
154159008|NCT03374670|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154159010|NCT03345095|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153655036|NCT04394130|Sensory System Agents|sensory system agents|mesh-ancestor
154159011|NCT03345095|Alkylating Agents|alkylating agents|mesh-ancestor
154159012|NCT03345095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154159013|NCT03345095|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154159015|NCT03344965|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
154159016|NCT03344965|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154159017|NCT03344965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154159018|NCT03344965|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153646498|NCT00115570|Insulin Lispro|insulin lispro|mesh-list
153646499|NCT00115570|Insulin glulisine|insulin glulisine|mesh-list
153646500|NCT00115570|Insulin, Isophane|insulin, isophane|mesh-list
153646501|NCT00115570|Isophane Insulin, Human|isophane insulin, human|mesh-list
153646502|NCT00115570|Isophane insulin, beef|isophane insulin, beef|mesh-list
153646503|NCT00115570|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153646504|NCT00115570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153655080|NCT00045955|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153646505|NCT00115609|Tenofovir|tenofovir|mesh-list
153646506|NCT00115609|Emtricitabine|emtricitabine|mesh-list
153646507|NCT00115609|Efavirenz|efavirenz|mesh-list
153646508|NCT00115609|Antiviral Agents|antiviral agents|mesh-ancestor
153646509|NCT00115609|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153646510|NCT00115609|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153646511|NCT00115609|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153646512|NCT00115609|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153646513|NCT00115609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153646514|NCT00115609|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153646515|NCT00115609|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154159049|NCT03265574|Enalapril|enalapril|mesh-list
154159050|NCT03265574|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
154159051|NCT03265574|Protease Inhibitors|protease inhibitors|mesh-ancestor
154159052|NCT03265574|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154159053|NCT03265574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154159054|NCT03265574|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154159055|NCT03236428|Daratumumab|daratumumab|mesh-list
154159056|NCT03236428|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154159057|NCT03235232|Ophthalmic Solutions|ophthalmic solutions|mesh-list
154159058|NCT03235232|Brimonidine Tartrate, Timolol Maleate Drug Combination|brimonidine tartrate, timolol maleate drug combination|mesh-list
154159059|NCT03235232|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
153655320|NCT04733781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154159060|NCT03235232|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
154159061|NCT03235232|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154159062|NCT03235232|Adrenergic Agents|adrenergic agents|mesh-ancestor
154159063|NCT03235232|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154159064|NCT03235232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154159065|NCT03235232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154159066|NCT03235232|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154159067|NCT03235232|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154159068|NCT03235232|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154159069|NCT03225664|Pembrolizumab|pembrolizumab|mesh-list
154159070|NCT03225664|Trametinib|trametinib|mesh-list
154159071|NCT03225664|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154159072|NCT03225664|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154159073|NCT03225664|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154159074|NCT03225664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154159091|NCT03179904|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154159092|NCT03179904|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154159093|NCT03179904|Tubulin Modulators|tubulin modulators|mesh-ancestor
154159094|NCT03179904|Antimitotic Agents|antimitotic agents|mesh-ancestor
154159095|NCT03179904|Mitosis Modulators|mitosis modulators|mesh-ancestor
154159096|NCT03179904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154159097|NCT03179904|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154159098|NCT03179904|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
154159099|NCT03179904|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154159100|NCT03179904|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154159101|NCT03179904|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
154159102|NCT03179904|Hormone Antagonists|hormone antagonists|mesh-ancestor
154159103|NCT03179904|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154159104|NCT03179904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154159105|NCT03179904|Immunologic Factors|immunologic factors|mesh-ancestor
154159106|NCT03179904|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153655440|NCT00047749|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154159107|NCT03179904|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
154159108|NCT03165734|Hydroxyurea|hydroxyurea|mesh-list
154159109|NCT03165734|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154159110|NCT03165734|Antisickling Agents|antisickling agents|mesh-ancestor
154159111|NCT03165734|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154159112|NCT03165734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154159113|NCT03165734|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154159114|NCT03133780|Midazolam|midazolam|mesh-list
154159115|NCT03133780|Ketamine|ketamine|mesh-list
154159116|NCT03133780|Analgesics|analgesics|mesh-ancestor
154159138|NCT03113500|Cyclophosphamide|cyclophosphamide|mesh-list
154159139|NCT03113500|Doxorubicin|doxorubicin|mesh-list
154159140|NCT03113500|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
154159141|NCT03113500|Etoposide|etoposide|mesh-list
154159142|NCT03113500|Etoposide phosphate|etoposide phosphate|mesh-list
154159143|NCT03113500|Daunorubicin|daunorubicin|mesh-list
154159144|NCT03113500|Brentuximab Vedotin|brentuximab vedotin|mesh-list
154159145|NCT03113500|Podophyllotoxin|podophyllotoxin|mesh-list
154159146|NCT03113500|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
154159147|NCT03113500|Antibodies|antibodies|mesh-list
154159148|NCT03113500|Immunoglobulins|immunoglobulins|mesh-list
154159149|NCT03113500|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154159150|NCT03113500|Immunoconjugates|immunoconjugates|mesh-list
154159151|NCT03113500|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154159152|NCT03113500|Immunologic Factors|immunologic factors|mesh-ancestor
154159153|NCT03113500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154159154|NCT03113500|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154159155|NCT03113500|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153655525|NCT00048763|Cilostazol|cilostazol|mesh-list
154159156|NCT03113500|Alkylating Agents|alkylating agents|mesh-ancestor
154159157|NCT03113500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154159158|NCT03113500|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154159159|NCT03113500|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154159160|NCT03113500|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153539469|NCT01533662|Phenylephrine|phenylephrine|mesh-list
153804540|NCT00417911|Bortezomib|bortezomib|mesh-list
154159162|NCT03113500|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154159163|NCT03113500|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154159164|NCT03113500|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154159165|NCT03113500|Glucocorticoids|glucocorticoids|mesh-ancestor
154159166|NCT03113500|Hormones|hormones|mesh-ancestor
154159167|NCT03113500|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154159168|NCT03113500|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154159170|NCT03113500|Immunotoxins|immunotoxins|mesh-ancestor
154159181|NCT03071406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154159182|NCT03059940|Nicotine|nicotine|mesh-list
154159183|NCT03059940|Carbon Monoxide|carbon monoxide|mesh-list
154159184|NCT03059940|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
154159185|NCT03059940|Autonomic Agents|autonomic agents|mesh-ancestor
154159186|NCT03059940|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154159187|NCT03059940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154159188|NCT03059940|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
154159189|NCT03059940|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
154159190|NCT03059940|Cholinergic Agents|cholinergic agents|mesh-ancestor
154159191|NCT03059940|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154159192|NCT03059940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154159193|NCT03059940|Antimetabolites|antimetabolites|mesh-ancestor
154159194|NCT03059940|Gasotransmitters|gasotransmitters|mesh-ancestor
154159195|NCT03053622|Mirikizumab|mirikizumab|mesh-list
154159196|NCT03053622|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154159197|NCT03053622|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154159198|NCT03053622|Analgesics|analgesics|mesh-ancestor
154159199|NCT03053622|Sensory System Agents|sensory system agents|mesh-ancestor
154159200|NCT03053622|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154159201|NCT03053622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154159202|NCT03053622|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154159203|NCT03053622|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154159204|NCT03053622|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154159205|NCT03053622|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154159206|NCT03047837|Metformin|metformin|mesh-list
154159207|NCT03047837|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154159208|NCT03047837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154159209|NCT03037515|Tranexamic Acid|tranexamic acid|mesh-list
154159210|NCT03037515|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
154159211|NCT03037515|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154159212|NCT03037515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154159213|NCT03037515|Hemostatics|hemostatics|mesh-ancestor
154159214|NCT03037515|Coagulants|coagulants|mesh-ancestor
154159215|NCT03033589|Bupivacaine|bupivacaine|mesh-list
154159218|NCT03033589|Anesthetics|anesthetics|mesh-ancestor
154159220|NCT03033589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154159221|NCT03033589|Sensory System Agents|sensory system agents|mesh-ancestor
154159222|NCT03033589|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154159223|NCT02979522|Doxorubicin|doxorubicin|mesh-list
154159224|NCT02979522|Dacarbazine|dacarbazine|mesh-list
154159225|NCT02979522|Brentuximab Vedotin|brentuximab vedotin|mesh-list
154159226|NCT02979522|Vinblastine|vinblastine|mesh-list
154159227|NCT02979522|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154159228|NCT02979522|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154159229|NCT02979522|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154159230|NCT02979522|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154159231|NCT02979522|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154159232|NCT02979522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154159233|NCT02979522|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154159234|NCT02979522|Alkylating Agents|alkylating agents|mesh-ancestor
154159235|NCT02979522|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154159236|NCT02979522|Immunotoxins|immunotoxins|mesh-ancestor
154159237|NCT02979522|Immunoconjugates|immunoconjugates|mesh-ancestor
154159238|NCT02979522|Immunologic Factors|immunologic factors|mesh-ancestor
154159239|NCT02979522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154159240|NCT02979522|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154159241|NCT02979522|Tubulin Modulators|tubulin modulators|mesh-ancestor
154159242|NCT02979522|Antimitotic Agents|antimitotic agents|mesh-ancestor
154159243|NCT02979522|Mitosis Modulators|mitosis modulators|mesh-ancestor
154159244|NCT02971761|Pembrolizumab|pembrolizumab|mesh-list
154159245|NCT02971761|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154159246|NCT02971761|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154159247|NCT02971761|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154159248|NCT02971761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154159249|NCT02922777|Docetaxel|docetaxel|mesh-list
154159250|NCT02922777|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154159255|NCT02906007|Bedaquiline|bedaquiline|mesh-list
154159262|NCT02846376|Nivolumab|nivolumab|mesh-list
154159263|NCT02846376|Ipilimumab|ipilimumab|mesh-list
154159264|NCT02846376|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154159265|NCT02846376|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154159266|NCT02846376|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154159267|NCT02846376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154159268|NCT02830594|Pembrolizumab|pembrolizumab|mesh-list
154159269|NCT02830594|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154159270|NCT02830594|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154159271|NCT02830594|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154159272|NCT02830594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154159274|NCT02827877|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
154159275|NCT02827877|Trastuzumab|trastuzumab|mesh-list
154159276|NCT02827877|Pertuzumab|pertuzumab|mesh-list
154159277|NCT02827877|Antibodies|antibodies|mesh-list
154159278|NCT02827877|Immunoglobulins|immunoglobulins|mesh-list
154159279|NCT02827877|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154159280|NCT02827877|Immunologic Factors|immunologic factors|mesh-ancestor
154159281|NCT02827877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154159282|NCT02827877|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154159283|NCT02827877|Trace Elements|trace elements|mesh-ancestor
154159284|NCT02827877|Micronutrients|micronutrients|mesh-ancestor
154159285|NCT02822092|Risperidone|risperidone|mesh-list
154159286|NCT02822092|Aripiprazole|aripiprazole|mesh-list
154159287|NCT02822092|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154159288|NCT02822092|Serotonin Agents|serotonin agents|mesh-ancestor
154159289|NCT02822092|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154159290|NCT02822092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154159310|NCT02782104|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154159311|NCT02728830|Pembrolizumab|pembrolizumab|mesh-list
154159312|NCT02728830|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154159313|NCT02728830|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154159314|NCT02728830|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154159315|NCT02728830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154159316|NCT02694874|Rosiglitazone|rosiglitazone|mesh-list
154159317|NCT02694874|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154159318|NCT02694874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154159321|NCT02681302|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154159322|NCT02681302|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154159323|NCT02681302|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154159324|NCT02681302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154159325|NCT02654171|Ziresovir|ziresovir|mesh-list
154159326|NCT02654171|Antiviral Agents|antiviral agents|mesh-ancestor
154159327|NCT02654171|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154159328|NCT02624869|Evolocumab|evolocumab|mesh-list
154159329|NCT02624869|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
154159330|NCT02624869|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154159331|NCT02624869|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154159332|NCT02624869|Antimetabolites|antimetabolites|mesh-ancestor
154159333|NCT02624869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154159334|NCT02624869|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154159335|NCT02624869|Protease Inhibitors|protease inhibitors|mesh-ancestor
154159336|NCT02624869|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154159337|NCT02624869|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154159338|NCT02590393|Nicotine|nicotine|mesh-list
153655789|NCT00050440|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154159339|NCT02590393|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
154159340|NCT02590393|Autonomic Agents|autonomic agents|mesh-ancestor
154159341|NCT02590393|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154159343|NCT02590393|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
154159354|NCT02588651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154159355|NCT02531932|Carboplatin|carboplatin|mesh-list
154159356|NCT02531932|Everolimus|everolimus|mesh-list
154159357|NCT02531932|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154159358|NCT02531932|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
154159359|NCT02531932|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154159360|NCT02531932|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154159361|NCT02531932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154159362|NCT02531932|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154159363|NCT02531932|Immunologic Factors|immunologic factors|mesh-ancestor
154159364|NCT02531932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154159365|NCT02444741|Pembrolizumab|pembrolizumab|mesh-list
154159366|NCT02444741|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154159367|NCT02444741|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154159368|NCT02444741|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154159369|NCT02444741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154159370|NCT02415621|Abiraterone Acetate|abiraterone acetate|mesh-list
154159371|NCT02415621|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154159372|NCT02415621|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154159408|NCT02393859|Glucocorticoids|glucocorticoids|mesh-ancestor
154159409|NCT02393859|Hormones|hormones|mesh-ancestor
154159410|NCT02393859|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154159411|NCT02393859|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154159412|NCT02393859|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154159413|NCT02393859|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154159414|NCT02393859|Abortifacient Agents|abortifacient agents|mesh-ancestor
154159415|NCT02393859|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154159416|NCT02393859|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154159417|NCT02393859|Antimetabolites|antimetabolites|mesh-ancestor
154159418|NCT02393859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154159419|NCT02393859|Dermatologic Agents|dermatologic agents|mesh-ancestor
154159420|NCT02393859|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154159421|NCT02393859|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154159422|NCT02393859|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154159423|NCT02393859|Immunologic Factors|immunologic factors|mesh-ancestor
154159424|NCT02393859|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154159425|NCT02393859|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154159426|NCT02393859|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154159427|NCT02393859|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154159428|NCT02393859|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154159429|NCT02393859|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154159430|NCT02393859|Alkylating Agents|alkylating agents|mesh-ancestor
154159431|NCT02365766|Gemcitabine|gemcitabine|mesh-list
154159432|NCT02365766|Pembrolizumab|pembrolizumab|mesh-list
154159467|NCT02048189|Insulin Detemir|insulin detemir|mesh-list
154159468|NCT02048189|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154159469|NCT02048189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154159470|NCT02042573|Sertraline|sertraline|mesh-list
154159471|NCT02042573|Antidepressive Agents|antidepressive agents|mesh-ancestor
154159472|NCT02042573|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154159473|NCT02042573|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
154159474|NCT02042573|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154159475|NCT02042573|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154159476|NCT02042573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154159477|NCT02042573|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154159478|NCT02042573|Serotonin Agents|serotonin agents|mesh-ancestor
154159479|NCT02042573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154159480|NCT02016924|Cobicistat|cobicistat|mesh-list
154159481|NCT02016924|Emtricitabine tenofovir alafenamide|emtricitabine tenofovir alafenamide|mesh-list
154159482|NCT02016924|Emtricitabine|emtricitabine|mesh-list
154159483|NCT02016924|Tenofovir|tenofovir|mesh-list
154159484|NCT02016924|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154159513|NCT01785641|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
154159514|NCT01785641|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154159515|NCT01785641|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
154159516|NCT01785641|Third Generation Cephalosporins|third generation cephalosporins|mesh-ancestor
154159517|NCT01785641|Beta Lactam Antibiotics|beta lactam antibiotics|mesh-ancestor
154159518|NCT01760226|Prednisone|prednisone|mesh-list
154159519|NCT01760226|Cyclophosphamide|cyclophosphamide|mesh-list
154159520|NCT01760226|Rituximab|rituximab|mesh-list
154159521|NCT01760226|Doxorubicin|doxorubicin|mesh-list
154159522|NCT01760226|Methotrexate|methotrexate|mesh-list
154159523|NCT01760226|Etoposide|etoposide|mesh-list
154159524|NCT01760226|Vincristine|vincristine|mesh-list
154159525|NCT01760226|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154159526|NCT01760226|Immunologic Factors|immunologic factors|mesh-ancestor
154159527|NCT01760226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154159528|NCT01760226|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154159529|NCT01760226|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154159530|NCT01760226|Alkylating Agents|alkylating agents|mesh-ancestor
154159531|NCT01760226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154159532|NCT01760226|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154159533|NCT01760226|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154159534|NCT01760226|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153539835|NCT01535989|MTOR Inhibitors|mtor inhibitors|mesh-list
154159535|NCT01760226|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154159536|NCT01760226|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154159537|NCT01760226|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154159538|NCT01760226|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154159539|NCT01760226|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154159540|NCT01760226|Glucocorticoids|glucocorticoids|mesh-ancestor
154159542|NCT01760226|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154159543|NCT01760226|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154159555|NCT01760226|Mitosis Modulators|mitosis modulators|mesh-ancestor
154159556|NCT01712490|Doxorubicin|doxorubicin|mesh-list
154159558|NCT01712490|Dacarbazine|dacarbazine|mesh-list
154159559|NCT01712490|Brentuximab Vedotin|brentuximab vedotin|mesh-list
153655855|NCT00051103|Antineoplastic Agents|antineoplastic agents|mesh-list
154159560|NCT01712490|Vinblastine|vinblastine|mesh-list
153655894|NCT00051298|Olanzapine|olanzapine|mesh-list
154159561|NCT01712490|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154159562|NCT01712490|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154159563|NCT01712490|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154159564|NCT01712490|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154159565|NCT01712490|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154159566|NCT01712490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154159567|NCT01712490|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154159568|NCT01712490|Alkylating Agents|alkylating agents|mesh-ancestor
154159569|NCT01712490|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154159570|NCT01712490|Immunotoxins|immunotoxins|mesh-ancestor
154159571|NCT01712490|Immunoconjugates|immunoconjugates|mesh-ancestor
154159572|NCT01712490|Immunologic Factors|immunologic factors|mesh-ancestor
154159573|NCT01712490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154159574|NCT01712490|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154159575|NCT01712490|Tubulin Modulators|tubulin modulators|mesh-ancestor
154159576|NCT01712490|Antimitotic Agents|antimitotic agents|mesh-ancestor
154159577|NCT01712490|Mitosis Modulators|mitosis modulators|mesh-ancestor
154159578|NCT01698840|Vitamin D|vitamin d|mesh-list
154159579|NCT01698840|Vitamins|vitamins|mesh-ancestor
154159580|NCT01698840|Micronutrients|micronutrients|mesh-ancestor
154159581|NCT01698840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154159582|NCT01698840|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154159583|NCT01563731|Antihypertensive Agents|antihypertensive agents|mesh-list
154159584|NCT01563731|Calcium Channel Blockers|calcium channel blockers|mesh-list
154159585|NCT01563731|Atorvastatin|atorvastatin|mesh-list
154159586|NCT01563731|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
154159587|NCT01563731|Simvastatin|simvastatin|mesh-list
154159588|NCT01563731|Pravastatin|pravastatin|mesh-list
154159589|NCT01563731|Enzyme Inhibitors|enzyme inhibitors|mesh-list
154159597|NCT01563731|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154159598|NCT01563731|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154159599|NCT01563731|Antimetabolites|antimetabolites|mesh-ancestor
154159600|NCT01563731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154159601|NCT01563731|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154159602|NCT01563731|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154159603|NCT01563731|Natriuretic Agents|natriuretic agents|mesh-ancestor
153655952|NCT05573958|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
154159604|NCT01563731|Protease Inhibitors|protease inhibitors|mesh-ancestor
154159605|NCT01563731|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154159606|NCT01563731|Hormone Antagonists|hormone antagonists|mesh-ancestor
154159607|NCT01563731|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154159608|NCT01563731|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
154159609|NCT01525966|Paclitaxel|paclitaxel|mesh-list
154159610|NCT01525966|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
154159611|NCT01525966|Carboplatin|carboplatin|mesh-list
154159612|NCT01525966|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154159613|NCT01525966|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154159614|NCT01525966|Tubulin Modulators|tubulin modulators|mesh-ancestor
154159615|NCT01525966|Antimitotic Agents|antimitotic agents|mesh-ancestor
154159616|NCT01525966|Mitosis Modulators|mitosis modulators|mesh-ancestor
154159617|NCT01525966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154159618|NCT01463072|Paclitaxel|paclitaxel|mesh-list
154159619|NCT01463072|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
154159620|NCT01463072|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154159647|NCT01154920|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153656009|NCT00052312|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
153656012|NCT00052312|Tubulin Modulators|tubulin modulators|mesh-ancestor
154159648|NCT01154920|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154159649|NCT01154920|Tubulin Modulators|tubulin modulators|mesh-ancestor
154159650|NCT01154920|Antimitotic Agents|antimitotic agents|mesh-ancestor
154159651|NCT01154920|Mitosis Modulators|mitosis modulators|mesh-ancestor
154159652|NCT01154920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154159653|NCT01154920|Antimetabolites|antimetabolites|mesh-ancestor
154159654|NCT01154920|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154159655|NCT01154920|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154159656|NCT01154920|Immunologic Factors|immunologic factors|mesh-ancestor
153656119|NCT00052936|Alkylating Agents|alkylating agents|mesh-ancestor
153656138|NCT00053092|Rituximab|rituximab|mesh-list
153656139|NCT00053092|Fludarabine|fludarabine|mesh-list
153656140|NCT00053092|Fludarabine phosphate|fludarabine phosphate|mesh-list
153656141|NCT00053092|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153656142|NCT00053092|Immunologic Factors|immunologic factors|mesh-ancestor
153656143|NCT00053092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153656144|NCT00053092|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154159657|NCT01154920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154159658|NCT01154920|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154159659|NCT00947531|Cerebrolysin|cerebrolysin|mesh-list
154159660|NCT00947531|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
154159661|NCT00947531|Protective Agents|protective agents|mesh-ancestor
154159662|NCT00947531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154159663|NCT00947531|Nootropic Agents|nootropic agents|mesh-ancestor
154159664|NCT00941473|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
154159665|NCT00941473|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154159666|NCT00941473|Glucocorticoids|glucocorticoids|mesh-ancestor
154159667|NCT00941473|Hormones|hormones|mesh-ancestor
154159668|NCT00941473|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154159669|NCT00941473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154159697|NCT00630032|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154159698|NCT00630032|Alkylating Agents|alkylating agents|mesh-ancestor
154159699|NCT00630032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154159700|NCT00630032|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154159701|NCT00630032|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154159702|NCT00630032|Tubulin Modulators|tubulin modulators|mesh-ancestor
154159703|NCT00630032|Antimitotic Agents|antimitotic agents|mesh-ancestor
154159704|NCT00630032|Mitosis Modulators|mitosis modulators|mesh-ancestor
154159705|NCT00630032|Antimetabolites|antimetabolites|mesh-ancestor
154159706|NCT00630032|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154159707|NCT00630032|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154159708|NCT00630032|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154159709|NCT00630032|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154159710|NCT00630032|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154159711|NCT00609791|Paclitaxel|paclitaxel|mesh-list
154159712|NCT00609791|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
154159713|NCT00609791|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154159714|NCT00609791|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154159715|NCT00609791|Tubulin Modulators|tubulin modulators|mesh-ancestor
154159716|NCT00609791|Antimitotic Agents|antimitotic agents|mesh-ancestor
154159719|NCT00544830|Leuprolide|leuprolide|mesh-list
154159751|NCT00534430|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
154159752|NCT00534430|Antitubercular Agents|antitubercular agents|mesh-ancestor
154159753|NCT00534430|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154159755|NCT00534430|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154159756|NCT00534430|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154159757|NCT00492050|Valacyclovir|valacyclovir|mesh-list
154159758|NCT00492050|Rituximab|rituximab|mesh-list
154159759|NCT00492050|Bortezomib|bortezomib|mesh-list
153540060|NCT01537094|Antioxidants|antioxidants|mesh-ancestor
154159760|NCT00492050|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154159761|NCT00492050|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154159762|NCT00492050|Immunologic Factors|immunologic factors|mesh-ancestor
154159763|NCT00492050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154159764|NCT00492050|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154159765|NCT00492050|Antiviral Agents|antiviral agents|mesh-ancestor
154159766|NCT00492050|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154159767|NCT00456963|Losartan|losartan|mesh-list
154159768|NCT00456963|Enalapril|enalapril|mesh-list
154159769|NCT00456963|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154159770|NCT00456963|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154159771|NCT00456963|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
154159772|NCT00456963|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
154159773|NCT00456963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154159774|NCT00456963|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
154159775|NCT00456963|Protease Inhibitors|protease inhibitors|mesh-ancestor
154159776|NCT00456963|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154159777|NCT00001379|Interferons|interferons|mesh-list
154159778|NCT00001379|Rituximab|rituximab|mesh-list
154159779|NCT00001379|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154159780|NCT00001379|Antiviral Agents|antiviral agents|mesh-ancestor
154159781|NCT00001379|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154159782|NCT00001379|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154159783|NCT00001379|Immunologic Factors|immunologic factors|mesh-ancestor
154159784|NCT00001379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154159785|NCT00001379|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154159786|NCT01267448|Metformin|metformin|mesh-list
154159787|NCT01267448|Saxagliptin|saxagliptin|mesh-list
154159789|NCT01267448|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154159790|NCT01267448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154159791|NCT01267448|Incretins|incretins|mesh-ancestor
154159792|NCT01267448|Hormones|hormones|mesh-ancestor
154159793|NCT01267448|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154159794|NCT01267448|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
154159795|NCT01267448|Protease Inhibitors|protease inhibitors|mesh-ancestor
154159796|NCT01267448|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154159797|NCT01267448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154159798|NCT01265030|Sirolimus|sirolimus|mesh-list
154159799|NCT01265030|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154159800|NCT01265030|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154159801|NCT01265030|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153656512|NCT00055666|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154159802|NCT01265030|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154159803|NCT01265030|Antifungal Agents|antifungal agents|mesh-ancestor
153656516|NCT00055822|Leucovorin|leucovorin|mesh-list
154159804|NCT01265030|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154159805|NCT01265030|Immunologic Factors|immunologic factors|mesh-ancestor
154159806|NCT01265030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154159807|NCT00901511|Sargramostim|sargramostim|mesh-list
154159808|NCT00901511|Immunologic Factors|immunologic factors|mesh-ancestor
154159809|NCT00901511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154159810|NCT00202813|Anti-Infective Agents|anti-infective agents|mesh-list
154159811|NCT00202813|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
154159812|NCT00004180|Rosiglitazone|rosiglitazone|mesh-list
154159813|NCT00004180|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154159814|NCT00004180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154159815|NCT00988494|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
154159816|NCT00988494|Ophthalmic Solutions|ophthalmic solutions|mesh-list
154159817|NCT00539994|Retapamulin|retapamulin|mesh-list
154159818|NCT00539994|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154159819|NCT00539994|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154159820|NCT04005222|Selenium|selenium|mesh-list
154159821|NCT04005222|Melatonin|melatonin|mesh-list
154159822|NCT04005222|Antioxidants|antioxidants|mesh-ancestor
154159829|NCT00098839|Leucovorin|leucovorin|mesh-list
154159830|NCT00098839|Cytarabine|cytarabine|mesh-list
154159831|NCT00098839|Prednisone|prednisone|mesh-list
154159832|NCT00098839|Hydrocortisone|hydrocortisone|mesh-list
154159833|NCT00098839|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
154159834|NCT00098839|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
154159835|NCT00098839|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
154159836|NCT00098839|Cyclophosphamide|cyclophosphamide|mesh-list
154159837|NCT00098839|Doxorubicin|doxorubicin|mesh-list
154159838|NCT00098839|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
154159840|NCT00098839|Etoposide|etoposide|mesh-list
154159841|NCT00098839|Vincristine|vincristine|mesh-list
154159842|NCT00098839|Etoposide phosphate|etoposide phosphate|mesh-list
154159843|NCT00098839|Asparaginase|asparaginase|mesh-list
154159844|NCT00098839|Pegaspargase|pegaspargase|mesh-list
154159845|NCT00098839|Epratuzumab|epratuzumab|mesh-list
154159846|NCT00098839|Dexrazoxane|dexrazoxane|mesh-list
154159847|NCT00098839|Razoxane|razoxane|mesh-list
154159848|NCT00098839|Levoleucovorin|levoleucovorin|mesh-list
154159849|NCT00098839|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154159850|NCT00098839|Immunologic Factors|immunologic factors|mesh-ancestor
154159851|NCT00098839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154159889|NCT02531191|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153656553|NCT00392106|Flecainide|flecainide|mesh-list
154159890|NCT02531191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154159891|NCT02531191|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153656554|NCT00392106|Propafenone|propafenone|mesh-list
154159892|NCT02531191|Immunologic Factors|immunologic factors|mesh-ancestor
154159893|NCT02531191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154159894|NCT01081639|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
154159895|NCT01081639|Hormones|hormones|mesh-ancestor
154159896|NCT01081639|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154159897|NCT01081639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154159898|NCT01081717|Golimumab|golimumab|mesh-list
154159899|NCT01081717|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
154159900|NCT01081717|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154159901|NCT01081717|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154159902|NCT01081717|Immunologic Factors|immunologic factors|mesh-ancestor
154159903|NCT01081717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154159904|NCT01085383|Aripiprazole|aripiprazole|mesh-list
154159905|NCT01085383|Antidepressive Agents|antidepressive agents|mesh-ancestor
154159906|NCT01085383|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154159907|NCT01085383|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154159908|NCT01085383|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154159909|NCT01085383|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154159911|NCT01085383|Dopamine Agonists|dopamine agonists|mesh-ancestor
154159939|NCT00490971|Olanzapine|olanzapine|mesh-list
154159940|NCT00490971|Paliperidone Palmitate|paliperidone palmitate|mesh-list
154159941|NCT00490971|Antiemetics|antiemetics|mesh-ancestor
154159942|NCT00490971|Autonomic Agents|autonomic agents|mesh-ancestor
154159943|NCT00490971|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154159944|NCT00490971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153656599|NCT00056095|Immunologic Factors|immunologic factors|mesh-ancestor
154159945|NCT00490971|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153656600|NCT00056095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154159946|NCT00490971|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154159947|NCT00490971|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154159948|NCT00490971|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154159949|NCT00490971|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154159950|NCT00490971|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
154159951|NCT00490971|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154159952|NCT00490971|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154159953|NCT00490971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154159954|NCT00490971|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154159995|NCT00750581|Tocolytic Agents|tocolytic agents|mesh-ancestor
154159996|NCT00750581|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154159997|NCT00750581|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154159998|NCT00750581|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154159999|NCT00750581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154160000|NCT00685763|Gemcitabine|gemcitabine|mesh-list
154160001|NCT00685763|Capecitabine|capecitabine|mesh-list
154160002|NCT00685763|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154160003|NCT00685763|Antimetabolites|antimetabolites|mesh-ancestor
154160004|NCT00685763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154160005|NCT00685763|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154160006|NCT00750659|Nilotinib|nilotinib|mesh-list
154160007|NCT00750659|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154160008|NCT00750659|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154160009|NCT00750659|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154160010|NCT00750659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154160011|NCT00098293|Lamivudine|lamivudine|mesh-list
154160012|NCT00098293|Zidovudine|zidovudine|mesh-list
154160013|NCT00098293|Efavirenz|efavirenz|mesh-list
154160014|NCT00098293|Maraviroc|maraviroc|mesh-list
154160050|NCT01087567|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154160051|NCT01087567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154160052|NCT01087567|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154160053|NCT01087567|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154160054|NCT01087567|Immunologic Factors|immunologic factors|mesh-ancestor
154160055|NCT00751049|Timolol|timolol|mesh-list
154160056|NCT00751049|Latanoprost|latanoprost|mesh-list
154160057|NCT00751049|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
153656768|NCT00057928|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153656770|NCT05309304|Cefazolin|cefazolin|mesh-list
154160058|NCT00751049|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154160059|NCT00751049|Adrenergic Agents|adrenergic agents|mesh-ancestor
154160060|NCT00751049|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153483601|NCT00930228|Flutamide|flutamide|mesh-list
154160061|NCT00751049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154160062|NCT00751049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154160070|NCT01019109|Cobalt|cobalt|mesh-list
154160111|NCT00097981|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154160112|NCT00097981|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154160114|NCT00097981|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154160115|NCT00097981|Immunologic Factors|immunologic factors|mesh-ancestor
154160116|NCT00097981|Leprostatic Agents|leprostatic agents|mesh-ancestor
154160117|NCT00097981|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154160118|NCT00097981|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154160119|NCT00097981|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154160120|NCT00097981|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154160121|NCT00097981|Growth Substances|growth substances|mesh-ancestor
154160122|NCT00097981|Growth Inhibitors|growth inhibitors|mesh-ancestor
154160123|NCT01016145|Antipsychotic Agents|antipsychotic agents|mesh-list
154160124|NCT01016145|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153656968|NCT00059800|Boron|boron|mesh-list
154160125|NCT01016145|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154160126|NCT01016145|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154160127|NCT01016145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154160128|NCT01016223|Beclomethasone|beclomethasone|mesh-list
154160129|NCT01016223|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154160130|NCT01016223|Glucocorticoids|glucocorticoids|mesh-ancestor
154160131|NCT01016223|Hormones|hormones|mesh-ancestor
154160132|NCT01016223|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154160133|NCT01016223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154160134|NCT01016223|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154160135|NCT01016223|Respiratory System Agents|respiratory system agents|mesh-ancestor
154160136|NCT04151017|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
154160137|NCT04151017|Hemostatics|hemostatics|mesh-ancestor
154160138|NCT04151017|Coagulants|coagulants|mesh-ancestor
154160139|NCT01019265|Buprenorphine|buprenorphine|mesh-list
154160140|NCT01019265|Tramadol|tramadol|mesh-list
154160141|NCT01019265|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154160142|NCT01019265|Narcotics|narcotics|mesh-ancestor
154160143|NCT01019265|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154160144|NCT01019265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154160145|NCT01019265|Analgesics|analgesics|mesh-ancestor
154160151|NCT01087879|Ethinyl Estradiol|ethinyl estradiol|mesh-list
154160152|NCT01087879|Etonogestrel|etonogestrel|mesh-list
154160153|NCT01087879|Desogestrel|desogestrel|mesh-list
154160154|NCT01087879|NuvaRing|nuvaring|mesh-list
154160155|NCT01087879|Norelgestromin|norelgestromin|mesh-list
153657134|NCT05038410|Wobenzym|wobenzym|mesh-list
153657135|NCT05038410|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154160156|NCT01087879|Contraceptive Agents|contraceptive agents|mesh-list
154160157|NCT01087879|Estradiol|estradiol|mesh-list
154160158|NCT01087879|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
154160159|NCT01087879|Estrogens|estrogens|mesh-ancestor
154160160|NCT01087879|Hormones|hormones|mesh-ancestor
154160161|NCT01087879|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154160162|NCT01087879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154160163|NCT01087879|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
154160164|NCT01087879|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154160165|NCT01087879|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
154160166|NCT01087879|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
154160167|NCT01087879|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
154160168|NCT01087879|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
154160169|NCT01087879|Progestins|progestins|mesh-ancestor
154160171|NCT01019421|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154160195|NCT00751127|Timolol|timolol|mesh-list
154160203|NCT00751127|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154160204|NCT00751127|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154160205|NCT00751127|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
154160206|NCT00751127|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
154160207|NCT00751205|Acetylcarnitine|acetylcarnitine|mesh-list
154160208|NCT00751205|Prednisone|prednisone|mesh-list
154160209|NCT00751205|Prednisolone|prednisolone|mesh-list
154160210|NCT00751205|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
154160211|NCT00751205|Methylprednisolone|methylprednisolone|mesh-list
153657206|NCT00061321|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153657207|NCT00061321|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154160212|NCT00751205|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
154160214|NCT00751205|Sagopilone|sagopilone|mesh-list
154160215|NCT00751205|Epothilones|epothilones|mesh-list
154160216|NCT00751205|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
154160217|NCT00751205|Prednisolone phosphate|prednisolone phosphate|mesh-list
154160218|NCT00751205|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154160219|NCT00751205|Glucocorticoids|glucocorticoids|mesh-ancestor
154160220|NCT00751205|Hormones|hormones|mesh-ancestor
154160221|NCT00751205|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154160222|NCT00751205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154160223|NCT00751205|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154160224|NCT00751205|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154160225|NCT00751205|Antiemetics|antiemetics|mesh-ancestor
154160226|NCT00751205|Autonomic Agents|autonomic agents|mesh-ancestor
154160227|NCT00751205|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154160228|NCT00751205|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154160257|NCT00752141|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153913845|NCT02722759|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154160258|NCT00752141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154160259|NCT00752141|Urological Agents|urological agents|mesh-ancestor
154160260|NCT00752141|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
154160261|NCT00752141|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154160262|NCT00752375|Trimethoprim|trimethoprim|mesh-list
154160263|NCT00752375|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
154160264|NCT00752375|Sulfamethoxazole|sulfamethoxazole|mesh-list
154160265|NCT00752375|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
154160266|NCT00752375|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154160267|NCT00752375|Antimalarials|antimalarials|mesh-ancestor
154160268|NCT00752375|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154160269|NCT00752375|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154160270|NCT00752375|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154160316|NCT00684515|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154160317|NCT00684515|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154160319|NCT00751751|Losartan|losartan|mesh-list
154160320|NCT00751751|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
154160321|NCT00751751|Olmesartan|olmesartan|mesh-list
154160322|NCT00751751|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
154160323|NCT00751751|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154160324|NCT00751751|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154160325|NCT00751751|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
154160326|NCT00751751|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
154160327|NCT00751751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154160328|NCT00751751|Diuretics|diuretics|mesh-ancestor
154160378|NCT00483717|Analgesics|analgesics|mesh-ancestor
154160379|NCT00483717|Sensory System Agents|sensory system agents|mesh-ancestor
154160380|NCT00483717|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154160381|NCT00483717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154160382|NCT00483717|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154160383|NCT00483717|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154160384|NCT00483717|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154160385|NCT00483717|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154160386|NCT00483717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154160387|NCT00406354|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
153657439|NCT06192238|Epinephrine|epinephrine|mesh-list
154160388|NCT00406354|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
154160389|NCT00406354|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154160390|NCT00406354|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154160391|NCT00406354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154160392|NCT00406354|Adrenergic Agents|adrenergic agents|mesh-ancestor
154160434|NCT00684203|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154160435|NCT00684203|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154160436|NCT00684203|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154160438|NCT00684203|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
153805797|NCT00332436|Timolol|timolol|mesh-list
154160439|NCT00684203|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
154160440|NCT00684203|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
154160441|NCT00684203|Purinergic Agents|purinergic agents|mesh-ancestor
154160442|NCT00684203|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154160443|NCT00423592|Ambrisentan|ambrisentan|mesh-list
154160444|NCT00423592|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154160445|NCT01037998|Gefitinib|gefitinib|mesh-list
154160446|NCT01037998|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154160447|NCT01037998|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154160448|NCT01037998|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154160449|NCT01037998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154160450|NCT01037998|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154160451|NCT00751907|Atorvastatin|atorvastatin|mesh-list
154160452|NCT00751907|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154160453|NCT00751907|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153657476|NCT06170346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153657477|NCT06170346|Protective Agents|protective agents|mesh-ancestor
154160454|NCT00751907|Antimetabolites|antimetabolites|mesh-ancestor
154160455|NCT00751907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154160456|NCT00751907|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154160457|NCT00751907|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154160458|NCT00751907|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154160459|NCT00752843|Mifepristone|mifepristone|mesh-list
154160480|NCT00752921|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154160481|NCT00752921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154160482|NCT00752921|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154160483|NCT00752921|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154160484|NCT00752921|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
154160485|NCT00752921|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154160486|NCT00752921|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154160487|NCT00752921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154160488|NCT00683657|Saxagliptin|saxagliptin|mesh-list
154160489|NCT00683657|Incretins|incretins|mesh-ancestor
154160490|NCT00683657|Hormones|hormones|mesh-ancestor
154160491|NCT00683657|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154160492|NCT00683657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154160493|NCT00683657|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
153657600|NCT05995704|Sensory System Agents|sensory system agents|mesh-ancestor
153657601|NCT05995704|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154160494|NCT00683657|Protease Inhibitors|protease inhibitors|mesh-ancestor
154160495|NCT00683657|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154160496|NCT00683657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154160497|NCT00683657|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154160498|NCT00755885|Abiraterone Acetate|abiraterone acetate|mesh-list
154160499|NCT00755885|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154160501|NCT00755885|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154160531|NCT00753467|Adefovir|adefovir|mesh-list
154160532|NCT00753467|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
154160533|NCT00753467|Interferon-gamma|interferon-gamma|mesh-list
154160534|NCT00753467|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154160535|NCT00753467|Antiviral Agents|antiviral agents|mesh-ancestor
154160536|NCT00753467|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154160537|NCT00753467|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
154160538|NCT00753467|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154160539|NCT00753467|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154160540|NCT00753467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154160541|NCT00482703|Dasatinib|dasatinib|mesh-list
154160542|NCT00482703|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154160543|NCT00482703|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154160544|NCT00482703|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154160545|NCT00482703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154160546|NCT00482703|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154160547|NCT04052867|Lidocaine|lidocaine|mesh-list
154160548|NCT04052867|Anesthetics, Local|anesthetics, local|mesh-ancestor
154160549|NCT04052867|Anesthetics|anesthetics|mesh-ancestor
154160550|NCT04052867|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153913846|NCT02722759|Analgesics|analgesics|mesh-ancestor
153657679|NCT05701059|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153657680|NCT05701059|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153657681|NCT05701059|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153657739|NCT05642026|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153657740|NCT05642026|Analgesics|analgesics|mesh-ancestor
153657741|NCT05642026|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153657742|NCT05642026|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153657743|NCT05606315|Midazolam|midazolam|mesh-list
153657744|NCT05606315|Propofol|propofol|mesh-list
153657745|NCT05606315|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153657810|NCT05472779|Estradiol|estradiol|mesh-list
154160551|NCT04052867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154160552|NCT04052867|Sensory System Agents|sensory system agents|mesh-ancestor
154160553|NCT04052867|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154160554|NCT04052867|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153484131|NCT04508166|Sodium Oxybate|sodium oxybate|mesh-list
154160581|NCT00482391|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153805942|NCT00329355|Naproxen|naproxen|mesh-list
154160582|NCT00482391|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154160583|NCT00482391|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154160584|NCT00482391|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154160586|NCT00753779|Colesevelam Hydrochloride|colesevelam hydrochloride|mesh-list
154160587|NCT00753779|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154160588|NCT00753779|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154160589|NCT00753779|Antimetabolites|antimetabolites|mesh-ancestor
154160590|NCT00753779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154160591|NCT00753779|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154160592|NCT00753779|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154160593|NCT00753779|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154160594|NCT00757523|Adapalene, Benzoyl Peroxide Drug Combination|adapalene, benzoyl peroxide drug combination|mesh-list
154160595|NCT00757523|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154160596|NCT00757523|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153657815|NCT05472779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154160597|NCT00757523|Analgesics|analgesics|mesh-ancestor
154160598|NCT00757523|Sensory System Agents|sensory system agents|mesh-ancestor
153657816|NCT05472779|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
153657817|NCT05472779|Contraceptive Agents|contraceptive agents|mesh-ancestor
153657818|NCT05472779|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153657828|NCT05455424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153657829|NCT05455424|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153657830|NCT05453565|Vasoconstrictor Agents|vasoconstrictor agents|mesh-list
154160599|NCT00757523|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154160600|NCT00757523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154160601|NCT00757523|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154160602|NCT00757523|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154160603|NCT00757523|Dermatologic Agents|dermatologic agents|mesh-ancestor
154160604|NCT00757679|Milnacipran|milnacipran|mesh-list
154160605|NCT00757679|Levomilnacipran|levomilnacipran|mesh-list
154160606|NCT00757679|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
154160607|NCT00757679|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154160608|NCT00757679|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154160609|NCT00757679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154160610|NCT00757679|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154160617|NCT00757679|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154160618|NCT00496587|Bevacizumab|bevacizumab|mesh-list
154160619|NCT00496587|Gemcitabine|gemcitabine|mesh-list
154160620|NCT00496587|Capecitabine|capecitabine|mesh-list
154160621|NCT00496587|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154160622|NCT00496587|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154160623|NCT00496587|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154160624|NCT00496587|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154160625|NCT00496587|Growth Substances|growth substances|mesh-ancestor
154160626|NCT00496587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154160627|NCT00496587|Growth Inhibitors|growth inhibitors|mesh-ancestor
154160628|NCT00496587|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154160629|NCT00496587|Antimetabolites|antimetabolites|mesh-ancestor
154160630|NCT00496587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154160631|NCT00757835|Timolol|timolol|mesh-list
154160632|NCT00757835|Latanoprost|latanoprost|mesh-list
154160633|NCT00757835|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
154160634|NCT00757835|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154160635|NCT00757835|Adrenergic Agents|adrenergic agents|mesh-ancestor
154160636|NCT00757835|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154160637|NCT00757835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154160638|NCT00757835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154160639|NCT00757835|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154160640|NCT00757835|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154160641|NCT00757835|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
154160642|NCT00757835|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
154160643|NCT01038154|Pravastatin|pravastatin|mesh-list
154160644|NCT01038154|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154160645|NCT01038154|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154160646|NCT01038154|Antimetabolites|antimetabolites|mesh-ancestor
154160647|NCT01038154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154160648|NCT01038154|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154160650|NCT01038154|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154160658|NCT00405652|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154160659|NCT00405652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154160661|NCT01324180|Dexamethasone|dexamethasone|mesh-list
154160662|NCT01324180|Doxorubicin|doxorubicin|mesh-list
154160663|NCT01324180|Vincristine|vincristine|mesh-list
154160664|NCT01324180|Asparaginase|asparaginase|mesh-list
154160665|NCT01324180|Pegaspargase|pegaspargase|mesh-list
154160666|NCT01324180|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154160667|NCT01324180|Antiemetics|antiemetics|mesh-ancestor
154160668|NCT01324180|Autonomic Agents|autonomic agents|mesh-ancestor
154160669|NCT01324180|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154160670|NCT01324180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154160671|NCT01324180|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154160672|NCT01324180|Glucocorticoids|glucocorticoids|mesh-ancestor
154160673|NCT01324180|Hormones|hormones|mesh-ancestor
153455612|NCT05660213|Atezolizumab|atezolizumab|mesh-list
153657853|NCT05413980|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154160674|NCT01324180|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154160675|NCT01324180|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154160676|NCT01324180|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154160677|NCT01324180|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154160678|NCT01324180|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154160679|NCT01324180|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154160680|NCT01324180|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154160681|NCT01324180|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154160682|NCT01324180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154160683|NCT01324180|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154160684|NCT01324180|Tubulin Modulators|tubulin modulators|mesh-ancestor
154160685|NCT01324180|Antimitotic Agents|antimitotic agents|mesh-ancestor
154160686|NCT01324180|Mitosis Modulators|mitosis modulators|mesh-ancestor
154160687|NCT02560649|Tenofovir|tenofovir|mesh-list
154160688|NCT02560649|Lamivudine|lamivudine|mesh-list
154160689|NCT02560649|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
154160690|NCT02560649|Interferon-alpha|interferon-alpha|mesh-list
154160703|NCT02560649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154160704|NCT00754403|Metformin|metformin|mesh-list
154160705|NCT00754403|Pioglitazone|pioglitazone|mesh-list
154160706|NCT00754403|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154160707|NCT00754403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154160708|NCT00758225|Idebenone|idebenone|mesh-list
154160709|NCT00758225|Antioxidants|antioxidants|mesh-ancestor
154160710|NCT00758225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154160711|NCT00758225|Protective Agents|protective agents|mesh-ancestor
154160712|NCT00758225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154160713|NCT02561039|Ibandronic Acid|ibandronic acid|mesh-list
154160714|NCT02561039|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154160715|NCT02561039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153657862|NCT05388006|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
153889996|NCT01263015|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
153431043|NCT00000349|Dopamine Agents|dopamine agents|mesh-ancestor
153657863|NCT05388006|Immunoglobulin G|immunoglobulin g|mesh-list
153657864|NCT05388006|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-list
153657882|NCT05326464|Tofacitinib|tofacitinib|mesh-list
154160716|NCT00422734|Tadalafil|tadalafil|mesh-list
154160717|NCT00422734|Vasodilator Agents|vasodilator agents|mesh-ancestor
154160718|NCT00422734|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
154160719|NCT00422734|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154160720|NCT00422734|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154160721|NCT00422734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154160722|NCT00422734|Urological Agents|urological agents|mesh-ancestor
154160723|NCT00422422|Brivaracetam|brivaracetam|mesh-list
154160724|NCT00422422|Anticonvulsants|anticonvulsants|mesh-ancestor
154160725|NCT00413374|Enoxaparin|enoxaparin|mesh-list
154160726|NCT00413374|Anticoagulants|anticoagulants|mesh-ancestor
154160727|NCT00413374|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154160728|NCT00413374|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154160729|NCT00413374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154160730|NCT00682643|Fluticasone|fluticasone|mesh-list
154160731|NCT00682643|Xhance|xhance|mesh-list
154160733|NCT00682643|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154160734|NCT00682643|Autonomic Agents|autonomic agents|mesh-ancestor
154160735|NCT00682643|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154160736|NCT00682643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154160737|NCT00682643|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154160739|NCT00682643|Dermatologic Agents|dermatologic agents|mesh-ancestor
154160745|NCT00758381|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154160746|NCT00758381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154160747|NCT00754871|Dienogest|dienogest|mesh-list
154160748|NCT00754871|Nandrolone|nandrolone|mesh-list
154160749|NCT00754871|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
154160750|NCT00754871|Contraceptive Agents|contraceptive agents|mesh-ancestor
154160751|NCT00754871|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154160752|NCT00754871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154160753|NCT00754871|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
154160754|NCT00754871|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
154160755|NCT00754871|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
154160756|NCT00754871|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
154160757|NCT00754871|Hormone Antagonists|hormone antagonists|mesh-ancestor
154160758|NCT00754871|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154160759|NCT00754871|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154160760|NCT00754871|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154160761|NCT00754871|Androgens|androgens|mesh-ancestor
154160762|NCT00754871|Hormones|hormones|mesh-ancestor
154160763|NCT00754871|Anabolic Agents|anabolic agents|mesh-ancestor
154160764|NCT00755027|Rasagiline|rasagiline|mesh-list
154160765|NCT00755027|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
154160766|NCT00755027|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153455613|NCT05660213|Apatinib|apatinib|mesh-list
154160767|NCT00755027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154160768|NCT00755027|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
154160769|NCT00755027|Protective Agents|protective agents|mesh-ancestor
154160770|NCT00755027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154160792|NCT01038388|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154160793|NCT01038388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154160794|NCT04050059|Lidocaine|lidocaine|mesh-list
154160795|NCT04050059|Lidocaine, Prilocaine Drug Combination|lidocaine, prilocaine drug combination|mesh-list
154160796|NCT04050059|Anesthetics, Local|anesthetics, local|mesh-ancestor
154160797|NCT04050059|Anesthetics|anesthetics|mesh-ancestor
154160798|NCT04050059|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154160799|NCT04050059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154160800|NCT04050059|Sensory System Agents|sensory system agents|mesh-ancestor
154160801|NCT04050059|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154160802|NCT04050059|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154160803|NCT04050059|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154160804|NCT04050059|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154160805|NCT04050059|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154160806|NCT04050059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154160807|NCT04050059|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
154160809|NCT00482001|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
153658143|NCT04770272|Paclitaxel|paclitaxel|mesh-list
154160810|NCT00482001|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154160811|NCT00482001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154160812|NCT00482001|Cholinergic Agents|cholinergic agents|mesh-ancestor
154160813|NCT00482001|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154160814|NCT00482001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154160815|NCT00482001|Nootropic Agents|nootropic agents|mesh-ancestor
154160816|NCT00490035|Brivaracetam|brivaracetam|mesh-list
154160817|NCT00490035|Anticonvulsants|anticonvulsants|mesh-ancestor
154160819|NCT00421174|Etanercept|etanercept|mesh-list
154160841|NCT00496197|Antifungal Agents|antifungal agents|mesh-ancestor
154160842|NCT00496197|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154160843|NCT00496197|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
154160844|NCT00496197|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154160845|NCT00496197|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154160846|NCT00496197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154160847|NCT00496197|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154160848|NCT00496197|Hormone Antagonists|hormone antagonists|mesh-ancestor
154160849|NCT00496197|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154160850|NCT00496197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154160851|NCT00496197|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
154160852|NCT00496197|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
154160853|NCT00496197|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154160854|NCT03996993|Bicalutamide|bicalutamide|mesh-list
154160855|NCT03996993|Androgen Antagonists|androgen antagonists|mesh-ancestor
154160856|NCT03996993|Hormone Antagonists|hormone antagonists|mesh-ancestor
154160857|NCT03996993|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154160858|NCT03996993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154160859|NCT03996993|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154160860|NCT01015053|Ropivacaine|ropivacaine|mesh-list
154160861|NCT01015053|Anesthetics, Local|anesthetics, local|mesh-ancestor
154160862|NCT01015053|Anesthetics|anesthetics|mesh-ancestor
154160863|NCT01015053|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154160864|NCT01015053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154160865|NCT01015053|Sensory System Agents|sensory system agents|mesh-ancestor
154160866|NCT01015053|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154160882|NCT00489489|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154160883|NCT00489489|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154160885|NCT00489489|Sensory System Agents|sensory system agents|mesh-ancestor
154160886|NCT00489489|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153658336|NCT04198662|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154160887|NCT00489489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154160888|NCT00489489|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154160889|NCT00489489|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154160890|NCT00489489|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154160891|NCT00489489|Immunologic Factors|immunologic factors|mesh-ancestor
154160892|NCT00489489|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154160893|NCT00489411|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
154160894|NCT00489411|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
154160895|NCT00489411|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154160896|NCT00489411|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154160898|NCT00489411|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154160940|NCT02303392|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154160941|NCT02303392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154160942|NCT00494871|Warfarin|warfarin|mesh-list
154160943|NCT00494871|Rivaroxaban|rivaroxaban|mesh-list
154160944|NCT00494871|Anticoagulants|anticoagulants|mesh-ancestor
154160945|NCT00494871|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
154160946|NCT00494871|Antithrombins|antithrombins|mesh-ancestor
154160947|NCT00494871|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154160948|NCT00494871|Protease Inhibitors|protease inhibitors|mesh-ancestor
154160949|NCT00494871|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154160950|NCT00494871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154160951|NCT00420238|Etanercept|etanercept|mesh-list
154160952|NCT00420238|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154160953|NCT00420238|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154160954|NCT00420238|Analgesics|analgesics|mesh-ancestor
153806313|NCT00420537|Everolimus|everolimus|mesh-list
154160955|NCT00420238|Sensory System Agents|sensory system agents|mesh-ancestor
154160956|NCT00420238|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154160995|NCT01082029|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154160996|NCT01082029|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
154160997|NCT01082029|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154160998|NCT01082029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154160999|NCT00419926|Cyclosporine|cyclosporine|mesh-list
154161000|NCT00419926|Mycophenolic Acid|mycophenolic acid|mesh-list
154161002|NCT00419926|Cyclosporins|cyclosporins|mesh-list
154161003|NCT00419926|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153658403|NCT03909412|Dexamethasone|dexamethasone|mesh-list
154161004|NCT00419926|Glucocorticoids|glucocorticoids|mesh-ancestor
154161005|NCT00419926|Hormones|hormones|mesh-ancestor
154161006|NCT00419926|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154161007|NCT00419926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154161008|NCT00419926|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154161009|NCT00419926|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154161010|NCT00419926|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154161011|NCT00419926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154161012|NCT00419926|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154161013|NCT00419926|Immunologic Factors|immunologic factors|mesh-ancestor
154161014|NCT00419926|Antifungal Agents|antifungal agents|mesh-ancestor
154161015|NCT00419926|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154161016|NCT00419926|Dermatologic Agents|dermatologic agents|mesh-ancestor
154161017|NCT00419926|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154161018|NCT00419926|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
154161019|NCT00419926|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154161020|NCT00419926|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
154161021|NCT00419926|Antitubercular Agents|antitubercular agents|mesh-ancestor
154161022|NCT00419926|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154161023|NCT00080119|Isoniazid|isoniazid|mesh-list
154161024|NCT00080119|Trimethoprim|trimethoprim|mesh-list
153484584|NCT01695330|Bortezomib|bortezomib|mesh-list
154161038|NCT00080119|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154161039|NCT00080119|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154161040|NCT00080119|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
154161041|NCT00080119|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
154161042|NCT00080119|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154161044|NCT01034878|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154161045|NCT01034878|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154161046|NCT01034878|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154161047|NCT01034878|Growth Substances|growth substances|mesh-ancestor
154161048|NCT01034878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154161049|NCT01034878|Growth Inhibitors|growth inhibitors|mesh-ancestor
154161050|NCT01034878|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154161051|NCT01034878|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154161098|NCT00494013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154161099|NCT00494013|Coagulants|coagulants|mesh-ancestor
154161100|NCT00079339|Tipifarnib|tipifarnib|mesh-list
154161101|NCT00079339|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154161102|NCT01088191|Hyaluronic Acid|hyaluronic acid|mesh-list
154161103|NCT01088191|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154161104|NCT01088191|Immunologic Factors|immunologic factors|mesh-ancestor
154161105|NCT01088191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154161106|NCT01088191|Viscosupplements|viscosupplements|mesh-ancestor
154161107|NCT01088191|Protective Agents|protective agents|mesh-ancestor
154161108|NCT01082341|Vaccines|vaccines|mesh-list
154161109|NCT01082341|Immunologic Factors|immunologic factors|mesh-ancestor
154161110|NCT01082341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154161111|NCT00541866|Cytarabine|cytarabine|mesh-list
154161112|NCT00541866|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154161113|NCT00541866|Antimetabolites|antimetabolites|mesh-ancestor
154161114|NCT00541866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154161115|NCT00541866|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154161116|NCT00541866|Antiviral Agents|antiviral agents|mesh-ancestor
154161117|NCT00541866|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154161118|NCT00541866|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154161119|NCT00541866|Immunologic Factors|immunologic factors|mesh-ancestor
154161121|NCT00493467|Rituximab|rituximab|mesh-list
154161151|NCT01017393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154161152|NCT01017393|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
154161153|NCT01017393|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154161154|NCT01017393|Anesthetics, General|anesthetics, general|mesh-ancestor
154161155|NCT01017393|Anesthetics|anesthetics|mesh-ancestor
154161156|NCT01017393|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154161157|NCT01017393|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154161158|NCT01017393|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154161159|NCT01017393|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154161160|NCT01017393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154161161|NCT00493311|Acetaminophen|acetaminophen|mesh-list
154161162|NCT00493311|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154161163|NCT00493311|Analgesics|analgesics|mesh-ancestor
154161164|NCT00493311|Sensory System Agents|sensory system agents|mesh-ancestor
154161165|NCT00493311|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154161166|NCT00493311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154161167|NCT00493311|Antipyretics|antipyretics|mesh-ancestor
154161168|NCT00571649|Enoxaparin|enoxaparin|mesh-list
154161169|NCT00571649|Rivaroxaban|rivaroxaban|mesh-list
154161170|NCT00571649|Enoxaparin sodium|enoxaparin sodium|mesh-list
154161206|NCT05677620|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154161207|NCT05677620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154161208|NCT05677620|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154161209|NCT05677620|Anesthetics, General|anesthetics, general|mesh-ancestor
154161210|NCT05677620|Anesthetics|anesthetics|mesh-ancestor
154161211|NCT00681629|Quetiapine Fumarate|quetiapine fumarate|mesh-list
154161212|NCT00681629|Antidepressive Agents|antidepressive agents|mesh-ancestor
154161213|NCT00681629|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154161214|NCT00681629|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154161215|NCT00681629|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154161216|NCT00681629|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154161217|NCT00681629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154161218|NCT00969176|Acetaminophen|acetaminophen|mesh-list
154161219|NCT00969176|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154161220|NCT00969176|Analgesics|analgesics|mesh-ancestor
154161221|NCT00969176|Sensory System Agents|sensory system agents|mesh-ancestor
154161222|NCT00969176|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153658819|NCT01394640|Vaccines|vaccines|mesh-list
154161223|NCT00969176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154161224|NCT00969176|Antipyretics|antipyretics|mesh-ancestor
154161225|NCT04503252|Cefazolin|cefazolin|mesh-list
154161226|NCT04503252|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154161227|NCT04503252|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154161228|NCT00679367|Dexamethasone|dexamethasone|mesh-list
154161229|NCT00679367|Lenalidomide|lenalidomide|mesh-list
154161230|NCT00679367|Melphalan|melphalan|mesh-list
154161231|NCT00679367|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154161232|NCT00679367|Antiemetics|antiemetics|mesh-ancestor
154161233|NCT00679367|Autonomic Agents|autonomic agents|mesh-ancestor
154161236|NCT00679367|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154161254|NCT00969566|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154161255|NCT00969566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154161256|NCT00969566|Incretins|incretins|mesh-ancestor
154161257|NCT00969566|Hormones|hormones|mesh-ancestor
154161258|NCT00969566|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154161259|NCT00969566|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
154161260|NCT00969566|Protease Inhibitors|protease inhibitors|mesh-ancestor
154161261|NCT00969566|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154161262|NCT00969566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154161263|NCT00755495|Doxepin|doxepin|mesh-list
154161264|NCT00755495|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
154161265|NCT00755495|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154161266|NCT00755495|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154161267|NCT00755495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154161268|NCT00755495|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
154161269|NCT00755495|Antidepressive Agents|antidepressive agents|mesh-ancestor
154161270|NCT00755495|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154161275|NCT00964184|Metformin|metformin|mesh-list
154161310|NCT00974012|Anticonvulsants|anticonvulsants|mesh-ancestor
154161311|NCT00974012|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154161312|NCT00974012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154161313|NCT00974012|GABA Agents|gaba agents|mesh-ancestor
154161314|NCT00974012|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154161315|NCT00974012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154161316|NCT00974012|Antimanic Agents|antimanic agents|mesh-ancestor
154161317|NCT00974012|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154161318|NCT00974012|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154161319|NCT00974012|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154161320|NCT00964574|Insulin|insulin|mesh-list
154161321|NCT00964574|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
154161322|NCT00964574|Insulin Glargine|insulin glargine|mesh-list
154161323|NCT00964574|Insulin glulisine|insulin glulisine|mesh-list
154161324|NCT00964574|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154161325|NCT00964574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154161326|NCT00970580|Paclitaxel|paclitaxel|mesh-list
154161327|NCT00970580|Carboplatin|carboplatin|mesh-list
154161328|NCT00970580|Alkylating Agents|alkylating agents|mesh-list
154161329|NCT00970580|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154161330|NCT00970580|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154161331|NCT00970580|Tubulin Modulators|tubulin modulators|mesh-ancestor
154161332|NCT00970580|Antimitotic Agents|antimitotic agents|mesh-ancestor
154161333|NCT00970580|Mitosis Modulators|mitosis modulators|mesh-ancestor
154161334|NCT00970580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154161335|NCT00974324|Endostar protein|endostar protein|mesh-list
154161336|NCT00974324|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154161337|NCT00974324|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154161338|NCT00974324|Growth Substances|growth substances|mesh-ancestor
154161339|NCT00974324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154161340|NCT00974324|Growth Inhibitors|growth inhibitors|mesh-ancestor
154161341|NCT00974324|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154161342|NCT00545714|Cyclophosphamide|cyclophosphamide|mesh-list
154161343|NCT00545714|Rituximab|rituximab|mesh-list
154161344|NCT00545714|Fludarabine|fludarabine|mesh-list
154161345|NCT00545714|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153671097|NCT04573777|Evolocumab|evolocumab|mesh-list
154161348|NCT00545714|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154161349|NCT00545714|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154161350|NCT00545714|Alkylating Agents|alkylating agents|mesh-ancestor
154161351|NCT00545714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154161352|NCT00545714|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154161353|NCT00545714|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154161354|NCT00545714|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154161355|NCT00964730|Moxifloxacin|moxifloxacin|mesh-list
154161356|NCT00964730|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154161357|NCT00964730|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154161414|NCT00970970|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154161415|NCT00970970|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154161416|NCT00970970|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154161417|NCT00970970|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154161418|NCT00970970|Growth Substances|growth substances|mesh-ancestor
154161419|NCT00970970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154161420|NCT00970970|Growth Inhibitors|growth inhibitors|mesh-ancestor
154161421|NCT00970970|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
154161422|NCT00970970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154161424|NCT03765450|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
154161425|NCT03765450|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154161426|NCT03765450|Dermatologic Agents|dermatologic agents|mesh-ancestor
154161427|NCT03765450|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154161428|NCT03765450|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154161429|NCT00971126|Thalidomide|thalidomide|mesh-list
154161430|NCT00971126|Sorafenib|sorafenib|mesh-list
154161431|NCT00971126|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154161432|NCT00971126|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154161433|NCT00971126|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154161434|NCT00971126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154161435|NCT00971126|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154161436|NCT00971126|Immunologic Factors|immunologic factors|mesh-ancestor
154161437|NCT00971126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154161438|NCT00971126|Leprostatic Agents|leprostatic agents|mesh-ancestor
154161439|NCT00971126|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154161440|NCT00971126|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154161441|NCT00971126|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154161442|NCT00971126|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154161443|NCT00971126|Growth Substances|growth substances|mesh-ancestor
154161444|NCT00971126|Growth Inhibitors|growth inhibitors|mesh-ancestor
154161445|NCT00964964|Insulin|insulin|mesh-list
154161446|NCT00964964|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
154161447|NCT00964964|Insulin, Long-Acting|insulin, long-acting|mesh-list
154161448|NCT00964964|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154161449|NCT00964964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154161452|NCT00965042|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154161453|NCT00965042|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154161454|NCT00974792|Leucovorin|leucovorin|mesh-list
154161455|NCT00974792|Cytarabine|cytarabine|mesh-list
154161456|NCT00974792|Cyclophosphamide|cyclophosphamide|mesh-list
154161457|NCT00974792|Ifosfamide|ifosfamide|mesh-list
154161458|NCT00974792|Rituximab|rituximab|mesh-list
154161459|NCT00974792|Doxorubicin|doxorubicin|mesh-list
154161460|NCT00974792|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
154161461|NCT00974792|Methotrexate|methotrexate|mesh-list
154161462|NCT00974792|Etoposide|etoposide|mesh-list
154161463|NCT00974792|Vincristine|vincristine|mesh-list
154161464|NCT00974792|Etoposide phosphate|etoposide phosphate|mesh-list
154161465|NCT00974792|Levoleucovorin|levoleucovorin|mesh-list
154161466|NCT00974792|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154161467|NCT00974792|Immunologic Factors|immunologic factors|mesh-ancestor
154161468|NCT00974792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154161469|NCT00974792|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154161491|NCT00974792|Antidotes|antidotes|mesh-ancestor
154161514|NCT00679211|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
154161515|NCT00679211|Maytansine|maytansine|mesh-list
154161516|NCT00679211|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154161517|NCT00679211|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154161518|NCT00679211|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154161519|NCT00679211|Tubulin Modulators|tubulin modulators|mesh-ancestor
154161520|NCT00679211|Antimitotic Agents|antimitotic agents|mesh-ancestor
154161521|NCT00679211|Mitosis Modulators|mitosis modulators|mesh-ancestor
154161522|NCT00679211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154161523|NCT00679211|Immunotoxins|immunotoxins|mesh-ancestor
154161524|NCT00679211|Immunoconjugates|immunoconjugates|mesh-ancestor
154161525|NCT00679211|Immunologic Factors|immunologic factors|mesh-ancestor
154161526|NCT00679211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154161527|NCT00545948|Cisplatin|cisplatin|mesh-list
154161528|NCT00545948|Pemetrexed|pemetrexed|mesh-list
154161529|NCT00545948|Vinorelbine|vinorelbine|mesh-list
154161573|NCT05271071|Anesthetics|anesthetics|mesh-ancestor
154161574|NCT05271071|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154161575|NCT05271071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154161576|NCT05271071|Sensory System Agents|sensory system agents|mesh-ancestor
154161577|NCT05271071|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154161578|NCT05271071|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154161579|NCT05271071|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154161580|NCT05271071|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154161581|NCT05271071|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154161582|NCT05271071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154161583|NCT00972140|Formoterol Fumarate|formoterol fumarate|mesh-list
154161584|NCT00972140|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154161585|NCT00972140|Autonomic Agents|autonomic agents|mesh-ancestor
154161586|NCT00972140|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154161587|NCT00972140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154161588|NCT00972140|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154161589|NCT00972140|Respiratory System Agents|respiratory system agents|mesh-ancestor
154161590|NCT00972140|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
154161591|NCT00972140|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154161592|NCT00972140|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154161593|NCT00972140|Adrenergic Agents|adrenergic agents|mesh-ancestor
154161594|NCT00972140|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154161595|NCT00972140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154161596|NCT00972218|Adalimumab|adalimumab|mesh-list
154161597|NCT00972218|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
154161598|NCT00972218|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154161599|NCT00972218|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154161600|NCT05230901|Dihydralazine|dihydralazine|mesh-list
154161601|NCT05230901|Spironolactone|spironolactone|mesh-list
154161615|NCT03927950|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
154161616|NCT03927950|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154161617|NCT03927950|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154161618|NCT03927950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154161619|NCT03927950|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154161621|NCT03927950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154161622|NCT03927950|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
154161623|NCT03927950|Antidepressive Agents|antidepressive agents|mesh-ancestor
154161624|NCT03927950|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154161625|NCT03927950|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
154161626|NCT03927950|Dopamine Agents|dopamine agents|mesh-ancestor
154161627|NCT03927950|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
154161628|NCT03927950|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154161629|NCT03927950|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154161630|NCT00972842|Lenalidomide|lenalidomide|mesh-list
154161631|NCT00972842|Vorinostat|vorinostat|mesh-list
154161632|NCT00972842|Immunologic Factors|immunologic factors|mesh-ancestor
154161633|NCT00972842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154161649|NCT00975572|Vaccines|vaccines|mesh-list
154161668|NCT04049747|Bicalutamide|bicalutamide|mesh-list
154161669|NCT04049747|Finasteride|finasteride|mesh-list
154161670|NCT04049747|Androgen Antagonists|androgen antagonists|mesh-ancestor
154161671|NCT04049747|Hormone Antagonists|hormone antagonists|mesh-ancestor
154161672|NCT04049747|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154161673|NCT04049747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154161674|NCT04049747|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154161675|NCT04049747|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
154161676|NCT04049747|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154161677|NCT04049747|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154161678|NCT04049747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154161679|NCT04049747|Urological Agents|urological agents|mesh-ancestor
154161680|NCT00973154|Prednisone|prednisone|mesh-list
154161681|NCT00973154|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154161682|NCT00973154|Glucocorticoids|glucocorticoids|mesh-ancestor
154161683|NCT00973154|Hormones|hormones|mesh-ancestor
154161684|NCT00973154|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154161685|NCT00973154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154161686|NCT00973154|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154161687|NCT00973154|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154161688|NCT00965900|Propranolol|propranolol|mesh-list
154161689|NCT00965900|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
154161690|NCT00965900|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154161691|NCT00965900|Adrenergic Agents|adrenergic agents|mesh-ancestor
154161692|NCT00965900|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154161693|NCT00965900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154161694|NCT00965900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154161695|NCT00965900|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154161696|NCT00965900|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154161697|NCT00965900|Vasodilator Agents|vasodilator agents|mesh-ancestor
154161698|NCT00973232|Acetaminophen|acetaminophen|mesh-list
154161708|NCT00973232|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154161709|NCT00973310|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
154161710|NCT00973310|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154161711|NCT00973310|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154161712|NCT00973310|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154161713|NCT00973310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154161714|NCT00973310|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154161715|NCT00973388|Moxifloxacin|moxifloxacin|mesh-list
154161716|NCT00973388|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154161717|NCT00973388|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154161718|NCT00973388|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154161719|NCT00973388|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154161720|NCT00973388|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154161721|NCT00973388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154161722|NCT00973388|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154161723|NCT00975962|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
154161724|NCT00975962|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153658985|NCT04917900|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154161764|NCT00979862|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154161765|NCT00966290|Warfarin|warfarin|mesh-list
154161766|NCT00966290|Anticoagulants|anticoagulants|mesh-list
154161767|NCT00966290|Acenocoumarol|acenocoumarol|mesh-list
154161768|NCT00966290|Fluindione|fluindione|mesh-list
154161769|NCT00966290|Phenindione|phenindione|mesh-list
154161770|NCT00966368|Insulin|insulin|mesh-list
154161771|NCT00966368|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
154161772|NCT00966368|Insulin, Long-Acting|insulin, long-acting|mesh-list
154161773|NCT00966368|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154161774|NCT00966368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154161775|NCT00980408|Cycloserine|cycloserine|mesh-list
154161776|NCT00980408|Memantine|memantine|mesh-list
154161777|NCT00980408|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
154161778|NCT00980408|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
154161779|NCT00980408|Dopamine Agents|dopamine agents|mesh-ancestor
154161780|NCT00980408|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154161781|NCT00980408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153542088|NCT01549418|Aspirin|aspirin|mesh-list
154161782|NCT00980408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154161783|NCT00980408|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154161784|NCT00980408|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154161785|NCT00980408|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
154161786|NCT00980408|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154161787|NCT00980408|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
154161788|NCT00980408|Antitubercular Agents|antitubercular agents|mesh-ancestor
154161789|NCT00980408|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154161790|NCT00980408|Antimetabolites|antimetabolites|mesh-ancestor
154161791|NCT00980876|Ciprofloxacin|ciprofloxacin|mesh-list
154161792|NCT00980876|Hydrocortisone|hydrocortisone|mesh-list
154161793|NCT00980876|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154161803|NCT00989898|Insulin|insulin|mesh-list
154161810|NCT00990054|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154161811|NCT05361408|Zoledronic Acid|zoledronic acid|mesh-list
154161812|NCT05361408|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154161813|NCT05361408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154161814|NCT05590572|Etoposide|etoposide|mesh-list
154161815|NCT05590572|Ifosfamide|ifosfamide|mesh-list
154161816|NCT05590572|Isophosphamide mustard|isophosphamide mustard|mesh-list
154161817|NCT05590572|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154161818|NCT05590572|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154161819|NCT05590572|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154161820|NCT05590572|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153659032|NCT00062062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154161821|NCT05590572|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154161822|NCT05590572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154161823|NCT05590572|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154161824|NCT05590572|Alkylating Agents|alkylating agents|mesh-ancestor
154161825|NCT00990444|Insulin|insulin|mesh-list
154161826|NCT00990444|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
154161827|NCT00990444|Dextrans|dextrans|mesh-list
154161828|NCT00990444|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154161829|NCT00990444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154161830|NCT00990444|Anticoagulants|anticoagulants|mesh-ancestor
154161831|NCT00990444|Plasma Substitutes|plasma substitutes|mesh-ancestor
154161832|NCT00990444|Blood Substitutes|blood substitutes|mesh-ancestor
154161833|NCT00990600|Tenofovir|tenofovir|mesh-list
154161834|NCT00990600|Emtricitabine|emtricitabine|mesh-list
154161835|NCT00990600|Efavirenz|efavirenz|mesh-list
154161836|NCT00990600|Antiviral Agents|antiviral agents|mesh-ancestor
154161837|NCT00990600|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154161858|NCT02897076|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154161859|NCT02897076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154161860|NCT02897076|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154161861|NCT02897076|Respiratory System Agents|respiratory system agents|mesh-ancestor
154161862|NCT00990678|Vitamin D|vitamin d|mesh-list
154161863|NCT00990678|Calcitriol|calcitriol|mesh-list
154161864|NCT00990678|Calcium|calcium|mesh-list
154161865|NCT00990678|Vitamins|vitamins|mesh-ancestor
154161866|NCT00990678|Micronutrients|micronutrients|mesh-ancestor
154161867|NCT00990678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154161868|NCT00990678|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154161869|NCT00990678|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154161870|NCT00990678|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
154161871|NCT00990678|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154161872|NCT00990678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154161917|NCT00989352|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154161918|NCT00989352|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154161919|NCT00989352|Antimetabolites|antimetabolites|mesh-ancestor
154161920|NCT00989352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154161921|NCT00989352|Dermatologic Agents|dermatologic agents|mesh-ancestor
154161922|NCT00989352|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154161923|NCT00989352|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154161924|NCT00989352|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154161925|NCT00989352|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154161926|NCT00989352|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154161981|NCT01589419|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154161982|NCT01589419|Antimetabolites|antimetabolites|mesh-ancestor
154161983|NCT01589419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154161984|NCT01589419|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154161985|NCT01589419|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
154161986|NCT01589419|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154161987|NCT00676403|Pregabalin|pregabalin|mesh-list
154161988|NCT00676403|Analgesics|analgesics|mesh-ancestor
154161989|NCT00676403|Sensory System Agents|sensory system agents|mesh-ancestor
154161990|NCT00676403|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154161991|NCT00676403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154161992|NCT00676403|Anticonvulsants|anticonvulsants|mesh-ancestor
154161993|NCT00676403|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154161994|NCT00676403|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154161995|NCT00676403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154161996|NCT00676403|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154161997|NCT00676403|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154161998|NCT00676403|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154161999|NCT00676403|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154162000|NCT00676403|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154162001|NCT00078325|Modafinil|modafinil|mesh-list
154162002|NCT00078325|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
154162003|NCT00078325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154162004|NCT00078325|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
154162005|NCT00078325|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
154162006|NCT00078325|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
154162007|NCT00078325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154162009|NCT03963193|Irinotecan|irinotecan|mesh-list
154162010|NCT03963193|Etoposide|etoposide|mesh-list
153814467|NCT00452166|Rosiglitazone|rosiglitazone|mesh-list
153814469|NCT00452166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154162011|NCT03963193|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154162012|NCT03963193|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
154162013|NCT03963193|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154162021|NCT03961867|Tubulin Modulators|tubulin modulators|mesh-ancestor
154162022|NCT03961867|Antimitotic Agents|antimitotic agents|mesh-ancestor
154162023|NCT03961867|Mitosis Modulators|mitosis modulators|mesh-ancestor
154162024|NCT03961867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154162026|NCT00077857|Capecitabine|capecitabine|mesh-list
154162027|NCT00077857|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154162028|NCT00077857|Tubulin Modulators|tubulin modulators|mesh-ancestor
154162029|NCT00077857|Antimitotic Agents|antimitotic agents|mesh-ancestor
154162030|NCT00077857|Mitosis Modulators|mitosis modulators|mesh-ancestor
154162031|NCT00077857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154162032|NCT00077857|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154162033|NCT00077857|Antimetabolites|antimetabolites|mesh-ancestor
154162034|NCT00545402|Mycophenolic Acid|mycophenolic acid|mesh-list
154162035|NCT00545402|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
154162036|NCT00545402|Tacrolimus|tacrolimus|mesh-list
154162037|NCT00545402|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154162038|NCT00545402|Immunologic Factors|immunologic factors|mesh-ancestor
154162039|NCT00545402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154162040|NCT00545402|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
154162041|NCT00545402|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154162042|NCT00545402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154162043|NCT00545402|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154162044|NCT00545402|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154162045|NCT00545402|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
154162046|NCT00545402|Antitubercular Agents|antitubercular agents|mesh-ancestor
154162047|NCT00545402|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154162067|NCT03963115|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154162068|NCT03963115|Respiratory System Agents|respiratory system agents|mesh-ancestor
154162070|NCT03963115|Sympathomimetics|sympathomimetics|mesh-ancestor
154162071|NCT03963115|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154162072|NCT01583023|Bupropion|bupropion|mesh-list
154162073|NCT01583023|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
154162074|NCT01583023|Antidepressive Agents|antidepressive agents|mesh-ancestor
153659093|NCT00062179|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154162075|NCT01583023|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154162076|NCT01583023|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
154162077|NCT01583023|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153485635|NCT05644223|Antioxidants|antioxidants|mesh-ancestor
154162078|NCT01583023|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154162079|NCT01583023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154162080|NCT01583023|Dopamine Agents|dopamine agents|mesh-ancestor
154162081|NCT01583023|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154162082|NCT01583023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154162124|NCT00977288|Atorvastatin|atorvastatin|mesh-list
154162125|NCT00977288|Anacetrapib|anacetrapib|mesh-list
154162126|NCT00977288|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154162127|NCT00977288|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154162128|NCT00977288|Antimetabolites|antimetabolites|mesh-ancestor
154162129|NCT00977288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154162130|NCT00977288|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154162131|NCT00977288|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154162132|NCT00977288|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154162133|NCT00966602|Ivacaftor|ivacaftor|mesh-list
154162134|NCT00966602|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
154162135|NCT00966602|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154162136|NCT00966602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154162137|NCT00966680|Anesthetics|anesthetics|mesh-list
154162185|NCT00967070|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
154162186|NCT00967070|Cholinergic Agents|cholinergic agents|mesh-ancestor
154162187|NCT00967070|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154162188|NCT00967070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154162189|NCT00977756|Ritonavir|ritonavir|mesh-list
154162190|NCT00977756|Lopinavir|lopinavir|mesh-list
154162191|NCT00977756|Atazanavir Sulfate|atazanavir sulfate|mesh-list
154162192|NCT00977756|Darunavir|darunavir|mesh-list
154162193|NCT00977756|Tenofovir|tenofovir|mesh-list
154162194|NCT00977756|Raltegravir Potassium|raltegravir potassium|mesh-list
154162195|NCT00977756|Maraviroc|maraviroc|mesh-list
154162196|NCT00977756|Etravirine|etravirine|mesh-list
154162197|NCT00977756|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
154162198|NCT00977756|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
154162199|NCT00977756|Protease Inhibitors|protease inhibitors|mesh-ancestor
154162200|NCT00977756|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154162201|NCT00977756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154162202|NCT00977756|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154162203|NCT00977756|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154162204|NCT00977756|Antiviral Agents|antiviral agents|mesh-ancestor
154162205|NCT00977756|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154162240|NCT00967382|Dalteparin|dalteparin|mesh-list
154162241|NCT00967382|Tinzaparin|tinzaparin|mesh-list
154162242|NCT00967382|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
154162243|NCT00967382|Anticoagulants|anticoagulants|mesh-ancestor
153659163|NCT00063310|Fertility Agents|fertility agents|mesh-ancestor
153659164|NCT00063310|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154162244|NCT00967382|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154162245|NCT00967382|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154162246|NCT00967382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154162247|NCT00982124|Zoledronic Acid|zoledronic acid|mesh-list
153659199|NCT00064090|Cytarabine|cytarabine|mesh-list
154162248|NCT00982124|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154162249|NCT00982124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154162250|NCT00982202|Pioglitazone|pioglitazone|mesh-list
154162251|NCT00982202|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154162252|NCT00982202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154162253|NCT00967538|Etanercept|etanercept|mesh-list
154162254|NCT00967538|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154162255|NCT00967538|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154162256|NCT00967538|Analgesics|analgesics|mesh-ancestor
154162257|NCT00967538|Sensory System Agents|sensory system agents|mesh-ancestor
154162258|NCT00967538|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154162259|NCT00967538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154162294|NCT00544544|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154162295|NCT00544544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154162296|NCT00544544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154162297|NCT00544544|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
154162298|NCT00544544|Protective Agents|protective agents|mesh-ancestor
154162299|NCT00979160|Dasatinib|dasatinib|mesh-list
154162300|NCT00979160|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154162301|NCT00979160|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154162302|NCT00979160|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154162303|NCT00979160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154162304|NCT00979160|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154162305|NCT00979316|Moxifloxacin|moxifloxacin|mesh-list
154162307|NCT00979316|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154162308|NCT00979316|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154162309|NCT00979316|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154162310|NCT00979316|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154162312|NCT00979316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154162313|NCT00979316|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154162314|NCT00979316|Gamma Secretase Inhibitors and Modulators|gamma secretase inhibitors and modulators|mesh-ancestor
154162315|NCT00983450|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
154162316|NCT00983450|Melanocyte-Stimulating Hormones|melanocyte-stimulating hormones|mesh-list
154162317|NCT00983450|beta-Endorphin|beta-endorphin|mesh-list
154162318|NCT00983450|Hormones|hormones|mesh-ancestor
153659204|NCT00064090|Antiviral Agents|antiviral agents|mesh-ancestor
154162319|NCT00983450|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154162320|NCT00983450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154162321|NCT00983450|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154162322|NCT00983450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154162323|NCT00983996|Alendronate|alendronate|mesh-list
154162324|NCT00983996|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154162325|NCT00983996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154162326|NCT00985244|Azithromycin|azithromycin|mesh-list
154162327|NCT00985244|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154162328|NCT00985244|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154162329|NCT00979472|Solifenacin Succinate|solifenacin succinate|mesh-list
153646516|NCT00115609|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
153646517|NCT00115609|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153646772|NCT00117052|Hormone Antagonists|hormone antagonists|mesh-ancestor
154162330|NCT00979472|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
154162331|NCT00979472|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154162332|NCT00979472|Cholinergic Agents|cholinergic agents|mesh-ancestor
154162333|NCT00979472|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154162334|NCT00979472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154162335|NCT00979472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154162336|NCT00979472|Urological Agents|urological agents|mesh-ancestor
154162337|NCT00984152|Efavirenz|efavirenz|mesh-list
154162338|NCT00984152|Efavirenz, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|efavirenz, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
154162339|NCT00984152|Raltegravir Potassium|raltegravir potassium|mesh-list
154162340|NCT00984152|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
154162341|NCT00984152|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154162342|NCT00984152|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154162343|NCT00984152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154162344|NCT00984152|Antiviral Agents|antiviral agents|mesh-ancestor
154162345|NCT00984152|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154162346|NCT00984152|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
154162347|NCT00984152|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154162348|NCT00984152|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
154162349|NCT00984152|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
154162352|NCT00984152|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154162379|NCT00984464|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154162380|NCT00984464|Tubulin Modulators|tubulin modulators|mesh-ancestor
154162381|NCT00984464|Antimitotic Agents|antimitotic agents|mesh-ancestor
154162382|NCT00984464|Mitosis Modulators|mitosis modulators|mesh-ancestor
154162383|NCT00984464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154162385|NCT00985556|Tegafur|tegafur|mesh-list
154162386|NCT00985556|Oxaliplatin|oxaliplatin|mesh-list
154162387|NCT00985556|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154162388|NCT00985556|Antimetabolites|antimetabolites|mesh-ancestor
154162389|NCT00985556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154162390|NCT00985556|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154162391|NCT04445246|Iloprost|iloprost|mesh-list
154162392|NCT04445246|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154162393|NCT04445246|Vasodilator Agents|vasodilator agents|mesh-ancestor
154162394|NCT00541346|Methylphenidate|methylphenidate|mesh-list
154162395|NCT00541346|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
154162396|NCT00541346|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154162397|NCT00541346|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
154162398|NCT00541346|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154162399|NCT00541346|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153455614|NCT05660213|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154162400|NCT00541346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154162401|NCT00541346|Dopamine Agents|dopamine agents|mesh-ancestor
154162402|NCT00541346|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154162430|NCT00541034|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154162431|NCT00541034|Immunologic Factors|immunologic factors|mesh-ancestor
154162432|NCT00541034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154162433|NCT00541034|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154162434|NCT00541034|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154162435|NCT00541034|Alkylating Agents|alkylating agents|mesh-ancestor
154162436|NCT00541034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154162437|NCT00541034|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154162438|NCT00541034|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154162439|NCT00541034|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154162440|NCT00541034|Adenosine Deaminase Inhibitors|adenosine deaminase inhibitors|mesh-ancestor
154162441|NCT00541034|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154162442|NCT00540644|Prednisone|prednisone|mesh-list
154162443|NCT00540644|Cyclophosphamide|cyclophosphamide|mesh-list
154162444|NCT00540644|Lenalidomide|lenalidomide|mesh-list
154162445|NCT00540644|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154162446|NCT00540644|Immunologic Factors|immunologic factors|mesh-ancestor
154162447|NCT00540644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154162448|NCT00540644|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154162449|NCT00540644|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154162451|NCT00540644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154162452|NCT00540644|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154162453|NCT00540644|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154162454|NCT00540644|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154162455|NCT00540644|Glucocorticoids|glucocorticoids|mesh-ancestor
154162456|NCT00540644|Hormones|hormones|mesh-ancestor
154162457|NCT00540644|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154162458|NCT00540644|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154162459|NCT00540644|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154162461|NCT00540644|Growth Substances|growth substances|mesh-ancestor
154162474|NCT00988910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154162475|NCT00988910|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
154162476|NCT00986336|Topiramate|topiramate|mesh-list
154162477|NCT00986336|Risperidone|risperidone|mesh-list
154162478|NCT00986336|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154162479|NCT00986336|Serotonin Agents|serotonin agents|mesh-ancestor
154162480|NCT00986336|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154162481|NCT00986336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154162482|NCT00986336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154162483|NCT00986336|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154162484|NCT00986336|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154162485|NCT00986336|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154162486|NCT00986336|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154162487|NCT00986336|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
154162488|NCT00986336|Dopamine Agents|dopamine agents|mesh-ancestor
154162489|NCT00986336|Anticonvulsants|anticonvulsants|mesh-ancestor
154162490|NCT00986336|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154162491|NCT00989300|Omeprazole|omeprazole|mesh-list
154162492|NCT00989300|Rabeprazole|rabeprazole|mesh-list
154162493|NCT00989300|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154162494|NCT00989300|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154162495|NCT00989300|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
154162496|NCT00989300|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154162497|NCT00989300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154162498|NCT01563614|Cytarabine|cytarabine|mesh-list
154162499|NCT01563614|Lomustine|lomustine|mesh-list
154162500|NCT01563614|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154162501|NCT01563614|Antimetabolites|antimetabolites|mesh-ancestor
153659347|NCT00066157|Hormones|hormones|mesh-ancestor
154162502|NCT01563614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154162503|NCT01563614|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154162504|NCT01563614|Antiviral Agents|antiviral agents|mesh-ancestor
154162505|NCT01563614|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154162506|NCT01563614|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154162507|NCT01563614|Immunologic Factors|immunologic factors|mesh-ancestor
154162508|NCT01563614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154162513|NCT00543296|Glucocorticoids|glucocorticoids|mesh-ancestor
154162514|NCT00543296|Hormones|hormones|mesh-ancestor
154162515|NCT00543296|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154162516|NCT00543296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154162517|NCT00543062|Moxifloxacin|moxifloxacin|mesh-list
154162518|NCT00543062|Prochlorperazine|prochlorperazine|mesh-list
154162519|NCT00543062|Loxapine|loxapine|mesh-list
154162520|NCT00543062|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154162521|NCT00543062|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154162522|NCT00543062|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153542829|NCT01554930|Mannitol|mannitol|mesh-list
154162523|NCT00543062|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154162524|NCT00543062|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154162525|NCT00543062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154162526|NCT00543062|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154162527|NCT00543062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154162528|NCT00543062|Antiemetics|antiemetics|mesh-ancestor
154162529|NCT00543062|Autonomic Agents|autonomic agents|mesh-ancestor
154162530|NCT00543062|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154162531|NCT00543062|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154162532|NCT00543062|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154162533|NCT00543062|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154162534|NCT00543062|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154162535|NCT00543062|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154162536|NCT00543062|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
154162537|NCT00543062|Dopamine Agents|dopamine agents|mesh-ancestor
154162538|NCT00543062|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154162539|NCT00986804|Decitabine|decitabine|mesh-list
154162540|NCT00986804|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154162541|NCT00986804|Antimetabolites|antimetabolites|mesh-ancestor
154162542|NCT00986804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154162543|NCT00986804|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154162544|NCT00986804|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154162545|NCT00676091|Vaccines|vaccines|mesh-list
154162546|NCT00676091|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
154162547|NCT00676091|Immunologic Factors|immunologic factors|mesh-ancestor
154162552|NCT02558933|Protective Agents|protective agents|mesh-ancestor
154162553|NCT02558933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154162554|NCT02558933|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
154162555|NCT02558933|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
154162556|NCT02558933|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154162557|NCT02558933|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
154162558|NCT00678041|Nitrofurantoin|nitrofurantoin|mesh-list
154162559|NCT00678041|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
154162560|NCT00678041|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154162561|NCT00678041|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154162562|NCT03903822|PF-06700841|pf-06700841|mesh-list
154162563|NCT03903822|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154162564|NCT03903822|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154162565|NCT03903822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154162566|NCT04003350|Acetaminophen|acetaminophen|mesh-list
154162567|NCT04003350|Meloxicam|meloxicam|mesh-list
154162568|NCT04003350|Oxycodone|oxycodone|mesh-list
154162569|NCT04003350|Tramadol|tramadol|mesh-list
154162570|NCT04003350|Gabapentin|gabapentin|mesh-list
154162571|NCT04003350|Esomeprazole|esomeprazole|mesh-list
154162572|NCT04003350|Metaxalone|metaxalone|mesh-list
153659687|NCT00069550|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154162573|NCT04003350|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154162574|NCT04003350|Narcotics|narcotics|mesh-ancestor
154162575|NCT04003350|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154162576|NCT04003350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154162577|NCT04003350|Analgesics|analgesics|mesh-ancestor
154162578|NCT04003350|Sensory System Agents|sensory system agents|mesh-ancestor
154162579|NCT04003350|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154162580|NCT04003350|Anticonvulsants|anticonvulsants|mesh-ancestor
154162581|NCT04003350|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154162582|NCT04003350|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154162583|NCT04003350|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154162584|NCT04003350|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154162596|NCT04003350|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154162597|NCT04003350|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154162598|NCT04003350|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
154162599|NCT04003350|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153486156|NCT03777813|Leucovorin|leucovorin|mesh-list
154162600|NCT04003350|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
154162601|NCT00748007|Rivastigmine|rivastigmine|mesh-list
154162602|NCT00748007|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-list
154162603|NCT00748007|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154162604|NCT00748007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154162605|NCT00748007|Cholinergic Agents|cholinergic agents|mesh-ancestor
154162606|NCT00748007|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154162607|NCT00748007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154162608|NCT00748007|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
154162609|NCT00748007|Protective Agents|protective agents|mesh-ancestor
154162611|NCT00748163|Sunitinib|sunitinib|mesh-list
154162612|NCT00748163|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
154162613|NCT00748163|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154162614|NCT00748163|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154162615|NCT00748163|Tubulin Modulators|tubulin modulators|mesh-ancestor
154162616|NCT00748163|Antimitotic Agents|antimitotic agents|mesh-ancestor
154162617|NCT00748163|Mitosis Modulators|mitosis modulators|mesh-ancestor
154162648|NCT00485693|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154162649|NCT00485693|Respiratory System Agents|respiratory system agents|mesh-ancestor
154162650|NCT00485693|Mydriatics|mydriatics|mesh-ancestor
154162651|NCT00485693|Sympathomimetics|sympathomimetics|mesh-ancestor
154162652|NCT00485693|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154162653|NCT00538902|Adalimumab|adalimumab|mesh-list
154162654|NCT00538902|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
154162655|NCT00538902|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154162656|NCT00538902|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154162657|NCT00541970|Vaccines|vaccines|mesh-list
154162658|NCT00541970|Immunologic Factors|immunologic factors|mesh-ancestor
154162659|NCT00541970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154162660|NCT00687323|Temozolomide|temozolomide|mesh-list
154162661|NCT00687323|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154162662|NCT00687323|Alkylating Agents|alkylating agents|mesh-ancestor
154162663|NCT00687323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154162664|NCT00687323|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154162665|NCT00989742|Doxycycline|doxycycline|mesh-list
154162666|NCT00989742|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154162667|NCT00989742|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154162668|NCT00989742|Antimalarials|antimalarials|mesh-ancestor
154162669|NCT00989742|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154162670|NCT00989742|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154162671|NCT05408208|Triamcinolone|triamcinolone|mesh-list
154162672|NCT05408208|Methotrexate|methotrexate|mesh-list
154162673|NCT05408208|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154162674|NCT05408208|Abortifacient Agents|abortifacient agents|mesh-ancestor
154162697|NCT00758693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154162698|NCT00758693|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154162699|NCT00758693|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154162700|NCT00758693|Alkylating Agents|alkylating agents|mesh-ancestor
154162701|NCT00758693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154162702|NCT00989820|Coal Tar|coal tar|mesh-list
154162703|NCT00989820|Keratolytic Agents|keratolytic agents|mesh-ancestor
154162704|NCT00989820|Dermatologic Agents|dermatologic agents|mesh-ancestor
154162705|NCT05357820|Itraconazole|itraconazole|mesh-list
154162706|NCT05357820|Rifampin|rifampin|mesh-list
154162707|NCT05357820|Antifungal Agents|antifungal agents|mesh-ancestor
154162708|NCT05357820|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154162761|NCT04360070|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154162762|NCT04360070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154162763|NCT04360070|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
154162764|NCT04360070|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154162765|NCT04360070|Anesthetics, General|anesthetics, general|mesh-ancestor
154162766|NCT04360070|Anesthetics|anesthetics|mesh-ancestor
154162767|NCT04360070|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154162768|NCT04360070|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154162769|NCT04360070|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154162770|NCT04360070|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154162771|NCT04360070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154162772|NCT00748943|Chlorine dioxide|chlorine dioxide|mesh-list
154162773|NCT00748943|Dental Disinfectants|dental disinfectants|mesh-ancestor
154162774|NCT00748943|Disinfectants|disinfectants|mesh-ancestor
154162775|NCT00748943|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154162776|NCT00749021|Ranibizumab|ranibizumab|mesh-list
154162777|NCT00749021|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154162778|NCT00749021|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154162779|NCT00749021|Growth Substances|growth substances|mesh-ancestor
154162780|NCT00749021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154162781|NCT00749021|Growth Inhibitors|growth inhibitors|mesh-ancestor
154162782|NCT00749021|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154162783|NCT04048889|Ropivacaine|ropivacaine|mesh-list
154162784|NCT04048889|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
154162785|NCT04048889|Anesthetics, Local|anesthetics, local|mesh-ancestor
154162786|NCT04048889|Anesthetics|anesthetics|mesh-ancestor
154162787|NCT04048889|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154162788|NCT04048889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154162789|NCT04048889|Sensory System Agents|sensory system agents|mesh-ancestor
154162790|NCT04048889|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154162791|NCT00987038|Midazolam|midazolam|mesh-list
154162792|NCT00987038|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154162793|NCT00987038|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154162802|NCT00987038|GABA Modulators|gaba modulators|mesh-ancestor
154162803|NCT00987038|GABA Agents|gaba agents|mesh-ancestor
154162804|NCT00987038|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154162805|NCT00987038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154162806|NCT05711810|Ubiquinone|ubiquinone|mesh-list
154162807|NCT05711810|Coenzyme Q10|coenzyme q10|mesh-list
154162808|NCT05711810|Tocopherols|tocopherols|mesh-list
154162809|NCT05711810|Vitamin E|vitamin e|mesh-list
154162810|NCT05711810|alpha-Tocopherol|alpha-tocopherol|mesh-list
154162811|NCT05711810|Metoprolol|metoprolol|mesh-list
154162812|NCT05711810|Enalapril|enalapril|mesh-list
154162813|NCT05711810|Enalaprilat|enalaprilat|mesh-list
154162814|NCT05711810|Nifedipine|nifedipine|mesh-list
154162815|NCT05711810|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
154162816|NCT05711810|Lansoprazole|lansoprazole|mesh-list
154162817|NCT05711810|Superoxide Dismutase|superoxide dismutase|mesh-list
154162818|NCT05711810|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
154162819|NCT05711810|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154162820|NCT05711810|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154162821|NCT05711810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154162822|NCT05711810|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154162823|NCT05711810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154162824|NCT05711810|Analgesics|analgesics|mesh-ancestor
154162825|NCT05711810|Sensory System Agents|sensory system agents|mesh-ancestor
153543128|NCT05847049|Diuretics|diuretics|mesh-ancestor
154162826|NCT05711810|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154162827|NCT05711810|Antidepressive Agents|antidepressive agents|mesh-ancestor
154162828|NCT05711810|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154162829|NCT05711810|Dopamine Agents|dopamine agents|mesh-ancestor
154162830|NCT05711810|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154162831|NCT05711810|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154162847|NCT05711810|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
154162848|NCT05711810|Protease Inhibitors|protease inhibitors|mesh-ancestor
154162849|NCT05711810|Micronutrients|micronutrients|mesh-ancestor
154162850|NCT05711810|Vitamins|vitamins|mesh-ancestor
154162851|NCT05711810|Antioxidants|antioxidants|mesh-ancestor
154162852|NCT05711810|Protective Agents|protective agents|mesh-ancestor
154162853|NCT05711810|Free Radical Scavengers|free radical scavengers|mesh-ancestor
154162854|NCT00759083|Bivalirudin|bivalirudin|mesh-list
154162855|NCT00759083|Antithrombins|antithrombins|mesh-ancestor
154162856|NCT00759083|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154162857|NCT00759083|Protease Inhibitors|protease inhibitors|mesh-ancestor
154162858|NCT00759083|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154162859|NCT00759083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154162860|NCT00759083|Anticoagulants|anticoagulants|mesh-ancestor
154162861|NCT00759239|Timolol|timolol|mesh-list
154162862|NCT00759239|Travoprost|travoprost|mesh-list
154162863|NCT00759239|Maleic acid|maleic acid|mesh-list
154162864|NCT00759239|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154162865|NCT00759239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154162866|NCT00759239|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
154162867|NCT00759239|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154162868|NCT00759239|Adrenergic Agents|adrenergic agents|mesh-ancestor
154162869|NCT00759239|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154162870|NCT00759239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154162871|NCT00759239|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154162872|NCT00759239|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154162873|NCT03742908|Clindamycin|clindamycin|mesh-list
154162874|NCT03742908|Clindamycin palmitate|clindamycin palmitate|mesh-list
154162875|NCT03742908|Clindamycin phosphate|clindamycin phosphate|mesh-list
154162876|NCT03742908|Cefazolin|cefazolin|mesh-list
154162877|NCT03742908|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154162878|NCT03742908|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154162879|NCT03742908|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
154162880|NCT03742908|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154162890|NCT03902574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154162891|NCT03902574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154162892|NCT03902574|Dopamine Agonists|dopamine agonists|mesh-ancestor
154162893|NCT03902574|Dopamine Agents|dopamine agents|mesh-ancestor
154162894|NCT01004874|Bevacizumab|bevacizumab|mesh-list
154162895|NCT01004874|Temozolomide|temozolomide|mesh-list
154162896|NCT01004874|Topotecan|topotecan|mesh-list
154162897|NCT01004874|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154162898|NCT01004874|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154162899|NCT01004874|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154162900|NCT01004874|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154162901|NCT01004874|Growth Substances|growth substances|mesh-ancestor
153486452|NCT00468234|Nicotine|nicotine|mesh-list
154162902|NCT01004874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154162903|NCT01004874|Growth Inhibitors|growth inhibitors|mesh-ancestor
154162904|NCT01004874|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154162905|NCT01004874|Alkylating Agents|alkylating agents|mesh-ancestor
153660034|NCT03959514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154162906|NCT01004874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154162907|NCT01004874|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
154162908|NCT01004874|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154162909|NCT01004874|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154162911|NCT00987116|Azathioprine|azathioprine|mesh-list
154162914|NCT00987116|Hormones|hormones|mesh-ancestor
154162941|NCT00542828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154162942|NCT00542828|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154162943|NCT00987662|Amlodipine|amlodipine|mesh-list
154162944|NCT00987662|Irbesartan|irbesartan|mesh-list
154162945|NCT00987662|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154162946|NCT00987662|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154162947|NCT00987662|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154162948|NCT00987662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154162949|NCT00987662|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154162950|NCT00987662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154162951|NCT00987662|Vasodilator Agents|vasodilator agents|mesh-ancestor
154162952|NCT00987662|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
154162953|NCT00987662|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
154162954|NCT00090103|Tamsulosin|tamsulosin|mesh-list
154162955|NCT00090103|Dutasteride|dutasteride|mesh-list
154162956|NCT00090103|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
154162957|NCT00090103|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
154162958|NCT00090103|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154162959|NCT00090103|Adrenergic Agents|adrenergic agents|mesh-ancestor
154162960|NCT00090103|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154162961|NCT00090103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154162962|NCT00090103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154162963|NCT00090103|Urological Agents|urological agents|mesh-ancestor
154162964|NCT00090103|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
154162965|NCT00090103|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154162966|NCT00090103|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154162967|NCT00090103|Hormone Antagonists|hormone antagonists|mesh-ancestor
154162968|NCT00090103|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154162969|NCT01088659|Tenofovir|tenofovir|mesh-list
154162970|NCT01088659|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
154162971|NCT01088659|Antiviral Agents|antiviral agents|mesh-ancestor
154162972|NCT01088659|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154162973|NCT01088659|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
154162977|NCT01088659|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154162978|NCT01088659|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154162979|NCT00087607|Ribavirin|ribavirin|mesh-list
154162980|NCT00087607|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
154162981|NCT00087607|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
154162982|NCT00087607|Antimetabolites|antimetabolites|mesh-ancestor
154162983|NCT00087607|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154162984|NCT00087607|Antiviral Agents|antiviral agents|mesh-ancestor
154162985|NCT00087607|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154162987|NCT01088737|Toll-Like Receptor Agonists|toll-like receptor agonists|mesh-ancestor
154162988|NCT01088737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154162989|NCT01088737|Immunomodulating Agents|immunomodulating agents|mesh-ancestor
154162990|NCT01088737|Immunologic Factors|immunologic factors|mesh-ancestor
154162991|NCT01088737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154162992|NCT01088737|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154162993|NCT01088737|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154162994|NCT01088737|Interferon Inducers|interferon inducers|mesh-ancestor
154162995|NCT00069823|Esomeprazole|esomeprazole|mesh-list
154162996|NCT00069823|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
154162997|NCT00069823|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154162998|NCT00069823|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154162999|NCT00069823|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154163000|NCT00069823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154163001|NCT01088815|Paclitaxel|paclitaxel|mesh-list
154163002|NCT01088815|Gemcitabine|gemcitabine|mesh-list
154163003|NCT01088815|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154163004|NCT01088815|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154163005|NCT01088815|Tubulin Modulators|tubulin modulators|mesh-ancestor
154163026|NCT00541658|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154163027|NCT00541658|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154163028|NCT00541658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153660281|NCT02966041|Ondansetron|ondansetron|mesh-list
153660282|NCT02966041|Antiemetics|antiemetics|mesh-ancestor
154163029|NCT00541658|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154163030|NCT00541658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154163031|NCT00541658|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154163032|NCT04334174|Brentuximab Vedotin|brentuximab vedotin|mesh-list
154163033|NCT04334174|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154163034|NCT04334174|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154163035|NCT04334174|Immunotoxins|immunotoxins|mesh-ancestor
154163036|NCT04334174|Immunoconjugates|immunoconjugates|mesh-ancestor
154163037|NCT04334174|Immunologic Factors|immunologic factors|mesh-ancestor
154163038|NCT04334174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154163039|NCT00987974|Atorvastatin|atorvastatin|mesh-list
154163040|NCT00987974|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
154163041|NCT00987974|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154163042|NCT00987974|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154163043|NCT00987974|Antimetabolites|antimetabolites|mesh-ancestor
154163044|NCT00987974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154163045|NCT00987974|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154163046|NCT00987974|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154163047|NCT00987974|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154163048|NCT03519074|Cisplatin|cisplatin|mesh-list
154163049|NCT03519074|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154163075|NCT04004234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154163076|NCT04004234|Immunologic Factors|immunologic factors|mesh-ancestor
154163077|NCT04004234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154163078|NCT04004234|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154163079|NCT04004234|Antimetabolites|antimetabolites|mesh-ancestor
154163080|NCT04004234|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154163081|NCT04004234|Trace Elements|trace elements|mesh-ancestor
154163082|NCT04004234|Micronutrients|micronutrients|mesh-ancestor
154163083|NCT00990158|Vitamin K|vitamin k|mesh-list
154163084|NCT00990158|Vitamin K 1|vitamin k 1|mesh-list
154163085|NCT00990158|Vitamins|vitamins|mesh-ancestor
154163086|NCT00990158|Micronutrients|micronutrients|mesh-ancestor
154163087|NCT00990158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154163088|NCT00990158|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
154163089|NCT00990158|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154163090|NCT00990158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154163091|NCT00990158|Hemostatics|hemostatics|mesh-ancestor
154163092|NCT00990158|Coagulants|coagulants|mesh-ancestor
154163093|NCT00412984|Warfarin|warfarin|mesh-list
154163094|NCT00412984|Apixaban|apixaban|mesh-list
154163133|NCT05404490|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154163135|NCT05359874|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154163136|NCT05359874|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154163137|NCT05359874|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154163138|NCT05359874|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154163139|NCT05359874|Growth Substances|growth substances|mesh-ancestor
154163140|NCT05359874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154163141|NCT05359874|Growth Inhibitors|growth inhibitors|mesh-ancestor
154163142|NCT00990392|Polymyxins|polymyxins|mesh-list
154163143|NCT00990392|Bacitracin|bacitracin|mesh-list
154163144|NCT00990392|Polymyxin B|polymyxin b|mesh-list
154163145|NCT00990392|Gramicidin|gramicidin|mesh-list
154163146|NCT00990392|Petrolatum|petrolatum|mesh-list
154163147|NCT00990392|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154163148|NCT00990392|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154163149|NCT00990392|Emollients|emollients|mesh-ancestor
154163150|NCT00990392|Dermatologic Agents|dermatologic agents|mesh-ancestor
154163151|NCT00990392|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154163152|NCT01034956|Calcium|calcium|mesh-list
154163153|NCT01034956|Hyaluronic Acid|hyaluronic acid|mesh-list
154163154|NCT01034956|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154163155|NCT01034956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154163156|NCT01034956|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154163157|NCT01034956|Immunologic Factors|immunologic factors|mesh-ancestor
154163158|NCT01034956|Viscosupplements|viscosupplements|mesh-ancestor
154163159|NCT01034956|Protective Agents|protective agents|mesh-ancestor
154163160|NCT01580878|Butenafine|butenafine|mesh-list
154163161|NCT01580878|Clotrimazole|clotrimazole|mesh-list
154163162|NCT01580878|Antifungal Agents|antifungal agents|mesh-ancestor
154163163|NCT01580878|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154163179|NCT04003844|Aspirin|aspirin|mesh-list
154163180|NCT04003844|Immunoglobulins|immunoglobulins|mesh-list
154163181|NCT04003844|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
154163182|NCT04003844|Antibodies|antibodies|mesh-list
154163183|NCT04003844|Immunoglobulin G|immunoglobulin g|mesh-list
154163184|NCT04003844|Immunologic Factors|immunologic factors|mesh-ancestor
154163185|NCT04003844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154163186|NCT04003844|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154163187|NCT04003844|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154163188|NCT04003844|Analgesics|analgesics|mesh-ancestor
154163189|NCT04003844|Sensory System Agents|sensory system agents|mesh-ancestor
154163190|NCT04003844|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154163191|NCT04003844|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154163192|NCT04003844|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154163193|NCT04003844|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154163194|NCT04003844|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153660327|NCT00074074|Infliximab|infliximab|mesh-list
154163195|NCT04003844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154163196|NCT04003844|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154163197|NCT04003844|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154163198|NCT04003844|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154163199|NCT04003844|Antipyretics|antipyretics|mesh-ancestor
154163200|NCT05589584|Acetylcysteine|acetylcysteine|mesh-list
154163201|NCT05589584|N-monoacetylcystine|n-monoacetylcystine|mesh-list
154163202|NCT05589584|Antiviral Agents|antiviral agents|mesh-ancestor
154163203|NCT05589584|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154163232|NCT00764855|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154163234|NCT00764855|Anesthetics|anesthetics|mesh-ancestor
154163235|NCT00759317|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
154163236|NCT00759317|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
154163237|NCT00759317|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154163238|NCT00759317|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154163239|NCT00759317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154163240|NCT00759317|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154163241|NCT00759317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154163242|NCT00759317|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
154163243|NCT00759317|Antidepressive Agents|antidepressive agents|mesh-ancestor
154163244|NCT00759317|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154163245|NCT00076999|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
154163246|NCT01041040|Gemtuzumab|gemtuzumab|mesh-list
154163247|NCT01041040|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154163248|NCT01041040|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154163249|NCT01041040|Immunotoxins|immunotoxins|mesh-ancestor
154163250|NCT01041040|Immunoconjugates|immunoconjugates|mesh-ancestor
154163251|NCT01041040|Immunologic Factors|immunologic factors|mesh-ancestor
154163252|NCT01041040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154163253|NCT00765011|Cetuximab|cetuximab|mesh-list
154163254|NCT00765011|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154163255|NCT00765011|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154163281|NCT03905096|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154163282|NCT03905096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154163283|NCT03905096|Cholinergic Agents|cholinergic agents|mesh-ancestor
154163284|NCT03905096|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154163285|NCT03905096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153660452|NCT00074776|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154163286|NCT03905096|Nootropic Agents|nootropic agents|mesh-ancestor
154163287|NCT00412360|Cyclosporine|cyclosporine|mesh-list
154163288|NCT00412360|Mycophenolic Acid|mycophenolic acid|mesh-list
153660453|NCT00074776|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154163289|NCT00412360|Cyclophosphamide|cyclophosphamide|mesh-list
154163290|NCT00412360|Fludarabine|fludarabine|mesh-list
154163291|NCT00412360|Cyclosporins|cyclosporins|mesh-list
154163292|NCT00412360|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154163293|NCT00412360|Immunologic Factors|immunologic factors|mesh-ancestor
154163294|NCT00412360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154163295|NCT00412360|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154163296|NCT00412360|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154163297|NCT00412360|Alkylating Agents|alkylating agents|mesh-ancestor
154163298|NCT00412360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154163310|NCT00761501|Naproxen|naproxen|mesh-list
154163337|NCT03026036|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154163338|NCT03026036|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
154163339|NCT03026036|Dopamine Agents|dopamine agents|mesh-ancestor
154163340|NCT03026036|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154163341|NCT03026036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154163342|NCT00990860|Doxorubicin|doxorubicin|mesh-list
154163343|NCT00990860|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154163344|NCT00990860|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154163345|NCT00990860|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154163346|NCT00990860|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154163347|NCT00990860|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154163348|NCT00990860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154163349|NCT01035190|Budesonide|budesonide|mesh-list
154163350|NCT01035190|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154163351|NCT01035190|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154163352|NCT01035190|Autonomic Agents|autonomic agents|mesh-ancestor
154163353|NCT01035190|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154163354|NCT01035190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154163365|NCT01086553|Budesonide|budesonide|mesh-list
154163393|NCT00766181|Anesthetics, Local|anesthetics, local|mesh-ancestor
154163394|NCT00766181|Anesthetics|anesthetics|mesh-ancestor
154163395|NCT00766181|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154163396|NCT00766181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154163397|NCT00766181|Sensory System Agents|sensory system agents|mesh-ancestor
154163398|NCT00766181|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154163399|NCT00766181|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154163400|NCT00766181|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154163401|NCT00766181|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154163402|NCT00766181|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154163403|NCT00766181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154163404|NCT04048577|Natalizumab|natalizumab|mesh-list
154163405|NCT04048577|Immunologic Factors|immunologic factors|mesh-ancestor
154163406|NCT04048577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154163407|NCT00991250|Temozolomide|temozolomide|mesh-list
154163408|NCT00991250|Dacarbazine|dacarbazine|mesh-list
154163409|NCT00991250|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154163410|NCT00991250|Alkylating Agents|alkylating agents|mesh-ancestor
153660558|NCT00075673|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154163411|NCT00991250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154163412|NCT00991250|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154163413|NCT00418522|Insulin|insulin|mesh-list
154163446|NCT00991562|Immunologic Factors|immunologic factors|mesh-ancestor
154163447|NCT00991562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154163448|NCT00991562|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154163449|NCT00991562|Tubulin Modulators|tubulin modulators|mesh-ancestor
154163450|NCT00991562|Antimitotic Agents|antimitotic agents|mesh-ancestor
154163451|NCT00991562|Mitosis Modulators|mitosis modulators|mesh-ancestor
154163452|NCT00991562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154163454|NCT00762671|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154163455|NCT00762671|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154163456|NCT00762671|Analgesics|analgesics|mesh-ancestor
154163457|NCT00762671|Sensory System Agents|sensory system agents|mesh-ancestor
154163458|NCT00762671|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154163459|NCT00762671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154163460|NCT00762671|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154163461|NCT00762671|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154163462|NCT00762671|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154163463|NCT00762671|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154163464|NCT00762671|Antioxidants|antioxidants|mesh-ancestor
154163465|NCT00762671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154163466|NCT00762671|Protective Agents|protective agents|mesh-ancestor
154163467|NCT00762671|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154163468|NCT00762671|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154163469|NCT00762671|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
154163470|NCT02558387|Nintedanib|nintedanib|mesh-list
154163471|NCT02558387|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154163472|NCT02558387|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154163473|NCT02558387|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153660582|NCT00075751|Carboplatin|carboplatin|mesh-list
154163474|NCT02558387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154163475|NCT00766805|Propranolol|propranolol|mesh-list
154163476|NCT00766805|Isosorbide|isosorbide|mesh-list
154163490|NCT00766805|Natriuretic Agents|natriuretic agents|mesh-ancestor
154163491|NCT00766805|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
154163492|NCT00762749|Diphenhydramine|diphenhydramine|mesh-list
154163493|NCT00762749|Promethazine|promethazine|mesh-list
154163494|NCT00762749|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
154163495|NCT00762749|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154163496|NCT00762749|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154163497|NCT00762749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154163498|NCT00762749|Anesthetics, Local|anesthetics, local|mesh-ancestor
154163499|NCT00762749|Anesthetics|anesthetics|mesh-ancestor
154163500|NCT00762749|Sensory System Agents|sensory system agents|mesh-ancestor
154163501|NCT00762749|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154163502|NCT00762749|Antiemetics|antiemetics|mesh-ancestor
154163503|NCT00762749|Autonomic Agents|autonomic agents|mesh-ancestor
154163504|NCT00762749|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154163505|NCT00762749|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
154163506|NCT00762749|Histamine Antagonists|histamine antagonists|mesh-ancestor
154163508|NCT00762749|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154163509|NCT00762749|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154163510|NCT00762749|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154163511|NCT00762749|Antipruritics|antipruritics|mesh-ancestor
154163512|NCT00762749|Dermatologic Agents|dermatologic agents|mesh-ancestor
154163513|NCT00403546|Ziprasidone|ziprasidone|mesh-list
154163514|NCT00403546|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154163515|NCT00403546|Serotonin Agents|serotonin agents|mesh-ancestor
154163516|NCT00403546|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153660614|NCT03958383|Nivolumab|nivolumab|mesh-list
154163519|NCT00403546|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154163540|NCT00767117|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154163541|NCT00762983|Loratadine|loratadine|mesh-list
154163542|NCT00762983|Antipruritics|antipruritics|mesh-ancestor
154163543|NCT00762983|Dermatologic Agents|dermatologic agents|mesh-ancestor
154163544|NCT00762983|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154163545|NCT00762983|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
154163546|NCT00762983|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
154163547|NCT00762983|Histamine Antagonists|histamine antagonists|mesh-ancestor
154163548|NCT00762983|Histamine Agents|histamine agents|mesh-ancestor
154163549|NCT00762983|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154163550|NCT00762983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154163551|NCT00762983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154163552|NCT00403234|Buprenorphine|buprenorphine|mesh-list
154163553|NCT00403234|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154163554|NCT00403234|Narcotics|narcotics|mesh-ancestor
154163555|NCT00403234|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154163556|NCT00403234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154163557|NCT00403234|Analgesics|analgesics|mesh-ancestor
154163558|NCT00403234|Sensory System Agents|sensory system agents|mesh-ancestor
154163559|NCT00403234|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154163560|NCT00403234|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
154163561|NCT04049201|Midazolam|midazolam|mesh-list
154163562|NCT04049201|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154163563|NCT04049201|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154163564|NCT04049201|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154163565|NCT04049201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154163566|NCT04049201|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154163567|NCT04049201|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154163568|NCT04049201|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154163569|NCT04049201|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154163570|NCT04049201|Anesthetics, General|anesthetics, general|mesh-ancestor
154163571|NCT04049201|Anesthetics|anesthetics|mesh-ancestor
154163572|NCT04049201|GABA Modulators|gaba modulators|mesh-ancestor
154163573|NCT04049201|GABA Agents|gaba agents|mesh-ancestor
154163574|NCT04049201|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154163580|NCT00767663|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154163581|NCT00767663|Vasodilator Agents|vasodilator agents|mesh-ancestor
154163582|NCT00402688|Levofloxacin|levofloxacin|mesh-list
154163583|NCT00402688|Ofloxacin|ofloxacin|mesh-list
154163584|NCT00402688|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
154163585|NCT00402688|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154163586|NCT00402688|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153660850|NCT00078247|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154163587|NCT00402688|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153462847|NCT04394598|Antimetabolites|antimetabolites|mesh-ancestor
154163588|NCT00402688|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154163589|NCT00402688|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154163590|NCT00402688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154163591|NCT00402688|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154163592|NCT00402688|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
154163593|NCT00402688|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154163594|NCT04049045|Empagliflozin|empagliflozin|mesh-list
154163595|NCT04049045|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
154163596|NCT04049045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154163597|NCT04049045|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154163598|NCT04049045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154163599|NCT00763373|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
154163600|NCT00763373|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
154163601|NCT00763373|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154163602|NCT00763373|Antitubercular Agents|antitubercular agents|mesh-ancestor
154163604|NCT01035580|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154163605|NCT01035580|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154163606|NCT01035580|Analgesics|analgesics|mesh-ancestor
154163607|NCT01035580|Sensory System Agents|sensory system agents|mesh-ancestor
154163608|NCT01035580|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154163609|NCT01035580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154163610|NCT01035580|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154163611|NCT01035580|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154163621|NCT00767975|Isoniazid|isoniazid|mesh-list
154163622|NCT00767975|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
154163623|NCT00767975|Antitubercular Agents|antitubercular agents|mesh-ancestor
154163624|NCT00767975|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154163625|NCT00767975|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154163626|NCT00767975|Leprostatic Agents|leprostatic agents|mesh-ancestor
154163627|NCT00767975|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154163628|NCT00767975|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154163629|NCT00767975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154163630|NCT00767975|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
154163631|NCT00767975|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
154163632|NCT00767975|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
154163633|NCT00767975|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
154163634|NCT00767975|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
154163635|NCT00767975|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
154163636|NCT00767975|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
154163637|NCT00767975|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154163638|NCT00767975|Antimetabolites|antimetabolites|mesh-ancestor
154163639|NCT00767975|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154163640|NCT00768131|Paclitaxel|paclitaxel|mesh-list
154163641|NCT00768131|Carboplatin|carboplatin|mesh-list
154163642|NCT00768131|Cetuximab|cetuximab|mesh-list
154163643|NCT00768131|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154163644|NCT00768131|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154163645|NCT00768131|Tubulin Modulators|tubulin modulators|mesh-ancestor
154163646|NCT00768131|Antimitotic Agents|antimitotic agents|mesh-ancestor
154163647|NCT00768131|Mitosis Modulators|mitosis modulators|mesh-ancestor
154163648|NCT00768131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154163649|NCT00768131|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154163650|NCT00401830|Lacosamide|lacosamide|mesh-list
154163651|NCT00401830|Anticonvulsants|anticonvulsants|mesh-ancestor
154163652|NCT00401830|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154163653|NCT00401830|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154163654|NCT00401830|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154163657|NCT00768209|Phentermine|phentermine|mesh-list
154163659|NCT00768209|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154163660|NCT00768209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154163661|NCT00768209|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
154163662|NCT00768209|Appetite Depressants|appetite depressants|mesh-ancestor
154163663|NCT00768209|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
154163664|NCT00768209|Sympathomimetics|sympathomimetics|mesh-ancestor
154163665|NCT00768209|Autonomic Agents|autonomic agents|mesh-ancestor
154163666|NCT00768209|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154163667|NCT00768209|Adrenergic Agents|adrenergic agents|mesh-ancestor
154163668|NCT00768209|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154163669|NCT00768209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154163670|NCT00401752|Esomeprazole|esomeprazole|mesh-list
154163671|NCT00401752|Ranitidine|ranitidine|mesh-list
154163672|NCT00401752|Ranitidine bismuth citrate|ranitidine bismuth citrate|mesh-list
154163673|NCT00401752|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154163674|NCT00401752|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154163675|NCT00401752|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
154163676|NCT00401752|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154163677|NCT00401752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154163678|NCT00401752|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
154163679|NCT00401752|Histamine Antagonists|histamine antagonists|mesh-ancestor
154163711|NCT00417976|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154163712|NCT00417976|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154163713|NCT00417976|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154163714|NCT00417976|Growth Substances|growth substances|mesh-ancestor
154163715|NCT00417976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154163716|NCT00417976|Growth Inhibitors|growth inhibitors|mesh-ancestor
154163717|NCT00417976|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154163718|NCT00417976|Antimetabolites|antimetabolites|mesh-ancestor
154163719|NCT00417976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154163720|NCT00417976|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154163721|NCT00417976|Immunologic Factors|immunologic factors|mesh-ancestor
154163722|NCT00770705|Phenoxybenzamine|phenoxybenzamine|mesh-list
154163723|NCT00770705|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
154163724|NCT00770705|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154163725|NCT00770705|Adrenergic Agents|adrenergic agents|mesh-ancestor
154163726|NCT00770705|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154163727|NCT00770705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154163728|NCT00770705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154163729|NCT00770705|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153462858|NCT05602428|Anesthetics|anesthetics|mesh-list
154163730|NCT00770705|Vasodilator Agents|vasodilator agents|mesh-ancestor
154163732|NCT00991796|Carboplatin|carboplatin|mesh-list
154163733|NCT00991796|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154163734|NCT00991796|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154163735|NCT00991796|Tubulin Modulators|tubulin modulators|mesh-ancestor
154163736|NCT00991796|Antimitotic Agents|antimitotic agents|mesh-ancestor
154163737|NCT00991796|Mitosis Modulators|mitosis modulators|mesh-ancestor
154163738|NCT00991796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154163740|NCT00673673|Fluorouracil|fluorouracil|mesh-list
154163741|NCT00673673|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154163742|NCT00673673|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154163743|NCT00673673|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154163744|NCT00673673|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154163745|NCT00673673|Growth Substances|growth substances|mesh-ancestor
154163746|NCT00673673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154163747|NCT00673673|Growth Inhibitors|growth inhibitors|mesh-ancestor
153646518|NCT00115609|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
154163748|NCT00673673|Antimetabolites|antimetabolites|mesh-ancestor
154163749|NCT00673673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154163750|NCT00673673|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154163751|NCT00673673|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154163752|NCT00673673|Immunologic Factors|immunologic factors|mesh-ancestor
154163753|NCT00763685|Etoricoxib|etoricoxib|mesh-list
154163754|NCT00763685|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154163755|NCT00763685|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154163756|NCT00763685|Analgesics|analgesics|mesh-ancestor
154163757|NCT00763685|Sensory System Agents|sensory system agents|mesh-ancestor
154163758|NCT00763685|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154163759|NCT00763685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154163760|NCT00763685|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154163761|NCT00763685|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154163762|NCT00763685|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
154163763|NCT00763685|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154163764|NCT00763685|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154163765|NCT00763685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154163766|NCT04048655|Neostigmine|neostigmine|mesh-list
154163767|NCT04048655|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
154163768|NCT04048655|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154163769|NCT04048655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154163776|NCT00768677|Topiramate|topiramate|mesh-list
154163797|NCT00763763|Interferons|interferons|mesh-list
154163798|NCT00763763|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
153661156|NCT00079924|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
154163799|NCT00763763|Interferon-alpha|interferon-alpha|mesh-list
154163800|NCT00763763|Dexamethasone|dexamethasone|mesh-list
154163801|NCT00763763|Vincristine|vincristine|mesh-list
154163802|NCT00763763|Imatinib Mesylate|imatinib mesylate|mesh-list
154163803|NCT00763763|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154163804|NCT00763763|Antiemetics|antiemetics|mesh-ancestor
154163805|NCT00763763|Autonomic Agents|autonomic agents|mesh-ancestor
153355774|NCT03977233|Micronutrients|micronutrients|mesh-ancestor
154163806|NCT00763763|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154163807|NCT00763763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154163808|NCT00763763|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154163861|NCT00069121|Antidotes|antidotes|mesh-ancestor
154163862|NCT00069121|Protective Agents|protective agents|mesh-ancestor
154163863|NCT00069121|Vitamin B Complex|vitamin b complex|mesh-ancestor
154163864|NCT00069121|Vitamins|vitamins|mesh-ancestor
154163865|NCT00069121|Micronutrients|micronutrients|mesh-ancestor
154163866|NCT00768911|Temozolomide|temozolomide|mesh-list
154163867|NCT00768911|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154163868|NCT00768911|Alkylating Agents|alkylating agents|mesh-ancestor
154163869|NCT00768911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154163870|NCT00768911|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154163871|NCT00769145|Ranibizumab|ranibizumab|mesh-list
154163872|NCT00769145|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154163873|NCT00769145|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154163874|NCT00769145|Growth Substances|growth substances|mesh-ancestor
154163875|NCT00769145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153544180|NCT00710554|Nabiximols|nabiximols|mesh-list
154163876|NCT00769145|Growth Inhibitors|growth inhibitors|mesh-ancestor
154163877|NCT00769145|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154163878|NCT00763997|Acetaminophen|acetaminophen|mesh-list
154163879|NCT00763997|Dipyrone|dipyrone|mesh-list
153661183|NCT00392886|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154163880|NCT00763997|Ibuprofen|ibuprofen|mesh-list
154163881|NCT00763997|Parecoxib|parecoxib|mesh-list
154163882|NCT00763997|Valdecoxib|valdecoxib|mesh-list
154163883|NCT00763997|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154163884|NCT00763997|Analgesics|analgesics|mesh-ancestor
154163885|NCT00763997|Sensory System Agents|sensory system agents|mesh-ancestor
154163886|NCT00763997|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154163887|NCT00763997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154163888|NCT00763997|Antipyretics|antipyretics|mesh-ancestor
154163889|NCT00763997|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154163890|NCT00763997|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154163907|NCT00399568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154163908|NCT00399568|Antipyretics|antipyretics|mesh-ancestor
154163909|NCT01039558|Ecabet|ecabet|mesh-list
154163910|NCT01039558|Lansoprazole|lansoprazole|mesh-list
154163911|NCT01039558|Dexlansoprazole|dexlansoprazole|mesh-list
154163912|NCT01039558|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154163913|NCT01039558|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154163914|NCT01039558|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
154163915|NCT01039558|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154163916|NCT01039558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154163917|NCT01039558|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154163918|NCT01039558|Protease Inhibitors|protease inhibitors|mesh-ancestor
154163919|NCT01039558|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
154163920|NCT01039558|Protective Agents|protective agents|mesh-ancestor
154163921|NCT01039558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154163922|NCT01039558|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154163923|NCT01324258|Gemcitabine|gemcitabine|mesh-list
154163924|NCT01324258|Trametinib|trametinib|mesh-list
154163925|NCT01324258|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154163926|NCT01324258|Antimetabolites|antimetabolites|mesh-ancestor
154163927|NCT01324258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154163928|NCT01324258|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154163929|NCT01324258|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154163930|NCT01324258|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154163931|NCT00068419|Tamoxifen|tamoxifen|mesh-list
154163932|NCT00068419|Sulindac|sulindac|mesh-list
154163933|NCT00068419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154163934|NCT00068419|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
154163935|NCT00068419|Hormone Antagonists|hormone antagonists|mesh-ancestor
154163936|NCT00068419|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154163937|NCT00068419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154163938|NCT00068419|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154163939|NCT00068419|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154163940|NCT00068419|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
154163941|NCT00068419|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
154163942|NCT00068419|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154163944|NCT00068419|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154163945|NCT00068419|Analgesics|analgesics|mesh-ancestor
154163946|NCT00068419|Sensory System Agents|sensory system agents|mesh-ancestor
154163947|NCT00068419|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154163948|NCT00068419|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154163949|NCT00068419|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154163950|NCT00068419|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154163951|NCT00068419|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154163952|NCT02557373|Vitamins|vitamins|mesh-list
154163954|NCT02557373|Retinol palmitate|retinol palmitate|mesh-list
154163955|NCT02557373|Micronutrients|micronutrients|mesh-ancestor
154163956|NCT02557373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154163957|NCT02557373|Antioxidants|antioxidants|mesh-ancestor
154163958|NCT02557373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154163959|NCT02557373|Protective Agents|protective agents|mesh-ancestor
154163960|NCT02557373|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
154163961|NCT02557373|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154163962|NCT01757626|Molgramostim|molgramostim|mesh-list
154163963|NCT01757626|Sargramostim|sargramostim|mesh-list
154163964|NCT01757626|Immunologic Factors|immunologic factors|mesh-ancestor
154163965|NCT01757626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154163966|NCT01757626|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154163967|NCT04048811|Propofol|propofol|mesh-list
153661219|NCT00080158|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
154163968|NCT04048811|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153661247|NCT00080275|Simvastatin|simvastatin|mesh-list
154163969|NCT04048811|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154163970|NCT04048811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154163971|NCT04048811|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154163972|NCT04048811|Anesthetics, General|anesthetics, general|mesh-ancestor
154163973|NCT04048811|Anesthetics|anesthetics|mesh-ancestor
154163974|NCT01086631|Rituximab|rituximab|mesh-list
154163975|NCT01086631|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154163976|NCT01086631|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154163977|NCT01086631|Immunologic Factors|immunologic factors|mesh-ancestor
154163978|NCT01086631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154163979|NCT01086631|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154163980|NCT00399490|Tanezumab|tanezumab|mesh-list
154163986|NCT00398866|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
154163987|NCT00398866|Bupivacaine|bupivacaine|mesh-list
154163988|NCT00398866|Hyaluronic Acid|hyaluronic acid|mesh-list
154163989|NCT00398866|Hylan|hylan|mesh-list
154163990|NCT00398866|Anesthetics, Local|anesthetics, local|mesh-ancestor
154163991|NCT00398866|Anesthetics|anesthetics|mesh-ancestor
154163992|NCT00398866|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154163993|NCT00398866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154163994|NCT00398866|Sensory System Agents|sensory system agents|mesh-ancestor
154163995|NCT00398866|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154163996|NCT00398866|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154163997|NCT00398866|Glucocorticoids|glucocorticoids|mesh-ancestor
154163998|NCT00398866|Hormones|hormones|mesh-ancestor
154163999|NCT00398866|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154164000|NCT00398866|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154164001|NCT00398866|Immunologic Factors|immunologic factors|mesh-ancestor
154164002|NCT00398866|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154164003|NCT00398866|Viscosupplements|viscosupplements|mesh-ancestor
154164004|NCT00398866|Protective Agents|protective agents|mesh-ancestor
154164005|NCT00771563|Cisplatin|cisplatin|mesh-list
154164006|NCT00771563|Docetaxel|docetaxel|mesh-list
154164007|NCT00771563|Enoxaparin|enoxaparin|mesh-list
154164008|NCT00771563|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154164009|NCT00771563|Tubulin Modulators|tubulin modulators|mesh-ancestor
154164010|NCT00771563|Antimitotic Agents|antimitotic agents|mesh-ancestor
154164011|NCT00771563|Mitosis Modulators|mitosis modulators|mesh-ancestor
154164012|NCT00771563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154164013|NCT00771563|Anticoagulants|anticoagulants|mesh-ancestor
154164014|NCT00771563|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154164015|NCT00771563|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154164016|NCT00775073|Bevacizumab|bevacizumab|mesh-list
154164017|NCT00775073|Everolimus|everolimus|mesh-list
154164018|NCT00775073|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154164019|NCT00775073|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154164020|NCT00775073|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154164021|NCT00775073|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154164027|NCT00775073|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154164028|NCT00775073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154164029|NCT00775073|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154164030|NCT00775073|Immunologic Factors|immunologic factors|mesh-ancestor
154164031|NCT00398632|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
154164032|NCT00398632|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
154164033|NCT00398632|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154164034|NCT00398632|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154164035|NCT00398632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154164036|NCT00398632|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154164037|NCT00398632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154164038|NCT00398632|Analgesics|analgesics|mesh-ancestor
154164039|NCT00398632|Sensory System Agents|sensory system agents|mesh-ancestor
154164040|NCT00398632|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154164041|NCT00398632|Antidepressive Agents|antidepressive agents|mesh-ancestor
154164042|NCT00398632|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154164043|NCT00398632|Dopamine Agents|dopamine agents|mesh-ancestor
154164044|NCT01589146|Heparin|heparin|mesh-list
154164082|NCT00771641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154164083|NCT05408000|Propofol|propofol|mesh-list
154164084|NCT05408000|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154164085|NCT05408000|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154164086|NCT05408000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154164087|NCT05408000|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154164088|NCT05408000|Anesthetics, General|anesthetics, general|mesh-ancestor
154164089|NCT05408000|Anesthetics|anesthetics|mesh-ancestor
154164090|NCT00771719|Ceftobiprole|ceftobiprole|mesh-list
154164091|NCT00771719|Ceftobiprole medocaril|ceftobiprole medocaril|mesh-list
154164092|NCT00771719|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154164093|NCT00771719|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154164094|NCT00673361|Temozolomide|temozolomide|mesh-list
154164095|NCT00673361|Sorafenib|sorafenib|mesh-list
154164096|NCT00673361|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154164097|NCT00673361|Alkylating Agents|alkylating agents|mesh-ancestor
154164098|NCT00673361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154164099|NCT00673361|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154164100|NCT00673361|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154164101|NCT00673361|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154164102|NCT00393718|Liraglutide|liraglutide|mesh-list
154164137|NCT00398320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154164138|NCT00670007|Protease Inhibitors|protease inhibitors|mesh-list
154164139|NCT00670007|Alpha 1-Antitrypsin|alpha 1-antitrypsin|mesh-list
154164140|NCT00670007|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154164141|NCT00670007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154164142|NCT00670007|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
154164143|NCT00670007|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154164144|NCT04003688|Magnesium Sulfate|magnesium sulfate|mesh-list
154164145|NCT04003688|Analgesics|analgesics|mesh-ancestor
154164146|NCT04003688|Sensory System Agents|sensory system agents|mesh-ancestor
154164147|NCT04003688|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154164148|NCT04003688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154164149|NCT04003688|Anesthetics|anesthetics|mesh-ancestor
154164150|NCT04003688|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154164151|NCT04003688|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154164152|NCT04003688|Anticonvulsants|anticonvulsants|mesh-ancestor
154164153|NCT04003688|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154164154|NCT04003688|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154164155|NCT04003688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154164156|NCT04003688|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154164157|NCT04003688|Tocolytic Agents|tocolytic agents|mesh-ancestor
154164158|NCT04003688|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154164159|NCT00779129|Cyclophosphamide|cyclophosphamide|mesh-list
154164160|NCT00779129|Doxorubicin|doxorubicin|mesh-list
154164161|NCT00779129|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154164162|NCT00779129|Immunologic Factors|immunologic factors|mesh-ancestor
154164163|NCT00779129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154164164|NCT00779129|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154164165|NCT00779129|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154164166|NCT00779129|Alkylating Agents|alkylating agents|mesh-ancestor
154164168|NCT00779129|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154164178|NCT00772187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154164179|NCT00772187|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154164180|NCT00772187|Narcotics|narcotics|mesh-ancestor
154164181|NCT00772187|Analgesics|analgesics|mesh-ancestor
154164182|NCT00772187|Sensory System Agents|sensory system agents|mesh-ancestor
154164183|NCT00772187|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154164184|NCT00772187|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154164185|NCT00772187|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154164186|NCT00772187|Anesthetics, General|anesthetics, general|mesh-ancestor
154164187|NCT00772265|Insulin|insulin|mesh-list
154164188|NCT00772265|Isophane Insulin, Human|isophane insulin, human|mesh-list
154164189|NCT00772265|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154164190|NCT00772265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154164191|NCT00779441|Zolpidem|zolpidem|mesh-list
154164192|NCT00779441|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
154164193|NCT00779441|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154164194|NCT00779441|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154164195|NCT00779441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154164196|NCT00779441|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
154164197|NCT00779441|GABA Agonists|gaba agonists|mesh-ancestor
154164198|NCT00779441|GABA Agents|gaba agents|mesh-ancestor
154164199|NCT00779441|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154164201|NCT02556437|Immunoglobulins|immunoglobulins|mesh-list
154164231|NCT00775697|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154164232|NCT00775697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154164233|NCT00775697|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
154164234|NCT00775697|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
154164235|NCT00775697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154164236|NCT05357066|Nitrous Oxide|nitrous oxide|mesh-list
154164237|NCT05357066|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
154164238|NCT05357066|Anesthetics, General|anesthetics, general|mesh-ancestor
154164239|NCT05357066|Anesthetics|anesthetics|mesh-ancestor
154164240|NCT05357066|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154164241|NCT05357066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154164242|NCT05357066|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154164243|NCT05357066|Analgesics|analgesics|mesh-ancestor
154164244|NCT05357066|Sensory System Agents|sensory system agents|mesh-ancestor
154164245|NCT05357066|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154164246|NCT02556905|Dexamethasone|dexamethasone|mesh-list
154164247|NCT02556905|Lenalidomide|lenalidomide|mesh-list
154164248|NCT02556905|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154164249|NCT02556905|Antiemetics|antiemetics|mesh-ancestor
154164250|NCT02556905|Autonomic Agents|autonomic agents|mesh-ancestor
154164253|NCT02556905|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154164284|NCT00537056|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154164285|NCT00537056|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154164286|NCT00537056|Growth Substances|growth substances|mesh-ancestor
154164287|NCT00537056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153661429|NCT00390260|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154164288|NCT00537056|Growth Inhibitors|growth inhibitors|mesh-ancestor
154164289|NCT00537056|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154164290|NCT00537056|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154164291|NCT00537056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154164292|NCT00537056|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
154164293|NCT00779831|Pseudoephedrine|pseudoephedrine|mesh-list
154164294|NCT00779831|Ephedrine|ephedrine|mesh-list
154164295|NCT00779831|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154164296|NCT00779831|Autonomic Agents|autonomic agents|mesh-ancestor
154164297|NCT00779831|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154164298|NCT00779831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154164299|NCT00779831|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154164300|NCT00779831|Respiratory System Agents|respiratory system agents|mesh-ancestor
154164301|NCT00779831|Nasal Decongestants|nasal decongestants|mesh-ancestor
154164302|NCT00779831|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154164303|NCT00779831|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
154164304|NCT00779831|Sympathomimetics|sympathomimetics|mesh-ancestor
154164305|NCT00779831|Adrenergic Agents|adrenergic agents|mesh-ancestor
154164306|NCT00779831|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154164307|NCT00779831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154164308|NCT00535262|Selegiline|selegiline|mesh-list
154164309|NCT00535262|Antidepressive Agents|antidepressive agents|mesh-ancestor
154164310|NCT00535262|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154164311|NCT00535262|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
154164312|NCT00535262|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
154164313|NCT00535262|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
154164314|NCT00535262|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154164315|NCT00535262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154164316|NCT00535262|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
154164317|NCT00535262|Protective Agents|protective agents|mesh-ancestor
154164318|NCT00535262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154164323|NCT00772499|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
154164324|NCT00772499|Hydralazine|hydralazine|mesh-list
154164325|NCT00772499|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154164326|NCT00772499|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154164327|NCT00772499|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154164328|NCT00772499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154164329|NCT00772499|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154164330|NCT00772499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154164331|NCT00772499|Vasodilator Agents|vasodilator agents|mesh-ancestor
154164333|NCT00772499|Natriuretic Agents|natriuretic agents|mesh-ancestor
154164334|NCT00772499|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
154164335|NCT00772499|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
153463071|NCT04392648|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153661464|NCT00399685|Efavirenz|efavirenz|mesh-list
154164336|NCT00772499|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
154164337|NCT00772499|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154164338|NCT00772499|Sympatholytics|sympatholytics|mesh-ancestor
154164339|NCT00772499|Autonomic Agents|autonomic agents|mesh-ancestor
154164340|NCT00772499|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154164341|NCT00772499|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
154164342|NCT00772499|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
154164343|NCT00772499|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154164344|NCT00772499|Adrenergic Agents|adrenergic agents|mesh-ancestor
154164345|NCT00772499|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154164346|NCT00989690|Docetaxel|docetaxel|mesh-list
154164347|NCT00989690|Pemetrexed|pemetrexed|mesh-list
154164348|NCT00989690|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
154164349|NCT00989690|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154164350|NCT00989690|Tubulin Modulators|tubulin modulators|mesh-ancestor
154164351|NCT00989690|Antimitotic Agents|antimitotic agents|mesh-ancestor
154164352|NCT00989690|Mitosis Modulators|mitosis modulators|mesh-ancestor
154164353|NCT00989690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154164354|NCT00989690|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154164355|NCT00989690|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154164356|NCT00989690|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154164357|NCT00989690|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154164358|NCT00989690|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153646519|NCT00115609|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
154164359|NCT00074581|Ritonavir|ritonavir|mesh-list
154164360|NCT00074581|Lopinavir|lopinavir|mesh-list
154164361|NCT00074581|Atazanavir Sulfate|atazanavir sulfate|mesh-list
154164362|NCT00074581|Tenofovir|tenofovir|mesh-list
154164363|NCT00074581|Lamivudine|lamivudine|mesh-list
154164364|NCT00074581|Emtricitabine|emtricitabine|mesh-list
154164365|NCT00074581|Zidovudine|zidovudine|mesh-list
154164366|NCT00074581|Nevirapine|nevirapine|mesh-list
154164367|NCT00074581|Didanosine|didanosine|mesh-list
154164368|NCT00074581|Stavudine|stavudine|mesh-list
154164369|NCT00074581|Efavirenz|efavirenz|mesh-list
154164370|NCT00074581|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
154164371|NCT00074581|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
154164372|NCT00074581|Protease Inhibitors|protease inhibitors|mesh-ancestor
154164373|NCT00074581|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154164374|NCT00074581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154164375|NCT00074581|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154164376|NCT00074581|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154164377|NCT00074581|Antiviral Agents|antiviral agents|mesh-ancestor
154164378|NCT00074581|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154164379|NCT00074581|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154164380|NCT00074581|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154164381|NCT00074581|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
154164382|NCT00074581|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154164383|NCT00074581|Antimetabolites|antimetabolites|mesh-ancestor
154164384|NCT00074581|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
154164385|NCT00074581|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
154164389|NCT00776477|Aspirin|aspirin|mesh-list
154164408|NCT00776477|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
154164409|NCT00776477|Purinergic Agents|purinergic agents|mesh-ancestor
154164410|NCT00776477|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154164412|NCT00772655|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154164413|NCT00772655|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154164414|NCT00772655|Immunologic Factors|immunologic factors|mesh-ancestor
154164415|NCT00772655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154164416|NCT00772655|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154164417|NCT00776633|Aspirin|aspirin|mesh-list
154164418|NCT00776633|Clopidogrel|clopidogrel|mesh-list
154164419|NCT00776633|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154164420|NCT00776633|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154164421|NCT00776633|Analgesics|analgesics|mesh-ancestor
154164422|NCT00776633|Sensory System Agents|sensory system agents|mesh-ancestor
154164423|NCT00776633|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154164424|NCT00776633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154164425|NCT00776633|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154164426|NCT00776633|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154164427|NCT00776633|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154164428|NCT00776633|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154164429|NCT00776633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154164448|NCT03961087|Ubiquinone|ubiquinone|mesh-list
154164461|NCT03960775|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154164462|NCT03960775|Analgesics|analgesics|mesh-ancestor
154164463|NCT03960775|Sensory System Agents|sensory system agents|mesh-ancestor
154164464|NCT03960775|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154164465|NCT03960775|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154164466|NCT03960775|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154164467|NCT03960775|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154164468|NCT03960775|Adrenergic Agents|adrenergic agents|mesh-ancestor
154164469|NCT03960775|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154164470|NCT03960775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154164471|NCT00536978|Cytarabine|cytarabine|mesh-list
154164472|NCT00536978|Cyclophosphamide|cyclophosphamide|mesh-list
154164473|NCT00536978|Melphalan|melphalan|mesh-list
154164474|NCT00536978|Carmustine|carmustine|mesh-list
153661543|NCT00083005|Leprostatic Agents|leprostatic agents|mesh-ancestor
154164475|NCT00536978|Rituximab|rituximab|mesh-list
154164476|NCT00536978|Methotrexate|methotrexate|mesh-list
154164477|NCT00536978|Fludarabine|fludarabine|mesh-list
154164478|NCT00536978|Fludarabine phosphate|fludarabine phosphate|mesh-list
154164479|NCT00536978|Etoposide|etoposide|mesh-list
154164480|NCT00536978|Alemtuzumab|alemtuzumab|mesh-list
154164481|NCT00536978|Tacrolimus|tacrolimus|mesh-list
154164482|NCT00536978|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154164483|NCT00536978|Immunologic Factors|immunologic factors|mesh-ancestor
154164484|NCT00536978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154164485|NCT00536978|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154164486|NCT00536978|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154164487|NCT00536978|Alkylating Agents|alkylating agents|mesh-ancestor
154164488|NCT00536978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154164489|NCT00536978|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154164490|NCT00536978|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154164509|NCT03809611|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154164510|NCT03809611|Antimetabolites|antimetabolites|mesh-ancestor
154164511|NCT03809611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154164512|NCT03809611|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154164513|NCT03809611|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154164514|NCT03809611|Nootropic Agents|nootropic agents|mesh-ancestor
154164515|NCT05360342|Vitamins|vitamins|mesh-list
154164516|NCT05360342|Vitamin K|vitamin k|mesh-list
154164517|NCT05360342|Vitamin K 1|vitamin k 1|mesh-list
154164518|NCT05360342|Micronutrients|micronutrients|mesh-ancestor
154164519|NCT05360342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154164520|NCT05360342|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
154164521|NCT05360342|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154164522|NCT05360342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154164523|NCT05360342|Hemostatics|hemostatics|mesh-ancestor
154164524|NCT05360342|Coagulants|coagulants|mesh-ancestor
154164525|NCT05290220|Lenvatinib|lenvatinib|mesh-list
154164526|NCT05290220|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154164527|NCT05290220|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154164528|NCT05290220|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153661564|NCT00083083|Mitosis Modulators|mitosis modulators|mesh-ancestor
154164529|NCT05290220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154164530|NCT04026230|Atorvastatin|atorvastatin|mesh-list
154164531|NCT04026230|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153661570|NCT03151863|Dexmedetomidine|dexmedetomidine|mesh-list
154164532|NCT04026230|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154164533|NCT04026230|Antimetabolites|antimetabolites|mesh-ancestor
154164534|NCT04026230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154164535|NCT04026230|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154164536|NCT04026230|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154164537|NCT04026230|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154164538|NCT00536510|Niacin|niacin|mesh-list
154164539|NCT00536510|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154164540|NCT00536510|Antimetabolites|antimetabolites|mesh-ancestor
154164541|NCT00536510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154164552|NCT04424264|Efavirenz, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|efavirenz, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
154164555|NCT04424264|Antiviral Agents|antiviral agents|mesh-ancestor
154164556|NCT04424264|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154164557|NCT04424264|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
154164558|NCT04424264|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154164559|NCT04424264|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154164560|NCT04424264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154164561|NCT04424264|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154164562|NCT04424264|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154164563|NCT04424264|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
154164564|NCT04424264|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154164565|NCT04424264|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
154164566|NCT04424264|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
154164606|NCT00393484|Lamivudine|lamivudine|mesh-list
154164607|NCT00393484|Entecavir|entecavir|mesh-list
154164608|NCT00393484|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
154164609|NCT00393484|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154164610|NCT00393484|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154164611|NCT00393484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154164612|NCT00393484|Antiviral Agents|antiviral agents|mesh-ancestor
154164613|NCT00393484|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154164614|NCT00393484|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154164615|NCT00393484|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154164616|NCT00667823|Macitentan|macitentan|mesh-list
154164617|NCT00667823|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
154164618|NCT00667823|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
154164619|NCT00667823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154164620|NCT00667823|Endothelin B Receptor Antagonists|endothelin b receptor antagonists|mesh-ancestor
154164621|NCT00536120|Natalizumab|natalizumab|mesh-list
154164622|NCT00536120|Keyhole-limpet hemocyanin|keyhole-limpet hemocyanin|mesh-list
154164623|NCT00536120|Immunologic Factors|immunologic factors|mesh-ancestor
154164624|NCT00536120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154164625|NCT00536120|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154164626|NCT00057811|Leucovorin|leucovorin|mesh-list
154164627|NCT00057811|Cytarabine|cytarabine|mesh-list
154164628|NCT00057811|Prednisone|prednisone|mesh-list
154164629|NCT00057811|Methylprednisolone|methylprednisolone|mesh-list
154164632|NCT00057811|Prednisolone|prednisolone|mesh-list
154164633|NCT00057811|Prednisolone acetate|prednisolone acetate|mesh-list
154164634|NCT00057811|Hydrocortisone|hydrocortisone|mesh-list
154164658|NCT00057811|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154164659|NCT00057811|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154164660|NCT00057811|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154164661|NCT00057811|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154164662|NCT00057811|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154164663|NCT00057811|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154164664|NCT00057811|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154164665|NCT00057811|Glucocorticoids|glucocorticoids|mesh-ancestor
154164666|NCT00057811|Hormones|hormones|mesh-ancestor
154164667|NCT00057811|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154164668|NCT00057811|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154164669|NCT00057811|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154164670|NCT00057811|Abortifacient Agents|abortifacient agents|mesh-ancestor
154164671|NCT00057811|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154164672|NCT00057811|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154164673|NCT00057811|Antimetabolites|antimetabolites|mesh-ancestor
154164674|NCT00057811|Dermatologic Agents|dermatologic agents|mesh-ancestor
154164675|NCT00057811|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154164676|NCT00057811|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154164677|NCT00057811|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154164710|NCT01091077|Naringenin|naringenin|mesh-list
154164711|NCT01091077|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154164712|NCT01091077|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154164713|NCT01091077|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
154164714|NCT01091077|Hormone Antagonists|hormone antagonists|mesh-ancestor
154164715|NCT01091077|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154164716|NCT01091077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154164717|NCT01094275|Omeprazole|omeprazole|mesh-list
154164718|NCT01094275|Clopidogrel|clopidogrel|mesh-list
154164719|NCT01094275|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154164720|NCT01094275|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
154164721|NCT01094275|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
154164722|NCT01094275|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
154164723|NCT01094275|Purinergic Agents|purinergic agents|mesh-ancestor
154164724|NCT01094275|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154164725|NCT01094275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154164726|NCT01094275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154164727|NCT01094275|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154164728|NCT01094275|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154164729|NCT01094275|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
154164730|NCT01094275|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154164731|NCT01089205|Metformin|metformin|mesh-list
154164732|NCT01089205|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154164733|NCT01089205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154164734|NCT02866682|Tacrolimus|tacrolimus|mesh-list
154164735|NCT02866682|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154164736|NCT02866682|Immunologic Factors|immunologic factors|mesh-ancestor
154164737|NCT02866682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154164738|NCT02866682|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
154164739|NCT02866682|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154164752|NCT01089439|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
154164753|NCT01089439|Vasodilator Agents|vasodilator agents|mesh-ancestor
154164754|NCT01089439|Gasotransmitters|gasotransmitters|mesh-ancestor
154164755|NCT01089439|Protective Agents|protective agents|mesh-ancestor
154164756|NCT00992030|Rituximab|rituximab|mesh-list
154164757|NCT00992030|Doxorubicin|doxorubicin|mesh-list
154164758|NCT00992030|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
154164759|NCT00992030|Dacarbazine|dacarbazine|mesh-list
154164760|NCT00992030|Bleomycin|bleomycin|mesh-list
154164761|NCT00992030|Vinblastine|vinblastine|mesh-list
154164762|NCT00992030|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154164763|NCT00992030|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154164764|NCT00992030|Immunologic Factors|immunologic factors|mesh-ancestor
154164765|NCT00992030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154164766|NCT00992030|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154164767|NCT00992030|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154164768|NCT00992030|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154164769|NCT00992030|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154164770|NCT00992030|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153661642|NCT00083668|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154164771|NCT00992030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154164772|NCT00992030|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154164773|NCT00992030|Alkylating Agents|alkylating agents|mesh-ancestor
154164774|NCT00992030|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154164775|NCT00992030|Tubulin Modulators|tubulin modulators|mesh-ancestor
154164776|NCT00992030|Antimitotic Agents|antimitotic agents|mesh-ancestor
154164777|NCT00992030|Mitosis Modulators|mitosis modulators|mesh-ancestor
154164778|NCT01976390|Sirolimus|sirolimus|mesh-list
154164779|NCT01976390|Everolimus|everolimus|mesh-list
154164780|NCT01976390|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
154164781|NCT01976390|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154164782|NCT01976390|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154164783|NCT01976390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154164784|NCT01976390|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154164792|NCT00570713|Gemcitabine|gemcitabine|mesh-list
154164795|NCT00570713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154164796|NCT00570713|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154164797|NCT04002440|Candesartan cilexetil|candesartan cilexetil|mesh-list
154164798|NCT04002440|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154164799|NCT04002440|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
154164800|NCT04002440|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
154164801|NCT04002440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154164802|NCT00780377|Bradykinin|bradykinin|mesh-list
154164803|NCT00780377|Kininogens|kininogens|mesh-list
154164804|NCT00780377|Vasodilator Agents|vasodilator agents|mesh-ancestor
154164805|NCT00780377|Cysteine Proteinase Inhibitors|cysteine proteinase inhibitors|mesh-ancestor
154164806|NCT00780377|Protease Inhibitors|protease inhibitors|mesh-ancestor
154164807|NCT00780377|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154164808|NCT00780377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154164809|NCT05219942|Insulin|insulin|mesh-list
154164810|NCT05219942|Insulin Glargine|insulin glargine|mesh-list
154164811|NCT05219942|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154164812|NCT05219942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154164813|NCT00669617|Fluticasone|fluticasone|mesh-list
154164814|NCT00669617|Xhance|xhance|mesh-list
154164815|NCT00669617|Albuterol|albuterol|mesh-list
154164816|NCT00669617|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
154164817|NCT00669617|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154164818|NCT00669617|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154164819|NCT00669617|Autonomic Agents|autonomic agents|mesh-ancestor
154164820|NCT00669617|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154164841|NCT00773201|Sotalol|sotalol|mesh-list
154164842|NCT00773201|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
154164843|NCT00773201|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154164844|NCT00773201|Adrenergic Agents|adrenergic agents|mesh-ancestor
154164845|NCT00773201|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154164846|NCT00773201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154164847|NCT00773201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154164848|NCT00773201|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154164849|NCT00773201|Sympatholytics|sympatholytics|mesh-ancestor
154164850|NCT00773201|Autonomic Agents|autonomic agents|mesh-ancestor
154164851|NCT00773201|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154164852|NCT00777413|Minocycline|minocycline|mesh-list
154164853|NCT00777413|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154164854|NCT00777413|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154164855|NCT05162690|Dapagliflozin|dapagliflozin|mesh-list
154164856|NCT05162690|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
154164857|NCT05162690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154164859|NCT05162690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154164861|NCT00992576|Naloxone|naloxone|mesh-list
154164862|NCT00992576|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
154164863|NCT00992576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154164864|NCT00992576|Sensory System Agents|sensory system agents|mesh-ancestor
154164865|NCT00992576|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154164866|NCT00992576|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154164867|NCT00992576|Narcotics|narcotics|mesh-ancestor
154164868|NCT00992576|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154164869|NCT00992576|Analgesics|analgesics|mesh-ancestor
154164870|NCT00777569|Nicotine|nicotine|mesh-list
154164871|NCT00777569|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
154164872|NCT00777569|Autonomic Agents|autonomic agents|mesh-ancestor
154164873|NCT00777569|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153814483|NCT00446082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154164874|NCT00777569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154164875|NCT00777569|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
153814484|NCT03275376|Atorvastatin|atorvastatin|mesh-list
154164876|NCT00777569|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
154164877|NCT00777569|Cholinergic Agents|cholinergic agents|mesh-ancestor
154164878|NCT00777569|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154164879|NCT00777569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154164880|NCT02556593|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
154164881|NCT02556593|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154164882|NCT02556593|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154164883|NCT02556593|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154164884|NCT02556593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154164885|NCT02556593|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154164887|NCT00535730|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
154164888|NCT00535730|Immunologic Factors|immunologic factors|mesh-ancestor
154164889|NCT00535730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154164890|NCT00992654|Maraviroc|maraviroc|mesh-list
154164891|NCT00992654|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
154164892|NCT00992654|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
154164893|NCT00992654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154164894|NCT00992654|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154164895|NCT00992654|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154164896|NCT00992654|Antiviral Agents|antiviral agents|mesh-ancestor
154164897|NCT00992654|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154164898|NCT00992654|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
154164899|NCT00773591|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
154164900|NCT00773591|Botulinum Toxins|botulinum toxins|mesh-list
154164901|NCT00773591|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
154164902|NCT00773591|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
154164903|NCT00773591|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154164904|NCT00773591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154164905|NCT00773591|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
154164906|NCT00773591|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154164907|NCT00773591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154164908|NCT00773591|Cholinergic Agents|cholinergic agents|mesh-ancestor
154164909|NCT00773591|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154164922|NCT00781157|Phenylephrine|phenylephrine|mesh-list
154164923|NCT00781157|Oxymetazoline|oxymetazoline|mesh-list
154164924|NCT00781157|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
154164925|NCT00781157|Mydriatics|mydriatics|mesh-ancestor
154164926|NCT00781157|Autonomic Agents|autonomic agents|mesh-ancestor
154164927|NCT00781157|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154164928|NCT00781157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154164929|NCT00781157|Sympathomimetics|sympathomimetics|mesh-ancestor
154164930|NCT00781157|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154164931|NCT00781157|Nasal Decongestants|nasal decongestants|mesh-ancestor
153661782|NCT00135811|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154164932|NCT00781157|Respiratory System Agents|respiratory system agents|mesh-ancestor
154164933|NCT00781157|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
154164934|NCT00781157|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154164935|NCT00781157|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154164936|NCT00781157|Adrenergic Agents|adrenergic agents|mesh-ancestor
154164937|NCT00781157|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154164938|NCT00781157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154164939|NCT00781157|Protective Agents|protective agents|mesh-ancestor
154164940|NCT00777959|Sirolimus|sirolimus|mesh-list
154164941|NCT00777959|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154164942|NCT00777959|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154164944|NCT00777959|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154164977|NCT00778193|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154164978|NCT00778193|Analgesics|analgesics|mesh-ancestor
154164979|NCT00778193|Sensory System Agents|sensory system agents|mesh-ancestor
154164980|NCT00778193|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154164981|NCT00778193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154164982|NCT00778193|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154164983|NCT00778193|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154164984|NCT00778193|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154164985|NCT00778193|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154164986|NCT00778193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154164987|NCT00778193|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154164988|NCT00778193|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154164989|NCT00778193|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154164990|NCT00778193|Antipyretics|antipyretics|mesh-ancestor
154164991|NCT00778193|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
154164992|NCT00778193|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
154164993|NCT00778193|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
154164994|NCT00778193|Purinergic Agents|purinergic agents|mesh-ancestor
154164995|NCT00778193|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154164996|NCT00778193|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
154164997|NCT00778193|Gout Suppressants|gout suppressants|mesh-ancestor
154164998|NCT00778271|Gabapentin|gabapentin|mesh-list
154164999|NCT00778271|Analgesics|analgesics|mesh-ancestor
154165029|NCT00995618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154165030|NCT00995618|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154165031|NCT00995618|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
153661843|NCT00136396|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154165032|NCT00995618|Histamine Antagonists|histamine antagonists|mesh-ancestor
154165033|NCT00995618|Histamine Agents|histamine agents|mesh-ancestor
154165034|NCT00995618|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154165035|NCT00995618|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154165036|NCT00995618|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154165037|NCT00778427|Metformin|metformin|mesh-list
154165038|NCT00778427|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154165039|NCT00778427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154165040|NCT03889886|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
154165041|NCT03889886|Ophthalmic Solutions|ophthalmic solutions|mesh-list
154165042|NCT00667355|Adalimumab|adalimumab|mesh-list
154165043|NCT00667355|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
154165044|NCT00667355|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154165045|NCT00667355|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154165046|NCT00778505|Remifentanil|remifentanil|mesh-list
154165047|NCT00778505|Propofol|propofol|mesh-list
154165048|NCT00778505|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154165049|NCT00778505|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154165050|NCT00778505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154165051|NCT00778505|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154165052|NCT00778505|Anesthetics, General|anesthetics, general|mesh-ancestor
154165053|NCT00778505|Anesthetics|anesthetics|mesh-ancestor
154165054|NCT00778505|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154165055|NCT00778505|Narcotics|narcotics|mesh-ancestor
154165056|NCT00778505|Analgesics|analgesics|mesh-ancestor
154165057|NCT00778505|Sensory System Agents|sensory system agents|mesh-ancestor
154165058|NCT00778505|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154165059|NCT00532844|Vitamins|vitamins|mesh-list
154165060|NCT00532844|Ascorbic Acid|ascorbic acid|mesh-list
154165061|NCT00532844|Verapamil|verapamil|mesh-list
154165064|NCT00532844|Antioxidants|antioxidants|mesh-ancestor
154165070|NCT00532844|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154165072|NCT00778583|Nitrofurantoin|nitrofurantoin|mesh-list
154165073|NCT00778583|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
154165074|NCT00778583|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154165075|NCT00778583|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154165076|NCT00778661|Amoxicillin|amoxicillin|mesh-list
154165077|NCT00778661|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154165078|NCT00778661|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153488614|NCT02282514|Hormones|hormones|mesh-ancestor
154165079|NCT00993356|Lanreotide|lanreotide|mesh-list
154165080|NCT00993356|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154165081|NCT00781547|Hormones|hormones|mesh-list
153810407|NCT00421473|Atovaquone|atovaquone|mesh-list
154165082|NCT00781547|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154165083|NCT00781547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154165084|NCT00778739|Cefprozil|cefprozil|mesh-list
154165085|NCT00778739|Beta Lactam Antibiotics|beta lactam antibiotics|mesh-ancestor
154165086|NCT00778739|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154165087|NCT00778739|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154165088|NCT00781625|Methenamine hippurate|methenamine hippurate|mesh-list
154165089|NCT00781625|Methenamine|methenamine|mesh-list
154165123|NCT00774527|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154165124|NCT00774527|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154165125|NCT00778973|Sertraline|sertraline|mesh-list
154165126|NCT00778973|Antidepressive Agents|antidepressive agents|mesh-ancestor
154165127|NCT00778973|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154165128|NCT00778973|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
154165129|NCT00778973|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153463280|NCT02884908|Pregabalin|pregabalin|mesh-list
153463281|NCT02884908|Analgesics|analgesics|mesh-ancestor
153463282|NCT02884908|Sensory System Agents|sensory system agents|mesh-ancestor
153463283|NCT02884908|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154165130|NCT00778973|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154165131|NCT00778973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154165132|NCT00778973|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154165133|NCT00778973|Serotonin Agents|serotonin agents|mesh-ancestor
154165134|NCT00778973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154165135|NCT00774605|Varenicline|varenicline|mesh-list
154165136|NCT00774605|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
154165137|NCT00774605|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
154165138|NCT00774605|Cholinergic Agents|cholinergic agents|mesh-ancestor
154165139|NCT00774605|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154165140|NCT00774605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154165141|NCT00774605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154165142|NCT00779051|Zolpidem|zolpidem|mesh-list
154165143|NCT00779051|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
154165144|NCT00779051|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154165145|NCT00779051|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154165146|NCT00779051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154165147|NCT00779051|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
154165148|NCT00779051|GABA Agonists|gaba agonists|mesh-ancestor
154165149|NCT00779051|GABA Agents|gaba agents|mesh-ancestor
154165150|NCT00779051|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154165151|NCT00779051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154165152|NCT00774683|Raltegravir Potassium|raltegravir potassium|mesh-list
154165165|NCT00784511|Micronutrients|micronutrients|mesh-ancestor
154165166|NCT00784511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154165167|NCT00784511|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154165168|NCT00784511|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154165169|NCT00784589|Rituximab|rituximab|mesh-list
154165170|NCT00784589|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154165171|NCT00784589|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154165172|NCT00784589|Immunologic Factors|immunologic factors|mesh-ancestor
154165173|NCT00784589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154165174|NCT00784589|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154165175|NCT00784667|Cetuximab|cetuximab|mesh-list
154165176|NCT00784667|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
154165177|NCT00784667|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154165178|NCT00784667|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154165179|NCT00784667|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154165180|NCT00784667|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154165181|NCT00784667|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154165182|NCT00784667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154165220|NCT00993746|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154165221|NCT00993746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154165222|NCT00993746|Sensory System Agents|sensory system agents|mesh-ancestor
154165223|NCT00993746|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154165224|NCT00993746|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154165225|NCT00993746|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154165226|NCT00993746|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154165227|NCT00993746|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154165228|NCT00993746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154165230|NCT00789971|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
154165231|NCT00789971|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
154165232|NCT00789971|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
154165233|NCT00789971|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154165234|NCT00789971|Glucocorticoids|glucocorticoids|mesh-ancestor
154165235|NCT00789971|Hormones|hormones|mesh-ancestor
154165236|NCT00789971|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154165237|NCT00789971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154165238|NCT00789971|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154165239|NCT00789971|Immunologic Factors|immunologic factors|mesh-ancestor
154165240|NCT00789971|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154165241|NCT00789971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154165242|NCT00782405|Quetiapine Fumarate|quetiapine fumarate|mesh-list
154165243|NCT00782405|Mirtazapine|mirtazapine|mesh-list
154165244|NCT00782405|Antidepressive Agents|antidepressive agents|mesh-ancestor
154165245|NCT00782405|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154165246|NCT00782405|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154165247|NCT00782405|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153463349|NCT03822936|Antimetabolites|antimetabolites|mesh-ancestor
153662071|NCT00137995|Alkylating Agents|alkylating agents|mesh-ancestor
153662074|NCT00138112|Vancomycin|vancomycin|mesh-list
154165248|NCT00782405|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154165261|NCT00782405|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154165262|NCT00782405|Serotonin Agents|serotonin agents|mesh-ancestor
154165263|NCT00782405|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
154165265|NCT05343260|Sevoflurane|sevoflurane|mesh-list
154165266|NCT05343260|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154165267|NCT05343260|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154165268|NCT05343260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154165269|NCT05343260|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154165270|NCT05343260|Anesthetics, General|anesthetics, general|mesh-ancestor
154165271|NCT05343260|Anesthetics|anesthetics|mesh-ancestor
154165272|NCT05343260|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154165273|NCT05343260|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
154165274|NCT00664859|Atorvastatin|atorvastatin|mesh-list
154165275|NCT00664859|Fenofibrate|fenofibrate|mesh-list
154165276|NCT00664859|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154165277|NCT00664859|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154165278|NCT00664859|Antimetabolites|antimetabolites|mesh-ancestor
154165279|NCT00664859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154165320|NCT00790439|Anticoagulants|anticoagulants|mesh-ancestor
154165321|NCT00790439|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154165322|NCT00790439|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154165323|NCT00790439|Plasma Substitutes|plasma substitutes|mesh-ancestor
154165324|NCT00790439|Blood Substitutes|blood substitutes|mesh-ancestor
154165326|NCT00785603|Paroxetine|paroxetine|mesh-list
154165327|NCT00785603|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154165328|NCT00785603|Narcotics|narcotics|mesh-ancestor
154165329|NCT00785603|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154165330|NCT00785603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154165331|NCT00785603|Analgesics|analgesics|mesh-ancestor
154165332|NCT00785603|Sensory System Agents|sensory system agents|mesh-ancestor
154165333|NCT00785603|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154165334|NCT00785603|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
154165335|NCT00785603|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154165336|NCT00785603|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154165337|NCT00785603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154165338|NCT00785603|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154165339|NCT00785603|Serotonin Agents|serotonin agents|mesh-ancestor
154165340|NCT00785603|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
154165341|NCT00785603|Antidepressive Agents|antidepressive agents|mesh-ancestor
154165342|NCT00785603|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154165343|NCT00785603|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
154165344|NCT00785603|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154165345|NCT00785603|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154165346|NCT00570401|Dasatinib|dasatinib|mesh-list
154165347|NCT00570401|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154165348|NCT00570401|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154165349|NCT00570401|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154165350|NCT00570401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154165351|NCT00570401|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154165352|NCT00532298|Vaccines|vaccines|mesh-list
154165353|NCT00532298|Immunologic Factors|immunologic factors|mesh-ancestor
154165355|NCT04047017|Apatinib|apatinib|mesh-list
154165359|NCT04047017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154165360|NCT00997022|Sorafenib|sorafenib|mesh-list
154165361|NCT00997022|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154165362|NCT00997022|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154165363|NCT00997022|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154165364|NCT00997022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154165365|NCT00786149|Varenicline|varenicline|mesh-list
154165366|NCT00786149|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
154165367|NCT00786149|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
154165368|NCT00786149|Cholinergic Agents|cholinergic agents|mesh-ancestor
154165369|NCT00786149|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154165370|NCT00786149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154165371|NCT00786149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154165372|NCT00410410|Abatacept|abatacept|mesh-list
154165373|NCT00410410|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154165374|NCT00410410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154165375|NCT00410410|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154165376|NCT00410410|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154165377|NCT00410410|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154165378|NCT00410410|Immunologic Factors|immunologic factors|mesh-ancestor
153545649|NCT06304298|Anesthetics, Local|anesthetics, local|mesh-ancestor
154165379|NCT00410410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154165380|NCT00410410|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154165381|NCT00782951|Morphine|morphine|mesh-list
154165382|NCT00782951|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154165383|NCT00782951|Narcotics|narcotics|mesh-ancestor
154165384|NCT00782951|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154165385|NCT00782951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154165386|NCT00782951|Analgesics|analgesics|mesh-ancestor
154165387|NCT00782951|Sensory System Agents|sensory system agents|mesh-ancestor
154165389|NCT02555813|Paclitaxel|paclitaxel|mesh-list
154165401|NCT00997412|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154165402|NCT00997412|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154165403|NCT00997412|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
154165404|NCT00997412|Antitubercular Agents|antitubercular agents|mesh-ancestor
154165405|NCT00997412|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154165406|NCT00997412|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154165407|NCT00997412|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154165408|NCT00997412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154165409|NCT00783107|Cyclosporine|cyclosporine|mesh-list
154165410|NCT00783107|Cyclosporins|cyclosporins|mesh-list
154165411|NCT00783107|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154165412|NCT00783107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154165413|NCT00783107|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154165414|NCT00783107|Immunologic Factors|immunologic factors|mesh-ancestor
154165415|NCT00783107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154165416|NCT00783107|Antifungal Agents|antifungal agents|mesh-ancestor
154165417|NCT00783107|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154165418|NCT00783107|Dermatologic Agents|dermatologic agents|mesh-ancestor
154165419|NCT00783107|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154165420|NCT00783107|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
154165421|NCT00534404|Nicotine|nicotine|mesh-list
154165422|NCT00534404|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
154165423|NCT00534404|Autonomic Agents|autonomic agents|mesh-ancestor
154165424|NCT00534404|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154165449|NCT00783653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154165450|NCT00783653|Growth Inhibitors|growth inhibitors|mesh-ancestor
154165451|NCT00783653|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154165452|NCT00783653|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154165453|NCT00783653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154165455|NCT00786305|Ceftazidime|ceftazidime|mesh-list
154165456|NCT00786305|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154165457|NCT00786305|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154165458|NCT00786305|Third Generation Cephalosporins|third generation cephalosporins|mesh-ancestor
154165459|NCT00786305|Beta Lactam Antibiotics|beta lactam antibiotics|mesh-ancestor
154165460|NCT01044004|Modafinil|modafinil|mesh-list
154165461|NCT01044004|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
154165462|NCT01044004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154165463|NCT01044004|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
153662339|NCT00139750|Cholinergic Agents|cholinergic agents|mesh-ancestor
153662340|NCT00139750|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154165464|NCT01044004|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
154165465|NCT01044004|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
154165466|NCT01044004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154165467|NCT00786383|Ramucirumab|ramucirumab|mesh-list
154165468|NCT00786383|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154165469|NCT00786383|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154165470|NCT00786383|Growth Substances|growth substances|mesh-ancestor
154165471|NCT00786383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154165472|NCT00786383|Growth Inhibitors|growth inhibitors|mesh-ancestor
154165473|NCT00786383|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154165474|NCT00790595|Sunitinib|sunitinib|mesh-list
154165484|NCT00783731|Midazolam|midazolam|mesh-list
154165497|NCT00783731|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154165498|NCT00783731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154165499|NCT00409708|Methylphenidate|methylphenidate|mesh-list
154165500|NCT00409708|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
154165501|NCT00409708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154165502|NCT00409708|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
154165503|NCT00409708|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154165504|NCT00409708|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154165505|NCT00409708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154165506|NCT00409708|Dopamine Agents|dopamine agents|mesh-ancestor
154165507|NCT00409708|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154165559|NCT00391846|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154165560|NCT00391846|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
154165561|NCT00391846|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
154165562|NCT00391846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154165563|NCT00391846|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154165564|NCT00391846|Sympatholytics|sympatholytics|mesh-ancestor
154165565|NCT00391846|Autonomic Agents|autonomic agents|mesh-ancestor
154165566|NCT00391846|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154165567|NCT00391846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154165568|NCT00391846|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
154165569|NCT00391846|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
154165570|NCT00391846|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154165571|NCT00391846|Adrenergic Agents|adrenergic agents|mesh-ancestor
154165572|NCT00391846|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154165573|NCT00391846|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
154165574|NCT00391846|Hormone Antagonists|hormone antagonists|mesh-ancestor
154165575|NCT00391846|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154165576|NCT00391846|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
154165577|NCT00391846|Natriuretic Agents|natriuretic agents|mesh-ancestor
154165578|NCT00391846|Antioxidants|antioxidants|mesh-ancestor
154165579|NCT00391846|Protective Agents|protective agents|mesh-ancestor
154165580|NCT00391846|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154165581|NCT00391846|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154165582|NCT00391846|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154165583|NCT00391846|Vasodilator Agents|vasodilator agents|mesh-ancestor
154165603|NCT00391222|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154165604|NCT00391222|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154165605|NCT00391222|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154165606|NCT00391222|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
154165607|NCT00391222|Dopamine Agents|dopamine agents|mesh-ancestor
154165609|NCT00391222|Autonomic Agents|autonomic agents|mesh-ancestor
154165610|NCT00391222|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154165611|NCT00391222|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154165612|NCT00391222|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
154165613|NCT00391222|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154165614|NCT00391222|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154165615|NCT00409006|Pemetrexed|pemetrexed|mesh-list
154165616|NCT00409006|Gefitinib|gefitinib|mesh-list
154165617|NCT00409006|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153662414|NCT00140452|Thalidomide|thalidomide|mesh-list
154165618|NCT00409006|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154165619|NCT00409006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154165620|NCT00409006|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154165621|NCT00409006|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154165622|NCT00409006|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154165623|NCT00409006|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154165624|NCT00997880|Calcium, Dietary|calcium, dietary|mesh-list
154165625|NCT00997880|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
154165626|NCT00997880|Calcium|calcium|mesh-list
154165627|NCT00997880|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154165628|NCT00997880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154165629|NCT00997880|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154165630|NCT00997880|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154165631|NCT00997880|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154165632|NCT00997880|Antimetabolites|antimetabolites|mesh-ancestor
154165633|NCT00997880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154165634|NCT00997880|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154165636|NCT00997880|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154165644|NCT00997958|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154165645|NCT00997958|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154165646|NCT00997958|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154165647|NCT00997958|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154165648|NCT00998036|Sirolimus|sirolimus|mesh-list
154165649|NCT00998036|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
154165650|NCT00998036|Temsirolimus|temsirolimus|mesh-list
154165651|NCT00998036|MTOR Inhibitors|mtor inhibitors|mesh-list
154165652|NCT00998036|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154165653|NCT00998036|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154165654|NCT00998036|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154165655|NCT00998036|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154165656|NCT00998036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154165657|NCT00998036|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154165658|NCT00998036|Immunologic Factors|immunologic factors|mesh-ancestor
154165659|NCT00998036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154165660|NCT00998036|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154165661|NCT00998036|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154165662|NCT00998036|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154165663|NCT00998036|Antifungal Agents|antifungal agents|mesh-ancestor
154165664|NCT05254808|Fosfomycin|fosfomycin|mesh-list
154165698|NCT00788684|Rituximab|rituximab|mesh-list
154165699|NCT00788684|Navitoclax|navitoclax|mesh-list
154165700|NCT00788684|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154165701|NCT00788684|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154165702|NCT00788684|Immunologic Factors|immunologic factors|mesh-ancestor
154165703|NCT00788684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154165704|NCT00788684|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154165705|NCT00998972|Acetylcysteine|acetylcysteine|mesh-list
154165706|NCT00998972|N-monoacetylcystine|n-monoacetylcystine|mesh-list
154165707|NCT00998972|Antiviral Agents|antiviral agents|mesh-ancestor
154165708|NCT00998972|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154165709|NCT00998972|Expectorants|expectorants|mesh-ancestor
154165710|NCT00998972|Respiratory System Agents|respiratory system agents|mesh-ancestor
154165711|NCT00998972|Free Radical Scavengers|free radical scavengers|mesh-ancestor
154165712|NCT00998972|Antioxidants|antioxidants|mesh-ancestor
154165713|NCT00998972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154165714|NCT00998972|Protective Agents|protective agents|mesh-ancestor
154165758|NCT00408694|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154165759|NCT00408694|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154165760|NCT00408694|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154165762|NCT00408694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154165763|NCT00408694|Growth Inhibitors|growth inhibitors|mesh-ancestor
154165764|NCT00408694|Immunologic Factors|immunologic factors|mesh-ancestor
154165765|NCT00408694|Antimetabolites|antimetabolites|mesh-ancestor
154165766|NCT00408694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154165767|NCT00408694|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153662417|NCT00140452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153662455|NCT00140725|Interferons|interferons|mesh-list
154165768|NCT00408694|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154165769|NCT00999128|Rabeprazole|rabeprazole|mesh-list
154165770|NCT00999128|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154165771|NCT00999128|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154165772|NCT00999128|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
154165773|NCT00999128|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154165774|NCT00999128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154165775|NCT00999206|Vaccines|vaccines|mesh-list
154165776|NCT00999206|Immunologic Factors|immunologic factors|mesh-ancestor
154165777|NCT00999206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154165778|NCT01043224|Clobetasol|clobetasol|mesh-list
154165811|NCT03474094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154165812|NCT03474094|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154165813|NCT03474094|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154165814|NCT03474094|Immunologic Factors|immunologic factors|mesh-ancestor
154165815|NCT03474094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154165816|NCT01043536|Temozolomide|temozolomide|mesh-list
154165817|NCT01043536|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154165818|NCT01043536|Alkylating Agents|alkylating agents|mesh-ancestor
154165819|NCT01043536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154165820|NCT01043536|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154165821|NCT01004198|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
154165822|NCT00056407|Dutasteride|dutasteride|mesh-list
154165823|NCT00056407|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
153619261|NCT01983735|Niacin|niacin|mesh-list
154165870|NCT04001348|Anticonvulsants|anticonvulsants|mesh-ancestor
154165871|NCT04001348|Antiemetics|antiemetics|mesh-ancestor
154165872|NCT04001348|Autonomic Agents|autonomic agents|mesh-ancestor
154165873|NCT04001348|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154165874|NCT04001348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154165875|NCT04001348|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154165876|NCT04001348|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154165877|NCT04001348|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154165878|NCT04001348|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
154165879|NCT04001348|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
154165880|NCT04001348|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154165881|NCT04001348|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153463415|NCT01891500|Nitric Oxide|nitric oxide|mesh-list
154165882|NCT04001348|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154165883|NCT04001348|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154165884|NCT04001348|Anesthetics, General|anesthetics, general|mesh-ancestor
154165885|NCT04001348|Anesthetics|anesthetics|mesh-ancestor
154165886|NCT04001348|GABA Modulators|gaba modulators|mesh-ancestor
154165887|NCT04001348|GABA Agents|gaba agents|mesh-ancestor
154165888|NCT04001348|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154165889|NCT04001348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154165890|NCT00395512|Pioglitazone|pioglitazone|mesh-list
154165891|NCT00395512|Alogliptin|alogliptin|mesh-list
154165892|NCT00395512|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154165893|NCT00395512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154165894|NCT00395512|Incretins|incretins|mesh-ancestor
154165895|NCT00395512|Hormones|hormones|mesh-ancestor
154165896|NCT00395512|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154165897|NCT00395512|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
154165898|NCT00395512|Protease Inhibitors|protease inhibitors|mesh-ancestor
154165899|NCT00395512|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154165900|NCT00395512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154165901|NCT03956017|Ubiquinone|ubiquinone|mesh-list
154165902|NCT03956017|Coenzyme Q10|coenzyme q10|mesh-list
154165914|NCT00999440|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154165915|NCT00999440|Narcotics|narcotics|mesh-ancestor
154165916|NCT00999440|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154165917|NCT00999440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154165918|NCT00999440|Analgesics|analgesics|mesh-ancestor
154165919|NCT00999440|Sensory System Agents|sensory system agents|mesh-ancestor
154165920|NCT00999440|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154165921|NCT00999440|Antitussive Agents|antitussive agents|mesh-ancestor
154165922|NCT00999440|Respiratory System Agents|respiratory system agents|mesh-ancestor
154165923|NCT00054691|Gefitinib|gefitinib|mesh-list
154165924|NCT00054691|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154165925|NCT00054691|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154165926|NCT00054691|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154165927|NCT00054691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154165928|NCT00054691|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154165929|NCT02530879|Esomeprazole|esomeprazole|mesh-list
154165930|NCT02530879|Omeprazole|omeprazole|mesh-list
154165931|NCT02530879|Lansoprazole|lansoprazole|mesh-list
154165932|NCT02530879|Dexlansoprazole|dexlansoprazole|mesh-list
154165933|NCT02530879|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154165934|NCT02530879|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154165935|NCT02530879|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
154165936|NCT02530879|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154165937|NCT02530879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154165938|NCT03957499|Dexamethasone|dexamethasone|mesh-list
154165939|NCT03957499|Magnesium Sulfate|magnesium sulfate|mesh-list
154165940|NCT03957499|Bupivacaine|bupivacaine|mesh-list
154165941|NCT03957499|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154165942|NCT03957499|Antiemetics|antiemetics|mesh-ancestor
154165943|NCT03957499|Autonomic Agents|autonomic agents|mesh-ancestor
154165944|NCT03957499|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154165945|NCT03957499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154165946|NCT03957499|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154165947|NCT03957499|Glucocorticoids|glucocorticoids|mesh-ancestor
154165948|NCT03957499|Hormones|hormones|mesh-ancestor
154165955|NCT03957499|Sensory System Agents|sensory system agents|mesh-ancestor
154165956|NCT03957499|Analgesics|analgesics|mesh-ancestor
154165957|NCT03957499|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154165958|NCT03957499|Anticonvulsants|anticonvulsants|mesh-ancestor
154165959|NCT03957499|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154165960|NCT03957499|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154165961|NCT03957499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154165962|NCT03957499|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154165963|NCT03957499|Tocolytic Agents|tocolytic agents|mesh-ancestor
154165964|NCT03957499|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154165965|NCT01040338|Nicotine|nicotine|mesh-list
154165966|NCT01040338|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
154165967|NCT01040338|Autonomic Agents|autonomic agents|mesh-ancestor
154165968|NCT01040338|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154165969|NCT01040338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154165970|NCT01040338|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
154165971|NCT01040338|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
154165972|NCT01040338|Cholinergic Agents|cholinergic agents|mesh-ancestor
154165973|NCT01040338|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154165974|NCT01040338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154165975|NCT03955939|Midazolam|midazolam|mesh-list
154165976|NCT03955939|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154165977|NCT03955939|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154165978|NCT03955939|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154165979|NCT03955939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154165980|NCT03955939|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154165981|NCT03955939|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154165982|NCT03955939|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154165983|NCT03955939|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154165984|NCT03955939|Anesthetics, General|anesthetics, general|mesh-ancestor
154165985|NCT03955939|Anesthetics|anesthetics|mesh-ancestor
154165990|NCT01094821|ATI 7505|ati 7505|mesh-list
154165998|NCT00072475|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154165999|NCT00072475|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154166000|NCT00072475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154166001|NCT01091701|Plasma-lyte 148|plasma-lyte 148|mesh-list
154166002|NCT01091701|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
154166003|NCT01091701|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
154166004|NCT00066469|Prednisone|prednisone|mesh-list
154166005|NCT00066469|Methylprednisolone|methylprednisolone|mesh-list
154166006|NCT00066469|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
154166007|NCT00066469|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
154166008|NCT00066469|Prednisolone|prednisolone|mesh-list
154166009|NCT00066469|Prednisolone acetate|prednisolone acetate|mesh-list
154166010|NCT00066469|Cyclophosphamide|cyclophosphamide|mesh-list
154166011|NCT00066469|Rituximab|rituximab|mesh-list
154166012|NCT00066469|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
154166013|NCT00066469|Prednisolone phosphate|prednisolone phosphate|mesh-list
154166014|NCT00066469|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154166015|NCT00066469|Immunologic Factors|immunologic factors|mesh-ancestor
154166016|NCT00066469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154166017|NCT00066469|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154166018|NCT00066469|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154166019|NCT00066469|Alkylating Agents|alkylating agents|mesh-ancestor
154166020|NCT00066469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154166021|NCT00066469|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154166022|NCT00066469|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154166023|NCT00066469|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154166024|NCT00066469|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154166025|NCT00066469|Glucocorticoids|glucocorticoids|mesh-ancestor
154166026|NCT00066469|Hormones|hormones|mesh-ancestor
154166027|NCT00066469|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154166028|NCT00066469|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154166029|NCT00066469|Antiemetics|antiemetics|mesh-ancestor
154166030|NCT00066469|Autonomic Agents|autonomic agents|mesh-ancestor
154166031|NCT00066469|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154166037|NCT01094977|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154166038|NCT01094977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154166039|NCT01094977|Hemostatics|hemostatics|mesh-ancestor
154166040|NCT01094977|Coagulants|coagulants|mesh-ancestor
154166041|NCT01095133|Amiloride|amiloride|mesh-list
154166042|NCT01095133|Diuretics|diuretics|mesh-ancestor
154166043|NCT01095133|Natriuretic Agents|natriuretic agents|mesh-ancestor
154166044|NCT01095133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154166045|NCT01095133|Acid Sensing Ion Channel Blockers|acid sensing ion channel blockers|mesh-ancestor
154166046|NCT01095133|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154166047|NCT01095133|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154166048|NCT01095133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154166049|NCT01095133|Epithelial Sodium Channel Blockers|epithelial sodium channel blockers|mesh-ancestor
154166050|NCT01095133|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
154166051|NCT00387088|Tiotropium Bromide|tiotropium bromide|mesh-list
154166052|NCT00387088|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154166053|NCT00387088|Autonomic Agents|autonomic agents|mesh-ancestor
154166054|NCT00387088|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154166055|NCT00387088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154166056|NCT00387088|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154166057|NCT00387088|Respiratory System Agents|respiratory system agents|mesh-ancestor
154166058|NCT00387088|Parasympatholytics|parasympatholytics|mesh-ancestor
154166059|NCT00387088|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154166060|NCT00387088|Cholinergic Agents|cholinergic agents|mesh-ancestor
154166061|NCT00387088|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154166062|NCT00387088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154166063|NCT01095211|Vitamin B Complex|vitamin b complex|mesh-list
154166065|NCT01095211|Micronutrients|micronutrients|mesh-ancestor
154166066|NCT01095211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154166067|NCT01089985|Ophthalmic Solutions|ophthalmic solutions|mesh-list
154166068|NCT01089985|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
154166069|NCT00053365|Irofulven|irofulven|mesh-list
154166070|NCT00053365|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154166071|NCT00053365|Alkylating Agents|alkylating agents|mesh-ancestor
154166072|NCT00053365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154166075|NCT00387010|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154166076|NCT00387010|Narcotics|narcotics|mesh-ancestor
154166077|NCT00387010|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154166078|NCT00387010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154166079|NCT00387010|Analgesics|analgesics|mesh-ancestor
154166080|NCT00387010|Sensory System Agents|sensory system agents|mesh-ancestor
154166081|NCT00387010|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154166082|NCT00387010|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154166083|NCT00387010|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154166084|NCT00387010|Anesthetics, General|anesthetics, general|mesh-ancestor
154166085|NCT00387010|Anesthetics|anesthetics|mesh-ancestor
154166086|NCT01092091|BCT-100|bct-100|mesh-list
154166087|NCT01092091|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154166088|NCT00065065|Rosiglitazone|rosiglitazone|mesh-list
154166089|NCT00065065|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154166090|NCT00065065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154166091|NCT00386308|Tranexamic Acid|tranexamic acid|mesh-list
154166092|NCT00386308|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
154166093|NCT00386308|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154166094|NCT00386308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154166095|NCT00386308|Hemostatics|hemostatics|mesh-ancestor
154166096|NCT00386308|Coagulants|coagulants|mesh-ancestor
154166097|NCT00064987|Hormones|hormones|mesh-list
154166098|NCT00064987|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
154166099|NCT00064987|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154166100|NCT00064987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154166101|NCT00374140|Everolimus|everolimus|mesh-list
154166102|NCT00374140|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
154166103|NCT00374140|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154166104|NCT00374140|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154166105|NCT00374140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154166106|NCT00374140|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154166107|NCT00374140|Immunologic Factors|immunologic factors|mesh-ancestor
154166108|NCT00374140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154166109|NCT00374140|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154166110|NCT00665561|Maraviroc|maraviroc|mesh-list
154166111|NCT00665561|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
153675873|NCT00031850|Goserelin|goserelin|mesh-list
153646520|NCT00115609|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
154166112|NCT00665561|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
154166113|NCT00665561|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
154166114|NCT00665561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154166115|NCT00665561|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154166116|NCT00665561|Antiviral Agents|antiviral agents|mesh-ancestor
154166117|NCT00665561|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154166118|NCT00665561|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
154166119|NCT03955705|Nefopam|nefopam|mesh-list
154166120|NCT03955705|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154166121|NCT03955705|Analgesics|analgesics|mesh-ancestor
154166122|NCT03955705|Sensory System Agents|sensory system agents|mesh-ancestor
154166123|NCT03955705|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154166124|NCT03955705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154166125|NCT00786461|Silver Nitrate|silver nitrate|mesh-list
153619557|NCT01985594|Hormones|hormones|mesh-ancestor
154166126|NCT00786461|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154166127|NCT00786461|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154166128|NCT00786695|Esomeprazole|esomeprazole|mesh-list
154166129|NCT00786695|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154166130|NCT00786695|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154166131|NCT00786695|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
154166132|NCT00786695|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154166133|NCT00786695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154166134|NCT00786851|Lenalidomide|lenalidomide|mesh-list
154166135|NCT00786851|Immunologic Factors|immunologic factors|mesh-ancestor
154166137|NCT00786851|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154166162|NCT00787553|Alkylating Agents|alkylating agents|mesh-ancestor
154166163|NCT00787553|Antitrichomonal Agents|antitrichomonal agents|mesh-ancestor
154166164|NCT00787553|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154166165|NCT00787553|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154166166|NCT00795353|Alefacept|alefacept|mesh-list
154166167|NCT00795353|Dermatologic Agents|dermatologic agents|mesh-ancestor
154166168|NCT00795353|Immunologic Factors|immunologic factors|mesh-ancestor
154166169|NCT00795353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154166170|NCT00791297|Ulipristal acetate|ulipristal acetate|mesh-list
154166171|NCT00791297|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
154166172|NCT00791297|Contraceptive Agents|contraceptive agents|mesh-ancestor
154166173|NCT00791297|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154166174|NCT00791297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154166175|NCT00791297|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
154166176|NCT01045876|Dexamethasone|dexamethasone|mesh-list
154166177|NCT01045876|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154166178|NCT01045876|Antiemetics|antiemetics|mesh-ancestor
154166179|NCT01045876|Autonomic Agents|autonomic agents|mesh-ancestor
154166180|NCT01045876|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154166181|NCT01045876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154166182|NCT01045876|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154166183|NCT01045876|Glucocorticoids|glucocorticoids|mesh-ancestor
154166184|NCT01045876|Hormones|hormones|mesh-ancestor
154166185|NCT01045876|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154166186|NCT01045876|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154166187|NCT01045876|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154166188|NCT00385762|Paroxetine|paroxetine|mesh-list
154166189|NCT00385762|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-list
154166209|NCT00385684|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154166210|NCT00385684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154166211|NCT00385684|Analgesics|analgesics|mesh-ancestor
154166212|NCT00385684|Sensory System Agents|sensory system agents|mesh-ancestor
154166213|NCT00385684|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154166214|NCT00385684|Antitussive Agents|antitussive agents|mesh-ancestor
154166215|NCT00385684|Respiratory System Agents|respiratory system agents|mesh-ancestor
154166216|NCT00385684|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154166217|NCT00385684|Antipyretics|antipyretics|mesh-ancestor
154166218|NCT00385684|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154166219|NCT00385684|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154166220|NCT00385684|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154166221|NCT00661661|Tofacitinib|tofacitinib|mesh-list
154166222|NCT00661661|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
154166223|NCT00661661|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154166224|NCT00661661|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154166225|NCT00661661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154166226|NCT00038467|Tamoxifen|tamoxifen|mesh-list
154166227|NCT00038467|Exemestane|exemestane|mesh-list
154166228|NCT00038467|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
154166229|NCT00038467|Hormone Antagonists|hormone antagonists|mesh-ancestor
154166261|NCT00050167|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154166262|NCT00050167|Antimetabolites|antimetabolites|mesh-ancestor
154166263|NCT01096927|Amoxicillin|amoxicillin|mesh-list
154166264|NCT01096927|Clavulanic Acids|clavulanic acids|mesh-list
154166265|NCT01096927|Clavulanic Acid|clavulanic acid|mesh-list
154166266|NCT01096927|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154166267|NCT01096927|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154166268|NCT01096927|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154166269|NCT01096927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153662834|NCT00143221|Sildenafil Citrate|sildenafil citrate|mesh-list
154166270|NCT01096927|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
154166271|NCT00660023|Epoetin Alfa|epoetin alfa|mesh-list
154166272|NCT00660023|Hematinics|hematinics|mesh-ancestor
154166273|NCT02554955|Mycophenolic Acid|mycophenolic acid|mesh-list
154166324|NCT00788099|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154166325|NCT00788099|Antimetabolites|antimetabolites|mesh-ancestor
154166326|NCT00788099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154166327|NCT00788099|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154166328|NCT00788099|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154166329|NCT00788099|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154166330|NCT00795587|Mannitol|mannitol|mesh-list
154166331|NCT00795587|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
154166332|NCT00795587|Diuretics|diuretics|mesh-ancestor
154166333|NCT00795587|Natriuretic Agents|natriuretic agents|mesh-ancestor
154166334|NCT00795587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154166335|NCT00661505|Epoetin Alfa|epoetin alfa|mesh-list
154166336|NCT00661505|Hematinics|hematinics|mesh-ancestor
153662988|NCT00144274|Ambroxol|ambroxol|mesh-list
154166337|NCT00788333|Trastuzumab|trastuzumab|mesh-list
154166338|NCT00788333|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154166339|NCT00788333|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154166340|NCT00795899|Paclitaxel|paclitaxel|mesh-list
154166341|NCT00795899|Cyclophosphamide|cyclophosphamide|mesh-list
154166342|NCT00795899|Trastuzumab|trastuzumab|mesh-list
154166343|NCT00795899|Epirubicin|epirubicin|mesh-list
154166344|NCT00795899|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154166345|NCT00795899|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154166346|NCT00795899|Tubulin Modulators|tubulin modulators|mesh-ancestor
154166347|NCT00795899|Antimitotic Agents|antimitotic agents|mesh-ancestor
154166348|NCT00795899|Mitosis Modulators|mitosis modulators|mesh-ancestor
154166349|NCT00795899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154166350|NCT00795899|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154166351|NCT00795899|Immunologic Factors|immunologic factors|mesh-ancestor
154166352|NCT00795899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154166354|NCT00795899|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154166355|NCT00795899|Alkylating Agents|alkylating agents|mesh-ancestor
154166356|NCT00795899|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154166357|NCT00795899|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154166358|NCT00795899|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154166359|NCT00795899|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154166360|NCT00795899|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154166361|NCT00795899|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154166362|NCT00795977|Picibanil|picibanil|mesh-list
153646521|NCT00115609|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
154166363|NCT00795977|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154166365|NCT00796211|Calcipotriene|calcipotriene|mesh-list
154166366|NCT00796211|Dermatologic Agents|dermatologic agents|mesh-ancestor
154166367|NCT00796211|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
154166368|NCT00796211|Antidepressive Agents|antidepressive agents|mesh-ancestor
154166369|NCT00796211|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154166370|NCT00796211|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
154166371|NCT00796211|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154166372|NCT00796211|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154166373|NCT00796211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154166374|NCT00796211|Adrenergic Agents|adrenergic agents|mesh-ancestor
154166375|NCT00796211|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154166376|NCT00796211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154166377|NCT00788567|Mycophenolic Acid|mycophenolic acid|mesh-list
154166378|NCT00788567|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154166379|NCT00788567|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154166380|NCT00788567|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
154166381|NCT00788567|Antitubercular Agents|antitubercular agents|mesh-ancestor
154166382|NCT00788567|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154166383|NCT00788567|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154166384|NCT00788567|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154166385|NCT00788567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154166386|NCT00662909|Mirabegron|mirabegron|mesh-list
154166387|NCT00662909|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
154166388|NCT00662909|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154166389|NCT00662909|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154166390|NCT00662909|Adrenergic Agents|adrenergic agents|mesh-ancestor
154166391|NCT00662909|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154166392|NCT00662909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154166393|NCT00662909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154166394|NCT00662909|Urological Agents|urological agents|mesh-ancestor
154166395|NCT00050011|Zoledronic Acid|zoledronic acid|mesh-list
154166402|NCT00050011|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
154166403|NCT00050011|Hormone Antagonists|hormone antagonists|mesh-ancestor
154166404|NCT00050011|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154166405|NCT00050011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154166406|NCT00050011|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154166407|NCT00661427|Cetuximab|cetuximab|mesh-list
154166408|NCT00661427|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154166409|NCT00661427|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154166410|NCT00049543|Gefitinib|gefitinib|mesh-list
154166411|NCT00049543|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154166412|NCT00049543|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154166413|NCT00049543|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154166417|NCT03955393|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
154166463|NCT00792857|1 alpha-hydroxyergocalciferol|1 alpha-hydroxyergocalciferol|mesh-list
154166465|NCT00792857|Micronutrients|micronutrients|mesh-ancestor
154166466|NCT00792857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154166467|NCT00792857|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154166468|NCT02554175|Propofol|propofol|mesh-list
154166469|NCT02554175|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154166470|NCT02554175|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154166471|NCT02554175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154166472|NCT02554175|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154166473|NCT02554175|Anesthetics, General|anesthetics, general|mesh-ancestor
154166474|NCT02554175|Anesthetics|anesthetics|mesh-ancestor
154166475|NCT00793091|Ophthalmic Solutions|ophthalmic solutions|mesh-list
154166476|NCT00793091|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
154166477|NCT00789503|Vitamin D|vitamin d|mesh-list
154166478|NCT00789503|Cholecalciferol|cholecalciferol|mesh-list
154166479|NCT00789503|Calcium|calcium|mesh-list
154166480|NCT00789503|Vitamins|vitamins|mesh-ancestor
154166481|NCT00789503|Micronutrients|micronutrients|mesh-ancestor
154166482|NCT00789503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154166483|NCT00789503|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154166484|NCT00789503|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154166485|NCT00797303|Bevacizumab|bevacizumab|mesh-list
154166486|NCT00797303|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154166487|NCT00797303|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154166488|NCT00797303|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154166489|NCT00797303|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154166490|NCT00797303|Growth Substances|growth substances|mesh-ancestor
154166491|NCT00797303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154166492|NCT00797303|Growth Inhibitors|growth inhibitors|mesh-ancestor
154166493|NCT00661193|Paclitaxel|paclitaxel|mesh-list
154166494|NCT00661193|Carboplatin|carboplatin|mesh-list
154166495|NCT00661193|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
154166496|NCT00661193|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154166497|NCT00661193|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154166505|NCT00801047|Remifentanil|remifentanil|mesh-list
154166506|NCT00801047|Bupivacaine|bupivacaine|mesh-list
154166507|NCT00801047|Anesthetics, Local|anesthetics, local|mesh-ancestor
154166508|NCT00801047|Anesthetics|anesthetics|mesh-ancestor
154166509|NCT00801047|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154166510|NCT00801047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154166511|NCT00801047|Sensory System Agents|sensory system agents|mesh-ancestor
154166512|NCT00801047|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154166513|NCT00801047|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154166514|NCT00801047|Narcotics|narcotics|mesh-ancestor
154166515|NCT00801047|Analgesics|analgesics|mesh-ancestor
154166516|NCT00801125|Natalizumab|natalizumab|mesh-list
154166517|NCT00801125|Immunologic Factors|immunologic factors|mesh-ancestor
154166518|NCT00801125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154166519|NCT00801281|Prednisone|prednisone|mesh-list
154166520|NCT00801281|Cyclophosphamide|cyclophosphamide|mesh-list
154166521|NCT00801281|Rituximab|rituximab|mesh-list
154166522|NCT00801281|Doxorubicin|doxorubicin|mesh-list
154166523|NCT00801281|Vincristine|vincristine|mesh-list
154166524|NCT00801281|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154166525|NCT00801281|Immunologic Factors|immunologic factors|mesh-ancestor
154166526|NCT00801281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154166527|NCT00801281|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153663419|NCT01806324|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153663420|NCT01806324|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154166528|NCT00801281|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154166529|NCT00801281|Alkylating Agents|alkylating agents|mesh-ancestor
154166530|NCT00801281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154166531|NCT00801281|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154166532|NCT00801281|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154166533|NCT00801281|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154166534|NCT00801281|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154166535|NCT00801281|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154166536|NCT00801281|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154166537|NCT00801281|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154166538|NCT00801281|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154166539|NCT00801281|Glucocorticoids|glucocorticoids|mesh-ancestor
154166540|NCT00801281|Hormones|hormones|mesh-ancestor
154166541|NCT00801281|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154166542|NCT00801281|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153646522|NCT00115648|Zidovudine|zidovudine|mesh-list
153646523|NCT00115648|Nevirapine|nevirapine|mesh-list
154166543|NCT00801281|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154166544|NCT00801281|Tubulin Modulators|tubulin modulators|mesh-ancestor
154166545|NCT00801281|Antimitotic Agents|antimitotic agents|mesh-ancestor
154166546|NCT00801281|Mitosis Modulators|mitosis modulators|mesh-ancestor
153663438|NCT01805895|Minocycline|minocycline|mesh-list
154166547|NCT00801359|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
154166549|NCT00801515|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
154166550|NCT00801515|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
154166551|NCT00801515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154166552|NCT00801515|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154166553|NCT00801515|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154166554|NCT00801515|Antiviral Agents|antiviral agents|mesh-ancestor
154166555|NCT00801515|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154166556|NCT00801515|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
154166557|NCT00797693|Misoprostol|misoprostol|mesh-list
154166558|NCT00797693|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154166559|NCT00797693|Abortifacient Agents|abortifacient agents|mesh-ancestor
154166560|NCT00797693|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154166561|NCT00797693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154166562|NCT00797693|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154166563|NCT00797693|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154166564|NCT00797693|Oxytocics|oxytocics|mesh-ancestor
154166565|NCT00797771|Insulin|insulin|mesh-list
154166566|NCT00797771|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154166567|NCT00797771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154166568|NCT00793559|Terlipressin|terlipressin|mesh-list
154166569|NCT00793559|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154166590|NCT00798083|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154166591|NCT00798083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154166592|NCT00798083|Analgesics|analgesics|mesh-ancestor
154166593|NCT00798083|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
154166594|NCT00798083|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154166595|NCT00798083|Anesthetics, General|anesthetics, general|mesh-ancestor
154166596|NCT00798083|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154166597|NCT00798083|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154166598|NCT00798083|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154166599|NCT00798083|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
154166600|NCT00798083|Antidepressive Agents|antidepressive agents|mesh-ancestor
154166601|NCT00798083|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154166602|NCT00798083|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154166603|NCT00798083|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
154166604|NCT00798083|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154166605|NCT00798083|Adrenergic Agents|adrenergic agents|mesh-ancestor
154166607|NCT00798395|Mirtazapine|mirtazapine|mesh-list
154166608|NCT00798395|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154166609|NCT00798395|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154166610|NCT00798395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154166611|NCT00798395|Antidepressive Agents|antidepressive agents|mesh-ancestor
154166612|NCT00798395|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154166613|NCT00798395|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
154166614|NCT00798395|Histamine Antagonists|histamine antagonists|mesh-ancestor
154166615|NCT00798395|Histamine Agents|histamine agents|mesh-ancestor
154166616|NCT00798395|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154166617|NCT00798395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154166618|NCT00798395|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154166619|NCT00798395|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154166620|NCT00798395|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
154166632|NCT00801905|Sensory System Agents|sensory system agents|mesh-ancestor
154166633|NCT00801905|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154166634|NCT00801905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154166635|NCT00801905|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154166637|NCT00658541|Zolpidem|zolpidem|mesh-list
154166638|NCT00658541|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
154166639|NCT00658541|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154166640|NCT00658541|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154166641|NCT00658541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154166642|NCT00658541|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
154166643|NCT00658541|GABA Agonists|gaba agonists|mesh-ancestor
154166644|NCT00658541|GABA Agents|gaba agents|mesh-ancestor
154166645|NCT00658541|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154166646|NCT00658541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154166647|NCT00048061|Vitamin D|vitamin d|mesh-list
154166648|NCT00048061|Ibandronic Acid|ibandronic acid|mesh-list
154166649|NCT00048061|Calcium|calcium|mesh-list
154166650|NCT00048061|Vitamins|vitamins|mesh-ancestor
154166651|NCT00048061|Micronutrients|micronutrients|mesh-ancestor
154166652|NCT00048061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154166653|NCT00048061|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154166654|NCT00048061|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154166656|NCT00802139|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
154166657|NCT00802139|Trace Elements|trace elements|mesh-ancestor
154166658|NCT00802139|Micronutrients|micronutrients|mesh-ancestor
154166659|NCT00802139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154166660|NCT00802139|Hematinics|hematinics|mesh-ancestor
154166661|NCT00802217|Capsaicin|capsaicin|mesh-list
154166662|NCT00802217|Antipruritics|antipruritics|mesh-ancestor
154166676|NCT03957109|Anesthetics|anesthetics|mesh-list
154166678|NCT03957109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154166679|NCT00802451|Mesalamine|mesalamine|mesh-list
154166680|NCT00802451|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154166681|NCT00802451|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154166682|NCT00802451|Analgesics|analgesics|mesh-ancestor
154166683|NCT00802451|Sensory System Agents|sensory system agents|mesh-ancestor
154166684|NCT00802451|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154166685|NCT00802451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154166686|NCT00802451|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154166687|NCT00802451|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154166688|NCT03956953|Deucravacitinib|deucravacitinib|mesh-list
154166689|NCT03956953|Dermatologic Agents|dermatologic agents|mesh-ancestor
154166690|NCT03956953|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154166691|NCT03956953|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154166692|NCT03956953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154166693|NCT00798473|Zoledronic Acid|zoledronic acid|mesh-list
154166694|NCT00798473|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154166695|NCT00798473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154166696|NCT04045769|Moxifloxacin|moxifloxacin|mesh-list
154166697|NCT04045769|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154166698|NCT04045769|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153663551|NCT01903421|Analgesics|analgesics|mesh-ancestor
154166699|NCT04045769|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154166700|NCT04045769|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154166701|NCT04045769|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154166702|NCT04045769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154166703|NCT04045769|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154166704|NCT01097317|Carboplatin|carboplatin|mesh-list
154166705|NCT01097317|Vinorelbine|vinorelbine|mesh-list
154166712|NCT01095679|Baclofen|baclofen|mesh-list
154166723|NCT00794261|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154166724|NCT00794261|Immunologic Factors|immunologic factors|mesh-ancestor
154166725|NCT00794261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154166727|NCT03953287|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154166728|NCT03953287|Analgesics|analgesics|mesh-ancestor
154166729|NCT03953287|Sensory System Agents|sensory system agents|mesh-ancestor
154166730|NCT03953287|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154166731|NCT03953287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154166732|NCT03953287|Antipyretics|antipyretics|mesh-ancestor
154166734|NCT01097551|Acetylcholine|acetylcholine|mesh-list
154166735|NCT01097551|Nitroglycerin|nitroglycerin|mesh-list
154166736|NCT01097551|Vasodilator Agents|vasodilator agents|mesh-ancestor
154166737|NCT01097551|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
154166738|NCT01097551|Cholinergic Agents|cholinergic agents|mesh-ancestor
154166739|NCT01097551|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154166740|NCT01097551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154166741|NCT01097551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154166742|NCT01097551|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
154166743|NCT01097551|Mydriatics|mydriatics|mesh-ancestor
154166744|NCT01097551|Autonomic Agents|autonomic agents|mesh-ancestor
154166745|NCT01097551|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154166746|NCT01097551|Sympathomimetics|sympathomimetics|mesh-ancestor
154166747|NCT01097551|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154166748|NCT01097551|Nasal Decongestants|nasal decongestants|mesh-ancestor
154166749|NCT01097551|Respiratory System Agents|respiratory system agents|mesh-ancestor
154166750|NCT01097551|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
154166751|NCT01097551|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154166752|NCT01097551|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154166753|NCT01097551|Adrenergic Agents|adrenergic agents|mesh-ancestor
154166754|NCT01097551|Protective Agents|protective agents|mesh-ancestor
154166755|NCT00803309|Interferons|interferons|mesh-list
154166756|NCT00803309|Ribavirin|ribavirin|mesh-list
154166769|NCT03953209|Hormone Antagonists|hormone antagonists|mesh-ancestor
154166770|NCT03953209|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154166771|NCT03953209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154166772|NCT03953209|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
154166773|NCT03953209|Diuretics|diuretics|mesh-ancestor
154166774|NCT03953209|Natriuretic Agents|natriuretic agents|mesh-ancestor
154166775|NCT01583959|Folic Acid|folic acid|mesh-list
154166776|NCT01583959|Hematinics|hematinics|mesh-ancestor
154166777|NCT01583959|Vitamin B Complex|vitamin b complex|mesh-ancestor
154166778|NCT01583959|Vitamins|vitamins|mesh-ancestor
154166779|NCT01583959|Micronutrients|micronutrients|mesh-ancestor
154166780|NCT01583959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154166781|NCT00803387|Travoprost|travoprost|mesh-list
154166782|NCT00803387|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154166783|NCT02553551|Vitamins|vitamins|mesh-list
154166784|NCT02553551|Micronutrients|micronutrients|mesh-ancestor
154166785|NCT02553551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154166786|NCT00803465|Fluticasone|fluticasone|mesh-list
154166787|NCT00803465|Xhance|xhance|mesh-list
154166829|NCT00794885|Hematinics|hematinics|mesh-ancestor
154166830|NCT00794885|Vitamins|vitamins|mesh-ancestor
154166831|NCT00794885|Micronutrients|micronutrients|mesh-ancestor
154166832|NCT00794885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154166833|NCT00794885|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154166834|NCT00794885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154166835|NCT00794885|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
154166836|NCT00794885|Protease Inhibitors|protease inhibitors|mesh-ancestor
154166837|NCT00794885|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154166838|NCT00803933|Pentamidine|pentamidine|mesh-list
154166839|NCT00803933|Pafuramidine|pafuramidine|mesh-list
154166840|NCT00803933|Antifungal Agents|antifungal agents|mesh-ancestor
154166841|NCT00803933|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154166842|NCT00803933|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154166843|NCT00803933|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154166844|NCT00803933|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
154166845|NCT02553707|Ibandronic Acid|ibandronic acid|mesh-list
154166846|NCT02553707|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154166847|NCT02553707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154166848|NCT00799175|Ketorolac|ketorolac|mesh-list
154166849|NCT00799175|Epinephrine|epinephrine|mesh-list
154166850|NCT00799175|Ropivacaine|ropivacaine|mesh-list
154166851|NCT00799175|Anesthetics, Local|anesthetics, local|mesh-ancestor
154166852|NCT00799175|Anesthetics|anesthetics|mesh-ancestor
154166853|NCT00799175|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154166854|NCT00799175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154166855|NCT00799175|Sensory System Agents|sensory system agents|mesh-ancestor
154166856|NCT00799175|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154166857|NCT00799175|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154166876|NCT00799175|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154166878|NCT00656513|Miotics|miotics|mesh-ancestor
154166879|NCT00656513|Autonomic Agents|autonomic agents|mesh-ancestor
154166880|NCT00656513|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154166881|NCT00656513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154166883|NCT00656513|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
154166884|NCT00656513|Cholinergic Agents|cholinergic agents|mesh-ancestor
154166885|NCT00656513|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154166886|NCT00656513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154166887|NCT04017221|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
154166888|NCT04017221|Protease Inhibitors|protease inhibitors|mesh-ancestor
154166889|NCT04017221|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154166890|NCT04017221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154166891|NCT04017221|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154166892|NCT04017221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154166893|NCT00804245|Choline|choline|mesh-list
154166894|NCT00804245|Lipotropic Agents|lipotropic agents|mesh-ancestor
154166895|NCT00804245|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154166896|NCT00804245|Antimetabolites|antimetabolites|mesh-ancestor
154166898|NCT00804245|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154166932|NCT00804947|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154166933|NCT00804947|Alkylating Agents|alkylating agents|mesh-ancestor
154166934|NCT00804947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154166935|NCT00804947|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154166936|NCT00804947|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154166937|NCT00804947|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154166938|NCT00804947|Immunologic Factors|immunologic factors|mesh-ancestor
154166939|NCT00804947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154166941|NCT00806663|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154166942|NCT00806663|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154166943|NCT00806663|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154166944|NCT00806663|Growth Substances|growth substances|mesh-ancestor
154166945|NCT00806663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154166946|NCT00806663|Growth Inhibitors|growth inhibitors|mesh-ancestor
154166947|NCT00806663|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154166948|NCT00806663|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154166949|NCT00806663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154166950|NCT00806741|Phenylephrine|phenylephrine|mesh-list
154166951|NCT00806741|Oxymetazoline|oxymetazoline|mesh-list
154166952|NCT00806741|omega-N-Methylarginine|omega-n-methylarginine|mesh-list
154166953|NCT00806741|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
154166954|NCT00806741|Mydriatics|mydriatics|mesh-ancestor
154166955|NCT00806741|Autonomic Agents|autonomic agents|mesh-ancestor
154166956|NCT00806741|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154166957|NCT00806741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154166958|NCT00806741|Sympathomimetics|sympathomimetics|mesh-ancestor
154166959|NCT00806741|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154166960|NCT00806741|Nasal Decongestants|nasal decongestants|mesh-ancestor
154166961|NCT00806741|Respiratory System Agents|respiratory system agents|mesh-ancestor
154166962|NCT00806741|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
153663606|NCT02825641|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154166973|NCT00805649|Dexamethasone|dexamethasone|mesh-list
154166974|NCT00805649|Bevacizumab|bevacizumab|mesh-list
154166975|NCT00805649|Temazepam|temazepam|mesh-list
154166976|NCT00805649|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154166977|NCT00805649|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154166978|NCT00805649|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154166979|NCT00805649|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154166980|NCT00805649|Growth Substances|growth substances|mesh-ancestor
154166981|NCT00805649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154166982|NCT00805649|Growth Inhibitors|growth inhibitors|mesh-ancestor
154166983|NCT00805649|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154166984|NCT00805649|Antiemetics|antiemetics|mesh-ancestor
154166985|NCT00805649|Autonomic Agents|autonomic agents|mesh-ancestor
154166986|NCT00805649|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154166987|NCT00805649|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154166988|NCT00805649|Glucocorticoids|glucocorticoids|mesh-ancestor
154166989|NCT00805649|Hormones|hormones|mesh-ancestor
154166990|NCT00805649|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154166992|NCT00805649|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154167032|NCT00809627|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
154167033|NCT00809627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154167034|NCT00809627|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154167035|NCT00809627|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154167036|NCT00809627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154167037|NCT00809627|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
154167038|NCT00809627|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
154167039|NCT00809627|Purinergic Agents|purinergic agents|mesh-ancestor
154167040|NCT00809627|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154167041|NCT00809705|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
154167042|NCT00809705|Incretins|incretins|mesh-ancestor
154167043|NCT00809705|Hormones|hormones|mesh-ancestor
154167044|NCT00809705|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154167045|NCT00809705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154167046|NCT00655499|Irinotecan|irinotecan|mesh-list
154167047|NCT00655499|Panitumumab|panitumumab|mesh-list
154167048|NCT00655499|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
154167049|NCT00655499|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154167050|NCT00655499|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154167051|NCT00655499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154167052|NCT00655499|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154167053|NCT00655499|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154167054|NCT00654875|Aliskiren|aliskiren|mesh-list
154167055|NCT00654875|Renin Inhibitors|renin inhibitors|mesh-ancestor
154167056|NCT00654875|Protease Inhibitors|protease inhibitors|mesh-ancestor
154167057|NCT00654875|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154167058|NCT00654875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154167059|NCT00800267|Timolol|timolol|mesh-list
154167060|NCT00800267|Latanoprost|latanoprost|mesh-list
154167061|NCT00800267|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
154167062|NCT00800267|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154167063|NCT00800267|Adrenergic Agents|adrenergic agents|mesh-ancestor
154167064|NCT00800267|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154167066|NCT00800267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154167070|NCT00800267|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
154167072|NCT00809939|17 alpha-Hydroxyprogesterone Caproate|17 alpha-hydroxyprogesterone caproate|mesh-list
154167073|NCT00809939|11-hydroxyprogesterone|11-hydroxyprogesterone|mesh-list
154167074|NCT00809939|Progestins|progestins|mesh-ancestor
154167075|NCT00809939|Hormones|hormones|mesh-ancestor
154167076|NCT00809939|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154167077|NCT00809939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154167078|NCT00809939|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
154167079|NCT00809939|Hormone Antagonists|hormone antagonists|mesh-ancestor
154167080|NCT00807443|Raltegravir Potassium|raltegravir potassium|mesh-list
154167081|NCT00807443|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154167082|NCT00807443|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154167083|NCT00807443|Antiviral Agents|antiviral agents|mesh-ancestor
154167084|NCT00807443|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154167085|NCT00807443|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
154167086|NCT00807443|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
154167087|NCT00807443|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154167088|NCT00807443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154167089|NCT00807521|Dexamethasone|dexamethasone|mesh-list
154167090|NCT00807521|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153434819|NCT00383396|Antifungal Agents|antifungal agents|mesh-ancestor
154167091|NCT00807521|Antiemetics|antiemetics|mesh-ancestor
154167092|NCT00807521|Autonomic Agents|autonomic agents|mesh-ancestor
154167093|NCT00807521|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154167094|NCT00807521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154167095|NCT00807521|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154167096|NCT00807521|Glucocorticoids|glucocorticoids|mesh-ancestor
154167097|NCT00807521|Hormones|hormones|mesh-ancestor
154167098|NCT00807521|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154167100|NCT00807521|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154167115|NCT00651755|Cyclophosphamide|cyclophosphamide|mesh-list
154167116|NCT00651755|Rituximab|rituximab|mesh-list
154167117|NCT00651755|Doxorubicin|doxorubicin|mesh-list
154167118|NCT00651755|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
154167119|NCT00651755|Vincristine|vincristine|mesh-list
154167120|NCT00651755|Ondansetron|ondansetron|mesh-list
154167121|NCT00651755|Aprepitant|aprepitant|mesh-list
154167122|NCT00651755|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154167123|NCT00651755|Immunologic Factors|immunologic factors|mesh-ancestor
154167124|NCT00651755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154167125|NCT00651755|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154167126|NCT00651755|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154167127|NCT00651755|Alkylating Agents|alkylating agents|mesh-ancestor
154167128|NCT00651755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154167129|NCT00651755|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154167130|NCT00651755|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154167131|NCT00651755|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154167132|NCT00651755|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154167133|NCT00651755|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154167134|NCT00651755|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154167135|NCT00651755|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154167136|NCT00651755|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154167137|NCT00651755|Glucocorticoids|glucocorticoids|mesh-ancestor
154167138|NCT00651755|Hormones|hormones|mesh-ancestor
154167139|NCT00651755|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154167140|NCT00651755|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153663682|NCT01466361|Nicotine|nicotine|mesh-list
154167141|NCT00651755|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154167157|NCT00807755|Etoposide|etoposide|mesh-list
154167163|NCT00807755|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154167164|NCT00807755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154167165|NCT00807755|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
154167166|NCT00807755|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154167167|NCT00807755|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154167168|NCT00807755|Immunologic Factors|immunologic factors|mesh-ancestor
154167169|NCT00807755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154167170|NCT00813527|Fenofibrate|fenofibrate|mesh-list
154167171|NCT00813527|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154167172|NCT00813527|Antimetabolites|antimetabolites|mesh-ancestor
154167173|NCT00813527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154167174|NCT00813527|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154167175|NCT00810563|Bupivacaine|bupivacaine|mesh-list
154167176|NCT00810563|Anesthetics, Local|anesthetics, local|mesh-ancestor
154167177|NCT00810563|Anesthetics|anesthetics|mesh-ancestor
153663748|NCT00009230|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154167178|NCT00810563|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154167179|NCT00810563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154167180|NCT00810563|Sensory System Agents|sensory system agents|mesh-ancestor
154167181|NCT00810563|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154167182|NCT00808145|Cisplatin|cisplatin|mesh-list
154167183|NCT00808145|Gemcitabine|gemcitabine|mesh-list
154167184|NCT00808145|Sorafenib|sorafenib|mesh-list
154167185|NCT00808145|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154167186|NCT00808145|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154167188|NCT00808145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154167189|NCT00808145|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154167190|NCT00808145|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154167191|NCT02552459|Sufentanil|sufentanil|mesh-list
154167192|NCT02552459|Dexmedetomidine|dexmedetomidine|mesh-list
154167193|NCT02552459|Dsuvia|dsuvia|mesh-list
154167194|NCT02552459|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154167195|NCT02552459|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154167197|NCT02552459|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154167206|NCT02552459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154167207|NCT02552459|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154167208|NCT02552459|Narcotics|narcotics|mesh-ancestor
154167209|NCT02552459|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154167210|NCT02552459|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154167211|NCT02552459|Anesthetics, General|anesthetics, general|mesh-ancestor
154167212|NCT02552459|Anesthetics|anesthetics|mesh-ancestor
154167213|NCT00810953|Pentamidine|pentamidine|mesh-list
154167214|NCT00810953|Antifungal Agents|antifungal agents|mesh-ancestor
154167215|NCT00810953|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154167216|NCT00810953|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154167217|NCT00810953|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154167218|NCT00810953|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
154167219|NCT00811031|Prednisone|prednisone|mesh-list
154167220|NCT00811031|Docetaxel|docetaxel|mesh-list
154167221|NCT00811031|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154167222|NCT00811031|Tubulin Modulators|tubulin modulators|mesh-ancestor
154167223|NCT00811031|Antimitotic Agents|antimitotic agents|mesh-ancestor
154167224|NCT00811031|Mitosis Modulators|mitosis modulators|mesh-ancestor
154167225|NCT00811031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154167226|NCT00811031|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154167227|NCT00811031|Glucocorticoids|glucocorticoids|mesh-ancestor
154167228|NCT00811031|Hormones|hormones|mesh-ancestor
154167229|NCT00811031|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154167230|NCT00811031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154167231|NCT00811031|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154167232|NCT02552537|Mannitol|mannitol|mesh-list
154167233|NCT02552537|Omeprazole|omeprazole|mesh-list
154167234|NCT02552537|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154167235|NCT02552537|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154167236|NCT02552537|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
154167237|NCT02552537|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154167238|NCT02552537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154167239|NCT02552537|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
154167240|NCT02552537|Diuretics|diuretics|mesh-ancestor
154167241|NCT02552537|Natriuretic Agents|natriuretic agents|mesh-ancestor
154167242|NCT02552537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154167243|NCT00808223|Alefacept|alefacept|mesh-list
154167245|NCT00808223|Immunologic Factors|immunologic factors|mesh-ancestor
154167246|NCT00808223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154167248|NCT00811421|Sulfadoxine|sulfadoxine|mesh-list
154167249|NCT00811421|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
154167250|NCT00811421|Mefloquine|mefloquine|mesh-list
154167251|NCT00811421|Antimalarials|antimalarials|mesh-ancestor
154167252|NCT00811421|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154167253|NCT00811421|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154167254|NCT00811421|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154167255|NCT00811421|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154167256|NCT00811421|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153620686|NCT01993771|Anesthetics|anesthetics|mesh-list
154167257|NCT00811421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154167258|NCT00811421|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
154167259|NCT00569777|Ketotifen|ketotifen|mesh-list
154167260|NCT00569777|Antipruritics|antipruritics|mesh-ancestor
154167261|NCT00569777|Dermatologic Agents|dermatologic agents|mesh-ancestor
154167262|NCT00569777|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
154167263|NCT00569777|Histamine Antagonists|histamine antagonists|mesh-ancestor
154167265|NCT00569777|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154167266|NCT00569777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154167267|NCT00569777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154167268|NCT00569777|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154167269|NCT00654095|Atorvastatin|atorvastatin|mesh-list
154167270|NCT00654095|Ezetimibe|ezetimibe|mesh-list
154167271|NCT00654095|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154167272|NCT00654095|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154167273|NCT00654095|Antimetabolites|antimetabolites|mesh-ancestor
154167274|NCT00654095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154167275|NCT00654095|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154167276|NCT00654095|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154167277|NCT00654095|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154167278|NCT00811967|Ribavirin|ribavirin|mesh-list
154167279|NCT00811967|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
154167280|NCT00811967|Interferon-alpha|interferon-alpha|mesh-list
154167285|NCT00811967|Immunologic Factors|immunologic factors|mesh-ancestor
154167286|NCT00811967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154167287|NCT04046159|Tamoxifen|tamoxifen|mesh-list
154167288|NCT04046159|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
154167289|NCT04046159|Hormone Antagonists|hormone antagonists|mesh-ancestor
154167290|NCT04046159|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154167291|NCT04046159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154167292|NCT04046159|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154167293|NCT04046159|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154167294|NCT04046159|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
154167295|NCT04046159|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
154167296|NCT04046159|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154167297|NCT00653939|Paclitaxel|paclitaxel|mesh-list
154167298|NCT00653939|Fosbretabulin|fosbretabulin|mesh-list
154167299|NCT00653939|Combretastatin|combretastatin|mesh-list
154167300|NCT00653939|Bevacizumab|bevacizumab|mesh-list
154167301|NCT00653939|Carboplatin|carboplatin|mesh-list
154167302|NCT00653939|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154167303|NCT00653939|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154167304|NCT00653939|Tubulin Modulators|tubulin modulators|mesh-ancestor
154167305|NCT00653939|Antimitotic Agents|antimitotic agents|mesh-ancestor
154167306|NCT00653939|Mitosis Modulators|mitosis modulators|mesh-ancestor
154167307|NCT00653939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154167308|NCT00653939|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154167309|NCT00653939|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154167310|NCT00653939|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154167311|NCT00653939|Growth Substances|growth substances|mesh-ancestor
154167312|NCT00653939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154167313|NCT00653939|Growth Inhibitors|growth inhibitors|mesh-ancestor
154167314|NCT00812123|Cyclosporine|cyclosporine|mesh-list
154167315|NCT00812123|Sirolimus|sirolimus|mesh-list
154167316|NCT00812123|Mycophenolic Acid|mycophenolic acid|mesh-list
154167317|NCT00812123|Prednisone|prednisone|mesh-list
154167318|NCT00812123|Cyclosporins|cyclosporins|mesh-list
154167319|NCT00812123|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154167322|NCT00812123|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154167323|NCT00812123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154167324|NCT00812123|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154167325|NCT00812123|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154167326|NCT00812123|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154167327|NCT00812123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154167328|NCT00812123|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154167329|NCT00812123|Immunologic Factors|immunologic factors|mesh-ancestor
154167330|NCT00812123|Antifungal Agents|antifungal agents|mesh-ancestor
154167331|NCT00812123|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154167332|NCT00812123|Dermatologic Agents|dermatologic agents|mesh-ancestor
153620767|NCT01994668|Lorazepam|lorazepam|mesh-list
154167333|NCT00812123|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154167334|NCT00812123|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
154167335|NCT00812123|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154167336|NCT00812123|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
154167337|NCT00812123|Antitubercular Agents|antitubercular agents|mesh-ancestor
154167338|NCT00812123|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154167339|NCT00646451|Pregabalin|pregabalin|mesh-list
154167340|NCT00646451|Analgesics|analgesics|mesh-ancestor
154167341|NCT00646451|Sensory System Agents|sensory system agents|mesh-ancestor
154167342|NCT00646451|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154167343|NCT00646451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154167344|NCT00646451|Anticonvulsants|anticonvulsants|mesh-ancestor
154167345|NCT00646451|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153463608|NCT05026398|Fenfluramine|fenfluramine|mesh-list
154167354|NCT00809237|Gefitinib|gefitinib|mesh-list
154167368|NCT00817583|Tubulin Modulators|tubulin modulators|mesh-ancestor
154167369|NCT00817583|Antimitotic Agents|antimitotic agents|mesh-ancestor
154167370|NCT00817583|Mitosis Modulators|mitosis modulators|mesh-ancestor
154167371|NCT00817583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154167373|NCT00817583|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154167374|NCT00817583|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154167375|NCT00817583|Immunologic Factors|immunologic factors|mesh-ancestor
154167376|NCT00817583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154167377|NCT00817661|Vitamin A|vitamin a|mesh-list
154167378|NCT00817661|Vitamins|vitamins|mesh-ancestor
154167379|NCT00817661|Micronutrients|micronutrients|mesh-ancestor
154167380|NCT00817661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154167381|NCT00642707|Leronlimab|leronlimab|mesh-list
154167382|NCT00642707|Antibodies|antibodies|mesh-list
154167383|NCT00642707|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154167384|NCT00642707|Immunologic Factors|immunologic factors|mesh-ancestor
154167385|NCT00642707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154167386|NCT00642707|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
154167387|NCT00642707|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
154167393|NCT02551523|Dolutegravir|dolutegravir|mesh-list
154167425|NCT00814229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154167426|NCT00814229|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154167427|NCT00568685|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
154167428|NCT00568685|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
154167429|NCT00568685|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154167430|NCT00568685|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154167431|NCT00568685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154167432|NCT00568685|Adrenergic Agents|adrenergic agents|mesh-ancestor
154167433|NCT00568685|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154167434|NCT00568685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154167436|NCT00061945|Cytarabine|cytarabine|mesh-list
154167437|NCT00061945|Acyclovir|acyclovir|mesh-list
154167438|NCT00061945|Trimethoprim|trimethoprim|mesh-list
154167439|NCT00061945|Sulfamethoxazole|sulfamethoxazole|mesh-list
154167440|NCT00061945|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
154167441|NCT00061945|Dexamethasone|dexamethasone|mesh-list
154167442|NCT00061945|Cyclophosphamide|cyclophosphamide|mesh-list
154167443|NCT00061945|Methotrexate|methotrexate|mesh-list
154167444|NCT00061945|Vincristine|vincristine|mesh-list
154167445|NCT00061945|Imatinib Mesylate|imatinib mesylate|mesh-list
154167446|NCT00061945|Daunorubicin|daunorubicin|mesh-list
154167447|NCT00061945|Asparaginase|asparaginase|mesh-list
154167448|NCT00061945|Mercaptopurine|mercaptopurine|mesh-list
154167449|NCT00061945|Alemtuzumab|alemtuzumab|mesh-list
154167450|NCT00061945|Allopurinol|allopurinol|mesh-list
154167451|NCT00061945|Levoleucovorin|levoleucovorin|mesh-list
154167452|NCT00061945|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154167453|NCT00061945|Immunologic Factors|immunologic factors|mesh-ancestor
154167454|NCT00061945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154167455|NCT00061945|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154167456|NCT00061945|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154167457|NCT00061945|Alkylating Agents|alkylating agents|mesh-ancestor
154167458|NCT00061945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154167468|NCT00061945|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154167469|NCT00061945|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154167470|NCT00061945|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154167472|NCT00061945|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154167473|NCT00061945|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154167474|NCT00061945|Antimetabolites|antimetabolites|mesh-ancestor
154167475|NCT00061945|Dermatologic Agents|dermatologic agents|mesh-ancestor
154167476|NCT00061945|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154167477|NCT00061945|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154167478|NCT00061945|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154167479|NCT00061945|Antiviral Agents|antiviral agents|mesh-ancestor
154167480|NCT00061945|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154167481|NCT00061945|Antidotes|antidotes|mesh-ancestor
154167482|NCT00061945|Protective Agents|protective agents|mesh-ancestor
154167483|NCT00061945|Vitamin B Complex|vitamin b complex|mesh-ancestor
154167484|NCT00061945|Vitamins|vitamins|mesh-ancestor
154167485|NCT00061945|Micronutrients|micronutrients|mesh-ancestor
154167486|NCT00061945|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154167488|NCT00061945|Antimitotic Agents|antimitotic agents|mesh-ancestor
154167523|NCT00642473|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154167524|NCT00642473|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154167525|NCT00645671|Loteprednol Etabonate|loteprednol etabonate|mesh-list
154167526|NCT00645671|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154167528|NCT00366340|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
154167529|NCT00366340|Immunologic Factors|immunologic factors|mesh-ancestor
154167530|NCT00366340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154167531|NCT03992326|Cyclophosphamide|cyclophosphamide|mesh-list
154167532|NCT03992326|Fludarabine|fludarabine|mesh-list
154167533|NCT03992326|Interleukin-2|interleukin-2|mesh-list
154167534|NCT03992326|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154167535|NCT03992326|Immunologic Factors|immunologic factors|mesh-ancestor
154167536|NCT03992326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154167537|NCT03992326|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154167538|NCT03992326|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154167539|NCT03992326|Alkylating Agents|alkylating agents|mesh-ancestor
154167540|NCT03992326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154167583|NCT01045018|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154167584|NCT01045018|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154167585|NCT01045018|Analgesics|analgesics|mesh-ancestor
154167586|NCT01045018|Sensory System Agents|sensory system agents|mesh-ancestor
154167587|NCT01045018|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154167588|NCT01045018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154167589|NCT01045018|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154167590|NCT01045018|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154167591|NCT01049464|Magnesium Sulfate|magnesium sulfate|mesh-list
154167592|NCT01049464|Analgesics|analgesics|mesh-ancestor
154167593|NCT01049464|Sensory System Agents|sensory system agents|mesh-ancestor
154167594|NCT01049464|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154167595|NCT01049464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154167596|NCT01049464|Anesthetics|anesthetics|mesh-ancestor
154167597|NCT01049464|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154167598|NCT01049464|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154167599|NCT01049464|Anticonvulsants|anticonvulsants|mesh-ancestor
154167600|NCT01049464|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154167601|NCT01049464|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154167602|NCT01049464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154167603|NCT01049464|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154167604|NCT01049464|Tocolytic Agents|tocolytic agents|mesh-ancestor
154167605|NCT01049464|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154167606|NCT01046266|Cetuximab|cetuximab|mesh-list
154167607|NCT01046266|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154167608|NCT01046266|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154167609|NCT00365794|Testosterone|testosterone|mesh-list
154167610|NCT00365794|Androgens|androgens|mesh-ancestor
154167611|NCT00365794|Hormones|hormones|mesh-ancestor
154167614|NCT01098019|Botulinum Toxins|botulinum toxins|mesh-list
154167624|NCT01098019|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154167625|NCT00365716|Vaccines|vaccines|mesh-list
154167626|NCT00365716|Immunologic Factors|immunologic factors|mesh-ancestor
154167627|NCT00365716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154167628|NCT01049542|Astressin|astressin|mesh-list
154167629|NCT01049542|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
154167630|NCT01049542|Protective Agents|protective agents|mesh-ancestor
154167631|NCT01049542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154167632|NCT01049620|Capecitabine|capecitabine|mesh-list
154167633|NCT01049620|Oxaliplatin|oxaliplatin|mesh-list
154167634|NCT01049620|Everolimus|everolimus|mesh-list
154167635|NCT01049620|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154167636|NCT01049620|Antimetabolites|antimetabolites|mesh-ancestor
154167637|NCT01049620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154167638|NCT01049620|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154167639|NCT01049620|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
154167640|NCT01049620|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154167641|NCT01049620|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154167642|NCT01049620|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154167643|NCT01049620|Immunologic Factors|immunologic factors|mesh-ancestor
154167644|NCT01049620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154167645|NCT00059839|Prednisone|prednisone|mesh-list
154167646|NCT00059839|Doxorubicin|doxorubicin|mesh-list
154167647|NCT00059839|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
154167648|NCT00059839|Methotrexate|methotrexate|mesh-list
154167649|NCT00059839|Vincristine|vincristine|mesh-list
154167650|NCT00059839|Mercaptopurine|mercaptopurine|mesh-list
154167651|NCT00059839|Vinblastine|vinblastine|mesh-list
154167652|NCT00059839|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154167659|NCT00059839|Glucocorticoids|glucocorticoids|mesh-ancestor
154167672|NCT00059839|Immunologic Factors|immunologic factors|mesh-ancestor
154167673|NCT00059839|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154167674|NCT00059839|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154167675|NCT00059839|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154167676|NCT00059839|Tubulin Modulators|tubulin modulators|mesh-ancestor
154167677|NCT00059839|Antimitotic Agents|antimitotic agents|mesh-ancestor
154167678|NCT00059839|Mitosis Modulators|mitosis modulators|mesh-ancestor
154167679|NCT00059215|Clopidogrel|clopidogrel|mesh-list
154167680|NCT00059215|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
154167681|NCT00059215|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154167682|NCT00059215|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
154167683|NCT00059215|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
154167684|NCT00059215|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
154167685|NCT00059215|Purinergic Agents|purinergic agents|mesh-ancestor
154167686|NCT00059215|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154167687|NCT00059215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154167688|NCT00059215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154167689|NCT00058825|Cyclosporine|cyclosporine|mesh-list
154167690|NCT00058825|Fludarabine|fludarabine|mesh-list
154167691|NCT00058825|Alemtuzumab|alemtuzumab|mesh-list
154167692|NCT00058825|Tacrolimus|tacrolimus|mesh-list
154167693|NCT00058825|Cyclosporins|cyclosporins|mesh-list
154167694|NCT00058825|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153664080|NCT00011297|Anticonvulsants|anticonvulsants|mesh-ancestor
154167722|NCT01046500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154167723|NCT01046500|Vitamin B Complex|vitamin b complex|mesh-ancestor
154167724|NCT01046500|Vitamins|vitamins|mesh-ancestor
154167725|NCT01046500|Micronutrients|micronutrients|mesh-ancestor
154167726|NCT01046578|Letrozole|letrozole|mesh-list
154167727|NCT01046578|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154167728|NCT01046578|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
154167729|NCT01046578|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154167730|NCT01046578|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154167731|NCT01046578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154167732|NCT01046578|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
154167733|NCT01046578|Hormone Antagonists|hormone antagonists|mesh-ancestor
154167734|NCT01046578|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154167735|NCT01046578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154167736|NCT00372424|Docetaxel|docetaxel|mesh-list
154167737|NCT00372424|Trastuzumab|trastuzumab|mesh-list
154167738|NCT00372424|Sunitinib|sunitinib|mesh-list
154167739|NCT00372424|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154167740|NCT00372424|Tubulin Modulators|tubulin modulators|mesh-ancestor
154167741|NCT00372424|Antimitotic Agents|antimitotic agents|mesh-ancestor
154167742|NCT00372424|Mitosis Modulators|mitosis modulators|mesh-ancestor
154167743|NCT00372424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154167744|NCT00372424|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154167774|NCT01093807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154167775|NCT01093807|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154167776|NCT01093807|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154167777|NCT01093807|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154167778|NCT01093807|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154167779|NCT01093807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154167781|NCT00044083|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
154167782|NCT00044083|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
154167783|NCT00044083|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
153621215|NCT01997255|Everolimus|everolimus|mesh-list
154167784|NCT00044083|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154167785|NCT00044083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154167787|NCT00058123|Interferon Inducers|interferon inducers|mesh-ancestor
154167788|NCT00058123|Immunologic Factors|immunologic factors|mesh-ancestor
154167789|NCT00058123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154167790|NCT00022633|Paclitaxel|paclitaxel|mesh-list
154167791|NCT00022633|Gemcitabine|gemcitabine|mesh-list
154167792|NCT00022633|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154167800|NCT00021541|Tipifarnib|tipifarnib|mesh-list
154167827|NCT01020279|Analgesics|analgesics|mesh-ancestor
154167828|NCT01020279|Sensory System Agents|sensory system agents|mesh-ancestor
154167829|NCT01020279|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154167830|NCT01020279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154167831|NCT01020279|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154167832|NCT01020279|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154167833|NCT01020279|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
154167834|NCT01020279|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154167835|NCT01020279|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154167836|NCT01020279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154167837|NCT01020357|Caffeine|caffeine|mesh-list
154167838|NCT01020357|Caffeine citrate|caffeine citrate|mesh-list
154167839|NCT01020357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154167840|NCT01020357|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
154167841|NCT01020357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154167842|NCT01020357|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154167843|NCT01020357|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154167844|NCT01020357|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
154167845|NCT01020357|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
154167846|NCT01020357|Purinergic Agents|purinergic agents|mesh-ancestor
154167847|NCT01020357|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153664099|NCT00011375|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
154167848|NCT00042991|Gefitinib|gefitinib|mesh-list
154167849|NCT00042991|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154167850|NCT00042991|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154167876|NCT01017939|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154167877|NCT01017939|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154167878|NCT01017939|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154167879|NCT01017939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154167880|NCT01017939|Hormone Antagonists|hormone antagonists|mesh-ancestor
154167881|NCT01017939|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154167882|NCT01017939|Antitussive Agents|antitussive agents|mesh-ancestor
154167883|NCT01017939|Respiratory System Agents|respiratory system agents|mesh-ancestor
154167884|NCT01017939|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154167885|NCT01017939|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154167886|NCT01017939|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154167887|NCT01017939|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154167888|NCT01017939|Narcotics|narcotics|mesh-ancestor
154167889|NCT01017939|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154167890|NCT01017939|Analgesics|analgesics|mesh-ancestor
154167891|NCT01017939|Sensory System Agents|sensory system agents|mesh-ancestor
154167892|NCT01017939|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154167893|NCT01017939|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154167894|NCT01017939|Autonomic Agents|autonomic agents|mesh-ancestor
154167895|NCT01017939|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154167896|NCT01017939|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154167897|NCT01017939|Vasodilator Agents|vasodilator agents|mesh-ancestor
154167898|NCT01017939|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
154167899|NCT01017939|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
154167900|NCT01017939|Purinergic Agents|purinergic agents|mesh-ancestor
154167923|NCT01022463|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
154167924|NCT01022463|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154167925|NCT01022463|Adrenergic Agents|adrenergic agents|mesh-ancestor
154167926|NCT01022463|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154167927|NCT01022463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154167928|NCT00488319|Paliperidone Palmitate|paliperidone palmitate|mesh-list
154167929|NCT00488319|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154167930|NCT00488319|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154167931|NCT00488319|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154167932|NCT00488319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154167933|NCT00488319|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154167934|NCT00488319|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
154167935|NCT00488319|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154167936|NCT00488319|Serotonin Agents|serotonin agents|mesh-ancestor
154167937|NCT00488319|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154167984|NCT00486603|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154167985|NCT00486603|Alkylating Agents|alkylating agents|mesh-ancestor
154167986|NCT00486603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154167987|NCT00486603|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154167988|NCT00486603|Antimalarials|antimalarials|mesh-ancestor
154167989|NCT00486603|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154167990|NCT00486603|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154167991|NCT00486603|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153664109|NCT00847938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154167992|NCT00486603|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154167993|NCT00486603|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154167994|NCT00474045|Insulin|insulin|mesh-list
154167995|NCT00474045|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
154167996|NCT00474045|Insulin Aspart|insulin aspart|mesh-list
154167997|NCT00474045|Insulin Detemir|insulin detemir|mesh-list
154167998|NCT00474045|Insulin, Isophane|insulin, isophane|mesh-list
154167999|NCT00474045|Isophane Insulin, Human|isophane insulin, human|mesh-list
154168044|NCT03996603|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154168045|NCT03996603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154168046|NCT00462345|Rituximab|rituximab|mesh-list
154168047|NCT00462345|Methotrexate|methotrexate|mesh-list
154168048|NCT00462345|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154168049|NCT00462345|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154168050|NCT00462345|Immunologic Factors|immunologic factors|mesh-ancestor
154168051|NCT00462345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154168052|NCT00462345|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154168053|NCT00462345|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154168054|NCT00462345|Abortifacient Agents|abortifacient agents|mesh-ancestor
154168055|NCT00462345|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154168056|NCT00462345|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154168057|NCT00462345|Antimetabolites|antimetabolites|mesh-ancestor
154168058|NCT00462345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154168059|NCT00462345|Dermatologic Agents|dermatologic agents|mesh-ancestor
154168060|NCT00462345|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154168061|NCT00462345|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154168062|NCT00462345|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154168063|NCT00462345|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154168064|NCT01022541|Bevacizumab|bevacizumab|mesh-list
154168065|NCT01022541|Capecitabine|capecitabine|mesh-list
154168066|NCT01022541|Oxaliplatin|oxaliplatin|mesh-list
154168067|NCT01022541|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154168068|NCT01022541|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154168069|NCT01022541|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154168070|NCT01022541|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154168071|NCT01022541|Growth Substances|growth substances|mesh-ancestor
154168072|NCT01022541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154168073|NCT01022541|Growth Inhibitors|growth inhibitors|mesh-ancestor
154168074|NCT01022541|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154168075|NCT01022541|Antimetabolites|antimetabolites|mesh-ancestor
154168076|NCT01022541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154168077|NCT01047202|Vaccines|vaccines|mesh-list
154168078|NCT01047202|Immunologic Factors|immunologic factors|mesh-ancestor
154168081|NCT01049854|Cyclophosphamide|cyclophosphamide|mesh-list
154168083|NCT01049854|Busulfan|busulfan|mesh-list
154168084|NCT01049854|Fludarabine phosphate|fludarabine phosphate|mesh-list
154168085|NCT01049854|Fludarabine|fludarabine|mesh-list
153621514|NCT01999309|Simvastatin|simvastatin|mesh-list
154168086|NCT01049854|Antilymphocyte Serum|antilymphocyte serum|mesh-list
154168087|NCT01049854|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154168088|NCT01049854|Immunologic Factors|immunologic factors|mesh-ancestor
154168089|NCT01049854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154168090|NCT01049854|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154168091|NCT01049854|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154168092|NCT01049854|Alkylating Agents|alkylating agents|mesh-ancestor
154168093|NCT01049854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154168094|NCT01049854|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154168095|NCT01049854|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154168096|NCT01049854|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154168097|NCT01049854|Antimetabolites|antimetabolites|mesh-ancestor
154168098|NCT01049854|Antiviral Agents|antiviral agents|mesh-ancestor
154168099|NCT01049854|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154168100|NCT00453999|Oseltamivir|oseltamivir|mesh-list
154168101|NCT00453999|Peramivir|peramivir|mesh-list
154168102|NCT00453999|Antiviral Agents|antiviral agents|mesh-ancestor
154168103|NCT00453999|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154168104|NCT00453999|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154168105|NCT00453999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154168106|NCT00453921|Methylphenidate|methylphenidate|mesh-list
154168107|NCT00453921|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
154168108|NCT00453921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154168109|NCT00453921|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
154168110|NCT00453921|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153664181|NCT00011765|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154168111|NCT00453921|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154168112|NCT00453921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154168113|NCT00453921|Dopamine Agents|dopamine agents|mesh-ancestor
154168114|NCT00453921|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154168115|NCT00382720|Docetaxel|docetaxel|mesh-list
154168116|NCT00382720|Capecitabine|capecitabine|mesh-list
154168119|NCT00382720|Tubulin Modulators|tubulin modulators|mesh-ancestor
154168120|NCT00382720|Antimitotic Agents|antimitotic agents|mesh-ancestor
154168121|NCT00382720|Mitosis Modulators|mitosis modulators|mesh-ancestor
154168122|NCT00382720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154168123|NCT00382720|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154168124|NCT00382720|Antimetabolites|antimetabolites|mesh-ancestor
154168125|NCT01025349|Bevacizumab|bevacizumab|mesh-list
154168126|NCT01025349|Docetaxel|docetaxel|mesh-list
154168127|NCT01025349|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154168128|NCT01025349|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154168129|NCT01025349|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154168130|NCT01025349|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154168131|NCT01025349|Growth Substances|growth substances|mesh-ancestor
154168132|NCT01025349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154168133|NCT01025349|Growth Inhibitors|growth inhibitors|mesh-ancestor
154168134|NCT01025349|Tubulin Modulators|tubulin modulators|mesh-ancestor
154168135|NCT01025349|Antimitotic Agents|antimitotic agents|mesh-ancestor
154168136|NCT01025349|Mitosis Modulators|mitosis modulators|mesh-ancestor
154168137|NCT01025349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154168138|NCT00453063|Mometasone Furoate|mometasone furoate|mesh-list
154168139|NCT00453063|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154168140|NCT00453063|Dermatologic Agents|dermatologic agents|mesh-ancestor
154168141|NCT00453063|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154168142|NCT00371566|Lapatinib|lapatinib|mesh-list
154168143|NCT00371566|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154168144|NCT00371566|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154168145|NCT00371566|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154168146|NCT00371566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154168147|NCT00371566|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154168148|NCT00371254|Dasatinib|dasatinib|mesh-list
154168162|NCT00452673|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154168163|NCT00461253|Copper|copper|mesh-list
154168164|NCT00461253|Levonorgestrel|levonorgestrel|mesh-list
154168165|NCT00461253|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
154168166|NCT00461253|Contraceptive Agents|contraceptive agents|mesh-ancestor
153664265|NCT00847080|Incretins|incretins|mesh-ancestor
154168167|NCT00461253|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154168168|NCT00461253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154168169|NCT00461253|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
154168170|NCT00461253|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
154168171|NCT00461253|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
154168172|NCT00461253|Trace Elements|trace elements|mesh-ancestor
154168173|NCT00461253|Micronutrients|micronutrients|mesh-ancestor
154168174|NCT00469833|Insulin|insulin|mesh-list
154168175|NCT00469833|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
154168176|NCT00469833|Insulin Glargine|insulin glargine|mesh-list
154168177|NCT00469833|Insulin, Long-Acting|insulin, long-acting|mesh-list
154168178|NCT00469833|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154168179|NCT00469833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154168180|NCT00641537|Cladribine|cladribine|mesh-list
154168181|NCT00641537|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154168182|NCT00641537|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154168183|NCT00641537|Immunologic Factors|immunologic factors|mesh-ancestor
154168184|NCT00641537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154168185|NCT01025583|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
154168186|NCT00814541|Dexamethasone|dexamethasone|mesh-list
154168187|NCT00814541|Doxorubicin|doxorubicin|mesh-list
154168188|NCT00814541|Bortezomib|bortezomib|mesh-list
154168190|NCT00814541|Antiemetics|antiemetics|mesh-ancestor
154168210|NCT00814619|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154168211|NCT00814619|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154168212|NCT00641147|Curcumin|curcumin|mesh-list
154168213|NCT00641147|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154168214|NCT00641147|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154168215|NCT00641147|Analgesics|analgesics|mesh-ancestor
154168216|NCT00641147|Sensory System Agents|sensory system agents|mesh-ancestor
154168217|NCT00641147|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154168218|NCT00641147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154168219|NCT00641147|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154168220|NCT00641147|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154168221|NCT00641147|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154168222|NCT00641147|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154168223|NCT00641147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154168224|NCT00460239|Morphine|morphine|mesh-list
154168225|NCT00460239|Buprenorphine|buprenorphine|mesh-list
154168226|NCT00460239|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154168227|NCT00460239|Narcotics|narcotics|mesh-ancestor
154168228|NCT00460239|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154168229|NCT00460239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154168230|NCT00460239|Analgesics|analgesics|mesh-ancestor
154168231|NCT00460239|Sensory System Agents|sensory system agents|mesh-ancestor
154168232|NCT00460239|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154168233|NCT00460239|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
154168250|NCT06334094|Immunologic Factors|immunologic factors|mesh-ancestor
154168274|NCT06333951|Carboplatin|carboplatin|mesh-list
154168275|NCT06333951|Pembrolizumab|pembrolizumab|mesh-list
154168277|NCT06333951|Sotorasib|sotorasib|mesh-list
154168278|NCT06333951|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154168279|NCT06333951|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154168280|NCT06333951|Tubulin Modulators|tubulin modulators|mesh-ancestor
154168281|NCT06333951|Antimitotic Agents|antimitotic agents|mesh-ancestor
154168282|NCT06333951|Mitosis Modulators|mitosis modulators|mesh-ancestor
154168283|NCT06333951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154168284|NCT06333951|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154168285|NCT06333951|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154168286|NCT06333951|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154168287|NCT06333951|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154168288|NCT06333951|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154168289|NCT06333860|Deucravacitinib|deucravacitinib|mesh-list
154168290|NCT06333860|Dermatologic Agents|dermatologic agents|mesh-ancestor
154168291|NCT06333860|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154168292|NCT06333860|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154168293|NCT06333860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154168294|NCT06333834|Antivenins|antivenins|mesh-list
154168295|NCT06333834|Immunologic Factors|immunologic factors|mesh-ancestor
154168296|NCT06333834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154168297|NCT06333821|Nimotuzumab|nimotuzumab|mesh-list
154168298|NCT06333821|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154168299|NCT06333821|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154168300|NCT06333769|Capecitabine|capecitabine|mesh-list
154168301|NCT06333769|Oxaliplatin|oxaliplatin|mesh-list
154168302|NCT06333769|Tislelizumab|tislelizumab|mesh-list
154168303|NCT06333769|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154168304|NCT06333769|Antimetabolites|antimetabolites|mesh-ancestor
154168305|NCT06333769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154168306|NCT06333769|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154168307|NCT06333769|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154168308|NCT06333704|Vaccines|vaccines|mesh-list
154168309|NCT06333704|Immunologic Factors|immunologic factors|mesh-ancestor
154168310|NCT06333704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154168313|NCT06333691|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154168314|NCT06333691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154168315|NCT06333691|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
154168316|NCT06333691|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
154168317|NCT06333691|Dopamine Agonists|dopamine agonists|mesh-ancestor
154168318|NCT06333691|Dopamine Agents|dopamine agents|mesh-ancestor
154168319|NCT06333691|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154168320|NCT06333691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154168321|NCT06333678|Durvalumab|durvalumab|mesh-list
154168322|NCT06333678|Sotorasib|sotorasib|mesh-list
154168323|NCT06333678|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154168324|NCT06333678|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154168325|NCT06333678|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154168326|NCT06333678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154168327|NCT06333652|Ravulizumab|ravulizumab|mesh-list
154168328|NCT06333652|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
154168329|NCT06333652|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154168330|NCT06333652|Immunologic Factors|immunologic factors|mesh-ancestor
154168331|NCT06333652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154168332|NCT06333626|Vitamins|vitamins|mesh-list
154168333|NCT06333626|Micronutrients|micronutrients|mesh-ancestor
154168334|NCT06333626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154168335|NCT06333600|Vitamin D|vitamin d|mesh-list
154168336|NCT06333600|Minoxidil|minoxidil|mesh-list
154168337|NCT06333600|Calcipotriene|calcipotriene|mesh-list
154168338|NCT06333600|Vitamins|vitamins|mesh-ancestor
154168339|NCT06333600|Micronutrients|micronutrients|mesh-ancestor
154168340|NCT06333600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154168341|NCT06333600|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154168342|NCT06333600|Dermatologic Agents|dermatologic agents|mesh-ancestor
154168343|NCT06333600|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154168344|NCT06333600|Vasodilator Agents|vasodilator agents|mesh-ancestor
154168345|NCT06333561|Lenvatinib|lenvatinib|mesh-list
154168352|NCT06333522|Losartan|losartan|mesh-list
154168354|NCT06333522|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154168355|NCT06333522|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
154168356|NCT06333522|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
154168357|NCT06333522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154168359|NCT06333418|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
154168360|NCT06333418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154168361|NCT06333418|Sympathomimetics|sympathomimetics|mesh-ancestor
154168362|NCT06333418|Autonomic Agents|autonomic agents|mesh-ancestor
154168363|NCT06333418|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154168364|NCT06333418|Dopamine Agents|dopamine agents|mesh-ancestor
154168365|NCT06333418|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154168366|NCT06333418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154168443|NCT06332638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154168444|NCT06332638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154168445|NCT06332612|Metformin|metformin|mesh-list
154168446|NCT06332612|Betamethasone|betamethasone|mesh-list
154168447|NCT06332612|Betamethasone Valerate|betamethasone valerate|mesh-list
154168448|NCT06332612|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
154168449|NCT06332612|Betamethasone benzoate|betamethasone benzoate|mesh-list
154168450|NCT06332612|Pentoxifylline|pentoxifylline|mesh-list
154168451|NCT06332612|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
153664327|NCT00012389|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154168452|NCT06332612|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154168453|NCT06332612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154168454|NCT06332612|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154168455|NCT06332612|Glucocorticoids|glucocorticoids|mesh-ancestor
154168456|NCT06332612|Hormones|hormones|mesh-ancestor
154168457|NCT06332612|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154168458|NCT06332612|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154168459|NCT06332612|Respiratory System Agents|respiratory system agents|mesh-ancestor
154168460|NCT06332612|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154168461|NCT06332612|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154168462|NCT06332612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154168463|NCT06332612|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154168464|NCT06332612|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
154168465|NCT06332612|Protective Agents|protective agents|mesh-ancestor
154168466|NCT06332612|Vasodilator Agents|vasodilator agents|mesh-ancestor
154168467|NCT06332612|Free Radical Scavengers|free radical scavengers|mesh-ancestor
154168468|NCT06332612|Antioxidants|antioxidants|mesh-ancestor
154168469|NCT06332560|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
154168470|NCT06332534|Upadacitinib|upadacitinib|mesh-list
154168471|NCT06332534|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
154168472|NCT06332534|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154168476|NCT06332443|Anesthetics|anesthetics|mesh-list
154168485|NCT06332365|Glucocorticoids|glucocorticoids|mesh-ancestor
154168486|NCT06332365|Hormones|hormones|mesh-ancestor
154168487|NCT06332365|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154168488|NCT06332365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154168489|NCT06332365|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154168490|NCT06332365|Immunologic Factors|immunologic factors|mesh-ancestor
154168491|NCT06332365|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154168492|NCT06332365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154168493|NCT06332365|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154168494|NCT06332365|Viscosupplements|viscosupplements|mesh-ancestor
154168495|NCT06332365|Protective Agents|protective agents|mesh-ancestor
154168496|NCT06332287|Pemetrexed|pemetrexed|mesh-list
154168497|NCT06332287|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154168498|NCT06332287|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154168499|NCT06332287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154168500|NCT06332287|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154168501|NCT06332287|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154168502|NCT06332274|Tislelizumab|tislelizumab|mesh-list
154168503|NCT06332274|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154168504|NCT06332274|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154168505|NCT06332235|Silodosin|silodosin|mesh-list
154168506|NCT06332235|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
154168507|NCT06332235|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
154168508|NCT06332235|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154168509|NCT06332235|Adrenergic Agents|adrenergic agents|mesh-ancestor
154168510|NCT06332235|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154168511|NCT06332235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154168512|NCT06332235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154168513|NCT06332235|Urological Agents|urological agents|mesh-ancestor
154168515|NCT06332170|Cetuximab|cetuximab|mesh-list
154168528|NCT06332092|Tubulin Modulators|tubulin modulators|mesh-ancestor
154168529|NCT06332092|Antimitotic Agents|antimitotic agents|mesh-ancestor
154168530|NCT06332092|Mitosis Modulators|mitosis modulators|mesh-ancestor
154168531|NCT06332092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154168533|NCT06332079|Cetuximab|cetuximab|mesh-list
154168534|NCT06332079|Panitumumab|panitumumab|mesh-list
154168536|NCT06332079|Fluorouracil|fluorouracil|mesh-list
154168537|NCT06332079|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154168538|NCT06332079|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154168539|NCT06332079|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154168540|NCT06332079|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154168541|NCT06332079|Growth Substances|growth substances|mesh-ancestor
154168542|NCT06332079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154168543|NCT06332079|Growth Inhibitors|growth inhibitors|mesh-ancestor
154168544|NCT06332079|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154168545|NCT06332079|Antimetabolites|antimetabolites|mesh-ancestor
154168546|NCT06332079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154168549|NCT06332066|Oxytocin|oxytocin|mesh-list
154168583|NCT06331182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153814523|NCT00340613|Insulin Glargine|insulin glargine|mesh-list
154168584|NCT06331182|Sensory System Agents|sensory system agents|mesh-ancestor
154168585|NCT06331182|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154168586|NCT06331182|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154168587|NCT06331182|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154168588|NCT06331182|Analgesics|analgesics|mesh-ancestor
154168589|NCT06331182|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154168590|NCT06331182|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154168591|NCT06331182|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154168592|NCT06331182|Adrenergic Agents|adrenergic agents|mesh-ancestor
154168593|NCT06331182|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154168594|NCT06331182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154168595|NCT06331182|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
154168596|NCT06331182|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154168597|NCT06331182|Anesthetics, General|anesthetics, general|mesh-ancestor
154168598|NCT06331182|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154168599|NCT06331182|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154168600|NCT06329830|Prednisone|prednisone|mesh-list
154168601|NCT06329830|Abiraterone Acetate|abiraterone acetate|mesh-list
154168602|NCT06329830|Niraparib|niraparib|mesh-list
154168603|NCT06329830|Pluvicto|pluvicto|mesh-list
154168604|NCT06329830|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154168605|NCT06329830|Glucocorticoids|glucocorticoids|mesh-ancestor
154168606|NCT06329830|Hormones|hormones|mesh-ancestor
154168607|NCT06329830|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154168620|NCT06329401|Sensory System Agents|sensory system agents|mesh-ancestor
154168621|NCT06329401|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154168622|NCT06329401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154168623|NCT06329401|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154168624|NCT06329401|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154168625|NCT06329401|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154168626|NCT06329401|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154168627|NCT06329401|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154168635|NCT06326684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154168651|NCT06324851|Drospirenone|drospirenone|mesh-list
154168652|NCT06324851|Ethinyl Estradiol|ethinyl estradiol|mesh-list
154168653|NCT06324851|Drospirenone and estetrol|drospirenone and estetrol|mesh-list
154168654|NCT06324851|Estradiol|estradiol|mesh-list
154168655|NCT06324851|Estrogens|estrogens|mesh-ancestor
154168656|NCT06324851|Hormones|hormones|mesh-ancestor
154168657|NCT06324851|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154168658|NCT06324851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154168659|NCT06324851|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
154168660|NCT06324851|Contraceptive Agents|contraceptive agents|mesh-ancestor
154168661|NCT06324851|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154168662|NCT06324851|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
154168663|NCT06324851|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
154168664|NCT06324851|Hormone Antagonists|hormone antagonists|mesh-ancestor
154168665|NCT06324851|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
154168666|NCT06324851|Diuretics|diuretics|mesh-ancestor
154168667|NCT06324851|Natriuretic Agents|natriuretic agents|mesh-ancestor
154168668|NCT06324851|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
154168669|NCT06324851|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
154168670|NCT06324851|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
154168671|NCT06324851|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154168672|NCT06324851|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154168700|NCT06316180|Drospirenone|drospirenone|mesh-list
154168701|NCT06316180|Drospirenone and estetrol|drospirenone and estetrol|mesh-list
154168702|NCT06316180|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
154168703|NCT06316180|Hormone Antagonists|hormone antagonists|mesh-ancestor
154168704|NCT06316180|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154168705|NCT06316180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154168706|NCT06316180|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
154168707|NCT06316180|Diuretics|diuretics|mesh-ancestor
154168708|NCT06316180|Natriuretic Agents|natriuretic agents|mesh-ancestor
154168709|NCT06316180|Contraceptive Agents|contraceptive agents|mesh-ancestor
154168710|NCT06316180|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154168716|NCT06307457|Palbociclib|palbociclib|mesh-list
154168717|NCT06307457|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154168718|NCT06307457|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154168719|NCT06307457|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154168720|NCT06307457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154168721|NCT06295809|Pembrolizumab|pembrolizumab|mesh-list
154168722|NCT06295809|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154168723|NCT06295809|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154168724|NCT06295809|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154168725|NCT06295809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154168726|NCT06295640|Insulin|insulin|mesh-list
153664466|NCT00394056|Paroxetine|paroxetine|mesh-list
154168727|NCT06295640|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154168728|NCT06295640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154168729|NCT06287073|Empagliflozin|empagliflozin|mesh-list
154168730|NCT06287073|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
154168731|NCT06287073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154168734|NCT06284486|Venetoclax|venetoclax|mesh-list
154168782|NCT06236815|Sensory System Agents|sensory system agents|mesh-ancestor
154168783|NCT06236815|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154168784|NCT06236815|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
154168785|NCT06236815|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
154168786|NCT06236815|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154168787|NCT06236815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154168788|NCT06236815|Hormones|hormones|mesh-ancestor
154168789|NCT06236815|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154168790|NCT06235281|Mogamulizumab|mogamulizumab|mesh-list
154168791|NCT06235281|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154168792|NCT06229483|Tranexamic Acid|tranexamic acid|mesh-list
154168793|NCT06229483|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
154168794|NCT06229483|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154168795|NCT06229483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154168796|NCT06229483|Hemostatics|hemostatics|mesh-ancestor
154168797|NCT06229483|Coagulants|coagulants|mesh-ancestor
154168801|NCT06227832|Metformin|metformin|mesh-list
154168802|NCT06227832|Clarithromycin|clarithromycin|mesh-list
154168803|NCT06227832|Midazolam|midazolam|mesh-list
154168804|NCT06227832|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154168805|NCT06227832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154168806|NCT06227832|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154168807|NCT06227832|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154168808|NCT06227832|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154168809|NCT06227832|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154168810|NCT06227832|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154168811|NCT06227832|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154168812|NCT06227832|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154168813|NCT06227832|Anesthetics, General|anesthetics, general|mesh-ancestor
154168814|NCT06227832|Anesthetics|anesthetics|mesh-ancestor
154168815|NCT06227832|GABA Modulators|gaba modulators|mesh-ancestor
154168816|NCT06227832|GABA Agents|gaba agents|mesh-ancestor
154168817|NCT06227832|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154168826|NCT06227377|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154168827|NCT06227377|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154168857|NCT06171555|Glucocorticoids|glucocorticoids|mesh-ancestor
154168858|NCT06171555|Hormones|hormones|mesh-ancestor
154168859|NCT06171555|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154168860|NCT06171555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154168861|NCT06171555|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154168862|NCT06171555|Respiratory System Agents|respiratory system agents|mesh-ancestor
154168901|NCT06159790|Pembrolizumab|pembrolizumab|mesh-list
154168902|NCT06159790|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154168903|NCT06159790|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154168904|NCT06159790|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154168905|NCT06159790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154168906|NCT06159621|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
154168907|NCT06159621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154168908|NCT06159621|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154168909|NCT06159621|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154168910|NCT06153238|Pembrolizumab|pembrolizumab|mesh-list
154168911|NCT06153238|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154168912|NCT06153238|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154168913|NCT06153238|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154168914|NCT06153238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154168915|NCT06136832|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
154168916|NCT06136832|Immunologic Factors|immunologic factors|mesh-ancestor
154168922|NCT06130254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154168923|NCT06130254|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154168924|NCT06109272|Bevacizumab|bevacizumab|mesh-list
154168925|NCT06109272|Atezolizumab|atezolizumab|mesh-list
154168926|NCT06109272|Durvalumab|durvalumab|mesh-list
154168927|NCT06109272|Tremelimumab|tremelimumab|mesh-list
154168928|NCT06109272|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154168929|NCT06109272|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154168930|NCT06109272|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154168931|NCT06109272|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154168932|NCT06109272|Growth Substances|growth substances|mesh-ancestor
154168933|NCT06109272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154168934|NCT06109272|Growth Inhibitors|growth inhibitors|mesh-ancestor
154168935|NCT06109272|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154168936|NCT06109272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154168937|NCT06104683|Pirtobrutinib|pirtobrutinib|mesh-list
154168938|NCT06104683|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154168939|NCT06104683|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154168940|NCT06104683|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154168941|NCT06104683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154168968|NCT06087835|Dapagliflozin|dapagliflozin|mesh-list
154168969|NCT06087835|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
154168970|NCT06087835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154168971|NCT06087835|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154168972|NCT06087835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154168973|NCT06084936|Rituximab|rituximab|mesh-list
154168974|NCT06084936|Obinutuzumab|obinutuzumab|mesh-list
154168975|NCT06084936|Lenalidomide|lenalidomide|mesh-list
154168987|NCT06084936|Alkylating Agents|alkylating agents|mesh-ancestor
154168988|NCT06084936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154168989|NCT06080698|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
154168990|NCT06080698|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
154168991|NCT06080698|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154168992|NCT06080698|Antitubercular Agents|antitubercular agents|mesh-ancestor
154168993|NCT06075953|Tamoxifen|tamoxifen|mesh-list
154168994|NCT06075953|Letrozole|letrozole|mesh-list
154168995|NCT06075953|Exemestane|exemestane|mesh-list
154168996|NCT06075953|Anastrozole|anastrozole|mesh-list
153664541|NCT00680628|Enoxaparin|enoxaparin|mesh-list
154168997|NCT06075953|Testosterone|testosterone|mesh-list
154168998|NCT06075953|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154168999|NCT06075953|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
154169000|NCT06075953|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154169001|NCT06075953|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154169002|NCT06075953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154169003|NCT06075953|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
154169004|NCT06075953|Hormone Antagonists|hormone antagonists|mesh-ancestor
154169005|NCT06075953|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154169006|NCT06075953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154169007|NCT06075953|Androgens|androgens|mesh-ancestor
154169008|NCT06075953|Hormones|hormones|mesh-ancestor
154169009|NCT06075953|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154169010|NCT06075953|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
154169054|NCT06048263|Ketamine|ketamine|mesh-list
154169055|NCT06048263|Analgesics|analgesics|mesh-ancestor
154169056|NCT06048263|Sensory System Agents|sensory system agents|mesh-ancestor
154169057|NCT06048263|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154169058|NCT06048263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154169059|NCT06048263|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
154169060|NCT06048263|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154169061|NCT06048263|Anesthetics, General|anesthetics, general|mesh-ancestor
154169062|NCT06048263|Anesthetics|anesthetics|mesh-ancestor
154169063|NCT06048263|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153664550|NCT00013520|Efavirenz|efavirenz|mesh-list
154169064|NCT06048263|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154169065|NCT06048263|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154169066|NCT06048263|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154169067|NCT06048263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154169068|NCT06047080|Prednisone|prednisone|mesh-list
154169069|NCT06047080|Cyclophosphamide|cyclophosphamide|mesh-list
154169070|NCT06047080|Rituximab|rituximab|mesh-list
154169071|NCT06047080|Doxorubicin|doxorubicin|mesh-list
154169072|NCT06047080|Polatuzumab vedotin|polatuzumab vedotin|mesh-list
154169073|NCT06047080|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154169074|NCT06047080|Immunologic Factors|immunologic factors|mesh-ancestor
154169075|NCT06047080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154169076|NCT06047080|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154169077|NCT06047080|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154169111|NCT06042725|Autonomic Agents|autonomic agents|mesh-ancestor
154169112|NCT06042725|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154169113|NCT06042725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154169114|NCT06042725|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154169115|NCT06042725|Glucocorticoids|glucocorticoids|mesh-ancestor
154169116|NCT06042725|Hormones|hormones|mesh-ancestor
154169117|NCT06042725|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154169118|NCT06042725|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154169119|NCT06042725|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154169120|NCT06042725|Protease Inhibitors|protease inhibitors|mesh-ancestor
154169121|NCT06042725|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154169122|NCT06042725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154169123|NCT06042725|Immunologic Factors|immunologic factors|mesh-ancestor
154169124|NCT06042725|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154169125|NCT06042725|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154169126|NCT06042725|Growth Substances|growth substances|mesh-ancestor
154169127|NCT06042725|Growth Inhibitors|growth inhibitors|mesh-ancestor
154169128|NCT06042725|Dermatologic Agents|dermatologic agents|mesh-ancestor
154169134|NCT06036914|Furosemide|furosemide|mesh-list
154169135|NCT06036914|Bumetanide|bumetanide|mesh-list
154169136|NCT06036914|Diuretics|diuretics|mesh-list
154169137|NCT06036914|Natriuretic Agents|natriuretic agents|mesh-ancestor
154169138|NCT06036914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154169139|NCT06036914|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
154169140|NCT06036914|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154169141|NCT06036914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154169142|NCT06028438|Certolizumab Pegol|certolizumab pegol|mesh-list
154169143|NCT06028438|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
154169144|NCT06028438|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154169145|NCT06028438|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154169146|NCT06028438|Immunologic Factors|immunologic factors|mesh-ancestor
154169147|NCT06028438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154169148|NCT06028438|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154169153|NCT05987332|Pembrolizumab|pembrolizumab|mesh-list
154169159|NCT05987332|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154169160|NCT05987332|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154169161|NCT05987332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154169162|NCT05987332|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154169163|NCT05987332|Alkylating Agents|alkylating agents|mesh-ancestor
154169164|NCT05987332|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154169165|NCT05987332|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154169166|NCT05987332|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154169167|NCT05981534|Vitamin D|vitamin d|mesh-list
154169168|NCT05981534|Vitamins|vitamins|mesh-ancestor
154169169|NCT05981534|Micronutrients|micronutrients|mesh-ancestor
154169185|NCT05911321|Dexamethasone|dexamethasone|mesh-list
154169186|NCT05911321|Pomalidomide|pomalidomide|mesh-list
154169187|NCT05911321|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154169188|NCT05911321|Antiemetics|antiemetics|mesh-ancestor
154169189|NCT05911321|Autonomic Agents|autonomic agents|mesh-ancestor
154169190|NCT05911321|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154169191|NCT05911321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154169192|NCT05911321|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154169193|NCT05911321|Glucocorticoids|glucocorticoids|mesh-ancestor
154169194|NCT05911321|Hormones|hormones|mesh-ancestor
154169195|NCT05911321|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154169196|NCT05911321|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154169230|NCT05901961|Dermatologic Agents|dermatologic agents|mesh-ancestor
154169231|NCT05901961|Sunscreening Agents|sunscreening agents|mesh-ancestor
154169232|NCT05901961|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
154169233|NCT05901961|Protective Agents|protective agents|mesh-ancestor
154169246|NCT05895955|Vaccines|vaccines|mesh-list
154169247|NCT05895955|Immunologic Factors|immunologic factors|mesh-ancestor
154169268|NCT05852691|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154169269|NCT05852691|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154169270|NCT05852691|Tubulin Modulators|tubulin modulators|mesh-ancestor
154169271|NCT05852691|Antimitotic Agents|antimitotic agents|mesh-ancestor
154169272|NCT05852691|Mitosis Modulators|mitosis modulators|mesh-ancestor
154169273|NCT05852691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154169274|NCT05852691|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154169275|NCT05852691|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153622707|NCT05969171|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
154169285|NCT05844982|Fluocinolone Acetonide|fluocinolone acetonide|mesh-list
154169286|NCT05844982|Faricimab|faricimab|mesh-list
154169287|NCT05844982|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154169288|NCT05844982|Glucocorticoids|glucocorticoids|mesh-ancestor
154169289|NCT05844982|Hormones|hormones|mesh-ancestor
154169290|NCT05844982|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154169291|NCT05844982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154169292|NCT05844982|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154169293|NCT05844982|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154169294|NCT05844982|Growth Substances|growth substances|mesh-ancestor
154169295|NCT05844982|Growth Inhibitors|growth inhibitors|mesh-ancestor
154169296|NCT05844982|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154169297|NCT05823961|Ophthalmic Solutions|ophthalmic solutions|mesh-list
154169316|NCT05807360|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
154169317|NCT05807360|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154169318|NCT05807360|Immunologic Factors|immunologic factors|mesh-ancestor
154169319|NCT05807360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154169320|NCT05807360|Viscosupplements|viscosupplements|mesh-ancestor
154169331|NCT05779943|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154169332|NCT05779943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154169348|NCT05757869|Apixaban|apixaban|mesh-list
154169428|NCT05694013|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154169429|NCT05694013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154169430|NCT05694013|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154169431|NCT05694013|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154169432|NCT05687721|Avelumab|avelumab|mesh-list
154169433|NCT05687721|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154169434|NCT05687721|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154169435|NCT05685953|Vaccines|vaccines|mesh-list
154169436|NCT05685953|Immunologic Factors|immunologic factors|mesh-ancestor
154169437|NCT05685953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154169438|NCT05663866|Dexamethasone|dexamethasone|mesh-list
154169439|NCT05663866|Methotrexate|methotrexate|mesh-list
154169440|NCT05663866|Amivantamab-vmjw|amivantamab-vmjw|mesh-list
154169441|NCT05663866|Montelukast|montelukast|mesh-list
154169442|NCT05663866|Lazertinib|lazertinib|mesh-list
154169443|NCT05663866|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154169444|NCT05663866|Antiemetics|antiemetics|mesh-ancestor
154169445|NCT05663866|Autonomic Agents|autonomic agents|mesh-ancestor
154169446|NCT05663866|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154169447|NCT05663866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153664849|NCT00276003|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
153455615|NCT05660213|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154169513|NCT05623020|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154169514|NCT05623020|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154169515|NCT05623020|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154169516|NCT05623020|Immunologic Factors|immunologic factors|mesh-ancestor
154169517|NCT05623020|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154169518|NCT05623020|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154169519|NCT05623020|Growth Substances|growth substances|mesh-ancestor
154169520|NCT05623020|Growth Inhibitors|growth inhibitors|mesh-ancestor
154169522|NCT05618808|Anticoagulants|anticoagulants|mesh-ancestor
154169523|NCT05618808|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154169524|NCT05618808|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154169525|NCT05618808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154169526|NCT05615012|Leucovorin|leucovorin|mesh-list
154169527|NCT05615012|Metformin|metformin|mesh-list
154169528|NCT05615012|Methotrexate|methotrexate|mesh-list
154169529|NCT05615012|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
154169530|NCT05615012|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154169531|NCT05615012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154169532|NCT05615012|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154169533|NCT05615012|Abortifacient Agents|abortifacient agents|mesh-ancestor
154169534|NCT05615012|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154169535|NCT05615012|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154169536|NCT05615012|Antimetabolites|antimetabolites|mesh-ancestor
154169537|NCT05615012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154169538|NCT05615012|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154169539|NCT05615012|Dermatologic Agents|dermatologic agents|mesh-ancestor
154169540|NCT05615012|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154169560|NCT05585320|Paclitaxel|paclitaxel|mesh-list
154169561|NCT05585320|Gemcitabine|gemcitabine|mesh-list
154169562|NCT05585320|Folfirinox|folfirinox|mesh-list
154169563|NCT05585320|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154169564|NCT05585320|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154169565|NCT05585320|Tubulin Modulators|tubulin modulators|mesh-ancestor
154169566|NCT05585320|Antimitotic Agents|antimitotic agents|mesh-ancestor
154169567|NCT05585320|Mitosis Modulators|mitosis modulators|mesh-ancestor
154169568|NCT05585320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154169569|NCT05585320|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154169570|NCT05585320|Antimetabolites|antimetabolites|mesh-ancestor
154169571|NCT05572515|Dexamethasone|dexamethasone|mesh-list
154169572|NCT05572515|Bortezomib|bortezomib|mesh-list
154169573|NCT05572515|Pomalidomide|pomalidomide|mesh-list
154169574|NCT05572515|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154169575|NCT05572515|Antiemetics|antiemetics|mesh-ancestor
154169576|NCT05572515|Autonomic Agents|autonomic agents|mesh-ancestor
154169577|NCT05572515|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154169578|NCT05572515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154169579|NCT05572515|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154169580|NCT05572515|Glucocorticoids|glucocorticoids|mesh-ancestor
154169581|NCT05572515|Hormones|hormones|mesh-ancestor
154169582|NCT05572515|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154169583|NCT05572515|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154169584|NCT05572515|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154169585|NCT05572515|Immunologic Factors|immunologic factors|mesh-ancestor
154169586|NCT05572515|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154169587|NCT05572515|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153664912|NCT00275730|Sensory System Agents|sensory system agents|mesh-ancestor
153664913|NCT00275730|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154169588|NCT05572515|Growth Substances|growth substances|mesh-ancestor
154169589|NCT05572515|Growth Inhibitors|growth inhibitors|mesh-ancestor
154169591|NCT05566041|Etoposide|etoposide|mesh-list
154169592|NCT05566041|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154169598|NCT05564117|Semaglutide|semaglutide|mesh-list
154169605|NCT05564052|Ibrutinib|ibrutinib|mesh-list
154169606|NCT05564052|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154169607|NCT05564052|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154169608|NCT05564052|Immunologic Factors|immunologic factors|mesh-ancestor
154169609|NCT05564052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154169610|NCT05564052|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154169611|NCT05564052|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154169612|NCT05564052|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154169613|NCT05564052|Growth Substances|growth substances|mesh-ancestor
154169614|NCT05564052|Growth Inhibitors|growth inhibitors|mesh-ancestor
154169615|NCT05564052|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154169616|NCT05564052|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154169617|NCT05564052|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154169618|NCT05564052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154169619|NCT05563961|Acetaminophen|acetaminophen|mesh-list
154169620|NCT05563961|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154169621|NCT05563961|Analgesics|analgesics|mesh-ancestor
153664933|NCT00275613|Rituximab|rituximab|mesh-list
154169622|NCT05563961|Sensory System Agents|sensory system agents|mesh-ancestor
154169623|NCT05563961|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154169654|NCT05550532|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154169673|NCT05528510|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154169674|NCT05528510|Immunologic Factors|immunologic factors|mesh-ancestor
154169675|NCT05528510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154169676|NCT05521087|Cytarabine|cytarabine|mesh-list
154169677|NCT05521087|Dexamethasone|dexamethasone|mesh-list
154169678|NCT05521087|Fludarabine|fludarabine|mesh-list
154169679|NCT05521087|Vincristine|vincristine|mesh-list
154169680|NCT05521087|Pegaspargase|pegaspargase|mesh-list
154169681|NCT05521087|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154169682|NCT05521087|Antiemetics|antiemetics|mesh-ancestor
154169683|NCT05521087|Autonomic Agents|autonomic agents|mesh-ancestor
154169684|NCT05521087|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154169685|NCT05521087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154169686|NCT05521087|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154169687|NCT05521087|Glucocorticoids|glucocorticoids|mesh-ancestor
154169688|NCT05521087|Hormones|hormones|mesh-ancestor
154169689|NCT05521087|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153646524|NCT00115648|Antimetabolites|antimetabolites|mesh-ancestor
154169690|NCT05521087|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153665053|NCT00015860|Prednisone|prednisone|mesh-list
154169691|NCT05521087|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154169692|NCT05521087|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154169693|NCT05521087|Antimetabolites|antimetabolites|mesh-ancestor
154169694|NCT05521087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154169695|NCT05521087|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154169696|NCT05521087|Immunologic Factors|immunologic factors|mesh-ancestor
154169697|NCT05521087|Antiviral Agents|antiviral agents|mesh-ancestor
154169698|NCT05521087|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154169700|NCT05521087|Tubulin Modulators|tubulin modulators|mesh-ancestor
154169701|NCT05521087|Antimitotic Agents|antimitotic agents|mesh-ancestor
154169753|NCT05505435|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154169754|NCT05505435|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154169755|NCT05498428|Carboplatin|carboplatin|mesh-list
154169756|NCT05498428|Pemetrexed|pemetrexed|mesh-list
154169757|NCT05498428|Amivantamab-vmjw|amivantamab-vmjw|mesh-list
154169758|NCT05498428|Heparin|heparin|mesh-list
154169759|NCT05498428|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
154169760|NCT05498428|Tinzaparin|tinzaparin|mesh-list
154169761|NCT05498428|Dalteparin|dalteparin|mesh-list
154169762|NCT05498428|Anticoagulants|anticoagulants|mesh-list
154169763|NCT05498428|Lazertinib|lazertinib|mesh-list
154169764|NCT05498428|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154169765|NCT05498428|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154169766|NCT05498428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154169767|NCT05498428|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154169768|NCT05498428|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154169769|NCT05498428|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154169770|NCT05498428|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154169771|NCT05498428|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154169772|NCT05498428|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154169773|NCT05464030|Bevacizumab|bevacizumab|mesh-list
154169833|NCT05453903|Immunologic Factors|immunologic factors|mesh-ancestor
154169834|NCT05453903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154169835|NCT05453903|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154169836|NCT05453903|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154169837|NCT05453903|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154169838|NCT05453903|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154169840|NCT05444530|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154169841|NCT05444530|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154169842|NCT05444530|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154169843|NCT05444530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154169844|NCT05438043|Dexamethasone|dexamethasone|mesh-list
154169845|NCT05438043|Lenalidomide|lenalidomide|mesh-list
154169846|NCT05438043|Daratumumab|daratumumab|mesh-list
154169847|NCT05438043|Pomalidomide|pomalidomide|mesh-list
154169848|NCT05438043|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154169849|NCT05438043|Antiemetics|antiemetics|mesh-ancestor
154169850|NCT05438043|Autonomic Agents|autonomic agents|mesh-ancestor
154169851|NCT05438043|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154169852|NCT05438043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154169853|NCT05438043|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154169854|NCT05438043|Glucocorticoids|glucocorticoids|mesh-ancestor
154169855|NCT05438043|Hormones|hormones|mesh-ancestor
154169856|NCT05438043|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154169857|NCT05438043|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154169858|NCT05438043|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154169859|NCT05438043|Immunologic Factors|immunologic factors|mesh-ancestor
154169860|NCT05438043|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154169861|NCT05438043|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154169862|NCT05438043|Growth Substances|growth substances|mesh-ancestor
154169863|NCT05438043|Growth Inhibitors|growth inhibitors|mesh-ancestor
154169864|NCT05431075|Amoxicillin|amoxicillin|mesh-list
154169865|NCT05431075|Tetracycline|tetracycline|mesh-list
154169866|NCT05431075|Potassium Citrate|potassium citrate|mesh-list
154169867|NCT05431075|Esomeprazole|esomeprazole|mesh-list
154169868|NCT05431075|Bismuth|bismuth|mesh-list
154169869|NCT05431075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153646525|NCT00115648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154169870|NCT05431075|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154169871|NCT05431075|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154169872|NCT05431075|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154169873|NCT05431075|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154169874|NCT05431075|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
154169875|NCT05431075|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154169876|NCT05431075|Antacids|antacids|mesh-ancestor
154169877|NCT05431075|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
154169878|NCT05431075|Diuretics|diuretics|mesh-ancestor
154169879|NCT05431075|Natriuretic Agents|natriuretic agents|mesh-ancestor
154169880|NCT05431075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154169881|NCT05431075|Expectorants|expectorants|mesh-ancestor
154169882|NCT05431075|Respiratory System Agents|respiratory system agents|mesh-ancestor
154169883|NCT05421091|Asciminib|asciminib|mesh-list
154169884|NCT05421091|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154169885|NCT05421091|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154169886|NCT05421091|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154169887|NCT05421091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154169888|NCT05419089|Cisplatin|cisplatin|mesh-list
154169889|NCT05419089|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154169929|NCT05371886|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154169930|NCT05371886|Anesthetics, General|anesthetics, general|mesh-ancestor
154169931|NCT05371886|Anesthetics|anesthetics|mesh-ancestor
154169932|NCT05371886|GABA Modulators|gaba modulators|mesh-ancestor
154169933|NCT05371886|GABA Agents|gaba agents|mesh-ancestor
154169934|NCT05371886|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154169935|NCT05371886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154169936|NCT05369533|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
154169937|NCT05369533|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154169938|NCT05369533|Immunologic Factors|immunologic factors|mesh-ancestor
154169939|NCT05369533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154169940|NCT05369533|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
154169941|NCT05369533|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
154169942|NCT05369533|Dopamine Agonists|dopamine agonists|mesh-ancestor
154169943|NCT05369533|Dopamine Agents|dopamine agents|mesh-ancestor
154169944|NCT05369533|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154169945|NCT05369533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154169946|NCT05343013|Trifluridine|trifluridine|mesh-list
153665338|NCT00016289|Interleukin-12|interleukin-12|mesh-list
154169947|NCT05343013|Antimetabolites|antimetabolites|mesh-ancestor
154169948|NCT05343013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154169949|NCT05343013|Antiviral Agents|antiviral agents|mesh-ancestor
154169950|NCT05343013|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154169951|NCT05340582|Acetaminophen|acetaminophen|mesh-list
154169952|NCT05340582|Ibuprofen|ibuprofen|mesh-list
154169953|NCT05340582|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154169954|NCT05340582|Analgesics|analgesics|mesh-ancestor
154169955|NCT05340582|Sensory System Agents|sensory system agents|mesh-ancestor
154169956|NCT05340582|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154169957|NCT05340582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154169972|NCT05328297|JNJ-55308942|jnj-55308942|mesh-list
154169973|NCT05328297|Purinergic P2X Receptor Antagonists|purinergic p2x receptor antagonists|mesh-ancestor
154169974|NCT05328297|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
154169975|NCT05328297|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
154169976|NCT05328297|Purinergic Agents|purinergic agents|mesh-ancestor
154169977|NCT05328297|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154169978|NCT05328297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154169979|NCT05328297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154169980|NCT05275023|Tenofovir|tenofovir|mesh-list
154169981|NCT05275023|Entecavir|entecavir|mesh-list
153665402|NCT00016406|Paclitaxel|paclitaxel|mesh-list
154169982|NCT05275023|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
154169983|NCT05275023|Antiviral Agents|antiviral agents|mesh-ancestor
154169984|NCT05275023|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154169985|NCT05275023|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
154169986|NCT05275023|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154169987|NCT05275023|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154169988|NCT05275023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154169989|NCT05275023|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154169990|NCT05275023|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154169991|NCT05275023|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154169992|NCT05275023|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154169993|NCT05250973|Dexamethasone|dexamethasone|mesh-list
154169994|NCT05250973|Cyclophosphamide|cyclophosphamide|mesh-list
154170022|NCT05242484|Immunologic Factors|immunologic factors|mesh-ancestor
153665495|NCT00129519|Imiquimod|imiquimod|mesh-list
154170023|NCT05242484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154170024|NCT05242471|Golimumab|golimumab|mesh-list
154170025|NCT05242471|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
154170026|NCT05242471|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154170027|NCT05242471|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154170028|NCT05242471|Immunologic Factors|immunologic factors|mesh-ancestor
154170029|NCT05242471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154170030|NCT05238155|Antimetabolites|antimetabolites|mesh-list
154170031|NCT05238155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154170032|NCT05232123|Cannabidiol|cannabidiol|mesh-list
154170033|NCT05232123|Anticonvulsants|anticonvulsants|mesh-ancestor
154170034|NCT05231122|Bevacizumab|bevacizumab|mesh-list
154170035|NCT05231122|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
154170036|NCT05231122|Pembrolizumab|pembrolizumab|mesh-list
154170037|NCT05231122|Endothelial Growth Factors|endothelial growth factors|mesh-list
154170038|NCT05231122|Antibodies|antibodies|mesh-list
153665576|NCT00017069|Hormones|hormones|mesh-ancestor
154170039|NCT05231122|Immunoglobulins|immunoglobulins|mesh-list
154170081|NCT05168787|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
154170082|NCT05168787|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154170083|NCT05168787|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
154170084|NCT05168787|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
154170085|NCT05168787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154170086|NCT05167825|Macitentan|macitentan|mesh-list
154170087|NCT05167825|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
154170088|NCT05167825|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
154170089|NCT05167825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154170090|NCT05167825|Endothelin B Receptor Antagonists|endothelin b receptor antagonists|mesh-ancestor
154170091|NCT05167734|Dextrans|dextrans|mesh-list
154170092|NCT05167734|Epoetin Alfa|epoetin alfa|mesh-list
154170093|NCT05167734|Iron-Dextran Complex|iron-dextran complex|mesh-list
154170094|NCT05167734|Hematinics|hematinics|mesh-ancestor
154170095|NCT05167734|Anticoagulants|anticoagulants|mesh-ancestor
154170138|NCT05092269|Dermatologic Agents|dermatologic agents|mesh-ancestor
154170139|NCT05083182|Ustekinumab|ustekinumab|mesh-list
154170140|NCT05083182|Dermatologic Agents|dermatologic agents|mesh-ancestor
154170141|NCT05083169|Dexamethasone|dexamethasone|mesh-list
154170142|NCT05083169|Bortezomib|bortezomib|mesh-list
154170143|NCT05083169|Daratumumab|daratumumab|mesh-list
154170144|NCT05083169|Pomalidomide|pomalidomide|mesh-list
154170145|NCT05083169|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154170146|NCT05083169|Antiemetics|antiemetics|mesh-ancestor
154170147|NCT05083169|Autonomic Agents|autonomic agents|mesh-ancestor
154170148|NCT05083169|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154170149|NCT05083169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154170150|NCT05083169|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154170151|NCT05083169|Glucocorticoids|glucocorticoids|mesh-ancestor
154170152|NCT05083169|Hormones|hormones|mesh-ancestor
154170153|NCT05083169|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154170154|NCT05083169|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154170155|NCT05083169|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154170156|NCT05083169|Immunologic Factors|immunologic factors|mesh-ancestor
154170157|NCT05083169|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154170158|NCT05083169|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154170159|NCT05083169|Growth Substances|growth substances|mesh-ancestor
154170160|NCT05083169|Growth Inhibitors|growth inhibitors|mesh-ancestor
154170161|NCT05071664|Golimumab|golimumab|mesh-list
154170162|NCT05071664|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
154170191|NCT05048524|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154170192|NCT05048524|Antidotes|antidotes|mesh-ancestor
154170193|NCT05048524|Protective Agents|protective agents|mesh-ancestor
154170194|NCT05048524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154170195|NCT05048524|Vitamin B Complex|vitamin b complex|mesh-ancestor
154170196|NCT05048524|Vitamins|vitamins|mesh-ancestor
154170197|NCT05048524|Micronutrients|micronutrients|mesh-ancestor
154170198|NCT05043506|Palbociclib|palbociclib|mesh-list
154170199|NCT05043506|Aromatase Inhibitors|aromatase inhibitors|mesh-list
154170200|NCT05043506|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154170201|NCT05043506|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154170202|NCT05043506|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154170203|NCT05043506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154170204|NCT05043506|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154170205|NCT05043506|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
154170206|NCT05043506|Hormone Antagonists|hormone antagonists|mesh-ancestor
154170207|NCT05043506|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154170208|NCT05043506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154170209|NCT05038592|Decitabine|decitabine|mesh-list
154170210|NCT05038592|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154170211|NCT05038592|Antimetabolites|antimetabolites|mesh-ancestor
154170212|NCT05038592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154170213|NCT05038592|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154170214|NCT05038592|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154170215|NCT05030415|Ixekizumab|ixekizumab|mesh-list
154170216|NCT05030415|Dermatologic Agents|dermatologic agents|mesh-ancestor
154170217|NCT05029921|Ustekinumab|ustekinumab|mesh-list
154170218|NCT05029921|Dermatologic Agents|dermatologic agents|mesh-ancestor
154170219|NCT05016882|Semaglutide|semaglutide|mesh-list
154170220|NCT05016882|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
154170221|NCT05016882|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153665704|NCT00128895|Azathioprine|azathioprine|mesh-list
154170222|NCT05016882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154170223|NCT05009979|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
154170224|NCT05009979|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
154170231|NCT04990167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154170232|NCT04990167|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154170233|NCT04990167|Respiratory System Agents|respiratory system agents|mesh-ancestor
154170234|NCT04990167|Parasympatholytics|parasympatholytics|mesh-ancestor
154170235|NCT04990167|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154170236|NCT04990167|Cholinergic Agents|cholinergic agents|mesh-ancestor
154170237|NCT04990167|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154170238|NCT04990167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154170239|NCT04990167|Anticonvulsants|anticonvulsants|mesh-ancestor
154170240|NCT04988295|Carboplatin|carboplatin|mesh-list
154170241|NCT04988295|Pemetrexed|pemetrexed|mesh-list
154170242|NCT04988295|Amivantamab-vmjw|amivantamab-vmjw|mesh-list
154170243|NCT04988295|Lazertinib|lazertinib|mesh-list
154170244|NCT04988295|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154170245|NCT04988295|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154170246|NCT04988295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154170247|NCT04988295|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154170248|NCT04988295|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154170249|NCT04988295|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154170250|NCT04988295|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154170251|NCT04969250|Vaccines|vaccines|mesh-list
154170252|NCT04969250|Immunologic Factors|immunologic factors|mesh-ancestor
154170253|NCT04969250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154170254|NCT04940039|Risperidone|risperidone|mesh-list
154170255|NCT04940039|Paliperidone Palmitate|paliperidone palmitate|mesh-list
154170256|NCT04940039|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154170257|NCT04940039|Serotonin Agents|serotonin agents|mesh-ancestor
154170258|NCT04940039|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154170259|NCT04940039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154170260|NCT04940039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154170261|NCT04940039|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154170262|NCT04940039|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154170266|NCT04940039|Dopamine Agents|dopamine agents|mesh-ancestor
154170273|NCT04930783|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154170274|NCT04930783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154170275|NCT04929041|Nivolumab|nivolumab|mesh-list
154170276|NCT04929041|Ipilimumab|ipilimumab|mesh-list
154170277|NCT04929041|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154170278|NCT04929041|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154170279|NCT04929041|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154170280|NCT04929041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154170281|NCT04925531|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
154170291|NCT04923893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154170292|NCT04923893|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154170293|NCT04923893|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154170294|NCT04923893|Alkylating Agents|alkylating agents|mesh-ancestor
154170295|NCT04923893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154170296|NCT04923893|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154170297|NCT04923893|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154170298|NCT04923893|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154170299|NCT04923893|Antiemetics|antiemetics|mesh-ancestor
154170300|NCT04923893|Autonomic Agents|autonomic agents|mesh-ancestor
153665757|NCT00128700|Temozolomide|temozolomide|mesh-list
154170301|NCT04923893|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154170302|NCT04923893|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154170303|NCT04923893|Glucocorticoids|glucocorticoids|mesh-ancestor
154170304|NCT04923893|Hormones|hormones|mesh-ancestor
154170305|NCT04923893|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154170306|NCT04923893|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154170307|NCT04923893|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154170308|NCT04923893|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154170309|NCT04923893|Growth Substances|growth substances|mesh-ancestor
154170310|NCT04923893|Growth Inhibitors|growth inhibitors|mesh-ancestor
154170329|NCT04876092|Ibrutinib|ibrutinib|mesh-list
154170330|NCT04876092|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154170331|NCT04876092|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154170332|NCT04876092|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154170333|NCT04876092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154170334|NCT04840602|Rituximab|rituximab|mesh-list
153679623|NCT00041288|Alkylating Agents|alkylating agents|mesh-ancestor
154170335|NCT04840602|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
154170337|NCT04840602|Antibodies|antibodies|mesh-list
154170338|NCT04840602|Immunoglobulins|immunoglobulins|mesh-list
154170339|NCT04840602|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154170340|NCT04840602|Ibrutinib|ibrutinib|mesh-list
154170341|NCT04840602|Immunologic Factors|immunologic factors|mesh-ancestor
154170342|NCT04840602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153623765|NCT04073615|Apatinib|apatinib|mesh-list
154170343|NCT04840602|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154170344|NCT04840602|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154170345|NCT04840602|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154170346|NCT04840602|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154170347|NCT04840602|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154170348|NCT04840602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154170349|NCT04838613|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
154170350|NCT04838613|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
154170351|NCT04838613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154170352|NCT04829318|Esketamine|esketamine|mesh-list
154170353|NCT04829318|Antidepressive Agents|antidepressive agents|mesh-ancestor
154170354|NCT04829318|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154170355|NCT04826341|Sacituzumab govitecan|sacituzumab govitecan|mesh-list
154170356|NCT04826341|Immunoconjugates|immunoconjugates|mesh-ancestor
154170357|NCT04826341|Immunologic Factors|immunologic factors|mesh-ancestor
154170358|NCT04826341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154170359|NCT04822181|Semaglutide|semaglutide|mesh-list
154170361|NCT04822181|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154170384|NCT04790812|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154170385|NCT04790812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154170386|NCT04784988|Factor VIII|factor viii|mesh-list
154170387|NCT04784988|Coagulants|coagulants|mesh-ancestor
154170388|NCT04775082|Liraglutide|liraglutide|mesh-list
154170389|NCT04775082|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
154170390|NCT04775082|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154170391|NCT04775082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154170392|NCT04775082|Incretins|incretins|mesh-ancestor
154170393|NCT04775082|Hormones|hormones|mesh-ancestor
154170394|NCT04775082|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153646526|NCT00115648|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153646527|NCT00115648|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153646528|NCT00115648|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153646529|NCT00115648|Antiviral Agents|antiviral agents|mesh-ancestor
153646547|NCT00008294|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153646548|NCT00008294|Glucocorticoids|glucocorticoids|mesh-ancestor
153646549|NCT00008294|Hormones|hormones|mesh-ancestor
153646550|NCT00008294|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153646551|NCT00008294|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153646552|NCT00008294|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153646553|NCT00008294|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153646554|NCT00008294|Antimetabolites|antimetabolites|mesh-ancestor
153646555|NCT00008294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153646558|NCT00008294|Immunologic Factors|immunologic factors|mesh-ancestor
153646559|NCT00008294|Antidotes|antidotes|mesh-ancestor
153646560|NCT00008294|Protective Agents|protective agents|mesh-ancestor
153646561|NCT00008294|Vitamin B Complex|vitamin b complex|mesh-ancestor
153646562|NCT00008294|Vitamins|vitamins|mesh-ancestor
153646563|NCT00008294|Micronutrients|micronutrients|mesh-ancestor
153646564|NCT00115687|Nicotine|nicotine|mesh-list
153646565|NCT00115687|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
153646566|NCT00115687|Autonomic Agents|autonomic agents|mesh-ancestor
153646567|NCT00115687|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154170451|NCT04722146|Lenalidomide|lenalidomide|mesh-list
154170452|NCT04722146|Pomalidomide|pomalidomide|mesh-list
154170453|NCT04722146|Bortezomib|bortezomib|mesh-list
154170454|NCT04722146|Daratumumab|daratumumab|mesh-list
154170455|NCT04722146|Nirogacestat|nirogacestat|mesh-list
154170456|NCT04722146|Immunologic Factors|immunologic factors|mesh-ancestor
154170457|NCT04722146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154170458|NCT04722146|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154170459|NCT04722146|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154170460|NCT04722146|Growth Substances|growth substances|mesh-ancestor
154170461|NCT04722146|Growth Inhibitors|growth inhibitors|mesh-ancestor
154170462|NCT04722146|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154170463|NCT04722146|Gamma Secretase Inhibitors and Modulators|gamma secretase inhibitors and modulators|mesh-ancestor
154170464|NCT04722146|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154170465|NCT04722146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154170466|NCT04708470|Entinostat|entinostat|mesh-list
154170467|NCT04708470|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154170468|NCT04708470|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
154170469|NCT04708470|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154170470|NCT04708470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154170471|NCT04701593|Triamcinolone|triamcinolone|mesh-list
154170472|NCT04701593|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
153646568|NCT00115687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153646569|NCT00115687|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
154170473|NCT04701593|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
154170474|NCT04701593|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
154170475|NCT04701593|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154170476|NCT04701593|Glucocorticoids|glucocorticoids|mesh-ancestor
154170477|NCT04701593|Hormones|hormones|mesh-ancestor
154170478|NCT04701593|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154170479|NCT04701593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154170480|NCT04701593|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154170481|NCT04701593|Immunologic Factors|immunologic factors|mesh-ancestor
154170482|NCT04701593|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154170483|NCT04701593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154170484|NCT04683029|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154170485|NCT04683029|Immunologic Factors|immunologic factors|mesh-ancestor
154170486|NCT04683029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154170487|NCT04674462|Vaccines|vaccines|mesh-list
154170488|NCT04674462|Immunologic Factors|immunologic factors|mesh-ancestor
154170489|NCT04674462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154170490|NCT04673383|N,N-Dimethyltryptamine|n,n-dimethyltryptamine|mesh-list
154170491|NCT04673383|Hallucinogens|hallucinogens|mesh-ancestor
154170492|NCT04673383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154170493|NCT04673383|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154170494|NCT04673383|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154170495|NCT04673383|Serotonin Agents|serotonin agents|mesh-ancestor
154170496|NCT04673383|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154170497|NCT04673383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154170498|NCT04673383|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
154170499|NCT04673357|Ustekinumab|ustekinumab|mesh-list
154170500|NCT04673357|Dermatologic Agents|dermatologic agents|mesh-ancestor
154170501|NCT04661358|Fenofibrate|fenofibrate|mesh-list
154170502|NCT04661358|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154170503|NCT04661358|Antimetabolites|antimetabolites|mesh-ancestor
154170504|NCT04661358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153679803|NCT00210808|Topiramate|topiramate|mesh-list
154170514|NCT04644237|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154170515|NCT04644237|Immunoconjugates|immunoconjugates|mesh-ancestor
154170516|NCT04644237|Immunologic Factors|immunologic factors|mesh-ancestor
154170517|NCT04644237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154170519|NCT04640623|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154170520|NCT04640623|Antimetabolites|antimetabolites|mesh-ancestor
154170521|NCT04640623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154170522|NCT04640623|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154170523|NCT04630145|Clarithromycin|clarithromycin|mesh-list
154170524|NCT04630145|Rifampin|rifampin|mesh-list
154170525|NCT04630145|Ethambutol|ethambutol|mesh-list
154170526|NCT04630145|Rifabutin|rifabutin|mesh-list
154170527|NCT04630145|Bedaquiline|bedaquiline|mesh-list
154170528|NCT04630145|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154170529|NCT04630145|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154170530|NCT04630145|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
154170531|NCT04630145|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154170532|NCT04630145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154170533|NCT04630145|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154170534|NCT04630145|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154170535|NCT04630145|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
154170545|NCT04630028|Ustekinumab|ustekinumab|mesh-list
154170568|NCT04628767|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154170569|NCT04628767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153623982|NCT03794388|Anticonvulsants|anticonvulsants|mesh-ancestor
154170570|NCT04628767|Dermatologic Agents|dermatologic agents|mesh-ancestor
154170571|NCT04628767|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154170572|NCT04628767|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154170573|NCT04628767|Immunologic Factors|immunologic factors|mesh-ancestor
154170574|NCT04628767|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154170575|NCT04628767|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154170576|NCT04628767|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154170577|NCT04628767|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154170578|NCT04628767|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154170579|NCT04628767|Tubulin Modulators|tubulin modulators|mesh-ancestor
154170580|NCT04628767|Antimitotic Agents|antimitotic agents|mesh-ancestor
153665934|NCT00018200|Clomipramine|clomipramine|mesh-list
154170581|NCT04628767|Mitosis Modulators|mitosis modulators|mesh-ancestor
154170583|NCT04619251|Antifungal Agents|antifungal agents|mesh-ancestor
154170584|NCT04619251|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154170585|NCT04619251|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
153665940|NCT00018200|Serotonin Agents|serotonin agents|mesh-ancestor
154170586|NCT04619251|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154170587|NCT04619251|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154170588|NCT04619251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154170589|NCT04619251|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154170590|NCT04619251|Hormone Antagonists|hormone antagonists|mesh-ancestor
154170592|NCT04619251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154170610|NCT04577833|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154170611|NCT04577833|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154170612|NCT04577833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154170613|NCT04577833|Hormone Antagonists|hormone antagonists|mesh-ancestor
154170614|NCT04577833|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154170615|NCT04577833|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
154170623|NCT04548752|Pembrolizumab|pembrolizumab|mesh-list
154170625|NCT04548752|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
154170626|NCT04548752|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154170627|NCT04548752|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154170628|NCT04548752|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154170629|NCT04548752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154170630|NCT04548752|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154170631|NCT04538664|Carboplatin|carboplatin|mesh-list
154170632|NCT04538664|Pemetrexed|pemetrexed|mesh-list
154170633|NCT04538664|Amivantamab-vmjw|amivantamab-vmjw|mesh-list
154170634|NCT04538664|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154170635|NCT04538664|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154170636|NCT04538664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154170637|NCT04538664|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154170638|NCT04538664|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154170639|NCT04538664|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154170640|NCT04535544|Tenofovir|tenofovir|mesh-list
154170641|NCT04535544|Entecavir|entecavir|mesh-list
154170642|NCT04535544|Antiviral Agents|antiviral agents|mesh-ancestor
154170643|NCT04535544|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154170644|NCT04535544|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
154170645|NCT04535544|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154170647|NCT04535544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153646570|NCT00115687|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
153646571|NCT00115687|Cholinergic Agents|cholinergic agents|mesh-ancestor
153646572|NCT00115687|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154170649|NCT04535544|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154170650|NCT04535037|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
154170651|NCT04535037|Immunologic Factors|immunologic factors|mesh-ancestor
154170652|NCT04535037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154170653|NCT04511039|Trifluridine|trifluridine|mesh-list
154170654|NCT04511039|Talazoparib|talazoparib|mesh-list
154170655|NCT04511039|Antimetabolites|antimetabolites|mesh-ancestor
154170656|NCT04511039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154170657|NCT04511039|Antiviral Agents|antiviral agents|mesh-ancestor
153665946|NCT00018200|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154170682|NCT04487080|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154170683|NCT04487080|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154170684|NCT04487080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154170685|NCT04487080|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154170686|NCT04487080|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154170699|NCT04438824|Palbociclib|palbociclib|mesh-list
154170700|NCT04438824|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154170701|NCT04438824|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154170702|NCT04438824|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154170703|NCT04438824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153624129|NCT02936622|Antimitotic Agents|antimitotic agents|mesh-ancestor
154170791|NCT04229979|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154170792|NCT04229979|Antimetabolites|antimetabolites|mesh-ancestor
154170793|NCT04229979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154170794|NCT04229979|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154170795|NCT04229979|Antiviral Agents|antiviral agents|mesh-ancestor
154170796|NCT04229979|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154170797|NCT04229979|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154170798|NCT04229979|Immunologic Factors|immunologic factors|mesh-ancestor
154170799|NCT04229979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153665978|NCT04734353|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
154170800|NCT04229979|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154170801|NCT04229979|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154170815|NCT04192136|Micronutrients|micronutrients|mesh-ancestor
154170816|NCT04192136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154170817|NCT04192136|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154170818|NCT04192136|Antimetabolites|antimetabolites|mesh-ancestor
154170819|NCT04192136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154170820|NCT04192136|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154170821|NCT04192136|Vasodilator Agents|vasodilator agents|mesh-ancestor
154170822|NCT04182997|Dexamethasone|dexamethasone|mesh-list
154170823|NCT04182997|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154170860|NCT04181060|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154170861|NCT04181060|Immunoglobulin G|immunoglobulin g|mesh-list
154170862|NCT04181060|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154170863|NCT04181060|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154170864|NCT04181060|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154170865|NCT04181060|Growth Substances|growth substances|mesh-ancestor
154170866|NCT04181060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154170867|NCT04181060|Growth Inhibitors|growth inhibitors|mesh-ancestor
154170868|NCT04181060|Immunologic Factors|immunologic factors|mesh-ancestor
153624281|NCT02274779|Fertility Agents|fertility agents|mesh-ancestor
154170869|NCT04181060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154170870|NCT04181060|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154170871|NCT04181060|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154170872|NCT04181060|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154170874|NCT04177108|Atezolizumab|atezolizumab|mesh-list
154170875|NCT04177108|Ipatasertib|ipatasertib|mesh-list
154170876|NCT04177108|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154170877|NCT04177108|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154170878|NCT04177108|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154170879|NCT04177108|Tubulin Modulators|tubulin modulators|mesh-ancestor
154170880|NCT04177108|Antimitotic Agents|antimitotic agents|mesh-ancestor
154170881|NCT04177108|Mitosis Modulators|mitosis modulators|mesh-ancestor
154170882|NCT04177108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154170883|NCT04177108|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154170884|NCT04177108|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154170885|NCT04177108|Immunologic Factors|immunologic factors|mesh-ancestor
154170886|NCT04177108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154170887|NCT04177108|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154170888|NCT04177108|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154170889|NCT04175600|Selexipag|selexipag|mesh-list
154170890|NCT04175600|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154170891|NCT04172675|Gemcitabine|gemcitabine|mesh-list
154170892|NCT04172675|Mitomycins|mitomycins|mesh-list
154170893|NCT04172675|Mitomycin|mitomycin|mesh-list
154170894|NCT04172675|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154170896|NCT04172675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154170897|NCT04172675|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154170898|NCT04172675|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154170899|NCT04172675|Alkylating Agents|alkylating agents|mesh-ancestor
154170900|NCT04172675|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154170901|NCT04172675|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154170902|NCT04170348|Vitamin D|vitamin d|mesh-list
154170903|NCT04170348|Ergocalciferols|ergocalciferols|mesh-list
154170904|NCT04170348|Cholecalciferol|cholecalciferol|mesh-list
154170905|NCT04170348|Vitamins|vitamins|mesh-list
154170906|NCT04170348|Trientine|trientine|mesh-list
154170907|NCT04170348|Micronutrients|micronutrients|mesh-ancestor
154170908|NCT04170348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154170909|NCT04170348|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154170910|NCT04170348|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154170911|NCT04170348|Chelating Agents|chelating agents|mesh-ancestor
154170912|NCT04170348|Sequestering Agents|sequestering agents|mesh-ancestor
154170913|NCT04170348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154170914|NCT04167813|Ondansetron|ondansetron|mesh-list
154170915|NCT04167813|Antiemetics|antiemetics|mesh-ancestor
154170916|NCT04167813|Autonomic Agents|autonomic agents|mesh-ancestor
154170917|NCT04167813|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154170918|NCT04167813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154170919|NCT04167813|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154170920|NCT04167813|Antipruritics|antipruritics|mesh-ancestor
154170921|NCT04167813|Dermatologic Agents|dermatologic agents|mesh-ancestor
154170922|NCT04167813|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
154170923|NCT04167813|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154170924|NCT04167813|Serotonin Agents|serotonin agents|mesh-ancestor
154170925|NCT04167813|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154170926|NCT04167813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154170927|NCT04153604|Doxycycline|doxycycline|mesh-list
154170928|NCT04153604|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154170929|NCT04153604|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154170930|NCT04153604|Antimalarials|antimalarials|mesh-ancestor
154170931|NCT04153604|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154170932|NCT04153604|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154170933|NCT04133636|Dexamethasone|dexamethasone|mesh-list
154170934|NCT04133636|Lenalidomide|lenalidomide|mesh-list
154170935|NCT04133636|Bortezomib|bortezomib|mesh-list
154170936|NCT04133636|Daratumumab|daratumumab|mesh-list
154170937|NCT04133636|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154170938|NCT04133636|Antiemetics|antiemetics|mesh-ancestor
154170939|NCT04133636|Autonomic Agents|autonomic agents|mesh-ancestor
153666247|NCT00020865|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154170940|NCT04133636|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154170941|NCT04133636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154170942|NCT04133636|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154170943|NCT04133636|Glucocorticoids|glucocorticoids|mesh-ancestor
154170944|NCT04133636|Hormones|hormones|mesh-ancestor
154170945|NCT04133636|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154170946|NCT04133636|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154170947|NCT04133636|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154170948|NCT04133636|Immunologic Factors|immunologic factors|mesh-ancestor
154170949|NCT04133636|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154170950|NCT04133636|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154170951|NCT04133636|Growth Substances|growth substances|mesh-ancestor
154170952|NCT04133636|Growth Inhibitors|growth inhibitors|mesh-ancestor
154170953|NCT04116541|Trametinib|trametinib|mesh-list
154170954|NCT04116541|Dabrafenib|dabrafenib|mesh-list
154170955|NCT04116541|Alectinib|alectinib|mesh-list
154170956|NCT04116541|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154170957|NCT04116541|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154170958|NCT04116541|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154170959|NCT04116541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154170960|NCT04116541|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154170962|NCT04116203|Hypoglycemic Agents|hypoglycemic agents|mesh-list
154170963|NCT04116203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154170964|NCT04114890|Tenofovir|tenofovir|mesh-list
154170965|NCT04114890|Antiviral Agents|antiviral agents|mesh-ancestor
154170966|NCT04114890|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154170967|NCT04114890|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
154170968|NCT04114890|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154170969|NCT04114890|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154170970|NCT04114890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154170971|NCT04114890|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154170972|NCT04114890|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154170974|NCT04108208|Hormones|hormones|mesh-ancestor
154170975|NCT04108208|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154170976|NCT04108208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154170977|NCT04108195|Daratumumab|daratumumab|mesh-list
154170978|NCT04108195|Pomalidomide|pomalidomide|mesh-list
154170979|NCT04108195|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154170980|NCT04108195|Immunologic Factors|immunologic factors|mesh-ancestor
154170981|NCT04108195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154170982|NCT04108195|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154170983|NCT04108195|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154170984|NCT04108195|Growth Substances|growth substances|mesh-ancestor
154170985|NCT04108195|Growth Inhibitors|growth inhibitors|mesh-ancestor
154170986|NCT04103554|Valsartan|valsartan|mesh-list
154170987|NCT04103554|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
154170988|NCT04103554|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154170989|NCT04103554|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
154170990|NCT04103554|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
154170991|NCT04103554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154171028|NCT04059562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154171029|NCT04059562|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154171030|NCT04053140|Penicillins|penicillins|mesh-list
154171031|NCT04053140|Penicillin G|penicillin g|mesh-list
154171032|NCT04053140|Penicillin G Benzathine|penicillin g benzathine|mesh-list
154171033|NCT04053140|Penicillin G Procaine|penicillin g procaine|mesh-list
154171034|NCT04053140|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153666294|NCT00020943|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154171035|NCT04053140|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154171058|NCT04034095|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154171059|NCT04034095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154171060|NCT04034095|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154171061|NCT04034095|Androgen Antagonists|androgen antagonists|mesh-ancestor
154171062|NCT04034095|Hormone Antagonists|hormone antagonists|mesh-ancestor
154171063|NCT04020913|Hormones|hormones|mesh-list
154171064|NCT04020913|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154171065|NCT04020913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154171066|NCT04008797|Lenvatinib|lenvatinib|mesh-list
154171067|NCT04008797|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154171068|NCT04008797|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154171069|NCT04008797|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154171070|NCT04008797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154171071|NCT03991936|Triamcinolone|triamcinolone|mesh-list
154171072|NCT03991936|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
154171073|NCT03991936|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
154171074|NCT03991936|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
154171075|NCT03991936|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154171076|NCT03991936|Glucocorticoids|glucocorticoids|mesh-ancestor
154171077|NCT03991936|Hormones|hormones|mesh-ancestor
154171078|NCT03991936|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154171146|NCT03923725|Antimalarials|antimalarials|mesh-ancestor
154171147|NCT03923725|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154171148|NCT03923725|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154171149|NCT03923725|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154171150|NCT03923725|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154171151|NCT03923725|Antiviral Agents|antiviral agents|mesh-ancestor
154171152|NCT03923725|Schistosomicides|schistosomicides|mesh-ancestor
154171153|NCT03923725|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
154171154|NCT03923725|Anthelmintics|anthelmintics|mesh-ancestor
154171155|NCT03901963|Lenalidomide|lenalidomide|mesh-list
154171156|NCT03901963|Daratumumab|daratumumab|mesh-list
154171157|NCT03901963|Immunologic Factors|immunologic factors|mesh-ancestor
154171158|NCT03901963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154171159|NCT03901963|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154171160|NCT03901963|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154171161|NCT03901963|Growth Substances|growth substances|mesh-ancestor
154171162|NCT03901963|Growth Inhibitors|growth inhibitors|mesh-ancestor
154171163|NCT03901963|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154171164|NCT03887702|Tenofovir|tenofovir|mesh-list
154171165|NCT03887702|Entecavir|entecavir|mesh-list
154171166|NCT03887702|Antiviral Agents|antiviral agents|mesh-ancestor
154171167|NCT03887702|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154171168|NCT03887702|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
154171169|NCT03887702|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154171170|NCT03887702|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154171171|NCT03887702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154171172|NCT03887702|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153624585|NCT02008162|Bromides|bromides|mesh-list
154171173|NCT03887702|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154171182|NCT03866382|Nivolumab|nivolumab|mesh-list
154171204|NCT03737955|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154171206|NCT03737955|Immunotoxins|immunotoxins|mesh-ancestor
154171207|NCT03737955|Immunoconjugates|immunoconjugates|mesh-ancestor
154171208|NCT03737955|Immunologic Factors|immunologic factors|mesh-ancestor
154171209|NCT03737955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154171210|NCT03737955|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154171216|NCT03672630|Azithromycin|azithromycin|mesh-list
154171217|NCT03672630|Rifampin|rifampin|mesh-list
154171218|NCT03672630|Ethambutol|ethambutol|mesh-list
154171219|NCT03672630|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154171220|NCT03672630|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154171221|NCT03672630|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
154171222|NCT03672630|Antitubercular Agents|antitubercular agents|mesh-ancestor
154171223|NCT03672630|Leprostatic Agents|leprostatic agents|mesh-ancestor
154171224|NCT03672630|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154171225|NCT03672630|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154171226|NCT03672630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154171227|NCT03672630|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
154171228|NCT03672630|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
154171229|NCT03672630|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
154171230|NCT03672630|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
153666391|NCT00021294|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154171231|NCT03672630|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
154171232|NCT03672630|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
154171233|NCT03652753|Acetylcysteine|acetylcysteine|mesh-list
154171234|NCT03652753|N-monoacetylcystine|n-monoacetylcystine|mesh-list
154171235|NCT03652753|Antiviral Agents|antiviral agents|mesh-ancestor
154171236|NCT03652753|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154171237|NCT03652753|Expectorants|expectorants|mesh-ancestor
154171238|NCT03652753|Respiratory System Agents|respiratory system agents|mesh-ancestor
154171239|NCT03652753|Free Radical Scavengers|free radical scavengers|mesh-ancestor
154171240|NCT03652753|Antioxidants|antioxidants|mesh-ancestor
154171241|NCT03652753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154171244|NCT03652753|Antidotes|antidotes|mesh-ancestor
154171245|NCT03652064|Dexamethasone|dexamethasone|mesh-list
154171246|NCT03652064|Lenalidomide|lenalidomide|mesh-list
154171247|NCT03652064|Bortezomib|bortezomib|mesh-list
154171248|NCT03652064|Daratumumab|daratumumab|mesh-list
154171249|NCT03652064|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153624680|NCT02008981|Aspirin|aspirin|mesh-list
154171251|NCT03652064|Autonomic Agents|autonomic agents|mesh-ancestor
154171252|NCT03652064|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154171253|NCT03652064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154171254|NCT03652064|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154171255|NCT03652064|Glucocorticoids|glucocorticoids|mesh-ancestor
153666439|NCT00021450|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153666440|NCT00021450|Androgen Antagonists|androgen antagonists|mesh-ancestor
154171256|NCT03652064|Hormones|hormones|mesh-ancestor
153666445|NCT00021489|Abacavir|abacavir|mesh-list
154171257|NCT03652064|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154171258|NCT03652064|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154171259|NCT03652064|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154171260|NCT03652064|Immunologic Factors|immunologic factors|mesh-ancestor
154171303|NCT03573648|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154171304|NCT03573648|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154171305|NCT03573648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154171306|NCT03573648|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154171307|NCT03573310|JNJ-64619178|jnj-64619178|mesh-list
154171308|NCT03573310|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154171309|NCT03573310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154171310|NCT03516812|Methyltestosterone|methyltestosterone|mesh-list
154171311|NCT03516812|Olaparib|olaparib|mesh-list
154171312|NCT03516812|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
154171313|NCT03516812|Testosterone|testosterone|mesh-list
154171314|NCT03516812|Testosterone undecanoate|testosterone undecanoate|mesh-list
154171315|NCT03516812|Testosterone enanthate|testosterone enanthate|mesh-list
154171316|NCT03516812|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
154171317|NCT03516812|Androgens|androgens|mesh-ancestor
154171318|NCT03516812|Hormones|hormones|mesh-ancestor
154171326|NCT03505320|Leucovorin|leucovorin|mesh-list
154171364|NCT03457701|Trace Elements|trace elements|mesh-ancestor
154171365|NCT03457701|Micronutrients|micronutrients|mesh-ancestor
154171366|NCT03457701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154171367|NCT03451851|Etanercept|etanercept|mesh-list
154171368|NCT03451851|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154171369|NCT03451851|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154171370|NCT03451851|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154171371|NCT03451851|Analgesics|analgesics|mesh-ancestor
154171372|NCT03451851|Sensory System Agents|sensory system agents|mesh-ancestor
154171373|NCT03451851|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154171374|NCT03451851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154171375|NCT03451851|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154171376|NCT03451851|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154171377|NCT03451851|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154171378|NCT03451851|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154171379|NCT03451851|Immunologic Factors|immunologic factors|mesh-ancestor
154171380|NCT03446612|Nitroprusside|nitroprusside|mesh-list
154171381|NCT03446612|Acetylcholine|acetylcholine|mesh-list
154171382|NCT03446612|Darbepoetin alfa|darbepoetin alfa|mesh-list
153729729|NCT00131027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153729730|NCT00131027|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153729731|NCT00131027|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153729732|NCT00131027|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153729733|NCT00131027|Antiemetics|antiemetics|mesh-ancestor
153729734|NCT00131027|Autonomic Agents|autonomic agents|mesh-ancestor
153729735|NCT00131027|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153729736|NCT00131027|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153566769|NCT06233344|Psilocybin|psilocybin|mesh-list
153729737|NCT00131027|Glucocorticoids|glucocorticoids|mesh-ancestor
153729738|NCT00131027|Hormones|hormones|mesh-ancestor
153729739|NCT00131027|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153729740|NCT00131027|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153666541|NCT00022191|Gemcitabine|gemcitabine|mesh-list
153666543|NCT00022191|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153729741|NCT00131027|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153729742|NCT00131027|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153729743|NCT00131027|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154171421|NCT03269669|Prednisone|prednisone|mesh-list
154171422|NCT03269669|Cortisone|cortisone|mesh-list
153729744|NCT00131027|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153729745|NCT00131027|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
153729746|NCT00131027|Abortifacient Agents|abortifacient agents|mesh-ancestor
153729747|NCT00131027|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153729748|NCT00131027|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153729750|NCT00131027|Dermatologic Agents|dermatologic agents|mesh-ancestor
153729751|NCT00131027|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153729752|NCT00131027|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153729753|NCT00131027|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153729754|NCT00131027|Antiviral Agents|antiviral agents|mesh-ancestor
154171439|NCT03269669|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154171440|NCT03269669|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153666589|NCT00022464|Sirolimus|sirolimus|mesh-list
154171441|NCT03269669|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154171443|NCT03269669|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154171444|NCT03269669|Glucocorticoids|glucocorticoids|mesh-ancestor
154171445|NCT03269669|Hormones|hormones|mesh-ancestor
154171446|NCT03269669|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154171447|NCT03269669|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154171448|NCT03269669|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154171449|NCT03269669|Tubulin Modulators|tubulin modulators|mesh-ancestor
154171450|NCT03269669|Antimitotic Agents|antimitotic agents|mesh-ancestor
154171451|NCT03269669|Mitosis Modulators|mitosis modulators|mesh-ancestor
154171452|NCT03269669|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154171453|NCT03269669|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154171454|NCT03269669|Growth Substances|growth substances|mesh-ancestor
154171455|NCT03269669|Growth Inhibitors|growth inhibitors|mesh-ancestor
154171456|NCT03269669|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154171457|NCT03234972|Dexamethasone|dexamethasone|mesh-list
154171458|NCT03234972|Bortezomib|bortezomib|mesh-list
154171459|NCT03234972|Daratumumab|daratumumab|mesh-list
154171460|NCT03234972|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154171461|NCT03234972|Antiemetics|antiemetics|mesh-ancestor
154171462|NCT03234972|Autonomic Agents|autonomic agents|mesh-ancestor
154171463|NCT03234972|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154171464|NCT03234972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154171465|NCT03234972|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154171466|NCT03234972|Glucocorticoids|glucocorticoids|mesh-ancestor
154171468|NCT03234972|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154171469|NCT03234972|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154171493|NCT03218488|Ustekinumab|ustekinumab|mesh-list
154171494|NCT03218488|Dermatologic Agents|dermatologic agents|mesh-ancestor
154171495|NCT03217812|Prednisone|prednisone|mesh-list
154171496|NCT03217812|Bortezomib|bortezomib|mesh-list
154171497|NCT03217812|Melphalan|melphalan|mesh-list
154171498|NCT03217812|Daratumumab|daratumumab|mesh-list
154171499|NCT03217812|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154171500|NCT03217812|Glucocorticoids|glucocorticoids|mesh-ancestor
154171501|NCT03217812|Hormones|hormones|mesh-ancestor
154171502|NCT03217812|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154171515|NCT03178643|Artenimol|artenimol|mesh-list
154171552|NCT03147612|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154171553|NCT03147612|Alkylating Agents|alkylating agents|mesh-ancestor
154171554|NCT03147612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154171555|NCT03147612|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154171556|NCT03147612|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154171557|NCT03147612|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154171558|NCT03147612|Abortifacient Agents|abortifacient agents|mesh-ancestor
154171559|NCT03147612|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154171560|NCT03147612|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154171561|NCT03147612|Antimetabolites|antimetabolites|mesh-ancestor
154171562|NCT03147612|Dermatologic Agents|dermatologic agents|mesh-ancestor
154171563|NCT03147612|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154171564|NCT03147612|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154171565|NCT03147612|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154171566|NCT03147612|Antiviral Agents|antiviral agents|mesh-ancestor
154171567|NCT03147612|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154171568|NCT03147612|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153666674|NCT00022737|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154171569|NCT03147612|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154171570|NCT03147612|Tubulin Modulators|tubulin modulators|mesh-ancestor
154171571|NCT03147612|Antimitotic Agents|antimitotic agents|mesh-ancestor
154171572|NCT03147612|Mitosis Modulators|mitosis modulators|mesh-ancestor
154171573|NCT03147612|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154171574|NCT03147612|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154171575|NCT03141671|Prednisone|prednisone|mesh-list
154171576|NCT03141671|Bicalutamide|bicalutamide|mesh-list
154171577|NCT03141671|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154171578|NCT03141671|Glucocorticoids|glucocorticoids|mesh-ancestor
154171579|NCT03141671|Hormones|hormones|mesh-ancestor
154171583|NCT03141671|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154171597|NCT03118986|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154171598|NCT03118986|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154171599|NCT03118986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154171600|NCT03118986|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154171601|NCT03118986|Serotonin Agents|serotonin agents|mesh-ancestor
153625027|NCT03994731|Fexofenadine|fexofenadine|mesh-list
154171645|NCT03056755|Hormone Antagonists|hormone antagonists|mesh-ancestor
154171646|NCT03056755|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154171647|NCT03056755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154171648|NCT03056755|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154171649|NCT03056755|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
154171650|NCT03056755|Fertility Agents, Female|fertility agents, female|mesh-ancestor
154171651|NCT03056755|Fertility Agents|fertility agents|mesh-ancestor
154171652|NCT03056755|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154171681|NCT02968212|Clofazimine|clofazimine|mesh-list
154171682|NCT02968212|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154171683|NCT02968212|Leprostatic Agents|leprostatic agents|mesh-ancestor
154171684|NCT02968212|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154171704|NCT02816021|Antimetabolites|antimetabolites|mesh-ancestor
154171705|NCT02816021|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154171706|NCT02636569|Diclofenac|diclofenac|mesh-list
154171707|NCT02636569|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154171708|NCT02636569|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154171709|NCT02636569|Analgesics|analgesics|mesh-ancestor
154171710|NCT02636569|Sensory System Agents|sensory system agents|mesh-ancestor
154171711|NCT02636569|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154171712|NCT02636569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153666722|NCT02971878|Protective Agents|protective agents|mesh-ancestor
154171713|NCT02636569|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154171714|NCT02636569|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154171715|NCT02636569|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154171716|NCT02636569|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154171717|NCT02636569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154171718|NCT02609776|Carboplatin|carboplatin|mesh-list
154171719|NCT02609776|Pemetrexed|pemetrexed|mesh-list
154171720|NCT02609776|Amivantamab-vmjw|amivantamab-vmjw|mesh-list
154171721|NCT02609776|Lazertinib|lazertinib|mesh-list
154171722|NCT02609776|Antibodies, Bispecific|antibodies, bispecific|mesh-list
154171723|NCT02609776|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154171724|NCT02609776|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154171725|NCT02609776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154171726|NCT02609776|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154171727|NCT02609776|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154171728|NCT02609776|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154171729|NCT02609776|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154171730|NCT02609776|Immunologic Factors|immunologic factors|mesh-ancestor
154171731|NCT02609776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154171732|NCT02603432|Avelumab|avelumab|mesh-list
154171733|NCT02603432|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154171748|NCT02592317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154171749|NCT02581787|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
154171750|NCT02581787|Antibodies|antibodies|mesh-list
154171751|NCT02581787|Immunoglobulins|immunoglobulins|mesh-list
154171752|NCT02581787|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154171753|NCT02581787|Immunoglobulin G|immunoglobulin g|mesh-list
154171754|NCT02581787|Immunologic Factors|immunologic factors|mesh-ancestor
154171755|NCT02581787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154171756|NCT02581787|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154171757|NCT02531516|Bicalutamide|bicalutamide|mesh-list
154171758|NCT02531516|Androgen Antagonists|androgen antagonists|mesh-ancestor
154171759|NCT02531516|Hormone Antagonists|hormone antagonists|mesh-ancestor
154171760|NCT02531516|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154171761|NCT02531516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154171762|NCT02531516|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154171763|NCT02494986|Rilpivirine|rilpivirine|mesh-list
154171764|NCT02494986|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
154171765|NCT02494986|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154171766|NCT02494986|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154171767|NCT02494986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154171768|NCT02494986|Antiviral Agents|antiviral agents|mesh-ancestor
154171769|NCT02494986|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154171770|NCT02494986|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154171771|NCT02494986|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154171772|NCT02435212|Deferasirox|deferasirox|mesh-list
154171773|NCT02435212|Iron Chelating Agents|iron chelating agents|mesh-ancestor
154171774|NCT02435212|Chelating Agents|chelating agents|mesh-ancestor
154171775|NCT02435212|Sequestering Agents|sequestering agents|mesh-ancestor
154171776|NCT02435212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154171783|NCT02354014|Bedaquiline|bedaquiline|mesh-list
154171784|NCT02354014|Diarylquinolines|diarylquinolines|mesh-list
154171785|NCT02354014|Antitubercular Agents|antitubercular agents|mesh-ancestor
154171786|NCT02354014|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154171788|NCT02339571|Nivolumab|nivolumab|mesh-list
154171789|NCT02339571|Ipilimumab|ipilimumab|mesh-list
154171790|NCT02339571|Sargramostim|sargramostim|mesh-list
154171791|NCT02339571|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154171792|NCT02339571|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154171793|NCT02339571|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154171794|NCT02339571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154171795|NCT02339571|Immunologic Factors|immunologic factors|mesh-ancestor
154171796|NCT02339571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154171797|NCT02316106|Daratumumab|daratumumab|mesh-list
154171798|NCT02316106|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154171799|NCT02316106|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154171800|NCT02316106|Immunologic Factors|immunologic factors|mesh-ancestor
154171801|NCT02316106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154171802|NCT02310321|Cytarabine|cytarabine|mesh-list
154171803|NCT02310321|Idarubicin|idarubicin|mesh-list
154171804|NCT02310321|Gilteritinib|gilteritinib|mesh-list
154171805|NCT02310321|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154171806|NCT02310321|Antimetabolites|antimetabolites|mesh-ancestor
154171807|NCT02310321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154171808|NCT02310321|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154171809|NCT02310321|Antiviral Agents|antiviral agents|mesh-ancestor
154171843|NCT02203526|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154171889|NCT02123758|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154171891|NCT02123758|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154171892|NCT02123758|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154171893|NCT02123758|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154171894|NCT02123758|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154171895|NCT02123758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154171896|NCT02123758|Hormone Antagonists|hormone antagonists|mesh-ancestor
154171897|NCT02123758|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154171898|NCT02078648|Poly I-C|poly i-c|mesh-list
154171899|NCT02078648|Bevacizumab|bevacizumab|mesh-list
154171900|NCT02078648|Imiquimod|imiquimod|mesh-list
154171901|NCT02078648|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
154171902|NCT02078648|Poly ICLC|poly iclc|mesh-list
153666776|NCT00023244|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
153666777|NCT00023244|Prednisone|prednisone|mesh-list
154171903|NCT02078648|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154171904|NCT02078648|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154171905|NCT02078648|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154171906|NCT02078648|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153729757|NCT00131027|Antimitotic Agents|antimitotic agents|mesh-ancestor
154171907|NCT02078648|Growth Substances|growth substances|mesh-ancestor
154171908|NCT02078648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154171909|NCT02078648|Growth Inhibitors|growth inhibitors|mesh-ancestor
154171910|NCT02078648|Toll-Like Receptor Agonists|toll-like receptor agonists|mesh-ancestor
154171922|NCT02052648|Tryptophan|tryptophan|mesh-list
154171960|NCT01998971|Acetaminophen|acetaminophen|mesh-list
154171961|NCT01998971|Diphenhydramine|diphenhydramine|mesh-list
154171962|NCT01998971|Promethazine|promethazine|mesh-list
154171963|NCT01998971|Thalidomide|thalidomide|mesh-list
154171964|NCT01998971|Dexamethasone|dexamethasone|mesh-list
154171965|NCT01998971|Prednisone|prednisone|mesh-list
154171966|NCT01998971|Lenalidomide|lenalidomide|mesh-list
154171967|NCT01998971|Melphalan|melphalan|mesh-list
154171968|NCT01998971|Bortezomib|bortezomib|mesh-list
154171969|NCT01998971|Daratumumab|daratumumab|mesh-list
154171970|NCT01998971|Pomalidomide|pomalidomide|mesh-list
154171971|NCT01998971|Montelukast|montelukast|mesh-list
154171972|NCT01998971|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154171973|NCT01998971|Antiemetics|antiemetics|mesh-ancestor
154171974|NCT01998971|Autonomic Agents|autonomic agents|mesh-ancestor
154171975|NCT01998971|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154171976|NCT01998971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154171977|NCT01998971|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154171978|NCT01998971|Glucocorticoids|glucocorticoids|mesh-ancestor
154171979|NCT01998971|Hormones|hormones|mesh-ancestor
154171980|NCT01998971|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154171981|NCT01998971|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154171982|NCT01998971|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154171983|NCT01998971|Immunologic Factors|immunologic factors|mesh-ancestor
154171984|NCT01998971|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154171985|NCT01998971|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153646573|NCT00115687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153646574|NCT00115726|Furosemide|furosemide|mesh-list
153646575|NCT00115726|Diuretics|diuretics|mesh-ancestor
153646576|NCT00115726|Natriuretic Agents|natriuretic agents|mesh-ancestor
153646577|NCT00115726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154171986|NCT01998971|Growth Substances|growth substances|mesh-ancestor
154171987|NCT01998971|Growth Inhibitors|growth inhibitors|mesh-ancestor
154171988|NCT01998971|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154171989|NCT01998971|Analgesics|analgesics|mesh-ancestor
154171990|NCT01998971|Sensory System Agents|sensory system agents|mesh-ancestor
154171991|NCT01998971|Antipyretics|antipyretics|mesh-ancestor
154171992|NCT01998971|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154171993|NCT01998971|Alkylating Agents|alkylating agents|mesh-ancestor
154171994|NCT01998971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154171995|NCT01998971|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154171996|NCT01998971|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154171997|NCT01998971|Leprostatic Agents|leprostatic agents|mesh-ancestor
154171998|NCT01998971|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154171999|NCT01998971|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154172000|NCT01998971|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154172001|NCT01998971|Respiratory System Agents|respiratory system agents|mesh-ancestor
154172002|NCT01998971|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
154172003|NCT01998971|Hormone Antagonists|hormone antagonists|mesh-ancestor
154172004|NCT01998971|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
154172005|NCT01998971|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
154172006|NCT01998971|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
154172007|NCT01998971|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154172008|NCT01998971|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154172009|NCT01998971|Anesthetics, Local|anesthetics, local|mesh-ancestor
154172011|NCT01998971|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
154172012|NCT01998971|Histamine Antagonists|histamine antagonists|mesh-ancestor
154172013|NCT01998971|Histamine Agents|histamine agents|mesh-ancestor
154172014|NCT01998971|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154172015|NCT01998971|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154172016|NCT01998971|Antipruritics|antipruritics|mesh-ancestor
154172017|NCT01998971|Dermatologic Agents|dermatologic agents|mesh-ancestor
154172018|NCT01840072|Antihypertensive Agents|antihypertensive agents|mesh-list
154172035|NCT01804686|Ibrutinib|ibrutinib|mesh-list
154172036|NCT01804686|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154172037|NCT01804686|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154172038|NCT01804686|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154172039|NCT01804686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154172040|NCT01804634|Cyclophosphamide|cyclophosphamide|mesh-list
154172041|NCT01804634|Melphalan|melphalan|mesh-list
154172042|NCT01804634|Fludarabine|fludarabine|mesh-list
154172043|NCT01804634|Tacrolimus|tacrolimus|mesh-list
154172044|NCT01804634|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154172045|NCT01804634|Immunologic Factors|immunologic factors|mesh-ancestor
154172046|NCT01804634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154172047|NCT01804634|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154172048|NCT01804634|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154172049|NCT01804634|Alkylating Agents|alkylating agents|mesh-ancestor
154172050|NCT01804634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154172051|NCT01804634|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154172052|NCT01804634|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154172053|NCT01804634|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
154172054|NCT01804634|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154172055|NCT01631617|Doxycycline|doxycycline|mesh-list
154172056|NCT01631617|Cephalexin|cephalexin|mesh-list
154172057|NCT01631617|Trimethoprim|trimethoprim|mesh-list
154172058|NCT01631617|Sulfamethoxazole|sulfamethoxazole|mesh-list
154172059|NCT01631617|Sodium Hypochlorite|sodium hypochlorite|mesh-list
154172060|NCT01631617|Eusol|eusol|mesh-list
154172061|NCT01631617|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154172062|NCT01631617|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154172063|NCT01631617|Antimalarials|antimalarials|mesh-ancestor
154172064|NCT01631617|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154172065|NCT01631617|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154172066|NCT01631617|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
154172067|NCT01631617|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154172068|NCT01631617|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154172070|NCT01631617|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
154172072|NCT01631617|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154172073|NCT01631617|Disinfectants|disinfectants|mesh-ancestor
154172086|NCT01420250|Bicalutamide|bicalutamide|mesh-list
154172088|NCT01420250|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
154172089|NCT01420250|Androgens|androgens|mesh-list
154172090|NCT01420250|Androgen Antagonists|androgen antagonists|mesh-list
154172091|NCT01420250|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154172092|NCT01420250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154172093|NCT01420250|Hormone Antagonists|hormone antagonists|mesh-ancestor
154172094|NCT01420250|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154172095|NCT01361711|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
154172096|NCT01361711|Alemtuzumab|alemtuzumab|mesh-list
154172097|NCT01361711|Ofatumumab|ofatumumab|mesh-list
154172098|NCT01361711|Antibodies|antibodies|mesh-list
154172099|NCT01361711|Immunoglobulins|immunoglobulins|mesh-list
154172100|NCT01361711|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154172101|NCT01361711|Immunologic Factors|immunologic factors|mesh-ancestor
154172102|NCT01361711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154172103|NCT01361711|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154172104|NCT01306019|Busulfan|busulfan|mesh-list
154172105|NCT01306019|Alkylating Agents|alkylating agents|mesh-ancestor
154172106|NCT01306019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154172107|NCT01306019|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154172108|NCT01306019|Immunologic Factors|immunologic factors|mesh-ancestor
154172109|NCT01306019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154172110|NCT01306019|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154172111|NCT01306019|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154172120|NCT01174121|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154172121|NCT01174121|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154172122|NCT01174121|Alkylating Agents|alkylating agents|mesh-ancestor
154172123|NCT01174121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154172124|NCT01174121|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154172125|NCT01174121|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154172126|NCT01174121|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154172127|NCT01174121|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154172128|NCT01174121|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154172129|NCT01174121|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154172130|NCT01174121|Antiviral Agents|antiviral agents|mesh-ancestor
154172131|NCT01174121|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154172142|NCT00606346|Infliximab|infliximab|mesh-list
154172143|NCT00606346|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
154172144|NCT00606346|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154172145|NCT00606346|Dermatologic Agents|dermatologic agents|mesh-ancestor
154172146|NCT00606346|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154172147|NCT00606346|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154172163|NCT00001481|Progesterone|progesterone|mesh-list
154172164|NCT00001481|Estrogens|estrogens|mesh-ancestor
154172165|NCT00001481|Hormones|hormones|mesh-ancestor
154172166|NCT00001481|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154172167|NCT00001481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154172168|NCT00001481|Progestins|progestins|mesh-ancestor
153646578|NCT00115726|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
153646579|NCT00115726|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153626007|NCT02013986|GABA Agents|gaba agents|mesh-ancestor
153729758|NCT00131027|Mitosis Modulators|mitosis modulators|mesh-ancestor
153729759|NCT00139854|Alprazolam|alprazolam|mesh-list
153626463|NCT02016495|Vitamins|vitamins|mesh-ancestor
153626606|NCT02018055|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153626832|NCT02019290|Anesthetics|anesthetics|mesh-ancestor
153627662|NCT02024568|Pregabalin|pregabalin|mesh-list
153627875|NCT02025803|Capecitabine|capecitabine|mesh-list
153729760|NCT00139854|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153628560|NCT02029937|Proflavine|proflavine|mesh-list
153628629|NCT02032043|Ivermectin|ivermectin|mesh-list
153628869|NCT02040597|Hormones|hormones|mesh-ancestor
153629149|NCT02042742|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153629298|NCT02044224|Sensory System Agents|sensory system agents|mesh-ancestor
153629412|NCT02045017|Hormones|hormones|mesh-ancestor
153629519|NCT02045914|Calcium Ionophores|calcium ionophores|mesh-list
153629812|NCT02047201|Docetaxel|docetaxel|mesh-list
153630188|NCT00005958|Gemcitabine|gemcitabine|mesh-list
153630789|NCT02936505|Tacrolimus|tacrolimus|mesh-list
153631093|NCT00006144|Ritonavir|ritonavir|mesh-list
153729761|NCT00139854|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153631465|NCT00005830|Doxorubicin|doxorubicin|mesh-list
153631693|NCT00005893|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153631996|NCT00005998|Etoposide|etoposide|mesh-list
153729784|NCT00139893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153667322|NCT00026364|Protective Agents|protective agents|mesh-ancestor
153667323|NCT00026364|Vitamin B Complex|vitamin b complex|mesh-ancestor
153667324|NCT00026364|Vitamins|vitamins|mesh-ancestor
153667325|NCT00026364|Micronutrients|micronutrients|mesh-ancestor
153667326|NCT00026364|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153667327|NCT00026364|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153729785|NCT00131183|Testosterone undecanoate|testosterone undecanoate|mesh-list
153729786|NCT00131183|Androgens|androgens|mesh-ancestor
153729787|NCT00131183|Hormones|hormones|mesh-ancestor
153667328|NCT00026403|Gemcitabine|gemcitabine|mesh-list
153641531|NCT00276133|Atorvastatin|atorvastatin|mesh-list
153641608|NCT02921555|Prednisolone|prednisolone|mesh-list
153641833|NCT00006050|Levoleucovorin|levoleucovorin|mesh-list
153641907|NCT00006056|Antilymphocyte Serum|antilymphocyte serum|mesh-list
153642057|NCT00400075|Cyclophosphamide|cyclophosphamide|mesh-list
153730471|NCT00144846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153642513|NCT00088036|Olanzapine|olanzapine|mesh-list
153730472|NCT00144846|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153642889|NCT00089830|Squalamine|squalamine|mesh-list
153643039|NCT04619706|Hormones|hormones|mesh-ancestor
153643113|NCT00091858|Darbepoetin alfa|darbepoetin alfa|mesh-list
153643189|NCT00092326|Acetaminophen|acetaminophen|mesh-list
153643262|NCT00093262|Clevidipine|clevidipine|mesh-list
153643336|NCT00006233|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153644088|NCT00006350|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153644161|NCT00006362|Bortezomib|bortezomib|mesh-list
153644307|NCT01350102|Antioxidants|antioxidants|mesh-ancestor
153644615|NCT00102778|Ritonavir|ritonavir|mesh-list
153645504|NCT00109603|Tenofovir|tenofovir|mesh-list
153645726|NCT00111280|Etravirine|etravirine|mesh-list
153646360|NCT00008177|Iodine|iodine|mesh-list
153646714|NCT00116896|Cisplatin|cisplatin|mesh-list
153646786|NCT00117208|Natriuretic Agents|natriuretic agents|mesh-ancestor
153647320|NCT04711096|Bupivacaine|bupivacaine|mesh-list
153647467|NCT00122629|Analgesics|analgesics|mesh-ancestor
153647838|NCT00009828|Leucovorin|leucovorin|mesh-list
153648299|NCT00021463|Zidovudine|zidovudine|mesh-list
153730473|NCT00144846|Respiratory System Agents|respiratory system agents|mesh-ancestor
153729791|NCT00139932|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153729793|NCT00139932|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153729794|NCT00139932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153729795|NCT00139932|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153729796|NCT00139932|Respiratory System Agents|respiratory system agents|mesh-ancestor
153729797|NCT00139932|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
153729798|NCT00139932|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
153729799|NCT00139932|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153729800|NCT00139932|Adrenergic Agents|adrenergic agents|mesh-ancestor
153729801|NCT00139932|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153729802|NCT00139932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153729803|NCT00131261|Dexamethasone|dexamethasone|mesh-list
153729804|NCT00131261|Belinostat|belinostat|mesh-list
153729805|NCT00131261|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153729806|NCT00131261|Antiemetics|antiemetics|mesh-ancestor
153729807|NCT00131261|Autonomic Agents|autonomic agents|mesh-ancestor
153729808|NCT00131261|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153729809|NCT00131261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153729810|NCT00131261|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153729811|NCT00131261|Glucocorticoids|glucocorticoids|mesh-ancestor
153729812|NCT00131261|Hormones|hormones|mesh-ancestor
153729813|NCT00131261|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153729814|NCT00131261|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153658052|NCT04967196|Nivolumab|nivolumab|mesh-list
153658456|NCT03815344|Oxytocics|oxytocics|mesh-ancestor
153729815|NCT00131261|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153729816|NCT00131261|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
153729817|NCT00131261|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153729818|NCT00131261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153729819|NCT00131300|Hylan|hylan|mesh-list
153659366|NCT00066274|Leucovorin|leucovorin|mesh-list
153665526|NCT00016952|Antimetabolites|antimetabolites|mesh-ancestor
153665687|NCT00128934|Estradiol|estradiol|mesh-list
153665750|NCT00017381|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153665834|NCT00017654|Antiemetics|antiemetics|mesh-ancestor
153666051|NCT00018356|Hormones|hormones|mesh-ancestor
153666283|NCT00020943|Hormones|hormones|mesh-ancestor
153666669|NCT00022737|Hormones|hormones|mesh-ancestor
153667035|NCT05080049|Epoetin Alfa|epoetin alfa|mesh-list
153667112|NCT00025194|Alkylating Agents|alkylating agents|mesh-ancestor
153667715|NCT00028665|Carmustine|carmustine|mesh-list
153667796|NCT00028860|Antimetabolites|antimetabolites|mesh-ancestor
153668244|NCT04711668|Analgesics|analgesics|mesh-ancestor
153668314|NCT00031434|Valganciclovir|valganciclovir|mesh-list
153668385|NCT00031785|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153669280|NCT01805687|Zileuton|zileuton|mesh-list
153669656|NCT01464671|Heparin|heparin|mesh-list
153669728|NCT00038259|Aldesleukin|aldesleukin|mesh-list
153729822|NCT00131300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153729823|NCT00131339|Cycloserine|cycloserine|mesh-list
153670851|NCT05379322|Analgesics|analgesics|mesh-ancestor
153671858|NCT04278092|Paclitaxel|paclitaxel|mesh-list
153672086|NCT02250326|Paclitaxel|paclitaxel|mesh-list
153672217|NCT00038844|Alkylating Agents|alkylating agents|mesh-ancestor
153923715|NCT00645307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153923716|NCT00645307|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
153923717|NCT00645307|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
153923719|NCT02668861|Vitamin D|vitamin d|mesh-list
153923720|NCT02668861|Budesonide|budesonide|mesh-list
153923721|NCT02668861|Vitamins|vitamins|mesh-ancestor
153923722|NCT02668861|Micronutrients|micronutrients|mesh-ancestor
153923723|NCT02668861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153923724|NCT02668861|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153923725|NCT02668861|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153923726|NCT02668861|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153923727|NCT02668861|Autonomic Agents|autonomic agents|mesh-ancestor
153923728|NCT02668861|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153923729|NCT02668861|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153923730|NCT02668861|Respiratory System Agents|respiratory system agents|mesh-ancestor
153923731|NCT02668861|Glucocorticoids|glucocorticoids|mesh-ancestor
153923732|NCT02668861|Hormones|hormones|mesh-ancestor
153923733|NCT02668861|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153923734|NCT00968253|Cytarabine|cytarabine|mesh-list
153923735|NCT00968253|Dexamethasone|dexamethasone|mesh-list
153923736|NCT00968253|Methylprednisolone|methylprednisolone|mesh-list
153923737|NCT00968253|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
153923738|NCT00968253|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
153923739|NCT00968253|Prednisolone|prednisolone|mesh-list
153923740|NCT00968253|Prednisolone acetate|prednisolone acetate|mesh-list
153923768|NCT00968253|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153923769|NCT00968253|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153923770|NCT00968253|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153923771|NCT00968253|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
153923772|NCT00968253|Abortifacient Agents|abortifacient agents|mesh-ancestor
153923773|NCT00968253|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153923774|NCT00968253|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153923775|NCT00968253|Antimetabolites|antimetabolites|mesh-ancestor
153923776|NCT00968253|Dermatologic Agents|dermatologic agents|mesh-ancestor
153923777|NCT00968253|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153923778|NCT00968253|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153923780|NCT00968253|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153923781|NCT00968253|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153923782|NCT00968253|Tubulin Modulators|tubulin modulators|mesh-ancestor
153923783|NCT00968253|Antimitotic Agents|antimitotic agents|mesh-ancestor
153923784|NCT00968253|Mitosis Modulators|mitosis modulators|mesh-ancestor
153923826|NCT00646087|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153923827|NCT00646087|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
153923828|NCT00646087|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
153923829|NCT00646087|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153923830|NCT00646087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153923831|NCT04255576|Vitamin D|vitamin d|mesh-list
153923832|NCT04255576|Calcium|calcium|mesh-list
153923833|NCT04255576|Vitamins|vitamins|mesh-ancestor
153923834|NCT04255576|Micronutrients|micronutrients|mesh-ancestor
153923835|NCT04255576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153923836|NCT04255576|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153923837|NCT04255576|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153923838|NCT04255498|Etanercept|etanercept|mesh-list
153923839|NCT04255498|Mifepristone|mifepristone|mesh-list
153923840|NCT04255498|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153923841|NCT04255498|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153923842|NCT04255498|Analgesics|analgesics|mesh-ancestor
153923843|NCT04255498|Sensory System Agents|sensory system agents|mesh-ancestor
153923844|NCT04255498|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153923845|NCT04255498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153923846|NCT04255498|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153923847|NCT04255498|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153923848|NCT04255498|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153923849|NCT04255498|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153923850|NCT04255498|Immunologic Factors|immunologic factors|mesh-ancestor
153923851|NCT04255498|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
153923852|NCT04255498|Abortifacient Agents|abortifacient agents|mesh-ancestor
153923853|NCT04255498|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153923854|NCT04255498|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
153923855|NCT04255498|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
153923868|NCT02666209|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153923870|NCT02666209|Autonomic Agents|autonomic agents|mesh-ancestor
153923871|NCT02666209|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153923872|NCT02666209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153923873|NCT02666209|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153923874|NCT02666209|Glucocorticoids|glucocorticoids|mesh-ancestor
153923875|NCT02666209|Hormones|hormones|mesh-ancestor
153923876|NCT02666209|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153923877|NCT02666209|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153923878|NCT02666209|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153923879|NCT02666209|Immunologic Factors|immunologic factors|mesh-ancestor
153923880|NCT02666209|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153923881|NCT02666209|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153923882|NCT02666209|Growth Substances|growth substances|mesh-ancestor
153923884|NCT00964743|Cytarabine|cytarabine|mesh-list
153923927|NCT02666365|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153667669|NCT00028353|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153667670|NCT00028353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153923928|NCT02666443|Dexamethasone|dexamethasone|mesh-list
153923929|NCT02666443|Dexamethasone acetate|dexamethasone acetate|mesh-list
153923930|NCT02666443|BB 1101|bb 1101|mesh-list
153923931|NCT02666443|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153923932|NCT02666443|Antiemetics|antiemetics|mesh-ancestor
153923933|NCT02666443|Autonomic Agents|autonomic agents|mesh-ancestor
153923934|NCT02666443|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153923935|NCT02666443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153923936|NCT02666443|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153923937|NCT02666443|Glucocorticoids|glucocorticoids|mesh-ancestor
153923938|NCT02666443|Hormones|hormones|mesh-ancestor
153923939|NCT02666443|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153923940|NCT02666443|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153923941|NCT02666443|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153923942|NCT02666443|Protease Inhibitors|protease inhibitors|mesh-ancestor
153923943|NCT02666443|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153923944|NCT02666443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153923945|NCT01130532|Tadalafil|tadalafil|mesh-list
153923946|NCT01130532|Vasodilator Agents|vasodilator agents|mesh-ancestor
153923947|NCT01130532|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
153923948|NCT01130532|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
153923949|NCT01130532|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153923950|NCT01130532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153923951|NCT01130532|Urological Agents|urological agents|mesh-ancestor
153923952|NCT04258306|Resveratrol|resveratrol|mesh-list
153923953|NCT04258306|Antioxidants|antioxidants|mesh-ancestor
153923954|NCT04258306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153923959|NCT00646711|Valproic Acid|valproic acid|mesh-list
153923972|NCT00972777|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153923973|NCT00972777|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153923974|NCT00972777|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153923975|NCT00972777|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153923976|NCT00972777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153923977|NCT00972777|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153923978|NCT04254874|Interferons|interferons|mesh-list
153923979|NCT04254874|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153923980|NCT04254874|Antiviral Agents|antiviral agents|mesh-ancestor
153923981|NCT04254874|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153923982|NCT02667223|Bococizumab|bococizumab|mesh-list
153923983|NCT02667223|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153923984|NCT02667223|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153923985|NCT02667223|Antimetabolites|antimetabolites|mesh-ancestor
153923986|NCT02667223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153923987|NCT02667223|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153923988|NCT00918736|Hyaluronic Acid|hyaluronic acid|mesh-list
153923989|NCT00918736|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153923990|NCT00918736|Immunologic Factors|immunologic factors|mesh-ancestor
153923991|NCT00918736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153923992|NCT00918736|Viscosupplements|viscosupplements|mesh-ancestor
153923993|NCT00918736|Protective Agents|protective agents|mesh-ancestor
153923994|NCT02666053|Fostemsavir|fostemsavir|mesh-list
153923995|NCT02666053|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153923996|NCT02666053|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153923997|NCT02666053|Antiviral Agents|antiviral agents|mesh-ancestor
153923998|NCT02666053|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153923999|NCT02666053|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
153924000|NCT02666053|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
153924001|NCT02666053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153924018|NCT01172639|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153924019|NCT01172639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153924020|NCT01172639|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153924021|NCT01172639|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153924022|NCT01172639|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
153924023|NCT01172639|Abortifacient Agents|abortifacient agents|mesh-ancestor
153924024|NCT01172639|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153924025|NCT01172639|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153924026|NCT01172639|Antimetabolites|antimetabolites|mesh-ancestor
153924027|NCT01172639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153924028|NCT01172639|Dermatologic Agents|dermatologic agents|mesh-ancestor
153924029|NCT01172639|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153924030|NCT01172639|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153924076|NCT00925132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153924077|NCT00925132|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153924078|NCT00925132|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153924080|NCT00925132|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153924081|NCT00925132|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
153924082|NCT02862015|Gemcitabine|gemcitabine|mesh-list
153924083|NCT02862015|Folfirinox|folfirinox|mesh-list
153924084|NCT02862015|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153924085|NCT02862015|Antimetabolites|antimetabolites|mesh-ancestor
153924086|NCT02862015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153924087|NCT02862015|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153924088|NCT01143402|Temozolomide|temozolomide|mesh-list
153924089|NCT01143402|Dacarbazine|dacarbazine|mesh-list
153924090|NCT01143402|Imidazole|imidazole|mesh-list
153924091|NCT01143402|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153924092|NCT01143402|Alkylating Agents|alkylating agents|mesh-ancestor
153924093|NCT01143402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153924094|NCT01143402|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153924095|NCT01143402|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153924096|NCT00646945|Nitrous Oxide|nitrous oxide|mesh-list
153924097|NCT00646945|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
153924098|NCT00646945|Anesthetics, General|anesthetics, general|mesh-ancestor
153924099|NCT00646945|Anesthetics|anesthetics|mesh-ancestor
153924100|NCT00646945|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153924101|NCT00646945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153924102|NCT00646945|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153924103|NCT00646945|Analgesics|analgesics|mesh-ancestor
153924104|NCT00646945|Sensory System Agents|sensory system agents|mesh-ancestor
153924105|NCT00646945|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153924106|NCT00629889|Pregabalin|pregabalin|mesh-list
153924107|NCT00629889|Levetiracetam|levetiracetam|mesh-list
153924108|NCT00629889|Analgesics|analgesics|mesh-ancestor
153924112|NCT00629889|Anticonvulsants|anticonvulsants|mesh-ancestor
153924116|NCT00629889|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153924117|NCT00629889|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153924118|NCT00629889|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153924119|NCT00629889|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153924120|NCT00629889|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153667793|NCT00028860|Mitosis Modulators|mitosis modulators|mesh-ancestor
153667795|NCT00028860|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153924121|NCT00629889|Nootropic Agents|nootropic agents|mesh-ancestor
153924122|NCT00630045|Capecitabine|capecitabine|mesh-list
153924123|NCT00630045|Oxaliplatin|oxaliplatin|mesh-list
153924124|NCT00630045|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153924125|NCT00630045|Antimetabolites|antimetabolites|mesh-ancestor
153924126|NCT00630045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153924127|NCT00630045|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153924128|NCT02861859|Olanzapine|olanzapine|mesh-list
153924129|NCT02861859|Antiemetics|antiemetics|mesh-ancestor
153924130|NCT02861859|Autonomic Agents|autonomic agents|mesh-ancestor
153924131|NCT02861859|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153924132|NCT02861859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153924133|NCT02861859|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153924134|NCT02861859|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153924135|NCT02861859|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153924136|NCT02861859|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153924137|NCT02861859|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153924138|NCT02861859|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
153924139|NCT02861859|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153924164|NCT01167192|Carboplatin|carboplatin|mesh-list
153924165|NCT01167192|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153924166|NCT00646321|Budesonide|budesonide|mesh-list
153924167|NCT00646321|Formoterol Fumarate|formoterol fumarate|mesh-list
153924168|NCT00646321|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
153924169|NCT00646321|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153924170|NCT00646321|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153924171|NCT00646321|Autonomic Agents|autonomic agents|mesh-ancestor
153924172|NCT00646321|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153924173|NCT00646321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153924174|NCT00646321|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153924175|NCT00646321|Respiratory System Agents|respiratory system agents|mesh-ancestor
153667880|NCT00392717|Atorvastatin|atorvastatin|mesh-list
153924176|NCT00646321|Glucocorticoids|glucocorticoids|mesh-ancestor
153924177|NCT00646321|Hormones|hormones|mesh-ancestor
153924178|NCT00646321|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153924179|NCT00646321|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
153924180|NCT00646321|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
153924181|NCT00646321|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153924182|NCT00646321|Adrenergic Agents|adrenergic agents|mesh-ancestor
153924183|NCT00646321|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153924184|NCT00646321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153924185|NCT00647101|Latanoprost|latanoprost|mesh-list
153915476|NCT02698267|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
153924186|NCT00647101|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
153924187|NCT00647101|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
153924188|NCT01166958|Teriparatide|teriparatide|mesh-list
153924189|NCT01166958|Raloxifene Hydrochloride|raloxifene hydrochloride|mesh-list
153924190|NCT01166958|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153924191|NCT01166958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153915477|NCT01011465|Oxytocin|oxytocin|mesh-list
153441502|NCT04069117|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
153814565|NCT00452322|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153924198|NCT01170221|Linezolid|linezolid|mesh-list
153924208|NCT04254640|Aclarubicin|aclarubicin|mesh-list
153924209|NCT04254640|Lenograstim|lenograstim|mesh-list
153924210|NCT04254640|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153924211|NCT04254640|Antimetabolites|antimetabolites|mesh-ancestor
153814566|NCT00452322|Anabolic Agents|anabolic agents|mesh-ancestor
153924212|NCT04254640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153924213|NCT04254640|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153924214|NCT04254640|Antiviral Agents|antiviral agents|mesh-ancestor
153924215|NCT04254640|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153924216|NCT04254640|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153924217|NCT04254640|Immunologic Factors|immunologic factors|mesh-ancestor
153924218|NCT04254640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153924219|NCT04254640|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153924220|NCT04254640|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153924221|NCT04254640|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153924222|NCT04254640|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153924223|NCT04254640|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153924224|NCT01166646|Clobetasol|clobetasol|mesh-list
153924225|NCT01166646|Halobetasol|halobetasol|mesh-list
153924226|NCT01166646|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
153924227|NCT01166646|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153924228|NCT01166646|Glucocorticoids|glucocorticoids|mesh-ancestor
153924229|NCT01166646|Hormones|hormones|mesh-ancestor
153924230|NCT01166646|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153924231|NCT01166646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153924232|NCT01129284|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
153924257|NCT00924820|Growth Inhibitors|growth inhibitors|mesh-ancestor
153924258|NCT01225172|Letrozole|letrozole|mesh-list
153924259|NCT01225172|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153924260|NCT01225172|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
153924261|NCT01225172|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153924262|NCT01225172|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153915488|NCT02494141|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153915493|NCT01011309|Antimony Sodium Gluconate|antimony sodium gluconate|mesh-list
153915494|NCT01011309|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153915495|NCT01011309|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153915496|NCT01011309|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153915497|NCT01011309|Schistosomicides|schistosomicides|mesh-ancestor
153895322|NCT03576690|Atoltivimab|atoltivimab|mesh-list
153924263|NCT01225172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153924264|NCT01225172|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
153924265|NCT01225172|Hormone Antagonists|hormone antagonists|mesh-ancestor
153924266|NCT01225172|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153924267|NCT01225172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153924268|NCT02665039|Carboplatin|carboplatin|mesh-list
153924269|NCT02665039|Gemcitabine|gemcitabine|mesh-list
153924270|NCT02665039|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153924271|NCT02665039|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153924272|NCT02665039|Antimetabolites|antimetabolites|mesh-ancestor
153924273|NCT02665039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153924274|NCT00647491|Adalimumab|adalimumab|mesh-list
153924275|NCT00647491|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
153924276|NCT00647491|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153924277|NCT00647491|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153924278|NCT04252456|Leucovorin|leucovorin|mesh-list
153924279|NCT04252456|Folic Acid|folic acid|mesh-list
153924280|NCT04252456|Fluorouracil|fluorouracil|mesh-list
153924281|NCT04252456|Aflibercept|aflibercept|mesh-list
153924282|NCT04252456|Levoleucovorin|levoleucovorin|mesh-list
153924283|NCT04252456|Antimetabolites|antimetabolites|mesh-ancestor
153924284|NCT04252456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153924285|NCT04252456|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153924286|NCT04252456|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153924288|NCT04252456|Immunologic Factors|immunologic factors|mesh-ancestor
153810958|NCT00331500|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153915501|NCT04214821|Levofloxacin|levofloxacin|mesh-list
153814575|NCT00452556|Fertility Agents, Female|fertility agents, female|mesh-ancestor
153814576|NCT00452556|Fertility Agents|fertility agents|mesh-ancestor
153814577|NCT00452556|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153814578|NCT00452556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153436527|NCT00004040|Antiviral Agents|antiviral agents|mesh-ancestor
153924302|NCT02665351|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153924303|NCT02665351|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153681857|NCT00126256|Antidotes|antidotes|mesh-ancestor
153924304|NCT02665351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153924306|NCT01222520|Telmisartan|telmisartan|mesh-list
153924307|NCT01222520|Telmisartan amlodipine combination|telmisartan amlodipine combination|mesh-list
153924308|NCT01222520|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153924309|NCT01222520|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153924310|NCT01222520|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153924311|NCT01222520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153924312|NCT01222520|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153924313|NCT01222520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153924314|NCT01222520|Vasodilator Agents|vasodilator agents|mesh-ancestor
153924315|NCT01222520|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
153924316|NCT01222520|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
153924317|NCT01221350|Thioctic Acid|thioctic acid|mesh-list
153924318|NCT01221350|Antioxidants|antioxidants|mesh-ancestor
153924319|NCT01221350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153924320|NCT01221350|Protective Agents|protective agents|mesh-ancestor
153924355|NCT01220180|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153924356|NCT01220180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153924357|NCT01220180|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153924358|NCT01220180|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153924359|NCT01220180|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153924360|NCT01220180|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153924361|NCT01220180|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153924363|NCT01220024|Anesthetics, Local|anesthetics, local|mesh-ancestor
153924364|NCT01220024|Anesthetics|anesthetics|mesh-ancestor
153924365|NCT01220024|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153924366|NCT01220024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153924367|NCT01220024|Sensory System Agents|sensory system agents|mesh-ancestor
153924368|NCT01220024|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153924369|NCT00625248|Anticoagulants|anticoagulants|mesh-list
153924370|NCT00625248|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-list
153924371|NCT01143090|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
153924372|NCT01143090|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153924373|NCT01143090|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153924374|NCT01143090|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153924375|NCT01143090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153924376|NCT01143090|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153924377|NCT01143090|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
153357526|NCT00724568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153895379|NCT03069352|Cytarabine|cytarabine|mesh-list
153924378|NCT01143090|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
153924379|NCT01143090|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
153924380|NCT01143090|Adrenergic Agents|adrenergic agents|mesh-ancestor
153924381|NCT01143090|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153924382|NCT01143090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153924383|NCT01143090|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
153924384|NCT01143090|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153924385|NCT01143090|Serotonin Agents|serotonin agents|mesh-ancestor
153924386|NCT01143090|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
153924394|NCT05125146|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153924395|NCT05125146|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
153924396|NCT05125146|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153924397|NCT05125146|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153924398|NCT05125146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153924399|NCT05125146|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153924400|NCT05125146|Serotonin Agents|serotonin agents|mesh-ancestor
153924401|NCT05125146|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
153924402|NCT05125146|Antidepressive Agents|antidepressive agents|mesh-ancestor
153924403|NCT01165554|Flutemetamol|flutemetamol|mesh-list
153924404|NCT01165554|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
153924405|NCT01165554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153924407|NCT01218308|Immunologic Factors|immunologic factors|mesh-ancestor
153924408|NCT01218308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153924409|NCT02887976|Methylprednisolone|methylprednisolone|mesh-list
153924410|NCT02887976|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
153924411|NCT02887976|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
153924412|NCT02887976|Prednisolone|prednisolone|mesh-list
153924413|NCT02887976|Prednisolone acetate|prednisolone acetate|mesh-list
153924414|NCT02887976|Abiraterone Acetate|abiraterone acetate|mesh-list
153924415|NCT02887976|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
153924416|NCT02887976|Prednisolone phosphate|prednisolone phosphate|mesh-list
153924417|NCT02887976|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153924418|NCT02887976|Antiemetics|antiemetics|mesh-ancestor
153924419|NCT02887976|Autonomic Agents|autonomic agents|mesh-ancestor
153924420|NCT02887976|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153924421|NCT02887976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153924422|NCT02887976|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153924423|NCT02887976|Glucocorticoids|glucocorticoids|mesh-ancestor
153924424|NCT02887976|Hormones|hormones|mesh-ancestor
153924425|NCT02887976|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153924435|NCT01165320|Caspofungin|caspofungin|mesh-list
153924436|NCT01165320|Antifungal Agents|antifungal agents|mesh-ancestor
153924437|NCT01165320|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153915502|NCT04214821|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
153814579|NCT00452556|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153436572|NCT00002689|Glucocorticoids|glucocorticoids|mesh-ancestor
153924438|NCT01165320|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153924439|NCT01165320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153924440|NCT01217606|Timolol|timolol|mesh-list
153924441|NCT01217606|Brimonidine Tartrate|brimonidine tartrate|mesh-list
153924442|NCT01217606|Bimatoprost|bimatoprost|mesh-list
153924443|NCT01217606|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
153924444|NCT01217606|Ophthalmic Solutions|ophthalmic solutions|mesh-list
153924445|NCT01217606|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
153924446|NCT01217606|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
153924447|NCT01217606|Adrenergic Agents|adrenergic agents|mesh-ancestor
153924448|NCT01217606|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153924449|NCT01217606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153924450|NCT01217606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153924451|NCT01217606|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153924452|NCT01217606|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153924453|NCT01217606|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
153924454|NCT01217606|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153924455|NCT01217606|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153924456|NCT01128114|Quetiapine Fumarate|quetiapine fumarate|mesh-list
153924457|NCT01128114|Antidepressive Agents|antidepressive agents|mesh-ancestor
153924458|NCT01128114|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153924485|NCT01170065|Nintedanib|nintedanib|mesh-list
153924486|NCT01170065|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153924487|NCT01170065|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153924488|NCT01170065|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153924489|NCT01170065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153924490|NCT02885922|Hypoglycemic Agents|hypoglycemic agents|mesh-list
153924491|NCT02885922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153924492|NCT00966693|Thalidomide|thalidomide|mesh-list
153924493|NCT00966693|Dexamethasone|dexamethasone|mesh-list
153924494|NCT00966693|Dexamethasone acetate|dexamethasone acetate|mesh-list
153924495|NCT00966693|Lenalidomide|lenalidomide|mesh-list
153924496|NCT00966693|Ichthammol|ichthammol|mesh-list
153924497|NCT00966693|BB 1101|bb 1101|mesh-list
153810959|NCT00331500|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153810960|NCT00331500|Analgesics|analgesics|mesh-ancestor
153924499|NCT00966693|Antiemetics|antiemetics|mesh-ancestor
153924549|NCT02664493|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
153924550|NCT02664493|Prednisolone phosphate|prednisolone phosphate|mesh-list
153924551|NCT02664493|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153924552|NCT02664493|Antiemetics|antiemetics|mesh-ancestor
153924553|NCT02664493|Autonomic Agents|autonomic agents|mesh-ancestor
153924554|NCT02664493|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153924555|NCT02664493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153924556|NCT02664493|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153924557|NCT02664493|Glucocorticoids|glucocorticoids|mesh-ancestor
153924558|NCT02664493|Hormones|hormones|mesh-ancestor
153924559|NCT02664493|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153924560|NCT02664493|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
153924561|NCT02664493|Protective Agents|protective agents|mesh-ancestor
153924562|NCT02664493|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153924563|NCT02664493|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153924564|NCT00963807|Deoxyglucose|deoxyglucose|mesh-list
153924565|NCT00963807|Alovudine|alovudine|mesh-list
153924566|NCT00963807|Dideoxynucleosides|dideoxynucleosides|mesh-list
153924567|NCT00963807|Cisplatin|cisplatin|mesh-list
153924568|NCT00963807|Docetaxel|docetaxel|mesh-list
153924569|NCT00963807|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
153924570|NCT00963807|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153924571|NCT00963807|Tubulin Modulators|tubulin modulators|mesh-ancestor
153924572|NCT00963807|Antimitotic Agents|antimitotic agents|mesh-ancestor
153924573|NCT00963807|Mitosis Modulators|mitosis modulators|mesh-ancestor
153924574|NCT00963807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153924603|NCT02863185|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153924604|NCT02863185|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153924606|NCT02863185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153924607|NCT02863185|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153924608|NCT02863185|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
153924609|NCT02863185|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153924610|NCT00647881|Paroxetine|paroxetine|mesh-list
153924611|NCT00647881|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
153924612|NCT00647881|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153924613|NCT00647881|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153924614|NCT00647881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153924615|NCT00647881|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153924616|NCT00647881|Serotonin Agents|serotonin agents|mesh-ancestor
153924617|NCT00647881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153924620|NCT00647881|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153464213|NCT01253070|Immunologic Factors|immunologic factors|mesh-ancestor
153915508|NCT04214821|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153915509|NCT04214821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153895451|NCT02795429|Spartalizumab|spartalizumab|mesh-list
153924654|NCT00648583|Antipruritics|antipruritics|mesh-ancestor
153924655|NCT00648583|Dermatologic Agents|dermatologic agents|mesh-ancestor
153924656|NCT00648583|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
153924657|NCT00648583|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153924658|NCT00648583|Serotonin Agents|serotonin agents|mesh-ancestor
153924659|NCT00648583|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153924660|NCT00648583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153924662|NCT03809481|Argatroban|argatroban|mesh-list
153924663|NCT03809481|Antithrombins|antithrombins|mesh-ancestor
153924664|NCT03809481|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
153924665|NCT03809481|Protease Inhibitors|protease inhibitors|mesh-ancestor
153924666|NCT03809481|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153924667|NCT03809481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153924668|NCT03809481|Anticoagulants|anticoagulants|mesh-ancestor
153924669|NCT03809481|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153924670|NCT03809481|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153924671|NCT03809481|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153924672|NCT00649129|Oxybutynin|oxybutynin|mesh-list
153924673|NCT00649129|Parasympatholytics|parasympatholytics|mesh-ancestor
153924674|NCT00649129|Autonomic Agents|autonomic agents|mesh-ancestor
153924675|NCT00649129|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153924676|NCT00649129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153924677|NCT00649129|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
153924678|NCT00649129|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
153924679|NCT00649129|Cholinergic Agents|cholinergic agents|mesh-ancestor
153924680|NCT00649129|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153924701|NCT02660047|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153924703|NCT00648661|Citalopram|citalopram|mesh-list
153924704|NCT00648661|Escitalopram|escitalopram|mesh-list
153924705|NCT00648661|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
153924706|NCT00648661|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153924707|NCT00648661|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153924708|NCT00648661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153924709|NCT00648661|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153924710|NCT00648661|Serotonin Agents|serotonin agents|mesh-ancestor
153924711|NCT00648661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153924712|NCT00648661|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
153924713|NCT00648661|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
153924714|NCT00648661|Parasympatholytics|parasympatholytics|mesh-ancestor
153924715|NCT00648661|Autonomic Agents|autonomic agents|mesh-ancestor
153924716|NCT00648661|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153924717|NCT00648661|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
153924718|NCT00648661|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
153924719|NCT00648661|Cholinergic Agents|cholinergic agents|mesh-ancestor
153924720|NCT00648661|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
153924721|NCT00648661|Antidepressive Agents|antidepressive agents|mesh-ancestor
153924722|NCT00648661|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153924723|NCT05367414|Tea Tree Oil|tea tree oil|mesh-list
153924724|NCT05367414|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
153924725|NCT05367414|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153810961|NCT00331500|Sensory System Agents|sensory system agents|mesh-ancestor
153924726|NCT04171687|Clopidogrel|clopidogrel|mesh-list
153924727|NCT04171687|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153924728|NCT04171687|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
153924735|NCT00648817|Tenofovir|tenofovir|mesh-list
153924744|NCT02663323|Sirolimus|sirolimus|mesh-list
153924745|NCT02663323|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153924746|NCT02663323|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153924747|NCT02663323|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153682305|NCT05497336|Cetuximab|cetuximab|mesh-list
153924748|NCT02663323|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153924749|NCT02663323|Antifungal Agents|antifungal agents|mesh-ancestor
153924750|NCT02663323|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153924751|NCT02663323|Immunologic Factors|immunologic factors|mesh-ancestor
153924752|NCT02663323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153924753|NCT01215188|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
153924754|NCT01215188|Immunologic Factors|immunologic factors|mesh-ancestor
153924755|NCT01215188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153924756|NCT04285281|Gabapentin|gabapentin|mesh-list
153924757|NCT04285281|Analgesics|analgesics|mesh-ancestor
153357527|NCT00724568|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153815092|NCT00344942|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
153895487|NCT02538198|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153895488|NCT02538198|Growth Substances|growth substances|mesh-ancestor
153895489|NCT02538198|Growth Inhibitors|growth inhibitors|mesh-ancestor
153895490|NCT02538198|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153895491|NCT02484287|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
153895492|NCT02484287|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153895493|NCT02341144|Ropivacaine|ropivacaine|mesh-list
153924758|NCT04285281|Sensory System Agents|sensory system agents|mesh-ancestor
153924759|NCT04285281|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153924760|NCT04285281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153924762|NCT04285281|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153924763|NCT04285281|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153924764|NCT04285281|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153924765|NCT04285281|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153924796|NCT01215032|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153924797|NCT01215032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153924798|NCT02663089|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
153924799|NCT02664103|Cyclophosphamide|cyclophosphamide|mesh-list
153924800|NCT02664103|Capecitabine|capecitabine|mesh-list
153924801|NCT02664103|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153924802|NCT02664103|Immunologic Factors|immunologic factors|mesh-ancestor
153924803|NCT02664103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153924804|NCT02664103|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153924805|NCT02664103|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153924806|NCT02664103|Alkylating Agents|alkylating agents|mesh-ancestor
153924807|NCT02664103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153924808|NCT02664103|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153924809|NCT02664103|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153924810|NCT02664103|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153924811|NCT02664103|Antimetabolites|antimetabolites|mesh-ancestor
153924812|NCT02662855|Favipiravir|favipiravir|mesh-list
153810962|NCT00331500|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153357528|NCT00724568|Glucocorticoids|glucocorticoids|mesh-ancestor
153915516|NCT00616213|Immunologic Factors|immunologic factors|mesh-ancestor
153915518|NCT00615667|Tacrolimus|tacrolimus|mesh-list
153895504|NCT02213328|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153924813|NCT02662855|Antiviral Agents|antiviral agents|mesh-ancestor
153924814|NCT02662855|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153924815|NCT00648271|Metoprolol|metoprolol|mesh-list
153924816|NCT00648271|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153924828|NCT00648349|Rabeprazole|rabeprazole|mesh-list
153924846|NCT00920686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153924847|NCT00648427|Paroxetine|paroxetine|mesh-list
153924848|NCT00648427|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
153924849|NCT00648427|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153924850|NCT00648427|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153924851|NCT00648427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153924852|NCT00648427|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153924853|NCT00648427|Serotonin Agents|serotonin agents|mesh-ancestor
153924854|NCT00648427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153924855|NCT00648427|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
153924856|NCT00648427|Antidepressive Agents|antidepressive agents|mesh-ancestor
153924857|NCT00648427|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153924858|NCT00648427|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
153924859|NCT00648427|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153924860|NCT00648427|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153924861|NCT04170751|Vasopressins|vasopressins|mesh-list
153924862|NCT04170751|Arginine Vasopressin|arginine vasopressin|mesh-list
153924863|NCT04170751|Norepinephrine|norepinephrine|mesh-list
153924864|NCT04170751|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153924865|NCT04170751|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153924866|NCT04170751|Adrenergic Agents|adrenergic agents|mesh-ancestor
153924867|NCT04170751|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153924868|NCT04170751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153924869|NCT04170751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153924870|NCT04170751|Sympathomimetics|sympathomimetics|mesh-ancestor
153924871|NCT04170751|Autonomic Agents|autonomic agents|mesh-ancestor
153924872|NCT04170751|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153924873|NCT04170751|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
153924874|NCT04170751|Hemostatics|hemostatics|mesh-ancestor
153924890|NCT04170595|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153924891|NCT04170595|Antimetabolites|antimetabolites|mesh-ancestor
153924892|NCT04170595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153924893|NCT04511533|Dacomitinib|dacomitinib|mesh-list
153682463|NCT00044837|Estradiol|estradiol|mesh-list
153924894|NCT04511533|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153924895|NCT04511533|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153924896|NCT04511533|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153924897|NCT04511533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153924899|NCT00648973|Promethazine|promethazine|mesh-list
153915522|NCT00615667|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
153915523|NCT00615667|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153915524|NCT00615667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153915525|NCT02697955|Epinephrine|epinephrine|mesh-list
153915526|NCT02697955|Bupivacaine|bupivacaine|mesh-list
153915527|NCT02697955|Anesthetics, Local|anesthetics, local|mesh-ancestor
153915530|NCT02697955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153810964|NCT00331500|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153810965|NCT00331500|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153895571|NCT02004782|Glucocorticoids|glucocorticoids|mesh-ancestor
153895572|NCT02004782|Hormones|hormones|mesh-ancestor
153895573|NCT02004782|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153895574|NCT02004782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153895575|NCT02004782|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153436749|NCT00003596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153436758|NCT00002719|Cytarabine|cytarabine|mesh-list
153924900|NCT00648973|Pseudoephedrine|pseudoephedrine|mesh-list
153924901|NCT00648973|Ephedrine|ephedrine|mesh-list
153924902|NCT00648973|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
153924903|NCT00648973|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153924904|NCT00648973|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153924905|NCT00648973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153924906|NCT00648973|Anesthetics, Local|anesthetics, local|mesh-ancestor
153924907|NCT00648973|Anesthetics|anesthetics|mesh-ancestor
153924908|NCT00648973|Sensory System Agents|sensory system agents|mesh-ancestor
153924909|NCT00648973|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153924910|NCT00648973|Antiemetics|antiemetics|mesh-ancestor
153924911|NCT00648973|Autonomic Agents|autonomic agents|mesh-ancestor
153924912|NCT00648973|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153924913|NCT00648973|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
153924914|NCT00648973|Histamine Antagonists|histamine antagonists|mesh-ancestor
153924929|NCT02662309|Atezolizumab|atezolizumab|mesh-list
153924939|NCT04032691|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153924940|NCT04032691|Sympatholytics|sympatholytics|mesh-ancestor
153924941|NCT04032691|Autonomic Agents|autonomic agents|mesh-ancestor
153924942|NCT04032691|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
153924943|NCT04032691|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153924944|NCT04032691|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153924945|NCT04032691|Adrenergic Agents|adrenergic agents|mesh-ancestor
153924946|NCT04032691|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153924947|NCT04032691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153924948|NCT02658799|Diclofenac|diclofenac|mesh-list
153924949|NCT02658799|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153924950|NCT02658799|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153924951|NCT02658799|Analgesics|analgesics|mesh-ancestor
153924952|NCT02658799|Sensory System Agents|sensory system agents|mesh-ancestor
153924953|NCT02658799|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153924954|NCT02658799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153924955|NCT02658799|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153924956|NCT02658799|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153924957|NCT02658799|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153924958|NCT02658799|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153924959|NCT02658799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153924960|NCT02655757|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
153924961|NCT02655757|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153924989|NCT04169269|Enoxaparin|enoxaparin|mesh-list
153924990|NCT04169269|Rivaroxaban|rivaroxaban|mesh-list
153924991|NCT04169269|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
153924992|NCT04169269|Antithrombins|antithrombins|mesh-ancestor
153924993|NCT04169269|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
153924994|NCT04169269|Protease Inhibitors|protease inhibitors|mesh-ancestor
153924995|NCT04169269|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153924996|NCT04169269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153924997|NCT04169269|Anticoagulants|anticoagulants|mesh-ancestor
153924998|NCT04169269|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153924999|NCT04169269|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153925000|NCT02661373|Cobicistat|cobicistat|mesh-list
153925001|NCT02661373|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153925002|NCT02661373|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153925003|NCT02661373|Antiviral Agents|antiviral agents|mesh-ancestor
153925004|NCT02661373|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153925005|NCT02661373|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
153925006|NCT02661373|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153925007|NCT02661373|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153455616|NCT05660213|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153915562|NCT02701309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153915563|NCT03250507|Bupivacaine|bupivacaine|mesh-list
153925008|NCT02661373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153925009|NCT00649051|Metolazone|metolazone|mesh-list
153925010|NCT00649051|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153925040|NCT01142232|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153925041|NCT01142232|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153925042|NCT01142232|Alkylating Agents|alkylating agents|mesh-ancestor
153925043|NCT01142232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153925044|NCT01142232|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153925045|NCT01142232|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153925046|NCT02536807|Hyaluronic Acid|hyaluronic acid|mesh-list
153925047|NCT02536807|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153925048|NCT02536807|Immunologic Factors|immunologic factors|mesh-ancestor
153925049|NCT02536807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153925050|NCT02536807|Viscosupplements|viscosupplements|mesh-ancestor
153925051|NCT02536807|Protective Agents|protective agents|mesh-ancestor
153925052|NCT02536495|Docetaxel|docetaxel|mesh-list
153925053|NCT02536495|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153925054|NCT02536495|Tubulin Modulators|tubulin modulators|mesh-ancestor
153925055|NCT02536495|Antimitotic Agents|antimitotic agents|mesh-ancestor
153925056|NCT02536495|Mitosis Modulators|mitosis modulators|mesh-ancestor
153925057|NCT02536495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153925058|NCT02536417|Melatonin|melatonin|mesh-list
153925059|NCT02536417|Antioxidants|antioxidants|mesh-ancestor
153925060|NCT02536417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153925061|NCT02536417|Protective Agents|protective agents|mesh-ancestor
153925062|NCT02536417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153925063|NCT02536417|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153925064|NCT01140906|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
153925087|NCT00650065|Cetirizine|cetirizine|mesh-list
153925088|NCT00650065|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
153925089|NCT00650065|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
153925090|NCT00650065|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
153925091|NCT00650065|Histamine Antagonists|histamine antagonists|mesh-ancestor
153925092|NCT00650065|Histamine Agents|histamine agents|mesh-ancestor
153925093|NCT00650065|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153925094|NCT00650065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153925095|NCT00650065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153925096|NCT04170439|Chromium|chromium|mesh-list
153925097|NCT04170439|Metformin|metformin|mesh-list
153925098|NCT04170439|Citric Acid|citric acid|mesh-list
153925099|NCT04170439|Sodium Citrate|sodium citrate|mesh-list
153925100|NCT04170439|Clomiphene|clomiphene|mesh-list
153915565|NCT03250507|Anesthetics|anesthetics|mesh-ancestor
153810966|NCT00331500|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
153815094|NCT00344942|Glucocorticoids|glucocorticoids|mesh-ancestor
153895600|NCT01873326|Paclitaxel|paclitaxel|mesh-list
153925101|NCT04170439|Enclomiphene|enclomiphene|mesh-list
153925102|NCT04170439|Zuclomiphene|zuclomiphene|mesh-list
153925103|NCT04170439|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153925120|NCT00649363|Ondansetron|ondansetron|mesh-list
153925146|NCT04168723|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153925147|NCT04168723|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
153925148|NCT04168723|Contraceptive Agents|contraceptive agents|mesh-ancestor
153925149|NCT04168723|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153925150|NCT04168723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153925151|NCT04168723|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
153925152|NCT04168723|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
153925153|NCT04168723|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
153925154|NCT00649441|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
153925156|NCT00649441|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153925157|NCT00649441|Diuretics|diuretics|mesh-ancestor
153925158|NCT00649441|Natriuretic Agents|natriuretic agents|mesh-ancestor
153925159|NCT00649441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153925160|NCT00649441|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
153925161|NCT00649441|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153925162|NCT00649441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153925163|NCT00649441|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
153925164|NCT00649441|Protease Inhibitors|protease inhibitors|mesh-ancestor
153925165|NCT00649441|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153925166|NCT02654665|Liraglutide|liraglutide|mesh-list
153925167|NCT02654665|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
153925168|NCT02654665|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153925170|NCT02654665|Incretins|incretins|mesh-ancestor
153925196|NCT02658721|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153925197|NCT02658721|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153925198|NCT02658721|Anesthetics, General|anesthetics, general|mesh-ancestor
153925199|NCT02658721|GABA Modulators|gaba modulators|mesh-ancestor
153925200|NCT02658721|GABA Agents|gaba agents|mesh-ancestor
153925201|NCT02658721|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153925202|NCT02658721|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153925203|NCT02658721|Narcotics|narcotics|mesh-ancestor
153925204|NCT02658721|Analgesics|analgesics|mesh-ancestor
153925205|NCT02658721|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153925206|NCT02658721|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153925207|NCT02658721|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153925208|NCT02658721|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153925261|NCT00649519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153925262|NCT00649519|Vasodilator Agents|vasodilator agents|mesh-ancestor
153925263|NCT00649519|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
153925264|NCT00649519|Protease Inhibitors|protease inhibitors|mesh-ancestor
153925265|NCT00649519|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153925266|NCT00629811|Mitogens|mitogens|mesh-list
153925267|NCT00629811|Mitosis Modulators|mitosis modulators|mesh-ancestor
153925268|NCT00629811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153925269|NCT02652091|Interferons|interferons|mesh-list
153925270|NCT02652091|Interferon-beta|interferon-beta|mesh-list
153925271|NCT02652091|Interferon beta-1b|interferon beta-1b|mesh-list
153925272|NCT02652091|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153925273|NCT02652091|Antiviral Agents|antiviral agents|mesh-ancestor
153925274|NCT02652091|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153925275|NCT02652091|Immunologic Factors|immunologic factors|mesh-ancestor
153925276|NCT02652091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153925277|NCT02652091|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153925278|NCT00625560|Lamivudine|lamivudine|mesh-list
153925280|NCT00625560|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153925281|NCT00625560|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153925282|NCT00625560|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153915566|NCT03250507|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153915567|NCT03250507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153464274|NCT02088216|Antioxidants|antioxidants|mesh-ancestor
153436790|NCT00002725|Bryostatin 1|bryostatin 1|mesh-list
153925283|NCT00625560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153925284|NCT00625560|Antiviral Agents|antiviral agents|mesh-ancestor
153925285|NCT00625560|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153925286|NCT00625560|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153925287|NCT00625560|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153925288|NCT00650455|Naproxen|naproxen|mesh-list
153925289|NCT00650455|Valdecoxib|valdecoxib|mesh-list
153925290|NCT00650455|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153925292|NCT00650455|Analgesics|analgesics|mesh-ancestor
153925307|NCT02654041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153925309|NCT02658409|Immunologic Factors|immunologic factors|mesh-ancestor
153925310|NCT02658409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153925311|NCT01121562|Sunitinib|sunitinib|mesh-list
153925312|NCT01121562|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153925313|NCT01121562|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153925314|NCT01121562|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153925315|NCT01121562|Growth Substances|growth substances|mesh-ancestor
153925316|NCT01121562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153925317|NCT01121562|Growth Inhibitors|growth inhibitors|mesh-ancestor
153925318|NCT01121562|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153925319|NCT01121562|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153925320|NCT01121562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153925321|NCT02658253|Aluminum Hydroxide|aluminum hydroxide|mesh-list
153925322|NCT02658253|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153925323|NCT02658253|Immunologic Factors|immunologic factors|mesh-ancestor
153925324|NCT02658253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153925363|NCT01169675|Afatinib|afatinib|mesh-list
153925364|NCT01169675|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153925365|NCT01169675|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153925366|NCT01169675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153925367|NCT01169675|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153925368|NCT01169675|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153925369|NCT01169675|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153925370|NCT01169675|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153925371|NCT00650533|Glimepiride|glimepiride|mesh-list
153925372|NCT00650533|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153925373|NCT00650533|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153925374|NCT00650533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153925375|NCT00650533|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153925376|NCT00650533|Immunologic Factors|immunologic factors|mesh-ancestor
153925377|NCT02881866|Furosemide|furosemide|mesh-list
153925378|NCT02881866|Diuretics|diuretics|mesh-ancestor
153925379|NCT02881866|Natriuretic Agents|natriuretic agents|mesh-ancestor
153925380|NCT02881866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153925381|NCT02881866|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
153925382|NCT02881866|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153464275|NCT02088216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153925383|NCT02881866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153464276|NCT02088216|Protective Agents|protective agents|mesh-ancestor
153464277|NCT02088216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153464278|NCT02088216|Antidotes|antidotes|mesh-ancestor
153815095|NCT00344942|Hormones|hormones|mesh-ancestor
153436812|NCT00003602|Analgesics|analgesics|mesh-ancestor
153925384|NCT00924664|Tanezumab|tanezumab|mesh-list
153925385|NCT00924664|Analgesics|analgesics|mesh-ancestor
153925386|NCT00924664|Sensory System Agents|sensory system agents|mesh-ancestor
153925387|NCT00924664|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153925388|NCT00924664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153925389|NCT02653651|Lidocaine|lidocaine|mesh-list
153925390|NCT02653651|Ketamine|ketamine|mesh-list
153925391|NCT02653651|Anesthetics, Local|anesthetics, local|mesh-ancestor
153925392|NCT02653651|Anesthetics|anesthetics|mesh-ancestor
153925393|NCT02653651|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153925394|NCT02653651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153925395|NCT02653651|Sensory System Agents|sensory system agents|mesh-ancestor
153925396|NCT02653651|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153925401|NCT02653651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153925402|NCT02653651|Analgesics|analgesics|mesh-ancestor
153925403|NCT02653651|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
153925404|NCT02653651|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153925405|NCT02653651|Anesthetics, General|anesthetics, general|mesh-ancestor
153925406|NCT02653651|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
153464279|NCT01014936|Tepotinib|tepotinib|mesh-list
153357530|NCT00724568|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153357531|NCT00724568|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153357532|NCT00724568|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153357533|NCT00724568|Immunologic Factors|immunologic factors|mesh-ancestor
153357534|NCT00724568|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153357535|NCT00724568|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153357536|NCT00724568|Growth Substances|growth substances|mesh-ancestor
153357537|NCT00724568|Growth Inhibitors|growth inhibitors|mesh-ancestor
153357538|NCT01274000|Ramosetron|ramosetron|mesh-list
153357539|NCT01274000|Antiemetics|antiemetics|mesh-ancestor
153357540|NCT01274000|Autonomic Agents|autonomic agents|mesh-ancestor
153357541|NCT01274000|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153464280|NCT01014936|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153464281|NCT01896180|Latanoprost|latanoprost|mesh-list
153464282|NCT01896180|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
153464284|NCT00981162|Everolimus|everolimus|mesh-list
153464287|NCT00981162|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153925407|NCT02653651|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
153925408|NCT02653651|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153925409|NCT02651311|Ibuprofen|ibuprofen|mesh-list
153925410|NCT02651311|Fentanyl|fentanyl|mesh-list
153925411|NCT02651311|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153925412|NCT02651311|Narcotics|narcotics|mesh-ancestor
153925413|NCT02651311|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153925414|NCT02651311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153925415|NCT02651311|Analgesics|analgesics|mesh-ancestor
153925416|NCT02651311|Sensory System Agents|sensory system agents|mesh-ancestor
153925417|NCT02651311|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153925460|NCT02653027|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153925461|NCT02653027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153925462|NCT02652793|Lamivudine|lamivudine|mesh-list
153925463|NCT02652793|Atazanavir Sulfate|atazanavir sulfate|mesh-list
153925464|NCT02652793|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153925465|NCT02652793|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153925466|NCT02652793|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153925467|NCT02652793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153925468|NCT02652793|Antiviral Agents|antiviral agents|mesh-ancestor
153925469|NCT02652793|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153925470|NCT02652793|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153925471|NCT02652793|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153925472|NCT02652793|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
153925473|NCT02652793|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
153925474|NCT02652793|Protease Inhibitors|protease inhibitors|mesh-ancestor
153925475|NCT00650611|Ziprasidone|ziprasidone|mesh-list
153925476|NCT00650611|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153925477|NCT00650611|Serotonin Agents|serotonin agents|mesh-ancestor
153925478|NCT00650611|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153925479|NCT00650611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153925480|NCT00650611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153925481|NCT00650611|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153925482|NCT00650611|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153925483|NCT00650611|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153925484|NCT00650611|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153925485|NCT00650611|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
153925486|NCT00650611|Dopamine Agents|dopamine agents|mesh-ancestor
153925487|NCT00600067|Topiramate|topiramate|mesh-list
153925488|NCT00600067|Phentermine|phentermine|mesh-list
153925489|NCT00600067|Anticonvulsants|anticonvulsants|mesh-ancestor
153925490|NCT00600067|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153925491|NCT00600067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153810973|NCT00322985|Lenalidomide|lenalidomide|mesh-list
153810974|NCT00322985|Immunologic Factors|immunologic factors|mesh-ancestor
153810975|NCT00322985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153810976|NCT00322985|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153810977|NCT00322985|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153810978|NCT00322985|Growth Substances|growth substances|mesh-ancestor
153436851|NCT00004100|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153436852|NCT00004100|Tubulin Modulators|tubulin modulators|mesh-ancestor
153436853|NCT00004100|Antimitotic Agents|antimitotic agents|mesh-ancestor
153436854|NCT00004100|Mitosis Modulators|mitosis modulators|mesh-ancestor
153436855|NCT00002737|Interferons|interferons|mesh-list
153436856|NCT00002737|Interferon-alpha|interferon-alpha|mesh-list
153895647|NCT01745588|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153895648|NCT01745588|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153925492|NCT00600067|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
153925493|NCT00600067|Appetite Depressants|appetite depressants|mesh-ancestor
153925494|NCT00600067|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
153925498|NCT00600067|Adrenergic Agents|adrenergic agents|mesh-ancestor
153925499|NCT00600067|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153925500|NCT00600067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153925501|NCT02650609|Methylprednisolone|methylprednisolone|mesh-list
153925503|NCT02650609|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
153925504|NCT02650609|Prednisolone|prednisolone|mesh-list
153925505|NCT02650609|Prednisolone acetate|prednisolone acetate|mesh-list
153925506|NCT02650609|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
153925507|NCT02650609|Prednisolone phosphate|prednisolone phosphate|mesh-list
153925508|NCT02650609|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153925509|NCT02650609|Antiemetics|antiemetics|mesh-ancestor
153925510|NCT02650609|Autonomic Agents|autonomic agents|mesh-ancestor
153925511|NCT02650609|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153925512|NCT02650609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153925513|NCT02650609|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153925514|NCT02650609|Glucocorticoids|glucocorticoids|mesh-ancestor
153925515|NCT02650609|Hormones|hormones|mesh-ancestor
153925516|NCT02650609|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153925517|NCT02650609|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
153925518|NCT02650609|Protective Agents|protective agents|mesh-ancestor
153925519|NCT02650609|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153925520|NCT02650609|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153925521|NCT02652871|Cytarabine|cytarabine|mesh-list
153925522|NCT02652871|Idarubicin|idarubicin|mesh-list
153464288|NCT00981162|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153814581|NCT00452556|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153814582|NCT00446667|Mannitol|mannitol|mesh-list
153360210|NCT00802100|Serotonin Agents|serotonin agents|mesh-ancestor
153895665|NCT00996866|Vitamins|vitamins|mesh-ancestor
153895666|NCT00996866|Micronutrients|micronutrients|mesh-ancestor
153925523|NCT02652871|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153925524|NCT02652871|Antimetabolites|antimetabolites|mesh-ancestor
153925525|NCT02652871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153731857|NCT00139724|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153731858|NCT00139724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153731859|NCT00139724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153731860|NCT00139724|Urological Agents|urological agents|mesh-ancestor
153731862|NCT00161577|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153731863|NCT00161577|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153545921|NCT06288035|Glucocorticoids|glucocorticoids|mesh-ancestor
153545922|NCT06288035|Hormones|hormones|mesh-ancestor
153545923|NCT06288035|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153545924|NCT06288035|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153545925|NCT06288035|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153545926|NCT06288035|Protease Inhibitors|protease inhibitors|mesh-ancestor
153545927|NCT06288035|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153545928|NCT06288035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153545929|NCT06287775|Atezolizumab|atezolizumab|mesh-list
153545930|NCT06287775|Durvalumab|durvalumab|mesh-list
153545938|NCT06287775|Immunologic Factors|immunologic factors|mesh-ancestor
153545939|NCT06287775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153545940|NCT06286098|Thioctic Acid|thioctic acid|mesh-list
153545941|NCT06286098|Antioxidants|antioxidants|mesh-ancestor
153545942|NCT06286098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153545943|NCT06286098|Protective Agents|protective agents|mesh-ancestor
153545944|NCT06286098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153545945|NCT06286098|Vitamin B Complex|vitamin b complex|mesh-ancestor
153545946|NCT06286098|Vitamins|vitamins|mesh-ancestor
153545947|NCT06286098|Micronutrients|micronutrients|mesh-ancestor
153545948|NCT06278779|Ketamine|ketamine|mesh-list
153371238|NCT01243112|Sensory System Agents|sensory system agents|mesh-ancestor
153545949|NCT06278779|Esketamine|esketamine|mesh-list
153545950|NCT06278779|Analgesics|analgesics|mesh-ancestor
153545951|NCT06278779|Sensory System Agents|sensory system agents|mesh-ancestor
153545954|NCT06278779|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
153545955|NCT06278779|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153545956|NCT06278779|Anesthetics, General|anesthetics, general|mesh-ancestor
153545957|NCT06278779|Anesthetics|anesthetics|mesh-ancestor
153545958|NCT06278779|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153545959|NCT06278779|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
153545960|NCT06278779|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
153545961|NCT06278779|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153545962|NCT06278779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153545963|NCT06278779|Antidepressive Agents|antidepressive agents|mesh-ancestor
153545964|NCT06278779|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153545965|NCT06276361|Risperidone|risperidone|mesh-list
153545966|NCT06276361|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153545997|NCT06270719|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153545998|NCT06270719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153545999|NCT06270030|Brimonidine Tartrate|brimonidine tartrate|mesh-list
153546000|NCT06270030|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
153546001|NCT06270030|Ophthalmic Solutions|ophthalmic solutions|mesh-list
153546002|NCT06270030|Aceclidine|aceclidine|mesh-list
153546003|NCT06270030|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153546004|NCT06270030|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
153546005|NCT06270030|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153546006|NCT06270030|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153546007|NCT06270030|Adrenergic Agents|adrenergic agents|mesh-ancestor
153546008|NCT06270030|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153546009|NCT06270030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153814583|NCT00446667|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
153814584|NCT00446667|Diuretics|diuretics|mesh-ancestor
153546010|NCT06270030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153546011|NCT06270030|Miotics|miotics|mesh-ancestor
153546012|NCT06270030|Autonomic Agents|autonomic agents|mesh-ancestor
153546013|NCT06270030|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153546014|NCT06270030|Parasympathomimetics|parasympathomimetics|mesh-ancestor
153546015|NCT06269133|Cemiplimab|cemiplimab|mesh-list
153546016|NCT06269133|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153546017|NCT06269133|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153546018|NCT06266338|Pembrolizumab|pembrolizumab|mesh-list
153546019|NCT06266338|Lenvatinib|lenvatinib|mesh-list
153546020|NCT06266338|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153546021|NCT06266338|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153546022|NCT06266338|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153546023|NCT06266338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153546024|NCT06266338|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153546025|NCT06266338|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153546026|NCT06263153|Durvalumab|durvalumab|mesh-list
153546027|NCT06263153|Futibatinib|futibatinib|mesh-list
153546028|NCT06263153|Immunoglobulins|immunoglobulins|mesh-list
153546029|NCT06263153|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
153546041|NCT06262932|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153546042|NCT06262932|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
153546043|NCT06262932|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153546044|NCT06262932|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153546045|NCT06262932|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
153546046|NCT06262932|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
153546047|NCT06262932|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
153546048|NCT06261905|Vitamin D|vitamin d|mesh-list
153546049|NCT06261905|Calcitriol|calcitriol|mesh-list
153546050|NCT06261905|Vitamins|vitamins|mesh-ancestor
153546051|NCT06261905|Micronutrients|micronutrients|mesh-ancestor
153546052|NCT06261905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153546053|NCT06261905|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153546054|NCT06261905|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153546055|NCT06261905|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
153782493|NCT00267813|Antidepressive Agents|antidepressive agents|mesh-ancestor
153782494|NCT00267813|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153546056|NCT06261905|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153546057|NCT06261905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153546058|NCT06261905|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
153546059|NCT06260891|Zinc|zinc|mesh-list
153546060|NCT06260891|Trace Elements|trace elements|mesh-ancestor
153546061|NCT06260891|Micronutrients|micronutrients|mesh-ancestor
153546062|NCT06260891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153546066|NCT06253364|Lenvatinib|lenvatinib|mesh-list
153546067|NCT06253364|Antibodies|antibodies|mesh-list
153546068|NCT06253364|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
153546069|NCT06253364|Immunologic Factors|immunologic factors|mesh-ancestor
153546070|NCT06253364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153546071|NCT06253364|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153360211|NCT00802100|Antidepressive Agents|antidepressive agents|mesh-ancestor
153895679|NCT00876993|Growth Inhibitors|growth inhibitors|mesh-ancestor
153895680|NCT00876993|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
153895681|NCT00876993|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153895682|NCT00876993|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153895683|NCT00876993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153895684|NCT00876993|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153895685|NCT00876993|Alkylating Agents|alkylating agents|mesh-ancestor
153895686|NCT00700882|Dasatinib|dasatinib|mesh-list
153895687|NCT00700882|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153895688|NCT00700882|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153546072|NCT06253364|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153546073|NCT06253364|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153546074|NCT06253364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153546075|NCT06252857|Imiquimod|imiquimod|mesh-list
153546076|NCT06252857|Toll-Like Receptor Agonists|toll-like receptor agonists|mesh-ancestor
153546080|NCT06252857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153546081|NCT06252857|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153546082|NCT06252857|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153546083|NCT06252857|Interferon Inducers|interferon inducers|mesh-ancestor
153546084|NCT06242691|Antiemetics|antiemetics|mesh-list
153546085|NCT06242691|Autonomic Agents|autonomic agents|mesh-ancestor
153546086|NCT06242691|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153546087|NCT06242691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153546088|NCT06242691|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153546089|NCT06239389|Thalidomide|thalidomide|mesh-list
153546090|NCT06239389|Hydroxyurea|hydroxyurea|mesh-list
153546091|NCT06239389|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153546092|NCT06239389|Immunologic Factors|immunologic factors|mesh-ancestor
153546093|NCT06239389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153546094|NCT06239389|Leprostatic Agents|leprostatic agents|mesh-ancestor
153546095|NCT06239389|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153546096|NCT06239389|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153546097|NCT06239389|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153546098|NCT06239389|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153546099|NCT06239389|Growth Substances|growth substances|mesh-ancestor
153546100|NCT06239389|Growth Inhibitors|growth inhibitors|mesh-ancestor
153546101|NCT06239389|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153546102|NCT06239389|Antisickling Agents|antisickling agents|mesh-ancestor
153546103|NCT06239389|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153546105|NCT06239389|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153546107|NCT06233071|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
153546108|NCT06233071|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
153546109|NCT06233071|Ethinyl Estradiol|ethinyl estradiol|mesh-list
153546110|NCT06233071|Estradiol|estradiol|mesh-list
153546111|NCT06233071|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
153546112|NCT06233071|Estrogens|estrogens|mesh-ancestor
153546114|NCT06233071|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153546125|NCT06233071|Diuretics|diuretics|mesh-ancestor
153546126|NCT06233071|Natriuretic Agents|natriuretic agents|mesh-ancestor
153546127|NCT06224049|Cyclophosphamide|cyclophosphamide|mesh-list
153546128|NCT06224049|Fludarabine|fludarabine|mesh-list
153782495|NCT00267813|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
153546129|NCT06224049|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153546130|NCT06224049|Immunologic Factors|immunologic factors|mesh-ancestor
153546131|NCT06224049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153546132|NCT06224049|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153546133|NCT06224049|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153546134|NCT06224049|Alkylating Agents|alkylating agents|mesh-ancestor
153546135|NCT06224049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153814587|NCT03277755|Adafosbuvir|adafosbuvir|mesh-list
153546136|NCT06224049|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153546137|NCT06224049|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153546138|NCT06207513|Chlorhexidine|chlorhexidine|mesh-list
153546139|NCT06207513|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
153546140|NCT06207513|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153546141|NCT06207513|Disinfectants|disinfectants|mesh-ancestor
153546142|NCT06207344|Dexmedetomidine|dexmedetomidine|mesh-list
153546144|NCT06207344|Desflurane|desflurane|mesh-list
153546145|NCT06207344|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153546146|NCT06207344|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153546147|NCT06207344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153546148|NCT06207344|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153546149|NCT06207344|Analgesics|analgesics|mesh-ancestor
153546150|NCT06207344|Sensory System Agents|sensory system agents|mesh-ancestor
153546151|NCT06207344|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153546152|NCT06207344|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
153546153|NCT06207344|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153546170|NCT06207331|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
153546171|NCT06207331|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153546172|NCT06207331|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153546173|NCT06207331|Adrenergic Agents|adrenergic agents|mesh-ancestor
153546174|NCT06207331|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153546178|NCT06205381|Midazolam|midazolam|mesh-list
153546179|NCT06205381|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153546180|NCT06205381|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153546181|NCT06205381|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153546182|NCT06205381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153546183|NCT06205381|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153546184|NCT06205381|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153546185|NCT06205381|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153546186|NCT06205381|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153546187|NCT06205381|Anesthetics, General|anesthetics, general|mesh-ancestor
153546188|NCT06205381|Anesthetics|anesthetics|mesh-ancestor
153546189|NCT06205381|GABA Modulators|gaba modulators|mesh-ancestor
153546190|NCT06205381|GABA Agents|gaba agents|mesh-ancestor
153546191|NCT06205381|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153546192|NCT06205381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153546193|NCT06205381|Antifungal Agents|antifungal agents|mesh-ancestor
153546194|NCT06205381|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153546195|NCT06205381|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
153546196|NCT06205381|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153546197|NCT06205381|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153546198|NCT06205381|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153546199|NCT06205381|Hormone Antagonists|hormone antagonists|mesh-ancestor
153546200|NCT06205381|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153546201|NCT06205381|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
153546202|NCT06205381|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
153546203|NCT06205381|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
153546204|NCT06205381|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
153546205|NCT06205381|Histamine Antagonists|histamine antagonists|mesh-ancestor
153546206|NCT06205381|Histamine Agents|histamine agents|mesh-ancestor
153546207|NCT06196814|Antibodies|antibodies|mesh-list
153546209|NCT06196814|Immunologic Factors|immunologic factors|mesh-ancestor
153546210|NCT06196814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153546212|NCT06193486|Fludarabine|fludarabine|mesh-list
153546213|NCT06193486|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153546214|NCT06193486|Immunologic Factors|immunologic factors|mesh-ancestor
153546215|NCT06193486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153546216|NCT06193486|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153546217|NCT06193486|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153546218|NCT06193486|Alkylating Agents|alkylating agents|mesh-ancestor
153546219|NCT06193486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153546220|NCT06193486|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153546221|NCT06193486|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153546222|NCT06191978|Venetoclax|venetoclax|mesh-list
153546223|NCT06191978|Decitabine and cedazuridine drug combination|decitabine and cedazuridine drug combination|mesh-list
153546224|NCT06191978|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153546225|NCT06191978|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153546226|NCT06191978|Antimetabolites|antimetabolites|mesh-ancestor
153546227|NCT06191978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153546228|NCT06180590|Sofosbuvir|sofosbuvir|mesh-list
153546229|NCT06180590|Velpatasvir|velpatasvir|mesh-list
153546230|NCT06180590|Sofosbuvir-velpatasvir drug combination|sofosbuvir-velpatasvir drug combination|mesh-list
153546231|NCT06180590|Antiviral Agents|antiviral agents|mesh-ancestor
153546232|NCT06180590|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153546233|NCT06172478|Patritumab deruxtecan|patritumab deruxtecan|mesh-list
153546234|NCT06172478|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153546263|NCT06172296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153546264|NCT06172296|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153546265|NCT06172296|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153546266|NCT06172296|Alkylating Agents|alkylating agents|mesh-ancestor
153546267|NCT06172296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153546268|NCT06172296|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153546269|NCT06172296|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153546270|NCT06172296|Vitamins|vitamins|mesh-ancestor
153546271|NCT06172296|Micronutrients|micronutrients|mesh-ancestor
153546272|NCT06172296|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153546273|NCT06172296|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153782496|NCT00267813|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153546274|NCT06172296|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153546275|NCT06172296|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153546276|NCT06172296|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
153546277|NCT06172296|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153546278|NCT06172296|Tubulin Modulators|tubulin modulators|mesh-ancestor
153546279|NCT06172296|Antimitotic Agents|antimitotic agents|mesh-ancestor
153546280|NCT06172296|Mitosis Modulators|mitosis modulators|mesh-ancestor
153546281|NCT06172296|Keratolytic Agents|keratolytic agents|mesh-ancestor
153546282|NCT06172296|Dermatologic Agents|dermatologic agents|mesh-ancestor
153546283|NCT06172296|Protective Agents|protective agents|mesh-ancestor
153546284|NCT06172296|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
153546285|NCT06162806|Magnesium Sulfate|magnesium sulfate|mesh-list
153546286|NCT06162806|Fentanyl|fentanyl|mesh-list
153546287|NCT06162806|Bupivacaine|bupivacaine|mesh-list
153546288|NCT06162806|Anesthetics, Local|anesthetics, local|mesh-ancestor
153546289|NCT06162806|Anesthetics|anesthetics|mesh-ancestor
153546290|NCT06162806|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153546291|NCT06162806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153546292|NCT06162806|Sensory System Agents|sensory system agents|mesh-ancestor
153546293|NCT06162806|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153546294|NCT06162806|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153546295|NCT06162806|Narcotics|narcotics|mesh-ancestor
153546296|NCT06162806|Analgesics|analgesics|mesh-ancestor
153546297|NCT06162806|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153546298|NCT06162806|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153546299|NCT06162806|Anesthetics, General|anesthetics, general|mesh-ancestor
153546300|NCT06162806|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153546301|NCT06162806|Anticonvulsants|anticonvulsants|mesh-ancestor
153546302|NCT06162806|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153546303|NCT06162806|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153546304|NCT06162806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153546305|NCT06162806|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153546306|NCT06162806|Tocolytic Agents|tocolytic agents|mesh-ancestor
153546307|NCT06162806|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153546308|NCT06162715|Tirzepatide|tirzepatide|mesh-list
153546309|NCT06162715|Incretins|incretins|mesh-ancestor
153546310|NCT06162715|Hormones|hormones|mesh-ancestor
153546311|NCT06162715|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153546312|NCT06162715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153546313|NCT06161805|Esketamine|esketamine|mesh-list
153546314|NCT06161805|Antidepressive Agents|antidepressive agents|mesh-ancestor
153546315|NCT06161805|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153546316|NCT06158620|Diclofenac|diclofenac|mesh-list
153546317|NCT06158620|Ketorolac|ketorolac|mesh-list
153546318|NCT06158620|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153546319|NCT06158620|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153546320|NCT06158620|Analgesics|analgesics|mesh-ancestor
153546350|NCT06139536|Immunologic Factors|immunologic factors|mesh-ancestor
153782497|NCT00267813|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153546351|NCT06139536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153546352|NCT06139536|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153546353|NCT06134349|Lithium Carbonate|lithium carbonate|mesh-list
153546354|NCT06134349|Antidepressive Agents|antidepressive agents|mesh-ancestor
153546356|NCT06134349|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153546357|NCT06134349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153546358|NCT06134349|Antimanic Agents|antimanic agents|mesh-ancestor
153546359|NCT06134349|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153546360|NCT06134349|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153546361|NCT06134349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153546362|NCT06133517|Sacituzumab govitecan|sacituzumab govitecan|mesh-list
153546363|NCT06133517|Immunoconjugates|immunoconjugates|mesh-ancestor
153546364|NCT06133517|Immunologic Factors|immunologic factors|mesh-ancestor
153546365|NCT06133517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153546371|NCT06131372|Semaglutide|semaglutide|mesh-list
153546372|NCT06131372|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
153546373|NCT06131372|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153546374|NCT06131372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153546410|NCT06108063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153371470|NCT04292483|Antioxidants|antioxidants|mesh-ancestor
153546412|NCT06106412|Ionomycin|ionomycin|mesh-list
153546413|NCT06106412|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153546414|NCT06106412|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153546415|NCT06106412|Calcium Ionophores|calcium ionophores|mesh-ancestor
153546416|NCT06106412|Ionophores|ionophores|mesh-ancestor
153546417|NCT06106412|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153546418|NCT06106412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153546419|NCT06101173|Vaccines|vaccines|mesh-list
153546420|NCT06101173|Immunologic Factors|immunologic factors|mesh-ancestor
153546421|NCT06101173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153546422|NCT06101134|Nivolumab|nivolumab|mesh-list
153546423|NCT06101134|Relatlimab|relatlimab|mesh-list
153546424|NCT06101134|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153546425|NCT06101134|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153546426|NCT06101134|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153546427|NCT06101134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153546428|NCT06099379|Dronabinol|dronabinol|mesh-list
153546429|NCT06099379|Cannabidiol|cannabidiol|mesh-list
153546430|NCT06099379|Anticonvulsants|anticonvulsants|mesh-ancestor
153546431|NCT06099379|Hallucinogens|hallucinogens|mesh-ancestor
153546432|NCT06099379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153546433|NCT06099379|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153546434|NCT06099379|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153546435|NCT06099379|Analgesics|analgesics|mesh-ancestor
153546436|NCT06099379|Sensory System Agents|sensory system agents|mesh-ancestor
153546437|NCT06099379|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153546438|NCT06099379|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
153546439|NCT06099379|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
153546440|NCT06099379|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153546441|NCT06099379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153546442|NCT06099379|Hormones|hormones|mesh-ancestor
153546443|NCT06099379|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153546444|NCT06089122|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
153546445|NCT06089122|Immunologic Factors|immunologic factors|mesh-ancestor
153464300|NCT05320692|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153915572|NCT00997893|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
153436894|NCT00003632|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153436895|NCT00003632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153436896|NCT00003632|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153436897|NCT00003632|Antimetabolites|antimetabolites|mesh-ancestor
153436898|NCT00003632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153436899|NCT00003632|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153436900|NCT00003632|Dermatologic Agents|dermatologic agents|mesh-ancestor
153436901|NCT00003632|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153436902|NCT00003632|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153571327|NCT04464577|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153546446|NCT06089122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153546447|NCT06088732|Ibuprofen|ibuprofen|mesh-list
153546448|NCT06088732|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153546449|NCT06088732|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153546450|NCT06088732|Analgesics|analgesics|mesh-ancestor
153546451|NCT06088732|Sensory System Agents|sensory system agents|mesh-ancestor
153546452|NCT06088732|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153546453|NCT06088732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153546454|NCT06088732|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153546455|NCT06088732|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153546456|NCT06088732|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153546457|NCT06088732|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153546458|NCT06088732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153546459|NCT06083662|Neratinib|neratinib|mesh-list
153546460|NCT06083662|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153546461|NCT06083662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153546462|NCT06083662|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153546463|NCT06083662|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153546464|NCT06083103|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
153546465|NCT06083103|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
153546466|NCT06083103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153546478|NCT06071442|Metformin|metformin|mesh-list
153546479|NCT06071442|Carbamazepine|carbamazepine|mesh-list
153546480|NCT06071442|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
153546481|NCT06071442|Levonorgestrel|levonorgestrel|mesh-list
153546482|NCT06071442|Ethinyl Estradiol|ethinyl estradiol|mesh-list
153546483|NCT06071442|Estradiol|estradiol|mesh-list
153371490|NCT05343429|Aspirin|aspirin|mesh-list
153546484|NCT06071442|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153546485|NCT06071442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153571328|NCT04464577|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153571329|NCT04464577|Antifungal Agents|antifungal agents|mesh-ancestor
153546486|NCT06071442|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153546487|NCT06071442|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153546488|NCT06071442|Antimetabolites|antimetabolites|mesh-ancestor
153546489|NCT06071442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153546490|NCT06071442|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153546491|NCT06071442|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
153546492|NCT06071442|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153546493|NCT06071442|Estrogens|estrogens|mesh-ancestor
153546494|NCT06071442|Hormones|hormones|mesh-ancestor
153546495|NCT06071442|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153546496|NCT06071442|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
153546497|NCT06071442|Contraceptive Agents|contraceptive agents|mesh-ancestor
153546498|NCT06071442|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153546499|NCT06071442|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
153546500|NCT06071442|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
153546501|NCT06071442|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
153546502|NCT06071442|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
153546503|NCT06071442|Anticonvulsants|anticonvulsants|mesh-ancestor
153546504|NCT06071442|Antimanic Agents|antimanic agents|mesh-ancestor
153546505|NCT06071442|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153546506|NCT06071442|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153546536|NCT06065735|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
153546537|NCT06065735|Antidepressive Agents|antidepressive agents|mesh-ancestor
153546538|NCT06065735|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153546539|NCT06065735|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
153546542|NCT06047457|Botulinum Toxins|botulinum toxins|mesh-list
153546543|NCT06047457|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
153546544|NCT06047457|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
153546545|NCT06047457|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
153546546|NCT06047457|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153546547|NCT06047457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153546548|NCT06047457|Cholinergic Agents|cholinergic agents|mesh-ancestor
153546549|NCT06047457|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153546550|NCT06047457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153546551|NCT06047457|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
153546552|NCT06047457|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153546553|NCT06047444|Botulinum Toxins|botulinum toxins|mesh-list
153546554|NCT06047444|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
153546555|NCT06047444|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
153546556|NCT06047444|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
153546557|NCT06047444|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153546558|NCT06047444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153546559|NCT06047444|Cholinergic Agents|cholinergic agents|mesh-ancestor
153546560|NCT06047444|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153546561|NCT06047444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153546562|NCT06047444|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
153546563|NCT06047444|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153546564|NCT06044025|Metformin|metformin|mesh-list
153546575|NCT06040970|Immunoconjugates|immunoconjugates|mesh-ancestor
153546576|NCT06040970|Immunologic Factors|immunologic factors|mesh-ancestor
153546577|NCT06040970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153546578|NCT06038929|Central Nervous System Stimulants|central nervous system stimulants|mesh-list
153546579|NCT06038929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153546582|NCT06037330|Nalbuphine|nalbuphine|mesh-list
153546583|NCT06037330|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153546584|NCT06037330|Narcotics|narcotics|mesh-ancestor
153546585|NCT06037330|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153546586|NCT06037330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153546587|NCT06037330|Analgesics|analgesics|mesh-ancestor
153546588|NCT06037330|Sensory System Agents|sensory system agents|mesh-ancestor
153546589|NCT06037330|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153546590|NCT06037330|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153546591|NCT06037330|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153546592|NCT06037330|Anesthetics, General|anesthetics, general|mesh-ancestor
153546593|NCT06037330|Anesthetics|anesthetics|mesh-ancestor
153546594|NCT06029309|Zanubrutinib|zanubrutinib|mesh-list
153546595|NCT06029309|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153546596|NCT06029309|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153546597|NCT06029309|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153546598|NCT06029309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153546599|NCT06029309|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153546600|NCT06015516|Minoxidil|minoxidil|mesh-list
153546601|NCT06015516|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153546602|NCT06015516|Vasodilator Agents|vasodilator agents|mesh-ancestor
153546603|NCT06015477|Ticagrelor|ticagrelor|mesh-list
153546604|NCT06015477|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153546649|NCT06003179|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153546650|NCT06003114|Palbociclib|palbociclib|mesh-list
153546651|NCT06003114|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153546652|NCT06003114|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153546653|NCT06003114|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153546654|NCT06003114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153546655|NCT06001385|Mycophenolic Acid|mycophenolic acid|mesh-list
153546656|NCT06001385|Cyclophosphamide|cyclophosphamide|mesh-list
153547543|NCT05412576|Sensory System Agents|sensory system agents|mesh-ancestor
153547544|NCT05412576|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153547545|NCT05412576|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153547546|NCT05412576|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
153547547|NCT05412576|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153547548|NCT05412576|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153547549|NCT05412576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153547550|NCT05411718|Aspirin|aspirin|mesh-list
153547551|NCT05411718|Naproxen|naproxen|mesh-list
153547552|NCT05411718|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153547553|NCT05411718|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153547554|NCT05411718|Analgesics|analgesics|mesh-ancestor
153547555|NCT05411718|Sensory System Agents|sensory system agents|mesh-ancestor
153547556|NCT05411718|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153810979|NCT00322985|Growth Inhibitors|growth inhibitors|mesh-ancestor
153895707|NCT00673309|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153895708|NCT00673309|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153895709|NCT00673309|Hormone Antagonists|hormone antagonists|mesh-ancestor
153895710|NCT00673309|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
153547557|NCT05411718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153547558|NCT05411718|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153547559|NCT05411718|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153547560|NCT05411718|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153547561|NCT05411718|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153547562|NCT05411718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153547563|NCT05411718|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153547578|NCT05396833|Avelumab|avelumab|mesh-list
153547579|NCT05396833|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153547580|NCT05396833|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153547581|NCT05387941|Dexamethasone|dexamethasone|mesh-list
153547582|NCT05387941|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153547583|NCT05387941|Antiemetics|antiemetics|mesh-ancestor
153547584|NCT05387941|Autonomic Agents|autonomic agents|mesh-ancestor
153547585|NCT05387941|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153547586|NCT05387941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153547587|NCT05387941|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153547588|NCT05387941|Glucocorticoids|glucocorticoids|mesh-ancestor
153547589|NCT05387941|Hormones|hormones|mesh-ancestor
153547590|NCT05387941|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153547591|NCT05387941|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153547592|NCT05387941|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153547593|NCT05387616|Obinutuzumab|obinutuzumab|mesh-list
153547594|NCT05387616|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153547595|NCT05387616|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153547596|NCT05386914|Sirolimus|sirolimus|mesh-list
153547597|NCT05386914|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153547598|NCT05386914|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153547599|NCT05386914|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153547600|NCT05386914|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153547601|NCT05386914|Antifungal Agents|antifungal agents|mesh-ancestor
153547602|NCT05386914|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153547603|NCT05386914|Immunologic Factors|immunologic factors|mesh-ancestor
153547604|NCT05386914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153547605|NCT05383170|Pembrolizumab|pembrolizumab|mesh-list
153547609|NCT05383170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153547610|NCT05381909|Paclitaxel|paclitaxel|mesh-list
153547611|NCT05381909|Docetaxel|docetaxel|mesh-list
153547612|NCT05381909|Carboplatin|carboplatin|mesh-list
153547613|NCT05381909|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153547614|NCT05381909|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153547615|NCT05381909|Tubulin Modulators|tubulin modulators|mesh-ancestor
153547621|NCT05369832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153547622|NCT05369832|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153547623|NCT05369832|Immunologic Factors|immunologic factors|mesh-ancestor
153547624|NCT05369832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153547625|NCT05368207|Pembrolizumab|pembrolizumab|mesh-list
153547626|NCT05368207|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153547627|NCT05368207|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153547628|NCT05368207|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153547629|NCT05368207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153547639|NCT05327686|Pembrolizumab|pembrolizumab|mesh-list
153547640|NCT05327686|Nivolumab|nivolumab|mesh-list
153547641|NCT05327686|Ipilimumab|ipilimumab|mesh-list
153547642|NCT05327686|Avelumab|avelumab|mesh-list
153547643|NCT05327686|Lenvatinib|lenvatinib|mesh-list
153547644|NCT05327686|Axitinib|axitinib|mesh-list
153547645|NCT05327686|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
153547646|NCT05327686|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153547647|NCT05327686|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153547648|NCT05327686|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153547649|NCT05327686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153547650|NCT05327686|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153547651|NCT05327686|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153547652|NCT05327686|Immunologic Factors|immunologic factors|mesh-ancestor
153547653|NCT05327686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153547654|NCT05323955|Trastuzumab|trastuzumab|mesh-list
153547682|NCT05319730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153547683|NCT05319730|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153547685|NCT05319730|Autonomic Agents|autonomic agents|mesh-ancestor
153547686|NCT05319730|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153547687|NCT05319730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153547688|NCT05319730|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153547694|NCT05319730|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153547695|NCT05319730|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
153547697|NCT05319730|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153547698|NCT05319730|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153547699|NCT05319730|Analgesics|analgesics|mesh-ancestor
153547700|NCT05319730|Sensory System Agents|sensory system agents|mesh-ancestor
153547701|NCT05319730|Antipyretics|antipyretics|mesh-ancestor
153547702|NCT05319730|Immunologic Factors|immunologic factors|mesh-ancestor
153547703|NCT05319730|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153547704|NCT05319730|Histamine Agents|histamine agents|mesh-ancestor
153547705|NCT05319730|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153547707|NCT05319353|Antiviral Agents|antiviral agents|mesh-ancestor
153547708|NCT05319353|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153547709|NCT05318573|Gemcitabine|gemcitabine|mesh-list
153547710|NCT05318573|Pembrolizumab|pembrolizumab|mesh-list
153547711|NCT05318573|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153547712|NCT05318573|Antimetabolites|antimetabolites|mesh-ancestor
153547713|NCT05318573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153547714|NCT05318573|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153547715|NCT05318573|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153547716|NCT05318573|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153547717|NCT05317858|Pembrolizumab|pembrolizumab|mesh-list
153547718|NCT05317858|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153547719|NCT05317858|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153547720|NCT05317858|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153547721|NCT05317858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153547722|NCT05306340|Tamoxifen|tamoxifen|mesh-list
153547723|NCT05306340|Dexamethasone|dexamethasone|mesh-list
153547724|NCT05306340|Fulvestrant|fulvestrant|mesh-list
153547728|NCT05306340|Antiemetics|antiemetics|mesh-ancestor
153547729|NCT05306340|Autonomic Agents|autonomic agents|mesh-ancestor
153547730|NCT05306340|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153547731|NCT05306340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153547732|NCT05306340|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153547733|NCT05306340|Glucocorticoids|glucocorticoids|mesh-ancestor
153547734|NCT05306340|Hormones|hormones|mesh-ancestor
153547735|NCT05306340|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153547736|NCT05306340|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153547737|NCT05306340|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153547738|NCT05306340|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
153547739|NCT05306340|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153547740|NCT05306340|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153547741|NCT05306340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153547742|NCT05306340|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153547743|NCT05306340|Immunologic Factors|immunologic factors|mesh-ancestor
153547744|NCT05306340|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
153547745|NCT05306340|Hormone Antagonists|hormone antagonists|mesh-ancestor
153547794|NCT05286814|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153731921|NCT00161655|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153547795|NCT05286814|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153547796|NCT05286814|Antidotes|antidotes|mesh-ancestor
153547797|NCT05286814|Protective Agents|protective agents|mesh-ancestor
153547798|NCT05286814|Vitamin B Complex|vitamin b complex|mesh-ancestor
153547799|NCT05286814|Vitamins|vitamins|mesh-ancestor
153547800|NCT05286814|Micronutrients|micronutrients|mesh-ancestor
153547801|NCT05282121|Empagliflozin|empagliflozin|mesh-list
153547802|NCT05282121|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
153547803|NCT05282121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153547804|NCT05282121|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153547805|NCT05282121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153547806|NCT05281471|Paclitaxel|paclitaxel|mesh-list
153547807|NCT05281471|Docetaxel|docetaxel|mesh-list
153547808|NCT05281471|Bevacizumab|bevacizumab|mesh-list
153547809|NCT05281471|Carboplatin|carboplatin|mesh-list
153547810|NCT05281471|Gemcitabine|gemcitabine|mesh-list
153547811|NCT05281471|Doxorubicin|doxorubicin|mesh-list
153547812|NCT05281471|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
153547814|NCT05281471|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153547815|NCT05281471|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153547816|NCT05281471|Tubulin Modulators|tubulin modulators|mesh-ancestor
153547817|NCT05281471|Antimitotic Agents|antimitotic agents|mesh-ancestor
153547818|NCT05281471|Mitosis Modulators|mitosis modulators|mesh-ancestor
153547819|NCT05281471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153547820|NCT05281471|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153547821|NCT05281471|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153547822|NCT05281471|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153547823|NCT05281471|Growth Substances|growth substances|mesh-ancestor
153547825|NCT05281471|Growth Inhibitors|growth inhibitors|mesh-ancestor
153547843|NCT05263050|Nivolumab|nivolumab|mesh-list
153547844|NCT05263050|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153547845|NCT05263050|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153547846|NCT05263050|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153547847|NCT05263050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153547848|NCT05257408|Paclitaxel|paclitaxel|mesh-list
153547849|NCT05257408|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
153547850|NCT05257408|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153547851|NCT05257408|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153547852|NCT05257408|Tubulin Modulators|tubulin modulators|mesh-ancestor
153547853|NCT05257408|Antimitotic Agents|antimitotic agents|mesh-ancestor
153547854|NCT05257408|Mitosis Modulators|mitosis modulators|mesh-ancestor
153547855|NCT05257408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153547856|NCT05254002|Empagliflozin|empagliflozin|mesh-list
153547857|NCT05254002|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
153547858|NCT05254002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153547859|NCT05254002|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153547860|NCT05254002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153547862|NCT05253651|Bevacizumab|bevacizumab|mesh-list
153547863|NCT05253651|Trastuzumab|trastuzumab|mesh-list
153547864|NCT05253651|Cetuximab|cetuximab|mesh-list
153547865|NCT05253651|Fluorouracil|fluorouracil|mesh-list
153547866|NCT05253651|Oxaliplatin|oxaliplatin|mesh-list
153547867|NCT05253651|Tucatinib|tucatinib|mesh-list
153547868|NCT05253651|Levoleucovorin|levoleucovorin|mesh-list
153547869|NCT05253651|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153547870|NCT05253651|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153547871|NCT05253651|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153547872|NCT05253651|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153547873|NCT05253651|Growth Substances|growth substances|mesh-ancestor
153547874|NCT05253651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153547882|NCT05253651|Protective Agents|protective agents|mesh-ancestor
153547883|NCT05253651|Vitamin B Complex|vitamin b complex|mesh-ancestor
153547884|NCT05253651|Vitamins|vitamins|mesh-ancestor
153547885|NCT05253651|Micronutrients|micronutrients|mesh-ancestor
153547886|NCT05253651|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153547887|NCT05253651|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153547888|NCT05243342|Daratumumab|daratumumab|mesh-list
153547889|NCT05243342|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153547890|NCT05241470|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
153547891|NCT05241470|Ophthalmic Solutions|ophthalmic solutions|mesh-list
153547892|NCT05232032|Nocistatin|nocistatin|mesh-list
153547893|NCT05232032|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153547894|NCT05232032|Narcotics|narcotics|mesh-ancestor
153547895|NCT05232032|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153547896|NCT05232032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153547900|NCT05230810|Fulvestrant|fulvestrant|mesh-list
153547901|NCT05230810|Tucatinib|tucatinib|mesh-list
153547902|NCT05230810|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153547903|NCT05230810|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153547904|NCT05230810|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
153547905|NCT05230810|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
153547940|NCT05199311|Glucocorticoids|glucocorticoids|mesh-ancestor
153814595|NCT00452595|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153814598|NCT00452595|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153547941|NCT05199311|Hormones|hormones|mesh-ancestor
153547942|NCT05199311|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153547943|NCT05199311|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153547944|NCT05199311|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153547945|NCT05188222|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
153547946|NCT05169515|Obinutuzumab|obinutuzumab|mesh-list
153547947|NCT05169515|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153547948|NCT05169515|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153547949|NCT05166083|Testosterone|testosterone|mesh-list
153547950|NCT05166083|Androgens|androgens|mesh-ancestor
153547951|NCT05166083|Hormones|hormones|mesh-ancestor
153547952|NCT05166083|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153547953|NCT05166083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153547954|NCT05159284|Hydrocortisone|hydrocortisone|mesh-list
153547955|NCT05159284|Lubricant Eye Drops|lubricant eye drops|mesh-list
153547956|NCT05159284|Hyaluronic Acid|hyaluronic acid|mesh-list
153547957|NCT05159284|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153547958|NCT05159284|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153547959|NCT05159284|Immunologic Factors|immunologic factors|mesh-ancestor
153547960|NCT05159284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153547961|NCT05159284|Viscosupplements|viscosupplements|mesh-ancestor
153547962|NCT05159284|Protective Agents|protective agents|mesh-ancestor
153547963|NCT05159284|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
153547964|NCT05159284|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
153547965|NCT05153239|Irinotecan|irinotecan|mesh-list
153547966|NCT05153239|Topotecan|topotecan|mesh-list
153547967|NCT05153239|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
153547968|NCT05153239|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153547977|NCT05148195|Calcium|calcium|mesh-list
153547978|NCT05148195|Levoleucovorin|levoleucovorin|mesh-list
153547979|NCT05148195|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153547980|NCT05148195|Tubulin Modulators|tubulin modulators|mesh-ancestor
153547981|NCT05148195|Antimitotic Agents|antimitotic agents|mesh-ancestor
153547982|NCT05148195|Mitosis Modulators|mitosis modulators|mesh-ancestor
153547983|NCT05148195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153547988|NCT05148195|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153547989|NCT05148195|Antidotes|antidotes|mesh-ancestor
153547990|NCT05148195|Protective Agents|protective agents|mesh-ancestor
153547991|NCT05148195|Vitamin B Complex|vitamin b complex|mesh-ancestor
153547992|NCT05148195|Vitamins|vitamins|mesh-ancestor
153547993|NCT05148195|Micronutrients|micronutrients|mesh-ancestor
153547994|NCT05140499|Bupivacaine|bupivacaine|mesh-list
153547995|NCT05140499|Anesthetics, Local|anesthetics, local|mesh-ancestor
153547996|NCT05140499|Anesthetics|anesthetics|mesh-ancestor
153547997|NCT05140499|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153547998|NCT05140499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153547999|NCT05140499|Sensory System Agents|sensory system agents|mesh-ancestor
153548000|NCT05140499|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153548001|NCT05119907|Sacituzumab govitecan|sacituzumab govitecan|mesh-list
153548002|NCT05119907|Immunoconjugates|immunoconjugates|mesh-ancestor
153548003|NCT05119907|Immunologic Factors|immunologic factors|mesh-ancestor
153548004|NCT05119907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153548005|NCT05117736|Valsartan|valsartan|mesh-list
153548006|NCT05117736|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
153548007|NCT05117736|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153548011|NCT05103358|Sirolimus|sirolimus|mesh-list
153548058|NCT05092360|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
153548059|NCT05091424|Venetoclax|venetoclax|mesh-list
153548060|NCT05091424|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153548061|NCT05085002|Letrozole|letrozole|mesh-list
153548062|NCT05085002|Fulvestrant|fulvestrant|mesh-list
153548063|NCT05085002|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153548064|NCT05085002|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
153548065|NCT05085002|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153548066|NCT05085002|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153548067|NCT05085002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153548068|NCT05085002|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
153548069|NCT05085002|Hormone Antagonists|hormone antagonists|mesh-ancestor
153548070|NCT05085002|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153548071|NCT05085002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153548072|NCT05085002|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153548073|NCT05085002|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
153548074|NCT05081180|Lenvatinib|lenvatinib|mesh-list
153548075|NCT05081180|Avelumab|avelumab|mesh-list
153548076|NCT05081180|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153548077|NCT05081180|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153548078|NCT05081180|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153548079|NCT05081180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153548080|NCT05081180|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153548083|NCT05073718|Aspirin|aspirin|mesh-list
153915573|NCT00997893|Medroxyprogesterone|medroxyprogesterone|mesh-list
153915574|NCT00997893|Estradiol|estradiol|mesh-list
153915575|NCT00997893|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
153915576|NCT00997893|Estrogens|estrogens|mesh-list
153915583|NCT00997893|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153915584|NCT00997893|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
153548084|NCT05073718|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153548085|NCT05073718|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153548086|NCT05073718|Analgesics|analgesics|mesh-ancestor
153548087|NCT05073718|Sensory System Agents|sensory system agents|mesh-ancestor
153548088|NCT05073718|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153548113|NCT05030311|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153548114|NCT05030311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153548115|NCT05021991|Pramoxine|pramoxine|mesh-list
153548116|NCT05021991|Anesthetics, Local|anesthetics, local|mesh-ancestor
153548117|NCT05021991|Anesthetics|anesthetics|mesh-ancestor
153548118|NCT05021991|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153548119|NCT05021991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153548120|NCT05021991|Sensory System Agents|sensory system agents|mesh-ancestor
153548121|NCT05021991|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153548122|NCT05020236|Dexamethasone|dexamethasone|mesh-list
153548123|NCT05020236|Daratumumab|daratumumab|mesh-list
153548124|NCT05020236|Pomalidomide|pomalidomide|mesh-list
153548125|NCT05020236|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153548126|NCT05020236|Antiemetics|antiemetics|mesh-ancestor
153548127|NCT05020236|Autonomic Agents|autonomic agents|mesh-ancestor
153548128|NCT05020236|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153915585|NCT00997893|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
153915586|NCT00997893|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
153915587|NCT00997893|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
153915588|NCT00997893|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
153915589|NCT00997893|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153915590|NCT00997893|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153915591|NCT00997893|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
153548129|NCT05020236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153548130|NCT05020236|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153548131|NCT05020236|Glucocorticoids|glucocorticoids|mesh-ancestor
153548132|NCT05020236|Hormones|hormones|mesh-ancestor
153548133|NCT05020236|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153548134|NCT05020236|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153548135|NCT05020236|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153548136|NCT05020236|Immunologic Factors|immunologic factors|mesh-ancestor
153548137|NCT05020236|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153548138|NCT05020236|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153548139|NCT05020236|Growth Substances|growth substances|mesh-ancestor
153548141|NCT05017571|Colchicine|colchicine|mesh-list
153548177|NCT05001880|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153548178|NCT05001880|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153548179|NCT05001880|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153548180|NCT05001880|Growth Substances|growth substances|mesh-ancestor
153548181|NCT05001880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153548182|NCT05001880|Growth Inhibitors|growth inhibitors|mesh-ancestor
153548183|NCT05001880|Immunologic Factors|immunologic factors|mesh-ancestor
153548184|NCT05001880|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153548185|NCT05001880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153548186|NCT05001880|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153548187|NCT05001880|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153548188|NCT05001880|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153548190|NCT04992013|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
153548191|NCT04992013|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153548192|NCT04992013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153548193|NCT04992013|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153548194|NCT04989803|Cyclophosphamide|cyclophosphamide|mesh-list
153548195|NCT04989803|Fludarabine|fludarabine|mesh-list
153548196|NCT04989803|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153548197|NCT04989803|Immunologic Factors|immunologic factors|mesh-ancestor
153548198|NCT04989803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153548199|NCT04989803|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153548200|NCT04989803|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153548201|NCT04989803|Alkylating Agents|alkylating agents|mesh-ancestor
153548202|NCT04989803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153548203|NCT04989803|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153548204|NCT04989803|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153782522|NCT04669990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153548213|NCT04975334|Naloxone|naloxone|mesh-list
153548214|NCT04975334|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
153548215|NCT04975334|Hormones|hormones|mesh-ancestor
153548222|NCT04933266|Anesthetics, Local|anesthetics, local|mesh-ancestor
153548223|NCT04933266|Anesthetics|anesthetics|mesh-ancestor
153548224|NCT04933266|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153895808|NCT05643677|Irinotecan|irinotecan|mesh-list
153548225|NCT04933266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153548226|NCT04933266|Sensory System Agents|sensory system agents|mesh-ancestor
153548227|NCT04933266|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153548228|NCT04933227|Capecitabine|capecitabine|mesh-list
153548229|NCT04933227|Oxaliplatin|oxaliplatin|mesh-list
153548230|NCT04933227|Atezolizumab|atezolizumab|mesh-list
153548231|NCT04933227|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153548232|NCT04933227|Antimetabolites|antimetabolites|mesh-ancestor
153548233|NCT04933227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153548234|NCT04933227|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153548235|NCT04933227|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153548236|NCT04933227|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153548237|NCT04931615|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
153548239|NCT04931615|Hemostatics|hemostatics|mesh-ancestor
153548244|NCT04927312|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153548245|NCT04927312|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153548247|NCT04918186|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153548248|NCT04918186|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153548279|NCT04892446|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153548280|NCT04892446|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153782523|NCT04669990|Antiviral Agents|antiviral agents|mesh-ancestor
153548281|NCT04892446|Growth Substances|growth substances|mesh-ancestor
153548282|NCT04892446|Growth Inhibitors|growth inhibitors|mesh-ancestor
153548283|NCT04892446|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153548285|NCT04886154|Immunologic Factors|immunologic factors|mesh-ancestor
153548286|NCT04886154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153548287|NCT04875702|Prednisone|prednisone|mesh-list
153548288|NCT04875702|Naproxen|naproxen|mesh-list
153548289|NCT04875702|Colchicine|colchicine|mesh-list
153548290|NCT04875702|Allopurinol|allopurinol|mesh-list
153548291|NCT04875702|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153548292|NCT04875702|Glucocorticoids|glucocorticoids|mesh-ancestor
153548293|NCT04875702|Hormones|hormones|mesh-ancestor
153548294|NCT04875702|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153548295|NCT04875702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153548296|NCT04875702|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153548297|NCT04875702|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153548298|NCT04875702|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153548299|NCT04875702|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153548300|NCT04875702|Analgesics|analgesics|mesh-ancestor
153548301|NCT04875702|Sensory System Agents|sensory system agents|mesh-ancestor
153548302|NCT04875702|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153548303|NCT04875702|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153371816|NCT02242409|Paclitaxel|paclitaxel|mesh-list
153548364|NCT04821284|Tetrahydrofolates|tetrahydrofolates|mesh-list
153548366|NCT04821284|Camptothecin|camptothecin|mesh-list
153548367|NCT04821284|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
153548368|NCT04821284|Gemcitabine|gemcitabine|mesh-list
153548369|NCT04821284|Fluorouracil|fluorouracil|mesh-list
153548370|NCT04821284|Oxaliplatin|oxaliplatin|mesh-list
153548371|NCT04821284|Irinotecan|irinotecan|mesh-list
153548372|NCT04821284|Calcium|calcium|mesh-list
153548373|NCT04821284|Levoleucovorin|levoleucovorin|mesh-list
153548374|NCT04821284|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153548375|NCT04821284|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153548376|NCT04821284|Tubulin Modulators|tubulin modulators|mesh-ancestor
153548377|NCT04821284|Antimitotic Agents|antimitotic agents|mesh-ancestor
153548378|NCT04821284|Mitosis Modulators|mitosis modulators|mesh-ancestor
153548379|NCT04821284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153548380|NCT04821284|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153548381|NCT04821284|Antimetabolites|antimetabolites|mesh-ancestor
153548382|NCT04821284|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153548383|NCT04821284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153814602|NCT00341432|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153814603|NCT00341432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153548384|NCT04821284|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153548385|NCT04821284|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153548386|NCT04821284|Immunologic Factors|immunologic factors|mesh-ancestor
153548394|NCT04821284|Micronutrients|micronutrients|mesh-ancestor
153548395|NCT04821284|Hematinics|hematinics|mesh-ancestor
153548396|NCT04820933|Tenofovir|tenofovir|mesh-list
153548397|NCT04820933|Emtricitabine|emtricitabine|mesh-list
153548398|NCT04820933|Antiviral Agents|antiviral agents|mesh-ancestor
153548399|NCT04820933|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153548400|NCT04820933|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153548401|NCT04820933|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153548420|NCT04802759|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153548421|NCT04802759|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153548422|NCT04802759|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
153548423|NCT04802759|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153548424|NCT04802759|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153548425|NCT04802759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153548426|NCT04802759|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153548427|NCT04802759|Immunologic Factors|immunologic factors|mesh-ancestor
153548428|NCT04802759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153548429|NCT04802759|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153548430|NCT04802759|Phosphoinositide-3 Kinase Inhibitors|phosphoinositide-3 kinase inhibitors|mesh-ancestor
153548431|NCT04797780|Azacitidine|azacitidine|mesh-list
153915592|NCT02697877|Regadenoson|regadenoson|mesh-list
153464305|NCT05320692|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153464306|NCT05320692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153464307|NCT05320692|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153464308|NCT01763580|Prednisolone|prednisolone|mesh-list
153441882|NCT00005113|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153464309|NCT01763580|Tacrolimus|tacrolimus|mesh-list
153814604|NCT00341432|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
153437020|NCT00002755|Tamoxifen|tamoxifen|mesh-list
153548432|NCT04797780|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153548433|NCT04797780|Antimetabolites|antimetabolites|mesh-ancestor
153548434|NCT04797780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153548435|NCT04797780|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153548436|NCT04797780|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153548437|NCT04794127|Pioglitazone|pioglitazone|mesh-list
153548438|NCT04794127|Trabectedin|trabectedin|mesh-list
153548439|NCT04794127|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153548440|NCT04794127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153548441|NCT04794127|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153548442|NCT04794127|Alkylating Agents|alkylating agents|mesh-ancestor
153548443|NCT04794127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153548444|NCT04794127|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153548445|NCT04793399|Atezolizumab|atezolizumab|mesh-list
153548446|NCT04793399|Bosutinib|bosutinib|mesh-list
153548447|NCT04793399|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153548448|NCT04793399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153548449|NCT04793399|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153548450|NCT04793399|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153548451|NCT04793399|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153548470|NCT04761601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153548473|NCT04756037|Relugolix|relugolix|mesh-list
153548474|NCT04756037|Androgen Antagonists|androgen antagonists|mesh-ancestor
153548475|NCT04756037|Hormone Antagonists|hormone antagonists|mesh-ancestor
153548476|NCT04756037|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153548477|NCT04756037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153548478|NCT04755764|Atenolol|atenolol|mesh-list
153548479|NCT04755764|Labetalol|labetalol|mesh-list
153548480|NCT04755764|Nifedipine|nifedipine|mesh-list
153548481|NCT04755764|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153548482|NCT04755764|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153548483|NCT04755764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153548484|NCT04755764|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153548485|NCT04755764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153548486|NCT04755764|Vasodilator Agents|vasodilator agents|mesh-ancestor
153548487|NCT04755764|Tocolytic Agents|tocolytic agents|mesh-ancestor
153548488|NCT04755764|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153548489|NCT04755764|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153548490|NCT04755764|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153548491|NCT04755764|Sympatholytics|sympatholytics|mesh-ancestor
153548492|NCT04755764|Autonomic Agents|autonomic agents|mesh-ancestor
153548493|NCT04755764|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153548494|NCT04755764|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
153548495|NCT04755764|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
153548496|NCT04755764|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
153548497|NCT04755764|Adrenergic Agents|adrenergic agents|mesh-ancestor
153548498|NCT04755764|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153548525|NCT04744831|Immunologic Factors|immunologic factors|mesh-ancestor
153548526|NCT04744831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153548527|NCT04744831|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153548528|NCT04744831|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153548529|NCT04744831|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
153548530|NCT04744831|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153548531|NCT04744831|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153548532|NCT04744831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153548535|NCT04733118|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
153548536|NCT04733118|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153548537|NCT04733118|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153548538|NCT04733118|Tubulin Modulators|tubulin modulators|mesh-ancestor
153548539|NCT04733118|Antimitotic Agents|antimitotic agents|mesh-ancestor
153548540|NCT04733118|Mitosis Modulators|mitosis modulators|mesh-ancestor
153548541|NCT04733118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153548542|NCT04733118|Immunotoxins|immunotoxins|mesh-ancestor
153548543|NCT04733118|Immunoconjugates|immunoconjugates|mesh-ancestor
153548544|NCT04733118|Immunologic Factors|immunologic factors|mesh-ancestor
153548545|NCT04733118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153548546|NCT04719273|Anastrozole|anastrozole|mesh-list
153548547|NCT04719273|Onapristone|onapristone|mesh-list
153548548|NCT04719273|Progesterone|progesterone|mesh-list
153548550|NCT04719273|Progestins|progestins|mesh-ancestor
153548551|NCT04719273|Hormones|hormones|mesh-ancestor
153548552|NCT04719273|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153548553|NCT04719273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153548554|NCT04719273|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153548555|NCT04719273|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153548556|NCT04719273|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
153548557|NCT04719273|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153548572|NCT04717193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153548573|NCT04717193|Sensory System Agents|sensory system agents|mesh-ancestor
153548574|NCT04717193|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153548575|NCT04717193|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153548576|NCT04717193|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153548577|NCT04717193|Adrenergic Agents|adrenergic agents|mesh-ancestor
153548578|NCT04717193|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153548579|NCT04717193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153548580|NCT04717193|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
153548581|NCT04717193|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153548587|NCT04717193|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
153782524|NCT04669990|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153548589|NCT04708418|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153464310|NCT01763580|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153464311|NCT01763580|Immunologic Factors|immunologic factors|mesh-ancestor
153814605|NCT00341432|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
153548590|NCT04708418|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153548591|NCT04708418|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153548592|NCT04708418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153548594|NCT04706130|Primaquine|primaquine|mesh-list
153548595|NCT04706130|Antimalarials|antimalarials|mesh-ancestor
153548596|NCT04706130|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153548632|NCT04663347|Oxaliplatin|oxaliplatin|mesh-list
153548633|NCT04663347|Etoposide|etoposide|mesh-list
153548634|NCT04663347|Vincristine|vincristine|mesh-list
153548635|NCT04663347|Lenalidomide|lenalidomide|mesh-list
153548636|NCT04663347|Etoposide phosphate|etoposide phosphate|mesh-list
153548637|NCT04663347|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153548638|NCT04663347|Immunologic Factors|immunologic factors|mesh-ancestor
153548639|NCT04663347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153548640|NCT04663347|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153548641|NCT04663347|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153548642|NCT04663347|Alkylating Agents|alkylating agents|mesh-ancestor
153548643|NCT04663347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153548644|NCT04663347|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153548645|NCT04663347|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153548646|NCT04663347|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153548647|NCT04663347|Antiemetics|antiemetics|mesh-ancestor
153548648|NCT04663347|Autonomic Agents|autonomic agents|mesh-ancestor
153548649|NCT04663347|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153548650|NCT04663347|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153548651|NCT04663347|Glucocorticoids|glucocorticoids|mesh-ancestor
153548652|NCT04663347|Hormones|hormones|mesh-ancestor
153548653|NCT04663347|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153548654|NCT04663347|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153548655|NCT04663347|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153548656|NCT04663347|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153548663|NCT04663347|Antiviral Agents|antiviral agents|mesh-ancestor
153782525|NCT00556348|Bevacizumab|bevacizumab|mesh-list
153548664|NCT04663347|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153548665|NCT04663347|Tubulin Modulators|tubulin modulators|mesh-ancestor
153782526|NCT00556348|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153548666|NCT04663347|Antimitotic Agents|antimitotic agents|mesh-ancestor
153548667|NCT04663347|Mitosis Modulators|mitosis modulators|mesh-ancestor
153548679|NCT04655755|Decitabine and cedazuridine drug combination|decitabine and cedazuridine drug combination|mesh-list
153548680|NCT04655755|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153548681|NCT04655755|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153548682|NCT04655755|Antimetabolites|antimetabolites|mesh-ancestor
153548683|NCT04655755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153731926|NCT00161655|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153731927|NCT00161655|Analgesics|analgesics|mesh-ancestor
153371904|NCT02618343|Antiemetics|antiemetics|mesh-ancestor
153548684|NCT04655755|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153548685|NCT04635098|Dexmedetomidine|dexmedetomidine|mesh-list
153548686|NCT04635098|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153548687|NCT04635098|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153548688|NCT04635098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153548689|NCT04635098|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153548690|NCT04635098|Analgesics|analgesics|mesh-ancestor
153548691|NCT04635098|Sensory System Agents|sensory system agents|mesh-ancestor
153548692|NCT04635098|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153548693|NCT04635098|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
153548694|NCT04635098|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153548695|NCT04635098|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153548696|NCT04635098|Adrenergic Agents|adrenergic agents|mesh-ancestor
153548697|NCT04635098|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153548699|NCT04633967|Alemtuzumab|alemtuzumab|mesh-list
153548739|NCT04626791|Antiviral Agents|antiviral agents|mesh-ancestor
153548740|NCT04626791|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153548741|NCT04626791|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153548742|NCT04612725|Benralizumab|benralizumab|mesh-list
153548743|NCT04612725|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153548744|NCT04612725|Respiratory System Agents|respiratory system agents|mesh-ancestor
153548745|NCT04610684|Carboplatin|carboplatin|mesh-list
153548746|NCT04610684|Etoposide|etoposide|mesh-list
153548747|NCT04610684|Atezolizumab|atezolizumab|mesh-list
153548748|NCT04610684|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153548749|NCT04610684|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153548750|NCT04610684|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153548751|NCT04610684|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153548752|NCT04610684|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153548753|NCT04610684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153548754|NCT04610684|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153548755|NCT04610684|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153548756|NCT04608019|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
153548757|NCT04608019|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153548758|NCT04606901|Glycopyrrolate|glycopyrrolate|mesh-list
153548759|NCT04606901|Neostigmine|neostigmine|mesh-list
153548760|NCT04606901|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
153548761|NCT04606901|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153548762|NCT04606901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153548763|NCT04606901|Cholinergic Agents|cholinergic agents|mesh-ancestor
153548764|NCT04606901|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153548765|NCT04606901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153548766|NCT04606901|Parasympathomimetics|parasympathomimetics|mesh-ancestor
153548767|NCT04606901|Autonomic Agents|autonomic agents|mesh-ancestor
153548768|NCT04606901|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153548784|NCT04602221|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153548785|NCT04602221|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153548786|NCT04602221|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
153548802|NCT04589845|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153548803|NCT04589845|Tubulin Modulators|tubulin modulators|mesh-ancestor
153548804|NCT04589845|Antimitotic Agents|antimitotic agents|mesh-ancestor
153548805|NCT04589845|Mitosis Modulators|mitosis modulators|mesh-ancestor
153548806|NCT04589845|Immunotoxins|immunotoxins|mesh-ancestor
153548807|NCT04589845|Immunoconjugates|immunoconjugates|mesh-ancestor
153548808|NCT04589845|Immunologic Factors|immunologic factors|mesh-ancestor
153464314|NCT01763580|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153464326|NCT01740492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153464328|NCT01740492|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153548809|NCT04589845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153548810|NCT04589845|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153548811|NCT04589845|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153782527|NCT00556348|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153548812|NCT04589845|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153782528|NCT00556348|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153548813|NCT04589845|Phosphoinositide-3 Kinase Inhibitors|phosphoinositide-3 kinase inhibitors|mesh-ancestor
153548814|NCT04585295|Betaine|betaine|mesh-list
153548815|NCT04585295|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153548816|NCT04585295|Lipotropic Agents|lipotropic agents|mesh-ancestor
153548817|NCT04585295|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153548819|NCT04585295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153548820|NCT04585295|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153548821|NCT04564755|Abrocitinib|abrocitinib|mesh-list
153548822|NCT04564755|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153548823|NCT04564755|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153548824|NCT04564755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153548825|NCT04564222|Micronutrients|micronutrients|mesh-list
153548826|NCT04564222|Trace Elements|trace elements|mesh-list
153548827|NCT04564222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153548828|NCT04559230|Sacituzumab govitecan|sacituzumab govitecan|mesh-list
153548829|NCT04559230|Immunoconjugates|immunoconjugates|mesh-ancestor
153548830|NCT04559230|Immunologic Factors|immunologic factors|mesh-ancestor
153810981|NCT00353028|Fluvoxamine|fluvoxamine|mesh-list
153810982|NCT00353028|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153357542|NCT01274000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153915595|NCT02697877|Purinergic Agonists|purinergic agonists|mesh-ancestor
153915596|NCT02697877|Purinergic Agents|purinergic agents|mesh-ancestor
153915597|NCT02697877|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153548831|NCT04559230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153548832|NCT04556136|Vitamin D|vitamin d|mesh-list
153548833|NCT04556136|Vitamins|vitamins|mesh-ancestor
153548834|NCT04556136|Micronutrients|micronutrients|mesh-ancestor
153548835|NCT04556136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153571330|NCT04464577|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153548836|NCT04556136|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153548838|NCT04551131|Etoposide|etoposide|mesh-list
153548839|NCT04551131|Etoposide phosphate|etoposide phosphate|mesh-list
153548840|NCT04551131|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153548841|NCT04551131|Antiemetics|antiemetics|mesh-ancestor
153548842|NCT04551131|Autonomic Agents|autonomic agents|mesh-ancestor
153548843|NCT04551131|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153548844|NCT04551131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153548845|NCT04551131|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153548846|NCT04551131|Glucocorticoids|glucocorticoids|mesh-ancestor
153548847|NCT04551131|Hormones|hormones|mesh-ancestor
153548848|NCT04551131|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153548849|NCT04551131|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153548865|NCT04550260|Immunologic Factors|immunologic factors|mesh-ancestor
153548866|NCT04550260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153548867|NCT04550260|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153548868|NCT04549792|Ustekinumab|ustekinumab|mesh-list
153548869|NCT04549792|Dermatologic Agents|dermatologic agents|mesh-ancestor
153548878|NCT04544436|Methylprednisolone|methylprednisolone|mesh-list
153548881|NCT04544436|Histamine H1 Antagonists|histamine h1 antagonists|mesh-list
153548882|NCT04544436|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153548883|NCT04544436|Antiemetics|antiemetics|mesh-ancestor
153548884|NCT04544436|Autonomic Agents|autonomic agents|mesh-ancestor
153548885|NCT04544436|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153548886|NCT04544436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153548887|NCT04544436|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153548888|NCT04544436|Glucocorticoids|glucocorticoids|mesh-ancestor
153782529|NCT00556348|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153548889|NCT04544436|Hormones|hormones|mesh-ancestor
153548890|NCT04544436|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153548904|NCT04531462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153548905|NCT04530565|Cytarabine|cytarabine|mesh-list
153548906|NCT04530565|Dexamethasone|dexamethasone|mesh-list
153915602|NCT04214665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153810983|NCT00353028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153548907|NCT04530565|Dexamethasone acetate|dexamethasone acetate|mesh-list
153548908|NCT04530565|Prednisone|prednisone|mesh-list
153548909|NCT04530565|Cortisone|cortisone|mesh-list
153548910|NCT04530565|Cyclophosphamide|cyclophosphamide|mesh-list
153548911|NCT04530565|Doxorubicin|doxorubicin|mesh-list
153548912|NCT04530565|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
153548913|NCT04530565|Methotrexate|methotrexate|mesh-list
153548914|NCT04530565|Vincristine|vincristine|mesh-list
153548915|NCT04530565|Dasatinib|dasatinib|mesh-list
153548916|NCT04530565|Blinatumomab|blinatumomab|mesh-list
153548917|NCT04530565|Ponatinib|ponatinib|mesh-list
153548930|NCT04530565|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153548931|NCT04530565|Alkylating Agents|alkylating agents|mesh-ancestor
153548932|NCT04530565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153548933|NCT04530565|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153548934|NCT04530565|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153548935|NCT04530565|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153548936|NCT04530565|Antiemetics|antiemetics|mesh-ancestor
153548937|NCT04530565|Autonomic Agents|autonomic agents|mesh-ancestor
153548938|NCT04530565|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153548939|NCT04530565|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153548940|NCT04530565|Glucocorticoids|glucocorticoids|mesh-ancestor
153548941|NCT04530565|Hormones|hormones|mesh-ancestor
153548942|NCT04530565|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153548944|NCT04530565|Protease Inhibitors|protease inhibitors|mesh-ancestor
153548963|NCT04530565|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153548964|NCT04530565|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153371989|NCT01357148|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
153548965|NCT04530565|Protective Agents|protective agents|mesh-ancestor
153548967|NCT04529954|Anticonvulsants|anticonvulsants|mesh-ancestor
153548968|NCT04529954|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153548969|NCT04529954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153548970|NCT04529954|GABA Agents|gaba agents|mesh-ancestor
153548971|NCT04529954|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153548972|NCT04529954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153915603|NCT04214665|Protective Agents|protective agents|mesh-ancestor
153915604|NCT04214665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153915613|NCT02870673|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153915614|NCT02870673|Glucocorticoids|glucocorticoids|mesh-ancestor
153915615|NCT02870673|Hormones|hormones|mesh-ancestor
153437178|NCT00003380|Etoposide|etoposide|mesh-list
153548973|NCT04529954|Antimanic Agents|antimanic agents|mesh-ancestor
153548974|NCT04529954|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153548975|NCT04529954|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153548976|NCT04529954|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153548977|NCT04525547|Nintedanib|nintedanib|mesh-list
153548978|NCT04525547|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153548979|NCT04525547|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153548980|NCT04525547|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153548981|NCT04525547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153548982|NCT04524871|Bevacizumab|bevacizumab|mesh-list
153548983|NCT04524871|Atezolizumab|atezolizumab|mesh-list
153548994|NCT04504812|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
153548995|NCT04504812|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153549023|NCT04457284|Nivolumab|nivolumab|mesh-list
153549024|NCT04457284|Temozolomide|temozolomide|mesh-list
153549025|NCT04457284|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153549026|NCT04457284|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153549027|NCT04457284|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153549028|NCT04457284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153549029|NCT04457284|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153549030|NCT04457284|Alkylating Agents|alkylating agents|mesh-ancestor
153549043|NCT04442919|Morphine|morphine|mesh-list
153549044|NCT04442919|Methoxyflurane|methoxyflurane|mesh-list
153549045|NCT04442919|Ticagrelor|ticagrelor|mesh-list
153549046|NCT04442919|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153549053|NCT04442919|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153549054|NCT04442919|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
153549055|NCT04442919|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
153549057|NCT04442919|Purinergic Agents|purinergic agents|mesh-ancestor
153549058|NCT04442919|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153549059|NCT04442919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153549060|NCT04442919|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
153549061|NCT04442919|Anesthetics, General|anesthetics, general|mesh-ancestor
153549062|NCT04442919|Anesthetics|anesthetics|mesh-ancestor
153549063|NCT04440358|Carboplatin|carboplatin|mesh-list
153549064|NCT04440358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153549093|NCT04408638|Oxaliplatin|oxaliplatin|mesh-list
153549094|NCT04408638|Obinutuzumab|obinutuzumab|mesh-list
153549095|NCT04408638|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153549096|NCT04408638|Antimetabolites|antimetabolites|mesh-ancestor
153549097|NCT04408638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153549098|NCT04408638|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153549099|NCT04408638|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153810984|NCT00353028|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153895999|NCT01181271|Sirolimus|sirolimus|mesh-list
153549101|NCT04400994|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153549102|NCT04400994|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153549103|NCT04400994|Immunologic Factors|immunologic factors|mesh-ancestor
153549104|NCT04400994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153549105|NCT04400994|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153549106|NCT04396860|Nivolumab|nivolumab|mesh-list
153549107|NCT04396860|Ipilimumab|ipilimumab|mesh-list
153549108|NCT04396860|Temozolomide|temozolomide|mesh-list
153549109|NCT04396860|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153549110|NCT04396860|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153549111|NCT04396860|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153549112|NCT04396860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153782530|NCT00556348|Growth Substances|growth substances|mesh-ancestor
153549121|NCT04374630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153549122|NCT04374305|Neratinib|neratinib|mesh-list
153549123|NCT04374305|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153549124|NCT04374305|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153549125|NCT04374305|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153549126|NCT04374305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153549127|NCT04368559|Fluconazole|fluconazole|mesh-list
153549143|NCT04368559|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
153549144|NCT04368559|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
153549145|NCT04368559|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
153549147|NCT04368559|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153549148|NCT04368559|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153549149|NCT04368559|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153549150|NCT04368559|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
153549151|NCT04368559|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
153549152|NCT04368559|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
153549153|NCT04368559|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153549154|NCT04342975|Niacinamide|niacinamide|mesh-list
153549156|NCT04342975|Nicotinic Acids|nicotinic acids|mesh-list
153549157|NCT04342975|Vitamin B Complex|vitamin b complex|mesh-ancestor
153549158|NCT04342975|Vitamins|vitamins|mesh-ancestor
153549159|NCT04342975|Micronutrients|micronutrients|mesh-ancestor
153549160|NCT04342975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153549161|NCT04342975|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153549162|NCT04342975|Antimetabolites|antimetabolites|mesh-ancestor
153549163|NCT04342975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153549164|NCT04342975|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153549165|NCT04342975|Vasodilator Agents|vasodilator agents|mesh-ancestor
153549166|NCT04314193|Prednisolone|prednisolone|mesh-list
153549167|NCT04314193|Methotrexate|methotrexate|mesh-list
153549168|NCT04314193|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
153549169|NCT04314193|Abortifacient Agents|abortifacient agents|mesh-ancestor
153549170|NCT04314193|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153549171|NCT04314193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153549172|NCT04314193|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153549173|NCT04314193|Antimetabolites|antimetabolites|mesh-ancestor
153549174|NCT04314193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153549175|NCT04314193|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153915617|NCT02870673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153915628|NCT02870673|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
153915629|NCT02870673|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153915630|NCT02870673|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153549189|NCT04293562|Deoxyglucose|deoxyglucose|mesh-list
153549197|NCT04293562|Daunorubicin|daunorubicin|mesh-list
153549198|NCT04293562|Asparaginase|asparaginase|mesh-list
153549199|NCT04293562|Mitoxantrone|mitoxantrone|mesh-list
153549200|NCT04293562|Podophyllotoxin|podophyllotoxin|mesh-list
153549201|NCT04293562|Gemtuzumab|gemtuzumab|mesh-list
153549202|NCT04293562|Dexrazoxane|dexrazoxane|mesh-list
153549203|NCT04293562|Razoxane|razoxane|mesh-list
153549204|NCT04293562|Calicheamicins|calicheamicins|mesh-list
153549205|NCT04293562|Asparaginase erwinia chrysanthemi, recombinant-rywn|asparaginase erwinia chrysanthemi, recombinant-rywn|mesh-list
153549206|NCT04293562|Gilteritinib|gilteritinib|mesh-list
153549207|NCT04293562|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
153549208|NCT04293562|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
153549209|NCT04293562|Abortifacient Agents|abortifacient agents|mesh-ancestor
153549210|NCT04293562|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153549211|NCT04293562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153549212|NCT04293562|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153549213|NCT04293562|Antimetabolites|antimetabolites|mesh-ancestor
153549214|NCT04293562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153549215|NCT04293562|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153549216|NCT04293562|Dermatologic Agents|dermatologic agents|mesh-ancestor
153549217|NCT04293562|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153549218|NCT04293562|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153549219|NCT04293562|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153549220|NCT04293562|Immunologic Factors|immunologic factors|mesh-ancestor
153549221|NCT04293562|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153549222|NCT04293562|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153549223|NCT04293562|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153549224|NCT04293562|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153549225|NCT04293562|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153549226|NCT04293562|Antiviral Agents|antiviral agents|mesh-ancestor
153549227|NCT04293562|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153549229|NCT04293562|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153549230|NCT04293562|Analgesics|analgesics|mesh-ancestor
153549231|NCT04293562|Sensory System Agents|sensory system agents|mesh-ancestor
153549232|NCT04293562|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153549233|NCT04293562|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
153549237|NCT04293562|Mitosis Modulators|mitosis modulators|mesh-ancestor
153549238|NCT04293562|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153549239|NCT04293562|Immunotoxins|immunotoxins|mesh-ancestor
153549240|NCT04293562|Immunoconjugates|immunoconjugates|mesh-ancestor
153549241|NCT04293562|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153549242|NCT04293562|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153549243|NCT04293562|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
153549244|NCT04293562|Protective Agents|protective agents|mesh-ancestor
153549245|NCT04287049|Azithromycin|azithromycin|mesh-list
153549255|NCT04249739|Pembrolizumab|pembrolizumab|mesh-list
153549256|NCT04249739|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153549257|NCT04249739|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153549258|NCT04249739|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153549259|NCT04249739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153549260|NCT04235686|Amphetamine|amphetamine|mesh-list
153782531|NCT00556348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153549261|NCT04235686|Dextroamphetamine|dextroamphetamine|mesh-list
153549262|NCT04235686|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
153549263|NCT04235686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153549264|NCT04235686|Sympathomimetics|sympathomimetics|mesh-ancestor
153549265|NCT04235686|Autonomic Agents|autonomic agents|mesh-ancestor
153549266|NCT04235686|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153549267|NCT04235686|Dopamine Agents|dopamine agents|mesh-ancestor
153549268|NCT04235686|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153549269|NCT04235686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153549270|NCT04235686|Adrenergic Agents|adrenergic agents|mesh-ancestor
153549271|NCT04235686|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
153549272|NCT04235686|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153549273|NCT04235686|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153549276|NCT04231708|Yohimbine|yohimbine|mesh-list
153549285|NCT04231708|Adrenergic Agents|adrenergic agents|mesh-ancestor
153549286|NCT04231708|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153549287|NCT04231708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153549288|NCT04231708|Urological Agents|urological agents|mesh-ancestor
153549289|NCT04225117|Pembrolizumab|pembrolizumab|mesh-list
153814608|NCT00341432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153549290|NCT04225117|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153549291|NCT04225117|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153549292|NCT04225117|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153549293|NCT04225117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153549294|NCT04224740|Cisplatin|cisplatin|mesh-list
153549295|NCT04224740|Carboplatin|carboplatin|mesh-list
153549296|NCT04224740|Pembrolizumab|pembrolizumab|mesh-list
153549297|NCT04224740|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153549298|NCT04224740|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153549299|NCT04224740|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153549300|NCT04224740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153549301|NCT04199026|Sirolimus|sirolimus|mesh-list
153549302|NCT04199026|Doxorubicin|doxorubicin|mesh-list
153549303|NCT04199026|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
153549304|NCT04199026|Daunorubicin|daunorubicin|mesh-list
153549305|NCT04199026|Irinotecan|irinotecan|mesh-list
153549306|NCT04199026|Vincristine|vincristine|mesh-list
153549308|NCT04199026|Temozolomide|temozolomide|mesh-list
153549309|NCT04199026|Temsirolimus|temsirolimus|mesh-list
153549323|NCT04199026|Antimitotic Agents|antimitotic agents|mesh-ancestor
153549324|NCT04199026|Mitosis Modulators|mitosis modulators|mesh-ancestor
153549325|NCT04199026|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153549326|NCT04199026|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153549327|NCT04199026|Immunologic Factors|immunologic factors|mesh-ancestor
153549346|NCT04182204|Oxaliplatin|oxaliplatin|mesh-list
153549347|NCT04182204|Polatuzumab vedotin|polatuzumab vedotin|mesh-list
153549348|NCT04182204|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153549349|NCT04182204|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153549350|NCT04182204|Immunologic Factors|immunologic factors|mesh-ancestor
153549351|NCT04182204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153549352|NCT04182204|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153549353|NCT04182204|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153549354|NCT04182204|Antimetabolites|antimetabolites|mesh-ancestor
153549355|NCT04182204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153549356|NCT04182204|Immunoconjugates|immunoconjugates|mesh-ancestor
153549357|NCT04177433|Methylprednisolone|methylprednisolone|mesh-list
153549358|NCT04177433|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
153549359|NCT04177433|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
153549360|NCT04177433|Prednisolone|prednisolone|mesh-list
153549361|NCT04177433|Prednisolone acetate|prednisolone acetate|mesh-list
153549362|NCT04177433|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
153549363|NCT04177433|Prednisolone phosphate|prednisolone phosphate|mesh-list
153549364|NCT04177433|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153549365|NCT04177433|Antiemetics|antiemetics|mesh-ancestor
153549366|NCT04177433|Autonomic Agents|autonomic agents|mesh-ancestor
153549367|NCT04177433|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153549368|NCT04177433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153549369|NCT04177433|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153549370|NCT04177433|Glucocorticoids|glucocorticoids|mesh-ancestor
153549379|NCT04172597|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153549380|NCT04166604|Trifluridine|trifluridine|mesh-list
153549381|NCT04166604|Antimetabolites|antimetabolites|mesh-ancestor
153549382|NCT04166604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153549383|NCT04166604|Antiviral Agents|antiviral agents|mesh-ancestor
153549384|NCT04166604|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153549385|NCT04163419|Tanezumab|tanezumab|mesh-list
153549386|NCT04163419|Analgesics|analgesics|mesh-ancestor
153549390|NCT04161248|Dexamethasone|dexamethasone|mesh-list
153549396|NCT04161248|Antiemetics|antiemetics|mesh-ancestor
153549397|NCT04161248|Autonomic Agents|autonomic agents|mesh-ancestor
153549398|NCT04161248|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153549399|NCT04161248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153549400|NCT04161248|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153549401|NCT04161248|Glucocorticoids|glucocorticoids|mesh-ancestor
153549402|NCT04161248|Hormones|hormones|mesh-ancestor
153549403|NCT04161248|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153549404|NCT04161248|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153549405|NCT04161248|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153549406|NCT04161248|Immunologic Factors|immunologic factors|mesh-ancestor
153549407|NCT04161248|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153549408|NCT04161248|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153549409|NCT04161248|Antimetabolites|antimetabolites|mesh-ancestor
153549410|NCT04161248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153549411|NCT04158934|Factor VIII|factor viii|mesh-list
153549412|NCT04158934|BAX 855|bax 855|mesh-list
153549413|NCT04158934|Coagulants|coagulants|mesh-ancestor
153549414|NCT04145115|Nivolumab|nivolumab|mesh-list
153549415|NCT04145115|Ipilimumab|ipilimumab|mesh-list
153549416|NCT04145115|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153549417|NCT04145115|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153549418|NCT04145115|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153549419|NCT04145115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153549457|NCT04102436|Immunologic Factors|immunologic factors|mesh-ancestor
153549458|NCT04102436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153549459|NCT04102436|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153549460|NCT04102436|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153549461|NCT04102436|Alkylating Agents|alkylating agents|mesh-ancestor
153549462|NCT04102436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153549463|NCT04102436|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153549464|NCT04102436|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153549465|NCT04102436|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153549466|NCT04102436|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153549467|NCT04102436|Antiviral Agents|antiviral agents|mesh-ancestor
153549468|NCT04102436|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153549469|NCT04094961|Dexamethasone|dexamethasone|mesh-list
153549470|NCT04094961|Dexamethasone acetate|dexamethasone acetate|mesh-list
153549520|NCT04079621|Primaquine|primaquine|mesh-list
153549521|NCT04079621|Antimalarials|antimalarials|mesh-ancestor
153549522|NCT04079621|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153549523|NCT04079621|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153549524|NCT04079621|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153549525|NCT04075916|Sofosbuvir-velpatasvir drug combination|sofosbuvir-velpatasvir drug combination|mesh-list
153549526|NCT04075916|Antiviral Agents|antiviral agents|mesh-ancestor
153549527|NCT04075916|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153549529|NCT04062656|Folic Acid|folic acid|mesh-list
153549530|NCT04062656|Docetaxel|docetaxel|mesh-list
153549531|NCT04062656|Nivolumab|nivolumab|mesh-list
153549532|NCT04062656|Fluorouracil|fluorouracil|mesh-list
153549533|NCT04062656|Oxaliplatin|oxaliplatin|mesh-list
153357543|NCT01274000|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153549534|NCT04062656|Relatlimab|relatlimab|mesh-list
153549535|NCT04062656|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153896032|NCT00624741|Pergolide|pergolide|mesh-list
153549536|NCT04062656|Tubulin Modulators|tubulin modulators|mesh-ancestor
153549537|NCT04062656|Antimitotic Agents|antimitotic agents|mesh-ancestor
153549538|NCT04062656|Mitosis Modulators|mitosis modulators|mesh-ancestor
153549539|NCT04062656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153549540|NCT04062656|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153549541|NCT04062656|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153549542|NCT04062656|Antimetabolites|antimetabolites|mesh-ancestor
153549543|NCT04062656|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153549544|NCT04062656|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153549545|NCT04062656|Immunologic Factors|immunologic factors|mesh-ancestor
153549546|NCT04062656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153549547|NCT04062656|Antidotes|antidotes|mesh-ancestor
153549548|NCT04062656|Protective Agents|protective agents|mesh-ancestor
153549549|NCT04062656|Vitamin B Complex|vitamin b complex|mesh-ancestor
153549550|NCT04062656|Vitamins|vitamins|mesh-ancestor
153549551|NCT04062656|Micronutrients|micronutrients|mesh-ancestor
153549552|NCT04062656|Hematinics|hematinics|mesh-ancestor
153549553|NCT04060849|Ethanol|ethanol|mesh-list
153549554|NCT04060849|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
153549555|NCT04060849|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
153571331|NCT04464577|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
153571332|NCT04464577|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153571333|NCT04464577|Hormone Antagonists|hormone antagonists|mesh-ancestor
153549557|NCT04060849|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153549558|NCT04060849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153549559|NCT04060394|Prednisone|prednisone|mesh-list
153549560|NCT04060394|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153549561|NCT04060394|Glucocorticoids|glucocorticoids|mesh-ancestor
153549562|NCT04060394|Hormones|hormones|mesh-ancestor
153549563|NCT04060394|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153549564|NCT04060394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153549565|NCT04060394|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153549566|NCT04060394|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153549579|NCT04014634|Methylprednisolone|methylprednisolone|mesh-list
153549580|NCT04014634|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
153549581|NCT04014634|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
153814612|NCT00452634|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
153437258|NCT00002785|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153896071|NCT00629473|Hormones|hormones|mesh-ancestor
153549582|NCT04014634|Prednisolone|prednisolone|mesh-list
153549583|NCT04014634|Prednisolone acetate|prednisolone acetate|mesh-list
153549600|NCT04014361|Antifungal Agents|antifungal agents|mesh-ancestor
153549601|NCT04014361|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153549602|NCT04014361|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
153549603|NCT04014361|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153549604|NCT04014361|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153549605|NCT04014361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153549606|NCT04014361|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153549607|NCT04014361|Hormone Antagonists|hormone antagonists|mesh-ancestor
153549608|NCT04014361|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153549609|NCT04014361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153549610|NCT04014361|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
153549611|NCT03993912|Dexamethasone|dexamethasone|mesh-list
153549612|NCT03993912|Lenalidomide|lenalidomide|mesh-list
153549613|NCT03993912|Daratumumab|daratumumab|mesh-list
153549614|NCT03993912|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153549615|NCT03993912|Antiemetics|antiemetics|mesh-ancestor
153549616|NCT03993912|Autonomic Agents|autonomic agents|mesh-ancestor
153549617|NCT03993912|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153571334|NCT04464577|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153571335|NCT04464577|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
153549619|NCT03993912|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153549620|NCT03993912|Glucocorticoids|glucocorticoids|mesh-ancestor
153549622|NCT03993912|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153549623|NCT03993912|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153549624|NCT03993912|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153549625|NCT03993912|Immunologic Factors|immunologic factors|mesh-ancestor
153549626|NCT03993912|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153549627|NCT03993912|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153549628|NCT03993912|Growth Substances|growth substances|mesh-ancestor
153549629|NCT03993912|Growth Inhibitors|growth inhibitors|mesh-ancestor
153549630|NCT03982992|Blinatumomab|blinatumomab|mesh-list
153549631|NCT03982992|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153549633|NCT03972527|Sensory System Agents|sensory system agents|mesh-ancestor
153549634|NCT03972527|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153549635|NCT03972527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153782543|NCT00556387|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
153549637|NCT03969901|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
153549638|NCT03969901|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153549639|NCT03969901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153549662|NCT03933306|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153549663|NCT03933306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153549664|NCT03933306|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153549665|NCT03933306|Analgesics|analgesics|mesh-ancestor
153549666|NCT03933306|Sensory System Agents|sensory system agents|mesh-ancestor
153549667|NCT03933306|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153549668|NCT03933306|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
153549669|NCT03933306|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153549670|NCT03933306|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153549671|NCT03933306|Adrenergic Agents|adrenergic agents|mesh-ancestor
153549672|NCT03933306|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153549673|NCT03933306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153571336|NCT04464577|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
153571337|NCT04464577|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
153571338|NCT04402658|Albuterol|albuterol|mesh-list
153549686|NCT03918278|Paclitaxel|paclitaxel|mesh-list
153549687|NCT03918278|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
153549688|NCT03918278|Carboplatin|carboplatin|mesh-list
153549689|NCT03918278|Gemcitabine|gemcitabine|mesh-list
153549690|NCT03918278|Pembrolizumab|pembrolizumab|mesh-list
153549713|NCT03914625|Dexamethasone acetate|dexamethasone acetate|mesh-list
153549714|NCT03914625|Prednisone|prednisone|mesh-list
153549715|NCT03914625|Prednisolone|prednisolone|mesh-list
153549716|NCT03914625|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
153549717|NCT03914625|Methylprednisolone|methylprednisolone|mesh-list
153549718|NCT03914625|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
153549719|NCT03914625|Prednisolone acetate|prednisolone acetate|mesh-list
153549720|NCT03914625|Hydrocortisone|hydrocortisone|mesh-list
153549721|NCT03914625|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
153814613|NCT00452634|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153549722|NCT03914625|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
153549723|NCT03914625|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
153549724|NCT03914625|Cortisone|cortisone|mesh-list
153549725|NCT03914625|Cyclophosphamide|cyclophosphamide|mesh-list
153549726|NCT03914625|Doxorubicin|doxorubicin|mesh-list
153549727|NCT03914625|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
153549728|NCT03914625|Methotrexate|methotrexate|mesh-list
153549729|NCT03914625|Vincristine|vincristine|mesh-list
153549730|NCT03914625|Asparaginase|asparaginase|mesh-list
153549731|NCT03914625|Mercaptopurine|mercaptopurine|mesh-list
153549732|NCT03914625|Pegaspargase|pegaspargase|mesh-list
153549733|NCT03914625|Thioguanine|thioguanine|mesh-list
153549734|NCT03914625|Blinatumomab|blinatumomab|mesh-list
153549735|NCT03914625|Asparaginase erwinia chrysanthemi, recombinant-rywn|asparaginase erwinia chrysanthemi, recombinant-rywn|mesh-list
153549736|NCT03914625|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
153549737|NCT03914625|Muromonab-CD3|muromonab-cd3|mesh-list
153549738|NCT03914625|Antibodies|antibodies|mesh-list
153549739|NCT03914625|Immunoglobulins|immunoglobulins|mesh-list
153549740|NCT03914625|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
153549741|NCT03914625|Antibodies, Bispecific|antibodies, bispecific|mesh-list
153549742|NCT03914625|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
153549745|NCT03914625|Calcium|calcium|mesh-list
153549746|NCT03914625|2-Aminopurine|2-aminopurine|mesh-list
153549747|NCT03914625|Levoleucovorin|levoleucovorin|mesh-list
153549748|NCT03914625|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153549749|NCT03914625|Immunologic Factors|immunologic factors|mesh-ancestor
153549750|NCT03914625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153549768|NCT03914625|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153549769|NCT03914625|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153549770|NCT03914625|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153549771|NCT03914625|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153549772|NCT03914625|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153549773|NCT03914625|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
153549774|NCT03914625|Abortifacient Agents|abortifacient agents|mesh-ancestor
153549775|NCT03914625|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153549776|NCT03914625|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153549778|NCT03914625|Dermatologic Agents|dermatologic agents|mesh-ancestor
153549779|NCT03914625|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153549780|NCT03914625|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153549781|NCT03914625|Antiviral Agents|antiviral agents|mesh-ancestor
153549782|NCT03914625|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153549783|NCT03914625|Antidotes|antidotes|mesh-ancestor
153549784|NCT03914625|Protective Agents|protective agents|mesh-ancestor
153782544|NCT00556387|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
153549785|NCT03914625|Vitamin B Complex|vitamin b complex|mesh-ancestor
153549786|NCT03914625|Vitamins|vitamins|mesh-ancestor
153549787|NCT03914625|Micronutrients|micronutrients|mesh-ancestor
153549789|NCT03914625|Tubulin Modulators|tubulin modulators|mesh-ancestor
153549790|NCT03914625|Antimitotic Agents|antimitotic agents|mesh-ancestor
153549791|NCT03914625|Mitosis Modulators|mitosis modulators|mesh-ancestor
153549792|NCT03914625|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
153549793|NCT03914625|Hematinics|hematinics|mesh-ancestor
153549794|NCT03913442|Colchicine|colchicine|mesh-list
153549795|NCT03913442|Gout Suppressants|gout suppressants|mesh-ancestor
153549796|NCT03913442|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153549806|NCT03902782|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153731929|NCT00161655|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153549807|NCT03902782|Antiemetics|antiemetics|mesh-ancestor
153549817|NCT03902782|Anesthetics, Local|anesthetics, local|mesh-ancestor
153549818|NCT03902782|Anesthetics|anesthetics|mesh-ancestor
153549819|NCT03902782|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153549820|NCT03902782|Sensory System Agents|sensory system agents|mesh-ancestor
153549821|NCT03902782|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153549822|NCT03902782|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153549823|NCT03902782|Adrenergic Agents|adrenergic agents|mesh-ancestor
153549824|NCT03902782|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153549825|NCT03902782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153549826|NCT03902782|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
153549827|NCT03902782|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153549828|NCT03902782|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153549829|NCT03902782|Respiratory System Agents|respiratory system agents|mesh-ancestor
153549830|NCT03902782|Mydriatics|mydriatics|mesh-ancestor
153549831|NCT03902782|Sympathomimetics|sympathomimetics|mesh-ancestor
153549832|NCT03902782|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
153549833|NCT03881345|Anticoagulants|anticoagulants|mesh-list
153549834|NCT03858049|Dydrogesterone|dydrogesterone|mesh-list
153549835|NCT03858049|Progestins|progestins|mesh-ancestor
153549837|NCT03858049|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153549838|NCT03858049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153549839|NCT03856216|Rituximab|rituximab|mesh-list
153549840|NCT03856216|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
153549841|NCT03856216|Inotuzumab Ozogamicin|inotuzumab ozogamicin|mesh-list
153549842|NCT03856216|Fludarabine|fludarabine|mesh-list
153549843|NCT03856216|Melphalan|melphalan|mesh-list
153549859|NCT03856216|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
153782545|NCT00556387|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153549860|NCT03856216|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153549861|NCT03856216|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153549862|NCT03856216|Alkylating Agents|alkylating agents|mesh-ancestor
153782546|NCT00556387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153549863|NCT03856216|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153549864|NCT03856216|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153549865|NCT03856216|Immunotoxins|immunotoxins|mesh-ancestor
153549866|NCT03856216|Immunoconjugates|immunoconjugates|mesh-ancestor
153549867|NCT03851627|Methyltestosterone|methyltestosterone|mesh-list
153549868|NCT03851627|Testosterone|testosterone|mesh-list
153549869|NCT03851627|Testosterone undecanoate|testosterone undecanoate|mesh-list
153549870|NCT03851627|Testosterone enanthate|testosterone enanthate|mesh-list
153549871|NCT03851627|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
153549892|NCT03836261|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153549893|NCT03836261|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153549894|NCT03836261|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153549895|NCT03836261|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153549896|NCT03836261|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153549897|NCT03836261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153549902|NCT03810911|Darbepoetin alfa|darbepoetin alfa|mesh-list
153549903|NCT03810911|Hematinics|hematinics|mesh-ancestor
153549904|NCT03796884|Linaclotide|linaclotide|mesh-list
153549905|NCT03796884|Guanylyl Cyclase C Agonists|guanylyl cyclase c agonists|mesh-ancestor
153549943|NCT03691376|Nitrogen Mustard Compounds|nitrogen mustard compounds|mesh-list
153549945|NCT03691376|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153549946|NCT03691376|Alkylating Agents|alkylating agents|mesh-ancestor
153549947|NCT03691376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153549948|NCT03691376|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153549949|NCT03691376|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153549950|NCT03691376|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153549951|NCT03691376|Immunologic Factors|immunologic factors|mesh-ancestor
153549952|NCT03691376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153549953|NCT03691376|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153549954|NCT03691376|Analgesics|analgesics|mesh-ancestor
153549955|NCT03691376|Sensory System Agents|sensory system agents|mesh-ancestor
153549956|NCT03691376|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153549957|NCT03691376|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153549958|NCT03691376|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153549959|NCT03691376|Antiviral Agents|antiviral agents|mesh-ancestor
153549960|NCT03691376|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153549961|NCT03690115|Ponatinib|ponatinib|mesh-list
153549962|NCT03690115|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153549963|NCT03690115|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153549964|NCT03690115|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153549965|NCT03690115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153549966|NCT03690115|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153549967|NCT03678883|Paclitaxel|paclitaxel|mesh-list
153549968|NCT03678883|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
153549994|NCT03677830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153549995|NCT03677830|Antipyretics|antipyretics|mesh-ancestor
153550007|NCT03660930|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153731930|NCT00161655|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153550009|NCT03660930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153550010|NCT03649880|Misonidazole|misonidazole|mesh-list
153550011|NCT03649880|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153550012|NCT03649880|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153550013|NCT03649880|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153550014|NCT03649880|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153550015|NCT03615105|Cyclophosphamide|cyclophosphamide|mesh-list
153550017|NCT03615105|Busulfan|busulfan|mesh-list
153550018|NCT03615105|Thiotepa|thiotepa|mesh-list
153550019|NCT03615105|Rituximab|rituximab|mesh-list
153550020|NCT03615105|Fludarabine|fludarabine|mesh-list
153550021|NCT03615105|Clofarabine|clofarabine|mesh-list
153550022|NCT03615105|Antilymphocyte Serum|antilymphocyte serum|mesh-list
153550023|NCT03615105|Thymoglobulin|thymoglobulin|mesh-list
153550024|NCT03615105|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153550025|NCT03615105|Immunologic Factors|immunologic factors|mesh-ancestor
153550076|NCT03565445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153550077|NCT03556904|Docetaxel|docetaxel|mesh-list
153550078|NCT03556904|Hormones|hormones|mesh-list
153550079|NCT03556904|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153550080|NCT03556904|Tubulin Modulators|tubulin modulators|mesh-ancestor
153550081|NCT03556904|Antimitotic Agents|antimitotic agents|mesh-ancestor
153550082|NCT03556904|Mitosis Modulators|mitosis modulators|mesh-ancestor
153550083|NCT03556904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153550084|NCT03556904|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153550085|NCT03556904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153550086|NCT03550391|Memantine|memantine|mesh-list
153550087|NCT03550391|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
153782547|NCT04552093|Floxuridine|floxuridine|mesh-list
153550088|NCT03550391|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
153550089|NCT03550391|Dopamine Agents|dopamine agents|mesh-ancestor
153782548|NCT04552093|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153550090|NCT03550391|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153550091|NCT03550391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153550092|NCT03550391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153550093|NCT03550391|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
153550124|NCT03528369|Sensory System Agents|sensory system agents|mesh-ancestor
153550125|NCT03528369|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153550126|NCT03528369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153550127|NCT03519295|Cisplatin|cisplatin|mesh-list
153550137|NCT03519295|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153550138|NCT03519295|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153550139|NCT03519295|Immunologic Factors|immunologic factors|mesh-ancestor
153550140|NCT03519295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153550141|NCT03519295|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153550142|NCT03519295|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153550143|NCT03504397|Leucovorin|leucovorin|mesh-list
153550144|NCT03504397|Folic Acid|folic acid|mesh-list
153550145|NCT03504397|Fluorouracil|fluorouracil|mesh-list
153550146|NCT03504397|Oxaliplatin|oxaliplatin|mesh-list
153550147|NCT03504397|Levoleucovorin|levoleucovorin|mesh-list
153550148|NCT03504397|Antimetabolites|antimetabolites|mesh-ancestor
153550149|NCT03504397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153550150|NCT03504397|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153550151|NCT03504397|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153550152|NCT03504397|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153550153|NCT03504397|Immunologic Factors|immunologic factors|mesh-ancestor
153550154|NCT03504397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153550155|NCT03504397|Antidotes|antidotes|mesh-ancestor
153550156|NCT03504397|Protective Agents|protective agents|mesh-ancestor
153550157|NCT03504397|Vitamin B Complex|vitamin b complex|mesh-ancestor
153550158|NCT03504397|Vitamins|vitamins|mesh-ancestor
153550159|NCT03504397|Micronutrients|micronutrients|mesh-ancestor
153550160|NCT03504397|Hematinics|hematinics|mesh-ancestor
153550161|NCT03495232|Cimetidine|cimetidine|mesh-list
153550162|NCT03495232|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
153550163|NCT03495232|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153782549|NCT04552093|Antimetabolites|antimetabolites|mesh-ancestor
153550164|NCT03495232|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
153782550|NCT04552093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153550165|NCT03495232|Histamine Antagonists|histamine antagonists|mesh-ancestor
153550171|NCT03495232|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153550172|NCT03495232|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153550173|NCT03478878|Vitamin A|vitamin a|mesh-list
153550174|NCT03478878|Retinol palmitate|retinol palmitate|mesh-list
153550175|NCT03478878|Vitamins|vitamins|mesh-ancestor
153550176|NCT03478878|Micronutrients|micronutrients|mesh-ancestor
153550177|NCT03478878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153550178|NCT03478878|Antioxidants|antioxidants|mesh-ancestor
153550179|NCT03478878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153550180|NCT03478878|Protective Agents|protective agents|mesh-ancestor
153550181|NCT03478878|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
153550182|NCT03478878|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153550183|NCT03472573|Dexamethasone|dexamethasone|mesh-list
153550184|NCT03472573|Palbociclib|palbociclib|mesh-list
153550185|NCT03472573|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153550186|NCT03472573|Antiemetics|antiemetics|mesh-ancestor
153550187|NCT03472573|Autonomic Agents|autonomic agents|mesh-ancestor
153550188|NCT03472573|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153550189|NCT03472573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153550190|NCT03472573|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153550191|NCT03472573|Glucocorticoids|glucocorticoids|mesh-ancestor
153550192|NCT03472573|Hormones|hormones|mesh-ancestor
153550193|NCT03472573|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153550236|NCT03424005|Trastuzumab deruxtecan|trastuzumab deruxtecan|mesh-list
153550237|NCT03424005|SGN-LIV1A|sgn-liv1a|mesh-list
153550238|NCT03424005|Inavolisib|inavolisib|mesh-list
153550239|NCT03424005|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153550240|NCT03424005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153550241|NCT03424005|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153550242|NCT03424005|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153550243|NCT03424005|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153550244|NCT03424005|Growth Substances|growth substances|mesh-ancestor
153550245|NCT03424005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153550246|NCT03424005|Growth Inhibitors|growth inhibitors|mesh-ancestor
153550247|NCT03424005|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153550248|NCT03424005|Antimetabolites|antimetabolites|mesh-ancestor
153550249|NCT03424005|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153550250|NCT03424005|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153550251|NCT03424005|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
153550252|NCT03424005|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
153550253|NCT03424005|Hormone Antagonists|hormone antagonists|mesh-ancestor
153455617|NCT05660213|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153814615|NCT00452634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153550254|NCT03424005|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153550255|NCT03424005|Immunoconjugates|immunoconjugates|mesh-ancestor
153550256|NCT03424005|Immunologic Factors|immunologic factors|mesh-ancestor
153550257|NCT03424005|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153550270|NCT03386578|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153550271|NCT03381261|Botulinum Toxins|botulinum toxins|mesh-list
153372370|NCT01366196|Pregabalin|pregabalin|mesh-list
153550272|NCT03381261|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
153550273|NCT03381261|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
153550274|NCT03381261|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
153550275|NCT03381261|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153550276|NCT03381261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153550277|NCT03381261|Cholinergic Agents|cholinergic agents|mesh-ancestor
153550278|NCT03381261|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153550279|NCT03381261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153550280|NCT03381261|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
153550281|NCT03381261|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153550282|NCT03376477|Lenalidomide|lenalidomide|mesh-list
153550284|NCT03376477|Vaccines|vaccines|mesh-list
153550285|NCT03376477|Sargramostim|sargramostim|mesh-list
153550286|NCT03376477|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
153550287|NCT03376477|Immunologic Factors|immunologic factors|mesh-ancestor
153550288|NCT03376477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153550289|NCT03376477|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153550290|NCT03376477|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153550291|NCT03376477|Growth Substances|growth substances|mesh-ancestor
153550292|NCT03376477|Growth Inhibitors|growth inhibitors|mesh-ancestor
153550293|NCT03376477|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153550294|NCT03366155|Oxaliplatin|oxaliplatin|mesh-list
153550295|NCT03366155|Irinotecan|irinotecan|mesh-list
153550296|NCT03366155|Cetuximab|cetuximab|mesh-list
153550297|NCT03366155|Panitumumab|panitumumab|mesh-list
153550298|NCT03366155|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153550299|NCT03366155|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
153550300|NCT03366155|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153550301|NCT03366155|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153550302|NCT03366155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153550303|NCT03366155|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153550304|NCT03337698|Linagliptin|linagliptin|mesh-list
153550305|NCT03337698|Bevacizumab|bevacizumab|mesh-list
153550306|NCT03337698|Atezolizumab|atezolizumab|mesh-list
153550307|NCT03337698|Carboplatin|carboplatin|mesh-list
153550308|NCT03337698|Gemcitabine|gemcitabine|mesh-list
153550309|NCT03337698|Docetaxel|docetaxel|mesh-list
153550310|NCT03337698|Pemetrexed|pemetrexed|mesh-list
153550311|NCT03337698|Ipatasertib|ipatasertib|mesh-list
153550312|NCT03337698|Evolocumab|evolocumab|mesh-list
153550313|NCT03337698|Sacituzumab govitecan|sacituzumab govitecan|mesh-list
153550314|NCT03337698|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153782551|NCT04552093|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153550345|NCT03332797|Palbociclib|palbociclib|mesh-list
153550352|NCT03304054|Amifampridine|amifampridine|mesh-list
153550353|NCT03304054|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
153550354|NCT03304054|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153550355|NCT03304054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153550356|NCT03304054|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
153550357|NCT03304054|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153550358|NCT03304054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153550359|NCT03280563|Tamoxifen|tamoxifen|mesh-list
153550360|NCT03280563|Bevacizumab|bevacizumab|mesh-list
153550361|NCT03280563|Atezolizumab|atezolizumab|mesh-list
153550362|NCT03280563|Fulvestrant|fulvestrant|mesh-list
153550363|NCT03280563|Exemestane|exemestane|mesh-list
153550364|NCT03280563|Entinostat|entinostat|mesh-list
153550365|NCT03280563|Ipatasertib|ipatasertib|mesh-list
153550366|NCT03280563|Antibodies|antibodies|mesh-list
153550367|NCT03280563|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153550368|NCT03280563|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153550369|NCT03280563|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153372391|NCT01777217|Solifenacin Succinate|solifenacin succinate|mesh-list
153550370|NCT03280563|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153550371|NCT03280563|Growth Substances|growth substances|mesh-ancestor
153814616|NCT00452634|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153550372|NCT03280563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153550373|NCT03280563|Growth Inhibitors|growth inhibitors|mesh-ancestor
153550384|NCT03280563|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
153550385|NCT03280563|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
153550386|NCT03280563|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153550387|NCT03280563|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153550388|NCT03280563|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
153550389|NCT03280563|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153550395|NCT03207958|Belimumab|belimumab|mesh-list
153550396|NCT03207958|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153550397|NCT03207958|Immunologic Factors|immunologic factors|mesh-ancestor
153550398|NCT03207958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153550399|NCT03198650|Obinutuzumab|obinutuzumab|mesh-list
153781607|NCT00231101|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153781608|NCT00231101|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153571339|NCT04402658|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153571340|NCT04402658|Autonomic Agents|autonomic agents|mesh-ancestor
153571341|NCT04402658|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153550400|NCT03198650|Acalabrutinib|acalabrutinib|mesh-list
153550401|NCT03198650|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153550402|NCT03198650|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153550403|NCT03198650|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153550404|NCT03198650|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153550405|NCT03198650|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153550406|NCT03198650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153550407|NCT03193307|Ethinyl estradiol, levonorgestrel drug combination|ethinyl estradiol, levonorgestrel drug combination|mesh-list
153550408|NCT03193307|Ethinyl Estradiol-Norgestrel Combination|ethinyl estradiol-norgestrel combination|mesh-list
153550409|NCT03193307|BI 409306|bi 409306|mesh-list
153550410|NCT03193307|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
153550411|NCT03193307|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153550412|NCT03193307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153550413|NCT03193307|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
153550414|NCT03193307|Contraceptive Agents|contraceptive agents|mesh-ancestor
153550415|NCT03193307|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153550416|NCT03193307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153550417|NCT03193307|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
153550418|NCT03193307|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
153550419|NCT03193307|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
153550420|NCT03193307|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
153550421|NCT03193307|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
153550422|NCT03193307|Contraceptives, Postcoital, Hormonal|contraceptives, postcoital, hormonal|mesh-ancestor
153550423|NCT03193307|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
153550424|NCT03193307|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
153550425|NCT03191149|Osimertinib|osimertinib|mesh-list
153550426|NCT03191149|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153550427|NCT03191149|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153550428|NCT03191149|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153550429|NCT03191149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153550430|NCT03191149|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153550431|NCT03151057|Idelalisib|idelalisib|mesh-list
153550446|NCT03111485|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153550447|NCT03111485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153550448|NCT03111485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153550449|NCT03111485|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153550450|NCT03111485|Immunologic Factors|immunologic factors|mesh-ancestor
153550451|NCT03111485|Dopamine Agonists|dopamine agonists|mesh-ancestor
153550452|NCT03092518|Sodium thiosulfate|sodium thiosulfate|mesh-list
153550453|NCT03092518|Mitomycins|mitomycins|mesh-list
153550454|NCT03092518|Mitomycin|mitomycin|mesh-list
153550455|NCT03092518|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153550456|NCT03092518|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153550457|NCT03092518|Alkylating Agents|alkylating agents|mesh-ancestor
153550458|NCT03092518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153550459|NCT03092518|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153550460|NCT03092518|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153550461|NCT03092518|Antidotes|antidotes|mesh-ancestor
153550462|NCT03092518|Protective Agents|protective agents|mesh-ancestor
153913861|NCT01222403|MF59 oil emulsion|mf59 oil emulsion|mesh-list
153442033|NCT00004759|Methylprednisolone|methylprednisolone|mesh-list
153550463|NCT03092518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153550464|NCT03092518|Antioxidants|antioxidants|mesh-ancestor
153550465|NCT03092518|Antitubercular Agents|antitubercular agents|mesh-ancestor
153550466|NCT03092518|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153550467|NCT03092518|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153550468|NCT03092518|Chelating Agents|chelating agents|mesh-ancestor
153550469|NCT03092518|Sequestering Agents|sequestering agents|mesh-ancestor
153550470|NCT03064490|Pembrolizumab|pembrolizumab|mesh-list
153550471|NCT03064490|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153550472|NCT03064490|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153550473|NCT03064490|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153550474|NCT03064490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153550475|NCT03048084|Levetiracetam|levetiracetam|mesh-list
153550476|NCT03048084|Valproic Acid|valproic acid|mesh-list
153550487|NCT03048084|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153550488|NCT03034096|Propofol|propofol|mesh-list
153550489|NCT03034096|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153550490|NCT03034096|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153550491|NCT03034096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153550492|NCT03034096|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153550493|NCT03034096|Anesthetics, General|anesthetics, general|mesh-ancestor
153550494|NCT03034096|Anesthetics|anesthetics|mesh-ancestor
153550495|NCT02960022|Prednisone|prednisone|mesh-list
153550496|NCT02960022|Abiraterone Acetate|abiraterone acetate|mesh-list
153550497|NCT02960022|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153550498|NCT02960022|Glucocorticoids|glucocorticoids|mesh-ancestor
153550499|NCT02960022|Hormones|hormones|mesh-ancestor
153550500|NCT02960022|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153550522|NCT02923739|Mitosis Modulators|mitosis modulators|mesh-ancestor
153550523|NCT02923739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153550524|NCT02923739|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153550525|NCT02923739|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153550526|NCT02923739|Growth Substances|growth substances|mesh-ancestor
153550527|NCT02923739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153550528|NCT02923739|Growth Inhibitors|growth inhibitors|mesh-ancestor
153550529|NCT02923739|Immunologic Factors|immunologic factors|mesh-ancestor
153550530|NCT02896335|Palbociclib|palbociclib|mesh-list
153782552|NCT04556110|Perindopril|perindopril|mesh-list
153550531|NCT02896335|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153550532|NCT02896335|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153550533|NCT02896335|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153782553|NCT04556110|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
153550534|NCT02896335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153550535|NCT02886585|Pembrolizumab|pembrolizumab|mesh-list
153550536|NCT02886585|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153550537|NCT02886585|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153550538|NCT02886585|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153550539|NCT02886585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153550540|NCT02879318|Paclitaxel|paclitaxel|mesh-list
153550541|NCT02879318|Gemcitabine|gemcitabine|mesh-list
153550544|NCT02879318|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153357546|NCT01274000|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153550545|NCT02879318|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153550546|NCT02879318|Tubulin Modulators|tubulin modulators|mesh-ancestor
153550547|NCT02879318|Antimitotic Agents|antimitotic agents|mesh-ancestor
153550548|NCT02879318|Mitosis Modulators|mitosis modulators|mesh-ancestor
153550549|NCT02879318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153550550|NCT02879318|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153550551|NCT02879318|Antimetabolites|antimetabolites|mesh-ancestor
153550585|NCT02747004|Antidiarrheals|antidiarrheals|mesh-list
153550586|NCT02747004|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
153550659|NCT02636322|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
153550661|NCT02636322|Immunoglobulins|immunoglobulins|mesh-list
153550662|NCT02636322|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
153550663|NCT02636322|Ibrutinib|ibrutinib|mesh-list
153550664|NCT02636322|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153550665|NCT02636322|Immunologic Factors|immunologic factors|mesh-ancestor
153550666|NCT02636322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153550667|NCT02636322|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153550668|NCT02636322|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153550669|NCT02636322|Alkylating Agents|alkylating agents|mesh-ancestor
153550670|NCT02636322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153550671|NCT02636322|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153550672|NCT02636322|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153550673|NCT02636322|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153550674|NCT02636322|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153550675|NCT02636322|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153550676|NCT02636322|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153550677|NCT02636322|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153550678|NCT02636322|Glucocorticoids|glucocorticoids|mesh-ancestor
153550679|NCT02636322|Hormones|hormones|mesh-ancestor
153550681|NCT02636322|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153550692|NCT02636322|Keratolytic Agents|keratolytic agents|mesh-ancestor
153550693|NCT02636322|Dermatologic Agents|dermatologic agents|mesh-ancestor
153550694|NCT02584647|Sirolimus|sirolimus|mesh-list
153550695|NCT02584647|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153550696|NCT02584647|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153550697|NCT02584647|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153550698|NCT02584647|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153550699|NCT02584647|Antifungal Agents|antifungal agents|mesh-ancestor
153550700|NCT02584647|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153550701|NCT02584647|Immunologic Factors|immunologic factors|mesh-ancestor
153550702|NCT02584647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153550703|NCT02574910|Abiraterone Acetate|abiraterone acetate|mesh-list
153464353|NCT00644280|Ranibizumab|ranibizumab|mesh-list
153464354|NCT00644280|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153464355|NCT00644280|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153464356|NCT00644280|Growth Substances|growth substances|mesh-ancestor
153464357|NCT00644280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153464358|NCT00644280|Growth Inhibitors|growth inhibitors|mesh-ancestor
153464359|NCT00644280|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153915682|NCT04215445|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
153915683|NCT04215445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153915684|NCT04215445|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153915685|NCT04215445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153464361|NCT04779762|Dermatologic Agents|dermatologic agents|mesh-ancestor
153915686|NCT00951457|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
153915687|NCT00951457|Alemtuzumab|alemtuzumab|mesh-list
153896134|NCT00629863|Fluorouracil|fluorouracil|mesh-list
153550704|NCT02574910|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153550705|NCT02574910|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153550735|NCT02465060|Sunitinib|sunitinib|mesh-list
153550736|NCT02465060|Dasatinib|dasatinib|mesh-list
153550737|NCT02465060|Palbociclib|palbociclib|mesh-list
153550738|NCT02465060|Trametinib|trametinib|mesh-list
153550739|NCT02465060|Osimertinib|osimertinib|mesh-list
153550740|NCT02465060|Afatinib|afatinib|mesh-list
153550741|NCT02465060|Dabrafenib|dabrafenib|mesh-list
153550742|NCT02465060|Crizotinib|crizotinib|mesh-list
153550743|NCT02465060|Maytansine|maytansine|mesh-list
153550744|NCT02465060|Ipatasertib|ipatasertib|mesh-list
153550745|NCT02465060|Trastuzumab biosimilar HLX02|trastuzumab biosimilar hlx02|mesh-list
153550746|NCT02465060|GSK2636771|gsk2636771|mesh-list
153550747|NCT02465060|Antibodies|antibodies|mesh-list
153550748|NCT02465060|Immunoglobulins|immunoglobulins|mesh-list
153550749|NCT02465060|Immunoglobulin G|immunoglobulin g|mesh-list
153550750|NCT02465060|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
153550751|NCT02465060|Adavosertib|adavosertib|mesh-list
153550752|NCT02465060|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-list
153550775|NCT02451943|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153550789|NCT02451111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153550791|NCT02436707|Cyclophosphamide|cyclophosphamide|mesh-list
153550792|NCT02436707|Rituximab|rituximab|mesh-list
153550793|NCT02436707|Gemcitabine|gemcitabine|mesh-list
153550794|NCT02436707|Etoposide|etoposide|mesh-list
153550795|NCT02436707|Ibrutinib|ibrutinib|mesh-list
153550796|NCT02436707|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153550797|NCT02436707|Immunologic Factors|immunologic factors|mesh-ancestor
153550798|NCT02436707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153550799|NCT02436707|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153550800|NCT02436707|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153550801|NCT02436707|Alkylating Agents|alkylating agents|mesh-ancestor
153550802|NCT02436707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153550803|NCT02436707|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153550804|NCT02436707|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153550805|NCT02436707|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153550806|NCT02436707|Antiemetics|antiemetics|mesh-ancestor
153550807|NCT02436707|Autonomic Agents|autonomic agents|mesh-ancestor
153550831|NCT02389374|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153550832|NCT02389374|Antimalarials|antimalarials|mesh-ancestor
153550833|NCT02389374|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153550834|NCT02386800|Panobinostat|panobinostat|mesh-list
153550835|NCT02386800|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153550836|NCT02386800|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
153550837|NCT02386800|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153550838|NCT02386800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153550839|NCT02359565|Pembrolizumab|pembrolizumab|mesh-list
153550840|NCT02359565|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153550841|NCT02359565|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153550842|NCT02359565|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153550855|NCT02230930|Emetics|emetics|mesh-ancestor
153550856|NCT02230930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153550857|NCT02230930|Autonomic Agents|autonomic agents|mesh-ancestor
153550858|NCT02230930|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153550859|NCT02230930|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153550860|NCT02230930|Dopamine Agonists|dopamine agonists|mesh-ancestor
153550888|NCT02107703|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
153550889|NCT02107703|Hormone Antagonists|hormone antagonists|mesh-ancestor
153550890|NCT02107703|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153550891|NCT02107703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153550892|NCT02096588|Cyclophosphamide|cyclophosphamide|mesh-list
153550893|NCT02096588|Doxorubicin|doxorubicin|mesh-list
153550894|NCT02096588|Simvastatin|simvastatin|mesh-list
153550895|NCT02096588|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153550896|NCT02096588|Immunologic Factors|immunologic factors|mesh-ancestor
153550897|NCT02096588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153550898|NCT02096588|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153550899|NCT02096588|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153550900|NCT02096588|Alkylating Agents|alkylating agents|mesh-ancestor
153550901|NCT02096588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153550902|NCT02096588|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153550903|NCT02096588|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153550904|NCT02096588|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153814620|NCT00452634|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
153550905|NCT02096588|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153550906|NCT02096588|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153550985|NCT01861314|Antimetabolites|antimetabolites|mesh-ancestor
153550986|NCT01798004|Cyclophosphamide|cyclophosphamide|mesh-list
153550987|NCT01798004|Melphalan|melphalan|mesh-list
153550988|NCT01798004|Busulfan|busulfan|mesh-list
153550989|NCT01798004|Mechlorethamine|mechlorethamine|mesh-list
153550990|NCT01798004|Nitrogen Mustard Compounds|nitrogen mustard compounds|mesh-list
153550991|NCT01798004|Cisplatin|cisplatin|mesh-list
153550992|NCT01798004|Doxorubicin|doxorubicin|mesh-list
153550993|NCT01798004|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
153550994|NCT01798004|Etoposide|etoposide|mesh-list
153550995|NCT01798004|Vincristine|vincristine|mesh-list
153550996|NCT01798004|Etoposide phosphate|etoposide phosphate|mesh-list
153550997|NCT01798004|Topotecan|topotecan|mesh-list
153550998|NCT01798004|Podophyllotoxin|podophyllotoxin|mesh-list
153550999|NCT01798004|Lenograstim|lenograstim|mesh-list
153551000|NCT01798004|Mesna|mesna|mesh-list
153551001|NCT01798004|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153551024|NCT01660971|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
153551026|NCT01660971|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153551027|NCT01660971|Antimetabolites|antimetabolites|mesh-ancestor
153551028|NCT01660971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153551029|NCT01660971|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153551030|NCT01660971|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153551031|NCT01660971|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153551032|NCT01660971|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153551033|NCT01480154|Hydroxychloroquine|hydroxychloroquine|mesh-list
153551034|NCT01480154|Antimalarials|antimalarials|mesh-ancestor
153551035|NCT01480154|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153551036|NCT01480154|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153551037|NCT01480154|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153551038|NCT01480154|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153551039|NCT01480154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153551040|NCT01480154|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153551041|NCT01375829|Sirolimus|sirolimus|mesh-list
153551042|NCT01375829|Temsirolimus|temsirolimus|mesh-list
153551043|NCT01375829|Epothilone B|epothilone b|mesh-list
153551050|NCT01375829|Antifungal Agents|antifungal agents|mesh-ancestor
153551051|NCT01375829|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153551052|NCT01375829|Immunologic Factors|immunologic factors|mesh-ancestor
153551053|NCT01375829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153551075|NCT01352962|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153551076|NCT01352962|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153551077|NCT01352962|Antimetabolites|antimetabolites|mesh-ancestor
153551078|NCT01352962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153551079|NCT01352962|Immunologic Factors|immunologic factors|mesh-ancestor
153551080|NCT01352962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153551081|NCT01352962|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153551082|NCT01352962|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153551083|NCT01352962|Growth Substances|growth substances|mesh-ancestor
153551084|NCT01352962|Growth Inhibitors|growth inhibitors|mesh-ancestor
153551085|NCT01351909|Cyclophosphamide|cyclophosphamide|mesh-list
153814623|NCT03277599|Narcotics|narcotics|mesh-ancestor
153896153|NCT00976495|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
153551087|NCT01351909|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153551088|NCT01351909|Immunologic Factors|immunologic factors|mesh-ancestor
153551089|NCT01351909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153551090|NCT01351909|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153551091|NCT01351909|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153551092|NCT01351909|Alkylating Agents|alkylating agents|mesh-ancestor
153551093|NCT01351909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153551094|NCT01351909|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153551095|NCT01351909|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153551096|NCT01351909|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
153551097|NCT01351909|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153551098|NCT01343706|BI 409306|bi 409306|mesh-list
153551099|NCT01343706|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
153551100|NCT01343706|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153551101|NCT01343706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153551102|NCT01013649|Gemcitabine|gemcitabine|mesh-list
153551103|NCT01013649|Capecitabine|capecitabine|mesh-list
153551104|NCT01013649|Fluorouracil|fluorouracil|mesh-list
153551107|NCT01013649|Antimetabolites|antimetabolites|mesh-ancestor
153551133|NCT00588991|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
153551134|NCT00409435|Pyridostigmine Bromide|pyridostigmine bromide|mesh-list
153551135|NCT00409435|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
153551137|NCT00409435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153551138|NCT00409435|Cholinergic Agents|cholinergic agents|mesh-ancestor
153551139|NCT00409435|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153551140|NCT00409435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153551141|NCT00336063|Azacitidine|azacitidine|mesh-list
153551142|NCT00336063|Vorinostat|vorinostat|mesh-list
153551144|NCT00336063|Antimetabolites|antimetabolites|mesh-ancestor
153551145|NCT00336063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153551146|NCT00336063|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153551147|NCT00336063|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153551148|NCT00336063|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
153551149|NCT00107289|3-Iodobenzylguanidine|3-iodobenzylguanidine|mesh-list
153551150|NCT00107289|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153551151|NCT00107289|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153551152|NCT00107289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153551153|NCT00107289|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
153551182|NCT00001230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153810987|NCT00353028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153915688|NCT00951457|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153464417|NCT01895400|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
153551183|NCT01570478|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
153551184|NCT01570478|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153551185|NCT01570478|Autonomic Agents|autonomic agents|mesh-ancestor
153551186|NCT01570478|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153551187|NCT01570478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153551188|NCT01570478|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153551189|NCT01570478|Respiratory System Agents|respiratory system agents|mesh-ancestor
153551190|NCT01570478|Glucocorticoids|glucocorticoids|mesh-ancestor
153551191|NCT01570478|Hormones|hormones|mesh-ancestor
153551206|NCT01570569|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153551207|NCT01570569|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153551208|NCT01570569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153551209|NCT01570569|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153551210|NCT01570569|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153551211|NCT01570569|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153551212|NCT01570569|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153551213|NCT01570569|Anesthetics, General|anesthetics, general|mesh-ancestor
153551215|NCT01570569|GABA Modulators|gaba modulators|mesh-ancestor
153551216|NCT01570569|GABA Agents|gaba agents|mesh-ancestor
153551217|NCT01570569|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153551218|NCT01570569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153551219|NCT01570569|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153551251|NCT01570582|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153551253|NCT01570608|Ranibizumab|ranibizumab|mesh-list
153551254|NCT01570608|Verteporfin|verteporfin|mesh-list
153551255|NCT01570608|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153551256|NCT01570608|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153551257|NCT01570608|Growth Substances|growth substances|mesh-ancestor
153551258|NCT01570608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153551259|NCT01570608|Growth Inhibitors|growth inhibitors|mesh-ancestor
153551260|NCT01570608|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153551261|NCT01570608|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
153551288|NCT01570894|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153551289|NCT01570894|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153551290|NCT01570894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153551291|NCT01570907|Quetiapine Fumarate|quetiapine fumarate|mesh-list
153551292|NCT01570907|Antidepressive Agents|antidepressive agents|mesh-ancestor
153551293|NCT01570907|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153551294|NCT01570907|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153551295|NCT01570907|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153551296|NCT01570907|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153551297|NCT01570907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153551298|NCT01570959|Quetiapine Fumarate|quetiapine fumarate|mesh-list
153551299|NCT01570959|Antidepressive Agents|antidepressive agents|mesh-ancestor
153551300|NCT01570959|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153551303|NCT01570959|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153551304|NCT01570959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153551306|NCT01570985|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
153551307|NCT01570985|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
153551332|NCT01571024|Micronutrients|micronutrients|mesh-ancestor
153551333|NCT01571050|Calcium Carbonate|calcium carbonate|mesh-list
153551335|NCT01571050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153551336|NCT01571050|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153551337|NCT01571063|Vitamin D|vitamin d|mesh-list
153551338|NCT01571063|Cholecalciferol|cholecalciferol|mesh-list
153551339|NCT01571063|Vitamins|vitamins|mesh-ancestor
153551340|NCT01571063|Micronutrients|micronutrients|mesh-ancestor
153551341|NCT01571063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153551342|NCT01571063|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153551343|NCT01571063|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153551344|NCT01571167|Varenicline|varenicline|mesh-list
153551345|NCT01571167|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
153551346|NCT01571167|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
153551347|NCT01571167|Cholinergic Agents|cholinergic agents|mesh-ancestor
153551348|NCT01571167|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153551349|NCT01571167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153551350|NCT01571167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153551351|NCT01571206|Infliximab|infliximab|mesh-list
153551352|NCT01571206|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
153551353|NCT01571206|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153551354|NCT01571206|Dermatologic Agents|dermatologic agents|mesh-ancestor
153551355|NCT01571206|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153551356|NCT01571206|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153551357|NCT01571219|Infliximab|infliximab|mesh-list
153551358|NCT01571219|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
153551385|NCT01571414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153551386|NCT01571414|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153551387|NCT01571414|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153551388|NCT01571414|Antiviral Agents|antiviral agents|mesh-ancestor
153551389|NCT01571414|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153551390|NCT01571414|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
153551391|NCT01571414|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153551392|NCT01571414|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153551393|NCT01571414|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153551394|NCT01571414|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
153551395|NCT01571414|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
153551396|NCT01571414|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
153551397|NCT01571414|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
153551398|NCT01571414|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
153551399|NCT01571414|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
153551400|NCT01571414|Antitubercular Agents|antitubercular agents|mesh-ancestor
153551401|NCT01571414|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153551402|NCT01571414|Leprostatic Agents|leprostatic agents|mesh-ancestor
153551403|NCT01571414|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
153551404|NCT01571414|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
153551405|NCT01571414|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
153551406|NCT01571570|Simeprevir|simeprevir|mesh-list
153551407|NCT01571570|Antiviral Agents|antiviral agents|mesh-ancestor
153551408|NCT01571570|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153551426|NCT01571609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153551427|NCT01571648|Azacitidine|azacitidine|mesh-list
153551428|NCT01571648|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153551429|NCT01571648|Antimetabolites|antimetabolites|mesh-ancestor
153551430|NCT01571648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153551431|NCT01571648|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153551432|NCT01571648|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153782569|NCT00234299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153782570|NCT00234299|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153782571|NCT00234299|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153551473|NCT01571856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153551474|NCT01571856|Dermatologic Agents|dermatologic agents|mesh-ancestor
153551475|NCT01571882|Policosanol|policosanol|mesh-list
153551497|NCT01572012|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153551498|NCT01572012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153551499|NCT01572012|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153551501|NCT01572012|Dermatologic Agents|dermatologic agents|mesh-ancestor
153551502|NCT01572012|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
153551503|NCT01572012|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153551504|NCT01572012|Serotonin Agents|serotonin agents|mesh-ancestor
153551505|NCT01572012|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153551506|NCT01572012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153551507|NCT01572025|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
153551508|NCT01572025|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153551509|NCT01572025|Immunologic Factors|immunologic factors|mesh-ancestor
153551510|NCT01572025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153551511|NCT01572090|Hypoglycemic Agents|hypoglycemic agents|mesh-list
153551512|NCT01572090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153551513|NCT01571908|Rocuronium|rocuronium|mesh-list
153551514|NCT01571908|Succinylcholine|succinylcholine|mesh-list
153551515|NCT01571908|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
153551516|NCT01571908|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
153551517|NCT01571908|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
153551518|NCT01571908|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153551519|NCT01571908|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153551520|NCT01571908|Neuromuscular Depolarizing Agents|neuromuscular depolarizing agents|mesh-ancestor
153551521|NCT01572116|Lidocaine|lidocaine|mesh-list
153551522|NCT01572116|Epinephrine|epinephrine|mesh-list
153551523|NCT01572116|Racepinephrine|racepinephrine|mesh-list
153551567|NCT01572181|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153551568|NCT01572181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153551569|NCT01572181|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153551570|NCT01572181|Immunologic Factors|immunologic factors|mesh-ancestor
153551571|NCT01572181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153551572|NCT01572181|Alkylating Agents|alkylating agents|mesh-ancestor
153551573|NCT01572181|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153551574|NCT01572181|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153551575|NCT01572259|Hormones|hormones|mesh-list
153551576|NCT01572259|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153551577|NCT01572259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153551578|NCT01572285|Dexamethasone|dexamethasone|mesh-list
153551579|NCT01572285|Dexamethasone acetate|dexamethasone acetate|mesh-list
153551580|NCT01572285|BB 1101|bb 1101|mesh-list
153551606|NCT01572324|Antidotes|antidotes|mesh-ancestor
153551607|NCT01572324|Protective Agents|protective agents|mesh-ancestor
153551608|NCT01572324|Vitamin B Complex|vitamin b complex|mesh-ancestor
153551609|NCT01572324|Vitamins|vitamins|mesh-ancestor
153551610|NCT01572324|Micronutrients|micronutrients|mesh-ancestor
153551611|NCT01572350|Triamcinolone|triamcinolone|mesh-list
153551612|NCT01572350|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
153551613|NCT01572350|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
153551614|NCT01572350|Bevacizumab|bevacizumab|mesh-list
153551615|NCT01572350|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
153551616|NCT01572350|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153551617|NCT01572350|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153551618|NCT01572350|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153551619|NCT01572350|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153551621|NCT01572350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153551651|NCT01572454|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153551652|NCT01572454|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153551653|NCT01572454|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153551654|NCT01572454|Narcotics|narcotics|mesh-ancestor
153551655|NCT01572545|Zoledronic Acid|zoledronic acid|mesh-list
153551657|NCT01572545|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153551658|NCT01572545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153551659|NCT01572558|Ciprofloxacin|ciprofloxacin|mesh-list
153551660|NCT01572558|Meropenem|meropenem|mesh-list
153551661|NCT01572558|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153464418|NCT01895400|Protective Agents|protective agents|mesh-ancestor
153464419|NCT01895400|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
153464420|NCT01895400|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
153915696|NCT02691871|Tubulin Modulators|tubulin modulators|mesh-ancestor
153915697|NCT02691871|Antimitotic Agents|antimitotic agents|mesh-ancestor
153915698|NCT02691871|Mitosis Modulators|mitosis modulators|mesh-ancestor
153810988|NCT00353028|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153551662|NCT01572558|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153551734|NCT01572857|Antibodies|antibodies|mesh-list
153551735|NCT01572857|Immunologic Factors|immunologic factors|mesh-ancestor
153551736|NCT01572857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153551737|NCT01572961|Aspirin|aspirin|mesh-list
153551738|NCT01572961|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153551739|NCT01572961|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153551762|NCT01573143|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153551763|NCT01573143|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
153551764|NCT01573143|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153551766|NCT01573286|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
153551767|NCT01573286|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153551768|NCT01573286|Hormones|hormones|mesh-ancestor
153551769|NCT01573286|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153551770|NCT01573286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153551771|NCT01573286|Incretins|incretins|mesh-ancestor
153551772|NCT01573338|Carboplatin|carboplatin|mesh-list
153551773|NCT01573338|Etoposide|etoposide|mesh-list
153551774|NCT01573338|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153551775|NCT01573338|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153551776|NCT01573338|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153551777|NCT01573338|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153551778|NCT01573338|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153551779|NCT01573338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153551780|NCT01573377|Metformin|metformin|mesh-list
153551781|NCT01573377|Cyproterone Acetate|cyproterone acetate|mesh-list
153551782|NCT01573377|Ethinyl Estradiol|ethinyl estradiol|mesh-list
153551783|NCT01573377|Cyproterone|cyproterone|mesh-list
153551784|NCT01573377|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153551824|NCT01573663|Dipropizine|dipropizine|mesh-list
153782581|NCT04556071|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153551859|NCT01573806|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
153551861|NCT01573806|Hormones|hormones|mesh-ancestor
153551862|NCT01573806|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153551863|NCT01573975|Clarithromycin|clarithromycin|mesh-list
153551864|NCT01573975|Rabeprazole|rabeprazole|mesh-list
153551866|NCT01573975|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153551867|NCT01573975|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
153551868|NCT01573975|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153551869|NCT01573975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153551870|NCT01573975|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153551871|NCT01573975|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153551872|NCT01573975|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
153551873|NCT01573975|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
153551874|NCT01573975|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153551875|NCT01574014|Hydrocortisone|hydrocortisone|mesh-list
153551876|NCT01574014|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153551877|NCT01574027|Vitamin D|vitamin d|mesh-list
153551878|NCT01574027|Cholecalciferol|cholecalciferol|mesh-list
153551907|NCT01574313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153551908|NCT01574313|Protective Agents|protective agents|mesh-ancestor
153551909|NCT01574313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153551910|NCT01574313|Vitamins|vitamins|mesh-ancestor
153551911|NCT01574313|Micronutrients|micronutrients|mesh-ancestor
153915699|NCT02691871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153437413|NCT05495035|Hormones|hormones|mesh-ancestor
153551912|NCT01574313|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153551913|NCT01574313|Antimetabolites|antimetabolites|mesh-ancestor
153551914|NCT01574313|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153551915|NCT01574313|Vasodilator Agents|vasodilator agents|mesh-ancestor
153551951|NCT01575236|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
153551952|NCT01575236|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153551953|NCT01575236|Disinfectants|disinfectants|mesh-ancestor
153551954|NCT01575301|Liraglutide|liraglutide|mesh-list
153551955|NCT01575301|Exenatide|exenatide|mesh-list
153551956|NCT01575301|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
153551957|NCT01575301|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153551958|NCT01575301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153551959|NCT01575301|Incretins|incretins|mesh-ancestor
153551960|NCT01575301|Hormones|hormones|mesh-ancestor
153551961|NCT01575301|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153551962|NCT01575301|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
153551963|NCT01575405|Tenofovir|tenofovir|mesh-list
153551964|NCT01575405|Glycerol|glycerol|mesh-list
153551965|NCT01575405|Antiviral Agents|antiviral agents|mesh-ancestor
153551966|NCT01575405|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153551967|NCT01575405|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153551968|NCT01575405|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153551969|NCT01575405|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153551970|NCT01575405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153551971|NCT01575405|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153551972|NCT01575405|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153551973|NCT01575405|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
153551974|NCT01575405|Protective Agents|protective agents|mesh-ancestor
153551975|NCT01575405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153551976|NCT01575418|Tenofovir|tenofovir|mesh-list
153551977|NCT01575418|Glycerol|glycerol|mesh-list
153551978|NCT01575418|Antiviral Agents|antiviral agents|mesh-ancestor
153552019|NCT01575639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153552020|NCT01575639|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153552021|NCT01575639|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153552022|NCT01575652|Lisinopril|lisinopril|mesh-list
153552023|NCT01575652|Perindopril|perindopril|mesh-list
153552024|NCT01575652|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
153372841|NCT01267292|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
153552025|NCT01575652|Enzyme Inhibitors|enzyme inhibitors|mesh-list
153552026|NCT01575652|Protease Inhibitors|protease inhibitors|mesh-ancestor
153552027|NCT01575652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153552028|NCT01575652|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153552029|NCT01575652|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
153552030|NCT01575652|Protective Agents|protective agents|mesh-ancestor
153552031|NCT01575652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153552032|NCT01575678|Melatonin|melatonin|mesh-list
153552033|NCT01575678|Antioxidants|antioxidants|mesh-ancestor
153552058|NCT01575795|Purinergic Agents|purinergic agents|mesh-ancestor
153552059|NCT01575795|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153552060|NCT01575795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153552061|NCT01575795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153552062|NCT01576029|Docetaxel|docetaxel|mesh-list
153552063|NCT01576029|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153552064|NCT01576029|Tubulin Modulators|tubulin modulators|mesh-ancestor
153552065|NCT01576029|Antimitotic Agents|antimitotic agents|mesh-ancestor
153552066|NCT01576029|Mitosis Modulators|mitosis modulators|mesh-ancestor
153552067|NCT01576029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153552068|NCT01576094|Simendan|simendan|mesh-list
153552069|NCT01576094|Milrinone|milrinone|mesh-list
153552070|NCT01576094|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
153552118|NCT01576627|Dermatologic Agents|dermatologic agents|mesh-ancestor
153552119|NCT01576627|Sunscreening Agents|sunscreening agents|mesh-ancestor
153552120|NCT01576627|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
153552121|NCT01576627|Protective Agents|protective agents|mesh-ancestor
153552122|NCT01576640|Bupropion|bupropion|mesh-list
153552123|NCT01576640|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
153552124|NCT01576640|Antidepressive Agents|antidepressive agents|mesh-ancestor
153552125|NCT01576640|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153552126|NCT01576640|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
153552127|NCT01576640|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153552157|NCT01576731|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153552158|NCT01576731|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153552159|NCT01576731|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153782583|NCT04556071|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153552160|NCT01576731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153552162|NCT01576731|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153552163|NCT01576731|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
153552164|NCT01576731|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
153552165|NCT01576731|Protease Inhibitors|protease inhibitors|mesh-ancestor
153552166|NCT01576731|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
153552167|NCT01576731|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153552168|NCT01576731|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
153552169|NCT01576731|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
153552170|NCT01576770|Lidocaine|lidocaine|mesh-list
153552171|NCT01576770|Tetracaine|tetracaine|mesh-list
153552183|NCT01576770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153552185|NCT01576848|Chelating Agents|chelating agents|mesh-ancestor
153552186|NCT01576848|Sequestering Agents|sequestering agents|mesh-ancestor
153552187|NCT01576848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153552189|NCT01577017|Aromatase Inhibitors|aromatase inhibitors|mesh-list
153552197|NCT01577017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153552199|NCT01577043|Antidiarrheals|antidiarrheals|mesh-ancestor
153552200|NCT01577043|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153552201|NCT01577043|Protease Inhibitors|protease inhibitors|mesh-ancestor
153552202|NCT01577043|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153552203|NCT01577043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153552204|NCT01577121|Indomethacin|indomethacin|mesh-list
153552205|NCT01577121|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153552206|NCT01577121|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153552207|NCT01577121|Analgesics|analgesics|mesh-ancestor
153552208|NCT01577121|Sensory System Agents|sensory system agents|mesh-ancestor
153552209|NCT01577121|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153552210|NCT01577121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153552211|NCT01577121|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153552212|NCT01577121|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153552213|NCT01577121|Gout Suppressants|gout suppressants|mesh-ancestor
153552214|NCT01577121|Tocolytic Agents|tocolytic agents|mesh-ancestor
153552215|NCT01577121|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153552216|NCT01577121|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153552217|NCT01577121|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153552218|NCT01577121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153552219|NCT01577095|Rosiglitazone|rosiglitazone|mesh-list
153552220|NCT01577095|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153552221|NCT01577095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153552222|NCT01577199|Clomiphene|clomiphene|mesh-list
153552223|NCT01577199|Enclomiphene|enclomiphene|mesh-list
153552224|NCT01577199|Zuclomiphene|zuclomiphene|mesh-list
153552225|NCT01577199|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
153552226|NCT01577199|Hormone Antagonists|hormone antagonists|mesh-ancestor
153552227|NCT01577199|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153552228|NCT01577199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153552229|NCT01577199|Fertility Agents, Female|fertility agents, female|mesh-ancestor
153552267|NCT01577550|Immunologic Factors|immunologic factors|mesh-ancestor
153552268|NCT01577550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153552269|NCT01577589|Ceftaroline|ceftaroline|mesh-list
153552270|NCT01577589|Cephalosporins|cephalosporins|mesh-list
153552271|NCT01577589|Beta Lactam Antibiotics|beta lactam antibiotics|mesh-ancestor
153552272|NCT01577589|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153552273|NCT01577589|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153552274|NCT01577693|Dutasteride|dutasteride|mesh-list
153552275|NCT01577693|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
153552276|NCT01577693|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153552277|NCT01577693|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153552278|NCT01577693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153552300|NCT01577862|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153552301|NCT01577862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153552302|NCT01577862|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
153915700|NCT02691871|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153814631|NCT00452829|Inositol|inositol|mesh-list
153814632|NCT00452829|Hematinics|hematinics|mesh-ancestor
153552303|NCT01577862|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
153552304|NCT01577862|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
153552305|NCT01577862|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
153782584|NCT04556071|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153552306|NCT01577862|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
153552307|NCT01577862|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
153552308|NCT01577914|Carvedilol|carvedilol|mesh-list
153552309|NCT01577914|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
153552310|NCT01577914|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
153552311|NCT01577914|Adrenergic Agents|adrenergic agents|mesh-ancestor
153552313|NCT01577914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153552314|NCT01577914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153552315|NCT01577914|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153552316|NCT01577914|Antioxidants|antioxidants|mesh-ancestor
153552317|NCT01577914|Protective Agents|protective agents|mesh-ancestor
153552323|NCT01577914|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
153552324|NCT01577940|Ropivacaine|ropivacaine|mesh-list
153552325|NCT01577940|Anesthetics, Local|anesthetics, local|mesh-ancestor
153552326|NCT01577940|Anesthetics|anesthetics|mesh-ancestor
153552327|NCT01577940|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153552361|NCT01578161|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
153552362|NCT01578161|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153552363|NCT01578161|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153552364|NCT01578161|Adrenergic Agents|adrenergic agents|mesh-ancestor
153552365|NCT01578161|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153552366|NCT01578161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153552367|NCT01578174|Dexmedetomidine|dexmedetomidine|mesh-list
153552368|NCT01578174|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153552369|NCT01578174|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153552370|NCT01578174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153552371|NCT01578174|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153552372|NCT01578174|Analgesics|analgesics|mesh-ancestor
153552373|NCT01578174|Sensory System Agents|sensory system agents|mesh-ancestor
153552374|NCT01578174|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153552375|NCT01578174|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
153552376|NCT01578174|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153552377|NCT01578174|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153552400|NCT01578252|Antipruritics|antipruritics|mesh-ancestor
153552401|NCT01578252|Dermatologic Agents|dermatologic agents|mesh-ancestor
153552402|NCT01578252|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
153552403|NCT01578252|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153552404|NCT01578252|Serotonin Agents|serotonin agents|mesh-ancestor
153552405|NCT01578252|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153552406|NCT01578252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153552421|NCT01578304|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
153552422|NCT01578304|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
153552423|NCT01578304|Cholinergic Agents|cholinergic agents|mesh-ancestor
153552424|NCT01578304|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153552425|NCT01578304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153552426|NCT01578304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153552427|NCT01578304|Urological Agents|urological agents|mesh-ancestor
153552428|NCT01578343|Dexamethasone|dexamethasone|mesh-list
153552462|NCT01578434|Vitamins|vitamins|mesh-list
153915701|NCT02691871|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153915702|NCT02700217|Remifentanil|remifentanil|mesh-list
153915703|NCT02700217|Heroin|heroin|mesh-list
153552463|NCT01578434|Calcium Carbonate|calcium carbonate|mesh-list
153552464|NCT01578434|Calcium|calcium|mesh-list
153552465|NCT01578434|Micronutrients|micronutrients|mesh-ancestor
153552466|NCT01578434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153552467|NCT01578434|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153552468|NCT01578434|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153552469|NCT01578434|Antacids|antacids|mesh-ancestor
153552493|NCT01578473|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
153552494|NCT01578473|Micronutrients|micronutrients|mesh-ancestor
153552495|NCT01578473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153552496|NCT01578473|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153552498|NCT01578473|Hormones|hormones|mesh-ancestor
153552499|NCT01578473|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153552500|NCT01578473|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153552501|NCT01578473|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153552502|NCT01578473|Anabolic Agents|anabolic agents|mesh-ancestor
153552503|NCT01578473|Antioxidants|antioxidants|mesh-ancestor
153552504|NCT01578473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153552505|NCT01578473|Protective Agents|protective agents|mesh-ancestor
153552506|NCT01578473|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153552537|NCT01578629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153552538|NCT01578629|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153552539|NCT01578629|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153552540|NCT01578629|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153552543|NCT01578629|Protective Agents|protective agents|mesh-ancestor
153552545|NCT01578668|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
153552546|NCT01578668|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153552547|NCT01578668|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153552548|NCT01578668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153552549|NCT01578668|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153552550|NCT01578668|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153552551|NCT01578668|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153552552|NCT01578668|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153552553|NCT01578720|Aflibercept|aflibercept|mesh-list
153552554|NCT01578720|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153552555|NCT01578720|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153552556|NCT01578720|Growth Substances|growth substances|mesh-ancestor
153915704|NCT02700217|Bupivacaine|bupivacaine|mesh-list
153915705|NCT02700217|Propofol|propofol|mesh-list
153915706|NCT02700217|Anesthetics, Local|anesthetics, local|mesh-ancestor
153915707|NCT02700217|Anesthetics|anesthetics|mesh-ancestor
153820728|NCT03272802|Anticonvulsants|anticonvulsants|mesh-ancestor
153820729|NCT03272802|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
153820730|NCT03272802|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
153820731|NCT03272802|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153820732|NCT01050062|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
153820733|NCT01050062|Telmisartan|telmisartan|mesh-list
153820734|NCT01050062|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153820735|NCT01050062|Diuretics|diuretics|mesh-ancestor
153820736|NCT01050062|Natriuretic Agents|natriuretic agents|mesh-ancestor
153552557|NCT01578720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153552558|NCT01578720|Growth Inhibitors|growth inhibitors|mesh-ancestor
153552559|NCT01578720|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153552560|NCT01578824|Methacholine Chloride|methacholine chloride|mesh-list
153552561|NCT01578824|Miotics|miotics|mesh-ancestor
153552562|NCT01578824|Autonomic Agents|autonomic agents|mesh-ancestor
153552563|NCT01578824|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153552564|NCT01578824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153552565|NCT01578824|Parasympathomimetics|parasympathomimetics|mesh-ancestor
153552566|NCT01578824|Bronchoconstrictor Agents|bronchoconstrictor agents|mesh-ancestor
153552567|NCT01578824|Respiratory System Agents|respiratory system agents|mesh-ancestor
153552568|NCT01578824|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
153552569|NCT01578824|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
153552570|NCT01578824|Cholinergic Agents|cholinergic agents|mesh-ancestor
153552571|NCT01578824|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153552572|NCT01578824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153552573|NCT01578889|Vaccines|vaccines|mesh-list
153387593|NCT01645176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153552601|NCT01579058|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
153552603|NCT01579058|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
153552604|NCT01579058|Adrenergic Agents|adrenergic agents|mesh-ancestor
153552605|NCT01579058|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153552606|NCT01579058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153552608|NCT01579110|Prednisone|prednisone|mesh-list
153552609|NCT01579110|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153552610|NCT01579110|Glucocorticoids|glucocorticoids|mesh-ancestor
153552611|NCT01579110|Hormones|hormones|mesh-ancestor
153552612|NCT01579110|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153552613|NCT01579110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153552614|NCT01579110|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153552615|NCT01579110|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153814633|NCT00452829|Vitamins|vitamins|mesh-ancestor
153814634|NCT00452829|Micronutrients|micronutrients|mesh-ancestor
153820737|NCT01050062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153820738|NCT01050062|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
153820739|NCT01050062|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153820740|NCT01050062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153820741|NCT01050062|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
153820742|NCT01050062|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
153820743|NCT00464880|Aliskiren|aliskiren|mesh-list
153820744|NCT00464880|Renin Inhibitors|renin inhibitors|mesh-ancestor
153360730|NCT01368263|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153360731|NCT00815360|Triamcinolone|triamcinolone|mesh-list
153360732|NCT00815360|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
153360733|NCT00815360|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
153360734|NCT00815360|Ranibizumab|ranibizumab|mesh-list
153360735|NCT00815360|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
153360736|NCT00815360|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153552616|NCT01579110|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153552617|NCT01579110|Immunologic Factors|immunologic factors|mesh-ancestor
153552618|NCT01579110|Antinematodal Agents|antinematodal agents|mesh-ancestor
153552619|NCT01579110|Anthelmintics|anthelmintics|mesh-ancestor
153552620|NCT01579110|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153552621|NCT01579110|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153552622|NCT01579110|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153552624|NCT01579149|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153552625|NCT01579149|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153552626|NCT01579149|Antiviral Agents|antiviral agents|mesh-ancestor
153552642|NCT01579227|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
153552643|NCT01579227|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
153552645|NCT01579227|Antioxidants|antioxidants|mesh-ancestor
153552658|NCT01579279|Sensory System Agents|sensory system agents|mesh-ancestor
153552659|NCT01579279|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153552660|NCT01579279|Antidepressive Agents|antidepressive agents|mesh-ancestor
153552661|NCT01579279|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153552662|NCT01579279|Dopamine Agents|dopamine agents|mesh-ancestor
153552663|NCT01579383|Sumatriptan|sumatriptan|mesh-list
153552664|NCT01579383|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
153552665|NCT01579383|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
153552666|NCT01579383|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
153552667|NCT01579383|Serotonin Agents|serotonin agents|mesh-ancestor
153552668|NCT01579383|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153552669|NCT01579383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153552670|NCT01579383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153552671|NCT01579448|Vaccines|vaccines|mesh-list
153782587|NCT04556071|Growth Inhibitors|growth inhibitors|mesh-ancestor
153782588|NCT04556071|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
153552672|NCT01579448|Immunologic Factors|immunologic factors|mesh-ancestor
153552673|NCT01579448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153552675|NCT01579461|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
153552676|NCT01579461|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
153552677|NCT01579461|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153552678|NCT01579461|Adrenergic Agents|adrenergic agents|mesh-ancestor
153552679|NCT01579461|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153552680|NCT01579461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153552681|NCT01579461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153552682|NCT01579461|Urological Agents|urological agents|mesh-ancestor
153552683|NCT01579500|Botulinum Toxins|botulinum toxins|mesh-list
153552684|NCT01579500|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
153552695|NCT01579539|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
153913862|NCT01222403|Immunologic Factors|immunologic factors|mesh-ancestor
153915720|NCT02699827|Analgesics|analgesics|mesh-ancestor
153437474|NCT00004232|Hormones|hormones|mesh-ancestor
153552696|NCT01579539|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
153552698|NCT01579539|Prednisolone acetate|prednisolone acetate|mesh-list
153552699|NCT01579539|Esomeprazole|esomeprazole|mesh-list
153552701|NCT01579539|Prednisolone phosphate|prednisolone phosphate|mesh-list
153552708|NCT01579539|Glucocorticoids|glucocorticoids|mesh-ancestor
153552709|NCT01579539|Hormones|hormones|mesh-ancestor
153552710|NCT01579539|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153552711|NCT01579539|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
153552712|NCT01579539|Protective Agents|protective agents|mesh-ancestor
153552713|NCT01579539|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153552714|NCT01579539|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153552715|NCT01579539|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
153552716|NCT01579539|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
153552717|NCT01579539|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153552718|NCT01579539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153552719|NCT01579630|Pemetrexed|pemetrexed|mesh-list
153552720|NCT01579630|Gefitinib|gefitinib|mesh-list
153552721|NCT01579630|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153552722|NCT01579630|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153552723|NCT01579630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153552724|NCT01579630|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153552725|NCT01579630|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153552726|NCT01579630|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153552727|NCT01579630|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153552728|NCT01579695|Tesamorelin|tesamorelin|mesh-list
153552729|NCT01579695|Growth Substances|growth substances|mesh-ancestor
153552730|NCT01579695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153552731|NCT01579760|Aflibercept|aflibercept|mesh-list
153552732|NCT01579760|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153552733|NCT01579760|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153552734|NCT01579760|Growth Substances|growth substances|mesh-ancestor
153552735|NCT01579760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153552736|NCT01579760|Growth Inhibitors|growth inhibitors|mesh-ancestor
153552737|NCT01579760|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153552783|NCT01579994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153552784|NCT01579994|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153552785|NCT01580228|Ofatumumab|ofatumumab|mesh-list
153552786|NCT01580228|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153552787|NCT01581333|Anti-Infective Agents|anti-infective agents|mesh-list
153552806|NCT01581476|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
153552807|NCT01581476|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153552808|NCT01581476|Protease Inhibitors|protease inhibitors|mesh-ancestor
153552809|NCT01581476|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153552810|NCT01582321|Cantharidin|cantharidin|mesh-list
153552811|NCT01582321|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153552812|NCT01582321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153552813|NCT01582438|Sildenafil Citrate|sildenafil citrate|mesh-list
153552814|NCT01582438|Citric Acid|citric acid|mesh-list
153552815|NCT01582438|Sodium Citrate|sodium citrate|mesh-list
153552816|NCT01582438|Anticoagulants|anticoagulants|mesh-ancestor
153552817|NCT01582438|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
153552818|NCT01582438|Chelating Agents|chelating agents|mesh-ancestor
153782589|NCT04556071|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153552819|NCT01582438|Sequestering Agents|sequestering agents|mesh-ancestor
153552820|NCT01582438|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153552821|NCT01582438|Vasodilator Agents|vasodilator agents|mesh-ancestor
153552822|NCT01582438|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
153552823|NCT01582438|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
153552824|NCT01582438|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153552825|NCT01582438|Urological Agents|urological agents|mesh-ancestor
153552826|NCT01582711|Isoniazid|isoniazid|mesh-list
153552827|NCT01582711|Rifapentine|rifapentine|mesh-list
153552828|NCT01582711|Antitubercular Agents|antitubercular agents|mesh-ancestor
153552829|NCT01582711|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153552830|NCT01582711|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153552832|NCT01582711|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153552833|NCT01582711|Antimetabolites|antimetabolites|mesh-ancestor
153552860|NCT01583972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153552861|NCT01583972|Protective Agents|protective agents|mesh-ancestor
153552862|NCT01583972|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
153552863|NCT01583972|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153552864|NCT01584362|Oxfendazole|oxfendazole|mesh-list
153552865|NCT01584362|Anthelmintics|anthelmintics|mesh-ancestor
153552866|NCT01584362|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153552867|NCT01584362|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153552868|NCT01584362|Antinematodal Agents|antinematodal agents|mesh-ancestor
153552869|NCT01584921|Epoetin Alfa|epoetin alfa|mesh-list
153552870|NCT01584921|Hematinics|hematinics|mesh-ancestor
153552871|NCT01586013|Propofol|propofol|mesh-list
153552872|NCT01586013|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153552873|NCT01586013|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153552874|NCT01586013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153552875|NCT01586013|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153552876|NCT01586013|Anesthetics, General|anesthetics, general|mesh-ancestor
153552877|NCT01586013|Anesthetics|anesthetics|mesh-ancestor
153552878|NCT01586845|Cyclosporine|cyclosporine|mesh-list
153552879|NCT01586845|Tacrolimus|tacrolimus|mesh-list
153552880|NCT01586845|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153552881|NCT01586845|Immunologic Factors|immunologic factors|mesh-ancestor
153552882|NCT01586845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153552883|NCT01586845|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
153552884|NCT01586845|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153552885|NCT01586845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153552915|NCT01587482|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153552917|NCT01587482|Antimitotic Agents|antimitotic agents|mesh-ancestor
153552918|NCT01587482|Mitosis Modulators|mitosis modulators|mesh-ancestor
153552919|NCT01587482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153552921|NCT01587625|Oxytocics|oxytocics|mesh-ancestor
153552922|NCT01587625|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153552923|NCT01587625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153552924|NCT01587820|Cisplatin|cisplatin|mesh-list
153552925|NCT01587820|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153552926|NCT01587937|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
153552927|NCT01587937|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
153552928|NCT01587937|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153915721|NCT02699827|Sensory System Agents|sensory system agents|mesh-ancestor
153360763|NCT01368653|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153360764|NCT01368653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153360765|NCT01368653|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
153360766|NCT01368653|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
153360767|NCT01368653|Cholinergic Agents|cholinergic agents|mesh-ancestor
153360768|NCT01368653|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153896269|NCT04296370|Apatinib|apatinib|mesh-list
153552929|NCT01587937|Antitubercular Agents|antitubercular agents|mesh-ancestor
153552931|NCT01588171|Bemiparin|bemiparin|mesh-list
153552932|NCT01588171|Anticoagulants|anticoagulants|mesh-ancestor
153552933|NCT01588171|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153552934|NCT01588171|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153552935|NCT01588171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153552936|NCT01588873|Desogestrel|desogestrel|mesh-list
153552937|NCT01588873|NuvaRing|nuvaring|mesh-list
153552938|NCT01588873|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
153552939|NCT01588873|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
153552940|NCT01588873|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
153552941|NCT01588873|Contraceptive Agents|contraceptive agents|mesh-ancestor
153552942|NCT01588873|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153552949|NCT01589367|Metformin|metformin|mesh-list
153552970|NCT01589432|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153552971|NCT01589432|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153552972|NCT01589432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153552973|NCT01589614|Erythromycin|erythromycin|mesh-list
153552974|NCT01589614|Erythromycin Estolate|erythromycin estolate|mesh-list
153552975|NCT01589614|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
153552976|NCT01589614|Erythromycin stearate|erythromycin stearate|mesh-list
153552977|NCT01589614|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153552978|NCT01589614|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153552979|NCT01589614|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153552980|NCT01589614|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
153552981|NCT01589614|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153552982|NCT01589614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153552983|NCT01589861|Lapatinib|lapatinib|mesh-list
153552984|NCT01589861|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153552985|NCT01589861|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153552986|NCT01589861|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153552987|NCT01589861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153552988|NCT01589861|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153552989|NCT01590173|Prednisolone|prednisolone|mesh-list
153552990|NCT01590173|Heparin|heparin|mesh-list
153552991|NCT01590173|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153820759|NCT00434174|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153820760|NCT00434174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153820761|NCT00434174|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153820762|NCT00434174|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153820763|NCT00434174|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
153820764|NCT00434174|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153820765|NCT00434174|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153820766|NCT00434174|Immunologic Factors|immunologic factors|mesh-ancestor
153820767|NCT00434174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153820768|NCT00464958|Tizanidine|tizanidine|mesh-list
153820769|NCT00464958|Analgesics|analgesics|mesh-ancestor
153552992|NCT01590173|Glucocorticoids|glucocorticoids|mesh-ancestor
153552993|NCT01590173|Hormones|hormones|mesh-ancestor
153552994|NCT01590173|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153552995|NCT01590173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153552996|NCT01590173|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153552997|NCT01590173|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153552998|NCT01590173|Anticoagulants|anticoagulants|mesh-ancestor
153552999|NCT01590173|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153553000|NCT01590173|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153553001|NCT01590173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153553002|NCT01590199|Everolimus|everolimus|mesh-list
153553006|NCT01590199|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153553007|NCT01590199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153553008|NCT01590199|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153553009|NCT01590199|Immunologic Factors|immunologic factors|mesh-ancestor
153553026|NCT01590342|Analgesics|analgesics|mesh-ancestor
153553027|NCT01590342|Sensory System Agents|sensory system agents|mesh-ancestor
153553028|NCT01590342|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153553029|NCT01590342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153553030|NCT01590342|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153553031|NCT01590342|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153553032|NCT01590342|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153553033|NCT01590342|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153553034|NCT01590342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153553035|NCT01590537|Copper|copper|mesh-list
153553036|NCT01590537|Levonorgestrel|levonorgestrel|mesh-list
153553037|NCT01590537|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
153553038|NCT01590537|Contraceptive Agents|contraceptive agents|mesh-ancestor
153553039|NCT01590537|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153553040|NCT01590537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153553041|NCT01590537|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
153553042|NCT01590537|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
153553043|NCT01590537|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
153553044|NCT01590537|Trace Elements|trace elements|mesh-ancestor
153553045|NCT01590537|Micronutrients|micronutrients|mesh-ancestor
153553046|NCT01590641|Vesatolimod|vesatolimod|mesh-list
153553047|NCT01590641|Antiviral Agents|antiviral agents|mesh-ancestor
153553048|NCT01590641|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153553049|NCT01590654|Vesatolimod|vesatolimod|mesh-list
153553050|NCT01590654|Antiviral Agents|antiviral agents|mesh-ancestor
153553051|NCT01590654|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153553052|NCT01590693|Botulinum Toxins|botulinum toxins|mesh-list
153553053|NCT01590693|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
153553054|NCT01590693|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
153553055|NCT01590693|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
153553058|NCT01590693|Cholinergic Agents|cholinergic agents|mesh-ancestor
153553061|NCT01590693|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
153553062|NCT01590693|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153553063|NCT01590732|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
153553064|NCT01590732|Carboplatin|carboplatin|mesh-list
153553066|NCT01590732|Etoposide phosphate|etoposide phosphate|mesh-list
153553067|NCT01590732|Ifosfamide|ifosfamide|mesh-list
153553068|NCT01590732|Isophosphamide mustard|isophosphamide mustard|mesh-list
153553069|NCT01590732|Podophyllotoxin|podophyllotoxin|mesh-list
153553083|NCT01590732|Antimitotic Agents|antimitotic agents|mesh-ancestor
153553084|NCT01590732|Mitosis Modulators|mitosis modulators|mesh-ancestor
153553085|NCT01590732|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153553086|NCT01590732|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
153553087|NCT01590823|Dabigatran|dabigatran|mesh-list
153553088|NCT01590823|Antithrombins|antithrombins|mesh-ancestor
153553089|NCT01590823|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
153553090|NCT01590823|Protease Inhibitors|protease inhibitors|mesh-ancestor
153553091|NCT01590823|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153553092|NCT01590823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153553093|NCT01590823|Anticoagulants|anticoagulants|mesh-ancestor
153553094|NCT01590836|Insulin|insulin|mesh-list
153553095|NCT01590836|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
153553096|NCT01590836|Insulin Aspart|insulin aspart|mesh-list
153553097|NCT01590836|Insulin, Long-Acting|insulin, long-acting|mesh-list
153553098|NCT01590836|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153553099|NCT01590836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153553100|NCT01590849|Contraceptive Agents|contraceptive agents|mesh-list
153553101|NCT01590849|Contraceptives, Oral|contraceptives, oral|mesh-list
153553102|NCT01590849|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-list
153782604|NCT02211118|Sensory System Agents|sensory system agents|mesh-ancestor
153553103|NCT01590849|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153553104|NCT01590849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153553118|NCT01590966|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153553119|NCT01590966|Immunologic Factors|immunologic factors|mesh-ancestor
153553120|NCT01590966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153553121|NCT01590966|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153553123|NCT01591031|Rocuronium|rocuronium|mesh-list
153553124|NCT01591031|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153553125|NCT01591031|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
153553126|NCT01591031|Anesthetics, General|anesthetics, general|mesh-ancestor
153553127|NCT01591031|Anesthetics|anesthetics|mesh-ancestor
153553128|NCT01591031|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153553129|NCT01591031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153553147|NCT01591122|Prednisone|prednisone|mesh-list
153553148|NCT01591122|Abiraterone Acetate|abiraterone acetate|mesh-list
153553149|NCT01591122|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153553150|NCT01591122|Glucocorticoids|glucocorticoids|mesh-ancestor
153553151|NCT01591122|Hormones|hormones|mesh-ancestor
153553152|NCT01591122|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153553153|NCT01591122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153553154|NCT01591122|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153553155|NCT01591122|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153553156|NCT01591122|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153553157|NCT01591122|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153553158|NCT01591122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153553159|NCT01591122|Hormone Antagonists|hormone antagonists|mesh-ancestor
153553160|NCT01591122|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153553161|NCT01591135|Paclitaxel|paclitaxel|mesh-list
153553162|NCT01591135|Fluorouracil|fluorouracil|mesh-list
153820783|NCT00464958|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153820784|NCT00472758|Sifalimumab|sifalimumab|mesh-list
153820785|NCT00472758|Immunologic Factors|immunologic factors|mesh-ancestor
153820786|NCT00472758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153820787|NCT01055444|Lidocaine|lidocaine|mesh-list
153820788|NCT01055444|Tetracaine|tetracaine|mesh-list
153820789|NCT01055444|Anesthetics, Local|anesthetics, local|mesh-ancestor
153820790|NCT01055444|Anesthetics|anesthetics|mesh-ancestor
153820791|NCT01055444|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153553163|NCT01591135|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153553164|NCT01591135|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153553175|NCT01591148|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153553176|NCT01591148|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153553177|NCT01591148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153553178|NCT01591148|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153553179|NCT01591148|Anesthetics, General|anesthetics, general|mesh-ancestor
153553180|NCT01591148|Anesthetics|anesthetics|mesh-ancestor
153553181|NCT01591226|Mannitol|mannitol|mesh-list
153553182|NCT01591226|Caffeine|caffeine|mesh-list
153553183|NCT01591226|Citric Acid|citric acid|mesh-list
153553205|NCT01591551|Immunologic Factors|immunologic factors|mesh-ancestor
153553206|NCT01591551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153553207|NCT01591668|Vesatolimod|vesatolimod|mesh-list
153553208|NCT01591668|Antiviral Agents|antiviral agents|mesh-ancestor
153553209|NCT01591668|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153553210|NCT01591759|Cytidine Diphosphate Choline|cytidine diphosphate choline|mesh-list
153553211|NCT01591759|Nootropic Agents|nootropic agents|mesh-ancestor
153553212|NCT01591850|Ritonavir|ritonavir|mesh-list
153553213|NCT01591850|Atazanavir Sulfate|atazanavir sulfate|mesh-list
153553214|NCT01591850|Rifampin|rifampin|mesh-list
153553215|NCT01591850|Ketoconazole|ketoconazole|mesh-list
153553216|NCT01591850|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
153553217|NCT01591850|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
153731935|NCT00139841|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
153553218|NCT01591850|Protease Inhibitors|protease inhibitors|mesh-ancestor
153553219|NCT01591850|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153553220|NCT01591850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153553221|NCT01591850|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153553222|NCT01591850|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153553223|NCT01591850|Antiviral Agents|antiviral agents|mesh-ancestor
153553224|NCT01591850|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153553225|NCT01591850|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
153553226|NCT01591850|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153553227|NCT01591850|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
153553237|NCT01591850|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
153553257|NCT01591980|Sensory System Agents|sensory system agents|mesh-ancestor
153553258|NCT01591980|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153553259|NCT01591980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153553260|NCT01591980|Anticonvulsants|anticonvulsants|mesh-ancestor
153553261|NCT01591980|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153553262|NCT01591980|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153553263|NCT01591980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153553264|NCT01591980|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153553265|NCT01591980|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153553266|NCT01591980|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153553267|NCT01591980|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153553268|NCT01591980|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153553269|NCT01592019|Diclofenac hydroxyethylpyrrolidine|diclofenac hydroxyethylpyrrolidine|mesh-list
153553270|NCT01592019|Diclofenac|diclofenac|mesh-list
153553271|NCT01592019|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153553272|NCT01592019|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153553273|NCT01592019|Analgesics|analgesics|mesh-ancestor
153553274|NCT01592019|Sensory System Agents|sensory system agents|mesh-ancestor
153553275|NCT01592019|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153814639|NCT00452907|Sulfadoxine|sulfadoxine|mesh-list
153360793|NCT01369745|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153360794|NCT01369745|Glucocorticoids|glucocorticoids|mesh-ancestor
153360795|NCT01369745|Hormones|hormones|mesh-ancestor
153360796|NCT01369745|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153360797|NCT01369745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153896279|NCT00997438|Protective Agents|protective agents|mesh-ancestor
153553276|NCT01592019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153553277|NCT01592019|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153553278|NCT01592019|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153553279|NCT01592019|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153553280|NCT01592019|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153553281|NCT01592019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153553282|NCT01592032|Vancomycin|vancomycin|mesh-list
153553283|NCT01592032|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
153553284|NCT01592032|Linezolid|linezolid|mesh-list
153553285|NCT01592032|Daptomycin|daptomycin|mesh-list
153553286|NCT01592032|Tigecycline|tigecycline|mesh-list
153553287|NCT01592032|Teicoplanin|teicoplanin|mesh-list
153553288|NCT01592032|Anti-Infective Agents|anti-infective agents|mesh-list
153553290|NCT01592032|Calcium heparin|calcium heparin|mesh-list
153571342|NCT04402658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153553291|NCT01592032|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
153553292|NCT01592032|Anticoagulants|anticoagulants|mesh-ancestor
153553293|NCT01592032|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153553308|NCT01592162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153553309|NCT01592162|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153553311|NCT01592162|Anesthetics|anesthetics|mesh-ancestor
153553312|NCT01592162|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153553313|NCT01592162|Narcotics|narcotics|mesh-ancestor
153553314|NCT01592162|Analgesics|analgesics|mesh-ancestor
153553315|NCT01592162|Sensory System Agents|sensory system agents|mesh-ancestor
153553316|NCT01592162|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153553317|NCT01592201|Olanzapine|olanzapine|mesh-list
153553318|NCT01592201|Risperidone|risperidone|mesh-list
153553319|NCT01592201|Aripiprazole|aripiprazole|mesh-list
153553320|NCT01592201|Antipsychotic Agents|antipsychotic agents|mesh-list
153553321|NCT01592201|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153553322|NCT01592201|Serotonin Agents|serotonin agents|mesh-ancestor
153553323|NCT01592201|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153731936|NCT00139841|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153913863|NCT01222403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153360798|NCT01369745|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153360799|NCT01369745|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153360800|NCT01369745|Antiemetics|antiemetics|mesh-ancestor
153360801|NCT01369745|Autonomic Agents|autonomic agents|mesh-ancestor
153360802|NCT01369745|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153896292|NCT00997126|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153896300|NCT04433494|Tamoxifen|tamoxifen|mesh-list
153553324|NCT01592201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153553325|NCT01592201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153553326|NCT01592201|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153553327|NCT01592201|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153553328|NCT01592201|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153553329|NCT01592201|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
153553331|NCT01592201|Antiemetics|antiemetics|mesh-ancestor
153553332|NCT01592201|Autonomic Agents|autonomic agents|mesh-ancestor
153553333|NCT01592201|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153553334|NCT01592201|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153553335|NCT01592201|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
153553336|NCT01592201|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153553350|NCT01592214|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153553351|NCT01592227|Acetaminophen|acetaminophen|mesh-list
153553352|NCT01592227|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153553353|NCT01592227|Analgesics|analgesics|mesh-ancestor
153553379|NCT01592305|Protease Inhibitors|protease inhibitors|mesh-ancestor
153553380|NCT01592305|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153553381|NCT01592305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153553382|NCT01592305|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153553383|NCT01592305|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153553384|NCT01592305|Antiviral Agents|antiviral agents|mesh-ancestor
153553385|NCT01592305|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153553386|NCT01592305|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
153553387|NCT01592305|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153553388|NCT01592305|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153553389|NCT01592305|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153553390|NCT01592318|Ritonavir|ritonavir|mesh-list
153553391|NCT01592318|Lactams|lactams|mesh-list
153553392|NCT01592318|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
153553393|NCT01592318|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
153553394|NCT01592318|Protease Inhibitors|protease inhibitors|mesh-ancestor
153553395|NCT01592318|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153553396|NCT01592318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153915732|NCT02699827|Tocolytic Agents|tocolytic agents|mesh-ancestor
153915757|NCT01208051|Maleic acid|maleic acid|mesh-list
153553397|NCT01592318|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153553398|NCT01592318|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153553399|NCT01592318|Antiviral Agents|antiviral agents|mesh-ancestor
153553400|NCT01592318|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153553401|NCT01592318|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
153553402|NCT01592318|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153553403|NCT01592318|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153553425|NCT01592981|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153553426|NCT01592981|Immunologic Factors|immunologic factors|mesh-ancestor
153553427|NCT01592981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153553428|NCT01592981|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153553429|NCT01592981|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153553430|NCT01592981|Alkylating Agents|alkylating agents|mesh-ancestor
153571343|NCT04402658|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153571344|NCT04402658|Respiratory System Agents|respiratory system agents|mesh-ancestor
153571345|NCT04402658|Tocolytic Agents|tocolytic agents|mesh-ancestor
153553431|NCT01592981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153553432|NCT01592981|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153553433|NCT01592981|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153553434|NCT01592981|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153553436|NCT01593033|Trace Elements|trace elements|mesh-list
153553437|NCT01593033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153553438|NCT01593046|Cabotegravir|cabotegravir|mesh-list
153553439|NCT01593046|Rilpivirine|rilpivirine|mesh-list
153731937|NCT00139841|Alkylating Agents|alkylating agents|mesh-ancestor
153553440|NCT01593046|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
153553441|NCT01593046|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
153553442|NCT01593046|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153553443|NCT01593046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153553444|NCT01593046|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153553445|NCT01593046|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153553446|NCT01593046|Antiviral Agents|antiviral agents|mesh-ancestor
153553447|NCT01593046|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153553448|NCT01593046|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153553449|NCT01593046|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153553450|NCT01593124|Imiquimod|imiquimod|mesh-list
153553451|NCT01593124|Nonoxynol|nonoxynol|mesh-list
153553452|NCT01593124|Toll-Like Receptor Agonists|toll-like receptor agonists|mesh-ancestor
153553453|NCT01593124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153553454|NCT01593124|Immunomodulating Agents|immunomodulating agents|mesh-ancestor
153553455|NCT01593124|Immunologic Factors|immunologic factors|mesh-ancestor
153553456|NCT01593124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153553457|NCT01593124|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153553458|NCT01593124|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153553459|NCT01593124|Interferon Inducers|interferon inducers|mesh-ancestor
153820798|NCT01055444|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153820799|NCT01055444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153820800|NCT01055015|Morphine|morphine|mesh-list
153820801|NCT01055015|Oxycodone|oxycodone|mesh-list
153820802|NCT01055015|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153820803|NCT01055015|Narcotics|narcotics|mesh-ancestor
153820804|NCT01055015|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153820805|NCT01055015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153820806|NCT01055015|Analgesics|analgesics|mesh-ancestor
153896336|NCT00965341|Testosterone undecanoate|testosterone undecanoate|mesh-list
153896339|NCT00965341|Androgens|androgens|mesh-ancestor
153553476|NCT01593137|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153553477|NCT01593137|Immunologic Factors|immunologic factors|mesh-ancestor
153553478|NCT01593150|Dabigatran|dabigatran|mesh-list
153553479|NCT01593150|Antithrombins|antithrombins|mesh-ancestor
153553486|NCT01593163|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153553488|NCT01593163|Analgesics|analgesics|mesh-ancestor
153553489|NCT01593163|Sensory System Agents|sensory system agents|mesh-ancestor
153553490|NCT01593163|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153553491|NCT01593163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153553492|NCT01593163|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153553493|NCT01593163|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153553494|NCT01593163|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153553495|NCT01593163|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153553496|NCT01593163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153553497|NCT01593280|Morphine|morphine|mesh-list
153553498|NCT01593280|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153553499|NCT01593280|Narcotics|narcotics|mesh-ancestor
153553500|NCT01593280|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153553501|NCT01593280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153553502|NCT01593280|Analgesics|analgesics|mesh-ancestor
153553503|NCT01593280|Sensory System Agents|sensory system agents|mesh-ancestor
153553504|NCT01593280|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153553505|NCT01593293|Pemetrexed|pemetrexed|mesh-list
153553506|NCT01593293|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153553507|NCT01593293|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153553508|NCT01593293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153553509|NCT01593293|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153553510|NCT01593293|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153553511|NCT01593306|Paclitaxel|paclitaxel|mesh-list
153553512|NCT01593306|Cisplatin|cisplatin|mesh-list
153553513|NCT01593306|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153553514|NCT01593306|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153553515|NCT01593306|Tubulin Modulators|tubulin modulators|mesh-ancestor
153553516|NCT01593306|Antimitotic Agents|antimitotic agents|mesh-ancestor
153553517|NCT01593306|Mitosis Modulators|mitosis modulators|mesh-ancestor
153553518|NCT01593306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153553538|NCT01593397|Anesthetics|anesthetics|mesh-list
153553539|NCT01593397|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153553540|NCT01593397|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153553541|NCT01593397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153553542|NCT01593397|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153553543|NCT01593397|Anesthetics, General|anesthetics, general|mesh-ancestor
153553544|NCT01593397|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153553545|NCT01593397|Narcotics|narcotics|mesh-ancestor
153553546|NCT01593397|Analgesics|analgesics|mesh-ancestor
153553547|NCT01593397|Sensory System Agents|sensory system agents|mesh-ancestor
153553548|NCT01593397|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153553549|NCT01593397|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153553550|NCT01593410|Dexamethasone|dexamethasone|mesh-list
153553551|NCT01593410|Lenalidomide|lenalidomide|mesh-list
153553552|NCT01593410|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153553553|NCT01593410|Antiemetics|antiemetics|mesh-ancestor
153553554|NCT01593410|Autonomic Agents|autonomic agents|mesh-ancestor
153553555|NCT01593410|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153553556|NCT01593410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153553558|NCT01593410|Glucocorticoids|glucocorticoids|mesh-ancestor
153553559|NCT01593410|Hormones|hormones|mesh-ancestor
153820809|NCT00472875|Glyburide|glyburide|mesh-list
153553560|NCT01593410|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153553561|NCT01593410|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153553562|NCT01593410|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153553563|NCT01593410|Immunologic Factors|immunologic factors|mesh-ancestor
153553564|NCT01593410|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153553565|NCT01593410|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153553566|NCT01593410|Growth Substances|growth substances|mesh-ancestor
153553567|NCT01593410|Growth Inhibitors|growth inhibitors|mesh-ancestor
153553568|NCT01593501|Vitamin D|vitamin d|mesh-list
153553569|NCT01593501|Cholecalciferol|cholecalciferol|mesh-list
153553570|NCT01593501|Vitamins|vitamins|mesh-ancestor
153553571|NCT01593501|Micronutrients|micronutrients|mesh-ancestor
153553572|NCT01593501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153553573|NCT01593501|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153553574|NCT01593501|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153553602|NCT01593644|Vasodilator Agents|vasodilator agents|mesh-ancestor
153553603|NCT01593644|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
153553604|NCT01593644|Purinergic Agonists|purinergic agonists|mesh-ancestor
153553605|NCT01593644|Purinergic Agents|purinergic agents|mesh-ancestor
153553606|NCT01593644|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153553607|NCT01593644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153553608|NCT01593644|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
153553609|NCT01593644|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153553610|NCT01593644|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153553612|NCT01593774|Antioxidants|antioxidants|mesh-ancestor
153553613|NCT01593774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153553614|NCT01593774|Protective Agents|protective agents|mesh-ancestor
153553615|NCT01593774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153553616|NCT01593774|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153553617|NCT01593826|Budesonide|budesonide|mesh-list
153553618|NCT01593826|Formoterol Fumarate|formoterol fumarate|mesh-list
153553619|NCT01593826|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
153553620|NCT01593826|Charcoal|charcoal|mesh-list
153553621|NCT01593826|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153553622|NCT01593826|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153553623|NCT01593826|Autonomic Agents|autonomic agents|mesh-ancestor
153553624|NCT01593826|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153553625|NCT01593826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153553626|NCT01593826|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153553627|NCT01593826|Respiratory System Agents|respiratory system agents|mesh-ancestor
153553628|NCT01593826|Glucocorticoids|glucocorticoids|mesh-ancestor
153553629|NCT01593826|Hormones|hormones|mesh-ancestor
153782606|NCT02211118|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
153553630|NCT01593826|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153553663|NCT01594099|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153553665|NCT01594099|Tubulin Modulators|tubulin modulators|mesh-ancestor
153553666|NCT01594099|Antimitotic Agents|antimitotic agents|mesh-ancestor
153464469|NCT03012984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153553667|NCT01594099|Mitosis Modulators|mitosis modulators|mesh-ancestor
153820815|NCT00434447|Zoledronic Acid|zoledronic acid|mesh-list
153820816|NCT00434447|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153820817|NCT00434447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153820818|NCT00472953|Insulin|insulin|mesh-list
153820819|NCT00472953|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
153820820|NCT00472953|Insulin Aspart|insulin aspart|mesh-list
153820821|NCT00472953|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153820822|NCT00472953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153820823|NCT02957630|Drospirenone|drospirenone|mesh-list
153553668|NCT01594099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153553670|NCT01594177|Cyclophosphamide|cyclophosphamide|mesh-list
153553671|NCT01594177|Trastuzumab|trastuzumab|mesh-list
153553672|NCT01594177|Epirubicin|epirubicin|mesh-list
153553673|NCT01594177|Afatinib|afatinib|mesh-list
153553674|NCT01594177|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153553675|NCT01594177|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153553676|NCT01594177|Tubulin Modulators|tubulin modulators|mesh-ancestor
153553677|NCT01594177|Antimitotic Agents|antimitotic agents|mesh-ancestor
153553678|NCT01594177|Mitosis Modulators|mitosis modulators|mesh-ancestor
153553679|NCT01594177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153553680|NCT01594177|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153553681|NCT01594177|Immunologic Factors|immunologic factors|mesh-ancestor
153553682|NCT01594177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153553683|NCT01594177|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153553684|NCT01594177|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153553685|NCT01594177|Alkylating Agents|alkylating agents|mesh-ancestor
153553686|NCT01594177|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153553687|NCT01594177|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153553714|NCT01594255|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153553715|NCT01594268|Everolimus|everolimus|mesh-list
153553716|NCT01594268|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
153553734|NCT01594489|Aminophylline|aminophylline|mesh-list
153553735|NCT01594489|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153553736|NCT01594489|Autonomic Agents|autonomic agents|mesh-ancestor
153553737|NCT01594489|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153553754|NCT01594502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153553755|NCT01594502|Hormone Antagonists|hormone antagonists|mesh-ancestor
153553756|NCT01594502|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153553757|NCT01594502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153553758|NCT01594619|Diltiazem|diltiazem|mesh-list
153553759|NCT01594619|Naloxegol|naloxegol|mesh-list
153553760|NCT01594619|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153553761|NCT01594619|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153553762|NCT01594619|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153553763|NCT01594619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153553764|NCT01594619|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153553765|NCT01594619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153553766|NCT01594619|Vasodilator Agents|vasodilator agents|mesh-ancestor
153553767|NCT01594619|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
153553768|NCT01594619|Sensory System Agents|sensory system agents|mesh-ancestor
153553769|NCT01594619|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153553770|NCT01594671|Tranexamic Acid|tranexamic acid|mesh-list
153553771|NCT01594671|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
153553773|NCT01594671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153553774|NCT01594671|Hemostatics|hemostatics|mesh-ancestor
153553775|NCT01594671|Coagulants|coagulants|mesh-ancestor
153464476|NCT02744430|Adrenergic Agents|adrenergic agents|mesh-ancestor
153820824|NCT02957630|Levonorgestrel|levonorgestrel|mesh-list
153820825|NCT02957630|Ethinyl Estradiol|ethinyl estradiol|mesh-list
153820826|NCT02957630|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
153820827|NCT02957630|Contraceptive Agents|contraceptive agents|mesh-ancestor
153820828|NCT02957630|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153820829|NCT02957630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153360817|NCT01475513|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153360818|NCT01475513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153782607|NCT02211118|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153553777|NCT01594697|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153553778|NCT01594697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153553779|NCT01594775|Oxytocin|oxytocin|mesh-list
153553780|NCT01594775|Oxytocics|oxytocics|mesh-ancestor
153553781|NCT01594775|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153553782|NCT01594775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153553783|NCT01594866|Dexetimide|dexetimide|mesh-list
153553784|NCT01594866|Citalopram|citalopram|mesh-list
153553785|NCT01594866|Escitalopram|escitalopram|mesh-list
153571346|NCT04402658|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153571347|NCT04402658|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
153571348|NCT04402658|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
153539948|NCT01536314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153539949|NCT01536314|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
153539975|NCT01536613|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
153539977|NCT01536613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153539979|NCT01536626|Biphasic Insulins|biphasic insulins|mesh-list
153539980|NCT01536626|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
153539981|NCT01536626|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153539982|NCT01536626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153539983|NCT01536639|Insulin Aspart|insulin aspart|mesh-list
153539984|NCT01536639|Biphasic Insulins|biphasic insulins|mesh-list
153483232|NCT04738292|Fertility Agents|fertility agents|mesh-ancestor
153539985|NCT01536639|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
153539986|NCT01536639|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153539987|NCT01536639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153539988|NCT01536652|Insulin Aspart|insulin aspart|mesh-list
153539989|NCT01536652|Biphasic Insulins|biphasic insulins|mesh-list
153539990|NCT01536652|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
153539991|NCT01536652|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153539992|NCT01536652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153539994|NCT01536665|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
153540020|NCT01536717|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153540021|NCT01536717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153540022|NCT01536717|Sensory System Agents|sensory system agents|mesh-ancestor
153540023|NCT01536717|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153540024|NCT01536743|Palbociclib|palbociclib|mesh-list
153540033|NCT01536873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153540035|NCT01536873|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153540036|NCT01536873|Antiviral Agents|antiviral agents|mesh-ancestor
153540037|NCT01536873|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153540038|NCT01537055|Amoxicillin|amoxicillin|mesh-list
153540039|NCT01537055|Levofloxacin|levofloxacin|mesh-list
153540040|NCT01537055|Ofloxacin|ofloxacin|mesh-list
153540041|NCT01537055|Lansoprazole|lansoprazole|mesh-list
153540042|NCT01537055|Dexlansoprazole|dexlansoprazole|mesh-list
153540043|NCT01537055|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153540044|NCT01537055|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153540045|NCT01537055|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
153540063|NCT01537107|Sirolimus|sirolimus|mesh-list
153540064|NCT01537107|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
153540065|NCT01537107|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153540066|NCT01537107|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153540067|NCT01537107|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153540068|NCT01537107|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153540069|NCT01537107|Antifungal Agents|antifungal agents|mesh-ancestor
153540070|NCT01537107|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153540071|NCT01537107|Immunologic Factors|immunologic factors|mesh-ancestor
153540072|NCT01537107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153913864|NCT01222403|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153814640|NCT00452907|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
153896351|NCT01175811|Biphasic Insulins|biphasic insulins|mesh-list
153540073|NCT01537107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153540075|NCT01537146|Ropivacaine|ropivacaine|mesh-list
153540076|NCT01537146|Anesthetics, Local|anesthetics, local|mesh-ancestor
153540077|NCT01537146|Anesthetics|anesthetics|mesh-ancestor
153540078|NCT01537146|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153540098|NCT01537354|Respiratory System Agents|respiratory system agents|mesh-ancestor
153540099|NCT01537380|Cefazolin|cefazolin|mesh-list
153540100|NCT01537380|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153540101|NCT01537380|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153540102|NCT01537471|Meclizine|meclizine|mesh-list
153540103|NCT01537471|Dimenhydrinate|dimenhydrinate|mesh-list
153540133|NCT01537744|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153540134|NCT01537744|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153540135|NCT01537744|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
153540136|NCT01537770|Lidocaine|lidocaine|mesh-list
153540137|NCT01537770|Anesthetics, Local|anesthetics, local|mesh-ancestor
153540138|NCT01537770|Anesthetics|anesthetics|mesh-ancestor
153730521|NCT00134069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153540139|NCT01537770|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153540140|NCT01537770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153540141|NCT01537770|Sensory System Agents|sensory system agents|mesh-ancestor
153540142|NCT01537770|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153540143|NCT01537770|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153540144|NCT01537770|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
153540145|NCT01537770|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153540146|NCT01537770|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153540147|NCT01537770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153540148|NCT01537809|Vitamin D|vitamin d|mesh-list
153540149|NCT01537809|Ergocalciferols|ergocalciferols|mesh-list
153540182|NCT01537861|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153540183|NCT01537861|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153540184|NCT01537861|Growth Substances|growth substances|mesh-ancestor
153540185|NCT01537861|Growth Inhibitors|growth inhibitors|mesh-ancestor
153540186|NCT01537861|Leprostatic Agents|leprostatic agents|mesh-ancestor
153540187|NCT01537861|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153540188|NCT01537861|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153540189|NCT01538095|Trebananib|trebananib|mesh-list
153540190|NCT01538095|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153540191|NCT01538095|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153540192|NCT01538095|Growth Substances|growth substances|mesh-ancestor
153540193|NCT01538095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153540205|NCT01538225|Sensory System Agents|sensory system agents|mesh-ancestor
153540207|NCT01538225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153540208|NCT01538316|Genistein|genistein|mesh-list
153540209|NCT01538316|Quercetin|quercetin|mesh-list
153540210|NCT01538316|Antioxidants|antioxidants|mesh-ancestor
153618975|NCT01981369|Analgesics|analgesics|mesh-ancestor
153540211|NCT01538316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153540213|NCT01538316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153540214|NCT01538316|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
153540215|NCT01538316|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153540216|NCT01538316|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153540217|NCT01538316|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153540218|NCT01538316|Phytoestrogens|phytoestrogens|mesh-ancestor
153540219|NCT01538316|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
153540220|NCT01538316|Estrogens|estrogens|mesh-ancestor
153540221|NCT01538316|Hormones|hormones|mesh-ancestor
153540222|NCT01538316|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153540223|NCT01538329|Amantadine|amantadine|mesh-list
153540225|NCT01538329|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
153540226|NCT01538329|Antiviral Agents|antiviral agents|mesh-ancestor
153540227|NCT01538329|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153540228|NCT01538329|Dopamine Agents|dopamine agents|mesh-ancestor
153540229|NCT01538329|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153540230|NCT01538329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153820832|NCT02957630|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
153540231|NCT01538329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153540232|NCT01538329|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153540233|NCT01538329|Analgesics|analgesics|mesh-ancestor
153540234|NCT01538329|Sensory System Agents|sensory system agents|mesh-ancestor
153540235|NCT01538329|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153540236|NCT01538381|Afatinib|afatinib|mesh-list
153540237|NCT01538381|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153540238|NCT01538381|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153540239|NCT01538381|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153540240|NCT01538381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153540251|NCT01538394|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153540252|NCT01538394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153540253|NCT01538446|Clopidogrel|clopidogrel|mesh-list
153540254|NCT01538446|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
153730522|NCT00134069|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153540255|NCT01538446|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153540256|NCT01538446|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
153540257|NCT01538446|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
153540258|NCT01538446|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
153540259|NCT01538446|Purinergic Agents|purinergic agents|mesh-ancestor
153540273|NCT01538459|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153540275|NCT01538459|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153540276|NCT01538459|Anesthetics, Local|anesthetics, local|mesh-ancestor
153540277|NCT01538459|Anesthetics|anesthetics|mesh-ancestor
153540278|NCT01538459|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153540279|NCT01538459|Sensory System Agents|sensory system agents|mesh-ancestor
153540280|NCT01538485|Cholecalciferol|cholecalciferol|mesh-list
153540281|NCT01538485|Vitamin D|vitamin d|mesh-list
153540282|NCT01538485|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153540283|NCT01538485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153540284|NCT01538485|Vitamins|vitamins|mesh-ancestor
153540285|NCT01538485|Micronutrients|micronutrients|mesh-ancestor
153483525|NCT03068910|Diuretics|diuretics|mesh-ancestor
153540286|NCT01538485|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153540288|NCT01538511|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
153540289|NCT01538511|Insulin Aspart|insulin aspart|mesh-list
153540290|NCT01538511|Insulin, Long-Acting|insulin, long-acting|mesh-list
153540291|NCT01538511|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
153540292|NCT01538511|Biphasic Insulins|biphasic insulins|mesh-list
153540293|NCT01538511|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
153540294|NCT01538511|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153540295|NCT01538511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153540296|NCT01538537|ON 01910|on 01910|mesh-list
153540297|NCT01538537|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153571349|NCT04402658|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153540298|NCT01538537|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153540299|NCT01538537|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153540300|NCT01538537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153540301|NCT01538563|ON 01910|on 01910|mesh-list
153540302|NCT01538563|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153540303|NCT01538563|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153540304|NCT01538563|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153540305|NCT01538563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153540306|NCT01538576|Insulin Aspart|insulin aspart|mesh-list
153540307|NCT01538576|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153540308|NCT01538576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153540309|NCT01538589|Insulin Aspart|insulin aspart|mesh-list
153540310|NCT01538589|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153540311|NCT01538589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153540312|NCT01538641|Rituximab|rituximab|mesh-list
153540313|NCT01538641|Gemcitabine|gemcitabine|mesh-list
153540314|NCT01538641|Oxaliplatin|oxaliplatin|mesh-list
153540315|NCT01538641|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153540316|NCT01538641|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153540317|NCT01538641|Immunologic Factors|immunologic factors|mesh-ancestor
153540318|NCT01538641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153540319|NCT01538641|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153540320|NCT01538641|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153540325|NCT01538667|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153540326|NCT01538667|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153540327|NCT01538667|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153540328|NCT01538667|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153540329|NCT01538667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153540330|NCT01538667|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153540346|NCT01538693|Parasympatholytics|parasympatholytics|mesh-ancestor
153540347|NCT01538693|Autonomic Agents|autonomic agents|mesh-ancestor
153540348|NCT01538693|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153540349|NCT01538693|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
153540350|NCT01538693|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
153540351|NCT01538693|Cholinergic Agents|cholinergic agents|mesh-ancestor
153540352|NCT01538693|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
153540353|NCT01538693|Antidepressive Agents|antidepressive agents|mesh-ancestor
153540354|NCT01538693|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153540355|NCT01538693|Antipruritics|antipruritics|mesh-ancestor
153540356|NCT01538693|Dermatologic Agents|dermatologic agents|mesh-ancestor
153540357|NCT01538693|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153618976|NCT01981369|Sensory System Agents|sensory system agents|mesh-ancestor
153540358|NCT01538693|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
153540359|NCT01538693|Histamine Antagonists|histamine antagonists|mesh-ancestor
153540360|NCT01538693|Histamine Agents|histamine agents|mesh-ancestor
153540361|NCT01538693|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153540362|NCT01538693|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
153540363|NCT01538732|Alitretinoin|alitretinoin|mesh-list
153540364|NCT01538732|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153540365|NCT01538732|Dermatologic Agents|dermatologic agents|mesh-ancestor
153540366|NCT01538771|Darbepoetin alfa|darbepoetin alfa|mesh-list
153540367|NCT01538771|Hematinics|hematinics|mesh-ancestor
153540368|NCT01538797|Ranitidine|ranitidine|mesh-list
153540369|NCT01538797|Ranitidine bismuth citrate|ranitidine bismuth citrate|mesh-list
153540370|NCT01538797|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
153540371|NCT01538797|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153540372|NCT01538797|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
153540373|NCT01538797|Histamine Antagonists|histamine antagonists|mesh-ancestor
153540427|NCT01539044|Neostigmine|neostigmine|mesh-list
153540428|NCT01539044|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153540429|NCT01539044|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153540430|NCT01539044|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153540431|NCT01539044|Autonomic Agents|autonomic agents|mesh-ancestor
153540432|NCT01539044|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153540433|NCT01539044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153540465|NCT01539174|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153540466|NCT01539174|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153540467|NCT01539174|Glucocorticoids|glucocorticoids|mesh-ancestor
153540469|NCT01539174|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153540470|NCT01539174|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153540471|NCT01539174|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153540472|NCT01539174|Tubulin Modulators|tubulin modulators|mesh-ancestor
153540473|NCT01539174|Antimitotic Agents|antimitotic agents|mesh-ancestor
153540474|NCT01539174|Mitosis Modulators|mitosis modulators|mesh-ancestor
153540475|NCT01539265|Silodosin|silodosin|mesh-list
153540476|NCT01539265|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
153540486|NCT01539330|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153540487|NCT01539330|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
153540488|NCT01539330|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153540489|NCT01539330|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153540490|NCT01539330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153540491|NCT01539330|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153540492|NCT01539330|Hormone Antagonists|hormone antagonists|mesh-ancestor
153540507|NCT01539473|Tedizolid|tedizolid|mesh-list
153540512|NCT01539473|Autonomic Agents|autonomic agents|mesh-ancestor
153540513|NCT01539473|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153540514|NCT01539473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153540515|NCT01539473|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
153540516|NCT01539473|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153540517|NCT01539473|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153540518|NCT01539473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153540519|NCT01539473|Adrenergic Agents|adrenergic agents|mesh-ancestor
153540520|NCT01539473|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153540521|NCT01539564|Minocycline|minocycline|mesh-list
153540522|NCT01539564|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153540523|NCT01539564|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153540524|NCT01539577|Dexamethasone|dexamethasone|mesh-list
153540525|NCT01539577|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153540526|NCT01539577|Antiemetics|antiemetics|mesh-ancestor
153540527|NCT01539577|Autonomic Agents|autonomic agents|mesh-ancestor
153540528|NCT01539577|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153540529|NCT01539577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153540530|NCT01539577|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153540531|NCT01539577|Glucocorticoids|glucocorticoids|mesh-ancestor
153540532|NCT01539577|Hormones|hormones|mesh-ancestor
153540533|NCT01539577|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153455630|NCT05643794|Immunologic Factors|immunologic factors|mesh-ancestor
153540534|NCT01539577|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153540535|NCT01539577|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153540536|NCT01539603|Sirolimus|sirolimus|mesh-list
153540537|NCT01539603|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153540538|NCT01539603|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153540568|NCT01539707|Solifenacin Succinate|solifenacin succinate|mesh-list
153540569|NCT01539707|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
153540570|NCT01539707|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
153540571|NCT01539707|Cholinergic Agents|cholinergic agents|mesh-ancestor
153540572|NCT01539707|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153540573|NCT01539707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153540574|NCT01539707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153540575|NCT01539707|Urological Agents|urological agents|mesh-ancestor
153540576|NCT01539733|Haloperidol|haloperidol|mesh-list
153540577|NCT01539733|Olanzapine|olanzapine|mesh-list
153540578|NCT01539733|Haloperidol decanoate|haloperidol decanoate|mesh-list
153540579|NCT01539733|Antiemetics|antiemetics|mesh-ancestor
153540580|NCT01539733|Autonomic Agents|autonomic agents|mesh-ancestor
153618977|NCT01981369|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153540581|NCT01539733|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153540582|NCT01539733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153540583|NCT01539733|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153540584|NCT01539733|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153540585|NCT01539733|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153540629|NCT01540110|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153540630|NCT01540110|Immunologic Factors|immunologic factors|mesh-ancestor
153540631|NCT01540110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153540632|NCT01540110|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153540633|NCT01540110|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153540634|NCT01540110|Alkylating Agents|alkylating agents|mesh-ancestor
153814642|NCT00452907|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153540635|NCT01540110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153540636|NCT01540110|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153540637|NCT01540110|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153540638|NCT01540110|Tubulin Modulators|tubulin modulators|mesh-ancestor
153540639|NCT01540110|Antimitotic Agents|antimitotic agents|mesh-ancestor
153540640|NCT01540110|Mitosis Modulators|mitosis modulators|mesh-ancestor
153540642|NCT01540136|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153540643|NCT01540240|Zidovudine|zidovudine|mesh-list
153540644|NCT01540240|Antimetabolites|antimetabolites|mesh-ancestor
153540645|NCT01540240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153540646|NCT01540240|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153540647|NCT01540240|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153540648|NCT01540240|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153540649|NCT01540240|Antiviral Agents|antiviral agents|mesh-ancestor
153540650|NCT01540240|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153540651|NCT01540240|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153540652|NCT01540240|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153540653|NCT01540435|Bevacizumab|bevacizumab|mesh-list
153540654|NCT01540435|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153540655|NCT01540435|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153540656|NCT01540435|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153540657|NCT01540435|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153540658|NCT01540435|Growth Substances|growth substances|mesh-ancestor
153730523|NCT00134069|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
153540659|NCT01540435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153540660|NCT01540435|Growth Inhibitors|growth inhibitors|mesh-ancestor
153540661|NCT01540500|Fluvoxamine|fluvoxamine|mesh-list
153540676|NCT01540500|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153540677|NCT01540500|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153540678|NCT01540500|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
153540680|NCT01540526|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153540681|NCT01540526|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153540682|NCT01540526|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153540683|NCT01540526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153540684|NCT01540591|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
153540685|NCT01540591|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
153540686|NCT01540591|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
153540687|NCT01540591|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
153540688|NCT01540682|Cetuximab|cetuximab|mesh-list
153540689|NCT01540682|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153540690|NCT01540682|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153540691|NCT01540708|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
153540692|NCT01540708|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153540693|NCT01540708|Autonomic Agents|autonomic agents|mesh-ancestor
153540694|NCT01540708|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153540695|NCT01540708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153540696|NCT01540708|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153540741|NCT01540812|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153540742|NCT01540812|Antiemetics|antiemetics|mesh-ancestor
153540743|NCT01540812|Autonomic Agents|autonomic agents|mesh-ancestor
153540744|NCT01540812|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153540745|NCT01540812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153540746|NCT01540812|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153540747|NCT01540812|Glucocorticoids|glucocorticoids|mesh-ancestor
153540748|NCT01540812|Hormones|hormones|mesh-ancestor
153540749|NCT01540812|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153540750|NCT01540812|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153540751|NCT01540812|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153540752|NCT01540812|Protease Inhibitors|protease inhibitors|mesh-ancestor
153540753|NCT01540812|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153730524|NCT00134069|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153730525|NCT00134069|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153540754|NCT01540812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153540755|NCT01540812|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153540756|NCT01540812|Antimetabolites|antimetabolites|mesh-ancestor
153540757|NCT01540812|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153540758|NCT01540812|Immunologic Factors|immunologic factors|mesh-ancestor
153540759|NCT01540812|Antiviral Agents|antiviral agents|mesh-ancestor
153540760|NCT01540812|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153540761|NCT01540812|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153540762|NCT01540812|Tubulin Modulators|tubulin modulators|mesh-ancestor
153540763|NCT01540812|Antimitotic Agents|antimitotic agents|mesh-ancestor
153540764|NCT01540812|Mitosis Modulators|mitosis modulators|mesh-ancestor
153540765|NCT01540812|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153540766|NCT01540812|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153540767|NCT01540812|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153540768|NCT01540812|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
153540769|NCT01540812|Abortifacient Agents|abortifacient agents|mesh-ancestor
153540771|NCT01540812|Dermatologic Agents|dermatologic agents|mesh-ancestor
153540778|NCT01540877|Capsaicin|capsaicin|mesh-list
153540779|NCT01540877|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153540780|NCT01540877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153540781|NCT01540877|Sensory System Agents|sensory system agents|mesh-ancestor
153540782|NCT01540877|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153540783|NCT01540877|Antipruritics|antipruritics|mesh-ancestor
153540784|NCT01540877|Dermatologic Agents|dermatologic agents|mesh-ancestor
153540785|NCT01540877|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
153540786|NCT01541059|Ropivacaine|ropivacaine|mesh-list
153540787|NCT01541059|Anesthetics, Local|anesthetics, local|mesh-ancestor
153540788|NCT01541059|Anesthetics|anesthetics|mesh-ancestor
153540789|NCT01541059|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153540790|NCT01541059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153540791|NCT01541059|Sensory System Agents|sensory system agents|mesh-ancestor
153540792|NCT01541059|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153540816|NCT01541137|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153540818|NCT01541137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153540819|NCT01541137|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
153540820|NCT01541189|Valsartan|valsartan|mesh-list
153540821|NCT01541189|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153540822|NCT01541189|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
153540823|NCT01541189|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
153540825|NCT01541267|Telmisartan|telmisartan|mesh-list
153360217|NCT00802100|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153540866|NCT01541332|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153540867|NCT01541332|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153540868|NCT01541332|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153540869|NCT01541332|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153540870|NCT01541332|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153540871|NCT01541332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153540872|NCT01541332|Immunologic Factors|immunologic factors|mesh-ancestor
153540873|NCT01541332|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153540874|NCT01541332|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153540875|NCT01541332|Growth Substances|growth substances|mesh-ancestor
153540876|NCT01541332|Growth Inhibitors|growth inhibitors|mesh-ancestor
153540877|NCT01541436|Capsaicin|capsaicin|mesh-list
153540878|NCT01541436|Antipruritics|antipruritics|mesh-ancestor
153540879|NCT01541436|Dermatologic Agents|dermatologic agents|mesh-ancestor
153540880|NCT01541436|Sensory System Agents|sensory system agents|mesh-ancestor
153540881|NCT01541436|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153540882|NCT01541436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153540883|NCT01541475|Dexetimide|dexetimide|mesh-list
153540884|NCT01541475|Citalopram|citalopram|mesh-list
153540885|NCT01541475|Bupropion|bupropion|mesh-list
153540886|NCT01541475|Escitalopram|escitalopram|mesh-list
153540887|NCT01541475|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
153540888|NCT01541475|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153540889|NCT01541475|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153540923|NCT01541631|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153540924|NCT01541631|Anticestodal Agents|anticestodal agents|mesh-ancestor
153540925|NCT01541631|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
153540926|NCT01541631|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153540927|NCT01541631|Tubulin Modulators|tubulin modulators|mesh-ancestor
153540928|NCT01541631|Antimitotic Agents|antimitotic agents|mesh-ancestor
153540929|NCT01541631|Mitosis Modulators|mitosis modulators|mesh-ancestor
153540930|NCT01541631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153540931|NCT01541631|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153540932|NCT01541670|Antibodies|antibodies|mesh-list
153540933|NCT01541670|Immunologic Factors|immunologic factors|mesh-ancestor
153540934|NCT01541670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153540935|NCT01541683|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
153540936|NCT01541904|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
153540937|NCT01541904|Ophthalmic Solutions|ophthalmic solutions|mesh-list
153540938|NCT01541085|Ritonavir|ritonavir|mesh-list
153540939|NCT01541085|Darunavir|darunavir|mesh-list
153540940|NCT01541085|Efavirenz|efavirenz|mesh-list
153540941|NCT01541085|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
153540942|NCT01541085|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
153540943|NCT01541085|Protease Inhibitors|protease inhibitors|mesh-ancestor
153540944|NCT01541085|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153540945|NCT01541085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153540946|NCT01541085|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153540947|NCT01541085|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153540948|NCT01541085|Antiviral Agents|antiviral agents|mesh-ancestor
153540949|NCT01541085|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153540950|NCT01541085|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
153540951|NCT01541085|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153540952|NCT01541085|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153464486|NCT01896960|Bupivacaine|bupivacaine|mesh-list
153437628|NCT00004262|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
153540953|NCT01541085|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153540954|NCT01541085|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
153540955|NCT01541085|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
153540968|NCT01541943|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153540969|NCT01541943|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153540970|NCT01541943|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
153540971|NCT01541943|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
153540973|NCT01541956|Vildagliptin|vildagliptin|mesh-list
153540974|NCT01541956|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153540975|NCT01541956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153540976|NCT01541956|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
153540977|NCT01541956|Protease Inhibitors|protease inhibitors|mesh-ancestor
153540978|NCT01541956|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153540979|NCT01541956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153540980|NCT01542047|Carboplatin|carboplatin|mesh-list
153540981|NCT01542047|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153540982|NCT01542060|Insulin Aspart|insulin aspart|mesh-list
153540983|NCT01542060|Biphasic Insulins|biphasic insulins|mesh-list
153540984|NCT01542060|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
153540985|NCT01542060|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153540986|NCT01542060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153540987|NCT01542099|Remifentanil|remifentanil|mesh-list
153540988|NCT01542099|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153540989|NCT01542099|Narcotics|narcotics|mesh-ancestor
153540990|NCT01542099|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153540991|NCT01542099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153540992|NCT01542099|Analgesics|analgesics|mesh-ancestor
153540993|NCT01542099|Sensory System Agents|sensory system agents|mesh-ancestor
153540996|NCT01542138|Niacin|niacin|mesh-list
153541015|NCT01542190|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153541016|NCT01542190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153541018|NCT01542190|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153541019|NCT01542190|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153541020|NCT01542190|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153541021|NCT01542190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153541022|NCT01542242|Liraglutide|liraglutide|mesh-list
153541023|NCT01542242|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
153541024|NCT01542242|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153541025|NCT01542242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153541027|NCT01542242|Hormones|hormones|mesh-ancestor
153541028|NCT01542242|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153541040|NCT01542294|Oxaliplatin|oxaliplatin|mesh-list
153541041|NCT01542294|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153541042|NCT01542424|Insulin|insulin|mesh-list
153541043|NCT01542424|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
153541044|NCT01542424|Insulin Aspart|insulin aspart|mesh-list
153541046|NCT01542424|Biphasic Insulins|biphasic insulins|mesh-list
153541047|NCT01542424|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
153541048|NCT01542424|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153541049|NCT01542424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153541050|NCT01542450|Insulin|insulin|mesh-list
153541051|NCT01542450|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
153541052|NCT01542450|Insulin Detemir|insulin detemir|mesh-list
153541053|NCT01542450|Isophane Insulin, Human|isophane insulin, human|mesh-list
153541054|NCT01542450|Insulin, Isophane|insulin, isophane|mesh-list
153541055|NCT01542450|Isophane insulin, beef|isophane insulin, beef|mesh-list
153541073|NCT01542697|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153541074|NCT01542697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153541075|NCT01542697|Anesthetics|anesthetics|mesh-ancestor
153541076|NCT01542697|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153541077|NCT01542697|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153541078|NCT01542697|Anticonvulsants|anticonvulsants|mesh-ancestor
153541079|NCT01542697|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153541080|NCT01542697|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153541081|NCT01542697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153541082|NCT01542697|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153541083|NCT01542697|Tocolytic Agents|tocolytic agents|mesh-ancestor
153541084|NCT01542697|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153541085|NCT01542710|Timolol|timolol|mesh-list
153464487|NCT01896960|Anesthetics, Local|anesthetics, local|mesh-ancestor
153464488|NCT01896960|Anesthetics|anesthetics|mesh-ancestor
153541086|NCT01542710|Bimatoprost|bimatoprost|mesh-list
153541087|NCT01542710|Travoprost|travoprost|mesh-list
153541088|NCT01542710|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
153541089|NCT01542710|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
153541090|NCT01542710|Adrenergic Agents|adrenergic agents|mesh-ancestor
153541091|NCT01542710|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153541092|NCT01542710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153541093|NCT01542710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153541100|NCT01542723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153541102|NCT01542762|Anticoagulants|anticoagulants|mesh-ancestor
153541103|NCT01542762|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153541106|NCT01542801|Ciprofloxacin|ciprofloxacin|mesh-list
153541127|NCT01542918|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153541128|NCT01542918|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153541129|NCT01542918|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153541130|NCT01542918|Growth Substances|growth substances|mesh-ancestor
153541131|NCT01542918|Growth Inhibitors|growth inhibitors|mesh-ancestor
153541132|NCT01543035|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
153541133|NCT01543035|Antiviral Agents|antiviral agents|mesh-ancestor
153541134|NCT01543035|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153541135|NCT01543061|Ophthalmic Solutions|ophthalmic solutions|mesh-list
153541136|NCT01543061|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
153541137|NCT01543139|Valproic Acid|valproic acid|mesh-list
153541138|NCT01543139|Anticonvulsants|anticonvulsants|mesh-ancestor
153541139|NCT01543139|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153541140|NCT01543139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153541141|NCT01543139|GABA Agents|gaba agents|mesh-ancestor
153541142|NCT01543139|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153541143|NCT01543139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153541144|NCT01543139|Antimanic Agents|antimanic agents|mesh-ancestor
153541145|NCT01543139|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153541146|NCT01543139|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153541147|NCT01543139|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153541148|NCT01543165|Ketorolac|ketorolac|mesh-list
153541149|NCT01543165|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
153541150|NCT01543165|Morphine|morphine|mesh-list
153541151|NCT01543165|Analgesics|analgesics|mesh-list
153541152|NCT01543165|Nefopam|nefopam|mesh-list
153541153|NCT01543165|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153541154|NCT01543165|Narcotics|narcotics|mesh-ancestor
153541155|NCT01543165|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153541156|NCT01543165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153541157|NCT01543165|Sensory System Agents|sensory system agents|mesh-ancestor
153541158|NCT01543165|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153541189|NCT01543399|Tibolone|tibolone|mesh-list
153541196|NCT01543399|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153541197|NCT01543399|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
153541199|NCT01543399|Hormones|hormones|mesh-ancestor
153541200|NCT01543464|Temozolomide|temozolomide|mesh-list
153810990|NCT00353028|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153541201|NCT01543464|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153541202|NCT01543464|Alkylating Agents|alkylating agents|mesh-ancestor
153541203|NCT01543464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153541204|NCT01543464|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153541205|NCT01543555|Atorvastatin|atorvastatin|mesh-list
153541206|NCT01543555|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153541207|NCT01543555|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153541208|NCT01543555|Antimetabolites|antimetabolites|mesh-ancestor
153541209|NCT01543555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153541210|NCT01543555|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153541223|NCT01543737|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153541224|NCT01543737|Immunologic Factors|immunologic factors|mesh-ancestor
153541225|NCT01543737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153541226|NCT01543737|Viscosupplements|viscosupplements|mesh-ancestor
153730526|NCT00134069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153730527|NCT00134069|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153541227|NCT01543737|Protective Agents|protective agents|mesh-ancestor
153541228|NCT01543750|4-Aminopyridine|4-aminopyridine|mesh-list
153541229|NCT01543750|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
153541230|NCT01543750|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153541250|NCT01543945|Dexamethasone|dexamethasone|mesh-list
153541251|NCT01543945|Dexamethasone acetate|dexamethasone acetate|mesh-list
153541252|NCT01543945|Ondansetron|ondansetron|mesh-list
153541253|NCT01543945|Antiemetics|antiemetics|mesh-list
153541254|NCT01543945|Dimenhydrinate|dimenhydrinate|mesh-list
153541255|NCT01543945|BB 1101|bb 1101|mesh-list
153541256|NCT01543945|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153541257|NCT01543945|Autonomic Agents|autonomic agents|mesh-ancestor
153541258|NCT01543945|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153541259|NCT01543945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153541260|NCT01543945|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153541261|NCT01543945|Glucocorticoids|glucocorticoids|mesh-ancestor
153541262|NCT01543945|Hormones|hormones|mesh-ancestor
153541263|NCT01543945|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153541264|NCT01543945|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153541265|NCT01543945|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153541266|NCT01543945|Protease Inhibitors|protease inhibitors|mesh-ancestor
153541267|NCT01543945|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153541269|NCT01543945|Antipruritics|antipruritics|mesh-ancestor
153541320|NCT01544283|Sensory System Agents|sensory system agents|mesh-ancestor
153541321|NCT01544283|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153541322|NCT01544283|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153541323|NCT01544283|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
153541324|NCT01544283|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153541325|NCT01544283|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153541326|NCT01544283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153541327|NCT01544283|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153541360|NCT01544517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153541362|NCT01544517|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153541363|NCT01544517|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153541364|NCT01544517|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153541365|NCT01544517|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
153541366|NCT01544517|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153541367|NCT01544517|Alkylating Agents|alkylating agents|mesh-ancestor
153541368|NCT01544517|Antitrichomonal Agents|antitrichomonal agents|mesh-ancestor
153541387|NCT01544634|Respiratory System Agents|respiratory system agents|mesh-ancestor
153541388|NCT01544673|Linezolid|linezolid|mesh-list
153437666|NCT00004904|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153541389|NCT01544673|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153541390|NCT01544673|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153541391|NCT01544673|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
153541392|NCT01544673|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153541393|NCT01544673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153541394|NCT01544725|Ketamine|ketamine|mesh-list
153541395|NCT01544725|Propofol|propofol|mesh-list
153541396|NCT01544725|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153541397|NCT01544725|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153541400|NCT01544725|Anesthetics, General|anesthetics, general|mesh-ancestor
153541413|NCT01544751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153541414|NCT01544751|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153541415|NCT01544751|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153541416|NCT01544751|Antimetabolites|antimetabolites|mesh-ancestor
153541417|NCT01544751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153541418|NCT01544751|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153541419|NCT01544751|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
153541420|NCT01544751|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153541421|NCT01544829|Theobromine|theobromine|mesh-list
153541422|NCT01544829|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153541423|NCT01544829|Autonomic Agents|autonomic agents|mesh-ancestor
153541424|NCT01544829|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153541437|NCT01544842|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
153541438|NCT01544842|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153541439|NCT01544842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153541440|NCT01544842|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153541441|NCT01544842|Glucocorticoids|glucocorticoids|mesh-ancestor
153541443|NCT01544842|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153541444|NCT01544881|Insulin|insulin|mesh-list
153541445|NCT01544881|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153541446|NCT01544881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153541447|NCT01544894|Raloxifene Hydrochloride|raloxifene hydrochloride|mesh-list
153541448|NCT01544894|Strontium ranelate|strontium ranelate|mesh-list
153541449|NCT01544894|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
153541450|NCT01544894|Hormone Antagonists|hormone antagonists|mesh-ancestor
153541451|NCT01544894|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153541452|NCT01544894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153541453|NCT01544894|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
153541454|NCT01544894|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
153541463|NCT01544959|Fentanyl|fentanyl|mesh-list
153541467|NCT01544959|Narcotics|narcotics|mesh-ancestor
153541468|NCT01544959|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153541469|NCT01544959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153541470|NCT01544959|Analgesics|analgesics|mesh-ancestor
153541471|NCT01544959|Sensory System Agents|sensory system agents|mesh-ancestor
153541472|NCT01544959|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153541473|NCT01544959|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153541474|NCT01544959|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153541475|NCT01544959|Anesthetics, General|anesthetics, general|mesh-ancestor
153541476|NCT01544959|Anesthetics|anesthetics|mesh-ancestor
153541477|NCT01544959|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
153541478|NCT01544959|Adrenergic Agents|adrenergic agents|mesh-ancestor
153541479|NCT01544959|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153541480|NCT01544959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153541481|NCT01544959|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
153541483|NCT01544972|Ibuprofen|ibuprofen|mesh-list
153541484|NCT01544972|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153541485|NCT01544972|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153541486|NCT01544972|Analgesics|analgesics|mesh-ancestor
153541487|NCT01544972|Sensory System Agents|sensory system agents|mesh-ancestor
153541506|NCT01545284|Acitretin|acitretin|mesh-list
153541507|NCT01545284|Keratolytic Agents|keratolytic agents|mesh-ancestor
153541508|NCT01545284|Dermatologic Agents|dermatologic agents|mesh-ancestor
153541509|NCT01545297|Dexmedetomidine|dexmedetomidine|mesh-list
153541510|NCT01545297|Remifentanil|remifentanil|mesh-list
153541511|NCT01545297|Propofol|propofol|mesh-list
153541512|NCT01545297|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153541514|NCT01545297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153541534|NCT01545427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153541536|NCT01545440|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
153541537|NCT01545440|Immunologic Factors|immunologic factors|mesh-ancestor
153541538|NCT01545440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153541539|NCT01545479|Captopril|captopril|mesh-list
153541540|NCT01545479|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
153541541|NCT01545479|Protease Inhibitors|protease inhibitors|mesh-ancestor
153541542|NCT01545479|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153541543|NCT01545479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153541565|NCT01545791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153541566|NCT01545804|Lenalidomide|lenalidomide|mesh-list
153730528|NCT00141570|Methyltestosterone|methyltestosterone|mesh-list
153730529|NCT00141570|Estrogens|estrogens|mesh-list
153541567|NCT01545804|Immunologic Factors|immunologic factors|mesh-ancestor
153541568|NCT01545804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153541569|NCT01545804|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153541570|NCT01545804|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153541572|NCT01545804|Growth Inhibitors|growth inhibitors|mesh-ancestor
153541573|NCT01545804|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153541574|NCT01545830|Vitamin D|vitamin d|mesh-list
153541575|NCT01545830|Cholecalciferol|cholecalciferol|mesh-list
153541576|NCT01545830|Vitamins|vitamins|mesh-ancestor
153541577|NCT01545830|Micronutrients|micronutrients|mesh-ancestor
153541578|NCT01545830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153541579|NCT01545830|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153541580|NCT01545830|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153541581|NCT01545856|Levodopa|levodopa|mesh-list
153541582|NCT01545856|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
153541583|NCT01545856|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
153541584|NCT01545856|Dopamine Agents|dopamine agents|mesh-ancestor
153541585|NCT01545856|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153541587|NCT01545856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153541595|NCT01545947|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153541596|NCT01545947|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153541598|NCT01546051|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
153541610|NCT01546090|GABA Modulators|gaba modulators|mesh-ancestor
153541611|NCT01546090|GABA Agents|gaba agents|mesh-ancestor
153541612|NCT01546090|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153541613|NCT01546090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153541614|NCT01546103|Vitamin D|vitamin d|mesh-list
153541615|NCT01546103|Ergocalciferols|ergocalciferols|mesh-list
153541616|NCT01546103|Cholecalciferol|cholecalciferol|mesh-list
153541617|NCT01546103|Vitamins|vitamins|mesh-list
153541618|NCT01546103|Micronutrients|micronutrients|mesh-ancestor
153541619|NCT01546103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153541620|NCT01546103|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153541621|NCT01546103|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153541622|NCT01546116|Lamivudine|lamivudine|mesh-list
153541623|NCT01546116|Adefovir|adefovir|mesh-list
153541624|NCT01546116|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
153541625|NCT01546116|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153541626|NCT01546116|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153541627|NCT01546116|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153618980|NCT01981369|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153541628|NCT01546116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153541629|NCT01546116|Antiviral Agents|antiviral agents|mesh-ancestor
153541630|NCT01546116|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153541631|NCT01546116|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153541632|NCT01546116|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153541633|NCT01546389|Chloroquine|chloroquine|mesh-list
153541634|NCT01546389|Amebicides|amebicides|mesh-ancestor
153541635|NCT01546389|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153541636|NCT01546389|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153541637|NCT01546389|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153541638|NCT01546389|Antimalarials|antimalarials|mesh-ancestor
153541646|NCT01546558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153541647|NCT01546597|Metformin|metformin|mesh-list
153541648|NCT01546597|Ranolazine|ranolazine|mesh-list
153541649|NCT01546597|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153541650|NCT01546597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153730530|NCT00141570|Estrogens, Esterified (USP)|estrogens, esterified (usp)|mesh-list
153730531|NCT00141570|Testosterone|testosterone|mesh-list
153541651|NCT01546597|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153541652|NCT01546597|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153541653|NCT01546597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153541654|NCT01546701|Morphine|morphine|mesh-list
153541655|NCT01546701|Buprenorphine|buprenorphine|mesh-list
153541656|NCT01546701|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153541657|NCT01546701|Narcotics|narcotics|mesh-ancestor
153541658|NCT01546701|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153541659|NCT01546701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153541660|NCT01546701|Analgesics|analgesics|mesh-ancestor
153541661|NCT01546701|Sensory System Agents|sensory system agents|mesh-ancestor
153541669|NCT01546896|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153541670|NCT01546896|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153810992|NCT00353028|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153814647|NCT00452907|Schistosomicides|schistosomicides|mesh-ancestor
153541671|NCT01546896|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153541672|NCT01546896|GABA Modulators|gaba modulators|mesh-ancestor
153541673|NCT01546896|GABA Agents|gaba agents|mesh-ancestor
153541674|NCT01546896|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153541675|NCT01546896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153541676|NCT01546896|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
153541677|NCT01546896|Serotonin Agents|serotonin agents|mesh-ancestor
153541678|NCT01546935|Oseltamivir|oseltamivir|mesh-list
153541679|NCT01546935|Antiviral Agents|antiviral agents|mesh-ancestor
153541680|NCT01546935|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153541681|NCT01546935|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153541682|NCT01546935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153541683|NCT01546961|Chloroquine|chloroquine|mesh-list
153541690|NCT01547091|Antirheumatic Agents|antirheumatic agents|mesh-list
153541691|NCT01547104|Glimepiride|glimepiride|mesh-list
153541692|NCT01547104|Linagliptin|linagliptin|mesh-list
153541693|NCT01547104|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153541694|NCT01547104|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153541695|NCT01547104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153541696|NCT01547104|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153541697|NCT01547104|Immunologic Factors|immunologic factors|mesh-ancestor
153541698|NCT01547104|Incretins|incretins|mesh-ancestor
153541699|NCT01547104|Hormones|hormones|mesh-ancestor
153541700|NCT01547104|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153541701|NCT01547104|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
153541702|NCT01547104|Protease Inhibitors|protease inhibitors|mesh-ancestor
153541703|NCT01547104|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153541704|NCT01547104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153541705|NCT01547143|Cyclosporine|cyclosporine|mesh-list
153541706|NCT01547143|Dexamethasone|dexamethasone|mesh-list
153541707|NCT01547143|Etoposide|etoposide|mesh-list
153541708|NCT01547143|Cyclosporins|cyclosporins|mesh-list
153541709|NCT01547143|gamma-Globulins|gamma-globulins|mesh-list
153541710|NCT01547143|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153541711|NCT01547143|Antiemetics|antiemetics|mesh-ancestor
153541712|NCT01547143|Autonomic Agents|autonomic agents|mesh-ancestor
153541713|NCT01547143|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153541714|NCT01547143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153541715|NCT01547143|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153541716|NCT01547143|Glucocorticoids|glucocorticoids|mesh-ancestor
153541717|NCT01547143|Hormones|hormones|mesh-ancestor
153541749|NCT01547221|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153541750|NCT01547221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153541751|NCT01547221|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
153541752|NCT01547221|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
153541753|NCT01547312|Interferons|interferons|mesh-list
153541754|NCT01547312|Ribavirin|ribavirin|mesh-list
153541755|NCT01547312|Grazoprevir|grazoprevir|mesh-list
153541756|NCT01547312|Liver Extracts|liver extracts|mesh-list
153915768|NCT05322889|Telmisartan|telmisartan|mesh-list
153541757|NCT01547312|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153541758|NCT01547312|Antiviral Agents|antiviral agents|mesh-ancestor
153541759|NCT01547312|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153541760|NCT01547312|Antimetabolites|antimetabolites|mesh-ancestor
153541761|NCT01547312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153541762|NCT01547312|Hematinics|hematinics|mesh-ancestor
153541763|NCT01547325|Doxycycline|doxycycline|mesh-list
153541764|NCT01547325|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153541765|NCT01547325|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153541766|NCT01547325|Antimalarials|antimalarials|mesh-ancestor
153541767|NCT01547325|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153541768|NCT01547325|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153541769|NCT01547377|Zinc|zinc|mesh-list
153541770|NCT01547377|Selenium|selenium|mesh-list
153541771|NCT01547377|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
153541772|NCT01547377|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153541773|NCT01547377|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153541774|NCT01547377|Antimetabolites|antimetabolites|mesh-ancestor
153541775|NCT01547377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153541776|NCT01547377|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153541777|NCT01547377|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
153541778|NCT01547377|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153541812|NCT01547520|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153541813|NCT01547520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153541815|NCT01547520|Sensory System Agents|sensory system agents|mesh-ancestor
153541816|NCT01547520|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153541817|NCT01547520|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153541818|NCT01547546|GDC-0084|gdc-0084|mesh-list
153541819|NCT01547546|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153541820|NCT01547546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153541821|NCT01547559|Geranylgeranylacetone|geranylgeranylacetone|mesh-list
153541822|NCT01547559|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
153541823|NCT01547559|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153541824|NCT01547559|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153541825|NCT01548001|Methotrexate|methotrexate|mesh-list
153541826|NCT01548001|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
153541827|NCT01548001|Abortifacient Agents|abortifacient agents|mesh-ancestor
153541828|NCT01548001|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153541829|NCT01548001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153541830|NCT01548001|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153541831|NCT01548001|Antimetabolites|antimetabolites|mesh-ancestor
153541832|NCT01548001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153541833|NCT01548001|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153541861|NCT01548118|Vaccines|vaccines|mesh-list
153541868|NCT01548144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153541869|NCT01548144|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153541870|NCT01548144|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153541871|NCT01548144|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153541872|NCT01548144|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153541873|NCT01548157|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
153541874|NCT01548157|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153541875|NCT01548157|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153541876|NCT01548157|Antimetabolites|antimetabolites|mesh-ancestor
153541877|NCT01548157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153541878|NCT01548157|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153814649|NCT00452907|Anthelmintics|anthelmintics|mesh-ancestor
153814650|NCT00452907|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153814651|NCT00452907|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153437710|NCT00003758|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153541879|NCT01548157|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
153541880|NCT01548157|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153541882|NCT01548170|Sunitinib|sunitinib|mesh-list
153541883|NCT01548170|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153541884|NCT01548170|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153541885|NCT01548170|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153541886|NCT01548170|Growth Substances|growth substances|mesh-ancestor
153541887|NCT01548170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153541888|NCT01548170|Growth Inhibitors|growth inhibitors|mesh-ancestor
153541889|NCT01548170|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153541900|NCT01548209|Dexmedetomidine|dexmedetomidine|mesh-list
153541928|NCT01548274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153541931|NCT01548274|Serotonin Agents|serotonin agents|mesh-ancestor
153541932|NCT01548274|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153541933|NCT01548274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153541934|NCT01548326|Atorvastatin|atorvastatin|mesh-list
153541935|NCT01548326|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153541936|NCT01548326|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153541937|NCT01548326|Antimetabolites|antimetabolites|mesh-ancestor
153541938|NCT01548326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153541939|NCT01548326|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153541940|NCT01548326|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
153541941|NCT01548326|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153541942|NCT01548482|Sirolimus|sirolimus|mesh-list
153541943|NCT01548482|Temsirolimus|temsirolimus|mesh-list
153541944|NCT01548482|Trebananib|trebananib|mesh-list
153541946|NCT01548482|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153541947|NCT01548482|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153541948|NCT01548482|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153541949|NCT01548482|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153541950|NCT01548482|Antifungal Agents|antifungal agents|mesh-ancestor
153541951|NCT01548482|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153541952|NCT01548482|Immunologic Factors|immunologic factors|mesh-ancestor
153541953|NCT01548482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153541954|NCT01548482|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153541955|NCT01548482|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153541956|NCT01548482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153541957|NCT01548482|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153541958|NCT01548482|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153541959|NCT01548482|Growth Substances|growth substances|mesh-ancestor
153541960|NCT01548482|Growth Inhibitors|growth inhibitors|mesh-ancestor
153541961|NCT01548521|Oxytocin|oxytocin|mesh-list
153541962|NCT01548521|Oxytocics|oxytocics|mesh-ancestor
153541963|NCT01548521|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153541965|NCT01548560|Dapivirine|dapivirine|mesh-list
153541971|NCT01548612|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153541972|NCT01548612|Vasodilator Agents|vasodilator agents|mesh-ancestor
153541973|NCT01548612|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
153541974|NCT01548612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153541975|NCT01548677|Trastuzumab|trastuzumab|mesh-list
153541976|NCT01548677|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153541986|NCT01548794|Anesthetics|anesthetics|mesh-list
153541987|NCT01548794|Anesthetics, Local|anesthetics, local|mesh-ancestor
153541988|NCT01548794|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153541989|NCT01548794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153541990|NCT01548794|Sensory System Agents|sensory system agents|mesh-ancestor
153541991|NCT01548794|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153541992|NCT01548794|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153541993|NCT01548794|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
153541994|NCT01548794|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153541995|NCT01548794|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153541996|NCT01548794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153541998|NCT01548807|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
153357547|NCT01274000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153541999|NCT01548807|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153542000|NCT01548807|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153542001|NCT01548807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153542002|NCT01548807|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153542003|NCT01548807|Immunologic Factors|immunologic factors|mesh-ancestor
153542004|NCT01548807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153542005|NCT01548807|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153542006|NCT01548859|Midazolam|midazolam|mesh-list
153357549|NCT04274738|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153357550|NCT04274738|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153896520|NCT01296347|Ketamine|ketamine|mesh-list
153542007|NCT01548859|Sevoflurane|sevoflurane|mesh-list
153542013|NCT01548859|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153542014|NCT01548859|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153542015|NCT01548859|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153542016|NCT01548859|Anesthetics, General|anesthetics, general|mesh-ancestor
153542017|NCT01548859|Anesthetics|anesthetics|mesh-ancestor
153542018|NCT01548859|GABA Modulators|gaba modulators|mesh-ancestor
153542019|NCT01548859|GABA Agents|gaba agents|mesh-ancestor
153542020|NCT01548859|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153542021|NCT01548859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153542022|NCT01548859|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153542023|NCT01548859|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
153542024|NCT01548872|Cardioplegic Solutions|cardioplegic solutions|mesh-list
153542025|NCT01548872|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
153542027|NCT01548911|Calicheamicins|calicheamicins|mesh-list
153542028|NCT01548911|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153542029|NCT01548911|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153542030|NCT01548911|Immunotoxins|immunotoxins|mesh-ancestor
153542031|NCT01548911|Immunoconjugates|immunoconjugates|mesh-ancestor
153542032|NCT01548911|Immunologic Factors|immunologic factors|mesh-ancestor
153542033|NCT01548911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153542034|NCT01548911|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153542035|NCT01548924|Paclitaxel|paclitaxel|mesh-list
153542036|NCT01548924|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153542037|NCT01548924|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153542038|NCT01548924|Tubulin Modulators|tubulin modulators|mesh-ancestor
153810993|NCT00353028|Serotonin Agents|serotonin agents|mesh-ancestor
153542039|NCT01548924|Antimitotic Agents|antimitotic agents|mesh-ancestor
153542040|NCT01548924|Mitosis Modulators|mitosis modulators|mesh-ancestor
153542041|NCT01548924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153542062|NCT01549093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153542063|NCT01549093|Growth Inhibitors|growth inhibitors|mesh-ancestor
153542065|NCT01549158|Furosemide|furosemide|mesh-list
153542066|NCT01549158|Diuretics|diuretics|mesh-ancestor
153542067|NCT01549158|Natriuretic Agents|natriuretic agents|mesh-ancestor
153542068|NCT01549158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153542069|NCT01549158|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
153542070|NCT01549158|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153571350|NCT04402658|Adrenergic Agents|adrenergic agents|mesh-ancestor
153542071|NCT01549158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153542072|NCT01549158|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153542074|NCT01549171|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153542075|NCT01549171|Vasodilator Agents|vasodilator agents|mesh-ancestor
153542076|NCT01549236|Benzonidazole|benzonidazole|mesh-list
153542077|NCT01549236|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153542078|NCT01549236|Immunologic Factors|immunologic factors|mesh-ancestor
153542079|NCT01549236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153542080|NCT01549236|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
153810994|NCT00353028|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
153810995|NCT00353028|Antidepressive Agents|antidepressive agents|mesh-ancestor
153810996|NCT00353028|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
153618982|NCT01981369|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153542081|NCT01549236|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153542082|NCT01549236|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153542083|NCT01549236|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153542084|NCT01549301|Lenograstim|lenograstim|mesh-list
153542085|NCT01549301|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153542086|NCT01549301|Immunologic Factors|immunologic factors|mesh-ancestor
153542087|NCT01549301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153542089|NCT01549418|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153542090|NCT01549418|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153542091|NCT01549418|Analgesics|analgesics|mesh-ancestor
153542092|NCT01549418|Sensory System Agents|sensory system agents|mesh-ancestor
153542093|NCT01549418|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153542105|NCT01549431|Panobinostat|panobinostat|mesh-list
153542116|NCT01549431|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153542117|NCT01549431|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
153542118|NCT01549431|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153542119|NCT01549431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153542120|NCT01549496|Amlodipine|amlodipine|mesh-list
153542121|NCT01549496|Diltiazem|diltiazem|mesh-list
153542122|NCT01549496|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153542123|NCT01549496|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153542124|NCT01549496|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153542125|NCT01549496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153542126|NCT01549496|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153542127|NCT01549496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153542128|NCT01549496|Vasodilator Agents|vasodilator agents|mesh-ancestor
153542129|NCT01549548|Ponatinib|ponatinib|mesh-list
153542130|NCT01549548|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153542131|NCT01549548|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153542132|NCT01549548|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153542133|NCT01549548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153542134|NCT01549548|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153542135|NCT01549574|Crizotinib|crizotinib|mesh-list
153542136|NCT01549574|Esomeprazole|esomeprazole|mesh-list
153542137|NCT01549574|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
153542138|NCT01549574|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153542176|NCT01549743|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153542177|NCT01549743|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
153542178|NCT01549743|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153542179|NCT01549743|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153542180|NCT01549743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153542181|NCT01549743|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
153542182|NCT01549743|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153542184|NCT01549743|Protective Agents|protective agents|mesh-ancestor
153542185|NCT01549795|Capecitabine|capecitabine|mesh-list
153542186|NCT01549795|Liver Extracts|liver extracts|mesh-list
153542187|NCT01549795|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153542188|NCT01549795|Antimetabolites|antimetabolites|mesh-ancestor
153455631|NCT05643794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153814652|NCT00452907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153542189|NCT01549795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153542190|NCT01549795|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153542191|NCT01549795|Hematinics|hematinics|mesh-ancestor
153542192|NCT01549847|Piracetam|piracetam|mesh-list
153542193|NCT01549847|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
153542194|NCT01549847|Protective Agents|protective agents|mesh-ancestor
153730532|NCT00141570|Testosterone undecanoate|testosterone undecanoate|mesh-list
153542195|NCT01549847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153542196|NCT01549847|Nootropic Agents|nootropic agents|mesh-ancestor
153542197|NCT01549938|Cholecalciferol|cholecalciferol|mesh-list
153542198|NCT01549938|Vitamin D|vitamin d|mesh-list
153542199|NCT01549938|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153542200|NCT01549938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153542201|NCT01549938|Vitamins|vitamins|mesh-ancestor
153542202|NCT01549938|Micronutrients|micronutrients|mesh-ancestor
153542203|NCT01549938|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153542204|NCT01549990|Sevoflurane|sevoflurane|mesh-list
153542224|NCT01550107|Free Radical Scavengers|free radical scavengers|mesh-ancestor
153542225|NCT01550107|Antioxidants|antioxidants|mesh-ancestor
153542226|NCT01550107|Protective Agents|protective agents|mesh-ancestor
153542227|NCT01550107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153542228|NCT01550146|Dexamethasone|dexamethasone|mesh-list
153542259|NCT01550354|Anesthetics, General|anesthetics, general|mesh-ancestor
153542260|NCT01550354|Anesthetics|anesthetics|mesh-ancestor
153542261|NCT01550354|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
153542262|NCT01550354|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
153542263|NCT01550354|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
153542264|NCT01550354|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153542265|NCT01550354|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153542266|NCT01550354|Narcotics|narcotics|mesh-ancestor
153542267|NCT01550354|Analgesics|analgesics|mesh-ancestor
153542268|NCT01550354|Sensory System Agents|sensory system agents|mesh-ancestor
153542269|NCT01550419|Atorvastatin|atorvastatin|mesh-list
153542270|NCT01550419|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153542271|NCT01550419|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153542272|NCT01550419|Antimetabolites|antimetabolites|mesh-ancestor
153542273|NCT01550419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153542288|NCT01550640|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153542289|NCT01550640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153542290|NCT01550640|Analgesics|analgesics|mesh-ancestor
153542291|NCT01550640|Sensory System Agents|sensory system agents|mesh-ancestor
153542292|NCT01550640|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153542293|NCT01550653|Liraglutide|liraglutide|mesh-list
153542294|NCT01550653|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
153542295|NCT01550653|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153730533|NCT00141570|Testosterone enanthate|testosterone enanthate|mesh-list
153730534|NCT00141570|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
153542310|NCT01550848|Antimetabolites|antimetabolites|mesh-ancestor
153542311|NCT01550848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153542312|NCT01550848|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153542313|NCT01550900|Metformin|metformin|mesh-list
153542314|NCT01550900|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153542315|NCT01550900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153542316|NCT01550926|Orlistat|orlistat|mesh-list
153542317|NCT01550926|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153542318|NCT01550926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153542319|NCT01550926|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
153542320|NCT01550926|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153542321|NCT01551004|REP 3123|rep 3123|mesh-list
153542322|NCT01551004|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153542323|NCT01551004|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153542324|NCT01551069|Hydroxychloroquine|hydroxychloroquine|mesh-list
153542325|NCT01551069|Antimalarials|antimalarials|mesh-ancestor
153464529|NCT00056472|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153542326|NCT01551069|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153542327|NCT01551069|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153542328|NCT01551069|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153542329|NCT01551069|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153542330|NCT01551069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153542331|NCT01551069|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153542332|NCT01550458|Mibefradil|mibefradil|mesh-list
153814653|NCT00452907|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
153814654|NCT00446784|Methotrexate|methotrexate|mesh-list
153542348|NCT01551147|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153542349|NCT01551147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153542350|NCT01551147|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
153542351|NCT01551147|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
153542352|NCT01551147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153542353|NCT01551225|Escitalopram|escitalopram|mesh-list
153542358|NCT01551225|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153542359|NCT01551225|Serotonin Agents|serotonin agents|mesh-ancestor
153542360|NCT01551225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153542361|NCT01551290|Infliximab|infliximab|mesh-list
153542362|NCT01551290|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
153542363|NCT01551290|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153542364|NCT01551290|Dermatologic Agents|dermatologic agents|mesh-ancestor
153542365|NCT01551290|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153542366|NCT01551290|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153542367|NCT01551329|Ketamine|ketamine|mesh-list
153542368|NCT01551329|Analgesics|analgesics|mesh-ancestor
153542369|NCT01551329|Sensory System Agents|sensory system agents|mesh-ancestor
153542370|NCT01551329|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153810998|NCT00353028|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
153542371|NCT01551329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153542372|NCT01551329|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
153542373|NCT01551329|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153542374|NCT01551329|Anesthetics, General|anesthetics, general|mesh-ancestor
153542375|NCT01551329|Anesthetics|anesthetics|mesh-ancestor
153542376|NCT01551329|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153618983|NCT01981369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153542377|NCT01551329|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
153542378|NCT01551329|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
153542379|NCT01551329|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153542380|NCT01551329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153542381|NCT01551368|Nimodipine|nimodipine|mesh-list
153542382|NCT01551368|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153542383|NCT01551368|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153542384|NCT01551368|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153542395|NCT01551394|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153542409|NCT01551459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153542410|NCT01551459|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153542411|NCT01551459|Alkylating Agents|alkylating agents|mesh-ancestor
153542412|NCT01551485|Zolpidem|zolpidem|mesh-list
153542413|NCT01551485|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
153542414|NCT01551485|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153542415|NCT01551485|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153542416|NCT01551485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153542417|NCT01551485|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
153542418|NCT01551485|GABA Agonists|gaba agonists|mesh-ancestor
153542419|NCT01551485|GABA Agents|gaba agents|mesh-ancestor
153542420|NCT01551485|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153542421|NCT01551485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153542422|NCT01551511|Dronabinol|dronabinol|mesh-list
153542423|NCT01551511|Hallucinogens|hallucinogens|mesh-ancestor
153542424|NCT01551511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153542425|NCT01551511|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153542426|NCT01551511|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153542427|NCT01551511|Analgesics|analgesics|mesh-ancestor
153542428|NCT01551511|Sensory System Agents|sensory system agents|mesh-ancestor
153542429|NCT01551511|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153542430|NCT01551511|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
153542431|NCT01551511|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
153542434|NCT01551511|Hormones|hormones|mesh-ancestor
153542475|NCT01551719|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153542476|NCT01551719|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
153542477|NCT01551719|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153542478|NCT01551719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153542479|NCT01551797|Acetaminophen|acetaminophen|mesh-list
153542480|NCT01551797|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153542481|NCT01551797|Analgesics|analgesics|mesh-ancestor
153542482|NCT01551797|Sensory System Agents|sensory system agents|mesh-ancestor
153542483|NCT01551797|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153542484|NCT01551797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153542485|NCT01551797|Antipyretics|antipyretics|mesh-ancestor
153542486|NCT01551836|Acetaminophen|acetaminophen|mesh-list
153542487|NCT01551836|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153542488|NCT01551836|Analgesics|analgesics|mesh-ancestor
153542489|NCT01551836|Sensory System Agents|sensory system agents|mesh-ancestor
153730536|NCT00141570|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153542490|NCT01551836|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153542491|NCT01551836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153542492|NCT01551836|Antipyretics|antipyretics|mesh-ancestor
153542493|NCT01552005|Saxagliptin|saxagliptin|mesh-list
153542494|NCT01552005|Incretins|incretins|mesh-ancestor
153542495|NCT01552005|Hormones|hormones|mesh-ancestor
153542496|NCT01552005|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153542497|NCT01552005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153542498|NCT01552005|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
153542499|NCT01552005|Protease Inhibitors|protease inhibitors|mesh-ancestor
153542500|NCT01552005|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153542501|NCT01552005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153542502|NCT01552005|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153542503|NCT01552018|Saxagliptin|saxagliptin|mesh-list
153542504|NCT01552018|Incretins|incretins|mesh-ancestor
153542505|NCT01552018|Hormones|hormones|mesh-ancestor
153542506|NCT01552018|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153542507|NCT01552018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153542508|NCT01552018|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
153542511|NCT01552018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153542537|NCT01552148|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153542538|NCT01552148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153542539|NCT01552148|Analgesics|analgesics|mesh-ancestor
153542540|NCT01552148|Sensory System Agents|sensory system agents|mesh-ancestor
153542541|NCT01552148|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153542542|NCT01552187|Colchicine|colchicine|mesh-list
153542543|NCT01552187|Gout Suppressants|gout suppressants|mesh-ancestor
153542544|NCT01552187|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153542545|NCT01552187|Tubulin Modulators|tubulin modulators|mesh-ancestor
153542547|NCT01552187|Mitosis Modulators|mitosis modulators|mesh-ancestor
153542548|NCT01552187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153542549|NCT01552187|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153542550|NCT01552330|Artesunate|artesunate|mesh-list
153542551|NCT01552330|Primaquine|primaquine|mesh-list
153542552|NCT01552330|Pyronaridine|pyronaridine|mesh-list
153542553|NCT01552330|Pyronaridine tetraphosphate, artesunate drug combination|pyronaridine tetraphosphate, artesunate drug combination|mesh-list
153542554|NCT01552330|Antimalarials|antimalarials|mesh-ancestor
153542555|NCT01552330|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153542556|NCT01552330|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153542557|NCT01552330|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153542558|NCT01552330|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153542559|NCT01552330|Antiviral Agents|antiviral agents|mesh-ancestor
153542560|NCT01552330|Schistosomicides|schistosomicides|mesh-ancestor
153542561|NCT01552330|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
153542562|NCT01552330|Anthelmintics|anthelmintics|mesh-ancestor
153542563|NCT01552629|Cyclosporine|cyclosporine|mesh-list
153542564|NCT01552629|Cyclosporins|cyclosporins|mesh-list
153542598|NCT01552837|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153542599|NCT01552837|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153542600|NCT01552837|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153730537|NCT00141570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153542601|NCT01552837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153542602|NCT01552850|Oxycodone|oxycodone|mesh-list
153542603|NCT01552850|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153542604|NCT01552850|Narcotics|narcotics|mesh-ancestor
153542605|NCT01552850|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153542606|NCT01552850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153542607|NCT01552850|Analgesics|analgesics|mesh-ancestor
153542608|NCT01552850|Sensory System Agents|sensory system agents|mesh-ancestor
153542688|NCT01553721|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
153542690|NCT01553721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153542691|NCT01553773|Estradiol|estradiol|mesh-list
153542692|NCT01553773|Estrogens|estrogens|mesh-ancestor
153542693|NCT01553773|Hormones|hormones|mesh-ancestor
153542694|NCT01553773|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153542695|NCT01553773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153542697|NCT01553786|Immunologic Factors|immunologic factors|mesh-ancestor
153542698|NCT01553786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153542699|NCT01553786|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153730538|NCT00141570|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153542700|NCT01553786|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153542701|NCT01553786|Growth Substances|growth substances|mesh-ancestor
153896657|NCT01170039|Lubiprostone|lubiprostone|mesh-list
153542702|NCT01553786|Growth Inhibitors|growth inhibitors|mesh-ancestor
153542703|NCT01553786|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153542705|NCT01553903|Letrozole|letrozole|mesh-list
153542706|NCT01553903|Anastrozole|anastrozole|mesh-list
153542707|NCT01553903|Exemestane|exemestane|mesh-list
153542708|NCT01553903|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153542709|NCT01553903|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
153542710|NCT01553903|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153542711|NCT01553903|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153542712|NCT01553903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153542713|NCT01553903|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
153542714|NCT01553903|Hormone Antagonists|hormone antagonists|mesh-ancestor
153542715|NCT01553903|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153542716|NCT01553903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153542721|NCT01553942|Pemetrexed|pemetrexed|mesh-list
153542731|NCT01553981|Vasodilator Agents|vasodilator agents|mesh-ancestor
153542732|NCT01553981|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
153915814|NCT01206101|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153815047|NCT04715165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153814656|NCT00446784|Abortifacient Agents|abortifacient agents|mesh-ancestor
153814657|NCT00446784|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153542733|NCT01553981|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
153542734|NCT01553981|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153542735|NCT01553981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153542736|NCT01553981|Urological Agents|urological agents|mesh-ancestor
153542738|NCT01554059|Oxaliplatin|oxaliplatin|mesh-list
153542739|NCT01554059|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153542740|NCT01554059|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153542741|NCT01554059|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153542742|NCT01554059|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153542743|NCT01554059|Growth Substances|growth substances|mesh-ancestor
153542744|NCT01554059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153542745|NCT01554059|Growth Inhibitors|growth inhibitors|mesh-ancestor
153542756|NCT01554345|Selenium|selenium|mesh-list
153542757|NCT01554345|Vitamins|vitamins|mesh-ancestor
153542758|NCT01554345|Micronutrients|micronutrients|mesh-ancestor
153542759|NCT01554345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153542760|NCT01554345|Antioxidants|antioxidants|mesh-ancestor
153542761|NCT01554345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153542762|NCT01554345|Protective Agents|protective agents|mesh-ancestor
153542763|NCT01554345|Trace Elements|trace elements|mesh-ancestor
153542764|NCT01554397|Cisplatin|cisplatin|mesh-list
153542765|NCT01554397|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153542766|NCT01554540|Treprostinil|treprostinil|mesh-list
153542767|NCT01554540|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153542768|NCT01554592|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-list
153542769|NCT01554592|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153542770|NCT01554592|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153542771|NCT01554592|Antimetabolites|antimetabolites|mesh-ancestor
153542780|NCT01554631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153730539|NCT00141570|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153730540|NCT00141570|Anabolic Agents|anabolic agents|mesh-ancestor
153730541|NCT00141570|Androgens|androgens|mesh-ancestor
153542781|NCT01554657|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
153542782|NCT01554657|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
153542783|NCT01554657|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153542784|NCT01554657|Antitubercular Agents|antitubercular agents|mesh-ancestor
153542785|NCT01554813|Vaccines|vaccines|mesh-list
153542786|NCT01554813|Immunologic Factors|immunologic factors|mesh-ancestor
153542787|NCT01554813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153542788|NCT01554826|Vaccines|vaccines|mesh-list
153542789|NCT01554826|Immunologic Factors|immunologic factors|mesh-ancestor
153542790|NCT01554826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153542791|NCT01554852|Thalidomide|thalidomide|mesh-list
153542792|NCT01554852|Dexamethasone|dexamethasone|mesh-list
153542793|NCT01554852|Dexamethasone acetate|dexamethasone acetate|mesh-list
153542794|NCT01554852|Cyclophosphamide|cyclophosphamide|mesh-list
153542795|NCT01554852|Melphalan|melphalan|mesh-list
153542796|NCT01554852|Lenalidomide|lenalidomide|mesh-list
153542797|NCT01554852|Bortezomib|bortezomib|mesh-list
153542798|NCT01554852|Vorinostat|vorinostat|mesh-list
153542799|NCT01554852|BB 1101|bb 1101|mesh-list
153542800|NCT01554852|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153542801|NCT01554852|Immunologic Factors|immunologic factors|mesh-ancestor
153542802|NCT01554852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153542803|NCT01554852|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153542804|NCT01554852|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153542805|NCT01554852|Alkylating Agents|alkylating agents|mesh-ancestor
153542806|NCT01554852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153542807|NCT01554852|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153542882|NCT01555112|Protective Agents|protective agents|mesh-ancestor
153542883|NCT01555112|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153542884|NCT01555112|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153542885|NCT01555112|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153542886|NCT01555112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153542888|NCT01555112|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153542889|NCT01555190|Folic Acid|folic acid|mesh-list
153542890|NCT01555190|Inositol|inositol|mesh-list
153542891|NCT01555190|Hematinics|hematinics|mesh-ancestor
153542892|NCT01555190|Vitamin B Complex|vitamin b complex|mesh-ancestor
153542893|NCT01555190|Vitamins|vitamins|mesh-ancestor
153542894|NCT01555190|Micronutrients|micronutrients|mesh-ancestor
153542895|NCT01555190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153542896|NCT01555216|Ropivacaine|ropivacaine|mesh-list
153542897|NCT01555216|Anesthetics, Local|anesthetics, local|mesh-ancestor
153542898|NCT01555216|Anesthetics|anesthetics|mesh-ancestor
153542899|NCT01555216|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153542900|NCT01555216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153542901|NCT01555216|Sensory System Agents|sensory system agents|mesh-ancestor
153542919|NCT01555476|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153542920|NCT01555476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153542922|NCT01555580|Sargramostim|sargramostim|mesh-list
153542923|NCT01555580|Immunologic Factors|immunologic factors|mesh-ancestor
153542924|NCT01555580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153542925|NCT01555580|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153542926|NCT01555658|Heparin|heparin|mesh-list
153730543|NCT00134147|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153542927|NCT01555658|Bivalirudin|bivalirudin|mesh-list
153542928|NCT01555658|Anticoagulants|anticoagulants|mesh-ancestor
153542929|NCT01555658|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153542940|NCT01555710|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153542941|NCT01555710|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153668009|NCT00030498|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153542942|NCT01555710|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153542943|NCT01555710|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153542944|NCT01555710|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153542945|NCT01555710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153542946|NCT01555710|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153542947|NCT01555710|Alkylating Agents|alkylating agents|mesh-ancestor
153542948|NCT01555788|Pancrelipase|pancrelipase|mesh-list
153542949|NCT01555788|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153542950|NCT01555814|Amisulpride|amisulpride|mesh-list
153542951|NCT01555814|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153542952|NCT01555814|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153542953|NCT01555814|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153542954|NCT01555814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153542955|NCT01555814|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153542956|NCT01555814|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
153542957|NCT01555814|Dopamine Agents|dopamine agents|mesh-ancestor
153542958|NCT01555814|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153542959|NCT01555814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153542969|NCT01555879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153542970|NCT01555879|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153542973|NCT01555879|Immunologic Factors|immunologic factors|mesh-ancestor
153542999|NCT01556191|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
153543000|NCT01556191|Fulvestrant|fulvestrant|mesh-list
153543002|NCT01556191|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153543003|NCT01556191|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153543004|NCT01556191|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153543005|NCT01556191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153543006|NCT01556191|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153543007|NCT01556191|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153543008|NCT01556191|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
153543009|NCT01556191|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
153543010|NCT01556191|Hormone Antagonists|hormone antagonists|mesh-ancestor
153543011|NCT01556191|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153543012|NCT01556191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153543013|NCT01556321|Caffeine|caffeine|mesh-list
153543014|NCT01556321|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
153543015|NCT01556321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153543016|NCT01556321|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
153543017|NCT01556321|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153543018|NCT01556321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153543019|NCT01556321|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
153543020|NCT01556321|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
153543021|NCT01556321|Purinergic Agents|purinergic agents|mesh-ancestor
153543022|NCT01556321|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153543023|NCT01556334|Azithromycin|azithromycin|mesh-list
153543024|NCT01556334|Erythromycin|erythromycin|mesh-list
153543037|NCT01556477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153543039|NCT01556477|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153543040|NCT01556477|Growth Substances|growth substances|mesh-ancestor
153543047|NCT01556529|Unithiol|unithiol|mesh-list
153543053|NCT01556529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153543054|NCT01556542|Paclitaxel|paclitaxel|mesh-list
153543055|NCT01556542|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153543056|NCT01556542|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153543057|NCT01556542|Tubulin Modulators|tubulin modulators|mesh-ancestor
153543058|NCT01556542|Antimitotic Agents|antimitotic agents|mesh-ancestor
153543059|NCT01556542|Mitosis Modulators|mitosis modulators|mesh-ancestor
153543060|NCT01556542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153543061|NCT05847660|Cetrorelix|cetrorelix|mesh-list
153543200|NCT05840406|Levobupivacaine|levobupivacaine|mesh-list
153543201|NCT05840406|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153543202|NCT05840406|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153543203|NCT05840406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153543204|NCT05840406|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153543205|NCT05840406|Analgesics|analgesics|mesh-ancestor
153543206|NCT05840406|Sensory System Agents|sensory system agents|mesh-ancestor
153543207|NCT05840406|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153543208|NCT05840406|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
153543209|NCT05840406|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153543210|NCT05840406|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153543211|NCT05840406|Adrenergic Agents|adrenergic agents|mesh-ancestor
153543212|NCT05840406|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153543213|NCT05840406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153543214|NCT05840406|Antipyretics|antipyretics|mesh-ancestor
153543215|NCT05840406|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153543216|NCT05840406|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153543217|NCT05840406|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153543218|NCT05840406|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153543219|NCT05840406|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153543220|NCT05840406|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153543221|NCT05840406|Narcotics|narcotics|mesh-ancestor
153543222|NCT05840406|Anesthetics, Local|anesthetics, local|mesh-ancestor
153543223|NCT05840406|Anesthetics|anesthetics|mesh-ancestor
153543224|NCT05840328|Dexmedetomidine|dexmedetomidine|mesh-list
153543225|NCT05840328|Bupivacaine|bupivacaine|mesh-list
153543226|NCT05840328|Anesthetics, Local|anesthetics, local|mesh-ancestor
153543227|NCT05840328|Anesthetics|anesthetics|mesh-ancestor
153543228|NCT05840328|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153543229|NCT05840328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153543260|NCT05839548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153543262|NCT05839548|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
153543263|NCT05839548|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153543264|NCT05839548|Autonomic Agents|autonomic agents|mesh-ancestor
153543265|NCT05839548|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153543266|NCT05839548|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153730544|NCT00134147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153730545|NCT00403988|Oxaliplatin|oxaliplatin|mesh-list
153543267|NCT05839548|Respiratory System Agents|respiratory system agents|mesh-ancestor
153543268|NCT05839548|Mydriatics|mydriatics|mesh-ancestor
153543269|NCT05839548|Sympathomimetics|sympathomimetics|mesh-ancestor
153543270|NCT05839548|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
153543271|NCT05839548|Anesthetics, Local|anesthetics, local|mesh-ancestor
153543272|NCT05839548|Anesthetics|anesthetics|mesh-ancestor
153543273|NCT05839548|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153543274|NCT05839548|Sensory System Agents|sensory system agents|mesh-ancestor
153543275|NCT05839522|Antibodies|antibodies|mesh-list
153543276|NCT05839522|Immunoglobulins|immunoglobulins|mesh-list
153543277|NCT05839522|HIV Antibodies|hiv antibodies|mesh-list
153543278|NCT05839522|Hepatitis C Antibodies|hepatitis c antibodies|mesh-list
153543279|NCT05839522|Immunologic Factors|immunologic factors|mesh-ancestor
153543280|NCT05839522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153543281|NCT05839509|N,N-Dimethyltryptamine|n,n-dimethyltryptamine|mesh-list
153543282|NCT05839509|Hallucinogens|hallucinogens|mesh-ancestor
153543283|NCT05839509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153543284|NCT05839509|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153543285|NCT05839509|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153543286|NCT05839509|Serotonin Agents|serotonin agents|mesh-ancestor
153543316|NCT05837403|Nitroglycerin|nitroglycerin|mesh-list
153543326|NCT05830630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153543327|NCT05830630|Sensory System Agents|sensory system agents|mesh-ancestor
153543328|NCT05830630|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153543329|NCT05830630|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153543330|NCT05830630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153543331|NCT05823753|Cannabidiol|cannabidiol|mesh-list
153543332|NCT05823753|Anticonvulsants|anticonvulsants|mesh-ancestor
153543333|NCT05813158|Bupivacaine|bupivacaine|mesh-list
153543334|NCT05813158|Anesthetics, Local|anesthetics, local|mesh-ancestor
153543335|NCT05813158|Anesthetics|anesthetics|mesh-ancestor
153543336|NCT05813158|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153543337|NCT05813158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153543366|NCT05585112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153543367|NCT05552443|Hydromorphone|hydromorphone|mesh-list
153543368|NCT05552443|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153543369|NCT05552443|Narcotics|narcotics|mesh-ancestor
153543370|NCT05552443|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153543371|NCT05552443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153543372|NCT05552443|Analgesics|analgesics|mesh-ancestor
153543373|NCT05552443|Sensory System Agents|sensory system agents|mesh-ancestor
153543374|NCT05552443|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153543375|NCT05527483|Listerine|listerine|mesh-list
153543376|NCT05527483|Fluorides|fluorides|mesh-list
153543377|NCT05527483|Sodium Fluoride|sodium fluoride|mesh-list
153543430|NCT05095259|Respiratory System Agents|respiratory system agents|mesh-ancestor
153543431|NCT05095259|Mydriatics|mydriatics|mesh-ancestor
153543432|NCT05095259|Sympathomimetics|sympathomimetics|mesh-ancestor
153543441|NCT05049278|Mydriatics|mydriatics|mesh-ancestor
153543442|NCT05049278|Autonomic Agents|autonomic agents|mesh-ancestor
153543443|NCT05049278|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153543444|NCT05049278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153543445|NCT05049278|Sympathomimetics|sympathomimetics|mesh-ancestor
153543446|NCT05049278|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
153543447|NCT05049278|Nasal Decongestants|nasal decongestants|mesh-ancestor
153543448|NCT05049278|Respiratory System Agents|respiratory system agents|mesh-ancestor
153543449|NCT05049278|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
153543450|NCT05049278|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153543451|NCT05049278|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153543452|NCT05049278|Adrenergic Agents|adrenergic agents|mesh-ancestor
153543453|NCT05049278|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153543454|NCT05049278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153543455|NCT05049278|Protective Agents|protective agents|mesh-ancestor
153543456|NCT04982354|Fludarabine|fludarabine|mesh-list
153543457|NCT04982354|Melphalan|melphalan|mesh-list
153543458|NCT04982354|Busulfan|busulfan|mesh-list
153543459|NCT04982354|Midostaurin|midostaurin|mesh-list
153543460|NCT04982354|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153543461|NCT04982354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153543462|NCT04982354|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153543463|NCT04982354|Immunologic Factors|immunologic factors|mesh-ancestor
153543464|NCT04982354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153543465|NCT04982354|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153543487|NCT04901715|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
153543488|NCT04901715|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
153543489|NCT04901715|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153543490|NCT04901715|Adrenergic Agents|adrenergic agents|mesh-ancestor
153543491|NCT04901715|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153543492|NCT04901715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153543493|NCT04895592|Dexamethasone|dexamethasone|mesh-list
153543494|NCT04895592|Dexamethasone acetate|dexamethasone acetate|mesh-list
153543495|NCT04895592|Ichthammol|ichthammol|mesh-list
153543496|NCT04895592|BB 1101|bb 1101|mesh-list
153730547|NCT00403988|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153543497|NCT04895592|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153543498|NCT04895592|Antiemetics|antiemetics|mesh-ancestor
153543499|NCT04895592|Autonomic Agents|autonomic agents|mesh-ancestor
153543500|NCT04895592|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153543525|NCT04843761|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
153543526|NCT04843761|Adrenergic Agents|adrenergic agents|mesh-ancestor
153543527|NCT04843761|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153543528|NCT04843761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153543529|NCT04843761|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153543530|NCT04843761|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153543531|NCT04843761|Vasodilator Agents|vasodilator agents|mesh-ancestor
153543532|NCT04843761|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
153543533|NCT04843761|Protective Agents|protective agents|mesh-ancestor
153543535|NCT04699604|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
153543536|NCT04699604|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
153543537|NCT04699604|Histamine Antagonists|histamine antagonists|mesh-ancestor
153543538|NCT04699604|Histamine Agents|histamine agents|mesh-ancestor
153543539|NCT04699604|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153543540|NCT04699604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153543541|NCT04699604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153543542|NCT04571164|Rotigotine|rotigotine|mesh-list
153543543|NCT04571164|Dopamine Agonists|dopamine agonists|mesh-ancestor
153543546|NCT04571164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153543547|NCT04571164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153543548|NCT04559880|Tranexamic Acid|tranexamic acid|mesh-list
153543565|NCT04496596|Antinematodal Agents|antinematodal agents|mesh-ancestor
153543566|NCT04496596|Anthelmintics|anthelmintics|mesh-ancestor
153543567|NCT04496596|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153543568|NCT04496596|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153543569|NCT04496596|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153543570|NCT04496596|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
153543571|NCT04496596|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153543572|NCT04312503|Olanzapine|olanzapine|mesh-list
153543573|NCT04312503|Risperidone|risperidone|mesh-list
153543574|NCT04312503|Aripiprazole|aripiprazole|mesh-list
153543575|NCT04312503|Quetiapine Fumarate|quetiapine fumarate|mesh-list
153618988|NCT01981447|Anticonvulsants|anticonvulsants|mesh-ancestor
153543576|NCT04312503|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
153543577|NCT04312503|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153543578|NCT04312503|Serotonin Agents|serotonin agents|mesh-ancestor
153543579|NCT04312503|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153543580|NCT04312503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153543581|NCT04312503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153543582|NCT04312503|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153543583|NCT04312503|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153543584|NCT04312503|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153543585|NCT04312503|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153543586|NCT04312503|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
153543587|NCT04312503|Dopamine Agents|dopamine agents|mesh-ancestor
153543588|NCT04312503|Antiemetics|antiemetics|mesh-ancestor
153543589|NCT04312503|Autonomic Agents|autonomic agents|mesh-ancestor
153543590|NCT04312503|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153543591|NCT04312503|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153543592|NCT04312503|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
153543593|NCT04312503|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153543594|NCT04312503|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153543600|NCT04312503|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
153543601|NCT04312503|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
153543602|NCT04312503|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
153543603|NCT04312503|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
153543604|NCT04312503|Adrenergic Agents|adrenergic agents|mesh-ancestor
153543605|NCT04305444|Everolimus|everolimus|mesh-list
153543606|NCT04305444|Pomalidomide|pomalidomide|mesh-list
153543607|NCT04305444|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
153730548|NCT00403988|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153543608|NCT04305444|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153543617|NCT04305444|Growth Substances|growth substances|mesh-ancestor
153543618|NCT04305444|Growth Inhibitors|growth inhibitors|mesh-ancestor
153543619|NCT04249063|Lidocaine|lidocaine|mesh-list
153543620|NCT04249063|Anesthetics|anesthetics|mesh-list
153543621|NCT04249063|Anesthetics, Local|anesthetics, local|mesh-list
153543622|NCT04249063|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153543623|NCT04249063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153543624|NCT04249063|Sensory System Agents|sensory system agents|mesh-ancestor
153543625|NCT04249063|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153543626|NCT04249063|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153543627|NCT04249063|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
153543628|NCT04249063|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153543629|NCT04249063|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153543630|NCT04249063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153543631|NCT04239040|Nivolumab|nivolumab|mesh-list
153543632|NCT04239040|Ipilimumab|ipilimumab|mesh-list
153543633|NCT04239040|Vaccines|vaccines|mesh-list
153543634|NCT04239040|Immunologic Factors|immunologic factors|mesh-ancestor
153543635|NCT04239040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153543636|NCT04239040|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153543637|NCT04239040|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153543638|NCT04239040|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153543639|NCT04239040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153543640|NCT04204252|Alpha 1-Antitrypsin|alpha 1-antitrypsin|mesh-list
153543641|NCT04204252|Protein C Inhibitor|protein c inhibitor|mesh-list
153543642|NCT04204252|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
153543645|NCT04204252|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153543646|NCT04204252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153543647|NCT04192955|Salicylates|salicylates|mesh-list
153543648|NCT04192955|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153543649|NCT04192955|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153543650|NCT04192955|Analgesics|analgesics|mesh-ancestor
153543651|NCT04192955|Sensory System Agents|sensory system agents|mesh-ancestor
153543652|NCT04192955|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153543653|NCT04192955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153543654|NCT04192955|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153543655|NCT04192955|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153543656|NCT04192955|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153543657|NCT04192955|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153543658|NCT04192955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153543659|NCT04184869|Atazanavir Sulfate|atazanavir sulfate|mesh-list
153543660|NCT04184869|Belinostat|belinostat|mesh-list
153543661|NCT04184869|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
153543662|NCT04184869|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
153543663|NCT04184869|Protease Inhibitors|protease inhibitors|mesh-ancestor
153543664|NCT04184869|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153543665|NCT04184869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153543666|NCT04184869|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153543667|NCT04184869|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153543668|NCT04184869|Antiviral Agents|antiviral agents|mesh-ancestor
153543669|NCT04184869|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153543670|NCT04184869|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153543671|NCT04184869|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
153543672|NCT04175262|Sunitinib|sunitinib|mesh-list
153543680|NCT04175262|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153543684|NCT04149899|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
153543693|NCT04137536|Immunologic Factors|immunologic factors|mesh-ancestor
153543694|NCT04137536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153543696|NCT04087421|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
153543697|NCT04087421|Protective Agents|protective agents|mesh-ancestor
153543698|NCT04087421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153543699|NCT04014075|Trastuzumab|trastuzumab|mesh-list
153543700|NCT04014075|Trastuzumab deruxtecan|trastuzumab deruxtecan|mesh-list
153543701|NCT04014075|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153543702|NCT04014075|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153543703|NCT04014075|Immunoconjugates|immunoconjugates|mesh-ancestor
153543704|NCT04014075|Immunologic Factors|immunologic factors|mesh-ancestor
153543705|NCT04014075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153543706|NCT03983993|Panitumumab|panitumumab|mesh-list
153543707|NCT03983993|Niraparib|niraparib|mesh-list
153543708|NCT03983993|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153543709|NCT03983993|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153543710|NCT03983993|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
153464587|NCT04696224|Tranexamic Acid|tranexamic acid|mesh-list
153543711|NCT03983993|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153543712|NCT03983993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153543713|NCT03909152|Anastrozole|anastrozole|mesh-list
153543714|NCT03909152|Onapristone|onapristone|mesh-list
153543715|NCT03909152|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153543716|NCT03909152|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153543717|NCT03909152|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
153543718|NCT03909152|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153543719|NCT03909152|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153543720|NCT03909152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153543721|NCT03909152|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
153543722|NCT03909152|Hormone Antagonists|hormone antagonists|mesh-ancestor
153543738|NCT03776864|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153543764|NCT03664180|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153543765|NCT03664180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153543766|NCT03664180|Antithrombins|antithrombins|mesh-ancestor
153543767|NCT03664180|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
153543768|NCT03664180|Protease Inhibitors|protease inhibitors|mesh-ancestor
153543769|NCT03664180|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153543770|NCT03652870|Dexetimide|dexetimide|mesh-list
153543771|NCT03652870|Citalopram|citalopram|mesh-list
153543772|NCT03652870|Nortriptyline|nortriptyline|mesh-list
153543773|NCT03652870|Escitalopram|escitalopram|mesh-list
153543774|NCT03652870|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
153543775|NCT03652870|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153543776|NCT03652870|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153543777|NCT03652870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153543778|NCT03652870|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153543779|NCT03652870|Serotonin Agents|serotonin agents|mesh-ancestor
153543780|NCT03652870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153543781|NCT03652870|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
153543782|NCT03652870|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
153543783|NCT03652870|Parasympatholytics|parasympatholytics|mesh-ancestor
153543784|NCT03652870|Autonomic Agents|autonomic agents|mesh-ancestor
153543785|NCT03652870|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153543786|NCT03652870|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
153543787|NCT03652870|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
153543788|NCT03652870|Cholinergic Agents|cholinergic agents|mesh-ancestor
153543802|NCT03634852|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
153543803|NCT03634852|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153543804|NCT03634852|Antiemetics|antiemetics|mesh-ancestor
153543805|NCT03634852|Autonomic Agents|autonomic agents|mesh-ancestor
153543806|NCT03634852|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153543815|NCT03634852|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153543816|NCT03634852|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153543817|NCT03634852|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153543818|NCT03634852|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153543819|NCT03634852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153543820|NCT03634852|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
153543821|NCT03634852|Contraceptive Agents|contraceptive agents|mesh-ancestor
153543822|NCT03634852|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153543823|NCT03634852|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
153543824|NCT03634852|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
153543825|NCT03634852|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
153543826|NCT03634852|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
153543827|NCT03634852|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153543828|NCT03634852|Immunologic Factors|immunologic factors|mesh-ancestor
153543830|NCT03593811|Ondansetron|ondansetron|mesh-list
153543831|NCT03593811|Antiemetics|antiemetics|mesh-ancestor
153543832|NCT03593811|Autonomic Agents|autonomic agents|mesh-ancestor
153543833|NCT03593811|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153543834|NCT03593811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153543835|NCT03593811|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153543836|NCT03593811|Antipruritics|antipruritics|mesh-ancestor
153543837|NCT03593811|Dermatologic Agents|dermatologic agents|mesh-ancestor
153543838|NCT03593811|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
153543839|NCT03593811|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153543840|NCT03593811|Serotonin Agents|serotonin agents|mesh-ancestor
153543841|NCT03593811|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153543842|NCT03593811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153543843|NCT03593811|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
153543845|NCT03593811|Histamine Agents|histamine agents|mesh-ancestor
153543868|NCT03463408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153543869|NCT03420144|Hormones|hormones|mesh-list
153618989|NCT01981447|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
153543870|NCT03420144|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153543871|NCT03420144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153543872|NCT03384784|Galantamine|galantamine|mesh-list
153543873|NCT03384784|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
153543874|NCT03384784|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153543875|NCT03384784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153543876|NCT03384784|Cholinergic Agents|cholinergic agents|mesh-ancestor
153543877|NCT03384784|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153543878|NCT03384784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153543879|NCT03384784|Parasympathomimetics|parasympathomimetics|mesh-ancestor
153543880|NCT03384784|Autonomic Agents|autonomic agents|mesh-ancestor
153543881|NCT03384784|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153543882|NCT03384784|Nootropic Agents|nootropic agents|mesh-ancestor
153543883|NCT03383094|Pembrolizumab|pembrolizumab|mesh-list
153543884|NCT03383094|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153730551|NCT00403988|Mitosis Modulators|mitosis modulators|mesh-ancestor
153455633|NCT05603650|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
153442689|NCT02111850|Aldesleukin|aldesleukin|mesh-list
153810999|NCT00353067|2-(4-(quinolin-2-yl-methoxy)phenyl)-2-cyclopentylacetic acid|2-(4-(quinolin-2-yl-methoxy)phenyl)-2-cyclopentylacetic acid|mesh-list
153730552|NCT00403988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153543885|NCT03383094|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153543886|NCT03383094|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153543887|NCT03383094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153543888|NCT03344419|Ketamine|ketamine|mesh-list
153543889|NCT03344419|Analgesics|analgesics|mesh-ancestor
153543890|NCT03344419|Sensory System Agents|sensory system agents|mesh-ancestor
153543891|NCT03344419|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153543892|NCT03344419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153543893|NCT03344419|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
153543894|NCT03344419|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153543901|NCT03344419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153543902|NCT03321526|Norepinephrine|norepinephrine|mesh-list
153543903|NCT03321526|Quetiapine Fumarate|quetiapine fumarate|mesh-list
153543904|NCT03321526|Serotonin|serotonin|mesh-list
153543922|NCT03321526|Serotonin Agents|serotonin agents|mesh-ancestor
153543923|NCT03321526|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153543924|NCT03321526|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153543925|NCT03297593|Nivolumab|nivolumab|mesh-list
153543926|NCT03297593|Ipilimumab|ipilimumab|mesh-list
153543927|NCT03297593|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153543928|NCT03297593|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153543929|NCT03297593|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153543930|NCT03297593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153543931|NCT03217669|Sirolimus|sirolimus|mesh-list
153543932|NCT03217669|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153543933|NCT03217669|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153543934|NCT03217669|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153543935|NCT03217669|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153543936|NCT03217669|Antifungal Agents|antifungal agents|mesh-ancestor
153543937|NCT03217669|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153543938|NCT03217669|Immunologic Factors|immunologic factors|mesh-ancestor
153543939|NCT03217669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153543940|NCT03196427|Vedolizumab|vedolizumab|mesh-list
153543941|NCT03196427|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153543942|NCT03185819|Midazolam|midazolam|mesh-list
153543943|NCT03185819|Esketamine|esketamine|mesh-list
153543944|NCT03185819|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153543945|NCT03185819|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153543946|NCT03185819|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153543947|NCT03185819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153543948|NCT03185819|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153543949|NCT03185819|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153543950|NCT03185819|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153543951|NCT03185819|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153543952|NCT03185819|Anesthetics, General|anesthetics, general|mesh-ancestor
153543953|NCT03185819|Anesthetics|anesthetics|mesh-ancestor
153543954|NCT03185819|GABA Modulators|gaba modulators|mesh-ancestor
153543958|NCT03185819|Antidepressive Agents|antidepressive agents|mesh-ancestor
153543959|NCT03153111|Macitentan|macitentan|mesh-list
153543960|NCT03153111|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
153543961|NCT03153111|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
153543985|NCT03084939|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153543986|NCT03084939|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153543987|NCT03084939|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153543988|NCT03084939|Tubulin Modulators|tubulin modulators|mesh-ancestor
153543989|NCT03084939|Antimitotic Agents|antimitotic agents|mesh-ancestor
153543990|NCT03084939|Mitosis Modulators|mitosis modulators|mesh-ancestor
153543992|NCT03084939|Immunoconjugates|immunoconjugates|mesh-ancestor
153543993|NCT03084939|Immunologic Factors|immunologic factors|mesh-ancestor
153543994|NCT03084939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153543995|NCT03011684|Tamoxifen|tamoxifen|mesh-list
153543996|NCT03011684|Letrozole|letrozole|mesh-list
153730553|NCT00134186|Motexafin gadolinium|motexafin gadolinium|mesh-list
153543997|NCT03011684|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153543998|NCT03011684|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
153543999|NCT03011684|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153544000|NCT03011684|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153544001|NCT03011684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153544002|NCT03011684|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
153544003|NCT03011684|Hormone Antagonists|hormone antagonists|mesh-ancestor
153544004|NCT03011684|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153544005|NCT03011684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153544006|NCT03011684|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153544007|NCT03011684|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
153544008|NCT03011684|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
153544009|NCT03011684|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153544011|NCT02968108|Dermatologic Agents|dermatologic agents|mesh-ancestor
153544091|NCT02360280|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153544092|NCT02360280|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153544107|NCT02174575|Anesthetics|anesthetics|mesh-ancestor
153544108|NCT02174575|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153544109|NCT02174575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153544110|NCT01889810|Vitamin D|vitamin d|mesh-list
153544111|NCT01889810|Cholecalciferol|cholecalciferol|mesh-list
153544112|NCT01889810|Vitamins|vitamins|mesh-ancestor
153544113|NCT01889810|Micronutrients|micronutrients|mesh-ancestor
153544114|NCT01889810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153544115|NCT01889810|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153544116|NCT01889810|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153544117|NCT01840592|Doxorubicin|doxorubicin|mesh-list
153544118|NCT01840592|Sorafenib|sorafenib|mesh-list
153544119|NCT01840592|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153544120|NCT01840592|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153544121|NCT01840592|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153544122|NCT01840592|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153544123|NCT01840592|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153544124|NCT01840592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153544125|NCT01840592|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153544126|NCT01734694|Vancomycin|vancomycin|mesh-list
153544127|NCT01734694|Linezolid|linezolid|mesh-list
153544128|NCT01734694|Daptomycin|daptomycin|mesh-list
153544129|NCT01734694|Ceftaroline|ceftaroline|mesh-list
153544130|NCT01734694|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153544136|NCT01599234|Nabiximols|nabiximols|mesh-list
153544153|NCT00713817|Sensory System Agents|sensory system agents|mesh-ancestor
153544154|NCT00713817|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153544155|NCT00713817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153544157|NCT00713323|Analgesics|analgesics|mesh-ancestor
153544189|NCT00710424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153544190|NCT00674609|Nabiximols|nabiximols|mesh-list
153544191|NCT00674609|Analgesics|analgesics|mesh-ancestor
153544192|NCT00674609|Sensory System Agents|sensory system agents|mesh-ancestor
153544193|NCT00674609|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153544194|NCT00674609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153544195|NCT01556646|Tolvaptan|tolvaptan|mesh-list
153544196|NCT01556646|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
153544197|NCT01556646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153544198|NCT01556646|Natriuretic Agents|natriuretic agents|mesh-ancestor
153544199|NCT01556646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153544200|NCT01556659|Acenocoumarol|acenocoumarol|mesh-list
153544201|NCT01556659|Anticoagulants|anticoagulants|mesh-ancestor
153544324|NCT01557335|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153544325|NCT01557335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153544326|NCT01557335|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153544327|NCT01557335|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153544328|NCT01557335|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153544329|NCT01557335|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153544330|NCT01557335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153544331|NCT01557335|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153544332|NCT01557335|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153544333|NCT01557335|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153544334|NCT01557335|Antipyretics|antipyretics|mesh-ancestor
153544365|NCT01557478|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153544367|NCT01557634|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153730554|NCT00134186|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153730555|NCT00134186|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
153544368|NCT01557634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153544370|NCT01557647|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153544371|NCT01557660|Treprostinil|treprostinil|mesh-list
153544372|NCT01557660|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153544373|NCT01557712|Ketamine|ketamine|mesh-list
153544374|NCT01557712|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
153544375|NCT01557712|Analgesics|analgesics|mesh-ancestor
153544376|NCT01557712|Sensory System Agents|sensory system agents|mesh-ancestor
153544377|NCT01557712|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153544411|NCT01557816|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153544412|NCT01557816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153544534|NCT01558713|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153544535|NCT01558713|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153544536|NCT01558713|Anesthetics, General|anesthetics, general|mesh-ancestor
153544537|NCT01558830|Ranolazine|ranolazine|mesh-list
153544562|NCT01558934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153544564|NCT01558960|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153544565|NCT01558960|Alkylating Agents|alkylating agents|mesh-ancestor
153544566|NCT01558960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153544567|NCT01558960|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153544568|NCT01558960|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153544569|NCT01558960|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153544570|NCT01558960|Immunologic Factors|immunologic factors|mesh-ancestor
153544571|NCT01558960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153544573|NCT01558986|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153544574|NCT01558986|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153544575|NCT01559025|Vildagliptin|vildagliptin|mesh-list
153544576|NCT01559025|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
153544577|NCT01559025|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153544578|NCT01559025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153544579|NCT01559025|Protease Inhibitors|protease inhibitors|mesh-ancestor
153544580|NCT01559025|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153544581|NCT01559025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153544582|NCT01559051|Anesthetics|anesthetics|mesh-list
153544583|NCT01559051|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153544612|NCT01559272|Dopamine Agents|dopamine agents|mesh-ancestor
153544613|NCT01559285|Ropivacaine|ropivacaine|mesh-list
153544614|NCT01559285|Anesthetics, Local|anesthetics, local|mesh-ancestor
153544615|NCT01559285|Anesthetics|anesthetics|mesh-ancestor
153544616|NCT01559285|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153544617|NCT01559285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153544626|NCT01559298|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153730556|NCT00134186|Dermatologic Agents|dermatologic agents|mesh-ancestor
153730557|NCT00141648|Prednisolone|prednisolone|mesh-list
153544627|NCT01559298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153544640|NCT01559298|Purinergic Agents|purinergic agents|mesh-ancestor
153544641|NCT01559298|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153544642|NCT01559480|Desogestrel|desogestrel|mesh-list
153544643|NCT01559480|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
153544644|NCT01559480|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
153544645|NCT01559480|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
153544646|NCT01559480|Contraceptive Agents|contraceptive agents|mesh-ancestor
153544647|NCT01559480|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153544648|NCT01559480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153544649|NCT01559480|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
153544650|NCT01559480|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
153544651|NCT01559480|Progestins|progestins|mesh-ancestor
153544653|NCT01559480|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153544654|NCT01559545|Metronidazole|metronidazole|mesh-list
153544655|NCT01559545|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153544656|NCT01559545|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153544657|NCT01559545|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153544658|NCT01559545|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153544659|NCT01559584|Triamcinolone|triamcinolone|mesh-list
153544660|NCT01559584|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
153544661|NCT01559584|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
153544662|NCT01559584|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
153544663|NCT01559584|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153544683|NCT01559740|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153544684|NCT01559740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153544685|NCT01559740|Sensory System Agents|sensory system agents|mesh-ancestor
153544705|NCT01559974|Vitamin D|vitamin d|mesh-list
153544706|NCT01559974|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153544707|NCT01559974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153544708|NCT01559974|Vitamins|vitamins|mesh-ancestor
153544710|NCT01559974|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153544711|NCT01560117|Rituximab|rituximab|mesh-list
153544712|NCT01560117|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153544713|NCT01560117|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153544714|NCT01560117|Immunologic Factors|immunologic factors|mesh-ancestor
153544715|NCT01560117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153544716|NCT01560117|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153544717|NCT05570669|Simethicone|simethicone|mesh-list
153544718|NCT05570669|Sodium sulfate|sodium sulfate|mesh-list
153544719|NCT05570669|Antifoaming Agents|antifoaming agents|mesh-ancestor
153544720|NCT05570669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153544721|NCT05570669|Emollients|emollients|mesh-ancestor
153544722|NCT05570669|Dermatologic Agents|dermatologic agents|mesh-ancestor
153544723|NCT05570669|Cathartics|cathartics|mesh-ancestor
153544813|NCT05522582|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153544814|NCT05522582|Dermatologic Agents|dermatologic agents|mesh-ancestor
153544815|NCT05522582|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153544816|NCT05522582|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153544817|NCT05522582|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153544818|NCT05522582|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153544819|NCT05522582|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153544832|NCT05491304|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153544833|NCT05491304|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153544834|NCT05491304|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153544835|NCT05491304|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153544836|NCT05491304|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153544837|NCT05491304|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153544838|NCT05491304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153544839|NCT05391555|Remifentanil|remifentanil|mesh-list
153544840|NCT05391555|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153544841|NCT05391555|Narcotics|narcotics|mesh-ancestor
153544842|NCT05391555|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153544844|NCT05391555|Analgesics|analgesics|mesh-ancestor
153544874|NCT04705051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153544876|NCT04696952|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153544877|NCT04696952|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153544878|NCT04696952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153544879|NCT04496999|Midostaurin|midostaurin|mesh-list
153544880|NCT04496999|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153544891|NCT04298853|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153544893|NCT04232683|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
153544894|NCT04232683|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
153544895|NCT04232683|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
153544896|NCT04232683|Adrenergic Agents|adrenergic agents|mesh-ancestor
153544897|NCT04232683|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153544898|NCT04232683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153544899|NCT04232683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153544900|NCT04232683|Urological Agents|urological agents|mesh-ancestor
153544901|NCT04101227|Ondansetron|ondansetron|mesh-list
153544902|NCT04101227|Antiemetics|antiemetics|mesh-ancestor
153544903|NCT04101227|Autonomic Agents|autonomic agents|mesh-ancestor
153544904|NCT04101227|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153544905|NCT04101227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153544906|NCT04101227|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153544907|NCT04101227|Antipruritics|antipruritics|mesh-ancestor
153544908|NCT04101227|Dermatologic Agents|dermatologic agents|mesh-ancestor
153544909|NCT04101227|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
153544910|NCT04101227|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153544911|NCT04101227|Serotonin Agents|serotonin agents|mesh-ancestor
153544912|NCT04101227|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153544914|NCT04047004|Doxorubicin|doxorubicin|mesh-list
153544925|NCT03893435|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
153544926|NCT03893435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153544927|NCT03813121|Midazolam|midazolam|mesh-list
153544928|NCT03813121|Ketamine|ketamine|mesh-list
153544929|NCT03813121|Analgesics|analgesics|mesh-ancestor
153544930|NCT03813121|Sensory System Agents|sensory system agents|mesh-ancestor
153544931|NCT03813121|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153544932|NCT03813121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153544933|NCT03813121|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
153544934|NCT03813121|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153544935|NCT03813121|Anesthetics, General|anesthetics, general|mesh-ancestor
153544936|NCT03813121|Anesthetics|anesthetics|mesh-ancestor
153544937|NCT03813121|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153544938|NCT03813121|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
153544939|NCT03813121|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
153544940|NCT03813121|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153544941|NCT03813121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153544942|NCT03813121|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153544956|NCT03710590|Cholinergic Agents|cholinergic agents|mesh-ancestor
153544957|NCT03710590|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153544958|NCT03710590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153544959|NCT03676725|Lidocaine|lidocaine|mesh-list
153544960|NCT03676725|Anesthetics, Local|anesthetics, local|mesh-ancestor
153544961|NCT03676725|Anesthetics|anesthetics|mesh-ancestor
153544962|NCT03676725|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153544963|NCT03676725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153544964|NCT03676725|Sensory System Agents|sensory system agents|mesh-ancestor
153544965|NCT03676725|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153730561|NCT00141648|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153544966|NCT03676725|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153544968|NCT03676725|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153544977|NCT03425591|Ibrutinib|ibrutinib|mesh-list
153544978|NCT03425591|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153544979|NCT03425591|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153544980|NCT03425591|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153544981|NCT03425591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153544982|NCT03280511|Oxaliplatin|oxaliplatin|mesh-list
153544983|NCT03280511|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153544984|NCT03205423|Gabapentin|gabapentin|mesh-list
153544986|NCT03205423|Sensory System Agents|sensory system agents|mesh-ancestor
153544987|NCT03205423|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153544988|NCT03205423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153544989|NCT03205423|Anticonvulsants|anticonvulsants|mesh-ancestor
153815051|NCT00454272|Vancomycin|vancomycin|mesh-list
153544990|NCT03205423|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153357553|NCT04272320|Bupivacaine|bupivacaine|mesh-list
153357554|NCT04272320|Anesthetics, Local|anesthetics, local|mesh-ancestor
153544991|NCT03205423|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153544992|NCT03205423|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153544993|NCT03205423|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153544994|NCT03205423|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
153544995|NCT03205423|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
153544996|NCT03205423|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153544997|NCT03205423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153544998|NCT03205423|Antimanic Agents|antimanic agents|mesh-ancestor
153544999|NCT02918006|Vaccines|vaccines|mesh-list
153545000|NCT02918006|Immunologic Factors|immunologic factors|mesh-ancestor
153545042|NCT02553941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153545043|NCT02553941|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153545044|NCT02553941|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153545045|NCT02553941|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153545046|NCT02553941|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153545047|NCT02546492|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
153545048|NCT02546492|Melanocyte-Stimulating Hormones|melanocyte-stimulating hormones|mesh-list
153545049|NCT02546492|beta-Endorphin|beta-endorphin|mesh-list
153545050|NCT02546492|Hormones|hormones|mesh-ancestor
153545051|NCT02546492|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153730562|NCT00141648|Immunologic Factors|immunologic factors|mesh-ancestor
153730563|NCT00141648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153545052|NCT02546492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153545053|NCT02546492|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153545054|NCT02546492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153545055|NCT02527564|Suvorexant|suvorexant|mesh-list
153545056|NCT02527564|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
153545057|NCT02527564|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153545058|NCT02527564|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153545059|NCT02527564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153545060|NCT02527564|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
153545061|NCT02527564|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153545062|NCT02527564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153545063|NCT02179749|Mifepristone|mifepristone|mesh-list
153545064|NCT02179749|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
153545065|NCT02179749|Abortifacient Agents|abortifacient agents|mesh-ancestor
153545073|NCT02179749|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
153545074|NCT02179749|Hormone Antagonists|hormone antagonists|mesh-ancestor
153545075|NCT02179749|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153545076|NCT02179749|Luteolytic Agents|luteolytic agents|mesh-ancestor
153545077|NCT02179749|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
153545078|NCT02179749|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
153545079|NCT02065609|Trastuzumab|trastuzumab|mesh-list
153545080|NCT02065609|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153545082|NCT00641186|Sodium Oxybate|sodium oxybate|mesh-list
153545083|NCT00641186|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153545084|NCT00641186|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153545085|NCT00641186|Anesthetics, General|anesthetics, general|mesh-ancestor
153545086|NCT00641186|Anesthetics|anesthetics|mesh-ancestor
153545087|NCT00641186|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153545088|NCT00641186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153545089|NCT01561482|Metformin|metformin|mesh-list
153545090|NCT01561482|Simvastatin|simvastatin|mesh-list
153545091|NCT01561482|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153545092|NCT01561482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153545093|NCT01561482|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153545094|NCT01561482|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153545095|NCT01561482|Antimetabolites|antimetabolites|mesh-ancestor
153545096|NCT01561482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153545097|NCT01561482|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153545098|NCT01561482|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
153545099|NCT01561482|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153545100|NCT01561586|Cisplatin|cisplatin|mesh-list
153545101|NCT01561586|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153545102|NCT01562704|Acetaminophen|acetaminophen|mesh-list
153545103|NCT01562704|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153545104|NCT01562704|Analgesics|analgesics|mesh-ancestor
153545105|NCT01562704|Sensory System Agents|sensory system agents|mesh-ancestor
153545106|NCT01562704|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153545107|NCT01562704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153545108|NCT01562704|Antipyretics|antipyretics|mesh-ancestor
153545109|NCT01564095|Tryptophan|tryptophan|mesh-list
153545110|NCT01564095|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
153545111|NCT01564095|Tacrolimus|tacrolimus|mesh-list
153545112|NCT01564095|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153545113|NCT01564095|Immunologic Factors|immunologic factors|mesh-ancestor
153545114|NCT01564095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153545125|NCT01564238|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153730564|NCT00141648|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153730565|NCT00141648|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153545127|NCT01564576|Rocuronium|rocuronium|mesh-list
153545128|NCT01564576|Anticonvulsants|anticonvulsants|mesh-ancestor
153545129|NCT01564576|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
153545130|NCT01564576|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
153545131|NCT01564576|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
153545132|NCT01564576|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153545146|NCT01564823|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153545147|NCT01564823|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153545148|NCT01564823|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153545149|NCT01564823|Immunologic Factors|immunologic factors|mesh-ancestor
153545150|NCT01564823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153545151|NCT01565239|Thrombin|thrombin|mesh-list
153545152|NCT01565239|Hemostatics|hemostatics|mesh-ancestor
153545153|NCT01565239|Coagulants|coagulants|mesh-ancestor
153545154|NCT01565265|Cetrorelix|cetrorelix|mesh-list
153545155|NCT01565265|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
153545156|NCT01565265|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
153545157|NCT01565265|Hormones|hormones|mesh-ancestor
153545158|NCT01565265|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153545159|NCT01565265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153545160|NCT01565265|Fertility Agents, Female|fertility agents, female|mesh-ancestor
153545161|NCT01565265|Fertility Agents|fertility agents|mesh-ancestor
153545162|NCT01565265|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153545163|NCT01565265|Hormone Antagonists|hormone antagonists|mesh-ancestor
153545164|NCT01566292|Botulinum Toxins|botulinum toxins|mesh-list
153545165|NCT01566292|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
153545179|NCT01566760|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
153545180|NCT01566760|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
153545181|NCT01566760|Cholinergic Agents|cholinergic agents|mesh-ancestor
153545182|NCT01566760|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153545183|NCT01566760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153545184|NCT01566760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153545185|NCT01566760|Urological Agents|urological agents|mesh-ancestor
153545186|NCT01566890|Regadenoson|regadenoson|mesh-list
153545187|NCT01566890|Adenosine A2 Receptor Agonists|adenosine a2 receptor agonists|mesh-ancestor
153545188|NCT01566890|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
153545189|NCT01566890|Purinergic Agonists|purinergic agonists|mesh-ancestor
153545190|NCT01566890|Purinergic Agents|purinergic agents|mesh-ancestor
153545191|NCT01566890|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153545192|NCT01566890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153545199|NCT01567072|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153545200|NCT01567072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153545202|NCT01567072|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153545203|NCT01567072|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153545204|NCT01567072|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153618992|NCT01981447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153545205|NCT01567072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153545206|NCT01567423|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
153545207|NCT01567423|Antimalarials|antimalarials|mesh-ancestor
153545208|NCT01567423|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153545209|NCT01567423|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153545227|NCT01568645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153545228|NCT01568645|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153545229|NCT01568645|Antioxidants|antioxidants|mesh-ancestor
153545230|NCT01568645|Protective Agents|protective agents|mesh-ancestor
153545231|NCT01568645|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153545232|NCT01568645|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153545233|NCT01568645|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153545234|NCT01568645|Vasodilator Agents|vasodilator agents|mesh-ancestor
153545235|NCT01568645|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
153545236|NCT01568645|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
153545238|NCT01568684|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
153545239|NCT01568684|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153545240|NCT01568684|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153545241|NCT01568684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153545242|NCT01568684|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153545243|NCT01568684|Serotonin Agents|serotonin agents|mesh-ancestor
153545244|NCT01568684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153545245|NCT01568684|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
153545246|NCT01568684|Antidepressive Agents|antidepressive agents|mesh-ancestor
153545247|NCT01568684|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153545248|NCT01569685|Sertraline|sertraline|mesh-list
153545249|NCT01569685|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
153545250|NCT01569685|Antidepressive Agents|antidepressive agents|mesh-ancestor
153545251|NCT01569685|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153455634|NCT05603650|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153545252|NCT01569685|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
153545253|NCT01569685|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153545254|NCT01569685|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153545255|NCT01569685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153545265|NCT01570049|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153545266|NCT01570088|Folic Acid|folic acid|mesh-list
153545267|NCT01570088|Hematinics|hematinics|mesh-ancestor
153545268|NCT01570088|Vitamin B Complex|vitamin b complex|mesh-ancestor
153545269|NCT01570088|Vitamins|vitamins|mesh-ancestor
153545270|NCT01570088|Micronutrients|micronutrients|mesh-ancestor
153571351|NCT04402658|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153545271|NCT01570088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153545272|NCT06310057|Tofacitinib|tofacitinib|mesh-list
153545273|NCT06310057|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
153545274|NCT06310057|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153545275|NCT06310057|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153545276|NCT06310057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153545277|NCT06310044|Root Canal Irrigants|root canal irrigants|mesh-list
153545278|NCT06310044|Dental Disinfectants|dental disinfectants|mesh-ancestor
153545279|NCT06310044|Disinfectants|disinfectants|mesh-ancestor
153545280|NCT06310044|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153545281|NCT06309914|Grape Seed Extract|grape seed extract|mesh-list
153545282|NCT06309914|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153545283|NCT06309914|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153545284|NCT06309914|Antioxidants|antioxidants|mesh-ancestor
153545285|NCT06309914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153545286|NCT06309914|Protective Agents|protective agents|mesh-ancestor
153545287|NCT06309914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153545288|NCT06309745|Carboplatin|carboplatin|mesh-list
153545289|NCT06309745|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153545290|NCT06309732|Dactinomycin|dactinomycin|mesh-list
153730568|NCT00141648|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153545291|NCT06309732|Methotrexate|methotrexate|mesh-list
153545292|NCT06309732|Etoposide|etoposide|mesh-list
153545293|NCT06309732|Epirubicin|epirubicin|mesh-list
153545294|NCT06309732|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153545295|NCT06309732|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
153545296|NCT06309732|Abortifacient Agents|abortifacient agents|mesh-ancestor
153545297|NCT06309732|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153545298|NCT06309732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153545299|NCT06309732|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153545300|NCT06309732|Antimetabolites|antimetabolites|mesh-ancestor
153545301|NCT06309732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153545302|NCT06309732|Dermatologic Agents|dermatologic agents|mesh-ancestor
153545303|NCT06309732|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153545304|NCT06309732|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153545305|NCT06309732|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153571352|NCT04402658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153816667|NCT00458991|Levomethorphan|levomethorphan|mesh-list
153816668|NCT00458991|Dextromethorphan|dextromethorphan|mesh-list
153816669|NCT00458991|Caffeine|caffeine|mesh-list
153545306|NCT06309732|Immunologic Factors|immunologic factors|mesh-ancestor
153545307|NCT06309732|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153545308|NCT06309732|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153545309|NCT06309732|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153545310|NCT06309732|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153545311|NCT06309732|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153545312|NCT06309732|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153545313|NCT06309732|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153545314|NCT06309732|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153545315|NCT06309732|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
153545316|NCT06309719|Hyaluronic Acid|hyaluronic acid|mesh-list
153545317|NCT06309719|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153545318|NCT06309719|Immunologic Factors|immunologic factors|mesh-ancestor
153545319|NCT06309719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153545334|NCT06309485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153545336|NCT06309472|Antidepressive Agents|antidepressive agents|mesh-ancestor
153545337|NCT06309472|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153545338|NCT06309472|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
153545339|NCT06309472|Histamine Antagonists|histamine antagonists|mesh-ancestor
153545340|NCT06309472|Histamine Agents|histamine agents|mesh-ancestor
153545341|NCT06309472|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153545342|NCT06309472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153545343|NCT06309472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153545344|NCT06309472|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153545345|NCT06309472|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153545346|NCT06309472|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153545365|NCT06308978|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153545366|NCT06308978|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153545367|NCT06308978|Alkylating Agents|alkylating agents|mesh-ancestor
153545368|NCT06308978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153545369|NCT06308978|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153545370|NCT06308978|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153545371|NCT06308952|Atorvastatin|atorvastatin|mesh-list
153545372|NCT06308952|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153545373|NCT06308952|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153545374|NCT06308952|Antimetabolites|antimetabolites|mesh-ancestor
153545375|NCT06308952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153545376|NCT06308952|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153730569|NCT00141648|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153730570|NCT00141648|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153545377|NCT06308952|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
153545378|NCT06308952|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153545380|NCT06308887|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
153545381|NCT06308887|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
153545408|NCT06308588|Asciminib|asciminib|mesh-list
153545435|NCT06308406|Growth Inhibitors|growth inhibitors|mesh-ancestor
153545436|NCT06308367|Betaine|betaine|mesh-list
153545437|NCT06308367|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153545451|NCT06307808|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153545452|NCT06307808|Immunologic Factors|immunologic factors|mesh-ancestor
153545453|NCT06307808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153545454|NCT06307808|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153545455|NCT06307808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153545456|NCT06307808|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153545457|NCT06307808|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153545458|NCT06307808|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153545459|NCT06307808|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153545460|NCT06307717|Anesthetics|anesthetics|mesh-list
153545461|NCT06307717|Sevoflurane|sevoflurane|mesh-list
153545462|NCT06307717|Desflurane|desflurane|mesh-list
153545463|NCT06307717|Isoflurane|isoflurane|mesh-list
153545464|NCT06307717|Anesthetics, Inhalation|anesthetics, inhalation|mesh-list
153545465|NCT06307717|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153545466|NCT06307717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153545467|NCT06307717|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153545468|NCT06307717|Anesthetics, General|anesthetics, general|mesh-ancestor
153545469|NCT06307678|Calcium, Dietary|calcium, dietary|mesh-list
153545470|NCT06307678|Calcium|calcium|mesh-list
153545471|NCT06307678|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153545472|NCT06307678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153545473|NCT06307678|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153545474|NCT06307652|Dapagliflozin|dapagliflozin|mesh-list
153545475|NCT06307652|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
153545476|NCT06307652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153545489|NCT06305416|Ranibizumab|ranibizumab|mesh-list
153545490|NCT06305416|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153545496|NCT06305299|Cyclophosphamide|cyclophosphamide|mesh-list
153545510|NCT06305221|Sufentanil|sufentanil|mesh-list
153545511|NCT06305221|Dexmedetomidine|dexmedetomidine|mesh-list
153545512|NCT06305221|Remifentanil|remifentanil|mesh-list
153545513|NCT06305221|Analgesics|analgesics|mesh-list
153545514|NCT06305221|Analgesics, Opioid|analgesics, opioid|mesh-list
153545515|NCT06305221|Anesthetics|anesthetics|mesh-list
153545516|NCT06305221|Esketamine|esketamine|mesh-list
153545517|NCT06305221|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153545518|NCT06305221|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153545519|NCT06305221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153545520|NCT06305221|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153545521|NCT06305221|Sensory System Agents|sensory system agents|mesh-ancestor
153545522|NCT06305221|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153545523|NCT06305221|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
153545524|NCT06305221|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153545525|NCT06305221|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153545526|NCT06305221|Adrenergic Agents|adrenergic agents|mesh-ancestor
153545527|NCT06305221|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153545528|NCT06305221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153545529|NCT06305221|Narcotics|narcotics|mesh-ancestor
153545530|NCT06305221|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153545531|NCT06305221|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153545532|NCT06305221|Anesthetics, General|anesthetics, general|mesh-ancestor
153545533|NCT06305221|Antidepressive Agents|antidepressive agents|mesh-ancestor
153545534|NCT06305221|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153545535|NCT06304987|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
153545536|NCT06304987|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-list
153545537|NCT06304987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153545538|NCT06304987|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153545539|NCT06304987|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153545540|NCT06304987|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153545566|NCT06304896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153545567|NCT06304896|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153545585|NCT06304896|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153545586|NCT06304896|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153545587|NCT06304896|Vasodilator Agents|vasodilator agents|mesh-ancestor
153545588|NCT06304896|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
153545589|NCT06304896|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
153545590|NCT06304896|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
153545591|NCT06304896|Protease Inhibitors|protease inhibitors|mesh-ancestor
153545593|NCT06304779|Anesthetics, Local|anesthetics, local|mesh-ancestor
153545595|NCT06304779|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153545596|NCT06304779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153545597|NCT06304779|Sensory System Agents|sensory system agents|mesh-ancestor
153545598|NCT06304779|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153545599|NCT06304779|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153545600|NCT06304779|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
153545601|NCT06304779|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153545602|NCT06304779|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153545603|NCT06304779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153811004|NCT00353067|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153545605|NCT06304597|Durvalumab|durvalumab|mesh-list
153545606|NCT06304597|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153545607|NCT06304597|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153545608|NCT06304597|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153545609|NCT06304597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153545610|NCT06304441|Pemetrexed|pemetrexed|mesh-list
153545635|NCT06304324|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153545636|NCT06304324|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153545637|NCT06304324|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153545638|NCT06304324|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153545639|NCT06304324|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153545640|NCT06304324|Analgesics|analgesics|mesh-ancestor
153545641|NCT06304324|Sensory System Agents|sensory system agents|mesh-ancestor
153545642|NCT06304324|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
153545643|NCT06304324|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153545644|NCT06304324|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153545645|NCT06304324|Adrenergic Agents|adrenergic agents|mesh-ancestor
153545646|NCT06304324|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153545647|NCT06304324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153545648|NCT06304298|Ropivacaine|ropivacaine|mesh-list
153545650|NCT06304298|Anesthetics|anesthetics|mesh-ancestor
153545651|NCT06304298|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153545652|NCT06304298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153545653|NCT06304298|Sensory System Agents|sensory system agents|mesh-ancestor
153545654|NCT06304298|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153545655|NCT06304220|Levonorgestrel|levonorgestrel|mesh-list
153545656|NCT06304220|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
153545657|NCT06304220|Contraceptive Agents|contraceptive agents|mesh-ancestor
153545658|NCT06304220|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153545659|NCT06304220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153545660|NCT06304220|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
153545661|NCT06304220|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
153730571|NCT00141648|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153545662|NCT06304220|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
153545663|NCT06304181|Acetaminophen|acetaminophen|mesh-list
153545664|NCT06304181|Parecoxib|parecoxib|mesh-list
153545665|NCT06304181|Mannitol|mannitol|mesh-list
153545666|NCT06304181|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153545667|NCT06304181|Analgesics|analgesics|mesh-ancestor
153545668|NCT06304181|Sensory System Agents|sensory system agents|mesh-ancestor
153545669|NCT06304181|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153545674|NCT06304181|Natriuretic Agents|natriuretic agents|mesh-ancestor
153545675|NCT06304181|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
153545676|NCT06304181|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153545677|NCT06304181|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153545678|NCT06304181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153545679|NCT06304181|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153545680|NCT06304181|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153545681|NCT06304181|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153545683|NCT06303739|Hallucinogens|hallucinogens|mesh-ancestor
153545684|NCT06303739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153545685|NCT06303739|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153545686|NCT06303713|Carboplatin|carboplatin|mesh-list
153545687|NCT06303713|Pluvicto|pluvicto|mesh-list
153545688|NCT06303713|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153545689|NCT06303713|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
153545690|NCT06303713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153545700|NCT06303583|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153545702|NCT06303531|Ascorbic Acid|ascorbic acid|mesh-list
153545703|NCT06303531|Trace Elements|trace elements|mesh-ancestor
153545704|NCT06303531|Micronutrients|micronutrients|mesh-ancestor
153545705|NCT06303531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153545706|NCT06303531|Antioxidants|antioxidants|mesh-ancestor
153545707|NCT06303531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153545708|NCT06303531|Protective Agents|protective agents|mesh-ancestor
153545709|NCT06303531|Vitamins|vitamins|mesh-ancestor
153545710|NCT06303167|Osimertinib|osimertinib|mesh-list
153455635|NCT05590325|Dolutegravir|dolutegravir|mesh-list
153545711|NCT06303167|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153545712|NCT06303167|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153545713|NCT06303167|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153545729|NCT06303076|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153545730|NCT06303076|Anticonvulsants|anticonvulsants|mesh-ancestor
153545731|NCT06303076|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
153545732|NCT06303076|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
153545733|NCT06303076|Parasympatholytics|parasympatholytics|mesh-ancestor
153545734|NCT06303076|Autonomic Agents|autonomic agents|mesh-ancestor
153545735|NCT06303076|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
153545736|NCT06303076|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153545737|NCT06303076|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153545738|NCT06303076|Adrenergic Agents|adrenergic agents|mesh-ancestor
153545739|NCT06303037|Esketamine|esketamine|mesh-list
153545740|NCT06303037|Antidepressive Agents|antidepressive agents|mesh-ancestor
153545741|NCT06303037|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153545742|NCT06302907|Anesthetics|anesthetics|mesh-list
153545743|NCT06302907|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153545744|NCT06302907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153545746|NCT06302673|Emetics|emetics|mesh-list
153545747|NCT06302673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153545748|NCT06302673|Autonomic Agents|autonomic agents|mesh-ancestor
153730572|NCT00141648|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153545749|NCT06302673|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153545750|NCT06302673|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153545751|NCT06302621|Afatinib|afatinib|mesh-list
153545752|NCT06302621|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153545753|NCT06302621|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153545754|NCT06302621|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153545755|NCT06302621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153545756|NCT06302621|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153545757|NCT06301724|Lidocaine|lidocaine|mesh-list
153545758|NCT06301724|Anesthetics, Local|anesthetics, local|mesh-ancestor
153545768|NCT06301724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153545770|NCT06301711|Anesthetics, Local|anesthetics, local|mesh-ancestor
153545771|NCT06301711|Anesthetics|anesthetics|mesh-ancestor
153545772|NCT06301711|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153545773|NCT06301711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153545774|NCT06301711|Sensory System Agents|sensory system agents|mesh-ancestor
153545775|NCT06301711|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153816670|NCT00458991|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
153545777|NCT06301711|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
153545778|NCT06301711|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153545779|NCT06301711|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153545780|NCT06301711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153545781|NCT06301698|Lidocaine|lidocaine|mesh-list
153545782|NCT06301698|Anesthetics, Local|anesthetics, local|mesh-ancestor
153545783|NCT06301698|Anesthetics|anesthetics|mesh-ancestor
153545784|NCT06301698|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153545785|NCT06301698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153545786|NCT06301698|Sensory System Agents|sensory system agents|mesh-ancestor
153545787|NCT06301698|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153545788|NCT06301698|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153545789|NCT06301698|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
153545790|NCT06301698|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153545791|NCT06301698|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153545792|NCT06301698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153545793|NCT06301685|Lidocaine|lidocaine|mesh-list
153545794|NCT06301685|Anesthetics, Local|anesthetics, local|mesh-ancestor
153545795|NCT06301685|Anesthetics|anesthetics|mesh-ancestor
153545796|NCT06301685|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153545797|NCT06301685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153545798|NCT06301685|Sensory System Agents|sensory system agents|mesh-ancestor
153545799|NCT06301685|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153545801|NCT06301685|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
153545802|NCT06301685|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153545803|NCT06301685|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153545804|NCT06301685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153545806|NCT06300424|Carboplatin|carboplatin|mesh-list
153545807|NCT06300424|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153545808|NCT06300424|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153545809|NCT06300424|Tubulin Modulators|tubulin modulators|mesh-ancestor
153545810|NCT06300424|Antimitotic Agents|antimitotic agents|mesh-ancestor
153545811|NCT06300424|Mitosis Modulators|mitosis modulators|mesh-ancestor
153545812|NCT06300424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153545813|NCT06300229|Denosumab|denosumab|mesh-list
153545814|NCT06300229|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153545815|NCT06300229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153618995|NCT01981460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153618996|NCT01981499|Cetirizine|cetirizine|mesh-list
153618997|NCT01981499|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
153618998|NCT01981499|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
153618999|NCT01981499|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
153619000|NCT01981499|Histamine Antagonists|histamine antagonists|mesh-ancestor
153619001|NCT01981499|Histamine Agents|histamine agents|mesh-ancestor
153619002|NCT01981499|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153619003|NCT01981499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153619004|NCT01981499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153619005|NCT01981525|Metformin|metformin|mesh-list
153619021|NCT01981746|Sensory System Agents|sensory system agents|mesh-ancestor
153619022|NCT01981746|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153619023|NCT01981811|Aripiprazole|aripiprazole|mesh-list
153619024|NCT01981811|Antidepressive Agents|antidepressive agents|mesh-ancestor
153619025|NCT01981811|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153619026|NCT01981811|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153619027|NCT01981811|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153619028|NCT01981811|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153619029|NCT01981811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153619030|NCT01981811|Dopamine Agonists|dopamine agonists|mesh-ancestor
153619031|NCT01981811|Dopamine Agents|dopamine agents|mesh-ancestor
153619032|NCT01981811|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153619033|NCT01981811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153619034|NCT01981811|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
153619035|NCT01981811|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
153619036|NCT01981811|Serotonin Agents|serotonin agents|mesh-ancestor
153619037|NCT01981811|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
153619046|NCT01981889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153619047|NCT01981889|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153619049|NCT01981941|Gabapentin|gabapentin|mesh-list
153619050|NCT01981941|Analgesics|analgesics|mesh-ancestor
153619051|NCT01981941|Sensory System Agents|sensory system agents|mesh-ancestor
153619052|NCT01981941|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153619053|NCT01981941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153619054|NCT01981941|Anticonvulsants|anticonvulsants|mesh-ancestor
153619055|NCT01981941|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153619056|NCT01981941|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153619057|NCT01981941|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153619058|NCT01981941|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153619059|NCT01981941|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
153619060|NCT01981941|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
153619072|NCT01982097|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153619073|NCT01982097|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153619074|NCT01982097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153619075|NCT01982201|Lesinurad|lesinurad|mesh-list
153619076|NCT01982201|Gout Suppressants|gout suppressants|mesh-ancestor
153619077|NCT01982201|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153619078|NCT01982201|Uricosuric Agents|uricosuric agents|mesh-ancestor
153619079|NCT01982396|Lamivudine|lamivudine|mesh-list
153619080|NCT01982396|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153619081|NCT01982396|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153619082|NCT01982396|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153619083|NCT01982396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153619084|NCT01982396|Antiviral Agents|antiviral agents|mesh-ancestor
153619085|NCT01982396|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153619086|NCT01982396|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153619087|NCT01982396|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153619088|NCT01982461|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
153619089|NCT01982461|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153619090|NCT01982461|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153619091|NCT01982461|Antimetabolites|antimetabolites|mesh-ancestor
153619092|NCT01982461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153619093|NCT01982461|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153619094|NCT01982461|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
153619095|NCT01982461|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153619096|NCT01982578|Genistein|genistein|mesh-list
153619097|NCT01982578|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
153619098|NCT01982578|Protective Agents|protective agents|mesh-ancestor
153619099|NCT01982578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153619100|NCT01982578|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153619101|NCT01982578|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153619102|NCT01982578|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153619108|NCT01982578|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153619110|NCT01982734|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153619111|NCT01982734|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153619112|NCT01982734|Analgesics|analgesics|mesh-ancestor
153619113|NCT01982734|Sensory System Agents|sensory system agents|mesh-ancestor
153619114|NCT01982734|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153619115|NCT01982734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153619116|NCT01982734|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153619117|NCT01982734|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153619118|NCT01982734|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153619119|NCT01982734|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153619120|NCT01982734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153619121|NCT01982760|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
153619122|NCT01982760|Hemostatics|hemostatics|mesh-ancestor
153619123|NCT01982760|Coagulants|coagulants|mesh-ancestor
153619124|NCT01982760|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
153619125|NCT01982760|Natriuretic Agents|natriuretic agents|mesh-ancestor
153619126|NCT01982760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153619127|NCT01982799|Acetaminophen|acetaminophen|mesh-list
153619128|NCT01982799|Ibuprofen|ibuprofen|mesh-list
153619129|NCT01982799|Naproxen|naproxen|mesh-list
153619130|NCT01982799|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
153619131|NCT01982799|Hydrocodone|hydrocodone|mesh-list
153619132|NCT01982799|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153619133|NCT01982799|Analgesics|analgesics|mesh-ancestor
153619134|NCT01982799|Sensory System Agents|sensory system agents|mesh-ancestor
153619135|NCT01982799|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153619136|NCT01982799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153619137|NCT01982799|Antipyretics|antipyretics|mesh-ancestor
153619138|NCT01982799|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153619139|NCT01982799|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153619140|NCT01982799|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153619141|NCT01982799|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153619142|NCT01982799|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153619143|NCT01982799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153619144|NCT01982799|Gout Suppressants|gout suppressants|mesh-ancestor
153619145|NCT01982799|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153730573|NCT00141648|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153619146|NCT01982799|Narcotics|narcotics|mesh-ancestor
153619153|NCT01982864|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
153619154|NCT01982864|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153619155|NCT01982864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153619156|NCT01982929|Epinephrine|epinephrine|mesh-list
153619157|NCT01982929|Bupivacaine|bupivacaine|mesh-list
153619158|NCT01982929|Anesthetics, Local|anesthetics, local|mesh-ancestor
153619159|NCT01982929|Anesthetics|anesthetics|mesh-ancestor
153619160|NCT01982929|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153619161|NCT01982929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153619162|NCT01982929|Sensory System Agents|sensory system agents|mesh-ancestor
153619163|NCT01982929|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153619164|NCT01982929|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153619165|NCT01982929|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153619166|NCT01982929|Adrenergic Agents|adrenergic agents|mesh-ancestor
153619167|NCT01982929|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153619168|NCT01982929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153619169|NCT01982929|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
153619170|NCT01982929|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153619184|NCT01983137|Naloxone|naloxone|mesh-list
153619185|NCT01983137|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153619186|NCT01983137|Narcotics|narcotics|mesh-ancestor
153619187|NCT01983137|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153619188|NCT01983137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153619189|NCT01983137|Analgesics|analgesics|mesh-ancestor
153619190|NCT01983137|Sensory System Agents|sensory system agents|mesh-ancestor
153619191|NCT01983137|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153619192|NCT01983137|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
153619193|NCT01983371|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
153619194|NCT01983371|Hematinics|hematinics|mesh-ancestor
153619195|NCT01983371|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
153619196|NCT01983371|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
153619197|NCT01983384|Anesthetics|anesthetics|mesh-list
153619205|NCT01983449|Antiemetics|antiemetics|mesh-ancestor
153619206|NCT01983449|Autonomic Agents|autonomic agents|mesh-ancestor
153619207|NCT01983449|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153619208|NCT01983449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153619209|NCT01983449|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153619210|NCT01983449|Glucocorticoids|glucocorticoids|mesh-ancestor
153619211|NCT01983449|Hormones|hormones|mesh-ancestor
153619212|NCT01983449|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153619213|NCT01983449|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153619214|NCT01983449|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153619215|NCT01983449|Protease Inhibitors|protease inhibitors|mesh-ancestor
153619216|NCT01983449|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153619217|NCT01983449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153619218|NCT01983475|Denosumab|denosumab|mesh-list
153619219|NCT01983475|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153619220|NCT01983475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153619221|NCT01983501|Tucatinib|tucatinib|mesh-list
153619222|NCT01983501|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153619223|NCT01983501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153619224|NCT01983501|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153619225|NCT01983501|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153619226|NCT01983514|Oxytocin|oxytocin|mesh-list
153619227|NCT01983514|Oxytocics|oxytocics|mesh-ancestor
153619228|NCT01983514|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153619229|NCT01983514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153619230|NCT01983527|Methylprednisolone|methylprednisolone|mesh-list
153619231|NCT01983527|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
153619232|NCT01983527|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
153619233|NCT01983527|Prednisolone|prednisolone|mesh-list
153619234|NCT01983527|Prednisolone acetate|prednisolone acetate|mesh-list
153619268|NCT01983735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153619270|NCT01983735|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153619271|NCT01983735|Antimetabolites|antimetabolites|mesh-ancestor
153619272|NCT01983735|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153619273|NCT01983735|Vitamin B Complex|vitamin b complex|mesh-ancestor
153619295|NCT01983761|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153619296|NCT01983761|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
153619297|NCT01983761|Antitubercular Agents|antitubercular agents|mesh-ancestor
153619298|NCT01983761|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153619299|NCT01983761|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153619300|NCT01983761|Alkylating Agents|alkylating agents|mesh-ancestor
153619301|NCT01983761|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153619303|NCT01983800|Propofol|propofol|mesh-list
153619304|NCT01983800|Isoflurane|isoflurane|mesh-list
153619305|NCT01983800|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153619306|NCT01983800|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153619307|NCT01983800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153619308|NCT01983800|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153619309|NCT01983800|Anesthetics, General|anesthetics, general|mesh-ancestor
153619310|NCT01983800|Anesthetics|anesthetics|mesh-ancestor
153619311|NCT01983800|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153619312|NCT01983800|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153619313|NCT01983800|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153619314|NCT01983800|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153619315|NCT01983800|GABA Modulators|gaba modulators|mesh-ancestor
153619316|NCT01983800|GABA Agents|gaba agents|mesh-ancestor
153619317|NCT01983800|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153619318|NCT01983800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153619319|NCT01983800|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
153619320|NCT01983943|3,4-dihydroxyphenylethanol|3,4-dihydroxyphenylethanol|mesh-list
153619321|NCT01983943|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153619322|NCT01983943|Antioxidants|antioxidants|mesh-ancestor
153619323|NCT01983943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153619324|NCT01983943|Protective Agents|protective agents|mesh-ancestor
153619327|NCT01984008|Picosulfate sodium|picosulfate sodium|mesh-list
153619354|NCT01984086|Autonomic Agents|autonomic agents|mesh-ancestor
153619355|NCT01984086|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153619356|NCT01984086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153619357|NCT01984086|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153619358|NCT01984086|Respiratory System Agents|respiratory system agents|mesh-ancestor
153619359|NCT01984086|Tocolytic Agents|tocolytic agents|mesh-ancestor
153619360|NCT01984086|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153619361|NCT01984086|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
153619362|NCT01984086|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
153915908|NCT01204697|Docetaxel|docetaxel|mesh-list
153619363|NCT01984086|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153619364|NCT01984086|Adrenergic Agents|adrenergic agents|mesh-ancestor
153619365|NCT01984086|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153619366|NCT01984086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153619367|NCT01984086|Antidotes|antidotes|mesh-ancestor
153619368|NCT01984086|Protective Agents|protective agents|mesh-ancestor
153619369|NCT01984099|Folic Acid|folic acid|mesh-list
153619370|NCT01984099|Vitamin B Complex|vitamin b complex|mesh-list
153619371|NCT01984099|Methotrexate|methotrexate|mesh-list
153619374|NCT01984099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153619375|NCT01984099|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
153619376|NCT01984099|Abortifacient Agents|abortifacient agents|mesh-ancestor
153619377|NCT01984099|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153619378|NCT01984099|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153619379|NCT01984099|Antimetabolites|antimetabolites|mesh-ancestor
153619380|NCT01984099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153619381|NCT01984099|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153619382|NCT01984099|Dermatologic Agents|dermatologic agents|mesh-ancestor
153619383|NCT01984099|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153619384|NCT01984099|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153619400|NCT01984255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153619401|NCT01984372|Insulin|insulin|mesh-list
153619402|NCT01984372|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153619415|NCT01984463|Anesthetics, General|anesthetics, general|mesh-ancestor
153619416|NCT01984463|Anesthetics|anesthetics|mesh-ancestor
153619417|NCT01984567|Vitamin E|vitamin e|mesh-list
153619418|NCT01984567|Thioctic Acid|thioctic acid|mesh-list
153619419|NCT01984567|Vitamins|vitamins|mesh-ancestor
153619420|NCT01984567|Micronutrients|micronutrients|mesh-ancestor
153811006|NCT00353067|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153619421|NCT01984567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153619422|NCT01984567|Antioxidants|antioxidants|mesh-ancestor
153619423|NCT01984567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153619424|NCT01984567|Protective Agents|protective agents|mesh-ancestor
153619425|NCT01984567|Vitamin B Complex|vitamin b complex|mesh-ancestor
153619426|NCT01984606|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
153619427|NCT01984606|Empagliflozin|empagliflozin|mesh-list
153619428|NCT01984606|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153619429|NCT01984606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153619430|NCT01984606|Incretins|incretins|mesh-ancestor
153619431|NCT01984606|Hormones|hormones|mesh-ancestor
153619432|NCT01984606|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153619433|NCT01984606|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
153619434|NCT01984606|Protease Inhibitors|protease inhibitors|mesh-ancestor
153619435|NCT01984606|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153619436|NCT01984606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153619462|NCT01984931|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153811007|NCT00353067|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153357557|NCT04272320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153619463|NCT01984931|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
153619464|NCT01984931|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
153619465|NCT01984931|Dopamine Agents|dopamine agents|mesh-ancestor
153619466|NCT01984931|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153619467|NCT01984931|Parasympatholytics|parasympatholytics|mesh-ancestor
153619468|NCT01984931|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
153619484|NCT01985061|Alkylating Agents|alkylating agents|mesh-ancestor
153619485|NCT01985061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153619486|NCT01985061|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153619487|NCT01985061|Immunologic Factors|immunologic factors|mesh-ancestor
153619488|NCT01985061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153619489|NCT01985061|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153619490|NCT01985061|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153619491|NCT01985061|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153619492|NCT01985087|Temozolomide|temozolomide|mesh-list
153619493|NCT01985087|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153619494|NCT01985087|Alkylating Agents|alkylating agents|mesh-ancestor
153619495|NCT01985087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153619496|NCT01985087|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153619497|NCT01985152|Choline|choline|mesh-list
153619530|NCT01985477|Autonomic Agents|autonomic agents|mesh-ancestor
153619549|NCT01985594|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153619550|NCT01985594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153619551|NCT01985594|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153619552|NCT01985594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153619553|NCT01985594|Vasodilator Agents|vasodilator agents|mesh-ancestor
153619554|NCT01985594|Tocolytic Agents|tocolytic agents|mesh-ancestor
153619555|NCT01985594|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153619558|NCT01985594|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153619559|NCT01985724|Cyclophosphamide|cyclophosphamide|mesh-list
153619560|NCT01985724|Docetaxel|docetaxel|mesh-list
153619561|NCT01985724|Epirubicin|epirubicin|mesh-list
153619562|NCT01985724|Fluorouracil|fluorouracil|mesh-list
153619563|NCT01985724|Lenograstim|lenograstim|mesh-list
153619564|NCT01985724|Mitogens|mitogens|mesh-list
153730575|NCT00141648|Tubulin Modulators|tubulin modulators|mesh-ancestor
153619565|NCT01985724|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153619566|NCT01985724|Immunologic Factors|immunologic factors|mesh-ancestor
153619567|NCT01985724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153619568|NCT01985724|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153619569|NCT01985724|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153619570|NCT01985724|Alkylating Agents|alkylating agents|mesh-ancestor
153619571|NCT01985724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153619572|NCT01985724|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153619573|NCT01985724|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153619574|NCT01985724|Tubulin Modulators|tubulin modulators|mesh-ancestor
153619575|NCT01985724|Antimitotic Agents|antimitotic agents|mesh-ancestor
153619607|NCT01985789|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
153619608|NCT01985789|Histamine Antagonists|histamine antagonists|mesh-ancestor
153619609|NCT01985789|Histamine Agents|histamine agents|mesh-ancestor
153619610|NCT01985789|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153619611|NCT01985789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153619612|NCT01985789|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
153619613|NCT01985789|Antipruritics|antipruritics|mesh-ancestor
153619614|NCT01985789|Dermatologic Agents|dermatologic agents|mesh-ancestor
153619615|NCT01985789|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
153619616|NCT01985789|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
153619617|NCT01985789|Cholinergic Agents|cholinergic agents|mesh-ancestor
153619618|NCT01985828|Androgens|androgens|mesh-list
153619619|NCT01985828|Hormones|hormones|mesh-ancestor
153619620|NCT01985828|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153619621|NCT01985828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153619622|NCT01985841|Cyclophosphamide|cyclophosphamide|mesh-list
153619623|NCT01985841|Docetaxel|docetaxel|mesh-list
153619624|NCT01985841|Fluorouracil|fluorouracil|mesh-list
153619625|NCT01985841|Epirubicin|epirubicin|mesh-list
153619626|NCT01985841|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153619627|NCT01985841|Immunologic Factors|immunologic factors|mesh-ancestor
153619628|NCT01985841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153619629|NCT01985841|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153619630|NCT01985841|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153619631|NCT01985841|Alkylating Agents|alkylating agents|mesh-ancestor
153619632|NCT01985841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153619633|NCT01985841|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153619634|NCT01985841|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153619635|NCT01985841|Tubulin Modulators|tubulin modulators|mesh-ancestor
153619636|NCT01985841|Antimitotic Agents|antimitotic agents|mesh-ancestor
153619637|NCT01985841|Mitosis Modulators|mitosis modulators|mesh-ancestor
153619663|NCT01986036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153619664|NCT01986049|Bupivacaine|bupivacaine|mesh-list
153619665|NCT01986049|Anesthetics, Local|anesthetics, local|mesh-ancestor
153619666|NCT01986049|Anesthetics|anesthetics|mesh-ancestor
153619667|NCT01986049|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153619668|NCT01986049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153619669|NCT01986049|Sensory System Agents|sensory system agents|mesh-ancestor
153619670|NCT01986049|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153619671|NCT01986088|Sumatriptan|sumatriptan|mesh-list
153619672|NCT01986088|Eletriptan|eletriptan|mesh-list
153619673|NCT01986088|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
153619674|NCT01986088|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
153619675|NCT01986088|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
153619676|NCT01986088|Serotonin Agents|serotonin agents|mesh-ancestor
153619677|NCT01986088|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153619678|NCT01986088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153619679|NCT01986088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153619680|NCT01986127|Adalimumab|adalimumab|mesh-list
153619681|NCT01986127|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
153619682|NCT01986127|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153619683|NCT01986127|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153619684|NCT01986192|Warfarin|warfarin|mesh-list
153619685|NCT01986192|Rivaroxaban|rivaroxaban|mesh-list
153619686|NCT01986192|Anticoagulants|anticoagulants|mesh-ancestor
153619687|NCT01986192|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
153619688|NCT01986192|Antithrombins|antithrombins|mesh-ancestor
153619689|NCT01986192|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
153619690|NCT01986192|Protease Inhibitors|protease inhibitors|mesh-ancestor
153619691|NCT01986192|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153619692|NCT01986192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153619693|NCT01986218|BMS-986115|bms-986115|mesh-list
153619694|NCT01986218|Gamma Secretase Inhibitors and Modulators|gamma secretase inhibitors and modulators|mesh-ancestor
153619695|NCT01986218|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153619696|NCT01986218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153619697|NCT01986270|Sumatriptan|sumatriptan|mesh-list
153619698|NCT01986270|Eletriptan|eletriptan|mesh-list
153619701|NCT01986270|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
153619702|NCT01986270|Serotonin Agents|serotonin agents|mesh-ancestor
153619703|NCT01986270|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153619704|NCT01986270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153619705|NCT01986270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153619706|NCT01986283|Oxycodone|oxycodone|mesh-list
153619707|NCT01986283|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153619722|NCT01986309|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
153619723|NCT01986309|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153619724|NCT01986309|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153619725|NCT01986309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153619726|NCT01986322|Vaccines|vaccines|mesh-list
153619727|NCT01986322|Immunologic Factors|immunologic factors|mesh-ancestor
153619728|NCT01986322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153619729|NCT01986426|Pembrolizumab|pembrolizumab|mesh-list
153619730|NCT01986426|Ipilimumab|ipilimumab|mesh-list
153619731|NCT01986426|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153619732|NCT01986426|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153619733|NCT01986426|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153619734|NCT01986426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153619735|NCT01986465|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
153619736|NCT01986465|Methylprednisolone|methylprednisolone|mesh-list
153619737|NCT01986465|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
153619738|NCT01986465|Prednisolone|prednisolone|mesh-list
153619739|NCT01986465|Prednisolone acetate|prednisolone acetate|mesh-list
153619740|NCT01986465|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
153619741|NCT01986465|Prednisolone phosphate|prednisolone phosphate|mesh-list
153619742|NCT01986465|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153918420|NCT00641407|Insulin Glargine|insulin glargine|mesh-list
153619743|NCT01986465|Antiemetics|antiemetics|mesh-ancestor
153619744|NCT01986465|Autonomic Agents|autonomic agents|mesh-ancestor
153619748|NCT01986465|Glucocorticoids|glucocorticoids|mesh-ancestor
153619757|NCT01986556|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153619758|NCT01986556|Uricosuric Agents|uricosuric agents|mesh-ancestor
153619759|NCT01986582|Phenylephrine|phenylephrine|mesh-list
153619760|NCT01986582|Oxymetazoline|oxymetazoline|mesh-list
153619761|NCT01986582|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153619762|NCT01986582|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153619763|NCT01986582|Adrenergic Agents|adrenergic agents|mesh-ancestor
153619764|NCT01986582|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153619765|NCT01986582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153619766|NCT01986582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153619767|NCT01986582|Sympathomimetics|sympathomimetics|mesh-ancestor
153619768|NCT01986582|Autonomic Agents|autonomic agents|mesh-ancestor
153619781|NCT01986608|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153619782|NCT01986608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153619784|NCT01986660|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153619785|NCT01986660|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153619786|NCT01986660|Analgesics|analgesics|mesh-ancestor
153619787|NCT01986660|Sensory System Agents|sensory system agents|mesh-ancestor
153619788|NCT01986660|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153619789|NCT01986660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153619790|NCT01986660|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153918464|NCT00931528|Tadalafil|tadalafil|mesh-list
153357815|NCT00758420|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
153619791|NCT01986660|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153619792|NCT01986660|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153619793|NCT01986660|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153619794|NCT01986660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153619795|NCT01986673|Sildenafil Citrate|sildenafil citrate|mesh-list
153619796|NCT01986673|Vasodilator Agents|vasodilator agents|mesh-ancestor
153619797|NCT01986673|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
153619798|NCT01986673|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
153619799|NCT01986673|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153619800|NCT01986673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153619801|NCT01986673|Urological Agents|urological agents|mesh-ancestor
153619802|NCT01986764|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
153619803|NCT01986764|Estradiol|estradiol|mesh-list
153619804|NCT01986764|Estrogens|estrogens|mesh-list
153619805|NCT01986764|Hormones|hormones|mesh-ancestor
153816671|NCT00458991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153619807|NCT01986764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153619808|NCT01986764|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
153619809|NCT01986764|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
153619810|NCT01986764|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153619811|NCT01986764|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153619812|NCT01986764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153619813|NCT01986764|Dopamine Agents|dopamine agents|mesh-ancestor
153619814|NCT01986764|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153619815|NCT01986777|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
153619816|NCT01986777|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
153619817|NCT01986777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153619818|NCT01986777|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
153619819|NCT01986777|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153619820|NCT01986777|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153619821|NCT01986777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153619822|NCT01986777|Dopamine Agents|dopamine agents|mesh-ancestor
153619823|NCT01986777|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153619824|NCT01986894|Moxifloxacin|moxifloxacin|mesh-list
153619825|NCT01986894|Thalidomide|thalidomide|mesh-list
153619826|NCT01986894|Pomalidomide|pomalidomide|mesh-list
153619827|NCT01986894|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153619828|NCT01986894|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153619835|NCT01986894|Immunologic Factors|immunologic factors|mesh-ancestor
153619836|NCT01986894|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153619837|NCT01986894|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153619838|NCT01986894|Growth Substances|growth substances|mesh-ancestor
153619839|NCT01986894|Growth Inhibitors|growth inhibitors|mesh-ancestor
153619858|NCT01986998|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
153619859|NCT01986998|Protective Agents|protective agents|mesh-ancestor
153619860|NCT01986998|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153619861|NCT01986998|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153619862|NCT01987076|Prednisone|prednisone|mesh-list
153619863|NCT01987076|Clobetasol|clobetasol|mesh-list
153619864|NCT01987076|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153619865|NCT01987076|Glucocorticoids|glucocorticoids|mesh-ancestor
153619866|NCT01987076|Hormones|hormones|mesh-ancestor
153619867|NCT01987076|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153619868|NCT01987076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153619869|NCT01987076|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153619870|NCT01987076|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153619871|NCT01987128|Ropivacaine|ropivacaine|mesh-list
153619872|NCT01987128|Anesthetics, Local|anesthetics, local|mesh-ancestor
153619873|NCT01987128|Anesthetics|anesthetics|mesh-ancestor
153619874|NCT01987128|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153619875|NCT01987128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153619876|NCT01987128|Sensory System Agents|sensory system agents|mesh-ancestor
153619877|NCT01987128|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153619878|NCT01987154|Caseins|caseins|mesh-list
153619879|NCT01987154|Chelating Agents|chelating agents|mesh-ancestor
153619880|NCT01987154|Sequestering Agents|sequestering agents|mesh-ancestor
153619881|NCT01987154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153619882|NCT01987167|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
153619883|NCT01987167|Hormones|hormones|mesh-ancestor
153619884|NCT01987167|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153619885|NCT01987167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153619886|NCT01987297|Cytarabine|cytarabine|mesh-list
153619887|NCT01987297|Daunorubicin|daunorubicin|mesh-list
153619888|NCT01987297|Idarubicin|idarubicin|mesh-list
153619889|NCT01987297|Tretinoin|tretinoin|mesh-list
153619890|NCT01987297|Arsenic Trioxide|arsenic trioxide|mesh-list
153619891|NCT01987297|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153619892|NCT01987297|Antimetabolites|antimetabolites|mesh-ancestor
153619893|NCT01987297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153619894|NCT01987297|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153816672|NCT00458991|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
153816673|NCT00458991|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153619896|NCT01987297|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153619897|NCT01987297|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153619910|NCT01987310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153619911|NCT01987310|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153619912|NCT01987310|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
153619913|NCT01987310|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153619914|NCT01987323|Latanoprost|latanoprost|mesh-list
153619915|NCT01987323|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
153619916|NCT01987323|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
153619917|NCT01987375|Cetuximab|cetuximab|mesh-list
153619918|NCT01987375|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153619919|NCT01987375|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153619920|NCT01987570|Allopurinol|allopurinol|mesh-list
153619921|NCT01987570|Antimetabolites|antimetabolites|mesh-ancestor
153619922|NCT01987570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153619923|NCT01987570|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153619924|NCT01987570|Gout Suppressants|gout suppressants|mesh-ancestor
153619925|NCT01987570|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153619926|NCT01987570|Free Radical Scavengers|free radical scavengers|mesh-ancestor
153619927|NCT01987570|Antioxidants|antioxidants|mesh-ancestor
153619928|NCT01987570|Protective Agents|protective agents|mesh-ancestor
153619929|NCT01987570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153619930|NCT01987739|Zolpidem|zolpidem|mesh-list
153619931|NCT01987739|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
153619932|NCT01987739|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153619933|NCT01987739|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153619934|NCT01987739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153619935|NCT01987739|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
153619936|NCT01987739|GABA Agonists|gaba agonists|mesh-ancestor
153619937|NCT01987739|GABA Agents|gaba agents|mesh-ancestor
153619938|NCT01987739|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153619939|NCT01987739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153619940|NCT01987804|Oxytocin|oxytocin|mesh-list
153619941|NCT01987804|Oxytocics|oxytocics|mesh-ancestor
153619946|NCT01988077|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153619947|NCT01988077|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153619948|NCT01988077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153619949|NCT01988116|Calcitriol|calcitriol|mesh-list
153619950|NCT01988116|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153619951|NCT01988116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153619952|NCT01988116|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
153619953|NCT01988116|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153619954|NCT01988116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153619955|NCT01988116|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
153619956|NCT01988116|Vitamins|vitamins|mesh-ancestor
153619957|NCT01988116|Micronutrients|micronutrients|mesh-ancestor
153619958|NCT01988116|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153619969|NCT01988298|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153619970|NCT01988298|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153619971|NCT01988298|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153619972|NCT01988298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153619973|NCT01988311|Psilocybin|psilocybin|mesh-list
153619974|NCT01988311|Hallucinogens|hallucinogens|mesh-ancestor
153619975|NCT01988311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153619976|NCT01988311|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153619977|NCT01988428|Ceftriaxone|ceftriaxone|mesh-list
153619978|NCT01988428|Third Generation Cephalosporins|third generation cephalosporins|mesh-ancestor
153918509|NCT00642499|Analgesics|analgesics|mesh-ancestor
153619979|NCT01988428|Beta Lactam Antibiotics|beta lactam antibiotics|mesh-ancestor
153619980|NCT01988428|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153619981|NCT01988428|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153619982|NCT01988506|Interleukin-2|interleukin-2|mesh-list
153619983|NCT01988506|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153619984|NCT01988506|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153619985|NCT01988506|Analgesics|analgesics|mesh-ancestor
153619986|NCT01988506|Sensory System Agents|sensory system agents|mesh-ancestor
153619994|NCT01988545|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153619995|NCT01988545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153619996|NCT01988545|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153619997|NCT01988545|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
153619998|NCT01988545|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153619999|NCT01988545|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
153620000|NCT01988610|Mifepristone|mifepristone|mesh-list
153620001|NCT01988610|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
153620002|NCT01988610|Abortifacient Agents|abortifacient agents|mesh-ancestor
153620003|NCT01988610|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153620004|NCT01988610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153620005|NCT01988610|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
153620006|NCT01988610|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
153620007|NCT01988610|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
153620008|NCT01988610|Contraceptive Agents|contraceptive agents|mesh-ancestor
153620009|NCT01988610|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
153620010|NCT01988610|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
153620011|NCT01988610|Hormone Antagonists|hormone antagonists|mesh-ancestor
153620012|NCT01988610|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153620013|NCT01988610|Luteolytic Agents|luteolytic agents|mesh-ancestor
153620014|NCT01988610|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
153730577|NCT00141648|Mitosis Modulators|mitosis modulators|mesh-ancestor
153620015|NCT01988610|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
153620017|NCT01988649|Oxytocics|oxytocics|mesh-ancestor
153620018|NCT01988649|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153620020|NCT01988831|Propranolol|propranolol|mesh-list
153620052|NCT01989052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153620053|NCT01989052|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153620054|NCT01989052|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153620055|NCT01989052|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153620056|NCT01989052|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153620057|NCT01989052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153620058|NCT01989078|Losartan|losartan|mesh-list
153620059|NCT01989078|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153620060|NCT01989078|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153620061|NCT01989078|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
153620062|NCT01989078|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
153620063|NCT01989078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153620064|NCT01989091|Heparin|heparin|mesh-list
153620065|NCT01989091|Anticoagulants|anticoagulants|mesh-ancestor
153620066|NCT01989091|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153620067|NCT01989091|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153620068|NCT01989091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153620069|NCT01989312|Lidocaine|lidocaine|mesh-list
153620070|NCT01989312|Epinephrine|epinephrine|mesh-list
153620071|NCT01989312|Midazolam|midazolam|mesh-list
153620072|NCT01989312|Levobupivacaine|levobupivacaine|mesh-list
153620073|NCT01989312|Anesthetics, Local|anesthetics, local|mesh-ancestor
153620110|NCT01989416|Dermatologic Agents|dermatologic agents|mesh-ancestor
153620112|NCT01989507|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
153620113|NCT01989507|Autonomic Agents|autonomic agents|mesh-ancestor
153620114|NCT01989507|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153620115|NCT01989507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153620116|NCT01989507|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
153620117|NCT01989507|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
153620118|NCT01989507|Cholinergic Agents|cholinergic agents|mesh-ancestor
153620119|NCT01989507|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153620120|NCT01989507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153620121|NCT01989559|Vaccines|vaccines|mesh-list
153620122|NCT01989559|Immunologic Factors|immunologic factors|mesh-ancestor
153620123|NCT01989559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153620124|NCT01989611|Tenofovir|tenofovir|mesh-list
153357818|NCT01213043|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153620125|NCT01989611|Emtricitabine|emtricitabine|mesh-list
153620126|NCT01989611|Antiviral Agents|antiviral agents|mesh-ancestor
153620127|NCT01989611|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153620128|NCT01989611|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153620129|NCT01989611|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153620130|NCT01989611|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153620131|NCT01989611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153620132|NCT01989611|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153620133|NCT01989611|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153620134|NCT01989663|Tenofovir|tenofovir|mesh-list
153620135|NCT01989663|Antiviral Agents|antiviral agents|mesh-ancestor
153620136|NCT01989663|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153620137|NCT01989663|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153620138|NCT01989663|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153620139|NCT01989663|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153620141|NCT01989663|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153620165|NCT01989897|Histamine Agonists|histamine agonists|mesh-ancestor
153620166|NCT01989897|Histamine Agents|histamine agents|mesh-ancestor
153620167|NCT01989897|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153620168|NCT01989897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153620169|NCT01989897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153620170|NCT01989897|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
153814739|NCT00453375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153620171|NCT01989897|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153620172|NCT01989897|Disinfectants|disinfectants|mesh-ancestor
153620173|NCT01989897|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
153620174|NCT01989897|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
153620175|NCT01989923|Nicotine|nicotine|mesh-list
153620176|NCT01989923|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
153620177|NCT01989923|Autonomic Agents|autonomic agents|mesh-ancestor
153620178|NCT01989923|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153620179|NCT01989923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153620180|NCT01989923|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
153620181|NCT01989923|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
153620182|NCT01989923|Cholinergic Agents|cholinergic agents|mesh-ancestor
153620183|NCT01989923|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153620184|NCT01989923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153620185|NCT01989936|Eletriptan|eletriptan|mesh-list
153620186|NCT01989936|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
153620187|NCT01989936|Serotonin Agents|serotonin agents|mesh-ancestor
153620188|NCT01989936|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153620214|NCT01990118|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153620215|NCT01990118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153620216|NCT01990118|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153620217|NCT01990118|Immunologic Factors|immunologic factors|mesh-ancestor
153620218|NCT01990118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153620219|NCT01990118|Antifungal Agents|antifungal agents|mesh-ancestor
153620224|NCT01990144|Rituximab|rituximab|mesh-list
153620225|NCT01990144|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
153620226|NCT01990144|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153620227|NCT01990144|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153620228|NCT01990144|Immunologic Factors|immunologic factors|mesh-ancestor
153620229|NCT01990144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153620230|NCT01990144|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153620231|NCT01990144|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153620232|NCT01990144|Alkylating Agents|alkylating agents|mesh-ancestor
153620234|NCT01990378|Rabeprazole|rabeprazole|mesh-list
153620273|NCT01990755|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153620274|NCT01990755|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
153620275|NCT01990755|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153620276|NCT01990755|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153620277|NCT01990755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153620278|NCT01990755|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153620279|NCT01990755|Serotonin Agents|serotonin agents|mesh-ancestor
153620280|NCT01990755|Anticonvulsants|anticonvulsants|mesh-ancestor
153620281|NCT01990781|Dexamethasone|dexamethasone|mesh-list
153620282|NCT01990781|Dexamethasone acetate|dexamethasone acetate|mesh-list
153620283|NCT01990781|Lidocaine|lidocaine|mesh-list
153620284|NCT01990781|BB 1101|bb 1101|mesh-list
153620285|NCT01990781|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153620286|NCT01990781|Antiemetics|antiemetics|mesh-ancestor
153620287|NCT01990781|Autonomic Agents|autonomic agents|mesh-ancestor
153620288|NCT01990781|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153620289|NCT01990781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153620298|NCT01990781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153620299|NCT01990781|Anesthetics, Local|anesthetics, local|mesh-ancestor
153620300|NCT01990781|Anesthetics|anesthetics|mesh-ancestor
153620301|NCT01990781|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153620302|NCT01990781|Sensory System Agents|sensory system agents|mesh-ancestor
153620303|NCT01990781|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153620304|NCT01990781|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
153620307|NCT01990807|Idarubicin|idarubicin|mesh-list
153620323|NCT01990937|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153620324|NCT01990937|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153620325|NCT01990937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153620326|NCT01990937|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153620327|NCT01990937|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153620328|NCT01990937|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153620329|NCT01990937|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153620330|NCT01990937|Anesthetics, General|anesthetics, general|mesh-ancestor
153620332|NCT01990937|GABA Modulators|gaba modulators|mesh-ancestor
153620333|NCT01990937|GABA Agents|gaba agents|mesh-ancestor
153620334|NCT01990937|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153620335|NCT01990937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153620336|NCT01991028|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
153620337|NCT01991054|Vitamin D|vitamin d|mesh-list
153620338|NCT01991054|Cholecalciferol|cholecalciferol|mesh-list
153620339|NCT01991054|Vitamins|vitamins|mesh-ancestor
153620340|NCT01991054|Micronutrients|micronutrients|mesh-ancestor
153620341|NCT01991054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153620342|NCT01991054|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153620343|NCT01991054|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153620344|NCT01991119|Dronedarone|dronedarone|mesh-list
153620345|NCT01991119|Propafenone|propafenone|mesh-list
153620346|NCT01991119|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153620347|NCT01991119|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
153620348|NCT01991119|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153620349|NCT01991119|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153620351|NCT01991145|Epoetin Alfa|epoetin alfa|mesh-list
153620383|NCT01991275|Narcotics|narcotics|mesh-ancestor
153620384|NCT01991275|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153620385|NCT01991275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153620386|NCT01991275|Analgesics|analgesics|mesh-ancestor
153620387|NCT01991275|Sensory System Agents|sensory system agents|mesh-ancestor
153620388|NCT01991275|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153620389|NCT01991288|Epinephrine|epinephrine|mesh-list
153620390|NCT01991288|Racepinephrine|racepinephrine|mesh-list
153620391|NCT01991288|Bupivacaine|bupivacaine|mesh-list
153620392|NCT01991288|Levobupivacaine|levobupivacaine|mesh-list
153620393|NCT01991288|Epinephryl borate|epinephryl borate|mesh-list
153620394|NCT01991288|Anesthetics, Local|anesthetics, local|mesh-ancestor
153620395|NCT01991288|Anesthetics|anesthetics|mesh-ancestor
153620396|NCT01991288|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153620397|NCT01991288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153620398|NCT01991288|Sensory System Agents|sensory system agents|mesh-ancestor
153620399|NCT01991288|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153620400|NCT01991288|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153620401|NCT01991288|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153620402|NCT01991288|Adrenergic Agents|adrenergic agents|mesh-ancestor
153620403|NCT01991288|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153620404|NCT01991288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153811352|NCT00325169|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153620405|NCT01991288|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
153620406|NCT01991288|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153620407|NCT01991288|Autonomic Agents|autonomic agents|mesh-ancestor
153620408|NCT01991288|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153620462|NCT01992133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153620475|NCT01992198|Dermatologic Agents|dermatologic agents|mesh-ancestor
153918589|NCT04178785|Remifentanil|remifentanil|mesh-list
153620476|NCT01992198|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153620477|NCT01992198|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153620478|NCT01992198|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153620479|NCT01992198|Hormones|hormones|mesh-ancestor
153620480|NCT01992198|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153620481|NCT01992198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153620482|NCT01992198|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
153620483|NCT01992211|Metformin|metformin|mesh-list
153620484|NCT01992211|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
153620485|NCT01992211|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153620486|NCT01992211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153620487|NCT01992211|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153620488|NCT01992211|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153620489|NCT01992211|Antimetabolites|antimetabolites|mesh-ancestor
153620490|NCT01992211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153620491|NCT01992211|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153620492|NCT01992211|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
153620493|NCT01992211|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153620494|NCT01992263|Vitamin D|vitamin d|mesh-list
153620495|NCT01992263|Ergocalciferols|ergocalciferols|mesh-list
153620496|NCT01992263|Cholecalciferol|cholecalciferol|mesh-list
153620497|NCT01992263|Vitamins|vitamins|mesh-list
153620498|NCT01992263|Micronutrients|micronutrients|mesh-ancestor
153620499|NCT01992263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153620500|NCT01992263|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153620501|NCT01992263|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153620502|NCT01992328|Immunoglobulins|immunoglobulins|mesh-list
153620503|NCT01992328|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
153620504|NCT01992328|Antibodies|antibodies|mesh-list
153620505|NCT01992328|Immunoglobulin G|immunoglobulin g|mesh-list
153620506|NCT01992328|gamma-Globulins|gamma-globulins|mesh-list
153620510|NCT01992341|Paclitaxel|paclitaxel|mesh-list
153620513|NCT01992341|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153620514|NCT01992341|Tubulin Modulators|tubulin modulators|mesh-ancestor
153620515|NCT01992341|Antimitotic Agents|antimitotic agents|mesh-ancestor
153620516|NCT01992341|Mitosis Modulators|mitosis modulators|mesh-ancestor
153620517|NCT01992341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153620518|NCT01992341|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153620519|NCT01992341|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153620520|NCT01992341|Growth Substances|growth substances|mesh-ancestor
153620521|NCT01992341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153620522|NCT01992341|Growth Inhibitors|growth inhibitors|mesh-ancestor
153620523|NCT01992562|Ziconotide|ziconotide|mesh-list
153620524|NCT01992562|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153620525|NCT01992562|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153620526|NCT01992562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153620527|NCT01992562|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153620543|NCT01992601|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
153620544|NCT01992601|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153620545|NCT01992601|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153620546|NCT01992601|Antimetabolites|antimetabolites|mesh-ancestor
153620547|NCT01992601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153620548|NCT01992601|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153357820|NCT01213043|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
153357821|NCT01213043|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
153620549|NCT01992601|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
153620550|NCT01992601|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153620551|NCT01992601|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153620552|NCT01992601|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
153620553|NCT01992601|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
153730583|NCT00134420|Clonidine|clonidine|mesh-list
153730584|NCT00134420|Mitogens|mitogens|mesh-list
153620565|NCT01992705|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
153620566|NCT01992705|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153620567|NCT01992705|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153620568|NCT01992796|Telmisartan|telmisartan|mesh-list
153620569|NCT01992796|Candesartan|candesartan|mesh-list
153620570|NCT01992796|Olmesartan|olmesartan|mesh-list
153620571|NCT01992796|Irbesartan|irbesartan|mesh-list
153620572|NCT01992796|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153620573|NCT01992796|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
153620574|NCT01992796|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
153620575|NCT01992796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153620576|NCT01992900|Piperaquine|piperaquine|mesh-list
153620577|NCT01992900|Artenimol|artenimol|mesh-list
153620578|NCT01992900|Artemisinins|artemisinins|mesh-list
153620579|NCT01992900|Antimalarials|antimalarials|mesh-ancestor
153620580|NCT01992900|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153620581|NCT01992900|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153620582|NCT01992900|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153620583|NCT01993134|Cefazolin|cefazolin|mesh-list
153620584|NCT01993134|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153620585|NCT01993134|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153620586|NCT01993173|Vaccines|vaccines|mesh-list
153620587|NCT01993173|Immunologic Factors|immunologic factors|mesh-ancestor
153620588|NCT01993173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153620589|NCT01993212|Enclomiphene|enclomiphene|mesh-list
153620590|NCT01993212|Testosterone|testosterone|mesh-list
153620606|NCT01993225|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153620607|NCT01993225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153620608|NCT01993225|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
153620609|NCT01993225|Hormone Antagonists|hormone antagonists|mesh-ancestor
153620610|NCT01993225|Fertility Agents, Female|fertility agents, female|mesh-ancestor
153620611|NCT01993225|Fertility Agents|fertility agents|mesh-ancestor
153620612|NCT01993225|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153620613|NCT01993225|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
153620614|NCT01993225|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
153620615|NCT01993251|Melatonin|melatonin|mesh-list
153620616|NCT01993251|Antioxidants|antioxidants|mesh-ancestor
153620621|NCT01993290|Ropivacaine|ropivacaine|mesh-list
153620622|NCT01993290|Anesthetics, Local|anesthetics, local|mesh-ancestor
153620623|NCT01993290|Anesthetics|anesthetics|mesh-ancestor
153620624|NCT01993290|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153620625|NCT01993290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153620626|NCT01993290|Sensory System Agents|sensory system agents|mesh-ancestor
153620627|NCT01993290|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153620628|NCT01993459|Midazolam|midazolam|mesh-list
153620629|NCT01993459|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
153620630|NCT01993459|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153620631|NCT01993459|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153620632|NCT01993459|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153620633|NCT01993459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153620634|NCT01993459|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153620635|NCT01993459|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153620636|NCT01993459|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153620637|NCT01993459|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153620638|NCT01993459|Anesthetics, General|anesthetics, general|mesh-ancestor
153620639|NCT01993459|Anesthetics|anesthetics|mesh-ancestor
153620640|NCT01993459|GABA Modulators|gaba modulators|mesh-ancestor
153811370|NCT00325286|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153811371|NCT00325286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153811372|NCT00325286|Antimanic Agents|antimanic agents|mesh-ancestor
153620641|NCT01993459|GABA Agents|gaba agents|mesh-ancestor
153620642|NCT01993459|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153620643|NCT01993459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153620644|NCT01993472|Andrographolide|andrographolide|mesh-list
153620645|NCT01993472|Capecitabine|capecitabine|mesh-list
153620646|NCT01993472|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153620647|NCT01993472|Antimetabolites|antimetabolites|mesh-ancestor
153620648|NCT01993472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153620649|NCT01993472|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153620665|NCT01993537|Micronutrients|micronutrients|mesh-ancestor
153620668|NCT01993589|Acetaminophen|acetaminophen|mesh-list
153620672|NCT01993589|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153620673|NCT01993589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153620674|NCT01993589|Antipyretics|antipyretics|mesh-ancestor
153620675|NCT01993680|Fludrocortisone|fludrocortisone|mesh-list
153620676|NCT01993680|Bromides|bromides|mesh-list
153620677|NCT01993680|Pyridostigmine Bromide|pyridostigmine bromide|mesh-list
153811508|NCT00325949|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
153811509|NCT00325949|Hydrocodone|hydrocodone|mesh-list
153811510|NCT00325949|Oxycodone|oxycodone|mesh-list
153811511|NCT00325949|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153811512|NCT00325949|Analgesics|analgesics|mesh-ancestor
153811513|NCT00325949|Sensory System Agents|sensory system agents|mesh-ancestor
153811514|NCT00325949|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153811515|NCT00325949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153811516|NCT00325949|Antipyretics|antipyretics|mesh-ancestor
153811517|NCT00325949|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153811518|NCT00325949|Narcotics|narcotics|mesh-ancestor
153811519|NCT00325949|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153811520|NCT00325949|Antitussive Agents|antitussive agents|mesh-ancestor
153811521|NCT00325949|Respiratory System Agents|respiratory system agents|mesh-ancestor
153811522|NCT00325949|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153811523|NCT00325949|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153811541|NCT04714515|Ivermectin|ivermectin|mesh-list
153620678|NCT01993680|Anticonvulsants|anticonvulsants|mesh-ancestor
153620679|NCT01993680|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
153620680|NCT01993680|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153620681|NCT01993680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153620682|NCT01993680|Cholinergic Agents|cholinergic agents|mesh-ancestor
153620683|NCT01993680|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153620684|NCT01993680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153620685|NCT01993680|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153620687|NCT01993771|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153620688|NCT01993771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153620689|NCT01993784|Nimotuzumab|nimotuzumab|mesh-list
153620690|NCT01993784|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153620691|NCT01993784|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153620692|NCT01993979|Cisplatin|cisplatin|mesh-list
153620693|NCT01993979|Carboplatin|carboplatin|mesh-list
153620694|NCT01993979|Gemcitabine|gemcitabine|mesh-list
153620695|NCT01993979|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153620696|NCT01993979|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153620697|NCT01993979|Antimetabolites|antimetabolites|mesh-ancestor
153620698|NCT01993979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153620699|NCT01994031|Paclitaxel|paclitaxel|mesh-list
153620700|NCT01994031|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
153620727|NCT01994330|Hemostatics|hemostatics|mesh-ancestor
153811561|NCT00326105|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153811562|NCT00326105|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153811563|NCT00326105|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153811564|NCT00326105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153811565|NCT00354354|Ipratropium|ipratropium|mesh-list
153811566|NCT00354354|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153811567|NCT00354354|Autonomic Agents|autonomic agents|mesh-ancestor
153811568|NCT00354354|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153811569|NCT00354354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153811570|NCT00354354|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153811571|NCT00354354|Respiratory System Agents|respiratory system agents|mesh-ancestor
153811572|NCT00354354|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153811573|NCT00354354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153811574|NCT00354354|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
153811575|NCT00354354|Cholinergic Agents|cholinergic agents|mesh-ancestor
153811576|NCT00326144|Quetiapine Fumarate|quetiapine fumarate|mesh-list
153811577|NCT00326144|Antidepressive Agents|antidepressive agents|mesh-ancestor
153811578|NCT00326144|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153811579|NCT00326144|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153357975|NCT03805568|Remifentanil|remifentanil|mesh-list
153620728|NCT01994330|Coagulants|coagulants|mesh-ancestor
153620729|NCT01994330|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
153620730|NCT01994330|Natriuretic Agents|natriuretic agents|mesh-ancestor
153620731|NCT01994330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153620732|NCT01994356|Contraceptive Agents|contraceptive agents|mesh-list
153620733|NCT01994356|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153620734|NCT01994356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153620735|NCT01994460|Linezolid|linezolid|mesh-list
153620736|NCT01994460|Ethambutol|ethambutol|mesh-list
153620737|NCT01994460|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153811605|NCT00426777|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153811606|NCT00426777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153730585|NCT00134420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153730586|NCT00134420|Mitosis Modulators|mitosis modulators|mesh-ancestor
153730587|NCT00134420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153730588|NCT00134420|Analgesics|analgesics|mesh-ancestor
153730589|NCT00134420|Sensory System Agents|sensory system agents|mesh-ancestor
153730590|NCT00134420|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153730591|NCT00134420|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153730592|NCT00134420|Sympatholytics|sympatholytics|mesh-ancestor
153811607|NCT00426777|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153811608|NCT00426777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153811609|NCT00426777|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153811610|NCT00419549|Valdecoxib|valdecoxib|mesh-list
153811611|NCT00419549|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
153730593|NCT00134420|Autonomic Agents|autonomic agents|mesh-ancestor
153730594|NCT00134420|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
153730595|NCT00134420|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153730596|NCT00134420|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153730597|NCT00134420|Adrenergic Agents|adrenergic agents|mesh-ancestor
153620738|NCT01994460|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153620739|NCT01994460|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
153620740|NCT01994460|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153620741|NCT01994460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153620742|NCT01994460|Antitubercular Agents|antitubercular agents|mesh-ancestor
153620743|NCT01994642|Ciprofloxacin|ciprofloxacin|mesh-list
153620744|NCT01994642|Dexamethasone|dexamethasone|mesh-list
153620745|NCT01994642|Dexamethasone acetate|dexamethasone acetate|mesh-list
153620746|NCT01994642|BB 1101|bb 1101|mesh-list
153620755|NCT01994642|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153620757|NCT01994642|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153620758|NCT01994642|Protease Inhibitors|protease inhibitors|mesh-ancestor
153620759|NCT01994642|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153620760|NCT01994642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153620761|NCT01994642|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153620762|NCT01994642|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153620763|NCT01994642|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153620764|NCT01994642|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153620765|NCT01994642|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
153811673|NCT04708353|Pregabalin|pregabalin|mesh-list
153620766|NCT01994642|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153620768|NCT01994668|Anticonvulsants|anticonvulsants|mesh-ancestor
153620769|NCT01994668|Antiemetics|antiemetics|mesh-ancestor
153620770|NCT01994668|Autonomic Agents|autonomic agents|mesh-ancestor
153620771|NCT01994668|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153620772|NCT01994668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153620773|NCT01994668|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153620774|NCT01994668|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153620775|NCT01994668|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153620776|NCT01994668|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153620777|NCT01994668|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153620778|NCT01994668|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153620789|NCT01994733|Antacids|antacids|mesh-ancestor
153620808|NCT01994941|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
153620809|NCT01994941|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
153620810|NCT01994941|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
153620811|NCT01994941|Purinergic Agents|purinergic agents|mesh-ancestor
153620812|NCT01994941|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153620813|NCT01994941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153620814|NCT01994941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153620815|NCT01994967|Bupivacaine|bupivacaine|mesh-list
153620816|NCT01994967|Levobupivacaine|levobupivacaine|mesh-list
153620817|NCT01994967|Anesthetics, Local|anesthetics, local|mesh-ancestor
153620818|NCT01994967|Anesthetics|anesthetics|mesh-ancestor
153620819|NCT01994967|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153620820|NCT01994967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153620821|NCT01994967|Sensory System Agents|sensory system agents|mesh-ancestor
153620822|NCT01994967|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153620823|NCT01995006|Dipyrone|dipyrone|mesh-list
153620824|NCT01995006|Naproxen|naproxen|mesh-list
153620825|NCT01995006|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153620826|NCT01995006|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153620827|NCT01995006|Analgesics|analgesics|mesh-ancestor
153620828|NCT01995006|Sensory System Agents|sensory system agents|mesh-ancestor
153620829|NCT01995006|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153620830|NCT01995006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153620831|NCT01995006|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153620832|NCT01995006|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153620833|NCT01995006|Gout Suppressants|gout suppressants|mesh-ancestor
153620834|NCT01995006|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153620835|NCT01995006|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153620836|NCT01995006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153620838|NCT01995019|Methylprednisolone|methylprednisolone|mesh-list
153620839|NCT01995019|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
153620840|NCT01995019|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
153620841|NCT01995019|Prednisolone|prednisolone|mesh-list
153620842|NCT01995019|Prednisolone acetate|prednisolone acetate|mesh-list
153620843|NCT01995019|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
153620865|NCT01995058|Hormones|hormones|mesh-ancestor
153620866|NCT01995058|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153620867|NCT01995058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153620868|NCT01995058|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153620869|NCT01995058|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153620870|NCT01995058|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153620871|NCT01995058|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153620872|NCT01995058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153620873|NCT01995058|Hormone Antagonists|hormone antagonists|mesh-ancestor
153620874|NCT01995058|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153620875|NCT01995084|Imidazole|imidazole|mesh-list
153620876|NCT01995084|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153620877|NCT01995084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153620878|NCT01995188|Bevacizumab|bevacizumab|mesh-list
153620879|NCT01995188|Carboplatin|carboplatin|mesh-list
153620880|NCT01995188|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153620881|NCT01995188|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153620882|NCT01995188|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153620883|NCT01995188|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153730598|NCT00134420|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153730599|NCT00141804|Sirolimus|sirolimus|mesh-list
153620884|NCT01995188|Growth Substances|growth substances|mesh-ancestor
153620885|NCT01995188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153620886|NCT01995188|Growth Inhibitors|growth inhibitors|mesh-ancestor
153620887|NCT01995214|Propofol|propofol|mesh-list
153620888|NCT01995214|Sevoflurane|sevoflurane|mesh-list
153620889|NCT01995214|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153620890|NCT01995214|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153620893|NCT01995214|Anesthetics, General|anesthetics, general|mesh-ancestor
153620914|NCT01995331|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153620916|NCT01995331|Antifungal Agents|antifungal agents|mesh-ancestor
153620917|NCT01995331|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153620918|NCT01995331|Dermatologic Agents|dermatologic agents|mesh-ancestor
153620919|NCT01995331|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
153811735|NCT00425724|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153620920|NCT01995370|Aspirin|aspirin|mesh-list
153620921|NCT01995370|Cilostazol|cilostazol|mesh-list
153620922|NCT01995370|Clopidogrel|clopidogrel|mesh-list
153620923|NCT01995370|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153620924|NCT01995370|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153620925|NCT01995370|Analgesics|analgesics|mesh-ancestor
153620926|NCT01995370|Sensory System Agents|sensory system agents|mesh-ancestor
153620927|NCT01995370|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153620928|NCT01995370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153620929|NCT01995370|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153620930|NCT01995370|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153620931|NCT01995370|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153620932|NCT01995370|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153620933|NCT01995370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153620934|NCT01995370|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153620935|NCT01995370|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153620936|NCT01995370|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153620937|NCT01995370|Antipyretics|antipyretics|mesh-ancestor
153620938|NCT01995370|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
153620939|NCT01995370|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
153620940|NCT01995370|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
153620941|NCT01995370|Purinergic Agents|purinergic agents|mesh-ancestor
153620942|NCT01995370|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153620943|NCT01995370|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153620958|NCT01995734|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153620959|NCT01995734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153620960|NCT01995799|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
153620961|NCT01995799|Hematinics|hematinics|mesh-ancestor
153620962|NCT01995799|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
153730600|NCT00141804|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153620963|NCT01995799|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
153620964|NCT01995890|Nepafenac|nepafenac|mesh-list
153620965|NCT01995890|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153620966|NCT01995890|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153620982|NCT01996085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153620983|NCT01996085|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153620984|NCT01996085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153620985|NCT01996085|Vasodilator Agents|vasodilator agents|mesh-ancestor
153620987|NCT01996085|Natriuretic Agents|natriuretic agents|mesh-ancestor
153620988|NCT01996085|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
153620989|NCT01996085|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
153620990|NCT01996085|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
153620991|NCT01996085|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
153620992|NCT01996085|Protease Inhibitors|protease inhibitors|mesh-ancestor
153620993|NCT01996085|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153620994|NCT01996085|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
153620995|NCT01996085|Protective Agents|protective agents|mesh-ancestor
153620996|NCT01996085|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
153620997|NCT01996085|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
153620998|NCT01996085|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153620999|NCT01996085|Adrenergic Agents|adrenergic agents|mesh-ancestor
153621000|NCT01996085|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153621001|NCT01996150|Sodium Hypochlorite|sodium hypochlorite|mesh-list
153621005|NCT01996189|Insulin|insulin|mesh-list
153621016|NCT01996306|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153621017|NCT01996306|Growth Substances|growth substances|mesh-ancestor
153621018|NCT01996306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153621019|NCT01996306|Growth Inhibitors|growth inhibitors|mesh-ancestor
153811798|NCT00427167|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153811799|NCT00427167|Immunologic Factors|immunologic factors|mesh-ancestor
153811800|NCT00427167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153811801|NCT00427167|Antacids|antacids|mesh-ancestor
153811802|NCT00427167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153811803|NCT00427167|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153811804|NCT00427206|Acetaminophen|acetaminophen|mesh-list
153621020|NCT01996306|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153621021|NCT01996306|Antimetabolites|antimetabolites|mesh-ancestor
153621022|NCT01996306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153621023|NCT01996306|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153621024|NCT01996306|Immunologic Factors|immunologic factors|mesh-ancestor
153621025|NCT01996306|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
153621026|NCT01996306|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153621027|NCT01996306|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153621028|NCT01996306|Antidotes|antidotes|mesh-ancestor
153621029|NCT01996306|Protective Agents|protective agents|mesh-ancestor
153621045|NCT01996384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153621046|NCT01996384|Sensory System Agents|sensory system agents|mesh-ancestor
153621047|NCT01996384|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153621048|NCT01996384|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153621049|NCT01996384|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
153621050|NCT01996384|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153621051|NCT01996384|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153621054|NCT01996423|Cholecalciferol|cholecalciferol|mesh-list
153621080|NCT01996462|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153621081|NCT01996475|Dexetimide|dexetimide|mesh-list
153621082|NCT01996475|Citalopram|citalopram|mesh-list
153621083|NCT01996475|Escitalopram|escitalopram|mesh-list
153621084|NCT01996475|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
153621085|NCT01996475|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153621086|NCT01996475|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153811808|NCT00427206|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153811809|NCT00427206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153811810|NCT00427206|Antipyretics|antipyretics|mesh-ancestor
153811811|NCT00425997|Amlodipine|amlodipine|mesh-list
153811812|NCT00425997|Valsartan|valsartan|mesh-list
153811813|NCT00425997|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
153811826|NCT00427245|Cyclophosphamide|cyclophosphamide|mesh-list
153811827|NCT00427245|Goserelin|goserelin|mesh-list
153811828|NCT00427245|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153811829|NCT00427245|Immunologic Factors|immunologic factors|mesh-ancestor
153811830|NCT00427245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153811831|NCT00427245|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153811832|NCT00427245|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153811833|NCT00427245|Alkylating Agents|alkylating agents|mesh-ancestor
153811834|NCT00427245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153811835|NCT00427245|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153811836|NCT00427245|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153811837|NCT00427245|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153811838|NCT05458076|Ritonavir|ritonavir|mesh-list
153811839|NCT05458076|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
153621087|NCT01996475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153621095|NCT01996475|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153621096|NCT01996475|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
153621097|NCT01996475|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
153621099|NCT01996475|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
153621100|NCT01996475|Antidepressive Agents|antidepressive agents|mesh-ancestor
153621101|NCT01996475|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153621102|NCT01996488|Olanzapine|olanzapine|mesh-list
153621103|NCT01996488|Antiemetics|antiemetics|mesh-ancestor
153621104|NCT01996488|Autonomic Agents|autonomic agents|mesh-ancestor
153621105|NCT01996488|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153621106|NCT01996488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153621107|NCT01996488|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153621108|NCT01996488|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153621109|NCT01996488|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153621110|NCT01996488|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153621111|NCT01996488|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153621112|NCT01996488|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
153621113|NCT01996488|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153621114|NCT01996488|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153621133|NCT01996501|Serotonin Agents|serotonin agents|mesh-ancestor
153621134|NCT01996579|Lactoferrin|lactoferrin|mesh-list
153621135|NCT01996579|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153621137|NCT01996618|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153621138|NCT01996618|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153621139|NCT01996618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153621140|NCT01996683|Deferiprone|deferiprone|mesh-list
153621141|NCT01996683|Deferoxamine|deferoxamine|mesh-list
153621142|NCT01996683|Iron Chelating Agents|iron chelating agents|mesh-ancestor
153621143|NCT01996683|Chelating Agents|chelating agents|mesh-ancestor
153621144|NCT01996683|Sequestering Agents|sequestering agents|mesh-ancestor
153621145|NCT01996683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153621146|NCT01996683|Siderophores|siderophores|mesh-ancestor
153730603|NCT00141804|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153621147|NCT01996735|Ticagrelor|ticagrelor|mesh-list
153621148|NCT01996735|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153621149|NCT01996735|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
153621150|NCT01996735|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
153621151|NCT01996735|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
153621152|NCT01996735|Purinergic Agents|purinergic agents|mesh-ancestor
153621153|NCT01996735|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153621167|NCT01997099|Anticonvulsants|anticonvulsants|mesh-ancestor
153621168|NCT01997099|Antiemetics|antiemetics|mesh-ancestor
153621169|NCT01997099|Autonomic Agents|autonomic agents|mesh-ancestor
153621170|NCT01997099|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153621171|NCT01997099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153621172|NCT01997099|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153621173|NCT01997099|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153621174|NCT01997099|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153621190|NCT01997112|Sensory System Agents|sensory system agents|mesh-ancestor
153621191|NCT01997112|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153621192|NCT01997112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153621193|NCT01997112|Antipyretics|antipyretics|mesh-ancestor
153621194|NCT01997138|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
153621195|NCT01997138|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153621196|NCT01997164|Aflibercept|aflibercept|mesh-list
153621197|NCT01997164|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153811846|NCT05458076|Antiviral Agents|antiviral agents|mesh-ancestor
153448094|NCT00002933|Irinotecan|irinotecan|mesh-list
153621198|NCT01997164|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153621199|NCT01997164|Growth Substances|growth substances|mesh-ancestor
153621200|NCT01997164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153621201|NCT01997164|Growth Inhibitors|growth inhibitors|mesh-ancestor
153621202|NCT01997164|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153621203|NCT01997203|Vitamin D|vitamin d|mesh-list
153621204|NCT01997203|Interferons|interferons|mesh-list
153621205|NCT01997203|Ribavirin|ribavirin|mesh-list
153621206|NCT01997203|Vitamins|vitamins|mesh-ancestor
153621207|NCT01997203|Micronutrients|micronutrients|mesh-ancestor
153621208|NCT01997203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153621209|NCT01997203|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153621210|NCT01997203|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153621211|NCT01997203|Antiviral Agents|antiviral agents|mesh-ancestor
153621212|NCT01997203|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153621213|NCT01997203|Antimetabolites|antimetabolites|mesh-ancestor
153621214|NCT01997203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153621216|NCT01997255|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
153621225|NCT01997294|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153621226|NCT01997294|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153621227|NCT01997294|Antimetabolites|antimetabolites|mesh-ancestor
153621228|NCT01997294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153621229|NCT01997294|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153621231|NCT01997294|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153621235|NCT01997580|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153621236|NCT01997580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153621239|NCT01997580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153621241|NCT01997593|Anesthetics, Local|anesthetics, local|mesh-ancestor
153621242|NCT01997593|Anesthetics|anesthetics|mesh-ancestor
153621243|NCT01997593|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153621244|NCT01997593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153621245|NCT01997593|Sensory System Agents|sensory system agents|mesh-ancestor
153621246|NCT01997593|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153621247|NCT01997632|Vaccines|vaccines|mesh-list
153621248|NCT01997632|Immunologic Factors|immunologic factors|mesh-ancestor
153621249|NCT01997632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153621250|NCT01997658|Methylprednisolone|methylprednisolone|mesh-list
153621251|NCT01997658|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
153621252|NCT01997658|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
153621253|NCT01997658|Prednisolone|prednisolone|mesh-list
153621254|NCT01997658|Prednisolone acetate|prednisolone acetate|mesh-list
153621255|NCT01997658|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
153621256|NCT01997658|Prednisolone phosphate|prednisolone phosphate|mesh-list
153621257|NCT01997658|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153621258|NCT01997658|Antiemetics|antiemetics|mesh-ancestor
153621259|NCT01997658|Autonomic Agents|autonomic agents|mesh-ancestor
153621260|NCT01997658|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153621261|NCT01997658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153621262|NCT01997658|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153621263|NCT01997658|Glucocorticoids|glucocorticoids|mesh-ancestor
153621264|NCT01997658|Hormones|hormones|mesh-ancestor
153621265|NCT01997658|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153621282|NCT01997788|Narcotics|narcotics|mesh-ancestor
153621293|NCT01997801|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
153621294|NCT01997801|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153621295|NCT01997801|Anesthetics, General|anesthetics, general|mesh-ancestor
153621296|NCT01997801|Anesthetics|anesthetics|mesh-ancestor
153621297|NCT01997801|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153621298|NCT01997801|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
153621299|NCT01997801|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
153621300|NCT01997801|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153621301|NCT01997801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153621302|NCT01997814|Immunologic Factors|immunologic factors|mesh-list
153621303|NCT01997814|Adjuvants, Immunologic|adjuvants, immunologic|mesh-list
153621304|NCT01997814|Immunomodulating Agents|immunomodulating agents|mesh-list
153621305|NCT01997814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153621306|NCT01997944|Interferons|interferons|mesh-list
153621307|NCT01997944|Interferon-alpha|interferon-alpha|mesh-list
153621308|NCT01997944|Interferon alpha-2|interferon alpha-2|mesh-list
153621309|NCT01997944|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
153621310|NCT01997944|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153621311|NCT01997944|Antiviral Agents|antiviral agents|mesh-ancestor
153621312|NCT01997944|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153621313|NCT01997944|Immunologic Factors|immunologic factors|mesh-ancestor
153621314|NCT01997944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153621315|NCT01997983|Botulinum Toxins|botulinum toxins|mesh-list
153621316|NCT01997983|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
153621317|NCT01997983|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153621318|NCT01997983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153621319|NCT01997983|Cholinergic Agents|cholinergic agents|mesh-ancestor
153621320|NCT01997983|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153621326|NCT01998113|Insulin|insulin|mesh-list
153621334|NCT01998126|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
153621335|NCT01998126|Crizotinib|crizotinib|mesh-list
153621336|NCT01998126|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153621337|NCT01998126|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153621338|NCT01998126|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153621339|NCT01998126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153621340|NCT01998126|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153621341|NCT01998126|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153621342|NCT01998126|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153621343|NCT01998165|Remifentanil|remifentanil|mesh-list
153621344|NCT01998165|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153621345|NCT01998165|Narcotics|narcotics|mesh-ancestor
153621346|NCT01998165|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153621347|NCT01998165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153621358|NCT01998217|Sensory System Agents|sensory system agents|mesh-ancestor
153621359|NCT01998217|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153621360|NCT01998217|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153621361|NCT01998217|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153621362|NCT01998217|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153621363|NCT01998217|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153621364|NCT01998217|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153621365|NCT01998217|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153621366|NCT01998217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153621367|NCT01998295|Lumefantrine|lumefantrine|mesh-list
153621368|NCT01998295|Artemether|artemether|mesh-list
153621369|NCT01998295|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
153621370|NCT01998295|Antimalarials|antimalarials|mesh-ancestor
153621371|NCT01998295|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153621372|NCT01998295|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153621373|NCT01998295|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153621374|NCT01998308|Hyaluronic Acid|hyaluronic acid|mesh-list
153621375|NCT01998308|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153621376|NCT01998308|Immunologic Factors|immunologic factors|mesh-ancestor
153621380|NCT01998347|Paclitaxel|paclitaxel|mesh-list
153811867|NCT05457530|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153621384|NCT01998347|Tubulin Modulators|tubulin modulators|mesh-ancestor
153621385|NCT01998347|Antimitotic Agents|antimitotic agents|mesh-ancestor
153621386|NCT01998347|Mitosis Modulators|mitosis modulators|mesh-ancestor
153621387|NCT01998347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153621388|NCT01998347|Antimetabolites|antimetabolites|mesh-ancestor
153621389|NCT01998347|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153621390|NCT01998347|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153621391|NCT01998347|Immunologic Factors|immunologic factors|mesh-ancestor
153621392|NCT01998347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153621393|NCT01998386|Hydrogen Peroxide|hydrogen peroxide|mesh-list
153621394|NCT01998386|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
153621395|NCT01998386|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153621396|NCT01998451|Ursodoxicoltaurine|ursodoxicoltaurine|mesh-list
153621397|NCT01998451|Antiviral Agents|antiviral agents|mesh-ancestor
153621398|NCT01998451|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153621399|NCT01998451|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
153621400|NCT01998451|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153621401|NCT01998503|Dexamethasone|dexamethasone|mesh-list
153621402|NCT01998503|Bortezomib|bortezomib|mesh-list
153621403|NCT01998503|Melphalan|melphalan|mesh-list
153621404|NCT01998503|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153730606|NCT00141804|Immunologic Factors|immunologic factors|mesh-ancestor
153621405|NCT01998503|Antiemetics|antiemetics|mesh-ancestor
153621406|NCT01998503|Autonomic Agents|autonomic agents|mesh-ancestor
153621407|NCT01998503|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153621408|NCT01998503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153621409|NCT01998503|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153621410|NCT01998503|Glucocorticoids|glucocorticoids|mesh-ancestor
153621411|NCT01998503|Hormones|hormones|mesh-ancestor
153621412|NCT01998503|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153621438|NCT01998685|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153621439|NCT01998685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153621440|NCT01998685|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153621442|NCT01998685|Analgesics|analgesics|mesh-ancestor
153621443|NCT01998685|Sensory System Agents|sensory system agents|mesh-ancestor
153621444|NCT01998685|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153621445|NCT01998685|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153621446|NCT01998685|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
153621447|NCT01998698|Lidocaine|lidocaine|mesh-list
153621448|NCT01998698|Dipivefrin|dipivefrin|mesh-list
153621449|NCT01998698|Hyaluronic Acid|hyaluronic acid|mesh-list
153621450|NCT01998698|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153621451|NCT01998698|Adrenergic Agents|adrenergic agents|mesh-ancestor
153621452|NCT01998698|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153621453|NCT01998698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153621454|NCT01998698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153621455|NCT01998698|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153621456|NCT01998698|Immunologic Factors|immunologic factors|mesh-ancestor
153621457|NCT01998698|Viscosupplements|viscosupplements|mesh-ancestor
153621458|NCT01998698|Protective Agents|protective agents|mesh-ancestor
153621459|NCT01998698|Anesthetics, Local|anesthetics, local|mesh-ancestor
153621460|NCT01998698|Anesthetics|anesthetics|mesh-ancestor
153621461|NCT01998698|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153621462|NCT01998698|Sensory System Agents|sensory system agents|mesh-ancestor
153621463|NCT01998698|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153621464|NCT01998698|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153621465|NCT01998698|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
153621466|NCT01998698|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153621467|NCT01998698|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153621482|NCT01998776|Oxytocics|oxytocics|mesh-ancestor
153621483|NCT01998789|Everolimus|everolimus|mesh-list
153621484|NCT01998789|Tacrolimus|tacrolimus|mesh-list
153621493|NCT01998789|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153730607|NCT00141804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153730608|NCT00134498|Atorvastatin|atorvastatin|mesh-list
153621495|NCT01999153|Anesthetics, Local|anesthetics, local|mesh-ancestor
153621496|NCT01999153|Anesthetics|anesthetics|mesh-ancestor
153621497|NCT01999153|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153621498|NCT01999153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153621499|NCT01999153|Sensory System Agents|sensory system agents|mesh-ancestor
153621500|NCT01999153|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153621501|NCT01999270|Bevacizumab|bevacizumab|mesh-list
153621502|NCT01999270|Irinotecan|irinotecan|mesh-list
153621503|NCT01999270|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153621504|NCT01999270|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153621505|NCT01999270|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153621572|NCT01999829|Purinergic Agents|purinergic agents|mesh-ancestor
153621573|NCT01999829|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153621574|NCT01999842|Vaccines|vaccines|mesh-list
153621575|NCT01999842|Immunologic Factors|immunologic factors|mesh-ancestor
153621576|NCT01999842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153621577|NCT01999907|Vitamin D|vitamin d|mesh-list
153621578|NCT01999907|Ergocalciferols|ergocalciferols|mesh-list
153621579|NCT01999907|Cholecalciferol|cholecalciferol|mesh-list
153621580|NCT01999907|Vitamins|vitamins|mesh-list
153621581|NCT01999907|Micronutrients|micronutrients|mesh-ancestor
153621582|NCT01999907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153621583|NCT01999907|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153621584|NCT01999907|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153621586|NCT01999933|Docetaxel|docetaxel|mesh-list
153621587|NCT01999933|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153621588|NCT01999933|Tubulin Modulators|tubulin modulators|mesh-ancestor
153621589|NCT01999933|Antimitotic Agents|antimitotic agents|mesh-ancestor
153621590|NCT01999933|Mitosis Modulators|mitosis modulators|mesh-ancestor
153621591|NCT01999933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153621593|NCT02000102|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153621594|NCT02000102|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153621595|NCT02000102|Growth Substances|growth substances|mesh-ancestor
153621596|NCT02000102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153621597|NCT02000102|Growth Inhibitors|growth inhibitors|mesh-ancestor
153621598|NCT02000102|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153621599|NCT02000193|Fulvestrant|fulvestrant|mesh-list
153621600|NCT02000193|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153621601|NCT02000193|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153621602|NCT02000193|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
153621603|NCT02000193|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
153621604|NCT02000193|Hormone Antagonists|hormone antagonists|mesh-ancestor
153621616|NCT02000206|Analgesics|analgesics|mesh-ancestor
153621617|NCT02000206|Sensory System Agents|sensory system agents|mesh-ancestor
153621618|NCT02000206|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153621619|NCT02000206|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
153621620|NCT02000206|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
153621621|NCT02000206|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
153621622|NCT02000206|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153621623|NCT02000206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153621624|NCT02000206|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153621625|NCT02000206|Narcotics|narcotics|mesh-ancestor
153621626|NCT02000336|Prednisolone|prednisolone|mesh-list
153621627|NCT02000336|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153621628|NCT02000336|Glucocorticoids|glucocorticoids|mesh-ancestor
153811906|NCT02957448|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153621629|NCT02000336|Hormones|hormones|mesh-ancestor
153621630|NCT02000336|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153621631|NCT02000336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153621632|NCT02000336|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153621633|NCT02000336|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153621634|NCT02000375|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
153621635|NCT02000375|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153621636|NCT02000375|Immunologic Factors|immunologic factors|mesh-ancestor
153621637|NCT02000375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153621638|NCT02000388|Ketorolac|ketorolac|mesh-list
153621639|NCT02000388|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
153811907|NCT02957448|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153811908|NCT02957448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153621640|NCT02000388|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153621641|NCT02000388|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153621663|NCT02000401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153621665|NCT02000414|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153621666|NCT02000414|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153621667|NCT02000674|Rocuronium|rocuronium|mesh-list
153621677|NCT02000700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153621678|NCT02000700|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153621679|NCT02000700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153621680|NCT02000726|Antidepressive Agents|antidepressive agents|mesh-list
153621681|NCT02000726|Citalopram|citalopram|mesh-list
153621682|NCT02000726|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153621683|NCT02000726|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
153621684|NCT02000726|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153621685|NCT02000726|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153621686|NCT02000726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153621687|NCT02000726|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153621688|NCT02000726|Serotonin Agents|serotonin agents|mesh-ancestor
153621689|NCT02000726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153621690|NCT02000726|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
153621691|NCT02000765|Gepotidacin|gepotidacin|mesh-list
153621692|NCT02000765|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153621693|NCT02000765|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153621694|NCT02000765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153621695|NCT02000765|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153621696|NCT02000804|Darapladib|darapladib|mesh-list
153621697|NCT02000804|Phospholipase A2 Inhibitors|phospholipase a2 inhibitors|mesh-ancestor
153621698|NCT02000804|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153621699|NCT02000804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153621700|NCT02000830|Tin mesoporphyrin|tin mesoporphyrin|mesh-list
153621701|NCT02000830|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153621702|NCT02000830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153621703|NCT02000947|Durvalumab|durvalumab|mesh-list
153621704|NCT02000947|Tremelimumab|tremelimumab|mesh-list
153621705|NCT02000947|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
153621710|NCT02001012|Chloroquine|chloroquine|mesh-list
153621711|NCT02001012|Chloroquine diphosphate|chloroquine diphosphate|mesh-list
153621712|NCT02001012|Lumefantrine|lumefantrine|mesh-list
153621713|NCT02001012|Artemether|artemether|mesh-list
153621714|NCT02001012|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
153621715|NCT02001012|Amebicides|amebicides|mesh-ancestor
153621716|NCT02001012|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153621717|NCT02001012|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153621718|NCT02001012|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153621719|NCT02001012|Antimalarials|antimalarials|mesh-ancestor
153621720|NCT02001012|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153621721|NCT02001012|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153621722|NCT02001012|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153621723|NCT02001012|Analgesics|analgesics|mesh-ancestor
153621724|NCT02001012|Sensory System Agents|sensory system agents|mesh-ancestor
153621725|NCT02001012|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153621726|NCT02001012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153621727|NCT02001012|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153621728|NCT02001012|Filaricides|filaricides|mesh-ancestor
153621729|NCT02001012|Antinematodal Agents|antinematodal agents|mesh-ancestor
153621730|NCT02001012|Anthelmintics|anthelmintics|mesh-ancestor
153621741|NCT02001168|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153621742|NCT02001168|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153621743|NCT02001168|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153621744|NCT02001168|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153621746|NCT02001168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153621747|NCT02001168|Growth Inhibitors|growth inhibitors|mesh-ancestor
153621748|NCT02001207|Hydrocortisone|hydrocortisone|mesh-list
153621749|NCT02001207|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153621750|NCT02001259|Lidocaine|lidocaine|mesh-list
153621751|NCT02001259|Anesthetics, Local|anesthetics, local|mesh-ancestor
153621752|NCT02001259|Anesthetics|anesthetics|mesh-ancestor
153621753|NCT02001259|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153621754|NCT02001259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153621755|NCT02001259|Sensory System Agents|sensory system agents|mesh-ancestor
153621756|NCT02001259|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153621758|NCT02001259|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
153621759|NCT02001259|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153621760|NCT02001259|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153621761|NCT02001259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153621762|NCT02001272|Paclitaxel|paclitaxel|mesh-list
153621763|NCT02001272|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
153621764|NCT02001272|Carboplatin|carboplatin|mesh-list
153621765|NCT02001272|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153621766|NCT02001272|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153621767|NCT02001272|Tubulin Modulators|tubulin modulators|mesh-ancestor
153621768|NCT02001272|Antimitotic Agents|antimitotic agents|mesh-ancestor
153621769|NCT02001272|Mitosis Modulators|mitosis modulators|mesh-ancestor
153621770|NCT02001272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153621771|NCT02001285|Remifentanil|remifentanil|mesh-list
153621772|NCT02001285|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153621773|NCT02001285|Narcotics|narcotics|mesh-ancestor
153621774|NCT02001285|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153621775|NCT02001285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153621776|NCT02001285|Analgesics|analgesics|mesh-ancestor
153621777|NCT02001285|Sensory System Agents|sensory system agents|mesh-ancestor
153621778|NCT02001285|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153621779|NCT02001298|Nitroprusside|nitroprusside|mesh-list
153621780|NCT02001298|Remifentanil|remifentanil|mesh-list
153621781|NCT02001298|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153621782|NCT02001298|Narcotics|narcotics|mesh-ancestor
153621783|NCT02001298|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153621784|NCT02001298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153621785|NCT02001298|Analgesics|analgesics|mesh-ancestor
153621786|NCT02001298|Sensory System Agents|sensory system agents|mesh-ancestor
153621811|NCT02001506|Docetaxel|docetaxel|mesh-list
153621812|NCT02001506|Epirubicin|epirubicin|mesh-list
153621813|NCT02001506|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153621814|NCT02001506|Tubulin Modulators|tubulin modulators|mesh-ancestor
153621815|NCT02001506|Antimitotic Agents|antimitotic agents|mesh-ancestor
153621816|NCT02001506|Mitosis Modulators|mitosis modulators|mesh-ancestor
153621817|NCT02001506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153621818|NCT02001506|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153621819|NCT02001506|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153621820|NCT02001506|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153621821|NCT02001506|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153621822|NCT02001571|Abiraterone Acetate|abiraterone acetate|mesh-list
153621823|NCT02001571|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153621824|NCT02001571|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153621825|NCT02001571|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153621826|NCT02001571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153621827|NCT02001571|Hormone Antagonists|hormone antagonists|mesh-ancestor
153621828|NCT02001571|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153621829|NCT02001571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153621830|NCT02001571|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153621831|NCT02001584|Memantine|memantine|mesh-list
153621832|NCT02001584|Baclofen|baclofen|mesh-list
153621833|NCT02001584|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
153621834|NCT02001584|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
153621835|NCT02001584|Dopamine Agents|dopamine agents|mesh-ancestor
153621836|NCT02001584|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153621837|NCT02001584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153621838|NCT02001584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153621839|NCT02001584|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
153621840|NCT02001584|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
153621851|NCT02001740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153621852|NCT02001740|Sensory System Agents|sensory system agents|mesh-ancestor
153811923|NCT00432510|Complement C1s|complement c1s|mesh-list
153448120|NCT00002945|Cytarabine|cytarabine|mesh-list
153621853|NCT02001740|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153621854|NCT02001740|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153621855|NCT02001740|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
153621856|NCT02001740|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153621857|NCT02001740|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153621858|NCT02001740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153621859|NCT02001857|Hemostatics|hemostatics|mesh-list
153621860|NCT02001857|Coagulants|coagulants|mesh-ancestor
153621861|NCT02001883|Policosanol|policosanol|mesh-list
153621862|NCT02001883|Atorvastatin|atorvastatin|mesh-list
153621863|NCT02001883|Simvastatin|simvastatin|mesh-list
153621864|NCT02001883|Red yeast rice|red yeast rice|mesh-list
153621865|NCT02001883|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153621866|NCT02001883|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153621886|NCT02001909|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
153621887|NCT02001909|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153621888|NCT02001909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153621889|NCT02001935|Theophylline|theophylline|mesh-list
153621890|NCT02001935|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153621891|NCT02001935|Autonomic Agents|autonomic agents|mesh-ancestor
153621892|NCT02001935|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153621893|NCT02001935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153621897|NCT02001935|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153621919|NCT02001974|Antimitotic Agents|antimitotic agents|mesh-ancestor
153621931|NCT02001103|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
153621932|NCT02001103|Dopamine Agents|dopamine agents|mesh-ancestor
153621933|NCT02001103|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153621934|NCT02001103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153621935|NCT02001103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153621936|NCT02001103|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
153811949|NCT05354258|Mitosis Modulators|mitosis modulators|mesh-ancestor
153811950|NCT05354258|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153621937|NCT02001103|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
153621938|NCT02002039|Epoetin Alfa|epoetin alfa|mesh-list
153621939|NCT02002039|Hematinics|hematinics|mesh-ancestor
153621940|NCT02002065|Vaccines|vaccines|mesh-list
153621941|NCT02002065|Immunologic Factors|immunologic factors|mesh-ancestor
153621942|NCT02002065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153621943|NCT02002078|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
153621944|NCT02002078|Methylprednisolone|methylprednisolone|mesh-list
153811951|NCT05338580|Pembrolizumab|pembrolizumab|mesh-list
153811952|NCT05338580|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153811953|NCT05338580|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153811954|NCT05338580|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153811955|NCT05338580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153811956|NCT02273466|Desipramine|desipramine|mesh-list
153811957|NCT02273466|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
153811958|NCT02273466|Antidepressive Agents|antidepressive agents|mesh-ancestor
153811959|NCT02273466|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153811960|NCT02273466|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153811961|NCT02273466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153811962|NCT02273466|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
153811963|NCT02273466|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153811964|NCT02273466|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153811965|NCT02273466|Adrenergic Agents|adrenergic agents|mesh-ancestor
153621945|NCT02002078|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
153621946|NCT02002078|Prednisolone|prednisolone|mesh-list
153621947|NCT02002078|Prednisolone acetate|prednisolone acetate|mesh-list
153621948|NCT02002078|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
153621949|NCT02002078|Prednisolone phosphate|prednisolone phosphate|mesh-list
153621950|NCT02002078|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153621951|NCT02002078|Antiemetics|antiemetics|mesh-ancestor
153621952|NCT02002078|Autonomic Agents|autonomic agents|mesh-ancestor
153621953|NCT02002078|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153621954|NCT02002078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153621955|NCT02002078|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153621956|NCT02002078|Glucocorticoids|glucocorticoids|mesh-ancestor
153621957|NCT02002078|Hormones|hormones|mesh-ancestor
153621958|NCT02002078|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153621959|NCT02002078|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
153621960|NCT02002078|Protective Agents|protective agents|mesh-ancestor
153621973|NCT02002195|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153621974|NCT02002195|Antimetabolites|antimetabolites|mesh-ancestor
153621975|NCT02002195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153621976|NCT02002195|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153621977|NCT02002195|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153621978|NCT02002195|Immunologic Factors|immunologic factors|mesh-ancestor
153621979|NCT02002195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153621980|NCT02002195|Antidotes|antidotes|mesh-ancestor
153621981|NCT02002195|Protective Agents|protective agents|mesh-ancestor
153621982|NCT02002195|Vitamin B Complex|vitamin b complex|mesh-ancestor
153621983|NCT02002195|Vitamins|vitamins|mesh-ancestor
153621984|NCT02002195|Micronutrients|micronutrients|mesh-ancestor
153621985|NCT02002247|Selenium|selenium|mesh-list
153622002|NCT02002260|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153622004|NCT02002260|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
153622005|NCT02002260|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153622006|NCT02002260|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
153622007|NCT02002260|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
153622008|NCT02002260|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
153622009|NCT02002286|Triptolide|triptolide|mesh-list
153622010|NCT02002286|Antispermatogenic Agents|antispermatogenic agents|mesh-ancestor
153622011|NCT02002286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153622012|NCT02002286|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
153622013|NCT02002286|Contraceptive Agents|contraceptive agents|mesh-ancestor
153622014|NCT02002286|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153622015|NCT02002286|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153622016|NCT02002286|Immunologic Factors|immunologic factors|mesh-ancestor
153622017|NCT02002286|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153622018|NCT02002286|Alkylating Agents|alkylating agents|mesh-ancestor
153622020|NCT02002286|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153622032|NCT02002377|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153622033|NCT02002377|Growth Substances|growth substances|mesh-ancestor
153811967|NCT02273466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153811968|NCT00427713|Capecitabine|capecitabine|mesh-list
153811969|NCT00427713|Oxaliplatin|oxaliplatin|mesh-list
153811970|NCT00427713|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153811971|NCT00427713|Antimetabolites|antimetabolites|mesh-ancestor
153811972|NCT00427713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153811973|NCT00427713|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153811974|NCT02273505|Aspirin|aspirin|mesh-list
153811975|NCT02273505|Salicylic Acid|salicylic acid|mesh-list
153811976|NCT02273505|Salicylates|salicylates|mesh-list
153811977|NCT02273505|Dipyridamole|dipyridamole|mesh-list
153811978|NCT02273505|Aspirin, Dipyridamole Drug Combination|aspirin, dipyridamole drug combination|mesh-list
153622034|NCT02002377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153622035|NCT02002377|Growth Inhibitors|growth inhibitors|mesh-ancestor
153622036|NCT02002377|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153622037|NCT02002390|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
153622038|NCT02002390|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
153622039|NCT02002390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153622040|NCT02002390|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153622041|NCT02002390|Immunologic Factors|immunologic factors|mesh-ancestor
153622055|NCT02002598|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
153622057|NCT02002598|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153622059|NCT02002598|Autonomic Agents|autonomic agents|mesh-ancestor
153622060|NCT02002598|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153622061|NCT02002598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153622062|NCT02002598|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153622063|NCT02002598|Glucocorticoids|glucocorticoids|mesh-ancestor
153622064|NCT02002598|Hormones|hormones|mesh-ancestor
153622065|NCT02002598|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153622066|NCT02002598|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153622067|NCT02002598|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153622068|NCT02002598|Protease Inhibitors|protease inhibitors|mesh-ancestor
153622069|NCT02002598|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153622070|NCT02002598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153622071|NCT02002598|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153622072|NCT02002598|Alkylating Agents|alkylating agents|mesh-ancestor
153622073|NCT02002611|Warfarin|warfarin|mesh-list
153622074|NCT02002611|Anticoagulants|anticoagulants|mesh-ancestor
153622086|NCT02002663|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153622087|NCT02002663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153622088|NCT02002663|Analgesics|analgesics|mesh-ancestor
153622089|NCT02002663|Sensory System Agents|sensory system agents|mesh-ancestor
153622090|NCT02002663|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153622091|NCT02002663|Anesthetics, Local|anesthetics, local|mesh-ancestor
153622092|NCT02002663|Anesthetics|anesthetics|mesh-ancestor
153622093|NCT02002663|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153622094|NCT02002663|Antiemetics|antiemetics|mesh-ancestor
153622095|NCT02002663|Autonomic Agents|autonomic agents|mesh-ancestor
153622096|NCT02002663|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153622097|NCT02002663|Glucocorticoids|glucocorticoids|mesh-ancestor
153622098|NCT02002663|Hormones|hormones|mesh-ancestor
153622099|NCT02002663|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153622100|NCT02002663|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
153622101|NCT02002663|Protective Agents|protective agents|mesh-ancestor
153622102|NCT02002663|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153622103|NCT02002663|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153622104|NCT02002715|Budesonide|budesonide|mesh-list
153622105|NCT02002715|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153622106|NCT02002715|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153622115|NCT02002741|Acetaminophen|acetaminophen|mesh-list
153622116|NCT02002741|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153622117|NCT02002741|Analgesics|analgesics|mesh-ancestor
153622118|NCT02002741|Sensory System Agents|sensory system agents|mesh-ancestor
153622119|NCT02002741|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153622120|NCT02002741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153622121|NCT02002741|Antipyretics|antipyretics|mesh-ancestor
153622122|NCT02002754|Bambuterol|bambuterol|mesh-list
153622123|NCT02002754|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153622124|NCT02002754|Autonomic Agents|autonomic agents|mesh-ancestor
153622125|NCT02002754|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153622129|NCT02002806|Ethanol|ethanol|mesh-list
153622138|NCT02002858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153622139|NCT02002858|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
153622140|NCT02002858|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
153622141|NCT02002858|Cholinergic Agents|cholinergic agents|mesh-ancestor
153622142|NCT02002858|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153622143|NCT02002858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153811979|NCT02273505|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153622144|NCT02002923|Botulinum Toxins|botulinum toxins|mesh-list
153622145|NCT02002923|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
153622146|NCT02002923|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153622147|NCT02002923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153622148|NCT02002923|Cholinergic Agents|cholinergic agents|mesh-ancestor
153622149|NCT02002923|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153622150|NCT02002923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153622151|NCT02002962|Botulinum Toxins|botulinum toxins|mesh-list
153622152|NCT02002962|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
153622153|NCT02002962|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
153622154|NCT02002962|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
153622155|NCT02002962|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153622156|NCT02002962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153622157|NCT02002962|Cholinergic Agents|cholinergic agents|mesh-ancestor
153622158|NCT02002962|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153622159|NCT02002962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153622160|NCT02002962|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
153622161|NCT02002962|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153622162|NCT02003001|Botulinum Toxins|botulinum toxins|mesh-list
153622163|NCT02003001|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
153622164|NCT02003001|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153622189|NCT02003456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153622190|NCT02003495|Vaccines|vaccines|mesh-list
153622191|NCT02003495|Immunologic Factors|immunologic factors|mesh-ancestor
153622192|NCT02003495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153622193|NCT02003664|Baclofen|baclofen|mesh-list
153622194|NCT02003664|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
153622195|NCT02003664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153622196|NCT02003664|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
153622197|NCT02003664|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153622198|NCT02003664|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
153622199|NCT02003664|GABA Agonists|gaba agonists|mesh-ancestor
153622200|NCT02003664|GABA Agents|gaba agents|mesh-ancestor
153622201|NCT02003664|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153622202|NCT02003664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153622203|NCT02003677|Insulin|insulin|mesh-list
153622204|NCT02003677|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
153622205|NCT02003677|Insulin Aspart|insulin aspart|mesh-list
153622206|NCT02003677|Insulin, Long-Acting|insulin, long-acting|mesh-list
153622207|NCT02003677|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
153622208|NCT02003677|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153622209|NCT02003677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153622211|NCT02003768|Desflurane|desflurane|mesh-list
153622212|NCT02003768|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153622213|NCT02003768|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153622214|NCT02003768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153622215|NCT02003768|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153622216|NCT02003768|Anesthetics, General|anesthetics, general|mesh-ancestor
153622238|NCT02004067|Cathartics|cathartics|mesh-ancestor
153622239|NCT02004067|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153811988|NCT02273505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153812012|NCT00427947|Ropivacaine|ropivacaine|mesh-list
153622240|NCT02004171|Nicotine|nicotine|mesh-list
153622241|NCT02004171|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
153622242|NCT02004171|Autonomic Agents|autonomic agents|mesh-ancestor
153622252|NCT02004184|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153622253|NCT02004184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153622254|NCT02004184|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153622255|NCT02004184|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153622256|NCT02004197|Amoxicillin|amoxicillin|mesh-list
153622257|NCT02004197|Bismuth tripotassium dicitrate|bismuth tripotassium dicitrate|mesh-list
153622258|NCT02004197|Bismuth|bismuth|mesh-list
153622259|NCT02004197|Ranitidine|ranitidine|mesh-list
153622260|NCT02004197|Ranitidine bismuth citrate|ranitidine bismuth citrate|mesh-list
153622261|NCT02004197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153622262|NCT02004197|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153622263|NCT02004197|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153622264|NCT02004197|Antacids|antacids|mesh-ancestor
153622265|NCT02004197|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153622304|NCT02004574|Calcipotriene|calcipotriene|mesh-list
153622305|NCT02004574|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
153622306|NCT02004574|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153622307|NCT02004574|Glucocorticoids|glucocorticoids|mesh-ancestor
153622325|NCT02004769|Trastuzumab|trastuzumab|mesh-list
153622326|NCT02004769|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153622327|NCT02004769|Tubulin Modulators|tubulin modulators|mesh-ancestor
153622328|NCT02004769|Antimitotic Agents|antimitotic agents|mesh-ancestor
153622329|NCT02004769|Mitosis Modulators|mitosis modulators|mesh-ancestor
153622330|NCT02004769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153622331|NCT02004769|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153622332|NCT02004769|Antimetabolites|antimetabolites|mesh-ancestor
153622333|NCT02004769|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153622335|NCT02004860|Tacrolimus|tacrolimus|mesh-list
153622336|NCT02004860|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153622337|NCT02004860|Immunologic Factors|immunologic factors|mesh-ancestor
153622338|NCT02004860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153622339|NCT02004860|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
153622340|NCT02004860|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153622341|NCT02004860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153622342|NCT02004860|Antifungal Agents|antifungal agents|mesh-ancestor
153622343|NCT02004860|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153622344|NCT02004899|Fentanyl|fentanyl|mesh-list
153622345|NCT02004899|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153622346|NCT02004899|Narcotics|narcotics|mesh-ancestor
153622347|NCT02004899|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153622348|NCT02004899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153622349|NCT02004899|Analgesics|analgesics|mesh-ancestor
153622350|NCT02004899|Sensory System Agents|sensory system agents|mesh-ancestor
153622351|NCT02004899|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153622377|NCT02005120|Growth Substances|growth substances|mesh-ancestor
153622378|NCT02005120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153622379|NCT02005120|Growth Inhibitors|growth inhibitors|mesh-ancestor
153622380|NCT02005302|Vitamin D|vitamin d|mesh-list
153622381|NCT02005302|Ergocalciferols|ergocalciferols|mesh-list
153622382|NCT02005302|Cholecalciferol|cholecalciferol|mesh-list
153622383|NCT02005302|Vitamins|vitamins|mesh-list
153622384|NCT02005302|Micronutrients|micronutrients|mesh-ancestor
153622385|NCT02005302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153622386|NCT02005302|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153622387|NCT02005302|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153622388|NCT02005315|Paclitaxel|paclitaxel|mesh-list
153622389|NCT02005315|Gemcitabine|gemcitabine|mesh-list
153622390|NCT02005315|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153622391|NCT02005315|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153622392|NCT02005315|Tubulin Modulators|tubulin modulators|mesh-ancestor
153622393|NCT02005315|Antimitotic Agents|antimitotic agents|mesh-ancestor
153730613|NCT00134498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153730614|NCT00134498|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153730615|NCT00134498|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
153730616|NCT00134498|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153730618|NCT00141843|Coagulants|coagulants|mesh-ancestor
153730619|NCT00141882|Memantine|memantine|mesh-list
153730620|NCT00141882|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
153730621|NCT00141882|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
153622394|NCT02005315|Mitosis Modulators|mitosis modulators|mesh-ancestor
153622395|NCT02005315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153622396|NCT02005315|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153622414|NCT02005523|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153622415|NCT02005523|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
153622417|NCT02005575|Bupivacaine|bupivacaine|mesh-list
153622418|NCT02005575|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153622419|NCT02005575|Antiemetics|antiemetics|mesh-ancestor
153622420|NCT02005575|Autonomic Agents|autonomic agents|mesh-ancestor
153622421|NCT02005575|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153622422|NCT02005575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153622423|NCT02005575|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153622424|NCT02005575|Glucocorticoids|glucocorticoids|mesh-ancestor
153622425|NCT02005575|Hormones|hormones|mesh-ancestor
153622426|NCT02005575|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153622427|NCT02005575|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153622428|NCT02005575|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153622466|NCT02005718|Vitamins|vitamins|mesh-ancestor
153622467|NCT02005718|Micronutrients|micronutrients|mesh-ancestor
153622468|NCT02005718|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153622469|NCT02005757|Mizoribine|mizoribine|mesh-list
153622486|NCT02005757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153622488|NCT02005757|Immunologic Factors|immunologic factors|mesh-ancestor
153622489|NCT02005770|Propofol|propofol|mesh-list
153622490|NCT02005770|Sevoflurane|sevoflurane|mesh-list
153622491|NCT02005770|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153622492|NCT02005770|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153622496|NCT02005770|Anesthetics|anesthetics|mesh-ancestor
153622519|NCT02005822|Antiviral Agents|antiviral agents|mesh-ancestor
153622520|NCT02005822|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153622521|NCT02005848|Protease Inhibitors|protease inhibitors|mesh-list
153622522|NCT02005848|Alpha 1-Antitrypsin|alpha 1-antitrypsin|mesh-list
153622523|NCT02005848|Protein C Inhibitor|protein c inhibitor|mesh-list
153622524|NCT02005848|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153622543|NCT02006173|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153622544|NCT02006173|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153622545|NCT02006173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153622546|NCT02006225|Plerixafor|plerixafor|mesh-list
153622547|NCT02006225|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153622548|NCT02006225|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153622549|NCT02006225|Antiviral Agents|antiviral agents|mesh-ancestor
153622550|NCT02006225|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153622551|NCT02006277|Crizotinib|crizotinib|mesh-list
153622552|NCT02006277|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
153622553|NCT02006277|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153622554|NCT02006277|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153622555|NCT02006277|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153622556|NCT02006277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153622557|NCT02006277|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153622558|NCT02006355|Ropivacaine|ropivacaine|mesh-list
153622559|NCT02006355|Anesthetics, Local|anesthetics, local|mesh-ancestor
153622560|NCT02006355|Anesthetics|anesthetics|mesh-ancestor
153622561|NCT02006355|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153622562|NCT02006355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153622563|NCT02006355|Sensory System Agents|sensory system agents|mesh-ancestor
153622564|NCT02006355|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153622565|NCT02006485|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
153622566|NCT02006485|Ibrutinib|ibrutinib|mesh-list
153622577|NCT05970900|Imatinib Mesylate|imatinib mesylate|mesh-list
153622604|NCT05970627|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153622605|NCT05970536|Acetic Acid|acetic acid|mesh-list
153622606|NCT05970536|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153622607|NCT05970536|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153622608|NCT05970302|Bevacizumab|bevacizumab|mesh-list
153622609|NCT05970302|Tislelizumab|tislelizumab|mesh-list
153622610|NCT05970302|Capecitabine|capecitabine|mesh-list
153622611|NCT05970302|Oxaliplatin|oxaliplatin|mesh-list
153622612|NCT05970302|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153622613|NCT05970302|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153622614|NCT05970302|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153622615|NCT05970302|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153622616|NCT05970302|Growth Substances|growth substances|mesh-ancestor
153622617|NCT05970302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153622618|NCT05970302|Growth Inhibitors|growth inhibitors|mesh-ancestor
153622619|NCT05970302|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153622620|NCT05970302|Antimetabolites|antimetabolites|mesh-ancestor
153622621|NCT05970302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153622622|NCT05970250|Vitamin D|vitamin d|mesh-list
153622623|NCT05970250|Calcium|calcium|mesh-list
153622624|NCT05970250|Vitamins|vitamins|mesh-ancestor
153622625|NCT05970250|Micronutrients|micronutrients|mesh-ancestor
153622673|NCT05969522|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153622674|NCT05969522|Alkylating Agents|alkylating agents|mesh-ancestor
153622675|NCT05969522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153622676|NCT05969522|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153622677|NCT05969522|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153622678|NCT05969522|Hormones|hormones|mesh-ancestor
153622679|NCT05969522|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153622680|NCT05969457|Ropivacaine|ropivacaine|mesh-list
153622681|NCT05969457|Anesthetics, Local|anesthetics, local|mesh-ancestor
153622682|NCT05969457|Anesthetics|anesthetics|mesh-ancestor
153622683|NCT05969457|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153622684|NCT05969457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153622685|NCT05969457|Sensory System Agents|sensory system agents|mesh-ancestor
153622686|NCT05969457|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153622687|NCT05969392|Ethanol|ethanol|mesh-list
153622706|NCT05969171|Gemcitabine|gemcitabine|mesh-list
153622708|NCT05969171|Paclitaxel|paclitaxel|mesh-list
153622709|NCT05969171|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153622710|NCT05969171|Antimetabolites|antimetabolites|mesh-ancestor
153622711|NCT05969171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153622712|NCT05969171|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153622713|NCT05969171|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153622714|NCT05969171|Tubulin Modulators|tubulin modulators|mesh-ancestor
153622715|NCT05969171|Antimitotic Agents|antimitotic agents|mesh-ancestor
153622716|NCT05969171|Mitosis Modulators|mitosis modulators|mesh-ancestor
153622717|NCT05969119|Pyridostigmine Bromide|pyridostigmine bromide|mesh-list
153622718|NCT05969119|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
153622719|NCT05969119|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153622720|NCT05969119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153622721|NCT05969119|Cholinergic Agents|cholinergic agents|mesh-ancestor
153622722|NCT05969119|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153622723|NCT05969119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153622724|NCT05968885|Solifenacin Succinate|solifenacin succinate|mesh-list
153622726|NCT05968885|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
153622731|NCT05968885|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
153622732|NCT05968885|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153622733|NCT05968885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153622734|NCT05968885|Cholinergic Agents|cholinergic agents|mesh-ancestor
153622735|NCT05968885|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153622736|NCT05968885|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
153622737|NCT05968885|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
153622738|NCT05968885|Urological Agents|urological agents|mesh-ancestor
153622739|NCT05968885|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
153622740|NCT05968885|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
153622741|NCT05968885|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153622742|NCT05968885|Adrenergic Agents|adrenergic agents|mesh-ancestor
153622743|NCT05968846|Iodine|iodine|mesh-list
153622759|NCT05967936|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153622761|NCT05967936|Sensory System Agents|sensory system agents|mesh-ancestor
153622762|NCT05967936|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153622763|NCT05967884|Cemiplimab|cemiplimab|mesh-list
153622764|NCT05967884|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153622765|NCT05967884|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153622766|NCT05967650|Vaccines|vaccines|mesh-list
153622767|NCT05967650|Immunologic Factors|immunologic factors|mesh-ancestor
153622768|NCT05967650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153622769|NCT05967442|Magnesium Sulfate|magnesium sulfate|mesh-list
153622770|NCT05967442|Metoclopramide|metoclopramide|mesh-list
153622771|NCT05967442|Prochlorperazine|prochlorperazine|mesh-list
153622772|NCT05967442|Analgesics|analgesics|mesh-ancestor
153622773|NCT05967442|Sensory System Agents|sensory system agents|mesh-ancestor
153622774|NCT05967442|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153622775|NCT05967442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153622776|NCT05967442|Anesthetics|anesthetics|mesh-ancestor
153622777|NCT05967442|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153622778|NCT05967442|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153622779|NCT05967442|Anticonvulsants|anticonvulsants|mesh-ancestor
153622780|NCT05967442|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153812028|NCT00428025|Diclofenac|diclofenac|mesh-list
153622781|NCT05967442|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153622784|NCT05967442|Tocolytic Agents|tocolytic agents|mesh-ancestor
153622785|NCT05967442|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153622786|NCT05967442|Antiemetics|antiemetics|mesh-ancestor
153622787|NCT05967442|Autonomic Agents|autonomic agents|mesh-ancestor
153622788|NCT05967442|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153622789|NCT05967442|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
153622790|NCT05967442|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
153622791|NCT05967442|Dopamine Agents|dopamine agents|mesh-ancestor
153622792|NCT05967442|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153622793|NCT05967442|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153622794|NCT05967442|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153622795|NCT05967442|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153622796|NCT05967377|Leucovorin|leucovorin|mesh-list
153622797|NCT05967377|Sorafenib|sorafenib|mesh-list
153622798|NCT05967377|Fluorouracil|fluorouracil|mesh-list
153622799|NCT05967377|Methotrexate|methotrexate|mesh-list
153622800|NCT05967377|Carboplatin|carboplatin|mesh-list
153622801|NCT05967377|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153622802|NCT05967377|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153622803|NCT05967377|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153622804|NCT05967377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153622805|NCT05967377|Antidotes|antidotes|mesh-ancestor
153622829|NCT05966818|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
153622830|NCT05966818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153622831|NCT05966818|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153622832|NCT05966818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153622833|NCT05966818|Protease Inhibitors|protease inhibitors|mesh-ancestor
153622834|NCT05966818|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153622835|NCT05966792|Metformin|metformin|mesh-list
153622837|NCT05966792|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153622850|NCT05951387|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153622851|NCT05951387|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153622852|NCT05951387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153622853|NCT05951387|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153622854|NCT05951387|Analgesics|analgesics|mesh-ancestor
153622855|NCT05951387|Sensory System Agents|sensory system agents|mesh-ancestor
153622862|NCT05951387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153622863|NCT05951387|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
153622864|NCT05951387|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153622865|NCT05951387|Anesthetics, General|anesthetics, general|mesh-ancestor
153622866|NCT05951387|Anesthetics|anesthetics|mesh-ancestor
153622867|NCT05951387|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
153622868|NCT05951387|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
153622869|NCT05940220|Acetazolamide|acetazolamide|mesh-list
153622870|NCT05940220|Anticonvulsants|anticonvulsants|mesh-ancestor
153622871|NCT05940220|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
153622872|NCT05940220|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153622873|NCT05940220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153622874|NCT05940220|Diuretics|diuretics|mesh-ancestor
153622875|NCT05940220|Natriuretic Agents|natriuretic agents|mesh-ancestor
153622876|NCT05940220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153622877|NCT05935631|Folic Acid|folic acid|mesh-list
153622878|NCT05935631|Hematinics|hematinics|mesh-ancestor
153622879|NCT05935631|Vitamin B Complex|vitamin b complex|mesh-ancestor
153622880|NCT05935631|Vitamins|vitamins|mesh-ancestor
153622881|NCT05935631|Micronutrients|micronutrients|mesh-ancestor
153622882|NCT05935631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153622883|NCT05928858|Calcium|calcium|mesh-list
153812033|NCT00428025|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153622884|NCT05928858|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153622901|NCT05871684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153622902|NCT05871684|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153622903|NCT05871684|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153622904|NCT05845138|Capecitabine|capecitabine|mesh-list
153622905|NCT05845138|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153622906|NCT05845138|Antimetabolites|antimetabolites|mesh-ancestor
153622907|NCT05845138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153622908|NCT05845138|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153622909|NCT05835258|Melatonin|melatonin|mesh-list
153622910|NCT05835258|Capsaicin|capsaicin|mesh-list
153622912|NCT05835258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153622977|NCT05694637|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
153622978|NCT05694637|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
153622979|NCT05694637|Cholinergic Agents|cholinergic agents|mesh-ancestor
153622980|NCT05694637|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153622981|NCT05694637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153622982|NCT05694637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153622983|NCT05687253|Bromides|bromides|mesh-list
153622984|NCT05687253|Rocuronium|rocuronium|mesh-list
153622985|NCT05687253|Anticonvulsants|anticonvulsants|mesh-ancestor
153622986|NCT05687253|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
153623023|NCT05555823|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
153623024|NCT05555823|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153623025|NCT05555823|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153623056|NCT05474560|Gout Suppressants|gout suppressants|mesh-ancestor
153623057|NCT05474560|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153623058|NCT05474560|Free Radical Scavengers|free radical scavengers|mesh-ancestor
153623060|NCT05474560|Protective Agents|protective agents|mesh-ancestor
153623061|NCT05474560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153623062|NCT05469893|Dexamethasone|dexamethasone|mesh-list
153623063|NCT05469893|Lenalidomide|lenalidomide|mesh-list
153623064|NCT05469893|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153623065|NCT05469893|Antiemetics|antiemetics|mesh-ancestor
153623106|NCT05422066|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153623107|NCT05422066|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153623108|NCT05422066|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153623109|NCT05422066|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153623110|NCT05422066|Glucocorticoids|glucocorticoids|mesh-ancestor
153623111|NCT05422066|Hormones|hormones|mesh-ancestor
153623112|NCT05422066|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153623113|NCT05422066|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153623114|NCT05422066|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153623115|NCT05422066|Tubulin Modulators|tubulin modulators|mesh-ancestor
153623116|NCT05422066|Antimitotic Agents|antimitotic agents|mesh-ancestor
153623117|NCT05422066|Mitosis Modulators|mitosis modulators|mesh-ancestor
153623118|NCT05419505|Antifibrinolytic Agents|antifibrinolytic agents|mesh-list
153623119|NCT05419505|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153623120|NCT05419505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153623121|NCT05419505|Hemostatics|hemostatics|mesh-ancestor
153623122|NCT05419505|Coagulants|coagulants|mesh-ancestor
153623123|NCT05413343|Ceftazidime|ceftazidime|mesh-list
153623181|NCT05291221|Sensory System Agents|sensory system agents|mesh-ancestor
153623191|NCT05291221|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
153623192|NCT05291221|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153623193|NCT05291221|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153623194|NCT05291221|Adrenergic Agents|adrenergic agents|mesh-ancestor
153623195|NCT05291221|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153623196|NCT05274269|Ivacaftor|ivacaftor|mesh-list
153623197|NCT05274269|Elexacaftor|elexacaftor|mesh-list
153623198|NCT05274269|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
153623199|NCT05274269|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153623200|NCT05274269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153623203|NCT05266924|Hormones|hormones|mesh-list
153623204|NCT05266924|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
153623205|NCT05266924|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153623206|NCT05266924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153623207|NCT05266196|Cyclophosphamide|cyclophosphamide|mesh-list
153623208|NCT05266196|Topotecan|topotecan|mesh-list
153623209|NCT05266196|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153623210|NCT05266196|Immunologic Factors|immunologic factors|mesh-ancestor
153623211|NCT05266196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153623212|NCT05266196|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153623213|NCT05266196|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153623221|NCT05194592|Dapagliflozin|dapagliflozin|mesh-list
153623235|NCT05152472|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153623236|NCT05152472|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153623237|NCT05152472|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153623238|NCT05152472|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153623240|NCT05077683|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
153623241|NCT05077683|Antithrombins|antithrombins|mesh-ancestor
153623242|NCT05077683|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
153623243|NCT05077683|Protease Inhibitors|protease inhibitors|mesh-ancestor
153623244|NCT05077683|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153623245|NCT05077683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153623257|NCT05022147|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153623258|NCT05022147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153730629|NCT00152295|Estrogens|estrogens|mesh-ancestor
153730630|NCT00152295|Hormones|hormones|mesh-ancestor
153730631|NCT00152295|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153730632|NCT00152295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153623259|NCT05022147|Protective Agents|protective agents|mesh-ancestor
153623260|NCT05010538|Sarecycline|sarecycline|mesh-list
153623261|NCT05010538|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153623262|NCT05010538|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153623263|NCT05010538|Dermatologic Agents|dermatologic agents|mesh-ancestor
153623264|NCT05005299|Cyclophosphamide|cyclophosphamide|mesh-list
153623265|NCT05005299|Fludarabine|fludarabine|mesh-list
153623267|NCT05005299|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153623268|NCT05005299|Immunologic Factors|immunologic factors|mesh-ancestor
153623269|NCT05005299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153623270|NCT05005299|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153623271|NCT05005299|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153623272|NCT05005299|Alkylating Agents|alkylating agents|mesh-ancestor
153623273|NCT05005299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153623274|NCT05005299|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153623275|NCT05005299|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153623285|NCT04999449|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
153623286|NCT04999449|Cholinergic Agents|cholinergic agents|mesh-ancestor
153623287|NCT04999449|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153623288|NCT04999449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153623289|NCT04999449|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
153623290|NCT04999449|Parasympatholytics|parasympatholytics|mesh-ancestor
153623291|NCT04971187|Cisplatin|cisplatin|mesh-list
153623292|NCT04971187|Carboplatin|carboplatin|mesh-list
153623293|NCT04971187|Pemetrexed|pemetrexed|mesh-list
153623294|NCT04971187|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153623295|NCT04971187|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153623296|NCT04971187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153623297|NCT04971187|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153623298|NCT04971187|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153623299|NCT04929379|Fenofibrate|fenofibrate|mesh-list
153623300|NCT04929379|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153623301|NCT04929379|Antimetabolites|antimetabolites|mesh-ancestor
153623302|NCT04929379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153623354|NCT04893655|Protective Agents|protective agents|mesh-ancestor
153623355|NCT04886986|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
153812050|NCT00428064|Dermatologic Agents|dermatologic agents|mesh-ancestor
153812061|NCT00419783|Moxifloxacin|moxifloxacin|mesh-list
153623356|NCT04886986|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
153623357|NCT04886986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153623358|NCT04882072|Ustekinumab|ustekinumab|mesh-list
153623359|NCT04882072|Dermatologic Agents|dermatologic agents|mesh-ancestor
153623360|NCT04841343|Triamcinolone|triamcinolone|mesh-list
153623361|NCT04841343|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153623362|NCT04841343|Glucocorticoids|glucocorticoids|mesh-ancestor
153623363|NCT04841343|Hormones|hormones|mesh-ancestor
153623364|NCT04841343|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153623365|NCT04841343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153623366|NCT04840342|Amlodipine|amlodipine|mesh-list
153623377|NCT04840342|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153623378|NCT04840342|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
153623379|NCT04840342|Diuretics|diuretics|mesh-ancestor
153623380|NCT04840342|Natriuretic Agents|natriuretic agents|mesh-ancestor
153623381|NCT04839627|Progesterone|progesterone|mesh-list
153623382|NCT04839627|Progestins|progestins|mesh-ancestor
153623383|NCT04839627|Hormones|hormones|mesh-ancestor
153623384|NCT04839627|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153623385|NCT04839627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153623386|NCT04816162|Dexmedetomidine|dexmedetomidine|mesh-list
153623387|NCT04816162|Ketamine|ketamine|mesh-list
153623415|NCT04792580|Lifitegrast|lifitegrast|mesh-list
153623416|NCT04792580|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
153623417|NCT04742491|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
153623418|NCT04742491|Emtricitabine tenofovir alafenamide|emtricitabine tenofovir alafenamide|mesh-list
153623419|NCT04742491|Emtricitabine|emtricitabine|mesh-list
153623420|NCT04742491|Tenofovir|tenofovir|mesh-list
153623421|NCT04742491|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153623422|NCT04742491|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153623423|NCT04742491|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153623424|NCT04742491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153623425|NCT04742491|Antiviral Agents|antiviral agents|mesh-ancestor
153623426|NCT04742491|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153623438|NCT04736433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153623439|NCT04736433|Protease Inhibitors|protease inhibitors|mesh-ancestor
153623440|NCT04736433|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153623441|NCT04735523|Warfarin|warfarin|mesh-list
153623442|NCT04735523|Dabigatran|dabigatran|mesh-list
153623443|NCT04735523|Anticoagulants|anticoagulants|mesh-ancestor
153623444|NCT04735523|Antithrombins|antithrombins|mesh-ancestor
153623445|NCT04735523|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
153623446|NCT04735523|Protease Inhibitors|protease inhibitors|mesh-ancestor
153623447|NCT04735523|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153623448|NCT04735523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153623449|NCT04734730|Prednisone|prednisone|mesh-list
153623450|NCT04734730|Cortisone|cortisone|mesh-list
153623451|NCT04734730|Leuprolide|leuprolide|mesh-list
153623452|NCT04734730|Goserelin|goserelin|mesh-list
153623453|NCT04734730|Abiraterone Acetate|abiraterone acetate|mesh-list
153623454|NCT04734730|Bicalutamide|bicalutamide|mesh-list
153623455|NCT04734730|Talazoparib|talazoparib|mesh-list
153623456|NCT04734730|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153623457|NCT04734730|Glucocorticoids|glucocorticoids|mesh-ancestor
153623466|NCT04734730|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153623468|NCT04734730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153623469|NCT04734730|Hormone Antagonists|hormone antagonists|mesh-ancestor
153623470|NCT04734730|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153623471|NCT04734730|Androgen Antagonists|androgen antagonists|mesh-ancestor
153623472|NCT04734730|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
153623473|NCT04681820|Nilotinib|nilotinib|mesh-list
153623474|NCT04681820|Flumatinib|flumatinib|mesh-list
153623475|NCT04681820|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153623476|NCT04681820|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153623477|NCT04681820|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153623478|NCT04681820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153623479|NCT04675788|Ibutilide|ibutilide|mesh-list
153623480|NCT04675788|Testosterone|testosterone|mesh-list
153623481|NCT04675788|Progesterone|progesterone|mesh-list
153623482|NCT04675788|Androgens|androgens|mesh-ancestor
153623483|NCT04675788|Hormones|hormones|mesh-ancestor
153623484|NCT04675788|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153623485|NCT04675788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153623486|NCT04675788|Progestins|progestins|mesh-ancestor
153623487|NCT04675788|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153623488|NCT04667572|Riboflavin|riboflavin|mesh-list
153623489|NCT04667572|Vitamin B Complex|vitamin b complex|mesh-ancestor
153623490|NCT04667572|Vitamins|vitamins|mesh-ancestor
153623510|NCT04539314|Anesthetics, Local|anesthetics, local|mesh-ancestor
153623511|NCT04539314|Anesthetics|anesthetics|mesh-ancestor
153623512|NCT04539314|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153623513|NCT04539314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153623514|NCT04539314|Sensory System Agents|sensory system agents|mesh-ancestor
153623515|NCT04539314|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153623516|NCT04539314|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153623517|NCT04539314|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153623518|NCT04539314|Analgesics|analgesics|mesh-ancestor
153623519|NCT04539314|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
153623520|NCT04539314|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153623521|NCT04539314|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153623522|NCT04539314|Adrenergic Agents|adrenergic agents|mesh-ancestor
153623523|NCT04539314|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153623524|NCT04539314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153623525|NCT04520711|Pembrolizumab|pembrolizumab|mesh-list
153730635|NCT00152373|Nootropic Agents|nootropic agents|mesh-ancestor
153623526|NCT04520711|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153623527|NCT04520711|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153623528|NCT04520711|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153623529|NCT04520711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153623530|NCT04508894|Dexmedetomidine|dexmedetomidine|mesh-list
153623531|NCT04508894|Ketamine|ketamine|mesh-list
153623532|NCT04508894|Bupivacaine|bupivacaine|mesh-list
153623533|NCT04508894|Anesthetics, Local|anesthetics, local|mesh-ancestor
153623534|NCT04508894|Anesthetics|anesthetics|mesh-ancestor
153623535|NCT04508894|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153623536|NCT04508894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153623537|NCT04508894|Sensory System Agents|sensory system agents|mesh-ancestor
153623538|NCT04508894|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153623539|NCT04508894|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153623540|NCT04508894|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153623541|NCT04508894|Analgesics|analgesics|mesh-ancestor
153623542|NCT04508894|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
153623543|NCT04508894|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153623544|NCT04508894|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153623545|NCT04508894|Adrenergic Agents|adrenergic agents|mesh-ancestor
153623546|NCT04508894|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153623554|NCT04506125|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153623555|NCT04506125|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153623556|NCT04506125|Analgesics|analgesics|mesh-ancestor
153623557|NCT04506125|Sensory System Agents|sensory system agents|mesh-ancestor
153623558|NCT04506125|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153623559|NCT04506125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153623560|NCT04506125|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153623570|NCT04473664|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153623571|NCT04473664|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153623573|NCT04473664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153623574|NCT04429022|Acetaminophen|acetaminophen|mesh-list
153623575|NCT04429022|Celecoxib|celecoxib|mesh-list
153623576|NCT04429022|Ketorolac|ketorolac|mesh-list
153623577|NCT04429022|Oxycodone|oxycodone|mesh-list
153623578|NCT04429022|Gabapentin|gabapentin|mesh-list
153623579|NCT04429022|Hydromorphone|hydromorphone|mesh-list
153623580|NCT04429022|Ropivacaine|ropivacaine|mesh-list
153623581|NCT04429022|Anesthetics, Local|anesthetics, local|mesh-list
153623582|NCT04429022|Anesthetics|anesthetics|mesh-list
153623583|NCT04429022|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153623584|NCT04429022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153623585|NCT04429022|Sensory System Agents|sensory system agents|mesh-ancestor
153623586|NCT04429022|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153623587|NCT04429022|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153623588|NCT04429022|Analgesics|analgesics|mesh-ancestor
153623589|NCT04429022|Antipyretics|antipyretics|mesh-ancestor
153623590|NCT04429022|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153623591|NCT04429022|Narcotics|narcotics|mesh-ancestor
153623592|NCT04429022|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153623593|NCT04429022|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153623594|NCT04429022|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153623595|NCT04429022|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
153623596|NCT04429022|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153623597|NCT04429022|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153623598|NCT04429022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153623599|NCT04429022|Anticonvulsants|anticonvulsants|mesh-ancestor
153623625|NCT04324606|Vaccines|vaccines|mesh-list
153623626|NCT04324606|Immunologic Factors|immunologic factors|mesh-ancestor
153623627|NCT04324606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153623628|NCT04324606|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153623629|NCT04324606|Analgesics|analgesics|mesh-ancestor
153623630|NCT04324606|Sensory System Agents|sensory system agents|mesh-ancestor
153623631|NCT04324606|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153623632|NCT04324606|Antipyretics|antipyretics|mesh-ancestor
153623633|NCT04321408|Ziconotide|ziconotide|mesh-list
153623634|NCT04321408|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153623635|NCT04321408|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153623636|NCT04321408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153623637|NCT04321408|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153623638|NCT04321408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153623639|NCT04321408|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
153623640|NCT04321408|Protective Agents|protective agents|mesh-ancestor
153623641|NCT04321408|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153623642|NCT04321408|Analgesics|analgesics|mesh-ancestor
153623643|NCT04321408|Sensory System Agents|sensory system agents|mesh-ancestor
153623644|NCT04321408|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153623645|NCT04298606|Vaccines|vaccines|mesh-list
153623646|NCT04298606|Monatide (IMS 3015)|monatide (ims 3015)|mesh-list
153623647|NCT04298606|Mitogens|mitogens|mesh-list
153623648|NCT04298606|Immunologic Factors|immunologic factors|mesh-ancestor
153623649|NCT04298606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153623650|NCT04298606|Mitosis Modulators|mitosis modulators|mesh-ancestor
153623694|NCT04243122|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153623695|NCT04243122|Antipyretics|antipyretics|mesh-ancestor
153623696|NCT04243122|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
153623697|NCT04243122|Antithrombins|antithrombins|mesh-ancestor
153623698|NCT04243122|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
153623699|NCT04243122|Protease Inhibitors|protease inhibitors|mesh-ancestor
153623700|NCT04243122|Anticoagulants|anticoagulants|mesh-ancestor
153623701|NCT04230109|Pembrolizumab|pembrolizumab|mesh-list
153623702|NCT04230109|Sacituzumab govitecan|sacituzumab govitecan|mesh-list
153623703|NCT04230109|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153623704|NCT04230109|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153623705|NCT04230109|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153623706|NCT04230109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153623707|NCT04230109|Immunoconjugates|immunoconjugates|mesh-ancestor
153623708|NCT04230109|Immunologic Factors|immunologic factors|mesh-ancestor
153623709|NCT04230109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153623710|NCT04221191|Dimethyl Fumarate|dimethyl fumarate|mesh-list
153623711|NCT04221191|Dermatologic Agents|dermatologic agents|mesh-ancestor
153623712|NCT04221191|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153623713|NCT04221191|Immunologic Factors|immunologic factors|mesh-ancestor
153623714|NCT04221191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153623716|NCT04209296|Analgesics|analgesics|mesh-ancestor
153623717|NCT04209296|Sensory System Agents|sensory system agents|mesh-ancestor
153623718|NCT04209296|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153623719|NCT04209296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153623746|NCT04106115|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153623747|NCT04106115|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153623748|NCT04106115|Immunologic Factors|immunologic factors|mesh-ancestor
153623749|NCT04106115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153623750|NCT04105231|Cannabidiol|cannabidiol|mesh-list
153623751|NCT04105231|Risperidone|risperidone|mesh-list
153623752|NCT04105231|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153623753|NCT04105231|Serotonin Agents|serotonin agents|mesh-ancestor
153623754|NCT04105231|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153623755|NCT04105231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153623756|NCT04105231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153623757|NCT04105231|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153623758|NCT04105231|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153623759|NCT04105231|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153623760|NCT04105231|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153623761|NCT04105231|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
153623762|NCT04105231|Dopamine Agents|dopamine agents|mesh-ancestor
153623763|NCT04105231|Anticonvulsants|anticonvulsants|mesh-ancestor
153623764|NCT04073615|Trifluridine|trifluridine|mesh-list
153623766|NCT04073615|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153623767|NCT04073615|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153623768|NCT04073615|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153623769|NCT04073615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153623770|NCT04073615|Antimetabolites|antimetabolites|mesh-ancestor
153623771|NCT04073615|Antiviral Agents|antiviral agents|mesh-ancestor
153623772|NCT04073615|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153623773|NCT04050085|Nivolumab|nivolumab|mesh-list
153623774|NCT04050085|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153623775|NCT04050085|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153623776|NCT04050085|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153623777|NCT04050085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153623791|NCT04042558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153623793|NCT04042558|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153623794|NCT04042558|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153623795|NCT04042558|Immunologic Factors|immunologic factors|mesh-ancestor
153623796|NCT04040946|Choline|choline|mesh-list
153623810|NCT04038099|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153623811|NCT04038099|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153623812|NCT04038099|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
153623813|NCT04038099|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153623814|NCT04038099|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153623815|NCT04038099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153623816|NCT04034238|Tofacitinib|tofacitinib|mesh-list
153623818|NCT04034238|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
153623819|NCT04034238|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153623820|NCT04034238|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153623821|NCT04034238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153623822|NCT04034238|Immunoconjugates|immunoconjugates|mesh-ancestor
153623823|NCT04034238|Immunologic Factors|immunologic factors|mesh-ancestor
153623824|NCT04034238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153623825|NCT03994172|Calcium, Dietary|calcium, dietary|mesh-list
153623826|NCT03994172|Vitamin D|vitamin d|mesh-list
153623827|NCT03994172|Cholecalciferol|cholecalciferol|mesh-list
153623847|NCT03994172|Hormone Antagonists|hormone antagonists|mesh-ancestor
153623848|NCT03978442|Bupropion|bupropion|mesh-list
153623849|NCT03978442|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
153623850|NCT03978442|Antidepressive Agents|antidepressive agents|mesh-ancestor
153623851|NCT03978442|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153623852|NCT03978442|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
153623853|NCT03978442|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153623854|NCT03978442|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153623855|NCT03978442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153623856|NCT03978442|Dopamine Agents|dopamine agents|mesh-ancestor
153623857|NCT03978442|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153623885|NCT03956056|Laxatives|laxatives|mesh-ancestor
153623886|NCT03956056|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153623887|NCT03956056|Antiviral Agents|antiviral agents|mesh-ancestor
153623888|NCT03956056|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153623889|NCT03954041|Glyburide|glyburide|mesh-list
153623890|NCT03954041|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153623891|NCT03954041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153623892|NCT03950154|Bevacizumab|bevacizumab|mesh-list
153623893|NCT03950154|Capecitabine|capecitabine|mesh-list
153623894|NCT03950154|Oxaliplatin|oxaliplatin|mesh-list
153623895|NCT03950154|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153623896|NCT03950154|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153623897|NCT03950154|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153623898|NCT03950154|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153623899|NCT03950154|Growth Substances|growth substances|mesh-ancestor
153623900|NCT03950154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153623901|NCT03950154|Growth Inhibitors|growth inhibitors|mesh-ancestor
153623902|NCT03950154|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153623903|NCT03950154|Antimetabolites|antimetabolites|mesh-ancestor
153623904|NCT03950154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153623920|NCT03936829|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153623921|NCT03936023|Saxagliptin|saxagliptin|mesh-list
153623922|NCT03936023|Incretins|incretins|mesh-ancestor
153812069|NCT00419783|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153623923|NCT03936023|Hormones|hormones|mesh-ancestor
153816674|NCT00458991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153623924|NCT03936023|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153623925|NCT03936023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153623926|NCT03936023|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
153623927|NCT03936023|Protease Inhibitors|protease inhibitors|mesh-ancestor
153623928|NCT03936023|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153623929|NCT03936023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153623930|NCT03936023|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153623932|NCT03859024|Dexamethasone|dexamethasone|mesh-list
153623933|NCT03859024|Ibuprofen|ibuprofen|mesh-list
153623934|NCT03859024|Celecoxib|celecoxib|mesh-list
153623935|NCT03859024|Oxycodone|oxycodone|mesh-list
153623936|NCT03859024|Gabapentin|gabapentin|mesh-list
153623937|NCT03859024|Bupivacaine|bupivacaine|mesh-list
153623938|NCT03859024|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153623939|NCT03859024|Antiemetics|antiemetics|mesh-ancestor
153623940|NCT03859024|Autonomic Agents|autonomic agents|mesh-ancestor
153623941|NCT03859024|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153623942|NCT03859024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153623943|NCT03859024|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153623944|NCT03859024|Glucocorticoids|glucocorticoids|mesh-ancestor
153623945|NCT03859024|Hormones|hormones|mesh-ancestor
153623946|NCT03859024|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153623947|NCT03859024|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153623948|NCT03859024|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153623949|NCT03859024|Anesthetics, Local|anesthetics, local|mesh-ancestor
153623950|NCT03859024|Anesthetics|anesthetics|mesh-ancestor
153623951|NCT03859024|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153623952|NCT03859024|Sensory System Agents|sensory system agents|mesh-ancestor
153623953|NCT03859024|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153623954|NCT03859024|Analgesics|analgesics|mesh-ancestor
153623955|NCT03859024|Antipyretics|antipyretics|mesh-ancestor
153623956|NCT03859024|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153623986|NCT03794388|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153623987|NCT03794388|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153623988|NCT03794388|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153623989|NCT03794388|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153623990|NCT03794388|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153623991|NCT03794388|Antipruritics|antipruritics|mesh-ancestor
153623992|NCT03794388|Dermatologic Agents|dermatologic agents|mesh-ancestor
153623993|NCT03725761|Sacituzumab govitecan|sacituzumab govitecan|mesh-list
153623994|NCT03725761|Immunoconjugates|immunoconjugates|mesh-ancestor
153623995|NCT03725761|Immunologic Factors|immunologic factors|mesh-ancestor
153623996|NCT03725761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153623997|NCT03679949|Oxycodone|oxycodone|mesh-list
153623998|NCT03679949|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153623999|NCT03679949|Narcotics|narcotics|mesh-ancestor
153624000|NCT03679949|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153624001|NCT03679949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153624002|NCT03679949|Analgesics|analgesics|mesh-ancestor
153624003|NCT03679949|Sensory System Agents|sensory system agents|mesh-ancestor
153624004|NCT03679949|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153624005|NCT03630666|Hormones|hormones|mesh-list
153624006|NCT03630666|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
153624044|NCT03520842|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153624045|NCT03520842|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153624046|NCT03479554|Antihypertensive Agents|antihypertensive agents|mesh-list
153624047|NCT03454529|Simvastatin|simvastatin|mesh-list
153624048|NCT03454529|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153624049|NCT03454529|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153812078|NCT00428181|Ethanol|ethanol|mesh-list
153812079|NCT00428181|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
153624050|NCT03454529|Antimetabolites|antimetabolites|mesh-ancestor
153624051|NCT03454529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153624052|NCT03454529|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153624053|NCT03454529|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
153624054|NCT03454529|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153624055|NCT03414658|Trastuzumab|trastuzumab|mesh-list
153624056|NCT03414658|Avelumab|avelumab|mesh-list
153624057|NCT03414658|Vinorelbine|vinorelbine|mesh-list
153624058|NCT03414658|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153624059|NCT03414658|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153624060|NCT03414658|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153624061|NCT03414658|Tubulin Modulators|tubulin modulators|mesh-ancestor
153624062|NCT03414658|Antimitotic Agents|antimitotic agents|mesh-ancestor
153624063|NCT03414658|Mitosis Modulators|mitosis modulators|mesh-ancestor
153624064|NCT03414658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153624065|NCT03398148|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
153624066|NCT03398148|Immunologic Factors|immunologic factors|mesh-ancestor
153624067|NCT03398148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153624068|NCT03284502|Cetuximab|cetuximab|mesh-list
153624070|NCT03284502|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153624088|NCT03149770|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
153624089|NCT03149770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153624090|NCT03149770|Sensory System Agents|sensory system agents|mesh-ancestor
153624101|NCT03012971|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153624102|NCT03012971|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153624103|NCT03012971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153624104|NCT03012971|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153624105|NCT03012971|Analgesics|analgesics|mesh-ancestor
153624106|NCT03012971|Sensory System Agents|sensory system agents|mesh-ancestor
153624107|NCT03012971|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153624108|NCT03012971|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
153624109|NCT03012971|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153624110|NCT03012971|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153624111|NCT03012971|Adrenergic Agents|adrenergic agents|mesh-ancestor
153624112|NCT03012971|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153624113|NCT03012971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153624114|NCT03012971|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153624115|NCT03012971|Narcotics|narcotics|mesh-ancestor
153624117|NCT02960659|Liraglutide|liraglutide|mesh-list
153812092|NCT04575233|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153624118|NCT02960659|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153624119|NCT02960659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153624120|NCT02960659|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
153624121|NCT02960659|Incretins|incretins|mesh-ancestor
153624123|NCT02960659|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153624124|NCT02936622|Paclitaxel|paclitaxel|mesh-list
153624125|NCT02936622|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
153624126|NCT02936622|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153624127|NCT02936622|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153624128|NCT02936622|Tubulin Modulators|tubulin modulators|mesh-ancestor
153624130|NCT02936622|Mitosis Modulators|mitosis modulators|mesh-ancestor
153624131|NCT02936622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153624132|NCT02916771|Dexamethasone|dexamethasone|mesh-list
153624133|NCT02916771|Lenalidomide|lenalidomide|mesh-list
153624138|NCT02916771|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153624139|NCT02916771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153624140|NCT02916771|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153624141|NCT02916771|Glucocorticoids|glucocorticoids|mesh-ancestor
153624142|NCT02916771|Hormones|hormones|mesh-ancestor
153624143|NCT02916771|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153624144|NCT02916771|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153624145|NCT02916771|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153624146|NCT02916771|Immunologic Factors|immunologic factors|mesh-ancestor
153624147|NCT02916771|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153624148|NCT02916771|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153624149|NCT02916771|Growth Substances|growth substances|mesh-ancestor
153624150|NCT02916771|Growth Inhibitors|growth inhibitors|mesh-ancestor
153624151|NCT02916771|Protease Inhibitors|protease inhibitors|mesh-ancestor
153624152|NCT02916771|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153624153|NCT02916771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153624203|NCT02797470|Immunologic Factors|immunologic factors|mesh-ancestor
153624204|NCT02797470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153624205|NCT02797470|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153624206|NCT02797470|Alkylating Agents|alkylating agents|mesh-ancestor
153624207|NCT02797470|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153624208|NCT02797470|Keratolytic Agents|keratolytic agents|mesh-ancestor
153624209|NCT02797470|Dermatologic Agents|dermatologic agents|mesh-ancestor
153624210|NCT02797470|Tubulin Modulators|tubulin modulators|mesh-ancestor
153624211|NCT02797470|Antimitotic Agents|antimitotic agents|mesh-ancestor
153624212|NCT02797470|Mitosis Modulators|mitosis modulators|mesh-ancestor
153624213|NCT02744690|Mitomycins|mitomycins|mesh-list
153624214|NCT02744690|Mitomycin|mitomycin|mesh-list
153624215|NCT02744690|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153624216|NCT02744690|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153624217|NCT02744690|Alkylating Agents|alkylating agents|mesh-ancestor
153624218|NCT02744690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153624219|NCT02744690|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153624220|NCT02744690|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153812139|NCT01056276|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153624221|NCT02705820|Pembrolizumab|pembrolizumab|mesh-list
153624222|NCT02705820|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153624223|NCT02705820|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153624224|NCT02705820|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153624225|NCT02705820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153624244|NCT02582775|Antimetabolites|antimetabolites|mesh-ancestor
153624245|NCT02582775|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153624271|NCT02460289|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153624272|NCT02460289|Vasodilator Agents|vasodilator agents|mesh-ancestor
153624273|NCT02286154|Hydroxyurea|hydroxyurea|mesh-list
153624274|NCT02286154|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153624275|NCT02286154|Antisickling Agents|antisickling agents|mesh-ancestor
153624276|NCT02286154|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153624277|NCT02286154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153624278|NCT02286154|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153624279|NCT02274779|Leuprolide|leuprolide|mesh-list
153624280|NCT02274779|Fertility Agents, Female|fertility agents, female|mesh-ancestor
153624282|NCT02274779|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153624283|NCT02274779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153624284|NCT02274779|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153624301|NCT02253316|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153624302|NCT02253316|Protease Inhibitors|protease inhibitors|mesh-ancestor
153624303|NCT02253316|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153624304|NCT02253316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153624305|NCT02253316|Immunologic Factors|immunologic factors|mesh-ancestor
153624306|NCT02253316|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153624307|NCT02253316|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153624308|NCT02253316|Growth Substances|growth substances|mesh-ancestor
153624309|NCT02253316|Growth Inhibitors|growth inhibitors|mesh-ancestor
153624339|NCT00601198|Levoleucovorin|levoleucovorin|mesh-list
153624340|NCT00601198|Amifostine|amifostine|mesh-list
153624341|NCT00601198|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153624342|NCT00601198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153624343|NCT00601198|Antidotes|antidotes|mesh-ancestor
153624351|NCT02006498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153624353|NCT02006498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153624354|NCT02006589|Candesartan|candesartan|mesh-list
153624355|NCT02006589|Candesartan cilexetil|candesartan cilexetil|mesh-list
153624356|NCT02006589|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153624357|NCT02006589|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
153624358|NCT02006589|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
153624359|NCT02006589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153624360|NCT02006602|Candesartan|candesartan|mesh-list
153624361|NCT02006602|Candesartan cilexetil|candesartan cilexetil|mesh-list
153624362|NCT02006602|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153624363|NCT02006602|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
153624364|NCT02006602|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
153624365|NCT02006602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153624366|NCT02006745|Ribavirin|ribavirin|mesh-list
153624367|NCT02006745|Antimetabolites|antimetabolites|mesh-ancestor
153730639|NCT00134654|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153624368|NCT02006745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153624370|NCT02006745|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153624371|NCT02006849|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
153624390|NCT02006966|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153624391|NCT02006966|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153624392|NCT02006966|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
153624393|NCT02006966|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153624394|NCT02006966|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153624395|NCT02006966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153624396|NCT02007005|Viscum album peptide|viscum album peptide|mesh-list
153624397|NCT02007005|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153624398|NCT02007005|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153624399|NCT02007005|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153624400|NCT02007005|Antiviral Agents|antiviral agents|mesh-ancestor
153624401|NCT02007005|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153624402|NCT02007148|Docetaxel|docetaxel|mesh-list
153624403|NCT02007148|Capecitabine|capecitabine|mesh-list
153624404|NCT02007148|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153624405|NCT02007148|Tubulin Modulators|tubulin modulators|mesh-ancestor
153624410|NCT02007148|Antimetabolites|antimetabolites|mesh-ancestor
153624460|NCT02007603|Clavulanic Acids|clavulanic acids|mesh-list
153624461|NCT02007603|Clavulanic Acid|clavulanic acid|mesh-list
153624462|NCT02007603|Ampicillin|ampicillin|mesh-list
153624463|NCT02007603|Sulbactam|sulbactam|mesh-list
153624464|NCT02007603|Sultamicillin|sultamicillin|mesh-list
153624465|NCT02007603|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153624466|NCT02007603|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153624467|NCT02007603|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153624468|NCT02007603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153624469|NCT02007603|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
153624470|NCT02007629|Riociguat|riociguat|mesh-list
153624471|NCT02007629|Enzyme Activators|enzyme activators|mesh-ancestor
153624491|NCT02007837|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153624492|NCT02007837|Analgesics|analgesics|mesh-ancestor
153624493|NCT02007837|Sensory System Agents|sensory system agents|mesh-ancestor
153624494|NCT02007837|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153624504|NCT02007837|Antipyretics|antipyretics|mesh-ancestor
153624575|NCT02008123|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153624576|NCT02008123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153624577|NCT02008123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153624578|NCT02008136|Botulinum Toxins|botulinum toxins|mesh-list
153624579|NCT02008136|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
153624580|NCT02008136|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153624581|NCT02008136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153624582|NCT02008136|Cholinergic Agents|cholinergic agents|mesh-ancestor
153624583|NCT02008136|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153624584|NCT02008136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153624586|NCT02008162|Albuterol|albuterol|mesh-list
153624587|NCT02008162|Tiotropium Bromide|tiotropium bromide|mesh-list
153624588|NCT02008162|Bronchodilator Agents|bronchodilator agents|mesh-list
153624589|NCT02008162|Autonomic Agents|autonomic agents|mesh-ancestor
153624590|NCT02008162|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153624591|NCT02008162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153624592|NCT02008162|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153624593|NCT02008162|Respiratory System Agents|respiratory system agents|mesh-ancestor
153624594|NCT02008162|Parasympatholytics|parasympatholytics|mesh-ancestor
153624595|NCT02008162|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
153624596|NCT02008162|Cholinergic Agents|cholinergic agents|mesh-ancestor
153624599|NCT02008162|Anticonvulsants|anticonvulsants|mesh-ancestor
153624627|NCT02008422|Endostar protein|endostar protein|mesh-list
153624628|NCT02008422|Endostatins|endostatins|mesh-list
153624629|NCT02008422|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153624630|NCT02008422|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153624631|NCT02008422|Antimetabolites|antimetabolites|mesh-ancestor
153624632|NCT02008422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153624633|NCT02008422|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153624653|NCT02008734|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153624654|NCT02008734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153624655|NCT02008747|Magnesium Sulfate|magnesium sulfate|mesh-list
153624656|NCT02008747|Analgesics|analgesics|mesh-ancestor
153624657|NCT02008747|Sensory System Agents|sensory system agents|mesh-ancestor
153624658|NCT02008747|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153624659|NCT02008747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153624660|NCT02008747|Anesthetics|anesthetics|mesh-ancestor
153624661|NCT02008747|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153624662|NCT02008747|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153624663|NCT02008747|Anticonvulsants|anticonvulsants|mesh-ancestor
153624664|NCT02008747|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153624665|NCT02008747|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153624666|NCT02008747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153624668|NCT02008747|Tocolytic Agents|tocolytic agents|mesh-ancestor
153624724|NCT02009189|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153624725|NCT02009189|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
153624726|NCT02009189|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153624727|NCT02009202|Picosulfate sodium|picosulfate sodium|mesh-list
153624729|NCT02009202|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153624730|NCT02009215|Piperaquine|piperaquine|mesh-list
153624731|NCT02009215|Artenimol|artenimol|mesh-list
153624732|NCT02009215|Antimalarials|antimalarials|mesh-ancestor
153624733|NCT02009215|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153624734|NCT02009215|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153624735|NCT02009215|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153624736|NCT05778461|N-Methylaspartate|n-methylaspartate|mesh-list
153624737|NCT05778461|Excitatory Amino Acid Agonists|excitatory amino acid agonists|mesh-ancestor
153624738|NCT05778461|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
153624739|NCT05778461|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153624747|NCT05778305|Analgesics|analgesics|mesh-ancestor
153624787|NCT05777369|Mitoxantrone|mitoxantrone|mesh-list
153624788|NCT05777369|Vindesine|vindesine|mesh-list
153624789|NCT05777369|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153624790|NCT05777369|Immunologic Factors|immunologic factors|mesh-ancestor
153624791|NCT05777369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153624792|NCT05777369|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153624793|NCT05777369|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153624794|NCT05777369|Alkylating Agents|alkylating agents|mesh-ancestor
153624795|NCT05777369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153624796|NCT05777369|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153624797|NCT05777369|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153624798|NCT05777369|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153624799|NCT05777369|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153624800|NCT05777369|Glucocorticoids|glucocorticoids|mesh-ancestor
153624801|NCT05777369|Hormones|hormones|mesh-ancestor
153624802|NCT05777369|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153624803|NCT05777369|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153624804|NCT05777369|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153624821|NCT05777122|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153624852|NCT05410158|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
153624853|NCT05410158|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153624854|NCT05410158|Anesthetics, General|anesthetics, general|mesh-ancestor
153624855|NCT05410158|Anesthetics|anesthetics|mesh-ancestor
153624856|NCT05410158|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153624857|NCT05410158|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
153624858|NCT05410158|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
153624859|NCT05410158|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153624860|NCT05410158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153624861|NCT05121168|Bupivacaine|bupivacaine|mesh-list
153624862|NCT05121168|Anesthetics, Local|anesthetics, local|mesh-ancestor
153624863|NCT05121168|Anesthetics|anesthetics|mesh-ancestor
153624864|NCT05121168|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153624879|NCT04983589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153624880|NCT04983589|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
153624881|NCT04983589|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
153624882|NCT04983589|Cholinergic Agents|cholinergic agents|mesh-ancestor
153624883|NCT04983589|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153624884|NCT04983589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153624886|NCT04861922|Calcium heparin|calcium heparin|mesh-list
153624887|NCT04861922|Anticoagulants|anticoagulants|mesh-ancestor
153624891|NCT04840472|Panitumumab|panitumumab|mesh-list
153624946|NCT04371107|Azithromycin|azithromycin|mesh-list
153624947|NCT04371107|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153624948|NCT04371107|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153624949|NCT04364984|Enzyme Inhibitors|enzyme inhibitors|mesh-list
153624950|NCT04364984|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
153624951|NCT04364984|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-list
153624968|NCT04278833|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153624969|NCT04278833|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153624970|NCT04278833|Respiratory System Agents|respiratory system agents|mesh-ancestor
153624971|NCT04225065|Chlorhexidine|chlorhexidine|mesh-list
153624972|NCT04225065|Povidone-Iodine|povidone-iodine|mesh-list
153624973|NCT04225065|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
153624974|NCT04225065|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153624975|NCT04225065|Disinfectants|disinfectants|mesh-ancestor
153624976|NCT04221087|Dexamethasone|dexamethasone|mesh-list
153624977|NCT04221087|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153624978|NCT04221087|Antiemetics|antiemetics|mesh-ancestor
153624979|NCT04221087|Autonomic Agents|autonomic agents|mesh-ancestor
153624980|NCT04221087|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153624981|NCT04221087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153624984|NCT04221087|Hormones|hormones|mesh-ancestor
153625018|NCT04050280|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153625019|NCT04050280|Immunologic Factors|immunologic factors|mesh-ancestor
153625020|NCT04050280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153625021|NCT04050280|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153625022|NCT04050280|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153625023|NCT04050280|Immunotoxins|immunotoxins|mesh-ancestor
153625024|NCT04050280|Immunoconjugates|immunoconjugates|mesh-ancestor
153625025|NCT03994731|Acetaminophen|acetaminophen|mesh-list
153625026|NCT03994731|Folic Acid|folic acid|mesh-list
153625028|NCT03994731|Methylprednisolone|methylprednisolone|mesh-list
153625029|NCT03994731|Methotrexate|methotrexate|mesh-list
153625030|NCT03994731|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
153625031|NCT03994731|Abortifacient Agents|abortifacient agents|mesh-ancestor
153625032|NCT03994731|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153625033|NCT03994731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153625034|NCT03994731|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153625035|NCT03994731|Antimetabolites|antimetabolites|mesh-ancestor
153625036|NCT03994731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153625037|NCT03994731|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153625038|NCT03994731|Dermatologic Agents|dermatologic agents|mesh-ancestor
153625039|NCT03994731|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153625040|NCT03994731|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153625041|NCT03994731|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153625042|NCT03994731|Immunologic Factors|immunologic factors|mesh-ancestor
153625043|NCT03994731|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153625044|NCT03994731|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153625045|NCT03994731|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153625046|NCT03994731|Analgesics|analgesics|mesh-ancestor
153625047|NCT03994731|Sensory System Agents|sensory system agents|mesh-ancestor
153625048|NCT03994731|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153625049|NCT03994731|Antipyretics|antipyretics|mesh-ancestor
153625050|NCT03994731|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153625051|NCT03994731|Antiemetics|antiemetics|mesh-ancestor
153625052|NCT03994731|Autonomic Agents|autonomic agents|mesh-ancestor
153625053|NCT03994731|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153625054|NCT03994731|Glucocorticoids|glucocorticoids|mesh-ancestor
153625055|NCT03994731|Hormones|hormones|mesh-ancestor
153625058|NCT03994731|Protective Agents|protective agents|mesh-ancestor
153625059|NCT03994731|Hematinics|hematinics|mesh-ancestor
153625060|NCT03994731|Vitamin B Complex|vitamin b complex|mesh-ancestor
153625061|NCT03994731|Vitamins|vitamins|mesh-ancestor
153625062|NCT03994731|Micronutrients|micronutrients|mesh-ancestor
153625063|NCT03994731|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
153625064|NCT03994731|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
153625065|NCT03994731|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
153625066|NCT03994731|Histamine Antagonists|histamine antagonists|mesh-ancestor
153625067|NCT03994731|Histamine Agents|histamine agents|mesh-ancestor
153625068|NCT03994731|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153625069|NCT03812991|Calcitonin|calcitonin|mesh-list
153625070|NCT03812991|Salmon calcitonin|salmon calcitonin|mesh-list
153625071|NCT03812991|Calcitonin Gene-Related Peptide|calcitonin gene-related peptide|mesh-list
153625072|NCT03812991|Katacalcin|katacalcin|mesh-list
153625073|NCT03812991|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153625074|NCT03812991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153625075|NCT03812991|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153625076|NCT03812991|Vasodilator Agents|vasodilator agents|mesh-ancestor
153625077|NCT03737968|Durvalumab|durvalumab|mesh-list
153625078|NCT03737968|Tremelimumab|tremelimumab|mesh-list
153625079|NCT03737968|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
153625080|NCT03737968|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153461772|NCT03087162|Lansoprazole|lansoprazole|mesh-list
153625135|NCT03396588|Adrenergic Agents|adrenergic agents|mesh-ancestor
153625136|NCT03396588|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153625137|NCT03396588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153625138|NCT03350451|Lumasiran|lumasiran|mesh-list
153625139|NCT03350451|Renal Agents|renal agents|mesh-ancestor
153625140|NCT03329508|Pramipexole|pramipexole|mesh-list
153625141|NCT03329508|Rasagiline|rasagiline|mesh-list
153625142|NCT03329508|Dexpramipexole|dexpramipexole|mesh-list
153625143|NCT03329508|Antioxidants|antioxidants|mesh-ancestor
153625144|NCT03329508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153625161|NCT03153319|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
153625162|NCT03153319|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153625163|NCT03153319|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153625164|NCT03145272|Oxycodone|oxycodone|mesh-list
153625165|NCT03145272|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153625166|NCT03145272|Narcotics|narcotics|mesh-ancestor
153625167|NCT03145272|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153625168|NCT03145272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153625169|NCT03145272|Analgesics|analgesics|mesh-ancestor
153625170|NCT03145272|Sensory System Agents|sensory system agents|mesh-ancestor
153625171|NCT03145272|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153625172|NCT03109093|Blinatumomab|blinatumomab|mesh-list
153625173|NCT03109093|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153625174|NCT02691065|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-list
153625175|NCT02691065|Integrase Inhibitors|integrase inhibitors|mesh-list
153625176|NCT02691065|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153625196|NCT02503358|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
153625197|NCT02503358|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153625198|NCT02503358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153625199|NCT02503358|Tubulin Modulators|tubulin modulators|mesh-ancestor
153625200|NCT02503358|Antimitotic Agents|antimitotic agents|mesh-ancestor
153625201|NCT02503358|Mitosis Modulators|mitosis modulators|mesh-ancestor
153625202|NCT02503358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153625203|NCT02432963|Pembrolizumab|pembrolizumab|mesh-list
153625229|NCT02336087|Tubulin Modulators|tubulin modulators|mesh-ancestor
153625230|NCT02336087|Antimitotic Agents|antimitotic agents|mesh-ancestor
153625231|NCT02336087|Mitosis Modulators|mitosis modulators|mesh-ancestor
153625232|NCT02336087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153625233|NCT02336087|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153625234|NCT02336087|Antimetabolites|antimetabolites|mesh-ancestor
153625235|NCT02336087|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153625238|NCT02332980|Idelalisib|idelalisib|mesh-list
153625297|NCT01476839|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153625298|NCT01476839|Immunologic Factors|immunologic factors|mesh-ancestor
153625299|NCT01476839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153625300|NCT01476839|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153625301|NCT01476839|Alkylating Agents|alkylating agents|mesh-ancestor
153625302|NCT01476839|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153625304|NCT01332097|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153625305|NCT01332097|Glucocorticoids|glucocorticoids|mesh-ancestor
153625306|NCT01332097|Hormones|hormones|mesh-ancestor
153625307|NCT01332097|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153625308|NCT01332097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153625309|NCT01332097|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153625310|NCT01332097|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153625343|NCT00967005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153625345|NCT00538031|Celecoxib|celecoxib|mesh-list
153625346|NCT00538031|Cyclophosphamide|cyclophosphamide|mesh-list
153625347|NCT00538031|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153625348|NCT00538031|Immunologic Factors|immunologic factors|mesh-ancestor
153625349|NCT00538031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153625350|NCT00538031|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153625351|NCT00538031|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153625352|NCT00538031|Alkylating Agents|alkylating agents|mesh-ancestor
153625353|NCT00538031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153625354|NCT00538031|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153625375|NCT00203996|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153625376|NCT00203996|Hormones|hormones|mesh-ancestor
153625377|NCT00203996|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153625378|NCT02009280|Anesthetics|anesthetics|mesh-list
153625394|NCT02009306|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153625395|NCT02009306|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153625396|NCT02009306|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153625397|NCT02009306|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153625398|NCT02009306|Anesthetics, General|anesthetics, general|mesh-ancestor
153625399|NCT02009306|Anesthetics|anesthetics|mesh-ancestor
153625400|NCT02009306|GABA Modulators|gaba modulators|mesh-ancestor
153625401|NCT02009306|GABA Agents|gaba agents|mesh-ancestor
153625402|NCT02009306|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153625403|NCT02009306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153625404|NCT02009306|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153625405|NCT02009306|Narcotics|narcotics|mesh-ancestor
153625406|NCT02009306|Analgesics|analgesics|mesh-ancestor
153625407|NCT02009306|Sensory System Agents|sensory system agents|mesh-ancestor
153625408|NCT02009306|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153625409|NCT03581877|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
153625410|NCT03581877|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153625411|NCT03581877|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153625424|NCT02009462|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
153625425|NCT02009462|Protective Agents|protective agents|mesh-ancestor
153625426|NCT02009462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153625427|NCT02009488|Canagliflozin|canagliflozin|mesh-list
153625428|NCT02009488|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
153625429|NCT02009488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153625430|NCT02009488|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153625431|NCT02009488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153625432|NCT02009514|Dialysis Solutions|dialysis solutions|mesh-list
153625452|NCT02009618|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153625453|NCT02009618|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153625454|NCT02009631|Veliparib|veliparib|mesh-list
153625455|NCT02009631|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
153625456|NCT02009631|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153625457|NCT02009631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153625458|NCT02009631|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153625459|NCT02009709|Riboflavin|riboflavin|mesh-list
153625460|NCT02009709|Ophthalmic Solutions|ophthalmic solutions|mesh-list
153358653|NCT01259063|Everolimus|everolimus|mesh-list
153625461|NCT02009709|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
153812255|NCT00428883|Antidotes|antidotes|mesh-ancestor
153625462|NCT02009709|Vitamin B Complex|vitamin b complex|mesh-ancestor
153625463|NCT02009709|Vitamins|vitamins|mesh-ancestor
153625464|NCT02009709|Micronutrients|micronutrients|mesh-ancestor
153625465|NCT02009709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153625466|NCT02009709|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
153625467|NCT02009709|Dermatologic Agents|dermatologic agents|mesh-ancestor
153625468|NCT02009748|Vitamin D|vitamin d|mesh-list
153625469|NCT02009748|Vitamins|vitamins|mesh-ancestor
153625470|NCT02009748|Micronutrients|micronutrients|mesh-ancestor
153625471|NCT02009748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153625472|NCT02009748|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153625473|NCT02009787|Vitamin D|vitamin d|mesh-list
153625474|NCT02009787|Cholecalciferol|cholecalciferol|mesh-list
153625475|NCT02009787|Vitamins|vitamins|mesh-ancestor
153625496|NCT02010723|Polidocanol|polidocanol|mesh-list
153625525|NCT02010905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153625527|NCT02010944|Mirabegron|mirabegron|mesh-list
153625528|NCT02010944|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
153462232|NCT00633360|Estradiol|estradiol|mesh-list
153625558|NCT02010970|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153625559|NCT02010970|Anesthetics, General|anesthetics, general|mesh-ancestor
153625561|NCT02010970|GABA Modulators|gaba modulators|mesh-ancestor
153625562|NCT02010970|GABA Agents|gaba agents|mesh-ancestor
153625563|NCT02010970|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153625564|NCT02010970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153625565|NCT02010970|Antifungal Agents|antifungal agents|mesh-ancestor
153625566|NCT02010970|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153625567|NCT02010970|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
153625568|NCT02010970|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153625569|NCT02010970|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153730648|NCT00141960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153730649|NCT00141960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153730651|NCT00134693|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
153730652|NCT00134693|Methylprednisolone|methylprednisolone|mesh-list
153730653|NCT00134693|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
153625600|NCT02011347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153625601|NCT02011594|Nimotuzumab|nimotuzumab|mesh-list
153625602|NCT02011594|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153625603|NCT02011594|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153625604|NCT02011620|Isosorbide|isosorbide|mesh-list
153625605|NCT02011620|Isosorbide Dinitrate|isosorbide dinitrate|mesh-list
153625606|NCT02011620|Isosorbide-5-mononitrate|isosorbide-5-mononitrate|mesh-list
153625607|NCT02011620|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
153625608|NCT02011620|Diuretics|diuretics|mesh-ancestor
153625609|NCT02011620|Natriuretic Agents|natriuretic agents|mesh-ancestor
153625610|NCT02011620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153812263|NCT04702971|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
153625611|NCT02011620|Vasodilator Agents|vasodilator agents|mesh-ancestor
153625612|NCT02011620|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
153625613|NCT02011620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153625614|NCT02011633|Metformin|metformin|mesh-list
153625615|NCT02011633|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
153625616|NCT02011633|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153625617|NCT02011633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153625618|NCT02011633|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153625619|NCT02011633|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153625620|NCT02011633|Antimetabolites|antimetabolites|mesh-ancestor
153625621|NCT02011633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153625622|NCT02011633|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153625623|NCT02011633|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
153625624|NCT02011633|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153625625|NCT02011659|Ramosetron|ramosetron|mesh-list
153625626|NCT02011659|Antiemetics|antiemetics|mesh-ancestor
153625668|NCT02011841|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153625669|NCT02011841|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153625670|NCT02011841|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153625671|NCT02011841|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153625672|NCT02011841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153625673|NCT02011841|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153625674|NCT02011841|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
153625675|NCT02011841|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153625676|NCT02011841|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153625677|NCT02011906|Vitamins|vitamins|mesh-list
153625678|NCT02011906|Vitamin E|vitamin e|mesh-list
153625679|NCT02011906|Tocopherols|tocopherols|mesh-list
153625680|NCT02011906|Tocotrienols|tocotrienols|mesh-list
153625681|NCT02011906|alpha-Tocopherol|alpha-tocopherol|mesh-list
153625682|NCT02011906|Micronutrients|micronutrients|mesh-ancestor
153625683|NCT02011906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153625684|NCT02011906|Antioxidants|antioxidants|mesh-ancestor
153625685|NCT02011906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153625686|NCT02011906|Protective Agents|protective agents|mesh-ancestor
153625687|NCT02011958|Amphotericin B|amphotericin b|mesh-list
153625732|NCT02012075|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153625733|NCT02012075|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153625734|NCT02012075|Vasodilator Agents|vasodilator agents|mesh-ancestor
153625735|NCT02012075|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
153625736|NCT02012075|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
153625738|NCT02012140|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153625739|NCT02012140|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
153625740|NCT02012140|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
153625741|NCT02012140|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
153625742|NCT02012140|Purinergic Agents|purinergic agents|mesh-ancestor
153625743|NCT02012140|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153625744|NCT02012140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153625745|NCT02012140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153625746|NCT02012166|Insulin|insulin|mesh-list
153625747|NCT02012166|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
153625748|NCT02012166|Octreotide|octreotide|mesh-list
153625749|NCT02012166|Glucagon|glucagon|mesh-list
153625750|NCT02012166|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153625751|NCT02012166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153625752|NCT02012166|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153625753|NCT02012166|Hormones|hormones|mesh-ancestor
153625754|NCT02012166|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153625755|NCT02012166|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153625756|NCT02012166|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153625767|NCT02012244|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153625768|NCT02012244|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153625769|NCT02012244|Anesthetics, General|anesthetics, general|mesh-ancestor
153625777|NCT02012322|Vitamins|vitamins|mesh-ancestor
153625787|NCT02012335|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153625788|NCT02012335|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
153625789|NCT02012335|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
153625790|NCT02012335|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153625791|NCT02012335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153625793|NCT02012387|Vaccines|vaccines|mesh-list
153625794|NCT02012387|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
153625795|NCT02012387|Immunologic Factors|immunologic factors|mesh-ancestor
153625796|NCT02012387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153625797|NCT02012387|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
153625798|NCT02012387|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153625799|NCT02012387|Respiratory System Agents|respiratory system agents|mesh-ancestor
153625800|NCT02012465|Insulin|insulin|mesh-list
153625801|NCT02012465|Insulin Glargine|insulin glargine|mesh-list
153625802|NCT02012465|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153625803|NCT02012465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153625804|NCT02012517|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
153625805|NCT02012517|Cefazolin|cefazolin|mesh-list
153625806|NCT02012517|Cephalexin|cephalexin|mesh-list
153625807|NCT02012517|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
153625808|NCT02012517|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153625862|NCT02012946|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
153625863|NCT02012946|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
153625864|NCT02012946|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153625865|NCT02012946|Adrenergic Agents|adrenergic agents|mesh-ancestor
153625866|NCT02012946|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153625867|NCT02012998|Vaccines|vaccines|mesh-list
153625868|NCT02012998|Immunologic Factors|immunologic factors|mesh-ancestor
153625869|NCT02012998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153625870|NCT02013102|Decitabine|decitabine|mesh-list
153625871|NCT02013102|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153625872|NCT02013102|Antimetabolites|antimetabolites|mesh-ancestor
153625873|NCT02013102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153462586|NCT01928316|Mizolastine|mizolastine|mesh-list
153625900|NCT02013232|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153625901|NCT02013232|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153625902|NCT02013232|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153625903|NCT02013232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153625904|NCT02013232|Dopamine Agonists|dopamine agonists|mesh-ancestor
153625905|NCT02013232|Dopamine Agents|dopamine agents|mesh-ancestor
153625906|NCT02013232|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153625907|NCT02013232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153625908|NCT02013232|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
153625909|NCT02013232|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
153625910|NCT02013232|Serotonin Agents|serotonin agents|mesh-ancestor
153625911|NCT02013232|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
153625912|NCT02013232|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153625913|NCT02013232|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
153625914|NCT02013232|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
153625915|NCT02013258|Oxytocin|oxytocin|mesh-list
153625916|NCT02013258|Oxytocics|oxytocics|mesh-ancestor
153625917|NCT02013258|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153625918|NCT02013258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153625947|NCT02013453|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153625948|NCT02013453|Immunologic Factors|immunologic factors|mesh-ancestor
153625949|NCT02013453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153625950|NCT02013453|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153625951|NCT02013453|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153731750|NCT00161226|Levonorgestrel|levonorgestrel|mesh-list
153625952|NCT02013453|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153625953|NCT02013453|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
153625954|NCT02013453|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153625955|NCT02013453|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
153625956|NCT02013570|Dexmedetomidine|dexmedetomidine|mesh-list
153625957|NCT02013570|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153625958|NCT02013570|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153625959|NCT02013570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153625960|NCT02013570|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153625961|NCT02013570|Analgesics|analgesics|mesh-ancestor
153625962|NCT02013570|Sensory System Agents|sensory system agents|mesh-ancestor
153625963|NCT02013570|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153625964|NCT02013570|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
153625965|NCT02013570|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153625966|NCT02013570|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153625967|NCT02013570|Adrenergic Agents|adrenergic agents|mesh-ancestor
153625968|NCT02013570|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153625969|NCT02013570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153625970|NCT02013856|Proanthocyanidin|proanthocyanidin|mesh-list
153625971|NCT02013856|Procyanidin|procyanidin|mesh-list
153625972|NCT02013856|Antioxidants|antioxidants|mesh-ancestor
153625973|NCT02013856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153625974|NCT02013856|Protective Agents|protective agents|mesh-ancestor
153625975|NCT02013856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153625976|NCT02013856|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153625977|NCT02013856|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153462687|NCT04123392|Alkylating Agents|alkylating agents|mesh-ancestor
153626004|NCT02013986|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153626005|NCT02013986|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153626006|NCT02013986|GABA Modulators|gaba modulators|mesh-ancestor
153626008|NCT02013986|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153626009|NCT02013986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153626010|NCT02014064|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
153626011|NCT02014064|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
153626012|NCT02014064|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153626013|NCT02014064|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153626014|NCT02014064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153626015|NCT02014064|Adrenergic Agents|adrenergic agents|mesh-ancestor
153626016|NCT02014064|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153626017|NCT02014064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153626018|NCT02013089|Everolimus|everolimus|mesh-list
153626019|NCT02013089|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
153626020|NCT02013089|Sorafenib|sorafenib|mesh-list
153626021|NCT02013089|Sunitinib|sunitinib|mesh-list
153626022|NCT02013089|Imatinib Mesylate|imatinib mesylate|mesh-list
153626023|NCT02013089|Gefitinib|gefitinib|mesh-list
153626024|NCT02013089|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
153626025|NCT02013089|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153626026|NCT02013089|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153626097|NCT02014532|Respiratory System Agents|respiratory system agents|mesh-ancestor
153626098|NCT02014532|Hormone Antagonists|hormone antagonists|mesh-ancestor
153626099|NCT02014532|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153626100|NCT02014532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153626101|NCT02014532|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
153626102|NCT02014532|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
153626103|NCT02014532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153626105|NCT02014545|Schistosomicides|schistosomicides|mesh-ancestor
153626106|NCT02014545|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
153626107|NCT02014545|Anthelmintics|anthelmintics|mesh-ancestor
153626108|NCT02014545|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153626109|NCT02014545|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153626110|NCT02014558|Voriconazole|voriconazole|mesh-list
153626111|NCT02014558|Cephalexin|cephalexin|mesh-list
153626112|NCT02014558|Midazolam|midazolam|mesh-list
153626113|NCT02014558|Gilteritinib|gilteritinib|mesh-list
153626114|NCT02014558|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153626115|NCT02014558|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153626116|NCT02014558|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153626117|NCT02014558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153626118|NCT02014558|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153626119|NCT02014558|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153626120|NCT02014558|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153626121|NCT02014558|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153626156|NCT02014714|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153626157|NCT02014714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153626158|NCT02014714|Analgesics|analgesics|mesh-ancestor
153626159|NCT02014714|Sensory System Agents|sensory system agents|mesh-ancestor
153626160|NCT02014714|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153626161|NCT02014714|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153626162|NCT02014714|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153626163|NCT02014714|Anesthetics, General|anesthetics, general|mesh-ancestor
153626164|NCT02014714|Anesthetics|anesthetics|mesh-ancestor
153626165|NCT02014727|Aluminum Hydroxide|aluminum hydroxide|mesh-list
153626166|NCT02014727|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153626167|NCT02014727|Immunologic Factors|immunologic factors|mesh-ancestor
153626168|NCT02014727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153626169|NCT02014727|Antacids|antacids|mesh-ancestor
153626170|NCT02014727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153626171|NCT02014727|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153626172|NCT02014753|Cobalt|cobalt|mesh-list
153626232|NCT02015299|Protease Inhibitors|protease inhibitors|mesh-ancestor
153626233|NCT02015299|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153626234|NCT02015299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153626235|NCT02015312|Silicon|silicon|mesh-list
153626236|NCT02015312|Epigallocatechin gallate|epigallocatechin gallate|mesh-list
153626237|NCT02015312|Mannitol|mannitol|mesh-list
153626238|NCT02015312|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
153626239|NCT02015312|Diuretics|diuretics|mesh-ancestor
153626240|NCT02015312|Natriuretic Agents|natriuretic agents|mesh-ancestor
153626241|NCT02015312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153626242|NCT02015312|Trace Elements|trace elements|mesh-ancestor
153626243|NCT02015312|Micronutrients|micronutrients|mesh-ancestor
153626244|NCT02015312|Antioxidants|antioxidants|mesh-ancestor
153626245|NCT02015312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153626246|NCT02015312|Protective Agents|protective agents|mesh-ancestor
153626247|NCT02015312|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
153626248|NCT02015312|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
153626249|NCT02015312|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153626250|NCT02015312|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
153626251|NCT02015403|Acetylcysteine|acetylcysteine|mesh-list
153626252|NCT02015403|N-monoacetylcystine|n-monoacetylcystine|mesh-list
153626253|NCT02015403|Antiviral Agents|antiviral agents|mesh-ancestor
153626364|NCT02016209|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
153626365|NCT02016209|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153626366|NCT02016209|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153626367|NCT02016209|Tubulin Modulators|tubulin modulators|mesh-ancestor
153626368|NCT02016209|Antimitotic Agents|antimitotic agents|mesh-ancestor
153626369|NCT02016209|Mitosis Modulators|mitosis modulators|mesh-ancestor
153626370|NCT02016209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153626372|NCT02016261|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153626373|NCT02016261|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153626374|NCT02016261|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153626375|NCT02016261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153626376|NCT02016261|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153626377|NCT02016261|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
153626378|NCT02016261|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153626379|NCT02016261|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153626380|NCT02016261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153626381|NCT02016261|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153626382|NCT02016261|Serotonin Agents|serotonin agents|mesh-ancestor
153626383|NCT02016261|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
153626384|NCT02016261|Antidepressive Agents|antidepressive agents|mesh-ancestor
153626385|NCT02016261|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
153626386|NCT02016261|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153626387|NCT02016261|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153626388|NCT02016261|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
153626390|NCT02016274|Cisplatin|cisplatin|mesh-list
153626391|NCT02016274|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153626435|NCT02016417|Tubulin Modulators|tubulin modulators|mesh-ancestor
153626436|NCT02016417|Antimitotic Agents|antimitotic agents|mesh-ancestor
153626437|NCT02016417|Mitosis Modulators|mitosis modulators|mesh-ancestor
153730660|NCT00134693|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153626438|NCT02016417|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153626439|NCT02016417|Immunologic Factors|immunologic factors|mesh-ancestor
153626440|NCT02016417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153626441|NCT02016443|Tizanidine|tizanidine|mesh-list
153626442|NCT02016443|Analgesics|analgesics|mesh-ancestor
153626443|NCT02016443|Sensory System Agents|sensory system agents|mesh-ancestor
153626444|NCT02016443|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153626445|NCT02016443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153626446|NCT02016443|Anticonvulsants|anticonvulsants|mesh-ancestor
153626447|NCT02016443|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
153626474|NCT02016664|Sensory System Agents|sensory system agents|mesh-ancestor
153626475|NCT02016664|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153626476|NCT02016664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153626477|NCT02016664|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
153626478|NCT02016664|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153626479|NCT02016664|Anesthetics, General|anesthetics, general|mesh-ancestor
153626480|NCT02016664|Anesthetics|anesthetics|mesh-ancestor
153626481|NCT02016664|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153626482|NCT02016664|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
153626483|NCT02016664|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
153626484|NCT02016664|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153626485|NCT02016664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153626486|NCT02016703|Erythritol|erythritol|mesh-list
153626487|NCT02016703|Vasodilator Agents|vasodilator agents|mesh-ancestor
153626488|NCT02016729|Trametinib|trametinib|mesh-list
153626489|NCT02016729|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153626490|NCT02016729|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153626491|NCT02016729|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153626492|NCT02016729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153626493|NCT02016807|Sucralfate|sucralfate|mesh-list
153626494|NCT02016807|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
153626495|NCT02016807|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153816675|NCT00458991|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
153626496|NCT02016846|Liraglutide|liraglutide|mesh-list
153626514|NCT02016976|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153626515|NCT02016976|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153626516|NCT02016976|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153626517|NCT02016976|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153626518|NCT02016976|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153626519|NCT02016976|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153626520|NCT02016976|Anesthetics, General|anesthetics, general|mesh-ancestor
153626521|NCT02016976|Anesthetics|anesthetics|mesh-ancestor
153626522|NCT02016976|GABA Modulators|gaba modulators|mesh-ancestor
153626523|NCT02016976|GABA Agents|gaba agents|mesh-ancestor
153626524|NCT02016976|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153626525|NCT02016976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153626526|NCT02016976|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153626527|NCT02016976|Narcotics|narcotics|mesh-ancestor
153626528|NCT02017119|Lactulose|lactulose|mesh-list
153626529|NCT02017119|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153626530|NCT02017197|Warfarin|warfarin|mesh-list
153626531|NCT02017197|Anticoagulants|anticoagulants|mesh-ancestor
153626533|NCT02017314|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153626534|NCT02017314|Narcotics|narcotics|mesh-ancestor
153626535|NCT02017314|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153626536|NCT02017314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153626537|NCT02017314|Analgesics|analgesics|mesh-ancestor
153626538|NCT02017314|Sensory System Agents|sensory system agents|mesh-ancestor
153626539|NCT02017314|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153626540|NCT02017340|Nilvadipine|nilvadipine|mesh-list
153626541|NCT02017340|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153626542|NCT02017340|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153626543|NCT02017340|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153626547|NCT02017392|Lidocaine|lidocaine|mesh-list
153626585|NCT02017639|Simvastatin|simvastatin|mesh-list
153626586|NCT02017639|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153626587|NCT02017639|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153626588|NCT02017639|Antimetabolites|antimetabolites|mesh-ancestor
153626589|NCT02017639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153626590|NCT02017639|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153626591|NCT02017639|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
153626592|NCT02017639|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153626593|NCT02017873|Carbamide Peroxide|carbamide peroxide|mesh-list
153626594|NCT02017873|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
153626595|NCT02017873|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153626596|NCT02018055|Aspirin|aspirin|mesh-list
153626597|NCT02018055|Clopidogrel|clopidogrel|mesh-list
153626598|NCT02018055|Ticagrelor|ticagrelor|mesh-list
153463332|NCT01452828|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153736480|NCT02274155|Antibodies|antibodies|mesh-list
153736481|NCT02274155|Immunologic Factors|immunologic factors|mesh-ancestor
153736482|NCT02274155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153736490|NCT01824875|Temozolomide|temozolomide|mesh-list
153736491|NCT01824875|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153736492|NCT01824875|Antimetabolites|antimetabolites|mesh-ancestor
153736493|NCT01824875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153736494|NCT01824875|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153736496|NCT01824875|Alkylating Agents|alkylating agents|mesh-ancestor
153736518|NCT01701986|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
153736519|NCT01701986|Tacrolimus|tacrolimus|mesh-list
153736520|NCT01701986|Thymoglobulin|thymoglobulin|mesh-list
153736521|NCT01701986|Antilymphocyte Serum|antilymphocyte serum|mesh-list
153736522|NCT01701986|Immunologic Factors|immunologic factors|mesh-ancestor
153736523|NCT01701986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153736524|NCT01701986|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153736525|NCT01701986|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153736526|NCT01701986|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153736527|NCT01701986|Antimetabolites|antimetabolites|mesh-ancestor
153736528|NCT01701986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153736529|NCT01701986|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153736530|NCT01701986|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
153736531|NCT01701986|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153736532|NCT01701986|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153736533|NCT01701986|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
153736534|NCT01701986|Antitubercular Agents|antitubercular agents|mesh-ancestor
153736535|NCT01701986|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153472493|NCT04353336|Amebicides|amebicides|mesh-ancestor
153736558|NCT01602666|Etoposide phosphate|etoposide phosphate|mesh-list
153736560|NCT01602666|Isophosphamide mustard|isophosphamide mustard|mesh-list
153736561|NCT01602666|Podophyllotoxin|podophyllotoxin|mesh-list
153736583|NCT01527149|Ofatumumab|ofatumumab|mesh-list
153736605|NCT01527149|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153736606|NCT01527149|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153736607|NCT01527149|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153736608|NCT01527149|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
153736609|NCT01527149|Abortifacient Agents|abortifacient agents|mesh-ancestor
153736610|NCT01527149|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153736611|NCT01527149|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153736612|NCT01527149|Antimetabolites|antimetabolites|mesh-ancestor
153736613|NCT01527149|Dermatologic Agents|dermatologic agents|mesh-ancestor
153736614|NCT01527149|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153736615|NCT01527149|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153736616|NCT01527149|Antiviral Agents|antiviral agents|mesh-ancestor
153736617|NCT01527149|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153736618|NCT01527149|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153736619|NCT01527149|Tubulin Modulators|tubulin modulators|mesh-ancestor
153736620|NCT01527149|Antimitotic Agents|antimitotic agents|mesh-ancestor
153736621|NCT01527149|Mitosis Modulators|mitosis modulators|mesh-ancestor
153736622|NCT01527149|Protease Inhibitors|protease inhibitors|mesh-ancestor
153736623|NCT00616967|Paclitaxel|paclitaxel|mesh-list
153736624|NCT00616967|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
153736625|NCT00616967|Carboplatin|carboplatin|mesh-list
153736626|NCT00616967|Vorinostat|vorinostat|mesh-list
153736627|NCT00616967|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153736628|NCT00616967|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153736629|NCT00616967|Tubulin Modulators|tubulin modulators|mesh-ancestor
153736630|NCT00616967|Antimitotic Agents|antimitotic agents|mesh-ancestor
153736631|NCT00616967|Mitosis Modulators|mitosis modulators|mesh-ancestor
153736632|NCT00616967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153736633|NCT00616967|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
153736634|NCT00616967|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153736635|NCT00502463|Docetaxel|docetaxel|mesh-list
153736647|NCT00390793|Cortisone|cortisone|mesh-list
153736648|NCT00390793|Cyclophosphamide|cyclophosphamide|mesh-list
153736649|NCT00390793|Doxorubicin|doxorubicin|mesh-list
153736650|NCT00390793|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
153736651|NCT00390793|Methotrexate|methotrexate|mesh-list
153736652|NCT00390793|Vincristine|vincristine|mesh-list
153736653|NCT00390793|Daunorubicin|daunorubicin|mesh-list
153736654|NCT00390793|Dasatinib|dasatinib|mesh-list
153736655|NCT00390793|BB 1101|bb 1101|mesh-list
153472615|NCT04345458|Analgesics|analgesics|mesh-ancestor
153736666|NCT00390793|Antiemetics|antiemetics|mesh-ancestor
153736667|NCT00390793|Autonomic Agents|autonomic agents|mesh-ancestor
153736668|NCT00390793|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153736669|NCT00390793|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153736670|NCT00390793|Glucocorticoids|glucocorticoids|mesh-ancestor
153736671|NCT00390793|Hormones|hormones|mesh-ancestor
153736672|NCT00390793|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153736673|NCT00390793|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153736674|NCT00390793|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153736675|NCT00390793|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153736676|NCT00390793|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153736677|NCT00390793|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153736678|NCT00390793|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
153736679|NCT00390793|Abortifacient Agents|abortifacient agents|mesh-ancestor
153736680|NCT00390793|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153736681|NCT00390793|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153736682|NCT00390793|Antimetabolites|antimetabolites|mesh-ancestor
153736683|NCT00390793|Dermatologic Agents|dermatologic agents|mesh-ancestor
153736684|NCT00390793|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153736685|NCT00390793|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153736686|NCT00390793|Antiviral Agents|antiviral agents|mesh-ancestor
153736687|NCT00390793|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153736688|NCT00390793|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153736689|NCT00390793|Tubulin Modulators|tubulin modulators|mesh-ancestor
153736690|NCT00390793|Antimitotic Agents|antimitotic agents|mesh-ancestor
153736691|NCT00390793|Mitosis Modulators|mitosis modulators|mesh-ancestor
153736698|NCT00338377|Interleukin-2|interleukin-2|mesh-list
153736699|NCT00338377|Mesna|mesna|mesh-list
153736700|NCT00338377|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153736701|NCT00338377|Immunologic Factors|immunologic factors|mesh-ancestor
153736702|NCT00338377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153736703|NCT00338377|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153736704|NCT00338377|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153736705|NCT00338377|Alkylating Agents|alkylating agents|mesh-ancestor
153736706|NCT00338377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153736707|NCT00338377|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153736708|NCT00338377|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153736709|NCT00338377|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153736710|NCT00338377|Antimetabolites|antimetabolites|mesh-ancestor
153736711|NCT00338377|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153736712|NCT00338377|Analgesics|analgesics|mesh-ancestor
153736713|NCT00338377|Sensory System Agents|sensory system agents|mesh-ancestor
153736762|NCT06182111|Narcotics|narcotics|mesh-ancestor
153736763|NCT06182111|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153736764|NCT06182111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153736765|NCT06182111|Analgesics|analgesics|mesh-ancestor
153736766|NCT06182111|Sensory System Agents|sensory system agents|mesh-ancestor
153736767|NCT06182111|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153736768|NCT06182098|Diphenhydramine|diphenhydramine|mesh-list
153736769|NCT06182098|Promethazine|promethazine|mesh-list
153736770|NCT06182098|Ketorolac|ketorolac|mesh-list
153736771|NCT06182098|Prochlorperazine|prochlorperazine|mesh-list
153736772|NCT06182098|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153736773|NCT06182098|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153736774|NCT06182098|Analgesics|analgesics|mesh-ancestor
153736775|NCT06182098|Sensory System Agents|sensory system agents|mesh-ancestor
153736776|NCT06182098|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153736777|NCT06182098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153736778|NCT06182098|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153736779|NCT06182098|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153736780|NCT06182098|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153736781|NCT06182098|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153736784|NCT06182098|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153736831|NCT06181682|Dexmedetomidine|dexmedetomidine|mesh-list
153736832|NCT06181682|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153736833|NCT06181682|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153736834|NCT06181682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153736835|NCT06181682|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153736836|NCT06181682|Analgesics|analgesics|mesh-ancestor
153736837|NCT06181682|Sensory System Agents|sensory system agents|mesh-ancestor
153736838|NCT06181682|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153736839|NCT06181682|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
153736840|NCT06181682|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153736841|NCT06181682|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153736842|NCT06181682|Adrenergic Agents|adrenergic agents|mesh-ancestor
153736843|NCT06181682|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153736844|NCT06181682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153736845|NCT06181682|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153736846|NCT06181682|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153736847|NCT06181682|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153736848|NCT06181682|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153736849|NCT06181682|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153736850|NCT06181682|Anesthetics, General|anesthetics, general|mesh-ancestor
153736851|NCT06181682|Anesthetics|anesthetics|mesh-ancestor
153736852|NCT06181682|GABA Modulators|gaba modulators|mesh-ancestor
153736854|NCT06181422|Metformin|metformin|mesh-list
153736904|NCT06181019|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
153736905|NCT06181019|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
153736906|NCT06181019|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153736907|NCT06181019|Adrenergic Agents|adrenergic agents|mesh-ancestor
153736908|NCT06181019|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153472883|NCT04332042|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
153736921|NCT06180980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153736923|NCT06180967|Pirtobrutinib|pirtobrutinib|mesh-list
153736924|NCT06180967|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153736925|NCT06180967|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153736926|NCT06180967|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153736927|NCT06180967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153736928|NCT06180967|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153736929|NCT06180967|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153736930|NCT06180967|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153736931|NCT06180967|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153736932|NCT06180967|Anesthetics, General|anesthetics, general|mesh-ancestor
153736933|NCT06180967|Anesthetics|anesthetics|mesh-ancestor
153736934|NCT06180967|GABA Modulators|gaba modulators|mesh-ancestor
153736935|NCT06180967|GABA Agents|gaba agents|mesh-ancestor
153736936|NCT06180967|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153736937|NCT06180967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153736938|NCT06180967|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153736939|NCT06180967|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153736940|NCT06180967|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153736941|NCT06180954|Pirtobrutinib|pirtobrutinib|mesh-list
153736942|NCT06180954|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153736943|NCT06180954|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153736944|NCT06180954|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153736945|NCT06180954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153736946|NCT06180941|Magnesium Sulfate|magnesium sulfate|mesh-list
153736948|NCT06180941|Analgesics|analgesics|mesh-ancestor
153736949|NCT06180941|Sensory System Agents|sensory system agents|mesh-ancestor
153736956|NCT06180941|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153736957|NCT06180941|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153736958|NCT06180941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153736959|NCT06180941|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153736960|NCT06180941|Tocolytic Agents|tocolytic agents|mesh-ancestor
153736961|NCT06180941|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153736962|NCT06180941|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153736963|NCT06180941|Sympatholytics|sympatholytics|mesh-ancestor
153736964|NCT06180941|Autonomic Agents|autonomic agents|mesh-ancestor
153736965|NCT06180941|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
153736966|NCT06180941|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153736967|NCT06180941|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153736968|NCT06180941|Adrenergic Agents|adrenergic agents|mesh-ancestor
153736976|NCT06180876|Anesthetics|anesthetics|mesh-ancestor
153736977|NCT06180863|Azacitidine|azacitidine|mesh-list
153736979|NCT06180863|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153736980|NCT06180863|Antimetabolites|antimetabolites|mesh-ancestor
153736981|NCT06180863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153736982|NCT06180863|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153736983|NCT06180863|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153736984|NCT06176963|Ranibizumab|ranibizumab|mesh-list
153736985|NCT06176963|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153736986|NCT06176963|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153737014|NCT06174155|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
153737015|NCT06174155|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153737016|NCT06174155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153737017|NCT06174155|Cholinergic Agents|cholinergic agents|mesh-ancestor
153737018|NCT06174155|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153737019|NCT06174155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153737020|NCT06174155|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
153737021|NCT06174155|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153737022|NCT06172764|Vitamin D|vitamin d|mesh-list
153737023|NCT06172764|Ergocalciferols|ergocalciferols|mesh-list
153737024|NCT06172764|Cholecalciferol|cholecalciferol|mesh-list
153737025|NCT06172764|Vitamins|vitamins|mesh-list
153737026|NCT06172764|Fluorides|fluorides|mesh-list
153737027|NCT06172764|Fluorides, Topical|fluorides, topical|mesh-list
153737028|NCT06172764|Micronutrients|micronutrients|mesh-ancestor
153737029|NCT06172764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153737030|NCT06172764|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153737031|NCT06172764|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153737032|NCT06172764|Cariostatic Agents|cariostatic agents|mesh-ancestor
153737033|NCT06172764|Protective Agents|protective agents|mesh-ancestor
153737034|NCT06172400|Mepivacaine|mepivacaine|mesh-list
153737035|NCT06172400|Anesthetics, Local|anesthetics, local|mesh-ancestor
153737036|NCT06172400|Anesthetics|anesthetics|mesh-ancestor
153737037|NCT06172400|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153473006|NCT03030768|Antiviral Agents|antiviral agents|mesh-ancestor
153737049|NCT06163820|Nivolumab|nivolumab|mesh-list
153737050|NCT06163820|Ipilimumab|ipilimumab|mesh-list
153737051|NCT06163820|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153737052|NCT06163820|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153737055|NCT06163820|Growth Substances|growth substances|mesh-ancestor
153737070|NCT06145191|Tranexamic Acid|tranexamic acid|mesh-list
153737071|NCT06145191|Epinephryl borate|epinephryl borate|mesh-list
153737072|NCT06145191|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
153737073|NCT06145191|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153737074|NCT06145191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153737075|NCT06145191|Hemostatics|hemostatics|mesh-ancestor
153737076|NCT06145191|Coagulants|coagulants|mesh-ancestor
153737077|NCT06145191|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153737078|NCT06145191|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153737079|NCT06145191|Adrenergic Agents|adrenergic agents|mesh-ancestor
153737080|NCT06145191|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153737081|NCT06145191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153737082|NCT06145191|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
153737083|NCT06145191|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153737084|NCT06145191|Autonomic Agents|autonomic agents|mesh-ancestor
153737085|NCT06145191|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153737086|NCT06145191|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153737087|NCT06145191|Respiratory System Agents|respiratory system agents|mesh-ancestor
153737088|NCT06145191|Mydriatics|mydriatics|mesh-ancestor
153737089|NCT06145191|Sympathomimetics|sympathomimetics|mesh-ancestor
153737090|NCT06145191|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
153737135|NCT05938530|Antifungal Agents|antifungal agents|mesh-ancestor
153737136|NCT05938530|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153737137|NCT05938530|Immunologic Factors|immunologic factors|mesh-ancestor
153737138|NCT05938530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153737139|NCT05935202|Mitapivat|mitapivat|mesh-list
153737140|NCT05935202|Enzyme Activators|enzyme activators|mesh-ancestor
153737141|NCT05935202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153737142|NCT05923996|Botulinum Toxins|botulinum toxins|mesh-list
153737143|NCT05923996|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
153737144|NCT05923996|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
153737145|NCT05923996|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
153737146|NCT05923996|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153737147|NCT05923996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153737148|NCT05923996|Cholinergic Agents|cholinergic agents|mesh-ancestor
153737149|NCT05923996|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153737150|NCT05923996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153737151|NCT05923996|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
153737152|NCT05923996|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153737153|NCT05911906|Remdesivir|remdesivir|mesh-list
153737154|NCT05911906|Antimetabolites|antimetabolites|mesh-ancestor
153737155|NCT05911906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153737156|NCT05911906|Antiviral Agents|antiviral agents|mesh-ancestor
153737157|NCT05911906|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153737158|NCT05839314|Cyclosporine|cyclosporine|mesh-list
153737159|NCT05839314|Cyclosporins|cyclosporins|mesh-list
153737160|NCT05839314|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153737161|NCT05839314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153737188|NCT05805436|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
153737189|NCT05805436|Laxatives|laxatives|mesh-ancestor
153737190|NCT05805436|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153737191|NCT05780281|Remdesivir|remdesivir|mesh-list
153737192|NCT05780281|Sotrovimab|sotrovimab|mesh-list
153737193|NCT05780281|Antimetabolites|antimetabolites|mesh-ancestor
153730665|NCT00134693|Autonomic Agents|autonomic agents|mesh-ancestor
153730666|NCT00134693|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153730667|NCT00134693|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153730668|NCT00134693|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
153730669|NCT00134693|Protective Agents|protective agents|mesh-ancestor
153737194|NCT05780281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153737195|NCT05780281|Antiviral Agents|antiviral agents|mesh-ancestor
153737196|NCT05780281|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153737197|NCT05780268|Remdesivir|remdesivir|mesh-list
153737198|NCT05780268|Bamlanivimab|bamlanivimab|mesh-list
153737199|NCT05780268|Antimetabolites|antimetabolites|mesh-ancestor
153737200|NCT05780268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153737201|NCT05780268|Antiviral Agents|antiviral agents|mesh-ancestor
153737202|NCT05780268|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153737203|NCT05753735|Amoxicillin|amoxicillin|mesh-list
153737204|NCT05753735|Tazobactam|tazobactam|mesh-list
153737205|NCT05753735|Piperacillin|piperacillin|mesh-list
153737206|NCT05753735|Clavulanic Acids|clavulanic acids|mesh-list
153737207|NCT05753735|Clavulanic Acid|clavulanic acid|mesh-list
153737208|NCT05753735|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
153737209|NCT05753735|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153737210|NCT05753735|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153737211|NCT05753735|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
153737212|NCT05753735|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153737213|NCT05753735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153737214|NCT05726344|Lactulose|lactulose|mesh-list
153737215|NCT05726344|Bisacodyl|bisacodyl|mesh-list
153737216|NCT05726344|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
153737217|NCT05726344|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153737218|NCT05726344|Cathartics|cathartics|mesh-ancestor
153737219|NCT05726344|Laxatives|laxatives|mesh-ancestor
153737220|NCT05722704|Salicylic Acid|salicylic acid|mesh-list
153737224|NCT05722704|Dermatologic Agents|dermatologic agents|mesh-ancestor
153737225|NCT05721170|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
153737226|NCT05721170|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
153737227|NCT05721170|Adrenergic Agents|adrenergic agents|mesh-ancestor
153737228|NCT05721170|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153737229|NCT05721170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153737230|NCT05721170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153737231|NCT05717153|Eflornithine|eflornithine|mesh-list
153737232|NCT05717153|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153737233|NCT05717153|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
153737234|NCT05717153|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153737235|NCT05717153|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153737236|NCT05717153|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153737252|NCT05701917|Protease Inhibitors|protease inhibitors|mesh-ancestor
153737253|NCT05701917|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153737254|NCT05699408|Insulin Glargine|insulin glargine|mesh-list
153737255|NCT05699408|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153737256|NCT05699408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153737258|NCT05671653|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
153737259|NCT05671653|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153737260|NCT05671653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153737261|NCT05663905|Ambroxol|ambroxol|mesh-list
153737262|NCT05663905|Expectorants|expectorants|mesh-ancestor
153737263|NCT05663905|Respiratory System Agents|respiratory system agents|mesh-ancestor
153737264|NCT05661357|Disitamab vedotin|disitamab vedotin|mesh-list
153737288|NCT05514912|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153737289|NCT05514912|Tubulin Modulators|tubulin modulators|mesh-ancestor
153737290|NCT05514912|Antimitotic Agents|antimitotic agents|mesh-ancestor
153737291|NCT05514912|Mitosis Modulators|mitosis modulators|mesh-ancestor
153737292|NCT05514912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153737293|NCT05514912|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153737294|NCT05514912|Antimetabolites|antimetabolites|mesh-ancestor
153737295|NCT05514509|Cabotegravir|cabotegravir|mesh-list
153737296|NCT05514509|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
153737320|NCT05498610|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153737321|NCT05498610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153737322|NCT05485103|Glycerol|glycerol|mesh-list
153737323|NCT05485103|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
153737324|NCT05485103|Protective Agents|protective agents|mesh-ancestor
153737325|NCT05485103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153737326|NCT05443568|Semaglutide|semaglutide|mesh-list
153737327|NCT05443568|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
153737328|NCT05443568|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153737378|NCT05329740|Autonomic Agents|autonomic agents|mesh-ancestor
153737379|NCT05329740|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153737380|NCT05329740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153737381|NCT05329740|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153737382|NCT05329740|Glucocorticoids|glucocorticoids|mesh-ancestor
153737383|NCT05329740|Hormones|hormones|mesh-ancestor
153737384|NCT05329740|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153737385|NCT05329740|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
153737386|NCT05329740|Protective Agents|protective agents|mesh-ancestor
153737387|NCT05329740|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153737388|NCT05329740|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153737389|NCT05324748|Methylprednisolone|methylprednisolone|mesh-list
153737390|NCT05324748|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
153737391|NCT05324748|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
153737392|NCT05324748|Prednisolone|prednisolone|mesh-list
153737393|NCT05324748|Prednisolone acetate|prednisolone acetate|mesh-list
153737394|NCT05324748|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
153737395|NCT05324748|Prednisolone phosphate|prednisolone phosphate|mesh-list
153737396|NCT05324748|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153737397|NCT05324748|Antiemetics|antiemetics|mesh-ancestor
153737398|NCT05324748|Autonomic Agents|autonomic agents|mesh-ancestor
153737399|NCT05324748|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153737400|NCT05324748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153737449|NCT05302388|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
153737450|NCT05302388|Protective Agents|protective agents|mesh-ancestor
153737451|NCT05302388|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
153737452|NCT05302388|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153737453|NCT05302388|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153737454|NCT05302388|Anesthetics, Local|anesthetics, local|mesh-ancestor
153737455|NCT05302388|Anesthetics|anesthetics|mesh-ancestor
153737456|NCT05302388|Sensory System Agents|sensory system agents|mesh-ancestor
153737457|NCT05302388|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
153737458|NCT05302388|Histamine Antagonists|histamine antagonists|mesh-ancestor
153737459|NCT05302388|Histamine Agents|histamine agents|mesh-ancestor
153737460|NCT05302388|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153737461|NCT05302388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153737462|NCT05302388|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
153812383|NCT00328367|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153812385|NCT00328367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153737463|NCT05302388|Antipruritics|antipruritics|mesh-ancestor
153737464|NCT05302388|Dermatologic Agents|dermatologic agents|mesh-ancestor
153737465|NCT05300594|Vitamins|vitamins|mesh-list
153737466|NCT05300594|Micronutrients|micronutrients|mesh-ancestor
153737467|NCT05300594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153473467|NCT02989038|Nicotine|nicotine|mesh-list
153737492|NCT05230615|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153737493|NCT05230615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153737494|NCT05220722|Pembrolizumab|pembrolizumab|mesh-list
153737495|NCT05220722|Nivolumab|nivolumab|mesh-list
153737496|NCT05220722|Ipilimumab|ipilimumab|mesh-list
153737497|NCT05220722|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153737498|NCT05220722|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153737499|NCT05220722|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153737500|NCT05220722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153730671|NCT00152412|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
153737502|NCT05201638|Calcium|calcium|mesh-list
153737503|NCT05201638|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153737506|NCT05174026|Deoxyglucose|deoxyglucose|mesh-list
153737513|NCT05172050|Raloxifene Hydrochloride|raloxifene hydrochloride|mesh-list
153737514|NCT05172050|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
153737515|NCT05172050|Hormone Antagonists|hormone antagonists|mesh-ancestor
153737516|NCT05172050|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153737517|NCT05172050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153737525|NCT05134441|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153737527|NCT05131828|Clemastine|clemastine|mesh-list
153737528|NCT05131828|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153737529|NCT05131828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153737530|NCT05131828|Antipruritics|antipruritics|mesh-ancestor
153737531|NCT05131828|Dermatologic Agents|dermatologic agents|mesh-ancestor
153737532|NCT05131828|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
153737533|NCT05131828|Histamine Antagonists|histamine antagonists|mesh-ancestor
153737534|NCT05131828|Histamine Agents|histamine agents|mesh-ancestor
153737535|NCT05131828|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153737536|NCT05131828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153737537|NCT05131828|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
153737538|NCT05127980|Antibodies|antibodies|mesh-list
153737539|NCT05127980|Autoantibodies|autoantibodies|mesh-list
153737540|NCT05127980|Immunologic Factors|immunologic factors|mesh-ancestor
153737541|NCT05127980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153737542|NCT05114837|Cyclophosphamide|cyclophosphamide|mesh-list
153737543|NCT05114837|Fludarabine|fludarabine|mesh-list
153737544|NCT05114837|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153737545|NCT05114837|Immunologic Factors|immunologic factors|mesh-ancestor
153737546|NCT05114837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153737547|NCT05114837|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153737548|NCT05114837|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153737549|NCT05114837|Alkylating Agents|alkylating agents|mesh-ancestor
153737564|NCT05089916|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153737565|NCT05089916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153737566|NCT05089916|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153737567|NCT05060432|Pembrolizumab|pembrolizumab|mesh-list
153737568|NCT05060432|Dostarlimab|dostarlimab|mesh-list
153737569|NCT05060432|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153737570|NCT05060432|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153737571|NCT05060432|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153737572|NCT05060432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153737573|NCT05041907|Ritonavir|ritonavir|mesh-list
153737574|NCT05041907|Hydroxychloroquine|hydroxychloroquine|mesh-list
153737575|NCT05041907|Ivermectin|ivermectin|mesh-list
153737576|NCT05041907|Nitazoxanide|nitazoxanide|mesh-list
153737577|NCT05041907|Remdesivir|remdesivir|mesh-list
153737578|NCT05041907|Favipiravir|favipiravir|mesh-list
153737579|NCT05041907|Nirmatrelvir|nirmatrelvir|mesh-list
153737580|NCT05041907|Sotrovimab|sotrovimab|mesh-list
153730672|NCT00152412|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
153737581|NCT05041907|Nirmatrelvir and ritonavir drug combination|nirmatrelvir and ritonavir drug combination|mesh-list
153737582|NCT05041907|Molnupiravir|molnupiravir|mesh-list
153737583|NCT05041907|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
153737584|NCT05041907|Fluoxetine|fluoxetine|mesh-list
153737585|NCT05041907|Antibodies|antibodies|mesh-list
153473550|NCT02978976|Betamethasone|betamethasone|mesh-list
153737611|NCT05041907|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
153737612|NCT05041907|Antidepressive Agents|antidepressive agents|mesh-ancestor
153737613|NCT05041907|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153737614|NCT05041907|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
153737615|NCT05041907|Antimetabolites|antimetabolites|mesh-ancestor
153737616|NCT04992507|Anesthetics|anesthetics|mesh-list
153737617|NCT04992507|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153737618|NCT04992507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153737619|NCT04965506|Dulaglutide|dulaglutide|mesh-list
153737620|NCT04965506|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
153737621|NCT04965506|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153737622|NCT04965506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153737623|NCT04965038|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
153737626|NCT04965038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153737627|NCT04951947|Lenvatinib|lenvatinib|mesh-list
153737628|NCT04951947|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153574661|NCT01701453|Ticagrelor|ticagrelor|mesh-list
153737629|NCT04951947|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153737630|NCT04951947|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153737631|NCT04951947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153737655|NCT04886323|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
153737656|NCT04886323|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153737657|NCT04886323|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153737658|NCT04886323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153737659|NCT04886323|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153737660|NCT04886323|Hormone Antagonists|hormone antagonists|mesh-ancestor
153737661|NCT04886323|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153737662|NCT04886323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153737663|NCT04886323|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
153737664|NCT04870125|Carbon Monoxide|carbon monoxide|mesh-list
153737665|NCT04870125|Antimetabolites|antimetabolites|mesh-ancestor
153737666|NCT04870125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153737667|NCT04870125|Gasotransmitters|gasotransmitters|mesh-ancestor
153737668|NCT04870125|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153737669|NCT04870125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153737670|NCT04859465|Doxorubicin|doxorubicin|mesh-list
153737671|NCT04859465|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
153737672|NCT04859465|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
153737673|NCT04859465|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153737704|NCT04768686|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153737705|NCT04768686|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153737706|NCT04768686|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153737707|NCT04768686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153737708|NCT04756505|Interleukin-12|interleukin-12|mesh-list
153737709|NCT04756505|Immunoglobulin G|immunoglobulin g|mesh-list
153737710|NCT04756505|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153737711|NCT04756505|Immunologic Factors|immunologic factors|mesh-ancestor
153737712|NCT04756505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153737713|NCT04756505|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153737714|NCT04756505|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153737715|NCT04756505|Growth Substances|growth substances|mesh-ancestor
153737716|NCT04756505|Growth Inhibitors|growth inhibitors|mesh-ancestor
153737717|NCT04756505|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153737718|NCT04744116|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-list
153737719|NCT04744116|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153737720|NCT04744116|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153737721|NCT04744116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153737723|NCT04742023|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153737724|NCT04742023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153737725|NCT04739761|Trastuzumab|trastuzumab|mesh-list
153737726|NCT04739761|Trastuzumab deruxtecan|trastuzumab deruxtecan|mesh-list
153737727|NCT04739761|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153737728|NCT04739761|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153737729|NCT04739761|Immunoconjugates|immunoconjugates|mesh-ancestor
153737730|NCT04739761|Immunologic Factors|immunologic factors|mesh-ancestor
153737731|NCT04739761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153737732|NCT04737187|Trifluridine|trifluridine|mesh-list
153737733|NCT04737187|Bevacizumab|bevacizumab|mesh-list
153737734|NCT04737187|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153737741|NCT04737187|Antimetabolites|antimetabolites|mesh-ancestor
153737743|NCT04737187|Antiviral Agents|antiviral agents|mesh-ancestor
153737744|NCT04737187|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153737763|NCT04542278|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153737764|NCT04542278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153737765|NCT04542278|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153737766|NCT04542278|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153737767|NCT04535401|Calcium, Dietary|calcium, dietary|mesh-list
153737769|NCT04535401|Folic Acid|folic acid|mesh-list
153737770|NCT04535401|Fluorouracil|fluorouracil|mesh-list
153737771|NCT04535401|Irinotecan|irinotecan|mesh-list
153737772|NCT04535401|Camptothecin|camptothecin|mesh-list
153737773|NCT04535401|Calcium|calcium|mesh-list
153737774|NCT04535401|Levoleucovorin|levoleucovorin|mesh-list
153737775|NCT04535401|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153737776|NCT04535401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153737777|NCT04535401|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153737778|NCT04535401|Antimetabolites|antimetabolites|mesh-ancestor
153737779|NCT04535401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153737780|NCT04535401|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153737781|NCT04535401|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153737782|NCT04535401|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153737783|NCT04535401|Immunologic Factors|immunologic factors|mesh-ancestor
153737839|NCT04468360|Neurosteroids|neurosteroids|mesh-ancestor
153737840|NCT04468360|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153737841|NCT04468360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153737842|NCT04468360|GABA Modulators|gaba modulators|mesh-ancestor
153737844|NCT04466618|Heparin|heparin|mesh-list
153737845|NCT04466618|Calcium heparin|calcium heparin|mesh-list
153737846|NCT04466618|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
153737847|NCT04466618|Anticoagulants|anticoagulants|mesh-ancestor
153737848|NCT04466618|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153737849|NCT04466618|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153473838|NCT05313828|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
153737875|NCT04439006|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153737876|NCT04439006|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153730673|NCT00152412|Histamine Antagonists|histamine antagonists|mesh-ancestor
153737939|NCT04338191|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153737940|NCT04338191|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153737941|NCT04338191|Immunologic Factors|immunologic factors|mesh-ancestor
153737942|NCT04338191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153737943|NCT04338191|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
153737944|NCT04338191|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153737945|NCT04338191|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153737947|NCT04338191|Protective Agents|protective agents|mesh-ancestor
153737948|NCT04338191|Vitamin B Complex|vitamin b complex|mesh-ancestor
153737949|NCT04338191|Vitamins|vitamins|mesh-ancestor
153812406|NCT04703088|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153812434|NCT00328796|Lidocaine|lidocaine|mesh-list
153737950|NCT04338191|Micronutrients|micronutrients|mesh-ancestor
153737951|NCT04316117|Deoxyglucose|deoxyglucose|mesh-list
153737952|NCT04316117|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
153737953|NCT04316117|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
153737954|NCT04316117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153737955|NCT04316117|Antimetabolites|antimetabolites|mesh-ancestor
153737956|NCT04316117|Antiviral Agents|antiviral agents|mesh-ancestor
153737957|NCT04316117|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153737958|NCT04305041|Pembrolizumab|pembrolizumab|mesh-list
153737959|NCT04305041|Lenvatinib|lenvatinib|mesh-list
153737960|NCT04305041|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153737961|NCT04305041|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153737962|NCT04305041|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153738013|NCT04110028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153738014|NCT04110028|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153738015|NCT04110028|Vasodilator Agents|vasodilator agents|mesh-ancestor
153738016|NCT04099836|Bevacizumab|bevacizumab|mesh-list
153738017|NCT04099836|Atezolizumab|atezolizumab|mesh-list
153738018|NCT04099836|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153738019|NCT04099836|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153738020|NCT04099836|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153738021|NCT04099836|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153738022|NCT04099836|Growth Substances|growth substances|mesh-ancestor
153738023|NCT04099836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153738024|NCT04099836|Growth Inhibitors|growth inhibitors|mesh-ancestor
153738025|NCT04099836|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153738026|NCT04099836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153738027|NCT04094012|Isoniazid|isoniazid|mesh-list
153738028|NCT04094012|Rifapentine|rifapentine|mesh-list
153738029|NCT04094012|Antitubercular Agents|antitubercular agents|mesh-ancestor
153738030|NCT04094012|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153738078|NCT03939923|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
153738079|NCT03939923|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
153738080|NCT03939923|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
153738081|NCT03939923|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153738082|NCT03939923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153738083|NCT03939923|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
153738084|NCT03939923|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153738085|NCT03939923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153575109|NCT01704339|Capsaicin|capsaicin|mesh-list
153738086|NCT03939923|Cholinergic Agents|cholinergic agents|mesh-ancestor
153738087|NCT03939923|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153738088|NCT03939923|Parasympathomimetics|parasympathomimetics|mesh-ancestor
153738089|NCT03939923|Autonomic Agents|autonomic agents|mesh-ancestor
153738090|NCT03939923|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153738091|NCT03939923|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
153738092|NCT03939923|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
153738093|NCT03918252|Nivolumab|nivolumab|mesh-list
153738094|NCT03918252|Ipilimumab|ipilimumab|mesh-list
153738095|NCT03918252|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153738096|NCT03918252|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153738107|NCT03912831|Alkylating Agents|alkylating agents|mesh-ancestor
153738108|NCT03912831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153738109|NCT03912831|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153738110|NCT03912831|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153738111|NCT03912831|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153738112|NCT03912831|Analgesics|analgesics|mesh-ancestor
153738115|NCT03873883|Paclitaxel|paclitaxel|mesh-list
153738133|NCT03790800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153738134|NCT03790800|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
153738135|NCT03790800|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
153738136|NCT03790800|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
153738137|NCT03790800|Adrenergic Agents|adrenergic agents|mesh-ancestor
153738139|NCT03787628|Anticonvulsants|anticonvulsants|mesh-ancestor
153738140|NCT03647592|Bevacizumab|bevacizumab|mesh-list
153738141|NCT03647592|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
153738142|NCT03647592|Gefitinib|gefitinib|mesh-list
153738143|NCT03647592|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153738144|NCT03647592|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153738145|NCT03647592|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153738146|NCT03647592|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153738147|NCT03647592|Growth Substances|growth substances|mesh-ancestor
153738148|NCT03647592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153738149|NCT03647592|Growth Inhibitors|growth inhibitors|mesh-ancestor
153738150|NCT03647592|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153738151|NCT03647592|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153738152|NCT03647592|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153738153|NCT03647592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153738154|NCT03647111|Crizotinib|crizotinib|mesh-list
153738155|NCT03647111|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153738156|NCT03647111|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153738157|NCT03647111|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153738158|NCT03647111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153738159|NCT03647111|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153738160|NCT03646994|Crizotinib|crizotinib|mesh-list
153738175|NCT03637660|Penicillin G Procaine|penicillin g procaine|mesh-list
153738176|NCT03637660|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153738193|NCT03433183|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153738194|NCT03433183|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153738195|NCT03433183|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153738196|NCT03433183|Antifungal Agents|antifungal agents|mesh-ancestor
153738197|NCT03433183|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153738198|NCT03433183|Immunologic Factors|immunologic factors|mesh-ancestor
153738199|NCT03433183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153738200|NCT03331341|Doxorubicin|doxorubicin|mesh-list
153738201|NCT03331341|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
153738202|NCT03331341|Pembrolizumab|pembrolizumab|mesh-list
153738203|NCT03331341|Dacarbazine|dacarbazine|mesh-list
153738204|NCT03331341|Vinblastine|vinblastine|mesh-list
153738205|NCT03331341|Imidazole|imidazole|mesh-list
153738206|NCT03331341|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153738207|NCT03331341|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153738208|NCT03331341|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153738209|NCT03331341|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153738210|NCT03331341|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153738211|NCT03331341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153738212|NCT03331341|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153738213|NCT03331341|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153738214|NCT03331341|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153738215|NCT03331341|Alkylating Agents|alkylating agents|mesh-ancestor
153738216|NCT03331341|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153738217|NCT03331341|Tubulin Modulators|tubulin modulators|mesh-ancestor
153730676|NCT00152412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153730677|NCT00152412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153738250|NCT03118232|Disinfectants|disinfectants|mesh-ancestor
153738251|NCT03118232|Dermatologic Agents|dermatologic agents|mesh-ancestor
153738252|NCT03118232|Plasma Substitutes|plasma substitutes|mesh-ancestor
153738253|NCT03118232|Blood Substitutes|blood substitutes|mesh-ancestor
153738254|NCT03003962|Paclitaxel|paclitaxel|mesh-list
153738255|NCT03003962|Cisplatin|cisplatin|mesh-list
153738256|NCT03003962|Carboplatin|carboplatin|mesh-list
153738257|NCT03003962|Gemcitabine|gemcitabine|mesh-list
153738258|NCT03003962|Pemetrexed|pemetrexed|mesh-list
153738259|NCT03003962|Durvalumab|durvalumab|mesh-list
153738260|NCT03003962|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153738261|NCT03003962|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153738262|NCT03003962|Tubulin Modulators|tubulin modulators|mesh-ancestor
153738263|NCT03003962|Antimitotic Agents|antimitotic agents|mesh-ancestor
153738264|NCT03003962|Mitosis Modulators|mitosis modulators|mesh-ancestor
153738265|NCT03003962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153738266|NCT03003962|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153738267|NCT03003962|Antimetabolites|antimetabolites|mesh-ancestor
153738268|NCT03003962|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153738269|NCT03003962|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153738270|NCT03003962|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153738310|NCT02728102|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153738311|NCT02728102|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153738312|NCT02728102|Alkylating Agents|alkylating agents|mesh-ancestor
153738313|NCT02728102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153738314|NCT02728102|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153738315|NCT02728102|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153738317|NCT02660580|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
153738318|NCT02660580|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153738319|NCT02660580|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153738320|NCT02629809|Cyclophosphamide|cyclophosphamide|mesh-list
153738321|NCT02629809|Fludarabine|fludarabine|mesh-list
153738322|NCT02629809|Fludarabine phosphate|fludarabine phosphate|mesh-list
153738323|NCT02629809|Obinutuzumab|obinutuzumab|mesh-list
153738324|NCT02629809|Ibrutinib|ibrutinib|mesh-list
153738325|NCT02629809|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153738326|NCT02629809|Immunologic Factors|immunologic factors|mesh-ancestor
153738327|NCT02629809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153738328|NCT02629809|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153738329|NCT02629809|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153738330|NCT02629809|Alkylating Agents|alkylating agents|mesh-ancestor
153738331|NCT02629809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153738332|NCT02629809|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153738333|NCT02629809|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153738334|NCT02629809|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153738335|NCT02629809|Antimetabolites|antimetabolites|mesh-ancestor
153738336|NCT02629809|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153738337|NCT02629809|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153738338|NCT02629809|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153738339|NCT02629809|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153738340|NCT02600897|Rituximab|rituximab|mesh-list
153738341|NCT02600897|Obinutuzumab|obinutuzumab|mesh-list
153738342|NCT02600897|Lenalidomide|lenalidomide|mesh-list
153738343|NCT02600897|Polatuzumab vedotin|polatuzumab vedotin|mesh-list
153738353|NCT02600897|Immunoconjugates|immunoconjugates|mesh-ancestor
153738354|NCT02399215|Nintedanib|nintedanib|mesh-list
153738355|NCT02399215|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-list
153738364|NCT02365649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153738365|NCT02365649|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153738366|NCT02271919|Nicotine|nicotine|mesh-list
153738367|NCT02271919|Varenicline|varenicline|mesh-list
153738368|NCT02271919|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
153738369|NCT02271919|Autonomic Agents|autonomic agents|mesh-ancestor
153738370|NCT02271919|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153738371|NCT02271919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153738372|NCT02271919|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
153738373|NCT02271919|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
153738374|NCT02271919|Cholinergic Agents|cholinergic agents|mesh-ancestor
153738375|NCT02271919|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153738376|NCT02271919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153738377|NCT02225405|Cisplatin|cisplatin|mesh-list
153738378|NCT02225405|Docetaxel|docetaxel|mesh-list
153738379|NCT02225405|Nintedanib|nintedanib|mesh-list
153738380|NCT02225405|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-list
153738381|NCT02225405|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153738382|NCT02225405|Tubulin Modulators|tubulin modulators|mesh-ancestor
153738383|NCT02225405|Antimitotic Agents|antimitotic agents|mesh-ancestor
153738384|NCT02225405|Mitosis Modulators|mitosis modulators|mesh-ancestor
153738385|NCT02225405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153738386|NCT02225405|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153738387|NCT02225405|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153738388|NCT02110225|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
153738389|NCT02110225|Ophthalmic Solutions|ophthalmic solutions|mesh-list
153738390|NCT02110225|Mitogens|mitogens|mesh-list
153738391|NCT02110225|Mitosis Modulators|mitosis modulators|mesh-ancestor
153738392|NCT02110225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153738393|NCT02098954|Gemcitabine|gemcitabine|mesh-list
153738394|NCT02098954|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
153738401|NCT02098954|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153738402|NCT02065362|Cyclophosphamide|cyclophosphamide|mesh-list
153738403|NCT02065362|Fludarabine|fludarabine|mesh-list
153738404|NCT02065362|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153738405|NCT02065362|Immunologic Factors|immunologic factors|mesh-ancestor
153738406|NCT02065362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153738407|NCT02065362|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153738408|NCT02065362|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153738409|NCT02065362|Alkylating Agents|alkylating agents|mesh-ancestor
153738410|NCT02065362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153738411|NCT02065362|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153738412|NCT02065362|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153738413|NCT02016820|Omeprazole|omeprazole|mesh-list
153738414|NCT02016820|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
153738415|NCT02016820|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153738416|NCT02016820|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
153738506|NCT01371630|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153738507|NCT01371630|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153738508|NCT01371630|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153738509|NCT01371630|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
153812473|NCT00328913|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
153738511|NCT01371630|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153738512|NCT01371630|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153738513|NCT01371630|Antimetabolites|antimetabolites|mesh-ancestor
153738514|NCT01371630|Dermatologic Agents|dermatologic agents|mesh-ancestor
153738515|NCT01371630|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153738516|NCT01371630|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153738517|NCT01371630|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153738518|NCT01371630|Antiviral Agents|antiviral agents|mesh-ancestor
153738519|NCT01371630|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153738520|NCT01371630|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153738521|NCT01371630|Tubulin Modulators|tubulin modulators|mesh-ancestor
153738522|NCT01371630|Antimitotic Agents|antimitotic agents|mesh-ancestor
153738523|NCT01371630|Mitosis Modulators|mitosis modulators|mesh-ancestor
153738524|NCT01371630|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153738525|NCT01371630|Immunotoxins|immunotoxins|mesh-ancestor
153738526|NCT01371630|Immunoconjugates|immunoconjugates|mesh-ancestor
153738527|NCT01336803|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
153738528|NCT01336803|Hematinics|hematinics|mesh-ancestor
153738544|NCT00801489|Fludarabine|fludarabine|mesh-list
153738545|NCT00801489|Fludarabine phosphate|fludarabine phosphate|mesh-list
153738546|NCT00801489|Decitabine|decitabine|mesh-list
153738547|NCT00801489|Idarubicin|idarubicin|mesh-list
153738548|NCT00801489|Gemtuzumab|gemtuzumab|mesh-list
153738549|NCT00801489|Calicheamicins|calicheamicins|mesh-list
153738550|NCT00801489|Lenograstim|lenograstim|mesh-list
153738551|NCT00801489|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153738565|NCT00801489|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153738566|NCT00801489|Immunotoxins|immunotoxins|mesh-ancestor
153738567|NCT00801489|Immunoconjugates|immunoconjugates|mesh-ancestor
153738568|NCT00694655|Vaccines|vaccines|mesh-list
153738569|NCT00694655|Immunologic Factors|immunologic factors|mesh-ancestor
153738570|NCT00694655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153738571|NCT00642434|Metoprolol|metoprolol|mesh-list
153738572|NCT00642434|Carvedilol|carvedilol|mesh-list
153738573|NCT00642434|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153738574|NCT00642434|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153738575|NCT00642434|Sympatholytics|sympatholytics|mesh-ancestor
153738576|NCT00642434|Autonomic Agents|autonomic agents|mesh-ancestor
153738577|NCT00642434|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153738578|NCT00642434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153738579|NCT00642434|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
153738580|NCT00642434|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
153738581|NCT00642434|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
153738582|NCT00642434|Adrenergic Agents|adrenergic agents|mesh-ancestor
153738583|NCT00642434|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153738584|NCT00642434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153738585|NCT00642434|Antioxidants|antioxidants|mesh-ancestor
153738586|NCT00642434|Protective Agents|protective agents|mesh-ancestor
153738587|NCT00642434|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153738588|NCT00642434|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153738604|NCT00318981|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153738605|NCT00318981|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153738606|NCT00318981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153738608|NCT00318981|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153738610|NCT00089245|Cadexomer iodine|cadexomer iodine|mesh-list
153738611|NCT00089245|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
153738612|NCT00089245|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153738613|NCT00089245|Trace Elements|trace elements|mesh-ancestor
153575634|NCT01707537|Vaccines|vaccines|mesh-list
153738614|NCT00089245|Micronutrients|micronutrients|mesh-ancestor
153730680|NCT00142038|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153730681|NCT00142038|Tubulin Modulators|tubulin modulators|mesh-ancestor
153730682|NCT00142038|Antimitotic Agents|antimitotic agents|mesh-ancestor
153738615|NCT00089245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153738617|NCT00004198|Keyhole-limpet hemocyanin|keyhole-limpet hemocyanin|mesh-list
153738619|NCT00004198|Immunologic Factors|immunologic factors|mesh-ancestor
153738620|NCT00004198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153738621|NCT00004198|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153738622|NCT00004192|Cytarabine|cytarabine|mesh-list
153738623|NCT00004192|Methylprednisolone|methylprednisolone|mesh-list
153738624|NCT00004192|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
153738625|NCT00004192|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
153738626|NCT00004192|Prednisolone|prednisolone|mesh-list
153738627|NCT00004192|Prednisolone acetate|prednisolone acetate|mesh-list
153738628|NCT00004192|Etoposide|etoposide|mesh-list
153738629|NCT00004192|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
153738630|NCT00004192|Prednisolone phosphate|prednisolone phosphate|mesh-list
153738631|NCT00004192|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153738632|NCT00004192|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153738633|NCT00004192|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153738634|NCT00004192|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153738635|NCT00004192|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153738636|NCT00004192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153738637|NCT00004192|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153738638|NCT00004192|Antimetabolites|antimetabolites|mesh-ancestor
153738639|NCT00004192|Antiviral Agents|antiviral agents|mesh-ancestor
153738640|NCT00004192|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153738641|NCT00004192|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153738642|NCT00004192|Immunologic Factors|immunologic factors|mesh-ancestor
153738693|NCT00469885|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153738744|NCT00470197|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153738745|NCT00470197|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153738746|NCT00470197|Growth Inhibitors|growth inhibitors|mesh-ancestor
153738747|NCT00470197|Growth Substances|growth substances|mesh-ancestor
153738748|NCT00470197|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153738750|NCT00470314|Excitatory Amino Acid Agonists|excitatory amino acid agonists|mesh-ancestor
153738751|NCT00470314|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
153738752|NCT00470314|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153738753|NCT00470314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153738754|NCT00470314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153738755|NCT00149292|Olanzapine|olanzapine|mesh-list
153738756|NCT00149292|Antiemetics|antiemetics|mesh-ancestor
153738757|NCT00149292|Autonomic Agents|autonomic agents|mesh-ancestor
153738758|NCT00149292|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153738759|NCT00149292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153738760|NCT00149292|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153738761|NCT00149292|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153738762|NCT00149292|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153738763|NCT00149292|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153738764|NCT00149292|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153738765|NCT00149292|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
153738766|NCT00149292|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153738767|NCT00149292|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153738768|NCT00149292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153738769|NCT00149292|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153738770|NCT00149292|Serotonin Agents|serotonin agents|mesh-ancestor
153738771|NCT00470509|Adalimumab|adalimumab|mesh-list
153738772|NCT00470509|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
153738773|NCT00470509|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153738784|NCT05378906|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153738785|NCT00470665|Sirolimus|sirolimus|mesh-list
153738786|NCT00470665|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153738787|NCT00470665|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153738788|NCT00470665|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153738789|NCT00470665|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153738790|NCT00470665|Antifungal Agents|antifungal agents|mesh-ancestor
153738812|NCT00470821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153738814|NCT00470821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153738815|NCT00470821|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153738816|NCT00335920|Dexamethasone|dexamethasone|mesh-list
153738817|NCT00335920|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153738818|NCT00335920|Antiemetics|antiemetics|mesh-ancestor
153738819|NCT00335920|Autonomic Agents|autonomic agents|mesh-ancestor
153738820|NCT00335920|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153738821|NCT00335920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153738822|NCT00335920|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153738823|NCT00335920|Glucocorticoids|glucocorticoids|mesh-ancestor
153738824|NCT00335920|Hormones|hormones|mesh-ancestor
153738825|NCT00335920|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153738826|NCT00335920|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153738827|NCT00335920|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153738828|NCT00335998|Cisplatin|cisplatin|mesh-list
153738830|NCT00470977|Ranibizumab|ranibizumab|mesh-list
153738905|NCT00158028|Serotonin Agents|serotonin agents|mesh-ancestor
153738906|NCT00158028|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153738907|NCT00158028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153738908|NCT00158028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153738909|NCT00158028|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153730683|NCT00142038|Mitosis Modulators|mitosis modulators|mesh-ancestor
153738910|NCT00158028|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153738911|NCT00158028|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153738912|NCT00158028|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153738913|NCT00158028|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
153738914|NCT00158028|Dopamine Agents|dopamine agents|mesh-ancestor
153738915|NCT00471406|Verteporfin|verteporfin|mesh-list
153738916|NCT00471406|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
153738917|NCT00471406|Dermatologic Agents|dermatologic agents|mesh-ancestor
153738918|NCT00149565|Interferon alpha-2|interferon alpha-2|mesh-list
153738919|NCT00149565|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153738921|NCT00149565|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153738922|NCT00471484|Interferons|interferons|mesh-list
153738923|NCT00471484|Interferon-alpha|interferon-alpha|mesh-list
153738924|NCT00471484|Interferon alpha-2|interferon alpha-2|mesh-list
153738925|NCT00471484|Doxorubicin|doxorubicin|mesh-list
153738926|NCT00471484|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
153738927|NCT00471484|Fluorouracil|fluorouracil|mesh-list
153738928|NCT00471484|Oxaliplatin|oxaliplatin|mesh-list
153738929|NCT00471484|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153738930|NCT00471484|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153738931|NCT00471484|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153738932|NCT00471484|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153738933|NCT00471484|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153738934|NCT00471484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153738935|NCT00471484|Antimetabolites|antimetabolites|mesh-ancestor
153738936|NCT00471484|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153738937|NCT00471484|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153738938|NCT00471484|Immunologic Factors|immunologic factors|mesh-ancestor
153738940|NCT00471484|Antiviral Agents|antiviral agents|mesh-ancestor
153738994|NCT00471952|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
153738995|NCT00471952|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
153738996|NCT00471952|Purinergic Agents|purinergic agents|mesh-ancestor
153738997|NCT00471952|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153738998|NCT00471952|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
153738999|NCT00471952|Serotonin Agents|serotonin agents|mesh-ancestor
153739000|NCT00471991|Dienogest|dienogest|mesh-list
153739001|NCT00471991|Ethinyl Estradiol|ethinyl estradiol|mesh-list
153739002|NCT00471991|Estradiol|estradiol|mesh-list
153739003|NCT00471991|Estrogens|estrogens|mesh-ancestor
153739004|NCT00471991|Hormones|hormones|mesh-ancestor
153739005|NCT00471991|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153739006|NCT00471991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153739007|NCT00471991|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
153739008|NCT00471991|Contraceptive Agents|contraceptive agents|mesh-ancestor
153739009|NCT00471991|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153739010|NCT00471991|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
153739011|NCT00471991|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
153739012|NCT00471991|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
153739013|NCT00471991|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
153739014|NCT00471991|Hormone Antagonists|hormone antagonists|mesh-ancestor
153739015|NCT00471991|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153739016|NCT00471991|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153739017|NCT00472108|Methyl 5-aminolevulinate|methyl 5-aminolevulinate|mesh-list
153739019|NCT00472108|Dermatologic Agents|dermatologic agents|mesh-ancestor
153739070|NCT00337051|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153739071|NCT00337051|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153739072|NCT00337051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153739073|NCT00337051|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153739074|NCT00337051|Anesthetics, General|anesthetics, general|mesh-ancestor
153739075|NCT00337051|Anesthetics|anesthetics|mesh-ancestor
153739076|NCT00337051|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153739077|NCT00337051|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
153739078|NCT00472927|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
153739079|NCT00472927|Estrogens|estrogens|mesh-ancestor
153739080|NCT00472927|Hormones|hormones|mesh-ancestor
153739081|NCT00472927|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153739082|NCT00472927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153739083|NCT00337090|Mirabegron|mirabegron|mesh-list
153739084|NCT00337090|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
153739085|NCT00337090|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
153739086|NCT00337090|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153739087|NCT00337090|Adrenergic Agents|adrenergic agents|mesh-ancestor
153739088|NCT00337090|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153739109|NCT00337246|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153739111|NCT00337246|Analgesics|analgesics|mesh-ancestor
153739112|NCT00337246|Sensory System Agents|sensory system agents|mesh-ancestor
153739164|NCT00337558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153739167|NCT02964104|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
153739168|NCT02964104|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153739169|NCT02964104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153739170|NCT00158457|Tenofovir|tenofovir|mesh-list
153739171|NCT00158457|Emtricitabine|emtricitabine|mesh-list
153739172|NCT00158457|Efavirenz|efavirenz|mesh-list
153739173|NCT00158457|Antiviral Agents|antiviral agents|mesh-ancestor
153739174|NCT00158457|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153739175|NCT00158457|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153739176|NCT00158457|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153739177|NCT00158457|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153739178|NCT00158457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153739179|NCT00158457|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153739180|NCT00158457|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153739181|NCT00158457|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
153739182|NCT00158457|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153739184|NCT00158457|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
153739283|NCT00509431|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
153739284|NCT00509431|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153739320|NCT00405158|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153739321|NCT00405158|Analgesics|analgesics|mesh-ancestor
153739322|NCT00405158|Sensory System Agents|sensory system agents|mesh-ancestor
153739323|NCT00405158|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153739324|NCT00405158|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153739325|NCT00405158|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153739365|NCT02953210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153739366|NCT02953210|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153739394|NCT02953210|GABA Agents|gaba agents|mesh-ancestor
153739395|NCT02953210|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153739396|NCT02953210|Narcotics|narcotics|mesh-ancestor
153739397|NCT02953210|Antipruritics|antipruritics|mesh-ancestor
153739398|NCT02953210|Dermatologic Agents|dermatologic agents|mesh-ancestor
153739399|NCT02953210|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
153739400|NCT02953210|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153739401|NCT02953210|Serotonin Agents|serotonin agents|mesh-ancestor
153739402|NCT02953210|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153739403|NCT02953210|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153739404|NCT02953210|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153739405|NCT02953210|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153739406|NCT02953210|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153739407|NCT02953210|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
153739408|NCT02953210|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
153739409|NCT02953210|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
153739410|NCT02953210|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153739411|NCT02953210|Sympatholytics|sympatholytics|mesh-ancestor
153739412|NCT02953210|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
153739413|NCT02953210|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153739431|NCT00509743|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153739433|NCT00509860|Irinotecan|irinotecan|mesh-list
153739441|NCT00337948|Epoetin Alfa|epoetin alfa|mesh-list
153739442|NCT00337948|Hematinics|hematinics|mesh-ancestor
153739443|NCT02958215|Phenylephrine|phenylephrine|mesh-list
153739444|NCT02958215|Oxymetazoline|oxymetazoline|mesh-list
153576458|NCT01712321|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153739446|NCT02958215|Mydriatics|mydriatics|mesh-ancestor
153739447|NCT02958215|Autonomic Agents|autonomic agents|mesh-ancestor
153739448|NCT02958215|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153739449|NCT02958215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153739450|NCT02958215|Sympathomimetics|sympathomimetics|mesh-ancestor
153739451|NCT02958215|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
153739452|NCT02958215|Nasal Decongestants|nasal decongestants|mesh-ancestor
153739453|NCT02958215|Respiratory System Agents|respiratory system agents|mesh-ancestor
153739454|NCT02958215|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
153739455|NCT02958215|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153739456|NCT02958215|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153739457|NCT02958215|Adrenergic Agents|adrenergic agents|mesh-ancestor
153739458|NCT02958215|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153739459|NCT02958215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153739460|NCT02958215|Protective Agents|protective agents|mesh-ancestor
153739461|NCT00158574|Pyrimethamine|pyrimethamine|mesh-list
153739462|NCT00158574|Sulfadoxine|sulfadoxine|mesh-list
153739463|NCT00158574|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
153739464|NCT00158574|Dapsone|dapsone|mesh-list
153739465|NCT00158574|Mefloquine|mefloquine|mesh-list
153739466|NCT00158574|Chlorproguanil|chlorproguanil|mesh-list
153739467|NCT00158574|Proguanil|proguanil|mesh-list
153739468|NCT00158574|Antimalarials|antimalarials|mesh-ancestor
153739469|NCT00158574|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153739470|NCT00158574|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153739471|NCT00158574|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153739472|NCT00158574|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153475429|NCT00801138|Hormones|hormones|mesh-ancestor
153739495|NCT00510016|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153739505|NCT00150228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153739506|NCT00150228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153739508|NCT00338338|Lacidipine|lacidipine|mesh-list
153739509|NCT00338338|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153739510|NCT00338338|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153739511|NCT00338338|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153739512|NCT00338338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153739513|NCT00338338|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153739514|NCT00338338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153739515|NCT00338338|Vasodilator Agents|vasodilator agents|mesh-ancestor
153739516|NCT00338416|Epoetin Alfa|epoetin alfa|mesh-list
153739517|NCT00338416|Hematinics|hematinics|mesh-ancestor
153739518|NCT00338494|Clofarabine|clofarabine|mesh-list
153739519|NCT00338494|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153739520|NCT00338494|Antimetabolites|antimetabolites|mesh-ancestor
153739521|NCT00338494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153739522|NCT00338494|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153739523|NCT02953015|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
153739525|NCT02953015|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
153475488|NCT00803400|GABA Modulators|gaba modulators|mesh-ancestor
153739557|NCT00338767|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153739558|NCT00338767|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153739559|NCT00338767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153739560|NCT00338767|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153739561|NCT00338767|Serotonin Agents|serotonin agents|mesh-ancestor
153739562|NCT00338767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153739595|NCT00150384|Atorvastatin|atorvastatin|mesh-list
153739603|NCT00150384|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153739604|NCT00150384|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153739605|NCT00150384|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153739606|NCT00150384|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153739607|NCT00150384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153739608|NCT00150384|Vasodilator Agents|vasodilator agents|mesh-ancestor
153739609|NCT00425191|Gemcitabine|gemcitabine|mesh-list
153739610|NCT00425191|Docetaxel|docetaxel|mesh-list
153739611|NCT00425191|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153739612|NCT00425191|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153739613|NCT00425191|Antimetabolites|antimetabolites|mesh-ancestor
153739614|NCT00425191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153739615|NCT00425191|Tubulin Modulators|tubulin modulators|mesh-ancestor
153739616|NCT00425191|Antimitotic Agents|antimitotic agents|mesh-ancestor
153739617|NCT00425191|Mitosis Modulators|mitosis modulators|mesh-ancestor
153739618|NCT00339118|Doxorubicin|doxorubicin|mesh-list
153739647|NCT00339196|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153739648|NCT00339196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153739649|NCT00339196|Antimanic Agents|antimanic agents|mesh-ancestor
153739650|NCT00339196|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153739651|NCT00339196|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153739652|NCT00339196|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153739653|NCT00158730|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
153739654|NCT00158730|Antifungal Agents|antifungal agents|mesh-ancestor
153739655|NCT00158730|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153739656|NCT00158730|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153739657|NCT00158730|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153739658|NCT00510211|Olanzapine|olanzapine|mesh-list
153739659|NCT00510211|Antiemetics|antiemetics|mesh-ancestor
153739660|NCT00510211|Autonomic Agents|autonomic agents|mesh-ancestor
153739661|NCT00510211|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153739662|NCT00510211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153739663|NCT00510211|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153739664|NCT00510211|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153739704|NCT00510367|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153739738|NCT00158886|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153739739|NCT00158886|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153739740|NCT00158886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153739741|NCT00158886|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153739742|NCT00510406|Tamsulosin|tamsulosin|mesh-list
153739743|NCT00510406|Solifenacin Succinate|solifenacin succinate|mesh-list
153739744|NCT00510406|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
153739774|NCT00150579|Dopamine Agents|dopamine agents|mesh-ancestor
153739775|NCT00150579|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153739776|NCT00150579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153739777|NCT00150579|Adrenergic Agents|adrenergic agents|mesh-ancestor
153739778|NCT00150579|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
153739779|NCT00150579|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153739780|NCT00150579|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153739781|NCT00150579|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
153739782|NCT00511732|Insulin|insulin|mesh-list
153739783|NCT00511732|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153739784|NCT00511732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153739785|NCT00510445|Imetelstat|imetelstat|mesh-list
153739786|NCT00510445|Motesanib diphosphate|motesanib diphosphate|mesh-list
153739787|NCT00510445|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153739788|NCT00510445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153739789|NCT00510445|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153739823|NCT00511849|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153739824|NCT00511849|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153739825|NCT00511849|Growth Substances|growth substances|mesh-ancestor
153739826|NCT00511849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153739827|NCT00511849|Growth Inhibitors|growth inhibitors|mesh-ancestor
153739869|NCT00150735|Nootropic Agents|nootropic agents|mesh-ancestor
153739870|NCT04695925|Carboplatin|carboplatin|mesh-list
153739871|NCT04695925|Pemetrexed|pemetrexed|mesh-list
153739872|NCT04695925|Osimertinib|osimertinib|mesh-list
153739873|NCT04695925|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153739874|NCT04695925|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153739875|NCT04695925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153475882|NCT00848016|Gossypol|gossypol|mesh-list
153739943|NCT00511654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153739944|NCT00150852|Vancomycin|vancomycin|mesh-list
153739945|NCT00150852|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153739946|NCT00150852|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153739947|NCT02952235|Sunscreening Agents|sunscreening agents|mesh-list
153739948|NCT02952235|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
153739949|NCT02952235|Protective Agents|protective agents|mesh-ancestor
153739950|NCT02952235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153739951|NCT02952235|Dermatologic Agents|dermatologic agents|mesh-ancestor
153739952|NCT00165867|N-(3-chloro-7-indolyl)-1,4-benzenedisulphonamide|n-(3-chloro-7-indolyl)-1,4-benzenedisulphonamide|mesh-list
153739953|NCT00165867|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153739954|NCT00165867|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
153739955|NCT00165867|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153740062|NCT00513487|Bronchoconstrictor Agents|bronchoconstrictor agents|mesh-ancestor
153740063|NCT00513487|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
153740064|NCT00513487|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
153740065|NCT00513487|Cholinergic Agents|cholinergic agents|mesh-ancestor
153740066|NCT00513487|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153740067|NCT00513487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153740068|NCT00405236|Tiotropium Bromide|tiotropium bromide|mesh-list
153740069|NCT00405236|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153740070|NCT00405236|Autonomic Agents|autonomic agents|mesh-ancestor
153740071|NCT00405236|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153740072|NCT00405236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153740073|NCT00405236|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153740074|NCT00405236|Respiratory System Agents|respiratory system agents|mesh-ancestor
153740075|NCT00405236|Parasympatholytics|parasympatholytics|mesh-ancestor
153740076|NCT00405236|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
153740077|NCT00405236|Cholinergic Agents|cholinergic agents|mesh-ancestor
153740078|NCT00405236|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153740079|NCT00405236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153740080|NCT00403949|Azelaic acid|azelaic acid|mesh-list
153740081|NCT00403949|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153740082|NCT00403949|Dermatologic Agents|dermatologic agents|mesh-ancestor
153740084|NCT00513643|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
153740085|NCT00513643|Insulin Aspart|insulin aspart|mesh-list
153740086|NCT00513643|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153740088|NCT00151008|Bexarotene|bexarotene|mesh-list
153740168|NCT00151086|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153740170|NCT00514228|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153740171|NCT00514228|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153740172|NCT00514228|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153740173|NCT00514228|Growth Substances|growth substances|mesh-ancestor
153740174|NCT00514228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153740176|NCT00514228|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153740177|NCT00514228|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153740178|NCT00514228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153740180|NCT00151125|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153740181|NCT00514657|Mitogens|mitogens|mesh-list
153740182|NCT00514657|Mitosis Modulators|mitosis modulators|mesh-ancestor
153740183|NCT00514657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153740184|NCT00514774|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
153740185|NCT00514774|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
153740186|NCT00514774|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153740187|NCT02951260|Metformin|metformin|mesh-list
153740188|NCT02951260|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153740189|NCT02951260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153740190|NCT02951299|Pentoxifylline|pentoxifylline|mesh-list
153740191|NCT02951299|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
153740192|NCT02951299|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153740193|NCT02951299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153740194|NCT02951299|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153740195|NCT02951299|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
153740231|NCT00515554|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153740232|NCT00515554|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153740233|NCT00515554|Immunologic Factors|immunologic factors|mesh-ancestor
153740234|NCT00515554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153740235|NCT00515554|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153740236|NCT00151203|Clarithromycin|clarithromycin|mesh-list
153740237|NCT00151203|Dexamethasone|dexamethasone|mesh-list
153740238|NCT00151203|Lenalidomide|lenalidomide|mesh-list
153740239|NCT00151203|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153740240|NCT00151203|Antiemetics|antiemetics|mesh-ancestor
153740241|NCT00151203|Autonomic Agents|autonomic agents|mesh-ancestor
153740242|NCT00151203|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153740243|NCT00151203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153740244|NCT00151203|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153740245|NCT00151203|Glucocorticoids|glucocorticoids|mesh-ancestor
153740246|NCT00151203|Hormones|hormones|mesh-ancestor
153740247|NCT00151203|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153740248|NCT00151203|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153740249|NCT00151203|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153740250|NCT00151203|Immunologic Factors|immunologic factors|mesh-ancestor
153740251|NCT00151203|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153740252|NCT00151203|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153740253|NCT00151203|Growth Substances|growth substances|mesh-ancestor
153740254|NCT00151203|Growth Inhibitors|growth inhibitors|mesh-ancestor
153740255|NCT00151203|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153740256|NCT00151203|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153740257|NCT00151203|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
153740258|NCT00151203|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153740259|NCT00151203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153740260|NCT00151203|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
153740266|NCT04620200|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153740268|NCT04620200|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153816676|NCT00458991|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
153816677|NCT00458991|Purinergic Agents|purinergic agents|mesh-ancestor
153816678|NCT00458991|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153816679|NCT00458991|Antitussive Agents|antitussive agents|mesh-ancestor
153816680|NCT00458991|Respiratory System Agents|respiratory system agents|mesh-ancestor
153571353|NCT04391179|Dipyridamole|dipyridamole|mesh-list
153571354|NCT04391179|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
153571355|NCT04391179|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153571356|NCT04391179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153740269|NCT04620200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153740270|NCT04620200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153740272|NCT00515593|Parathyroid Hormone|parathyroid hormone|mesh-list
153740273|NCT00515593|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153740274|NCT00515593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153740275|NCT00515593|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153740277|NCT00515788|Temozolomide|temozolomide|mesh-list
153740278|NCT00515788|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153740279|NCT00515788|Antimetabolites|antimetabolites|mesh-ancestor
153740280|NCT00515788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153740281|NCT00515788|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153740282|NCT00515788|Antiviral Agents|antiviral agents|mesh-ancestor
153740283|NCT00515788|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153740284|NCT00515788|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153740285|NCT00515788|Immunologic Factors|immunologic factors|mesh-ancestor
153740286|NCT00515788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153740287|NCT00515788|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153740288|NCT00515788|Alkylating Agents|alkylating agents|mesh-ancestor
153740289|NCT02950870|Ritonavir|ritonavir|mesh-list
153571357|NCT04391179|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153571358|NCT04391179|Vasodilator Agents|vasodilator agents|mesh-ancestor
153571359|NCT04375683|Flumatinib|flumatinib|mesh-list
153571360|NCT04375683|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153571361|NCT04375683|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153571362|NCT04375683|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153571363|NCT04375683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153571364|NCT04356742|Metformin|metformin|mesh-list
153571365|NCT04356742|Dapagliflozin|dapagliflozin|mesh-list
153571366|NCT04356742|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153571367|NCT04356742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153571368|NCT04356742|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
153571369|NCT04356742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153571370|NCT04353284|Gabexate|gabexate|mesh-list
153571371|NCT04353284|Camostat|camostat|mesh-list
153571372|NCT04353284|Protease Inhibitors|protease inhibitors|mesh-ancestor
153571373|NCT04353284|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153571374|NCT04353284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153571375|NCT04353284|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
153571376|NCT04353284|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
153571377|NCT04353284|Anticoagulants|anticoagulants|mesh-ancestor
153571378|NCT04348864|Antibodies|antibodies|mesh-list
153571379|NCT04348864|Immunologic Factors|immunologic factors|mesh-ancestor
153571380|NCT04348864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153571381|NCT04328012|Losartan|losartan|mesh-list
153571398|NCT04264637|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153571399|NCT04264637|Autonomic Agents|autonomic agents|mesh-ancestor
153571400|NCT04264637|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153571401|NCT04264637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153571402|NCT04264637|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153571403|NCT04264637|Respiratory System Agents|respiratory system agents|mesh-ancestor
153571404|NCT04264637|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
153571405|NCT04264637|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153740290|NCT02950870|Ribavirin|ribavirin|mesh-list
153740291|NCT02950870|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
153740292|NCT02950870|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
153740293|NCT02950870|Protease Inhibitors|protease inhibitors|mesh-ancestor
153740294|NCT02950870|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153740295|NCT02950870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153740296|NCT02950870|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153740297|NCT02950870|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153740298|NCT02950870|Antiviral Agents|antiviral agents|mesh-ancestor
153740299|NCT02950870|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153740300|NCT02950870|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
153740301|NCT02950870|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153740302|NCT02950870|Antimetabolites|antimetabolites|mesh-ancestor
153740303|NCT00515866|Gemcitabine|gemcitabine|mesh-list
153740304|NCT00515866|Olaparib|olaparib|mesh-list
153740305|NCT00515866|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
153740306|NCT00515866|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153740307|NCT00515866|Antimetabolites|antimetabolites|mesh-ancestor
153740308|NCT00515866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153740309|NCT00515866|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153740310|NCT00515866|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153740311|NCT00515905|Propofol|propofol|mesh-list
153740312|NCT00515905|Sevoflurane|sevoflurane|mesh-list
153740313|NCT00515905|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153740314|NCT00515905|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153740315|NCT00515905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153740316|NCT00515905|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153740317|NCT00515905|Anesthetics, General|anesthetics, general|mesh-ancestor
153740318|NCT00515905|Anesthetics|anesthetics|mesh-ancestor
153740319|NCT00515905|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153740320|NCT00515905|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
153740321|NCT00515944|Botulinum Toxins|botulinum toxins|mesh-list
153740322|NCT00515944|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
153740323|NCT00515944|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
153740324|NCT00515944|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
153740325|NCT00515944|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153571406|NCT04264637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153740326|NCT00515944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153740327|NCT00515944|Cholinergic Agents|cholinergic agents|mesh-ancestor
153740328|NCT00515944|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153740329|NCT00515944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153740330|NCT00515944|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
153740349|NCT00151242|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153740350|NCT00151242|Keratolytic Agents|keratolytic agents|mesh-ancestor
153740351|NCT00151242|Dermatologic Agents|dermatologic agents|mesh-ancestor
153740353|NCT00516100|Bortezomib|bortezomib|mesh-list
153740354|NCT00516100|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153740355|NCT00516100|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153740356|NCT00516100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153740357|NCT00516100|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153740358|NCT00516100|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153740359|NCT00166413|Thalidomide|thalidomide|mesh-list
153740360|NCT00166413|Lenalidomide|lenalidomide|mesh-list
153740361|NCT00166413|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153740362|NCT00166413|Immunologic Factors|immunologic factors|mesh-ancestor
153740363|NCT00166413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153740364|NCT00166413|Leprostatic Agents|leprostatic agents|mesh-ancestor
153740365|NCT00166413|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153571407|NCT04264637|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
153571408|NCT04264637|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
153571409|NCT04264637|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
153571410|NCT04264637|Histamine Antagonists|histamine antagonists|mesh-ancestor
153571411|NCT04264637|Histamine Agents|histamine agents|mesh-ancestor
153571412|NCT04264637|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153571413|NCT04238091|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
153571414|NCT04238091|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153571416|NCT04169451|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153571417|NCT04169451|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
153571418|NCT04169451|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153571419|NCT04169451|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153571420|NCT04169451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153571421|NCT04169451|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
153571422|NCT04169451|Hormone Antagonists|hormone antagonists|mesh-ancestor
153571423|NCT04169451|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153571424|NCT04169451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153571425|NCT04169438|Petrolatum|petrolatum|mesh-list
153571426|NCT04169438|Emollients|emollients|mesh-ancestor
153571427|NCT04169438|Dermatologic Agents|dermatologic agents|mesh-ancestor
153571428|NCT04159818|Doxorubicin|doxorubicin|mesh-list
153571429|NCT04159818|Nivolumab|nivolumab|mesh-list
153571430|NCT04159818|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153571440|NCT04157881|Antithrombins|antithrombins|mesh-ancestor
153571441|NCT04157881|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
153571442|NCT04157881|Protease Inhibitors|protease inhibitors|mesh-ancestor
153571443|NCT04157881|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153571444|NCT04157881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153571445|NCT04157881|Anticoagulants|anticoagulants|mesh-ancestor
153571446|NCT04157881|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
153571447|NCT04157881|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153740366|NCT00166413|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153740367|NCT00166413|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153740368|NCT00166413|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153740369|NCT00166413|Growth Substances|growth substances|mesh-ancestor
153740370|NCT00166413|Growth Inhibitors|growth inhibitors|mesh-ancestor
153740371|NCT00166413|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153740374|NCT02950441|Nicotinic Acids|nicotinic acids|mesh-list
153740375|NCT02950441|Vitamin B Complex|vitamin b complex|mesh-ancestor
153740376|NCT02950441|Vitamins|vitamins|mesh-ancestor
153740377|NCT02950441|Micronutrients|micronutrients|mesh-ancestor
153740378|NCT02950441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153740379|NCT02950441|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153740380|NCT02950441|Antimetabolites|antimetabolites|mesh-ancestor
153740381|NCT02950441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153740382|NCT02950441|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153740383|NCT02950441|Vasodilator Agents|vasodilator agents|mesh-ancestor
153740384|NCT02950246|Chlorhexidine|chlorhexidine|mesh-list
153740385|NCT02950246|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
153571448|NCT04157881|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
153571449|NCT04136262|Methotrexate|methotrexate|mesh-list
153571450|NCT04136262|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
153571451|NCT04136262|Abortifacient Agents|abortifacient agents|mesh-ancestor
153571452|NCT04136262|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153571453|NCT04136262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153571502|NCT03990883|Anesthetics|anesthetics|mesh-ancestor
153571503|NCT03990883|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153571504|NCT03990883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153571505|NCT03990883|Sensory System Agents|sensory system agents|mesh-ancestor
153571506|NCT03990883|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153571507|NCT03990883|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153571508|NCT03990883|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
153571509|NCT03990883|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153571510|NCT03990883|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153571511|NCT03990883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153571513|NCT03984890|Cholecalciferol|cholecalciferol|mesh-list
153571514|NCT03984890|Vitamins|vitamins|mesh-ancestor
153571515|NCT03984890|Micronutrients|micronutrients|mesh-ancestor
153571516|NCT03984890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153571517|NCT03984890|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153571518|NCT03984890|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153571519|NCT03924427|Deucravacitinib|deucravacitinib|mesh-list
153571520|NCT03924427|Dermatologic Agents|dermatologic agents|mesh-ancestor
153571521|NCT03924427|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153571522|NCT03924427|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153571523|NCT03924427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153571524|NCT03922451|Cefazolin|cefazolin|mesh-list
153571525|NCT03922451|Tazobactam|tazobactam|mesh-list
153571526|NCT03922451|Piperacillin|piperacillin|mesh-list
153571527|NCT03922451|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
153571528|NCT03922451|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153571556|NCT05802290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153571557|NCT05802212|Metformin|metformin|mesh-list
153571558|NCT05802212|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153571559|NCT05802212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153740386|NCT02950246|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153740387|NCT02950246|Disinfectants|disinfectants|mesh-ancestor
153740388|NCT02950168|Edoxaban|edoxaban|mesh-list
153740389|NCT02950168|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
153476304|NCT00923910|Analgesics|analgesics|mesh-ancestor
153740426|NCT00516802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153740427|NCT00516802|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153476363|NCT00925938|Oxytocics|oxytocics|mesh-ancestor
153740440|NCT05861310|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153740441|NCT05861310|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153740442|NCT05861297|Dexamethasone|dexamethasone|mesh-list
153740443|NCT05861297|Prednisolone|prednisolone|mesh-list
153740445|NCT05861297|Azathioprine|azathioprine|mesh-list
153740446|NCT05861297|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153740447|NCT05861297|Antiemetics|antiemetics|mesh-ancestor
153740448|NCT05861297|Autonomic Agents|autonomic agents|mesh-ancestor
153740449|NCT05861297|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153740450|NCT05861297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153740451|NCT05861297|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153740452|NCT05861297|Glucocorticoids|glucocorticoids|mesh-ancestor
153740453|NCT05861297|Hormones|hormones|mesh-ancestor
153740454|NCT05861297|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153740455|NCT05861297|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153740456|NCT05861297|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153571560|NCT05802121|Acetic Acid|acetic acid|mesh-list
153571561|NCT05802121|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153571562|NCT05802121|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153571563|NCT05802108|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-list
153571564|NCT05802108|Evolocumab|evolocumab|mesh-list
153571565|NCT05802108|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153571566|NCT05802108|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153571567|NCT05802108|Antimetabolites|antimetabolites|mesh-ancestor
153571568|NCT05802108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153571569|NCT05802108|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153571570|NCT05802108|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153571571|NCT05802108|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
153571572|NCT05802108|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
153571573|NCT05802108|Protease Inhibitors|protease inhibitors|mesh-ancestor
153571574|NCT05802082|Anesthetics|anesthetics|mesh-list
153571575|NCT05802082|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153571576|NCT05802082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153571577|NCT05801900|Ibuprofen|ibuprofen|mesh-list
153571578|NCT05801900|Ketorolac|ketorolac|mesh-list
153571579|NCT05801900|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153571580|NCT05801900|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153816681|NCT00458991|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
153816682|NCT00458991|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
153816683|NCT00458991|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153816684|NCT00458991|Narcotics|narcotics|mesh-ancestor
153816685|NCT00458991|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153816686|NCT00458991|Analgesics|analgesics|mesh-ancestor
153571581|NCT05801900|Analgesics|analgesics|mesh-ancestor
153571582|NCT05801900|Sensory System Agents|sensory system agents|mesh-ancestor
153740457|NCT05861297|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153740459|NCT05861297|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153740460|NCT05861297|Antimetabolites|antimetabolites|mesh-ancestor
153740461|NCT05861297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153740462|NCT05861297|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153740463|NCT05861297|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153740464|NCT05861206|Listerine|listerine|mesh-list
153740465|NCT05861206|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
153740466|NCT05861206|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153740467|NCT05861154|Benzocaine|benzocaine|mesh-list
153740468|NCT05861154|Anesthetics, Local|anesthetics, local|mesh-ancestor
153740469|NCT05861154|Anesthetics|anesthetics|mesh-ancestor
153740470|NCT05861154|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153740471|NCT05861154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153740472|NCT05861154|Sensory System Agents|sensory system agents|mesh-ancestor
153740473|NCT05861154|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153740474|NCT05861063|Lidocaine|lidocaine|mesh-list
153740475|NCT05861063|Dezocine|dezocine|mesh-list
153740476|NCT05861063|Anesthetics, Local|anesthetics, local|mesh-ancestor
153740477|NCT05861063|Anesthetics|anesthetics|mesh-ancestor
153740478|NCT05861063|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153740479|NCT05861063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153740480|NCT05861063|Sensory System Agents|sensory system agents|mesh-ancestor
153730684|NCT00142038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153740481|NCT05861063|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153740482|NCT05861063|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153571583|NCT05801900|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153571586|NCT05801900|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153571587|NCT05801900|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153571588|NCT05801900|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153571589|NCT05801900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153571590|NCT05801523|Ethanol|ethanol|mesh-list
153571591|NCT05801523|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
153571592|NCT05801523|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153571593|NCT05801523|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153571594|NCT05801523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153571595|NCT05801484|Linezolid|linezolid|mesh-list
153571596|NCT05801484|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153571597|NCT05801484|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153571598|NCT05801484|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
153571599|NCT05801484|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153571600|NCT05801484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153571601|NCT05801380|Memantine|memantine|mesh-list
153571602|NCT05801380|Donepezil|donepezil|mesh-list
153571603|NCT05801380|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
153571604|NCT05801380|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153740483|NCT05861063|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
153740484|NCT05861063|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153740485|NCT05861063|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153740486|NCT05861063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153812482|NCT00433953|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153740487|NCT05861063|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153740488|NCT05861063|Narcotics|narcotics|mesh-ancestor
153740489|NCT05861063|Analgesics|analgesics|mesh-ancestor
153740490|NCT05860699|Ethanol|ethanol|mesh-list
153740491|NCT05860699|Cannabidiol|cannabidiol|mesh-list
153740519|NCT05860244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153740520|NCT05860153|Diazepam|diazepam|mesh-list
153740521|NCT05860153|Levetiracetam|levetiracetam|mesh-list
153740522|NCT05860153|Anticonvulsants|anticonvulsants|mesh-ancestor
153740523|NCT05860153|Nootropic Agents|nootropic agents|mesh-ancestor
153740524|NCT05860153|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153740525|NCT05860153|Antiemetics|antiemetics|mesh-ancestor
153740526|NCT05860153|Autonomic Agents|autonomic agents|mesh-ancestor
153740527|NCT05860153|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153740528|NCT05860153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153740529|NCT05860153|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153740530|NCT05860153|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153740531|NCT05860153|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153740532|NCT05860153|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
153740533|NCT05860153|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
153740534|NCT05860153|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153740535|NCT05860153|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153740536|NCT05860153|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153740537|NCT05860153|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153571605|NCT05801380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153571606|NCT05801380|Cholinergic Agents|cholinergic agents|mesh-ancestor
153571607|NCT05801380|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153571608|NCT05801380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153571609|NCT05801380|Nootropic Agents|nootropic agents|mesh-ancestor
153571610|NCT05801380|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
153571611|NCT05801380|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
153816687|NCT00458991|Sensory System Agents|sensory system agents|mesh-ancestor
153816688|NCT00458991|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153816689|NCT01059617|Vaccines|vaccines|mesh-list
153458029|NCT04196946|Alfentanil|alfentanil|mesh-list
153458030|NCT04196946|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153458031|NCT04196946|Narcotics|narcotics|mesh-ancestor
153458032|NCT04196946|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153458033|NCT04196946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153458034|NCT04196946|Analgesics|analgesics|mesh-ancestor
153458035|NCT04196946|Sensory System Agents|sensory system agents|mesh-ancestor
153458036|NCT04196946|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153458037|NCT04196946|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153571612|NCT05801380|Dopamine Agents|dopamine agents|mesh-ancestor
153740538|NCT05860153|Anesthetics, General|anesthetics, general|mesh-ancestor
153740539|NCT05860153|Anesthetics|anesthetics|mesh-ancestor
153740540|NCT05860153|GABA Modulators|gaba modulators|mesh-ancestor
153740541|NCT05860153|GABA Agents|gaba agents|mesh-ancestor
153740564|NCT05860010|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153740565|NCT05860010|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153740566|NCT05860010|Analgesics|analgesics|mesh-ancestor
153740567|NCT05860010|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
153740568|NCT05860010|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153740569|NCT05860010|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153740570|NCT05860010|Adrenergic Agents|adrenergic agents|mesh-ancestor
153740571|NCT05860010|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153740572|NCT05860010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153740573|NCT05860010|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
153740574|NCT05860010|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153740575|NCT05860010|Autonomic Agents|autonomic agents|mesh-ancestor
153740576|NCT05860010|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153740577|NCT05860010|Respiratory System Agents|respiratory system agents|mesh-ancestor
153740578|NCT05860010|Mydriatics|mydriatics|mesh-ancestor
153740579|NCT05860010|Sympathomimetics|sympathomimetics|mesh-ancestor
153740580|NCT05860010|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
153740581|NCT05859984|Interferons|interferons|mesh-list
153571613|NCT05801380|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
153571614|NCT05801380|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
153571615|NCT05801367|Allyl sulfide|allyl sulfide|mesh-list
153571616|NCT05801367|Antioxidants|antioxidants|mesh-ancestor
153571617|NCT05801367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153571618|NCT05801367|Protective Agents|protective agents|mesh-ancestor
153571619|NCT05801367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153571620|NCT05801367|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
153571621|NCT05801367|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153571622|NCT05801367|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153571623|NCT05801367|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153571624|NCT05801328|Salicylic Acid|salicylic acid|mesh-list
153571625|NCT05801328|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153571626|NCT05801328|Antifungal Agents|antifungal agents|mesh-ancestor
153571627|NCT05801328|Keratolytic Agents|keratolytic agents|mesh-ancestor
153571628|NCT05801328|Dermatologic Agents|dermatologic agents|mesh-ancestor
153571629|NCT05801289|Quetiapine Fumarate|quetiapine fumarate|mesh-list
153571630|NCT05801289|Antidepressive Agents|antidepressive agents|mesh-ancestor
153571631|NCT05801289|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153571632|NCT05801289|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153571633|NCT05801289|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153571634|NCT05801289|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153571635|NCT05801289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153571636|NCT05801068|Factor Xa Inhibitors|factor xa inhibitors|mesh-list
153571637|NCT05801068|Antithrombins|antithrombins|mesh-ancestor
153571638|NCT05801068|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
153571639|NCT05801068|Protease Inhibitors|protease inhibitors|mesh-ancestor
153571640|NCT05801068|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153571641|NCT05801068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153571642|NCT05801068|Anticoagulants|anticoagulants|mesh-ancestor
153458038|NCT04196946|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153458039|NCT04196946|Anesthetics, General|anesthetics, general|mesh-ancestor
153740582|NCT05859984|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153740583|NCT05859984|Antiviral Agents|antiviral agents|mesh-ancestor
153740584|NCT05859984|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153740585|NCT05859802|4-Aminopyridine|4-aminopyridine|mesh-list
153740586|NCT05859802|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
153740587|NCT05859802|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153740588|NCT05859802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153740590|NCT05859750|Gemcitabine|gemcitabine|mesh-list
153740591|NCT05859750|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153740592|NCT05859750|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153740593|NCT05859750|Tubulin Modulators|tubulin modulators|mesh-ancestor
153740604|NCT05858918|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
153740606|NCT05858918|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153740607|NCT05858918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153740608|NCT05858918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153740609|NCT05856877|Insulin|insulin|mesh-list
153740610|NCT05856877|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153740611|NCT05856877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153740612|NCT05856864|Ramucirumab|ramucirumab|mesh-list
153740613|NCT05856864|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153740614|NCT05856864|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153740615|NCT05856864|Growth Substances|growth substances|mesh-ancestor
153740616|NCT05856864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153740617|NCT05856864|Growth Inhibitors|growth inhibitors|mesh-ancestor
153740618|NCT05856864|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153740619|NCT05829187|Primaquine|primaquine|mesh-list
153740620|NCT05829187|Piperaquine|piperaquine|mesh-list
153740621|NCT05829187|Artenimol|artenimol|mesh-list
153740622|NCT05829187|Antimalarials|antimalarials|mesh-ancestor
153740623|NCT05829187|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153458046|NCT04196400|Betamethasone|betamethasone|mesh-list
153458047|NCT04196400|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153458048|NCT04196400|Glucocorticoids|glucocorticoids|mesh-ancestor
153458049|NCT04196400|Hormones|hormones|mesh-ancestor
153571644|NCT05800847|Analgesics|analgesics|mesh-ancestor
153571645|NCT05800847|Sensory System Agents|sensory system agents|mesh-ancestor
153571646|NCT05800847|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153571647|NCT05800847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153571648|NCT05800847|Anticonvulsants|anticonvulsants|mesh-ancestor
153571649|NCT05800847|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153571650|NCT05800847|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153571651|NCT05800847|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153571652|NCT05800847|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153571653|NCT05800847|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
153571654|NCT05800847|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
153571655|NCT05800847|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153740625|NCT05829187|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153740626|NCT05779644|Metformin|metformin|mesh-list
153740627|NCT05779644|Liraglutide|liraglutide|mesh-list
153740628|NCT05779644|Semaglutide|semaglutide|mesh-list
153740629|NCT05779644|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153740630|NCT05779644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153740631|NCT05779644|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
153740632|NCT05779644|Incretins|incretins|mesh-ancestor
153740633|NCT05779644|Hormones|hormones|mesh-ancestor
153740634|NCT05779644|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153740635|NCT05749211|Niraparib|niraparib|mesh-list
153740636|NCT05749211|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
153740637|NCT05749211|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153740638|NCT05749211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153740639|NCT05749211|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153571656|NCT05800847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153571657|NCT05800847|Antimanic Agents|antimanic agents|mesh-ancestor
153571658|NCT05800756|Trastuzumab|trastuzumab|mesh-list
153571659|NCT05800756|Letrozole|letrozole|mesh-list
153571660|NCT05800756|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153571661|NCT05800756|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153571662|NCT05800756|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
153571663|NCT05800756|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153571664|NCT05800756|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153571665|NCT05800756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153571666|NCT05800756|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
153571667|NCT05800756|Hormone Antagonists|hormone antagonists|mesh-ancestor
153571668|NCT05800756|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153458050|NCT04196400|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153458051|NCT04196400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153458052|NCT04196400|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153458053|NCT04196400|Respiratory System Agents|respiratory system agents|mesh-ancestor
153458055|NCT03023436|Fluorouracil|fluorouracil|mesh-list
153458056|NCT03023436|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153458057|NCT03023436|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153458058|NCT03023436|Antimetabolites|antimetabolites|mesh-ancestor
153458059|NCT03023436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153458060|NCT03023436|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153458061|NCT03023436|Immunologic Factors|immunologic factors|mesh-ancestor
153816690|NCT01059617|Immunologic Factors|immunologic factors|mesh-ancestor
153816691|NCT01059617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153816692|NCT04705337|Simendan|simendan|mesh-list
153816693|NCT04705337|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
153816694|NCT04705337|Vasodilator Agents|vasodilator agents|mesh-ancestor
153816695|NCT04705337|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
153816696|NCT04705337|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
153816697|NCT04705337|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153816698|NCT04705337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153571669|NCT05800756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153571670|NCT05800197|Tamoxifen|tamoxifen|mesh-list
153571671|NCT05800197|Letrozole|letrozole|mesh-list
153571672|NCT05800197|Anastrozole|anastrozole|mesh-list
153571673|NCT05800197|Goserelin|goserelin|mesh-list
153571674|NCT05800197|Triptorelin Pamoate|triptorelin pamoate|mesh-list
153571675|NCT05800197|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153571676|NCT05800197|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
153571677|NCT05800197|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153740640|NCT05748093|Cobicistat|cobicistat|mesh-list
153740641|NCT05748093|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153740642|NCT05748093|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153740643|NCT05748093|Antiviral Agents|antiviral agents|mesh-ancestor
153740644|NCT05748093|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153740645|NCT05748093|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
153740646|NCT05748093|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153740647|NCT05748093|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153740648|NCT05748093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153740649|NCT05731596|Ubiquinone|ubiquinone|mesh-list
153740650|NCT05731596|Coenzyme Q10|coenzyme q10|mesh-list
153740651|NCT05731596|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
153740652|NCT05731596|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153740653|NCT05731596|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153740654|NCT05731596|Antimetabolites|antimetabolites|mesh-ancestor
153740655|NCT05731596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153740656|NCT05731596|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153740657|NCT05731596|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
153740662|NCT05710328|Deoxyglucose|deoxyglucose|mesh-list
153740663|NCT05710328|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
153740664|NCT05710328|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
153740665|NCT05710328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153740666|NCT05710328|Antimetabolites|antimetabolites|mesh-ancestor
153740667|NCT05710328|Antiviral Agents|antiviral agents|mesh-ancestor
153740668|NCT05710328|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153740669|NCT05684744|Methotrexate|methotrexate|mesh-list
153740670|NCT05684744|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
153740671|NCT05684744|Abortifacient Agents|abortifacient agents|mesh-ancestor
153740672|NCT05684744|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153740673|NCT05684744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153740689|NCT05678114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153740690|NCT05675787|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
153740691|NCT05675787|Atorvastatin|atorvastatin|mesh-list
153740692|NCT05675787|Medroxyprogesterone|medroxyprogesterone|mesh-list
153740693|NCT05675787|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153740694|NCT05675787|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153740695|NCT05675787|Antimetabolites|antimetabolites|mesh-ancestor
153740696|NCT05675787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153740697|NCT05675787|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153740698|NCT05675787|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
153740699|NCT05675787|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153740700|NCT05675787|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
153740701|NCT05675787|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
153740702|NCT05675787|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
153740703|NCT05675787|Contraceptive Agents|contraceptive agents|mesh-ancestor
153740704|NCT05675787|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153740705|NCT05675787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153740706|NCT05675787|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
153740707|NCT05675787|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
153740708|NCT05675787|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
153740709|NCT05675787|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153740710|NCT05675787|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153740711|NCT05576792|Ranibizumab|ranibizumab|mesh-list
153740712|NCT05576792|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153740713|NCT05576792|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153740714|NCT05576792|Growth Substances|growth substances|mesh-ancestor
153740715|NCT05576792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153740716|NCT05576792|Growth Inhibitors|growth inhibitors|mesh-ancestor
153740717|NCT05576792|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153740718|NCT05491278|Remifentanil|remifentanil|mesh-list
153740719|NCT05491278|Propofol|propofol|mesh-list
153571678|NCT05800197|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153571679|NCT05800197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153571680|NCT05800197|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
153571681|NCT05800197|Hormone Antagonists|hormone antagonists|mesh-ancestor
153571683|NCT05800197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153571684|NCT05800197|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153571685|NCT05800197|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
153571686|NCT05800197|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
153571687|NCT05800197|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153571688|NCT05800197|Luteolytic Agents|luteolytic agents|mesh-ancestor
153571689|NCT05800197|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
153740720|NCT05491278|Fospropofol|fospropofol|mesh-list
153740721|NCT05491278|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153740722|NCT05491278|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153740723|NCT05491278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153740724|NCT05491278|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153740725|NCT05491278|Anesthetics, General|anesthetics, general|mesh-ancestor
153740726|NCT05491278|Anesthetics|anesthetics|mesh-ancestor
153740727|NCT05491278|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153740728|NCT05491278|Narcotics|narcotics|mesh-ancestor
153740729|NCT05491278|Analgesics|analgesics|mesh-ancestor
153740740|NCT05457582|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
153740741|NCT05457582|Protease Inhibitors|protease inhibitors|mesh-ancestor
153740742|NCT05375916|Hydromorphone|hydromorphone|mesh-list
153740743|NCT05375916|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153740744|NCT05375916|Narcotics|narcotics|mesh-ancestor
153740745|NCT05375916|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153740746|NCT05375916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153740747|NCT05375916|Analgesics|analgesics|mesh-ancestor
153740748|NCT05375916|Sensory System Agents|sensory system agents|mesh-ancestor
153740749|NCT05375916|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153740750|NCT05359354|Vaccines|vaccines|mesh-list
153740751|NCT05359354|Immunologic Factors|immunologic factors|mesh-ancestor
153740752|NCT05359354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153740753|NCT05346562|Cannabidiol|cannabidiol|mesh-list
153740754|NCT05346562|Anticonvulsants|anticonvulsants|mesh-ancestor
153740755|NCT05287633|Esomeprazole|esomeprazole|mesh-list
153740756|NCT05287633|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
153740757|NCT05287633|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153740758|NCT05287633|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
153740759|NCT05287633|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153740760|NCT05287633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153740761|NCT05285449|Cannabidiol|cannabidiol|mesh-list
153740762|NCT05285449|Anticonvulsants|anticonvulsants|mesh-ancestor
153740763|NCT05238597|Ophthalmic Solutions|ophthalmic solutions|mesh-list
153740764|NCT05238597|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
153571690|NCT05800197|Contraceptive Agents|contraceptive agents|mesh-ancestor
153571691|NCT05800197|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153571692|NCT05800197|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
153571717|NCT05792293|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153571718|NCT05792293|Antimetabolites|antimetabolites|mesh-ancestor
153571719|NCT05792293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153571720|NCT05792293|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153740765|NCT05188118|Nivolumab|nivolumab|mesh-list
153740766|NCT05188118|Ipilimumab|ipilimumab|mesh-list
153740767|NCT05188118|Everolimus|everolimus|mesh-list
153740768|NCT05188118|Lenvatinib|lenvatinib|mesh-list
153740769|NCT05188118|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153740770|NCT05188118|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153740771|NCT05188118|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153740772|NCT05188118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153740773|NCT05188118|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
153740774|NCT05188118|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153740775|NCT05188118|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153740776|NCT05188118|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153740777|NCT05188118|Immunologic Factors|immunologic factors|mesh-ancestor
153740778|NCT05188118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153740779|NCT05172908|Dexamethasone|dexamethasone|mesh-list
153740780|NCT05172908|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153740781|NCT05172908|Antiemetics|antiemetics|mesh-ancestor
153730685|NCT00142038|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153740782|NCT05172908|Autonomic Agents|autonomic agents|mesh-ancestor
153740783|NCT05172908|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153740784|NCT05172908|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153740785|NCT05172908|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153740786|NCT05172908|Glucocorticoids|glucocorticoids|mesh-ancestor
153740787|NCT05172908|Hormones|hormones|mesh-ancestor
153740788|NCT05172908|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153571721|NCT05792293|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
153571722|NCT05792293|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153571723|NCT05785689|Dexmedetomidine|dexmedetomidine|mesh-list
153571724|NCT05785689|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153571725|NCT05785689|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153571726|NCT05785689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153571727|NCT05785689|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153571728|NCT05785689|Analgesics|analgesics|mesh-ancestor
153571729|NCT05785689|Sensory System Agents|sensory system agents|mesh-ancestor
153571730|NCT05785689|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153571731|NCT05785689|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
153571732|NCT05785689|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153571733|NCT05785689|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153571734|NCT05785689|Adrenergic Agents|adrenergic agents|mesh-ancestor
153571735|NCT05785689|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153571736|NCT05785689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153571737|NCT05753644|Ropivacaine|ropivacaine|mesh-list
153571738|NCT05753644|Anesthetics, Local|anesthetics, local|mesh-ancestor
153571739|NCT05753644|Anesthetics|anesthetics|mesh-ancestor
153571740|NCT05753644|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153571741|NCT05753644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153571742|NCT05753644|Sensory System Agents|sensory system agents|mesh-ancestor
153571743|NCT05753644|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153571745|NCT05756504|Tramadol|tramadol|mesh-list
153571746|NCT05756504|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153740790|NCT05172908|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153740791|NCT05140512|Goserelin|goserelin|mesh-list
153740792|NCT05140512|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153740793|NCT05140512|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153740794|NCT05110170|Goserelin|goserelin|mesh-list
153740795|NCT05110170|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153740812|NCT04898231|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
153740813|NCT04898231|Prednisolone|prednisolone|mesh-list
153740814|NCT04898231|Prednisolone acetate|prednisolone acetate|mesh-list
153740815|NCT04898231|Infliximab|infliximab|mesh-list
153740816|NCT04898231|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
153740817|NCT04898231|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
153740818|NCT04898231|Prednisolone phosphate|prednisolone phosphate|mesh-list
153740819|NCT04898231|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153740820|NCT04898231|Antiemetics|antiemetics|mesh-ancestor
153740821|NCT04898231|Autonomic Agents|autonomic agents|mesh-ancestor
153740822|NCT04898231|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153740823|NCT04898231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153740824|NCT04898231|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153571747|NCT05756504|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153571748|NCT05756504|Analgesics|analgesics|mesh-ancestor
153571749|NCT05756504|Sensory System Agents|sensory system agents|mesh-ancestor
153571750|NCT05756504|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153816699|NCT04705337|Protective Agents|protective agents|mesh-ancestor
153816700|NCT04705337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153571751|NCT05756504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153571752|NCT05756504|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153571753|NCT05756504|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153571754|NCT05756504|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153571755|NCT05756504|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153571756|NCT05756504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153571757|NCT05756504|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153571758|NCT05756504|Narcotics|narcotics|mesh-ancestor
153571759|NCT05756504|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153571760|NCT05697510|Siltuximab|siltuximab|mesh-list
153571761|NCT05697510|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153571762|NCT05657925|Ondansetron|ondansetron|mesh-list
153571763|NCT05657925|Antiemetics|antiemetics|mesh-ancestor
153571764|NCT05657925|Autonomic Agents|autonomic agents|mesh-ancestor
153571765|NCT05657925|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153571766|NCT05657925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153571767|NCT05657925|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153571768|NCT05657925|Antipruritics|antipruritics|mesh-ancestor
153571769|NCT05657925|Dermatologic Agents|dermatologic agents|mesh-ancestor
153571770|NCT05657925|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
153571771|NCT05657925|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153571772|NCT05657925|Serotonin Agents|serotonin agents|mesh-ancestor
153571773|NCT05657925|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153819173|NCT03011567|Sensory System Agents|sensory system agents|mesh-ancestor
153571774|NCT05657925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153571776|NCT05611229|Nivolumab|nivolumab|mesh-list
153571777|NCT05611229|Ipilimumab|ipilimumab|mesh-list
153571778|NCT05611229|Trametinib|trametinib|mesh-list
153740825|NCT04898231|Glucocorticoids|glucocorticoids|mesh-ancestor
153740826|NCT04898231|Hormones|hormones|mesh-ancestor
153740827|NCT04898231|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153740828|NCT04898231|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
153740829|NCT04898231|Protective Agents|protective agents|mesh-ancestor
153740830|NCT04898231|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153740831|NCT04898231|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153740832|NCT04898231|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
153740833|NCT04898231|Dermatologic Agents|dermatologic agents|mesh-ancestor
153740834|NCT04898231|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153740835|NCT04849026|Clozapine|clozapine|mesh-list
153740836|NCT04849026|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153740837|NCT04849026|Serotonin Agents|serotonin agents|mesh-ancestor
153740838|NCT04849026|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153740839|NCT04849026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153740840|NCT04849026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153740841|NCT04849026|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153740842|NCT04849026|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153740843|NCT04849026|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153740844|NCT04849026|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153740845|NCT04849026|GABA Antagonists|gaba antagonists|mesh-ancestor
153740846|NCT04849026|GABA Agents|gaba agents|mesh-ancestor
153740847|NCT04841980|Rifaximin|rifaximin|mesh-list
153571779|NCT05611229|Dabrafenib|dabrafenib|mesh-list
153571780|NCT05611229|Vemurafenib|vemurafenib|mesh-list
153816701|NCT00467571|Amoxicillin|amoxicillin|mesh-list
153816702|NCT00467571|Clarithromycin|clarithromycin|mesh-list
153816703|NCT00467571|Lansoprazole|lansoprazole|mesh-list
153816704|NCT00467571|Dexlansoprazole|dexlansoprazole|mesh-list
153816705|NCT00467571|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153816706|NCT00467571|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153816707|NCT00467571|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
153816708|NCT00467571|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153816709|NCT00467571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153816710|NCT00467571|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
153816711|NCT00467571|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153816712|NCT00467571|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
153816713|NCT00467571|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153816714|NCT00467571|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
153816715|NCT00426296|Ritonavir|ritonavir|mesh-list
153816716|NCT00426296|Atazanavir Sulfate|atazanavir sulfate|mesh-list
153816717|NCT00426296|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
153571781|NCT05611229|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153571782|NCT05611229|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153571783|NCT05611229|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153571784|NCT05611229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153571785|NCT05611229|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153571787|NCT05566665|Meropenem|meropenem|mesh-list
153571788|NCT05566665|Tazobactam|tazobactam|mesh-list
153571789|NCT05566665|Ceftazidime|ceftazidime|mesh-list
153571790|NCT05566665|Avibactam|avibactam|mesh-list
153571791|NCT05566665|Ceftolozane|ceftolozane|mesh-list
153740848|NCT04841980|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153740849|NCT04841980|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153740850|NCT04841980|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153740851|NCT04831736|Ketamine|ketamine|mesh-list
153740852|NCT04831736|Analgesics|analgesics|mesh-ancestor
153740853|NCT04831736|Sensory System Agents|sensory system agents|mesh-ancestor
153740866|NCT04830462|Isoniazid|isoniazid|mesh-list
153740867|NCT04830462|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
153740868|NCT04830462|Antitubercular Agents|antitubercular agents|mesh-ancestor
153740869|NCT04830462|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153740870|NCT04830462|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153740871|NCT04830462|Leprostatic Agents|leprostatic agents|mesh-ancestor
153740872|NCT04830462|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153740873|NCT04830462|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153740874|NCT04830462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153740875|NCT04830462|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
153740876|NCT04830462|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
153740877|NCT04830462|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
153740878|NCT04830462|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
153740879|NCT04830462|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
153740880|NCT04830462|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
153730686|NCT00142038|Antimetabolites|antimetabolites|mesh-ancestor
153730687|NCT00134810|Botulinum Toxins|botulinum toxins|mesh-list
153740881|NCT04830462|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
153571792|NCT05566665|Ceftolozane, tazobactam drug combination|ceftolozane, tazobactam drug combination|mesh-list
153571793|NCT05566665|Cefiderocol|cefiderocol|mesh-list
153571794|NCT05566665|Avibactam, ceftazidime drug combination|avibactam, ceftazidime drug combination|mesh-list
153571795|NCT05566665|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153571796|NCT05566665|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153571797|NCT05566665|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
153571798|NCT05566665|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153571799|NCT05566665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153571800|NCT05566665|Third Generation Cephalosporins|third generation cephalosporins|mesh-ancestor
153571801|NCT05566665|Beta Lactam Antibiotics|beta lactam antibiotics|mesh-ancestor
153571802|NCT05566665|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
153571803|NCT05566665|Siderophores|siderophores|mesh-ancestor
153571804|NCT05566665|Iron Chelating Agents|iron chelating agents|mesh-ancestor
153816718|NCT00426296|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
153816719|NCT00426296|Protease Inhibitors|protease inhibitors|mesh-ancestor
153816720|NCT00426296|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153816721|NCT00426296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153816722|NCT00426296|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153816723|NCT00426296|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153816724|NCT00426296|Antiviral Agents|antiviral agents|mesh-ancestor
153816725|NCT00426296|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153816726|NCT00426296|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
153816727|NCT00426296|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153740882|NCT04830462|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153740883|NCT04830462|Antimetabolites|antimetabolites|mesh-ancestor
153740884|NCT04830462|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153740885|NCT04775381|Vitamin D|vitamin d|mesh-list
153740886|NCT04775381|Vitamins|vitamins|mesh-ancestor
153740887|NCT04775381|Micronutrients|micronutrients|mesh-ancestor
153740888|NCT04775381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153740889|NCT04775381|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153740890|NCT04721873|Topiramate|topiramate|mesh-list
153740891|NCT04721873|Phentermine|phentermine|mesh-list
153740892|NCT04721873|Anticonvulsants|anticonvulsants|mesh-ancestor
153740893|NCT04721873|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153740894|NCT04721873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153740895|NCT04721873|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
153740896|NCT04721873|Appetite Depressants|appetite depressants|mesh-ancestor
153740897|NCT04721873|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
153740898|NCT04721873|Sympathomimetics|sympathomimetics|mesh-ancestor
153740899|NCT04721873|Autonomic Agents|autonomic agents|mesh-ancestor
153740900|NCT04721873|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153740901|NCT04721873|Adrenergic Agents|adrenergic agents|mesh-ancestor
153740902|NCT04721873|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153740903|NCT04721873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153740904|NCT04721015|Docetaxel|docetaxel|mesh-list
153740905|NCT04721015|Osimertinib|osimertinib|mesh-list
153740906|NCT04721015|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153740907|NCT04721015|Tubulin Modulators|tubulin modulators|mesh-ancestor
153740908|NCT04721015|Antimitotic Agents|antimitotic agents|mesh-ancestor
153740909|NCT04721015|Mitosis Modulators|mitosis modulators|mesh-ancestor
153740910|NCT04721015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153740911|NCT04721015|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153740912|NCT04721015|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153816728|NCT03271905|Bromides|bromides|mesh-list
153816729|NCT03271905|Albuterol|albuterol|mesh-list
153816730|NCT03271905|Ipratropium|ipratropium|mesh-list
153816731|NCT03271905|Anticonvulsants|anticonvulsants|mesh-ancestor
153458071|NCT04195074|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153458072|NCT04195074|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153458074|NCT03590262|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153458075|NCT03590262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153458076|NCT04029636|Xenon|xenon|mesh-list
153458077|NCT04029636|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
153458078|NCT04029636|Anesthetics, General|anesthetics, general|mesh-ancestor
153458079|NCT04029636|Anesthetics|anesthetics|mesh-ancestor
153458080|NCT04029636|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153458081|NCT04029636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153458082|NCT04194684|Paclitaxel|paclitaxel|mesh-list
153458083|NCT04194684|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153458084|NCT04194684|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153740913|NCT04721015|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153740914|NCT04634162|Cangrelor|cangrelor|mesh-list
153740941|NCT04552795|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153740942|NCT04552795|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153740943|NCT04552795|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153740944|NCT04552795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153740945|NCT04552795|Antiviral Agents|antiviral agents|mesh-ancestor
153740946|NCT04552795|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153577954|NCT01724892|Dexamethasone|dexamethasone|mesh-list
153740948|NCT04552795|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153740949|NCT04463680|Rifampin|rifampin|mesh-list
153740950|NCT04463680|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
153740951|NCT04463680|Antitubercular Agents|antitubercular agents|mesh-ancestor
153740952|NCT04463680|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153740953|NCT04463680|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153740954|NCT04463680|Leprostatic Agents|leprostatic agents|mesh-ancestor
153740955|NCT04463680|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153740956|NCT04463680|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153740957|NCT04463680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153740958|NCT04463680|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
153740959|NCT04463680|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
153476893|NCT01005810|Antidotes|antidotes|mesh-ancestor
153740977|NCT04300231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153740978|NCT04300231|Sensory System Agents|sensory system agents|mesh-ancestor
153458085|NCT04194684|Tubulin Modulators|tubulin modulators|mesh-ancestor
153458086|NCT04194684|Antimitotic Agents|antimitotic agents|mesh-ancestor
153571805|NCT05566665|Chelating Agents|chelating agents|mesh-ancestor
153571811|NCT05521984|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153571812|NCT05521984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153571813|NCT05521984|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153460653|NCT00634634|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153571814|NCT05521984|Alkylating Agents|alkylating agents|mesh-ancestor
153812487|NCT02957643|Micronutrients|micronutrients|mesh-ancestor
153571815|NCT05521984|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153571816|NCT05497323|Adapalene|adapalene|mesh-list
153571817|NCT05497323|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153571818|NCT05497323|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153571819|NCT05497323|Analgesics|analgesics|mesh-ancestor
153571820|NCT05497323|Sensory System Agents|sensory system agents|mesh-ancestor
153571821|NCT05497323|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153571822|NCT05497323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153571823|NCT05497323|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153571824|NCT05497323|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153571825|NCT05497323|Dermatologic Agents|dermatologic agents|mesh-ancestor
153571826|NCT05345782|Bupivacaine|bupivacaine|mesh-list
153571827|NCT05345782|Anesthetics, Local|anesthetics, local|mesh-ancestor
153571828|NCT05345782|Anesthetics|anesthetics|mesh-ancestor
153571829|NCT05345782|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153571830|NCT05345782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153571831|NCT05345782|Sensory System Agents|sensory system agents|mesh-ancestor
153740979|NCT04300231|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153740980|NCT04300231|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153740981|NCT04300231|Narcotics|narcotics|mesh-ancestor
153740982|NCT04300231|Analgesics|analgesics|mesh-ancestor
153740983|NCT04171050|Anesthetics|anesthetics|mesh-list
153740984|NCT04171050|Anesthetics, Local|anesthetics, local|mesh-list
153740985|NCT04171050|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153740986|NCT04171050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153740987|NCT04171050|Sensory System Agents|sensory system agents|mesh-ancestor
153740988|NCT04171050|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153740989|NCT04098081|Gemcitabine|gemcitabine|mesh-list
153740990|NCT04098081|3-hydroxy-17-(1H-benzimidazole-1-yl)androsta-5,16-diene|3-hydroxy-17-(1h-benzimidazole-1-yl)androsta-5,16-diene|mesh-list
153740991|NCT04098081|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153740992|NCT04098081|Antimetabolites|antimetabolites|mesh-ancestor
153740993|NCT04098081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153740994|NCT04098081|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153740995|NCT04098081|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153740996|NCT04028986|Ulipristal acetate|ulipristal acetate|mesh-list
153740997|NCT04028986|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
153740998|NCT04028986|Contraceptive Agents|contraceptive agents|mesh-ancestor
153740999|NCT04028986|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153741000|NCT04028986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153741001|NCT04028986|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
153571832|NCT05345782|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153571833|NCT05265767|Factor VIII|factor viii|mesh-list
153571834|NCT05265767|Coagulants|coagulants|mesh-ancestor
153571835|NCT05215951|Osimertinib|osimertinib|mesh-list
153571836|NCT05215951|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153571837|NCT05215951|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153571838|NCT05215951|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153571846|NCT05161468|Glucocorticoids|glucocorticoids|mesh-list
153571847|NCT05161468|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
153571848|NCT05161468|Anesthetics, Local|anesthetics, local|mesh-ancestor
153571849|NCT05161468|Anesthetics|anesthetics|mesh-ancestor
153571850|NCT05161468|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153571851|NCT05161468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153571852|NCT05161468|Sensory System Agents|sensory system agents|mesh-ancestor
153571853|NCT05161468|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153571854|NCT05161468|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153571855|NCT05161468|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
153571856|NCT05161468|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153571857|NCT05161468|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153571858|NCT05161468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153571859|NCT05161468|Anticoagulants|anticoagulants|mesh-ancestor
153571860|NCT05161468|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153571862|NCT05161468|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153571863|NCT05161468|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153571864|NCT05161468|Immunologic Factors|immunologic factors|mesh-ancestor
153571865|NCT05161468|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153741003|NCT03914612|Carboplatin|carboplatin|mesh-list
153741004|NCT03914612|Pembrolizumab|pembrolizumab|mesh-list
153741005|NCT03914612|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
153741006|NCT03914612|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153741007|NCT03914612|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153741008|NCT03914612|Tubulin Modulators|tubulin modulators|mesh-ancestor
153741009|NCT03914612|Antimitotic Agents|antimitotic agents|mesh-ancestor
153741010|NCT03914612|Mitosis Modulators|mitosis modulators|mesh-ancestor
153741011|NCT03914612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153741012|NCT03914612|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153741013|NCT03914612|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153741014|NCT03896880|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
153741015|NCT03896880|Clotrimazole|clotrimazole|mesh-list
153741016|NCT03896880|Miconazole|miconazole|mesh-list
153741017|NCT03896880|Antifungal Agents|antifungal agents|mesh-list
153741029|NCT03896880|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
153741030|NCT03815019|Megestrol|megestrol|mesh-list
153741031|NCT03815019|Megestrol Acetate|megestrol acetate|mesh-list
153741032|NCT03815019|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
153741033|NCT03815019|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
153741034|NCT03815019|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
153741035|NCT03815019|Contraceptive Agents|contraceptive agents|mesh-ancestor
153571866|NCT05108389|Hemostatics|hemostatics|mesh-list
153571867|NCT05108389|Coagulants|coagulants|mesh-ancestor
153571868|NCT05104762|Immunoglobulins|immunoglobulins|mesh-list
153571869|NCT05104762|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
153571870|NCT05104762|Antibodies|antibodies|mesh-list
153571871|NCT05104762|gamma-Globulins|gamma-globulins|mesh-list
153571872|NCT05104762|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
153571873|NCT05104762|Immunologic Factors|immunologic factors|mesh-ancestor
153571874|NCT05104762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153571875|NCT05027425|Durvalumab|durvalumab|mesh-list
153571876|NCT05027425|Tremelimumab|tremelimumab|mesh-list
153571877|NCT05027425|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153571878|NCT05027425|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153571879|NCT05003648|Pramipexole|pramipexole|mesh-list
153571880|NCT05003648|Dexpramipexole|dexpramipexole|mesh-list
153571881|NCT05003648|Antioxidants|antioxidants|mesh-ancestor
153458087|NCT04194684|Mitosis Modulators|mitosis modulators|mesh-ancestor
153460654|NCT00634634|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
153571887|NCT05003648|Dopamine Agonists|dopamine agonists|mesh-ancestor
153571888|NCT05003648|Dopamine Agents|dopamine agents|mesh-ancestor
153571889|NCT05003648|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153571890|NCT04880278|Nabilone|nabilone|mesh-list
153571891|NCT04880278|Antiemetics|antiemetics|mesh-ancestor
153571892|NCT04880278|Autonomic Agents|autonomic agents|mesh-ancestor
153571893|NCT04880278|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153571894|NCT04880278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153571895|NCT04880278|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153571896|NCT04880278|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153571897|NCT04880278|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153571898|NCT04880278|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153571899|NCT04880278|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153571900|NCT04858425|Niclosamide|niclosamide|mesh-list
153741036|NCT03815019|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153741037|NCT03815019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153741038|NCT03815019|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
153741039|NCT03815019|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
153741040|NCT03815019|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153741041|NCT03815019|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153741042|NCT03815019|Appetite Stimulants|appetite stimulants|mesh-ancestor
153741043|NCT03815019|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
153741044|NCT03767218|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
153741045|NCT03767218|Hormones|hormones|mesh-ancestor
153741046|NCT03767218|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153741047|NCT03767218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153741048|NCT03739645|Metronidazole|metronidazole|mesh-list
153741049|NCT03739645|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153741050|NCT03739645|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153741051|NCT03739645|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153741052|NCT03739645|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153741053|NCT03603509|Vaccines|vaccines|mesh-list
153741054|NCT03603509|Immunologic Factors|immunologic factors|mesh-ancestor
153741055|NCT03603509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153741056|NCT03361345|Tranexamic Acid|tranexamic acid|mesh-list
153741057|NCT03361345|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
153741058|NCT03361345|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153741059|NCT03361345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153741060|NCT03361345|Hemostatics|hemostatics|mesh-ancestor
153741061|NCT03361345|Coagulants|coagulants|mesh-ancestor
153741062|NCT03216187|Pregabalin|pregabalin|mesh-list
153741063|NCT03216187|Analgesics|analgesics|mesh-ancestor
153741064|NCT03216187|Sensory System Agents|sensory system agents|mesh-ancestor
153741065|NCT03216187|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153741066|NCT03216187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153741067|NCT03216187|Anticonvulsants|anticonvulsants|mesh-ancestor
153571901|NCT04858425|Anticestodal Agents|anticestodal agents|mesh-ancestor
153571902|NCT04858425|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
153571903|NCT04858425|Anthelmintics|anthelmintics|mesh-ancestor
153571904|NCT04858425|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153571905|NCT04858425|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153571906|NCT04858425|Antinematodal Agents|antinematodal agents|mesh-ancestor
153571907|NCT04762758|Naltrexone|naltrexone|mesh-list
153571908|NCT04762758|Baclofen|baclofen|mesh-list
153571909|NCT04762758|Sorbitol|sorbitol|mesh-list
153571910|NCT04762758|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
153741068|NCT03216187|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153741069|NCT03216187|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153741070|NCT03216187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153741071|NCT03216187|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153741072|NCT03216187|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153741073|NCT03216187|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153741074|NCT03216187|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153741075|NCT03216187|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153741076|NCT03195270|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
153741110|NCT03007238|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153741111|NCT03007238|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153741112|NCT03007238|Analgesics|analgesics|mesh-ancestor
153730688|NCT00134810|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
153741113|NCT03007238|Sensory System Agents|sensory system agents|mesh-ancestor
153741114|NCT03007238|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153741115|NCT03007238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153741116|NCT03007238|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153741117|NCT03007238|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153741118|NCT03007238|Antiviral Agents|antiviral agents|mesh-ancestor
153477062|NCT02406222|Glucocorticoids|glucocorticoids|mesh-ancestor
153741131|NCT02902198|Sensory System Agents|sensory system agents|mesh-ancestor
153741132|NCT02858869|Pembrolizumab|pembrolizumab|mesh-list
153741133|NCT02858869|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153741134|NCT02858869|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153741135|NCT02858869|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153741136|NCT02858869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153741137|NCT02811523|Doxorubicin|doxorubicin|mesh-list
153741138|NCT02811523|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153741139|NCT02811523|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153741140|NCT02811523|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153741141|NCT02811523|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153571911|NCT04762758|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
153571912|NCT04762758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153458092|NCT04194294|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153458093|NCT04194294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153458094|NCT04194294|Sensory System Agents|sensory system agents|mesh-ancestor
153458096|NCT04194294|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153458097|NCT04194294|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
153458098|NCT04194294|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153458099|NCT04194294|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153458100|NCT04194294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153741142|NCT02811523|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153741143|NCT02811523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153741144|NCT02750319|Acetylcysteine|acetylcysteine|mesh-list
153741145|NCT02750319|Amiodarone|amiodarone|mesh-list
153741146|NCT02750319|N-monoacetylcystine|n-monoacetylcystine|mesh-list
153741147|NCT02750319|Antiviral Agents|antiviral agents|mesh-ancestor
153741148|NCT02750319|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153741149|NCT02750319|Expectorants|expectorants|mesh-ancestor
153741150|NCT02750319|Respiratory System Agents|respiratory system agents|mesh-ancestor
153741151|NCT02750319|Free Radical Scavengers|free radical scavengers|mesh-ancestor
153741152|NCT02750319|Antioxidants|antioxidants|mesh-ancestor
153741153|NCT02750319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153741154|NCT02750319|Protective Agents|protective agents|mesh-ancestor
153741155|NCT02750319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153741156|NCT02750319|Antidotes|antidotes|mesh-ancestor
153741157|NCT02750319|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153741158|NCT02750319|Vasodilator Agents|vasodilator agents|mesh-ancestor
153741159|NCT02750319|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
153741160|NCT02750319|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153741161|NCT02750319|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153741162|NCT02750319|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
153741163|NCT02750319|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153741164|NCT02750319|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153741165|NCT02750319|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
153741166|NCT02750319|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
153578192|NCT01731132|Copper|copper|mesh-list
153741167|NCT02750319|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
153741168|NCT02611258|Tadalafil|tadalafil|mesh-list
153741169|NCT02611258|Vasodilator Agents|vasodilator agents|mesh-ancestor
153571913|NCT04762758|Sensory System Agents|sensory system agents|mesh-ancestor
153571914|NCT04762758|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153571915|NCT04762758|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
153571917|NCT04762758|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
153571918|NCT04762758|GABA Agonists|gaba agonists|mesh-ancestor
153571919|NCT04762758|GABA Agents|gaba agents|mesh-ancestor
153571920|NCT04762758|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153571921|NCT04762758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153571922|NCT04762758|Cathartics|cathartics|mesh-ancestor
153571923|NCT04762758|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153571924|NCT04717908|Linezolid|linezolid|mesh-list
153571925|NCT04717908|Cycloserine|cycloserine|mesh-list
153571926|NCT04717908|Pyrazinamide|pyrazinamide|mesh-list
153571927|NCT04717908|Bedaquiline|bedaquiline|mesh-list
153571928|NCT04717908|Clofazimine|clofazimine|mesh-list
153571929|NCT04717908|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153571930|NCT04717908|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153460680|NCT00049595|Procarbazine|procarbazine|mesh-list
153741170|NCT02611258|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
153741171|NCT02611258|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
153741172|NCT02611258|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153741173|NCT02611258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153741174|NCT02611258|Urological Agents|urological agents|mesh-ancestor
153741175|NCT02172651|Vitamin D|vitamin d|mesh-list
153741176|NCT02172651|Ergocalciferols|ergocalciferols|mesh-list
153741177|NCT02172651|Cholecalciferol|cholecalciferol|mesh-list
153741178|NCT02172651|Vitamins|vitamins|mesh-list
153741179|NCT02172651|Micronutrients|micronutrients|mesh-ancestor
153741180|NCT02172651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153741181|NCT02172651|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153741189|NCT02144857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153741190|NCT02144857|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153741191|NCT02144857|Immunologic Factors|immunologic factors|mesh-ancestor
153741192|NCT02144857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153741193|NCT02144857|Antifungal Agents|antifungal agents|mesh-ancestor
153741194|NCT02144857|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153741195|NCT02144857|Dermatologic Agents|dermatologic agents|mesh-ancestor
153741196|NCT02144857|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153741197|NCT02144857|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
153741198|NCT02144857|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153741199|NCT02144857|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153741200|NCT02144857|Analgesics|analgesics|mesh-ancestor
153741201|NCT02144857|Sensory System Agents|sensory system agents|mesh-ancestor
153741202|NCT02144857|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153730689|NCT00134810|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
153741203|NCT02144857|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153741204|NCT02144857|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153571932|NCT04717908|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153571933|NCT04717908|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153571934|NCT04717908|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
153571935|NCT04717908|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
153571936|NCT04717908|Antitubercular Agents|antitubercular agents|mesh-ancestor
153571937|NCT04717908|Antimetabolites|antimetabolites|mesh-ancestor
153571938|NCT04717908|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153571939|NCT04717908|Leprostatic Agents|leprostatic agents|mesh-ancestor
153571940|NCT04665895|Fluticasone|fluticasone|mesh-list
153571941|NCT04665895|Xhance|xhance|mesh-list
153571942|NCT04665895|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153741206|NCT02144857|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
153741207|NCT02095184|Letrozole|letrozole|mesh-list
153741208|NCT02095184|Anastrozole|anastrozole|mesh-list
153741209|NCT02095184|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153741210|NCT02095184|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
153741211|NCT02095184|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153741212|NCT02095184|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153741213|NCT02095184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153741214|NCT02095184|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
153741215|NCT02095184|Hormone Antagonists|hormone antagonists|mesh-ancestor
153741216|NCT02095184|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153741217|NCT02095184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153741218|NCT02095184|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153741219|NCT01252953|Oxazolidinones|oxazolidinones|mesh-list
153741220|NCT01252953|Anacetrapib|anacetrapib|mesh-list
153741221|NCT01252953|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153741222|NCT01252953|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153741223|NCT01252953|Antimetabolites|antimetabolites|mesh-ancestor
153741224|NCT01252953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153741225|NCT01252953|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153741226|NCT01252953|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153741227|NCT01252953|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
153741228|NCT01252953|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153741229|NCT00937131|Rituximab|rituximab|mesh-list
153741230|NCT00937131|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153741231|NCT00937131|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153741232|NCT00937131|Immunologic Factors|immunologic factors|mesh-ancestor
153741233|NCT00937131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153741234|NCT00937131|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153814641|NCT00452907|Antimalarials|antimalarials|mesh-ancestor
153741235|NCT00837616|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
153741236|NCT00837616|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
153741237|NCT00837616|Estradiol|estradiol|mesh-list
153741238|NCT00837616|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
153741239|NCT00837616|Estrogens|estrogens|mesh-ancestor
153741240|NCT00837616|Hormones|hormones|mesh-ancestor
153741241|NCT00837616|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153741242|NCT00837616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153741243|NCT00837616|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
153741244|NCT00837616|Contraceptive Agents|contraceptive agents|mesh-ancestor
153741245|NCT00837616|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153741246|NCT00837616|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
153741247|NCT00610051|Alprostadil|alprostadil|mesh-list
153741248|NCT00610051|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153741249|NCT00610051|Vasodilator Agents|vasodilator agents|mesh-ancestor
153741250|NCT00610051|Urological Agents|urological agents|mesh-ancestor
153741271|NCT00516841|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153741272|NCT00516841|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153741273|NCT00516841|Growth Substances|growth substances|mesh-ancestor
153741274|NCT00516841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153741275|NCT00516841|Growth Inhibitors|growth inhibitors|mesh-ancestor
153741276|NCT00516841|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153741277|NCT00516880|Rosiglitazone|rosiglitazone|mesh-list
153741278|NCT00516880|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153741279|NCT00516880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153741280|NCT04694677|Misoprostol|misoprostol|mesh-list
153741281|NCT04694677|Tranexamic Acid|tranexamic acid|mesh-list
153741282|NCT04694677|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
153741283|NCT04694677|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153741284|NCT04694677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153741285|NCT04694677|Hemostatics|hemostatics|mesh-ancestor
153741286|NCT04694677|Coagulants|coagulants|mesh-ancestor
153741287|NCT04694677|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
153571943|NCT04665895|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153571944|NCT04665895|Autonomic Agents|autonomic agents|mesh-ancestor
153571945|NCT04665895|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153571946|NCT04665895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153571947|NCT04665895|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153571949|NCT04665895|Dermatologic Agents|dermatologic agents|mesh-ancestor
153571955|NCT04545554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153571956|NCT04545554|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153571957|NCT04545554|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153741288|NCT04694677|Abortifacient Agents|abortifacient agents|mesh-ancestor
153741289|NCT04694677|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153741290|NCT04694677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153741291|NCT04694677|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
153741292|NCT04694677|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153741293|NCT04694677|Oxytocics|oxytocics|mesh-ancestor
153741294|NCT00516958|Levofloxacin|levofloxacin|mesh-list
153741295|NCT00516958|Ofloxacin|ofloxacin|mesh-list
153741296|NCT00516958|Sodium Hypochlorite|sodium hypochlorite|mesh-list
153741297|NCT00516958|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
153741298|NCT00516958|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153741299|NCT00516958|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153741300|NCT00516958|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153741301|NCT00516958|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153741302|NCT00516958|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153741303|NCT00516958|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153741304|NCT00516958|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153741305|NCT00516958|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
153741310|NCT00517114|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153741311|NCT00517114|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
153741312|NCT00517114|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153741313|NCT00517114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153741314|NCT00517270|Rabeprazole|rabeprazole|mesh-list
153571959|NCT04500574|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
153571960|NCT04500574|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
153571961|NCT04416282|Terlipressin|terlipressin|mesh-list
153571962|NCT04416282|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153571963|NCT04416282|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
153571964|NCT04395469|Fluoroazomycin arabinoside|fluoroazomycin arabinoside|mesh-list
153571965|NCT04395469|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
153571966|NCT04395469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153571967|NCT04375150|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-list
153571968|NCT04375150|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153571969|NCT04375150|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153571970|NCT04375150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153571971|NCT04152551|Risedronic Acid|risedronic acid|mesh-list
153571972|NCT04152551|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153571973|NCT04152551|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153571974|NCT04152551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153571975|NCT04152551|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153571976|NCT04152551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153571977|NCT04152551|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153571978|NCT04112498|Nivolumab|nivolumab|mesh-list
153571979|NCT04112498|Relatlimab|relatlimab|mesh-list
153571980|NCT04112498|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153571981|NCT04112498|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153571982|NCT04112498|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153571983|NCT04112498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153571984|NCT04042051|Trastuzumab|trastuzumab|mesh-list
153741315|NCT00517270|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
153741316|NCT00517270|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153741317|NCT00517270|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
153741318|NCT00517270|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153741319|NCT00517270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153741321|NCT00517309|Immunologic Factors|immunologic factors|mesh-ancestor
153741322|NCT00517309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153741323|NCT00517387|Quetiapine Fumarate|quetiapine fumarate|mesh-list
153741324|NCT00517387|Antidepressive Agents|antidepressive agents|mesh-ancestor
153741325|NCT00517387|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153741326|NCT00517387|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153741327|NCT00517387|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153741328|NCT00517387|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153741329|NCT00517387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153741330|NCT00517426|Acetazolamide|acetazolamide|mesh-list
153741331|NCT00517426|Anticonvulsants|anticonvulsants|mesh-ancestor
153741332|NCT00517426|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
153741333|NCT00517426|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153741334|NCT00517426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153741335|NCT00517426|Diuretics|diuretics|mesh-ancestor
153741336|NCT00517426|Natriuretic Agents|natriuretic agents|mesh-ancestor
153741337|NCT00517426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153741338|NCT00517504|Methylphenidate|methylphenidate|mesh-list
153741339|NCT00517504|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
153741340|NCT00517504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153741341|NCT00517504|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
153741342|NCT00517504|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153741343|NCT00517504|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153741344|NCT00517504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153741345|NCT00517504|Dopamine Agents|dopamine agents|mesh-ancestor
153741346|NCT00517504|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153741347|NCT00517582|Icatibant|icatibant|mesh-list
153741348|NCT00517582|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153741354|NCT00517582|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153741355|NCT00517582|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153741356|NCT00517582|Bradykinin B2 Receptor Antagonists|bradykinin b2 receptor antagonists|mesh-ancestor
153741357|NCT00517582|Bradykinin Receptor Antagonists|bradykinin receptor antagonists|mesh-ancestor
153741358|NCT00517582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153741359|NCT00517582|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
153741360|NCT00517582|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153741361|NCT00517582|Immunologic Factors|immunologic factors|mesh-ancestor
153741362|NCT00517621|Paclitaxel|paclitaxel|mesh-list
153741363|NCT00517621|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153741364|NCT00517621|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153741365|NCT00517621|Tubulin Modulators|tubulin modulators|mesh-ancestor
153741366|NCT00517621|Antimitotic Agents|antimitotic agents|mesh-ancestor
153741367|NCT00517621|Mitosis Modulators|mitosis modulators|mesh-ancestor
153741368|NCT00517621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153741369|NCT00151515|Minoxidil|minoxidil|mesh-list
153741370|NCT00151515|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153741371|NCT00151515|Vasodilator Agents|vasodilator agents|mesh-ancestor
153741372|NCT00166686|Clonidine|clonidine|mesh-list
153741373|NCT00166686|Analgesics|analgesics|mesh-ancestor
153741374|NCT00166686|Sensory System Agents|sensory system agents|mesh-ancestor
153741375|NCT00166686|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153741376|NCT00166686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153741382|NCT00166686|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153741383|NCT00166686|Adrenergic Agents|adrenergic agents|mesh-ancestor
153741384|NCT00166686|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153741385|NCT00166686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153741386|NCT02949778|Ropivacaine|ropivacaine|mesh-list
153741387|NCT02949778|Anesthetics, Local|anesthetics, local|mesh-ancestor
153741388|NCT02949778|Anesthetics|anesthetics|mesh-ancestor
153741389|NCT02949778|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153741390|NCT02949778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153578411|NCT01732328|Vitamin D|vitamin d|mesh-list
153741391|NCT02949778|Sensory System Agents|sensory system agents|mesh-ancestor
153741392|NCT02949778|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153741393|NCT00518245|Enoxaparin|enoxaparin|mesh-list
153741395|NCT00518245|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153741396|NCT00518245|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153741397|NCT00518245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153741398|NCT02957903|Ropivacaine|ropivacaine|mesh-list
153741399|NCT02957903|Anesthetics, Local|anesthetics, local|mesh-ancestor
153741400|NCT02957903|Anesthetics|anesthetics|mesh-ancestor
153741401|NCT02957903|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153741402|NCT02957903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153741403|NCT02957903|Sensory System Agents|sensory system agents|mesh-ancestor
153741404|NCT02957903|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153741405|NCT00518479|Amlodipine|amlodipine|mesh-list
153741406|NCT00518479|Valsartan|valsartan|mesh-list
153741407|NCT00518479|Moxonidine|moxonidine|mesh-list
153741408|NCT00518479|Bendroflumethiazide|bendroflumethiazide|mesh-list
153741409|NCT00518479|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153741410|NCT00518479|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153741411|NCT00518479|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153741412|NCT00518479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153741413|NCT00518479|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153741414|NCT00518479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153741415|NCT00518479|Vasodilator Agents|vasodilator agents|mesh-ancestor
153571996|NCT04042051|Immunologic Factors|immunologic factors|mesh-ancestor
153571997|NCT04042051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153571998|NCT04033991|Sunitinib|sunitinib|mesh-list
153571999|NCT04033991|Axitinib|axitinib|mesh-list
153572000|NCT04033991|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153572001|NCT04033991|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153572002|NCT04033991|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153572003|NCT04033991|Growth Substances|growth substances|mesh-ancestor
153572004|NCT04033991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153572005|NCT04033991|Growth Inhibitors|growth inhibitors|mesh-ancestor
153572006|NCT04033991|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153572007|NCT04033991|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153572008|NCT04033991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153572009|NCT03961360|Aspirin|aspirin|mesh-list
153572010|NCT03961360|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153572011|NCT03961360|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153572012|NCT03961360|Analgesics|analgesics|mesh-ancestor
153572013|NCT03961360|Sensory System Agents|sensory system agents|mesh-ancestor
153572014|NCT03961360|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153572015|NCT03961360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153572016|NCT03961360|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153572017|NCT03961360|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153572018|NCT03961360|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153572019|NCT03961360|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153572020|NCT03961360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153816739|NCT03271905|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153816740|NCT03271905|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
153816741|NCT03271905|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
153816742|NCT03271905|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153816743|NCT03271905|Adrenergic Agents|adrenergic agents|mesh-ancestor
153816744|NCT03271905|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153741416|NCT00518479|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
153741417|NCT00518479|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
153741418|NCT00518479|Diuretics|diuretics|mesh-ancestor
153741419|NCT00518479|Natriuretic Agents|natriuretic agents|mesh-ancestor
153741420|NCT00518479|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
153741421|NCT00166725|Octreotide|octreotide|mesh-list
153741422|NCT00166725|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153741423|NCT00166725|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153741424|NCT00166725|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153741425|NCT00518635|Insulin|insulin|mesh-list
153741426|NCT00518635|Hormones|hormones|mesh-list
153741427|NCT00518635|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153741428|NCT00518635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153741429|NCT00518635|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153741430|NCT00151632|Mycophenolic Acid|mycophenolic acid|mesh-list
153741431|NCT00151632|Tacrolimus|tacrolimus|mesh-list
153741432|NCT00151632|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153741433|NCT00151632|Immunologic Factors|immunologic factors|mesh-ancestor
153741434|NCT00151632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153741435|NCT00151632|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
153741436|NCT00151632|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153741437|NCT00151632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153741438|NCT00151632|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153741439|NCT00151632|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153741440|NCT00151632|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
153741441|NCT00151632|Antitubercular Agents|antitubercular agents|mesh-ancestor
153741442|NCT00151632|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153741443|NCT00151632|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153741444|NCT02949232|Prednisolone|prednisolone|mesh-list
153741445|NCT02949232|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153741458|NCT00518908|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153741459|NCT00518947|Verapamil|verapamil|mesh-list
153741460|NCT00518947|Lithium Carbonate|lithium carbonate|mesh-list
153572021|NCT03961360|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153572022|NCT03961360|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153572023|NCT03961360|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153572026|NCT03924401|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153572027|NCT03924401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153572028|NCT03924401|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153741461|NCT00518947|Antidepressive Agents|antidepressive agents|mesh-ancestor
153741462|NCT00518947|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153741463|NCT00518947|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153730690|NCT00134810|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
153741464|NCT00518947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153741465|NCT00518947|Antimanic Agents|antimanic agents|mesh-ancestor
153741466|NCT00518947|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153741467|NCT00518947|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153741468|NCT00518947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153741469|NCT00518947|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153741470|NCT00518947|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153741471|NCT00518947|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153741472|NCT00518947|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153741473|NCT00518947|Vasodilator Agents|vasodilator agents|mesh-ancestor
153741474|NCT02949466|Triamcinolone|triamcinolone|mesh-list
153741475|NCT02949466|Hyaluronic Acid|hyaluronic acid|mesh-list
153741476|NCT02949466|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153741477|NCT02949466|Glucocorticoids|glucocorticoids|mesh-ancestor
153741478|NCT02949466|Hormones|hormones|mesh-ancestor
153741479|NCT02949466|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153741480|NCT02949466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153741481|NCT02949466|Immunologic Factors|immunologic factors|mesh-ancestor
153741482|NCT02949466|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153741483|NCT02949466|Viscosupplements|viscosupplements|mesh-ancestor
153741484|NCT02949466|Protective Agents|protective agents|mesh-ancestor
153741485|NCT00151710|Pioglitazone|pioglitazone|mesh-list
153741486|NCT00151710|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153741487|NCT00151710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153741488|NCT00519181|Valproic Acid|valproic acid|mesh-list
153741489|NCT00519181|Anticonvulsants|anticonvulsants|mesh-ancestor
153741490|NCT00519181|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153741491|NCT00519181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153741492|NCT00519181|GABA Agents|gaba agents|mesh-ancestor
153741493|NCT00519181|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153741494|NCT00519181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153572029|NCT03924401|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153572030|NCT03924401|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153572031|NCT03924401|Immunologic Factors|immunologic factors|mesh-ancestor
153741495|NCT00519181|Antimanic Agents|antimanic agents|mesh-ancestor
153741496|NCT00519181|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153741497|NCT00519181|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153741498|NCT00519181|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153741499|NCT00166803|Rosiglitazone|rosiglitazone|mesh-list
153741500|NCT00166803|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153741501|NCT00166803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153741502|NCT02949310|Nefopam|nefopam|mesh-list
153741503|NCT02949310|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153741504|NCT02949310|Analgesics|analgesics|mesh-ancestor
153741505|NCT02949310|Sensory System Agents|sensory system agents|mesh-ancestor
153741506|NCT02949310|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153741507|NCT02949310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153741508|NCT02949349|Mycophenolic Acid|mycophenolic acid|mesh-list
153741518|NCT02949349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153741520|NCT02949349|Glucocorticoids|glucocorticoids|mesh-ancestor
153741521|NCT02949349|Hormones|hormones|mesh-ancestor
153741522|NCT02949349|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153741523|NCT02949349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153741524|NCT02949349|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153741525|NCT02949349|Antimetabolites|antimetabolites|mesh-ancestor
153741526|NCT02949349|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153741527|NCT02949349|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153741528|NCT02949349|Immunologic Factors|immunologic factors|mesh-ancestor
153741529|NCT02949349|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153741530|NCT00166842|Cyclosporine|cyclosporine|mesh-list
153741531|NCT00166842|Sirolimus|sirolimus|mesh-list
153741532|NCT00166842|Tacrolimus|tacrolimus|mesh-list
153741533|NCT00166842|Cyclosporins|cyclosporins|mesh-list
153741534|NCT00166842|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153741535|NCT00166842|Immunologic Factors|immunologic factors|mesh-ancestor
153741536|NCT00166842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153741537|NCT00166842|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
153741538|NCT00166842|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153572032|NCT03924401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153572033|NCT03924401|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153572036|NCT03769285|Nicotinic Acids|nicotinic acids|mesh-list
153572037|NCT03769285|Vitamin B Complex|vitamin b complex|mesh-ancestor
153572038|NCT03769285|Vitamins|vitamins|mesh-ancestor
153572039|NCT03769285|Micronutrients|micronutrients|mesh-ancestor
153572040|NCT03769285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153572041|NCT03769285|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153741539|NCT00166842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153741541|NCT00166842|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153741542|NCT00166842|Dermatologic Agents|dermatologic agents|mesh-ancestor
153741543|NCT00166842|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153741544|NCT00166842|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153741545|NCT00166842|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153741546|NCT00166842|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153730691|NCT00134810|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153730692|NCT00134810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153730693|NCT00134810|Cholinergic Agents|cholinergic agents|mesh-ancestor
153730694|NCT00134810|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153730695|NCT00134810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153741547|NCT02949193|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
153741548|NCT02949193|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153741549|NCT02949193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153741550|NCT02949193|Incretins|incretins|mesh-ancestor
153741551|NCT02949193|Hormones|hormones|mesh-ancestor
153741552|NCT02949193|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153572042|NCT03769285|Antimetabolites|antimetabolites|mesh-ancestor
153572043|NCT03769285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153572044|NCT03769285|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153572045|NCT03769285|Vasodilator Agents|vasodilator agents|mesh-ancestor
153572046|NCT03710902|Antihypertensive Agents|antihypertensive agents|mesh-list
153572047|NCT03642132|Bevacizumab|bevacizumab|mesh-list
153572048|NCT03642132|Avelumab|avelumab|mesh-list
153572049|NCT03642132|Talazoparib|talazoparib|mesh-list
153572050|NCT03642132|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153572051|NCT03642132|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153572068|NCT03632330|Sensory System Agents|sensory system agents|mesh-ancestor
153572069|NCT03632330|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153572070|NCT03632330|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
153572071|NCT03632330|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153572072|NCT03632330|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153572073|NCT03632330|Adrenergic Agents|adrenergic agents|mesh-ancestor
153572074|NCT03632330|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153572075|NCT03632330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153572076|NCT03632330|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153572077|NCT03632330|Anesthetics, General|anesthetics, general|mesh-ancestor
153572078|NCT03632330|Anesthetics|anesthetics|mesh-ancestor
153572079|NCT03632330|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153572080|NCT03632330|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153572081|NCT03632330|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153572082|NCT03632330|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153572083|NCT03632330|GABA Modulators|gaba modulators|mesh-ancestor
153572084|NCT03632330|GABA Agents|gaba agents|mesh-ancestor
153572085|NCT03575949|Deoxyglucose|deoxyglucose|mesh-list
153572086|NCT03575949|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
153572087|NCT03575949|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
153572088|NCT03575949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153572089|NCT03575949|Antimetabolites|antimetabolites|mesh-ancestor
153572090|NCT03575949|Antiviral Agents|antiviral agents|mesh-ancestor
153572091|NCT03575949|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153572092|NCT03572764|Cytarabine|cytarabine|mesh-list
153572118|NCT03227705|Hormones|hormones|mesh-ancestor
153741553|NCT02949193|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
153741554|NCT02949193|Protease Inhibitors|protease inhibitors|mesh-ancestor
153741555|NCT02949193|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153741556|NCT02949193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153741558|NCT00519259|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
153741559|NCT00519259|Autonomic Agents|autonomic agents|mesh-ancestor
153741560|NCT00519259|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153741561|NCT00519259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153741562|NCT00519259|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
153741563|NCT00519259|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
153741564|NCT00519259|Cholinergic Agents|cholinergic agents|mesh-ancestor
153741565|NCT00519259|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153741566|NCT00519259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153741567|NCT00519259|Respiratory System Agents|respiratory system agents|mesh-ancestor
153741568|NCT00519298|Donepezil|donepezil|mesh-list
153741569|NCT00519298|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
153741570|NCT00519298|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153741571|NCT00519298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153741572|NCT00519298|Cholinergic Agents|cholinergic agents|mesh-ancestor
153741573|NCT00519298|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153572119|NCT03227705|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153572120|NCT03227705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153572121|NCT03150004|Cytarabine|cytarabine|mesh-list
153572122|NCT03150004|Mitoxantrone|mitoxantrone|mesh-list
153572123|NCT03150004|Cladribine|cladribine|mesh-list
153572124|NCT03150004|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153572125|NCT03150004|Antimetabolites|antimetabolites|mesh-ancestor
153572126|NCT03150004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153572127|NCT03150004|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153572128|NCT03150004|Antiviral Agents|antiviral agents|mesh-ancestor
153572129|NCT03150004|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153572130|NCT03150004|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153572131|NCT03150004|Immunologic Factors|immunologic factors|mesh-ancestor
153572132|NCT03150004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153572133|NCT03150004|Analgesics|analgesics|mesh-ancestor
153572134|NCT03150004|Sensory System Agents|sensory system agents|mesh-ancestor
153572135|NCT03150004|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153572136|NCT03150004|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153572137|NCT03150004|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153572138|NCT03150004|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153572139|NCT03082534|Pembrolizumab|pembrolizumab|mesh-list
153572140|NCT03082534|Cetuximab|cetuximab|mesh-list
153572141|NCT03082534|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153572142|NCT03082534|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153572143|NCT03082534|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153572167|NCT02351869|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153572168|NCT02351869|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153572169|NCT02351869|Anesthetics, General|anesthetics, general|mesh-ancestor
153572170|NCT02351869|Anesthetics|anesthetics|mesh-ancestor
153572171|NCT02351869|GABA Modulators|gaba modulators|mesh-ancestor
153572172|NCT02351869|GABA Agents|gaba agents|mesh-ancestor
153572173|NCT02351869|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153741587|NCT00151749|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153741588|NCT00151749|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153741589|NCT00166881|Docetaxel|docetaxel|mesh-list
153741590|NCT00166881|Irinotecan|irinotecan|mesh-list
153741591|NCT00166881|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153741592|NCT00166881|Tubulin Modulators|tubulin modulators|mesh-ancestor
153741593|NCT00166881|Antimitotic Agents|antimitotic agents|mesh-ancestor
153741594|NCT00166881|Mitosis Modulators|mitosis modulators|mesh-ancestor
153741595|NCT00166881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153741596|NCT00166881|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
153741597|NCT00166881|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153741598|NCT00166881|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153741599|NCT02948998|Spironolactone|spironolactone|mesh-list
153741600|NCT02948998|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
153741601|NCT02948998|Hormone Antagonists|hormone antagonists|mesh-ancestor
153572174|NCT02351869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153572175|NCT02351869|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
153572176|NCT02351869|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153572177|NCT02351869|Analgesics|analgesics|mesh-ancestor
153572178|NCT02351869|Sensory System Agents|sensory system agents|mesh-ancestor
153572179|NCT02351869|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153572180|NCT02311582|Pembrolizumab|pembrolizumab|mesh-list
153572181|NCT02311582|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153572182|NCT02311582|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153572183|NCT02311582|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153572184|NCT02311582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153572185|NCT02237820|Dexamethasone|dexamethasone|mesh-list
153572186|NCT02237820|Prednisone|prednisone|mesh-list
153572187|NCT02237820|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153572188|NCT02237820|Antiemetics|antiemetics|mesh-ancestor
153572189|NCT02237820|Autonomic Agents|autonomic agents|mesh-ancestor
153572190|NCT02237820|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153572191|NCT02237820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153572192|NCT02237820|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153572193|NCT02237820|Glucocorticoids|glucocorticoids|mesh-ancestor
153572194|NCT02237820|Hormones|hormones|mesh-ancestor
153572196|NCT02237820|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153572213|NCT02152358|Ganciclovir|ganciclovir|mesh-list
153572214|NCT02152358|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
153572215|NCT02152358|Antiviral Agents|antiviral agents|mesh-ancestor
153572216|NCT02152358|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153572217|NCT02152358|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153572218|NCT02152358|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153572219|NCT02152358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153572220|NCT01819064|Atropine|atropine|mesh-list
153572221|NCT01819064|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153741602|NCT02948998|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153741603|NCT02948998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153741604|NCT02948998|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
153741606|NCT02948998|Natriuretic Agents|natriuretic agents|mesh-ancestor
153741607|NCT00519688|Thalidomide|thalidomide|mesh-list
153741608|NCT00519688|Tegafur|tegafur|mesh-list
153741609|NCT00519688|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153741610|NCT00519688|Immunologic Factors|immunologic factors|mesh-ancestor
153741611|NCT00519688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153741612|NCT00519688|Leprostatic Agents|leprostatic agents|mesh-ancestor
153741613|NCT00519688|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153741614|NCT00519688|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153741615|NCT00519688|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153578637|NCT01734057|Antiemetics|antiemetics|mesh-ancestor
153741616|NCT00519688|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153741617|NCT00519688|Growth Substances|growth substances|mesh-ancestor
153741618|NCT00519688|Growth Inhibitors|growth inhibitors|mesh-ancestor
153741619|NCT00519688|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153741620|NCT00519688|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153730696|NCT00134810|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
153741622|NCT00519688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153741623|NCT02948920|Ephedrine|ephedrine|mesh-list
153741624|NCT02948920|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
153741625|NCT02948920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153741626|NCT02948920|Sympathomimetics|sympathomimetics|mesh-ancestor
153572222|NCT01819064|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153572223|NCT01819064|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153572224|NCT01819064|Autonomic Agents|autonomic agents|mesh-ancestor
153572225|NCT01819064|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153572226|NCT01819064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153572227|NCT01819064|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153572228|NCT01819064|Respiratory System Agents|respiratory system agents|mesh-ancestor
153572229|NCT01819064|Mydriatics|mydriatics|mesh-ancestor
153572230|NCT01819064|Parasympatholytics|parasympatholytics|mesh-ancestor
153572231|NCT01819064|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
153572232|NCT01819064|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
153572233|NCT01819064|Cholinergic Agents|cholinergic agents|mesh-ancestor
153572234|NCT01819064|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153572236|NCT01817751|Sorafenib|sorafenib|mesh-list
153572237|NCT01817751|Sildenafil Citrate|sildenafil citrate|mesh-list
153572238|NCT01817751|Valproic Acid|valproic acid|mesh-list
153572239|NCT01817751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153572240|NCT01817751|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153572241|NCT01817751|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153572242|NCT01817751|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153572243|NCT01817751|Vasodilator Agents|vasodilator agents|mesh-ancestor
153572244|NCT01817751|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
153816745|NCT03271905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153741628|NCT02948920|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153741629|NCT02948920|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
153741630|NCT02948920|Adrenergic Agents|adrenergic agents|mesh-ancestor
153741631|NCT02948920|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153741632|NCT02948920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153741633|NCT00151827|Losartan|losartan|mesh-list
153741634|NCT00151827|Olmesartan|olmesartan|mesh-list
153741635|NCT00151827|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
153741636|NCT00151827|Furosemide|furosemide|mesh-list
153741670|NCT04457180|Dopamine Agents|dopamine agents|mesh-ancestor
153741671|NCT04457180|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153741672|NCT04457180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153741673|NCT04457180|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
153477611|NCT05014087|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
153741681|NCT00520000|Tubulin Modulators|tubulin modulators|mesh-ancestor
153741682|NCT00520000|Antimitotic Agents|antimitotic agents|mesh-ancestor
153741683|NCT00520000|Mitosis Modulators|mitosis modulators|mesh-ancestor
153741684|NCT00520000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153741686|NCT00151944|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153741687|NCT00151944|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153741688|NCT00151944|Analgesics|analgesics|mesh-ancestor
153578724|NCT01734954|GABA Agents|gaba agents|mesh-ancestor
153741689|NCT00151944|Sensory System Agents|sensory system agents|mesh-ancestor
153741690|NCT00151944|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153741691|NCT00151944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153741692|NCT00151944|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153741693|NCT00151944|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153741694|NCT00520507|Olanzapine|olanzapine|mesh-list
153816746|NCT03271905|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
153816747|NCT03271905|Cholinergic Agents|cholinergic agents|mesh-ancestor
153816748|NCT00426413|Pioglitazone|pioglitazone|mesh-list
153816749|NCT00426413|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153816750|NCT00426413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153816751|NCT00459264|Folic Acid|folic acid|mesh-list
153816752|NCT00459264|Hematinics|hematinics|mesh-ancestor
153816753|NCT00459264|Vitamin B Complex|vitamin b complex|mesh-ancestor
153816754|NCT00459264|Vitamins|vitamins|mesh-ancestor
153816755|NCT00459264|Micronutrients|micronutrients|mesh-ancestor
153572245|NCT01817751|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
153572246|NCT01817751|Urological Agents|urological agents|mesh-ancestor
153572247|NCT01817751|Anticonvulsants|anticonvulsants|mesh-ancestor
153572248|NCT01817751|GABA Agents|gaba agents|mesh-ancestor
153572249|NCT01817751|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153572250|NCT01817751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153572251|NCT01817751|Antimanic Agents|antimanic agents|mesh-ancestor
153572252|NCT01817751|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153572253|NCT01817751|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153741695|NCT00520507|Antiemetics|antiemetics|mesh-ancestor
153741696|NCT00520507|Autonomic Agents|autonomic agents|mesh-ancestor
153741697|NCT00520507|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153741698|NCT00520507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153741699|NCT00520507|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153741700|NCT00520507|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153741701|NCT00520507|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153741702|NCT00520507|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153741703|NCT00520507|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153741704|NCT00520507|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
153741705|NCT00520507|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153741706|NCT00520507|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153741707|NCT00520507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153741708|NCT00520507|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153741709|NCT00520507|Serotonin Agents|serotonin agents|mesh-ancestor
153741710|NCT04694404|Oxaliplatin|oxaliplatin|mesh-list
153741711|NCT04694404|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153741712|NCT04694365|Fluzoparib|fluzoparib|mesh-list
153741713|NCT04694365|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
153741714|NCT04694365|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153741715|NCT04694365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153741716|NCT04694365|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153741717|NCT00151983|Methylphenidate|methylphenidate|mesh-list
153572254|NCT01817751|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153572255|NCT02744053|Technetium Tc 99m Sestamibi|technetium tc 99m sestamibi|mesh-list
153572256|NCT02744053|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
153572257|NCT02744053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153572258|NCT01549730|Fluoroazomycin arabinoside|fluoroazomycin arabinoside|mesh-list
153572259|NCT01549730|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
153572260|NCT01549730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153572261|NCT00812669|Cyclophosphamide|cyclophosphamide|mesh-list
153572262|NCT00812669|Rituximab|rituximab|mesh-list
153572263|NCT00812669|Fludarabine|fludarabine|mesh-list
153572264|NCT00812669|Fludarabine phosphate|fludarabine phosphate|mesh-list
153572265|NCT00812669|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153572266|NCT00812669|Immunologic Factors|immunologic factors|mesh-ancestor
153572268|NCT00812669|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153572295|NCT03870880|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
153572296|NCT03870880|Dopamine Agents|dopamine agents|mesh-ancestor
153572297|NCT03861377|Remifentanil|remifentanil|mesh-list
153572298|NCT03861377|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153572299|NCT03861377|Narcotics|narcotics|mesh-ancestor
153572300|NCT03861377|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153572301|NCT03861377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153572302|NCT03861377|Analgesics|analgesics|mesh-ancestor
153572303|NCT03861377|Sensory System Agents|sensory system agents|mesh-ancestor
153572304|NCT03861377|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153572305|NCT03844100|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
153572306|NCT03844100|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
153572307|NCT03844100|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153741718|NCT00151983|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
153741719|NCT00151983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153741720|NCT00151983|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
153741721|NCT00151983|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153741722|NCT00151983|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153741723|NCT00151983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153741724|NCT00151983|Dopamine Agents|dopamine agents|mesh-ancestor
153741725|NCT00151983|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153741726|NCT00520585|Atorvastatin|atorvastatin|mesh-list
153741727|NCT00520585|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153741728|NCT00520585|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153741729|NCT00520585|Antimetabolites|antimetabolites|mesh-ancestor
153741730|NCT00520585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153741731|NCT00520585|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153730697|NCT00134810|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153730698|NCT02964455|Docetaxel|docetaxel|mesh-list
153741732|NCT00520585|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
153741733|NCT00520585|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153741734|NCT00152022|Amphetamine|amphetamine|mesh-list
153741735|NCT00152022|Dextroamphetamine|dextroamphetamine|mesh-list
153741736|NCT00152022|Adderall|adderall|mesh-list
153741737|NCT00152022|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
153741738|NCT00152022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153741756|NCT00520897|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153741757|NCT00520897|Antiviral Agents|antiviral agents|mesh-ancestor
153741758|NCT00520897|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153741759|NCT00520897|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
153741760|NCT00520897|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
153741761|NCT00520897|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153572308|NCT03836144|Potassium Citrate|potassium citrate|mesh-list
153572309|NCT03836144|Diuretics|diuretics|mesh-ancestor
153572310|NCT03836144|Natriuretic Agents|natriuretic agents|mesh-ancestor
153572311|NCT03836144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153572312|NCT03836144|Expectorants|expectorants|mesh-ancestor
153741764|NCT00521092|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153741765|NCT00521092|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153741766|NCT00521092|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153741767|NCT00521092|Growth Substances|growth substances|mesh-ancestor
153741768|NCT00521092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153741769|NCT00521092|Growth Inhibitors|growth inhibitors|mesh-ancestor
153741770|NCT00521092|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153741771|NCT00521092|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153741772|NCT00521092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153741773|NCT00521131|Levocetirizine|levocetirizine|mesh-list
153741774|NCT00521131|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
153741775|NCT00521131|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
153741776|NCT00521131|Histamine Antagonists|histamine antagonists|mesh-ancestor
153741777|NCT00521131|Histamine Agents|histamine agents|mesh-ancestor
153741778|NCT00521131|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153741779|NCT00521131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153741780|NCT00521131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153741781|NCT04694092|Landiolol|landiolol|mesh-list
153741782|NCT04694092|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
153741783|NCT04694092|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
153741784|NCT04694092|Adrenergic Agents|adrenergic agents|mesh-ancestor
153741785|NCT04694092|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153572313|NCT03836144|Respiratory System Agents|respiratory system agents|mesh-ancestor
153572314|NCT03811574|Semaglutide|semaglutide|mesh-list
153572315|NCT03811574|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
153572316|NCT03811574|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153572317|NCT03811574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153572318|NCT03796416|Misoprostol|misoprostol|mesh-list
153816756|NCT00459264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153741786|NCT04694092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153741787|NCT04694092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153741788|NCT04694092|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153741789|NCT00521170|Levocetirizine|levocetirizine|mesh-list
153741790|NCT00521170|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
153741791|NCT00521170|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
153741792|NCT00521170|Histamine Antagonists|histamine antagonists|mesh-ancestor
153477719|NCT04761159|Analgesics|analgesics|mesh-ancestor
153741803|NCT00521248|Analgesics|analgesics|mesh-ancestor
153741804|NCT00521248|Sensory System Agents|sensory system agents|mesh-ancestor
153741805|NCT00521248|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153741806|NCT00521248|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
153741807|NCT00167154|Risperidone|risperidone|mesh-list
153741808|NCT00167154|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153741809|NCT00167154|Serotonin Agents|serotonin agents|mesh-ancestor
153741810|NCT00167154|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153741811|NCT00167154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153741812|NCT00167154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153741813|NCT00167154|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153741814|NCT00167154|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153741815|NCT00167154|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153741816|NCT00167154|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153741817|NCT00167154|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
153741818|NCT00167154|Dopamine Agents|dopamine agents|mesh-ancestor
153741819|NCT00521482|Thalidomide|thalidomide|mesh-list
153741820|NCT00521482|Temozolomide|temozolomide|mesh-list
153741821|NCT00521482|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153741822|NCT00521482|Alkylating Agents|alkylating agents|mesh-ancestor
153741823|NCT00521482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153741824|NCT00521482|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153741840|NCT00521521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153741841|NCT00152100|Alemtuzumab|alemtuzumab|mesh-list
153741842|NCT00152100|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153741843|NCT00152100|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153741844|NCT00522184|Etanercept|etanercept|mesh-list
153741845|NCT00522184|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153741846|NCT00522184|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153741847|NCT00522184|Analgesics|analgesics|mesh-ancestor
153741848|NCT00522184|Sensory System Agents|sensory system agents|mesh-ancestor
153741849|NCT00522184|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153741850|NCT00522184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153741851|NCT00522184|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153741852|NCT00522184|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153741853|NCT00522184|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153741854|NCT00522184|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153741855|NCT00522184|Immunologic Factors|immunologic factors|mesh-ancestor
153741856|NCT03458923|Diclofenac|diclofenac|mesh-list
153741857|NCT03458923|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-list
153741868|NCT03458923|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153741870|NCT03458923|Sensory System Agents|sensory system agents|mesh-ancestor
153741871|NCT03458923|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153741872|NCT03458923|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153741873|NCT03458923|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153741874|NCT03458923|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153741875|NCT04186013|Atezolizumab|atezolizumab|mesh-list
153741880|NCT00152139|Antibodies|antibodies|mesh-list
153741900|NCT04083560|Hematinics|hematinics|mesh-ancestor
153741901|NCT04083560|Vitamin B Complex|vitamin b complex|mesh-ancestor
153741902|NCT04083560|Vitamins|vitamins|mesh-ancestor
153741903|NCT04083560|Micronutrients|micronutrients|mesh-ancestor
153741904|NCT04083560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153741905|NCT00511966|Rabeprazole|rabeprazole|mesh-list
153741906|NCT00511966|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
153741907|NCT00511966|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153741908|NCT00511966|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
153741909|NCT00511966|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153741910|NCT00511966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153741911|NCT00152178|Tamoxifen|tamoxifen|mesh-list
153741912|NCT00152178|Cyclophosphamide|cyclophosphamide|mesh-list
153741913|NCT00152178|Fluorouracil|fluorouracil|mesh-list
153730699|NCT02964455|Nedaplatin|nedaplatin|mesh-list
153730700|NCT02964455|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153741914|NCT00152178|Methotrexate|methotrexate|mesh-list
153741915|NCT00152178|Tegafur|tegafur|mesh-list
153741916|NCT00152178|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153741917|NCT00152178|Immunologic Factors|immunologic factors|mesh-ancestor
153741918|NCT00152178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153741919|NCT00152178|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153741920|NCT00152178|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153741921|NCT00152178|Alkylating Agents|alkylating agents|mesh-ancestor
153741922|NCT00152178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153741933|NCT00152178|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153741934|NCT00152178|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
153741935|NCT00152178|Hormone Antagonists|hormone antagonists|mesh-ancestor
153741936|NCT00152178|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153741937|NCT00152178|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153741939|NCT00152178|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
153741940|NCT00152178|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153741941|NCT00523120|Diclofenac|diclofenac|mesh-list
153741942|NCT00523120|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153741943|NCT00523120|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153741944|NCT00523120|Analgesics|analgesics|mesh-ancestor
153741945|NCT00523120|Sensory System Agents|sensory system agents|mesh-ancestor
153741946|NCT00523120|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153741947|NCT00523120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153741948|NCT00523120|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153741949|NCT00523120|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153741950|NCT00523120|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153741951|NCT00523120|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153741952|NCT00523120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153741953|NCT00523159|Sargramostim|sargramostim|mesh-list
153741954|NCT00523159|Immunologic Factors|immunologic factors|mesh-ancestor
153741955|NCT00523159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153741956|NCT04693897|Solifenacin Succinate|solifenacin succinate|mesh-list
153741957|NCT04693897|Mirabegron|mirabegron|mesh-list
153741958|NCT04693897|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
153741959|NCT04693897|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
153741960|NCT04693897|Cholinergic Agents|cholinergic agents|mesh-ancestor
153741961|NCT04693897|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153741962|NCT04693897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153741963|NCT04693897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153741964|NCT04693897|Urological Agents|urological agents|mesh-ancestor
153741965|NCT04693897|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
153741966|NCT04693897|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
153741967|NCT04693897|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153741968|NCT04693897|Adrenergic Agents|adrenergic agents|mesh-ancestor
153741969|NCT00424242|Pemetrexed|pemetrexed|mesh-list
153741970|NCT00424242|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153741971|NCT00424242|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153741977|NCT04726553|Methotrexate|methotrexate|mesh-list
153741978|NCT04726553|Azathioprine|azathioprine|mesh-list
153741979|NCT04726553|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
153741980|NCT04726553|Abortifacient Agents|abortifacient agents|mesh-ancestor
153741981|NCT04726553|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153741982|NCT04726553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153741983|NCT04726553|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153579010|NCT01736761|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153741984|NCT04726553|Antimetabolites|antimetabolites|mesh-ancestor
153742004|NCT02948101|Cyclophosphamide|cyclophosphamide|mesh-list
153742005|NCT02948101|Antibodies|antibodies|mesh-list
153742006|NCT02948101|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
153742007|NCT02948101|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153742008|NCT02948101|Immunologic Factors|immunologic factors|mesh-ancestor
153742009|NCT02948101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153742010|NCT02948101|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153742011|NCT02948101|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153742012|NCT02948101|Alkylating Agents|alkylating agents|mesh-ancestor
153742013|NCT02948101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153742014|NCT02948101|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153742015|NCT02948101|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153742017|NCT02952157|Anesthetics, Local|anesthetics, local|mesh-ancestor
153742018|NCT02952157|Anesthetics|anesthetics|mesh-ancestor
153742019|NCT02952157|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153742020|NCT02952157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153742021|NCT02952157|Sensory System Agents|sensory system agents|mesh-ancestor
153742022|NCT02952157|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153742023|NCT02952157|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153742024|NCT02952157|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
153742025|NCT02952157|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153742026|NCT02952157|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153742027|NCT02952157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153816757|NCT00426452|Vatalanib|vatalanib|mesh-list
153816758|NCT00426452|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153816759|NCT00426452|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153816760|NCT00426452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153816761|NCT00426491|Misoprostol|misoprostol|mesh-list
153742034|NCT02951728|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153742035|NCT02951728|Immunologic Factors|immunologic factors|mesh-ancestor
153742036|NCT02951728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153742037|NCT02951728|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153742038|NCT02951728|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153742039|NCT02951728|Alkylating Agents|alkylating agents|mesh-ancestor
153742040|NCT02951728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153742041|NCT02951728|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153742050|NCT02951728|Hormones|hormones|mesh-ancestor
153742051|NCT02951728|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153742052|NCT02951728|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153742053|NCT02951728|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153742054|NCT02951728|Tubulin Modulators|tubulin modulators|mesh-ancestor
153742055|NCT02951728|Antimitotic Agents|antimitotic agents|mesh-ancestor
153814648|NCT00452907|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
153458101|NCT04029090|Edaravone|edaravone|mesh-list
153458112|NCT04193982|Antioxidants|antioxidants|mesh-ancestor
153458113|NCT04193982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153458114|NCT04193982|Protective Agents|protective agents|mesh-ancestor
153572319|NCT03796416|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
153572321|NCT03796416|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153572322|NCT03796416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153742056|NCT02951728|Mitosis Modulators|mitosis modulators|mesh-ancestor
153742057|NCT02951728|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153579084|NCT01737203|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153742058|NCT02951728|Antimetabolites|antimetabolites|mesh-ancestor
153742059|NCT04726046|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
153742060|NCT04726046|Cefotetan|cefotetan|mesh-list
153742061|NCT04726046|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153742062|NCT00523354|Infliximab|infliximab|mesh-list
153742063|NCT00523354|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
153742064|NCT00523354|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153742065|NCT00523354|Dermatologic Agents|dermatologic agents|mesh-ancestor
153742066|NCT00523354|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153742067|NCT00523354|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153742068|NCT00523393|Insulin|insulin|mesh-list
153742069|NCT00523393|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
153742070|NCT00523393|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153742071|NCT00523393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153742072|NCT00523432|Sirolimus|sirolimus|mesh-list
153742073|NCT00523432|Topotecan|topotecan|mesh-list
153742074|NCT00523432|Temsirolimus|temsirolimus|mesh-list
153742075|NCT00523432|MTOR Inhibitors|mtor inhibitors|mesh-list
153742076|NCT00523432|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
153742077|NCT00523432|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153742078|NCT00523432|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153742079|NCT00523432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153742080|NCT00523432|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153742081|NCT00523432|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153742082|NCT00523432|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153742083|NCT00523432|Immunologic Factors|immunologic factors|mesh-ancestor
153742084|NCT00523432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153742085|NCT00523432|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153742086|NCT00523432|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153742087|NCT00523432|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153742088|NCT00523432|Antifungal Agents|antifungal agents|mesh-ancestor
153742089|NCT00512044|Anesthetics|anesthetics|mesh-list
153742090|NCT00512044|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153742091|NCT00512044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153572323|NCT03796416|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
153572324|NCT03796416|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153572325|NCT03796416|Oxytocics|oxytocics|mesh-ancestor
153742092|NCT04726007|Fibrinolytic Agents|fibrinolytic agents|mesh-list
153730702|NCT02964455|Antimitotic Agents|antimitotic agents|mesh-ancestor
153730703|NCT02964455|Mitosis Modulators|mitosis modulators|mesh-ancestor
153730704|NCT02964455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153730705|NCT00142155|Rituximab|rituximab|mesh-list
153730706|NCT00142155|Antibodies|antibodies|mesh-list
153730707|NCT00142155|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
153730708|NCT00142155|Immunologic Factors|immunologic factors|mesh-ancestor
153730709|NCT00142155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153567738|NCT05017987|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153730710|NCT00142155|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153742093|NCT04726007|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153742094|NCT04726007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153742095|NCT00521950|Mercaptopurine|mercaptopurine|mesh-list
153742096|NCT00521950|Azathioprine|azathioprine|mesh-list
153742097|NCT00521950|Antimetabolites|antimetabolites|mesh-ancestor
153742098|NCT00521950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153742099|NCT00521950|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153742100|NCT00521950|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153812492|NCT02957604|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153742101|NCT00521950|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153742102|NCT00521950|Immunologic Factors|immunologic factors|mesh-ancestor
153742103|NCT00521950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153742104|NCT00521950|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153742105|NCT00521950|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153742106|NCT00521950|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153478023|NCT01060098|Adalimumab|adalimumab|mesh-list
153742113|NCT00523666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153742114|NCT00523666|Parasympathomimetics|parasympathomimetics|mesh-ancestor
153742115|NCT00523666|Autonomic Agents|autonomic agents|mesh-ancestor
153742116|NCT00523666|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153742117|NCT00523666|Nootropic Agents|nootropic agents|mesh-ancestor
153742118|NCT00167583|Interferons|interferons|mesh-list
153742119|NCT00167583|Interferon-alpha|interferon-alpha|mesh-list
153742120|NCT00167583|Interferon alpha-2|interferon alpha-2|mesh-list
153572327|NCT03782142|Dolutegravir|dolutegravir|mesh-list
153572328|NCT03782142|Rilpivirine|rilpivirine|mesh-list
153572329|NCT03782142|Cobicistat mixture with darunavir|cobicistat mixture with darunavir|mesh-list
153572330|NCT03782142|Antiviral Agents|antiviral agents|mesh-ancestor
153572331|NCT03782142|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153572332|NCT03782142|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153572333|NCT03782142|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153742121|NCT00167583|Cyclosporine|cyclosporine|mesh-list
153742122|NCT00167583|Cyclosporins|cyclosporins|mesh-list
153742123|NCT00167583|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153742124|NCT00167583|Antiviral Agents|antiviral agents|mesh-ancestor
153742125|NCT00167583|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153742126|NCT00167583|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153742127|NCT00167583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153742128|NCT00167583|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153742129|NCT00167583|Immunologic Factors|immunologic factors|mesh-ancestor
153742130|NCT00167583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153742131|NCT00167583|Antifungal Agents|antifungal agents|mesh-ancestor
153579156|NCT01737671|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153742132|NCT00167583|Dermatologic Agents|dermatologic agents|mesh-ancestor
153742133|NCT00167583|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153742134|NCT00167583|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
153742135|NCT03943511|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
153742136|NCT03943511|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153742137|NCT00172809|Interferons|interferons|mesh-list
153742138|NCT00172809|Interferon-alpha|interferon-alpha|mesh-list
153742139|NCT00172809|Interferon alpha-2|interferon alpha-2|mesh-list
153742140|NCT00172809|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
153742141|NCT00172809|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153742142|NCT00172809|Antiviral Agents|antiviral agents|mesh-ancestor
153742143|NCT00172809|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153742144|NCT00172809|Immunologic Factors|immunologic factors|mesh-ancestor
153742145|NCT00172809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153742146|NCT04696120|Apixaban|apixaban|mesh-list
153742147|NCT04696120|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
153742148|NCT04696120|Antithrombins|antithrombins|mesh-ancestor
153742149|NCT04696120|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
153742150|NCT04696120|Protease Inhibitors|protease inhibitors|mesh-ancestor
153742151|NCT04696120|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153742152|NCT04696120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153742153|NCT04696120|Anticoagulants|anticoagulants|mesh-ancestor
153742154|NCT00512395|Fentanyl|fentanyl|mesh-list
153742155|NCT00512395|Ropivacaine|ropivacaine|mesh-list
153742156|NCT00512395|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153742157|NCT00512395|Narcotics|narcotics|mesh-ancestor
153572334|NCT03782142|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153572335|NCT03782142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153742158|NCT00512395|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153742159|NCT00512395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153742160|NCT00512395|Analgesics|analgesics|mesh-ancestor
153742161|NCT00512395|Sensory System Agents|sensory system agents|mesh-ancestor
153742162|NCT00512395|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153742163|NCT00512395|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153742164|NCT00512395|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153742165|NCT00512395|Anesthetics, General|anesthetics, general|mesh-ancestor
153742166|NCT00512395|Anesthetics|anesthetics|mesh-ancestor
153742167|NCT00512395|Anesthetics, Local|anesthetics, local|mesh-ancestor
153742168|NCT00512473|Hormones|hormones|mesh-list
153742169|NCT00512473|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153742170|NCT00512473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153742171|NCT00524095|Fluticasone|fluticasone|mesh-list
153742172|NCT00524095|Xhance|xhance|mesh-list
153742173|NCT00524095|Azithromycin|azithromycin|mesh-list
153742174|NCT00524095|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153742175|NCT00524095|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153742176|NCT00524095|Autonomic Agents|autonomic agents|mesh-ancestor
153742177|NCT00524095|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153742187|NCT00512629|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
153742188|NCT00512629|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
153742189|NCT00512668|Sirolimus|sirolimus|mesh-list
153742190|NCT00512668|Leuprolide|leuprolide|mesh-list
153742191|NCT00512668|Goserelin|goserelin|mesh-list
153742192|NCT00512668|Flutamide|flutamide|mesh-list
153742193|NCT00512668|Temsirolimus|temsirolimus|mesh-list
153742194|NCT00512668|Bicalutamide|bicalutamide|mesh-list
153742195|NCT00512668|Nilutamide|nilutamide|mesh-list
153742196|NCT00512668|MTOR Inhibitors|mtor inhibitors|mesh-list
153742197|NCT00512668|Fertility Agents, Female|fertility agents, female|mesh-ancestor
153742198|NCT00512668|Fertility Agents|fertility agents|mesh-ancestor
153572336|NCT03782142|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153572337|NCT03782142|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153572338|NCT03782142|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
153572339|NCT03782142|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
153572340|NCT03782142|Protease Inhibitors|protease inhibitors|mesh-ancestor
153572341|NCT03782142|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
153572342|NCT03782142|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153572343|NCT03770299|Paclitaxel|paclitaxel|mesh-list
153572344|NCT03770299|Vinorelbine|vinorelbine|mesh-list
153572345|NCT03770299|Docetaxel|docetaxel|mesh-list
153572346|NCT03770299|Carboplatin|carboplatin|mesh-list
153572369|NCT03760835|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
153572370|NCT03760835|Cortisone|cortisone|mesh-list
153572371|NCT03760835|Glucocorticoids|glucocorticoids|mesh-list
153572372|NCT03760835|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153572373|NCT03760835|Antiemetics|antiemetics|mesh-ancestor
153572374|NCT03760835|Autonomic Agents|autonomic agents|mesh-ancestor
153742199|NCT00512668|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153742200|NCT00512668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153742201|NCT00512668|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153742202|NCT00512668|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153742203|NCT00512668|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153742204|NCT00512668|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153742205|NCT00512668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153742206|NCT00512668|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153742207|NCT00512668|Immunologic Factors|immunologic factors|mesh-ancestor
153742208|NCT00512668|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153742209|NCT00512668|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153579239|NCT01738282|Baclofen|baclofen|mesh-list
153742210|NCT00512668|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153742211|NCT00512668|Antifungal Agents|antifungal agents|mesh-ancestor
153742212|NCT00512668|Androgen Antagonists|androgen antagonists|mesh-ancestor
153742213|NCT00512668|Hormone Antagonists|hormone antagonists|mesh-ancestor
153742214|NCT00512668|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153742215|NCT00167739|Pyrimethamine|pyrimethamine|mesh-list
153742216|NCT00167739|Sulfadoxine|sulfadoxine|mesh-list
153742217|NCT00167739|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
153742218|NCT00167739|Quinine|quinine|mesh-list
153742219|NCT00167739|Antimalarials|antimalarials|mesh-ancestor
153572375|NCT03760835|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153572376|NCT03760835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153572377|NCT03760835|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153572378|NCT03760835|Hormones|hormones|mesh-ancestor
153572379|NCT03760835|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153572380|NCT03760835|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153572381|NCT03760835|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153572382|NCT03759496|Durvalumab|durvalumab|mesh-list
153572383|NCT03759496|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153572384|NCT03759496|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153572385|NCT03759184|Obinutuzumab|obinutuzumab|mesh-list
153572386|NCT03759184|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153572387|NCT03759184|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153572388|NCT03727750|Gemtuzumab|gemtuzumab|mesh-list
153572389|NCT03727750|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153572390|NCT03727750|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153572391|NCT03727750|Immunotoxins|immunotoxins|mesh-ancestor
153572392|NCT03727750|Immunoconjugates|immunoconjugates|mesh-ancestor
153572393|NCT03727750|Immunologic Factors|immunologic factors|mesh-ancestor
153572420|NCT03660241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153572422|NCT03651102|Hydroxyurea|hydroxyurea|mesh-list
153572433|NCT03651102|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153572434|NCT03651102|Antisickling Agents|antisickling agents|mesh-ancestor
153572435|NCT03651102|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153572436|NCT03651102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153572437|NCT03651102|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153572438|NCT03649802|Vitamin D|vitamin d|mesh-list
153572439|NCT03649802|Ergocalciferols|ergocalciferols|mesh-list
153572440|NCT03649802|Cholecalciferol|cholecalciferol|mesh-list
153572441|NCT03649802|Vitamins|vitamins|mesh-list
153742220|NCT00167739|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153742221|NCT00167739|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153742222|NCT00167739|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153742223|NCT00167739|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153742224|NCT00167739|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153742225|NCT00167739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153742226|NCT00167739|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
153742227|NCT00167739|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
153742228|NCT00167739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153742229|NCT00167739|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
153742230|NCT00167739|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153742231|NCT00167739|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153742232|NCT00167739|Analgesics|analgesics|mesh-ancestor
153742233|NCT00167739|Sensory System Agents|sensory system agents|mesh-ancestor
153742234|NCT00524251|Esomeprazole|esomeprazole|mesh-list
153742235|NCT00524251|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
153730712|NCT00142155|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153730713|NCT00152490|Certolizumab Pegol|certolizumab pegol|mesh-list
153730714|NCT00152490|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
153730715|NCT00152490|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153730716|NCT00152490|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153730717|NCT00152490|Immunologic Factors|immunologic factors|mesh-ancestor
153572442|NCT03649802|Micronutrients|micronutrients|mesh-ancestor
153572443|NCT03649802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153572444|NCT03649802|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153572445|NCT03649802|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153572446|NCT03573115|Adapalene|adapalene|mesh-list
153572447|NCT03573115|Benzoyl Peroxide|benzoyl peroxide|mesh-list
153572448|NCT03573115|Dermatologic Agents|dermatologic agents|mesh-ancestor
153572449|NCT03573115|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153572450|NCT03573115|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153572451|NCT03573115|Analgesics|analgesics|mesh-ancestor
153572452|NCT03573115|Sensory System Agents|sensory system agents|mesh-ancestor
153572453|NCT03573115|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153572454|NCT03573115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153572455|NCT03573115|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153572456|NCT03573115|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153572458|NCT03569475|Fluoxetine|fluoxetine|mesh-list
153572459|NCT03569475|Levomilnacipran|levomilnacipran|mesh-list
153572460|NCT03569475|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
153572461|NCT03569475|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153572462|NCT03569475|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153572463|NCT03569475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153572464|NCT03569475|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153572465|NCT03569475|Serotonin Agents|serotonin agents|mesh-ancestor
153572466|NCT03569475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153572467|NCT03569475|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
153572468|NCT03569475|Antidepressive Agents|antidepressive agents|mesh-ancestor
153572470|NCT03569475|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
153572471|NCT03569475|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153572472|NCT03569475|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153742236|NCT00524251|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153742237|NCT00524251|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
153742238|NCT00524251|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153742239|NCT00524251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153742240|NCT00512824|Calcium Carbonate|calcium carbonate|mesh-list
153742241|NCT00512824|Calcium|calcium|mesh-list
153742242|NCT00512824|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153742243|NCT00512824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153742259|NCT00525889|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153742260|NCT00525889|Immunologic Factors|immunologic factors|mesh-ancestor
153742261|NCT00525889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153742262|NCT00524524|Beta-lapachone|beta-lapachone|mesh-list
153812494|NCT02957604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153742263|NCT00524524|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153742264|NCT00524524|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153742265|NCT00524524|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153742266|NCT00524524|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153742267|NCT00524524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153742268|NCT00524524|Antiviral Agents|antiviral agents|mesh-ancestor
153742269|NCT03879122|Docetaxel|docetaxel|mesh-list
153742270|NCT03879122|Nivolumab|nivolumab|mesh-list
153742271|NCT03879122|Ipilimumab|ipilimumab|mesh-list
153742272|NCT03879122|Androgens|androgens|mesh-list
153742273|NCT03879122|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153742274|NCT03879122|Tubulin Modulators|tubulin modulators|mesh-ancestor
153742275|NCT03879122|Antimitotic Agents|antimitotic agents|mesh-ancestor
153742276|NCT03879122|Mitosis Modulators|mitosis modulators|mesh-ancestor
153742277|NCT03879122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153572473|NCT03569475|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
153572474|NCT03569475|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153572489|NCT03533712|Vitamin B Complex|vitamin b complex|mesh-ancestor
153572490|NCT03533712|Vitamins|vitamins|mesh-ancestor
153572491|NCT03533712|Micronutrients|micronutrients|mesh-ancestor
153572492|NCT03533712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153572493|NCT03523520|Naltrexone|naltrexone|mesh-list
153572494|NCT03523520|Bromides|bromides|mesh-list
153572495|NCT03523520|Methylnaltrexone|methylnaltrexone|mesh-list
153572496|NCT03523520|Naloxegol|naloxegol|mesh-list
153572497|NCT03523520|Anticonvulsants|anticonvulsants|mesh-ancestor
153572498|NCT03523520|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
153572499|NCT03523520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153572500|NCT03523520|Sensory System Agents|sensory system agents|mesh-ancestor
153572501|NCT03523520|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153572502|NCT03523520|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
153572503|NCT03518242|Cyclophosphamide|cyclophosphamide|mesh-list
153572504|NCT03518242|Capecitabine|capecitabine|mesh-list
153572505|NCT03518242|Methotrexate|methotrexate|mesh-list
153572506|NCT03518242|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153572507|NCT03518242|Immunologic Factors|immunologic factors|mesh-ancestor
153816762|NCT00426491|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
153816763|NCT00426491|Abortifacient Agents|abortifacient agents|mesh-ancestor
153742278|NCT03879122|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153742279|NCT03879122|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153742280|NCT03879122|Hormones|hormones|mesh-ancestor
153742281|NCT03879122|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153742282|NCT03879122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153742283|NCT00525928|Varenicline|varenicline|mesh-list
153742284|NCT00525928|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
153742285|NCT00525928|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
153742286|NCT00525928|Cholinergic Agents|cholinergic agents|mesh-ancestor
153742287|NCT00525928|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153742288|NCT00525928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153742289|NCT00525928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153742291|NCT00167817|Antidepressive Agents|antidepressive agents|mesh-ancestor
153742292|NCT00167817|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153742293|NCT00167817|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153742294|NCT00167817|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153742295|NCT00167817|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153742296|NCT00167817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153742297|NCT00167817|Dopamine Agonists|dopamine agonists|mesh-ancestor
153742298|NCT00167817|Dopamine Agents|dopamine agents|mesh-ancestor
153742299|NCT00167817|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153742300|NCT00167817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153742301|NCT00167817|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
153742302|NCT00167817|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
153742303|NCT00167817|Serotonin Agents|serotonin agents|mesh-ancestor
153742304|NCT00167817|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
153742320|NCT03845348|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153742321|NCT03845348|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153742322|NCT03845348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153742323|NCT03845348|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153742324|NCT03845348|Hormone Antagonists|hormone antagonists|mesh-ancestor
153816764|NCT00426491|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153816765|NCT00426491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153816766|NCT00426491|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
153816767|NCT00426491|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153816768|NCT00426491|Oxytocics|oxytocics|mesh-ancestor
153816769|NCT00426530|Everolimus|everolimus|mesh-list
153816770|NCT00426530|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
153742325|NCT03845348|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153742326|NCT03845348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153730718|NCT00152490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153742327|NCT03845348|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
153742329|NCT04723563|Anticoagulants|anticoagulants|mesh-ancestor
153742330|NCT04723563|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153742331|NCT04723563|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153742332|NCT04723563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153742334|NCT00525967|Methadone|methadone|mesh-list
153742335|NCT00525967|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153742336|NCT00525967|Analgesics|analgesics|mesh-ancestor
153742337|NCT00525967|Sensory System Agents|sensory system agents|mesh-ancestor
153742338|NCT00525967|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153742339|NCT00525967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153742340|NCT00525967|Antipyretics|antipyretics|mesh-ancestor
153742341|NCT00525967|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153742342|NCT00525967|Narcotics|narcotics|mesh-ancestor
153742343|NCT00525967|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153742344|NCT00525967|Antitussive Agents|antitussive agents|mesh-ancestor
153742345|NCT00525967|Respiratory System Agents|respiratory system agents|mesh-ancestor
153742346|NCT00167856|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
153742347|NCT00167856|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
153742348|NCT00167856|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153742349|NCT00167856|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153742350|NCT00167856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153742351|NCT00167856|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153742352|NCT00167856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153742353|NCT00167856|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
153742354|NCT00167856|Antidepressive Agents|antidepressive agents|mesh-ancestor
153742355|NCT00167856|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153742356|NCT00526006|Esomeprazole|esomeprazole|mesh-list
153816771|NCT00426530|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153816772|NCT00426530|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153816773|NCT00426530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153816774|NCT00426530|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153572508|NCT03518242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153572509|NCT03518242|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153742357|NCT00526006|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
153742358|NCT00526006|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153742359|NCT00526006|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
153742360|NCT00526006|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153742368|NCT02946814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153742370|NCT00524836|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
153742371|NCT00524836|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
153742372|NCT00524836|Histamine Antagonists|histamine antagonists|mesh-ancestor
153742373|NCT00524836|Histamine Agents|histamine agents|mesh-ancestor
153742374|NCT00524836|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153742375|NCT00524836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153742376|NCT00524836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153742377|NCT00524875|Bevacizumab|bevacizumab|mesh-list
153742378|NCT00524875|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153742379|NCT00524875|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153742380|NCT00524875|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153742381|NCT00524875|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153812504|NCT00329069|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153572510|NCT03518242|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153572511|NCT03518242|Alkylating Agents|alkylating agents|mesh-ancestor
153572514|NCT03518242|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153572515|NCT03518242|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153572516|NCT03518242|Antimetabolites|antimetabolites|mesh-ancestor
153572517|NCT03518242|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
153572518|NCT03518242|Abortifacient Agents|abortifacient agents|mesh-ancestor
153572519|NCT03518242|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153572520|NCT03518242|Dermatologic Agents|dermatologic agents|mesh-ancestor
153572521|NCT03518242|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153572522|NCT03518242|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153572523|NCT03518242|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153572524|NCT03500549|Eculizumab|eculizumab|mesh-list
153572525|NCT03500549|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
153572526|NCT03500549|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153572527|NCT03500549|Immunologic Factors|immunologic factors|mesh-ancestor
153572528|NCT03500549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153572529|NCT03435185|Lidocaine|lidocaine|mesh-list
153572530|NCT03435185|Anesthetics, Local|anesthetics, local|mesh-ancestor
153572531|NCT03435185|Anesthetics|anesthetics|mesh-ancestor
153572532|NCT03435185|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153572533|NCT03435185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153572534|NCT03435185|Sensory System Agents|sensory system agents|mesh-ancestor
153572535|NCT03435185|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153572536|NCT03435185|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153572537|NCT03435185|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
153572538|NCT03435185|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153572549|NCT03383380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153572550|NCT03242772|Amphetamine|amphetamine|mesh-list
153572551|NCT03242772|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
153572552|NCT03242772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153572553|NCT03242772|Sympathomimetics|sympathomimetics|mesh-ancestor
153572554|NCT03242772|Autonomic Agents|autonomic agents|mesh-ancestor
153572555|NCT03242772|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153572556|NCT03242772|Dopamine Agents|dopamine agents|mesh-ancestor
153572557|NCT03242772|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153572558|NCT03242772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153742383|NCT00524875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153742384|NCT00524875|Growth Inhibitors|growth inhibitors|mesh-ancestor
153742385|NCT00524914|Apomorphine|apomorphine|mesh-list
153742386|NCT00524914|Emetics|emetics|mesh-ancestor
153742387|NCT00524914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153742388|NCT00524914|Autonomic Agents|autonomic agents|mesh-ancestor
153742389|NCT00524914|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153742390|NCT00524914|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153742391|NCT00524914|Dopamine Agonists|dopamine agonists|mesh-ancestor
153742392|NCT00524914|Dopamine Agents|dopamine agents|mesh-ancestor
153742393|NCT00524914|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153742394|NCT00524914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153742395|NCT02957864|Tenofovir|tenofovir|mesh-list
153742396|NCT02957864|Abacavir|abacavir|mesh-list
153742397|NCT02957864|Antiviral Agents|antiviral agents|mesh-ancestor
153742398|NCT02957864|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153742399|NCT02957864|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153742400|NCT02957864|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153812508|NCT00429624|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153812509|NCT00429624|Analgesics|analgesics|mesh-ancestor
153812510|NCT00429624|Sensory System Agents|sensory system agents|mesh-ancestor
153812511|NCT00429624|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153812512|NCT00429624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153812513|NCT00429624|Antipyretics|antipyretics|mesh-ancestor
153812514|NCT00329147|Paroxetine|paroxetine|mesh-list
153812515|NCT00329147|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
153742401|NCT02957864|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153572559|NCT03242772|Adrenergic Agents|adrenergic agents|mesh-ancestor
153572560|NCT03242772|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
153572561|NCT03242772|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153572562|NCT03242772|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153572563|NCT03242772|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
153572564|NCT03236311|Adenosine|adenosine|mesh-list
153572565|NCT03236311|Regadenoson|regadenoson|mesh-list
153572566|NCT03236311|Analgesics|analgesics|mesh-ancestor
153572567|NCT03236311|Sensory System Agents|sensory system agents|mesh-ancestor
153572568|NCT03236311|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153572569|NCT03236311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153572570|NCT03236311|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153572571|NCT03236311|Vasodilator Agents|vasodilator agents|mesh-ancestor
153572572|NCT03236311|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
153572573|NCT03236311|Purinergic Agonists|purinergic agonists|mesh-ancestor
153572574|NCT03236311|Purinergic Agents|purinergic agents|mesh-ancestor
153572575|NCT03236311|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153572576|NCT03236311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153572577|NCT03236311|Adenosine A2 Receptor Agonists|adenosine a2 receptor agonists|mesh-ancestor
153572578|NCT03234686|Deferiprone|deferiprone|mesh-list
153572579|NCT03234686|Iron Chelating Agents|iron chelating agents|mesh-ancestor
153572580|NCT03234686|Chelating Agents|chelating agents|mesh-ancestor
153572581|NCT03234686|Sequestering Agents|sequestering agents|mesh-ancestor
153572589|NCT03223974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153572591|NCT03192046|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
153572592|NCT03192046|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153572594|NCT03190369|Viscosupplements|viscosupplements|mesh-ancestor
153572595|NCT03190369|Protective Agents|protective agents|mesh-ancestor
153572596|NCT03190369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153572597|NCT05438342|Immunomodulating Agents|immunomodulating agents|mesh-list
153572598|NCT05438342|Immunologic Factors|immunologic factors|mesh-ancestor
153572599|NCT05438342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153572600|NCT05438108|Bevacizumab|bevacizumab|mesh-list
153572601|NCT05438108|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153742402|NCT02957864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153742404|NCT02957864|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153742405|NCT00168012|Immunoglobulins|immunoglobulins|mesh-list
153742406|NCT00168012|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
153742407|NCT00168012|Antibodies|antibodies|mesh-list
153730719|NCT00152490|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153742408|NCT00168012|Immunologic Factors|immunologic factors|mesh-ancestor
153742409|NCT00168012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153742411|NCT03585452|Propofol|propofol|mesh-list
153742412|NCT03585452|Anesthetics|anesthetics|mesh-ancestor
153742413|NCT03585452|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153742414|NCT03585452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153742415|NCT03585452|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153742416|NCT03585452|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153742417|NCT03585452|Analgesics|analgesics|mesh-ancestor
153742418|NCT03585452|Sensory System Agents|sensory system agents|mesh-ancestor
153742419|NCT03585452|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153742420|NCT03585452|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
153742421|NCT03585452|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153742422|NCT03585452|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153742423|NCT03585452|Adrenergic Agents|adrenergic agents|mesh-ancestor
153742424|NCT03585452|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153742425|NCT03585452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153742426|NCT03585452|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153572612|NCT05437718|Anesthetics, Local|anesthetics, local|mesh-ancestor
153572613|NCT05437718|Anesthetics|anesthetics|mesh-ancestor
153572614|NCT05437718|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153572615|NCT05437718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153572616|NCT05437718|Sensory System Agents|sensory system agents|mesh-ancestor
153352518|NCT00539942|PENTA|penta|mesh-list
153572617|NCT05437718|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153572618|NCT05437497|Propofol|propofol|mesh-list
153458116|NCT04028778|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153458117|NCT04028778|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153458118|NCT04028778|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153458119|NCT04028778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153458120|NCT04028778|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153458121|NCT04028856|Interferons|interferons|mesh-list
153458122|NCT04028856|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153458123|NCT04028856|Antiviral Agents|antiviral agents|mesh-ancestor
153458124|NCT04028856|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153458125|NCT03594474|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
153458126|NCT03594474|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-list
153572619|NCT05437497|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153572620|NCT05437497|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153572621|NCT05437497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153742427|NCT03585452|Anesthetics, General|anesthetics, general|mesh-ancestor
153742428|NCT02947672|Dexamethasone|dexamethasone|mesh-list
153742429|NCT02947672|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153742452|NCT00168051|Coagulants|coagulants|mesh-ancestor
153742453|NCT00526318|Cyclophosphamide|cyclophosphamide|mesh-list
153742454|NCT00526318|Melphalan|melphalan|mesh-list
153742455|NCT00526318|Ifosfamide|ifosfamide|mesh-list
153742456|NCT00526318|Dacarbazine|dacarbazine|mesh-list
153742457|NCT00526318|Carboplatin|carboplatin|mesh-list
153742458|NCT00526318|Doxorubicin|doxorubicin|mesh-list
153742459|NCT00526318|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
153742460|NCT00526318|Etoposide|etoposide|mesh-list
153742461|NCT00526318|Vincristine|vincristine|mesh-list
153742462|NCT00526318|Topotecan|topotecan|mesh-list
153742463|NCT00526318|Etoposide phosphate|etoposide phosphate|mesh-list
153742464|NCT00526318|Vindesine|vindesine|mesh-list
153742465|NCT00526318|3-Iodobenzylguanidine|3-iodobenzylguanidine|mesh-list
153742466|NCT00526318|Isotretinoin|isotretinoin|mesh-list
153742467|NCT00526318|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153742468|NCT00526318|Immunologic Factors|immunologic factors|mesh-ancestor
153742469|NCT00526318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153742470|NCT00526318|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153742471|NCT00526318|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153742472|NCT00526318|Alkylating Agents|alkylating agents|mesh-ancestor
153742473|NCT00526318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153742474|NCT00526318|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153742475|NCT00526318|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153742476|NCT00526318|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153742477|NCT00526318|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153742517|NCT00526513|Insulin glulisine|insulin glulisine|mesh-list
153742518|NCT00526513|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153742519|NCT00526513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153742520|NCT00168168|Lenograstim|lenograstim|mesh-list
153742521|NCT00168168|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153742522|NCT00168168|Immunologic Factors|immunologic factors|mesh-ancestor
153742523|NCT00168168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153742525|NCT03225755|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153742526|NCT03225755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153742527|NCT00525577|Probucol|probucol|mesh-list
153742528|NCT00525577|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153742529|NCT00525577|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153742530|NCT00525577|Antimetabolites|antimetabolites|mesh-ancestor
153742531|NCT00525577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153742532|NCT00525577|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153742533|NCT00525577|Antioxidants|antioxidants|mesh-ancestor
153742534|NCT00525577|Protective Agents|protective agents|mesh-ancestor
153742535|NCT00525577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153742536|NCT03186755|Olopatadine Hydrochloride|olopatadine hydrochloride|mesh-list
153742537|NCT03186755|Ophthalmic Solutions|ophthalmic solutions|mesh-list
153742538|NCT03186755|Hyaluronic Acid|hyaluronic acid|mesh-list
153742539|NCT03186755|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
153742540|NCT03186755|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153742541|NCT03186755|Immunologic Factors|immunologic factors|mesh-ancestor
153742542|NCT03186755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153742543|NCT03186755|Viscosupplements|viscosupplements|mesh-ancestor
153742561|NCT00525616|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153742562|NCT00525616|Immunologic Factors|immunologic factors|mesh-ancestor
153742563|NCT00525616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153742579|NCT02947243|Morphine|morphine|mesh-list
153742580|NCT02947243|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153742581|NCT02947243|Narcotics|narcotics|mesh-ancestor
153742582|NCT02947243|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153742583|NCT02947243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153742584|NCT02947243|Analgesics|analgesics|mesh-ancestor
153742585|NCT02947243|Sensory System Agents|sensory system agents|mesh-ancestor
153742586|NCT02947243|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153742587|NCT02946970|Quinine|quinine|mesh-list
153742588|NCT02946970|Antimalarials|antimalarials|mesh-ancestor
153742589|NCT02946970|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153742590|NCT02946970|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153742591|NCT02946970|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153742592|NCT02946970|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
153742593|NCT02946970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153742594|NCT02946970|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
153742595|NCT02946970|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153742596|NCT02946970|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153742597|NCT02946970|Analgesics|analgesics|mesh-ancestor
153742598|NCT02946970|Sensory System Agents|sensory system agents|mesh-ancestor
153742599|NCT00527020|Nicotine|nicotine|mesh-list
153478525|NCT01134198|Mifepristone|mifepristone|mesh-list
153742610|NCT00407277|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
153742611|NCT00407277|Autonomic Agents|autonomic agents|mesh-ancestor
153742612|NCT00407277|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153572622|NCT05437497|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153572623|NCT05437497|Anesthetics, General|anesthetics, general|mesh-ancestor
153572624|NCT05437497|Anesthetics|anesthetics|mesh-ancestor
153572625|NCT05437471|Letrozole|letrozole|mesh-list
153572626|NCT05437471|Dydrogesterone|dydrogesterone|mesh-list
153572627|NCT05437471|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153572628|NCT05437471|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
153572629|NCT05437471|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153572630|NCT05437471|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153572631|NCT05437471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153572632|NCT05437471|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
153572633|NCT05437471|Hormone Antagonists|hormone antagonists|mesh-ancestor
153572634|NCT05437471|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153572635|NCT05437471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153572636|NCT05437471|Progestins|progestins|mesh-ancestor
153572637|NCT05437471|Hormones|hormones|mesh-ancestor
153572638|NCT05437432|Lithium Carbonate|lithium carbonate|mesh-list
153572639|NCT05437432|Methamphetamine|methamphetamine|mesh-list
153572640|NCT05437432|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
153572641|NCT05437432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153572642|NCT05437432|Sympathomimetics|sympathomimetics|mesh-ancestor
153572643|NCT05437432|Autonomic Agents|autonomic agents|mesh-ancestor
153572644|NCT05437432|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153572645|NCT05437432|Dopamine Agents|dopamine agents|mesh-ancestor
153572660|NCT05437224|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153572661|NCT05436990|Pembrolizumab|pembrolizumab|mesh-list
153572662|NCT05436990|Vactosertib|vactosertib|mesh-list
153572663|NCT05436990|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153742614|NCT00407277|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
153742615|NCT00407277|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
153742616|NCT00407277|Cholinergic Agents|cholinergic agents|mesh-ancestor
153742617|NCT00407277|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153742618|NCT00407277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153742619|NCT00527059|Simendan|simendan|mesh-list
153742620|NCT00527059|Spironolactone|spironolactone|mesh-list
153742621|NCT00527059|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
153742622|NCT00527059|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
153742623|NCT00527059|Hormone Antagonists|hormone antagonists|mesh-ancestor
153742624|NCT00527059|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153730720|NCT00134888|Buprenorphine|buprenorphine|mesh-list
153742625|NCT00527059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153742626|NCT00527059|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
153742627|NCT00527059|Diuretics|diuretics|mesh-ancestor
153742628|NCT00527059|Natriuretic Agents|natriuretic agents|mesh-ancestor
153742629|NCT00527059|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
153742630|NCT00527059|Adrenergic Agents|adrenergic agents|mesh-ancestor
153742631|NCT00527059|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153742632|NCT00527059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153742633|NCT00527059|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
153742634|NCT00527059|Vasodilator Agents|vasodilator agents|mesh-ancestor
153572664|NCT05436990|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153572665|NCT05436990|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153572666|NCT05436990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153572667|NCT05436990|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153572668|NCT05436990|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153572669|NCT05426811|Raltitrexed|raltitrexed|mesh-list
153572670|NCT05426811|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153572671|NCT05426811|Antimetabolites|antimetabolites|mesh-ancestor
153572672|NCT05426811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153572673|NCT05426811|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153812516|NCT00329147|Desipramine|desipramine|mesh-list
153572674|NCT05426811|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153572689|NCT04895046|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153781609|NCT00231101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153572690|NCT04590586|Thalidomide|thalidomide|mesh-list
153572691|NCT04590586|Apremilast|apremilast|mesh-list
153572692|NCT04590586|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
153572693|NCT04590586|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153572694|NCT04590586|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153572695|NCT04590586|Analgesics|analgesics|mesh-ancestor
153572696|NCT04590586|Sensory System Agents|sensory system agents|mesh-ancestor
153572697|NCT04590586|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153572698|NCT04590586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153742641|NCT03156452|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153742642|NCT03156452|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153742643|NCT03156452|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
153742644|NCT03156452|Antitubercular Agents|antitubercular agents|mesh-ancestor
153742645|NCT03156452|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153742646|NCT03156452|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153742647|NCT03156452|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153742648|NCT03156452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153742649|NCT03156452|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153742650|NCT03156452|Glucocorticoids|glucocorticoids|mesh-ancestor
153742651|NCT03156452|Hormones|hormones|mesh-ancestor
153742652|NCT03156452|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153742653|NCT03156452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153742654|NCT03156452|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153742655|NCT00525772|Ciclesonide|ciclesonide|mesh-list
153742656|NCT00525772|Glucocorticoids|glucocorticoids|mesh-ancestor
153742657|NCT00525772|Hormones|hormones|mesh-ancestor
153781931|NCT04557475|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153579684|NCT01741558|Riboflavin|riboflavin|mesh-list
153742658|NCT00525772|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153742659|NCT00525772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153742660|NCT00525772|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
153742672|NCT02957786|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
153742745|NCT00173745|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153742746|NCT00173745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153742747|NCT00173745|Cholinergic Agents|cholinergic agents|mesh-ancestor
153742748|NCT00173745|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153742749|NCT00173745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153742750|NCT00173745|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
153742751|NCT00173745|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153742752|NCT02945644|Trazodone|trazodone|mesh-list
153742753|NCT02945644|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153742754|NCT02945644|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153742755|NCT02945644|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153742756|NCT02945644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153742757|NCT02945644|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153742758|NCT02945644|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
153742759|NCT02945644|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153742760|NCT02945644|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153742761|NCT02945644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153742762|NCT02945644|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153742763|NCT02945644|Serotonin Agents|serotonin agents|mesh-ancestor
153742764|NCT02945644|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
153742765|NCT02945644|Antidepressive Agents|antidepressive agents|mesh-ancestor
153742766|NCT02945527|Dexamethasone|dexamethasone|mesh-list
153742767|NCT02945527|Acetazolamide|acetazolamide|mesh-list
153742768|NCT02945527|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153742769|NCT02945527|Antiemetics|antiemetics|mesh-ancestor
153742770|NCT02945527|Autonomic Agents|autonomic agents|mesh-ancestor
153742792|NCT00168363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153572699|NCT04590586|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153572700|NCT04590586|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153742834|NCT00529750|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153742835|NCT00529750|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
153742836|NCT00529750|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
153742837|NCT00529750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153742838|NCT00529750|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153742839|NCT00529750|Sympatholytics|sympatholytics|mesh-ancestor
153742840|NCT00529750|Autonomic Agents|autonomic agents|mesh-ancestor
153742841|NCT00529750|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153742842|NCT00529750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153742843|NCT00529750|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
153742844|NCT00529750|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
153742845|NCT00529750|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
153742846|NCT00529750|Adrenergic Agents|adrenergic agents|mesh-ancestor
153742847|NCT00529750|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153742862|NCT00168441|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153742863|NCT00168441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153742864|NCT00168441|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
153742865|NCT00168441|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153742866|NCT00168480|Botulinum Toxins|botulinum toxins|mesh-list
153742867|NCT00168480|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
153742868|NCT00168480|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
153742879|NCT00527449|Epirubicin|epirubicin|mesh-list
153742945|NCT00527800|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153742946|NCT00527800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153742947|NCT00527800|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
153742948|NCT00527800|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
153742949|NCT00527800|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153742950|NCT00527800|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153742952|NCT02945293|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153742953|NCT02945293|Narcotics|narcotics|mesh-ancestor
153742954|NCT02945293|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153742955|NCT02945293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153742956|NCT02945293|Analgesics|analgesics|mesh-ancestor
153742957|NCT02945293|Sensory System Agents|sensory system agents|mesh-ancestor
153742958|NCT02945293|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153742959|NCT04692415|Insulin Glargine|insulin glargine|mesh-list
153742960|NCT04692415|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153742961|NCT04692415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153742971|NCT00144677|Immunologic Factors|immunologic factors|mesh-ancestor
153742972|NCT00144677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153743002|NCT00531193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153743003|NCT00531193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153743005|NCT00144755|Hematinics|hematinics|mesh-ancestor
153730722|NCT00134888|Naloxone|naloxone|mesh-list
153730723|NCT00134888|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153730724|NCT00134888|Narcotics|narcotics|mesh-ancestor
153730725|NCT00134888|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153730726|NCT00134888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153730727|NCT00134888|Analgesics|analgesics|mesh-ancestor
153730728|NCT00134888|Sensory System Agents|sensory system agents|mesh-ancestor
153730729|NCT00134888|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153743006|NCT00531271|Docetaxel|docetaxel|mesh-list
153743007|NCT00531271|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153743008|NCT00531271|Tubulin Modulators|tubulin modulators|mesh-ancestor
153743009|NCT00531271|Antimitotic Agents|antimitotic agents|mesh-ancestor
153743010|NCT00531271|Mitosis Modulators|mitosis modulators|mesh-ancestor
153743011|NCT00531271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153743012|NCT00531310|Fludarabine|fludarabine|mesh-list
153743013|NCT00531310|Busulfan|busulfan|mesh-list
153478962|NCT01218048|Carboplatin|carboplatin|mesh-list
153743026|NCT00407862|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
153743027|NCT00407862|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
153743028|NCT00407862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153580056|NCT01743300|GABA Agents|gaba agents|mesh-ancestor
153743029|NCT00527995|Sildenafil Citrate|sildenafil citrate|mesh-list
153743030|NCT00527995|Vasodilator Agents|vasodilator agents|mesh-ancestor
153572701|NCT04590586|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
153572702|NCT04590586|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
153572703|NCT04590586|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153572704|NCT04590586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153572705|NCT04590586|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153572706|NCT04590586|Immunologic Factors|immunologic factors|mesh-ancestor
153572707|NCT04590586|Leprostatic Agents|leprostatic agents|mesh-ancestor
153572708|NCT04590586|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153572709|NCT04590586|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153572710|NCT04590586|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153572711|NCT04590586|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153572712|NCT04590586|Growth Substances|growth substances|mesh-ancestor
153572713|NCT04590586|Growth Inhibitors|growth inhibitors|mesh-ancestor
153572714|NCT04590586|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153572715|NCT04312009|Losartan|losartan|mesh-list
153572716|NCT04312009|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153743063|NCT00144872|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153743064|NCT00144872|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153743065|NCT02945020|Simeprevir|simeprevir|mesh-list
153743066|NCT02945020|Odalasvir|odalasvir|mesh-list
153743067|NCT02945020|Dabigatran|dabigatran|mesh-list
153743068|NCT02945020|Antithrombins|antithrombins|mesh-ancestor
153743069|NCT02945020|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
153743070|NCT02945020|Protease Inhibitors|protease inhibitors|mesh-ancestor
153743119|NCT00528385|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
153743121|NCT00528385|Natriuretic Agents|natriuretic agents|mesh-ancestor
153743122|NCT02944981|Gabapentin|gabapentin|mesh-list
153743123|NCT02944981|Analgesics|analgesics|mesh-ancestor
153743124|NCT02944981|Sensory System Agents|sensory system agents|mesh-ancestor
153743125|NCT02944981|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153743126|NCT02944981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153743127|NCT02944981|Anticonvulsants|anticonvulsants|mesh-ancestor
153743162|NCT00528502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153743165|NCT00528619|Sunitinib|sunitinib|mesh-list
153743166|NCT00528619|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153743167|NCT00528619|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153814660|NCT00446784|Antimetabolites|antimetabolites|mesh-ancestor
153743243|NCT00531544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153743244|NCT00531544|Growth Inhibitors|growth inhibitors|mesh-ancestor
153743245|NCT00531544|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153743246|NCT00531544|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153743247|NCT00531544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153743248|NCT00145106|Minocycline|minocycline|mesh-list
153743249|NCT00145106|Tazarotene|tazarotene|mesh-list
153743250|NCT00145106|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153743251|NCT00145106|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153743252|NCT00145106|Dermatologic Agents|dermatologic agents|mesh-ancestor
153580304|NCT01744873|Bisoprolol|bisoprolol|mesh-list
153743253|NCT00145106|Keratolytic Agents|keratolytic agents|mesh-ancestor
153743254|NCT00145184|Vitamins|vitamins|mesh-list
153743255|NCT00145184|Vitamin B Complex|vitamin b complex|mesh-list
153743256|NCT00145184|Micronutrients|micronutrients|mesh-ancestor
153743257|NCT00145184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153743258|NCT02944357|Cisplatin|cisplatin|mesh-list
153743259|NCT02944357|Gemcitabine|gemcitabine|mesh-list
153743260|NCT02944357|Vaccines|vaccines|mesh-list
153743261|NCT02944357|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153743273|NCT02944396|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153743275|NCT02944396|Antimitotic Agents|antimitotic agents|mesh-ancestor
153743276|NCT02944396|Mitosis Modulators|mitosis modulators|mesh-ancestor
153743277|NCT02944396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153743278|NCT02944396|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153743279|NCT02944396|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153743280|NCT02944396|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153743281|NCT02944396|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153743282|NCT02944396|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153743283|NCT02944396|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
153743284|NCT00174174|Modafinil|modafinil|mesh-list
153743304|NCT02944552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153743305|NCT02944552|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153743306|NCT00145301|Lumiracoxib|lumiracoxib|mesh-list
153743307|NCT00145301|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
153743308|NCT00145301|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153743309|NCT00145301|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153730740|NCT00134966|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
153743332|NCT02944201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153743333|NCT02944201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153743334|NCT02944201|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153743336|NCT02944201|Protective Agents|protective agents|mesh-ancestor
153743337|NCT02944201|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153743338|NCT02944201|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153743339|NCT02944201|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153743340|NCT02944201|Vasodilator Agents|vasodilator agents|mesh-ancestor
153743341|NCT02944201|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
153743414|NCT00169026|Antipsychotic Agents|antipsychotic agents|mesh-list
153743415|NCT00169026|Clozapine|clozapine|mesh-list
153743416|NCT00169026|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153743417|NCT00169026|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153743418|NCT00169026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153743419|NCT00169026|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153743420|NCT00169026|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153743421|NCT00169026|Serotonin Agents|serotonin agents|mesh-ancestor
153743422|NCT00169026|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153743423|NCT00169026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153743424|NCT00169026|GABA Antagonists|gaba antagonists|mesh-ancestor
153743425|NCT00169026|GABA Agents|gaba agents|mesh-ancestor
153743426|NCT00145613|Antibodies|antibodies|mesh-list
153743427|NCT00145613|Immunologic Factors|immunologic factors|mesh-ancestor
153743428|NCT00145613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153743429|NCT00531973|Doxorubicin|doxorubicin|mesh-list
153743430|NCT00531973|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
153743431|NCT00531973|Epirubicin|epirubicin|mesh-list
153743432|NCT00531973|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153743433|NCT00531973|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153743434|NCT00531973|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153743435|NCT00531973|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153743436|NCT00531973|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153743437|NCT00531973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153743438|NCT00145652|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
153743439|NCT00145652|Hematinics|hematinics|mesh-ancestor
153743440|NCT00174486|Tadalafil|tadalafil|mesh-list
153743441|NCT00174486|Vasodilator Agents|vasodilator agents|mesh-ancestor
153743442|NCT00174486|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
153743443|NCT00174486|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
153743444|NCT00174486|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153743499|NCT00169143|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153743500|NCT02942680|Aspirin|aspirin|mesh-list
153743501|NCT02942680|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153743502|NCT02942680|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153743503|NCT02942680|Analgesics|analgesics|mesh-ancestor
153743504|NCT02942680|Sensory System Agents|sensory system agents|mesh-ancestor
153730741|NCT00134966|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153743505|NCT02942680|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153743506|NCT02942680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153743507|NCT02942680|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153743508|NCT02942680|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153743509|NCT02942680|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153743510|NCT02942680|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153743525|NCT02276911|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153743526|NCT02276911|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153743527|NCT02276911|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153743528|NCT02276911|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153743529|NCT02276911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153743531|NCT00145847|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
153743532|NCT00145847|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
153743533|NCT00145847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153743534|NCT00145847|Sensory System Agents|sensory system agents|mesh-ancestor
153743535|NCT00145847|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153743536|NCT00169182|Nicotinic Acids|nicotinic acids|mesh-list
153743563|NCT02944825|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153743564|NCT02944825|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
153743587|NCT00174603|Antidepressive Agents|antidepressive agents|mesh-ancestor
153743588|NCT00174603|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153743589|NCT00174603|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153743590|NCT00174603|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153743591|NCT00174603|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153743592|NCT00174603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153743594|NCT02942563|Oxaliplatin|oxaliplatin|mesh-list
153743595|NCT02942563|Irinotecan|irinotecan|mesh-list
153731756|NCT00161226|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
153743603|NCT00145925|Gliclazide|gliclazide|mesh-list
153743604|NCT00145925|Perindopril|perindopril|mesh-list
153743605|NCT00145925|Indapamide|indapamide|mesh-list
153743606|NCT00145925|Indapamide, perindopril drug combination|indapamide, perindopril drug combination|mesh-list
153743607|NCT00145925|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
153743608|NCT00145925|Protease Inhibitors|protease inhibitors|mesh-ancestor
153743609|NCT00145925|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153743610|NCT00145925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153743611|NCT00145925|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153743612|NCT00145925|Diuretics|diuretics|mesh-ancestor
153743613|NCT00145925|Natriuretic Agents|natriuretic agents|mesh-ancestor
153743614|NCT00145925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153743615|NCT00145925|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
153812518|NCT00329147|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153743616|NCT00145925|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153743617|NCT00145925|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153743618|NCT00529321|Immunomodulating Agents|immunomodulating agents|mesh-list
153743619|NCT00529321|Immunologic Factors|immunologic factors|mesh-ancestor
153743620|NCT00529321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153743621|NCT00169221|Gefitinib|gefitinib|mesh-list
153743622|NCT00169221|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153743623|NCT00169221|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153743624|NCT00169221|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153580657|NCT01746992|Tubulin Modulators|tubulin modulators|mesh-ancestor
153743625|NCT00169221|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153743626|NCT00169221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153743627|NCT00529360|Clofarabine|clofarabine|mesh-list
153743663|NCT00169299|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
153743664|NCT00169299|Hormones|hormones|mesh-ancestor
153743665|NCT00169299|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153743666|NCT00169299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153743667|NCT00169299|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
153743668|NCT00169299|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
153743669|NCT00169299|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
153743670|NCT00169299|Contraceptive Agents|contraceptive agents|mesh-ancestor
153743671|NCT00169299|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153743672|NCT00169299|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
153743673|NCT00169299|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
153743674|NCT00169299|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
153743675|NCT00169299|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153743677|NCT02942602|Atorvastatin|atorvastatin|mesh-list
153479637|NCT01328964|Hormones|hormones|mesh-ancestor
153743705|NCT02942212|Cholinergic Agents|cholinergic agents|mesh-ancestor
153743706|NCT02942212|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153743707|NCT02942212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153743714|NCT00146120|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153743828|NCT02940379|(2S,3R,4R,5S,6R)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2H-pyran-3,4,5-triol|(2s,3r,4r,5s,6r)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2h-pyran-3,4,5-triol|mesh-list
153743896|NCT00146588|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153743897|NCT00146588|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153743898|NCT00175032|Aspirin|aspirin|mesh-list
153731758|NCT00139256|Betamethasone|betamethasone|mesh-list
153743899|NCT00175032|Celecoxib|celecoxib|mesh-list
153743900|NCT00175032|Naproxen|naproxen|mesh-list
153743901|NCT00175032|Lansoprazole|lansoprazole|mesh-list
153743902|NCT00175032|Dexlansoprazole|dexlansoprazole|mesh-list
153743903|NCT00175032|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153743904|NCT00175032|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153743905|NCT00175032|Analgesics|analgesics|mesh-ancestor
153743906|NCT00175032|Sensory System Agents|sensory system agents|mesh-ancestor
153743907|NCT00175032|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153743908|NCT00175032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153743910|NCT00175032|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153743911|NCT00175032|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153743912|NCT00175032|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153743913|NCT00175032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153743914|NCT00175032|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153743915|NCT00175032|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153743916|NCT00175032|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153743917|NCT00175032|Antipyretics|antipyretics|mesh-ancestor
153743918|NCT00175032|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
153743919|NCT00175032|Gout Suppressants|gout suppressants|mesh-ancestor
153743920|NCT00175032|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
153743921|NCT00175032|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153743922|NCT00175032|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
153743923|NCT00146627|Eflornithine|eflornithine|mesh-list
153743924|NCT00146627|Nifurtimox|nifurtimox|mesh-list
153743925|NCT00146627|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153743926|NCT00146627|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
153743939|NCT00424229|Lenalidomide|lenalidomide|mesh-list
153743940|NCT00424229|Immunologic Factors|immunologic factors|mesh-ancestor
153743941|NCT00424229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153743942|NCT00424229|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153743943|NCT00424229|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153743944|NCT00424229|Growth Substances|growth substances|mesh-ancestor
153743945|NCT00424229|Growth Inhibitors|growth inhibitors|mesh-ancestor
153743946|NCT00424229|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153743947|NCT02944123|Clopidogrel|clopidogrel|mesh-list
153743948|NCT02944123|Ticagrelor|ticagrelor|mesh-list
153743949|NCT02944123|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
153743950|NCT02944123|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153743951|NCT02944123|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
153743952|NCT02944123|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
153743953|NCT02944123|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
153743954|NCT02944123|Purinergic Agents|purinergic agents|mesh-ancestor
153814670|NCT00452985|Carboplatin|carboplatin|mesh-list
153814671|NCT00452985|Docetaxel|docetaxel|mesh-list
153743957|NCT02944123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153743959|NCT02944045|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
153743960|NCT02944045|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
153743961|NCT02944045|Prednisolone|prednisolone|mesh-list
153743962|NCT02944045|Prednisolone acetate|prednisolone acetate|mesh-list
153743963|NCT02944045|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
153743964|NCT02944045|Prednisolone phosphate|prednisolone phosphate|mesh-list
153743965|NCT02944045|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153743966|NCT02944045|Antiemetics|antiemetics|mesh-ancestor
153743967|NCT02944045|Autonomic Agents|autonomic agents|mesh-ancestor
153743968|NCT02944045|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153743969|NCT02944045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153743970|NCT02944045|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153743971|NCT02944045|Glucocorticoids|glucocorticoids|mesh-ancestor
153743972|NCT02944045|Hormones|hormones|mesh-ancestor
153743973|NCT02944045|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153743974|NCT02944045|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
153743975|NCT02944045|Protective Agents|protective agents|mesh-ancestor
153743976|NCT02944045|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153743977|NCT02944045|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153743978|NCT00169572|Dexamethasone|dexamethasone|mesh-list
153743979|NCT00169572|Ondansetron|ondansetron|mesh-list
153743980|NCT00169572|Aprepitant|aprepitant|mesh-list
153743981|NCT00169572|Fosaprepitant|fosaprepitant|mesh-list
153743982|NCT00169572|Casopitant|casopitant|mesh-list
153743983|NCT00169572|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153743984|NCT00169572|Antiemetics|antiemetics|mesh-ancestor
153572731|NCT03850483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153572733|NCT03563742|Lamivudine|lamivudine|mesh-list
153572734|NCT03563742|Rilpivirine|rilpivirine|mesh-list
153572735|NCT03563742|Antiviral Agents|antiviral agents|mesh-ancestor
153572736|NCT03563742|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153572737|NCT03563742|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153572738|NCT03563742|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153572739|NCT03563742|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153572740|NCT03563742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153572741|NCT03563742|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153572742|NCT03563742|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153572743|NCT03473925|Pembrolizumab|pembrolizumab|mesh-list
153743985|NCT00169572|Autonomic Agents|autonomic agents|mesh-ancestor
153743986|NCT00169572|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153730742|NCT00134966|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
153743988|NCT00169572|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153743989|NCT00169572|Glucocorticoids|glucocorticoids|mesh-ancestor
153744004|NCT00146783|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
153744005|NCT00146783|Amodiaquine|amodiaquine|mesh-list
153744006|NCT00146783|Antimalarials|antimalarials|mesh-ancestor
153744007|NCT00146783|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153744008|NCT00146783|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153744009|NCT00146783|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153744010|NCT00146783|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153744011|NCT00146783|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153744012|NCT00146783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153744013|NCT00146783|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
153744014|NCT00169611|Methylphenidate|methylphenidate|mesh-list
153744015|NCT00169611|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
153744016|NCT00169611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153744017|NCT00169611|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
153744018|NCT00169611|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153744019|NCT00169611|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153744020|NCT00169611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153744021|NCT00169611|Dopamine Agents|dopamine agents|mesh-ancestor
153744022|NCT00169611|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153744023|NCT02943655|Mefenamic Acid|mefenamic acid|mesh-list
153744024|NCT02943655|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
153744025|NCT02943655|Contraceptive Agents|contraceptive agents|mesh-list
153744026|NCT02943655|Medroxyprogesterone|medroxyprogesterone|mesh-list
153744027|NCT02943655|Progesterone|progesterone|mesh-list
153744028|NCT02943655|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153744033|NCT02943655|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
153744034|NCT02943655|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
153744035|NCT02943655|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
153744036|NCT02943655|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153744037|NCT02943655|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153744038|NCT02943655|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153744039|NCT02943655|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153744040|NCT02943655|Analgesics|analgesics|mesh-ancestor
153744041|NCT02943655|Sensory System Agents|sensory system agents|mesh-ancestor
153744042|NCT02943655|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153744043|NCT02943655|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153744044|NCT02943655|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153744045|NCT02943655|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153744046|NCT02943655|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153479989|NCT06189742|Immunologic Factors|immunologic factors|mesh-ancestor
153744055|NCT00175227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153744056|NCT00175227|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
153744057|NCT00175227|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153744058|NCT00175227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153744059|NCT00175227|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
153744061|NCT02940262|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
153744062|NCT02940262|Chelating Agents|chelating agents|mesh-ancestor
153744063|NCT02940262|Sequestering Agents|sequestering agents|mesh-ancestor
153744064|NCT02940262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153744065|NCT02940262|Anticoagulants|anticoagulants|mesh-ancestor
153744066|NCT02940262|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
153744067|NCT02940262|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
153744068|NCT00146900|Escitalopram|escitalopram|mesh-list
153744069|NCT00146900|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
153744070|NCT00146900|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153744071|NCT00146900|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153744072|NCT00146900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153572744|NCT03473925|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153572745|NCT03473925|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153572746|NCT03473925|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153572747|NCT03473925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153572749|NCT03424122|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
153572750|NCT03424122|Ibrutinib|ibrutinib|mesh-list
153744080|NCT02939482|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153744081|NCT02939482|Glucocorticoids|glucocorticoids|mesh-ancestor
153744082|NCT02939482|Hormones|hormones|mesh-ancestor
153744083|NCT02939482|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153744084|NCT02939482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153744085|NCT02939482|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153744086|NCT02939482|Immunologic Factors|immunologic factors|mesh-ancestor
153744087|NCT02939482|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153744088|NCT02939482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153744089|NCT00175266|Infliximab|infliximab|mesh-list
153744090|NCT00175266|Alemtuzumab|alemtuzumab|mesh-list
153744091|NCT00175266|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
153744092|NCT00175266|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153744093|NCT00175266|Dermatologic Agents|dermatologic agents|mesh-ancestor
153744094|NCT00175266|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153814673|NCT00452985|Tubulin Modulators|tubulin modulators|mesh-ancestor
153814674|NCT00452985|Antimitotic Agents|antimitotic agents|mesh-ancestor
153814675|NCT00452985|Mitosis Modulators|mitosis modulators|mesh-ancestor
153744106|NCT02939248|Sensory System Agents|sensory system agents|mesh-ancestor
153744107|NCT02939248|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153744108|NCT02939248|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153744109|NCT02939248|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
153744110|NCT02939248|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
153744111|NCT02939248|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
153744180|NCT00147563|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
153744181|NCT00147563|Hormone Antagonists|hormone antagonists|mesh-ancestor
153744182|NCT00147563|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153744183|NCT00147563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153744184|NCT00147563|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
153572751|NCT03424122|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153572752|NCT03424122|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153572753|NCT03424122|Immunologic Factors|immunologic factors|mesh-ancestor
153572754|NCT03424122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153572755|NCT03424122|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153572756|NCT03424122|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153572757|NCT03424122|Alkylating Agents|alkylating agents|mesh-ancestor
153572758|NCT03424122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153572759|NCT03424122|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153572760|NCT03424122|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153572761|NCT03424122|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153572762|NCT03230097|BI 409306|bi 409306|mesh-list
153572763|NCT03230097|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
153572764|NCT03230097|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153572765|NCT03230097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153572766|NCT02968940|Avelumab|avelumab|mesh-list
153572767|NCT02968940|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153572768|NCT02968940|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153572769|NCT02663908|Leuprolide|leuprolide|mesh-list
153744185|NCT00147563|Diuretics|diuretics|mesh-ancestor
153744186|NCT00147563|Natriuretic Agents|natriuretic agents|mesh-ancestor
153744187|NCT00147563|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153744188|NCT02938273|Cetuximab|cetuximab|mesh-list
153744189|NCT02938273|Avelumab|avelumab|mesh-list
153744190|NCT02938273|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153744191|NCT02938273|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153744192|NCT00147602|Atorvastatin|atorvastatin|mesh-list
153744193|NCT00147602|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153744194|NCT00147602|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153744195|NCT00147602|Antimetabolites|antimetabolites|mesh-ancestor
153744196|NCT00147602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153744197|NCT00147602|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153744198|NCT00147602|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
153744199|NCT00147602|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153744200|NCT02941744|Nivolumab|nivolumab|mesh-list
153744201|NCT02941744|Ipilimumab|ipilimumab|mesh-list
153744202|NCT02941744|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153744203|NCT02941744|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153744204|NCT02941744|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153744205|NCT02941744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153744206|NCT02941822|Ambroxol|ambroxol|mesh-list
153744207|NCT02941822|Expectorants|expectorants|mesh-ancestor
153744208|NCT02941822|Respiratory System Agents|respiratory system agents|mesh-ancestor
153744209|NCT02941510|Budesonide|budesonide|mesh-list
153744244|NCT03458143|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
153744245|NCT03458143|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153744246|NCT03458143|Anesthetics, General|anesthetics, general|mesh-ancestor
153744247|NCT03458143|Anesthetics|anesthetics|mesh-ancestor
153744248|NCT03458143|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153744249|NCT03458143|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
153744250|NCT03458143|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
153744251|NCT03458143|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153744252|NCT03458143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153744253|NCT03458143|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153744254|NCT03458143|Narcotics|narcotics|mesh-ancestor
153744256|NCT02941198|Trace Elements|trace elements|mesh-ancestor
153744257|NCT02941198|Micronutrients|micronutrients|mesh-ancestor
153744258|NCT02941198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153744259|NCT00147719|Colesevelam Hydrochloride|colesevelam hydrochloride|mesh-list
153744260|NCT00147719|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153744261|NCT00147719|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153744262|NCT00147719|Antimetabolites|antimetabolites|mesh-ancestor
153744263|NCT00147719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153744264|NCT00147719|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153744265|NCT05273671|Dexmedetomidine|dexmedetomidine|mesh-list
153744266|NCT05273671|Nalbuphine|nalbuphine|mesh-list
153744267|NCT05273671|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153744268|NCT05273671|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153744269|NCT05273671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153744270|NCT05273671|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153744271|NCT05273671|Analgesics|analgesics|mesh-ancestor
153744280|NCT05273671|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153744281|NCT05273671|Narcotics|narcotics|mesh-ancestor
153744282|NCT00147758|Colesevelam Hydrochloride|colesevelam hydrochloride|mesh-list
153572770|NCT02663908|Fertility Agents, Female|fertility agents, female|mesh-ancestor
153572771|NCT02663908|Fertility Agents|fertility agents|mesh-ancestor
153572772|NCT02663908|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153572776|NCT02333292|Ritonavir|ritonavir|mesh-list
153572796|NCT02203773|Venetoclax|venetoclax|mesh-list
153744291|NCT02931526|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
153744292|NCT02931526|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153781932|NCT04557475|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153581339|NCT06176144|Sevoflurane|sevoflurane|mesh-list
153744293|NCT02931526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153744294|NCT00169845|Tocopherols|tocopherols|mesh-list
153744295|NCT00169845|Vitamin E|vitamin e|mesh-list
153744296|NCT00169845|alpha-Tocopherol|alpha-tocopherol|mesh-list
153744297|NCT00169845|Beta Carotene|beta carotene|mesh-list
153744298|NCT00169845|Carotenoids|carotenoids|mesh-list
153744299|NCT00169845|Antioxidants|antioxidants|mesh-ancestor
153744300|NCT00169845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153744301|NCT00169845|Protective Agents|protective agents|mesh-ancestor
153744302|NCT00169845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153744303|NCT00169845|Vitamins|vitamins|mesh-ancestor
153744304|NCT00169845|Micronutrients|micronutrients|mesh-ancestor
153744305|NCT00169845|Provitamins|provitamins|mesh-ancestor
153572797|NCT02203773|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153572798|NCT02203773|Antimetabolites|antimetabolites|mesh-ancestor
153572799|NCT02203773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153572803|NCT02203773|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153572804|NCT02203773|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
153572805|NCT02203773|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153572806|NCT02203773|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153572807|NCT02203773|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
153572808|NCT02203773|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153744307|NCT00147836|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
153744309|NCT00147836|Gliclazide|gliclazide|mesh-list
153744310|NCT00147836|Isophane Insulin, Human|isophane insulin, human|mesh-list
153744311|NCT00147836|Insulin, Isophane|insulin, isophane|mesh-list
153744312|NCT00147836|Isophane insulin, beef|isophane insulin, beef|mesh-list
153744313|NCT00147836|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153744314|NCT00147836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153744315|NCT02931136|Huperzine A|huperzine a|mesh-list
153744316|NCT02931136|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
153744317|NCT02931136|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153744318|NCT02931136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153744319|NCT02931136|Cholinergic Agents|cholinergic agents|mesh-ancestor
153744320|NCT02931136|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153744321|NCT02931136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153744322|NCT02931136|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
153744323|NCT02931136|Protective Agents|protective agents|mesh-ancestor
153744324|NCT02931175|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
153744325|NCT02931175|Hormones|hormones|mesh-ancestor
153744326|NCT02931175|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153744327|NCT02931175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153744328|NCT00147875|Prednisone|prednisone|mesh-list
153744329|NCT00147875|Gemcitabine|gemcitabine|mesh-list
153744330|NCT00147875|Doxorubicin|doxorubicin|mesh-list
153744331|NCT00147875|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
153744332|NCT00147875|Vinblastine|vinblastine|mesh-list
153744333|NCT00147875|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153744334|NCT00147875|Antimetabolites|antimetabolites|mesh-ancestor
153744335|NCT00147875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153744336|NCT00147875|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153744337|NCT00147875|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153572809|NCT02203773|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153572810|NCT02203773|Hormone Antagonists|hormone antagonists|mesh-ancestor
153572811|NCT02203773|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153572812|NCT02203773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153572813|NCT02175030|Copper|copper|mesh-list
153572814|NCT02175030|Levonorgestrel|levonorgestrel|mesh-list
153572815|NCT02175030|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
153572816|NCT02175030|Contraceptive Agents|contraceptive agents|mesh-ancestor
153572817|NCT02175030|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153572818|NCT02175030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153744361|NCT00147914|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
153744362|NCT00147914|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153744363|NCT00147914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153744364|NCT00147914|Third Generation Cephalosporins|third generation cephalosporins|mesh-ancestor
153744365|NCT00147914|Beta Lactam Antibiotics|beta lactam antibiotics|mesh-ancestor
153744366|NCT00147953|Rituximab|rituximab|mesh-list
153744367|NCT00147953|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153744368|NCT00147953|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153744369|NCT00147953|Immunologic Factors|immunologic factors|mesh-ancestor
153744370|NCT00147953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153744371|NCT00147953|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153744372|NCT02930551|Lidocaine|lidocaine|mesh-list
153744373|NCT02930551|Anesthetics, Local|anesthetics, local|mesh-ancestor
153744374|NCT02930551|Anesthetics|anesthetics|mesh-ancestor
153744375|NCT02930551|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153744376|NCT02930551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153744377|NCT02930551|Sensory System Agents|sensory system agents|mesh-ancestor
153744378|NCT02930551|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153744379|NCT02930551|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153744380|NCT02930551|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
153744381|NCT02930551|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153744382|NCT02930551|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153744383|NCT02930551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153744384|NCT00175617|Minoxidil|minoxidil|mesh-list
153572819|NCT02175030|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
153572820|NCT02175030|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
153572821|NCT02175030|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
153572822|NCT02175030|Trace Elements|trace elements|mesh-ancestor
153572823|NCT02175030|Micronutrients|micronutrients|mesh-ancestor
153572824|NCT01555541|Cytarabine|cytarabine|mesh-list
153572825|NCT01555541|Etoposide|etoposide|mesh-list
153572826|NCT01555541|Ofatumumab|ofatumumab|mesh-list
153572827|NCT01555541|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153572828|NCT01555541|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153572835|NCT01555541|Antiviral Agents|antiviral agents|mesh-ancestor
153572836|NCT01555541|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153572837|NCT01555541|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153572838|NCT01555541|Immunologic Factors|immunologic factors|mesh-ancestor
153744386|NCT00175617|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
153744387|NCT00175617|Hormone Antagonists|hormone antagonists|mesh-ancestor
153744388|NCT00175617|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153744389|NCT00175617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153480348|NCT05736341|Midazolam|midazolam|mesh-list
153744412|NCT00148031|Interferons|interferons|mesh-list
153744413|NCT00148031|Ribavirin|ribavirin|mesh-list
153744414|NCT00148031|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153744415|NCT00148031|Antiviral Agents|antiviral agents|mesh-ancestor
153744416|NCT00148031|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153744417|NCT00148031|Antimetabolites|antimetabolites|mesh-ancestor
153744418|NCT00148031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153744419|NCT02930473|Psychotropic Drugs|psychotropic drugs|mesh-list
153744420|NCT02930434|Vitamin D|vitamin d|mesh-list
153744421|NCT02930434|Cholecalciferol|cholecalciferol|mesh-list
153744422|NCT02930434|Vitamins|vitamins|mesh-ancestor
153744423|NCT02930434|Micronutrients|micronutrients|mesh-ancestor
153744424|NCT02930434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153744425|NCT02930434|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153744426|NCT02930434|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153744427|NCT00148070|Erythromycin|erythromycin|mesh-list
153744428|NCT00148070|Erythromycin Estolate|erythromycin estolate|mesh-list
153744429|NCT00148070|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
153744430|NCT00148070|Erythromycin stearate|erythromycin stearate|mesh-list
153744431|NCT00148070|Docetaxel|docetaxel|mesh-list
153744432|NCT00148070|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153744433|NCT00148070|Tubulin Modulators|tubulin modulators|mesh-ancestor
153744434|NCT00148070|Antimitotic Agents|antimitotic agents|mesh-ancestor
153744435|NCT00148070|Mitosis Modulators|mitosis modulators|mesh-ancestor
153744436|NCT00148070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153744437|NCT00148070|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153744438|NCT00148070|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153744439|NCT00148070|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153744440|NCT00148070|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
153744441|NCT00148070|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153744442|NCT00175695|Drotrecogin alfa activated|drotrecogin alfa activated|mesh-list
153744454|NCT00148148|Amebicides|amebicides|mesh-ancestor
153744455|NCT00148148|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153744456|NCT00148148|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153744457|NCT00148148|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153744458|NCT00148148|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153744459|NCT00148148|Antifungal Agents|antifungal agents|mesh-ancestor
153744460|NCT00148148|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153744461|NCT00148148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153744462|NCT00170001|Esomeprazole|esomeprazole|mesh-list
153744463|NCT00170001|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
153744464|NCT00170001|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153744465|NCT00170001|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
153744466|NCT00170001|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153744467|NCT00170001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153744468|NCT00148265|Triamcinolone|triamcinolone|mesh-list
153744469|NCT00148265|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153744470|NCT00148265|Glucocorticoids|glucocorticoids|mesh-ancestor
153744471|NCT00148265|Hormones|hormones|mesh-ancestor
153744472|NCT00148265|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153744473|NCT00148265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153744474|NCT02929693|Gefitinib|gefitinib|mesh-list
153744475|NCT02929693|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153744476|NCT02929693|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153744477|NCT02929693|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153744478|NCT02929693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153744479|NCT02929693|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153744480|NCT00175734|Chrysarobin|chrysarobin|mesh-list
153744481|NCT00175734|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153744482|NCT00175734|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153744485|NCT00175734|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153744486|NCT00175734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153744487|NCT00175734|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153744488|NCT00175734|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153744489|NCT00148382|Cetilistat|cetilistat|mesh-list
153744490|NCT00148382|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153744491|NCT00148382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153744492|NCT00148382|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
153744493|NCT00148382|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153744494|NCT00148421|Epoetin Alfa|epoetin alfa|mesh-list
153744495|NCT00148421|Darbepoetin alfa|darbepoetin alfa|mesh-list
153744496|NCT00148421|Hematinics|hematinics|mesh-ancestor
153744497|NCT02929888|Aspirin|aspirin|mesh-list
153744498|NCT02929888|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153744499|NCT02929888|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153744500|NCT02929888|Analgesics|analgesics|mesh-ancestor
153744501|NCT02929888|Sensory System Agents|sensory system agents|mesh-ancestor
153744502|NCT02929888|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153744503|NCT02929888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153744504|NCT02929888|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153744505|NCT02929888|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153744506|NCT02929888|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153744507|NCT02929888|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153744508|NCT02929888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153744509|NCT02929888|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153744510|NCT02929888|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153744511|NCT02929888|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153744512|NCT02929888|Antipyretics|antipyretics|mesh-ancestor
153744513|NCT04689412|Resveratrol|resveratrol|mesh-list
153572839|NCT01555541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153572840|NCT01398852|Riboflavin|riboflavin|mesh-list
153572841|NCT01398852|Vitamin B Complex|vitamin b complex|mesh-ancestor
153572842|NCT01398852|Vitamins|vitamins|mesh-ancestor
153572843|NCT01398852|Micronutrients|micronutrients|mesh-ancestor
153572844|NCT01398852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153572845|NCT01398852|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
153572846|NCT01398852|Dermatologic Agents|dermatologic agents|mesh-ancestor
153572847|NCT01398839|Riboflavin|riboflavin|mesh-list
153572848|NCT01398839|Vitamin B Complex|vitamin b complex|mesh-ancestor
153572849|NCT01398839|Vitamins|vitamins|mesh-ancestor
153572850|NCT01398839|Micronutrients|micronutrients|mesh-ancestor
153812522|NCT00329147|Serotonin Agents|serotonin agents|mesh-ancestor
153572851|NCT01398839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153572852|NCT01398839|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
153572853|NCT01398839|Dermatologic Agents|dermatologic agents|mesh-ancestor
153572854|NCT00496795|Docetaxel|docetaxel|mesh-list
153572855|NCT00496795|Epirubicin|epirubicin|mesh-list
153572856|NCT00496795|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153572857|NCT00496795|Tubulin Modulators|tubulin modulators|mesh-ancestor
153744514|NCT04689412|Antioxidants|antioxidants|mesh-ancestor
153744526|NCT00170196|Glucocorticoids|glucocorticoids|mesh-ancestor
153744527|NCT00170196|Hormones|hormones|mesh-ancestor
153744528|NCT00170196|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153744529|NCT00170196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153744530|NCT00170196|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153744531|NCT00170196|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153744532|NCT02929459|Vitamins|vitamins|mesh-list
153744533|NCT02929459|Riboflavin|riboflavin|mesh-list
153744534|NCT02929459|Vitamin B Complex|vitamin b complex|mesh-list
153744535|NCT02929459|Micronutrients|micronutrients|mesh-ancestor
153744536|NCT02929459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153744537|NCT02929459|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
153744538|NCT02929459|Dermatologic Agents|dermatologic agents|mesh-ancestor
153744539|NCT02929576|Paclitaxel|paclitaxel|mesh-list
153744540|NCT02929576|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153744541|NCT02929576|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153744542|NCT02929576|Tubulin Modulators|tubulin modulators|mesh-ancestor
153744543|NCT02929576|Antimitotic Agents|antimitotic agents|mesh-ancestor
153744544|NCT02929576|Mitosis Modulators|mitosis modulators|mesh-ancestor
153744545|NCT02929576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153744546|NCT00175812|Tretinoin|tretinoin|mesh-list
153744547|NCT00175812|Theophylline|theophylline|mesh-list
153744548|NCT00175812|Valproic Acid|valproic acid|mesh-list
153744549|NCT00175812|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153744550|NCT00175812|Keratolytic Agents|keratolytic agents|mesh-ancestor
153744551|NCT00175812|Dermatologic Agents|dermatologic agents|mesh-ancestor
153744552|NCT00175812|Anticonvulsants|anticonvulsants|mesh-ancestor
153744553|NCT00175812|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153744554|NCT00175812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153744555|NCT00175812|GABA Agents|gaba agents|mesh-ancestor
153744556|NCT00175812|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153744557|NCT00175812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153744558|NCT00175812|Antimanic Agents|antimanic agents|mesh-ancestor
153744559|NCT00175812|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153744560|NCT00175812|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153744561|NCT00175812|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153572858|NCT00496795|Antimitotic Agents|antimitotic agents|mesh-ancestor
153572859|NCT00496795|Mitosis Modulators|mitosis modulators|mesh-ancestor
153572860|NCT00496795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153744562|NCT00175812|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153744563|NCT00175812|Autonomic Agents|autonomic agents|mesh-ancestor
153744564|NCT00175812|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153744565|NCT00175812|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153744566|NCT00175812|Respiratory System Agents|respiratory system agents|mesh-ancestor
153744567|NCT00175812|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
153744568|NCT00175812|Vasodilator Agents|vasodilator agents|mesh-ancestor
153744569|NCT00175812|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
153744570|NCT00175812|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
153744571|NCT00175812|Purinergic Agents|purinergic agents|mesh-ancestor
153744572|NCT00148499|Benzocaine|benzocaine|mesh-list
153730747|NCT00135005|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153744573|NCT00148499|Ambroxol|ambroxol|mesh-list
153744574|NCT00148499|Anesthetics, Local|anesthetics, local|mesh-ancestor
153744575|NCT00148499|Anesthetics|anesthetics|mesh-ancestor
153744576|NCT00148499|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153744577|NCT00148499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153744578|NCT00148499|Sensory System Agents|sensory system agents|mesh-ancestor
153744589|NCT03457597|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153744590|NCT03457597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153744591|NCT03457597|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153744592|NCT03457597|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153744593|NCT03457597|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153581640|NCT05781620|Vitamins|vitamins|mesh-ancestor
153744594|NCT03457597|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153744595|NCT03457597|Anesthetics, General|anesthetics, general|mesh-ancestor
153744596|NCT03457597|Anesthetics|anesthetics|mesh-ancestor
153744597|NCT03457597|GABA Modulators|gaba modulators|mesh-ancestor
153744598|NCT03457597|GABA Agents|gaba agents|mesh-ancestor
153781933|NCT04557475|Analgesics|analgesics|mesh-ancestor
153744599|NCT03457597|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153744601|NCT03457597|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153744605|NCT03457597|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153744606|NCT03457597|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153744607|NCT03457597|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153744609|NCT03457597|Autonomic Agents|autonomic agents|mesh-ancestor
153744610|NCT03457597|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153744611|NCT03457597|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
153744612|NCT03457597|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
153744613|NCT03457597|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
153744614|NCT03457597|Adrenergic Agents|adrenergic agents|mesh-ancestor
153744615|NCT02929147|Dexketoprofen trometamol|dexketoprofen trometamol|mesh-list
153744616|NCT02929147|Morphine|morphine|mesh-list
153744617|NCT02929147|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153744618|NCT02929147|Narcotics|narcotics|mesh-ancestor
153744619|NCT02929147|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153744620|NCT02929147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153744621|NCT02929147|Analgesics|analgesics|mesh-ancestor
153744622|NCT02929147|Sensory System Agents|sensory system agents|mesh-ancestor
153744623|NCT02929147|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153744624|NCT02929147|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153744625|NCT02929147|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153572861|NCT00496795|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153572862|NCT00496795|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153572863|NCT00496795|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153572864|NCT00496795|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153572865|NCT03164889|Entecavir|entecavir|mesh-list
153572883|NCT03133260|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153572884|NCT03133260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153572885|NCT03133260|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153572886|NCT03133260|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153572887|NCT03133260|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153572888|NCT03133260|Antipyretics|antipyretics|mesh-ancestor
153572889|NCT03096834|Erenumab|erenumab|mesh-list
153572890|NCT03096834|Calcitonin Gene-Related Peptide Receptor Antagonists|calcitonin gene-related peptide receptor antagonists|mesh-ancestor
153572891|NCT03096834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153572892|NCT03096834|Analgesics|analgesics|mesh-ancestor
153572893|NCT03096834|Sensory System Agents|sensory system agents|mesh-ancestor
153572894|NCT03096834|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153572895|NCT03096834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153572896|NCT03056014|Acetylcysteine|acetylcysteine|mesh-list
153572902|NCT03056014|Free Radical Scavengers|free radical scavengers|mesh-ancestor
153572903|NCT03056014|Antioxidants|antioxidants|mesh-ancestor
153572904|NCT03056014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153572905|NCT03056014|Protective Agents|protective agents|mesh-ancestor
153572906|NCT03056014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153572907|NCT03056014|Antidotes|antidotes|mesh-ancestor
153572908|NCT03126812|Paclitaxel|paclitaxel|mesh-list
153572909|NCT03126812|Carboplatin|carboplatin|mesh-list
153572910|NCT03126812|Pembrolizumab|pembrolizumab|mesh-list
153572911|NCT03126812|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153572912|NCT03126812|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153572913|NCT03126812|Tubulin Modulators|tubulin modulators|mesh-ancestor
153572914|NCT03126812|Antimitotic Agents|antimitotic agents|mesh-ancestor
153572915|NCT03126812|Mitosis Modulators|mitosis modulators|mesh-ancestor
153744635|NCT00148616|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153744636|NCT00148616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153744637|NCT00148616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153744638|NCT00148616|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
153744639|NCT00148616|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
153744640|NCT00175929|Brivaracetam|brivaracetam|mesh-list
153744641|NCT00175929|Anticonvulsants|anticonvulsants|mesh-ancestor
153744642|NCT02928679|Liraglutide|liraglutide|mesh-list
153744643|NCT02928679|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
153744644|NCT02928679|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153744645|NCT02928679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153744662|NCT02928328|Lidocaine|lidocaine|mesh-list
153744663|NCT02928328|Lorazepam|lorazepam|mesh-list
153744664|NCT02928328|Capsaicin|capsaicin|mesh-list
153744665|NCT02928328|gamma-Aminobutyric Acid|gamma-aminobutyric acid|mesh-list
153744666|NCT02928328|Butyric Acid|butyric acid|mesh-list
153744667|NCT02928328|Anesthetics, Local|anesthetics, local|mesh-ancestor
153744668|NCT02928328|Anesthetics|anesthetics|mesh-ancestor
153744669|NCT02928328|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153455636|NCT05590325|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
153572916|NCT03126812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153572921|NCT03026972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153572922|NCT03012815|Chlordiazepoxide|chlordiazepoxide|mesh-list
153572923|NCT03012815|Gabapentin|gabapentin|mesh-list
153572924|NCT03012815|Lorazepam|lorazepam|mesh-list
153572925|NCT03012815|Valproic Acid|valproic acid|mesh-list
153744670|NCT02928328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153744671|NCT02928328|Sensory System Agents|sensory system agents|mesh-ancestor
153744672|NCT02928328|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153744673|NCT02928328|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153744674|NCT02928328|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
153744676|NCT02928328|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153744677|NCT02928328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153744679|NCT02928328|Dermatologic Agents|dermatologic agents|mesh-ancestor
153744680|NCT02928328|Anticonvulsants|anticonvulsants|mesh-ancestor
153744682|NCT02928328|Autonomic Agents|autonomic agents|mesh-ancestor
153744683|NCT02928328|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153744684|NCT02928328|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153744685|NCT02928328|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153744686|NCT02928328|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153744687|NCT02928328|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153744688|NCT02928328|GABA Modulators|gaba modulators|mesh-ancestor
153744689|NCT02928328|GABA Agents|gaba agents|mesh-ancestor
153744690|NCT02928328|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153744691|NCT02928328|Histamine Antagonists|histamine antagonists|mesh-ancestor
153744692|NCT02928328|Histamine Agents|histamine agents|mesh-ancestor
153744693|NCT00148694|Cisplatin|cisplatin|mesh-list
153744694|NCT00148694|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153744695|NCT00148772|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
153744696|NCT00148772|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153744697|NCT00148772|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153744698|NCT00148772|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153744699|NCT00148772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153744700|NCT00148772|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153572926|NCT03012815|Analgesics|analgesics|mesh-ancestor
153572927|NCT03012815|Sensory System Agents|sensory system agents|mesh-ancestor
153572928|NCT03012815|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153572929|NCT03012815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153572930|NCT03012815|Anticonvulsants|anticonvulsants|mesh-ancestor
153572931|NCT03012815|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153572932|NCT03012815|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153572933|NCT03012815|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153572934|NCT03012815|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153572935|NCT03012815|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
153572936|NCT03012815|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
153572937|NCT03012815|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153816775|NCT00426530|Immunologic Factors|immunologic factors|mesh-ancestor
153816776|NCT00426530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153816777|NCT00426530|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153816778|NCT00459420|Caffeine|caffeine|mesh-list
153816779|NCT00459420|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
153744701|NCT00176046|Viscum album peptide|viscum album peptide|mesh-list
153744702|NCT00176046|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153744704|NCT00176046|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153744705|NCT00176046|Antiviral Agents|antiviral agents|mesh-ancestor
153744706|NCT00176046|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153744718|NCT02927353|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
153744719|NCT02927353|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153744720|NCT02927353|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153744721|NCT02927509|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-list
153744722|NCT02927509|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
153744723|NCT02927509|Adrenergic Agents|adrenergic agents|mesh-ancestor
153744724|NCT02927509|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153744725|NCT02927509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153744726|NCT02927509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153744727|NCT02926885|Liver Extracts|liver extracts|mesh-list
153744728|NCT02926885|Hematinics|hematinics|mesh-ancestor
153744729|NCT02926846|Vancomycin|vancomycin|mesh-list
153744730|NCT02926846|Gentamicins|gentamicins|mesh-list
153744731|NCT02926846|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153744732|NCT02926846|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153744733|NCT02926846|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
153744734|NCT02926846|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153744735|NCT02926846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153744736|NCT02926183|Paclitaxel|paclitaxel|mesh-list
153744737|NCT02926183|Gemcitabine|gemcitabine|mesh-list
153744738|NCT02926183|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153744739|NCT02926183|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153744740|NCT02926183|Tubulin Modulators|tubulin modulators|mesh-ancestor
153744741|NCT02926183|Antimitotic Agents|antimitotic agents|mesh-ancestor
153744742|NCT02926183|Mitosis Modulators|mitosis modulators|mesh-ancestor
153744743|NCT02926183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153744744|NCT02926183|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153744745|NCT02926183|Antimetabolites|antimetabolites|mesh-ancestor
153744746|NCT02925832|Bupivacaine|bupivacaine|mesh-list
153744754|NCT02925832|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153744755|NCT00170430|Fluconazole|fluconazole|mesh-list
153744756|NCT00170430|Antifungal Agents|antifungal agents|mesh-ancestor
153744757|NCT00170430|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153744758|NCT00170430|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
153744759|NCT00170430|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153744760|NCT00170430|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153744761|NCT00170430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153744762|NCT00170430|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153744763|NCT00170430|Hormone Antagonists|hormone antagonists|mesh-ancestor
153744764|NCT00170430|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153744765|NCT00170430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153744766|NCT00170430|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
153744767|NCT00170430|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
153744768|NCT00149084|Amoxicillin|amoxicillin|mesh-list
153744769|NCT00149084|Clarithromycin|clarithromycin|mesh-list
153744770|NCT00149084|Lansoprazole|lansoprazole|mesh-list
153744771|NCT00149084|Dexlansoprazole|dexlansoprazole|mesh-list
153480723|NCT05289063|Atorvastatin|atorvastatin|mesh-list
153744791|NCT00149162|Aldesleukin|aldesleukin|mesh-list
153744792|NCT00149162|Interleukin-2|interleukin-2|mesh-list
153744793|NCT00149162|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153744794|NCT00149162|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153744795|NCT00149162|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153744796|NCT00149162|Antiviral Agents|antiviral agents|mesh-ancestor
153744797|NCT00149162|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153744798|NCT00149162|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153744799|NCT00149162|Analgesics|analgesics|mesh-ancestor
153744800|NCT00149162|Sensory System Agents|sensory system agents|mesh-ancestor
153744812|NCT00149201|Immunologic Factors|immunologic factors|mesh-ancestor
153744813|NCT00149201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153744814|NCT02925559|Dapagliflozin|dapagliflozin|mesh-list
153744816|NCT02925559|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
153744817|NCT02925559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153744818|NCT02925559|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153744819|NCT02925559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153744820|NCT00149240|Botulinum Toxins|botulinum toxins|mesh-list
153744821|NCT00149240|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
153744822|NCT00149240|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
153744823|NCT00149240|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
153744824|NCT00149240|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153744825|NCT00149240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153744842|NCT00170742|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153744843|NCT00170742|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153744845|NCT02917525|Vitamin K 2|vitamin k 2|mesh-list
153744846|NCT02917525|Vitamins|vitamins|mesh-ancestor
153744847|NCT02917525|Micronutrients|micronutrients|mesh-ancestor
153744848|NCT02917525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153744849|NCT02917525|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
153744850|NCT02917525|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153744851|NCT02917525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153744852|NCT02917525|Hemostatics|hemostatics|mesh-ancestor
153744853|NCT02917525|Coagulants|coagulants|mesh-ancestor
153744854|NCT00170781|Lumiracoxib|lumiracoxib|mesh-list
153744855|NCT00170781|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
153744856|NCT00170781|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153744857|NCT00170781|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153744858|NCT00170781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153744859|NCT00170781|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153744860|NCT00170781|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153744861|NCT00170781|Analgesics|analgesics|mesh-ancestor
153730748|NCT00135005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153744867|NCT00170820|Everolimus|everolimus|mesh-list
153744868|NCT00170820|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
153744869|NCT00170820|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153744870|NCT00170820|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153744871|NCT00170820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153744872|NCT00170820|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153744873|NCT00170820|Immunologic Factors|immunologic factors|mesh-ancestor
153744874|NCT00170820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153744875|NCT00170820|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153744876|NCT02917018|Dexmedetomidine|dexmedetomidine|mesh-list
153744877|NCT02917018|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153744878|NCT02917018|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153744879|NCT02917018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153744880|NCT02917018|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153744881|NCT02917018|Analgesics|analgesics|mesh-ancestor
153744882|NCT02917018|Sensory System Agents|sensory system agents|mesh-ancestor
153744883|NCT02917018|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153480833|NCT04907370|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153744892|NCT00170859|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153744894|NCT00170859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153744895|NCT00170859|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153744896|NCT00170859|Immunologic Factors|immunologic factors|mesh-ancestor
153744897|NCT00170859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153744898|NCT00170859|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153744899|NCT02917057|Exenatide|exenatide|mesh-list
153744901|NCT02917057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153744902|NCT02917057|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
153744903|NCT02917057|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
153744904|NCT02917057|Incretins|incretins|mesh-ancestor
153744905|NCT02917057|Hormones|hormones|mesh-ancestor
153744906|NCT02917057|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153816780|NCT00459420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153816781|NCT00459420|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
153744907|NCT02916940|Betamethasone dipropionate, betamethasone sodium phosphate drug combination|betamethasone dipropionate, betamethasone sodium phosphate drug combination|mesh-list
153744908|NCT02916940|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153744909|NCT02916940|Glucocorticoids|glucocorticoids|mesh-ancestor
153744910|NCT02916940|Hormones|hormones|mesh-ancestor
153744911|NCT02916940|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153744912|NCT02916940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153744913|NCT00170898|Lumiracoxib|lumiracoxib|mesh-list
153744914|NCT00170898|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
153744915|NCT00170898|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153744916|NCT00170898|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153744917|NCT00170898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153744918|NCT00170898|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153744919|NCT00170898|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153744920|NCT00170898|Analgesics|analgesics|mesh-ancestor
153744921|NCT00170898|Sensory System Agents|sensory system agents|mesh-ancestor
153744922|NCT00170898|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153744923|NCT00170898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153744924|NCT00170898|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153744925|NCT00170898|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153744926|NCT02916355|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
153744927|NCT02916355|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153744928|NCT00170937|Valsartan|valsartan|mesh-list
153744929|NCT00170937|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
153744930|NCT00170937|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153744931|NCT00170937|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
153744932|NCT00170937|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
153744933|NCT00170937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153744934|NCT00170937|Diuretics|diuretics|mesh-ancestor
153744935|NCT00170937|Natriuretic Agents|natriuretic agents|mesh-ancestor
153744936|NCT00170937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153744939|NCT02916238|Fluoxetine|fluoxetine|mesh-list
153744945|NCT02916238|Serotonin Agents|serotonin agents|mesh-ancestor
153480897|NCT04781088|Paclitaxel|paclitaxel|mesh-list
153744968|NCT00163761|Alkylating Agents|alkylating agents|mesh-ancestor
153744970|NCT02916160|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
153744971|NCT02916160|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153744972|NCT02916160|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
153744973|NCT02916160|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
153744974|NCT02916160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153744976|NCT02916121|Vitamin B 12|vitamin b 12|mesh-list
153744977|NCT02916121|Vitamins|vitamins|mesh-ancestor
153744978|NCT02916121|Micronutrients|micronutrients|mesh-ancestor
153744979|NCT02916121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153744980|NCT02916121|Hematinics|hematinics|mesh-ancestor
153744981|NCT02916121|Vitamin B Complex|vitamin b complex|mesh-ancestor
153744982|NCT00170976|Amlodipine|amlodipine|mesh-list
153744983|NCT00170976|Valsartan|valsartan|mesh-list
153744984|NCT00170976|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153744985|NCT00170976|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153744986|NCT00170976|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153744987|NCT00170976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153744988|NCT00170976|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153744989|NCT00170976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153744990|NCT00170976|Vasodilator Agents|vasodilator agents|mesh-ancestor
153744991|NCT00170976|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
153744992|NCT00170976|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
153744993|NCT00149864|Mycophenolic Acid|mycophenolic acid|mesh-list
153744994|NCT00149864|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153480959|NCT04704999|Artemether|artemether|mesh-list
153745005|NCT00149903|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
153745006|NCT00149903|Antitubercular Agents|antitubercular agents|mesh-ancestor
153745007|NCT00149903|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153745008|NCT00149903|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153745018|NCT04688632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153745019|NCT04688632|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153745020|NCT04688632|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
153745021|NCT04688632|Contraceptive Agents|contraceptive agents|mesh-ancestor
153745022|NCT04688632|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153745023|NCT04688632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153745024|NCT04688632|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
153745025|NCT04688632|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
153745026|NCT04688632|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
153745028|NCT05786677|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-list
153745029|NCT05786677|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
153745030|NCT05786677|Serotonin Agents|serotonin agents|mesh-ancestor
153745031|NCT05786677|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153745032|NCT05786677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153745033|NCT05786677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153745034|NCT05786677|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153745035|NCT05786677|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153745036|NCT05786495|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
153745037|NCT05786495|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153745038|NCT05786430|Carboplatin|carboplatin|mesh-list
153745039|NCT05786430|Pemetrexed|pemetrexed|mesh-list
153745040|NCT05786430|Lazertinib|lazertinib|mesh-list
153582094|NCT04450212|Vitamin K|vitamin k|mesh-list
153745041|NCT05786430|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153745042|NCT05786430|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153745043|NCT05786430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153745044|NCT05786430|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153745045|NCT05786430|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153745046|NCT05786430|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153730749|NCT00135005|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153730750|NCT00142233|N-Methylaspartate|n-methylaspartate|mesh-list
153745047|NCT05786339|Irbesartan|irbesartan|mesh-list
153745051|NCT05786339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153745052|NCT05785234|Sufentanil|sufentanil|mesh-list
153745053|NCT05785234|Remifentanil|remifentanil|mesh-list
153745054|NCT05785234|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153745055|NCT05785234|Narcotics|narcotics|mesh-ancestor
153745088|NCT05784987|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153745089|NCT05784987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153455637|NCT05590325|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
153745090|NCT05784987|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153745091|NCT05784987|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153745092|NCT05784987|Growth Substances|growth substances|mesh-ancestor
153745093|NCT05784987|Growth Inhibitors|growth inhibitors|mesh-ancestor
153745094|NCT05784987|Analgesics|analgesics|mesh-ancestor
153745095|NCT05784987|Sensory System Agents|sensory system agents|mesh-ancestor
153745096|NCT05784987|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153745097|NCT05784987|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153745098|NCT05784987|Alkylating Agents|alkylating agents|mesh-ancestor
153481070|NCT04284397|Aspirin|aspirin|mesh-list
153745113|NCT05784467|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153745114|NCT05784467|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
153745115|NCT05781516|Prednisolone|prednisolone|mesh-list
153745116|NCT05781516|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153745117|NCT05781516|Glucocorticoids|glucocorticoids|mesh-ancestor
153745118|NCT05781516|Hormones|hormones|mesh-ancestor
153745137|NCT05774405|Hormones|hormones|mesh-ancestor
153745138|NCT05774405|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153745139|NCT05774405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153745140|NCT05774405|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
153745141|NCT05774405|Contraceptive Agents|contraceptive agents|mesh-ancestor
153745142|NCT05774405|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153745143|NCT05774405|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
153745144|NCT05764941|Vinorelbine|vinorelbine|mesh-list
153745145|NCT05764941|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153745146|NCT05764941|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153745147|NCT05764941|Tubulin Modulators|tubulin modulators|mesh-ancestor
153745148|NCT05764941|Antimitotic Agents|antimitotic agents|mesh-ancestor
153745149|NCT05764941|Mitosis Modulators|mitosis modulators|mesh-ancestor
153745150|NCT05764941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153745151|NCT05750017|Vaccines|vaccines|mesh-list
153745152|NCT05750017|Immunologic Factors|immunologic factors|mesh-ancestor
153745153|NCT05750017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153745154|NCT05723705|Liver Extracts|liver extracts|mesh-list
153745155|NCT05723705|Hematinics|hematinics|mesh-ancestor
153745156|NCT05634577|Pembrolizumab|pembrolizumab|mesh-list
153745157|NCT05634577|Mitotane|mitotane|mesh-list
153481111|NCT04167514|Protein C Inhibitor|protein c inhibitor|mesh-list
153745184|NCT05550597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153745185|NCT05550597|Sensory System Agents|sensory system agents|mesh-ancestor
153745186|NCT05550597|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153745187|NCT05550597|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153745189|NCT05550597|Analgesics|analgesics|mesh-ancestor
153730751|NCT00142233|Excitatory Amino Acid Agonists|excitatory amino acid agonists|mesh-ancestor
153745190|NCT05550597|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153745191|NCT05550597|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153745192|NCT05550597|Anesthetics, General|anesthetics, general|mesh-ancestor
153745193|NCT05495269|Ophthalmic Solutions|ophthalmic solutions|mesh-list
153745194|NCT05495269|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
153745195|NCT05355935|Moxifloxacin|moxifloxacin|mesh-list
153745196|NCT05355935|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153745199|NCT05355935|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153745200|NCT05355935|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153745201|NCT05355935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153745202|NCT05355935|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153745203|NCT05334017|Cocaine|cocaine|mesh-list
153745204|NCT05334017|Xylometazoline|xylometazoline|mesh-list
153745205|NCT05334017|Anesthetics, Local|anesthetics, local|mesh-ancestor
153745206|NCT05334017|Anesthetics|anesthetics|mesh-ancestor
153745224|NCT05292339|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
153745225|NCT05292339|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
153745226|NCT05292339|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153745227|NCT05292339|Glucocorticoids|glucocorticoids|mesh-ancestor
153745228|NCT05292339|Hormones|hormones|mesh-ancestor
153745229|NCT05292339|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153745230|NCT05292339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153745231|NCT05292339|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153745232|NCT05292339|Immunologic Factors|immunologic factors|mesh-ancestor
153745233|NCT05292339|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153745234|NCT05292339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153745235|NCT05292339|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153745236|NCT05292339|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153745237|NCT05292339|Analgesics|analgesics|mesh-ancestor
153745238|NCT05292339|Sensory System Agents|sensory system agents|mesh-ancestor
153745239|NCT05292339|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153745240|NCT05292339|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153745241|NCT05292339|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153745242|NCT05291650|Hyaluronic Acid|hyaluronic acid|mesh-list
153745243|NCT05291650|Glucocorticoids|glucocorticoids|mesh-list
153745244|NCT05291650|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153745245|NCT05291650|Immunologic Factors|immunologic factors|mesh-ancestor
153745262|NCT05157867|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153745274|NCT05129332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153745276|NCT05111262|Budesonide|budesonide|mesh-list
153745277|NCT05111262|Formoterol Fumarate|formoterol fumarate|mesh-list
153745278|NCT05111262|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153745279|NCT05111262|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153745280|NCT05111262|Autonomic Agents|autonomic agents|mesh-ancestor
153745281|NCT05111262|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153745282|NCT05111262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153745283|NCT05111262|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153745284|NCT05111262|Respiratory System Agents|respiratory system agents|mesh-ancestor
153745285|NCT05111262|Glucocorticoids|glucocorticoids|mesh-ancestor
153745286|NCT05111262|Hormones|hormones|mesh-ancestor
153745287|NCT05111262|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153745288|NCT05111262|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
153745289|NCT05111262|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
153745290|NCT05111262|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153745291|NCT05111262|Adrenergic Agents|adrenergic agents|mesh-ancestor
153745292|NCT05111262|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153745293|NCT05111262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153745294|NCT05091242|Clonidine|clonidine|mesh-list
153745295|NCT05091242|Analgesics|analgesics|mesh-ancestor
153745296|NCT05091242|Sensory System Agents|sensory system agents|mesh-ancestor
153745297|NCT05091242|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153745298|NCT05091242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153745299|NCT05091242|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153745300|NCT05091242|Sympatholytics|sympatholytics|mesh-ancestor
153745301|NCT05091242|Autonomic Agents|autonomic agents|mesh-ancestor
153745302|NCT05091242|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
153816782|NCT00459420|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153816783|NCT00459420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153816784|NCT00459420|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
153458127|NCT03594474|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
153458128|NCT03594474|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
153458129|NCT04193592|Pirfenidone|pirfenidone|mesh-list
153458130|NCT04193592|Analgesics|analgesics|mesh-ancestor
153458131|NCT04193592|Sensory System Agents|sensory system agents|mesh-ancestor
153458132|NCT04193592|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153458133|NCT04193592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153458134|NCT04193592|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153458135|NCT04193592|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153745303|NCT05091242|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153745304|NCT05091242|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153745305|NCT05091242|Adrenergic Agents|adrenergic agents|mesh-ancestor
153745306|NCT05091242|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153745307|NCT05091242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153745308|NCT05027516|Azithromycin|azithromycin|mesh-list
153745309|NCT05027516|Ceftriaxone|ceftriaxone|mesh-list
153745310|NCT05027516|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153745311|NCT05027516|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153745312|NCT05027516|Third Generation Cephalosporins|third generation cephalosporins|mesh-ancestor
153745313|NCT05027516|Beta Lactam Antibiotics|beta lactam antibiotics|mesh-ancestor
153745314|NCT04947124|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
153745315|NCT04947124|Ophthalmic Solutions|ophthalmic solutions|mesh-list
153745316|NCT04933630|Norepinephrine|norepinephrine|mesh-list
153745317|NCT04933630|Serotonin|serotonin|mesh-list
153745318|NCT04933630|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-list
153745319|NCT04933630|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153745320|NCT04933630|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153745321|NCT04933630|Adrenergic Agents|adrenergic agents|mesh-ancestor
153745322|NCT04933630|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153745323|NCT04933630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153745324|NCT04933630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153745328|NCT04933630|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
153745329|NCT04933630|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
153745330|NCT04933630|Serotonin Agents|serotonin agents|mesh-ancestor
153745331|NCT04933630|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153745332|NCT04933630|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153745333|NCT04923841|Atropine|atropine|mesh-list
153745334|NCT04923841|Ophthalmic Solutions|ophthalmic solutions|mesh-list
153745335|NCT04923841|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
153745336|NCT04923841|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153745337|NCT04923841|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153745338|NCT04923841|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153745339|NCT04923841|Autonomic Agents|autonomic agents|mesh-ancestor
153458136|NCT04193592|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153458137|NCT04193592|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153458138|NCT04193592|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153458139|NCT04027764|Paclitaxel|paclitaxel|mesh-list
153458140|NCT04027764|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153458141|NCT04027764|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153458142|NCT04027764|Tubulin Modulators|tubulin modulators|mesh-ancestor
153745340|NCT04923841|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153745341|NCT04923841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153745342|NCT04923841|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153745343|NCT04923841|Respiratory System Agents|respiratory system agents|mesh-ancestor
153745344|NCT04923841|Mydriatics|mydriatics|mesh-ancestor
153745345|NCT04923841|Parasympatholytics|parasympatholytics|mesh-ancestor
153745346|NCT04923841|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
153745347|NCT04923841|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
153745348|NCT04923841|Cholinergic Agents|cholinergic agents|mesh-ancestor
153745349|NCT04923841|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153745350|NCT04923841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153745351|NCT04838808|Rivaroxaban|rivaroxaban|mesh-list
153745352|NCT04838808|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
153745353|NCT04838808|Antithrombins|antithrombins|mesh-ancestor
153745354|NCT04838808|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
153745355|NCT04838808|Protease Inhibitors|protease inhibitors|mesh-ancestor
153745356|NCT04838808|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153745357|NCT04838808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153745358|NCT04838808|Anticoagulants|anticoagulants|mesh-ancestor
153745359|NCT04748276|Norepinephrine|norepinephrine|mesh-list
153745360|NCT04748276|Serotonin|serotonin|mesh-list
153745361|NCT04748276|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-list
153745362|NCT04748276|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153745363|NCT04748276|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153745364|NCT04748276|Adrenergic Agents|adrenergic agents|mesh-ancestor
153745365|NCT04748276|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153745366|NCT04748276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153745367|NCT04748276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153745381|NCT04610658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153745407|NCT04532918|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
153745408|NCT04532918|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
153745409|NCT04532918|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
153745410|NCT04532918|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
153745411|NCT04532918|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
153745412|NCT04532918|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
153745413|NCT04532918|Antimetabolites|antimetabolites|mesh-ancestor
153745414|NCT04532918|Gout Suppressants|gout suppressants|mesh-ancestor
153745415|NCT04532918|Free Radical Scavengers|free radical scavengers|mesh-ancestor
153582469|NCT02953509|Antimetabolites|antimetabolites|mesh-ancestor
153745416|NCT04532918|Antioxidants|antioxidants|mesh-ancestor
153745417|NCT04532918|Protective Agents|protective agents|mesh-ancestor
153745418|NCT04511247|Sirolimus|sirolimus|mesh-list
153745419|NCT04511247|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153745420|NCT04511247|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153745421|NCT04511247|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153745422|NCT04511247|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153745423|NCT04511247|Antifungal Agents|antifungal agents|mesh-ancestor
153745424|NCT04511247|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153745425|NCT04511247|Immunologic Factors|immunologic factors|mesh-ancestor
153745426|NCT04511247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153745442|NCT04351334|Alectinib|alectinib|mesh-list
153745443|NCT04351334|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153745444|NCT04351334|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153745445|NCT04351334|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153745446|NCT04351334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153745447|NCT04347798|Hydroxychloroquine|hydroxychloroquine|mesh-list
153745448|NCT04347798|Chloroquine|chloroquine|mesh-list
153745449|NCT04347798|Antimalarials|antimalarials|mesh-ancestor
153745450|NCT04347798|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153745451|NCT04347798|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153745452|NCT04347798|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153745453|NCT04347798|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153745454|NCT04347798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153745458|NCT04335669|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
153745459|NCT04335669|Cyclophosphamide|cyclophosphamide|mesh-list
153745460|NCT04335669|Carboplatin|carboplatin|mesh-list
153745461|NCT04335669|Pembrolizumab|pembrolizumab|mesh-list
153745462|NCT04335669|Capecitabine|capecitabine|mesh-list
153745463|NCT04335669|Epirubicin|epirubicin|mesh-list
153745465|NCT04335669|Antimetabolites|antimetabolites|mesh-list
153745466|NCT04335669|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153745467|NCT04335669|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153745476|NCT04335669|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153745477|NCT04335669|Alkylating Agents|alkylating agents|mesh-ancestor
153745478|NCT04335669|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153745479|NCT04335669|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153745480|NCT04335669|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153745481|NCT04335669|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153745482|NCT04335669|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153745483|NCT04335669|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153745484|NCT04335669|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153745485|NCT04335669|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153745486|NCT04298983|Androgens|androgens|mesh-list
153745487|NCT04298983|Hormones|hormones|mesh-ancestor
153745488|NCT04298983|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153745489|NCT04298983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153745490|NCT04236609|Sirolimus|sirolimus|mesh-list
153745491|NCT04236609|Everolimus|everolimus|mesh-list
153745492|NCT04236609|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
153582546|NCT02531854|Pemetrexed|pemetrexed|mesh-list
153745493|NCT04236609|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153745494|NCT04236609|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153745495|NCT04236609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153745496|NCT04236609|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153745497|NCT04236609|Immunologic Factors|immunologic factors|mesh-ancestor
153745498|NCT04236609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153745499|NCT04236609|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153745500|NCT04236609|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153745501|NCT04236609|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153458143|NCT04027764|Antimitotic Agents|antimitotic agents|mesh-ancestor
153458144|NCT04027764|Mitosis Modulators|mitosis modulators|mesh-ancestor
153458145|NCT04027764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153745502|NCT04236609|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153745503|NCT04236609|Antifungal Agents|antifungal agents|mesh-ancestor
153745504|NCT04232657|Denosumab|denosumab|mesh-list
153745505|NCT04232657|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153745506|NCT04232657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153745507|NCT04173585|Bortezomib|bortezomib|mesh-list
153745508|NCT04173585|Gemtuzumab|gemtuzumab|mesh-list
153745509|NCT04173585|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153745510|NCT04173585|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153745511|NCT04173585|Immunotoxins|immunotoxins|mesh-ancestor
153745512|NCT04173585|Immunoconjugates|immunoconjugates|mesh-ancestor
153745513|NCT04173585|Immunologic Factors|immunologic factors|mesh-ancestor
153745514|NCT04173585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153745515|NCT04172987|Tirzepatide|tirzepatide|mesh-list
153745516|NCT04172987|Incretins|incretins|mesh-ancestor
153745517|NCT04172987|Hormones|hormones|mesh-ancestor
153745518|NCT04172987|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153745519|NCT04172987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153745520|NCT04138381|Imatinib Mesylate|imatinib mesylate|mesh-list
153745521|NCT04138381|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153745522|NCT04138381|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153745523|NCT04138381|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153745524|NCT04138381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153745525|NCT04138381|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153745526|NCT04033055|Ropivacaine|ropivacaine|mesh-list
153745527|NCT04033055|Anesthetics, Local|anesthetics, local|mesh-ancestor
153745528|NCT04033055|Anesthetics|anesthetics|mesh-ancestor
153745529|NCT04033055|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153812564|NCT00434031|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153745530|NCT04033055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153745531|NCT04033055|Sensory System Agents|sensory system agents|mesh-ancestor
153745532|NCT04033055|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153745533|NCT04015596|Naproxen|naproxen|mesh-list
153745541|NCT04015596|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153745542|NCT04015596|Gout Suppressants|gout suppressants|mesh-ancestor
153745551|NCT03985722|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153745552|NCT03762096|Resveratrol|resveratrol|mesh-list
153745553|NCT03762096|Antioxidants|antioxidants|mesh-ancestor
153745554|NCT03762096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153745555|NCT03762096|Protective Agents|protective agents|mesh-ancestor
153745556|NCT03762096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153745557|NCT03762096|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153745558|NCT03762096|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153745559|NCT03460379|Citalopram|citalopram|mesh-list
153745560|NCT03460379|Escitalopram|escitalopram|mesh-list
153745561|NCT03460379|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
153745562|NCT03460379|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153745563|NCT03460379|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153745564|NCT03460379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153745565|NCT03460379|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153745566|NCT03460379|Serotonin Agents|serotonin agents|mesh-ancestor
153745567|NCT03460379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153745568|NCT03460379|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
153745569|NCT03460379|Antidepressive Agents|antidepressive agents|mesh-ancestor
153745570|NCT03460379|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153745572|NCT03460366|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
153745573|NCT03460366|Protease Inhibitors|protease inhibitors|mesh-ancestor
153745574|NCT03460366|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153745575|NCT03460366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153745576|NCT03460366|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153745577|NCT03460353|Dextroamphetamine|dextroamphetamine|mesh-list
153745578|NCT03460353|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
153745579|NCT03460353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153745580|NCT03460353|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
153745581|NCT03460353|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153814720|NCT00446862|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-list
153814721|NCT00446862|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
153745592|NCT03460314|Buprenorphine|buprenorphine|mesh-list
153745593|NCT03460314|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153745594|NCT03460314|Narcotics|narcotics|mesh-ancestor
153745595|NCT03460314|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153745596|NCT03460314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153745597|NCT03460314|Analgesics|analgesics|mesh-ancestor
153745598|NCT03460314|Sensory System Agents|sensory system agents|mesh-ancestor
153745608|NCT03460210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153745609|NCT03449472|Quetiapine Fumarate|quetiapine fumarate|mesh-list
153745610|NCT03449472|Antidepressive Agents|antidepressive agents|mesh-ancestor
153745611|NCT03449472|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153745612|NCT03449472|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153745613|NCT03449472|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153745614|NCT03449472|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153745615|NCT03449472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153745617|NCT03440879|Androgens|androgens|mesh-list
153745618|NCT03440879|Hormones|hormones|mesh-ancestor
153745619|NCT03440879|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153745620|NCT03440879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154027527|NCT04210544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154027529|NCT04168944|Immunosuppressive Agents|immunosuppressive agents|mesh-list
154027530|NCT04168944|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154027531|NCT04168944|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154027532|NCT04168944|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154027533|NCT04168944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154027534|NCT04168944|Immunologic Factors|immunologic factors|mesh-ancestor
154027535|NCT04168944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154027536|NCT02697032|Bicalutamide|bicalutamide|mesh-list
154027537|NCT02697032|Androgen Antagonists|androgen antagonists|mesh-ancestor
154027538|NCT02697032|Hormone Antagonists|hormone antagonists|mesh-ancestor
154027547|NCT02647632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154027548|NCT02647632|Antiviral Agents|antiviral agents|mesh-ancestor
154027549|NCT02647632|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154027550|NCT00621452|Aldesleukin|aldesleukin|mesh-list
154027551|NCT00621452|Cyclophosphamide|cyclophosphamide|mesh-list
154027552|NCT00621452|Interleukin-2|interleukin-2|mesh-list
154027553|NCT00621452|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154027554|NCT00621452|Immunologic Factors|immunologic factors|mesh-ancestor
154027555|NCT00621452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154027556|NCT00621452|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154027557|NCT00621452|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154027558|NCT00621452|Alkylating Agents|alkylating agents|mesh-ancestor
154027559|NCT00621452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154027560|NCT00621452|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154027561|NCT00621452|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154027562|NCT00621452|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154027563|NCT00621452|Analgesics|analgesics|mesh-ancestor
154027589|NCT00651612|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154027590|NCT00651612|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154027591|NCT00651612|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154027592|NCT00651612|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154027593|NCT00650754|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
154027594|NCT00650754|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154027595|NCT00650754|Immunologic Factors|immunologic factors|mesh-ancestor
154027596|NCT00650754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154027598|NCT02650206|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
154027599|NCT02650206|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154027600|NCT02650206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154027601|NCT02650206|Incretins|incretins|mesh-ancestor
154027602|NCT02650206|Hormones|hormones|mesh-ancestor
154027603|NCT02650206|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154027604|NCT05368766|Diuretics|diuretics|mesh-list
154027605|NCT05368766|Natriuretic Agents|natriuretic agents|mesh-ancestor
154027606|NCT05368766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154027607|NCT00891293|Fenofibrate|fenofibrate|mesh-list
154027608|NCT00891293|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154027609|NCT00891293|Antimetabolites|antimetabolites|mesh-ancestor
154027610|NCT00891293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154027611|NCT00891293|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154027612|NCT05368142|Cell Wall Skeleton|cell wall skeleton|mesh-list
154027634|NCT02827643|Micronutrients|micronutrients|mesh-ancestor
154027635|NCT02827643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154027636|NCT02827643|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154027637|NCT02827643|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154027638|NCT02827643|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
154027639|NCT02827643|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154027640|NCT02827643|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154027641|NCT02827643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154027642|NCT02827643|Antiviral Agents|antiviral agents|mesh-ancestor
154027643|NCT02827643|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154027644|NCT02827643|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154027645|NCT02827643|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154027646|NCT02646774|Micafungin|micafungin|mesh-list
154027647|NCT02646774|Antifungal Agents|antifungal agents|mesh-ancestor
154027648|NCT02646774|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154027649|NCT02647086|Metoprolol|metoprolol|mesh-list
153812596|NCT00429780|Immunologic Factors|immunologic factors|mesh-ancestor
153359016|NCT06212830|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153359017|NCT06212830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153359020|NCT06212648|Candesartan|candesartan|mesh-list
153359021|NCT06212648|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154027650|NCT02647086|Midazolam|midazolam|mesh-list
154027651|NCT02647086|Caffeine|caffeine|mesh-list
153359022|NCT06212648|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153359023|NCT06212648|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154027652|NCT02647086|Omeprazole|omeprazole|mesh-list
154027653|NCT02647086|Warfarin|warfarin|mesh-list
154027654|NCT02647086|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154027655|NCT02647086|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154027656|NCT02647086|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154027657|NCT02647086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154027658|NCT02647086|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154027659|NCT02647086|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154027660|NCT02647086|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154027661|NCT02647086|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154027662|NCT02647086|Anesthetics, General|anesthetics, general|mesh-ancestor
154027663|NCT02647086|Anesthetics|anesthetics|mesh-ancestor
154027664|NCT02647086|GABA Modulators|gaba modulators|mesh-ancestor
154027665|NCT02647086|GABA Agents|gaba agents|mesh-ancestor
154027666|NCT02647086|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154027667|NCT02647086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154027668|NCT02647086|Anticoagulants|anticoagulants|mesh-ancestor
154027676|NCT02647086|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154027677|NCT02647086|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
154027678|NCT02647086|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154027679|NCT02647086|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154027680|NCT02647086|Sympatholytics|sympatholytics|mesh-ancestor
154027681|NCT02647086|Autonomic Agents|autonomic agents|mesh-ancestor
154027682|NCT02647086|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154027683|NCT02647086|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
154027684|NCT02647086|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
154027685|NCT02647086|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154027686|NCT02647086|Adrenergic Agents|adrenergic agents|mesh-ancestor
154027687|NCT00651690|Botulinum Toxins|botulinum toxins|mesh-list
154027688|NCT00651690|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
154027689|NCT00651690|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
154027690|NCT00651690|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
154027691|NCT00651690|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154027692|NCT00651690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154027693|NCT00651690|Cholinergic Agents|cholinergic agents|mesh-ancestor
154027694|NCT00651690|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154027695|NCT00651690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154027696|NCT00651690|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
154027697|NCT00651690|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154027698|NCT00651768|Budesonide|budesonide|mesh-list
154027699|NCT00651768|Formoterol Fumarate|formoterol fumarate|mesh-list
153570360|NCT01693289|Metformin|metformin|mesh-list
154027700|NCT00651768|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
154027701|NCT00651768|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154027702|NCT00651768|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154027703|NCT00651768|Autonomic Agents|autonomic agents|mesh-ancestor
154027704|NCT00651768|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154027705|NCT00651768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154027706|NCT00651768|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154027707|NCT00651768|Respiratory System Agents|respiratory system agents|mesh-ancestor
154027708|NCT00651768|Glucocorticoids|glucocorticoids|mesh-ancestor
154027709|NCT00651768|Hormones|hormones|mesh-ancestor
154027711|NCT00651768|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
154027713|NCT00651768|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154027714|NCT00651768|Adrenergic Agents|adrenergic agents|mesh-ancestor
154027715|NCT00651768|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154027716|NCT00651768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154027717|NCT00651846|Ethinyl estradiol, levonorgestrel drug combination|ethinyl estradiol, levonorgestrel drug combination|mesh-list
154027718|NCT00651846|Ethinyl Estradiol-Norgestrel Combination|ethinyl estradiol-norgestrel combination|mesh-list
154027719|NCT00651846|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154027720|NCT00651846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154027721|NCT00651846|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
154027722|NCT00651846|Contraceptive Agents|contraceptive agents|mesh-ancestor
154027723|NCT00651846|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
154027724|NCT00651846|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
154027725|NCT00651846|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
154027726|NCT00651846|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
154027727|NCT00651846|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
154027728|NCT00651846|Contraceptives, Postcoital, Hormonal|contraceptives, postcoital, hormonal|mesh-ancestor
154027729|NCT00651846|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
154027730|NCT00651846|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
154027731|NCT04167306|Bupropion|bupropion|mesh-list
154027732|NCT04167306|Varenicline|varenicline|mesh-list
154027733|NCT04167306|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
154027734|NCT04167306|Antidepressive Agents|antidepressive agents|mesh-ancestor
153458146|NCT04027530|Ertugliflozin|ertugliflozin|mesh-list
153458147|NCT04027530|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
153458148|NCT04027530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153458150|NCT04027530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153458151|NCT03023358|Prednisone|prednisone|mesh-list
153458152|NCT03023358|Cyclophosphamide|cyclophosphamide|mesh-list
153572938|NCT03012815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153572939|NCT03012815|Antimanic Agents|antimanic agents|mesh-ancestor
153572940|NCT03012815|Antiemetics|antiemetics|mesh-ancestor
153572941|NCT03012815|Autonomic Agents|autonomic agents|mesh-ancestor
153572942|NCT03012815|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153572943|NCT03012815|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153572944|NCT03012815|GABA Modulators|gaba modulators|mesh-ancestor
153572945|NCT03012815|GABA Agents|gaba agents|mesh-ancestor
153572946|NCT03012815|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153572947|NCT03012815|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153572948|NCT03001011|Sevelamer|sevelamer|mesh-list
153572949|NCT03001011|Chelating Agents|chelating agents|mesh-ancestor
153572950|NCT03001011|Sequestering Agents|sequestering agents|mesh-ancestor
153572951|NCT03001011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153572952|NCT02993757|Vaccines|vaccines|mesh-list
153572953|NCT02993757|Immunologic Factors|immunologic factors|mesh-ancestor
153572954|NCT02993757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153572955|NCT02979535|Vaccines|vaccines|mesh-list
154027735|NCT04167306|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154027736|NCT04167306|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
154027737|NCT04167306|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154027738|NCT04167306|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154027739|NCT04167306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154027740|NCT04167306|Dopamine Agents|dopamine agents|mesh-ancestor
154027741|NCT04167306|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154027742|NCT04167306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154027743|NCT04167306|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
154027744|NCT04167306|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154027745|NCT04167306|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154027746|NCT04167306|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
154027747|NCT04167306|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
154027748|NCT04167306|Cholinergic Agents|cholinergic agents|mesh-ancestor
154027749|NCT04244591|Methylprednisolone|methylprednisolone|mesh-list
154027750|NCT04244591|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
154027751|NCT04244591|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
154027752|NCT04244591|Prednisolone|prednisolone|mesh-list
154027753|NCT04244591|Prednisolone acetate|prednisolone acetate|mesh-list
154027754|NCT04244591|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
154027755|NCT04244591|Prednisolone phosphate|prednisolone phosphate|mesh-list
154027756|NCT04244591|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154027757|NCT04244591|Antiemetics|antiemetics|mesh-ancestor
154027758|NCT04244591|Autonomic Agents|autonomic agents|mesh-ancestor
154027759|NCT04244591|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154027760|NCT04244591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154027761|NCT04244591|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154027762|NCT04244591|Glucocorticoids|glucocorticoids|mesh-ancestor
154027763|NCT04244591|Hormones|hormones|mesh-ancestor
154027764|NCT04244591|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154027765|NCT04244591|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
153572956|NCT02979535|Immunologic Factors|immunologic factors|mesh-ancestor
153572957|NCT02979535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153572958|NCT02978716|Carboplatin|carboplatin|mesh-list
153572959|NCT02978716|Gemcitabine|gemcitabine|mesh-list
153572960|NCT02978716|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153572961|NCT02978716|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153572962|NCT02978716|Antimetabolites|antimetabolites|mesh-ancestor
153572963|NCT02978716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153572964|NCT02973321|Metformin|metformin|mesh-list
153572965|NCT02973321|Liraglutide|liraglutide|mesh-list
153359027|NCT06212648|Vasodilator Agents|vasodilator agents|mesh-ancestor
153572966|NCT02973321|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153455638|NCT05590325|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153572967|NCT02973321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154027769|NCT04167696|Cyclophosphamide|cyclophosphamide|mesh-list
154027771|NCT04167696|Fludarabine phosphate|fludarabine phosphate|mesh-list
154027772|NCT04167696|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154027773|NCT04167696|Immunologic Factors|immunologic factors|mesh-ancestor
154027774|NCT04167696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154027775|NCT04167696|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154027776|NCT04167696|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154027777|NCT04167696|Alkylating Agents|alkylating agents|mesh-ancestor
154027778|NCT04167696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154027779|NCT04167696|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154027780|NCT04167696|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154027781|NCT04167696|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154027782|NCT04167696|Antimetabolites|antimetabolites|mesh-ancestor
154027783|NCT02827487|Celecoxib|celecoxib|mesh-list
154027784|NCT02827487|Tramadol|tramadol|mesh-list
154027785|NCT02827487|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154027786|NCT02827487|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154027787|NCT02827487|Analgesics|analgesics|mesh-ancestor
154027788|NCT02827487|Sensory System Agents|sensory system agents|mesh-ancestor
154027789|NCT02827487|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154027790|NCT02827487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154027791|NCT02827487|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154027792|NCT02827487|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154027793|NCT02827487|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
154027794|NCT02827487|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154027795|NCT02827487|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154027796|NCT02827487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154027798|NCT02827487|Narcotics|narcotics|mesh-ancestor
153572968|NCT02973321|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
153572969|NCT02973321|Incretins|incretins|mesh-ancestor
153572970|NCT02973321|Hormones|hormones|mesh-ancestor
153572971|NCT02973321|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154027800|NCT02649504|Mycophenolic Acid|mycophenolic acid|mesh-list
154027801|NCT02649504|Dexamethasone|dexamethasone|mesh-list
154027802|NCT02649504|Rituximab|rituximab|mesh-list
154027803|NCT02649504|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154027804|NCT02649504|Antiemetics|antiemetics|mesh-ancestor
154027805|NCT02649504|Autonomic Agents|autonomic agents|mesh-ancestor
154027806|NCT02649504|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154027807|NCT02649504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154027808|NCT02649504|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154027809|NCT02649504|Glucocorticoids|glucocorticoids|mesh-ancestor
154027810|NCT02649504|Hormones|hormones|mesh-ancestor
154027811|NCT02649504|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154027812|NCT02649504|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154027813|NCT02649504|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154027814|NCT02649504|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154027815|NCT02649504|Immunologic Factors|immunologic factors|mesh-ancestor
154027816|NCT02649504|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154027817|NCT02649504|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154027818|NCT02649504|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
154027819|NCT02649504|Antitubercular Agents|antitubercular agents|mesh-ancestor
154027820|NCT02649504|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154027821|NCT02649504|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154027822|NCT02649504|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154027823|NCT02649504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154027824|NCT00650910|Lapatinib|lapatinib|mesh-list
154027825|NCT00650910|Digoxin|digoxin|mesh-list
154027826|NCT00650910|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154027827|NCT00650910|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154027828|NCT00650910|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153812622|NCT00329498|Vitamins|vitamins|mesh-ancestor
153812623|NCT00329498|Micronutrients|micronutrients|mesh-ancestor
154027829|NCT00650910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154027830|NCT00650910|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154027831|NCT00650910|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154027832|NCT00650910|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
153814733|NCT00446901|Trace Elements|trace elements|mesh-ancestor
153572972|NCT02967250|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
153458153|NCT03023358|Doxorubicin|doxorubicin|mesh-list
153458154|NCT03023358|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
153458156|NCT03023358|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153458157|NCT03023358|Immunologic Factors|immunologic factors|mesh-ancestor
154027833|NCT00650910|Protective Agents|protective agents|mesh-ancestor
154027834|NCT00650910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154027836|NCT02654730|Piperaquine|piperaquine|mesh-list
154027837|NCT02654730|Artenimol|artenimol|mesh-list
154027838|NCT02654730|Artemisinins|artemisinins|mesh-list
154027839|NCT02654730|Antimalarials|antimalarials|mesh-ancestor
154027840|NCT02654730|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154027841|NCT02654730|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154027842|NCT02654730|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154027843|NCT00888329|Aprepitant|aprepitant|mesh-list
154027844|NCT00888329|Antiemetics|antiemetics|mesh-ancestor
154027845|NCT00888329|Autonomic Agents|autonomic agents|mesh-ancestor
154027846|NCT00888329|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154027847|NCT00888329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154027848|NCT00888329|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154027849|NCT00888329|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
154027850|NCT00888329|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154027851|NCT00888329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154027853|NCT00652002|Formoterol Fumarate|formoterol fumarate|mesh-list
154027854|NCT00652002|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154027855|NCT00652002|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154027856|NCT00652002|Autonomic Agents|autonomic agents|mesh-ancestor
154027857|NCT00652002|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154027858|NCT00652002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154027859|NCT00652002|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154027860|NCT00652002|Respiratory System Agents|respiratory system agents|mesh-ancestor
154027861|NCT00652002|Glucocorticoids|glucocorticoids|mesh-ancestor
154027862|NCT00652002|Hormones|hormones|mesh-ancestor
154027863|NCT00652002|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154027864|NCT00652002|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
154027865|NCT00652002|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154027870|NCT02646540|Metolazone|metolazone|mesh-list
154027879|NCT02646540|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
154027880|NCT02646540|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154027881|NCT02646540|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
154027883|NCT00651066|Lopinavir|lopinavir|mesh-list
154027884|NCT00651066|Rifabutin|rifabutin|mesh-list
154027885|NCT00651066|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
154027886|NCT00651066|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
154027887|NCT00651066|Protease Inhibitors|protease inhibitors|mesh-ancestor
154027888|NCT00651066|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154027889|NCT00651066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154027890|NCT00651066|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154027891|NCT00651066|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154027892|NCT00651066|Antiviral Agents|antiviral agents|mesh-ancestor
154027893|NCT00651066|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154027894|NCT00651066|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154027895|NCT00651066|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154027896|NCT00651066|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154027897|NCT00651066|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
154027898|NCT00651066|Antitubercular Agents|antitubercular agents|mesh-ancestor
154027899|NCT02646072|Ketorolac|ketorolac|mesh-list
154027900|NCT02646072|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
154027901|NCT02646072|Ophthalmic Solutions|ophthalmic solutions|mesh-list
154027902|NCT02646072|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
154027903|NCT02646072|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154027904|NCT02646072|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154027905|NCT02646072|Analgesics|analgesics|mesh-ancestor
154027906|NCT02646072|Sensory System Agents|sensory system agents|mesh-ancestor
154027907|NCT02646072|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154027908|NCT02646072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154027909|NCT02646072|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154027910|NCT02646072|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153812634|NCT00429897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154027911|NCT02646072|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154027912|NCT02646072|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154027913|NCT02646072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154027914|NCT02654106|Temozolomide|temozolomide|mesh-list
154027915|NCT02654106|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154027916|NCT02654106|Alkylating Agents|alkylating agents|mesh-ancestor
154027917|NCT02654106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154027918|NCT02654106|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154027919|NCT04243733|Pemetrexed|pemetrexed|mesh-list
154027920|NCT04243733|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154027921|NCT04243733|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154027922|NCT04243733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154027923|NCT04243733|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154027924|NCT04243733|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154027925|NCT03434366|Dexmedetomidine|dexmedetomidine|mesh-list
154027926|NCT03434366|Ketamine|ketamine|mesh-list
154027927|NCT03434366|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154027928|NCT03434366|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154027929|NCT03434366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154027930|NCT03434366|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154027931|NCT03434366|Analgesics|analgesics|mesh-ancestor
154027932|NCT03434366|Sensory System Agents|sensory system agents|mesh-ancestor
154027933|NCT03434366|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154027934|NCT03434366|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154027935|NCT03434366|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154027936|NCT03434366|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154027937|NCT03434366|Adrenergic Agents|adrenergic agents|mesh-ancestor
154027938|NCT03434366|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154027939|NCT03434366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154027940|NCT03434366|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
154027941|NCT03434366|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154027942|NCT03434366|Anesthetics, General|anesthetics, general|mesh-ancestor
154027943|NCT03434366|Anesthetics|anesthetics|mesh-ancestor
154027944|NCT03434366|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154027945|NCT03434366|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154027946|NCT04167228|Ceftazidime|ceftazidime|mesh-list
153458158|NCT03023358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153572973|NCT02967250|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
153572974|NCT02967250|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153572975|NCT02943785|Edoxaban|edoxaban|mesh-list
154027947|NCT04167228|Avibactam, ceftazidime drug combination|avibactam, ceftazidime drug combination|mesh-list
154027949|NCT04167228|Third Generation Cephalosporins|third generation cephalosporins|mesh-ancestor
154027950|NCT04167228|Beta Lactam Antibiotics|beta lactam antibiotics|mesh-ancestor
154027951|NCT04167228|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154027952|NCT04167228|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154027953|NCT04167228|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
154027954|NCT04167228|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154027955|NCT04167228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154027956|NCT02687438|Mometasone Furoate|mometasone furoate|mesh-list
154027957|NCT02687438|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154027958|NCT02687438|Dermatologic Agents|dermatologic agents|mesh-ancestor
154027959|NCT02687438|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154027960|NCT02537834|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-list
154027961|NCT02537834|6-((4-ethylphenyl)methyl)-3',4',5',6'-tetrahydro-6'-(hydroxymethyl)spiro(isobenzofuran-1(3H),2'-(2H)pyran)-3',4',5'-triol|6-((4-ethylphenyl)methyl)-3',4',5',6'-tetrahydro-6'-(hydroxymethyl)spiro(isobenzofuran-1(3h),2'-(2h)pyran)-3',4',5'-triol|mesh-list
154027962|NCT02537834|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154027963|NCT02537834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154027964|NCT02537834|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
154027965|NCT02537834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154027966|NCT02648958|Dexmedetomidine|dexmedetomidine|mesh-list
154027967|NCT02648958|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154027968|NCT02648958|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154027969|NCT02648958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154027970|NCT02648958|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154027971|NCT02648958|Analgesics|analgesics|mesh-ancestor
154027972|NCT02648958|Sensory System Agents|sensory system agents|mesh-ancestor
154027973|NCT02648958|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154027974|NCT02648958|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154027975|NCT02648958|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154027976|NCT02648958|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154027984|NCT00887549|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154027985|NCT00887549|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154027987|NCT04243811|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154027988|NCT04243811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154027989|NCT00638300|Dialysis Solutions|dialysis solutions|mesh-list
154027990|NCT00638300|Calcium|calcium|mesh-list
154027991|NCT00638300|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154027992|NCT00638300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154027993|NCT00638300|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
154027994|NCT00887315|Cisplatin|cisplatin|mesh-list
154027996|NCT00887315|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154027997|NCT00887315|Tubulin Modulators|tubulin modulators|mesh-ancestor
154027998|NCT00887315|Antimitotic Agents|antimitotic agents|mesh-ancestor
154027999|NCT00887315|Mitosis Modulators|mitosis modulators|mesh-ancestor
154028000|NCT00887315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154028001|NCT02645994|Anesthetics|anesthetics|mesh-list
154028002|NCT02645994|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154028003|NCT02645994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154028004|NCT02645058|Analgesics|analgesics|mesh-list
154028005|NCT02645058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154028006|NCT02645058|Sensory System Agents|sensory system agents|mesh-ancestor
154028007|NCT02645058|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154028008|NCT02644980|Anesthetics|anesthetics|mesh-list
154028009|NCT02644980|Propofol|propofol|mesh-list
154028010|NCT02644980|Etomidate|etomidate|mesh-list
154028011|NCT02644980|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154028012|NCT02644980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154028013|NCT02644980|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154028014|NCT02644980|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154028015|NCT02644980|Anesthetics, General|anesthetics, general|mesh-ancestor
154028017|NCT04187456|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154028018|NCT04187456|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154028019|NCT04187456|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153572976|NCT02943785|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
153572977|NCT02943785|Antithrombins|antithrombins|mesh-ancestor
153572978|NCT02943785|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
153572979|NCT02943785|Protease Inhibitors|protease inhibitors|mesh-ancestor
153572980|NCT02943785|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153572981|NCT02943785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153572982|NCT02943785|Anticoagulants|anticoagulants|mesh-ancestor
154028020|NCT04187456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154028021|NCT04187456|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154028022|NCT04187456|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154028023|NCT04187456|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154028024|NCT04187456|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154028025|NCT04187456|Anesthetics, General|anesthetics, general|mesh-ancestor
154028026|NCT04187456|Anesthetics|anesthetics|mesh-ancestor
154028027|NCT04187456|GABA Modulators|gaba modulators|mesh-ancestor
154028028|NCT04187456|GABA Agents|gaba agents|mesh-ancestor
154028029|NCT04187456|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154028030|NCT04187456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154028031|NCT02827331|Hypnotics and Sedatives|hypnotics and sedatives|mesh-list
154028032|NCT02827331|Anti-Anxiety Agents|anti-anxiety agents|mesh-list
154028033|NCT02827331|Antidepressive Agents|antidepressive agents|mesh-list
154028034|NCT02827331|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154028035|NCT02827331|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154028036|NCT02827331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154028037|NCT02827331|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154028038|NCT02687204|Enoxaparin|enoxaparin|mesh-list
154028039|NCT02687204|Enoxaparin sodium|enoxaparin sodium|mesh-list
154028040|NCT02687204|Anticoagulants|anticoagulants|mesh-ancestor
154028041|NCT02687204|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154028042|NCT02687204|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154028043|NCT02687204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154028044|NCT00650208|Lamotrigine|lamotrigine|mesh-list
154028045|NCT00650208|Anticonvulsants|anticonvulsants|mesh-ancestor
154028046|NCT00650208|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154028047|NCT00650208|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154028048|NCT00650208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154028049|NCT00650208|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154028050|NCT00650208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154028051|NCT00650208|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154028052|NCT00650208|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154028053|NCT00650208|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154028057|NCT02645370|Anticonvulsants|anticonvulsants|mesh-ancestor
154028058|NCT02645370|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154028059|NCT02645370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154028060|NCT00652392|Budesonide|budesonide|mesh-list
154028061|NCT00652392|Formoterol Fumarate|formoterol fumarate|mesh-list
154028062|NCT00652392|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154028063|NCT00652392|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154028064|NCT00652392|Autonomic Agents|autonomic agents|mesh-ancestor
154028065|NCT00652392|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154028066|NCT00652392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154028067|NCT00652392|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154028068|NCT00652392|Respiratory System Agents|respiratory system agents|mesh-ancestor
154028069|NCT00652392|Glucocorticoids|glucocorticoids|mesh-ancestor
154028070|NCT00652392|Hormones|hormones|mesh-ancestor
154028071|NCT00652392|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154028072|NCT00652392|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
154028073|NCT00652392|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154028074|NCT00652392|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154028075|NCT00652392|Adrenergic Agents|adrenergic agents|mesh-ancestor
154028076|NCT00652392|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154028077|NCT00652392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154028078|NCT02645214|Anti-Infective Agents, Local|anti-infective agents, local|mesh-list
154028079|NCT02645214|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154028080|NCT02653638|Indomethacin|indomethacin|mesh-list
154028081|NCT02653638|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154028082|NCT02653638|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154028083|NCT02653638|Analgesics|analgesics|mesh-ancestor
154028084|NCT02653638|Sensory System Agents|sensory system agents|mesh-ancestor
154028085|NCT02653638|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154028086|NCT02653638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154028087|NCT02653638|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154028088|NCT02653638|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154028089|NCT02653638|Gout Suppressants|gout suppressants|mesh-ancestor
154028091|NCT02653638|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154028092|NCT02653638|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154028093|NCT02653638|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154028094|NCT02653638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154028095|NCT02644590|Melatonin|melatonin|mesh-list
154028096|NCT02644590|Antioxidants|antioxidants|mesh-ancestor
154028097|NCT02644590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154028098|NCT02644590|Protective Agents|protective agents|mesh-ancestor
154028099|NCT02644590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154028100|NCT02644590|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154028101|NCT00910806|Nevirapine|nevirapine|mesh-list
154028102|NCT00910806|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
154028103|NCT00910806|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154028104|NCT00910806|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154028105|NCT00910806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154028106|NCT00910806|Antiviral Agents|antiviral agents|mesh-ancestor
154028107|NCT00910806|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154028108|NCT00910806|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154028109|NCT00910806|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154028110|NCT00910806|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
154028111|NCT00910806|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
154028112|NCT00652704|Doxycycline|doxycycline|mesh-list
154028113|NCT00652704|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154028114|NCT00652704|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153812640|NCT00429897|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153812642|NCT00429897|Epithelial Sodium Channel Blockers|epithelial sodium channel blockers|mesh-ancestor
154028115|NCT00652704|Antimalarials|antimalarials|mesh-ancestor
154028116|NCT00652704|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154028117|NCT00652704|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154028118|NCT00652782|Rolofylline|rolofylline|mesh-list
154028133|NCT00887159|Etoposide|etoposide|mesh-list
154028134|NCT00887159|Etoposide phosphate|etoposide phosphate|mesh-list
154028135|NCT00887159|Podophyllotoxin|podophyllotoxin|mesh-list
154028136|NCT00887159|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154028137|NCT00887159|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154028138|NCT00887159|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154028139|NCT00887159|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154028140|NCT00887159|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154028141|NCT00887159|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154028142|NCT00887159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154028143|NCT00887159|Keratolytic Agents|keratolytic agents|mesh-ancestor
154028144|NCT00887159|Dermatologic Agents|dermatologic agents|mesh-ancestor
154028145|NCT00887159|Tubulin Modulators|tubulin modulators|mesh-ancestor
154028146|NCT00887159|Antimitotic Agents|antimitotic agents|mesh-ancestor
154028147|NCT00887159|Mitosis Modulators|mitosis modulators|mesh-ancestor
154028148|NCT00887159|Immunologic Factors|immunologic factors|mesh-ancestor
154028149|NCT00887159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154028150|NCT00650286|Modafinil|modafinil|mesh-list
154028181|NCT02644044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154028182|NCT02644044|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154028183|NCT02644044|Antimetabolites|antimetabolites|mesh-ancestor
154028184|NCT02644044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154028185|NCT02644044|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154028186|NCT02644044|Dermatologic Agents|dermatologic agents|mesh-ancestor
154028187|NCT02644044|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154028188|NCT02644044|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154028189|NCT02644044|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154028190|NCT02644044|Immunologic Factors|immunologic factors|mesh-ancestor
154028191|NCT02644044|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154028192|NCT02644044|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154028193|NCT00652860|Doxorubicin|doxorubicin|mesh-list
154028194|NCT00652860|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
154028195|NCT00652860|Ifosfamide|ifosfamide|mesh-list
154028196|NCT00652860|Molgramostim|molgramostim|mesh-list
154028197|NCT00652860|Mitomycins|mitomycins|mesh-list
154028198|NCT00652860|Mitomycin|mitomycin|mesh-list
154028199|NCT00652860|Sargramostim|sargramostim|mesh-list
154028200|NCT00652860|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154028201|NCT00652860|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154028202|NCT00652860|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154028203|NCT00652860|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154028204|NCT00652860|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154028205|NCT00652860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154028206|NCT00652860|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154028207|NCT00652860|Alkylating Agents|alkylating agents|mesh-ancestor
154028208|NCT00652860|Immunologic Factors|immunologic factors|mesh-ancestor
154028209|NCT00652860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154028210|NCT00652860|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154028211|NCT02536014|Dexmedetomidine|dexmedetomidine|mesh-list
154028212|NCT02536014|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154028213|NCT02536014|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154028214|NCT02536014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154028215|NCT02536014|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154028216|NCT02536014|Analgesics|analgesics|mesh-ancestor
154028217|NCT02536014|Sensory System Agents|sensory system agents|mesh-ancestor
154028218|NCT02536014|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154028219|NCT02536014|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154028220|NCT02536014|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154028221|NCT02536014|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154028222|NCT02536014|Adrenergic Agents|adrenergic agents|mesh-ancestor
154028223|NCT02536014|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154028224|NCT02536014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154028225|NCT00886613|Vaccines|vaccines|mesh-list
154028226|NCT00886613|Immunologic Factors|immunologic factors|mesh-ancestor
154028227|NCT00886613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154028228|NCT00653016|Ethinyl Estradiol|ethinyl estradiol|mesh-list
154028229|NCT00653016|Norelgestromin|norelgestromin|mesh-list
154028230|NCT00653016|Estradiol|estradiol|mesh-list
154028231|NCT00653016|Estrogens|estrogens|mesh-ancestor
154028232|NCT00653016|Hormones|hormones|mesh-ancestor
154028233|NCT00653016|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154028234|NCT00653016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154028235|NCT00653016|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
154028236|NCT00653016|Contraceptive Agents|contraceptive agents|mesh-ancestor
154028237|NCT00653016|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154028238|NCT00653016|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
154028239|NCT00653016|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
154028240|NCT00653016|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
154028242|NCT00886379|Ergocalciferols|ergocalciferols|mesh-list
154028243|NCT00886379|Cholecalciferol|cholecalciferol|mesh-list
154028244|NCT00886379|Vitamins|vitamins|mesh-list
154028245|NCT00886379|Micronutrients|micronutrients|mesh-ancestor
154028246|NCT00886379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154028247|NCT00886379|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154028248|NCT00886379|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154028249|NCT00633581|Ascorbic Acid|ascorbic acid|mesh-list
154028250|NCT00633581|Vitamins|vitamins|mesh-ancestor
154028251|NCT00633581|Micronutrients|micronutrients|mesh-ancestor
154028252|NCT00633581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154028253|NCT00633581|Antioxidants|antioxidants|mesh-ancestor
154028255|NCT00633581|Protective Agents|protective agents|mesh-ancestor
154028259|NCT02825147|Pegaspargase|pegaspargase|mesh-list
154028260|NCT02825147|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154028261|NCT02825147|Antiemetics|antiemetics|mesh-ancestor
154028262|NCT02825147|Autonomic Agents|autonomic agents|mesh-ancestor
154028263|NCT02825147|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154028264|NCT02825147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154028265|NCT02825147|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154028266|NCT02825147|Glucocorticoids|glucocorticoids|mesh-ancestor
154028267|NCT02825147|Hormones|hormones|mesh-ancestor
154028268|NCT02825147|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154028269|NCT02825147|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154028270|NCT02825147|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154028271|NCT02825147|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154028272|NCT02825147|Abortifacient Agents|abortifacient agents|mesh-ancestor
154028273|NCT02825147|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154028274|NCT02825147|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154028275|NCT02825147|Antimetabolites|antimetabolites|mesh-ancestor
154028276|NCT02825147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154028277|NCT02825147|Dermatologic Agents|dermatologic agents|mesh-ancestor
154028278|NCT02825147|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154028279|NCT02825147|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154028280|NCT02825147|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154028281|NCT02825147|Immunologic Factors|immunologic factors|mesh-ancestor
154028282|NCT02825147|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154028283|NCT02825147|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154028284|NCT02825147|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154028285|NCT02825147|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154028286|NCT02825147|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154028287|NCT02825225|Anesthetics|anesthetics|mesh-list
154028288|NCT02825225|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154028289|NCT02825225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154028290|NCT00637949|Rofecoxib|rofecoxib|mesh-list
154028291|NCT00637949|Lumiracoxib|lumiracoxib|mesh-list
154028292|NCT00637949|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
154028293|NCT00637949|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154028294|NCT00637949|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153572983|NCT02908334|Sertraline|sertraline|mesh-list
153572984|NCT02908334|Antidepressive Agents|antidepressive agents|mesh-ancestor
154028295|NCT00637949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154028297|NCT00637949|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154028298|NCT00637949|Analgesics|analgesics|mesh-ancestor
154028299|NCT00637949|Sensory System Agents|sensory system agents|mesh-ancestor
154028300|NCT00637949|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154028301|NCT00637949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154028302|NCT00637949|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154028303|NCT00637949|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154028304|NCT00599196|Rotigotine|rotigotine|mesh-list
154028305|NCT00599196|Dopamine Agonists|dopamine agonists|mesh-ancestor
154028306|NCT00599196|Dopamine Agents|dopamine agents|mesh-ancestor
154028307|NCT00599196|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154028308|NCT00599196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154028309|NCT00599196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153812651|NCT00429975|Levofloxacin|levofloxacin|mesh-list
154028310|NCT04201145|Pembrolizumab|pembrolizumab|mesh-list
154028311|NCT04201145|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154028313|NCT04201145|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154028314|NCT04201145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154028315|NCT02824601|Calcium|calcium|mesh-list
154028316|NCT02824601|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154028317|NCT02824601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154028318|NCT02643732|Methylphenidate|methylphenidate|mesh-list
154028319|NCT02643732|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
154028320|NCT02643732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154028321|NCT02643732|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
154028322|NCT02643732|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154028323|NCT02643732|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154028324|NCT02643732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154028325|NCT02643732|Dopamine Agents|dopamine agents|mesh-ancestor
154028333|NCT04876937|Sensory System Agents|sensory system agents|mesh-ancestor
154028334|NCT04876937|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154028335|NCT04876937|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154028336|NCT04876937|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154028337|NCT04876937|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154028338|NCT04876937|Adrenergic Agents|adrenergic agents|mesh-ancestor
154028339|NCT04876937|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154028340|NCT04876937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154028341|NCT05660993|Nivolumab|nivolumab|mesh-list
154028342|NCT05660993|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154028343|NCT05660993|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154028344|NCT05660993|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154028345|NCT05660993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154028346|NCT00633659|Hydroxyethyl Starch Derivatives|hydroxyethyl starch derivatives|mesh-list
154028347|NCT00633659|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
154028348|NCT00633659|Plasma Substitutes|plasma substitutes|mesh-ancestor
154028349|NCT00633659|Blood Substitutes|blood substitutes|mesh-ancestor
154028350|NCT04241705|Lumefantrine|lumefantrine|mesh-list
154028351|NCT04241705|Artemether|artemether|mesh-list
154028352|NCT04241705|Primaquine|primaquine|mesh-list
154028353|NCT04241705|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
154028354|NCT04241705|Antimalarials|antimalarials|mesh-ancestor
154028355|NCT04241705|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154028356|NCT04241705|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154028357|NCT04241705|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154028358|NCT04243109|Dexamethasone|dexamethasone|mesh-list
154028359|NCT04243109|Cyclophosphamide|cyclophosphamide|mesh-list
154028360|NCT04243109|Pomalidomide|pomalidomide|mesh-list
154028361|NCT04243109|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154028362|NCT04243109|Immunologic Factors|immunologic factors|mesh-ancestor
154028379|NCT04243109|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154028380|NCT04243109|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154028381|NCT04243109|Growth Substances|growth substances|mesh-ancestor
154028382|NCT04243109|Growth Inhibitors|growth inhibitors|mesh-ancestor
154028383|NCT04861181|Niraparib|niraparib|mesh-list
154028384|NCT04861181|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
154028386|NCT04861181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154028387|NCT04861181|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154028388|NCT00603512|Tofacitinib|tofacitinib|mesh-list
154028389|NCT00603512|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
154028390|NCT00603512|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154028391|NCT00603512|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154028392|NCT00603512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154028393|NCT04167774|Paclitaxel|paclitaxel|mesh-list
154028394|NCT04167774|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
154028395|NCT04167774|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154028396|NCT04167774|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153812671|NCT01056393|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154028397|NCT04167774|Tubulin Modulators|tubulin modulators|mesh-ancestor
154028398|NCT04167774|Antimitotic Agents|antimitotic agents|mesh-ancestor
154028399|NCT04167774|Mitosis Modulators|mitosis modulators|mesh-ancestor
154028400|NCT04167774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154028401|NCT02640300|Clozapine|clozapine|mesh-list
154028402|NCT02640300|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154028403|NCT02640300|Serotonin Agents|serotonin agents|mesh-ancestor
154028404|NCT02640300|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154028405|NCT02640300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154028406|NCT02640300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154028407|NCT02640300|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154028408|NCT02640300|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154028409|NCT02640300|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154028410|NCT02640300|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154028411|NCT02640300|GABA Antagonists|gaba antagonists|mesh-ancestor
154028412|NCT02640300|GABA Agents|gaba agents|mesh-ancestor
154028413|NCT02640144|Hyaluronic Acid|hyaluronic acid|mesh-list
154028414|NCT02640144|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153572985|NCT02908334|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154028418|NCT02640144|Protective Agents|protective agents|mesh-ancestor
154028419|NCT02643186|Misoprostol|misoprostol|mesh-list
154028420|NCT02643186|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154028421|NCT02643186|Abortifacient Agents|abortifacient agents|mesh-ancestor
154028422|NCT02643186|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154028423|NCT02643186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154028424|NCT02643186|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154028425|NCT02643186|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154028426|NCT02643186|Oxytocics|oxytocics|mesh-ancestor
154028427|NCT02652312|Diclofenac|diclofenac|mesh-list
154028428|NCT02652312|Fentanyl|fentanyl|mesh-list
154028429|NCT02652312|Dexmedetomidine|dexmedetomidine|mesh-list
154028430|NCT02652312|Ondansetron|ondansetron|mesh-list
154028431|NCT02652312|Propofol|propofol|mesh-list
154028432|NCT02652312|Desflurane|desflurane|mesh-list
154028433|NCT02652312|Atracurium|atracurium|mesh-list
154028434|NCT02652312|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154028435|NCT02652312|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154028436|NCT02652312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154028437|NCT02652312|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154028438|NCT02652312|Analgesics|analgesics|mesh-ancestor
154028439|NCT02652312|Sensory System Agents|sensory system agents|mesh-ancestor
154028440|NCT02652312|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154028441|NCT02652312|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154028442|NCT02652312|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154028443|NCT02652312|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154028444|NCT02652312|Adrenergic Agents|adrenergic agents|mesh-ancestor
154028445|NCT02652312|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154028446|NCT02652312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154028447|NCT02652312|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154028448|NCT02652312|Anesthetics, General|anesthetics, general|mesh-ancestor
154028449|NCT02652312|Anesthetics|anesthetics|mesh-ancestor
154028450|NCT02652312|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154028451|NCT02652312|Narcotics|narcotics|mesh-ancestor
154028452|NCT02652312|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154028453|NCT02652312|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154028454|NCT02652312|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154028455|NCT02652312|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154028456|NCT02652312|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154028457|NCT02652312|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154028458|NCT02652312|Antiemetics|antiemetics|mesh-ancestor
154028459|NCT02652312|Autonomic Agents|autonomic agents|mesh-ancestor
154028460|NCT02652312|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154028461|NCT02652312|Antipruritics|antipruritics|mesh-ancestor
154028462|NCT02652312|Dermatologic Agents|dermatologic agents|mesh-ancestor
154028463|NCT02652312|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
154028464|NCT02652312|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154028465|NCT02652312|Serotonin Agents|serotonin agents|mesh-ancestor
154028466|NCT02652312|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
154028467|NCT02652312|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
154028468|NCT02652312|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
154028469|NCT02652312|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
154028470|NCT02652312|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
154028471|NCT02652312|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154028472|NCT02652312|Cholinergic Agents|cholinergic agents|mesh-ancestor
154028473|NCT04165512|Triamcinolone|triamcinolone|mesh-list
154028474|NCT04165512|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
154028475|NCT04165512|Bupivacaine|bupivacaine|mesh-list
154028476|NCT04165512|Anesthetics, Local|anesthetics, local|mesh-ancestor
154028477|NCT04165512|Anesthetics|anesthetics|mesh-ancestor
154028478|NCT04165512|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154028479|NCT04165512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154028480|NCT04165512|Sensory System Agents|sensory system agents|mesh-ancestor
154028481|NCT04165512|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154028482|NCT04165512|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154028483|NCT04165512|Glucocorticoids|glucocorticoids|mesh-ancestor
154028484|NCT04165512|Hormones|hormones|mesh-ancestor
153814744|NCT00446940|Antimetabolites|antimetabolites|mesh-ancestor
153572986|NCT02908334|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
153572987|NCT02908334|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153572988|NCT02908334|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153572989|NCT02908334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153572990|NCT02908334|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153572991|NCT02908334|Serotonin Agents|serotonin agents|mesh-ancestor
153572992|NCT02908334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153572993|NCT02886286|Fentanyl|fentanyl|mesh-list
154028485|NCT04165512|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154028486|NCT04165512|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154028487|NCT04165512|Immunologic Factors|immunologic factors|mesh-ancestor
154028488|NCT02642874|Methocarbamol|methocarbamol|mesh-list
154028489|NCT02642874|Calcium Carbonate|calcium carbonate|mesh-list
154028490|NCT02642874|Calcium|calcium|mesh-list
154028491|NCT02642874|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154028492|NCT02642874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154028493|NCT02642874|Antacids|antacids|mesh-ancestor
154028494|NCT02642874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154028495|NCT02642874|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154028496|NCT02642874|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
154028497|NCT02642874|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
154028498|NCT02642874|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154028499|NCT00653874|Bilirubin|bilirubin|mesh-list
154028500|NCT00653874|Antioxidants|antioxidants|mesh-ancestor
154028501|NCT00653874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154028502|NCT00653874|Protective Agents|protective agents|mesh-ancestor
154028503|NCT00653874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154028504|NCT04224701|Vaccines|vaccines|mesh-list
154028505|NCT04224701|Immunologic Factors|immunologic factors|mesh-ancestor
154028506|NCT04224701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154028507|NCT00653952|Paclitaxel|paclitaxel|mesh-list
154028508|NCT00653952|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154028509|NCT00653952|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154028510|NCT00653952|Tubulin Modulators|tubulin modulators|mesh-ancestor
154028511|NCT00653952|Antimitotic Agents|antimitotic agents|mesh-ancestor
154028512|NCT00653952|Mitosis Modulators|mitosis modulators|mesh-ancestor
154028513|NCT00653952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154028514|NCT00650364|Midodrine|midodrine|mesh-list
154028515|NCT00650364|Sympathomimetics|sympathomimetics|mesh-ancestor
154028516|NCT00650364|Autonomic Agents|autonomic agents|mesh-ancestor
154028517|NCT00650364|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154028518|NCT00650364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154028519|NCT00650364|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154028520|NCT00650364|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
153572994|NCT02886286|Morphine|morphine|mesh-list
153572996|NCT02886286|Bupivacaine|bupivacaine|mesh-list
153572997|NCT02886286|Anesthetics, Local|anesthetics, local|mesh-ancestor
154028522|NCT00650364|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154028523|NCT00650364|Adrenergic Agents|adrenergic agents|mesh-ancestor
154028524|NCT00650364|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154028525|NCT00650364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154028527|NCT04909697|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154028528|NCT04909697|Protease Inhibitors|protease inhibitors|mesh-ancestor
154028529|NCT04909697|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154028530|NCT04909697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154028531|NCT00654108|Ascorbic Acid|ascorbic acid|mesh-list
154028532|NCT00654108|Ciprofloxacin|ciprofloxacin|mesh-list
154028533|NCT00654108|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154028534|NCT00654108|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154028535|NCT00654108|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154028536|NCT00654108|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154028537|NCT00654108|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154028538|NCT00654108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154028539|NCT00654108|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154028540|NCT00654108|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
154028541|NCT00654108|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154028542|NCT00654108|Antioxidants|antioxidants|mesh-ancestor
154028543|NCT00654108|Protective Agents|protective agents|mesh-ancestor
154028544|NCT00654108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154028545|NCT00654108|Vitamins|vitamins|mesh-ancestor
154028546|NCT00654108|Micronutrients|micronutrients|mesh-ancestor
154028547|NCT04165902|Hyaluronic Acid|hyaluronic acid|mesh-list
154028548|NCT04165902|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154028549|NCT04165902|Immunologic Factors|immunologic factors|mesh-ancestor
154028550|NCT04165902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154028551|NCT04165902|Viscosupplements|viscosupplements|mesh-ancestor
154028552|NCT04165902|Protective Agents|protective agents|mesh-ancestor
154028553|NCT02639598|Topiramate|topiramate|mesh-list
154028554|NCT02639598|Flunarizine|flunarizine|mesh-list
154028555|NCT02639598|Anticonvulsants|anticonvulsants|mesh-ancestor
154028556|NCT02639598|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153572998|NCT02886286|Anesthetics|anesthetics|mesh-ancestor
153572999|NCT02886286|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153573000|NCT02886286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153573001|NCT02886286|Sensory System Agents|sensory system agents|mesh-ancestor
154028558|NCT02639598|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154028559|NCT02639598|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154028560|NCT02639598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154028561|NCT02639598|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154028562|NCT02639598|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
154028563|NCT02639598|Histamine Antagonists|histamine antagonists|mesh-ancestor
154028564|NCT02639598|Histamine Agents|histamine agents|mesh-ancestor
154028565|NCT02639598|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154028566|NCT02639598|Vasodilator Agents|vasodilator agents|mesh-ancestor
154028567|NCT04907279|Aripiprazole|aripiprazole|mesh-list
154028568|NCT04907279|Antidepressive Agents|antidepressive agents|mesh-ancestor
154028569|NCT04907279|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154028570|NCT04907279|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154028571|NCT04907279|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154028572|NCT04907279|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154028573|NCT04907279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154028574|NCT04907279|Dopamine Agonists|dopamine agonists|mesh-ancestor
154028575|NCT04907279|Dopamine Agents|dopamine agents|mesh-ancestor
154028576|NCT04907279|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154028577|NCT04907279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154028578|NCT04907279|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
154028579|NCT04907279|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
154028580|NCT04907279|Serotonin Agents|serotonin agents|mesh-ancestor
154028581|NCT04907279|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
154028582|NCT04907279|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154028583|NCT04907279|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
154028584|NCT04907279|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
154028586|NCT02642718|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
154028587|NCT02642718|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154028588|NCT02642718|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154028589|NCT02642718|Analgesics|analgesics|mesh-ancestor
153573002|NCT02886286|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153573003|NCT02886286|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153573004|NCT02886286|Narcotics|narcotics|mesh-ancestor
153573005|NCT02886286|Analgesics|analgesics|mesh-ancestor
153573022|NCT02787551|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
153573023|NCT02787551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154028590|NCT02642718|Sensory System Agents|sensory system agents|mesh-ancestor
154028591|NCT02642718|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154028592|NCT02642718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154028593|NCT02642718|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154028594|NCT02642718|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154028595|NCT02642718|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154028596|NCT02642718|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154028597|NCT02642718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154028598|NCT02642484|Gabapentin|gabapentin|mesh-list
154028599|NCT02642484|Calcium Carbonate|calcium carbonate|mesh-list
154028600|NCT02642484|Calcium|calcium|mesh-list
154028601|NCT02642484|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154028602|NCT02642484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154028603|NCT02642484|Analgesics|analgesics|mesh-ancestor
154028604|NCT02642484|Sensory System Agents|sensory system agents|mesh-ancestor
154028605|NCT02642484|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154028606|NCT02642484|Anticonvulsants|anticonvulsants|mesh-ancestor
154028607|NCT02642484|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154028608|NCT02642484|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154028609|NCT02642484|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154028610|NCT02642484|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154028611|NCT02642484|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154028612|NCT02642484|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154028613|NCT02642484|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154028614|NCT02642484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153573024|NCT02787551|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
153573025|NCT02787551|Incretins|incretins|mesh-ancestor
153573027|NCT02787551|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153573028|NCT02787551|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
153573029|NCT02787551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153573030|NCT02735044|Insulin|insulin|mesh-list
153573031|NCT02735044|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
153573032|NCT02735044|Insulin Glargine|insulin glargine|mesh-list
153573033|NCT02735044|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153573034|NCT02735044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153573035|NCT02692651|Vancomycin|vancomycin|mesh-list
153573036|NCT02692651|Fidaxomicin|fidaxomicin|mesh-list
153573037|NCT02692651|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153573038|NCT02692651|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153573039|NCT02674061|Pembrolizumab|pembrolizumab|mesh-list
153573040|NCT02674061|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153573041|NCT02674061|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153573042|NCT02674061|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153573043|NCT02674061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153573044|NCT02654314|Melatonin|melatonin|mesh-list
153573045|NCT02654314|Antioxidants|antioxidants|mesh-ancestor
153573046|NCT02654314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153573047|NCT02654314|Protective Agents|protective agents|mesh-ancestor
154028616|NCT02642484|Antacids|antacids|mesh-ancestor
154028617|NCT02642484|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154028618|NCT00639392|Zoledronic Acid|zoledronic acid|mesh-list
154028619|NCT00639392|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154028620|NCT00639392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154028621|NCT04185350|Exenatide|exenatide|mesh-list
154028622|NCT04185350|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
154028623|NCT04185350|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154028624|NCT04185350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154028625|NCT04185350|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
154028626|NCT04185350|Incretins|incretins|mesh-ancestor
154028627|NCT04185350|Hormones|hormones|mesh-ancestor
154028628|NCT04185350|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154028629|NCT00653172|Streptogramin A|streptogramin a|mesh-list
154028630|NCT00653172|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154028631|NCT00653172|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154028632|NCT02639520|Fosfomycin|fosfomycin|mesh-list
154028633|NCT02639520|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154028634|NCT02639520|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154028635|NCT02822729|Timolol|timolol|mesh-list
154028636|NCT02822729|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
154028637|NCT02822729|Ophthalmic Solutions|ophthalmic solutions|mesh-list
154028638|NCT02822729|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
154028639|NCT02822729|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154028640|NCT02822729|Adrenergic Agents|adrenergic agents|mesh-ancestor
154028641|NCT02822729|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154028642|NCT02822729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154028643|NCT02822729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154028644|NCT02822729|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154028645|NCT02822729|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153573048|NCT02654314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153573049|NCT02654314|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153573050|NCT02626962|Nivolumab|nivolumab|mesh-list
153458159|NCT03023358|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153458160|NCT03023358|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153458161|NCT03023358|Alkylating Agents|alkylating agents|mesh-ancestor
153816785|NCT00459420|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
153816786|NCT00459420|Purinergic Agents|purinergic agents|mesh-ancestor
153458162|NCT03023358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153816787|NCT00459420|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153816788|NCT00467766|Donepezil|donepezil|mesh-list
153573052|NCT02626962|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153573053|NCT02626962|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154028646|NCT02642250|Metronidazole|metronidazole|mesh-list
154028647|NCT02642250|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154028648|NCT02642250|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154028649|NCT02642250|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154028650|NCT02642250|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154028651|NCT00653250|Celecoxib|celecoxib|mesh-list
154028652|NCT00653250|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154028653|NCT00653250|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154028654|NCT00653250|Analgesics|analgesics|mesh-ancestor
154028655|NCT00653250|Sensory System Agents|sensory system agents|mesh-ancestor
154028656|NCT00653250|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154028657|NCT00653250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154028658|NCT00653250|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154028659|NCT00653250|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154028660|NCT00653250|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
154028661|NCT00653250|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154028662|NCT00653250|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154028663|NCT00653250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154028664|NCT00638534|Telithromycin|telithromycin|mesh-list
154028665|NCT00638534|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154028666|NCT00638534|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154028667|NCT04240535|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
154028668|NCT04240535|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
154028669|NCT04240535|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
154028670|NCT04240535|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154028671|NCT04240535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154028672|NCT04240535|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
154028673|NCT04240535|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154028674|NCT04240535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153573054|NCT02626962|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153573055|NCT02626962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153573056|NCT02623998|Metformin|metformin|mesh-list
153573057|NCT02623998|Insulin Glargine|insulin glargine|mesh-list
153573058|NCT02623998|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
153573059|NCT02623998|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153573060|NCT02623998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153573061|NCT02623998|Incretins|incretins|mesh-ancestor
153573062|NCT02623998|Hormones|hormones|mesh-ancestor
153573063|NCT02623998|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153573064|NCT02623998|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
153573065|NCT02623998|Protease Inhibitors|protease inhibitors|mesh-ancestor
153573066|NCT02623998|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153573067|NCT02623998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153573068|NCT02608684|Gemcitabine|gemcitabine|mesh-list
154028677|NCT02638896|Sulfasalazine|sulfasalazine|mesh-list
154028678|NCT02638896|Celecoxib|celecoxib|mesh-list
154028679|NCT02638896|Etanercept|etanercept|mesh-list
154028680|NCT02638896|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154028681|NCT02638896|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154028682|NCT02638896|Analgesics|analgesics|mesh-ancestor
154028683|NCT02638896|Sensory System Agents|sensory system agents|mesh-ancestor
154028684|NCT02638896|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154028685|NCT02638896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154028686|NCT02638896|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154028687|NCT02638896|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154028688|NCT02638896|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
154028689|NCT02638896|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154028690|NCT02638896|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154028691|NCT02638896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154028692|NCT02638896|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154028693|NCT02638896|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154028694|NCT02638896|Immunologic Factors|immunologic factors|mesh-ancestor
154028695|NCT02638896|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154028696|NCT04240223|Brilacidin|brilacidin|mesh-list
154028697|NCT04240223|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154028698|NCT00653406|Risperidone|risperidone|mesh-list
154028699|NCT00653406|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154028700|NCT00653406|Serotonin Agents|serotonin agents|mesh-ancestor
154028701|NCT00653406|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154028702|NCT00653406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154028703|NCT00653406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154028704|NCT00653406|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154028705|NCT00653406|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154028706|NCT00653406|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153573069|NCT02608684|Pembrolizumab|pembrolizumab|mesh-list
153573070|NCT02608684|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153573071|NCT02608684|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153573072|NCT02608684|Antimetabolites|antimetabolites|mesh-ancestor
153573073|NCT02608684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153573074|NCT02608684|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153573075|NCT02608684|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153573076|NCT02587520|Vaccines|vaccines|mesh-list
153573077|NCT02587520|Immunologic Factors|immunologic factors|mesh-ancestor
153573078|NCT02587520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153573079|NCT02584829|Interferons|interferons|mesh-list
154028707|NCT00653406|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154028708|NCT00653406|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
154028709|NCT00653406|Dopamine Agents|dopamine agents|mesh-ancestor
154028710|NCT04239755|Doxycycline|doxycycline|mesh-list
154028711|NCT04239755|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154028712|NCT04239755|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154028713|NCT04239755|Antimalarials|antimalarials|mesh-ancestor
154028714|NCT04239755|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154028715|NCT04239755|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154028716|NCT04185194|Lidocaine|lidocaine|mesh-list
154028717|NCT04185194|Anesthetics, Local|anesthetics, local|mesh-ancestor
154028718|NCT04185194|Anesthetics|anesthetics|mesh-ancestor
154028719|NCT04185194|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154028720|NCT04185194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154028721|NCT04185194|Sensory System Agents|sensory system agents|mesh-ancestor
154028722|NCT04185194|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154028723|NCT04185194|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154028724|NCT04185194|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154028725|NCT04185194|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154028726|NCT04185194|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154028727|NCT04185194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154028728|NCT00876447|Botulinum Toxins|botulinum toxins|mesh-list
154028729|NCT00876447|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
154028730|NCT00876447|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
154028731|NCT00876447|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
154028732|NCT00876447|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154028733|NCT00876447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154028734|NCT00876447|Cholinergic Agents|cholinergic agents|mesh-ancestor
154028735|NCT00876447|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154028736|NCT00876447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154028739|NCT04239833|Gefitinib|gefitinib|mesh-list
154028750|NCT03513770|Sensory System Agents|sensory system agents|mesh-ancestor
154028751|NCT03513770|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154028752|NCT03513770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154028753|NCT03513770|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154028754|NCT03513770|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154028756|NCT03513770|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154028757|NCT03513770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154028758|NCT02638740|Mechlorethamine|mechlorethamine|mesh-list
154028759|NCT02638740|Alkylating Agents|alkylating agents|mesh-ancestor
154028760|NCT02638740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154028761|NCT02638740|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154028762|NCT02638740|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154028763|NCT02823977|Dexmedetomidine|dexmedetomidine|mesh-list
154028764|NCT02823977|Ketamine|ketamine|mesh-list
154028765|NCT02823977|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154028766|NCT02823977|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154028767|NCT02823977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154028768|NCT02823977|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154028769|NCT02823977|Analgesics|analgesics|mesh-ancestor
154028770|NCT02823977|Sensory System Agents|sensory system agents|mesh-ancestor
154028771|NCT02823977|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154028772|NCT02823977|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154028773|NCT02823977|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154028774|NCT02823977|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154028775|NCT02823977|Adrenergic Agents|adrenergic agents|mesh-ancestor
154028776|NCT02823977|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153812683|NCT00329693|Quinagolide|quinagolide|mesh-list
154028777|NCT02823977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154028778|NCT02823977|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
154028779|NCT02823977|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154028780|NCT02823977|Anesthetics, General|anesthetics, general|mesh-ancestor
154028781|NCT02823977|Anesthetics|anesthetics|mesh-ancestor
154028782|NCT02823977|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154028783|NCT02823977|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154028784|NCT00680511|Methamphetamine|methamphetamine|mesh-list
154028789|NCT00680511|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154028790|NCT00680511|Dopamine Agents|dopamine agents|mesh-ancestor
154028791|NCT00680511|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154028792|NCT00680511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154028793|NCT00680511|Adrenergic Agents|adrenergic agents|mesh-ancestor
154028794|NCT00680511|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
154028795|NCT00680511|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154028796|NCT00680511|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154028797|NCT00680511|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
154028798|NCT00654576|Olanzapine|olanzapine|mesh-list
154028799|NCT00654576|Chlorpromazine|chlorpromazine|mesh-list
154028800|NCT00654576|Risperidone|risperidone|mesh-list
154028801|NCT00654576|Quetiapine Fumarate|quetiapine fumarate|mesh-list
154028802|NCT00654576|Clozapine|clozapine|mesh-list
154028803|NCT00654576|Sulpiride|sulpiride|mesh-list
154028804|NCT00654576|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154028805|NCT00654576|Serotonin Agents|serotonin agents|mesh-ancestor
154028806|NCT00654576|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154028807|NCT00654576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154028808|NCT00654576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154028809|NCT00654576|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154028810|NCT00654576|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154028811|NCT00654576|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154028812|NCT00654576|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154028813|NCT00654576|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
154028814|NCT00654576|Dopamine Agents|dopamine agents|mesh-ancestor
154028815|NCT00654576|Antiemetics|antiemetics|mesh-ancestor
154028816|NCT00654576|Autonomic Agents|autonomic agents|mesh-ancestor
154028817|NCT00654576|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154028818|NCT00654576|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154028819|NCT00654576|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
154028820|NCT00654576|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154028821|NCT00654576|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154028822|NCT00654576|Antidepressive Agents|antidepressive agents|mesh-ancestor
154028829|NCT00622622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154028830|NCT00622622|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154028831|NCT00598650|Donepezil|donepezil|mesh-list
154028832|NCT00598650|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
154028833|NCT00598650|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154028834|NCT00598650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154028835|NCT00598650|Cholinergic Agents|cholinergic agents|mesh-ancestor
154028836|NCT00598650|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154028837|NCT00598650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154028838|NCT00598650|Nootropic Agents|nootropic agents|mesh-ancestor
154028839|NCT02641938|Dexmedetomidine|dexmedetomidine|mesh-list
154028840|NCT02641938|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154028841|NCT02641938|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154028842|NCT02641938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154028843|NCT02641938|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154028844|NCT02641938|Analgesics|analgesics|mesh-ancestor
154028845|NCT02641938|Sensory System Agents|sensory system agents|mesh-ancestor
154028846|NCT02641938|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154028847|NCT02641938|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154028848|NCT02641938|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154028849|NCT02641938|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154028850|NCT02641938|Adrenergic Agents|adrenergic agents|mesh-ancestor
154028851|NCT02641938|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154028852|NCT02641938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154028853|NCT04249076|Clobetasol|clobetasol|mesh-list
154028854|NCT04249076|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154028855|NCT04249076|Glucocorticoids|glucocorticoids|mesh-ancestor
154028856|NCT04249076|Hormones|hormones|mesh-ancestor
154028857|NCT04249076|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154028858|NCT04249076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154028859|NCT00681135|Olaflur|olaflur|mesh-list
154028860|NCT00681135|Cariostatic Agents|cariostatic agents|mesh-ancestor
154028869|NCT02821559|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154028871|NCT02821559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154028872|NCT02821559|Growth Inhibitors|growth inhibitors|mesh-ancestor
154028873|NCT02821559|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154028874|NCT02821559|Antimetabolites|antimetabolites|mesh-ancestor
154028875|NCT02821559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154028876|NCT02821559|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154028877|NCT02821559|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154028878|NCT00681213|Sirolimus|sirolimus|mesh-list
154028879|NCT00681213|Temsirolimus|temsirolimus|mesh-list
154028880|NCT00681213|MTOR Inhibitors|mtor inhibitors|mesh-list
154028881|NCT00681213|Tacrolimus|tacrolimus|mesh-list
154028882|NCT00681213|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154028883|NCT00681213|Immunologic Factors|immunologic factors|mesh-ancestor
154028884|NCT00681213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154028885|NCT00681213|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
154028886|NCT00681213|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154028887|NCT00681213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154028888|NCT00681213|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154028889|NCT00681213|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154028890|NCT00681213|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154028891|NCT00681213|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154028892|NCT00681213|Antifungal Agents|antifungal agents|mesh-ancestor
154028893|NCT00681213|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154028894|NCT02638506|Fentanyl|fentanyl|mesh-list
154028895|NCT02638506|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154028896|NCT02638506|Narcotics|narcotics|mesh-ancestor
154028897|NCT02638506|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154028898|NCT02638506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154028899|NCT02638506|Analgesics|analgesics|mesh-ancestor
154028900|NCT02638506|Sensory System Agents|sensory system agents|mesh-ancestor
154028901|NCT02638506|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154028902|NCT02638506|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154028903|NCT02638506|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154028904|NCT02638506|Anesthetics, General|anesthetics, general|mesh-ancestor
154028905|NCT02638506|Anesthetics|anesthetics|mesh-ancestor
153573080|NCT02584829|Interferon-beta|interferon-beta|mesh-list
153816789|NCT00467766|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
154028906|NCT04745975|Paclitaxel|paclitaxel|mesh-list
154028907|NCT04745975|Vinorelbine|vinorelbine|mesh-list
154028908|NCT04745975|Gemcitabine|gemcitabine|mesh-list
154028909|NCT04745975|Capecitabine|capecitabine|mesh-list
154028910|NCT04745975|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154028911|NCT04745975|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154028912|NCT04745975|Tubulin Modulators|tubulin modulators|mesh-ancestor
154028913|NCT04745975|Antimitotic Agents|antimitotic agents|mesh-ancestor
154028914|NCT04745975|Mitosis Modulators|mitosis modulators|mesh-ancestor
154028915|NCT04745975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154028916|NCT04745975|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154028917|NCT04745975|Antimetabolites|antimetabolites|mesh-ancestor
154028918|NCT04150107|Insulin|insulin|mesh-list
154028919|NCT04150107|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
154028920|NCT04150107|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154028921|NCT04150107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154028922|NCT02638428|Cytarabine|cytarabine|mesh-list
154028923|NCT02638428|Carboplatin|carboplatin|mesh-list
154028924|NCT02638428|Trastuzumab|trastuzumab|mesh-list
154028925|NCT02638428|Fludarabine|fludarabine|mesh-list
154028926|NCT02638428|Etoposide|etoposide|mesh-list
154028927|NCT02638428|Everolimus|everolimus|mesh-list
154028928|NCT02638428|Sorafenib|sorafenib|mesh-list
154028929|NCT02638428|Dasatinib|dasatinib|mesh-list
154028930|NCT02638428|Ifosfamide|ifosfamide|mesh-list
154028931|NCT02638428|Axitinib|axitinib|mesh-list
154028932|NCT02638428|Vemurafenib|vemurafenib|mesh-list
154028933|NCT02638428|Crizotinib|crizotinib|mesh-list
154028934|NCT02638428|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154028935|NCT02638428|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154028936|NCT02638428|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154028937|NCT02638428|Antimetabolites|antimetabolites|mesh-ancestor
154028938|NCT02638428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154028939|NCT02638428|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154028940|NCT02638428|Immunologic Factors|immunologic factors|mesh-ancestor
154028941|NCT02638428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154028942|NCT02638428|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154028943|NCT02638428|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154028951|NCT02638428|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154028952|NCT02638428|Alkylating Agents|alkylating agents|mesh-ancestor
154028953|NCT01003964|Cisplatin|cisplatin|mesh-list
154028954|NCT01003964|Gemcitabine|gemcitabine|mesh-list
154028955|NCT01003964|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154028956|NCT01003964|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154028957|NCT01003964|Antimetabolites|antimetabolites|mesh-ancestor
154028958|NCT01003964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154028959|NCT02823743|Aspirin|aspirin|mesh-list
154028960|NCT02823743|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154028961|NCT02823743|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154028962|NCT02823743|Analgesics|analgesics|mesh-ancestor
154028963|NCT02823743|Sensory System Agents|sensory system agents|mesh-ancestor
154028964|NCT02823743|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154028965|NCT02823743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154028966|NCT02823743|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154028967|NCT02823743|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154028968|NCT02823743|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154028969|NCT02823743|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154028970|NCT02823743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154028971|NCT02823743|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154028972|NCT02823743|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154028973|NCT02823743|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154028974|NCT02823743|Antipyretics|antipyretics|mesh-ancestor
154028975|NCT00654888|Mitomycins|mitomycins|mesh-list
154028976|NCT00654888|Mitomycin|mitomycin|mesh-list
154028977|NCT00654888|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154028992|NCT02638584|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154028993|NCT02638584|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154028994|NCT02638584|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
154028995|NCT02638584|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154028996|NCT02638584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154028997|NCT02821169|Ropivacaine|ropivacaine|mesh-list
154028998|NCT02821169|Anesthetics, Local|anesthetics, local|mesh-ancestor
154028999|NCT02821169|Anesthetics|anesthetics|mesh-ancestor
154029000|NCT02821169|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154029001|NCT02821169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154029002|NCT02821169|Sensory System Agents|sensory system agents|mesh-ancestor
154029003|NCT02821169|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154029004|NCT02820935|Itraconazole|itraconazole|mesh-list
154029005|NCT02820935|Rifampin|rifampin|mesh-list
154029006|NCT02820935|Antifungal Agents|antifungal agents|mesh-ancestor
154029007|NCT02820935|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154029008|NCT02820935|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
154029009|NCT02820935|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154029010|NCT02820935|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154029011|NCT02820935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154029012|NCT02820935|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154029013|NCT02820935|Hormone Antagonists|hormone antagonists|mesh-ancestor
154029014|NCT02820935|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154029015|NCT02820935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154029016|NCT02820935|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154029017|NCT02820935|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
154029018|NCT02820935|Antitubercular Agents|antitubercular agents|mesh-ancestor
154029019|NCT02820935|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154029028|NCT02626845|Rituximab|rituximab|mesh-list
154029029|NCT02626845|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154029030|NCT02626845|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154029031|NCT02626845|Immunologic Factors|immunologic factors|mesh-ancestor
154029032|NCT02626845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154029033|NCT02626845|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154029034|NCT02821247|Aflibercept|aflibercept|mesh-list
154029035|NCT02821247|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154029036|NCT02821247|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154029037|NCT02821247|Growth Substances|growth substances|mesh-ancestor
154029038|NCT02821247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154029039|NCT02821247|Growth Inhibitors|growth inhibitors|mesh-ancestor
154029040|NCT02821247|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154029041|NCT00681525|Atorvastatin|atorvastatin|mesh-list
154029042|NCT00681525|Ezetimibe|ezetimibe|mesh-list
154029043|NCT00681525|Fenofibric acid|fenofibric acid|mesh-list
154029044|NCT00681525|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154029045|NCT00681525|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154029046|NCT00681525|Antimetabolites|antimetabolites|mesh-ancestor
154029047|NCT00681525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154029048|NCT00681525|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154029049|NCT00681525|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154029050|NCT00681525|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154029052|NCT00681603|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154029053|NCT00681603|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154029054|NCT00681603|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154029055|NCT00681603|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154029056|NCT00681603|Growth Substances|growth substances|mesh-ancestor
154029057|NCT00681603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154029058|NCT00681603|Growth Inhibitors|growth inhibitors|mesh-ancestor
154029059|NCT04239443|Apatinib|apatinib|mesh-list
154029060|NCT04239443|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
154029061|NCT04239443|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153816790|NCT00467766|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153816791|NCT00467766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153816792|NCT00467766|Cholinergic Agents|cholinergic agents|mesh-ancestor
153816793|NCT00467766|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153816794|NCT00467766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153816795|NCT00467766|Nootropic Agents|nootropic agents|mesh-ancestor
153816797|NCT00467883|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
153816798|NCT00467883|Amebicides|amebicides|mesh-ancestor
153816799|NCT00467883|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154029062|NCT04239443|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154029063|NCT04239443|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154029064|NCT04239443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154029065|NCT04239443|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154029066|NCT04200599|Oxytocin|oxytocin|mesh-list
154029067|NCT04200599|Oxytocics|oxytocics|mesh-ancestor
154029068|NCT04200599|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154029069|NCT04200599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154029070|NCT02820077|Hemostatics|hemostatics|mesh-list
154029071|NCT02820077|Coagulants|coagulants|mesh-ancestor
154029072|NCT00681993|Cyclophosphamide|cyclophosphamide|mesh-list
154029073|NCT00681993|Carboplatin|carboplatin|mesh-list
154029074|NCT00681993|Docetaxel|docetaxel|mesh-list
154029075|NCT00681993|Trastuzumab|trastuzumab|mesh-list
154029076|NCT00681993|Doxorubicin|doxorubicin|mesh-list
154029077|NCT00681993|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
154029078|NCT00681993|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154029079|NCT00681993|Immunologic Factors|immunologic factors|mesh-ancestor
154029080|NCT00681993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154029081|NCT00681993|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154029082|NCT00681993|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154029083|NCT00681993|Alkylating Agents|alkylating agents|mesh-ancestor
154029084|NCT00681993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154029085|NCT00681993|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154029086|NCT00681993|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154029087|NCT00681993|Tubulin Modulators|tubulin modulators|mesh-ancestor
154029088|NCT00681993|Antimitotic Agents|antimitotic agents|mesh-ancestor
154029089|NCT00681993|Mitosis Modulators|mitosis modulators|mesh-ancestor
154029090|NCT00681993|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154029091|NCT00681993|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154029092|NCT00681993|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154029093|NCT00681993|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154029094|NCT00681993|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154029095|NCT02819999|Etoposide|etoposide|mesh-list
154029096|NCT02819999|Rovalpituzumab tesirine|rovalpituzumab tesirine|mesh-list
154029097|NCT02819999|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153816800|NCT00467883|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153573081|NCT02584829|Avelumab|avelumab|mesh-list
153573082|NCT02584829|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
153573083|NCT02584829|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153812686|NCT00329693|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154029099|NCT02819999|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154029100|NCT02819999|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154029101|NCT02819999|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154029102|NCT02819999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154029103|NCT02819999|Immunoconjugates|immunoconjugates|mesh-ancestor
154029104|NCT02819999|Immunologic Factors|immunologic factors|mesh-ancestor
154029105|NCT02819999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154029106|NCT02819921|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
154029107|NCT02819921|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
154029108|NCT02819921|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154029109|NCT02819921|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154029110|NCT02819921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154029111|NCT02819921|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154029112|NCT02819921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154029113|NCT02819921|Antidepressive Agents|antidepressive agents|mesh-ancestor
154029114|NCT02819921|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153571786|NCT05611229|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154029115|NCT00875979|Trastuzumab|trastuzumab|mesh-list
154029117|NCT00875979|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
154029118|NCT00875979|Maytansine|maytansine|mesh-list
154029119|NCT00875979|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154029120|NCT00875979|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154029121|NCT00875979|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154029122|NCT00875979|Tubulin Modulators|tubulin modulators|mesh-ancestor
154029123|NCT00875979|Antimitotic Agents|antimitotic agents|mesh-ancestor
154029125|NCT00875979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154029126|NCT00875979|Immunotoxins|immunotoxins|mesh-ancestor
154029127|NCT00875979|Immunoconjugates|immunoconjugates|mesh-ancestor
154029128|NCT00875979|Immunologic Factors|immunologic factors|mesh-ancestor
154029129|NCT00875979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154029130|NCT02818751|Escitalopram|escitalopram|mesh-list
154029131|NCT02818751|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
154029132|NCT02818751|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153573084|NCT02584829|Antiviral Agents|antiviral agents|mesh-ancestor
153814753|NCT00446979|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154029133|NCT02818751|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154029134|NCT02818751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154029135|NCT02818751|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154029136|NCT02818751|Serotonin Agents|serotonin agents|mesh-ancestor
154029137|NCT02818751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154029139|NCT04238975|Immunologic Factors|immunologic factors|mesh-ancestor
154029140|NCT04238975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154029141|NCT00602420|Naproxen|naproxen|mesh-list
154029142|NCT00602420|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154029143|NCT00602420|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154029144|NCT00602420|Analgesics|analgesics|mesh-ancestor
154029145|NCT00602420|Sensory System Agents|sensory system agents|mesh-ancestor
154029146|NCT00602420|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154029147|NCT00602420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154029148|NCT00602420|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154029149|NCT00602420|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154029150|NCT00602420|Gout Suppressants|gout suppressants|mesh-ancestor
154029151|NCT00602420|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154029152|NCT00602420|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154029153|NCT00602420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154029154|NCT04635605|Methylene Blue|methylene blue|mesh-list
154029155|NCT04635605|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154029156|NCT04635605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154029157|NCT02688374|Nicotine|nicotine|mesh-list
154029158|NCT02688374|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
154029159|NCT02688374|Autonomic Agents|autonomic agents|mesh-ancestor
154029160|NCT02688374|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154029161|NCT02688374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154029162|NCT02688374|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
154029163|NCT02688374|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
154029164|NCT02688374|Cholinergic Agents|cholinergic agents|mesh-ancestor
154029165|NCT02688374|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153573085|NCT02584829|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153573086|NCT02584829|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153573087|NCT02584829|Immunologic Factors|immunologic factors|mesh-ancestor
153812689|NCT00329810|Aripiprazole|aripiprazole|mesh-list
153573088|NCT02584829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153573089|NCT02512172|Pembrolizumab|pembrolizumab|mesh-list
154029167|NCT02819375|Ketamine|ketamine|mesh-list
154029168|NCT02819375|Remifentanil|remifentanil|mesh-list
154029169|NCT02819375|Propofol|propofol|mesh-list
154029170|NCT02819375|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154029171|NCT02819375|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154029172|NCT02819375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154029173|NCT02819375|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154029174|NCT02819375|Anesthetics, General|anesthetics, general|mesh-ancestor
154029175|NCT02819375|Anesthetics|anesthetics|mesh-ancestor
154029176|NCT02819375|Analgesics|analgesics|mesh-ancestor
154029177|NCT02819375|Sensory System Agents|sensory system agents|mesh-ancestor
154029178|NCT02819375|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154029179|NCT02819375|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
154029180|NCT02819375|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154029181|NCT02819375|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154029182|NCT02819375|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154029183|NCT02819375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154029184|NCT02819375|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154029185|NCT02819375|Narcotics|narcotics|mesh-ancestor
154029186|NCT02818985|Dexamethasone|dexamethasone|mesh-list
154029187|NCT02818985|Dexmedetomidine|dexmedetomidine|mesh-list
154029188|NCT02818985|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154029189|NCT02818985|Antiemetics|antiemetics|mesh-ancestor
154029190|NCT02818985|Autonomic Agents|autonomic agents|mesh-ancestor
154029191|NCT02818985|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154029192|NCT02818985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154029193|NCT02818985|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154029194|NCT02818985|Glucocorticoids|glucocorticoids|mesh-ancestor
154029195|NCT02818985|Hormones|hormones|mesh-ancestor
154029196|NCT02818985|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154029197|NCT02818985|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154029198|NCT02818985|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154029199|NCT02818985|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153573090|NCT02512172|Azacitidine|azacitidine|mesh-list
153573091|NCT02512172|Romidepsin|romidepsin|mesh-list
153573092|NCT02512172|Cc-486|cc-486|mesh-list
153573093|NCT02512172|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153814754|NCT00446979|Antiviral Agents|antiviral agents|mesh-ancestor
154029200|NCT02818985|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154029201|NCT02818985|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154029202|NCT02818985|Analgesics|analgesics|mesh-ancestor
154029203|NCT02818985|Sensory System Agents|sensory system agents|mesh-ancestor
154029204|NCT02818985|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154029205|NCT02818985|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154029206|NCT02818985|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154029207|NCT02818985|Adrenergic Agents|adrenergic agents|mesh-ancestor
154029208|NCT02818985|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154029209|NCT02818985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154029211|NCT02815787|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154029212|NCT02815787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154029213|NCT00639938|Nevirapine|nevirapine|mesh-list
154029214|NCT00639938|Immunoglobulins|immunoglobulins|mesh-list
154029215|NCT00639938|Antibodies|antibodies|mesh-list
154029216|NCT00639938|gamma-Globulins|gamma-globulins|mesh-list
154029217|NCT00639938|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
154029218|NCT00639938|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
154029219|NCT00639938|Immunologic Factors|immunologic factors|mesh-ancestor
154029220|NCT00639938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154029221|NCT00639938|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
154029222|NCT00639938|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154029223|NCT00639938|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154029224|NCT00639938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154029225|NCT00639938|Antiviral Agents|antiviral agents|mesh-ancestor
154029226|NCT00639938|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154029227|NCT00639938|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154029228|NCT00639938|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154029229|NCT00639938|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
154029230|NCT00639938|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
154029231|NCT02815319|Dexamethasone|dexamethasone|mesh-list
154029240|NCT02815319|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153812693|NCT00329810|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154029241|NCT02815319|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154029242|NCT02815319|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154029243|NCT02815475|Curcumin|curcumin|mesh-list
154029244|NCT02815475|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154029245|NCT02815475|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154029246|NCT02815475|Analgesics|analgesics|mesh-ancestor
154029247|NCT02815475|Sensory System Agents|sensory system agents|mesh-ancestor
154029248|NCT02815475|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154029249|NCT02815475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154029250|NCT02815475|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154029251|NCT02815475|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154029252|NCT02815475|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154029253|NCT02815475|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154029254|NCT02815475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154029255|NCT00640796|Aldesleukin|aldesleukin|mesh-list
154029256|NCT00640796|Cyclophosphamide|cyclophosphamide|mesh-list
154029257|NCT00640796|Fludarabine|fludarabine|mesh-list
154029258|NCT00640796|Interleukin-2|interleukin-2|mesh-list
154029259|NCT00640796|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154029260|NCT00640796|Immunologic Factors|immunologic factors|mesh-ancestor
154029261|NCT00640796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154029262|NCT00640796|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154029263|NCT00640796|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154029264|NCT00640796|Alkylating Agents|alkylating agents|mesh-ancestor
154029265|NCT00640796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154029266|NCT00640796|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154029267|NCT00640796|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154029268|NCT00640796|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154029269|NCT00640796|Analgesics|analgesics|mesh-ancestor
154029270|NCT00640796|Sensory System Agents|sensory system agents|mesh-ancestor
154029271|NCT00640796|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154029272|NCT00640796|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154029273|NCT00640796|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154029279|NCT02687984|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154029280|NCT02687984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154029281|NCT02687984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154029282|NCT02687984|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154029283|NCT02687984|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154029284|NCT02687984|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154029285|NCT02687984|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154029286|NCT02687984|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
154029287|NCT02687984|Dopamine Agents|dopamine agents|mesh-ancestor
154029288|NCT02683148|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
154029289|NCT02683148|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154029290|NCT02683148|Immunologic Factors|immunologic factors|mesh-ancestor
154029291|NCT02683148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154029293|NCT02684786|Reserpine|reserpine|mesh-list
154029294|NCT02684786|Anesthetics, Local|anesthetics, local|mesh-ancestor
154029295|NCT02684786|Anesthetics|anesthetics|mesh-ancestor
154029296|NCT02684786|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154029297|NCT02684786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154029298|NCT02684786|Sensory System Agents|sensory system agents|mesh-ancestor
154029299|NCT02684786|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154029300|NCT02684786|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154029301|NCT02684786|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154029302|NCT02684786|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154029303|NCT02684786|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154029304|NCT02684786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154029305|NCT02684786|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154029306|NCT02684786|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153573094|NCT02512172|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153573095|NCT02512172|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153573096|NCT02512172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153573097|NCT02512172|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153573098|NCT02512172|Antimetabolites|antimetabolites|mesh-ancestor
153573099|NCT02512172|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153573100|NCT02512172|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153573101|NCT02512172|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
153573102|NCT02499367|Cyclophosphamide|cyclophosphamide|mesh-list
153573103|NCT02499367|Doxorubicin|doxorubicin|mesh-list
153573104|NCT02499367|Nivolumab|nivolumab|mesh-list
153573105|NCT02499367|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153573106|NCT02499367|Immunologic Factors|immunologic factors|mesh-ancestor
153573107|NCT02499367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153573108|NCT02499367|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153573109|NCT02499367|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153573110|NCT02499367|Alkylating Agents|alkylating agents|mesh-ancestor
154029307|NCT02684786|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154029308|NCT02684786|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154029309|NCT02684786|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
154029310|NCT02684786|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154029311|NCT02684786|Adrenergic Agents|adrenergic agents|mesh-ancestor
154029312|NCT02684786|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154029313|NCT02683070|Tramadol|tramadol|mesh-list
154029314|NCT02683070|Ropivacaine|ropivacaine|mesh-list
154029315|NCT02683070|Anesthetics, Local|anesthetics, local|mesh-ancestor
154029316|NCT02683070|Anesthetics|anesthetics|mesh-ancestor
154029317|NCT02683070|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154029318|NCT02683070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154029319|NCT02683070|Sensory System Agents|sensory system agents|mesh-ancestor
154029320|NCT02683070|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154029321|NCT02683070|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154029322|NCT02683070|Narcotics|narcotics|mesh-ancestor
154029323|NCT02683070|Analgesics|analgesics|mesh-ancestor
154029324|NCT02685176|Charcoal|charcoal|mesh-list
154029325|NCT02685176|Antidotes|antidotes|mesh-ancestor
154029326|NCT02685176|Protective Agents|protective agents|mesh-ancestor
154029327|NCT02685176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154029328|NCT00634205|Doxorubicin|doxorubicin|mesh-list
154029329|NCT00634205|Valproic Acid|valproic acid|mesh-list
154029330|NCT00634205|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154029331|NCT00634205|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154029332|NCT00634205|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154029333|NCT00634205|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154029334|NCT00634205|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153573111|NCT02499367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153573112|NCT02499367|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153573113|NCT02499367|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153573114|NCT02499367|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153573115|NCT02499367|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153573116|NCT02499367|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153573119|NCT02499367|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153573120|NCT02497612|Artefenomel|artefenomel|mesh-list
153573121|NCT02497612|Ferroquine|ferroquine|mesh-list
153573122|NCT02497612|Antimalarials|antimalarials|mesh-ancestor
153573123|NCT02497612|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153573124|NCT02497612|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153573125|NCT02497612|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153573126|NCT02497131|Brentuximab Vedotin|brentuximab vedotin|mesh-list
153573127|NCT02497131|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153573128|NCT02497131|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153573129|NCT02497131|Immunotoxins|immunotoxins|mesh-ancestor
153573130|NCT02497131|Immunoconjugates|immunoconjugates|mesh-ancestor
153573131|NCT02497131|Immunologic Factors|immunologic factors|mesh-ancestor
153573132|NCT02497131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153573133|NCT02491333|Metformin|metformin|mesh-list
153573134|NCT02491333|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153573135|NCT02491333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154029335|NCT00634205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154029337|NCT00634205|GABA Agents|gaba agents|mesh-ancestor
154029338|NCT00634205|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154029339|NCT00634205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153572024|NCT03961360|Antipyretics|antipyretics|mesh-ancestor
154029340|NCT00634205|Antimanic Agents|antimanic agents|mesh-ancestor
154029341|NCT00634205|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154029342|NCT00634205|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154029343|NCT00634205|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154029344|NCT04238195|Moxifloxacin|moxifloxacin|mesh-list
154029345|NCT04238195|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154029346|NCT04238195|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154029347|NCT04238195|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154029349|NCT04238195|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154029350|NCT04238195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154029351|NCT04238195|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154029352|NCT02818049|Dimercaprol|dimercaprol|mesh-list
154029353|NCT02818049|Chelating Agents|chelating agents|mesh-ancestor
154029354|NCT02818049|Sequestering Agents|sequestering agents|mesh-ancestor
154029355|NCT02818049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154029356|NCT02817503|Folic Acid|folic acid|mesh-list
154029357|NCT02817503|Vitamin B Complex|vitamin b complex|mesh-list
154029358|NCT02817503|Amlodipine|amlodipine|mesh-list
154029359|NCT02817503|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
154029360|NCT02817503|Enalapril|enalapril|mesh-list
154029361|NCT02817503|Enalaprilat|enalaprilat|mesh-list
154029362|NCT02817503|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154029363|NCT02817503|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154029364|NCT02817503|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154029365|NCT02817503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154029366|NCT02817503|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154029367|NCT02817503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154029368|NCT02817503|Vasodilator Agents|vasodilator agents|mesh-ancestor
154029369|NCT02817503|Hematinics|hematinics|mesh-ancestor
153573136|NCT02469987|Bevacizumab|bevacizumab|mesh-list
153573137|NCT02469987|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153573138|NCT02469987|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153573139|NCT02469987|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153573140|NCT02469987|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153573141|NCT02469987|Growth Substances|growth substances|mesh-ancestor
154029370|NCT02817503|Vitamins|vitamins|mesh-ancestor
154029371|NCT02817503|Micronutrients|micronutrients|mesh-ancestor
154029372|NCT02817503|Diuretics|diuretics|mesh-ancestor
154029373|NCT02817503|Natriuretic Agents|natriuretic agents|mesh-ancestor
154029374|NCT02817503|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
154029375|NCT02817503|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
154029376|NCT02817503|Protease Inhibitors|protease inhibitors|mesh-ancestor
154029377|NCT02817503|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154029378|NCT02814461|Axitinib|axitinib|mesh-list
154029379|NCT02814461|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154029380|NCT02814461|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154029381|NCT02814461|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154029382|NCT02814461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154029383|NCT00875667|Fludarabine|fludarabine|mesh-list
154029384|NCT00875667|Fludarabine phosphate|fludarabine phosphate|mesh-list
154029385|NCT00875667|Lenalidomide|lenalidomide|mesh-list
154029386|NCT00875667|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154029387|NCT00875667|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154029388|NCT00875667|Antimetabolites|antimetabolites|mesh-ancestor
154029389|NCT00875667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154029390|NCT00875667|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154029391|NCT00875667|Immunologic Factors|immunologic factors|mesh-ancestor
154029392|NCT00875667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154029393|NCT00875667|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154029394|NCT00875667|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154029395|NCT00875667|Growth Substances|growth substances|mesh-ancestor
153573142|NCT02469987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153573143|NCT02469987|Growth Inhibitors|growth inhibitors|mesh-ancestor
153816801|NCT00467883|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153816802|NCT00467883|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153816803|NCT00467883|Antifungal Agents|antifungal agents|mesh-ancestor
153816804|NCT00426608|Alprazolam|alprazolam|mesh-list
153816805|NCT00426608|Metyrapone|metyrapone|mesh-list
153816806|NCT00426608|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153816816|NCT00426608|Antimetabolites|antimetabolites|mesh-ancestor
153816817|NCT00426608|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153816818|NCT00426647|Buprenorphine|buprenorphine|mesh-list
153816819|NCT00426647|Tramadol|tramadol|mesh-list
153816820|NCT00426647|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153816821|NCT00426647|Narcotics|narcotics|mesh-ancestor
153816822|NCT00426647|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153816823|NCT00426647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153458165|NCT03023358|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153458166|NCT03023358|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153458167|NCT03023358|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153458168|NCT03023358|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153573144|NCT02439307|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
153573145|NCT02439307|Rifaximin|rifaximin|mesh-list
153573146|NCT02439307|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153573147|NCT02439307|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153573148|NCT02381652|Triamcinolone|triamcinolone|mesh-list
154029398|NCT02811185|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
154029399|NCT02811185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154029400|NCT02811341|Scopolamine|scopolamine|mesh-list
154029401|NCT02811341|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
154029402|NCT02811341|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154029403|NCT02811341|Antiemetics|antiemetics|mesh-ancestor
154029404|NCT02811341|Autonomic Agents|autonomic agents|mesh-ancestor
154029405|NCT02811341|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154029406|NCT02811341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154029407|NCT02811341|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154029408|NCT02811341|Mydriatics|mydriatics|mesh-ancestor
154029409|NCT02811341|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154029410|NCT02811341|Cholinergic Agents|cholinergic agents|mesh-ancestor
154029411|NCT02811341|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154029412|NCT02811341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154029413|NCT02811341|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
154029414|NCT02811341|Parasympatholytics|parasympatholytics|mesh-ancestor
154029415|NCT00682383|Docetaxel|docetaxel|mesh-list
154029416|NCT00682383|Etoposide|etoposide|mesh-list
154029417|NCT00682383|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154029418|NCT00682383|Tubulin Modulators|tubulin modulators|mesh-ancestor
154029419|NCT00682383|Antimitotic Agents|antimitotic agents|mesh-ancestor
154029420|NCT00682383|Mitosis Modulators|mitosis modulators|mesh-ancestor
154029421|NCT00682383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154029422|NCT00682383|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154029424|NCT00682383|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154029425|NCT00682383|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154029426|NCT04237493|Insulin|insulin|mesh-list
154029427|NCT04237493|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
154029428|NCT04237493|Metformin|metformin|mesh-list
154029429|NCT04237493|Insulin Glargine|insulin glargine|mesh-list
154029437|NCT04237493|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
154029439|NCT04237493|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154029440|NCT04237493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154029441|NCT00683319|Cyclophosphamide|cyclophosphamide|mesh-list
154029442|NCT00683319|Carboplatin|carboplatin|mesh-list
154029443|NCT00683319|Methotrexate|methotrexate|mesh-list
154029444|NCT00683319|Vincristine|vincristine|mesh-list
154029445|NCT00683319|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154029446|NCT00683319|Immunologic Factors|immunologic factors|mesh-ancestor
154029447|NCT00683319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154029448|NCT00683319|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154029449|NCT00683319|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154029450|NCT00683319|Alkylating Agents|alkylating agents|mesh-ancestor
154029451|NCT00683319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154029452|NCT00683319|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154029453|NCT00683319|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154029454|NCT00683319|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154029455|NCT00683319|Abortifacient Agents|abortifacient agents|mesh-ancestor
154029456|NCT00683319|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154029457|NCT00683319|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154029458|NCT00683319|Antimetabolites|antimetabolites|mesh-ancestor
154029459|NCT00683319|Dermatologic Agents|dermatologic agents|mesh-ancestor
154029460|NCT00683319|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154029461|NCT00683319|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154029462|NCT00683319|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154029463|NCT00683319|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154029464|NCT00683319|Tubulin Modulators|tubulin modulators|mesh-ancestor
154029465|NCT00683319|Antimitotic Agents|antimitotic agents|mesh-ancestor
154029466|NCT00683319|Mitosis Modulators|mitosis modulators|mesh-ancestor
154029467|NCT00634361|Eicosapentaenoic acid ethyl ester|eicosapentaenoic acid ethyl ester|mesh-list
154029468|NCT00634361|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154029469|NCT00634361|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154029470|NCT02810483|Topiramate|topiramate|mesh-list
154029471|NCT02810483|Anticonvulsants|anticonvulsants|mesh-ancestor
153573149|NCT02381652|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
153573150|NCT02381652|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
153573151|NCT02381652|Hyaluronic Acid|hyaluronic acid|mesh-list
153573152|NCT02381652|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
154029472|NCT02810483|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154029473|NCT02810483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154029475|NCT00683865|Ofloxacin|ofloxacin|mesh-list
154029476|NCT00683865|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
154029477|NCT00683865|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154029478|NCT00683865|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154029479|NCT00683865|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154029480|NCT00683865|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154029481|NCT00683865|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154029482|NCT00683865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154029483|NCT00683865|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154029484|NCT00683865|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
154029485|NCT00683865|Contraceptive Agents|contraceptive agents|mesh-ancestor
154029486|NCT00683865|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154029487|NCT00683865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154029488|NCT00683865|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
154029489|NCT00683865|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
154029490|NCT00683865|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
154029491|NCT00683865|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
154029492|NCT00683865|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
154029493|NCT00683865|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154029494|NCT00683943|Lithium Carbonate|lithium carbonate|mesh-list
154029495|NCT00683943|Antidepressive Agents|antidepressive agents|mesh-ancestor
154029496|NCT00683943|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154029497|NCT00683943|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154029498|NCT00683943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154029500|NCT00683943|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154029501|NCT00683943|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154029502|NCT00683943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154029503|NCT02810015|Botulinum Toxins|botulinum toxins|mesh-list
154029504|NCT02810015|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
154029505|NCT02810015|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
154029506|NCT02810015|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
154029507|NCT02810015|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153573153|NCT02381652|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154029513|NCT02810015|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154029515|NCT02809781|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154029516|NCT02809781|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154029517|NCT02809781|Analgesics|analgesics|mesh-ancestor
154029518|NCT02809781|Sensory System Agents|sensory system agents|mesh-ancestor
154029519|NCT02809781|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154029520|NCT02809781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154029521|NCT02809781|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154029522|NCT02809781|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154029523|NCT02809781|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154029524|NCT02809781|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154029525|NCT02809781|Immunologic Factors|immunologic factors|mesh-ancestor
154029546|NCT02812979|Respiratory System Agents|respiratory system agents|mesh-ancestor
154029547|NCT02812979|Tocolytic Agents|tocolytic agents|mesh-ancestor
154029548|NCT02812979|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154029549|NCT02812979|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
154029550|NCT02812979|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154029551|NCT02812979|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154029552|NCT02812979|Adrenergic Agents|adrenergic agents|mesh-ancestor
154029553|NCT02812979|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154029554|NCT02812979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154029555|NCT02809469|Apixaban|apixaban|mesh-list
154029556|NCT02809469|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
154029557|NCT02809469|Antithrombins|antithrombins|mesh-ancestor
154029558|NCT02809469|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154029559|NCT02809469|Protease Inhibitors|protease inhibitors|mesh-ancestor
154029560|NCT02809469|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154029561|NCT02809469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154029562|NCT02809469|Anticoagulants|anticoagulants|mesh-ancestor
154029563|NCT02809079|Mycophenolic Acid|mycophenolic acid|mesh-list
154029564|NCT02809079|Prednisone|prednisone|mesh-list
154029565|NCT02809079|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154029566|NCT02809079|Glucocorticoids|glucocorticoids|mesh-ancestor
154029567|NCT02809079|Hormones|hormones|mesh-ancestor
154029568|NCT02809079|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154029569|NCT02809079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154029571|NCT02809079|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154029572|NCT02809079|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154029573|NCT02809079|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
154029574|NCT02809079|Antitubercular Agents|antitubercular agents|mesh-ancestor
154029575|NCT02809079|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154029576|NCT02809079|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154029577|NCT02809079|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154029578|NCT02809079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154029579|NCT02812199|Lidocaine|lidocaine|mesh-list
154029580|NCT02812199|Epinephrine|epinephrine|mesh-list
154029581|NCT02812199|Racepinephrine|racepinephrine|mesh-list
153573154|NCT02381652|Glucocorticoids|glucocorticoids|mesh-ancestor
153573155|NCT02381652|Hormones|hormones|mesh-ancestor
154029586|NCT02812199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154029587|NCT02812199|Sensory System Agents|sensory system agents|mesh-ancestor
154029588|NCT02812199|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154029589|NCT02812199|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154029590|NCT02812199|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154029591|NCT02812199|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154029592|NCT02812199|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154029593|NCT02812199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154029594|NCT02812199|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154029595|NCT02812199|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154029596|NCT02812199|Adrenergic Agents|adrenergic agents|mesh-ancestor
154029597|NCT02812199|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154029598|NCT02812199|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154029599|NCT02812199|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154029600|NCT02812199|Autonomic Agents|autonomic agents|mesh-ancestor
154029601|NCT02812199|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154029602|NCT02812199|Respiratory System Agents|respiratory system agents|mesh-ancestor
154029603|NCT02812199|Mydriatics|mydriatics|mesh-ancestor
154029604|NCT02812199|Sympathomimetics|sympathomimetics|mesh-ancestor
154029605|NCT02812199|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154029606|NCT02812043|Amorolfine|amorolfine|mesh-list
154029609|NCT02808767|Ticagrelor|ticagrelor|mesh-list
154029612|NCT02808767|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
154029613|NCT02808767|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
154029615|NCT02808767|Purinergic Agents|purinergic agents|mesh-ancestor
154029616|NCT02808767|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154029617|NCT02808767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154029618|NCT02808767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154029619|NCT02812355|Heparin|heparin|mesh-list
154029620|NCT02812355|Anticoagulants|anticoagulants|mesh-ancestor
154029621|NCT02812355|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154029622|NCT02812355|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154029623|NCT02812355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154029624|NCT02811731|Amlodipine|amlodipine|mesh-list
154029625|NCT02811731|Candesartan|candesartan|mesh-list
154029626|NCT02811731|Candesartan cilexetil|candesartan cilexetil|mesh-list
154029627|NCT02811731|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154029628|NCT02811731|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154029629|NCT02811731|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154029630|NCT02811731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154029631|NCT02811731|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154029632|NCT02811731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154029633|NCT02811731|Vasodilator Agents|vasodilator agents|mesh-ancestor
154029634|NCT02811731|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
154029635|NCT02811731|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
154029636|NCT02811809|Leuprolide|leuprolide|mesh-list
153572326|NCT03782142|Tenofovir|tenofovir|mesh-list
154029637|NCT02811809|Fertility Agents, Female|fertility agents, female|mesh-ancestor
154029638|NCT02811809|Fertility Agents|fertility agents|mesh-ancestor
154029639|NCT02811809|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154029640|NCT02811809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154029641|NCT02811809|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154029643|NCT05569421|Budesonide|budesonide|mesh-list
153814759|NCT00447018|Mannitol|mannitol|mesh-list
154029650|NCT05569421|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154029651|NCT05569421|Respiratory System Agents|respiratory system agents|mesh-ancestor
154029652|NCT05569421|Glucocorticoids|glucocorticoids|mesh-ancestor
154029653|NCT05569421|Hormones|hormones|mesh-ancestor
154029654|NCT05569421|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154029655|NCT05569421|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
154029656|NCT05569421|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154029657|NCT05569421|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154029658|NCT05569421|Adrenergic Agents|adrenergic agents|mesh-ancestor
154029659|NCT05569421|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154029660|NCT05569421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154029661|NCT02808611|Propranolol|propranolol|mesh-list
154029662|NCT02808611|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
154029663|NCT02808611|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154029664|NCT02808611|Adrenergic Agents|adrenergic agents|mesh-ancestor
154029665|NCT02808611|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153812698|NCT00329810|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153919254|NCT04205838|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154029666|NCT02808611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154029667|NCT02808611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154029668|NCT02808611|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154029669|NCT02808611|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154029670|NCT02808611|Vasodilator Agents|vasodilator agents|mesh-ancestor
154029671|NCT02808533|Topiramate|topiramate|mesh-list
154029672|NCT02808533|Anticonvulsants|anticonvulsants|mesh-ancestor
154029673|NCT02808533|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154029674|NCT02808533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154029675|NCT02811497|Azacitidine|azacitidine|mesh-list
154029676|NCT02811497|Durvalumab|durvalumab|mesh-list
154029677|NCT02811497|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154029678|NCT02811497|Antimetabolites|antimetabolites|mesh-ancestor
154029679|NCT02811497|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154029680|NCT02811497|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154029689|NCT00634439|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154029690|NCT00634439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154029691|NCT02807909|Itraconazole|itraconazole|mesh-list
154029692|NCT02807909|Diltiazem|diltiazem|mesh-list
154029693|NCT02807909|Antifungal Agents|antifungal agents|mesh-ancestor
154029694|NCT02807909|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154029695|NCT02807909|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
154029696|NCT02807909|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154029697|NCT02807909|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154029698|NCT02807909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154029699|NCT02807909|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154029700|NCT02807909|Hormone Antagonists|hormone antagonists|mesh-ancestor
154029701|NCT02807909|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154029702|NCT02807909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154029703|NCT02807909|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154029704|NCT02807909|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154029705|NCT02807909|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154029706|NCT02807909|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154029707|NCT02807909|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154029708|NCT02807909|Vasodilator Agents|vasodilator agents|mesh-ancestor
154029709|NCT02808065|Mycophenolic Acid|mycophenolic acid|mesh-list
154029710|NCT02808065|Tacrolimus|tacrolimus|mesh-list
154029711|NCT02808065|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154029712|NCT02808065|Immunologic Factors|immunologic factors|mesh-ancestor
154029713|NCT02808065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154029714|NCT02808065|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
154029715|NCT02808065|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154029716|NCT02808065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154029717|NCT02808065|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154029718|NCT02808065|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154029719|NCT02808065|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
154029720|NCT02808065|Antitubercular Agents|antitubercular agents|mesh-ancestor
154029721|NCT02808065|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153573156|NCT02381652|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154029722|NCT02808065|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154029723|NCT00602030|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
154029725|NCT00602030|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154029726|NCT00602030|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154029727|NCT00602030|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154029728|NCT00602030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154029729|NCT00602030|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154029730|NCT00602030|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
154029731|NCT02804711|Vaccines|vaccines|mesh-list
154029732|NCT02804711|Immunologic Factors|immunologic factors|mesh-ancestor
154029733|NCT02804711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154029734|NCT00640094|Melatonin|melatonin|mesh-list
154029735|NCT00640094|Antioxidants|antioxidants|mesh-ancestor
154029736|NCT00640094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154029737|NCT00640094|Protective Agents|protective agents|mesh-ancestor
154029738|NCT00640094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154029739|NCT00640094|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154029740|NCT04183634|Rotigotine|rotigotine|mesh-list
154029741|NCT04183634|Dopamine Agonists|dopamine agonists|mesh-ancestor
154029742|NCT04183634|Dopamine Agents|dopamine agents|mesh-ancestor
154029743|NCT04183634|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154029744|NCT04183634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154029745|NCT04183634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154029746|NCT00549757|Aliskiren|aliskiren|mesh-list
154029747|NCT00549757|Renin Inhibitors|renin inhibitors|mesh-ancestor
154029748|NCT00549757|Protease Inhibitors|protease inhibitors|mesh-ancestor
154029749|NCT00549757|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154029750|NCT00549757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154029751|NCT02804633|Acetaminophen|acetaminophen|mesh-list
154029752|NCT02804633|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154029753|NCT02804633|Analgesics|analgesics|mesh-ancestor
154029754|NCT02804633|Sensory System Agents|sensory system agents|mesh-ancestor
154029757|NCT02804633|Antipyretics|antipyretics|mesh-ancestor
154029769|NCT02807441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154029771|NCT02807441|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154029772|NCT02807441|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154029773|NCT02807441|Antipyretics|antipyretics|mesh-ancestor
154029774|NCT02807285|Ocrelizumab|ocrelizumab|mesh-list
154029775|NCT02807285|Immunologic Factors|immunologic factors|mesh-ancestor
154029776|NCT02807285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154029777|NCT02682680|Ezetimibe|ezetimibe|mesh-list
154029778|NCT02682680|Colesevelam Hydrochloride|colesevelam hydrochloride|mesh-list
154029779|NCT02682680|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154029780|NCT02682680|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154029781|NCT02682680|Antimetabolites|antimetabolites|mesh-ancestor
154029782|NCT02682680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153572469|NCT03569475|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154029783|NCT02682680|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154029784|NCT02682758|Xenon|xenon|mesh-list
154029785|NCT02682758|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
154029786|NCT02682758|Anesthetics, General|anesthetics, general|mesh-ancestor
154029787|NCT02682758|Anesthetics|anesthetics|mesh-ancestor
154029788|NCT02682758|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154029789|NCT02682758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154029790|NCT02682524|Aceclofenac|aceclofenac|mesh-list
154029791|NCT02682524|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154029810|NCT04183556|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154029811|NCT04183556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154029812|NCT00640952|Acamprosate|acamprosate|mesh-list
154029813|NCT00640952|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
154029829|NCT02684084|Autonomic Agents|autonomic agents|mesh-ancestor
154029830|NCT02684084|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154029831|NCT02684084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154029832|NCT02684084|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154029833|NCT02684084|Glucocorticoids|glucocorticoids|mesh-ancestor
154029834|NCT02684084|Hormones|hormones|mesh-ancestor
154029835|NCT02684084|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154029836|NCT02684084|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154029837|NCT02684084|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154029838|NCT02684084|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154029839|NCT02684084|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154029840|NCT02684084|Growth Substances|growth substances|mesh-ancestor
154029841|NCT02684084|Growth Inhibitors|growth inhibitors|mesh-ancestor
154029842|NCT02684318|Olaparib|olaparib|mesh-list
154029843|NCT02684318|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
154029844|NCT02684318|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154029845|NCT02684318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154029846|NCT02684318|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154029847|NCT02806817|Bevacizumab|bevacizumab|mesh-list
154029848|NCT02806817|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154029849|NCT02806817|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154029850|NCT02806817|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154029851|NCT02806817|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153572593|NCT03190369|Hylan|hylan|mesh-list
154029880|NCT02680808|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154029881|NCT05663684|Proxymetacaine|proxymetacaine|mesh-list
154029882|NCT05663684|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
154029883|NCT05663684|Ophthalmic Solutions|ophthalmic solutions|mesh-list
154029884|NCT05663684|Anesthetics, Local|anesthetics, local|mesh-ancestor
154029885|NCT05663684|Anesthetics|anesthetics|mesh-ancestor
154029886|NCT05663684|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154029887|NCT05663684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154029888|NCT05663684|Sensory System Agents|sensory system agents|mesh-ancestor
154029889|NCT05663684|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154029890|NCT04004819|Rituximab|rituximab|mesh-list
154029891|NCT04004819|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154029892|NCT04004819|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154029893|NCT04004819|Immunologic Factors|immunologic factors|mesh-ancestor
154029894|NCT04004819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154029895|NCT04004819|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154029896|NCT00641654|Interferons|interferons|mesh-list
154029897|NCT00641654|Ribavirin|ribavirin|mesh-list
154029898|NCT00641654|Interferon-alpha|interferon-alpha|mesh-list
154029899|NCT00641654|Interferon alpha-2|interferon alpha-2|mesh-list
154029909|NCT00549601|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
154029910|NCT00549601|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154029911|NCT00549601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154029912|NCT00549601|Cholinergic Agents|cholinergic agents|mesh-ancestor
154029913|NCT00549601|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154029914|NCT00549601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154029915|NCT00549601|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
154029916|NCT00549601|Protective Agents|protective agents|mesh-ancestor
154029917|NCT02806349|(1-6)-alpha-glucomannan|(1-6)-alpha-glucomannan|mesh-list
154029918|NCT02806349|Cathartics|cathartics|mesh-ancestor
154029919|NCT02806349|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154029920|NCT04184492|Insulin|insulin|mesh-list
154029921|NCT04184492|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
154029922|NCT04184492|Insulin Aspart|insulin aspart|mesh-list
154029923|NCT04184492|Insulin, Long-Acting|insulin, long-acting|mesh-list
154029924|NCT04184492|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
153812702|NCT00329810|Serotonin Agents|serotonin agents|mesh-ancestor
154029925|NCT04184492|Biphasic Insulins|biphasic insulins|mesh-list
154029926|NCT04184492|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
154029927|NCT04184492|Insulin, Isophane|insulin, isophane|mesh-list
154029928|NCT04184492|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154029929|NCT04184492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154029968|NCT04236323|Narcotics|narcotics|mesh-ancestor
154029969|NCT04236323|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154029970|NCT04236323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154029971|NCT04236323|Analgesics|analgesics|mesh-ancestor
154029972|NCT04236323|Sensory System Agents|sensory system agents|mesh-ancestor
154029973|NCT04236323|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154029974|NCT04206163|Edotreotide|edotreotide|mesh-list
154029975|NCT04206163|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
154029976|NCT04206163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154029977|NCT00909974|Micronutrients|micronutrients|mesh-list
154029978|NCT00909974|Trace Elements|trace elements|mesh-list
154029979|NCT00909974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154029980|NCT05300347|Adenosine|adenosine|mesh-list
154029981|NCT05300347|Analgesics|analgesics|mesh-ancestor
154029982|NCT05300347|Sensory System Agents|sensory system agents|mesh-ancestor
154029983|NCT05300347|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154029984|NCT05300347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154029985|NCT05300347|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154029986|NCT05300347|Vasodilator Agents|vasodilator agents|mesh-ancestor
154029987|NCT05300347|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
154029988|NCT05300347|Purinergic Agonists|purinergic agonists|mesh-ancestor
154029992|NCT00956059|Prednisone|prednisone|mesh-list
154030018|NCT00640640|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154030019|NCT00640640|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154030020|NCT00640640|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154030021|NCT00640640|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154030022|NCT00640640|Growth Substances|growth substances|mesh-ancestor
154030023|NCT00640640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154030024|NCT00640640|Growth Inhibitors|growth inhibitors|mesh-ancestor
154030025|NCT03973177|Phenol|phenol|mesh-list
154030026|NCT03973177|Methylprednisolone|methylprednisolone|mesh-list
154030027|NCT03973177|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
154030028|NCT03973177|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
154030029|NCT03973177|Prednisolone|prednisolone|mesh-list
154030030|NCT03973177|Prednisolone acetate|prednisolone acetate|mesh-list
154030031|NCT03973177|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
154030032|NCT03973177|Prednisolone phosphate|prednisolone phosphate|mesh-list
154030033|NCT03973177|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154030034|NCT03973177|Antiemetics|antiemetics|mesh-ancestor
154030035|NCT03973177|Autonomic Agents|autonomic agents|mesh-ancestor
154030036|NCT03973177|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154030037|NCT03973177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154030038|NCT03973177|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154030039|NCT03973177|Glucocorticoids|glucocorticoids|mesh-ancestor
154030040|NCT03973177|Hormones|hormones|mesh-ancestor
154030041|NCT03973177|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154030042|NCT03973177|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
154030043|NCT03973177|Protective Agents|protective agents|mesh-ancestor
154030044|NCT03973177|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154030045|NCT03973177|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154030072|NCT02678234|Phenylephrine|phenylephrine|mesh-list
154030073|NCT02678234|Oxymetazoline|oxymetazoline|mesh-list
154030075|NCT02678234|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154030093|NCT02678234|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154030094|NCT00601640|Eflornithine|eflornithine|mesh-list
154030095|NCT00601640|Diclofenac|diclofenac|mesh-list
154030096|NCT00601640|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154030097|NCT00601640|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154030098|NCT00601640|Analgesics|analgesics|mesh-ancestor
154030099|NCT00601640|Sensory System Agents|sensory system agents|mesh-ancestor
154030100|NCT00601640|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154030101|NCT00601640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154030102|NCT00601640|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154030103|NCT00601640|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154030104|NCT00601640|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154030105|NCT00601640|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154030106|NCT00601640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154030107|NCT00601640|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154030108|NCT00601640|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
154030109|NCT00601640|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154030110|NCT00601640|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154030111|NCT00601640|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154030112|NCT00601640|Ornithine Decarboxylase Inhibitors|ornithine decarboxylase inhibitors|mesh-ancestor
154030113|NCT02805725|Cyclophosphamide|cyclophosphamide|mesh-list
154030114|NCT02805725|Trabectedin|trabectedin|mesh-list
154030115|NCT02805725|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154030116|NCT02805725|Immunologic Factors|immunologic factors|mesh-ancestor
154030117|NCT02805725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154030118|NCT02805725|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154030120|NCT02805725|Alkylating Agents|alkylating agents|mesh-ancestor
154030124|NCT02803385|Analgesics, Opioid|analgesics, opioid|mesh-list
154030125|NCT02803385|Anesthetics|anesthetics|mesh-list
154030126|NCT02803385|Anesthetics, Local|anesthetics, local|mesh-list
154030127|NCT02803385|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154030128|NCT02803385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154030129|NCT02803385|Narcotics|narcotics|mesh-ancestor
154030130|NCT02803385|Analgesics|analgesics|mesh-ancestor
154030131|NCT02803385|Sensory System Agents|sensory system agents|mesh-ancestor
154030132|NCT02803385|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154030133|NCT00958321|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
154030134|NCT00958321|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
154030135|NCT00958321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154030136|NCT05352373|Calcium|calcium|mesh-list
154030137|NCT05352373|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154030138|NCT05352373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154030139|NCT02677532|Acetaminophen|acetaminophen|mesh-list
154030140|NCT02677532|Sufentanil|sufentanil|mesh-list
154030141|NCT02677532|Morphine|morphine|mesh-list
154030142|NCT02677532|Dsuvia|dsuvia|mesh-list
154030143|NCT02677532|Levobupivacaine|levobupivacaine|mesh-list
154030144|NCT02677532|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154030145|NCT02677532|Narcotics|narcotics|mesh-ancestor
154030146|NCT02677532|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154030147|NCT02677532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154030148|NCT02677532|Analgesics|analgesics|mesh-ancestor
154030149|NCT02677532|Sensory System Agents|sensory system agents|mesh-ancestor
154030150|NCT02677532|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154030151|NCT02677532|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154030152|NCT02677532|Antipyretics|antipyretics|mesh-ancestor
154030153|NCT02677532|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154030154|NCT02677532|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154030164|NCT00641810|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
154030165|NCT00641810|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
154030166|NCT00641810|Purinergic Agents|purinergic agents|mesh-ancestor
154030167|NCT00641810|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154030170|NCT02802995|Coagulants|coagulants|mesh-ancestor
154030171|NCT00910052|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
154030172|NCT00910052|Hemostatics|hemostatics|mesh-ancestor
154030173|NCT00910052|Coagulants|coagulants|mesh-ancestor
154030174|NCT02677376|Listerine|listerine|mesh-list
154030175|NCT02677376|Fluorides|fluorides|mesh-list
154030176|NCT02677376|Sodium Fluoride|sodium fluoride|mesh-list
154030177|NCT02677376|Cariostatic Agents|cariostatic agents|mesh-ancestor
154030178|NCT02677376|Protective Agents|protective agents|mesh-ancestor
154030179|NCT02677376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154030180|NCT02677376|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154030181|NCT02677376|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154030182|NCT02800889|Pixantrone|pixantrone|mesh-list
154030183|NCT02800889|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154030184|NCT02800889|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154030185|NCT02800889|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154030186|NCT02800889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154030187|NCT02800889|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154030188|NCT02803073|Methyltestosterone|methyltestosterone|mesh-list
154030189|NCT02803073|Testosterone|testosterone|mesh-list
154030190|NCT02803073|Testosterone undecanoate|testosterone undecanoate|mesh-list
154030191|NCT02803073|Testosterone enanthate|testosterone enanthate|mesh-list
154030192|NCT02803073|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
154030193|NCT02803073|Androgens|androgens|mesh-ancestor
154030194|NCT02803073|Hormones|hormones|mesh-ancestor
154030195|NCT02803073|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154030200|NCT00922532|Nitric Oxide|nitric oxide|mesh-list
154030210|NCT00922532|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154030211|NCT00922532|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
154030212|NCT00922532|Vasodilator Agents|vasodilator agents|mesh-ancestor
154030213|NCT00922532|Gasotransmitters|gasotransmitters|mesh-ancestor
154030214|NCT00922532|Protective Agents|protective agents|mesh-ancestor
154030215|NCT05662904|Gemtuzumab|gemtuzumab|mesh-list
154030216|NCT05662904|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154030217|NCT05662904|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154030218|NCT05662904|Immunotoxins|immunotoxins|mesh-ancestor
154030219|NCT05662904|Immunoconjugates|immunoconjugates|mesh-ancestor
154030220|NCT05662904|Immunologic Factors|immunologic factors|mesh-ancestor
154030221|NCT05662904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154030222|NCT00642512|Dronabinol|dronabinol|mesh-list
154030223|NCT00642512|Ondansetron|ondansetron|mesh-list
154030224|NCT00642512|Antiemetics|antiemetics|mesh-ancestor
154030225|NCT00642512|Autonomic Agents|autonomic agents|mesh-ancestor
154030226|NCT00642512|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154030227|NCT00642512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154030228|NCT00642512|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154030229|NCT00642512|Antipruritics|antipruritics|mesh-ancestor
154030230|NCT00642512|Dermatologic Agents|dermatologic agents|mesh-ancestor
154030231|NCT00642512|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
154030232|NCT00642512|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154030233|NCT00642512|Serotonin Agents|serotonin agents|mesh-ancestor
154030234|NCT00642512|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154030235|NCT00642512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154030237|NCT00642512|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154030238|NCT00642512|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154030239|NCT00642512|Analgesics|analgesics|mesh-ancestor
154030240|NCT00642512|Sensory System Agents|sensory system agents|mesh-ancestor
154030241|NCT00642512|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
154030242|NCT00642512|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
154030243|NCT00642512|Hormones|hormones|mesh-ancestor
154030244|NCT00642512|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154030245|NCT02802683|Phenylephrine|phenylephrine|mesh-list
154030246|NCT02802683|Oxymetazoline|oxymetazoline|mesh-list
154030247|NCT02802683|Bupivacaine|bupivacaine|mesh-list
153577501|NCT01718314|Lidocaine|lidocaine|mesh-list
154030253|NCT02802683|Sensory System Agents|sensory system agents|mesh-ancestor
154030254|NCT02802683|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154030255|NCT02802683|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
154030256|NCT02802683|Mydriatics|mydriatics|mesh-ancestor
154030257|NCT02802683|Autonomic Agents|autonomic agents|mesh-ancestor
154030258|NCT02802683|Sympathomimetics|sympathomimetics|mesh-ancestor
154030259|NCT02802683|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154030260|NCT02802683|Nasal Decongestants|nasal decongestants|mesh-ancestor
154030261|NCT02802683|Respiratory System Agents|respiratory system agents|mesh-ancestor
154030262|NCT02802683|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
154030263|NCT02802683|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154030264|NCT02802683|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154030265|NCT02802683|Adrenergic Agents|adrenergic agents|mesh-ancestor
154030266|NCT02802683|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154030267|NCT02802683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154030268|NCT02802683|Protective Agents|protective agents|mesh-ancestor
154030270|NCT00641264|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154030271|NCT00641264|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154030272|NCT00641264|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
154030275|NCT05484167|Methyltestosterone|methyltestosterone|mesh-list
154030310|NCT02802215|Folic Acid|folic acid|mesh-list
154030311|NCT02802215|Metformin|metformin|mesh-list
154030312|NCT02802215|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154030313|NCT02802215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154030314|NCT02802215|Hematinics|hematinics|mesh-ancestor
154030315|NCT02802215|Vitamin B Complex|vitamin b complex|mesh-ancestor
154030316|NCT02802215|Vitamins|vitamins|mesh-ancestor
154030317|NCT02802215|Micronutrients|micronutrients|mesh-ancestor
154030318|NCT02799797|Sufentanil|sufentanil|mesh-list
154030320|NCT02799797|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154030321|NCT02799797|Narcotics|narcotics|mesh-ancestor
154030322|NCT02799797|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154030323|NCT02799797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154030324|NCT02799797|Analgesics|analgesics|mesh-ancestor
154030325|NCT02799797|Sensory System Agents|sensory system agents|mesh-ancestor
154030326|NCT02799797|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154030327|NCT02799797|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154030328|NCT02799797|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154030329|NCT02799797|Anesthetics, General|anesthetics, general|mesh-ancestor
154030330|NCT02799797|Anesthetics|anesthetics|mesh-ancestor
154030331|NCT05663372|Eplerenone|eplerenone|mesh-list
154030332|NCT05663372|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
154030333|NCT05663372|Hormone Antagonists|hormone antagonists|mesh-ancestor
154030334|NCT05663372|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154030335|NCT05663372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154030336|NCT05663372|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
154030337|NCT05663372|Diuretics|diuretics|mesh-ancestor
154030338|NCT05663372|Natriuretic Agents|natriuretic agents|mesh-ancestor
154030339|NCT05663372|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154030340|NCT02802137|Timolol|timolol|mesh-list
154030341|NCT02802137|Dorzolamide|dorzolamide|mesh-list
154030342|NCT02802137|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
154030343|NCT02802137|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154030344|NCT02802137|Adrenergic Agents|adrenergic agents|mesh-ancestor
154030345|NCT02802137|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154030346|NCT02802137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154030348|NCT02802137|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154030349|NCT02802137|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154030350|NCT02802137|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
154030352|NCT04033562|Lidocaine|lidocaine|mesh-list
154030353|NCT04033562|Bupivacaine|bupivacaine|mesh-list
154030354|NCT04033562|Anesthetics, Local|anesthetics, local|mesh-ancestor
154030355|NCT04033562|Anesthetics|anesthetics|mesh-ancestor
154030356|NCT04033562|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154030357|NCT04033562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154030358|NCT04033562|Sensory System Agents|sensory system agents|mesh-ancestor
154030359|NCT04033562|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154030360|NCT04033562|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154030361|NCT04033562|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154030362|NCT04033562|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154030363|NCT04033562|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154030364|NCT04033562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154030365|NCT04032834|Budesonide|budesonide|mesh-list
154030366|NCT04032834|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154030367|NCT04032834|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154030368|NCT04032834|Autonomic Agents|autonomic agents|mesh-ancestor
154030369|NCT04032834|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154030370|NCT04032834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154030371|NCT04032834|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154030372|NCT04032834|Respiratory System Agents|respiratory system agents|mesh-ancestor
154030373|NCT04032834|Glucocorticoids|glucocorticoids|mesh-ancestor
154030374|NCT04032834|Hormones|hormones|mesh-ancestor
154030375|NCT04032834|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154030376|NCT02817191|Tobramycin|tobramycin|mesh-list
154030377|NCT02817191|Tobramycin, Dexamethasone Drug Combination|tobramycin, dexamethasone drug combination|mesh-list
154030378|NCT02817191|Dexamethasone|dexamethasone|mesh-list
154030379|NCT02817191|Dexamethasone acetate|dexamethasone acetate|mesh-list
154030380|NCT02817191|Ophthalmic Solutions|ophthalmic solutions|mesh-list
154030381|NCT02817191|BB 1101|bb 1101|mesh-list
154030382|NCT02817191|Dipivefrin|dipivefrin|mesh-list
154030384|NCT02817191|Antiemetics|antiemetics|mesh-ancestor
154030385|NCT02817191|Autonomic Agents|autonomic agents|mesh-ancestor
154030396|NCT02817191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154030397|NCT02817191|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
154030398|NCT02817191|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154030399|NCT02817191|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154030400|NCT02817191|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154030401|NCT02817191|Adrenergic Agents|adrenergic agents|mesh-ancestor
154030402|NCT02817191|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154030403|NCT02636010|Pembrolizumab|pembrolizumab|mesh-list
154030404|NCT02636010|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154030405|NCT02636010|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154030406|NCT02636010|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154030407|NCT02636010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154030408|NCT00642824|Bevacizumab|bevacizumab|mesh-list
154030409|NCT00642824|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154030410|NCT00642824|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154030411|NCT00642824|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154030412|NCT00642824|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154030413|NCT00642824|Growth Substances|growth substances|mesh-ancestor
154030419|NCT02801357|Lofexidine|lofexidine|mesh-list
154030424|NCT02801357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154030426|NCT02801357|Sensory System Agents|sensory system agents|mesh-ancestor
154030427|NCT02801357|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154030428|NCT02801357|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
154030429|NCT02801357|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154030430|NCT02801357|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154030431|NCT02801357|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154030432|NCT02801357|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154030433|NCT02801357|Adrenergic Agents|adrenergic agents|mesh-ancestor
154030434|NCT02801357|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154030435|NCT02801357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154030436|NCT02676674|Vitamin D|vitamin d|mesh-list
154030437|NCT02676674|Cholecalciferol|cholecalciferol|mesh-list
154030438|NCT02676674|Vitamins|vitamins|mesh-ancestor
154030439|NCT02676674|Micronutrients|micronutrients|mesh-ancestor
154030440|NCT02676674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154030441|NCT02676674|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154030442|NCT02676674|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154030443|NCT00962299|Beclomethasone|beclomethasone|mesh-list
154030444|NCT00962299|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154030445|NCT00962299|Glucocorticoids|glucocorticoids|mesh-ancestor
154030446|NCT00962299|Hormones|hormones|mesh-ancestor
154030447|NCT00962299|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154030448|NCT00962299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154030449|NCT00962299|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154030450|NCT00962299|Respiratory System Agents|respiratory system agents|mesh-ancestor
154030451|NCT02679092|Misoprostol|misoprostol|mesh-list
154030452|NCT02679092|Mifepristone|mifepristone|mesh-list
154030453|NCT02679092|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154030454|NCT02679092|Abortifacient Agents|abortifacient agents|mesh-ancestor
154030455|NCT02679092|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154030459|NCT02679092|Oxytocics|oxytocics|mesh-ancestor
154030460|NCT02679092|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
154030461|NCT02679092|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
154030462|NCT02679092|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
154030463|NCT02679092|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
154030464|NCT02679092|Contraceptive Agents|contraceptive agents|mesh-ancestor
154030465|NCT02679092|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
154030466|NCT02679092|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
154030467|NCT02679092|Hormone Antagonists|hormone antagonists|mesh-ancestor
154030468|NCT02679092|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154030469|NCT02679092|Luteolytic Agents|luteolytic agents|mesh-ancestor
154030470|NCT02679092|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
154030471|NCT02679092|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
154030472|NCT04183088|Tislelizumab|tislelizumab|mesh-list
154030473|NCT04183088|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154030474|NCT04183088|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154030475|NCT00642122|Budesonide|budesonide|mesh-list
154030476|NCT00642122|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154030477|NCT00642122|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154030478|NCT00642122|Autonomic Agents|autonomic agents|mesh-ancestor
154030479|NCT00642122|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154030480|NCT00642122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154030481|NCT00642122|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154030482|NCT00642122|Respiratory System Agents|respiratory system agents|mesh-ancestor
154030483|NCT00642122|Glucocorticoids|glucocorticoids|mesh-ancestor
154030484|NCT00642122|Hormones|hormones|mesh-ancestor
154030485|NCT00642122|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154030486|NCT00546871|Immunoglobulins|immunoglobulins|mesh-list
154030487|NCT00546871|Antibodies|antibodies|mesh-list
154030488|NCT00546871|gamma-Globulins|gamma-globulins|mesh-list
154030489|NCT00546871|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
154030490|NCT00546871|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
154030491|NCT00546871|Immunologic Factors|immunologic factors|mesh-ancestor
154030492|NCT00546871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154030496|NCT02817113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154030497|NCT02817113|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154030498|NCT02817113|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154030499|NCT02817113|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154030500|NCT02817113|Immunologic Factors|immunologic factors|mesh-ancestor
154030501|NCT02817113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154030502|NCT02817113|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154030503|NCT02801201|Midazolam|midazolam|mesh-list
154030504|NCT02801201|Bupivacaine|bupivacaine|mesh-list
154030505|NCT02801201|Anesthetics, Local|anesthetics, local|mesh-ancestor
154030506|NCT02801201|Anesthetics|anesthetics|mesh-ancestor
154030507|NCT02801201|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154030508|NCT02801201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154030509|NCT02801201|Sensory System Agents|sensory system agents|mesh-ancestor
154030510|NCT02801201|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154030511|NCT02801201|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154030512|NCT02801201|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154030513|NCT02801201|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154030514|NCT02801201|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154030515|NCT02801201|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154030516|NCT02801201|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154030517|NCT02801201|Anesthetics, General|anesthetics, general|mesh-ancestor
154030518|NCT02801201|GABA Modulators|gaba modulators|mesh-ancestor
154030519|NCT02801201|GABA Agents|gaba agents|mesh-ancestor
154030520|NCT02801201|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154030522|NCT04182932|Vaccines|vaccines|mesh-list
154030537|NCT02681198|Serotonin Agents|serotonin agents|mesh-ancestor
154030538|NCT02681198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154030539|NCT02681198|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
154030540|NCT02681198|Antidepressive Agents|antidepressive agents|mesh-ancestor
154030541|NCT02681198|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154030542|NCT02681198|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
154030543|NCT02681198|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154030544|NCT02681198|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154030545|NCT02681198|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154030546|NCT02681198|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
154030547|NCT02681198|Sensory System Agents|sensory system agents|mesh-ancestor
154030548|NCT02681198|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154030549|NCT02681198|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154030550|NCT02681198|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154030551|NCT02681198|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154030552|NCT02681198|Adrenergic Agents|adrenergic agents|mesh-ancestor
154030553|NCT00962533|Telbivudine|telbivudine|mesh-list
154030554|NCT00962533|Antiviral Agents|antiviral agents|mesh-ancestor
154030555|NCT00962533|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154030556|NCT00962533|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154030557|NCT00962533|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154030558|NCT00962533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154030559|NCT00642980|Clindamycin|clindamycin|mesh-list
154030560|NCT00642980|Clindamycin palmitate|clindamycin palmitate|mesh-list
154030561|NCT00642980|Clindamycin phosphate|clindamycin phosphate|mesh-list
154030562|NCT00642980|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154030563|NCT00642980|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154030564|NCT00642980|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
153812728|NCT00430365|Growth Inhibitors|growth inhibitors|mesh-ancestor
154030565|NCT00642980|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154030566|NCT00642980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154030567|NCT02798159|Sildenafil Citrate|sildenafil citrate|mesh-list
154030578|NCT00962767|Immunoconjugates|immunoconjugates|mesh-ancestor
154030579|NCT00962767|Immunologic Factors|immunologic factors|mesh-ancestor
154030580|NCT00962767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154030581|NCT02678780|Lenvatinib|lenvatinib|mesh-list
154030582|NCT02678780|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154030583|NCT02678780|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154030584|NCT02678780|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154030585|NCT02678780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154030586|NCT00963001|Treprostinil|treprostinil|mesh-list
154030587|NCT00963001|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154030588|NCT00643136|Pregabalin|pregabalin|mesh-list
154030589|NCT00643136|Analgesics|analgesics|mesh-ancestor
154030590|NCT00643136|Sensory System Agents|sensory system agents|mesh-ancestor
154030591|NCT00643136|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154030592|NCT00643136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154030593|NCT00643136|Anticonvulsants|anticonvulsants|mesh-ancestor
154030594|NCT00643136|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154030595|NCT00643136|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154030596|NCT00643136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154030597|NCT00643136|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154030598|NCT00643136|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154030599|NCT00643136|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154030600|NCT00643136|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154030601|NCT00643136|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154030602|NCT01563367|Iron isomaltoside 1000|iron isomaltoside 1000|mesh-list
154030603|NCT01563367|Hematinics|hematinics|mesh-ancestor
154030604|NCT00963313|Adalimumab|adalimumab|mesh-list
154030605|NCT00963313|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
154030606|NCT00963313|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154030608|NCT02797145|Digoxin|digoxin|mesh-list
154030623|NCT00883116|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154030624|NCT00883116|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154030625|NCT00883116|Tubulin Modulators|tubulin modulators|mesh-ancestor
154030626|NCT00883116|Antimitotic Agents|antimitotic agents|mesh-ancestor
154030627|NCT00883116|Mitosis Modulators|mitosis modulators|mesh-ancestor
154030628|NCT00883116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154030629|NCT00883116|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154030630|NCT00883116|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154030631|NCT00883116|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154030632|NCT00883116|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154030634|NCT00643292|Azithromycin|azithromycin|mesh-list
154030635|NCT00643292|Clavulanic Acid|clavulanic acid|mesh-list
154030636|NCT00643292|Clavulanic Acids|clavulanic acids|mesh-list
154030637|NCT00643292|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
154030638|NCT00643292|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154030639|NCT00643292|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154030651|NCT02797067|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154030652|NCT02797067|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154030653|NCT02797067|Gout Suppressants|gout suppressants|mesh-ancestor
154030654|NCT02797067|Tocolytic Agents|tocolytic agents|mesh-ancestor
154030655|NCT02797067|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154030656|NCT02797067|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154030657|NCT02797067|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154030658|NCT02797067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154030659|NCT02797067|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
154030660|NCT02797067|Protective Agents|protective agents|mesh-ancestor
154030661|NCT00655044|Insulin Detemir|insulin detemir|mesh-list
154030662|NCT00655044|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154030663|NCT00655044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154030664|NCT00963703|Rituximab|rituximab|mesh-list
154030665|NCT00963703|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154030666|NCT00963703|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154030667|NCT00963703|Immunologic Factors|immunologic factors|mesh-ancestor
154030668|NCT00963703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154030669|NCT00963703|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154030670|NCT00655122|Dalteparin|dalteparin|mesh-list
154030671|NCT00655122|Tinzaparin|tinzaparin|mesh-list
154030672|NCT00655122|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
154030673|NCT00655122|Anticoagulants|anticoagulants|mesh-ancestor
154030674|NCT00655122|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154030675|NCT00655122|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154030676|NCT00655122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154030677|NCT02638116|Omeprazole|omeprazole|mesh-list
154030678|NCT02638116|Ibrutinib|ibrutinib|mesh-list
154030679|NCT02638116|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154030680|NCT02638116|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154030681|NCT02638116|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
154030682|NCT02638116|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154030683|NCT02638116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154030684|NCT02638116|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154030685|NCT02638116|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154030686|NCT04164264|Propofol|propofol|mesh-list
154030687|NCT04164264|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154030688|NCT04164264|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154030689|NCT04164264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154030690|NCT04164264|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154030691|NCT04164264|Anesthetics, General|anesthetics, general|mesh-ancestor
154030692|NCT04164264|Anesthetics|anesthetics|mesh-ancestor
154030693|NCT02795039|Fulvestrant|fulvestrant|mesh-list
154030694|NCT02795039|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154030695|NCT02795039|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154030696|NCT02795039|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
154030697|NCT02795039|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
154030698|NCT02795039|Hormone Antagonists|hormone antagonists|mesh-ancestor
154030699|NCT02795039|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154030700|NCT02795039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154030701|NCT02796833|SMOFlipid|smoflipid|mesh-list
154030702|NCT02796833|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
154030703|NCT02796833|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
154030704|NCT02796833|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
154030705|NCT04009603|Metformin|metformin|mesh-list
154030706|NCT04009603|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154030707|NCT04009603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154030708|NCT02635230|Aspirin|aspirin|mesh-list
154030709|NCT02635230|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154030710|NCT02635230|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154030711|NCT02635230|Analgesics|analgesics|mesh-ancestor
154030712|NCT02635230|Sensory System Agents|sensory system agents|mesh-ancestor
154030713|NCT02635230|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154030714|NCT02635230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154030715|NCT02635230|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154030716|NCT02635230|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154030717|NCT02635230|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154030718|NCT02635230|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154030719|NCT02635230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154030720|NCT02635230|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154030721|NCT02635230|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154030722|NCT02635230|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154030723|NCT02635230|Antipyretics|antipyretics|mesh-ancestor
154030724|NCT00964015|Hydroxyethyl Starch Derivatives|hydroxyethyl starch derivatives|mesh-list
153573157|NCT02381652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153573158|NCT02381652|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154030725|NCT00964015|Plasma Substitutes|plasma substitutes|mesh-ancestor
154030726|NCT00964015|Blood Substitutes|blood substitutes|mesh-ancestor
154030727|NCT02673632|Triptorelin Pamoate|triptorelin pamoate|mesh-list
154030728|NCT02673632|Luteolytic Agents|luteolytic agents|mesh-ancestor
154030729|NCT02673632|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
154030730|NCT02673632|Contraceptive Agents|contraceptive agents|mesh-ancestor
154030731|NCT02673632|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154030732|NCT02673632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154030733|NCT02673632|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
154030734|NCT02673632|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154030735|NCT02673632|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154030736|NCT04009525|Cyclosporine|cyclosporine|mesh-list
154030737|NCT04009525|Mycophenolic Acid|mycophenolic acid|mesh-list
154030738|NCT04009525|Cyclophosphamide|cyclophosphamide|mesh-list
154030739|NCT04009525|Busulfan|busulfan|mesh-list
154030740|NCT04009525|Methotrexate|methotrexate|mesh-list
154030741|NCT04009525|Fludarabine|fludarabine|mesh-list
154030742|NCT04009525|Tacrolimus|tacrolimus|mesh-list
154030743|NCT04009525|Cyclosporins|cyclosporins|mesh-list
154030744|NCT04009525|Thymoglobulin|thymoglobulin|mesh-list
154030745|NCT04009525|Basiliximab|basiliximab|mesh-list
154030746|NCT04009525|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154030747|NCT04009525|Immunologic Factors|immunologic factors|mesh-ancestor
154030748|NCT04009525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154030749|NCT04009525|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154030750|NCT04009525|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154030751|NCT04009525|Alkylating Agents|alkylating agents|mesh-ancestor
154030752|NCT04009525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154030754|NCT04009525|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154030755|NCT04009525|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154030756|NCT04009525|Abortifacient Agents|abortifacient agents|mesh-ancestor
154030757|NCT04009525|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154030758|NCT04009525|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154030759|NCT04009525|Antimetabolites|antimetabolites|mesh-ancestor
154030760|NCT04009525|Dermatologic Agents|dermatologic agents|mesh-ancestor
154030761|NCT04009525|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154030762|NCT04009525|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154030763|NCT04009525|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153573159|NCT02381652|Immunologic Factors|immunologic factors|mesh-ancestor
153573160|NCT02381652|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154030767|NCT04009525|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154030768|NCT04009525|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
154030769|NCT04009525|Antitubercular Agents|antitubercular agents|mesh-ancestor
154030770|NCT04009525|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154030772|NCT04032366|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154030773|NCT04032366|Autonomic Agents|autonomic agents|mesh-ancestor
154030774|NCT04032366|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154030775|NCT04032366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154030776|NCT04032366|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154030777|NCT04032366|Respiratory System Agents|respiratory system agents|mesh-ancestor
154030778|NCT04032366|Free Radical Scavengers|free radical scavengers|mesh-ancestor
154030779|NCT04032366|Antioxidants|antioxidants|mesh-ancestor
154030780|NCT04032366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154030781|NCT04032366|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154030782|NCT04032366|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
154030783|NCT04032366|Vasodilator Agents|vasodilator agents|mesh-ancestor
154030784|NCT04032366|Gasotransmitters|gasotransmitters|mesh-ancestor
154030785|NCT04032366|Protective Agents|protective agents|mesh-ancestor
154030786|NCT02537600|Vemurafenib|vemurafenib|mesh-list
154030787|NCT02537600|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154030788|NCT02537600|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154030789|NCT02537600|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154030790|NCT02537600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154030791|NCT00684099|Docetaxel|docetaxel|mesh-list
154030792|NCT00684099|Pemetrexed|pemetrexed|mesh-list
154030793|NCT00684099|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154030794|NCT00684099|Tubulin Modulators|tubulin modulators|mesh-ancestor
154030795|NCT00684099|Antimitotic Agents|antimitotic agents|mesh-ancestor
154030796|NCT00684099|Mitosis Modulators|mitosis modulators|mesh-ancestor
154030802|NCT04159896|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-list
154030803|NCT04159896|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154030804|NCT04159896|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154030805|NCT04159896|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154030806|NCT04159896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154030807|NCT04159896|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154030808|NCT04159896|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154030809|NCT02635074|Cytarabine|cytarabine|mesh-list
154030810|NCT02635074|Idarubicin|idarubicin|mesh-list
154030811|NCT02635074|Ibrutinib|ibrutinib|mesh-list
154030812|NCT02635074|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154030813|NCT02635074|Antimetabolites|antimetabolites|mesh-ancestor
154030814|NCT02635074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154030815|NCT02635074|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154030816|NCT02635074|Antiviral Agents|antiviral agents|mesh-ancestor
154030817|NCT02635074|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154030818|NCT02635074|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154030819|NCT02635074|Immunologic Factors|immunologic factors|mesh-ancestor
154030820|NCT02635074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154030821|NCT02635074|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154030822|NCT02635074|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154030823|NCT02635074|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154030824|NCT02635074|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154030825|NCT02635074|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154030826|NCT02635074|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154030828|NCT02537366|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154030829|NCT02537366|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154030830|NCT02537366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153814771|NCT00343070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153812729|NCT00430365|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153814772|NCT00453492|Risedronic Acid|risedronic acid|mesh-list
154030848|NCT05434559|Insulin|insulin|mesh-list
154030849|NCT05434559|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154030850|NCT05434559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154030851|NCT00546637|Fesoterodine|fesoterodine|mesh-list
154030852|NCT00546637|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
154030853|NCT00546637|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154030854|NCT00546637|Cholinergic Agents|cholinergic agents|mesh-ancestor
154030855|NCT00546637|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154030856|NCT00546637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154030857|NCT00546637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154030858|NCT00546637|Urological Agents|urological agents|mesh-ancestor
154030859|NCT00690885|Interferons|interferons|mesh-list
154030860|NCT00690885|Interferon-alpha|interferon-alpha|mesh-list
154030861|NCT00690885|Interferon alpha-2|interferon alpha-2|mesh-list
154030862|NCT00690885|Interferon-alfa-1b|interferon-alfa-1b|mesh-list
154030863|NCT00690885|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154030864|NCT00690885|Antiviral Agents|antiviral agents|mesh-ancestor
154030865|NCT00690885|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154030866|NCT00690885|Immunologic Factors|immunologic factors|mesh-ancestor
154030867|NCT00690885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154030868|NCT04138719|Paclitaxel|paclitaxel|mesh-list
154030869|NCT04138719|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
154030870|NCT04138719|Carboplatin|carboplatin|mesh-list
154030871|NCT04138719|Epirubicin|epirubicin|mesh-list
154030872|NCT04138719|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154030873|NCT04138719|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154030874|NCT04138719|Tubulin Modulators|tubulin modulators|mesh-ancestor
154030882|NCT02790203|Celecoxib|celecoxib|mesh-list
154030893|NCT02790203|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154030894|NCT02790203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154030896|NCT02816567|Propofol|propofol|mesh-list
154030897|NCT02816567|Cisatracurium|cisatracurium|mesh-list
154030898|NCT02816567|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154030899|NCT02816567|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154030900|NCT02816567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154030901|NCT02816567|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154030902|NCT02816567|Anesthetics, General|anesthetics, general|mesh-ancestor
154030903|NCT02816567|Anesthetics|anesthetics|mesh-ancestor
154030904|NCT02816567|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154030905|NCT02816567|Narcotics|narcotics|mesh-ancestor
154030906|NCT02816567|Analgesics|analgesics|mesh-ancestor
154030907|NCT02816567|Sensory System Agents|sensory system agents|mesh-ancestor
154030908|NCT02816567|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154030909|NCT02816567|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154030910|NCT02816567|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
154030911|NCT02816567|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
154030912|NCT00657774|Prednisone|prednisone|mesh-list
154030913|NCT00657774|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154030914|NCT00657774|Glucocorticoids|glucocorticoids|mesh-ancestor
154030915|NCT00657774|Hormones|hormones|mesh-ancestor
154030916|NCT00657774|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154030917|NCT00657774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154030918|NCT00657774|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154030919|NCT00657774|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154030920|NCT04138485|Immunoglobulins|immunoglobulins|mesh-list
154030921|NCT04138485|Immunologic Factors|immunologic factors|mesh-ancestor
154030922|NCT04138485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154030923|NCT02789969|Fentanyl|fentanyl|mesh-list
154030924|NCT02789969|Hydromorphone|hydromorphone|mesh-list
154030925|NCT02789969|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154030926|NCT02789969|Narcotics|narcotics|mesh-ancestor
154030927|NCT02789969|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154030928|NCT02789969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154030934|NCT02789969|Anesthetics, General|anesthetics, general|mesh-ancestor
154030935|NCT02789969|Anesthetics|anesthetics|mesh-ancestor
154030936|NCT00657852|Pamidronate|pamidronate|mesh-list
154030937|NCT00657852|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154030938|NCT00657852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154030939|NCT00691275|Ondansetron|ondansetron|mesh-list
154030940|NCT00691275|Antiemetics|antiemetics|mesh-ancestor
154030941|NCT00691275|Autonomic Agents|autonomic agents|mesh-ancestor
154030942|NCT00691275|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154030943|NCT00691275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153782155|NCT00259896|Exenatide|exenatide|mesh-list
154030944|NCT00691275|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154030945|NCT00691275|Antipruritics|antipruritics|mesh-ancestor
154030946|NCT00691275|Dermatologic Agents|dermatologic agents|mesh-ancestor
154030947|NCT00691275|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
154030948|NCT00691275|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154030949|NCT00691275|Serotonin Agents|serotonin agents|mesh-ancestor
154030950|NCT00691275|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154030951|NCT00691275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154030952|NCT00657930|Insulin Detemir|insulin detemir|mesh-list
154030953|NCT00657930|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154030954|NCT00657930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154030956|NCT00655512|Pimecrolimus|pimecrolimus|mesh-list
154030957|NCT00655512|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154030958|NCT00655512|Glucocorticoids|glucocorticoids|mesh-ancestor
154030959|NCT00655512|Hormones|hormones|mesh-ancestor
154030960|NCT00655512|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154030961|NCT00655512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154030962|NCT00655512|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154030963|NCT00655512|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154030964|NCT00655512|Analgesics|analgesics|mesh-ancestor
154030965|NCT00655512|Sensory System Agents|sensory system agents|mesh-ancestor
154030973|NCT00655512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154030974|NCT00644306|Thalidomide|thalidomide|mesh-list
154030975|NCT00644306|Prednisone|prednisone|mesh-list
154030976|NCT00644306|Melphalan|melphalan|mesh-list
154030977|NCT00644306|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154030978|NCT00644306|Glucocorticoids|glucocorticoids|mesh-ancestor
154030979|NCT00644306|Hormones|hormones|mesh-ancestor
154030980|NCT00644306|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154030981|NCT00644306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154030982|NCT00644306|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154030983|NCT00644306|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154030984|NCT00644306|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154030985|NCT00644306|Alkylating Agents|alkylating agents|mesh-ancestor
154030986|NCT00644306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154030987|NCT00644306|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154030988|NCT00644306|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154030989|NCT00644306|Immunologic Factors|immunologic factors|mesh-ancestor
154030990|NCT00644306|Leprostatic Agents|leprostatic agents|mesh-ancestor
154030991|NCT00644306|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154030992|NCT00644306|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154030993|NCT00644306|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154030994|NCT00644306|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154030995|NCT00644306|Growth Substances|growth substances|mesh-ancestor
154030996|NCT00644306|Growth Inhibitors|growth inhibitors|mesh-ancestor
154030998|NCT02634528|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
154030999|NCT02634528|Insulin, Isophane|insulin, isophane|mesh-list
154031000|NCT02634528|Isophane Insulin, Human|isophane insulin, human|mesh-list
154031001|NCT02634528|Isophane insulin, beef|isophane insulin, beef|mesh-list
154031002|NCT02634528|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154031003|NCT02634528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154031004|NCT02816411|Caseins|caseins|mesh-list
154031018|NCT02794025|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
154031019|NCT02794025|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154031020|NCT02794025|Adrenergic Agents|adrenergic agents|mesh-ancestor
154031021|NCT02794025|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154031022|NCT02794025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154031023|NCT02794025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154031024|NCT00546481|Epoetin Alfa|epoetin alfa|mesh-list
154031025|NCT00546481|Hematinics|hematinics|mesh-ancestor
154031026|NCT02789813|Valproic Acid|valproic acid|mesh-list
154031027|NCT02789813|Anticonvulsants|anticonvulsants|mesh-ancestor
154031028|NCT02789813|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154031029|NCT02789813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154031030|NCT02789813|GABA Agents|gaba agents|mesh-ancestor
154031031|NCT02789813|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154031032|NCT02789813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154031033|NCT02789813|Antimanic Agents|antimanic agents|mesh-ancestor
154031034|NCT02789813|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154031035|NCT02789813|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154031036|NCT02789813|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154031037|NCT02632578|Vaccines|vaccines|mesh-list
154031038|NCT02632578|Immunologic Factors|immunologic factors|mesh-ancestor
154031039|NCT02632578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154031040|NCT04138251|Empagliflozin|empagliflozin|mesh-list
154031041|NCT04138251|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
154031042|NCT04138251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154031043|NCT04138251|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154031044|NCT04138251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154031045|NCT00964171|Efavirenz|efavirenz|mesh-list
154031046|NCT00964171|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
154031050|NCT00964171|Antiviral Agents|antiviral agents|mesh-ancestor
154031059|NCT04016246|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154031060|NCT04016246|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154031061|NCT04016246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154031062|NCT04016246|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154031064|NCT04016246|Anesthetics|anesthetics|mesh-ancestor
154031065|NCT02789501|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
154031066|NCT04178876|Ethanol|ethanol|mesh-list
154031067|NCT04178876|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154031068|NCT04178876|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154031069|NCT04178876|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154031070|NCT04178876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154031071|NCT02789579|Levofloxacin|levofloxacin|mesh-list
154031072|NCT02789579|Nitrofurantoin|nitrofurantoin|mesh-list
154031073|NCT02789579|Cefuroxime|cefuroxime|mesh-list
154031074|NCT02789579|Cefuroxime axetil|cefuroxime axetil|mesh-list
154031075|NCT02789579|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
154031076|NCT02789579|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154031077|NCT02789579|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154031078|NCT02789579|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154031079|NCT02789579|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154031080|NCT02789579|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154031081|NCT02789579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154031082|NCT02789579|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154031083|NCT02789579|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
154031085|NCT04233203|Insulin|insulin|mesh-list
154031091|NCT00959101|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154031092|NCT00959101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154031093|NCT04233359|Anesthetics|anesthetics|mesh-list
154031094|NCT04233359|Anesthetics, Local|anesthetics, local|mesh-list
154031095|NCT04233359|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154031096|NCT04233359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154031097|NCT04233359|Sensory System Agents|sensory system agents|mesh-ancestor
154031098|NCT04233359|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154031099|NCT00964327|Darunavir|darunavir|mesh-list
154031100|NCT00964327|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
154031101|NCT00964327|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
154031102|NCT00964327|Protease Inhibitors|protease inhibitors|mesh-ancestor
154031103|NCT00964327|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154031104|NCT00964327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154031105|NCT00964327|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154031106|NCT00964327|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154031107|NCT00964327|Antiviral Agents|antiviral agents|mesh-ancestor
154031108|NCT00964327|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154031109|NCT05252546|Loperamide|loperamide|mesh-list
154031110|NCT05252546|Antidiarrheals|antidiarrheals|mesh-list
154031111|NCT05252546|Bentonite|bentonite|mesh-list
154031112|NCT05252546|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154031113|NCT05252546|Antidotes|antidotes|mesh-ancestor
154031114|NCT05252546|Protective Agents|protective agents|mesh-ancestor
154031115|NCT05252546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154031116|NCT00644384|Acitretin|acitretin|mesh-list
154031117|NCT00644384|Keratolytic Agents|keratolytic agents|mesh-ancestor
154031126|NCT02815865|Oxytocin|oxytocin|mesh-list
154031127|NCT02815865|Dinoprostone|dinoprostone|mesh-list
154031129|NCT02815865|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154031130|NCT02815865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154031131|NCT02673866|Pregabalin|pregabalin|mesh-list
154031132|NCT02673866|DS-1971a|ds-1971a|mesh-list
154031133|NCT02673866|Analgesics|analgesics|mesh-ancestor
154031134|NCT02673866|Sensory System Agents|sensory system agents|mesh-ancestor
154031135|NCT02673866|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154031136|NCT02673866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154031137|NCT02673866|Anticonvulsants|anticonvulsants|mesh-ancestor
154031138|NCT02673866|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154031139|NCT02673866|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154031140|NCT02673866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154031141|NCT02673866|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154031142|NCT02673866|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154031143|NCT02673866|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154031144|NCT02673866|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154031145|NCT02673866|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154031146|NCT02673866|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154031147|NCT02673866|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154031148|NCT00964561|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
154031149|NCT00964561|Ciprofloxacin|ciprofloxacin|mesh-list
154031150|NCT00964561|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
154031151|NCT00964561|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154031152|NCT00964561|Antitubercular Agents|antitubercular agents|mesh-ancestor
154031153|NCT00964561|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154031154|NCT00964561|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154031155|NCT00964561|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154031156|NCT00964561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154031160|NCT02793323|Anesthetics|anesthetics|mesh-list
154031174|NCT06322212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154031175|NCT06322147|Cetuximab|cetuximab|mesh-list
154031176|NCT06322147|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154031177|NCT06322147|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154031178|NCT06322095|Immunomodulating Agents|immunomodulating agents|mesh-list
154031179|NCT06322095|Immunologic Factors|immunologic factors|mesh-list
154031180|NCT06322095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154031181|NCT06322017|Digoxin|digoxin|mesh-list
154031182|NCT06322017|Amiodarone|amiodarone|mesh-list
154031183|NCT06322017|Sotalol|sotalol|mesh-list
154031184|NCT06322017|Flecainide|flecainide|mesh-list
154031185|NCT06322017|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-list
154031186|NCT06322017|Calcium Channel Blockers|calcium channel blockers|mesh-list
154031187|NCT06322017|Calcium|calcium|mesh-list
154031188|NCT06322017|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154031189|NCT06322017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154031190|NCT06322017|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
154031191|NCT06322017|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154031192|NCT06322017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154031193|NCT06322017|Protective Agents|protective agents|mesh-ancestor
154031194|NCT06322017|Vasodilator Agents|vasodilator agents|mesh-ancestor
154031195|NCT06322017|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
154031196|NCT06322017|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154031203|NCT06322017|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
154031204|NCT06322017|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154031205|NCT06322017|Adrenergic Agents|adrenergic agents|mesh-ancestor
154031206|NCT06322017|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154031207|NCT06322017|Sympatholytics|sympatholytics|mesh-ancestor
154031208|NCT06322017|Autonomic Agents|autonomic agents|mesh-ancestor
154031209|NCT06322017|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154031210|NCT06322017|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154031212|NCT06321887|Ferrous fumarate|ferrous fumarate|mesh-list
154031213|NCT06321887|Trace Elements|trace elements|mesh-ancestor
154031214|NCT06321887|Micronutrients|micronutrients|mesh-ancestor
154031215|NCT06321887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154031216|NCT06321861|Caffeine|caffeine|mesh-list
154031217|NCT06321861|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
154031218|NCT06321861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154031219|NCT06321861|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154031221|NCT06321861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154031222|NCT06321861|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
154031223|NCT06321861|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
154031224|NCT06321861|Purinergic Agents|purinergic agents|mesh-ancestor
154031225|NCT06321861|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154031226|NCT06321796|Vancomycin|vancomycin|mesh-list
154031227|NCT06321796|Magnesium citrate|magnesium citrate|mesh-list
154031228|NCT06321796|Antacids|antacids|mesh-list
154031229|NCT06321796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154031230|NCT06321796|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154031231|NCT06321796|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154031232|NCT06321796|Cathartics|cathartics|mesh-ancestor
154031233|NCT06321796|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154031234|NCT06321536|Glycerol|glycerol|mesh-list
154031235|NCT06321536|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
154031236|NCT06321536|Protective Agents|protective agents|mesh-ancestor
154031237|NCT06321536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154031238|NCT06321354|Betamethasone dipropionate, betamethasone sodium phosphate drug combination|betamethasone dipropionate, betamethasone sodium phosphate drug combination|mesh-list
154031239|NCT06321354|Ropivacaine|ropivacaine|mesh-list
154031240|NCT06321354|Anesthetics, Local|anesthetics, local|mesh-ancestor
154031250|NCT06321302|Aflibercept|aflibercept|mesh-list
154031251|NCT06321302|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154031252|NCT06321302|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154031253|NCT06321302|Growth Substances|growth substances|mesh-ancestor
154031254|NCT06321302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154031255|NCT06321302|Growth Inhibitors|growth inhibitors|mesh-ancestor
154031256|NCT06321302|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154031257|NCT06321120|Lenvatinib|lenvatinib|mesh-list
154031258|NCT06321120|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154031259|NCT06321120|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154031260|NCT06321120|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154031261|NCT06321120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154031262|NCT06321081|Irinotecan|irinotecan|mesh-list
154031263|NCT06321081|Cetuximab|cetuximab|mesh-list
154031264|NCT06321081|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
154031275|NCT06321068|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154031276|NCT06321068|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154031277|NCT06321068|Tubulin Modulators|tubulin modulators|mesh-ancestor
154031278|NCT06321068|Antimitotic Agents|antimitotic agents|mesh-ancestor
154031279|NCT06321068|Mitosis Modulators|mitosis modulators|mesh-ancestor
154031280|NCT06321068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154031281|NCT06321068|Immunologic Factors|immunologic factors|mesh-ancestor
154031282|NCT06321068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154031284|NCT06320990|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
154031285|NCT06320990|Hormone Antagonists|hormone antagonists|mesh-ancestor
154031286|NCT06320990|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154031287|NCT06320990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154031288|NCT06320990|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154031289|NCT06320990|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154031290|NCT06320990|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
154031291|NCT06320990|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
154031292|NCT06320990|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154031293|NCT06320951|Insulin|insulin|mesh-list
154031294|NCT06320951|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154031295|NCT06320951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154031296|NCT06320704|Salicylic Acid|salicylic acid|mesh-list
154031297|NCT06320704|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154031298|NCT06320704|Antifungal Agents|antifungal agents|mesh-ancestor
154031299|NCT06320704|Keratolytic Agents|keratolytic agents|mesh-ancestor
154031300|NCT06320704|Dermatologic Agents|dermatologic agents|mesh-ancestor
154031301|NCT06320691|Anesthetics|anesthetics|mesh-list
154031302|NCT06320691|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154031303|NCT06320691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154031304|NCT06320626|Antibodies, Bispecific|antibodies, bispecific|mesh-list
154031305|NCT06320626|Immunologic Factors|immunologic factors|mesh-ancestor
154031306|NCT06320626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154031307|NCT06320431|Tenecteplase|tenecteplase|mesh-list
154031308|NCT06320431|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154031309|NCT06320431|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154031311|NCT06320405|Paclitaxel|paclitaxel|mesh-list
154031314|NCT06320405|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154031315|NCT06320405|Tubulin Modulators|tubulin modulators|mesh-ancestor
154031316|NCT06320405|Antimitotic Agents|antimitotic agents|mesh-ancestor
154031317|NCT06320405|Mitosis Modulators|mitosis modulators|mesh-ancestor
154031318|NCT06320405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154031319|NCT06320353|Pembrolizumab|pembrolizumab|mesh-list
154031320|NCT06320353|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154031321|NCT06320353|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154031322|NCT06320353|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154031323|NCT06320353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154031324|NCT06320327|Cannabidiol|cannabidiol|mesh-list
154031325|NCT06320327|Anticonvulsants|anticonvulsants|mesh-ancestor
154031326|NCT06320301|Gemcitabine|gemcitabine|mesh-list
154031327|NCT06320301|Oxaliplatin|oxaliplatin|mesh-list
154031328|NCT06320301|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-list
154031329|NCT06320301|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154031330|NCT06320301|Antimetabolites|antimetabolites|mesh-ancestor
154031331|NCT06320301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154031332|NCT06320301|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154031333|NCT06320301|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154031334|NCT06320301|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154031335|NCT06320067|Ascorbic Acid|ascorbic acid|mesh-list
154031336|NCT06320067|Prednisolone|prednisolone|mesh-list
154031337|NCT06320067|Docetaxel|docetaxel|mesh-list
154031338|NCT06320067|Abiraterone Acetate|abiraterone acetate|mesh-list
154031339|NCT06320067|Niraparib|niraparib|mesh-list
154031340|NCT06320067|Methyltestosterone|methyltestosterone|mesh-list
154031341|NCT06320067|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
154031342|NCT06320067|Androgens|androgens|mesh-list
154031343|NCT06320067|Pluvicto|pluvicto|mesh-list
154031344|NCT06320067|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154031345|NCT06320067|Tubulin Modulators|tubulin modulators|mesh-ancestor
154031346|NCT06320067|Antimitotic Agents|antimitotic agents|mesh-ancestor
154031347|NCT06320067|Mitosis Modulators|mitosis modulators|mesh-ancestor
154031348|NCT06320067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154031353|NCT06320067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154031354|NCT06320067|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154031355|NCT06320067|Protective Agents|protective agents|mesh-ancestor
154031356|NCT06320067|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154031357|NCT06320067|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154031358|NCT06320067|Hormone Antagonists|hormone antagonists|mesh-ancestor
154031359|NCT06320067|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154031360|NCT06320067|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
154031361|NCT06320067|Antioxidants|antioxidants|mesh-ancestor
154031362|NCT06320067|Vitamins|vitamins|mesh-ancestor
154031363|NCT06320067|Micronutrients|micronutrients|mesh-ancestor
154031364|NCT06320067|Estrogens|estrogens|mesh-ancestor
154031365|NCT06320067|Anabolic Agents|anabolic agents|mesh-ancestor
154031366|NCT06320067|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
153574051|NCT01697436|Ribavirin|ribavirin|mesh-list
154031367|NCT06320041|Hydromorphone|hydromorphone|mesh-list
154031368|NCT06320041|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154031369|NCT06320041|Narcotics|narcotics|mesh-ancestor
154031370|NCT06320041|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154031371|NCT06320041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154031372|NCT06320041|Analgesics|analgesics|mesh-ancestor
154031373|NCT06320041|Sensory System Agents|sensory system agents|mesh-ancestor
154031374|NCT06320041|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154031375|NCT06319950|Osimertinib|osimertinib|mesh-list
154031376|NCT06319950|Aflutinib|aflutinib|mesh-list
154031377|NCT06319950|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154031378|NCT06319950|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154031379|NCT06319950|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154031380|NCT06319950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154031381|NCT06319950|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154031382|NCT06319924|Simethicone|simethicone|mesh-list
154031393|NCT06319859|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154031394|NCT06319859|Narcotics|narcotics|mesh-ancestor
154031395|NCT06319859|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154031396|NCT06319859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154031397|NCT06319859|Analgesics|analgesics|mesh-ancestor
154031398|NCT06319859|Sensory System Agents|sensory system agents|mesh-ancestor
154031399|NCT06319859|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154031400|NCT06319846|Tirofiban|tirofiban|mesh-list
154031401|NCT06319846|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154031402|NCT06319846|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154031403|NCT06319846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154031404|NCT06319846|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154031410|NCT06319768|Pentoxifylline|pentoxifylline|mesh-list
154031411|NCT06319768|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154031412|NCT06319768|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154031413|NCT06319768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154031414|NCT06319768|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154031415|NCT06319768|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
154031416|NCT06319768|Protective Agents|protective agents|mesh-ancestor
154031417|NCT06319768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154031418|NCT06319768|Vasodilator Agents|vasodilator agents|mesh-ancestor
154031419|NCT06319768|Free Radical Scavengers|free radical scavengers|mesh-ancestor
154031420|NCT06319768|Antioxidants|antioxidants|mesh-ancestor
154031421|NCT06319638|Lidocaine|lidocaine|mesh-list
154031422|NCT06319638|Anesthetics, Local|anesthetics, local|mesh-ancestor
154031423|NCT06319638|Anesthetics|anesthetics|mesh-ancestor
154031424|NCT06319638|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154031425|NCT06319638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154031426|NCT06319638|Sensory System Agents|sensory system agents|mesh-ancestor
154031427|NCT06319638|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154031428|NCT06319638|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154031429|NCT06319638|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154031430|NCT06319638|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154031431|NCT06319638|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153573161|NCT02381652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154031437|NCT06319625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154031438|NCT06319625|Sensory System Agents|sensory system agents|mesh-ancestor
154031439|NCT06319625|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154031440|NCT06319625|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154031441|NCT06319625|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154031442|NCT06319625|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154031443|NCT06319625|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154031444|NCT06319625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154031445|NCT06319612|Lidocaine|lidocaine|mesh-list
154031446|NCT06319612|Anesthetics, Local|anesthetics, local|mesh-ancestor
154031447|NCT06319612|Anesthetics|anesthetics|mesh-ancestor
154031448|NCT06319612|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154031449|NCT06319612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154031450|NCT06319612|Sensory System Agents|sensory system agents|mesh-ancestor
154031451|NCT06319612|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154031452|NCT06319612|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154031453|NCT06319612|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154031454|NCT06319612|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154031455|NCT06319612|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154031456|NCT06319612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154031457|NCT06319599|Lidocaine|lidocaine|mesh-list
154031458|NCT06319599|Anesthetics, Local|anesthetics, local|mesh-ancestor
154031459|NCT06319599|Anesthetics|anesthetics|mesh-ancestor
154031464|NCT06319599|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154031465|NCT06319599|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154031466|NCT06319599|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154031467|NCT06319599|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154031468|NCT06319599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154031469|NCT06319560|Hydroxychloroquine|hydroxychloroquine|mesh-list
154031470|NCT06319560|Antimalarials|antimalarials|mesh-ancestor
154031471|NCT06319560|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154031472|NCT06319560|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154031473|NCT06319560|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154031474|NCT06319560|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154031475|NCT06319560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154031476|NCT06319560|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154031477|NCT06319534|Lidocaine|lidocaine|mesh-list
154031478|NCT06319534|Anesthetics, Local|anesthetics, local|mesh-ancestor
154031479|NCT06319534|Anesthetics|anesthetics|mesh-ancestor
154031480|NCT06319534|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154031481|NCT06319534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154031482|NCT06319534|Sensory System Agents|sensory system agents|mesh-ancestor
154031483|NCT06319534|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154031484|NCT06319534|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154031485|NCT06319534|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154031486|NCT06319534|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154031487|NCT06319534|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154031488|NCT06319534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154031489|NCT06319521|Lidocaine|lidocaine|mesh-list
154031490|NCT06319521|Anesthetics, Local|anesthetics, local|mesh-ancestor
154031491|NCT06319521|Anesthetics|anesthetics|mesh-ancestor
154031507|NCT06319508|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154031508|NCT06319508|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154031509|NCT06319508|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154031510|NCT06319508|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154031511|NCT06319508|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154031512|NCT06319508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154031513|NCT06319495|Lidocaine|lidocaine|mesh-list
154031514|NCT06319495|Anesthetics, Local|anesthetics, local|mesh-ancestor
154031515|NCT06319495|Anesthetics|anesthetics|mesh-ancestor
154031516|NCT06319495|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154031517|NCT06319495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154031518|NCT06319495|Sensory System Agents|sensory system agents|mesh-ancestor
154031519|NCT06319495|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154031520|NCT06319495|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154031521|NCT06319495|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154031522|NCT06319495|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154031523|NCT06319495|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154031524|NCT06319495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154031525|NCT06319469|Bromides|bromides|mesh-list
154031526|NCT06319469|Silodosin|silodosin|mesh-list
154031527|NCT06319469|Pyridostigmine Bromide|pyridostigmine bromide|mesh-list
154031528|NCT06319469|Anticonvulsants|anticonvulsants|mesh-ancestor
154031529|NCT06319469|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
154031530|NCT06319469|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154031531|NCT06319469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154031532|NCT06319469|Cholinergic Agents|cholinergic agents|mesh-ancestor
154031538|NCT06319469|Adrenergic Agents|adrenergic agents|mesh-ancestor
154031552|NCT06319456|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154031553|NCT06319456|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154031554|NCT06319456|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154031555|NCT06319456|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154031556|NCT06319456|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154031557|NCT06319456|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154031558|NCT06319443|Acetic Acid|acetic acid|mesh-list
154031559|NCT06319443|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154031560|NCT06319443|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154031561|NCT06319417|3,4-dihydroxyphenylethanol|3,4-dihydroxyphenylethanol|mesh-list
154031562|NCT06319417|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154031563|NCT06319417|Antioxidants|antioxidants|mesh-ancestor
154031564|NCT06319417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154031614|NCT06316843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154031615|NCT06316843|Antiviral Agents|antiviral agents|mesh-ancestor
154031616|NCT06316843|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154031618|NCT06315972|Antipruritics|antipruritics|mesh-ancestor
154031619|NCT06315972|Dermatologic Agents|dermatologic agents|mesh-ancestor
154031620|NCT06315972|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
154031683|NCT06280976|Aspirin|aspirin|mesh-list
154031684|NCT06280976|Empagliflozin|empagliflozin|mesh-list
154031685|NCT06280976|8-hydroxy-2,2,14,14-tetramethylpentadecanedioic acid|8-hydroxy-2,2,14,14-tetramethylpentadecanedioic acid|mesh-list
154031686|NCT06280976|Colchicine|colchicine|mesh-list
154031687|NCT06280976|Eicosapentaenoic acid ethyl ester|eicosapentaenoic acid ethyl ester|mesh-list
154031688|NCT06280976|Atorvastatin|atorvastatin|mesh-list
154031689|NCT06280976|Ezetimibe|ezetimibe|mesh-list
154031690|NCT06280976|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154031691|NCT06280976|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154031692|NCT06280976|Analgesics|analgesics|mesh-ancestor
154031693|NCT06280976|Sensory System Agents|sensory system agents|mesh-ancestor
154031694|NCT06280976|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154031695|NCT06280976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154031696|NCT06280976|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154031697|NCT06280976|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154031698|NCT06280976|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154031699|NCT06280976|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154031700|NCT06280976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154031701|NCT06280976|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154031702|NCT06280976|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154031703|NCT06280976|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154031704|NCT06280976|Antipyretics|antipyretics|mesh-ancestor
154031705|NCT06280976|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154031706|NCT06280976|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154031707|NCT06280976|Antimetabolites|antimetabolites|mesh-ancestor
154031708|NCT06280976|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154031709|NCT06280976|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154031710|NCT06280976|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
154031711|NCT06280976|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154031726|NCT06257147|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154031727|NCT06256432|Terlipressin|terlipressin|mesh-list
154031728|NCT06256432|Ambrisentan|ambrisentan|mesh-list
154031729|NCT06256432|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154031730|NCT06256432|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154031731|NCT06238414|Psychotropic Drugs|psychotropic drugs|mesh-list
154031732|NCT06225596|Carboplatin|carboplatin|mesh-list
154031733|NCT06225596|Gemcitabine|gemcitabine|mesh-list
154031734|NCT06225596|Pembrolizumab|pembrolizumab|mesh-list
154031735|NCT06225596|Avelumab|avelumab|mesh-list
153574426|NCT01699932|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154031736|NCT06225596|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153574499|NCT01700426|Vitamins|vitamins|mesh-list
154031737|NCT06225596|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154031738|NCT06225596|Antimetabolites|antimetabolites|mesh-ancestor
154031739|NCT06225596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154031740|NCT06225596|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154031741|NCT06225596|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154031742|NCT06223828|Azithromycin|azithromycin|mesh-list
154031743|NCT06223828|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154031744|NCT06223828|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154031745|NCT06223360|Thiamine|thiamine|mesh-list
154031746|NCT06223360|Benphothiamine|benphothiamine|mesh-list
154031747|NCT06223360|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154031748|NCT06223360|Immunologic Factors|immunologic factors|mesh-ancestor
154031779|NCT06221683|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154031780|NCT06221683|Analgesics|analgesics|mesh-ancestor
154031781|NCT06221683|Sensory System Agents|sensory system agents|mesh-ancestor
154031782|NCT06221683|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154031783|NCT06221683|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154031784|NCT06221683|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154031785|NCT06221683|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154031786|NCT06221683|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
154031788|NCT06217757|Olaparib|olaparib|mesh-list
154031789|NCT06217757|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154031790|NCT06217757|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153730805|NCT00135317|Hematinics|hematinics|mesh-ancestor
154031791|NCT06217757|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154031792|NCT06217757|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154031793|NCT06217757|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154031794|NCT06217757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154031796|NCT06216665|Insulin|insulin|mesh-list
154031836|NCT06182774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154031837|NCT06182774|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154031838|NCT06182774|Glucocorticoids|glucocorticoids|mesh-ancestor
154031839|NCT06182774|Hormones|hormones|mesh-ancestor
154031840|NCT06182774|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154031841|NCT06182774|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154031842|NCT06182774|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154031843|NCT06182774|Immunologic Factors|immunologic factors|mesh-ancestor
154031844|NCT06182774|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154031845|NCT06182774|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154031846|NCT06182774|Growth Substances|growth substances|mesh-ancestor
154031847|NCT06182774|Growth Inhibitors|growth inhibitors|mesh-ancestor
154031848|NCT06182176|Pyrimethamine|pyrimethamine|mesh-list
154031849|NCT06182176|Sulfadoxine|sulfadoxine|mesh-list
154031850|NCT06182176|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
154031851|NCT06182176|Amodiaquine|amodiaquine|mesh-list
154031852|NCT06182176|Antimalarials|antimalarials|mesh-ancestor
154031853|NCT06182176|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154031854|NCT06182176|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154031855|NCT06182176|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154031856|NCT06182176|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154031857|NCT06182176|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154031858|NCT06182176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154031859|NCT06182176|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
154031860|NCT06176248|Triamcinolone|triamcinolone|mesh-list
154031861|NCT06176248|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
154031862|NCT06176248|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
154031863|NCT06176248|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
154031864|NCT06176248|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154031865|NCT06176248|Glucocorticoids|glucocorticoids|mesh-ancestor
154031866|NCT06176248|Hormones|hormones|mesh-ancestor
154031867|NCT06176248|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154031868|NCT06176248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154031869|NCT06176248|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154031878|NCT06154252|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154031880|NCT06154252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154031881|NCT06154252|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154031882|NCT06154252|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154031883|NCT06154252|Alkylating Agents|alkylating agents|mesh-ancestor
154031884|NCT06154252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154031885|NCT06154252|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154031886|NCT06154252|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154031887|NCT06148766|Propolis|propolis|mesh-list
154031888|NCT06148766|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154031889|NCT06148753|Propolis|propolis|mesh-list
154031890|NCT06148753|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154031891|NCT06136559|Acalabrutinib|acalabrutinib|mesh-list
154031892|NCT06136559|Ibrutinib|ibrutinib|mesh-list
154031893|NCT06136559|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154031894|NCT06136559|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154031895|NCT06136559|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154031896|NCT06136559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154031897|NCT06136559|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154031898|NCT06136208|Estradiol|estradiol|mesh-list
154031899|NCT06136208|Estrogens|estrogens|mesh-ancestor
154031900|NCT06136208|Hormones|hormones|mesh-ancestor
154031901|NCT06136208|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154031902|NCT06136208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154031903|NCT06128356|Dexmedetomidine|dexmedetomidine|mesh-list
154031904|NCT06128356|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154031908|NCT06128356|Analgesics|analgesics|mesh-ancestor
154031912|NCT06128356|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154031913|NCT06128356|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154031914|NCT06128356|Adrenergic Agents|adrenergic agents|mesh-ancestor
154031915|NCT06128356|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154031916|NCT06128356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154031917|NCT06103864|Paclitaxel|paclitaxel|mesh-list
154031918|NCT06103864|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
154031919|NCT06103864|Carboplatin|carboplatin|mesh-list
154031920|NCT06103864|Gemcitabine|gemcitabine|mesh-list
154031921|NCT06103864|Pembrolizumab|pembrolizumab|mesh-list
154031922|NCT06103864|Durvalumab|durvalumab|mesh-list
154031923|NCT06103864|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154031924|NCT06103864|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154031925|NCT06103864|Tubulin Modulators|tubulin modulators|mesh-ancestor
154031926|NCT06103864|Antimitotic Agents|antimitotic agents|mesh-ancestor
154031927|NCT06103864|Mitosis Modulators|mitosis modulators|mesh-ancestor
154031928|NCT06103864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154031929|NCT06103864|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154031930|NCT06103864|Antimetabolites|antimetabolites|mesh-ancestor
154031931|NCT06103864|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154031932|NCT06103864|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154031933|NCT06091020|Botulinum Toxins|botulinum toxins|mesh-list
154031934|NCT06091020|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
154031935|NCT06091020|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
154031936|NCT06091020|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
154031937|NCT06091020|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
154031938|NCT06091020|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154031939|NCT06091020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154031940|NCT06091020|Cholinergic Agents|cholinergic agents|mesh-ancestor
154031941|NCT06091020|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154031942|NCT06091020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154031969|NCT06060665|Seladelpar|seladelpar|mesh-list
154031970|NCT06060665|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154031971|NCT06060665|Antimetabolites|antimetabolites|mesh-ancestor
154031972|NCT06060665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154031973|NCT06060665|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154031974|NCT06056895|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
154031975|NCT06056895|Antibodies|antibodies|mesh-list
154031976|NCT06056895|Immunoglobulins|immunoglobulins|mesh-list
154031977|NCT06056895|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154031978|NCT06056895|Immunologic Factors|immunologic factors|mesh-ancestor
154031979|NCT06056895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154031980|NCT06056895|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154031981|NCT06051617|Seladelpar|seladelpar|mesh-list
154031982|NCT06051617|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154031983|NCT06051617|Antimetabolites|antimetabolites|mesh-ancestor
154031984|NCT06051617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154031985|NCT06051617|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154031986|NCT06045689|Luspatercept|luspatercept|mesh-list
154031987|NCT06045689|Hematinics|hematinics|mesh-ancestor
154031988|NCT06030089|Azacitidine|azacitidine|mesh-list
154031989|NCT06030089|Venetoclax|venetoclax|mesh-list
154031990|NCT06030089|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154031991|NCT06030089|Antimetabolites|antimetabolites|mesh-ancestor
154031992|NCT06030089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153573162|NCT02381652|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153573163|NCT02381652|Viscosupplements|viscosupplements|mesh-ancestor
153573164|NCT02381652|Protective Agents|protective agents|mesh-ancestor
153573165|NCT02367794|Paclitaxel|paclitaxel|mesh-list
153573166|NCT02367794|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
153573167|NCT02367794|Carboplatin|carboplatin|mesh-list
153573168|NCT02367794|Atezolizumab|atezolizumab|mesh-list
153573169|NCT02367794|Antibodies|antibodies|mesh-list
153573170|NCT02367794|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154031996|NCT06021145|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
154031997|NCT06021145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154031999|NCT06021145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154032000|NCT06020118|Vaccines|vaccines|mesh-list
154032001|NCT06020118|Immunologic Factors|immunologic factors|mesh-ancestor
154032002|NCT06020118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154032003|NCT06018025|Antibodies|antibodies|mesh-list
154032004|NCT06018025|Immunologic Factors|immunologic factors|mesh-ancestor
154032005|NCT06018025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154032006|NCT06008522|Bevacizumab|bevacizumab|mesh-list
154032007|NCT06008522|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154032008|NCT06008522|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154032009|NCT06008522|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154032010|NCT06008522|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154032011|NCT06008522|Growth Substances|growth substances|mesh-ancestor
154032012|NCT06008522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154032013|NCT06008522|Growth Inhibitors|growth inhibitors|mesh-ancestor
154032014|NCT06008093|Carboplatin|carboplatin|mesh-list
154032015|NCT06008093|Pembrolizumab|pembrolizumab|mesh-list
154032016|NCT06008093|Pemetrexed|pemetrexed|mesh-list
154032017|NCT06008093|Durvalumab|durvalumab|mesh-list
154032018|NCT06008093|Tremelimumab|tremelimumab|mesh-list
154032019|NCT06008093|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154032020|NCT06008093|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154032021|NCT06008093|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154032022|NCT06008093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154032023|NCT06008093|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154032024|NCT06008093|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154032025|NCT06008093|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154032032|NCT06002477|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154032034|NCT06002477|Autonomic Agents|autonomic agents|mesh-ancestor
154032035|NCT06002477|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154032036|NCT06002477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154032037|NCT06002477|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
154032038|NCT06002477|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
153574750|NCT01701882|Tenofovir|tenofovir|mesh-list
154032039|NCT06002477|Cholinergic Agents|cholinergic agents|mesh-ancestor
154032041|NCT06002477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154032042|NCT05999435|Fenretinide|fenretinide|mesh-list
154032043|NCT05999435|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154032044|NCT05999435|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
154032045|NCT05999435|Protective Agents|protective agents|mesh-ancestor
154032046|NCT05999435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154032047|NCT05967286|Olaparib|olaparib|mesh-list
154032048|NCT05967286|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
154032049|NCT05967286|Phosphoinositide-3 Kinase Inhibitors|phosphoinositide-3 kinase inhibitors|mesh-list
154032050|NCT05967286|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154032051|NCT05967286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154032052|NCT05967286|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154032053|NCT05933577|Pembrolizumab|pembrolizumab|mesh-list
154032054|NCT05933577|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154032055|NCT05933577|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154032063|NCT05921760|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154032064|NCT05921760|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154032065|NCT05921760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154032066|NCT05921760|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154032067|NCT05921760|Glycine Agents|glycine agents|mesh-ancestor
154032068|NCT05921760|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154032069|NCT05921760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154032070|NCT05892341|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
154032072|NCT05892341|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154032073|NCT05886036|Deoxyglucose|deoxyglucose|mesh-list
154032074|NCT05886036|Rituximab|rituximab|mesh-list
154032075|NCT05886036|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
154032076|NCT05886036|Antibodies|antibodies|mesh-list
154032077|NCT05886036|Immunoglobulins|immunoglobulins|mesh-list
154032078|NCT05886036|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154032079|NCT05886036|Antibodies, Bispecific|antibodies, bispecific|mesh-list
154032080|NCT05886036|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
154032081|NCT05886036|Immunologic Factors|immunologic factors|mesh-ancestor
154032082|NCT05886036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154032083|NCT05886036|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154032084|NCT05886036|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154032085|NCT05886036|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
154032086|NCT05886036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154032087|NCT05886036|Antimetabolites|antimetabolites|mesh-ancestor
154032088|NCT05886036|Antiviral Agents|antiviral agents|mesh-ancestor
154032089|NCT05886036|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154032090|NCT05884528|Botulinum Toxins|botulinum toxins|mesh-list
154032091|NCT05884528|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
154032092|NCT05884528|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
154032093|NCT05884528|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
154032094|NCT05884528|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
154032095|NCT05884528|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154032096|NCT05884528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154032097|NCT05884528|Cholinergic Agents|cholinergic agents|mesh-ancestor
154032098|NCT05884528|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154032099|NCT05884528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154032103|NCT05844501|Antiemetics|antiemetics|mesh-ancestor
154032104|NCT05844501|Autonomic Agents|autonomic agents|mesh-ancestor
154032105|NCT05844501|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154032106|NCT05844501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154032107|NCT05844501|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154032108|NCT05844501|Antipruritics|antipruritics|mesh-ancestor
154032109|NCT05844501|Dermatologic Agents|dermatologic agents|mesh-ancestor
154032110|NCT05844501|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
154032111|NCT05844501|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154032112|NCT05844501|Serotonin Agents|serotonin agents|mesh-ancestor
153574804|NCT01702129|Cetuximab|cetuximab|mesh-list
154032113|NCT05844501|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154032114|NCT05844501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154032115|NCT05823948|Insulin|insulin|mesh-list
154032116|NCT05823948|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154032117|NCT05823948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154032118|NCT05818852|Moxifloxacin|moxifloxacin|mesh-list
154032119|NCT05818852|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
154032120|NCT05818852|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154032121|NCT05818852|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154032122|NCT05818852|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154032123|NCT05818852|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154032124|NCT05818852|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154032125|NCT05818852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154032126|NCT05818852|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154032127|NCT05818852|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
154032128|NCT05818852|Contraceptive Agents|contraceptive agents|mesh-ancestor
154032138|NCT05800015|Paclitaxel|paclitaxel|mesh-list
154032139|NCT05800015|Carboplatin|carboplatin|mesh-list
154032140|NCT05800015|Pemetrexed|pemetrexed|mesh-list
154032141|NCT05800015|Cemiplimab|cemiplimab|mesh-list
154032142|NCT05800015|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154032143|NCT05800015|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154032144|NCT05800015|Tubulin Modulators|tubulin modulators|mesh-ancestor
154032145|NCT05800015|Antimitotic Agents|antimitotic agents|mesh-ancestor
154032146|NCT05800015|Mitosis Modulators|mitosis modulators|mesh-ancestor
154032147|NCT05800015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154032148|NCT05800015|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154032149|NCT05800015|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154032150|NCT05800015|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154032151|NCT05800015|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154032152|NCT05784363|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
154032153|NCT05784363|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
154032154|NCT05784363|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154032155|NCT05784363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154032156|NCT05784363|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
154032157|NCT05784363|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154032158|NCT05784363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154032159|NCT05784363|Cholinergic Agents|cholinergic agents|mesh-ancestor
154032160|NCT05784363|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154032161|NCT05760248|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
154032162|NCT05742841|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
154032163|NCT05742841|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154032164|NCT05742841|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154032166|NCT05742841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154032167|NCT05742841|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153573171|NCT02367794|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153573172|NCT02367794|Tubulin Modulators|tubulin modulators|mesh-ancestor
153573173|NCT02367794|Antimitotic Agents|antimitotic agents|mesh-ancestor
153458169|NCT03023358|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153458170|NCT03023358|Glucocorticoids|glucocorticoids|mesh-ancestor
153458172|NCT03023358|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153458173|NCT03023358|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153458174|NCT03023358|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153458175|NCT03023358|Tubulin Modulators|tubulin modulators|mesh-ancestor
153458176|NCT03023358|Antimitotic Agents|antimitotic agents|mesh-ancestor
153458177|NCT03023358|Mitosis Modulators|mitosis modulators|mesh-ancestor
153573174|NCT02367794|Mitosis Modulators|mitosis modulators|mesh-ancestor
154032193|NCT05722418|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154032195|NCT05716906|Antioxidants|antioxidants|mesh-ancestor
154032196|NCT05716906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154032197|NCT05716906|Protective Agents|protective agents|mesh-ancestor
154032198|NCT05716906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154032199|NCT05716906|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154032200|NCT05711628|Carboplatin|carboplatin|mesh-list
154032224|NCT05711628|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154032225|NCT05711628|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154032226|NCT05711628|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154032227|NCT05711628|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154032228|NCT05711628|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154032229|NCT05711628|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154032230|NCT05711628|Tubulin Modulators|tubulin modulators|mesh-ancestor
154032231|NCT05711628|Antimitotic Agents|antimitotic agents|mesh-ancestor
154032232|NCT05711628|Mitosis Modulators|mitosis modulators|mesh-ancestor
154032233|NCT05711628|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154032234|NCT05711628|Alkylating Agents|alkylating agents|mesh-ancestor
154032235|NCT05711628|Immunotoxins|immunotoxins|mesh-ancestor
154032236|NCT05711628|Keratolytic Agents|keratolytic agents|mesh-ancestor
154032237|NCT05711628|Dermatologic Agents|dermatologic agents|mesh-ancestor
154032238|NCT05691465|Lutetium Lu 177 dotatate|lutetium lu 177 dotatate|mesh-list
154032239|NCT05691465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154032240|NCT05691465|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
154032241|NCT05685836|Bevacizumab|bevacizumab|mesh-list
154032242|NCT05685836|89Zr-bevacizumab|89zr-bevacizumab|mesh-list
154032243|NCT05685836|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154032244|NCT05685836|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154032245|NCT05685836|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154032246|NCT05685836|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154032247|NCT05685836|Growth Substances|growth substances|mesh-ancestor
154032248|NCT05685836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154032249|NCT05685836|Growth Inhibitors|growth inhibitors|mesh-ancestor
154032250|NCT05685836|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
153814782|NCT00343187|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154032254|NCT05672342|Anticonvulsants|anticonvulsants|mesh-ancestor
154032255|NCT05672342|Hallucinogens|hallucinogens|mesh-ancestor
154032256|NCT05672342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154032257|NCT05672342|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154032258|NCT05672342|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154032260|NCT05672342|Sensory System Agents|sensory system agents|mesh-ancestor
154032261|NCT05672342|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154032262|NCT05672342|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
154032263|NCT05672342|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
154032264|NCT05672342|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154032265|NCT05672342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154032266|NCT05672342|Hormones|hormones|mesh-ancestor
154032267|NCT05672342|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154032268|NCT05660538|Pregabalin|pregabalin|mesh-list
154032269|NCT05660538|Analgesics|analgesics|mesh-ancestor
154032270|NCT05660538|Sensory System Agents|sensory system agents|mesh-ancestor
154032271|NCT05660538|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154032272|NCT05660538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154032273|NCT05660538|Anticonvulsants|anticonvulsants|mesh-ancestor
154032274|NCT05660538|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154032275|NCT05660538|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154032276|NCT05660538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154032277|NCT05660538|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154032278|NCT05660538|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154032279|NCT05660538|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154032280|NCT05660538|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154032281|NCT05660538|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154032282|NCT05648591|Iloperidone|iloperidone|mesh-list
154032292|NCT05644496|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154032293|NCT05644496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154032294|NCT05644496|Sensory System Agents|sensory system agents|mesh-ancestor
154032295|NCT05644496|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154032296|NCT05644496|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154032297|NCT05644496|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154032299|NCT05644496|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154032300|NCT05644496|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154032301|NCT05644496|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
154032302|NCT05644496|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154032303|NCT05644496|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154032304|NCT05644496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154032305|NCT05609578|Carboplatin|carboplatin|mesh-list
154032306|NCT05609578|Pembrolizumab|pembrolizumab|mesh-list
154032307|NCT05609578|Pemetrexed|pemetrexed|mesh-list
154032308|NCT05609578|Adagrasib|adagrasib|mesh-list
154032309|NCT05609578|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154032310|NCT05609578|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154032311|NCT05609578|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153730808|NCT00152646|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
154032312|NCT05609578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154032313|NCT05609578|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154032314|NCT05609578|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154032315|NCT05609578|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154032316|NCT05608291|Pembrolizumab|pembrolizumab|mesh-list
154032317|NCT05608291|Cemiplimab|cemiplimab|mesh-list
154032318|NCT05608291|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154032319|NCT05608291|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154032320|NCT05608291|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154032341|NCT05553366|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154032342|NCT05553366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154032343|NCT05553366|Antipyretics|antipyretics|mesh-ancestor
154032344|NCT05541471|Digoxin|digoxin|mesh-list
154032345|NCT05541471|Midazolam|midazolam|mesh-list
154032346|NCT05541471|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154032347|NCT05541471|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154032348|NCT05541471|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154032349|NCT05541471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154032350|NCT05541471|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154032351|NCT05541471|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154032352|NCT05541471|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154032353|NCT05541471|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154032354|NCT05541471|Anesthetics, General|anesthetics, general|mesh-ancestor
154032368|NCT05528588|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
154032369|NCT05528588|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154032370|NCT05528588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154032371|NCT05515978|Metformin|metformin|mesh-list
154032372|NCT05515978|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154032373|NCT05515978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154032374|NCT05498792|Nivolumab|nivolumab|mesh-list
154032375|NCT05498792|Ipilimumab|ipilimumab|mesh-list
154032376|NCT05498792|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154032377|NCT05498792|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154032378|NCT05498792|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154032379|NCT05498792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154032380|NCT05485831|Cannabidiol|cannabidiol|mesh-list
154032381|NCT05485831|Anticonvulsants|anticonvulsants|mesh-ancestor
154032382|NCT05397600|Bimatoprost|bimatoprost|mesh-list
154032383|NCT05397600|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154032384|NCT05352815|Insulin|insulin|mesh-list
154032385|NCT05352815|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154032386|NCT05352815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154032387|NCT05327296|Propofol|propofol|mesh-list
154032388|NCT05327296|Isoflurane|isoflurane|mesh-list
154032389|NCT05327296|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154032390|NCT05327296|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154032391|NCT05327296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154032392|NCT05327296|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154032393|NCT05327296|Anesthetics, General|anesthetics, general|mesh-ancestor
154032395|NCT05327296|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
154032396|NCT05314998|Leucovorin|leucovorin|mesh-list
154032397|NCT05314998|Folic Acid|folic acid|mesh-list
154032398|NCT05314998|Gemcitabine|gemcitabine|mesh-list
154032399|NCT05314998|Capecitabine|capecitabine|mesh-list
154032400|NCT05314998|Fluorouracil|fluorouracil|mesh-list
154032401|NCT05314998|Oxaliplatin|oxaliplatin|mesh-list
154032402|NCT05314998|Irinotecan|irinotecan|mesh-list
153814784|NCT00343187|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154032412|NCT05314998|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154032413|NCT05314998|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154032414|NCT05314998|Antidotes|antidotes|mesh-ancestor
154032415|NCT05314998|Protective Agents|protective agents|mesh-ancestor
154032416|NCT05314998|Vitamin B Complex|vitamin b complex|mesh-ancestor
154032417|NCT05314998|Vitamins|vitamins|mesh-ancestor
154032418|NCT05314998|Micronutrients|micronutrients|mesh-ancestor
154032419|NCT05314998|Hematinics|hematinics|mesh-ancestor
154032420|NCT05312385|Propofol|propofol|mesh-list
154032421|NCT05312385|Isoflurane|isoflurane|mesh-list
154032422|NCT05312385|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154032423|NCT05312385|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154032424|NCT05312385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154032425|NCT05312385|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154032426|NCT05312385|Anesthetics, General|anesthetics, general|mesh-ancestor
154032427|NCT05312385|Anesthetics|anesthetics|mesh-ancestor
154032428|NCT05312385|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
154032429|NCT05307705|Paclitaxel|paclitaxel|mesh-list
154032430|NCT05307705|Letrozole|letrozole|mesh-list
154032431|NCT05307705|Fulvestrant|fulvestrant|mesh-list
154032432|NCT05307705|Anastrozole|anastrozole|mesh-list
154032433|NCT05307705|Exemestane|exemestane|mesh-list
154032434|NCT05307705|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154032435|NCT05307705|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154032436|NCT05307705|Tubulin Modulators|tubulin modulators|mesh-ancestor
154032437|NCT05307705|Antimitotic Agents|antimitotic agents|mesh-ancestor
154032438|NCT05307705|Mitosis Modulators|mitosis modulators|mesh-ancestor
154032439|NCT05307705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154032440|NCT05307705|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
154032441|NCT05307705|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154032442|NCT05307705|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154032443|NCT05307705|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
154032444|NCT05307705|Hormone Antagonists|hormone antagonists|mesh-ancestor
154032445|NCT05307705|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154032454|NCT05300490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154032455|NCT05300490|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154032456|NCT05300490|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154032457|NCT05285982|Nintedanib|nintedanib|mesh-list
154032458|NCT05285982|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154032459|NCT05285982|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154032460|NCT05285982|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154032461|NCT05285982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154032462|NCT05282901|Pembrolizumab|pembrolizumab|mesh-list
154032463|NCT05282901|Lenvatinib|lenvatinib|mesh-list
154032464|NCT05282901|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154032465|NCT05282901|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154032466|NCT05282901|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154032467|NCT05282901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154032468|NCT05282901|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154032469|NCT05282901|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154032470|NCT05211895|Durvalumab|durvalumab|mesh-list
154032471|NCT05211895|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154032472|NCT05211895|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154032473|NCT05209841|Heparin|heparin|mesh-list
154032474|NCT05209841|Anticoagulants|anticoagulants|mesh-ancestor
154032475|NCT05209841|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154032476|NCT05209841|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154032477|NCT05209841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154032478|NCT05201248|Prednisone|prednisone|mesh-list
154032479|NCT05201248|Cyclophosphamide|cyclophosphamide|mesh-list
154032480|NCT05201248|Rituximab|rituximab|mesh-list
154032481|NCT05201248|Doxorubicin|doxorubicin|mesh-list
154032482|NCT05201248|Vincristine|vincristine|mesh-list
154032483|NCT05201248|Lenalidomide|lenalidomide|mesh-list
154032484|NCT05201248|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154032485|NCT05201248|Immunologic Factors|immunologic factors|mesh-ancestor
154032486|NCT05201248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154032487|NCT05201248|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154032488|NCT05201248|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154032489|NCT05201248|Alkylating Agents|alkylating agents|mesh-ancestor
154032491|NCT05201248|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154032501|NCT05201248|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154032502|NCT05201248|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154032503|NCT05201248|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154032505|NCT05201248|Antimitotic Agents|antimitotic agents|mesh-ancestor
154032506|NCT05201248|Mitosis Modulators|mitosis modulators|mesh-ancestor
154032507|NCT05201248|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154032508|NCT05201248|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154032509|NCT05201248|Growth Substances|growth substances|mesh-ancestor
154032511|NCT05173714|Semaglutide|semaglutide|mesh-list
154032523|NCT05065671|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
154032524|NCT05065671|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154032525|NCT05065671|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154032529|NCT05065671|Analgesics|analgesics|mesh-ancestor
154032595|NCT05034536|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154032596|NCT05034536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154032597|NCT05034536|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
154032611|NCT04984759|Primaquine|primaquine|mesh-list
154032612|NCT04984759|Tafenoquine|tafenoquine|mesh-list
154032613|NCT04984759|Antimalarials|antimalarials|mesh-ancestor
154032614|NCT04984759|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154032615|NCT04984759|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154032616|NCT04984759|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154032617|NCT04982614|Vaccines|vaccines|mesh-list
154032618|NCT04982614|Immunologic Factors|immunologic factors|mesh-ancestor
154032619|NCT04982614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154032620|NCT04963283|Nivolumab|nivolumab|mesh-list
154032621|NCT04963283|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154032622|NCT04963283|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154032623|NCT04963283|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154032624|NCT04963283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154032625|NCT04940052|Trametinib|trametinib|mesh-list
154032626|NCT04940052|Dabrafenib|dabrafenib|mesh-list
154032627|NCT04940052|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154032628|NCT04940052|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154032629|NCT04940052|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154032630|NCT04940052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154032631|NCT04938232|Nivolumab|nivolumab|mesh-list
154032632|NCT04938232|Ipilimumab|ipilimumab|mesh-list
154032633|NCT04938232|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154032634|NCT04938232|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154032635|NCT04938232|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154032636|NCT04938232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153575332|NCT01705392|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154032650|NCT04915846|Tamoxifen|tamoxifen|mesh-list
154032651|NCT04915846|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
154032652|NCT04915846|Hormone Antagonists|hormone antagonists|mesh-ancestor
154032653|NCT04915846|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153814787|NCT00343187|Leprostatic Agents|leprostatic agents|mesh-ancestor
154032658|NCT04915846|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
154032659|NCT04915846|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154032661|NCT04876781|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
154032662|NCT04876781|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154032663|NCT04876781|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154032664|NCT04876781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154032665|NCT04875871|Copper|copper|mesh-list
154032666|NCT04875871|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
154032667|NCT04875871|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
154032668|NCT04875871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154032669|NCT04875871|Trace Elements|trace elements|mesh-ancestor
154032670|NCT04875871|Micronutrients|micronutrients|mesh-ancestor
154032671|NCT04875871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154032672|NCT04862585|Diphenhydramine|diphenhydramine|mesh-list
154032673|NCT04862585|Promethazine|promethazine|mesh-list
154032674|NCT04862585|Dexamethasone|dexamethasone|mesh-list
154032675|NCT04862585|Dexamethasone acetate|dexamethasone acetate|mesh-list
154032676|NCT04862585|Paclitaxel|paclitaxel|mesh-list
154032677|NCT04862585|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
154032678|NCT04862585|Famotidine|famotidine|mesh-list
154032679|NCT04862585|Ranitidine|ranitidine|mesh-list
154032680|NCT04862585|Cimetidine|cimetidine|mesh-list
154032681|NCT04862585|BB 1101|bb 1101|mesh-list
154032682|NCT04862585|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154032683|NCT04862585|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154032684|NCT04862585|Tubulin Modulators|tubulin modulators|mesh-ancestor
154032685|NCT04862585|Antimitotic Agents|antimitotic agents|mesh-ancestor
154032686|NCT04862585|Mitosis Modulators|mitosis modulators|mesh-ancestor
154032687|NCT04862585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154032688|NCT04862585|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154032689|NCT04862585|Antiemetics|antiemetics|mesh-ancestor
154032690|NCT04862585|Autonomic Agents|autonomic agents|mesh-ancestor
154032691|NCT04862585|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154032701|NCT04862585|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154032702|NCT04862585|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154032703|NCT04862585|Anesthetics, Local|anesthetics, local|mesh-ancestor
154032704|NCT04862585|Anesthetics|anesthetics|mesh-ancestor
154032705|NCT04862585|Sensory System Agents|sensory system agents|mesh-ancestor
154032706|NCT04862585|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
153730849|NCT00135551|Adrenergic Agents|adrenergic agents|mesh-ancestor
154032707|NCT04862585|Histamine Antagonists|histamine antagonists|mesh-ancestor
154032708|NCT04862585|Histamine Agents|histamine agents|mesh-ancestor
154032709|NCT04862585|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154032710|NCT04862585|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154032711|NCT04862585|Antipruritics|antipruritics|mesh-ancestor
154032712|NCT04862585|Dermatologic Agents|dermatologic agents|mesh-ancestor
154032713|NCT04862585|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154032714|NCT04862585|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
154032715|NCT04862585|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
154032716|NCT04862585|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154032717|NCT04850495|Prednisone|prednisone|mesh-list
154032718|NCT04850495|Cortisone|cortisone|mesh-list
154032719|NCT04850495|Cyclophosphamide|cyclophosphamide|mesh-list
154032720|NCT04850495|Rituximab|rituximab|mesh-list
154032722|NCT04850495|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
154032723|NCT04850495|Vincristine|vincristine|mesh-list
154032724|NCT04850495|Zanubrutinib|zanubrutinib|mesh-list
154032725|NCT04850495|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
154032726|NCT04850495|Antibodies|antibodies|mesh-list
154032727|NCT04850495|Immunoglobulins|immunoglobulins|mesh-list
154032728|NCT04850495|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154032729|NCT04850495|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154032730|NCT04850495|Immunologic Factors|immunologic factors|mesh-ancestor
154032731|NCT04850495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154032732|NCT04850495|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154032733|NCT04850495|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154032734|NCT04850495|Alkylating Agents|alkylating agents|mesh-ancestor
154032749|NCT04850495|Antimitotic Agents|antimitotic agents|mesh-ancestor
154032750|NCT04850495|Mitosis Modulators|mitosis modulators|mesh-ancestor
154032751|NCT04850495|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154032752|NCT04850495|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154032753|NCT04847453|Dexamethasone|dexamethasone|mesh-list
154032754|NCT04847453|Dexamethasone acetate|dexamethasone acetate|mesh-list
154032755|NCT04847453|Venetoclax|venetoclax|mesh-list
154032756|NCT04847453|Ixazomib|ixazomib|mesh-list
154032757|NCT04847453|Ichthammol|ichthammol|mesh-list
154032758|NCT04847453|BB 1101|bb 1101|mesh-list
154032759|NCT04847453|Glycine|glycine|mesh-list
154032760|NCT04847453|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154032761|NCT04847453|Antiemetics|antiemetics|mesh-ancestor
154032762|NCT04847453|Autonomic Agents|autonomic agents|mesh-ancestor
154032763|NCT04847453|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154032764|NCT04847453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154032765|NCT04847453|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154032766|NCT04847453|Glucocorticoids|glucocorticoids|mesh-ancestor
154032767|NCT04847453|Hormones|hormones|mesh-ancestor
154032768|NCT04847453|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154032769|NCT04847453|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154032770|NCT04847453|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154032771|NCT04847453|Protease Inhibitors|protease inhibitors|mesh-ancestor
154032772|NCT04847453|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154032773|NCT04847453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154032790|NCT04785820|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154032792|NCT04785820|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154032793|NCT04785820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154032794|NCT04765202|Carisoprodol|carisoprodol|mesh-list
154032795|NCT04765202|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
154032796|NCT04765202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154032797|NCT04765202|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
154032798|NCT04765202|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154032800|NCT04756804|Chlorhexidine|chlorhexidine|mesh-list
154032801|NCT04756804|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
154032802|NCT04756804|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154032803|NCT04756804|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154032814|NCT04682691|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
154032815|NCT04682691|Erythromycin stearate|erythromycin stearate|mesh-list
154032816|NCT04682691|Metoclopramide|metoclopramide|mesh-list
154032817|NCT04682691|Antiemetics|antiemetics|mesh-ancestor
154032818|NCT04682691|Autonomic Agents|autonomic agents|mesh-ancestor
154032819|NCT04682691|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154032820|NCT04682691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154032821|NCT04682691|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154032822|NCT04682691|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
154032823|NCT04682691|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
154032824|NCT04682691|Dopamine Agents|dopamine agents|mesh-ancestor
154032825|NCT04682691|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154032826|NCT04682691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154032827|NCT04682691|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154032828|NCT04682691|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154032830|NCT04682691|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154032871|NCT04622228|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154032872|NCT04622228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154032873|NCT04622228|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154032874|NCT04622228|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154032875|NCT04596631|Semaglutide|semaglutide|mesh-list
154032876|NCT04596631|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
154032877|NCT04596631|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154032878|NCT04596631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154032879|NCT04588259|Insulin|insulin|mesh-list
154032880|NCT04588259|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
154032881|NCT04588259|Insulin Aspart|insulin aspart|mesh-list
154032882|NCT04588259|Insulin, Long-Acting|insulin, long-acting|mesh-list
154032883|NCT04588259|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
154032884|NCT04588259|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154032885|NCT04588259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154032886|NCT04522804|Psilocybin|psilocybin|mesh-list
154032887|NCT04522804|Hallucinogens|hallucinogens|mesh-ancestor
154032888|NCT04522804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154032889|NCT04522804|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154032890|NCT04504669|Durvalumab|durvalumab|mesh-list
154032891|NCT04504669|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154032892|NCT04504669|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154032893|NCT04459715|Cisplatin|cisplatin|mesh-list
154032894|NCT04459715|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154032895|NCT04394858|Temozolomide|temozolomide|mesh-list
154032896|NCT04394858|Olaparib|olaparib|mesh-list
154032899|NCT04394858|Alkylating Agents|alkylating agents|mesh-ancestor
154032919|NCT04195945|Daunorubicin|daunorubicin|mesh-list
154032920|NCT04195945|Mitoxantrone|mitoxantrone|mesh-list
154032921|NCT04195945|Cladribine|cladribine|mesh-list
154032922|NCT04195945|Lenograstim|lenograstim|mesh-list
154032923|NCT04195945|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154032924|NCT04195945|Antimetabolites|antimetabolites|mesh-ancestor
154032925|NCT04195945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154032926|NCT04195945|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154032927|NCT04195945|Antiviral Agents|antiviral agents|mesh-ancestor
154032928|NCT04195945|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154032929|NCT04195945|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154032930|NCT04195945|Immunologic Factors|immunologic factors|mesh-ancestor
154032931|NCT04195945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154032932|NCT04195945|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154032933|NCT04195945|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154032934|NCT04195945|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154032935|NCT04195945|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154032936|NCT04195945|Analgesics|analgesics|mesh-ancestor
154032937|NCT04195945|Sensory System Agents|sensory system agents|mesh-ancestor
154032946|NCT04145297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154032947|NCT04145297|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154032948|NCT04142658|Warfarin|warfarin|mesh-list
154032949|NCT04142658|Apixaban|apixaban|mesh-list
154032950|NCT04142658|Anticoagulants|anticoagulants|mesh-ancestor
154032951|NCT04142658|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
154032952|NCT04142658|Antithrombins|antithrombins|mesh-ancestor
154032953|NCT04142658|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154032954|NCT04142658|Protease Inhibitors|protease inhibitors|mesh-ancestor
154032955|NCT04142658|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154032956|NCT04142658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154032957|NCT04138277|Miglustat|miglustat|mesh-list
154032958|NCT04138277|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154032959|NCT04138277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154032960|NCT04138277|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154032961|NCT04138277|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154032962|NCT04138277|Antiviral Agents|antiviral agents|mesh-ancestor
154032963|NCT04138277|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154032964|NCT04138277|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
154032965|NCT04138277|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154032966|NCT04138277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154032967|NCT04128501|Azacitidine|azacitidine|mesh-list
154032968|NCT04128501|Venetoclax|venetoclax|mesh-list
154032969|NCT04128501|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154032970|NCT04128501|Antimetabolites|antimetabolites|mesh-ancestor
154032971|NCT04128501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154032973|NCT04128501|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154032987|NCT04112823|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154032988|NCT04112823|Protease Inhibitors|protease inhibitors|mesh-ancestor
154032989|NCT04112823|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154032990|NCT04112823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154032991|NCT04104893|Pembrolizumab|pembrolizumab|mesh-list
154032992|NCT04104893|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154032993|NCT04104893|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154032994|NCT04104893|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154032995|NCT04104893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154032996|NCT04041973|Lumefantrine|lumefantrine|mesh-list
154032997|NCT04041973|Artemether|artemether|mesh-list
154032998|NCT04041973|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
154032999|NCT04041973|Antimalarials|antimalarials|mesh-ancestor
154033000|NCT04041973|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154033001|NCT04041973|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154033002|NCT04041973|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154033003|NCT04029480|Metformin|metformin|mesh-list
154033004|NCT04029480|Ertugliflozin|ertugliflozin|mesh-list
154033005|NCT04029480|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154033006|NCT04029480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154033007|NCT04029480|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
154033008|NCT04029480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154033009|NCT03987802|Insulin Aspart|insulin aspart|mesh-list
154033010|NCT03987802|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154033011|NCT03987802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154033012|NCT03980184|Guanfacine|guanfacine|mesh-list
154033013|NCT03980184|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154033014|NCT03980184|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154033015|NCT03980184|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154033016|NCT03980184|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154033017|NCT03980184|Adrenergic Agents|adrenergic agents|mesh-ancestor
154033018|NCT03980184|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153814793|NCT00343265|Progesterone|progesterone|mesh-list
154033029|NCT03971071|Calcitonin Gene-Related Peptide Receptor Antagonists|calcitonin gene-related peptide receptor antagonists|mesh-ancestor
154033030|NCT03971071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154033031|NCT03971071|Analgesics|analgesics|mesh-ancestor
154033032|NCT03971071|Sensory System Agents|sensory system agents|mesh-ancestor
154033033|NCT03971071|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154033034|NCT03971071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154033035|NCT03971071|Immunologic Factors|immunologic factors|mesh-ancestor
154033036|NCT03939104|Artesunate|artesunate|mesh-list
154033037|NCT03939104|Lumefantrine|lumefantrine|mesh-list
154033038|NCT03939104|Artemether|artemether|mesh-list
154033039|NCT03939104|Piperaquine|piperaquine|mesh-list
154033040|NCT03939104|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
154033041|NCT03939104|Amodiaquine|amodiaquine|mesh-list
154033042|NCT03939104|Mefloquine|mefloquine|mesh-list
154033043|NCT03939104|Antimalarials|antimalarials|mesh-ancestor
154033044|NCT03939104|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154033045|NCT03939104|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154033046|NCT03939104|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154033047|NCT03939104|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154033048|NCT03939104|Antiviral Agents|antiviral agents|mesh-ancestor
154033049|NCT03939104|Schistosomicides|schistosomicides|mesh-ancestor
154033050|NCT03939104|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
154033051|NCT03939104|Anthelmintics|anthelmintics|mesh-ancestor
154033052|NCT03914326|Semaglutide|semaglutide|mesh-list
154033053|NCT03914326|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
154033054|NCT03914326|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154033055|NCT03914326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154033056|NCT03897244|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
154033057|NCT03897244|Amoxicillin|amoxicillin|mesh-list
154033058|NCT03897244|Metronidazole|metronidazole|mesh-list
154033060|NCT03897244|Rabeprazole|rabeprazole|mesh-list
154033070|NCT03897244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154033071|NCT03897244|Antacids|antacids|mesh-ancestor
154033072|NCT03873805|Vidarabine|vidarabine|mesh-list
154033073|NCT03873805|Cyclophosphamide|cyclophosphamide|mesh-list
154033074|NCT03873805|Fludarabine|fludarabine|mesh-list
154033075|NCT03873805|Fludarabine phosphate|fludarabine phosphate|mesh-list
154033076|NCT03873805|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154033077|NCT03873805|Immunologic Factors|immunologic factors|mesh-ancestor
154033078|NCT03873805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154033079|NCT03873805|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154033080|NCT03873805|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154033081|NCT03873805|Alkylating Agents|alkylating agents|mesh-ancestor
154033082|NCT03873805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154033083|NCT03873805|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154033084|NCT03873805|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154033085|NCT03873805|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154033086|NCT03873805|Antimetabolites|antimetabolites|mesh-ancestor
154033087|NCT03873805|Antiviral Agents|antiviral agents|mesh-ancestor
154033088|NCT03873805|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154033095|NCT03823768|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154033096|NCT03823768|Immunologic Factors|immunologic factors|mesh-ancestor
154033097|NCT03823768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154033098|NCT03823768|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
154033099|NCT03823768|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154033100|NCT03823768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153360221|NCT00802100|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
154033126|NCT03803553|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154033127|NCT03668613|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154033128|NCT03668613|Immunologic Factors|immunologic factors|mesh-ancestor
154033129|NCT03668613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154033130|NCT03635164|Durvalumab|durvalumab|mesh-list
154033131|NCT03635164|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154033132|NCT03635164|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154033133|NCT03633604|HBOC 201|hboc 201|mesh-list
154033134|NCT03633604|Blood Substitutes|blood substitutes|mesh-ancestor
154033135|NCT03602066|Chlorine dioxide|chlorine dioxide|mesh-list
154033136|NCT03602066|Dental Disinfectants|dental disinfectants|mesh-ancestor
154033137|NCT03602066|Disinfectants|disinfectants|mesh-ancestor
154033138|NCT03602066|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154033139|NCT03583086|Nivolumab|nivolumab|mesh-list
154033140|NCT03583086|Vorolanib|vorolanib|mesh-list
154033141|NCT03583086|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154033142|NCT03583086|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154033143|NCT03583086|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154033144|NCT03583086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154033145|NCT03583086|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154033146|NCT03583086|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154033147|NCT03582774|Edetic Acid|edetic acid|mesh-list
154033148|NCT03582774|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
154033149|NCT03582774|Chelating Agents|chelating agents|mesh-ancestor
154033150|NCT03582774|Sequestering Agents|sequestering agents|mesh-ancestor
153814795|NCT00343265|Hormones|hormones|mesh-ancestor
154033172|NCT03527732|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154033173|NCT03500133|Cytarabine|cytarabine|mesh-list
153575851|NCT01708876|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154033174|NCT03500133|Methylprednisolone|methylprednisolone|mesh-list
154033175|NCT03500133|Cisplatin|cisplatin|mesh-list
154033176|NCT03500133|Etoposide|etoposide|mesh-list
154033177|NCT03500133|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154033178|NCT03500133|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154033179|NCT03500133|Antimetabolites|antimetabolites|mesh-ancestor
154033180|NCT03500133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154033181|NCT03500133|Antiviral Agents|antiviral agents|mesh-ancestor
154033182|NCT03500133|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154033183|NCT03500133|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154033184|NCT03500133|Immunologic Factors|immunologic factors|mesh-ancestor
154033185|NCT03500133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154033186|NCT03500133|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154033187|NCT03500133|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154033188|NCT03500133|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154033189|NCT03500133|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154033190|NCT03500133|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154033191|NCT03500133|Antiemetics|antiemetics|mesh-ancestor
154033192|NCT03500133|Autonomic Agents|autonomic agents|mesh-ancestor
154033193|NCT03500133|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154033194|NCT03500133|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154033195|NCT03500133|Glucocorticoids|glucocorticoids|mesh-ancestor
154033222|NCT03317158|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154033223|NCT03317158|Antimetabolites|antimetabolites|mesh-ancestor
154033224|NCT03317158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154033225|NCT03317158|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154033226|NCT03317158|Tubulin Modulators|tubulin modulators|mesh-ancestor
154033227|NCT03317158|Antimitotic Agents|antimitotic agents|mesh-ancestor
154033228|NCT03317158|Mitosis Modulators|mitosis modulators|mesh-ancestor
154033229|NCT03317158|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154033230|NCT03317158|Immunologic Factors|immunologic factors|mesh-ancestor
154033231|NCT03317158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154033232|NCT03317158|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154033233|NCT03281954|Atezolizumab|atezolizumab|mesh-list
154033234|NCT03281954|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154033235|NCT03281954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154033236|NCT03281954|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154033237|NCT03281954|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154033238|NCT03225417|Sirolimus|sirolimus|mesh-list
154033239|NCT03225417|Cyclophosphamide|cyclophosphamide|mesh-list
154033240|NCT03225417|Ixazomib|ixazomib|mesh-list
154033241|NCT03225417|Tacrolimus|tacrolimus|mesh-list
154033242|NCT03225417|Antilymphocyte Serum|antilymphocyte serum|mesh-list
154033243|NCT03225417|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154033244|NCT03225417|Immunologic Factors|immunologic factors|mesh-ancestor
154033245|NCT03225417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154033246|NCT03225417|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154033247|NCT03225417|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154033248|NCT03225417|Alkylating Agents|alkylating agents|mesh-ancestor
154033249|NCT03225417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154033250|NCT03225417|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154033251|NCT03225417|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153575932|NCT01709760|Methotrexate|methotrexate|mesh-list
154033252|NCT03225417|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
154033253|NCT03225417|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154033254|NCT03225417|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154033255|NCT03225417|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154033256|NCT03225417|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153573175|NCT02367794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154033259|NCT03171025|Nivolumab|nivolumab|mesh-list
154033260|NCT03171025|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154033261|NCT03171025|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154033262|NCT03171025|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154033263|NCT03171025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154033264|NCT03031821|Metformin|metformin|mesh-list
154033265|NCT03031821|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154033266|NCT03031821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154033267|NCT02998567|Pembrolizumab|pembrolizumab|mesh-list
154033268|NCT02998567|Decitabine and cedazuridine drug combination|decitabine and cedazuridine drug combination|mesh-list
154033269|NCT02998567|Guadecitabine|guadecitabine|mesh-list
154033270|NCT02998567|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154033271|NCT02998567|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154033272|NCT02998567|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154033273|NCT02998567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154033274|NCT02998567|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154033275|NCT02998567|Antimetabolites|antimetabolites|mesh-ancestor
154033276|NCT02983981|Desoximetasone|desoximetasone|mesh-list
154033277|NCT02983981|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154033278|NCT02983981|Glucocorticoids|glucocorticoids|mesh-ancestor
154033279|NCT02983981|Hormones|hormones|mesh-ancestor
154033280|NCT02983981|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154033281|NCT02983981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154033282|NCT02975934|Docetaxel|docetaxel|mesh-list
154033283|NCT02975934|Abiraterone Acetate|abiraterone acetate|mesh-list
154033284|NCT02975934|Rucaparib|rucaparib|mesh-list
154033285|NCT02975934|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154033286|NCT02975934|Tubulin Modulators|tubulin modulators|mesh-ancestor
154033287|NCT02975934|Antimitotic Agents|antimitotic agents|mesh-ancestor
154033288|NCT02975934|Mitosis Modulators|mitosis modulators|mesh-ancestor
154033289|NCT02975934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154033290|NCT02975934|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154033293|NCT02975934|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154033294|NCT02975934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154033295|NCT02975934|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154033296|NCT02975934|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
154033297|NCT02962414|Everolimus|everolimus|mesh-list
154033298|NCT02962414|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
154033299|NCT02962414|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154033300|NCT02962414|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154033301|NCT02962414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154033302|NCT02962414|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154033303|NCT02962414|Immunologic Factors|immunologic factors|mesh-ancestor
154033304|NCT02962414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154033305|NCT02962414|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154033306|NCT02764541|Tamoxifen|tamoxifen|mesh-list
154033307|NCT02764541|Letrozole|letrozole|mesh-list
154033308|NCT02764541|Palbociclib|palbociclib|mesh-list
154033309|NCT02764541|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154033310|NCT02764541|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
154033311|NCT02764541|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154033312|NCT02764541|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154033313|NCT02764541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154033314|NCT02764541|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
154033315|NCT02764541|Hormone Antagonists|hormone antagonists|mesh-ancestor
154033316|NCT02764541|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154033317|NCT02764541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154033318|NCT02764541|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154033319|NCT02764541|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
154033342|NCT02576574|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154033343|NCT02576574|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154033344|NCT02576574|Tubulin Modulators|tubulin modulators|mesh-ancestor
154033345|NCT02576574|Antimitotic Agents|antimitotic agents|mesh-ancestor
154033346|NCT02576574|Mitosis Modulators|mitosis modulators|mesh-ancestor
154033347|NCT02576574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154033348|NCT02576574|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154033349|NCT02576574|Antimetabolites|antimetabolites|mesh-ancestor
154033350|NCT02576574|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154033351|NCT02576574|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154033352|NCT02576574|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154033353|NCT02576574|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154033354|NCT02576574|Immunologic Factors|immunologic factors|mesh-ancestor
154033355|NCT02576574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154033356|NCT02535338|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
154033357|NCT02535338|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154033358|NCT02535338|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154033359|NCT02535338|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154033360|NCT02535338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154033361|NCT02535338|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154033362|NCT02502266|Paclitaxel|paclitaxel|mesh-list
154033363|NCT02502266|Doxorubicin|doxorubicin|mesh-list
154033364|NCT02502266|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
154033365|NCT02502266|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
154033366|NCT02502266|Topotecan|topotecan|mesh-list
154033367|NCT02502266|Olaparib|olaparib|mesh-list
154033368|NCT02502266|Cediranib|cediranib|mesh-list
154033369|NCT02502266|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
154033374|NCT02502266|Antimitotic Agents|antimitotic agents|mesh-ancestor
154033375|NCT02502266|Mitosis Modulators|mitosis modulators|mesh-ancestor
154033376|NCT02502266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154033377|NCT02502266|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154033378|NCT02502266|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154033379|NCT02502266|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154033380|NCT02502266|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154033381|NCT02502266|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
154033382|NCT02502266|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154033383|NCT02460302|Progesterone|progesterone|mesh-list
154033384|NCT02460302|Progestins|progestins|mesh-ancestor
154033385|NCT02460302|Hormones|hormones|mesh-ancestor
154033386|NCT02460302|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154033387|NCT02460302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154033388|NCT02453620|Nivolumab|nivolumab|mesh-list
154033389|NCT02453620|Ipilimumab|ipilimumab|mesh-list
154033390|NCT02453620|Entinostat|entinostat|mesh-list
154033391|NCT02453620|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-list
154033392|NCT02453620|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154033393|NCT02453620|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154033394|NCT02453620|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154033395|NCT02453620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154033396|NCT02453620|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154033397|NCT02420912|Nivolumab|nivolumab|mesh-list
154033398|NCT02420912|Ibrutinib|ibrutinib|mesh-list
154033399|NCT02420912|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154033400|NCT02420912|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154033401|NCT02420912|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153814796|NCT00343265|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154033421|NCT02400281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154033422|NCT02400281|Antiviral Agents|antiviral agents|mesh-ancestor
154033423|NCT02400281|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154033424|NCT02400281|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154033425|NCT02400281|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154033426|NCT02400281|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154033427|NCT02400281|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154033428|NCT02400281|Analgesics|analgesics|mesh-ancestor
154033429|NCT02400281|Sensory System Agents|sensory system agents|mesh-ancestor
154033430|NCT02400281|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154033431|NCT02400281|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154033432|NCT02398773|Estradiol|estradiol|mesh-list
154033433|NCT02398773|Estrogens|estrogens|mesh-ancestor
154033434|NCT02398773|Hormones|hormones|mesh-ancestor
154033435|NCT02398773|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154033436|NCT02398773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154033437|NCT02344290|Pitavastatin|pitavastatin|mesh-list
154033438|NCT02344290|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154033439|NCT02344290|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154033440|NCT02344290|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154033441|NCT02344290|Antimetabolites|antimetabolites|mesh-ancestor
154033442|NCT02344290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154033443|NCT02344290|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154033444|NCT02344290|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154033445|NCT02259621|Paclitaxel|paclitaxel|mesh-list
154033446|NCT02259621|Carboplatin|carboplatin|mesh-list
154033447|NCT02259621|Nivolumab|nivolumab|mesh-list
154033448|NCT02259621|Ipilimumab|ipilimumab|mesh-list
154033449|NCT02259621|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154033450|NCT02259621|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154033451|NCT02259621|Tubulin Modulators|tubulin modulators|mesh-ancestor
154033452|NCT02259621|Antimitotic Agents|antimitotic agents|mesh-ancestor
154033453|NCT02259621|Mitosis Modulators|mitosis modulators|mesh-ancestor
154033454|NCT02259621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154033458|NCT02052778|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154033459|NCT01915810|Nicotine|nicotine|mesh-list
154033460|NCT01915810|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
154033461|NCT01915810|Autonomic Agents|autonomic agents|mesh-ancestor
154033462|NCT01915810|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154033463|NCT01915810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154033464|NCT01915810|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
154033465|NCT01915810|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
154033466|NCT01915810|Cholinergic Agents|cholinergic agents|mesh-ancestor
154033467|NCT01915810|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154033468|NCT01915810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154033469|NCT01787500|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
154033470|NCT01787500|Cetuximab|cetuximab|mesh-list
154033471|NCT01787500|Irinotecan|irinotecan|mesh-list
154033472|NCT01787500|Camptothecin|camptothecin|mesh-list
154033473|NCT01787500|Vemurafenib|vemurafenib|mesh-list
154033474|NCT01787500|Antibodies|antibodies|mesh-list
154033475|NCT01787500|Immunoglobulins|immunoglobulins|mesh-list
154033476|NCT01787500|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154033477|NCT01787500|Immunologic Factors|immunologic factors|mesh-ancestor
154033478|NCT01787500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154033479|NCT01787500|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154033480|NCT01787500|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
154033481|NCT01787500|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154033482|NCT01787500|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154033483|NCT01787500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154033484|NCT01787500|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154033485|NCT01787500|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154033486|NCT01585194|Nivolumab|nivolumab|mesh-list
154033487|NCT01585194|Ipilimumab|ipilimumab|mesh-list
154033488|NCT01585194|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154033489|NCT01585194|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154033490|NCT01585194|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154033492|NCT01508312|Brentuximab Vedotin|brentuximab vedotin|mesh-list
154033498|NCT01508312|Immunologic Factors|immunologic factors|mesh-ancestor
154033499|NCT01508312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154033500|NCT01424982|Cytarabine|cytarabine|mesh-list
154033501|NCT01424982|Dexamethasone|dexamethasone|mesh-list
154033502|NCT01424982|Prednisone|prednisone|mesh-list
154033503|NCT01424982|Dexamethasone acetate|dexamethasone acetate|mesh-list
154033504|NCT01424982|Cortisone|cortisone|mesh-list
154033505|NCT01424982|Cyclophosphamide|cyclophosphamide|mesh-list
154033506|NCT01424982|Rituximab|rituximab|mesh-list
154033507|NCT01424982|Doxorubicin|doxorubicin|mesh-list
154033508|NCT01424982|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
154033509|NCT01424982|Methotrexate|methotrexate|mesh-list
154033510|NCT01424982|Vincristine|vincristine|mesh-list
154033511|NCT01424982|Daunorubicin|daunorubicin|mesh-list
154033512|NCT01424982|Ponatinib|ponatinib|mesh-list
154033513|NCT01424982|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
154033514|NCT01424982|Antibodies|antibodies|mesh-list
154033515|NCT01424982|Immunoglobulins|immunoglobulins|mesh-list
154033516|NCT01424982|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154033517|NCT01424982|BB 1101|bb 1101|mesh-list
154033518|NCT01424982|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154033519|NCT01424982|Immunologic Factors|immunologic factors|mesh-ancestor
154033520|NCT01424982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154033521|NCT01424982|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154033522|NCT01424982|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154033523|NCT01424982|Alkylating Agents|alkylating agents|mesh-ancestor
154033524|NCT01424982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154033525|NCT01424982|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154033526|NCT01424982|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154033527|NCT01424982|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154033528|NCT01424982|Antiemetics|antiemetics|mesh-ancestor
154033529|NCT01424982|Autonomic Agents|autonomic agents|mesh-ancestor
154033530|NCT01424982|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154033531|NCT01424982|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154033532|NCT01424982|Glucocorticoids|glucocorticoids|mesh-ancestor
154033533|NCT01424982|Hormones|hormones|mesh-ancestor
154033534|NCT01424982|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154033538|NCT01424982|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154033544|NCT01424982|Antimetabolites|antimetabolites|mesh-ancestor
154033545|NCT01424982|Dermatologic Agents|dermatologic agents|mesh-ancestor
154033546|NCT01424982|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154033547|NCT01424982|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154033548|NCT01424982|Antiviral Agents|antiviral agents|mesh-ancestor
154033549|NCT01424982|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154033550|NCT01424982|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154033551|NCT01424982|Tubulin Modulators|tubulin modulators|mesh-ancestor
154033552|NCT01424982|Antimitotic Agents|antimitotic agents|mesh-ancestor
154033553|NCT01424982|Mitosis Modulators|mitosis modulators|mesh-ancestor
154033554|NCT01424982|Protease Inhibitors|protease inhibitors|mesh-ancestor
154033555|NCT01424982|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154033556|NCT01424982|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154033557|NCT01349881|Eflornithine|eflornithine|mesh-list
154033558|NCT01349881|Sulindac|sulindac|mesh-list
154033559|NCT01349881|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154033560|NCT01349881|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
154033561|NCT01349881|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154033562|NCT01349881|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154033563|NCT01349881|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154033564|NCT01349881|Ornithine Decarboxylase Inhibitors|ornithine decarboxylase inhibitors|mesh-ancestor
154033565|NCT01349881|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154033566|NCT01349881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154033567|NCT01349881|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154033568|NCT01349881|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154033569|NCT01349881|Analgesics|analgesics|mesh-ancestor
154033570|NCT01349881|Sensory System Agents|sensory system agents|mesh-ancestor
154033574|NCT01349881|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154033578|NCT01294020|Immunologic Factors|immunologic factors|mesh-ancestor
154033579|NCT01294020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154033580|NCT01294020|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
154033581|NCT01294020|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154033582|NCT01294020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154033583|NCT01246869|Deoxyglucose|deoxyglucose|mesh-list
154033585|NCT01246869|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154033586|NCT01246869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154033587|NCT01246869|Antimetabolites|antimetabolites|mesh-ancestor
154033588|NCT01246869|Antiviral Agents|antiviral agents|mesh-ancestor
154033589|NCT01246869|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154033590|NCT01120249|Everolimus|everolimus|mesh-list
153814797|NCT00343265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153814799|NCT00453609|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
153814800|NCT00453609|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
153814801|NCT00453609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153814802|NCT00453609|Sensory System Agents|sensory system agents|mesh-ancestor
153814803|NCT00453609|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153814804|NCT00447213|Insulin|insulin|mesh-list
154033628|NCT00880620|Levodopa|levodopa|mesh-list
154033629|NCT00880620|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154033630|NCT00880620|Immunologic Factors|immunologic factors|mesh-ancestor
154033631|NCT00880620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154033632|NCT00880620|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
154033633|NCT00880620|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
154033634|NCT00880620|Dopamine Agonists|dopamine agonists|mesh-ancestor
154033635|NCT00880620|Dopamine Agents|dopamine agents|mesh-ancestor
154033636|NCT00880620|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154033637|NCT00880620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154033638|NCT00880620|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
154033639|NCT00880620|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154033640|NCT00959335|Bicalutamide|bicalutamide|mesh-list
154033641|NCT00959335|Androgen Antagonists|androgen antagonists|mesh-ancestor
154033642|NCT00959335|Hormone Antagonists|hormone antagonists|mesh-ancestor
154033643|NCT00959335|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154033681|NCT00881868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154033682|NCT04176068|Calcium|calcium|mesh-list
154033685|NCT00959725|Infliximab|infliximab|mesh-list
153814820|NCT00343421|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
153814822|NCT00343421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154033699|NCT04234607|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154033700|NCT04234607|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154033701|NCT04234607|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154033702|NCT04234607|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154033703|NCT04234607|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154033704|NCT04234607|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154033705|NCT03955471|Niraparib|niraparib|mesh-list
154033706|NCT03955471|Dostarlimab|dostarlimab|mesh-list
154033707|NCT03955471|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
154033708|NCT03955471|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154033709|NCT03955471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154033710|NCT03955471|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154033712|NCT02637726|Propofol|propofol|mesh-list
153814823|NCT00343499|Valsartan|valsartan|mesh-list
153814824|NCT00343499|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153360222|NCT00802100|Parasympatholytics|parasympatholytics|mesh-ancestor
154033751|NCT00965107|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154033752|NCT00965107|Anesthetics, General|anesthetics, general|mesh-ancestor
154033753|NCT00965107|Anesthetics|anesthetics|mesh-ancestor
154033754|NCT00965107|Anticonvulsants|anticonvulsants|mesh-ancestor
154033755|NCT00965107|GABA Modulators|gaba modulators|mesh-ancestor
154033756|NCT00965107|GABA Agents|gaba agents|mesh-ancestor
154033757|NCT00965107|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153730878|NCT00152724|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
154033758|NCT00965107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154033759|NCT02788877|Aflibercept|aflibercept|mesh-list
154033760|NCT02788877|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154033761|NCT02788877|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154033762|NCT02788877|Growth Substances|growth substances|mesh-ancestor
154033763|NCT02788877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154033764|NCT02788877|Growth Inhibitors|growth inhibitors|mesh-ancestor
154033765|NCT02788877|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154033766|NCT00959881|Donepezil|donepezil|mesh-list
154033767|NCT00959881|Begacestat|begacestat|mesh-list
154033768|NCT00959881|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
154033769|NCT00959881|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154033770|NCT00959881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154033771|NCT00959881|Cholinergic Agents|cholinergic agents|mesh-ancestor
154033772|NCT00959881|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154033773|NCT00959881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154033774|NCT00959881|Nootropic Agents|nootropic agents|mesh-ancestor
154033775|NCT00959881|Gamma Secretase Inhibitors and Modulators|gamma secretase inhibitors and modulators|mesh-ancestor
154033776|NCT00959959|3-hydroxy-17-(1H-benzimidazole-1-yl)androsta-5,16-diene|3-hydroxy-17-(1h-benzimidazole-1-yl)androsta-5,16-diene|mesh-list
154033777|NCT00959959|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154033778|NCT00959959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154033789|NCT00880542|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154033790|NCT00880542|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154033791|NCT00880542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154033792|NCT00880542|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154033793|NCT00880542|Alkylating Agents|alkylating agents|mesh-ancestor
154033794|NCT00960037|Vitamin D|vitamin d|mesh-list
154033795|NCT00960037|Cholecalciferol|cholecalciferol|mesh-list
154033796|NCT00960037|Vitamins|vitamins|mesh-ancestor
154033797|NCT00960037|Micronutrients|micronutrients|mesh-ancestor
154033798|NCT00960037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154033799|NCT00960037|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154033800|NCT00960037|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154033801|NCT04161690|Dexketoprofen trometamol|dexketoprofen trometamol|mesh-list
154033802|NCT04161690|Ropivacaine|ropivacaine|mesh-list
154033803|NCT04161690|Anesthetics, Local|anesthetics, local|mesh-ancestor
154033804|NCT04161690|Anesthetics|anesthetics|mesh-ancestor
154033805|NCT04161690|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154033806|NCT04161690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154033807|NCT04161690|Sensory System Agents|sensory system agents|mesh-ancestor
154033808|NCT04161690|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154033809|NCT04161690|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154033810|NCT04161690|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154033811|NCT04161690|Analgesics|analgesics|mesh-ancestor
154033812|NCT04161690|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154033813|NCT04161690|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154033847|NCT00960349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154033849|NCT00960349|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154033850|NCT02670434|Pitavastatin|pitavastatin|mesh-list
154033851|NCT02670434|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154033852|NCT02670434|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154033853|NCT02670434|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154033854|NCT02670434|Antimetabolites|antimetabolites|mesh-ancestor
154033855|NCT02670434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154033856|NCT02670434|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154033857|NCT02670434|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154033858|NCT00965653|Folic Acid|folic acid|mesh-list
154033859|NCT00965653|Methotrexate|methotrexate|mesh-list
154033860|NCT00965653|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154033861|NCT00965653|Abortifacient Agents|abortifacient agents|mesh-ancestor
154033862|NCT00965653|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154033863|NCT00965653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154033872|NCT00965653|Immunologic Factors|immunologic factors|mesh-ancestor
154033873|NCT00965653|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154033874|NCT00965653|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154033875|NCT00965653|Hematinics|hematinics|mesh-ancestor
154033876|NCT00965653|Vitamin B Complex|vitamin b complex|mesh-ancestor
154033877|NCT00965653|Vitamins|vitamins|mesh-ancestor
154033878|NCT00965653|Micronutrients|micronutrients|mesh-ancestor
154033879|NCT00644696|Cefixime|cefixime|mesh-list
154033880|NCT00644696|Cefpodoxime|cefpodoxime|mesh-list
154033881|NCT00644696|Irinotecan|irinotecan|mesh-list
154033882|NCT00644696|Bortezomib|bortezomib|mesh-list
154033883|NCT00644696|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
154033884|NCT00644696|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154033885|NCT00644696|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154033886|NCT00644696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154033887|NCT00644696|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154033888|NCT00644696|Third Generation Cephalosporins|third generation cephalosporins|mesh-ancestor
154033889|NCT00644696|Beta Lactam Antibiotics|beta lactam antibiotics|mesh-ancestor
154033890|NCT00644696|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154033891|NCT00644696|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154033892|NCT00960739|Topotecan|topotecan|mesh-list
154033893|NCT00960739|3-Iodobenzylguanidine|3-iodobenzylguanidine|mesh-list
154033894|NCT00960739|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
154033895|NCT00960739|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154033896|NCT00960739|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154033897|NCT00960739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154033898|NCT00960739|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154033899|NCT00960739|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
154033900|NCT00659022|Bevacizumab|bevacizumab|mesh-list
154033901|NCT00659022|Capecitabine|capecitabine|mesh-list
154033902|NCT00659022|Oxaliplatin|oxaliplatin|mesh-list
154033903|NCT00659022|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154033917|NCT04175522|Immunoglobulins|immunoglobulins|mesh-list
154033918|NCT04175522|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
154033919|NCT04175522|Antibodies|antibodies|mesh-list
154033920|NCT04175522|Immunoglobulin G|immunoglobulin g|mesh-list
154033921|NCT04175522|Immunologic Factors|immunologic factors|mesh-ancestor
154033922|NCT04175522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154033923|NCT00960817|Aspirin|aspirin|mesh-list
154033924|NCT00960817|Dipyridamole|dipyridamole|mesh-list
154033925|NCT00960817|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154033926|NCT00960817|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154033927|NCT00960817|Analgesics|analgesics|mesh-ancestor
154033928|NCT00960817|Sensory System Agents|sensory system agents|mesh-ancestor
154033929|NCT00960817|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154033930|NCT00960817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153576601|NCT01713101|Coagulants|coagulants|mesh-ancestor
154033931|NCT00960817|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154033932|NCT00960817|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154033933|NCT00960817|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154033934|NCT00960817|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154033935|NCT00960817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154033936|NCT00960817|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154033942|NCT00965809|Dronabinol|dronabinol|mesh-list
154033965|NCT00885378|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154033966|NCT00885378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154033967|NCT04095494|Nitrous Oxide|nitrous oxide|mesh-list
154033968|NCT04095494|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
154033969|NCT04095494|Anesthetics, General|anesthetics, general|mesh-ancestor
154033970|NCT04095494|Anesthetics|anesthetics|mesh-ancestor
154033971|NCT04095494|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154033972|NCT04095494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154033973|NCT04095494|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154033974|NCT04095494|Analgesics|analgesics|mesh-ancestor
154033975|NCT04095494|Sensory System Agents|sensory system agents|mesh-ancestor
154033976|NCT04095494|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154033977|NCT02537210|Mesalamine|mesalamine|mesh-list
154033978|NCT02537210|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154034027|NCT00659178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154034028|NCT02792621|Acipimox|acipimox|mesh-list
154034029|NCT02792621|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154034030|NCT02792621|Antimetabolites|antimetabolites|mesh-ancestor
154034031|NCT02792621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154034032|NCT02792621|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154034033|NCT04009759|Ketamine|ketamine|mesh-list
154034034|NCT04009759|Morphine|morphine|mesh-list
154034035|NCT04009759|Analgesics|analgesics|mesh-ancestor
154034036|NCT04009759|Sensory System Agents|sensory system agents|mesh-ancestor
154034037|NCT04009759|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154034038|NCT04009759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154034039|NCT04009759|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
154034040|NCT04009759|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154034041|NCT04009759|Anesthetics, General|anesthetics, general|mesh-ancestor
154034042|NCT04009759|Anesthetics|anesthetics|mesh-ancestor
154034043|NCT04009759|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154034044|NCT04009759|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154034045|NCT04009759|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154034046|NCT04009759|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154034047|NCT04009759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154034048|NCT04009759|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154034049|NCT04009759|Narcotics|narcotics|mesh-ancestor
154034050|NCT00645086|Clarithromycin|clarithromycin|mesh-list
154034051|NCT00645086|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154034053|NCT00645086|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
154034054|NCT00645086|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154034074|NCT05003245|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154034076|NCT05003245|Endothelial Growth Factors|endothelial growth factors|mesh-list
154034077|NCT05003245|Immunologic Factors|immunologic factors|mesh-ancestor
154034078|NCT05003245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154034079|NCT05003245|Mitosis Modulators|mitosis modulators|mesh-ancestor
154034080|NCT05003245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154034081|NCT05003245|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154034082|NCT05003245|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154034083|NCT05003245|Growth Substances|growth substances|mesh-ancestor
154034084|NCT05003245|Growth Inhibitors|growth inhibitors|mesh-ancestor
154034085|NCT05003245|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154034086|NCT05367089|Fluconazole|fluconazole|mesh-list
154034087|NCT05367089|Antifungal Agents|antifungal agents|mesh-ancestor
154034088|NCT05367089|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154034089|NCT05367089|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
154034090|NCT05367089|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154034091|NCT05367089|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154034092|NCT05367089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154034093|NCT05367089|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154034094|NCT05367089|Hormone Antagonists|hormone antagonists|mesh-ancestor
154034095|NCT05367089|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154034096|NCT05367089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154034097|NCT05367089|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
154034098|NCT05367089|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
154034099|NCT02671058|Hydrocortisone|hydrocortisone|mesh-list
154034100|NCT02671058|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
154034101|NCT02671058|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
154034102|NCT02671058|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
154034103|NCT02671058|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154034104|NCT02791919|Cytarabine|cytarabine|mesh-list
154034105|NCT02791919|Fludarabine|fludarabine|mesh-list
154034106|NCT02791919|Fludarabine phosphate|fludarabine phosphate|mesh-list
154034107|NCT02791919|Lenograstim|lenograstim|mesh-list
154034109|NCT02791919|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154034110|NCT02791919|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154034111|NCT02791919|Antimetabolites|antimetabolites|mesh-ancestor
154034112|NCT02791919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154034113|NCT02791919|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154034114|NCT02791919|Immunologic Factors|immunologic factors|mesh-ancestor
154034115|NCT02791919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154034116|NCT02791919|Antiviral Agents|antiviral agents|mesh-ancestor
154034117|NCT02791919|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154034118|NCT02791919|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154034119|NCT02791919|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154034121|NCT00961207|Renin Inhibitors|renin inhibitors|mesh-ancestor
154034122|NCT00961207|Protease Inhibitors|protease inhibitors|mesh-ancestor
154034123|NCT00961207|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154034124|NCT00961207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154034125|NCT00966121|Propranolol|propranolol|mesh-list
154034126|NCT00966121|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
154034127|NCT00966121|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154034128|NCT00966121|Adrenergic Agents|adrenergic agents|mesh-ancestor
154034129|NCT00966121|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154034130|NCT00966121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154034131|NCT00966121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154034132|NCT00966121|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154034159|NCT00659412|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154034161|NCT04158102|Bupivacaine|bupivacaine|mesh-list
154034162|NCT04158102|Anesthetics, Local|anesthetics, local|mesh-ancestor
154034163|NCT04158102|Anesthetics|anesthetics|mesh-ancestor
154034164|NCT04158102|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154034165|NCT04158102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154034166|NCT04158102|Sensory System Agents|sensory system agents|mesh-ancestor
154034167|NCT04158102|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154034168|NCT02689895|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
154034169|NCT02689895|Antiviral Agents|antiviral agents|mesh-ancestor
154034170|NCT02689895|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154034171|NCT00961363|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
154034172|NCT00961363|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154034173|NCT00961363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154034174|NCT00961363|Incretins|incretins|mesh-ancestor
154034175|NCT00961363|Hormones|hormones|mesh-ancestor
154034176|NCT00961363|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154034177|NCT00961363|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
154034178|NCT00961363|Protease Inhibitors|protease inhibitors|mesh-ancestor
154034179|NCT00961363|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154034180|NCT00961363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154034181|NCT02633202|Cisplatin|cisplatin|mesh-list
154034182|NCT02633202|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154034183|NCT00645242|Fluconazole|fluconazole|mesh-list
154034184|NCT00645242|Antifungal Agents|antifungal agents|mesh-ancestor
154034185|NCT00645242|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154034201|NCT00659568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154034202|NCT00659568|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154034203|NCT00659568|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154034204|NCT00659568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154034205|NCT00659568|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154034206|NCT00659568|Immunologic Factors|immunologic factors|mesh-ancestor
154034207|NCT00659568|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154034208|NCT00659568|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154034209|NCT00659568|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154034210|NCT00659568|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154034211|NCT00659568|Antifungal Agents|antifungal agents|mesh-ancestor
154034213|NCT00961753|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154034214|NCT00961753|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154034215|NCT00961753|Analgesics|analgesics|mesh-ancestor
154034216|NCT00961753|Sensory System Agents|sensory system agents|mesh-ancestor
154034217|NCT00961753|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154034218|NCT00961753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154034219|NCT00961753|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154034220|NCT00961753|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154034221|NCT00961753|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154034222|NCT00961753|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154034223|NCT00961753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154034224|NCT04232813|Estradiol|estradiol|mesh-list
154034225|NCT04232813|Estrogens|estrogens|mesh-ancestor
154034226|NCT04232813|Hormones|hormones|mesh-ancestor
154034227|NCT04232813|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154034228|NCT04232813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154034242|NCT00545779|Ibandronic Acid|ibandronic acid|mesh-list
154034243|NCT00545779|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154034244|NCT00545779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154034245|NCT00910442|Acetylcysteine|acetylcysteine|mesh-list
154034246|NCT00910442|N-monoacetylcystine|n-monoacetylcystine|mesh-list
154034247|NCT00910442|Antiviral Agents|antiviral agents|mesh-ancestor
154034248|NCT00910442|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154034249|NCT00910442|Expectorants|expectorants|mesh-ancestor
154034250|NCT00910442|Respiratory System Agents|respiratory system agents|mesh-ancestor
154034251|NCT00910442|Free Radical Scavengers|free radical scavengers|mesh-ancestor
154034252|NCT00910442|Antioxidants|antioxidants|mesh-ancestor
154034253|NCT00910442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154034254|NCT00910442|Protective Agents|protective agents|mesh-ancestor
154034255|NCT00910442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154034256|NCT00910442|Antidotes|antidotes|mesh-ancestor
154034257|NCT00660036|Etoposide|etoposide|mesh-list
154034258|NCT00660036|Mitoxantrone|mitoxantrone|mesh-list
154034259|NCT00660036|Gemtuzumab|gemtuzumab|mesh-list
154034260|NCT00660036|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154034261|NCT00660036|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154034262|NCT00660036|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154034263|NCT00660036|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154034264|NCT00660036|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154034265|NCT00660036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154034266|NCT00660036|Analgesics|analgesics|mesh-ancestor
154034267|NCT00660036|Sensory System Agents|sensory system agents|mesh-ancestor
154034268|NCT00660036|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154034269|NCT00660036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154034270|NCT00660036|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154034271|NCT00660036|Immunotoxins|immunotoxins|mesh-ancestor
154034272|NCT00660036|Immunoconjugates|immunoconjugates|mesh-ancestor
154034273|NCT00660036|Immunologic Factors|immunologic factors|mesh-ancestor
154034274|NCT02791373|Gemcitabine|gemcitabine|mesh-list
154034286|NCT03102047|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154034287|NCT00966745|Milrinone|milrinone|mesh-list
154034288|NCT00966745|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
154034289|NCT00966745|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154034290|NCT00966745|Vasodilator Agents|vasodilator agents|mesh-ancestor
154034291|NCT00966745|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
153919283|NCT04147013|Analgesics|analgesics|mesh-ancestor
154034292|NCT00966745|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154034293|NCT00966745|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154034294|NCT00966745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154034295|NCT00966745|Protective Agents|protective agents|mesh-ancestor
154034296|NCT00966745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154034297|NCT02669030|Suvorexant|suvorexant|mesh-list
154034298|NCT02669030|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
154034299|NCT02669030|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154034300|NCT02669030|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154034301|NCT02669030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154034302|NCT02669030|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
153576971|NCT01714856|Dopamine Agonists|dopamine agonists|mesh-ancestor
154034303|NCT02669030|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154034304|NCT02669030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154034305|NCT02668796|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
154034306|NCT02668796|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
154034307|NCT02668796|Estradiol|estradiol|mesh-list
154034308|NCT02668796|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
154034309|NCT02668796|Estrogens|estrogens|mesh-ancestor
154034310|NCT02668796|Hormones|hormones|mesh-ancestor
154034311|NCT02668796|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154034317|NCT00645320|Ziprasidone|ziprasidone|mesh-list
154034325|NCT00645320|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154034326|NCT00645320|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154034327|NCT00645320|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
154034328|NCT00645320|Dopamine Agents|dopamine agents|mesh-ancestor
154034329|NCT03938857|Fentanyl|fentanyl|mesh-list
154034330|NCT03938857|Dexmedetomidine|dexmedetomidine|mesh-list
154034331|NCT03938857|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154034332|NCT03938857|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154034333|NCT03938857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154034334|NCT03938857|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154034335|NCT03938857|Analgesics|analgesics|mesh-ancestor
154034336|NCT03938857|Sensory System Agents|sensory system agents|mesh-ancestor
154034337|NCT03938857|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154034338|NCT03938857|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154034339|NCT03938857|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154034340|NCT03938857|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154034341|NCT03938857|Adrenergic Agents|adrenergic agents|mesh-ancestor
154034342|NCT03938857|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154034343|NCT03938857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154034344|NCT03938857|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154034408|NCT04032132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154034409|NCT04032132|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154034410|NCT04032132|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154034411|NCT04032132|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154034412|NCT04032132|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154034413|NCT04032132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154034414|NCT00967057|Dexamethasone|dexamethasone|mesh-list
154034416|NCT00967057|Vincristine|vincristine|mesh-list
154034417|NCT00967057|Asparaginase|asparaginase|mesh-list
154034418|NCT00967057|Mitoxantrone|mitoxantrone|mesh-list
154034420|NCT00967057|Pegaspargase|pegaspargase|mesh-list
154034421|NCT00967057|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154034422|NCT00967057|Antiemetics|antiemetics|mesh-ancestor
154034423|NCT00967057|Autonomic Agents|autonomic agents|mesh-ancestor
154034424|NCT00967057|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154034425|NCT00967057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154034426|NCT00967057|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154034427|NCT00967057|Glucocorticoids|glucocorticoids|mesh-ancestor
154034428|NCT00967057|Hormones|hormones|mesh-ancestor
154034429|NCT00967057|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154034430|NCT00967057|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154034431|NCT00967057|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154034432|NCT00967057|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154034433|NCT00967057|Abortifacient Agents|abortifacient agents|mesh-ancestor
154034434|NCT00967057|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154034435|NCT00967057|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154034436|NCT00967057|Antimetabolites|antimetabolites|mesh-ancestor
154034437|NCT00967057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154034438|NCT00967057|Dermatologic Agents|dermatologic agents|mesh-ancestor
154034439|NCT00967057|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153812741|NCT00330239|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
154034475|NCT02790671|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154034476|NCT02790671|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154034477|NCT02790671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154034478|NCT02790671|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154034479|NCT02790671|Hormone Antagonists|hormone antagonists|mesh-ancestor
154034480|NCT02790671|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154034481|NCT02790671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154034482|NCT02790671|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154034483|NCT02790671|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154034484|NCT02668094|Lidocaine|lidocaine|mesh-list
154034485|NCT02668094|Pregabalin|pregabalin|mesh-list
154034486|NCT02668094|Propofol|propofol|mesh-list
154034487|NCT02668094|Anesthetics, Local|anesthetics, local|mesh-ancestor
154034488|NCT02668094|Anesthetics|anesthetics|mesh-ancestor
154034489|NCT02668094|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154034490|NCT02668094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154034491|NCT02668094|Sensory System Agents|sensory system agents|mesh-ancestor
154034492|NCT02668094|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154034493|NCT02668094|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154034494|NCT02668094|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154034495|NCT02668094|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154034496|NCT02668094|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154034497|NCT02668094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154034498|NCT02668094|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154034499|NCT02668094|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154034500|NCT02668094|Anesthetics, General|anesthetics, general|mesh-ancestor
154034501|NCT02668094|Analgesics|analgesics|mesh-ancestor
154034502|NCT02668094|Anticonvulsants|anticonvulsants|mesh-ancestor
154034503|NCT02668094|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154034504|NCT02668094|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154034505|NCT02668094|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154034506|NCT02668094|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154034507|NCT02668094|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154034509|NCT00967135|Analgesics|analgesics|mesh-ancestor
154034510|NCT00967135|Sensory System Agents|sensory system agents|mesh-ancestor
153573176|NCT02367794|Immunologic Factors|immunologic factors|mesh-ancestor
154034514|NCT00967135|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154034515|NCT00967135|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154034516|NCT00967135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154034517|NCT00967135|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154034518|NCT00967135|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154034519|NCT00967135|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154034520|NCT00967135|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154034521|NCT00967135|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154034522|NCT00967213|Ranibizumab|ranibizumab|mesh-list
154034523|NCT00967213|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154034524|NCT00967213|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154034525|NCT00967213|Growth Substances|growth substances|mesh-ancestor
154034526|NCT00967213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154034527|NCT00967213|Growth Inhibitors|growth inhibitors|mesh-ancestor
154034528|NCT00967213|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154034529|NCT04160676|Ascorbic Acid|ascorbic acid|mesh-list
154034530|NCT04160676|Thiamine|thiamine|mesh-list
154034531|NCT04160676|Hydrocortisone|hydrocortisone|mesh-list
154034532|NCT04160676|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154034533|NCT04160676|Antioxidants|antioxidants|mesh-ancestor
154034534|NCT04160676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154034535|NCT04160676|Protective Agents|protective agents|mesh-ancestor
154034536|NCT04160676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154034537|NCT04160676|Vitamins|vitamins|mesh-ancestor
154034538|NCT04160676|Micronutrients|micronutrients|mesh-ancestor
154034539|NCT04160676|Vitamin B Complex|vitamin b complex|mesh-ancestor
154034540|NCT00660426|Gemcitabine|gemcitabine|mesh-list
154034541|NCT00660426|Capecitabine|capecitabine|mesh-list
154034542|NCT00660426|Oxaliplatin|oxaliplatin|mesh-list
154034543|NCT00660426|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154034544|NCT00660426|Antimetabolites|antimetabolites|mesh-ancestor
154034545|NCT00660426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154034546|NCT00660426|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154034552|NCT00967291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154034553|NCT00967291|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154034554|NCT00967291|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154034555|NCT00967291|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154034556|NCT00967291|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154034558|NCT00645398|Analgesics|analgesics|mesh-ancestor
154034559|NCT00645398|Sensory System Agents|sensory system agents|mesh-ancestor
154034560|NCT00645398|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154034561|NCT00645398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154034562|NCT00645398|Anticonvulsants|anticonvulsants|mesh-ancestor
154034563|NCT00645398|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154034564|NCT00645398|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154034565|NCT00645398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154034566|NCT00645398|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154034567|NCT00645398|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154034568|NCT00645398|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154034569|NCT00645398|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154034570|NCT00645398|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154034571|NCT00884832|Clonidine|clonidine|mesh-list
154034572|NCT00884832|Analgesics|analgesics|mesh-ancestor
154034573|NCT00884832|Sensory System Agents|sensory system agents|mesh-ancestor
154034574|NCT00884832|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154034575|NCT00884832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154034576|NCT00884832|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154034577|NCT00884832|Sympatholytics|sympatholytics|mesh-ancestor
154034578|NCT00884832|Autonomic Agents|autonomic agents|mesh-ancestor
154034579|NCT00884832|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154034580|NCT00884832|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154034581|NCT00884832|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154034582|NCT00884832|Adrenergic Agents|adrenergic agents|mesh-ancestor
154034583|NCT00884832|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154034584|NCT00884832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154034592|NCT00660582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154034593|NCT00660582|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154034594|NCT00660582|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154034595|NCT00660582|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154034596|NCT00660582|Immunologic Factors|immunologic factors|mesh-ancestor
154034597|NCT00660582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154034598|NCT00660582|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154034599|NCT00660582|Antidotes|antidotes|mesh-ancestor
154034600|NCT00660582|Protective Agents|protective agents|mesh-ancestor
154034601|NCT00660582|Vitamin B Complex|vitamin b complex|mesh-ancestor
154034603|NCT00660582|Micronutrients|micronutrients|mesh-ancestor
154034604|NCT00660582|Hematinics|hematinics|mesh-ancestor
154034605|NCT00646802|Progesterone|progesterone|mesh-list
154034606|NCT00646802|Progestins|progestins|mesh-ancestor
154034607|NCT00646802|Hormones|hormones|mesh-ancestor
154034608|NCT00646802|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154034609|NCT00646802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154034610|NCT00968383|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-list
154034611|NCT00968383|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
154034612|NCT00968383|Adrenergic Agents|adrenergic agents|mesh-list
154034613|NCT00968383|Adrenergic Antagonists|adrenergic antagonists|mesh-list
154034614|NCT00968383|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
154034615|NCT00968383|Protease Inhibitors|protease inhibitors|mesh-ancestor
154034616|NCT00968383|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154034617|NCT00968383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154034618|NCT00968383|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154034619|NCT00968383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154034620|NCT00657228|Heparin|heparin|mesh-list
154034621|NCT00657228|Anticoagulants|anticoagulants|mesh-ancestor
154034634|NCT02666534|Sensory System Agents|sensory system agents|mesh-ancestor
154034635|NCT02666534|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154034636|NCT02666534|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154034637|NCT02666534|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154034638|NCT02666534|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154034639|NCT02666534|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154034640|NCT02666534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154034641|NCT02666534|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
154034642|NCT02666534|Dermatologic Agents|dermatologic agents|mesh-ancestor
154034643|NCT02666534|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
154034644|NCT02787473|Docetaxel|docetaxel|mesh-list
154034645|NCT02787473|Pemetrexed|pemetrexed|mesh-list
154034646|NCT02787473|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154034647|NCT02787473|Tubulin Modulators|tubulin modulators|mesh-ancestor
154034648|NCT02787473|Antimitotic Agents|antimitotic agents|mesh-ancestor
154034649|NCT02787473|Mitosis Modulators|mitosis modulators|mesh-ancestor
154034650|NCT02787473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154034651|NCT02787473|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154034652|NCT02787473|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154034653|NCT02787473|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154034654|NCT00657306|Hydrocortisone|hydrocortisone|mesh-list
154034655|NCT00657306|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154034656|NCT00967603|Sunitinib|sunitinib|mesh-list
154034657|NCT00967603|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154034658|NCT00967603|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154034659|NCT00967603|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154034660|NCT00967603|Growth Substances|growth substances|mesh-ancestor
154034661|NCT00967603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154034662|NCT00967603|Growth Inhibitors|growth inhibitors|mesh-ancestor
154034663|NCT00967603|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154034664|NCT00967603|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154034665|NCT00967603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154034666|NCT00657384|Tranexamic Acid|tranexamic acid|mesh-list
154034667|NCT00657384|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
154034668|NCT00657384|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154034669|NCT00657384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154034671|NCT00657384|Coagulants|coagulants|mesh-ancestor
154034672|NCT00973453|Immunomodulating Agents|immunomodulating agents|mesh-list
154034673|NCT00973453|Immunologic Factors|immunologic factors|mesh-list
154034674|NCT00973453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154034675|NCT00646880|Tolterodine Tartrate|tolterodine tartrate|mesh-list
154034676|NCT00646880|Propiverine|propiverine|mesh-list
154034677|NCT00646880|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
154034678|NCT00646880|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
153577346|NCT01717599|Diclofenac|diclofenac|mesh-list
154034679|NCT00646880|Cholinergic Agents|cholinergic agents|mesh-ancestor
154034680|NCT00646880|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154034681|NCT00646880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154034682|NCT00646880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154034683|NCT00646880|Urological Agents|urological agents|mesh-ancestor
154034684|NCT00646880|Parasympatholytics|parasympatholytics|mesh-ancestor
154034685|NCT00646880|Autonomic Agents|autonomic agents|mesh-ancestor
154034686|NCT00646880|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154034687|NCT00910598|Glatiramer Acetate|glatiramer acetate|mesh-list
154034688|NCT00910598|(T,G)-A-L|(t,g)-a-l|mesh-list
154034689|NCT00910598|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154034690|NCT00910598|Immunologic Factors|immunologic factors|mesh-ancestor
154034691|NCT00910598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154034692|NCT00910598|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154034693|NCT00910598|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154034694|NCT00968461|Phenethyl isothiocyanate|phenethyl isothiocyanate|mesh-list
154034695|NCT00968461|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154034696|NCT00968461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154034697|NCT00968461|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
154034698|NCT00968461|Protective Agents|protective agents|mesh-ancestor
154034699|NCT00968461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154034700|NCT00968461|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154034701|NCT04157010|Methotrexate|methotrexate|mesh-list
154034702|NCT04157010|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154034703|NCT04157010|Abortifacient Agents|abortifacient agents|mesh-ancestor
154034710|NCT04157010|Dermatologic Agents|dermatologic agents|mesh-ancestor
154034711|NCT04157010|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154034712|NCT04157010|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154034713|NCT04157010|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154034714|NCT04157010|Immunologic Factors|immunologic factors|mesh-ancestor
154034715|NCT04157010|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154034716|NCT04157010|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154034717|NCT02632032|Insulin|insulin|mesh-list
154034718|NCT02632032|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
154034719|NCT02632032|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154034720|NCT02632032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154034721|NCT00973609|Folic Acid|folic acid|mesh-list
154034722|NCT00973609|Vitamin B Complex|vitamin b complex|mesh-list
154034723|NCT00973609|Bevacizumab|bevacizumab|mesh-list
154034724|NCT00973609|Capecitabine|capecitabine|mesh-list
154034725|NCT00973609|Fluorouracil|fluorouracil|mesh-list
154034726|NCT00973609|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154034727|NCT00973609|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154034728|NCT00973609|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154034729|NCT00973609|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154034730|NCT00973609|Growth Substances|growth substances|mesh-ancestor
154034731|NCT00973609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154034732|NCT00973609|Growth Inhibitors|growth inhibitors|mesh-ancestor
154034733|NCT00973609|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154034734|NCT00973609|Antimetabolites|antimetabolites|mesh-ancestor
154034735|NCT00973609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154034736|NCT00973609|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154034737|NCT00973609|Immunologic Factors|immunologic factors|mesh-ancestor
154034784|NCT02785601|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154034785|NCT02785601|Serotonin Agents|serotonin agents|mesh-ancestor
154034786|NCT02785601|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
154034787|NCT02785601|Antidepressive Agents|antidepressive agents|mesh-ancestor
154034789|NCT05299567|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154034790|NCT05299567|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154034791|NCT00660894|Leucovorin|leucovorin|mesh-list
154034792|NCT00660894|Tegafur|tegafur|mesh-list
154034793|NCT00660894|Calcium|calcium|mesh-list
154034794|NCT00660894|Levoleucovorin|levoleucovorin|mesh-list
154034795|NCT00660894|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154034796|NCT00660894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154034797|NCT00660894|Antidotes|antidotes|mesh-ancestor
154034798|NCT00660894|Protective Agents|protective agents|mesh-ancestor
154034799|NCT00660894|Vitamin B Complex|vitamin b complex|mesh-ancestor
154034800|NCT00660894|Vitamins|vitamins|mesh-ancestor
154034801|NCT00660894|Micronutrients|micronutrients|mesh-ancestor
154034802|NCT00660894|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154034803|NCT00660894|Antimetabolites|antimetabolites|mesh-ancestor
154034804|NCT00660894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154034805|NCT00660894|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154034806|NCT00660972|Tenofovir|tenofovir|mesh-list
154034807|NCT00660972|Emtricitabine|emtricitabine|mesh-list
154034808|NCT00660972|Raltegravir Potassium|raltegravir potassium|mesh-list
154034809|NCT00660972|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
154034810|NCT00660972|Antiviral Agents|antiviral agents|mesh-ancestor
154034811|NCT00660972|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154034812|NCT00660972|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
154034813|NCT00660972|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153814830|NCT04715360|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154034817|NCT00660972|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154034818|NCT00660972|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
154034819|NCT00660972|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
154034820|NCT02667470|Solifenacin Succinate|solifenacin succinate|mesh-list
154034821|NCT02667470|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
154034822|NCT02667470|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154034823|NCT02667470|Cholinergic Agents|cholinergic agents|mesh-ancestor
154034824|NCT02667470|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154034825|NCT02667470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154034826|NCT02667470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154034827|NCT02667470|Urological Agents|urological agents|mesh-ancestor
154034828|NCT04157478|Temozolomide|temozolomide|mesh-list
154034829|NCT04157478|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154034830|NCT04157478|Alkylating Agents|alkylating agents|mesh-ancestor
154034831|NCT04157478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154034832|NCT04157478|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154034834|NCT00647192|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
154034835|NCT00647192|Hormone Antagonists|hormone antagonists|mesh-ancestor
154034836|NCT00647192|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154034837|NCT00647192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154034838|NCT00647192|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
154034839|NCT00647192|Diuretics|diuretics|mesh-ancestor
154034840|NCT00647192|Natriuretic Agents|natriuretic agents|mesh-ancestor
154034841|NCT00647192|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154034842|NCT00661206|Clopidogrel|clopidogrel|mesh-list
154034843|NCT00661206|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154034844|NCT00661206|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
154034845|NCT00661206|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
154034846|NCT00661206|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
154034847|NCT00661206|Purinergic Agents|purinergic agents|mesh-ancestor
154034848|NCT00661206|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154034868|NCT00645632|Doxorubicin|doxorubicin|mesh-list
154034869|NCT00645632|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
154034870|NCT00645632|Methotrexate|methotrexate|mesh-list
154034871|NCT00645632|Ifosfamide|ifosfamide|mesh-list
154034872|NCT00645632|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154034873|NCT00645632|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154034874|NCT00645632|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154034875|NCT00645632|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154034886|NCT00645632|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154034887|NCT00645632|Immunologic Factors|immunologic factors|mesh-ancestor
154034888|NCT00645632|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154034889|NCT00645632|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154034890|NCT00645632|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154034891|NCT00645632|Alkylating Agents|alkylating agents|mesh-ancestor
154034892|NCT04156464|Lorazepam|lorazepam|mesh-list
154034893|NCT04156464|Phenobarbital|phenobarbital|mesh-list
154034894|NCT04156464|Anticonvulsants|anticonvulsants|mesh-ancestor
154034895|NCT04156464|Antiemetics|antiemetics|mesh-ancestor
154034896|NCT04156464|Autonomic Agents|autonomic agents|mesh-ancestor
154034897|NCT04156464|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154034898|NCT04156464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154034899|NCT04156464|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154034900|NCT04156464|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154034901|NCT04156464|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154034902|NCT04156464|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153577642|NCT01718899|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154034903|NCT04156464|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154034904|NCT04156464|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154034905|NCT04156464|GABA Modulators|gaba modulators|mesh-ancestor
154034906|NCT04156464|GABA Agents|gaba agents|mesh-ancestor
154034907|NCT04156464|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154034931|NCT00968929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154034932|NCT00661596|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
154034933|NCT00661596|Vasodilator Agents|vasodilator agents|mesh-ancestor
154034934|NCT00661596|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
154034935|NCT00661596|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154034936|NCT00661596|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154034937|NCT00661596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154034938|NCT00661596|Urological Agents|urological agents|mesh-ancestor
154034940|NCT00969085|Turmeric extract|turmeric extract|mesh-list
154034941|NCT00969085|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154034942|NCT00969085|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154034943|NCT00969085|Analgesics|analgesics|mesh-ancestor
154034944|NCT00969085|Sensory System Agents|sensory system agents|mesh-ancestor
154034945|NCT00969085|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154034946|NCT00969085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154034947|NCT00969085|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154034948|NCT00969085|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154034949|NCT00969085|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154034950|NCT00969085|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154034951|NCT00969085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154034952|NCT00969085|Antioxidants|antioxidants|mesh-ancestor
154034953|NCT00969085|Protective Agents|protective agents|mesh-ancestor
154034954|NCT00974155|Dexetimide|dexetimide|mesh-list
154034955|NCT00974155|Citalopram|citalopram|mesh-list
154034956|NCT00974155|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
154034957|NCT00974155|Escitalopram|escitalopram|mesh-list
154034958|NCT00974155|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
154034959|NCT00974155|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154034960|NCT00974155|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154034961|NCT00974155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154034972|NCT00974155|Cholinergic Agents|cholinergic agents|mesh-ancestor
154034973|NCT00974155|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
154034974|NCT00974155|Antidepressive Agents|antidepressive agents|mesh-ancestor
154034975|NCT00974155|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154034976|NCT00974155|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
154034977|NCT00879996|Buprenorphine|buprenorphine|mesh-list
154034978|NCT00879996|Methadone|methadone|mesh-list
154034979|NCT00879996|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
154034980|NCT00879996|Naloxone|naloxone|mesh-list
154034981|NCT00879996|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154034982|NCT00879996|Narcotics|narcotics|mesh-ancestor
154034983|NCT00879996|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154034984|NCT00879996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154034985|NCT00879996|Analgesics|analgesics|mesh-ancestor
154034986|NCT00879996|Sensory System Agents|sensory system agents|mesh-ancestor
154034987|NCT00879996|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154034988|NCT00879996|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
154034989|NCT00879996|Antitussive Agents|antitussive agents|mesh-ancestor
154034990|NCT00879996|Respiratory System Agents|respiratory system agents|mesh-ancestor
154034991|NCT00969163|Testosterone|testosterone|mesh-list
154034992|NCT00969163|Androgens|androgens|mesh-ancestor
154034993|NCT00969163|Hormones|hormones|mesh-ancestor
154034994|NCT00969163|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154034995|NCT00969163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154034996|NCT00873093|Leucovorin|leucovorin|mesh-list
154034997|NCT00873093|Cytarabine|cytarabine|mesh-list
154034998|NCT00873093|Prednisone|prednisone|mesh-list
154034999|NCT00873093|Hydrocortisone|hydrocortisone|mesh-list
154035000|NCT00873093|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
154035001|NCT00873093|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
154035020|NCT00873093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154035021|NCT00873093|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154035022|NCT00873093|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154035023|NCT00873093|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154035024|NCT00873093|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154035025|NCT00873093|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154035026|NCT00873093|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154035027|NCT00873093|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154035028|NCT00873093|Glucocorticoids|glucocorticoids|mesh-ancestor
154035029|NCT00873093|Hormones|hormones|mesh-ancestor
154035030|NCT00873093|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154035031|NCT00873093|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154035032|NCT00873093|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154035033|NCT00873093|Abortifacient Agents|abortifacient agents|mesh-ancestor
154035034|NCT00873093|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154035035|NCT00873093|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154035036|NCT00873093|Antimetabolites|antimetabolites|mesh-ancestor
154035037|NCT00873093|Dermatologic Agents|dermatologic agents|mesh-ancestor
154035038|NCT00873093|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154035039|NCT00873093|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154035040|NCT00873093|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154035041|NCT00873093|Antiviral Agents|antiviral agents|mesh-ancestor
154035042|NCT00873093|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154035043|NCT00873093|Antidotes|antidotes|mesh-ancestor
154035044|NCT00873093|Protective Agents|protective agents|mesh-ancestor
154035045|NCT00873093|Vitamin B Complex|vitamin b complex|mesh-ancestor
154035046|NCT00873093|Vitamins|vitamins|mesh-ancestor
154035064|NCT00974389|Growth Inhibitors|growth inhibitors|mesh-ancestor
154035065|NCT00974389|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154035066|NCT00974389|Antimetabolites|antimetabolites|mesh-ancestor
154035067|NCT00974389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154035068|NCT00969397|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-list
154035069|NCT00969397|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154035070|NCT00969397|Growth Substances|growth substances|mesh-ancestor
154035071|NCT00969397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154035072|NCT00969397|Growth Inhibitors|growth inhibitors|mesh-ancestor
154035073|NCT00969397|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154035074|NCT02783885|Immunomodulating Agents|immunomodulating agents|mesh-list
154035075|NCT02783885|Immunologic Factors|immunologic factors|mesh-ancestor
154035076|NCT02783885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154035078|NCT00647660|Bendroflumethiazide|bendroflumethiazide|mesh-list
154035079|NCT00647660|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
154035080|NCT00647660|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154035081|NCT00647660|Adrenergic Agents|adrenergic agents|mesh-ancestor
154035082|NCT00647660|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154035083|NCT00647660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154035084|NCT00647660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154035111|NCT00647738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154035112|NCT04008511|Capecitabine|capecitabine|mesh-list
154035113|NCT04008511|Oxaliplatin|oxaliplatin|mesh-list
154035114|NCT04008511|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154035115|NCT04008511|Antimetabolites|antimetabolites|mesh-ancestor
154035116|NCT04008511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154035117|NCT04008511|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154035118|NCT00979537|Nisoldipine|nisoldipine|mesh-list
154035119|NCT00979537|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154035120|NCT00979537|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154035121|NCT00979537|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154035122|NCT00979537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154035123|NCT00979537|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154035124|NCT00979537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154035125|NCT00979537|Vasodilator Agents|vasodilator agents|mesh-ancestor
154035126|NCT00692055|Naproxen|naproxen|mesh-list
153577792|NCT01719835|Methylprednisolone|methylprednisolone|mesh-list
154035127|NCT00692055|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154035129|NCT00692055|Analgesics|analgesics|mesh-ancestor
154035130|NCT00692055|Sensory System Agents|sensory system agents|mesh-ancestor
154035131|NCT00692055|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154035132|NCT00692055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154035133|NCT00692055|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154035134|NCT00692055|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154035135|NCT00692055|Gout Suppressants|gout suppressants|mesh-ancestor
154035136|NCT00692055|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154035137|NCT00692055|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154035138|NCT00692055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154035139|NCT04033250|Bisacodyl|bisacodyl|mesh-list
154035140|NCT04033250|Picosulfate sodium|picosulfate sodium|mesh-list
154035141|NCT04033250|Magnesium Oxide|magnesium oxide|mesh-list
154035142|NCT04033250|Sodium Citrate|sodium citrate|mesh-list
154035152|NCT04033250|Antacids|antacids|mesh-ancestor
154035153|NCT02624973|Tamoxifen|tamoxifen|mesh-list
154035154|NCT02624973|Cyclophosphamide|cyclophosphamide|mesh-list
154035155|NCT02624973|Docetaxel|docetaxel|mesh-list
154035156|NCT02624973|Trastuzumab|trastuzumab|mesh-list
154035157|NCT02624973|Letrozole|letrozole|mesh-list
154035158|NCT02624973|Epirubicin|epirubicin|mesh-list
154035159|NCT02624973|Olaparib|olaparib|mesh-list
154035160|NCT02624973|Palbociclib|palbociclib|mesh-list
154035161|NCT02624973|Pertuzumab|pertuzumab|mesh-list
154035162|NCT02624973|Goserelin|goserelin|mesh-list
154035163|NCT02624973|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154035164|NCT02624973|Immunologic Factors|immunologic factors|mesh-ancestor
154035165|NCT02624973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154035166|NCT02624973|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154035167|NCT02624973|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154035168|NCT02624973|Alkylating Agents|alkylating agents|mesh-ancestor
154035169|NCT02624973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154035170|NCT02624973|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154035171|NCT02624973|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154035172|NCT02624973|Tubulin Modulators|tubulin modulators|mesh-ancestor
154035173|NCT02624973|Antimitotic Agents|antimitotic agents|mesh-ancestor
154035174|NCT02624973|Mitosis Modulators|mitosis modulators|mesh-ancestor
154035175|NCT02624973|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154035176|NCT02624973|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
154035177|NCT02624973|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154035178|NCT02624973|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154035203|NCT00647894|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154035204|NCT00647894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154035205|NCT00647894|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154035206|NCT00647894|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154035207|NCT00647894|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154035208|NCT00647894|GABA Modulators|gaba modulators|mesh-ancestor
154035209|NCT00647894|GABA Agents|gaba agents|mesh-ancestor
154035210|NCT00647894|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154035211|NCT00647894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154035212|NCT02782559|Sildenafil Citrate|sildenafil citrate|mesh-list
154035213|NCT02782559|Vasodilator Agents|vasodilator agents|mesh-ancestor
154035214|NCT02782559|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
154035215|NCT02782559|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154035216|NCT02782559|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154035217|NCT02782559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154035218|NCT02782559|Urological Agents|urological agents|mesh-ancestor
154035219|NCT00647972|Olanzapine|olanzapine|mesh-list
154035220|NCT00647972|Antiemetics|antiemetics|mesh-ancestor
154035221|NCT00647972|Autonomic Agents|autonomic agents|mesh-ancestor
154035222|NCT00647972|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154035223|NCT00647972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154035224|NCT00647972|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154035225|NCT00647972|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154035226|NCT00647972|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154035227|NCT00647972|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154035228|NCT00647972|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154035229|NCT00647972|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
154035230|NCT00647972|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154035231|NCT00647972|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154035232|NCT00647972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154035233|NCT00647972|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154035235|NCT02782403|Axitinib|axitinib|mesh-list
154035236|NCT02782403|Bosutinib|bosutinib|mesh-list
154035237|NCT02782403|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154035243|NCT00646178|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
154035244|NCT00646178|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154035245|NCT00646178|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154035246|NCT02624817|Glyburide|glyburide|mesh-list
154035247|NCT02624817|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154035248|NCT02624817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154035249|NCT02664116|Diclofenac|diclofenac|mesh-list
154035250|NCT02664116|Ketorolac|ketorolac|mesh-list
154035251|NCT02664116|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
154035252|NCT02664116|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154035253|NCT02664116|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154035254|NCT02664116|Analgesics|analgesics|mesh-ancestor
154035255|NCT02664116|Sensory System Agents|sensory system agents|mesh-ancestor
154035256|NCT02664116|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154035257|NCT02664116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154035258|NCT02664116|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154035259|NCT02664116|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154035260|NCT02664116|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154035261|NCT02664116|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154035262|NCT02664116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154035263|NCT00692601|Capsaicin|capsaicin|mesh-list
154035264|NCT00692601|Antipruritics|antipruritics|mesh-ancestor
154035265|NCT00692601|Dermatologic Agents|dermatologic agents|mesh-ancestor
154035266|NCT00692601|Sensory System Agents|sensory system agents|mesh-ancestor
154035267|NCT00692601|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154035268|NCT00692601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154035307|NCT02624505|Adrenergic Agents|adrenergic agents|mesh-ancestor
154035324|NCT00648128|Clarithromycin|clarithromycin|mesh-list
154035325|NCT00648128|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154035326|NCT00648128|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154035327|NCT00648128|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
154035328|NCT00648128|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154035329|NCT00648128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154035330|NCT00648128|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154035331|NCT00648128|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154035332|NCT02784821|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
154035333|NCT02784821|Gentamicins|gentamicins|mesh-list
154035334|NCT02784821|Ampicillin|ampicillin|mesh-list
154035335|NCT02784821|Cefotaxime|cefotaxime|mesh-list
154035336|NCT02784821|Cefoxitin|cefoxitin|mesh-list
154035337|NCT02784821|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
154035338|NCT02784821|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154035339|NCT02784821|Antitubercular Agents|antitubercular agents|mesh-ancestor
154035340|NCT02784821|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
154035341|NCT02784821|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154035342|NCT02784821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154035343|NCT00693069|Clopidogrel|clopidogrel|mesh-list
154035344|NCT00693069|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154035345|NCT00693069|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
154035346|NCT00693069|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
154035347|NCT00693069|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
154035348|NCT00693069|Purinergic Agents|purinergic agents|mesh-ancestor
154035349|NCT00693069|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154035350|NCT00693069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154035351|NCT00693069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154035352|NCT04949282|Lutetium Lu 177 dotatate|lutetium lu 177 dotatate|mesh-list
154035353|NCT04949282|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
154035354|NCT04949282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154035357|NCT00974935|Immunologic Factors|immunologic factors|mesh-ancestor
154035358|NCT00974935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154035359|NCT00974935|Antacids|antacids|mesh-ancestor
154035360|NCT00974935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154035361|NCT00974935|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154035362|NCT00665808|Insulin|insulin|mesh-list
154035363|NCT00665808|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
154035364|NCT00665808|Insulin Detemir|insulin detemir|mesh-list
154035365|NCT00665808|Isophane Insulin, Human|isophane insulin, human|mesh-list
154035366|NCT00665808|Insulin, Isophane|insulin, isophane|mesh-list
154035367|NCT00665808|Isophane insulin, beef|isophane insulin, beef|mesh-list
154035368|NCT00665808|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154035369|NCT00665808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154035370|NCT04230083|Dienogest|dienogest|mesh-list
154035371|NCT04230083|Nandrolone|nandrolone|mesh-list
154035372|NCT04230083|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
154035373|NCT04230083|Contraceptive Agents|contraceptive agents|mesh-ancestor
154035374|NCT04230083|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154035375|NCT04230083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154035376|NCT04230083|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
154035413|NCT05221151|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154035414|NCT05221151|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154035415|NCT05221151|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154035416|NCT05221151|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154035417|NCT05221151|Antioxidants|antioxidants|mesh-ancestor
154035418|NCT05221151|Protective Agents|protective agents|mesh-ancestor
154035419|NCT05221151|Antiemetics|antiemetics|mesh-ancestor
154035420|NCT05221151|Autonomic Agents|autonomic agents|mesh-ancestor
154035421|NCT05221151|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154035422|NCT05221151|Antipruritics|antipruritics|mesh-ancestor
154035423|NCT05221151|Dermatologic Agents|dermatologic agents|mesh-ancestor
154035424|NCT05221151|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
154035425|NCT05221151|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154035426|NCT05221151|Serotonin Agents|serotonin agents|mesh-ancestor
153578100|NCT01726400|Interferons|interferons|mesh-list
154035427|NCT05221151|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154035428|NCT04008043|Acetaminophen|acetaminophen|mesh-list
154035429|NCT04008043|Dexamethasone|dexamethasone|mesh-list
154035430|NCT04008043|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
154035431|NCT04008043|Hydrocodone|hydrocodone|mesh-list
154035432|NCT04008043|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154035433|NCT04008043|Antiemetics|antiemetics|mesh-ancestor
154035434|NCT04008043|Autonomic Agents|autonomic agents|mesh-ancestor
154035435|NCT04008043|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154035436|NCT04008043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154035437|NCT04008043|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154035438|NCT04008043|Glucocorticoids|glucocorticoids|mesh-ancestor
154035440|NCT04008043|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154035441|NCT04008043|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154035442|NCT04008043|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154035443|NCT04008043|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154035444|NCT04008043|Analgesics|analgesics|mesh-ancestor
154035445|NCT04008043|Sensory System Agents|sensory system agents|mesh-ancestor
154035446|NCT04008043|Antipyretics|antipyretics|mesh-ancestor
154035447|NCT04008043|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154035448|NCT04008043|Narcotics|narcotics|mesh-ancestor
154035455|NCT02783183|Analgesics|analgesics|mesh-ancestor
154035456|NCT02783183|Sensory System Agents|sensory system agents|mesh-ancestor
154035457|NCT02783183|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154035458|NCT02783183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154035459|NCT02783183|Anticonvulsants|anticonvulsants|mesh-ancestor
154035460|NCT02783183|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154035461|NCT02783183|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154035462|NCT02783183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154035463|NCT02783183|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154035464|NCT02783183|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154035465|NCT02783183|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154035466|NCT02783183|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154035467|NCT02783183|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154035468|NCT00693381|Mycophenolic Acid|mycophenolic acid|mesh-list
154035469|NCT00693381|Prednisone|prednisone|mesh-list
154035470|NCT00693381|Methylprednisolone|methylprednisolone|mesh-list
154035471|NCT00693381|Tacrolimus|tacrolimus|mesh-list
154035472|NCT00693381|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154035473|NCT00693381|Glucocorticoids|glucocorticoids|mesh-ancestor
154035474|NCT00693381|Hormones|hormones|mesh-ancestor
154035489|NCT00693381|Antiemetics|antiemetics|mesh-ancestor
154035507|NCT00693771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154035508|NCT00693849|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
154035510|NCT00693849|Escitalopram|escitalopram|mesh-list
154035511|NCT00693849|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
154035512|NCT00693849|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154035513|NCT00693849|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154035514|NCT00693849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154035515|NCT00693849|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154035516|NCT00693849|Serotonin Agents|serotonin agents|mesh-ancestor
154035517|NCT00693849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154035518|NCT00693849|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
154035519|NCT00693849|Antidepressive Agents|antidepressive agents|mesh-ancestor
154035520|NCT00693849|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154035521|NCT00693849|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
154035522|NCT00693927|Fludarabine|fludarabine|mesh-list
154035523|NCT00693927|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154035524|NCT00648362|Glimepiride|glimepiride|mesh-list
154035525|NCT00648362|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154035526|NCT00648362|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154035527|NCT00648362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154035528|NCT00648362|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154035529|NCT00648362|Immunologic Factors|immunologic factors|mesh-ancestor
154035531|NCT00648440|Sympathomimetics|sympathomimetics|mesh-ancestor
154035532|NCT00648440|Autonomic Agents|autonomic agents|mesh-ancestor
154035533|NCT00648440|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154035534|NCT00648440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154035535|NCT00648440|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154035536|NCT00648440|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
154035537|NCT00648440|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154035538|NCT00648440|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154035539|NCT00648440|Adrenergic Agents|adrenergic agents|mesh-ancestor
154035540|NCT00648440|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154035550|NCT00694005|Tubulin Modulators|tubulin modulators|mesh-ancestor
154035551|NCT00694005|Antimitotic Agents|antimitotic agents|mesh-ancestor
154035552|NCT00694005|Mitosis Modulators|mitosis modulators|mesh-ancestor
154035553|NCT00694005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154035554|NCT00694005|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154035555|NCT00694005|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154035556|NCT00694005|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154035557|NCT00694005|Immunologic Factors|immunologic factors|mesh-ancestor
154035558|NCT00694005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154035559|NCT00694005|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154035560|NCT00694005|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154035561|NCT00694005|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154035562|NCT00694005|Antifungal Agents|antifungal agents|mesh-ancestor
154035564|NCT00975325|Mydriatics|mydriatics|mesh-ancestor
154035565|NCT00975325|Autonomic Agents|autonomic agents|mesh-ancestor
154035566|NCT00975325|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154035567|NCT00975325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154035568|NCT00975325|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
154035569|NCT00975325|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
154035570|NCT00975325|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154035571|NCT00975325|Adrenergic Agents|adrenergic agents|mesh-ancestor
154035572|NCT00975325|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154035573|NCT00975325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154035574|NCT00975325|Urological Agents|urological agents|mesh-ancestor
154035575|NCT00910676|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
153578254|NCT01731340|Calcium|calcium|mesh-list
154035576|NCT00910676|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154035577|NCT00648518|Metformin|metformin|mesh-list
154035578|NCT00648518|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154035579|NCT00648518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154035580|NCT00648596|Sildenafil Citrate|sildenafil citrate|mesh-list
154035581|NCT00648596|Vasodilator Agents|vasodilator agents|mesh-ancestor
154035582|NCT00648596|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
153577502|NCT01718314|Misoprostol|misoprostol|mesh-list
154035584|NCT00648596|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154035585|NCT00648596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154035586|NCT00648596|Urological Agents|urological agents|mesh-ancestor
154035587|NCT03921151|Mirtazapine|mirtazapine|mesh-list
154035588|NCT03921151|Antidepressive Agents|antidepressive agents|mesh-ancestor
154035589|NCT03921151|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154035590|NCT03921151|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
154035591|NCT03921151|Histamine Antagonists|histamine antagonists|mesh-ancestor
154035592|NCT03921151|Histamine Agents|histamine agents|mesh-ancestor
154035593|NCT03921151|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154035594|NCT03921151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154035595|NCT03921151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154035596|NCT03921151|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154035597|NCT03921151|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154035598|NCT03921151|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154035599|NCT03921151|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
154035600|NCT03921151|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
154035601|NCT03921151|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154035602|NCT03921151|Adrenergic Agents|adrenergic agents|mesh-ancestor
154035603|NCT03921151|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
154035604|NCT03921151|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154035605|NCT03921151|Serotonin Agents|serotonin agents|mesh-ancestor
154035606|NCT03921151|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
154035634|NCT04229459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154035635|NCT00980239|Bevacizumab|bevacizumab|mesh-list
154035636|NCT00980239|Cetuximab|cetuximab|mesh-list
154035637|NCT00980239|Oxaliplatin|oxaliplatin|mesh-list
154035638|NCT00980239|Irinotecan|irinotecan|mesh-list
154035639|NCT00980239|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154035640|NCT00980239|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154035641|NCT00980239|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154035642|NCT00980239|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154035643|NCT00980239|Growth Substances|growth substances|mesh-ancestor
154035644|NCT00980239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154035645|NCT00980239|Growth Inhibitors|growth inhibitors|mesh-ancestor
154035646|NCT00980239|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
154035647|NCT00980239|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154035648|NCT00980239|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153578325|NCT01731756|Sensory System Agents|sensory system agents|mesh-ancestor
154035649|NCT00980239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154035650|NCT02665832|Amlodipine|amlodipine|mesh-list
154035651|NCT02665832|Olmesartan|olmesartan|mesh-list
154035652|NCT02665832|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
154035653|NCT02665832|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154035654|NCT02665832|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154035655|NCT02665832|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154035656|NCT02665832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154035657|NCT02665832|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154035658|NCT02665832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154035659|NCT02665832|Vasodilator Agents|vasodilator agents|mesh-ancestor
154035660|NCT02665832|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154035661|NCT02665832|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154035662|NCT02665832|Antimetabolites|antimetabolites|mesh-ancestor
154035663|NCT02665832|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154035675|NCT02781467|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154035676|NCT02781467|Alkylating Agents|alkylating agents|mesh-ancestor
154035677|NCT02781467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154035678|NCT02781467|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154035679|NCT02781467|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154035680|NCT02781467|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154035682|NCT02781467|Sensory System Agents|sensory system agents|mesh-ancestor
154035683|NCT02781467|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154035684|NCT00648830|Clarithromycin|clarithromycin|mesh-list
154035685|NCT00648830|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154035686|NCT00648830|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154035687|NCT00648830|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
154035688|NCT00648830|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154035689|NCT00648830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154035690|NCT00648830|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154035691|NCT00648830|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154035692|NCT00970567|Insulin|insulin|mesh-list
154035693|NCT00970567|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154035694|NCT00970567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154035695|NCT02663570|Melatonin|melatonin|mesh-list
154035696|NCT02663570|Antioxidants|antioxidants|mesh-ancestor
154035697|NCT02663570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154035698|NCT02663570|Protective Agents|protective agents|mesh-ancestor
154035699|NCT02663570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154035700|NCT02663570|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154035701|NCT00980473|Timolol|timolol|mesh-list
154035702|NCT00980473|Travoprost|travoprost|mesh-list
154035703|NCT00980473|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
154035711|NCT02784743|Ivermectin|ivermectin|mesh-list
154035718|NCT02784743|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154035719|NCT02784743|Tubulin Modulators|tubulin modulators|mesh-ancestor
154035720|NCT02784743|Antimitotic Agents|antimitotic agents|mesh-ancestor
154035721|NCT02784743|Mitosis Modulators|mitosis modulators|mesh-ancestor
154035722|NCT02784743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154035723|NCT02784743|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154035724|NCT00980551|Carboplatin|carboplatin|mesh-list
154035725|NCT00980551|Vincristine|vincristine|mesh-list
154035726|NCT00980551|Topotecan|topotecan|mesh-list
154035727|NCT00980551|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154035728|NCT00980551|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154035729|NCT00980551|Tubulin Modulators|tubulin modulators|mesh-ancestor
154035730|NCT00980551|Antimitotic Agents|antimitotic agents|mesh-ancestor
154035731|NCT00980551|Mitosis Modulators|mitosis modulators|mesh-ancestor
154035732|NCT00980551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154035733|NCT00980551|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
154035734|NCT00980551|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154035735|NCT00980551|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154035736|NCT02660060|Pramipexole|pramipexole|mesh-list
154035737|NCT02660060|Dexpramipexole|dexpramipexole|mesh-list
154035738|NCT02660060|Antioxidants|antioxidants|mesh-ancestor
154035739|NCT02660060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154035740|NCT02660060|Protective Agents|protective agents|mesh-ancestor
154035741|NCT02660060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154035742|NCT02660060|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
154035743|NCT02660060|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
154035744|NCT02660060|Dopamine Agonists|dopamine agonists|mesh-ancestor
154035745|NCT02660060|Dopamine Agents|dopamine agents|mesh-ancestor
154035746|NCT02660060|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153814842|NCT00447369|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154035752|NCT04008979|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154035753|NCT04008979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154035754|NCT04008979|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154035755|NCT04008979|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154035756|NCT04008979|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154035757|NCT04008979|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154035758|NCT04008979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154035759|NCT04008979|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154035760|NCT04008979|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154035761|NCT04008979|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154035762|NCT04008979|Antipyretics|antipyretics|mesh-ancestor
154035764|NCT05263583|Anticonvulsants|anticonvulsants|mesh-ancestor
154035765|NCT00970879|Mefloquine|mefloquine|mesh-list
154035766|NCT00970879|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
154035767|NCT00970879|Antimalarials|antimalarials|mesh-ancestor
154035768|NCT00970879|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154035769|NCT00970879|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154035770|NCT00970879|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154035771|NCT00970879|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
154035772|NCT00970879|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154035773|NCT05340803|Magnesium Sulfate|magnesium sulfate|mesh-list
154035774|NCT05340803|Midazolam|midazolam|mesh-list
154035775|NCT05340803|Dexmedetomidine|dexmedetomidine|mesh-list
154035776|NCT05340803|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154035777|NCT05340803|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154035780|NCT05340803|Analgesics|analgesics|mesh-ancestor
154035799|NCT05340803|Anticonvulsants|anticonvulsants|mesh-ancestor
154035800|NCT05340803|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154035801|NCT05340803|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154035802|NCT05340803|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154035803|NCT05340803|Tocolytic Agents|tocolytic agents|mesh-ancestor
154035804|NCT05340803|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154035805|NCT02663258|Pembrolizumab|pembrolizumab|mesh-list
154035806|NCT02663258|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154035807|NCT02663258|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154035808|NCT02663258|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154035809|NCT02663258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154035810|NCT04033172|Fulvestrant|fulvestrant|mesh-list
154035811|NCT04033172|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154035812|NCT04033172|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154035813|NCT04033172|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
154035814|NCT04033172|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
154035815|NCT04033172|Hormone Antagonists|hormone antagonists|mesh-ancestor
154035816|NCT04033172|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154035817|NCT04033172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154035818|NCT00980707|Fluticasone|fluticasone|mesh-list
154035819|NCT00980707|Xhance|xhance|mesh-list
154035820|NCT00980707|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154035847|NCT00970957|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154035848|NCT00970957|Growth Substances|growth substances|mesh-ancestor
154035849|NCT00970957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154035850|NCT00970957|Growth Inhibitors|growth inhibitors|mesh-ancestor
154035851|NCT00976105|Zolpidem|zolpidem|mesh-list
154035852|NCT00976105|Hypnotics and Sedatives|hypnotics and sedatives|mesh-list
154035853|NCT00976105|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
154035854|NCT00976105|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154035855|NCT00976105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154035856|NCT00976105|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
154035857|NCT00976105|GABA Agonists|gaba agonists|mesh-ancestor
154035858|NCT00976105|GABA Agents|gaba agents|mesh-ancestor
154035859|NCT00976105|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154035860|NCT00976105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154035861|NCT00976261|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
154035862|NCT00976261|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154035863|NCT00976261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154035864|NCT00976261|Incretins|incretins|mesh-ancestor
154035865|NCT00976261|Hormones|hormones|mesh-ancestor
154035868|NCT00976261|Protease Inhibitors|protease inhibitors|mesh-ancestor
153360223|NCT00802100|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
154035901|NCT02662322|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154035902|NCT02662322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154035903|NCT00971659|Insulin|insulin|mesh-list
154035904|NCT00971659|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
154035905|NCT00971659|Metformin|metformin|mesh-list
154035906|NCT00971659|Insulin Glargine|insulin glargine|mesh-list
154035907|NCT00971659|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
154035908|NCT00971659|Exenatide|exenatide|mesh-list
154035909|NCT00971659|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154035910|NCT00971659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154035911|NCT00971659|Incretins|incretins|mesh-ancestor
154035912|NCT00971659|Hormones|hormones|mesh-ancestor
154035913|NCT00971659|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154035914|NCT00971659|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
154035915|NCT00971659|Protease Inhibitors|protease inhibitors|mesh-ancestor
154035916|NCT00971659|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154035917|NCT00971659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154035918|NCT00971659|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
154035919|NCT00971659|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
154035920|NCT00648986|Tazarotene|tazarotene|mesh-list
154035921|NCT00648986|Dermatologic Agents|dermatologic agents|mesh-ancestor
154035922|NCT00648986|Keratolytic Agents|keratolytic agents|mesh-ancestor
154035923|NCT00971815|Dexetimide|dexetimide|mesh-list
154035924|NCT00971815|Citalopram|citalopram|mesh-list
154035925|NCT00971815|Escitalopram|escitalopram|mesh-list
154035926|NCT00971815|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
154035927|NCT00971815|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154035928|NCT00971815|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154035929|NCT00971815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154035930|NCT00971815|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154035931|NCT00971815|Serotonin Agents|serotonin agents|mesh-ancestor
154035942|NCT00971815|Antidepressive Agents|antidepressive agents|mesh-ancestor
154035943|NCT00971815|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154035945|NCT00981487|Antiemetics|antiemetics|mesh-ancestor
153578626|NCT01734044|Glucocorticoids|glucocorticoids|mesh-ancestor
154035946|NCT00981487|Autonomic Agents|autonomic agents|mesh-ancestor
154035947|NCT00981487|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154035948|NCT00981487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154035949|NCT00981487|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154035950|NCT00981487|Antipruritics|antipruritics|mesh-ancestor
154035951|NCT00981487|Dermatologic Agents|dermatologic agents|mesh-ancestor
154035952|NCT00981487|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
154035953|NCT00981487|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154035954|NCT00981487|Serotonin Agents|serotonin agents|mesh-ancestor
154035955|NCT00981487|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154035956|NCT00981487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154035957|NCT00646568|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
154035958|NCT00646568|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154035959|NCT00646568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154035960|NCT00971893|Methylprednisolone|methylprednisolone|mesh-list
154035961|NCT00971893|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
154035962|NCT00971893|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
154035963|NCT00971893|Prednisolone|prednisolone|mesh-list
154035964|NCT00971893|Prednisolone acetate|prednisolone acetate|mesh-list
154035965|NCT00971893|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
154035966|NCT00971893|Prednisolone phosphate|prednisolone phosphate|mesh-list
154035991|NCT00977353|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
154035992|NCT00977353|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154035993|NCT00977353|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154035994|NCT00977353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154035995|NCT00977353|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154035996|NCT00977353|Serotonin Agents|serotonin agents|mesh-ancestor
154035997|NCT00977353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154035998|NCT00977353|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
154035999|NCT00977353|Antidepressive Agents|antidepressive agents|mesh-ancestor
154036000|NCT00977353|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154036001|NCT00871923|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
154036002|NCT00871923|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154036003|NCT00871923|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154036004|NCT00871923|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154036005|NCT00871923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154036006|NCT00871923|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154036007|NCT04170530|Oxaliplatin|oxaliplatin|mesh-list
154036008|NCT04170530|Irinotecan|irinotecan|mesh-list
154036009|NCT04170530|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154036010|NCT04170530|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
154036011|NCT04170530|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154036012|NCT04170530|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154036013|NCT04170530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154036014|NCT02617017|Buspirone|buspirone|mesh-list
154036015|NCT02617017|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154036016|NCT02617017|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154036017|NCT02617017|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154036018|NCT02617017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153578701|NCT01734824|Denosumab|denosumab|mesh-list
154036019|NCT02617017|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154036020|NCT02617017|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
154036021|NCT02617017|Serotonin Agents|serotonin agents|mesh-ancestor
154036022|NCT02617017|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154036027|NCT02616861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154036028|NCT02616861|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154036030|NCT00981721|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154036031|NCT00981721|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154036032|NCT00981721|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154036033|NCT00981721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154036034|NCT04133337|Apatinib|apatinib|mesh-list
154036035|NCT04133337|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154036036|NCT04133337|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154036038|NCT04133337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154036039|NCT04133259|Tenofovir|tenofovir|mesh-list
154036040|NCT04133259|Entecavir|entecavir|mesh-list
154036041|NCT04133259|Antibodies|antibodies|mesh-list
154036042|NCT04133259|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154036043|NCT04133259|Immunologic Factors|immunologic factors|mesh-ancestor
154036044|NCT04133259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154036045|NCT04133259|Antiviral Agents|antiviral agents|mesh-ancestor
154036046|NCT04133259|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154036047|NCT04133259|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
154036048|NCT04133259|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154036049|NCT04133259|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154036050|NCT04133259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154036051|NCT04133259|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154036052|NCT04133259|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154036053|NCT02616315|Naltrexone|naltrexone|mesh-list
154036054|NCT02616315|Bupropion|bupropion|mesh-list
154036055|NCT02616315|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
154036056|NCT02616315|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
154036057|NCT02616315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154036058|NCT02616315|Sensory System Agents|sensory system agents|mesh-ancestor
154036059|NCT02616315|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154036069|NCT02616315|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
154036070|NCT02616315|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154036071|NCT02616315|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154036072|NCT02779283|Calcium, Dietary|calcium, dietary|mesh-list
154036073|NCT02779283|Leucovorin|leucovorin|mesh-list
154036074|NCT02779283|Folic Acid|folic acid|mesh-list
154036075|NCT02779283|Cytarabine|cytarabine|mesh-list
154036076|NCT02779283|Dexamethasone|dexamethasone|mesh-list
154036077|NCT02779283|Methylprednisolone|methylprednisolone|mesh-list
154036078|NCT02779283|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
154036079|NCT02779283|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
154036080|NCT02779283|Prednisolone|prednisolone|mesh-list
154036081|NCT02779283|Prednisolone acetate|prednisolone acetate|mesh-list
154036082|NCT02779283|Dexamethasone acetate|dexamethasone acetate|mesh-list
154036083|NCT02779283|Cyclophosphamide|cyclophosphamide|mesh-list
154036084|NCT02779283|Rituximab|rituximab|mesh-list
154036085|NCT02779283|Doxorubicin|doxorubicin|mesh-list
154036086|NCT02779283|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
154036087|NCT02779283|Methotrexate|methotrexate|mesh-list
154036088|NCT02779283|Vincristine|vincristine|mesh-list
154036089|NCT02779283|Sorafenib|sorafenib|mesh-list
154036090|NCT02779283|Sunitinib|sunitinib|mesh-list
154036091|NCT02779283|Dasatinib|dasatinib|mesh-list
154036092|NCT02779283|Idarubicin|idarubicin|mesh-list
154036093|NCT02779283|Ponatinib|ponatinib|mesh-list
153812742|NCT00330239|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154036094|NCT02779283|Idelalisib|idelalisib|mesh-list
154036096|NCT02779283|Antibodies|antibodies|mesh-list
153814844|NCT00447369|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154036126|NCT02779283|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154036127|NCT02779283|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154036128|NCT02779283|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154036129|NCT02779283|Abortifacient Agents|abortifacient agents|mesh-ancestor
154036130|NCT02779283|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154036131|NCT02779283|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154036132|NCT02779283|Antimetabolites|antimetabolites|mesh-ancestor
154036133|NCT02779283|Dermatologic Agents|dermatologic agents|mesh-ancestor
154036134|NCT02779283|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154036135|NCT02779283|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154036136|NCT02779283|Antiviral Agents|antiviral agents|mesh-ancestor
154036137|NCT02779283|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154036138|NCT02779283|Antidotes|antidotes|mesh-ancestor
154036139|NCT02779283|Protective Agents|protective agents|mesh-ancestor
154036140|NCT02779283|Vitamin B Complex|vitamin b complex|mesh-ancestor
154036141|NCT02779283|Vitamins|vitamins|mesh-ancestor
154036142|NCT02779283|Micronutrients|micronutrients|mesh-ancestor
154036143|NCT02779283|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154036144|NCT02779283|Tubulin Modulators|tubulin modulators|mesh-ancestor
154036145|NCT02779283|Antimitotic Agents|antimitotic agents|mesh-ancestor
154036146|NCT02779283|Mitosis Modulators|mitosis modulators|mesh-ancestor
154036147|NCT02779283|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154036148|NCT02779283|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
154036149|NCT02779283|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154036150|NCT02779283|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154036151|NCT02779283|Growth Substances|growth substances|mesh-ancestor
154036152|NCT02779283|Growth Inhibitors|growth inhibitors|mesh-ancestor
154036153|NCT02779283|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154036154|NCT02779283|Hematinics|hematinics|mesh-ancestor
154036170|NCT00697671|Interleukin-2|interleukin-2|mesh-list
154036171|NCT00697671|Clofarabine|clofarabine|mesh-list
153578849|NCT01735669|Narcotics|narcotics|mesh-ancestor
154036172|NCT00697671|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154036173|NCT00697671|Immunologic Factors|immunologic factors|mesh-ancestor
154036174|NCT00697671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154036175|NCT00697671|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154036176|NCT00697671|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154036177|NCT00697671|Alkylating Agents|alkylating agents|mesh-ancestor
154036178|NCT00697671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154036179|NCT00697671|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154036180|NCT00697671|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154036181|NCT00697671|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153812743|NCT00330239|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154036182|NCT00697671|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154036183|NCT00697671|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154036184|NCT00697671|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154036185|NCT00697671|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154036186|NCT00697671|Analgesics|analgesics|mesh-ancestor
154036187|NCT00697671|Sensory System Agents|sensory system agents|mesh-ancestor
154036189|NCT00697671|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154036190|NCT00697671|Antimetabolites|antimetabolites|mesh-ancestor
154036192|NCT03922945|Phentermine|phentermine|mesh-list
154036193|NCT03922945|Anticonvulsants|anticonvulsants|mesh-ancestor
154036194|NCT03922945|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154036195|NCT03922945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154036196|NCT03922945|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
154036197|NCT03922945|Appetite Depressants|appetite depressants|mesh-ancestor
154036198|NCT03922945|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
154036199|NCT03922945|Sympathomimetics|sympathomimetics|mesh-ancestor
154036200|NCT03922945|Autonomic Agents|autonomic agents|mesh-ancestor
154036201|NCT03922945|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154036202|NCT03922945|Adrenergic Agents|adrenergic agents|mesh-ancestor
154036203|NCT03922945|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154036204|NCT03922945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154036205|NCT05236985|Oxytocin|oxytocin|mesh-list
154036211|NCT03922477|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154036212|NCT03922477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154036213|NCT03922477|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154036214|NCT03922477|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154036215|NCT00978211|Octreotide|octreotide|mesh-list
154036216|NCT00978211|Somatostatin|somatostatin|mesh-list
154036217|NCT00978211|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154036218|NCT00978211|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154036219|NCT00978211|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154036220|NCT00978211|Hormones|hormones|mesh-ancestor
154036221|NCT00978211|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154036222|NCT00978211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154036223|NCT00867165|Ezetimibe|ezetimibe|mesh-list
154036224|NCT00867165|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154036225|NCT00867165|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154036226|NCT00867165|Antimetabolites|antimetabolites|mesh-ancestor
154036227|NCT00867165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154036228|NCT00867165|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154036229|NCT00981955|Caffeine|caffeine|mesh-list
154036230|NCT00981955|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
154036231|NCT00981955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154036232|NCT00981955|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154036233|NCT00981955|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154036234|NCT00981955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154036235|NCT00981955|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
154036236|NCT00981955|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
154036237|NCT00981955|Purinergic Agents|purinergic agents|mesh-ancestor
154036238|NCT00981955|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154036239|NCT00972829|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
154036240|NCT00972829|Ezetimibe|ezetimibe|mesh-list
154036241|NCT00972829|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154036242|NCT00972829|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154036243|NCT00972829|Antimetabolites|antimetabolites|mesh-ancestor
154036244|NCT00972829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154036245|NCT00972829|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153573177|NCT02367794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153573178|NCT02367794|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154036246|NCT00972829|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154036247|NCT00972829|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154036248|NCT00972907|Nifedipine|nifedipine|mesh-list
154036249|NCT00972907|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154036250|NCT00972907|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154036251|NCT00972907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154036252|NCT00972907|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154036253|NCT00972907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154036254|NCT00972907|Vasodilator Agents|vasodilator agents|mesh-ancestor
154036255|NCT00972907|Tocolytic Agents|tocolytic agents|mesh-ancestor
154036256|NCT00972907|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154036257|NCT04008433|Lidocaine|lidocaine|mesh-list
154036258|NCT04008433|Anesthetics, Local|anesthetics, local|mesh-ancestor
154036259|NCT04008433|Anesthetics|anesthetics|mesh-ancestor
154036260|NCT04008433|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154036261|NCT04008433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154036262|NCT04008433|Sensory System Agents|sensory system agents|mesh-ancestor
154036263|NCT04008433|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154036264|NCT04008433|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154036265|NCT04008433|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154036266|NCT04008433|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154036267|NCT04008433|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154036269|NCT04132479|Amoxicillin|amoxicillin|mesh-list
154036295|NCT00972985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154036296|NCT00972985|Dopamine Agents|dopamine agents|mesh-ancestor
154036297|NCT00972985|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154036298|NCT00972985|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
154036299|NCT00972985|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
154036300|NCT00972985|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
154036301|NCT00972985|Anticonvulsants|anticonvulsants|mesh-ancestor
154036302|NCT00972985|Antiemetics|antiemetics|mesh-ancestor
154036303|NCT00972985|Autonomic Agents|autonomic agents|mesh-ancestor
154036304|NCT00972985|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154036305|NCT00972985|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154036306|NCT00972985|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154036307|NCT00972985|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154036308|NCT00972985|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154036309|NCT00972985|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154036310|NCT00972985|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154036311|NCT00972985|GABA Modulators|gaba modulators|mesh-ancestor
154036312|NCT00972985|GABA Agents|gaba agents|mesh-ancestor
154036313|NCT00867087|Rituximab|rituximab|mesh-list
154036314|NCT00867087|Inotuzumab Ozogamicin|inotuzumab ozogamicin|mesh-list
154036315|NCT00867087|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154036316|NCT00867087|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154036317|NCT00867087|Immunologic Factors|immunologic factors|mesh-ancestor
154036318|NCT00867087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154036319|NCT00867087|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154036320|NCT00867087|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154036321|NCT00867087|Immunotoxins|immunotoxins|mesh-ancestor
154036322|NCT00867087|Immunoconjugates|immunoconjugates|mesh-ancestor
153578999|NCT01736761|Ritonavir|ritonavir|mesh-list
154036323|NCT02778425|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
154036325|NCT02778425|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154036340|NCT04227041|Antimetabolites|antimetabolites|mesh-ancestor
154036341|NCT04227041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154036342|NCT04227041|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154036343|NCT00545233|Pioglitazone|pioglitazone|mesh-list
154036344|NCT00545233|Ribavirin|ribavirin|mesh-list
154036345|NCT00545233|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
154036346|NCT00545233|Antimetabolites|antimetabolites|mesh-ancestor
154036347|NCT00545233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154036348|NCT00545233|Antiviral Agents|antiviral agents|mesh-ancestor
154036349|NCT00545233|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154036350|NCT00545233|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154036351|NCT00545233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154036352|NCT02393248|Gemcitabine|gemcitabine|mesh-list
154036353|NCT02393248|Docetaxel|docetaxel|mesh-list
154036354|NCT02393248|Pembrolizumab|pembrolizumab|mesh-list
154036355|NCT02393248|Trastuzumab|trastuzumab|mesh-list
154036356|NCT02393248|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154036357|NCT02393248|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154036358|NCT02393248|Antimetabolites|antimetabolites|mesh-ancestor
154036359|NCT02393248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154036360|NCT02393248|Tubulin Modulators|tubulin modulators|mesh-ancestor
154036361|NCT02393248|Antimitotic Agents|antimitotic agents|mesh-ancestor
154036362|NCT02393248|Mitosis Modulators|mitosis modulators|mesh-ancestor
154036363|NCT02393248|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154036364|NCT02393248|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154036365|NCT00601484|Tanezumab|tanezumab|mesh-list
154036366|NCT00601484|Analgesics|analgesics|mesh-ancestor
154036367|NCT00601484|Sensory System Agents|sensory system agents|mesh-ancestor
154036368|NCT00601484|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154036382|NCT02778191|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154036383|NCT05170685|Nivolumab|nivolumab|mesh-list
154036384|NCT05170685|Relatlimab|relatlimab|mesh-list
154036385|NCT05170685|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154036386|NCT05170685|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154036387|NCT05170685|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154036388|NCT05170685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154036389|NCT02778893|Thalidomide|thalidomide|mesh-list
154036390|NCT02778893|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154036391|NCT02778893|Immunologic Factors|immunologic factors|mesh-ancestor
154036392|NCT02778893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154036393|NCT02778893|Leprostatic Agents|leprostatic agents|mesh-ancestor
153579072|NCT01737177|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154036394|NCT02778893|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154036395|NCT02778893|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154036396|NCT02778893|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154036397|NCT02778893|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154036398|NCT02778893|Growth Substances|growth substances|mesh-ancestor
154036399|NCT02778893|Growth Inhibitors|growth inhibitors|mesh-ancestor
154036400|NCT02778893|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154036401|NCT02671864|Hypoglycemic Agents|hypoglycemic agents|mesh-list
154036402|NCT02671864|Incretins|incretins|mesh-list
154036403|NCT02671864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154036404|NCT02671864|Hormones|hormones|mesh-ancestor
154036405|NCT02671864|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154036430|NCT00666042|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
154036431|NCT00666042|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
154036433|NCT02660840|Flupenthixol decanoate|flupenthixol decanoate|mesh-list
154036434|NCT02660840|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154036435|NCT02660840|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154036436|NCT02660840|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154036437|NCT02660840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154036438|NCT02660840|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154036439|NCT02660840|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
154036440|NCT02660840|Dopamine Agents|dopamine agents|mesh-ancestor
154036441|NCT02660840|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154036442|NCT02660840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154036443|NCT02777801|Entecavir|entecavir|mesh-list
154036444|NCT02777801|Antiviral Agents|antiviral agents|mesh-ancestor
154036445|NCT02777801|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154036446|NCT00649064|Ziprasidone|ziprasidone|mesh-list
154036447|NCT00649064|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154036448|NCT00649064|Serotonin Agents|serotonin agents|mesh-ancestor
154036449|NCT00649064|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154036450|NCT00649064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154036451|NCT00649064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154036452|NCT00649064|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154036453|NCT00649064|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154036454|NCT00649064|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154036455|NCT00649064|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154036456|NCT00649064|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
154036457|NCT00649064|Dopamine Agents|dopamine agents|mesh-ancestor
154036458|NCT04132713|Capecitabine|capecitabine|mesh-list
154036459|NCT04132713|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154036460|NCT04132713|Antimetabolites|antimetabolites|mesh-ancestor
154036461|NCT04132713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154036462|NCT04132713|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154036463|NCT04007341|Dexmedetomidine|dexmedetomidine|mesh-list
154036468|NCT04007341|Analgesics|analgesics|mesh-ancestor
154036470|NCT04007341|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154036471|NCT04007341|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154036472|NCT04007341|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154036474|NCT04007341|Adrenergic Agents|adrenergic agents|mesh-ancestor
154036475|NCT04007341|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154036476|NCT04007341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154036477|NCT02656082|Etanercept|etanercept|mesh-list
154036478|NCT02656082|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154036479|NCT02656082|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154036480|NCT02656082|Analgesics|analgesics|mesh-ancestor
154036481|NCT02656082|Sensory System Agents|sensory system agents|mesh-ancestor
154036483|NCT02656082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154036484|NCT02656082|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154036485|NCT02656082|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154036486|NCT02656082|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154036487|NCT02656082|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154036488|NCT02656082|Immunologic Factors|immunologic factors|mesh-ancestor
154036489|NCT04132635|Mitogens|mitogens|mesh-list
154036490|NCT04132635|Mitosis Modulators|mitosis modulators|mesh-ancestor
154036491|NCT04132635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154036525|NCT04226885|Fentanyl|fentanyl|mesh-list
154036526|NCT04226885|Dexmedetomidine|dexmedetomidine|mesh-list
154036527|NCT04226885|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154036528|NCT04226885|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154036529|NCT04226885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154036530|NCT04226885|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154036531|NCT04226885|Analgesics|analgesics|mesh-ancestor
154036532|NCT04226885|Sensory System Agents|sensory system agents|mesh-ancestor
154036533|NCT04226885|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154036534|NCT04226885|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154036535|NCT04226885|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154036536|NCT04226885|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154036537|NCT04226885|Adrenergic Agents|adrenergic agents|mesh-ancestor
154036538|NCT04226885|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154036539|NCT04226885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154036540|NCT04226885|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154036541|NCT04226885|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154036542|NCT04226885|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154036543|NCT04226885|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154036544|NCT04226885|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154036545|NCT04226885|Anesthetics, General|anesthetics, general|mesh-ancestor
154036547|NCT04226885|GABA Modulators|gaba modulators|mesh-ancestor
154036548|NCT04226885|GABA Agents|gaba agents|mesh-ancestor
154036549|NCT04226885|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154036550|NCT04226885|Narcotics|narcotics|mesh-ancestor
154036551|NCT00866775|Eslicarbazepine acetate|eslicarbazepine acetate|mesh-list
154036552|NCT00866775|Anticonvulsants|anticonvulsants|mesh-ancestor
154036553|NCT00866775|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154036554|NCT00866775|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154036555|NCT00866775|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154036556|NCT00866775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154036558|NCT02777411|Immunologic Factors|immunologic factors|mesh-ancestor
154036561|NCT02777489|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
154036562|NCT02777489|Protease Inhibitors|protease inhibitors|mesh-ancestor
154036563|NCT02777489|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154036564|NCT02777489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154036565|NCT02777489|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154036566|NCT02660762|Cytarabine|cytarabine|mesh-list
154036567|NCT02660762|Dexamethasone|dexamethasone|mesh-list
154036568|NCT02660762|Dexamethasone acetate|dexamethasone acetate|mesh-list
154036569|NCT02660762|Prednisone|prednisone|mesh-list
154036570|NCT02660762|Cyclophosphamide|cyclophosphamide|mesh-list
154036571|NCT02660762|Methotrexate|methotrexate|mesh-list
154036572|NCT02660762|Etoposide|etoposide|mesh-list
154036573|NCT02660762|Vincristine|vincristine|mesh-list
154036574|NCT02660762|Daunorubicin|daunorubicin|mesh-list
154036575|NCT02660762|Mercaptopurine|mercaptopurine|mesh-list
154036576|NCT02660762|Pegaspargase|pegaspargase|mesh-list
154036577|NCT02660762|Thioguanine|thioguanine|mesh-list
154036578|NCT02660762|BB 1101|bb 1101|mesh-list
154036579|NCT02660762|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154036580|NCT02660762|Immunologic Factors|immunologic factors|mesh-ancestor
154036581|NCT02660762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154036582|NCT02660762|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154036583|NCT02660762|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154036584|NCT02660762|Alkylating Agents|alkylating agents|mesh-ancestor
154036585|NCT02660762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154036586|NCT02660762|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154036587|NCT02660762|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154036588|NCT02660762|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154036589|NCT02660762|Antiemetics|antiemetics|mesh-ancestor
154036590|NCT02660762|Autonomic Agents|autonomic agents|mesh-ancestor
154036604|NCT02660762|Dermatologic Agents|dermatologic agents|mesh-ancestor
154036605|NCT02660762|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154036606|NCT02660762|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154036607|NCT02660762|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154036608|NCT02660762|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154036609|NCT02660762|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154036610|NCT02660762|Antiviral Agents|antiviral agents|mesh-ancestor
154036611|NCT02660762|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154036612|NCT02660762|Tubulin Modulators|tubulin modulators|mesh-ancestor
154036613|NCT02660762|Antimitotic Agents|antimitotic agents|mesh-ancestor
154036614|NCT02660762|Mitosis Modulators|mitosis modulators|mesh-ancestor
154036615|NCT02660762|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154036616|NCT02660684|Cyclosporine|cyclosporine|mesh-list
154036617|NCT02660684|Methotrexate|methotrexate|mesh-list
154036618|NCT02660684|Tacrolimus|tacrolimus|mesh-list
153579296|NCT01738763|Inositol|inositol|mesh-list
154036619|NCT02660684|Cyclosporins|cyclosporins|mesh-list
154036620|NCT02660684|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154036621|NCT02660684|Abortifacient Agents|abortifacient agents|mesh-ancestor
154036622|NCT02660684|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154036623|NCT02660684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154036624|NCT02660684|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154036625|NCT02660684|Antimetabolites|antimetabolites|mesh-ancestor
154036626|NCT02660684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154036627|NCT02660684|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154036628|NCT02660684|Dermatologic Agents|dermatologic agents|mesh-ancestor
154036629|NCT02660684|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154036651|NCT02615223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154036652|NCT02615223|Androgen Antagonists|androgen antagonists|mesh-ancestor
154036653|NCT02615223|Hormone Antagonists|hormone antagonists|mesh-ancestor
154036654|NCT02615223|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154036655|NCT04132557|Methylphenidate|methylphenidate|mesh-list
154036656|NCT04132557|Amphetamine|amphetamine|mesh-list
154036657|NCT04132557|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
154036658|NCT04132557|Dextroamphetamine|dextroamphetamine|mesh-list
154036659|NCT04132557|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
154036660|NCT04132557|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
154036661|NCT04132557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154036662|NCT04132557|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
154036663|NCT04132557|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154036664|NCT04132557|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154036665|NCT04132557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154036666|NCT04132557|Dopamine Agents|dopamine agents|mesh-ancestor
154036667|NCT04132557|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154036668|NCT04132557|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
154036669|NCT04132557|Adrenergic Agents|adrenergic agents|mesh-ancestor
154036670|NCT04132557|Sympathomimetics|sympathomimetics|mesh-ancestor
154036671|NCT04132557|Autonomic Agents|autonomic agents|mesh-ancestor
154036672|NCT04132557|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154036673|NCT00978913|Cyclophosphamide|cyclophosphamide|mesh-list
154036674|NCT00978913|Vaccines|vaccines|mesh-list
154036675|NCT00978913|Immunologic Factors|immunologic factors|mesh-ancestor
154036676|NCT00978913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153814851|NCT00343655|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153814852|NCT00343655|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154036698|NCT02778659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154036699|NCT04072900|Imiquimod|imiquimod|mesh-list
154036700|NCT04072900|Toll-Like Receptor Agonists|toll-like receptor agonists|mesh-ancestor
154036701|NCT04072900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154036702|NCT04072900|Immunomodulating Agents|immunomodulating agents|mesh-ancestor
154036703|NCT04072900|Immunologic Factors|immunologic factors|mesh-ancestor
154036704|NCT04072900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154036705|NCT04072900|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154036706|NCT04072900|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154036707|NCT04072900|Interferon Inducers|interferon inducers|mesh-ancestor
154036708|NCT00984763|Aluminum Hydroxide|aluminum hydroxide|mesh-list
154036709|NCT00984763|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154036710|NCT00984763|Immunologic Factors|immunologic factors|mesh-ancestor
154036711|NCT00984763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154036712|NCT00984763|Antacids|antacids|mesh-ancestor
154036713|NCT00984763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154036714|NCT00984763|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154036715|NCT02578108|Lidocaine|lidocaine|mesh-list
154036716|NCT02578108|Anesthetics, Local|anesthetics, local|mesh-list
154036717|NCT02578108|Anesthetics|anesthetics|mesh-list
154036718|NCT02578108|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154036719|NCT02578108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154036720|NCT02578108|Sensory System Agents|sensory system agents|mesh-ancestor
154036740|NCT05325346|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154036741|NCT00984997|Etoposide|etoposide|mesh-list
154036742|NCT00984997|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154036743|NCT00984997|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154036744|NCT00984997|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154036745|NCT00984997|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154036746|NCT00984997|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154036747|NCT00984997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154036748|NCT00973219|Interferons|interferons|mesh-list
154036749|NCT00973219|Tenofovir|tenofovir|mesh-list
154036750|NCT00973219|Interferon-alpha|interferon-alpha|mesh-list
154036751|NCT00973219|Interferon alpha-2|interferon alpha-2|mesh-list
154036752|NCT00973219|Adefovir|adefovir|mesh-list
154036753|NCT00973219|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
154036754|NCT00973219|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
154036755|NCT00973219|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154036756|NCT00973219|Antiviral Agents|antiviral agents|mesh-ancestor
154036757|NCT00973219|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154036758|NCT00973219|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
154036759|NCT00973219|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154036760|NCT00973219|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154036761|NCT00973219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154036762|NCT00973219|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154036763|NCT00973219|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154036764|NCT00973219|Immunologic Factors|immunologic factors|mesh-ancestor
154036765|NCT00973219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154036766|NCT04194125|Edotreotide lutetium LU-177|edotreotide lutetium lu-177|mesh-list
153579444|NCT01739582|Fertility Agents|fertility agents|mesh-ancestor
154036767|NCT04194125|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
154036768|NCT04194125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154036769|NCT04973891|Metformin|metformin|mesh-list
154036770|NCT04973891|Canagliflozin|canagliflozin|mesh-list
154036771|NCT04973891|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154036781|NCT00983047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154036782|NCT00983047|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154036784|NCT00983125|Analgesics|analgesics|mesh-ancestor
154036785|NCT00983125|Sensory System Agents|sensory system agents|mesh-ancestor
154036786|NCT00983125|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154036787|NCT00983125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154036788|NCT00983125|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154036789|NCT00983125|Sympatholytics|sympatholytics|mesh-ancestor
154036790|NCT00983125|Autonomic Agents|autonomic agents|mesh-ancestor
154036791|NCT00983125|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154036792|NCT00983125|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154036793|NCT00983125|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154036794|NCT00983125|Adrenergic Agents|adrenergic agents|mesh-ancestor
154036795|NCT00983125|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153814854|NCT00343655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154036837|NCT00985387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154036838|NCT00985387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154036839|NCT00985387|Urological Agents|urological agents|mesh-ancestor
154036840|NCT02776943|Hyaluronic Acid|hyaluronic acid|mesh-list
154036841|NCT02776943|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154036842|NCT02776943|Immunologic Factors|immunologic factors|mesh-ancestor
153579520|NCT01740245|Biguanides|biguanides|mesh-list
154036843|NCT02776943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154036844|NCT02776943|Viscosupplements|viscosupplements|mesh-ancestor
154036845|NCT02776943|Protective Agents|protective agents|mesh-ancestor
154036846|NCT04005781|Hydroxychloroquine|hydroxychloroquine|mesh-list
154036847|NCT04005781|Antimalarials|antimalarials|mesh-ancestor
154036848|NCT04005781|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154036849|NCT04005781|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154036850|NCT04005781|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154036851|NCT04005781|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154036852|NCT04005781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154036853|NCT04005781|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154036854|NCT04654351|Icatibant|icatibant|mesh-list
154036855|NCT04654351|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154036856|NCT04654351|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154036857|NCT04654351|Analgesics|analgesics|mesh-ancestor
154036858|NCT04654351|Sensory System Agents|sensory system agents|mesh-ancestor
154036859|NCT04654351|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154036860|NCT04654351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154036861|NCT04654351|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154036862|NCT04654351|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154036863|NCT04654351|Bradykinin B2 Receptor Antagonists|bradykinin b2 receptor antagonists|mesh-ancestor
154036867|NCT04654351|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154036876|NCT00582556|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154036877|NCT00582556|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154036878|NCT02776397|Vitamin E|vitamin e|mesh-list
154036879|NCT02776397|Tocopherols|tocopherols|mesh-list
154036880|NCT02776397|alpha-Tocopherol|alpha-tocopherol|mesh-list
154036881|NCT02776397|Vitamins|vitamins|mesh-ancestor
154036882|NCT02776397|Micronutrients|micronutrients|mesh-ancestor
154036883|NCT02776397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154036884|NCT02776397|Antioxidants|antioxidants|mesh-ancestor
154036885|NCT02776397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154036886|NCT02776397|Protective Agents|protective agents|mesh-ancestor
154036887|NCT00985777|Vitamin E|vitamin e|mesh-list
154036888|NCT00985777|Tocopherols|tocopherols|mesh-list
154036889|NCT00985777|Tocotrienols|tocotrienols|mesh-list
154036890|NCT00985777|Vitamins|vitamins|mesh-ancestor
154036891|NCT00985777|Micronutrients|micronutrients|mesh-ancestor
154036892|NCT00985777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154036893|NCT00985777|Antioxidants|antioxidants|mesh-ancestor
154036894|NCT00985777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154036895|NCT00985777|Protective Agents|protective agents|mesh-ancestor
154036896|NCT01563601|Carboplatin|carboplatin|mesh-list
154036897|NCT01563601|Etoposide|etoposide|mesh-list
154036898|NCT01563601|Etoposide phosphate|etoposide phosphate|mesh-list
154036933|NCT04226105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154036934|NCT02776865|Lidocaine|lidocaine|mesh-list
154036935|NCT02776865|Anesthetics, Local|anesthetics, local|mesh-ancestor
154036936|NCT02776865|Anesthetics|anesthetics|mesh-ancestor
154036937|NCT02776865|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154036938|NCT02776865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154036939|NCT02776865|Sensory System Agents|sensory system agents|mesh-ancestor
154036940|NCT02776865|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154036941|NCT02776865|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154036942|NCT02776865|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154036943|NCT02776865|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154036944|NCT02776865|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154036945|NCT02776865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154036946|NCT02772653|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
154036947|NCT02772653|Natriuretic Agents|natriuretic agents|mesh-ancestor
154036948|NCT02772653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154036949|NCT00542269|Amlodipine|amlodipine|mesh-list
154036950|NCT00542269|Ramipril|ramipril|mesh-list
154036951|NCT00542269|Aliskiren|aliskiren|mesh-list
154036952|NCT00542269|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154036953|NCT00542269|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154036954|NCT00542269|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154036955|NCT00542269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154036956|NCT00542269|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154036957|NCT00542269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154036958|NCT00542269|Vasodilator Agents|vasodilator agents|mesh-ancestor
154036959|NCT00542269|Renin Inhibitors|renin inhibitors|mesh-ancestor
154036960|NCT00542269|Protease Inhibitors|protease inhibitors|mesh-ancestor
154036961|NCT00542269|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154036962|NCT00542269|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
154036963|NCT02579434|Midazolam|midazolam|mesh-list
154036975|NCT02579434|GABA Agents|gaba agents|mesh-ancestor
154036976|NCT02579434|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154036977|NCT02579434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154036978|NCT00542191|Paclitaxel|paclitaxel|mesh-list
154036979|NCT00542191|Cyclophosphamide|cyclophosphamide|mesh-list
154036980|NCT00542191|Carboplatin|carboplatin|mesh-list
154036981|NCT00542191|Doxorubicin|doxorubicin|mesh-list
154036982|NCT00542191|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154036983|NCT00542191|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154036984|NCT00542191|Tubulin Modulators|tubulin modulators|mesh-ancestor
154036985|NCT00542191|Antimitotic Agents|antimitotic agents|mesh-ancestor
154036986|NCT00542191|Mitosis Modulators|mitosis modulators|mesh-ancestor
154036987|NCT00542191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154036988|NCT00542191|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154036989|NCT00542191|Immunologic Factors|immunologic factors|mesh-ancestor
154036990|NCT00542191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154036991|NCT00542191|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154036992|NCT00542191|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154036993|NCT00542191|Alkylating Agents|alkylating agents|mesh-ancestor
153579674|NCT01741519|Landiolol|landiolol|mesh-list
154036994|NCT00542191|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154036995|NCT00542191|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154036996|NCT00542191|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154036997|NCT00542191|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154036998|NCT00542191|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154036999|NCT00600938|Deferasirox|deferasirox|mesh-list
154037001|NCT00600938|Iron Chelating Agents|iron chelating agents|mesh-ancestor
154037002|NCT00600938|Chelating Agents|chelating agents|mesh-ancestor
154037003|NCT00600938|Sequestering Agents|sequestering agents|mesh-ancestor
154037004|NCT00600938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154037021|NCT04072198|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154037022|NCT04072198|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154037023|NCT04072198|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154037024|NCT04072198|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154037025|NCT04072198|Growth Substances|growth substances|mesh-ancestor
154037026|NCT04072198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154037027|NCT04072198|Growth Inhibitors|growth inhibitors|mesh-ancestor
154037028|NCT04072198|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154037029|NCT04072198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154037030|NCT04072198|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
154037031|NCT04072198|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154037032|NCT04072198|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154037034|NCT04072198|Protective Agents|protective agents|mesh-ancestor
154037035|NCT04072198|Vitamin B Complex|vitamin b complex|mesh-ancestor
154037036|NCT04072198|Vitamins|vitamins|mesh-ancestor
154037037|NCT04072198|Micronutrients|micronutrients|mesh-ancestor
154037038|NCT04072198|Antimetabolites|antimetabolites|mesh-ancestor
154037039|NCT04072198|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154037040|NCT04072198|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154037041|NCT04072198|Immunologic Factors|immunologic factors|mesh-ancestor
154037042|NCT02772419|Benralizumab|benralizumab|mesh-list
154037043|NCT02772419|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154037045|NCT00543439|Factor VIII|factor viii|mesh-list
154037138|NCT00988897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154037139|NCT00988897|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154037140|NCT00988897|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154037141|NCT00988897|Immunologic Factors|immunologic factors|mesh-ancestor
154037142|NCT00988897|Antidotes|antidotes|mesh-ancestor
154037143|NCT00988897|Protective Agents|protective agents|mesh-ancestor
154037144|NCT00988897|Vitamin B Complex|vitamin b complex|mesh-ancestor
154037145|NCT00988897|Vitamins|vitamins|mesh-ancestor
154037146|NCT00988897|Micronutrients|micronutrients|mesh-ancestor
154037147|NCT02775227|Hydrocortisone|hydrocortisone|mesh-list
154037148|NCT02775227|Pasireotide|pasireotide|mesh-list
154037149|NCT02775227|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154037150|NCT02775227|Hormones|hormones|mesh-ancestor
154037151|NCT02775227|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154037152|NCT02775227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154037182|NCT04033094|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154037183|NCT04033094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154037184|NCT04033094|Analgesics|analgesics|mesh-ancestor
154037185|NCT04033094|Sensory System Agents|sensory system agents|mesh-ancestor
154037186|NCT04033094|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154037187|NCT04073758|Dexmedetomidine|dexmedetomidine|mesh-list
154037188|NCT04073758|Remifentanil|remifentanil|mesh-list
154037189|NCT04073758|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154037190|NCT04073758|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154037191|NCT04073758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154037192|NCT04073758|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154037193|NCT04073758|Analgesics|analgesics|mesh-ancestor
154037194|NCT04073758|Sensory System Agents|sensory system agents|mesh-ancestor
154037195|NCT04073758|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154037196|NCT04073758|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154037197|NCT04073758|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154037198|NCT04073758|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154037199|NCT04073758|Adrenergic Agents|adrenergic agents|mesh-ancestor
154037200|NCT04073758|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154037201|NCT04073758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154037202|NCT04073758|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154037203|NCT04073758|Narcotics|narcotics|mesh-ancestor
154037204|NCT02660606|Analgesics, Opioid|analgesics, opioid|mesh-list
154037205|NCT02660606|Narcotics|narcotics|mesh-ancestor
154037206|NCT02660606|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154037207|NCT02660606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154037208|NCT02660606|Analgesics|analgesics|mesh-ancestor
154037209|NCT02660606|Sensory System Agents|sensory system agents|mesh-ancestor
154037210|NCT02660606|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154037211|NCT00582010|Nitric Oxide|nitric oxide|mesh-list
154037212|NCT00582010|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154037213|NCT00582010|Autonomic Agents|autonomic agents|mesh-ancestor
154037214|NCT00582010|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154037251|NCT00986557|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154037252|NCT00986557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154037253|NCT00986557|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
154037254|NCT00910754|Prednisone|prednisone|mesh-list
154037255|NCT00910754|Abiraterone Acetate|abiraterone acetate|mesh-list
154037256|NCT00910754|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154037257|NCT00910754|Glucocorticoids|glucocorticoids|mesh-ancestor
154037258|NCT00910754|Hormones|hormones|mesh-ancestor
154037259|NCT00910754|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154037260|NCT00910754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154037261|NCT00910754|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154037262|NCT00910754|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154037263|NCT00910754|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154037264|NCT00910754|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154037265|NCT00910754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154037266|NCT00910754|Hormone Antagonists|hormone antagonists|mesh-ancestor
154037267|NCT00910754|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154037268|NCT00649376|Fexofenadine|fexofenadine|mesh-list
154037269|NCT00649376|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154037270|NCT00649376|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
154037271|NCT00649376|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
154037272|NCT00649376|Histamine Antagonists|histamine antagonists|mesh-ancestor
154037273|NCT00649376|Histamine Agents|histamine agents|mesh-ancestor
154037274|NCT00649376|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154037275|NCT00649376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154037276|NCT00649376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154037277|NCT00649454|Metformin|metformin|mesh-list
154037278|NCT00649454|Glipizide|glipizide|mesh-list
154037279|NCT00649454|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154037280|NCT00649454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154037281|NCT02655770|Liraglutide|liraglutide|mesh-list
154037282|NCT02655770|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
153814858|NCT00453765|Montelukast|montelukast|mesh-list
153814859|NCT00453765|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154037283|NCT02655770|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154037284|NCT02655770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154037285|NCT02655770|Incretins|incretins|mesh-ancestor
154037286|NCT02655770|Hormones|hormones|mesh-ancestor
154037287|NCT02655770|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154037288|NCT00986713|Amphotericin B|amphotericin b|mesh-list
154037289|NCT00986713|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
154037290|NCT00986713|Amebicides|amebicides|mesh-ancestor
153579979|NCT01743066|Vitamin E|vitamin e|mesh-list
154037291|NCT00986713|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154037292|NCT00986713|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154037293|NCT00986713|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154037294|NCT00986713|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154037295|NCT00986713|Antifungal Agents|antifungal agents|mesh-ancestor
154037296|NCT02651870|Amlodipine|amlodipine|mesh-list
154037297|NCT02651870|Candesartan|candesartan|mesh-list
154037298|NCT02651870|Candesartan cilexetil|candesartan cilexetil|mesh-list
154037299|NCT02651870|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154037300|NCT02651870|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154037301|NCT02651870|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154037302|NCT02651870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154037303|NCT02651870|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154037304|NCT02651870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154037305|NCT02651870|Vasodilator Agents|vasodilator agents|mesh-ancestor
154037306|NCT02651870|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
154037307|NCT02651870|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
154037308|NCT02766803|Resveratrol|resveratrol|mesh-list
154037309|NCT02766803|Simvastatin|simvastatin|mesh-list
154037310|NCT02766803|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154037311|NCT02766803|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154037328|NCT00650468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154037329|NCT00650468|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154037330|NCT00650468|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154037331|NCT00650468|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154037332|NCT00650468|Immunologic Factors|immunologic factors|mesh-ancestor
154037333|NCT00650468|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
154037334|NCT00650468|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154037335|NCT00650468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154037336|NCT00650468|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154037337|NCT00650468|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
154037338|NCT00650468|Antitubercular Agents|antitubercular agents|mesh-ancestor
154037339|NCT00650468|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154037340|NCT00650468|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154037341|NCT02576080|Imatinib Mesylate|imatinib mesylate|mesh-list
154037342|NCT02576080|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154037343|NCT02576080|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154037344|NCT02576080|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154037345|NCT02576080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154037346|NCT02576080|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154037347|NCT02651792|Meperidine|meperidine|mesh-list
154037348|NCT02651792|Ketamine|ketamine|mesh-list
154037349|NCT02651792|Propofol|propofol|mesh-list
154037357|NCT02651792|Sensory System Agents|sensory system agents|mesh-ancestor
154037358|NCT02651792|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154037359|NCT02651792|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
154037360|NCT02651792|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154037361|NCT02651792|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154037362|NCT02651792|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154037363|NCT02651792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154037364|NCT02651792|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154037365|NCT02651792|Narcotics|narcotics|mesh-ancestor
154037366|NCT02651792|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154037367|NCT04754815|Paclitaxel|paclitaxel|mesh-list
154037368|NCT04754815|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
154037369|NCT04754815|Pembrolizumab|pembrolizumab|mesh-list
154037370|NCT04754815|Pemetrexed|pemetrexed|mesh-list
154037371|NCT04754815|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154037372|NCT04754815|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154037373|NCT04754815|Tubulin Modulators|tubulin modulators|mesh-ancestor
154037374|NCT04754815|Antimitotic Agents|antimitotic agents|mesh-ancestor
154037375|NCT04754815|Mitosis Modulators|mitosis modulators|mesh-ancestor
154037376|NCT04754815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154037377|NCT04754815|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154037378|NCT04754815|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154037379|NCT04754815|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154037380|NCT04754815|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154037381|NCT04754815|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154037382|NCT00649532|Ondansetron|ondansetron|mesh-list
154037383|NCT00649532|Antiemetics|antiemetics|mesh-ancestor
154037399|NCT02655614|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154037400|NCT02655614|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154037401|NCT02655614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154037402|NCT02655614|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154037403|NCT02655614|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154037404|NCT02655614|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154037405|NCT02655614|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154037406|NCT02655614|Anesthetics, General|anesthetics, general|mesh-ancestor
154037407|NCT02655614|Anesthetics|anesthetics|mesh-ancestor
154037408|NCT02655614|GABA Modulators|gaba modulators|mesh-ancestor
154037409|NCT02655614|GABA Agents|gaba agents|mesh-ancestor
154037410|NCT02655614|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154037411|NCT02655614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154037412|NCT02655614|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
154037413|NCT02655614|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154037414|NCT02655614|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154037415|NCT02655614|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
154037416|NCT02655614|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
154037417|NCT02655614|Purinergic Agents|purinergic agents|mesh-ancestor
154037418|NCT02655614|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154037419|NCT02655614|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154037420|NCT02655614|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
154037421|NCT02772029|Apatinib|apatinib|mesh-list
154037422|NCT02772029|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154037423|NCT02772029|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154037424|NCT02772029|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154037425|NCT02772029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154037426|NCT02766725|Sildenafil Citrate|sildenafil citrate|mesh-list
154037427|NCT02766725|Vasodilator Agents|vasodilator agents|mesh-ancestor
154037428|NCT02766725|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
154037429|NCT02766725|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154037430|NCT02766725|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154037431|NCT02766725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154037432|NCT02766725|Urological Agents|urological agents|mesh-ancestor
154037433|NCT02658422|Montelukast|montelukast|mesh-list
154037434|NCT02658422|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154037435|NCT02658422|Respiratory System Agents|respiratory system agents|mesh-ancestor
154037436|NCT02658422|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
154037437|NCT02658422|Hormone Antagonists|hormone antagonists|mesh-ancestor
153580122|NCT01743794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153730923|NCT00159081|Serotonin Agents|serotonin agents|mesh-ancestor
154037438|NCT02658422|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154037439|NCT02658422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154037440|NCT02658422|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
154037441|NCT02658422|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
154037442|NCT02658422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154037443|NCT02771795|Trastuzumab|trastuzumab|mesh-list
154037444|NCT02771795|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154037445|NCT02771795|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154037446|NCT02655536|Bevacizumab|bevacizumab|mesh-list
154037447|NCT02655536|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
154037448|NCT02655536|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154037449|NCT02655536|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154037450|NCT02655536|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154037451|NCT02655536|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154037452|NCT02655536|Growth Substances|growth substances|mesh-ancestor
154037453|NCT02655536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154037454|NCT02655536|Growth Inhibitors|growth inhibitors|mesh-ancestor
154037455|NCT02655536|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154037456|NCT02655536|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154037457|NCT02655536|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154037458|NCT02655536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154037459|NCT02766647|Lenograstim|lenograstim|mesh-list
154037460|NCT02766647|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154037461|NCT02766647|Immunologic Factors|immunologic factors|mesh-ancestor
154037462|NCT02766647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154037463|NCT02651636|Folic Acid|folic acid|mesh-list
154037471|NCT02651636|Antioxidants|antioxidants|mesh-ancestor
154037472|NCT02651636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154037473|NCT02651636|Protective Agents|protective agents|mesh-ancestor
154037474|NCT02774993|Doxycycline|doxycycline|mesh-list
154037475|NCT02774993|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154037476|NCT02774993|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154037477|NCT02774993|Antimalarials|antimalarials|mesh-ancestor
154037478|NCT02774993|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154037479|NCT02774993|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154037480|NCT02774837|Tenofovir|tenofovir|mesh-list
154037481|NCT02774837|Telbivudine|telbivudine|mesh-list
154037482|NCT02774837|Antiviral Agents|antiviral agents|mesh-ancestor
154037483|NCT02774837|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154037484|NCT02774837|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
154037485|NCT02774837|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154037486|NCT02774837|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154037487|NCT02774837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154037488|NCT02774837|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154037489|NCT02774837|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154037490|NCT02658188|Gabapentin|gabapentin|mesh-list
154037491|NCT02658188|Analgesics|analgesics|mesh-ancestor
154037492|NCT02658188|Sensory System Agents|sensory system agents|mesh-ancestor
154037493|NCT02658188|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154037494|NCT02658188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154037495|NCT02658188|Anticonvulsants|anticonvulsants|mesh-ancestor
154037496|NCT02658188|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154037497|NCT02658188|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153814861|NCT00453765|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
154037518|NCT02655380|Analgesics|analgesics|mesh-ancestor
154037519|NCT02655380|Sensory System Agents|sensory system agents|mesh-ancestor
154037520|NCT02655380|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154037521|NCT02655380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154037522|NCT02655380|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
154037523|NCT02655380|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154037524|NCT02655380|Anesthetics, General|anesthetics, general|mesh-ancestor
154037525|NCT02655380|Anesthetics|anesthetics|mesh-ancestor
154037526|NCT02655380|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154037527|NCT02655380|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154037528|NCT02655380|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154037529|NCT02655380|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154037530|NCT02655380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154037531|NCT02655380|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154037532|NCT02655380|Narcotics|narcotics|mesh-ancestor
154037533|NCT00580840|Certolizumab Pegol|certolizumab pegol|mesh-list
154037534|NCT00580840|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
154037535|NCT00580840|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154037536|NCT00580840|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154037537|NCT00580840|Immunologic Factors|immunologic factors|mesh-ancestor
154037538|NCT00580840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154037539|NCT00580840|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154037540|NCT00987103|Tacrolimus|tacrolimus|mesh-list
154037541|NCT00987103|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154037542|NCT00987103|Immunologic Factors|immunologic factors|mesh-ancestor
154037543|NCT00987103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154037544|NCT00987103|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
154037545|NCT00987103|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154037559|NCT04006093|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154037560|NCT04006093|Protease Inhibitors|protease inhibitors|mesh-ancestor
154037561|NCT04006093|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154037562|NCT04006093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154037563|NCT04006093|Anticoagulants|anticoagulants|mesh-ancestor
154037564|NCT02766257|Anesthetics|anesthetics|mesh-list
154037565|NCT02766257|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154037566|NCT02766257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154037567|NCT04005469|Treprostinil|treprostinil|mesh-list
154037568|NCT04005469|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154037569|NCT02651324|Ketamine|ketamine|mesh-list
154037570|NCT02651324|Analgesics|analgesics|mesh-ancestor
154037571|NCT02651324|Sensory System Agents|sensory system agents|mesh-ancestor
154037572|NCT02651324|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154037573|NCT02651324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154037574|NCT02651324|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
154037575|NCT02651324|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154037576|NCT02651324|Anesthetics, General|anesthetics, general|mesh-ancestor
154037577|NCT02651324|Anesthetics|anesthetics|mesh-ancestor
154037578|NCT02651324|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154037579|NCT02651324|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154037580|NCT02651324|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154037581|NCT02651324|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154037582|NCT02651324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154037583|NCT00662220|Ribavirin|ribavirin|mesh-list
154037584|NCT00662220|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
154037585|NCT00662220|Interferon-alpha|interferon-alpha|mesh-list
154037586|NCT00662220|Antimetabolites|antimetabolites|mesh-ancestor
154037587|NCT00662220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154037588|NCT00662220|Antiviral Agents|antiviral agents|mesh-ancestor
154037589|NCT00662220|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154037590|NCT00662220|Immunologic Factors|immunologic factors|mesh-ancestor
154037591|NCT00662220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154037593|NCT02575924|Cholinergic Agents|cholinergic agents|mesh-ancestor
154037594|NCT02575924|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154037595|NCT02575924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153573179|NCT02367794|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153573180|NCT02363998|Lofexidine|lofexidine|mesh-list
154037598|NCT02651168|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154037599|NCT02651168|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154037600|NCT02651168|Growth Substances|growth substances|mesh-ancestor
154037601|NCT02651168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154037602|NCT02651168|Growth Inhibitors|growth inhibitors|mesh-ancestor
154037603|NCT02651168|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154037604|NCT00650000|Modafinil|modafinil|mesh-list
154037605|NCT00650000|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
154037606|NCT00650000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154037607|NCT00650000|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
154037608|NCT00650000|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
154037609|NCT00650000|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
154037610|NCT00650000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154037611|NCT02630862|Aspirin|aspirin|mesh-list
154037612|NCT02630862|Dipyridamole|dipyridamole|mesh-list
154037613|NCT02630862|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154037614|NCT02630862|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154037615|NCT02630862|Analgesics|analgesics|mesh-ancestor
154037616|NCT02630862|Sensory System Agents|sensory system agents|mesh-ancestor
154037617|NCT02630862|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154037618|NCT02630862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154037619|NCT02630862|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154037630|NCT02536430|Ketorolac|ketorolac|mesh-list
153814862|NCT00453765|Hormone Antagonists|hormone antagonists|mesh-ancestor
154037642|NCT02536430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154037643|NCT02631174|Antithrombins|antithrombins|mesh-list
154037644|NCT02631174|Antithrombin III|antithrombin iii|mesh-list
154037645|NCT02631174|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154037646|NCT02631174|Protease Inhibitors|protease inhibitors|mesh-ancestor
154037647|NCT02631174|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154037648|NCT02631174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154037649|NCT02631174|Anticoagulants|anticoagulants|mesh-ancestor
154037651|NCT04686929|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154037652|NCT04686929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154037653|NCT04686929|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154037654|NCT04686929|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154037655|NCT04686929|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154037656|NCT04686929|Immunologic Factors|immunologic factors|mesh-ancestor
154037657|NCT04686929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154037658|NCT04686929|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154037659|NCT02765633|Cangrelor|cangrelor|mesh-list
154037660|NCT02765633|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154037661|NCT02765633|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
153580351|NCT01745263|Vitamin D|vitamin d|mesh-list
154037662|NCT02765633|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
154037663|NCT02765633|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
154037664|NCT02765633|Purinergic Agents|purinergic agents|mesh-ancestor
154037665|NCT02765633|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154037666|NCT02765633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154037667|NCT02765633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154037668|NCT00581776|Dexamethasone|dexamethasone|mesh-list
154037669|NCT00581776|Cyclophosphamide|cyclophosphamide|mesh-list
154037670|NCT00581776|Rituximab|rituximab|mesh-list
154037671|NCT00581776|Doxorubicin|doxorubicin|mesh-list
154037672|NCT00581776|Vincristine|vincristine|mesh-list
154037673|NCT00581776|Bortezomib|bortezomib|mesh-list
154037674|NCT00581776|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154037678|NCT00581776|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154037679|NCT00581776|Alkylating Agents|alkylating agents|mesh-ancestor
154037680|NCT00581776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154037681|NCT00581776|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154037682|NCT00581776|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154037683|NCT00581776|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154037684|NCT00581776|Antiemetics|antiemetics|mesh-ancestor
154037685|NCT00581776|Autonomic Agents|autonomic agents|mesh-ancestor
154037686|NCT00581776|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154037687|NCT00581776|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154037688|NCT00581776|Glucocorticoids|glucocorticoids|mesh-ancestor
154037689|NCT00581776|Hormones|hormones|mesh-ancestor
154037690|NCT00581776|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154037691|NCT00581776|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154037692|NCT00581776|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154037693|NCT00581776|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154037694|NCT00581776|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154037695|NCT00581776|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154037696|NCT00581776|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154037697|NCT00581776|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154037698|NCT00581776|Tubulin Modulators|tubulin modulators|mesh-ancestor
154037699|NCT00581776|Antimitotic Agents|antimitotic agents|mesh-ancestor
154037700|NCT00581776|Mitosis Modulators|mitosis modulators|mesh-ancestor
154037701|NCT00662454|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
154037702|NCT00662454|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
154037703|NCT00662454|Levonorgestrel|levonorgestrel|mesh-list
154037704|NCT00662454|Ethinyl Estradiol|ethinyl estradiol|mesh-list
154037705|NCT00662454|Ethinyl estradiol, levonorgestrel drug combination|ethinyl estradiol, levonorgestrel drug combination|mesh-list
154037706|NCT00662454|Estradiol|estradiol|mesh-list
154037707|NCT00662454|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
154037708|NCT00662454|Estrogens|estrogens|mesh-ancestor
154037709|NCT00662454|Hormones|hormones|mesh-ancestor
154037710|NCT00662454|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154037711|NCT00662454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154037712|NCT00662454|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
154037713|NCT00662454|Contraceptive Agents|contraceptive agents|mesh-ancestor
154037716|NCT00662454|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
154037717|NCT00662454|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
154037718|NCT00662454|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
154037719|NCT00662454|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
154037720|NCT04156152|Listerine|listerine|mesh-list
154037721|NCT04156152|Fluorides|fluorides|mesh-list
154037722|NCT04156152|Sodium Fluoride|sodium fluoride|mesh-list
154037723|NCT04156152|Cariostatic Agents|cariostatic agents|mesh-ancestor
154037724|NCT04156152|Protective Agents|protective agents|mesh-ancestor
154037725|NCT04156152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154037726|NCT04156152|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154037727|NCT04156152|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154037728|NCT00662610|Naproxen|naproxen|mesh-list
154037729|NCT00662610|Naproxen-n-butyl nitrate|naproxen-n-butyl nitrate|mesh-list
154037730|NCT00662610|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154037732|NCT00662610|Analgesics|analgesics|mesh-ancestor
154037733|NCT00662610|Sensory System Agents|sensory system agents|mesh-ancestor
154037734|NCT00662610|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154037735|NCT00662610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153580426|NCT01745614|Analgesics|analgesics|mesh-ancestor
154037736|NCT00662610|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154037737|NCT00662610|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154037738|NCT00662610|Gout Suppressants|gout suppressants|mesh-ancestor
154037739|NCT00662610|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154037740|NCT00662610|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154037741|NCT00662610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154037742|NCT00662610|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
154037743|NCT04225325|Dolutegravir|dolutegravir|mesh-list
154037759|NCT04225325|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
154037760|NCT04225325|Protease Inhibitors|protease inhibitors|mesh-ancestor
154037761|NCT04225325|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154037762|NCT04225325|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154037763|NCT00649610|Diclofenac|diclofenac|mesh-list
154037764|NCT00649610|Valdecoxib|valdecoxib|mesh-list
154037765|NCT00649610|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154037766|NCT00649610|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154037767|NCT00649610|Analgesics|analgesics|mesh-ancestor
154037768|NCT00649610|Sensory System Agents|sensory system agents|mesh-ancestor
154037769|NCT00649610|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154037770|NCT00649610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154037771|NCT00649610|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154037772|NCT00649610|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154037773|NCT00649610|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154037774|NCT00649610|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154037775|NCT00649610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154037776|NCT00649610|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
154037777|NCT02655146|Triptorelin Pamoate|triptorelin pamoate|mesh-list
154037778|NCT02655146|Progesterone|progesterone|mesh-list
154037779|NCT02655146|Estradiol|estradiol|mesh-list
154037780|NCT02655146|Progestins|progestins|mesh-ancestor
154037781|NCT02655146|Hormones|hormones|mesh-ancestor
154037791|NCT02655146|Estrogens|estrogens|mesh-ancestor
153580499|NCT01746199|Sulfamethoxazole|sulfamethoxazole|mesh-list
154037810|NCT00650624|Analgesics|analgesics|mesh-ancestor
154037811|NCT00650624|Sensory System Agents|sensory system agents|mesh-ancestor
154037812|NCT00650624|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154037813|NCT00650624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154037814|NCT00650624|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154037815|NCT00650624|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154037816|NCT00666354|Methotrexate|methotrexate|mesh-list
154037817|NCT00666354|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154037818|NCT00666354|Abortifacient Agents|abortifacient agents|mesh-ancestor
154037819|NCT00666354|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154037820|NCT00666354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154037821|NCT00666354|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154037822|NCT00666354|Antimetabolites|antimetabolites|mesh-ancestor
154037823|NCT00666354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154037824|NCT00666354|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154037825|NCT00666354|Dermatologic Agents|dermatologic agents|mesh-ancestor
154037826|NCT00666354|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154037827|NCT00666354|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154037828|NCT00666354|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154037829|NCT00666354|Immunologic Factors|immunologic factors|mesh-ancestor
154037830|NCT00666354|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154037857|NCT02650544|Histamine Agents|histamine agents|mesh-ancestor
154037858|NCT02650544|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154037859|NCT02650544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154037860|NCT02650544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154037861|NCT02650544|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154037862|NCT02650544|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154037863|NCT02650544|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154037864|NCT02650544|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
154037865|NCT02650544|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
154037866|NCT02650544|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154037867|NCT02650544|Adrenergic Agents|adrenergic agents|mesh-ancestor
154037868|NCT02650544|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
154037869|NCT02650544|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154037870|NCT02650544|Serotonin Agents|serotonin agents|mesh-ancestor
154037871|NCT02650544|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
154037872|NCT02650388|Chrysarobin|chrysarobin|mesh-list
154037873|NCT02650388|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154037874|NCT02650388|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154037875|NCT02650388|Analgesics|analgesics|mesh-ancestor
154037876|NCT02650388|Sensory System Agents|sensory system agents|mesh-ancestor
154037877|NCT02650388|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154037878|NCT02650388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154037879|NCT02650388|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154037880|NCT02650388|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154037881|NCT00883740|Pregabalin|pregabalin|mesh-list
154037882|NCT00883740|Analgesics|analgesics|mesh-ancestor
154037883|NCT00883740|Sensory System Agents|sensory system agents|mesh-ancestor
154037884|NCT00883740|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154037885|NCT00883740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154037886|NCT00883740|Anticonvulsants|anticonvulsants|mesh-ancestor
154037887|NCT00883740|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154037888|NCT00883740|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154037889|NCT00883740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154037892|NCT00883740|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154037893|NCT00883740|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154037894|NCT00883740|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154037895|NCT04183712|Gemcitabine|gemcitabine|mesh-list
154037896|NCT04183712|Oxaliplatin|oxaliplatin|mesh-list
154037897|NCT04183712|Afatinib|afatinib|mesh-list
154037898|NCT04183712|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154037899|NCT04183712|Antimetabolites|antimetabolites|mesh-ancestor
154037900|NCT04183712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154037901|NCT04183712|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154037902|NCT04183712|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154037903|NCT04183712|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154037904|NCT04183712|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154037905|NCT02773199|Bupivacaine|bupivacaine|mesh-list
154037906|NCT02773199|Anesthetics, Local|anesthetics, local|mesh-ancestor
154037907|NCT02773199|Anesthetics|anesthetics|mesh-ancestor
154037908|NCT02773199|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154037909|NCT02773199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154037910|NCT02773199|Sensory System Agents|sensory system agents|mesh-ancestor
154037911|NCT02773199|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154037912|NCT02654834|Nitrous Oxide|nitrous oxide|mesh-list
154037913|NCT02654834|Anesthetics|anesthetics|mesh-list
154037914|NCT02654834|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154037915|NCT02654834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154037916|NCT02654834|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
154037917|NCT02654834|Anesthetics, General|anesthetics, general|mesh-ancestor
154037918|NCT02654834|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154037919|NCT02654834|Analgesics|analgesics|mesh-ancestor
154037939|NCT02765009|Natriuretic Agents|natriuretic agents|mesh-ancestor
154037940|NCT02765009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154037941|NCT02765009|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
154037942|NCT02765009|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154037943|NCT02765009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154037944|NCT02765009|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
154037945|NCT02649920|Dinoprostone|dinoprostone|mesh-list
154037946|NCT02649920|Oxytocics|oxytocics|mesh-ancestor
154037947|NCT02649920|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154037948|NCT02649920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154037949|NCT00649688|Metoprolol|metoprolol|mesh-list
154037950|NCT00649688|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
154037967|NCT00667056|Tacrolimus|tacrolimus|mesh-list
154038001|NCT04223219|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154038002|NCT04223219|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154038003|NCT04223219|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154038004|NCT04223219|Adrenergic Agents|adrenergic agents|mesh-ancestor
154038005|NCT04223219|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154038006|NCT04223219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154038007|NCT04223219|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154038008|NCT04223219|Anesthetics, General|anesthetics, general|mesh-ancestor
154038010|NCT04223219|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
154038011|NCT04223219|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154038012|NCT04223219|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154038013|NCT04223219|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154038014|NCT04223219|Narcotics|narcotics|mesh-ancestor
154038015|NCT04223219|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154038016|NCT04223219|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154038017|NCT04223219|Anticonvulsants|anticonvulsants|mesh-ancestor
154038018|NCT04223219|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154038019|NCT04223219|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154038020|NCT04223219|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154038021|NCT04223219|Tocolytic Agents|tocolytic agents|mesh-ancestor
154038022|NCT04223219|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154038023|NCT02631252|Hydroxychloroquine|hydroxychloroquine|mesh-list
154038024|NCT02631252|Etoposide|etoposide|mesh-list
154038026|NCT02631252|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154038027|NCT02631252|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154038028|NCT02631252|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154038029|NCT02631252|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154038030|NCT02631252|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154038031|NCT02631252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154038032|NCT02631252|Antimalarials|antimalarials|mesh-ancestor
154038033|NCT02631252|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154038034|NCT02631252|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153580729|NCT01747564|Mirabegron|mirabegron|mesh-list
154038035|NCT02631252|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154038036|NCT02631252|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154038037|NCT02631252|Analgesics|analgesics|mesh-ancestor
154038039|NCT02631252|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154038040|NCT02631252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154038041|NCT02631408|Vancomycin|vancomycin|mesh-list
154038042|NCT02631408|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154038043|NCT02631408|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154038044|NCT02630394|Azithromycin|azithromycin|mesh-list
154038045|NCT02630394|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154038046|NCT02630394|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154038047|NCT02771405|Ribavirin|ribavirin|mesh-list
154038048|NCT02771405|Sofosbuvir|sofosbuvir|mesh-list
154038049|NCT02771405|Simeprevir|simeprevir|mesh-list
154038050|NCT02771405|Ledipasvir|ledipasvir|mesh-list
154038051|NCT02771405|Antimetabolites|antimetabolites|mesh-ancestor
154038052|NCT02771405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154038053|NCT02771405|Antiviral Agents|antiviral agents|mesh-ancestor
154038054|NCT02771405|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154038055|NCT02771405|Protease Inhibitors|protease inhibitors|mesh-ancestor
154038056|NCT02771405|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154038057|NCT00667758|Cetrorelix|cetrorelix|mesh-list
154038058|NCT00667758|Fertility Agents, Female|fertility agents, female|mesh-ancestor
154038059|NCT00667758|Fertility Agents|fertility agents|mesh-ancestor
154038060|NCT00667758|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154038061|NCT00667758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154038062|NCT00667758|Hormone Antagonists|hormone antagonists|mesh-ancestor
154038063|NCT00667758|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154038064|NCT00542815|Sevelamer|sevelamer|mesh-list
154038065|NCT00542815|Chelating Agents|chelating agents|mesh-ancestor
154038066|NCT00542815|Sequestering Agents|sequestering agents|mesh-ancestor
154038067|NCT00542815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154038068|NCT02762591|Pimavanserin|pimavanserin|mesh-list
154038069|NCT02762591|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
154038070|NCT02762591|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
154038071|NCT02762591|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154038072|NCT02762591|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154038073|NCT02762591|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154038074|NCT02762591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154038078|NCT02762591|Serotonin Agents|serotonin agents|mesh-ancestor
154038079|NCT02762591|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154038080|NCT02762591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154038081|NCT02696369|Lidocaine|lidocaine|mesh-list
154038082|NCT02696369|Epinephrine|epinephrine|mesh-list
154038083|NCT02696369|Racepinephrine|racepinephrine|mesh-list
154038084|NCT02696369|Epinephryl borate|epinephryl borate|mesh-list
154038085|NCT02696369|Anesthetics, Local|anesthetics, local|mesh-ancestor
154038086|NCT02696369|Anesthetics|anesthetics|mesh-ancestor
154038087|NCT02696369|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154038088|NCT02696369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154038089|NCT02696369|Sensory System Agents|sensory system agents|mesh-ancestor
154038090|NCT02696369|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154038091|NCT02696369|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154038092|NCT02696369|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154038093|NCT02696369|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154038094|NCT02696369|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154038095|NCT02696369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154038096|NCT02696369|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154038097|NCT02696369|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154038098|NCT02696369|Adrenergic Agents|adrenergic agents|mesh-ancestor
153730932|NCT00159081|Dopamine Agents|dopamine agents|mesh-ancestor
154038099|NCT02696369|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154038100|NCT02696369|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154038101|NCT02696369|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154038102|NCT02696369|Autonomic Agents|autonomic agents|mesh-ancestor
154038103|NCT02696369|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154038104|NCT02696369|Respiratory System Agents|respiratory system agents|mesh-ancestor
154038105|NCT02696369|Mydriatics|mydriatics|mesh-ancestor
154038106|NCT02696369|Sympathomimetics|sympathomimetics|mesh-ancestor
154038122|NCT02630160|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154038123|NCT02630160|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154038124|NCT02630160|Adrenergic Agents|adrenergic agents|mesh-ancestor
154038125|NCT02630160|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154038126|NCT02630160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154038127|NCT02630160|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154038128|NCT02630160|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154038129|NCT02630160|Autonomic Agents|autonomic agents|mesh-ancestor
154038130|NCT02630160|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154038131|NCT02630160|Respiratory System Agents|respiratory system agents|mesh-ancestor
154038132|NCT02630160|Mydriatics|mydriatics|mesh-ancestor
154038133|NCT02630160|Sympathomimetics|sympathomimetics|mesh-ancestor
154038134|NCT02630160|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154038135|NCT00668304|Moxifloxacin|moxifloxacin|mesh-list
154038136|NCT00668304|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
154038137|NCT00668304|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154038138|NCT00668304|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154038139|NCT00668304|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154038140|NCT00668304|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154038141|NCT00668304|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154038142|NCT00668304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154038143|NCT00668304|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154038144|NCT00668304|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
154038145|NCT00668304|Contraceptive Agents|contraceptive agents|mesh-ancestor
154038146|NCT00668304|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154038147|NCT00668304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154038148|NCT00668304|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
154038151|NCT00542425|Teriparatide|teriparatide|mesh-list
154038166|NCT00668538|Hormone Antagonists|hormone antagonists|mesh-ancestor
154038167|NCT00668538|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154038168|NCT00668538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154038169|NCT00668538|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
154038170|NCT00668538|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154038171|NCT00668538|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154038173|NCT00668616|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
154038174|NCT00668616|Cyclophosphamide|cyclophosphamide|mesh-list
154038175|NCT00668616|Epirubicin|epirubicin|mesh-list
154038176|NCT00668616|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154038177|NCT00668616|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154038178|NCT00668616|Tubulin Modulators|tubulin modulators|mesh-ancestor
154038179|NCT00668616|Antimitotic Agents|antimitotic agents|mesh-ancestor
154038180|NCT00668616|Mitosis Modulators|mitosis modulators|mesh-ancestor
154038181|NCT00668616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154038182|NCT00668616|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154038236|NCT02763839|Dopamine Agents|dopamine agents|mesh-ancestor
154038237|NCT02763839|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154038238|NCT02763839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154038239|NCT00541099|Bevacizumab|bevacizumab|mesh-list
154038240|NCT00541099|Docetaxel|docetaxel|mesh-list
154038241|NCT00541099|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154038242|NCT00541099|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154038252|NCT00580606|Glycerol|glycerol|mesh-list
153814867|NCT00453765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154038257|NCT02575768|Analgesics|analgesics|mesh-ancestor
154038258|NCT02575768|Sensory System Agents|sensory system agents|mesh-ancestor
154038259|NCT02575768|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154038260|NCT02575768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154038261|NCT02575768|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154038262|NCT02575768|Vasodilator Agents|vasodilator agents|mesh-ancestor
154038263|NCT02575768|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
154038264|NCT02575768|Purinergic Agonists|purinergic agonists|mesh-ancestor
154038265|NCT02575768|Purinergic Agents|purinergic agents|mesh-ancestor
154038266|NCT02575768|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154038267|NCT02575768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154038269|NCT00987493|Lenalidomide|lenalidomide|mesh-list
154038270|NCT00987493|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
154038271|NCT00987493|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154038272|NCT00987493|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154038273|NCT00987493|Immunologic Factors|immunologic factors|mesh-ancestor
154038274|NCT00987493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154038275|NCT00987493|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154038276|NCT00987493|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154038302|NCT02577250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153814868|NCT00343733|Fentanyl|fentanyl|mesh-list
153814869|NCT00343733|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154038303|NCT02577250|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
154038304|NCT02577250|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154038305|NCT02577250|Anesthetics, General|anesthetics, general|mesh-ancestor
154038306|NCT02577250|Anesthetics|anesthetics|mesh-ancestor
154038307|NCT02577250|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154038308|NCT02577250|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154038309|NCT02577250|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154038310|NCT02577250|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154038311|NCT02577250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154038312|NCT00668850|Insulin|insulin|mesh-list
154038313|NCT00668850|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
154038314|NCT00668850|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153812889|NCT00430794|Diuretics|diuretics|mesh-ancestor
154038315|NCT00668850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154038316|NCT02762123|Flurbiprofen|flurbiprofen|mesh-list
154038317|NCT02762123|Digoxin|digoxin|mesh-list
154038318|NCT02762123|Midazolam|midazolam|mesh-list
154038319|NCT02762123|Omeprazole|omeprazole|mesh-list
154038320|NCT02762123|Montelukast|montelukast|mesh-list
154038321|NCT02762123|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154038322|NCT02762123|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154038323|NCT02762123|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154038324|NCT02762123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154038325|NCT02762123|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154038326|NCT02762123|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154038327|NCT02762123|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154038328|NCT02762123|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154038329|NCT02762123|Anesthetics, General|anesthetics, general|mesh-ancestor
154038330|NCT02762123|Anesthetics|anesthetics|mesh-ancestor
154038331|NCT02762123|GABA Modulators|gaba modulators|mesh-ancestor
154038344|NCT02762123|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
154038345|NCT02762123|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
154038346|NCT02762123|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154038347|NCT02762123|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
154038348|NCT02762123|Protective Agents|protective agents|mesh-ancestor
154038349|NCT02762123|Analgesics|analgesics|mesh-ancestor
154038350|NCT02762123|Sensory System Agents|sensory system agents|mesh-ancestor
154038351|NCT02762123|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154038352|NCT02762123|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154038353|NCT02762123|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154038354|NCT02762123|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154038355|NCT02762123|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154038356|NCT02762123|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154038358|NCT04153734|Carboplatin|carboplatin|mesh-list
154038359|NCT04153734|Pembrolizumab|pembrolizumab|mesh-list
154038360|NCT04153734|Pemetrexed|pemetrexed|mesh-list
154038361|NCT04153734|Cisplatin|cisplatin|mesh-list
154038362|NCT04153734|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154038363|NCT04153734|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154038364|NCT04153734|Tubulin Modulators|tubulin modulators|mesh-ancestor
154038365|NCT04153734|Antimitotic Agents|antimitotic agents|mesh-ancestor
154038366|NCT04153734|Mitosis Modulators|mitosis modulators|mesh-ancestor
154038367|NCT04153734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153814870|NCT00343733|Narcotics|narcotics|mesh-ancestor
154038396|NCT00579982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154038397|NCT00579982|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154038398|NCT00579982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154038399|NCT00579982|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154038400|NCT00579982|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154038401|NCT00579982|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154038402|NCT00579982|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154038403|NCT00579982|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154038404|NCT00596466|Pregabalin|pregabalin|mesh-list
154038405|NCT00596466|Analgesics|analgesics|mesh-ancestor
154038406|NCT00596466|Sensory System Agents|sensory system agents|mesh-ancestor
154038407|NCT00596466|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154038408|NCT00596466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154038409|NCT00596466|Anticonvulsants|anticonvulsants|mesh-ancestor
154038410|NCT00596466|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154038411|NCT00596466|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154038412|NCT00596466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154038413|NCT00596466|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154038414|NCT00596466|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154038415|NCT00596466|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154038416|NCT00596466|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154038417|NCT00596466|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154038418|NCT02763059|Acetaminophen|acetaminophen|mesh-list
154038419|NCT02763059|Dexamethasone|dexamethasone|mesh-list
154038420|NCT02763059|Ibuprofen|ibuprofen|mesh-list
154038421|NCT02763059|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154038422|NCT02763059|Antiemetics|antiemetics|mesh-ancestor
154038423|NCT02763059|Autonomic Agents|autonomic agents|mesh-ancestor
154038424|NCT02763059|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154038425|NCT02763059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154038426|NCT02763059|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153812919|NCT00331097|Immunologic Factors|immunologic factors|mesh-ancestor
154038427|NCT02763059|Glucocorticoids|glucocorticoids|mesh-ancestor
154038435|NCT02763059|Antipyretics|antipyretics|mesh-ancestor
154038436|NCT02763059|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154038437|NCT02763059|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154038438|NCT02763059|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154038439|NCT02763059|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154038440|NCT02763059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154038441|NCT04222517|Hemostatics|hemostatics|mesh-list
154038442|NCT04222517|Coagulants|coagulants|mesh-ancestor
154038443|NCT00671112|Everolimus|everolimus|mesh-list
154038444|NCT00671112|Bortezomib|bortezomib|mesh-list
154038445|NCT00671112|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
154038446|NCT00671112|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154038447|NCT00671112|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154038448|NCT00671112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154038449|NCT00671112|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154038450|NCT00671112|Immunologic Factors|immunologic factors|mesh-ancestor
154038451|NCT00671112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154038452|NCT00671112|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154038453|NCT04857385|Hemostatics|hemostatics|mesh-list
154038454|NCT04857385|Coagulants|coagulants|mesh-ancestor
154038455|NCT00664014|Tolvaptan|tolvaptan|mesh-list
154038456|NCT00664014|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
154038457|NCT00664014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154038458|NCT00664014|Natriuretic Agents|natriuretic agents|mesh-ancestor
154038459|NCT00664014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154038460|NCT02696915|Fentanyl|fentanyl|mesh-list
154038474|NCT00911664|Vitamin D|vitamin d|mesh-list
154038485|NCT00664170|Antimitotic Agents|antimitotic agents|mesh-ancestor
154038486|NCT00664170|Mitosis Modulators|mitosis modulators|mesh-ancestor
154038487|NCT00664170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154038489|NCT02758067|Brexpiprazole|brexpiprazole|mesh-list
154038490|NCT02758067|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154038491|NCT02758067|Serotonin Agents|serotonin agents|mesh-ancestor
154038492|NCT02758067|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154038493|NCT02758067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154038494|NCT02758067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154038495|NCT02758067|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154038496|NCT02758067|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154038497|NCT02758067|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154038498|NCT02758067|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154038499|NCT02758067|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
154038500|NCT02758067|Dopamine Agents|dopamine agents|mesh-ancestor
154038501|NCT02758067|Dopamine Agonists|dopamine agonists|mesh-ancestor
154038502|NCT00664248|Clindamycin|clindamycin|mesh-list
154038503|NCT00664248|Clindamycin palmitate|clindamycin palmitate|mesh-list
154038504|NCT00664248|Clindamycin phosphate|clindamycin phosphate|mesh-list
154038505|NCT00664248|Benzoyl Peroxide|benzoyl peroxide|mesh-list
154038506|NCT00664248|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154038507|NCT00664248|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154038508|NCT00664248|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
154038509|NCT00664248|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154038510|NCT00664248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154038512|NCT00579670|Ziprasidone|ziprasidone|mesh-list
154038531|NCT00669786|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154038533|NCT02760953|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154038534|NCT02760953|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154038535|NCT02760953|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154038536|NCT02760953|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154038537|NCT02760953|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154038538|NCT02760953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154038539|NCT02630004|Melatonin|melatonin|mesh-list
154038540|NCT02630004|Antioxidants|antioxidants|mesh-ancestor
154038541|NCT02630004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154038542|NCT02630004|Protective Agents|protective agents|mesh-ancestor
153730938|NCT00152841|Vitamin E|vitamin e|mesh-list
154038543|NCT02630004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154038544|NCT02630004|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154038546|NCT00129922|Cyclophosphamide|cyclophosphamide|mesh-list
154038547|NCT00129922|Fluorouracil|fluorouracil|mesh-list
154038548|NCT00129922|Epirubicin|epirubicin|mesh-list
154038549|NCT00129922|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154038550|NCT00129922|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154038551|NCT00129922|Tubulin Modulators|tubulin modulators|mesh-ancestor
154038552|NCT00129922|Antimitotic Agents|antimitotic agents|mesh-ancestor
154038553|NCT00129922|Mitosis Modulators|mitosis modulators|mesh-ancestor
154038554|NCT00129922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154038555|NCT00129922|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154038556|NCT00129922|Immunologic Factors|immunologic factors|mesh-ancestor
154038557|NCT00129922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154038575|NCT04153968|Protective Agents|protective agents|mesh-ancestor
154038576|NCT04153968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154038577|NCT04153968|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154038578|NCT04153968|Immunologic Factors|immunologic factors|mesh-ancestor
154038579|NCT04153968|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
154038580|NCT04153968|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154038581|NCT00671424|Remogliflozin etabonate|remogliflozin etabonate|mesh-list
154038582|NCT00671424|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
154038583|NCT00671424|Furosemide|furosemide|mesh-list
154038584|NCT00671424|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154038585|NCT00671424|Diuretics|diuretics|mesh-ancestor
154038586|NCT00671424|Natriuretic Agents|natriuretic agents|mesh-ancestor
154038587|NCT00671424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154038588|NCT00671424|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
154038589|NCT00671424|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154038590|NCT00671424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154038591|NCT00671424|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
154038592|NCT00671424|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
154038593|NCT00671424|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154038594|NCT00599924|Leucovorin|leucovorin|mesh-list
154038595|NCT00599924|Sunitinib|sunitinib|mesh-list
154038596|NCT00599924|Fluorouracil|fluorouracil|mesh-list
154038597|NCT00599924|Oxaliplatin|oxaliplatin|mesh-list
154038598|NCT00599924|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154038599|NCT00599924|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154038600|NCT00599924|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154038601|NCT00599924|Growth Substances|growth substances|mesh-ancestor
154038602|NCT00599924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154038603|NCT00599924|Growth Inhibitors|growth inhibitors|mesh-ancestor
154038604|NCT00599924|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154038605|NCT00599924|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154038606|NCT00599924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154038607|NCT00599924|Antimetabolites|antimetabolites|mesh-ancestor
154038619|NCT02757209|Formoterol Fumarate|formoterol fumarate|mesh-list
154038620|NCT02757209|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
154038621|NCT02757209|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
154038622|NCT02757209|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154038623|NCT02757209|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154038624|NCT02757209|Autonomic Agents|autonomic agents|mesh-ancestor
154038625|NCT02757209|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154038626|NCT02757209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154038627|NCT02757209|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154038628|NCT02757209|Respiratory System Agents|respiratory system agents|mesh-ancestor
154038629|NCT02757209|Dermatologic Agents|dermatologic agents|mesh-ancestor
154038630|NCT02757209|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154038631|NCT02757209|Glucocorticoids|glucocorticoids|mesh-ancestor
154038632|NCT02757209|Hormones|hormones|mesh-ancestor
154038633|NCT02757209|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153581333|NCT06176157|Cholecalciferol|cholecalciferol|mesh-list
154038634|NCT02757209|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
154038636|NCT02757209|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154038637|NCT02757209|Adrenergic Agents|adrenergic agents|mesh-ancestor
154038638|NCT02757209|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154038639|NCT02757209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154038640|NCT00670254|Hydrocortisone|hydrocortisone|mesh-list
154038641|NCT00670254|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154038642|NCT00581542|Moxifloxacin|moxifloxacin|mesh-list
154038650|NCT02757287|Desogestrel|desogestrel|mesh-list
154038658|NCT02757287|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
154038660|NCT02757287|Hormones|hormones|mesh-ancestor
154038661|NCT02757287|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154038662|NCT02757365|Aspirin|aspirin|mesh-list
154038663|NCT02757365|Levofloxacin|levofloxacin|mesh-list
154038664|NCT02757365|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154038665|NCT02757365|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154038666|NCT02757365|Analgesics|analgesics|mesh-ancestor
154038667|NCT02757365|Sensory System Agents|sensory system agents|mesh-ancestor
154038668|NCT02757365|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154038669|NCT02757365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154038670|NCT02757365|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154038671|NCT02757365|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154038672|NCT02757365|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154038673|NCT02757365|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154038674|NCT02757365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154038675|NCT02757365|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154038676|NCT02757365|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154038677|NCT02757365|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154038678|NCT02757365|Antipyretics|antipyretics|mesh-ancestor
154038679|NCT02757365|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
154038680|NCT02757365|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154038681|NCT02757365|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154038682|NCT02757365|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154038683|NCT02757365|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154038684|NCT02757365|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154038687|NCT02649530|LGK974|lgk974|mesh-list
153814874|NCT00343733|Sensory System Agents|sensory system agents|mesh-ancestor
154038703|NCT04071262|Abiraterone Acetate|abiraterone acetate|mesh-list
154038704|NCT04071262|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154038705|NCT04071262|Glucocorticoids|glucocorticoids|mesh-ancestor
154038706|NCT04071262|Hormones|hormones|mesh-ancestor
154038707|NCT04071262|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154038708|NCT04071262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154038709|NCT04071262|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154038710|NCT04071262|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154038711|NCT04071262|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154038712|NCT04071262|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154038713|NCT04071262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154038714|NCT04071262|Hormone Antagonists|hormone antagonists|mesh-ancestor
154038715|NCT04071262|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154038716|NCT04154748|Omeprazole|omeprazole|mesh-list
154038717|NCT04154748|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154038718|NCT04154748|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154038719|NCT04154748|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
154038720|NCT04154748|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154038721|NCT04154748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154038722|NCT02657096|Hybenx|hybenx|mesh-list
154038723|NCT02657096|Dental Disinfectants|dental disinfectants|mesh-ancestor
154038724|NCT02657096|Disinfectants|disinfectants|mesh-ancestor
154038727|NCT00670410|Busulfan|busulfan|mesh-list
153729904|NCT04696666|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153729905|NCT04696666|Immunologic Factors|immunologic factors|mesh-ancestor
153729906|NCT04696666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153729907|NCT04696666|Viscosupplements|viscosupplements|mesh-ancestor
153729908|NCT04696666|Protective Agents|protective agents|mesh-ancestor
153729909|NCT01248793|Golimumab|golimumab|mesh-list
153729910|NCT01248793|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
153729911|NCT01248793|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
153729912|NCT01248793|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153729913|NCT01248793|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153730942|NCT00152841|Antioxidants|antioxidants|mesh-ancestor
153729914|NCT01248793|Immunologic Factors|immunologic factors|mesh-ancestor
153729915|NCT01248793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153729916|NCT00403715|Ophthalmic Solutions|ophthalmic solutions|mesh-list
153729917|NCT00403715|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
153729918|NCT01248364|Empagliflozin|empagliflozin|mesh-list
153729919|NCT01248364|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
154038742|NCT02756663|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153812932|NCT00331097|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154038743|NCT02756663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154038744|NCT02756663|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154038745|NCT02756663|Glucocorticoids|glucocorticoids|mesh-ancestor
154038746|NCT02756663|Hormones|hormones|mesh-ancestor
154038747|NCT02756663|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154038748|NCT02756663|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154038749|NCT02756663|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154038750|NCT02756663|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
154038751|NCT02756663|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154038752|NCT02756663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154038761|NCT00670566|Irbesartan|irbesartan|mesh-list
154038762|NCT00670566|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154038763|NCT00670566|Diuretics|diuretics|mesh-ancestor
154038764|NCT00670566|Natriuretic Agents|natriuretic agents|mesh-ancestor
154038765|NCT00670566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154038766|NCT00670566|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
154038767|NCT00670566|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154038768|NCT00670566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154038769|NCT00670566|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
154038770|NCT00670566|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
154038771|NCT02629848|Paclitaxel|paclitaxel|mesh-list
154038772|NCT02629848|Carboplatin|carboplatin|mesh-list
154038773|NCT02629848|Motesanib diphosphate|motesanib diphosphate|mesh-list
154038774|NCT02629848|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154038775|NCT02629848|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154038776|NCT02629848|Tubulin Modulators|tubulin modulators|mesh-ancestor
154038777|NCT02629848|Antimitotic Agents|antimitotic agents|mesh-ancestor
154038778|NCT02629848|Mitosis Modulators|mitosis modulators|mesh-ancestor
154038779|NCT02629848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154038780|NCT02629848|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154038781|NCT02629848|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154038782|NCT03912337|Erenumab|erenumab|mesh-list
154038783|NCT03912337|Calcitonin Gene-Related Peptide Receptor Antagonists|calcitonin gene-related peptide receptor antagonists|mesh-ancestor
154038784|NCT03912337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154038785|NCT03912337|Analgesics|analgesics|mesh-ancestor
154038786|NCT03912337|Sensory System Agents|sensory system agents|mesh-ancestor
154038789|NCT00650156|Adalimumab|adalimumab|mesh-list
153814876|NCT00343733|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154038807|NCT02576782|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154038808|NCT02576782|Protease Inhibitors|protease inhibitors|mesh-ancestor
154038809|NCT02576782|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154038810|NCT02576782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154038811|NCT02576782|Anesthetics, Local|anesthetics, local|mesh-ancestor
154038813|NCT02576782|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154038814|NCT02576782|Sensory System Agents|sensory system agents|mesh-ancestor
154038815|NCT02629770|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
154038816|NCT02629770|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154038818|NCT02577094|Busulfan|busulfan|mesh-list
154038819|NCT02577094|Epratuzumab|epratuzumab|mesh-list
154038820|NCT02577094|Thymoglobulin|thymoglobulin|mesh-list
154038821|NCT02577094|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154038822|NCT02577094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154038823|NCT02577094|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154038824|NCT02577094|Immunologic Factors|immunologic factors|mesh-ancestor
154038825|NCT02577094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154038826|NCT02577094|Alkylating Agents|alkylating agents|mesh-ancestor
154038827|NCT02577094|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154038828|NCT02577094|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154038829|NCT02577094|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154038830|NCT00649844|Ziprasidone|ziprasidone|mesh-list
154038831|NCT00649844|Clozapine|clozapine|mesh-list
154038832|NCT00649844|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154038833|NCT00649844|Serotonin Agents|serotonin agents|mesh-ancestor
154038834|NCT00649844|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154038835|NCT00649844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154038836|NCT00649844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154038847|NCT02656472|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
154038848|NCT02656472|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154038849|NCT02656472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154038851|NCT02656472|Coagulants|coagulants|mesh-ancestor
154038852|NCT00665340|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
154038853|NCT00665340|Vasodilator Agents|vasodilator agents|mesh-ancestor
154038854|NCT00665340|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
154038855|NCT00665340|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154038856|NCT00665340|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154038857|NCT00665340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154038858|NCT00665340|Urological Agents|urological agents|mesh-ancestor
154038859|NCT00665418|Sevoflurane|sevoflurane|mesh-list
154038860|NCT00665418|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154038861|NCT00665418|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
154038862|NCT00665418|Anesthetics, General|anesthetics, general|mesh-ancestor
154038863|NCT00665418|Anesthetics|anesthetics|mesh-ancestor
154038864|NCT00665418|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154038865|NCT00665418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154038866|NCT00595920|Vaccines|vaccines|mesh-list
154038867|NCT00595920|Immunologic Factors|immunologic factors|mesh-ancestor
154038868|NCT00595920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154038869|NCT02654288|Gemcitabine|gemcitabine|mesh-list
154038870|NCT02654288|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154038871|NCT02654288|Antimetabolites|antimetabolites|mesh-ancestor
154038872|NCT02654288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154038873|NCT02654288|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154038874|NCT02649140|Acetic Acid|acetic acid|mesh-list
154038875|NCT02649140|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154038876|NCT02649140|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154038877|NCT00665496|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
154038891|NCT02653898|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154038892|NCT02653898|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154038893|NCT02653898|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154038894|NCT02653898|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154038895|NCT02653898|Antiviral Agents|antiviral agents|mesh-ancestor
154038896|NCT02653898|Schistosomicides|schistosomicides|mesh-ancestor
154038897|NCT02653898|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
154038898|NCT02653898|Anthelmintics|anthelmintics|mesh-ancestor
154038899|NCT02653898|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154038900|NCT02653898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154038901|NCT02629536|Acetylcysteine|acetylcysteine|mesh-list
154038902|NCT02629536|N-monoacetylcystine|n-monoacetylcystine|mesh-list
154038903|NCT02629536|Antiviral Agents|antiviral agents|mesh-ancestor
154038904|NCT02629536|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154038905|NCT02629536|Expectorants|expectorants|mesh-ancestor
154038906|NCT02629536|Respiratory System Agents|respiratory system agents|mesh-ancestor
154038907|NCT02629536|Free Radical Scavengers|free radical scavengers|mesh-ancestor
154038908|NCT02629536|Antioxidants|antioxidants|mesh-ancestor
154038909|NCT02629536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154038910|NCT02629536|Protective Agents|protective agents|mesh-ancestor
154038911|NCT02629536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154038912|NCT02629536|Antidotes|antidotes|mesh-ancestor
154038913|NCT04071106|Betamethasone|betamethasone|mesh-list
154038914|NCT04071106|Calcipotriene|calcipotriene|mesh-list
154038915|NCT04071106|Petrolatum|petrolatum|mesh-list
154038916|NCT04071106|Turmeric extract|turmeric extract|mesh-list
154038917|NCT04071106|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154038918|NCT04071106|Glucocorticoids|glucocorticoids|mesh-ancestor
154038936|NCT00670722|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
154038938|NCT00670722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154038939|NCT02648906|Choline|choline|mesh-list
154038940|NCT02648906|Lipotropic Agents|lipotropic agents|mesh-ancestor
154038941|NCT02648906|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154038942|NCT02648906|Antimetabolites|antimetabolites|mesh-ancestor
154038943|NCT02648906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154038944|NCT02648906|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154038945|NCT02648906|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154038946|NCT02648906|Nootropic Agents|nootropic agents|mesh-ancestor
154038947|NCT00670878|Gemcitabine|gemcitabine|mesh-list
154038948|NCT00670878|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154038949|NCT00670878|Antimetabolites|antimetabolites|mesh-ancestor
154038950|NCT00670878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154038951|NCT00670878|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154038952|NCT02760095|Vitamin A|vitamin a|mesh-list
154038953|NCT02760095|Acetic Acid|acetic acid|mesh-list
154038954|NCT02760095|Retinol acetate|retinol acetate|mesh-list
154038955|NCT02760095|Zinc Sulfate|zinc sulfate|mesh-list
153812973|NCT00431106|Tubulin Modulators|tubulin modulators|mesh-ancestor
154038956|NCT02760095|Vitamins|vitamins|mesh-ancestor
154038957|NCT02760095|Micronutrients|micronutrients|mesh-ancestor
154038958|NCT02760095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154038959|NCT02760095|Protective Agents|protective agents|mesh-ancestor
154038960|NCT02760095|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
154038961|NCT02760095|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154038987|NCT02576626|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154038988|NCT02576626|Cholinergic Agents|cholinergic agents|mesh-ancestor
154038990|NCT00877890|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
154038991|NCT00877890|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154038992|NCT00877890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154038993|NCT00877890|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
154038994|NCT00877890|Incretins|incretins|mesh-ancestor
154038995|NCT00877890|Hormones|hormones|mesh-ancestor
154038996|NCT00877890|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154038997|NCT02648672|BPN14770|bpn14770|mesh-list
154038998|NCT02648672|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
154038999|NCT02648672|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154039000|NCT02648672|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154039001|NCT02648672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154039002|NCT04221971|Cyclophosphamide|cyclophosphamide|mesh-list
154039003|NCT04221971|Fludarabine|fludarabine|mesh-list
154039004|NCT04221971|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154039005|NCT04221971|Immunologic Factors|immunologic factors|mesh-ancestor
154039006|NCT04221971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154039007|NCT04221971|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154039008|NCT04221971|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154039009|NCT04221971|Alkylating Agents|alkylating agents|mesh-ancestor
154039010|NCT04221971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154039011|NCT04221971|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154039012|NCT04221971|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154039013|NCT02644694|Dexamethasone|dexamethasone|mesh-list
154039014|NCT02644694|Ophthalmic Solutions|ophthalmic solutions|mesh-list
154039015|NCT02644694|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
153814879|NCT00343733|Anesthetics|anesthetics|mesh-ancestor
153814880|NCT00343811|Modafinil|modafinil|mesh-list
154039032|NCT02653742|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154039033|NCT02653742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154039034|NCT02653742|Analgesics|analgesics|mesh-ancestor
154039035|NCT02653742|Sensory System Agents|sensory system agents|mesh-ancestor
154039036|NCT02653742|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154039037|NCT02653742|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154039038|NCT02653742|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154039039|NCT02653742|Anesthetics, General|anesthetics, general|mesh-ancestor
154039040|NCT02653742|Anesthetics|anesthetics|mesh-ancestor
154039041|NCT02653742|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154039042|NCT02653742|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154039043|NCT02653742|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154039044|NCT02653742|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154039045|NCT02653742|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154039046|NCT02653742|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154039047|NCT02653742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154039048|NCT02755259|Acetazolamide|acetazolamide|mesh-list
154039049|NCT02755259|Anticonvulsants|anticonvulsants|mesh-ancestor
154039050|NCT02755259|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
154039051|NCT02755259|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154039052|NCT02755259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154039053|NCT02755259|Diuretics|diuretics|mesh-ancestor
154039054|NCT02755259|Natriuretic Agents|natriuretic agents|mesh-ancestor
154039055|NCT02755259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154039056|NCT02575222|Nivolumab|nivolumab|mesh-list
154039076|NCT00680394|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
154039077|NCT00680394|Hormone Antagonists|hormone antagonists|mesh-ancestor
154039078|NCT00680394|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154039079|NCT00680394|Luteolytic Agents|luteolytic agents|mesh-ancestor
154039080|NCT00680394|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
154039081|NCT00680394|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
154039082|NCT02768519|OTS167|ots167|mesh-list
153813004|NCT00331604|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
154039083|NCT02768519|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154039084|NCT02768519|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153813011|NCT00331643|Epothilones|epothilones|mesh-list
154039085|NCT02768519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154039086|NCT00671814|Linezolid|linezolid|mesh-list
154039087|NCT00671814|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154039088|NCT00671814|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154039089|NCT00671814|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
154039090|NCT00671814|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154039091|NCT00671814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154039092|NCT02627430|Talazoparib|talazoparib|mesh-list
154039093|NCT02627430|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
154039094|NCT02627430|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154039095|NCT02627430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154039096|NCT02627430|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154039097|NCT02759393|Lansoprazole|lansoprazole|mesh-list
154039098|NCT02759393|Dexlansoprazole|dexlansoprazole|mesh-list
154039099|NCT02759393|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154039100|NCT02759393|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154039101|NCT02759393|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
154039102|NCT02759393|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154039103|NCT02759393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154039104|NCT02576548|MEDI4276|medi4276|mesh-list
154039105|NCT02576548|Immunoconjugates|immunoconjugates|mesh-ancestor
154039106|NCT02576548|Immunologic Factors|immunologic factors|mesh-ancestor
154039107|NCT02576548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154039108|NCT02758925|Cytarabine|cytarabine|mesh-list
154039109|NCT02758925|Rituximab|rituximab|mesh-list
154039116|NCT02758925|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154039118|NCT02758925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154039119|NCT02758925|Antiviral Agents|antiviral agents|mesh-ancestor
154039120|NCT02758925|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154039121|NCT02758925|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154039122|NCT02758925|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154039123|NCT02758925|Alkylating Agents|alkylating agents|mesh-ancestor
154039124|NCT00676260|Pioglitazone|pioglitazone|mesh-list
154039125|NCT00676260|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154039126|NCT00676260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154039127|NCT00652652|Furosemide|furosemide|mesh-list
154039128|NCT00652652|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
154039129|NCT00652652|Diuretics|diuretics|mesh-ancestor
153581869|NCT05165485|Tiotropium Bromide|tiotropium bromide|mesh-list
154039130|NCT00652652|Natriuretic Agents|natriuretic agents|mesh-ancestor
154039131|NCT00652652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154039132|NCT00652652|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
154039168|NCT03474679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153814881|NCT00343811|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
154039170|NCT00676416|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154039171|NCT00676416|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154039172|NCT00676416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154039173|NCT00676416|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154039174|NCT00676416|Anesthetics, General|anesthetics, general|mesh-ancestor
154039175|NCT00676416|Anesthetics|anesthetics|mesh-ancestor
154039176|NCT04150536|Lidocaine|lidocaine|mesh-list
154039177|NCT04150536|Anesthetics, Local|anesthetics, local|mesh-ancestor
154039178|NCT04150536|Anesthetics|anesthetics|mesh-ancestor
154039179|NCT04150536|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154039180|NCT04150536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154039181|NCT04150536|Sensory System Agents|sensory system agents|mesh-ancestor
154039182|NCT04150536|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154039183|NCT04150536|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154039184|NCT04150536|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154039185|NCT04150536|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154039186|NCT04150536|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154039188|NCT05167123|Calcium|calcium|mesh-list
154039194|NCT02576314|Sofosbuvir|sofosbuvir|mesh-list
154039218|NCT06262048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154039219|NCT06262048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154039220|NCT06262048|Urological Agents|urological agents|mesh-ancestor
154039221|NCT06261996|Fospropofol|fospropofol|mesh-list
154039222|NCT06261996|Propofol|propofol|mesh-list
154039223|NCT06261996|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154039224|NCT06261996|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154039225|NCT06261996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154039226|NCT06261996|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154039227|NCT06261996|Anesthetics, General|anesthetics, general|mesh-ancestor
154039228|NCT06261996|Anesthetics|anesthetics|mesh-ancestor
154039229|NCT06261957|Norflurane|norflurane|mesh-list
154039230|NCT06261957|Albuterol|albuterol|mesh-list
154039231|NCT06261957|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154039232|NCT06261957|Autonomic Agents|autonomic agents|mesh-ancestor
154039233|NCT06261957|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154039234|NCT06261957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154039235|NCT06261957|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154039236|NCT06261957|Respiratory System Agents|respiratory system agents|mesh-ancestor
154039237|NCT06261957|Tocolytic Agents|tocolytic agents|mesh-ancestor
154039238|NCT06261957|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154039239|NCT06261957|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
154039240|NCT06261957|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154039241|NCT06261957|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154039242|NCT06261957|Adrenergic Agents|adrenergic agents|mesh-ancestor
154039243|NCT06261957|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154039270|NCT06261580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154039271|NCT06261489|Dronabinol|dronabinol|mesh-list
154039272|NCT06261489|Cannabidiol|cannabidiol|mesh-list
154039273|NCT06261489|Anticonvulsants|anticonvulsants|mesh-ancestor
153582009|NCT04921943|Ethambutol|ethambutol|mesh-list
154039274|NCT06261489|Hallucinogens|hallucinogens|mesh-ancestor
154039275|NCT06261489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154039276|NCT06261489|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154039277|NCT06261489|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154039278|NCT06261489|Analgesics|analgesics|mesh-ancestor
154039279|NCT06261489|Sensory System Agents|sensory system agents|mesh-ancestor
154039280|NCT06261489|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154039281|NCT06261489|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
154039282|NCT06261489|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
154039283|NCT06261489|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154039284|NCT06261489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154039285|NCT06261489|Hormones|hormones|mesh-ancestor
154039286|NCT06261489|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154039287|NCT06261359|Paclitaxel|paclitaxel|mesh-list
154039288|NCT06261359|Gemcitabine|gemcitabine|mesh-list
154039289|NCT06261359|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154039290|NCT06261359|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154039291|NCT06261359|Tubulin Modulators|tubulin modulators|mesh-ancestor
154039292|NCT06261359|Antimitotic Agents|antimitotic agents|mesh-ancestor
154039293|NCT06261359|Mitosis Modulators|mitosis modulators|mesh-ancestor
154039294|NCT06261359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154039295|NCT06261359|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154039296|NCT06261359|Antimetabolites|antimetabolites|mesh-ancestor
154039297|NCT06261320|Amitriptyline|amitriptyline|mesh-list
154039298|NCT06261320|Trimecaine|trimecaine|mesh-list
154039304|NCT06261320|Sensory System Agents|sensory system agents|mesh-ancestor
154039305|NCT06261320|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154039306|NCT06261320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154039307|NCT06261320|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
154039308|NCT06261320|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154039309|NCT06261320|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154039310|NCT06261320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154039311|NCT06261320|Adrenergic Agents|adrenergic agents|mesh-ancestor
154039312|NCT06261320|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154039313|NCT06261320|Anesthetics, Local|anesthetics, local|mesh-ancestor
154039314|NCT06261320|Anesthetics|anesthetics|mesh-ancestor
154039315|NCT06261320|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154039316|NCT06261203|Aspirin|aspirin|mesh-list
154039317|NCT06261203|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153813013|NCT00331643|Tubulin Modulators|tubulin modulators|mesh-ancestor
153813023|NCT00431379|Tenecteplase|tenecteplase|mesh-list
154039318|NCT06261203|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154039319|NCT06261203|Analgesics|analgesics|mesh-ancestor
154039320|NCT06261203|Sensory System Agents|sensory system agents|mesh-ancestor
154039321|NCT06261203|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154039322|NCT06261203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154039323|NCT06261203|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154039324|NCT06261203|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154039325|NCT06261203|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154039326|NCT06261203|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154039327|NCT06261203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154039328|NCT06261203|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154039350|NCT06260904|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154039351|NCT06260904|Dermatologic Agents|dermatologic agents|mesh-ancestor
154039352|NCT06260904|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154039353|NCT06260904|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154039354|NCT06260904|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154039355|NCT06260904|Immunologic Factors|immunologic factors|mesh-ancestor
154039356|NCT06260904|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154039357|NCT06260904|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154039358|NCT06260904|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154039359|NCT06260904|Glucocorticoids|glucocorticoids|mesh-ancestor
154039361|NCT06260904|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154039362|NCT06260904|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154039363|NCT06260904|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154039364|NCT06260904|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154039365|NCT06260904|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154039366|NCT06260904|Analgesics|analgesics|mesh-ancestor
154039367|NCT06260904|Sensory System Agents|sensory system agents|mesh-ancestor
154039368|NCT06260904|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
154039369|NCT06260904|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154039404|NCT06260046|Narcotics|narcotics|mesh-ancestor
154039405|NCT06260046|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154039406|NCT06260046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154039407|NCT06260046|Analgesics|analgesics|mesh-ancestor
154039408|NCT06260046|Sensory System Agents|sensory system agents|mesh-ancestor
154039409|NCT06260046|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154039410|NCT06260046|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154039411|NCT06260046|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154039412|NCT06260046|Anesthetics, General|anesthetics, general|mesh-ancestor
154039413|NCT06260046|Anesthetics|anesthetics|mesh-ancestor
154039415|NCT06260033|Estrogens|estrogens|mesh-ancestor
154039416|NCT06260033|Hormones|hormones|mesh-ancestor
154039417|NCT06260033|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154039418|NCT06260033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154039419|NCT06258785|Tizanidine|tizanidine|mesh-list
154039420|NCT06258785|Analgesics|analgesics|mesh-ancestor
154039421|NCT06258785|Sensory System Agents|sensory system agents|mesh-ancestor
154039422|NCT06258785|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154039423|NCT06258785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154039424|NCT06258785|Anticonvulsants|anticonvulsants|mesh-ancestor
154039425|NCT06258785|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
154039426|NCT06258785|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
154039427|NCT06258785|Parasympatholytics|parasympatholytics|mesh-ancestor
154039428|NCT06258785|Autonomic Agents|autonomic agents|mesh-ancestor
154039429|NCT06258785|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154039430|NCT06258785|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154039431|NCT06258785|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154039432|NCT06258785|Adrenergic Agents|adrenergic agents|mesh-ancestor
154039433|NCT06258785|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154039434|NCT06258785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154039435|NCT06257316|Ephedrine|ephedrine|mesh-list
154039436|NCT06257316|Pseudoephedrine|pseudoephedrine|mesh-list
154039437|NCT06257316|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
154039445|NCT06257316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154039446|NCT06257316|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154039447|NCT06257316|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154039448|NCT06257316|Respiratory System Agents|respiratory system agents|mesh-ancestor
154039449|NCT06257316|Nasal Decongestants|nasal decongestants|mesh-ancestor
154039450|NCT06253871|Trastuzumab|trastuzumab|mesh-list
154039451|NCT06253871|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154039452|NCT06253871|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154039453|NCT06250205|Drospirenone|drospirenone|mesh-list
154039454|NCT06250205|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
154039455|NCT06250205|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
154039456|NCT06250205|Ethinyl Estradiol|ethinyl estradiol|mesh-list
154039457|NCT06250205|Drospirenone and ethinyl estradiol combination|drospirenone and ethinyl estradiol combination|mesh-list
154039458|NCT06250205|Estradiol|estradiol|mesh-list
154039459|NCT06250205|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
154039460|NCT06250205|Estrogens|estrogens|mesh-ancestor
154039461|NCT06250205|Hormones|hormones|mesh-ancestor
154039462|NCT06250205|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154039463|NCT06250205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154039464|NCT06250205|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
154039473|NCT06250205|Diuretics|diuretics|mesh-ancestor
154039499|NCT06229678|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154039500|NCT06229678|Antimetabolites|antimetabolites|mesh-ancestor
154039501|NCT06229678|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154039502|NCT06213324|Ketamine|ketamine|mesh-list
154039503|NCT06213324|Analgesics|analgesics|mesh-ancestor
154039504|NCT06213324|Sensory System Agents|sensory system agents|mesh-ancestor
154039505|NCT06213324|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154039506|NCT06213324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154039507|NCT06213324|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
154039508|NCT06213324|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154039509|NCT06213324|Anesthetics, General|anesthetics, general|mesh-ancestor
154039510|NCT06213324|Anesthetics|anesthetics|mesh-ancestor
154039511|NCT06213324|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154039512|NCT06213324|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154039513|NCT06213324|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154039514|NCT06213324|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154039515|NCT06213324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154039516|NCT06186622|Acetaminophen|acetaminophen|mesh-list
154039517|NCT06186622|Digoxin|digoxin|mesh-list
154039518|NCT06186622|Midazolam|midazolam|mesh-list
154039519|NCT06186622|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
154039520|NCT06186622|Simvastatin|simvastatin|mesh-list
154039521|NCT06186622|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154039522|NCT06186622|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154039523|NCT06186622|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154039525|NCT06186622|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154039550|NCT06177964|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154039552|NCT06177964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154039553|NCT06177964|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154039554|NCT06130995|Relugolix|relugolix|mesh-list
154039555|NCT06130995|Androgen Antagonists|androgen antagonists|mesh-ancestor
154039556|NCT06130995|Hormone Antagonists|hormone antagonists|mesh-ancestor
154039557|NCT06130995|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154039558|NCT06130995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154039559|NCT06103760|Esketamine|esketamine|mesh-list
154039560|NCT06103760|Antidepressive Agents|antidepressive agents|mesh-ancestor
154039561|NCT06103760|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154039562|NCT06097468|Nisin|nisin|mesh-list
154039563|NCT06097468|Nisin Z|nisin z|mesh-list
154039564|NCT06097468|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154039565|NCT06097468|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154039566|NCT06052852|Pembrolizumab|pembrolizumab|mesh-list
154039602|NCT05998642|Immunologic Factors|immunologic factors|mesh-ancestor
154039603|NCT05998642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154039604|NCT05998642|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154039605|NCT05998642|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154039606|NCT05998642|Abortifacient Agents|abortifacient agents|mesh-ancestor
154039607|NCT05998642|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154039608|NCT05998642|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154039609|NCT05998642|Antimetabolites|antimetabolites|mesh-ancestor
154039610|NCT05998642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154039611|NCT05998642|Dermatologic Agents|dermatologic agents|mesh-ancestor
154039612|NCT05998642|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154039613|NCT05998642|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154039614|NCT05998642|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154039615|NCT05998642|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154039616|NCT05998642|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154039617|NCT05998642|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153813028|NCT00331838|Semuloparin|semuloparin|mesh-list
154039618|NCT05959447|Dabigatran|dabigatran|mesh-list
154039619|NCT05959447|Gemfibrozil|gemfibrozil|mesh-list
154039620|NCT05959447|Antithrombins|antithrombins|mesh-ancestor
154039621|NCT05959447|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154039622|NCT05959447|Protease Inhibitors|protease inhibitors|mesh-ancestor
154039623|NCT05959447|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154039624|NCT05959447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154039625|NCT05959447|Anticoagulants|anticoagulants|mesh-ancestor
154039626|NCT05959447|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154039650|NCT05899829|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
154039651|NCT05899829|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
154039652|NCT05899829|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
154039653|NCT05884320|Sacituzumab govitecan|sacituzumab govitecan|mesh-list
154039654|NCT05884320|Immunoconjugates|immunoconjugates|mesh-ancestor
154039655|NCT05884320|Immunologic Factors|immunologic factors|mesh-ancestor
154039656|NCT05884320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154039657|NCT05859074|Pembrolizumab|pembrolizumab|mesh-list
154039658|NCT05859074|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154039659|NCT05859074|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154039660|NCT05859074|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154039661|NCT05859074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154039662|NCT05846880|Vitamin D|vitamin d|mesh-list
154039663|NCT05846880|Ergocalciferols|ergocalciferols|mesh-list
154039664|NCT05846880|Cholecalciferol|cholecalciferol|mesh-list
154039665|NCT05846880|Vitamins|vitamins|mesh-list
154039666|NCT05846880|Lenalidomide|lenalidomide|mesh-list
154039667|NCT05846880|Micronutrients|micronutrients|mesh-ancestor
154039668|NCT05846880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154039669|NCT05846880|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154039670|NCT05846880|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154039671|NCT05846880|Immunologic Factors|immunologic factors|mesh-ancestor
154039672|NCT05846880|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154039674|NCT05846880|Growth Substances|growth substances|mesh-ancestor
153814886|NCT00343811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154039699|NCT05746572|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
154039700|NCT05746572|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154039701|NCT05746572|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154039702|NCT05746572|Adrenergic Agents|adrenergic agents|mesh-ancestor
154039703|NCT05743244|Abrocitinib|abrocitinib|mesh-list
154039704|NCT05743244|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154039705|NCT05743244|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154039706|NCT05743244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154039707|NCT05726253|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
154039708|NCT05726253|Amoxicillin|amoxicillin|mesh-list
154039709|NCT05726253|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154039710|NCT05705518|Ophthalmic Solutions|ophthalmic solutions|mesh-list
154039711|NCT05705518|Lubricant Eye Drops|lubricant eye drops|mesh-list
154039712|NCT05705518|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
154039713|NCT05702931|Semaglutide|semaglutide|mesh-list
154039714|NCT05702931|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
154039715|NCT05702931|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154039716|NCT05702931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154039717|NCT05669989|Dexamethasone|dexamethasone|mesh-list
154039718|NCT05669989|Lenalidomide|lenalidomide|mesh-list
154039719|NCT05669989|Pomalidomide|pomalidomide|mesh-list
154039720|NCT05669989|Cemiplimab|cemiplimab|mesh-list
154039721|NCT05669989|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154039722|NCT05669989|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154039723|NCT05669989|Antiemetics|antiemetics|mesh-ancestor
154039724|NCT05669989|Autonomic Agents|autonomic agents|mesh-ancestor
154039725|NCT05669989|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154039726|NCT05669989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154039727|NCT05669989|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154039728|NCT05669989|Glucocorticoids|glucocorticoids|mesh-ancestor
154039729|NCT05669989|Hormones|hormones|mesh-ancestor
154039740|NCT05663710|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154039741|NCT05663710|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154039742|NCT05663710|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154039743|NCT05663710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154039744|NCT05645861|Benzocaine|benzocaine|mesh-list
154039745|NCT05645861|Anesthetics, Local|anesthetics, local|mesh-ancestor
154039746|NCT05645861|Anesthetics|anesthetics|mesh-ancestor
154039747|NCT05645861|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154039748|NCT05645861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154039749|NCT05645861|Sensory System Agents|sensory system agents|mesh-ancestor
154039750|NCT05645861|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154039751|NCT05645718|Cytarabine|cytarabine|mesh-list
154039752|NCT05645718|Dexamethasone|dexamethasone|mesh-list
154039753|NCT05645718|Prednisone|prednisone|mesh-list
154039754|NCT05645718|Cyclophosphamide|cyclophosphamide|mesh-list
154039755|NCT05645718|Rituximab|rituximab|mesh-list
154039756|NCT05645718|Methotrexate|methotrexate|mesh-list
154039757|NCT05645718|Vincristine|vincristine|mesh-list
154039758|NCT05645718|Mercaptopurine|mercaptopurine|mesh-list
154039759|NCT05645718|Blinatumomab|blinatumomab|mesh-list
154039760|NCT05645718|Inotuzumab Ozogamicin|inotuzumab ozogamicin|mesh-list
154039761|NCT05645718|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154039762|NCT05645718|Immunologic Factors|immunologic factors|mesh-ancestor
154039763|NCT05645718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154039764|NCT05645718|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154039765|NCT05645718|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154039766|NCT05645718|Alkylating Agents|alkylating agents|mesh-ancestor
154039767|NCT05645718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154039768|NCT05645718|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154039769|NCT05645718|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154039770|NCT05645718|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154039771|NCT05645718|Antiemetics|antiemetics|mesh-ancestor
154039772|NCT05645718|Autonomic Agents|autonomic agents|mesh-ancestor
154039775|NCT05645718|Glucocorticoids|glucocorticoids|mesh-ancestor
153814888|NCT00453804|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
154039781|NCT05645718|Abortifacient Agents|abortifacient agents|mesh-ancestor
154039782|NCT05645718|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154039783|NCT05645718|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154039784|NCT05645718|Antimetabolites|antimetabolites|mesh-ancestor
154039785|NCT05645718|Dermatologic Agents|dermatologic agents|mesh-ancestor
154039786|NCT05645718|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154039787|NCT05645718|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154039788|NCT05645718|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154039789|NCT05645718|Antiviral Agents|antiviral agents|mesh-ancestor
154039790|NCT05645718|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154039791|NCT05645718|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154039792|NCT05645718|Tubulin Modulators|tubulin modulators|mesh-ancestor
154039793|NCT05645718|Antimitotic Agents|antimitotic agents|mesh-ancestor
154039794|NCT05645718|Mitosis Modulators|mitosis modulators|mesh-ancestor
154039795|NCT05645718|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154039796|NCT05645718|Immunotoxins|immunotoxins|mesh-ancestor
154039797|NCT05645718|Immunoconjugates|immunoconjugates|mesh-ancestor
153582540|NCT02626715|Antiviral Agents|antiviral agents|mesh-ancestor
154039798|NCT05590624|Phentermine|phentermine|mesh-list
154039799|NCT05590624|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
154039800|NCT05590624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154039801|NCT05590624|Appetite Depressants|appetite depressants|mesh-ancestor
154039802|NCT05590624|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
154039803|NCT05590624|Sympathomimetics|sympathomimetics|mesh-ancestor
154039804|NCT05590624|Autonomic Agents|autonomic agents|mesh-ancestor
154039805|NCT05590624|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154039806|NCT05590624|Adrenergic Agents|adrenergic agents|mesh-ancestor
154039807|NCT05590624|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154039809|NCT05589896|Vidarabine|vidarabine|mesh-list
154039824|NCT05589896|Antimetabolites|antimetabolites|mesh-ancestor
154039825|NCT05589896|Antiviral Agents|antiviral agents|mesh-ancestor
154039826|NCT05589896|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154039827|NCT05589896|Protective Agents|protective agents|mesh-ancestor
154039828|NCT05562947|Ranibizumab|ranibizumab|mesh-list
154039829|NCT05562947|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154039830|NCT05562947|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154039831|NCT05562947|Growth Substances|growth substances|mesh-ancestor
154039832|NCT05562947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154039833|NCT05562947|Growth Inhibitors|growth inhibitors|mesh-ancestor
154039834|NCT05562947|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154039835|NCT05557695|Acalabrutinib|acalabrutinib|mesh-list
154039836|NCT05557695|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154039837|NCT05557695|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154039838|NCT05557695|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154039839|NCT05557695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154039840|NCT05557695|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154039841|NCT05527548|Alendronate|alendronate|mesh-list
154039842|NCT05527548|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154039843|NCT05527548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154039844|NCT05523440|Bevacizumab|bevacizumab|mesh-list
154039845|NCT05523440|Niraparib|niraparib|mesh-list
154039846|NCT05523440|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154039847|NCT05523440|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154039848|NCT05523440|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154039849|NCT05523440|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154039850|NCT05523440|Growth Substances|growth substances|mesh-ancestor
154039851|NCT05523440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154039852|NCT05523440|Growth Inhibitors|growth inhibitors|mesh-ancestor
154039853|NCT05523440|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
154039869|NCT05500092|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154039870|NCT05500092|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154039871|NCT05500092|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154039872|NCT05500092|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154039873|NCT05378763|Docetaxel|docetaxel|mesh-list
154039874|NCT05378763|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154039875|NCT05378763|Tubulin Modulators|tubulin modulators|mesh-ancestor
154039876|NCT05378763|Antimitotic Agents|antimitotic agents|mesh-ancestor
154039877|NCT05378763|Mitosis Modulators|mitosis modulators|mesh-ancestor
154039878|NCT05378763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154039879|NCT05319561|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
154039880|NCT05319561|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154039881|NCT05299944|Cannabidiol|cannabidiol|mesh-list
154039882|NCT05299944|Anticonvulsants|anticonvulsants|mesh-ancestor
154039883|NCT05288361|Acetylcholine|acetylcholine|mesh-list
154039884|NCT05288361|Vasodilator Agents|vasodilator agents|mesh-ancestor
154039885|NCT05288361|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
154039886|NCT05288361|Cholinergic Agents|cholinergic agents|mesh-ancestor
154039887|NCT05288361|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154039888|NCT05288361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154039889|NCT05288361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154039890|NCT05280197|Bupivacaine|bupivacaine|mesh-list
154039891|NCT05280197|Anesthetics, Local|anesthetics, local|mesh-ancestor
154039892|NCT05280197|Anesthetics|anesthetics|mesh-ancestor
154039893|NCT05280197|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154039894|NCT05280197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154039895|NCT05280197|Sensory System Agents|sensory system agents|mesh-ancestor
154039896|NCT05280197|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154039897|NCT05279690|Colchicine|colchicine|mesh-list
154039898|NCT05279690|Gout Suppressants|gout suppressants|mesh-ancestor
154039899|NCT05279690|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154039900|NCT05279690|Tubulin Modulators|tubulin modulators|mesh-ancestor
154039909|NCT05259137|Enalapril|enalapril|mesh-list
154039912|NCT05259137|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154039913|NCT05259137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154039914|NCT05259137|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154039915|NCT05215574|Pembrolizumab|pembrolizumab|mesh-list
154039916|NCT05215574|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154039917|NCT05215574|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154039918|NCT05215574|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154039919|NCT05215574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154039920|NCT05205837|Letrozole|letrozole|mesh-list
154039921|NCT05205837|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154039922|NCT05205837|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
154039923|NCT05205837|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154039925|NCT05205837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154039926|NCT05205837|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
154039927|NCT05205837|Hormone Antagonists|hormone antagonists|mesh-ancestor
154039928|NCT05205837|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154039929|NCT05205837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154039930|NCT05156385|Antihypertensive Agents|antihypertensive agents|mesh-list
154039931|NCT05139225|Daratumumab|daratumumab|mesh-list
154039932|NCT05139225|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154039933|NCT05132504|Pembrolizumab|pembrolizumab|mesh-list
154039962|NCT05007132|Growth Inhibitors|growth inhibitors|mesh-ancestor
154039963|NCT05007132|Antimetabolites|antimetabolites|mesh-ancestor
154039964|NCT05007132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154039965|NCT05007132|Antiviral Agents|antiviral agents|mesh-ancestor
154039966|NCT05007132|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154039967|NCT04998604|Omalizumab|omalizumab|mesh-list
154039968|NCT04998604|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154039969|NCT04998604|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154039970|NCT04998604|Respiratory System Agents|respiratory system agents|mesh-ancestor
154039971|NCT04963764|Amoxicillin|amoxicillin|mesh-list
154039972|NCT04963764|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154039973|NCT04963764|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154039974|NCT04944017|Ketamine|ketamine|mesh-list
154039975|NCT04944017|Analgesics|analgesics|mesh-ancestor
154039976|NCT04944017|Sensory System Agents|sensory system agents|mesh-ancestor
154039977|NCT04944017|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154039978|NCT04944017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154039979|NCT04944017|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
154039980|NCT04944017|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154039981|NCT04944017|Anesthetics, General|anesthetics, general|mesh-ancestor
154039982|NCT04944017|Anesthetics|anesthetics|mesh-ancestor
154039983|NCT04944017|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154039984|NCT04944017|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154039985|NCT04944017|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154039986|NCT04944017|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154039987|NCT04944017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154039988|NCT04930991|Omeprazole|omeprazole|mesh-list
154039989|NCT04930991|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154039990|NCT04930991|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154039991|NCT04930991|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
154039992|NCT04930991|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154039994|NCT04930107|Fluconazole|fluconazole|mesh-list
154040004|NCT04930107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154040005|NCT04930107|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
154040006|NCT04930107|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
154040007|NCT04855695|Venetoclax|venetoclax|mesh-list
154040008|NCT04855695|Obinutuzumab|obinutuzumab|mesh-list
154040009|NCT04855695|Acalabrutinib|acalabrutinib|mesh-list
154040010|NCT04855695|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154040011|NCT04855695|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154040012|NCT04855695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154040013|NCT04855695|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154040014|NCT04855695|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154040015|NCT04855695|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154040016|NCT04817202|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
154040017|NCT04817202|Antibodies|antibodies|mesh-list
154040018|NCT04817202|Immunoglobulins|immunoglobulins|mesh-list
154040019|NCT04817202|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154040020|NCT04817202|Immunologic Factors|immunologic factors|mesh-ancestor
154040021|NCT04817202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154040022|NCT04817202|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154040023|NCT04788043|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
154040024|NCT04788043|Pembrolizumab|pembrolizumab|mesh-list
154040025|NCT04788043|Magrolimab|magrolimab|mesh-list
154040026|NCT04788043|Antibodies|antibodies|mesh-list
154040027|NCT04788043|Immunoglobulins|immunoglobulins|mesh-list
154040028|NCT04788043|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154040029|NCT04788043|Immunologic Factors|immunologic factors|mesh-ancestor
154040030|NCT04788043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154040031|NCT04788043|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153814890|NCT00453804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154040050|NCT04720326|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154040051|NCT04720326|Immunologic Factors|immunologic factors|mesh-ancestor
154040052|NCT04720326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154040053|NCT04720326|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
154040054|NCT04720326|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154040055|NCT04720326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154040056|NCT04711135|Lutetium Lu 177 dotatate|lutetium lu 177 dotatate|mesh-list
154040057|NCT04711135|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
154040058|NCT04711135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154040060|NCT04641026|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154040061|NCT04641026|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
154040062|NCT04641026|Protective Agents|protective agents|mesh-ancestor
154040063|NCT04641026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154040064|NCT04639219|Trastuzumab|trastuzumab|mesh-list
154040065|NCT04639219|Trastuzumab deruxtecan|trastuzumab deruxtecan|mesh-list
154040066|NCT04639219|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154040067|NCT04639219|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154040068|NCT04639219|Immunoconjugates|immunoconjugates|mesh-ancestor
153359553|NCT04899765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154040069|NCT04639219|Immunologic Factors|immunologic factors|mesh-ancestor
154040070|NCT04639219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154040071|NCT04603807|Crizotinib|crizotinib|mesh-list
154040072|NCT04603807|Entrectinib|entrectinib|mesh-list
154040073|NCT04603807|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154040074|NCT04603807|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154040075|NCT04603807|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154040076|NCT04603807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154040077|NCT04603807|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154040078|NCT04565431|Natalizumab|natalizumab|mesh-list
154040079|NCT04565431|Immunologic Factors|immunologic factors|mesh-ancestor
154040080|NCT04565431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154040081|NCT04559217|Radiopharmaceuticals|radiopharmaceuticals|mesh-list
154040083|NCT04526691|Carboplatin|carboplatin|mesh-list
154040086|NCT04526691|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154040087|NCT04526691|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154040088|NCT04526691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154040089|NCT04522661|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
154040090|NCT04522661|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154040091|NCT04504318|Enoxaparin|enoxaparin|mesh-list
154040092|NCT04504318|Apixaban|apixaban|mesh-list
154040093|NCT04504318|Anticoagulants|anticoagulants|mesh-ancestor
154040094|NCT04504318|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154040095|NCT04504318|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154040096|NCT04504318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154040097|NCT04504318|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
154040098|NCT04504318|Antithrombins|antithrombins|mesh-ancestor
154040099|NCT04504318|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154040100|NCT04504318|Protease Inhibitors|protease inhibitors|mesh-ancestor
154040101|NCT04504318|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154040103|NCT04474353|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154040104|NCT04474353|Alkylating Agents|alkylating agents|mesh-ancestor
154040105|NCT04474353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154040106|NCT04474353|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154040107|NCT04454489|Pembrolizumab|pembrolizumab|mesh-list
154040108|NCT04454489|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154040109|NCT04454489|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154040110|NCT04454489|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154040111|NCT04454489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154040112|NCT04437836|Rifampin|rifampin|mesh-list
154040113|NCT04437836|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
154040131|NCT04428333|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154040132|NCT04428333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154040133|NCT04428333|Antimetabolites|antimetabolites|mesh-ancestor
154040134|NCT04428333|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154040135|NCT04428333|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154040136|NCT04428333|Immunologic Factors|immunologic factors|mesh-ancestor
154040137|NCT04428333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154040138|NCT04389866|Hyaluronic Acid|hyaluronic acid|mesh-list
154040139|NCT04389866|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154040140|NCT04389866|Immunologic Factors|immunologic factors|mesh-ancestor
154040141|NCT04389866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154040142|NCT04389866|Viscosupplements|viscosupplements|mesh-ancestor
154040143|NCT04389866|Protective Agents|protective agents|mesh-ancestor
154040144|NCT04359784|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
154040145|NCT04359784|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154040146|NCT04348747|Pembrolizumab|pembrolizumab|mesh-list
154040147|NCT04348747|Vaccines|vaccines|mesh-list
154040148|NCT04348747|Immunologic Factors|immunologic factors|mesh-ancestor
154040149|NCT04348747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154040150|NCT04348747|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154040151|NCT04348747|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154040152|NCT04348747|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154040154|NCT04341311|Panobinostat|panobinostat|mesh-list
154040180|NCT04260477|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
154040181|NCT04260477|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
154040182|NCT04260477|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
154040183|NCT04260477|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
154040184|NCT04260477|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154040185|NCT04260477|Antimetabolites|antimetabolites|mesh-ancestor
154040186|NCT04260477|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154040187|NCT04232761|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
154040188|NCT04232761|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154040189|NCT04227028|Bevacizumab|bevacizumab|mesh-list
154040190|NCT04227028|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
154040191|NCT04227028|Endothelial Growth Factors|endothelial growth factors|mesh-list
154040192|NCT04227028|Antibodies|antibodies|mesh-list
154040193|NCT04227028|Immunoglobulins|immunoglobulins|mesh-list
154040194|NCT04227028|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154040195|NCT04227028|Immunoglobulin G|immunoglobulin g|mesh-list
154040196|NCT04227028|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154040197|NCT04227028|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154040198|NCT04227028|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154040236|NCT04181606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154040237|NCT04175912|Paclitaxel|paclitaxel|mesh-list
154040238|NCT04175912|Carboplatin|carboplatin|mesh-list
154040239|NCT04175912|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
154040240|NCT04175912|Enzyme Inhibitors|enzyme inhibitors|mesh-list
154040241|NCT04175912|Pevonedistat|pevonedistat|mesh-list
154040242|NCT04175912|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154040243|NCT04175912|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154040244|NCT04175912|Tubulin Modulators|tubulin modulators|mesh-ancestor
154040245|NCT04175912|Antimitotic Agents|antimitotic agents|mesh-ancestor
154040246|NCT04175912|Mitosis Modulators|mitosis modulators|mesh-ancestor
154040247|NCT04175912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154040248|NCT04134845|Dantrolene|dantrolene|mesh-list
154040249|NCT04134845|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
154040250|NCT04134845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154040251|NCT04134845|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
154040252|NCT04134845|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154040253|NCT04092283|Paclitaxel|paclitaxel|mesh-list
154040254|NCT04092283|Etoposide|etoposide|mesh-list
154040255|NCT04092283|Podophyllotoxin|podophyllotoxin|mesh-list
154040256|NCT04092283|Cisplatin|cisplatin|mesh-list
154040257|NCT04092283|Carboplatin|carboplatin|mesh-list
154040258|NCT04092283|Pemetrexed|pemetrexed|mesh-list
154040259|NCT04092283|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
154040260|NCT04092283|Etoposide phosphate|etoposide phosphate|mesh-list
154040261|NCT04092283|Durvalumab|durvalumab|mesh-list
154040262|NCT04092283|Immunoglobulins|immunoglobulins|mesh-list
154040263|NCT04092283|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154040264|NCT04092283|Immunoglobulin G|immunoglobulin g|mesh-list
154040265|NCT04092283|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154040285|NCT04068753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154040286|NCT04068753|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154040289|NCT04068597|Venetoclax|venetoclax|mesh-list
154040290|NCT04068597|Pomalidomide|pomalidomide|mesh-list
154040291|NCT04068597|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154040292|NCT04068597|Antiemetics|antiemetics|mesh-ancestor
154040293|NCT04068597|Autonomic Agents|autonomic agents|mesh-ancestor
154040294|NCT04068597|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154040295|NCT04068597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154040296|NCT04068597|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154040297|NCT04068597|Glucocorticoids|glucocorticoids|mesh-ancestor
154040298|NCT04068597|Hormones|hormones|mesh-ancestor
154040299|NCT04068597|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154040300|NCT04068597|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154040301|NCT04068597|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154040302|NCT04068597|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154040303|NCT04068597|Antimetabolites|antimetabolites|mesh-ancestor
154040305|NCT04068597|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154040342|NCT03840148|Cefepime|cefepime|mesh-list
154040343|NCT03840148|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154040344|NCT03840148|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154040345|NCT03818776|Durvalumab|durvalumab|mesh-list
154040346|NCT03818776|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154040347|NCT03818776|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154040348|NCT03780829|Cycloserine|cycloserine|mesh-list
154040349|NCT03780829|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
154040350|NCT03780829|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154040351|NCT03780829|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
154040352|NCT03780829|Antitubercular Agents|antitubercular agents|mesh-ancestor
154040353|NCT03780829|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154040354|NCT03780829|Antimetabolites|antimetabolites|mesh-ancestor
154040355|NCT03780829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154040356|NCT03777163|Vaccines|vaccines|mesh-list
154040357|NCT03777163|Immunologic Factors|immunologic factors|mesh-ancestor
154040358|NCT03777163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154040359|NCT03715933|Carboplatin|carboplatin|mesh-list
154040360|NCT03715933|Fluorouracil|fluorouracil|mesh-list
154040361|NCT03715933|Irinotecan|irinotecan|mesh-list
154040363|NCT03715933|Temozolomide|temozolomide|mesh-list
154040364|NCT03715933|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154040365|NCT03715933|Antimetabolites|antimetabolites|mesh-ancestor
154040366|NCT03715933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154040394|NCT03600961|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153583143|NCT01754116|Anesthetics|anesthetics|mesh-ancestor
154040395|NCT03600961|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154040396|NCT03600961|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154040397|NCT03600961|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154040398|NCT03600961|Antifungal Agents|antifungal agents|mesh-ancestor
154040399|NCT03600961|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154040400|NCT03600961|Immunologic Factors|immunologic factors|mesh-ancestor
154040401|NCT03600961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154040402|NCT03600948|Sirolimus|sirolimus|mesh-list
154040403|NCT03600948|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154040404|NCT03600948|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154040405|NCT03600948|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154040406|NCT03600948|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154040407|NCT03600948|Antifungal Agents|antifungal agents|mesh-ancestor
154040408|NCT03600948|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154040409|NCT03600948|Immunologic Factors|immunologic factors|mesh-ancestor
154040410|NCT03600948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154040411|NCT03587701|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
154040412|NCT03587701|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154040413|NCT03587038|Temozolomide|temozolomide|mesh-list
154040414|NCT03587038|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154040415|NCT03587038|Alkylating Agents|alkylating agents|mesh-ancestor
154040416|NCT03587038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154040417|NCT03587038|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154040418|NCT03531645|Fulvestrant|fulvestrant|mesh-list
154040419|NCT03531645|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154040420|NCT03531645|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154040426|NCT03516214|Trametinib|trametinib|mesh-list
154040437|NCT03476798|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154040438|NCT03476798|Growth Substances|growth substances|mesh-ancestor
154040439|NCT03476798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154040440|NCT03476798|Growth Inhibitors|growth inhibitors|mesh-ancestor
154040441|NCT03476798|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
154040442|NCT03476798|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154040443|NCT03476798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154040444|NCT03464019|Etripamil|etripamil|mesh-list
154040445|NCT03464019|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154040446|NCT03464019|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154040447|NCT03464019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154040448|NCT03464019|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154040449|NCT03464019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154040450|NCT03399773|Cyclophosphamide|cyclophosphamide|mesh-list
154040495|NCT03190941|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154040496|NCT03190941|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154040497|NCT03190941|Alkylating Agents|alkylating agents|mesh-ancestor
154040498|NCT03190941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154040500|NCT03190941|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154040502|NCT03190941|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154040503|NCT03190941|Antiviral Agents|antiviral agents|mesh-ancestor
154040504|NCT03190941|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154040505|NCT03188432|Carboplatin|carboplatin|mesh-list
154040506|NCT03188432|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154040507|NCT03018366|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
154040559|NCT02740699|Atorvastatin|atorvastatin|mesh-list
154040560|NCT02740699|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
154040561|NCT02740699|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154040562|NCT02740699|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154040563|NCT02740699|Antimetabolites|antimetabolites|mesh-ancestor
154040564|NCT02740699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154040565|NCT02740699|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154040566|NCT02740699|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154040567|NCT02740699|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154040568|NCT02717156|Pembrolizumab|pembrolizumab|mesh-list
154040569|NCT02717156|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154040570|NCT02717156|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154040571|NCT02717156|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154040572|NCT02717156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154040618|NCT02443077|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154040619|NCT02443077|Alkylating Agents|alkylating agents|mesh-ancestor
154040620|NCT02443077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154040621|NCT02443077|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154040622|NCT02443077|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154040623|NCT02443077|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154040624|NCT02443077|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154040625|NCT02443077|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154040626|NCT02443077|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154040627|NCT02443077|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154040628|NCT02443077|Antimetabolites|antimetabolites|mesh-ancestor
154040629|NCT02443077|Antiviral Agents|antiviral agents|mesh-ancestor
154040630|NCT02443077|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154040631|NCT02443077|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154040632|NCT02443077|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154040633|NCT02443077|Keratolytic Agents|keratolytic agents|mesh-ancestor
154040634|NCT02443077|Dermatologic Agents|dermatologic agents|mesh-ancestor
154040635|NCT02443077|Tubulin Modulators|tubulin modulators|mesh-ancestor
154040636|NCT02443077|Antimitotic Agents|antimitotic agents|mesh-ancestor
154040637|NCT02443077|Mitosis Modulators|mitosis modulators|mesh-ancestor
154040638|NCT02420613|Sirolimus|sirolimus|mesh-list
154040639|NCT02420613|Temsirolimus|temsirolimus|mesh-list
154040640|NCT02420613|Vorinostat|vorinostat|mesh-list
154040641|NCT02420613|MTOR Inhibitors|mtor inhibitors|mesh-list
154040642|NCT02420613|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154040643|NCT02420613|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154040644|NCT02420613|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154040645|NCT02420613|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153814900|NCT00343850|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153814901|NCT00343850|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154040666|NCT02227199|Immunologic Factors|immunologic factors|mesh-ancestor
154040667|NCT02227199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154040668|NCT02227199|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154040669|NCT02227199|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154040670|NCT02227199|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154040671|NCT02227199|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154040672|NCT02227199|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154040675|NCT02227199|Alkylating Agents|alkylating agents|mesh-ancestor
154040730|NCT02143414|Antimitotic Agents|antimitotic agents|mesh-ancestor
154040731|NCT02143414|Mitosis Modulators|mitosis modulators|mesh-ancestor
154040732|NCT02143414|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154040733|NCT02143414|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154040734|NCT01997840|Dexamethasone|dexamethasone|mesh-list
154040735|NCT01997840|Dexamethasone acetate|dexamethasone acetate|mesh-list
154040736|NCT01997840|Pomalidomide|pomalidomide|mesh-list
154040737|NCT01997840|Ricolinostat|ricolinostat|mesh-list
154040739|NCT01997840|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154040740|NCT01997840|Antiemetics|antiemetics|mesh-ancestor
154040741|NCT01997840|Autonomic Agents|autonomic agents|mesh-ancestor
154040742|NCT01997840|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154040743|NCT01997840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154040744|NCT01997840|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154040745|NCT01997840|Glucocorticoids|glucocorticoids|mesh-ancestor
154040746|NCT01997840|Hormones|hormones|mesh-ancestor
154040747|NCT01997840|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154040748|NCT01997840|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154040749|NCT01997840|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154040750|NCT01997840|Protease Inhibitors|protease inhibitors|mesh-ancestor
153813150|NCT00332384|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154040751|NCT01997840|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154040752|NCT01997840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154040753|NCT01997840|Immunologic Factors|immunologic factors|mesh-ancestor
154040783|NCT01856192|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154040784|NCT01856192|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154040785|NCT01856192|Glucocorticoids|glucocorticoids|mesh-ancestor
154040786|NCT01856192|Hormones|hormones|mesh-ancestor
154040787|NCT01856192|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154040788|NCT01856192|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154040789|NCT01856192|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154040790|NCT01856192|Tubulin Modulators|tubulin modulators|mesh-ancestor
154040791|NCT01856192|Antimitotic Agents|antimitotic agents|mesh-ancestor
154040792|NCT01856192|Mitosis Modulators|mitosis modulators|mesh-ancestor
154040793|NCT01856192|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154040794|NCT01856192|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154040795|NCT01856192|Growth Substances|growth substances|mesh-ancestor
154040796|NCT01856192|Growth Inhibitors|growth inhibitors|mesh-ancestor
154040797|NCT01812252|Azacitidine|azacitidine|mesh-list
154040798|NCT01812252|Decitabine|decitabine|mesh-list
154040799|NCT01812252|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154040800|NCT01812252|Antimetabolites|antimetabolites|mesh-ancestor
154040801|NCT01812252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154040802|NCT01812252|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154040803|NCT01812252|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154040804|NCT01708954|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
154040805|NCT01708954|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154040806|NCT01708954|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154040807|NCT01708954|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154040809|NCT01708954|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154040832|NCT01275677|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154040833|NCT01275677|Tubulin Modulators|tubulin modulators|mesh-ancestor
154040834|NCT01275677|Antimitotic Agents|antimitotic agents|mesh-ancestor
154040835|NCT01275677|Mitosis Modulators|mitosis modulators|mesh-ancestor
154040836|NCT01275677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154040837|NCT01275677|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154040838|NCT01275677|Immunologic Factors|immunologic factors|mesh-ancestor
154040839|NCT01275677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154040840|NCT01275677|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154040841|NCT01275677|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154040842|NCT01275677|Alkylating Agents|alkylating agents|mesh-ancestor
154040843|NCT01275677|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154040844|NCT01275677|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154040845|NCT01275677|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154040846|NCT01275677|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154040847|NCT01275677|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154040848|NCT01275677|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154040849|NCT01251861|Bicalutamide|bicalutamide|mesh-list
154040850|NCT01251861|Androgen Antagonists|androgen antagonists|mesh-ancestor
154040851|NCT01251861|Hormone Antagonists|hormone antagonists|mesh-ancestor
154040852|NCT01251861|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154040853|NCT01251861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154040854|NCT01251861|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154040855|NCT01142388|Paclitaxel|paclitaxel|mesh-list
154040856|NCT01142388|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
154040857|NCT01142388|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154040858|NCT01142388|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154040859|NCT01142388|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154040860|NCT01142388|Tubulin Modulators|tubulin modulators|mesh-ancestor
154040861|NCT01142388|Antimitotic Agents|antimitotic agents|mesh-ancestor
154040862|NCT01142388|Mitosis Modulators|mitosis modulators|mesh-ancestor
154040864|NCT01142388|Immunologic Factors|immunologic factors|mesh-ancestor
154040871|NCT01134614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154040873|NCT01134614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154040874|NCT01125228|Interferons|interferons|mesh-list
154040875|NCT01125228|Interferon-alpha|interferon-alpha|mesh-list
154040876|NCT01125228|Interferon-alfa-1b|interferon-alfa-1b|mesh-list
154040877|NCT01125228|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154040878|NCT01125228|Antiviral Agents|antiviral agents|mesh-ancestor
154040879|NCT01125228|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154040880|NCT01125228|Immunologic Factors|immunologic factors|mesh-ancestor
154040881|NCT01125228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154040882|NCT00601900|Tamoxifen|tamoxifen|mesh-list
154040883|NCT00601900|Bevacizumab|bevacizumab|mesh-list
154040884|NCT00601900|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
154040885|NCT00601900|Letrozole|letrozole|mesh-list
154040886|NCT00601900|Endothelial Growth Factors|endothelial growth factors|mesh-list
154040887|NCT00601900|Antibodies|antibodies|mesh-list
154040888|NCT00601900|Immunoglobulins|immunoglobulins|mesh-list
154040889|NCT00601900|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154040890|NCT00601900|Immunoglobulin G|immunoglobulin g|mesh-list
154040891|NCT00601900|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154040892|NCT00601900|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154040893|NCT00601900|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154040894|NCT00601900|Growth Substances|growth substances|mesh-ancestor
154040895|NCT00601900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154040896|NCT00601900|Growth Inhibitors|growth inhibitors|mesh-ancestor
154040922|NCT00217737|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154040923|NCT00217737|Immunoglobulin G|immunoglobulin g|mesh-list
154040924|NCT00217737|Calcium|calcium|mesh-list
154040925|NCT00217737|Levoleucovorin|levoleucovorin|mesh-list
154040926|NCT00217737|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154040927|NCT00217737|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154040928|NCT00217737|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154040929|NCT00217737|Growth Substances|growth substances|mesh-ancestor
154040930|NCT00217737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154040931|NCT00217737|Growth Inhibitors|growth inhibitors|mesh-ancestor
154040932|NCT00217737|Immunologic Factors|immunologic factors|mesh-ancestor
154040933|NCT00217737|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154040934|NCT00217737|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154040935|NCT00217737|Antimetabolites|antimetabolites|mesh-ancestor
154040936|NCT00217737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154040937|NCT00217737|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154040938|NCT00217737|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154040939|NCT00217737|Antidotes|antidotes|mesh-ancestor
154040940|NCT00217737|Protective Agents|protective agents|mesh-ancestor
154040941|NCT00217737|Vitamin B Complex|vitamin b complex|mesh-ancestor
154040942|NCT00217737|Vitamins|vitamins|mesh-ancestor
154040943|NCT00217737|Micronutrients|micronutrients|mesh-ancestor
154040944|NCT00217737|Hematinics|hematinics|mesh-ancestor
154040945|NCT00680940|Paclitaxel|paclitaxel|mesh-list
154040946|NCT00680940|Cisplatin|cisplatin|mesh-list
154040947|NCT00680940|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154040948|NCT00680940|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154040949|NCT00680940|Tubulin Modulators|tubulin modulators|mesh-ancestor
154040950|NCT00680940|Antimitotic Agents|antimitotic agents|mesh-ancestor
154040951|NCT00680940|Mitosis Modulators|mitosis modulators|mesh-ancestor
154040952|NCT00680940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154040953|NCT02644304|Cabergoline|cabergoline|mesh-list
154040954|NCT02644304|Clomiphene|clomiphene|mesh-list
154040955|NCT02644304|Enclomiphene|enclomiphene|mesh-list
154040956|NCT02644304|Zuclomiphene|zuclomiphene|mesh-list
154040957|NCT02644304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154040958|NCT02644304|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
154040959|NCT02644304|Hormone Antagonists|hormone antagonists|mesh-ancestor
153573206|NCT02325466|Sensory System Agents|sensory system agents|mesh-ancestor
153573207|NCT02325466|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153814903|NCT00344006|Lumefantrine|lumefantrine|mesh-list
153814904|NCT00344006|Artemether|artemether|mesh-list
154040960|NCT02644304|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154040961|NCT02644304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154040962|NCT02644304|Fertility Agents, Female|fertility agents, female|mesh-ancestor
154040963|NCT02644304|Fertility Agents|fertility agents|mesh-ancestor
154040964|NCT02644304|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154040965|NCT02644304|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
154040966|NCT02644304|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
154040967|NCT02644304|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
154040968|NCT02644304|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
154040969|NCT02644304|Dopamine Agonists|dopamine agonists|mesh-ancestor
154040970|NCT02644304|Dopamine Agents|dopamine agents|mesh-ancestor
154040971|NCT02644304|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154040972|NCT00681174|Acetaminophen|acetaminophen|mesh-list
154040973|NCT00681174|Morphine|morphine|mesh-list
154040974|NCT00681174|Remifentanil|remifentanil|mesh-list
154040975|NCT00681174|Oxycodone|oxycodone|mesh-list
154040976|NCT00681174|Propofol|propofol|mesh-list
154040977|NCT00681174|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154040978|NCT00681174|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154040979|NCT00681174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154040980|NCT00681174|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154040981|NCT00681174|Anesthetics, General|anesthetics, general|mesh-ancestor
154040982|NCT00681174|Anesthetics|anesthetics|mesh-ancestor
154041011|NCT00652730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154041012|NCT00652730|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154041013|NCT00652730|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
154041014|NCT00652730|Serotonin Agents|serotonin agents|mesh-ancestor
154041015|NCT00652730|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154041016|NCT00652730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154041017|NCT00652808|Naproxen|naproxen|mesh-list
154041018|NCT00652808|Valdecoxib|valdecoxib|mesh-list
154041019|NCT00652808|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154041020|NCT00652808|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154041021|NCT00652808|Analgesics|analgesics|mesh-ancestor
154041022|NCT00652808|Sensory System Agents|sensory system agents|mesh-ancestor
154041023|NCT00652808|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154041024|NCT00652808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154041025|NCT00652808|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154041026|NCT00652808|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154041027|NCT00652808|Gout Suppressants|gout suppressants|mesh-ancestor
154041028|NCT00652808|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154041029|NCT00652808|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154041030|NCT00652808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154041031|NCT00652808|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
154041032|NCT00635531|Alprazolam|alprazolam|mesh-list
154041033|NCT00635531|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154041034|NCT00635531|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154041035|NCT00635531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154041036|NCT00635531|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154041037|NCT00635531|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154041038|NCT00635531|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154041039|NCT00635531|GABA Modulators|gaba modulators|mesh-ancestor
154041040|NCT00635531|GABA Agents|gaba agents|mesh-ancestor
154041055|NCT03417895|Apatinib|apatinib|mesh-list
154041056|NCT03417895|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154041057|NCT03417895|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154041058|NCT03417895|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154041059|NCT03417895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154041060|NCT01563835|Fentanyl|fentanyl|mesh-list
154041061|NCT01563835|Bupivacaine|bupivacaine|mesh-list
154041062|NCT01563835|Citric Acid|citric acid|mesh-list
154041063|NCT01563835|Sodium Citrate|sodium citrate|mesh-list
154041064|NCT01563835|Anesthetics, Local|anesthetics, local|mesh-ancestor
154041065|NCT01563835|Anesthetics|anesthetics|mesh-ancestor
154041066|NCT01563835|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154041067|NCT01563835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154041068|NCT01563835|Sensory System Agents|sensory system agents|mesh-ancestor
154041069|NCT01563835|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153814905|NCT00344006|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
154041117|NCT02653196|Mitosis Modulators|mitosis modulators|mesh-ancestor
154041118|NCT02653196|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154041119|NCT05135845|Spartalizumab|spartalizumab|mesh-list
154041120|NCT05135845|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154041121|NCT05135845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154041122|NCT05135845|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154041123|NCT05135845|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154041124|NCT04479436|Patritumab deruxtecan|patritumab deruxtecan|mesh-list
154041125|NCT04479436|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154041126|NCT04479436|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154041127|NCT00677118|Cisplatin|cisplatin|mesh-list
154041176|NCT04725695|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154041177|NCT04725695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154041179|NCT04070794|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154041180|NCT04070794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154041181|NCT02695901|Chlorhexidine|chlorhexidine|mesh-list
154041182|NCT02695901|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
154041183|NCT02695901|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154041184|NCT02695901|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154041185|NCT02695901|Disinfectants|disinfectants|mesh-ancestor
154041186|NCT02695901|Dermatologic Agents|dermatologic agents|mesh-ancestor
154041187|NCT00677664|Glatiramer Acetate|glatiramer acetate|mesh-list
154041240|NCT02753309|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154041241|NCT02753309|Antifungal Agents|antifungal agents|mesh-ancestor
154041242|NCT02753309|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154041243|NCT02753309|Immunologic Factors|immunologic factors|mesh-ancestor
154041244|NCT02753309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154041245|NCT04147728|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-list
154041246|NCT04147728|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154041247|NCT04147728|Growth Substances|growth substances|mesh-ancestor
154041248|NCT04147728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154041249|NCT04147728|Growth Inhibitors|growth inhibitors|mesh-ancestor
154041250|NCT04147728|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154041252|NCT03083041|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154041253|NCT03083041|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154041254|NCT03083041|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154041255|NCT03083041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154041256|NCT00672360|Folic Acid|folic acid|mesh-list
154041257|NCT00672360|Hematinics|hematinics|mesh-ancestor
154041258|NCT00672360|Vitamin B Complex|vitamin b complex|mesh-ancestor
154041259|NCT00672360|Vitamins|vitamins|mesh-ancestor
154041260|NCT00672360|Micronutrients|micronutrients|mesh-ancestor
154041261|NCT00672360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154041262|NCT02628522|Lidocaine|lidocaine|mesh-list
154041263|NCT02628522|Epinephrine|epinephrine|mesh-list
154041264|NCT02628522|Anesthetics, Local|anesthetics, local|mesh-ancestor
154041265|NCT02628522|Anesthetics|anesthetics|mesh-ancestor
154041266|NCT02628522|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154041267|NCT02628522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154041268|NCT02628522|Sensory System Agents|sensory system agents|mesh-ancestor
154041269|NCT02628522|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154041270|NCT02628522|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154041271|NCT02628522|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154041272|NCT02628522|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154041275|NCT02628522|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154041281|NCT02628522|Autonomic Agents|autonomic agents|mesh-ancestor
154041282|NCT02628522|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154041283|NCT02628522|Respiratory System Agents|respiratory system agents|mesh-ancestor
154041284|NCT02628522|Mydriatics|mydriatics|mesh-ancestor
154041285|NCT02628522|Sympathomimetics|sympathomimetics|mesh-ancestor
154041286|NCT02628522|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154041287|NCT02572336|Plasminogen|plasminogen|mesh-list
154041288|NCT02572336|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
154041289|NCT02572336|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154041290|NCT02572336|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154041291|NCT02572336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154041292|NCT02750969|Lidocaine|lidocaine|mesh-list
154041293|NCT02750969|Anesthetics, Local|anesthetics, local|mesh-ancestor
154041294|NCT02750969|Anesthetics|anesthetics|mesh-ancestor
154041295|NCT02750969|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154041296|NCT02750969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154041297|NCT02750969|Sensory System Agents|sensory system agents|mesh-ancestor
154041298|NCT02750969|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154041337|NCT00990067|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
154041338|NCT00990067|N-Methyl-3,4-methylenedioxyamphetamine|n-methyl-3,4-methylenedioxyamphetamine|mesh-list
154041339|NCT00990067|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
154041340|NCT00990067|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154041341|NCT00990067|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154041342|NCT00990067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154041343|NCT00990067|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154041344|NCT00990067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154041345|NCT00990067|Analgesics|analgesics|mesh-ancestor
154041346|NCT00990067|Sensory System Agents|sensory system agents|mesh-ancestor
154041347|NCT00990067|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154041348|NCT00990067|Antidepressive Agents|antidepressive agents|mesh-ancestor
154041349|NCT00990067|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154041350|NCT00990067|Dopamine Agents|dopamine agents|mesh-ancestor
154041351|NCT00990067|Hallucinogens|hallucinogens|mesh-ancestor
154041352|NCT00990067|Serotonin Agents|serotonin agents|mesh-ancestor
154041361|NCT00635921|Ziprasidone|ziprasidone|mesh-list
154041395|NCT00652886|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154041396|NCT00652886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154041397|NCT00652886|Anabolic Agents|anabolic agents|mesh-ancestor
154041398|NCT00539305|Methyltestosterone|methyltestosterone|mesh-list
153359674|NCT04412096|Ophthalmic Solutions|ophthalmic solutions|mesh-list
154041399|NCT00539305|Testosterone|testosterone|mesh-list
154041400|NCT00539305|Testosterone undecanoate|testosterone undecanoate|mesh-list
154041401|NCT00539305|Testosterone enanthate|testosterone enanthate|mesh-list
154041402|NCT00539305|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
154041403|NCT00539305|Androgens|androgens|mesh-ancestor
154041404|NCT00539305|Hormones|hormones|mesh-ancestor
154041406|NCT00539305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154041455|NCT02652884|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154041456|NCT02652884|Respiratory System Agents|respiratory system agents|mesh-ancestor
154041457|NCT00990301|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
154041458|NCT00990301|Moexipril|moexipril|mesh-list
154041459|NCT00990301|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154041460|NCT00990301|Diuretics|diuretics|mesh-ancestor
154041461|NCT00990301|Natriuretic Agents|natriuretic agents|mesh-ancestor
154041462|NCT00990301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153730981|NCT00135902|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
154041463|NCT00990301|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
154041464|NCT00990301|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154041465|NCT00990301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154041466|NCT00990301|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
154041467|NCT00990301|Protease Inhibitors|protease inhibitors|mesh-ancestor
154041468|NCT00990301|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154041469|NCT00715858|Doxycycline|doxycycline|mesh-list
154041471|NCT00715858|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154041472|NCT00715858|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154041473|NCT00715858|Antimalarials|antimalarials|mesh-ancestor
154041474|NCT00715858|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154041475|NCT00715858|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154041476|NCT00715858|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
154041477|NCT00715858|Antitubercular Agents|antitubercular agents|mesh-ancestor
154041478|NCT00715858|Leprostatic Agents|leprostatic agents|mesh-ancestor
154041480|NCT00715858|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154041505|NCT05360953|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154041506|NCT05360953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154041507|NCT05360953|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154041508|NCT05360953|Sympatholytics|sympatholytics|mesh-ancestor
154041509|NCT05360953|Autonomic Agents|autonomic agents|mesh-ancestor
154041510|NCT05360953|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154041511|NCT05360953|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154041512|NCT05360953|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154041513|NCT05360953|Adrenergic Agents|adrenergic agents|mesh-ancestor
154041514|NCT05360953|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154041515|NCT05360953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154041516|NCT05360953|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
154041517|NCT05360953|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
154041518|NCT05360953|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154041519|NCT02647424|Letrozole|letrozole|mesh-list
154041520|NCT02647424|Clomiphene|clomiphene|mesh-list
154041521|NCT02647424|Enclomiphene|enclomiphene|mesh-list
154041522|NCT02647424|Zuclomiphene|zuclomiphene|mesh-list
154041523|NCT02647424|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154041524|NCT02647424|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
154041525|NCT02647424|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154041526|NCT02647424|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154041527|NCT02647424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154041528|NCT02647424|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
154041555|NCT00719602|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
154041556|NCT00719602|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154041558|NCT00719602|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
154041559|NCT00719602|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
154041560|NCT02652650|Ethinyl Estradiol|ethinyl estradiol|mesh-list
154041561|NCT02652650|Norethindrone|norethindrone|mesh-list
154041562|NCT02652650|Norethindrone Acetate|norethindrone acetate|mesh-list
154041563|NCT02652650|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
154041564|NCT02652650|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
154041565|NCT02652650|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
154041566|NCT02652650|Contraceptive Agents|contraceptive agents|mesh-ancestor
154041567|NCT02652650|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154041568|NCT02652650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154041569|NCT02652650|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
153919440|NCT02396043|Cytarabine|cytarabine|mesh-list
154041611|NCT04529135|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154041612|NCT04529135|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154041613|NCT04529135|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154041614|NCT04529135|Adrenergic Agents|adrenergic agents|mesh-ancestor
154041615|NCT04529135|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154041616|NCT04529135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154041617|NCT04529135|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154041618|NCT04529135|Narcotics|narcotics|mesh-ancestor
154041619|NCT02647190|Asparaginase|asparaginase|mesh-list
154041620|NCT02647190|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154041621|NCT00653042|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
154041622|NCT00653042|Natriuretic Agents|natriuretic agents|mesh-ancestor
154041623|NCT00653042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154041624|NCT04165850|Ciprofloxacin|ciprofloxacin|mesh-list
154041625|NCT04165850|Celecoxib|celecoxib|mesh-list
154041626|NCT04165850|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154041627|NCT04165850|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154041628|NCT04165850|Analgesics|analgesics|mesh-ancestor
154041668|NCT04218149|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154041669|NCT04218149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154041670|NCT04218149|Sensory System Agents|sensory system agents|mesh-ancestor
154041671|NCT04218149|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154041672|NCT04032860|Tenofovir|tenofovir|mesh-list
154041673|NCT04032860|Entecavir|entecavir|mesh-list
154041674|NCT04032860|Antiviral Agents|antiviral agents|mesh-ancestor
154041675|NCT04032860|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154041676|NCT04032860|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
154041677|NCT04032860|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154041678|NCT04032860|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154041679|NCT04032860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154041680|NCT04032860|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154041681|NCT04032860|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154041682|NCT00716248|Bucillamine|bucillamine|mesh-list
154041683|NCT00716248|Methotrexate|methotrexate|mesh-list
154041684|NCT00716248|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154041685|NCT00716248|Abortifacient Agents|abortifacient agents|mesh-ancestor
154041686|NCT00716248|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154041687|NCT00716248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154041721|NCT02642900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154041723|NCT02652728|Enalaprilat|enalaprilat|mesh-list
154041724|NCT02652728|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
154041725|NCT02652728|Protease Inhibitors|protease inhibitors|mesh-ancestor
154041726|NCT02652728|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154041727|NCT02652728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154041728|NCT02652728|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154041788|NCT00678132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154041789|NCT00678132|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
154041790|NCT00678132|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154041791|NCT02772965|Methotrexate|methotrexate|mesh-list
154041792|NCT02772965|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154041793|NCT02772965|Abortifacient Agents|abortifacient agents|mesh-ancestor
154041794|NCT02772965|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154041795|NCT02772965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154041796|NCT02772965|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154041797|NCT02772965|Antimetabolites|antimetabolites|mesh-ancestor
153731019|NCT00136058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154041798|NCT02772965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154041799|NCT02772965|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154041800|NCT02772965|Dermatologic Agents|dermatologic agents|mesh-ancestor
154041801|NCT02772965|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153359679|NCT04412096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153359680|NCT04412096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153359681|NCT04412096|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153359682|NCT04412096|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154041802|NCT02772965|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154041803|NCT02772965|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154041804|NCT02772965|Immunologic Factors|immunologic factors|mesh-ancestor
154041805|NCT02772965|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154041806|NCT02772965|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154041807|NCT00681720|Flumazenil|flumazenil|mesh-list
154041839|NCT00681876|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154041840|NCT00681876|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154041841|NCT00681876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154041842|NCT02226367|Prazosin|prazosin|mesh-list
154041843|NCT02226367|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154041844|NCT02226367|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
154041845|NCT02226367|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
154041846|NCT02226367|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154041847|NCT02226367|Adrenergic Agents|adrenergic agents|mesh-ancestor
154041848|NCT02226367|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154041849|NCT02226367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154041850|NCT02226367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154041851|NCT03885934|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
154041852|NCT03885934|Immunologic Factors|immunologic factors|mesh-ancestor
154041853|NCT03885934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154041854|NCT02628132|Paclitaxel|paclitaxel|mesh-list
154041855|NCT02628132|Durvalumab|durvalumab|mesh-list
154041879|NCT01822015|Cytarabine|cytarabine|mesh-list
154041888|NCT01822015|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154041889|NCT01822015|Immunologic Factors|immunologic factors|mesh-ancestor
154041890|NCT01822015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154041891|NCT01822015|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154041892|NCT01822015|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154041893|NCT01822015|Antifungal Agents|antifungal agents|mesh-ancestor
154041894|NCT01822015|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154041895|NCT01822015|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154041896|NCT01822015|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154041897|NCT00990535|Octreotide|octreotide|mesh-list
154041898|NCT00990535|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154041899|NCT00990535|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154041900|NCT00990535|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154041901|NCT05590897|Anti-Infective Agents|anti-infective agents|mesh-list
154041949|NCT04391855|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154041950|NCT04391855|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154041951|NCT04391855|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154041952|NCT04391855|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154041953|NCT04391855|Adrenergic Agents|adrenergic agents|mesh-ancestor
154041954|NCT04391855|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154041955|NCT04391855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154041956|NCT04391855|Anesthetics, Local|anesthetics, local|mesh-ancestor
154041957|NCT04391855|Anesthetics|anesthetics|mesh-ancestor
154041958|NCT04391855|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154041959|NCT04391855|Narcotics|narcotics|mesh-ancestor
154041960|NCT00716950|Losartan|losartan|mesh-list
154041961|NCT00716950|Valsartan|valsartan|mesh-list
154041962|NCT00716950|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154041963|NCT00716950|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
154041964|NCT00716950|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
154041966|NCT00716950|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154042004|NCT02629224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154042005|NCT02629224|Anticonvulsants|anticonvulsants|mesh-ancestor
154042006|NCT02629224|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154042007|NCT02629224|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154042008|NCT02629224|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154042009|NCT02629224|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154042010|NCT02629224|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154042011|NCT02629224|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154042012|NCT02629224|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154042013|NCT02629224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154042014|NCT02629224|Antimanic Agents|antimanic agents|mesh-ancestor
154042015|NCT00711256|Sunscreening Agents|sunscreening agents|mesh-list
154042016|NCT00711256|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
154042017|NCT00711256|Protective Agents|protective agents|mesh-ancestor
154042018|NCT00711256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154042019|NCT00711256|Dermatologic Agents|dermatologic agents|mesh-ancestor
154042020|NCT04069234|Clopidogrel|clopidogrel|mesh-list
154042021|NCT04069234|Ticagrelor|ticagrelor|mesh-list
154042022|NCT04069234|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154042023|NCT04069234|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
154042024|NCT04069234|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
154042025|NCT04069234|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
154042026|NCT04069234|Purinergic Agents|purinergic agents|mesh-ancestor
154042027|NCT04069234|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154042028|NCT04069234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153814924|NCT02273661|Amphotericin B|amphotericin b|mesh-list
153814925|NCT02273661|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
154042051|NCT00679146|Ketoprofen|ketoprofen|mesh-list
154042052|NCT00679146|Colchicine|colchicine|mesh-list
154042053|NCT00679146|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154042054|NCT00679146|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154042055|NCT00679146|Analgesics|analgesics|mesh-ancestor
154042056|NCT00679146|Sensory System Agents|sensory system agents|mesh-ancestor
154042057|NCT00679146|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154042058|NCT00679146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154042059|NCT00679146|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154042060|NCT00679146|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154042061|NCT00679146|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154042062|NCT00679146|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154042063|NCT00679146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154042064|NCT00679146|Gout Suppressants|gout suppressants|mesh-ancestor
154042065|NCT00679146|Tubulin Modulators|tubulin modulators|mesh-ancestor
154042066|NCT00679146|Antimitotic Agents|antimitotic agents|mesh-ancestor
154042067|NCT00679146|Mitosis Modulators|mitosis modulators|mesh-ancestor
154042068|NCT00679146|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154042069|NCT00679224|Ambrisentan|ambrisentan|mesh-list
154042074|NCT00990847|Procaterol|procaterol|mesh-list
154042098|NCT00594516|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154042099|NCT00594516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154042101|NCT00594516|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154042102|NCT00682500|Calfactant|calfactant|mesh-list
154042103|NCT00682500|Pulmonary Surfactants|pulmonary surfactants|mesh-ancestor
154042104|NCT00682500|Respiratory System Agents|respiratory system agents|mesh-ancestor
154042105|NCT00538291|Capecitabine|capecitabine|mesh-list
154042106|NCT00538291|Cetuximab|cetuximab|mesh-list
154042107|NCT00538291|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154042108|NCT00538291|Antimetabolites|antimetabolites|mesh-ancestor
154042109|NCT00538291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154042110|NCT00538291|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154042111|NCT00538291|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154042112|NCT00682578|Artesunate|artesunate|mesh-list
154042113|NCT00682578|Chloroquine|chloroquine|mesh-list
154042114|NCT00682578|Pyrimethamine|pyrimethamine|mesh-list
154042115|NCT00682578|Piperaquine|piperaquine|mesh-list
154042116|NCT00682578|Artenimol|artenimol|mesh-list
154042117|NCT00682578|Antimalarials|antimalarials|mesh-ancestor
154042118|NCT00682578|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154042119|NCT00682578|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154042120|NCT00682578|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154042121|NCT00682578|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154042122|NCT00682578|Antiviral Agents|antiviral agents|mesh-ancestor
154042123|NCT00682578|Schistosomicides|schistosomicides|mesh-ancestor
154042124|NCT00682578|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
154042125|NCT00682578|Anthelmintics|anthelmintics|mesh-ancestor
154042126|NCT00682578|Amebicides|amebicides|mesh-ancestor
154042127|NCT00682578|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153813159|NCT00332540|Timolol|timolol|mesh-list
153813160|NCT00332540|Bimatoprost|bimatoprost|mesh-list
153813161|NCT00332540|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
153813162|NCT00332540|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
153813163|NCT00332540|Adrenergic Agents|adrenergic agents|mesh-ancestor
154042128|NCT00682578|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154042129|NCT00682578|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154042130|NCT00682578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154042131|NCT00594906|Teriparatide|teriparatide|mesh-list
154042135|NCT02745431|Oxytocin|oxytocin|mesh-list
153814926|NCT02273661|Amebicides|amebicides|mesh-ancestor
154042141|NCT00682656|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154042142|NCT00682656|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154042143|NCT00682656|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154042144|NCT00682656|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154042145|NCT05590117|Leucovorin|leucovorin|mesh-list
154042146|NCT05590117|Fluorouracil|fluorouracil|mesh-list
154042148|NCT05590117|Pentoxifylline|pentoxifylline|mesh-list
154042149|NCT05590117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154042150|NCT05590117|Antimetabolites|antimetabolites|mesh-ancestor
154042151|NCT05590117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154042152|NCT05590117|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154042153|NCT05590117|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154042154|NCT05590117|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154042155|NCT05590117|Immunologic Factors|immunologic factors|mesh-ancestor
154042156|NCT05590117|Antidotes|antidotes|mesh-ancestor
154042157|NCT05590117|Protective Agents|protective agents|mesh-ancestor
154042158|NCT05590117|Vitamin B Complex|vitamin b complex|mesh-ancestor
154042159|NCT05590117|Vitamins|vitamins|mesh-ancestor
154042160|NCT05590117|Micronutrients|micronutrients|mesh-ancestor
154042161|NCT05590117|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154042167|NCT05590117|Antioxidants|antioxidants|mesh-ancestor
154042198|NCT02747537|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154042199|NCT02747537|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154042200|NCT02747537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154042201|NCT02747537|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154042202|NCT02747537|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154042203|NCT02747381|Alfacalcidol|alfacalcidol|mesh-list
154042204|NCT02747381|Hydroxycholecalciferols|hydroxycholecalciferols|mesh-list
153731045|NCT00136175|Antimetabolites|antimetabolites|mesh-ancestor
154042206|NCT02747381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154042207|NCT02747381|Vitamins|vitamins|mesh-ancestor
154042208|NCT02747381|Micronutrients|micronutrients|mesh-ancestor
154042209|NCT00673218|Omalizumab|omalizumab|mesh-list
154042210|NCT00673218|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154042211|NCT00673218|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154042212|NCT00673218|Respiratory System Agents|respiratory system agents|mesh-ancestor
154042213|NCT00673296|Bevacizumab|bevacizumab|mesh-list
154042214|NCT00673296|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154042215|NCT00673296|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154042216|NCT00673296|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154042254|NCT00683202|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154042255|NCT00683202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154042256|NCT00683202|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154042257|NCT00683202|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154042258|NCT00683202|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154042259|NCT00683202|Antipyretics|antipyretics|mesh-ancestor
154042260|NCT00679536|Fludarabine|fludarabine|mesh-list
154042261|NCT00679536|Busulfan|busulfan|mesh-list
154042262|NCT00679536|Thymoglobulin|thymoglobulin|mesh-list
154042263|NCT00679536|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154042264|NCT00679536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154042265|NCT00679536|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154042266|NCT00679536|Immunologic Factors|immunologic factors|mesh-ancestor
154042267|NCT00679536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154042268|NCT00679536|Alkylating Agents|alkylating agents|mesh-ancestor
154042269|NCT00679536|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154042270|NCT00679536|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154042271|NCT00537979|Ergocalciferols|ergocalciferols|mesh-list
153585020|NCT01764295|Olmesartan|olmesartan|mesh-list
154042272|NCT00537979|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153813164|NCT00332540|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153813165|NCT00332540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153813166|NCT00332540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153813167|NCT00332540|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153813168|NCT00332540|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154042273|NCT00537979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154042308|NCT02744417|Dopamine Agents|dopamine agents|mesh-ancestor
154042309|NCT02744417|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
154042310|NCT02744417|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154042311|NCT02744417|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154042312|NCT02629146|Midazolam|midazolam|mesh-list
154042313|NCT02629146|Fentanyl|fentanyl|mesh-list
154042314|NCT02629146|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154042315|NCT02629146|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154042316|NCT02629146|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154042317|NCT02629146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154042318|NCT02629146|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154042319|NCT02629146|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154042320|NCT02629146|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154042321|NCT02629146|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154042322|NCT02629146|Anesthetics, General|anesthetics, general|mesh-ancestor
154042323|NCT02629146|Anesthetics|anesthetics|mesh-ancestor
154042324|NCT02629146|GABA Modulators|gaba modulators|mesh-ancestor
154042325|NCT02629146|GABA Agents|gaba agents|mesh-ancestor
154042326|NCT02629146|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153814928|NCT02273661|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154042365|NCT02744495|Dopamine Agents|dopamine agents|mesh-ancestor
154042366|NCT02744495|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154042367|NCT02744495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154042368|NCT00683358|Monatide (IMS 3015)|monatide (ims 3015)|mesh-list
154042369|NCT00683358|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154042370|NCT00683358|Immunologic Factors|immunologic factors|mesh-ancestor
154042371|NCT00683358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154042372|NCT00683436|Adipiplon|adipiplon|mesh-list
154042373|NCT00683436|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154042374|NCT00683436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154042375|NCT00683436|GABA Agonists|gaba agonists|mesh-ancestor
153814929|NCT02273661|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154042423|NCT02743247|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154042424|NCT02743247|Immunologic Factors|immunologic factors|mesh-ancestor
154042425|NCT02743247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154042426|NCT02743247|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
154042427|NCT02743247|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154042428|NCT02743247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154042429|NCT02743247|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154042430|NCT02743247|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154042431|NCT02743247|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
154042432|NCT02743247|Antitubercular Agents|antitubercular agents|mesh-ancestor
154042433|NCT02743247|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154042434|NCT02743247|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154042436|NCT00680160|Antifungal Agents|antifungal agents|mesh-ancestor
154042437|NCT00680160|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154042438|NCT00683982|Nitazoxanide|nitazoxanide|mesh-list
154042439|NCT00683982|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154042440|NCT00683982|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154042441|NCT00537823|Leucovorin|leucovorin|mesh-list
154042442|NCT00537823|Bevacizumab|bevacizumab|mesh-list
154042443|NCT00537823|Cetuximab|cetuximab|mesh-list
154042444|NCT00537823|Fluorouracil|fluorouracil|mesh-list
154042445|NCT00537823|Oxaliplatin|oxaliplatin|mesh-list
154042446|NCT00537823|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154042476|NCT05589025|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154042477|NCT02742233|Saxagliptin|saxagliptin|mesh-list
154042478|NCT02742233|Incretins|incretins|mesh-ancestor
154042479|NCT02742233|Hormones|hormones|mesh-ancestor
154042480|NCT02742233|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154042481|NCT02742233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154042482|NCT02742233|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
154042483|NCT02742233|Protease Inhibitors|protease inhibitors|mesh-ancestor
154042484|NCT02742233|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154042485|NCT02742233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154042486|NCT02742233|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154042487|NCT00673608|Deferasirox|deferasirox|mesh-list
154042488|NCT00673608|Iron Chelating Agents|iron chelating agents|mesh-ancestor
154042489|NCT00673608|Chelating Agents|chelating agents|mesh-ancestor
154042490|NCT00673608|Sequestering Agents|sequestering agents|mesh-ancestor
154042491|NCT00673608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154042492|NCT00537277|Insulin Aspart|insulin aspart|mesh-list
154042493|NCT00537277|Biphasic Insulins|biphasic insulins|mesh-list
154042494|NCT00537277|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
154042495|NCT00537277|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154042496|NCT00537277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154042497|NCT02742467|Amlodipine|amlodipine|mesh-list
154042498|NCT02742467|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
154042499|NCT02742467|Perindopril|perindopril|mesh-list
154042500|NCT02742467|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154042501|NCT02742467|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154042502|NCT02742467|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154042503|NCT02742467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154042504|NCT02742467|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154042505|NCT02742467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154042520|NCT00684216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154042521|NCT00684216|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154042523|NCT00684216|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154042524|NCT00684216|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154042525|NCT00684216|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
154042526|NCT00684216|Hormone Antagonists|hormone antagonists|mesh-ancestor
154042527|NCT00684216|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154042528|NCT00684216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154042529|NCT00684216|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154042530|NCT00684216|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
154042531|NCT00684216|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
154042532|NCT00684216|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154042533|NCT00684450|Protamines|protamines|mesh-list
154042534|NCT00684450|Heparin Antagonists|heparin antagonists|mesh-ancestor
154042535|NCT00684450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154042536|NCT00684450|Coagulants|coagulants|mesh-ancestor
154042537|NCT00684528|Metformin|metformin|mesh-list
154042538|NCT00684528|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154042539|NCT00684528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154042540|NCT00684606|Oxytocin|oxytocin|mesh-list
154042541|NCT00684606|Oxytocics|oxytocics|mesh-ancestor
154042542|NCT00684606|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154042543|NCT00684606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154042566|NCT00991627|Anesthetics|anesthetics|mesh-list
154042567|NCT00991627|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154042568|NCT00991627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154042569|NCT00991627|Sensory System Agents|sensory system agents|mesh-ancestor
154042570|NCT00991627|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154042571|NCT00991627|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154042572|NCT00991627|Narcotics|narcotics|mesh-ancestor
154042573|NCT00991627|Analgesics|analgesics|mesh-ancestor
154042574|NCT00991627|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153585309|NCT01765881|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154042575|NCT00991627|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154042576|NCT00991627|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154042577|NCT00991627|Autonomic Agents|autonomic agents|mesh-ancestor
154042578|NCT00991627|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154042579|NCT00991627|Respiratory System Agents|respiratory system agents|mesh-ancestor
154042580|NCT00991627|Mydriatics|mydriatics|mesh-ancestor
154042581|NCT00991627|Parasympatholytics|parasympatholytics|mesh-ancestor
154042582|NCT00991627|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
154042583|NCT00991627|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154042584|NCT00991627|Cholinergic Agents|cholinergic agents|mesh-ancestor
154042585|NCT00991627|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154042586|NCT00991627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154042587|NCT00991627|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
154042588|NCT00991627|Sympathomimetics|sympathomimetics|mesh-ancestor
154042612|NCT02736071|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154042613|NCT02736071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154042614|NCT02736071|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154042615|NCT02736071|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154042616|NCT02736071|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
154042617|NCT02736071|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154042618|NCT02736071|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154042619|NCT02736071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154042620|NCT02736071|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154042621|NCT02736071|Narcotics|narcotics|mesh-ancestor
154042622|NCT02736071|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154042623|NCT00690300|Docetaxel|docetaxel|mesh-list
154042624|NCT00690300|Oxaliplatin|oxaliplatin|mesh-list
154042625|NCT00690300|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154042626|NCT00690300|Tubulin Modulators|tubulin modulators|mesh-ancestor
154042627|NCT00690300|Antimitotic Agents|antimitotic agents|mesh-ancestor
154042628|NCT00690300|Mitosis Modulators|mitosis modulators|mesh-ancestor
154042629|NCT00690300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154042630|NCT02741219|Sufentanil|sufentanil|mesh-list
154042631|NCT02741219|Dexmedetomidine|dexmedetomidine|mesh-list
154042632|NCT02741219|Dsuvia|dsuvia|mesh-list
154042633|NCT02741219|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154042634|NCT02741219|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154042664|NCT00991705|Antimetabolites|antimetabolites|mesh-ancestor
154042665|NCT00991705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154042666|NCT00991705|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154042667|NCT00991705|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154042668|NCT00991705|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154042669|NCT02735837|Doxycycline|doxycycline|mesh-list
154042670|NCT02735837|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154042671|NCT02735837|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154042672|NCT02735837|Antimalarials|antimalarials|mesh-ancestor
154042673|NCT02735837|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154042674|NCT02735837|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154042675|NCT02625558|Riociguat|riociguat|mesh-list
154042676|NCT02625558|Enzyme Activators|enzyme activators|mesh-ancestor
154042678|NCT00685230|Antivenins|antivenins|mesh-list
154042727|NCT04138836|Anesthetics, General|anesthetics, general|mesh-ancestor
154042728|NCT04138836|Anesthetics|anesthetics|mesh-ancestor
154042729|NCT04138836|GABA Modulators|gaba modulators|mesh-ancestor
154042730|NCT04138836|GABA Agents|gaba agents|mesh-ancestor
154042731|NCT04138836|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154042732|NCT04138836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154042733|NCT04138836|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154042734|NCT04138836|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154042735|NCT04138836|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
154042736|NCT04138836|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154042737|NCT04138836|Antifungal Agents|antifungal agents|mesh-ancestor
154042738|NCT04138836|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154042739|NCT04138836|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
154042740|NCT04138836|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154042741|NCT04138836|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154042742|NCT04138836|Hormone Antagonists|hormone antagonists|mesh-ancestor
154042743|NCT04138836|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154042744|NCT04138836|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154042745|NCT00922584|Sorafenib|sorafenib|mesh-list
154042746|NCT00922584|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154042747|NCT00922584|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154042748|NCT00922584|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154042749|NCT00922584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154042750|NCT02735603|Moxifloxacin|moxifloxacin|mesh-list
154042751|NCT02735603|Naltrexone|naltrexone|mesh-list
154042752|NCT02735603|Bupropion|bupropion|mesh-list
154042753|NCT02735603|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154042754|NCT02735603|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154042755|NCT02735603|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154042756|NCT02735603|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154042757|NCT02735603|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154042759|NCT02735603|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154042764|NCT02735603|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154042765|NCT02735603|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
154042766|NCT02735603|Antidepressive Agents|antidepressive agents|mesh-ancestor
154042768|NCT02735603|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
154042769|NCT02735603|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154042770|NCT02735603|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154042771|NCT02735603|Dopamine Agents|dopamine agents|mesh-ancestor
154042772|NCT02735603|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154042773|NCT02735603|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
154042774|NCT02735603|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154042775|NCT00685776|Anacetrapib|anacetrapib|mesh-list
154042776|NCT00685776|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154042777|NCT00685776|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154042778|NCT00685776|Antimetabolites|antimetabolites|mesh-ancestor
154042779|NCT00685776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154042821|NCT01564303|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154042822|NCT01564303|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154042823|NCT00674232|Misoprostol|misoprostol|mesh-list
154042824|NCT00674232|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154042825|NCT00674232|Abortifacient Agents|abortifacient agents|mesh-ancestor
154042826|NCT00674232|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154042827|NCT00674232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154042828|NCT00674232|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154042829|NCT00674232|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154042830|NCT00674232|Oxytocics|oxytocics|mesh-ancestor
154042831|NCT00674310|Ropinirole|ropinirole|mesh-list
154042832|NCT00674310|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
154042833|NCT00674310|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
154042834|NCT00674310|Dopamine Agonists|dopamine agonists|mesh-ancestor
154042835|NCT00674310|Dopamine Agents|dopamine agents|mesh-ancestor
154042836|NCT00674310|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154042837|NCT00674310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154042838|NCT00674310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154042839|NCT00686010|Dalcetrapib|dalcetrapib|mesh-list
154042878|NCT02739815|Tranexamic Acid|tranexamic acid|mesh-list
154042879|NCT02739815|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154042880|NCT02739815|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
154042881|NCT02739815|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154042882|NCT02739815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154042883|NCT02739815|Hemostatics|hemostatics|mesh-ancestor
154042884|NCT02739815|Coagulants|coagulants|mesh-ancestor
154042886|NCT00720616|Hormones|hormones|mesh-list
154042887|NCT00720616|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154042888|NCT00720616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154042889|NCT00720616|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154042890|NCT00720772|Sodium thiosulfate|sodium thiosulfate|mesh-list
154042891|NCT00720772|Antidotes|antidotes|mesh-ancestor
154042931|NCT00717340|Antimitotic Agents|antimitotic agents|mesh-ancestor
154042932|NCT00717340|Mitosis Modulators|mitosis modulators|mesh-ancestor
154042933|NCT00717340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154042934|NCT00717340|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154042935|NCT00717340|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154042936|NCT02733887|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
154042937|NCT02733887|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
154042938|NCT02733887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154042939|NCT00874848|Paclitaxel|paclitaxel|mesh-list
154042940|NCT00874848|Carboplatin|carboplatin|mesh-list
154042941|NCT00874848|Cetuximab|cetuximab|mesh-list
154042942|NCT00874848|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
153731081|NCT00159510|Respiratory System Agents|respiratory system agents|mesh-ancestor
154042943|NCT00874848|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154042944|NCT00874848|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154042945|NCT00874848|Tubulin Modulators|tubulin modulators|mesh-ancestor
154042946|NCT00874848|Antimitotic Agents|antimitotic agents|mesh-ancestor
154042947|NCT00874848|Mitosis Modulators|mitosis modulators|mesh-ancestor
154042948|NCT00874848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154042949|NCT00874848|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154042950|NCT00691236|Zoledronic Acid|zoledronic acid|mesh-list
154042951|NCT00691236|Doxorubicin|doxorubicin|mesh-list
154042984|NCT05407597|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154042985|NCT05407597|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154042986|NCT05407597|Analgesics|analgesics|mesh-ancestor
154042987|NCT05407597|Sensory System Agents|sensory system agents|mesh-ancestor
154042988|NCT05407597|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154042989|NCT05407597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154042990|NCT05407597|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154042991|NCT05407597|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154042992|NCT05407597|Bradykinin B2 Receptor Antagonists|bradykinin b2 receptor antagonists|mesh-ancestor
154042993|NCT05407597|Bradykinin Receptor Antagonists|bradykinin receptor antagonists|mesh-ancestor
154042994|NCT05407597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154042995|NCT05407597|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
154042996|NCT05407597|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154042997|NCT05407597|Immunologic Factors|immunologic factors|mesh-ancestor
154042998|NCT05407207|Immunologic Factors|immunologic factors|mesh-list
154042999|NCT05407207|Immunomodulating Agents|immunomodulating agents|mesh-list
154043000|NCT05407207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154043001|NCT05493995|Paclitaxel|paclitaxel|mesh-list
154043002|NCT05493995|Gemcitabine|gemcitabine|mesh-list
154043003|NCT05493995|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154043004|NCT05493995|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154043005|NCT05493995|Tubulin Modulators|tubulin modulators|mesh-ancestor
154043033|NCT02738177|Isosorbide Dinitrate|isosorbide dinitrate|mesh-list
154043034|NCT02738177|Isosorbide-5-mononitrate|isosorbide-5-mononitrate|mesh-list
154043035|NCT02738177|Misoprostol|misoprostol|mesh-list
154043036|NCT02738177|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154043037|NCT02738177|Abortifacient Agents|abortifacient agents|mesh-ancestor
154043038|NCT02738177|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154043039|NCT02738177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154043040|NCT02738177|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154043041|NCT02738177|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154043042|NCT02738177|Oxytocics|oxytocics|mesh-ancestor
154043043|NCT02738177|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
154043044|NCT02738177|Diuretics|diuretics|mesh-ancestor
154043045|NCT02738177|Natriuretic Agents|natriuretic agents|mesh-ancestor
154043046|NCT02738177|Vasodilator Agents|vasodilator agents|mesh-ancestor
154043047|NCT02738177|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
154043048|NCT02738177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154043049|NCT04043806|Ivacaftor|ivacaftor|mesh-list
154043050|NCT04043806|Elexacaftor|elexacaftor|mesh-list
154043051|NCT04043806|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
154043052|NCT04043806|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154043053|NCT04043806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154043054|NCT02737943|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
154043055|NCT02737943|Analgesics|analgesics|mesh-list
154043056|NCT02737943|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154043057|NCT02737943|Sensory System Agents|sensory system agents|mesh-ancestor
154043058|NCT02737943|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154043059|NCT02737943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154043060|NCT05290753|Erythromycin|erythromycin|mesh-list
154043080|NCT02572960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154043081|NCT02572960|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154043082|NCT02572960|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154043083|NCT02572960|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154043084|NCT02572960|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
154043085|NCT02572960|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
154043086|NCT02572960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154043087|NCT04001959|Fluorides|fluorides|mesh-list
154043088|NCT04001959|Cariostatic Agents|cariostatic agents|mesh-ancestor
154043089|NCT04001959|Protective Agents|protective agents|mesh-ancestor
154043090|NCT04001959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154043091|NCT00721240|Montelukast|montelukast|mesh-list
154043138|NCT00721552|Protease Inhibitors|protease inhibitors|mesh-ancestor
154043139|NCT00721552|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154043140|NCT00721552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154043141|NCT04069078|Scopolamine|scopolamine|mesh-list
154043142|NCT04069078|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
154043143|NCT04069078|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154043144|NCT04069078|Antiemetics|antiemetics|mesh-ancestor
154043145|NCT04069078|Autonomic Agents|autonomic agents|mesh-ancestor
154043146|NCT04069078|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154043147|NCT04069078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154043148|NCT04069078|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154043149|NCT04069078|Mydriatics|mydriatics|mesh-ancestor
154043150|NCT04069078|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154043151|NCT04069078|Cholinergic Agents|cholinergic agents|mesh-ancestor
154043152|NCT04069078|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154043153|NCT04069078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154043154|NCT04069078|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
154043155|NCT04069078|Parasympatholytics|parasympatholytics|mesh-ancestor
154043156|NCT02732249|Metronidazole|metronidazole|mesh-list
154043157|NCT02732249|Clarithromycin|clarithromycin|mesh-list
154043158|NCT02732249|Potassium Citrate|potassium citrate|mesh-list
154043159|NCT02732249|Esomeprazole|esomeprazole|mesh-list
154043161|NCT02732249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154043190|NCT02732093|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154043191|NCT02732093|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154043192|NCT02732093|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154043193|NCT02732093|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154043194|NCT02732093|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154043195|NCT02732093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154043196|NCT00718276|Vitamin D|vitamin d|mesh-list
154043197|NCT00718276|Cholecalciferol|cholecalciferol|mesh-list
154043198|NCT00718276|Vitamins|vitamins|mesh-ancestor
154043199|NCT00718276|Micronutrients|micronutrients|mesh-ancestor
154043200|NCT00718276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154043201|NCT00718276|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154043202|NCT00718276|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154043203|NCT00718354|Cisplatin|cisplatin|mesh-list
154043204|NCT00718354|Carboplatin|carboplatin|mesh-list
154043205|NCT00718354|Capecitabine|capecitabine|mesh-list
154043206|NCT00718354|Fluorouracil|fluorouracil|mesh-list
154043207|NCT00718354|Oxaliplatin|oxaliplatin|mesh-list
154043208|NCT00718354|Epirubicin|epirubicin|mesh-list
154043209|NCT00718354|Enoxaparin|enoxaparin|mesh-list
154043210|NCT00718354|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154043211|NCT00718354|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154043212|NCT00718354|Antimetabolites|antimetabolites|mesh-ancestor
154043213|NCT00718354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154043214|NCT00718354|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154043215|NCT00718354|Immunologic Factors|immunologic factors|mesh-ancestor
154043216|NCT00718354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154043217|NCT00718354|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154043218|NCT00718354|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154043219|NCT00718354|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154043220|NCT00718354|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154043221|NCT00718354|Anticoagulants|anticoagulants|mesh-ancestor
154043222|NCT00718354|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154043223|NCT00718354|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154043224|NCT00536809|Capecitabine|capecitabine|mesh-list
154043225|NCT00536809|Oxaliplatin|oxaliplatin|mesh-list
154043226|NCT00536809|Lapatinib|lapatinib|mesh-list
154043229|NCT00536809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154043230|NCT00536809|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154043231|NCT00536809|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154043232|NCT00536809|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154043233|NCT00536809|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154043234|NCT04189601|Complement System Proteins|complement system proteins|mesh-list
154043235|NCT04189601|Immunologic Factors|immunologic factors|mesh-ancestor
154043236|NCT04189601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154043237|NCT04067986|Apatinib|apatinib|mesh-list
154043238|NCT04067986|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154043239|NCT04067986|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154043240|NCT04067986|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154043241|NCT04067986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154043242|NCT00536731|Budesonide|budesonide|mesh-list
154043243|NCT00536731|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
154043244|NCT00536731|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154043245|NCT00536731|Respiratory System Agents|respiratory system agents|mesh-ancestor
153585980|NCT01769677|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154043246|NCT00536731|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154043247|NCT00536731|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154043248|NCT00536731|Autonomic Agents|autonomic agents|mesh-ancestor
154043249|NCT00536731|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154043250|NCT00536731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154043276|NCT02730845|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154043277|NCT02730845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154043278|NCT02730689|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
154043279|NCT02730689|Ezetimibe|ezetimibe|mesh-list
154043280|NCT02730689|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154043281|NCT02730689|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154043282|NCT02730689|Antimetabolites|antimetabolites|mesh-ancestor
153782298|NCT00260247|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154043283|NCT02730689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154043284|NCT02730689|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154043285|NCT02730689|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154043286|NCT02730689|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154043287|NCT02730533|Esomeprazole|esomeprazole|mesh-list
154043288|NCT02730533|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154043289|NCT02730533|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154043290|NCT02730533|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
154043291|NCT02730533|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154043292|NCT02730533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154043293|NCT00536575|Bortezomib|bortezomib|mesh-list
154043294|NCT00536575|Sorafenib|sorafenib|mesh-list
154043295|NCT00536575|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154043329|NCT00992095|Buprenorphine|buprenorphine|mesh-list
154043330|NCT00992095|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154043331|NCT00992095|Narcotics|narcotics|mesh-ancestor
154043332|NCT00992095|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154043333|NCT00992095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154043334|NCT00992095|Analgesics|analgesics|mesh-ancestor
154043335|NCT00992095|Sensory System Agents|sensory system agents|mesh-ancestor
154043336|NCT00992095|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154043337|NCT00992095|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
154043338|NCT00653354|Valdecoxib|valdecoxib|mesh-list
154043339|NCT00653354|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
154043340|NCT00653354|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154043341|NCT00653354|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154043342|NCT00653354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154043343|NCT00653354|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154043344|NCT00653354|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154043345|NCT00653354|Analgesics|analgesics|mesh-ancestor
154043346|NCT00653354|Sensory System Agents|sensory system agents|mesh-ancestor
154043347|NCT00653354|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154043348|NCT00653354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154043349|NCT00653354|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154043350|NCT00653354|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154043351|NCT00712504|Docetaxel|docetaxel|mesh-list
154043352|NCT00712504|Sunitinib|sunitinib|mesh-list
154043353|NCT00712504|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154043354|NCT00712504|Tubulin Modulators|tubulin modulators|mesh-ancestor
154043355|NCT00712504|Antimitotic Agents|antimitotic agents|mesh-ancestor
154043356|NCT00712504|Mitosis Modulators|mitosis modulators|mesh-ancestor
154043357|NCT00712504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154043375|NCT02694653|Antipyretics|antipyretics|mesh-ancestor
154043376|NCT00722956|N-(1-(3-(3,5-difluorophenyl)-3-(4-methanesulfonylphenyl)propyl)piperidin-4-yl)-N-ethyl-2-(4-methanesulfonylphenyl)acetamide|n-(1-(3-(3,5-difluorophenyl)-3-(4-methanesulfonylphenyl)propyl)piperidin-4-yl)-n-ethyl-2-(4-methanesulfonylphenyl)acetamide|mesh-list
154043377|NCT00722956|Atorvastatin|atorvastatin|mesh-list
154043378|NCT00722956|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154043379|NCT00722956|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154043380|NCT00722956|Antimetabolites|antimetabolites|mesh-ancestor
154043381|NCT00722956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154043382|NCT00722956|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154043383|NCT00722956|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154043384|NCT00722956|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154043385|NCT00722956|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
154043386|NCT00722956|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154043387|NCT00722956|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154043388|NCT00722956|Antiviral Agents|antiviral agents|mesh-ancestor
154043389|NCT00722956|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154043390|NCT00992173|3-Iodobenzylguanidine|3-iodobenzylguanidine|mesh-list
154043391|NCT00992173|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154043392|NCT00992173|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154043393|NCT00992173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154043394|NCT00992173|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
154043396|NCT02729285|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
154043424|NCT02729441|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154043425|NCT02729441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154043426|NCT02729441|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154043427|NCT00712660|Antipsychotic Agents|antipsychotic agents|mesh-list
154043428|NCT00712660|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154043429|NCT00712660|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154043430|NCT00712660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154043431|NCT00712660|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154043433|NCT00636545|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154043434|NCT00722488|Pevonedistat|pevonedistat|mesh-list
154043435|NCT00722488|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154043437|NCT00652106|Timolol|timolol|mesh-list
154043488|NCT00578344|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154043489|NCT00578344|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154043490|NCT00578344|Alkylating Agents|alkylating agents|mesh-ancestor
154043491|NCT00578344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154043492|NCT00578344|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154043493|NCT00578344|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154043494|NCT00578344|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154043495|NCT00653588|Atorvastatin|atorvastatin|mesh-list
154043496|NCT00653588|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
154043497|NCT00653588|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154043498|NCT00653588|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154043499|NCT00653588|Antimetabolites|antimetabolites|mesh-ancestor
154043500|NCT00653588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154043501|NCT00653588|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154043502|NCT00653588|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154043503|NCT00653588|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154043504|NCT00723346|Asparaginase|asparaginase|mesh-list
154043505|NCT00723346|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154043506|NCT02571400|Analgesics, Opioid|analgesics, opioid|mesh-list
154043507|NCT02571400|Analgesics|analgesics|mesh-list
154043508|NCT02571400|Narcotics|narcotics|mesh-ancestor
154043509|NCT02571400|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154043510|NCT02571400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154043511|NCT02571400|Sensory System Agents|sensory system agents|mesh-ancestor
154043512|NCT02571400|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154043513|NCT02641652|Sertraline|sertraline|mesh-list
154043514|NCT02641652|Antidepressive Agents|antidepressive agents|mesh-ancestor
154043515|NCT02641652|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154043516|NCT02641652|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
154043517|NCT02641652|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154043531|NCT00686478|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154043532|NCT00686478|Antiviral Agents|antiviral agents|mesh-ancestor
154043533|NCT00686478|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154043534|NCT00686478|Immunologic Factors|immunologic factors|mesh-ancestor
154043535|NCT00686478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154043536|NCT00723424|N-(1-(3-(3,5-difluorophenyl)-3-(4-methanesulfonylphenyl)propyl)piperidin-4-yl)-N-ethyl-2-(4-methanesulfonylphenyl)acetamide|n-(1-(3-(3,5-difluorophenyl)-3-(4-methanesulfonylphenyl)propyl)piperidin-4-yl)-n-ethyl-2-(4-methanesulfonylphenyl)acetamide|mesh-list
154043537|NCT00723424|Digoxin|digoxin|mesh-list
154043538|NCT00723424|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154043539|NCT00723424|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
154043540|NCT00723424|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154043541|NCT00723424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154043542|NCT00723424|Protective Agents|protective agents|mesh-ancestor
154043543|NCT00723424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154043544|NCT00723424|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
154043545|NCT00723424|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154043588|NCT00712738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154043589|NCT00712738|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154043590|NCT00712738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154043591|NCT00712738|Vasodilator Agents|vasodilator agents|mesh-ancestor
154043592|NCT00712738|Tocolytic Agents|tocolytic agents|mesh-ancestor
154043593|NCT00712738|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154043594|NCT00686556|Cyclosporine|cyclosporine|mesh-list
154043595|NCT00686556|Mycophenolic Acid|mycophenolic acid|mesh-list
154043596|NCT00686556|Cyclophosphamide|cyclophosphamide|mesh-list
154043597|NCT00686556|Fludarabine|fludarabine|mesh-list
154043598|NCT00686556|Cyclosporins|cyclosporins|mesh-list
154043599|NCT00686556|Lenograstim|lenograstim|mesh-list
154043600|NCT00686556|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154043601|NCT00686556|Immunologic Factors|immunologic factors|mesh-ancestor
154043602|NCT00686556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154043649|NCT00723502|Amoxicillin|amoxicillin|mesh-list
154043650|NCT00723502|Finafloxacin|finafloxacin|mesh-list
154043651|NCT00723502|Fluoroquinolones|fluoroquinolones|mesh-list
154043652|NCT00723502|Esomeprazole|esomeprazole|mesh-list
154043653|NCT00723502|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154043654|NCT00723502|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154043655|NCT00723502|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154043656|NCT00723502|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154043657|NCT00723502|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
154043658|NCT00723502|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154043659|NCT00723502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154043660|NCT00723502|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
154043661|NCT00723502|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154043662|NCT00723502|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154043663|NCT00723502|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154043664|NCT00723502|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154043665|NCT02727881|Squalamine|squalamine|mesh-list
154043666|NCT02727881|Ranibizumab|ranibizumab|mesh-list
154043708|NCT00723658|Alkylating Agents|alkylating agents|mesh-ancestor
154043709|NCT00723658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154043710|NCT00723658|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154043711|NCT00723658|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154043712|NCT00723658|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154043713|NCT00723658|Antiemetics|antiemetics|mesh-ancestor
154043714|NCT00723658|Autonomic Agents|autonomic agents|mesh-ancestor
154043715|NCT00723658|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154043716|NCT00723658|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154043717|NCT00723658|Glucocorticoids|glucocorticoids|mesh-ancestor
154043718|NCT00723658|Hormones|hormones|mesh-ancestor
154043719|NCT00723658|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154043720|NCT00723658|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154043721|NCT00723658|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154043722|NCT00723658|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154043723|NCT00723658|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154043724|NCT00723658|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154043725|NCT00723658|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154043726|NCT00723658|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154043727|NCT00723658|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154043728|NCT00723658|Antimetabolites|antimetabolites|mesh-ancestor
154043729|NCT00723658|Antiviral Agents|antiviral agents|mesh-ancestor
154043730|NCT00723658|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154043731|NCT00723658|Leprostatic Agents|leprostatic agents|mesh-ancestor
154043732|NCT00723658|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154043733|NCT00723658|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154043734|NCT00723658|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154043735|NCT00723658|Growth Substances|growth substances|mesh-ancestor
154043736|NCT00723658|Growth Inhibitors|growth inhibitors|mesh-ancestor
154043737|NCT04139850|Antiviral Agents|antiviral agents|mesh-list
154043739|NCT02638142|Furosemide|furosemide|mesh-list
154043750|NCT02727491|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154043751|NCT02727491|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154043752|NCT02727491|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153731093|NCT00136409|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154043753|NCT02727491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154043754|NCT02727491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154043755|NCT02727491|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154043756|NCT02727491|Narcotics|narcotics|mesh-ancestor
154043757|NCT02727491|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154043758|NCT02727491|Analgesics|analgesics|mesh-ancestor
154043759|NCT02727491|Sensory System Agents|sensory system agents|mesh-ancestor
154043760|NCT02727491|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154043761|NCT03562195|Albuterol|albuterol|mesh-list
154043762|NCT03562195|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154043763|NCT03562195|Autonomic Agents|autonomic agents|mesh-ancestor
154043764|NCT03562195|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154043765|NCT03562195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154043766|NCT03562195|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154043767|NCT03562195|Respiratory System Agents|respiratory system agents|mesh-ancestor
154043768|NCT03562195|Tocolytic Agents|tocolytic agents|mesh-ancestor
154043769|NCT03562195|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154043770|NCT03562195|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
154043771|NCT03562195|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
153877831|NCT05316168|Autonomic Agents|autonomic agents|mesh-ancestor
154043772|NCT03562195|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153586502|NCT01772979|Trabectedin|trabectedin|mesh-list
154043773|NCT03562195|Adrenergic Agents|adrenergic agents|mesh-ancestor
154043774|NCT03562195|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154043775|NCT03562195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154043776|NCT00686868|Ofatumumab|ofatumumab|mesh-list
154043777|NCT00686868|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154043790|NCT02645864|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
154043792|NCT02645864|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154043793|NCT02645864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154043794|NCT02645864|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154043795|NCT02645864|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154043796|NCT00674856|Naproxen-n-butyl nitrate|naproxen-n-butyl nitrate|mesh-list
154043797|NCT00674856|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
154043798|NCT00674856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154043799|NCT02574130|Amikacin|amikacin|mesh-list
154043800|NCT02574130|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154043801|NCT02574130|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154043802|NCT00652184|Valacyclovir|valacyclovir|mesh-list
154043803|NCT00652184|Sorivudine|sorivudine|mesh-list
154043804|NCT00652184|Antiviral Agents|antiviral agents|mesh-ancestor
154043805|NCT00652184|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154043806|NCT00652184|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154043807|NCT00652184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154043808|NCT02726867|Lacosamide|lacosamide|mesh-list
154043809|NCT02726867|Ketamine|ketamine|mesh-list
154043810|NCT02726867|Levetiracetam|levetiracetam|mesh-list
154043811|NCT02726867|Phenobarbital|phenobarbital|mesh-list
154043812|NCT02726867|Analgesics|analgesics|mesh-ancestor
154043813|NCT02726867|Sensory System Agents|sensory system agents|mesh-ancestor
154043814|NCT02726867|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154043815|NCT02726867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154043816|NCT02726867|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
154043817|NCT02726867|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154043818|NCT02726867|Anesthetics, General|anesthetics, general|mesh-ancestor
154043819|NCT02726867|Anesthetics|anesthetics|mesh-ancestor
154043820|NCT02726867|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154043821|NCT02726867|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154043822|NCT02726867|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154043823|NCT02726867|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154043824|NCT02726867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154043825|NCT02726867|Anticonvulsants|anticonvulsants|mesh-ancestor
154043829|NCT02726867|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154043830|NCT02726867|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154043831|NCT02726867|GABA Modulators|gaba modulators|mesh-ancestor
154043832|NCT02726867|GABA Agents|gaba agents|mesh-ancestor
154043833|NCT02726867|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
154043834|NCT02726867|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
154043835|NCT02726867|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
154043836|NCT00723970|Quetiapine Fumarate|quetiapine fumarate|mesh-list
154043837|NCT00723970|Antidepressive Agents|antidepressive agents|mesh-ancestor
154043838|NCT00723970|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154043839|NCT00723970|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154043840|NCT00723970|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154043841|NCT00723970|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154043842|NCT00723970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154043843|NCT00873366|Tamoxifen|tamoxifen|mesh-list
154043844|NCT00873366|Levomethorphan|levomethorphan|mesh-list
154043845|NCT00873366|Dextromethorphan|dextromethorphan|mesh-list
154043846|NCT00873366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153586588|NCT01773538|Rifaximin|rifaximin|mesh-list
154043847|NCT00873366|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
154043848|NCT00873366|Hormone Antagonists|hormone antagonists|mesh-ancestor
154043849|NCT00873366|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154043850|NCT00873366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154043851|NCT00873366|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153877835|NCT05316168|Glucocorticoids|glucocorticoids|mesh-ancestor
154043852|NCT00873366|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154043853|NCT00873366|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
154043854|NCT00873366|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
154043855|NCT00873366|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154043856|NCT00873366|Antitussive Agents|antitussive agents|mesh-ancestor
154043857|NCT00873366|Respiratory System Agents|respiratory system agents|mesh-ancestor
154043858|NCT00873366|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154043859|NCT00873366|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154043868|NCT00712894|Diltiazem|diltiazem|mesh-list
154043869|NCT00712894|Nitroglycerin|nitroglycerin|mesh-list
154043870|NCT00712894|Vasodilator Agents|vasodilator agents|mesh-ancestor
154043871|NCT00712894|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154043872|NCT00712894|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154043873|NCT00712894|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154043874|NCT00712894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154043875|NCT00712894|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154043876|NCT00712894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154043877|NCT00712894|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154043878|NCT04164368|Lenalidomide|lenalidomide|mesh-list
154043879|NCT04164368|Immunologic Factors|immunologic factors|mesh-ancestor
154043880|NCT04164368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154043881|NCT04164368|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154043882|NCT04164368|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154043883|NCT04164368|Growth Substances|growth substances|mesh-ancestor
154043884|NCT04164368|Growth Inhibitors|growth inhibitors|mesh-ancestor
154043885|NCT04164368|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154043886|NCT02726555|Atorvastatin|atorvastatin|mesh-list
154043887|NCT02726555|Red yeast rice|red yeast rice|mesh-list
154043888|NCT02726555|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154043889|NCT02726555|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154043890|NCT02726555|Antimetabolites|antimetabolites|mesh-ancestor
154043891|NCT02726555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154043892|NCT02726555|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154043893|NCT02726555|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154043915|NCT00724360|Trastuzumab|trastuzumab|mesh-list
154043916|NCT00724360|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154043917|NCT00724360|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154043918|NCT02637830|Fluorides|fluorides|mesh-list
154043919|NCT02637830|Fluorides, Topical|fluorides, topical|mesh-list
154043920|NCT02637830|Sodium fluoride topical preparation|sodium fluoride topical preparation|mesh-list
154043921|NCT02637830|Cariostatic Agents|cariostatic agents|mesh-ancestor
154043922|NCT02637830|Protective Agents|protective agents|mesh-ancestor
154043923|NCT02637830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154043924|NCT00687258|Vitamin E|vitamin e|mesh-list
154043925|NCT00687258|Vitamins|vitamins|mesh-ancestor
154043926|NCT00687258|Micronutrients|micronutrients|mesh-ancestor
154043927|NCT00687258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154043928|NCT00687258|Antioxidants|antioxidants|mesh-ancestor
154043929|NCT00687258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154043930|NCT00687258|Protective Agents|protective agents|mesh-ancestor
154043931|NCT04001569|Paclitaxel|paclitaxel|mesh-list
154043932|NCT04001569|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154043933|NCT04001569|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154043934|NCT04001569|Tubulin Modulators|tubulin modulators|mesh-ancestor
154043935|NCT04001569|Antimitotic Agents|antimitotic agents|mesh-ancestor
154043970|NCT00652262|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154043971|NCT00652262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154043972|NCT00652262|Urological Agents|urological agents|mesh-ancestor
154043973|NCT02640794|Aspirin|aspirin|mesh-list
154043974|NCT02640794|Clopidogrel|clopidogrel|mesh-list
154043975|NCT02640794|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154043976|NCT02640794|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154043977|NCT02640794|Analgesics|analgesics|mesh-ancestor
154043978|NCT02640794|Sensory System Agents|sensory system agents|mesh-ancestor
154043979|NCT02640794|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154043980|NCT02640794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154043981|NCT02640794|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154043982|NCT02640794|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154043983|NCT02640794|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154043984|NCT02640794|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154043985|NCT02640794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154043986|NCT02640794|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154043987|NCT02640794|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154043988|NCT02640794|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154043989|NCT02640794|Antipyretics|antipyretics|mesh-ancestor
154043990|NCT02640794|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
154043991|NCT02640794|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
154043992|NCT02640794|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
154043993|NCT02640794|Purinergic Agents|purinergic agents|mesh-ancestor
154043994|NCT02640794|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154043996|NCT00724672|Infliximab|infliximab|mesh-list
154043997|NCT00724672|Etanercept|etanercept|mesh-list
154043998|NCT00724672|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
154043999|NCT00724672|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154044013|NCT02624856|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154044014|NCT02624856|Antiemetics|antiemetics|mesh-ancestor
154044015|NCT02624856|Autonomic Agents|autonomic agents|mesh-ancestor
154044016|NCT02624856|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154044017|NCT02624856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154044018|NCT02624856|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154044019|NCT02624856|Glucocorticoids|glucocorticoids|mesh-ancestor
154044020|NCT02624856|Hormones|hormones|mesh-ancestor
154044021|NCT02624856|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154044022|NCT02624856|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154044023|NCT02624856|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154044024|NCT02624856|Anesthetics, Local|anesthetics, local|mesh-ancestor
154044025|NCT02624856|Anesthetics|anesthetics|mesh-ancestor
154044026|NCT02624856|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154044027|NCT02624856|Sensory System Agents|sensory system agents|mesh-ancestor
154044028|NCT02646020|Loratadine|loratadine|mesh-list
154044029|NCT02646020|Aprepitant|aprepitant|mesh-list
154044030|NCT02646020|Fosaprepitant|fosaprepitant|mesh-list
154044031|NCT02646020|Desloratadine|desloratadine|mesh-list
154044032|NCT02646020|Antiemetics|antiemetics|mesh-ancestor
154044033|NCT02646020|Autonomic Agents|autonomic agents|mesh-ancestor
154044034|NCT02646020|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154044035|NCT02646020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154044036|NCT02646020|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154044037|NCT02646020|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
154044038|NCT02646020|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154044039|NCT02646020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154044040|NCT02646020|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154044060|NCT00992797|Micronutrients|micronutrients|mesh-ancestor
154044061|NCT00992797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154044062|NCT00992797|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154044063|NCT00992797|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154044064|NCT02725541|Trastuzumab|trastuzumab|mesh-list
154044065|NCT02725541|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
154044066|NCT02725541|Maytansine|maytansine|mesh-list
154044067|NCT02725541|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154044068|NCT02725541|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154044069|NCT02725541|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154044070|NCT02725541|Tubulin Modulators|tubulin modulators|mesh-ancestor
154044071|NCT02725541|Antimitotic Agents|antimitotic agents|mesh-ancestor
154044072|NCT02725541|Mitosis Modulators|mitosis modulators|mesh-ancestor
154044073|NCT02725541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154044075|NCT02725541|Immunoconjugates|immunoconjugates|mesh-ancestor
154044076|NCT02725541|Immunologic Factors|immunologic factors|mesh-ancestor
154044077|NCT02725541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154044078|NCT00911066|Azacitidine|azacitidine|mesh-list
154044079|NCT00911066|Pevonedistat|pevonedistat|mesh-list
154044080|NCT00911066|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153418619|NCT02823080|Hormone Antagonists|hormone antagonists|mesh-ancestor
153418620|NCT02823080|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153418621|NCT03022916|Efinaconazole|efinaconazole|mesh-list
153418622|NCT03022916|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
153418623|NCT03022916|Antifungal Agents|antifungal agents|mesh-ancestor
153418624|NCT03022916|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154044081|NCT00911066|Antimetabolites|antimetabolites|mesh-ancestor
154044082|NCT00911066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154044083|NCT00911066|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154044084|NCT00911066|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154044085|NCT02733341|Ticagrelor|ticagrelor|mesh-list
154044086|NCT02733341|Cangrelor|cangrelor|mesh-list
154044087|NCT02733341|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154044088|NCT02733341|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
154044106|NCT03675139|Medroxyprogesterone|medroxyprogesterone|mesh-list
154044107|NCT03675139|Dydrogesterone|dydrogesterone|mesh-list
154044108|NCT03675139|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
154044109|NCT03675139|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
154044110|NCT03675139|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
154044111|NCT03675139|Contraceptive Agents|contraceptive agents|mesh-ancestor
154044112|NCT03675139|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154044113|NCT03675139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154044114|NCT03675139|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
154044115|NCT03675139|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
154044116|NCT03675139|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
154044117|NCT03675139|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154044118|NCT03675139|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154044166|NCT00687648|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
154044167|NCT00687648|Hormone Antagonists|hormone antagonists|mesh-ancestor
154044168|NCT00725218|Flurbiprofen|flurbiprofen|mesh-list
154044169|NCT00725218|Flurbiprofen axetil|flurbiprofen axetil|mesh-list
154044170|NCT00725218|Analgesics|analgesics|mesh-ancestor
154044171|NCT00725218|Sensory System Agents|sensory system agents|mesh-ancestor
154044172|NCT00725218|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154044173|NCT00725218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154044174|NCT00725218|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154044175|NCT00725218|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154044176|NCT00725218|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154044181|NCT02732795|Morphine|morphine|mesh-list
154044229|NCT00713440|Hormones|hormones|mesh-ancestor
154044230|NCT00713440|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154044231|NCT00713440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154044232|NCT00713440|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154044233|NCT00713440|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154044234|NCT00713440|Antiemetics|antiemetics|mesh-ancestor
154044235|NCT00713440|Autonomic Agents|autonomic agents|mesh-ancestor
154044236|NCT00713440|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154044237|NCT00713440|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154044238|NCT00713440|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
154044239|NCT00713440|Protective Agents|protective agents|mesh-ancestor
154044240|NCT00713440|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154044241|NCT00713440|Analgesics|analgesics|mesh-ancestor
154044242|NCT00713440|Sensory System Agents|sensory system agents|mesh-ancestor
154044243|NCT00713440|Antipyretics|antipyretics|mesh-ancestor
154044244|NCT00993109|Valsartan|valsartan|mesh-list
154044245|NCT00993109|Nifedipine|nifedipine|mesh-list
154044246|NCT00993109|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154044247|NCT00993109|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
154044248|NCT00993109|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
154044249|NCT00993109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154044250|NCT00993109|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154044251|NCT00993109|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154044252|NCT00993109|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154044282|NCT02732405|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154044283|NCT04001725|Metformin|metformin|mesh-list
154044284|NCT04001725|Dexamethasone|dexamethasone|mesh-list
154044285|NCT04001725|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154044333|NCT05366062|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154044335|NCT02645240|Calcium heparin|calcium heparin|mesh-list
154044336|NCT02645240|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
154044337|NCT02645240|Tinzaparin|tinzaparin|mesh-list
154044338|NCT02645240|Dalteparin|dalteparin|mesh-list
154044339|NCT02645240|Anticoagulants|anticoagulants|mesh-ancestor
154044340|NCT02645240|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154044341|NCT02645240|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154044342|NCT02645240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154044343|NCT00688194|Letrozole|letrozole|mesh-list
154044344|NCT00688194|Fulvestrant|fulvestrant|mesh-list
154044345|NCT00688194|Lapatinib|lapatinib|mesh-list
154044346|NCT00688194|Anastrozole|anastrozole|mesh-list
154044347|NCT00688194|Exemestane|exemestane|mesh-list
154044348|NCT00688194|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154044349|NCT00688194|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
154044350|NCT00688194|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154044351|NCT00688194|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154044352|NCT00688194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154044353|NCT00688194|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
154044354|NCT00688194|Hormone Antagonists|hormone antagonists|mesh-ancestor
154044355|NCT00688194|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154044356|NCT00688194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154044357|NCT00688194|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154044358|NCT00688194|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
154044359|NCT00688194|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154044360|NCT00688194|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154044361|NCT00653744|Atorvastatin|atorvastatin|mesh-list
154044362|NCT00653744|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
154044363|NCT00653744|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154044364|NCT00653744|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154044378|NCT00652496|Ophthalmic Solutions|ophthalmic solutions|mesh-list
154044379|NCT00652496|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154044380|NCT00688272|Ciprofloxacin|ciprofloxacin|mesh-list
154044381|NCT00688272|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154044382|NCT00688272|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154044383|NCT00688272|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154044384|NCT00688272|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154044385|NCT00688272|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154044386|NCT00688272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154044387|NCT00688272|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154044388|NCT00688272|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
154044389|NCT00688272|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154044390|NCT00993343|Cyclosporine|cyclosporine|mesh-list
154044391|NCT00993343|Sirolimus|sirolimus|mesh-list
154044392|NCT00993343|Methotrexate|methotrexate|mesh-list
154044393|NCT00993343|Tacrolimus|tacrolimus|mesh-list
154044394|NCT00993343|Cyclosporins|cyclosporins|mesh-list
154044395|NCT00993343|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154044400|NCT00993343|Antimetabolites|antimetabolites|mesh-ancestor
154044436|NCT04138992|Bevacizumab|bevacizumab|mesh-list
154044437|NCT04138992|Cisplatin|cisplatin|mesh-list
154044438|NCT04138992|Docetaxel|docetaxel|mesh-list
154044439|NCT04138992|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154044440|NCT04138992|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154044441|NCT04138992|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154044442|NCT04138992|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154044443|NCT04138992|Growth Substances|growth substances|mesh-ancestor
154044444|NCT04138992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154044445|NCT04138992|Growth Inhibitors|growth inhibitors|mesh-ancestor
153587182|NCT01779362|Metformin|metformin|mesh-list
154044446|NCT04138992|Tubulin Modulators|tubulin modulators|mesh-ancestor
154044447|NCT04138992|Antimitotic Agents|antimitotic agents|mesh-ancestor
154044448|NCT04138992|Mitosis Modulators|mitosis modulators|mesh-ancestor
154044449|NCT04138992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154044450|NCT04137588|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
154044451|NCT04137588|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-list
154044452|NCT04137588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154044453|NCT04137588|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154044454|NCT04137588|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154044455|NCT04137588|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154044456|NCT04137588|Growth Substances|growth substances|mesh-ancestor
154044457|NCT04137588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154044458|NCT04137588|Growth Inhibitors|growth inhibitors|mesh-ancestor
154044459|NCT02721329|Acetaminophen|acetaminophen|mesh-list
154044485|NCT02624622|Dermatologic Agents|dermatologic agents|mesh-ancestor
154044487|NCT00585247|Toll-Like Receptor Agonists|toll-like receptor agonists|mesh-ancestor
154044488|NCT00585247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154044489|NCT00585247|Immunomodulating Agents|immunomodulating agents|mesh-ancestor
154044490|NCT00585247|Immunologic Factors|immunologic factors|mesh-ancestor
154044491|NCT00585247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154044492|NCT00585247|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154044493|NCT00585247|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154044494|NCT00585247|Interferon Inducers|interferon inducers|mesh-ancestor
154044495|NCT04002349|Budesonide|budesonide|mesh-list
154044496|NCT04002349|Levocabastine|levocabastine|mesh-list
154044497|NCT04002349|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154044498|NCT04002349|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154044499|NCT04002349|Autonomic Agents|autonomic agents|mesh-ancestor
154044500|NCT04002349|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154044501|NCT04002349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154044502|NCT04002349|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154044503|NCT04002349|Respiratory System Agents|respiratory system agents|mesh-ancestor
154044504|NCT04002349|Glucocorticoids|glucocorticoids|mesh-ancestor
154044505|NCT04002349|Hormones|hormones|mesh-ancestor
154044506|NCT04002349|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154044513|NCT00688428|Aspirin|aspirin|mesh-list
154044537|NCT02724761|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154044538|NCT02724761|Adrenergic Agents|adrenergic agents|mesh-ancestor
154044539|NCT02724761|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154044540|NCT02724761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154044541|NCT02724761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154044542|NCT02724761|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154044543|NCT02724761|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154044544|NCT02724761|Autonomic Agents|autonomic agents|mesh-ancestor
154044545|NCT02724761|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154044546|NCT02724761|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154044547|NCT02724761|Respiratory System Agents|respiratory system agents|mesh-ancestor
154044548|NCT02724761|Mydriatics|mydriatics|mesh-ancestor
154044549|NCT02724761|Sympathomimetics|sympathomimetics|mesh-ancestor
154044550|NCT02724761|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154044551|NCT04350190|Apatinib|apatinib|mesh-list
153731113|NCT00136448|Analgesics|analgesics|mesh-ancestor
154044552|NCT04350190|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154044553|NCT04350190|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154044554|NCT04350190|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154044555|NCT04350190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154044557|NCT02721173|Clindamycin palmitate|clindamycin palmitate|mesh-list
154044558|NCT02721173|Clindamycin phosphate|clindamycin phosphate|mesh-list
154044559|NCT02721173|Adapalene|adapalene|mesh-list
154044560|NCT02721173|Tazarotene|tazarotene|mesh-list
154044587|NCT00692640|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154044588|NCT04137432|Oxytocin|oxytocin|mesh-list
154044589|NCT04137432|Oxytocics|oxytocics|mesh-ancestor
154044590|NCT04137432|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154044591|NCT04137432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154044592|NCT00885170|Vitamin D|vitamin d|mesh-list
154044593|NCT00885170|Cholecalciferol|cholecalciferol|mesh-list
154044594|NCT00885170|Calcium|calcium|mesh-list
154044595|NCT00885170|Vitamins|vitamins|mesh-ancestor
154044596|NCT00885170|Micronutrients|micronutrients|mesh-ancestor
154044597|NCT00885170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154044598|NCT00885170|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154044599|NCT00885170|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154044600|NCT02720783|Econazole|econazole|mesh-list
154044601|NCT02720783|Benzydamine|benzydamine|mesh-list
154044602|NCT02720783|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154044603|NCT02720783|Antifungal Agents|antifungal agents|mesh-ancestor
154044604|NCT02720783|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154044605|NCT02720783|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
154044644|NCT02720471|Sensory System Agents|sensory system agents|mesh-ancestor
154044645|NCT02720471|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154044646|NCT00688818|Quetiapine Fumarate|quetiapine fumarate|mesh-list
154044647|NCT00688818|Antidepressive Agents|antidepressive agents|mesh-ancestor
154044648|NCT00688818|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154044649|NCT00688818|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154044650|NCT00688818|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154044651|NCT00688818|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154044652|NCT00688818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154044653|NCT00656006|Ribavirin|ribavirin|mesh-list
154044654|NCT00656006|Antimetabolites|antimetabolites|mesh-ancestor
154044655|NCT00656006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154044656|NCT00656006|Antiviral Agents|antiviral agents|mesh-ancestor
154044657|NCT00656006|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154044658|NCT00688896|Pravastatin|pravastatin|mesh-list
154044659|NCT00688896|Dalcetrapib|dalcetrapib|mesh-list
154044660|NCT00688896|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154044661|NCT00688896|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154044662|NCT00688896|Antimetabolites|antimetabolites|mesh-ancestor
154044663|NCT00688896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154044664|NCT00688896|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154044665|NCT00688896|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154044696|NCT04137198|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154044697|NCT04137198|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154044698|NCT04137198|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154044699|NCT04137198|Anesthetics, General|anesthetics, general|mesh-ancestor
154044700|NCT04137198|Anesthetics|anesthetics|mesh-ancestor
154044701|NCT00995293|Docetaxel|docetaxel|mesh-list
154044702|NCT00995293|Fluorouracil|fluorouracil|mesh-list
154044703|NCT00995293|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154044704|NCT00995293|Tubulin Modulators|tubulin modulators|mesh-ancestor
154044705|NCT00995293|Antimitotic Agents|antimitotic agents|mesh-ancestor
154044706|NCT00995293|Mitosis Modulators|mitosis modulators|mesh-ancestor
154044707|NCT00995293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154044708|NCT00995293|Antimetabolites|antimetabolites|mesh-ancestor
154044709|NCT00995293|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154044710|NCT00995293|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154044711|NCT00995293|Immunologic Factors|immunologic factors|mesh-ancestor
154044712|NCT00995293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154044756|NCT00726466|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154044757|NCT02694263|Pioglitazone|pioglitazone|mesh-list
154044758|NCT02694263|Glimepiride|glimepiride|mesh-list
154044759|NCT02694263|Canagliflozin|canagliflozin|mesh-list
154044760|NCT02694263|Repaglinide|repaglinide|mesh-list
154044761|NCT02694263|Gliclazide|gliclazide|mesh-list
154044762|NCT02694263|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154044763|NCT02694263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154044764|NCT02694263|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154044765|NCT02694263|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154044766|NCT02694263|Immunologic Factors|immunologic factors|mesh-ancestor
153731116|NCT00136448|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154044767|NCT02694263|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
154044768|NCT02694263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154044770|NCT04139070|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154044771|NCT04139070|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154044772|NCT00693030|Sirolimus|sirolimus|mesh-list
154044773|NCT00693030|Paclitaxel|paclitaxel|mesh-list
154044774|NCT00693030|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154044775|NCT00693030|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154044776|NCT00693030|Tubulin Modulators|tubulin modulators|mesh-ancestor
154044777|NCT00693030|Antimitotic Agents|antimitotic agents|mesh-ancestor
154044778|NCT00693030|Mitosis Modulators|mitosis modulators|mesh-ancestor
154044779|NCT00693030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154044807|NCT02723981|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
154044808|NCT02723981|Purinergic Agents|purinergic agents|mesh-ancestor
154044809|NCT02723981|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154044810|NCT02723981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154044811|NCT02723981|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
154044812|NCT02723981|Antithrombins|antithrombins|mesh-ancestor
154044813|NCT02723981|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154044814|NCT02723981|Protease Inhibitors|protease inhibitors|mesh-ancestor
154044815|NCT02723981|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154044816|NCT02723981|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
154044817|NCT02723981|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154044818|NCT02723981|Hemostatics|hemostatics|mesh-ancestor
154044819|NCT02723981|Coagulants|coagulants|mesh-ancestor
154044820|NCT00912444|Cyclophosphamide|cyclophosphamide|mesh-list
154044821|NCT00912444|Docetaxel|docetaxel|mesh-list
154044822|NCT00912444|Doxorubicin|doxorubicin|mesh-list
154044823|NCT00912444|Epirubicin|epirubicin|mesh-list
154044824|NCT00912444|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154044825|NCT00912444|Immunologic Factors|immunologic factors|mesh-ancestor
154044826|NCT00912444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154044827|NCT00912444|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154044828|NCT00912444|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154044829|NCT00912444|Alkylating Agents|alkylating agents|mesh-ancestor
153731125|NCT00136487|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154044846|NCT00726700|Prednisone|prednisone|mesh-list
154044858|NCT00726700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154044859|NCT00726700|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154044860|NCT00726700|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154044861|NCT00726700|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154044862|NCT00726700|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154044863|NCT00726700|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154044864|NCT00726700|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154044865|NCT00726700|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154044866|NCT00726700|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154044868|NCT00726700|Hormones|hormones|mesh-ancestor
154044869|NCT00726700|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154044870|NCT00726700|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154044871|NCT00726700|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154044872|NCT00726700|Tubulin Modulators|tubulin modulators|mesh-ancestor
154044873|NCT00726700|Antimitotic Agents|antimitotic agents|mesh-ancestor
154044874|NCT00726700|Mitosis Modulators|mitosis modulators|mesh-ancestor
154044875|NCT02723903|Fluoxetine|fluoxetine|mesh-list
154044876|NCT02723903|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
154044877|NCT02723903|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154044878|NCT02723903|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154044879|NCT02723903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154044880|NCT02723903|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154044881|NCT02723903|Serotonin Agents|serotonin agents|mesh-ancestor
154044882|NCT02723903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154044883|NCT02723903|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
154044903|NCT00675714|Nandrolone phenpropionate|nandrolone phenpropionate|mesh-list
154044904|NCT00675714|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154044905|NCT00675714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154044906|NCT00675714|Androgens|androgens|mesh-ancestor
154044907|NCT00675714|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154044908|NCT00675714|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154044909|NCT00675714|Anabolic Agents|anabolic agents|mesh-ancestor
154044910|NCT00675714|Antifungal Agents|antifungal agents|mesh-ancestor
154044911|NCT00675714|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154044912|NCT00675714|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
154044913|NCT00675714|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154044914|NCT00675714|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154044915|NCT00675714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154044916|NCT00675714|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154044917|NCT00675714|Hormone Antagonists|hormone antagonists|mesh-ancestor
154044918|NCT00675714|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154044919|NCT00675714|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
154044920|NCT00675714|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154044921|NCT00675714|Adrenergic Agents|adrenergic agents|mesh-ancestor
154044922|NCT00675714|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154044923|NCT00675714|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154044924|NCT00675714|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154044925|NCT00675714|Vasodilator Agents|vasodilator agents|mesh-ancestor
154044926|NCT00675714|Sympatholytics|sympatholytics|mesh-ancestor
154044927|NCT00675714|Autonomic Agents|autonomic agents|mesh-ancestor
154044950|NCT00656318|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154044951|NCT00656318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154044952|NCT00656318|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
154044953|NCT02451553|Capecitabine|capecitabine|mesh-list
154044954|NCT02451553|Afatinib|afatinib|mesh-list
154044955|NCT02451553|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154044956|NCT02451553|Antimetabolites|antimetabolites|mesh-ancestor
154044957|NCT02451553|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154044958|NCT02451553|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154044959|NCT02451553|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154044960|NCT02451553|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154044961|NCT02451553|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154044962|NCT02636816|Carbetocin|carbetocin|mesh-list
154044963|NCT02636816|Oxytocics|oxytocics|mesh-ancestor
154044964|NCT02636816|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154044965|NCT02636816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154044966|NCT00730054|Clonidine|clonidine|mesh-list
154044967|NCT00730054|Remifentanil|remifentanil|mesh-list
154044968|NCT00730054|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154045006|NCT02719379|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
154045008|NCT02719379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154045009|NCT00689442|Atorvastatin|atorvastatin|mesh-list
154045010|NCT00689442|Dalcetrapib|dalcetrapib|mesh-list
154045011|NCT00689442|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154045012|NCT00689442|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154045013|NCT00689442|Antimetabolites|antimetabolites|mesh-ancestor
154045014|NCT00689442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154045015|NCT00689442|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154045016|NCT00689442|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154045017|NCT00689442|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154045018|NCT02625636|Glucagon|glucagon|mesh-list
154045019|NCT02625636|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
154045020|NCT02625636|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154045021|NCT02625636|Hormones|hormones|mesh-ancestor
154045022|NCT02625636|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154045023|NCT02625636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154045024|NCT02625636|Incretins|incretins|mesh-ancestor
154045025|NCT03012100|Cyclophosphamide|cyclophosphamide|mesh-list
154045026|NCT03012100|Vaccines|vaccines|mesh-list
154045027|NCT03012100|Sargramostim|sargramostim|mesh-list
154045028|NCT03012100|Immunologic Factors|immunologic factors|mesh-ancestor
154045029|NCT03012100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154045030|NCT03012100|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154045031|NCT03012100|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154045032|NCT03012100|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154045033|NCT03012100|Alkylating Agents|alkylating agents|mesh-ancestor
154045034|NCT03012100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154045035|NCT03012100|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154045036|NCT03012100|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154045037|NCT02379247|Paclitaxel|paclitaxel|mesh-list
154045044|NCT00689520|Vitamin K|vitamin k|mesh-list
154045045|NCT00689520|Tinzaparin|tinzaparin|mesh-list
154045046|NCT00689520|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
154045047|NCT00689520|Dalteparin|dalteparin|mesh-list
154045048|NCT00689520|Acenocoumarol|acenocoumarol|mesh-list
153587782|NCT01783756|Antimetabolites|antimetabolites|mesh-ancestor
154045049|NCT00689520|Vitamins|vitamins|mesh-ancestor
154045050|NCT00689520|Micronutrients|micronutrients|mesh-ancestor
154045051|NCT00689520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154045052|NCT00689520|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
154045053|NCT00689520|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154045054|NCT00689520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154045056|NCT00689520|Coagulants|coagulants|mesh-ancestor
154045057|NCT00689520|Anticoagulants|anticoagulants|mesh-ancestor
154045058|NCT00689520|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154045059|NCT02723279|Tolterodine Tartrate|tolterodine tartrate|mesh-list
154045060|NCT02723279|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
154045061|NCT02723279|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154045062|NCT02723279|Cholinergic Agents|cholinergic agents|mesh-ancestor
154045063|NCT02723279|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154045066|NCT02723279|Urological Agents|urological agents|mesh-ancestor
154045101|NCT00697905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154045102|NCT02718755|Cytarabine|cytarabine|mesh-list
154045103|NCT02718755|Fludarabine|fludarabine|mesh-list
154045104|NCT02718755|Fludarabine phosphate|fludarabine phosphate|mesh-list
154045105|NCT02718755|Asparaginase|asparaginase|mesh-list
154045106|NCT02718755|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154045107|NCT02718755|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154045108|NCT02718755|Antimetabolites|antimetabolites|mesh-ancestor
154045109|NCT02718755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154045110|NCT02718755|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154045111|NCT02718755|Immunologic Factors|immunologic factors|mesh-ancestor
154045112|NCT02718755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154045113|NCT02718755|Antiviral Agents|antiviral agents|mesh-ancestor
154045114|NCT02718755|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154045115|NCT00730210|Parathyroid Hormone|parathyroid hormone|mesh-list
154045116|NCT00730210|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154045117|NCT00730210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154045118|NCT00730288|Vaccines|vaccines|mesh-list
153877860|NCT05293509|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154045119|NCT00730288|Immunologic Factors|immunologic factors|mesh-ancestor
154045120|NCT00730288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154045121|NCT00872898|Memantine|memantine|mesh-list
154045122|NCT00872898|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
154045123|NCT00872898|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
154045124|NCT00872898|Dopamine Agents|dopamine agents|mesh-ancestor
154045125|NCT00872898|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154045126|NCT00872898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154045127|NCT00872898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154045128|NCT00872898|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154045129|NCT00872898|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154045147|NCT04132011|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154045149|NCT00693576|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154045150|NCT00693576|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154045151|NCT00693576|Antimetabolites|antimetabolites|mesh-ancestor
154045152|NCT00693576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154045153|NCT00693576|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154045154|NCT00693576|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154045155|NCT00693576|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154045156|NCT04116047|Durvalumab|durvalumab|mesh-list
154045157|NCT04116047|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154045158|NCT04116047|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154045159|NCT00693732|Escitalopram|escitalopram|mesh-list
154045160|NCT00693732|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
154045161|NCT00693732|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154045205|NCT00689832|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154045207|NCT02718521|Isosorbide Dinitrate|isosorbide dinitrate|mesh-list
154045208|NCT02718521|Isosorbide-5-mononitrate|isosorbide-5-mononitrate|mesh-list
154045209|NCT02718521|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
154045210|NCT02718521|Diuretics|diuretics|mesh-ancestor
154045211|NCT02718521|Natriuretic Agents|natriuretic agents|mesh-ancestor
154045212|NCT02718521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154045213|NCT02718521|Vasodilator Agents|vasodilator agents|mesh-ancestor
154045214|NCT02718521|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
154045215|NCT02718521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154045216|NCT02718599|Terlipressin|terlipressin|mesh-list
154045217|NCT02718599|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154045218|NCT02718599|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154045219|NCT00693966|Vaccines|vaccines|mesh-list
154045220|NCT00693966|Immunologic Factors|immunologic factors|mesh-ancestor
154045221|NCT00693966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154045222|NCT00694044|Varenicline|varenicline|mesh-list
154045223|NCT00694044|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
154045224|NCT00694044|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
154045225|NCT00694044|Cholinergic Agents|cholinergic agents|mesh-ancestor
154045226|NCT00694044|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154045227|NCT00694044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154045228|NCT00694044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154045229|NCT02722811|Etanercept|etanercept|mesh-list
154045230|NCT02722811|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154045231|NCT02722811|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154045232|NCT02722811|Analgesics|analgesics|mesh-ancestor
154045233|NCT02722811|Sensory System Agents|sensory system agents|mesh-ancestor
154045234|NCT02722811|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154045235|NCT02722811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154045236|NCT02722811|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154045237|NCT02722811|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154045238|NCT02722811|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154045239|NCT02722811|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154045240|NCT02722811|Immunologic Factors|immunologic factors|mesh-ancestor
154045246|NCT00534313|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154045247|NCT00534313|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154045248|NCT00534313|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154045249|NCT00534313|Immunologic Factors|immunologic factors|mesh-ancestor
154045250|NCT00534313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154045251|NCT00534313|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154045252|NCT00694200|Bevacizumab|bevacizumab|mesh-list
154045253|NCT00694200|Vinorelbine|vinorelbine|mesh-list
154045254|NCT00694200|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154045255|NCT00694200|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154045256|NCT00694200|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154045257|NCT00694200|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154045258|NCT00694200|Growth Substances|growth substances|mesh-ancestor
154045259|NCT00694200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154045260|NCT00694200|Growth Inhibitors|growth inhibitors|mesh-ancestor
154045261|NCT00694200|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154045262|NCT00694200|Tubulin Modulators|tubulin modulators|mesh-ancestor
154045263|NCT00694200|Antimitotic Agents|antimitotic agents|mesh-ancestor
154045264|NCT00694200|Mitosis Modulators|mitosis modulators|mesh-ancestor
154045265|NCT00694200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154045266|NCT02722733|Cytarabine|cytarabine|mesh-list
154045267|NCT02722733|Lenograstim|lenograstim|mesh-list
154045268|NCT02722733|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154045269|NCT02722733|Immunologic Factors|immunologic factors|mesh-ancestor
154045270|NCT02722733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154045271|NCT02722733|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154045278|NCT02617290|Clopidogrel|clopidogrel|mesh-list
154045294|NCT02007655|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
154045295|NCT02007655|Antithrombins|antithrombins|mesh-ancestor
154045296|NCT02007655|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154045297|NCT02007655|Protease Inhibitors|protease inhibitors|mesh-ancestor
154045298|NCT02007655|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154045299|NCT02007655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154045300|NCT02007655|Anticoagulants|anticoagulants|mesh-ancestor
154045301|NCT05298462|Antibodies|antibodies|mesh-list
154045302|NCT05298462|Immunologic Factors|immunologic factors|mesh-ancestor
154045303|NCT05298462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154045304|NCT00730366|Chloroquine|chloroquine|mesh-list
154045305|NCT00730366|Pyrimethamine|pyrimethamine|mesh-list
154045306|NCT00730366|Sulfadoxine|sulfadoxine|mesh-list
154045307|NCT00730366|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
154045308|NCT00730366|Amebicides|amebicides|mesh-ancestor
154045309|NCT00730366|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154045354|NCT03903406|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154045355|NCT03903406|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154045356|NCT03903406|Growth Substances|growth substances|mesh-ancestor
154045357|NCT03903406|Growth Inhibitors|growth inhibitors|mesh-ancestor
154045358|NCT03903406|Protease Inhibitors|protease inhibitors|mesh-ancestor
154045359|NCT03903406|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154045360|NCT03903406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154045361|NCT00594204|Varenicline|varenicline|mesh-list
154045362|NCT00594204|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
154045363|NCT00594204|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
154045364|NCT00594204|Cholinergic Agents|cholinergic agents|mesh-ancestor
154045365|NCT00594204|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154045366|NCT00594204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154045367|NCT00594204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154045368|NCT00999271|Gastric Inhibitory Polypeptide|gastric inhibitory polypeptide|mesh-list
154045369|NCT00999271|Hormones|hormones|mesh-list
154045370|NCT00999271|Incretins|incretins|mesh-list
154045371|NCT00999271|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154045372|NCT00999271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154045373|NCT00999271|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154045374|NCT02716961|Gemcitabine|gemcitabine|mesh-list
154045375|NCT02716961|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154045376|NCT02716961|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154045377|NCT02716961|Antimetabolites|antimetabolites|mesh-ancestor
154045378|NCT02716961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154045379|NCT02704156|Gemcitabine|gemcitabine|mesh-list
154045380|NCT02704156|Pembrolizumab|pembrolizumab|mesh-list
154045381|NCT02704156|Trametinib|trametinib|mesh-list
154045382|NCT02704156|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154045383|NCT02704156|Antimetabolites|antimetabolites|mesh-ancestor
154045389|NCT02704156|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154045397|NCT00912678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154045398|NCT00912678|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154045399|NCT00912678|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154045400|NCT00912678|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
154045401|NCT00912678|Antitubercular Agents|antitubercular agents|mesh-ancestor
154045402|NCT00912678|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154045403|NCT00912678|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154045404|NCT00995839|Terlipressin|terlipressin|mesh-list
154045405|NCT00995839|Vasopressins|vasopressins|mesh-list
154045406|NCT00995839|Arginine Vasopressin|arginine vasopressin|mesh-list
154045407|NCT00995839|Hemostatics|hemostatics|mesh-ancestor
154045408|NCT00995839|Coagulants|coagulants|mesh-ancestor
154045409|NCT00995839|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154045410|NCT00995839|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
154045411|NCT00995839|Natriuretic Agents|natriuretic agents|mesh-ancestor
154045412|NCT00995839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154045413|NCT00995839|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154045414|NCT00994513|Thioctic Acid|thioctic acid|mesh-list
154045415|NCT00994513|Antioxidants|antioxidants|mesh-ancestor
154045417|NCT00994513|Protective Agents|protective agents|mesh-ancestor
154045455|NCT00912756|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
154045456|NCT00912756|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154045457|NCT00912756|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154045458|NCT04426240|Cyclosporine|cyclosporine|mesh-list
154045459|NCT04426240|Cyclosporins|cyclosporins|mesh-list
154045460|NCT04426240|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154045461|NCT04426240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154045462|NCT04426240|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154045463|NCT04426240|Immunologic Factors|immunologic factors|mesh-ancestor
154045464|NCT04426240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154045465|NCT04426240|Antifungal Agents|antifungal agents|mesh-ancestor
154045466|NCT04426240|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154045467|NCT04426240|Dermatologic Agents|dermatologic agents|mesh-ancestor
154045468|NCT04426240|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154045469|NCT04426240|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
154045470|NCT00995995|Rosiglitazone|rosiglitazone|mesh-list
154045471|NCT00995995|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154045473|NCT00999349|Silymarin|silymarin|mesh-list
154045516|NCT00866307|Asparaginase|asparaginase|mesh-list
154045517|NCT00866307|Mercaptopurine|mercaptopurine|mesh-list
154045518|NCT00866307|Pegaspargase|pegaspargase|mesh-list
154045519|NCT00866307|Thioguanine|thioguanine|mesh-list
154045520|NCT00866307|BB 1101|bb 1101|mesh-list
154045521|NCT00866307|2-Aminopurine|2-aminopurine|mesh-list
154045522|NCT00866307|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154045523|NCT00866307|Immunologic Factors|immunologic factors|mesh-ancestor
154045524|NCT00866307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154045525|NCT00866307|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154045526|NCT00866307|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154045527|NCT00866307|Alkylating Agents|alkylating agents|mesh-ancestor
154045528|NCT00866307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154045529|NCT00866307|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154045530|NCT00866307|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154045531|NCT00866307|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154045532|NCT00866307|Antiemetics|antiemetics|mesh-ancestor
154045533|NCT00866307|Autonomic Agents|autonomic agents|mesh-ancestor
154045535|NCT00866307|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154045576|NCT00731224|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
154045577|NCT00731224|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154045578|NCT00731224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154045579|NCT00731224|Cholinergic Agents|cholinergic agents|mesh-ancestor
154045580|NCT00731224|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154045581|NCT00731224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154045582|NCT00731224|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
154045584|NCT00531427|Buprenorphine|buprenorphine|mesh-list
154045585|NCT00531427|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154045586|NCT00531427|Narcotics|narcotics|mesh-ancestor
154045587|NCT00531427|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154045588|NCT00531427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154045589|NCT00531427|Analgesics|analgesics|mesh-ancestor
154045590|NCT00531427|Sensory System Agents|sensory system agents|mesh-ancestor
154045591|NCT00531427|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154045592|NCT00531427|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
154045593|NCT00731302|Aspirin|aspirin|mesh-list
154045594|NCT00731302|Meloxicam|meloxicam|mesh-list
154045595|NCT00731302|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154045596|NCT00731302|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154045597|NCT00731302|Analgesics|analgesics|mesh-ancestor
154045598|NCT00731302|Sensory System Agents|sensory system agents|mesh-ancestor
154045599|NCT00731302|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154045600|NCT00731302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154045601|NCT00731302|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154045602|NCT00731302|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154045603|NCT00731302|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154045604|NCT00731302|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154045620|NCT00871728|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154045621|NCT00871728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154045622|NCT00871728|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154045624|NCT00731380|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154045625|NCT00999427|Povidone-Iodine|povidone-iodine|mesh-list
154045626|NCT00999427|Povidone|povidone|mesh-list
154045627|NCT00999427|Plasma Substitutes|plasma substitutes|mesh-ancestor
154045628|NCT00999427|Blood Substitutes|blood substitutes|mesh-ancestor
154045629|NCT00999427|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154045630|NCT00999427|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154045631|NCT04189211|Trastuzumab|trastuzumab|mesh-list
154045632|NCT04189211|Maytansine|maytansine|mesh-list
154045633|NCT04189211|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154045634|NCT04189211|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154045635|NCT04189211|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154045636|NCT04189211|Tubulin Modulators|tubulin modulators|mesh-ancestor
154045640|NCT00364780|XL647|xl647|mesh-list
154045677|NCT04131231|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154045678|NCT04131231|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154045680|NCT04131231|Sensory System Agents|sensory system agents|mesh-ancestor
154045681|NCT04131231|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154045682|NCT04131231|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154045683|NCT04131231|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154045684|NCT04131231|Antiviral Agents|antiviral agents|mesh-ancestor
154045685|NCT04131231|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154045686|NCT02716259|Fluorides|fluorides|mesh-list
154045687|NCT02716259|Sodium Fluoride|sodium fluoride|mesh-list
154045688|NCT02716259|Cariostatic Agents|cariostatic agents|mesh-ancestor
154045689|NCT02716259|Protective Agents|protective agents|mesh-ancestor
154045690|NCT02716259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154045691|NCT00996229|Resveratrol|resveratrol|mesh-list
154045692|NCT00996229|Antioxidants|antioxidants|mesh-ancestor
154045693|NCT00996229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154045694|NCT00996229|Protective Agents|protective agents|mesh-ancestor
154045695|NCT00996229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154045696|NCT00996229|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154045697|NCT00996229|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154045698|NCT02712671|Interferons|interferons|mesh-list
154045699|NCT02712671|Interferon-gamma|interferon-gamma|mesh-list
154045700|NCT02712671|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154045701|NCT02712671|Antiviral Agents|antiviral agents|mesh-ancestor
154045702|NCT02712671|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154045703|NCT02614833|Paclitaxel|paclitaxel|mesh-list
154045704|NCT02614833|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154045705|NCT02614833|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154045706|NCT02614833|Tubulin Modulators|tubulin modulators|mesh-ancestor
154045707|NCT02614833|Antimitotic Agents|antimitotic agents|mesh-ancestor
154045708|NCT02614833|Mitosis Modulators|mitosis modulators|mesh-ancestor
154045709|NCT02614833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154045710|NCT00999505|Amantadine|amantadine|mesh-list
154045711|NCT00999505|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
154045712|NCT00999505|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
154045713|NCT00999505|Antiviral Agents|antiviral agents|mesh-ancestor
154045716|NCT00999505|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154045717|NCT00999505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154045718|NCT00999505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154045719|NCT00999505|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154045720|NCT00999505|Analgesics|analgesics|mesh-ancestor
154045721|NCT00999505|Sensory System Agents|sensory system agents|mesh-ancestor
154045722|NCT00999505|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154045723|NCT00996385|Oxaliplatin|oxaliplatin|mesh-list
154045724|NCT00996385|Bortezomib|bortezomib|mesh-list
154045725|NCT00996385|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154045726|NCT00533845|Bupivacaine|bupivacaine|mesh-list
154045727|NCT00533845|Anesthetics, Local|anesthetics, local|mesh-ancestor
154045728|NCT00533845|Anesthetics|anesthetics|mesh-ancestor
154045729|NCT00533845|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154045730|NCT00533845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153418634|NCT03031795|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154045731|NCT00533845|Sensory System Agents|sensory system agents|mesh-ancestor
154045732|NCT00533845|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154045733|NCT02752763|Dextrans|dextrans|mesh-list
154045734|NCT02752763|Povidone|povidone|mesh-list
154045735|NCT02752763|Ophthalmic Solutions|ophthalmic solutions|mesh-list
154045736|NCT02752763|Lubricant Eye Drops|lubricant eye drops|mesh-list
154045737|NCT02752763|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
154045738|NCT02752763|Plasma Substitutes|plasma substitutes|mesh-ancestor
154045739|NCT02752763|Blood Substitutes|blood substitutes|mesh-ancestor
154045740|NCT02752763|Anticoagulants|anticoagulants|mesh-ancestor
154045741|NCT00857649|Memantine|memantine|mesh-list
154045742|NCT00857649|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
154045743|NCT00857649|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
154045750|NCT02752841|Vitamin D|vitamin d|mesh-list
154045764|NCT00532441|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154045765|NCT00532441|Tubulin Modulators|tubulin modulators|mesh-ancestor
154045766|NCT00532441|Antimitotic Agents|antimitotic agents|mesh-ancestor
154045767|NCT00532441|Mitosis Modulators|mitosis modulators|mesh-ancestor
154045768|NCT00532441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154045769|NCT00532441|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154045770|NCT00532441|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154045771|NCT00532441|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154045772|NCT00999739|Vaccines|vaccines|mesh-list
154045773|NCT00999739|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
154045774|NCT00999739|Immunologic Factors|immunologic factors|mesh-ancestor
154045775|NCT00999739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154045776|NCT00996463|Antimony Sodium Gluconate|antimony sodium gluconate|mesh-list
154045777|NCT00996463|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154045778|NCT00996463|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154045779|NCT00996463|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154045780|NCT00996463|Schistosomicides|schistosomicides|mesh-ancestor
154045822|NCT00868608|Immunologic Factors|immunologic factors|mesh-ancestor
154045823|NCT00868608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154045825|NCT04000633|Anesthetics, Local|anesthetics, local|mesh-ancestor
154045826|NCT04000633|Anesthetics|anesthetics|mesh-ancestor
154045827|NCT04000633|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154045828|NCT04000633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154045829|NCT04000633|Sensory System Agents|sensory system agents|mesh-ancestor
154045830|NCT04000633|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154045831|NCT04000633|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154045832|NCT04000633|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154045833|NCT04000633|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154045834|NCT04000633|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154045835|NCT04000633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154045836|NCT00994825|Simendan|simendan|mesh-list
154045837|NCT00994825|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
154045838|NCT00994825|Vasodilator Agents|vasodilator agents|mesh-ancestor
154045839|NCT00994825|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
154045840|NCT00994825|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154045841|NCT00994825|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154045842|NCT00994825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154045843|NCT00994825|Protective Agents|protective agents|mesh-ancestor
154045844|NCT00994825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154045845|NCT02752529|Tacrolimus|tacrolimus|mesh-list
154045846|NCT02752529|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154045853|NCT00856635|(T,G)-A-L|(t,g)-a-l|mesh-list
154045871|NCT02620800|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154045872|NCT02620800|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154045873|NCT02620800|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154045874|NCT02620800|Growth Substances|growth substances|mesh-ancestor
154045875|NCT02620800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153418635|NCT03031795|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153418637|NCT02942654|Insulin Lispro|insulin lispro|mesh-list
154045876|NCT02620800|Growth Inhibitors|growth inhibitors|mesh-ancestor
154045877|NCT02620800|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154045878|NCT02620800|Antidotes|antidotes|mesh-ancestor
154045879|NCT02620800|Protective Agents|protective agents|mesh-ancestor
154045880|NCT02620800|Vitamin B Complex|vitamin b complex|mesh-ancestor
154045881|NCT02620800|Vitamins|vitamins|mesh-ancestor
154045882|NCT02620800|Micronutrients|micronutrients|mesh-ancestor
154045883|NCT04135014|Midazolam|midazolam|mesh-list
154045884|NCT04135014|Dexmedetomidine|dexmedetomidine|mesh-list
154045885|NCT04135014|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153588631|NCT01789437|Hormones|hormones|mesh-ancestor
154045886|NCT04135014|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154045887|NCT04135014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154045888|NCT04135014|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154045889|NCT04135014|Analgesics|analgesics|mesh-ancestor
154045925|NCT00996697|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154045926|NCT00996697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154045927|NCT00996697|Parasympatholytics|parasympatholytics|mesh-ancestor
154045928|NCT00996697|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154045929|NCT00996697|Cholinergic Agents|cholinergic agents|mesh-ancestor
154045931|NCT00999973|Mitomycin|mitomycin|mesh-list
154045932|NCT00999973|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154045933|NCT00999973|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154045934|NCT00999973|Alkylating Agents|alkylating agents|mesh-ancestor
154045935|NCT00999973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154045936|NCT00999973|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154045937|NCT00999973|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154045938|NCT02715947|Methotrexate|methotrexate|mesh-list
154045939|NCT02715947|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154045940|NCT02715947|Abortifacient Agents|abortifacient agents|mesh-ancestor
154045941|NCT02715947|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154045942|NCT02715947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154045943|NCT02715947|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154045944|NCT02715947|Antimetabolites|antimetabolites|mesh-ancestor
154045945|NCT02715947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154045946|NCT02715947|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154045947|NCT02715947|Dermatologic Agents|dermatologic agents|mesh-ancestor
154045948|NCT02715947|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154045949|NCT02715947|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154045950|NCT02715947|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154045951|NCT02715947|Immunologic Factors|immunologic factors|mesh-ancestor
154045971|NCT00855933|Cetylpyridinium|cetylpyridinium|mesh-list
154045972|NCT00855933|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154045973|NCT00855933|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154045974|NCT00994903|Simvastatin|simvastatin|mesh-list
154045975|NCT00994903|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154045976|NCT00994903|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154045977|NCT00994903|Antimetabolites|antimetabolites|mesh-ancestor
154045978|NCT00994903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154045979|NCT00994903|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154045980|NCT00994903|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154045981|NCT00994903|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154045982|NCT00699777|Risedronic Acid|risedronic acid|mesh-list
154045983|NCT00699777|Etidronic Acid|etidronic acid|mesh-list
154045984|NCT00699777|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154045985|NCT00699777|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154045986|NCT00699777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154045987|NCT00699777|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154045988|NCT00699777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154045989|NCT00699777|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154045990|NCT02712125|Isosorbide|isosorbide|mesh-list
154045991|NCT02712125|Isosorbide Dinitrate|isosorbide dinitrate|mesh-list
154045992|NCT02712125|Isosorbide-5-mononitrate|isosorbide-5-mononitrate|mesh-list
154045993|NCT02712125|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
154045994|NCT02712125|Diuretics|diuretics|mesh-ancestor
154045995|NCT02712125|Natriuretic Agents|natriuretic agents|mesh-ancestor
154045996|NCT02712125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154045997|NCT02712125|Vasodilator Agents|vasodilator agents|mesh-ancestor
154045998|NCT02712125|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
154046014|NCT00994981|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154046015|NCT02715479|Dolutegravir|dolutegravir|mesh-list
154046016|NCT02715479|BMS-955176|bms-955176|mesh-list
154046017|NCT02715479|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
154046018|NCT02715479|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
154046019|NCT02715479|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154046020|NCT02715479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154046021|NCT02715479|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154046022|NCT02715479|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154046023|NCT02715479|Antiviral Agents|antiviral agents|mesh-ancestor
154046024|NCT02715479|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154046025|NCT01000441|Adalimumab|adalimumab|mesh-list
154046026|NCT01000441|Infliximab|infliximab|mesh-list
154046027|NCT01000441|Etanercept|etanercept|mesh-list
154046028|NCT01000441|Rituximab|rituximab|mesh-list
154046029|NCT01000441|Abatacept|abatacept|mesh-list
154046030|NCT01000441|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154046031|NCT01000441|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154046032|NCT01000441|Immunologic Factors|immunologic factors|mesh-ancestor
154046033|NCT01000441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154046034|NCT01000441|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154046035|NCT01000441|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
154046036|NCT01000441|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154046037|NCT01000441|Dermatologic Agents|dermatologic agents|mesh-ancestor
154046038|NCT01000441|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154046039|NCT01000441|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154046040|NCT01000441|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154046042|NCT01000441|Sensory System Agents|sensory system agents|mesh-ancestor
154046043|NCT01000441|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154046062|NCT01000597|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154046063|NCT01000597|Respiratory System Agents|respiratory system agents|mesh-ancestor
154046064|NCT01000597|Dermatologic Agents|dermatologic agents|mesh-ancestor
154046065|NCT01000597|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154046067|NCT02751593|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154046068|NCT02751593|Antiemetics|antiemetics|mesh-ancestor
154046069|NCT02751593|Autonomic Agents|autonomic agents|mesh-ancestor
154046070|NCT02751593|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154046071|NCT02751593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154046072|NCT02751593|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154046073|NCT02751593|Glucocorticoids|glucocorticoids|mesh-ancestor
154046074|NCT02751593|Hormones|hormones|mesh-ancestor
154046075|NCT02751593|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154046123|NCT00997711|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154046124|NCT00997711|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154046125|NCT00997711|Antifungal Agents|antifungal agents|mesh-ancestor
154046126|NCT00997711|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154046127|NCT00997711|Immunologic Factors|immunologic factors|mesh-ancestor
154046128|NCT00997711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154046129|NCT01001143|Decitabine|decitabine|mesh-list
154046130|NCT01001143|Bexarotene|bexarotene|mesh-list
154046131|NCT01001143|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154046132|NCT01001143|Antimetabolites|antimetabolites|mesh-ancestor
154046133|NCT01001143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154046134|NCT01001143|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154046135|NCT01001143|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154046136|NCT02715167|Budesonide|budesonide|mesh-list
154046137|NCT02715167|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154046138|NCT02715167|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154046139|NCT02715167|Autonomic Agents|autonomic agents|mesh-ancestor
154046140|NCT02715167|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154046141|NCT02715167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154046144|NCT02715167|Glucocorticoids|glucocorticoids|mesh-ancestor
154046179|NCT02714699|Cholinergic Agents|cholinergic agents|mesh-ancestor
154046180|NCT02714699|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154046181|NCT02714699|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
154046182|NCT02714699|Parasympatholytics|parasympatholytics|mesh-ancestor
154046184|NCT01004419|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154046185|NCT01004419|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154046186|NCT01004419|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
154046187|NCT01004419|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
154046188|NCT01004419|Hormone Antagonists|hormone antagonists|mesh-ancestor
154046189|NCT01004419|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154046190|NCT01004419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154046191|NCT02714855|Apixaban|apixaban|mesh-list
154046242|NCT02714231|Parasympatholytics|parasympatholytics|mesh-ancestor
154046243|NCT00855309|Acyclovir|acyclovir|mesh-list
154046244|NCT00855309|Antiviral Agents|antiviral agents|mesh-ancestor
154046245|NCT00855309|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154046246|NCT00532129|Rituximab|rituximab|mesh-list
154046247|NCT00532129|Chlorambucil|chlorambucil|mesh-list
154046248|NCT00532129|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154046249|NCT00532129|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154046309|NCT02635334|Hormone Antagonists|hormone antagonists|mesh-ancestor
154046310|NCT02635334|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154046311|NCT02635334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154046312|NCT02635334|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
154046313|NCT02635334|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
154046314|NCT02635334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154046315|NCT00853905|Triamcinolone|triamcinolone|mesh-list
154046316|NCT00853905|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
154046317|NCT00853905|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
154046318|NCT00853905|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
154046319|NCT00853905|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
154046320|NCT00853905|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154046321|NCT00853905|Glucocorticoids|glucocorticoids|mesh-ancestor
154046322|NCT00853905|Hormones|hormones|mesh-ancestor
154046323|NCT00853905|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154046324|NCT00853905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154046364|NCT05429567|Fentanyl|fentanyl|mesh-list
154046365|NCT05429567|Bupivacaine|bupivacaine|mesh-list
154046366|NCT05429567|Anesthetics, Local|anesthetics, local|mesh-ancestor
154046367|NCT05429567|Anesthetics|anesthetics|mesh-ancestor
154046368|NCT05429567|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154046369|NCT05429567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154046370|NCT05429567|Sensory System Agents|sensory system agents|mesh-ancestor
154046371|NCT05429567|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154046372|NCT05429567|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154046373|NCT05429567|Narcotics|narcotics|mesh-ancestor
154046374|NCT05429567|Analgesics|analgesics|mesh-ancestor
154046375|NCT05429567|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154046376|NCT05429567|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154046377|NCT05429567|Anesthetics, General|anesthetics, general|mesh-ancestor
154046378|NCT00868296|Pantoprazole|pantoprazole|mesh-list
154046379|NCT00868296|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154046380|NCT00868296|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154046381|NCT00868296|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
154046382|NCT00868296|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154046384|NCT01002157|Vitamin K|vitamin k|mesh-list
154046423|NCT01004497|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154046424|NCT01004497|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154046425|NCT01004497|Antimetabolites|antimetabolites|mesh-ancestor
154046426|NCT01004497|Antiviral Agents|antiviral agents|mesh-ancestor
154046427|NCT01004497|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154046428|NCT01004497|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154046429|NCT01004497|Tubulin Modulators|tubulin modulators|mesh-ancestor
154046430|NCT01004497|Antimitotic Agents|antimitotic agents|mesh-ancestor
154046431|NCT01004497|Mitosis Modulators|mitosis modulators|mesh-ancestor
154046432|NCT01004497|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154046433|NCT01004497|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154046434|NCT01004497|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154046435|NCT01004497|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154046436|NCT01004497|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154046438|NCT01004497|Sensory System Agents|sensory system agents|mesh-ancestor
154046439|NCT02713841|Insulin|insulin|mesh-list
154046440|NCT02713841|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
154046444|NCT01004575|Cobalt|cobalt|mesh-list
154046484|NCT02714075|Dermatologic Agents|dermatologic agents|mesh-ancestor
154046485|NCT02714075|Sunscreening Agents|sunscreening agents|mesh-ancestor
154046486|NCT02714075|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
154046487|NCT02714075|Protective Agents|protective agents|mesh-ancestor
154046488|NCT02636426|Sorafenib|sorafenib|mesh-list
154046489|NCT02636426|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154046490|NCT02636426|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154046491|NCT02636426|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154046492|NCT02636426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154046494|NCT02713763|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154046495|NCT02713763|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154046496|NCT02713763|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154046497|NCT02713763|Growth Substances|growth substances|mesh-ancestor
154046498|NCT02713763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154046503|NCT00867360|Mifepristone|mifepristone|mesh-list
154046540|NCT00883688|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154046541|NCT00883688|Growth Substances|growth substances|mesh-ancestor
154046542|NCT00883688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154046543|NCT00883688|Growth Inhibitors|growth inhibitors|mesh-ancestor
154046544|NCT00883688|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154046545|NCT00883688|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154046546|NCT00883688|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154046547|NCT00883688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154046549|NCT04191863|Anticonvulsants|anticonvulsants|mesh-ancestor
154046550|NCT04191863|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154046551|NCT04191863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154046552|NCT04191863|GABA Agents|gaba agents|mesh-ancestor
154046553|NCT04191863|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154046554|NCT04191863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154046555|NCT04191863|Antimanic Agents|antimanic agents|mesh-ancestor
154046556|NCT04191863|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154046557|NCT04191863|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154046596|NCT00654290|Propranolol|propranolol|mesh-list
154046597|NCT00654290|Amiodarone|amiodarone|mesh-list
154046598|NCT00654290|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
154046599|NCT00654290|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154046600|NCT00654290|Adrenergic Agents|adrenergic agents|mesh-ancestor
154046601|NCT00654290|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154046604|NCT00654290|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154046663|NCT00611195|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154046664|NCT00611195|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154046665|NCT00611195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154046666|NCT00611195|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154046667|NCT00611195|Anesthetics, General|anesthetics, general|mesh-ancestor
154046668|NCT00611195|Anesthetics|anesthetics|mesh-ancestor
154046669|NCT00611195|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154046670|NCT00611195|Narcotics|narcotics|mesh-ancestor
154046671|NCT00611195|Analgesics|analgesics|mesh-ancestor
154046672|NCT00611195|Sensory System Agents|sensory system agents|mesh-ancestor
154046727|NCT02638922|Trisequens|trisequens|mesh-list
154046728|NCT02638922|Norethindrone|norethindrone|mesh-list
154046729|NCT02638922|Estradiol|estradiol|mesh-list
154046730|NCT02638922|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
154046731|NCT02638922|Estrogens|estrogens|mesh-ancestor
154046732|NCT02638922|Hormones|hormones|mesh-ancestor
154046733|NCT02638922|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154046734|NCT02638922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154046735|NCT02638922|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
154046736|NCT02638922|Contraceptive Agents|contraceptive agents|mesh-ancestor
154046737|NCT02638922|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154046738|NCT02638922|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
154046739|NCT02638922|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
154046740|NCT02638922|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
154046741|NCT02638922|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
154046742|NCT01005199|Everolimus|everolimus|mesh-list
154046743|NCT01005199|Sorafenib|sorafenib|mesh-list
154046744|NCT01005199|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
154046745|NCT01005199|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154046746|NCT01005199|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154046747|NCT01005199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154046783|NCT00853749|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
154046784|NCT00853749|Immunologic Factors|immunologic factors|mesh-ancestor
154046785|NCT00853749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154046786|NCT00657410|Dexamethasone|dexamethasone|mesh-list
154046787|NCT00657410|Prednisone|prednisone|mesh-list
154046788|NCT00657410|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154046789|NCT00657410|Antiemetics|antiemetics|mesh-ancestor
154046790|NCT00657410|Autonomic Agents|autonomic agents|mesh-ancestor
154046791|NCT00657410|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154046792|NCT00657410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154046793|NCT00657410|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154046794|NCT00657410|Glucocorticoids|glucocorticoids|mesh-ancestor
154046795|NCT00657410|Hormones|hormones|mesh-ancestor
154046796|NCT00657410|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154046797|NCT00657410|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154046798|NCT00657410|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154046799|NCT01009021|Diclofenac|diclofenac|mesh-list
154046800|NCT01009021|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154046801|NCT01009021|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154046802|NCT01009021|Analgesics|analgesics|mesh-ancestor
154046816|NCT01005433|Analgesics|analgesics|mesh-ancestor
154046836|NCT01003483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154046837|NCT01003483|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
154046838|NCT01003483|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154046839|NCT00592839|Estrogens|estrogens|mesh-list
154046840|NCT00592839|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
154046841|NCT00592839|Estrogens, conjugated synthetic A|estrogens, conjugated synthetic a|mesh-list
154046842|NCT00592839|Estrogens, conjugated synthetic B|estrogens, conjugated synthetic b|mesh-list
154046843|NCT00592839|Hormones|hormones|mesh-ancestor
154046844|NCT00592839|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154046845|NCT00592839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154046846|NCT01009177|Bosentan|bosentan|mesh-list
154046847|NCT01009177|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154046848|NCT01009177|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
154046849|NCT01009177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154046851|NCT00598832|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154046852|NCT00598832|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154046853|NCT00598832|Analgesics|analgesics|mesh-ancestor
154046854|NCT00598832|Sensory System Agents|sensory system agents|mesh-ancestor
154046855|NCT00598832|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154046856|NCT00598832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154046857|NCT00598832|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154046858|NCT00598832|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154046859|NCT00598832|Dermatologic Agents|dermatologic agents|mesh-ancestor
154046860|NCT01003561|Anesthetics|anesthetics|mesh-list
154046861|NCT01003561|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154046862|NCT01003561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154046863|NCT02711267|Acyclovir|acyclovir|mesh-list
154046864|NCT02711267|Antiviral Agents|antiviral agents|mesh-ancestor
154046865|NCT02711267|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154046866|NCT04219553|Anti-Infective Agents|anti-infective agents|mesh-list
154046867|NCT04219553|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
154046880|NCT01005979|Rituximab|rituximab|mesh-list
154046881|NCT01005979|Lenalidomide|lenalidomide|mesh-list
154046882|NCT01005979|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154046883|NCT01005979|Immunologic Factors|immunologic factors|mesh-ancestor
154046884|NCT01005979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154046885|NCT01005979|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154046886|NCT01005979|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154046887|NCT01005979|Alkylating Agents|alkylating agents|mesh-ancestor
154046888|NCT01005979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154046889|NCT01005979|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154046890|NCT01005979|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154046891|NCT01005979|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154046892|NCT01005979|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154046940|NCT02710877|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154046941|NCT02710877|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154046942|NCT02710877|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154046943|NCT02710877|Anesthetics, General|anesthetics, general|mesh-ancestor
154046944|NCT02710877|Anesthetics|anesthetics|mesh-ancestor
154046945|NCT02710877|Anesthetics, Local|anesthetics, local|mesh-ancestor
154046946|NCT00530023|Insulin|insulin|mesh-list
154046947|NCT00530023|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154046948|NCT00530023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154046949|NCT02707445|Clopidogrel|clopidogrel|mesh-list
154046950|NCT02707445|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154046951|NCT02707445|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
154046952|NCT02707445|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
154046953|NCT02707445|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
154046954|NCT02707445|Purinergic Agents|purinergic agents|mesh-ancestor
154046955|NCT02707445|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154046956|NCT02707445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154046957|NCT02707445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154046958|NCT03999775|Calcium, Dietary|calcium, dietary|mesh-list
154046959|NCT03999775|Vitamin D|vitamin d|mesh-list
154046962|NCT03999775|Vitamins|vitamins|mesh-list
154046995|NCT01006525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154046996|NCT01006681|Vaccines|vaccines|mesh-list
153877868|NCT05293509|Autonomic Agents|autonomic agents|mesh-ancestor
154046997|NCT01006681|MF59 oil emulsion|mf59 oil emulsion|mesh-list
154046998|NCT01006681|Immunologic Factors|immunologic factors|mesh-ancestor
154046999|NCT01006681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154047000|NCT01006681|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154047001|NCT03893903|Avelumab|avelumab|mesh-list
154047002|NCT03893903|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154047003|NCT03893903|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154047004|NCT02706509|Tramadol|tramadol|mesh-list
154047005|NCT02706509|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154047006|NCT02706509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154047007|NCT02706509|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154047008|NCT02706509|Narcotics|narcotics|mesh-ancestor
154047009|NCT02706509|Analgesics|analgesics|mesh-ancestor
154047010|NCT02706509|Sensory System Agents|sensory system agents|mesh-ancestor
154047011|NCT02706509|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154047012|NCT02710409|Vaccines|vaccines|mesh-list
154047013|NCT02710409|Immunologic Factors|immunologic factors|mesh-ancestor
154047014|NCT02710409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154047015|NCT00529087|Bromides|bromides|mesh-list
154047016|NCT00529087|Methylnaltrexone|methylnaltrexone|mesh-list
154047017|NCT00529087|Anticonvulsants|anticonvulsants|mesh-ancestor
154047018|NCT00529087|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
154047019|NCT00529087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154047047|NCT00731926|Vitamin E|vitamin e|mesh-list
154047048|NCT00731926|Micronutrients|micronutrients|mesh-ancestor
154047049|NCT00731926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154047050|NCT00731926|Antioxidants|antioxidants|mesh-ancestor
154047051|NCT00731926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154047052|NCT00731926|Protective Agents|protective agents|mesh-ancestor
154047053|NCT00732082|Gemcitabine|gemcitabine|mesh-list
154047054|NCT00732082|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154047055|NCT00732082|Antimetabolites|antimetabolites|mesh-ancestor
154047056|NCT00732082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154047057|NCT00732082|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154047058|NCT00611741|Furosemide|furosemide|mesh-list
154047059|NCT00611741|Diuretics|diuretics|mesh-ancestor
154047060|NCT00611741|Natriuretic Agents|natriuretic agents|mesh-ancestor
154047061|NCT00611741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154047062|NCT00611741|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
154047105|NCT00612755|Antimetabolites|antimetabolites|mesh-ancestor
154047106|NCT00612755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154047107|NCT00612755|Antiviral Agents|antiviral agents|mesh-ancestor
154047108|NCT00612755|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154047109|NCT04132674|Tenofovir|tenofovir|mesh-list
154047110|NCT04132674|Emtricitabine|emtricitabine|mesh-list
154047111|NCT04132674|Emtricitabine tenofovir alafenamide|emtricitabine tenofovir alafenamide|mesh-list
154047112|NCT04132674|Antiviral Agents|antiviral agents|mesh-ancestor
154047113|NCT04132674|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154047114|NCT04132674|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
154047115|NCT04132674|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154047116|NCT04132674|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154047117|NCT04132674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154047118|NCT04132674|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154047119|NCT04132674|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154047120|NCT00612287|Buprenorphine|buprenorphine|mesh-list
154047121|NCT00612287|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154047122|NCT00612287|Narcotics|narcotics|mesh-ancestor
154047123|NCT00612287|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154047124|NCT00612287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154047125|NCT00612287|Analgesics|analgesics|mesh-ancestor
154047126|NCT00612287|Sensory System Agents|sensory system agents|mesh-ancestor
154047127|NCT00612287|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154047128|NCT00612287|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
154047129|NCT00732784|Imatinib Mesylate|imatinib mesylate|mesh-list
154047130|NCT00732784|Calcium Carbonate|calcium carbonate|mesh-list
154047131|NCT00732784|Calcium|calcium|mesh-list
154047132|NCT00732784|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154047136|NCT00732784|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154047151|NCT04492553|Testosterone|testosterone|mesh-list
154047152|NCT04492553|Androgens|androgens|mesh-ancestor
154047153|NCT04492553|Hormones|hormones|mesh-ancestor
154047154|NCT04492553|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154047155|NCT04492553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154047156|NCT00871494|Azithromycin|azithromycin|mesh-list
154047157|NCT00871494|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154047158|NCT00871494|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154047159|NCT01007539|Choline|choline|mesh-list
154047160|NCT01007539|Cytidine Diphosphate Choline|cytidine diphosphate choline|mesh-list
154047161|NCT01007539|Lipotropic Agents|lipotropic agents|mesh-ancestor
153589821|NCT01809301|Niacin|niacin|mesh-list
154047162|NCT01007539|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154047163|NCT01007539|Antimetabolites|antimetabolites|mesh-ancestor
154047164|NCT01007539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154047165|NCT01007539|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154047166|NCT01007539|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154047167|NCT01007539|Nootropic Agents|nootropic agents|mesh-ancestor
154047168|NCT04951817|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
154047169|NCT04951817|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
154047170|NCT04951817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154047171|NCT00733174|Rosiglitazone|rosiglitazone|mesh-list
154047172|NCT00733174|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154047173|NCT00733174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154047174|NCT00529789|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
154047175|NCT00529789|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
154047176|NCT00529789|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154047177|NCT00529789|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154047178|NCT00529789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154047179|NCT00529789|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154047196|NCT00611819|Antimetabolites|antimetabolites|mesh-ancestor
154047197|NCT00611819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154047198|NCT00611819|Immunologic Factors|immunologic factors|mesh-ancestor
154047199|NCT00611819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154047200|NCT00577642|Zoledronic Acid|zoledronic acid|mesh-list
154047201|NCT00577642|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154047202|NCT00577642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154047203|NCT02619162|Letrozole|letrozole|mesh-list
154047204|NCT02619162|Nintedanib|nintedanib|mesh-list
154047205|NCT02619162|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154047206|NCT02619162|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
154047207|NCT02619162|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154047208|NCT02619162|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154047209|NCT02619162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154047210|NCT02619162|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
154047211|NCT02619162|Hormone Antagonists|hormone antagonists|mesh-ancestor
154047212|NCT02619162|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154047213|NCT02619162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154047214|NCT02619162|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154047215|NCT04018690|Triamcinolone|triamcinolone|mesh-list
154047216|NCT04018690|Ropivacaine|ropivacaine|mesh-list
154047218|NCT04018690|Anesthetics|anesthetics|mesh-ancestor
154047241|NCT00733564|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154047242|NCT00733564|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154047243|NCT00733564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154047244|NCT00733564|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154047245|NCT00733564|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154047246|NCT00733564|Anesthetics, General|anesthetics, general|mesh-ancestor
154047247|NCT00733564|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154047248|NCT00733564|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
154047250|NCT00727870|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
154047251|NCT00727870|Protective Agents|protective agents|mesh-ancestor
154047252|NCT00727870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154047302|NCT02615106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154047303|NCT02615106|Growth Inhibitors|growth inhibitors|mesh-ancestor
154047304|NCT02615106|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154047305|NCT04930237|Methylnaltrexone|methylnaltrexone|mesh-list
154047306|NCT04930237|Bisacodyl|bisacodyl|mesh-list
154047307|NCT04930237|Magnesium citrate|magnesium citrate|mesh-list
154047308|NCT04930237|Magnesium Oxide|magnesium oxide|mesh-list
154047309|NCT04930237|Bismuth subsalicylate|bismuth subsalicylate|mesh-list
154047310|NCT04930237|Magnesium Hydroxide|magnesium hydroxide|mesh-list
154047311|NCT04930237|Calcium|calcium|mesh-list
154047312|NCT04930237|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154047313|NCT04930237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154047314|NCT04930237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154047315|NCT04930237|Cathartics|cathartics|mesh-ancestor
154047316|NCT04930237|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154047317|NCT04930237|Laxatives|laxatives|mesh-ancestor
154047318|NCT04930237|Antacids|antacids|mesh-ancestor
154047319|NCT04930237|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
154047320|NCT04930237|Sensory System Agents|sensory system agents|mesh-ancestor
154047321|NCT04930237|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154047322|NCT04930237|Antidiarrheals|antidiarrheals|mesh-ancestor
154047323|NCT02615262|Dexamethasone|dexamethasone|mesh-list
154047324|NCT02615262|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154047325|NCT02615262|Antiemetics|antiemetics|mesh-ancestor
154047326|NCT02615262|Autonomic Agents|autonomic agents|mesh-ancestor
154047327|NCT02615262|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154047328|NCT02615262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154047329|NCT02615262|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154047330|NCT02615262|Glucocorticoids|glucocorticoids|mesh-ancestor
154047331|NCT02615262|Hormones|hormones|mesh-ancestor
154047332|NCT02615262|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154047333|NCT02615262|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154047334|NCT02615262|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154047335|NCT00733720|Naltrexone|naltrexone|mesh-list
154047346|NCT00733720|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
154047347|NCT00733720|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
154047348|NCT04134312|Smallpox and monkeypox vaccine modified vaccinia ankara-bavarian nordic|smallpox and monkeypox vaccine modified vaccinia ankara-bavarian nordic|mesh-list
154047349|NCT04134312|Antiviral Agents|antiviral agents|mesh-ancestor
154047350|NCT04134312|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154047351|NCT02624388|Genistein|genistein|mesh-list
154047352|NCT02624388|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
154047353|NCT02624388|Protective Agents|protective agents|mesh-ancestor
154047354|NCT02624388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154047355|NCT02624388|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154047356|NCT02624388|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154047357|NCT02624388|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154047358|NCT02624388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154047359|NCT02624388|Phytoestrogens|phytoestrogens|mesh-ancestor
154047360|NCT02624388|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
154047361|NCT02624388|Estrogens|estrogens|mesh-ancestor
154047362|NCT02624388|Hormones|hormones|mesh-ancestor
154047363|NCT02624388|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154047364|NCT00727948|Aspirin|aspirin|mesh-list
154047365|NCT00727948|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154047366|NCT00727948|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154047367|NCT00727948|Analgesics|analgesics|mesh-ancestor
154047368|NCT00727948|Sensory System Agents|sensory system agents|mesh-ancestor
154047369|NCT00727948|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154047370|NCT00727948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154047371|NCT00727948|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154047372|NCT00727948|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154047373|NCT00727948|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154047374|NCT00727948|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154047375|NCT00727948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154047376|NCT00727948|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154047377|NCT00727948|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154047378|NCT00727948|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153573208|NCT02325466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154047379|NCT00727948|Antipyretics|antipyretics|mesh-ancestor
154047380|NCT01007851|Triptorelin Pamoate|triptorelin pamoate|mesh-list
154047381|NCT01007851|Luteolytic Agents|luteolytic agents|mesh-ancestor
154047382|NCT01007851|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
154047383|NCT01007851|Contraceptive Agents|contraceptive agents|mesh-ancestor
154047384|NCT01007851|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154047385|NCT01007851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153590050|NCT01810926|Cyclosporins|cyclosporins|mesh-list
154047386|NCT01007851|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
154047387|NCT01007851|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154047388|NCT01007851|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154047389|NCT05580016|Plasminogen|plasminogen|mesh-list
154047390|NCT05580016|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154047391|NCT05580016|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154047392|NCT05580016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154047394|NCT05730673|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
154047395|NCT05730673|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
154047396|NCT05730673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154047397|NCT05730673|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154047398|NCT05730673|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154047399|NCT05730673|Antiviral Agents|antiviral agents|mesh-ancestor
154047432|NCT00597584|Hematinics|hematinics|mesh-ancestor
154047433|NCT00529633|Thalidomide|thalidomide|mesh-list
154047434|NCT00529633|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154047435|NCT00529633|Immunologic Factors|immunologic factors|mesh-ancestor
154047436|NCT00529633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154047437|NCT00529633|Leprostatic Agents|leprostatic agents|mesh-ancestor
154047438|NCT00529633|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154047439|NCT00529633|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154047440|NCT00529633|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154047441|NCT00529633|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154047442|NCT00529633|Growth Substances|growth substances|mesh-ancestor
154047443|NCT00529633|Growth Inhibitors|growth inhibitors|mesh-ancestor
154047444|NCT00529633|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154047445|NCT00697944|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
154047446|NCT00697944|Antifungal Agents|antifungal agents|mesh-ancestor
154047447|NCT00697944|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154047448|NCT00697944|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154047449|NCT00697944|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154047450|NCT00657488|Thalidomide|thalidomide|mesh-list
154047451|NCT00657488|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154047452|NCT00657488|Immunologic Factors|immunologic factors|mesh-ancestor
154047453|NCT00657488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154047454|NCT00657488|Leprostatic Agents|leprostatic agents|mesh-ancestor
154047455|NCT00657488|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154047456|NCT00657488|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154047457|NCT00657488|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154047458|NCT00657488|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153590169|NCT01811836|Zinc|zinc|mesh-list
154047479|NCT00712270|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154047480|NCT00712270|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154047481|NCT00712270|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
154047482|NCT00712270|Dopamine Agents|dopamine agents|mesh-ancestor
154047483|NCT00712270|Antidepressive Agents|antidepressive agents|mesh-ancestor
154047484|NCT00712270|Dopamine Agonists|dopamine agonists|mesh-ancestor
154047485|NCT00712270|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
154047486|NCT00712270|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
154047487|NCT00712270|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
154047488|NCT00712270|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
154047490|NCT03860597|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
154047491|NCT03860597|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
154047492|NCT03860597|Dopamine Agents|dopamine agents|mesh-ancestor
154047493|NCT03860597|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154047494|NCT03860597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154047495|NCT03860597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154047496|NCT03860597|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154047497|NCT03860597|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154047498|NCT02614872|Alpha 1-Antitrypsin|alpha 1-antitrypsin|mesh-list
154047531|NCT05260619|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154047532|NCT00695682|Infliximab|infliximab|mesh-list
154047533|NCT00695682|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
154047534|NCT00695682|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154047535|NCT00695682|Dermatologic Agents|dermatologic agents|mesh-ancestor
154047536|NCT00695682|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154047537|NCT00695682|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154047538|NCT00657566|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
154047539|NCT00657566|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
154047540|NCT00657566|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154047541|NCT00657566|Antitubercular Agents|antitubercular agents|mesh-ancestor
154047542|NCT00530257|Methylphenidate|methylphenidate|mesh-list
154047543|NCT00530257|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
154047544|NCT00530257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154047590|NCT00656786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154047591|NCT00656786|Hemostatics|hemostatics|mesh-ancestor
154047592|NCT00656786|Coagulants|coagulants|mesh-ancestor
154047593|NCT00656786|Vitamins|vitamins|mesh-ancestor
154047594|NCT00656786|Micronutrients|micronutrients|mesh-ancestor
154047595|NCT00656786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154047596|NCT01008631|Sodium thiosulfate|sodium thiosulfate|mesh-list
154047597|NCT01008631|Antidotes|antidotes|mesh-ancestor
154047598|NCT01008631|Protective Agents|protective agents|mesh-ancestor
154047599|NCT01008631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154047600|NCT01008631|Antioxidants|antioxidants|mesh-ancestor
154047601|NCT01008631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154047602|NCT01008631|Antitubercular Agents|antitubercular agents|mesh-ancestor
154047603|NCT01008631|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154047604|NCT01008631|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154047605|NCT01008631|Chelating Agents|chelating agents|mesh-ancestor
154047651|NCT00735124|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154047652|NCT00735124|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154047653|NCT00735124|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154047654|NCT00735124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154047656|NCT04131348|Botulinum Toxins|botulinum toxins|mesh-list
154047657|NCT04131348|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
154047658|NCT04131348|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
154047659|NCT04131348|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
154047660|NCT04131348|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154047661|NCT04131348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154047662|NCT04131348|Cholinergic Agents|cholinergic agents|mesh-ancestor
154047663|NCT04131348|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154047664|NCT04131348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154047665|NCT04131348|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
154047666|NCT04131348|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154047667|NCT04246541|Acetaminophen|acetaminophen|mesh-list
154047668|NCT04246541|Ketorolac|ketorolac|mesh-list
154047669|NCT04246541|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
154047670|NCT04246541|Oxycodone|oxycodone|mesh-list
154047671|NCT04246541|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154047672|NCT04246541|Analgesics|analgesics|mesh-ancestor
154047673|NCT04246541|Sensory System Agents|sensory system agents|mesh-ancestor
154047674|NCT04246541|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154047675|NCT04246541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154047676|NCT04246541|Antipyretics|antipyretics|mesh-ancestor
154047677|NCT04246541|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154047678|NCT04246541|Narcotics|narcotics|mesh-ancestor
154047679|NCT04246541|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154047680|NCT04246541|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154047681|NCT04246541|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154047682|NCT04246541|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154047683|NCT04246541|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153573209|NCT02325466|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153573210|NCT02325466|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153573211|NCT02325466|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153573212|NCT02325466|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154047684|NCT04246541|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154047685|NCT04246541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154047687|NCT04902859|Analgesics|analgesics|mesh-ancestor
154047688|NCT04902859|Sensory System Agents|sensory system agents|mesh-ancestor
154047689|NCT04902859|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154047690|NCT04902859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154047691|NCT04902859|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154047692|NCT04902859|Sympatholytics|sympatholytics|mesh-ancestor
154047693|NCT04902859|Autonomic Agents|autonomic agents|mesh-ancestor
154047694|NCT04902859|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154047695|NCT04902859|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154047696|NCT04902859|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154047697|NCT04902859|Adrenergic Agents|adrenergic agents|mesh-ancestor
154047698|NCT04902859|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153877876|NCT05293509|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
154047699|NCT04902859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154047700|NCT05227313|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
154047701|NCT00711958|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
154047702|NCT04180943|Bupivacaine|bupivacaine|mesh-list
154047703|NCT04180943|Anesthetics, Local|anesthetics, local|mesh-ancestor
154047704|NCT04180943|Anesthetics|anesthetics|mesh-ancestor
154047709|NCT00711880|Nabiximols|nabiximols|mesh-list
154047739|NCT00735280|Anticoagulants|anticoagulants|mesh-ancestor
154047740|NCT00735280|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154047741|NCT00735280|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154047742|NCT00735280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154047744|NCT00612989|O(6)-benzylguanine|o(6)-benzylguanine|mesh-list
154047745|NCT00612989|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154047746|NCT00612989|Alkylating Agents|alkylating agents|mesh-ancestor
154047747|NCT00612989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154047748|NCT00612989|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154047749|NCT00612989|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154047750|NCT04929067|Immunomodulating Agents|immunomodulating agents|mesh-list
154047751|NCT04929067|Immunologic Factors|immunologic factors|mesh-ancestor
154047752|NCT04929067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154047753|NCT00613067|Escitalopram|escitalopram|mesh-list
154047754|NCT00613067|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
154047755|NCT00613067|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154047758|NCT00613067|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154047791|NCT05268419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154047792|NCT00852969|Niacin|niacin|mesh-list
154047793|NCT00852969|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154047794|NCT00852969|Antimetabolites|antimetabolites|mesh-ancestor
154047795|NCT00852969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154047796|NCT00852969|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154047797|NCT00852969|Vasodilator Agents|vasodilator agents|mesh-ancestor
154047798|NCT00852969|Vitamin B Complex|vitamin b complex|mesh-ancestor
154047799|NCT00852969|Vitamins|vitamins|mesh-ancestor
154047800|NCT00852969|Micronutrients|micronutrients|mesh-ancestor
154047801|NCT00852969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154047802|NCT00613457|Cytarabine|cytarabine|mesh-list
154047803|NCT00613457|Dexamethasone|dexamethasone|mesh-list
154047804|NCT00613457|Prednisone|prednisone|mesh-list
154047805|NCT00613457|Cyclophosphamide|cyclophosphamide|mesh-list
154047806|NCT00613457|Ifosfamide|ifosfamide|mesh-list
154047807|NCT00613457|Doxorubicin|doxorubicin|mesh-list
154047808|NCT00613457|Methotrexate|methotrexate|mesh-list
154047809|NCT00613457|Etoposide|etoposide|mesh-list
154047810|NCT00613457|Vincristine|vincristine|mesh-list
154047811|NCT00613457|Daunorubicin|daunorubicin|mesh-list
154047812|NCT00613457|Asparaginase|asparaginase|mesh-list
154047813|NCT00613457|Mercaptopurine|mercaptopurine|mesh-list
154047814|NCT00613457|Thioguanine|thioguanine|mesh-list
154047815|NCT00613457|Vindesine|vindesine|mesh-list
154047816|NCT00613457|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154047817|NCT00613457|Immunologic Factors|immunologic factors|mesh-ancestor
154047818|NCT00613457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154047819|NCT00613457|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154047820|NCT00613457|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154047821|NCT00613457|Alkylating Agents|alkylating agents|mesh-ancestor
154047822|NCT00613457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154047823|NCT00613457|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154047824|NCT00613457|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154047825|NCT00613457|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154047826|NCT00613457|Antiemetics|antiemetics|mesh-ancestor
154047827|NCT00613457|Autonomic Agents|autonomic agents|mesh-ancestor
154047828|NCT00613457|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154047833|NCT00613457|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154047834|NCT00613457|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154047835|NCT00613457|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154047836|NCT00613457|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154047837|NCT00613457|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154047838|NCT00613457|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154047839|NCT00613457|Abortifacient Agents|abortifacient agents|mesh-ancestor
154047840|NCT00613457|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154047841|NCT00613457|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154047843|NCT00613457|Dermatologic Agents|dermatologic agents|mesh-ancestor
154047844|NCT00613457|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153418652|NCT00373802|Sympathomimetics|sympathomimetics|mesh-ancestor
154047845|NCT00613457|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154047846|NCT00613457|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154047894|NCT00851877|Mitosis Modulators|mitosis modulators|mesh-ancestor
154047895|NCT00851877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154047896|NCT00851877|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154047897|NCT00613223|Etoposide|etoposide|mesh-list
154047898|NCT00613223|Etoposide phosphate|etoposide phosphate|mesh-list
154047899|NCT00613223|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154047900|NCT00613223|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154047901|NCT00613223|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154047902|NCT00613223|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154047903|NCT00613223|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154047904|NCT00613223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154047905|NCT00882908|Ribavirin|ribavirin|mesh-list
154047906|NCT00882908|Simeprevir|simeprevir|mesh-list
154047907|NCT00882908|Antimetabolites|antimetabolites|mesh-ancestor
154047908|NCT00882908|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154047909|NCT00882908|Antiviral Agents|antiviral agents|mesh-ancestor
154047910|NCT00882908|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154047911|NCT00882908|Protease Inhibitors|protease inhibitors|mesh-ancestor
154047912|NCT00882908|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154047913|NCT03580967|Vortioxetine|vortioxetine|mesh-list
154047947|NCT00851799|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154047948|NCT00851799|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
154047949|NCT00851799|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154047950|NCT00851799|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
154047951|NCT00851799|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
154047952|NCT00853047|Octreotide|octreotide|mesh-list
154047953|NCT00853047|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154047954|NCT00853047|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154047955|NCT00853047|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154047956|NCT04117191|Tryptophan|tryptophan|mesh-list
154047957|NCT04117191|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
154047958|NCT04117191|Antidepressive Agents|antidepressive agents|mesh-ancestor
154047959|NCT04117191|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154047960|NCT00520975|Paclitaxel|paclitaxel|mesh-list
154047961|NCT00520975|Bevacizumab|bevacizumab|mesh-list
154047962|NCT00520975|Carboplatin|carboplatin|mesh-list
154047963|NCT00520975|Trastuzumab|trastuzumab|mesh-list
154047964|NCT00520975|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
154047965|NCT00520975|Antibodies|antibodies|mesh-list
154047966|NCT00520975|Immunoglobulins|immunoglobulins|mesh-list
154047967|NCT00520975|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154047968|NCT00520975|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154047969|NCT00520975|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154047970|NCT00520975|Tubulin Modulators|tubulin modulators|mesh-ancestor
154047971|NCT00520975|Antimitotic Agents|antimitotic agents|mesh-ancestor
154047972|NCT00520975|Mitosis Modulators|mitosis modulators|mesh-ancestor
154047973|NCT00520975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154047974|NCT00520975|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154047975|NCT00520975|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154047976|NCT00520975|Growth Substances|growth substances|mesh-ancestor
154047977|NCT00520975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154047978|NCT00520975|Growth Inhibitors|growth inhibitors|mesh-ancestor
154047979|NCT00520975|Immunologic Factors|immunologic factors|mesh-ancestor
154047980|NCT00614159|Ketamine|ketamine|mesh-list
154047981|NCT00614159|Propofol|propofol|mesh-list
154047982|NCT00614159|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154047987|NCT00614159|Anesthetics|anesthetics|mesh-ancestor
154047988|NCT00614159|Analgesics|analgesics|mesh-ancestor
154047990|NCT00614159|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154047991|NCT00614159|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
154047992|NCT00614159|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154047993|NCT00614159|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154047994|NCT00614159|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154047995|NCT00614159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154047996|NCT05042531|Azacitidine|azacitidine|mesh-list
154047997|NCT05042531|Dasatinib|dasatinib|mesh-list
154047998|NCT05042531|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154047999|NCT05042531|Antimetabolites|antimetabolites|mesh-ancestor
154048000|NCT05042531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154048001|NCT05042531|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154048002|NCT05042531|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154048003|NCT05042531|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154048004|NCT05042531|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154048005|NCT00851721|Factor VIII|factor viii|mesh-list
154048006|NCT00851721|Anti-inhibitor coagulant complex|anti-inhibitor coagulant complex|mesh-list
154048007|NCT00851721|Coagulants|coagulants|mesh-ancestor
154048008|NCT04071119|Oxytocin|oxytocin|mesh-list
154048009|NCT04071119|Oxytocics|oxytocics|mesh-ancestor
154048010|NCT04071119|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154048011|NCT04071119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154048038|NCT04159142|Tubulin Modulators|tubulin modulators|mesh-ancestor
154048039|NCT04159142|Antimitotic Agents|antimitotic agents|mesh-ancestor
154048040|NCT04159142|Mitosis Modulators|mitosis modulators|mesh-ancestor
154048041|NCT04159142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154048042|NCT04159142|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154048043|NCT04159142|Antimetabolites|antimetabolites|mesh-ancestor
154048044|NCT00654680|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
154048045|NCT00654680|Vasodilator Agents|vasodilator agents|mesh-ancestor
154048046|NCT00654680|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
154048047|NCT00654680|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154048048|NCT00654680|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154048049|NCT00654680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154048050|NCT00654680|Urological Agents|urological agents|mesh-ancestor
154048051|NCT00520741|Lacosamide|lacosamide|mesh-list
154048052|NCT00520741|Anticonvulsants|anticonvulsants|mesh-ancestor
154048053|NCT00520741|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154048054|NCT00520741|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154048055|NCT00520741|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154048056|NCT00520741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154048058|NCT00729118|Vorinostat|vorinostat|mesh-list
154048059|NCT00729118|Immunologic Factors|immunologic factors|mesh-ancestor
154048060|NCT00729118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154048061|NCT00729118|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153590728|NCT01814709|Rifampin|rifampin|mesh-list
154048089|NCT00882518|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154048090|NCT00882518|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154048091|NCT00882518|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154048092|NCT00882518|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154048093|NCT00882518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154048094|NCT00882518|Antiemetics|antiemetics|mesh-ancestor
154048095|NCT00882518|Autonomic Agents|autonomic agents|mesh-ancestor
154048096|NCT00882518|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154048097|NCT00882518|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154048098|NCT00882518|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
154048099|NCT00882518|Dopamine Agents|dopamine agents|mesh-ancestor
154048100|NCT00882518|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154048101|NCT00882518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154048102|NCT00882362|Aripiprazole|aripiprazole|mesh-list
154048103|NCT00882362|Antidepressive Agents|antidepressive agents|mesh-ancestor
154048104|NCT00882362|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154048105|NCT00882362|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154048106|NCT00882362|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154048107|NCT00882362|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154048108|NCT00882362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154048109|NCT00882362|Dopamine Agonists|dopamine agonists|mesh-ancestor
154048110|NCT00882362|Dopamine Agents|dopamine agents|mesh-ancestor
154048111|NCT00882362|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154048112|NCT00882362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154048113|NCT00882362|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
154048114|NCT00882362|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
153590800|NCT01815073|Vaccines|vaccines|mesh-list
154048135|NCT00636935|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
154048136|NCT00636935|Primaquine|primaquine|mesh-list
153418662|NCT00373802|Protective Agents|protective agents|mesh-ancestor
153418663|NCT02945150|Grazoprevir|grazoprevir|mesh-list
154048137|NCT00636935|Trimethoprim|trimethoprim|mesh-list
154048138|NCT00636935|Atovaquone|atovaquone|mesh-list
154048139|NCT00636935|Pentamidine|pentamidine|mesh-list
154048140|NCT00636935|Prednisone|prednisone|mesh-list
154048141|NCT00636935|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154048142|NCT00636935|Glucocorticoids|glucocorticoids|mesh-ancestor
154048143|NCT00636935|Hormones|hormones|mesh-ancestor
154048144|NCT00636935|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154048145|NCT00636935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154048146|NCT00636935|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154048147|NCT00636935|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154048148|NCT00636935|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154048149|NCT00636935|Antitubercular Agents|antitubercular agents|mesh-ancestor
154048150|NCT00636935|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
154048151|NCT00636935|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154048152|NCT00636935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154048153|NCT00636935|Antimalarials|antimalarials|mesh-ancestor
154048154|NCT00636935|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154048155|NCT00636935|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154048156|NCT00636935|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
154048157|NCT00636935|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154048158|NCT00636935|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
154048159|NCT00636935|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
154048160|NCT00636935|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154048161|NCT00636935|Leprostatic Agents|leprostatic agents|mesh-ancestor
154048162|NCT00636935|Antifungal Agents|antifungal agents|mesh-ancestor
154048163|NCT00636935|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
154048164|NCT00654758|Paclitaxel|paclitaxel|mesh-list
154048165|NCT00654758|Carboplatin|carboplatin|mesh-list
154048166|NCT00654758|Volociximab|volociximab|mesh-list
154048177|NCT00654758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154048178|NCT00654758|Growth Inhibitors|growth inhibitors|mesh-ancestor
154048179|NCT00654758|Immunologic Factors|immunologic factors|mesh-ancestor
154048180|NCT00656864|Pioglitazone|pioglitazone|mesh-list
154048181|NCT00656864|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154048182|NCT00656864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154048183|NCT00658268|Clodronic Acid|clodronic acid|mesh-list
154048184|NCT00658268|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154048185|NCT00658268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154048186|NCT00613613|Fenofibrate|fenofibrate|mesh-list
154048187|NCT00613613|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154048188|NCT00613613|Antimetabolites|antimetabolites|mesh-ancestor
154048189|NCT00613613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154048239|NCT00512707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154048240|NCT00512707|Androgens|androgens|mesh-ancestor
154048241|NCT00512707|Hormones|hormones|mesh-ancestor
154048242|NCT00512707|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154048243|NCT00512707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154048244|NCT00512707|Vasodilator Agents|vasodilator agents|mesh-ancestor
154048245|NCT00512707|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
154048246|NCT00512707|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154048247|NCT00512707|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154048248|NCT00512707|Urological Agents|urological agents|mesh-ancestor
154048249|NCT00729274|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
154048250|NCT03471767|Dextromethorphan|dextromethorphan|mesh-list
154048251|NCT03471767|Bupropion|bupropion|mesh-list
154048252|NCT03471767|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
154048253|NCT03471767|Antidepressive Agents|antidepressive agents|mesh-ancestor
154048254|NCT03471767|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154048255|NCT03471767|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
154048256|NCT03471767|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154048257|NCT03471767|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154048258|NCT03471767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154048259|NCT03471767|Dopamine Agents|dopamine agents|mesh-ancestor
154048260|NCT03471767|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154048261|NCT03471767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154048262|NCT03471767|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
154048270|NCT00849693|Fluoxetine|fluoxetine|mesh-list
154048284|NCT00849693|Serotonin Agents|serotonin agents|mesh-ancestor
154048285|NCT00849693|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
154048286|NCT00849693|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
154048287|NCT00849693|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154048288|NCT00849693|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154048289|NCT00736606|Simvastatin|simvastatin|mesh-list
154048290|NCT00736606|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154048291|NCT00736606|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154048292|NCT00736606|Antimetabolites|antimetabolites|mesh-ancestor
154048293|NCT00736606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154048294|NCT00736606|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154048295|NCT00736606|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154048296|NCT00736606|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154048297|NCT00527605|Dutasteride|dutasteride|mesh-list
154048298|NCT00527605|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
154048299|NCT00527605|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154048300|NCT00527605|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154048301|NCT00527605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154048302|NCT00527605|Hormone Antagonists|hormone antagonists|mesh-ancestor
154048303|NCT00527605|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154048304|NCT00527605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154048305|NCT00741052|Azithromycin|azithromycin|mesh-list
154048306|NCT00741052|Ciprofloxacin|ciprofloxacin|mesh-list
154048307|NCT00741052|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154048308|NCT00741052|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154048309|NCT00741052|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154048310|NCT00741052|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154048311|NCT00741052|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154048312|NCT00741052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154048313|NCT00741052|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154048314|NCT00741052|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
154048315|NCT00741052|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154048316|NCT04116411|Valganciclovir|valganciclovir|mesh-list
153573213|NCT02325466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153573214|NCT02325466|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153573215|NCT02325466|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153573216|NCT02325466|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154048318|NCT04116411|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154048319|NCT04116411|Alkylating Agents|alkylating agents|mesh-ancestor
154048320|NCT04116411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154048321|NCT04116411|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154048322|NCT04116411|Antiviral Agents|antiviral agents|mesh-ancestor
154048323|NCT04116411|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154048324|NCT00706953|Doxorubicin|doxorubicin|mesh-list
154048325|NCT00706953|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
154048326|NCT00706953|Bortezomib|bortezomib|mesh-list
154048327|NCT00706953|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154048328|NCT00706953|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154048329|NCT00706953|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154048330|NCT00706953|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154048331|NCT00706953|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154048332|NCT00706953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154048333|NCT03462017|Sildenafil Citrate|sildenafil citrate|mesh-list
154048334|NCT03462017|Acetylcholine|acetylcholine|mesh-list
154048335|NCT03462017|Vasodilator Agents|vasodilator agents|mesh-ancestor
154048336|NCT03462017|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
154048337|NCT03462017|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154048338|NCT03462017|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154048339|NCT03462017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154048340|NCT03462017|Urological Agents|urological agents|mesh-ancestor
154048341|NCT03462017|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
154048342|NCT03462017|Cholinergic Agents|cholinergic agents|mesh-ancestor
154048364|NCT00913419|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154048365|NCT00711412|Capecitabine|capecitabine|mesh-list
154048366|NCT00711412|Oxaliplatin|oxaliplatin|mesh-list
154048367|NCT00711412|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154048368|NCT00711412|Antimetabolites|antimetabolites|mesh-ancestor
154048369|NCT00711412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154048370|NCT00711412|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154048372|NCT01840007|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154048373|NCT01840007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154048374|NCT03746951|Ropivacaine|ropivacaine|mesh-list
154048375|NCT03746951|Anesthetics, Local|anesthetics, local|mesh-ancestor
154048376|NCT03746951|Anesthetics|anesthetics|mesh-ancestor
154048377|NCT03746951|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154048378|NCT03746951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154048379|NCT03746951|Sensory System Agents|sensory system agents|mesh-ancestor
154048380|NCT03746951|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154048381|NCT00577408|Naltrexone|naltrexone|mesh-list
154048382|NCT00577408|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
154048383|NCT00577408|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
154048384|NCT00577408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154048385|NCT00577408|Sensory System Agents|sensory system agents|mesh-ancestor
154048386|NCT00577408|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154048387|NCT03391193|Vaccines|vaccines|mesh-list
154048388|NCT03391193|Immunologic Factors|immunologic factors|mesh-ancestor
154048389|NCT03391193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154048390|NCT00741364|Vitamin D|vitamin d|mesh-list
154048391|NCT00741364|Cholecalciferol|cholecalciferol|mesh-list
154048392|NCT00741364|Vitamins|vitamins|mesh-ancestor
154048393|NCT00741364|Micronutrients|micronutrients|mesh-ancestor
154048394|NCT00741364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154048411|NCT05742256|Sensory System Agents|sensory system agents|mesh-ancestor
154048412|NCT05742256|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154048413|NCT05742256|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154048414|NCT05742256|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154048415|NCT05742256|Anesthetics, General|anesthetics, general|mesh-ancestor
154048416|NCT05742256|Anesthetics|anesthetics|mesh-ancestor
154048417|NCT00713596|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
154048418|NCT00713596|Hemostatics|hemostatics|mesh-ancestor
154048419|NCT00713596|Coagulants|coagulants|mesh-ancestor
154048420|NCT00729664|Atezolizumab|atezolizumab|mesh-list
154048421|NCT00729664|BMS-936559|bms-936559|mesh-list
154048422|NCT00729664|Antibodies|antibodies|mesh-list
154048423|NCT00729664|Immunoglobulins|immunoglobulins|mesh-list
154048424|NCT00729664|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
153591099|NCT01817348|Anesthetics, Local|anesthetics, local|mesh-ancestor
154048425|NCT00729664|Immunologic Factors|immunologic factors|mesh-ancestor
154048426|NCT00729664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154048427|NCT00729664|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154048428|NCT00729664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154048429|NCT00729664|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154048430|NCT00729664|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154048431|NCT04229615|Apatinib|apatinib|mesh-list
154048433|NCT04229615|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154048434|NCT04229615|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154048435|NCT04229615|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154048436|NCT04229615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154048437|NCT04229615|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
154048438|NCT00881894|Rotigotine|rotigotine|mesh-list
154048439|NCT00881894|Dopamine Agonists|dopamine agonists|mesh-ancestor
154048459|NCT04158674|Simendan|simendan|mesh-list
154048460|NCT04158674|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
154048461|NCT04158674|Vasodilator Agents|vasodilator agents|mesh-ancestor
154048462|NCT04158674|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
154048463|NCT04158674|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154048464|NCT04158674|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154048465|NCT04158674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154048466|NCT04158674|Protective Agents|protective agents|mesh-ancestor
154048467|NCT04158674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154048468|NCT00526669|Capecitabine|capecitabine|mesh-list
154048469|NCT00526669|Lapatinib|lapatinib|mesh-list
154048470|NCT00526669|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154048471|NCT00526669|Antimetabolites|antimetabolites|mesh-ancestor
154048472|NCT00526669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154048473|NCT00526669|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154048474|NCT00526669|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154048475|NCT00526669|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154048476|NCT00526669|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154048477|NCT03640949|Methylprednisolone|methylprednisolone|mesh-list
154048478|NCT03640949|Vasopressins|vasopressins|mesh-list
154048479|NCT03640949|Arginine Vasopressin|arginine vasopressin|mesh-list
154048480|NCT03640949|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154048481|NCT03640949|Antiemetics|antiemetics|mesh-ancestor
154048482|NCT03640949|Autonomic Agents|autonomic agents|mesh-ancestor
154048483|NCT03640949|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154048484|NCT03640949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154048485|NCT03640949|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154048486|NCT03640949|Glucocorticoids|glucocorticoids|mesh-ancestor
154048487|NCT03640949|Hormones|hormones|mesh-ancestor
154048488|NCT03640949|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154048489|NCT03640949|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
154048490|NCT03640949|Protective Agents|protective agents|mesh-ancestor
154048491|NCT03640949|Hemostatics|hemostatics|mesh-ancestor
154048492|NCT03640949|Coagulants|coagulants|mesh-ancestor
154048493|NCT03640949|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154048494|NCT03640949|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
154048495|NCT03640949|Natriuretic Agents|natriuretic agents|mesh-ancestor
154048498|NCT00827775|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154048499|NCT00827775|Adrenergic Agents|adrenergic agents|mesh-ancestor
154048500|NCT00827775|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154048501|NCT00827775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154048502|NCT00827775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154048503|NCT00827775|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154048504|NCT00827775|Antioxidants|antioxidants|mesh-ancestor
154048505|NCT00827775|Protective Agents|protective agents|mesh-ancestor
153591173|NCT01817816|Cholinergic Agents|cholinergic agents|mesh-ancestor
154048506|NCT00827775|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154048507|NCT00827775|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154048508|NCT00827775|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154048510|NCT00827775|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
154048511|NCT00827775|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
154048512|NCT02544308|Dexamethasone|dexamethasone|mesh-list
154048513|NCT02544308|Lenalidomide|lenalidomide|mesh-list
154048514|NCT02544308|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154048515|NCT02544308|Antiemetics|antiemetics|mesh-ancestor
154048516|NCT02544308|Autonomic Agents|autonomic agents|mesh-ancestor
154048517|NCT02544308|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154048518|NCT02544308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154048519|NCT02544308|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154048520|NCT02544308|Glucocorticoids|glucocorticoids|mesh-ancestor
154048547|NCT00658580|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154048548|NCT00658580|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154048549|NCT00658580|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154048550|NCT00658580|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154048551|NCT00658580|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154048552|NCT00658580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154048553|NCT00658580|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154048554|NCT00658580|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154048555|NCT00658580|Alkylating Agents|alkylating agents|mesh-ancestor
154048556|NCT00729742|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
154048557|NCT00729742|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154048558|NCT00729742|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154048559|NCT00729742|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154048560|NCT00729742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154048561|NCT00729742|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154048563|NCT03435107|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154048564|NCT03435107|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154048565|NCT03612791|Atezolizumab|atezolizumab|mesh-list
153877878|NCT05293509|Antifungal Agents|antifungal agents|mesh-ancestor
154048566|NCT03612791|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153877879|NCT05293509|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154048567|NCT03612791|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154048568|NCT03612791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154048569|NCT03612791|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154048570|NCT00827541|Tigecycline|tigecycline|mesh-list
154048571|NCT00827541|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154048574|NCT00827541|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154048591|NCT00518323|Serotonin Agents|serotonin agents|mesh-ancestor
154048592|NCT00518323|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154048593|NCT00518323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154048594|NCT00518323|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
154048595|NCT00518323|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
154048596|NCT00518323|Dopamine Agents|dopamine agents|mesh-ancestor
154048597|NCT00707421|Fluorometholone|fluorometholone|mesh-list
154048599|NCT00707421|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154048600|NCT00707421|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154048601|NCT00707421|Analgesics|analgesics|mesh-ancestor
154048602|NCT00707421|Sensory System Agents|sensory system agents|mesh-ancestor
154048603|NCT00707421|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154048604|NCT00707421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154048605|NCT00707421|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154048606|NCT00707421|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154048607|NCT00707421|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154048608|NCT00707421|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154048609|NCT00707421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154048610|NCT00707421|Glucocorticoids|glucocorticoids|mesh-ancestor
154048611|NCT00707421|Hormones|hormones|mesh-ancestor
154048612|NCT00707421|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154048613|NCT00707421|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154048614|NCT03570437|Paclitaxel|paclitaxel|mesh-list
154048615|NCT03570437|Olaparib|olaparib|mesh-list
154048616|NCT03570437|Cediranib|cediranib|mesh-list
154048617|NCT03570437|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154048618|NCT03570437|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154048619|NCT03570437|Tubulin Modulators|tubulin modulators|mesh-ancestor
154048620|NCT03570437|Antimitotic Agents|antimitotic agents|mesh-ancestor
154048621|NCT03570437|Mitosis Modulators|mitosis modulators|mesh-ancestor
154048622|NCT03570437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154048623|NCT03570437|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
154048624|NCT03570437|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154048625|NCT03570437|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154048627|NCT00826449|Dasatinib|dasatinib|mesh-list
154048629|NCT00826449|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154048630|NCT00826449|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154048631|NCT00826449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154048632|NCT00826449|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154048633|NCT03632213|Losartan|losartan|mesh-list
154048634|NCT03632213|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154048635|NCT03632213|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154048636|NCT03632213|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
154048637|NCT03632213|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
154048638|NCT03632213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154048639|NCT00825825|Citalopram|citalopram|mesh-list
154048640|NCT00825825|Escitalopram|escitalopram|mesh-list
154048641|NCT00825825|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
154048642|NCT00825825|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154048643|NCT00825825|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154048644|NCT00825825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154048646|NCT00825825|Serotonin Agents|serotonin agents|mesh-ancestor
154048647|NCT00825825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154048648|NCT00825825|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
154048649|NCT00825825|Antidepressive Agents|antidepressive agents|mesh-ancestor
154048650|NCT00825825|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154048651|NCT03802487|(2S,3R,4R,5S,6R)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2H-pyran-3,4,5-triol|(2s,3r,4r,5s,6r)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2h-pyran-3,4,5-triol|mesh-list
154048652|NCT03802487|Charcoal|charcoal|mesh-list
154048653|NCT03802487|Antidotes|antidotes|mesh-ancestor
154048654|NCT03802487|Protective Agents|protective agents|mesh-ancestor
154048655|NCT03802487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154048669|NCT00654914|Vasodilator Agents|vasodilator agents|mesh-ancestor
154048670|NCT00654914|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
154048671|NCT00654914|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154048672|NCT00654914|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154048673|NCT00654914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154048674|NCT00654914|Urological Agents|urological agents|mesh-ancestor
154048675|NCT00865566|Vaccines|vaccines|mesh-list
154048676|NCT00865566|Immunologic Factors|immunologic factors|mesh-ancestor
154048677|NCT00865566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154048678|NCT00658970|Tirbanibulin|tirbanibulin|mesh-list
154048679|NCT00658970|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154048680|NCT00658970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154048681|NCT00659048|Ciclesonide|ciclesonide|mesh-list
154048682|NCT00659048|Glucocorticoids|glucocorticoids|mesh-ancestor
154048683|NCT00659048|Hormones|hormones|mesh-ancestor
154048684|NCT00659048|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154048728|NCT02617680|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154048730|NCT02568280|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
154048731|NCT02568280|Insulin Aspart|insulin aspart|mesh-list
154048732|NCT02568280|Insulin, Long-Acting|insulin, long-acting|mesh-list
154048733|NCT02568280|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
154048734|NCT02568280|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154048735|NCT02568280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154048736|NCT00525265|Tolvaptan|tolvaptan|mesh-list
154048737|NCT00525265|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
154048738|NCT00525265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154048739|NCT00525265|Natriuretic Agents|natriuretic agents|mesh-ancestor
154048740|NCT00525265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154048741|NCT04158830|Aspirin|aspirin|mesh-list
154048742|NCT04158830|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154048743|NCT04158830|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154048744|NCT04158830|Analgesics|analgesics|mesh-ancestor
154048745|NCT04158830|Sensory System Agents|sensory system agents|mesh-ancestor
154048746|NCT04158830|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154048782|NCT00737542|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154048783|NCT00737542|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154048784|NCT00737542|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154048785|NCT00737542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154048786|NCT00865098|Cetuximab|cetuximab|mesh-list
154048787|NCT00865098|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154048788|NCT00865098|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154048789|NCT00880100|Pancrelipase|pancrelipase|mesh-list
154048790|NCT00880100|Pancreatin|pancreatin|mesh-list
154048792|NCT00729898|Insulin Aspart|insulin aspart|mesh-list
154048793|NCT00729898|Biphasic Insulins|biphasic insulins|mesh-list
154048794|NCT00729898|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
154048795|NCT00729898|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154048796|NCT00729898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153591470|NCT01820299|Vitamin D|vitamin d|mesh-list
154048797|NCT00659594|Ciclesonide|ciclesonide|mesh-list
154048798|NCT00659594|Glucocorticoids|glucocorticoids|mesh-ancestor
154048799|NCT00659594|Hormones|hormones|mesh-ancestor
154048800|NCT00659594|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154048801|NCT00659594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154048802|NCT00659594|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154048803|NCT00659750|Ciclesonide|ciclesonide|mesh-list
154048804|NCT00659750|Glucocorticoids|glucocorticoids|mesh-ancestor
154048805|NCT00659750|Hormones|hormones|mesh-ancestor
154048806|NCT00659750|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154048807|NCT00659750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154048808|NCT00659750|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154048809|NCT00697476|Topotecan|topotecan|mesh-list
154048810|NCT00697476|Vorinostat|vorinostat|mesh-list
154048811|NCT00697476|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
154048812|NCT00697476|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154048813|NCT00697476|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153877884|NCT05293509|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154048814|NCT00697476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154048815|NCT00697476|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154048822|NCT00660062|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154048823|NCT00660062|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154048824|NCT00660062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154048825|NCT00660062|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154048826|NCT00660062|Serotonin Agents|serotonin agents|mesh-ancestor
154048827|NCT00660062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154048828|NCT00660062|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
154048829|NCT00660062|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
154048830|NCT00660062|Parasympatholytics|parasympatholytics|mesh-ancestor
154048831|NCT00660062|Autonomic Agents|autonomic agents|mesh-ancestor
154048832|NCT00660062|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154048833|NCT00660062|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
154048834|NCT00660062|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154048835|NCT00660062|Cholinergic Agents|cholinergic agents|mesh-ancestor
154048836|NCT00660062|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
154048837|NCT00660062|Antidepressive Agents|antidepressive agents|mesh-ancestor
154048838|NCT00660062|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154048841|NCT00660062|Adrenergic Agents|adrenergic agents|mesh-ancestor
154048871|NCT02633930|Lansoprazole|lansoprazole|mesh-list
154048872|NCT02633930|Dexlansoprazole|dexlansoprazole|mesh-list
154048874|NCT02633930|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154048875|NCT02633930|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154048876|NCT02633930|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
154048877|NCT02633930|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154048878|NCT02633930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154048879|NCT02633930|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154048880|NCT02633930|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154048881|NCT02633930|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154048882|NCT02633930|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154048883|NCT02633930|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
154048884|NCT02633930|Antacids|antacids|mesh-ancestor
154048885|NCT00698334|Rifampin|rifampin|mesh-list
154048886|NCT00698334|Pyrazinamide|pyrazinamide|mesh-list
154048887|NCT00698334|Ethambutol|ethambutol|mesh-list
154048888|NCT00698334|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
154048889|NCT00698334|Antitubercular Agents|antitubercular agents|mesh-ancestor
154048890|NCT00698334|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154048891|NCT00698334|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154048892|NCT00698334|Leprostatic Agents|leprostatic agents|mesh-ancestor
154048893|NCT00698334|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154048894|NCT00698334|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154048895|NCT00698334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154048896|NCT00698334|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
154048897|NCT00698334|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
154048917|NCT02633696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154048918|NCT02633696|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154048919|NCT02633696|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154048920|NCT02633852|Aflibercept|aflibercept|mesh-list
154048921|NCT02633852|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154048922|NCT02633852|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154048923|NCT02633852|Growth Substances|growth substances|mesh-ancestor
154048924|NCT02633852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154048925|NCT02633852|Growth Inhibitors|growth inhibitors|mesh-ancestor
154048926|NCT02633852|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154048927|NCT02633774|Propafenone|propafenone|mesh-list
154048928|NCT02633774|Apixaban|apixaban|mesh-list
154048929|NCT02633774|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
154048930|NCT02633774|Antithrombins|antithrombins|mesh-ancestor
154048931|NCT02633774|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154048932|NCT02633774|Protease Inhibitors|protease inhibitors|mesh-ancestor
154048933|NCT02633774|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154048934|NCT02633774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153877889|NCT05284643|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153877890|NCT05284643|Growth Substances|growth substances|mesh-ancestor
153877891|NCT05284643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154048935|NCT02633774|Anticoagulants|anticoagulants|mesh-ancestor
154048936|NCT02633774|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154048937|NCT02633774|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154048938|NCT02633774|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154048939|NCT02633774|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154048940|NCT02633618|Neurotropin|neurotropin|mesh-list
154048941|NCT02633618|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153591615|NCT01821040|Hormones|hormones|mesh-ancestor
154048942|NCT02633618|Immunologic Factors|immunologic factors|mesh-ancestor
154048943|NCT02633618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154048944|NCT02633618|Analgesics|analgesics|mesh-ancestor
154048945|NCT02633618|Sensory System Agents|sensory system agents|mesh-ancestor
154048946|NCT02633618|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154048947|NCT02633618|Anticonvulsants|anticonvulsants|mesh-ancestor
154048948|NCT00865020|Telmisartan|telmisartan|mesh-list
154048950|NCT00865020|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153573218|NCT02325466|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
153573219|NCT02325466|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
153573220|NCT02325466|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
153573221|NCT02325466|Purinergic Agents|purinergic agents|mesh-ancestor
153816830|NCT00459615|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153816831|NCT00459615|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153816832|NCT00459615|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154048951|NCT00865020|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
154048952|NCT00865020|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
154048953|NCT00865020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154048955|NCT00865020|Protease Inhibitors|protease inhibitors|mesh-ancestor
154048956|NCT00865020|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154048957|NCT00517933|Sildenafil Citrate|sildenafil citrate|mesh-list
154048958|NCT00517933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154048959|NCT00517933|Vasodilator Agents|vasodilator agents|mesh-ancestor
154048960|NCT00517933|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
154048961|NCT00517933|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154048962|NCT00517933|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154048964|NCT02633384|Sorbitol|sorbitol|mesh-list
154049015|NCT00517699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154049016|NCT00517699|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154049017|NCT00517699|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154049018|NCT00517699|Abortifacient Agents|abortifacient agents|mesh-ancestor
154049019|NCT00517699|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154049020|NCT00517699|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154049022|NCT00517699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154049023|NCT00517699|Dermatologic Agents|dermatologic agents|mesh-ancestor
154049024|NCT00517699|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154049025|NCT00517699|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154049026|NCT00517699|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154049027|NCT00517699|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154049029|NCT00517699|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154049030|NCT04161014|Nintedanib|nintedanib|mesh-list
154049031|NCT04161014|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154049032|NCT04161014|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154049033|NCT04161014|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154049034|NCT04161014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154049035|NCT00699504|Moxifloxacin|moxifloxacin|mesh-list
154049036|NCT00699504|Cangrelor|cangrelor|mesh-list
154049037|NCT00699504|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154049038|NCT00699504|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154049039|NCT00699504|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154049040|NCT00699504|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154049041|NCT00699504|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154049042|NCT00699504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154049043|NCT00699504|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153816833|NCT00459615|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153816834|NCT00459615|Antiviral Agents|antiviral agents|mesh-ancestor
153816835|NCT00459615|Schistosomicides|schistosomicides|mesh-ancestor
153816836|NCT00459615|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
153816837|NCT00459615|Anthelmintics|anthelmintics|mesh-ancestor
153573223|NCT02323100|4-phenylbutyric acid|4-phenylbutyric acid|mesh-list
153573224|NCT02323100|Glycerol|glycerol|mesh-list
153573225|NCT02323100|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
153877896|NCT05256472|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153877897|NCT05256472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153573226|NCT02323100|Protective Agents|protective agents|mesh-ancestor
153573227|NCT02323100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153573228|NCT02323100|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153573229|NCT02322710|Petrolatum|petrolatum|mesh-list
154049045|NCT00699504|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154049046|NCT00699504|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
154049047|NCT00699504|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
154049048|NCT00699504|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
154049049|NCT00699504|Purinergic Agents|purinergic agents|mesh-ancestor
154049050|NCT00699504|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154049051|NCT02997605|Prednisone|prednisone|mesh-list
154049052|NCT02997605|Hydrocortisone|hydrocortisone|mesh-list
154049053|NCT02997605|Glucocorticoids|glucocorticoids|mesh-list
154049054|NCT02997605|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154049055|NCT02997605|Hormones|hormones|mesh-ancestor
154049056|NCT02997605|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154049057|NCT02997605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154049058|NCT02997605|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154049059|NCT02997605|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154049060|NCT03767543|Insulin Glargine|insulin glargine|mesh-list
154049061|NCT03767543|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154049062|NCT03767543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154049063|NCT00857454|Testosterone|testosterone|mesh-list
154049064|NCT00857454|Androgens|androgens|mesh-ancestor
154049065|NCT00857454|Hormones|hormones|mesh-ancestor
154049066|NCT00857454|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154049067|NCT00857454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154049068|NCT00660140|Carboplatin|carboplatin|mesh-list
154049069|NCT00660140|Gemcitabine|gemcitabine|mesh-list
154049070|NCT00660140|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154049071|NCT00660140|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154049072|NCT00660140|Antimetabolites|antimetabolites|mesh-ancestor
154049073|NCT00660140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154049074|NCT03760991|Insulin Glargine|insulin glargine|mesh-list
154049075|NCT03760991|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154049076|NCT03760991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154049077|NCT00525031|Interferons|interferons|mesh-list
154049078|NCT00525031|Interferon-alpha|interferon-alpha|mesh-list
153573230|NCT02322710|Emollients|emollients|mesh-ancestor
153573231|NCT02322710|Dermatologic Agents|dermatologic agents|mesh-ancestor
154049079|NCT00525031|Interferon alpha-2|interferon alpha-2|mesh-list
154049080|NCT00525031|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
154049082|NCT00525031|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154049083|NCT00525031|Antiviral Agents|antiviral agents|mesh-ancestor
154049084|NCT00525031|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154049085|NCT00525031|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154049086|NCT00525031|Alkylating Agents|alkylating agents|mesh-ancestor
154049087|NCT00525031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154049088|NCT00525031|Immunologic Factors|immunologic factors|mesh-ancestor
154049089|NCT00525031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154049090|NCT00660374|Isophane Insulin, Human|isophane insulin, human|mesh-list
154049091|NCT00660374|Insulin, Isophane|insulin, isophane|mesh-list
154049092|NCT00660374|Isophane insulin, beef|isophane insulin, beef|mesh-list
154049093|NCT00660374|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154049094|NCT00660374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154049095|NCT00524485|Aminolevulinic Acid|aminolevulinic acid|mesh-list
154049096|NCT00524485|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
154049097|NCT00524485|Dermatologic Agents|dermatologic agents|mesh-ancestor
154049098|NCT00857220|Eszopiclone|eszopiclone|mesh-list
154049099|NCT00857220|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154049100|NCT00857220|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154049101|NCT00857220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154049102|NCT00524173|Tenofovir|tenofovir|mesh-list
154049103|NCT00524173|Emtricitabine|emtricitabine|mesh-list
154049104|NCT00524173|Antiviral Agents|antiviral agents|mesh-ancestor
154049105|NCT00524173|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154049106|NCT00524173|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
154049107|NCT00524173|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153573232|NCT02162563|Leucovorin|leucovorin|mesh-list
153573233|NCT02162563|Bevacizumab|bevacizumab|mesh-list
153573234|NCT02162563|Panitumumab|panitumumab|mesh-list
153573235|NCT02162563|Fluorouracil|fluorouracil|mesh-list
153573236|NCT02162563|Oxaliplatin|oxaliplatin|mesh-list
153573237|NCT02162563|Irinotecan|irinotecan|mesh-list
153573238|NCT02162563|Levoleucovorin|levoleucovorin|mesh-list
153573239|NCT02162563|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153573240|NCT02162563|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153573241|NCT02162563|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153573242|NCT02162563|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153573243|NCT02162563|Growth Substances|growth substances|mesh-ancestor
153573244|NCT02162563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153573245|NCT02162563|Growth Inhibitors|growth inhibitors|mesh-ancestor
153573246|NCT02162563|Antimetabolites|antimetabolites|mesh-ancestor
153573247|NCT02162563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153573248|NCT02162563|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153573249|NCT02162563|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153573250|NCT02162563|Immunologic Factors|immunologic factors|mesh-ancestor
154049109|NCT00524173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154049110|NCT00524173|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154049111|NCT00524173|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154049112|NCT02704481|Misoprostol|misoprostol|mesh-list
154049113|NCT02704481|Mifepristone|mifepristone|mesh-list
154049114|NCT02704481|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154049115|NCT02704481|Abortifacient Agents|abortifacient agents|mesh-ancestor
154049116|NCT02704481|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154049117|NCT02704481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154049118|NCT02704481|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154049119|NCT02704481|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154049120|NCT02704481|Oxytocics|oxytocics|mesh-ancestor
154049121|NCT02704481|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
154049122|NCT02704481|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
154049123|NCT02704481|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
154049124|NCT02704481|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
154049125|NCT02704481|Contraceptive Agents|contraceptive agents|mesh-ancestor
154049126|NCT02704481|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
154049127|NCT02704481|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
154049128|NCT02704481|Hormone Antagonists|hormone antagonists|mesh-ancestor
154049129|NCT02704481|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154049130|NCT02704481|Luteolytic Agents|luteolytic agents|mesh-ancestor
154049131|NCT02704481|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
154049132|NCT02704481|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
154049133|NCT02614482|Fesoterodine|fesoterodine|mesh-list
154049134|NCT02614482|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
154049135|NCT02614482|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154049136|NCT02614482|Cholinergic Agents|cholinergic agents|mesh-ancestor
154049151|NCT00879710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154049152|NCT00879710|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154049153|NCT00879710|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154049154|NCT00879710|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154049155|NCT02703857|Cefoxitin|cefoxitin|mesh-list
154049156|NCT02703857|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154049157|NCT02703857|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154049158|NCT02623062|Alginate, aluminium hydroxide, magnesium trisilicate, sodium bicarbonate drug combination|alginate, aluminium hydroxide, magnesium trisilicate, sodium bicarbonate drug combination|mesh-list
154049159|NCT02623062|Antacids|antacids|mesh-ancestor
154049160|NCT02623062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154049161|NCT02623062|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154049162|NCT00597506|Bevacizumab|bevacizumab|mesh-list
154049163|NCT00597506|Everolimus|everolimus|mesh-list
154049164|NCT00597506|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154049165|NCT00597506|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154049166|NCT00597506|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154049167|NCT00597506|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154049168|NCT00597506|Growth Substances|growth substances|mesh-ancestor
154049169|NCT00597506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154049204|NCT04032236|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
154049205|NCT04032236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154049206|NCT04032236|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154049207|NCT04032236|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154049208|NCT04032236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154049209|NCT04032236|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
154049210|NCT04032236|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
154049211|NCT04032236|Purinergic Agents|purinergic agents|mesh-ancestor
154049212|NCT04032236|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154049214|NCT02313389|Methotrexate|methotrexate|mesh-list
154049215|NCT02313389|Temozolomide|temozolomide|mesh-list
154049216|NCT02313389|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154049217|NCT02313389|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154049218|NCT02313389|Immunologic Factors|immunologic factors|mesh-ancestor
154049219|NCT02313389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154049220|NCT02313389|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154049221|NCT02313389|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154049222|NCT02313389|Abortifacient Agents|abortifacient agents|mesh-ancestor
154049223|NCT02313389|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154049224|NCT02313389|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154049225|NCT02313389|Antimetabolites|antimetabolites|mesh-ancestor
154049226|NCT02313389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154049227|NCT02313389|Dermatologic Agents|dermatologic agents|mesh-ancestor
154049228|NCT02313389|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154049229|NCT02313389|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154049230|NCT02313389|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154049231|NCT02313389|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154049232|NCT02313389|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154049233|NCT02313389|Alkylating Agents|alkylating agents|mesh-ancestor
154049234|NCT00708682|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
154049244|NCT00881504|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154049245|NCT00881504|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154049246|NCT00881504|Growth Substances|growth substances|mesh-ancestor
154049247|NCT00881504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154049248|NCT00881504|Growth Inhibitors|growth inhibitors|mesh-ancestor
154049249|NCT00660764|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
154049250|NCT00660764|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154049251|NCT00660764|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154049252|NCT00660764|Antimetabolites|antimetabolites|mesh-ancestor
154049253|NCT00660764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154049254|NCT00660764|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154049255|NCT00660764|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154049256|NCT00660764|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154049257|NCT02131493|Gemcitabine|gemcitabine|mesh-list
154049258|NCT02131493|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154049259|NCT02131493|Antimetabolites|antimetabolites|mesh-ancestor
154049260|NCT02131493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154049261|NCT02131493|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154049262|NCT02096159|Trimethoprim|trimethoprim|mesh-list
154049263|NCT02096159|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
154049264|NCT02096159|Sulfamethoxazole|sulfamethoxazole|mesh-list
154049265|NCT02096159|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
154049266|NCT02096159|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154049267|NCT02096159|Antimalarials|antimalarials|mesh-ancestor
154049268|NCT02096159|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154049291|NCT01936831|Pyridoxal|pyridoxal|mesh-list
154049292|NCT01936831|Pyridoxine|pyridoxine|mesh-list
154049293|NCT01936831|Isoniazid|isoniazid|mesh-list
154049294|NCT01936831|Vitamins|vitamins|mesh-ancestor
154049295|NCT01936831|Micronutrients|micronutrients|mesh-ancestor
154049296|NCT01936831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154049297|NCT01936831|Vitamin B Complex|vitamin b complex|mesh-ancestor
154049298|NCT01936831|Antitubercular Agents|antitubercular agents|mesh-ancestor
154049299|NCT01936831|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154049300|NCT01936831|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154049301|NCT01936831|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
154049302|NCT01936831|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154049303|NCT01936831|Antimetabolites|antimetabolites|mesh-ancestor
154049304|NCT01936831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154049305|NCT01936831|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154049306|NCT00615173|Cyclophosphamide|cyclophosphamide|mesh-list
154049307|NCT00615173|Azathioprine|azathioprine|mesh-list
154049308|NCT00615173|Tacrolimus|tacrolimus|mesh-list
154049309|NCT00615173|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154049310|NCT00615173|Immunologic Factors|immunologic factors|mesh-ancestor
154049311|NCT00615173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154049312|NCT00615173|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154049313|NCT00615173|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154049314|NCT00615173|Alkylating Agents|alkylating agents|mesh-ancestor
154049344|NCT01455389|Glucocorticoids|glucocorticoids|mesh-ancestor
154049346|NCT01455389|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154049347|NCT01455389|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154049348|NCT01455389|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154049349|NCT01455389|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154049350|NCT01455389|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154049351|NCT01455389|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154049352|NCT01455389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154049353|NCT01455389|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
154049354|NCT01455389|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154049355|NCT01455389|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154049356|NCT01455389|Anesthetics, Local|anesthetics, local|mesh-ancestor
154049357|NCT01455389|Anesthetics|anesthetics|mesh-ancestor
154049358|NCT01455389|Sensory System Agents|sensory system agents|mesh-ancestor
154049359|NCT01455389|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
154049360|NCT01455389|Histamine Antagonists|histamine antagonists|mesh-ancestor
154049361|NCT01455389|Histamine Agents|histamine agents|mesh-ancestor
154049362|NCT01455389|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154049363|NCT01455389|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154049364|NCT01455389|Antipruritics|antipruritics|mesh-ancestor
154049365|NCT01455389|Dermatologic Agents|dermatologic agents|mesh-ancestor
154049366|NCT00661076|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
154049367|NCT00661076|Adefovir|adefovir|mesh-list
154049368|NCT00661076|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
154049369|NCT00661076|Antiviral Agents|antiviral agents|mesh-ancestor
154049370|NCT00661076|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154049371|NCT00661076|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
154049372|NCT00661076|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154049373|NCT00661076|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154049374|NCT00661076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154049386|NCT00613769|Sulfamethoxazole|sulfamethoxazole|mesh-list
154049387|NCT00613769|Cefuroxime|cefuroxime|mesh-list
154049388|NCT00613769|Cefuroxime axetil|cefuroxime axetil|mesh-list
154049389|NCT00613769|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
154049390|NCT00613769|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154049391|NCT00613769|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154049392|NCT00613769|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154049393|NCT00613769|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154049394|NCT00613769|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
154049395|NCT00613769|Antimalarials|antimalarials|mesh-ancestor
154049396|NCT00613769|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154049397|NCT00613769|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154049398|NCT00613769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154049399|NCT00613769|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
154049400|NCT00613769|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
154049401|NCT00613769|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154049402|NCT00661154|Bevacizumab|bevacizumab|mesh-list
154049403|NCT00661154|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154049404|NCT00661154|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154049405|NCT00661154|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154049406|NCT00661154|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154049407|NCT00661154|Growth Substances|growth substances|mesh-ancestor
154049408|NCT00661154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154049409|NCT00661154|Growth Inhibitors|growth inhibitors|mesh-ancestor
154049410|NCT00523705|Escitalopram|escitalopram|mesh-list
154049411|NCT00523705|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
154049412|NCT00523705|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153573251|NCT02162563|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
153573252|NCT02162563|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153573253|NCT02162563|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153573254|NCT02162563|Antidotes|antidotes|mesh-ancestor
153573255|NCT02162563|Protective Agents|protective agents|mesh-ancestor
153573256|NCT02162563|Vitamin B Complex|vitamin b complex|mesh-ancestor
153573257|NCT02162563|Vitamins|vitamins|mesh-ancestor
153573258|NCT02162563|Micronutrients|micronutrients|mesh-ancestor
153573259|NCT02127086|Analgesics|analgesics|mesh-list
153573260|NCT02127086|Sensory System Agents|sensory system agents|mesh-ancestor
153458179|NCT04192812|Fertility Agents, Female|fertility agents, female|mesh-ancestor
153458180|NCT04192812|Fertility Agents|fertility agents|mesh-ancestor
153573261|NCT02127086|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153573262|NCT02127086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153573263|NCT02120079|Loteprednol Etabonate|loteprednol etabonate|mesh-list
153573264|NCT02120079|Ophthalmic Solutions|ophthalmic solutions|mesh-list
153573265|NCT02120079|Lubricant Eye Drops|lubricant eye drops|mesh-list
153573266|NCT02120079|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
153573267|NCT02120079|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
153577503|NCT01718314|Anesthetics, Local|anesthetics, local|mesh-ancestor
154049413|NCT00523705|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154049414|NCT00523705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154049415|NCT00523705|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154049416|NCT00523705|Serotonin Agents|serotonin agents|mesh-ancestor
154049417|NCT00523705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154049418|NCT00193427|Carboplatin|carboplatin|mesh-list
154049419|NCT00193427|Gemcitabine|gemcitabine|mesh-list
154049420|NCT00193427|Docetaxel|docetaxel|mesh-list
154049421|NCT00193427|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154049422|NCT00193427|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154049423|NCT00193427|Antimetabolites|antimetabolites|mesh-ancestor
154049424|NCT00193427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154049425|NCT00193427|Tubulin Modulators|tubulin modulators|mesh-ancestor
154049426|NCT00193427|Antimitotic Agents|antimitotic agents|mesh-ancestor
154049427|NCT00193427|Mitosis Modulators|mitosis modulators|mesh-ancestor
154049428|NCT00665678|Paroxetine|paroxetine|mesh-list
154049429|NCT00665678|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
154049430|NCT00665678|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154049431|NCT00665678|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154049432|NCT00665678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154049433|NCT00665678|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154049434|NCT00665678|Serotonin Agents|serotonin agents|mesh-ancestor
154049435|NCT00665678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154049438|NCT00665678|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154049461|NCT02706119|Insulin Glargine|insulin glargine|mesh-list
154049462|NCT02706119|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154049463|NCT02706119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154049464|NCT02631668|Ferrous succinate|ferrous succinate|mesh-list
154049465|NCT02631668|Hematinics|hematinics|mesh-ancestor
154049466|NCT00665756|Mitomycins|mitomycins|mesh-list
153592144|NCT01825031|Isoniazid|isoniazid|mesh-list
154049467|NCT00665756|Mitomycin|mitomycin|mesh-list
154049468|NCT00665756|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154049469|NCT00665756|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154049470|NCT00665756|Alkylating Agents|alkylating agents|mesh-ancestor
154049471|NCT00665756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154049472|NCT00665756|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154049473|NCT00665756|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154049474|NCT00661856|Genistein|genistein|mesh-list
154049475|NCT00661856|Daidzein|daidzein|mesh-list
154049476|NCT00661856|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
154049477|NCT00661856|Protective Agents|protective agents|mesh-ancestor
154049478|NCT00661856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154049479|NCT00661856|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154049480|NCT00661856|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154049481|NCT00661856|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154049482|NCT00661856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154049483|NCT00661856|Phytoestrogens|phytoestrogens|mesh-ancestor
154049484|NCT00661856|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
154049485|NCT00661856|Estrogens|estrogens|mesh-ancestor
153418694|NCT03030638|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154049486|NCT00661856|Hormones|hormones|mesh-ancestor
154049487|NCT00661856|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154049488|NCT04215731|Leucovorin|leucovorin|mesh-list
154049489|NCT04215731|Bevacizumab|bevacizumab|mesh-list
153573269|NCT02106195|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153573270|NCT02106195|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153573271|NCT02106195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153573272|NCT02075177|Ketoconazole|ketoconazole|mesh-list
153573273|NCT02075177|Fenretinide|fenretinide|mesh-list
153573274|NCT02075177|Antifungal Agents|antifungal agents|mesh-ancestor
153573275|NCT02075177|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153573276|NCT02075177|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
153573277|NCT02075177|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153573278|NCT02075177|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153573279|NCT02075177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153573280|NCT02075177|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154049490|NCT04215731|Fluorouracil|fluorouracil|mesh-list
154049491|NCT04215731|Oxaliplatin|oxaliplatin|mesh-list
154049492|NCT04215731|Irinotecan|irinotecan|mesh-list
154049493|NCT04215731|Levoleucovorin|levoleucovorin|mesh-list
154049494|NCT04215731|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154049495|NCT04215731|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154049496|NCT04215731|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154049497|NCT04215731|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154049498|NCT04215731|Growth Substances|growth substances|mesh-ancestor
154049499|NCT04215731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154049500|NCT04215731|Growth Inhibitors|growth inhibitors|mesh-ancestor
154049501|NCT04215731|Antimetabolites|antimetabolites|mesh-ancestor
154049502|NCT04215731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154049503|NCT04215731|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154049504|NCT04215731|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154049505|NCT04215731|Immunologic Factors|immunologic factors|mesh-ancestor
154049506|NCT04215731|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
154049507|NCT04215731|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154049508|NCT04215731|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154049509|NCT04215731|Antidotes|antidotes|mesh-ancestor
154049510|NCT04215731|Protective Agents|protective agents|mesh-ancestor
154049511|NCT04215731|Vitamin B Complex|vitamin b complex|mesh-ancestor
154049512|NCT04215731|Vitamins|vitamins|mesh-ancestor
154049513|NCT04215731|Micronutrients|micronutrients|mesh-ancestor
154049514|NCT00665834|Atorvastatin|atorvastatin|mesh-list
154049515|NCT00665834|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
154049516|NCT00665834|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154049517|NCT00665834|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154049518|NCT00665834|Antimetabolites|antimetabolites|mesh-ancestor
154049519|NCT00665834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154049542|NCT00665990|Alkylating Agents|alkylating agents|mesh-ancestor
153592209|NCT01825395|Amifampridine|amifampridine|mesh-list
154049543|NCT00665990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154049544|NCT00665990|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154049545|NCT00665990|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154049546|NCT00665990|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154049547|NCT00665990|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154049548|NCT00665990|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154049549|NCT00665990|Growth Substances|growth substances|mesh-ancestor
154049550|NCT00665990|Growth Inhibitors|growth inhibitors|mesh-ancestor
154049551|NCT00665990|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154049552|NCT00665990|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154049553|NCT00666068|Hormones|hormones|mesh-list
154049554|NCT00666068|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
154049555|NCT00666068|Corticotropin-Releasing Hormone|corticotropin-releasing hormone|mesh-list
154049556|NCT00666068|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154049557|NCT00666068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154049558|NCT00700102|Bevacizumab|bevacizumab|mesh-list
154049625|NCT03362099|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154049626|NCT03362099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154049627|NCT03362099|Dopamine Agents|dopamine agents|mesh-ancestor
154049628|NCT03362099|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154049629|NCT03362099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154049630|NCT03362099|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
154049631|NCT03362099|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154049632|NCT03362099|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154049633|NCT03362099|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
154049634|NCT03362099|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
154049635|NCT03362099|Cholinergic Agents|cholinergic agents|mesh-ancestor
154049636|NCT03861559|Mometasone Furoate|mometasone furoate|mesh-list
154049637|NCT03861559|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154049638|NCT03861559|Dermatologic Agents|dermatologic agents|mesh-ancestor
154049639|NCT03861559|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154049640|NCT02705651|Somatostatin|somatostatin|mesh-list
154049641|NCT02705651|Hormones|hormones|mesh-ancestor
154049667|NCT00516139|Anticonvulsants|anticonvulsants|mesh-ancestor
154049668|NCT00516139|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154049669|NCT00516139|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154049670|NCT00516139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154049671|NCT00516139|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154049672|NCT00516139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154049673|NCT00516139|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154049674|NCT00516139|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154049675|NCT00516139|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154049676|NCT00516139|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154049677|NCT00516139|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154049678|NCT02704715|Anesthetics|anesthetics|mesh-list
154049679|NCT02704715|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154049680|NCT02704715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154049681|NCT00515827|Raltegravir Potassium|raltegravir potassium|mesh-list
154049682|NCT00515827|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154049683|NCT00515827|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154049684|NCT00515827|Antiviral Agents|antiviral agents|mesh-ancestor
154049685|NCT00515827|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154049686|NCT00515827|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
154049687|NCT00515827|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
154049688|NCT00515827|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154049689|NCT00515827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154049691|NCT00615875|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154049692|NCT00615875|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154049693|NCT00615875|Analgesics|analgesics|mesh-ancestor
154049694|NCT00615875|Sensory System Agents|sensory system agents|mesh-ancestor
154049695|NCT00615875|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154049711|NCT02630888|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154049713|NCT00666302|Tacrolimus|tacrolimus|mesh-list
154049714|NCT00666302|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154049715|NCT00666302|Immunologic Factors|immunologic factors|mesh-ancestor
154049716|NCT00666302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154049717|NCT00666302|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
154049718|NCT00666302|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154049719|NCT00666302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154049720|NCT00666302|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154049721|NCT00666302|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154049722|NCT00666302|Analgesics|analgesics|mesh-ancestor
154049723|NCT00666302|Sensory System Agents|sensory system agents|mesh-ancestor
154049724|NCT00666302|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154049725|NCT00666302|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154049726|NCT00666302|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154049727|NCT00666302|Dermatologic Agents|dermatologic agents|mesh-ancestor
154049728|NCT00671372|Bevacizumab|bevacizumab|mesh-list
154049729|NCT00671372|Cetuximab|cetuximab|mesh-list
154049730|NCT00671372|Irinotecan|irinotecan|mesh-list
154049766|NCT00666692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154049767|NCT00666692|Growth Inhibitors|growth inhibitors|mesh-ancestor
154049768|NCT00666692|Immunologic Factors|immunologic factors|mesh-ancestor
154049770|NCT00707746|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154049771|NCT00707746|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154049772|NCT00707746|Antimetabolites|antimetabolites|mesh-ancestor
154049773|NCT00707746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154049774|NCT00707746|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154049775|NCT00666770|Gabapentin|gabapentin|mesh-list
154049776|NCT00666770|Analgesics|analgesics|mesh-ancestor
154049777|NCT00666770|Sensory System Agents|sensory system agents|mesh-ancestor
154049778|NCT00666770|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154049779|NCT00666770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154049780|NCT00666770|Anticonvulsants|anticonvulsants|mesh-ancestor
154049781|NCT00666770|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154049782|NCT00666770|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154049783|NCT00666770|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154049784|NCT00666770|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154049785|NCT00666770|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154049786|NCT00666770|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154049787|NCT00666770|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154049788|NCT00666770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154049789|NCT00666770|Antimanic Agents|antimanic agents|mesh-ancestor
154049790|NCT04188353|Mannitol|mannitol|mesh-list
154049791|NCT04188353|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
154049792|NCT04188353|Diuretics|diuretics|mesh-ancestor
154049798|NCT02630420|Cetuximab|cetuximab|mesh-list
154049815|NCT05343299|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154049817|NCT05343299|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154049818|NCT05343299|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154049819|NCT05343299|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154049820|NCT05343299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154049821|NCT00667160|Pimecrolimus|pimecrolimus|mesh-list
154049822|NCT00667160|Tacrolimus|tacrolimus|mesh-list
154049875|NCT00856830|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154049876|NCT00856830|Alkylating Agents|alkylating agents|mesh-ancestor
154049877|NCT02614404|Piperaquine|piperaquine|mesh-list
154049878|NCT02614404|Artenimol|artenimol|mesh-list
154049879|NCT02614404|Imatinib Mesylate|imatinib mesylate|mesh-list
154049880|NCT02614404|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154049881|NCT02614404|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154049882|NCT02614404|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154049883|NCT02614404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154049884|NCT02614404|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154049885|NCT02614404|Antimalarials|antimalarials|mesh-ancestor
154049886|NCT02614404|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154049887|NCT02614404|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154049888|NCT02614404|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154049889|NCT00522301|Sorafenib|sorafenib|mesh-list
154049890|NCT00522301|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154049894|NCT00662636|Dasatinib|dasatinib|mesh-list
154049934|NCT00668018|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
154049935|NCT00668018|Vasodilator Agents|vasodilator agents|mesh-ancestor
154049936|NCT00668018|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
154049937|NCT00668018|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154049938|NCT00668018|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154049939|NCT00668018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154049940|NCT00668018|Urological Agents|urological agents|mesh-ancestor
154049941|NCT00871338|Vaccines|vaccines|mesh-list
154049942|NCT00871338|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
154049943|NCT00871338|Immunologic Factors|immunologic factors|mesh-ancestor
154049944|NCT00871338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154049945|NCT04130100|Hyaluronic Acid|hyaluronic acid|mesh-list
154049946|NCT04130100|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154049947|NCT04130100|Immunologic Factors|immunologic factors|mesh-ancestor
154049948|NCT04130100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154049949|NCT04130100|Viscosupplements|viscosupplements|mesh-ancestor
154049950|NCT04130100|Protective Agents|protective agents|mesh-ancestor
154049951|NCT00597116|Vinorelbine|vinorelbine|mesh-list
154049952|NCT00597116|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154049953|NCT00597116|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154049954|NCT00597116|Tubulin Modulators|tubulin modulators|mesh-ancestor
154049955|NCT00597116|Antimitotic Agents|antimitotic agents|mesh-ancestor
154049956|NCT00597116|Mitosis Modulators|mitosis modulators|mesh-ancestor
154049957|NCT00597116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154049958|NCT00668096|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
154049959|NCT00668096|Vasodilator Agents|vasodilator agents|mesh-ancestor
154049960|NCT00668096|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
153573281|NCT02075177|Hormone Antagonists|hormone antagonists|mesh-ancestor
153573282|NCT02075177|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153573283|NCT02075177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153573284|NCT02075177|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
153573285|NCT02075177|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153418695|NCT03030638|Respiratory System Agents|respiratory system agents|mesh-ancestor
153573286|NCT02075177|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
153573287|NCT02075177|Protective Agents|protective agents|mesh-ancestor
153573288|NCT02050919|Sorafenib|sorafenib|mesh-list
153573289|NCT02050919|Epirubicin|epirubicin|mesh-list
153573290|NCT02050919|Ifosfamide|ifosfamide|mesh-list
153573291|NCT02050919|Isophosphamide mustard|isophosphamide mustard|mesh-list
153573292|NCT02050919|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153573293|NCT02050919|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153573301|NCT01997463|Albuterol|albuterol|mesh-list
153573302|NCT01997463|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153573303|NCT01997463|Autonomic Agents|autonomic agents|mesh-ancestor
153573304|NCT01997463|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153573305|NCT01997463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153573306|NCT01997463|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153573307|NCT01997463|Respiratory System Agents|respiratory system agents|mesh-ancestor
154049962|NCT00668096|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154049963|NCT00668096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154049964|NCT00668096|Urological Agents|urological agents|mesh-ancestor
154049965|NCT00514735|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-list
154049966|NCT03252587|Deucravacitinib|deucravacitinib|mesh-list
154049967|NCT03252587|Dermatologic Agents|dermatologic agents|mesh-ancestor
154049968|NCT03252587|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154049969|NCT03252587|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154049970|NCT03252587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154049971|NCT02630264|Paclitaxel|paclitaxel|mesh-list
154049972|NCT02630264|Endostatins|endostatins|mesh-list
154049973|NCT02630264|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154049974|NCT02630264|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154049975|NCT02630264|Tubulin Modulators|tubulin modulators|mesh-ancestor
154049976|NCT02630264|Antimitotic Agents|antimitotic agents|mesh-ancestor
154049977|NCT02630264|Mitosis Modulators|mitosis modulators|mesh-ancestor
153573308|NCT01997463|Tocolytic Agents|tocolytic agents|mesh-ancestor
153573309|NCT01997463|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153573310|NCT01997463|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
153573311|NCT01997463|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
153573312|NCT01997463|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153573313|NCT01997463|Adrenergic Agents|adrenergic agents|mesh-ancestor
153573314|NCT01997463|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153573315|NCT01997463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153573316|NCT01976754|Dexmedetomidine|dexmedetomidine|mesh-list
153573317|NCT01976754|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153573318|NCT01976754|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153573319|NCT01976754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153573320|NCT01976754|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153573321|NCT01976754|Analgesics|analgesics|mesh-ancestor
153573322|NCT01976754|Sensory System Agents|sensory system agents|mesh-ancestor
153573323|NCT01976754|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153573324|NCT01976754|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
153573325|NCT01976754|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153573326|NCT01976754|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153573327|NCT01976754|Adrenergic Agents|adrenergic agents|mesh-ancestor
153573328|NCT01976754|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153573329|NCT01976754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153573330|NCT01943825|Vaccines|vaccines|mesh-list
153573331|NCT01943825|Immunologic Factors|immunologic factors|mesh-ancestor
153573332|NCT01943825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153573333|NCT01863186|Lofexidine|lofexidine|mesh-list
153573334|NCT01863186|Clonidine|clonidine|mesh-list
153573335|NCT01863186|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153458181|NCT04192812|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153573337|NCT01863186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153573338|NCT01863186|Sensory System Agents|sensory system agents|mesh-ancestor
153573339|NCT01863186|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153573340|NCT01863186|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
153573341|NCT01863186|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153573342|NCT01863186|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153573343|NCT01863186|Adrenergic Agents|adrenergic agents|mesh-ancestor
153573344|NCT01863186|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153573345|NCT01863186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154049978|NCT02630264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154049979|NCT02630264|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154049980|NCT02630264|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154049981|NCT02630264|Growth Substances|growth substances|mesh-ancestor
154049982|NCT02630264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154049983|NCT02630264|Growth Inhibitors|growth inhibitors|mesh-ancestor
154049985|NCT00668330|Ibandronic Acid|ibandronic acid|mesh-list
154049986|NCT00668330|Alfacalcidol|alfacalcidol|mesh-list
154049987|NCT00668330|Hydroxycholecalciferols|hydroxycholecalciferols|mesh-list
154049988|NCT00668330|Calcium|calcium|mesh-list
154049989|NCT00668330|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154049990|NCT00668330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154049991|NCT00668330|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154049992|NCT00668330|Vitamins|vitamins|mesh-ancestor
154049993|NCT00668330|Micronutrients|micronutrients|mesh-ancestor
154049994|NCT01012687|Perindopril|perindopril|mesh-list
154049995|NCT01012687|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
154049996|NCT01012687|Protease Inhibitors|protease inhibitors|mesh-ancestor
154049997|NCT01012687|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154049998|NCT01012687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154049999|NCT01012687|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154050000|NCT00662948|Rituximab|rituximab|mesh-list
154050001|NCT00662948|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154050002|NCT00662948|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154050003|NCT00662948|Immunologic Factors|immunologic factors|mesh-ancestor
154050004|NCT00662948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154050005|NCT00662948|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154050006|NCT00511147|Immunoglobulins|immunoglobulins|mesh-list
154050007|NCT00511147|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
154050008|NCT00511147|gamma-Globulins|gamma-globulins|mesh-list
154050009|NCT00511147|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
154050010|NCT00511147|Immunologic Factors|immunologic factors|mesh-ancestor
154050011|NCT00511147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154050012|NCT00672464|Metformin|metformin|mesh-list
154050013|NCT00672464|Olanzapine|olanzapine|mesh-list
154050014|NCT00672464|Simvastatin|simvastatin|mesh-list
154050015|NCT00672464|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154050017|NCT00672464|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154050018|NCT00672464|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154050019|NCT00672464|Antimetabolites|antimetabolites|mesh-ancestor
154050020|NCT00672464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154050021|NCT00672464|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154050022|NCT00672464|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154050023|NCT00672464|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154050024|NCT00672464|Antiemetics|antiemetics|mesh-ancestor
154050025|NCT00672464|Autonomic Agents|autonomic agents|mesh-ancestor
154050026|NCT00672464|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154050027|NCT00672464|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154050028|NCT00672464|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154050029|NCT00672464|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154050030|NCT00672464|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154050031|NCT00672464|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154050032|NCT00672464|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
154050033|NCT00672464|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154050034|NCT00672464|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154050035|NCT00672464|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154050036|NCT00672464|Serotonin Agents|serotonin agents|mesh-ancestor
154050037|NCT02701595|Amoxicillin|amoxicillin|mesh-list
154050038|NCT02701595|Vancomycin|vancomycin|mesh-list
154050039|NCT02701595|Gentamicins|gentamicins|mesh-list
154050069|NCT00663182|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154050071|NCT00616031|Carboplatin|carboplatin|mesh-list
154050072|NCT00616031|Nitroglycerin|nitroglycerin|mesh-list
154050073|NCT00616031|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154050074|NCT00616031|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154050075|NCT00616031|Tubulin Modulators|tubulin modulators|mesh-ancestor
154050076|NCT00616031|Antimitotic Agents|antimitotic agents|mesh-ancestor
154050077|NCT00616031|Mitosis Modulators|mitosis modulators|mesh-ancestor
154050078|NCT00616031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154050079|NCT00616031|Vasodilator Agents|vasodilator agents|mesh-ancestor
154050080|NCT04213937|Paclitaxel|paclitaxel|mesh-list
154050081|NCT04213937|Topotecan|topotecan|mesh-list
154050082|NCT04213937|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154050083|NCT04213937|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154050084|NCT04213937|Tubulin Modulators|tubulin modulators|mesh-ancestor
154050085|NCT04213937|Antimitotic Agents|antimitotic agents|mesh-ancestor
154050086|NCT04213937|Mitosis Modulators|mitosis modulators|mesh-ancestor
154050087|NCT04213937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154050088|NCT04213937|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
154050089|NCT04213937|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154050090|NCT04213937|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154050091|NCT02701517|Cyclosporine|cyclosporine|mesh-list
154050092|NCT02701517|Methotrexate|methotrexate|mesh-list
154050093|NCT02701517|Alemtuzumab|alemtuzumab|mesh-list
154050094|NCT02701517|Cyclosporins|cyclosporins|mesh-list
154050095|NCT02701517|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154050096|NCT02701517|Abortifacient Agents|abortifacient agents|mesh-ancestor
154050097|NCT02701517|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154050098|NCT02701517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154050099|NCT02701517|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153573346|NCT01863186|Analgesics|analgesics|mesh-ancestor
153573347|NCT01863186|Sympatholytics|sympatholytics|mesh-ancestor
153573348|NCT01863186|Autonomic Agents|autonomic agents|mesh-ancestor
153573349|NCT01828840|Fentanyl|fentanyl|mesh-list
153573350|NCT01828840|Morphine|morphine|mesh-list
153573351|NCT01828840|Methadone|methadone|mesh-list
153573352|NCT01828840|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153573353|NCT01828840|Narcotics|narcotics|mesh-ancestor
153573354|NCT01828840|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154050100|NCT02701517|Antimetabolites|antimetabolites|mesh-ancestor
154050101|NCT02701517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154050102|NCT02701517|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154050103|NCT02701517|Dermatologic Agents|dermatologic agents|mesh-ancestor
154050104|NCT02701517|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154050105|NCT02701517|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154050106|NCT02701517|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154050107|NCT02701517|Immunologic Factors|immunologic factors|mesh-ancestor
154050108|NCT02701517|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154050109|NCT02701517|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154050110|NCT02701517|Antifungal Agents|antifungal agents|mesh-ancestor
154050111|NCT02701517|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154050112|NCT02701517|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
154050113|NCT02701517|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154050114|NCT02630108|Epirubicin|epirubicin|mesh-list
154050115|NCT02630108|Ethiodized Oil|ethiodized oil|mesh-list
154050116|NCT02630108|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154050117|NCT02630108|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154050118|NCT02630108|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154050119|NCT02630108|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154050120|NCT02630108|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154050121|NCT02630108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154050122|NCT00505921|Cytarabine|cytarabine|mesh-list
154050123|NCT00505921|Cyclophosphamide|cyclophosphamide|mesh-list
154050124|NCT00505921|Melphalan|melphalan|mesh-list
154050125|NCT00505921|Carmustine|carmustine|mesh-list
154050126|NCT00505921|Fludarabine|fludarabine|mesh-list
154050127|NCT00505921|Fludarabine phosphate|fludarabine phosphate|mesh-list
154050128|NCT00505921|Etoposide|etoposide|mesh-list
154050129|NCT00505921|Etoposide phosphate|etoposide phosphate|mesh-list
154050130|NCT00505921|Molgramostim|molgramostim|mesh-list
154050131|NCT00505921|Alemtuzumab|alemtuzumab|mesh-list
154050132|NCT00505921|Sargramostim|sargramostim|mesh-list
154050133|NCT00505921|Lenograstim|lenograstim|mesh-list
154050134|NCT00505921|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154050135|NCT00505921|Immunologic Factors|immunologic factors|mesh-ancestor
153573355|NCT01828840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153573356|NCT01828840|Analgesics|analgesics|mesh-ancestor
153573357|NCT01828840|Sensory System Agents|sensory system agents|mesh-ancestor
153573358|NCT01828840|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153573359|NCT01828840|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153573360|NCT01828840|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153573361|NCT01828840|Anesthetics, General|anesthetics, general|mesh-ancestor
154050138|NCT00505921|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154050139|NCT00505921|Alkylating Agents|alkylating agents|mesh-ancestor
154050140|NCT00505921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154050141|NCT00505921|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154050142|NCT00505921|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153877919|NCT05199753|Antibodies|antibodies|mesh-list
154050143|NCT00505921|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154050144|NCT00505921|Antimetabolites|antimetabolites|mesh-ancestor
154050145|NCT00505921|Antiviral Agents|antiviral agents|mesh-ancestor
154050146|NCT00505921|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154050147|NCT00505921|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154050148|NCT00505921|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154050149|NCT00505921|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154050150|NCT00505921|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154050151|NCT00505921|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154050152|NCT00505921|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154050154|NCT00669344|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
154050155|NCT00669344|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154050156|NCT00669344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154050157|NCT00669344|Cholinergic Agents|cholinergic agents|mesh-ancestor
154050158|NCT00669344|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154050159|NCT00669344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154050160|NCT00669344|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
154050161|NCT00669344|Protective Agents|protective agents|mesh-ancestor
154050162|NCT02701127|Niacinamide|niacinamide|mesh-list
154050183|NCT02700893|Anesthetics|anesthetics|mesh-ancestor
154050184|NCT02700893|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154050185|NCT02700893|Narcotics|narcotics|mesh-ancestor
154050186|NCT02700893|Analgesics|analgesics|mesh-ancestor
154050187|NCT02700893|Sensory System Agents|sensory system agents|mesh-ancestor
154050188|NCT02700893|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154050189|NCT02700893|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154050190|NCT02700893|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154050191|NCT02700893|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154050192|NCT02700893|Autonomic Agents|autonomic agents|mesh-ancestor
154050193|NCT02700893|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154050194|NCT02700893|Respiratory System Agents|respiratory system agents|mesh-ancestor
154050195|NCT02700893|Mydriatics|mydriatics|mesh-ancestor
154050196|NCT02700893|Parasympatholytics|parasympatholytics|mesh-ancestor
154050197|NCT02700893|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
154050198|NCT02700893|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154050206|NCT04213781|Sufentanil|sufentanil|mesh-list
154050225|NCT00505687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154050226|NCT00669656|Vitamin D|vitamin d|mesh-list
154050227|NCT00669656|Cholecalciferol|cholecalciferol|mesh-list
154050228|NCT00669656|Vitamins|vitamins|mesh-list
154050229|NCT00669656|Vitamin E|vitamin e|mesh-list
154050230|NCT00669656|Tocopherols|tocopherols|mesh-list
154050231|NCT00669656|alpha-Tocopherol|alpha-tocopherol|mesh-list
154050232|NCT00669656|Selenium|selenium|mesh-list
154050233|NCT00669656|Lycopene|lycopene|mesh-list
154050234|NCT00669656|Daidzein|daidzein|mesh-list
154050235|NCT00669656|Micronutrients|micronutrients|mesh-ancestor
154050236|NCT00669656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154050237|NCT00669656|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154050238|NCT00669656|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154050239|NCT00669656|Antioxidants|antioxidants|mesh-ancestor
154050240|NCT00669656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154050241|NCT00669656|Protective Agents|protective agents|mesh-ancestor
154050242|NCT00669656|Trace Elements|trace elements|mesh-ancestor
154050243|NCT00669656|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154050244|NCT00669656|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
154050245|NCT00669656|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
154050246|NCT00669656|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154050247|NCT00669656|Phytoestrogens|phytoestrogens|mesh-ancestor
154050248|NCT00669656|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
154050249|NCT00669656|Estrogens|estrogens|mesh-ancestor
154050250|NCT00669656|Hormones|hormones|mesh-ancestor
153573362|NCT01828840|Anesthetics|anesthetics|mesh-ancestor
153573363|NCT01828840|Antitussive Agents|antitussive agents|mesh-ancestor
153573376|NCT01741103|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153573377|NCT01741103|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
153573378|NCT01741103|Protease Inhibitors|protease inhibitors|mesh-ancestor
153573379|NCT01741103|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153573380|NCT01741103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153573381|NCT01722331|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
153573382|NCT01722331|Immunologic Factors|immunologic factors|mesh-ancestor
153573383|NCT01722331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153573384|NCT01630590|Androgens|androgens|mesh-list
153573385|NCT01630590|Hormones|hormones|mesh-ancestor
153573386|NCT01630590|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153573387|NCT01630590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153573388|NCT01619085|Nintedanib|nintedanib|mesh-list
153573389|NCT01619085|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153573390|NCT01619085|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153573391|NCT01619085|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153573392|NCT01619085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153573393|NCT01499095|Insulin|insulin|mesh-list
153573394|NCT01499095|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
154050251|NCT00669656|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154050253|NCT00672776|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
154050254|NCT00672776|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154050255|NCT00672776|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154050256|NCT00672776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154050257|NCT00672776|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154050259|NCT00672776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154050260|NCT00672776|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
154050261|NCT00672776|Antidepressive Agents|antidepressive agents|mesh-ancestor
154050262|NCT00672776|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154050263|NCT00672776|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
154050264|NCT00672776|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154050265|NCT00672776|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154050266|NCT00616187|Interferons|interferons|mesh-list
154050267|NCT00616187|Interferon-beta|interferon-beta|mesh-list
154050268|NCT00616187|Atorvastatin|atorvastatin|mesh-list
154050269|NCT00616187|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154050270|NCT00616187|Antiviral Agents|antiviral agents|mesh-ancestor
154050271|NCT00616187|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154050272|NCT00616187|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154050273|NCT00616187|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154050274|NCT00616187|Antimetabolites|antimetabolites|mesh-ancestor
154050275|NCT00616187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154050276|NCT00616187|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154050277|NCT00616187|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154050278|NCT00616187|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154050279|NCT00616187|Immunologic Factors|immunologic factors|mesh-ancestor
154050280|NCT00616187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154050281|NCT00663338|Rotigotine|rotigotine|mesh-list
154050282|NCT00663338|Dopamine Agonists|dopamine agonists|mesh-ancestor
154050283|NCT00663338|Dopamine Agents|dopamine agents|mesh-ancestor
154050284|NCT00663338|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153573395|NCT01499095|Insulin Glargine|insulin glargine|mesh-list
154050285|NCT00663338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154050286|NCT00663338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154050287|NCT01009567|Cabergoline|cabergoline|mesh-list
154050288|NCT01009567|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
154050289|NCT01009567|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
153877920|NCT05199753|Immunologic Factors|immunologic factors|mesh-ancestor
153877921|NCT05199753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153877922|NCT05184348|Acitretin|acitretin|mesh-list
153877923|NCT05184348|Keratolytic Agents|keratolytic agents|mesh-ancestor
153877924|NCT05184348|Dermatologic Agents|dermatologic agents|mesh-ancestor
154050290|NCT01009567|Dopamine Agonists|dopamine agonists|mesh-ancestor
154050291|NCT01009567|Dopamine Agents|dopamine agents|mesh-ancestor
154050292|NCT01009567|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154050293|NCT01009567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154050294|NCT01009567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154050295|NCT00669812|Cytarabine|cytarabine|mesh-list
154050296|NCT00669812|Prednisolone|prednisolone|mesh-list
153592958|NCT01836614|Lidocaine|lidocaine|mesh-list
154050297|NCT00669812|Cyclophosphamide|cyclophosphamide|mesh-list
154050298|NCT00669812|Melphalan|melphalan|mesh-list
154050299|NCT00669812|Ifosfamide|ifosfamide|mesh-list
154050300|NCT00669812|Carmustine|carmustine|mesh-list
154050301|NCT00669812|Doxorubicin|doxorubicin|mesh-list
154050302|NCT00669812|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
154050303|NCT00669812|Methotrexate|methotrexate|mesh-list
154050304|NCT00669812|Etoposide|etoposide|mesh-list
154050305|NCT00669812|Vincristine|vincristine|mesh-list
154050306|NCT00669812|Epirubicin|epirubicin|mesh-list
154050307|NCT00669812|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154050308|NCT00669812|Immunologic Factors|immunologic factors|mesh-ancestor
154050309|NCT00669812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154050310|NCT00669812|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153573397|NCT01499095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153573398|NCT01499082|Insulin|insulin|mesh-list
153573399|NCT01499082|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
153573400|NCT01499082|Insulin Glargine|insulin glargine|mesh-list
153573401|NCT01499082|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153573402|NCT01499082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153573403|NCT01488890|Vaccines|vaccines|mesh-list
153573404|NCT01488890|Immunologic Factors|immunologic factors|mesh-ancestor
153573405|NCT01488890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153573406|NCT01436396|Vaccines|vaccines|mesh-list
153573407|NCT01436396|Immunologic Factors|immunologic factors|mesh-ancestor
153573408|NCT01436396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153573409|NCT01414777|Ondansetron|ondansetron|mesh-list
153573410|NCT01414777|Antiemetics|antiemetics|mesh-ancestor
153573411|NCT01414777|Autonomic Agents|autonomic agents|mesh-ancestor
153573412|NCT01414777|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153573413|NCT01414777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153573414|NCT01414777|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153573429|NCT01380938|Antimetabolites|antimetabolites|mesh-ancestor
153573430|NCT01380938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153573431|NCT01380938|Antiviral Agents|antiviral agents|mesh-ancestor
153573432|NCT01380938|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153573433|NCT01380938|Immunologic Factors|immunologic factors|mesh-ancestor
153573434|NCT01380938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153573435|NCT01374516|Vaccines|vaccines|mesh-list
153573436|NCT01374516|Immunologic Factors|immunologic factors|mesh-ancestor
153577504|NCT01718314|Anesthetics|anesthetics|mesh-ancestor
154050312|NCT00669812|Alkylating Agents|alkylating agents|mesh-ancestor
154050313|NCT00669812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154050314|NCT00669812|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154050315|NCT00669812|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154050316|NCT00669812|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154050317|NCT00669812|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154050318|NCT00669812|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154050319|NCT00669812|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154050320|NCT00669812|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154050321|NCT00669812|Abortifacient Agents|abortifacient agents|mesh-ancestor
154050322|NCT00669812|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153418700|NCT02949674|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154050323|NCT00669812|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154050324|NCT00669812|Antimetabolites|antimetabolites|mesh-ancestor
154050325|NCT00669812|Dermatologic Agents|dermatologic agents|mesh-ancestor
154050326|NCT00669812|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154050327|NCT00669812|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154050328|NCT00669812|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154050329|NCT00669812|Antiviral Agents|antiviral agents|mesh-ancestor
153573437|NCT01374516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153573438|NCT01373281|Vaccines|vaccines|mesh-list
153573439|NCT01373281|Immunologic Factors|immunologic factors|mesh-ancestor
153573440|NCT01373281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153573441|NCT01254422|Vaccines|vaccines|mesh-list
153573442|NCT01254422|Immunologic Factors|immunologic factors|mesh-ancestor
153573443|NCT01254422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153573444|NCT01204242|Lidocaine|lidocaine|mesh-list
153573445|NCT01204242|Anesthetics, Local|anesthetics, local|mesh-ancestor
153573446|NCT01204242|Anesthetics|anesthetics|mesh-ancestor
153573447|NCT01204242|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153573448|NCT01204242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153573449|NCT01204242|Sensory System Agents|sensory system agents|mesh-ancestor
153573450|NCT01204242|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153573451|NCT01204242|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153573452|NCT01204242|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
153573453|NCT01204242|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153573454|NCT01204242|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153573455|NCT01204242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153573457|NCT01187433|Immunologic Factors|immunologic factors|mesh-ancestor
153573458|NCT01187433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153573460|NCT01150045|Celecoxib|celecoxib|mesh-list
153573461|NCT01150045|Fluorouracil|fluorouracil|mesh-list
153573462|NCT01150045|Oxaliplatin|oxaliplatin|mesh-list
153573463|NCT01150045|Antimetabolites|antimetabolites|mesh-ancestor
153573464|NCT01150045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153573465|NCT01150045|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153573466|NCT01150045|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153573467|NCT01150045|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153573468|NCT01150045|Immunologic Factors|immunologic factors|mesh-ancestor
153573469|NCT01150045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153573470|NCT01150045|Antidotes|antidotes|mesh-ancestor
154050330|NCT00669812|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154050331|NCT00669812|Tubulin Modulators|tubulin modulators|mesh-ancestor
154050332|NCT00669812|Antimitotic Agents|antimitotic agents|mesh-ancestor
154050333|NCT00669812|Mitosis Modulators|mitosis modulators|mesh-ancestor
154050334|NCT00669812|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154050335|NCT00669812|Glucocorticoids|glucocorticoids|mesh-ancestor
154050336|NCT00669812|Hormones|hormones|mesh-ancestor
154050337|NCT00669812|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154050338|NCT00669812|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154050339|NCT02697851|Atazanavir Sulfate|atazanavir sulfate|mesh-list
154050340|NCT02697851|Cobicistat|cobicistat|mesh-list
154050341|NCT02697851|Levonorgestrel|levonorgestrel|mesh-list
154050342|NCT02697851|Ethinyl Estradiol|ethinyl estradiol|mesh-list
154050343|NCT02697851|Ethinyl estradiol, levonorgestrel drug combination|ethinyl estradiol, levonorgestrel drug combination|mesh-list
154050344|NCT02697851|Ethinyl Estradiol-Norgestrel Combination|ethinyl estradiol-norgestrel combination|mesh-list
154050345|NCT02697851|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
154050346|NCT02697851|Contraceptive Agents|contraceptive agents|mesh-ancestor
154050347|NCT02697851|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154050348|NCT02697851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154050349|NCT02697851|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
154050350|NCT02697851|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
154050351|NCT02697851|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
154050352|NCT02697851|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
154050353|NCT02697851|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
154050377|NCT01012843|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
154050378|NCT01012843|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154050379|NCT01012843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154050380|NCT00669890|Mycophenolic Acid|mycophenolic acid|mesh-list
154050381|NCT00669890|Cyclophosphamide|cyclophosphamide|mesh-list
154050383|NCT00669890|Methotrexate|methotrexate|mesh-list
154050384|NCT00669890|Gemtuzumab|gemtuzumab|mesh-list
153418716|NCT03033511|Hormones|hormones|mesh-ancestor
153418717|NCT03033511|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154050385|NCT00669890|Tacrolimus|tacrolimus|mesh-list
154050386|NCT00669890|Thymoglobulin|thymoglobulin|mesh-list
154050387|NCT00669890|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154050388|NCT00669890|Immunologic Factors|immunologic factors|mesh-ancestor
154050389|NCT00669890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154050390|NCT00669890|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154050391|NCT00669890|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154050392|NCT00669890|Alkylating Agents|alkylating agents|mesh-ancestor
154050393|NCT00669890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154050394|NCT00669890|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154050395|NCT00669890|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154050396|NCT00669890|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154050397|NCT00669890|Abortifacient Agents|abortifacient agents|mesh-ancestor
154050398|NCT00669890|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154050399|NCT00669890|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154050400|NCT00669890|Antimetabolites|antimetabolites|mesh-ancestor
154050401|NCT00669890|Dermatologic Agents|dermatologic agents|mesh-ancestor
154050402|NCT00669890|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154050403|NCT00669890|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154050412|NCT00669890|Immunotoxins|immunotoxins|mesh-ancestor
154050426|NCT00505375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154050427|NCT00505375|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154050428|NCT00505375|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154050429|NCT00505375|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154050430|NCT00505375|Immunologic Factors|immunologic factors|mesh-ancestor
154050431|NCT00505375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154050432|NCT00505375|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154050434|NCT02700347|Allopurinol|allopurinol|mesh-list
154050435|NCT02700347|Antimetabolites|antimetabolites|mesh-ancestor
154050436|NCT02700347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154050437|NCT02700347|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154050438|NCT02700347|Gout Suppressants|gout suppressants|mesh-ancestor
154050439|NCT02700347|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154050440|NCT02700347|Free Radical Scavengers|free radical scavengers|mesh-ancestor
154050441|NCT02700347|Antioxidants|antioxidants|mesh-ancestor
154050442|NCT02700347|Protective Agents|protective agents|mesh-ancestor
154050443|NCT02700347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154050444|NCT02700347|Antitubercular Agents|antitubercular agents|mesh-ancestor
154050445|NCT02700347|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154050446|NCT02700347|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154050447|NCT00594932|Mycophenolic Acid|mycophenolic acid|mesh-list
154050448|NCT00594932|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154050449|NCT00594932|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154050450|NCT00594932|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
154050451|NCT00594932|Antitubercular Agents|antitubercular agents|mesh-ancestor
154050452|NCT00594932|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154050453|NCT00594932|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154050454|NCT00594932|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154050455|NCT00594932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154050456|NCT00616889|Quetiapine Fumarate|quetiapine fumarate|mesh-list
153573471|NCT01150045|Protective Agents|protective agents|mesh-ancestor
153573472|NCT01150045|Vitamin B Complex|vitamin b complex|mesh-ancestor
153573473|NCT01150045|Vitamins|vitamins|mesh-ancestor
153573474|NCT01150045|Micronutrients|micronutrients|mesh-ancestor
153573475|NCT01150045|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153573476|NCT01150045|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153573477|NCT01150045|Analgesics|analgesics|mesh-ancestor
153573478|NCT01150045|Sensory System Agents|sensory system agents|mesh-ancestor
154050458|NCT00616889|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154050459|NCT00616889|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154050460|NCT00616889|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154050461|NCT00616889|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154050462|NCT00616889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154050464|NCT00673088|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
154050465|NCT00673088|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
154050466|NCT00673088|Dopamine Agonists|dopamine agonists|mesh-ancestor
154050467|NCT00673088|Dopamine Agents|dopamine agents|mesh-ancestor
154050468|NCT00673088|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154050469|NCT00673088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154050470|NCT00673088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154050471|NCT00504829|Atorvastatin|atorvastatin|mesh-list
154050472|NCT00504829|Fenofibrate|fenofibrate|mesh-list
154050473|NCT00504829|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154050474|NCT00504829|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154050475|NCT00504829|Antimetabolites|antimetabolites|mesh-ancestor
154050476|NCT00504829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154050477|NCT00504829|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154050478|NCT00504829|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154050507|NCT02699879|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154050508|NCT02699879|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154050509|NCT02699879|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154050510|NCT02699723|Itraconazole|itraconazole|mesh-list
154050511|NCT02699723|Arsenic Trioxide|arsenic trioxide|mesh-list
154050512|NCT02699723|Antifungal Agents|antifungal agents|mesh-ancestor
154050513|NCT02699723|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154050514|NCT02699723|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
154050515|NCT02699723|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154050516|NCT02699723|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154050517|NCT02699723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154050518|NCT02699723|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154050519|NCT02699723|Hormone Antagonists|hormone antagonists|mesh-ancestor
153593183|NCT01841242|Chlorhexidine|chlorhexidine|mesh-list
154050520|NCT02699723|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154050521|NCT02699723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154050522|NCT02699723|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154050523|NCT02699723|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154050524|NCT02699645|Amlodipine|amlodipine|mesh-list
154050525|NCT02699645|Telmisartan|telmisartan|mesh-list
154050526|NCT02699645|Indapamide|indapamide|mesh-list
154050527|NCT02699645|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154050528|NCT02699645|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154050529|NCT02699645|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154050554|NCT00615797|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
154050555|NCT00615797|Immunologic Factors|immunologic factors|mesh-ancestor
154050556|NCT00615797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154050558|NCT00615797|Autonomic Agents|autonomic agents|mesh-ancestor
154050559|NCT00615797|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154050560|NCT00615797|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154050561|NCT00615797|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154050562|NCT00615797|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154050563|NCT00615797|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154050564|NCT00615797|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154050565|NCT00615797|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
154050566|NCT00615797|Dopamine Agents|dopamine agents|mesh-ancestor
154050567|NCT00615797|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154050568|NCT00615797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154050569|NCT00615797|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
154050570|NCT00615797|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154050571|NCT00615797|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154050572|NCT00705016|Fluorouracil|fluorouracil|mesh-list
154050620|NCT00663728|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154050621|NCT00663728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154050622|NCT00663728|Urological Agents|urological agents|mesh-ancestor
154050650|NCT02629718|Carboplatin|carboplatin|mesh-list
154050651|NCT02629718|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154050652|NCT02629718|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154050653|NCT02629718|Tubulin Modulators|tubulin modulators|mesh-ancestor
154050654|NCT02629718|Antimitotic Agents|antimitotic agents|mesh-ancestor
154050655|NCT02629718|Mitosis Modulators|mitosis modulators|mesh-ancestor
154050701|NCT00510289|Sorafenib|sorafenib|mesh-list
154050702|NCT00510289|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154050703|NCT00510289|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154050704|NCT00510289|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154050705|NCT00510289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154050706|NCT01013155|Perindopril|perindopril|mesh-list
154050707|NCT01013155|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
154050708|NCT01013155|Protease Inhibitors|protease inhibitors|mesh-ancestor
154050709|NCT01013155|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154050710|NCT01013155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154050711|NCT01013155|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154050712|NCT00663806|Ciprofloxacin|ciprofloxacin|mesh-list
154050713|NCT00663806|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154050714|NCT00663806|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154050715|NCT00663806|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154050716|NCT00663806|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154050717|NCT00663806|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154050718|NCT00663806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154050719|NCT00663806|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154050720|NCT00663806|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
154050721|NCT00663806|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154050722|NCT01015339|Paclitaxel|paclitaxel|mesh-list
154050723|NCT01015339|Capecitabine|capecitabine|mesh-list
154050724|NCT01015339|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154050725|NCT01015339|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154050726|NCT01015339|Tubulin Modulators|tubulin modulators|mesh-ancestor
154050727|NCT01015339|Antimitotic Agents|antimitotic agents|mesh-ancestor
154050728|NCT01015339|Mitosis Modulators|mitosis modulators|mesh-ancestor
154050729|NCT01015339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154050730|NCT01015339|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154050731|NCT01015339|Antimetabolites|antimetabolites|mesh-ancestor
154050732|NCT02622906|Pasireotide|pasireotide|mesh-list
154050742|NCT00675896|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154050743|NCT00675896|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154050744|NCT00675896|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154050745|NCT00675896|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154050746|NCT00675896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154050747|NCT01015417|Amoxicillin|amoxicillin|mesh-list
154050748|NCT01015417|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
154050749|NCT01015417|Clavulanic Acids|clavulanic acids|mesh-list
154050750|NCT01015417|Clavulanic Acid|clavulanic acid|mesh-list
154050751|NCT01015417|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154050752|NCT01015417|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154050753|NCT01015417|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
154050754|NCT01015417|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154050755|NCT01015417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154050757|NCT04061824|Angiotensin II|angiotensin ii|mesh-list
154050758|NCT04061824|Giapreza|giapreza|mesh-list
154050759|NCT04061824|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
154050760|NCT04061824|Angiotensinogen|angiotensinogen|mesh-list
154050761|NCT04061824|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-list
154050762|NCT04061824|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154050763|NCT04061824|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154050774|NCT04212533|Vitamin D|vitamin d|mesh-list
154050801|NCT00663884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154050802|NCT00856206|Rilonacept|rilonacept|mesh-list
154050803|NCT00856206|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154050804|NCT03997279|Amoxicillin|amoxicillin|mesh-list
154050805|NCT03997279|Metronidazole|metronidazole|mesh-list
154050806|NCT03997279|Clarithromycin|clarithromycin|mesh-list
154050807|NCT03997279|Rabeprazole|rabeprazole|mesh-list
154050808|NCT03997279|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154050809|NCT03997279|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154050810|NCT03997279|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154050850|NCT05323565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154050852|NCT05323565|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154050853|NCT05323565|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154050854|NCT05323565|Analgesics|analgesics|mesh-ancestor
154050855|NCT05323565|Sensory System Agents|sensory system agents|mesh-ancestor
154050856|NCT05323565|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154050857|NCT05323565|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154050858|NCT05323565|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154050859|NCT05323565|Adrenergic Agents|adrenergic agents|mesh-ancestor
154050860|NCT05323565|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154050861|NCT01015495|Ranibizumab|ranibizumab|mesh-list
154050862|NCT01015495|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154050863|NCT01015495|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154050864|NCT01015495|Growth Substances|growth substances|mesh-ancestor
154050865|NCT01015495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154050866|NCT01015495|Growth Inhibitors|growth inhibitors|mesh-ancestor
154050867|NCT01015495|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154050868|NCT00676286|Choline|choline|mesh-list
154050869|NCT00676286|Lipotropic Agents|lipotropic agents|mesh-ancestor
154050870|NCT00676286|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154050871|NCT00676286|Antimetabolites|antimetabolites|mesh-ancestor
154050872|NCT00676286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154050873|NCT00676286|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154050874|NCT00676286|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154050875|NCT00676286|Nootropic Agents|nootropic agents|mesh-ancestor
154050876|NCT00699894|Ondansetron|ondansetron|mesh-list
154050877|NCT00699894|Aprepitant|aprepitant|mesh-list
154050878|NCT00699894|Antiemetics|antiemetics|mesh-ancestor
154050879|NCT00699894|Autonomic Agents|autonomic agents|mesh-ancestor
154050880|NCT00699894|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154050881|NCT00699894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154050882|NCT00699894|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154050883|NCT00699894|Antipruritics|antipruritics|mesh-ancestor
153573479|NCT01150045|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153573480|NCT01150045|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153573481|NCT01150045|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153573482|NCT01150045|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
153573483|NCT01150045|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153573484|NCT01150045|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154050884|NCT00699894|Dermatologic Agents|dermatologic agents|mesh-ancestor
154050885|NCT00699894|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
154050886|NCT00699894|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154050887|NCT00699894|Serotonin Agents|serotonin agents|mesh-ancestor
154050888|NCT00699894|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154050889|NCT00699894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154050890|NCT00699894|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
154050891|NCT00664196|Hormones|hormones|mesh-list
154050892|NCT00664196|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154050893|NCT00664196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154050894|NCT00616499|Gefitinib|gefitinib|mesh-list
154050895|NCT00616499|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154050896|NCT00616499|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154050897|NCT00616499|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154050898|NCT00616499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154050899|NCT00616499|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154050900|NCT02614248|Protective Agents|protective agents|mesh-list
153877925|NCT05183412|Methamphetamine|methamphetamine|mesh-list
153877926|NCT05183412|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
154050901|NCT02614248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154050902|NCT00491179|Interferons|interferons|mesh-list
154050903|NCT00491179|Ribavirin|ribavirin|mesh-list
154050904|NCT00491179|Interferon-alpha|interferon-alpha|mesh-list
154050905|NCT00491179|Interferon alpha-2|interferon alpha-2|mesh-list
154050906|NCT00491179|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
154050907|NCT00491179|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154050908|NCT00491179|Antiviral Agents|antiviral agents|mesh-ancestor
154050933|NCT00677144|Oxaliplatin|oxaliplatin|mesh-list
154050934|NCT00677144|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154050935|NCT00677144|Antimetabolites|antimetabolites|mesh-ancestor
154050936|NCT00677144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154050937|NCT00677144|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154050938|NCT00703534|Lesogaberan|lesogaberan|mesh-list
154050939|NCT00703534|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154050940|NCT00703534|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
154050941|NCT00703534|GABA Agonists|gaba agonists|mesh-ancestor
154050942|NCT00703534|GABA Agents|gaba agents|mesh-ancestor
154050943|NCT00703534|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154050944|NCT00703534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154050945|NCT00703534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154050946|NCT00503425|Rituximab|rituximab|mesh-list
154050947|NCT00503425|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154050948|NCT00503425|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154050949|NCT00503425|Immunologic Factors|immunologic factors|mesh-ancestor
154050950|NCT00503425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154050951|NCT00503425|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154050952|NCT00863772|Tanezumab|tanezumab|mesh-list
154050953|NCT00863772|Analgesics|analgesics|mesh-ancestor
154050954|NCT00863772|Sensory System Agents|sensory system agents|mesh-ancestor
154050955|NCT00863772|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154050956|NCT00863772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154050957|NCT01010425|Hormones|hormones|mesh-list
153573502|NCT00945009|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153573503|NCT00945009|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153573504|NCT00945009|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153573505|NCT00945009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153573506|NCT00945009|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153573507|NCT00945009|Tubulin Modulators|tubulin modulators|mesh-ancestor
153573508|NCT00945009|Antimitotic Agents|antimitotic agents|mesh-ancestor
153573509|NCT00945009|Mitosis Modulators|mitosis modulators|mesh-ancestor
153573510|NCT00945009|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153573511|NCT00945009|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153573512|NCT00945009|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
153573513|NCT00945009|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153573514|NCT00896389|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
153573515|NCT00896389|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153573516|NCT00896389|Diuretics|diuretics|mesh-ancestor
153573517|NCT00896389|Natriuretic Agents|natriuretic agents|mesh-ancestor
153573518|NCT00896389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154050958|NCT01010425|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154050959|NCT01010425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154050961|NCT00677300|Darunavir|darunavir|mesh-list
154050962|NCT00677300|Tenofovir|tenofovir|mesh-list
154050963|NCT00677300|Emtricitabine|emtricitabine|mesh-list
154050964|NCT00677300|Raltegravir Potassium|raltegravir potassium|mesh-list
154050965|NCT00677300|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
154050966|NCT00677300|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
154050967|NCT00677300|Protease Inhibitors|protease inhibitors|mesh-ancestor
154050968|NCT00677300|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154050969|NCT00677300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154050970|NCT00677300|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154050971|NCT00677300|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154050972|NCT00677300|Antiviral Agents|antiviral agents|mesh-ancestor
154050973|NCT00677300|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154050974|NCT00677300|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154050975|NCT00677300|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154050976|NCT00677300|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
154050977|NCT00677300|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154050978|NCT00677300|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
154050979|NCT00677300|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
154050980|NCT02628392|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
154050981|NCT02628392|Firuglipel|firuglipel|mesh-list
154050982|NCT02628392|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154050983|NCT02628392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154050984|NCT02628392|Incretins|incretins|mesh-ancestor
154050985|NCT02628392|Hormones|hormones|mesh-ancestor
154050986|NCT02628392|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154050987|NCT02628392|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
154050988|NCT02628392|Protease Inhibitors|protease inhibitors|mesh-ancestor
154050989|NCT02628392|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154050991|NCT00664586|Masoprocol|masoprocol|mesh-list
154051048|NCT00674414|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
154051049|NCT00674414|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154051050|NCT00674414|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154051051|NCT00674414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154051052|NCT00674414|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154051053|NCT00674414|Immunologic Factors|immunologic factors|mesh-ancestor
154051054|NCT00674414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154051055|NCT05272930|Dienogest|dienogest|mesh-list
154051056|NCT05272930|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
154051057|NCT05272930|Contraceptive Agents|contraceptive agents|mesh-ancestor
154051058|NCT05272930|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154051059|NCT05272930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154051060|NCT05272930|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
154051061|NCT05272930|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
154051062|NCT05272930|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
154051063|NCT05272930|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
154051064|NCT05272930|Hormone Antagonists|hormone antagonists|mesh-ancestor
154051065|NCT05272930|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154051066|NCT05272930|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154051067|NCT05272930|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154051068|NCT00855894|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
154051069|NCT00855894|Pertuzumab|pertuzumab|mesh-list
154051070|NCT00855894|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154051071|NCT00855894|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154051072|NCT00855894|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154051073|NCT00855894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154051074|NCT00855894|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154051075|NCT00855894|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154051076|NCT02566096|Morphine|morphine|mesh-list
153573519|NCT00896389|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
153573520|NCT00896389|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153573521|NCT00896389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153573522|NCT00880893|Vaccines|vaccines|mesh-list
153573523|NCT00880893|Immunologic Factors|immunologic factors|mesh-ancestor
153573524|NCT00880893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154051112|NCT00855738|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154051113|NCT00855738|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154051114|NCT00855738|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154051115|NCT00855738|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154051116|NCT00855738|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154051117|NCT00855738|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154051118|NCT00855738|Antimanic Agents|antimanic agents|mesh-ancestor
154051119|NCT00855738|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154051120|NCT00855738|Nootropic Agents|nootropic agents|mesh-ancestor
154051121|NCT00855738|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154051122|NCT00855738|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154051123|NCT00855738|GABA Uptake Inhibitors|gaba uptake inhibitors|mesh-ancestor
154051124|NCT00855738|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154051125|NCT00855738|GABA Agents|gaba agents|mesh-ancestor
154051126|NCT02628002|Regadenoson|regadenoson|mesh-list
154051127|NCT02628002|Adenosine A2 Receptor Agonists|adenosine a2 receptor agonists|mesh-ancestor
154051128|NCT02628002|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
154051129|NCT02628002|Purinergic Agonists|purinergic agonists|mesh-ancestor
154051130|NCT02628002|Purinergic Agents|purinergic agents|mesh-ancestor
154051131|NCT02628002|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154051133|NCT02628002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154051147|NCT06157359|Anesthetics|anesthetics|mesh-ancestor
154051148|NCT06157359|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154051149|NCT06157359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154051150|NCT06157359|Sensory System Agents|sensory system agents|mesh-ancestor
154051151|NCT06157359|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154051152|NCT06157320|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
154051153|NCT06157320|Norepinephrine|norepinephrine|mesh-list
154051154|NCT06157320|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154051155|NCT06157320|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154051156|NCT06157320|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154051157|NCT06157320|Adrenergic Agents|adrenergic agents|mesh-ancestor
154051158|NCT06157320|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154051159|NCT06157320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154051160|NCT06157320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154051161|NCT06157320|Sympathomimetics|sympathomimetics|mesh-ancestor
154051162|NCT06157320|Autonomic Agents|autonomic agents|mesh-ancestor
154051163|NCT06157320|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154051164|NCT06157320|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154051165|NCT06157099|Atorvastatin|atorvastatin|mesh-list
154051166|NCT06157099|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154051167|NCT06157099|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154051168|NCT06157099|Antimetabolites|antimetabolites|mesh-ancestor
154051169|NCT06157099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154051198|NCT06156709|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154051199|NCT06156709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154051201|NCT06156592|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154051202|NCT06156592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154051203|NCT06156579|Venetoclax|venetoclax|mesh-list
154051204|NCT06156579|Decitabine|decitabine|mesh-list
154051205|NCT06156579|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154051206|NCT06156579|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154051207|NCT06156579|Antimetabolites|antimetabolites|mesh-ancestor
154051208|NCT06156579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154051209|NCT06156579|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154051210|NCT06156566|Tecovirimat|tecovirimat|mesh-list
154051211|NCT06156566|Antiviral Agents|antiviral agents|mesh-ancestor
154051212|NCT06156566|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154051213|NCT06156527|Bevacizumab|bevacizumab|mesh-list
154051214|NCT06156527|Lazertinib|lazertinib|mesh-list
154051215|NCT06156527|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154051216|NCT06156527|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154051217|NCT06156527|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154051218|NCT06156527|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154051219|NCT06156527|Growth Substances|growth substances|mesh-ancestor
154051220|NCT06156527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154051221|NCT06156527|Growth Inhibitors|growth inhibitors|mesh-ancestor
154051222|NCT06156527|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154051223|NCT06156527|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154051224|NCT06156527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154051225|NCT06156085|Amoxicillin|amoxicillin|mesh-list
154051226|NCT06156085|Metronidazole|metronidazole|mesh-list
154051227|NCT06156085|Clarithromycin|clarithromycin|mesh-list
154051228|NCT06156085|Lansoprazole|lansoprazole|mesh-list
154051229|NCT06156085|Dexlansoprazole|dexlansoprazole|mesh-list
154051230|NCT06156085|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154051231|NCT06156085|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154051232|NCT06156085|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154051237|NCT06156085|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154051238|NCT06156085|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154051239|NCT06156085|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154051240|NCT06156085|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154051241|NCT06156085|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
154051242|NCT06155916|Pregabalin|pregabalin|mesh-list
154051243|NCT06155916|Analgesics|analgesics|mesh-ancestor
154051244|NCT06155916|Sensory System Agents|sensory system agents|mesh-ancestor
154051245|NCT06155916|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154051246|NCT06155916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154051247|NCT06155916|Anticonvulsants|anticonvulsants|mesh-ancestor
154051248|NCT06155916|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154051249|NCT06155916|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154051250|NCT06155916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154051251|NCT06155916|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154051252|NCT06155916|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154051253|NCT06155916|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154051254|NCT06155916|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154051255|NCT06155916|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154051256|NCT06155903|Anesthetics|anesthetics|mesh-list
154051257|NCT06155903|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154051258|NCT06155903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154051259|NCT06151171|Coenzyme Q10|coenzyme q10|mesh-list
154051260|NCT06151171|Vitamins|vitamins|mesh-ancestor
154051286|NCT06134375|Chelating Agents|chelating agents|mesh-ancestor
154051287|NCT06134375|Sequestering Agents|sequestering agents|mesh-ancestor
154051288|NCT06134375|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154051289|NCT06134375|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154051290|NCT06134375|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154051291|NCT06134375|Growth Substances|growth substances|mesh-ancestor
154051292|NCT06134375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154051293|NCT06134375|Growth Inhibitors|growth inhibitors|mesh-ancestor
154051294|NCT06109506|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
154051295|NCT06109506|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154051296|NCT06099184|Aflibercept|aflibercept|mesh-list
154051297|NCT06099184|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154051298|NCT06099184|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154051299|NCT06099184|Growth Substances|growth substances|mesh-ancestor
154051300|NCT06099184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154051301|NCT06099184|Growth Inhibitors|growth inhibitors|mesh-ancestor
154051302|NCT06099184|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154051303|NCT06094660|Phenol|phenol|mesh-list
154051304|NCT06094660|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154051305|NCT06094660|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154051306|NCT06094660|Disinfectants|disinfectants|mesh-ancestor
154051307|NCT06094660|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
154051308|NCT06094660|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
154051309|NCT06093945|Omeprazole|omeprazole|mesh-list
154051310|NCT06093945|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154051311|NCT06093945|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154051312|NCT06093945|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
154051313|NCT06093945|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154051314|NCT06093945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154051315|NCT06070116|Ivermectin|ivermectin|mesh-list
154051316|NCT06070116|Albendazole|albendazole|mesh-list
154051317|NCT06070116|Moxidectin|moxidectin|mesh-list
153573525|NCT00579527|Cyclosporine|cyclosporine|mesh-list
153573526|NCT00579527|Mycophenolic Acid|mycophenolic acid|mesh-list
153573527|NCT00579527|Methylprednisolone|methylprednisolone|mesh-list
153573528|NCT00579527|Prednisolone|prednisolone|mesh-list
153573529|NCT00579527|Tacrolimus|tacrolimus|mesh-list
153573530|NCT00579527|Cyclosporins|cyclosporins|mesh-list
153573531|NCT00579527|Thymoglobulin|thymoglobulin|mesh-list
153573532|NCT00579527|Antilymphocyte Serum|antilymphocyte serum|mesh-list
153573533|NCT00579527|Daclizumab|daclizumab|mesh-list
153573534|NCT00579527|Parathyroid Hormone|parathyroid hormone|mesh-list
153573535|NCT00579527|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153573536|NCT00579527|Immunologic Factors|immunologic factors|mesh-ancestor
153573540|NCT00579527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153573541|NCT00579527|Antifungal Agents|antifungal agents|mesh-ancestor
153573542|NCT00579527|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154051318|NCT06070116|Diethylcarbamazine|diethylcarbamazine|mesh-list
154051319|NCT06070116|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154051320|NCT06070116|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154051321|NCT06070116|Anthelmintics|anthelmintics|mesh-ancestor
154051322|NCT06070116|Anticestodal Agents|anticestodal agents|mesh-ancestor
154051323|NCT06070116|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
154051324|NCT06070116|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154051325|NCT06070116|Tubulin Modulators|tubulin modulators|mesh-ancestor
154051326|NCT06070116|Antimitotic Agents|antimitotic agents|mesh-ancestor
154051327|NCT06070116|Mitosis Modulators|mitosis modulators|mesh-ancestor
154051328|NCT06070116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154051329|NCT06070116|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154051330|NCT06070116|Antinematodal Agents|antinematodal agents|mesh-ancestor
154051331|NCT06070116|Filaricides|filaricides|mesh-ancestor
154051332|NCT06070116|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
154051333|NCT06070116|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154051334|NCT06005662|Buprenorphine|buprenorphine|mesh-list
154051335|NCT06005662|Psilocybin|psilocybin|mesh-list
154051336|NCT06005662|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154051337|NCT06005662|Narcotics|narcotics|mesh-ancestor
154051338|NCT06005662|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154051339|NCT06005662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154051340|NCT06005662|Analgesics|analgesics|mesh-ancestor
154051341|NCT06005662|Sensory System Agents|sensory system agents|mesh-ancestor
154051342|NCT06005662|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154051343|NCT06005662|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
154051344|NCT06005662|Hallucinogens|hallucinogens|mesh-ancestor
154051346|NCT05996471|Cabotegravir|cabotegravir|mesh-list
154051368|NCT05952024|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154051369|NCT05952024|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154051370|NCT05952024|Immunologic Factors|immunologic factors|mesh-ancestor
154051371|NCT05952024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154051372|NCT05952024|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154051373|NCT05952024|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154051374|NCT05952024|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154051375|NCT05952024|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154051376|NCT05952024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154051377|NCT05938725|Cyclophosphamide|cyclophosphamide|mesh-list
154051378|NCT05938725|Fludarabine|fludarabine|mesh-list
154051379|NCT05938725|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154051380|NCT05938725|Immunologic Factors|immunologic factors|mesh-ancestor
154051381|NCT05938725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154051382|NCT05938725|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154051383|NCT05938725|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154051384|NCT05938725|Alkylating Agents|alkylating agents|mesh-ancestor
154051385|NCT05938725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154051386|NCT05938725|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154051387|NCT05938725|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154051388|NCT05930028|Atorvastatin|atorvastatin|mesh-list
154051389|NCT05930028|Ezetimibe|ezetimibe|mesh-list
154051390|NCT05930028|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154051391|NCT05930028|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154051392|NCT05930028|Antimetabolites|antimetabolites|mesh-ancestor
154051415|NCT05893108|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154051416|NCT05893108|Immunologic Factors|immunologic factors|mesh-ancestor
154051417|NCT05893108|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154051418|NCT05893108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154051419|NCT05893108|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154051420|NCT05893108|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154051421|NCT05893108|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
154051422|NCT05893108|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
154051423|NCT05878093|Budesonide|budesonide|mesh-list
154051424|NCT05878093|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154051425|NCT05878093|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154051426|NCT05878093|Autonomic Agents|autonomic agents|mesh-ancestor
154051427|NCT05878093|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154051428|NCT05878093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154051429|NCT05878093|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154051430|NCT05878093|Respiratory System Agents|respiratory system agents|mesh-ancestor
154051431|NCT05878093|Glucocorticoids|glucocorticoids|mesh-ancestor
154051432|NCT05878093|Hormones|hormones|mesh-ancestor
154051433|NCT05878093|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154051434|NCT05874921|Mitomycins|mitomycins|mesh-list
154051435|NCT05874921|Mitomycin|mitomycin|mesh-list
154051436|NCT05874921|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154051437|NCT05874921|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154051438|NCT05874921|Alkylating Agents|alkylating agents|mesh-ancestor
154051439|NCT05874921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154051440|NCT05874921|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154051441|NCT05874921|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154051442|NCT05842330|Methylphenidate|methylphenidate|mesh-list
154051443|NCT05842330|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
154051444|NCT05842330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154051445|NCT05842330|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
154051449|NCT05842330|Dopamine Agents|dopamine agents|mesh-ancestor
154051454|NCT05829655|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154051455|NCT05829655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154051456|NCT05829655|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
154051457|NCT05829655|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154051458|NCT05829655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154051460|NCT05794230|Immunologic Factors|immunologic factors|mesh-ancestor
154051461|NCT05794230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154051462|NCT05788679|Azacitidine|azacitidine|mesh-list
154051463|NCT05788679|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154051464|NCT05788679|Antimetabolites|antimetabolites|mesh-ancestor
154051465|NCT05788679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154051466|NCT05788679|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154051467|NCT05788679|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154051468|NCT05774639|Omalizumab|omalizumab|mesh-list
154051469|NCT05774639|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154051470|NCT05774639|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154051471|NCT05774639|Respiratory System Agents|respiratory system agents|mesh-ancestor
154051472|NCT05702853|Cyclophosphamide|cyclophosphamide|mesh-list
154051473|NCT05702853|Fludarabine|fludarabine|mesh-list
154051474|NCT05702853|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154051475|NCT05702853|Immunologic Factors|immunologic factors|mesh-ancestor
154051476|NCT05702853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154051477|NCT05702853|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154051478|NCT05702853|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154051479|NCT05702853|Alkylating Agents|alkylating agents|mesh-ancestor
154051480|NCT05702853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154051481|NCT05702853|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154051482|NCT05702853|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154051483|NCT05674526|Cetuximab|cetuximab|mesh-list
154051484|NCT05674526|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154051485|NCT05674526|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154051495|NCT05588388|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154051496|NCT05588388|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154051497|NCT05588388|Growth Substances|growth substances|mesh-ancestor
154051498|NCT05588388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154051499|NCT05588388|Growth Inhibitors|growth inhibitors|mesh-ancestor
154051500|NCT05575167|Vitamin D|vitamin d|mesh-list
154051501|NCT05575167|Alendronate|alendronate|mesh-list
154051502|NCT05575167|Zoledronic Acid|zoledronic acid|mesh-list
154051503|NCT05575167|Vitamins|vitamins|mesh-ancestor
154051504|NCT05575167|Micronutrients|micronutrients|mesh-ancestor
154051505|NCT05575167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154051506|NCT05575167|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154051507|NCT05564637|Treprostinil|treprostinil|mesh-list
154051508|NCT05564637|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154051509|NCT05495061|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
154051510|NCT05495061|Latanoprost|latanoprost|mesh-list
154051511|NCT05495061|Ophthalmic Solutions|ophthalmic solutions|mesh-list
154051512|NCT05464810|Letrozole|letrozole|mesh-list
154051513|NCT05464810|Simvastatin|simvastatin|mesh-list
154051514|NCT05464810|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154051515|NCT05464810|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154051516|NCT05464810|Antimetabolites|antimetabolites|mesh-ancestor
154051517|NCT05464810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154051518|NCT05464810|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154051519|NCT05464810|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154051520|NCT05464810|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154051521|NCT05464810|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154051522|NCT05464810|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
154051523|NCT05464810|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154051524|NCT05464810|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
154051525|NCT05464810|Hormone Antagonists|hormone antagonists|mesh-ancestor
154051526|NCT05464810|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154051527|NCT05464810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154051528|NCT05450042|Paclitaxel|paclitaxel|mesh-list
154051529|NCT05450042|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154051530|NCT05450042|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154051531|NCT05450042|Tubulin Modulators|tubulin modulators|mesh-ancestor
154051533|NCT05450042|Mitosis Modulators|mitosis modulators|mesh-ancestor
154051534|NCT05450042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154051535|NCT05445856|Fentanyl|fentanyl|mesh-list
154051536|NCT05445856|Methadone|methadone|mesh-list
154051537|NCT05445856|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154051538|NCT05445856|Narcotics|narcotics|mesh-ancestor
154051539|NCT05445856|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154051540|NCT05445856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154051541|NCT05445856|Analgesics|analgesics|mesh-ancestor
154051542|NCT05445856|Sensory System Agents|sensory system agents|mesh-ancestor
154051543|NCT05445856|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154051544|NCT05445856|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154051545|NCT05445856|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154051546|NCT05445856|Anesthetics, General|anesthetics, general|mesh-ancestor
154051547|NCT05445856|Anesthetics|anesthetics|mesh-ancestor
154051548|NCT05445856|Antitussive Agents|antitussive agents|mesh-ancestor
154051549|NCT05445856|Respiratory System Agents|respiratory system agents|mesh-ancestor
154051550|NCT05379686|Glucagon|glucagon|mesh-list
154051551|NCT05379686|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154051552|NCT05379686|Hormones|hormones|mesh-ancestor
154051553|NCT05379686|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154051554|NCT05379686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154051555|NCT05361486|Primaquine|primaquine|mesh-list
154051556|NCT05361486|Tafenoquine|tafenoquine|mesh-list
154051557|NCT05361486|Antimalarials|antimalarials|mesh-ancestor
154051558|NCT05361486|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154051559|NCT05361486|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154051560|NCT05361486|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154051561|NCT05292664|Leucovorin|leucovorin|mesh-list
154051562|NCT05292664|Cytarabine|cytarabine|mesh-list
154051563|NCT05292664|Dexamethasone|dexamethasone|mesh-list
154051564|NCT05292664|Dexamethasone acetate|dexamethasone acetate|mesh-list
154051565|NCT05292664|Hydrocortisone|hydrocortisone|mesh-list
154051566|NCT05292664|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
154051567|NCT05292664|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
154051568|NCT05292664|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
154051577|NCT05292664|Razoxane|razoxane|mesh-list
154051578|NCT05292664|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
154051579|NCT05292664|BB 1101|bb 1101|mesh-list
154051580|NCT05292664|Levoleucovorin|levoleucovorin|mesh-list
154051581|NCT05292664|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154051582|NCT05292664|Antiemetics|antiemetics|mesh-ancestor
154051583|NCT05292664|Autonomic Agents|autonomic agents|mesh-ancestor
154051584|NCT05292664|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154051585|NCT05292664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154051586|NCT05292664|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154051587|NCT05292664|Glucocorticoids|glucocorticoids|mesh-ancestor
154051588|NCT05292664|Hormones|hormones|mesh-ancestor
154051589|NCT05292664|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154051590|NCT05292664|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154051591|NCT05292664|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154051592|NCT05292664|Protease Inhibitors|protease inhibitors|mesh-ancestor
154051593|NCT05292664|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154051594|NCT05292664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154051595|NCT05292664|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154051596|NCT05292664|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154051597|NCT05292664|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154051598|NCT05292664|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154051599|NCT05292664|Abortifacient Agents|abortifacient agents|mesh-ancestor
154051630|NCT05244057|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
154051631|NCT05244057|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154051632|NCT05244057|Antiviral Agents|antiviral agents|mesh-ancestor
154051633|NCT05244057|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154051634|NCT05244057|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
154051635|NCT05244057|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154051636|NCT05244057|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154051637|NCT05244057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154051638|NCT05244057|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154051639|NCT05244057|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154051640|NCT05244057|Immunologic Factors|immunologic factors|mesh-ancestor
154051641|NCT05244057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154051643|NCT05239533|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154051644|NCT05239533|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154051645|NCT05239533|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154051646|NCT05239533|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154051647|NCT05239533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154051648|NCT05239533|Immunologic Factors|immunologic factors|mesh-ancestor
154051649|NCT05239533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154051651|NCT05229003|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
154051652|NCT05229003|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154051653|NCT05229003|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154051654|NCT05229003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154051655|NCT05229003|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154051680|NCT05205603|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154051681|NCT05205603|Analgesics|analgesics|mesh-ancestor
154051682|NCT05205603|Sensory System Agents|sensory system agents|mesh-ancestor
154051683|NCT05205603|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154051684|NCT05205603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154051685|NCT05181527|Levomethorphan|levomethorphan|mesh-list
154051686|NCT05181527|Dextromethorphan|dextromethorphan|mesh-list
154051688|NCT05181527|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-list
154051689|NCT05181527|Antitussive Agents|antitussive agents|mesh-ancestor
154051690|NCT05181527|Respiratory System Agents|respiratory system agents|mesh-ancestor
154051691|NCT05181527|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154051692|NCT05181527|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154051693|NCT05181527|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154051694|NCT05181527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154051695|NCT05181527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154051696|NCT05181527|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154051697|NCT05181527|Narcotics|narcotics|mesh-ancestor
154051698|NCT05181527|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154051699|NCT05181527|Analgesics|analgesics|mesh-ancestor
154051700|NCT05181527|Sensory System Agents|sensory system agents|mesh-ancestor
154051701|NCT05181527|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154051702|NCT05181527|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
154051703|NCT05181527|Serotonin Agents|serotonin agents|mesh-ancestor
154051704|NCT05181527|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154051705|NCT05181527|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154051706|NCT05148715|Tacrolimus|tacrolimus|mesh-list
154051707|NCT05148715|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154051708|NCT05148715|Immunologic Factors|immunologic factors|mesh-ancestor
154051709|NCT05148715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153573543|NCT00579527|Dermatologic Agents|dermatologic agents|mesh-ancestor
153573544|NCT00579527|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153573545|NCT00579527|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153573546|NCT00579527|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153573547|NCT00579527|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
153573548|NCT00579527|Antitubercular Agents|antitubercular agents|mesh-ancestor
153573549|NCT00579527|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153573550|NCT00579527|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153573552|NCT00579527|Autonomic Agents|autonomic agents|mesh-ancestor
153573553|NCT00579527|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153573558|NCT00579527|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
153573559|NCT00579527|Protective Agents|protective agents|mesh-ancestor
153573560|NCT00579527|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154051710|NCT05148715|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
154051711|NCT05148715|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154051712|NCT05148715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154051714|NCT05093790|Ticagrelor|ticagrelor|mesh-list
154051715|NCT05093790|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154051716|NCT05093790|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154051717|NCT05093790|Analgesics|analgesics|mesh-ancestor
154051718|NCT05093790|Sensory System Agents|sensory system agents|mesh-ancestor
154051719|NCT05093790|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154051720|NCT05093790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154051721|NCT05093790|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154051722|NCT05093790|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153594387|NCT01848925|Antisickling Agents|antisickling agents|mesh-ancestor
154051723|NCT05093790|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154051724|NCT05093790|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154051725|NCT05093790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154051726|NCT05093790|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154051727|NCT05093790|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154051728|NCT05093790|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154051729|NCT05093790|Antipyretics|antipyretics|mesh-ancestor
154051730|NCT05093790|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
154051731|NCT05093790|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
154051732|NCT05093790|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
154051733|NCT05093790|Purinergic Agents|purinergic agents|mesh-ancestor
154051734|NCT05093790|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154051735|NCT05076292|Glucagon|glucagon|mesh-list
154051736|NCT05076292|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154051737|NCT05076292|Hormones|hormones|mesh-ancestor
154051738|NCT05076292|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154051739|NCT05076292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154051740|NCT05074485|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
154051742|NCT05018221|Vitamins|vitamins|mesh-list
154051750|NCT05018221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154051751|NCT05018221|Anticoagulants|anticoagulants|mesh-ancestor
154051752|NCT05018221|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
154051753|NCT05018221|Chelating Agents|chelating agents|mesh-ancestor
154051754|NCT05018221|Sequestering Agents|sequestering agents|mesh-ancestor
154051755|NCT05018221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154051756|NCT05018221|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
154051757|NCT05018221|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154051758|NCT05018221|Hemostatics|hemostatics|mesh-ancestor
154051759|NCT05018221|Coagulants|coagulants|mesh-ancestor
154051760|NCT05018221|Antidotes|antidotes|mesh-ancestor
154051761|NCT05018221|Protective Agents|protective agents|mesh-ancestor
154051762|NCT05018221|Antioxidants|antioxidants|mesh-ancestor
154051763|NCT05018221|Antitubercular Agents|antitubercular agents|mesh-ancestor
153782436|NCT00260364|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154051764|NCT05018221|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154051765|NCT05018221|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154051766|NCT05018221|Cathartics|cathartics|mesh-ancestor
154051767|NCT05018221|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154051768|NCT04984837|Gemcitabine|gemcitabine|mesh-list
154051769|NCT04984837|Oxaliplatin|oxaliplatin|mesh-list
154051770|NCT04984837|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154051771|NCT04984837|Antimetabolites|antimetabolites|mesh-ancestor
154051772|NCT04984837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154051773|NCT04984837|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154051774|NCT04983095|Hormones|hormones|mesh-list
154051775|NCT04983095|Androgens|androgens|mesh-list
154051776|NCT04983095|Hormone Antagonists|hormone antagonists|mesh-list
154051777|NCT04983095|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154051778|NCT04983095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154051779|NCT04920539|Dronabinol|dronabinol|mesh-list
154051780|NCT04920539|Hallucinogens|hallucinogens|mesh-ancestor
154051791|NCT04920539|Hormones|hormones|mesh-ancestor
154051794|NCT04894994|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154051795|NCT04894994|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154051796|NCT04894994|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153594462|NCT01849926|Amdinocillin|amdinocillin|mesh-list
154051797|NCT04894994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154051798|NCT04836910|Metformin|metformin|mesh-list
154051799|NCT04836910|Contraceptive Agents|contraceptive agents|mesh-list
154051800|NCT04836910|Contraceptives, Oral|contraceptives, oral|mesh-list
154051801|NCT04836910|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-list
154051802|NCT04836910|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154051803|NCT04836910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154051804|NCT04836910|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154051805|NCT04836910|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
154051806|NCT04800510|Carbon Fiber|carbon fiber|mesh-list
154051807|NCT04800510|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
154051808|NCT04800510|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154051809|NCT04774419|Dostarlimab|dostarlimab|mesh-list
154051810|NCT04774419|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154051811|NCT04773392|Mycophenolic Acid|mycophenolic acid|mesh-list
154051812|NCT04773392|Prednisone|prednisone|mesh-list
154051813|NCT04773392|Methylprednisolone|methylprednisolone|mesh-list
154051814|NCT04773392|Azathioprine|azathioprine|mesh-list
154051815|NCT04773392|Tacrolimus|tacrolimus|mesh-list
154051816|NCT04773392|Thymoglobulin|thymoglobulin|mesh-list
154051817|NCT04773392|Basiliximab|basiliximab|mesh-list
154051818|NCT04773392|Antilymphocyte Serum|antilymphocyte serum|mesh-list
154051819|NCT04773392|Antimetabolites|antimetabolites|mesh-list
154051820|NCT04773392|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154051821|NCT04773392|Glucocorticoids|glucocorticoids|mesh-ancestor
154051822|NCT04773392|Hormones|hormones|mesh-ancestor
154051826|NCT04773392|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154051841|NCT04773392|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
154051842|NCT04773392|Protective Agents|protective agents|mesh-ancestor
154051843|NCT04773392|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154051844|NCT04773392|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154051845|NCT04726085|Ibuprofen|ibuprofen|mesh-list
154051846|NCT04726085|Indomethacin|indomethacin|mesh-list
154051847|NCT04726085|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154051848|NCT04726085|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154051849|NCT04726085|Analgesics|analgesics|mesh-ancestor
154051850|NCT04726085|Sensory System Agents|sensory system agents|mesh-ancestor
154051851|NCT04726085|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154051852|NCT04726085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154051853|NCT04726085|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154051854|NCT04726085|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154051855|NCT04726085|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154051856|NCT04726085|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154051857|NCT04726085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154051858|NCT04726085|Gout Suppressants|gout suppressants|mesh-ancestor
154051859|NCT04726085|Tocolytic Agents|tocolytic agents|mesh-ancestor
154051860|NCT04726085|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154051861|NCT04713514|Pembrolizumab|pembrolizumab|mesh-list
154051862|NCT04713514|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154051863|NCT04713514|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154051864|NCT04713514|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154051865|NCT04713514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154051866|NCT04703686|Obinutuzumab|obinutuzumab|mesh-list
154051867|NCT04703686|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154051868|NCT04703686|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154051869|NCT04680910|Propofol|propofol|mesh-list
154051870|NCT04680910|Anesthetics|anesthetics|mesh-list
154051871|NCT04680910|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154051872|NCT04680910|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154051873|NCT04680910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154051874|NCT04680910|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154051875|NCT04680910|Anesthetics, General|anesthetics, general|mesh-ancestor
153573561|NCT00579527|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154051878|NCT04620759|Hallucinogens|hallucinogens|mesh-ancestor
154051879|NCT04620759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154051880|NCT04620759|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154051881|NCT04620759|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154051882|NCT04620759|Serotonin Agents|serotonin agents|mesh-ancestor
154051883|NCT04620759|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154051884|NCT04620759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154051885|NCT04620759|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
154051886|NCT04537403|1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid|1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid|mesh-list
154051887|NCT04537403|Chelating Agents|chelating agents|mesh-ancestor
154051888|NCT04537403|Sequestering Agents|sequestering agents|mesh-ancestor
154051889|NCT04537403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154051890|NCT04537026|Dexamethasone|dexamethasone|mesh-list
154051891|NCT04537026|Dexamethasone acetate|dexamethasone acetate|mesh-list
154051892|NCT04537026|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
154051893|NCT04537026|BB 1101|bb 1101|mesh-list
154051894|NCT04537026|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154051895|NCT04537026|Antiemetics|antiemetics|mesh-ancestor
154051896|NCT04537026|Autonomic Agents|autonomic agents|mesh-ancestor
154051897|NCT04537026|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154051898|NCT04537026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154051899|NCT04537026|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154051900|NCT04537026|Glucocorticoids|glucocorticoids|mesh-ancestor
154051901|NCT04537026|Hormones|hormones|mesh-ancestor
154051902|NCT04537026|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154051903|NCT04537026|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154051904|NCT04537026|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154051905|NCT04537026|Protease Inhibitors|protease inhibitors|mesh-ancestor
154051906|NCT04537026|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153573562|NCT01904123|Tyrphostins|tyrphostins|mesh-list
153573563|NCT01904123|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153573564|NCT01904123|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153573565|NCT01904123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153573566|NCT00576836|Parathyroid Hormone|parathyroid hormone|mesh-list
153573567|NCT00576836|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153573568|NCT00576836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153573569|NCT00531232|Clofarabine|clofarabine|mesh-list
153573570|NCT00531232|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153573571|NCT00531232|Antimetabolites|antimetabolites|mesh-ancestor
154051907|NCT04537026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154051909|NCT04524000|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154051910|NCT04524000|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154051911|NCT04524000|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
154051912|NCT04524000|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
154051913|NCT04524000|Hormone Antagonists|hormone antagonists|mesh-ancestor
154051914|NCT04524000|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154051915|NCT04524000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154051916|NCT04512235|Dexamethasone|dexamethasone|mesh-list
154051917|NCT04512235|Cyclophosphamide|cyclophosphamide|mesh-list
154051918|NCT04512235|Bortezomib|bortezomib|mesh-list
154051919|NCT04512235|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154051920|NCT04512235|Immunologic Factors|immunologic factors|mesh-ancestor
154051921|NCT04512235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154051922|NCT04512235|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154051923|NCT04512235|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154051924|NCT04512235|Alkylating Agents|alkylating agents|mesh-ancestor
154051925|NCT04512235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154051926|NCT04512235|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154051927|NCT04512235|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154051928|NCT04512235|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154051929|NCT04512235|Antiemetics|antiemetics|mesh-ancestor
154051930|NCT04512235|Autonomic Agents|autonomic agents|mesh-ancestor
154051931|NCT04512235|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154051932|NCT04512235|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154051933|NCT04512235|Glucocorticoids|glucocorticoids|mesh-ancestor
154051934|NCT04512235|Hormones|hormones|mesh-ancestor
154051936|NCT04512235|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154051952|NCT04469075|Glucocorticoids|glucocorticoids|mesh-ancestor
154051953|NCT04469075|Hormones|hormones|mesh-ancestor
154051954|NCT04469075|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154051955|NCT04469075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154051956|NCT04469075|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154051957|NCT04469075|Immunologic Factors|immunologic factors|mesh-ancestor
154051958|NCT04469075|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154051959|NCT04469075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154051960|NCT04469075|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154051961|NCT04469075|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154051962|NCT04469075|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
154051963|NCT04463615|Leflunomide|leflunomide|mesh-list
154051964|NCT04463615|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154051965|NCT04463615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154051966|NCT04463615|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154051967|NCT04463615|Immunologic Factors|immunologic factors|mesh-ancestor
154051968|NCT04463615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154051969|NCT04444492|Ranibizumab|ranibizumab|mesh-list
154051970|NCT04444492|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154051971|NCT04444492|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154051972|NCT04444492|Growth Substances|growth substances|mesh-ancestor
154051973|NCT04444492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154051974|NCT04444492|Growth Inhibitors|growth inhibitors|mesh-ancestor
154051975|NCT04444492|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154051976|NCT04442490|Zuranolone|zuranolone|mesh-list
154051977|NCT04442490|Antidepressive Agents|antidepressive agents|mesh-ancestor
154051978|NCT04442490|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154051979|NCT04393350|Pembrolizumab|pembrolizumab|mesh-list
154051980|NCT04393350|Lenvatinib|lenvatinib|mesh-list
154051981|NCT04393350|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154051987|NCT04361058|Nivolumab|nivolumab|mesh-list
154051995|NCT04341155|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154051997|NCT04341155|Autonomic Agents|autonomic agents|mesh-ancestor
154051998|NCT04341155|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154051999|NCT04341155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154052000|NCT04341155|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154052001|NCT04341155|Glucocorticoids|glucocorticoids|mesh-ancestor
154052002|NCT04341155|Hormones|hormones|mesh-ancestor
154052003|NCT04341155|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154052004|NCT04341155|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154052005|NCT04341155|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154052006|NCT04341155|Protease Inhibitors|protease inhibitors|mesh-ancestor
154052007|NCT04341155|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154052008|NCT04341155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154052009|NCT04339036|Capecitabine|capecitabine|mesh-list
154052010|NCT04339036|Temozolomide|temozolomide|mesh-list
154052011|NCT04339036|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154052012|NCT04339036|Antimetabolites|antimetabolites|mesh-ancestor
154052013|NCT04339036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154052014|NCT04339036|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154052015|NCT04339036|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154052016|NCT04339036|Alkylating Agents|alkylating agents|mesh-ancestor
154052017|NCT04315558|Bromides|bromides|mesh-list
154052018|NCT04315558|Ipratropium|ipratropium|mesh-list
154052019|NCT04315558|Anticonvulsants|anticonvulsants|mesh-ancestor
154052020|NCT04315558|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154052043|NCT04225598|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154052044|NCT04225598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154052045|NCT04225598|Analgesics|analgesics|mesh-ancestor
154052046|NCT04225598|Sensory System Agents|sensory system agents|mesh-ancestor
154052047|NCT04225598|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154052048|NCT04225598|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
154052049|NCT04217694|Memantine|memantine|mesh-list
154052050|NCT04217694|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
154052051|NCT04217694|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
154052052|NCT04217694|Dopamine Agents|dopamine agents|mesh-ancestor
154052053|NCT04217694|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154052054|NCT04217694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154052055|NCT04217694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154052056|NCT04217694|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154052057|NCT04217694|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154052058|NCT04214626|Prednisone|prednisone|mesh-list
154052059|NCT04214626|Cyclophosphamide|cyclophosphamide|mesh-list
154052060|NCT04214626|Rituximab|rituximab|mesh-list
154052061|NCT04214626|Methotrexate|methotrexate|mesh-list
154052062|NCT04214626|Vincristine|vincristine|mesh-list
154052063|NCT04214626|Lenalidomide|lenalidomide|mesh-list
154052064|NCT04214626|Epirubicin|epirubicin|mesh-list
154052065|NCT04214626|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154052066|NCT04214626|Immunologic Factors|immunologic factors|mesh-ancestor
154052067|NCT04214626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154052068|NCT04214626|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154052069|NCT04214626|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154052070|NCT04214626|Alkylating Agents|alkylating agents|mesh-ancestor
154052071|NCT04214626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154052072|NCT04214626|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154052073|NCT04214626|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154052074|NCT04214626|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154052075|NCT04214626|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154052076|NCT04214626|Glucocorticoids|glucocorticoids|mesh-ancestor
154052077|NCT04214626|Hormones|hormones|mesh-ancestor
154052078|NCT04214626|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153573572|NCT00531232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153816838|NCT00468351|Triamcinolone|triamcinolone|mesh-list
154052079|NCT04214626|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154052080|NCT04214626|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154052081|NCT04214626|Abortifacient Agents|abortifacient agents|mesh-ancestor
154052082|NCT04214626|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154052083|NCT04214626|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154052084|NCT04214626|Antimetabolites|antimetabolites|mesh-ancestor
154052085|NCT04214626|Dermatologic Agents|dermatologic agents|mesh-ancestor
154052086|NCT04214626|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154052087|NCT04214626|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154052088|NCT04214626|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154052089|NCT04214626|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154052090|NCT04214626|Tubulin Modulators|tubulin modulators|mesh-ancestor
154052091|NCT04214626|Antimitotic Agents|antimitotic agents|mesh-ancestor
154052092|NCT04214626|Mitosis Modulators|mitosis modulators|mesh-ancestor
154052093|NCT04214626|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154052094|NCT04214626|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154052095|NCT04214626|Growth Substances|growth substances|mesh-ancestor
154052096|NCT04214626|Growth Inhibitors|growth inhibitors|mesh-ancestor
154052097|NCT04214626|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154052098|NCT04214626|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154052100|NCT04209725|Quizartinib|quizartinib|mesh-list
154052101|NCT04209725|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154052102|NCT04209725|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154052103|NCT04209725|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154052104|NCT04209725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154052106|NCT04196868|Methotrexate|methotrexate|mesh-list
154052107|NCT04196868|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154052108|NCT04196868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154052109|NCT04196868|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154052110|NCT04196868|Abortifacient Agents|abortifacient agents|mesh-ancestor
154052111|NCT04196868|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154052112|NCT04196868|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154052113|NCT04196868|Antimetabolites|antimetabolites|mesh-ancestor
154052114|NCT04196868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154052118|NCT04196868|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154052119|NCT04196868|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154052120|NCT04196868|Immunologic Factors|immunologic factors|mesh-ancestor
154052121|NCT04196868|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154052122|NCT04196868|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154052124|NCT04179162|BCG Vaccine|bcg vaccine|mesh-list
154052125|NCT04179162|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154052126|NCT04179162|Antimetabolites|antimetabolites|mesh-ancestor
154052127|NCT04179162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154052128|NCT04179162|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154052129|NCT04179162|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154052130|NCT04179162|Immunologic Factors|immunologic factors|mesh-ancestor
154052131|NCT04179162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154052132|NCT04140162|Dexamethasone|dexamethasone|mesh-list
154052133|NCT04140162|Lenalidomide|lenalidomide|mesh-list
154052134|NCT04140162|Bortezomib|bortezomib|mesh-list
154052135|NCT04140162|Daratumumab|daratumumab|mesh-list
154052136|NCT04140162|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154052137|NCT04140162|Antiemetics|antiemetics|mesh-ancestor
154052138|NCT04140162|Autonomic Agents|autonomic agents|mesh-ancestor
154052139|NCT04140162|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154052140|NCT04140162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154052141|NCT04140162|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154052142|NCT04140162|Glucocorticoids|glucocorticoids|mesh-ancestor
154052143|NCT04140162|Hormones|hormones|mesh-ancestor
154052144|NCT04140162|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154052145|NCT04140162|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153816839|NCT00468351|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
153573573|NCT00531232|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153573574|NCT00066950|Chlorhexidine|chlorhexidine|mesh-list
153573575|NCT00066950|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
153573577|NCT00066950|Fluorides, Topical|fluorides, topical|mesh-list
153573578|NCT00066950|Cariostatic Agents|cariostatic agents|mesh-ancestor
153573579|NCT00066950|Protective Agents|protective agents|mesh-ancestor
153573580|NCT00066950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153573581|NCT00066950|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
153573582|NCT00066950|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153573583|NCT00066950|Disinfectants|disinfectants|mesh-ancestor
153573584|NCT00066950|Dermatologic Agents|dermatologic agents|mesh-ancestor
153573585|NCT01694134|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
153573586|NCT01694134|Methylprednisolone|methylprednisolone|mesh-list
153573587|NCT01694134|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
153573588|NCT01694134|Prednisolone|prednisolone|mesh-list
153573589|NCT01694134|Prednisolone acetate|prednisolone acetate|mesh-list
153573590|NCT01694134|Lidocaine|lidocaine|mesh-list
153573591|NCT01694134|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
154052147|NCT04140162|Immunologic Factors|immunologic factors|mesh-ancestor
154052148|NCT04140162|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154052149|NCT04140162|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154052150|NCT04140162|Growth Substances|growth substances|mesh-ancestor
154052151|NCT04140162|Growth Inhibitors|growth inhibitors|mesh-ancestor
154052152|NCT04038346|Acetaminophen|acetaminophen|mesh-list
154052154|NCT04038346|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154052155|NCT04038346|Analgesics|analgesics|mesh-ancestor
154052156|NCT04038346|Sensory System Agents|sensory system agents|mesh-ancestor
154052157|NCT04038346|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154052158|NCT04038346|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154052159|NCT04038346|Antipyretics|antipyretics|mesh-ancestor
154052160|NCT04038346|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154052161|NCT04038346|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154052162|NCT04038346|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154052163|NCT04038346|Gout Suppressants|gout suppressants|mesh-ancestor
154052164|NCT04038346|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154052165|NCT04038346|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154052166|NCT04038346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154052167|NCT04037176|Omalizumab|omalizumab|mesh-list
154052168|NCT04037176|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154052169|NCT04037176|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154052170|NCT04037176|Respiratory System Agents|respiratory system agents|mesh-ancestor
154052171|NCT04036305|Lidocaine|lidocaine|mesh-list
154052172|NCT04036305|Bupivacaine|bupivacaine|mesh-list
154052173|NCT04036305|Anesthetics, Local|anesthetics, local|mesh-ancestor
154052174|NCT04036305|Anesthetics|anesthetics|mesh-ancestor
154052175|NCT04036305|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154052176|NCT04036305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154052177|NCT04036305|Sensory System Agents|sensory system agents|mesh-ancestor
154052178|NCT04036305|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154052190|NCT03967977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154052191|NCT03967977|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154052192|NCT03820193|Acetaminophen|acetaminophen|mesh-list
154052194|NCT03820193|Ketorolac|ketorolac|mesh-list
154052195|NCT03820193|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
154052196|NCT03820193|Diazepam|diazepam|mesh-list
154052197|NCT03820193|Gabapentin|gabapentin|mesh-list
154052198|NCT03820193|Hydrocodone|hydrocodone|mesh-list
154052199|NCT03820193|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154052200|NCT03820193|Analgesics|analgesics|mesh-ancestor
154052201|NCT03820193|Sensory System Agents|sensory system agents|mesh-ancestor
154052202|NCT03820193|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154052203|NCT03820193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154052204|NCT03820193|Antipyretics|antipyretics|mesh-ancestor
154052205|NCT03820193|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154052206|NCT03820193|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154052207|NCT03820193|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153782437|NCT00260364|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154052208|NCT03820193|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
154052209|NCT03820193|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154052210|NCT03820193|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154052211|NCT03820193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154052212|NCT03820193|Anticonvulsants|anticonvulsants|mesh-ancestor
154052213|NCT03820193|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154052214|NCT03820193|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154052215|NCT03820193|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154052216|NCT03820193|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154052217|NCT03820193|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
154052218|NCT03820193|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
154052236|NCT03820193|GABA Agents|gaba agents|mesh-ancestor
154052250|NCT03763643|Rituximab|rituximab|mesh-list
154052251|NCT03763643|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154052252|NCT03763643|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154052253|NCT03763643|Immunologic Factors|immunologic factors|mesh-ancestor
154052254|NCT03763643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154052255|NCT03763643|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154052256|NCT03753204|Furosemide|furosemide|mesh-list
154052257|NCT03753204|Diuretics|diuretics|mesh-ancestor
154052258|NCT03753204|Natriuretic Agents|natriuretic agents|mesh-ancestor
154052259|NCT03753204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154052260|NCT03753204|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
154052261|NCT03753204|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154052262|NCT03753204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154052263|NCT03751709|Blinatumomab|blinatumomab|mesh-list
154052264|NCT03751709|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153573592|NCT01694134|Prednisolone phosphate|prednisolone phosphate|mesh-list
153573593|NCT01694134|Anesthetics, Local|anesthetics, local|mesh-ancestor
153573594|NCT01694134|Anesthetics|anesthetics|mesh-ancestor
153573595|NCT01694134|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153573596|NCT01694134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153573597|NCT01694134|Sensory System Agents|sensory system agents|mesh-ancestor
153573598|NCT01694134|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153573599|NCT01694134|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153573600|NCT01694134|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
153816840|NCT00468351|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
153816841|NCT00468351|Bevacizumab|bevacizumab|mesh-list
153816842|NCT00468351|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
153816843|NCT00468351|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153816844|NCT00468351|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153816845|NCT00468351|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153458186|NCT04407000|Antiviral Agents|antiviral agents|mesh-ancestor
153458187|NCT04407000|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153458188|NCT04192656|Methylprednisolone|methylprednisolone|mesh-list
153458189|NCT04192656|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
153458190|NCT04192656|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
153458191|NCT04192656|Prednisolone|prednisolone|mesh-list
153458192|NCT04192656|Prednisolone acetate|prednisolone acetate|mesh-list
153458193|NCT04192656|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
153458194|NCT04192656|Prednisolone phosphate|prednisolone phosphate|mesh-list
153458195|NCT04192656|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153458196|NCT04192656|Antiemetics|antiemetics|mesh-ancestor
153458197|NCT04192656|Autonomic Agents|autonomic agents|mesh-ancestor
153458198|NCT04192656|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153458199|NCT04192656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154052266|NCT03735979|Eptifibatide|eptifibatide|mesh-list
154052267|NCT03735979|Antithrombins|antithrombins|mesh-ancestor
154052268|NCT03735979|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
154052269|NCT03735979|Protease Inhibitors|protease inhibitors|mesh-ancestor
154052270|NCT03735979|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154052271|NCT03735979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154052272|NCT03735979|Anticoagulants|anticoagulants|mesh-ancestor
154052273|NCT03735979|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153782438|NCT04557007|Pembrolizumab|pembrolizumab|mesh-list
154052274|NCT03732352|Deoxyglucose|deoxyglucose|mesh-list
154052275|NCT03732352|Osimertinib|osimertinib|mesh-list
154052276|NCT03732352|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
154052277|NCT03732352|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
154052278|NCT03732352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154052279|NCT03732352|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154052280|NCT03732352|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154052281|NCT03732352|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154052282|NCT03732352|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154052283|NCT03732352|Antimetabolites|antimetabolites|mesh-ancestor
154052284|NCT03732352|Antiviral Agents|antiviral agents|mesh-ancestor
154052285|NCT03732352|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154052286|NCT03676764|Azithromycin|azithromycin|mesh-list
154052287|NCT03676764|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154052288|NCT03676764|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154052289|NCT03667482|Cetuximab|cetuximab|mesh-list
154052290|NCT03667482|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154052291|NCT03667482|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154052292|NCT03650387|Lidocaine|lidocaine|mesh-list
154052293|NCT03650387|Anesthetics, Local|anesthetics, local|mesh-ancestor
154052294|NCT03650387|Anesthetics|anesthetics|mesh-ancestor
154052295|NCT03650387|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154052296|NCT03650387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154052297|NCT03650387|Sensory System Agents|sensory system agents|mesh-ancestor
154052298|NCT03650387|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154052299|NCT03650387|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154052300|NCT03650387|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154052301|NCT03650387|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153458200|NCT04192656|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153573601|NCT01694134|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154052302|NCT03650387|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154052303|NCT03650387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154052305|NCT03638141|Ipilimumab|ipilimumab|mesh-list
154052306|NCT03638141|Tremelimumab|tremelimumab|mesh-list
154052307|NCT03638141|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154052308|NCT03638141|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154052309|NCT03638141|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154052310|NCT03638141|Immunologic Factors|immunologic factors|mesh-ancestor
154052311|NCT03638141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154052312|NCT03638141|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154052313|NCT03638141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154052314|NCT03618758|Paclitaxel|paclitaxel|mesh-list
154052315|NCT03618758|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154052316|NCT03618758|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154052317|NCT03618758|Tubulin Modulators|tubulin modulators|mesh-ancestor
154052318|NCT03618758|Antimitotic Agents|antimitotic agents|mesh-ancestor
154052319|NCT03618758|Mitosis Modulators|mitosis modulators|mesh-ancestor
154052320|NCT03618758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154052321|NCT03618550|Gemcitabine|gemcitabine|mesh-list
154052322|NCT03618550|Doxorubicin|doxorubicin|mesh-list
154052323|NCT03618550|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
154052324|NCT03618550|Pembrolizumab|pembrolizumab|mesh-list
154052325|NCT03618550|Vinorelbine|vinorelbine|mesh-list
154052326|NCT03618550|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154052327|NCT03618550|Antimetabolites|antimetabolites|mesh-ancestor
154052328|NCT03618550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154052329|NCT03618550|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154052330|NCT03618550|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153573602|NCT01694134|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153573613|NCT01694134|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153573614|NCT01694134|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153573616|NCT01694212|Ophthalmic Solutions|ophthalmic solutions|mesh-list
153573617|NCT01694212|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
153573618|NCT01694212|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153573619|NCT01694212|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153573620|NCT01694212|Analgesics|analgesics|mesh-ancestor
153573621|NCT01694212|Sensory System Agents|sensory system agents|mesh-ancestor
153573622|NCT01694212|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153573623|NCT01694212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153573624|NCT01694212|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153458201|NCT04192656|Glucocorticoids|glucocorticoids|mesh-ancestor
153458202|NCT04192656|Hormones|hormones|mesh-ancestor
154052331|NCT03618550|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154052332|NCT03618550|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154052333|NCT03618550|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154052334|NCT03618550|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154052335|NCT03618550|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154052336|NCT03618550|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154052337|NCT03618550|Tubulin Modulators|tubulin modulators|mesh-ancestor
154052338|NCT03618550|Antimitotic Agents|antimitotic agents|mesh-ancestor
154052339|NCT03618550|Mitosis Modulators|mitosis modulators|mesh-ancestor
154052340|NCT03611738|Docetaxel|docetaxel|mesh-list
154052341|NCT03611738|Ceritinib|ceritinib|mesh-list
154052342|NCT03611738|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-list
154052343|NCT03611738|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154052344|NCT03611738|Tubulin Modulators|tubulin modulators|mesh-ancestor
154052345|NCT03611738|Antimitotic Agents|antimitotic agents|mesh-ancestor
154052346|NCT03611738|Mitosis Modulators|mitosis modulators|mesh-ancestor
154052347|NCT03611738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154052348|NCT03611738|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154052349|NCT03611738|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154052350|NCT03595917|Prednisone|prednisone|mesh-list
154052351|NCT03595917|Dasatinib|dasatinib|mesh-list
154052352|NCT03595917|Blinatumomab|blinatumomab|mesh-list
154052353|NCT03595917|Asciminib|asciminib|mesh-list
154052354|NCT03595917|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154052355|NCT03595917|Glucocorticoids|glucocorticoids|mesh-ancestor
154052356|NCT03595917|Hormones|hormones|mesh-ancestor
154052357|NCT03595917|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154052358|NCT03595917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154052367|NCT03524235|Rituximab|rituximab|mesh-list
154052379|NCT03462342|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
154052381|NCT03462342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154052382|NCT03462342|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154052383|NCT03461445|Tacrolimus|tacrolimus|mesh-list
154052384|NCT03461445|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154052385|NCT03461445|Immunologic Factors|immunologic factors|mesh-ancestor
154052386|NCT03461445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154052387|NCT03461445|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
154052388|NCT03461445|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154052389|NCT03461445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154052390|NCT03436862|Nivolumab|nivolumab|mesh-list
154052391|NCT03436862|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154052392|NCT03436862|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154052393|NCT03436862|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154052394|NCT03436862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154052395|NCT03334617|Trastuzumab|trastuzumab|mesh-list
154052396|NCT03334617|Durvalumab|durvalumab|mesh-list
154052397|NCT03334617|Olaparib|olaparib|mesh-list
154052398|NCT03334617|Cediranib|cediranib|mesh-list
154052399|NCT03334617|Trastuzumab deruxtecan|trastuzumab deruxtecan|mesh-list
153595064|NCT01854203|Cisplatin|cisplatin|mesh-list
154052400|NCT03334617|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154052401|NCT03334617|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153573625|NCT01694212|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153573626|NCT01694212|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153573627|NCT01694212|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153573628|NCT01694212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153573629|NCT01694264|Entecavir|entecavir|mesh-list
153573630|NCT01694264|Antiviral Agents|antiviral agents|mesh-ancestor
153573631|NCT01694264|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153573632|NCT01694355|Vitamin D|vitamin d|mesh-list
153573633|NCT01694355|Vitamins|vitamins|mesh-ancestor
153573634|NCT01694355|Micronutrients|micronutrients|mesh-ancestor
153573635|NCT01694355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153573636|NCT01694355|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153573637|NCT01694381|Complement C1 Inhibitor Protein|complement c1 inhibitor protein|mesh-list
153573638|NCT01694381|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
153573639|NCT01694381|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153573640|NCT01694381|Immunologic Factors|immunologic factors|mesh-ancestor
153573641|NCT01694381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153573642|NCT01694407|Tenofovir|tenofovir|mesh-list
153816854|NCT00468351|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153816855|NCT00468351|Immunologic Factors|immunologic factors|mesh-ancestor
153816856|NCT00468351|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153816857|NCT00468351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153816858|NCT00459654|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
153816859|NCT00459654|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153816860|NCT00468429|Bevacizumab|bevacizumab|mesh-list
153816861|NCT00468429|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154052402|NCT03334617|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
154052403|NCT03334617|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154052404|NCT03334617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154052405|NCT03334617|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154052407|NCT03334617|Immunologic Factors|immunologic factors|mesh-ancestor
154052408|NCT03334617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154052409|NCT03329313|Dialysis Solutions|dialysis solutions|mesh-list
154052410|NCT03329313|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
154052411|NCT03298802|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
154052412|NCT03298802|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154052413|NCT03298802|Diuretics|diuretics|mesh-ancestor
154052414|NCT03298802|Natriuretic Agents|natriuretic agents|mesh-ancestor
154052415|NCT03298802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154052416|NCT03298802|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
154052417|NCT03298802|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154052418|NCT03298802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154052419|NCT03202316|Atezolizumab|atezolizumab|mesh-list
154052420|NCT03202316|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154052421|NCT03202316|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154052422|NCT03202316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154052423|NCT03202316|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154052424|NCT03202316|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154052425|NCT03202316|Immunologic Factors|immunologic factors|mesh-ancestor
154052426|NCT03202316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154052428|NCT03131765|Antiviral Agents|antiviral agents|mesh-ancestor
154052429|NCT03131765|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154052430|NCT03131765|Interferon Inducers|interferon inducers|mesh-ancestor
154052431|NCT03131765|Immunologic Factors|immunologic factors|mesh-ancestor
154052432|NCT03131765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154052433|NCT03095781|Pembrolizumab|pembrolizumab|mesh-list
154052434|NCT03095781|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154052435|NCT03095781|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154052436|NCT03095781|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154052439|NCT02960555|Immunologic Factors|immunologic factors|mesh-ancestor
154052440|NCT02960555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154052441|NCT02887248|Paclitaxel|paclitaxel|mesh-list
154052442|NCT02887248|Gemcitabine|gemcitabine|mesh-list
154052443|NCT02887248|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154052444|NCT02887248|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154052445|NCT02887248|Tubulin Modulators|tubulin modulators|mesh-ancestor
154052446|NCT02887248|Antimitotic Agents|antimitotic agents|mesh-ancestor
154052447|NCT02887248|Mitosis Modulators|mitosis modulators|mesh-ancestor
154052448|NCT02887248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153731171|NCT00136565|Immunologic Factors|immunologic factors|mesh-ancestor
154052454|NCT02873962|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154052455|NCT02873962|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154052456|NCT02873962|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154052457|NCT02873962|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154052458|NCT02873962|Growth Substances|growth substances|mesh-ancestor
154052459|NCT02873962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154052460|NCT02873962|Growth Inhibitors|growth inhibitors|mesh-ancestor
154052461|NCT02873962|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154052462|NCT02873962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154052463|NCT02873962|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
154052464|NCT02873962|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154052465|NCT02859064|Lanreotide|lanreotide|mesh-list
154052466|NCT02859064|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154052467|NCT02843074|Dexamethasone|dexamethasone|mesh-list
153458203|NCT04192656|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153458204|NCT04192656|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
153458205|NCT04192656|Protective Agents|protective agents|mesh-ancestor
153458206|NCT04192656|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153573643|NCT01694407|Emtricitabine|emtricitabine|mesh-list
153573644|NCT01694407|Antiviral Agents|antiviral agents|mesh-ancestor
153573645|NCT01694407|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153573646|NCT01694407|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153573647|NCT01694407|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153573648|NCT01694407|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153573649|NCT01694407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153573650|NCT01694407|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153573651|NCT01694407|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153573652|NCT01694459|Heparin|heparin|mesh-list
153573653|NCT01694459|Calcium heparin|calcium heparin|mesh-list
153573654|NCT01694459|Anticoagulants|anticoagulants|mesh-ancestor
153573655|NCT01694459|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153573656|NCT01694459|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153573657|NCT01694459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153573658|NCT01694498|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
153573659|NCT01694498|Hemostatics|hemostatics|mesh-ancestor
153573660|NCT01694498|Coagulants|coagulants|mesh-ancestor
153573661|NCT01694498|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
154052468|NCT02843074|Lenalidomide|lenalidomide|mesh-list
154052469|NCT02843074|Elotuzumab|elotuzumab|mesh-list
154052470|NCT02843074|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154052471|NCT02843074|Antiemetics|antiemetics|mesh-ancestor
154052472|NCT02843074|Autonomic Agents|autonomic agents|mesh-ancestor
154052473|NCT02843074|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154052474|NCT02843074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154052475|NCT02843074|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154052476|NCT02843074|Glucocorticoids|glucocorticoids|mesh-ancestor
154052477|NCT02843074|Hormones|hormones|mesh-ancestor
154052478|NCT02843074|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154052479|NCT02843074|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154052480|NCT02843074|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154052481|NCT02843074|Immunologic Factors|immunologic factors|mesh-ancestor
154052482|NCT02843074|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154052483|NCT02843074|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154052484|NCT02843074|Growth Substances|growth substances|mesh-ancestor
154052485|NCT02843074|Growth Inhibitors|growth inhibitors|mesh-ancestor
154052486|NCT02795156|Afatinib|afatinib|mesh-list
153573662|NCT01694498|Natriuretic Agents|natriuretic agents|mesh-ancestor
153573663|NCT01694498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153573664|NCT01694576|Paclitaxel|paclitaxel|mesh-list
153573665|NCT01694576|Nedaplatin|nedaplatin|mesh-list
153573666|NCT01694576|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153573667|NCT01694576|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153573668|NCT01694576|Tubulin Modulators|tubulin modulators|mesh-ancestor
153573669|NCT01694576|Antimitotic Agents|antimitotic agents|mesh-ancestor
153573670|NCT01694576|Mitosis Modulators|mitosis modulators|mesh-ancestor
153573671|NCT01694576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153573672|NCT01694693|Abatacept|abatacept|mesh-list
153573673|NCT01694693|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153458207|NCT04192656|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153458208|NCT04191954|Fasudil|fasudil|mesh-list
153458209|NCT04191954|Ophthalmic Solutions|ophthalmic solutions|mesh-list
153458210|NCT04191954|Lubricant Eye Drops|lubricant eye drops|mesh-list
153458211|NCT04191954|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
153458212|NCT04191954|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153458213|NCT04191954|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153458214|NCT04191954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153458215|NCT04191954|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153458216|NCT04191954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153458217|NCT04191954|Vasodilator Agents|vasodilator agents|mesh-ancestor
153458218|NCT04191954|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153458219|NCT04191954|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153573674|NCT01694693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153573684|NCT01694732|Cholinergic Agents|cholinergic agents|mesh-ancestor
153573685|NCT01694732|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153573686|NCT01694732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153573687|NCT01694732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153573689|NCT01694797|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153573690|NCT01694797|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153573691|NCT01694797|Sympatholytics|sympatholytics|mesh-ancestor
153573692|NCT01694797|Autonomic Agents|autonomic agents|mesh-ancestor
153573693|NCT01694797|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153573694|NCT01694797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154052487|NCT02795156|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154052488|NCT02795156|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154052489|NCT02795156|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154052490|NCT02795156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154052491|NCT02795156|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154052496|NCT02649673|Topotecan|topotecan|mesh-list
154052497|NCT02649673|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
154052498|NCT02649673|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154052499|NCT02649673|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154052500|NCT02649673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154052501|NCT02649673|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154052502|NCT02642094|Sirolimus|sirolimus|mesh-list
154052503|NCT02642094|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154052504|NCT02642094|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154052505|NCT02642094|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154052506|NCT02642094|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154052507|NCT02642094|Antifungal Agents|antifungal agents|mesh-ancestor
154052508|NCT02642094|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154052509|NCT02642094|Immunologic Factors|immunologic factors|mesh-ancestor
154052510|NCT02642094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154052511|NCT02636582|Molgramostim|molgramostim|mesh-list
154052512|NCT02636582|Vaccines|vaccines|mesh-list
154052513|NCT02636582|Sargramostim|sargramostim|mesh-list
154052514|NCT02636582|Immunologic Factors|immunologic factors|mesh-ancestor
154052515|NCT02636582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154052516|NCT02636582|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154052517|NCT02627443|Carboplatin|carboplatin|mesh-list
154052518|NCT02627443|Gemcitabine|gemcitabine|mesh-list
154052519|NCT02627443|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154052520|NCT02627443|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154052521|NCT02627443|Antimetabolites|antimetabolites|mesh-ancestor
154052522|NCT02627443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154052523|NCT02616666|Dapagliflozin|dapagliflozin|mesh-list
153731172|NCT00136565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154052530|NCT02598726|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154052531|NCT02598726|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154052532|NCT02598726|Analgesics|analgesics|mesh-ancestor
154052533|NCT02598726|Sensory System Agents|sensory system agents|mesh-ancestor
154052534|NCT02598726|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154052535|NCT02598726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154052536|NCT02598726|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154052537|NCT02598726|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154052538|NCT02598726|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154052539|NCT02598726|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154052540|NCT02598726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154052541|NCT02598726|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154052542|NCT02578914|Ophthalmic Solutions|ophthalmic solutions|mesh-list
154052543|NCT02578914|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
154052544|NCT02509546|Adenosine|adenosine|mesh-list
154052545|NCT02509546|Analgesics|analgesics|mesh-ancestor
154052546|NCT02509546|Sensory System Agents|sensory system agents|mesh-ancestor
154052547|NCT02509546|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154052548|NCT02509546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154052549|NCT02509546|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154052550|NCT02509546|Vasodilator Agents|vasodilator agents|mesh-ancestor
154052551|NCT02509546|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
154052552|NCT02509546|Purinergic Agonists|purinergic agonists|mesh-ancestor
154052553|NCT02509546|Purinergic Agents|purinergic agents|mesh-ancestor
154052554|NCT02509546|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154052555|NCT02509546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154052556|NCT02501954|Paclitaxel|paclitaxel|mesh-list
154052578|NCT02394834|Growth Inhibitors|growth inhibitors|mesh-ancestor
154052579|NCT02394834|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154052580|NCT02394834|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154052581|NCT02394834|Antimetabolites|antimetabolites|mesh-ancestor
154052582|NCT02394834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154052583|NCT02394834|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154052584|NCT02394834|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154052585|NCT02394834|Immunologic Factors|immunologic factors|mesh-ancestor
154052586|NCT02394834|Antidotes|antidotes|mesh-ancestor
154052587|NCT02394834|Protective Agents|protective agents|mesh-ancestor
154052588|NCT02394834|Vitamin B Complex|vitamin b complex|mesh-ancestor
154052590|NCT02394834|Micronutrients|micronutrients|mesh-ancestor
154052591|NCT02170090|Gemcitabine|gemcitabine|mesh-list
154052592|NCT02170090|Capecitabine|capecitabine|mesh-list
154052593|NCT02170090|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154052594|NCT02170090|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154052595|NCT02170090|Antimetabolites|antimetabolites|mesh-ancestor
154052596|NCT02170090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154052597|NCT01947023|Lapatinib|lapatinib|mesh-list
154052598|NCT01947023|Dabrafenib|dabrafenib|mesh-list
154052599|NCT01947023|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154052600|NCT01947023|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154052601|NCT01947023|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154052602|NCT01947023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154052603|NCT01947023|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154052604|NCT01897454|Calcium, Dietary|calcium, dietary|mesh-list
154052622|NCT01897454|Immunologic Factors|immunologic factors|mesh-ancestor
154052623|NCT01897454|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
154052624|NCT01897454|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154052625|NCT01897454|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154052627|NCT01897454|Protective Agents|protective agents|mesh-ancestor
154052628|NCT01897454|Vitamin B Complex|vitamin b complex|mesh-ancestor
154052629|NCT01897454|Vitamins|vitamins|mesh-ancestor
154052630|NCT01897454|Micronutrients|micronutrients|mesh-ancestor
154052631|NCT01897454|Hematinics|hematinics|mesh-ancestor
154052632|NCT01897454|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154052633|NCT01865110|Prednisone|prednisone|mesh-list
154052634|NCT01865110|Rituximab|rituximab|mesh-list
154052635|NCT01865110|Lenalidomide|lenalidomide|mesh-list
154052636|NCT01865110|Cyclophosphamide|cyclophosphamide|mesh-list
154052637|NCT01865110|Vincristine|vincristine|mesh-list
154052638|NCT01865110|Doxorubicin|doxorubicin|mesh-list
154052639|NCT01865110|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154052640|NCT01865110|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154052641|NCT01865110|Immunologic Factors|immunologic factors|mesh-ancestor
154052642|NCT01865110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154052643|NCT01865110|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154052644|NCT01865110|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154052645|NCT01865110|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154052646|NCT01865110|Growth Substances|growth substances|mesh-ancestor
154052647|NCT01865110|Growth Inhibitors|growth inhibitors|mesh-ancestor
154052648|NCT01865110|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154052649|NCT01865110|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154052650|NCT01865110|Alkylating Agents|alkylating agents|mesh-ancestor
154052651|NCT01865110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154052652|NCT01865110|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154052653|NCT01865110|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154052654|NCT01865110|Glucocorticoids|glucocorticoids|mesh-ancestor
154052655|NCT01865110|Hormones|hormones|mesh-ancestor
154052656|NCT01865110|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154052663|NCT01865110|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154052664|NCT01865110|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154052666|NCT01856023|Aldesleukin|aldesleukin|mesh-list
154052667|NCT01856023|Ipilimumab|ipilimumab|mesh-list
154052668|NCT01856023|Interleukin-2|interleukin-2|mesh-list
154052669|NCT01856023|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154052670|NCT01856023|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154052671|NCT01856023|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154052672|NCT01856023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154052673|NCT01856023|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154052674|NCT01856023|Analgesics|analgesics|mesh-ancestor
154052675|NCT01856023|Sensory System Agents|sensory system agents|mesh-ancestor
154052676|NCT01856023|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154052677|NCT01856023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154052678|NCT01856023|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154052679|NCT01856023|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154052680|NCT01856023|Antiviral Agents|antiviral agents|mesh-ancestor
154052681|NCT01856023|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154052683|NCT01815359|Mitomycins|mitomycins|mesh-list
154052684|NCT01815359|Mitomycin|mitomycin|mesh-list
154052685|NCT01815359|Antidotes|antidotes|mesh-ancestor
154052686|NCT01815359|Protective Agents|protective agents|mesh-ancestor
154052687|NCT01815359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154052688|NCT01815359|Vitamin B Complex|vitamin b complex|mesh-ancestor
154052689|NCT01815359|Vitamins|vitamins|mesh-ancestor
154052690|NCT01815359|Micronutrients|micronutrients|mesh-ancestor
154052692|NCT01815359|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154052712|NCT01787487|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154052713|NCT01787487|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154052714|NCT01751425|Imatinib Mesylate|imatinib mesylate|mesh-list
154052715|NCT01751425|Dasatinib|dasatinib|mesh-list
154052716|NCT01751425|Nilotinib|nilotinib|mesh-list
154052717|NCT01751425|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-list
154052718|NCT01751425|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154052719|NCT01751425|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154052720|NCT01751425|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154052721|NCT01751425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154052722|NCT01751425|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154052723|NCT01393756|Lenalidomide|lenalidomide|mesh-list
154052724|NCT01393756|Immunologic Factors|immunologic factors|mesh-ancestor
154052725|NCT01393756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154052726|NCT01393756|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154052727|NCT01393756|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154052728|NCT01393756|Growth Substances|growth substances|mesh-ancestor
154052729|NCT01393756|Growth Inhibitors|growth inhibitors|mesh-ancestor
154052730|NCT01393756|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154052731|NCT01364597|Brivaracetam|brivaracetam|mesh-list
154052732|NCT01364597|Anticonvulsants|anticonvulsants|mesh-ancestor
154052733|NCT01311648|Factor VIII|factor viii|mesh-list
154052734|NCT01311648|Coagulants|coagulants|mesh-ancestor
154052735|NCT00758342|Travoprost|travoprost|mesh-list
154052736|NCT00758342|Brinzolamide|brinzolamide|mesh-list
154052737|NCT00758342|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154052738|NCT00758342|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
154052739|NCT00758342|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154052740|NCT00758342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154052741|NCT00470704|Trastuzumab|trastuzumab|mesh-list
154052742|NCT00470704|Lapatinib|lapatinib|mesh-list
154052743|NCT00470704|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154052744|NCT00470704|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154052755|NCT00144196|Respiratory System Agents|respiratory system agents|mesh-ancestor
154052756|NCT00144196|Parasympatholytics|parasympatholytics|mesh-ancestor
154052757|NCT00144196|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154052758|NCT00144196|Cholinergic Agents|cholinergic agents|mesh-ancestor
154052759|NCT00144196|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154052760|NCT00144196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154052761|NCT04152356|Sorafenib|sorafenib|mesh-list
154052762|NCT04152356|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154052763|NCT04152356|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154052764|NCT04152356|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154052765|NCT04152356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154052766|NCT04271956|Tislelizumab|tislelizumab|mesh-list
154052767|NCT04271956|Zanubrutinib|zanubrutinib|mesh-list
154052768|NCT04271956|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154052769|NCT04271956|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154052770|NCT04271956|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154052771|NCT04271956|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154052772|NCT04271956|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154052773|NCT04271956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154052774|NCT02628080|Atovaquone|atovaquone|mesh-list
154052775|NCT02628080|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154052776|NCT02628080|Antimalarials|antimalarials|mesh-ancestor
154052777|NCT02628080|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154052778|NCT02628080|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154052779|NCT02628080|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154052780|NCT02628080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154052781|NCT00678236|Gentamicins|gentamicins|mesh-list
154052782|NCT00678236|Cimetidine|cimetidine|mesh-list
154052783|NCT00678236|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154052784|NCT00678236|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154052785|NCT00678236|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
154052786|NCT00678236|Histamine Antagonists|histamine antagonists|mesh-ancestor
153573695|NCT01694797|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
153573696|NCT01694797|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
153458220|NCT04192032|Nicotine|nicotine|mesh-list
153458221|NCT04192032|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
153458222|NCT04192032|Autonomic Agents|autonomic agents|mesh-ancestor
153458223|NCT04192032|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153458224|NCT04192032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153458225|NCT04192032|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
153458226|NCT04192032|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
153458227|NCT04192032|Cholinergic Agents|cholinergic agents|mesh-ancestor
153458228|NCT04192032|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154052787|NCT00678236|Histamine Agents|histamine agents|mesh-ancestor
154052788|NCT00678236|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154052789|NCT00678236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154052790|NCT00678236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154052791|NCT00678236|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
154052792|NCT00678236|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154052793|NCT00678236|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154052794|NCT00678236|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154052795|NCT00678236|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154052796|NCT00678236|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
154052797|NCT00678314|Ropivacaine|ropivacaine|mesh-list
154052798|NCT00678314|Anesthetics, Local|anesthetics, local|mesh-ancestor
154052799|NCT00678314|Anesthetics|anesthetics|mesh-ancestor
154052800|NCT00678314|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154052801|NCT00678314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154052802|NCT00678314|Sensory System Agents|sensory system agents|mesh-ancestor
154052803|NCT00678314|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154052804|NCT02566720|Amantadine|amantadine|mesh-list
154052805|NCT02566720|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
154052806|NCT02566720|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
154052807|NCT02566720|Antiviral Agents|antiviral agents|mesh-ancestor
154052808|NCT02566720|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154052809|NCT02566720|Dopamine Agents|dopamine agents|mesh-ancestor
154052810|NCT02566720|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154052811|NCT02566720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154052812|NCT02566720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154052813|NCT02566720|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154052814|NCT02566720|Analgesics|analgesics|mesh-ancestor
154052815|NCT02566720|Sensory System Agents|sensory system agents|mesh-ancestor
154052816|NCT02566720|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154052817|NCT00675194|Capecitabine|capecitabine|mesh-list
154052818|NCT00675194|Irinotecan|irinotecan|mesh-list
154052821|NCT00675194|Antimetabolites|antimetabolites|mesh-ancestor
154052828|NCT00665522|Narcotics|narcotics|mesh-ancestor
154052829|NCT00665522|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154052830|NCT00665522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154052831|NCT00665522|Analgesics|analgesics|mesh-ancestor
154052832|NCT00665522|Sensory System Agents|sensory system agents|mesh-ancestor
154052833|NCT00665522|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154052834|NCT00665522|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154052835|NCT00665522|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154052836|NCT00665522|Anesthetics, General|anesthetics, general|mesh-ancestor
154052837|NCT00665522|Anesthetics|anesthetics|mesh-ancestor
154052838|NCT00675272|Hydrocortisone|hydrocortisone|mesh-list
154052839|NCT00675272|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154052840|NCT00678626|Docetaxel|docetaxel|mesh-list
154052841|NCT00678626|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154052842|NCT00678626|Tubulin Modulators|tubulin modulators|mesh-ancestor
154052843|NCT00678626|Antimitotic Agents|antimitotic agents|mesh-ancestor
154052844|NCT00678626|Mitosis Modulators|mitosis modulators|mesh-ancestor
154052845|NCT00678626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154052846|NCT00678704|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
154052847|NCT00678704|Vasodilator Agents|vasodilator agents|mesh-ancestor
154052848|NCT00678704|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
154052850|NCT00678704|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154052880|NCT00675350|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
154052881|NCT00675350|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154052882|NCT00675350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154052883|NCT02565862|Metformin|metformin|mesh-list
154052884|NCT02565862|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154052885|NCT02565862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154052886|NCT04060888|Ustekinumab|ustekinumab|mesh-list
154052887|NCT04060888|Dermatologic Agents|dermatologic agents|mesh-ancestor
154052888|NCT00879398|Fesoterodine|fesoterodine|mesh-list
154052889|NCT00879398|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
154052890|NCT00879398|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154052891|NCT00879398|Cholinergic Agents|cholinergic agents|mesh-ancestor
154052892|NCT00879398|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154052893|NCT00879398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154052894|NCT00879398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154052895|NCT00879398|Urological Agents|urological agents|mesh-ancestor
154052896|NCT00679250|Cetirizine|cetirizine|mesh-list
154052897|NCT00679250|Levocetirizine|levocetirizine|mesh-list
154052898|NCT00679250|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
154052899|NCT00679250|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
154052900|NCT00679250|Histamine Antagonists|histamine antagonists|mesh-ancestor
154052901|NCT00679250|Histamine Agents|histamine agents|mesh-ancestor
154052902|NCT00679250|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154052903|NCT00679250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154052904|NCT00679250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154052905|NCT00679250|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
154052906|NCT00696436|Valsartan|valsartan|mesh-list
154052907|NCT00696436|Olmesartan|olmesartan|mesh-list
154052908|NCT00696436|Azilsartan medoxomil|azilsartan medoxomil|mesh-list
154052909|NCT00696436|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154052910|NCT00696436|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
154052911|NCT00696436|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
153816862|NCT00468429|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153816863|NCT00468429|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153816864|NCT00468429|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153816865|NCT00468429|Growth Substances|growth substances|mesh-ancestor
153816866|NCT00468429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153573697|NCT01694797|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
153573698|NCT01694797|Adrenergic Agents|adrenergic agents|mesh-ancestor
153573699|NCT01694797|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153573700|NCT01694797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153573701|NCT01695005|Prednisone|prednisone|mesh-list
153573702|NCT01695005|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154052912|NCT00696436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154052914|NCT00878072|Antiviral Agents|antiviral agents|mesh-ancestor
154052915|NCT00878072|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154052916|NCT00878072|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154052917|NCT00878072|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154052918|NCT00878072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154052919|NCT00675740|Rosiglitazone|rosiglitazone|mesh-list
154052920|NCT00675740|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154052921|NCT00675740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154052922|NCT03045341|Naltrexone|naltrexone|mesh-list
154052923|NCT03045341|Bupropion|bupropion|mesh-list
154052924|NCT03045341|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
154052925|NCT03045341|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
154052926|NCT03045341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153595595|NCT01857154|Calcium Carbonate|calcium carbonate|mesh-list
154052927|NCT03045341|Sensory System Agents|sensory system agents|mesh-ancestor
154052928|NCT03045341|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154052929|NCT03045341|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
154052930|NCT03045341|Antidepressive Agents|antidepressive agents|mesh-ancestor
154052931|NCT03045341|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154052932|NCT03045341|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
154052933|NCT03045341|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154052934|NCT03045341|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154052935|NCT03045341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154052936|NCT03045341|Dopamine Agents|dopamine agents|mesh-ancestor
153418743|NCT03035929|Hormones|hormones|mesh-ancestor
154052937|NCT03045341|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154052938|NCT03045341|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
154052939|NCT03045341|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154052941|NCT00679484|Candesartan|candesartan|mesh-list
154052953|NCT00679640|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
154052954|NCT00679640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154052956|NCT00921388|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
154052957|NCT00921388|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
154052958|NCT00921388|Cholinergic Agents|cholinergic agents|mesh-ancestor
154052959|NCT00921388|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154052960|NCT00921388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154052961|NCT00921388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154052962|NCT04212065|Buprenorphine|buprenorphine|mesh-list
154052963|NCT04212065|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154052964|NCT04212065|Narcotics|narcotics|mesh-ancestor
154052965|NCT04212065|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154052966|NCT04212065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154052967|NCT04212065|Analgesics|analgesics|mesh-ancestor
154052968|NCT04212065|Sensory System Agents|sensory system agents|mesh-ancestor
154052969|NCT04212065|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154052970|NCT04212065|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
154052971|NCT02627534|Anti-Infective Agents|anti-infective agents|mesh-list
154052972|NCT02627534|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
154052973|NCT02627456|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
154052974|NCT02627456|Antimalarials|antimalarials|mesh-ancestor
154052975|NCT02627456|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154052976|NCT02627456|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154052977|NCT02627456|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154052978|NCT00617513|Prucalopride|prucalopride|mesh-list
154052979|NCT00617513|Laxatives|laxatives|mesh-ancestor
154052980|NCT00617513|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154052981|NCT00617513|Serotonin 5-HT4 Receptor Agonists|serotonin 5-ht4 receptor agonists|mesh-ancestor
154052982|NCT00617513|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
154052983|NCT00617513|Serotonin Agents|serotonin agents|mesh-ancestor
154052984|NCT00617513|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154052985|NCT00617513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154052986|NCT00617513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153573703|NCT01695005|Glucocorticoids|glucocorticoids|mesh-ancestor
153573704|NCT01695005|Hormones|hormones|mesh-ancestor
153573705|NCT01695005|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153573706|NCT01695005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153573707|NCT01695005|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154052988|NCT02627222|Provitamins|provitamins|mesh-list
154052989|NCT02627222|Vitamins|vitamins|mesh-ancestor
154052990|NCT02627222|Micronutrients|micronutrients|mesh-ancestor
154052991|NCT02627222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154052992|NCT00684476|Immunomodulating Agents|immunomodulating agents|mesh-list
154052993|NCT00684476|Immunologic Factors|immunologic factors|mesh-ancestor
154052994|NCT00684476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154052995|NCT00594854|Diclofenac|diclofenac|mesh-list
154052996|NCT00594854|Arthrotec|arthrotec|mesh-list
154052997|NCT00594854|Misoprostol|misoprostol|mesh-list
154052998|NCT00594854|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154052999|NCT00594854|Abortifacient Agents|abortifacient agents|mesh-ancestor
154053000|NCT00594854|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154053001|NCT00594854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154053002|NCT00594854|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154053003|NCT00594854|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154053004|NCT00594854|Oxytocics|oxytocics|mesh-ancestor
154053005|NCT00594854|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154053006|NCT00594854|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154053007|NCT00594854|Analgesics|analgesics|mesh-ancestor
154053008|NCT00594854|Sensory System Agents|sensory system agents|mesh-ancestor
154053009|NCT00594854|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154053010|NCT00594854|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154053011|NCT00594854|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154053012|NCT00594854|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154053013|NCT00594854|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154053014|NCT00594854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154053015|NCT00679718|Ophthalmic Solutions|ophthalmic solutions|mesh-list
154053016|NCT00679718|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
154053017|NCT00684632|Fentanyl|fentanyl|mesh-list
154053018|NCT00684632|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154053019|NCT00684632|Narcotics|narcotics|mesh-ancestor
154053031|NCT00855582|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
154053032|NCT00855582|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154053033|NCT00855582|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154053034|NCT00855582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154053035|NCT00855582|Urological Agents|urological agents|mesh-ancestor
154053036|NCT00619541|Fluorouracil|fluorouracil|mesh-list
154053038|NCT00619541|Antimetabolites|antimetabolites|mesh-ancestor
154053039|NCT00619541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154053040|NCT00619541|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154053041|NCT00619541|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154053042|NCT00619541|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154053043|NCT00619541|Immunologic Factors|immunologic factors|mesh-ancestor
154053044|NCT00619541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154053045|NCT00619541|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154053046|NCT00619541|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153418768|NCT02953886|Protective Agents|protective agents|mesh-ancestor
153418769|NCT02953886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153418770|NCT03035708|Varenicline|varenicline|mesh-list
153877959|NCT05118854|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154053047|NCT00680498|Ranibizumab|ranibizumab|mesh-list
154053048|NCT00680498|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154053049|NCT00680498|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154053050|NCT00680498|Growth Substances|growth substances|mesh-ancestor
154053051|NCT00680498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154053052|NCT00680498|Growth Inhibitors|growth inhibitors|mesh-ancestor
154053053|NCT00680498|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154053083|NCT00619697|Immunologic Factors|immunologic factors|mesh-ancestor
154053085|NCT00680654|Enzyme Activators|enzyme activators|mesh-ancestor
154053086|NCT00680654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154053087|NCT00680108|Ophthalmic Solutions|ophthalmic solutions|mesh-list
154053088|NCT00680108|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
154053089|NCT00680732|Folic Acid|folic acid|mesh-list
154053090|NCT00680732|Micronutrients|micronutrients|mesh-list
154053091|NCT00680732|Trace Elements|trace elements|mesh-list
154053092|NCT00680732|Chloroquine|chloroquine|mesh-list
154053093|NCT00680732|Pyrimethamine|pyrimethamine|mesh-list
154053094|NCT00680732|Hematinics|hematinics|mesh-ancestor
154053095|NCT00680732|Vitamin B Complex|vitamin b complex|mesh-ancestor
154053096|NCT00680732|Vitamins|vitamins|mesh-ancestor
154053097|NCT00680732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154053098|NCT00680732|Amebicides|amebicides|mesh-ancestor
154053099|NCT00680732|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154053100|NCT00680732|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154053101|NCT00680732|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154053102|NCT00680732|Antimalarials|antimalarials|mesh-ancestor
154053103|NCT00680732|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154053104|NCT00680732|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154053105|NCT00680732|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154053106|NCT00680732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154053107|NCT00698932|Saxagliptin|saxagliptin|mesh-list
154053108|NCT00698932|Incretins|incretins|mesh-ancestor
154053156|NCT00708591|Immunologic Factors|immunologic factors|mesh-ancestor
154053157|NCT00708591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154053158|NCT00708591|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154053159|NCT00708591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154053160|NCT00708591|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
154053161|NCT00708591|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154053162|NCT00708591|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154053163|NCT00708591|Hormone Antagonists|hormone antagonists|mesh-ancestor
154053164|NCT00708591|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154053165|NCT00708591|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
154053191|NCT00708747|Immunoglobulins|immunoglobulins|mesh-list
154053192|NCT00708747|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
154053193|NCT00708747|Antibodies|antibodies|mesh-list
154053194|NCT00708747|Immunologic Factors|immunologic factors|mesh-ancestor
154053195|NCT00708747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154053196|NCT00685022|Albuterol|albuterol|mesh-list
154053197|NCT00685022|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154053198|NCT00685022|Autonomic Agents|autonomic agents|mesh-ancestor
154053224|NCT00685100|Hormones|hormones|mesh-ancestor
154053235|NCT00708903|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154053236|NCT00708903|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154053237|NCT00708903|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154053238|NCT00637091|Irinotecan|irinotecan|mesh-list
154053239|NCT00637091|Cetuximab|cetuximab|mesh-list
153782440|NCT04557007|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154053240|NCT00637091|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
154053241|NCT00637091|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154053242|NCT00637091|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154053243|NCT00637091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154053244|NCT00637091|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154053245|NCT00637091|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154053246|NCT04213391|Sulforaphane|sulforaphane|mesh-list
154053247|NCT04213391|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
154053248|NCT04213391|Protective Agents|protective agents|mesh-ancestor
154053249|NCT04213391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154053250|NCT04213391|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154053251|NCT00709137|Amiloride|amiloride|mesh-list
154053252|NCT00709137|Spironolactone|spironolactone|mesh-list
154053253|NCT00709137|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
154053254|NCT00709137|Hormone Antagonists|hormone antagonists|mesh-ancestor
154053255|NCT00709137|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154053256|NCT00709137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154053257|NCT00709137|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
154053258|NCT00709137|Diuretics|diuretics|mesh-ancestor
154053259|NCT00709137|Natriuretic Agents|natriuretic agents|mesh-ancestor
154053260|NCT00709137|Acid Sensing Ion Channel Blockers|acid sensing ion channel blockers|mesh-ancestor
154053261|NCT00709137|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154053262|NCT00709137|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154053263|NCT00709137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154053264|NCT00709137|Epithelial Sodium Channel Blockers|epithelial sodium channel blockers|mesh-ancestor
154053265|NCT04150172|Rebamipide|rebamipide|mesh-list
154053278|NCT02325011|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154053279|NCT02325011|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
154053280|NCT02325011|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154053281|NCT02325011|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154053282|NCT02325011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154053283|NCT02325011|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154053284|NCT02325011|Hormone Antagonists|hormone antagonists|mesh-ancestor
154053285|NCT02325011|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154053286|NCT02325011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154053287|NCT02325011|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
154053288|NCT02325011|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
154053289|NCT02325011|Analgesics|analgesics|mesh-ancestor
154053290|NCT02325011|Sensory System Agents|sensory system agents|mesh-ancestor
154053291|NCT02325011|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154053292|NCT02325011|Anticonvulsants|anticonvulsants|mesh-ancestor
154053293|NCT02325011|Hallucinogens|hallucinogens|mesh-ancestor
154053294|NCT02325011|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154053295|NCT02325011|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154053296|NCT02325011|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
154053297|NCT02325011|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
154053298|NCT02325011|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154053299|NCT02325011|Hormones|hormones|mesh-ancestor
153573708|NCT01695005|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153573709|NCT01695057|Vorinostat|vorinostat|mesh-list
153573710|NCT01695057|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153573711|NCT01695057|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
153573712|NCT01695057|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153573713|NCT01695057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153573714|NCT01695070|Melatonin|melatonin|mesh-list
153573715|NCT01695070|Antioxidants|antioxidants|mesh-ancestor
153573716|NCT01695070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153573717|NCT01695070|Protective Agents|protective agents|mesh-ancestor
153573718|NCT01695070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153573719|NCT01695070|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153573721|NCT01695109|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
153573722|NCT01695109|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153573723|NCT01695109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153573724|NCT01695109|Incretins|incretins|mesh-ancestor
153573725|NCT01695109|Hormones|hormones|mesh-ancestor
153573726|NCT01695109|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153816867|NCT00468429|Growth Inhibitors|growth inhibitors|mesh-ancestor
153816868|NCT00459771|Candesartan|candesartan|mesh-list
153816869|NCT00459771|Candesartan cilexetil|candesartan cilexetil|mesh-list
153816870|NCT00459771|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153577505|NCT01718314|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154053301|NCT00577096|Dexamethasone|dexamethasone|mesh-list
154053302|NCT00577096|Cyclophosphamide|cyclophosphamide|mesh-list
154053303|NCT00577096|Melphalan|melphalan|mesh-list
154053304|NCT00577096|Cisplatin|cisplatin|mesh-list
154053305|NCT00577096|Doxorubicin|doxorubicin|mesh-list
154053306|NCT00577096|Etoposide|etoposide|mesh-list
154053307|NCT00577096|Vincristine|vincristine|mesh-list
154053308|NCT00577096|Heparin|heparin|mesh-list
154053309|NCT00577096|Calcium heparin|calcium heparin|mesh-list
154053310|NCT00577096|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
154053311|NCT00577096|Tinzaparin|tinzaparin|mesh-list
154053312|NCT00577096|Dalteparin|dalteparin|mesh-list
154053313|NCT00577096|Epoetin Alfa|epoetin alfa|mesh-list
154053314|NCT00577096|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154053315|NCT00577096|Immunologic Factors|immunologic factors|mesh-ancestor
154053316|NCT00577096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154053317|NCT00577096|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154053318|NCT00577096|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154053319|NCT00577096|Alkylating Agents|alkylating agents|mesh-ancestor
154053320|NCT00577096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154053321|NCT00577096|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154053322|NCT00577096|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154053323|NCT00577096|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154053324|NCT00577096|Antiemetics|antiemetics|mesh-ancestor
154053325|NCT00577096|Autonomic Agents|autonomic agents|mesh-ancestor
154053326|NCT00577096|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154053327|NCT00577096|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153816871|NCT00459771|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
153816872|NCT00459771|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
153816873|NCT00459771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153816874|NCT01058369|Deferasirox|deferasirox|mesh-list
153816875|NCT01058369|Iron Chelating Agents|iron chelating agents|mesh-ancestor
153816876|NCT01058369|Chelating Agents|chelating agents|mesh-ancestor
153816877|NCT01058369|Sequestering Agents|sequestering agents|mesh-ancestor
153573727|NCT01695122|Valproic Acid|valproic acid|mesh-list
153573728|NCT01695122|Anticonvulsants|anticonvulsants|mesh-ancestor
153573729|NCT01695122|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153573730|NCT01695122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153573731|NCT01695122|GABA Agents|gaba agents|mesh-ancestor
153573732|NCT01695122|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153573733|NCT01695122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153573734|NCT01695122|Antimanic Agents|antimanic agents|mesh-ancestor
153573735|NCT01695122|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153573736|NCT01695122|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153573737|NCT01695122|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153573738|NCT01695148|Carotenoids|carotenoids|mesh-list
153573739|NCT01695148|Antioxidants|antioxidants|mesh-ancestor
153573740|NCT01695148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153573741|NCT01695148|Protective Agents|protective agents|mesh-ancestor
154053330|NCT00577096|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154053331|NCT00577096|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154053333|NCT00577096|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154053334|NCT00577096|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154053335|NCT00577096|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154053336|NCT00577096|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154053337|NCT00577096|Tubulin Modulators|tubulin modulators|mesh-ancestor
154053338|NCT00577096|Antimitotic Agents|antimitotic agents|mesh-ancestor
154053339|NCT00577096|Mitosis Modulators|mitosis modulators|mesh-ancestor
154053340|NCT00577096|Anticoagulants|anticoagulants|mesh-ancestor
154053341|NCT00577096|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154053342|NCT00577096|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154053343|NCT00577096|Leprostatic Agents|leprostatic agents|mesh-ancestor
154053344|NCT00577096|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154053345|NCT00577096|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154053346|NCT00577096|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154053347|NCT00577096|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154053348|NCT00577096|Growth Substances|growth substances|mesh-ancestor
154053349|NCT00577096|Growth Inhibitors|growth inhibitors|mesh-ancestor
154053350|NCT00577096|Hematinics|hematinics|mesh-ancestor
154053351|NCT02625506|Tramadol|tramadol|mesh-list
154053352|NCT02625506|Levobupivacaine|levobupivacaine|mesh-list
154053353|NCT02625506|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154053354|NCT02625506|Narcotics|narcotics|mesh-ancestor
154053355|NCT02625506|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154053356|NCT02625506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154053357|NCT02625506|Analgesics|analgesics|mesh-ancestor
153573742|NCT01695148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153573743|NCT01695174|Rifaximin|rifaximin|mesh-list
153573744|NCT01695174|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153573745|NCT01695174|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153418783|NCT00374426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153418784|NCT00374426|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153418785|NCT00374426|Serotonin Agents|serotonin agents|mesh-ancestor
153418786|NCT00374426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153418787|NCT02916745|Dihematoporphyrin Ether|dihematoporphyrin ether|mesh-list
153418788|NCT02916745|Trioxsalen|trioxsalen|mesh-list
153573746|NCT01695174|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153573747|NCT01695187|5-((2-(6-Amino-9H-purin-9-yl) ethyl) amino)-1-pentanol|5-((2-(6-amino-9h-purin-9-yl) ethyl) amino)-1-pentanol|mesh-list
153573748|NCT01695187|Adenylyl Cyclase Inhibitors|adenylyl cyclase inhibitors|mesh-ancestor
153573749|NCT01695187|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153781612|NCT00231140|Immunologic Factors|immunologic factors|mesh-ancestor
153573750|NCT01695187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153573751|NCT01695226|Celecoxib|celecoxib|mesh-list
153573752|NCT01695226|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153573753|NCT01695226|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153573754|NCT01695226|Analgesics|analgesics|mesh-ancestor
154053358|NCT02625506|Sensory System Agents|sensory system agents|mesh-ancestor
154053359|NCT02625506|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154053360|NCT02625506|Anesthetics, Local|anesthetics, local|mesh-ancestor
154053361|NCT02625506|Anesthetics|anesthetics|mesh-ancestor
154053362|NCT04209959|Nifekalant|nifekalant|mesh-list
154053363|NCT04209959|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154053364|NCT04209803|Minoxidil|minoxidil|mesh-list
154053365|NCT04209803|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154053366|NCT04209803|Vasodilator Agents|vasodilator agents|mesh-ancestor
154053367|NCT02567032|Oxytocin|oxytocin|mesh-list
154053368|NCT02567032|Oxytocics|oxytocics|mesh-ancestor
154053369|NCT02567032|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154053370|NCT02567032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154053371|NCT00618059|Pilocarpine|pilocarpine|mesh-list
154053372|NCT00618059|Miotics|miotics|mesh-ancestor
154053373|NCT00618059|Autonomic Agents|autonomic agents|mesh-ancestor
154053374|NCT00618059|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154053375|NCT00618059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154053376|NCT00618059|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
154053377|NCT00618059|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
154053378|NCT00618059|Cholinergic Agents|cholinergic agents|mesh-ancestor
154053379|NCT00618059|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153877993|NCT05069935|Fludarabine|fludarabine|mesh-list
153877994|NCT05069935|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
153877995|NCT05069935|Antibodies|antibodies|mesh-list
153877996|NCT05069935|Immunoglobulins|immunoglobulins|mesh-list
153877997|NCT05069935|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
153877998|NCT05069935|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153877999|NCT05069935|Immunologic Factors|immunologic factors|mesh-ancestor
153878000|NCT05069935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153878002|NCT05069935|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153878003|NCT05069935|Alkylating Agents|alkylating agents|mesh-ancestor
153878004|NCT05069935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153878005|NCT05069935|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153878006|NCT05069935|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153878007|NCT05062902|Botulinum Toxins|botulinum toxins|mesh-list
154053380|NCT00618059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154053381|NCT00863304|Naproxen|naproxen|mesh-list
154053382|NCT00863304|Tanezumab|tanezumab|mesh-list
154053383|NCT00863304|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154053384|NCT00863304|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154053385|NCT00863304|Analgesics|analgesics|mesh-ancestor
154053386|NCT00863304|Sensory System Agents|sensory system agents|mesh-ancestor
154053387|NCT00863304|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154053388|NCT00863304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153816878|NCT01058369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153816879|NCT01057433|Ritonavir|ritonavir|mesh-list
153816880|NCT01057433|Lopinavir|lopinavir|mesh-list
153816881|NCT01057433|Pitavastatin|pitavastatin|mesh-list
153816882|NCT01057433|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
153816883|NCT01057433|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
153816884|NCT01057433|Protease Inhibitors|protease inhibitors|mesh-ancestor
153816885|NCT01057433|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153816886|NCT01057433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153458229|NCT04192032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153573756|NCT01695226|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153573757|NCT01695226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153573759|NCT01695226|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153573760|NCT01695226|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
154053389|NCT00863304|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154053390|NCT00863304|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154053391|NCT00863304|Gout Suppressants|gout suppressants|mesh-ancestor
154053392|NCT00863304|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154053393|NCT00863304|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154053394|NCT00863304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154053395|NCT00695110|Methyltestosterone|methyltestosterone|mesh-list
154053397|NCT00695110|Testosterone undecanoate|testosterone undecanoate|mesh-list
153418791|NCT02916745|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
154053398|NCT00695110|Testosterone enanthate|testosterone enanthate|mesh-list
154053399|NCT00695110|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
154053400|NCT00695110|Androgens|androgens|mesh-ancestor
154053401|NCT00695110|Hormones|hormones|mesh-ancestor
154053402|NCT00695110|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154053403|NCT00695110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154053404|NCT00695110|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154053405|NCT00695110|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154053406|NCT00695110|Anabolic Agents|anabolic agents|mesh-ancestor
153418792|NCT02954198|Mycophenolic Acid|mycophenolic acid|mesh-list
153418793|NCT02954198|Prednisone|prednisone|mesh-list
153418794|NCT02954198|Methylprednisolone|methylprednisolone|mesh-list
153418795|NCT02954198|Everolimus|everolimus|mesh-list
153418796|NCT02954198|Tacrolimus|tacrolimus|mesh-list
153418797|NCT02954198|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153418798|NCT02954198|Glucocorticoids|glucocorticoids|mesh-ancestor
153418799|NCT02954198|Hormones|hormones|mesh-ancestor
153418800|NCT02954198|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153418801|NCT02954198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153418802|NCT02954198|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153418803|NCT02954198|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153418804|NCT02954198|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153418805|NCT02954198|Immunologic Factors|immunologic factors|mesh-ancestor
153418806|NCT02954198|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
153782441|NCT04557007|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
154053407|NCT03264352|Amlodipine|amlodipine|mesh-list
154053408|NCT03264352|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154053409|NCT03264352|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
154053410|NCT03264352|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154053411|NCT03264352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154053412|NCT03264352|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154053413|NCT03264352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154053414|NCT03264352|Vasodilator Agents|vasodilator agents|mesh-ancestor
154053415|NCT04897919|Lumefantrine|lumefantrine|mesh-list
154053416|NCT04897919|Artemether|artemether|mesh-list
154053417|NCT04897919|Piperaquine|piperaquine|mesh-list
154053418|NCT04897919|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
154053419|NCT04897919|Artenimol|artenimol|mesh-list
154053420|NCT04897919|Antimalarials|antimalarials|mesh-ancestor
154053421|NCT04897919|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154053422|NCT04897919|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153878011|NCT05062902|Cholinergic Agents|cholinergic agents|mesh-ancestor
153878012|NCT05062902|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154053423|NCT04897919|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154053424|NCT00594386|Rotigotine|rotigotine|mesh-list
154053425|NCT00594386|Dopamine Agonists|dopamine agonists|mesh-ancestor
154053428|NCT00594386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154053429|NCT00594386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154053430|NCT00690560|Prednisone|prednisone|mesh-list
154053431|NCT00690560|Cyclophosphamide|cyclophosphamide|mesh-list
154053432|NCT00690560|Rituximab|rituximab|mesh-list
154053433|NCT00690560|Doxorubicin|doxorubicin|mesh-list
154053434|NCT00690560|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
154053435|NCT00690560|Vincristine|vincristine|mesh-list
154053436|NCT00690560|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154053437|NCT00690560|Immunologic Factors|immunologic factors|mesh-ancestor
154053438|NCT00690560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154053439|NCT00690560|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154053440|NCT00690560|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153418808|NCT02954198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153418809|NCT02954198|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
153418810|NCT02954198|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153418811|NCT02954198|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153418812|NCT02954198|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
154053441|NCT00690560|Alkylating Agents|alkylating agents|mesh-ancestor
154053442|NCT00690560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153573761|NCT01695226|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153573762|NCT01695226|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153573763|NCT01695226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153573764|NCT01695356|Sunscreening Agents|sunscreening agents|mesh-list
153573765|NCT01695356|Zinc Oxide|zinc oxide|mesh-list
153573766|NCT01695356|Titanium dioxide|titanium dioxide|mesh-list
153573767|NCT01695356|Avobenzone|avobenzone|mesh-list
153573768|NCT01695356|Terephthalylidene dicamphor sulfonic acid|terephthalylidene dicamphor sulfonic acid|mesh-list
153573769|NCT01695356|Benzophenone|benzophenone|mesh-list
153573770|NCT01695356|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
153458246|NCT04025736|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153360249|NCT01355705|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153782451|NCT00233792|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153782452|NCT00233792|Immunologic Factors|immunologic factors|mesh-ancestor
153878027|NCT05043870|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153878028|NCT05043870|Dermatologic Agents|dermatologic agents|mesh-ancestor
153878029|NCT05043870|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153878030|NCT05043870|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153878031|NCT05043870|Immunologic Factors|immunologic factors|mesh-ancestor
153878032|NCT05043870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153878033|NCT05029596|Heparin|heparin|mesh-list
153878034|NCT05029596|Calcium heparin|calcium heparin|mesh-list
153878035|NCT05029596|Anticoagulants|anticoagulants|mesh-ancestor
153878036|NCT05029596|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153782465|NCT00556270|Fentanyl|fentanyl|mesh-list
153458247|NCT04025736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153458248|NCT04025736|Hemostatics|hemostatics|mesh-ancestor
153458249|NCT04025736|Coagulants|coagulants|mesh-ancestor
153458252|NCT04190160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153458253|NCT04190160|Incretins|incretins|mesh-ancestor
153573777|NCT01695460|Micronutrients|micronutrients|mesh-ancestor
153573778|NCT01695460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153573779|NCT01695460|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153573780|NCT01695460|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153573781|NCT01695707|Pioglitazone|pioglitazone|mesh-list
153573782|NCT01695707|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153573783|NCT01695707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153573784|NCT01695733|Vaccines|vaccines|mesh-list
153878037|NCT05029596|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153878038|NCT05029596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153878039|NCT05027386|Irinotecan|irinotecan|mesh-list
153878040|NCT05027386|Temozolomide|temozolomide|mesh-list
153878041|NCT05027386|Apatinib|apatinib|mesh-list
153878042|NCT05027386|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
153418824|NCT02956070|BB 1101|bb 1101|mesh-list
153418825|NCT02956070|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153878043|NCT05027386|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153878044|NCT05027386|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153878045|NCT05027386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153878046|NCT05027386|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153878047|NCT05027386|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153878048|NCT05027386|Alkylating Agents|alkylating agents|mesh-ancestor
153878049|NCT05027386|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153878050|NCT05010434|Bevacizumab|bevacizumab|mesh-list
153573785|NCT01695733|Immunologic Factors|immunologic factors|mesh-ancestor
153573786|NCT01695733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153573787|NCT01695759|Epoetin Alfa|epoetin alfa|mesh-list
153573788|NCT01695759|Hematinics|hematinics|mesh-ancestor
153573789|NCT01695798|Vaccines|vaccines|mesh-list
153573790|NCT01695798|Immunologic Factors|immunologic factors|mesh-ancestor
153573791|NCT01695798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153573792|NCT01695824|Warfarin|warfarin|mesh-list
153573793|NCT01695824|Anticoagulants|anticoagulants|mesh-ancestor
153573794|NCT01695850|Sennosides|sennosides|mesh-list
153573795|NCT01695850|Laxatives|laxatives|mesh-ancestor
153573796|NCT01695850|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153816887|NCT01057433|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153816888|NCT01057433|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153816889|NCT01057433|Antiviral Agents|antiviral agents|mesh-ancestor
153816890|NCT01057433|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153816891|NCT01057433|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
153816892|NCT01057433|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153816894|NCT01057433|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154053443|NCT00690560|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154053444|NCT00690560|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154053445|NCT00690560|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154053446|NCT00690560|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154053447|NCT00690560|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153878051|NCT05010434|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153878052|NCT05010434|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153878053|NCT05010434|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153878054|NCT05010434|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153878055|NCT05010434|Growth Substances|growth substances|mesh-ancestor
153878056|NCT05010434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153878057|NCT05010434|Growth Inhibitors|growth inhibitors|mesh-ancestor
153878058|NCT04984993|Tadalafil|tadalafil|mesh-list
153878059|NCT04984993|Vasodilator Agents|vasodilator agents|mesh-ancestor
153878060|NCT04984993|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
153782487|NCT00233909|Immunotoxins|immunotoxins|mesh-ancestor
153782488|NCT00233909|Immunoconjugates|immunoconjugates|mesh-ancestor
154053448|NCT00690560|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154053449|NCT00690560|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154053450|NCT00690560|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154053451|NCT00690560|Glucocorticoids|glucocorticoids|mesh-ancestor
154053452|NCT00690560|Hormones|hormones|mesh-ancestor
154053453|NCT00690560|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153878061|NCT04984993|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154053454|NCT00690560|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154053455|NCT00690560|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153596132|NCT01860014|Beractant|beractant|mesh-list
153816895|NCT01057433|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153816896|NCT01057433|Antimetabolites|antimetabolites|mesh-ancestor
153816897|NCT01057433|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153816898|NCT01058642|Pregabalin|pregabalin|mesh-list
153816899|NCT01058642|Analgesics|analgesics|mesh-ancestor
153816900|NCT01058642|Sensory System Agents|sensory system agents|mesh-ancestor
153816901|NCT01058642|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153816902|NCT01058642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153816903|NCT01058642|Anticonvulsants|anticonvulsants|mesh-ancestor
153816904|NCT01058642|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153816905|NCT01058642|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153816906|NCT01058642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153816907|NCT01058642|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153816908|NCT01058642|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153573798|NCT01695902|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
153878062|NCT04984993|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153418845|NCT02956616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153418846|NCT02956616|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153573799|NCT01695902|Contraceptive Agents|contraceptive agents|mesh-ancestor
153573800|NCT01695902|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153573801|NCT01695902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153573802|NCT01695902|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
153573803|NCT01695902|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
153573804|NCT01695902|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
153573805|NCT01696110|Heparin|heparin|mesh-list
153573806|NCT01696110|Calcium heparin|calcium heparin|mesh-list
153573807|NCT01696110|Tirofiban|tirofiban|mesh-list
153573808|NCT01696110|Bivalirudin|bivalirudin|mesh-list
153573809|NCT01696110|Anticoagulants|anticoagulants|mesh-ancestor
153573810|NCT01696110|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153573811|NCT01696110|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153573812|NCT01696110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153573813|NCT01696110|Antithrombins|antithrombins|mesh-ancestor
153573814|NCT01696110|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
153573815|NCT01696110|Protease Inhibitors|protease inhibitors|mesh-ancestor
153573816|NCT01696110|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153573817|NCT01696110|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153573818|NCT01696240|Udenafil|udenafil|mesh-list
153573819|NCT01696240|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
153573820|NCT01696240|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
153573821|NCT01696240|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153573822|NCT01696240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153816909|NCT01058642|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153546623|NCT06012435|Antimitotic Agents|antimitotic agents|mesh-ancestor
153546624|NCT06012435|Mitosis Modulators|mitosis modulators|mesh-ancestor
153546625|NCT06012435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153546626|NCT06006273|Irinotecan|irinotecan|mesh-list
153546627|NCT06006273|Temozolomide|temozolomide|mesh-list
153546628|NCT06006273|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
153546629|NCT06006273|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153546630|NCT06006273|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153546631|NCT06006273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153546632|NCT06006273|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153546633|NCT06006273|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153546634|NCT06006273|Alkylating Agents|alkylating agents|mesh-ancestor
153546635|NCT06003231|Disitamab vedotin|disitamab vedotin|mesh-list
153546658|NCT06001385|Busulfan|busulfan|mesh-list
153546659|NCT06001385|Fludarabine|fludarabine|mesh-list
153546660|NCT06001385|Tacrolimus|tacrolimus|mesh-list
153546661|NCT06001385|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153546662|NCT06001385|Immunologic Factors|immunologic factors|mesh-ancestor
153546663|NCT06001385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153546664|NCT06001385|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153546665|NCT06001385|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153546666|NCT06001385|Alkylating Agents|alkylating agents|mesh-ancestor
153816910|NCT01058642|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153458255|NCT04190160|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153458256|NCT04190004|Vasopressins|vasopressins|mesh-list
153458257|NCT04190004|Arginine Vasopressin|arginine vasopressin|mesh-list
153458258|NCT04190004|Hemostatics|hemostatics|mesh-ancestor
153458259|NCT04190004|Coagulants|coagulants|mesh-ancestor
154053457|NCT00690560|Antimitotic Agents|antimitotic agents|mesh-ancestor
154053458|NCT00690560|Mitosis Modulators|mitosis modulators|mesh-ancestor
154053460|NCT00742690|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154053461|NCT00742690|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154053462|NCT00742768|Vitamins|vitamins|mesh-list
154053463|NCT00742768|Vitamin K|vitamin k|mesh-list
154053464|NCT00742768|Vitamin K 2|vitamin k 2|mesh-list
154053465|NCT00742768|Micronutrients|micronutrients|mesh-ancestor
154053466|NCT00742768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154053467|NCT00742768|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
154053468|NCT00742768|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154053469|NCT00742768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154053470|NCT00742768|Hemostatics|hemostatics|mesh-ancestor
154053471|NCT00742768|Coagulants|coagulants|mesh-ancestor
154053472|NCT00862992|Cariprazine|cariprazine|mesh-list
154053473|NCT00862992|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154053474|NCT00862992|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154053475|NCT00862992|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154053476|NCT00862992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154053477|NCT00862992|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154053478|NCT02565316|Sertraline|sertraline|mesh-list
154053479|NCT02565316|Antidepressive Agents|antidepressive agents|mesh-ancestor
154053480|NCT02565316|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154053481|NCT02565316|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
154053482|NCT02565316|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153458260|NCT04190004|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
153458261|NCT04190004|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
153878063|NCT04984993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153878064|NCT04984993|Urological Agents|urological agents|mesh-ancestor
153878066|NCT04979611|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
153878067|NCT04979611|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153878068|NCT04979611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153878071|NCT04979611|Hormones|hormones|mesh-ancestor
153546667|NCT06001385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153546668|NCT06001385|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153546669|NCT06001385|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153546670|NCT06001385|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
153546671|NCT06001385|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153546672|NCT06001385|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153546673|NCT06001385|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
153546674|NCT06001385|Antitubercular Agents|antitubercular agents|mesh-ancestor
153546675|NCT06001385|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153458262|NCT04190004|Natriuretic Agents|natriuretic agents|mesh-ancestor
153458263|NCT04190004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153458264|NCT04406376|Prednisone|prednisone|mesh-list
153458265|NCT04406376|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153458266|NCT04406376|Glucocorticoids|glucocorticoids|mesh-ancestor
153458267|NCT04406376|Hormones|hormones|mesh-ancestor
153458268|NCT04406376|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153458269|NCT04406376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153458270|NCT04406376|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153458271|NCT04406376|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153458272|NCT04024800|Pembrolizumab|pembrolizumab|mesh-list
153458273|NCT04024800|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153458274|NCT04024800|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153573824|NCT01696370|Vasodilator Agents|vasodilator agents|mesh-ancestor
153573825|NCT01696383|Timolol|timolol|mesh-list
153573826|NCT01696383|Travoprost|travoprost|mesh-list
153573827|NCT01696383|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
153573828|NCT01696383|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
153573829|NCT01696383|Adrenergic Agents|adrenergic agents|mesh-ancestor
153573830|NCT01696383|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153577515|NCT01718314|Abortifacient Agents|abortifacient agents|mesh-ancestor
154053484|NCT02565316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154053485|NCT02565316|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154053486|NCT02565316|Serotonin Agents|serotonin agents|mesh-ancestor
154053487|NCT02565316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153546676|NCT06001385|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153546677|NCT05996185|Prednisone|prednisone|mesh-list
153546678|NCT05996185|Cyclophosphamide|cyclophosphamide|mesh-list
153418866|NCT05829148|Pregabalin|pregabalin|mesh-list
154053488|NCT00742846|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
154053489|NCT00742846|Triamcinolone|triamcinolone|mesh-list
154053490|NCT00742846|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
154053491|NCT00742846|Lidocaine|lidocaine|mesh-list
154053492|NCT00742846|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
154053493|NCT00742846|Anesthetics, Local|anesthetics, local|mesh-ancestor
154053494|NCT00742846|Anesthetics|anesthetics|mesh-ancestor
154053495|NCT00742846|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154053496|NCT00742846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154053497|NCT00742846|Sensory System Agents|sensory system agents|mesh-ancestor
154053498|NCT00742846|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154053499|NCT00742846|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154053500|NCT00742846|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154053501|NCT00742846|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154053502|NCT00742846|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153546679|NCT05996185|Doxorubicin|doxorubicin|mesh-list
153546680|NCT05996185|Etoposide|etoposide|mesh-list
153546681|NCT05996185|Vincristine|vincristine|mesh-list
153546682|NCT05996185|Mogamulizumab|mogamulizumab|mesh-list
153546683|NCT05996185|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153546684|NCT05996185|Immunologic Factors|immunologic factors|mesh-ancestor
153546685|NCT05996185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153546686|NCT05996185|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153546687|NCT05996185|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153546688|NCT05996185|Alkylating Agents|alkylating agents|mesh-ancestor
153546689|NCT05996185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153546690|NCT05996185|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153546691|NCT05996185|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153546692|NCT05996185|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153546693|NCT05996185|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153546694|NCT05996185|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153546695|NCT05996185|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153546696|NCT05996185|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153546697|NCT05996185|Glucocorticoids|glucocorticoids|mesh-ancestor
153546698|NCT05996185|Hormones|hormones|mesh-ancestor
153546699|NCT05996185|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153546700|NCT05996185|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153546701|NCT05996185|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153546702|NCT05996185|Tubulin Modulators|tubulin modulators|mesh-ancestor
153573831|NCT01696383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153573832|NCT01696383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153573833|NCT01696383|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153458280|NCT04023630|Rivaroxaban|rivaroxaban|mesh-list
153458281|NCT04023630|Clopidogrel|clopidogrel|mesh-list
153458282|NCT04023630|Ticagrelor|ticagrelor|mesh-list
153816911|NCT01058642|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153816912|NCT00426920|Insulin|insulin|mesh-list
153816913|NCT00426920|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153816914|NCT00426920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153816915|NCT00426998|Bevacizumab|bevacizumab|mesh-list
153816916|NCT00426998|Verteporfin|verteporfin|mesh-list
153816917|NCT00426998|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153816918|NCT00426998|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153816919|NCT00426998|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153816920|NCT00426998|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153816921|NCT00426998|Growth Substances|growth substances|mesh-ancestor
153816922|NCT00426998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153816923|NCT00426998|Growth Inhibitors|growth inhibitors|mesh-ancestor
153816924|NCT00426998|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
153573841|NCT01696409|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153573842|NCT01696409|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153573843|NCT01696422|Vaccines|vaccines|mesh-list
153573844|NCT01696422|Immunologic Factors|immunologic factors|mesh-ancestor
153573845|NCT01696422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153573846|NCT01696448|Thioctic Acid|thioctic acid|mesh-list
153546703|NCT05996185|Antimitotic Agents|antimitotic agents|mesh-ancestor
153546704|NCT05996185|Mitosis Modulators|mitosis modulators|mesh-ancestor
153546705|NCT05993234|Trastuzumab|trastuzumab|mesh-list
153546706|NCT05993234|Trastuzumab deruxtecan|trastuzumab deruxtecan|mesh-list
153546707|NCT05993234|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153546711|NCT05993234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153546712|NCT05953610|Acetazolamide|acetazolamide|mesh-list
153546713|NCT05953610|Eszopiclone|eszopiclone|mesh-list
153546714|NCT05953610|Anticonvulsants|anticonvulsants|mesh-ancestor
153546715|NCT05953610|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
153546716|NCT05953610|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153546717|NCT05953610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153546718|NCT05953610|Diuretics|diuretics|mesh-ancestor
153782500|NCT00267813|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153546719|NCT05953610|Natriuretic Agents|natriuretic agents|mesh-ancestor
153546720|NCT05953610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153546721|NCT05953610|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153573847|NCT01696448|Antioxidants|antioxidants|mesh-ancestor
153573848|NCT01696448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153573849|NCT01696448|Protective Agents|protective agents|mesh-ancestor
153573850|NCT01696448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153573851|NCT01696448|Vitamin B Complex|vitamin b complex|mesh-ancestor
153573852|NCT01696448|Vitamins|vitamins|mesh-ancestor
154053503|NCT00742846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154053504|NCT00742846|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154053505|NCT00742846|Glucocorticoids|glucocorticoids|mesh-ancestor
154053507|NCT00742846|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154053508|NCT00742846|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154053509|NCT00742846|Immunologic Factors|immunologic factors|mesh-ancestor
154053510|NCT00742846|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154053512|NCT00690872|Gemcitabine|gemcitabine|mesh-list
154053513|NCT00690872|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154053514|NCT00690872|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154053515|NCT00690872|Antimetabolites|antimetabolites|mesh-ancestor
154053516|NCT00690872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154053517|NCT00694096|Sunitinib|sunitinib|mesh-list
154053518|NCT00694096|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154053519|NCT00694096|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153546722|NCT05953610|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153546723|NCT05952804|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
153546725|NCT05952804|Antibodies|antibodies|mesh-list
153546726|NCT05952804|gamma-Globulins|gamma-globulins|mesh-list
153546727|NCT05952804|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
153546728|NCT05952804|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
153546729|NCT05952804|Immunologic Factors|immunologic factors|mesh-ancestor
153546730|NCT05952804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153546731|NCT05949190|Azithromycin|azithromycin|mesh-list
153546732|NCT05949190|Pyrimethamine|pyrimethamine|mesh-list
153546733|NCT05949190|Sulfadoxine|sulfadoxine|mesh-list
153546734|NCT05949190|Albendazole|albendazole|mesh-list
153546735|NCT05949190|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
153546736|NCT05949190|Choline|choline|mesh-list
153546737|NCT05949190|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153546738|NCT05949190|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153546739|NCT05949190|Lipotropic Agents|lipotropic agents|mesh-ancestor
153878129|NCT04893161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153878130|NCT04891757|Cytarabine|cytarabine|mesh-list
153878131|NCT04891757|Decitabine|decitabine|mesh-list
153878132|NCT04891757|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153878133|NCT04891757|Antimetabolites|antimetabolites|mesh-ancestor
154053520|NCT00694096|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154053521|NCT00694096|Growth Substances|growth substances|mesh-ancestor
154053522|NCT00694096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154053523|NCT00694096|Growth Inhibitors|growth inhibitors|mesh-ancestor
154053524|NCT00694096|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154053525|NCT00694096|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154053526|NCT00694096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154053527|NCT04808531|Oxycodone|oxycodone|mesh-list
154053528|NCT04808531|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154053529|NCT04808531|Narcotics|narcotics|mesh-ancestor
154053530|NCT04808531|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153596199|NCT01860300|Amoxicillin|amoxicillin|mesh-list
154053531|NCT04808531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154053533|NCT04808531|Sensory System Agents|sensory system agents|mesh-ancestor
154053534|NCT04808531|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154053535|NCT00690950|Dutasteride|dutasteride|mesh-list
154053536|NCT00690950|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
154053537|NCT00690950|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154053538|NCT00690950|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153573853|NCT01696448|Micronutrients|micronutrients|mesh-ancestor
153573854|NCT01696474|Bortezomib|bortezomib|mesh-list
153573855|NCT01696474|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153573856|NCT01696500|Immunoglobulins|immunoglobulins|mesh-list
154053539|NCT00690950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154053540|NCT00690950|Hormone Antagonists|hormone antagonists|mesh-ancestor
154053541|NCT00690950|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154053542|NCT00690950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154053544|NCT02622126|Ephedrine|ephedrine|mesh-list
154053545|NCT02622126|Morphine|morphine|mesh-list
154053546|NCT02622126|Bupivacaine|bupivacaine|mesh-list
153878134|NCT04891757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153878135|NCT04891757|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153878136|NCT04891757|Antiviral Agents|antiviral agents|mesh-ancestor
153878137|NCT04891757|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153878138|NCT04891757|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153878139|NCT04891757|Immunologic Factors|immunologic factors|mesh-ancestor
153878140|NCT04891757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153878141|NCT04891757|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153878142|NCT04890470|Vasopressins|vasopressins|mesh-list
153878143|NCT04890470|Arginine Vasopressin|arginine vasopressin|mesh-list
153878144|NCT04890470|Oxytocin|oxytocin|mesh-list
153878145|NCT04890470|Oxytocics|oxytocics|mesh-ancestor
153878146|NCT04890470|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153878147|NCT04890470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153878148|NCT04890470|Hemostatics|hemostatics|mesh-ancestor
153878149|NCT04890470|Coagulants|coagulants|mesh-ancestor
153418931|NCT05827796|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
153418932|NCT05827796|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153418933|NCT05827796|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153418934|NCT05827796|Tubulin Modulators|tubulin modulators|mesh-ancestor
153418935|NCT05827796|Antimitotic Agents|antimitotic agents|mesh-ancestor
153418936|NCT05827796|Mitosis Modulators|mitosis modulators|mesh-ancestor
154053547|NCT02622126|Anesthetics, Local|anesthetics, local|mesh-ancestor
154053548|NCT02622126|Anesthetics|anesthetics|mesh-ancestor
154053549|NCT02622126|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154053550|NCT02622126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154053551|NCT02622126|Sensory System Agents|sensory system agents|mesh-ancestor
154053552|NCT02622126|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154053553|NCT02622126|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154053554|NCT02622126|Narcotics|narcotics|mesh-ancestor
154053555|NCT02622126|Analgesics|analgesics|mesh-ancestor
153573857|NCT01696500|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
153573858|NCT01696500|Antibodies|antibodies|mesh-list
153573859|NCT01696500|gamma-Globulins|gamma-globulins|mesh-list
153573860|NCT01696500|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
153573861|NCT01696500|Immunologic Factors|immunologic factors|mesh-ancestor
153573862|NCT01696500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153573863|NCT01696526|Vitamin D|vitamin d|mesh-list
153573864|NCT01696526|Vitamins|vitamins|mesh-ancestor
153573865|NCT01696526|Micronutrients|micronutrients|mesh-ancestor
153573866|NCT01696526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153573867|NCT01696526|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153573868|NCT01696552|Cimetidine|cimetidine|mesh-list
153573869|NCT01696552|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
153573870|NCT01696552|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153816925|NCT00426998|Dermatologic Agents|dermatologic agents|mesh-ancestor
153816926|NCT00427076|Vancomycin|vancomycin|mesh-list
153816927|NCT00427076|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
153816928|NCT00427076|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153816929|NCT00427076|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153816930|NCT00427076|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
153816931|NCT00427076|Antimalarials|antimalarials|mesh-ancestor
153816932|NCT00427076|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153546740|NCT05949190|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153546741|NCT05949190|Antimetabolites|antimetabolites|mesh-ancestor
153546742|NCT05949190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153878150|NCT04890470|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
153878151|NCT04890470|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
153878152|NCT04890470|Natriuretic Agents|natriuretic agents|mesh-ancestor
153878153|NCT04865159|Tipifarnib|tipifarnib|mesh-list
153878154|NCT04865159|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153878155|NCT04864210|Bupivacaine|bupivacaine|mesh-list
153878156|NCT04864210|Anesthetics, Local|anesthetics, local|mesh-ancestor
153878157|NCT04864210|Anesthetics|anesthetics|mesh-ancestor
153546743|NCT05949190|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153546744|NCT05949190|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153546745|NCT05949190|Nootropic Agents|nootropic agents|mesh-ancestor
153546746|NCT05949190|Antimalarials|antimalarials|mesh-ancestor
153546747|NCT05949190|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153546748|NCT05949190|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153546749|NCT05949190|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153546750|NCT05949190|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153546751|NCT05949190|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
153546752|NCT05949190|Anthelmintics|anthelmintics|mesh-ancestor
153546753|NCT05949190|Anticestodal Agents|anticestodal agents|mesh-ancestor
153816933|NCT00427076|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153816934|NCT00427232|BQ 788|bq 788|mesh-list
153816935|NCT00427232|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153816936|NCT00427232|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
153816937|NCT00427232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153458283|NCT04023630|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153573872|NCT01696552|Histamine Antagonists|histamine antagonists|mesh-ancestor
153573873|NCT01696552|Histamine Agents|histamine agents|mesh-ancestor
153573874|NCT01696552|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153573875|NCT01696552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153573876|NCT01696552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153573877|NCT01696552|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
153573878|NCT01696552|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153573879|NCT01696552|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153573880|NCT01696617|Aripiprazole|aripiprazole|mesh-list
153573881|NCT01696617|Antidepressive Agents|antidepressive agents|mesh-ancestor
153573882|NCT01696617|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153573883|NCT01696617|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153573884|NCT01696617|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154053557|NCT02622126|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154053558|NCT02622126|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154053559|NCT02622126|Autonomic Agents|autonomic agents|mesh-ancestor
154053560|NCT02622126|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154053561|NCT02622126|Respiratory System Agents|respiratory system agents|mesh-ancestor
154053562|NCT02622126|Mydriatics|mydriatics|mesh-ancestor
154053563|NCT02622126|Parasympatholytics|parasympatholytics|mesh-ancestor
154053564|NCT02622126|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
154053565|NCT02622126|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154053566|NCT02622126|Cholinergic Agents|cholinergic agents|mesh-ancestor
154053567|NCT02622126|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154053568|NCT02622126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154053569|NCT02622126|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
154053570|NCT02622126|Sympathomimetics|sympathomimetics|mesh-ancestor
154053571|NCT02622126|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154053572|NCT02622126|Adrenergic Agents|adrenergic agents|mesh-ancestor
154053573|NCT04140188|Sodium Pertechnetate Tc 99m|sodium pertechnetate tc 99m|mesh-list
154053574|NCT04140188|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
154053609|NCT04210739|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154053610|NCT04210739|Respiratory System Agents|respiratory system agents|mesh-ancestor
154053611|NCT00696540|Albuterol|albuterol|mesh-list
154053612|NCT00696540|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154053613|NCT00696540|Autonomic Agents|autonomic agents|mesh-ancestor
154053614|NCT00696540|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154053615|NCT00696540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154053616|NCT00696540|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154053617|NCT00696540|Respiratory System Agents|respiratory system agents|mesh-ancestor
154053618|NCT00696540|Tocolytic Agents|tocolytic agents|mesh-ancestor
154053619|NCT00696540|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154053620|NCT00696540|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
154053621|NCT00696540|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154053622|NCT00696540|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154053623|NCT00696540|Adrenergic Agents|adrenergic agents|mesh-ancestor
154053624|NCT00696540|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154053625|NCT00696540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154053626|NCT04212845|Dexamethasone|dexamethasone|mesh-list
154053627|NCT04212845|Bupivacaine|bupivacaine|mesh-list
154053628|NCT04212845|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154053664|NCT04138472|Sensory System Agents|sensory system agents|mesh-ancestor
154053665|NCT04138472|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154053666|NCT04138472|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154053667|NCT04138472|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154053668|NCT04138472|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154053669|NCT04138472|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154053670|NCT04138472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154053671|NCT04138472|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154053672|NCT04138472|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154053673|NCT04138472|Analgesics|analgesics|mesh-ancestor
154053674|NCT04138472|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154053675|NCT04138472|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154053676|NCT04138472|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154053677|NCT04138472|Adrenergic Agents|adrenergic agents|mesh-ancestor
154053678|NCT04138472|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154053679|NCT04138472|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154053680|NCT04138472|Narcotics|narcotics|mesh-ancestor
154053684|NCT00620789|Dexetimide|dexetimide|mesh-list
154053720|NCT00691262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154053721|NCT00691262|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
154053722|NCT00691262|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154053723|NCT00691262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154053724|NCT00620867|Ibuprofen|ibuprofen|mesh-list
154053725|NCT00620867|Celecoxib|celecoxib|mesh-list
154053726|NCT00620867|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154053727|NCT00620867|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154053728|NCT00620867|Analgesics|analgesics|mesh-ancestor
154053729|NCT00620867|Sensory System Agents|sensory system agents|mesh-ancestor
154053730|NCT00620867|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154053731|NCT00620867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154053732|NCT00620867|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154053733|NCT00620867|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154053734|NCT00620867|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154053735|NCT00620867|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154053736|NCT00620867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154053737|NCT00620867|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
154053738|NCT04271917|Acetaminophen|acetaminophen|mesh-list
154053739|NCT04271917|Ibuprofen|ibuprofen|mesh-list
154053740|NCT04271917|Cannabidiol|cannabidiol|mesh-list
154053741|NCT04271917|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154053742|NCT04271917|Analgesics|analgesics|mesh-ancestor
154053743|NCT04271917|Sensory System Agents|sensory system agents|mesh-ancestor
154053744|NCT04271917|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154053745|NCT04271917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154053746|NCT04271917|Antipyretics|antipyretics|mesh-ancestor
154053747|NCT04271917|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154053748|NCT04271917|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154053749|NCT04271917|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154053750|NCT04271917|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
154053751|NCT04271917|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154053752|NCT04271917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153573885|NCT01696617|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153573886|NCT01696617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153573887|NCT01696617|Dopamine Agonists|dopamine agonists|mesh-ancestor
153573888|NCT01696617|Dopamine Agents|dopamine agents|mesh-ancestor
153573889|NCT01696617|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153573890|NCT01696617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154053754|NCT04122222|Vaccines|vaccines|mesh-list
154053755|NCT04122222|Immunologic Factors|immunologic factors|mesh-ancestor
153878171|NCT04825496|Fludarabine|fludarabine|mesh-list
153418952|NCT05827497|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153418954|NCT05827497|Dermatologic Agents|dermatologic agents|mesh-ancestor
153418955|NCT05827497|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153418956|NCT05827497|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153418957|NCT05827497|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154053756|NCT04122222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154053757|NCT00686114|Paclitaxel|paclitaxel|mesh-list
154053758|NCT00686114|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
154053759|NCT00686114|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154053760|NCT00686114|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154053761|NCT00686114|Tubulin Modulators|tubulin modulators|mesh-ancestor
154053762|NCT00686114|Antimitotic Agents|antimitotic agents|mesh-ancestor
154053763|NCT00686114|Mitosis Modulators|mitosis modulators|mesh-ancestor
154053764|NCT00686114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154053765|NCT00686114|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154053766|NCT00686114|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154053767|NCT00686114|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154053768|NCT01015729|Esomeprazole|esomeprazole|mesh-list
154053769|NCT01015729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154053770|NCT01015729|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154053771|NCT01015729|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
154053772|NCT01015729|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154053773|NCT01015729|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
154053774|NCT00698724|Prednisolone acetate|prednisolone acetate|mesh-list
153573891|NCT01696617|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
153573892|NCT01696617|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
153573893|NCT01696617|Serotonin Agents|serotonin agents|mesh-ancestor
153573894|NCT01696617|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
153573895|NCT01696617|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153573896|NCT01696617|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
153573897|NCT01696617|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
153573898|NCT01696630|Desflurane|desflurane|mesh-list
153573916|NCT01696799|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153573917|NCT01696799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153573919|NCT01696825|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153573920|NCT01696825|Anticonvulsants|anticonvulsants|mesh-ancestor
153573921|NCT01696825|Antiemetics|antiemetics|mesh-ancestor
153573922|NCT01696825|Autonomic Agents|autonomic agents|mesh-ancestor
153573923|NCT01696825|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153573924|NCT01696825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153573925|NCT01696825|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153573926|NCT01696825|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153573927|NCT01696825|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153573928|NCT01696825|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
153573929|NCT01696825|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
153418964|NCT05827263|Keratolytic Agents|keratolytic agents|mesh-ancestor
153573930|NCT01696825|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153573931|NCT01696825|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153573932|NCT01696825|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153573933|NCT01696825|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153573934|NCT01696825|Anesthetics, General|anesthetics, general|mesh-ancestor
153573935|NCT01696825|Anesthetics|anesthetics|mesh-ancestor
153573936|NCT01696825|GABA Modulators|gaba modulators|mesh-ancestor
153573937|NCT01696825|GABA Agents|gaba agents|mesh-ancestor
153418965|NCT05827263|Dermatologic Agents|dermatologic agents|mesh-ancestor
153418966|NCT05825443|Paclitaxel|paclitaxel|mesh-list
153418967|NCT05825443|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
153418968|NCT05825443|Cisplatin|cisplatin|mesh-list
153418969|NCT05825443|Carboplatin|carboplatin|mesh-list
153418970|NCT05825443|Pemetrexed|pemetrexed|mesh-list
153418971|NCT05825443|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153418972|NCT05825443|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154053775|NCT00698724|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
154053776|NCT00698724|Methylprednisolone|methylprednisolone|mesh-list
154053777|NCT00698724|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
154053778|NCT00698724|Prednisolone|prednisolone|mesh-list
154053779|NCT00698724|Bromfenac|bromfenac|mesh-list
154053780|NCT00698724|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
154053781|NCT00698724|Prednisolone phosphate|prednisolone phosphate|mesh-list
154053782|NCT00698724|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154053783|NCT00698724|Antiemetics|antiemetics|mesh-ancestor
154053784|NCT00698724|Autonomic Agents|autonomic agents|mesh-ancestor
154053785|NCT00698724|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154053786|NCT00698724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154053787|NCT00698724|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154053788|NCT00698724|Glucocorticoids|glucocorticoids|mesh-ancestor
154053789|NCT00698724|Hormones|hormones|mesh-ancestor
154053790|NCT00698724|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154053791|NCT00698724|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
154053792|NCT00698724|Protective Agents|protective agents|mesh-ancestor
154053793|NCT00698724|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154053794|NCT00698724|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154053795|NCT00698724|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
154053796|NCT00698724|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154053797|NCT00698724|Analgesics|analgesics|mesh-ancestor
154053798|NCT00698724|Sensory System Agents|sensory system agents|mesh-ancestor
154053799|NCT00698724|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154053800|NCT00686192|Calcium Carbonate|calcium carbonate|mesh-list
154053801|NCT00686192|Calcium|calcium|mesh-list
154053802|NCT00686192|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154053803|NCT00686192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154053805|NCT00686192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154053806|NCT00686192|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154053807|NCT04117776|Chlorhexidine|chlorhexidine|mesh-list
154053821|NCT04118322|Autonomic Agents|autonomic agents|mesh-ancestor
154053822|NCT04118322|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154053823|NCT04118322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154053824|NCT04118322|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154053825|NCT04118322|Parasympatholytics|parasympatholytics|mesh-ancestor
154053826|NCT00698802|Insulin|insulin|mesh-list
153596495|NCT01862497|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154053827|NCT00698802|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
154053828|NCT00698802|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154053829|NCT00698802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154053830|NCT00621647|Quetiapine Fumarate|quetiapine fumarate|mesh-list
154053831|NCT00621647|Antidepressive Agents|antidepressive agents|mesh-ancestor
154053832|NCT00621647|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154053833|NCT00621647|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154053834|NCT00621647|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154053835|NCT00621647|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153546754|NCT05949190|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
153546755|NCT05949190|Tubulin Modulators|tubulin modulators|mesh-ancestor
153546756|NCT05949190|Antimitotic Agents|antimitotic agents|mesh-ancestor
153546757|NCT05949190|Mitosis Modulators|mitosis modulators|mesh-ancestor
153546758|NCT05949190|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153546759|NCT05948891|Beclomethasone|beclomethasone|mesh-list
153546760|NCT05948891|Glycopyrrolate|glycopyrrolate|mesh-list
153546761|NCT05948891|Formoterol Fumarate|formoterol fumarate|mesh-list
154053836|NCT00621647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154053837|NCT02621970|Cisplatin|cisplatin|mesh-list
154053838|NCT02621970|Docetaxel|docetaxel|mesh-list
154053839|NCT02621970|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154053840|NCT02621970|Tubulin Modulators|tubulin modulators|mesh-ancestor
154053841|NCT02621970|Antimitotic Agents|antimitotic agents|mesh-ancestor
154053842|NCT02621970|Mitosis Modulators|mitosis modulators|mesh-ancestor
154053843|NCT02621970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154053844|NCT00820755|Cetuximab|cetuximab|mesh-list
154053845|NCT00820755|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154053846|NCT00820755|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154053847|NCT00700128|Frovatriptan|frovatriptan|mesh-list
154053848|NCT00700128|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
154053849|NCT00700128|Serotonin Agents|serotonin agents|mesh-ancestor
154053850|NCT00700128|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154053851|NCT00700128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154053852|NCT00700128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153573938|NCT01696825|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153573939|NCT01696825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153573940|NCT01697020|Mercaptopurine|mercaptopurine|mesh-list
153573941|NCT01697020|Antimetabolites|antimetabolites|mesh-ancestor
153626783|NCT02018991|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154053854|NCT04660097|Etoposide phosphate|etoposide phosphate|mesh-list
154053856|NCT04660097|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154053857|NCT04660097|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154053858|NCT04660097|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154053859|NCT04660097|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154053860|NCT04660097|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154053861|NCT04660097|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154053862|NCT04660097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154053863|NCT04660097|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154053864|NCT04660097|Immunologic Factors|immunologic factors|mesh-ancestor
154053865|NCT04660097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154053866|NCT00621101|Sirolimus|sirolimus|mesh-list
154053867|NCT00621101|Temsirolimus|temsirolimus|mesh-list
154053868|NCT00621101|MTOR Inhibitors|mtor inhibitors|mesh-list
154053869|NCT00621101|Ezetimibe|ezetimibe|mesh-list
154053870|NCT00621101|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154053871|NCT00621101|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154053872|NCT00621101|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154053873|NCT00621101|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154053874|NCT00621101|Antifungal Agents|antifungal agents|mesh-ancestor
154053875|NCT00621101|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154053876|NCT00621101|Immunologic Factors|immunologic factors|mesh-ancestor
154053877|NCT00621101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154053878|NCT00621101|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154053879|NCT00621101|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154053880|NCT00621101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154053881|NCT00621101|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154053882|NCT00621101|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154053883|NCT00621101|Antimetabolites|antimetabolites|mesh-ancestor
153458284|NCT04023630|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
153458285|NCT04023630|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
153878172|NCT04825496|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153878173|NCT04825496|Immunologic Factors|immunologic factors|mesh-ancestor
153878174|NCT04825496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153878175|NCT04825496|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153878176|NCT04825496|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153878177|NCT04825496|Alkylating Agents|alkylating agents|mesh-ancestor
153878179|NCT04825496|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153458286|NCT04023630|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
153458287|NCT04023630|Purinergic Agents|purinergic agents|mesh-ancestor
153458300|NCT04022304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153458301|NCT04020666|Kallikreins|kallikreins|mesh-list
153458302|NCT04020666|Coagulants|coagulants|mesh-ancestor
153458303|NCT04020666|Fertility Agents, Male|fertility agents, male|mesh-ancestor
153458306|NCT04020666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153573942|NCT01697020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154053886|NCT00709215|Pentostatin|pentostatin|mesh-list
154053887|NCT00709215|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154053888|NCT00709215|Adenosine Deaminase Inhibitors|adenosine deaminase inhibitors|mesh-ancestor
154053889|NCT00709215|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154053890|NCT00709215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154053891|NCT00709215|Antifungal Agents|antifungal agents|mesh-ancestor
154053892|NCT00709215|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154053893|NCT00699036|Metformin|metformin|mesh-list
154053894|NCT00699036|Rosiglitazone|rosiglitazone|mesh-list
154053895|NCT00699036|Losartan|losartan|mesh-list
154053896|NCT00699036|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154053897|NCT00699036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154053898|NCT00699036|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154053899|NCT00699036|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154053900|NCT00699036|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
154053901|NCT00699036|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
154053902|NCT00699036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154053903|NCT00709293|Antilymphocyte Serum|antilymphocyte serum|mesh-list
154053904|NCT00709293|Immunologic Factors|immunologic factors|mesh-ancestor
154053905|NCT00709293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154053906|NCT00709293|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154053907|NCT00819741|Metformin|metformin|mesh-list
154053908|NCT00819741|Repaglinide|repaglinide|mesh-list
154053909|NCT00819741|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154053910|NCT00819741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154053911|NCT04208555|Terconazole|terconazole|mesh-list
154053912|NCT04208555|Antifungal Agents|antifungal agents|mesh-ancestor
154053913|NCT04208555|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154053914|NCT00621725|Cediranib|cediranib|mesh-list
154053915|NCT00621725|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153573943|NCT01697020|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153573944|NCT01697020|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153573945|NCT01697020|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153573946|NCT01697020|Immunologic Factors|immunologic factors|mesh-ancestor
153573947|NCT01697020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153573948|NCT01697020|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153573949|NCT01697020|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153573950|NCT01697046|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
153573951|NCT01697046|Raltegravir Potassium|raltegravir potassium|mesh-list
154053916|NCT00621725|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154053917|NCT00621725|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154053918|NCT00621725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154053919|NCT00862134|Docetaxel|docetaxel|mesh-list
154053920|NCT00862134|Lenograstim|lenograstim|mesh-list
154053921|NCT00862134|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154053922|NCT00862134|Tubulin Modulators|tubulin modulators|mesh-ancestor
154053923|NCT00862134|Antimitotic Agents|antimitotic agents|mesh-ancestor
154053924|NCT00862134|Mitosis Modulators|mitosis modulators|mesh-ancestor
154053925|NCT00862134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154053926|NCT00862134|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
154053927|NCT00862134|Immunologic Factors|immunologic factors|mesh-ancestor
154053928|NCT00862134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154053929|NCT00700284|Dapivirine|dapivirine|mesh-list
154053930|NCT00700284|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154053931|NCT00700284|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154053932|NCT00700284|Antiviral Agents|antiviral agents|mesh-ancestor
154053933|NCT00700284|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154053934|NCT00618527|Interferons|interferons|mesh-list
154053935|NCT00618527|Interferon-beta|interferon-beta|mesh-list
154053936|NCT00618527|Interferon beta-1a|interferon beta-1a|mesh-list
154053937|NCT00618527|Mycophenolic Acid|mycophenolic acid|mesh-list
154053938|NCT00618527|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154053939|NCT00618527|Antiviral Agents|antiviral agents|mesh-ancestor
154053940|NCT00618527|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154053941|NCT00618527|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154053942|NCT00618527|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
154053943|NCT00618527|Antitubercular Agents|antitubercular agents|mesh-ancestor
154053944|NCT00618527|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154053945|NCT00618527|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154053946|NCT00618527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154053947|NCT00618527|Immunologic Factors|immunologic factors|mesh-ancestor
153573952|NCT01697046|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153573953|NCT01697046|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153573954|NCT01697046|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153573955|NCT01697046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153573956|NCT01697046|Antiviral Agents|antiviral agents|mesh-ancestor
153573957|NCT01697046|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153573958|NCT01697046|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153573959|NCT01697046|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153573960|NCT01697046|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
153573961|NCT01697046|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
153573962|NCT01697059|Amoxicillin|amoxicillin|mesh-list
153573963|NCT01697059|Piperacillin|piperacillin|mesh-list
154053948|NCT00618527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154053950|NCT02691533|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
154053951|NCT02691533|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
154053952|NCT02691533|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
154053953|NCT02691533|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
154053954|NCT00621881|Naproxen-n-butyl nitrate|naproxen-n-butyl nitrate|mesh-list
154053955|NCT00621881|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
154053956|NCT00621881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154053957|NCT04115982|Cholecalciferol|cholecalciferol|mesh-list
154053959|NCT04115982|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154053960|NCT04115982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154053961|NCT04115982|Vitamins|vitamins|mesh-ancestor
154053962|NCT04115982|Micronutrients|micronutrients|mesh-ancestor
154053963|NCT04115982|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154053964|NCT00622037|Lubricant Eye Drops|lubricant eye drops|mesh-list
154053965|NCT00622037|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
153878182|NCT04809220|Hypoglycemic Agents|hypoglycemic agents|mesh-list
153878183|NCT04809220|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
153878184|NCT04809220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153878185|NCT04798755|Adalimumab|adalimumab|mesh-list
154053966|NCT00622037|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
154053967|NCT01010581|Folic Acid|folic acid|mesh-list
154053968|NCT01010581|Methotrexate|methotrexate|mesh-list
154053969|NCT01010581|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
154053970|NCT01010581|Abortifacient Agents|abortifacient agents|mesh-ancestor
154053971|NCT01010581|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154053972|NCT01010581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154053973|NCT01010581|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154053974|NCT01010581|Antimetabolites|antimetabolites|mesh-ancestor
154053975|NCT01010581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154053976|NCT01010581|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154053977|NCT01010581|Dermatologic Agents|dermatologic agents|mesh-ancestor
153782107|NCT00232700|Escitalopram|escitalopram|mesh-list
153573964|NCT01697059|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
153573965|NCT01697059|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153573966|NCT01697059|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153573967|NCT01697059|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
153573968|NCT01697059|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153626784|NCT02019017|Botulinum Toxins|botulinum toxins|mesh-list
153458308|NCT04021992|Gemcitabine|gemcitabine|mesh-list
153458309|NCT04021992|Doxorubicin|doxorubicin|mesh-list
153458310|NCT04021992|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
153458311|NCT04021992|Vinorelbine|vinorelbine|mesh-list
153573969|NCT01697059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153573970|NCT01697098|Dexamethasone|dexamethasone|mesh-list
153573971|NCT01697098|Dexamethasone acetate|dexamethasone acetate|mesh-list
153573972|NCT01697098|Glucocorticoids|glucocorticoids|mesh-list
154053978|NCT01010581|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154053979|NCT01010581|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
154053980|NCT01010581|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154053981|NCT01010581|Immunologic Factors|immunologic factors|mesh-ancestor
154053982|NCT01010581|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154053983|NCT01010581|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154053984|NCT01010581|Hematinics|hematinics|mesh-ancestor
154053985|NCT01010581|Vitamin B Complex|vitamin b complex|mesh-ancestor
154053986|NCT01010581|Vitamins|vitamins|mesh-ancestor
154053987|NCT01010581|Micronutrients|micronutrients|mesh-ancestor
154053988|NCT04382885|Cariprazine|cariprazine|mesh-list
154053989|NCT04382885|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154053990|NCT04382885|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154053991|NCT04382885|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154053992|NCT04382885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153418974|NCT05825443|Antimitotic Agents|antimitotic agents|mesh-ancestor
153418975|NCT05825443|Mitosis Modulators|mitosis modulators|mesh-ancestor
153418976|NCT05825443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153418977|NCT05825443|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153418978|NCT05825443|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153418979|NCT05825443|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153418981|NCT05822934|Gemcitabine|gemcitabine|mesh-list
153418982|NCT05822934|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154053993|NCT04382885|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154053994|NCT04208945|Colistin|colistin|mesh-list
154053995|NCT04208945|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154053996|NCT04208945|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154053997|NCT01016041|Paclitaxel|paclitaxel|mesh-list
154053998|NCT01016041|Everolimus|everolimus|mesh-list
154053999|NCT01016041|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154054000|NCT01016041|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154054001|NCT01016041|Tubulin Modulators|tubulin modulators|mesh-ancestor
154054002|NCT01016041|Antimitotic Agents|antimitotic agents|mesh-ancestor
154054003|NCT01016041|Mitosis Modulators|mitosis modulators|mesh-ancestor
154054004|NCT01016041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154054005|NCT01016041|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
154054006|NCT01016041|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154054007|NCT01016041|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154054025|NCT00490555|Testosterone|testosterone|mesh-list
154054026|NCT00490555|Testosterone undecanoate|testosterone undecanoate|mesh-list
154054027|NCT00490555|Testosterone enanthate|testosterone enanthate|mesh-list
154054028|NCT00490555|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
154054029|NCT00490555|Dutasteride|dutasteride|mesh-list
154054030|NCT00490555|Androgens|androgens|mesh-ancestor
154054031|NCT00490555|Hormones|hormones|mesh-ancestor
154054032|NCT00490555|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154054033|NCT00490555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154054034|NCT00490555|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154054035|NCT00490555|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154054036|NCT00490555|Anabolic Agents|anabolic agents|mesh-ancestor
154054037|NCT00490555|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
154054038|NCT00490555|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154054039|NCT00490555|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154054040|NCT00490555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154054041|NCT00490555|Hormone Antagonists|hormone antagonists|mesh-ancestor
154054042|NCT00490555|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
154054043|NCT00490555|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
153546769|NCT05948891|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
153546771|NCT05948891|Adrenergic Agents|adrenergic agents|mesh-ancestor
153546772|NCT05948891|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153546773|NCT05948891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153546774|NCT05948891|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153546775|NCT05948891|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
153546776|NCT05948891|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
154054044|NCT00490555|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
154054045|NCT00490555|Contraceptive Agents|contraceptive agents|mesh-ancestor
154054046|NCT00490555|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154054047|NCT00490555|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
154054048|NCT00490555|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
154054049|NCT00490555|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
154054050|NCT01014247|Moxifloxacin|moxifloxacin|mesh-list
154054051|NCT01014247|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
154054052|NCT01014247|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154054053|NCT01014247|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154054054|NCT01014247|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154054055|NCT01014247|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154054067|NCT00873860|Immunologic Factors|immunologic factors|mesh-ancestor
154054068|NCT00873860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154054069|NCT03854227|Docetaxel|docetaxel|mesh-list
154054070|NCT03854227|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154054071|NCT03854227|Tubulin Modulators|tubulin modulators|mesh-ancestor
154054072|NCT03854227|Antimitotic Agents|antimitotic agents|mesh-ancestor
154054073|NCT03854227|Mitosis Modulators|mitosis modulators|mesh-ancestor
154054074|NCT03854227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154054075|NCT05368961|Anti-Anxiety Agents|anti-anxiety agents|mesh-list
154054076|NCT05368961|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154054077|NCT05368961|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154054078|NCT05368961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154054079|NCT05368961|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154054080|NCT02626754|Sunitinib|sunitinib|mesh-list
154054081|NCT02626754|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154054082|NCT02626754|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154054083|NCT02626754|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154054084|NCT02626754|Growth Substances|growth substances|mesh-ancestor
154054085|NCT02626754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154054086|NCT02626754|Growth Inhibitors|growth inhibitors|mesh-ancestor
154054087|NCT02626754|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154054088|NCT02626754|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154054089|NCT02626754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154054090|NCT00691886|Dexmedetomidine|dexmedetomidine|mesh-list
154054091|NCT00691886|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154054092|NCT00691886|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154054093|NCT00691886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154054094|NCT00691886|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154054095|NCT00691886|Analgesics|analgesics|mesh-ancestor
154054096|NCT00691886|Sensory System Agents|sensory system agents|mesh-ancestor
153573973|NCT01697098|BB 1101|bb 1101|mesh-list
153573974|NCT01697098|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153573975|NCT01697098|Antiemetics|antiemetics|mesh-ancestor
153573976|NCT01697098|Autonomic Agents|autonomic agents|mesh-ancestor
153573977|NCT01697098|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153573978|NCT01697098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153573979|NCT01697098|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154054097|NCT00691886|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154054098|NCT00691886|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
153878191|NCT04798755|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154054099|NCT00691886|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
154054100|NCT00691886|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154054101|NCT00691886|Adrenergic Agents|adrenergic agents|mesh-ancestor
154054102|NCT00691886|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153878192|NCT04798755|Antimetabolites|antimetabolites|mesh-ancestor
153878193|NCT04798755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153878194|NCT04798755|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153878195|NCT04798755|Dermatologic Agents|dermatologic agents|mesh-ancestor
154054103|NCT00691886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154054104|NCT04138004|Lubiprostone|lubiprostone|mesh-list
154054105|NCT04138004|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
154054106|NCT04138004|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154054107|NCT04138004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154054108|NCT00621491|Warfarin|warfarin|mesh-list
154054109|NCT00621491|Anticoagulants|anticoagulants|mesh-list
154054110|NCT00622349|Cisplatin|cisplatin|mesh-list
154054111|NCT00622349|Gemcitabine|gemcitabine|mesh-list
154054112|NCT00622349|Docetaxel|docetaxel|mesh-list
154054113|NCT00622349|Ifosfamide|ifosfamide|mesh-list
154054114|NCT00622349|Isophosphamide mustard|isophosphamide mustard|mesh-list
154054115|NCT00622349|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154054116|NCT00622349|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154054117|NCT00622349|Antimetabolites|antimetabolites|mesh-ancestor
154054118|NCT00622349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154054119|NCT00622349|Tubulin Modulators|tubulin modulators|mesh-ancestor
154054120|NCT00622349|Antimitotic Agents|antimitotic agents|mesh-ancestor
154054121|NCT00622349|Mitosis Modulators|mitosis modulators|mesh-ancestor
154054122|NCT00622349|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154054123|NCT00622349|Alkylating Agents|alkylating agents|mesh-ancestor
154054124|NCT00686816|Sucrose polyester|sucrose polyester|mesh-list
154054125|NCT00686816|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154054126|NCT00686816|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154054127|NCT00686816|Antimetabolites|antimetabolites|mesh-ancestor
154054129|NCT00686816|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154054140|NCT05368181|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154054141|NCT05368181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154054142|NCT05368181|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154054144|NCT05368181|Hormones|hormones|mesh-ancestor
154054145|NCT05368181|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154054146|NCT05368181|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
154054147|NCT05368181|Protective Agents|protective agents|mesh-ancestor
154054148|NCT05368181|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154054149|NCT05368181|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154054150|NCT05662163|Anesthetics|anesthetics|mesh-list
154054151|NCT05662163|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154054152|NCT05662163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154054153|NCT02666105|Exemestane|exemestane|mesh-list
154054154|NCT02666105|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154054155|NCT02666105|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
154054156|NCT02666105|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154054157|NCT02666105|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154054158|NCT02666105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154054159|NCT02666105|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
154054160|NCT02666105|Hormone Antagonists|hormone antagonists|mesh-ancestor
154054161|NCT02666105|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154054162|NCT02666105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154054163|NCT04138238|Sirolimus|sirolimus|mesh-list
154054164|NCT04138238|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153418986|NCT05821972|Dexmedetomidine|dexmedetomidine|mesh-list
154054165|NCT04138238|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154054166|NCT04138238|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154054167|NCT04138238|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154054183|NCT00622817|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154054184|NCT00622817|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154054185|NCT00622817|Respiratory System Agents|respiratory system agents|mesh-ancestor
154054186|NCT00622817|Mydriatics|mydriatics|mesh-ancestor
154054187|NCT00622817|Sympathomimetics|sympathomimetics|mesh-ancestor
154054188|NCT00622817|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
154054189|NCT00622817|Nasal Decongestants|nasal decongestants|mesh-ancestor
154054190|NCT00692120|Vitamin D|vitamin d|mesh-list
154054191|NCT00692120|Ergocalciferols|ergocalciferols|mesh-list
154054192|NCT00692120|Cholecalciferol|cholecalciferol|mesh-list
154054193|NCT00692120|Vitamins|vitamins|mesh-list
154054194|NCT00692120|Micronutrients|micronutrients|mesh-ancestor
154054195|NCT00692120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154054196|NCT00692120|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154054197|NCT00692120|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154054198|NCT00819585|Colchicine|colchicine|mesh-list
154054199|NCT00819585|Allopurinol|allopurinol|mesh-list
154054200|NCT00819585|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
154054201|NCT00819585|Gout Suppressants|gout suppressants|mesh-ancestor
154054202|NCT00819585|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154054203|NCT00819585|Tubulin Modulators|tubulin modulators|mesh-ancestor
154054204|NCT00819585|Antimitotic Agents|antimitotic agents|mesh-ancestor
154054205|NCT00819585|Mitosis Modulators|mitosis modulators|mesh-ancestor
154054207|NCT00819585|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154054237|NCT03928847|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
154054238|NCT03928847|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154054239|NCT03928847|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
154054240|NCT02624726|Leucovorin|leucovorin|mesh-list
154054241|NCT02624726|Fluorouracil|fluorouracil|mesh-list
154054242|NCT02624726|Irinotecan|irinotecan|mesh-list
154054243|NCT02624726|Aflibercept|aflibercept|mesh-list
154054244|NCT02624726|Levoleucovorin|levoleucovorin|mesh-list
154054245|NCT02624726|Antimetabolites|antimetabolites|mesh-ancestor
154054246|NCT02624726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154054247|NCT02624726|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154054248|NCT02624726|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154054249|NCT02624726|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154054250|NCT02624726|Immunologic Factors|immunologic factors|mesh-ancestor
154054251|NCT02624726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154054252|NCT02624726|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
154054253|NCT02624726|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154054254|NCT02624726|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154054256|NCT02624726|Protective Agents|protective agents|mesh-ancestor
154054257|NCT02624726|Vitamin B Complex|vitamin b complex|mesh-ancestor
154054258|NCT02624726|Vitamins|vitamins|mesh-ancestor
154054259|NCT02624726|Micronutrients|micronutrients|mesh-ancestor
154054260|NCT02624726|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154054261|NCT02624726|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
154054289|NCT00819039|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
154054290|NCT00692510|Rosiglitazone|rosiglitazone|mesh-list
154054291|NCT00692510|Midazolam|midazolam|mesh-list
154054292|NCT00692510|Caffeine|caffeine|mesh-list
154054293|NCT00692510|Bupropion|bupropion|mesh-list
154054294|NCT00692510|Omeprazole|omeprazole|mesh-list
154054295|NCT00692510|Bilirubin|bilirubin|mesh-list
154054296|NCT00692510|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154054297|NCT00692510|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154054298|NCT00692510|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154054299|NCT00692510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154054300|NCT00692510|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154054301|NCT00692510|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154054302|NCT00692510|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154054303|NCT00692510|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154054304|NCT00692510|Anesthetics, General|anesthetics, general|mesh-ancestor
154054305|NCT00692510|Anesthetics|anesthetics|mesh-ancestor
154054306|NCT00692510|GABA Modulators|gaba modulators|mesh-ancestor
154054307|NCT00692510|GABA Agents|gaba agents|mesh-ancestor
154054308|NCT00692510|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154054349|NCT04187417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154054350|NCT04187417|Sensory System Agents|sensory system agents|mesh-ancestor
154054351|NCT04187417|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154054352|NCT00818883|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
154054353|NCT00818883|Chlorthalidone|chlorthalidone|mesh-list
154054354|NCT00818883|Azilsartan medoxomil|azilsartan medoxomil|mesh-list
154054355|NCT00818883|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154054356|NCT00818883|Diuretics|diuretics|mesh-ancestor
154054357|NCT00818883|Natriuretic Agents|natriuretic agents|mesh-ancestor
154054358|NCT00818883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154054359|NCT00818883|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
154054360|NCT00818883|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154054361|NCT00818883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154054362|NCT00818883|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
154054363|NCT00818883|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
154054364|NCT01014481|Tenofovir|tenofovir|mesh-list
154054365|NCT01014481|Lamivudine|lamivudine|mesh-list
154054366|NCT01014481|Efavirenz|efavirenz|mesh-list
154054367|NCT01014481|Antiviral Agents|antiviral agents|mesh-ancestor
154054368|NCT01014481|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153475844|NCT00835224|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153546792|NCT05929794|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153546793|NCT05929794|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153546795|NCT05925504|Hematinics|hematinics|mesh-ancestor
153546796|NCT05924152|Adagrasib|adagrasib|mesh-list
153546797|NCT05924152|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153546798|NCT05922930|Cyclophosphamide|cyclophosphamide|mesh-list
153546799|NCT05922930|Fludarabine|fludarabine|mesh-list
153546800|NCT05922930|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153546801|NCT05922930|Immunologic Factors|immunologic factors|mesh-ancestor
153546802|NCT05922930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153546803|NCT05922930|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153546804|NCT05922930|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154054369|NCT01014481|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
154054370|NCT01014481|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
154054371|NCT01014481|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154054372|NCT01014481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154054373|NCT01014481|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
154054374|NCT01014481|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
154054375|NCT01014481|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
154054376|NCT01014481|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
154054377|NCT01014481|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
154054378|NCT01014481|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
153573986|NCT01697098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153573987|NCT01697111|Dienogest|dienogest|mesh-list
153573988|NCT01697111|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
153573989|NCT01697111|Contraceptive Agents|contraceptive agents|mesh-ancestor
153573990|NCT01697111|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153573991|NCT01697111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153816938|NCT00427232|Endothelin B Receptor Antagonists|endothelin b receptor antagonists|mesh-ancestor
153816939|NCT00427271|Aspirin|aspirin|mesh-list
153816940|NCT00427271|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153816941|NCT00427271|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153816942|NCT00427271|Analgesics|analgesics|mesh-ancestor
154054379|NCT01014481|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
154054380|NCT01014481|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
154054382|NCT02167763|Contraceptive Agents|contraceptive agents|mesh-list
154054383|NCT02167763|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154054384|NCT02167763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154054385|NCT02167763|Trace Elements|trace elements|mesh-ancestor
154054386|NCT02167763|Micronutrients|micronutrients|mesh-ancestor
154054387|NCT00508027|Simvastatin|simvastatin|mesh-list
154054388|NCT00508027|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154054389|NCT00508027|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154054390|NCT00508027|Antimetabolites|antimetabolites|mesh-ancestor
154054391|NCT00508027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154054392|NCT00508027|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154054393|NCT00508027|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154054394|NCT00508027|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154054395|NCT01986101|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
154054396|NCT01986101|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154054397|NCT01986101|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154054398|NCT01986101|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154054399|NCT01986101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154054400|NCT01986101|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154054401|NCT01986101|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
154054402|NCT01986101|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
154054403|NCT01986101|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154054404|NCT01986101|Adrenergic Agents|adrenergic agents|mesh-ancestor
154054405|NCT01986101|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154054406|NCT01986101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154054407|NCT01986101|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
154054408|NCT01986101|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154054409|NCT01986101|Serotonin Agents|serotonin agents|mesh-ancestor
154054418|NCT00500149|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153419000|NCT05821972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153419001|NCT05821972|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
153419002|NCT05821972|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153419003|NCT05821972|Anesthetics, General|anesthetics, general|mesh-ancestor
153419005|NCT05821972|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
153419006|NCT05821972|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
153419007|NCT05774236|Dinoprostone|dinoprostone|mesh-list
153419008|NCT05774236|Oxytocics|oxytocics|mesh-ancestor
154054419|NCT00500149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154054420|NCT00500149|Dopamine Agents|dopamine agents|mesh-ancestor
154054421|NCT00500149|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154054422|NCT00681902|Lidocaine|lidocaine|mesh-list
154054423|NCT00681902|Anesthetics, Local|anesthetics, local|mesh-ancestor
154054424|NCT00681902|Anesthetics|anesthetics|mesh-ancestor
154054425|NCT00681902|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154054426|NCT00681902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154054427|NCT00681902|Sensory System Agents|sensory system agents|mesh-ancestor
154054428|NCT00681902|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154054429|NCT00681902|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154054430|NCT00681902|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
154054431|NCT00681902|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
154054432|NCT00681902|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154054433|NCT00681902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154054434|NCT04185857|Olmesartan|olmesartan|mesh-list
154054435|NCT04185857|Canrenone|canrenone|mesh-list
154054436|NCT04185857|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
154054437|NCT04185857|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
154054438|NCT04185857|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
154054439|NCT04185857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154054440|NCT04185857|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
154054466|NCT01011127|Antimetabolites|antimetabolites|mesh-ancestor
154054467|NCT01011127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154054468|NCT01011127|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154054469|NCT01011127|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154054470|NCT01011127|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154054471|NCT00912548|Tamoxifen|tamoxifen|mesh-list
154054472|NCT00912548|Goserelin|goserelin|mesh-list
154054473|NCT00912548|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
154054474|NCT00912548|Hormone Antagonists|hormone antagonists|mesh-ancestor
154054475|NCT00912548|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154054476|NCT00912548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154054477|NCT00912548|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154054478|NCT00912548|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154054479|NCT00912548|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
154054480|NCT00912548|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
154054481|NCT00912548|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154054482|NCT01016665|Anastrozole|anastrozole|mesh-list
154054483|NCT01016665|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154054484|NCT01016665|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154054485|NCT01016665|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
154054486|NCT01016665|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
154054487|NCT01016665|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154054488|NCT01016665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154054489|NCT01016665|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
154054493|NCT00681980|Valproic Acid|valproic acid|mesh-list
154054512|NCT00489853|Formoterol Fumarate|formoterol fumarate|mesh-list
154054513|NCT00489853|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154054514|NCT00489853|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153546807|NCT05922930|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153546808|NCT05922930|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153546809|NCT05910554|Metformin|metformin|mesh-list
153546810|NCT05910554|Glyburide|glyburide|mesh-list
153546811|NCT05910554|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153878219|NCT04775550|Immunologic Factors|immunologic factors|mesh-ancestor
153878220|NCT04775550|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153878221|NCT04775550|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153878222|NCT04775550|Growth Substances|growth substances|mesh-ancestor
153878223|NCT04775550|Growth Inhibitors|growth inhibitors|mesh-ancestor
153419012|NCT05748587|Deferoxamine|deferoxamine|mesh-list
154054515|NCT00489853|Autonomic Agents|autonomic agents|mesh-ancestor
154054516|NCT00489853|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154054517|NCT00489853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154054518|NCT00489853|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154054519|NCT00489853|Respiratory System Agents|respiratory system agents|mesh-ancestor
154054520|NCT00489853|Glucocorticoids|glucocorticoids|mesh-ancestor
154054521|NCT00489853|Hormones|hormones|mesh-ancestor
154054522|NCT00489853|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154054523|NCT00489853|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
154054524|NCT00489853|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154054525|NCT00489853|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154054526|NCT00489853|Adrenergic Agents|adrenergic agents|mesh-ancestor
154054527|NCT00489853|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154054528|NCT00489853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154054529|NCT00682136|Ropivacaine|ropivacaine|mesh-list
154054530|NCT00682136|Anesthetics, Local|anesthetics, local|mesh-ancestor
154054531|NCT00682136|Anesthetics|anesthetics|mesh-ancestor
154054532|NCT00682136|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154054533|NCT00682136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154054534|NCT00682136|Sensory System Agents|sensory system agents|mesh-ancestor
154054536|NCT00693056|beta-Lactams|beta-lactams|mesh-list
154054562|NCT00499681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154054564|NCT00499681|Hormone Antagonists|hormone antagonists|mesh-ancestor
154054565|NCT00499681|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154054566|NCT00499681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154054567|NCT00499681|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154054568|NCT00499681|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154054569|NCT02687009|Niclosamide|niclosamide|mesh-list
154054570|NCT02687009|Anticestodal Agents|anticestodal agents|mesh-ancestor
154054571|NCT02687009|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
154054572|NCT02687009|Anthelmintics|anthelmintics|mesh-ancestor
154054573|NCT02687009|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153419016|NCT05748587|Siderophores|siderophores|mesh-ancestor
153419017|NCT05748587|Iron Chelating Agents|iron chelating agents|mesh-ancestor
153419018|NCT05748587|Chelating Agents|chelating agents|mesh-ancestor
153419019|NCT05748587|Sequestering Agents|sequestering agents|mesh-ancestor
153419020|NCT05748587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153419021|NCT05683535|Atropine|atropine|mesh-list
153419022|NCT05683535|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154054574|NCT02687009|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154054575|NCT02687009|Antinematodal Agents|antinematodal agents|mesh-ancestor
154054576|NCT00693212|Methylphenidate|methylphenidate|mesh-list
154054577|NCT00693212|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
154054578|NCT00693212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154054579|NCT00693212|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
154054580|NCT00693212|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154054582|NCT00693212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154054583|NCT00693212|Dopamine Agents|dopamine agents|mesh-ancestor
154054584|NCT00693212|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154054585|NCT00688298|Imidacloprid|imidacloprid|mesh-list
154054586|NCT00688298|Cholinergic Agents|cholinergic agents|mesh-ancestor
154054587|NCT00688298|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154054588|NCT00688298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154054589|NCT00688298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154054590|NCT00499603|Paclitaxel|paclitaxel|mesh-list
154054591|NCT00499603|Cyclophosphamide|cyclophosphamide|mesh-list
154054592|NCT00499603|Fluorouracil|fluorouracil|mesh-list
154054593|NCT00499603|Epirubicin|epirubicin|mesh-list
154054594|NCT00499603|Everolimus|everolimus|mesh-list
154054597|NCT00499603|Tubulin Modulators|tubulin modulators|mesh-ancestor
153782116|NCT04564456|Xhance|xhance|mesh-list
154054603|NCT00499603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154054604|NCT00499603|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154054605|NCT00499603|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154054606|NCT00499603|Alkylating Agents|alkylating agents|mesh-ancestor
154054607|NCT00499603|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
154054608|NCT00499603|Antimetabolites|antimetabolites|mesh-ancestor
154054609|NCT00499603|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
154054610|NCT00499603|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154054611|NCT00499603|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154054612|NCT00499603|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154054613|NCT00499603|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154054614|NCT00499603|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
154054615|NCT00499603|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154054616|NCT01946711|Budesonide|budesonide|mesh-list
154054617|NCT01946711|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154054618|NCT01946711|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154054619|NCT01946711|Autonomic Agents|autonomic agents|mesh-ancestor
154054620|NCT01946711|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154054621|NCT01946711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154054622|NCT01946711|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154054623|NCT01946711|Respiratory System Agents|respiratory system agents|mesh-ancestor
154054624|NCT01946711|Glucocorticoids|glucocorticoids|mesh-ancestor
154054625|NCT01946711|Hormones|hormones|mesh-ancestor
154054626|NCT01946711|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154054627|NCT00693446|Sirolimus|sirolimus|mesh-list
154054628|NCT00693446|Tacrolimus|tacrolimus|mesh-list
154054629|NCT00693446|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154054630|NCT00693446|Immunologic Factors|immunologic factors|mesh-ancestor
153878231|NCT04774991|Azithromycin|azithromycin|mesh-list
153878232|NCT04774991|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153878233|NCT04774991|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153878234|NCT04764162|Choline|choline|mesh-list
154054631|NCT00693446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154054632|NCT00693446|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
154054647|NCT00693524|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154054648|NCT00693524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154054649|NCT00693524|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
154054650|NCT00693524|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154054651|NCT00693524|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154054652|NCT00693524|Immunologic Factors|immunologic factors|mesh-ancestor
154054653|NCT00693524|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
154054654|NCT00693524|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154054655|NCT00693524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154054656|NCT00693524|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154054657|NCT00693524|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
154054659|NCT00693524|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154054660|NCT00693524|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154054661|NCT00693602|Asparaginase|asparaginase|mesh-list
154054662|NCT00693602|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154054663|NCT00682214|Vitamin D|vitamin d|mesh-list
154054664|NCT00682214|Cholecalciferol|cholecalciferol|mesh-list
154054665|NCT00682214|Vitamins|vitamins|mesh-ancestor
154054666|NCT00682214|Micronutrients|micronutrients|mesh-ancestor
154054667|NCT00682214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154054668|NCT00682214|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
154054669|NCT00682214|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
154054670|NCT00693680|Imipramine|imipramine|mesh-list
154054671|NCT00693680|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
154054672|NCT00693680|Antidepressive Agents|antidepressive agents|mesh-ancestor
154054673|NCT00693680|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154054674|NCT00693680|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
154054675|NCT00693680|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154054676|NCT00693680|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154054677|NCT00693680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154054678|NCT00693680|Adrenergic Agents|adrenergic agents|mesh-ancestor
153878235|NCT04764162|Lipotropic Agents|lipotropic agents|mesh-ancestor
153878236|NCT04764162|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153878237|NCT04764162|Antimetabolites|antimetabolites|mesh-ancestor
153546826|NCT05900895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153546827|NCT05900895|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154054681|NCT00682292|Thymoglobulin|thymoglobulin|mesh-list
154054689|NCT00810069|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
154054690|NCT00810069|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
154054691|NCT00810069|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153745622|NCT03440879|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154054692|NCT00810069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154054693|NCT00810069|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154054694|NCT00810069|Serotonin Agents|serotonin agents|mesh-ancestor
154054695|NCT00810069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154054696|NCT00810069|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154054697|NCT00810069|Antidepressive Agents|antidepressive agents|mesh-ancestor
154054698|NCT00810069|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154054699|NCT00810069|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
154054700|NCT00810069|Analgesics|analgesics|mesh-ancestor
154054701|NCT00810069|Sensory System Agents|sensory system agents|mesh-ancestor
154054702|NCT00810069|Dopamine Agents|dopamine agents|mesh-ancestor
154054703|NCT00693758|Adenosine|adenosine|mesh-list
154054704|NCT00693758|Analgesics|analgesics|mesh-ancestor
154054705|NCT00693758|Sensory System Agents|sensory system agents|mesh-ancestor
154054706|NCT00693758|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153816943|NCT00427271|Sensory System Agents|sensory system agents|mesh-ancestor
153816944|NCT00427271|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153546830|NCT05899049|Belzutifan|belzutifan|mesh-list
153816945|NCT00427271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153816946|NCT00427271|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153816947|NCT00427271|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153546831|NCT05899049|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153816948|NCT00427271|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153816949|NCT00427271|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153816950|NCT00427271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153816951|NCT00427271|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153816952|NCT00427271|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153816953|NCT00427271|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153816954|NCT00427271|Antipyretics|antipyretics|mesh-ancestor
153816955|NCT00460083|Pimecrolimus|pimecrolimus|mesh-list
153816956|NCT00460083|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153573992|NCT01697111|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
153573993|NCT01697111|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
153573994|NCT01697111|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
153573995|NCT01697111|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
153573996|NCT01697111|Hormone Antagonists|hormone antagonists|mesh-ancestor
153573997|NCT01697111|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153573998|NCT01697111|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153573999|NCT01697111|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153574000|NCT01697150|Pancrelipase|pancrelipase|mesh-list
153574001|NCT01697150|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153574002|NCT01697228|Vitamin D|vitamin d|mesh-list
153574003|NCT01697228|Vitamins|vitamins|mesh-ancestor
153574004|NCT01697228|Micronutrients|micronutrients|mesh-ancestor
153574005|NCT01697228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153574006|NCT01697228|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153574007|NCT01697293|Paclitaxel|paclitaxel|mesh-list
153546832|NCT05899049|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153546833|NCT05899049|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153574008|NCT01697293|Cyclophosphamide|cyclophosphamide|mesh-list
153574009|NCT01697293|Doxorubicin|doxorubicin|mesh-list
154054708|NCT00693758|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
154054709|NCT00693758|Vasodilator Agents|vasodilator agents|mesh-ancestor
154054710|NCT00693758|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
154054711|NCT00693758|Purinergic Agonists|purinergic agonists|mesh-ancestor
154054712|NCT00693758|Purinergic Agents|purinergic agents|mesh-ancestor
154054713|NCT00693758|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154054714|NCT00693758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154054715|NCT02625740|Paclitaxel|paclitaxel|mesh-list
154054716|NCT02625740|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154054717|NCT02625740|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154054718|NCT02625740|Tubulin Modulators|tubulin modulators|mesh-ancestor
154054719|NCT02625740|Antimitotic Agents|antimitotic agents|mesh-ancestor
154054720|NCT02625740|Mitosis Modulators|mitosis modulators|mesh-ancestor
154054721|NCT02625740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154054722|NCT00688922|Pravastatin|pravastatin|mesh-list
154054723|NCT00688922|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
154054724|NCT00688922|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
154054725|NCT00688922|Antimetabolites|antimetabolites|mesh-ancestor
154054726|NCT00688922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154054727|NCT00688922|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
154054728|NCT00688922|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
154054729|NCT00688922|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154054730|NCT00694148|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
154054731|NCT00694148|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
154054732|NCT00694148|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153574010|NCT01697293|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
153574011|NCT01697293|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
153574012|NCT01697293|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153574013|NCT01697293|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153574014|NCT01697293|Tubulin Modulators|tubulin modulators|mesh-ancestor
153574015|NCT01697293|Antimitotic Agents|antimitotic agents|mesh-ancestor
153574016|NCT01697293|Mitosis Modulators|mitosis modulators|mesh-ancestor
153574017|NCT01697293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153574018|NCT01697293|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153816957|NCT00460083|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153816958|NCT00460083|Analgesics|analgesics|mesh-ancestor
153816959|NCT00460083|Sensory System Agents|sensory system agents|mesh-ancestor
153816960|NCT00460083|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153816961|NCT00460083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153546834|NCT05899049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153546835|NCT05899049|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153546836|NCT05899049|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153419065|NCT05675319|Hormones|hormones|mesh-ancestor
153816962|NCT00460083|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153816963|NCT00460083|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153816964|NCT00460083|Dermatologic Agents|dermatologic agents|mesh-ancestor
153458312|NCT04021992|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154054733|NCT00694148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154054734|NCT00694148|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
154054735|NCT00694148|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
154054736|NCT00694148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154054737|NCT00694148|Cholinergic Agents|cholinergic agents|mesh-ancestor
154054738|NCT00694148|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154054739|NCT02626364|Crenolanib|crenolanib|mesh-list
154054740|NCT02626364|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154054741|NCT00694460|Vaccines|vaccines|mesh-list
154054742|NCT00694460|Immunologic Factors|immunologic factors|mesh-ancestor
154054743|NCT00694460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154054744|NCT04776525|Doxorubicin|doxorubicin|mesh-list
154054745|NCT04776525|Ifosfamide|ifosfamide|mesh-list
154054746|NCT04776525|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154054747|NCT04776525|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154054748|NCT04776525|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154054749|NCT04776525|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154054750|NCT04776525|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154054751|NCT04776525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154054752|NCT04776525|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
154054753|NCT04776525|Alkylating Agents|alkylating agents|mesh-ancestor
154054789|NCT01016821|Narcotics|narcotics|mesh-ancestor
154054790|NCT01016821|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154054791|NCT01016821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154054792|NCT01016821|Analgesics|analgesics|mesh-ancestor
154054793|NCT01016821|Sensory System Agents|sensory system agents|mesh-ancestor
154054794|NCT01016821|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154054795|NCT01011205|Mycophenolic Acid|mycophenolic acid|mesh-list
154054796|NCT01011205|Methylprednisolone|methylprednisolone|mesh-list
154054797|NCT01011205|Tacrolimus|tacrolimus|mesh-list
154054798|NCT01011205|Basiliximab|basiliximab|mesh-list
154054799|NCT01011205|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
154054800|NCT01011205|Immunologic Factors|immunologic factors|mesh-ancestor
154054801|NCT01011205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154054802|NCT01011205|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
154054803|NCT01011205|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154054804|NCT01011205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154054805|NCT01011205|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
154054806|NCT01011205|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154054807|NCT01011205|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
154054808|NCT01011205|Antitubercular Agents|antitubercular agents|mesh-ancestor
154054809|NCT01011205|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
154054810|NCT01011205|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154054811|NCT01011205|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
154054812|NCT01011205|Antiemetics|antiemetics|mesh-ancestor
154054813|NCT01011205|Autonomic Agents|autonomic agents|mesh-ancestor
153419083|NCT05641376|Sensory System Agents|sensory system agents|mesh-ancestor
153458313|NCT04021992|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153458315|NCT04021992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153458316|NCT04021992|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153458317|NCT04021992|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153458318|NCT04021992|Antimetabolites|antimetabolites|mesh-ancestor
153458319|NCT04021992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153458320|NCT04021992|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153458321|NCT04021992|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153458322|NCT04021992|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153574019|NCT01697293|Immunologic Factors|immunologic factors|mesh-ancestor
153574020|NCT01697293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153574021|NCT01697293|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153574022|NCT01697293|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153574023|NCT01697293|Alkylating Agents|alkylating agents|mesh-ancestor
153574024|NCT01697293|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153574025|NCT01697293|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153574026|NCT01697293|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153574027|NCT01697293|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153574028|NCT01697293|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153574029|NCT01697306|Gemcitabine|gemcitabine|mesh-list
154054815|NCT01011205|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154054816|NCT01011205|Glucocorticoids|glucocorticoids|mesh-ancestor
154054817|NCT01011205|Hormones|hormones|mesh-ancestor
154054818|NCT01011205|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
154054819|NCT01011205|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
154054820|NCT01011205|Protective Agents|protective agents|mesh-ancestor
154054821|NCT00809835|Galantamine|galantamine|mesh-list
154054822|NCT00809835|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
154054823|NCT00809835|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154054824|NCT00809835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154054825|NCT00809835|Cholinergic Agents|cholinergic agents|mesh-ancestor
154054826|NCT00809835|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154054827|NCT00809835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154054828|NCT00809835|Parasympathomimetics|parasympathomimetics|mesh-ancestor
154054829|NCT00809835|Autonomic Agents|autonomic agents|mesh-ancestor
154054830|NCT00809835|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154054831|NCT00809835|Nootropic Agents|nootropic agents|mesh-ancestor
154054832|NCT01014559|Oxycodone|oxycodone|mesh-list
154054833|NCT01014559|Naloxone|naloxone|mesh-list
154054834|NCT01014559|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
154054835|NCT01014559|Narcotics|narcotics|mesh-ancestor
154054836|NCT01014559|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154054837|NCT01014559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154054838|NCT01014559|Analgesics|analgesics|mesh-ancestor
154054839|NCT01014559|Sensory System Agents|sensory system agents|mesh-ancestor
154054840|NCT01014559|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154054842|NCT00853242|Sevelamer|sevelamer|mesh-list
154054861|NCT00694694|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
154054862|NCT00694694|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
154054863|NCT00694694|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154054864|NCT00694694|Antiviral Agents|antiviral agents|mesh-ancestor
154054865|NCT00694694|Schistosomicides|schistosomicides|mesh-ancestor
154054866|NCT00694694|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
154054867|NCT00694694|Anthelmintics|anthelmintics|mesh-ancestor
154054868|NCT00700362|Insulin|insulin|mesh-list
154054869|NCT00700362|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
154054870|NCT00700362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153419084|NCT05641376|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153419085|NCT05641376|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
153419086|NCT05641376|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153419087|NCT05641376|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153419088|NCT05641376|Adrenergic Agents|adrenergic agents|mesh-ancestor
153419089|NCT05641376|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153419090|NCT05641376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153419091|NCT05615311|Vitamin D|vitamin d|mesh-list
154054871|NCT04136600|Antibodies|antibodies|mesh-list
154054872|NCT04136600|Immunologic Factors|immunologic factors|mesh-ancestor
154054873|NCT04136600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154054874|NCT00809757|Albuterol|albuterol|mesh-list
154054875|NCT00809757|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154054876|NCT00809757|Autonomic Agents|autonomic agents|mesh-ancestor
154054877|NCT00809757|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153597547|NCT01870050|Leprostatic Agents|leprostatic agents|mesh-ancestor
154054878|NCT00809757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154054879|NCT00809757|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154054880|NCT00809757|Respiratory System Agents|respiratory system agents|mesh-ancestor
154054881|NCT00809757|Tocolytic Agents|tocolytic agents|mesh-ancestor
154054882|NCT00809757|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154054883|NCT00809757|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
154054884|NCT00809757|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154054885|NCT00809757|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154054910|NCT05326269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154054911|NCT05326269|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154054912|NCT05326269|Respiratory System Agents|respiratory system agents|mesh-ancestor
154054914|NCT05326269|Tocolytic Agents|tocolytic agents|mesh-ancestor
154054915|NCT05326269|Reproductive Control Agents|reproductive control agents|mesh-ancestor
154054916|NCT05326269|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
154054917|NCT05326269|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
154054918|NCT05326269|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
154054919|NCT05326269|Adrenergic Agents|adrenergic agents|mesh-ancestor
154054920|NCT05326269|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154054921|NCT05326269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154054922|NCT02624570|Midostaurin|midostaurin|mesh-list
154054923|NCT02624570|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154054924|NCT02624570|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154054925|NCT02624570|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154054926|NCT02624570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154054927|NCT04665453|Dexmedetomidine|dexmedetomidine|mesh-list
154054928|NCT04665453|Melatonin|melatonin|mesh-list
154054929|NCT04665453|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154054930|NCT04665453|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154054931|NCT04665453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154054932|NCT04665453|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
154054933|NCT04665453|Analgesics|analgesics|mesh-ancestor
154054934|NCT04665453|Sensory System Agents|sensory system agents|mesh-ancestor
154054935|NCT04665453|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154054936|NCT04665453|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
154054942|NCT04665453|Antioxidants|antioxidants|mesh-ancestor
154054956|NCT00689702|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154054957|NCT00689702|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
154054958|NCT00689780|Midazolam|midazolam|mesh-list
154054959|NCT00689780|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
154054960|NCT00689780|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
154054961|NCT00689780|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154054962|NCT00689780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154054963|NCT00689780|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
154054964|NCT00689780|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154054965|NCT00689780|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154054966|NCT00689780|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
154054967|NCT00689780|Anesthetics, General|anesthetics, general|mesh-ancestor
154054968|NCT00689780|Anesthetics|anesthetics|mesh-ancestor
154054969|NCT00689780|GABA Modulators|gaba modulators|mesh-ancestor
154054970|NCT00689780|GABA Agents|gaba agents|mesh-ancestor
153419108|NCT05593939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153419109|NCT05593939|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153419110|NCT05593939|Antimetabolites|antimetabolites|mesh-ancestor
153419111|NCT05593939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154054971|NCT00689780|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154054972|NCT00689780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154054973|NCT00689858|Cilostazol|cilostazol|mesh-list
154054974|NCT00689858|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
154054975|NCT00689858|Autonomic Agents|autonomic agents|mesh-ancestor
154054976|NCT00689858|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
154054977|NCT00689858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154054978|NCT00689858|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
154054979|NCT00689858|Respiratory System Agents|respiratory system agents|mesh-ancestor
154054980|NCT00689858|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
154054981|NCT00689858|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
154054982|NCT00689858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154054983|NCT00689858|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
154054984|NCT00689858|Vasodilator Agents|vasodilator agents|mesh-ancestor
154054985|NCT00689858|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
154054986|NCT00689858|Protective Agents|protective agents|mesh-ancestor
154054987|NCT00689858|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
154054988|NCT00689858|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
154054989|NCT00689858|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154054990|NCT00695630|Flumazenil|flumazenil|mesh-list
154054991|NCT00695630|Antidotes|antidotes|mesh-ancestor
154054992|NCT00695630|Protective Agents|protective agents|mesh-ancestor
153574030|NCT01697306|BCG Vaccine|bcg vaccine|mesh-list
154054995|NCT00695630|GABA Agents|gaba agents|mesh-ancestor
154054996|NCT00695630|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154054997|NCT00695630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154054998|NCT01614899|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
154054999|NCT01614899|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
154055000|NCT01614899|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
154055001|NCT01614899|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
154055002|NCT01614899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154055003|NCT01614899|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
154055004|NCT01614899|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
154055005|NCT01614899|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
154055006|NCT01614899|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
154055007|NCT01614899|Adrenergic Agents|adrenergic agents|mesh-ancestor
154055008|NCT01614899|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
154055009|NCT01614899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153878309|NCT04588246|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
153878310|NCT04588246|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
153878311|NCT04553666|Vitamins|vitamins|mesh-list
153878312|NCT04553666|Ascorbic Acid|ascorbic acid|mesh-list
153878313|NCT04553666|Epigallocatechin gallate|epigallocatechin gallate|mesh-list
153878314|NCT04553666|Micronutrients|micronutrients|mesh-ancestor
153878315|NCT04553666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154055010|NCT01614899|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
154055011|NCT01614899|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
154055012|NCT01614899|Serotonin Agents|serotonin agents|mesh-ancestor
154055013|NCT01614899|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
154055014|NCT01614899|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
154055015|NCT01614899|Dopamine Agents|dopamine agents|mesh-ancestor
154055016|NCT00690014|Probenecid|probenecid|mesh-list
154055017|NCT00690014|Uricosuric Agents|uricosuric agents|mesh-ancestor
154055018|NCT00690014|Gout Suppressants|gout suppressants|mesh-ancestor
154055019|NCT00690014|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
154055020|NCT00683306|Gefitinib|gefitinib|mesh-list
154055021|NCT00683306|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
154055022|NCT00683306|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
154055023|NCT00683306|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154055024|NCT00683306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153574031|NCT01697306|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153574032|NCT01697306|Antimetabolites|antimetabolites|mesh-ancestor
153574033|NCT01697306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153574034|NCT01697306|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153574035|NCT01697306|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153574036|NCT01697306|Immunologic Factors|immunologic factors|mesh-ancestor
153574037|NCT01697306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
154055026|NCT04208399|JNJ-56136379|jnj-56136379|mesh-list
154055027|NCT04208399|Antiviral Agents|antiviral agents|mesh-ancestor
153597696|NCT01870635|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
154055028|NCT04208399|Anti-Infective Agents|anti-infective agents|mesh-ancestor
154055030|NCT00912392|Etoposide|etoposide|mesh-list
154055031|NCT00912392|Endostar protein|endostar protein|mesh-list
154055032|NCT00912392|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
154055033|NCT00912392|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
154055034|NCT00912392|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
154055035|NCT00912392|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
154055036|NCT00912392|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
154055037|NCT00912392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
154055038|NCT00912392|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
154055039|NCT00912392|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153546872|NCT05889624|Sensory System Agents|sensory system agents|mesh-ancestor
153782501|NCT00267813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153546873|NCT05889624|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153546874|NCT05889624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153546875|NCT05889624|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
153913893|NCT01014975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153546878|NCT05889624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153913894|NCT03982537|Acetylcysteine|acetylcysteine|mesh-list
153913895|NCT03982537|N-monoacetylcystine|n-monoacetylcystine|mesh-list
153913896|NCT03982537|Antiviral Agents|antiviral agents|mesh-ancestor
153913897|NCT03982537|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153455678|NCT05289349|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153455679|NCT05289349|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
153455680|NCT05194293|Durvalumab|durvalumab|mesh-list
153455681|NCT05194293|Immunoglobulins|immunoglobulins|mesh-list
153455683|NCT05194293|Immunoglobulin G|immunoglobulin g|mesh-list
153455684|NCT05194293|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153455685|NCT05194293|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153455686|NCT05194293|Immunologic Factors|immunologic factors|mesh-ancestor
153546879|NCT05889624|Adrenergic Agents|adrenergic agents|mesh-ancestor
153546880|NCT05889624|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153546881|NCT05886049|Cytarabine|cytarabine|mesh-list
153546882|NCT05886049|Daunorubicin|daunorubicin|mesh-list
153419135|NCT05491187|Fentanyl|fentanyl|mesh-list
153419136|NCT05491187|Bupivacaine|bupivacaine|mesh-list
153419137|NCT05491187|Anesthetics, Local|anesthetics, local|mesh-ancestor
153419138|NCT05491187|Anesthetics|anesthetics|mesh-ancestor
153419139|NCT05491187|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153419140|NCT05491187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153419141|NCT05491187|Sensory System Agents|sensory system agents|mesh-ancestor
153419142|NCT05491187|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153419143|NCT05491187|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153419144|NCT05491187|Narcotics|narcotics|mesh-ancestor
153546884|NCT05886049|Antimetabolites|antimetabolites|mesh-ancestor
153546885|NCT05886049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153546886|NCT05886049|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153546887|NCT05886049|Antiviral Agents|antiviral agents|mesh-ancestor
153546888|NCT05886049|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153546889|NCT05886049|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153546890|NCT05886049|Immunologic Factors|immunologic factors|mesh-ancestor
153546891|NCT05886049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153546892|NCT05886049|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153878338|NCT04551885|Antiviral Agents|antiviral agents|mesh-ancestor
153878339|NCT04551885|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153878340|NCT04551885|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153878341|NCT04516447|Paclitaxel|paclitaxel|mesh-list
153878342|NCT04516447|Carboplatin|carboplatin|mesh-list
153455687|NCT05194293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153455688|NCT05183048|Panitumumab|panitumumab|mesh-list
153455689|NCT05183048|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153455704|NCT05150938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153455705|NCT05150938|Anticoagulants|anticoagulants|mesh-ancestor
153455706|NCT05150938|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153455707|NCT05150938|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153546893|NCT05886049|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153546894|NCT05886049|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153546895|NCT05886049|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153546896|NCT05883540|Lysergic Acid Diethylamide|lysergic acid diethylamide|mesh-list
153546897|NCT05883540|Hallucinogens|hallucinogens|mesh-ancestor
153546898|NCT05883540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153546899|NCT05883540|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153546900|NCT05883540|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153878356|NCT04516447|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153419145|NCT05491187|Analgesics|analgesics|mesh-ancestor
153419146|NCT05491187|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153475855|NCT00837252|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153419148|NCT05491187|Anesthetics, General|anesthetics, general|mesh-ancestor
153419150|NCT05480878|Escitalopram|escitalopram|mesh-list
153419151|NCT05480878|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
153546901|NCT05883540|Serotonin Agents|serotonin agents|mesh-ancestor
153546902|NCT05883540|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153546903|NCT05883540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153546904|NCT05883540|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
153546906|NCT05878964|Mitosis Modulators|mitosis modulators|mesh-ancestor
153546907|NCT05878964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153546908|NCT05872867|Pembrolizumab|pembrolizumab|mesh-list
153546909|NCT05872867|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153546910|NCT05872867|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153546911|NCT05872867|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153546912|NCT05872867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153546913|NCT05838599|Imiquimod|imiquimod|mesh-list
153916628|NCT00639925|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153916629|NCT00639925|Antimetabolites|antimetabolites|mesh-ancestor
153916642|NCT00994461|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
153916643|NCT00994461|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153916644|NCT00994461|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153916645|NCT00994461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153418614|NCT02823080|Cetrorelix|cetrorelix|mesh-list
153465373|NCT00282282|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153916647|NCT00993915|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153916648|NCT00993915|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153916649|NCT00993915|Antimetabolites|antimetabolites|mesh-ancestor
153455708|NCT05150938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153455709|NCT05150938|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
153455710|NCT05150938|Antithrombins|antithrombins|mesh-ancestor
153455711|NCT05150938|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
153455712|NCT05150938|Protease Inhibitors|protease inhibitors|mesh-ancestor
153455713|NCT05150938|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153455714|NCT05150938|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
153455715|NCT05150938|Hemostatics|hemostatics|mesh-ancestor
153878357|NCT04516447|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153878358|NCT04485559|Everolimus|everolimus|mesh-list
153878359|NCT04485559|Trametinib|trametinib|mesh-list
153878360|NCT04485559|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
153878361|NCT04485559|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153878362|NCT04485559|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153878364|NCT04485559|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153546921|NCT05838599|Interferon Inducers|interferon inducers|mesh-ancestor
153546922|NCT05836584|Calcium, Dietary|calcium, dietary|mesh-list
153878373|NCT04466150|Immunologic Factors|immunologic factors|mesh-ancestor
153878374|NCT04466150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153878375|NCT04464265|Propofol|propofol|mesh-list
153878376|NCT04464265|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153878377|NCT04464265|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153878378|NCT04464265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153878379|NCT04464265|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153878380|NCT04464265|Anesthetics, General|anesthetics, general|mesh-ancestor
153501284|NCT00376662|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153455729|NCT05110001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153444275|NCT02708849|Anticonvulsants|anticonvulsants|mesh-ancestor
153501285|NCT00376662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153501286|NCT00376662|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153501287|NCT00376740|Zoledronic Acid|zoledronic acid|mesh-list
153501288|NCT00376740|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153501289|NCT00376740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153501290|NCT00376818|Hormones|hormones|mesh-list
153546924|NCT05836584|Folic Acid|folic acid|mesh-list
153546925|NCT05836584|Docetaxel|docetaxel|mesh-list
153546926|NCT05836584|Capecitabine|capecitabine|mesh-list
153546927|NCT05836584|Fluorouracil|fluorouracil|mesh-list
153546928|NCT05836584|Oxaliplatin|oxaliplatin|mesh-list
153546929|NCT05836584|Atezolizumab|atezolizumab|mesh-list
153546930|NCT05836584|Calcium|calcium|mesh-list
153546931|NCT05836584|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
153546932|NCT05836584|Levoleucovorin|levoleucovorin|mesh-list
153546933|NCT05836584|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153546934|NCT05836584|Tubulin Modulators|tubulin modulators|mesh-ancestor
153546935|NCT05836584|Antimitotic Agents|antimitotic agents|mesh-ancestor
153546936|NCT05836584|Mitosis Modulators|mitosis modulators|mesh-ancestor
153546937|NCT05836584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153546938|NCT05836584|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153546939|NCT05836584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153501291|NCT00376818|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153501292|NCT00376818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153501293|NCT00377442|Simvastatin|simvastatin|mesh-list
153501303|NCT00377910|Anesthetics, Local|anesthetics, local|mesh-ancestor
153501304|NCT00377910|Anesthetics|anesthetics|mesh-ancestor
153501305|NCT00377910|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153501306|NCT00377910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153501307|NCT00377910|Sensory System Agents|sensory system agents|mesh-ancestor
153455730|NCT05110001|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153455731|NCT05110001|Antifungal Agents|antifungal agents|mesh-ancestor
153546940|NCT05836584|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153546941|NCT05836584|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153546942|NCT05836584|Antimetabolites|antimetabolites|mesh-ancestor
153546943|NCT05836584|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153546944|NCT05836584|Immunologic Factors|immunologic factors|mesh-ancestor
153546945|NCT05836584|Antidotes|antidotes|mesh-ancestor
153546946|NCT05836584|Protective Agents|protective agents|mesh-ancestor
153546947|NCT05836584|Vitamin B Complex|vitamin b complex|mesh-ancestor
153546948|NCT05836584|Vitamins|vitamins|mesh-ancestor
153546949|NCT05836584|Micronutrients|micronutrients|mesh-ancestor
153546951|NCT05836584|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153546952|NCT05836584|Hematinics|hematinics|mesh-ancestor
153546953|NCT05835284|Silicon|silicon|mesh-list
153546954|NCT05835284|Trace Elements|trace elements|mesh-ancestor
153546955|NCT05835284|Micronutrients|micronutrients|mesh-ancestor
153419225|NCT05322252|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
153419226|NCT05322252|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
153546956|NCT05835284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153878426|NCT04356729|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153455732|NCT05084196|Melatonin|melatonin|mesh-list
153455733|NCT05084196|Antioxidants|antioxidants|mesh-ancestor
153455734|NCT05084196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153455735|NCT05084196|Protective Agents|protective agents|mesh-ancestor
153455736|NCT05084196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153455737|NCT05084196|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153455738|NCT05060315|Treprostinil|treprostinil|mesh-list
153455739|NCT05060315|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153455741|NCT05031234|Anesthetics|anesthetics|mesh-list
153455742|NCT05031234|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153455743|NCT05031234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153455744|NCT05031234|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153455745|NCT05031234|Narcotics|narcotics|mesh-ancestor
153501308|NCT00377910|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153501309|NCT00377910|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153501310|NCT00377910|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
153501311|NCT00377910|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153501312|NCT00377910|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153501313|NCT00377910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153501315|NCT00377910|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
153878427|NCT04356729|Growth Substances|growth substances|mesh-ancestor
153878428|NCT04356729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153878429|NCT04356729|Growth Inhibitors|growth inhibitors|mesh-ancestor
153878430|NCT04356729|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153878431|NCT04356729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153878432|NCT04329650|Dexamethasone|dexamethasone|mesh-list
153546957|NCT05827055|Paclitaxel|paclitaxel|mesh-list
153546958|NCT05827055|Gemcitabine|gemcitabine|mesh-list
153546959|NCT05827055|Proglumide|proglumide|mesh-list
153546960|NCT05827055|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153546961|NCT05827055|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153546962|NCT05827055|Tubulin Modulators|tubulin modulators|mesh-ancestor
153878433|NCT04329650|Siltuximab|siltuximab|mesh-list
153501316|NCT00377988|Contraceptive Agents|contraceptive agents|mesh-list
153501317|NCT00377988|Norgestimate|norgestimate|mesh-list
153455751|NCT05005260|Anesthetics|anesthetics|mesh-ancestor
153878434|NCT04329650|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153878435|NCT04329650|Antiemetics|antiemetics|mesh-ancestor
153455752|NCT05005260|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153455753|NCT05005260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153455754|NCT05005260|Sensory System Agents|sensory system agents|mesh-ancestor
153455755|NCT05005260|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153455756|NCT04968587|Dialysis Solutions|dialysis solutions|mesh-list
153878436|NCT04329650|Autonomic Agents|autonomic agents|mesh-ancestor
153878437|NCT04329650|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153878438|NCT04329650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153878439|NCT04329650|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153878453|NCT04282187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153878454|NCT04282187|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153878455|NCT04282187|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153878456|NCT04282187|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153878457|NCT04275336|Lidocaine, Prilocaine Drug Combination|lidocaine, prilocaine drug combination|mesh-list
153878458|NCT04275336|Anesthetics, Local|anesthetics, local|mesh-ancestor
153878459|NCT04275336|Anesthetics|anesthetics|mesh-ancestor
153878460|NCT04275336|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153878461|NCT04275336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153878462|NCT04275336|Sensory System Agents|sensory system agents|mesh-ancestor
153878463|NCT04275336|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153878464|NCT04275336|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
153878465|NCT04251910|Dexmedetomidine|dexmedetomidine|mesh-list
153878466|NCT04251910|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153419256|NCT05010954|Dexlansoprazole|dexlansoprazole|mesh-list
153419257|NCT05010954|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
153419258|NCT05010954|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153419259|NCT05010954|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
153419260|NCT05010954|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153455757|NCT04968587|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
153455758|NCT04965519|Trastuzumab|trastuzumab|mesh-list
153455759|NCT04965519|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153546964|NCT05827055|Mitosis Modulators|mitosis modulators|mesh-ancestor
153546965|NCT05827055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153455760|NCT04965519|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153455761|NCT04965298|Lansoprazole|lansoprazole|mesh-list
153455762|NCT04965298|Dexlansoprazole|dexlansoprazole|mesh-list
153455763|NCT04965298|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
153455765|NCT04965298|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
153546966|NCT05827055|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153546967|NCT05827055|Antimetabolites|antimetabolites|mesh-ancestor
153546968|NCT05827055|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
153546969|NCT05827055|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153546971|NCT05822583|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153419261|NCT05010954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153419263|NCT05001724|Lenvatinib|lenvatinib|mesh-list
153419264|NCT05001724|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153419265|NCT05001724|Tubulin Modulators|tubulin modulators|mesh-ancestor
153419266|NCT05001724|Antimitotic Agents|antimitotic agents|mesh-ancestor
153419267|NCT05001724|Mitosis Modulators|mitosis modulators|mesh-ancestor
153419268|NCT05001724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153419269|NCT05001724|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153419270|NCT05001724|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153419271|NCT04996368|Tranexamic Acid|tranexamic acid|mesh-list
153419272|NCT04996368|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
153419273|NCT04996368|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153546972|NCT05822583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153546973|NCT05822583|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153455766|NCT04965298|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153455767|NCT04965298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153546975|NCT05822583|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153546976|NCT05822583|Immunologic Factors|immunologic factors|mesh-ancestor
153913974|NCT02722603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153913975|NCT02722603|Anticonvulsants|anticonvulsants|mesh-ancestor
153913976|NCT02722603|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153913977|NCT02722603|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153913978|NCT02722603|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153913979|NCT02722603|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153913980|NCT02722603|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
153913984|NCT02722603|Antimanic Agents|antimanic agents|mesh-ancestor
153501318|NCT00377988|Contraceptives, Oral|contraceptives, oral|mesh-list
153455777|NCT04938557|Insulin|insulin|mesh-list
153455819|NCT04756401|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153455820|NCT04756401|Antiemetics|antiemetics|mesh-ancestor
153455821|NCT04756401|Autonomic Agents|autonomic agents|mesh-ancestor
153455822|NCT04756401|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153455823|NCT04756401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153455824|NCT04756401|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153546977|NCT05822583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153878467|NCT04251910|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153878468|NCT04251910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153878469|NCT04251910|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153878470|NCT04251910|Analgesics|analgesics|mesh-ancestor
153878471|NCT04251910|Sensory System Agents|sensory system agents|mesh-ancestor
153878472|NCT04251910|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153878473|NCT04251910|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
153546978|NCT05822583|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153546979|NCT05819541|Albuterol|albuterol|mesh-list
153546980|NCT05819541|Montelukast|montelukast|mesh-list
153546981|NCT05819541|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153878480|NCT04246151|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153878481|NCT04246151|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153878482|NCT04235140|Ivacaftor|ivacaftor|mesh-list
153455825|NCT04756401|Glucocorticoids|glucocorticoids|mesh-ancestor
153455826|NCT04756401|Hormones|hormones|mesh-ancestor
153455827|NCT04756401|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153455829|NCT04756401|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153455830|NCT04756401|Protease Inhibitors|protease inhibitors|mesh-ancestor
153455848|NCT04588727|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153455849|NCT04588727|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153455850|NCT04588727|Analgesics|analgesics|mesh-ancestor
153878483|NCT04235140|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
153878484|NCT04235140|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153419274|NCT04996368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153419275|NCT04996368|Hemostatics|hemostatics|mesh-ancestor
153419276|NCT04996368|Coagulants|coagulants|mesh-ancestor
153419277|NCT04994444|Nicotine|nicotine|mesh-list
153419278|NCT04994444|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
153419279|NCT04994444|Autonomic Agents|autonomic agents|mesh-ancestor
153419280|NCT04994444|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153419281|NCT04994444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153419282|NCT04994444|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
153419283|NCT04994444|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
153419284|NCT04994444|Cholinergic Agents|cholinergic agents|mesh-ancestor
153419285|NCT04994444|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153419286|NCT04994444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153419287|NCT04987892|Tamsulosin|tamsulosin|mesh-list
153419288|NCT04987892|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
153419289|NCT04987892|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
153419290|NCT04987892|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
153419291|NCT04987892|Adrenergic Agents|adrenergic agents|mesh-ancestor
153546983|NCT05819541|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
153546984|NCT05819541|Hormone Antagonists|hormone antagonists|mesh-ancestor
153546985|NCT05819541|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153546986|NCT05819541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153546987|NCT05819541|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
153546988|NCT05819541|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
153455851|NCT04588727|Sensory System Agents|sensory system agents|mesh-ancestor
153455852|NCT04588727|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153455853|NCT04588727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153546989|NCT05819541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153878485|NCT04235140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153455854|NCT04588727|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153455855|NCT04588727|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153455873|NCT04564547|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153455874|NCT04564547|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153455875|NCT04564547|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153455876|NCT04559607|Apatinib|apatinib|mesh-list
153455877|NCT04559607|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153455878|NCT04559607|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153455879|NCT04559607|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153914084|NCT02711917|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
153914085|NCT02711917|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
153914086|NCT02711917|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153914087|NCT02711449|Methylprednisolone|methylprednisolone|mesh-list
153914088|NCT02711449|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
153914089|NCT02711449|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
153914090|NCT02711449|Prednisolone|prednisolone|mesh-list
153914091|NCT02711449|Prednisolone acetate|prednisolone acetate|mesh-list
153878486|NCT04220684|Cytarabine|cytarabine|mesh-list
153878487|NCT04220684|Fludarabine|fludarabine|mesh-list
153878488|NCT04220684|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153878489|NCT04220684|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153878490|NCT04220684|Antimetabolites|antimetabolites|mesh-ancestor
153878491|NCT04220684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153878492|NCT04220684|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153878493|NCT04220684|Immunologic Factors|immunologic factors|mesh-ancestor
153914092|NCT02711449|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
153914093|NCT02711449|Prednisolone phosphate|prednisolone phosphate|mesh-list
153878494|NCT04220684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153878495|NCT04220684|Antiviral Agents|antiviral agents|mesh-ancestor
153878496|NCT04220684|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153878497|NCT04216589|Semaglutide|semaglutide|mesh-list
153878498|NCT04216589|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
153914094|NCT02711449|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153878499|NCT04216589|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153914095|NCT02711449|Antiemetics|antiemetics|mesh-ancestor
153914096|NCT02711449|Autonomic Agents|autonomic agents|mesh-ancestor
153914097|NCT02711449|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153501319|NCT00377988|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153501320|NCT00377988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153501321|NCT00377988|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
153501322|NCT00377988|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
153878500|NCT04216589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153546991|NCT05819541|Autonomic Agents|autonomic agents|mesh-ancestor
153546992|NCT05819541|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153546993|NCT05819541|Tocolytic Agents|tocolytic agents|mesh-ancestor
153878503|NCT04204798|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153878504|NCT04204798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153501323|NCT00377988|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
153501324|NCT00378066|Bevacizumab|bevacizumab|mesh-list
153501325|NCT00378066|Capecitabine|capecitabine|mesh-list
153501326|NCT00378066|Oxaliplatin|oxaliplatin|mesh-list
153501353|NCT00378144|Sympathomimetics|sympathomimetics|mesh-ancestor
153501354|NCT00378144|Adrenergic Agents|adrenergic agents|mesh-ancestor
153501355|NCT00378144|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153501357|NCT00378456|Vitamins|vitamins|mesh-list
153546994|NCT05819541|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153546995|NCT05819541|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
153546996|NCT05819541|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
153546997|NCT05819541|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153781869|NCT02212210|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153501359|NCT00378456|Folic Acid|folic acid|mesh-list
153546998|NCT05819541|Adrenergic Agents|adrenergic agents|mesh-ancestor
153546999|NCT05819541|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153547000|NCT05816707|Turmeric extract|turmeric extract|mesh-list
153547002|NCT05816707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153547003|NCT05816707|Protective Agents|protective agents|mesh-ancestor
153547004|NCT05816707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153547005|NCT05807412|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
153878506|NCT04204798|Analgesics|analgesics|mesh-ancestor
153547006|NCT05807412|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
153501360|NCT00378456|Vitamin A|vitamin a|mesh-list
153501362|NCT00378456|Selenium|selenium|mesh-list
153501363|NCT00378456|Retinol palmitate|retinol palmitate|mesh-list
153501364|NCT00378456|Levoleucovorin|levoleucovorin|mesh-list
153501365|NCT00378456|Antioxidants|antioxidants|mesh-list
153501366|NCT00378456|Micronutrients|micronutrients|mesh-ancestor
153501367|NCT00378456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153501368|NCT00378456|Trace Elements|trace elements|mesh-ancestor
153501369|NCT00378456|Antidotes|antidotes|mesh-ancestor
153501370|NCT00378456|Protective Agents|protective agents|mesh-ancestor
153501371|NCT00378456|Vitamin B Complex|vitamin b complex|mesh-ancestor
153547007|NCT05807412|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
153547008|NCT05807412|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153547009|NCT05807412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153547010|NCT05807412|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
153547011|NCT05807412|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153547012|NCT05807412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153547013|NCT05807412|Cholinergic Agents|cholinergic agents|mesh-ancestor
153547014|NCT05807412|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153419315|NCT04966663|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153419316|NCT04922593|Paliperidone Palmitate|paliperidone palmitate|mesh-list
153419317|NCT04922593|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153501372|NCT00378456|Hematinics|hematinics|mesh-ancestor
153501373|NCT00378456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153501374|NCT00378456|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
153501375|NCT00378456|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153547015|NCT05803421|Insulin Glargine|insulin glargine|mesh-list
153501376|NCT00378612|Sirolimus|sirolimus|mesh-list
153501377|NCT00378612|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153455893|NCT04515329|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
153914102|NCT02711449|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153547016|NCT05803421|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153547017|NCT05803421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153547019|NCT05803382|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153782502|NCT00267813|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
153547020|NCT05803382|Antimetabolites|antimetabolites|mesh-ancestor
153547021|NCT05803382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153547022|NCT05803382|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153547023|NCT05802264|Amphotericin B|amphotericin b|mesh-list
153547024|NCT05802264|Amebicides|amebicides|mesh-ancestor
153547025|NCT05802264|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153547026|NCT05802264|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153914103|NCT02711449|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
153914104|NCT02711449|Protective Agents|protective agents|mesh-ancestor
153914105|NCT02711449|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153914106|NCT02711449|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153914107|NCT00612079|Sertindole|sertindole|mesh-list
153914108|NCT00612079|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153914109|NCT00612079|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153914110|NCT00612079|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153878521|NCT04171843|Fludarabine|fludarabine|mesh-list
153878522|NCT04171843|Nirogacestat|nirogacestat|mesh-list
153878523|NCT04171843|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153878524|NCT04171843|Immunologic Factors|immunologic factors|mesh-ancestor
153878525|NCT04171843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153878526|NCT04171843|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153878527|NCT04171843|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153878528|NCT04171843|Alkylating Agents|alkylating agents|mesh-ancestor
153547027|NCT05802264|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153547028|NCT05802264|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153547029|NCT05802264|Antifungal Agents|antifungal agents|mesh-ancestor
153547030|NCT05794828|Bupivacaine|bupivacaine|mesh-list
153547031|NCT05794828|Anesthetics, Local|anesthetics, local|mesh-ancestor
153547032|NCT05794828|Anesthetics|anesthetics|mesh-ancestor
153547033|NCT05794828|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153547034|NCT05794828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153547035|NCT05794828|Sensory System Agents|sensory system agents|mesh-ancestor
153547036|NCT05794828|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153914111|NCT00612079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153914112|NCT00612079|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153914113|NCT00940498|Gedatolisib|gedatolisib|mesh-list
153914114|NCT00940498|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153914115|NCT00940498|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153914116|NCT00940498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153914117|NCT03820531|Pancrelipase|pancrelipase|mesh-list
153914118|NCT03820531|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153914119|NCT02850718|Sildenafil Citrate|sildenafil citrate|mesh-list
153914120|NCT02850718|Vasodilator Agents|vasodilator agents|mesh-ancestor
153914121|NCT02850718|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
153914122|NCT02850718|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
153914123|NCT02850718|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153914124|NCT02850718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153914125|NCT02850718|Urological Agents|urological agents|mesh-ancestor
153914126|NCT02707393|Cyclosporine|cyclosporine|mesh-list
153914127|NCT02707393|Mycophenolic Acid|mycophenolic acid|mesh-list
153914128|NCT02707393|Fludarabine|fludarabine|mesh-list
153914129|NCT02707393|Melphalan|melphalan|mesh-list
153878534|NCT04165993|Docetaxel|docetaxel|mesh-list
153547037|NCT05791617|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
153547038|NCT05791617|Natriuretic Agents|natriuretic agents|mesh-ancestor
153547039|NCT05791617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153547040|NCT05779241|Risperidone|risperidone|mesh-list
153547041|NCT05779241|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153547042|NCT05779241|Serotonin Agents|serotonin agents|mesh-ancestor
153547043|NCT05779241|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153547044|NCT05779241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153547045|NCT05779241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153547046|NCT05779241|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153455907|NCT04506554|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153455908|NCT04506554|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153455909|NCT04506554|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153455910|NCT04506554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153455911|NCT04498117|Paclitaxel|paclitaxel|mesh-list
153455912|NCT04498117|Carboplatin|carboplatin|mesh-list
153455913|NCT04498117|Oregovomab|oregovomab|mesh-list
153455914|NCT04498117|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153547047|NCT05779241|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153547048|NCT05779241|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153547049|NCT05779241|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153547050|NCT05779241|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
153547051|NCT05779241|Dopamine Agents|dopamine agents|mesh-ancestor
153547053|NCT05775289|Carboplatin|carboplatin|mesh-list
153547054|NCT05775289|Pembrolizumab|pembrolizumab|mesh-list
153547055|NCT05775289|Pemetrexed|pemetrexed|mesh-list
153547056|NCT05775289|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153547057|NCT05775289|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153547058|NCT05775289|Tubulin Modulators|tubulin modulators|mesh-ancestor
153419356|NCT04724148|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153419357|NCT04724148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153878535|NCT04165993|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153878536|NCT04165993|Tubulin Modulators|tubulin modulators|mesh-ancestor
153878537|NCT04165993|Antimitotic Agents|antimitotic agents|mesh-ancestor
153878538|NCT04165993|Mitosis Modulators|mitosis modulators|mesh-ancestor
153878539|NCT04165993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153878540|NCT04141501|Psilocybin|psilocybin|mesh-list
153878541|NCT04141501|Hallucinogens|hallucinogens|mesh-ancestor
153878542|NCT04141501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153878544|NCT04091490|Nivolumab|nivolumab|mesh-list
153914130|NCT02707393|Thiotepa|thiotepa|mesh-list
153914131|NCT02707393|Cyclosporins|cyclosporins|mesh-list
153914132|NCT02707393|Thymoglobulin|thymoglobulin|mesh-list
153914133|NCT02707393|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153914134|NCT02707393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153914135|NCT02707393|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153914136|NCT02707393|Immunologic Factors|immunologic factors|mesh-ancestor
153914137|NCT02707393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153914138|NCT02707393|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153914139|NCT02707393|Antifungal Agents|antifungal agents|mesh-ancestor
153914140|NCT02707393|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153914141|NCT02707393|Dermatologic Agents|dermatologic agents|mesh-ancestor
153914142|NCT02707393|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153455922|NCT04359017|Anesthetics, Local|anesthetics, local|mesh-ancestor
153547059|NCT05775289|Antimitotic Agents|antimitotic agents|mesh-ancestor
153547060|NCT05775289|Mitosis Modulators|mitosis modulators|mesh-ancestor
153547061|NCT05775289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153547062|NCT05775289|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153547063|NCT05775289|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153547064|NCT05775289|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153547065|NCT05775289|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153547066|NCT05775289|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153547067|NCT05775159|Bevacizumab|bevacizumab|mesh-list
153547068|NCT05775159|Gemcitabine|gemcitabine|mesh-list
153547069|NCT05775159|Lenvatinib|lenvatinib|mesh-list
153547070|NCT05775159|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153547071|NCT05775159|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153501378|NCT00378612|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153501379|NCT00378612|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153501380|NCT00378612|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153501381|NCT00378612|Antifungal Agents|antifungal agents|mesh-ancestor
153501385|NCT00378690|Leuprolide|leuprolide|mesh-list
153501403|NCT00380328|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153501404|NCT00380328|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153501405|NCT00380328|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153501406|NCT00380328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153547072|NCT05775159|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153547073|NCT05775159|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153547074|NCT05775159|Growth Substances|growth substances|mesh-ancestor
153547075|NCT05775159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153547076|NCT05775159|Growth Inhibitors|growth inhibitors|mesh-ancestor
153547077|NCT05775159|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153878560|NCT04067115|Irinotecan|irinotecan|mesh-list
153419367|NCT04703803|Anesthetics|anesthetics|mesh-ancestor
153419368|NCT04703803|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153419369|NCT04703803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153914145|NCT02707393|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
153914146|NCT02707393|Antitubercular Agents|antitubercular agents|mesh-ancestor
153914147|NCT02707393|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153914148|NCT02707393|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153914149|NCT02707393|Alkylating Agents|alkylating agents|mesh-ancestor
153914150|NCT02707393|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153914151|NCT00940342|Rituximab|rituximab|mesh-list
153914152|NCT00940342|Molgramostim|molgramostim|mesh-list
153914153|NCT00940342|Sargramostim|sargramostim|mesh-list
153914154|NCT00940342|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153914155|NCT00940342|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153914156|NCT00940342|Immunologic Factors|immunologic factors|mesh-ancestor
153914157|NCT00940342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153914158|NCT00940342|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153914159|NCT00936910|Amphotericin B|amphotericin b|mesh-list
153419370|NCT04703803|Sensory System Agents|sensory system agents|mesh-ancestor
153419371|NCT04703803|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153419372|NCT04703803|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153547079|NCT05775159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153547080|NCT05775159|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153547082|NCT05772546|Maleic acid|maleic acid|mesh-list
153547083|NCT05772546|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153547084|NCT05772546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153547085|NCT05758597|Midazolam|midazolam|mesh-list
153547086|NCT05758597|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153547087|NCT05758597|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153547088|NCT05758597|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153547089|NCT05758597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153547090|NCT05758597|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153547091|NCT05758597|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153547092|NCT05758597|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153547093|NCT05758597|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153547094|NCT05758597|Anesthetics, General|anesthetics, general|mesh-ancestor
153547095|NCT05758597|Anesthetics|anesthetics|mesh-ancestor
153547096|NCT05758597|GABA Modulators|gaba modulators|mesh-ancestor
153547097|NCT05758597|GABA Agents|gaba agents|mesh-ancestor
153547098|NCT05758597|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153547099|NCT05758597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153547100|NCT05756153|Cetuximab|cetuximab|mesh-list
153547101|NCT05756153|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153547102|NCT05756153|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153914160|NCT00936910|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
153914161|NCT00936910|Amebicides|amebicides|mesh-ancestor
153914162|NCT00936910|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153914163|NCT00936910|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153914164|NCT00936910|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153914165|NCT00936910|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153914166|NCT00936910|Antifungal Agents|antifungal agents|mesh-ancestor
153914167|NCT02707315|Gemcitabine|gemcitabine|mesh-list
153547103|NCT05753189|Brimonidine Tartrate|brimonidine tartrate|mesh-list
153547104|NCT05753189|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
153547105|NCT05753189|Ophthalmic Solutions|ophthalmic solutions|mesh-list
153547106|NCT05753189|Aceclidine|aceclidine|mesh-list
153547107|NCT05753189|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153547108|NCT05753189|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
153547109|NCT05753189|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153547110|NCT05753189|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153547111|NCT05753189|Adrenergic Agents|adrenergic agents|mesh-ancestor
153547112|NCT05753189|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153914168|NCT02707315|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153455944|NCT04273776|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
153455945|NCT04258488|Vitamin K|vitamin k|mesh-list
153455946|NCT04258488|Warfarin|warfarin|mesh-list
153455947|NCT04258488|Rivaroxaban|rivaroxaban|mesh-list
153455948|NCT04258488|Vitamins|vitamins|mesh-ancestor
153455949|NCT04258488|Micronutrients|micronutrients|mesh-ancestor
153455950|NCT04258488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153455951|NCT04258488|Anticoagulants|anticoagulants|mesh-ancestor
153455952|NCT04258488|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
153878566|NCT04067115|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153878567|NCT04067115|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153878568|NCT04067115|Alkylating Agents|alkylating agents|mesh-ancestor
153547114|NCT05753189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153547115|NCT05753189|Miotics|miotics|mesh-ancestor
153547116|NCT05753189|Autonomic Agents|autonomic agents|mesh-ancestor
153547117|NCT05753189|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153547118|NCT05753189|Parasympathomimetics|parasympathomimetics|mesh-ancestor
153547119|NCT05748665|Etomidate|etomidate|mesh-list
153455953|NCT04258488|Antithrombins|antithrombins|mesh-ancestor
153501407|NCT00380406|Leuprolide|leuprolide|mesh-list
153501408|NCT00380406|Fertility Agents, Female|fertility agents, female|mesh-ancestor
153501409|NCT00380406|Fertility Agents|fertility agents|mesh-ancestor
153501410|NCT00380406|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153501411|NCT00380406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153501412|NCT00380406|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153501413|NCT00380406|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153501414|NCT00380484|Budesonide|budesonide|mesh-list
153501415|NCT00380484|Montelukast|montelukast|mesh-list
153501416|NCT00380484|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153501417|NCT00380484|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153501418|NCT00380484|Autonomic Agents|autonomic agents|mesh-ancestor
153914169|NCT02707315|Antimetabolites|antimetabolites|mesh-ancestor
153419382|NCT04670978|Growth Substances|growth substances|mesh-ancestor
153419383|NCT04670978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153547120|NCT05748665|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153547121|NCT05748665|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153547122|NCT05748665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153547123|NCT05748665|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153547124|NCT05748665|Anesthetics, General|anesthetics, general|mesh-ancestor
153547125|NCT05748665|Anesthetics|anesthetics|mesh-ancestor
153878580|NCT04028830|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
153878581|NCT04028830|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
153878584|NCT04017442|Morphine|morphine|mesh-list
153914170|NCT02707315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153914171|NCT02707315|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153914172|NCT00604942|Domperidone|domperidone|mesh-list
153914173|NCT00604942|Esomeprazole|esomeprazole|mesh-list
153914174|NCT00604942|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
153914175|NCT00604942|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153914176|NCT00604942|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
153455954|NCT04258488|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
153419438|NCT04150042|Vitamin B 12|vitamin b 12|mesh-list
153878614|NCT03959488|Antiviral Agents|antiviral agents|mesh-ancestor
153878615|NCT03959488|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153878616|NCT03950817|Ketamine|ketamine|mesh-list
153878617|NCT03950817|Analgesics|analgesics|mesh-ancestor
153878618|NCT03950817|Sensory System Agents|sensory system agents|mesh-ancestor
153878619|NCT03950817|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153878620|NCT03950817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153878621|NCT03950817|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
153878622|NCT03950817|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153878623|NCT03950817|Anesthetics, General|anesthetics, general|mesh-ancestor
153878624|NCT03950817|Anesthetics|anesthetics|mesh-ancestor
153878625|NCT03950817|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153547143|NCT05734625|Methylprednisolone|methylprednisolone|mesh-list
153547144|NCT05734625|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
153547145|NCT05734625|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
153455955|NCT04258488|Protease Inhibitors|protease inhibitors|mesh-ancestor
153455956|NCT04258488|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153455957|NCT04258488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153455958|NCT04258488|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
153455959|NCT04258488|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153455960|NCT04258488|Hemostatics|hemostatics|mesh-ancestor
153455961|NCT04258488|Coagulants|coagulants|mesh-ancestor
153455962|NCT04228965|Varenicline|varenicline|mesh-list
153455963|NCT04228965|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
153455964|NCT04228965|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
153455965|NCT04228965|Cholinergic Agents|cholinergic agents|mesh-ancestor
153455966|NCT04228965|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153455967|NCT04228965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153455968|NCT04228965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153455969|NCT04197687|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
153455970|NCT04197687|Trastuzumab|trastuzumab|mesh-list
153455971|NCT04197687|Pertuzumab|pertuzumab|mesh-list
153455972|NCT04197687|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
153455973|NCT04197687|Maytansine|maytansine|mesh-list
153914177|NCT00604942|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153914178|NCT00604942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153914179|NCT00604942|Antiemetics|antiemetics|mesh-ancestor
153914180|NCT00604942|Autonomic Agents|autonomic agents|mesh-ancestor
153547146|NCT05734625|Prednisolone|prednisolone|mesh-list
153419453|NCT04150042|Protective Agents|protective agents|mesh-ancestor
153419454|NCT04150042|Vitamin B Complex|vitamin b complex|mesh-ancestor
153419455|NCT04150042|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
153547147|NCT05734625|Prednisolone acetate|prednisolone acetate|mesh-list
153547148|NCT05734625|Bupivacaine|bupivacaine|mesh-list
153547149|NCT05734625|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
153547150|NCT05734625|Prednisolone phosphate|prednisolone phosphate|mesh-list
153547151|NCT05734625|Anesthetics, Local|anesthetics, local|mesh-ancestor
153547152|NCT05734625|Anesthetics|anesthetics|mesh-ancestor
153914181|NCT00604942|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153914182|NCT00604942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153914183|NCT00604942|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
153914184|NCT00604942|Dopamine Agents|dopamine agents|mesh-ancestor
153914185|NCT00604942|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153914186|NCT02711683|3-n-butylphthalide|3-n-butylphthalide|mesh-list
153914187|NCT02711683|Donepezil|donepezil|mesh-list
153914188|NCT02711683|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
153501419|NCT00380484|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153501420|NCT00380484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153501421|NCT00380484|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153547153|NCT05734625|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153547154|NCT05734625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153878644|NCT03873818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153878645|NCT03848676|Immunomodulating Agents|immunomodulating agents|mesh-list
153878646|NCT03848676|Immunologic Factors|immunologic factors|mesh-ancestor
153501422|NCT00380484|Respiratory System Agents|respiratory system agents|mesh-ancestor
153455998|NCT04155541|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153501423|NCT00380484|Glucocorticoids|glucocorticoids|mesh-ancestor
153501424|NCT00380484|Hormones|hormones|mesh-ancestor
153501425|NCT00380484|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153501426|NCT00380484|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
153501427|NCT00380484|Hormone Antagonists|hormone antagonists|mesh-ancestor
153501428|NCT00380484|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
153455999|NCT04155541|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153456000|NCT04155541|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153547155|NCT05734625|Sensory System Agents|sensory system agents|mesh-ancestor
153547156|NCT05734625|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153547157|NCT05734625|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153547158|NCT05734625|Antiemetics|antiemetics|mesh-ancestor
153547159|NCT05734625|Autonomic Agents|autonomic agents|mesh-ancestor
153547160|NCT05734625|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153547161|NCT05734625|Glucocorticoids|glucocorticoids|mesh-ancestor
153547162|NCT05734625|Hormones|hormones|mesh-ancestor
153419463|NCT04093024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153419464|NCT04091503|Temozolomide|temozolomide|mesh-list
153419465|NCT04091503|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153419466|NCT04091503|Alkylating Agents|alkylating agents|mesh-ancestor
153419467|NCT04091503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153419468|NCT04091503|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153419469|NCT04067752|Dialysis Solutions|dialysis solutions|mesh-list
153419470|NCT04067752|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
153419472|NCT04014790|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153878660|NCT03765541|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153878661|NCT03765541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153878662|NCT03765541|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153878663|NCT03765541|Glucocorticoids|glucocorticoids|mesh-ancestor
153878664|NCT03765541|Hormones|hormones|mesh-ancestor
153878665|NCT03765541|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153878667|NCT03765541|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153547166|NCT05734625|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153782503|NCT00267813|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153547168|NCT05726383|Viscum album peptide|viscum album peptide|mesh-list
153547169|NCT05726383|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153547170|NCT05726383|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153547171|NCT05726383|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153547172|NCT05726383|Antiviral Agents|antiviral agents|mesh-ancestor
153456001|NCT04155541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153456002|NCT04115319|Quetiapine Fumarate|quetiapine fumarate|mesh-list
153456003|NCT04115319|Antidepressive Agents|antidepressive agents|mesh-ancestor
153456004|NCT04115319|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153914198|NCT05079061|Misoprostol|misoprostol|mesh-list
153501429|NCT00380484|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
153501430|NCT00380484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153501443|NCT00381030|Carvedilol|carvedilol|mesh-list
153501445|NCT00381030|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
153547174|NCT05720949|Dexamethasone|dexamethasone|mesh-list
153547175|NCT05720949|Bupivacaine|bupivacaine|mesh-list
153547176|NCT05720949|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153547177|NCT05720949|Antiemetics|antiemetics|mesh-ancestor
153547178|NCT05720949|Autonomic Agents|autonomic agents|mesh-ancestor
153547179|NCT05720949|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153547180|NCT05720949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153878676|NCT03712956|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
153878677|NCT03712956|Doxorubicin|doxorubicin|mesh-list
153878678|NCT03712956|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153878679|NCT03712956|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153878680|NCT03712956|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153878681|NCT03712956|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153878682|NCT03712956|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153878683|NCT03712956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153878684|NCT03712098|Liraglutide|liraglutide|mesh-list
153878686|NCT03712098|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153501446|NCT00381030|Adrenergic Agents|adrenergic agents|mesh-ancestor
153501454|NCT00381030|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153501455|NCT00381030|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153501456|NCT00381030|Vasodilator Agents|vasodilator agents|mesh-ancestor
153501457|NCT00381030|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
153501458|NCT00381030|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
153501460|NCT00381264|Antiemetics|antiemetics|mesh-ancestor
153501461|NCT00381264|Autonomic Agents|autonomic agents|mesh-ancestor
153501462|NCT00381264|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153501463|NCT00381264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153501464|NCT00381264|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153456133|NCT03695237|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153456135|NCT03665597|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153456136|NCT03665597|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153456137|NCT03665597|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153914327|NCT02706535|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
153878701|NCT03686332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153878702|NCT03686332|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153878703|NCT03686332|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153878704|NCT03686332|Immunologic Factors|immunologic factors|mesh-ancestor
153878706|NCT03671746|Ketorolac|ketorolac|mesh-list
153547181|NCT05720949|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153914328|NCT02706535|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
153914329|NCT02706535|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
153914330|NCT02711059|Parathyroid Hormone|parathyroid hormone|mesh-list
153914331|NCT02711059|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153914332|NCT02711059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153501465|NCT00381264|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153501466|NCT00381264|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153501467|NCT00381264|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153501468|NCT00381264|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153501469|NCT00381342|Exenatide|exenatide|mesh-list
153501470|NCT00381342|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
153501471|NCT00381342|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153501472|NCT00381342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153501473|NCT00381342|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
153914352|NCT01025817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153914353|NCT01025817|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
153914354|NCT01025817|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153914355|NCT01025817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153914356|NCT01025817|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
153914357|NCT01025817|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153914358|NCT01025817|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153914359|NCT01025817|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153914360|NCT01025817|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
153914362|NCT01025817|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153914363|NCT01025817|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153914364|NCT00636883|Gemcitabine|gemcitabine|mesh-list
153914365|NCT00636883|Oxaliplatin|oxaliplatin|mesh-list
153914366|NCT00636883|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153914367|NCT00636883|Antimetabolites|antimetabolites|mesh-ancestor
153547182|NCT05720949|Glucocorticoids|glucocorticoids|mesh-ancestor
153547183|NCT05720949|Hormones|hormones|mesh-ancestor
153547184|NCT05720949|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153547185|NCT05720949|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153547186|NCT05720949|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153547187|NCT05720949|Anesthetics, Local|anesthetics, local|mesh-ancestor
153547188|NCT05720949|Anesthetics|anesthetics|mesh-ancestor
153547189|NCT05720949|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153914674|NCT04188691|Immunologic Factors|immunologic factors|mesh-ancestor
153456156|NCT03586609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153456157|NCT03586609|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153456158|NCT03586609|Antiviral Agents|antiviral agents|mesh-ancestor
153456159|NCT03586609|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153456160|NCT03586609|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153456161|NCT03586609|Immunologic Factors|immunologic factors|mesh-ancestor
153456162|NCT03586609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153456163|NCT03586609|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153456165|NCT03584373|Ketorolac|ketorolac|mesh-list
153456166|NCT03584373|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
153456167|NCT03584373|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
153456168|NCT03584373|Oxycodone|oxycodone|mesh-list
153456169|NCT03584373|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153456170|NCT03584373|Analgesics|analgesics|mesh-ancestor
153501487|NCT00381732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153501488|NCT00381732|Urological Agents|urological agents|mesh-ancestor
153501489|NCT00382044|Darbepoetin alfa|darbepoetin alfa|mesh-list
153501490|NCT00382044|Hematinics|hematinics|mesh-ancestor
153501491|NCT00382356|Dutasteride|dutasteride|mesh-list
153501492|NCT00382356|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
153501493|NCT00382356|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153547190|NCT05720949|Sensory System Agents|sensory system agents|mesh-ancestor
153878707|NCT03671746|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153878708|NCT03671746|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153878709|NCT03671746|Analgesics|analgesics|mesh-ancestor
153878710|NCT03671746|Sensory System Agents|sensory system agents|mesh-ancestor
153878711|NCT03671746|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153878712|NCT03671746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153878713|NCT03671746|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153878714|NCT03671746|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153878715|NCT03671746|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153878716|NCT03671746|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153878717|NCT03671746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153878718|NCT03646175|Choline|choline|mesh-list
153878719|NCT03646175|Lipotropic Agents|lipotropic agents|mesh-ancestor
153878720|NCT03646175|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153878721|NCT03646175|Antimetabolites|antimetabolites|mesh-ancestor
153878722|NCT03646175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153878747|NCT03616886|Tubulin Modulators|tubulin modulators|mesh-ancestor
153501494|NCT00382356|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153501495|NCT00382356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153501496|NCT00382356|Hormone Antagonists|hormone antagonists|mesh-ancestor
153501497|NCT00382356|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153501498|NCT00382356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153501499|NCT00382668|Dasatinib|dasatinib|mesh-list
153501500|NCT00382668|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153501501|NCT00382668|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153501502|NCT00382668|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153501503|NCT00382668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153501504|NCT00382668|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153878748|NCT03616886|Antimitotic Agents|antimitotic agents|mesh-ancestor
153878749|NCT03616886|Mitosis Modulators|mitosis modulators|mesh-ancestor
153878750|NCT03616886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153878751|NCT03616886|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153878752|NCT03609840|Thiotepa|thiotepa|mesh-list
153878753|NCT03609840|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-list
153878754|NCT03609840|Antineoplastic Agents|antineoplastic agents|mesh-list
153878755|NCT03609840|Alkylating Agents|alkylating agents|mesh-ancestor
153419584|NCT02856425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153419585|NCT02856425|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153419586|NCT02856425|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153419587|NCT02785952|Nivolumab|nivolumab|mesh-list
153419588|NCT02785952|Ipilimumab|ipilimumab|mesh-list
153419589|NCT02785952|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153419590|NCT02785952|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153914368|NCT00636883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153914369|NCT00636883|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153914370|NCT00605410|Bromides|bromides|mesh-list
153914371|NCT00605410|Ipratropium|ipratropium|mesh-list
153914372|NCT00605410|Anticonvulsants|anticonvulsants|mesh-ancestor
153914373|NCT00605410|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153914374|NCT00605410|Autonomic Agents|autonomic agents|mesh-ancestor
153914375|NCT00605410|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153914376|NCT00605410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153914377|NCT00605410|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153419604|NCT02429700|Antimitotic Agents|antimitotic agents|mesh-ancestor
153419605|NCT02429700|Mitosis Modulators|mitosis modulators|mesh-ancestor
153419606|NCT02429700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153878792|NCT03518203|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153878793|NCT03518203|Immunologic Factors|immunologic factors|mesh-ancestor
153878794|NCT03518203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153878795|NCT03507062|Plasma-lyte 148|plasma-lyte 148|mesh-list
153547212|NCT05706701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153878796|NCT03507062|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
153878797|NCT03507062|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
153914378|NCT00605410|Respiratory System Agents|respiratory system agents|mesh-ancestor
153914379|NCT00605410|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
153914381|NCT00605410|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153914382|NCT00605410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153914383|NCT04300881|Eplerenone|eplerenone|mesh-list
153914389|NCT04300881|Diuretics|diuretics|mesh-ancestor
153914390|NCT04300881|Natriuretic Agents|natriuretic agents|mesh-ancestor
153914391|NCT04300881|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153914392|NCT03873493|Venetoclax|venetoclax|mesh-list
153914393|NCT03873493|Ibrutinib|ibrutinib|mesh-list
153914394|NCT03873493|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153914395|NCT03873493|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153914396|NCT03873493|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153419631|NCT02194829|Tubulin Modulators|tubulin modulators|mesh-ancestor
153419632|NCT02194829|Antimitotic Agents|antimitotic agents|mesh-ancestor
153419633|NCT02194829|Mitosis Modulators|mitosis modulators|mesh-ancestor
153878818|NCT03470922|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153878819|NCT03470922|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153878820|NCT03470922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153878827|NCT03427814|Pamiparib|pamiparib|mesh-list
153419635|NCT02194829|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153914397|NCT03873493|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153914398|NCT03873493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153914399|NCT00611689|Imatinib Mesylate|imatinib mesylate|mesh-list
153914400|NCT00611689|Vatalanib|vatalanib|mesh-list
153456197|NCT03523858|Immunologic Factors|immunologic factors|mesh-ancestor
153456198|NCT03523858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153456199|NCT03409718|Cimetidine|cimetidine|mesh-list
153456200|NCT03409718|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
153456201|NCT03409718|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153419664|NCT02839772|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
153419665|NCT02839772|Protective Agents|protective agents|mesh-ancestor
153878851|NCT03368664|Dexchlorpheniramine|dexchlorpheniramine|mesh-list
153878852|NCT03368664|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153878853|NCT03368664|Antiviral Agents|antiviral agents|mesh-ancestor
153878854|NCT03368664|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153878855|NCT03368664|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153878856|NCT03368664|Antiemetics|antiemetics|mesh-ancestor
153878857|NCT03368664|Autonomic Agents|autonomic agents|mesh-ancestor
153878858|NCT03368664|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153878859|NCT03368664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153878860|NCT03368664|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153878861|NCT03368664|Glucocorticoids|glucocorticoids|mesh-ancestor
153878862|NCT03368664|Hormones|hormones|mesh-ancestor
153878863|NCT03368664|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153501505|NCT00382980|Aluminum Hydroxide|aluminum hydroxide|mesh-list
153501506|NCT00382980|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153501507|NCT00382980|Immunologic Factors|immunologic factors|mesh-ancestor
153501508|NCT00382980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153501509|NCT00382980|Antacids|antacids|mesh-ancestor
153501510|NCT00382980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153501511|NCT00382980|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153501512|NCT00383136|Tirofiban|tirofiban|mesh-list
153501513|NCT00383136|Abciximab|abciximab|mesh-list
153456226|NCT03386929|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153456227|NCT03386929|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153419701|NCT00374647|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153547217|NCT05687058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153547218|NCT05679258|Daratumumab|daratumumab|mesh-list
153547219|NCT05679258|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
153547220|NCT05679258|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153878890|NCT03322358|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153878891|NCT03322358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153878892|NCT03322358|Anesthetics, Local|anesthetics, local|mesh-ancestor
153878893|NCT03322358|Anesthetics|anesthetics|mesh-ancestor
153878894|NCT03322358|Sensory System Agents|sensory system agents|mesh-ancestor
153878895|NCT03322358|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153878896|NCT03322358|Antiemetics|antiemetics|mesh-ancestor
153456228|NCT03386929|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153456229|NCT03386929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153456230|NCT03386929|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153456231|NCT03335839|Plasminogen|plasminogen|mesh-list
153456232|NCT03335839|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
153456233|NCT03335839|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153456234|NCT03335839|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153419727|NCT02969876|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
153419728|NCT02969876|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153419731|NCT02969876|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153419749|NCT02813551|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153419750|NCT02813551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153419751|NCT02817763|Dipyrone|dipyrone|mesh-list
153878919|NCT03298295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153878920|NCT03291158|Minocycline|minocycline|mesh-list
153878949|NCT03202628|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153878950|NCT03202628|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153878951|NCT03202628|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153878952|NCT03202628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153878953|NCT03202628|Protease Inhibitors|protease inhibitors|mesh-ancestor
153878954|NCT03202628|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153878955|NCT03202628|Immunologic Factors|immunologic factors|mesh-ancestor
153878956|NCT03202628|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153878957|NCT03202628|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153878958|NCT03202628|Growth Substances|growth substances|mesh-ancestor
153878959|NCT03202628|Growth Inhibitors|growth inhibitors|mesh-ancestor
153878960|NCT03202628|Dermatologic Agents|dermatologic agents|mesh-ancestor
153419766|NCT03053401|Anesthetics|anesthetics|mesh-list
153419767|NCT03053401|Anesthetics, Local|anesthetics, local|mesh-list
153419768|NCT03053401|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153419769|NCT03053401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153419770|NCT03053401|Sensory System Agents|sensory system agents|mesh-ancestor
153419771|NCT03053401|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153419772|NCT03054103|Midazolam|midazolam|mesh-list
153419773|NCT03054103|Ketamine|ketamine|mesh-list
153914421|NCT05264077|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153914422|NCT05264077|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153914423|NCT05264077|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153914424|NCT05264077|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153914425|NCT05264077|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153914426|NCT05264077|Anesthetics, General|anesthetics, general|mesh-ancestor
153914427|NCT05264077|Anesthetics|anesthetics|mesh-ancestor
153914428|NCT05264077|GABA Modulators|gaba modulators|mesh-ancestor
153914429|NCT05264077|GABA Agents|gaba agents|mesh-ancestor
153914430|NCT00612859|Levetiracetam|levetiracetam|mesh-list
153914431|NCT00612859|Anticonvulsants|anticonvulsants|mesh-ancestor
153914432|NCT00612859|Nootropic Agents|nootropic agents|mesh-ancestor
153914433|NCT01010217|Mycophenolic Acid|mycophenolic acid|mesh-list
153626716|NCT02018523|Growth Inhibitors|growth inhibitors|mesh-ancestor
153547226|NCT05671757|Immunologic Factors|immunologic factors|mesh-ancestor
153547227|NCT05671757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153547228|NCT05661201|Doxorubicin|doxorubicin|mesh-list
153547229|NCT05661201|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153419781|NCT03054103|Anesthetics|anesthetics|mesh-ancestor
153419782|NCT03054103|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153419783|NCT03054103|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
153419784|NCT03054103|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
153419785|NCT03054103|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153419786|NCT03054103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153878962|NCT03202628|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153878963|NCT03176472|Ricolinostat|ricolinostat|mesh-list
153878964|NCT03176472|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153878965|NCT03176472|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
153878966|NCT03176472|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153878967|NCT03176472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153419790|NCT03054103|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153419791|NCT03054103|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153419792|NCT03054103|GABA Modulators|gaba modulators|mesh-ancestor
153419793|NCT03054103|GABA Agents|gaba agents|mesh-ancestor
153419794|NCT03043274|Cangrelor|cangrelor|mesh-list
153626717|NCT02018523|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153626718|NCT02018536|Simeprevir|simeprevir|mesh-list
153626719|NCT02018536|Antiviral Agents|antiviral agents|mesh-ancestor
153626720|NCT02018536|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153626721|NCT02018536|Protease Inhibitors|protease inhibitors|mesh-ancestor
153469705|NCT04548700|Prednisone|prednisone|mesh-list
153456246|NCT03223220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153456247|NCT03223220|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
153456248|NCT03223220|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153456249|NCT03223220|Anesthetics, General|anesthetics, general|mesh-ancestor
153456250|NCT03223220|Anesthetics|anesthetics|mesh-ancestor
153456251|NCT03223220|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153547230|NCT05661201|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153879026|NCT03127631|Pravastatin|pravastatin|mesh-list
153879027|NCT03127631|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
153879028|NCT03127631|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153879029|NCT03127631|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153879030|NCT03127631|Antimetabolites|antimetabolites|mesh-ancestor
153879031|NCT03127631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153879032|NCT03127631|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153879033|NCT03127631|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
153879034|NCT03127631|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153419836|NCT02831569|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153419837|NCT02831569|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153547232|NCT05661201|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153456252|NCT03223220|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
153456253|NCT03223220|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
153456254|NCT03223220|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153456258|NCT03223220|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153501514|NCT00383136|Anticoagulants|anticoagulants|mesh-ancestor
153501515|NCT00383136|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153501528|NCT00383370|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153501529|NCT00383526|Vaccines|vaccines|mesh-list
153501530|NCT00383526|Immunologic Factors|immunologic factors|mesh-ancestor
153501531|NCT00383526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153501533|NCT00383682|Morphine|morphine|mesh-list
153501534|NCT00383682|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153501535|NCT00383682|Narcotics|narcotics|mesh-ancestor
153501536|NCT00383682|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153501537|NCT00383682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153501538|NCT00383682|Analgesics|analgesics|mesh-ancestor
153501539|NCT00383682|Sensory System Agents|sensory system agents|mesh-ancestor
153501540|NCT00383682|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153501541|NCT00383682|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153501542|NCT00383682|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
153501543|NCT00383682|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153501544|NCT00383682|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153419925|NCT02935699|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153419926|NCT02935699|Antiemetics|antiemetics|mesh-ancestor
153419927|NCT02935699|Autonomic Agents|autonomic agents|mesh-ancestor
153419928|NCT02935699|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153419929|NCT02935699|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
153419930|NCT02935699|Histamine Antagonists|histamine antagonists|mesh-ancestor
153419931|NCT02935699|Histamine Agents|histamine agents|mesh-ancestor
153419932|NCT02935699|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153419933|NCT02935699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153419934|NCT02935699|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
153879118|NCT06079983|Gemcitabine|gemcitabine|mesh-list
153879119|NCT06079983|Capecitabine|capecitabine|mesh-list
153879120|NCT06079983|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153879121|NCT06079983|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153879122|NCT06079983|Tubulin Modulators|tubulin modulators|mesh-ancestor
153879123|NCT06079983|Antimitotic Agents|antimitotic agents|mesh-ancestor
153879124|NCT06079983|Mitosis Modulators|mitosis modulators|mesh-ancestor
153879125|NCT06079983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153879126|NCT06079983|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153879127|NCT06079983|Antimetabolites|antimetabolites|mesh-ancestor
153879128|NCT06079788|Hormones|hormones|mesh-list
153879129|NCT06079788|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
153456267|NCT02969083|Gemcitabine|gemcitabine|mesh-list
153456268|NCT02969083|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153456269|NCT02969083|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153456270|NCT02969083|Antimetabolites|antimetabolites|mesh-ancestor
153456271|NCT02969083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153456272|NCT02943590|Atorvastatin|atorvastatin|mesh-list
153456273|NCT02943590|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153456274|NCT02943590|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153456275|NCT02943590|Antimetabolites|antimetabolites|mesh-ancestor
153456276|NCT02943590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153456277|NCT02943590|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153879185|NCT06078696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153879186|NCT06078696|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153419994|NCT02865590|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153419995|NCT02865590|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
153419996|NCT02865590|Histamine Antagonists|histamine antagonists|mesh-ancestor
153419997|NCT02865590|Histamine Agents|histamine agents|mesh-ancestor
153419998|NCT02865590|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153419999|NCT02865590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153420000|NCT02865590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153420001|NCT02865590|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
153420002|NCT02865590|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153420003|NCT02865590|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153420005|NCT02868242|Ledipasvir, sofosbuvir drug combination|ledipasvir, sofosbuvir drug combination|mesh-list
153420006|NCT02868242|Ledipasvir|ledipasvir|mesh-list
153420007|NCT02868242|Antiviral Agents|antiviral agents|mesh-ancestor
153420008|NCT02868242|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153420009|NCT03075553|Nivolumab|nivolumab|mesh-list
153547236|NCT05658003|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
153547237|NCT05658003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153547238|NCT05655754|Methohexital|methohexital|mesh-list
153547239|NCT05655754|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153879216|NCT06078592|Brimonidine Tartrate, Timolol Maleate Drug Combination|brimonidine tartrate, timolol maleate drug combination|mesh-list
153879217|NCT06078592|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
153879218|NCT06078592|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153879219|NCT06078592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153879220|NCT06078592|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
153879221|NCT06078592|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
153879222|NCT06078592|Adrenergic Agents|adrenergic agents|mesh-ancestor
153456278|NCT02943590|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
153914470|NCT00604084|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153914471|NCT00604084|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153914472|NCT00604084|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153914473|NCT00604084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153914474|NCT05379478|Antibodies|antibodies|mesh-list
153914475|NCT05379478|Immunologic Factors|immunologic factors|mesh-ancestor
153456286|NCT02773238|Antimetabolites|antimetabolites|mesh-ancestor
153456287|NCT02773238|Antiviral Agents|antiviral agents|mesh-ancestor
153456288|NCT02773238|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153456289|NCT02630628|Mycophenolic Acid|mycophenolic acid|mesh-list
153456290|NCT02630628|Tacrolimus|tacrolimus|mesh-list
153456291|NCT02630628|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153456292|NCT02630628|Immunologic Factors|immunologic factors|mesh-ancestor
153456293|NCT02630628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153456294|NCT02630628|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
153879223|NCT06078592|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153879224|NCT06078592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153879225|NCT06078592|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153879226|NCT06078592|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153879227|NCT06078592|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
153879228|NCT06078592|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153879229|NCT06078592|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153879230|NCT06076980|Acetaminophen|acetaminophen|mesh-list
153879262|NCT05988697|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153879263|NCT05988697|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153879264|NCT05988697|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153879265|NCT05988697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153879266|NCT05975450|Abatacept|abatacept|mesh-list
153420079|NCT02874092|Ticagrelor|ticagrelor|mesh-list
153456295|NCT02630628|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153456296|NCT02630628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153456308|NCT02619253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153456309|NCT02619253|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
153456310|NCT02619253|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153456311|NCT02544815|Digoxin|digoxin|mesh-list
153456312|NCT02544815|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153456313|NCT02544815|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
153456314|NCT02544815|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153456315|NCT02544815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153456316|NCT02544815|Protective Agents|protective agents|mesh-ancestor
153879289|NCT05878951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153879290|NCT05878951|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
153879291|NCT05878951|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153879292|NCT05878951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153879293|NCT05878951|Cholinergic Agents|cholinergic agents|mesh-ancestor
153879294|NCT05878951|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153879295|NCT05837806|Tislelizumab|tislelizumab|mesh-list
153456317|NCT02544815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153456318|NCT02476786|Tamoxifen|tamoxifen|mesh-list
153456319|NCT02476786|Fulvestrant|fulvestrant|mesh-list
153456320|NCT02476786|Anastrozole|anastrozole|mesh-list
153914531|NCT00935818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153914532|NCT00935818|Dopamine Agents|dopamine agents|mesh-ancestor
153914533|NCT00935818|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153914534|NCT00935818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153420144|NCT03118466|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153420145|NCT03118466|Immunologic Factors|immunologic factors|mesh-ancestor
153879330|NCT05717166|Hormones|hormones|mesh-list
153879370|NCT05579977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153879371|NCT05553145|Antibodies|antibodies|mesh-list
153879372|NCT05553145|Autoantibodies|autoantibodies|mesh-list
153879373|NCT05553145|Immunologic Factors|immunologic factors|mesh-ancestor
153879374|NCT05553145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153879375|NCT05509257|Naltrexone|naltrexone|mesh-list
153879376|NCT05509257|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
153879377|NCT05509257|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
153420192|NCT03123614|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
153420193|NCT03123614|Prednisolone acetate|prednisolone acetate|mesh-list
153420194|NCT03123614|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
153420195|NCT03123614|Prednisolone phosphate|prednisolone phosphate|mesh-list
153420196|NCT03123614|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153420197|NCT03123614|Glucocorticoids|glucocorticoids|mesh-ancestor
153420199|NCT03123614|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153420200|NCT03123614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153420201|NCT03123614|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153420204|NCT03123614|Autonomic Agents|autonomic agents|mesh-ancestor
153914535|NCT00935818|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
153914536|NCT00935818|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153914537|NCT00935818|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153914538|NCT00935818|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
153456331|NCT02476786|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153456333|NCT02476786|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
153501545|NCT00383682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153501546|NCT00383916|Pantoprazole|pantoprazole|mesh-list
153501547|NCT00383916|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
153501548|NCT00383916|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153501552|NCT00383994|Rituximab|rituximab|mesh-list
153501579|NCT00384384|Glycyrrhetinic Acid|glycyrrhetinic acid|mesh-list
153547247|NCT05652400|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
153547248|NCT05652400|Antiviral Agents|antiviral agents|mesh-ancestor
153879399|NCT05395091|Denosumab|denosumab|mesh-list
153420249|NCT03074630|Antimetabolites|antimetabolites|mesh-ancestor
153420250|NCT03074630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153420251|NCT03074630|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153420252|NCT03074630|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
153420253|NCT03074630|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153420254|NCT03074630|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
153420255|NCT03074630|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153879417|NCT05373186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153879418|NCT05321758|Immunosuppressive Agents|immunosuppressive agents|mesh-list
153879419|NCT05321758|Immunologic Factors|immunologic factors|mesh-ancestor
153879420|NCT05321758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153879422|NCT05314933|Antimetabolites|antimetabolites|mesh-ancestor
153879426|NCT05309187|Pembrolizumab|pembrolizumab|mesh-list
153501580|NCT00384384|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153501582|NCT00384540|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
153501583|NCT00384540|Sympathomimetics|sympathomimetics|mesh-ancestor
153456342|NCT02263729|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
153456343|NCT02263729|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
153456344|NCT02263729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153456345|NCT02161783|Cyclophosphamide|cyclophosphamide|mesh-list
153456346|NCT02161783|Fludarabine|fludarabine|mesh-list
153914539|NCT00935818|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
153914540|NCT00935818|Cholinergic Agents|cholinergic agents|mesh-ancestor
153914541|NCT02709265|Amikacin|amikacin|mesh-list
153914542|NCT02709265|Fosfomycin|fosfomycin|mesh-list
153914543|NCT02709265|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153914544|NCT02709265|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153914545|NCT00611845|Aprotinin|aprotinin|mesh-list
153914546|NCT00611845|Hemostatics|hemostatics|mesh-ancestor
153914547|NCT00611845|Coagulants|coagulants|mesh-ancestor
153914548|NCT00611845|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
153914549|NCT00611845|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
153914550|NCT00611845|Protease Inhibitors|protease inhibitors|mesh-ancestor
153914551|NCT00611845|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153914552|NCT00611845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153626722|NCT02018536|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153626723|NCT02018536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153626724|NCT02018588|Tryptophan|tryptophan|mesh-list
153626725|NCT02018588|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
153626726|NCT02018588|Antidepressive Agents|antidepressive agents|mesh-ancestor
153914553|NCT01216163|Acetaminophen|acetaminophen|mesh-list
153914554|NCT01216163|Ibuprofen|ibuprofen|mesh-list
153914555|NCT01216163|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153914556|NCT01216163|Analgesics|analgesics|mesh-ancestor
153456347|NCT02161783|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153879472|NCT05154994|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
153456348|NCT02161783|Immunologic Factors|immunologic factors|mesh-ancestor
153456349|NCT02161783|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153456350|NCT02161783|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153456351|NCT02161783|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153501584|NCT00384540|Autonomic Agents|autonomic agents|mesh-ancestor
153501585|NCT00384540|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153501586|NCT00384540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153879473|NCT05154994|Immunoglobulin G|immunoglobulin g|mesh-list
153879474|NCT05154994|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153501587|NCT00384540|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
153501588|NCT00384540|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
153501589|NCT00384540|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153501590|NCT00384540|Adrenergic Agents|adrenergic agents|mesh-ancestor
153501591|NCT00384540|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153501592|NCT00384540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153501593|NCT00384540|Protective Agents|protective agents|mesh-ancestor
153501594|NCT00384618|Vitamin E|vitamin e|mesh-list
153501595|NCT00384618|Pravastatin|pravastatin|mesh-list
153501596|NCT00384618|Vitamins|vitamins|mesh-ancestor
153501597|NCT00384618|Micronutrients|micronutrients|mesh-ancestor
153501598|NCT00384618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153501599|NCT00384618|Antioxidants|antioxidants|mesh-ancestor
153501600|NCT00384618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153501634|NCT00385632|Antiviral Agents|antiviral agents|mesh-ancestor
153501635|NCT00385632|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153501636|NCT00385710|Valproic Acid|valproic acid|mesh-list
153501638|NCT00385710|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153501639|NCT00385710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153501640|NCT00385710|GABA Agents|gaba agents|mesh-ancestor
153501641|NCT00385710|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153879475|NCT05154994|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153879476|NCT05154994|Immunologic Factors|immunologic factors|mesh-ancestor
153879477|NCT05154994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153879479|NCT05154994|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153501642|NCT00385710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153501643|NCT00385710|Antimanic Agents|antimanic agents|mesh-ancestor
153456386|NCT01208662|Glucocorticoids|glucocorticoids|mesh-ancestor
153456388|NCT01208662|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153456389|NCT01208662|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153456390|NCT01208662|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153456391|NCT01208662|Immunologic Factors|immunologic factors|mesh-ancestor
153456392|NCT01208662|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153456393|NCT01208662|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153879514|NCT04852224|Androgens|androgens|mesh-list
153879515|NCT04852224|Fertility Agents, Female|fertility agents, female|mesh-ancestor
153879516|NCT04852224|Fertility Agents|fertility agents|mesh-ancestor
153879517|NCT04852224|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153879518|NCT04852224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153879519|NCT04852224|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153879520|NCT04852224|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153879521|NCT04852224|Hormones|hormones|mesh-ancestor
153879522|NCT04852224|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153879523|NCT04833114|Carboplatin|carboplatin|mesh-list
153879524|NCT04833114|Etoposide|etoposide|mesh-list
153879525|NCT04833114|Rituximab|rituximab|mesh-list
153420347|NCT02953561|Azacitidine|azacitidine|mesh-list
153420348|NCT02953561|Avelumab|avelumab|mesh-list
153420349|NCT02953561|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
153420350|NCT02953561|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153420351|NCT02953561|Antimetabolites|antimetabolites|mesh-ancestor
153420358|NCT03090620|Lorazepam|lorazepam|mesh-list
153456394|NCT01208662|Growth Substances|growth substances|mesh-ancestor
153456395|NCT01208662|Growth Inhibitors|growth inhibitors|mesh-ancestor
153456396|NCT00929045|Hormones|hormones|mesh-list
153456397|NCT00929045|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153456398|NCT00929045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153456399|NCT01457118|Etirinotecan pegol|etirinotecan pegol|mesh-list
153456400|NCT01457118|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153501644|NCT00385710|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153420369|NCT03090620|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153420370|NCT03090620|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153420371|NCT03090620|GABA Modulators|gaba modulators|mesh-ancestor
153420372|NCT03090620|GABA Agents|gaba agents|mesh-ancestor
153420373|NCT03090620|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153420374|NCT03090620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153420375|NCT03090620|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
153879543|NCT04812535|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153879544|NCT04812535|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153879545|NCT04812535|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153879546|NCT04812535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153879547|NCT04812535|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
153879548|NCT04812535|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153879549|NCT04812535|Immunologic Factors|immunologic factors|mesh-ancestor
153547286|NCT05634057|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
153547287|NCT05634057|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153547288|NCT05634057|Parasympatholytics|parasympatholytics|mesh-ancestor
153547289|NCT05634057|Autonomic Agents|autonomic agents|mesh-ancestor
153547290|NCT05634057|Vasodilator Agents|vasodilator agents|mesh-ancestor
153547291|NCT05634057|Free Radical Scavengers|free radical scavengers|mesh-ancestor
153547292|NCT05634057|Antioxidants|antioxidants|mesh-ancestor
153547293|NCT05634057|Protective Agents|protective agents|mesh-ancestor
153547294|NCT05614102|Pembrolizumab|pembrolizumab|mesh-list
153547295|NCT05614102|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153547296|NCT05614102|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153547297|NCT05614102|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153547298|NCT05614102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153547299|NCT05614089|Insulin|insulin|mesh-list
153879573|NCT04660799|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153879574|NCT04660799|Immunologic Factors|immunologic factors|mesh-ancestor
153879575|NCT04660799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153879576|NCT04660799|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153501645|NCT00385710|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153501646|NCT00385710|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153501648|NCT00386178|Tocopherols|tocopherols|mesh-list
153501649|NCT00386178|Tocotrienols|tocotrienols|mesh-list
153501650|NCT00386178|alpha-Tocopherol|alpha-tocopherol|mesh-list
153501651|NCT00386178|gamma-Tocopherol|gamma-tocopherol|mesh-list
153501652|NCT00386178|Vitamins|vitamins|mesh-ancestor
153501653|NCT00386178|Micronutrients|micronutrients|mesh-ancestor
153501654|NCT00386178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153501655|NCT00386178|Antioxidants|antioxidants|mesh-ancestor
153501656|NCT00386178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153501657|NCT00386178|Protective Agents|protective agents|mesh-ancestor
153501658|NCT00421824|Capecitabine|capecitabine|mesh-list
153501659|NCT00421824|Oxaliplatin|oxaliplatin|mesh-list
153501660|NCT00421824|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153501661|NCT00421824|Antimetabolites|antimetabolites|mesh-ancestor
153456411|NCT01501110|Free Radical Scavengers|free radical scavengers|mesh-ancestor
153456412|NCT01501110|Antioxidants|antioxidants|mesh-ancestor
153456413|NCT01501110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153456414|NCT01501110|Protective Agents|protective agents|mesh-ancestor
153456415|NCT01501110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153456416|NCT01501110|Antidotes|antidotes|mesh-ancestor
153456417|NCT01500720|Topotecan|topotecan|mesh-list
153456418|NCT01500720|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
153456419|NCT01500720|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153879594|NCT04660799|Antimitotic Agents|antimitotic agents|mesh-ancestor
153879595|NCT04660799|Mitosis Modulators|mitosis modulators|mesh-ancestor
153879597|NCT04660799|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153879598|NCT04660799|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
153879599|NCT04660799|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153879600|NCT04660799|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153879601|NCT04660799|Anesthetics, Local|anesthetics, local|mesh-ancestor
153879602|NCT04660799|Anesthetics|anesthetics|mesh-ancestor
153879603|NCT04660799|Antiemetics|antiemetics|mesh-ancestor
153879604|NCT04660799|Autonomic Agents|autonomic agents|mesh-ancestor
153456420|NCT01500720|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153456421|NCT01500720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153456422|NCT01500720|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153456423|NCT01476696|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
153456425|NCT01455012|Rotigotine|rotigotine|mesh-list
153501662|NCT00421824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153501663|NCT00421824|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153879647|NCT04598321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153879648|NCT04598321|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153879649|NCT04523701|SMOFlipid|smoflipid|mesh-list
153547304|NCT05608005|MF59 oil emulsion|mf59 oil emulsion|mesh-list
153547305|NCT05608005|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153547306|NCT05608005|Immunologic Factors|immunologic factors|mesh-ancestor
153547307|NCT05608005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153547308|NCT05604222|Mirabegron|mirabegron|mesh-list
153547309|NCT05604222|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
153547310|NCT05604222|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
153547311|NCT05604222|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153547312|NCT05604222|Adrenergic Agents|adrenergic agents|mesh-ancestor
153547313|NCT05604222|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153547314|NCT05604222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153879650|NCT04523701|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
153879651|NCT04523701|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
153879652|NCT04523701|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
153879653|NCT04477850|Luspatercept|luspatercept|mesh-list
153879654|NCT04477850|Hematinics|hematinics|mesh-ancestor
153879655|NCT04471233|Pregabalin|pregabalin|mesh-list
153501665|NCT00421980|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153501681|NCT00422214|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153501682|NCT00422214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153501684|NCT00422526|Progestins|progestins|mesh-ancestor
153501685|NCT00422526|Hormones|hormones|mesh-ancestor
153456434|NCT01454778|Tubulin Modulators|tubulin modulators|mesh-ancestor
153456435|NCT01454778|Antimitotic Agents|antimitotic agents|mesh-ancestor
153456438|NCT01454076|Clarithromycin|clarithromycin|mesh-list
153501686|NCT00422526|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153420505|NCT03098420|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153420506|NCT03098420|Glucocorticoids|glucocorticoids|mesh-ancestor
153420507|NCT03098420|Hormones|hormones|mesh-ancestor
153420508|NCT03098420|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153420509|NCT03098420|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153420510|NCT03098420|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153420511|NCT03098420|Protease Inhibitors|protease inhibitors|mesh-ancestor
153420512|NCT03098420|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153420513|NCT03098420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153420515|NCT03098420|Anesthetics|anesthetics|mesh-ancestor
153501687|NCT00422526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153501689|NCT00422604|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
153501690|NCT00422604|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153501691|NCT00422604|Autonomic Agents|autonomic agents|mesh-ancestor
153501692|NCT00422604|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153501693|NCT00422604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153501694|NCT00422604|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153879693|NCT04151342|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153879694|NCT04151342|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153879695|NCT04151342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153879696|NCT04116112|Labetalol|labetalol|mesh-list
153879697|NCT04116112|Hydralazine|hydralazine|mesh-list
153879698|NCT04116112|Nicardipine|nicardipine|mesh-list
153879699|NCT04116112|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
153626734|NCT02018601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153626735|NCT02018601|Antipyretics|antipyretics|mesh-ancestor
153626736|NCT02018601|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153626737|NCT02018601|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153626738|NCT02018601|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153626739|NCT02018731|Metformin|metformin|mesh-list
153626740|NCT02018731|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153626741|NCT02018731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153626742|NCT02018757|Chlorotrianisene|chlorotrianisene|mesh-list
153626743|NCT02018757|Arsenic Trioxide|arsenic trioxide|mesh-list
153626744|NCT02018757|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
153626745|NCT02018757|Estrogens|estrogens|mesh-ancestor
153626746|NCT02018757|Hormones|hormones|mesh-ancestor
153626747|NCT02018757|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153456517|NCT01499160|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153547333|NCT05598567|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
153547334|NCT05598567|Anesthetics, General|anesthetics, general|mesh-ancestor
153547335|NCT05597540|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
153547336|NCT05597540|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
153547337|NCT05597540|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153547338|NCT05597540|Antitubercular Agents|antitubercular agents|mesh-ancestor
153547339|NCT05575180|Acetazolamide|acetazolamide|mesh-list
153547340|NCT05575180|Methazolamide|methazolamide|mesh-list
153547341|NCT05575180|Anticonvulsants|anticonvulsants|mesh-ancestor
153547342|NCT05575180|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
153547343|NCT05575180|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153547344|NCT05575180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153547345|NCT05575180|Diuretics|diuretics|mesh-ancestor
153547346|NCT05575180|Natriuretic Agents|natriuretic agents|mesh-ancestor
153420653|NCT03795350|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153420654|NCT03795350|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
153420655|NCT03795350|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
153420656|NCT03795350|Cholinergic Agents|cholinergic agents|mesh-ancestor
153420657|NCT03795350|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153420658|NCT03795350|Glucocorticoids|glucocorticoids|mesh-ancestor
153420659|NCT03795350|Hormones|hormones|mesh-ancestor
153501695|NCT00422604|Respiratory System Agents|respiratory system agents|mesh-ancestor
153501696|NCT00422604|Parasympatholytics|parasympatholytics|mesh-ancestor
153501697|NCT00422604|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
153501698|NCT00422604|Cholinergic Agents|cholinergic agents|mesh-ancestor
153501699|NCT00422604|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153501700|NCT00422604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153501701|NCT00422604|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
153501702|NCT00422604|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
153815239|NCT00454740|Cholinergic Agents|cholinergic agents|mesh-ancestor
153815240|NCT00454740|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153815241|NCT00454740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153815242|NCT00454740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153815243|NCT00454740|Urological Agents|urological agents|mesh-ancestor
153815244|NCT03276858|Midazolam|midazolam|mesh-list
153815245|NCT03276858|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
153815246|NCT03276858|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153815247|NCT03276858|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153815248|NCT03276858|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153815249|NCT03276858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153815250|NCT03276858|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153547348|NCT05574400|Caffeine|caffeine|mesh-list
153547349|NCT05574400|Caffeine citrate|caffeine citrate|mesh-list
153547350|NCT05574400|Citric Acid|citric acid|mesh-list
153547351|NCT05574400|Sodium Citrate|sodium citrate|mesh-list
153547352|NCT05574400|Anticoagulants|anticoagulants|mesh-ancestor
153547353|NCT05574400|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
153547354|NCT05574400|Chelating Agents|chelating agents|mesh-ancestor
153547355|NCT05574400|Sequestering Agents|sequestering agents|mesh-ancestor
153547356|NCT05574400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153879812|NCT03709992|Trospium chloride|trospium chloride|mesh-list
153879813|NCT03709992|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
153879814|NCT03709992|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
153879815|NCT03709992|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
153879816|NCT03709992|Adrenergic Agents|adrenergic agents|mesh-ancestor
153879817|NCT03709992|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153879818|NCT03709992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153815251|NCT03276858|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153501703|NCT00422604|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153501704|NCT00422604|Adrenergic Agents|adrenergic agents|mesh-ancestor
153501705|NCT00422682|Paclitaxel|paclitaxel|mesh-list
153815309|NCT00346463|Antioxidants|antioxidants|mesh-ancestor
153815310|NCT00346463|Protective Agents|protective agents|mesh-ancestor
153815311|NCT00346463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153815313|NCT00455091|Adefovir|adefovir|mesh-list
153879819|NCT03709992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153879820|NCT03709992|Urological Agents|urological agents|mesh-ancestor
153879821|NCT03709992|Parasympatholytics|parasympatholytics|mesh-ancestor
153879822|NCT03709992|Autonomic Agents|autonomic agents|mesh-ancestor
153420660|NCT03795350|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153420661|NCT03118843|Velpatasvir|velpatasvir|mesh-list
153420662|NCT03118843|Antiviral Agents|antiviral agents|mesh-ancestor
153420663|NCT03118843|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153420664|NCT02222922|Fluconazole|fluconazole|mesh-list
153420666|NCT02222922|Cofetuzumab pelidotin|cofetuzumab pelidotin|mesh-list
153420668|NCT02222922|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153815314|NCT00455091|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
153815315|NCT00455091|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153815316|NCT00455091|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153815317|NCT00455091|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153815319|NCT00455091|Antiviral Agents|antiviral agents|mesh-ancestor
153501706|NCT00422682|Carboplatin|carboplatin|mesh-list
153501707|NCT00422682|Gemcitabine|gemcitabine|mesh-list
153501708|NCT00422682|Temozolomide|temozolomide|mesh-list
153501709|NCT00422682|Topotecan|topotecan|mesh-list
153501729|NCT00422994|Dopamine Agents|dopamine agents|mesh-ancestor
153879843|NCT03490760|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153879844|NCT03398135|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
153879845|NCT03398135|Immunologic Factors|immunologic factors|mesh-ancestor
153879846|NCT03398135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153879847|NCT03341689|Psilocybin|psilocybin|mesh-list
153879848|NCT03341689|Hallucinogens|hallucinogens|mesh-ancestor
153879849|NCT03341689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153879850|NCT03341689|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153879851|NCT03307746|Rituximab|rituximab|mesh-list
153879852|NCT03307746|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153879853|NCT03307746|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153879854|NCT03307746|Immunologic Factors|immunologic factors|mesh-ancestor
153879855|NCT03307746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153879856|NCT03307746|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153879857|NCT03287908|Dexamethasone|dexamethasone|mesh-list
153879858|NCT03287908|Pomalidomide|pomalidomide|mesh-list
153879859|NCT03287908|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153420694|NCT02161146|Analgesics|analgesics|mesh-ancestor
153420695|NCT02161146|Sensory System Agents|sensory system agents|mesh-ancestor
153547366|NCT05548660|Sensory System Agents|sensory system agents|mesh-ancestor
153547367|NCT05548660|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153547368|NCT05548660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153547369|NCT05538663|Gemcitabine|gemcitabine|mesh-list
153547370|NCT05538663|Docetaxel|docetaxel|mesh-list
153547371|NCT05538663|BCG Vaccine|bcg vaccine|mesh-list
153547372|NCT05538663|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153547373|NCT05538663|Antimetabolites|antimetabolites|mesh-ancestor
153420707|NCT03447782|Naltrexone|naltrexone|mesh-list
153501730|NCT00422994|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153501731|NCT00422994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153501732|NCT00422994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153815341|NCT00346619|Antiviral Agents|antiviral agents|mesh-ancestor
153815342|NCT00346619|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153815343|NCT02273700|Rivaroxaban|rivaroxaban|mesh-list
153815344|NCT02273700|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
153815345|NCT02273700|Antithrombins|antithrombins|mesh-ancestor
153815346|NCT02273700|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
153815347|NCT02273700|Protease Inhibitors|protease inhibitors|mesh-ancestor
153815348|NCT02273700|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153815349|NCT02273700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153815350|NCT02273700|Anticoagulants|anticoagulants|mesh-ancestor
153547377|NCT05538663|Antimitotic Agents|antimitotic agents|mesh-ancestor
153547378|NCT05538663|Mitosis Modulators|mitosis modulators|mesh-ancestor
153547379|NCT05538663|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153547380|NCT05538663|Immunologic Factors|immunologic factors|mesh-ancestor
153547381|NCT05538663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153547382|NCT05538247|Indomethacin|indomethacin|mesh-list
153782506|NCT00234026|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153782507|NCT00234026|Antimetabolites|antimetabolites|mesh-ancestor
153815351|NCT02959658|Dimethyl Fumarate|dimethyl fumarate|mesh-list
153815352|NCT02959658|Dermatologic Agents|dermatologic agents|mesh-ancestor
153815353|NCT02959658|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153815354|NCT02959658|Immunologic Factors|immunologic factors|mesh-ancestor
153456644|NCT01473420|Epoetin Alfa|epoetin alfa|mesh-list
153456645|NCT01473420|Hematinics|hematinics|mesh-ancestor
153456646|NCT04674774|Lansoprazole|lansoprazole|mesh-list
153456647|NCT04674774|Dexlansoprazole|dexlansoprazole|mesh-list
153456648|NCT04674774|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
153456649|NCT04674774|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153456650|NCT04674774|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
153456651|NCT04674774|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153456652|NCT04674774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153456653|NCT01492686|Edaravone|edaravone|mesh-list
153456654|NCT01492686|Free Radical Scavengers|free radical scavengers|mesh-ancestor
153456655|NCT01492686|Antioxidants|antioxidants|mesh-ancestor
153456656|NCT01492686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153456657|NCT01492686|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
153456658|NCT01492686|Protective Agents|protective agents|mesh-ancestor
153782516|NCT00234182|Antiviral Agents|antiviral agents|mesh-ancestor
153547383|NCT05538247|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153547384|NCT05538247|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153547385|NCT05538247|Analgesics|analgesics|mesh-ancestor
153547386|NCT05538247|Sensory System Agents|sensory system agents|mesh-ancestor
153547387|NCT05538247|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153547388|NCT05538247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153547389|NCT05538247|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153547391|NCT05538247|Gout Suppressants|gout suppressants|mesh-ancestor
153456659|NCT01492686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153456660|NCT01449006|Maraviroc|maraviroc|mesh-list
153456661|NCT01449006|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
153501735|NCT00423228|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153501736|NCT00423228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153501737|NCT00423228|Cholinergic Agents|cholinergic agents|mesh-ancestor
153501738|NCT00423228|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153501739|NCT00423228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153501740|NCT00423228|Nootropic Agents|nootropic agents|mesh-ancestor
153501741|NCT01799616|Pamidronate|pamidronate|mesh-list
153815359|NCT04698213|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153815360|NCT04698213|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153547398|NCT05537220|N-monoacetylcystine|n-monoacetylcystine|mesh-list
153547399|NCT05537220|Antiviral Agents|antiviral agents|mesh-ancestor
153547400|NCT05537220|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153547401|NCT05537220|Expectorants|expectorants|mesh-ancestor
153547402|NCT05537220|Respiratory System Agents|respiratory system agents|mesh-ancestor
153547403|NCT05537220|Free Radical Scavengers|free radical scavengers|mesh-ancestor
153547404|NCT05537220|Antioxidants|antioxidants|mesh-ancestor
153547405|NCT05537220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153547406|NCT05537220|Protective Agents|protective agents|mesh-ancestor
153547407|NCT05537220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153815361|NCT04698213|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153815362|NCT04698213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153815363|NCT02273817|Ciclesonide|ciclesonide|mesh-list
153815364|NCT02273817|Glucocorticoids|glucocorticoids|mesh-ancestor
153815365|NCT02273817|Hormones|hormones|mesh-ancestor
153815366|NCT02273817|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153815367|NCT02273817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153501742|NCT01799616|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153501743|NCT01799616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153547409|NCT05530421|Dexamethasone|dexamethasone|mesh-list
153547410|NCT05530421|Venetoclax|venetoclax|mesh-list
153547411|NCT05530421|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153547412|NCT05530421|Antiemetics|antiemetics|mesh-ancestor
153547413|NCT05530421|Autonomic Agents|autonomic agents|mesh-ancestor
153547415|NCT05530421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153547416|NCT05530421|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153547418|NCT05530421|Hormones|hormones|mesh-ancestor
153547419|NCT05530421|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153547420|NCT05530421|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153547421|NCT05530421|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153411127|NCT00004941|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
153501745|NCT01799850|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153501746|NCT01799850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153501747|NCT01792050|Paclitaxel|paclitaxel|mesh-list
153501748|NCT01792050|Docetaxel|docetaxel|mesh-list
153501749|NCT01792050|Tryptophan|tryptophan|mesh-list
153501751|NCT01792050|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153501782|NCT01799460|Dermatologic Agents|dermatologic agents|mesh-ancestor
153501783|NCT01799460|Hormones|hormones|mesh-ancestor
153501784|NCT01799460|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153501785|NCT02999724|Gabapentin|gabapentin|mesh-list
153501786|NCT02999724|Analgesics|analgesics|mesh-ancestor
153501787|NCT02999724|Sensory System Agents|sensory system agents|mesh-ancestor
153501788|NCT02999724|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153501789|NCT02999724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153501790|NCT02999724|Anticonvulsants|anticonvulsants|mesh-ancestor
153501791|NCT02999724|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153501792|NCT02999724|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153815485|NCT00455442|Abortifacient Agents|abortifacient agents|mesh-ancestor
153815486|NCT00455442|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153815487|NCT00455442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153815488|NCT00455442|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
153815489|NCT00455442|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
153815490|NCT00455442|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
153815491|NCT00455442|Contraceptive Agents|contraceptive agents|mesh-ancestor
153456795|NCT01470144|Epoprostenol|epoprostenol|mesh-list
153501793|NCT02999724|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153501794|NCT02999724|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153501795|NCT02999724|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
153501796|NCT02999724|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
153501797|NCT02999724|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153501798|NCT02999724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153501799|NCT02999724|Antimanic Agents|antimanic agents|mesh-ancestor
153547422|NCT05513872|Nicotine|nicotine|mesh-list
153547423|NCT05513872|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
153547424|NCT05513872|Autonomic Agents|autonomic agents|mesh-ancestor
153547425|NCT05513872|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153547426|NCT05513872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153547427|NCT05513872|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
153547428|NCT05513872|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
153547429|NCT05513872|Cholinergic Agents|cholinergic agents|mesh-ancestor
153547430|NCT05513872|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153547431|NCT05513872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153547432|NCT05507983|Tranexamic Acid|tranexamic acid|mesh-list
153547433|NCT05507983|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
153547434|NCT05507983|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153501800|NCT02999490|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
153501801|NCT02999490|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
153501802|NCT02999490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153501803|NCT02998242|Apatinib|apatinib|mesh-list
153501804|NCT02998242|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153501805|NCT02998242|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153501806|NCT02998242|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153501807|NCT02998242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153501808|NCT02998398|Infliximab|infliximab|mesh-list
153501809|NCT02998398|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
153444799|NCT03724877|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
153501810|NCT02998398|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153501819|NCT02996916|Amlodipine|amlodipine|mesh-list
153815710|NCT00348452|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
153815711|NCT00348452|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153815713|NCT00348452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153815714|NCT00348452|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153815715|NCT00348452|Narcotics|narcotics|mesh-ancestor
153815716|NCT00348452|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153457026|NCT01435122|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153457027|NCT01435122|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153547449|NCT05491616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153547450|NCT05487456|Menthol|menthol|mesh-list
153547451|NCT05487456|Nicotine|nicotine|mesh-list
153547452|NCT05487456|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
153547453|NCT05487456|Autonomic Agents|autonomic agents|mesh-ancestor
153457028|NCT01435122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153457029|NCT01393626|Tofacitinib|tofacitinib|mesh-list
153457030|NCT01393626|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
153457031|NCT01393626|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153457032|NCT01393626|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153457033|NCT01393626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153457034|NCT01393158|Apremilast|apremilast|mesh-list
153457037|NCT01393158|Analgesics|analgesics|mesh-ancestor
153501823|NCT02996916|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153501824|NCT02996916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153501825|NCT02996916|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153501826|NCT02996916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153547454|NCT05487456|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153547455|NCT05487456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153547456|NCT05487456|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
153547457|NCT05487456|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
153547458|NCT05487456|Cholinergic Agents|cholinergic agents|mesh-ancestor
153547459|NCT05487456|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153547460|NCT05487456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153547461|NCT05487456|Antipruritics|antipruritics|mesh-ancestor
153547462|NCT05487456|Dermatologic Agents|dermatologic agents|mesh-ancestor
153547464|NCT05467176|Androgen Antagonists|androgen antagonists|mesh-ancestor
153547465|NCT05467176|Hormone Antagonists|hormone antagonists|mesh-ancestor
153547466|NCT05467176|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153501828|NCT02996916|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
153501829|NCT02996916|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
153501830|NCT02996214|Paclitaxel|paclitaxel|mesh-list
153501831|NCT02996214|Gemcitabine|gemcitabine|mesh-list
153501832|NCT02996214|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153547468|NCT05458674|Trastuzumab|trastuzumab|mesh-list
153501833|NCT02996214|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153501834|NCT02996214|Tubulin Modulators|tubulin modulators|mesh-ancestor
153501835|NCT02996214|Antimitotic Agents|antimitotic agents|mesh-ancestor
153815731|NCT00348491|Analgesics|analgesics|mesh-ancestor
153547469|NCT05458674|Tucatinib|tucatinib|mesh-list
153547470|NCT05458674|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153547471|NCT05458674|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153547472|NCT05458674|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153547473|NCT05458674|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153815732|NCT00348491|Sensory System Agents|sensory system agents|mesh-ancestor
153815733|NCT00348491|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153501836|NCT02996214|Mitosis Modulators|mitosis modulators|mesh-ancestor
153501837|NCT02996214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153501838|NCT02996214|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153501840|NCT02996058|Dexmedetomidine|dexmedetomidine|mesh-list
153501841|NCT02996058|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153501842|NCT02996058|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153501843|NCT02996058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153501844|NCT02996058|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153501846|NCT02996058|Sensory System Agents|sensory system agents|mesh-ancestor
153501847|NCT02996058|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153501848|NCT02996058|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
153501849|NCT02996058|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153501850|NCT02996058|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153815759|NCT00449436|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153879860|NCT03287908|Antiemetics|antiemetics|mesh-ancestor
153879861|NCT03287908|Autonomic Agents|autonomic agents|mesh-ancestor
153879862|NCT03287908|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153879863|NCT03287908|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153879864|NCT03287908|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153879865|NCT03287908|Glucocorticoids|glucocorticoids|mesh-ancestor
153879866|NCT03287908|Hormones|hormones|mesh-ancestor
153879867|NCT03287908|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153547475|NCT05457959|Poly I-C|poly i-c|mesh-list
153547476|NCT05457959|Nivolumab|nivolumab|mesh-list
153547477|NCT05457959|Ipilimumab|ipilimumab|mesh-list
153547478|NCT05457959|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
153547479|NCT05457959|Vaccines|vaccines|mesh-list
153547480|NCT05457959|Poly ICLC|poly iclc|mesh-list
153547481|NCT05457959|Immunologic Factors|immunologic factors|mesh-ancestor
153879868|NCT03287908|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153879869|NCT03287908|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153879870|NCT03287908|Immunologic Factors|immunologic factors|mesh-ancestor
153879871|NCT03287908|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153879872|NCT03287908|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153879873|NCT03287908|Growth Substances|growth substances|mesh-ancestor
153879874|NCT03287908|Growth Inhibitors|growth inhibitors|mesh-ancestor
153879875|NCT03266991|Isoniazid|isoniazid|mesh-list
153420709|NCT03447782|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
153420710|NCT03447782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153420711|NCT03447782|Sensory System Agents|sensory system agents|mesh-ancestor
153420712|NCT03447782|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153815760|NCT00449436|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153457072|NCT01412424|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153457073|NCT01412424|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153457074|NCT01412424|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153457076|NCT01433250|Immunologic Factors|immunologic factors|mesh-ancestor
153457077|NCT01433250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153457078|NCT01432938|Dulaglutide|dulaglutide|mesh-list
153457079|NCT01432938|Warfarin|warfarin|mesh-list
153420719|NCT02969317|Olodaterol|olodaterol|mesh-list
153457080|NCT01432938|Anticoagulants|anticoagulants|mesh-ancestor
153420720|NCT02969317|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153420721|NCT02969317|Autonomic Agents|autonomic agents|mesh-ancestor
153879876|NCT03266991|Rifapentine|rifapentine|mesh-list
153879877|NCT03266991|Antitubercular Agents|antitubercular agents|mesh-ancestor
153879878|NCT03266991|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153879879|NCT03266991|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153879880|NCT03266991|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
153547490|NCT05457959|Antiviral Agents|antiviral agents|mesh-ancestor
153547491|NCT05457959|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153547492|NCT05456191|Nilotinib|nilotinib|mesh-list
153547493|NCT05456191|Asciminib|asciminib|mesh-list
153420734|NCT05347082|Vitamin D|vitamin d|mesh-list
153420735|NCT05347082|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153457081|NCT01432938|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
153457082|NCT01432938|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153457083|NCT01432938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153457084|NCT01392300|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
153457085|NCT01392300|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
153457086|NCT01392300|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153457087|NCT01392300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153879890|NCT03104855|Micronutrients|micronutrients|mesh-ancestor
153879891|NCT03104855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153879892|NCT03104855|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153879893|NCT03089905|Dexmedetomidine|dexmedetomidine|mesh-list
153879894|NCT03089905|Remifentanil|remifentanil|mesh-list
153879895|NCT03089905|Sevoflurane|sevoflurane|mesh-list
153879896|NCT03089905|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153879897|NCT03089905|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153879898|NCT03089905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153879899|NCT03089905|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153879900|NCT03089905|Analgesics|analgesics|mesh-ancestor
153879901|NCT03089905|Sensory System Agents|sensory system agents|mesh-ancestor
153879903|NCT03089905|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
153420736|NCT05347082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153420737|NCT05347082|Vitamins|vitamins|mesh-ancestor
153420738|NCT05347082|Micronutrients|micronutrients|mesh-ancestor
153420739|NCT05347082|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153420740|NCT03087578|Mirabegron|mirabegron|mesh-list
153420741|NCT03087578|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
153420742|NCT03087578|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
153420743|NCT03087578|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153420744|NCT03087578|Adrenergic Agents|adrenergic agents|mesh-ancestor
153420745|NCT03087578|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153879904|NCT03089905|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153879905|NCT03089905|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153879906|NCT03089905|Adrenergic Agents|adrenergic agents|mesh-ancestor
153879907|NCT03089905|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153879908|NCT03089905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153879909|NCT03089905|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153879910|NCT03089905|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
153879911|NCT03089905|Anesthetics, General|anesthetics, general|mesh-ancestor
153879912|NCT03089905|Anesthetics|anesthetics|mesh-ancestor
153879913|NCT03089905|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153815761|NCT00456027|Aluminum Hydroxide|aluminum hydroxide|mesh-list
153815762|NCT00456027|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153815763|NCT00456027|Immunologic Factors|immunologic factors|mesh-ancestor
153815764|NCT00456027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153815765|NCT00456027|Antacids|antacids|mesh-ancestor
153815766|NCT00456027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153815767|NCT00456027|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153815768|NCT00448734|Docetaxel|docetaxel|mesh-list
153815769|NCT00448734|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153815770|NCT00448734|Tubulin Modulators|tubulin modulators|mesh-ancestor
153815771|NCT00448734|Antimitotic Agents|antimitotic agents|mesh-ancestor
153501851|NCT02996058|Adrenergic Agents|adrenergic agents|mesh-ancestor
153501852|NCT02996058|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153501853|NCT02996058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153501854|NCT02995512|Colchicine|colchicine|mesh-list
153501855|NCT02995512|Gout Suppressants|gout suppressants|mesh-ancestor
153501859|NCT02995512|Mitosis Modulators|mitosis modulators|mesh-ancestor
153501860|NCT02995512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153501861|NCT02995512|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153815776|NCT00348725|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153457088|NCT01392300|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
153420746|NCT03087578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153420747|NCT03087578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153420748|NCT03087578|Urological Agents|urological agents|mesh-ancestor
153420749|NCT02975557|Brimonidine Tartrate|brimonidine tartrate|mesh-list
153420750|NCT02975557|Lubricant Eye Drops|lubricant eye drops|mesh-list
153420751|NCT02975557|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153420752|NCT02975557|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
153420753|NCT02975557|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153420754|NCT02975557|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153420755|NCT02975557|Adrenergic Agents|adrenergic agents|mesh-ancestor
153420756|NCT02975557|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153420757|NCT02975557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153547501|NCT05453968|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153547503|NCT05438420|Pembrolizumab|pembrolizumab|mesh-list
153547504|NCT05438420|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153547505|NCT05438420|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153457089|NCT01392300|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153457090|NCT01392300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153457091|NCT01392300|Cholinergic Agents|cholinergic agents|mesh-ancestor
153457092|NCT01392300|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153457118|NCT01408914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153457119|NCT01408914|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
153457120|NCT01408914|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
153457121|NCT01408914|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
153457122|NCT01408914|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
153547511|NCT05432804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153547512|NCT05432804|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153547514|NCT05425979|Mepivacaine|mepivacaine|mesh-list
153547515|NCT05425979|Anesthetics, Local|anesthetics, local|mesh-ancestor
153547516|NCT05425979|Anesthetics|anesthetics|mesh-ancestor
153457123|NCT01408914|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
153457124|NCT01408914|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
153457126|NCT04044222|Etoposide|etoposide|mesh-list
153457127|NCT04044222|Etoposide phosphate|etoposide phosphate|mesh-list
153457128|NCT04044222|Ifosfamide|ifosfamide|mesh-list
153457131|NCT04044222|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153457132|NCT04044222|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153457133|NCT04044222|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153547517|NCT05425979|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153547519|NCT05425979|Sensory System Agents|sensory system agents|mesh-ancestor
153457134|NCT04044222|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153457135|NCT04044222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153457136|NCT04044222|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153457137|NCT04044222|Alkylating Agents|alkylating agents|mesh-ancestor
153457138|NCT01390428|Grazoprevir|grazoprevir|mesh-list
153457139|NCT01390428|Antiviral Agents|antiviral agents|mesh-ancestor
153457140|NCT01390428|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153457141|NCT01429584|Bupivacaine|bupivacaine|mesh-list
153457142|NCT01429584|Anesthetics, Local|anesthetics, local|mesh-ancestor
153501863|NCT02994888|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153501864|NCT02994888|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153501865|NCT02993718|Dexmedetomidine|dexmedetomidine|mesh-list
153547527|NCT05421858|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153547528|NCT05421858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153547529|NCT05421858|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153547530|NCT05421858|Hormone Antagonists|hormone antagonists|mesh-ancestor
153547531|NCT05421858|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153547532|NCT05421858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153547533|NCT05421858|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
153547534|NCT05421858|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
153547536|NCT05419050|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153501866|NCT02993718|Propofol|propofol|mesh-list
153501867|NCT02993718|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153501868|NCT02993718|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153501869|NCT02993718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153501870|NCT02993718|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153501871|NCT02993718|Analgesics|analgesics|mesh-ancestor
153501872|NCT02993718|Sensory System Agents|sensory system agents|mesh-ancestor
153501873|NCT02993718|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153501874|NCT02993718|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
153501875|NCT02993718|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153501876|NCT02993718|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153457156|NCT01405950|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
153457157|NCT01405950|Parasympatholytics|parasympatholytics|mesh-ancestor
153547538|NCT05412576|Lidocaine|lidocaine|mesh-list
153457159|NCT01405950|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
153457160|NCT01405950|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153457161|NCT01405950|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153457162|NCT01405950|Adrenergic Agents|adrenergic agents|mesh-ancestor
153457163|NCT01405950|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153457164|NCT01405950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153457165|NCT01405950|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153457166|NCT01405950|Sympatholytics|sympatholytics|mesh-ancestor
153457167|NCT01405560|Ribavirin|ribavirin|mesh-list
153457168|NCT01405560|Antimetabolites|antimetabolites|mesh-ancestor
153815841|NCT00349076|Immunologic Factors|immunologic factors|mesh-ancestor
153815842|NCT00349076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153815843|NCT00349115|Thalidomide|thalidomide|mesh-list
153815844|NCT00349115|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153815845|NCT00349115|Immunologic Factors|immunologic factors|mesh-ancestor
153815846|NCT00349115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153815847|NCT00349115|Leprostatic Agents|leprostatic agents|mesh-ancestor
153815848|NCT00349115|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153815849|NCT00349115|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153815850|NCT00349115|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153815851|NCT00349115|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153815852|NCT00349115|Growth Substances|growth substances|mesh-ancestor
153549649|NCT03939897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153815853|NCT00349115|Growth Inhibitors|growth inhibitors|mesh-ancestor
153815854|NCT00349115|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153815855|NCT00456339|Amoxicillin|amoxicillin|mesh-list
153457171|NCT01405560|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153457175|NCT01428882|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153457176|NCT01428882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153457177|NCT01428882|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153457178|NCT01428882|Anesthetics, General|anesthetics, general|mesh-ancestor
153457179|NCT01428882|Anesthetics|anesthetics|mesh-ancestor
153457180|NCT01428882|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153457181|NCT01428882|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153457182|NCT01428882|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153457183|NCT01428882|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153457184|NCT01428882|GABA Modulators|gaba modulators|mesh-ancestor
153457185|NCT01428882|GABA Agents|gaba agents|mesh-ancestor
153457186|NCT01428882|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153457187|NCT01428882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153457188|NCT01428258|Coal Tar|coal tar|mesh-list
153457189|NCT01428258|Keratolytic Agents|keratolytic agents|mesh-ancestor
153457190|NCT01428258|Dermatologic Agents|dermatologic agents|mesh-ancestor
153457191|NCT01442688|Amoxicillin|amoxicillin|mesh-list
153457192|NCT01442688|Mesalamine|mesalamine|mesh-list
153457193|NCT01442688|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153501877|NCT02993718|Adrenergic Agents|adrenergic agents|mesh-ancestor
153501878|NCT02993718|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153501879|NCT02993718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153781871|NCT02212210|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153501880|NCT02993718|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153501881|NCT02993718|Anesthetics, General|anesthetics, general|mesh-ancestor
153501883|NCT02993640|Vasopressins|vasopressins|mesh-list
153501884|NCT02993640|Arginine Vasopressin|arginine vasopressin|mesh-list
153501885|NCT02993640|Hemostatics|hemostatics|mesh-ancestor
153501886|NCT02993640|Coagulants|coagulants|mesh-ancestor
153501887|NCT02993640|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
153501888|NCT02993640|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
153501889|NCT02993640|Natriuretic Agents|natriuretic agents|mesh-ancestor
153501890|NCT02993640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153501891|NCT02993094|Carboplatin|carboplatin|mesh-list
153501892|NCT02993094|Ixazomib|ixazomib|mesh-list
153501899|NCT02992938|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
153914594|NCT00933244|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153457194|NCT01442688|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153457195|NCT01442688|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153457196|NCT01442688|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153457198|NCT01442688|Sensory System Agents|sensory system agents|mesh-ancestor
153457199|NCT01442688|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153457200|NCT01442688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153457201|NCT01442688|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153457202|NCT01442688|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153457204|NCT03814200|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
153550584|NCT02747004|Loperamide|loperamide|mesh-list
153457205|NCT03814200|Antitubercular Agents|antitubercular agents|mesh-ancestor
153457206|NCT03814200|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153457207|NCT03814200|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153457208|NCT03814200|Leprostatic Agents|leprostatic agents|mesh-ancestor
153501901|NCT02992938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153501903|NCT02992938|Natriuretic Agents|natriuretic agents|mesh-ancestor
153501904|NCT02992938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153501905|NCT02992704|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
153501907|NCT02992704|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153501908|NCT02992548|Pravastatin|pravastatin|mesh-list
153501909|NCT02992548|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153457215|NCT03814200|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
153457217|NCT03814200|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
153457219|NCT01426854|Ophthalmic Solutions|ophthalmic solutions|mesh-list
153457220|NCT01426854|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
153457221|NCT01426854|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153457222|NCT01426854|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153457223|NCT01426854|Analgesics|analgesics|mesh-ancestor
153457224|NCT01426854|Sensory System Agents|sensory system agents|mesh-ancestor
153457225|NCT01426854|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153457226|NCT01426854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153457227|NCT01426854|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153471792|NCT02126969|Carboplatin|carboplatin|mesh-list
153815899|NCT03274167|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153815900|NCT03274167|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153815901|NCT03274167|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153815902|NCT03274167|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
153815903|NCT03274167|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
153815904|NCT03274167|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153815905|NCT03274167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153815906|NCT03274167|Antimanic Agents|antimanic agents|mesh-ancestor
153815907|NCT00349427|Rosiglitazone|rosiglitazone|mesh-list
153815908|NCT00349427|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153815909|NCT00349427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153815910|NCT00349583|Cyclosporine|cyclosporine|mesh-list
153815911|NCT00349583|Cyclosporins|cyclosporins|mesh-list
153457228|NCT01426854|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153457229|NCT01403610|Bevacizumab|bevacizumab|mesh-list
153457230|NCT01403610|Phosphoramide Mustards|phosphoramide mustards|mesh-list
153501910|NCT02992548|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153457278|NCT01388478|Dexpramipexole|dexpramipexole|mesh-list
153457279|NCT01388478|Antioxidants|antioxidants|mesh-ancestor
153457280|NCT01388478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153457281|NCT01388478|Protective Agents|protective agents|mesh-ancestor
153457282|NCT01388478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153457283|NCT01388478|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
153457284|NCT01388478|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
153457285|NCT01388478|Dopamine Agonists|dopamine agonists|mesh-ancestor
153457286|NCT01388478|Dopamine Agents|dopamine agents|mesh-ancestor
153457287|NCT01388478|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153457289|NCT01400958|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
153815961|NCT04699110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153815962|NCT04699110|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153815963|NCT04699110|Vasodilator Agents|vasodilator agents|mesh-ancestor
153815964|NCT04699110|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
153815965|NCT04699110|Purinergic Agonists|purinergic agonists|mesh-ancestor
153815966|NCT04699110|Purinergic Agents|purinergic agents|mesh-ancestor
153501911|NCT02992548|Antimetabolites|antimetabolites|mesh-ancestor
153501912|NCT02992548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153501913|NCT02992548|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153501914|NCT02992548|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
153501915|NCT02992548|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153501917|NCT02992392|Anticoagulants|anticoagulants|mesh-ancestor
153501918|NCT02992392|Plasma Substitutes|plasma substitutes|mesh-ancestor
153501919|NCT02992392|Blood Substitutes|blood substitutes|mesh-ancestor
153501920|NCT02991768|Budesonide|budesonide|mesh-list
153501921|NCT02991768|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153501922|NCT02991768|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153501923|NCT02991768|Autonomic Agents|autonomic agents|mesh-ancestor
153501924|NCT02991768|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153501925|NCT02991768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153457294|NCT01400958|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153457295|NCT01400412|Ritonavir|ritonavir|mesh-list
153457296|NCT01400412|Darunavir|darunavir|mesh-list
153457297|NCT01400412|Tenofovir|tenofovir|mesh-list
153457298|NCT01400412|Emtricitabine|emtricitabine|mesh-list
153457299|NCT01400412|Maraviroc|maraviroc|mesh-list
153457300|NCT01400412|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
153457301|NCT01400412|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
153457302|NCT01400412|Protease Inhibitors|protease inhibitors|mesh-ancestor
153815975|NCT04699110|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153815976|NCT04699110|Respiratory System Agents|respiratory system agents|mesh-ancestor
153815977|NCT04699110|Mydriatics|mydriatics|mesh-ancestor
153815978|NCT04699110|Sympathomimetics|sympathomimetics|mesh-ancestor
153815979|NCT04699110|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
153815980|NCT00350168|Amlodipine|amlodipine|mesh-list
153815981|NCT00350168|Valsartan|valsartan|mesh-list
153815982|NCT00350168|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153815983|NCT00350168|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153815984|NCT00350168|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153815985|NCT00350168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153815986|NCT00350168|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153457303|NCT01400412|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153457304|NCT01400412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153457305|NCT01400412|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153457306|NCT01400412|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153501927|NCT02991768|Respiratory System Agents|respiratory system agents|mesh-ancestor
153501928|NCT02991768|Glucocorticoids|glucocorticoids|mesh-ancestor
153501930|NCT02991768|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153501931|NCT02991612|Rifaximin|rifaximin|mesh-list
153501932|NCT02991612|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153501933|NCT02991612|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153457307|NCT01400412|Antiviral Agents|antiviral agents|mesh-ancestor
153457308|NCT01400412|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153457309|NCT01400412|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
153457310|NCT01400412|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153457311|NCT01400412|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153457312|NCT01400412|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153457313|NCT01400412|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
153457314|NCT01400412|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
153457315|NCT01400412|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
153815987|NCT00350168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153815988|NCT00350168|Vasodilator Agents|vasodilator agents|mesh-ancestor
153815989|NCT00350168|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
153815990|NCT00350168|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
153815991|NCT00105534|Azithromycin|azithromycin|mesh-list
153815992|NCT00105534|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153815993|NCT00105534|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153815994|NCT00350441|Sildenafil Citrate|sildenafil citrate|mesh-list
153815995|NCT00350441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153815996|NCT00350441|Vasodilator Agents|vasodilator agents|mesh-ancestor
153815997|NCT00350441|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
153815998|NCT00350441|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
153815999|NCT00350441|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153816000|NCT00350441|Urological Agents|urological agents|mesh-ancestor
153457318|NCT01422876|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153457319|NCT01422876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153457320|NCT01422876|Incretins|incretins|mesh-ancestor
153457321|NCT01422876|Hormones|hormones|mesh-ancestor
153501938|NCT02990286|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153501939|NCT02990286|Immunologic Factors|immunologic factors|mesh-ancestor
153501940|NCT02990286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153550731|NCT02465060|Trastuzumab|trastuzumab|mesh-list
153550732|NCT02465060|Pertuzumab|pertuzumab|mesh-list
153550734|NCT02465060|Relatlimab|relatlimab|mesh-list
153501941|NCT02990286|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153501942|NCT02990286|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153501943|NCT02990286|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
153501944|NCT02990286|Antitubercular Agents|antitubercular agents|mesh-ancestor
153501945|NCT02990286|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153501946|NCT02990286|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153501947|NCT02990286|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153501948|NCT02990286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153501949|NCT02999958|Thioctic Acid|thioctic acid|mesh-list
153501950|NCT02999958|Acetylcarnitine|acetylcarnitine|mesh-list
153501951|NCT02999958|Acetylcysteine|acetylcysteine|mesh-list
153457322|NCT01422876|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153457323|NCT01422876|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
153457324|NCT01422876|Protease Inhibitors|protease inhibitors|mesh-ancestor
153457325|NCT01422876|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153457326|NCT01422876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153457327|NCT01422876|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
153457328|NCT01422720|Eslicarbazepine acetate|eslicarbazepine acetate|mesh-list
153457331|NCT01422720|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153501953|NCT02999958|N-monoacetylcystine|n-monoacetylcystine|mesh-list
153501954|NCT02999958|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153501955|NCT02999958|Protective Agents|protective agents|mesh-ancestor
153501956|NCT02999958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153501957|NCT02999958|Vitamin B Complex|vitamin b complex|mesh-ancestor
153501959|NCT02999958|Micronutrients|micronutrients|mesh-ancestor
153501960|NCT02999958|Nootropic Agents|nootropic agents|mesh-ancestor
153501961|NCT02999958|Antiviral Agents|antiviral agents|mesh-ancestor
153457347|NCT01422408|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153457348|NCT01422408|Glucocorticoids|glucocorticoids|mesh-ancestor
153457349|NCT01422408|Hormones|hormones|mesh-ancestor
153457350|NCT01422408|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153457351|NCT01422408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153457352|NCT01422408|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
153457353|NCT01387542|Paliperidone Palmitate|paliperidone palmitate|mesh-list
153816026|NCT00350753|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153816027|NCT00350753|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153816028|NCT00350753|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153816029|NCT00350753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153816030|NCT00457119|Everolimus|everolimus|mesh-list
153816031|NCT00457119|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
153816032|NCT00457119|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153816033|NCT00457119|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153816034|NCT00457119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153816035|NCT00457119|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153816036|NCT00457119|Immunologic Factors|immunologic factors|mesh-ancestor
153457354|NCT01387542|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153457355|NCT01387542|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153457356|NCT01387542|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153457357|NCT01387542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153457358|NCT01387542|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153457359|NCT01387542|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
153457360|NCT01387542|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153457362|NCT01387542|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153457363|NCT01387542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153457364|NCT01387542|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
153457365|NCT01387542|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
153457366|NCT01387542|Dopamine Agents|dopamine agents|mesh-ancestor
153457367|NCT01387074|Botulinum Toxins|botulinum toxins|mesh-list
153457368|NCT01387074|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
153457369|NCT01387074|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
153501962|NCT02999958|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153501963|NCT02999958|Expectorants|expectorants|mesh-ancestor
153501964|NCT02999958|Respiratory System Agents|respiratory system agents|mesh-ancestor
153501965|NCT02999958|Free Radical Scavengers|free radical scavengers|mesh-ancestor
153501966|NCT02999958|Antidotes|antidotes|mesh-ancestor
153501967|NCT02995746|Dexamethasone|dexamethasone|mesh-list
153501968|NCT02995746|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153501969|NCT02995746|Antiemetics|antiemetics|mesh-ancestor
153501970|NCT02995746|Autonomic Agents|autonomic agents|mesh-ancestor
153501971|NCT02995746|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153501972|NCT02995746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153501973|NCT02995746|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153501975|NCT02995746|Hormones|hormones|mesh-ancestor
153501978|NCT02995746|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153501979|NCT02990364|Lidocaine|lidocaine|mesh-list
153501980|NCT02990364|Anesthetics, Local|anesthetics, local|mesh-list
153457376|NCT01387074|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
153457377|NCT01387074|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153457378|NCT01386606|Methyltestosterone|methyltestosterone|mesh-list
153457379|NCT01386606|Enclomiphene|enclomiphene|mesh-list
153457381|NCT01386606|Zuclomiphene|zuclomiphene|mesh-list
153457382|NCT01386606|Testosterone|testosterone|mesh-list
153457383|NCT01386606|Testosterone undecanoate|testosterone undecanoate|mesh-list
153457384|NCT01386606|Testosterone enanthate|testosterone enanthate|mesh-list
153457404|NCT01385748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153457405|NCT01385748|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153457406|NCT01385748|Sympatholytics|sympatholytics|mesh-ancestor
153457407|NCT01385748|Autonomic Agents|autonomic agents|mesh-ancestor
153457408|NCT01385748|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
153457409|NCT01385748|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153457410|NCT01385748|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153457411|NCT01385748|Adrenergic Agents|adrenergic agents|mesh-ancestor
153457412|NCT01385748|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153816080|NCT00351143|Fluticasone|fluticasone|mesh-list
153501981|NCT02990364|Lidocaine, Prilocaine Drug Combination|lidocaine, prilocaine drug combination|mesh-list
153501983|NCT02990364|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153501984|NCT02990364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153501985|NCT02990364|Sensory System Agents|sensory system agents|mesh-ancestor
153501986|NCT02990364|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153501987|NCT02990364|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153501988|NCT02990364|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
153501989|NCT02990364|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153457421|NCT01384734|Atazanavir Sulfate|atazanavir sulfate|mesh-list
153457424|NCT01384734|Fostemsavir|fostemsavir|mesh-list
153457425|NCT01384734|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
153457426|NCT01384734|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
153457427|NCT01384734|Protease Inhibitors|protease inhibitors|mesh-ancestor
153457428|NCT01384734|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153457429|NCT01384734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153457430|NCT01384734|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153457431|NCT01384734|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153457432|NCT01384734|Antiviral Agents|antiviral agents|mesh-ancestor
153457433|NCT01384734|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153457434|NCT01384734|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
153626757|NCT02018783|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153626759|NCT02018874|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153626760|NCT02018874|Antimetabolites|antimetabolites|mesh-ancestor
153626761|NCT02018874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153626762|NCT02018874|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153626763|NCT02018965|Vitamins|vitamins|mesh-list
153626765|NCT02018965|Niacinamide|niacinamide|mesh-list
153626766|NCT02018965|Nicotinic Acids|nicotinic acids|mesh-list
153736721|NCT06182800|Docetaxel|docetaxel|mesh-list
153737913|NCT04375605|Antimetabolites|antimetabolites|mesh-ancestor
153501990|NCT02990364|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153738650|NCT00004192|Hormones|hormones|mesh-ancestor
153738740|NCT00470197|Analgesics|analgesics|mesh-ancestor
153739730|NCT00339586|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
153501991|NCT02990364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153740049|NCT00513487|Fluticasone|fluticasone|mesh-list
153501992|NCT02990364|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
153501993|NCT01270074|Azithromycin|azithromycin|mesh-list
153740208|NCT00514969|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153740444|NCT05861297|Rituximab|rituximab|mesh-list
153501994|NCT01270074|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153501995|NCT01270074|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153741079|NCT03172754|Nivolumab|nivolumab|mesh-list
153550763|NCT02465060|Growth Inhibitors|growth inhibitors|mesh-ancestor
153501996|NCT01270308|Lansoprazole|lansoprazole|mesh-list
153742247|NCT00512863|Adalimumab|adalimumab|mesh-list
153501997|NCT01270308|Dexlansoprazole|dexlansoprazole|mesh-list
153501998|NCT01270308|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
153501999|NCT01270308|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153744343|NCT00147875|Hormones|hormones|mesh-ancestor
153502000|NCT01270308|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
153502001|NCT01270308|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153745163|NCT05616260|Acetazolamide|acetazolamide|mesh-list
153502002|NCT01270308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153745839|NCT02915731|Vitamins|vitamins|mesh-ancestor
153502003|NCT01270386|Apatinib|apatinib|mesh-list
153746140|NCT02911870|Moxifloxacin|moxifloxacin|mesh-list
153746265|NCT02910817|Metformin|metformin|mesh-list
153502004|NCT01270386|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153502005|NCT01270386|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153502006|NCT01270386|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153748040|NCT02920060|Levetiracetam|levetiracetam|mesh-list
153748193|NCT00155402|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
153748449|NCT00181935|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153748841|NCT00182442|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153749068|NCT00534586|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153749200|NCT00157586|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153749201|NCT00157586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153749202|NCT00157586|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153749203|NCT00157586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153749204|NCT00157586|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
153749205|NCT00157586|Protease Inhibitors|protease inhibitors|mesh-ancestor
153749271|NCT00157898|Metronidazole|metronidazole|mesh-list
153749272|NCT00157898|Ceftriaxone|ceftriaxone|mesh-list
153749592|NCT00537121|Leucovorin|leucovorin|mesh-list
153750043|NCT00190437|Amoxicillin|amoxicillin|mesh-list
153750044|NCT00190437|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153750045|NCT00190437|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153750047|NCT00159575|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153750048|NCT00159575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153750049|NCT00541567|Ibipinabant|ibipinabant|mesh-list
153750050|NCT00541567|Cannabinoid Receptor Antagonists|cannabinoid receptor antagonists|mesh-ancestor
153750051|NCT00541567|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
153750052|NCT00541567|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153750053|NCT00541567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153750054|NCT00541567|Hormones|hormones|mesh-ancestor
153750055|NCT00541567|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153750056|NCT00541567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153502007|NCT01270386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153502008|NCT01270854|Plasma-lyte 148|plasma-lyte 148|mesh-list
153750843|NCT00184626|Insulin|insulin|mesh-list
153502009|NCT01270854|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
153752615|NCT03330028|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153502010|NCT01270854|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
153502011|NCT01270932|Dexamethasone|dexamethasone|mesh-list
153683714|NCT00134212|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153502018|NCT01270932|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153502019|NCT01270932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153684660|NCT00148447|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153502020|NCT01270932|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153502021|NCT01270932|Glucocorticoids|glucocorticoids|mesh-ancestor
153502022|NCT01270932|Hormones|hormones|mesh-ancestor
153685774|NCT00050414|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153502023|NCT01270932|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153686138|NCT00083460|Autonomic Agents|autonomic agents|mesh-ancestor
153502024|NCT01270932|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153686537|NCT00157885|Anthelmintics|anthelmintics|mesh-ancestor
153686770|NCT00159484|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153502025|NCT01270932|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153687534|NCT00163969|Analgesics|analgesics|mesh-ancestor
153688741|NCT00171457|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
153502028|NCT01270932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153502029|NCT01270932|Immunologic Factors|immunologic factors|mesh-ancestor
153502030|NCT01270932|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153690747|NCT00187057|Antiviral Agents|antiviral agents|mesh-ancestor
153691105|NCT00189358|Hormone Antagonists|hormone antagonists|mesh-ancestor
153502031|NCT01270932|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153502032|NCT01270932|Growth Substances|growth substances|mesh-ancestor
153502033|NCT01270932|Growth Inhibitors|growth inhibitors|mesh-ancestor
153502034|NCT01271088|Acetylcysteine|acetylcysteine|mesh-list
153502035|NCT01271088|N-monoacetylcystine|n-monoacetylcystine|mesh-list
153502036|NCT01271088|Antiviral Agents|antiviral agents|mesh-ancestor
153502037|NCT01271088|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153502038|NCT01271088|Expectorants|expectorants|mesh-ancestor
153502039|NCT01271088|Respiratory System Agents|respiratory system agents|mesh-ancestor
153502040|NCT01271088|Free Radical Scavengers|free radical scavengers|mesh-ancestor
153502041|NCT01271088|Antioxidants|antioxidants|mesh-ancestor
153502042|NCT01271088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153502043|NCT01271088|Protective Agents|protective agents|mesh-ancestor
153502044|NCT01271088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153502045|NCT01271088|Antidotes|antidotes|mesh-ancestor
153502046|NCT01271166|Leucovorin|leucovorin|mesh-list
153502047|NCT01271166|Bevacizumab|bevacizumab|mesh-list
153502049|NCT01271166|Oxaliplatin|oxaliplatin|mesh-list
153502050|NCT01271166|Imatinib Mesylate|imatinib mesylate|mesh-list
153502071|NCT01271556|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
153502072|NCT01271556|Bronchodilator Agents|bronchodilator agents|mesh-list
153502073|NCT01271556|Autonomic Agents|autonomic agents|mesh-ancestor
153502074|NCT01271556|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153502075|NCT01271556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153502076|NCT01271556|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153502077|NCT01271556|Respiratory System Agents|respiratory system agents|mesh-ancestor
153502078|NCT01271556|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
153502079|NCT01271556|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
153502080|NCT01271556|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153502081|NCT01271556|Adrenergic Agents|adrenergic agents|mesh-ancestor
153502082|NCT01271556|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153502083|NCT01271556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153502084|NCT01272258|Leronlimab|leronlimab|mesh-list
153502085|NCT01272258|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
153502086|NCT01272258|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
153692918|NCT00061256|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153502087|NCT01272258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153502088|NCT01272258|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153502089|NCT01272258|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153502090|NCT01272258|Antiviral Agents|antiviral agents|mesh-ancestor
153502091|NCT01272258|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153502092|NCT01272414|Botulinum Toxins|botulinum toxins|mesh-list
153502093|NCT01272414|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
153502094|NCT01272414|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
153502095|NCT01272414|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
153502096|NCT01272414|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153502097|NCT01272414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153502099|NCT01272414|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153502100|NCT01272414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153502101|NCT01272414|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
153502102|NCT01272414|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153502103|NCT01273506|Tapentadol|tapentadol|mesh-list
153502104|NCT01273506|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153502105|NCT01273506|Narcotics|narcotics|mesh-ancestor
153502106|NCT01273506|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153502107|NCT01273506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153502108|NCT01273506|Analgesics|analgesics|mesh-ancestor
153502109|NCT01273506|Sensory System Agents|sensory system agents|mesh-ancestor
153502110|NCT01273506|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153502111|NCT01273506|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
153502112|NCT01273506|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153502113|NCT01273506|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153502114|NCT01273506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153502116|NCT01273506|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153502117|NCT01273662|Axitinib|axitinib|mesh-list
153502118|NCT01273662|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153502122|NCT01273974|Vaccines|vaccines|mesh-list
153502148|NCT01277172|Immunologic Factors|immunologic factors|mesh-ancestor
153502149|NCT01277172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153502150|NCT01277172|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153502151|NCT01277172|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153502152|NCT01277640|Dapivirine|dapivirine|mesh-list
153502153|NCT01277640|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153502154|NCT01277640|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153502155|NCT01277640|Antiviral Agents|antiviral agents|mesh-ancestor
153502156|NCT01277640|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153502157|NCT01278576|Botulinum Toxins|botulinum toxins|mesh-list
153502158|NCT01278576|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
153502159|NCT01278576|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
153502160|NCT01278576|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
153502161|NCT01278576|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153502162|NCT01278576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153502163|NCT01278576|Cholinergic Agents|cholinergic agents|mesh-ancestor
153502164|NCT01278576|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153502165|NCT01278576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153502166|NCT01278576|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
153502167|NCT01278576|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153502168|NCT01279434|Vitamins|vitamins|mesh-list
153502169|NCT01279434|Vitamin E|vitamin e|mesh-list
153502170|NCT01279434|Tocopherols|tocopherols|mesh-list
153502171|NCT01279434|Tocotrienols|tocotrienols|mesh-list
153502172|NCT01279434|alpha-Tocopherol|alpha-tocopherol|mesh-list
153502173|NCT01279434|Micronutrients|micronutrients|mesh-ancestor
153502174|NCT01279434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153502175|NCT01279434|Antioxidants|antioxidants|mesh-ancestor
153502176|NCT01279434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153502177|NCT01279434|Protective Agents|protective agents|mesh-ancestor
153502178|NCT01279512|Metformin|metformin|mesh-list
153502179|NCT01279512|Acarbose|acarbose|mesh-list
153502180|NCT01279512|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153502181|NCT01279512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153502182|NCT01279512|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
153502188|NCT01279668|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
153502189|NCT01279668|Hormone Antagonists|hormone antagonists|mesh-ancestor
153502190|NCT01279668|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153502191|NCT01279668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153502192|NCT01279668|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
153502193|NCT01279668|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
153502194|NCT01279668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153502195|NCT01279902|Rituximab|rituximab|mesh-list
153502196|NCT01279902|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153502197|NCT01279902|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153502198|NCT01279902|Immunologic Factors|immunologic factors|mesh-ancestor
153502199|NCT01279902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153502200|NCT01279902|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153502201|NCT01278342|Octreotide|octreotide|mesh-list
153502202|NCT01278342|Cabergoline|cabergoline|mesh-list
153502203|NCT01278342|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153502204|NCT01278342|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153502205|NCT01278342|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153502206|NCT01278342|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
153502207|NCT01278342|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
153502209|NCT01278342|Dopamine Agents|dopamine agents|mesh-ancestor
153502210|NCT01278342|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153502211|NCT01278342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153502212|NCT01278342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153502213|NCT01277718|Rabeprazole|rabeprazole|mesh-list
153502214|NCT01277718|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
153502215|NCT01277718|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153502216|NCT01277718|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
153502217|NCT01277718|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153502218|NCT01277718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153502219|NCT01276236|Maraviroc|maraviroc|mesh-list
153502223|NCT01276236|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153502228|NCT01275222|Everolimus|everolimus|mesh-list
153502229|NCT01275222|Imatinib Mesylate|imatinib mesylate|mesh-list
153502230|NCT01275222|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
153502231|NCT01275222|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153502232|NCT01275222|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153502233|NCT01275222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153502234|NCT01275222|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153502235|NCT01275222|Immunologic Factors|immunologic factors|mesh-ancestor
153502236|NCT01275222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153502237|NCT01275222|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153502238|NCT01275222|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153502239|NCT01275144|Lorazepam|lorazepam|mesh-list
153502240|NCT01275144|Anticonvulsants|anticonvulsants|mesh-ancestor
153502241|NCT01275144|Antiemetics|antiemetics|mesh-ancestor
153502242|NCT01275144|Autonomic Agents|autonomic agents|mesh-ancestor
153502243|NCT01275144|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153502244|NCT01275144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153502245|NCT01275144|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153502246|NCT01275144|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153502247|NCT01275144|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153502248|NCT01275144|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153502249|NCT01275144|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153502281|NCT01270464|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153502282|NCT01270464|Respiratory System Agents|respiratory system agents|mesh-ancestor
153502284|NCT01279590|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153502285|NCT01279590|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153502286|NCT01279590|Antimetabolites|antimetabolites|mesh-ancestor
153502287|NCT01279590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153502288|NCT01279590|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153502289|NCT01279590|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
153502290|NCT01279590|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153502291|NCT01271790|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
153502292|NCT01271790|Interferon-alpha|interferon-alpha|mesh-list
153502293|NCT01271790|Ribavirin|ribavirin|mesh-list
153502294|NCT01271790|Antiviral Agents|antiviral agents|mesh-ancestor
153502295|NCT01271790|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153502296|NCT01271790|Immunologic Factors|immunologic factors|mesh-ancestor
153502297|NCT01271790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153502298|NCT01271790|Antimetabolites|antimetabolites|mesh-ancestor
153502299|NCT01271790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153502300|NCT01270152|Ascorbic Acid|ascorbic acid|mesh-list
153502301|NCT01270152|Antioxidants|antioxidants|mesh-ancestor
153502302|NCT01270152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153502303|NCT01270152|Protective Agents|protective agents|mesh-ancestor
153502304|NCT01270152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153502305|NCT01270152|Vitamins|vitamins|mesh-ancestor
153502306|NCT01270152|Micronutrients|micronutrients|mesh-ancestor
153502307|NCT01274988|Methadone|methadone|mesh-list
153502308|NCT01274988|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153502309|NCT01274988|Narcotics|narcotics|mesh-ancestor
153502327|NCT01279980|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153502328|NCT01279980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153502329|NCT01279980|Sensory System Agents|sensory system agents|mesh-ancestor
153502330|NCT01279980|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153502331|NCT00249834|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
153502332|NCT00249834|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
153502334|NCT00249834|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153445324|NCT00000839|Didanosine|didanosine|mesh-list
153502335|NCT00249834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153502336|NCT00249834|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153502337|NCT00249444|Mirtazapine|mirtazapine|mesh-list
153502338|NCT00249444|Antidepressive Agents|antidepressive agents|mesh-ancestor
153502339|NCT00249444|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153502340|NCT00249444|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
153502341|NCT00249444|Histamine Antagonists|histamine antagonists|mesh-ancestor
153502342|NCT00249444|Histamine Agents|histamine agents|mesh-ancestor
153502343|NCT00249444|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153502344|NCT00249444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153502345|NCT00249444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153502346|NCT00249444|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153502347|NCT00249444|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153502348|NCT00249444|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153694119|NCT00399243|Serotonin Agents|serotonin agents|mesh-ancestor
153502349|NCT00249444|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
153502374|NCT00247962|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153502375|NCT00247962|Immunologic Factors|immunologic factors|mesh-ancestor
153502376|NCT00247962|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153502377|NCT00247416|Dexamethasone|dexamethasone|mesh-list
153502378|NCT00247416|Carboplatin|carboplatin|mesh-list
153502379|NCT00247416|Gemcitabine|gemcitabine|mesh-list
153502380|NCT00247416|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153502381|NCT00247416|Antiemetics|antiemetics|mesh-ancestor
153502382|NCT00247416|Autonomic Agents|autonomic agents|mesh-ancestor
153502383|NCT00247416|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153502384|NCT00247416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153502385|NCT00247416|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153502386|NCT00247416|Glucocorticoids|glucocorticoids|mesh-ancestor
153502387|NCT00247416|Hormones|hormones|mesh-ancestor
153502388|NCT00247416|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153502389|NCT00247416|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153502390|NCT00247416|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153502391|NCT00247416|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153502392|NCT00247416|Antimetabolites|antimetabolites|mesh-ancestor
153502393|NCT00247416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153502394|NCT00246012|Dacarbazine|dacarbazine|mesh-list
153502395|NCT00246012|Intetumumab|intetumumab|mesh-list
153502396|NCT00246012|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153502401|NCT00245856|Dalteparin|dalteparin|mesh-list
153502425|NCT00241644|Vaccines|vaccines|mesh-list
153502426|NCT00241644|Immunologic Factors|immunologic factors|mesh-ancestor
153502427|NCT00241644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153502428|NCT03805152|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
153502429|NCT03805152|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
153502431|NCT03805152|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153502432|NCT03805152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153502433|NCT03805152|Cholinergic Agents|cholinergic agents|mesh-ancestor
153502434|NCT03805152|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153694521|NCT02967653|Antimetabolites|antimetabolites|mesh-ancestor
153502435|NCT03805152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153502436|NCT03805152|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
153502437|NCT03805152|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153502438|NCT03804840|Dronabinol|dronabinol|mesh-list
153502439|NCT03804840|Hallucinogens|hallucinogens|mesh-ancestor
153502440|NCT03804840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153502441|NCT03804840|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153502443|NCT03804840|Analgesics|analgesics|mesh-ancestor
153502477|NCT03802032|Sensory System Agents|sensory system agents|mesh-ancestor
153502478|NCT03802032|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153694798|NCT00075738|Vitamins|vitamins|mesh-ancestor
153502479|NCT03802032|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153502480|NCT03802032|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
153502482|NCT03802032|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153502483|NCT03802032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153502484|NCT03801252|Azithromycin|azithromycin|mesh-list
153502485|NCT03801252|Cefazolin|cefazolin|mesh-list
153502486|NCT03801252|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153502487|NCT03801252|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153502488|NCT03800550|Clarithromycin|clarithromycin|mesh-list
153502489|NCT03800550|Bedaquiline|bedaquiline|mesh-list
153502490|NCT03800550|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153502491|NCT03800550|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153502492|NCT03800550|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
153502493|NCT03800550|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153502494|NCT03800550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153502495|NCT03800550|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
153502497|NCT03800550|Antitubercular Agents|antitubercular agents|mesh-ancestor
153502498|NCT05742750|Apatinib|apatinib|mesh-list
153502499|NCT05742750|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153502500|NCT05742750|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153502501|NCT05742750|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153502502|NCT05742750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153502504|NCT05740332|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
153502505|NCT05740332|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153502506|NCT05740332|Disinfectants|disinfectants|mesh-ancestor
153502507|NCT04295772|Islatravir|islatravir|mesh-list
153502508|NCT04295772|Antiviral Agents|antiviral agents|mesh-ancestor
153502509|NCT04295772|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153502510|NCT04295772|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153502511|NCT04295772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153502512|NCT04295772|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153502513|NCT04295772|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153502514|NCT04295772|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153502516|NCT03467256|Dexamethasone|dexamethasone|mesh-list
153502517|NCT03467256|Cyclophosphamide|cyclophosphamide|mesh-list
153502518|NCT03467256|Fludarabine|fludarabine|mesh-list
153502519|NCT03467256|Etoposide|etoposide|mesh-list
153502520|NCT03467256|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153502521|NCT03467256|Immunologic Factors|immunologic factors|mesh-ancestor
153502522|NCT03467256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153502523|NCT03467256|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153502524|NCT03467256|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153502525|NCT03467256|Alkylating Agents|alkylating agents|mesh-ancestor
153502526|NCT03467256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153502527|NCT03467256|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153502528|NCT03467256|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153502529|NCT03467256|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153502530|NCT03467256|Antiemetics|antiemetics|mesh-ancestor
153502531|NCT03467256|Autonomic Agents|autonomic agents|mesh-ancestor
153502532|NCT03467256|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153502533|NCT03467256|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153502534|NCT03467256|Glucocorticoids|glucocorticoids|mesh-ancestor
153502535|NCT03467256|Hormones|hormones|mesh-ancestor
153502536|NCT03467256|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153695556|NCT00235105|Adalimumab|adalimumab|mesh-list
153502537|NCT03467256|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153502538|NCT03467256|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153502539|NCT03467256|Antimetabolites|antimetabolites|mesh-ancestor
153502540|NCT03467256|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153502541|NCT03467256|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153502542|NCT03467256|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153502543|NCT03467256|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153502544|NCT03467256|Antiviral Agents|antiviral agents|mesh-ancestor
153502552|NCT05313282|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153502553|NCT05313282|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153502554|NCT05313282|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153502555|NCT05313282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153695857|NCT00237133|Letrozole|letrozole|mesh-list
153502556|NCT05312034|Anti-Infective Agents|anti-infective agents|mesh-list
153502557|NCT05312034|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
153502558|NCT05311722|Dexmedetomidine|dexmedetomidine|mesh-list
153502559|NCT05311722|Ketamine|ketamine|mesh-list
153502560|NCT05311722|Tramadol|tramadol|mesh-list
153502561|NCT05311722|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153502562|NCT05311722|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153502563|NCT05311722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153502564|NCT05311722|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153502565|NCT05311722|Analgesics|analgesics|mesh-ancestor
153502566|NCT05311722|Sensory System Agents|sensory system agents|mesh-ancestor
153502568|NCT05311722|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
153502569|NCT05311722|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153502570|NCT05311722|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153502571|NCT05311722|Adrenergic Agents|adrenergic agents|mesh-ancestor
153502572|NCT05311722|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153696559|NCT00240604|Rosiglitazone|rosiglitazone|mesh-list
153502573|NCT05311722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153502574|NCT05311722|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
153502575|NCT05311722|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153502576|NCT05311722|Anesthetics, General|anesthetics, general|mesh-ancestor
153502577|NCT05311722|Anesthetics|anesthetics|mesh-ancestor
153696758|NCT00241618|Interferons|interferons|mesh-list
153502578|NCT05311722|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
153502579|NCT05311722|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
153502580|NCT05311722|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153502581|NCT05311722|Narcotics|narcotics|mesh-ancestor
153502582|NCT03215940|Dronabinol|dronabinol|mesh-list
153502583|NCT03215940|Cannabidiol|cannabidiol|mesh-list
153502584|NCT03215940|Anticonvulsants|anticonvulsants|mesh-ancestor
153502585|NCT03215940|Hallucinogens|hallucinogens|mesh-ancestor
153502586|NCT03215940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153502592|NCT03215940|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
153502593|NCT03215940|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
153502594|NCT03215940|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153502595|NCT03215940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153502597|NCT03215940|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153502598|NCT03219762|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
153502599|NCT03219762|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153502600|NCT03218514|Dalteparin|dalteparin|mesh-list
153502601|NCT03218514|Tinzaparin|tinzaparin|mesh-list
153502602|NCT03218514|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
153502603|NCT03218514|Anticoagulants|anticoagulants|mesh-ancestor
153502604|NCT03218514|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153502605|NCT03218514|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153502606|NCT03218514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153502607|NCT03218124|Remifentanil|remifentanil|mesh-list
153502608|NCT03218124|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153502609|NCT03218124|Narcotics|narcotics|mesh-ancestor
153502610|NCT03218124|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153502611|NCT03218124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153502612|NCT03218124|Analgesics|analgesics|mesh-ancestor
153502613|NCT03218124|Sensory System Agents|sensory system agents|mesh-ancestor
153502614|NCT03218124|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153502615|NCT03217734|Adalimumab|adalimumab|mesh-list
153502616|NCT03217734|Methotrexate|methotrexate|mesh-list
153502617|NCT03217734|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
153502618|NCT03217734|Abortifacient Agents|abortifacient agents|mesh-ancestor
153502619|NCT03217734|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153502620|NCT03217734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153502621|NCT03217734|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153502622|NCT03217734|Antimetabolites|antimetabolites|mesh-ancestor
153502623|NCT03217734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153502624|NCT03217734|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153502625|NCT03217734|Dermatologic Agents|dermatologic agents|mesh-ancestor
153502626|NCT03217734|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153502629|NCT03217734|Immunologic Factors|immunologic factors|mesh-ancestor
153502630|NCT03217734|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153502631|NCT03217734|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153502632|NCT03217734|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
153502633|NCT03217734|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153502634|NCT03216876|Ursolic Acid|ursolic acid|mesh-list
153502635|NCT03216876|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153502636|NCT03216876|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153502637|NCT03216876|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153502638|NCT03216876|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153502639|NCT03216876|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153697534|NCT00400998|Xhance|xhance|mesh-list
153502640|NCT03216876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153502641|NCT03216876|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153502642|NCT03216876|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153502643|NCT03216876|Analgesics|analgesics|mesh-ancestor
153502644|NCT03216876|Sensory System Agents|sensory system agents|mesh-ancestor
153502645|NCT03216876|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153698457|NCT00253552|Abortifacient Agents|abortifacient agents|mesh-ancestor
153502646|NCT03216876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153502647|NCT03216876|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153698968|NCT00100776|Serotonin Agents|serotonin agents|mesh-ancestor
153502648|NCT03216876|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153502649|NCT03216642|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
153502650|NCT03216642|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153502651|NCT03216408|Botulinum Toxins|botulinum toxins|mesh-list
153502652|NCT03216408|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
153502653|NCT03216408|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
153700816|NCT00074399|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153701186|NCT00401427|Trastuzumab|trastuzumab|mesh-list
153701720|NCT00075959|Disufenton sodium|disufenton sodium|mesh-list
153702019|NCT04730297|Respiratory System Agents|respiratory system agents|mesh-ancestor
153702020|NCT00399269|Epoetin Alfa|epoetin alfa|mesh-list
153502677|NCT03214848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153502678|NCT03214536|Ropivacaine|ropivacaine|mesh-list
153502679|NCT03214536|Anesthetics|anesthetics|mesh-ancestor
153502680|NCT03214536|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153502681|NCT03214536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153502682|NCT03214536|Anesthetics, Local|anesthetics, local|mesh-ancestor
153502683|NCT03214536|Sensory System Agents|sensory system agents|mesh-ancestor
153502684|NCT03214536|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153502685|NCT03214770|Calcium, Dietary|calcium, dietary|mesh-list
153502687|NCT03214770|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153702100|NCT00281593|Protease Inhibitors|protease inhibitors|mesh-ancestor
153502688|NCT03214770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153502689|NCT03214770|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153502691|NCT03213444|Fluorouracil|fluorouracil|mesh-list
153502692|NCT03213444|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153502693|NCT03213444|Antimetabolites|antimetabolites|mesh-ancestor
153502694|NCT03213444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153502695|NCT03213444|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153502696|NCT03213444|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153502697|NCT03213444|Immunologic Factors|immunologic factors|mesh-ancestor
153502698|NCT03213444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153502699|NCT03212820|Methamphetamine|methamphetamine|mesh-list
153502700|NCT03212820|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
153502701|NCT03212820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153502702|NCT03212820|Sympathomimetics|sympathomimetics|mesh-ancestor
153502703|NCT03212820|Autonomic Agents|autonomic agents|mesh-ancestor
153502704|NCT03212820|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153502705|NCT03212820|Dopamine Agents|dopamine agents|mesh-ancestor
153703136|NCT00288223|Telithromycin|telithromycin|mesh-list
153502706|NCT03212820|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153502707|NCT03212820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153502708|NCT03212820|Adrenergic Agents|adrenergic agents|mesh-ancestor
153502709|NCT03212820|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
153502713|NCT03211728|Pregabalin|pregabalin|mesh-list
153502716|NCT03211728|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153502717|NCT03211728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153502718|NCT03211728|Anticonvulsants|anticonvulsants|mesh-ancestor
153502719|NCT03211728|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153502720|NCT03211728|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153502721|NCT03211728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153502722|NCT03211728|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153502723|NCT03211728|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153502724|NCT03211728|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153502725|NCT03211728|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153502726|NCT03211728|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153704190|NCT00119652|Paroxetine|paroxetine|mesh-list
153502728|NCT03211572|Anastrozole|anastrozole|mesh-list
153502729|NCT03211572|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
153502730|NCT03211572|Hormone Antagonists|hormone antagonists|mesh-ancestor
153502731|NCT03211572|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153502732|NCT03211572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153550913|NCT02079740|Trametinib|trametinib|mesh-list
153502733|NCT03211572|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153502734|NCT03211572|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153502735|NCT03211572|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
153502736|NCT03211572|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
153502737|NCT03211572|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153502738|NCT03211572|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
153502740|NCT03211572|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153502762|NCT03210246|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
153502763|NCT03210246|Contraceptive Agents|contraceptive agents|mesh-ancestor
153502764|NCT03210246|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153502765|NCT03210246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153502766|NCT03210246|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
153502767|NCT03210246|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
153502768|NCT03210246|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
153502769|NCT03210246|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
153502770|NCT03210246|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
153502771|NCT03210246|Contraceptives, Postcoital, Hormonal|contraceptives, postcoital, hormonal|mesh-ancestor
153502772|NCT03210246|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
153502773|NCT03210246|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
153502775|NCT03210324|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
153706983|NCT00295672|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153502783|NCT03210324|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
153502784|NCT03210324|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
153502785|NCT03210324|Hormone Antagonists|hormone antagonists|mesh-ancestor
153502786|NCT03210324|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153502787|NCT03210324|Luteolytic Agents|luteolytic agents|mesh-ancestor
153502788|NCT03210324|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
153502789|NCT03210324|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
153502791|NCT03210480|Antidepressive Agents|antidepressive agents|mesh-ancestor
153502792|NCT03210480|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153502793|NCT03210480|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153502794|NCT03210480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153502795|NCT03210480|Antimanic Agents|antimanic agents|mesh-ancestor
153502796|NCT03210480|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153502797|NCT03210480|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153502798|NCT03210480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153502800|NCT01831674|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153502801|NCT01831674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153502803|NCT01832922|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
153707604|NCT00312598|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153502804|NCT01832922|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153502805|NCT01832922|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153708435|NCT05688085|Amlodipine|amlodipine|mesh-list
153502806|NCT01832922|Immunologic Factors|immunologic factors|mesh-ancestor
153502807|NCT01832922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153502808|NCT01832922|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153502809|NCT01832922|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153502810|NCT01832922|Alkylating Agents|alkylating agents|mesh-ancestor
153502811|NCT01832922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153781874|NCT02212210|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153781875|NCT02212210|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
153781876|NCT02212210|Protective Agents|protective agents|mesh-ancestor
153781878|NCT02212210|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153781883|NCT00232076|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153781884|NCT00232076|Immunologic Factors|immunologic factors|mesh-ancestor
153781885|NCT00232076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153781886|NCT00232076|Antifungal Agents|antifungal agents|mesh-ancestor
153781887|NCT00232076|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153781888|NCT00232076|Dermatologic Agents|dermatologic agents|mesh-ancestor
153781889|NCT00232076|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153708897|NCT04935931|Naltrexone|naltrexone|mesh-list
153709084|NCT04630002|Ritonavir|ritonavir|mesh-list
153709433|NCT03840915|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
153781890|NCT00232076|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
153502812|NCT01833312|Meperidine|meperidine|mesh-list
153502813|NCT01833312|Buspirone|buspirone|mesh-list
153709669|NCT03319498|Peppermint oil|peppermint oil|mesh-list
153502814|NCT01833312|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153502815|NCT01833312|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153502816|NCT01833312|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153502817|NCT01833312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153502818|NCT01833312|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153502819|NCT01833312|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
153502820|NCT01833312|Serotonin Agents|serotonin agents|mesh-ancestor
153502821|NCT01833312|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153502822|NCT01833312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153502823|NCT01833312|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153710146|NCT00122577|Ritonavir|ritonavir|mesh-list
153502826|NCT01833312|Sensory System Agents|sensory system agents|mesh-ancestor
153502827|NCT01833312|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153502828|NCT01833312|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153502829|NCT01834014|Bevacizumab|bevacizumab|mesh-list
153502831|NCT01834014|Fluorouracil|fluorouracil|mesh-list
153502832|NCT01834014|Oxaliplatin|oxaliplatin|mesh-list
153711328|NCT00329368|Micronutrients|micronutrients|mesh-ancestor
153711689|NCT00324454|Anticonvulsants|anticonvulsants|mesh-ancestor
153502833|NCT01834014|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153502835|NCT01834014|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153502836|NCT01834014|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153502837|NCT01834014|Growth Substances|growth substances|mesh-ancestor
153502838|NCT01834014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153502839|NCT01834014|Growth Inhibitors|growth inhibitors|mesh-ancestor
153502840|NCT01834014|Antimetabolites|antimetabolites|mesh-ancestor
153712495|NCT00086177|Progesterone|progesterone|mesh-list
153502842|NCT01834014|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153502844|NCT01834014|Immunologic Factors|immunologic factors|mesh-ancestor
153502845|NCT01834170|Gemcitabine|gemcitabine|mesh-list
153502846|NCT01834170|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153502847|NCT01834170|Antimetabolites|antimetabolites|mesh-ancestor
153502848|NCT01834170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153502849|NCT01834170|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153502850|NCT01835184|Vemurafenib|vemurafenib|mesh-list
153713111|NCT00331084|Hormones|hormones|mesh-ancestor
153502851|NCT01835184|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153502852|NCT01835184|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153502853|NCT01835184|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153502854|NCT01835184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153502856|NCT01835340|Propofol|propofol|mesh-list
153714069|NCT01946477|Hormones|hormones|mesh-ancestor
153502857|NCT01835340|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153714381|NCT05376111|Antimetabolites|antimetabolites|mesh-ancestor
153714617|NCT04293393|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153502858|NCT01835340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153502859|NCT01835340|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153502860|NCT01835340|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153502861|NCT01835340|Anesthetics, General|anesthetics, general|mesh-ancestor
153502863|NCT01836120|Raltitrexed|raltitrexed|mesh-list
153502864|NCT01836120|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153502865|NCT01836120|Tubulin Modulators|tubulin modulators|mesh-ancestor
153502866|NCT01836120|Antimitotic Agents|antimitotic agents|mesh-ancestor
153502867|NCT01836120|Mitosis Modulators|mitosis modulators|mesh-ancestor
153502870|NCT01836120|Antimetabolites|antimetabolites|mesh-ancestor
153502890|NCT01838460|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
153502891|NCT01838460|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
153502892|NCT01838460|Cholinergic Agents|cholinergic agents|mesh-ancestor
153716477|NCT00126243|Rituximab|rituximab|mesh-list
153502893|NCT01838460|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153502894|NCT01838460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153502895|NCT01838460|Respiratory System Agents|respiratory system agents|mesh-ancestor
153502896|NCT01838538|Paclitaxel|paclitaxel|mesh-list
153502897|NCT01838538|Bevacizumab|bevacizumab|mesh-list
153502898|NCT01838538|Carboplatin|carboplatin|mesh-list
153502899|NCT01838538|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153502900|NCT01838538|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153502901|NCT01838538|Tubulin Modulators|tubulin modulators|mesh-ancestor
153502902|NCT01838538|Antimitotic Agents|antimitotic agents|mesh-ancestor
153502903|NCT01838538|Mitosis Modulators|mitosis modulators|mesh-ancestor
153502904|NCT01838538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153550919|NCT02008721|Neuroprotective Agents|neuroprotective agents|mesh-list
153502905|NCT01838538|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153502906|NCT01838538|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153502907|NCT01838538|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153502908|NCT01838538|Growth Substances|growth substances|mesh-ancestor
153502909|NCT01838538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153502910|NCT01838538|Growth Inhibitors|growth inhibitors|mesh-ancestor
153502911|NCT01838772|Interferons|interferons|mesh-list
153502912|NCT01838772|Ribavirin|ribavirin|mesh-list
153502913|NCT01838772|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153502914|NCT01838772|Antiviral Agents|antiviral agents|mesh-ancestor
153716847|NCT00092339|Valdecoxib|valdecoxib|mesh-list
153502915|NCT01838772|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153502916|NCT01838772|Antimetabolites|antimetabolites|mesh-ancestor
153717204|NCT00428818|Sulfamethoxazole|sulfamethoxazole|mesh-list
153502918|NCT01838928|Bupivacaine|bupivacaine|mesh-list
153502919|NCT01838928|Anesthetics, Local|anesthetics, local|mesh-ancestor
153502925|NCT01839084|Isoflurane|isoflurane|mesh-list
153502935|NCT01839240|Antimetabolites|antimetabolites|mesh-ancestor
153502936|NCT01839240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153502937|NCT01839240|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153502938|NCT01839240|Antiviral Agents|antiviral agents|mesh-ancestor
153502939|NCT01839240|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153502940|NCT01839240|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153502941|NCT01839240|Immunologic Factors|immunologic factors|mesh-ancestor
153502942|NCT01839240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153502943|NCT01839240|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153502944|NCT01839240|Analgesics|analgesics|mesh-ancestor
153502945|NCT01839240|Sensory System Agents|sensory system agents|mesh-ancestor
153502946|NCT01839240|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153502947|NCT01839240|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153502948|NCT01839240|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153502950|NCT01839552|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153502956|NCT01839552|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153502957|NCT01839552|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153502958|NCT01839552|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153502959|NCT01839552|Anesthetics, General|anesthetics, general|mesh-ancestor
153502985|NCT01834248|Immunologic Factors|immunologic factors|mesh-ancestor
153502986|NCT01834248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153502987|NCT01834248|Laxatives|laxatives|mesh-ancestor
153502988|NCT01834248|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153502989|NCT01834248|Antiviral Agents|antiviral agents|mesh-ancestor
153502990|NCT01834248|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153502991|NCT01833858|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
153502992|NCT01833858|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153502993|NCT01833858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153502995|NCT01836432|Paclitaxel|paclitaxel|mesh-list
153502996|NCT01836432|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
153502997|NCT01836432|Gemcitabine|gemcitabine|mesh-list
153502998|NCT01836432|Capecitabine|capecitabine|mesh-list
153502999|NCT01836432|Fluorouracil|fluorouracil|mesh-list
153503000|NCT01836432|Oxaliplatin|oxaliplatin|mesh-list
153503001|NCT01836432|Irinotecan|irinotecan|mesh-list
153503002|NCT01836432|Folfirinox|folfirinox|mesh-list
153503003|NCT01836432|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153503004|NCT01836432|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153503005|NCT01836432|Tubulin Modulators|tubulin modulators|mesh-ancestor
153503006|NCT01836432|Antimitotic Agents|antimitotic agents|mesh-ancestor
153503007|NCT01836432|Mitosis Modulators|mitosis modulators|mesh-ancestor
153503008|NCT01836432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153503009|NCT01836432|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153503010|NCT01836432|Antimetabolites|antimetabolites|mesh-ancestor
153503035|NCT01720056|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153503036|NCT01720056|Vasodilator Agents|vasodilator agents|mesh-ancestor
153503037|NCT01720212|Mirabegron|mirabegron|mesh-list
153503038|NCT01720212|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
153503039|NCT01720212|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
153503040|NCT01720212|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153503041|NCT01720212|Adrenergic Agents|adrenergic agents|mesh-ancestor
153503042|NCT01720212|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153503043|NCT01720212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153503044|NCT01720212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153503045|NCT01720212|Urological Agents|urological agents|mesh-ancestor
153503047|NCT01720290|Repaglinide|repaglinide|mesh-list
153503048|NCT01720290|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153503049|NCT01720290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153550923|NCT01910610|Cetuximab|cetuximab|mesh-list
153503050|NCT01721382|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
153503051|NCT01721382|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153503052|NCT01721382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153503053|NCT01721382|Incretins|incretins|mesh-ancestor
153503054|NCT01721382|Hormones|hormones|mesh-ancestor
153503055|NCT01721382|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153503056|NCT01721382|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
153503057|NCT01721382|Protease Inhibitors|protease inhibitors|mesh-ancestor
153503058|NCT01721382|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153503059|NCT01721382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153718063|NCT00432796|Dalteparin|dalteparin|mesh-list
153503089|NCT01722942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153503090|NCT01722942|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153503091|NCT01722942|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
153503092|NCT01722942|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153503093|NCT01722942|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153503094|NCT01722942|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
153503095|NCT01722942|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
153503096|NCT01722942|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
153503097|NCT01723800|Carboplatin|carboplatin|mesh-list
153503098|NCT01723800|Pemetrexed|pemetrexed|mesh-list
153503099|NCT01723800|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153503100|NCT01723800|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153503101|NCT01723800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153503102|NCT01723800|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153503103|NCT01723800|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153503104|NCT01724268|Prednisolone|prednisolone|mesh-list
153503105|NCT01724268|Methotrexate|methotrexate|mesh-list
153503106|NCT01724268|Methamphetamine|methamphetamine|mesh-list
153503107|NCT01724268|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
153503108|NCT01724268|Abortifacient Agents|abortifacient agents|mesh-ancestor
153503109|NCT01724268|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153503110|NCT01724268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153503130|NCT01724268|Sympathomimetics|sympathomimetics|mesh-ancestor
153503131|NCT01724268|Dopamine Agents|dopamine agents|mesh-ancestor
153503132|NCT01724268|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153503133|NCT01724268|Adrenergic Agents|adrenergic agents|mesh-ancestor
153503134|NCT01724268|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
153503135|NCT01724268|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153718176|NCT00433225|Prednisolone acetate|prednisolone acetate|mesh-list
153503137|NCT01724268|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
153503138|NCT01724424|Melatonin|melatonin|mesh-list
153503139|NCT01724424|Antioxidants|antioxidants|mesh-ancestor
153503140|NCT01724424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153503141|NCT01724424|Protective Agents|protective agents|mesh-ancestor
153503142|NCT01724424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153503143|NCT01724424|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153503144|NCT01724814|Insulin|insulin|mesh-list
153503145|NCT01724814|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153503146|NCT01724814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153503147|NCT01725048|Mirtazapine|mirtazapine|mesh-list
153503148|NCT01725048|Citalopram|citalopram|mesh-list
153503149|NCT01725048|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
153503150|NCT01725048|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153503151|NCT01725048|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153503152|NCT01725048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153503153|NCT01725048|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153503154|NCT01725048|Serotonin Agents|serotonin agents|mesh-ancestor
153503155|NCT01725048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153503156|NCT01725048|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
153503157|NCT01725048|Antidepressive Agents|antidepressive agents|mesh-ancestor
153503158|NCT01725048|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153503161|NCT01725048|Histamine Agents|histamine agents|mesh-ancestor
153503172|NCT01725204|Dasatinib|dasatinib|mesh-list
153503177|NCT01725204|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153503178|NCT01725360|Montelukast|montelukast|mesh-list
153503179|NCT01725360|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153503180|NCT01725360|Respiratory System Agents|respiratory system agents|mesh-ancestor
153503181|NCT01725360|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
153503182|NCT01725360|Hormone Antagonists|hormone antagonists|mesh-ancestor
153503183|NCT01725360|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153503184|NCT01725360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153503185|NCT01725360|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
153503186|NCT01725360|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
153503187|NCT01725360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153503188|NCT01725672|Metformin|metformin|mesh-list
153503189|NCT01725672|Glimepiride|glimepiride|mesh-list
153503190|NCT01725672|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153503191|NCT01725672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153503192|NCT01725672|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153503193|NCT01725672|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153503194|NCT01725672|Immunologic Factors|immunologic factors|mesh-ancestor
153503199|NCT01726530|Fentanyl|fentanyl|mesh-list
153503218|NCT01726764|Metformin|metformin|mesh-list
153503219|NCT01726764|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153503220|NCT01726764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153503221|NCT01726920|Naproxen|naproxen|mesh-list
153503222|NCT01726920|Naratriptan|naratriptan|mesh-list
153503223|NCT01726920|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153503224|NCT01726920|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153503225|NCT01726920|Analgesics|analgesics|mesh-ancestor
153503226|NCT01726920|Sensory System Agents|sensory system agents|mesh-ancestor
153503227|NCT01726920|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153503228|NCT01726920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153503229|NCT01726920|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153503230|NCT01726920|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153503231|NCT01726920|Gout Suppressants|gout suppressants|mesh-ancestor
153503232|NCT01726920|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153503233|NCT01726920|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153503234|NCT01726920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153503235|NCT01726920|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
153503236|NCT01726920|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
153503237|NCT01726920|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
153503238|NCT01726920|Serotonin Agents|serotonin agents|mesh-ancestor
153503239|NCT01726920|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153503240|NCT01727622|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
153503241|NCT01727622|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
153503242|NCT01727622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153503243|NCT01728090|Hand Sanitizers|hand sanitizers|mesh-list
153503244|NCT01728090|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
153503245|NCT01728090|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153503246|NCT01728090|Disinfectants|disinfectants|mesh-ancestor
153503263|NCT01729104|Growth Substances|growth substances|mesh-ancestor
153503264|NCT01729104|Growth Inhibitors|growth inhibitors|mesh-ancestor
153503266|NCT01729260|Piperazine|piperazine|mesh-list
153503267|NCT01729260|Piperazine citrate|piperazine citrate|mesh-list
153503268|NCT01729260|DMP 777|dmp 777|mesh-list
153503269|NCT01729260|Antinematodal Agents|antinematodal agents|mesh-ancestor
153503270|NCT01729260|Anthelmintics|anthelmintics|mesh-ancestor
153503271|NCT01729260|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153503272|NCT01729260|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153503273|NCT01729260|Tubulin Modulators|tubulin modulators|mesh-ancestor
153503274|NCT01729260|Antimitotic Agents|antimitotic agents|mesh-ancestor
153503275|NCT01729260|Mitosis Modulators|mitosis modulators|mesh-ancestor
153503276|NCT01729260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153503277|NCT01729260|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153503278|NCT01729260|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153503279|NCT01729806|Rituximab|rituximab|mesh-list
153503280|NCT01729806|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
153503281|NCT01729806|Ipilimumab|ipilimumab|mesh-list
153503282|NCT01729806|Antibodies|antibodies|mesh-list
153503283|NCT01729806|Immunoglobulins|immunoglobulins|mesh-list
153503284|NCT01729806|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
153503285|NCT01729806|Immunologic Factors|immunologic factors|mesh-ancestor
153503286|NCT01729806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153503287|NCT01729806|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153503288|NCT01729806|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153503289|NCT01729806|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153503290|NCT01729806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153503291|NCT01724658|Methyltestosterone|methyltestosterone|mesh-list
153503312|NCT01049334|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153503314|NCT01049334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153503315|NCT01048944|Bupropion|bupropion|mesh-list
153503316|NCT01048944|Nicotine|nicotine|mesh-list
153503317|NCT01048944|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
153503318|NCT01048944|Autonomic Agents|autonomic agents|mesh-ancestor
153503319|NCT01048944|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153503320|NCT01048944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153503321|NCT01048944|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
153503322|NCT01048944|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
153503323|NCT01048944|Cholinergic Agents|cholinergic agents|mesh-ancestor
153503324|NCT01048944|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153503325|NCT01048944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153503326|NCT01048944|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
153503327|NCT01048944|Antidepressive Agents|antidepressive agents|mesh-ancestor
153503328|NCT01048944|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153503329|NCT01048944|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
153503330|NCT01048944|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153919705|NCT00927394|Renin Inhibitors|renin inhibitors|mesh-ancestor
153503331|NCT01048944|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153503332|NCT01048944|Dopamine Agents|dopamine agents|mesh-ancestor
153503362|NCT01046682|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153503363|NCT01046682|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153503364|NCT01044498|Norinyl|norinyl|mesh-list
153503365|NCT01044498|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
153503366|NCT01044498|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
153503367|NCT01044498|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
153503368|NCT01044498|Contraceptive Agents|contraceptive agents|mesh-ancestor
153503369|NCT01044498|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153503370|NCT01044498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153503371|NCT01044498|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
153503372|NCT01044498|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
153503373|NCT01043874|Nilotinib|nilotinib|mesh-list
153503374|NCT01043874|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153503375|NCT01043874|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153503377|NCT01043874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153503378|NCT01042938|Curcumin|curcumin|mesh-list
153503379|NCT01042938|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153503380|NCT01042938|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153503381|NCT01042938|Analgesics|analgesics|mesh-ancestor
153503382|NCT01042938|Sensory System Agents|sensory system agents|mesh-ancestor
153503383|NCT01042938|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153503384|NCT01042938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153503385|NCT01042938|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153503386|NCT01042938|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153503387|NCT01042938|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153503388|NCT01042938|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153503389|NCT01042938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153503390|NCT01042158|Ambrisentan|ambrisentan|mesh-list
153503391|NCT01042158|Tadalafil|tadalafil|mesh-list
153503392|NCT01042158|Vasodilator Agents|vasodilator agents|mesh-ancestor
153503393|NCT01042158|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
153550955|NCT01892722|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153503394|NCT01042158|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
153503395|NCT01042158|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153503397|NCT01042158|Urological Agents|urological agents|mesh-ancestor
153503400|NCT03405870|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
153503401|NCT03405870|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
153503402|NCT03405870|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
153503403|NCT03409068|Anesthetics|anesthetics|mesh-list
153503404|NCT03409068|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153503405|NCT03409068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153503406|NCT03408054|Nitroglycerin|nitroglycerin|mesh-list
153503407|NCT03408054|Oxytocin|oxytocin|mesh-list
153503408|NCT03408054|Oxytocics|oxytocics|mesh-ancestor
153503409|NCT03408054|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153503410|NCT03408054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153503411|NCT03408054|Vasodilator Agents|vasodilator agents|mesh-ancestor
153503413|NCT03407976|Apatinib|apatinib|mesh-list
153503414|NCT03407976|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153503415|NCT03407976|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153503416|NCT03407976|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153503417|NCT03407976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153503418|NCT03407976|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153503419|NCT03407976|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153503420|NCT03407196|Dapagliflozin|dapagliflozin|mesh-list
153503421|NCT03407196|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
153503422|NCT03407196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153503423|NCT03407196|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153503424|NCT03407196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153503425|NCT03405948|Botulinum Toxins|botulinum toxins|mesh-list
153503426|NCT03405948|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
153503427|NCT03405948|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153503428|NCT03405948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153503432|NCT03405168|Moxifloxacin|moxifloxacin|mesh-list
153503443|NCT03405168|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153503444|NCT03405168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153503445|NCT03405168|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
153503447|NCT03405168|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
153503448|NCT03403452|Apatinib|apatinib|mesh-list
153503449|NCT03403452|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153503450|NCT03403452|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153503451|NCT03403452|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153503452|NCT03403452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153503453|NCT03403140|Etanercept|etanercept|mesh-list
153503454|NCT03403140|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153503455|NCT03403140|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153503456|NCT03403140|Analgesics|analgesics|mesh-ancestor
153503457|NCT03403140|Sensory System Agents|sensory system agents|mesh-ancestor
153503458|NCT03403140|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153503459|NCT03403140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153503460|NCT03403140|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153503461|NCT03403140|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153503463|NCT03403140|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153503464|NCT03403140|Immunologic Factors|immunologic factors|mesh-ancestor
153503466|NCT03402984|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
153503467|NCT03402984|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153503473|NCT03402438|Fulacimstat|fulacimstat|mesh-list
153503489|NCT03402204|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153503490|NCT03402204|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153503491|NCT03402204|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153503492|NCT03402204|Protease Inhibitors|protease inhibitors|mesh-ancestor
153503493|NCT03402204|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153503494|NCT03402204|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153503495|NCT03402204|Antiviral Agents|antiviral agents|mesh-ancestor
153503496|NCT03402048|Carboplatin|carboplatin|mesh-list
153503497|NCT03402048|Gemcitabine|gemcitabine|mesh-list
153503498|NCT03402048|Docetaxel|docetaxel|mesh-list
153503499|NCT03402048|Pemetrexed|pemetrexed|mesh-list
153503500|NCT03402048|Vinorelbine|vinorelbine|mesh-list
153503501|NCT03402048|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153503502|NCT03402048|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153503503|NCT03402048|Antimetabolites|antimetabolites|mesh-ancestor
153503504|NCT03402048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153503505|NCT03402048|Tubulin Modulators|tubulin modulators|mesh-ancestor
153503506|NCT03402048|Antimitotic Agents|antimitotic agents|mesh-ancestor
153503507|NCT03402048|Mitosis Modulators|mitosis modulators|mesh-ancestor
153503508|NCT03402048|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153503509|NCT03402048|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153503510|NCT03402048|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153503511|NCT03402048|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153503512|NCT03401502|Ranolazine|ranolazine|mesh-list
153503513|NCT03401502|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153503514|NCT03401502|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153503515|NCT03401502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153503516|NCT03401346|Dihydroergotamine|dihydroergotamine|mesh-list
153503517|NCT03401346|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
153503518|NCT03401346|Dopamine Agonists|dopamine agonists|mesh-ancestor
153503519|NCT03401346|Dopamine Agents|dopamine agents|mesh-ancestor
153503520|NCT03401346|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153503521|NCT03401346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153503522|NCT03401346|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153503529|NCT03401268|Antibodies|antibodies|mesh-list
153503530|NCT03401268|Immunologic Factors|immunologic factors|mesh-ancestor
153503531|NCT03401268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153503533|NCT03400722|Hormones|hormones|mesh-list
153719098|NCT00133341|Parthenolide|parthenolide|mesh-list
153503534|NCT03400722|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153503535|NCT03400722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153503536|NCT03400722|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
153503537|NCT03400722|Hormone Antagonists|hormone antagonists|mesh-ancestor
153503538|NCT03400722|Fertility Agents, Female|fertility agents, female|mesh-ancestor
153503539|NCT03400722|Fertility Agents|fertility agents|mesh-ancestor
153503540|NCT03400722|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153503541|NCT03400722|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
153503542|NCT03400722|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
153503543|NCT03400254|Hydroxychloroquine|hydroxychloroquine|mesh-list
153503544|NCT03400254|Gedatolisib|gedatolisib|mesh-list
153503545|NCT03400254|Antimalarials|antimalarials|mesh-ancestor
153503546|NCT03400254|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153503547|NCT03400254|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153503549|NCT03400254|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153503550|NCT03400254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153503551|NCT03400254|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153503552|NCT03400254|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153503555|NCT03400020|Micronutrients|micronutrients|mesh-ancestor
153503556|NCT03400020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153503557|NCT03400020|Antioxidants|antioxidants|mesh-ancestor
153503558|NCT03400020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153503560|NCT00012012|Amifostine|amifostine|mesh-list
153503561|NCT00012012|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
153503562|NCT00012012|Protective Agents|protective agents|mesh-ancestor
153503563|NCT00012012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153503564|NCT02240160|Nabiximols|nabiximols|mesh-list
153503565|NCT02240160|Analgesics|analgesics|mesh-ancestor
153503573|NCT02240238|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153503575|NCT02241096|Anesthetics, Local|anesthetics, local|mesh-ancestor
153503576|NCT02241096|Anesthetics|anesthetics|mesh-ancestor
153503577|NCT02241096|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153503578|NCT02241096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153503579|NCT02241096|Sensory System Agents|sensory system agents|mesh-ancestor
153719251|NCT00102635|Protective Agents|protective agents|mesh-ancestor
153503580|NCT02241096|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153503581|NCT02241096|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153503582|NCT02241096|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
153503583|NCT02241096|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153503584|NCT02241096|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153550968|NCT01869114|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153503585|NCT02241096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153503586|NCT02241174|Sodium Hypochlorite|sodium hypochlorite|mesh-list
153503587|NCT02241174|Eusol|eusol|mesh-list
153503588|NCT02241174|Disinfectants|disinfectants|mesh-ancestor
153503589|NCT02241174|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153503590|NCT02241564|Sirolimus|sirolimus|mesh-list
153503591|NCT02241564|MTOR Inhibitors|mtor inhibitors|mesh-list
153503592|NCT02241564|Temsirolimus|temsirolimus|mesh-list
153503593|NCT02241564|Calcineurin Inhibitors|calcineurin inhibitors|mesh-list
153503594|NCT02241564|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153503595|NCT02241564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153503596|NCT02241564|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153503597|NCT02241564|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153503598|NCT02241564|Immunologic Factors|immunologic factors|mesh-ancestor
153503599|NCT02241564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153503600|NCT02241564|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153503620|NCT02242344|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153503621|NCT02242344|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
153503622|NCT02242344|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
153503623|NCT02242344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153503625|NCT02242656|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153503626|NCT02242656|Narcotics|narcotics|mesh-ancestor
153503627|NCT02242656|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153503628|NCT02242656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153503629|NCT02242656|Analgesics|analgesics|mesh-ancestor
153503630|NCT02242656|Sensory System Agents|sensory system agents|mesh-ancestor
153503631|NCT02242656|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153503632|NCT02242656|Antidiarrheals|antidiarrheals|mesh-ancestor
153503633|NCT02242656|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153503634|NCT02242656|Antitussive Agents|antitussive agents|mesh-ancestor
153503635|NCT02242656|Respiratory System Agents|respiratory system agents|mesh-ancestor
153503637|NCT02242812|Telmisartan|telmisartan|mesh-list
153503638|NCT02242812|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153503639|NCT02242812|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
153503640|NCT02242812|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
153503641|NCT02242812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153503642|NCT02242812|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153503643|NCT02242812|Sympatholytics|sympatholytics|mesh-ancestor
153503644|NCT02242812|Autonomic Agents|autonomic agents|mesh-ancestor
153503645|NCT02242812|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153503646|NCT02242812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153503647|NCT02242812|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
153503648|NCT02242812|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
153503649|NCT02242812|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
153503650|NCT02242812|Adrenergic Agents|adrenergic agents|mesh-ancestor
153503651|NCT02242812|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153503652|NCT02243124|Dexamethasone|dexamethasone|mesh-list
153503653|NCT02243124|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153503661|NCT02243124|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153503662|NCT02243124|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153503663|NCT02243124|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153503664|NCT02243436|Cytarabine|cytarabine|mesh-list
153503665|NCT02243436|Methylprednisolone|methylprednisolone|mesh-list
153503666|NCT02243436|Etoposide|etoposide|mesh-list
153503667|NCT02243436|Brentuximab Vedotin|brentuximab vedotin|mesh-list
153503668|NCT02243436|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153503669|NCT02243436|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153503670|NCT02243436|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153503671|NCT02243436|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153503672|NCT02243436|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153503673|NCT02243436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153503674|NCT02243436|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153503675|NCT02243436|Antimetabolites|antimetabolites|mesh-ancestor
153503676|NCT02243436|Antiviral Agents|antiviral agents|mesh-ancestor
153503677|NCT02243436|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153503678|NCT02243436|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153503679|NCT02243436|Immunologic Factors|immunologic factors|mesh-ancestor
153503680|NCT02243436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153503681|NCT02243436|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153503682|NCT02243436|Antiemetics|antiemetics|mesh-ancestor
153503683|NCT02243436|Autonomic Agents|autonomic agents|mesh-ancestor
153503684|NCT02243436|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153503685|NCT02243436|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153503710|NCT02244216|Respiratory System Agents|respiratory system agents|mesh-ancestor
153503711|NCT02244216|Sympathomimetics|sympathomimetics|mesh-ancestor
153503712|NCT02244216|Tocolytic Agents|tocolytic agents|mesh-ancestor
153503713|NCT02244216|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153503714|NCT02244216|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
153503715|NCT02244216|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
153503716|NCT02244216|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153503717|NCT02244216|Adrenergic Agents|adrenergic agents|mesh-ancestor
153503718|NCT02244216|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153503719|NCT02244216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153503721|NCT02244294|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
153503722|NCT02244294|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
153503723|NCT02244294|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
153503724|NCT02244294|Adrenergic Agents|adrenergic agents|mesh-ancestor
153503725|NCT02244294|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153503726|NCT02244294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153503727|NCT02244294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153503728|NCT02244294|Urological Agents|urological agents|mesh-ancestor
153503729|NCT02244528|Sildenafil Citrate|sildenafil citrate|mesh-list
153503730|NCT02244528|Vasodilator Agents|vasodilator agents|mesh-ancestor
153503731|NCT02244528|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
153503732|NCT02244528|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
153503733|NCT02244528|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153503759|NCT02247258|Azathioprine|azathioprine|mesh-list
153503760|NCT02247258|Antimetabolites|antimetabolites|mesh-ancestor
153503761|NCT02247258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153503762|NCT02247258|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153719792|NCT00104741|Flutamide|flutamide|mesh-list
153503772|NCT02247414|Dalteparin|dalteparin|mesh-list
153503773|NCT02247414|Dipyridamole|dipyridamole|mesh-list
153503774|NCT02247414|Warfarin|warfarin|mesh-list
153503775|NCT02247414|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153503776|NCT02247414|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153503777|NCT02247414|Analgesics|analgesics|mesh-ancestor
153503778|NCT02247414|Sensory System Agents|sensory system agents|mesh-ancestor
153503779|NCT02247414|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153503780|NCT02247414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153503781|NCT02247414|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153503782|NCT02247414|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153503783|NCT02247414|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153503784|NCT02247414|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153503785|NCT02247414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153503786|NCT02247414|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153503787|NCT02247414|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153503807|NCT02248428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153503808|NCT02248428|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153503809|NCT02248428|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153503810|NCT02248428|Alkylating Agents|alkylating agents|mesh-ancestor
153503811|NCT02248428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153503812|NCT02248428|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153503813|NCT02248428|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153503814|NCT02248428|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153503815|NCT02248428|Antiemetics|antiemetics|mesh-ancestor
153503816|NCT02248428|Autonomic Agents|autonomic agents|mesh-ancestor
153503817|NCT02248428|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153503818|NCT02248428|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153503819|NCT02248428|Glucocorticoids|glucocorticoids|mesh-ancestor
153503820|NCT02248428|Hormones|hormones|mesh-ancestor
153503821|NCT02248428|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153503823|NCT02248428|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153503824|NCT02248428|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153503825|NCT02248428|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
153503826|NCT02248428|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153503827|NCT02248428|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
153503828|NCT02248428|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153503829|NCT02248428|Leprostatic Agents|leprostatic agents|mesh-ancestor
153503830|NCT02248428|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153503831|NCT02248428|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153503832|NCT02248428|Growth Substances|growth substances|mesh-ancestor
153503833|NCT02248428|Growth Inhibitors|growth inhibitors|mesh-ancestor
153503834|NCT02248506|Clotrimazole|clotrimazole|mesh-list
153503835|NCT02248506|Miconazole|miconazole|mesh-list
153503836|NCT02248506|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
153503837|NCT02248506|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153503838|NCT02248506|Antifungal Agents|antifungal agents|mesh-ancestor
153503845|NCT02248506|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153503846|NCT02248506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153503847|NCT02248506|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
153503848|NCT02248506|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
153503849|NCT02248896|Telmisartan|telmisartan|mesh-list
153503850|NCT02248896|Antihypertensive Agents|antihypertensive agents|mesh-list
153503851|NCT02248896|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-list
153503852|NCT02248896|Enzyme Inhibitors|enzyme inhibitors|mesh-list
153503853|NCT02248896|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
153503854|NCT02248896|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
153503855|NCT02248896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153503856|NCT02248896|Protease Inhibitors|protease inhibitors|mesh-ancestor
153503857|NCT02249130|Ritonavir|ritonavir|mesh-list
153503858|NCT02249130|Lamivudine|lamivudine|mesh-list
153503859|NCT02249130|Zidovudine|zidovudine|mesh-list
153503860|NCT02249130|Stavudine|stavudine|mesh-list
153503861|NCT02249130|Tipranavir|tipranavir|mesh-list
153503862|NCT02249130|Delavirdine|delavirdine|mesh-list
153719975|NCT00105404|Glucocorticoids|glucocorticoids|mesh-ancestor
153503864|NCT02249130|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
153503865|NCT02249130|Protease Inhibitors|protease inhibitors|mesh-ancestor
153503866|NCT02249130|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153503867|NCT02249130|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153503868|NCT02249130|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153503869|NCT02249130|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153503870|NCT02249130|Antiviral Agents|antiviral agents|mesh-ancestor
153503871|NCT02249130|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153503872|NCT02249130|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
153503873|NCT02249130|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153503874|NCT02249130|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153503875|NCT02249130|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153503876|NCT02249130|Antimetabolites|antimetabolites|mesh-ancestor
153503877|NCT02249364|Propofol|propofol|mesh-list
153503878|NCT02249364|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153503879|NCT02249364|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153503881|NCT02249364|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153503882|NCT02249364|Anesthetics, General|anesthetics, general|mesh-ancestor
153503884|NCT02249442|Ritonavir|ritonavir|mesh-list
153503885|NCT02249442|Tipranavir|tipranavir|mesh-list
153503886|NCT02249442|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
153503887|NCT02249442|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
153503888|NCT02249442|Protease Inhibitors|protease inhibitors|mesh-ancestor
153503889|NCT02249442|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153551060|NCT01374984|Immunoglobulins|immunoglobulins|mesh-list
153551066|NCT01364051|Cediranib|cediranib|mesh-list
153503890|NCT02249442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153503892|NCT02249442|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153503894|NCT02249442|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153503895|NCT02249442|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
153503896|NCT02249442|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153503897|NCT02244762|Hydrocodone|hydrocodone|mesh-list
153503898|NCT02244762|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153503899|NCT02244762|Narcotics|narcotics|mesh-ancestor
153503900|NCT02244762|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153503901|NCT02244762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153503934|NCT02245308|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
153503935|NCT02245308|Autonomic Agents|autonomic agents|mesh-ancestor
153503936|NCT02245308|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153919979|NCT00970281|Autonomic Agents|autonomic agents|mesh-ancestor
153503937|NCT02245308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153503939|NCT02245308|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
153503940|NCT02245308|Cholinergic Agents|cholinergic agents|mesh-ancestor
153503941|NCT02245308|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153503942|NCT02245308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153503943|NCT02245308|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
153503944|NCT02245308|Antidepressive Agents|antidepressive agents|mesh-ancestor
153503945|NCT02245308|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153503946|NCT02245308|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
153503947|NCT02245308|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153503948|NCT02245308|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153503949|NCT02245308|Dopamine Agents|dopamine agents|mesh-ancestor
153503950|NCT02245308|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
153503951|NCT02245308|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153503952|NCT02245308|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153503953|NCT02243358|Gemcitabine|gemcitabine|mesh-list
153503954|NCT02243358|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153503955|NCT02243358|Antimetabolites|antimetabolites|mesh-ancestor
153503956|NCT02243358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153503957|NCT02243358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153503958|NCT00559962|Atorvastatin|atorvastatin|mesh-list
153503959|NCT00559962|Ezetimibe|ezetimibe|mesh-list
153503960|NCT00559962|Fenofibrate|fenofibrate|mesh-list
153503961|NCT00559962|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153503962|NCT00559962|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153503963|NCT00559962|Antimetabolites|antimetabolites|mesh-ancestor
153503964|NCT00559962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153503965|NCT00559962|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153503966|NCT00559962|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
153503967|NCT00559962|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153503968|NCT00559104|Cyclophosphamide|cyclophosphamide|mesh-list
153503971|NCT00559104|Lenograstim|lenograstim|mesh-list
153503972|NCT00559104|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153503973|NCT00559104|Immunologic Factors|immunologic factors|mesh-ancestor
153503974|NCT00559104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153503975|NCT00559104|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153503976|NCT00559104|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153503977|NCT00559104|Alkylating Agents|alkylating agents|mesh-ancestor
153503978|NCT00559104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153503979|NCT00559104|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153503980|NCT00559104|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153503981|NCT00559104|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153503982|NCT00559104|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153504016|NCT00557622|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153551072|NCT01352962|Carboplatin|carboplatin|mesh-list
153504018|NCT00557466|Formoterol Fumarate|formoterol fumarate|mesh-list
153504019|NCT00557466|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153720736|NCT03279601|Dacarbazine|dacarbazine|mesh-list
153504020|NCT00557466|Autonomic Agents|autonomic agents|mesh-ancestor
153504021|NCT00557466|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153504022|NCT00557466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153504023|NCT00557466|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153504024|NCT00557466|Respiratory System Agents|respiratory system agents|mesh-ancestor
153504025|NCT00557466|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
153504026|NCT00557466|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
153504027|NCT00557466|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153504028|NCT00557466|Adrenergic Agents|adrenergic agents|mesh-ancestor
153504029|NCT00557466|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153504030|NCT00557466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153504031|NCT00557310|Teriparatide|teriparatide|mesh-list
153504032|NCT00557310|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153504033|NCT00557310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153504034|NCT00557310|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153504035|NCT00555438|PENTA|penta|mesh-list
153504036|NCT00555438|Fondaparinux|fondaparinux|mesh-list
153504037|NCT00555438|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
153504038|NCT00555438|Antithrombins|antithrombins|mesh-ancestor
153504039|NCT00555438|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
153504040|NCT00555438|Protease Inhibitors|protease inhibitors|mesh-ancestor
153504041|NCT00555438|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153504042|NCT00555438|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153504043|NCT00555438|Anticoagulants|anticoagulants|mesh-ancestor
153504044|NCT00555438|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153504045|NCT00555438|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153504046|NCT00553644|Lenalidomide|lenalidomide|mesh-list
153504048|NCT00553644|Immunologic Factors|immunologic factors|mesh-ancestor
153504049|NCT00553644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153504050|NCT00553644|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153504051|NCT00553644|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153504053|NCT00553644|Growth Inhibitors|growth inhibitors|mesh-ancestor
153504054|NCT00553644|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153504055|NCT00552240|Ritonavir|ritonavir|mesh-list
153504056|NCT00552240|Atazanavir Sulfate|atazanavir sulfate|mesh-list
153504057|NCT00552240|Tenofovir|tenofovir|mesh-list
153504058|NCT00552240|Emtricitabine|emtricitabine|mesh-list
153504059|NCT00552240|Nevirapine|nevirapine|mesh-list
153504060|NCT00552240|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
153504061|NCT00552240|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
153504062|NCT00552240|Protease Inhibitors|protease inhibitors|mesh-ancestor
153504063|NCT00552240|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153504064|NCT00552240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153504065|NCT00552240|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153504066|NCT00552240|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153504067|NCT00552240|Antiviral Agents|antiviral agents|mesh-ancestor
153504068|NCT00552240|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153504069|NCT00552240|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
153504070|NCT00552240|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153504071|NCT00552240|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153504072|NCT00552240|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153504073|NCT00552240|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
153504074|NCT00552240|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
153504075|NCT00550836|Gemcitabine|gemcitabine|mesh-list
153781892|NCT00232115|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153504076|NCT00550836|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
153504077|NCT00550836|Panitumumab|panitumumab|mesh-list
153504078|NCT00550836|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153504079|NCT00550836|Antimetabolites|antimetabolites|mesh-ancestor
153504080|NCT00550836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153504097|NCT00556920|Protective Agents|protective agents|mesh-ancestor
153504098|NCT00556920|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153504099|NCT00556920|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153551116|NCT00878163|Gemcitabine|gemcitabine|mesh-list
153504100|NCT00556920|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153504101|NCT00556920|Vasodilator Agents|vasodilator agents|mesh-ancestor
153504102|NCT00556920|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
153504103|NCT00556920|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
153504105|NCT00552708|Carvedilol|carvedilol|mesh-list
153504106|NCT00552708|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
153504107|NCT00552708|Protease Inhibitors|protease inhibitors|mesh-ancestor
153504108|NCT00552708|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153504109|NCT00552708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153504111|NCT00552708|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
153504112|NCT00552708|Protective Agents|protective agents|mesh-ancestor
153504113|NCT00552708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153721007|NCT03279328|Petrolatum|petrolatum|mesh-list
153504114|NCT00552708|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
153504115|NCT00552708|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
153504117|NCT00552708|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153504118|NCT00552708|Antioxidants|antioxidants|mesh-ancestor
153504119|NCT00552708|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153504120|NCT00552708|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153504125|NCT00556374|Zoledronic Acid|zoledronic acid|mesh-list
153504146|NCT03029676|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153504147|NCT03029676|Anesthetics, General|anesthetics, general|mesh-ancestor
153504148|NCT03029676|GABA Modulators|gaba modulators|mesh-ancestor
153504149|NCT03029676|GABA Agents|gaba agents|mesh-ancestor
153504150|NCT03029676|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153504151|NCT03029676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153504153|NCT03029676|Narcotics|narcotics|mesh-ancestor
153504154|NCT03029676|Analgesics|analgesics|mesh-ancestor
153504155|NCT03029676|Sensory System Agents|sensory system agents|mesh-ancestor
153504156|NCT03029676|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153504157|NCT04270344|Valsartan|valsartan|mesh-list
153504158|NCT04270344|Pitavastatin|pitavastatin|mesh-list
153504159|NCT04270344|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153504160|NCT04270344|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
153504161|NCT04270344|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
153504162|NCT04270344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153504163|NCT04270344|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
153504164|NCT04270344|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153721180|NCT00108251|Diuretics|diuretics|mesh-ancestor
153504165|NCT04270344|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153504166|NCT04270344|Antimetabolites|antimetabolites|mesh-ancestor
153504167|NCT04270344|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153504168|NCT04270344|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153504169|NCT04278846|Bupivacaine|bupivacaine|mesh-list
153504170|NCT04278846|Anesthetics, Local|anesthetics, local|mesh-ancestor
153504171|NCT04278846|Anesthetics|anesthetics|mesh-ancestor
153504172|NCT04278846|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153504173|NCT04278846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153504174|NCT04278846|Sensory System Agents|sensory system agents|mesh-ancestor
153504175|NCT04278846|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153504176|NCT03839550|Apatinib|apatinib|mesh-list
153504177|NCT03839550|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153504181|NCT03839160|Morphine|morphine|mesh-list
153504188|NCT03839160|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153504189|NCT03838926|Trichostatin A|trichostatin a|mesh-list
153504190|NCT03838926|Antifungal Agents|antifungal agents|mesh-ancestor
153504191|NCT03838926|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153504192|NCT03838926|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
153504193|NCT03838926|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153504194|NCT03838926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153504195|NCT03838926|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
153504196|NCT03834012|Beclomethasone|beclomethasone|mesh-list
153504206|NCT03833466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153504207|NCT03833388|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
153504208|NCT03833388|Ophthalmic Solutions|ophthalmic solutions|mesh-list
153504210|NCT03830034|Ferrous fumarate|ferrous fumarate|mesh-list
153504211|NCT03830034|Iron Chelating Agents|iron chelating agents|mesh-list
153504212|NCT03830034|Trace Elements|trace elements|mesh-ancestor
153504213|NCT03830034|Micronutrients|micronutrients|mesh-ancestor
153504214|NCT03830034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153504215|NCT03830034|Chelating Agents|chelating agents|mesh-ancestor
153504216|NCT03830034|Sequestering Agents|sequestering agents|mesh-ancestor
153504219|NCT03838068|Procaine|procaine|mesh-list
153504236|NCT05444556|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153504237|NCT05444556|Antimetabolites|antimetabolites|mesh-ancestor
153504238|NCT05444556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153504239|NCT05444556|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153504240|NCT05444556|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
153504241|NCT05444556|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153504242|NCT05444556|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
153504243|NCT05444556|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153504244|NCT05444556|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
153504245|NCT05444556|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153504246|NCT05444556|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
153504247|NCT05444556|Protective Agents|protective agents|mesh-ancestor
153504248|NCT05444556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153504249|NCT05444556|Antitussive Agents|antitussive agents|mesh-ancestor
153504250|NCT05444556|Respiratory System Agents|respiratory system agents|mesh-ancestor
153504251|NCT05444556|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
153504252|NCT05444556|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
153504253|NCT05444556|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153504254|NCT05444556|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153504255|NCT05444556|Narcotics|narcotics|mesh-ancestor
153504260|NCT05444556|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153504261|NCT05444556|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
153504262|NCT05444556|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
153504263|NCT05444556|Adrenergic Agents|adrenergic agents|mesh-ancestor
153504264|NCT05444556|Antimalarials|antimalarials|mesh-ancestor
153504265|NCT05444556|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153504266|NCT05444556|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153504267|NCT05444556|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153504268|NCT05444556|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
153504274|NCT05444556|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
153504275|NCT05444556|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153504276|NCT05440578|Bevacizumab|bevacizumab|mesh-list
153504277|NCT05440578|Olaparib|olaparib|mesh-list
153504278|NCT05440578|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153504279|NCT05440578|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153504280|NCT05440578|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153504281|NCT05440578|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153504282|NCT05440578|Growth Substances|growth substances|mesh-ancestor
153504283|NCT05440578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153504284|NCT05440578|Growth Inhibitors|growth inhibitors|mesh-ancestor
153504285|NCT05440578|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
153504286|NCT05440578|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153504287|NCT05440578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153504288|NCT01689558|Endostatins|endostatins|mesh-list
153504289|NCT01689558|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153504290|NCT01689558|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153504291|NCT01689558|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153504292|NCT01689558|Growth Substances|growth substances|mesh-ancestor
153504293|NCT01689558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153504294|NCT01689558|Growth Inhibitors|growth inhibitors|mesh-ancestor
153504295|NCT01689870|Ipilimumab|ipilimumab|mesh-list
153504296|NCT01689870|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153504297|NCT01689870|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153504298|NCT01689870|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153504299|NCT01689870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153504300|NCT05768542|Metoprolol|metoprolol|mesh-list
153504301|NCT05768542|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153504302|NCT05768542|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153504303|NCT05768542|Sympatholytics|sympatholytics|mesh-ancestor
153504316|NCT05768464|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153504317|NCT05768464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153504318|NCT05768243|Hyaluronic Acid|hyaluronic acid|mesh-list
153504319|NCT05768243|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153504320|NCT05768243|Immunologic Factors|immunologic factors|mesh-ancestor
153504321|NCT05768243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153504329|NCT05768230|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153504330|NCT05768230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153504331|NCT05768230|Protective Agents|protective agents|mesh-ancestor
153504332|NCT05768230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153504333|NCT05768204|Prednisolone|prednisolone|mesh-list
153504334|NCT05768204|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
153504335|NCT05768204|Methylprednisolone|methylprednisolone|mesh-list
153504336|NCT05768204|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
153504337|NCT05768204|Prednisolone acetate|prednisolone acetate|mesh-list
153504338|NCT05768204|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
153504339|NCT05768204|Prednisolone phosphate|prednisolone phosphate|mesh-list
153504340|NCT05768204|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153504341|NCT05768204|Glucocorticoids|glucocorticoids|mesh-ancestor
153504342|NCT05768204|Hormones|hormones|mesh-ancestor
153504343|NCT05768204|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153504344|NCT05768204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153504360|NCT05768126|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
153504361|NCT05768126|Protective Agents|protective agents|mesh-ancestor
153504363|NCT05767827|Epinephrine|epinephrine|mesh-list
153504364|NCT05767827|Racepinephrine|racepinephrine|mesh-list
153504365|NCT05767827|Dexmedetomidine|dexmedetomidine|mesh-list
153504366|NCT05767827|Ropivacaine|ropivacaine|mesh-list
153504367|NCT05767827|Epinephryl borate|epinephryl borate|mesh-list
153504368|NCT05767827|Anesthetics, Local|anesthetics, local|mesh-ancestor
153504369|NCT05767827|Anesthetics|anesthetics|mesh-ancestor
153504370|NCT05767827|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153504371|NCT05767827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153504372|NCT05767827|Sensory System Agents|sensory system agents|mesh-ancestor
153504373|NCT05767827|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153504374|NCT05767827|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153504375|NCT05767827|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
153504376|NCT05767827|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153504377|NCT05767827|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153504378|NCT05767827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153504379|NCT05767827|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153504380|NCT05767827|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153504381|NCT05767827|Analgesics|analgesics|mesh-ancestor
153504382|NCT05767827|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
153504383|NCT05767827|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153504384|NCT05767827|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153504385|NCT05767827|Adrenergic Agents|adrenergic agents|mesh-ancestor
153504386|NCT05767827|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153504387|NCT05767827|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
153504388|NCT05767827|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153504405|NCT05767723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153504406|NCT05767723|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153504407|NCT05767723|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153504408|NCT05767723|Analgesics|analgesics|mesh-ancestor
153504409|NCT05767723|Sensory System Agents|sensory system agents|mesh-ancestor
153504410|NCT05767723|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153504411|NCT05767723|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153504412|NCT05767723|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153504413|NCT05767723|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153504414|NCT05767723|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153504415|NCT05767723|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153504416|NCT05767723|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153504417|NCT05767723|Antipyretics|antipyretics|mesh-ancestor
153504419|NCT05767632|Mirabegron|mirabegron|mesh-list
153504466|NCT05753267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153504467|NCT05753267|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153504468|NCT05753267|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153504469|NCT05753267|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153504470|NCT05753267|Analgesics|analgesics|mesh-ancestor
153504471|NCT05753267|Sensory System Agents|sensory system agents|mesh-ancestor
153504472|NCT05753267|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153504473|NCT05753267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153504474|NCT05753267|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153504475|NCT05753267|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153504476|NCT05751343|Bevacizumab|bevacizumab|mesh-list
153504477|NCT05751343|Atezolizumab|atezolizumab|mesh-list
153504478|NCT05751343|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153504479|NCT05751343|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153504480|NCT05751343|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153504481|NCT05751343|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153504482|NCT05751343|Growth Substances|growth substances|mesh-ancestor
153504483|NCT05751343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153504484|NCT05751343|Growth Inhibitors|growth inhibitors|mesh-ancestor
153504485|NCT05751343|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153504486|NCT05751343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153504487|NCT05647681|Acetaminophen|acetaminophen|mesh-list
153504488|NCT05647681|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153504489|NCT05647681|Analgesics|analgesics|mesh-ancestor
153504490|NCT05647681|Sensory System Agents|sensory system agents|mesh-ancestor
153504491|NCT05647681|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153504492|NCT05647681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153504493|NCT05647681|Antipyretics|antipyretics|mesh-ancestor
153504494|NCT05644145|Vaccines|vaccines|mesh-list
153504495|NCT05644145|Immunologic Factors|immunologic factors|mesh-ancestor
153504496|NCT05644145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153504497|NCT05642416|Ropivacaine|ropivacaine|mesh-list
153504498|NCT05642416|Anesthetics, Local|anesthetics, local|mesh-ancestor
153504499|NCT05642416|Anesthetics|anesthetics|mesh-ancestor
153504500|NCT05642416|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153504501|NCT05642416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153504503|NCT05642416|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153504504|NCT05631028|Dexmedetomidine|dexmedetomidine|mesh-list
153504505|NCT05631028|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153504506|NCT05631028|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153504507|NCT05631028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153504517|NCT05631028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153504518|NCT05604599|Fentanyl|fentanyl|mesh-list
153504519|NCT05604599|Dexmedetomidine|dexmedetomidine|mesh-list
153781893|NCT00232115|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153504520|NCT05604599|Propofol|propofol|mesh-list
153504521|NCT05604599|Isoflurane|isoflurane|mesh-list
153504522|NCT05604599|Atracurium|atracurium|mesh-list
153504523|NCT05604599|Cisatracurium|cisatracurium|mesh-list
153504524|NCT05604599|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153504525|NCT05604599|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153504553|NCT05543837|Sensory System Agents|sensory system agents|mesh-ancestor
153504554|NCT05543837|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153504555|NCT05543837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153504556|NCT05486026|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
153504557|NCT05486026|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-list
153504558|NCT05486026|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
153504559|NCT05486026|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
153504560|NCT05486026|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153504561|NCT05486026|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153504562|NCT05486026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153504563|NCT05486026|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153504564|NCT05486026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153504565|NCT05486026|Analgesics|analgesics|mesh-ancestor
153504566|NCT05486026|Sensory System Agents|sensory system agents|mesh-ancestor
153504567|NCT05486026|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153504568|NCT05486026|Antidepressive Agents|antidepressive agents|mesh-ancestor
153504569|NCT05486026|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153504570|NCT05486026|Dopamine Agents|dopamine agents|mesh-ancestor
153504571|NCT05486026|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153504572|NCT05486026|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153504573|NCT05332067|Omalizumab|omalizumab|mesh-list
153504574|NCT05332067|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
153504575|NCT05332067|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
153504576|NCT05332067|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153504577|NCT05332067|Respiratory System Agents|respiratory system agents|mesh-ancestor
153504578|NCT05332067|Immunologic Factors|immunologic factors|mesh-ancestor
153504579|NCT05332067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153504580|NCT05323890|Tislelizumab|tislelizumab|mesh-list
153504581|NCT05323890|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153504582|NCT05323890|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153504583|NCT05284019|Erenumab|erenumab|mesh-list
153504584|NCT05284019|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
153504585|NCT05284019|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
153504586|NCT05284019|Calcitonin Gene-Related Peptide Receptor Antagonists|calcitonin gene-related peptide receptor antagonists|mesh-ancestor
153504589|NCT05284019|Sensory System Agents|sensory system agents|mesh-ancestor
153504590|NCT05284019|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153504596|NCT05284019|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153504598|NCT05217342|Natriuretic Agents|natriuretic agents|mesh-ancestor
153504599|NCT05217342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153504600|NCT05172947|Resveratrol|resveratrol|mesh-list
153504601|NCT05172947|Antioxidants|antioxidants|mesh-ancestor
153504602|NCT05172947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153504603|NCT05172947|Protective Agents|protective agents|mesh-ancestor
153504604|NCT05172947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153504605|NCT05172947|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153504606|NCT05172947|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153504641|NCT04804072|Narcotics|narcotics|mesh-ancestor
153504642|NCT04804072|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153504643|NCT04804072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153504644|NCT04804072|Analgesics|analgesics|mesh-ancestor
153504645|NCT04804072|Sensory System Agents|sensory system agents|mesh-ancestor
153504646|NCT04804072|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153504647|NCT04759144|Insulin|insulin|mesh-list
153504648|NCT04759144|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
153504649|NCT04759144|Insulin Aspart|insulin aspart|mesh-list
153504650|NCT04759144|Insulin, Long-Acting|insulin, long-acting|mesh-list
153504651|NCT04759144|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
153504652|NCT04759144|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153551265|NCT01570660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153504653|NCT04759144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153504654|NCT04724031|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
153722550|NCT00347971|Rituximab|rituximab|mesh-list
153504656|NCT04724031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153504657|NCT04724031|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153504658|NCT04679376|Atorvastatin|atorvastatin|mesh-list
153504659|NCT04679376|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153504660|NCT04679376|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153504661|NCT04679376|Antimetabolites|antimetabolites|mesh-ancestor
153504662|NCT04679376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153504663|NCT04679376|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153504664|NCT04679376|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
153504665|NCT04679376|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153504666|NCT04677959|Fluticasone|fluticasone|mesh-list
153504669|NCT04677959|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
153504670|NCT04677959|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153504671|NCT04677959|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153504672|NCT04677959|Autonomic Agents|autonomic agents|mesh-ancestor
153504673|NCT04677959|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153504683|NCT04677959|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153504684|NCT04677959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153504686|NCT04677959|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153504688|NCT04671043|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
153504689|NCT04671043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153504690|NCT04671043|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
153504691|NCT04671043|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153504692|NCT04671043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153504693|NCT04671043|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
153504694|NCT04671043|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
153504695|NCT04671043|Purinergic Agents|purinergic agents|mesh-ancestor
153504696|NCT04671043|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153504697|NCT04612920|Acetaminophen|acetaminophen|mesh-list
153504698|NCT04612920|Ibuprofen|ibuprofen|mesh-list
153504699|NCT04612920|Oxycodone|oxycodone|mesh-list
153504700|NCT04612920|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153504701|NCT04612920|Analgesics|analgesics|mesh-ancestor
153504702|NCT04612920|Sensory System Agents|sensory system agents|mesh-ancestor
153504703|NCT04612920|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153504735|NCT04477317|Nordefrin|nordefrin|mesh-list
153504736|NCT04477317|Mepivacaine|mepivacaine|mesh-list
153504737|NCT04477317|Carticaine|carticaine|mesh-list
153504738|NCT04477317|Epinephryl borate|epinephryl borate|mesh-list
153504739|NCT04477317|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153504740|NCT04477317|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153504741|NCT04477317|Adrenergic Agents|adrenergic agents|mesh-ancestor
153504742|NCT04477317|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153504743|NCT04477317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153504744|NCT04477317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153504745|NCT04477317|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
153504746|NCT04477317|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153504747|NCT04477317|Autonomic Agents|autonomic agents|mesh-ancestor
153504748|NCT04477317|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153504749|NCT04477317|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153504750|NCT04477317|Respiratory System Agents|respiratory system agents|mesh-ancestor
153504751|NCT04477317|Mydriatics|mydriatics|mesh-ancestor
153504752|NCT04477317|Sympathomimetics|sympathomimetics|mesh-ancestor
153504753|NCT04477317|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
153504754|NCT04477317|Anesthetics, Local|anesthetics, local|mesh-ancestor
153504755|NCT04477317|Anesthetics|anesthetics|mesh-ancestor
153504757|NCT04477317|Sensory System Agents|sensory system agents|mesh-ancestor
153504791|NCT04131309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153551276|NCT01570790|Fosbretabulin|fosbretabulin|mesh-list
153504792|NCT04131309|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153504793|NCT04131309|Glucocorticoids|glucocorticoids|mesh-ancestor
153504794|NCT04131309|Hormones|hormones|mesh-ancestor
153504795|NCT04131309|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153504796|NCT04131309|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153551286|NCT01570894|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153504797|NCT04131309|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153504798|NCT04040959|Niacinamide|niacinamide|mesh-list
153504799|NCT04040959|Niacin|niacin|mesh-list
153504800|NCT04040959|Nicotinic Acids|nicotinic acids|mesh-list
153504806|NCT04040959|Antimetabolites|antimetabolites|mesh-ancestor
153504807|NCT04040959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153504808|NCT04040959|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153504809|NCT04040959|Vasodilator Agents|vasodilator agents|mesh-ancestor
153504810|NCT04035031|Dapagliflozin|dapagliflozin|mesh-list
153504811|NCT04035031|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
153504848|NCT03786783|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153504849|NCT03786783|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153504851|NCT03786783|Micronutrients|micronutrients|mesh-ancestor
153504852|NCT03786783|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153504853|NCT03786783|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153504854|NCT03786783|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153504855|NCT03786783|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153504856|NCT03786783|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153504857|NCT03786783|Tubulin Modulators|tubulin modulators|mesh-ancestor
153504858|NCT03786783|Antimitotic Agents|antimitotic agents|mesh-ancestor
153504859|NCT03786783|Mitosis Modulators|mitosis modulators|mesh-ancestor
153504860|NCT03786783|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
153504861|NCT03786783|Keratolytic Agents|keratolytic agents|mesh-ancestor
153504862|NCT03786783|Dermatologic Agents|dermatologic agents|mesh-ancestor
153504863|NCT03786783|Protective Agents|protective agents|mesh-ancestor
153504864|NCT03786783|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
153504865|NCT03785587|Bromides|bromides|mesh-list
153504866|NCT03785587|Anticonvulsants|anticonvulsants|mesh-ancestor
153504867|NCT03654833|Bevacizumab|bevacizumab|mesh-list
153504868|NCT03654833|Pembrolizumab|pembrolizumab|mesh-list
153504869|NCT03654833|Atezolizumab|atezolizumab|mesh-list
153504870|NCT03654833|Niraparib|niraparib|mesh-list
153504871|NCT03654833|Dostarlimab|dostarlimab|mesh-list
153504872|NCT03654833|Rucaparib|rucaparib|mesh-list
153504873|NCT03654833|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153504874|NCT03654833|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153504875|NCT03654833|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153504876|NCT03654833|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153504877|NCT03654833|Growth Substances|growth substances|mesh-ancestor
153504878|NCT03654833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153504879|NCT03654833|Growth Inhibitors|growth inhibitors|mesh-ancestor
153504884|NCT03426904|Leucovorin|leucovorin|mesh-list
153504893|NCT03426904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153504894|NCT03426904|Antidotes|antidotes|mesh-ancestor
153504895|NCT03426904|Protective Agents|protective agents|mesh-ancestor
153504896|NCT03426904|Vitamin B Complex|vitamin b complex|mesh-ancestor
153504898|NCT03426904|Micronutrients|micronutrients|mesh-ancestor
153504899|NCT03361072|Immunomodulating Agents|immunomodulating agents|mesh-list
153504900|NCT03361072|Immunologic Factors|immunologic factors|mesh-ancestor
153504901|NCT03361072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153504902|NCT03292315|Semaglutide|semaglutide|mesh-list
153504903|NCT03292315|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
153504904|NCT03292315|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153504905|NCT03292315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153504906|NCT03287778|Pyridoxine|pyridoxine|mesh-list
153504907|NCT03287778|Vitamin B 6|vitamin b 6|mesh-list
153504908|NCT03287778|Vitamins|vitamins|mesh-ancestor
153504909|NCT03287778|Micronutrients|micronutrients|mesh-ancestor
153504910|NCT03287778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153551287|NCT01570894|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153551308|NCT01570985|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
153551309|NCT01570985|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153504911|NCT03287778|Vitamin B Complex|vitamin b complex|mesh-ancestor
153504912|NCT03273413|Pravastatin|pravastatin|mesh-list
153551310|NCT01570985|Glucocorticoids|glucocorticoids|mesh-ancestor
153504913|NCT03273413|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153504914|NCT03273413|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153504915|NCT03273413|Antimetabolites|antimetabolites|mesh-ancestor
153504916|NCT03273413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153504917|NCT03273413|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153504918|NCT03273413|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
153504919|NCT03273413|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153504920|NCT03227458|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
153504921|NCT03227458|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153504926|NCT03074539|Riociguat|riociguat|mesh-list
153504941|NCT02995252|Antiviral Agents|antiviral agents|mesh-ancestor
153504942|NCT02995252|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153504943|NCT02995252|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153504944|NCT02995252|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153504945|NCT02995252|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153504946|NCT02995252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153504947|NCT02995252|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153504948|NCT02995252|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153504949|NCT02995252|Hematinics|hematinics|mesh-ancestor
153504950|NCT02932826|Insulin|insulin|mesh-list
153504951|NCT02932826|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153504952|NCT02932826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153504953|NCT02817360|Losartan|losartan|mesh-list
153504954|NCT02817360|Valsartan|valsartan|mesh-list
153504955|NCT02817360|Carvedilol|carvedilol|mesh-list
153504956|NCT02817360|Candesartan|candesartan|mesh-list
153504957|NCT02817360|Ramipril|ramipril|mesh-list
153504958|NCT02817360|Enalapril|enalapril|mesh-list
153504959|NCT02817360|Lisinopril|lisinopril|mesh-list
153504960|NCT02817360|Irbesartan|irbesartan|mesh-list
153504961|NCT02817360|Nebivolol|nebivolol|mesh-list
153504962|NCT02817360|Bisoprolol|bisoprolol|mesh-list
153504963|NCT02817360|Perindopril|perindopril|mesh-list
153504964|NCT02817360|Captopril|captopril|mesh-list
153504965|NCT02817360|Quinapril|quinapril|mesh-list
153504966|NCT02817360|Trandolapril|trandolapril|mesh-list
153504997|NCT02817360|Sympatholytics|sympatholytics|mesh-ancestor
153504998|NCT02817360|Autonomic Agents|autonomic agents|mesh-ancestor
153504999|NCT02817360|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153505000|NCT02817360|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
153505001|NCT02817360|Angiotensin II Type 2 Receptor Blockers|angiotensin ii type 2 receptor blockers|mesh-ancestor
153505002|NCT02689778|Pirfenidone|pirfenidone|mesh-list
153505003|NCT02689778|Analgesics|analgesics|mesh-ancestor
153505004|NCT02689778|Sensory System Agents|sensory system agents|mesh-ancestor
153505005|NCT02689778|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153505006|NCT02689778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153505007|NCT02689778|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153505008|NCT02689778|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153505061|NCT02387203|Clarithromycin|clarithromycin|mesh-list
153505062|NCT02387203|Lansoprazole|lansoprazole|mesh-list
153505063|NCT02387203|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153505064|NCT02387203|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153505065|NCT02387203|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
153505066|NCT02387203|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153505067|NCT02387203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153505068|NCT02387203|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
153505069|NCT02387203|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153505070|NCT02387203|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
153505071|NCT02387203|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153505072|NCT02387203|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
153505073|NCT02381353|Bupivacaine|bupivacaine|mesh-list
153505074|NCT02381353|Anesthetics, Local|anesthetics, local|mesh-ancestor
153505075|NCT02381353|Anesthetics|anesthetics|mesh-ancestor
153505076|NCT02381353|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153505077|NCT02381353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153505078|NCT02381353|Sensory System Agents|sensory system agents|mesh-ancestor
153505079|NCT02381353|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153505080|NCT01992653|Prednisone|prednisone|mesh-list
153551314|NCT01570985|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153505081|NCT01992653|Prednisolone|prednisolone|mesh-list
153505115|NCT01850303|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153505116|NCT01763671|Paclitaxel|paclitaxel|mesh-list
153505117|NCT01763671|Docetaxel|docetaxel|mesh-list
153505118|NCT01763671|Bevacizumab|bevacizumab|mesh-list
153505119|NCT01763671|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153505120|NCT01763671|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153505121|NCT01763671|Tubulin Modulators|tubulin modulators|mesh-ancestor
153505122|NCT01763671|Antimitotic Agents|antimitotic agents|mesh-ancestor
153505123|NCT01763671|Mitosis Modulators|mitosis modulators|mesh-ancestor
153505124|NCT01763671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153505125|NCT01763671|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153505127|NCT01763671|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153505128|NCT01763671|Growth Substances|growth substances|mesh-ancestor
153448184|NCT00002987|Bleomycin|bleomycin|mesh-list
153505129|NCT01763671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153505130|NCT01763671|Growth Inhibitors|growth inhibitors|mesh-ancestor
153505131|NCT01696435|Vitamin D|vitamin d|mesh-list
153505132|NCT01696435|Ergocalciferols|ergocalciferols|mesh-list
153505134|NCT01696435|Vitamins|vitamins|mesh-list
153505172|NCT00590122|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153505173|NCT00590122|Immunologic Factors|immunologic factors|mesh-ancestor
153505174|NCT00590122|Dopamine Agonists|dopamine agonists|mesh-ancestor
153505175|NCT00309192|Triamcinolone|triamcinolone|mesh-list
153505176|NCT00309192|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
153505177|NCT00309192|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
153505178|NCT00309192|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
153505179|NCT00309192|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153505180|NCT00309192|Glucocorticoids|glucocorticoids|mesh-ancestor
153505182|NCT00309192|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153505183|NCT00309192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153505184|NCT00309192|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153505185|NCT00309192|Immunologic Factors|immunologic factors|mesh-ancestor
153505186|NCT00309192|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153505187|NCT00309192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153505188|NCT00110591|Leronlimab|leronlimab|mesh-list
153505189|NCT00110591|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
153505190|NCT00110591|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
153505191|NCT00110591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153505192|NCT00110591|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153505193|NCT00110591|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153505194|NCT00110591|Antiviral Agents|antiviral agents|mesh-ancestor
153505221|NCT01683084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153505223|NCT04823442|Mirabegron|mirabegron|mesh-list
153505224|NCT04823442|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
153505225|NCT04823442|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
153505226|NCT04823442|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153505227|NCT04823442|Adrenergic Agents|adrenergic agents|mesh-ancestor
153505228|NCT04823442|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153505229|NCT04823442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153505230|NCT04823442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153505231|NCT04823442|Urological Agents|urological agents|mesh-ancestor
153505232|NCT04823442|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153505233|NCT04823442|Sympatholytics|sympatholytics|mesh-ancestor
153505234|NCT04823442|Autonomic Agents|autonomic agents|mesh-ancestor
153505235|NCT04823442|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153505236|NCT04823442|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
153505237|NCT04823442|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
153505238|NCT04823442|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
153505239|NCT01384448|Dobutamine|dobutamine|mesh-list
153723399|NCT00352768|Fluvoxamine|fluvoxamine|mesh-list
153505240|NCT01384448|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
153505241|NCT01384448|Sympathomimetics|sympathomimetics|mesh-ancestor
153505275|NCT01384643|Anesthetics|anesthetics|mesh-ancestor
153781896|NCT00232115|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153505276|NCT01384656|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
153505277|NCT01384682|Maraviroc|maraviroc|mesh-list
153505278|NCT01384682|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
153505279|NCT01384682|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
153505294|NCT01384812|Dinoprostone|dinoprostone|mesh-list
153505295|NCT01384812|Oxytocics|oxytocics|mesh-ancestor
153551321|NCT01571024|Antimetabolites|antimetabolites|mesh-ancestor
153505296|NCT01384812|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153505297|NCT01384812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153505298|NCT01384864|Proflavine|proflavine|mesh-list
153505299|NCT01384864|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
153505326|NCT01385020|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153505327|NCT01385020|Antimetabolites|antimetabolites|mesh-ancestor
153505328|NCT01385020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153505329|NCT01385020|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153505330|NCT01385020|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
153505331|NCT01385020|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153505332|NCT01385020|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153505333|NCT01385020|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
153505334|NCT01385020|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153505335|NCT01385124|Cannabidiol|cannabidiol|mesh-list
153505336|NCT01385124|Anticonvulsants|anticonvulsants|mesh-ancestor
153505337|NCT01385228|Prednisone|prednisone|mesh-list
153505338|NCT01385228|Docetaxel|docetaxel|mesh-list
153505339|NCT01385228|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153505340|NCT01385228|Tubulin Modulators|tubulin modulators|mesh-ancestor
153505341|NCT01385228|Antimitotic Agents|antimitotic agents|mesh-ancestor
153505342|NCT01385228|Mitosis Modulators|mitosis modulators|mesh-ancestor
153505343|NCT01385228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153505344|NCT01385228|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153505345|NCT01385228|Glucocorticoids|glucocorticoids|mesh-ancestor
153505346|NCT01385228|Hormones|hormones|mesh-ancestor
153505347|NCT01385228|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153505348|NCT01385228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153505349|NCT01385228|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153505350|NCT01385345|Vitamin D|vitamin d|mesh-list
153505351|NCT01385345|Cholecalciferol|cholecalciferol|mesh-list
153505352|NCT01385345|Vitamins|vitamins|mesh-ancestor
153505353|NCT01385345|Micronutrients|micronutrients|mesh-ancestor
153505354|NCT01385345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153505356|NCT01385345|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153505357|NCT01385527|Triamcinolone|triamcinolone|mesh-list
153505358|NCT01385527|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153505359|NCT01385527|Glucocorticoids|glucocorticoids|mesh-ancestor
153505361|NCT01385527|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153505364|NCT01385631|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153505365|NCT01385631|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153505366|NCT01385631|Antimetabolites|antimetabolites|mesh-ancestor
153505367|NCT01385631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153505368|NCT01385631|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153505369|NCT01385683|Clarithromycin|clarithromycin|mesh-list
153505370|NCT01385683|Dabigatran|dabigatran|mesh-list
153505371|NCT01385683|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153505372|NCT01385683|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153505373|NCT01385683|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
153505374|NCT01385683|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153505375|NCT01385683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153505376|NCT01385683|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
153505377|NCT01385683|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153505378|NCT01385683|Antithrombins|antithrombins|mesh-ancestor
153505382|NCT01385735|Rasagiline|rasagiline|mesh-list
153505421|NCT01386086|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153505422|NCT01386086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153505423|NCT01386086|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
153505424|NCT01386086|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
153505425|NCT01386086|Serotonin Agents|serotonin agents|mesh-ancestor
153505426|NCT01386086|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
153505427|NCT01386086|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153505428|NCT01386086|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
153505429|NCT01386086|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
153505430|NCT01386151|Mitogens|mitogens|mesh-list
153505431|NCT01386151|Mitosis Modulators|mitosis modulators|mesh-ancestor
153551328|NCT01571024|Antidotes|antidotes|mesh-ancestor
153505432|NCT01386151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153505433|NCT01386164|Vaccines|vaccines|mesh-list
153505434|NCT01386164|Immunologic Factors|immunologic factors|mesh-ancestor
153505435|NCT01386164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153505436|NCT01386177|Doxazosin|doxazosin|mesh-list
153505437|NCT01386177|N-Methyl-3,4-methylenedioxyamphetamine|n-methyl-3,4-methylenedioxyamphetamine|mesh-list
153505438|NCT01386177|Hallucinogens|hallucinogens|mesh-ancestor
153505439|NCT01386177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153505440|NCT01386177|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153505441|NCT01386177|Serotonin Agents|serotonin agents|mesh-ancestor
153505442|NCT01386177|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153505469|NCT01386242|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153505470|NCT01386242|Antiviral Agents|antiviral agents|mesh-ancestor
153505471|NCT01386242|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153505472|NCT01386255|Baclofen|baclofen|mesh-list
153505473|NCT01386255|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
153505474|NCT01386255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153505475|NCT01386255|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
153505476|NCT01386255|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153505477|NCT01386255|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
153505479|NCT01386255|GABA Agents|gaba agents|mesh-ancestor
153505480|NCT01386255|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153505482|NCT01386268|Factor VIII|factor viii|mesh-list
153505483|NCT01386268|Coagulants|coagulants|mesh-ancestor
153505484|NCT01386294|Tenofovir|tenofovir|mesh-list
153505485|NCT01386294|Antiviral Agents|antiviral agents|mesh-ancestor
153505486|NCT01386294|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153505487|NCT01386294|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153505488|NCT01386294|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153505489|NCT01386294|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153505490|NCT01386294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153505491|NCT01386294|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153505492|NCT01386294|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153505493|NCT01386333|Oxytocin|oxytocin|mesh-list
153505494|NCT01386333|Oxytocics|oxytocics|mesh-ancestor
153505495|NCT01386333|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153505496|NCT01386333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153505497|NCT01386346|Capecitabine|capecitabine|mesh-list
153505498|NCT01386346|Azacitidine|azacitidine|mesh-list
153781897|NCT00232115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153505499|NCT01386346|Oxaliplatin|oxaliplatin|mesh-list
153505500|NCT01386346|Epirubicin|epirubicin|mesh-list
153505501|NCT01386346|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153505502|NCT01386346|Antimetabolites|antimetabolites|mesh-ancestor
153505510|NCT01386372|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
153505511|NCT01386372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153505512|NCT01386372|Natriuretic Agents|natriuretic agents|mesh-ancestor
153505513|NCT01386372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153505514|NCT01386398|Bortezomib|bortezomib|mesh-list
153505515|NCT01386398|Vorinostat|vorinostat|mesh-list
153505516|NCT01386398|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153505517|NCT01386398|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
153505518|NCT01386398|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153505519|NCT01386398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153505520|NCT01386502|Pidilizumab|pidilizumab|mesh-list
153505573|NCT01386593|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
153505574|NCT01386593|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153505575|NCT01386593|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
153505576|NCT01386593|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153505577|NCT01386593|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153505578|NCT01386593|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153505580|NCT01386593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153505581|NCT01386593|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
153505582|NCT01386593|Antidepressive Agents|antidepressive agents|mesh-ancestor
153505583|NCT01386593|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153505584|NCT01386593|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
153505585|NCT01386593|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
153505586|NCT01386593|Antitubercular Agents|antitubercular agents|mesh-ancestor
153505587|NCT01386593|Leprostatic Agents|leprostatic agents|mesh-ancestor
153551364|NCT01571323|Oxytocin|oxytocin|mesh-list
153505588|NCT01386593|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153505589|NCT01386593|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
153505590|NCT01386593|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
153505591|NCT01386593|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
153505592|NCT01386593|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
153505593|NCT01386593|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
153505594|NCT01386593|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
153505595|NCT01386593|Antifungal Agents|antifungal agents|mesh-ancestor
153505596|NCT01386593|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
153505597|NCT01386593|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153505598|NCT01386593|Hormone Antagonists|hormone antagonists|mesh-ancestor
153505599|NCT01386593|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153505600|NCT01386593|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
153505612|NCT01386658|Bradykinin Receptor Antagonists|bradykinin receptor antagonists|mesh-ancestor
153505613|NCT01386658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153505614|NCT01386658|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
153505615|NCT01386658|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153505616|NCT01386658|Immunologic Factors|immunologic factors|mesh-ancestor
153505618|NCT01386671|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153505619|NCT01386671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153505622|NCT01386736|Micronutrients|micronutrients|mesh-ancestor
153505623|NCT01386736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153505624|NCT01386736|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153505625|NCT01386853|Atorvastatin|atorvastatin|mesh-list
153505626|NCT01386853|Pitavastatin|pitavastatin|mesh-list
153505627|NCT01386853|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153505628|NCT01386853|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153505629|NCT01386853|Antimetabolites|antimetabolites|mesh-ancestor
153505630|NCT01386853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153505631|NCT01386853|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153505632|NCT01386853|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
153505633|NCT01386853|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153505634|NCT01386866|Motesanib diphosphate|motesanib diphosphate|mesh-list
153505635|NCT01386866|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153505636|NCT01386866|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153505637|NCT01386866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153505638|NCT01386879|Methylene Blue|methylene blue|mesh-list
153505639|NCT01386879|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153505640|NCT01386879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153505641|NCT01386996|Budesonide|budesonide|mesh-list
153505642|NCT01386996|Formoterol Fumarate|formoterol fumarate|mesh-list
153505643|NCT01386996|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
153505644|NCT01386996|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153505652|NCT01386996|Hormones|hormones|mesh-ancestor
153505653|NCT01386996|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153505654|NCT01386996|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
153505655|NCT01386996|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
153505656|NCT01386996|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153505657|NCT01386996|Adrenergic Agents|adrenergic agents|mesh-ancestor
153505658|NCT01386996|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153505659|NCT01386996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153505661|NCT01387048|Azelaic acid|azelaic acid|mesh-list
153505662|NCT01387048|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153505664|NCT01387048|Analgesics|analgesics|mesh-ancestor
153505665|NCT01387048|Sensory System Agents|sensory system agents|mesh-ancestor
153505666|NCT01387048|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153505667|NCT01387048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153505668|NCT01387048|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153551369|NCT01571323|Abortifacient Agents|abortifacient agents|mesh-ancestor
153505669|NCT01387048|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153505670|NCT01387048|Dermatologic Agents|dermatologic agents|mesh-ancestor
153505671|NCT01387048|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153505672|NCT01387087|Peficitinib|peficitinib|mesh-list
153505673|NCT01387087|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153505674|NCT01387087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153505675|NCT01387087|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153505676|NCT01387087|Immunologic Factors|immunologic factors|mesh-ancestor
153505677|NCT01387087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153505678|NCT01387191|Epoprostenol|epoprostenol|mesh-list
153505680|NCT01387191|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153505681|NCT01387191|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153505682|NCT01387191|Vasodilator Agents|vasodilator agents|mesh-ancestor
153505683|NCT01387204|Trametinib|trametinib|mesh-list
153505684|NCT01387204|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153505686|NCT01387204|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153505692|NCT01387243|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153505694|NCT01387373|Oxaliplatin|oxaliplatin|mesh-list
153505695|NCT01387373|Trastuzumab|trastuzumab|mesh-list
153505696|NCT01387373|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153505697|NCT01387373|Antimetabolites|antimetabolites|mesh-ancestor
153505698|NCT01387373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153505699|NCT01387373|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153505700|NCT01387373|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153505701|NCT01387399|Cisplatin|cisplatin|mesh-list
153505702|NCT01387399|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153505703|NCT01387425|Varenicline|varenicline|mesh-list
153505704|NCT01387425|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
153505705|NCT01387425|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
153505706|NCT01387425|Cholinergic Agents|cholinergic agents|mesh-ancestor
153505707|NCT01387425|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153505708|NCT01387425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153505709|NCT01387425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153505710|NCT01387568|Lidocaine|lidocaine|mesh-list
153505711|NCT01387568|Anesthetics, Local|anesthetics, local|mesh-ancestor
153505712|NCT01387568|Anesthetics|anesthetics|mesh-ancestor
153505713|NCT01387568|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153505714|NCT01387568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153505715|NCT01387568|Sensory System Agents|sensory system agents|mesh-ancestor
153505716|NCT01387568|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153505717|NCT01387568|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153505728|NCT01387880|Everolimus|everolimus|mesh-list
153505740|NCT01387997|Immunologic Factors|immunologic factors|mesh-ancestor
153505741|NCT01387997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153505742|NCT01388023|Chlorhexidine|chlorhexidine|mesh-list
153505743|NCT01388023|Listerine|listerine|mesh-list
153505744|NCT01388023|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
153505745|NCT01388023|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153505746|NCT01388023|Disinfectants|disinfectants|mesh-ancestor
153505747|NCT01388036|Esmolol|esmolol|mesh-list
153505748|NCT01388036|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
153505749|NCT01388036|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
153505750|NCT01388036|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
153505751|NCT01388036|Adrenergic Agents|adrenergic agents|mesh-ancestor
153505752|NCT01388036|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153505753|NCT01388036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153505754|NCT01388036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153505755|NCT01388049|Antibodies|antibodies|mesh-list
153505756|NCT01388049|Immunologic Factors|immunologic factors|mesh-ancestor
153505757|NCT01388049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153505758|NCT01388062|Antibodies|antibodies|mesh-list
153505759|NCT01388062|Immunologic Factors|immunologic factors|mesh-ancestor
153505760|NCT01388062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153505761|NCT01388075|Rifampin|rifampin|mesh-list
153505762|NCT01388075|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
153505763|NCT01388075|Antitubercular Agents|antitubercular agents|mesh-ancestor
153505764|NCT01388075|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153505765|NCT01388075|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153505766|NCT01388075|Leprostatic Agents|leprostatic agents|mesh-ancestor
153505776|NCT01388088|Amiloride|amiloride|mesh-list
153505785|NCT01388088|Acid Sensing Ion Channel Blockers|acid sensing ion channel blockers|mesh-ancestor
153505786|NCT01388088|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153505787|NCT01388088|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153505788|NCT01388088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153505789|NCT01388088|Epithelial Sodium Channel Blockers|epithelial sodium channel blockers|mesh-ancestor
153505790|NCT01388101|Antibodies|antibodies|mesh-list
153505791|NCT01388101|Immunologic Factors|immunologic factors|mesh-ancestor
153505792|NCT01388101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153505793|NCT01388114|Antibodies|antibodies|mesh-list
153505794|NCT01388114|Immunologic Factors|immunologic factors|mesh-ancestor
153505795|NCT01388114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153505796|NCT01388153|Acarbose|acarbose|mesh-list
153505797|NCT01388153|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
153505798|NCT01388153|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153505799|NCT01388153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153505800|NCT01388153|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153505842|NCT01388582|Etonogestrel|etonogestrel|mesh-list
153505843|NCT01388582|Desogestrel|desogestrel|mesh-list
153505844|NCT01388582|Contraceptives, Oral|contraceptives, oral|mesh-list
153505845|NCT01388582|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153505846|NCT01388582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153505847|NCT01388582|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
153505848|NCT01388582|Trace Elements|trace elements|mesh-ancestor
153505849|NCT01388582|Micronutrients|micronutrients|mesh-ancestor
153505850|NCT01388582|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
153505851|NCT01388582|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
153505852|NCT01388582|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
153505853|NCT01388582|Progestins|progestins|mesh-ancestor
153505854|NCT01388582|Hormones|hormones|mesh-ancestor
153505855|NCT01388582|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153505856|NCT01388595|Fluticasone|fluticasone|mesh-list
153505857|NCT01388595|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
153505858|NCT01388595|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153505859|NCT01388595|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153505860|NCT01388595|Autonomic Agents|autonomic agents|mesh-ancestor
153505861|NCT01388595|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153724439|NCT00450736|Celecoxib|celecoxib|mesh-list
153505862|NCT01388595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153505865|NCT01388595|Dermatologic Agents|dermatologic agents|mesh-ancestor
153505894|NCT01388660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153505895|NCT01388660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153505896|NCT01388738|Cerebrolysin|cerebrolysin|mesh-list
153505897|NCT01388738|Cytidine Diphosphate Choline|cytidine diphosphate choline|mesh-list
153505898|NCT01388738|Nootropic Agents|nootropic agents|mesh-ancestor
153505899|NCT01388738|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
153505900|NCT01388738|Protective Agents|protective agents|mesh-ancestor
153505901|NCT01388738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153505902|NCT01388842|Nitric Oxide|nitric oxide|mesh-list
153505903|NCT01388842|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153505904|NCT01388842|Autonomic Agents|autonomic agents|mesh-ancestor
153505956|NCT01389193|Vasodilator Agents|vasodilator agents|mesh-ancestor
153505958|NCT01389206|Selexipag|selexipag|mesh-list
153505959|NCT01389206|Iloprost|iloprost|mesh-list
153505960|NCT01389206|Macitentan|macitentan|mesh-list
153505961|NCT01389206|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153505962|NCT01389206|Vasodilator Agents|vasodilator agents|mesh-ancestor
153505963|NCT01389206|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153505964|NCT01389206|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
153505965|NCT01389206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153505966|NCT01389206|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
153505967|NCT01389206|Endothelin B Receptor Antagonists|endothelin b receptor antagonists|mesh-ancestor
153505968|NCT01389271|Iloprost|iloprost|mesh-list
153505969|NCT01389271|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153505970|NCT01389271|Vasodilator Agents|vasodilator agents|mesh-ancestor
153505971|NCT01389388|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
153505973|NCT01389388|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153505974|NCT01389388|Antimetabolites|antimetabolites|mesh-ancestor
153505975|NCT01389388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153505976|NCT01389388|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153505977|NCT01389388|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
153505978|NCT01389388|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153505979|NCT01389401|Omeprazole|omeprazole|mesh-list
153505980|NCT01389401|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
153505981|NCT01389401|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153505982|NCT01389401|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
153505983|NCT01389401|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153724541|NCT00458458|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
153505984|NCT01389401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153505985|NCT01389414|Gemcitabine|gemcitabine|mesh-list
153505986|NCT01389414|Oxaliplatin|oxaliplatin|mesh-list
153506001|NCT01389427|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153506002|NCT01389427|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153506003|NCT01389427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153506004|NCT01389427|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153506005|NCT01389427|Immunologic Factors|immunologic factors|mesh-ancestor
153506006|NCT01389427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153506007|NCT01389427|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153506008|NCT01389427|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153506009|NCT01389427|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153506010|NCT01389427|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153506011|NCT01389427|Antifungal Agents|antifungal agents|mesh-ancestor
153506012|NCT01389427|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153506013|NCT01389427|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153506014|NCT01389427|Alkylating Agents|alkylating agents|mesh-ancestor
153506015|NCT01389427|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153506016|NCT01389427|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153506017|NCT01389427|Glucocorticoids|glucocorticoids|mesh-ancestor
153506018|NCT01389427|Hormones|hormones|mesh-ancestor
153545904|NCT06297499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153506053|NCT01389544|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153506054|NCT01389544|Antiviral Agents|antiviral agents|mesh-ancestor
153506055|NCT01389544|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153506056|NCT01389544|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
153724638|NCT00401804|Glucocorticoids|glucocorticoids|mesh-ancestor
153506057|NCT01389544|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153506058|NCT01389544|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153506059|NCT01389544|Narcotics|narcotics|mesh-ancestor
153506060|NCT01389544|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153506061|NCT01389544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153506062|NCT01389544|Analgesics|analgesics|mesh-ancestor
153506063|NCT01389544|Sensory System Agents|sensory system agents|mesh-ancestor
153506064|NCT01389544|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153506065|NCT01389544|Antitussive Agents|antitussive agents|mesh-ancestor
153506066|NCT01389544|Respiratory System Agents|respiratory system agents|mesh-ancestor
153506067|NCT01389557|Primaquine|primaquine|mesh-list
153506068|NCT01389557|Piperaquine|piperaquine|mesh-list
153506069|NCT01389557|Artenimol|artenimol|mesh-list
153506070|NCT01389557|Antimalarials|antimalarials|mesh-ancestor
153506071|NCT01389557|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153506074|NCT01389609|Doxazosin|doxazosin|mesh-list
153506109|NCT01389791|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153506110|NCT01389791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153506111|NCT01389791|Anesthetics|anesthetics|mesh-ancestor
153506112|NCT01389791|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153506113|NCT01389791|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153506114|NCT01389791|Anticonvulsants|anticonvulsants|mesh-ancestor
153506115|NCT01389791|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153506116|NCT01389791|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153506117|NCT01389791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153506118|NCT01389791|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153506120|NCT01389791|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153506121|NCT01389791|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
153506122|NCT01389791|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
153506123|NCT01389791|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
153506124|NCT01389908|Olanzapine|olanzapine|mesh-list
153506125|NCT01389908|Antiemetics|antiemetics|mesh-ancestor
153506126|NCT01389908|Autonomic Agents|autonomic agents|mesh-ancestor
153506127|NCT01389908|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153506129|NCT01389908|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153506162|NCT01390051|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153506163|NCT01390051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153506164|NCT01390311|Azacitidine|azacitidine|mesh-list
153506165|NCT01390311|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153506166|NCT01390311|Antimetabolites|antimetabolites|mesh-ancestor
153506167|NCT01390311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153506168|NCT01390311|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153506169|NCT01390311|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153506171|NCT01390324|Naratriptan|naratriptan|mesh-list
153506172|NCT01390324|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153506173|NCT01390324|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153506174|NCT01390324|Analgesics|analgesics|mesh-ancestor
153506175|NCT01390324|Sensory System Agents|sensory system agents|mesh-ancestor
153506176|NCT01390324|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153506177|NCT01390324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153506178|NCT01390324|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153506179|NCT01390324|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153506180|NCT01390324|Gout Suppressants|gout suppressants|mesh-ancestor
153506181|NCT01390324|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153506182|NCT01390324|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153506183|NCT01390324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153506184|NCT01390324|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
153506185|NCT01390324|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
153506186|NCT01390324|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
153506187|NCT01390324|Serotonin Agents|serotonin agents|mesh-ancestor
153506188|NCT01390324|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153506189|NCT01390337|Cytarabine|cytarabine|mesh-list
153506190|NCT01390337|Daunorubicin|daunorubicin|mesh-list
153506191|NCT01390337|Quizartinib|quizartinib|mesh-list
153506192|NCT01390337|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153506193|NCT01390337|Antimetabolites|antimetabolites|mesh-ancestor
153506194|NCT01390337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153506195|NCT01390337|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153506202|NCT01390337|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153506203|NCT01390337|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153506204|NCT01390337|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153506205|NCT01390337|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153506206|NCT01390337|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153506208|NCT01390480|Vitamin D|vitamin d|mesh-list
153506209|NCT01390480|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153506210|NCT01390480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153506211|NCT01390480|Vitamins|vitamins|mesh-ancestor
153506212|NCT01390480|Micronutrients|micronutrients|mesh-ancestor
153506213|NCT01390480|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153506214|NCT01390506|Selenious Acid|selenious acid|mesh-list
153506215|NCT01390506|Sodium Selenite|sodium selenite|mesh-list
153506216|NCT01390506|Trace Elements|trace elements|mesh-ancestor
153506217|NCT01390506|Micronutrients|micronutrients|mesh-ancestor
153506218|NCT01390506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153506219|NCT01390519|Everolimus|everolimus|mesh-list
153506220|NCT01390519|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
153506221|NCT01390519|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153506222|NCT01390519|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153506223|NCT01390519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153506224|NCT01390519|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153506225|NCT01390519|Immunologic Factors|immunologic factors|mesh-ancestor
153506226|NCT01390519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153506227|NCT01390519|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153506228|NCT01390571|Temozolomide|temozolomide|mesh-list
153506229|NCT01390571|Olaparib|olaparib|mesh-list
153506251|NCT01390766|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153506252|NCT01390766|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153506253|NCT01390766|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153506254|NCT01390766|Immunologic Factors|immunologic factors|mesh-ancestor
153506255|NCT01390766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153506256|NCT01390766|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153506258|NCT01390792|Antiviral Agents|antiviral agents|mesh-ancestor
153506259|NCT01390792|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153506260|NCT01390792|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153506261|NCT01390792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153506262|NCT01390805|Valacyclovir|valacyclovir|mesh-list
153506263|NCT01390805|Antiviral Agents|antiviral agents|mesh-ancestor
153506264|NCT01390805|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153506265|NCT01390883|PENTA|penta|mesh-list
153506266|NCT01390883|Fondaparinux|fondaparinux|mesh-list
153506267|NCT01390883|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
153506268|NCT01390883|Antithrombins|antithrombins|mesh-ancestor
153506269|NCT01390883|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
153506270|NCT01390883|Protease Inhibitors|protease inhibitors|mesh-ancestor
153506271|NCT01390883|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153506307|NCT01390961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153506308|NCT01390961|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153506309|NCT01390961|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153506310|NCT01390961|Adrenergic Agents|adrenergic agents|mesh-ancestor
153506311|NCT01390961|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153506312|NCT01390961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153506313|NCT01390961|Nasal Decongestants|nasal decongestants|mesh-ancestor
153506314|NCT01390961|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
153506315|NCT01390961|Respiratory System Agents|respiratory system agents|mesh-ancestor
153506316|NCT01390961|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
153506317|NCT01390961|Histamine Antagonists|histamine antagonists|mesh-ancestor
153506318|NCT01390961|Histamine Agents|histamine agents|mesh-ancestor
153506319|NCT01390961|Antipruritics|antipruritics|mesh-ancestor
153506320|NCT01390961|Dermatologic Agents|dermatologic agents|mesh-ancestor
153506321|NCT01390961|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
153506323|NCT01391052|Norethindrone Acetate|norethindrone acetate|mesh-list
153506324|NCT01391052|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
153506325|NCT01391052|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
153506326|NCT01391052|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
153506327|NCT01391052|Contraceptive Agents|contraceptive agents|mesh-ancestor
153506328|NCT01391052|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153506329|NCT01391052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153506332|NCT01391104|Sildenafil Citrate|sildenafil citrate|mesh-list
153506354|NCT01391221|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153506355|NCT01391221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153506356|NCT01391221|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153506357|NCT01391221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153506358|NCT01391221|Analgesics|analgesics|mesh-ancestor
153506359|NCT01391221|Sensory System Agents|sensory system agents|mesh-ancestor
153506360|NCT01391221|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153506361|NCT01391221|Antidepressive Agents|antidepressive agents|mesh-ancestor
153506362|NCT01391221|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153506363|NCT01391221|Dopamine Agents|dopamine agents|mesh-ancestor
153506364|NCT01391260|Gefitinib|gefitinib|mesh-list
153724955|NCT00462397|Paclitaxel|paclitaxel|mesh-list
153506365|NCT01391260|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153506366|NCT01391260|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153506367|NCT01391260|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153506368|NCT01391260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153506369|NCT01391260|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153506371|NCT01391377|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153506372|NCT01391377|Antimetabolites|antimetabolites|mesh-ancestor
153506373|NCT01391377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153506374|NCT01391377|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153506375|NCT01391377|Vasodilator Agents|vasodilator agents|mesh-ancestor
153506376|NCT01391377|Vitamin B Complex|vitamin b complex|mesh-ancestor
153506377|NCT01391377|Vitamins|vitamins|mesh-ancestor
153506378|NCT01391377|Micronutrients|micronutrients|mesh-ancestor
153506379|NCT01391377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153506380|NCT01391390|Melatonin|melatonin|mesh-list
153506381|NCT01391390|Antioxidants|antioxidants|mesh-ancestor
153506383|NCT01391390|Protective Agents|protective agents|mesh-ancestor
153506399|NCT01391572|Antimetabolites|antimetabolites|mesh-ancestor
153506400|NCT01391572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153506401|NCT01391572|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153506402|NCT01391572|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153506403|NCT01391572|Immunologic Factors|immunologic factors|mesh-ancestor
153506404|NCT01391572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153506405|NCT01391598|Lidocaine|lidocaine|mesh-list
153506406|NCT01391598|Anesthetics, Local|anesthetics, local|mesh-ancestor
153506407|NCT01391598|Anesthetics|anesthetics|mesh-ancestor
153506408|NCT01391598|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153506409|NCT01391598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153506410|NCT01391598|Sensory System Agents|sensory system agents|mesh-ancestor
153506411|NCT01391598|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153506412|NCT01391598|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153506413|NCT01391598|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
153506414|NCT01391598|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153506415|NCT01391598|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153506416|NCT01391598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153506417|NCT01391624|Mineral Oil|mineral oil|mesh-list
153506418|NCT01391624|Emollients|emollients|mesh-ancestor
153506419|NCT01391624|Dermatologic Agents|dermatologic agents|mesh-ancestor
153506420|NCT01391689|3,3'-diindolylmethane|3,3'-diindolylmethane|mesh-list
153506421|NCT01391689|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
153506422|NCT01391689|Protective Agents|protective agents|mesh-ancestor
153506423|NCT01391689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153506424|NCT01391689|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153506425|NCT01391715|Rabeprazole|rabeprazole|mesh-list
153506426|NCT01391715|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
153506427|NCT01391715|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153506428|NCT01391715|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
153506443|NCT01392014|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153506444|NCT01392014|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153506445|NCT01392079|Alemtuzumab|alemtuzumab|mesh-list
153506446|NCT01392079|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153506447|NCT01392079|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153506448|NCT01392144|Nitric Oxide|nitric oxide|mesh-list
153506449|NCT01392144|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153506450|NCT01392144|Autonomic Agents|autonomic agents|mesh-ancestor
153506451|NCT01392144|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153506452|NCT01392144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153506453|NCT01392144|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153506454|NCT01392144|Respiratory System Agents|respiratory system agents|mesh-ancestor
153506455|NCT01392144|Free Radical Scavengers|free radical scavengers|mesh-ancestor
153506456|NCT01392144|Antioxidants|antioxidants|mesh-ancestor
153506457|NCT01392144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153506458|NCT01392144|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153506459|NCT01392144|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
153506460|NCT01392144|Vasodilator Agents|vasodilator agents|mesh-ancestor
153506461|NCT01392144|Gasotransmitters|gasotransmitters|mesh-ancestor
153506462|NCT01392144|Protective Agents|protective agents|mesh-ancestor
153506463|NCT01392157|Copper|copper|mesh-list
153506464|NCT01392157|Levonorgestrel|levonorgestrel|mesh-list
153506465|NCT01392157|Trace Elements|trace elements|mesh-ancestor
153506466|NCT01392157|Micronutrients|micronutrients|mesh-ancestor
153506468|NCT01392157|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
153506469|NCT01392157|Contraceptive Agents|contraceptive agents|mesh-ancestor
153506470|NCT01392157|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153506471|NCT01392157|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
153506472|NCT01392157|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
153506473|NCT01392157|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
153506484|NCT01392287|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
153506485|NCT01392287|Dopamine Agents|dopamine agents|mesh-ancestor
153506486|NCT01392287|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153506487|NCT01392287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153506488|NCT01392287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153506489|NCT01392287|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
153506490|NCT01392287|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
153506491|NCT01392430|Azithromycin|azithromycin|mesh-list
153506492|NCT01392430|Dapsone|dapsone|mesh-list
153506493|NCT01392430|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
153506494|NCT01392430|Itraconazole|itraconazole|mesh-list
153506495|NCT01392430|Fluconazole|fluconazole|mesh-list
153506496|NCT01392430|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153506497|NCT01392430|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153506498|NCT01392430|Antifungal Agents|antifungal agents|mesh-ancestor
153506499|NCT01392430|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
153506500|NCT01392430|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153506501|NCT01392430|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153506502|NCT01392430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153506503|NCT01392430|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153506535|NCT01392638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153506536|NCT01392638|Urological Agents|urological agents|mesh-ancestor
153506538|NCT01392716|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153506539|NCT01392716|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153506540|NCT01392716|Immunologic Factors|immunologic factors|mesh-ancestor
153506541|NCT01392716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153506542|NCT01392716|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153506544|NCT01392755|Omeprazole|omeprazole|mesh-list
153506545|NCT01392755|Ranitidine|ranitidine|mesh-list
153506546|NCT01392755|Ranitidine bismuth citrate|ranitidine bismuth citrate|mesh-list
153506547|NCT01392755|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
153725090|NCT00463762|Sulbactam|sulbactam|mesh-list
153506548|NCT01392755|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
153506549|NCT01392755|Protease Inhibitors|protease inhibitors|mesh-ancestor
153506550|NCT01392755|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153506551|NCT01392755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153506596|NCT01392833|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153506597|NCT01392833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153506598|NCT01392833|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153506599|NCT01392833|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153506601|NCT01392833|Autonomic Agents|autonomic agents|mesh-ancestor
153506602|NCT01392833|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153506603|NCT01392833|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153506604|NCT01392833|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
153506605|NCT01392833|Protective Agents|protective agents|mesh-ancestor
153506606|NCT01392833|Antimetabolites|antimetabolites|mesh-ancestor
153506607|NCT01392833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153506608|NCT01392833|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153506609|NCT01392833|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153506610|NCT01392833|Immunologic Factors|immunologic factors|mesh-ancestor
153506611|NCT01392833|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153506613|NCT01392898|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153506614|NCT01392898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153506648|NCT01393145|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
153506650|NCT01393145|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153506651|NCT01393145|Autonomic Agents|autonomic agents|mesh-ancestor
153506652|NCT01393145|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153506653|NCT01393145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153506654|NCT01393145|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153506655|NCT01393145|Respiratory System Agents|respiratory system agents|mesh-ancestor
153506656|NCT01393145|Dermatologic Agents|dermatologic agents|mesh-ancestor
153506657|NCT01393145|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
153725126|NCT00463957|Tadalafil|tadalafil|mesh-list
153506659|NCT01393145|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
153506660|NCT01393145|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153506661|NCT01393145|Adrenergic Agents|adrenergic agents|mesh-ancestor
153506662|NCT01393145|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153506663|NCT01393145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153506664|NCT01393145|Glucocorticoids|glucocorticoids|mesh-ancestor
153506665|NCT01393145|Hormones|hormones|mesh-ancestor
153506666|NCT01393145|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153506667|NCT01393145|Sympathomimetics|sympathomimetics|mesh-ancestor
153506668|NCT01393184|Nimotuzumab|nimotuzumab|mesh-list
153506669|NCT01393184|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153506670|NCT01393184|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153506671|NCT01393288|Lorazepam|lorazepam|mesh-list
153506672|NCT01393288|Ondansetron|ondansetron|mesh-list
153506673|NCT01393288|Aprepitant|aprepitant|mesh-list
153506674|NCT01393288|Antiemetics|antiemetics|mesh-ancestor
153506675|NCT01393288|Autonomic Agents|autonomic agents|mesh-ancestor
153506676|NCT01393288|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153506677|NCT01393288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153506678|NCT01393288|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153506679|NCT01393288|Antipruritics|antipruritics|mesh-ancestor
153506689|NCT01393288|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153506690|NCT01393288|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153506691|NCT01393288|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153506692|NCT01393288|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153506693|NCT01393288|GABA Modulators|gaba modulators|mesh-ancestor
153506694|NCT01393288|GABA Agents|gaba agents|mesh-ancestor
153506695|NCT01393340|Omalizumab|omalizumab|mesh-list
153506696|NCT01393340|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
153506697|NCT01393340|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153506698|NCT01393340|Respiratory System Agents|respiratory system agents|mesh-ancestor
153506699|NCT01393548|Brompheniramine|brompheniramine|mesh-list
153506700|NCT01393548|Phenylephrine|phenylephrine|mesh-list
153506701|NCT01393548|Oxymetazoline|oxymetazoline|mesh-list
153506702|NCT01393548|Pseudoephedrine|pseudoephedrine|mesh-list
153506703|NCT01393548|Ephedrine|ephedrine|mesh-list
153506704|NCT01393548|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
153506709|NCT01393548|Sympathomimetics|sympathomimetics|mesh-ancestor
153506744|NCT01393769|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153506745|NCT01393769|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153506746|NCT01393769|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153506747|NCT01393769|Immunologic Factors|immunologic factors|mesh-ancestor
153506748|NCT01393769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153506749|NCT01393782|Angiotensin II|angiotensin ii|mesh-list
153506750|NCT01393782|Giapreza|giapreza|mesh-list
153506751|NCT01393782|Angiotensinogen|angiotensinogen|mesh-list
153506752|NCT01393782|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
153506753|NCT01393782|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
153506754|NCT01393782|Protease Inhibitors|protease inhibitors|mesh-ancestor
153506755|NCT01393782|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153506758|NCT01393912|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153506760|NCT01393925|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
153506761|NCT01393925|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153506762|NCT01393925|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153781901|NCT00232115|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153449860|NCT00004433|Pergolide|pergolide|mesh-list
153506763|NCT01393925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153506764|NCT01393925|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153506765|NCT01393925|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153506767|NCT01393925|Sensory System Agents|sensory system agents|mesh-ancestor
153506768|NCT01393925|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153506769|NCT01393925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153506770|NCT01393925|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153506771|NCT01393925|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153506772|NCT01394029|Deferasirox|deferasirox|mesh-list
153506787|NCT01394133|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153506788|NCT01394133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153506790|NCT01394133|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153506791|NCT01394133|Antiviral Agents|antiviral agents|mesh-ancestor
153506792|NCT01394133|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153506793|NCT01394133|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
153506794|NCT01394133|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153506795|NCT01394133|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153506796|NCT01394133|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153506797|NCT01394224|Levetiracetam|levetiracetam|mesh-list
153506798|NCT01394224|Anticonvulsants|anticonvulsants|mesh-ancestor
153506799|NCT01394224|Nootropic Agents|nootropic agents|mesh-ancestor
153506800|NCT01394341|Liraglutide|liraglutide|mesh-list
153506801|NCT01394341|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
153506802|NCT01394341|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153506803|NCT01394341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153506804|NCT01394341|Incretins|incretins|mesh-ancestor
153506805|NCT01394341|Hormones|hormones|mesh-ancestor
153506806|NCT01394341|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153506807|NCT01394354|Dexamethasone|dexamethasone|mesh-list
153506808|NCT01394354|Dexamethasone acetate|dexamethasone acetate|mesh-list
153506838|NCT01394406|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153725440|NCT00117182|Hormones|hormones|mesh-ancestor
153506839|NCT01394406|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
153506840|NCT01394406|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
153506841|NCT01394406|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153506842|NCT01394406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153506843|NCT01394419|Acetylcysteine|acetylcysteine|mesh-list
153506844|NCT01394419|N-monoacetylcystine|n-monoacetylcystine|mesh-list
153506845|NCT01394419|Antiviral Agents|antiviral agents|mesh-ancestor
153506846|NCT01394419|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153506847|NCT01394419|Expectorants|expectorants|mesh-ancestor
153506848|NCT01394419|Respiratory System Agents|respiratory system agents|mesh-ancestor
153506849|NCT01394419|Free Radical Scavengers|free radical scavengers|mesh-ancestor
153506850|NCT01394419|Antioxidants|antioxidants|mesh-ancestor
153506851|NCT01394419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153506852|NCT01394419|Protective Agents|protective agents|mesh-ancestor
153506853|NCT01394419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153506854|NCT01394419|Antidotes|antidotes|mesh-ancestor
153506855|NCT01394445|Physostigmine|physostigmine|mesh-list
153506856|NCT01394445|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
153506857|NCT01394445|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153506859|NCT01394445|Cholinergic Agents|cholinergic agents|mesh-ancestor
153506892|NCT01394497|Protective Agents|protective agents|mesh-ancestor
153506893|NCT01394497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153506894|NCT01394653|Ramosetron|ramosetron|mesh-list
153506895|NCT01394653|Antiemetics|antiemetics|mesh-ancestor
153506896|NCT01394653|Autonomic Agents|autonomic agents|mesh-ancestor
153506897|NCT01394653|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153506898|NCT01394653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153506899|NCT01394653|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153506900|NCT01394653|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153506901|NCT01394653|Serotonin Agents|serotonin agents|mesh-ancestor
153506902|NCT01394653|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153506903|NCT01394653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153506904|NCT01394679|Deoxyglucose|deoxyglucose|mesh-list
153506905|NCT01394679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153506906|NCT01394679|Antimetabolites|antimetabolites|mesh-ancestor
153506907|NCT01394679|Antiviral Agents|antiviral agents|mesh-ancestor
153506950|NCT01394796|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153506951|NCT01394796|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
153506953|NCT01394835|Protein C Inhibitor|protein c inhibitor|mesh-list
153506954|NCT01394835|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
153506955|NCT01394835|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
153506956|NCT01394835|Protease Inhibitors|protease inhibitors|mesh-ancestor
153506957|NCT01394835|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153506958|NCT01394835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153506959|NCT01394848|Everolimus|everolimus|mesh-list
153506960|NCT01394848|Clopidogrel|clopidogrel|mesh-list
153506961|NCT01394848|Atorvastatin|atorvastatin|mesh-list
153506962|NCT01394848|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153506963|NCT01394848|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153506964|NCT01394848|Antimetabolites|antimetabolites|mesh-ancestor
153506965|NCT01394848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153506966|NCT01394848|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153506967|NCT01394848|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
153506968|NCT01394848|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153506969|NCT01394848|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
153506970|NCT01394848|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153506971|NCT01394848|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153506972|NCT01394848|Immunologic Factors|immunologic factors|mesh-ancestor
153507001|NCT01395069|Sensory System Agents|sensory system agents|mesh-ancestor
153725621|NCT00117455|Immunologic Factors|immunologic factors|mesh-ancestor
153507002|NCT01395069|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153507003|NCT01395069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153507004|NCT01395069|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153507005|NCT01395069|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153507006|NCT01395069|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153507007|NCT01395069|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153507008|NCT01395069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153507009|NCT01395108|Nemonoxacin|nemonoxacin|mesh-list
153507010|NCT01395108|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153507011|NCT01395108|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153507012|NCT01395121|Nilotinib|nilotinib|mesh-list
153507013|NCT01395121|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153507014|NCT01395121|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153507015|NCT01395121|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153507016|NCT01395121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153507017|NCT01395147|Vortioxetine|vortioxetine|mesh-list
153725768|NCT00117273|Estradiol|estradiol|mesh-list
153507019|NCT01395147|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153507020|NCT01395147|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153507021|NCT01395147|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153507022|NCT01395147|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153507023|NCT01395147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153507024|NCT01395147|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
153507028|NCT01395147|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153507048|NCT01395251|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153507049|NCT01395251|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153507050|NCT01395290|Cholecalciferol|cholecalciferol|mesh-list
153507051|NCT01395290|Vitamin D|vitamin d|mesh-list
153507052|NCT01395290|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153507053|NCT01395290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153507054|NCT01395290|Vitamins|vitamins|mesh-ancestor
153507055|NCT01395290|Micronutrients|micronutrients|mesh-ancestor
153507056|NCT01395290|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153507057|NCT01395381|Albendazole|albendazole|mesh-list
153507058|NCT01395381|Anthelmintics|anthelmintics|mesh-ancestor
153507059|NCT01395381|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153507060|NCT01395381|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153507061|NCT01395381|Anticestodal Agents|anticestodal agents|mesh-ancestor
153551548|NCT01572116|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
153507062|NCT01395381|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
153507063|NCT01395381|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153507064|NCT01395381|Tubulin Modulators|tubulin modulators|mesh-ancestor
153507065|NCT01395381|Antimitotic Agents|antimitotic agents|mesh-ancestor
153507066|NCT01395381|Mitosis Modulators|mitosis modulators|mesh-ancestor
153551554|NCT01572116|Anesthetics, General|anesthetics, general|mesh-ancestor
153507067|NCT01395381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153507068|NCT01395381|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153507069|NCT01395420|Ceftazidime|ceftazidime|mesh-list
153507070|NCT01395420|Avibactam|avibactam|mesh-list
153507071|NCT01395420|Third Generation Cephalosporins|third generation cephalosporins|mesh-ancestor
153507097|NCT01395433|Antidepressive Agents|antidepressive agents|mesh-ancestor
153507098|NCT01395433|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153507100|NCT01395485|Dermatologic Agents|dermatologic agents|mesh-ancestor
153507101|NCT01395589|Vitamin D|vitamin d|mesh-list
153507102|NCT01395589|Vitamins|vitamins|mesh-ancestor
153507103|NCT01395589|Micronutrients|micronutrients|mesh-ancestor
153507104|NCT01395589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153507105|NCT01395589|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153507106|NCT01395602|Cabergoline|cabergoline|mesh-list
153507107|NCT01395602|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
153507108|NCT01395602|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
153507109|NCT01395602|Dopamine Agonists|dopamine agonists|mesh-ancestor
153507110|NCT01395602|Dopamine Agents|dopamine agents|mesh-ancestor
153507111|NCT01395602|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153725901|NCT00477061|Analgesics|analgesics|mesh-ancestor
153507112|NCT01395602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153507113|NCT01395602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153507114|NCT01395654|Rifampin|rifampin|mesh-list
153507115|NCT01395654|Isoniazid|isoniazid|mesh-list
153507116|NCT01395654|Pyrazinamide|pyrazinamide|mesh-list
153507117|NCT01395654|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
153507118|NCT01395654|Antitubercular Agents|antitubercular agents|mesh-ancestor
153507119|NCT01395654|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153507120|NCT01395654|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153507121|NCT01395654|Leprostatic Agents|leprostatic agents|mesh-ancestor
153507123|NCT01395654|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153507148|NCT01395667|Vitamins|vitamins|mesh-ancestor
153507149|NCT01395667|Micronutrients|micronutrients|mesh-ancestor
153507150|NCT01395732|Bosentan|bosentan|mesh-list
153507151|NCT01395732|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153507152|NCT01395732|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
153507153|NCT01395732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153507154|NCT01395849|Fluticasone|fluticasone|mesh-list
153507155|NCT01395849|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
153507156|NCT01395849|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
153507161|NCT01395849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153507162|NCT01395849|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153507163|NCT01395849|Respiratory System Agents|respiratory system agents|mesh-ancestor
153725959|NCT00478114|Sorafenib|sorafenib|mesh-list
153507164|NCT01395849|Dermatologic Agents|dermatologic agents|mesh-ancestor
153507165|NCT01395849|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
153507166|NCT01395849|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
153507167|NCT01395849|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
153507168|NCT01395849|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153507169|NCT01395849|Adrenergic Agents|adrenergic agents|mesh-ancestor
153507170|NCT01395849|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153507171|NCT01395849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153507172|NCT01395849|Glucocorticoids|glucocorticoids|mesh-ancestor
153507173|NCT01395849|Hormones|hormones|mesh-ancestor
153507174|NCT01395849|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153507175|NCT01395849|Sympathomimetics|sympathomimetics|mesh-ancestor
153507176|NCT01395862|Fluticasone|fluticasone|mesh-list
153507177|NCT01395862|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
153507178|NCT01395862|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
153507179|NCT01395862|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153507180|NCT01395862|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153507181|NCT01395862|Autonomic Agents|autonomic agents|mesh-ancestor
153507182|NCT01395862|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153507183|NCT01395862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153507185|NCT01395862|Respiratory System Agents|respiratory system agents|mesh-ancestor
153507186|NCT01395862|Dermatologic Agents|dermatologic agents|mesh-ancestor
153507187|NCT01395862|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
153507188|NCT01395862|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
153507189|NCT01395862|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
153507190|NCT01395862|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153507191|NCT01395862|Adrenergic Agents|adrenergic agents|mesh-ancestor
153507192|NCT01395862|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153507193|NCT01395862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153507194|NCT01395862|Glucocorticoids|glucocorticoids|mesh-ancestor
153507195|NCT01395862|Hormones|hormones|mesh-ancestor
153507196|NCT01395862|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153507197|NCT01395862|Sympathomimetics|sympathomimetics|mesh-ancestor
153507198|NCT01395875|Fluticasone|fluticasone|mesh-list
153507200|NCT01395875|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
153507201|NCT01395875|Cholinergic Antagonists|cholinergic antagonists|mesh-list
153507202|NCT01395875|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153507203|NCT01395875|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153507204|NCT01395875|Autonomic Agents|autonomic agents|mesh-ancestor
153507205|NCT01395875|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153507206|NCT01395875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153507207|NCT01395875|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153545905|NCT06294821|4-Aminopyridine|4-aminopyridine|mesh-list
153507209|NCT01395875|Dermatologic Agents|dermatologic agents|mesh-ancestor
153507233|NCT01395927|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
153507234|NCT01395927|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
153507235|NCT01395927|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153507236|NCT01395927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153507237|NCT01395953|Buspirone|buspirone|mesh-list
153507238|NCT01395953|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153507239|NCT01395953|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153507240|NCT01395953|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153507241|NCT01395953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153507242|NCT01395953|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153507243|NCT01395953|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
153507244|NCT01395953|Serotonin Agents|serotonin agents|mesh-ancestor
153507245|NCT01395953|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153507246|NCT01395953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153507247|NCT01395992|Asenapine|asenapine|mesh-list
153507248|NCT01395992|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153507249|NCT01395992|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153507250|NCT01395992|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153507251|NCT01395992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153507252|NCT01395992|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153507253|NCT01396200|Hydroxychloroquine|hydroxychloroquine|mesh-list
153507254|NCT01396200|Sirolimus|sirolimus|mesh-list
153507255|NCT01396200|Antimalarials|antimalarials|mesh-ancestor
153507256|NCT01396200|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153507257|NCT01396200|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153726266|NCT00480649|Xhance|xhance|mesh-list
153507258|NCT01396200|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153507259|NCT01396200|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153507260|NCT01396200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153507261|NCT01396200|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153507262|NCT01396200|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153507263|NCT01396200|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153507264|NCT01396200|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153507265|NCT01396200|Antifungal Agents|antifungal agents|mesh-ancestor
153507266|NCT01396200|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153507267|NCT01396200|Immunologic Factors|immunologic factors|mesh-ancestor
153507268|NCT01396200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153507269|NCT01396291|Asenapine|asenapine|mesh-list
153507270|NCT01396291|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153507271|NCT01396291|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153507272|NCT01396291|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153507273|NCT01396291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153507274|NCT01396291|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153507275|NCT01396304|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
153507276|NCT01396304|Calcium|calcium|mesh-list
153507277|NCT01396304|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153507278|NCT01396304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153507279|NCT01396304|Laxatives|laxatives|mesh-ancestor
153507280|NCT01396304|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153507281|NCT01396564|Metformin|metformin|mesh-list
153507282|NCT01396564|Pioglitazone|pioglitazone|mesh-list
153507283|NCT01396564|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153507286|NCT01396642|Dermatologic Agents|dermatologic agents|mesh-ancestor
153507287|NCT01396655|Docetaxel|docetaxel|mesh-list
153507325|NCT01396720|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153507326|NCT01396720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153507328|NCT01396720|Serotonin Agents|serotonin agents|mesh-ancestor
153507329|NCT01396720|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
153507330|NCT01396720|Antidepressive Agents|antidepressive agents|mesh-ancestor
153507331|NCT01396720|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
153507332|NCT01396720|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153507333|NCT01396720|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153507334|NCT01396720|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
153507335|NCT01396733|Thioctic Acid|thioctic acid|mesh-list
153507336|NCT01396733|Antioxidants|antioxidants|mesh-ancestor
153507337|NCT01396733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153507338|NCT01396733|Protective Agents|protective agents|mesh-ancestor
153507339|NCT01396733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153507340|NCT01396733|Vitamin B Complex|vitamin b complex|mesh-ancestor
153507341|NCT01396733|Vitamins|vitamins|mesh-ancestor
153507342|NCT01396733|Micronutrients|micronutrients|mesh-ancestor
153507343|NCT01397006|Pregabalin|pregabalin|mesh-list
153507344|NCT01397006|Analgesics|analgesics|mesh-ancestor
153507345|NCT01397006|Sensory System Agents|sensory system agents|mesh-ancestor
153507346|NCT01397006|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153551593|NCT01572285|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153551594|NCT01572285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153551595|NCT01572324|Leucovorin|leucovorin|mesh-list
153551596|NCT01572324|Capecitabine|capecitabine|mesh-list
153551597|NCT01572324|Fluorouracil|fluorouracil|mesh-list
153551598|NCT01572324|Oxaliplatin|oxaliplatin|mesh-list
153551599|NCT01572324|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153507348|NCT01397006|Anticonvulsants|anticonvulsants|mesh-ancestor
153507365|NCT01397019|Antidotes|antidotes|mesh-ancestor
153507366|NCT01397019|Protective Agents|protective agents|mesh-ancestor
153507367|NCT01397019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153507368|NCT01397019|Vitamin B Complex|vitamin b complex|mesh-ancestor
153507369|NCT01397019|Vitamins|vitamins|mesh-ancestor
153507370|NCT01397019|Micronutrients|micronutrients|mesh-ancestor
153507371|NCT01397097|Etonogestrel|etonogestrel|mesh-list
153507372|NCT01397097|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
153507373|NCT01397097|Contraceptive Agents|contraceptive agents|mesh-ancestor
153507374|NCT01397097|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153507375|NCT01397097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153507376|NCT01397097|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
153507377|NCT01397175|Everolimus|everolimus|mesh-list
153507378|NCT01397175|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
153507379|NCT01397175|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153507380|NCT01397175|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153507381|NCT01397175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153507382|NCT01397175|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153726583|NCT00483028|Nootropic Agents|nootropic agents|mesh-ancestor
153507384|NCT01397175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153507385|NCT01397175|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153507386|NCT01397214|Megestrol Acetate|megestrol acetate|mesh-list
153507387|NCT01397214|Megestrol|megestrol|mesh-list
153507388|NCT01397214|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153507389|NCT01397214|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153507390|NCT01397214|Appetite Stimulants|appetite stimulants|mesh-ancestor
153507391|NCT01397214|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
153507392|NCT01397214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153507393|NCT01397214|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
153507394|NCT01397214|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
153507395|NCT01397214|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
153507396|NCT01397214|Contraceptive Agents|contraceptive agents|mesh-ancestor
153507408|NCT01397331|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153507409|NCT01397331|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153507410|NCT01397331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153507411|NCT01397331|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153507412|NCT01397331|Anesthetics, General|anesthetics, general|mesh-ancestor
153507413|NCT01397331|Anesthetics|anesthetics|mesh-ancestor
153507414|NCT01397331|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
153507415|NCT05269290|Pentanedioic acid imidazolyl ethanamide|pentanedioic acid imidazolyl ethanamide|mesh-list
153507416|NCT05269290|Antiviral Agents|antiviral agents|mesh-ancestor
153507417|NCT05269290|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153507418|NCT05268835|Clindamycin|clindamycin|mesh-list
153507419|NCT05268835|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153507420|NCT05268835|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153507421|NCT05268835|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
153507422|NCT05268835|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153726852|NCT00120887|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153507423|NCT05268835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153507424|NCT05268718|Voriconazole|voriconazole|mesh-list
153507425|NCT05268718|Ophthalmic Solutions|ophthalmic solutions|mesh-list
153507426|NCT05268718|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
153507427|NCT05268718|Antifungal Agents|antifungal agents|mesh-ancestor
153507428|NCT05268718|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153507429|NCT05268718|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
153507430|NCT05268718|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153507431|NCT05268718|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153507432|NCT05268718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153507433|NCT05268718|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153507434|NCT05268718|Hormone Antagonists|hormone antagonists|mesh-ancestor
153507435|NCT05268718|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153507451|NCT05268068|Immunologic Factors|immunologic factors|mesh-ancestor
153507452|NCT05268068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153507453|NCT05267977|Cephalosporins|cephalosporins|mesh-list
153507454|NCT05267977|First Generation Cephalosporins|first generation cephalosporins|mesh-list
153507455|NCT05267977|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153507456|NCT05267977|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153507457|NCT05267977|Beta Lactam Antibiotics|beta lactam antibiotics|mesh-ancestor
153507458|NCT05186558|Rituximab|rituximab|mesh-list
153507459|NCT05186558|Gemcitabine|gemcitabine|mesh-list
153507460|NCT05186558|Oxaliplatin|oxaliplatin|mesh-list
153507461|NCT05186558|Lenalidomide|lenalidomide|mesh-list
153507462|NCT05186558|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153507463|NCT05186558|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153507464|NCT05186558|Immunologic Factors|immunologic factors|mesh-ancestor
153507465|NCT05186558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153507466|NCT05186558|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153507467|NCT05186558|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153727086|NCT00486772|Calcium|calcium|mesh-list
153507469|NCT05186558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153507470|NCT05186558|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153507471|NCT05186558|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153507472|NCT05186558|Growth Substances|growth substances|mesh-ancestor
153507473|NCT05186558|Growth Inhibitors|growth inhibitors|mesh-ancestor
153507503|NCT06104644|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153507504|NCT06104644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153507505|NCT06104423|Ramipril|ramipril|mesh-list
153507506|NCT06104423|Nebivolol|nebivolol|mesh-list
153507507|NCT06104423|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
153507508|NCT06104423|Protease Inhibitors|protease inhibitors|mesh-ancestor
153507509|NCT06104423|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153507510|NCT06104423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153507511|NCT06104423|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153507512|NCT06104423|Vasodilator Agents|vasodilator agents|mesh-ancestor
153507515|NCT06104423|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153507568|NCT06103188|GABA Modulators|gaba modulators|mesh-ancestor
153507569|NCT06103188|GABA Agents|gaba agents|mesh-ancestor
153507570|NCT06103188|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153507571|NCT06100497|Paclitaxel|paclitaxel|mesh-list
153507572|NCT06100497|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
153507573|NCT06100497|Pembrolizumab|pembrolizumab|mesh-list
153507574|NCT06100497|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153507575|NCT06100497|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153507576|NCT06100497|Tubulin Modulators|tubulin modulators|mesh-ancestor
153507577|NCT06100497|Antimitotic Agents|antimitotic agents|mesh-ancestor
153507578|NCT06100497|Mitosis Modulators|mitosis modulators|mesh-ancestor
153507579|NCT06100497|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153507580|NCT06100497|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153507581|NCT06100497|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153507583|NCT06066905|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153507584|NCT06066905|Antimetabolites|antimetabolites|mesh-ancestor
153507585|NCT06066905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153507586|NCT06066905|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153507587|NCT06066905|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153507622|NCT06037590|Dopamine Agents|dopamine agents|mesh-ancestor
153507623|NCT06037590|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153507624|NCT06037590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153507625|NCT06037590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153507626|NCT06011798|Aflibercept|aflibercept|mesh-list
153507627|NCT06011798|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153551643|NCT01572454|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153507628|NCT06011798|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153507629|NCT06011798|Growth Substances|growth substances|mesh-ancestor
153507630|NCT06011798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153507631|NCT06011798|Growth Inhibitors|growth inhibitors|mesh-ancestor
153507632|NCT06011798|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153507634|NCT05988710|Buprenorphine|buprenorphine|mesh-list
153507635|NCT05988710|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153507636|NCT05988710|Narcotics|narcotics|mesh-ancestor
153507637|NCT05988710|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153507638|NCT05988710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153507639|NCT05988710|Analgesics|analgesics|mesh-ancestor
153507640|NCT05988710|Sensory System Agents|sensory system agents|mesh-ancestor
153507641|NCT05988710|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153507642|NCT05988710|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
153507643|NCT05882357|Ivacaftor|ivacaftor|mesh-list
153507644|NCT05882357|Elexacaftor|elexacaftor|mesh-list
153551689|NCT01572597|Free Radical Scavengers|free radical scavengers|mesh-ancestor
153507645|NCT05882357|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
153507646|NCT05882357|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153507647|NCT05882357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153507648|NCT05879653|Pembrolizumab|pembrolizumab|mesh-list
153507649|NCT05879653|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153507650|NCT05879653|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153507651|NCT05879653|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153507652|NCT05879653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153507653|NCT05878288|Cemiplimab|cemiplimab|mesh-list
153507654|NCT05878288|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153507662|NCT05775809|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153507663|NCT05775809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153507664|NCT05775809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153507665|NCT05775809|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153507672|NCT05597878|Sensory System Agents|sensory system agents|mesh-ancestor
153507673|NCT05597878|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153507674|NCT05597878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153507675|NCT05597878|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
153507676|NCT05597878|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153507677|NCT05597878|Anesthetics, General|anesthetics, general|mesh-ancestor
153507678|NCT05597878|Anesthetics|anesthetics|mesh-ancestor
153507679|NCT05597878|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153727452|NCT00490243|Glucocorticoids|glucocorticoids|mesh-ancestor
153507680|NCT05597878|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
153507681|NCT05597878|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
153507682|NCT05597878|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153507683|NCT05597878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153507684|NCT05597878|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153507685|NCT05597878|Antipyretics|antipyretics|mesh-ancestor
153507686|NCT05597878|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153507687|NCT05597878|Narcotics|narcotics|mesh-ancestor
153507688|NCT05597878|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153507689|NCT05597878|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153507690|NCT05597878|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153507691|NCT05597878|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153507692|NCT05597878|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153507693|NCT05594589|Lemborexant|lemborexant|mesh-list
153507694|NCT05594589|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
153507695|NCT05594589|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153507696|NCT05594589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153507698|NCT05594589|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153507699|NCT05594589|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153507700|NCT05594589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153507701|NCT05584657|Amoxicillin|amoxicillin|mesh-list
153507702|NCT05584657|Clavulanic Acid|clavulanic acid|mesh-list
153507703|NCT05584657|Clavulanic Acids|clavulanic acids|mesh-list
153507704|NCT05584657|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
153507705|NCT05584657|Lactams|lactams|mesh-list
153507706|NCT05584657|Probenecid|probenecid|mesh-list
153507707|NCT05584657|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153507708|NCT05584657|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153507709|NCT05584657|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
153507710|NCT05584657|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153507711|NCT05584657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153507712|NCT05584657|Uricosuric Agents|uricosuric agents|mesh-ancestor
153507713|NCT05584657|Gout Suppressants|gout suppressants|mesh-ancestor
153507714|NCT05584657|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153507715|NCT05568615|Edaravone|edaravone|mesh-list
153507716|NCT05568615|Free Radical Scavengers|free radical scavengers|mesh-ancestor
153507717|NCT05568615|Antioxidants|antioxidants|mesh-ancestor
153507718|NCT05568615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153507719|NCT05568615|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
153507720|NCT05568615|Protective Agents|protective agents|mesh-ancestor
153507721|NCT05568615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153507722|NCT05509634|Dexamethasone|dexamethasone|mesh-list
153507723|NCT05509634|Dexamethasone acetate|dexamethasone acetate|mesh-list
153507724|NCT05509634|Palonosetron|palonosetron|mesh-list
153507725|NCT05509634|Fosaprepitant|fosaprepitant|mesh-list
153507728|NCT05509634|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153507729|NCT05509634|Antiemetics|antiemetics|mesh-ancestor
153507743|NCT05509634|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153507744|NCT05509634|Serotonin Agents|serotonin agents|mesh-ancestor
153507745|NCT05509634|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153507746|NCT05509634|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
153507747|NCT05430230|Naproxen|naproxen|mesh-list
153507748|NCT05430230|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-list
153507749|NCT05430230|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
153507750|NCT05430230|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153507751|NCT05430230|Analgesics|analgesics|mesh-ancestor
153507752|NCT05430230|Sensory System Agents|sensory system agents|mesh-ancestor
153507753|NCT05430230|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153507754|NCT05430230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153507755|NCT05430230|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153507756|NCT05430230|Gout Suppressants|gout suppressants|mesh-ancestor
153507757|NCT05430230|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153507758|NCT05430230|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153727654|NCT00492505|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
153507759|NCT05430230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153507760|NCT05370820|Tranexamic Acid|tranexamic acid|mesh-list
153507761|NCT05370820|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
153507762|NCT05370820|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153507763|NCT05370820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153507764|NCT05370820|Hemostatics|hemostatics|mesh-ancestor
153507765|NCT05370820|Coagulants|coagulants|mesh-ancestor
153507766|NCT05328258|Triptorelin Pamoate|triptorelin pamoate|mesh-list
153507767|NCT05328258|Luteolytic Agents|luteolytic agents|mesh-ancestor
153507768|NCT05328258|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
153507769|NCT05328258|Contraceptive Agents|contraceptive agents|mesh-ancestor
153507770|NCT05328258|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153507775|NCT05301322|Vaccines|vaccines|mesh-list
153507789|NCT05256537|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153507790|NCT05256537|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153507791|NCT05256537|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
153507792|NCT05256537|Antitubercular Agents|antitubercular agents|mesh-ancestor
153507793|NCT05256537|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153551703|NCT01572623|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
153507794|NCT05256537|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153507795|NCT05256537|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153507796|NCT05256537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153507797|NCT05253573|Nicotine|nicotine|mesh-list
153507798|NCT05253573|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
153507800|NCT05253573|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153507801|NCT05253573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153507802|NCT05253573|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
153507803|NCT05253573|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
153507804|NCT05253573|Cholinergic Agents|cholinergic agents|mesh-ancestor
153507805|NCT05253573|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153507806|NCT05253573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153507807|NCT05048212|Nivolumab|nivolumab|mesh-list
153507808|NCT05048212|Ipilimumab|ipilimumab|mesh-list
153507809|NCT05048212|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153507810|NCT05048212|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153507811|NCT05048212|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153507812|NCT05048212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153507813|NCT05020821|Dexmedetomidine|dexmedetomidine|mesh-list
153507815|NCT05020821|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153507816|NCT05020821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153507817|NCT05020821|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153507818|NCT05020821|Analgesics|analgesics|mesh-ancestor
153507819|NCT05020821|Sensory System Agents|sensory system agents|mesh-ancestor
153507820|NCT05020821|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153507821|NCT05020821|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
153507822|NCT05020821|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153507823|NCT05020821|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153507827|NCT05007873|Decitabine|decitabine|mesh-list
153507828|NCT05007873|Decitabine and cedazuridine drug combination|decitabine and cedazuridine drug combination|mesh-list
153507829|NCT05007873|Dasatinib|dasatinib|mesh-list
153507833|NCT05007873|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153507834|NCT05007873|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153507835|NCT05007873|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153507836|NCT05007873|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153507837|NCT04956575|Vaccines|vaccines|mesh-list
153507838|NCT04956575|Immunologic Factors|immunologic factors|mesh-ancestor
153507839|NCT04956575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153507840|NCT04948294|Pyrithione zinc|pyrithione zinc|mesh-list
153507841|NCT04948294|Keratolytic Agents|keratolytic agents|mesh-ancestor
153507842|NCT04948294|Dermatologic Agents|dermatologic agents|mesh-ancestor
153507843|NCT04920708|Fulvestrant|fulvestrant|mesh-list
153507844|NCT04920708|Palbociclib|palbociclib|mesh-list
153507845|NCT04920708|Ipatasertib|ipatasertib|mesh-list
153507846|NCT04920708|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153507847|NCT04920708|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153507881|NCT04693234|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153507882|NCT04585542|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
153507883|NCT04585542|Polystyrene sulfonic acid|polystyrene sulfonic acid|mesh-list
153507884|NCT04585542|Laxatives|laxatives|mesh-ancestor
153507885|NCT04585542|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153507886|NCT04585542|Chelating Agents|chelating agents|mesh-ancestor
153507887|NCT04585542|Sequestering Agents|sequestering agents|mesh-ancestor
153507888|NCT04585542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153507889|NCT04585334|Diclofenac|diclofenac|mesh-list
153507890|NCT04585334|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153507891|NCT04585334|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153507892|NCT04585334|Analgesics|analgesics|mesh-ancestor
153507893|NCT04585334|Sensory System Agents|sensory system agents|mesh-ancestor
153507894|NCT04585334|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153507895|NCT04585334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153507896|NCT04585334|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153507897|NCT04585334|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153507898|NCT04585334|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153507899|NCT04585334|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153507900|NCT04585334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153551749|NCT01572961|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153551750|NCT01572961|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153551751|NCT01572961|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153507901|NCT04554693|Metronidazole|metronidazole|mesh-list
153507902|NCT04554693|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153507906|NCT04410406|Ivermectin|ivermectin|mesh-list
153507934|NCT04323189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153507935|NCT04220866|Pembrolizumab|pembrolizumab|mesh-list
153507936|NCT04220866|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153507937|NCT04220866|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153507938|NCT04220866|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153507939|NCT04220866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153507940|NCT04170946|Talazoparib|talazoparib|mesh-list
153507941|NCT04170946|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
153507942|NCT04170946|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153507943|NCT04170946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153507944|NCT04170946|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153507945|NCT04170283|Tislelizumab|tislelizumab|mesh-list
153507946|NCT04170283|Zanubrutinib|zanubrutinib|mesh-list
153507947|NCT04170283|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153507948|NCT04170283|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153507949|NCT04170283|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153507951|NCT04170283|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153507952|NCT04170283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153507954|NCT04160052|Venetoclax|venetoclax|mesh-list
153451058|NCT03912220|Niacinamide|niacinamide|mesh-list
153507955|NCT04160052|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153507956|NCT04160052|Antimetabolites|antimetabolites|mesh-ancestor
153507957|NCT04160052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153507958|NCT04160052|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153507959|NCT04160052|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153507960|NCT04149574|Nivolumab|nivolumab|mesh-list
153507961|NCT04149574|BCG Vaccine|bcg vaccine|mesh-list
153507962|NCT04149574|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153507963|NCT04149574|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153507964|NCT04149574|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153507972|NCT04115384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153507974|NCT04075149|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
153507975|NCT04075149|Hormone Antagonists|hormone antagonists|mesh-ancestor
153507976|NCT04075149|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153507977|NCT04075149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153507978|NCT04075149|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
153507979|NCT04075149|Diuretics|diuretics|mesh-ancestor
153507980|NCT04075149|Natriuretic Agents|natriuretic agents|mesh-ancestor
153507981|NCT04025554|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
153507982|NCT04025554|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153507983|NCT04025372|Bicalutamide|bicalutamide|mesh-list
153507984|NCT04025372|Androgen Antagonists|androgen antagonists|mesh-ancestor
153507985|NCT04025372|Hormone Antagonists|hormone antagonists|mesh-ancestor
153507986|NCT04025372|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153507987|NCT04025372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153507988|NCT04025372|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153508000|NCT03939767|Aflibercept|aflibercept|mesh-list
153508001|NCT03939767|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153508002|NCT03939767|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153508003|NCT03939767|Growth Substances|growth substances|mesh-ancestor
153508004|NCT03939767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153508005|NCT03939767|Growth Inhibitors|growth inhibitors|mesh-ancestor
153508006|NCT03939767|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153508007|NCT03914820|Mitomycins|mitomycins|mesh-list
153508008|NCT03914820|Mitomycin|mitomycin|mesh-list
153508009|NCT03914820|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153508010|NCT03914820|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153508011|NCT03914820|Alkylating Agents|alkylating agents|mesh-ancestor
153508012|NCT03914820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153551758|NCT01573143|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153551759|NCT01573143|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153551760|NCT01573143|Antimetabolites|antimetabolites|mesh-ancestor
153508013|NCT03914820|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153551794|NCT01573377|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153508014|NCT03914820|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153508015|NCT03859427|Dexamethasone|dexamethasone|mesh-list
153508016|NCT03859427|Lenalidomide|lenalidomide|mesh-list
153508018|NCT03859427|Antiemetics|antiemetics|mesh-ancestor
153508021|NCT03859427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153508022|NCT03859427|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153508024|NCT03859427|Hormones|hormones|mesh-ancestor
153508025|NCT03859427|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153508026|NCT03859427|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153781903|NCT00232115|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
153451134|NCT03864042|Narcotics|narcotics|mesh-ancestor
153508027|NCT03859427|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153508028|NCT03859427|Immunologic Factors|immunologic factors|mesh-ancestor
153508029|NCT03859427|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153508030|NCT03859427|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153508031|NCT03859427|Growth Substances|growth substances|mesh-ancestor
153508032|NCT03859427|Growth Inhibitors|growth inhibitors|mesh-ancestor
153508033|NCT03824938|Aspirin|aspirin|mesh-list
153508034|NCT03824938|Acetaminophen|acetaminophen|mesh-list
153508035|NCT03824938|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153508036|NCT03824938|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153508037|NCT03824938|Analgesics|analgesics|mesh-ancestor
153508038|NCT03824938|Sensory System Agents|sensory system agents|mesh-ancestor
153508039|NCT03824938|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153508040|NCT03824938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153508041|NCT03824938|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153508042|NCT03824938|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153508043|NCT03824938|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153508044|NCT03824938|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153508045|NCT03824938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153508046|NCT03824938|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153508047|NCT03824938|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153508063|NCT03766425|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153508064|NCT03705806|Immunomodulating Agents|immunomodulating agents|mesh-list
153508065|NCT03705806|Immunologic Factors|immunologic factors|mesh-ancestor
153508066|NCT03705806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153508067|NCT03636373|Triamcinolone|triamcinolone|mesh-list
153508068|NCT03636373|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
153508069|NCT03636373|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
153508070|NCT03636373|Etanercept|etanercept|mesh-list
153508071|NCT03636373|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
153508072|NCT03636373|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153508073|NCT03636373|Glucocorticoids|glucocorticoids|mesh-ancestor
153508074|NCT03636373|Hormones|hormones|mesh-ancestor
153508075|NCT03636373|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153508076|NCT03636373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153508077|NCT03636373|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153508078|NCT03636373|Immunologic Factors|immunologic factors|mesh-ancestor
153508079|NCT03636373|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153508080|NCT03636373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153508081|NCT03636373|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153508082|NCT03636373|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153508083|NCT03636373|Analgesics|analgesics|mesh-ancestor
153508084|NCT03636373|Sensory System Agents|sensory system agents|mesh-ancestor
153508085|NCT03636373|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153728772|NCT02274610|Docetaxel|docetaxel|mesh-list
153508086|NCT03636373|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153508087|NCT03636373|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153508088|NCT03560310|Ticagrelor|ticagrelor|mesh-list
153508089|NCT03560310|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153508090|NCT03560310|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
153508091|NCT03560310|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
153508106|NCT03470675|Anesthetics|anesthetics|mesh-ancestor
153551804|NCT01573598|Vilazodone Hydrochloride|vilazodone hydrochloride|mesh-list
153551805|NCT01573598|Antidepressive Agents|antidepressive agents|mesh-ancestor
153508107|NCT03470675|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153508108|NCT03470675|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
153508109|NCT03470675|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
153508110|NCT03470675|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153508111|NCT03470675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153508113|NCT03470675|Narcotics|narcotics|mesh-ancestor
153508115|NCT03456063|Carboplatin|carboplatin|mesh-list
153508116|NCT03456063|Gemcitabine|gemcitabine|mesh-list
153508117|NCT03456063|Pemetrexed|pemetrexed|mesh-list
153508118|NCT03456063|Atezolizumab|atezolizumab|mesh-list
153508119|NCT03456063|Antibodies|antibodies|mesh-list
153508120|NCT03456063|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153508121|NCT03456063|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153508122|NCT03456063|Tubulin Modulators|tubulin modulators|mesh-ancestor
153508123|NCT03456063|Antimitotic Agents|antimitotic agents|mesh-ancestor
153508124|NCT03456063|Mitosis Modulators|mitosis modulators|mesh-ancestor
153508125|NCT03456063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153508126|NCT03456063|Immunologic Factors|immunologic factors|mesh-ancestor
153508127|NCT03456063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153508128|NCT03456063|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153508158|NCT03281369|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153508159|NCT03281369|Tubulin Modulators|tubulin modulators|mesh-ancestor
153508160|NCT03281369|Antimitotic Agents|antimitotic agents|mesh-ancestor
153508161|NCT03281369|Mitosis Modulators|mitosis modulators|mesh-ancestor
153508162|NCT03281369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153508163|NCT03281369|Antimetabolites|antimetabolites|mesh-ancestor
153508164|NCT03281369|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153508165|NCT03281369|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153508166|NCT03281369|Immunologic Factors|immunologic factors|mesh-ancestor
153508167|NCT03281369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153508168|NCT03281369|Antidotes|antidotes|mesh-ancestor
153508169|NCT03281369|Protective Agents|protective agents|mesh-ancestor
153508170|NCT03281369|Vitamin B Complex|vitamin b complex|mesh-ancestor
153508172|NCT03281369|Micronutrients|micronutrients|mesh-ancestor
153508217|NCT02869841|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153508218|NCT02869841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153508219|NCT02869841|Sensory System Agents|sensory system agents|mesh-ancestor
153508220|NCT02869841|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153508221|NCT02701699|Fluoroazomycin arabinoside|fluoroazomycin arabinoside|mesh-list
153508222|NCT02701699|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
153728920|NCT00502684|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153508223|NCT02701699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153508226|NCT02402920|Pembrolizumab|pembrolizumab|mesh-list
153508227|NCT02402920|Etoposide|etoposide|mesh-list
153508228|NCT02402920|Etoposide phosphate|etoposide phosphate|mesh-list
153508229|NCT02402920|Podophyllotoxin|podophyllotoxin|mesh-list
153508278|NCT01545141|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153508279|NCT01545141|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153508280|NCT01545141|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
153508281|NCT01545141|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153508282|NCT01545141|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153508283|NCT01545141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153508284|NCT01545141|Interferon Inducers|interferon inducers|mesh-ancestor
153508285|NCT01422759|Spironolactone|spironolactone|mesh-list
153508286|NCT01422759|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
153508287|NCT01422759|Hormone Antagonists|hormone antagonists|mesh-ancestor
153508288|NCT01422759|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153508289|NCT01422759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153551806|NCT01573598|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153508290|NCT01422759|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
153508291|NCT01422759|Diuretics|diuretics|mesh-ancestor
153508292|NCT01422759|Natriuretic Agents|natriuretic agents|mesh-ancestor
153508293|NCT01421797|Dexamethasone|dexamethasone|mesh-list
153508294|NCT01421797|Cosyntropin|cosyntropin|mesh-list
153508295|NCT01421797|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153508296|NCT01421797|Antiemetics|antiemetics|mesh-ancestor
153508297|NCT01421797|Autonomic Agents|autonomic agents|mesh-ancestor
153508298|NCT01421797|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153508299|NCT01421797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153508300|NCT01421797|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153508301|NCT01421797|Glucocorticoids|glucocorticoids|mesh-ancestor
153508302|NCT01421797|Hormones|hormones|mesh-ancestor
153551815|NCT01573598|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
153508303|NCT01421797|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153508304|NCT01421797|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153508305|NCT01421797|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153508306|NCT01404741|Azacitidine|azacitidine|mesh-list
153508307|NCT01404741|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153508308|NCT01404741|Antimetabolites|antimetabolites|mesh-ancestor
153508309|NCT01404741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153508318|NCT00777998|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153508319|NCT00777998|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153508320|NCT00777998|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153508321|NCT00777998|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153508322|NCT00777998|Growth Substances|growth substances|mesh-ancestor
153508323|NCT00777998|Growth Inhibitors|growth inhibitors|mesh-ancestor
153508324|NCT00777998|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153508325|NCT00777998|Trace Elements|trace elements|mesh-ancestor
153451427|NCT00003803|Gemcitabine|gemcitabine|mesh-list
153508326|NCT00777998|Micronutrients|micronutrients|mesh-ancestor
153508327|NCT00188539|Anesthetics|anesthetics|mesh-list
153508328|NCT00188539|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153508329|NCT00188539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153508330|NCT04453449|Midazolam|midazolam|mesh-list
153508331|NCT04453449|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153508332|NCT04453449|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153508333|NCT04453449|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153508334|NCT04453449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153508335|NCT04453449|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153508374|NCT03129321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153508375|NCT03129321|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153508376|NCT03129321|Hormone Antagonists|hormone antagonists|mesh-ancestor
153508377|NCT03129321|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153508378|NCT03129321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153508379|NCT03107611|Pimecrolimus|pimecrolimus|mesh-list
153508380|NCT03107611|Tacrolimus|tacrolimus|mesh-list
153508381|NCT03107611|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153508382|NCT03107611|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153508383|NCT03107611|Analgesics|analgesics|mesh-ancestor
153508384|NCT03107611|Sensory System Agents|sensory system agents|mesh-ancestor
153508385|NCT03107611|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153508386|NCT03107611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153508388|NCT03107611|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153508389|NCT03107611|Dermatologic Agents|dermatologic agents|mesh-ancestor
153508390|NCT03107611|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153729150|NCT03981146|Nivolumab|nivolumab|mesh-list
153508392|NCT03107611|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
153508393|NCT03107611|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153508394|NCT03107611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153508395|NCT02607956|Dolutegravir|dolutegravir|mesh-list
153508396|NCT02607956|Emtricitabine tenofovir alafenamide|emtricitabine tenofovir alafenamide|mesh-list
153508397|NCT02607956|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
153508398|NCT02607956|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
153508399|NCT02607956|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153729203|NCT01248403|Mitosis Modulators|mitosis modulators|mesh-ancestor
153508400|NCT02607956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153508417|NCT02499666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153508418|NCT02499666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153508419|NCT02094716|Permethrin|permethrin|mesh-list
153508420|NCT02094716|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153508421|NCT02094716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153508422|NCT01460810|Silicon|silicon|mesh-list
153508423|NCT01460810|Trace Elements|trace elements|mesh-ancestor
153508424|NCT01460810|Micronutrients|micronutrients|mesh-ancestor
153508425|NCT01460810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153508426|NCT00667329|Cyclophosphamide|cyclophosphamide|mesh-list
153508427|NCT00667329|Rituximab|rituximab|mesh-list
153508428|NCT00667329|Cladribine|cladribine|mesh-list
153508429|NCT00667329|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153508430|NCT00667329|Immunologic Factors|immunologic factors|mesh-ancestor
153508431|NCT00667329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153508432|NCT00667329|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153508433|NCT00667329|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153508434|NCT00667329|Alkylating Agents|alkylating agents|mesh-ancestor
153508435|NCT00667329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153508436|NCT00667329|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153508437|NCT00667329|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153508438|NCT00667329|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153508439|NCT00492167|Antibodies|antibodies|mesh-list
153508440|NCT00492167|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
153508441|NCT00492167|Immunologic Factors|immunologic factors|mesh-ancestor
153508442|NCT00492167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153508465|NCT05274139|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153508466|NCT05274139|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153566488|NCT06235151|Copper|copper|mesh-list
153508467|NCT05274139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153508468|NCT05274139|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153508469|NCT05274139|Antimetabolites|antimetabolites|mesh-ancestor
153508470|NCT05274139|Antiviral Agents|antiviral agents|mesh-ancestor
153508471|NCT05274139|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153508472|NCT05274139|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153508473|NCT05274139|Immunologic Factors|immunologic factors|mesh-ancestor
153508474|NCT05274139|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153508475|NCT05274139|Alkylating Agents|alkylating agents|mesh-ancestor
153508477|NCT05274113|Ropivacaine|ropivacaine|mesh-list
153508478|NCT05274113|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153508479|NCT05274113|Antiemetics|antiemetics|mesh-ancestor
153508480|NCT05274113|Autonomic Agents|autonomic agents|mesh-ancestor
153508481|NCT05274113|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153508482|NCT05274113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153508483|NCT05274113|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153508484|NCT05274113|Glucocorticoids|glucocorticoids|mesh-ancestor
153508485|NCT05274113|Hormones|hormones|mesh-ancestor
153508486|NCT05274113|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153508520|NCT05273398|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153508521|NCT05273398|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153508522|NCT05273398|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153508523|NCT05273398|Anesthetics, General|anesthetics, general|mesh-ancestor
153508525|NCT05273398|GABA Modulators|gaba modulators|mesh-ancestor
153508526|NCT05273398|GABA Agents|gaba agents|mesh-ancestor
153508527|NCT05273398|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153508528|NCT05273398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153508529|NCT05272839|Hypoglycemic Agents|hypoglycemic agents|mesh-list
153508530|NCT05272839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153551836|NCT01573715|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
153508531|NCT05272371|Dinutuximab|dinutuximab|mesh-list
153551845|NCT01573741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153508532|NCT05272371|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153508581|NCT05271188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153508582|NCT05271188|Sensory System Agents|sensory system agents|mesh-ancestor
153508583|NCT05271188|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153508584|NCT05271136|Sunscreening Agents|sunscreening agents|mesh-list
153508585|NCT05271136|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
153508586|NCT05271136|Protective Agents|protective agents|mesh-ancestor
153508587|NCT05271136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153508588|NCT05271136|Dermatologic Agents|dermatologic agents|mesh-ancestor
153508589|NCT05271058|Dexamethasone|dexamethasone|mesh-list
153508590|NCT05271058|Dexamethasone acetate|dexamethasone acetate|mesh-list
153508591|NCT05271058|Triamcinolone|triamcinolone|mesh-list
153508592|NCT05271058|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
153508593|NCT05271058|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
153508594|NCT05271058|BB 1101|bb 1101|mesh-list
153508595|NCT05271058|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
153508596|NCT05271058|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153508597|NCT05271058|Antiemetics|antiemetics|mesh-ancestor
153508598|NCT05271058|Autonomic Agents|autonomic agents|mesh-ancestor
153508599|NCT05271058|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153508600|NCT05271058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153508601|NCT05271058|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153508602|NCT05271058|Glucocorticoids|glucocorticoids|mesh-ancestor
153508603|NCT05271058|Hormones|hormones|mesh-ancestor
153508605|NCT05271058|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153508606|NCT05271058|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153508607|NCT05271058|Protease Inhibitors|protease inhibitors|mesh-ancestor
153508608|NCT05271058|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153508611|NCT05271058|Immunologic Factors|immunologic factors|mesh-ancestor
153508626|NCT05270824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153508627|NCT05270434|Dipyrone|dipyrone|mesh-list
153508628|NCT05270434|Meperidine|meperidine|mesh-list
153508629|NCT05270434|Morphine|morphine|mesh-list
153508630|NCT05270434|Buprenorphine|buprenorphine|mesh-list
153508631|NCT05270434|Analgesics|analgesics|mesh-list
153508632|NCT05270434|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153508633|NCT05270434|Narcotics|narcotics|mesh-ancestor
153508634|NCT05270434|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153508635|NCT05270434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153508636|NCT05270434|Sensory System Agents|sensory system agents|mesh-ancestor
153508637|NCT05270434|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153508638|NCT05270434|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
153508639|NCT05270434|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153508640|NCT05270434|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153508641|NCT05270434|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153508642|NCT05270434|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153508643|NCT05270434|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153508644|NCT05270434|Antipyretics|antipyretics|mesh-ancestor
153508646|NCT05270421|Diuretics|diuretics|mesh-ancestor
153508647|NCT05270421|Natriuretic Agents|natriuretic agents|mesh-ancestor
153508648|NCT05270421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153508649|NCT05270421|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
153508653|NCT05270343|Vitamin D|vitamin d|mesh-list
153508677|NCT05250141|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153508679|NCT05248724|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
153508680|NCT05248724|Epinephrine|epinephrine|mesh-list
153508681|NCT05248724|Racepinephrine|racepinephrine|mesh-list
153508682|NCT05248724|Morphine|morphine|mesh-list
153508683|NCT05248724|Ropivacaine|ropivacaine|mesh-list
153508684|NCT05248724|Epinephryl borate|epinephryl borate|mesh-list
153508685|NCT05248724|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153508686|NCT05248724|Narcotics|narcotics|mesh-ancestor
153729645|NCT00130676|Mifepristone|mifepristone|mesh-list
153508687|NCT05248724|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153508688|NCT05248724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153508689|NCT05248724|Analgesics|analgesics|mesh-ancestor
153508690|NCT05248724|Sensory System Agents|sensory system agents|mesh-ancestor
153508691|NCT05248724|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153508692|NCT05248724|Anesthetics, Local|anesthetics, local|mesh-ancestor
153508693|NCT05248724|Anesthetics|anesthetics|mesh-ancestor
153508694|NCT05248724|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153508695|NCT05248724|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153508696|NCT05248724|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153508697|NCT05248724|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153508731|NCT05165875|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153508732|NCT05165875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153508733|NCT05165875|Sensory System Agents|sensory system agents|mesh-ancestor
153508734|NCT05165875|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153508735|NCT05165875|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153508736|NCT05165875|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
153508737|NCT05165875|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153508738|NCT05165875|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153783933|NCT02215720|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153508739|NCT05165875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153508740|NCT05165875|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153508741|NCT05162118|Nivolumab|nivolumab|mesh-list
153508742|NCT05162118|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153508743|NCT05162118|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153508744|NCT05162118|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153508745|NCT05162118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153508746|NCT05155917|Insulin Glargine|insulin glargine|mesh-list
153508747|NCT05155917|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153508748|NCT05155917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153508749|NCT05138029|Dexamethasone|dexamethasone|mesh-list
153508750|NCT05138029|Dexamethasone acetate|dexamethasone acetate|mesh-list
153508751|NCT05138029|Ranibizumab|ranibizumab|mesh-list
153508752|NCT05138029|BB 1101|bb 1101|mesh-list
153508753|NCT05138029|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153508754|NCT05138029|Antiemetics|antiemetics|mesh-ancestor
153508755|NCT05138029|Autonomic Agents|autonomic agents|mesh-ancestor
153508756|NCT05138029|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153508757|NCT05138029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153508758|NCT05138029|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153508759|NCT05138029|Glucocorticoids|glucocorticoids|mesh-ancestor
153508760|NCT05138029|Hormones|hormones|mesh-ancestor
153508761|NCT05138029|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153508771|NCT05135039|Canagliflozin|canagliflozin|mesh-list
153784035|NCT04538521|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153508772|NCT05135039|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
153781906|NCT04558021|Niclosamide|niclosamide|mesh-list
153508773|NCT05135039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153508774|NCT05135039|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153508775|NCT05135039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153508776|NCT05128591|Rivaroxaban|rivaroxaban|mesh-list
153508777|NCT05128591|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
153508778|NCT05128591|Antithrombins|antithrombins|mesh-ancestor
153508779|NCT05128591|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
153508780|NCT05128591|Protease Inhibitors|protease inhibitors|mesh-ancestor
153508781|NCT05128591|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153508782|NCT05128591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153508783|NCT05128591|Anticoagulants|anticoagulants|mesh-ancestor
153508784|NCT05088928|Rivaroxaban|rivaroxaban|mesh-list
153508785|NCT05088928|Apixaban|apixaban|mesh-list
153508786|NCT05088928|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
153551884|NCT01574092|Irinotecan|irinotecan|mesh-list
153551885|NCT01574092|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153508787|NCT05088928|Antithrombins|antithrombins|mesh-ancestor
153508788|NCT05088928|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
153508789|NCT05088928|Protease Inhibitors|protease inhibitors|mesh-ancestor
153508790|NCT05088928|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153508791|NCT05088928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153508792|NCT05088928|Anticoagulants|anticoagulants|mesh-ancestor
153508793|NCT05075122|Pembrolizumab|pembrolizumab|mesh-list
153508794|NCT05075122|Sargramostim|sargramostim|mesh-list
153508795|NCT05075122|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153508796|NCT05075122|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153508801|NCT05067439|Efavirenz|efavirenz|mesh-list
153508817|NCT05067439|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153508818|NCT05067439|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153508819|NCT05067439|Antiviral Agents|antiviral agents|mesh-ancestor
153508820|NCT05067439|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153508821|NCT05067439|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
153508822|NCT05067439|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153508823|NCT05067439|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
153508824|NCT05067439|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
153508825|NCT05067439|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
153508826|NCT05067439|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
153508827|NCT05067439|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153508829|NCT05064137|Fluorides|fluorides|mesh-list
153508830|NCT05064137|Sodium Fluoride|sodium fluoride|mesh-list
153508831|NCT05064137|Fluorides, Topical|fluorides, topical|mesh-list
153508832|NCT05064137|Cariostatic Agents|cariostatic agents|mesh-ancestor
153508833|NCT05064137|Protective Agents|protective agents|mesh-ancestor
153508834|NCT05064137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153508835|NCT05064137|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
153508836|NCT05064137|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153508837|NCT05052528|Cyclophosphamide|cyclophosphamide|mesh-list
153508838|NCT05052528|Rituximab|rituximab|mesh-list
153508839|NCT05052528|Fludarabine|fludarabine|mesh-list
153508840|NCT05052528|Fludarabine phosphate|fludarabine phosphate|mesh-list
153508841|NCT05052528|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
153508842|NCT05052528|Antibodies|antibodies|mesh-list
153508865|NCT05051150|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
153508867|NCT05051150|Autonomic Agents|autonomic agents|mesh-ancestor
153508868|NCT05051150|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153508869|NCT05051150|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153508870|NCT05051150|Respiratory System Agents|respiratory system agents|mesh-ancestor
153508871|NCT05051150|Mydriatics|mydriatics|mesh-ancestor
153508872|NCT05051150|Sympathomimetics|sympathomimetics|mesh-ancestor
153508873|NCT05051150|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
153508874|NCT05045313|Probenecid|probenecid|mesh-list
153508875|NCT05045313|Digoxin|digoxin|mesh-list
153508876|NCT05045313|Warfarin|warfarin|mesh-list
153508877|NCT05045313|Anticoagulants|anticoagulants|mesh-ancestor
153508878|NCT05045313|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153508879|NCT05045313|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
153508880|NCT05045313|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153508881|NCT05045313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153508882|NCT05045313|Protective Agents|protective agents|mesh-ancestor
153508883|NCT05045313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153508884|NCT05045313|Uricosuric Agents|uricosuric agents|mesh-ancestor
153508885|NCT05045313|Gout Suppressants|gout suppressants|mesh-ancestor
153508886|NCT05045313|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153508887|NCT05007561|Naltrexone|naltrexone|mesh-list
153551896|NCT01574261|Vitamin B Complex|vitamin b complex|mesh-ancestor
153508890|NCT05007561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153508892|NCT05007561|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153508893|NCT04961801|Methotrexate|methotrexate|mesh-list
153508894|NCT04961801|Acalabrutinib|acalabrutinib|mesh-list
153508895|NCT04961801|Tacrolimus|tacrolimus|mesh-list
153508911|NCT04961801|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
153508912|NCT04961801|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153508913|NCT04961801|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153508914|NCT04938388|Semaglutide|semaglutide|mesh-list
153508915|NCT04938388|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
153508916|NCT04938388|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153508917|NCT04938388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153508918|NCT04886284|Ertapenem|ertapenem|mesh-list
153508919|NCT04886284|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153508920|NCT04886284|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153508921|NCT04835402|Pembrolizumab|pembrolizumab|mesh-list
153508922|NCT04835402|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153781907|NCT04558021|Anticestodal Agents|anticestodal agents|mesh-ancestor
153508923|NCT04835402|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153508924|NCT04835402|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153508925|NCT04835402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153508926|NCT04783376|Insulin|insulin|mesh-list
153508927|NCT04783376|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
153508928|NCT04783376|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153508929|NCT04783376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153508930|NCT04768829|Carbamide Peroxide|carbamide peroxide|mesh-list
153508931|NCT04768829|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
153508932|NCT04768829|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153508933|NCT04760912|Bromides|bromides|mesh-list
153508934|NCT04760912|Anesthetics|anesthetics|mesh-list
153508935|NCT04760912|Rocuronium|rocuronium|mesh-list
153508936|NCT04760912|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153508937|NCT04760912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153508938|NCT04760912|Anticonvulsants|anticonvulsants|mesh-ancestor
153508939|NCT04760912|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
153508940|NCT04760912|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
153508941|NCT04760912|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
153508942|NCT04760912|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153508943|NCT04706767|Lidocaine|lidocaine|mesh-list
153508945|NCT04706767|Anesthetics, Local|anesthetics, local|mesh-ancestor
153508946|NCT04706767|Anesthetics|anesthetics|mesh-ancestor
153508949|NCT04706767|Sensory System Agents|sensory system agents|mesh-ancestor
153508950|NCT04706767|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153508951|NCT04706767|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153508952|NCT04706767|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
153508953|NCT04706767|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153508954|NCT04706767|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153508955|NCT04706767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153508956|NCT04706767|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153508957|NCT04706767|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153508958|NCT04706767|Analgesics|analgesics|mesh-ancestor
153551941|NCT01575158|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153551942|NCT01575158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153508959|NCT04706767|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
153508960|NCT04706767|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153508961|NCT04706767|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153551994|NCT01575483|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
153508962|NCT04706767|Adrenergic Agents|adrenergic agents|mesh-ancestor
153508963|NCT04706767|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153508964|NCT04690686|Paclitaxel|paclitaxel|mesh-list
153508965|NCT04690686|Atezolizumab|atezolizumab|mesh-list
153508966|NCT04690686|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153508967|NCT04690686|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153508968|NCT04690686|Tubulin Modulators|tubulin modulators|mesh-ancestor
153508969|NCT04690686|Antimitotic Agents|antimitotic agents|mesh-ancestor
153508970|NCT04690686|Mitosis Modulators|mitosis modulators|mesh-ancestor
153508971|NCT04690686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153509000|NCT04433390|Sensory System Agents|sensory system agents|mesh-ancestor
153509001|NCT04433390|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153509002|NCT04399746|Cholecalciferol|cholecalciferol|mesh-list
153509003|NCT04399746|Vitamin D|vitamin d|mesh-list
153509004|NCT04399746|Azithromycin|azithromycin|mesh-list
153509005|NCT04399746|Ivermectin|ivermectin|mesh-list
153509006|NCT04399746|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153509007|NCT04399746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153509008|NCT04399746|Vitamins|vitamins|mesh-ancestor
153784369|NCT04536493|Mydriatics|mydriatics|mesh-ancestor
153509010|NCT04399746|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153509011|NCT04399746|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153509012|NCT04399746|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153509013|NCT04399746|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153509014|NCT04391608|Tenofovir|tenofovir|mesh-list
153509015|NCT04391608|Antiviral Agents|antiviral agents|mesh-ancestor
153509016|NCT04391608|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153509017|NCT04391608|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153509018|NCT04391608|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153509019|NCT04391608|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153509020|NCT04391608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153509021|NCT04391608|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153509022|NCT04391608|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153509023|NCT04368091|Sirolimus|sirolimus|mesh-list
153784456|NCT02216383|Oxytocin|oxytocin|mesh-list
153509024|NCT04368091|Temsirolimus|temsirolimus|mesh-list
153509025|NCT04368091|MTOR Inhibitors|mtor inhibitors|mesh-list
153509041|NCT04238845|Vitamin A|vitamin a|mesh-list
153509047|NCT04223037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153509048|NCT04209621|Ibrutinib|ibrutinib|mesh-list
153509049|NCT04209621|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153509050|NCT04209621|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153509051|NCT04209621|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153509052|NCT04209621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153509053|NCT04186663|Fluorides|fluorides|mesh-list
153509054|NCT04186663|Cariostatic Agents|cariostatic agents|mesh-ancestor
153509055|NCT04186663|Protective Agents|protective agents|mesh-ancestor
153509056|NCT04186663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153509057|NCT04095104|Topiramate|topiramate|mesh-list
153509058|NCT04095104|Phentermine|phentermine|mesh-list
153509059|NCT04095104|Anticonvulsants|anticonvulsants|mesh-ancestor
153509060|NCT04095104|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153509061|NCT04095104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153509062|NCT04095104|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
153509063|NCT04095104|Appetite Depressants|appetite depressants|mesh-ancestor
153509064|NCT04095104|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
153509065|NCT04095104|Sympathomimetics|sympathomimetics|mesh-ancestor
153509066|NCT04095104|Autonomic Agents|autonomic agents|mesh-ancestor
153509067|NCT04095104|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153509068|NCT04095104|Adrenergic Agents|adrenergic agents|mesh-ancestor
153509071|NCT04044729|Cannabidiol|cannabidiol|mesh-list
153784612|NCT04533724|Amisulpride|amisulpride|mesh-list
153509101|NCT03858621|Fentanyl|fentanyl|mesh-list
153509102|NCT03858621|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153509103|NCT03858621|Narcotics|narcotics|mesh-ancestor
153509104|NCT03858621|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153509105|NCT03858621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153509106|NCT03858621|Analgesics|analgesics|mesh-ancestor
153509107|NCT03858621|Sensory System Agents|sensory system agents|mesh-ancestor
153552007|NCT01575626|Sevoflurane|sevoflurane|mesh-list
153784674|NCT00238082|Hormones|hormones|mesh-ancestor
153509108|NCT03858621|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153509109|NCT03858621|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153509110|NCT03858621|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153509111|NCT03858621|Anesthetics, General|anesthetics, general|mesh-ancestor
153509112|NCT03858621|Anesthetics|anesthetics|mesh-ancestor
153509113|NCT03758170|Dexamethasone|dexamethasone|mesh-list
153509114|NCT03758170|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153509115|NCT03758170|Antiemetics|antiemetics|mesh-ancestor
153509116|NCT03758170|Autonomic Agents|autonomic agents|mesh-ancestor
153509117|NCT03758170|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153509118|NCT03758170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153509119|NCT03758170|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153509120|NCT03758170|Glucocorticoids|glucocorticoids|mesh-ancestor
153509121|NCT03758170|Hormones|hormones|mesh-ancestor
153509122|NCT03758170|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153509123|NCT03758170|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153509124|NCT03758170|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153509125|NCT03733119|TIC10 compound|tic10 compound|mesh-list
153509127|NCT03705338|Propofol|propofol|mesh-list
153509148|NCT03661996|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153509149|NCT03661996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153509150|NCT03661996|Sensory System Agents|sensory system agents|mesh-ancestor
153509151|NCT03661996|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153452250|NCT01854918|Evolocumab|evolocumab|mesh-list
153509152|NCT03661996|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153509153|NCT03661996|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
153509154|NCT03661996|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153509155|NCT03661996|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153922625|NCT04620382|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
153509157|NCT03661996|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153509158|NCT03661996|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153509159|NCT03661996|Adrenergic Agents|adrenergic agents|mesh-ancestor
153509160|NCT03661996|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153509161|NCT03661996|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
153509162|NCT03661996|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153509163|NCT03661996|Autonomic Agents|autonomic agents|mesh-ancestor
153509164|NCT03661996|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153509165|NCT03661996|Respiratory System Agents|respiratory system agents|mesh-ancestor
153509166|NCT03661996|Mydriatics|mydriatics|mesh-ancestor
153509167|NCT03661996|Sympathomimetics|sympathomimetics|mesh-ancestor
153509168|NCT03661996|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
153509169|NCT03661996|Antipruritics|antipruritics|mesh-ancestor
153509170|NCT03661996|Dermatologic Agents|dermatologic agents|mesh-ancestor
153509195|NCT03359239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153509196|NCT03359239|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153509197|NCT03359239|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153509198|NCT03359239|Interferon Inducers|interferon inducers|mesh-ancestor
153509199|NCT03359239|Immunologic Factors|immunologic factors|mesh-ancestor
153509200|NCT03359239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153509202|NCT03332173|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153509203|NCT03332173|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153509204|NCT03332173|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153509205|NCT03332173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153509206|NCT03332173|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153509207|NCT03328676|Chlorophyllin|chlorophyllin|mesh-list
153509208|NCT03328676|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
153552034|NCT01575678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153509209|NCT03328676|Protective Agents|protective agents|mesh-ancestor
153509210|NCT03328676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153784849|NCT05669547|Hormones|hormones|mesh-list
153509211|NCT03322293|Aminolevulinic Acid|aminolevulinic acid|mesh-list
153509212|NCT03322293|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
153509213|NCT03322293|Dermatologic Agents|dermatologic agents|mesh-ancestor
153509214|NCT03315039|Annamycin|annamycin|mesh-list
153509221|NCT03276533|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153509222|NCT03276533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153509223|NCT03276533|Sensory System Agents|sensory system agents|mesh-ancestor
153509224|NCT03276533|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153509225|NCT03276533|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153509236|NCT03276533|Adrenergic Agents|adrenergic agents|mesh-ancestor
153509237|NCT03276533|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153509239|NCT03254394|Anesthetics, Local|anesthetics, local|mesh-ancestor
153509240|NCT03254394|Anesthetics|anesthetics|mesh-ancestor
153509241|NCT03254394|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153509242|NCT03254394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153509243|NCT03254394|Sensory System Agents|sensory system agents|mesh-ancestor
153509244|NCT03254394|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153509245|NCT03254394|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153509246|NCT03254394|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
153509247|NCT03254394|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153509248|NCT03254394|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153509249|NCT03254394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153509251|NCT03203876|Ipilimumab|ipilimumab|mesh-list
153509252|NCT03203876|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153509253|NCT03203876|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153509254|NCT03203876|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153509255|NCT03203876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153509256|NCT03191240|Vasopressins|vasopressins|mesh-list
153509257|NCT03191240|Arginine Vasopressin|arginine vasopressin|mesh-list
153509258|NCT03191240|Hemostatics|hemostatics|mesh-ancestor
153509259|NCT03191240|Coagulants|coagulants|mesh-ancestor
153509285|NCT03071601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153784886|NCT05250791|Lidocaine|lidocaine|mesh-list
153509287|NCT03071601|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153509288|NCT03071601|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153509289|NCT03071601|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
153509290|NCT03071601|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153509291|NCT03071601|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153509292|NCT03071601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153509293|NCT03071601|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153509294|NCT03071601|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153509295|NCT03071601|Adrenergic Agents|adrenergic agents|mesh-ancestor
153509296|NCT03071601|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153781911|NCT04558021|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153509297|NCT03071601|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
153509298|NCT03071601|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153509299|NCT03071601|Autonomic Agents|autonomic agents|mesh-ancestor
153509300|NCT03071601|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153509301|NCT03071601|Respiratory System Agents|respiratory system agents|mesh-ancestor
153509302|NCT03071601|Mydriatics|mydriatics|mesh-ancestor
153509338|NCT03055390|Parasympatholytics|parasympatholytics|mesh-ancestor
153509340|NCT03012672|2-chloro-3'-deoxyadenosine|2-chloro-3'-deoxyadenosine|mesh-list
153509341|NCT03012672|Mitoxantrone|mitoxantrone|mesh-list
153509343|NCT03012672|Lenograstim|lenograstim|mesh-list
153784957|NCT04521920|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153784959|NCT04521920|Analgesics|analgesics|mesh-ancestor
153784960|NCT04521920|Sensory System Agents|sensory system agents|mesh-ancestor
153552042|NCT01575717|Micronutrients|micronutrients|mesh-ancestor
153552043|NCT01575717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153552044|NCT01575717|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153552045|NCT01575717|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153552046|NCT01575782|Chloroquine|chloroquine|mesh-list
153784961|NCT04521920|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153784962|NCT04521920|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
153784979|NCT04108897|Doxycycline|doxycycline|mesh-list
153784980|NCT04108897|Ivermectin|ivermectin|mesh-list
153784981|NCT04108897|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153784982|NCT04108897|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153784983|NCT04108897|Antimalarials|antimalarials|mesh-ancestor
153784984|NCT04108897|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153784985|NCT04108897|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153785003|NCT04026958|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153785004|NCT04026958|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
153509344|NCT03012672|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153509345|NCT03012672|Antimetabolites|antimetabolites|mesh-ancestor
153509346|NCT03012672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153509347|NCT03012672|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153509348|NCT03012672|Antiviral Agents|antiviral agents|mesh-ancestor
153509349|NCT03012672|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153509350|NCT03012672|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153509351|NCT03012672|Immunologic Factors|immunologic factors|mesh-ancestor
153509352|NCT03012672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153509353|NCT03012672|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153509354|NCT03012672|Analgesics|analgesics|mesh-ancestor
153509355|NCT03012672|Sensory System Agents|sensory system agents|mesh-ancestor
153509356|NCT03012672|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153509357|NCT03012672|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153509358|NCT03012672|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153509359|NCT03012672|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153509361|NCT03011775|Pioglitazone|pioglitazone|mesh-list
153509362|NCT03011775|Hypoglycemic Agents|hypoglycemic agents|mesh-list
153509363|NCT03011775|Ramipril|ramipril|mesh-list
153509364|NCT03011775|Bisoprolol|bisoprolol|mesh-list
153509365|NCT03011775|Isosorbide|isosorbide|mesh-list
153509366|NCT03011775|Isosorbide Dinitrate|isosorbide dinitrate|mesh-list
153509387|NCT03011775|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153509388|NCT03011775|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153509389|NCT03011775|Antipyretics|antipyretics|mesh-ancestor
153509390|NCT03011775|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
153509391|NCT03011775|Protease Inhibitors|protease inhibitors|mesh-ancestor
153509392|NCT03011775|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153509393|NCT03011775|Sympatholytics|sympatholytics|mesh-ancestor
153509394|NCT03011775|Autonomic Agents|autonomic agents|mesh-ancestor
153509395|NCT03011775|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
153509396|NCT03011775|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
153509398|NCT03011775|Adrenergic Agents|adrenergic agents|mesh-ancestor
153509399|NCT03011775|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153509400|NCT03011775|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
153509401|NCT03011775|Diuretics|diuretics|mesh-ancestor
153509402|NCT03011775|Natriuretic Agents|natriuretic agents|mesh-ancestor
153509403|NCT03011775|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
153509404|NCT02960997|Sirolimus|sirolimus|mesh-list
153509405|NCT02960997|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153509406|NCT02960997|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153509407|NCT02960997|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153509408|NCT02960997|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153509409|NCT02960997|Antifungal Agents|antifungal agents|mesh-ancestor
153509410|NCT02960997|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153509411|NCT02960997|Immunologic Factors|immunologic factors|mesh-ancestor
153509412|NCT02960997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153509413|NCT02924480|Lidocaine|lidocaine|mesh-list
153509437|NCT02879942|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153509438|NCT02879942|Growth Substances|growth substances|mesh-ancestor
153509439|NCT02879942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153509440|NCT02879942|Growth Inhibitors|growth inhibitors|mesh-ancestor
153509441|NCT02879942|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153509442|NCT02873819|Cyclophosphamide|cyclophosphamide|mesh-list
153509443|NCT02873819|Sargramostim|sargramostim|mesh-list
153509444|NCT02873819|Poly ICLC|poly iclc|mesh-list
153552051|NCT01575782|Antimalarials|antimalarials|mesh-ancestor
153552052|NCT01575782|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153552053|NCT01575795|Ticagrelor|ticagrelor|mesh-list
153509445|NCT02873819|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153509446|NCT02873819|Immunologic Factors|immunologic factors|mesh-ancestor
153509447|NCT02873819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153509448|NCT02873819|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153509451|NCT02873819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153509452|NCT02873819|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153509453|NCT02873819|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153509454|NCT02873819|Interferon Inducers|interferon inducers|mesh-ancestor
153509456|NCT02810457|Bevacizumab|bevacizumab|mesh-list
153509457|NCT02810457|Carboplatin|carboplatin|mesh-list
153509458|NCT02810457|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153509459|NCT02810457|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153509460|NCT02810457|Tubulin Modulators|tubulin modulators|mesh-ancestor
153509461|NCT02810457|Antimitotic Agents|antimitotic agents|mesh-ancestor
153509462|NCT02810457|Mitosis Modulators|mitosis modulators|mesh-ancestor
153509463|NCT02810457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153509464|NCT02810457|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153509465|NCT02810457|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153509466|NCT02810457|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153509467|NCT02810457|Growth Substances|growth substances|mesh-ancestor
153509468|NCT02810457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153509469|NCT02810457|Growth Inhibitors|growth inhibitors|mesh-ancestor
153509470|NCT02745535|Sofosbuvir|sofosbuvir|mesh-list
153509471|NCT02745535|Velpatasvir|velpatasvir|mesh-list
153509473|NCT02745535|Antiviral Agents|antiviral agents|mesh-ancestor
153509477|NCT02729701|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
153509478|NCT02729701|Hormones|hormones|mesh-ancestor
153509479|NCT02729701|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153509480|NCT02729701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153509481|NCT02729701|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
153509482|NCT02729701|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
153509483|NCT02729701|Hormone Antagonists|hormone antagonists|mesh-ancestor
153509484|NCT02729701|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153509485|NCT02684253|Nivolumab|nivolumab|mesh-list
153509486|NCT02684253|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153509487|NCT02684253|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153509488|NCT02684253|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153509489|NCT02684253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153509490|NCT02666794|Vasoconstrictor Agents|vasoconstrictor agents|mesh-list
153509491|NCT02666794|Sufentanil|sufentanil|mesh-list
153509492|NCT02666794|Morphine|morphine|mesh-list
153509493|NCT02666794|Dsuvia|dsuvia|mesh-list
153509494|NCT02666794|Bupivacaine|bupivacaine|mesh-list
153509495|NCT02666794|Anesthetics, Local|anesthetics, local|mesh-ancestor
153509496|NCT02666794|Anesthetics|anesthetics|mesh-ancestor
153509497|NCT02666794|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153509498|NCT02666794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153509499|NCT02666794|Sensory System Agents|sensory system agents|mesh-ancestor
153509500|NCT02666794|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153509501|NCT02666794|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153509502|NCT02666794|Narcotics|narcotics|mesh-ancestor
153509503|NCT02666794|Analgesics|analgesics|mesh-ancestor
153509504|NCT02666794|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153509505|NCT02666794|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153509506|NCT02666794|Anesthetics, General|anesthetics, general|mesh-ancestor
153509507|NCT02656550|Thymoglobulin|thymoglobulin|mesh-list
153509508|NCT02656550|Immunologic Factors|immunologic factors|mesh-ancestor
153509509|NCT02656550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153509510|NCT02656550|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153509511|NCT02619552|Prednisone|prednisone|mesh-list
153509526|NCT02619552|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153509527|NCT02619552|Respiratory System Agents|respiratory system agents|mesh-ancestor
153509528|NCT02619552|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
153509529|NCT02619552|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153552085|NCT01576185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153552087|NCT01576263|Anesthetics, Local|anesthetics, local|mesh-ancestor
153552088|NCT01576263|Anesthetics|anesthetics|mesh-ancestor
153509530|NCT02619552|Dermatologic Agents|dermatologic agents|mesh-ancestor
153509531|NCT02619552|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153509532|NCT02619552|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153509533|NCT02619552|Immunologic Factors|immunologic factors|mesh-ancestor
153509534|NCT02539225|Paclitaxel|paclitaxel|mesh-list
153509535|NCT02539225|Oxaliplatin|oxaliplatin|mesh-list
153509536|NCT02539225|Ramucirumab|ramucirumab|mesh-list
153509537|NCT02539225|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153509573|NCT02423525|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153509574|NCT02423525|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153509575|NCT02423525|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153509576|NCT02423525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153509577|NCT02423525|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153509578|NCT02369653|Apixaban|apixaban|mesh-list
153509579|NCT02369653|Anticoagulants|anticoagulants|mesh-list
153509580|NCT02369653|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
153509581|NCT02369653|Antithrombins|antithrombins|mesh-ancestor
153509582|NCT02369653|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
153509583|NCT02369653|Protease Inhibitors|protease inhibitors|mesh-ancestor
153509584|NCT02369653|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153509585|NCT02369653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153509586|NCT02293109|Leucovorin|leucovorin|mesh-list
153509587|NCT02293109|Cytarabine|cytarabine|mesh-list
153509588|NCT02293109|Dexamethasone|dexamethasone|mesh-list
153509589|NCT02293109|Methylprednisolone|methylprednisolone|mesh-list
153509590|NCT02293109|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
153509591|NCT02293109|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
153509592|NCT02293109|Prednisolone|prednisolone|mesh-list
153509593|NCT02293109|Prednisolone acetate|prednisolone acetate|mesh-list
153509594|NCT02293109|Cyclophosphamide|cyclophosphamide|mesh-list
153509595|NCT02293109|Rituximab|rituximab|mesh-list
153509596|NCT02293109|Doxorubicin|doxorubicin|mesh-list
153509597|NCT02293109|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
153509598|NCT02293109|Methotrexate|methotrexate|mesh-list
153509599|NCT02293109|Vincristine|vincristine|mesh-list
153509600|NCT02293109|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
153509601|NCT02293109|Prednisolone phosphate|prednisolone phosphate|mesh-list
153509602|NCT02293109|Levoleucovorin|levoleucovorin|mesh-list
153509603|NCT02293109|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153509604|NCT02293109|Immunologic Factors|immunologic factors|mesh-ancestor
153509605|NCT02293109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153509606|NCT02293109|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153509607|NCT02293109|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153509608|NCT02293109|Alkylating Agents|alkylating agents|mesh-ancestor
153509615|NCT02293109|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153509619|NCT02293109|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153509621|NCT02293109|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153509622|NCT02293109|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153509623|NCT02293109|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153509624|NCT02293109|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153509625|NCT02293109|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153509626|NCT02293109|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
153509627|NCT02293109|Abortifacient Agents|abortifacient agents|mesh-ancestor
153509628|NCT02293109|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153509629|NCT02293109|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153509630|NCT02293109|Antimetabolites|antimetabolites|mesh-ancestor
153509674|NCT01940809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153509675|NCT01940809|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153509676|NCT01940809|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153509677|NCT01879228|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
153781913|NCT00232154|Azithromycin|azithromycin|mesh-list
153509678|NCT01879228|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153509679|NCT01879228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153509680|NCT01879228|Incretins|incretins|mesh-ancestor
153509681|NCT01879228|Hormones|hormones|mesh-ancestor
153509682|NCT01879228|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153509683|NCT01879228|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
153509684|NCT01879228|Protease Inhibitors|protease inhibitors|mesh-ancestor
153509685|NCT01879228|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153509686|NCT01879228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153509687|NCT01779557|Dialysis Solutions|dialysis solutions|mesh-list
153509688|NCT01779557|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
153509689|NCT01729754|Etanercept|etanercept|mesh-list
153509690|NCT01729754|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
153509691|NCT01729754|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153509692|NCT01729754|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153509693|NCT01729754|Analgesics|analgesics|mesh-ancestor
153509694|NCT01729754|Sensory System Agents|sensory system agents|mesh-ancestor
153509695|NCT01729754|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153509722|NCT01595620|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
153509723|NCT01595620|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153509724|NCT01595620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153509725|NCT01595620|Hormones|hormones|mesh-ancestor
153509726|NCT01595620|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153509727|NCT01595620|Antipruritics|antipruritics|mesh-ancestor
153509728|NCT01595620|Dermatologic Agents|dermatologic agents|mesh-ancestor
153509729|NCT01591629|Dronabinol|dronabinol|mesh-list
153509730|NCT01591629|Naloxone|naloxone|mesh-list
153509731|NCT01591629|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
153509732|NCT01591629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153509733|NCT01591629|Sensory System Agents|sensory system agents|mesh-ancestor
153509734|NCT01591629|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153509735|NCT01591629|Hallucinogens|hallucinogens|mesh-ancestor
153509736|NCT01591629|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153509737|NCT01591629|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153509738|NCT01591629|Analgesics|analgesics|mesh-ancestor
153509739|NCT01591629|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
153509740|NCT01591629|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
153509741|NCT01591629|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153509775|NCT01360593|Capecitabine|capecitabine|mesh-list
153509776|NCT01360593|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153509777|NCT01360593|Antimetabolites|antimetabolites|mesh-ancestor
153785564|NCT01642030|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153509778|NCT01360593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153509779|NCT01360593|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153509780|NCT01354977|Resveratrol|resveratrol|mesh-list
153509781|NCT01354977|Antioxidants|antioxidants|mesh-ancestor
153509782|NCT01354977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153509783|NCT01354977|Protective Agents|protective agents|mesh-ancestor
153509784|NCT01354977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153509785|NCT01354977|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153509786|NCT01354977|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153509788|NCT01334606|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153509789|NCT01334606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153509790|NCT01226732|Capecitabine|capecitabine|mesh-list
153509791|NCT01226732|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153509792|NCT01226732|Antimetabolites|antimetabolites|mesh-ancestor
153509793|NCT01226732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153509794|NCT01226732|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153509795|NCT00962988|Bupropion|bupropion|mesh-list
153509796|NCT00962988|Nicotine|nicotine|mesh-list
153552101|NCT01576419|Sensory System Agents|sensory system agents|mesh-ancestor
153552102|NCT01576419|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153552103|NCT01576419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153552104|NCT01576419|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153552105|NCT01576419|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153552106|NCT01576419|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
153552107|NCT01576419|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153552108|NCT01576419|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153509797|NCT00962988|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
153509798|NCT00962988|Autonomic Agents|autonomic agents|mesh-ancestor
153509799|NCT00962988|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153509800|NCT00962988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153509801|NCT00962988|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
153509815|NCT00962988|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153509817|NCT00768820|Methylphenidate|methylphenidate|mesh-list
153509818|NCT00768820|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153509819|NCT00768820|Serotonin Agents|serotonin agents|mesh-ancestor
153509820|NCT00768820|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153509821|NCT00768820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153509822|NCT00768820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153509823|NCT00768820|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153509824|NCT00768820|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153509825|NCT00768820|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153509826|NCT00768820|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153509827|NCT00768820|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
153509828|NCT00768820|Dopamine Agents|dopamine agents|mesh-ancestor
153509829|NCT00768820|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
153509830|NCT00768820|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
153509831|NCT00768820|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153509832|NCT00768820|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153509833|NCT00678730|Dronabinol|dronabinol|mesh-list
153509834|NCT00678730|Hallucinogens|hallucinogens|mesh-ancestor
153509835|NCT00678730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153509836|NCT00678730|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153509837|NCT00678730|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153509838|NCT00678730|Analgesics|analgesics|mesh-ancestor
153509839|NCT00678730|Sensory System Agents|sensory system agents|mesh-ancestor
153509840|NCT00678730|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153509841|NCT00678730|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
153509842|NCT00678730|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
153509843|NCT00678730|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153509844|NCT00678730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153509845|NCT00678730|Hormones|hormones|mesh-ancestor
153509848|NCT00600015|Sorafenib|sorafenib|mesh-list
153509855|NCT00500071|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
153509856|NCT00500071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153509857|NCT00500071|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
153509858|NCT00500071|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153509859|NCT00500071|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153509860|NCT00500071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153509861|NCT00500071|Dopamine Agents|dopamine agents|mesh-ancestor
153509862|NCT00500071|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153509863|NCT00447122|Gemcitabine|gemcitabine|mesh-list
153509864|NCT00447122|Oxaliplatin|oxaliplatin|mesh-list
153509865|NCT00447122|Lapatinib|lapatinib|mesh-list
153509866|NCT00447122|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153509867|NCT00447122|Antimetabolites|antimetabolites|mesh-ancestor
153509868|NCT00447122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153509869|NCT00447122|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153509870|NCT00447122|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153509871|NCT00447122|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153509872|NCT00447122|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153509873|NCT00430040|Carvedilol|carvedilol|mesh-list
153509874|NCT00430040|Lisinopril|lisinopril|mesh-list
153509875|NCT00430040|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
153509876|NCT00430040|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
153509877|NCT00430040|Adrenergic Agents|adrenergic agents|mesh-ancestor
153509878|NCT00430040|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153509879|NCT00430040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153509880|NCT00430040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153509881|NCT00430040|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153618874|NCT01980550|Nicotine|nicotine|mesh-list
153509898|NCT00290251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153552128|NCT01576640|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153509899|NCT00290251|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
153509900|NCT00066963|Fluorides|fluorides|mesh-list
153509901|NCT00066963|Fluorides, Topical|fluorides, topical|mesh-list
153509902|NCT00066963|Cariostatic Agents|cariostatic agents|mesh-ancestor
153509903|NCT00066963|Protective Agents|protective agents|mesh-ancestor
153509904|NCT00066963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153509905|NCT01397500|Testosterone|testosterone|mesh-list
153509906|NCT01397500|Androgens|androgens|mesh-ancestor
153509907|NCT01397500|Hormones|hormones|mesh-ancestor
153509908|NCT01397500|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153509909|NCT01397500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153509910|NCT01397513|Aspirin|aspirin|mesh-list
153509911|NCT01397513|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153509912|NCT01397513|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153509913|NCT01397513|Analgesics|analgesics|mesh-ancestor
153509914|NCT01397513|Sensory System Agents|sensory system agents|mesh-ancestor
153509915|NCT01397513|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153509916|NCT01397513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153509917|NCT01397513|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153509918|NCT01397513|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153509919|NCT01397513|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153509920|NCT01397513|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153509921|NCT01397513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153509922|NCT01397513|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153509923|NCT01397513|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153509924|NCT01397513|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153509925|NCT01397513|Antipyretics|antipyretics|mesh-ancestor
153509927|NCT01397630|Oxytocics|oxytocics|mesh-ancestor
153509928|NCT01397630|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153509929|NCT01397630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153509930|NCT01397734|Arsenic Trioxide|arsenic trioxide|mesh-list
153509931|NCT01397734|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153509932|NCT01397799|Tirbanibulin|tirbanibulin|mesh-list
153509933|NCT01397799|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153509938|NCT01397994|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153509939|NCT01397994|Sympatholytics|sympatholytics|mesh-ancestor
153509941|NCT01397994|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153509942|NCT01397994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153509943|NCT01397994|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
153509944|NCT01397994|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
153509945|NCT01397994|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
153509946|NCT01397994|Adrenergic Agents|adrenergic agents|mesh-ancestor
153509947|NCT01397994|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153509948|NCT01397994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153509949|NCT01397994|Vasodilator Agents|vasodilator agents|mesh-ancestor
153509950|NCT01397994|Vitamin B Complex|vitamin b complex|mesh-ancestor
153509951|NCT01397994|Vitamins|vitamins|mesh-ancestor
153509952|NCT01397994|Micronutrients|micronutrients|mesh-ancestor
153509953|NCT01398033|Paclitaxel|paclitaxel|mesh-list
153509954|NCT01398033|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153509955|NCT01398033|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153509956|NCT01398033|Tubulin Modulators|tubulin modulators|mesh-ancestor
153509957|NCT01398033|Antimitotic Agents|antimitotic agents|mesh-ancestor
153509958|NCT01398033|Mitosis Modulators|mitosis modulators|mesh-ancestor
153509959|NCT01398033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153509960|NCT01398046|Dasatinib|dasatinib|mesh-list
153509961|NCT01398046|Rabeprazole|rabeprazole|mesh-list
153509962|NCT01398046|Betaine|betaine|mesh-list
153509963|NCT01398046|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153509964|NCT01398046|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153509965|NCT01398046|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153509966|NCT01398046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153509967|NCT01398046|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153509968|NCT01398046|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
153785970|NCT00240422|Ramipril|ramipril|mesh-list
153552140|NCT01576692|Aldesleukin|aldesleukin|mesh-list
153509969|NCT01398046|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153509970|NCT01398046|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
153509971|NCT01398046|Lipotropic Agents|lipotropic agents|mesh-ancestor
153509972|NCT01398046|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153509973|NCT01398046|Antimetabolites|antimetabolites|mesh-ancestor
153509974|NCT01398046|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153509976|NCT01398072|Azithromycin|azithromycin|mesh-list
153509977|NCT01398072|Doxycycline|doxycycline|mesh-list
153509978|NCT01398072|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153509979|NCT01398072|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153509980|NCT01398072|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153509981|NCT01398072|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153509982|NCT01398072|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153509983|NCT01398072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153509984|NCT01398072|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153509985|NCT01398072|Antimalarials|antimalarials|mesh-ancestor
153509987|NCT01398072|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153509988|NCT01398111|Glycopyrrolate|glycopyrrolate|mesh-list
153509989|NCT01398111|Formoterol Fumarate|formoterol fumarate|mesh-list
153509990|NCT01398111|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153509991|NCT01398111|Autonomic Agents|autonomic agents|mesh-ancestor
153509992|NCT01398111|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153509993|NCT01398111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153509994|NCT01398111|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153509995|NCT01398111|Respiratory System Agents|respiratory system agents|mesh-ancestor
153509996|NCT01398111|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
153509997|NCT01398111|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
153509998|NCT01398111|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153509999|NCT01398111|Adrenergic Agents|adrenergic agents|mesh-ancestor
153510000|NCT01398111|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153510001|NCT01398111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153510003|NCT01398111|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
153510004|NCT01398111|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
153510005|NCT01398111|Cholinergic Agents|cholinergic agents|mesh-ancestor
153510006|NCT01398189|Clozapine|clozapine|mesh-list
153510007|NCT01398189|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153510008|NCT01398189|Serotonin Agents|serotonin agents|mesh-ancestor
153510009|NCT01398189|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153510010|NCT01398189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153510012|NCT01398189|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153510016|NCT01398189|GABA Antagonists|gaba antagonists|mesh-ancestor
153510018|NCT01398202|Vitamin D|vitamin d|mesh-list
153510019|NCT01398202|Cholecalciferol|cholecalciferol|mesh-list
153510020|NCT01398202|Hydroxycholecalciferols|hydroxycholecalciferols|mesh-list
153510021|NCT01398202|Calcifediol|calcifediol|mesh-list
153510022|NCT01398202|Vitamins|vitamins|mesh-ancestor
153510023|NCT01398202|Micronutrients|micronutrients|mesh-ancestor
153510024|NCT01398202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153510025|NCT01398202|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153510026|NCT01398202|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153510027|NCT01398267|Lisinopril|lisinopril|mesh-list
153510028|NCT01398267|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
153510029|NCT01398267|Protease Inhibitors|protease inhibitors|mesh-ancestor
153510030|NCT01398267|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153510031|NCT01398267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153510032|NCT01398267|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153510033|NCT01398267|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
153510034|NCT01398267|Protective Agents|protective agents|mesh-ancestor
153510035|NCT01398267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153510036|NCT01398293|Ritonavir|ritonavir|mesh-list
153510037|NCT01398293|Moxifloxacin|moxifloxacin|mesh-list
153510038|NCT01398293|Lactams|lactams|mesh-list
153510039|NCT01398293|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
153420783|NCT03132571|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153420784|NCT03132571|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153420785|NCT02374424|Obinutuzumab|obinutuzumab|mesh-list
153552144|NCT01576692|Immunologic Factors|immunologic factors|mesh-ancestor
153552145|NCT01576692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153552146|NCT01576692|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153510066|NCT01398371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153510067|NCT01398371|Protective Agents|protective agents|mesh-ancestor
153510068|NCT01398371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153510069|NCT01398384|Nitric Oxide|nitric oxide|mesh-list
153510070|NCT01398384|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153510071|NCT01398384|Autonomic Agents|autonomic agents|mesh-ancestor
153510072|NCT01398384|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153510073|NCT01398384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153510074|NCT01398384|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153510075|NCT01398384|Respiratory System Agents|respiratory system agents|mesh-ancestor
153510076|NCT01398384|Free Radical Scavengers|free radical scavengers|mesh-ancestor
153510077|NCT01398384|Antioxidants|antioxidants|mesh-ancestor
153510078|NCT01398384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153510079|NCT01398384|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153510080|NCT01398384|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
153510081|NCT01398384|Vasodilator Agents|vasodilator agents|mesh-ancestor
153510082|NCT01398384|Gasotransmitters|gasotransmitters|mesh-ancestor
153510083|NCT01398384|Protective Agents|protective agents|mesh-ancestor
153510085|NCT01398501|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153510086|NCT01398501|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153510087|NCT01398501|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153510088|NCT01398501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153510089|NCT01398592|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
153510090|NCT01398592|Vildagliptin|vildagliptin|mesh-list
153510091|NCT01398592|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153510092|NCT01398592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153510093|NCT01398592|Incretins|incretins|mesh-ancestor
153510094|NCT01398592|Hormones|hormones|mesh-ancestor
153510095|NCT01398592|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153510096|NCT01398592|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
153510107|NCT01398618|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153510108|NCT01398618|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153510109|NCT01398618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153510110|NCT01398618|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
153786144|NCT00240734|Epoetin Alfa|epoetin alfa|mesh-list
153510111|NCT01398618|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
153510112|NCT01398618|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
153510113|NCT01398618|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
153510114|NCT01398618|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
153510115|NCT01398618|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
153510116|NCT01398618|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
153510117|NCT01398618|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153510118|NCT01398618|Antimetabolites|antimetabolites|mesh-ancestor
153510119|NCT01398618|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153510120|NCT01398657|Androgens|androgens|mesh-list
153510121|NCT01398657|Hormones|hormones|mesh-ancestor
153510122|NCT01398657|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153618875|NCT01980550|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
153510123|NCT01398657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153510124|NCT01398670|Insulin|insulin|mesh-list
153510125|NCT01398670|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
153510126|NCT01398670|Insulin Lispro|insulin lispro|mesh-list
153510127|NCT01398670|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153510128|NCT01398670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153510129|NCT01398722|Insulin|insulin|mesh-list
153510130|NCT01398722|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
153510131|NCT01398722|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153510132|NCT01398722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153510133|NCT01398995|Insulin|insulin|mesh-list
153510150|NCT01399151|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153552150|NCT01576692|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153552151|NCT01576731|Tenofovir|tenofovir|mesh-list
153552152|NCT01576731|Emtricitabine|emtricitabine|mesh-list
153510151|NCT01399151|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153510152|NCT01399216|Fucoidan|fucoidan|mesh-list
153510153|NCT01399216|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
153510154|NCT01399216|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153510155|NCT01399216|Anticoagulants|anticoagulants|mesh-ancestor
153552177|NCT01576770|Sensory System Agents|sensory system agents|mesh-ancestor
153510156|NCT01399216|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153510157|NCT01399242|Everolimus|everolimus|mesh-list
153510158|NCT01399242|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153510159|NCT01399242|Immunologic Factors|immunologic factors|mesh-ancestor
153510160|NCT01399242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153510161|NCT01399242|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153510162|NCT01399242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153510163|NCT01399242|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153510164|NCT01399242|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
153510165|NCT01399242|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153510166|NCT01399255|Insulin Lispro|insulin lispro|mesh-list
153510167|NCT01399255|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153510168|NCT01399255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153510169|NCT01399346|Insulin|insulin|mesh-list
153510170|NCT01399346|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
153510171|NCT01399346|Insulin Aspart|insulin aspart|mesh-list
153510172|NCT01399346|Insulin, Long-Acting|insulin, long-acting|mesh-list
153510173|NCT01399346|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
153510174|NCT01399346|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153510175|NCT01399346|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153510176|NCT01399450|Paliperidone Palmitate|paliperidone palmitate|mesh-list
153510177|NCT01399450|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153510178|NCT01399450|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153510179|NCT01399450|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153510190|NCT01399463|Paclitaxel|paclitaxel|mesh-list
153510195|NCT01399463|Mitosis Modulators|mitosis modulators|mesh-ancestor
153510196|NCT01399463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153510197|NCT01399515|Valproic Acid|valproic acid|mesh-list
153510198|NCT01399515|Anticonvulsants|anticonvulsants|mesh-ancestor
153453315|NCT01777152|Glucocorticoids|glucocorticoids|mesh-ancestor
153510199|NCT01399515|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153510200|NCT01399515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153510201|NCT01399515|GABA Agents|gaba agents|mesh-ancestor
153510202|NCT01399515|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153510203|NCT01399515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153786270|NCT01688791|Paclitaxel|paclitaxel|mesh-list
153510205|NCT01399515|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153510206|NCT01399515|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153510207|NCT01399515|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153510208|NCT01399645|Insulin|insulin|mesh-list
153510209|NCT01399645|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
153510210|NCT01399645|Metformin|metformin|mesh-list
153510211|NCT01399645|Insulin Glargine|insulin glargine|mesh-list
153510212|NCT01399645|Liraglutide|liraglutide|mesh-list
153510213|NCT01399645|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153510214|NCT01399645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153510215|NCT01399645|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
153510216|NCT01399645|Incretins|incretins|mesh-ancestor
153510217|NCT01399645|Hormones|hormones|mesh-ancestor
153510218|NCT01399645|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153510219|NCT01399840|Talazoparib|talazoparib|mesh-list
153510220|NCT01399840|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
153510221|NCT01399840|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153510222|NCT01399840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153510223|NCT01399840|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153510224|NCT01399853|Vaccines|vaccines|mesh-list
153510225|NCT01399853|Immunologic Factors|immunologic factors|mesh-ancestor
153510233|NCT01400009|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153510234|NCT01400022|Cortisone|cortisone|mesh-list
153552178|NCT01576770|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153510235|NCT01400022|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153510236|NCT01400074|Imatinib Mesylate|imatinib mesylate|mesh-list
153510237|NCT01400074|Nilotinib|nilotinib|mesh-list
153510238|NCT01400074|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153510239|NCT01400074|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153510240|NCT01400074|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153510241|NCT01400074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153510242|NCT01400074|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153510243|NCT01400100|Octreotide|octreotide|mesh-list
153510244|NCT01400100|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
153510245|NCT01400100|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153510246|NCT01400100|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153510247|NCT01400100|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153510248|NCT01400165|Pindolol|pindolol|mesh-list
153510249|NCT01400165|Quetiapine Fumarate|quetiapine fumarate|mesh-list
153510250|NCT01400165|Trazodone|trazodone|mesh-list
153510251|NCT01400165|Antidepressive Agents|antidepressive agents|mesh-ancestor
153510252|NCT01400165|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153510253|NCT01400165|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153510254|NCT01400165|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153510255|NCT01400165|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153510256|NCT01400165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153510257|NCT01400165|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153510258|NCT01400165|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
153510259|NCT01400165|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153510260|NCT01400165|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153510261|NCT01400165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153510262|NCT01400165|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153510263|NCT01400165|Serotonin Agents|serotonin agents|mesh-ancestor
153510266|NCT01400165|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
153510275|NCT01400217|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153510276|NCT01400217|Glucocorticoids|glucocorticoids|mesh-ancestor
153510277|NCT01400217|Hormones|hormones|mesh-ancestor
153510278|NCT01400217|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153510279|NCT01400217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153510280|NCT01400217|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153510281|NCT01400217|Respiratory System Agents|respiratory system agents|mesh-ancestor
153510282|NCT01400256|Valsartan|valsartan|mesh-list
153510283|NCT01400256|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153510284|NCT01400256|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
153510285|NCT01400256|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
153510286|NCT01400256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153510287|NCT01400308|Mupirocin|mupirocin|mesh-list
153510288|NCT01400308|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153510289|NCT01400308|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153510290|NCT01400308|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
153510291|NCT01400308|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153510292|NCT01400308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153510331|NCT01400646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153510332|NCT01400646|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
153510333|NCT01400646|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153510336|NCT01400672|Imiquimod|imiquimod|mesh-list
153510337|NCT01400672|Toll-Like Receptor Agonists|toll-like receptor agonists|mesh-ancestor
153510338|NCT01400672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153510339|NCT01400672|Immunomodulating Agents|immunomodulating agents|mesh-ancestor
153510340|NCT01400672|Immunologic Factors|immunologic factors|mesh-ancestor
153510341|NCT01400672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153510342|NCT01400672|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153510343|NCT01400672|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153510344|NCT01400672|Interferon Inducers|interferon inducers|mesh-ancestor
153552235|NCT01577342|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153510345|NCT01400685|Rituximab|rituximab|mesh-list
153510346|NCT01400685|Lenalidomide|lenalidomide|mesh-list
153552247|NCT01577368|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
153510347|NCT01400685|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
153510348|NCT01400685|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153510349|NCT01400685|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153510350|NCT01400685|Immunologic Factors|immunologic factors|mesh-ancestor
153510351|NCT01400685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153510352|NCT01400685|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153510353|NCT01400685|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153510354|NCT01400685|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153510355|NCT01400685|Growth Substances|growth substances|mesh-ancestor
153510356|NCT01400685|Growth Inhibitors|growth inhibitors|mesh-ancestor
153510357|NCT01400685|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153510358|NCT01400685|Alkylating Agents|alkylating agents|mesh-ancestor
153786574|NCT02219659|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153510362|NCT01400737|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153510371|NCT01400737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153510372|NCT01400750|Ciprofloxacin|ciprofloxacin|mesh-list
153510373|NCT01400750|Tobramycin|tobramycin|mesh-list
153510374|NCT01400750|Colistin|colistin|mesh-list
153510375|NCT01400750|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153510376|NCT01400750|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153510377|NCT01400750|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153510378|NCT01400750|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153510379|NCT01400750|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153923304|NCT03304678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153510380|NCT01400750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153510381|NCT01400750|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153510382|NCT01400750|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
153510383|NCT01400750|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153510385|NCT01400789|Isophane insulin, insulin lispro drug combination 50:50|isophane insulin, insulin lispro drug combination 50:50|mesh-list
153510386|NCT01400789|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153510387|NCT01400789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153510388|NCT01400802|Insulin Lispro|insulin lispro|mesh-list
153510389|NCT01400802|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153510390|NCT01400802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153510391|NCT01400828|Desloratadine|desloratadine|mesh-list
153510392|NCT01400828|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
153510393|NCT01400828|Cholinergic Agents|cholinergic agents|mesh-ancestor
153510394|NCT01400828|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153510395|NCT01400828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153510396|NCT01400828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153510397|NCT01400828|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
153510398|NCT01400828|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
153510401|NCT01400867|Vancomycin|vancomycin|mesh-list
153510414|NCT01400867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153510415|NCT01400867|Beta Lactam Antibiotics|beta lactam antibiotics|mesh-ancestor
153510416|NCT01400945|Pantoprazole|pantoprazole|mesh-list
153510417|NCT01400945|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
153510418|NCT01400945|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153510419|NCT01400945|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
153510420|NCT01400945|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153453528|NCT01706250|Analgesics|analgesics|mesh-ancestor
153510421|NCT01400945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153510423|NCT01401036|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153510424|NCT01401036|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153510425|NCT01401036|Immunologic Factors|immunologic factors|mesh-ancestor
153510426|NCT01401036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153510427|NCT01401075|Viscum album peptide|viscum album peptide|mesh-list
153510428|NCT01401075|Doxifluridine|doxifluridine|mesh-list
153510429|NCT01401075|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153510430|NCT01401075|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153510431|NCT01401075|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153510432|NCT01401075|Antiviral Agents|antiviral agents|mesh-ancestor
153510433|NCT01401075|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153510434|NCT01401075|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153510435|NCT01401075|Antimetabolites|antimetabolites|mesh-ancestor
153510436|NCT01401075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153510437|NCT01401075|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153510438|NCT01401075|Immunologic Factors|immunologic factors|mesh-ancestor
153510439|NCT01401075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153510440|NCT01401075|Appetite Stimulants|appetite stimulants|mesh-ancestor
153510441|NCT01401075|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
153510444|NCT01401179|Erythromycin|erythromycin|mesh-list
153510445|NCT01401179|Erythromycin Estolate|erythromycin estolate|mesh-list
153510446|NCT01401179|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
153510455|NCT01401179|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153510457|NCT01401192|Gemcitabine|gemcitabine|mesh-list
153510458|NCT01401192|Pemetrexed|pemetrexed|mesh-list
153510459|NCT01401192|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153510460|NCT01401192|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153787037|NCT00244439|Permethrin|permethrin|mesh-list
153510461|NCT01401192|Antimetabolites|antimetabolites|mesh-ancestor
153510462|NCT01401192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153510463|NCT01401192|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153510464|NCT01401192|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153510465|NCT01401192|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153510466|NCT01401387|Pancreatin|pancreatin|mesh-list
153510467|NCT01401387|Pancrelipase|pancrelipase|mesh-list
153510468|NCT01401387|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153510469|NCT01401491|Clozapine|clozapine|mesh-list
153510470|NCT01401491|Fluvoxamine|fluvoxamine|mesh-list
153510471|NCT01401491|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153510472|NCT01401491|Serotonin Agents|serotonin agents|mesh-ancestor
153510473|NCT01401491|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153510474|NCT01401491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153510475|NCT01401491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153510476|NCT01401491|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153510477|NCT01401491|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153510478|NCT01401491|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153510479|NCT01401491|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153510480|NCT01401491|GABA Antagonists|gaba antagonists|mesh-ancestor
153510481|NCT01401491|GABA Agents|gaba agents|mesh-ancestor
153510482|NCT01401491|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153453627|NCT01725126|Metformin|metformin|mesh-list
153510501|NCT01401933|Antitubercular Agents|antitubercular agents|mesh-ancestor
153510502|NCT01401933|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153510503|NCT01401933|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153510504|NCT01401933|Leprostatic Agents|leprostatic agents|mesh-ancestor
153510505|NCT01401933|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153510506|NCT01401933|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153923372|NCT03032601|Antidotes|antidotes|mesh-ancestor
153510507|NCT01401933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153510508|NCT01401933|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
153510509|NCT01401933|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
153510510|NCT01401933|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
153510511|NCT01401933|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
153510512|NCT01401933|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
153510513|NCT01401933|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
153510514|NCT01402024|Aprepitant|aprepitant|mesh-list
153510515|NCT01402024|Antiemetics|antiemetics|mesh-ancestor
153510516|NCT01402024|Autonomic Agents|autonomic agents|mesh-ancestor
153787249|NCT02961803|Vitamins|vitamins|mesh-ancestor
153510518|NCT01402024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153510519|NCT01402024|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153510520|NCT01402024|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
153510521|NCT01402024|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153510522|NCT01402024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153510523|NCT01402076|Rosiglitazone|rosiglitazone|mesh-list
153510524|NCT01402076|Midazolam|midazolam|mesh-list
153510525|NCT01402076|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153510526|NCT01402076|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153510527|NCT01402076|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153552257|NCT01577459|Tedizolid|tedizolid|mesh-list
153510528|NCT01402076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153552281|NCT01577693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153510529|NCT01402076|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153510530|NCT01402076|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153510531|NCT01402076|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153510532|NCT01402076|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153510537|NCT01402076|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153510538|NCT01402076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153510539|NCT01402076|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153510540|NCT01402089|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
153510541|NCT01402089|Sunitinib|sunitinib|mesh-list
153510542|NCT01402089|Midazolam|midazolam|mesh-list
153510543|NCT01402089|Caffeine|caffeine|mesh-list
153510544|NCT01402089|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153510545|NCT01402089|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153510546|NCT01402089|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153510547|NCT01402089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153510548|NCT01402089|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153510549|NCT01402089|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153510550|NCT01402089|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153510551|NCT01402089|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153510552|NCT01402089|Anesthetics, General|anesthetics, general|mesh-ancestor
153510553|NCT01402089|Anesthetics|anesthetics|mesh-ancestor
153510554|NCT01402089|GABA Modulators|gaba modulators|mesh-ancestor
153510555|NCT01402089|GABA Agents|gaba agents|mesh-ancestor
153510556|NCT01402089|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153510557|NCT01402089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153510558|NCT01402089|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153510559|NCT01402089|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153510560|NCT01402089|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153510561|NCT01402089|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153510562|NCT01402089|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153510563|NCT01402089|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153510564|NCT01402089|Growth Substances|growth substances|mesh-ancestor
153510565|NCT01402089|Growth Inhibitors|growth inhibitors|mesh-ancestor
153618878|NCT01980550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153510569|NCT01402089|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
153510581|NCT01402193|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
153510582|NCT01402193|Hormone Antagonists|hormone antagonists|mesh-ancestor
153510583|NCT01402193|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153510584|NCT01402193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153510586|NCT01402245|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
153510587|NCT01402245|Immunologic Factors|immunologic factors|mesh-ancestor
153510588|NCT01402245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153510589|NCT01402297|Acetovanillone|acetovanillone|mesh-list
153510590|NCT01402297|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153510591|NCT01402297|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153510592|NCT01402297|Analgesics|analgesics|mesh-ancestor
153510593|NCT01402297|Sensory System Agents|sensory system agents|mesh-ancestor
153510595|NCT01402297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153510596|NCT01402297|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153510597|NCT01402297|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153510598|NCT01402297|Antioxidants|antioxidants|mesh-ancestor
153510599|NCT01402297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153510600|NCT01402297|Protective Agents|protective agents|mesh-ancestor
153510601|NCT01402297|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153510602|NCT01402336|Triptorelin Pamoate|triptorelin pamoate|mesh-list
153510603|NCT01402336|Cetrorelix|cetrorelix|mesh-list
153510604|NCT01402336|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
153510626|NCT01402583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153510627|NCT01402583|Antiviral Agents|antiviral agents|mesh-ancestor
153510628|NCT01402583|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153510629|NCT01402596|Midazolam|midazolam|mesh-list
153510630|NCT01402596|Chloral Hydrate|chloral hydrate|mesh-list
153552287|NCT01577849|Vitamins|vitamins|mesh-ancestor
153510631|NCT01402596|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153510632|NCT01402596|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153510633|NCT01402596|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153510634|NCT01402596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153510636|NCT01402596|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153510637|NCT01402596|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153510638|NCT01402596|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153510639|NCT01402596|Anesthetics, General|anesthetics, general|mesh-ancestor
153510640|NCT01402596|Anesthetics|anesthetics|mesh-ancestor
153510641|NCT01402596|GABA Modulators|gaba modulators|mesh-ancestor
153510684|NCT01403025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153510685|NCT01403025|Incretins|incretins|mesh-ancestor
153510686|NCT01403025|Hormones|hormones|mesh-ancestor
153510687|NCT01403025|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153510688|NCT01403103|Vitamin D|vitamin d|mesh-list
153510689|NCT01403103|Cholecalciferol|cholecalciferol|mesh-list
153510690|NCT01403103|Vitamins|vitamins|mesh-ancestor
153510691|NCT01403103|Micronutrients|micronutrients|mesh-ancestor
153510692|NCT01403103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153510693|NCT01403103|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153787819|NCT00278265|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153510694|NCT01403103|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153510695|NCT01403168|Analgesics|analgesics|mesh-list
153510696|NCT01403168|Sensory System Agents|sensory system agents|mesh-ancestor
153510697|NCT01403168|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153510698|NCT01403168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153510699|NCT01403181|Ribavirin|ribavirin|mesh-list
153510700|NCT01403181|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
153510701|NCT01403181|Antimetabolites|antimetabolites|mesh-ancestor
153510702|NCT01403181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153510703|NCT01403181|Antiviral Agents|antiviral agents|mesh-ancestor
153510704|NCT01403181|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153510705|NCT01403259|Oxaliplatin|oxaliplatin|mesh-list
153510706|NCT01403259|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153510707|NCT01403285|Cyclophosphamide|cyclophosphamide|mesh-list
153510708|NCT01403285|Molgramostim|molgramostim|mesh-list
153510709|NCT01403285|Imiquimod|imiquimod|mesh-list
153510710|NCT01403285|Sargramostim|sargramostim|mesh-list
153510733|NCT01403363|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153510734|NCT01403363|Anesthetics, General|anesthetics, general|mesh-ancestor
153510735|NCT01403363|Anesthetics|anesthetics|mesh-ancestor
153510736|NCT01403389|Eculizumab|eculizumab|mesh-list
153510737|NCT01403389|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
153510738|NCT01403389|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153510739|NCT01403389|Immunologic Factors|immunologic factors|mesh-ancestor
153510740|NCT01403389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153510741|NCT01403415|Sirolimus|sirolimus|mesh-list
153510742|NCT01403415|Dexamethasone|dexamethasone|mesh-list
153510743|NCT01403415|Dexamethasone acetate|dexamethasone acetate|mesh-list
153510744|NCT01403415|Methotrexate|methotrexate|mesh-list
153510745|NCT01403415|Vincristine|vincristine|mesh-list
153510746|NCT01403415|Asparaginase|asparaginase|mesh-list
153510747|NCT01403415|Temsirolimus|temsirolimus|mesh-list
153510748|NCT01403415|Mitoxantrone|mitoxantrone|mesh-list
153510749|NCT01403415|Pegaspargase|pegaspargase|mesh-list
153510750|NCT01403415|MTOR Inhibitors|mtor inhibitors|mesh-list
153510751|NCT01403415|BB 1101|bb 1101|mesh-list
153510752|NCT01403415|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153510753|NCT01403415|Antiemetics|antiemetics|mesh-ancestor
153510754|NCT01403415|Autonomic Agents|autonomic agents|mesh-ancestor
153510755|NCT01403415|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153510756|NCT01403415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153510757|NCT01403415|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153510758|NCT01403415|Glucocorticoids|glucocorticoids|mesh-ancestor
153510759|NCT01403415|Hormones|hormones|mesh-ancestor
153510760|NCT01403415|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153510761|NCT01403415|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153510762|NCT01403415|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153510763|NCT01403415|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
153510764|NCT01403415|Abortifacient Agents|abortifacient agents|mesh-ancestor
153510765|NCT01403415|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153510778|NCT01403415|Antimitotic Agents|antimitotic agents|mesh-ancestor
153510779|NCT01403415|Mitosis Modulators|mitosis modulators|mesh-ancestor
153510780|NCT01403415|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153510781|NCT01403415|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153510782|NCT01403415|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153510783|NCT01403415|Antifungal Agents|antifungal agents|mesh-ancestor
153787968|NCT00249041|Immunologic Factors|immunologic factors|mesh-ancestor
153510784|NCT01403415|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153510785|NCT01403415|Protease Inhibitors|protease inhibitors|mesh-ancestor
153510786|NCT01403415|Analgesics|analgesics|mesh-ancestor
153510787|NCT01403415|Sensory System Agents|sensory system agents|mesh-ancestor
153618879|NCT01980550|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
153510788|NCT01403415|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153510789|NCT01403415|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153510790|NCT01403506|Acetylcysteine|acetylcysteine|mesh-list
153510791|NCT01403506|N-monoacetylcystine|n-monoacetylcystine|mesh-list
153510792|NCT01403506|Antiviral Agents|antiviral agents|mesh-ancestor
153510793|NCT01403506|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153510794|NCT01403506|Expectorants|expectorants|mesh-ancestor
153510795|NCT01403506|Respiratory System Agents|respiratory system agents|mesh-ancestor
153510796|NCT01403506|Free Radical Scavengers|free radical scavengers|mesh-ancestor
153510797|NCT01403506|Antioxidants|antioxidants|mesh-ancestor
153510798|NCT01403506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153510799|NCT01403506|Protective Agents|protective agents|mesh-ancestor
153510800|NCT01403506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153510801|NCT01403506|Antidotes|antidotes|mesh-ancestor
153510802|NCT01403545|Curcumin|curcumin|mesh-list
153510803|NCT01403545|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153510827|NCT01403740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153510828|NCT01403740|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153510829|NCT01403740|Antifungal Agents|antifungal agents|mesh-ancestor
153510830|NCT01403740|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153510831|NCT01403740|Dermatologic Agents|dermatologic agents|mesh-ancestor
153510832|NCT01403740|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
153510833|NCT01403740|Antimetabolites|antimetabolites|mesh-ancestor
153510834|NCT01403740|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153510835|NCT01403818|Ipragliflozin|ipragliflozin|mesh-list
153510836|NCT01403818|Mitiglinide|mitiglinide|mesh-list
153788035|NCT00249236|Risperidone|risperidone|mesh-list
153510838|NCT01403818|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153510839|NCT01403818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153510840|NCT01403818|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
153510841|NCT01403818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153510842|NCT01403818|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153510843|NCT01403844|Carotenoids|carotenoids|mesh-list
153510844|NCT01403844|Antioxidants|antioxidants|mesh-ancestor
153510846|NCT01403844|Protective Agents|protective agents|mesh-ancestor
153510881|NCT01404104|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153510882|NCT01404104|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153510883|NCT01404104|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153510884|NCT01404104|Antifungal Agents|antifungal agents|mesh-ancestor
153510885|NCT01404117|Interferons|interferons|mesh-list
153510886|NCT01404117|Interferon-beta|interferon-beta|mesh-list
153510887|NCT01404117|Glatiramer Acetate|glatiramer acetate|mesh-list
153510888|NCT01404117|(T,G)-A-L|(t,g)-a-l|mesh-list
153510889|NCT01404117|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153510890|NCT01404117|Antiviral Agents|antiviral agents|mesh-ancestor
153510891|NCT01404117|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153788136|NCT00279162|Hormones|hormones|mesh-ancestor
153510893|NCT01404117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153510894|NCT01404117|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153510895|NCT01404117|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153510896|NCT01404117|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153510898|NCT01404130|Dermatologic Agents|dermatologic agents|mesh-ancestor
153510899|NCT01404156|Leucovorin|leucovorin|mesh-list
153510900|NCT01404156|Paclitaxel|paclitaxel|mesh-list
153510901|NCT01404156|Docetaxel|docetaxel|mesh-list
153510902|NCT01404156|Carboplatin|carboplatin|mesh-list
153510903|NCT01404156|Fluorouracil|fluorouracil|mesh-list
153510904|NCT01404156|Oxaliplatin|oxaliplatin|mesh-list
153510905|NCT01404156|Epirubicin|epirubicin|mesh-list
153510906|NCT01404156|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153510907|NCT01404156|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153510908|NCT01404156|Tubulin Modulators|tubulin modulators|mesh-ancestor
153510909|NCT01404156|Antimitotic Agents|antimitotic agents|mesh-ancestor
153510910|NCT01404156|Mitosis Modulators|mitosis modulators|mesh-ancestor
153510911|NCT01404156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153510912|NCT01404156|Antimetabolites|antimetabolites|mesh-ancestor
153510913|NCT01404156|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153510914|NCT01404156|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153510915|NCT01404156|Immunologic Factors|immunologic factors|mesh-ancestor
153510916|NCT01404156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153510917|NCT01404156|Antidotes|antidotes|mesh-ancestor
153510918|NCT01404156|Protective Agents|protective agents|mesh-ancestor
153510919|NCT01404156|Vitamin B Complex|vitamin b complex|mesh-ancestor
153510920|NCT01404156|Vitamins|vitamins|mesh-ancestor
153510921|NCT01404156|Micronutrients|micronutrients|mesh-ancestor
153510922|NCT01404156|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153510923|NCT01404156|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153510924|NCT01404156|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153510925|NCT01404156|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153510926|NCT01404169|Donepezil|donepezil|mesh-list
153510927|NCT01404169|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
153510928|NCT01404169|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153788185|NCT00249899|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153510929|NCT01404169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153510930|NCT01404169|Cholinergic Agents|cholinergic agents|mesh-ancestor
153510931|NCT01404169|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153510932|NCT01404169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153510933|NCT01404169|Nootropic Agents|nootropic agents|mesh-ancestor
153510934|NCT01404182|Vaccines|vaccines|mesh-list
153510935|NCT01404182|Immunologic Factors|immunologic factors|mesh-ancestor
153510936|NCT01404182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153510937|NCT01404312|Pyridoxine|pyridoxine|mesh-list
153510938|NCT01404312|Pyridoxal|pyridoxal|mesh-list
153510939|NCT01404312|Vitamin B 6|vitamin b 6|mesh-list
153510940|NCT01404312|Isoniazid|isoniazid|mesh-list
153510941|NCT01404312|Rifapentine|rifapentine|mesh-list
153510942|NCT01404312|Vitamins|vitamins|mesh-ancestor
153618881|NCT01980550|Cholinergic Agents|cholinergic agents|mesh-ancestor
153454098|NCT01687296|Xhance|xhance|mesh-list
153510943|NCT01404312|Micronutrients|micronutrients|mesh-ancestor
153510944|NCT01404312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153510945|NCT01404312|Vitamin B Complex|vitamin b complex|mesh-ancestor
153510946|NCT01404312|Antitubercular Agents|antitubercular agents|mesh-ancestor
153510947|NCT01404312|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153510948|NCT01404312|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153510949|NCT01404312|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
153510950|NCT01404312|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153510965|NCT01404364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153510966|NCT01404364|Antiemetics|antiemetics|mesh-ancestor
153510967|NCT01404364|Autonomic Agents|autonomic agents|mesh-ancestor
153510968|NCT01404364|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153510969|NCT01404364|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153510970|NCT01404364|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153510971|NCT01404364|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153510972|NCT01404364|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153510973|NCT01404364|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153510974|NCT01404364|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
153510975|NCT01404364|Dopamine Agents|dopamine agents|mesh-ancestor
153510976|NCT01404364|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153510977|NCT01404377|Ropivacaine|ropivacaine|mesh-list
153510978|NCT01404377|Anesthetics, Local|anesthetics, local|mesh-ancestor
153510980|NCT01404377|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153510981|NCT01404377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153510982|NCT01404377|Sensory System Agents|sensory system agents|mesh-ancestor
153510983|NCT01404377|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153510984|NCT01404442|Midazolam|midazolam|mesh-list
153510985|NCT01404442|Ketamine|ketamine|mesh-list
153510986|NCT01404442|Analgesics|analgesics|mesh-ancestor
153511019|NCT01404507|Anticoagulants|anticoagulants|mesh-ancestor
153511036|NCT01404637|Tamsulosin|tamsulosin|mesh-list
153511037|NCT01404637|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
153511038|NCT01404637|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
153511039|NCT01404637|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
153511040|NCT01404637|Adrenergic Agents|adrenergic agents|mesh-ancestor
153511041|NCT01404637|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153552331|NCT01577992|Levodopa|levodopa|mesh-list
153511042|NCT01404637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153511043|NCT01404637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153511044|NCT01404637|Urological Agents|urological agents|mesh-ancestor
153511045|NCT01404676|Glimepiride|glimepiride|mesh-list
153511046|NCT01404676|Vildagliptin|vildagliptin|mesh-list
153511047|NCT01404676|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153511062|NCT01404689|Sensory System Agents|sensory system agents|mesh-ancestor
153511063|NCT01404689|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153511064|NCT01404689|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
153511065|NCT01404689|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153511066|NCT01404689|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153511067|NCT01404689|Adrenergic Agents|adrenergic agents|mesh-ancestor
153511068|NCT01404689|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153511069|NCT01404689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153511070|NCT01404702|Zoledronic Acid|zoledronic acid|mesh-list
153511071|NCT01404702|Aldesleukin|aldesleukin|mesh-list
153511072|NCT01404702|Interleukin-2|interleukin-2|mesh-list
153511074|NCT01404702|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153511075|NCT01404702|Analgesics|analgesics|mesh-ancestor
153511076|NCT01404702|Sensory System Agents|sensory system agents|mesh-ancestor
153511077|NCT01404702|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153511078|NCT01404702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153511079|NCT01404702|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153511080|NCT01404702|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153511081|NCT01404702|Antiviral Agents|antiviral agents|mesh-ancestor
153511082|NCT01404702|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153511083|NCT01404702|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153511085|NCT01404715|Imatinib Mesylate|imatinib mesylate|mesh-list
153511086|NCT01404715|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153511087|NCT01404715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153511088|NCT01404715|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153511093|NCT01404767|Metoprolol|metoprolol|mesh-list
153511108|NCT01404793|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
153511109|NCT01404793|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
153511110|NCT01404793|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
153511111|NCT01404793|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153511112|NCT01404793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153511113|NCT01404806|Dolutegravir|dolutegravir|mesh-list
153511114|NCT01404806|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
153511115|NCT01404806|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
153511116|NCT01404806|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153511117|NCT01404806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153511118|NCT01404806|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153511119|NCT01404806|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153511120|NCT01404806|Antiviral Agents|antiviral agents|mesh-ancestor
153511121|NCT01404806|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153511122|NCT01404819|Anesthetics|anesthetics|mesh-list
153511123|NCT01404819|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153511124|NCT01404819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153511125|NCT01404871|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
153511126|NCT01404871|Clomipramine|clomipramine|mesh-list
153511127|NCT01404871|Escitalopram|escitalopram|mesh-list
153511128|NCT01404871|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
153511129|NCT01404871|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153511130|NCT01404871|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153511131|NCT01404871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153511132|NCT01404871|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153511133|NCT01404871|Serotonin Agents|serotonin agents|mesh-ancestor
153511134|NCT01404871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153511139|NCT01404871|Analgesics|analgesics|mesh-ancestor
153511152|NCT01405079|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153511153|NCT01405079|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153552338|NCT01578057|Ethanol|ethanol|mesh-list
153511155|NCT01405118|Tofacitinib|tofacitinib|mesh-list
153511156|NCT01405118|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153511157|NCT01405118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153511158|NCT01405118|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
153511159|NCT01405118|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153511160|NCT01405118|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153511161|NCT01405118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153511162|NCT01405131|Methylprednisolone|methylprednisolone|mesh-list
153511163|NCT01405131|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
153511164|NCT01405131|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
153511165|NCT01405131|Prednisolone|prednisolone|mesh-list
153511166|NCT01405131|Prednisolone acetate|prednisolone acetate|mesh-list
153511167|NCT01405131|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
153511168|NCT01405131|Prednisolone phosphate|prednisolone phosphate|mesh-list
153511169|NCT01405131|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153511170|NCT01405131|Antiemetics|antiemetics|mesh-ancestor
153511171|NCT01405131|Autonomic Agents|autonomic agents|mesh-ancestor
153511172|NCT01405131|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153511173|NCT01405131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153511174|NCT01405131|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153511175|NCT01405131|Glucocorticoids|glucocorticoids|mesh-ancestor
153511176|NCT01405131|Hormones|hormones|mesh-ancestor
153511177|NCT01405131|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153511178|NCT01405131|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
153511179|NCT01405131|Protective Agents|protective agents|mesh-ancestor
153511180|NCT01405131|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153511198|NCT01405157|Antiemetics|antiemetics|mesh-ancestor
153511199|NCT01405157|Autonomic Agents|autonomic agents|mesh-ancestor
153511200|NCT01405157|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153511201|NCT01405157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153511202|NCT01405157|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153511203|NCT01405157|Glucocorticoids|glucocorticoids|mesh-ancestor
153511204|NCT01405157|Hormones|hormones|mesh-ancestor
153511205|NCT01405157|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153511206|NCT01405157|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
153511207|NCT01405157|Protective Agents|protective agents|mesh-ancestor
153511208|NCT01405157|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153511209|NCT01405157|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153511210|NCT01405170|Methylprednisolone|methylprednisolone|mesh-list
153511211|NCT01405170|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
153511212|NCT01405170|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
153511213|NCT01405170|Prednisolone|prednisolone|mesh-list
153511214|NCT01405170|Prednisolone acetate|prednisolone acetate|mesh-list
153511215|NCT01405170|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
153511216|NCT01405170|Prednisolone phosphate|prednisolone phosphate|mesh-list
153511217|NCT01405170|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153511218|NCT01405170|Antiemetics|antiemetics|mesh-ancestor
153511224|NCT01405170|Hormones|hormones|mesh-ancestor
153511249|NCT01405339|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153511250|NCT01405339|Autonomic Agents|autonomic agents|mesh-ancestor
153511251|NCT01405339|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153511252|NCT01405339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153511253|NCT01405339|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153511254|NCT01405339|Respiratory System Agents|respiratory system agents|mesh-ancestor
153511255|NCT01405339|Glucocorticoids|glucocorticoids|mesh-ancestor
153511256|NCT01405339|Hormones|hormones|mesh-ancestor
153511257|NCT01405339|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153511258|NCT01405352|Vitamin A|vitamin a|mesh-list
153511259|NCT01405352|Vitamins|vitamins|mesh-ancestor
153511260|NCT01405352|Micronutrients|micronutrients|mesh-ancestor
153511261|NCT01405352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153511262|NCT01405365|Metronidazole|metronidazole|mesh-list
153511263|NCT01405365|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153511264|NCT01405365|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153511265|NCT01405365|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153511266|NCT01405365|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153511267|NCT01405430|Bevacizumab|bevacizumab|mesh-list
153511268|NCT01405430|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153511274|NCT01405430|Growth Inhibitors|growth inhibitors|mesh-ancestor
153511275|NCT01405482|Botulinum Toxins|botulinum toxins|mesh-list
153511276|NCT01405482|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
153511277|NCT01405482|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
153511278|NCT01405482|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
153511281|NCT01405482|Cholinergic Agents|cholinergic agents|mesh-ancestor
153511293|NCT01405612|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153511294|NCT01405612|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153511295|NCT01405612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153511296|NCT01405612|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153511297|NCT01405612|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153511298|NCT01405612|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153511299|NCT01405612|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153511300|NCT01405612|Anesthetics, General|anesthetics, general|mesh-ancestor
153511301|NCT01405612|Anesthetics|anesthetics|mesh-ancestor
153511302|NCT01405612|GABA Modulators|gaba modulators|mesh-ancestor
153511303|NCT01405612|GABA Agents|gaba agents|mesh-ancestor
153511304|NCT01405612|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153511305|NCT01405612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153511306|NCT01405807|Alemtuzumab|alemtuzumab|mesh-list
153788548|NCT01641796|Paromomycin|paromomycin|mesh-list
153511307|NCT01405807|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153511308|NCT01405807|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153511309|NCT01405846|Gefitinib|gefitinib|mesh-list
153511310|NCT01405846|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153511311|NCT01405846|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153511312|NCT01405846|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153618882|NCT01980550|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153454421|NCT01585038|Antiviral Agents|antiviral agents|mesh-ancestor
153511313|NCT01405846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153511314|NCT01405846|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153511315|NCT01405872|Interferon beta-1a|interferon beta-1a|mesh-list
153511316|NCT01405872|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153511317|NCT01405872|Immunologic Factors|immunologic factors|mesh-ancestor
153511318|NCT01405872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153511319|NCT01405872|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153511320|NCT01405872|Antiviral Agents|antiviral agents|mesh-ancestor
153511321|NCT01405872|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153511322|NCT01405989|Ketoconazole|ketoconazole|mesh-list
153511323|NCT01405989|Darexaban|darexaban|mesh-list
153511332|NCT01405989|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153511333|NCT01405989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153511334|NCT01405989|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
153511335|NCT01405989|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
153511336|NCT01405989|Antithrombins|antithrombins|mesh-ancestor
153511337|NCT01405989|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
153511338|NCT01405989|Protease Inhibitors|protease inhibitors|mesh-ancestor
153511339|NCT01405989|Anticoagulants|anticoagulants|mesh-ancestor
153511340|NCT01406002|Rifampin|rifampin|mesh-list
153511341|NCT01406002|Darexaban|darexaban|mesh-list
153511342|NCT01406002|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
153511343|NCT01406002|Antitubercular Agents|antitubercular agents|mesh-ancestor
153511344|NCT01406002|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153511352|NCT01406002|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
153511353|NCT01406002|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
153511354|NCT01406002|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
153511355|NCT01406002|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
153511356|NCT01406002|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
153511358|NCT01406002|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
153511359|NCT01406002|Protease Inhibitors|protease inhibitors|mesh-ancestor
153511360|NCT01406002|Anticoagulants|anticoagulants|mesh-ancestor
153511361|NCT01406080|Adapalene|adapalene|mesh-list
153511362|NCT01406080|Tretinoin|tretinoin|mesh-list
153511363|NCT01406080|Emollients|emollients|mesh-list
153511364|NCT01406080|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153511372|NCT01406080|Dermatologic Agents|dermatologic agents|mesh-ancestor
153511373|NCT01406080|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153511374|NCT01406080|Keratolytic Agents|keratolytic agents|mesh-ancestor
153511375|NCT01406132|Peficitinib|peficitinib|mesh-list
153511376|NCT01406132|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153552379|NCT01578174|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153511377|NCT01406132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153511378|NCT01406132|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153511379|NCT01406132|Immunologic Factors|immunologic factors|mesh-ancestor
153511380|NCT01406132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153511381|NCT01406158|Solifenacin Succinate|solifenacin succinate|mesh-list
153511382|NCT01406158|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
153511383|NCT01406158|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
153511384|NCT01406158|Cholinergic Agents|cholinergic agents|mesh-ancestor
153618883|NCT01980550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153511385|NCT01406158|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153511386|NCT01406158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153511387|NCT01406158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153511388|NCT01406158|Urological Agents|urological agents|mesh-ancestor
153511389|NCT01406171|Isavuconazole|isavuconazole|mesh-list
153511390|NCT01406171|Midazolam|midazolam|mesh-list
153511391|NCT01406171|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153511392|NCT01406171|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153511393|NCT01406171|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153511394|NCT01406171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153511395|NCT01406171|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153511396|NCT01406171|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153511418|NCT01406262|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153511419|NCT01406275|Amoxicillin|amoxicillin|mesh-list
153511420|NCT01406275|Clavulanic Acid|clavulanic acid|mesh-list
153511421|NCT01406275|Clavulanic Acids|clavulanic acids|mesh-list
153511422|NCT01406275|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153511423|NCT01406275|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153511424|NCT01406275|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
153511425|NCT01406275|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153511426|NCT01406275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153511427|NCT01406301|PENTA|penta|mesh-list
153511432|NCT01406301|Protease Inhibitors|protease inhibitors|mesh-ancestor
153511433|NCT01406301|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153511434|NCT01406301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153511435|NCT01406301|Anticoagulants|anticoagulants|mesh-ancestor
153511436|NCT01406301|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153511437|NCT01406301|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153511438|NCT01406327|Ambrisentan|ambrisentan|mesh-list
153511439|NCT01406327|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153511440|NCT01406392|Misoprostol|misoprostol|mesh-list
153511441|NCT01406392|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
153511442|NCT01406392|Abortifacient Agents|abortifacient agents|mesh-ancestor
153511443|NCT01406392|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153511444|NCT01406392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153511445|NCT01406392|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
153511446|NCT01406392|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153511447|NCT01406392|Oxytocics|oxytocics|mesh-ancestor
153511448|NCT01406431|Valsartan|valsartan|mesh-list
153511449|NCT01406431|Pitavastatin|pitavastatin|mesh-list
153511450|NCT01406431|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153511451|NCT01406431|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
153511460|NCT01406470|Immunoglobulins|immunoglobulins|mesh-list
153511461|NCT01406470|Antibodies|antibodies|mesh-list
153511462|NCT01406470|gamma-Globulins|gamma-globulins|mesh-list
153511463|NCT01406470|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
153511464|NCT01406470|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
153511465|NCT01406470|Immunoglobulin G|immunoglobulin g|mesh-list
153511466|NCT01406470|Immunologic Factors|immunologic factors|mesh-ancestor
153511467|NCT01406470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153511468|NCT01406496|Insulin|insulin|mesh-list
153511469|NCT01406496|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
153511470|NCT01406496|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153511471|NCT01406496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153511472|NCT01406522|Tacrine|tacrine|mesh-list
153511473|NCT01406522|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
153511474|NCT01406522|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153511475|NCT01406522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153511476|NCT01406522|Cholinergic Agents|cholinergic agents|mesh-ancestor
153511477|NCT01406522|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153511478|NCT01406522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153511479|NCT01406522|Parasympathomimetics|parasympathomimetics|mesh-ancestor
153511480|NCT01406522|Autonomic Agents|autonomic agents|mesh-ancestor
153511481|NCT01406522|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153788802|NCT00252356|Amibegron|amibegron|mesh-list
153511482|NCT01406522|Nootropic Agents|nootropic agents|mesh-ancestor
153511483|NCT01406535|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
153511484|NCT01406535|Vasodilator Agents|vasodilator agents|mesh-ancestor
153511485|NCT01406535|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
153511486|NCT01406535|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
153511487|NCT01406535|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153511508|NCT01406704|Vitamins|vitamins|mesh-ancestor
153511509|NCT01406704|Micronutrients|micronutrients|mesh-ancestor
153511510|NCT01406782|Rituximab|rituximab|mesh-list
153511511|NCT01406782|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153511512|NCT01406782|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153511513|NCT01406782|Immunologic Factors|immunologic factors|mesh-ancestor
153511514|NCT01406782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153511515|NCT01406782|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153511516|NCT01407016|Metronidazole|metronidazole|mesh-list
153511517|NCT01407016|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153511523|NCT01407211|Micronutrients|micronutrients|mesh-ancestor
153511524|NCT01407211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153511525|NCT01407237|Angiotensin II|angiotensin ii|mesh-list
153511570|NCT01407822|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
153511571|NCT01407822|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153511572|NCT01407822|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153511573|NCT01407822|Antimetabolites|antimetabolites|mesh-ancestor
153511574|NCT01407822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153511575|NCT01407822|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153511576|NCT01407822|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153511577|NCT01407822|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153511579|NCT01407848|Diuretics|diuretics|mesh-ancestor
153511580|NCT01407848|Natriuretic Agents|natriuretic agents|mesh-ancestor
153511581|NCT01407848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153511582|NCT01407848|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
153511583|NCT01407848|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153511584|NCT01407848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153511585|NCT01407887|Artesunate|artesunate|mesh-list
153511586|NCT01407887|Amodiaquine|amodiaquine|mesh-list
153511587|NCT01407887|Methylene Blue|methylene blue|mesh-list
153511588|NCT01407887|Antimalarials|antimalarials|mesh-ancestor
153511589|NCT01407887|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153511590|NCT01407887|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153511591|NCT01407887|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153511592|NCT01407887|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153511593|NCT01407887|Antiviral Agents|antiviral agents|mesh-ancestor
153511594|NCT01407887|Schistosomicides|schistosomicides|mesh-ancestor
153511595|NCT01407887|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
153511596|NCT01407887|Anthelmintics|anthelmintics|mesh-ancestor
153511597|NCT01407887|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153511598|NCT01407887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153511599|NCT01408004|Everolimus|everolimus|mesh-list
153511600|NCT01408004|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
153511601|NCT01408004|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153511602|NCT01408004|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153511603|NCT01408004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153511604|NCT01408004|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153511610|NCT01408056|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
153511611|NCT01408056|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
153511612|NCT01408056|Adrenergic Agents|adrenergic agents|mesh-ancestor
153511613|NCT01408056|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153788939|NCT00287352|Serotonin Agents|serotonin agents|mesh-ancestor
153552437|NCT01578343|Autonomic Agents|autonomic agents|mesh-ancestor
153781914|NCT00232154|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153511614|NCT01408056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153511615|NCT01408056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153511616|NCT01408056|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153511617|NCT01408056|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153511618|NCT01408056|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153511619|NCT01408056|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153511620|NCT01408056|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
153511621|NCT01408056|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153511623|NCT01408095|Globalagliatin|globalagliatin|mesh-list
153511624|NCT01408095|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153511625|NCT01408095|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153511626|NCT01408095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153511627|NCT01408095|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153511628|NCT01408095|Immunologic Factors|immunologic factors|mesh-ancestor
153511629|NCT01408095|Enzyme Activators|enzyme activators|mesh-ancestor
153788996|NCT01680406|Chloroquine|chloroquine|mesh-list
153511660|NCT01408186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153511661|NCT01408186|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
153511662|NCT01408186|Histamine Antagonists|histamine antagonists|mesh-ancestor
153511663|NCT01408186|Histamine Agents|histamine agents|mesh-ancestor
153511664|NCT01408186|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153511665|NCT01408186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153511667|NCT01408199|Immunologic Factors|immunologic factors|mesh-ancestor
153511668|NCT01408199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153511669|NCT01408199|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153511670|NCT01408199|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153511671|NCT01408199|Growth Substances|growth substances|mesh-ancestor
153511672|NCT01408199|Growth Inhibitors|growth inhibitors|mesh-ancestor
153511673|NCT01408199|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153511674|NCT01408342|Rituximab|rituximab|mesh-list
153511675|NCT01408342|Alemtuzumab|alemtuzumab|mesh-list
153511676|NCT01408342|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153511677|NCT01408342|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153511678|NCT01408342|Immunologic Factors|immunologic factors|mesh-ancestor
153511679|NCT01408342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153511680|NCT01408342|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153511681|NCT01408394|Ecopipam|ecopipam|mesh-list
153511682|NCT01408394|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153511683|NCT01408394|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153511684|NCT01408394|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153511685|NCT01408394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153511686|NCT01408394|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153511687|NCT01408394|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
153511688|NCT01408394|Dopamine Agents|dopamine agents|mesh-ancestor
153511706|NCT01408524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153511707|NCT01408524|Vasodilator Agents|vasodilator agents|mesh-ancestor
153511708|NCT01408524|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
153511709|NCT01408524|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
153511710|NCT01408524|Adrenergic Agents|adrenergic agents|mesh-ancestor
153511711|NCT01408524|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153511712|NCT01408524|Sympathomimetics|sympathomimetics|mesh-ancestor
153511713|NCT01408524|Autonomic Agents|autonomic agents|mesh-ancestor
153511714|NCT01408524|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153511715|NCT01408524|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
153511716|NCT01408524|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
153511717|NCT01408589|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
153511718|NCT01408589|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
153511719|NCT01408589|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153511720|NCT01408589|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153511721|NCT01408589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153511722|NCT01408589|Adrenergic Agents|adrenergic agents|mesh-ancestor
153511759|NCT01408849|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
153511760|NCT01408849|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153511761|NCT01408849|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
153511762|NCT01408849|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153511763|NCT01408849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153511764|NCT01408927|Aspirin|aspirin|mesh-list
153454884|NCT01570686|Aliskiren|aliskiren|mesh-list
153511765|NCT01408927|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153511766|NCT01408927|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153511767|NCT01408927|Analgesics|analgesics|mesh-ancestor
153511768|NCT01408927|Sensory System Agents|sensory system agents|mesh-ancestor
153511769|NCT01408927|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153789201|NCT02279914|Oxytocics|oxytocics|mesh-ancestor
153511770|NCT01408927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153511771|NCT01408927|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153511772|NCT01408927|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153511773|NCT01408927|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153511774|NCT01408927|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153511775|NCT01408927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153511776|NCT01408927|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153511806|NCT01409005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153511807|NCT01409005|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153511808|NCT01409018|Itraconazole|itraconazole|mesh-list
153511809|NCT01409018|Hydroxyitraconazole|hydroxyitraconazole|mesh-list
153511810|NCT01409018|Antifungal Agents|antifungal agents|mesh-ancestor
153511811|NCT01409018|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153511812|NCT01409018|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
153511813|NCT01409018|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153511814|NCT01409018|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153511815|NCT01409018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153511816|NCT01409018|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153511817|NCT01409018|Hormone Antagonists|hormone antagonists|mesh-ancestor
153511818|NCT01409018|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153511819|NCT01409018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153511820|NCT01409018|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
153511821|NCT01409122|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
153511822|NCT01409148|Antibodies|antibodies|mesh-list
153511823|NCT01409148|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
153511824|NCT01409148|Immunologic Factors|immunologic factors|mesh-ancestor
153511825|NCT01409148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153511826|NCT01409174|Interferons|interferons|mesh-list
153511827|NCT01409174|Interferon-alpha|interferon-alpha|mesh-list
153511828|NCT01409174|Interferon alpha-2|interferon alpha-2|mesh-list
153511829|NCT01409174|Aldesleukin|aldesleukin|mesh-list
153511855|NCT01409187|Interleukin-2|interleukin-2|mesh-list
153511856|NCT01409187|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153511857|NCT01409187|Antiviral Agents|antiviral agents|mesh-ancestor
153511858|NCT01409187|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153511864|NCT01409187|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153511865|NCT01409187|Analgesics|analgesics|mesh-ancestor
153511866|NCT01409187|Sensory System Agents|sensory system agents|mesh-ancestor
153511867|NCT01409187|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153511868|NCT01409187|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153511869|NCT01409187|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153511870|NCT01409278|Ropivacaine|ropivacaine|mesh-list
153511871|NCT01409278|Anesthetics, Local|anesthetics, local|mesh-ancestor
153511872|NCT01409278|Anesthetics|anesthetics|mesh-ancestor
153511873|NCT01409278|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153511874|NCT01409278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153511875|NCT01409278|Sensory System Agents|sensory system agents|mesh-ancestor
153511876|NCT01409278|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153511878|NCT01409369|Antidotes|antidotes|mesh-ancestor
153511879|NCT01409369|Protective Agents|protective agents|mesh-ancestor
153511880|NCT01409369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153511881|NCT01409395|Metformin|metformin|mesh-list
153511882|NCT01409395|Nizatidine|nizatidine|mesh-list
153511883|NCT01409395|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153511884|NCT01409395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153511885|NCT01409395|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
153511886|NCT01409395|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153511887|NCT01409395|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
153511888|NCT01409395|Histamine Antagonists|histamine antagonists|mesh-ancestor
153511893|NCT01409408|Aliskiren|aliskiren|mesh-list
153511894|NCT01409408|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153511895|NCT01409408|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153511896|NCT01409408|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153511897|NCT01409408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153511898|NCT01409408|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153511899|NCT01409408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153511900|NCT01409408|Vasodilator Agents|vasodilator agents|mesh-ancestor
153511901|NCT01409408|Renin Inhibitors|renin inhibitors|mesh-ancestor
153511902|NCT01409408|Protease Inhibitors|protease inhibitors|mesh-ancestor
153511903|NCT01409408|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153511904|NCT01409421|Ophthalmic Solutions|ophthalmic solutions|mesh-list
153511905|NCT01409421|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
153511906|NCT01409603|Naproxen|naproxen|mesh-list
153511907|NCT01409603|Darexaban|darexaban|mesh-list
153511952|NCT01409616|Keratolytic Agents|keratolytic agents|mesh-ancestor
153511953|NCT01409616|Dermatologic Agents|dermatologic agents|mesh-ancestor
153511954|NCT01409616|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
153511955|NCT01409616|Antithrombins|antithrombins|mesh-ancestor
153511956|NCT01409616|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
153511957|NCT01409616|Protease Inhibitors|protease inhibitors|mesh-ancestor
153511958|NCT01409616|Anticoagulants|anticoagulants|mesh-ancestor
153511960|NCT01409694|Ergocalciferols|ergocalciferols|mesh-list
153511961|NCT01409694|Cholecalciferol|cholecalciferol|mesh-list
153511962|NCT01409694|Vitamins|vitamins|mesh-list
153511963|NCT01409694|Memantine|memantine|mesh-list
153511964|NCT01409694|Micronutrients|micronutrients|mesh-ancestor
153789408|NCT00287820|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153789424|NCT02272348|Insulin|insulin|mesh-list
153511965|NCT01409694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153511966|NCT01409694|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153511967|NCT01409694|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153511968|NCT01409694|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
153511969|NCT01409694|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
153511970|NCT01409694|Dopamine Agents|dopamine agents|mesh-ancestor
153511971|NCT01409694|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153511972|NCT01409694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153511973|NCT01409694|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
153511974|NCT01409694|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
153511976|NCT01409733|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153511977|NCT01409733|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153511978|NCT01409733|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153512001|NCT01410201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153512002|NCT01410201|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153512003|NCT01410201|Glucocorticoids|glucocorticoids|mesh-ancestor
153512005|NCT01410201|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153512006|NCT01410201|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153512007|NCT01410201|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153512008|NCT01410201|Protease Inhibitors|protease inhibitors|mesh-ancestor
153512009|NCT01410201|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153512010|NCT01410201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153512011|NCT01410214|Cisplatin|cisplatin|mesh-list
153512012|NCT01410214|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
153512013|NCT01410214|Vinorelbine|vinorelbine|mesh-list
153512014|NCT01410214|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153512015|NCT01410214|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153512016|NCT01410214|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153512017|NCT01410214|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153512018|NCT01410214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153512019|NCT01410214|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153512020|NCT01410214|Tubulin Modulators|tubulin modulators|mesh-ancestor
153512021|NCT01410214|Antimitotic Agents|antimitotic agents|mesh-ancestor
153512022|NCT01410214|Mitosis Modulators|mitosis modulators|mesh-ancestor
153512023|NCT01410370|Endostar protein|endostar protein|mesh-list
153512024|NCT01410370|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153512025|NCT01410370|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153512026|NCT01410370|Growth Substances|growth substances|mesh-ancestor
153512049|NCT01410747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153512050|NCT01410747|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
153512051|NCT01410747|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153512052|NCT01410747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153512054|NCT01410916|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
153512055|NCT01410916|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153512056|NCT01410916|Immunologic Factors|immunologic factors|mesh-ancestor
153512057|NCT01410916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153512072|NCT01411098|Etoposide phosphate|etoposide phosphate|mesh-list
153512073|NCT01411098|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153512074|NCT01411098|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153512075|NCT01411098|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153512076|NCT01411098|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153512077|NCT01411098|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153512078|NCT01411098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153512079|NCT01411111|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
153512080|NCT01411111|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153512092|NCT01411124|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153512093|NCT01411124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153512095|NCT01411124|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153512096|NCT01411124|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153512097|NCT01411124|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153512098|NCT01411124|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153512099|NCT01411124|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
153512100|NCT01411124|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
153512101|NCT01411124|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153512102|NCT01411124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153512103|NCT01411124|Antimanic Agents|antimanic agents|mesh-ancestor
153512104|NCT01411124|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
153512105|NCT01411124|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153512106|NCT01411124|Anesthetics, Local|anesthetics, local|mesh-ancestor
153512107|NCT01411124|Anesthetics|anesthetics|mesh-ancestor
153512108|NCT01411124|Antiemetics|antiemetics|mesh-ancestor
153512109|NCT01411124|Autonomic Agents|autonomic agents|mesh-ancestor
153512110|NCT01411124|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153512111|NCT01411124|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
153512112|NCT01411124|Histamine Antagonists|histamine antagonists|mesh-ancestor
153789679|NCT01687348|Anesthetics|anesthetics|mesh-ancestor
153512113|NCT01411124|Histamine Agents|histamine agents|mesh-ancestor
153512117|NCT01411176|Menthol|menthol|mesh-list
153512146|NCT01411280|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153512161|NCT01411423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153512163|NCT01411436|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153512164|NCT01411436|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153512165|NCT01411436|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153512166|NCT01411436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153512167|NCT01411514|Prednisone|prednisone|mesh-list
153512168|NCT01411514|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153512169|NCT01411514|Glucocorticoids|glucocorticoids|mesh-ancestor
153512170|NCT01411514|Hormones|hormones|mesh-ancestor
153512171|NCT01411514|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153512193|NCT01411930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153512194|NCT01411930|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153512195|NCT01411930|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153512196|NCT01411930|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153512197|NCT01411930|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153789718|NCT00287937|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153512198|NCT01411930|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153512199|NCT01411930|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
153512200|NCT01411930|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153512201|NCT01411930|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153512202|NCT01411930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153512203|NCT01411930|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153512204|NCT01411930|Serotonin Agents|serotonin agents|mesh-ancestor
153512205|NCT01411930|Antidepressive Agents|antidepressive agents|mesh-ancestor
153512206|NCT01411930|Dopamine Agonists|dopamine agonists|mesh-ancestor
153512207|NCT01411930|Dopamine Agents|dopamine agents|mesh-ancestor
153512208|NCT01411930|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
153512209|NCT01411930|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
153512210|NCT01411930|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
153512211|NCT01411930|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153512212|NCT01411930|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
153512213|NCT01411930|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
153512214|NCT01411969|Phenylephrine|phenylephrine|mesh-list
153512215|NCT01411969|Oxymetazoline|oxymetazoline|mesh-list
153512216|NCT01411969|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153512222|NCT01411969|Sympathomimetics|sympathomimetics|mesh-ancestor
153512240|NCT01412073|Oxytocin|oxytocin|mesh-list
153512241|NCT01412073|Oxytocics|oxytocics|mesh-ancestor
153512242|NCT01412073|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153512243|NCT01412073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153512244|NCT01412073|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
153512245|NCT01412073|Abortifacient Agents|abortifacient agents|mesh-ancestor
153512246|NCT01412073|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
153512248|NCT01412294|Capecitabine|capecitabine|mesh-list
153512249|NCT01412294|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153512250|NCT01412294|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153512252|NCT01412294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153512253|NCT01412307|Lenalidomide|lenalidomide|mesh-list
153512254|NCT01412307|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
153512255|NCT01412307|Immunologic Factors|immunologic factors|mesh-ancestor
153512256|NCT01412307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153512257|NCT01412307|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153512258|NCT01412307|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153512259|NCT01412307|Growth Substances|growth substances|mesh-ancestor
153512260|NCT01412307|Growth Inhibitors|growth inhibitors|mesh-ancestor
153512261|NCT01412307|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153512265|NCT01412385|Immunoglobulins|immunoglobulins|mesh-list
153512292|NCT01412515|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153512294|NCT01412567|Immunologic Factors|immunologic factors|mesh-ancestor
153512295|NCT01412567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153512296|NCT01412632|Remifentanil|remifentanil|mesh-list
153512297|NCT01412632|Propofol|propofol|mesh-list
153512298|NCT01412632|Prilocaine|prilocaine|mesh-list
153512299|NCT01412632|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153512300|NCT01412632|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153512301|NCT01412632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153512302|NCT01412632|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153512303|NCT01412632|Anesthetics, General|anesthetics, general|mesh-ancestor
153512304|NCT01412632|Anesthetics|anesthetics|mesh-ancestor
153512305|NCT01412632|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153512306|NCT01412632|Narcotics|narcotics|mesh-ancestor
153512307|NCT01412632|Analgesics|analgesics|mesh-ancestor
153512308|NCT01412632|Sensory System Agents|sensory system agents|mesh-ancestor
153512309|NCT01412632|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153512310|NCT01412632|Anesthetics, Local|anesthetics, local|mesh-ancestor
153512311|NCT01412645|Resveratrol|resveratrol|mesh-list
153512312|NCT01412645|Antioxidants|antioxidants|mesh-ancestor
153512313|NCT01412645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153512314|NCT01412645|Protective Agents|protective agents|mesh-ancestor
153789880|NCT00417729|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153512315|NCT01412645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153512345|NCT01412892|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153512346|NCT01412892|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153512347|NCT01412892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153512348|NCT01412892|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153512349|NCT01412892|Immunologic Factors|immunologic factors|mesh-ancestor
153512350|NCT01412892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153512351|NCT01412892|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153512353|NCT01413022|Fluorouracil|fluorouracil|mesh-list
153512354|NCT01413022|Oxaliplatin|oxaliplatin|mesh-list
153512355|NCT01413022|Irinotecan|irinotecan|mesh-list
153512356|NCT01413022|Antimetabolites|antimetabolites|mesh-ancestor
153512357|NCT01413022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153552459|NCT01578434|Vitamin D|vitamin d|mesh-list
153512358|NCT01413022|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153512359|NCT01413022|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153512360|NCT01413022|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153512361|NCT01413022|Immunologic Factors|immunologic factors|mesh-ancestor
153512362|NCT01413022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153512363|NCT01413022|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
153512364|NCT01413022|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153512365|NCT01413022|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153512366|NCT01413022|Antidotes|antidotes|mesh-ancestor
153512367|NCT01413022|Protective Agents|protective agents|mesh-ancestor
153512368|NCT01413022|Vitamin B Complex|vitamin b complex|mesh-ancestor
153512369|NCT01413022|Vitamins|vitamins|mesh-ancestor
153512370|NCT01413022|Micronutrients|micronutrients|mesh-ancestor
153512371|NCT01413048|Carvedilol|carvedilol|mesh-list
153512372|NCT01413048|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
153512373|NCT01413048|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
153512374|NCT01413048|Adrenergic Agents|adrenergic agents|mesh-ancestor
153512375|NCT01413048|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153512377|NCT01413048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153512386|NCT01413048|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
153512387|NCT01413230|Cholecalciferol|cholecalciferol|mesh-list
153512389|NCT01413230|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153512390|NCT01413230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153512391|NCT01413230|Vitamins|vitamins|mesh-ancestor
153512392|NCT01413230|Micronutrients|micronutrients|mesh-ancestor
153512393|NCT01413230|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153512394|NCT01413477|Calcitriol|calcitriol|mesh-list
153512395|NCT01413477|Betamethasone|betamethasone|mesh-list
153512396|NCT01413477|Betamethasone Valerate|betamethasone valerate|mesh-list
153512397|NCT01413477|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
153512398|NCT01413477|Betamethasone benzoate|betamethasone benzoate|mesh-list
153512399|NCT01413477|Calcipotriene|calcipotriene|mesh-list
153512400|NCT01413477|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
153512401|NCT01413477|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153512403|NCT01413477|Hormones|hormones|mesh-ancestor
153512404|NCT01413477|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153512405|NCT01413477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153512406|NCT01413477|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153512407|NCT01413477|Respiratory System Agents|respiratory system agents|mesh-ancestor
153512408|NCT01413477|Dermatologic Agents|dermatologic agents|mesh-ancestor
153512409|NCT01413477|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153512410|NCT01413477|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
153512411|NCT01413477|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153512412|NCT01413477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153512414|NCT01413477|Vitamins|vitamins|mesh-ancestor
153790040|NCT00254735|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
153512433|NCT01413620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153512434|NCT01413620|Protective Agents|protective agents|mesh-ancestor
153512436|NCT01413711|Anticonvulsants|anticonvulsants|mesh-ancestor
153512437|NCT01413711|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153512438|NCT01413711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153512439|NCT01413711|GABA Agents|gaba agents|mesh-ancestor
153512440|NCT01413711|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153512441|NCT01413711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153512442|NCT01413763|Imiquimod|imiquimod|mesh-list
153512443|NCT01413763|Toll-Like Receptor Agonists|toll-like receptor agonists|mesh-ancestor
153512444|NCT01413763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153512445|NCT01413763|Immunomodulating Agents|immunomodulating agents|mesh-ancestor
153512446|NCT01413763|Immunologic Factors|immunologic factors|mesh-ancestor
153512447|NCT01413763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153512491|NCT01414530|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153512492|NCT01414530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153512494|NCT01414556|Gastric Inhibitory Polypeptide|gastric inhibitory polypeptide|mesh-list
153512495|NCT01414556|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153512496|NCT01414556|Incretins|incretins|mesh-ancestor
153512497|NCT01414556|Hormones|hormones|mesh-ancestor
153512498|NCT01414556|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153512499|NCT01414556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153512500|NCT01414569|Dexamethasone|dexamethasone|mesh-list
153512501|NCT01414569|Dexamethasone acetate|dexamethasone acetate|mesh-list
153512502|NCT01414569|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153512503|NCT01414569|Antiemetics|antiemetics|mesh-ancestor
153512504|NCT01414569|Autonomic Agents|autonomic agents|mesh-ancestor
153512505|NCT01414569|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153512506|NCT01414569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153512507|NCT01414569|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153512508|NCT01414569|Glucocorticoids|glucocorticoids|mesh-ancestor
153512509|NCT01414569|Hormones|hormones|mesh-ancestor
153512510|NCT01414569|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153512511|NCT01414569|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153512512|NCT01414569|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153512513|NCT01414608|Paclitaxel|paclitaxel|mesh-list
153512515|NCT01414608|Carboplatin|carboplatin|mesh-list
153512516|NCT01414608|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
153512542|NCT01414868|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
153512543|NCT01414868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153512544|NCT01414881|Mipomersen|mipomersen|mesh-list
153512545|NCT01414881|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153512546|NCT01414881|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153512547|NCT01414881|Antimetabolites|antimetabolites|mesh-ancestor
153512548|NCT01414881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153512549|NCT01414881|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153512550|NCT01414972|Vitamin A|vitamin a|mesh-list
153512551|NCT01414972|Vitamins|vitamins|mesh-ancestor
153512552|NCT01414972|Micronutrients|micronutrients|mesh-ancestor
153512553|NCT01414972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153512554|NCT01414998|Nicotine|nicotine|mesh-list
153512555|NCT01414998|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
153512556|NCT01414998|Autonomic Agents|autonomic agents|mesh-ancestor
153512557|NCT01414998|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153512597|NCT01415336|Cyclophosphamide|cyclophosphamide|mesh-list
153512598|NCT01415336|Doxorubicin|doxorubicin|mesh-list
153512599|NCT01415336|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
153512600|NCT01415336|Capecitabine|capecitabine|mesh-list
153512601|NCT01415336|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153512602|NCT01415336|Immunologic Factors|immunologic factors|mesh-ancestor
153512603|NCT01415336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153512604|NCT01415336|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153512605|NCT01415336|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153512606|NCT01415336|Alkylating Agents|alkylating agents|mesh-ancestor
153512607|NCT01415336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153512608|NCT01415336|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153512609|NCT01415336|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153512610|NCT01415336|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153512611|NCT01415336|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153512612|NCT01415336|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153512613|NCT01415336|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153512614|NCT01415336|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153512615|NCT01415336|Antimetabolites|antimetabolites|mesh-ancestor
153512651|NCT01415596|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
153512652|NCT01415596|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
153552490|NCT01578473|Testosterone|testosterone|mesh-list
153552491|NCT01578473|Testosterone undecanoate|testosterone undecanoate|mesh-list
153512653|NCT01415596|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153552492|NCT01578473|Testosterone enanthate|testosterone enanthate|mesh-list
153552522|NCT01578629|Vitamin E|vitamin e|mesh-list
153512654|NCT01415596|Adrenergic Agents|adrenergic agents|mesh-ancestor
153512655|NCT01415596|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153512656|NCT01415596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153512657|NCT01415687|Bisacodyl|bisacodyl|mesh-list
153512658|NCT01415687|Magnesium citrate|magnesium citrate|mesh-list
153512659|NCT01415687|Citric Acid|citric acid|mesh-list
153512660|NCT01415687|Sodium Citrate|sodium citrate|mesh-list
153618886|NCT01980615|Respiratory System Agents|respiratory system agents|mesh-ancestor
153455764|NCT04965298|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153512661|NCT01415687|Anticoagulants|anticoagulants|mesh-ancestor
153512662|NCT01415687|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
153512663|NCT01415687|Chelating Agents|chelating agents|mesh-ancestor
153512664|NCT01415687|Sequestering Agents|sequestering agents|mesh-ancestor
153512665|NCT01415687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153512709|NCT01415765|Tubulin Modulators|tubulin modulators|mesh-ancestor
153512710|NCT01415765|Antimitotic Agents|antimitotic agents|mesh-ancestor
153512711|NCT01415765|Mitosis Modulators|mitosis modulators|mesh-ancestor
153512712|NCT01415778|Bicalutamide|bicalutamide|mesh-list
153512713|NCT01415778|Androgen Antagonists|androgen antagonists|mesh-ancestor
153512714|NCT01415778|Hormone Antagonists|hormone antagonists|mesh-ancestor
153512715|NCT01415778|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153512716|NCT01415778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153512717|NCT01415778|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153512718|NCT01415791|Bicalutamide|bicalutamide|mesh-list
153512719|NCT01415791|Androgen Antagonists|androgen antagonists|mesh-ancestor
153512720|NCT01415791|Hormone Antagonists|hormone antagonists|mesh-ancestor
153512721|NCT01415791|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153512722|NCT01415791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153512723|NCT01415791|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153512724|NCT01415895|Clonidine|clonidine|mesh-list
153512725|NCT01415895|Naltrexone|naltrexone|mesh-list
153512726|NCT01415895|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
153512727|NCT01415895|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
153512728|NCT01415895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153512729|NCT01415895|Sensory System Agents|sensory system agents|mesh-ancestor
153512730|NCT01415895|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153512761|NCT01416116|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
153512762|NCT01416116|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153790432|NCT01600456|Sertraline|sertraline|mesh-list
153512763|NCT01416116|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153512764|NCT01416116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153512765|NCT01416116|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153512766|NCT01416116|Narcotics|narcotics|mesh-ancestor
153512767|NCT01416116|Analgesics|analgesics|mesh-ancestor
153512768|NCT01416116|Antipruritics|antipruritics|mesh-ancestor
153512769|NCT01416116|Dermatologic Agents|dermatologic agents|mesh-ancestor
153512770|NCT01416207|Interferons|interferons|mesh-list
153512772|NCT01416207|Interferon-beta|interferon-beta|mesh-list
153512773|NCT01416207|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153512774|NCT01416207|Antiviral Agents|antiviral agents|mesh-ancestor
153512775|NCT01416207|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153512777|NCT01416207|Immunologic Factors|immunologic factors|mesh-ancestor
153512778|NCT01416207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153512779|NCT01416220|Lithium Carbonate|lithium carbonate|mesh-list
153512780|NCT01416220|Paroxetine|paroxetine|mesh-list
153512781|NCT01416220|Antidepressive Agents|antidepressive agents|mesh-ancestor
153512782|NCT01416220|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153512783|NCT01416220|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153790482|NCT00256178|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153512784|NCT01416220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153512785|NCT01416220|Antimanic Agents|antimanic agents|mesh-ancestor
153512786|NCT01416220|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153512787|NCT01416220|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153512788|NCT01416220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153512789|NCT01416220|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
153512790|NCT01416220|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153512791|NCT01416220|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153512792|NCT01416220|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153512805|NCT01416350|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153512806|NCT01416350|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153512807|NCT01416415|Ophthalmic Solutions|ophthalmic solutions|mesh-list
153512808|NCT01416415|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
153512809|NCT01416480|Theobromine|theobromine|mesh-list
153512810|NCT01416480|Dipropizine|dipropizine|mesh-list
153512811|NCT01416480|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153512813|NCT01416480|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153512814|NCT01416480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153512815|NCT01416480|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153512816|NCT01416480|Respiratory System Agents|respiratory system agents|mesh-ancestor
153512817|NCT01416480|Vasodilator Agents|vasodilator agents|mesh-ancestor
153512818|NCT01416480|Antitussive Agents|antitussive agents|mesh-ancestor
153512819|NCT01416558|Paclitaxel|paclitaxel|mesh-list
153512820|NCT01416558|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153512821|NCT01416558|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153512822|NCT01416558|Tubulin Modulators|tubulin modulators|mesh-ancestor
153512823|NCT01416558|Antimitotic Agents|antimitotic agents|mesh-ancestor
153512824|NCT01416558|Mitosis Modulators|mitosis modulators|mesh-ancestor
153512825|NCT01416558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153512827|NCT01416649|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
153512828|NCT01416649|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153512829|NCT01416649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153512830|NCT01416649|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
153512831|NCT01416649|Incretins|incretins|mesh-ancestor
153512832|NCT01416649|Hormones|hormones|mesh-ancestor
153512833|NCT01416649|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153512834|NCT01416662|Gemcitabine|gemcitabine|mesh-list
153512835|NCT01416662|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153512848|NCT01416870|Hormone Antagonists|hormone antagonists|mesh-ancestor
153512849|NCT01416870|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153512850|NCT01416870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153512851|NCT01416870|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153512852|NCT01416883|Bicalutamide|bicalutamide|mesh-list
153512853|NCT01416883|Androgen Antagonists|androgen antagonists|mesh-ancestor
153512854|NCT01416883|Hormone Antagonists|hormone antagonists|mesh-ancestor
153512855|NCT01416883|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153512856|NCT01416883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153512857|NCT01416883|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153512858|NCT01416909|Laxatives|laxatives|mesh-list
153512859|NCT01416909|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153512860|NCT01416948|Methylphenidate|methylphenidate|mesh-list
153512861|NCT01416948|Galantamine|galantamine|mesh-list
153512862|NCT01416948|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
153512864|NCT01416948|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
153512865|NCT01416948|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153512866|NCT01416948|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153512867|NCT01416948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153512868|NCT01416948|Dopamine Agents|dopamine agents|mesh-ancestor
153512869|NCT01416948|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153512870|NCT01416948|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
153512871|NCT01416948|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153512895|NCT01416974|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153512897|NCT01417013|Lubricant Eye Drops|lubricant eye drops|mesh-list
153512898|NCT01417013|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
153512899|NCT01417065|Sirolimus|sirolimus|mesh-list
153512900|NCT01417065|Temsirolimus|temsirolimus|mesh-list
153512901|NCT01417065|MTOR Inhibitors|mtor inhibitors|mesh-list
153512902|NCT01417065|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153512903|NCT01417065|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153512904|NCT01417065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153512905|NCT01417065|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153512906|NCT01417065|Immunologic Factors|immunologic factors|mesh-ancestor
153512907|NCT01417065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153512908|NCT01417065|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153512909|NCT01417065|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153512910|NCT01417065|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153512911|NCT01417065|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153512912|NCT01417065|Antifungal Agents|antifungal agents|mesh-ancestor
153512913|NCT01417169|Micafungin|micafungin|mesh-list
153512914|NCT01417169|Antifungal Agents|antifungal agents|mesh-ancestor
153512915|NCT01417169|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153512916|NCT01417273|Vitamin A|vitamin a|mesh-list
153512917|NCT01417273|Vitamins|vitamins|mesh-ancestor
153512918|NCT01417273|Micronutrients|micronutrients|mesh-ancestor
153512919|NCT01417273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153512920|NCT01417351|Vitamin D|vitamin d|mesh-list
153512921|NCT01417351|Ergocalciferols|ergocalciferols|mesh-list
153512922|NCT01417351|Cholecalciferol|cholecalciferol|mesh-list
153512923|NCT01417351|Vitamins|vitamins|mesh-list
153512924|NCT01417351|Micronutrients|micronutrients|mesh-ancestor
153512945|NCT01417390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153512947|NCT01417403|Antimalarials|antimalarials|mesh-ancestor
153512948|NCT01417403|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153512949|NCT01417403|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153790686|NCT00290121|Olanzapine|olanzapine|mesh-list
153512951|NCT01417403|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153512952|NCT01417403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153512953|NCT01417403|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153512954|NCT01417429|Galantamine|galantamine|mesh-list
153512955|NCT01417429|Nicotine|nicotine|mesh-list
153512956|NCT01417429|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
153512957|NCT01417429|Autonomic Agents|autonomic agents|mesh-ancestor
153512958|NCT01417429|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153512959|NCT01417429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153512960|NCT01417429|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
153512961|NCT01417429|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
153512962|NCT01417429|Cholinergic Agents|cholinergic agents|mesh-ancestor
153512963|NCT01417429|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153512964|NCT01417429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153512965|NCT01417429|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
153512966|NCT01417429|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153512967|NCT01417429|Parasympathomimetics|parasympathomimetics|mesh-ancestor
153512968|NCT01417429|Nootropic Agents|nootropic agents|mesh-ancestor
153512969|NCT01417494|Leucovorin|leucovorin|mesh-list
153512970|NCT01417494|Bevacizumab|bevacizumab|mesh-list
153512971|NCT01417494|Fluorouracil|fluorouracil|mesh-list
153512972|NCT01417494|Oxaliplatin|oxaliplatin|mesh-list
153512994|NCT01417572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153512995|NCT01417572|Sensory System Agents|sensory system agents|mesh-ancestor
153512996|NCT01417572|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153512997|NCT01417572|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153790747|NCT02271958|Abortifacient Agents|abortifacient agents|mesh-ancestor
153512998|NCT01417572|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
153513000|NCT01417572|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153513001|NCT01417572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153513002|NCT01417689|Ophthalmic Solutions|ophthalmic solutions|mesh-list
153513003|NCT01417689|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
153513004|NCT01417754|Toremifene|toremifene|mesh-list
153513005|NCT01417754|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153513006|NCT01417754|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153513007|NCT01417754|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
153513008|NCT01417754|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
153552594|NCT01579019|Antimetabolites|antimetabolites|mesh-ancestor
153513009|NCT01417754|Hormone Antagonists|hormone antagonists|mesh-ancestor
153513011|NCT01417754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153513047|NCT01417923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153513048|NCT01417923|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153513049|NCT01417949|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
153513050|NCT01417949|Antiviral Agents|antiviral agents|mesh-ancestor
153513051|NCT01417949|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153513052|NCT01418118|Dobutamine|dobutamine|mesh-list
153552636|NCT01579227|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
153513053|NCT01418118|Epinephrine|epinephrine|mesh-list
153513054|NCT01418118|Norepinephrine|norepinephrine|mesh-list
153513055|NCT01418118|Dopexamine|dopexamine|mesh-list
153513056|NCT01418118|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153513057|NCT01418118|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153513058|NCT01418118|Adrenergic Agents|adrenergic agents|mesh-ancestor
153513059|NCT01418118|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153513060|NCT01418118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153513061|NCT01418118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153513062|NCT01418118|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
153513063|NCT01418118|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153513064|NCT01418118|Autonomic Agents|autonomic agents|mesh-ancestor
153513065|NCT01418118|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153513066|NCT01418118|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153513068|NCT01418118|Mydriatics|mydriatics|mesh-ancestor
153513102|NCT01418183|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153513103|NCT01418183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153513104|NCT01418183|Sensory System Agents|sensory system agents|mesh-ancestor
153513105|NCT01418183|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153513106|NCT01418235|MF59 oil emulsion|mf59 oil emulsion|mesh-list
153513107|NCT01418235|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153513108|NCT01418235|Immunologic Factors|immunologic factors|mesh-ancestor
153513109|NCT01418235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153513110|NCT01418274|Ritonavir|ritonavir|mesh-list
153513111|NCT01418274|Escitalopram|escitalopram|mesh-list
153513112|NCT01418274|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
153513113|NCT01418274|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
153513114|NCT01418274|Protease Inhibitors|protease inhibitors|mesh-ancestor
153513115|NCT01418274|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153513116|NCT01418274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153513117|NCT01418274|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153513118|NCT01418274|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153513119|NCT01418274|Antiviral Agents|antiviral agents|mesh-ancestor
153513120|NCT01418274|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153513121|NCT01418274|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
153513156|NCT01418534|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
153513157|NCT01418534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153513158|NCT01418547|Isosorbide|isosorbide|mesh-list
153513159|NCT01418547|Isosorbide Dinitrate|isosorbide dinitrate|mesh-list
153513160|NCT01418547|Isosorbide-5-mononitrate|isosorbide-5-mononitrate|mesh-list
153513161|NCT01418547|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
153513162|NCT01418547|Diuretics|diuretics|mesh-ancestor
153513163|NCT01418547|Natriuretic Agents|natriuretic agents|mesh-ancestor
153513164|NCT01418547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153513165|NCT01418547|Vasodilator Agents|vasodilator agents|mesh-ancestor
153513166|NCT01418547|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
153513167|NCT01418547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153513168|NCT01418586|Alfuzosin|alfuzosin|mesh-list
153513169|NCT01418586|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
153513170|NCT01418586|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
153513171|NCT01418586|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
153513172|NCT01418586|Adrenergic Agents|adrenergic agents|mesh-ancestor
153513173|NCT01418586|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153513174|NCT01418586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153513175|NCT01418586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153513176|NCT01418586|Urological Agents|urological agents|mesh-ancestor
153552637|NCT01579227|Hormone Antagonists|hormone antagonists|mesh-ancestor
153513203|NCT01418625|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
153513204|NCT01418625|Antidepressive Agents|antidepressive agents|mesh-ancestor
153513205|NCT01418625|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153513206|NCT01418651|Milnacipran|milnacipran|mesh-list
153513207|NCT01418651|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
153513208|NCT01418651|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153513209|NCT01418651|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153513210|NCT01418651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153513211|NCT01418651|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153513212|NCT01418651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153513214|NCT01418651|Analgesics|analgesics|mesh-ancestor
153513215|NCT01418651|Sensory System Agents|sensory system agents|mesh-ancestor
153513216|NCT01418651|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153513217|NCT01418729|Pravastatin|pravastatin|mesh-list
153513218|NCT01418729|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153513219|NCT01418729|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153513220|NCT01418729|Antimetabolites|antimetabolites|mesh-ancestor
153513221|NCT01418729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153513222|NCT01418729|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153513223|NCT01418729|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
153513224|NCT01418729|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153513225|NCT01418742|Doxycycline|doxycycline|mesh-list
153513226|NCT01418742|Panitumumab|panitumumab|mesh-list
153513227|NCT01418742|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153513249|NCT01419041|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153513250|NCT01419041|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153513251|NCT01419041|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153513252|NCT01419041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153513253|NCT01419041|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153513254|NCT01419119|Cholecalciferol|cholecalciferol|mesh-list
153513255|NCT01419119|Vitamin D|vitamin d|mesh-list
153513256|NCT01419119|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
153513257|NCT01419119|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153513258|NCT01419119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153513259|NCT01419119|Vitamins|vitamins|mesh-ancestor
153513260|NCT01419119|Micronutrients|micronutrients|mesh-ancestor
153513261|NCT01419119|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153513262|NCT01419132|Furosemide|furosemide|mesh-list
153513263|NCT01419132|Diuretics|diuretics|mesh-list
153513264|NCT01419132|Natriuretic Agents|natriuretic agents|mesh-ancestor
153513269|NCT01419262|Vitamin D|vitamin d|mesh-list
153513306|NCT01419392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153513307|NCT01419392|Vasodilator Agents|vasodilator agents|mesh-ancestor
153513308|NCT01419392|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
153513309|NCT01419392|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
153513310|NCT01419392|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153513311|NCT01419392|Urological Agents|urological agents|mesh-ancestor
153513313|NCT01419405|Remifentanil|remifentanil|mesh-list
153513314|NCT01419405|Analgesics|analgesics|mesh-ancestor
153513315|NCT01419405|Sensory System Agents|sensory system agents|mesh-ancestor
153513316|NCT01419405|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153513317|NCT01419405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153513318|NCT01419405|Anticonvulsants|anticonvulsants|mesh-ancestor
153513319|NCT01419405|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153513320|NCT01419405|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153513321|NCT01419405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153513322|NCT01419405|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153513323|NCT01419405|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153513324|NCT01419405|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153513325|NCT01419405|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153513326|NCT01419405|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153513327|NCT01419405|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153513328|NCT01419405|Narcotics|narcotics|mesh-ancestor
153513329|NCT01419457|Favipiravir|favipiravir|mesh-list
153552689|NCT01579500|Cholinergic Agents|cholinergic agents|mesh-ancestor
153513330|NCT01419457|Antiviral Agents|antiviral agents|mesh-ancestor
153513331|NCT01419457|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153513332|NCT01419548|Paclitaxel|paclitaxel|mesh-list
153513333|NCT01419548|Carboplatin|carboplatin|mesh-list
153513335|NCT01419548|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153513336|NCT01419548|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153337636|NCT00982865|Vitamins|vitamins|mesh-ancestor
153513337|NCT01419548|Tubulin Modulators|tubulin modulators|mesh-ancestor
153513345|NCT01419691|Auranofin|auranofin|mesh-list
153513351|NCT01419730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153513352|NCT01419730|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153513353|NCT01419730|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153513354|NCT01419821|Vitamin D|vitamin d|mesh-list
153513355|NCT01419821|Ergocalciferols|ergocalciferols|mesh-list
153513356|NCT01419821|Cholecalciferol|cholecalciferol|mesh-list
153513357|NCT01419821|Vitamins|vitamins|mesh-list
153513358|NCT01419821|Micronutrients|micronutrients|mesh-ancestor
153513359|NCT01419821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153513360|NCT01419821|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153513361|NCT01419821|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153513362|NCT01419847|Ciclopirox|ciclopirox|mesh-list
153513363|NCT01419847|Antifungal Agents|antifungal agents|mesh-ancestor
153513364|NCT01419847|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153513365|NCT01419873|Insulin|insulin|mesh-list
153513366|NCT01419873|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
153513367|NCT01419873|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153513368|NCT01419873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153513369|NCT01420055|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
153513370|NCT01420055|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
153513371|NCT01420055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153513372|NCT01420055|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153513373|NCT01420055|Immunologic Factors|immunologic factors|mesh-ancestor
153513374|NCT01420055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153513375|NCT01420094|Aspirin|aspirin|mesh-list
153513376|NCT01420094|Acetaminophen|acetaminophen|mesh-list
153513377|NCT01420094|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153513378|NCT01420094|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153513379|NCT01420094|Analgesics|analgesics|mesh-ancestor
153513380|NCT01420094|Sensory System Agents|sensory system agents|mesh-ancestor
153513381|NCT01420094|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153513384|NCT01420094|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153513393|NCT01420159|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
153513394|NCT01420159|Anesthetics, General|anesthetics, general|mesh-ancestor
153513396|NCT01420159|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153513397|NCT01420159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153513398|NCT01420302|Insulin|insulin|mesh-list
153513399|NCT01420302|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
153513400|NCT01420302|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153513401|NCT01420302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153513402|NCT01420328|Simvastatin|simvastatin|mesh-list
153513403|NCT01420328|Ezetimibe, Simvastatin Drug Combination|ezetimibe, simvastatin drug combination|mesh-list
153513404|NCT01420328|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153513405|NCT01420328|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153513406|NCT01420328|Antimetabolites|antimetabolites|mesh-ancestor
153513407|NCT01420328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153513408|NCT01420328|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153513409|NCT01420328|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
153513410|NCT01420328|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153513411|NCT01420341|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
153513412|NCT01420341|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
153513413|NCT01420341|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153513414|NCT01420341|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153513415|NCT01420341|Antimalarials|antimalarials|mesh-ancestor
153552748|NCT01579838|Immunologic Factors|immunologic factors|mesh-ancestor
153513416|NCT01420341|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153513417|NCT01420341|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153552759|NCT01579890|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153791249|NCT01603342|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
153791250|NCT01603342|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
153791251|NCT01603342|Purinergic Agents|purinergic agents|mesh-ancestor
153791269|NCT01603498|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
153791270|NCT01603498|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
153791272|NCT01603498|Prednisolone acetate|prednisolone acetate|mesh-list
153791273|NCT01603498|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
153791274|NCT01603498|Prednisolone phosphate|prednisolone phosphate|mesh-list
153791275|NCT01603498|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153791276|NCT01603498|Antiemetics|antiemetics|mesh-ancestor
153791277|NCT01603498|Autonomic Agents|autonomic agents|mesh-ancestor
153791278|NCT01603498|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153791279|NCT01603498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153791280|NCT01603498|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153791282|NCT01603498|Hormones|hormones|mesh-ancestor
153513418|NCT01420367|Metronidazole|metronidazole|mesh-list
153513419|NCT01420367|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153513440|NCT01420523|Raltegravir Potassium|raltegravir potassium|mesh-list
153513442|NCT01420523|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153513443|NCT01420523|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153513444|NCT01420523|Antiviral Agents|antiviral agents|mesh-ancestor
153513445|NCT01420523|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153513446|NCT01420523|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
153513447|NCT01420523|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
153513448|NCT01420523|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153513449|NCT01420523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153513450|NCT01420523|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
153513451|NCT01420523|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
153513452|NCT01420523|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
153513454|NCT01420575|Antiemetics|antiemetics|mesh-ancestor
153513455|NCT01420575|Autonomic Agents|autonomic agents|mesh-ancestor
153513456|NCT01420575|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153513457|NCT01420575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153513458|NCT01420575|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153513459|NCT01420575|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153513460|NCT01420575|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153513461|NCT01420575|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153513462|NCT01420575|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153513463|NCT01420575|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
153513464|NCT01420575|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153513465|NCT01420575|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153513466|NCT01420575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153513467|NCT01420575|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153513468|NCT01420575|Serotonin Agents|serotonin agents|mesh-ancestor
153513469|NCT01420666|Acetaminophen|acetaminophen|mesh-list
153513470|NCT01420666|Ibuprofen|ibuprofen|mesh-list
153513471|NCT01420666|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153513472|NCT01420666|Analgesics|analgesics|mesh-ancestor
153513473|NCT01420666|Sensory System Agents|sensory system agents|mesh-ancestor
153513474|NCT01420666|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153513479|NCT01420666|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153513480|NCT01420666|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153513481|NCT01420666|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153513482|NCT01420666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153552778|NCT01579929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153513483|NCT01420692|Insulin Detemir|insulin detemir|mesh-list
153513484|NCT01420692|Gliclazide|gliclazide|mesh-list
153513485|NCT01420692|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153513486|NCT01420692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153513487|NCT01420822|Fluticasone|fluticasone|mesh-list
153513488|NCT01420822|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153513489|NCT01420822|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153513490|NCT01420822|Autonomic Agents|autonomic agents|mesh-ancestor
153791384|NCT06301880|Protective Agents|protective agents|mesh-ancestor
153513491|NCT01420822|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153513492|NCT01420822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153513493|NCT01420822|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153513540|NCT01421160|Chelating Agents|chelating agents|mesh-ancestor
153513541|NCT01421160|Sequestering Agents|sequestering agents|mesh-ancestor
153513542|NCT01421160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153513544|NCT01421173|Dexamethasone acetate|dexamethasone acetate|mesh-list
153513546|NCT01421173|Gemcitabine|gemcitabine|mesh-list
153513547|NCT01421173|Melphalan|melphalan|mesh-list
153513548|NCT01421173|Busulfan|busulfan|mesh-list
153513549|NCT01421173|Vorinostat|vorinostat|mesh-list
153513550|NCT01421173|BB 1101|bb 1101|mesh-list
153513551|NCT01421173|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153513552|NCT01421173|Antiemetics|antiemetics|mesh-ancestor
153513553|NCT01421173|Autonomic Agents|autonomic agents|mesh-ancestor
153513554|NCT01421173|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153513555|NCT01421173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153513556|NCT01421173|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153513557|NCT01421173|Glucocorticoids|glucocorticoids|mesh-ancestor
153513558|NCT01421173|Hormones|hormones|mesh-ancestor
153513559|NCT01421173|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153513560|NCT01421173|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153513561|NCT01421173|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153513562|NCT01421173|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153513563|NCT01421173|Immunologic Factors|immunologic factors|mesh-ancestor
153513564|NCT01421173|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153513565|NCT01421173|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153513566|NCT01421173|Antimetabolites|antimetabolites|mesh-ancestor
153513567|NCT01421173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153513568|NCT01421173|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153513569|NCT01421173|Alkylating Agents|alkylating agents|mesh-ancestor
153513570|NCT01421173|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153513571|NCT01421173|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153513572|NCT01421173|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
153513573|NCT01421173|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153513574|NCT01421173|Protease Inhibitors|protease inhibitors|mesh-ancestor
153513575|NCT01421212|Immunoglobulins|immunoglobulins|mesh-list
153513577|NCT01421212|gamma-Globulins|gamma-globulins|mesh-list
153513578|NCT01421212|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
153513579|NCT01421212|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
153513580|NCT01421212|Immunoglobulin G|immunoglobulin g|mesh-list
153513581|NCT01421212|Immunologic Factors|immunologic factors|mesh-ancestor
153791524|NCT06301061|Antidepressive Agents|antidepressive agents|mesh-ancestor
153513582|NCT01421212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153513584|NCT01421368|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
153552779|NCT01579994|Crizotinib|crizotinib|mesh-list
153513585|NCT01421368|Contraceptive Agents|contraceptive agents|mesh-list
153513586|NCT01421368|Medroxyprogesterone|medroxyprogesterone|mesh-list
153513587|NCT01421368|Contraceptives, Oral|contraceptives, oral|mesh-list
153513589|NCT01421368|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153513590|NCT01421368|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153552780|NCT01579994|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153513591|NCT01421368|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153513592|NCT01421368|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153513593|NCT01421368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153513594|NCT01421368|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153513595|NCT01421368|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153513596|NCT01421368|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153513597|NCT01421368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153513598|NCT01421368|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
153513599|NCT01421368|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
153513600|NCT01421368|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
153513601|NCT01421368|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
153791637|NCT06300138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153513603|NCT01421368|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153513604|NCT01421368|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153552797|NCT01581359|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153513605|NCT01421693|Ceftriaxone|ceftriaxone|mesh-list
153513625|NCT01421706|Purinergic Agents|purinergic agents|mesh-ancestor
153513626|NCT01421706|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153513627|NCT01421706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153513628|NCT01421706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153513629|NCT01421706|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153513630|NCT01421706|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153513631|NCT01421706|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
153513632|NCT01421706|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153513633|NCT01421706|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
153513634|NCT01421706|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153513635|NCT01421706|Antidepressive Agents|antidepressive agents|mesh-ancestor
153513636|NCT01421706|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153513637|NCT01421706|Appetite Depressants|appetite depressants|mesh-ancestor
153513638|NCT01421706|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
153513639|NCT01421901|Ertapenem|ertapenem|mesh-list
153513640|NCT01421901|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153513641|NCT01421901|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153513642|NCT01421914|Bupivacaine|bupivacaine|mesh-list
153513643|NCT01421914|Anesthetics, Local|anesthetics, local|mesh-ancestor
153513644|NCT01421914|Anesthetics|anesthetics|mesh-ancestor
153513645|NCT01421914|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153513646|NCT01421914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153513647|NCT01421914|Sensory System Agents|sensory system agents|mesh-ancestor
153513648|NCT01421914|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153513649|NCT01421927|Lenalidomide|lenalidomide|mesh-list
153513673|NCT01421992|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
153513674|NCT01421992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153513675|NCT01421992|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
153513676|NCT01421992|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153513677|NCT01421992|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153791797|NCT06279234|Antimetabolites|antimetabolites|mesh-ancestor
153513678|NCT01421992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153513679|NCT01421992|Dopamine Agents|dopamine agents|mesh-ancestor
153513680|NCT01421992|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153513682|NCT01422018|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153513683|NCT01422018|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153513684|NCT01422018|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153513685|NCT01422018|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153513686|NCT01422018|Growth Substances|growth substances|mesh-ancestor
153513687|NCT01422018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153513688|NCT01422018|Growth Inhibitors|growth inhibitors|mesh-ancestor
153513689|NCT01422096|Leuprolide|leuprolide|mesh-list
153513690|NCT01422096|Fertility Agents, Female|fertility agents, female|mesh-ancestor
153552798|NCT01581476|Quinapril|quinapril|mesh-list
153513691|NCT01422096|Fertility Agents|fertility agents|mesh-ancestor
153513692|NCT01422096|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153513693|NCT01422096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153513695|NCT01422096|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153513724|NCT01422122|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153513725|NCT01422122|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153791882|NCT06171100|Tolvaptan|tolvaptan|mesh-list
153513726|NCT01422291|Acetaminophen|acetaminophen|mesh-list
153513727|NCT01422291|Dexketoprofen trometamol|dexketoprofen trometamol|mesh-list
153513728|NCT01422291|Morphine|morphine|mesh-list
153513729|NCT01422291|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153513730|NCT01422291|Narcotics|narcotics|mesh-ancestor
153513731|NCT01422291|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153513732|NCT01422291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153513733|NCT01422291|Analgesics|analgesics|mesh-ancestor
153513734|NCT01422291|Sensory System Agents|sensory system agents|mesh-ancestor
153513735|NCT01422291|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153513736|NCT01422291|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153513737|NCT01422291|Antipyretics|antipyretics|mesh-ancestor
153513738|NCT01422291|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153513739|NCT01422291|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153513740|NCT01422291|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153513741|NCT01422317|Tocopherols|tocopherols|mesh-list
153513742|NCT01422317|Vitamin E|vitamin e|mesh-list
153513743|NCT01422317|Tocotrienols|tocotrienols|mesh-list
153513744|NCT01422317|alpha-Tocopherol|alpha-tocopherol|mesh-list
153513745|NCT01422317|Antioxidants|antioxidants|mesh-ancestor
153513746|NCT01422317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153513747|NCT01422317|Protective Agents|protective agents|mesh-ancestor
153513748|NCT01422317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153513749|NCT01422317|Vitamins|vitamins|mesh-ancestor
153513750|NCT01422317|Micronutrients|micronutrients|mesh-ancestor
153513751|NCT01422330|Etravirine|etravirine|mesh-list
153513752|NCT01422330|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153513753|NCT01422330|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153513754|NCT01422330|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153513769|NCT01422590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153513770|NCT01422590|Incretins|incretins|mesh-ancestor
153513771|NCT01422590|Hormones|hormones|mesh-ancestor
153791939|NCT06152575|Bortezomib|bortezomib|mesh-list
153513772|NCT01422590|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153513773|NCT01422590|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
153513774|NCT01422590|Protease Inhibitors|protease inhibitors|mesh-ancestor
153513775|NCT01422590|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153513776|NCT01422590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153513778|NCT01422603|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153513779|NCT01422603|Antimetabolites|antimetabolites|mesh-ancestor
153513780|NCT01422603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153513781|NCT01422603|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153513782|NCT01422616|Metoprolol|metoprolol|mesh-list
153513783|NCT01422616|Clonidine|clonidine|mesh-list
153513784|NCT01422616|Labetalol|labetalol|mesh-list
153513785|NCT01422616|Hydralazine|hydralazine|mesh-list
153513786|NCT01422616|Nicardipine|nicardipine|mesh-list
153513787|NCT01422616|Phentolamine|phentolamine|mesh-list
153513788|NCT01422616|Urapidil|urapidil|mesh-list
153513789|NCT01422616|Enalaprilat|enalaprilat|mesh-list
153513790|NCT01422616|Enalapril|enalapril|mesh-list
153513791|NCT01422616|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
153513792|NCT01422616|Nitroglycerin|nitroglycerin|mesh-list
153513793|NCT01422616|Esmolol|esmolol|mesh-list
153513794|NCT01422616|Glycerol|glycerol|mesh-list
153513795|NCT01422616|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153792029|NCT06031883|Fentanyl|fentanyl|mesh-list
153513797|NCT01422616|Sympatholytics|sympatholytics|mesh-ancestor
153513798|NCT01422616|Autonomic Agents|autonomic agents|mesh-ancestor
153513799|NCT01422616|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153513800|NCT01422616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153513801|NCT01422616|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
153513802|NCT01422616|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
153513803|NCT01422616|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
153513804|NCT01422616|Adrenergic Agents|adrenergic agents|mesh-ancestor
153513810|NCT01422616|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153513811|NCT01422616|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153513812|NCT01422616|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
153513813|NCT01422616|Protective Agents|protective agents|mesh-ancestor
153513814|NCT01422616|Sympathomimetics|sympathomimetics|mesh-ancestor
153513815|NCT01422616|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
153513816|NCT01422616|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
153513817|NCT01422616|Vasodilator Agents|vasodilator agents|mesh-ancestor
153513818|NCT01422616|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153513819|NCT01422616|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153513820|NCT01422616|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153513821|NCT01422616|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153513822|NCT01422616|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153513823|NCT01422616|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
153513824|NCT01422616|Serotonin Agents|serotonin agents|mesh-ancestor
153513825|NCT01422616|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
153513826|NCT01422616|Protease Inhibitors|protease inhibitors|mesh-ancestor
153513827|NCT01422616|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153513828|NCT01422707|Hydrocortisone|hydrocortisone|mesh-list
153513829|NCT01422707|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153513830|NCT01422733|Dexamethasone|dexamethasone|mesh-list
153513831|NCT01422733|Hydrocortisone|hydrocortisone|mesh-list
153513832|NCT01422733|Cosyntropin|cosyntropin|mesh-list
153513833|NCT01422733|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153513834|NCT01422733|Antiemetics|antiemetics|mesh-ancestor
153513835|NCT01422733|Autonomic Agents|autonomic agents|mesh-ancestor
153513836|NCT01422733|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153513837|NCT01422733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153513838|NCT01422733|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153513839|NCT01422733|Glucocorticoids|glucocorticoids|mesh-ancestor
153513840|NCT01422733|Hormones|hormones|mesh-ancestor
153513841|NCT01422733|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153513842|NCT01422733|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153513843|NCT01422733|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153513844|NCT01422785|Clindamycin|clindamycin|mesh-list
153513845|NCT01422785|Clindamycin palmitate|clindamycin palmitate|mesh-list
153513847|NCT01422785|Tretinoin|tretinoin|mesh-list
153513849|NCT01422785|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153513850|NCT01422785|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153513851|NCT01422785|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
153513852|NCT01422785|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153513853|NCT01422785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153513854|NCT01422785|Dermatologic Agents|dermatologic agents|mesh-ancestor
153513855|NCT01422785|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153513856|NCT01422785|Keratolytic Agents|keratolytic agents|mesh-ancestor
153513857|NCT01422954|Chloroquine|chloroquine|mesh-list
153513858|NCT01422954|Mefloquine|mefloquine|mesh-list
153513859|NCT01422954|Proguanil|proguanil|mesh-list
153513860|NCT01422954|Atovaquone, proguanil drug combination|atovaquone, proguanil drug combination|mesh-list
153513861|NCT01422954|Amebicides|amebicides|mesh-ancestor
153513862|NCT01422954|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153513863|NCT01422954|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153513864|NCT01422954|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153513865|NCT01422954|Antimalarials|antimalarials|mesh-ancestor
153513866|NCT01422954|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153513867|NCT01422954|Antimetabolites|antimetabolites|mesh-ancestor
153513868|NCT01422954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153513869|NCT01423019|Synephrine|synephrine|mesh-list
153513870|NCT01423019|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153513871|NCT01423019|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153513872|NCT01423019|Adrenergic Agents|adrenergic agents|mesh-ancestor
153513873|NCT01423019|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153513874|NCT01423019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153513875|NCT01423019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153513877|NCT01423019|Autonomic Agents|autonomic agents|mesh-ancestor
153513879|NCT01423019|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
153513895|NCT01423123|Mitosis Modulators|mitosis modulators|mesh-ancestor
153513896|NCT01423123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153513897|NCT01423123|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153513898|NCT01423123|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153513899|NCT01423123|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153513900|NCT01423123|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153513902|NCT01423175|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153513903|NCT01423175|Antimetabolites|antimetabolites|mesh-ancestor
153513904|NCT01423175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153513905|NCT01423175|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153513906|NCT01423240|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
153513907|NCT01423240|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153513908|NCT01423240|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153513909|NCT01423240|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153513910|NCT01423240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153513911|NCT01423240|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153513912|NCT01423240|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
153513913|NCT01423240|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
153513914|NCT01423240|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
153513916|NCT01423240|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153513917|NCT01423240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153513918|NCT01423240|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
153513919|NCT01423240|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153513920|NCT01423240|Serotonin Agents|serotonin agents|mesh-ancestor
153513921|NCT01423240|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
153513924|NCT01423292|Bupivacaine|bupivacaine|mesh-list
153513937|NCT01423305|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153513938|NCT01423305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153513939|NCT01423305|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153513940|NCT01423305|Respiratory System Agents|respiratory system agents|mesh-ancestor
153513941|NCT01423305|Glucocorticoids|glucocorticoids|mesh-ancestor
153513943|NCT01423305|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153513944|NCT01423305|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
153513945|NCT01423305|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
153513946|NCT01423305|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153513947|NCT01423305|Adrenergic Agents|adrenergic agents|mesh-ancestor
153513948|NCT01423305|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153513949|NCT01423305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153792307|NCT05686408|Tianeptine|tianeptine|mesh-list
153513950|NCT01423370|Tadalafil|tadalafil|mesh-list
153513951|NCT01423370|Vasodilator Agents|vasodilator agents|mesh-ancestor
153513952|NCT01423370|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
153513953|NCT01423370|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
153513954|NCT01423370|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153513955|NCT01423370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153513956|NCT01423370|Urological Agents|urological agents|mesh-ancestor
153513957|NCT01423435|Beraprost|beraprost|mesh-list
153513958|NCT01423435|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153513959|NCT01423435|Vasodilator Agents|vasodilator agents|mesh-ancestor
153513960|NCT01423487|Metformin|metformin|mesh-list
153513961|NCT01423487|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153513962|NCT01423487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153513963|NCT01423500|Fludarabine|fludarabine|mesh-list
153513964|NCT01423500|Etoposide|etoposide|mesh-list
153513965|NCT01423500|Etoposide phosphate|etoposide phosphate|mesh-list
153513966|NCT01423500|Thiotepa|thiotepa|mesh-list
153513967|NCT01423500|Treosulfan|treosulfan|mesh-list
153513968|NCT01423500|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153513969|NCT01423500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153513970|NCT01423500|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153513976|NCT01423500|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153792371|NCT05546879|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153513977|NCT01423500|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153513978|NCT01423500|Alkylating Agents|alkylating agents|mesh-ancestor
153513979|NCT01423500|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153513980|NCT01423539|Rituximab|rituximab|mesh-list
153552859|NCT01583972|Antioxidants|antioxidants|mesh-ancestor
153513981|NCT01423539|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
153513982|NCT01423539|Navitoclax|navitoclax|mesh-list
153513983|NCT01423539|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153513984|NCT01423539|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153513985|NCT01423539|Immunologic Factors|immunologic factors|mesh-ancestor
153513986|NCT01423539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153513987|NCT01423539|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153513988|NCT01423539|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153513989|NCT01423539|Alkylating Agents|alkylating agents|mesh-ancestor
153513990|NCT01423539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153513991|NCT01423591|Infliximab|infliximab|mesh-list
153513992|NCT01423591|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
153513993|NCT01423591|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153513994|NCT01423591|Dermatologic Agents|dermatologic agents|mesh-ancestor
153513995|NCT01423591|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153513996|NCT01423591|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153513997|NCT01423695|Paclitaxel|paclitaxel|mesh-list
153513998|NCT01423695|Trastuzumab|trastuzumab|mesh-list
153513999|NCT01423695|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153514000|NCT01423695|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153514001|NCT01423695|Tubulin Modulators|tubulin modulators|mesh-ancestor
153514025|NCT01423747|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153514026|NCT01423747|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153514027|NCT01423747|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153514028|NCT01423747|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153514029|NCT01423747|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153514030|NCT01423747|Alkylating Agents|alkylating agents|mesh-ancestor
153514031|NCT01423747|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153514032|NCT01423838|Solifenacin Succinate|solifenacin succinate|mesh-list
153514033|NCT01423838|Oxybutynin|oxybutynin|mesh-list
153514034|NCT01423838|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
153514035|NCT01423838|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
153514036|NCT01423838|Cholinergic Agents|cholinergic agents|mesh-ancestor
153514037|NCT01423838|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153514038|NCT01423838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153514039|NCT01423838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153514040|NCT01423838|Urological Agents|urological agents|mesh-ancestor
153514041|NCT01423838|Parasympatholytics|parasympatholytics|mesh-ancestor
153514042|NCT01423838|Autonomic Agents|autonomic agents|mesh-ancestor
153514043|NCT01423838|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153514044|NCT01423864|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
153514046|NCT01423864|Methylprednisolone|methylprednisolone|mesh-list
153514047|NCT01423864|Prednisolone|prednisolone|mesh-list
153514048|NCT01423864|Prednisolone acetate|prednisolone acetate|mesh-list
153792465|NCT05482789|Hormones|hormones|mesh-ancestor
153514049|NCT01423864|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
153514050|NCT01423864|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
153514051|NCT01423864|Prednisolone phosphate|prednisolone phosphate|mesh-list
153514052|NCT01423864|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153514053|NCT01423864|Glucocorticoids|glucocorticoids|mesh-ancestor
153514054|NCT01423864|Hormones|hormones|mesh-ancestor
153514055|NCT01423864|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153514056|NCT01423864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153514057|NCT01423864|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
153514058|NCT01423864|Protective Agents|protective agents|mesh-ancestor
153514059|NCT01423864|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153514060|NCT01423864|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153514061|NCT01423864|Antiemetics|antiemetics|mesh-ancestor
153820681|NCT04702490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153514062|NCT01423864|Autonomic Agents|autonomic agents|mesh-ancestor
153514063|NCT01423864|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153514064|NCT01423864|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153514065|NCT01423955|Epoetin Alfa|epoetin alfa|mesh-list
153514066|NCT01423955|Hematinics|hematinics|mesh-ancestor
153514067|NCT01424046|Insulin Glargine|insulin glargine|mesh-list
153514068|NCT01424046|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153552900|NCT01587339|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153514069|NCT01424046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153514070|NCT01424111|Escitalopram|escitalopram|mesh-list
153514071|NCT01424111|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
153514072|NCT01424111|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153514073|NCT01424111|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153514074|NCT01424111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153514075|NCT01424111|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153514076|NCT01424111|Serotonin Agents|serotonin agents|mesh-ancestor
153514077|NCT01424111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153514078|NCT01424124|Montelukast|montelukast|mesh-list
153514080|NCT01424124|Respiratory System Agents|respiratory system agents|mesh-ancestor
153514081|NCT01424124|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
153514082|NCT01424124|Hormone Antagonists|hormone antagonists|mesh-ancestor
153514089|NCT01424137|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153514113|NCT01424241|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153514114|NCT01424319|Atrasentan|atrasentan|mesh-list
153514115|NCT01424319|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153514116|NCT01424319|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
153514117|NCT01424319|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
153514118|NCT01424319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153514119|NCT01424332|Aspirin|aspirin|mesh-list
153514120|NCT01424332|Salicylic Acid|salicylic acid|mesh-list
153514121|NCT01424332|Salicylates|salicylates|mesh-list
153514122|NCT01424332|Darexaban|darexaban|mesh-list
153514123|NCT01424332|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153514124|NCT01424332|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153514125|NCT01424332|Analgesics|analgesics|mesh-ancestor
153514126|NCT01424332|Sensory System Agents|sensory system agents|mesh-ancestor
153514127|NCT01424332|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153514128|NCT01424332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153514129|NCT01424332|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153514130|NCT01424332|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153514131|NCT01424332|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153514132|NCT01424332|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153514133|NCT01424332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153792635|NCT05192889|Antiemetics|antiemetics|mesh-ancestor
153514134|NCT01424332|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153514135|NCT01424332|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153514136|NCT01424332|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153514137|NCT01424332|Antipyretics|antipyretics|mesh-ancestor
153514138|NCT01424332|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153514139|NCT01424332|Antifungal Agents|antifungal agents|mesh-ancestor
153514140|NCT01424332|Keratolytic Agents|keratolytic agents|mesh-ancestor
153514141|NCT01424332|Dermatologic Agents|dermatologic agents|mesh-ancestor
153514142|NCT01424332|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
153514143|NCT01424332|Antithrombins|antithrombins|mesh-ancestor
153514144|NCT01424332|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
153514145|NCT01424332|Protease Inhibitors|protease inhibitors|mesh-ancestor
153514146|NCT01424332|Anticoagulants|anticoagulants|mesh-ancestor
153514147|NCT01424345|Immunosuppressive Agents|immunosuppressive agents|mesh-list
153514148|NCT01424345|Immunologic Factors|immunologic factors|mesh-ancestor
153514152|NCT01424384|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153514153|NCT01424384|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153792683|NCT05070247|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153552944|NCT01588873|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
153552946|NCT01588873|Progestins|progestins|mesh-ancestor
153553024|NCT01590342|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153514154|NCT01424384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153514155|NCT01424384|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153514156|NCT01424384|Serotonin Agents|serotonin agents|mesh-ancestor
153514157|NCT01424384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153514158|NCT01424384|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
153514159|NCT01424384|Antidepressive Agents|antidepressive agents|mesh-ancestor
153514160|NCT01424384|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153514161|NCT01424449|Aripiprazole|aripiprazole|mesh-list
153514162|NCT01424449|Antidepressive Agents|antidepressive agents|mesh-ancestor
153514163|NCT01424449|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153514164|NCT01424449|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153514165|NCT01424449|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153514166|NCT01424449|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153514167|NCT01424449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153514168|NCT01424449|Dopamine Agonists|dopamine agonists|mesh-ancestor
153514169|NCT01424449|Dopamine Agents|dopamine agents|mesh-ancestor
153514170|NCT01424449|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153514171|NCT01424449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153514172|NCT01424449|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
153514173|NCT01424449|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
153514174|NCT01424449|Serotonin Agents|serotonin agents|mesh-ancestor
153514175|NCT01424449|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
153514176|NCT01424449|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153514177|NCT01424449|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
153514179|NCT01424618|Leuprolide|leuprolide|mesh-list
153514197|NCT01424709|Tubulin Modulators|tubulin modulators|mesh-ancestor
153514198|NCT01424709|Antimitotic Agents|antimitotic agents|mesh-ancestor
153514199|NCT01424709|Mitosis Modulators|mitosis modulators|mesh-ancestor
153514200|NCT01424709|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
153514201|NCT01424709|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153514202|NCT01424709|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153514203|NCT01424761|Ubiquinone|ubiquinone|mesh-list
153514204|NCT01424761|Coenzyme Q10|coenzyme q10|mesh-list
153514205|NCT01424761|Micronutrients|micronutrients|mesh-ancestor
153514206|NCT01424761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153514207|NCT01424761|Vitamins|vitamins|mesh-ancestor
153514208|NCT01424826|Raltegravir Potassium|raltegravir potassium|mesh-list
153514209|NCT01424826|Rifampin|rifampin|mesh-list
153514210|NCT01424826|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153514211|NCT01424826|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153514212|NCT01424826|Antiviral Agents|antiviral agents|mesh-ancestor
153514213|NCT01424826|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153514214|NCT01424826|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
153514215|NCT01424826|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
153514216|NCT01424826|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153514254|NCT01425073|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
153514255|NCT01425073|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
153514256|NCT01425073|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153514257|NCT01425073|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153514258|NCT01425073|Antimalarials|antimalarials|mesh-ancestor
153514259|NCT01425073|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153514260|NCT01425073|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153514262|NCT01425099|Prednisone|prednisone|mesh-list
153514263|NCT01425099|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153514264|NCT01425099|Glucocorticoids|glucocorticoids|mesh-ancestor
153514265|NCT01425099|Hormones|hormones|mesh-ancestor
153553025|NCT01590342|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153514266|NCT01425099|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153514267|NCT01425099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153514268|NCT01425099|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153514269|NCT01425099|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153514270|NCT01425099|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
153514271|NCT01425099|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
153514272|NCT01425099|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153514308|NCT01425242|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153514309|NCT01425242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153514310|NCT01425242|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153514311|NCT01425242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153514313|NCT01425242|Renin Inhibitors|renin inhibitors|mesh-ancestor
153514314|NCT01425242|Protease Inhibitors|protease inhibitors|mesh-ancestor
153514315|NCT01425242|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153514316|NCT01425320|Dapsone|dapsone|mesh-list
153514317|NCT01425320|Adapalene|adapalene|mesh-list
153514318|NCT01425320|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153514319|NCT01425320|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153514320|NCT01425320|Analgesics|analgesics|mesh-ancestor
153514321|NCT01425320|Sensory System Agents|sensory system agents|mesh-ancestor
153792882|NCT04652544|Cholecalciferol|cholecalciferol|mesh-list
153514322|NCT01425320|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153514323|NCT01425320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153514325|NCT01425320|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153514326|NCT01425320|Dermatologic Agents|dermatologic agents|mesh-ancestor
153514327|NCT01425320|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153514328|NCT01425320|Antimalarials|antimalarials|mesh-ancestor
153514329|NCT01425320|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153514330|NCT01425320|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153514331|NCT01425320|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153514332|NCT01425320|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153514333|NCT01425320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153514344|NCT01425411|Valsartan|valsartan|mesh-list
153514355|NCT01425424|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153514356|NCT01425424|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153514358|NCT01425476|Cholecalciferol|cholecalciferol|mesh-list
153514359|NCT01425476|Celecoxib|celecoxib|mesh-list
153514360|NCT01425476|Vitamins|vitamins|mesh-ancestor
153514361|NCT01425476|Micronutrients|micronutrients|mesh-ancestor
153514362|NCT01425476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153514363|NCT01425476|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153514364|NCT01425476|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153514365|NCT01425476|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153514366|NCT01425476|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153514367|NCT01425476|Analgesics|analgesics|mesh-ancestor
153514368|NCT01425476|Sensory System Agents|sensory system agents|mesh-ancestor
153514369|NCT01425476|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153514370|NCT01425476|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153514371|NCT01425476|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153514372|NCT01425476|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
153514373|NCT01425476|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153514374|NCT01425476|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153514375|NCT01425476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153514376|NCT01425567|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-list
153514377|NCT01425567|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
153514378|NCT01425567|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
153514379|NCT01425580|Metformin|metformin|mesh-list
153514380|NCT01425580|Liraglutide|liraglutide|mesh-list
153514381|NCT01425580|Glimepiride|glimepiride|mesh-list
153514382|NCT01425580|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153514383|NCT01425580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153514384|NCT01425580|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
153514385|NCT01425580|Incretins|incretins|mesh-ancestor
153514386|NCT01425580|Hormones|hormones|mesh-ancestor
153514391|NCT01425619|Lidocaine|lidocaine|mesh-list
153514398|NCT01425619|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153553132|NCT01591031|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
153553134|NCT01591070|Tacrolimus|tacrolimus|mesh-list
153514399|NCT01425619|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153514400|NCT01425619|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
153514401|NCT01425619|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153514402|NCT01425619|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153514403|NCT01425619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153514404|NCT01425658|Clonidine|clonidine|mesh-list
153514405|NCT01425658|Fentanyl|fentanyl|mesh-list
153514406|NCT01425658|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153514408|NCT01425658|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153514409|NCT01425658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153514410|NCT01425658|Analgesics|analgesics|mesh-ancestor
153514411|NCT01425658|Sensory System Agents|sensory system agents|mesh-ancestor
153793026|NCT04270409|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
153514413|NCT01425658|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153514414|NCT01425658|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153514415|NCT01425658|Anesthetics, General|anesthetics, general|mesh-ancestor
153514417|NCT01425658|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153514418|NCT01425658|Sympatholytics|sympatholytics|mesh-ancestor
153514419|NCT01425658|Autonomic Agents|autonomic agents|mesh-ancestor
153514420|NCT01425658|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
153514421|NCT01425658|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153514422|NCT01425658|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153514423|NCT01425658|Adrenergic Agents|adrenergic agents|mesh-ancestor
153514424|NCT01425658|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153514425|NCT01425658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153514426|NCT01425697|Chlorhexidine|chlorhexidine|mesh-list
153514427|NCT01425697|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
153514441|NCT01425736|Antimetabolites|antimetabolites|mesh-ancestor
153793085|NCT04232553|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
153514442|NCT01425736|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153514443|NCT01425736|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153514444|NCT01425736|Immunologic Factors|immunologic factors|mesh-ancestor
153514445|NCT01425736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153514446|NCT01425736|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153514448|NCT01425775|Vitamins|vitamins|mesh-ancestor
153514449|NCT01425775|Micronutrients|micronutrients|mesh-ancestor
153514450|NCT01425775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153514451|NCT01425775|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153514452|NCT05386446|Interferons|interferons|mesh-list
153514453|NCT05386446|Interferon-gamma|interferon-gamma|mesh-list
153514454|NCT05386446|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153514455|NCT05386446|Antiviral Agents|antiviral agents|mesh-ancestor
153514456|NCT05386446|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153514457|NCT05386433|Nirmatrelvir and ritonavir drug combination|nirmatrelvir and ritonavir drug combination|mesh-list
153514458|NCT05386433|Antiviral Agents|antiviral agents|mesh-ancestor
153514459|NCT05386433|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153514460|NCT05386290|Infliximab|infliximab|mesh-list
153514461|NCT05386290|Mesalamine|mesalamine|mesh-list
153514462|NCT05386290|Ustekinumab|ustekinumab|mesh-list
153514463|NCT05386290|Vedolizumab|vedolizumab|mesh-list
153514464|NCT05386290|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
153514465|NCT05386290|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153514466|NCT05386290|Dermatologic Agents|dermatologic agents|mesh-ancestor
153514467|NCT05386290|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153514468|NCT05386290|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153514469|NCT05386290|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153514470|NCT05386290|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153514471|NCT05386290|Analgesics|analgesics|mesh-ancestor
153514472|NCT05386290|Sensory System Agents|sensory system agents|mesh-ancestor
153514485|NCT05386186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153514486|NCT05386186|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153514487|NCT05386186|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153514488|NCT05386186|Immunologic Factors|immunologic factors|mesh-ancestor
153514489|NCT05386160|Ranibizumab|ranibizumab|mesh-list
153514491|NCT05386160|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153514493|NCT05386160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153514494|NCT05386160|Growth Inhibitors|growth inhibitors|mesh-ancestor
153514495|NCT05386160|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153514496|NCT05386121|Fentanyl|fentanyl|mesh-list
153514497|NCT05386121|Meperidine|meperidine|mesh-list
153514498|NCT05386121|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153514499|NCT05386121|Narcotics|narcotics|mesh-ancestor
153514500|NCT05386121|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153514501|NCT05386121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153514502|NCT05386121|Analgesics|analgesics|mesh-ancestor
153514503|NCT05386121|Sensory System Agents|sensory system agents|mesh-ancestor
153514504|NCT05386121|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153514505|NCT05386121|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153514506|NCT05386121|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153514507|NCT05386121|Anesthetics, General|anesthetics, general|mesh-ancestor
153514509|NCT05386056|Pembrolizumab|pembrolizumab|mesh-list
153514510|NCT05386056|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153514511|NCT05386056|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153514512|NCT05386056|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153514534|NCT05385185|Endostatins|endostatins|mesh-list
153514535|NCT05385185|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153514536|NCT05385185|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153514537|NCT05385185|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153514538|NCT05385185|Growth Substances|growth substances|mesh-ancestor
153514539|NCT05385185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153514540|NCT05385185|Growth Inhibitors|growth inhibitors|mesh-ancestor
153514541|NCT05385094|Cystatins|cystatins|mesh-list
153514542|NCT05385094|Cysteine Proteinase Inhibitors|cysteine proteinase inhibitors|mesh-ancestor
153514543|NCT05385094|Protease Inhibitors|protease inhibitors|mesh-ancestor
153514544|NCT05385094|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153514545|NCT05385094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153514546|NCT05385068|Niraparib|niraparib|mesh-list
153514547|NCT05385068|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
153514548|NCT05385068|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153514549|NCT05385068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153514550|NCT05385068|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153514551|NCT05385029|Carbimazole|carbimazole|mesh-list
153514552|NCT05385029|Antithyroid Agents|antithyroid agents|mesh-ancestor
153514553|NCT05385029|Hormone Antagonists|hormone antagonists|mesh-ancestor
153514554|NCT05385029|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153793359|NCT03308448|Epoetin Alfa|epoetin alfa|mesh-list
153793360|NCT03308448|Hematinics|hematinics|mesh-ancestor
153793361|NCT03189446|Paclitaxel|paclitaxel|mesh-list
153793362|NCT03189446|Carboplatin|carboplatin|mesh-list
153514555|NCT05385029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153514557|NCT05379413|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
153514558|NCT05379413|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
153514559|NCT05379413|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
153514560|NCT05379413|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153514562|NCT05379413|Cholinergic Agents|cholinergic agents|mesh-ancestor
153514577|NCT05379374|Analgesics|analgesics|mesh-ancestor
153514578|NCT05375708|Bevacizumab|bevacizumab|mesh-list
153514579|NCT05375708|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153514580|NCT05375708|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153514581|NCT05375708|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153514582|NCT05375708|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153553185|NCT01591226|Anticoagulants|anticoagulants|mesh-ancestor
153553186|NCT01591226|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
153514583|NCT05375708|Growth Substances|growth substances|mesh-ancestor
153514584|NCT05375708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153514585|NCT05375708|Growth Inhibitors|growth inhibitors|mesh-ancestor
153553187|NCT01591226|Chelating Agents|chelating agents|mesh-ancestor
153553188|NCT01591226|Sequestering Agents|sequestering agents|mesh-ancestor
153553189|NCT01591226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153553190|NCT01591226|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
153553191|NCT01591226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153553193|NCT01591226|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153514587|NCT05113615|Tiotropium Bromide|tiotropium bromide|mesh-list
153514588|NCT05113615|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153514589|NCT05113615|Autonomic Agents|autonomic agents|mesh-ancestor
153514590|NCT05113615|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153514591|NCT05113615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153514592|NCT05113615|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153340044|NCT00002470|Antiviral Agents|antiviral agents|mesh-ancestor
153793520|NCT02193425|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
153793521|NCT02193425|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
153793522|NCT02193425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153793523|NCT02156895|Axitinib|axitinib|mesh-list
153793524|NCT02156895|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153793525|NCT02156895|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153793526|NCT02156895|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153514593|NCT05113615|Respiratory System Agents|respiratory system agents|mesh-ancestor
153514594|NCT05113615|Parasympatholytics|parasympatholytics|mesh-ancestor
153514595|NCT05113615|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
153514596|NCT05113615|Cholinergic Agents|cholinergic agents|mesh-ancestor
153514597|NCT05113615|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153514598|NCT05113615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153514599|NCT05113615|Anticonvulsants|anticonvulsants|mesh-ancestor
153514602|NCT04850378|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
153514603|NCT04850378|Apixaban|apixaban|mesh-list
153514604|NCT04850378|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
153514605|NCT04850378|Antithrombins|antithrombins|mesh-ancestor
153514606|NCT04850378|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
153514607|NCT04850378|Protease Inhibitors|protease inhibitors|mesh-ancestor
153514608|NCT04850378|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153514609|NCT04850378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153514610|NCT04850378|Anticoagulants|anticoagulants|mesh-ancestor
153514611|NCT04850378|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153514612|NCT04850378|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153514613|NCT04809103|Cisplatin|cisplatin|mesh-list
153514614|NCT04809103|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153514616|NCT04804371|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
153514617|NCT04804371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153514619|NCT04765371|Dexamethasone acetate|dexamethasone acetate|mesh-list
153514620|NCT04765371|Prednisolone|prednisolone|mesh-list
153514621|NCT04765371|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
153514622|NCT04765371|Methylprednisolone|methylprednisolone|mesh-list
153514623|NCT04765371|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
153514624|NCT04765371|Prednisolone acetate|prednisolone acetate|mesh-list
153514625|NCT04765371|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
153514626|NCT04765371|Prednisolone phosphate|prednisolone phosphate|mesh-list
153514627|NCT04765371|BB 1101|bb 1101|mesh-list
153514628|NCT04765371|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153514629|NCT04765371|Antiemetics|antiemetics|mesh-ancestor
153514630|NCT04765371|Autonomic Agents|autonomic agents|mesh-ancestor
153514631|NCT04765371|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153514632|NCT04765371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153514633|NCT04765371|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153514634|NCT04765371|Glucocorticoids|glucocorticoids|mesh-ancestor
153514635|NCT04765371|Hormones|hormones|mesh-ancestor
153514636|NCT04765371|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153514671|NCT04311762|Cisplatin|cisplatin|mesh-list
153514672|NCT04311762|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153514673|NCT04203472|Budesonide|budesonide|mesh-list
153514674|NCT04203472|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153514675|NCT04203472|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153514676|NCT04203472|Autonomic Agents|autonomic agents|mesh-ancestor
153514677|NCT04203472|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153514678|NCT04203472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153514679|NCT04203472|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153514680|NCT04203472|Respiratory System Agents|respiratory system agents|mesh-ancestor
153514681|NCT04203472|Glucocorticoids|glucocorticoids|mesh-ancestor
153514682|NCT04203472|Hormones|hormones|mesh-ancestor
153514683|NCT04203472|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153514684|NCT04072146|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
153514685|NCT04072146|Varenicline|varenicline|mesh-list
153514686|NCT04072146|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
153514687|NCT04072146|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
153793830|NCT00258245|Aspirin|aspirin|mesh-list
153514688|NCT04072146|Cholinergic Agents|cholinergic agents|mesh-ancestor
153514689|NCT04072146|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153514690|NCT04072146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153514691|NCT04072146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153514693|NCT03945084|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
153514694|NCT03945084|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153514695|NCT03945084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153514696|NCT03945084|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153514697|NCT03882463|Insulin|insulin|mesh-list
153514698|NCT03882463|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153514699|NCT03882463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153514700|NCT03861481|Rozanolixizumab|rozanolixizumab|mesh-list
153514701|NCT03861481|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153514702|NCT03861481|Immunologic Factors|immunologic factors|mesh-ancestor
153514703|NCT03861481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153514704|NCT03821649|Naloxone|naloxone|mesh-list
153514705|NCT03821649|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
153514707|NCT03821649|Sensory System Agents|sensory system agents|mesh-ancestor
153514710|NCT03811262|Anesthetics, Local|anesthetics, local|mesh-ancestor
153514711|NCT03811262|Anesthetics|anesthetics|mesh-ancestor
153553194|NCT01591226|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
153514712|NCT03811262|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153514713|NCT03811262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153514714|NCT03811262|Sensory System Agents|sensory system agents|mesh-ancestor
153514715|NCT03811262|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153794192|NCT04709081|Digoxin|digoxin|mesh-list
153514716|NCT03730974|Snake venom protein C activator|snake venom protein c activator|mesh-list
153514717|NCT03730974|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153514718|NCT03730974|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153514719|NCT03730974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153514720|NCT03708198|Bupivacaine|bupivacaine|mesh-list
153514721|NCT03708198|Anesthetics, Local|anesthetics, local|mesh-ancestor
153514722|NCT03708198|Anesthetics|anesthetics|mesh-ancestor
153514723|NCT03708198|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153514724|NCT03708198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153514725|NCT03708198|Sensory System Agents|sensory system agents|mesh-ancestor
153514726|NCT03708198|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153514727|NCT03559426|Antipsychotic Agents|antipsychotic agents|mesh-list
153514728|NCT03559426|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153514729|NCT03559426|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153514730|NCT03559426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153514731|NCT03559426|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153514732|NCT03444753|Nivolumab|nivolumab|mesh-list
153514733|NCT03444753|Ipilimumab|ipilimumab|mesh-list
153514734|NCT03444753|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153514735|NCT03444753|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153514736|NCT03444753|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153514737|NCT03444753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153514738|NCT03142035|Dienogest|dienogest|mesh-list
153514739|NCT03142035|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
153514740|NCT03142035|Contraceptive Agents|contraceptive agents|mesh-ancestor
153514741|NCT03142035|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153514749|NCT03142035|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153514750|NCT03142035|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153514751|NCT02786875|Vitamin D|vitamin d|mesh-list
153514752|NCT02786875|Ergocalciferols|ergocalciferols|mesh-list
153514753|NCT02786875|Cholecalciferol|cholecalciferol|mesh-list
153514754|NCT02786875|Vitamins|vitamins|mesh-list
153514755|NCT02786875|Micronutrients|micronutrients|mesh-ancestor
153794260|NCT00259766|Budesonide|budesonide|mesh-list
153514756|NCT02786875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153514757|NCT02786875|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153457864|NCT03986970|Tenofovir|tenofovir|mesh-list
153553196|NCT01591226|Purinergic Agents|purinergic agents|mesh-ancestor
153514758|NCT02786875|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153514759|NCT02767882|Dexamethasone|dexamethasone|mesh-list
153514760|NCT02767882|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153514761|NCT02767882|Antiemetics|antiemetics|mesh-ancestor
153514762|NCT02767882|Autonomic Agents|autonomic agents|mesh-ancestor
153514763|NCT02767882|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153514764|NCT02767882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153514765|NCT02767882|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153514766|NCT02767882|Glucocorticoids|glucocorticoids|mesh-ancestor
153514767|NCT02767882|Hormones|hormones|mesh-ancestor
153514768|NCT02767882|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153514769|NCT02767882|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153514770|NCT02767882|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153514771|NCT02246257|Metformin|metformin|mesh-list
153514772|NCT02246257|Losartan|losartan|mesh-list
153514773|NCT02246257|Simvastatin|simvastatin|mesh-list
153514774|NCT02246257|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153794357|NCT00292266|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153514775|NCT02246257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153514776|NCT02246257|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153514777|NCT02246257|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153514778|NCT02246257|Antimetabolites|antimetabolites|mesh-ancestor
153514779|NCT02246257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153514792|NCT02197221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153514794|NCT02197221|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153514795|NCT02197221|Immunologic Factors|immunologic factors|mesh-ancestor
153514796|NCT02197221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153514797|NCT02010385|Octreotide|octreotide|mesh-list
153514798|NCT02010385|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153514799|NCT02010385|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153514800|NCT02010385|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153514801|NCT01949714|Epinephrine|epinephrine|mesh-list
153514802|NCT01949714|Racepinephrine|racepinephrine|mesh-list
153514803|NCT01949714|Epinephryl borate|epinephryl borate|mesh-list
153514804|NCT01949714|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153514805|NCT01949714|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153514806|NCT01949714|Adrenergic Agents|adrenergic agents|mesh-ancestor
153514807|NCT01949714|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153514808|NCT01949714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153514809|NCT01949714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153514810|NCT01949714|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
153514811|NCT01949714|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153514812|NCT01949714|Autonomic Agents|autonomic agents|mesh-ancestor
153514813|NCT01949714|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153514814|NCT01949714|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153514815|NCT01949714|Respiratory System Agents|respiratory system agents|mesh-ancestor
153514817|NCT01949714|Sympathomimetics|sympathomimetics|mesh-ancestor
153514818|NCT01949714|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
153514819|NCT00223145|Goserelin|goserelin|mesh-list
153514835|NCT01425827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153514837|NCT01425827|Sensory System Agents|sensory system agents|mesh-ancestor
153514838|NCT01425827|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153514839|NCT01425827|Antidepressive Agents|antidepressive agents|mesh-ancestor
153514840|NCT01425827|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153514841|NCT01425827|Dopamine Agents|dopamine agents|mesh-ancestor
153514842|NCT01425840|Lidocaine|lidocaine|mesh-list
153514843|NCT01425840|Anesthetics, Local|anesthetics, local|mesh-ancestor
153514844|NCT01425840|Anesthetics|anesthetics|mesh-ancestor
153514845|NCT01425840|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153514846|NCT01425840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153514847|NCT01425840|Sensory System Agents|sensory system agents|mesh-ancestor
153514848|NCT01425840|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153514849|NCT01425840|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153514850|NCT01425840|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
153514851|NCT01425840|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153514852|NCT01425840|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153514853|NCT01425840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153514854|NCT01425996|Camptothecin|camptothecin|mesh-list
153514855|NCT01425996|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153514856|NCT01425996|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153514857|NCT01425996|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
153514858|NCT01425996|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153514859|NCT01425996|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153514881|NCT01426100|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153514882|NCT01426100|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
153514884|NCT01426100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153514885|NCT01426126|genexol-PM|genexol-pm|mesh-list
153514886|NCT01426126|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153514887|NCT01426126|Tubulin Modulators|tubulin modulators|mesh-ancestor
153514888|NCT01426126|Antimitotic Agents|antimitotic agents|mesh-ancestor
153514889|NCT01426126|Mitosis Modulators|mitosis modulators|mesh-ancestor
153514890|NCT01426126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153514891|NCT01426165|Magnesium Sulfate|magnesium sulfate|mesh-list
153514893|NCT01426165|Sensory System Agents|sensory system agents|mesh-ancestor
153514894|NCT01426165|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153514895|NCT01426165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153514896|NCT01426165|Anesthetics|anesthetics|mesh-ancestor
153514897|NCT01426165|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153514898|NCT01426165|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153514899|NCT01426165|Anticonvulsants|anticonvulsants|mesh-ancestor
153514900|NCT01426165|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153618889|NCT01980680|Estradiol|estradiol|mesh-list
153458019|NCT03591744|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153514901|NCT01426165|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153514902|NCT01426165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153514903|NCT01426165|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153514905|NCT01426165|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153514906|NCT01426256|Vitamin D|vitamin d|mesh-list
153514907|NCT01426256|Cholecalciferol|cholecalciferol|mesh-list
153514908|NCT01426256|Vitamins|vitamins|mesh-ancestor
153514909|NCT01426256|Micronutrients|micronutrients|mesh-ancestor
153514910|NCT01426256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153514911|NCT01426256|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153514921|NCT01426334|Antifungal Agents|antifungal agents|mesh-ancestor
153514922|NCT01426334|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153514923|NCT01426334|Dermatologic Agents|dermatologic agents|mesh-ancestor
153514924|NCT01426334|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153514926|NCT01426334|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153514927|NCT01426334|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153514928|NCT01426334|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153514929|NCT01426399|Metformin|metformin|mesh-list
153514930|NCT01426399|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153514931|NCT01426399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153514932|NCT01426464|Latanoprost|latanoprost|mesh-list
153514933|NCT01426464|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
153514934|NCT01426464|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
153514935|NCT01426490|Vitamins|vitamins|mesh-list
153514936|NCT01426490|Ascorbic Acid|ascorbic acid|mesh-list
153514937|NCT01426490|Folic Acid|folic acid|mesh-list
153514938|NCT01426490|Pyridoxine|pyridoxine|mesh-list
153514939|NCT01426490|Pyridoxal|pyridoxal|mesh-list
153514940|NCT01426490|Vitamin B 6|vitamin b 6|mesh-list
153514941|NCT01426490|Vitamin B Complex|vitamin b complex|mesh-list
153514943|NCT01426490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153514944|NCT01426490|Antioxidants|antioxidants|mesh-ancestor
153514945|NCT01426490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153795180|NCT06258265|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
153514947|NCT01426490|Hematinics|hematinics|mesh-ancestor
153514948|NCT01426542|Topiramate|topiramate|mesh-list
153514949|NCT01426542|Anticonvulsants|anticonvulsants|mesh-ancestor
153514950|NCT01426542|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153514951|NCT01426542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153514952|NCT01426633|Gemcitabine|gemcitabine|mesh-list
153514953|NCT01426633|Trabectedin|trabectedin|mesh-list
153514954|NCT01426633|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153514955|NCT01426633|Antimetabolites|antimetabolites|mesh-ancestor
153514956|NCT01426633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153514957|NCT01426633|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153514958|NCT01426633|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153514959|NCT01426633|Alkylating Agents|alkylating agents|mesh-ancestor
153514960|NCT01426646|Cisplatin|cisplatin|mesh-list
153514961|NCT01426646|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153514964|NCT01426737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153514965|NCT01426737|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
153514966|NCT01426737|Protease Inhibitors|protease inhibitors|mesh-ancestor
153514967|NCT01426737|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153514968|NCT01426737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153514969|NCT01426802|Vildagliptin|vildagliptin|mesh-list
153514970|NCT01426802|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153514971|NCT01426802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153514972|NCT01426802|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
153514973|NCT01426802|Protease Inhibitors|protease inhibitors|mesh-ancestor
153514976|NCT01426815|Golimumab|golimumab|mesh-list
153515020|NCT01426971|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153515021|NCT01426971|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153515022|NCT01426971|Analgesics|analgesics|mesh-ancestor
153515023|NCT01426971|Sensory System Agents|sensory system agents|mesh-ancestor
153515024|NCT01426971|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153515025|NCT01426971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153515026|NCT01426971|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153515027|NCT01426971|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153515028|NCT01426971|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153515029|NCT01426971|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153515030|NCT01426971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153515031|NCT01426971|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
153515032|NCT01426971|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
153515033|NCT01426971|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
153515034|NCT01426971|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
153515035|NCT01426971|Purinergic Agents|purinergic agents|mesh-ancestor
153515075|NCT01427192|Natriuretic Agents|natriuretic agents|mesh-ancestor
153515076|NCT01427192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153515077|NCT01427205|Cetuximab|cetuximab|mesh-list
153515078|NCT01427205|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153515079|NCT01427205|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153515080|NCT01427244|Trastuzumab|trastuzumab|mesh-list
153515081|NCT01427244|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153515082|NCT01427244|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153515083|NCT01427270|Oxycodone|oxycodone|mesh-list
153515084|NCT01427270|Naloxone|naloxone|mesh-list
153515085|NCT01427270|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153515086|NCT01427270|Narcotics|narcotics|mesh-ancestor
153515087|NCT01427270|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153515088|NCT01427270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153515089|NCT01427270|Analgesics|analgesics|mesh-ancestor
153515090|NCT01427270|Sensory System Agents|sensory system agents|mesh-ancestor
153515091|NCT01427270|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153515092|NCT01427270|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
153515093|NCT01427283|Oxycodone|oxycodone|mesh-list
153515094|NCT01427283|Naloxone|naloxone|mesh-list
153515095|NCT01427283|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153515096|NCT01427283|Narcotics|narcotics|mesh-ancestor
153515097|NCT01427283|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153515098|NCT01427283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153515099|NCT01427283|Analgesics|analgesics|mesh-ancestor
153515100|NCT01427283|Sensory System Agents|sensory system agents|mesh-ancestor
153515101|NCT01427283|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153515102|NCT01427283|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
153515103|NCT01427322|Lapatinib|lapatinib|mesh-list
153515104|NCT01427322|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153515106|NCT01427322|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153515120|NCT01427400|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
153515122|NCT01427400|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
153515123|NCT01427400|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153515124|NCT01427400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153515125|NCT01427400|Cholinergic Agents|cholinergic agents|mesh-ancestor
153515126|NCT01427400|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153515127|NCT01427400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153515128|NCT01427400|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
153515129|NCT01427400|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153515130|NCT01427478|Afatinib|afatinib|mesh-list
153515131|NCT01427478|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153515132|NCT01427478|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153515133|NCT01427478|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153515134|NCT01427478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153515135|NCT01427478|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153515136|NCT01427491|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
153515144|NCT01427686|Dobutamine|dobutamine|mesh-list
153515175|NCT01427946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153515176|NCT01427946|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153515177|NCT01427985|Atropine|atropine|mesh-list
153515178|NCT01427985|Fentanyl|fentanyl|mesh-list
153515179|NCT01427985|Mivacurium|mivacurium|mesh-list
153515180|NCT01427985|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153515181|NCT01427985|Narcotics|narcotics|mesh-ancestor
153515182|NCT01427985|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153515183|NCT01427985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153515184|NCT01427985|Analgesics|analgesics|mesh-ancestor
153515185|NCT01427985|Sensory System Agents|sensory system agents|mesh-ancestor
153515186|NCT01427985|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153515187|NCT01427985|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153515188|NCT01427985|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153515189|NCT01427985|Anesthetics, General|anesthetics, general|mesh-ancestor
153515190|NCT01427985|Anesthetics|anesthetics|mesh-ancestor
153515191|NCT01427985|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153515192|NCT01427985|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153515193|NCT01427985|Autonomic Agents|autonomic agents|mesh-ancestor
153515194|NCT01427985|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153515195|NCT01427985|Respiratory System Agents|respiratory system agents|mesh-ancestor
153515196|NCT01427985|Mydriatics|mydriatics|mesh-ancestor
153515197|NCT01427985|Parasympatholytics|parasympatholytics|mesh-ancestor
153515198|NCT01427985|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
153515199|NCT01427985|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
153458329|NCT04020588|Celecoxib|celecoxib|mesh-list
153515206|NCT01428037|Misoprostol|misoprostol|mesh-list
153515224|NCT01428050|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
153515225|NCT01428154|Darbepoetin alfa|darbepoetin alfa|mesh-list
153515226|NCT01428154|Hematinics|hematinics|mesh-ancestor
153515227|NCT01428180|Ibuprofen|ibuprofen|mesh-list
153515228|NCT01428180|Indomethacin|indomethacin|mesh-list
153515229|NCT01428180|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153515230|NCT01428180|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153515231|NCT01428180|Analgesics|analgesics|mesh-ancestor
153515232|NCT01428180|Sensory System Agents|sensory system agents|mesh-ancestor
153515233|NCT01428180|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153515234|NCT01428180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153553361|NCT01592253|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153420800|NCT01306994|Analgesics|analgesics|mesh-ancestor
153515235|NCT01428180|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153515236|NCT01428180|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153515237|NCT01428180|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153515238|NCT01428180|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153515239|NCT01428180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153515240|NCT01428180|Gout Suppressants|gout suppressants|mesh-ancestor
153515241|NCT01428180|Tocolytic Agents|tocolytic agents|mesh-ancestor
153515242|NCT01428180|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153515243|NCT01428284|Canagliflozin|canagliflozin|mesh-list
153515244|NCT01428284|Probenecid|probenecid|mesh-list
153515245|NCT01428284|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
153515246|NCT01428284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153515247|NCT01428284|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153515248|NCT01428284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153515249|NCT01428284|Uricosuric Agents|uricosuric agents|mesh-ancestor
153515250|NCT01428284|Gout Suppressants|gout suppressants|mesh-ancestor
153515251|NCT01428284|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153515252|NCT01428375|Acetaminophen|acetaminophen|mesh-list
153515253|NCT01428375|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153515254|NCT01428375|Analgesics|analgesics|mesh-ancestor
153515255|NCT01428375|Sensory System Agents|sensory system agents|mesh-ancestor
153515256|NCT01428375|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153515257|NCT01428375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153515258|NCT01428375|Antipyretics|antipyretics|mesh-ancestor
153515259|NCT01428388|Bevacizumab|bevacizumab|mesh-list
153515260|NCT01428388|Ranibizumab|ranibizumab|mesh-list
153820682|NCT00464763|Dexmedetomidine|dexmedetomidine|mesh-list
153515262|NCT01428388|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153515263|NCT01428388|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153515264|NCT01428388|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153515265|NCT01428388|Growth Substances|growth substances|mesh-ancestor
153515266|NCT01428388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153515267|NCT01428388|Growth Inhibitors|growth inhibitors|mesh-ancestor
153515269|NCT01428414|Carboplatin|carboplatin|mesh-list
153515270|NCT01428414|Trastuzumab|trastuzumab|mesh-list
153515271|NCT01428414|Epirubicin|epirubicin|mesh-list
153515272|NCT01428414|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153515273|NCT01428414|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153515274|NCT01428414|Tubulin Modulators|tubulin modulators|mesh-ancestor
153618890|NCT01980680|Progesterone|progesterone|mesh-list
153515275|NCT01428414|Antimitotic Agents|antimitotic agents|mesh-ancestor
153515276|NCT01428414|Mitosis Modulators|mitosis modulators|mesh-ancestor
153515277|NCT01428414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153515278|NCT01428414|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153515279|NCT01428414|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153515280|NCT01428414|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153796396|NCT03622788|Fludarabine|fludarabine|mesh-list
153515281|NCT01428414|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153515282|NCT01428414|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153515283|NCT01428427|Gemcitabine|gemcitabine|mesh-list
153515286|NCT01428427|Antimetabolites|antimetabolites|mesh-ancestor
153515287|NCT01428427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153515288|NCT01428427|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153515289|NCT01428427|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153515290|NCT01428427|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153515291|NCT01428466|Benzoyl Peroxide|benzoyl peroxide|mesh-list
153515292|NCT01428466|Dermatologic Agents|dermatologic agents|mesh-ancestor
153515293|NCT01428492|Dexamethasone|dexamethasone|mesh-list
153515294|NCT01428492|Bortezomib|bortezomib|mesh-list
153515295|NCT01428492|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153515303|NCT01428492|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153515304|NCT01428492|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153515305|NCT01428492|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153553371|NCT01592279|Incretins|incretins|mesh-ancestor
153515306|NCT01428518|Lamotrigine|lamotrigine|mesh-list
153515307|NCT01428518|Anticonvulsants|anticonvulsants|mesh-ancestor
153515308|NCT01428518|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153515309|NCT01428518|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153796483|NCT03435003|Sevoflurane|sevoflurane|mesh-list
153515311|NCT01428518|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153515312|NCT01428518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153515313|NCT01428518|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153515314|NCT01428518|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153515315|NCT01428518|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153515316|NCT01428518|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153515317|NCT01428518|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153515318|NCT01428531|PENTA|penta|mesh-list
153515319|NCT01428531|Fondaparinux|fondaparinux|mesh-list
153515320|NCT01428531|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
153515321|NCT01428531|Antithrombins|antithrombins|mesh-ancestor
153515322|NCT01428531|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
153515323|NCT01428531|Protease Inhibitors|protease inhibitors|mesh-ancestor
153515329|NCT01428544|PENTA|penta|mesh-list
153515356|NCT01428986|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
153515357|NCT01428986|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
153515358|NCT01428986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153515359|NCT01428986|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153515360|NCT01428986|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153515361|NCT01428986|Antiviral Agents|antiviral agents|mesh-ancestor
153515362|NCT01428986|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153515363|NCT01428986|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
153515364|NCT01429025|Rituximab|rituximab|mesh-list
153515365|NCT01429025|Lenalidomide|lenalidomide|mesh-list
153515366|NCT01429025|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
153515367|NCT01429025|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153515368|NCT01429025|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153515369|NCT01429025|Immunologic Factors|immunologic factors|mesh-ancestor
153515370|NCT01429025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153515371|NCT01429025|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153515372|NCT01429025|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153515373|NCT01429025|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153515374|NCT01429025|Growth Substances|growth substances|mesh-ancestor
153515375|NCT01429025|Growth Inhibitors|growth inhibitors|mesh-ancestor
153515376|NCT01429025|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153515409|NCT01429337|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153515410|NCT01429337|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153515411|NCT01429337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153515413|NCT01429402|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
153515414|NCT01429402|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
153515415|NCT01429402|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
153515416|NCT01429402|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153515417|NCT01429402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153515419|NCT01429402|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153515420|NCT01429402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153515421|NCT01429402|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
153515422|NCT01429402|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153515423|NCT01429415|Magnesium Sulfate|magnesium sulfate|mesh-list
153515425|NCT01429415|Sensory System Agents|sensory system agents|mesh-ancestor
153515426|NCT01429415|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153515427|NCT01429415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153515428|NCT01429415|Anesthetics|anesthetics|mesh-ancestor
153553409|NCT01592526|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
153553410|NCT01592526|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
153553414|NCT01592630|Ropivacaine|ropivacaine|mesh-list
153515429|NCT01429415|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153515430|NCT01429415|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153515431|NCT01429415|Anticonvulsants|anticonvulsants|mesh-ancestor
153515438|NCT01429545|Nifedipine|nifedipine|mesh-list
153796977|NCT00692939|Cyclophosphamide|cyclophosphamide|mesh-list
153515457|NCT01429610|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153515458|NCT01429610|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153515459|NCT01429610|Immunologic Factors|immunologic factors|mesh-ancestor
153515460|NCT01429610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153515461|NCT01429610|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153515462|NCT01429610|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153515463|NCT01429610|Antimetabolites|antimetabolites|mesh-ancestor
153515464|NCT01429610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153515465|NCT01429610|Antiviral Agents|antiviral agents|mesh-ancestor
153515466|NCT01429610|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153515467|NCT01429610|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153515468|NCT01429675|Ibandronic Acid|ibandronic acid|mesh-list
153797134|NCT00294255|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153515469|NCT01429675|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153515470|NCT01429675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153515471|NCT01429701|Gentamicins|gentamicins|mesh-list
153515472|NCT01429701|Polymyxins|polymyxins|mesh-list
153515473|NCT01429701|Polymyxin B|polymyxin b|mesh-list
153515474|NCT01429701|Prednisolone|prednisolone|mesh-list
153515475|NCT01429701|Betamethasone|betamethasone|mesh-list
153515476|NCT01429701|Benzocaine|benzocaine|mesh-list
153515477|NCT01429701|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153515478|NCT01429701|Glucocorticoids|glucocorticoids|mesh-ancestor
153515479|NCT01429701|Hormones|hormones|mesh-ancestor
153515480|NCT01429701|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153515481|NCT01429701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153515482|NCT01429701|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153515483|NCT01429701|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153515484|NCT01429701|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153515485|NCT01429701|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153515486|NCT01429701|Respiratory System Agents|respiratory system agents|mesh-ancestor
153515487|NCT01429701|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153515488|NCT01429701|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153515489|NCT01429701|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
153515490|NCT01429701|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153515497|NCT01429714|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153515498|NCT01429714|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153515499|NCT01429714|Adrenergic Agents|adrenergic agents|mesh-ancestor
153515500|NCT01429714|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153515501|NCT01429714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153797238|NCT00294606|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
153515502|NCT01429714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153515504|NCT01429714|Autonomic Agents|autonomic agents|mesh-ancestor
153515505|NCT01429714|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153515506|NCT01429714|Nasal Decongestants|nasal decongestants|mesh-ancestor
153515507|NCT01429714|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
153515508|NCT01429714|Respiratory System Agents|respiratory system agents|mesh-ancestor
153515509|NCT01429818|Metformin|metformin|mesh-list
153515510|NCT01429818|Glimepiride|glimepiride|mesh-list
153515511|NCT01429818|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153515512|NCT01429818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153515513|NCT01429818|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153515514|NCT01429818|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153515515|NCT01429818|Immunologic Factors|immunologic factors|mesh-ancestor
153515516|NCT01429831|Aripiprazole|aripiprazole|mesh-list
153515517|NCT01429831|Antidepressive Agents|antidepressive agents|mesh-ancestor
153515518|NCT01429831|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153515519|NCT01429831|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153515520|NCT01429831|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153515521|NCT01429831|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153553461|NCT01593124|Antispermatogenic Agents|antispermatogenic agents|mesh-ancestor
153515522|NCT01429831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153515523|NCT01429831|Dopamine Agonists|dopamine agonists|mesh-ancestor
153515524|NCT01429831|Dopamine Agents|dopamine agents|mesh-ancestor
153515525|NCT01429831|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153797341|NCT00264719|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
153553471|NCT01593137|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
153515526|NCT01429831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153515527|NCT01429831|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
153515528|NCT01429831|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
153515530|NCT01429831|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
153515531|NCT01429831|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153515536|NCT01429844|Cyclosporins|cyclosporins|mesh-list
153515537|NCT01429844|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153515538|NCT01429844|Immunologic Factors|immunologic factors|mesh-ancestor
153515539|NCT01429844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153515540|NCT01429844|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
153515541|NCT01429844|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153515542|NCT01429844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153515543|NCT01429844|Antifungal Agents|antifungal agents|mesh-ancestor
153515544|NCT01429844|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153515545|NCT01429844|Dermatologic Agents|dermatologic agents|mesh-ancestor
153515546|NCT01429844|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153515548|NCT01429870|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153515549|NCT01429870|Glucocorticoids|glucocorticoids|mesh-ancestor
153515550|NCT01429870|Hormones|hormones|mesh-ancestor
153515551|NCT01429870|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153515552|NCT01429870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153515553|NCT01429935|Ibuprofen|ibuprofen|mesh-list
153515554|NCT01429935|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153515555|NCT01429935|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153515556|NCT01429935|Analgesics|analgesics|mesh-ancestor
153515557|NCT01429935|Sensory System Agents|sensory system agents|mesh-ancestor
153515558|NCT01429935|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153515559|NCT01429935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153515560|NCT01429935|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153515561|NCT01429935|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153515562|NCT01429935|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153515563|NCT01429935|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153875077|NCT01647165|Dexamethasone|dexamethasone|mesh-list
153515564|NCT01429935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153515565|NCT01430013|Endostar protein|endostar protein|mesh-list
153515577|NCT01430052|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153515579|NCT01430065|Peficitinib|peficitinib|mesh-list
153515580|NCT01430065|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153515581|NCT01430065|Immunologic Factors|immunologic factors|mesh-ancestor
153515582|NCT01430065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153515583|NCT01430065|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
153515584|NCT01430065|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153515585|NCT01430065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153515586|NCT01430078|Niacinamide|niacinamide|mesh-list
153515587|NCT01430078|Peficitinib|peficitinib|mesh-list
153515588|NCT01430078|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153515589|NCT01430078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153515590|NCT01430078|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153515591|NCT01430078|Immunologic Factors|immunologic factors|mesh-ancestor
153797536|NCT00295308|Clonidine|clonidine|mesh-list
153515592|NCT01430078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153515593|NCT01430078|Vitamin B Complex|vitamin b complex|mesh-ancestor
153515594|NCT01430078|Vitamins|vitamins|mesh-ancestor
153515595|NCT01430078|Micronutrients|micronutrients|mesh-ancestor
153553472|NCT01593137|Incretins|incretins|mesh-ancestor
153515596|NCT01430195|Afamelanotide|afamelanotide|mesh-list
153515598|NCT01430234|Pancreatin|pancreatin|mesh-list
153515633|NCT01430793|Vitamin D|vitamin d|mesh-list
153515634|NCT01430793|Ergocalciferols|ergocalciferols|mesh-list
153515635|NCT01430793|Cholecalciferol|cholecalciferol|mesh-list
153515636|NCT01430793|Vitamins|vitamins|mesh-list
153515637|NCT01430793|Micronutrients|micronutrients|mesh-ancestor
153515638|NCT01430793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153515639|NCT01430793|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153515640|NCT01430793|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153515641|NCT01430806|Dronedarone|dronedarone|mesh-list
153515642|NCT01430806|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153515643|NCT01430910|Ceftazidime|ceftazidime|mesh-list
153515644|NCT01430910|Avibactam|avibactam|mesh-list
153515645|NCT01430910|Third Generation Cephalosporins|third generation cephalosporins|mesh-ancestor
153515646|NCT01430910|Beta Lactam Antibiotics|beta lactam antibiotics|mesh-ancestor
153515647|NCT01430910|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153515648|NCT01430910|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153618891|NCT01980680|Estrogens|estrogens|mesh-ancestor
153618892|NCT01980680|Hormones|hormones|mesh-ancestor
153515649|NCT01430910|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
153515650|NCT01430910|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153515651|NCT01430910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153515652|NCT01430923|Ophthalmic Solutions|ophthalmic solutions|mesh-list
153515653|NCT01430923|Latanoprost|latanoprost|mesh-list
153515654|NCT01430923|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
153515655|NCT01431053|Aspirin|aspirin|mesh-list
153515656|NCT01431053|Exemestane|exemestane|mesh-list
153515657|NCT01431053|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153515658|NCT01431053|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153515659|NCT01431053|Analgesics|analgesics|mesh-ancestor
153515660|NCT01431053|Sensory System Agents|sensory system agents|mesh-ancestor
153515661|NCT01431053|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153515662|NCT01431053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153515663|NCT01431053|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153515664|NCT01431053|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153515665|NCT01431053|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153515666|NCT01431053|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153515672|NCT01431053|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153515673|NCT01431053|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
153515674|NCT01431053|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153515675|NCT01431053|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
153515676|NCT01431053|Hormone Antagonists|hormone antagonists|mesh-ancestor
153515677|NCT01431053|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153515680|NCT01431092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153515681|NCT01431092|Protective Agents|protective agents|mesh-ancestor
153515682|NCT01431092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153515683|NCT01431092|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153515684|NCT01431118|Camphor|camphor|mesh-list
153515685|NCT01431118|Salicylates|salicylates|mesh-list
153515686|NCT01431118|Methyl salicylate|methyl salicylate|mesh-list
153515687|NCT01431118|Menthol|menthol|mesh-list
153515688|NCT01431118|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
153515689|NCT01431118|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153515690|NCT01431118|Antipruritics|antipruritics|mesh-ancestor
153515691|NCT01431118|Dermatologic Agents|dermatologic agents|mesh-ancestor
153515692|NCT01431118|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153515693|NCT01431118|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153515694|NCT01431118|Analgesics|analgesics|mesh-ancestor
153515695|NCT01431118|Sensory System Agents|sensory system agents|mesh-ancestor
153515696|NCT01431118|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153515697|NCT01431118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153515698|NCT01431118|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153515699|NCT01431118|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153515700|NCT01431118|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153515716|NCT01431404|Analgesics|analgesics|mesh-ancestor
153553530|NCT01593332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153515717|NCT01431404|Sensory System Agents|sensory system agents|mesh-ancestor
153553532|NCT01593371|Metformin|metformin|mesh-list
153515718|NCT01431404|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153515719|NCT01431404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153515720|NCT01431404|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153515721|NCT01431404|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153515722|NCT01431404|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153515723|NCT01431404|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153515724|NCT01431404|Immunologic Factors|immunologic factors|mesh-ancestor
153515725|NCT01431430|Cholecalciferol|cholecalciferol|mesh-list
153515726|NCT01431430|Vitamin D|vitamin d|mesh-list
153515727|NCT01431430|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153515728|NCT01431430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153515729|NCT01431430|Vitamins|vitamins|mesh-ancestor
153515730|NCT01431430|Micronutrients|micronutrients|mesh-ancestor
153515731|NCT01431430|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153515733|NCT01431443|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153553581|NCT01593566|Bupivacaine|bupivacaine|mesh-list
153515734|NCT01431443|Autonomic Agents|autonomic agents|mesh-ancestor
153515735|NCT01431443|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153515736|NCT01431443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153515737|NCT01431443|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153515738|NCT01431443|Respiratory System Agents|respiratory system agents|mesh-ancestor
153515739|NCT01431443|Vasodilator Agents|vasodilator agents|mesh-ancestor
153515740|NCT01431456|Nadroparin|nadroparin|mesh-list
153515741|NCT01431456|Rivaroxaban|rivaroxaban|mesh-list
153515742|NCT01431456|Dabigatran|dabigatran|mesh-list
153515743|NCT01431456|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
153515752|NCT01431495|Clopidogrel|clopidogrel|mesh-list
153515763|NCT01431547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153515764|NCT01431612|Phenylephrine|phenylephrine|mesh-list
153515765|NCT01431612|Oxymetazoline|oxymetazoline|mesh-list
153515766|NCT01431612|Esmolol|esmolol|mesh-list
153515767|NCT01431612|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
153515768|NCT01431612|Mydriatics|mydriatics|mesh-ancestor
153515769|NCT01431612|Autonomic Agents|autonomic agents|mesh-ancestor
153515770|NCT01431612|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153515771|NCT01431612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153515772|NCT01431612|Sympathomimetics|sympathomimetics|mesh-ancestor
153515773|NCT01431612|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
153515774|NCT01431612|Nasal Decongestants|nasal decongestants|mesh-ancestor
153515775|NCT01431612|Respiratory System Agents|respiratory system agents|mesh-ancestor
153515776|NCT01431612|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
153515777|NCT01431612|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153515778|NCT01431612|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153515779|NCT01431612|Adrenergic Agents|adrenergic agents|mesh-ancestor
153515780|NCT01431612|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153515781|NCT01431612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153515782|NCT01431612|Protective Agents|protective agents|mesh-ancestor
153515783|NCT01431612|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
153515784|NCT01431612|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
153515785|NCT01431612|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
153515816|NCT01431924|Respiratory System Agents|respiratory system agents|mesh-ancestor
153515817|NCT01431924|Dermatologic Agents|dermatologic agents|mesh-ancestor
153515818|NCT01431924|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
153515819|NCT01431924|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
153515820|NCT01431924|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
153515821|NCT01431924|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153515822|NCT01431924|Adrenergic Agents|adrenergic agents|mesh-ancestor
153515823|NCT01431924|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153515824|NCT01431924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153515825|NCT01432028|Drospirenone|drospirenone|mesh-list
153515826|NCT01432028|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
153515827|NCT01432028|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
153515828|NCT01432028|Estradiol|estradiol|mesh-list
153515829|NCT01432028|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
153553582|NCT01593566|Anesthetics, Local|anesthetics, local|mesh-ancestor
153515830|NCT01432028|Progesterone|progesterone|mesh-list
153515831|NCT01432028|Estrogens|estrogens|mesh-ancestor
153515832|NCT01432028|Hormones|hormones|mesh-ancestor
153515833|NCT01432028|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153515834|NCT01432028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153798579|NCT00298194|Z 338|z 338|mesh-list
153515835|NCT01432028|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
153515836|NCT01432028|Contraceptive Agents|contraceptive agents|mesh-ancestor
153553592|NCT01593605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153515837|NCT01432028|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153515838|NCT01432028|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
153515839|NCT01432028|Progestins|progestins|mesh-ancestor
153515840|NCT01432028|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
153515841|NCT01432028|Hormone Antagonists|hormone antagonists|mesh-ancestor
153515842|NCT01432028|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
153515843|NCT01432028|Diuretics|diuretics|mesh-ancestor
153515844|NCT01432028|Natriuretic Agents|natriuretic agents|mesh-ancestor
153515845|NCT01432080|Azithromycin|azithromycin|mesh-list
153515846|NCT01432080|Prednisone|prednisone|mesh-list
153515847|NCT01432080|Budesonide|budesonide|mesh-list
153515848|NCT01432080|Formoterol Fumarate|formoterol fumarate|mesh-list
153515853|NCT01432080|Hormones|hormones|mesh-ancestor
153515858|NCT01432080|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153515859|NCT01432080|Autonomic Agents|autonomic agents|mesh-ancestor
153515860|NCT01432080|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153515861|NCT01432080|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153515862|NCT01432080|Respiratory System Agents|respiratory system agents|mesh-ancestor
153515863|NCT01432080|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153515864|NCT01432080|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153798666|NCT00271271|Oxaliplatin|oxaliplatin|mesh-list
153515865|NCT01432080|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
153515867|NCT01432080|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153515868|NCT01432080|Adrenergic Agents|adrenergic agents|mesh-ancestor
153515869|NCT01432080|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153515870|NCT01432080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153515871|NCT01432080|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
153515872|NCT01432080|Hormone Antagonists|hormone antagonists|mesh-ancestor
153515873|NCT01432080|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
153515874|NCT01432080|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
153515876|NCT01432106|Ramipril|ramipril|mesh-list
153515877|NCT01432106|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153515878|NCT01432106|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
153515879|NCT01432106|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
153515880|NCT01432106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153515881|NCT01432106|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
153515906|NCT01432249|Sensory System Agents|sensory system agents|mesh-ancestor
153515907|NCT01432249|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153515908|NCT01432249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153515909|NCT01432249|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153515910|NCT01432249|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153515911|NCT01432249|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153515912|NCT01432249|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153515913|NCT01432249|Immunologic Factors|immunologic factors|mesh-ancestor
153515914|NCT01432470|Oxytocin|oxytocin|mesh-list
153515915|NCT01432470|Oxytocics|oxytocics|mesh-ancestor
153515916|NCT01432470|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153515917|NCT01432470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153515918|NCT01432483|Denileukin diftitox|denileukin diftitox|mesh-list
153515919|NCT01432483|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153515920|NCT01432496|Ropivacaine|ropivacaine|mesh-list
153515921|NCT01432496|Anesthetics, Local|anesthetics, local|mesh-ancestor
153515922|NCT01432496|Anesthetics|anesthetics|mesh-ancestor
153515923|NCT01432496|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153515924|NCT01432496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153515925|NCT01432496|Sensory System Agents|sensory system agents|mesh-ancestor
153515926|NCT01432496|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153515927|NCT01432522|Epinephrine|epinephrine|mesh-list
153515928|NCT01432522|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153515929|NCT01432522|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153515930|NCT01432522|Adrenergic Agents|adrenergic agents|mesh-ancestor
153515931|NCT01432522|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153515932|NCT01432522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153515933|NCT01432522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153515934|NCT01432522|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
153515935|NCT01432522|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153515936|NCT01432522|Autonomic Agents|autonomic agents|mesh-ancestor
153515937|NCT01432522|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153515938|NCT01432522|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153515939|NCT01432522|Respiratory System Agents|respiratory system agents|mesh-ancestor
153515940|NCT01432522|Mydriatics|mydriatics|mesh-ancestor
153515941|NCT01432522|Sympathomimetics|sympathomimetics|mesh-ancestor
153515942|NCT01432522|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
153515943|NCT01432587|Diflunisal|diflunisal|mesh-list
153515944|NCT01432587|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153515945|NCT01432587|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153515946|NCT01432587|Analgesics|analgesics|mesh-ancestor
153798816|NCT00272207|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153515947|NCT01432587|Sensory System Agents|sensory system agents|mesh-ancestor
153515948|NCT01432587|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153515949|NCT01432587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153515950|NCT01432587|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153515951|NCT01432587|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153515952|NCT01432587|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153515953|NCT01432587|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153515954|NCT01432587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153515955|NCT01432665|Sildenafil Citrate|sildenafil citrate|mesh-list
153515956|NCT01432665|Testosterone|testosterone|mesh-list
153515957|NCT01432665|Androgens|androgens|mesh-ancestor
153515958|NCT01432665|Hormones|hormones|mesh-ancestor
153515959|NCT01432665|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153515960|NCT01432665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153515961|NCT01432665|Vasodilator Agents|vasodilator agents|mesh-ancestor
153515962|NCT01432665|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
153515963|NCT01432665|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
153515964|NCT01432665|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153515965|NCT01432665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153515966|NCT01432665|Urological Agents|urological agents|mesh-ancestor
153515967|NCT01432704|Cholecalciferol|cholecalciferol|mesh-list
153515968|NCT01432704|Vitamin D|vitamin d|mesh-list
153798963|NCT00281970|Docetaxel|docetaxel|mesh-list
153515969|NCT01432704|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153515970|NCT01432704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153515971|NCT01432704|Vitamins|vitamins|mesh-ancestor
153515972|NCT01432704|Micronutrients|micronutrients|mesh-ancestor
153515973|NCT01432704|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153515974|NCT01432717|Luspatercept|luspatercept|mesh-list
153515975|NCT01432717|Hematinics|hematinics|mesh-ancestor
153515976|NCT01432782|Botulinum Toxins|botulinum toxins|mesh-list
153515977|NCT01432782|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
153515980|NCT01432782|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153515981|NCT01432782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153515982|NCT01432782|Cholinergic Agents|cholinergic agents|mesh-ancestor
153515983|NCT01432782|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153515984|NCT01432782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153515985|NCT01432782|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
153515986|NCT01432782|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153515987|NCT01432821|Apomorphine|apomorphine|mesh-list
153515988|NCT01432821|Emetics|emetics|mesh-ancestor
153515989|NCT01432821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153515990|NCT01432821|Autonomic Agents|autonomic agents|mesh-ancestor
153515991|NCT01432821|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153515993|NCT01432821|Dopamine Agonists|dopamine agonists|mesh-ancestor
153515994|NCT01432821|Dopamine Agents|dopamine agents|mesh-ancestor
153515995|NCT01432821|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153515996|NCT01432821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153515998|NCT01432873|Antioxidants|antioxidants|mesh-ancestor
153515999|NCT01432873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153516000|NCT01432873|Protective Agents|protective agents|mesh-ancestor
153516001|NCT01432873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153516002|NCT01432873|Trace Elements|trace elements|mesh-ancestor
153516003|NCT01432873|Micronutrients|micronutrients|mesh-ancestor
153516004|NCT01432977|Acetaminophen|acetaminophen|mesh-list
153516005|NCT01432977|Droperidol|droperidol|mesh-list
153516006|NCT01432977|Ondansetron|ondansetron|mesh-list
153516007|NCT01432977|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153516008|NCT01432977|Analgesics|analgesics|mesh-ancestor
153516009|NCT01432977|Sensory System Agents|sensory system agents|mesh-ancestor
153516012|NCT01432977|Antipyretics|antipyretics|mesh-ancestor
153799332|NCT00274079|Parasympatholytics|parasympatholytics|mesh-ancestor
153516026|NCT01432977|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153516027|NCT01432977|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153516028|NCT01432977|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
153516029|NCT01432977|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
153516031|NCT01433445|Panobinostat|panobinostat|mesh-list
153516032|NCT01433445|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153516033|NCT01433445|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
153516034|NCT01433445|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153516035|NCT01433445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153516036|NCT01433614|Paclitaxel|paclitaxel|mesh-list
153516037|NCT01433614|Capecitabine|capecitabine|mesh-list
153516038|NCT01433614|Epirubicin|epirubicin|mesh-list
153516039|NCT01433614|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153516040|NCT01433614|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153516041|NCT01433614|Tubulin Modulators|tubulin modulators|mesh-ancestor
153516083|NCT01433887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153516084|NCT01433887|Antiviral Agents|antiviral agents|mesh-ancestor
153516085|NCT01433887|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153516086|NCT01433900|Latanoprost|latanoprost|mesh-list
153516087|NCT01433900|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
153516088|NCT01433900|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
153516089|NCT01433952|Thiamine|thiamine|mesh-list
153516090|NCT01433952|Vitamin B Complex|vitamin b complex|mesh-ancestor
153516091|NCT01433952|Vitamins|vitamins|mesh-ancestor
153516092|NCT01433952|Micronutrients|micronutrients|mesh-ancestor
153516093|NCT01433952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153516094|NCT01434017|Dexamethasone|dexamethasone|mesh-list
153516095|NCT01434017|Dexamethasone acetate|dexamethasone acetate|mesh-list
153516096|NCT01434017|Droperidol|droperidol|mesh-list
153516097|NCT01434017|Ondansetron|ondansetron|mesh-list
153516099|NCT01434017|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153516100|NCT01434017|Antiemetics|antiemetics|mesh-ancestor
153516101|NCT01434017|Autonomic Agents|autonomic agents|mesh-ancestor
153516102|NCT01434017|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153516103|NCT01434017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153516104|NCT01434017|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153516105|NCT01434017|Glucocorticoids|glucocorticoids|mesh-ancestor
153516106|NCT01434017|Hormones|hormones|mesh-ancestor
153516107|NCT01434017|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153516108|NCT01434017|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153516109|NCT01434017|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153516110|NCT01434017|Protease Inhibitors|protease inhibitors|mesh-ancestor
153516111|NCT01434017|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153516112|NCT01434017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153516113|NCT01434017|Antipruritics|antipruritics|mesh-ancestor
153516114|NCT01434017|Dermatologic Agents|dermatologic agents|mesh-ancestor
153516115|NCT01434017|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
153516116|NCT01434017|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153516125|NCT01434017|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
153516127|NCT01434069|Leucovorin|leucovorin|mesh-list
153516128|NCT01434069|Fluorouracil|fluorouracil|mesh-list
153516129|NCT01434069|Pasireotide|pasireotide|mesh-list
153516130|NCT01434069|Antimetabolites|antimetabolites|mesh-ancestor
153516131|NCT01434069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153516132|NCT01434069|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153516133|NCT01434069|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153516134|NCT01434069|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153516135|NCT01434069|Immunologic Factors|immunologic factors|mesh-ancestor
153516136|NCT01434069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153516137|NCT01434069|Antidotes|antidotes|mesh-ancestor
153516138|NCT01434069|Protective Agents|protective agents|mesh-ancestor
153516139|NCT01434069|Vitamin B Complex|vitamin b complex|mesh-ancestor
153516140|NCT01434069|Vitamins|vitamins|mesh-ancestor
153516141|NCT01434069|Micronutrients|micronutrients|mesh-ancestor
153516142|NCT01434069|Hormones|hormones|mesh-ancestor
153516143|NCT01434069|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153516144|NCT01434108|Phenylacetic acid|phenylacetic acid|mesh-list
153516145|NCT01434108|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153516146|NCT01434108|Antimetabolites|antimetabolites|mesh-ancestor
153516147|NCT01434108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153516148|NCT01434108|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153516149|NCT01434134|Metoprolol|metoprolol|mesh-list
153516150|NCT01434134|Candesartan|candesartan|mesh-list
153516151|NCT01434134|Candesartan cilexetil|candesartan cilexetil|mesh-list
153516152|NCT01434134|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153516153|NCT01434134|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153516154|NCT01434134|Sympatholytics|sympatholytics|mesh-ancestor
153516155|NCT01434134|Autonomic Agents|autonomic agents|mesh-ancestor
153516156|NCT01434134|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153516157|NCT01434134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153516158|NCT01434134|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
153516167|NCT01434147|Capecitabine|capecitabine|mesh-list
153516168|NCT01434147|Oxaliplatin|oxaliplatin|mesh-list
153516169|NCT01434147|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153516170|NCT01434147|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153516171|NCT01434147|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153516172|NCT01434147|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153516173|NCT01434147|Growth Substances|growth substances|mesh-ancestor
153516175|NCT01434147|Growth Inhibitors|growth inhibitors|mesh-ancestor
153516176|NCT01434147|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153516177|NCT01434147|Antimetabolites|antimetabolites|mesh-ancestor
153459290|NCT01345656|Natriuretic Agents|natriuretic agents|mesh-ancestor
153516178|NCT01434147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153516179|NCT01434160|Levonorgestrel|levonorgestrel|mesh-list
153516180|NCT01434160|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
153516181|NCT01434160|Contraceptive Agents|contraceptive agents|mesh-ancestor
153516182|NCT01434160|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153516183|NCT01434160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153516184|NCT01434160|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
153516185|NCT01434160|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
153516186|NCT01434160|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
153516187|NCT01434173|Amoxicillin|amoxicillin|mesh-list
153516188|NCT01434173|Moxifloxacin|moxifloxacin|mesh-list
153516189|NCT01434173|Clarithromycin|clarithromycin|mesh-list
153516190|NCT01434173|Doxycycline|doxycycline|mesh-list
153516191|NCT01434173|Levofloxacin|levofloxacin|mesh-list
153516192|NCT01434173|Clavulanic Acids|clavulanic acids|mesh-list
153553739|NCT01594489|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153553740|NCT01594489|Respiratory System Agents|respiratory system agents|mesh-ancestor
153800002|NCT00310011|Paclitaxel|paclitaxel|mesh-list
153516193|NCT01434173|Clavulanic Acid|clavulanic acid|mesh-list
153516194|NCT01434173|Cefuroxime|cefuroxime|mesh-list
153516195|NCT01434173|Telithromycin|telithromycin|mesh-list
153516196|NCT01434173|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
153516197|NCT01434173|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153516198|NCT01434173|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153516206|NCT01434173|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153516207|NCT01434173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153516208|NCT01434173|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
153516209|NCT01434173|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
153516210|NCT01434173|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
153516211|NCT01434173|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
153516212|NCT01434173|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
153516213|NCT01434173|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153516214|NCT01434173|Antimalarials|antimalarials|mesh-ancestor
153516215|NCT01434173|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153516216|NCT01434173|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153516217|NCT01434173|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
153516218|NCT01434173|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
153516219|NCT01434173|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
153516220|NCT01434212|Interferons|interferons|mesh-list
153516221|NCT01434212|Ribavirin|ribavirin|mesh-list
153516222|NCT01434212|Interferon-alpha|interferon-alpha|mesh-list
153516223|NCT01434212|Interferon alpha-2|interferon alpha-2|mesh-list
153516224|NCT01434212|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153516225|NCT01434212|Antiviral Agents|antiviral agents|mesh-ancestor
153516226|NCT01434212|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153516227|NCT01434212|Antimetabolites|antimetabolites|mesh-ancestor
153516228|NCT01434212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153516229|NCT01434212|Immunologic Factors|immunologic factors|mesh-ancestor
153516230|NCT01434212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153516253|NCT01434303|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153516254|NCT01434303|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153516255|NCT01434303|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153516256|NCT01434303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153516257|NCT01434381|Aluminum Hydroxide|aluminum hydroxide|mesh-list
153516258|NCT01434381|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153516259|NCT01434381|Immunologic Factors|immunologic factors|mesh-ancestor
153516260|NCT01434381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153516261|NCT01434381|Antacids|antacids|mesh-ancestor
153516262|NCT01434381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153516263|NCT01434381|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153516264|NCT01434394|Cetuximab|cetuximab|mesh-list
153516265|NCT01434394|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153516266|NCT01434394|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153516267|NCT01434459|Gemcitabine|gemcitabine|mesh-list
153516268|NCT01434459|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153516269|NCT01434459|Antimetabolites|antimetabolites|mesh-ancestor
153516270|NCT01434459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153516271|NCT01434459|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153516272|NCT01434849|Timolol|timolol|mesh-list
153516273|NCT01434849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153516274|NCT01434849|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
153516275|NCT01434849|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
153516276|NCT01434849|Adrenergic Agents|adrenergic agents|mesh-ancestor
153516277|NCT01434849|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153516301|NCT01434901|Parasympathomimetics|parasympathomimetics|mesh-ancestor
153516302|NCT01434901|Autonomic Agents|autonomic agents|mesh-ancestor
153516303|NCT01434901|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153516304|NCT01434901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153516305|NCT01434901|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
153516306|NCT01434901|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
153516307|NCT01434901|Cholinergic Agents|cholinergic agents|mesh-ancestor
153516308|NCT01434901|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153516309|NCT01434901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153516310|NCT01434914|Octenidine|octenidine|mesh-list
153516311|NCT01434914|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153516312|NCT01434914|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
153516313|NCT01435083|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
153516314|NCT01435083|Hemostatics|hemostatics|mesh-ancestor
153516315|NCT01435083|Coagulants|coagulants|mesh-ancestor
153516316|NCT01435083|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
153516317|NCT01435083|Natriuretic Agents|natriuretic agents|mesh-ancestor
153516318|NCT01435083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153516319|NCT01435161|Telmisartan|telmisartan|mesh-list
153516320|NCT01435161|Antihypertensive Agents|antihypertensive agents|mesh-list
153516321|NCT01435161|Nifedipine|nifedipine|mesh-list
153516330|NCT01435161|Tocolytic Agents|tocolytic agents|mesh-ancestor
153516353|NCT01435213|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
153516354|NCT01435213|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153516355|NCT01435213|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153516356|NCT01435213|Adrenergic Agents|adrenergic agents|mesh-ancestor
153516357|NCT01435213|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
153516358|NCT01435213|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
153516362|NCT01435252|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153516363|NCT01435291|Tacrolimus|tacrolimus|mesh-list
153516364|NCT01435291|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153516365|NCT01435291|Immunologic Factors|immunologic factors|mesh-ancestor
153516366|NCT01435291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153516367|NCT01435291|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
153516368|NCT01435291|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153516369|NCT01435291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153516370|NCT01435343|Cytarabine|cytarabine|mesh-list
153516371|NCT01435343|Plerixafor|plerixafor|mesh-list
153516372|NCT01435343|Fludarabine|fludarabine|mesh-list
153516374|NCT01435343|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153516375|NCT01435343|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153516376|NCT01435343|Antimetabolites|antimetabolites|mesh-ancestor
153516377|NCT01435343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153516378|NCT01435343|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153516379|NCT01435343|Immunologic Factors|immunologic factors|mesh-ancestor
153516380|NCT01435343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153516400|NCT01435395|Alkylating Agents|alkylating agents|mesh-ancestor
153516401|NCT01435395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153516403|NCT01435486|Caffeine citrate|caffeine citrate|mesh-list
153516404|NCT01435486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153516405|NCT01435486|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
153516406|NCT01435486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153516407|NCT01435486|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
153516408|NCT01435486|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153516409|NCT01435486|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
153516410|NCT01435486|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
153516412|NCT01435486|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153516413|NCT01435499|Cyclophosphamide|cyclophosphamide|mesh-list
153516414|NCT01435499|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153516415|NCT01435499|Immunologic Factors|immunologic factors|mesh-ancestor
153516416|NCT01435499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153516417|NCT01435499|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153516418|NCT01435499|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153516419|NCT01435499|Alkylating Agents|alkylating agents|mesh-ancestor
153516420|NCT01435499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153516421|NCT01435499|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153553752|NCT01594502|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153553796|NCT01594866|Autonomic Agents|autonomic agents|mesh-ancestor
153516422|NCT01435499|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153516423|NCT01435707|Triamcinolone|triamcinolone|mesh-list
153516424|NCT01435707|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
153516425|NCT01435707|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
153516426|NCT01435707|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
153516427|NCT01435707|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153516428|NCT01435707|Glucocorticoids|glucocorticoids|mesh-ancestor
153516429|NCT01435707|Hormones|hormones|mesh-ancestor
153516430|NCT01435707|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153516432|NCT01435707|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153516433|NCT01435707|Immunologic Factors|immunologic factors|mesh-ancestor
153516435|NCT01435707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153516437|NCT01435837|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
153516438|NCT01435837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153516439|NCT01435837|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
153516440|NCT01435837|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153516442|NCT01435837|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
153516443|NCT01435837|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
153516444|NCT01435837|Purinergic Agents|purinergic agents|mesh-ancestor
153516445|NCT01435837|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153516446|NCT01435915|Ropinirole|ropinirole|mesh-list
153516447|NCT01435915|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
153516448|NCT01435915|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
153516449|NCT01435915|Dopamine Agonists|dopamine agonists|mesh-ancestor
153516450|NCT01435915|Dopamine Agents|dopamine agents|mesh-ancestor
153516451|NCT01435915|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153516452|NCT01435915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153516453|NCT01435915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153516454|NCT01435941|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
153516455|NCT01435941|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-list
153516456|NCT01435941|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153516457|NCT01435941|Analgesics|analgesics|mesh-ancestor
153516458|NCT01435941|Sensory System Agents|sensory system agents|mesh-ancestor
153516459|NCT01435941|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153516460|NCT01435941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153516461|NCT01435941|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153516478|NCT01435954|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153516479|NCT01435954|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153516480|NCT01435954|Hormone Antagonists|hormone antagonists|mesh-ancestor
153516481|NCT01435954|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153516482|NCT01435954|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153516484|NCT01435980|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
153516485|NCT01435980|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153516486|NCT01435980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153516487|NCT01435980|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
153516489|NCT01435980|Hormones|hormones|mesh-ancestor
153516490|NCT01435980|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153516492|NCT01436123|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
153516493|NCT01436123|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153516494|NCT01436123|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153516495|NCT01436123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153516496|NCT01436123|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153516497|NCT01436123|Immunologic Factors|immunologic factors|mesh-ancestor
153516498|NCT01436123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153516499|NCT01436123|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153516500|NCT01436188|Ibuprofen|ibuprofen|mesh-list
153516501|NCT01436188|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153516502|NCT01436188|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153516503|NCT01436188|Analgesics|analgesics|mesh-ancestor
153516504|NCT01436188|Sensory System Agents|sensory system agents|mesh-ancestor
153516524|NCT01435902|Dermatologic Agents|dermatologic agents|mesh-ancestor
153516525|NCT01435902|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
153516526|NCT01436474|Varenicline|varenicline|mesh-list
153516527|NCT01436474|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
153553800|NCT01594866|Cholinergic Agents|cholinergic agents|mesh-ancestor
153516528|NCT01436474|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
153516529|NCT01436474|Cholinergic Agents|cholinergic agents|mesh-ancestor
153516530|NCT01436474|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153516531|NCT01436474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153516532|NCT01436474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153516533|NCT01436513|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
153516534|NCT01436513|Estrogens|estrogens|mesh-ancestor
153516535|NCT01436513|Hormones|hormones|mesh-ancestor
153516536|NCT01436513|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153516537|NCT01436513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153516538|NCT01436539|Adefovir|adefovir|mesh-list
153516539|NCT01436539|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
153516540|NCT01436539|Polyene phosphatidylcholine|polyene phosphatidylcholine|mesh-list
153516541|NCT01436539|Antiviral Agents|antiviral agents|mesh-ancestor
153516542|NCT01436539|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153516543|NCT01436539|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153516544|NCT01436539|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153516545|NCT01436539|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153618894|NCT01980680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153459672|NCT06123702|Cannabidiol|cannabidiol|mesh-list
153516570|NCT01436838|Antiviral Agents|antiviral agents|mesh-ancestor
153516571|NCT01436838|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153516572|NCT01436838|Immunologic Factors|immunologic factors|mesh-ancestor
153516573|NCT01436838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153516574|NCT01436838|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153801120|NCT00285896|Hormones|hormones|mesh-ancestor
153516576|NCT01436916|Vitamin D|vitamin d|mesh-list
153516577|NCT01436916|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153516580|NCT01436916|Micronutrients|micronutrients|mesh-ancestor
153516581|NCT01436916|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153516582|NCT01436929|Silymarin|silymarin|mesh-list
153516583|NCT01436929|Antioxidants|antioxidants|mesh-ancestor
153516585|NCT01436929|Protective Agents|protective agents|mesh-ancestor
153516630|NCT01437306|Lofexidine|lofexidine|mesh-list
153516631|NCT01437306|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153516632|NCT01437306|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
153516633|NCT01437306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153516634|NCT01437306|Sensory System Agents|sensory system agents|mesh-ancestor
153516635|NCT01437306|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153516636|NCT01437306|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
153516637|NCT01437306|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153516638|NCT01437306|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153516639|NCT01437306|Adrenergic Agents|adrenergic agents|mesh-ancestor
153516640|NCT01437306|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153516641|NCT01437306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153516642|NCT01437371|Ramipril|ramipril|mesh-list
153516643|NCT01437371|Enalapril|enalapril|mesh-list
153516644|NCT01437371|Lisinopril|lisinopril|mesh-list
153516645|NCT01437371|Captopril|captopril|mesh-list
153516646|NCT01437371|Trandolapril|trandolapril|mesh-list
153516647|NCT01437371|Enzyme Inhibitors|enzyme inhibitors|mesh-list
153516648|NCT01437371|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
153516686|NCT01437618|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153516687|NCT01437618|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153516688|NCT01437618|Growth Substances|growth substances|mesh-ancestor
153516689|NCT01437618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153516690|NCT01437618|Growth Inhibitors|growth inhibitors|mesh-ancestor
153516691|NCT01437644|Botulinum Toxins|botulinum toxins|mesh-list
153516692|NCT01437644|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
153516693|NCT01437644|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153801328|NCT00417443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153516694|NCT01437644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153516695|NCT01437644|Cholinergic Agents|cholinergic agents|mesh-ancestor
153516696|NCT01437644|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153516697|NCT01437644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153516698|NCT01437670|Solifenacin Succinate|solifenacin succinate|mesh-list
153516699|NCT01437670|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
153516700|NCT01437670|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
153516701|NCT01437670|Cholinergic Agents|cholinergic agents|mesh-ancestor
153516702|NCT01437670|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153516703|NCT01437670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153516704|NCT01437670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153516705|NCT01437670|Urological Agents|urological agents|mesh-ancestor
153516707|NCT01437696|Ergocalciferols|ergocalciferols|mesh-list
153516708|NCT01437696|Cholecalciferol|cholecalciferol|mesh-list
153516709|NCT01437696|Vitamins|vitamins|mesh-list
153516710|NCT01437696|Micronutrients|micronutrients|mesh-ancestor
153801449|NCT00320619|Aminocaproic Acid|aminocaproic acid|mesh-list
153516711|NCT01437696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153516712|NCT01437696|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153516733|NCT01437800|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153516735|NCT01437813|Metformin|metformin|mesh-list
153516736|NCT01437813|Glimepiride|glimepiride|mesh-list
153516737|NCT01437813|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153516738|NCT01437813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153516739|NCT01437813|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153516740|NCT01437813|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153516741|NCT01437813|Immunologic Factors|immunologic factors|mesh-ancestor
153516742|NCT01437826|Selenium|selenium|mesh-list
153516743|NCT01437826|Antioxidants|antioxidants|mesh-list
153516744|NCT01437826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153801537|NCT00287768|Mitosis Modulators|mitosis modulators|mesh-ancestor
153516746|NCT01437826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153516747|NCT01437826|Trace Elements|trace elements|mesh-ancestor
153516748|NCT01437826|Micronutrients|micronutrients|mesh-ancestor
153516750|NCT01437839|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
153516751|NCT01437839|Antithrombins|antithrombins|mesh-ancestor
153516752|NCT01437839|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
153516753|NCT01437839|Protease Inhibitors|protease inhibitors|mesh-ancestor
153516754|NCT01437839|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153516755|NCT01437839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153516756|NCT01437839|Anticoagulants|anticoagulants|mesh-ancestor
153516757|NCT01437982|Loteprednol Etabonate|loteprednol etabonate|mesh-list
153516758|NCT01437982|Prednisolone|prednisolone|mesh-list
153516759|NCT01437982|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
153516760|NCT01437982|Methylprednisolone|methylprednisolone|mesh-list
153516761|NCT01437982|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
153516762|NCT01437982|Prednisolone acetate|prednisolone acetate|mesh-list
153516763|NCT01437982|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
153516764|NCT01437982|Prednisolone phosphate|prednisolone phosphate|mesh-list
153516765|NCT01437982|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153516766|NCT01437982|Glucocorticoids|glucocorticoids|mesh-ancestor
153516767|NCT01437982|Hormones|hormones|mesh-ancestor
153516768|NCT01437982|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153516769|NCT01437982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153516773|NCT01437982|Autonomic Agents|autonomic agents|mesh-ancestor
153516774|NCT01437982|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153516775|NCT01437982|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153516776|NCT01437982|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
153516777|NCT01437982|Protective Agents|protective agents|mesh-ancestor
153516778|NCT01437982|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
153516779|NCT01438021|Methotrexate|methotrexate|mesh-list
153516780|NCT01438021|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
153516781|NCT01438021|Abortifacient Agents|abortifacient agents|mesh-ancestor
153516782|NCT01438021|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153516783|NCT01438021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153516784|NCT01438021|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153516785|NCT01438021|Antimetabolites|antimetabolites|mesh-ancestor
153516786|NCT01438021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153516787|NCT01438021|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153516788|NCT01438021|Dermatologic Agents|dermatologic agents|mesh-ancestor
153516789|NCT01438021|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153516790|NCT01438021|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153516791|NCT01438021|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153516792|NCT01438021|Immunologic Factors|immunologic factors|mesh-ancestor
153516793|NCT01438021|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153553808|NCT01594879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153516794|NCT01438021|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153516795|NCT01438086|Mecasermin|mecasermin|mesh-list
153516826|NCT05578859|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153516827|NCT05578859|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153516828|NCT05371275|Palbociclib|palbociclib|mesh-list
153516829|NCT05371275|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153516830|NCT05371275|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153516831|NCT05371275|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153516832|NCT05371275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153516833|NCT05370794|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
153516834|NCT05370794|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153516835|NCT05370794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153516836|NCT05343507|Ketamine|ketamine|mesh-list
153516837|NCT05343507|Analgesics|analgesics|mesh-ancestor
153516838|NCT05343507|Sensory System Agents|sensory system agents|mesh-ancestor
153516839|NCT05343507|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153516840|NCT05343507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153516841|NCT05343507|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
153516842|NCT05343507|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153516843|NCT05343507|Anesthetics, General|anesthetics, general|mesh-ancestor
153516844|NCT05343507|Anesthetics|anesthetics|mesh-ancestor
153618896|NCT01980745|Chloroquine|chloroquine|mesh-list
153618897|NCT01980745|Chloroquine diphosphate|chloroquine diphosphate|mesh-list
153516845|NCT05343507|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153516846|NCT05343507|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
153516847|NCT05343507|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
153516848|NCT05343507|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153516850|NCT05164159|Propofol|propofol|mesh-list
153516871|NCT05111431|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153516872|NCT05111431|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
153516873|NCT05111431|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153516875|NCT05111431|Adrenergic Agents|adrenergic agents|mesh-ancestor
153516876|NCT05111431|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153516877|NCT05111431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153516878|NCT04956939|Levodopa|levodopa|mesh-list
153516879|NCT04956939|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
153516880|NCT04956939|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
153516881|NCT04956939|Dopamine Agents|dopamine agents|mesh-ancestor
153516882|NCT04956939|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153516883|NCT04956939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153516884|NCT04956939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153516885|NCT04955470|Midazolam|midazolam|mesh-list
153516886|NCT04955470|Ketamine|ketamine|mesh-list
153516887|NCT04955470|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
153516888|NCT04955470|Analgesics|analgesics|mesh-ancestor
153516889|NCT04955470|Sensory System Agents|sensory system agents|mesh-ancestor
153516890|NCT04955470|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153516891|NCT04955470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153516892|NCT04955470|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
153516893|NCT04955470|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153516894|NCT04955470|Anesthetics, General|anesthetics, general|mesh-ancestor
153516895|NCT04955470|Anesthetics|anesthetics|mesh-ancestor
153516896|NCT04955470|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153516897|NCT04955470|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
153516898|NCT04955470|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
153516899|NCT04955470|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153516900|NCT04955470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153516901|NCT04955470|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153516902|NCT04955470|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153516904|NCT04955470|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153516905|NCT04955470|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153516906|NCT04955470|GABA Modulators|gaba modulators|mesh-ancestor
153516908|NCT04922567|Prednisone|prednisone|mesh-list
153516909|NCT04922567|Cyclophosphamide|cyclophosphamide|mesh-list
153516910|NCT04922567|Doxorubicin|doxorubicin|mesh-list
153516911|NCT04922567|Vincristine|vincristine|mesh-list
153516912|NCT04922567|Lenalidomide|lenalidomide|mesh-list
153516913|NCT04922567|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153516914|NCT04922567|Immunologic Factors|immunologic factors|mesh-ancestor
153516915|NCT04922567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153553822|NCT01594918|Prednisone|prednisone|mesh-list
153516916|NCT04922567|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153516917|NCT04922567|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153516919|NCT04922567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153516920|NCT04922567|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153516921|NCT04922567|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153516922|NCT04922567|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153516923|NCT04922567|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153516924|NCT04922567|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153516925|NCT04922567|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153516926|NCT04922567|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153516928|NCT04922567|Hormones|hormones|mesh-ancestor
153516929|NCT04922567|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153516930|NCT04922567|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153516931|NCT04922567|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153516932|NCT04922567|Tubulin Modulators|tubulin modulators|mesh-ancestor
153516933|NCT04922567|Antimitotic Agents|antimitotic agents|mesh-ancestor
153516934|NCT04922567|Mitosis Modulators|mitosis modulators|mesh-ancestor
153516935|NCT04922567|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153516936|NCT04922567|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153516937|NCT04922567|Growth Substances|growth substances|mesh-ancestor
153516938|NCT04922567|Growth Inhibitors|growth inhibitors|mesh-ancestor
153516939|NCT04636632|Fosaprepitant|fosaprepitant|mesh-list
153516940|NCT04636632|Aprepitant|aprepitant|mesh-list
153516950|NCT04545060|Antiviral Agents|antiviral agents|mesh-ancestor
153516951|NCT04545060|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153516952|NCT04375202|Colchicine|colchicine|mesh-list
153516953|NCT04375202|Gout Suppressants|gout suppressants|mesh-ancestor
153516954|NCT04375202|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153516955|NCT04375202|Tubulin Modulators|tubulin modulators|mesh-ancestor
153516956|NCT04375202|Antimitotic Agents|antimitotic agents|mesh-ancestor
153516957|NCT04375202|Mitosis Modulators|mitosis modulators|mesh-ancestor
153516958|NCT04375202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153516959|NCT04375202|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153516960|NCT04345744|Chlorhexidine|chlorhexidine|mesh-list
153516961|NCT04345744|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
153516962|NCT04345744|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
153516963|NCT04345744|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153516964|NCT04345744|Disinfectants|disinfectants|mesh-ancestor
153516965|NCT04345744|Dermatologic Agents|dermatologic agents|mesh-ancestor
153516966|NCT04329572|Azithromycin|azithromycin|mesh-list
153516967|NCT04329572|Hydroxychloroquine|hydroxychloroquine|mesh-list
153516968|NCT04329572|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153516969|NCT04329572|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153516970|NCT04329572|Antimalarials|antimalarials|mesh-ancestor
153516971|NCT04329572|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153516972|NCT04329572|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153516973|NCT04329572|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153516974|NCT04329572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153516975|NCT04329572|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153516976|NCT04322552|Apatinib|apatinib|mesh-list
153516977|NCT04322552|Digoxin|digoxin|mesh-list
153516978|NCT04322552|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153516979|NCT04322552|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153516980|NCT04322552|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153879964|NCT02703623|Ipilimumab|ipilimumab|mesh-list
153516981|NCT04322552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153516982|NCT04322552|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153516983|NCT04322552|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
153516984|NCT04322552|Protective Agents|protective agents|mesh-ancestor
153516991|NCT04234061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153516992|NCT04234061|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153516994|NCT04189848|Semaglutide|semaglutide|mesh-list
153516995|NCT04189848|Dulaglutide|dulaglutide|mesh-list
153460115|NCT04597190|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153516996|NCT04189848|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
153516997|NCT04189848|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153516998|NCT04189848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153516999|NCT04156334|Anesthetics|anesthetics|mesh-list
153517000|NCT04156334|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153517001|NCT04156334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153517003|NCT04078906|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-list
153517004|NCT04078906|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
153517005|NCT04078906|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
153517006|NCT03980171|Lenalidomide|lenalidomide|mesh-list
153517007|NCT03980171|Venetoclax|venetoclax|mesh-list
153517008|NCT03980171|Obinutuzumab|obinutuzumab|mesh-list
153517009|NCT03980171|Immunologic Factors|immunologic factors|mesh-ancestor
153517010|NCT03980171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153517011|NCT03980171|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153517012|NCT03980171|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153517014|NCT03980171|Growth Inhibitors|growth inhibitors|mesh-ancestor
153517015|NCT03980171|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153517016|NCT03980171|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153517017|NCT03860077|Nicotine|nicotine|mesh-list
153517018|NCT03860077|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
153517019|NCT03860077|Autonomic Agents|autonomic agents|mesh-ancestor
153517020|NCT03860077|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153517021|NCT03860077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153517022|NCT03860077|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
153517023|NCT03860077|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
153517031|NCT03558724|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153517032|NCT03558724|Growth Substances|growth substances|mesh-ancestor
153517033|NCT03558724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153517034|NCT03558724|Growth Inhibitors|growth inhibitors|mesh-ancestor
153517036|NCT03512496|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
153517037|NCT03512496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153517038|NCT03512496|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
153517039|NCT03512496|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153517040|NCT03512496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153517042|NCT03512496|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
153517043|NCT03512496|Purinergic Agents|purinergic agents|mesh-ancestor
153517044|NCT03512496|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153517045|NCT03416127|Metformin|metformin|mesh-list
153517046|NCT03416127|Propolis|propolis|mesh-list
153517047|NCT03416127|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153517048|NCT03416127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153517049|NCT03416127|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153517050|NCT03293069|Deferiprone|deferiprone|mesh-list
153553856|NCT01595152|Fesoterodine|fesoterodine|mesh-list
153517051|NCT03293069|Iron Chelating Agents|iron chelating agents|mesh-ancestor
153517052|NCT03293069|Chelating Agents|chelating agents|mesh-ancestor
153517053|NCT03293069|Sequestering Agents|sequestering agents|mesh-ancestor
153517054|NCT03293069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153517055|NCT03232346|Buprenorphine|buprenorphine|mesh-list
153517078|NCT03149640|Amikacin|amikacin|mesh-list
153517079|NCT03149640|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153517080|NCT03149640|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153517082|NCT02986334|Omeprazole|omeprazole|mesh-list
153517083|NCT02986334|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
153517084|NCT02986334|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153517085|NCT02986334|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
153517086|NCT02986334|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153517087|NCT02986334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153517088|NCT02986334|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153517089|NCT02986334|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153517090|NCT02986334|Analgesics|analgesics|mesh-ancestor
153517091|NCT02986334|Sensory System Agents|sensory system agents|mesh-ancestor
153517092|NCT02986334|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153517093|NCT02986334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153517094|NCT02986334|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153517095|NCT02986334|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153517096|NCT02986334|Gout Suppressants|gout suppressants|mesh-ancestor
153517097|NCT02986334|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153517098|NCT02863718|Ibrutinib|ibrutinib|mesh-list
153517099|NCT02863718|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153517100|NCT02863718|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153517101|NCT02863718|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153517102|NCT02863718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153517103|NCT02668289|Anesthetics|anesthetics|mesh-list
153517104|NCT02668289|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153517105|NCT02668289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153517106|NCT02655315|Deferiprone|deferiprone|mesh-list
153517107|NCT02655315|Iron Chelating Agents|iron chelating agents|mesh-ancestor
153517108|NCT02655315|Chelating Agents|chelating agents|mesh-ancestor
153517109|NCT02655315|Sequestering Agents|sequestering agents|mesh-ancestor
153517111|NCT02436733|Pemetrexed|pemetrexed|mesh-list
153517119|NCT02426502|Prednisone|prednisone|mesh-list
153517120|NCT02426502|Azathioprine|azathioprine|mesh-list
153517121|NCT02426502|Antihypertensive Agents|antihypertensive agents|mesh-list
153517122|NCT02426502|Cyclosporins|cyclosporins|mesh-list
153517123|NCT02426502|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153517124|NCT02426502|Glucocorticoids|glucocorticoids|mesh-ancestor
153517125|NCT02426502|Hormones|hormones|mesh-ancestor
153517126|NCT02426502|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153517128|NCT02426502|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153517129|NCT02426502|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153517130|NCT02426502|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153517131|NCT02426502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153517132|NCT02426502|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153517133|NCT02426502|Immunologic Factors|immunologic factors|mesh-ancestor
153517134|NCT02426502|Antifungal Agents|antifungal agents|mesh-ancestor
153517135|NCT02426502|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153517136|NCT02426502|Dermatologic Agents|dermatologic agents|mesh-ancestor
153517137|NCT02426502|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153517138|NCT02426502|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
153517139|NCT02426502|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153517140|NCT02426502|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
153618899|NCT01980745|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153517141|NCT02426502|Antitubercular Agents|antitubercular agents|mesh-ancestor
153517142|NCT02426502|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153802514|NCT04679012|Hormones|hormones|mesh-ancestor
153517167|NCT02067182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153517170|NCT01877837|Fludarabine phosphate|fludarabine phosphate|mesh-list
153517171|NCT01877837|Melphalan|melphalan|mesh-list
153553909|NCT01595685|Entecavir|entecavir|mesh-list
153517172|NCT01877837|Alemtuzumab|alemtuzumab|mesh-list
153517173|NCT01877837|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153517174|NCT01877837|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153517175|NCT01877837|Antimetabolites|antimetabolites|mesh-ancestor
153517176|NCT01877837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153517177|NCT01877837|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153517178|NCT01877837|Immunologic Factors|immunologic factors|mesh-ancestor
153517179|NCT01877837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153517180|NCT01877837|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153517181|NCT01877837|Alkylating Agents|alkylating agents|mesh-ancestor
153517182|NCT01877837|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153517183|NCT01877837|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153517184|NCT01624142|Evolocumab|evolocumab|mesh-list
153517185|NCT01624142|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
153517186|NCT01624142|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153517187|NCT01624142|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153517188|NCT01624142|Antimetabolites|antimetabolites|mesh-ancestor
153517189|NCT01624142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153517190|NCT01624142|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
153517191|NCT01624142|Protease Inhibitors|protease inhibitors|mesh-ancestor
153517192|NCT01624142|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153517193|NCT01624142|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153802622|NCT04421560|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153517195|NCT01375764|Evolocumab|evolocumab|mesh-list
153517196|NCT01375764|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
153517197|NCT01375764|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153517198|NCT01375764|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153517199|NCT01375764|Antimetabolites|antimetabolites|mesh-ancestor
153517200|NCT01375764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153517201|NCT01375764|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153517207|NCT01375764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153517208|NCT00523341|Denosumab|denosumab|mesh-list
153517209|NCT00523341|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153517210|NCT00523341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153517211|NCT00364013|Panitumumab|panitumumab|mesh-list
153517212|NCT00364013|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153517213|NCT00364013|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153517214|NCT00345839|Cinacalcet|cinacalcet|mesh-list
153517215|NCT00345839|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153618900|NCT01980745|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153517216|NCT00345839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153517218|NCT00345839|Hormone Antagonists|hormone antagonists|mesh-ancestor
153517219|NCT00345839|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153517220|NCT00330759|Zoledronic Acid|zoledronic acid|mesh-list
153517221|NCT00330759|Denosumab|denosumab|mesh-list
153517222|NCT00330759|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153517223|NCT00330759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153517224|NCT00113763|Panitumumab|panitumumab|mesh-list
153517225|NCT00113763|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153517261|NCT01438515|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
153517262|NCT01438554|Trametinib|trametinib|mesh-list
153517263|NCT01438554|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153517264|NCT01438554|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153517265|NCT01438554|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153517266|NCT01438554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153517267|NCT01438567|Oxycodone|oxycodone|mesh-list
153517268|NCT01438567|Naloxone|naloxone|mesh-list
153517269|NCT01438567|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153517270|NCT01438567|Narcotics|narcotics|mesh-ancestor
153802767|NCT03947385|Crizotinib|crizotinib|mesh-list
153517271|NCT01438567|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153517272|NCT01438567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153517274|NCT01438567|Sensory System Agents|sensory system agents|mesh-ancestor
153517275|NCT01438567|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153517276|NCT01438567|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
153517277|NCT01438580|Aspirin|aspirin|mesh-list
153517278|NCT01438580|Warfarin|warfarin|mesh-list
153517279|NCT01438580|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153517280|NCT01438580|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153517281|NCT01438580|Analgesics|analgesics|mesh-ancestor
153517282|NCT01438580|Sensory System Agents|sensory system agents|mesh-ancestor
153517283|NCT01438580|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153517284|NCT01438580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153517285|NCT01438580|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153517286|NCT01438580|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153517287|NCT01438580|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153517288|NCT01438580|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153517289|NCT01438580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153517308|NCT01438736|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
153517309|NCT01438736|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
153517310|NCT01438736|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
153517311|NCT01438736|Progestins|progestins|mesh-ancestor
153517313|NCT01438736|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153517314|NCT01438749|Diazepam|diazepam|mesh-list
153517315|NCT01438749|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153517316|NCT01438749|Anticonvulsants|anticonvulsants|mesh-ancestor
153517317|NCT01438749|Antiemetics|antiemetics|mesh-ancestor
153517318|NCT01438749|Autonomic Agents|autonomic agents|mesh-ancestor
153517319|NCT01438749|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153517320|NCT01438749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153517321|NCT01438749|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153517322|NCT01438749|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153517323|NCT01438749|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153802874|NCT03859973|BI 425809|bi 425809|mesh-list
153517324|NCT01438749|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
153517325|NCT01438749|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
153517326|NCT01438749|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153517327|NCT01438749|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153517328|NCT01438749|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153517329|NCT01438749|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153517330|NCT01438749|Anesthetics, General|anesthetics, general|mesh-ancestor
153517361|NCT01439100|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
153517363|NCT01439152|Anetumab ravtansine|anetumab ravtansine|mesh-list
153517364|NCT01439152|Immunoconjugates|immunoconjugates|mesh-list
153517365|NCT01439152|Immunologic Factors|immunologic factors|mesh-ancestor
153517366|NCT01439152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153517367|NCT01439152|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153517368|NCT01439152|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153517369|NCT01439152|Tubulin Modulators|tubulin modulators|mesh-ancestor
153517370|NCT01439152|Antimitotic Agents|antimitotic agents|mesh-ancestor
153517371|NCT01439152|Mitosis Modulators|mitosis modulators|mesh-ancestor
153517372|NCT01439152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153517373|NCT01439178|Bevacizumab|bevacizumab|mesh-list
153517374|NCT01439178|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153517375|NCT01439178|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153517376|NCT01439178|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153517377|NCT01439178|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153517378|NCT01439178|Growth Substances|growth substances|mesh-ancestor
153517379|NCT01439178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153517380|NCT01439178|Growth Inhibitors|growth inhibitors|mesh-ancestor
153517381|NCT01439191|Vinorelbine|vinorelbine|mesh-list
153517382|NCT01439191|Antibodies|antibodies|mesh-list
153517383|NCT01439191|Immunologic Factors|immunologic factors|mesh-ancestor
153517384|NCT01439191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153517385|NCT01439191|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153517387|NCT01439191|Tubulin Modulators|tubulin modulators|mesh-ancestor
153517388|NCT01439191|Antimitotic Agents|antimitotic agents|mesh-ancestor
153517389|NCT01439191|Mitosis Modulators|mitosis modulators|mesh-ancestor
153517390|NCT01439191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153517404|NCT01439243|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153517405|NCT01439243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153517406|NCT01439243|Nootropic Agents|nootropic agents|mesh-ancestor
153517407|NCT01439399|Lidocaine|lidocaine|mesh-list
153517408|NCT01439399|Ketamine|ketamine|mesh-list
153517409|NCT01439399|Anesthetics, Local|anesthetics, local|mesh-ancestor
153517410|NCT01439399|Anesthetics|anesthetics|mesh-ancestor
153517411|NCT01439399|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153517412|NCT01439399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153517413|NCT01439399|Sensory System Agents|sensory system agents|mesh-ancestor
153517414|NCT01439399|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153517415|NCT01439399|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153517416|NCT01439399|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
153517417|NCT01439399|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153517418|NCT01439399|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153517419|NCT01439399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153517421|NCT01439399|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
153517422|NCT01439399|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153517423|NCT01439399|Anesthetics, General|anesthetics, general|mesh-ancestor
153517424|NCT01439399|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
153803164|NCT03004287|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153517425|NCT01439399|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
153517426|NCT01439399|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153517428|NCT01439438|Anticonvulsants|anticonvulsants|mesh-ancestor
153517429|NCT01439438|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153517451|NCT01439984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153517452|NCT01439984|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153517454|NCT01439984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153517455|NCT01440062|Vitamin D|vitamin d|mesh-list
153517456|NCT01440062|Ergocalciferols|ergocalciferols|mesh-list
153517457|NCT01440062|Cholecalciferol|cholecalciferol|mesh-list
153517458|NCT01440062|Vitamins|vitamins|mesh-list
153517459|NCT01440062|Micronutrients|micronutrients|mesh-ancestor
153517460|NCT01440062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153517461|NCT01440062|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153517462|NCT01440062|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153517463|NCT01440088|Doxorubicin|doxorubicin|mesh-list
153517464|NCT01440088|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
153517465|NCT01440088|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153517466|NCT01440088|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153517467|NCT01440088|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153517468|NCT01440088|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153517469|NCT01440088|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153517507|NCT01440335|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153517508|NCT01440335|Adrenergic Agents|adrenergic agents|mesh-ancestor
153517509|NCT01440335|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153517510|NCT01440335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153517511|NCT01440361|Belimumab|belimumab|mesh-list
153517512|NCT01440361|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153517513|NCT01440361|Immunologic Factors|immunologic factors|mesh-ancestor
153517514|NCT01440361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153517515|NCT01440400|Anesthetics|anesthetics|mesh-list
153517516|NCT01440400|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153517517|NCT01440400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153517519|NCT01440439|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
153803227|NCT02615119|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153803228|NCT02615119|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153803229|NCT02615119|Respiratory System Agents|respiratory system agents|mesh-ancestor
153803274|NCT02143050|Metformin|metformin|mesh-list
153517520|NCT01440439|Insulin Glargine|insulin glargine|mesh-list
153517521|NCT01440439|Insulin Detemir|insulin detemir|mesh-list
153517522|NCT01440439|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153517523|NCT01440439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153517525|NCT01440582|Lenalidomide|lenalidomide|mesh-list
153517526|NCT01440582|Bortezomib|bortezomib|mesh-list
153517527|NCT01440582|Panobinostat|panobinostat|mesh-list
153517528|NCT01440582|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153517529|NCT01440582|Antiemetics|antiemetics|mesh-ancestor
153553922|NCT01595724|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
153517530|NCT01440582|Autonomic Agents|autonomic agents|mesh-ancestor
153517531|NCT01440582|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153517563|NCT01440621|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
153517564|NCT01440621|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
153517565|NCT01440621|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
153517566|NCT01440621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153517567|NCT01440621|Vitamin B Complex|vitamin b complex|mesh-ancestor
153517568|NCT01440621|Vitamins|vitamins|mesh-ancestor
153517569|NCT01440621|Micronutrients|micronutrients|mesh-ancestor
153517570|NCT01440673|Aprepitant|aprepitant|mesh-list
153517571|NCT01440673|Antiemetics|antiemetics|mesh-ancestor
153517572|NCT01440673|Autonomic Agents|autonomic agents|mesh-ancestor
153517573|NCT01440673|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153517574|NCT01440673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153517575|NCT01440673|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153517576|NCT01440673|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
153517577|NCT01440673|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153517578|NCT01440673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153517580|NCT01440725|Mitosis Modulators|mitosis modulators|mesh-ancestor
153517581|NCT01440725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153517582|NCT01440751|Mitomycins|mitomycins|mesh-list
153517583|NCT01440751|Mitomycin|mitomycin|mesh-list
153517584|NCT01440751|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153517585|NCT01440751|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153517586|NCT01440751|Alkylating Agents|alkylating agents|mesh-ancestor
153517608|NCT01440933|Analgesics|analgesics|mesh-ancestor
153517609|NCT01440933|Sensory System Agents|sensory system agents|mesh-ancestor
153517610|NCT01440933|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153517611|NCT01440933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153517612|NCT01440933|Anesthetics|anesthetics|mesh-ancestor
153517613|NCT01440933|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153517614|NCT01440933|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153517615|NCT01440933|Anticonvulsants|anticonvulsants|mesh-ancestor
153517616|NCT01440933|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153517617|NCT01440933|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153517618|NCT01440933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153517619|NCT01440933|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153517620|NCT01440933|Tocolytic Agents|tocolytic agents|mesh-ancestor
153517621|NCT01440933|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153517623|NCT01440985|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
153517624|NCT01440985|Autonomic Agents|autonomic agents|mesh-ancestor
153517625|NCT01440985|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153517626|NCT01440985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153517627|NCT01440985|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
153517628|NCT01440985|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
153517629|NCT01440985|Cholinergic Agents|cholinergic agents|mesh-ancestor
153517630|NCT01440985|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153517631|NCT01440985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153517632|NCT01440998|Paclitaxel|paclitaxel|mesh-list
153517633|NCT01440998|Carboplatin|carboplatin|mesh-list
153517634|NCT01440998|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
153517654|NCT01441193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153517655|NCT01441206|Rifampin|rifampin|mesh-list
153517656|NCT01441206|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
153517657|NCT01441206|Antitubercular Agents|antitubercular agents|mesh-ancestor
153517658|NCT01441206|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153517659|NCT01441206|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153517660|NCT01441206|Leprostatic Agents|leprostatic agents|mesh-ancestor
153517661|NCT01441206|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153517662|NCT01441206|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153517663|NCT01441206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153517664|NCT01441206|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
153517665|NCT01441206|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
153517666|NCT01441206|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
153517667|NCT01441206|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
153517668|NCT01441206|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
153517669|NCT01441206|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
153517670|NCT01441232|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
153517671|NCT01441232|(2S,3R,4R,5S,6R)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2H-pyran-3,4,5-triol|(2s,3r,4r,5s,6r)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2h-pyran-3,4,5-triol|mesh-list
153517672|NCT01441232|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153517673|NCT01441232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153517674|NCT01441232|Incretins|incretins|mesh-ancestor
153517675|NCT01441232|Hormones|hormones|mesh-ancestor
153517702|NCT01441388|Crizotinib|crizotinib|mesh-list
153517703|NCT01441388|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153803596|NCT00324051|Olanzapine|olanzapine|mesh-list
153517704|NCT01441388|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153517705|NCT01441388|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153517706|NCT01441388|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153517707|NCT01441388|Growth Substances|growth substances|mesh-ancestor
153517708|NCT01441388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153517709|NCT01441388|Growth Inhibitors|growth inhibitors|mesh-ancestor
153517710|NCT01441388|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153517711|NCT01441388|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153517712|NCT01441388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153517713|NCT01441388|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153517714|NCT01441427|Lenograstim|lenograstim|mesh-list
153517715|NCT01441427|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153517716|NCT01441427|Immunologic Factors|immunologic factors|mesh-ancestor
153517717|NCT01441427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153517718|NCT01441505|Midazolam|midazolam|mesh-list
153517719|NCT01441505|Ketamine|ketamine|mesh-list
153517720|NCT01441505|Analgesics|analgesics|mesh-ancestor
153517722|NCT01441505|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153517723|NCT01441505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153517727|NCT01441505|Anesthetics|anesthetics|mesh-ancestor
153517755|NCT01441557|Amifampridine|amifampridine|mesh-list
153517756|NCT01441557|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
153517757|NCT01441557|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153517758|NCT01441557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153517759|NCT01441557|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
153517760|NCT01441557|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153517761|NCT01441557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153517762|NCT01441700|Anesthetics|anesthetics|mesh-list
153517763|NCT01441700|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153517764|NCT01441700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153517765|NCT01441804|Ribavirin|ribavirin|mesh-list
153517766|NCT01441804|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
153517767|NCT01441804|Interferon-alpha|interferon-alpha|mesh-list
153517768|NCT01441804|Antimetabolites|antimetabolites|mesh-ancestor
153517769|NCT01441804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153517770|NCT01441804|Antiviral Agents|antiviral agents|mesh-ancestor
153517771|NCT01441804|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153517772|NCT01441804|Immunologic Factors|immunologic factors|mesh-ancestor
153517773|NCT01441804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153517774|NCT01441869|Metformin|metformin|mesh-list
153517775|NCT01441869|Saxagliptin|saxagliptin|mesh-list
153517776|NCT01441869|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153517778|NCT01441869|Incretins|incretins|mesh-ancestor
153517807|NCT01441986|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153517808|NCT01441986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153517809|NCT01441986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153517810|NCT01441986|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153517811|NCT01441986|Narcotics|narcotics|mesh-ancestor
153517812|NCT01441986|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153517813|NCT01441986|Analgesics|analgesics|mesh-ancestor
153517814|NCT01441986|Sensory System Agents|sensory system agents|mesh-ancestor
153517815|NCT01441986|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153517816|NCT01441986|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
153517817|NCT01441986|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
153517818|NCT01441986|Antiviral Agents|antiviral agents|mesh-ancestor
153517819|NCT01441986|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153517820|NCT01441986|Dopamine Agents|dopamine agents|mesh-ancestor
153517821|NCT01441986|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153517823|NCT01442025|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
153517824|NCT01442025|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153517825|NCT01442025|Dermatologic Agents|dermatologic agents|mesh-ancestor
153517826|NCT01442025|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153517828|NCT01442168|Atovaquone|atovaquone|mesh-list
153517829|NCT01442168|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153517830|NCT01442168|Antimalarials|antimalarials|mesh-ancestor
153517831|NCT01442168|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153517832|NCT01442168|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153517833|NCT01442168|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153517834|NCT01442168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153517835|NCT01442272|Calcifediol|calcifediol|mesh-list
153517836|NCT01442272|Vitamins|vitamins|mesh-ancestor
153517837|NCT01442272|Micronutrients|micronutrients|mesh-ancestor
153517851|NCT01442311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153517852|NCT01442428|Dexamethasone|dexamethasone|mesh-list
153517853|NCT01442428|Naproxen|naproxen|mesh-list
153517854|NCT01442428|Atorvastatin|atorvastatin|mesh-list
153517855|NCT01442428|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153517856|NCT01442428|Antiemetics|antiemetics|mesh-ancestor
153517857|NCT01442428|Autonomic Agents|autonomic agents|mesh-ancestor
153517858|NCT01442428|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153517859|NCT01442428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153517860|NCT01442428|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153517861|NCT01442428|Glucocorticoids|glucocorticoids|mesh-ancestor
153517862|NCT01442428|Hormones|hormones|mesh-ancestor
153517863|NCT01442428|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153517864|NCT01442428|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153517865|NCT01442428|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153517866|NCT01442428|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153517867|NCT01442428|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153517868|NCT01442428|Antimetabolites|antimetabolites|mesh-ancestor
153517869|NCT01442428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153517870|NCT01442428|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153517871|NCT01442428|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
153517872|NCT01442428|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153517873|NCT01442428|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153517874|NCT01442428|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153517875|NCT01442428|Analgesics|analgesics|mesh-ancestor
153517876|NCT01442428|Sensory System Agents|sensory system agents|mesh-ancestor
153517877|NCT01442428|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153517878|NCT01442428|Gout Suppressants|gout suppressants|mesh-ancestor
153517879|NCT01442428|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153517880|NCT01442519|Mitomycins|mitomycins|mesh-list
153517894|NCT01442532|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153517895|NCT01442532|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153517896|NCT01442532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153517897|NCT01442532|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153517898|NCT01442532|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153517899|NCT01442532|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153517900|NCT01442532|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153517901|NCT01442532|Anesthetics, General|anesthetics, general|mesh-ancestor
153517904|NCT01442532|GABA Agents|gaba agents|mesh-ancestor
153517905|NCT01442532|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153517906|NCT01442532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153517907|NCT01442558|Bupivacaine|bupivacaine|mesh-list
153517908|NCT01442558|Anesthetics, Local|anesthetics, local|mesh-ancestor
153517909|NCT01442558|Anesthetics|anesthetics|mesh-ancestor
153517910|NCT01442558|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153517911|NCT01442558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153517912|NCT01442558|Sensory System Agents|sensory system agents|mesh-ancestor
153517913|NCT01442558|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153517914|NCT01442571|Hyaluronic Acid|hyaluronic acid|mesh-list
153517915|NCT01442571|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153517916|NCT01442571|Immunologic Factors|immunologic factors|mesh-ancestor
153517917|NCT01442571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153517918|NCT01442571|Viscosupplements|viscosupplements|mesh-ancestor
153517919|NCT01442571|Protective Agents|protective agents|mesh-ancestor
153517920|NCT01442610|Rasagiline|rasagiline|mesh-list
153517921|NCT01442610|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
153517922|NCT01442610|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153517939|NCT01442701|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153517940|NCT01442727|Selenium|selenium|mesh-list
153517941|NCT01442727|Selenious Acid|selenious acid|mesh-list
153517942|NCT01442727|Sodium Selenite|sodium selenite|mesh-list
153517943|NCT01442727|Antioxidants|antioxidants|mesh-ancestor
153517944|NCT01442727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153517945|NCT01442727|Protective Agents|protective agents|mesh-ancestor
153517946|NCT01442727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153517948|NCT01442727|Micronutrients|micronutrients|mesh-ancestor
153517949|NCT01442766|Donepezil|donepezil|mesh-list
153517950|NCT01442766|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
153517951|NCT01442766|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153517952|NCT01442766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153517954|NCT01442766|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153517955|NCT01442766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153517956|NCT01442766|Nootropic Agents|nootropic agents|mesh-ancestor
153517957|NCT01442818|Hydromorphone|hydromorphone|mesh-list
153517958|NCT01442818|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153517959|NCT01442818|Narcotics|narcotics|mesh-ancestor
153517960|NCT01442818|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153517961|NCT01442818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153517962|NCT01442818|Analgesics|analgesics|mesh-ancestor
153517964|NCT01442818|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153618901|NCT01980745|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153517965|NCT01442870|Metformin|metformin|mesh-list
153517966|NCT01442870|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153517967|NCT01442870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153517968|NCT01442909|Docetaxel|docetaxel|mesh-list
153517969|NCT01442909|Pemetrexed|pemetrexed|mesh-list
153517970|NCT01442909|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153517971|NCT01442909|Tubulin Modulators|tubulin modulators|mesh-ancestor
153517972|NCT01442909|Antimitotic Agents|antimitotic agents|mesh-ancestor
153517973|NCT01442909|Mitosis Modulators|mitosis modulators|mesh-ancestor
153517974|NCT01442909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153517977|NCT01442909|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153517979|NCT01442935|Folic Acid|folic acid|mesh-list
153517980|NCT01442935|Bevacizumab|bevacizumab|mesh-list
153517981|NCT01442935|Cetuximab|cetuximab|mesh-list
153517982|NCT01442935|Oxaliplatin|oxaliplatin|mesh-list
153517983|NCT01442935|Irinotecan|irinotecan|mesh-list
153517984|NCT01442935|Fluorouracil|fluorouracil|mesh-list
153517985|NCT01442935|Levoleucovorin|levoleucovorin|mesh-list
153517986|NCT01442935|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153517987|NCT01442935|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153517988|NCT01442935|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153517989|NCT01442935|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153517990|NCT01442935|Growth Substances|growth substances|mesh-ancestor
153517991|NCT01442935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153517992|NCT01442935|Growth Inhibitors|growth inhibitors|mesh-ancestor
153517993|NCT01442935|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
153517994|NCT01442935|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153517995|NCT01442935|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153517996|NCT01442935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153517997|NCT01442935|Antidotes|antidotes|mesh-ancestor
153517998|NCT01442935|Protective Agents|protective agents|mesh-ancestor
153517999|NCT01442935|Vitamin B Complex|vitamin b complex|mesh-ancestor
153518000|NCT01442935|Vitamins|vitamins|mesh-ancestor
153518001|NCT01442935|Micronutrients|micronutrients|mesh-ancestor
153518002|NCT01442935|Hematinics|hematinics|mesh-ancestor
153518003|NCT01442935|Antimetabolites|antimetabolites|mesh-ancestor
153518004|NCT01442935|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153518005|NCT01442935|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153518007|NCT01442974|Paclitaxel|paclitaxel|mesh-list
153518026|NCT01442987|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153518027|NCT01442987|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
153518028|NCT01442987|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
153518029|NCT01443065|Leucovorin|leucovorin|mesh-list
153518030|NCT01443065|Folic Acid|folic acid|mesh-list
153518031|NCT01443065|Oxaliplatin|oxaliplatin|mesh-list
153518032|NCT01443065|Panitumumab|panitumumab|mesh-list
153518033|NCT01443065|Fluorouracil|fluorouracil|mesh-list
153518034|NCT01443065|Rilotumumab|rilotumumab|mesh-list
153518035|NCT01443065|Levoleucovorin|levoleucovorin|mesh-list
153518036|NCT01443065|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153518037|NCT01443065|Antidotes|antidotes|mesh-ancestor
153518038|NCT01443065|Protective Agents|protective agents|mesh-ancestor
153518039|NCT01443065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153518040|NCT01443065|Vitamin B Complex|vitamin b complex|mesh-ancestor
153518042|NCT01443065|Micronutrients|micronutrients|mesh-ancestor
153518043|NCT01443065|Hematinics|hematinics|mesh-ancestor
153518044|NCT01443065|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153518045|NCT01443065|Antimetabolites|antimetabolites|mesh-ancestor
153518046|NCT01443065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153518047|NCT01443065|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153518048|NCT01443065|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153518049|NCT01443065|Immunologic Factors|immunologic factors|mesh-ancestor
153518050|NCT01443104|Sirolimus|sirolimus|mesh-list
153518051|NCT01443104|Everolimus|everolimus|mesh-list
153518052|NCT01443104|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
153518054|NCT01443104|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153518055|NCT01443104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153518056|NCT01443104|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153518057|NCT01443104|Immunologic Factors|immunologic factors|mesh-ancestor
153518058|NCT01443104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153518059|NCT01443104|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153518064|NCT01443117|Vaccines|vaccines|mesh-list
153518070|NCT01443169|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153518071|NCT01443169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153518073|NCT01443169|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153518074|NCT01443169|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153518075|NCT01443169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153518076|NCT01443169|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153518077|NCT01443169|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153518078|NCT01443169|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153518079|NCT01443169|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153518080|NCT01443169|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153518081|NCT01443195|Iron|iron|mesh-list
153518082|NCT01443195|Trace Elements|trace elements|mesh-ancestor
153518083|NCT01443195|Micronutrients|micronutrients|mesh-ancestor
153518084|NCT01443195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153518085|NCT01443208|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
153518086|NCT01443208|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
153518087|NCT01443208|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153518088|NCT01443208|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153518089|NCT01443208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153518090|NCT01443208|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153518121|NCT01443416|Vaccines|vaccines|mesh-list
153518122|NCT01443416|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
153518124|NCT01443416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153518125|NCT01443429|Beraprost|beraprost|mesh-list
153518126|NCT01443429|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153518127|NCT01443429|Vasodilator Agents|vasodilator agents|mesh-ancestor
153518128|NCT01443520|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
153518129|NCT01443520|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
153518130|NCT01443520|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
153518131|NCT01443520|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153518132|NCT01443520|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153518133|NCT01443520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153518134|NCT01443520|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153518135|NCT01443520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153518136|NCT01443520|Analgesics|analgesics|mesh-ancestor
153518137|NCT01443520|Sensory System Agents|sensory system agents|mesh-ancestor
153518138|NCT01443520|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153518139|NCT01443520|Antidepressive Agents|antidepressive agents|mesh-ancestor
153518140|NCT01443520|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153518141|NCT01443520|Dopamine Agents|dopamine agents|mesh-ancestor
153518142|NCT01443520|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
153518143|NCT01443572|Anesthetics|anesthetics|mesh-list
153518144|NCT01443572|Sevoflurane|sevoflurane|mesh-list
153518145|NCT01443572|Desflurane|desflurane|mesh-list
153518146|NCT01443572|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153518147|NCT01443572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153805110|NCT00300131|Everolimus|everolimus|mesh-list
153518148|NCT01443572|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153518149|NCT01443572|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
153518150|NCT01443572|Anesthetics, General|anesthetics, general|mesh-ancestor
153518151|NCT01443624|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
153518153|NCT01443650|Alirocumab|alirocumab|mesh-list
153518154|NCT01443650|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
153518155|NCT01443650|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153518159|NCT01443650|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
153518160|NCT01443650|Protease Inhibitors|protease inhibitors|mesh-ancestor
153518161|NCT01443650|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153518162|NCT01443650|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153518163|NCT01443676|Bevacizumab|bevacizumab|mesh-list
153518164|NCT01443676|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153518165|NCT01443676|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153518166|NCT01443676|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153518167|NCT01443676|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153518168|NCT01443676|Growth Substances|growth substances|mesh-ancestor
153518169|NCT01443676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153518170|NCT01443676|Growth Inhibitors|growth inhibitors|mesh-ancestor
153518171|NCT01443741|Insulin|insulin|mesh-list
153518172|NCT01443741|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
153518173|NCT01443741|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153518174|NCT01443741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153518175|NCT01443780|Selenium|selenium|mesh-list
153518176|NCT01443780|Antioxidants|antioxidants|mesh-ancestor
153518177|NCT01443780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153518178|NCT01443780|Protective Agents|protective agents|mesh-ancestor
153518179|NCT01443780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153518180|NCT01443780|Trace Elements|trace elements|mesh-ancestor
153518181|NCT01443780|Micronutrients|micronutrients|mesh-ancestor
153518182|NCT01443806|Oseltamivir|oseltamivir|mesh-list
153518183|NCT01443806|Antiviral Agents|antiviral agents|mesh-ancestor
153518184|NCT01443806|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153518185|NCT01443806|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153518186|NCT01443806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153518187|NCT01443897|Vitamin D|vitamin d|mesh-list
153518206|NCT01444118|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153518207|NCT01444118|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153518208|NCT01444118|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153518209|NCT01444118|Alkylating Agents|alkylating agents|mesh-ancestor
153518210|NCT01444118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153518211|NCT01444118|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153518212|NCT01444118|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153518213|NCT01444118|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153518214|NCT01444131|Nicotine|nicotine|mesh-list
153518215|NCT01444131|Varenicline|varenicline|mesh-list
153518216|NCT01444131|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
153518217|NCT01444131|Autonomic Agents|autonomic agents|mesh-ancestor
153518218|NCT01444131|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153518219|NCT01444131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153518235|NCT01444248|Metformin|metformin|mesh-list
153518266|NCT01444586|Antithrombins|antithrombins|mesh-ancestor
153518267|NCT01444586|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
153518268|NCT01444586|Protease Inhibitors|protease inhibitors|mesh-ancestor
153618902|NCT01980745|Antimalarials|antimalarials|mesh-ancestor
153461390|NCT05345574|Narcotics|narcotics|mesh-ancestor
153518269|NCT01444586|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153518270|NCT01444586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153518271|NCT01444586|Anticoagulants|anticoagulants|mesh-ancestor
153518272|NCT01444612|Heparin|heparin|mesh-list
153518273|NCT01444612|Calcium heparin|calcium heparin|mesh-list
153518274|NCT01444612|Enoxaparin|enoxaparin|mesh-list
153518275|NCT01444612|Dalteparin|dalteparin|mesh-list
153518276|NCT01444612|Tinzaparin|tinzaparin|mesh-list
153518277|NCT01444612|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
153518326|NCT01444885|Nitroglycerin|nitroglycerin|mesh-list
153518327|NCT01444885|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153518328|NCT01444885|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153518329|NCT01444885|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153518330|NCT01444885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153518331|NCT01444885|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153518332|NCT01444885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153518388|NCT01445223|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
153518389|NCT01445223|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
153518391|NCT01445236|Tacrolimus|tacrolimus|mesh-list
153518392|NCT01445236|Cyclosporins|cyclosporins|mesh-list
153518393|NCT01445236|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153518394|NCT01445236|Immunologic Factors|immunologic factors|mesh-ancestor
153518395|NCT01445236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153518396|NCT01445236|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
153518397|NCT01445236|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153518398|NCT01445236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153518451|NCT01445522|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
153518452|NCT01445522|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153518453|NCT01445561|Interleukin-2|interleukin-2|mesh-list
153518454|NCT01445561|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153518455|NCT01445561|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153518456|NCT01445561|Analgesics|analgesics|mesh-ancestor
153518457|NCT01445561|Sensory System Agents|sensory system agents|mesh-ancestor
153518458|NCT01445561|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153518459|NCT01445561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153518460|NCT01445587|Bortezomib|bortezomib|mesh-list
153518461|NCT01445587|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153518462|NCT01445600|Retapamulin|retapamulin|mesh-list
153518463|NCT01445600|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153518464|NCT01445600|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153518465|NCT01445639|Dexmedetomidine|dexmedetomidine|mesh-list
153518466|NCT01445639|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153518467|NCT01445639|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153518468|NCT01445639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153518469|NCT01445639|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153518470|NCT01445639|Analgesics|analgesics|mesh-ancestor
153518505|NCT01445938|Lumefantrine|lumefantrine|mesh-list
153518506|NCT01445938|Antimalarials|antimalarials|mesh-ancestor
153518507|NCT01445938|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153518508|NCT01445938|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153805443|NCT00302627|Antacids|antacids|mesh-ancestor
153518509|NCT01445938|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153518510|NCT01445964|Atenolol|atenolol|mesh-list
153518511|NCT01445964|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153518512|NCT01445964|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153518513|NCT01445964|Sympatholytics|sympatholytics|mesh-ancestor
153518514|NCT01445964|Autonomic Agents|autonomic agents|mesh-ancestor
153518515|NCT01445964|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153518516|NCT01445964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153518517|NCT01445964|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
153518518|NCT01445964|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
153518519|NCT01445964|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
153518520|NCT01445964|Adrenergic Agents|adrenergic agents|mesh-ancestor
153518521|NCT01445964|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153518522|NCT01445964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153518524|NCT01446094|Adenosine A2 Receptor Agonists|adenosine a2 receptor agonists|mesh-ancestor
153518560|NCT01446211|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153518561|NCT01446211|Antimetabolites|antimetabolites|mesh-ancestor
153518562|NCT01446211|Dermatologic Agents|dermatologic agents|mesh-ancestor
153518563|NCT01446211|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153518564|NCT01446211|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153518565|NCT01446211|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153518566|NCT01446211|Hormones|hormones|mesh-ancestor
153518567|NCT01446211|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153518568|NCT01446211|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153518579|NCT01446328|Olanzapine|olanzapine|mesh-list
153518625|NCT01446484|Immunologic Factors|immunologic factors|mesh-ancestor
153518626|NCT01446484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153518627|NCT01446484|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
153518628|NCT01446484|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153518629|NCT01446484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153518630|NCT01446484|Antifungal Agents|antifungal agents|mesh-ancestor
153518631|NCT01446484|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153518632|NCT01446484|Dermatologic Agents|dermatologic agents|mesh-ancestor
153518633|NCT01446484|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153518692|NCT01446952|Vitamins|vitamins|mesh-ancestor
153518693|NCT01446952|Micronutrients|micronutrients|mesh-ancestor
153518694|NCT01446952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153518695|NCT01446952|Antioxidants|antioxidants|mesh-ancestor
153518696|NCT01446952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153518697|NCT01446952|Protective Agents|protective agents|mesh-ancestor
153518698|NCT01446978|Vaccines|vaccines|mesh-list
153518699|NCT01446978|Immunologic Factors|immunologic factors|mesh-ancestor
153518700|NCT01446978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153518701|NCT01447043|Ranibizumab|ranibizumab|mesh-list
153554178|NCT01596647|Analgesics|analgesics|mesh-ancestor
153518702|NCT01447043|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153518703|NCT01447043|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153518704|NCT01447043|Growth Substances|growth substances|mesh-ancestor
153518705|NCT01447043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153518706|NCT01447043|Growth Inhibitors|growth inhibitors|mesh-ancestor
153518707|NCT01447043|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153518708|NCT01447069|Albuterol|albuterol|mesh-list
153518709|NCT01447069|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153518710|NCT01447069|Autonomic Agents|autonomic agents|mesh-ancestor
153518750|NCT01447355|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153518751|NCT01447368|Cinacalcet|cinacalcet|mesh-list
153518752|NCT01447368|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153518753|NCT01447368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153518754|NCT01447368|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
153518755|NCT01447368|Hormone Antagonists|hormone antagonists|mesh-ancestor
153518756|NCT01447368|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153518757|NCT01447394|Interferons|interferons|mesh-list
153518813|NCT01447797|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
153518814|NCT01447797|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
153518816|NCT01447862|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153518817|NCT01447875|Propofol|propofol|mesh-list
153518818|NCT01447875|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153518819|NCT01447875|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153518820|NCT01447875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153518821|NCT01447875|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153518822|NCT01447875|Anesthetics, General|anesthetics, general|mesh-ancestor
153518880|NCT01448291|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153518881|NCT01448291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153518882|NCT01448291|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
153518883|NCT01448291|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153518884|NCT01448291|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
153518885|NCT01448291|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
153518946|NCT01448499|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153518947|NCT01448499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153518948|NCT01448499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153518949|NCT01448499|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153518950|NCT01448499|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153518951|NCT01448499|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153518952|NCT01448499|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153518953|NCT01448499|GABA Antagonists|gaba antagonists|mesh-ancestor
153518954|NCT01448499|GABA Agents|gaba agents|mesh-ancestor
153518955|NCT01448499|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
153518956|NCT01448499|Dopamine Agents|dopamine agents|mesh-ancestor
153518957|NCT01448499|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
153518958|NCT01448499|Antidepressive Agents|antidepressive agents|mesh-ancestor
153518959|NCT01448642|Atorvastatin|atorvastatin|mesh-list
153518960|NCT01448642|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153518961|NCT01448642|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153518962|NCT01448642|Antimetabolites|antimetabolites|mesh-ancestor
153518963|NCT01448642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153519002|NCT01448772|Dronabinol|dronabinol|mesh-list
153519003|NCT01448772|Hallucinogens|hallucinogens|mesh-ancestor
153519004|NCT01448772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153519005|NCT01448772|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153519006|NCT01448772|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153519007|NCT01448772|Analgesics|analgesics|mesh-ancestor
153519008|NCT01448772|Sensory System Agents|sensory system agents|mesh-ancestor
153519009|NCT01448772|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153519010|NCT01448772|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
153519011|NCT01448772|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
153519012|NCT01448772|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153519067|NCT01449188|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153519068|NCT01449188|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153519069|NCT01449188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153519070|NCT01449188|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153519071|NCT01449188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153519072|NCT01449188|Antiemetics|antiemetics|mesh-ancestor
153519073|NCT01449188|Autonomic Agents|autonomic agents|mesh-ancestor
153519074|NCT01449188|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153519135|NCT01449435|Respiratory System Agents|respiratory system agents|mesh-ancestor
153519136|NCT01449435|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
153519137|NCT01449435|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
153519139|NCT01449435|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153519140|NCT01449435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153519142|NCT01449448|Ketorolac|ketorolac|mesh-list
153519143|NCT01449448|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153519144|NCT01449448|Glucocorticoids|glucocorticoids|mesh-ancestor
153519145|NCT01449448|Hormones|hormones|mesh-ancestor
153519146|NCT01449448|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153519197|NCT01449617|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153519199|NCT01449617|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
153519200|NCT01449617|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
153519201|NCT01449617|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
153519202|NCT01449617|Purinergic Agents|purinergic agents|mesh-ancestor
153519203|NCT01449617|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153519204|NCT01449799|Fluticasone|fluticasone|mesh-list
153519205|NCT01449799|Xhance|xhance|mesh-list
153519206|NCT01449799|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153519207|NCT01449799|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153519208|NCT01449799|Autonomic Agents|autonomic agents|mesh-ancestor
153519209|NCT01449799|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153519210|NCT01449799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153519211|NCT01449799|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153519212|NCT01449799|Respiratory System Agents|respiratory system agents|mesh-ancestor
153519213|NCT01449799|Dermatologic Agents|dermatologic agents|mesh-ancestor
153519214|NCT01449799|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
153519215|NCT01449825|Bevacizumab|bevacizumab|mesh-list
153519216|NCT01449825|Sunitinib|sunitinib|mesh-list
153519217|NCT01449825|Sorafenib|sorafenib|mesh-list
153519218|NCT01449825|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153519251|NCT01450163|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153519260|NCT01450995|Sumatriptan|sumatriptan|mesh-list
153519321|NCT01452373|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153519322|NCT01452373|Immunologic Factors|immunologic factors|mesh-ancestor
153519323|NCT01452373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153519324|NCT01452607|Ebselen|ebselen|mesh-list
153519325|NCT01452607|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153519327|NCT01452607|Analgesics|analgesics|mesh-ancestor
153519328|NCT01452607|Sensory System Agents|sensory system agents|mesh-ancestor
153519329|NCT01452607|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153519330|NCT01452607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153519331|NCT01452607|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153519332|NCT01452607|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153519333|NCT01452607|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
153519334|NCT01452607|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153519335|NCT01452607|Antioxidants|antioxidants|mesh-ancestor
153519336|NCT01452607|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153519337|NCT01452607|Protective Agents|protective agents|mesh-ancestor
153519338|NCT01452607|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153519339|NCT01452607|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153519375|NCT05964387|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153519376|NCT05964387|Autonomic Agents|autonomic agents|mesh-ancestor
153519377|NCT05964387|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153519378|NCT05964387|Respiratory System Agents|respiratory system agents|mesh-ancestor
153519379|NCT05964387|Mydriatics|mydriatics|mesh-ancestor
153519380|NCT05964387|Sympathomimetics|sympathomimetics|mesh-ancestor
153519381|NCT05964387|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
153519382|NCT05964257|Botulinum Toxins|botulinum toxins|mesh-list
153554290|NCT01596907|Respiratory System Agents|respiratory system agents|mesh-ancestor
153554291|NCT01596907|Nasal Decongestants|nasal decongestants|mesh-ancestor
153554340|NCT01597232|Analgesics|analgesics|mesh-ancestor
153519383|NCT05964257|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
153519441|NCT05962671|Sevoflurane|sevoflurane|mesh-list
153519442|NCT05962671|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153519443|NCT05962671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153519444|NCT05962671|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153519445|NCT05962671|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
153519446|NCT05962671|Anesthetics, General|anesthetics, general|mesh-ancestor
153519448|NCT05962671|Analgesics|analgesics|mesh-ancestor
153519449|NCT05962671|Sensory System Agents|sensory system agents|mesh-ancestor
153519450|NCT05962671|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153519451|NCT05962632|Fluorides|fluorides|mesh-list
153519452|NCT05962632|Cariostatic Agents|cariostatic agents|mesh-ancestor
153519453|NCT05962632|Protective Agents|protective agents|mesh-ancestor
153519454|NCT05962632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153519455|NCT05962619|Hyaluronic Acid|hyaluronic acid|mesh-list
153519456|NCT05962619|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153519497|NCT05961202|Glucocorticoids|glucocorticoids|mesh-ancestor
153519498|NCT05961202|Hormones|hormones|mesh-ancestor
153519499|NCT05961202|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153519500|NCT05961202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153519501|NCT05961202|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153519502|NCT05961202|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153519503|NCT05961202|Antimalarials|antimalarials|mesh-ancestor
153519504|NCT05961202|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153519505|NCT05961202|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153519561|NCT05928611|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153519562|NCT05928611|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153519563|NCT05928611|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153519564|NCT05928611|Protease Inhibitors|protease inhibitors|mesh-ancestor
153519565|NCT05928611|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153519567|NCT05917912|Amitriptyline|amitriptyline|mesh-list
153519627|NCT05867550|Sensory System Agents|sensory system agents|mesh-ancestor
153519628|NCT05867550|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153519629|NCT05867550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153519631|NCT05867550|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153519632|NCT05867550|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153519633|NCT05867550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153519634|NCT05867550|Adrenergic Agents|adrenergic agents|mesh-ancestor
153519635|NCT05867550|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153519637|NCT05867550|Antidiarrheals|antidiarrheals|mesh-ancestor
153519638|NCT05867550|Anticonvulsants|anticonvulsants|mesh-ancestor
153519639|NCT05867550|Parasympatholytics|parasympatholytics|mesh-ancestor
153519688|NCT05620901|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
153519689|NCT05620901|Prednisolone|prednisolone|mesh-list
153519690|NCT05620901|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
153519691|NCT05620901|Prednisolone phosphate|prednisolone phosphate|mesh-list
153519692|NCT05620901|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153519693|NCT05620901|Antiemetics|antiemetics|mesh-ancestor
153519694|NCT05620901|Autonomic Agents|autonomic agents|mesh-ancestor
153519695|NCT05620901|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153519697|NCT05620901|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153519753|NCT05498233|Histamine Antagonists|histamine antagonists|mesh-ancestor
153519755|NCT05498233|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153519756|NCT05498233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153519758|NCT05434000|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153519759|NCT05434000|Antisickling Agents|antisickling agents|mesh-ancestor
153519760|NCT05434000|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153519818|NCT05275738|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153519820|NCT05264168|Rivaroxaban|rivaroxaban|mesh-list
153519821|NCT05264168|Apixaban|apixaban|mesh-list
153519822|NCT05264168|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
153519823|NCT05264168|Antithrombins|antithrombins|mesh-ancestor
153519824|NCT05264168|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
153519825|NCT05264168|Protease Inhibitors|protease inhibitors|mesh-ancestor
153519826|NCT05264168|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153519884|NCT05164081|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153519885|NCT05164081|Antitubercular Agents|antitubercular agents|mesh-ancestor
153519886|NCT05164081|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
153519887|NCT05164081|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153519888|NCT05164081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153519951|NCT05083429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153519952|NCT05083429|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153519953|NCT05083429|Respiratory System Agents|respiratory system agents|mesh-ancestor
153519954|NCT05083429|Parasympatholytics|parasympatholytics|mesh-ancestor
153519955|NCT05083429|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
153519956|NCT05083429|Cholinergic Agents|cholinergic agents|mesh-ancestor
153519957|NCT05083429|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153519959|NCT05083429|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
153520018|NCT04979884|Dermatologic Agents|dermatologic agents|mesh-ancestor
153520019|NCT04979884|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153520020|NCT04979884|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
153520021|NCT04979884|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153520022|NCT04979884|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153520023|NCT04979884|Analgesics|analgesics|mesh-ancestor
153520024|NCT04979884|Sensory System Agents|sensory system agents|mesh-ancestor
153520025|NCT04979884|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153520026|NCT04971304|Lenograstim|lenograstim|mesh-list
153520027|NCT04971304|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153520028|NCT04971304|Immunologic Factors|immunologic factors|mesh-ancestor
153520029|NCT04971304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153520030|NCT04951115|Carboplatin|carboplatin|mesh-list
153520032|NCT04951115|Durvalumab|durvalumab|mesh-list
153520033|NCT04951115|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153520034|NCT04951115|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153520035|NCT04951115|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153520140|NCT06255886|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
153520141|NCT06255886|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153520142|NCT06255886|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
153520143|NCT06255886|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153520144|NCT06255886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153520145|NCT06255886|Chelating Agents|chelating agents|mesh-ancestor
153520146|NCT06255886|Sequestering Agents|sequestering agents|mesh-ancestor
153520147|NCT06255847|Cyclophosphamide|cyclophosphamide|mesh-list
153520148|NCT06255847|Pomalidomide|pomalidomide|mesh-list
153520149|NCT06255847|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153520150|NCT06255847|Immunologic Factors|immunologic factors|mesh-ancestor
153520151|NCT06255847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153520152|NCT06255847|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153520153|NCT06255847|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153520154|NCT06255847|Alkylating Agents|alkylating agents|mesh-ancestor
153520155|NCT06255847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153520156|NCT06255847|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153520157|NCT06255847|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153520158|NCT06255847|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153520159|NCT06255847|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153520160|NCT06255847|Growth Substances|growth substances|mesh-ancestor
153520161|NCT06255847|Growth Inhibitors|growth inhibitors|mesh-ancestor
153520162|NCT06255795|Pegaspargase|pegaspargase|mesh-list
153520163|NCT06255795|Antibodies|antibodies|mesh-list
153520164|NCT06255795|Immunologic Factors|immunologic factors|mesh-ancestor
153520165|NCT06255795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153520166|NCT06255795|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153520167|NCT06255743|Antibodies|antibodies|mesh-list
153520168|NCT06255743|Immunologic Factors|immunologic factors|mesh-ancestor
153520169|NCT06255743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153520170|NCT06255704|Zanubrutinib|zanubrutinib|mesh-list
153520171|NCT06255704|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153520172|NCT06255704|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153520173|NCT06255704|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153520180|NCT06255496|Coagulants|coagulants|mesh-ancestor
153520181|NCT06255392|Paclitaxel|paclitaxel|mesh-list
153520182|NCT06255392|Vinorelbine|vinorelbine|mesh-list
153520183|NCT06255392|Gemcitabine|gemcitabine|mesh-list
153520184|NCT06255392|Capecitabine|capecitabine|mesh-list
153520185|NCT06255392|Apatinib|apatinib|mesh-list
153520186|NCT06255392|Fluzoparib|fluzoparib|mesh-list
153520187|NCT06255392|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153520188|NCT06255392|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153520189|NCT06255392|Tubulin Modulators|tubulin modulators|mesh-ancestor
153520190|NCT06255392|Antimitotic Agents|antimitotic agents|mesh-ancestor
153520191|NCT06255392|Mitosis Modulators|mitosis modulators|mesh-ancestor
153520192|NCT06255392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153520193|NCT06255392|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153520195|NCT06255392|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153520196|NCT06255392|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153520197|NCT06255392|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
153520198|NCT06255262|Durvalumab|durvalumab|mesh-list
153520199|NCT06255262|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153520200|NCT06255262|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153520201|NCT06255223|Antibodies|antibodies|mesh-list
153520202|NCT06255223|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
153520203|NCT06255223|Immunologic Factors|immunologic factors|mesh-ancestor
153520204|NCT06255223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153520205|NCT06255210|Cyclophosphamide|cyclophosphamide|mesh-list
153520206|NCT06255210|Cisplatin|cisplatin|mesh-list
153520207|NCT06255210|Gemcitabine|gemcitabine|mesh-list
153520208|NCT06255210|Etoposide|etoposide|mesh-list
153520209|NCT06255210|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153520229|NCT06254131|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153520230|NCT06254131|Antipruritics|antipruritics|mesh-ancestor
153520231|NCT06254131|Dermatologic Agents|dermatologic agents|mesh-ancestor
153520232|NCT06254131|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
153520233|NCT06254131|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153520234|NCT06254131|Serotonin Agents|serotonin agents|mesh-ancestor
153520235|NCT06254131|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153520236|NCT06254131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153520237|NCT06253546|Olanzapine|olanzapine|mesh-list
153520238|NCT06253546|Antiemetics|antiemetics|mesh-ancestor
153520293|NCT06245564|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
153520294|NCT06245564|Antidepressive Agents|antidepressive agents|mesh-ancestor
153520295|NCT06245564|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153520296|NCT06245564|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153520297|NCT06245564|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
153520298|NCT06245564|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153520299|NCT06245564|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153520300|NCT06245564|Adrenergic Agents|adrenergic agents|mesh-ancestor
153520301|NCT06245564|Histamine Agonists|histamine agonists|mesh-ancestor
153520302|NCT06245564|Histamine Agents|histamine agents|mesh-ancestor
153520355|NCT06185933|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
153520356|NCT06185933|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153520357|NCT06185933|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153520358|NCT06185933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153520360|NCT06162949|Clarithromycin|clarithromycin|mesh-list
153520361|NCT06162949|Esomeprazole|esomeprazole|mesh-list
153520423|NCT06057519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153520424|NCT06057519|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
153520425|NCT06057519|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
153520426|NCT06057519|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
153520427|NCT06057519|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
153463591|NCT01459146|Lumefantrine|lumefantrine|mesh-list
153520489|NCT05964868|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
153520491|NCT05963139|Bupivacaine|bupivacaine|mesh-list
153520492|NCT05963139|Anesthetics, Local|anesthetics, local|mesh-ancestor
153520493|NCT05963139|Anesthetics|anesthetics|mesh-ancestor
153554413|NCT01597648|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153520494|NCT05963139|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153520495|NCT05963139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153520496|NCT05963139|Sensory System Agents|sensory system agents|mesh-ancestor
153520497|NCT05963139|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153520498|NCT05963139|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153520499|NCT05963139|Narcotics|narcotics|mesh-ancestor
153520500|NCT05963139|Analgesics|analgesics|mesh-ancestor
153520552|NCT05862545|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153520553|NCT05862545|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153520554|NCT05862545|Autonomic Agents|autonomic agents|mesh-ancestor
153520555|NCT05862545|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153520556|NCT05862545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153520557|NCT05862545|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153520558|NCT05862545|Respiratory System Agents|respiratory system agents|mesh-ancestor
153520559|NCT05862545|Glucocorticoids|glucocorticoids|mesh-ancestor
153520560|NCT05862545|Hormones|hormones|mesh-ancestor
153520561|NCT05862545|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153520562|NCT05862545|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
153520563|NCT05862545|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
153520564|NCT05862545|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153520613|NCT05813288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153520614|NCT05813288|Dopamine Agents|dopamine agents|mesh-ancestor
153520615|NCT05813288|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153520616|NCT05813288|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
153520687|NCT05735639|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
153520688|NCT05735639|Antithrombins|antithrombins|mesh-ancestor
153520689|NCT05735639|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
153520690|NCT05735639|Protease Inhibitors|protease inhibitors|mesh-ancestor
153520691|NCT05735639|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153520692|NCT05735639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153520693|NCT05735639|Anticoagulants|anticoagulants|mesh-ancestor
153520694|NCT05735639|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153520695|NCT05735639|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153520696|NCT05723055|Nivolumab|nivolumab|mesh-list
153520697|NCT05723055|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153520698|NCT05723055|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153520744|NCT05633654|Pembrolizumab|pembrolizumab|mesh-list
153520745|NCT05633654|Capecitabine|capecitabine|mesh-list
153520746|NCT05633654|Sacituzumab govitecan|sacituzumab govitecan|mesh-list
153520747|NCT05633654|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153520748|NCT05633654|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153520749|NCT05633654|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153520750|NCT05633654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153520751|NCT05633654|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153520752|NCT05633654|Antimetabolites|antimetabolites|mesh-ancestor
153520753|NCT05633654|Immunoconjugates|immunoconjugates|mesh-ancestor
153520754|NCT05633654|Immunologic Factors|immunologic factors|mesh-ancestor
153520755|NCT05633654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153520756|NCT05629585|Pembrolizumab|pembrolizumab|mesh-list
153520757|NCT05629585|Durvalumab|durvalumab|mesh-list
153520758|NCT05629585|Capecitabine|capecitabine|mesh-list
153520759|NCT05629585|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153520760|NCT05629585|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153520780|NCT05583188|Pemetrexed|pemetrexed|mesh-list
153520781|NCT05583188|Carboplatin|carboplatin|mesh-list
153520782|NCT05583188|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153520783|NCT05583188|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153520784|NCT05583188|Tubulin Modulators|tubulin modulators|mesh-ancestor
153520785|NCT05583188|Antimitotic Agents|antimitotic agents|mesh-ancestor
153520786|NCT05583188|Mitosis Modulators|mitosis modulators|mesh-ancestor
153520787|NCT05583188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153554420|NCT01597648|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153520788|NCT05583188|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153520789|NCT05583188|Antimetabolites|antimetabolites|mesh-ancestor
153520790|NCT05583188|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153520791|NCT05583188|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153807149|NCT00307502|Ritonavir|ritonavir|mesh-list
153520792|NCT05583188|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153520793|NCT05583188|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153520794|NCT05583188|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153520796|NCT05581030|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153520797|NCT05581030|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153520798|NCT05581030|Immunologic Factors|immunologic factors|mesh-ancestor
153520799|NCT05581030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153520800|NCT05581030|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153520801|NCT05569681|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
153520802|NCT05569681|Bemiparin|bemiparin|mesh-list
153520803|NCT05569681|Anticoagulants|anticoagulants|mesh-ancestor
153520804|NCT05569681|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153520805|NCT05569681|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153520806|NCT05569681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153520807|NCT05557591|Cemiplimab|cemiplimab|mesh-list
153520808|NCT05557591|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153520809|NCT05557591|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153520810|NCT05554679|Metformin|metformin|mesh-list
153520811|NCT05554679|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153520812|NCT05554679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153807220|NCT00338052|Estrogens|estrogens|mesh-ancestor
153520814|NCT05528718|Nitrous Oxide|nitrous oxide|mesh-list
153520815|NCT05528718|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153520816|NCT05528718|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153520818|NCT05528718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153520819|NCT05528718|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153520820|NCT05528718|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153520821|NCT05528718|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153520822|NCT05528718|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153520823|NCT05528718|Anesthetics, General|anesthetics, general|mesh-ancestor
153520824|NCT05528718|Anesthetics|anesthetics|mesh-ancestor
153520825|NCT05528718|GABA Modulators|gaba modulators|mesh-ancestor
153520826|NCT05528718|GABA Agents|gaba agents|mesh-ancestor
153520827|NCT05528718|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153520828|NCT05528718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153520829|NCT05528718|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
153520830|NCT05528718|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153520831|NCT05528718|Analgesics|analgesics|mesh-ancestor
153520832|NCT05528718|Sensory System Agents|sensory system agents|mesh-ancestor
153520833|NCT05528718|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153520834|NCT05526989|Niraparib|niraparib|mesh-list
153520835|NCT05526989|Dostarlimab|dostarlimab|mesh-list
153520836|NCT05526989|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
153520837|NCT05526989|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153520838|NCT05526989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153520839|NCT05526989|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153520840|NCT05513027|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
153520841|NCT05513027|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
153520842|NCT05513027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153520843|NCT05512962|Triamcinolone|triamcinolone|mesh-list
153520844|NCT05512962|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
153520845|NCT05512962|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
153520848|NCT05512962|Glucocorticoids|glucocorticoids|mesh-ancestor
153520864|NCT05504291|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153520865|NCT05504291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153520866|NCT05504291|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153520867|NCT05504291|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153520868|NCT05504291|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153520869|NCT05504291|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153520870|NCT05504291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153520872|NCT05504291|Antimitotic Agents|antimitotic agents|mesh-ancestor
153520873|NCT05504291|Mitosis Modulators|mitosis modulators|mesh-ancestor
153520874|NCT05504291|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153520875|NCT05504291|Alkylating Agents|alkylating agents|mesh-ancestor
153520876|NCT05504291|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153464009|NCT05586126|Anesthetics, General|anesthetics, general|mesh-ancestor
153520877|NCT05504291|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153520878|NCT05504291|Immunologic Factors|immunologic factors|mesh-ancestor
153520879|NCT05504291|Keratolytic Agents|keratolytic agents|mesh-ancestor
153520880|NCT05504291|Dermatologic Agents|dermatologic agents|mesh-ancestor
153520881|NCT05501704|Tamoxifen|tamoxifen|mesh-list
153520882|NCT05501704|Anastrozole|anastrozole|mesh-list
153520883|NCT05501704|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
153520884|NCT05501704|Hormone Antagonists|hormone antagonists|mesh-ancestor
153520885|NCT05501704|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153520886|NCT05501704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153520911|NCT05447520|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153520912|NCT05447520|Respiratory System Agents|respiratory system agents|mesh-ancestor
153520913|NCT05447520|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
153520914|NCT05447520|Hormone Antagonists|hormone antagonists|mesh-ancestor
153520915|NCT05447520|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153520916|NCT05447520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153520917|NCT05447520|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
153520918|NCT05447520|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
153520919|NCT05447520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153520920|NCT05438992|Bupivacaine|bupivacaine|mesh-list
153520921|NCT05438992|Anesthetics, Local|anesthetics, local|mesh-ancestor
153520922|NCT05438992|Anesthetics|anesthetics|mesh-ancestor
153520923|NCT05438992|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153520924|NCT05438992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153520925|NCT05438992|Sensory System Agents|sensory system agents|mesh-ancestor
153520926|NCT05438992|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153520927|NCT05412030|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
153520928|NCT05412030|Immunologic Factors|immunologic factors|mesh-ancestor
153520929|NCT05412030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153520930|NCT05405387|Budesonide|budesonide|mesh-list
153520931|NCT05405387|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153520932|NCT05405387|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153520933|NCT05405387|Autonomic Agents|autonomic agents|mesh-ancestor
153520934|NCT05405387|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153520935|NCT05405387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153520936|NCT05405387|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153520937|NCT05405387|Respiratory System Agents|respiratory system agents|mesh-ancestor
153520938|NCT05405387|Glucocorticoids|glucocorticoids|mesh-ancestor
153520939|NCT05405387|Hormones|hormones|mesh-ancestor
153520940|NCT05405387|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153520950|NCT05389995|Anticoagulants|anticoagulants|mesh-ancestor
153520951|NCT05389995|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
153520952|NCT05389995|Chelating Agents|chelating agents|mesh-ancestor
153520954|NCT05389995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153520955|NCT05389995|Diuretics|diuretics|mesh-ancestor
153520956|NCT05389995|Natriuretic Agents|natriuretic agents|mesh-ancestor
153520957|NCT05389995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153520958|NCT05389995|Expectorants|expectorants|mesh-ancestor
153520959|NCT05389995|Respiratory System Agents|respiratory system agents|mesh-ancestor
153520960|NCT05389995|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
153520961|NCT05389995|Sympathomimetics|sympathomimetics|mesh-ancestor
153520962|NCT05389995|Autonomic Agents|autonomic agents|mesh-ancestor
153520963|NCT05389995|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153520964|NCT05389995|Dopamine Agents|dopamine agents|mesh-ancestor
153520965|NCT05389995|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153520966|NCT05389995|Adrenergic Agents|adrenergic agents|mesh-ancestor
153520967|NCT05389995|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
153520968|NCT05389995|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153520969|NCT05389995|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153520970|NCT05389995|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
153520971|NCT05369351|Mirabegron|mirabegron|mesh-list
153520972|NCT05369351|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
153520973|NCT05369351|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
153520974|NCT05369351|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153520975|NCT05369351|Adrenergic Agents|adrenergic agents|mesh-ancestor
153520976|NCT05369351|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153520997|NCT05359861|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153520998|NCT05359861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153520999|NCT05340309|Atezolizumab|atezolizumab|mesh-list
153521000|NCT05340309|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
153521001|NCT05340309|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153521002|NCT05340309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153521003|NCT05340309|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153521004|NCT05340309|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153521005|NCT05340309|Immunologic Factors|immunologic factors|mesh-ancestor
153521006|NCT05340309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153521007|NCT05338671|Anesthetics|anesthetics|mesh-list
153521008|NCT05338671|Anesthetics, Local|anesthetics, local|mesh-list
153521009|NCT05338671|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153521010|NCT05338671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153521011|NCT05338671|Sensory System Agents|sensory system agents|mesh-ancestor
153521012|NCT05338671|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153521013|NCT05300048|Paclitaxel|paclitaxel|mesh-list
153521014|NCT05300048|Serabelisib|serabelisib|mesh-list
153521015|NCT05300048|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153521016|NCT05300048|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153521017|NCT05300048|Tubulin Modulators|tubulin modulators|mesh-ancestor
153521018|NCT05300048|Antimitotic Agents|antimitotic agents|mesh-ancestor
153521019|NCT05300048|Mitosis Modulators|mitosis modulators|mesh-ancestor
153521046|NCT05247788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153521047|NCT05226351|Dronabinol|dronabinol|mesh-list
153521048|NCT05226351|Hallucinogens|hallucinogens|mesh-ancestor
153521049|NCT05226351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153521050|NCT05226351|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153521051|NCT05226351|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153521052|NCT05226351|Analgesics|analgesics|mesh-ancestor
153521053|NCT05226351|Sensory System Agents|sensory system agents|mesh-ancestor
153521054|NCT05226351|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153521055|NCT05226351|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
153521056|NCT05226351|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
153521057|NCT05226351|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153521058|NCT05226351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153521059|NCT05226351|Hormones|hormones|mesh-ancestor
153521060|NCT05226351|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153521061|NCT05221320|Hydroxychloroquine|hydroxychloroquine|mesh-list
153521062|NCT05221320|Antimalarials|antimalarials|mesh-ancestor
153521063|NCT05221320|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153521064|NCT05221320|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153554524|NCT01597986|Antifungal Agents|antifungal agents|mesh-ancestor
153521065|NCT05221320|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153521066|NCT05221320|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153521067|NCT05221320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153521068|NCT05221320|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153521095|NCT05144984|Semaglutide|semaglutide|mesh-list
153521096|NCT05144984|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
153521097|NCT05144984|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153521098|NCT05144984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153521099|NCT04895579|Durvalumab|durvalumab|mesh-list
153521100|NCT04895579|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153521102|NCT04891770|Tenofovir|tenofovir|mesh-list
153521103|NCT04891770|Nivolumab|nivolumab|mesh-list
153521104|NCT04891770|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153521105|NCT04891770|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153521106|NCT04891770|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153521107|NCT04891770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153521108|NCT04891770|Antiviral Agents|antiviral agents|mesh-ancestor
153521109|NCT04891770|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153521110|NCT04891770|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153521111|NCT04891770|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153521112|NCT04891770|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153521113|NCT04891770|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153521114|NCT04891770|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153521115|NCT04874480|Decitabine|decitabine|mesh-list
153521116|NCT04874480|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153521145|NCT04858490|Diazepam|diazepam|mesh-list
153521146|NCT04858490|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153521147|NCT04858490|Anticonvulsants|anticonvulsants|mesh-ancestor
153521148|NCT04858490|Antiemetics|antiemetics|mesh-ancestor
153521149|NCT04858490|Autonomic Agents|autonomic agents|mesh-ancestor
153521150|NCT04858490|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153521151|NCT04858490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153521152|NCT04858490|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153521153|NCT04858490|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153521154|NCT04858490|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153521155|NCT04858490|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
153521156|NCT04858490|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
153521157|NCT04858490|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153521158|NCT04858490|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153521159|NCT04858490|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153521160|NCT04858490|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153521161|NCT04858490|Anesthetics, General|anesthetics, general|mesh-ancestor
153521162|NCT04858490|Anesthetics|anesthetics|mesh-ancestor
153521163|NCT04858490|GABA Modulators|gaba modulators|mesh-ancestor
153521164|NCT04858490|GABA Agents|gaba agents|mesh-ancestor
153521165|NCT04858490|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153521166|NCT04858490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153521167|NCT04808323|Capecitabine|capecitabine|mesh-list
153521168|NCT04808323|Oxaliplatin|oxaliplatin|mesh-list
153464313|NCT01763580|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
153521169|NCT04808323|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153521170|NCT04808323|Antimetabolites|antimetabolites|mesh-ancestor
153521171|NCT04808323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153521173|NCT04701333|Cabergoline|cabergoline|mesh-list
153521174|NCT04701333|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
153521175|NCT04701333|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
153521176|NCT04701333|Dopamine Agonists|dopamine agonists|mesh-ancestor
153521178|NCT04701333|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153521181|NCT04673617|Cyclophosphamide|cyclophosphamide|mesh-list
153521187|NCT04673617|Immunologic Factors|immunologic factors|mesh-ancestor
153521188|NCT04673617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153521189|NCT04673617|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153521190|NCT04673617|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153521191|NCT04673617|Alkylating Agents|alkylating agents|mesh-ancestor
153521192|NCT04673617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153521193|NCT04673617|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153521194|NCT04673617|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153521195|NCT04673617|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153521196|NCT04673617|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153521197|NCT04673617|Analgesics|analgesics|mesh-ancestor
153521198|NCT04673617|Sensory System Agents|sensory system agents|mesh-ancestor
153521199|NCT04673617|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153521210|NCT04626635|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153521211|NCT04626635|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153521212|NCT04570839|Nivolumab|nivolumab|mesh-list
153521213|NCT04570839|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153521214|NCT04570839|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153521215|NCT04570839|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153521216|NCT04570839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153521217|NCT04559074|Amlodipine|amlodipine|mesh-list
153808249|NCT00348231|Insulin|insulin|mesh-list
153521218|NCT04559074|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153521219|NCT04559074|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153521220|NCT04559074|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153521221|NCT04559074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153521222|NCT04559074|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153521223|NCT04559074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153521231|NCT04546009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153521233|NCT04546009|Hormone Antagonists|hormone antagonists|mesh-ancestor
153521234|NCT04546009|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153521235|NCT04546009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153521236|NCT04546009|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153521237|NCT04540211|Paclitaxel|paclitaxel|mesh-list
153521238|NCT04540211|Atezolizumab|atezolizumab|mesh-list
153521239|NCT04540211|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
153521240|NCT04540211|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153618913|NCT01980745|Anthelmintics|anthelmintics|mesh-ancestor
153618914|NCT01980810|Paclitaxel|paclitaxel|mesh-list
153521241|NCT04540211|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153521242|NCT04540211|Tubulin Modulators|tubulin modulators|mesh-ancestor
153521243|NCT04540211|Antimitotic Agents|antimitotic agents|mesh-ancestor
153521244|NCT04540211|Mitosis Modulators|mitosis modulators|mesh-ancestor
153808320|NCT00314405|Methylene Blue|methylene blue|mesh-list
153521245|NCT04540211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153521247|NCT04540211|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153521248|NCT04540211|Immunologic Factors|immunologic factors|mesh-ancestor
153521250|NCT04533737|Brodalumab|brodalumab|mesh-list
153521280|NCT04439357|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153521281|NCT04439357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153521283|NCT04439357|Protective Agents|protective agents|mesh-ancestor
153521284|NCT04439357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153521285|NCT04439357|Free Radical Scavengers|free radical scavengers|mesh-ancestor
153521286|NCT04439357|Antioxidants|antioxidants|mesh-ancestor
153554566|NCT01598337|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153521287|NCT04424303|Tofacitinib|tofacitinib|mesh-list
153521288|NCT04424303|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
153521289|NCT04424303|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153521290|NCT04424303|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153521291|NCT04424303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153521292|NCT04401995|Nivolumab|nivolumab|mesh-list
153521293|NCT04401995|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153521294|NCT04401995|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153521295|NCT04401995|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153521296|NCT04401995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153521297|NCT04354246|Pembrolizumab|pembrolizumab|mesh-list
153521298|NCT04354246|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153521299|NCT04354246|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153521300|NCT04354246|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153521301|NCT04354246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153521302|NCT04340882|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
153521326|NCT04338204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153521327|NCT04295408|Ropivacaine|ropivacaine|mesh-list
153521329|NCT04295408|Anesthetics|anesthetics|mesh-ancestor
153521330|NCT04295408|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153521331|NCT04295408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153521332|NCT04295408|Sensory System Agents|sensory system agents|mesh-ancestor
153521333|NCT04295408|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153521334|NCT04246086|Lenalidomide|lenalidomide|mesh-list
153521335|NCT04246086|Immunologic Factors|immunologic factors|mesh-ancestor
153521336|NCT04246086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153521337|NCT04246086|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153521338|NCT04246086|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153521339|NCT04246086|Growth Substances|growth substances|mesh-ancestor
153521340|NCT04246086|Growth Inhibitors|growth inhibitors|mesh-ancestor
153521341|NCT04246086|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153521343|NCT04231968|Antiviral Agents|antiviral agents|mesh-ancestor
153521344|NCT04231968|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153521345|NCT04169841|Durvalumab|durvalumab|mesh-list
153521346|NCT04169841|Olaparib|olaparib|mesh-list
153521347|NCT04169841|Tremelimumab|tremelimumab|mesh-list
153521348|NCT04169841|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153521349|NCT04169841|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153521350|NCT04169841|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
153521351|NCT04169841|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153521352|NCT04169841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153521353|NCT04165096|Acetaminophen|acetaminophen|mesh-list
153521354|NCT04165096|Diphenhydramine|diphenhydramine|mesh-list
153521355|NCT04165096|Promethazine|promethazine|mesh-list
153521356|NCT04165096|Pembrolizumab|pembrolizumab|mesh-list
153521357|NCT04165096|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153521358|NCT04165096|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153521368|NCT04165096|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153521369|NCT04165096|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153521371|NCT04165096|Anesthetics|anesthetics|mesh-ancestor
153521372|NCT04165096|Antiemetics|antiemetics|mesh-ancestor
153521373|NCT04165096|Autonomic Agents|autonomic agents|mesh-ancestor
153808762|NCT06158399|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153521374|NCT04165096|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153521375|NCT04165096|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
153521376|NCT04165096|Histamine Antagonists|histamine antagonists|mesh-ancestor
153521377|NCT04165096|Histamine Agents|histamine agents|mesh-ancestor
153521378|NCT04165096|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153521379|NCT04165096|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
153521380|NCT04165096|Antipruritics|antipruritics|mesh-ancestor
153521381|NCT04165096|Dermatologic Agents|dermatologic agents|mesh-ancestor
153521382|NCT04165083|Pembrolizumab|pembrolizumab|mesh-list
153521383|NCT04165083|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153521384|NCT04165083|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153521385|NCT04165083|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153521386|NCT04165083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153521387|NCT04165070|Paclitaxel|paclitaxel|mesh-list
153521388|NCT04165070|Carboplatin|carboplatin|mesh-list
153521389|NCT04165070|Pembrolizumab|pembrolizumab|mesh-list
153521390|NCT04165070|Pemetrexed|pemetrexed|mesh-list
153464538|NCT00056550|Anticoagulants|anticoagulants|mesh-ancestor
153521391|NCT04165070|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153521392|NCT04165070|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153521393|NCT04165070|Tubulin Modulators|tubulin modulators|mesh-ancestor
153521394|NCT04165070|Antimitotic Agents|antimitotic agents|mesh-ancestor
153521395|NCT04165070|Mitosis Modulators|mitosis modulators|mesh-ancestor
153521396|NCT04165070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153521397|NCT04165070|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153521398|NCT04165070|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153521399|NCT04165070|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153521400|NCT04165070|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153808812|NCT05965570|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153521401|NCT04165070|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153521404|NCT04162873|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153521406|NCT04162873|Sensory System Agents|sensory system agents|mesh-ancestor
153521407|NCT04162873|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153521408|NCT04162873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153521409|NCT04162873|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153521410|NCT04162873|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153521411|NCT04162873|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
153521412|NCT04162873|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153521413|NCT04162873|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153521414|NCT04162873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153521415|NCT04158258|Bevacizumab|bevacizumab|mesh-list
153521416|NCT04158258|Trastuzumab|trastuzumab|mesh-list
153521417|NCT04158258|Atezolizumab|atezolizumab|mesh-list
153521418|NCT04158258|Pertuzumab|pertuzumab|mesh-list
153521419|NCT04158258|Capecitabine|capecitabine|mesh-list
153521420|NCT04158258|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153521421|NCT04158258|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153521422|NCT04158258|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153521423|NCT04158258|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153521424|NCT04158258|Growth Substances|growth substances|mesh-ancestor
153521425|NCT04158258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153521426|NCT04158258|Growth Inhibitors|growth inhibitors|mesh-ancestor
153808956|NCT05590260|Iron|iron|mesh-list
153521427|NCT04158258|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153521428|NCT04158258|Antimetabolites|antimetabolites|mesh-ancestor
153521429|NCT04158258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153521430|NCT04158258|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153521431|NCT04143217|Viloxazine|viloxazine|mesh-list
153521432|NCT04143217|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
153521433|NCT04143217|Antidepressive Agents|antidepressive agents|mesh-ancestor
153521434|NCT04143217|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153521435|NCT04143217|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
153521447|NCT04111133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153521448|NCT03976063|Nifedipine|nifedipine|mesh-list
153521449|NCT03976063|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153521450|NCT03976063|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153521451|NCT03976063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153521452|NCT03976063|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153521453|NCT03976063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153521454|NCT03976063|Vasodilator Agents|vasodilator agents|mesh-ancestor
153521455|NCT03976063|Tocolytic Agents|tocolytic agents|mesh-ancestor
153521456|NCT03976063|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153521457|NCT03965130|Glucagon|glucagon|mesh-list
153521458|NCT03965130|Hormones|hormones|mesh-ancestor
153521459|NCT03965130|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153521460|NCT03965130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153618915|NCT01980810|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
153464612|NCT01897038|Sorafenib|sorafenib|mesh-list
153521461|NCT03965130|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153521462|NCT03941288|Cannabidiol|cannabidiol|mesh-list
153521463|NCT03941288|Anticonvulsants|anticonvulsants|mesh-ancestor
153521464|NCT03902951|Leuprolide|leuprolide|mesh-list
153521465|NCT03902951|Abiraterone Acetate|abiraterone acetate|mesh-list
153808998|NCT05413551|Isoniazid|isoniazid|mesh-list
153521467|NCT03902951|Fertility Agents|fertility agents|mesh-ancestor
153521468|NCT03902951|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153521469|NCT03902951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153521470|NCT03902951|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153521471|NCT03902951|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153521489|NCT03869437|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153521490|NCT03869437|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153521491|NCT03850782|Bimatoprost|bimatoprost|mesh-list
153521492|NCT03850782|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153521494|NCT03845075|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153521495|NCT03845075|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153521496|NCT03845075|Sympatholytics|sympatholytics|mesh-ancestor
153521497|NCT03845075|Autonomic Agents|autonomic agents|mesh-ancestor
153521498|NCT03845075|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153521499|NCT03845075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153521500|NCT03845075|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
153521501|NCT03845075|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
153521502|NCT03845075|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
153521504|NCT03845075|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153521505|NCT03845075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153521506|NCT03830918|Temozolomide|temozolomide|mesh-list
153521507|NCT03830918|Atezolizumab|atezolizumab|mesh-list
153521508|NCT03830918|Niraparib|niraparib|mesh-list
153521509|NCT03830918|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
153521510|NCT03830918|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153521511|NCT03830918|Alkylating Agents|alkylating agents|mesh-ancestor
153521512|NCT03830918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153521513|NCT03830918|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153521514|NCT03830918|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153521515|NCT03830918|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153521516|NCT03830918|Immunologic Factors|immunologic factors|mesh-ancestor
153618916|NCT01980810|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153521534|NCT03709758|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153521535|NCT03709758|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153521537|NCT03689946|Evolocumab|evolocumab|mesh-list
153809279|NCT04402073|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153521538|NCT03689946|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-list
153521539|NCT03689946|Fluorides|fluorides|mesh-list
153521540|NCT03689946|Sodium Fluoride|sodium fluoride|mesh-list
153521541|NCT03689946|Cariostatic Agents|cariostatic agents|mesh-ancestor
153521542|NCT03689946|Protective Agents|protective agents|mesh-ancestor
153521543|NCT03689946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153521544|NCT03689946|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
153521545|NCT03689946|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153521546|NCT03689946|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153521547|NCT03689946|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153521548|NCT03689946|Antimetabolites|antimetabolites|mesh-ancestor
153521549|NCT03689946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153521550|NCT03689946|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
153521551|NCT03689946|Protease Inhibitors|protease inhibitors|mesh-ancestor
153521552|NCT03689946|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153521553|NCT03689946|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153521554|NCT03667716|Nivolumab|nivolumab|mesh-list
153521555|NCT03667716|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153521556|NCT03667716|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153521557|NCT03667716|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153521558|NCT03667716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153521559|NCT03662659|Nivolumab|nivolumab|mesh-list
153521560|NCT03662659|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153521561|NCT03662659|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153521562|NCT03662659|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153521563|NCT03662659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153521564|NCT03646058|Buprenorphine|buprenorphine|mesh-list
153521578|NCT03623373|Rituximab|rituximab|mesh-list
153521579|NCT03623373|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
153521580|NCT03623373|Acalabrutinib|acalabrutinib|mesh-list
153521581|NCT03623373|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153521582|NCT03623373|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153521583|NCT03623373|Immunologic Factors|immunologic factors|mesh-ancestor
153521584|NCT03623373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153521585|NCT03623373|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153521586|NCT03623373|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153521587|NCT03623373|Antimetabolites|antimetabolites|mesh-ancestor
153521588|NCT03623373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153521589|NCT03623373|Antiviral Agents|antiviral agents|mesh-ancestor
153521590|NCT03623373|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153521591|NCT03623373|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153521592|NCT03623373|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153521593|NCT03623373|Alkylating Agents|alkylating agents|mesh-ancestor
153521594|NCT03623373|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153521595|NCT03623373|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153521596|NCT03623373|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153521598|NCT03601923|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
153521599|NCT03601923|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153521600|NCT03601923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153521627|NCT03475134|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153521629|NCT03475134|Sensory System Agents|sensory system agents|mesh-ancestor
153521630|NCT03475134|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153521631|NCT03412591|Suvorexant|suvorexant|mesh-list
153521632|NCT03412591|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
153521633|NCT03412591|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153521634|NCT03412591|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153521635|NCT03412591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153521636|NCT03412591|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
153521637|NCT03412591|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153521638|NCT03412591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153521640|NCT03400332|Ipilimumab|ipilimumab|mesh-list
153521641|NCT03400332|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153521642|NCT03400332|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153521643|NCT03400332|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153521644|NCT03400332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153521645|NCT03389477|Cisplatin|cisplatin|mesh-list
153521646|NCT03389477|Cetuximab|cetuximab|mesh-list
153521647|NCT03389477|Palbociclib|palbociclib|mesh-list
153521648|NCT03389477|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153521649|NCT03389477|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153521650|NCT03389477|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153521651|NCT03389477|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153521652|NCT03389477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153521653|NCT03310957|Pembrolizumab|pembrolizumab|mesh-list
153521654|NCT03310957|SGN-LIV1A|sgn-liv1a|mesh-list
153521655|NCT03310957|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153521656|NCT03310957|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153809833|NCT00349362|Androgens|androgens|mesh-ancestor
153521670|NCT03289039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153521671|NCT03289039|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153521672|NCT03289039|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153521673|NCT03289039|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153521674|NCT03289039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153521676|NCT03239899|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153521677|NCT03239899|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153554641|NCT01598649|Diuretics|diuretics|mesh-ancestor
153521678|NCT03239899|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153521679|NCT03239899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153521680|NCT03138512|Nivolumab|nivolumab|mesh-list
153521681|NCT03138512|Ipilimumab|ipilimumab|mesh-list
153521682|NCT03138512|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153521683|NCT03138512|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153521684|NCT03138512|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153521685|NCT03138512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153521686|NCT03137888|Temozolomide|temozolomide|mesh-list
153521687|NCT03137888|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153521688|NCT03137888|Alkylating Agents|alkylating agents|mesh-ancestor
153521689|NCT03137888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153521690|NCT03137888|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153521691|NCT03101319|Vitamin D|vitamin d|mesh-list
153521692|NCT03101319|Cholecalciferol|cholecalciferol|mesh-list
153521693|NCT03101319|Vitamins|vitamins|mesh-ancestor
153521694|NCT03101319|Micronutrients|micronutrients|mesh-ancestor
153521698|NCT03057106|Durvalumab|durvalumab|mesh-list
153521716|NCT02995330|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153521718|NCT02995330|Hormones|hormones|mesh-ancestor
153521719|NCT02995330|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153521720|NCT02995330|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153521722|NCT02935361|Atezolizumab|atezolizumab|mesh-list
153521723|NCT02935361|Guadecitabine|guadecitabine|mesh-list
153521724|NCT02935361|Azacitidine|azacitidine|mesh-list
153521725|NCT02935361|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
153521726|NCT02935361|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153521727|NCT02935361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153521728|NCT02935361|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153521729|NCT02935361|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153521730|NCT02935361|Immunologic Factors|immunologic factors|mesh-ancestor
153521731|NCT02935361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153521732|NCT02935361|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153521733|NCT02935361|Antimetabolites|antimetabolites|mesh-ancestor
153521734|NCT02935361|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153521735|NCT02864953|Glyburide|glyburide|mesh-list
153521736|NCT02864953|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153521737|NCT02864953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153521767|NCT02542852|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153521768|NCT02542852|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
153521769|NCT02542852|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
153521771|NCT02480803|Carbidopa|carbidopa|mesh-list
153521772|NCT02480803|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
153521773|NCT02480803|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
153521774|NCT02480803|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
153521775|NCT02480803|Dopamine Agents|dopamine agents|mesh-ancestor
153521776|NCT02480803|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153521777|NCT02480803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153521778|NCT02480803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153521779|NCT02480803|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
153521780|NCT02480803|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153521781|NCT02480803|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153521782|NCT02480803|Immunologic Factors|immunologic factors|mesh-ancestor
153521783|NCT02480803|Dopamine Agonists|dopamine agonists|mesh-ancestor
153521784|NCT02458014|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
153521785|NCT02458014|Blinatumomab|blinatumomab|mesh-list
153521786|NCT02458014|Antibodies|antibodies|mesh-list
153521787|NCT02458014|Immunoglobulins|immunoglobulins|mesh-list
153521788|NCT02458014|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
153521789|NCT02458014|Muromonab-CD3|muromonab-cd3|mesh-list
153521790|NCT02458014|Antibodies, Bispecific|antibodies, bispecific|mesh-list
153521791|NCT02458014|Immunologic Factors|immunologic factors|mesh-ancestor
153521792|NCT02458014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153521793|NCT02458014|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153521794|NCT02458014|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153521815|NCT02456857|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153554644|NCT01598649|Chelating Agents|chelating agents|mesh-ancestor
153521816|NCT02456857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153521817|NCT02456857|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
153521818|NCT02456857|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153521819|NCT02456857|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153521820|NCT02435849|Tisagenlecleucel|tisagenlecleucel|mesh-list
153521821|NCT02435849|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153521822|NCT02435849|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153521823|NCT02197234|Osimertinib|osimertinib|mesh-list
153521824|NCT02197234|Simvastatin|simvastatin|mesh-list
153521825|NCT02197234|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153521826|NCT02197234|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153521827|NCT02197234|Antimetabolites|antimetabolites|mesh-ancestor
153521828|NCT02197234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153521829|NCT02197234|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153521830|NCT02197234|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
153521831|NCT02197234|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153521832|NCT02197234|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153521833|NCT02197234|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153521834|NCT02197234|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153521835|NCT02168140|Thioctic Acid|thioctic acid|mesh-list
153521836|NCT02168140|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
153521837|NCT02168140|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153521838|NCT02168140|Alkylating Agents|alkylating agents|mesh-ancestor
153521839|NCT02168140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153521840|NCT02168140|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153521841|NCT02168140|Antioxidants|antioxidants|mesh-ancestor
153521842|NCT02168140|Protective Agents|protective agents|mesh-ancestor
153810350|NCT00346047|Analgesics|analgesics|mesh-ancestor
153521843|NCT02168140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153521844|NCT02168140|Vitamin B Complex|vitamin b complex|mesh-ancestor
153521857|NCT02114229|Carboplatin|carboplatin|mesh-list
153521858|NCT02114229|Methotrexate|methotrexate|mesh-list
153521859|NCT02114229|Etoposide|etoposide|mesh-list
153521860|NCT02114229|Etoposide phosphate|etoposide phosphate|mesh-list
153521861|NCT02114229|Vincristine|vincristine|mesh-list
153521862|NCT02114229|Topotecan|topotecan|mesh-list
153521863|NCT02114229|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153521864|NCT02114229|Immunologic Factors|immunologic factors|mesh-ancestor
153521865|NCT02114229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153521866|NCT02114229|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153521867|NCT02114229|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153521868|NCT02114229|Alkylating Agents|alkylating agents|mesh-ancestor
153521869|NCT02114229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153521870|NCT02114229|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153521871|NCT02114229|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153521872|NCT02114229|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
153810450|NCT00319319|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153521874|NCT02114229|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153521875|NCT02114229|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153521876|NCT02114229|Antimetabolites|antimetabolites|mesh-ancestor
153521877|NCT02114229|Dermatologic Agents|dermatologic agents|mesh-ancestor
153521878|NCT02114229|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153521879|NCT02114229|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153521880|NCT02114229|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153521881|NCT02114229|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153521882|NCT02114229|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153521883|NCT02114229|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153521884|NCT02114229|Tubulin Modulators|tubulin modulators|mesh-ancestor
153521885|NCT02114229|Antimitotic Agents|antimitotic agents|mesh-ancestor
153521886|NCT02114229|Mitosis Modulators|mitosis modulators|mesh-ancestor
153521887|NCT02114229|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
153521888|NCT02106572|Viscum album peptide|viscum album peptide|mesh-list
153521889|NCT02106572|Mitomycins|mitomycins|mesh-list
153521899|NCT02106572|Antiviral Agents|antiviral agents|mesh-ancestor
153521900|NCT02106572|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153521901|NCT02075840|Crizotinib|crizotinib|mesh-list
153521902|NCT02075840|Alectinib|alectinib|mesh-list
153521903|NCT02075840|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153521904|NCT02075840|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153521905|NCT02075840|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153521906|NCT02075840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153521907|NCT02075840|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153521908|NCT02073994|Ivosidenib|ivosidenib|mesh-list
153521909|NCT02073994|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153521910|NCT02073994|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153521911|NCT02073994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153521912|NCT02048813|Cyclophosphamide|cyclophosphamide|mesh-list
153521914|NCT02048813|Fludarabine|fludarabine|mesh-list
153521915|NCT02048813|Fludarabine phosphate|fludarabine phosphate|mesh-list
153521916|NCT02048813|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
153521917|NCT02048813|Antibodies|antibodies|mesh-list
153521918|NCT02048813|Immunoglobulins|immunoglobulins|mesh-list
153521919|NCT02048813|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
153521920|NCT02048813|Ibrutinib|ibrutinib|mesh-list
153521921|NCT02048813|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153521922|NCT02048813|Immunologic Factors|immunologic factors|mesh-ancestor
153521923|NCT02048813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153521924|NCT02048813|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153521925|NCT02048813|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153521926|NCT02048813|Alkylating Agents|alkylating agents|mesh-ancestor
153521927|NCT02048813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153521948|NCT02029001|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
153521949|NCT02029001|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153521950|NCT02029001|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153521951|NCT02029001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153521952|NCT02029001|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153521953|NCT02029001|Immunologic Factors|immunologic factors|mesh-ancestor
153521954|NCT02029001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153521955|NCT02029001|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153521956|NCT02029001|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153521957|NCT02029001|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
153521958|NCT02029001|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153521960|NCT01615731|Misoprostol|misoprostol|mesh-list
153521961|NCT01615731|Mifepristone|mifepristone|mesh-list
153521962|NCT01615731|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
153521963|NCT01615731|Abortifacient Agents|abortifacient agents|mesh-ancestor
153521964|NCT01615731|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153521965|NCT01615731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153521966|NCT01615731|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
153521967|NCT01615731|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153521968|NCT01615731|Oxytocics|oxytocics|mesh-ancestor
153521969|NCT01615731|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153521970|NCT01615731|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
153521971|NCT01615731|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153521972|NCT01615731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153521973|NCT01615731|Protective Agents|protective agents|mesh-ancestor
153521974|NCT01615731|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
153521975|NCT01615731|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
153521976|NCT01615731|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
153521977|NCT01615731|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
153521978|NCT01615731|Contraceptive Agents|contraceptive agents|mesh-ancestor
153521979|NCT01615731|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
153521986|NCT01589302|Ibrutinib|ibrutinib|mesh-list
153521987|NCT01589302|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-list
153521988|NCT01589302|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153521990|NCT01589302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153521991|NCT01479842|Rituximab|rituximab|mesh-list
153521992|NCT01479842|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
153521993|NCT01479842|Ibrutinib|ibrutinib|mesh-list
153521994|NCT01479842|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-list
153521995|NCT01479842|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153521996|NCT01479842|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153521997|NCT01479842|Immunologic Factors|immunologic factors|mesh-ancestor
153521998|NCT01479842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153522000|NCT01479842|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153522001|NCT01479842|Alkylating Agents|alkylating agents|mesh-ancestor
153522002|NCT01479842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153522003|NCT01479842|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153522004|NCT01479842|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153522005|NCT01345136|Everolimus|everolimus|mesh-list
153522006|NCT01345136|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
153522007|NCT01345136|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153522008|NCT01345136|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153522009|NCT01345136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153522010|NCT01345136|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153522011|NCT01345136|Immunologic Factors|immunologic factors|mesh-ancestor
153522012|NCT01345136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153522013|NCT01345136|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153522014|NCT00521846|Cimetidine|cimetidine|mesh-list
153522015|NCT00521846|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
153522016|NCT00521846|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153522017|NCT00521846|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
153522026|NCT04932980|Aflibercept|aflibercept|mesh-list
153522027|NCT04932980|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153522029|NCT04932980|Growth Substances|growth substances|mesh-ancestor
153522030|NCT04932980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153522031|NCT04932980|Growth Inhibitors|growth inhibitors|mesh-ancestor
153522032|NCT04932980|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153522033|NCT04927390|Mycophenolic Acid|mycophenolic acid|mesh-list
153522034|NCT04927390|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153522035|NCT04927390|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153522036|NCT04927390|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
153522037|NCT04927390|Antitubercular Agents|antitubercular agents|mesh-ancestor
153522038|NCT04927390|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153522039|NCT04927390|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153522040|NCT04927390|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153522041|NCT04927390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153522042|NCT04910711|Dolutegravir|dolutegravir|mesh-list
153522043|NCT04910711|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
153522044|NCT04910711|Levonorgestrel|levonorgestrel|mesh-list
153522045|NCT04910711|Medroxyprogesterone|medroxyprogesterone|mesh-list
153522046|NCT04910711|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
153522049|NCT04910711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153522050|NCT04910711|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
153522070|NCT04909333|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
153522071|NCT04909333|Incretins|incretins|mesh-ancestor
153522072|NCT04909333|Hormones|hormones|mesh-ancestor
153522073|NCT04909333|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153522074|NCT04897958|Leuprolide|leuprolide|mesh-list
153522075|NCT04897958|Fertility Agents, Female|fertility agents, female|mesh-ancestor
153522076|NCT04897958|Fertility Agents|fertility agents|mesh-ancestor
153522077|NCT04897958|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153522078|NCT04897958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153522079|NCT04897958|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153522080|NCT04897958|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153522081|NCT04892758|Mometasone Furoate|mometasone furoate|mesh-list
153522082|NCT04892758|Formoterol Fumarate|formoterol fumarate|mesh-list
153522083|NCT04892758|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153522084|NCT04892758|Autonomic Agents|autonomic agents|mesh-ancestor
153522085|NCT04892758|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153522086|NCT04892758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153522087|NCT04892758|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153522088|NCT04892758|Respiratory System Agents|respiratory system agents|mesh-ancestor
153522089|NCT04892758|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
153522090|NCT04892758|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
153522091|NCT04892758|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153522092|NCT04892758|Adrenergic Agents|adrenergic agents|mesh-ancestor
153522093|NCT04892758|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153522094|NCT04892758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153522095|NCT04892758|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153522096|NCT04892758|Dermatologic Agents|dermatologic agents|mesh-ancestor
153522097|NCT04892758|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
153522115|NCT04892732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153522116|NCT04879420|Teriparatide|teriparatide|mesh-list
153522117|NCT04879420|Risedronic Acid|risedronic acid|mesh-list
153522118|NCT04879420|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153522119|NCT04879420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153522120|NCT04879420|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153522121|NCT04879420|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153522122|NCT04879420|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153522123|NCT04879420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153522124|NCT04849910|Gemtuzumab|gemtuzumab|mesh-list
153522125|NCT04849910|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153618918|NCT01980810|Tubulin Modulators|tubulin modulators|mesh-ancestor
153522126|NCT04849910|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153522127|NCT04849910|Immunotoxins|immunotoxins|mesh-ancestor
153522128|NCT04849910|Immunoconjugates|immunoconjugates|mesh-ancestor
153522129|NCT04849910|Immunologic Factors|immunologic factors|mesh-ancestor
153522130|NCT04849910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153522131|NCT04848519|Pembrolizumab|pembrolizumab|mesh-list
153522133|NCT04848519|Avelumab|avelumab|mesh-list
153522134|NCT04848519|Propranolol|propranolol|mesh-list
153522135|NCT04848519|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153522136|NCT04848519|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153522140|NCT04848519|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
153522167|NCT06040489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153522168|NCT06040489|Vasodilator Agents|vasodilator agents|mesh-ancestor
153522169|NCT06040489|Free Radical Scavengers|free radical scavengers|mesh-ancestor
153522170|NCT06040489|Antioxidants|antioxidants|mesh-ancestor
153522171|NCT06040489|Amebicides|amebicides|mesh-ancestor
153522172|NCT06040489|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153522173|NCT06040489|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153522174|NCT06040489|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153522175|NCT06040489|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153522176|NCT06040489|Antifungal Agents|antifungal agents|mesh-ancestor
153522177|NCT06040489|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153522179|NCT06040112|Anesthetics, Local|anesthetics, local|mesh-ancestor
153522180|NCT06040112|Anesthetics|anesthetics|mesh-ancestor
153522181|NCT06040112|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153522182|NCT06040112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153522183|NCT06040112|Sensory System Agents|sensory system agents|mesh-ancestor
153522223|NCT06039592|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153522225|NCT06039540|Captopril|captopril|mesh-list
153522226|NCT06039540|Torsemide|torsemide|mesh-list
153522227|NCT06039540|Spironolactone|spironolactone|mesh-list
153522229|NCT06039540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153522230|NCT06039540|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153522232|NCT06039540|Sympatholytics|sympatholytics|mesh-ancestor
153522233|NCT06039540|Autonomic Agents|autonomic agents|mesh-ancestor
153522234|NCT06039540|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153522235|NCT06039540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153522236|NCT06039540|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
153522237|NCT06039540|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
153522238|NCT06039540|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
153522239|NCT06039540|Adrenergic Agents|adrenergic agents|mesh-ancestor
153522240|NCT06039540|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153522241|NCT06039540|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
153522242|NCT06039540|Hormone Antagonists|hormone antagonists|mesh-ancestor
153522243|NCT06039540|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153522244|NCT06039540|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
153522245|NCT06039540|Diuretics|diuretics|mesh-ancestor
153522246|NCT06039540|Natriuretic Agents|natriuretic agents|mesh-ancestor
153522273|NCT06039280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153522274|NCT06039280|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153522275|NCT06039280|Glucocorticoids|glucocorticoids|mesh-ancestor
153522276|NCT06039280|Hormones|hormones|mesh-ancestor
153465438|NCT00224952|Analgesics|analgesics|mesh-ancestor
153522277|NCT06039280|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153522278|NCT06039280|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153522279|NCT06039280|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153522280|NCT06039280|Antiviral Agents|antiviral agents|mesh-ancestor
153522281|NCT06039280|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153522282|NCT06039280|Expectorants|expectorants|mesh-ancestor
153522283|NCT06039280|Respiratory System Agents|respiratory system agents|mesh-ancestor
153522284|NCT06039280|Free Radical Scavengers|free radical scavengers|mesh-ancestor
153522285|NCT06039280|Antioxidants|antioxidants|mesh-ancestor
153522286|NCT06039280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153522287|NCT06039280|Protective Agents|protective agents|mesh-ancestor
153522288|NCT06039280|Antidotes|antidotes|mesh-ancestor
153522290|NCT06039202|Bevacizumab|bevacizumab|mesh-list
153522291|NCT06039202|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153522292|NCT06039202|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153522293|NCT06039202|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153522294|NCT06039202|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153522295|NCT06039202|Growth Substances|growth substances|mesh-ancestor
153522296|NCT06039202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153522297|NCT06039202|Growth Inhibitors|growth inhibitors|mesh-ancestor
153522298|NCT06039202|Antimetabolites|antimetabolites|mesh-ancestor
153522299|NCT06039202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153522317|NCT06038552|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153522318|NCT06038552|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153522319|NCT06038552|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153522320|NCT06038552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153522321|NCT06038552|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153522322|NCT06037811|Prednisone|prednisone|mesh-list
153522323|NCT06037811|Adalimumab|adalimumab|mesh-list
153522324|NCT06037811|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153522325|NCT06037811|Glucocorticoids|glucocorticoids|mesh-ancestor
153522326|NCT06037811|Hormones|hormones|mesh-ancestor
153522327|NCT06037811|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153522328|NCT06037811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153522329|NCT06037811|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153522330|NCT06037811|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153522331|NCT06037811|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
153522333|NCT06037434|Metoprolol|metoprolol|mesh-list
153522334|NCT06037434|Captopril|captopril|mesh-list
153522335|NCT06037434|Torsemide|torsemide|mesh-list
153522336|NCT06037434|Spironolactone|spironolactone|mesh-list
153522337|NCT06037434|Potassium Citrate|potassium citrate|mesh-list
153522338|NCT06037434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153522339|NCT06037434|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153522340|NCT06037434|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153522341|NCT06037434|Sympatholytics|sympatholytics|mesh-ancestor
153522342|NCT06037434|Autonomic Agents|autonomic agents|mesh-ancestor
153522343|NCT06037434|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153522344|NCT06037434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153522345|NCT06037434|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
153522346|NCT06037434|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
153522347|NCT06037434|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
153618919|NCT01980810|Antimitotic Agents|antimitotic agents|mesh-ancestor
153522348|NCT06037434|Adrenergic Agents|adrenergic agents|mesh-ancestor
153522349|NCT06037434|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153522354|NCT06037434|Diuretics|diuretics|mesh-ancestor
153522355|NCT06037434|Natriuretic Agents|natriuretic agents|mesh-ancestor
153522356|NCT06037434|Expectorants|expectorants|mesh-ancestor
153554689|NCT01599013|Antimetabolites|antimetabolites|mesh-ancestor
153522357|NCT06037434|Respiratory System Agents|respiratory system agents|mesh-ancestor
153522358|NCT06037434|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
153522359|NCT06037434|Protease Inhibitors|protease inhibitors|mesh-ancestor
153522360|NCT06037434|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153522361|NCT06037434|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
153522362|NCT06037434|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153522363|NCT06035523|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
153522364|NCT06035523|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153522365|NCT06031740|Polidocanol|polidocanol|mesh-list
153522366|NCT06031740|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
153522367|NCT06031740|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
153522368|NCT06010927|Midazolam|midazolam|mesh-list
153522369|NCT06010927|Ketamine|ketamine|mesh-list
153522370|NCT06010927|Analgesics|analgesics|mesh-ancestor
153522371|NCT06010927|Sensory System Agents|sensory system agents|mesh-ancestor
153522372|NCT06010927|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153522373|NCT06010927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153522374|NCT06010927|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
153522375|NCT06010927|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153522376|NCT06010927|Anesthetics, General|anesthetics, general|mesh-ancestor
153522378|NCT06010927|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153522379|NCT06010927|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
153522380|NCT06010927|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
153522381|NCT06010927|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153522383|NCT06010927|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153522400|NCT05810649|Hyaluronic Acid|hyaluronic acid|mesh-list
153522401|NCT05810649|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153522402|NCT05810649|Immunologic Factors|immunologic factors|mesh-ancestor
153522403|NCT05810649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153522404|NCT05810649|Viscosupplements|viscosupplements|mesh-ancestor
153522405|NCT05810649|Protective Agents|protective agents|mesh-ancestor
153522406|NCT05799326|Levofloxacin|levofloxacin|mesh-list
153522407|NCT05799326|Ofloxacin|ofloxacin|mesh-list
153522408|NCT05799326|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
153522409|NCT05799326|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153522411|NCT05799326|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153522412|NCT05799326|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153522413|NCT05799326|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153522414|NCT05799326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153522415|NCT05799326|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153522416|NCT05799326|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
153522417|NCT05799326|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153522418|NCT05775731|Hemostatics|hemostatics|mesh-list
153522419|NCT05775731|Coagulants|coagulants|mesh-ancestor
153522420|NCT05710783|Vaccines|vaccines|mesh-list
153522421|NCT05710783|Immunologic Factors|immunologic factors|mesh-ancestor
153522422|NCT05710783|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153522423|NCT05696847|Tirzepatide|tirzepatide|mesh-list
153522424|NCT05696847|Incretins|incretins|mesh-ancestor
153522425|NCT05696847|Hormones|hormones|mesh-ancestor
153522426|NCT05696847|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153522427|NCT05696847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153522428|NCT05679492|Meplazumab|meplazumab|mesh-list
153522429|NCT05679492|Antiviral Agents|antiviral agents|mesh-ancestor
153522430|NCT05679492|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153522431|NCT05548985|Midodrine|midodrine|mesh-list
153522454|NCT05473741|Risperidone|risperidone|mesh-list
153522455|NCT05473741|Aripiprazole|aripiprazole|mesh-list
153522456|NCT05473741|Paliperidone Palmitate|paliperidone palmitate|mesh-list
153522457|NCT05473741|Antipsychotic Agents|antipsychotic agents|mesh-list
153522458|NCT05473741|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153522459|NCT05473741|Serotonin Agents|serotonin agents|mesh-ancestor
153522460|NCT05473741|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153522461|NCT05473741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153522462|NCT05473741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153554702|NCT01599117|Udenafil|udenafil|mesh-list
153522463|NCT05473741|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153522464|NCT05473741|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153522465|NCT05473741|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153522466|NCT05473741|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
153522467|NCT05473741|Dopamine Agents|dopamine agents|mesh-ancestor
153522468|NCT05473741|Antidepressive Agents|antidepressive agents|mesh-ancestor
153522469|NCT05473741|Dopamine Agonists|dopamine agonists|mesh-ancestor
153522470|NCT05473741|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
153522471|NCT05473741|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
153522472|NCT05473741|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
153522473|NCT05473741|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
153522475|NCT05435053|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153522480|NCT05433116|Lenvatinib|lenvatinib|mesh-list
153522483|NCT05433116|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153522484|NCT05433116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153522485|NCT05433116|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153522486|NCT05433116|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153522487|NCT05401214|Prednisone|prednisone|mesh-list
153522488|NCT05401214|Prednisolone|prednisolone|mesh-list
153522489|NCT05401214|Abiraterone Acetate|abiraterone acetate|mesh-list
153522490|NCT05401214|Niraparib|niraparib|mesh-list
153522491|NCT05401214|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153522492|NCT05401214|Glucocorticoids|glucocorticoids|mesh-ancestor
153522493|NCT05401214|Hormones|hormones|mesh-ancestor
153522494|NCT05401214|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153522495|NCT05401214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153522496|NCT05401214|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153522497|NCT05401214|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153522498|NCT05401214|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153522499|NCT05401214|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153522500|NCT05401214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153522501|NCT05401214|Hormone Antagonists|hormone antagonists|mesh-ancestor
153522502|NCT05401214|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153522503|NCT05401214|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
153522504|NCT05373212|Insulin Lispro|insulin lispro|mesh-list
153522505|NCT05373212|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153522506|NCT05373212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153522507|NCT05373199|Insulin Lispro|insulin lispro|mesh-list
153522508|NCT05373199|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153522509|NCT05373199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153522511|NCT05353361|Pertuzumab|pertuzumab|mesh-list
153522512|NCT05353361|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153522526|NCT05284214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153522527|NCT05168163|Atezolizumab|atezolizumab|mesh-list
153522528|NCT05168163|Lenvatinib|lenvatinib|mesh-list
153522529|NCT05168163|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
153522530|NCT05168163|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153522531|NCT05168163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153522532|NCT05168163|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153522533|NCT05168163|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153522534|NCT05168163|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153522535|NCT05168163|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153522536|NCT05168163|Immunologic Factors|immunologic factors|mesh-ancestor
153522537|NCT05168163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153522538|NCT05122182|Propagermanium|propagermanium|mesh-list
153522539|NCT05122182|Candesartan|candesartan|mesh-list
153522540|NCT05122182|Candesartan cilexetil|candesartan cilexetil|mesh-list
153417265|NCT02226198|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153554708|NCT01599130|Entecavir|entecavir|mesh-list
153522543|NCT05122182|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
153522544|NCT05122182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153522545|NCT05122182|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153522546|NCT05122182|Interferon Inducers|interferon inducers|mesh-ancestor
153522547|NCT05122182|Immunologic Factors|immunologic factors|mesh-ancestor
153522548|NCT05122182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153522549|NCT05113784|Meplazumab|meplazumab|mesh-list
153522550|NCT05113784|Antiviral Agents|antiviral agents|mesh-ancestor
153522551|NCT05113784|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153522552|NCT05113186|Lenvatinib|lenvatinib|mesh-list
153522577|NCT04826900|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153522578|NCT04826900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153522579|NCT04826900|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
153522580|NCT04826900|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153522581|NCT04826900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153522583|NCT04826900|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153522584|NCT04819906|Moxifloxacin|moxifloxacin|mesh-list
153522585|NCT04819906|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153522586|NCT04819906|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153522587|NCT04819906|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153522588|NCT04819906|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153522589|NCT04819906|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153522590|NCT04819906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153522591|NCT04819906|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153522593|NCT04809766|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
153522595|NCT04809766|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153522596|NCT04809766|Immunologic Factors|immunologic factors|mesh-ancestor
153522597|NCT04809766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153522598|NCT04809766|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153522599|NCT04809766|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153522600|NCT04809766|Alkylating Agents|alkylating agents|mesh-ancestor
153522601|NCT04809766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153522602|NCT04809766|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153522603|NCT04809766|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153522618|NCT04735926|Calcifediol|calcifediol|mesh-list
153522619|NCT04735926|Vitamins|vitamins|mesh-ancestor
153522620|NCT04735926|Micronutrients|micronutrients|mesh-ancestor
153522621|NCT04735926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153522622|NCT04735926|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153522623|NCT04595825|Antibodies|antibodies|mesh-list
153522624|NCT04595825|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
153522625|NCT04595825|Immunologic Factors|immunologic factors|mesh-ancestor
153522626|NCT04595825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153522627|NCT04594772|Paclitaxel|paclitaxel|mesh-list
153522628|NCT04594772|Gemcitabine|gemcitabine|mesh-list
153522629|NCT04594772|Fluorouracil|fluorouracil|mesh-list
153522630|NCT04594772|Oxaliplatin|oxaliplatin|mesh-list
153522631|NCT04594772|Irinotecan|irinotecan|mesh-list
153522632|NCT04594772|Folfirinox|folfirinox|mesh-list
153522633|NCT04594772|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153522634|NCT04594772|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153522635|NCT04594772|Tubulin Modulators|tubulin modulators|mesh-ancestor
153522636|NCT04594772|Antimitotic Agents|antimitotic agents|mesh-ancestor
153522637|NCT04594772|Mitosis Modulators|mitosis modulators|mesh-ancestor
153522638|NCT04594772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153522639|NCT04594772|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153522640|NCT04594772|Antimetabolites|antimetabolites|mesh-ancestor
153522658|NCT04561206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153522660|NCT04536363|Alprostadil|alprostadil|mesh-list
153522661|NCT04536363|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153522662|NCT04536363|Vasodilator Agents|vasodilator agents|mesh-ancestor
153522663|NCT04536363|Urological Agents|urological agents|mesh-ancestor
153522664|NCT04481919|Diuretics|diuretics|mesh-list
153522665|NCT04481919|Natriuretic Agents|natriuretic agents|mesh-ancestor
153522666|NCT04481919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153522667|NCT04427306|Talimogene laherparepvec|talimogene laherparepvec|mesh-list
153522668|NCT04427306|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153522669|NCT04427306|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153522670|NCT04421222|Abiraterone Acetate|abiraterone acetate|mesh-list
153522671|NCT04421222|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153522672|NCT04421222|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153522673|NCT04421222|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153522674|NCT04421222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153522676|NCT04421222|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153522677|NCT04421222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153522678|NCT04421222|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153522679|NCT04421079|Resveratrol|resveratrol|mesh-list
153522680|NCT04421079|Antioxidants|antioxidants|mesh-ancestor
153522682|NCT04421079|Protective Agents|protective agents|mesh-ancestor
153522704|NCT04225988|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
153522705|NCT04225988|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153522706|NCT04225988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153522707|NCT04023253|Solifenacin Succinate|solifenacin succinate|mesh-list
153522708|NCT04023253|Mirabegron|mirabegron|mesh-list
153522710|NCT04023253|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
153522711|NCT04023253|Cholinergic Agents|cholinergic agents|mesh-ancestor
153522712|NCT04023253|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153522713|NCT04023253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153522714|NCT04023253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153522715|NCT04023253|Urological Agents|urological agents|mesh-ancestor
153522716|NCT04023253|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
153522717|NCT04023253|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
153522718|NCT04023253|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153522719|NCT04023253|Adrenergic Agents|adrenergic agents|mesh-ancestor
153522720|NCT04007029|Cyclophosphamide|cyclophosphamide|mesh-list
153522721|NCT04007029|Fludarabine|fludarabine|mesh-list
153522722|NCT04007029|Fludarabine phosphate|fludarabine phosphate|mesh-list
153465889|NCT00134004|Mycophenolic Acid|mycophenolic acid|mesh-list
153522723|NCT04007029|Immunoglobulins|immunoglobulins|mesh-list
153522724|NCT04007029|Immunoglobulin G|immunoglobulin g|mesh-list
153522725|NCT04007029|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153522726|NCT04007029|Immunologic Factors|immunologic factors|mesh-ancestor
153522727|NCT04007029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153522728|NCT04007029|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153522729|NCT04007029|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153522730|NCT04007029|Alkylating Agents|alkylating agents|mesh-ancestor
153522731|NCT04007029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153522732|NCT04007029|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153522733|NCT04007029|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153522734|NCT04007029|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153522737|NCT03887650|Epinephrine|epinephrine|mesh-list
153522738|NCT03887650|Bupivacaine|bupivacaine|mesh-list
153522739|NCT03887650|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153522740|NCT03887650|Antiemetics|antiemetics|mesh-ancestor
153522741|NCT03887650|Autonomic Agents|autonomic agents|mesh-ancestor
153522742|NCT03887650|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153522743|NCT03887650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153522744|NCT03887650|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153522745|NCT03887650|Glucocorticoids|glucocorticoids|mesh-ancestor
153522747|NCT03887650|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153522748|NCT03887650|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153522749|NCT03887650|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153554754|NCT05691088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153522750|NCT03887650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153522751|NCT03887650|Anesthetics, Local|anesthetics, local|mesh-ancestor
153522752|NCT03887650|Anesthetics|anesthetics|mesh-ancestor
153522753|NCT03887650|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153522754|NCT03887650|Sensory System Agents|sensory system agents|mesh-ancestor
153522755|NCT03887650|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153522756|NCT03887650|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153417346|NCT04737980|Hormones|hormones|mesh-ancestor
153522758|NCT03887650|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153522759|NCT03887650|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
153522760|NCT03887650|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153522761|NCT03887650|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153522762|NCT03887650|Respiratory System Agents|respiratory system agents|mesh-ancestor
153522763|NCT03887650|Mydriatics|mydriatics|mesh-ancestor
153522764|NCT03887650|Sympathomimetics|sympathomimetics|mesh-ancestor
153522765|NCT03887650|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
153522766|NCT03854500|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
153522767|NCT03854500|Tenecteplase|tenecteplase|mesh-list
153522768|NCT03854500|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153522769|NCT03854500|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153522770|NCT03854500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153522771|NCT03783949|Paclitaxel|paclitaxel|mesh-list
153522772|NCT03783949|Carboplatin|carboplatin|mesh-list
153522773|NCT03783949|Gemcitabine|gemcitabine|mesh-list
153522774|NCT03783949|Niraparib|niraparib|mesh-list
153522776|NCT03783949|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153522779|NCT03783949|Mitosis Modulators|mitosis modulators|mesh-ancestor
153522780|NCT03783949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153522781|NCT03783949|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153522782|NCT03783949|Antimetabolites|antimetabolites|mesh-ancestor
153522783|NCT03783949|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
153522784|NCT03783949|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153522785|NCT03699254|Valganciclovir|valganciclovir|mesh-list
153522786|NCT03699254|Ganciclovir|ganciclovir|mesh-list
153522787|NCT03699254|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
153522788|NCT03699254|Antiviral Agents|antiviral agents|mesh-ancestor
153522789|NCT03699254|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153522790|NCT03699254|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153522791|NCT03699254|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153522792|NCT03699254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153522793|NCT03522246|Nivolumab|nivolumab|mesh-list
153522794|NCT03522246|Rucaparib|rucaparib|mesh-list
153522795|NCT03522246|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153522796|NCT03522246|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153522797|NCT03522246|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153522798|NCT03522246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153522799|NCT03522246|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
153522800|NCT03522246|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153522801|NCT03513328|Thiotepa|thiotepa|mesh-list
153522802|NCT03513328|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153522803|NCT03513328|Alkylating Agents|alkylating agents|mesh-ancestor
153522804|NCT03513328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153522805|NCT03513328|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153522806|NCT03513328|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153522807|NCT03513328|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153522819|NCT03498716|Mitosis Modulators|mitosis modulators|mesh-ancestor
153522820|NCT03498716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153522821|NCT03498716|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153522822|NCT03498716|Immunologic Factors|immunologic factors|mesh-ancestor
153522823|NCT03498716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153522824|NCT03498716|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153522825|NCT03498716|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153522826|NCT03498716|Alkylating Agents|alkylating agents|mesh-ancestor
153522827|NCT03498716|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153522828|NCT03498716|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153522829|NCT03498716|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153522830|NCT03498716|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153522831|NCT03498716|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153522832|NCT03498716|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153522833|NCT03498716|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153522834|NCT03404180|Dexmedetomidine|dexmedetomidine|mesh-list
153522835|NCT03404180|Propofol|propofol|mesh-list
153522836|NCT03404180|Hypnotics and Sedatives|hypnotics and sedatives|mesh-list
153522837|NCT03404180|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153522838|NCT03404180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153522839|NCT03404180|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153522840|NCT03404180|Analgesics|analgesics|mesh-ancestor
153522841|NCT03404180|Sensory System Agents|sensory system agents|mesh-ancestor
153522842|NCT03404180|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153522843|NCT03404180|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
153522846|NCT03404180|Adrenergic Agents|adrenergic agents|mesh-ancestor
153522847|NCT03404180|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153522848|NCT03404180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153522849|NCT03404180|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153522850|NCT03404180|Anesthetics, General|anesthetics, general|mesh-ancestor
153522851|NCT03404180|Anesthetics|anesthetics|mesh-ancestor
153522853|NCT03390686|Bevacizumab|bevacizumab|mesh-list
153522856|NCT03390686|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153522857|NCT03390686|Tubulin Modulators|tubulin modulators|mesh-ancestor
153522858|NCT03390686|Antimitotic Agents|antimitotic agents|mesh-ancestor
153522859|NCT03390686|Mitosis Modulators|mitosis modulators|mesh-ancestor
153522860|NCT03390686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153522861|NCT03390686|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153522862|NCT03390686|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153522863|NCT03390686|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153522864|NCT03390686|Growth Substances|growth substances|mesh-ancestor
153522865|NCT03390686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153522866|NCT03390686|Growth Inhibitors|growth inhibitors|mesh-ancestor
153522867|NCT03270969|Tenofovir|tenofovir|mesh-list
153522868|NCT03270969|Emtricitabine|emtricitabine|mesh-list
153522869|NCT03270969|Antiviral Agents|antiviral agents|mesh-ancestor
153522870|NCT03270969|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153618921|NCT01980810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153522871|NCT03270969|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153522872|NCT03270969|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153522873|NCT03270969|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153522874|NCT03270969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153522875|NCT03270969|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153522876|NCT03270969|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153522877|NCT03264131|Brentuximab Vedotin|brentuximab vedotin|mesh-list
153522878|NCT03264131|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153522880|NCT03264131|Immunotoxins|immunotoxins|mesh-ancestor
153522881|NCT03264131|Immunoconjugates|immunoconjugates|mesh-ancestor
153522882|NCT03264131|Immunologic Factors|immunologic factors|mesh-ancestor
153522884|NCT03233347|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
153522886|NCT03233347|Brentuximab Vedotin|brentuximab vedotin|mesh-list
153522887|NCT03233347|Doxorubicin|doxorubicin|mesh-list
153522888|NCT03233347|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
153522895|NCT03233347|Imidazole|imidazole|mesh-list
153522896|NCT03233347|Immunoconjugates|immunoconjugates|mesh-list
153522897|NCT03233347|Immunologic Factors|immunologic factors|mesh-ancestor
153522898|NCT03233347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153522900|NCT03233347|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153522901|NCT03233347|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153522902|NCT03233347|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153522903|NCT03233347|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153522904|NCT03233347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153522905|NCT03233347|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153522907|NCT03233347|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153522908|NCT03233347|Alkylating Agents|alkylating agents|mesh-ancestor
153522909|NCT03233347|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153522910|NCT03233347|Tubulin Modulators|tubulin modulators|mesh-ancestor
153522911|NCT03233347|Antimitotic Agents|antimitotic agents|mesh-ancestor
153522912|NCT03233347|Mitosis Modulators|mitosis modulators|mesh-ancestor
153522913|NCT03016013|Methotrexate|methotrexate|mesh-list
153522914|NCT03016013|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
153522915|NCT03016013|Abortifacient Agents|abortifacient agents|mesh-ancestor
153522916|NCT03016013|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153522917|NCT03016013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153522918|NCT03016013|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153522919|NCT03016013|Antimetabolites|antimetabolites|mesh-ancestor
153522920|NCT03016013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153522921|NCT03016013|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153522922|NCT03016013|Dermatologic Agents|dermatologic agents|mesh-ancestor
153522923|NCT03016013|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153522924|NCT03016013|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153522925|NCT03016013|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153522926|NCT03016013|Immunologic Factors|immunologic factors|mesh-ancestor
153522935|NCT02940496|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153522936|NCT02940496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153522937|NCT02940496|Antimetabolites|antimetabolites|mesh-ancestor
153522938|NCT02940496|Antiviral Agents|antiviral agents|mesh-ancestor
153522939|NCT02940496|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153522940|NCT02828761|Calcium, Dietary|calcium, dietary|mesh-list
153522942|NCT02828761|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153522943|NCT02828761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153522944|NCT02828761|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153618922|NCT01980849|Nadroparin|nadroparin|mesh-list
153522946|NCT02807207|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
153522947|NCT02807207|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153522948|NCT02807207|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153522949|NCT02807207|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153522951|NCT02807207|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153522952|NCT02807207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153522953|NCT02807207|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153522954|NCT02807207|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
153522955|NCT02807207|Contraceptive Agents|contraceptive agents|mesh-ancestor
153522956|NCT02807207|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153522957|NCT02807207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153522958|NCT02807207|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
153522959|NCT02807207|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
153522980|NCT02265770|Etoposide|etoposide|mesh-list
153522981|NCT02265770|Etoposide phosphate|etoposide phosphate|mesh-list
153522982|NCT02265770|Vincristine|vincristine|mesh-list
153522983|NCT02265770|Valproic Acid|valproic acid|mesh-list
153522984|NCT02265770|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153522985|NCT02265770|Immunologic Factors|immunologic factors|mesh-ancestor
153522986|NCT02265770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153522987|NCT02265770|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153522988|NCT02265770|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153522989|NCT02265770|Alkylating Agents|alkylating agents|mesh-ancestor
153522990|NCT02265770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153522991|NCT02265770|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153522992|NCT02265770|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153522993|NCT02265770|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
153522994|NCT02265770|Abortifacient Agents|abortifacient agents|mesh-ancestor
153522995|NCT02265770|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153522996|NCT02265770|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153522997|NCT02265770|Antimetabolites|antimetabolites|mesh-ancestor
153522998|NCT02265770|Dermatologic Agents|dermatologic agents|mesh-ancestor
153522999|NCT02265770|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153523000|NCT02265770|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153523001|NCT02265770|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153523002|NCT02265770|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153523003|NCT02265770|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153523004|NCT02265770|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153523006|NCT02265770|Antimitotic Agents|antimitotic agents|mesh-ancestor
153523007|NCT02265770|Mitosis Modulators|mitosis modulators|mesh-ancestor
153523008|NCT02265770|Anticonvulsants|anticonvulsants|mesh-ancestor
153523010|NCT02265770|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153523011|NCT02265770|Antimanic Agents|antimanic agents|mesh-ancestor
153523012|NCT02265770|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153523019|NCT02140242|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153466187|NCT00345384|Analgesics|analgesics|mesh-ancestor
153523020|NCT02140242|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153523021|NCT02140242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153523024|NCT01990196|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153523025|NCT01990196|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153523026|NCT01990196|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153523027|NCT01990196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153523028|NCT01990196|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153523029|NCT01612351|Paclitaxel|paclitaxel|mesh-list
153523030|NCT01612351|Cisplatin|cisplatin|mesh-list
153523031|NCT01612351|Carboplatin|carboplatin|mesh-list
153523032|NCT01612351|Lapatinib|lapatinib|mesh-list
153523033|NCT01612351|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153523034|NCT01612351|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153523035|NCT01612351|Tubulin Modulators|tubulin modulators|mesh-ancestor
153523036|NCT01612351|Antimitotic Agents|antimitotic agents|mesh-ancestor
153523037|NCT01612351|Mitosis Modulators|mitosis modulators|mesh-ancestor
153523038|NCT01612351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153523039|NCT01612351|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153523040|NCT01612351|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153523041|NCT01612351|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153523043|NCT01506856|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
153523044|NCT01506856|Carboplatin|carboplatin|mesh-list
153523045|NCT01506856|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153523046|NCT01506856|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153523047|NCT01506856|Tubulin Modulators|tubulin modulators|mesh-ancestor
153523048|NCT01506856|Antimitotic Agents|antimitotic agents|mesh-ancestor
153523049|NCT01506856|Mitosis Modulators|mitosis modulators|mesh-ancestor
153523050|NCT01506856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153523051|NCT01376505|Vaccines|vaccines|mesh-list
153523052|NCT01376505|Immunologic Factors|immunologic factors|mesh-ancestor
153523053|NCT01376505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153523054|NCT01256593|Pregabalin|pregabalin|mesh-list
153523055|NCT01256593|Analgesics|analgesics|mesh-ancestor
153523060|NCT01256593|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153523061|NCT01256593|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153523062|NCT01256593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153523063|NCT01256593|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153523064|NCT01256593|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153523065|NCT01256593|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153523066|NCT01256593|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153523067|NCT01256593|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153523069|NCT01179009|Ketamine|ketamine|mesh-list
153523070|NCT01179009|Analgesics|analgesics|mesh-ancestor
153523071|NCT01179009|Sensory System Agents|sensory system agents|mesh-ancestor
153523072|NCT01179009|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153523073|NCT01179009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153523074|NCT01179009|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
153523075|NCT01179009|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153523076|NCT01179009|Anesthetics, General|anesthetics, general|mesh-ancestor
153523077|NCT01179009|Anesthetics|anesthetics|mesh-ancestor
153523078|NCT01179009|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153523079|NCT01179009|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
153523080|NCT01179009|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
153523081|NCT01179009|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153523082|NCT01179009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153523083|NCT01179009|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153523084|NCT01179009|Sympatholytics|sympatholytics|mesh-ancestor
153523102|NCT04787289|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153523103|NCT04787289|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153523104|NCT04787289|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153523105|NCT04787289|Growth Substances|growth substances|mesh-ancestor
153523106|NCT04787289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153523107|NCT04787289|Growth Inhibitors|growth inhibitors|mesh-ancestor
153523108|NCT04749641|Vaccines|vaccines|mesh-list
153523109|NCT04749641|Immunologic Factors|immunologic factors|mesh-ancestor
153523110|NCT04749641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153523111|NCT04725201|Heparin|heparin|mesh-list
153523112|NCT04725201|Calcium heparin|calcium heparin|mesh-list
153523113|NCT04725201|Anticoagulants|anticoagulants|mesh-ancestor
153523114|NCT04725201|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153523115|NCT04725201|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153523116|NCT04725201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153523117|NCT04724239|Bevacizumab|bevacizumab|mesh-list
153523119|NCT04724239|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153523120|NCT04724239|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153523121|NCT04724239|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153523122|NCT04724239|Growth Substances|growth substances|mesh-ancestor
153523123|NCT04724239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153523124|NCT04724239|Growth Inhibitors|growth inhibitors|mesh-ancestor
153523125|NCT04705727|Budesonide|budesonide|mesh-list
153523126|NCT04705727|Terbutaline|terbutaline|mesh-list
153523127|NCT04705727|Formoterol Fumarate|formoterol fumarate|mesh-list
153523128|NCT04705727|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
153554845|NCT05688046|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-list
153523129|NCT04705727|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153523130|NCT04705727|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153523131|NCT04705727|Autonomic Agents|autonomic agents|mesh-ancestor
153523132|NCT04705727|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153523133|NCT04705727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153523134|NCT04705727|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153523135|NCT04705727|Respiratory System Agents|respiratory system agents|mesh-ancestor
153523142|NCT04705727|Adrenergic Agents|adrenergic agents|mesh-ancestor
153523143|NCT04705727|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153523144|NCT04705727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153523145|NCT04705727|Sympathomimetics|sympathomimetics|mesh-ancestor
153523146|NCT04705727|Tocolytic Agents|tocolytic agents|mesh-ancestor
153523147|NCT04705727|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153523148|NCT04674683|Nivolumab|nivolumab|mesh-list
153523149|NCT04674683|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153523150|NCT04674683|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153523151|NCT04674683|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153523152|NCT04674683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153523153|NCT04662944|Ranibizumab|ranibizumab|mesh-list
153523154|NCT04662944|Aflibercept|aflibercept|mesh-list
153523155|NCT04662944|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153523158|NCT04662944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153523159|NCT04662944|Growth Inhibitors|growth inhibitors|mesh-ancestor
153523160|NCT04662944|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153523161|NCT04635826|Adderall|adderall|mesh-list
153523162|NCT04635826|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
153523163|NCT04635826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153523164|NCT04629781|Docetaxel|docetaxel|mesh-list
153523165|NCT04629781|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153523166|NCT04629781|Tubulin Modulators|tubulin modulators|mesh-ancestor
153523167|NCT04629781|Antimitotic Agents|antimitotic agents|mesh-ancestor
153523168|NCT04629781|Mitosis Modulators|mitosis modulators|mesh-ancestor
153523169|NCT04629781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153523170|NCT04624945|Thromboplastin|thromboplastin|mesh-list
153523171|NCT04624945|Hemostatics|hemostatics|mesh-ancestor
153523172|NCT04624945|Coagulants|coagulants|mesh-ancestor
153523174|NCT04608474|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-list
153523175|NCT04608474|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
153523176|NCT04608474|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153523177|NCT04608474|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153523178|NCT04608474|Antimetabolites|antimetabolites|mesh-ancestor
153523179|NCT04608474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153523180|NCT04608474|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
153523181|NCT04608474|Protease Inhibitors|protease inhibitors|mesh-ancestor
153523182|NCT04608474|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153523183|NCT04608474|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153523184|NCT04600414|Analgesics, Opioid|analgesics, opioid|mesh-list
153523185|NCT04600414|Narcotics|narcotics|mesh-ancestor
153523186|NCT04600414|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153523187|NCT04600414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153523188|NCT04600414|Analgesics|analgesics|mesh-ancestor
153523189|NCT04600414|Sensory System Agents|sensory system agents|mesh-ancestor
153523190|NCT04600414|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153523192|NCT04593043|Dabigatran|dabigatran|mesh-list
153523193|NCT04593043|Anticoagulants|anticoagulants|mesh-ancestor
153523194|NCT04593043|Antithrombins|antithrombins|mesh-ancestor
153523195|NCT04593043|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
153523196|NCT04593043|Protease Inhibitors|protease inhibitors|mesh-ancestor
153523197|NCT04593043|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153523198|NCT04593043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153523199|NCT04593030|Warfarin|warfarin|mesh-list
153523200|NCT04593030|Apixaban|apixaban|mesh-list
153523201|NCT04593030|Anticoagulants|anticoagulants|mesh-ancestor
153523202|NCT04593030|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
153523203|NCT04593030|Antithrombins|antithrombins|mesh-ancestor
153523204|NCT04593030|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
153523205|NCT04593030|Protease Inhibitors|protease inhibitors|mesh-ancestor
153523206|NCT04593030|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153523207|NCT04593030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153554948|NCT04753216|Irinotecan|irinotecan|mesh-list
153523208|NCT04532229|Nimotuzumab|nimotuzumab|mesh-list
153523209|NCT04532229|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153523210|NCT04532229|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153523211|NCT04518410|Cilgavimab and tixagevimab drug combination|cilgavimab and tixagevimab drug combination|mesh-list
153523212|NCT04518410|Bamlanivimab|bamlanivimab|mesh-list
153523214|NCT04518410|Gabexate|gabexate|mesh-list
153523219|NCT04518410|Immunologic Factors|immunologic factors|mesh-ancestor
153523220|NCT04518410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153523221|NCT04518410|Antiviral Agents|antiviral agents|mesh-ancestor
153523222|NCT04518410|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153523223|NCT04518410|Protease Inhibitors|protease inhibitors|mesh-ancestor
153523224|NCT04518410|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153523225|NCT04518410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153523226|NCT04518410|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
153523227|NCT04518410|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
153554950|NCT04753216|Antibodies|antibodies|mesh-list
153554965|NCT04714619|Letrozole|letrozole|mesh-list
153523228|NCT04518410|Anticoagulants|anticoagulants|mesh-ancestor
153523230|NCT04507204|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
153523231|NCT04507204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153523232|NCT04507204|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
153523233|NCT04507204|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153523234|NCT04507204|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153523235|NCT04507204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153523236|NCT04507204|Dopamine Agents|dopamine agents|mesh-ancestor
153523273|NCT04263051|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153523274|NCT04263051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153523275|NCT04237935|Clopidogrel|clopidogrel|mesh-list
153523277|NCT04237935|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153523278|NCT04237935|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
153523279|NCT04237935|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
153523280|NCT04237935|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
153523281|NCT04237935|Purinergic Agents|purinergic agents|mesh-ancestor
153523283|NCT04237935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153523284|NCT04237935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153523285|NCT04237922|Clopidogrel|clopidogrel|mesh-list
153523286|NCT04237922|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
153523287|NCT04237922|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153523288|NCT04237922|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
153523289|NCT04237922|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
153523290|NCT04237922|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
153523291|NCT04237922|Purinergic Agents|purinergic agents|mesh-ancestor
153523292|NCT04237922|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153523293|NCT04237922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153523294|NCT04237922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153523295|NCT04233021|Osimertinib|osimertinib|mesh-list
153523319|NCT04215523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153523320|NCT04215523|Protease Inhibitors|protease inhibitors|mesh-ancestor
153523321|NCT04215523|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153523323|NCT04169347|Oxaliplatin|oxaliplatin|mesh-list
153523324|NCT04169347|Irinotecan|irinotecan|mesh-list
153523325|NCT04169347|Panitumumab|panitumumab|mesh-list
153523326|NCT04169347|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153523327|NCT04169347|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
153523328|NCT04169347|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153523329|NCT04169347|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153523330|NCT04169347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153523332|NCT04169347|Protective Agents|protective agents|mesh-ancestor
153523333|NCT04169347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153523335|NCT04169347|Vitamins|vitamins|mesh-ancestor
153523336|NCT04169347|Micronutrients|micronutrients|mesh-ancestor
153523337|NCT04169347|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153523338|NCT04135937|Bupropion|bupropion|mesh-list
153523339|NCT04135937|Nicotine|nicotine|mesh-list
153523340|NCT04135937|Varenicline|varenicline|mesh-list
153523341|NCT04135937|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
153523342|NCT04135937|Autonomic Agents|autonomic agents|mesh-ancestor
153523343|NCT04135937|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153523344|NCT04135937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153523345|NCT04135937|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
153523346|NCT04135937|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
153523347|NCT04135937|Cholinergic Agents|cholinergic agents|mesh-ancestor
153523348|NCT04135937|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153523349|NCT04135937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153523350|NCT04135937|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
153523351|NCT04135937|Antidepressive Agents|antidepressive agents|mesh-ancestor
153523352|NCT04135937|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153523353|NCT04135937|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
153523354|NCT04135937|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153523362|NCT04126070|Leuprolide|leuprolide|mesh-list
153523363|NCT04126070|Goserelin|goserelin|mesh-list
153523364|NCT04126070|Androgens|androgens|mesh-list
153523365|NCT04126070|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153523366|NCT04126070|Tubulin Modulators|tubulin modulators|mesh-ancestor
153523367|NCT04126070|Antimitotic Agents|antimitotic agents|mesh-ancestor
153523368|NCT04126070|Mitosis Modulators|mitosis modulators|mesh-ancestor
153523369|NCT04126070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153523370|NCT04126070|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153523371|NCT04126070|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153523372|NCT04126070|Fertility Agents, Female|fertility agents, female|mesh-ancestor
153523373|NCT04126070|Fertility Agents|fertility agents|mesh-ancestor
153523374|NCT04126070|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153523375|NCT04126070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153523376|NCT04126070|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153523378|NCT04126070|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153523379|NCT04120987|Ophthalmic Solutions|ophthalmic solutions|mesh-list
153523380|NCT04120987|Lifitegrast|lifitegrast|mesh-list
153523381|NCT04120987|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
153523382|NCT04019093|Ethanol|ethanol|mesh-list
153523383|NCT04019093|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
153523384|NCT04019093|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153523385|NCT04019093|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153523386|NCT04019093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153523387|NCT03936062|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
153523388|NCT03936062|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153523389|NCT03936062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153523390|NCT03936062|Incretins|incretins|mesh-ancestor
153523391|NCT03936062|Hormones|hormones|mesh-ancestor
153618924|NCT01980849|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153523400|NCT03936049|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153523401|NCT03936049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153523402|NCT03936049|Incretins|incretins|mesh-ancestor
153523403|NCT03936049|Hormones|hormones|mesh-ancestor
153523404|NCT03936049|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153523405|NCT03936049|Protease Inhibitors|protease inhibitors|mesh-ancestor
153523406|NCT03936049|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153523407|NCT03936049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153523408|NCT03936036|Linagliptin|linagliptin|mesh-list
153523409|NCT03936036|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153523411|NCT03936036|Incretins|incretins|mesh-ancestor
153523412|NCT03936036|Hormones|hormones|mesh-ancestor
153523413|NCT03936036|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153523414|NCT03936036|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
153523415|NCT03936036|Protease Inhibitors|protease inhibitors|mesh-ancestor
153523416|NCT03936036|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153523417|NCT03936036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153523418|NCT03936010|Canagliflozin|canagliflozin|mesh-list
153523419|NCT03936010|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
153523420|NCT03936010|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
153523421|NCT03936010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153523422|NCT03936010|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153523423|NCT03936010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153523424|NCT03936010|Protease Inhibitors|protease inhibitors|mesh-ancestor
153523425|NCT03936010|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153523426|NCT03919448|Bevacizumab|bevacizumab|mesh-list
153523427|NCT03919448|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153523428|NCT03919448|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153523429|NCT03919448|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153523430|NCT03919448|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153523431|NCT03919448|Growth Substances|growth substances|mesh-ancestor
153523439|NCT03900637|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153523440|NCT03900637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153523441|NCT03900637|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
153523442|NCT03900637|Hormone Antagonists|hormone antagonists|mesh-ancestor
153523443|NCT03900637|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153523444|NCT03900637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153523445|NCT03900637|Fertility Agents, Female|fertility agents, female|mesh-ancestor
153523446|NCT03900637|Fertility Agents|fertility agents|mesh-ancestor
153523447|NCT03900637|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153523448|NCT03900637|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153523449|NCT03893045|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
153523450|NCT03893045|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
153523452|NCT03893045|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
153523453|NCT03893045|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
153523496|NCT03769025|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153523520|NCT03613792|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
153523522|NCT03613792|Anesthetics, General|anesthetics, general|mesh-ancestor
153523523|NCT03613792|Anesthetics|anesthetics|mesh-ancestor
153523524|NCT03613792|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153523525|NCT03613792|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
153523526|NCT03613792|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
153523527|NCT03613792|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153523529|NCT03613792|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153523540|NCT03575598|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153523541|NCT03575598|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153523542|NCT03575598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153523573|NCT03423667|Expectorants|expectorants|mesh-ancestor
153523574|NCT03423667|Respiratory System Agents|respiratory system agents|mesh-ancestor
153523575|NCT03423667|Free Radical Scavengers|free radical scavengers|mesh-ancestor
153523582|NCT03419897|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153523583|NCT03419897|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153523584|NCT03377049|Acetazolamide|acetazolamide|mesh-list
153523585|NCT03377049|Anticonvulsants|anticonvulsants|mesh-ancestor
153523586|NCT03377049|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
153523587|NCT03377049|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153523588|NCT03377049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153523589|NCT03377049|Diuretics|diuretics|mesh-ancestor
153523590|NCT03377049|Natriuretic Agents|natriuretic agents|mesh-ancestor
153523591|NCT03377049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153523593|NCT03355976|Ipilimumab|ipilimumab|mesh-list
153523594|NCT03355976|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153523595|NCT03355976|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153523596|NCT03355976|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153523597|NCT03355976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153523598|NCT03335488|4-phenylbutyric acid|4-phenylbutyric acid|mesh-list
153523639|NCT03170960|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153523640|NCT03170960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153523641|NCT03170960|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153523642|NCT03170960|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153523643|NCT02922192|Antirheumatic Agents|antirheumatic agents|mesh-list
153523644|NCT02921191|Lenograstim|lenograstim|mesh-list
153523645|NCT02921191|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153523646|NCT02921191|Immunologic Factors|immunologic factors|mesh-ancestor
153523704|NCT02576990|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153523705|NCT02576990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153523706|NCT02511106|Osimertinib|osimertinib|mesh-list
153523707|NCT02511106|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153523709|NCT02511106|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153523710|NCT02511106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153523711|NCT02511106|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153523712|NCT02494882|Dexamethasone|dexamethasone|mesh-list
153523713|NCT02494882|Dasatinib|dasatinib|mesh-list
153523714|NCT02494882|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153523715|NCT02494882|Antiemetics|antiemetics|mesh-ancestor
153523716|NCT02494882|Autonomic Agents|autonomic agents|mesh-ancestor
153523717|NCT02494882|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153523718|NCT02494882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153523719|NCT02494882|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153523720|NCT02494882|Glucocorticoids|glucocorticoids|mesh-ancestor
153523722|NCT02494882|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153523723|NCT02494882|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153523724|NCT02494882|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153523757|NCT02220426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153523758|NCT02123121|Resveratrol|resveratrol|mesh-list
153523759|NCT02123121|Antioxidants|antioxidants|mesh-ancestor
153523760|NCT02123121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153523761|NCT02123121|Protective Agents|protective agents|mesh-ancestor
153523762|NCT02123121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153523763|NCT02123121|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153523764|NCT02123121|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153523765|NCT02009579|Nintedanib|nintedanib|mesh-list
153523767|NCT02009579|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153523768|NCT02009579|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153523769|NCT02009579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153523770|NCT01959698|Rituximab|rituximab|mesh-list
153523771|NCT01959698|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
153523772|NCT01959698|Carboplatin|carboplatin|mesh-list
153523773|NCT01959698|Etoposide|etoposide|mesh-list
153523774|NCT01959698|Etoposide phosphate|etoposide phosphate|mesh-list
153523775|NCT01959698|Ifosfamide|ifosfamide|mesh-list
153523776|NCT01959698|Isophosphamide mustard|isophosphamide mustard|mesh-list
153523777|NCT01959698|Podophyllotoxin|podophyllotoxin|mesh-list
153523778|NCT01959698|Antibodies|antibodies|mesh-list
153523779|NCT01959698|Immunoglobulins|immunoglobulins|mesh-list
153523780|NCT01959698|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
153523781|NCT01959698|Immunologic Factors|immunologic factors|mesh-ancestor
153523782|NCT01959698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153523808|NCT01728363|Clavulanic Acid|clavulanic acid|mesh-list
153523809|NCT01728363|Ticarcillin|ticarcillin|mesh-list
153523810|NCT01728363|Ticarcillin-clavulanic acid|ticarcillin-clavulanic acid|mesh-list
153523811|NCT01728363|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153523812|NCT01728363|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
153523813|NCT01728363|Antitubercular Agents|antitubercular agents|mesh-ancestor
153523814|NCT01728363|Leprostatic Agents|leprostatic agents|mesh-ancestor
153523815|NCT01728363|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153523816|NCT01728363|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153523817|NCT01728363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153523818|NCT01728363|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
153523819|NCT01728363|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
153523820|NCT01728363|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
153523821|NCT01728363|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
153523822|NCT01728363|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
153523823|NCT01728363|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
153523824|NCT01728363|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
153523825|NCT01728363|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
153523827|NCT01614197|Hydrocortisone|hydrocortisone|mesh-list
153523860|NCT01614197|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153523862|NCT01422148|Amiodarone|amiodarone|mesh-list
153523863|NCT01422148|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153523864|NCT01422148|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153523865|NCT01422148|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153523866|NCT01422148|Vasodilator Agents|vasodilator agents|mesh-ancestor
153523867|NCT01422148|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
153523868|NCT01422148|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153523869|NCT01422148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153523870|NCT01422148|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153523871|NCT01422148|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
153523872|NCT01422148|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153523873|NCT01422148|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153523874|NCT01422148|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
153523875|NCT01422148|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
153523876|NCT01422148|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
153523877|NCT01341964|Aspirin|aspirin|mesh-list
153523878|NCT01341964|Clopidogrel|clopidogrel|mesh-list
153523879|NCT01341964|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153523880|NCT01341964|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153523881|NCT01341964|Analgesics|analgesics|mesh-ancestor
153523882|NCT01341964|Sensory System Agents|sensory system agents|mesh-ancestor
153523883|NCT01341964|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153523884|NCT01341964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153523885|NCT01341964|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153523886|NCT01341964|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153523887|NCT01341964|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153523888|NCT01341964|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153523889|NCT01341964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153523890|NCT01341964|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153523891|NCT01341964|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153523892|NCT01341964|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153523893|NCT01341964|Antipyretics|antipyretics|mesh-ancestor
153523899|NCT01267812|Rituximab|rituximab|mesh-list
153523900|NCT01267812|Bortezomib|bortezomib|mesh-list
153523901|NCT01267812|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153523902|NCT01267812|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153523903|NCT01267812|Immunologic Factors|immunologic factors|mesh-ancestor
153523904|NCT01267812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153523905|NCT01267812|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153523906|NCT01236521|Analgesics|analgesics|mesh-list
153523907|NCT01236521|Sensory System Agents|sensory system agents|mesh-ancestor
153523908|NCT01236521|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153523910|NCT01042379|Metformin|metformin|mesh-list
153523967|NCT00544115|Busulfan|busulfan|mesh-list
153523968|NCT00544115|Methotrexate|methotrexate|mesh-list
153523969|NCT00544115|Fludarabine|fludarabine|mesh-list
153523970|NCT00544115|Fludarabine phosphate|fludarabine phosphate|mesh-list
153523971|NCT00544115|Etoposide|etoposide|mesh-list
153523972|NCT00544115|Tacrolimus|tacrolimus|mesh-list
153523973|NCT00544115|Cyclosporins|cyclosporins|mesh-list
153523974|NCT00544115|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153523975|NCT00544115|Immunologic Factors|immunologic factors|mesh-ancestor
153523976|NCT00544115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153523977|NCT00544115|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153523978|NCT00544115|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153523979|NCT00544115|Alkylating Agents|alkylating agents|mesh-ancestor
153523980|NCT00544115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153523981|NCT00544115|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153523982|NCT00544115|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153523983|NCT00544115|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
153523984|NCT00544115|Abortifacient Agents|abortifacient agents|mesh-ancestor
153523985|NCT00544115|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153523986|NCT00544115|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153523987|NCT00544115|Antimetabolites|antimetabolites|mesh-ancestor
153524022|NCT01456078|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
153524023|NCT01456078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153524025|NCT01456507|Oxycodone|oxycodone|mesh-list
153524026|NCT01456507|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153524027|NCT01456507|Narcotics|narcotics|mesh-ancestor
153524028|NCT01456507|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153524029|NCT01456507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153524030|NCT01456507|Analgesics|analgesics|mesh-ancestor
153524031|NCT01456507|Sensory System Agents|sensory system agents|mesh-ancestor
153524033|NCT01456507|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
153524082|NCT01459445|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
153524083|NCT01459445|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
153524084|NCT01459445|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
153524085|NCT01459445|Contraceptive Agents|contraceptive agents|mesh-ancestor
153524086|NCT01459445|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153524087|NCT01459445|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
153524088|NCT01459445|Estrogens|estrogens|mesh-ancestor
153524089|NCT01459445|Hormones|hormones|mesh-ancestor
153524090|NCT01460030|Cinacalcet|cinacalcet|mesh-list
153524091|NCT01460030|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153524092|NCT01460030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153524093|NCT01460030|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
153524094|NCT01460030|Hormone Antagonists|hormone antagonists|mesh-ancestor
153524095|NCT01460030|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153524096|NCT01460069|Liraglutide|liraglutide|mesh-list
153524097|NCT01460069|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
153524138|NCT01460355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153524139|NCT01460355|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
153524140|NCT01460355|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153524142|NCT01460420|Bortezomib|bortezomib|mesh-list
153524143|NCT01460420|Immunologic Factors|immunologic factors|mesh-ancestor
153781916|NCT00259662|Atorvastatin|atorvastatin|mesh-list
153524144|NCT01460420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153524145|NCT01460420|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153524146|NCT01460420|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153524147|NCT01460420|Growth Substances|growth substances|mesh-ancestor
153524148|NCT01460420|Growth Inhibitors|growth inhibitors|mesh-ancestor
153524149|NCT01460420|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153524150|NCT01460498|Azacitidine|azacitidine|mesh-list
153524151|NCT01460498|Decitabine|decitabine|mesh-list
153524152|NCT01460498|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-list
153524153|NCT01460498|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153524154|NCT01460498|Antimetabolites|antimetabolites|mesh-ancestor
153524155|NCT01460498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153524156|NCT01460498|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153524157|NCT01460498|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153524158|NCT01460498|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153524159|NCT01460537|Gemcitabine|gemcitabine|mesh-list
153524160|NCT01460537|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153524161|NCT01460537|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153524162|NCT01460537|Antimetabolites|antimetabolites|mesh-ancestor
153524163|NCT01460537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153524164|NCT01460563|Magnesium Sulfate|magnesium sulfate|mesh-list
153524181|NCT01460602|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153524182|NCT01460602|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153524183|NCT01460602|Immunologic Factors|immunologic factors|mesh-ancestor
153524184|NCT01460602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153524185|NCT01460602|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153524187|NCT01460615|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153524189|NCT01460667|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153524190|NCT01460667|Analgesics|analgesics|mesh-ancestor
153524191|NCT01460667|Sensory System Agents|sensory system agents|mesh-ancestor
153524192|NCT01460667|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153524193|NCT01460667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153524194|NCT01460667|Antipyretics|antipyretics|mesh-ancestor
153524195|NCT01460693|Imatinib Mesylate|imatinib mesylate|mesh-list
153524197|NCT01460693|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153524198|NCT01460693|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153524199|NCT01460693|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153524200|NCT01460693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153524236|NCT01461018|Immunologic Factors|immunologic factors|mesh-ancestor
153524237|NCT01461018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153524239|NCT01461031|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153524240|NCT01461031|Analgesics|analgesics|mesh-ancestor
153524241|NCT01461031|Sensory System Agents|sensory system agents|mesh-ancestor
153524242|NCT01461031|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153524243|NCT01461031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153524244|NCT01461174|Memantine|memantine|mesh-list
153524245|NCT01461174|Modafinil|modafinil|mesh-list
153524246|NCT01461174|Donepezil|donepezil|mesh-list
153524247|NCT01461174|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
153524248|NCT01461174|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153524249|NCT01461174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153524250|NCT01461174|Cholinergic Agents|cholinergic agents|mesh-ancestor
153524263|NCT01461460|Moxifloxacin|moxifloxacin|mesh-list
153782628|NCT00234455|Antifungal Agents|antifungal agents|mesh-ancestor
153524298|NCT01462006|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153524300|NCT01462006|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153524301|NCT01462006|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153524302|NCT01462006|Antifungal Agents|antifungal agents|mesh-ancestor
153524303|NCT01462006|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153524304|NCT01462006|Immunologic Factors|immunologic factors|mesh-ancestor
153524305|NCT01462006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153524308|NCT01462058|Vitamins|vitamins|mesh-ancestor
153524364|NCT01463046|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153524365|NCT01463046|Antimetabolites|antimetabolites|mesh-ancestor
153524366|NCT01463046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153524367|NCT01463046|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153524368|NCT01463046|Antiviral Agents|antiviral agents|mesh-ancestor
153524369|NCT01463046|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153524370|NCT01463046|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153524371|NCT01463046|Immunologic Factors|immunologic factors|mesh-ancestor
153524372|NCT01463046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153524373|NCT01463046|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153524374|NCT01463046|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153524375|NCT01463046|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153524376|NCT01463046|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153524377|NCT01463046|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
153524379|NCT01463150|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
153524380|NCT01463150|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153524381|NCT01463150|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
153524382|NCT01463150|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
153524383|NCT01463150|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
153524384|NCT01463150|Purinergic Agents|purinergic agents|mesh-ancestor
153524385|NCT01463150|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153524386|NCT01463150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153524387|NCT01463150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153524389|NCT01463163|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
153524390|NCT01463163|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153524391|NCT01463163|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
153524392|NCT01463163|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
153524393|NCT01463163|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
153524394|NCT01463163|Purinergic Agents|purinergic agents|mesh-ancestor
153524404|NCT01463228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153524405|NCT01463228|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
153524406|NCT01463228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153524407|NCT01463280|Lidocaine|lidocaine|mesh-list
153524408|NCT01463280|Anesthetics, Local|anesthetics, local|mesh-ancestor
153524409|NCT01463280|Anesthetics|anesthetics|mesh-ancestor
153524410|NCT01463280|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153524411|NCT01463280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153524412|NCT01463280|Sensory System Agents|sensory system agents|mesh-ancestor
153524413|NCT01463280|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153524414|NCT01463280|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153524415|NCT01463280|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
153524416|NCT01463280|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153524417|NCT01463280|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153524418|NCT01463280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153524419|NCT01463332|Dexmedetomidine|dexmedetomidine|mesh-list
153524420|NCT01463332|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153524422|NCT01463332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153524423|NCT01463332|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153524424|NCT01463332|Analgesics|analgesics|mesh-ancestor
153524425|NCT01463332|Sensory System Agents|sensory system agents|mesh-ancestor
153524426|NCT01463332|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153524427|NCT01463332|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
153524428|NCT01463332|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153524429|NCT01463332|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153524430|NCT01463332|Adrenergic Agents|adrenergic agents|mesh-ancestor
153524431|NCT01463332|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153524432|NCT01463332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153524434|NCT01463592|Interferons|interferons|mesh-list
153524435|NCT01463592|Ribavirin|ribavirin|mesh-list
153524436|NCT01463592|Interferon-alpha|interferon-alpha|mesh-list
153524437|NCT01463592|Interferon alpha-2|interferon alpha-2|mesh-list
153524438|NCT01463592|Cadexomer iodine|cadexomer iodine|mesh-list
153524441|NCT01463592|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153524443|NCT01463592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153524444|NCT01463592|Immunologic Factors|immunologic factors|mesh-ancestor
153524445|NCT01463592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153524446|NCT01463592|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
153524447|NCT01463592|Trace Elements|trace elements|mesh-ancestor
153524448|NCT01463592|Micronutrients|micronutrients|mesh-ancestor
153524449|NCT01463605|Nimotuzumab|nimotuzumab|mesh-list
153524450|NCT01463605|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153524451|NCT01463605|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153524453|NCT01463735|Vitamins|vitamins|mesh-ancestor
153524506|NCT01464060|Amoxicillin|amoxicillin|mesh-list
153524507|NCT01464060|Metronidazole|metronidazole|mesh-list
153524508|NCT01464060|Clarithromycin|clarithromycin|mesh-list
153524509|NCT01464060|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153524510|NCT01464060|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153524511|NCT01464060|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153524512|NCT01464060|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153524513|NCT01464060|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
153524514|NCT01464060|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153524515|NCT01464060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153524573|NCT01464450|Protease Inhibitors|protease inhibitors|mesh-ancestor
153524574|NCT01464450|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153524575|NCT01464450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153524576|NCT01464450|Anticoagulants|anticoagulants|mesh-ancestor
153524578|NCT01464476|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153524579|NCT01464476|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153524580|NCT01464476|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153524581|NCT01464476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153524582|NCT01464476|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153524583|NCT01464476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153524584|NCT01464489|Atropine|atropine|mesh-list
153524632|NCT01466829|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153524634|NCT01466829|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153524635|NCT01466855|Topotecan|topotecan|mesh-list
153524636|NCT01466855|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
153524637|NCT01466855|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153524638|NCT01466855|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153524639|NCT01466855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153524640|NCT01466855|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153524641|NCT01466959|Acetic Acid|acetic acid|mesh-list
153524642|NCT01466959|Retinol acetate|retinol acetate|mesh-list
153524643|NCT01466959|Citric Acid|citric acid|mesh-list
153524644|NCT01466959|Dialysis Solutions|dialysis solutions|mesh-list
153524696|NCT01467141|Isophane insulin, beef|isophane insulin, beef|mesh-list
153524697|NCT01467141|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153524698|NCT01467141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153524699|NCT01467219|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
153524700|NCT01467219|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
153524701|NCT01467219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153524703|NCT01467258|Amantadine|amantadine|mesh-list
153524704|NCT01467258|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
153524705|NCT01467258|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
153524706|NCT01467258|Antiviral Agents|antiviral agents|mesh-ancestor
153524707|NCT01467258|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153524708|NCT01467258|Dopamine Agents|dopamine agents|mesh-ancestor
153524709|NCT01467258|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153524710|NCT01467258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153524711|NCT01467258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153524712|NCT01467258|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153524713|NCT01467258|Analgesics|analgesics|mesh-ancestor
153524714|NCT01467258|Sensory System Agents|sensory system agents|mesh-ancestor
153524715|NCT01467258|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153524716|NCT01467297|Levofloxacin|levofloxacin|mesh-list
153524717|NCT01467297|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
153524718|NCT01467297|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153524719|NCT01467297|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153524720|NCT01467297|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153524721|NCT01467297|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153524722|NCT01467297|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153524723|NCT01467297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153524724|NCT01467297|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153524725|NCT01467297|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
153524726|NCT01467297|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153524727|NCT01467310|Trametinib|trametinib|mesh-list
153524728|NCT01467310|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153524730|NCT01467310|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153524734|NCT01467323|Insulin Aspart|insulin aspart|mesh-list
153524735|NCT01467323|Biphasic Insulins|biphasic insulins|mesh-list
153524736|NCT01467323|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153524737|NCT01467323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153524738|NCT01467362|Desonide|desonide|mesh-list
153524739|NCT01467362|V0034CR|v0034cr|mesh-list
153524740|NCT01467362|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153524741|NCT01467362|Emollients|emollients|mesh-ancestor
153524742|NCT01467362|Dermatologic Agents|dermatologic agents|mesh-ancestor
153524743|NCT01467375|Insulin Aspart|insulin aspart|mesh-list
153524744|NCT01467375|Biphasic Insulins|biphasic insulins|mesh-list
153524745|NCT01467375|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153524746|NCT01467375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153524747|NCT01467401|Insulin|insulin|mesh-list
153524748|NCT01467401|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
153524749|NCT01467401|Insulin Aspart|insulin aspart|mesh-list
153524797|NCT01467596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153524798|NCT01467648|Doripenem|doripenem|mesh-list
153524799|NCT01467648|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153524800|NCT01467648|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153524801|NCT01467687|Verapamil|verapamil|mesh-list
153524802|NCT01467687|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153524803|NCT01467687|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153524804|NCT01467687|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153524805|NCT01467687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153524806|NCT01467687|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153524807|NCT01467687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153524808|NCT01467687|Vasodilator Agents|vasodilator agents|mesh-ancestor
153524809|NCT01467804|Sertraline|sertraline|mesh-list
153524810|NCT01467804|Antidepressive Agents|antidepressive agents|mesh-ancestor
153524811|NCT01467804|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153524812|NCT01467804|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
153524813|NCT01467804|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153524817|NCT01467804|Serotonin Agents|serotonin agents|mesh-ancestor
153524852|NCT01468025|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153524853|NCT01468025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153524854|NCT01468038|Trazodone|trazodone|mesh-list
153524855|NCT01468038|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153524856|NCT01468038|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153524857|NCT01468038|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153524858|NCT01468038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153524859|NCT01468038|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153524860|NCT01468038|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
153524864|NCT01468038|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153524916|NCT01468415|Phenol|phenol|mesh-list
153524917|NCT01468415|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
153524918|NCT01468415|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153524919|NCT01468415|Disinfectants|disinfectants|mesh-ancestor
153524920|NCT01468415|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
153524921|NCT01468415|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
153524922|NCT01468441|Triptorelin Pamoate|triptorelin pamoate|mesh-list
153417899|NCT00966914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153524923|NCT01468441|Cetrorelix|cetrorelix|mesh-list
153524924|NCT01468441|Luteolytic Agents|luteolytic agents|mesh-ancestor
153524925|NCT01468441|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
153524926|NCT01468441|Contraceptive Agents|contraceptive agents|mesh-ancestor
153524927|NCT01468441|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153524928|NCT01468441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153524929|NCT01468441|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
153524930|NCT01468441|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153524931|NCT01468441|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153524932|NCT01468441|Fertility Agents, Female|fertility agents, female|mesh-ancestor
153524933|NCT01468441|Fertility Agents|fertility agents|mesh-ancestor
153524934|NCT01468441|Hormone Antagonists|hormone antagonists|mesh-ancestor
153524935|NCT01468441|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153524936|NCT01468467|Quizartinib|quizartinib|mesh-list
153524939|NCT01468467|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153524965|NCT01468610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153524966|NCT01468610|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153524967|NCT01468610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153524968|NCT01468610|Antidepressive Agents|antidepressive agents|mesh-ancestor
153524969|NCT01468610|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153524970|NCT01468688|Imatinib Mesylate|imatinib mesylate|mesh-list
153524971|NCT01468688|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153524972|NCT01468688|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153468145|NCT04388202|Serotonin Agents|serotonin agents|mesh-ancestor
153524973|NCT01468688|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153525028|NCT01469169|Vasodilator Agents|vasodilator agents|mesh-ancestor
153525029|NCT06078449|Hyaluronic Acid|hyaluronic acid|mesh-list
153525030|NCT06078449|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153525031|NCT06078449|Immunologic Factors|immunologic factors|mesh-ancestor
153525032|NCT06078449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153525033|NCT06078449|Viscosupplements|viscosupplements|mesh-ancestor
153525034|NCT06078449|Protective Agents|protective agents|mesh-ancestor
153525035|NCT06078423|Vaccines|vaccines|mesh-list
153525036|NCT06078423|Immunologic Factors|immunologic factors|mesh-ancestor
153525037|NCT06078423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153525093|NCT06077292|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
153525094|NCT06077292|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
153525095|NCT06077292|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153525096|NCT06077292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153525097|NCT06077292|Hormones|hormones|mesh-ancestor
153525098|NCT06077292|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153525099|NCT06077058|Nicotine|nicotine|mesh-list
153525100|NCT06077058|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
153525101|NCT06077058|Autonomic Agents|autonomic agents|mesh-ancestor
153525102|NCT06077058|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153525103|NCT06077058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153525104|NCT06077058|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
153525105|NCT06077058|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
153525106|NCT06077058|Cholinergic Agents|cholinergic agents|mesh-ancestor
153525107|NCT06077058|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153525108|NCT06077058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153525109|NCT06077019|Fluticasone|fluticasone|mesh-list
153525110|NCT06077019|Xhance|xhance|mesh-list
153525111|NCT06077019|Mometasone Furoate|mometasone furoate|mesh-list
153525148|NCT06076824|Prednisolone acetate|prednisolone acetate|mesh-list
153525149|NCT06076824|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
153525150|NCT06076824|Prednisolone phosphate|prednisolone phosphate|mesh-list
153525151|NCT06076824|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153525154|NCT06076824|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153525155|NCT06076824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153525156|NCT06076824|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153525157|NCT06076824|Glucocorticoids|glucocorticoids|mesh-ancestor
153525158|NCT06076824|Hormones|hormones|mesh-ancestor
153525159|NCT06076824|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153525160|NCT06076824|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
153525161|NCT06076824|Protective Agents|protective agents|mesh-ancestor
153525162|NCT06076824|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153525163|NCT06076824|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153525164|NCT06076772|Denosumab|denosumab|mesh-list
153525165|NCT06076772|Palbociclib|palbociclib|mesh-list
153525166|NCT06076772|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153525167|NCT06076772|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153525204|NCT06074367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153525205|NCT06074367|Protective Agents|protective agents|mesh-ancestor
153525206|NCT06074172|Cannabidiol|cannabidiol|mesh-list
153525207|NCT06074172|Anticonvulsants|anticonvulsants|mesh-ancestor
153525208|NCT06073873|Ozanimod|ozanimod|mesh-list
153525209|NCT06073873|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
153525211|NCT06073873|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153525212|NCT06073873|Immunologic Factors|immunologic factors|mesh-ancestor
153525213|NCT06073873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153525214|NCT06073860|Luspatercept|luspatercept|mesh-list
153525215|NCT06073860|Hematinics|hematinics|mesh-ancestor
153525216|NCT06073769|Azacitidine|azacitidine|mesh-list
153525217|NCT06073769|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153525218|NCT06073769|Antimetabolites|antimetabolites|mesh-ancestor
153525219|NCT06073769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153525220|NCT06073769|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153525221|NCT06073769|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153525222|NCT06073730|Azacitidine|azacitidine|mesh-list
153525223|NCT06073730|Decitabine|decitabine|mesh-list
153525224|NCT06073730|Sorafenib|sorafenib|mesh-list
153525225|NCT06073730|Venetoclax|venetoclax|mesh-list
153525226|NCT06073730|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153525254|NCT06072729|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153525255|NCT06072729|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153525256|NCT06072729|Anticonvulsants|anticonvulsants|mesh-ancestor
153525257|NCT06072729|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153525258|NCT06072729|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153525259|NCT06072729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153525260|NCT06072729|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153525261|NCT06072729|Tocolytic Agents|tocolytic agents|mesh-ancestor
153525262|NCT06072729|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153525263|NCT06072716|Chitosan|chitosan|mesh-list
153525264|NCT06072716|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153525265|NCT06072716|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153525266|NCT06072716|Antimetabolites|antimetabolites|mesh-ancestor
153525267|NCT06072716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153525268|NCT06072716|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153525270|NCT06072716|Sequestering Agents|sequestering agents|mesh-ancestor
153471268|NCT05765617|Calcitriol|calcitriol|mesh-list
153525271|NCT06072716|Hemostatics|hemostatics|mesh-ancestor
153525272|NCT06072716|Coagulants|coagulants|mesh-ancestor
153525274|NCT06072547|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
153525275|NCT06072547|Autonomic Agents|autonomic agents|mesh-ancestor
153525276|NCT06072547|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153525277|NCT06072547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153525278|NCT06072547|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
153525279|NCT06072547|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
153525280|NCT06072547|Cholinergic Agents|cholinergic agents|mesh-ancestor
153525281|NCT06072547|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153525299|NCT06072118|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153525300|NCT06072118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153525301|NCT06072118|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153525302|NCT06072118|Respiratory System Agents|respiratory system agents|mesh-ancestor
153525303|NCT06072118|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
153525304|NCT06072118|Vasodilator Agents|vasodilator agents|mesh-ancestor
153525305|NCT06072118|Protective Agents|protective agents|mesh-ancestor
153525306|NCT06071897|Antibodies|antibodies|mesh-list
153525307|NCT06071897|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
153525308|NCT06071897|Immunologic Factors|immunologic factors|mesh-ancestor
153525309|NCT06071897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153525310|NCT06071871|Obinutuzumab|obinutuzumab|mesh-list
153525311|NCT06071871|Polatuzumab vedotin|polatuzumab vedotin|mesh-list
153525312|NCT06071871|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153525314|NCT06071871|Immunoconjugates|immunoconjugates|mesh-ancestor
153525361|NCT06060704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153525362|NCT06060704|Growth Inhibitors|growth inhibitors|mesh-ancestor
153525363|NCT06060704|Antimetabolites|antimetabolites|mesh-ancestor
153525364|NCT06060704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153525365|NCT06060704|Antiviral Agents|antiviral agents|mesh-ancestor
153525366|NCT06060704|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153525367|NCT06058884|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
153525368|NCT06058884|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153525369|NCT06058884|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153525423|NCT05998317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153525424|NCT05978713|Tirzepatide|tirzepatide|mesh-list
153525425|NCT05978713|Incretins|incretins|mesh-ancestor
153525426|NCT05978713|Hormones|hormones|mesh-ancestor
153525427|NCT05978713|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153525428|NCT05978713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153525429|NCT05974852|Ocrelizumab|ocrelizumab|mesh-list
153525430|NCT05974852|Immunologic Factors|immunologic factors|mesh-ancestor
153525431|NCT05974852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153877204|NCT06034158|Benserazide, levodopa drug combination|benserazide, levodopa drug combination|mesh-list
153525433|NCT05974839|Immunologic Factors|immunologic factors|mesh-ancestor
153525434|NCT05974839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153525435|NCT05965895|Dexmedetomidine|dexmedetomidine|mesh-list
153525436|NCT05965895|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153525437|NCT05965895|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153525438|NCT05965895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153525439|NCT05965895|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153525440|NCT05965895|Analgesics|analgesics|mesh-ancestor
153525441|NCT05965895|Sensory System Agents|sensory system agents|mesh-ancestor
153525442|NCT05965895|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153525443|NCT05965895|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
153525444|NCT05965895|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153525445|NCT05965895|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153525446|NCT05965895|Adrenergic Agents|adrenergic agents|mesh-ancestor
153525447|NCT05965895|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153525450|NCT05939674|Antidotes|antidotes|mesh-ancestor
153525469|NCT05860881|Antifungal Agents|antifungal agents|mesh-ancestor
153525470|NCT05860881|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153525471|NCT05860881|Immunologic Factors|immunologic factors|mesh-ancestor
153525472|NCT05860881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153525474|NCT05847244|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153525475|NCT05847244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153525476|NCT05801913|Vaccines|vaccines|mesh-list
153525477|NCT05801913|Immunologic Factors|immunologic factors|mesh-ancestor
153525478|NCT05801913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153525479|NCT05789303|Dexamethasone|dexamethasone|mesh-list
153525480|NCT05789303|Pomalidomide|pomalidomide|mesh-list
153525481|NCT05789303|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153525482|NCT05789303|Antiemetics|antiemetics|mesh-ancestor
153525483|NCT05789303|Autonomic Agents|autonomic agents|mesh-ancestor
153525484|NCT05789303|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153525485|NCT05789303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153525486|NCT05789303|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153525487|NCT05789303|Glucocorticoids|glucocorticoids|mesh-ancestor
153525488|NCT05789303|Hormones|hormones|mesh-ancestor
153525489|NCT05789303|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153525526|NCT05767086|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153525527|NCT05767086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153525528|NCT05767086|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
153525529|NCT05767086|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
153525530|NCT05767086|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
153525531|NCT05767086|Contraceptive Agents|contraceptive agents|mesh-ancestor
153525532|NCT05767086|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153525533|NCT05767086|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
153525534|NCT05767086|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
153525535|NCT05767086|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
153525536|NCT05767086|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153525537|NCT05767086|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153525538|NCT05767086|Progestins|progestins|mesh-ancestor
153525539|NCT05767086|Fertility Agents, Female|fertility agents, female|mesh-ancestor
153525540|NCT05767086|Fertility Agents|fertility agents|mesh-ancestor
153525541|NCT05750745|Fluorides|fluorides|mesh-list
153525542|NCT05750745|Cariostatic Agents|cariostatic agents|mesh-ancestor
153525543|NCT05750745|Protective Agents|protective agents|mesh-ancestor
153525544|NCT05750745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153525545|NCT05746546|Nicotine|nicotine|mesh-list
153525546|NCT05746546|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
153525547|NCT05746546|Autonomic Agents|autonomic agents|mesh-ancestor
153525548|NCT05746546|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153525549|NCT05746546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153525550|NCT05746546|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
153525551|NCT05746546|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
153525552|NCT05746546|Cholinergic Agents|cholinergic agents|mesh-ancestor
153525553|NCT05746546|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153525554|NCT05746546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153525555|NCT05746273|Nicotine|nicotine|mesh-list
153525557|NCT05746273|Autonomic Agents|autonomic agents|mesh-ancestor
153525568|NCT05742295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153525569|NCT05742295|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
153525570|NCT05742295|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153525571|NCT05742295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153525572|NCT05742295|Hemostatics|hemostatics|mesh-ancestor
153525573|NCT05742295|Coagulants|coagulants|mesh-ancestor
153525574|NCT05733364|Vitamin B Complex|vitamin b complex|mesh-list
153525575|NCT05733364|Vitamins|vitamins|mesh-ancestor
153525576|NCT05733364|Micronutrients|micronutrients|mesh-ancestor
153525577|NCT05733364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153525578|NCT05728372|Copper|copper|mesh-list
153525579|NCT05728372|Pembrolizumab|pembrolizumab|mesh-list
153525580|NCT05728372|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153525630|NCT05641649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153525632|NCT05641649|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153525633|NCT05641649|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153525634|NCT05641649|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153525635|NCT05639972|Aldesleukin|aldesleukin|mesh-list
153525636|NCT05639972|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153525637|NCT05639972|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153525638|NCT05639972|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153525639|NCT05639972|Antiviral Agents|antiviral agents|mesh-ancestor
153525640|NCT05639972|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153525641|NCT05632211|Golimumab|golimumab|mesh-list
153525642|NCT05632211|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
153525643|NCT05632211|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153525644|NCT05632211|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153525645|NCT05632211|Immunologic Factors|immunologic factors|mesh-ancestor
153525646|NCT05632211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153525647|NCT05606757|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
153525648|NCT05606757|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
153525649|NCT05606757|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
153525650|NCT05606757|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153525651|NCT05606757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153525652|NCT05606757|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
153468821|NCT05962229|Nicotine|nicotine|mesh-list
153525653|NCT05606757|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153525654|NCT05606757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153525657|NCT05605470|Vaccines|vaccines|mesh-list
153525677|NCT05558124|Immunologic Factors|immunologic factors|mesh-ancestor
153525678|NCT05558124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153525679|NCT05558124|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153525680|NCT05558124|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153525681|NCT05558124|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153525682|NCT05558124|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153525683|NCT05558124|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153525684|NCT05558124|Immunotoxins|immunotoxins|mesh-ancestor
153525685|NCT05558124|Immunoconjugates|immunoconjugates|mesh-ancestor
153525686|NCT05487196|Clonidine|clonidine|mesh-list
153525687|NCT05487196|Fentanyl|fentanyl|mesh-list
153525688|NCT05487196|Dexmedetomidine|dexmedetomidine|mesh-list
153525689|NCT05487196|Ropivacaine|ropivacaine|mesh-list
153525690|NCT05487196|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153525691|NCT05487196|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153525692|NCT05487196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153525693|NCT05487196|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153525694|NCT05487196|Analgesics|analgesics|mesh-ancestor
153525696|NCT05487196|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153525702|NCT05487196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153525703|NCT05487196|Anesthetics, Local|anesthetics, local|mesh-ancestor
153525704|NCT05487196|Anesthetics|anesthetics|mesh-ancestor
153525705|NCT05487196|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153525706|NCT05487196|Narcotics|narcotics|mesh-ancestor
153525707|NCT05487196|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153525708|NCT05487196|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153525709|NCT05487196|Anesthetics, General|anesthetics, general|mesh-ancestor
153525710|NCT05487196|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153525711|NCT05487196|Sympatholytics|sympatholytics|mesh-ancestor
153525712|NCT05487196|Autonomic Agents|autonomic agents|mesh-ancestor
153525713|NCT05471700|Azacitidine|azacitidine|mesh-list
153525714|NCT05471700|Venetoclax|venetoclax|mesh-list
153820683|NCT00464763|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153525715|NCT05471700|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153525716|NCT05471700|Antimetabolites|antimetabolites|mesh-ancestor
153525717|NCT05471700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153525718|NCT05471700|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153525719|NCT05471700|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153525720|NCT05469178|Carboplatin|carboplatin|mesh-list
153525721|NCT05469178|Pembrolizumab|pembrolizumab|mesh-list
153525722|NCT05469178|Pemetrexed|pemetrexed|mesh-list
153525723|NCT05469178|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153525724|NCT05469178|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153525725|NCT05469178|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153525726|NCT05469178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153618928|NCT01980966|Antiviral Agents|antiviral agents|mesh-ancestor
153525727|NCT05469178|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153525728|NCT05469178|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153525729|NCT05469178|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153525730|NCT05461378|Cilgavimab and tixagevimab drug combination|cilgavimab and tixagevimab drug combination|mesh-list
153525731|NCT05461378|Antiviral Agents|antiviral agents|mesh-ancestor
153525732|NCT05461378|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153525733|NCT05412914|Propofol|propofol|mesh-list
153525734|NCT05412914|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153525735|NCT05412914|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153525736|NCT05412914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153525737|NCT05412914|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153525738|NCT05412914|Anesthetics, General|anesthetics, general|mesh-ancestor
153525739|NCT05412914|Anesthetics|anesthetics|mesh-ancestor
153525740|NCT05406856|Cisplatin|cisplatin|mesh-list
153525761|NCT05287100|Autonomic Agents|autonomic agents|mesh-ancestor
153525762|NCT05287100|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153525763|NCT05287100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153525764|NCT05287100|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
153525765|NCT05287100|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
153525767|NCT05287100|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153525770|NCT05287100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153525772|NCT05275426|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153525773|NCT05275426|Antimetabolites|antimetabolites|mesh-ancestor
153525774|NCT05275426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153525775|NCT05275426|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153525776|NCT05224141|Carboplatin|carboplatin|mesh-list
153525777|NCT05224141|Pembrolizumab|pembrolizumab|mesh-list
153525778|NCT05224141|Etoposide|etoposide|mesh-list
153525779|NCT05224141|Atezolizumab|atezolizumab|mesh-list
153525780|NCT05224141|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153525781|NCT05224141|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153525782|NCT05224141|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153525783|NCT05224141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153525784|NCT05224141|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153525809|NCT05196308|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153525810|NCT05196308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153525812|NCT05196308|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153525814|NCT05187377|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153525815|NCT05187377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153525816|NCT05168618|Atezolizumab|atezolizumab|mesh-list
153525817|NCT05168618|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
153525818|NCT05168618|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153525875|NCT05081674|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153525876|NCT05081674|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153525877|NCT05081674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153525878|NCT05081674|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153525879|NCT05081674|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153525947|NCT04988282|Autonomic Agents|autonomic agents|mesh-ancestor
153525948|NCT04988282|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153525949|NCT04988282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153525950|NCT04988282|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153526018|NCT04933695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153526019|NCT04933695|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153526020|NCT04933695|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153526021|NCT04919317|Dexamethasone|dexamethasone|mesh-list
153526022|NCT04919317|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153526023|NCT04919317|Antiemetics|antiemetics|mesh-ancestor
153526024|NCT04919317|Autonomic Agents|autonomic agents|mesh-ancestor
153526025|NCT04919317|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153526026|NCT04919317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153526027|NCT04919317|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153526028|NCT04919317|Glucocorticoids|glucocorticoids|mesh-ancestor
153526030|NCT04919317|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153526031|NCT04919317|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153526032|NCT04919317|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153526033|NCT04915248|Dexamethasone|dexamethasone|mesh-list
153526034|NCT04915248|Dexamethasone acetate|dexamethasone acetate|mesh-list
153526035|NCT04915248|Bortezomib|bortezomib|mesh-list
153526036|NCT04915248|Daratumumab|daratumumab|mesh-list
153526037|NCT04915248|BB 1101|bb 1101|mesh-list
153526038|NCT04915248|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
153526039|NCT04915248|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153526040|NCT04915248|Antiemetics|antiemetics|mesh-ancestor
153526041|NCT04915248|Autonomic Agents|autonomic agents|mesh-ancestor
153526042|NCT04915248|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153526046|NCT04915248|Hormones|hormones|mesh-ancestor
153555423|NCT02039063|Quetmolimab|quetmolimab|mesh-list
153526066|NCT04892199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153526068|NCT04871594|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153526069|NCT04871594|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153526070|NCT04871594|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153526071|NCT04871594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153526072|NCT04848857|Colchicine|colchicine|mesh-list
153526073|NCT04848857|Gout Suppressants|gout suppressants|mesh-ancestor
153526074|NCT04848857|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153526075|NCT04848857|Tubulin Modulators|tubulin modulators|mesh-ancestor
153526076|NCT04848857|Antimitotic Agents|antimitotic agents|mesh-ancestor
153526077|NCT04848857|Mitosis Modulators|mitosis modulators|mesh-ancestor
153526078|NCT04848857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153526079|NCT04848857|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153526080|NCT04826562|Lamivudine|lamivudine|mesh-list
153526081|NCT04826562|Dolutegravir|dolutegravir|mesh-list
153526086|NCT04826562|Antiviral Agents|antiviral agents|mesh-ancestor
153526123|NCT04649502|Metformin|metformin|mesh-list
153526124|NCT04649502|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153526125|NCT04649502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153526126|NCT04629651|Captopril|captopril|mesh-list
153526127|NCT04629651|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
153526128|NCT04629651|Protease Inhibitors|protease inhibitors|mesh-ancestor
153526192|NCT04510051|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153526194|NCT04480463|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153526195|NCT04480463|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153526196|NCT04480463|Growth Substances|growth substances|mesh-ancestor
153526197|NCT04480463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153526198|NCT04480463|Growth Inhibitors|growth inhibitors|mesh-ancestor
153526199|NCT04480463|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153526200|NCT04470609|Vaccines|vaccines|mesh-list
153526201|NCT04470609|Immunologic Factors|immunologic factors|mesh-ancestor
153526202|NCT04470609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153526203|NCT04464759|Hydroxychloroquine|hydroxychloroquine|mesh-list
153526204|NCT04464759|Nivolumab|nivolumab|mesh-list
153526205|NCT04464759|Ipilimumab|ipilimumab|mesh-list
153526207|NCT04464759|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153526255|NCT04332341|Micronutrients|micronutrients|mesh-ancestor
153526256|NCT04332341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153526257|NCT04332341|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153526258|NCT04332341|Antimetabolites|antimetabolites|mesh-ancestor
153526259|NCT04332341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153526260|NCT04332341|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153526261|NCT04332341|Vasodilator Agents|vasodilator agents|mesh-ancestor
153526262|NCT04325659|Lofexidine|lofexidine|mesh-list
153526263|NCT04325659|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153526264|NCT04325659|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
153526265|NCT04325659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153526266|NCT04325659|Sensory System Agents|sensory system agents|mesh-ancestor
153526267|NCT04325659|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153526269|NCT04325659|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153526270|NCT04325659|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153526271|NCT04325659|Adrenergic Agents|adrenergic agents|mesh-ancestor
153526272|NCT04325659|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153526273|NCT04325659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153555427|NCT02039063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153526274|NCT04314375|Budesonide|budesonide|mesh-list
153526275|NCT04314375|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153526307|NCT04093362|Gemcitabine|gemcitabine|mesh-list
153526309|NCT04093362|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153526310|NCT04093362|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153526311|NCT04093362|Antimetabolites|antimetabolites|mesh-ancestor
153526312|NCT04093362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153526313|NCT04061239|Cytarabine|cytarabine|mesh-list
153526314|NCT04061239|Azacitidine|azacitidine|mesh-list
153526315|NCT04061239|Daunorubicin|daunorubicin|mesh-list
153526316|NCT04061239|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153526317|NCT04061239|Antimetabolites|antimetabolites|mesh-ancestor
153526318|NCT04061239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153526319|NCT04061239|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153526320|NCT04061239|Antiviral Agents|antiviral agents|mesh-ancestor
153526321|NCT04061239|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153526322|NCT04061239|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153526323|NCT04061239|Immunologic Factors|immunologic factors|mesh-ancestor
153526324|NCT04061239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153526325|NCT04061239|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153526326|NCT04061239|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153526327|NCT04061239|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153526328|NCT04061239|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153526329|NCT04034004|Naloxone|naloxone|mesh-list
153526330|NCT04034004|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
153526331|NCT04034004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153526356|NCT03995641|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153526357|NCT03995641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153526358|NCT03995641|Sensory System Agents|sensory system agents|mesh-ancestor
153526359|NCT03995641|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153526360|NCT03995641|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153526361|NCT03995641|Glucocorticoids|glucocorticoids|mesh-ancestor
153526362|NCT03995641|Hormones|hormones|mesh-ancestor
153526363|NCT03995641|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153526364|NCT03995641|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153526365|NCT03995641|Immunologic Factors|immunologic factors|mesh-ancestor
153526366|NCT03862950|Metformin|metformin|mesh-list
153526367|NCT03862950|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153526368|NCT03862950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153526369|NCT03844750|Pembrolizumab|pembrolizumab|mesh-list
153526424|NCT03568383|Isoniazid|isoniazid|mesh-list
153526425|NCT03568383|Vitamins|vitamins|mesh-ancestor
153526426|NCT03568383|Micronutrients|micronutrients|mesh-ancestor
153526427|NCT03568383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153526428|NCT03568383|Vitamin B Complex|vitamin b complex|mesh-ancestor
153526429|NCT03568383|Antitubercular Agents|antitubercular agents|mesh-ancestor
153526430|NCT03568383|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153526431|NCT03568383|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153526432|NCT03568383|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
153526437|NCT03567473|Dexamethasone|dexamethasone|mesh-list
153526490|NCT03425669|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153526491|NCT03420014|Doxorubicin|doxorubicin|mesh-list
153526492|NCT03420014|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
153526493|NCT03420014|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153526494|NCT03420014|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153526495|NCT03420014|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153526496|NCT03420014|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153526497|NCT03420014|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153526498|NCT03420014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153526501|NCT03395405|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153526502|NCT03381248|Hyaluronic Acid|hyaluronic acid|mesh-list
153526503|NCT03381248|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153526504|NCT03381248|Immunologic Factors|immunologic factors|mesh-ancestor
153526505|NCT03381248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153526506|NCT03381248|Viscosupplements|viscosupplements|mesh-ancestor
153526507|NCT03381248|Protective Agents|protective agents|mesh-ancestor
153526508|NCT03357757|Avelumab|avelumab|mesh-list
153526509|NCT03357757|Valproic Acid|valproic acid|mesh-list
153526546|NCT03097939|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153526547|NCT03097939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153526549|NCT03096782|Cyclophosphamide|cyclophosphamide|mesh-list
153526550|NCT03096782|Melphalan|melphalan|mesh-list
153618930|NCT01980966|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153526616|NCT02966665|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
153526617|NCT02966665|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
153526618|NCT02966665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153526619|NCT02966665|Antioxidants|antioxidants|mesh-ancestor
153526620|NCT02966665|Protective Agents|protective agents|mesh-ancestor
153526684|NCT02681211|Antipruritics|antipruritics|mesh-ancestor
153526685|NCT02681211|Dermatologic Agents|dermatologic agents|mesh-ancestor
153526686|NCT02681211|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
153526687|NCT02681211|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
153526688|NCT02681211|Dopamine Agents|dopamine agents|mesh-ancestor
153526689|NCT02666768|Interferons|interferons|mesh-list
153526690|NCT02666768|Interferon-gamma|interferon-gamma|mesh-list
153526691|NCT02666768|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153526692|NCT02666768|Antiviral Agents|antiviral agents|mesh-ancestor
153526694|NCT02632708|Cytarabine|cytarabine|mesh-list
153526695|NCT02632708|Etoposide|etoposide|mesh-list
153526696|NCT02632708|Daunorubicin|daunorubicin|mesh-list
153526697|NCT02632708|Mitoxantrone|mitoxantrone|mesh-list
153526698|NCT02632708|Idarubicin|idarubicin|mesh-list
153526699|NCT02632708|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153526700|NCT02632708|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153526701|NCT02632708|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153526702|NCT02632708|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153526703|NCT02632708|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153526706|NCT02632708|Antimetabolites|antimetabolites|mesh-ancestor
153526741|NCT02448420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153526742|NCT02448420|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153526743|NCT02448420|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153526744|NCT02448420|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153526745|NCT02448420|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153526746|NCT02448420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153526750|NCT02448420|Immunotoxins|immunotoxins|mesh-ancestor
153526806|NCT02315326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153526807|NCT02315326|Dermatologic Agents|dermatologic agents|mesh-ancestor
153526808|NCT02315326|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153526809|NCT02315326|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153526810|NCT02315326|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153526811|NCT02315326|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153526812|NCT02315326|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153526813|NCT02315326|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153526814|NCT02303431|Edoxaban|edoxaban|mesh-list
153526871|NCT01860456|Nilotinib|nilotinib|mesh-list
153526872|NCT01860456|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153526873|NCT01860456|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153526874|NCT01860456|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153526875|NCT01860456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153526876|NCT01860456|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153526877|NCT01848639|Spironolactone|spironolactone|mesh-list
153526878|NCT01848639|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
153526879|NCT01848639|Hormone Antagonists|hormone antagonists|mesh-ancestor
153526880|NCT01848639|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153526881|NCT01848639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153526882|NCT01848639|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
153526884|NCT01848639|Natriuretic Agents|natriuretic agents|mesh-ancestor
153526928|NCT01279850|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153526929|NCT01279850|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153526930|NCT01279850|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153526931|NCT01068327|Leucovorin|leucovorin|mesh-list
153526932|NCT01068327|Nelfinavir|nelfinavir|mesh-list
153526933|NCT01068327|Gemcitabine|gemcitabine|mesh-list
153526934|NCT01068327|Fluorouracil|fluorouracil|mesh-list
153526935|NCT01068327|Calcium|calcium|mesh-list
153526936|NCT01068327|Levoleucovorin|levoleucovorin|mesh-list
153526937|NCT01068327|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153526938|NCT01068327|Antimetabolites|antimetabolites|mesh-ancestor
153526939|NCT01068327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153526940|NCT01068327|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153526945|NCT01068327|Antidotes|antidotes|mesh-ancestor
153526994|NCT01035463|Dermatologic Agents|dermatologic agents|mesh-ancestor
153526995|NCT01035463|Tubulin Modulators|tubulin modulators|mesh-ancestor
153526996|NCT01035463|Antimitotic Agents|antimitotic agents|mesh-ancestor
153526997|NCT01035463|Mitosis Modulators|mitosis modulators|mesh-ancestor
153526998|NCT00936390|Leuprolide|leuprolide|mesh-list
153526999|NCT00936390|Goserelin|goserelin|mesh-list
153527000|NCT00936390|Triptorelin Pamoate|triptorelin pamoate|mesh-list
153527001|NCT00936390|Flutamide|flutamide|mesh-list
153527002|NCT00936390|Bicalutamide|bicalutamide|mesh-list
153527003|NCT00936390|Buserelin|buserelin|mesh-list
153527004|NCT00936390|Androgens|androgens|mesh-list
153527005|NCT00936390|Androgen Antagonists|androgen antagonists|mesh-list
153527006|NCT00936390|Fertility Agents, Female|fertility agents, female|mesh-ancestor
153470168|NCT03383575|Azacitidine|azacitidine|mesh-list
153527007|NCT00936390|Fertility Agents|fertility agents|mesh-ancestor
153527057|NCT00149149|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
153527058|NCT00149149|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153527059|NCT01469338|Prednisone|prednisone|mesh-list
153527060|NCT01469338|Octreotide|octreotide|mesh-list
153527061|NCT01469338|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153527062|NCT01469338|Glucocorticoids|glucocorticoids|mesh-ancestor
153527063|NCT01469338|Hormones|hormones|mesh-ancestor
153527064|NCT01469338|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153527065|NCT01469338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153527066|NCT01469338|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153527067|NCT01469338|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153527068|NCT01469338|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153527069|NCT01469351|Liraglutide|liraglutide|mesh-list
153527071|NCT01469351|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153527115|NCT01469520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153527116|NCT01469520|Antiviral Agents|antiviral agents|mesh-ancestor
153527117|NCT01469520|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153527118|NCT01469520|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153527119|NCT01469520|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153527120|NCT01469520|Antimetabolites|antimetabolites|mesh-ancestor
153527121|NCT01469520|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
153527123|NCT01469559|Insulin|insulin|mesh-list
153527184|NCT01469975|Sequestering Agents|sequestering agents|mesh-ancestor
153527185|NCT01469975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153527186|NCT01469975|Iron Chelating Agents|iron chelating agents|mesh-ancestor
153527187|NCT01469975|Anticoagulants|anticoagulants|mesh-ancestor
153527188|NCT01469975|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
153527189|NCT01469988|Testosterone|testosterone|mesh-list
153527190|NCT01469988|Androgens|androgens|mesh-ancestor
153527192|NCT01469988|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153527193|NCT01469988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153527194|NCT01470040|Aspirin|aspirin|mesh-list
153527195|NCT01470040|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153527196|NCT01470040|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153527197|NCT01470040|Analgesics|analgesics|mesh-ancestor
153527198|NCT01470040|Sensory System Agents|sensory system agents|mesh-ancestor
153527199|NCT01470040|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153527200|NCT01470040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153527240|NCT01470157|Ketamine|ketamine|mesh-list
153527241|NCT01470157|Analgesics|analgesics|mesh-ancestor
153527242|NCT01470157|Sensory System Agents|sensory system agents|mesh-ancestor
153527243|NCT01470157|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153527244|NCT01470157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153527245|NCT01470157|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
153527246|NCT01470157|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153555536|NCT02855229|Dopamine Agents|dopamine agents|mesh-ancestor
153527247|NCT01470157|Anesthetics, General|anesthetics, general|mesh-ancestor
153527248|NCT01470157|Anesthetics|anesthetics|mesh-ancestor
153527249|NCT01470157|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153527300|NCT01470456|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153527301|NCT01470456|Immunologic Factors|immunologic factors|mesh-ancestor
153527302|NCT01470456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153527303|NCT01470456|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153527304|NCT01470495|Sorafenib|sorafenib|mesh-list
153527305|NCT01470495|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153527306|NCT01470495|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153527307|NCT01470495|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153527308|NCT01470495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153527309|NCT01470690|Omeprazole|omeprazole|mesh-list
153527310|NCT01470690|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
153527311|NCT01470690|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153527313|NCT01470690|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153527314|NCT01470690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153527315|NCT01470742|Capecitabine|capecitabine|mesh-list
153527316|NCT01470742|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153527317|NCT01470742|Antimetabolites|antimetabolites|mesh-ancestor
153527319|NCT01470742|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153527357|NCT01471067|Antitubercular Agents|antitubercular agents|mesh-ancestor
153527358|NCT01471067|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153527359|NCT01471067|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153527360|NCT01471067|Alkylating Agents|alkylating agents|mesh-ancestor
153527361|NCT01471067|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153527362|NCT01471132|Paclitaxel|paclitaxel|mesh-list
153527363|NCT01471132|Oxaliplatin|oxaliplatin|mesh-list
153527364|NCT01471132|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153527365|NCT01471132|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153527366|NCT01471132|Tubulin Modulators|tubulin modulators|mesh-ancestor
153527367|NCT01471132|Antimitotic Agents|antimitotic agents|mesh-ancestor
153527368|NCT01471132|Mitosis Modulators|mitosis modulators|mesh-ancestor
153527369|NCT01471132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153527370|NCT01471145|Naltrexone|naltrexone|mesh-list
153527371|NCT01471145|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
153527372|NCT01471145|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
153527373|NCT01471145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153470546|NCT00114101|Lenalidomide|lenalidomide|mesh-list
153527375|NCT01471145|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153527376|NCT01471158|Timolol|timolol|mesh-list
153527377|NCT01471158|Dorzolamide|dorzolamide|mesh-list
153527378|NCT01471158|Maleic acid|maleic acid|mesh-list
153527379|NCT01471158|Brinzolamide|brinzolamide|mesh-list
153527380|NCT01471158|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153527381|NCT01471158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153527382|NCT01471158|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
153527383|NCT01471158|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
153527384|NCT01471158|Adrenergic Agents|adrenergic agents|mesh-ancestor
153527385|NCT01471158|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153527386|NCT01471158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153527387|NCT01471158|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153527388|NCT01471158|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153527389|NCT01471158|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
153527390|NCT01471184|Ophthalmic Solutions|ophthalmic solutions|mesh-list
153527391|NCT01471184|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
153527396|NCT01471275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153527397|NCT01471418|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
153527398|NCT01471418|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
153555580|NCT02652455|Fludarabine|fludarabine|mesh-list
153527399|NCT01471418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153527400|NCT01471470|Bevacizumab|bevacizumab|mesh-list
153527401|NCT01471470|Docetaxel|docetaxel|mesh-list
153527403|NCT01471470|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153527404|NCT01471470|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153527405|NCT01471470|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153527406|NCT01471470|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153527408|NCT01471470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153527409|NCT01471470|Growth Inhibitors|growth inhibitors|mesh-ancestor
153527410|NCT01471470|Tubulin Modulators|tubulin modulators|mesh-ancestor
153527411|NCT01471470|Antimitotic Agents|antimitotic agents|mesh-ancestor
153527412|NCT01471470|Mitosis Modulators|mitosis modulators|mesh-ancestor
153527413|NCT01471470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153527414|NCT01471470|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153527415|NCT01471470|Antimetabolites|antimetabolites|mesh-ancestor
153527416|NCT01471535|Interferons|interferons|mesh-list
153527417|NCT01471535|Interferon-alpha|interferon-alpha|mesh-list
153527418|NCT01471535|Interferon alpha-2|interferon alpha-2|mesh-list
153527419|NCT01471535|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
153527420|NCT01471535|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153527421|NCT01471535|Antiviral Agents|antiviral agents|mesh-ancestor
153527422|NCT01471535|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153527443|NCT01471678|Urological Agents|urological agents|mesh-ancestor
153527444|NCT01471678|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
153527445|NCT01471678|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153527446|NCT01471678|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153527447|NCT01471678|Hormone Antagonists|hormone antagonists|mesh-ancestor
153527448|NCT01471678|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153527450|NCT01471704|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153527451|NCT01471704|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153527452|NCT01471704|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153527453|NCT01471704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153527454|NCT01471704|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153527455|NCT01471704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153527456|NCT01471704|Vasodilator Agents|vasodilator agents|mesh-ancestor
153527457|NCT01471730|Thrombin|thrombin|mesh-list
153527458|NCT01471730|Hemostatics|hemostatics|mesh-ancestor
153527459|NCT01471730|Coagulants|coagulants|mesh-ancestor
153527460|NCT01471808|Metformin|metformin|mesh-list
153527461|NCT01471808|Pioglitazone|pioglitazone|mesh-list
153527462|NCT01471808|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
153527463|NCT01471808|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153527464|NCT01471808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153527467|NCT01471808|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153527468|NCT01471808|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
153527469|NCT01471808|Protease Inhibitors|protease inhibitors|mesh-ancestor
153527470|NCT01471808|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153527489|NCT01471886|Naproxen|naproxen|mesh-list
153527490|NCT01471886|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153527491|NCT01471886|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153527492|NCT01471886|Analgesics|analgesics|mesh-ancestor
153527493|NCT01471886|Sensory System Agents|sensory system agents|mesh-ancestor
153527494|NCT01471886|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153527495|NCT01471886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153527496|NCT01471886|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153527497|NCT01471886|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153555644|NCT02185417|Natriuretic Agents|natriuretic agents|mesh-ancestor
153555655|NCT01859026|Mitogens|mitogens|mesh-list
153527498|NCT01471886|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153527499|NCT01471886|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153527500|NCT01471886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153527501|NCT01471886|Gout Suppressants|gout suppressants|mesh-ancestor
153527502|NCT01471899|Ketorolac|ketorolac|mesh-list
153527503|NCT01471899|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
153527504|NCT01471899|Naproxen|naproxen|mesh-list
153527505|NCT01471899|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153527506|NCT01471899|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153527507|NCT01471899|Analgesics|analgesics|mesh-ancestor
153527508|NCT01471899|Sensory System Agents|sensory system agents|mesh-ancestor
153527509|NCT01471899|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153527510|NCT01471899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153527511|NCT01471899|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153527512|NCT01471899|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153527513|NCT01471899|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153527514|NCT01471899|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153527536|NCT01471990|Growth Substances|growth substances|mesh-ancestor
153527537|NCT01471990|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153527538|NCT01471990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153527539|NCT01472016|Docetaxel|docetaxel|mesh-list
153527540|NCT01472016|Cetuximab|cetuximab|mesh-list
153527541|NCT01472016|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
153527542|NCT01472016|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153527543|NCT01472016|Tubulin Modulators|tubulin modulators|mesh-ancestor
153527544|NCT01472016|Antimitotic Agents|antimitotic agents|mesh-ancestor
153527545|NCT01472016|Mitosis Modulators|mitosis modulators|mesh-ancestor
153527546|NCT01472016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153527547|NCT01472016|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153527548|NCT01472016|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153527549|NCT01472016|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153527550|NCT01472016|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153527551|NCT01472029|Leucovorin|leucovorin|mesh-list
153527595|NCT01472315|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
153527596|NCT01472315|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
153527597|NCT01472315|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
153527598|NCT01472315|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153527599|NCT01472315|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153527601|NCT01472406|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153527602|NCT01472497|Pioglitazone|pioglitazone|mesh-list
153527603|NCT01472497|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153527604|NCT01472497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153527605|NCT01472510|Ranibizumab|ranibizumab|mesh-list
153527607|NCT01472510|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153527608|NCT01472510|Growth Substances|growth substances|mesh-ancestor
153527609|NCT01472510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153527610|NCT01472510|Growth Inhibitors|growth inhibitors|mesh-ancestor
153527611|NCT01472510|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153527612|NCT01472640|Liraglutide|liraglutide|mesh-list
153527613|NCT01472640|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
153527614|NCT01472640|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153527649|NCT01472796|Protease Inhibitors|protease inhibitors|mesh-ancestor
153527650|NCT01472796|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153527651|NCT01472796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153527652|NCT01472900|Benzoyl Peroxide|benzoyl peroxide|mesh-list
153527653|NCT01472900|Dermatologic Agents|dermatologic agents|mesh-ancestor
153527654|NCT01472913|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
153527655|NCT01472913|Hemostatics|hemostatics|mesh-ancestor
153527656|NCT01472913|Coagulants|coagulants|mesh-ancestor
153527657|NCT01472926|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
153527658|NCT01472926|Plasminogen|plasminogen|mesh-list
153527659|NCT01472926|Tenecteplase|tenecteplase|mesh-list
153527660|NCT01472926|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153527661|NCT01472926|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153527662|NCT01472926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153527663|NCT01472978|Metronidazole|metronidazole|mesh-list
153527664|NCT01472978|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153527665|NCT01472978|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153527666|NCT01472978|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153527667|NCT01472978|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153527669|NCT01473043|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153527670|NCT01473043|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153527671|NCT01473043|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153527672|NCT01473043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153527673|NCT01473069|Ketoconazole|ketoconazole|mesh-list
153527675|NCT01473069|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153527676|NCT01473069|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
153527677|NCT01473069|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153527678|NCT01473069|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153527679|NCT01473069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153527680|NCT01473069|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153527681|NCT01473069|Hormone Antagonists|hormone antagonists|mesh-ancestor
153527688|NCT01473147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153527689|NCT01473147|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
153527690|NCT01473147|Incretins|incretins|mesh-ancestor
153527691|NCT01473147|Hormones|hormones|mesh-ancestor
153527692|NCT01473147|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153527693|NCT01473173|Esomeprazole|esomeprazole|mesh-list
153527694|NCT01473173|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
153527695|NCT01473173|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153527696|NCT01473173|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
153527697|NCT01473173|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153527698|NCT01473173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153527699|NCT01473251|Bevacizumab|bevacizumab|mesh-list
153527751|NCT01473316|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
153527753|NCT01473316|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153527754|NCT01473316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153527755|NCT01473316|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153527756|NCT01473316|Hormone Antagonists|hormone antagonists|mesh-ancestor
153527757|NCT01473316|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153527758|NCT01473316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153527759|NCT01473316|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
153527760|NCT01473472|Tenofovir|tenofovir|mesh-list
153527761|NCT01473472|Emtricitabine|emtricitabine|mesh-list
153527762|NCT01473472|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
153527763|NCT01473472|Antiviral Agents|antiviral agents|mesh-ancestor
153527764|NCT01473472|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153527765|NCT01473472|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153527766|NCT01473472|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153527767|NCT01473472|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153527768|NCT01473472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153527769|NCT01473472|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153527770|NCT01473472|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153527771|NCT01473537|Calcium|calcium|mesh-list
153527772|NCT01473537|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153527773|NCT01473537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153527774|NCT01473797|Cladribine|cladribine|mesh-list
153527776|NCT01473797|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153527777|NCT01473797|Immunologic Factors|immunologic factors|mesh-ancestor
153527796|NCT01473914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153527798|NCT01473914|Antioxidants|antioxidants|mesh-ancestor
153527799|NCT01473914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153527800|NCT01473914|Protective Agents|protective agents|mesh-ancestor
153527801|NCT01474174|Vaccines|vaccines|mesh-list
153527802|NCT01474174|Immunologic Factors|immunologic factors|mesh-ancestor
153527803|NCT01474174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153527804|NCT01474187|Capecitabine|capecitabine|mesh-list
153527805|NCT01474187|Irinotecan|irinotecan|mesh-list
153527806|NCT01474187|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153527807|NCT01474187|Antimetabolites|antimetabolites|mesh-ancestor
153527808|NCT01474187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153527809|NCT01474187|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153527810|NCT01474187|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
153527855|NCT01474473|Protease Inhibitors|protease inhibitors|mesh-ancestor
153527856|NCT01474473|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153527857|NCT01474473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153527859|NCT01474499|Bismuth subsalicylate|bismuth subsalicylate|mesh-list
153527860|NCT01474499|Glycerol|glycerol|mesh-list
153527861|NCT01474499|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
153527862|NCT01474499|Protective Agents|protective agents|mesh-ancestor
153527864|NCT01474499|Cathartics|cathartics|mesh-ancestor
153527865|NCT01474499|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153527866|NCT01474499|Antidiarrheals|antidiarrheals|mesh-ancestor
153527867|NCT01474642|Capecitabine|capecitabine|mesh-list
153527868|NCT01474642|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153527869|NCT01474642|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153527870|NCT01474642|Antimetabolites|antimetabolites|mesh-ancestor
153527871|NCT01474642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153527872|NCT01474902|Enoxaparin|enoxaparin|mesh-list
153527873|NCT01474902|Anticoagulants|anticoagulants|mesh-ancestor
153527875|NCT01474902|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153527876|NCT01474902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153527877|NCT01474967|Metformin|metformin|mesh-list
153527878|NCT01474967|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153527879|NCT01474967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153527880|NCT01475006|AMG 595|amg 595|mesh-list
153527881|NCT01475006|Immunoconjugates|immunoconjugates|mesh-ancestor
153527882|NCT01475006|Immunologic Factors|immunologic factors|mesh-ancestor
153527883|NCT01475006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153527884|NCT01475019|Orlistat|orlistat|mesh-list
153527885|NCT01475019|Sibutramine|sibutramine|mesh-list
153527886|NCT01475019|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153527887|NCT01475019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153527898|NCT01475032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153527899|NCT01475032|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153555750|NCT01599988|Caseins|caseins|mesh-list
153527900|NCT01475032|Respiratory System Agents|respiratory system agents|mesh-ancestor
153527901|NCT01475032|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
153527902|NCT01475032|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
153527903|NCT01475032|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153527904|NCT01475032|Adrenergic Agents|adrenergic agents|mesh-ancestor
153527905|NCT01475032|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153527906|NCT01475032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153527907|NCT01475032|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153527908|NCT01475032|Glucocorticoids|glucocorticoids|mesh-ancestor
153527909|NCT01475032|Hormones|hormones|mesh-ancestor
153527910|NCT01475032|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153527911|NCT01475227|Zinc|zinc|mesh-list
153527912|NCT01475227|Zinc Sulfate|zinc sulfate|mesh-list
153527913|NCT01475227|Trace Elements|trace elements|mesh-ancestor
153527914|NCT01475227|Micronutrients|micronutrients|mesh-ancestor
153527915|NCT01475227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153527955|NCT01475552|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
153527956|NCT01475552|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
153527957|NCT01475552|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
153527958|NCT01475552|Purinergic Agents|purinergic agents|mesh-ancestor
153527959|NCT01475552|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153527960|NCT01475552|Anticoagulants|anticoagulants|mesh-ancestor
153527961|NCT01475578|Ergoloid Mesylates|ergoloid mesylates|mesh-list
153527962|NCT01475578|Dihydroergotoxine|dihydroergotoxine|mesh-list
153527963|NCT01475578|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
153527964|NCT01475578|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
153527965|NCT01475578|Adrenergic Agents|adrenergic agents|mesh-ancestor
153527966|NCT01475578|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153527967|NCT01475578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153527968|NCT01475578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153527969|NCT01475578|Vasodilator Agents|vasodilator agents|mesh-ancestor
153527970|NCT01475578|Nootropic Agents|nootropic agents|mesh-ancestor
153527971|NCT01475578|Dopamine Agonists|dopamine agonists|mesh-ancestor
153527972|NCT01475578|Dopamine Agents|dopamine agents|mesh-ancestor
153527974|NCT01475617|Vitamin B 12|vitamin b 12|mesh-list
153527975|NCT01475617|Hydroxocobalamin|hydroxocobalamin|mesh-list
153527976|NCT01475617|Calcium|calcium|mesh-list
153527977|NCT01475617|Vitamins|vitamins|mesh-ancestor
153471147|NCT01168219|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153527978|NCT01475617|Micronutrients|micronutrients|mesh-ancestor
153527979|NCT01475617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153527980|NCT01475617|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153527981|NCT01475617|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153527982|NCT01475617|Vitamin B Complex|vitamin b complex|mesh-ancestor
153527983|NCT01475617|Hematinics|hematinics|mesh-ancestor
153527984|NCT01475656|Levetiracetam|levetiracetam|mesh-list
153528000|NCT01475760|Sequestering Agents|sequestering agents|mesh-ancestor
153528001|NCT01475760|Hemostatics|hemostatics|mesh-ancestor
153528002|NCT01475760|Coagulants|coagulants|mesh-ancestor
153528003|NCT01475877|Bromfenac|bromfenac|mesh-list
153528004|NCT01475877|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153528005|NCT01475877|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153528008|NCT01475877|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153528009|NCT01475877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153528010|NCT01475877|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153528011|NCT01475877|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153528012|NCT01475890|Vitamin D|vitamin d|mesh-list
153528013|NCT01475890|Cholecalciferol|cholecalciferol|mesh-list
153528014|NCT01475890|Vitamins|vitamins|mesh-ancestor
153528015|NCT01475890|Micronutrients|micronutrients|mesh-ancestor
153528019|NCT01476007|Vitamins|vitamins|mesh-list
153528059|NCT01476215|Antipyretics|antipyretics|mesh-ancestor
153528060|NCT01476280|Palonosetron|palonosetron|mesh-list
153528061|NCT01476280|Ramosetron|ramosetron|mesh-list
153528062|NCT01476280|Antiemetics|antiemetics|mesh-ancestor
153528063|NCT01476280|Autonomic Agents|autonomic agents|mesh-ancestor
153528064|NCT01476280|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153528065|NCT01476280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153528066|NCT01476280|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153528067|NCT01476280|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
153528068|NCT01476280|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153528069|NCT01476280|Serotonin Agents|serotonin agents|mesh-ancestor
153528070|NCT01476280|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153528071|NCT01476280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153528072|NCT01476332|Ophthalmic Solutions|ophthalmic solutions|mesh-list
153528073|NCT01476332|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
153528074|NCT01476358|Vitamin A|vitamin a|mesh-list
153528077|NCT01476358|Micronutrients|micronutrients|mesh-ancestor
153528078|NCT01476358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153528080|NCT01476358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153528081|NCT01476358|Protective Agents|protective agents|mesh-ancestor
153528082|NCT01476358|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
153528083|NCT01476358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153528085|NCT01476410|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
153528086|NCT01476410|Brentuximab Vedotin|brentuximab vedotin|mesh-list
153528087|NCT01476410|Dacarbazine|dacarbazine|mesh-list
153528088|NCT01476410|Vinblastine|vinblastine|mesh-list
153528089|NCT01476410|Antibodies|antibodies|mesh-list
153528105|NCT01476410|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153528106|NCT01476410|Alkylating Agents|alkylating agents|mesh-ancestor
153528107|NCT01476410|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153528108|NCT01476410|Tubulin Modulators|tubulin modulators|mesh-ancestor
153528109|NCT01476410|Antimitotic Agents|antimitotic agents|mesh-ancestor
153528110|NCT01476410|Mitosis Modulators|mitosis modulators|mesh-ancestor
153528112|NCT01476488|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153528113|NCT01476488|Immunologic Factors|immunologic factors|mesh-ancestor
153528114|NCT01476488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153528115|NCT01476488|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
153528117|NCT01476488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153528119|NCT01476592|Antioxidants|antioxidants|mesh-ancestor
153528120|NCT01476592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153528121|NCT01476592|Protective Agents|protective agents|mesh-ancestor
153528122|NCT01476592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153528123|NCT01476592|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153528124|NCT01476592|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153528125|NCT01476605|Sodium Morrhuate|sodium morrhuate|mesh-list
153528126|NCT01476605|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
153528127|NCT01476605|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
153528128|NCT01476683|Racecadotril|racecadotril|mesh-list
153528129|NCT01476683|Thiorphan|thiorphan|mesh-list
153528130|NCT01476683|Antidiarrheals|antidiarrheals|mesh-ancestor
153528131|NCT01476683|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153528132|NCT01476683|Protease Inhibitors|protease inhibitors|mesh-ancestor
153528133|NCT01476683|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153528134|NCT01476683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153528135|NCT01476774|Buprenorphine|buprenorphine|mesh-list
153528138|NCT01476774|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153528139|NCT01476774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153528140|NCT01476774|Analgesics|analgesics|mesh-ancestor
153528143|NCT01476774|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
153528144|NCT01476800|Ketoconazole|ketoconazole|mesh-list
153528145|NCT01476800|Mirabegron|mirabegron|mesh-list
153528146|NCT01476800|Antifungal Agents|antifungal agents|mesh-ancestor
153528147|NCT01476800|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153528148|NCT01476800|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
153528149|NCT01476800|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153528150|NCT01476800|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153528151|NCT01476800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153528152|NCT01476800|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153528153|NCT01476800|Hormone Antagonists|hormone antagonists|mesh-ancestor
153528154|NCT01476800|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153528155|NCT01476800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153528156|NCT01476800|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
153528157|NCT01476800|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
153528158|NCT01476800|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
153528159|NCT01476800|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153528160|NCT01476800|Adrenergic Agents|adrenergic agents|mesh-ancestor
153528161|NCT01476800|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153528162|NCT01476800|Urological Agents|urological agents|mesh-ancestor
153528163|NCT01476813|Glycopyrrolate|glycopyrrolate|mesh-list
153528164|NCT01476813|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153528165|NCT01476813|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
153528166|NCT01476813|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
153528167|NCT01476813|Cholinergic Agents|cholinergic agents|mesh-ancestor
153528168|NCT01476813|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153528169|NCT01476813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153528171|NCT01477021|Cyclophosphamide|cyclophosphamide|mesh-list
153528172|NCT01477021|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153528173|NCT01477021|Immunologic Factors|immunologic factors|mesh-ancestor
153528184|NCT01477034|Vitamins|vitamins|mesh-list
153528185|NCT01477034|Micronutrients|micronutrients|mesh-ancestor
153528186|NCT01477034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153528187|NCT01477034|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153528188|NCT01477034|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153528189|NCT01477060|Metformin|metformin|mesh-list
153528190|NCT01477060|Lapatinib|lapatinib|mesh-list
153528191|NCT01477060|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153528192|NCT01477060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153528193|NCT01477060|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153528194|NCT01477060|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153528195|NCT01477060|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153528196|NCT01477060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153528197|NCT01477060|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153528198|NCT01477073|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
153528199|NCT01477073|Hormones|hormones|mesh-ancestor
153528201|NCT01477073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153528202|NCT01477112|Beta Carotene|beta carotene|mesh-list
153528203|NCT01477112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153528204|NCT01477112|Provitamins|provitamins|mesh-ancestor
153528206|NCT01477112|Micronutrients|micronutrients|mesh-ancestor
153528207|NCT01477151|Anesthetics|anesthetics|mesh-list
153528208|NCT01477151|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153528209|NCT01477151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153528210|NCT01477190|Morphine|morphine|mesh-list
153528211|NCT01477190|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153528212|NCT01477190|Narcotics|narcotics|mesh-ancestor
153528231|NCT01477242|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153528233|NCT01477242|Dermatologic Agents|dermatologic agents|mesh-ancestor
153528234|NCT01477242|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
153528235|NCT01477242|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153528236|NCT01477242|Serotonin Agents|serotonin agents|mesh-ancestor
153528237|NCT01477242|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153528238|NCT01477242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153528239|NCT01477268|Sertraline|sertraline|mesh-list
153528240|NCT01477268|Antidepressive Agents|antidepressive agents|mesh-list
153528241|NCT01477268|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153528242|NCT01477268|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
153528243|NCT01477268|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153528244|NCT01477268|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153528245|NCT01477268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153528246|NCT01477268|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153528247|NCT01477268|Serotonin Agents|serotonin agents|mesh-ancestor
153528250|NCT01477294|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
153555832|NCT01604213|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153528251|NCT01477294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153528252|NCT01477294|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
153528253|NCT01477294|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153528254|NCT01477294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153528255|NCT01477294|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
153528256|NCT01477294|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
153528257|NCT01477294|Purinergic Agents|purinergic agents|mesh-ancestor
153528258|NCT01477294|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153528259|NCT01477385|Fluorides|fluorides|mesh-list
153528260|NCT01477385|Cariostatic Agents|cariostatic agents|mesh-ancestor
153528261|NCT01477385|Protective Agents|protective agents|mesh-ancestor
153528262|NCT01477385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153528263|NCT01477411|Digoxin|digoxin|mesh-list
153528264|NCT01477411|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153528269|NCT01477411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153528270|NCT01477424|Warfarin|warfarin|mesh-list
153528271|NCT01477424|Anticoagulants|anticoagulants|mesh-ancestor
153528272|NCT01477476|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
153528273|NCT01477476|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153528274|NCT01477489|Veliparib|veliparib|mesh-list
153528275|NCT01477489|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
153528276|NCT01477489|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153528277|NCT01477489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153528278|NCT01477489|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153528279|NCT01477580|Aluminum Hydroxide|aluminum hydroxide|mesh-list
153528280|NCT01477580|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153528281|NCT01477580|Immunologic Factors|immunologic factors|mesh-ancestor
153528282|NCT01477580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153528283|NCT01477580|Antacids|antacids|mesh-ancestor
153528284|NCT01477580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153528285|NCT01477580|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153528286|NCT01477606|Cytarabine|cytarabine|mesh-list
153528287|NCT01477606|Daunorubicin|daunorubicin|mesh-list
153528288|NCT01477606|Midostaurin|midostaurin|mesh-list
153528289|NCT01477606|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153528290|NCT01477606|Antimetabolites|antimetabolites|mesh-ancestor
153528291|NCT01477606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153528305|NCT01477632|Norethindrone|norethindrone|mesh-list
153528319|NCT01477632|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
153528320|NCT01477736|Oxybutynin|oxybutynin|mesh-list
153528321|NCT01477736|Botulinum Toxins|botulinum toxins|mesh-list
153528322|NCT01477736|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
153528323|NCT01477736|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
153528324|NCT01477736|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
153528325|NCT01477736|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153528326|NCT01477736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153528327|NCT01477736|Cholinergic Agents|cholinergic agents|mesh-ancestor
153528328|NCT01477736|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153528382|NCT01478022|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153528383|NCT01478022|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153528384|NCT01478022|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153528385|NCT01478022|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153528454|NCT01478386|Viscosupplements|viscosupplements|mesh-ancestor
153528455|NCT01478386|Protective Agents|protective agents|mesh-ancestor
153528456|NCT01478490|Metoprolol|metoprolol|mesh-list
153528457|NCT01478490|Mirabegron|mirabegron|mesh-list
153528458|NCT01478490|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153528459|NCT01478490|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153528460|NCT01478490|Sympatholytics|sympatholytics|mesh-ancestor
153528461|NCT01478490|Autonomic Agents|autonomic agents|mesh-ancestor
153528462|NCT01478490|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153528463|NCT01478490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153528464|NCT01478490|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
153528465|NCT01478490|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
153528466|NCT01478490|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
153528467|NCT01478490|Adrenergic Agents|adrenergic agents|mesh-ancestor
153528468|NCT01478490|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153528469|NCT01478490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153528471|NCT01478490|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
153528510|NCT01478607|Antipruritics|antipruritics|mesh-ancestor
153528511|NCT01478607|Dermatologic Agents|dermatologic agents|mesh-ancestor
153528512|NCT01478607|Sensory System Agents|sensory system agents|mesh-ancestor
153528513|NCT01478607|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153528526|NCT01478685|Paclitaxel|paclitaxel|mesh-list
153528582|NCT01479179|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153528583|NCT01479179|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153528584|NCT01479192|Fenretinide|fenretinide|mesh-list
153528585|NCT01479192|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153528586|NCT01479192|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
153528587|NCT01479192|Protective Agents|protective agents|mesh-ancestor
153528588|NCT01479192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153528589|NCT01479231|Dexlansoprazole|dexlansoprazole|mesh-list
153528590|NCT01479231|Lansoprazole|lansoprazole|mesh-list
153528591|NCT01479231|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
153528592|NCT01479231|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153528593|NCT01479231|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
153528594|NCT01479231|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153528595|NCT01479231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153528596|NCT01479244|Molgramostim|molgramostim|mesh-list
153528597|NCT01479244|Sargramostim|sargramostim|mesh-list
153528598|NCT01479244|Immunologic Factors|immunologic factors|mesh-ancestor
153528599|NCT01479244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153528601|NCT01479283|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
153528602|NCT01479283|Cefazolin|cefazolin|mesh-list
153528603|NCT01479283|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
153528604|NCT01479283|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153528605|NCT01479283|Antitubercular Agents|antitubercular agents|mesh-ancestor
153528606|NCT01479296|Vaccines|vaccines|mesh-list
153528607|NCT01479296|Immunologic Factors|immunologic factors|mesh-ancestor
153528608|NCT01479296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153528610|NCT01479361|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153528611|NCT01479361|Antimalarials|antimalarials|mesh-ancestor
153528612|NCT01479361|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153528613|NCT01479361|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153528616|NCT01479504|Cisplatin|cisplatin|mesh-list
153528628|NCT01479556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153528629|NCT01479556|Anticonvulsants|anticonvulsants|mesh-ancestor
153528630|NCT01479556|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153528631|NCT01479556|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153528632|NCT01479556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153528633|NCT01479556|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153528634|NCT01479556|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153528635|NCT01479556|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153528636|NCT01479556|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153528637|NCT01479556|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153528638|NCT01479634|Efavirenz|efavirenz|mesh-list
153528688|NCT01479881|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153528689|NCT01479881|Dermatologic Agents|dermatologic agents|mesh-ancestor
153528690|NCT01479881|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153528691|NCT01479881|Antiviral Agents|antiviral agents|mesh-ancestor
153528692|NCT01479881|Protease Inhibitors|protease inhibitors|mesh-ancestor
153528693|NCT01479920|Fluoxetine|fluoxetine|mesh-list
153528694|NCT01479920|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
153528695|NCT01479920|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153528696|NCT01479920|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153528698|NCT01479920|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153528750|NCT01480323|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153528751|NCT01480323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153528752|NCT01480323|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153528753|NCT01480323|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153528754|NCT01480323|Antiviral Agents|antiviral agents|mesh-ancestor
153528755|NCT01480323|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153528757|NCT01480336|Ranolazine|ranolazine|mesh-list
153528758|NCT01480336|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153528759|NCT01480336|Vasodilator Agents|vasodilator agents|mesh-ancestor
153528766|NCT01480336|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153528813|NCT01480765|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153528814|NCT01480765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153528815|NCT01480765|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
153528816|NCT01480765|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153528817|NCT01480765|Anesthetics, General|anesthetics, general|mesh-ancestor
153528818|NCT01480765|Anesthetics|anesthetics|mesh-ancestor
153528819|NCT01480765|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153528820|NCT01480765|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
153528877|NCT01480986|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153528878|NCT01480986|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153528879|NCT01481194|Dexamethasone|dexamethasone|mesh-list
153528880|NCT01481194|Cyclophosphamide|cyclophosphamide|mesh-list
153528882|NCT01481194|Lenalidomide|lenalidomide|mesh-list
153528884|NCT01481194|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153528885|NCT01481194|Immunologic Factors|immunologic factors|mesh-ancestor
153528946|NCT01481519|Dexamethasone acetate|dexamethasone acetate|mesh-list
153528947|NCT01481519|Povidone|povidone|mesh-list
153528948|NCT01481519|Lubricant Eye Drops|lubricant eye drops|mesh-list
153528949|NCT01481519|BB 1101|bb 1101|mesh-list
153528950|NCT01481519|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153528951|NCT01481519|Antiemetics|antiemetics|mesh-ancestor
153528952|NCT01481519|Autonomic Agents|autonomic agents|mesh-ancestor
153529018|NCT01481844|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153529019|NCT01481844|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153529089|NCT01482299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153529090|NCT01482299|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153529091|NCT01482299|Immunologic Factors|immunologic factors|mesh-ancestor
153529092|NCT01482299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153529093|NCT01482299|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153529094|NCT01482338|Drospirenone|drospirenone|mesh-list
153529095|NCT01482338|Desogestrel|desogestrel|mesh-list
153529096|NCT01482338|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
153472287|NCT04362384|Vitamin E|vitamin e|mesh-list
153529101|NCT01482338|Diuretics|diuretics|mesh-ancestor
153529152|NCT01482624|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153529153|NCT01482624|Immunologic Factors|immunologic factors|mesh-ancestor
153529154|NCT01482624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153529155|NCT01482624|Viscosupplements|viscosupplements|mesh-ancestor
153529156|NCT01482624|Protective Agents|protective agents|mesh-ancestor
153529157|NCT01482728|Dasatinib|dasatinib|mesh-list
153529158|NCT01482728|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153529159|NCT01482728|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153529160|NCT01482728|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153529214|NCT01483248|Interferons|interferons|mesh-list
153529215|NCT01483248|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
153529216|NCT01483248|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153529217|NCT01483248|Antiviral Agents|antiviral agents|mesh-ancestor
153529218|NCT01483248|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153529219|NCT01483248|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
153529220|NCT01483248|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153529221|NCT01483274|Vaccines|vaccines|mesh-list
153529222|NCT01483274|Immunologic Factors|immunologic factors|mesh-ancestor
153529223|NCT01483274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153529224|NCT01483300|Cisplatin|cisplatin|mesh-list
153529225|NCT01483300|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153529279|NCT01484080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153529280|NCT01484145|Terbinafine|terbinafine|mesh-list
153529281|NCT01484145|Antifungal Agents|antifungal agents|mesh-ancestor
153529283|NCT01484145|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153529284|NCT01484145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153529285|NCT01484171|Idarubicin|idarubicin|mesh-list
153529286|NCT01484171|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153529287|NCT01484171|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153529292|NCT01484184|Levodopa|levodopa|mesh-list
153529343|NCT01484847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153529344|NCT01484964|Peficitinib|peficitinib|mesh-list
153529345|NCT01484964|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153529347|NCT01484964|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153529413|NCT01485198|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153529414|NCT01485198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153529415|NCT01485198|Antipyretics|antipyretics|mesh-ancestor
153529416|NCT01485211|Riboflavin|riboflavin|mesh-list
153529417|NCT01485211|Vitamin B Complex|vitamin b complex|mesh-ancestor
153529418|NCT01485211|Vitamins|vitamins|mesh-ancestor
153529419|NCT01485211|Micronutrients|micronutrients|mesh-ancestor
153529420|NCT01485211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153529421|NCT01485211|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
153529422|NCT01485211|Dermatologic Agents|dermatologic agents|mesh-ancestor
153529423|NCT01485224|Thalidomide|thalidomide|mesh-list
153529424|NCT01485224|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153529425|NCT01485224|Immunologic Factors|immunologic factors|mesh-ancestor
153529426|NCT01485224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153529427|NCT01485224|Leprostatic Agents|leprostatic agents|mesh-ancestor
153529428|NCT01485224|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153529429|NCT01485224|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153529430|NCT01485224|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153529431|NCT01485224|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153529432|NCT01485224|Growth Substances|growth substances|mesh-ancestor
153529433|NCT01485224|Growth Inhibitors|growth inhibitors|mesh-ancestor
153472664|NCT04342650|Analgesics|analgesics|mesh-ancestor
153529469|NCT01485562|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
153529470|NCT01485562|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153529471|NCT01485562|Oxytocics|oxytocics|mesh-ancestor
153529472|NCT01485653|Mepivacaine|mepivacaine|mesh-list
153529473|NCT01485653|Anesthetics, Local|anesthetics, local|mesh-ancestor
153529474|NCT01485653|Anesthetics|anesthetics|mesh-ancestor
153529475|NCT01485653|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153529476|NCT01485653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153529477|NCT01485653|Sensory System Agents|sensory system agents|mesh-ancestor
153529478|NCT01485653|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153529480|NCT01485679|Antimetabolites|antimetabolites|mesh-ancestor
153529481|NCT01485679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153529532|NCT01485731|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
153529533|NCT01485731|Protease Inhibitors|protease inhibitors|mesh-ancestor
153555989|NCT01610921|Adenosine|adenosine|mesh-list
153529534|NCT01485731|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153529535|NCT01485731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153529536|NCT01485731|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153529537|NCT01485731|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153529538|NCT01485731|Antiviral Agents|antiviral agents|mesh-ancestor
153529539|NCT01485731|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153529540|NCT01485744|Leucovorin|leucovorin|mesh-list
153529541|NCT01485744|Fluorouracil|fluorouracil|mesh-list
153529542|NCT01485744|Oxaliplatin|oxaliplatin|mesh-list
153529543|NCT01485744|Irinotecan|irinotecan|mesh-list
153529544|NCT01485744|Folfirinox|folfirinox|mesh-list
153529545|NCT01485744|Antimetabolites|antimetabolites|mesh-ancestor
153529594|NCT01485926|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153529595|NCT01485926|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153529597|NCT01485939|Lidocaine|lidocaine|mesh-list
153529598|NCT01485939|Anesthetics, Local|anesthetics, local|mesh-ancestor
153529599|NCT01485939|Anesthetics|anesthetics|mesh-ancestor
153529600|NCT01485939|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153529601|NCT01485939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153529602|NCT01485939|Sensory System Agents|sensory system agents|mesh-ancestor
153529603|NCT01485939|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153529609|NCT01485978|Ramipril|ramipril|mesh-list
153529655|NCT01486433|Sensory System Agents|sensory system agents|mesh-ancestor
153529656|NCT01486433|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153529657|NCT01486433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153529658|NCT01486433|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153529659|NCT01486433|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153529660|NCT01486433|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153529661|NCT01486433|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153529662|NCT01486433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153529663|NCT01486433|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153529664|NCT01486433|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153529665|NCT01486433|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153529715|NCT01486602|Antimitotic Agents|antimitotic agents|mesh-ancestor
153529716|NCT01486602|Mitosis Modulators|mitosis modulators|mesh-ancestor
153529717|NCT01486602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153529718|NCT01486706|Gabapentin|gabapentin|mesh-list
153529719|NCT01486706|Solifenacin Succinate|solifenacin succinate|mesh-list
153529785|NCT01486979|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
153529786|NCT01486979|Contraceptive Agents|contraceptive agents|mesh-ancestor
153529787|NCT01486979|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153529788|NCT01486979|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
153529789|NCT01486992|Nimotuzumab|nimotuzumab|mesh-list
153529790|NCT01486992|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153877619|NCT05589220|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153529791|NCT01486992|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153529794|NCT01487096|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153529849|NCT01487395|Cholinergic Agents|cholinergic agents|mesh-ancestor
153529850|NCT01487395|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153529851|NCT01487395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153529852|NCT01487395|Nootropic Agents|nootropic agents|mesh-ancestor
153529853|NCT01487408|Insulin Aspart|insulin aspart|mesh-list
153529854|NCT01487408|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153529855|NCT01487408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153529856|NCT01487421|Insulin|insulin|mesh-list
153529857|NCT01487421|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
153529858|NCT01487421|Insulin Aspart|insulin aspart|mesh-list
153529860|NCT01487421|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153529861|NCT01487421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153529862|NCT01487512|Hydromorphone|hydromorphone|mesh-list
153529863|NCT01487512|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153529864|NCT01487512|Narcotics|narcotics|mesh-ancestor
153529892|NCT01487798|Insulin|insulin|mesh-list
153529910|NCT01488201|Brodalumab|brodalumab|mesh-list
153529911|NCT01488201|Dermatologic Agents|dermatologic agents|mesh-ancestor
153529912|NCT01488227|Vitamin D|vitamin d|mesh-list
153529913|NCT01488227|Ergocalciferols|ergocalciferols|mesh-list
153529914|NCT01488227|Cholecalciferol|cholecalciferol|mesh-list
153529916|NCT01488227|Micronutrients|micronutrients|mesh-ancestor
153529917|NCT01488227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153529918|NCT01488227|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153529919|NCT01488227|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153529920|NCT01488253|Sirolimus|sirolimus|mesh-list
153529975|NCT01488266|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
153529976|NCT01488266|Histamine Antagonists|histamine antagonists|mesh-ancestor
153529977|NCT01488266|Histamine Agents|histamine agents|mesh-ancestor
153529978|NCT01488266|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153529979|NCT01488266|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
153529980|NCT01488266|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
153529981|NCT01488266|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
153529982|NCT01488266|Adrenergic Agents|adrenergic agents|mesh-ancestor
153529985|NCT01488305|Micronutrients|micronutrients|mesh-list
153530041|NCT01488656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153530042|NCT01488656|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153530043|NCT01488656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153530044|NCT01488656|Protective Agents|protective agents|mesh-ancestor
153530045|NCT01488734|Vitamin D|vitamin d|mesh-list
153530046|NCT01488734|Ergocalciferols|ergocalciferols|mesh-list
153530047|NCT01488734|Cholecalciferol|cholecalciferol|mesh-list
153530048|NCT01488734|Vitamins|vitamins|mesh-list
153530049|NCT01488734|Micronutrients|micronutrients|mesh-ancestor
153530050|NCT01488734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153530052|NCT01488734|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153530053|NCT01488773|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
153530054|NCT01488773|Montelukast|montelukast|mesh-list
153530055|NCT01488773|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153530056|NCT01488773|Autonomic Agents|autonomic agents|mesh-ancestor
153530057|NCT01488773|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153530058|NCT01488773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153530059|NCT01488773|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153530096|NCT01489059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153530097|NCT01489072|Remifentanil|remifentanil|mesh-list
153530098|NCT01489072|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153530099|NCT01489072|Narcotics|narcotics|mesh-ancestor
153530100|NCT01489072|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153530102|NCT01489072|Analgesics|analgesics|mesh-ancestor
153530103|NCT01489072|Sensory System Agents|sensory system agents|mesh-ancestor
153530104|NCT01489072|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153530105|NCT01489124|Imipenem|imipenem|mesh-list
153530161|NCT01489371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153530162|NCT01489371|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153530163|NCT01489371|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153530164|NCT01489371|Growth Substances|growth substances|mesh-ancestor
153530165|NCT01489371|Growth Inhibitors|growth inhibitors|mesh-ancestor
153530166|NCT01489410|Ethanol|ethanol|mesh-list
153530167|NCT01489410|Doxorubicin|doxorubicin|mesh-list
153530168|NCT01489410|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
153530169|NCT01489410|Ethiodized Oil|ethiodized oil|mesh-list
153530170|NCT01489410|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153530171|NCT01489410|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153530172|NCT01489410|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153530173|NCT01489410|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153530174|NCT01489410|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153530175|NCT01489410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153530176|NCT01489410|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
153530177|NCT01489410|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153530178|NCT01489410|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153530179|NCT01489410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153530180|NCT01489488|Riociguat|riociguat|mesh-list
153530181|NCT01489488|Enzyme Activators|enzyme activators|mesh-ancestor
153530182|NCT01489488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153530183|NCT01489566|Fluorouracil|fluorouracil|mesh-list
153530184|NCT01489566|Mitomycins|mitomycins|mesh-list
153530186|NCT01489566|Antimetabolites|antimetabolites|mesh-ancestor
153530187|NCT01489566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153530188|NCT01489566|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153530189|NCT01489566|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153530190|NCT01489566|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153530191|NCT01489566|Immunologic Factors|immunologic factors|mesh-ancestor
153530192|NCT01489566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153530193|NCT01489566|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153530194|NCT01489566|Alkylating Agents|alkylating agents|mesh-ancestor
153530202|NCT01489631|Sufentanil|sufentanil|mesh-list
153530203|NCT01489631|Gabapentin|gabapentin|mesh-list
153530204|NCT01489631|Bupivacaine|bupivacaine|mesh-list
153530205|NCT01489631|Ropivacaine|ropivacaine|mesh-list
153530206|NCT01489631|Anesthetics, Local|anesthetics, local|mesh-ancestor
153530207|NCT01489631|Anesthetics|anesthetics|mesh-ancestor
153530208|NCT01489631|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153530209|NCT01489631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153530210|NCT01489631|Sensory System Agents|sensory system agents|mesh-ancestor
153530211|NCT01489631|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153530212|NCT01489631|Analgesics|analgesics|mesh-ancestor
153530213|NCT01489631|Anticonvulsants|anticonvulsants|mesh-ancestor
153530214|NCT01489631|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153530215|NCT01489631|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153530223|NCT01489631|Narcotics|narcotics|mesh-ancestor
153530263|NCT01489709|Urological Agents|urological agents|mesh-ancestor
153530264|NCT01489852|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
153530265|NCT01489852|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
153530266|NCT01489852|Estradiol|estradiol|mesh-list
153530267|NCT01489852|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
153530268|NCT01489852|Estrogens|estrogens|mesh-ancestor
153530269|NCT01489852|Hormones|hormones|mesh-ancestor
153530270|NCT01489852|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153530271|NCT01489852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153530272|NCT01489852|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
153530273|NCT01489852|Contraceptive Agents|contraceptive agents|mesh-ancestor
153530274|NCT01489852|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153530275|NCT01489852|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
153530276|NCT01489865|Fluorouracil|fluorouracil|mesh-list
153530277|NCT01489865|Veliparib|veliparib|mesh-list
153530278|NCT01489865|Antimetabolites|antimetabolites|mesh-ancestor
153530279|NCT01489865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153530280|NCT01489865|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153530321|NCT01489943|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153530322|NCT01489943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153530323|NCT01489943|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153530325|NCT01489943|Antimetabolites|antimetabolites|mesh-ancestor
153530326|NCT01489943|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153530327|NCT01489943|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
153530328|NCT01489943|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153530329|NCT01489943|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153530330|NCT01489943|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
153530331|NCT01489943|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153530332|NCT01489943|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
153530333|NCT01489982|Zopiclone|zopiclone|mesh-list
153530334|NCT01489982|Doxepin|doxepin|mesh-list
153530335|NCT01489982|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153530351|NCT01490047|Etanercept|etanercept|mesh-list
153530381|NCT01490203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153530382|NCT01490203|Chelating Agents|chelating agents|mesh-ancestor
153530383|NCT01490203|Sequestering Agents|sequestering agents|mesh-ancestor
153530384|NCT01490203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153530385|NCT01490203|Iron Chelating Agents|iron chelating agents|mesh-ancestor
153530386|NCT01490203|Anticoagulants|anticoagulants|mesh-ancestor
153530387|NCT01490203|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
153530388|NCT01490216|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
153530389|NCT01490216|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
153530390|NCT01490216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153530395|NCT01490216|Dopamine Agents|dopamine agents|mesh-ancestor
153530444|NCT01490398|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153530445|NCT01490411|Immunomodulating Agents|immunomodulating agents|mesh-list
153530446|NCT01490411|Immunologic Factors|immunologic factors|mesh-list
153530449|NCT01490437|Pemetrexed|pemetrexed|mesh-list
153556057|NCT01611324|Mepivacaine|mepivacaine|mesh-list
153530450|NCT01490437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153530451|NCT01490437|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153530452|NCT01490437|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153530453|NCT01490437|Antiemetics|antiemetics|mesh-ancestor
153530454|NCT01490437|Autonomic Agents|autonomic agents|mesh-ancestor
153530510|NCT01490762|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
153530511|NCT01490762|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153530512|NCT01490762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153530513|NCT01490905|Ibuprofen|ibuprofen|mesh-list
153530514|NCT01490905|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153530515|NCT01490905|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153530516|NCT01490905|Analgesics|analgesics|mesh-ancestor
153530517|NCT01490905|Sensory System Agents|sensory system agents|mesh-ancestor
153530518|NCT01490905|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153618943|NCT01981278|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153530519|NCT01490905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153530520|NCT01490905|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153530521|NCT01490905|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153530522|NCT01490905|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153530523|NCT01490905|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153530524|NCT01490905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153530567|NCT01491009|Narcotics|narcotics|mesh-ancestor
153530568|NCT01491009|Analgesics|analgesics|mesh-ancestor
153530569|NCT01491009|Sensory System Agents|sensory system agents|mesh-ancestor
153530570|NCT01491009|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153530571|NCT01491048|Tacrine|tacrine|mesh-list
153530572|NCT01491048|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
153530573|NCT01491048|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153530574|NCT01491048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153530575|NCT01491048|Cholinergic Agents|cholinergic agents|mesh-ancestor
153530576|NCT01491048|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153530577|NCT01491048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153530578|NCT01491048|Parasympathomimetics|parasympathomimetics|mesh-ancestor
153530579|NCT01491048|Autonomic Agents|autonomic agents|mesh-ancestor
153530580|NCT01491048|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153530626|NCT01491217|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153530627|NCT01491217|Tubulin Modulators|tubulin modulators|mesh-ancestor
153530628|NCT01491217|Antimitotic Agents|antimitotic agents|mesh-ancestor
153530629|NCT01491217|Mitosis Modulators|mitosis modulators|mesh-ancestor
153530630|NCT01491217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153530631|NCT01491256|Atorvastatin|atorvastatin|mesh-list
153530632|NCT01491256|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153530694|NCT01492114|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153530695|NCT01492114|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153530696|NCT01492153|Insulin|insulin|mesh-list
153530697|NCT01492153|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
153530698|NCT01492153|Isophane Insulin, Human|isophane insulin, human|mesh-list
153530699|NCT01492153|Insulin, Isophane|insulin, isophane|mesh-list
153530700|NCT01492153|Isophane insulin, beef|isophane insulin, beef|mesh-list
153530701|NCT01492153|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153530760|NCT01492621|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
153530761|NCT01492621|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
153530762|NCT01492621|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153530763|NCT01492621|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153530764|NCT01492621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153530765|NCT01492621|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153530766|NCT01492621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153556120|NCT01611675|Immunologic Factors|immunologic factors|mesh-ancestor
153530767|NCT01492621|Antidepressive Agents|antidepressive agents|mesh-ancestor
153530768|NCT01492621|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153530825|NCT01493050|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153530826|NCT01493050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153530827|NCT01493050|Antacids|antacids|mesh-ancestor
153530828|NCT01493050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153530829|NCT01493050|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153530892|NCT01493336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153530893|NCT01493336|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153530894|NCT01493388|Insulin|insulin|mesh-list
153530895|NCT01493388|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153530896|NCT01493388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153530897|NCT01493440|Atosiban|atosiban|mesh-list
153530898|NCT01493440|Hormone Antagonists|hormone antagonists|mesh-ancestor
153530899|NCT01493440|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153530900|NCT01493440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153530901|NCT01493440|Tocolytic Agents|tocolytic agents|mesh-ancestor
153530903|NCT01493479|Rituximab|rituximab|mesh-list
153530904|NCT01493479|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153530905|NCT01493479|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153530906|NCT01493479|Immunologic Factors|immunologic factors|mesh-ancestor
153530907|NCT01493479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153530908|NCT01493479|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153530950|NCT01493856|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
153530951|NCT01493856|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153530952|NCT01493856|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
153530953|NCT01493856|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
153530954|NCT01493856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153530955|NCT01493973|Epoetin Alfa|epoetin alfa|mesh-list
153530956|NCT01493973|Hematinics|hematinics|mesh-ancestor
153530957|NCT01493986|Ropivacaine|ropivacaine|mesh-list
153530958|NCT01493986|Anesthetics, Local|anesthetics, local|mesh-ancestor
153530959|NCT01493986|Anesthetics|anesthetics|mesh-ancestor
153530960|NCT01493986|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153530961|NCT01493986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153530962|NCT01493986|Sensory System Agents|sensory system agents|mesh-ancestor
153531009|NCT01494259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153531010|NCT01494259|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
153531011|NCT01494259|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153531013|NCT01494259|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153531014|NCT01494259|Respiratory System Agents|respiratory system agents|mesh-ancestor
153531015|NCT01494259|Mydriatics|mydriatics|mesh-ancestor
153531018|NCT01494311|Lidocaine|lidocaine|mesh-list
153531078|NCT01494597|Cyclosporine|cyclosporine|mesh-list
153531079|NCT01494597|Isavuconazole|isavuconazole|mesh-list
153531080|NCT01494597|Cyclosporins|cyclosporins|mesh-list
153531081|NCT01494597|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153531082|NCT01494597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153531083|NCT01494597|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153531084|NCT01494597|Immunologic Factors|immunologic factors|mesh-ancestor
153531085|NCT01494597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153531086|NCT01494597|Antifungal Agents|antifungal agents|mesh-ancestor
153531087|NCT01494597|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153531088|NCT01494597|Dermatologic Agents|dermatologic agents|mesh-ancestor
153531089|NCT01494597|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153531090|NCT01494597|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
153531091|NCT01494636|Lidocaine|lidocaine|mesh-list
153531092|NCT01494636|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
153531093|NCT01494636|Anesthetics, Local|anesthetics, local|mesh-ancestor
153531094|NCT01494636|Anesthetics|anesthetics|mesh-ancestor
153531095|NCT01494636|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153531096|NCT01494636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153531097|NCT01494636|Sensory System Agents|sensory system agents|mesh-ancestor
153531098|NCT01494636|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153531099|NCT01494636|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153531100|NCT01494636|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
153531128|NCT01494740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153531130|NCT01494805|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153531131|NCT01494805|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153531132|NCT01494805|Growth Substances|growth substances|mesh-ancestor
153531133|NCT01494805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153531134|NCT01494805|Growth Inhibitors|growth inhibitors|mesh-ancestor
153531135|NCT01494805|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153531136|NCT01494857|Adalimumab|adalimumab|mesh-list
153531137|NCT01494857|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
153531138|NCT01494857|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153531139|NCT01494857|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153531140|NCT01495026|Tamsulosin|tamsulosin|mesh-list
153531141|NCT01495026|Dutasteride|dutasteride|mesh-list
153531142|NCT01495026|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
153531143|NCT01495026|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
153531144|NCT01495026|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
153531155|NCT01495039|Nystatin|nystatin|mesh-list
153531187|NCT01495117|Blood Substitutes|blood substitutes|mesh-ancestor
153531188|NCT01495156|Antipsychotic Agents|antipsychotic agents|mesh-list
153531189|NCT01495156|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153531190|NCT01495156|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153531193|NCT01495169|Iloperidone|iloperidone|mesh-list
153531194|NCT01495169|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153531195|NCT01495169|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153531197|NCT01495169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153531250|NCT01495338|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
153531251|NCT01495338|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
153531252|NCT01495338|Histamine Antagonists|histamine antagonists|mesh-ancestor
153531253|NCT01495338|Histamine Agents|histamine agents|mesh-ancestor
153531254|NCT01495338|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153531255|NCT01495338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153531256|NCT01495351|Bortezomib|bortezomib|mesh-list
153531257|NCT01495351|Veliparib|veliparib|mesh-list
153531258|NCT01495351|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153531259|NCT01495351|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
153531260|NCT01495351|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153531261|NCT01495351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153531262|NCT01495377|Remifentanil|remifentanil|mesh-list
153531263|NCT01495377|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153531264|NCT01495377|Narcotics|narcotics|mesh-ancestor
153531265|NCT01495377|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153531266|NCT01495377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153531267|NCT01495377|Analgesics|analgesics|mesh-ancestor
153531268|NCT01495377|Sensory System Agents|sensory system agents|mesh-ancestor
153531269|NCT01495377|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153531270|NCT01495468|Hormones|hormones|mesh-list
153531271|NCT01495468|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153531272|NCT01495468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153531273|NCT01495520|Ranolazine|ranolazine|mesh-list
153531274|NCT01495520|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153531275|NCT01495520|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153531276|NCT01495520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153531277|NCT01495624|Dexamethasone|dexamethasone|mesh-list
153531278|NCT01495624|Dexamethasone acetate|dexamethasone acetate|mesh-list
153531279|NCT01495624|Ropivacaine|ropivacaine|mesh-list
153531280|NCT01495624|Anesthetics|anesthetics|mesh-list
153531290|NCT01495624|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153531291|NCT01495624|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153531292|NCT01495624|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153531293|NCT01495624|Protease Inhibitors|protease inhibitors|mesh-ancestor
153531294|NCT01495624|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153531296|NCT01495624|Anesthetics, Local|anesthetics, local|mesh-ancestor
153531356|NCT01496105|Anesthetics, Local|anesthetics, local|mesh-ancestor
153531357|NCT01496105|Anesthetics|anesthetics|mesh-ancestor
153531358|NCT01496105|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153531359|NCT01496105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153531360|NCT01496105|Sensory System Agents|sensory system agents|mesh-ancestor
153531361|NCT01496105|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153531362|NCT01496105|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153531363|NCT01496105|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
153531364|NCT01496105|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153531365|NCT01496105|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153531366|NCT01496105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153531368|NCT01496196|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
153531369|NCT01496196|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153531370|NCT01496196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153531371|NCT01496196|Hemostatics|hemostatics|mesh-ancestor
153531372|NCT01496196|Coagulants|coagulants|mesh-ancestor
153531373|NCT01496261|Aspirin|aspirin|mesh-list
153531374|NCT01496261|Clopidogrel|clopidogrel|mesh-list
153531375|NCT01496261|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153531376|NCT01496261|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153531377|NCT01496261|Analgesics|analgesics|mesh-ancestor
153531378|NCT01496261|Sensory System Agents|sensory system agents|mesh-ancestor
153531379|NCT01496261|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153531380|NCT01496261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153531381|NCT01496261|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153531382|NCT01496261|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153531383|NCT01496261|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153531384|NCT01496261|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153531385|NCT01496261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153531396|NCT01496326|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153531397|NCT01496326|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153531399|NCT01496326|Sensory System Agents|sensory system agents|mesh-ancestor
153531400|NCT01496326|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153531401|NCT01496326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153531402|NCT01496326|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153531403|NCT01496326|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153531404|NCT01496326|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153531405|NCT01496326|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153531406|NCT01496326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153531407|NCT01496417|Abatacept|abatacept|mesh-list
153531459|NCT01496742|Carboplatin|carboplatin|mesh-list
153531460|NCT01496742|Pemetrexed|pemetrexed|mesh-list
153531461|NCT01496742|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153531462|NCT01496742|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153531464|NCT01496742|Antimitotic Agents|antimitotic agents|mesh-ancestor
153531465|NCT01496742|Mitosis Modulators|mitosis modulators|mesh-ancestor
153531466|NCT01496742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153531467|NCT01496742|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153531468|NCT01496742|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153531469|NCT01496742|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153531476|NCT01496911|Hydroxyzine|hydroxyzine|mesh-list
153531520|NCT01497093|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153531521|NCT01497093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153531522|NCT01497093|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153531523|NCT01497093|Glucocorticoids|glucocorticoids|mesh-ancestor
153531524|NCT01497093|Hormones|hormones|mesh-ancestor
153531525|NCT01497093|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153531590|NCT01497483|Immunologic Factors|immunologic factors|mesh-ancestor
153531591|NCT01497483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153531592|NCT01497483|Antifungal Agents|antifungal agents|mesh-ancestor
153531593|NCT01497483|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153531594|NCT01497483|Dermatologic Agents|dermatologic agents|mesh-ancestor
153531595|NCT01497483|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153531596|NCT01497483|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
153531597|NCT01497483|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153531599|NCT01497483|Antimetabolites|antimetabolites|mesh-ancestor
153531600|NCT01497483|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153531601|NCT01497483|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
153531602|NCT01497522|Vildagliptin|vildagliptin|mesh-list
153531603|NCT01497522|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153531609|NCT01497535|Insulin|insulin|mesh-list
153531653|NCT01497626|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153531654|NCT01497626|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153531655|NCT01497626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153531658|NCT01497652|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153531659|NCT01497652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153531660|NCT01497652|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
153531717|NCT01498380|Dexmedetomidine|dexmedetomidine|mesh-list
153531718|NCT01498380|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153531719|NCT01498380|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153531720|NCT01498380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153531721|NCT01498380|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153531723|NCT01498380|Sensory System Agents|sensory system agents|mesh-ancestor
153531724|NCT01498380|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153531725|NCT01498380|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
153531726|NCT01498380|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153531727|NCT01498380|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153531728|NCT01498380|Adrenergic Agents|adrenergic agents|mesh-ancestor
153531729|NCT01498380|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153531730|NCT01498380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153531732|NCT01498406|Ergocalciferols|ergocalciferols|mesh-list
153531733|NCT01498406|Cholecalciferol|cholecalciferol|mesh-list
153531734|NCT01498406|Vitamins|vitamins|mesh-list
153531735|NCT01498406|Micronutrients|micronutrients|mesh-ancestor
153531774|NCT01498809|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153531775|NCT01498809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153531776|NCT01498809|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
153531777|NCT01498809|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
153531778|NCT01498809|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153531779|NCT01498809|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153531780|NCT01498809|Adrenergic Agents|adrenergic agents|mesh-ancestor
153531840|NCT01499069|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153531841|NCT01499069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153556276|NCT01612832|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153531842|NCT01499069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153531843|NCT01499069|Urological Agents|urological agents|mesh-ancestor
153531844|NCT01499069|Parasympatholytics|parasympatholytics|mesh-ancestor
153531845|NCT01499069|Autonomic Agents|autonomic agents|mesh-ancestor
153531846|NCT01499069|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153531847|NCT01499108|Liraglutide|liraglutide|mesh-list
153531848|NCT01499108|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
153531849|NCT01499108|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153531850|NCT01499108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153531851|NCT01499108|Incretins|incretins|mesh-ancestor
153531852|NCT01499108|Hormones|hormones|mesh-ancestor
153531854|NCT01499121|Sunitinib|sunitinib|mesh-list
153531901|NCT01499485|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153531902|NCT01499485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153531903|NCT01499485|Diuretics|diuretics|mesh-ancestor
153531904|NCT01499485|Natriuretic Agents|natriuretic agents|mesh-ancestor
153531905|NCT01499485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153531906|NCT01499589|Anesthetics|anesthetics|mesh-list
153531907|NCT01499589|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153531908|NCT01499589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153531909|NCT01499602|Norethindrone|norethindrone|mesh-list
153531910|NCT01499602|Norethindrone Acetate|norethindrone acetate|mesh-list
153531911|NCT01499602|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
153531912|NCT01499602|Contraceptive Agents|contraceptive agents|mesh-ancestor
153531913|NCT01499602|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153531962|NCT01499875|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153531964|NCT01500005|Vitamin D|vitamin d|mesh-list
153531965|NCT01500005|Vitamins|vitamins|mesh-ancestor
153531966|NCT01500005|Micronutrients|micronutrients|mesh-ancestor
153531967|NCT01500005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153531968|NCT01500005|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153531969|NCT01500018|Phentermine|phentermine|mesh-list
153531970|NCT01500018|Ketamine|ketamine|mesh-list
153531971|NCT01500018|Analgesics|analgesics|mesh-ancestor
153531972|NCT01500018|Sensory System Agents|sensory system agents|mesh-ancestor
153531973|NCT01500018|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153531974|NCT01500018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153531975|NCT01500018|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
153531976|NCT01500018|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153531977|NCT01500018|Anesthetics, General|anesthetics, general|mesh-ancestor
153531978|NCT01500018|Anesthetics|anesthetics|mesh-ancestor
153531979|NCT01500018|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153532021|NCT01500161|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153532023|NCT01500408|Interferon-beta|interferon-beta|mesh-list
153532024|NCT01500408|Interferon beta-1a|interferon beta-1a|mesh-list
153532025|NCT01500408|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153532026|NCT01500408|Antiviral Agents|antiviral agents|mesh-ancestor
153532027|NCT01500408|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153532028|NCT01500408|Immunologic Factors|immunologic factors|mesh-ancestor
153532029|NCT01500408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153532088|NCT01500837|Clindamycin palmitate|clindamycin palmitate|mesh-list
153532089|NCT01500837|Clindamycin phosphate|clindamycin phosphate|mesh-list
153532090|NCT01500837|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
153532091|NCT01500837|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153532092|NCT01500837|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153532093|NCT01500837|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153532094|NCT01500837|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153532095|NCT01500837|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153532096|NCT01500837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153532097|NCT01500837|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153532098|NCT01500837|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
153532099|NCT01500837|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153532100|NCT01500837|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
153532101|NCT01500837|Antitubercular Agents|antitubercular agents|mesh-ancestor
153532146|NCT01500928|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153532147|NCT01500928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153532148|NCT01500980|Chloroquine|chloroquine|mesh-list
153532149|NCT01500980|Primaquine|primaquine|mesh-list
153532150|NCT01500980|Amebicides|amebicides|mesh-ancestor
153532151|NCT01500980|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153532152|NCT01500980|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153532153|NCT01500980|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153532215|NCT01501136|Autonomic Agents|autonomic agents|mesh-ancestor
153532216|NCT01501136|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153532217|NCT01501136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153532218|NCT01501136|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153532219|NCT01501136|Glucocorticoids|glucocorticoids|mesh-ancestor
153532220|NCT01501136|Hormones|hormones|mesh-ancestor
153532221|NCT01501136|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153532281|NCT01501370|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153532282|NCT01501370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153532283|NCT01501370|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153532284|NCT01501370|Glucocorticoids|glucocorticoids|mesh-ancestor
153532285|NCT01501370|Hormones|hormones|mesh-ancestor
153532286|NCT01501370|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153532287|NCT01501370|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153532288|NCT01501370|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153532289|NCT01501370|Protease Inhibitors|protease inhibitors|mesh-ancestor
153532290|NCT01501370|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153532291|NCT01501370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153532292|NCT01501370|Immunologic Factors|immunologic factors|mesh-ancestor
153532293|NCT01501370|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153532294|NCT01501370|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153532295|NCT01501370|Growth Substances|growth substances|mesh-ancestor
153532296|NCT01501370|Growth Inhibitors|growth inhibitors|mesh-ancestor
153532297|NCT01501370|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
153532298|NCT01501396|Megestrol|megestrol|mesh-list
153532299|NCT01501396|Megestrol Acetate|megestrol acetate|mesh-list
153532300|NCT01501396|Mirtazapine|mirtazapine|mesh-list
153532301|NCT01501396|Antidepressive Agents|antidepressive agents|mesh-ancestor
153532302|NCT01501396|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153532303|NCT01501396|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
153532304|NCT01501396|Histamine Antagonists|histamine antagonists|mesh-ancestor
153532305|NCT01501396|Histamine Agents|histamine agents|mesh-ancestor
153532306|NCT01501396|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153532307|NCT01501396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153532308|NCT01501396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153532309|NCT01501396|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153532310|NCT01501396|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153532322|NCT01501396|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
153532323|NCT01501396|Contraceptive Agents|contraceptive agents|mesh-ancestor
153532324|NCT01501396|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153532325|NCT01501396|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
153532326|NCT01501396|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
153532327|NCT01501396|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153532328|NCT01501396|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153532329|NCT01501396|Appetite Stimulants|appetite stimulants|mesh-ancestor
153532330|NCT01501396|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
153532331|NCT01501422|Estrogens|estrogens|mesh-list
153532332|NCT01501422|Hormones|hormones|mesh-ancestor
153532333|NCT01501422|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153532334|NCT01501422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153532381|NCT01501591|Hydroxyzine|hydroxyzine|mesh-list
153532382|NCT01501591|Antipruritics|antipruritics|mesh-ancestor
153877790|NCT05370235|Dermatologic Agents|dermatologic agents|mesh-ancestor
153532383|NCT01501591|Dermatologic Agents|dermatologic agents|mesh-ancestor
153532384|NCT01501591|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
153532385|NCT01501591|Histamine Antagonists|histamine antagonists|mesh-ancestor
153532386|NCT01501591|Histamine Agents|histamine agents|mesh-ancestor
153532387|NCT01501591|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153618948|NCT01981278|Sensory System Agents|sensory system agents|mesh-ancestor
153532388|NCT01501591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153532389|NCT01501591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153532391|NCT01501669|Irinotecan|irinotecan|mesh-list
153532392|NCT01501669|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153532393|NCT01501669|Antimetabolites|antimetabolites|mesh-ancestor
153556335|NCT01613053|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153532395|NCT01501669|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153532441|NCT01501747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153532442|NCT01501747|Antipyretics|antipyretics|mesh-ancestor
153532443|NCT01501747|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
153532444|NCT01501747|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
153532445|NCT01501747|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
153532446|NCT01501747|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
153532447|NCT01501747|Purinergic Agents|purinergic agents|mesh-ancestor
153532448|NCT01501747|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153532449|NCT01501747|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153532450|NCT01501747|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153532451|NCT01501760|Bevacizumab|bevacizumab|mesh-list
153532504|NCT01501916|Vitamins|vitamins|mesh-ancestor
153532505|NCT01501916|Micronutrients|micronutrients|mesh-ancestor
153532506|NCT01501916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153532507|NCT01501916|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153532508|NCT01501916|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153532509|NCT01501942|Glycine|glycine|mesh-list
153532510|NCT01501942|Glycine Agents|glycine agents|mesh-ancestor
153532512|NCT01501942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153532513|NCT01501942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153532514|NCT01501968|Ascorbic Acid|ascorbic acid|mesh-list
153532515|NCT01501968|Colistin|colistin|mesh-list
153532516|NCT01501968|Vitamins|vitamins|mesh-ancestor
153532517|NCT01501968|Micronutrients|micronutrients|mesh-ancestor
153532518|NCT01501968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153532519|NCT01501968|Antioxidants|antioxidants|mesh-ancestor
153532520|NCT01501968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153532521|NCT01501968|Protective Agents|protective agents|mesh-ancestor
153532522|NCT01501968|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153532523|NCT01501968|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153532524|NCT01502020|Imiquimod|imiquimod|mesh-list
153532525|NCT01502020|Toll-Like Receptor Agonists|toll-like receptor agonists|mesh-ancestor
153532554|NCT01502202|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153532555|NCT01502202|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153532556|NCT01502202|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153532557|NCT01502202|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153532559|NCT01502241|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153532560|NCT01502241|Alkylating Agents|alkylating agents|mesh-ancestor
153532561|NCT01502241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153532562|NCT01502241|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153532619|NCT01502904|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153532620|NCT01502904|Immunologic Factors|immunologic factors|mesh-ancestor
153532621|NCT01502904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153532622|NCT01502904|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153532623|NCT01502904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153532625|NCT01502904|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153532626|NCT01502904|Antimetabolites|antimetabolites|mesh-ancestor
153532627|NCT01502904|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153532628|NCT01502904|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
153532629|NCT01502943|Atorvastatin|atorvastatin|mesh-list
153532630|NCT01502943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153532631|NCT01502943|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153532632|NCT01502943|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153532633|NCT01502943|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153532635|NCT01502943|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153532636|NCT01502943|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
153532637|NCT01503008|Metformin|metformin|mesh-list
153532638|NCT01503008|2,4-thiazolidinedione|2,4-thiazolidinedione|mesh-list
153532639|NCT01503008|Hypoglycemic Agents|hypoglycemic agents|mesh-list
153532640|NCT01503008|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-list
153532641|NCT01503008|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
153532642|NCT01503008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153532643|NCT01503008|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153532646|NCT01503060|Lidocaine|lidocaine|mesh-list
153532666|NCT01503242|Cyclosporine|cyclosporine|mesh-list
153532667|NCT01503242|Mycophenolic Acid|mycophenolic acid|mesh-list
153532668|NCT01503242|Fludarabine|fludarabine|mesh-list
153532670|NCT01503242|Antibodies|antibodies|mesh-list
153532671|NCT01503242|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
153532672|NCT01503242|Cyclosporins|cyclosporins|mesh-list
153532673|NCT01503242|Immunologic Factors|immunologic factors|mesh-ancestor
153532674|NCT01503242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153532675|NCT01503242|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153532676|NCT01503242|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153532677|NCT01503242|Antimetabolites|antimetabolites|mesh-ancestor
153532678|NCT01503242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153532729|NCT01503398|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153532730|NCT01503398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153532731|NCT01503398|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153532732|NCT01503398|Serotonin Agents|serotonin agents|mesh-ancestor
153532733|NCT01503424|Olanzapine|olanzapine|mesh-list
153532734|NCT01503424|Antiemetics|antiemetics|mesh-ancestor
153532794|NCT01503580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153532795|NCT01503580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153532796|NCT01503580|Urological Agents|urological agents|mesh-ancestor
153532797|NCT01503593|Calcium|calcium|mesh-list
153532798|NCT01503593|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153532799|NCT01503593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153532800|NCT01503658|Aspirin|aspirin|mesh-list
153532801|NCT01503658|Clopidogrel|clopidogrel|mesh-list
153532802|NCT01503658|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153532803|NCT01503658|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153532804|NCT01503658|Analgesics|analgesics|mesh-ancestor
153532805|NCT01503658|Sensory System Agents|sensory system agents|mesh-ancestor
153532816|NCT01503658|Antipyretics|antipyretics|mesh-ancestor
153532855|NCT01503801|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-list
153532856|NCT01503801|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153532857|NCT01503801|Autonomic Agents|autonomic agents|mesh-ancestor
153532858|NCT01503801|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153532863|NCT01503801|Antioxidants|antioxidants|mesh-ancestor
153532924|NCT01504074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153532925|NCT01504074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153532926|NCT01504074|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153532927|NCT01504074|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
153532928|NCT01504074|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
153532929|NCT01504074|Adrenergic Agents|adrenergic agents|mesh-ancestor
153532930|NCT01504074|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153532931|NCT01504074|Sympatholytics|sympatholytics|mesh-ancestor
153532932|NCT01504074|Autonomic Agents|autonomic agents|mesh-ancestor
153532934|NCT01504126|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
153532935|NCT01504126|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
153532936|NCT01504126|Adrenergic Agents|adrenergic agents|mesh-ancestor
153532937|NCT01504126|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153532938|NCT01504126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153532939|NCT01504126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153532940|NCT01504126|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153532941|NCT01504126|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153532942|NCT01504126|Vasodilator Agents|vasodilator agents|mesh-ancestor
153532943|NCT01504139|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
153532944|NCT01504139|Estradiol|estradiol|mesh-list
153532977|NCT01504256|Oxaliplatin|oxaliplatin|mesh-list
153532978|NCT01504256|Catumaxomab|catumaxomab|mesh-list
153532979|NCT01504256|Antibodies, Bispecific|antibodies, bispecific|mesh-list
153532980|NCT01504256|Levoleucovorin|levoleucovorin|mesh-list
153532981|NCT01504256|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153532982|NCT01504256|Tubulin Modulators|tubulin modulators|mesh-ancestor
153532983|NCT01504256|Antimitotic Agents|antimitotic agents|mesh-ancestor
153532984|NCT01504256|Mitosis Modulators|mitosis modulators|mesh-ancestor
153532985|NCT01504256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153532986|NCT01504256|Antimetabolites|antimetabolites|mesh-ancestor
153533045|NCT01504516|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153533046|NCT01504516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153533047|NCT01504516|Nootropic Agents|nootropic agents|mesh-ancestor
153533048|NCT01504542|Vaccines|vaccines|mesh-list
153533049|NCT01504542|Immunologic Factors|immunologic factors|mesh-ancestor
153533050|NCT01504542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153533051|NCT01504581|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
153533052|NCT01504581|Antiviral Agents|antiviral agents|mesh-ancestor
153533053|NCT01504581|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153533054|NCT01504620|Insulin|insulin|mesh-list
153533055|NCT01504620|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153533056|NCT01504620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153533109|NCT01504906|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153533110|NCT01504906|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
153533111|NCT01504906|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
153533112|NCT01504906|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
153533113|NCT01504906|Purinergic Agents|purinergic agents|mesh-ancestor
153533114|NCT01504906|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153533116|NCT01504984|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153533117|NCT01504984|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153533118|NCT01504984|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153533119|NCT01504984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153533120|NCT01504984|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153533122|NCT01505049|Immunologic Factors|immunologic factors|mesh-ancestor
153533145|NCT01505088|Hormones|hormones|mesh-ancestor
153533170|NCT01505127|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153533171|NCT01505127|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
153533172|NCT01505218|Propofol|propofol|mesh-list
153533173|NCT01505218|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153533174|NCT01505218|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153533175|NCT01505218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153533238|NCT01505439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153533239|NCT01505439|Urological Agents|urological agents|mesh-ancestor
153533240|NCT01505504|Mirtazapine|mirtazapine|mesh-list
153533241|NCT01505504|Antidepressive Agents|antidepressive agents|mesh-ancestor
153533242|NCT01505504|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153533243|NCT01505504|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
153533304|NCT01505998|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
153533305|NCT01505998|Protease Inhibitors|protease inhibitors|mesh-ancestor
153533306|NCT01505998|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153533307|NCT01506011|Amlodipine|amlodipine|mesh-list
153533308|NCT01506011|Benazepril|benazepril|mesh-list
153533310|NCT01506011|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153533311|NCT01506011|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153533312|NCT01506011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153533313|NCT01506011|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153533314|NCT01506011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153533315|NCT01506011|Vasodilator Agents|vasodilator agents|mesh-ancestor
153533316|NCT01506011|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
153533317|NCT01506011|Protease Inhibitors|protease inhibitors|mesh-ancestor
153533318|NCT01506011|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153533319|NCT01506024|Tacrine|tacrine|mesh-list
153533320|NCT01506024|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
153533321|NCT01506024|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153533322|NCT01506024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153533323|NCT01506024|Cholinergic Agents|cholinergic agents|mesh-ancestor
153533324|NCT01506024|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153533325|NCT01506024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153533326|NCT01506024|Parasympathomimetics|parasympathomimetics|mesh-ancestor
153533327|NCT01506024|Autonomic Agents|autonomic agents|mesh-ancestor
153533329|NCT01506024|Nootropic Agents|nootropic agents|mesh-ancestor
153533330|NCT01506037|Desloratadine|desloratadine|mesh-list
153533331|NCT01506037|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
153533332|NCT01506037|Cholinergic Agents|cholinergic agents|mesh-ancestor
153533347|NCT01506050|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
153533348|NCT01506050|Histamine Antagonists|histamine antagonists|mesh-ancestor
153533349|NCT01506050|Histamine Agents|histamine agents|mesh-ancestor
153533350|NCT01506063|Levocetirizine|levocetirizine|mesh-list
153533351|NCT01506063|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
153533352|NCT01506063|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
153533353|NCT01506063|Histamine Antagonists|histamine antagonists|mesh-ancestor
153533354|NCT01506063|Histamine Agents|histamine agents|mesh-ancestor
153533355|NCT01506063|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153533358|NCT01506076|Levocetirizine|levocetirizine|mesh-list
153533359|NCT01506076|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
153533360|NCT01506076|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
153533361|NCT01506076|Histamine Antagonists|histamine antagonists|mesh-ancestor
153533408|NCT01506336|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153533409|NCT01506336|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153533410|NCT01506336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153533412|NCT01506388|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
153533477|NCT01506622|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153533478|NCT01506622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153533479|NCT01506622|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153533480|NCT01506622|Anesthetics, General|anesthetics, general|mesh-ancestor
153533481|NCT01506622|Anesthetics|anesthetics|mesh-ancestor
153533482|NCT01506622|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153533483|NCT01506622|Narcotics|narcotics|mesh-ancestor
153533484|NCT01506622|Analgesics|analgesics|mesh-ancestor
153533485|NCT01506622|Sensory System Agents|sensory system agents|mesh-ancestor
153533486|NCT01506622|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153533487|NCT01506622|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153533488|NCT01506635|Timolol|timolol|mesh-list
153533489|NCT01506635|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
153533538|NCT01506791|Cholinergic Agents|cholinergic agents|mesh-ancestor
153533539|NCT01506791|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153533540|NCT01506791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153533541|NCT01506791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153533542|NCT01506791|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
153533543|NCT01506791|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
153533544|NCT01506791|Histamine Antagonists|histamine antagonists|mesh-ancestor
153533545|NCT01506791|Histamine Agents|histamine agents|mesh-ancestor
153533604|NCT01507077|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153533605|NCT01507077|Growth Substances|growth substances|mesh-ancestor
153533607|NCT01507077|Growth Inhibitors|growth inhibitors|mesh-ancestor
153533608|NCT01507077|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153533609|NCT01507194|Ondansetron|ondansetron|mesh-list
153533610|NCT01507194|Vestipitant|vestipitant|mesh-list
153533611|NCT01507194|Antiemetics|antiemetics|mesh-ancestor
153533612|NCT01507194|Autonomic Agents|autonomic agents|mesh-ancestor
153533613|NCT01507194|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153533614|NCT01507194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153533615|NCT01507194|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153533616|NCT01507194|Antipruritics|antipruritics|mesh-ancestor
153533617|NCT01507194|Dermatologic Agents|dermatologic agents|mesh-ancestor
153533618|NCT01507194|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
153533619|NCT01507194|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153533620|NCT01507194|Serotonin Agents|serotonin agents|mesh-ancestor
153533621|NCT01507194|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153533622|NCT01507194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153533623|NCT01507194|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
153533624|NCT01507272|Liraglutide|liraglutide|mesh-list
153533625|NCT01507272|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
153533626|NCT01507272|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153533627|NCT01507272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153533628|NCT01507272|Incretins|incretins|mesh-ancestor
153533629|NCT01507272|Hormones|hormones|mesh-ancestor
153533630|NCT01507272|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153533650|NCT01507363|Anticonvulsants|anticonvulsants|mesh-ancestor
153533651|NCT01507363|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153533652|NCT01507363|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153533653|NCT01507363|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153533654|NCT01507363|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153533655|NCT01507363|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
153533719|NCT01507519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153533720|NCT01507558|Dexamethasone|dexamethasone|mesh-list
153533721|NCT01507558|Dexamethasone acetate|dexamethasone acetate|mesh-list
153533722|NCT01507558|BB 1101|bb 1101|mesh-list
153533723|NCT01507558|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153533724|NCT01507558|Antiemetics|antiemetics|mesh-ancestor
153533725|NCT01507558|Autonomic Agents|autonomic agents|mesh-ancestor
153533726|NCT01507558|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153533727|NCT01507558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153533728|NCT01507558|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153533729|NCT01507558|Glucocorticoids|glucocorticoids|mesh-ancestor
153533730|NCT01507558|Hormones|hormones|mesh-ancestor
153533731|NCT01507558|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153533732|NCT01507558|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153533733|NCT01507558|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153533734|NCT01507558|Protease Inhibitors|protease inhibitors|mesh-ancestor
153533735|NCT01507558|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153533736|NCT01507558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153533737|NCT01507571|Psychotropic Drugs|psychotropic drugs|mesh-list
153533738|NCT01507597|Glucagon|glucagon|mesh-list
153533739|NCT01507597|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
153533772|NCT01507740|Growth Inhibitors|growth inhibitors|mesh-ancestor
153533773|NCT01507740|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153533774|NCT01507740|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153533775|NCT01507740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153533776|NCT01507792|Loratadine|loratadine|mesh-list
153533777|NCT01507792|Omeprazole|omeprazole|mesh-list
153533778|NCT01507792|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
153533782|NCT01507792|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153533783|NCT01507792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153533784|NCT01507792|Antipruritics|antipruritics|mesh-ancestor
153533785|NCT01507792|Dermatologic Agents|dermatologic agents|mesh-ancestor
153533786|NCT01507792|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
153533787|NCT01507792|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
153533788|NCT01507792|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
153533789|NCT01507792|Histamine Antagonists|histamine antagonists|mesh-ancestor
153533790|NCT01507792|Histamine Agents|histamine agents|mesh-ancestor
153533791|NCT01507792|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153533792|NCT01507792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153533828|NCT01508000|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153533829|NCT01508000|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153533830|NCT01508000|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153533831|NCT01508000|Growth Substances|growth substances|mesh-ancestor
153533833|NCT01508000|Growth Inhibitors|growth inhibitors|mesh-ancestor
153533899|NCT01508468|Giapreza|giapreza|mesh-list
153533900|NCT01508468|Calcium|calcium|mesh-list
153533901|NCT01508468|Diuretics|diuretics|mesh-list
153533902|NCT01508468|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
153533903|NCT01508468|Enzyme Inhibitors|enzyme inhibitors|mesh-list
153533904|NCT01508468|Angiotensinogen|angiotensinogen|mesh-list
153533905|NCT01508468|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-list
153533906|NCT01508468|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153533907|NCT01508468|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153533908|NCT01508468|Immunologic Factors|immunologic factors|mesh-ancestor
153533909|NCT01508468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153533910|NCT01508468|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153533911|NCT01508468|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153533912|NCT01508468|Natriuretic Agents|natriuretic agents|mesh-ancestor
153533913|NCT01508468|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
153533914|NCT01508468|Adrenergic Agents|adrenergic agents|mesh-ancestor
153533917|NCT01508468|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
153533918|NCT01508468|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
153533919|NCT01508468|Protease Inhibitors|protease inhibitors|mesh-ancestor
153533920|NCT01508468|Hormone Antagonists|hormone antagonists|mesh-ancestor
153533921|NCT01508468|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153533947|NCT01508637|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
153533948|NCT01508637|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
153533949|NCT01508637|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
153533951|NCT01508637|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153533952|NCT01508637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153533953|NCT01508637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153533954|NCT01508637|Urological Agents|urological agents|mesh-ancestor
153533955|NCT01508663|Everolimus|everolimus|mesh-list
153533956|NCT01508663|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
153533957|NCT01508663|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
153533958|NCT01508663|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153533959|NCT01508663|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153533960|NCT01508663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153533961|NCT01508663|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153533962|NCT01508663|Immunologic Factors|immunologic factors|mesh-ancestor
153534005|NCT01508884|Toll-Like Receptor Agonists|toll-like receptor agonists|mesh-ancestor
153534006|NCT01508884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153534007|NCT01508884|Immunomodulating Agents|immunomodulating agents|mesh-ancestor
153534008|NCT01508884|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153534009|NCT01508884|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153534010|NCT01508884|Interferon Inducers|interferon inducers|mesh-ancestor
153534012|NCT01508923|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
153534079|NCT01509300|Antitubercular Agents|antitubercular agents|mesh-ancestor
153534080|NCT01509300|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153534082|NCT01509365|Clopidogrel|clopidogrel|mesh-list
153534140|NCT01509755|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153534141|NCT01509755|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153534142|NCT01509755|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153534143|NCT01509755|Immunologic Factors|immunologic factors|mesh-ancestor
153534144|NCT01509911|Gemcitabine|gemcitabine|mesh-list
153534145|NCT01509911|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153534146|NCT01509911|Antimetabolites|antimetabolites|mesh-ancestor
153534147|NCT01509911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153534205|NCT01510509|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153534206|NCT01510509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153534207|NCT01510509|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153534208|NCT01510509|Immunologic Factors|immunologic factors|mesh-ancestor
153534209|NCT01510509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153534210|NCT01510509|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153534211|NCT01510522|Metformin|metformin|mesh-list
153534212|NCT01510522|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153534213|NCT01510522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153534214|NCT01510548|Adalimumab|adalimumab|mesh-list
153534215|NCT01510548|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
153534216|NCT01510548|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153534217|NCT01510548|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153534218|NCT01510561|Gemcitabine|gemcitabine|mesh-list
153534219|NCT01510561|1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid|1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid|mesh-list
153534220|NCT01510561|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
153534226|NCT01510561|Sequestering Agents|sequestering agents|mesh-ancestor
153534227|NCT01510561|Immunologic Factors|immunologic factors|mesh-ancestor
153534228|NCT01510561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153534229|NCT01510574|Misoprostol|misoprostol|mesh-list
153534230|NCT01510574|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
153534231|NCT01510574|Abortifacient Agents|abortifacient agents|mesh-ancestor
153534232|NCT01510574|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153534233|NCT01510574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153556510|NCT01613963|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
153534234|NCT01510574|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
153534235|NCT01510574|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153534236|NCT01510574|Oxytocics|oxytocics|mesh-ancestor
153534237|NCT01510613|Dexamethasone|dexamethasone|mesh-list
153534246|NCT01510613|Hormones|hormones|mesh-ancestor
153534247|NCT01510613|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153534248|NCT01510613|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153534249|NCT01510613|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153534250|NCT01510613|Immunologic Factors|immunologic factors|mesh-ancestor
153534251|NCT01510613|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153534316|NCT01511146|Mitomycin|mitomycin|mesh-list
153534317|NCT01511146|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153534318|NCT01511146|Antimetabolites|antimetabolites|mesh-ancestor
153534319|NCT01511146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153534320|NCT01511146|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153534321|NCT01511146|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153534322|NCT01511146|Alkylating Agents|alkylating agents|mesh-ancestor
153534323|NCT01511146|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153534377|NCT01511211|Sensory System Agents|sensory system agents|mesh-ancestor
153534379|NCT01511237|Zidovudine|zidovudine|mesh-list
153534380|NCT01511237|Nevirapine|nevirapine|mesh-list
153534381|NCT01511237|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153534382|NCT01511237|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153534383|NCT01511237|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153534384|NCT01511237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153534385|NCT01511237|Antiviral Agents|antiviral agents|mesh-ancestor
153534386|NCT01511237|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153534387|NCT01511237|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153534388|NCT01511237|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153534389|NCT01511237|Antimetabolites|antimetabolites|mesh-ancestor
153534390|NCT01511237|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
153534436|NCT01511367|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153534437|NCT01511367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153534438|NCT01511367|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153534439|NCT01511367|Respiratory System Agents|respiratory system agents|mesh-ancestor
153534440|NCT01511367|Glucocorticoids|glucocorticoids|mesh-ancestor
153534441|NCT01511367|Hormones|hormones|mesh-ancestor
153534443|NCT01511367|Sympathomimetics|sympathomimetics|mesh-ancestor
153534503|NCT01511718|Ondansetron|ondansetron|mesh-list
153534504|NCT01511718|Antiemetics|antiemetics|mesh-ancestor
153534505|NCT01511718|Autonomic Agents|autonomic agents|mesh-ancestor
153534506|NCT01511718|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153534507|NCT01511718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153534508|NCT01511718|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153534509|NCT01511718|Antipruritics|antipruritics|mesh-ancestor
153534510|NCT01511718|Dermatologic Agents|dermatologic agents|mesh-ancestor
153534511|NCT01511718|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
153534512|NCT01511718|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153534513|NCT01511718|Serotonin Agents|serotonin agents|mesh-ancestor
153534514|NCT01511718|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153534515|NCT01511718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153534516|NCT01511731|Famotidine|famotidine|mesh-list
153534517|NCT01511731|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
153534518|NCT01511731|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153534519|NCT01511731|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
153534520|NCT01511731|Histamine Antagonists|histamine antagonists|mesh-ancestor
153534521|NCT01511731|Histamine Agents|histamine agents|mesh-ancestor
153534522|NCT01511731|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153534523|NCT01511731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153534524|NCT01511731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153534525|NCT01511757|Fluconazole|fluconazole|mesh-list
153534526|NCT01511757|Antifungal Agents|antifungal agents|mesh-ancestor
153534531|NCT01511757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153534532|NCT01511757|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153534535|NCT01511757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153534542|NCT01511770|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153534543|NCT01511770|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153534544|NCT01511770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153534545|NCT01511770|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153534546|NCT01511770|Hormone Antagonists|hormone antagonists|mesh-ancestor
153534547|NCT01511770|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153534548|NCT01511770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153534549|NCT01511770|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
153534551|NCT01511822|Inositol|inositol|mesh-list
153534607|NCT01511887|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153534608|NCT01511887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153534610|NCT01511991|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153534611|NCT01511991|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
153534612|NCT01511991|Anesthetics, General|anesthetics, general|mesh-ancestor
153534613|NCT01511991|Anesthetics|anesthetics|mesh-ancestor
153534614|NCT01511991|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153534674|NCT01512355|Dexmedetomidine|dexmedetomidine|mesh-list
153534675|NCT01512355|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153534676|NCT01512355|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153534677|NCT01512355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153534680|NCT01512355|Sensory System Agents|sensory system agents|mesh-ancestor
153534681|NCT01512355|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153534682|NCT01512355|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
153534738|NCT01512862|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153534739|NCT01512862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153534740|NCT01512862|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
153534742|NCT01512862|Micronutrients|micronutrients|mesh-ancestor
153534743|NCT01512862|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153534744|NCT01512901|Betamethasone|betamethasone|mesh-list
153534745|NCT01512901|Betamethasone Valerate|betamethasone valerate|mesh-list
153534746|NCT01512901|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
153534747|NCT01512901|Betamethasone benzoate|betamethasone benzoate|mesh-list
153534748|NCT01512901|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
153534749|NCT01512901|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153534750|NCT01512901|Glucocorticoids|glucocorticoids|mesh-ancestor
153534751|NCT01512901|Hormones|hormones|mesh-ancestor
153534752|NCT01512901|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153534794|NCT01513057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153534795|NCT01513070|Aspirin|aspirin|mesh-list
153534796|NCT01513070|Isosorbide|isosorbide|mesh-list
153534797|NCT01513070|Isosorbide Dinitrate|isosorbide dinitrate|mesh-list
153534798|NCT01513070|Isosorbide-5-mononitrate|isosorbide-5-mononitrate|mesh-list
153534799|NCT01513070|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153534800|NCT01513070|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153534801|NCT01513070|Analgesics|analgesics|mesh-ancestor
153534802|NCT01513070|Sensory System Agents|sensory system agents|mesh-ancestor
153534803|NCT01513070|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153534804|NCT01513070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153534805|NCT01513070|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153534806|NCT01513070|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153534807|NCT01513070|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153534808|NCT01513070|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153534855|NCT01513525|Incretins|incretins|mesh-ancestor
153534857|NCT01513525|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153534858|NCT01513564|Morphine|morphine|mesh-list
153534859|NCT01513564|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153534860|NCT01513564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153534861|NCT01513564|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153534862|NCT01513564|Narcotics|narcotics|mesh-ancestor
153534863|NCT01513564|Analgesics|analgesics|mesh-ancestor
153534864|NCT01513564|Sensory System Agents|sensory system agents|mesh-ancestor
153534865|NCT01513564|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153534866|NCT01513603|Cytarabine|cytarabine|mesh-list
153534867|NCT01513603|Mitoxantrone|mitoxantrone|mesh-list
153534868|NCT01513603|Cladribine|cladribine|mesh-list
153534870|NCT01513603|Antimetabolites|antimetabolites|mesh-ancestor
153534908|NCT01513720|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153534909|NCT01513720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153534910|NCT01513720|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153534911|NCT01513720|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153534912|NCT01513720|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153534913|NCT01513720|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153534914|NCT01513720|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153534915|NCT01513772|Dexmedetomidine|dexmedetomidine|mesh-list
153534916|NCT01513772|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153534917|NCT01513772|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153534971|NCT01514110|Everolimus|everolimus|mesh-list
153534972|NCT01514110|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153534973|NCT01514110|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153534974|NCT01514110|Tubulin Modulators|tubulin modulators|mesh-ancestor
153534975|NCT01514110|Antimitotic Agents|antimitotic agents|mesh-ancestor
153535039|NCT01514266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153535040|NCT01514409|5-Hydroxytryptophan|5-hydroxytryptophan|mesh-list
153535041|NCT01514409|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
153535042|NCT01514409|Antidepressive Agents|antidepressive agents|mesh-ancestor
153535043|NCT01514409|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153535044|NCT01514487|Liraglutide|liraglutide|mesh-list
153535046|NCT01514487|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153535108|NCT01514838|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153535109|NCT01514838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153535110|NCT01514838|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
153535111|NCT01514851|Calcium Carbonate|calcium carbonate|mesh-list
153535112|NCT01514851|Calcium|calcium|mesh-list
153535113|NCT01514851|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153535114|NCT01514851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153535115|NCT01514851|Antacids|antacids|mesh-ancestor
153535116|NCT01514851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153535117|NCT01514851|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153535118|NCT01514929|Moxifloxacin|moxifloxacin|mesh-list
153535119|NCT01514929|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153535120|NCT01514929|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153535121|NCT01514929|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153535122|NCT01514929|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153535123|NCT01514929|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153535124|NCT01514929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153535125|NCT01514929|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153535127|NCT01514942|Vitamin B Complex|vitamin b complex|mesh-list
153535128|NCT01514942|Hydroxocobalamin|hydroxocobalamin|mesh-list
153535129|NCT01514942|Vitamin B 12|vitamin b 12|mesh-list
153535133|NCT01514942|Vitamins|vitamins|mesh-ancestor
153535134|NCT01514942|Micronutrients|micronutrients|mesh-ancestor
153535135|NCT01514942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153535136|NCT01514942|Trace Elements|trace elements|mesh-ancestor
153535137|NCT01514968|Cyclosporine|cyclosporine|mesh-list
153535138|NCT01514968|Ritonavir|ritonavir|mesh-list
153535139|NCT01514968|Cyclosporins|cyclosporins|mesh-list
153478360|NCT01119222|Anesthetics|anesthetics|mesh-ancestor
153535140|NCT01514968|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153535152|NCT01514968|Protease Inhibitors|protease inhibitors|mesh-ancestor
153535153|NCT01514968|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153535154|NCT01514968|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153535155|NCT01514968|Antiviral Agents|antiviral agents|mesh-ancestor
153535156|NCT01514968|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
153535157|NCT01514968|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153535158|NCT01514981|Mogamulizumab|mogamulizumab|mesh-list
153535159|NCT01514981|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153535160|NCT01515020|Vancomycin|vancomycin|mesh-list
153535161|NCT01515020|Daptomycin|daptomycin|mesh-list
153535162|NCT01515020|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153535163|NCT01515020|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153535164|NCT01515228|Paclitaxel|paclitaxel|mesh-list
153535165|NCT01515228|Everolimus|everolimus|mesh-list
153535166|NCT01515228|Cilostazol|cilostazol|mesh-list
153535167|NCT01515228|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153535168|NCT01515228|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153535169|NCT01515228|Tubulin Modulators|tubulin modulators|mesh-ancestor
153535170|NCT01515228|Antimitotic Agents|antimitotic agents|mesh-ancestor
153535171|NCT01515228|Mitosis Modulators|mitosis modulators|mesh-ancestor
153535172|NCT01515228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153535173|NCT01515228|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
153535174|NCT01515228|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153535175|NCT01515228|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153535176|NCT01515228|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153535177|NCT01515228|Immunologic Factors|immunologic factors|mesh-ancestor
153535178|NCT01515228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153535201|NCT01515397|Polygeline|polygeline|mesh-list
153535203|NCT01515397|Blood Substitutes|blood substitutes|mesh-ancestor
153535204|NCT01515553|Liraglutide|liraglutide|mesh-list
153535205|NCT01515553|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
153535206|NCT01515553|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153535208|NCT01515553|Incretins|incretins|mesh-ancestor
153535209|NCT01515553|Hormones|hormones|mesh-ancestor
153535210|NCT01515553|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153535211|NCT01515579|Liraglutide|liraglutide|mesh-list
153535212|NCT01515579|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
153535213|NCT01515579|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153535214|NCT01515579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153535216|NCT01515579|Hormones|hormones|mesh-ancestor
153535217|NCT01515579|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153535218|NCT01515592|Liraglutide|liraglutide|mesh-list
153535219|NCT01515592|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
153535221|NCT01515592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153535222|NCT01515592|Incretins|incretins|mesh-ancestor
153535223|NCT01515592|Hormones|hormones|mesh-ancestor
153535224|NCT01515592|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153535225|NCT01515683|Anesthetics|anesthetics|mesh-list
153535226|NCT01515683|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153535249|NCT01515813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153535250|NCT01515813|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153535251|NCT01515813|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153535252|NCT01515813|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
153535253|NCT01515813|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153535254|NCT01515813|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
153535255|NCT01515813|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
153535256|NCT01515813|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
153535257|NCT01515813|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
153535258|NCT01515813|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153535259|NCT01515813|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153535260|NCT01515813|Antimetabolites|antimetabolites|mesh-ancestor
153535261|NCT01515813|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153535262|NCT01515813|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
153535264|NCT01515826|Dexamethasone|dexamethasone|mesh-list
153535265|NCT01515826|Dexamethasone acetate|dexamethasone acetate|mesh-list
153535305|NCT01515839|Vitamins|vitamins|mesh-ancestor
153535306|NCT01515839|Micronutrients|micronutrients|mesh-ancestor
153535307|NCT01515839|Nootropic Agents|nootropic agents|mesh-ancestor
153535308|NCT01515839|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
153535309|NCT01515839|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153535310|NCT01515839|Cholinergic Agents|cholinergic agents|mesh-ancestor
153535311|NCT01515839|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153535312|NCT01515839|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
153535313|NCT01515839|Antiviral Agents|antiviral agents|mesh-ancestor
153535314|NCT01515839|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153535315|NCT01515839|Expectorants|expectorants|mesh-ancestor
153535316|NCT01515839|Respiratory System Agents|respiratory system agents|mesh-ancestor
153535317|NCT01515839|Free Radical Scavengers|free radical scavengers|mesh-ancestor
153535318|NCT01515839|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
153535319|NCT01515839|Vasodilator Agents|vasodilator agents|mesh-ancestor
153535320|NCT01515852|Anesthetics|anesthetics|mesh-list
153535321|NCT01515852|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153535322|NCT01515852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153535323|NCT01515917|Cytidine Diphosphate Choline|cytidine diphosphate choline|mesh-list
153535324|NCT01515917|Nootropic Agents|nootropic agents|mesh-ancestor
153535328|NCT01515969|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153535357|NCT01516255|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
153535358|NCT01516255|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153535359|NCT01516255|Incretins|incretins|mesh-ancestor
153535360|NCT01516255|Hormones|hormones|mesh-ancestor
153535361|NCT01516255|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153535362|NCT01514903|Sildenafil Citrate|sildenafil citrate|mesh-list
153535363|NCT01514903|Vasodilator Agents|vasodilator agents|mesh-ancestor
153535364|NCT01514903|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
153535365|NCT01514903|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
153535421|NCT01516567|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153535422|NCT01516567|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153535423|NCT01516567|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153535424|NCT01516567|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153535425|NCT01516567|Tubulin Modulators|tubulin modulators|mesh-ancestor
153535426|NCT01516567|Antimitotic Agents|antimitotic agents|mesh-ancestor
153535427|NCT01516567|Mitosis Modulators|mitosis modulators|mesh-ancestor
153535428|NCT01516580|Cytarabine|cytarabine|mesh-list
153556609|NCT01614366|Vasodilator Agents|vasodilator agents|mesh-ancestor
153535429|NCT01516580|Cyclophosphamide|cyclophosphamide|mesh-list
153535430|NCT01516580|Rituximab|rituximab|mesh-list
153535431|NCT01516580|Doxorubicin|doxorubicin|mesh-list
153535432|NCT01516580|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
153535433|NCT01516580|Methotrexate|methotrexate|mesh-list
153535434|NCT01516580|Vincristine|vincristine|mesh-list
153535435|NCT01516580|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153535436|NCT01516580|Immunologic Factors|immunologic factors|mesh-ancestor
153478661|NCT01153620|Polihexanide|polihexanide|mesh-list
153535437|NCT01516580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153535438|NCT01516580|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153535439|NCT01516580|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153535440|NCT01516580|Alkylating Agents|alkylating agents|mesh-ancestor
153535477|NCT01516723|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153535478|NCT01516723|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153535480|NCT01516762|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
153535481|NCT01516762|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153535482|NCT01516814|Heparin|heparin|mesh-list
153535483|NCT01516814|Calcium heparin|calcium heparin|mesh-list
153535548|NCT01517308|Interferon-alpha|interferon-alpha|mesh-list
153535549|NCT01517308|Interferon alpha-2|interferon alpha-2|mesh-list
153535550|NCT01517308|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
153535551|NCT01517308|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153535552|NCT01517308|Antiviral Agents|antiviral agents|mesh-ancestor
153535553|NCT01517308|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153535554|NCT01517308|Antimetabolites|antimetabolites|mesh-ancestor
153535555|NCT01517308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153535556|NCT01517308|Immunologic Factors|immunologic factors|mesh-ancestor
153535557|NCT01517308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153535558|NCT01517321|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
153535559|NCT01517321|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153535560|NCT01517321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153535561|NCT01517321|Incretins|incretins|mesh-ancestor
153535562|NCT01517321|Hormones|hormones|mesh-ancestor
153535563|NCT01517321|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153535565|NCT01517321|Protease Inhibitors|protease inhibitors|mesh-ancestor
153535566|NCT01517321|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153535567|NCT01517321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153535568|NCT01517334|Minocycline|minocycline|mesh-list
153535569|NCT01517334|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153535570|NCT01517334|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153535571|NCT01517347|Interleukin-2|interleukin-2|mesh-list
153535572|NCT01517347|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153535573|NCT01517347|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153535597|NCT01517399|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153535598|NCT01517399|Anesthetics, General|anesthetics, general|mesh-ancestor
153535599|NCT01517399|Anesthetics|anesthetics|mesh-ancestor
153535600|NCT01517399|GABA Modulators|gaba modulators|mesh-ancestor
153535601|NCT01517399|GABA Agents|gaba agents|mesh-ancestor
153535602|NCT01517399|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153535603|NCT01517399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153535604|NCT01517399|Anticoagulants|anticoagulants|mesh-ancestor
153535666|NCT01517828|Ketamine|ketamine|mesh-list
153535667|NCT01517828|Analgesics|analgesics|mesh-ancestor
153535668|NCT01517828|Sensory System Agents|sensory system agents|mesh-ancestor
153535669|NCT01517828|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153535670|NCT01517828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153535671|NCT01517828|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
153535672|NCT01517828|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153535673|NCT01517828|Anesthetics, General|anesthetics, general|mesh-ancestor
153535674|NCT01517828|Anesthetics|anesthetics|mesh-ancestor
153535675|NCT01517828|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153535676|NCT01517828|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
153535677|NCT01517828|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
153535678|NCT01517828|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153535679|NCT01517828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153535680|NCT01517828|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153535681|NCT01517828|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153535682|NCT01517828|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153535683|NCT01517828|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153556640|NCT01614496|Insulin|insulin|mesh-list
153535686|NCT01517828|GABA Agents|gaba agents|mesh-ancestor
153535720|NCT01518101|Liraglutide|liraglutide|mesh-list
153535721|NCT01518101|Vildagliptin|vildagliptin|mesh-list
153535722|NCT01518101|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153535723|NCT01518101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153535724|NCT01518101|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
153535788|NCT01518231|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
153535789|NCT01518231|Anticoagulants|anticoagulants|mesh-ancestor
153535790|NCT01518231|Free Radical Scavengers|free radical scavengers|mesh-ancestor
153535792|NCT01518231|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
153535793|NCT01518231|Protective Agents|protective agents|mesh-ancestor
153535794|NCT01518413|Irinotecan|irinotecan|mesh-list
153535856|NCT01518634|Antidepressive Agents|antidepressive agents|mesh-ancestor
153535857|NCT01518634|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153535858|NCT01518634|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
153535859|NCT01518634|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153535860|NCT01518634|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153535861|NCT01518634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153535862|NCT01518634|Adrenergic Agents|adrenergic agents|mesh-ancestor
153535863|NCT01518634|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153535864|NCT01518634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153535865|NCT01518712|Metformin|metformin|mesh-list
153535866|NCT01518712|Canagliflozin|canagliflozin|mesh-list
153535867|NCT01518712|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153535868|NCT01518712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153535869|NCT01518712|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
153535870|NCT01518712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153535872|NCT01518725|Cholecalciferol|cholecalciferol|mesh-list
153535873|NCT01518725|Vitamins|vitamins|mesh-ancestor
153535908|NCT01518998|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153535909|NCT01518998|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153535910|NCT01518998|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153535911|NCT01518998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153535912|NCT01518998|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153535913|NCT01518998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153535914|NCT01518998|Vasodilator Agents|vasodilator agents|mesh-ancestor
153535915|NCT01519011|Azacitidine|azacitidine|mesh-list
153535916|NCT01519011|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153535917|NCT01519011|Antimetabolites|antimetabolites|mesh-ancestor
153535918|NCT01519011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153535919|NCT01519011|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153535920|NCT01519011|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153535921|NCT01519037|Cinacalcet|cinacalcet|mesh-list
153535922|NCT01519037|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153535923|NCT01519037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153535924|NCT01519037|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
153535925|NCT01519037|Hormone Antagonists|hormone antagonists|mesh-ancestor
153535926|NCT01519037|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153535927|NCT01519076|Coal Tar|coal tar|mesh-list
153535928|NCT01519076|Keratolytic Agents|keratolytic agents|mesh-ancestor
153535929|NCT01519076|Dermatologic Agents|dermatologic agents|mesh-ancestor
153535950|NCT01519154|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153535951|NCT01519154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153535952|NCT01519154|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153810836|NCT00352443|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153535958|NCT01519154|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
153535959|NCT01519154|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
153535960|NCT01519154|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
153535961|NCT01519154|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153536008|NCT01519401|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
153536009|NCT01519401|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
153536010|NCT01519401|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
153536011|NCT01519401|Hormone Antagonists|hormone antagonists|mesh-ancestor
153536012|NCT01519401|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
153536014|NCT01519401|Natriuretic Agents|natriuretic agents|mesh-ancestor
153536015|NCT01519544|Acetazolamide|acetazolamide|mesh-list
153536016|NCT01519544|Temazepam|temazepam|mesh-list
153536017|NCT01519544|Anticonvulsants|anticonvulsants|mesh-ancestor
153536032|NCT01519687|Tofisopam|tofisopam|mesh-list
153536075|NCT01520025|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
153536076|NCT01520025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153536078|NCT01520077|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153536079|NCT01520077|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153536080|NCT01520077|Antimetabolites|antimetabolites|mesh-ancestor
153536081|NCT01520077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153536082|NCT01520077|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153536083|NCT01520103|Everolimus|everolimus|mesh-list
153536084|NCT01520103|Vinorelbine|vinorelbine|mesh-list
153536097|NCT01520116|Timolol|timolol|mesh-list
153536137|NCT01520350|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
153536138|NCT01520350|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
153536139|NCT01520350|Serotonin Agents|serotonin agents|mesh-ancestor
153536140|NCT01520350|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
153536141|NCT01520350|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153536142|NCT01520350|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
153536145|NCT01520389|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
153536146|NCT01520389|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
153536147|NCT01520389|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153536148|NCT01520389|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153536149|NCT01520389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153536150|NCT01520389|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153536151|NCT01520389|Immunologic Factors|immunologic factors|mesh-ancestor
153536152|NCT01520389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153536153|NCT01520415|Lidocaine|lidocaine|mesh-list
153536154|NCT01520415|Bupivacaine|bupivacaine|mesh-list
153536192|NCT01520753|Insulin, Long-Acting|insulin, long-acting|mesh-list
153536193|NCT01520753|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
153536194|NCT01520753|Biphasic Insulins|biphasic insulins|mesh-list
153536195|NCT01520753|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153536196|NCT01520753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153536197|NCT01520766|Methamphetamine|methamphetamine|mesh-list
153536198|NCT01520766|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
153536199|NCT01520766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153536200|NCT01520766|Sympathomimetics|sympathomimetics|mesh-ancestor
153536201|NCT01520766|Autonomic Agents|autonomic agents|mesh-ancestor
153536202|NCT01520766|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153536203|NCT01520766|Dopamine Agents|dopamine agents|mesh-ancestor
153536204|NCT01520766|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153536205|NCT01520766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153536248|NCT01520896|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
153536249|NCT01520896|Sensory System Agents|sensory system agents|mesh-ancestor
153536250|NCT01520896|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153536251|NCT01521130|Levetiracetam|levetiracetam|mesh-list
153536252|NCT01521130|Anticonvulsants|anticonvulsants|mesh-ancestor
153536253|NCT01521130|Nootropic Agents|nootropic agents|mesh-ancestor
153536255|NCT01521299|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153536256|NCT01521299|Antisickling Agents|antisickling agents|mesh-ancestor
153536257|NCT01521299|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153536258|NCT01521299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153536259|NCT01521299|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153536260|NCT01521312|Saxagliptin|saxagliptin|mesh-list
153536261|NCT01521312|Incretins|incretins|mesh-ancestor
153536262|NCT01521312|Hormones|hormones|mesh-ancestor
153536263|NCT01521312|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153536264|NCT01521312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153536265|NCT01521312|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
153536266|NCT01521312|Protease Inhibitors|protease inhibitors|mesh-ancestor
153536267|NCT01521312|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153536268|NCT01521312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153536269|NCT01521312|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153536270|NCT01521325|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
153536271|NCT01521325|Immunologic Factors|immunologic factors|mesh-ancestor
153536272|NCT01521325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153536273|NCT01521377|Moxifloxacin|moxifloxacin|mesh-list
153536274|NCT01521377|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
153536275|NCT01521377|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153536276|NCT01521377|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153536277|NCT01521377|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153536278|NCT01521377|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153536279|NCT01521377|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153536280|NCT01521377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153810841|NCT00352443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153536281|NCT01521377|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153536282|NCT01521377|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
153536283|NCT01521377|Contraceptive Agents|contraceptive agents|mesh-ancestor
153536285|NCT01521377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153536286|NCT01521377|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
153536287|NCT01521377|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
153536288|NCT01521377|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
153536289|NCT01521455|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
153536290|NCT01521455|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153536291|NCT01521455|Autonomic Agents|autonomic agents|mesh-ancestor
153536292|NCT01521455|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153536293|NCT01521455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153536294|NCT01521455|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153536349|NCT01521819|Growth Substances|growth substances|mesh-ancestor
153536350|NCT01521819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153536351|NCT01521819|Growth Inhibitors|growth inhibitors|mesh-ancestor
153536352|NCT01521819|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153536354|NCT01521936|Ergocalciferols|ergocalciferols|mesh-list
153536355|NCT01521936|Cholecalciferol|cholecalciferol|mesh-list
153536357|NCT01521936|Micronutrients|micronutrients|mesh-ancestor
153536358|NCT01521936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153536359|NCT01521936|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153536360|NCT01521936|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153536409|NCT01522326|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153536410|NCT01522326|Analgesics|analgesics|mesh-ancestor
153536411|NCT01522326|Sensory System Agents|sensory system agents|mesh-ancestor
153536412|NCT01522326|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153536413|NCT01522326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153536414|NCT01522326|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153536415|NCT01522326|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153536417|NCT01522326|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153536418|NCT01522326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153536419|NCT01522326|Antiemetics|antiemetics|mesh-ancestor
153536420|NCT01522326|Autonomic Agents|autonomic agents|mesh-ancestor
153536421|NCT01522326|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153536422|NCT01522326|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
153536423|NCT01522326|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
153536424|NCT01522326|Dopamine Agents|dopamine agents|mesh-ancestor
153536425|NCT01522326|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153536426|NCT01522378|3-Iodobenzylguanidine|3-iodobenzylguanidine|mesh-list
153536427|NCT01522378|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153536428|NCT01522378|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153556732|NCT01615224|Misoprostol|misoprostol|mesh-list
153556734|NCT01615224|Abortifacient Agents|abortifacient agents|mesh-ancestor
153536429|NCT01522378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153536430|NCT01522378|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
153536431|NCT01522534|Morphine|morphine|mesh-list
153536432|NCT01522534|Mepivacaine|mepivacaine|mesh-list
153536433|NCT01522534|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153536435|NCT01522534|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153536458|NCT01522612|Immunologic Factors|immunologic factors|mesh-ancestor
153536459|NCT01522612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153536461|NCT01522612|Protective Agents|protective agents|mesh-ancestor
153536462|NCT01522612|Vitamin B Complex|vitamin b complex|mesh-ancestor
153536464|NCT01522612|Micronutrients|micronutrients|mesh-ancestor
153536465|NCT01522612|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153536466|NCT01522625|Tenofovir|tenofovir|mesh-list
153536467|NCT01522625|Antiviral Agents|antiviral agents|mesh-ancestor
153536468|NCT01522625|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153536469|NCT01522625|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153536470|NCT01522625|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153536471|NCT01522625|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153536472|NCT01522625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153536473|NCT01522625|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153536474|NCT01522625|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153536475|NCT01522677|Aminolevulinic Acid|aminolevulinic acid|mesh-list
153536476|NCT01522677|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
153536477|NCT01522677|Dermatologic Agents|dermatologic agents|mesh-ancestor
153536478|NCT01522729|Fentanyl|fentanyl|mesh-list
153536479|NCT01522729|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153536512|NCT01522872|Autonomic Agents|autonomic agents|mesh-ancestor
153536513|NCT01522872|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153536514|NCT01522872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153536515|NCT01522872|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153536516|NCT01522872|Glucocorticoids|glucocorticoids|mesh-ancestor
153536517|NCT01522872|Hormones|hormones|mesh-ancestor
153536518|NCT01522872|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153536519|NCT01522872|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153536520|NCT01522872|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153536521|NCT01522872|Protease Inhibitors|protease inhibitors|mesh-ancestor
153536522|NCT01522872|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153536523|NCT01522872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153536524|NCT01522872|Immunologic Factors|immunologic factors|mesh-ancestor
153536574|NCT01523054|Adrenergic Agents|adrenergic agents|mesh-ancestor
153536575|NCT01523054|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153536576|NCT01523054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153536577|NCT01523067|VIP-ELP fusion molecule PB1046|vip-elp fusion molecule pb1046|mesh-list
153536578|NCT01523067|Vasodilator Agents|vasodilator agents|mesh-ancestor
153536580|NCT01523080|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153536581|NCT01523080|Analgesics|analgesics|mesh-ancestor
153536582|NCT01523080|Sensory System Agents|sensory system agents|mesh-ancestor
153536583|NCT01523080|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153536638|NCT01523327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153536640|NCT01523327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153536642|NCT01523379|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
153536643|NCT01523379|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153536644|NCT01523379|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153536645|NCT01523379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153536646|NCT01523379|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153536647|NCT01523379|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153536648|NCT01523379|Analgesics|analgesics|mesh-ancestor
153536649|NCT01523379|Sensory System Agents|sensory system agents|mesh-ancestor
153536650|NCT01523379|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153536651|NCT01523379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153536652|NCT01523379|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153536653|NCT01523379|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153536654|NCT01523418|Rivaroxaban|rivaroxaban|mesh-list
153536655|NCT01523418|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
153536656|NCT01523418|Antithrombins|antithrombins|mesh-ancestor
153536694|NCT01523574|Magnesium Sulfate|magnesium sulfate|mesh-list
153536696|NCT01523574|Vitamins|vitamins|mesh-ancestor
153536697|NCT01523574|Micronutrients|micronutrients|mesh-ancestor
153536698|NCT01523574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153536699|NCT01523574|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153536716|NCT01523639|Metformin|metformin|mesh-list
153536762|NCT01524081|Cefuroxime axetil|cefuroxime axetil|mesh-list
153536763|NCT01524081|Fluconazole|fluconazole|mesh-list
153536764|NCT01524081|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
153536765|NCT01524081|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153536766|NCT01524081|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153536767|NCT01524081|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153536768|NCT01524081|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153536769|NCT01524081|Antifungal Agents|antifungal agents|mesh-ancestor
153536770|NCT01524081|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
153536771|NCT01524081|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153536826|NCT01524367|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153536827|NCT01524367|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
153536828|NCT01524367|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153536829|NCT01524367|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153536830|NCT01524367|Adrenergic Agents|adrenergic agents|mesh-ancestor
153536831|NCT01524367|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153536832|NCT01524367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153536833|NCT01524432|Clotrimazole|clotrimazole|mesh-list
153536834|NCT01524432|Miconazole|miconazole|mesh-list
153536835|NCT01524432|Antifungal Agents|antifungal agents|mesh-list
153536836|NCT01524432|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
153536837|NCT01524432|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153536840|NCT01524432|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153536841|NCT01524432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153536842|NCT01524432|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153536843|NCT01524432|Hormone Antagonists|hormone antagonists|mesh-ancestor
153536844|NCT01524432|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153536845|NCT01524432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153536846|NCT01524432|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
153536847|NCT01524432|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
153536848|NCT01524445|Bortezomib|bortezomib|mesh-list
153536849|NCT01524445|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153536850|NCT01524497|Trazodone|trazodone|mesh-list
153536851|NCT01524497|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153536852|NCT01524497|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153536853|NCT01524497|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153536854|NCT01524497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153536855|NCT01524497|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153536856|NCT01524497|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
153536857|NCT01524497|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153536858|NCT01524497|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153536860|NCT01524497|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153536861|NCT01524497|Serotonin Agents|serotonin agents|mesh-ancestor
153536862|NCT01524497|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
153556799|NCT01615757|Cytarabine|cytarabine|mesh-list
153536863|NCT01524497|Antidepressive Agents|antidepressive agents|mesh-ancestor
153536864|NCT01524575|Gemcitabine|gemcitabine|mesh-list
153536865|NCT01524575|Oxaliplatin|oxaliplatin|mesh-list
153536867|NCT01524575|Antimetabolites|antimetabolites|mesh-ancestor
153536928|NCT01524809|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
153536929|NCT01524809|Biphasic Insulins|biphasic insulins|mesh-list
153702336|NCT00282607|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153536930|NCT01524809|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
153536932|NCT01524809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153536933|NCT01524861|Thioctic Acid|thioctic acid|mesh-list
153536934|NCT01524861|Acetylcarnitine|acetylcarnitine|mesh-list
153536936|NCT01524861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153536937|NCT01524861|Protective Agents|protective agents|mesh-ancestor
153536938|NCT01524861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153536939|NCT01524861|Vitamin B Complex|vitamin b complex|mesh-ancestor
153536940|NCT01524861|Vitamins|vitamins|mesh-ancestor
153536941|NCT01524861|Micronutrients|micronutrients|mesh-ancestor
153536942|NCT01524861|Nootropic Agents|nootropic agents|mesh-ancestor
153536943|NCT01524874|Vitamin D|vitamin d|mesh-list
153536944|NCT01524874|Ergocalciferols|ergocalciferols|mesh-list
153536945|NCT01524874|Cholecalciferol|cholecalciferol|mesh-list
153536946|NCT01524874|Calcitriol|calcitriol|mesh-list
153536947|NCT01524874|Vitamins|vitamins|mesh-list
153536948|NCT01524874|Micronutrients|micronutrients|mesh-ancestor
153536949|NCT01524874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153536950|NCT01524874|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153536951|NCT01524874|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153536979|NCT06052995|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
153536980|NCT06052995|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153536981|NCT06052995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153536982|NCT06052826|Coal Tar|coal tar|mesh-list
153536983|NCT06052826|Keratolytic Agents|keratolytic agents|mesh-ancestor
153536984|NCT06052826|Dermatologic Agents|dermatologic agents|mesh-ancestor
153536985|NCT06052163|Bumetanide|bumetanide|mesh-list
153536986|NCT06052163|Diuretics|diuretics|mesh-ancestor
153536987|NCT06052163|Natriuretic Agents|natriuretic agents|mesh-ancestor
153536988|NCT06052163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153536989|NCT06052163|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
153536990|NCT06052163|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153536991|NCT06052163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153536992|NCT06052111|Fentanyl|fentanyl|mesh-list
153537013|NCT06051981|Listerine|listerine|mesh-list
153537039|NCT06051851|Antimetabolites|antimetabolites|mesh-ancestor
153537040|NCT06051786|Fluticasone|fluticasone|mesh-list
153537041|NCT06051786|Azelastine|azelastine|mesh-list
153537043|NCT06051786|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153537044|NCT06051786|Autonomic Agents|autonomic agents|mesh-ancestor
153537045|NCT06051786|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153537046|NCT06051786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153537047|NCT06051786|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153537048|NCT06051786|Respiratory System Agents|respiratory system agents|mesh-ancestor
153537049|NCT06051786|Dermatologic Agents|dermatologic agents|mesh-ancestor
153537050|NCT06051786|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
153537051|NCT06051786|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
153537052|NCT06051786|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153537053|NCT06051786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153537054|NCT06051786|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
153537096|NCT06046248|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153537097|NCT06046248|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153537098|NCT06046248|Immunologic Factors|immunologic factors|mesh-ancestor
153537099|NCT06046248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153537100|NCT06046248|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153537101|NCT06046248|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153537102|NCT06046248|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153537103|NCT06046248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153537104|NCT06045481|Doxycycline|doxycycline|mesh-list
153537105|NCT06045481|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153537106|NCT06045481|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153537107|NCT06045481|Antimalarials|antimalarials|mesh-ancestor
153537108|NCT06045481|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153537109|NCT06045481|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153537110|NCT06015490|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
153537113|NCT05891262|Norethindrone acetate, ethinyl estradiol, ferrous fumarate drug combination|norethindrone acetate, ethinyl estradiol, ferrous fumarate drug combination|mesh-list
153537115|NCT05891262|Estrogens|estrogens|mesh-ancestor
153537116|NCT05891262|Hormones|hormones|mesh-ancestor
153537117|NCT05891262|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153537118|NCT05891262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153537148|NCT05874570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153537149|NCT05874570|Expectorants|expectorants|mesh-ancestor
153537150|NCT05874570|Respiratory System Agents|respiratory system agents|mesh-ancestor
153537151|NCT05808608|Axitinib|axitinib|mesh-list
153537152|NCT05808608|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153537153|NCT05808608|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153537154|NCT05808608|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153537155|NCT05808608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153537156|NCT05603702|Lacosamide|lacosamide|mesh-list
153537157|NCT05603702|Anticonvulsants|anticonvulsants|mesh-ancestor
153537158|NCT05603702|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
153537159|NCT05603702|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153537162|NCT05494593|Rituximab|rituximab|mesh-list
153537205|NCT05415397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153537206|NCT05414201|Adalimumab|adalimumab|mesh-list
153537207|NCT05414201|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
153537208|NCT05414201|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153537209|NCT05414201|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153537210|NCT05386810|Vaccines|vaccines|mesh-list
153537211|NCT05386810|Immunologic Factors|immunologic factors|mesh-ancestor
153537212|NCT05386810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153537213|NCT05368090|Epinephrine|epinephrine|mesh-list
153537214|NCT05368090|Racepinephrine|racepinephrine|mesh-list
153537215|NCT05368090|Epinephryl borate|epinephryl borate|mesh-list
153537216|NCT05368090|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153537218|NCT05368090|Adrenergic Agents|adrenergic agents|mesh-ancestor
153537219|NCT05368090|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153537220|NCT05368090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153537221|NCT05368090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153537260|NCT05296564|Sensory System Agents|sensory system agents|mesh-ancestor
153537261|NCT05296564|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153537262|NCT05296564|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153537263|NCT05296564|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153537264|NCT05296564|Antiviral Agents|antiviral agents|mesh-ancestor
153537265|NCT05296564|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153537267|NCT05290025|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
153537268|NCT05290025|Autonomic Agents|autonomic agents|mesh-ancestor
153537269|NCT05290025|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153537270|NCT05290025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153537271|NCT05290025|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
153537272|NCT05290025|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
153537273|NCT05290025|Cholinergic Agents|cholinergic agents|mesh-ancestor
153537274|NCT05290025|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153537275|NCT05290025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153537318|NCT04941664|Anesthetics, Local|anesthetics, local|mesh-ancestor
153537320|NCT04941664|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153537321|NCT04941664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153537322|NCT04941664|Sensory System Agents|sensory system agents|mesh-ancestor
153537323|NCT04941664|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153537324|NCT04888858|Fentanyl|fentanyl|mesh-list
153357435|NCT04385264|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153537327|NCT04888858|Anesthetics|anesthetics|mesh-ancestor
153537328|NCT04888858|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153537329|NCT04888858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153537333|NCT04888858|Narcotics|narcotics|mesh-ancestor
153537379|NCT04593940|Antiviral Agents|antiviral agents|mesh-ancestor
153537380|NCT04593940|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153537381|NCT04593940|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
153537382|NCT04593940|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153537383|NCT04593940|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153537384|NCT04562831|Niacinamide|niacinamide|mesh-list
153537449|NCT04397484|Respiratory System Agents|respiratory system agents|mesh-ancestor
153537450|NCT04397484|Mydriatics|mydriatics|mesh-ancestor
153537451|NCT04397484|Sympathomimetics|sympathomimetics|mesh-ancestor
153537452|NCT04397484|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
153537453|NCT04150497|Alemtuzumab|alemtuzumab|mesh-list
153537454|NCT04150497|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153537455|NCT04150497|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153537457|NCT04074746|Cyclophosphamide|cyclophosphamide|mesh-list
153537458|NCT04074746|Fludarabine|fludarabine|mesh-list
153537459|NCT04074746|Fludarabine phosphate|fludarabine phosphate|mesh-list
153537460|NCT04074746|Antibodies|antibodies|mesh-list
153537461|NCT04074746|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
153537462|NCT04074746|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153537463|NCT04074746|Immunologic Factors|immunologic factors|mesh-ancestor
153537465|NCT04074746|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153537511|NCT03803761|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153537512|NCT03803761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153537513|NCT03772834|Methylphenidate|methylphenidate|mesh-list
153537514|NCT03772834|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
153537515|NCT03772834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153537516|NCT03772834|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
153537517|NCT03772834|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153537518|NCT03772834|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153537519|NCT03772834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153537574|NCT03630042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153537575|NCT03565991|Avelumab|avelumab|mesh-list
153537576|NCT03565991|Talazoparib|talazoparib|mesh-list
153537577|NCT03565991|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153537578|NCT03565991|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153537579|NCT03565991|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
153537580|NCT03565991|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153537581|NCT03565991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153537582|NCT03504488|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
153702337|NCT00282724|Liarozole|liarozole|mesh-list
153537583|NCT03504488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153537584|NCT03504488|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153556831|NCT01615978|Incretins|incretins|mesh-ancestor
153537585|NCT03504488|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153537586|NCT03364868|Insulin|insulin|mesh-list
153537587|NCT03364868|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153537630|NCT02876302|Antimitotic Agents|antimitotic agents|mesh-ancestor
153537631|NCT02876302|Mitosis Modulators|mitosis modulators|mesh-ancestor
153537632|NCT02876302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153537633|NCT02876302|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153537634|NCT02876302|Immunologic Factors|immunologic factors|mesh-ancestor
153537635|NCT02876302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153537636|NCT02876302|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153537637|NCT02876302|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153537638|NCT02876302|Alkylating Agents|alkylating agents|mesh-ancestor
153537698|NCT01415882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153537699|NCT01415882|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153537700|NCT01415882|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153537702|NCT01415882|Antiemetics|antiemetics|mesh-ancestor
153537703|NCT01415882|Autonomic Agents|autonomic agents|mesh-ancestor
153537704|NCT01415882|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153537705|NCT01415882|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153537706|NCT01415882|Glucocorticoids|glucocorticoids|mesh-ancestor
153537707|NCT01415882|Hormones|hormones|mesh-ancestor
153537708|NCT01415882|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153537709|NCT01415882|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153537710|NCT01415882|Protease Inhibitors|protease inhibitors|mesh-ancestor
153537758|NCT00667121|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153537759|NCT00667121|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153537760|NCT00667121|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153537761|NCT00667121|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
153537762|NCT00667121|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
153537763|NCT00667121|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153537764|NCT00667121|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
153537765|NCT00591851|Paclitaxel|paclitaxel|mesh-list
153537766|NCT00591851|Cyclophosphamide|cyclophosphamide|mesh-list
153537821|NCT00336024|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153481048|NCT04357795|Antifungal Agents|antifungal agents|mesh-ancestor
153537822|NCT00336024|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153537823|NCT00336024|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153537824|NCT00336024|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153537825|NCT00336024|Antidotes|antidotes|mesh-ancestor
153537826|NCT00336024|Protective Agents|protective agents|mesh-ancestor
153537827|NCT00336024|Vitamin B Complex|vitamin b complex|mesh-ancestor
153537828|NCT00336024|Vitamins|vitamins|mesh-ancestor
153537829|NCT00336024|Micronutrients|micronutrients|mesh-ancestor
153537830|NCT00336024|Tubulin Modulators|tubulin modulators|mesh-ancestor
153537831|NCT00336024|Antimitotic Agents|antimitotic agents|mesh-ancestor
153537832|NCT00336024|Mitosis Modulators|mitosis modulators|mesh-ancestor
153537833|NCT00336024|Hematinics|hematinics|mesh-ancestor
153537834|NCT00336024|Keratolytic Agents|keratolytic agents|mesh-ancestor
153537837|NCT00133705|Abortifacient Agents|abortifacient agents|mesh-ancestor
153537878|NCT01525537|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153537879|NCT01525537|Anesthetics, General|anesthetics, general|mesh-ancestor
153537880|NCT01525537|Anesthetics|anesthetics|mesh-ancestor
153537881|NCT01525680|Hydrocortisone|hydrocortisone|mesh-list
153537882|NCT01525680|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153537883|NCT01525706|Ethanol|ethanol|mesh-list
153537884|NCT01525706|Paclitaxel|paclitaxel|mesh-list
153537885|NCT01525706|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
153537886|NCT01525706|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153537887|NCT01525706|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153537888|NCT01525706|Tubulin Modulators|tubulin modulators|mesh-ancestor
153537889|NCT01525706|Antimitotic Agents|antimitotic agents|mesh-ancestor
153537890|NCT01525706|Mitosis Modulators|mitosis modulators|mesh-ancestor
153537891|NCT01525706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153537892|NCT01525706|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
153618964|NCT01981330|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153537893|NCT01525706|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153537894|NCT01525706|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153618965|NCT01981330|Immunologic Factors|immunologic factors|mesh-ancestor
153537932|NCT01525914|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153537933|NCT01525914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153537934|NCT01525914|Hormone Antagonists|hormone antagonists|mesh-ancestor
153537935|NCT01525914|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153537936|NCT01525914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153537937|NCT01526005|Nicotine|nicotine|mesh-list
153537938|NCT01526005|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
153537939|NCT01526005|Autonomic Agents|autonomic agents|mesh-ancestor
153537940|NCT01526005|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153537941|NCT01526005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153537942|NCT01526005|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
153537943|NCT01526005|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
153537944|NCT01526005|Cholinergic Agents|cholinergic agents|mesh-ancestor
153537945|NCT01526005|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153537996|NCT01526161|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
153537997|NCT01526161|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
153537998|NCT01526161|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
153537999|NCT01526161|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153538054|NCT01526395|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153538055|NCT01526395|Anesthetics, General|anesthetics, general|mesh-ancestor
153538057|NCT01526460|Atorvastatin|atorvastatin|mesh-list
153538058|NCT01526460|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
153538059|NCT01526460|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153538060|NCT01526460|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153538061|NCT01526460|Antimetabolites|antimetabolites|mesh-ancestor
153538122|NCT01526616|Diuretics|diuretics|mesh-ancestor
153538123|NCT01526616|Natriuretic Agents|natriuretic agents|mesh-ancestor
153538124|NCT01526694|Thalidomide|thalidomide|mesh-list
153538125|NCT01526694|Dexamethasone|dexamethasone|mesh-list
153538126|NCT01526694|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
153538127|NCT01526694|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153538128|NCT01526694|Antiemetics|antiemetics|mesh-ancestor
153538129|NCT01526694|Autonomic Agents|autonomic agents|mesh-ancestor
153538130|NCT01526694|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153538131|NCT01526694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153538132|NCT01526694|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153538133|NCT01526694|Glucocorticoids|glucocorticoids|mesh-ancestor
153538134|NCT01526694|Hormones|hormones|mesh-ancestor
153538136|NCT01526694|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153538183|NCT01526941|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
153538184|NCT01526941|Biphasic Insulins|biphasic insulins|mesh-list
153538185|NCT01526941|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
153538186|NCT01526941|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153538187|NCT01526941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153538188|NCT01526980|Insulin|insulin|mesh-list
153538189|NCT01526980|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
153618967|NCT01981330|Viscosupplements|viscosupplements|mesh-ancestor
153481432|NCT03457142|Abatacept|abatacept|mesh-list
153538245|NCT01527279|Histamine Antagonists|histamine antagonists|mesh-ancestor
153538246|NCT01527279|Histamine Agents|histamine agents|mesh-ancestor
153538249|NCT01527279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153538250|NCT01527279|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
153538251|NCT01527305|Paliperidone Palmitate|paliperidone palmitate|mesh-list
153538252|NCT01527305|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153538253|NCT01527305|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153538254|NCT01527305|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153538307|NCT01527474|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
153538308|NCT01527474|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153538309|NCT01527474|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153538310|NCT01527474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153538311|NCT01527474|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153538313|NCT01527474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153556893|NCT01616355|Eusol|eusol|mesh-list
153538315|NCT01527539|Biphasic Insulins|biphasic insulins|mesh-list
153538316|NCT01527539|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
153538368|NCT01527864|Paclitaxel|paclitaxel|mesh-list
153538369|NCT01527864|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
153538370|NCT01527864|Carboplatin|carboplatin|mesh-list
153538371|NCT01527864|Endostatins|endostatins|mesh-list
153538372|NCT01527864|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153538373|NCT01527864|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153538374|NCT01527864|Tubulin Modulators|tubulin modulators|mesh-ancestor
153538375|NCT01527864|Antimitotic Agents|antimitotic agents|mesh-ancestor
153538376|NCT01527864|Mitosis Modulators|mitosis modulators|mesh-ancestor
153538377|NCT01527864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153538378|NCT01527864|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153538379|NCT01527864|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153538380|NCT01527864|Growth Substances|growth substances|mesh-ancestor
153538381|NCT01527864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153538430|NCT01528007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153538431|NCT01528007|Sensory System Agents|sensory system agents|mesh-ancestor
153538432|NCT01528007|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153538433|NCT01528085|Nilotinib|nilotinib|mesh-list
153538434|NCT01528085|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153538435|NCT01528085|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153538436|NCT01528085|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153538437|NCT01528085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153538438|NCT01528137|Lactoferrin|lactoferrin|mesh-list
153538439|NCT01528137|Talactoferrin alfa|talactoferrin alfa|mesh-list
153538440|NCT01528137|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153538493|NCT01528540|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153538494|NCT01528540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153538495|NCT01528540|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153538496|NCT01528540|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153538497|NCT01528540|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153538498|NCT01528540|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153538499|NCT01528540|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153538500|NCT01528540|Protective Agents|protective agents|mesh-ancestor
153538501|NCT01528618|Cisplatin|cisplatin|mesh-list
153538502|NCT01528618|Gemcitabine|gemcitabine|mesh-list
153538503|NCT01528618|Fluorouracil|fluorouracil|mesh-list
153538504|NCT01528618|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153538555|NCT01528865|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153538556|NCT01528865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153538558|NCT01528865|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153538559|NCT01528930|Amikacin|amikacin|mesh-list
153538560|NCT01528930|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153538561|NCT01528930|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153538562|NCT01528943|Epoprostenol|epoprostenol|mesh-list
153538627|NCT01529177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153538628|NCT01529177|Anticoagulants|anticoagulants|mesh-ancestor
153538629|NCT01529177|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
153538630|NCT01529177|Chelating Agents|chelating agents|mesh-ancestor
153538631|NCT01529177|Sequestering Agents|sequestering agents|mesh-ancestor
153538632|NCT01529177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153538633|NCT01529177|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
153538634|NCT01529177|Hormone Antagonists|hormone antagonists|mesh-ancestor
153538692|NCT01529242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153538693|NCT01529242|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
153538694|NCT01529242|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
153538695|NCT01529242|Histamine Antagonists|histamine antagonists|mesh-ancestor
153538697|NCT01529255|Telbivudine|telbivudine|mesh-list
153538761|NCT01529541|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153538762|NCT01529541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153538763|NCT01529554|Everolimus|everolimus|mesh-list
153538764|NCT01529554|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
153538765|NCT01529554|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153538766|NCT01529554|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153538767|NCT01529554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153538768|NCT01529554|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153538769|NCT01529554|Immunologic Factors|immunologic factors|mesh-ancestor
153538770|NCT01529554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153538773|NCT01529619|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
153538774|NCT01529619|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153538775|NCT01529619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153538776|NCT01529619|Cholinergic Agents|cholinergic agents|mesh-ancestor
153538818|NCT01530022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153538819|NCT01530022|Antimanic Agents|antimanic agents|mesh-ancestor
153538820|NCT01530022|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153538821|NCT01530022|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153538822|NCT01530022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153538823|NCT01530022|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153538824|NCT01530022|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153538826|NCT01530022|Sensory System Agents|sensory system agents|mesh-ancestor
153538827|NCT01530022|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153538828|NCT01530022|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
153538829|NCT01530022|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
153538830|NCT01530048|Insulin Aspart|insulin aspart|mesh-list
153538831|NCT01530048|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153538832|NCT01530048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153538833|NCT01530126|Becaplermin|becaplermin|mesh-list
153538834|NCT01530126|Anticoagulants|anticoagulants|mesh-ancestor
153538835|NCT01530126|Angiogenesis Inducing Agents|angiogenesis inducing agents|mesh-ancestor
153538836|NCT01530126|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153538837|NCT01530126|Growth Substances|growth substances|mesh-ancestor
153538838|NCT01530126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153538839|NCT01530152|Lidocaine|lidocaine|mesh-list
153538840|NCT01530152|Anesthetics, Local|anesthetics, local|mesh-ancestor
153538841|NCT01530152|Anesthetics|anesthetics|mesh-ancestor
153538842|NCT01530152|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153538843|NCT01530152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153538844|NCT01530152|Sensory System Agents|sensory system agents|mesh-ancestor
153538845|NCT01530152|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153538846|NCT01530152|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153702338|NCT00282724|Androgen Antagonists|androgen antagonists|mesh-ancestor
153538848|NCT01530152|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153538849|NCT01530152|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153538858|NCT01530217|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153538859|NCT01530217|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153538860|NCT01530217|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153538861|NCT01530217|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153538862|NCT01530217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153538865|NCT01530230|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153538866|NCT01530230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153538867|NCT01530295|Docetaxel|docetaxel|mesh-list
153538868|NCT01530295|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153538869|NCT01530295|Tubulin Modulators|tubulin modulators|mesh-ancestor
153538870|NCT01530295|Antimitotic Agents|antimitotic agents|mesh-ancestor
153538871|NCT01530295|Mitosis Modulators|mitosis modulators|mesh-ancestor
153538872|NCT01530295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153538874|NCT01530308|Haloperidol|haloperidol|mesh-list
153538875|NCT01530308|Haloperidol decanoate|haloperidol decanoate|mesh-list
153538876|NCT01530308|Antipsychotic Agents|antipsychotic agents|mesh-list
153538877|NCT01530308|Dopamine Antagonists|dopamine antagonists|mesh-list
153538878|NCT01530308|Antiemetics|antiemetics|mesh-ancestor
153538879|NCT01530308|Autonomic Agents|autonomic agents|mesh-ancestor
153538880|NCT01530308|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153538881|NCT01530308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153538882|NCT01530308|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153538883|NCT01530308|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153538884|NCT01530308|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153538886|NCT01530308|Dopamine Agents|dopamine agents|mesh-ancestor
153538887|NCT01530308|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153538888|NCT01530308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153538889|NCT01530308|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
153538890|NCT01530308|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
153538891|NCT01530308|Sympathomimetics|sympathomimetics|mesh-ancestor
153538892|NCT01530308|Protective Agents|protective agents|mesh-ancestor
153538893|NCT01530386|Lacosamide|lacosamide|mesh-list
153538894|NCT01530386|Anticonvulsants|anticonvulsants|mesh-ancestor
153538898|NCT01530386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153538899|NCT01530438|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
153538900|NCT01530438|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
153538901|NCT01530438|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153538902|NCT01530451|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
153538903|NCT01530451|Hemostatics|hemostatics|mesh-ancestor
153538904|NCT01530451|Coagulants|coagulants|mesh-ancestor
153538905|NCT01530451|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
153538906|NCT01530451|Natriuretic Agents|natriuretic agents|mesh-ancestor
153538907|NCT01530451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153538908|NCT01530490|Cabergoline|cabergoline|mesh-list
153538909|NCT01530490|Hydroxyethyl Starch Derivatives|hydroxyethyl starch derivatives|mesh-list
153538910|NCT01530490|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
153538911|NCT01530490|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
153538912|NCT01530490|Dopamine Agonists|dopamine agonists|mesh-ancestor
153538913|NCT01530490|Dopamine Agents|dopamine agents|mesh-ancestor
153538914|NCT01530490|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153538915|NCT01530490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153538916|NCT01530490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153538917|NCT01530490|Plasma Substitutes|plasma substitutes|mesh-ancestor
153538918|NCT01530490|Blood Substitutes|blood substitutes|mesh-ancestor
153538921|NCT01530503|Mitomycin|mitomycin|mesh-list
153538922|NCT01530503|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153538923|NCT01530503|Antimetabolites|antimetabolites|mesh-ancestor
153538925|NCT01530503|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153538926|NCT01530503|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153538942|NCT01530594|Lenalidomide|lenalidomide|mesh-list
153538943|NCT01530594|Bortezomib|bortezomib|mesh-list
153538944|NCT01530594|Immunologic Factors|immunologic factors|mesh-ancestor
153538945|NCT01530594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153538946|NCT01530594|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153538947|NCT01530594|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153538948|NCT01530594|Growth Substances|growth substances|mesh-ancestor
153538949|NCT01530594|Growth Inhibitors|growth inhibitors|mesh-ancestor
153538950|NCT01530594|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153538952|NCT01530607|Goserelin|goserelin|mesh-list
153538953|NCT01530607|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153538954|NCT01530607|Immunologic Factors|immunologic factors|mesh-ancestor
153538955|NCT01530607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153538956|NCT01530607|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153538957|NCT01530607|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153539004|NCT01530815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153539005|NCT01530815|Sensory System Agents|sensory system agents|mesh-ancestor
153539006|NCT01530815|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153539007|NCT01530984|Ipilimumab|ipilimumab|mesh-list
153539008|NCT01530984|Sargramostim|sargramostim|mesh-list
153539009|NCT01530984|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153539010|NCT01530984|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153539011|NCT01530984|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153618971|NCT01981369|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153539012|NCT01530984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153539013|NCT01530984|Immunologic Factors|immunologic factors|mesh-ancestor
153539014|NCT01530984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153539015|NCT01531049|Nicotine|nicotine|mesh-list
153539016|NCT01531049|Varenicline|varenicline|mesh-list
153539017|NCT01531049|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
153539018|NCT01531049|Autonomic Agents|autonomic agents|mesh-ancestor
153539019|NCT01531049|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153539026|NCT01531114|Ticagrelor|ticagrelor|mesh-list
153539060|NCT01531218|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153539061|NCT01531244|Dactinomycin|dactinomycin|mesh-list
153539062|NCT01531244|Cactinomycin|cactinomycin|mesh-list
153539063|NCT01531244|Melphalan|melphalan|mesh-list
153539064|NCT01531244|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153539066|NCT01531244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153539067|NCT01531244|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153539068|NCT01531244|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153539069|NCT01531244|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153539070|NCT01531244|Immunologic Factors|immunologic factors|mesh-ancestor
153539071|NCT01531244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153539072|NCT01531244|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153539073|NCT01531244|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153539074|NCT01531244|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153539076|NCT01531244|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153539121|NCT01531595|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153539123|NCT01531595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153539124|NCT01531647|Ritonavir|ritonavir|mesh-list
153539125|NCT01531647|Raltegravir Potassium|raltegravir potassium|mesh-list
153539126|NCT01531647|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
153539127|NCT01531647|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
153539128|NCT01531647|Protease Inhibitors|protease inhibitors|mesh-ancestor
153539129|NCT01531647|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153539130|NCT01531647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153539131|NCT01531647|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153539132|NCT01531647|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153539133|NCT01531647|Antiviral Agents|antiviral agents|mesh-ancestor
153539134|NCT01531647|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153539135|NCT01531647|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
153539137|NCT01531647|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
153539138|NCT01531647|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
153539139|NCT01531712|Gemcitabine|gemcitabine|mesh-list
153539140|NCT01531712|Oxaliplatin|oxaliplatin|mesh-list
153539141|NCT01531712|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
153539142|NCT01531712|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153539143|NCT01531712|Antimetabolites|antimetabolites|mesh-ancestor
153539144|NCT01531712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153539145|NCT01531712|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153539146|NCT01531712|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153539147|NCT01531712|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153539148|NCT01531712|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153539149|NCT01531764|Vinorelbine|vinorelbine|mesh-list
153539150|NCT01531764|Afatinib|afatinib|mesh-list
153539151|NCT01531764|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153539152|NCT01531764|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153539153|NCT01531764|Tubulin Modulators|tubulin modulators|mesh-ancestor
153539154|NCT01531764|Antimitotic Agents|antimitotic agents|mesh-ancestor
153539155|NCT01531764|Mitosis Modulators|mitosis modulators|mesh-ancestor
153539159|NCT01531764|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153539160|NCT01531777|Apatinib|apatinib|mesh-list
153539161|NCT01531777|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153539162|NCT01531777|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153539163|NCT01531777|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153618972|NCT01981369|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153539164|NCT01531777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153539165|NCT01531790|Carboplatin|carboplatin|mesh-list
153539166|NCT01531790|Pemetrexed|pemetrexed|mesh-list
153539167|NCT01531790|Endostar protein|endostar protein|mesh-list
153539168|NCT01531790|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153539178|NCT01531829|Heparin|heparin|mesh-list
153539223|NCT01532115|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
153539224|NCT01532154|4-Aminopyridine|4-aminopyridine|mesh-list
153539226|NCT01532154|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153539227|NCT01532154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153539229|NCT01532232|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
153539230|NCT01532232|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
153539231|NCT01532232|Cholinergic Agents|cholinergic agents|mesh-ancestor
153539232|NCT01532232|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153539233|NCT01532232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153539234|NCT01532232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153539286|NCT01532856|BB 1101|bb 1101|mesh-list
153539287|NCT01532856|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153539288|NCT01532856|Immunologic Factors|immunologic factors|mesh-ancestor
153539289|NCT01532856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153539290|NCT01532856|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153539291|NCT01532856|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153539292|NCT01532856|Alkylating Agents|alkylating agents|mesh-ancestor
153539355|NCT01533155|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153539356|NCT01533155|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
153539357|NCT01533155|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
153539358|NCT01533155|Cholinergic Agents|cholinergic agents|mesh-ancestor
153539359|NCT01533155|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
153539360|NCT01533155|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153539361|NCT01533155|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153539362|NCT01533155|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
153539363|NCT01533155|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153539365|NCT01533220|Naphazoline|naphazoline|mesh-list
153539366|NCT01533220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153539367|NCT01533220|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153539368|NCT01533220|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153539369|NCT01533220|Adrenergic Agents|adrenergic agents|mesh-ancestor
153539370|NCT01533220|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153539373|NCT01533220|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
153539374|NCT01533220|Respiratory System Agents|respiratory system agents|mesh-ancestor
153539408|NCT01533324|Micronutrients|micronutrients|mesh-ancestor
153539409|NCT01533376|Timolol|timolol|mesh-list
153539410|NCT01533376|Lubricant Eye Drops|lubricant eye drops|mesh-list
153539411|NCT01533376|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
153539412|NCT01533376|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
153539413|NCT01533376|Adrenergic Agents|adrenergic agents|mesh-ancestor
153539414|NCT01533376|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153539415|NCT01533376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153539416|NCT01533376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153539417|NCT01533376|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153539418|NCT01533376|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153539419|NCT01533376|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
153539420|NCT01533376|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
153539421|NCT01533389|Silodosin|silodosin|mesh-list
153539422|NCT01533389|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
153539423|NCT01533389|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
153539424|NCT01533389|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
153539425|NCT01533389|Adrenergic Agents|adrenergic agents|mesh-ancestor
153539426|NCT01533389|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153539427|NCT01533389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153539428|NCT01533389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153539429|NCT01533389|Urological Agents|urological agents|mesh-ancestor
153539430|NCT01533441|Vitamin K|vitamin k|mesh-list
153539431|NCT01533441|Vitamin K 2|vitamin k 2|mesh-list
153539432|NCT01533441|Vitamin K 1|vitamin k 1|mesh-list
153539433|NCT01533441|Vitamins|vitamins|mesh-ancestor
153539434|NCT01533441|Micronutrients|micronutrients|mesh-ancestor
153539435|NCT01533441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153539456|NCT01533545|Respiratory System Agents|respiratory system agents|mesh-ancestor
153539458|NCT01533545|Sympathomimetics|sympathomimetics|mesh-ancestor
153539459|NCT01533545|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
153539460|NCT01533545|Anesthetics, Local|anesthetics, local|mesh-ancestor
153539461|NCT01533545|Anesthetics|anesthetics|mesh-ancestor
153539462|NCT01533545|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153539463|NCT01533545|Sensory System Agents|sensory system agents|mesh-ancestor
153539464|NCT01533558|Caspofungin|caspofungin|mesh-list
153539465|NCT01533558|Antifungal Agents|antifungal agents|mesh-ancestor
153539466|NCT01533558|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153539467|NCT01533558|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153539468|NCT01533558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153539470|NCT01533662|Oxymetazoline|oxymetazoline|mesh-list
153539471|NCT01533662|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
153539472|NCT01533662|Mydriatics|mydriatics|mesh-ancestor
153539519|NCT01533818|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153539521|NCT01533870|Naloxegol|naloxegol|mesh-list
153539522|NCT01533870|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
153539523|NCT01533870|Antitubercular Agents|antitubercular agents|mesh-ancestor
153539524|NCT01533870|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153539525|NCT01533870|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153539526|NCT01533870|Leprostatic Agents|leprostatic agents|mesh-ancestor
153539527|NCT01533870|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153539529|NCT01533870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153539531|NCT01533870|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
153539532|NCT01533870|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
153539533|NCT01533870|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
153539534|NCT01533870|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
153539535|NCT01533870|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
153539536|NCT01533870|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
153539537|NCT01533870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153539538|NCT01533870|Sensory System Agents|sensory system agents|mesh-ancestor
153539539|NCT01533870|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153539540|NCT01534026|Aspirin|aspirin|mesh-list
153482776|NCT06114225|Antimetabolites|antimetabolites|mesh-ancestor
153539541|NCT01534026|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153539542|NCT01534026|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153539543|NCT01534026|Analgesics|analgesics|mesh-ancestor
153539544|NCT01534026|Sensory System Agents|sensory system agents|mesh-ancestor
153539545|NCT01534026|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153539562|NCT01534169|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153539563|NCT01534169|Glucocorticoids|glucocorticoids|mesh-ancestor
153539565|NCT01534169|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153539566|NCT01534169|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153539567|NCT01534169|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153539568|NCT01534247|Metronidazole|metronidazole|mesh-list
153539569|NCT01534247|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153539570|NCT01534247|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153539571|NCT01534247|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153539572|NCT01534247|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153539627|NCT01534702|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153539628|NCT01534702|Immunologic Factors|immunologic factors|mesh-ancestor
153418183|NCT02790788|Antiemetics|antiemetics|mesh-ancestor
153539629|NCT01534702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153539631|NCT01534702|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153539632|NCT01534702|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153539633|NCT01534702|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153539634|NCT01534754|Mesalamine|mesalamine|mesh-list
153539635|NCT01534754|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153539636|NCT01534754|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153539637|NCT01534754|Analgesics|analgesics|mesh-ancestor
153539638|NCT01534754|Sensory System Agents|sensory system agents|mesh-ancestor
153539639|NCT01534754|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153539640|NCT01534754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153539641|NCT01534754|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153539642|NCT01534754|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153539644|NCT01534806|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153539645|NCT01534806|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153539646|NCT01534806|Analgesics|analgesics|mesh-ancestor
153539647|NCT01534806|Sensory System Agents|sensory system agents|mesh-ancestor
153539648|NCT01534806|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153539649|NCT01534806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153539650|NCT01534806|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153539651|NCT01534806|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153539676|NCT01534949|Rituximab|rituximab|mesh-list
153539677|NCT01534949|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153539678|NCT01534949|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153539679|NCT01534949|Immunologic Factors|immunologic factors|mesh-ancestor
153539680|NCT01534949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153539681|NCT01534949|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153539682|NCT01535027|Alendronate|alendronate|mesh-list
153539683|NCT01535027|Teriparatide|teriparatide|mesh-list
153539684|NCT01535027|Raloxifene Hydrochloride|raloxifene hydrochloride|mesh-list
153539687|NCT01535027|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153539688|NCT01535027|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
153539689|NCT01535027|Hormone Antagonists|hormone antagonists|mesh-ancestor
153539690|NCT01535027|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153539691|NCT01535027|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
153539733|NCT01535183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153539734|NCT01535183|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153539736|NCT01535391|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153539737|NCT01535391|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153539738|NCT01535391|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153539739|NCT01535391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153539740|NCT01535417|Celecoxib|celecoxib|mesh-list
153702371|NCT00282997|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153539742|NCT01535417|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153539743|NCT01535417|Analgesics|analgesics|mesh-ancestor
153539744|NCT01535417|Sensory System Agents|sensory system agents|mesh-ancestor
153539745|NCT01535417|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153539746|NCT01535417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153539747|NCT01535417|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153539748|NCT01535417|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153539749|NCT01535417|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
153539787|NCT01535612|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153539788|NCT01535612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153539790|NCT01535677|Dapagliflozin|dapagliflozin|mesh-list
153539791|NCT01535677|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153539792|NCT01535677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153539793|NCT01535677|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
153702372|NCT00283036|Irbesartan|irbesartan|mesh-list
153539794|NCT01535677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153539795|NCT01535690|Methylene Blue|methylene blue|mesh-list
153539796|NCT01535690|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153539797|NCT01535690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153539798|NCT01535768|Travoprost|travoprost|mesh-list
153539799|NCT01535768|Brimonidine Tartrate|brimonidine tartrate|mesh-list
153539800|NCT01535768|Ophthalmic Solutions|ophthalmic solutions|mesh-list
153539801|NCT01535768|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
153539802|NCT01535768|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153539803|NCT01535768|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
153539804|NCT01535768|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153539806|NCT01535768|Adrenergic Agents|adrenergic agents|mesh-ancestor
153539807|NCT01535768|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153539808|NCT01535768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153539809|NCT01535768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153539810|NCT01535781|Tranexamic Acid|tranexamic acid|mesh-list
153539811|NCT01535781|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
153539812|NCT01535781|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153539813|NCT01535781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153539814|NCT01535781|Hemostatics|hemostatics|mesh-ancestor
153539815|NCT01535781|Coagulants|coagulants|mesh-ancestor
153539816|NCT01535820|Ortho Evra|ortho evra|mesh-list
153539817|NCT01535820|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
153539828|NCT01535859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153539829|NCT01535872|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
153539894|NCT01536158|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153539895|NCT01536158|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153539896|NCT01536158|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153539897|NCT01536158|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153539898|NCT01536158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153539899|NCT01536158|Antipyretics|antipyretics|mesh-ancestor
153539900|NCT01536223|Cisplatin|cisplatin|mesh-list
153539958|NCT01536470|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153539959|NCT01536470|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153539960|NCT01536470|Adrenergic Agents|adrenergic agents|mesh-ancestor
153539961|NCT01536470|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153539962|NCT01536470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153539963|NCT01536470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153539964|NCT01536470|Sympathomimetics|sympathomimetics|mesh-ancestor
153539965|NCT01536470|Autonomic Agents|autonomic agents|mesh-ancestor
153539967|NCT01536470|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
153539969|NCT01536600|Biphasic Insulins|biphasic insulins|mesh-list
153539970|NCT01536600|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
153539971|NCT01536600|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153539972|NCT01536600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153539973|NCT01536613|Insulin Aspart|insulin aspart|mesh-list
153539974|NCT01536613|Biphasic Insulins|biphasic insulins|mesh-list
153539978|NCT01536626|Insulin Aspart|insulin aspart|mesh-list
153539995|NCT01536665|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153539996|NCT01536665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153539998|NCT01536665|Hormones|hormones|mesh-ancestor
153539999|NCT01536665|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153540000|NCT01536691|Ondansetron|ondansetron|mesh-list
153540001|NCT01536691|Aprepitant|aprepitant|mesh-list
153540002|NCT01536691|Fosaprepitant|fosaprepitant|mesh-list
153540003|NCT01536691|Ramosetron|ramosetron|mesh-list
153540004|NCT01536691|Antiemetics|antiemetics|mesh-ancestor
153540005|NCT01536691|Autonomic Agents|autonomic agents|mesh-ancestor
153540006|NCT01536691|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153540007|NCT01536691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153540008|NCT01536691|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153540009|NCT01536691|Antipruritics|antipruritics|mesh-ancestor
153540010|NCT01536691|Dermatologic Agents|dermatologic agents|mesh-ancestor
153540011|NCT01536691|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
153540012|NCT01536691|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153540013|NCT01536691|Serotonin Agents|serotonin agents|mesh-ancestor
153540014|NCT01536691|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153540015|NCT01536691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153540016|NCT01536691|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
153540017|NCT01536717|Carticaine|carticaine|mesh-list
153540018|NCT01536717|Anesthetics, Local|anesthetics, local|mesh-ancestor
153540019|NCT01536717|Anesthetics|anesthetics|mesh-ancestor
153540046|NCT01537055|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153540049|NCT01537055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153540050|NCT01537055|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153540051|NCT01537055|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
153540052|NCT01537055|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153540053|NCT01537055|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
153540054|NCT01537055|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153540055|NCT01537055|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
153540056|NCT01537094|Vitamins|vitamins|mesh-list
153540057|NCT01537094|Ascorbic Acid|ascorbic acid|mesh-list
153618974|NCT01981369|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153540058|NCT01537094|Micronutrients|micronutrients|mesh-ancestor
153540059|NCT01537094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153540061|NCT01537094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153540062|NCT01537094|Protective Agents|protective agents|mesh-ancestor
153540104|NCT01537471|Antiemetics|antiemetics|mesh-ancestor
153540105|NCT01537471|Autonomic Agents|autonomic agents|mesh-ancestor
153540106|NCT01537471|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153540107|NCT01537471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153540108|NCT01537471|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153540109|NCT01537471|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
153540110|NCT01537471|Histamine Antagonists|histamine antagonists|mesh-ancestor
153540111|NCT01537471|Histamine Agents|histamine agents|mesh-ancestor
153540112|NCT01537471|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153540113|NCT01537471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153540114|NCT01537471|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
153540115|NCT01537471|Cholinergic Agents|cholinergic agents|mesh-ancestor
153540116|NCT01537471|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
153540117|NCT01537575|Immunoglobulins|immunoglobulins|mesh-list
153540118|NCT01537575|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
153540119|NCT01537575|Antibodies|antibodies|mesh-list
153540120|NCT01537575|gamma-Globulins|gamma-globulins|mesh-list
153540121|NCT01537575|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
153540122|NCT01537575|Immunologic Factors|immunologic factors|mesh-ancestor
153540123|NCT01537575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153540124|NCT01537640|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
153540125|NCT01537640|Immunologic Factors|immunologic factors|mesh-ancestor
153540126|NCT01537640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153540127|NCT01537744|Azacitidine|azacitidine|mesh-list
153540129|NCT01537744|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153540130|NCT01537744|Antimetabolites|antimetabolites|mesh-ancestor
153540131|NCT01537744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153540132|NCT01537744|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153540151|NCT01537809|Vitamins|vitamins|mesh-list
153540152|NCT01537809|Micronutrients|micronutrients|mesh-ancestor
153540153|NCT01537809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153540154|NCT01537809|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153540155|NCT01537809|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153540156|NCT01537861|Thalidomide|thalidomide|mesh-list
153540157|NCT01537861|Dexamethasone|dexamethasone|mesh-list
153540158|NCT01537861|Cyclophosphamide|cyclophosphamide|mesh-list
153540159|NCT01537861|Lenalidomide|lenalidomide|mesh-list
153540160|NCT01537861|Bortezomib|bortezomib|mesh-list
153540161|NCT01537861|Pomalidomide|pomalidomide|mesh-list
153540162|NCT01537861|Lenograstim|lenograstim|mesh-list
153540163|NCT01537861|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153540164|NCT01537861|Immunologic Factors|immunologic factors|mesh-ancestor
153540165|NCT01537861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153540166|NCT01537861|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153540167|NCT01537861|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153540168|NCT01537861|Alkylating Agents|alkylating agents|mesh-ancestor
153557113|NCT01617694|Dexmedetomidine|dexmedetomidine|mesh-list
153540169|NCT01537861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153540170|NCT01537861|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153540171|NCT01537861|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153540172|NCT01537861|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153540173|NCT01537861|Antiemetics|antiemetics|mesh-ancestor
153540174|NCT01537861|Autonomic Agents|autonomic agents|mesh-ancestor
153540175|NCT01537861|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153540178|NCT01537861|Hormones|hormones|mesh-ancestor
153540179|NCT01537861|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153540180|NCT01537861|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153540181|NCT01537861|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153540194|NCT01538095|Growth Inhibitors|growth inhibitors|mesh-ancestor
153540195|NCT01538095|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153540196|NCT01538108|Paclitaxel|paclitaxel|mesh-list
153540197|NCT01538108|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153540198|NCT01538108|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153540199|NCT01538108|Tubulin Modulators|tubulin modulators|mesh-ancestor
153540200|NCT01538108|Antimitotic Agents|antimitotic agents|mesh-ancestor
153540201|NCT01538108|Mitosis Modulators|mitosis modulators|mesh-ancestor
153540202|NCT01538108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153540203|NCT01538225|Nabiximols|nabiximols|mesh-list
153540204|NCT01538225|Analgesics|analgesics|mesh-ancestor
153540260|NCT01538446|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153540261|NCT01538446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153540262|NCT01538446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153540263|NCT01538459|Dexamethasone|dexamethasone|mesh-list
153540264|NCT01538459|Bupivacaine|bupivacaine|mesh-list
153540265|NCT01538459|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153540266|NCT01538459|Antiemetics|antiemetics|mesh-ancestor
153540267|NCT01538459|Autonomic Agents|autonomic agents|mesh-ancestor
153540270|NCT01538459|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153540271|NCT01538459|Glucocorticoids|glucocorticoids|mesh-ancestor
153540274|NCT01538459|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153540321|NCT01538641|Antimetabolites|antimetabolites|mesh-ancestor
153540322|NCT01538641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153540323|NCT01538667|Ciprofloxacin|ciprofloxacin|mesh-list
153540324|NCT01538667|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153540391|NCT01538875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153540392|NCT01538875|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153540394|NCT01538875|Autonomic Agents|autonomic agents|mesh-ancestor
153540395|NCT01538875|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153540396|NCT01538875|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
153540397|NCT01538875|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
153540398|NCT01538875|Vasodilator Agents|vasodilator agents|mesh-ancestor
153540399|NCT01538901|Imiquimod|imiquimod|mesh-list
153540400|NCT01538901|Toll-Like Receptor Agonists|toll-like receptor agonists|mesh-ancestor
153540401|NCT01538901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153540402|NCT01538901|Immunomodulating Agents|immunomodulating agents|mesh-ancestor
153540403|NCT01538901|Immunologic Factors|immunologic factors|mesh-ancestor
153540404|NCT01538901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153540405|NCT01538901|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153540406|NCT01538901|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153540407|NCT01538901|Interferon Inducers|interferon inducers|mesh-ancestor
153540408|NCT01538927|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
153540409|NCT01538927|Hemostatics|hemostatics|mesh-ancestor
153540410|NCT01538927|Coagulants|coagulants|mesh-ancestor
153540411|NCT01538940|Vaccines|vaccines|mesh-list
153540413|NCT01538940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153540414|NCT01538953|Sodium Hypochlorite|sodium hypochlorite|mesh-list
153540415|NCT01538953|Disinfectants|disinfectants|mesh-list
153540417|NCT01538953|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153540418|NCT01539018|Sorafenib|sorafenib|mesh-list
153540419|NCT01539018|Tegafur|tegafur|mesh-list
153540420|NCT01539018|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153540421|NCT01539018|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153540422|NCT01539018|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153540423|NCT01539018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153540434|NCT01539044|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153540435|NCT01539044|Respiratory System Agents|respiratory system agents|mesh-ancestor
153540437|NCT01539044|Parasympatholytics|parasympatholytics|mesh-ancestor
153540438|NCT01539044|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
153540439|NCT01539044|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
153540440|NCT01539044|Cholinergic Agents|cholinergic agents|mesh-ancestor
153540441|NCT01539044|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153540442|NCT01539044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153540443|NCT01539044|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
153540444|NCT01539044|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153540445|NCT01539044|Parasympathomimetics|parasympathomimetics|mesh-ancestor
153540447|NCT01539174|Cyclophosphamide|cyclophosphamide|mesh-list
153540448|NCT01539174|Rituximab|rituximab|mesh-list
153540449|NCT01539174|Doxorubicin|doxorubicin|mesh-list
153540450|NCT01539174|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
153540451|NCT01539174|Vincristine|vincristine|mesh-list
153540452|NCT01539174|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153540453|NCT01539174|Immunologic Factors|immunologic factors|mesh-ancestor
153540454|NCT01539174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153540456|NCT01539174|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153540457|NCT01539174|Alkylating Agents|alkylating agents|mesh-ancestor
153540458|NCT01539174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153540459|NCT01539174|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153540460|NCT01539174|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153540461|NCT01539174|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153540462|NCT01539174|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153540463|NCT01539174|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153540464|NCT01539174|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153540477|NCT01539265|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
153540478|NCT01539265|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
153540479|NCT01539265|Adrenergic Agents|adrenergic agents|mesh-ancestor
153540480|NCT01539265|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153540481|NCT01539265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153540482|NCT01539265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153540483|NCT01539265|Urological Agents|urological agents|mesh-ancestor
153540485|NCT01539330|Antifungal Agents|antifungal agents|mesh-ancestor
153540540|NCT01539603|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153540541|NCT01539603|Antifungal Agents|antifungal agents|mesh-ancestor
153540542|NCT01539603|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153540543|NCT01539603|Immunologic Factors|immunologic factors|mesh-ancestor
153540544|NCT01539603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153540545|NCT01539616|Fenofibrate|fenofibrate|mesh-list
153540546|NCT01539616|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153540547|NCT01539616|Antimetabolites|antimetabolites|mesh-ancestor
153540548|NCT01539616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153540549|NCT01539616|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153540550|NCT01539655|Omeprazole|omeprazole|mesh-list
153540551|NCT01539655|Ranitidine|ranitidine|mesh-list
153540552|NCT01539655|Ranitidine bismuth citrate|ranitidine bismuth citrate|mesh-list
153540553|NCT01539655|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
153540563|NCT01539681|Sorafenib|sorafenib|mesh-list
153540599|NCT01539902|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153540600|NCT01539902|Immunologic Factors|immunologic factors|mesh-ancestor
153540601|NCT01539902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153540602|NCT01539902|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153540603|NCT01539902|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153540604|NCT01539902|Alkylating Agents|alkylating agents|mesh-ancestor
153540605|NCT01539902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153540606|NCT01539902|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153540607|NCT01539902|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153540608|NCT01540032|Salicylates|salicylates|mesh-list
153540609|NCT01540032|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153540664|NCT01540500|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153540665|NCT01540500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153540666|NCT01540500|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153540667|NCT01540500|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
153540668|NCT01540500|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153540669|NCT01540500|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153540670|NCT01540500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153540671|NCT01540500|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153540673|NCT01540500|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
153540674|NCT01540500|Antidepressive Agents|antidepressive agents|mesh-ancestor
153540723|NCT01540747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153540724|NCT01540747|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153540725|NCT01540747|Hematinics|hematinics|mesh-ancestor
153540726|NCT01540747|Vitamins|vitamins|mesh-ancestor
153540727|NCT01540747|Micronutrients|micronutrients|mesh-ancestor
153540728|NCT01540812|Cytarabine|cytarabine|mesh-list
153540729|NCT01540812|Dexamethasone|dexamethasone|mesh-list
153540730|NCT01540812|Dexamethasone acetate|dexamethasone acetate|mesh-list
153540793|NCT01541072|Lenograstim|lenograstim|mesh-list
153540794|NCT01541072|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153540795|NCT01541072|Immunologic Factors|immunologic factors|mesh-ancestor
153540796|NCT01541072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153540798|NCT01541124|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153540799|NCT01541124|Narcotics|narcotics|mesh-ancestor
153540800|NCT01541124|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153540801|NCT01541124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153540802|NCT01541124|Analgesics|analgesics|mesh-ancestor
153540803|NCT01541124|Sensory System Agents|sensory system agents|mesh-ancestor
153540804|NCT01541124|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153540805|NCT01541137|Diclofenac|diclofenac|mesh-list
153540806|NCT01541137|Parecoxib|parecoxib|mesh-list
153540807|NCT01541137|Valdecoxib|valdecoxib|mesh-list
153540808|NCT01541137|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153540809|NCT01541137|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153540810|NCT01541137|Analgesics|analgesics|mesh-ancestor
153540811|NCT01541137|Sensory System Agents|sensory system agents|mesh-ancestor
153540812|NCT01541137|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153540813|NCT01541137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153540814|NCT01541137|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153540815|NCT01541137|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153540817|NCT01541137|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153540844|NCT01541293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153540845|NCT01541293|Sensory System Agents|sensory system agents|mesh-ancestor
153540846|NCT01541293|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153540847|NCT01541293|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153540848|NCT01541293|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
153540849|NCT01541293|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153540850|NCT01541293|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153540851|NCT01541293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153540852|NCT01541332|Dexamethasone|dexamethasone|mesh-list
153540853|NCT01541332|Doxorubicin|doxorubicin|mesh-list
153540854|NCT01541332|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
153540855|NCT01541332|Pomalidomide|pomalidomide|mesh-list
153540856|NCT01541332|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153357523|NCT00724568|Antiemetics|antiemetics|mesh-ancestor
153540859|NCT01541332|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153540860|NCT01541332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153540861|NCT01541332|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153540862|NCT01541332|Glucocorticoids|glucocorticoids|mesh-ancestor
153540898|NCT01541475|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153540899|NCT01541475|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
153540900|NCT01541475|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
153540901|NCT01541475|Cholinergic Agents|cholinergic agents|mesh-ancestor
153540902|NCT01541475|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
153540903|NCT01541475|Antidepressive Agents|antidepressive agents|mesh-ancestor
153540904|NCT01541475|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153540905|NCT01541475|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
153540906|NCT01541475|Dopamine Agents|dopamine agents|mesh-ancestor
153540962|NCT01541943|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153540963|NCT01541943|Antimetabolites|antimetabolites|mesh-ancestor
153540964|NCT01541943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153540965|NCT01541943|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153540966|NCT01541943|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
153541030|NCT01542268|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
153541031|NCT01542268|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153541032|NCT01542268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153541033|NCT01542268|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153541034|NCT01542268|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
153541035|NCT01542268|Protective Agents|protective agents|mesh-ancestor
153541036|NCT01542268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153541037|NCT01542268|Vasodilator Agents|vasodilator agents|mesh-ancestor
153541038|NCT01542268|Free Radical Scavengers|free radical scavengers|mesh-ancestor
153541039|NCT01542268|Antioxidants|antioxidants|mesh-ancestor
153541094|NCT01542710|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153541095|NCT01542710|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153541097|NCT01542723|Anticoagulants|anticoagulants|mesh-ancestor
153541098|NCT01542723|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153541099|NCT01542723|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153541101|NCT01542762|Nadroparin|nadroparin|mesh-list
153541163|NCT01543165|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153541165|NCT01543165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153541166|NCT01543321|Tetrabenazine|tetrabenazine|mesh-list
153541167|NCT01543321|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
153541168|NCT01543321|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153541169|NCT01543321|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153541170|NCT01543321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153541171|NCT01543321|Adrenergic Agents|adrenergic agents|mesh-ancestor
153541172|NCT01543321|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153541173|NCT01543321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153541174|NCT01543347|Temocillin|temocillin|mesh-list
153541175|NCT01543347|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153541176|NCT01543347|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153541177|NCT01543386|Curcumin|curcumin|mesh-list
153541178|NCT01543386|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153541179|NCT01543386|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153541180|NCT01543386|Analgesics|analgesics|mesh-ancestor
153541183|NCT01543386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153541185|NCT01543386|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153541211|NCT01543555|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
153541212|NCT01543555|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153541213|NCT01543724|Lithium Carbonate|lithium carbonate|mesh-list
153541215|NCT01543724|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153541216|NCT01543724|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153541217|NCT01543724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153541218|NCT01543724|Antimanic Agents|antimanic agents|mesh-ancestor
153541219|NCT01543724|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153541220|NCT01543724|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153541221|NCT01543724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153541222|NCT01543737|Hyaluronic Acid|hyaluronic acid|mesh-list
153541240|NCT01543932|Ticagrelor|ticagrelor|mesh-list
153541270|NCT01543945|Dermatologic Agents|dermatologic agents|mesh-ancestor
153541271|NCT01543945|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
153541272|NCT01543945|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153541273|NCT01543945|Serotonin Agents|serotonin agents|mesh-ancestor
153541275|NCT01543945|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
153541276|NCT01543945|Histamine Antagonists|histamine antagonists|mesh-ancestor
153541277|NCT01543945|Histamine Agents|histamine agents|mesh-ancestor
153541278|NCT01543971|Angiotensin I (1-7)|angiotensin i (1-7)|mesh-list
153541279|NCT01543971|Lenograstim|lenograstim|mesh-list
153541280|NCT01543971|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153541281|NCT01543971|Immunologic Factors|immunologic factors|mesh-ancestor
153541282|NCT01543971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153541283|NCT01543971|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153541284|NCT01543971|Vasodilator Agents|vasodilator agents|mesh-ancestor
153541286|NCT01544140|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153541287|NCT01544140|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153541288|NCT01544140|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153541289|NCT01544140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153618979|NCT01981369|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153541328|NCT01544283|Glucocorticoids|glucocorticoids|mesh-ancestor
153541330|NCT01544283|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153541331|NCT01544283|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153541332|NCT01544283|Immunologic Factors|immunologic factors|mesh-ancestor
153541333|NCT01544283|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153541334|NCT01544439|Salicylic Acid|salicylic acid|mesh-list
153541335|NCT01544439|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153541336|NCT01544439|Antifungal Agents|antifungal agents|mesh-ancestor
153541337|NCT01544439|Keratolytic Agents|keratolytic agents|mesh-ancestor
153541338|NCT01544439|Dermatologic Agents|dermatologic agents|mesh-ancestor
153541339|NCT01544504|Norepinephrine|norepinephrine|mesh-list
153541340|NCT01544504|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153541341|NCT01544504|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153541342|NCT01544504|Adrenergic Agents|adrenergic agents|mesh-ancestor
153541343|NCT01544504|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153541344|NCT01544504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153541345|NCT01544504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153541346|NCT01544504|Sympathomimetics|sympathomimetics|mesh-ancestor
153541347|NCT01544504|Autonomic Agents|autonomic agents|mesh-ancestor
153541348|NCT01544504|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153541350|NCT01544517|Amoxicillin|amoxicillin|mesh-list
153541351|NCT01544517|Levofloxacin|levofloxacin|mesh-list
153541352|NCT01544517|Tinidazole|tinidazole|mesh-list
153541353|NCT01544517|Esomeprazole|esomeprazole|mesh-list
153541354|NCT01544517|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
153541355|NCT01544517|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153541356|NCT01544517|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153541357|NCT01544517|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
153541358|NCT01544517|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153541359|NCT01544517|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153541361|NCT01544517|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
153541369|NCT01544517|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153541370|NCT01544517|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153541372|NCT01544634|Propranolol|propranolol|mesh-list
153541373|NCT01544634|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
153541374|NCT01544634|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
153541375|NCT01544634|Adrenergic Agents|adrenergic agents|mesh-ancestor
153541376|NCT01544634|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153541377|NCT01544634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153541378|NCT01544634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153541379|NCT01544634|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153541380|NCT01544634|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153541381|NCT01544634|Vasodilator Agents|vasodilator agents|mesh-ancestor
153541382|NCT01544634|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153541383|NCT01544634|Glucocorticoids|glucocorticoids|mesh-ancestor
153541384|NCT01544634|Hormones|hormones|mesh-ancestor
153541385|NCT01544634|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153541386|NCT01544634|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153541425|NCT01544829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153541426|NCT01544829|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153541427|NCT01544829|Respiratory System Agents|respiratory system agents|mesh-ancestor
153541429|NCT01544842|Triamcinolone|triamcinolone|mesh-list
153541430|NCT01544842|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
153541431|NCT01544842|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
153541433|NCT01544842|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
153541434|NCT01544842|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153541435|NCT01544842|Immunologic Factors|immunologic factors|mesh-ancestor
153541436|NCT01544842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153541442|NCT01544842|Hormones|hormones|mesh-ancestor
153541488|NCT01544972|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153541489|NCT01544972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153541490|NCT01544972|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153557404|NCT01619163|Hormones|hormones|mesh-ancestor
153541491|NCT01544972|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153541492|NCT01544972|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153541494|NCT01544972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153541495|NCT01544972|Antipyretics|antipyretics|mesh-ancestor
153541496|NCT01545024|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
153541497|NCT01545024|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153541498|NCT01545024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153541499|NCT01545024|Incretins|incretins|mesh-ancestor
153541500|NCT01545024|Hormones|hormones|mesh-ancestor
153541501|NCT01545024|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153541502|NCT01545024|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
153541503|NCT01545024|Protease Inhibitors|protease inhibitors|mesh-ancestor
153541504|NCT01545024|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153541505|NCT01545024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153541544|NCT01545479|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153541545|NCT01545635|Thrombin|thrombin|mesh-list
153541546|NCT01545635|Hemostatics|hemostatics|mesh-ancestor
153541547|NCT01545635|Coagulants|coagulants|mesh-ancestor
153541548|NCT01545778|Oxycodone|oxycodone|mesh-list
153541549|NCT01545778|Tapentadol|tapentadol|mesh-list
153541550|NCT01545778|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153541551|NCT01545778|Narcotics|narcotics|mesh-ancestor
153541552|NCT01545778|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153541553|NCT01545778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153541554|NCT01545778|Analgesics|analgesics|mesh-ancestor
153541555|NCT01545778|Sensory System Agents|sensory system agents|mesh-ancestor
153541556|NCT01545778|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153541557|NCT01545778|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
153541558|NCT01545778|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153541559|NCT01545778|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153541560|NCT01545778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153541561|NCT01545778|Adrenergic Agents|adrenergic agents|mesh-ancestor
153541562|NCT01545778|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153541563|NCT01545791|Insulin Detemir|insulin detemir|mesh-list
153541564|NCT01545791|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153541599|NCT01546051|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
153541600|NCT01546051|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153541601|NCT01546051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153541602|NCT01546051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153541603|NCT01546090|Alprazolam|alprazolam|mesh-list
153541604|NCT01546090|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153541605|NCT01546090|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153541606|NCT01546090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153541607|NCT01546090|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153541608|NCT01546090|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153541609|NCT01546090|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153541662|NCT01546701|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153541663|NCT01546701|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
153541664|NCT01546896|Alprazolam|alprazolam|mesh-list
153541665|NCT01546896|Buspirone|buspirone|mesh-list
153541666|NCT01546896|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153541667|NCT01546896|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153541668|NCT01546896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153541730|NCT01547143|Dermatologic Agents|dermatologic agents|mesh-ancestor
153541731|NCT01547143|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153541732|NCT01547143|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
153541733|NCT01547169|Insulin|insulin|mesh-list
153541734|NCT01547169|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
153541735|NCT01547169|Insulin Detemir|insulin detemir|mesh-list
153557419|NCT01619436|Analgesics|analgesics|mesh-ancestor
153541736|NCT01547169|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153541737|NCT01547169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153541738|NCT01547221|Clotrimazole|clotrimazole|mesh-list
153541739|NCT01547221|Miconazole|miconazole|mesh-list
153541740|NCT01547221|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
153541741|NCT01547221|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153541742|NCT01547221|Antifungal Agents|antifungal agents|mesh-ancestor
153541745|NCT01547221|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153541793|NCT01547416|Narcotics|narcotics|mesh-ancestor
153541794|NCT01547416|Analgesics|analgesics|mesh-ancestor
153541795|NCT01547416|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153541796|NCT01547416|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153541797|NCT01547416|Anesthetics, General|anesthetics, general|mesh-ancestor
153541798|NCT01547455|Atorvastatin|atorvastatin|mesh-list
153541799|NCT01547455|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153541800|NCT01547455|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153541801|NCT01547455|Antimetabolites|antimetabolites|mesh-ancestor
153541802|NCT01547455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153541803|NCT01547455|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153541804|NCT01547455|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
153541805|NCT01547455|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153541806|NCT01547494|Vitamins|vitamins|mesh-list
153541807|NCT01547494|Micronutrients|micronutrients|mesh-ancestor
153541808|NCT01547494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153541809|NCT01547520|Meperidine|meperidine|mesh-list
153541852|NCT01548066|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153541853|NCT01548066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153541854|NCT01548066|Antimanic Agents|antimanic agents|mesh-ancestor
153541855|NCT01548066|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153541856|NCT01548066|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153541857|NCT01548066|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153541859|NCT01548079|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
153541915|NCT01548235|Biphasic Insulins|biphasic insulins|mesh-list
153541916|NCT01548235|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
153541917|NCT01548235|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153541918|NCT01548235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153541919|NCT01548248|Insulin|insulin|mesh-list
153541920|NCT01548248|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
153541921|NCT01548248|Insulin Aspart|insulin aspart|mesh-list
153541922|NCT01548248|Insulin Detemir|insulin detemir|mesh-list
153541923|NCT01548248|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153541924|NCT01548248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153541925|NCT01548274|Sarpogrelate|sarpogrelate|mesh-list
153541926|NCT01548274|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153541927|NCT01548274|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153541929|NCT01548274|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153541977|NCT01548677|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153541978|NCT01548703|BCI-838|bci-838|mesh-list
153541979|NCT01548703|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
153541980|NCT01548703|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
153541981|NCT01548703|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153541982|NCT01548703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153541983|NCT01548703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153541984|NCT01548794|Lidocaine|lidocaine|mesh-list
153541985|NCT01548794|Bupivacaine|bupivacaine|mesh-list
153542043|NCT01548950|Sildenafil Citrate|sildenafil citrate|mesh-list
153542044|NCT01548950|Vasodilator Agents|vasodilator agents|mesh-ancestor
153542045|NCT01548950|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
153542046|NCT01548950|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
153542049|NCT01548950|Urological Agents|urological agents|mesh-ancestor
153542050|NCT01548950|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153542051|NCT01548950|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
153542052|NCT01549093|Carboplatin|carboplatin|mesh-list
153542053|NCT01549093|Gemcitabine|gemcitabine|mesh-list
153542054|NCT01549093|Endostar protein|endostar protein|mesh-list
153542055|NCT01549093|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153542056|NCT01549093|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153542057|NCT01549093|Antimetabolites|antimetabolites|mesh-ancestor
153542058|NCT01549093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153542059|NCT01549093|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153542060|NCT01549093|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153542061|NCT01549093|Growth Substances|growth substances|mesh-ancestor
153542064|NCT01549158|Torsemide|torsemide|mesh-list
153542096|NCT01549418|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153542097|NCT01549418|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153542098|NCT01549418|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153542099|NCT01549418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153542100|NCT01549418|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153542101|NCT01549418|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153542102|NCT01549418|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153542104|NCT01549431|Dexamethasone|dexamethasone|mesh-list
153542164|NCT01549704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153542165|NCT01549704|Sensory System Agents|sensory system agents|mesh-ancestor
153542166|NCT01549704|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153542168|NCT01549743|Rebamipide|rebamipide|mesh-list
153542169|NCT01549743|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153542170|NCT01549743|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153542171|NCT01549743|Analgesics|analgesics|mesh-ancestor
153542172|NCT01549743|Sensory System Agents|sensory system agents|mesh-ancestor
153542173|NCT01549743|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153542183|NCT01549743|Antioxidants|antioxidants|mesh-ancestor
153542229|NCT01550146|Dexamethasone acetate|dexamethasone acetate|mesh-list
153542230|NCT01550146|BB 1101|bb 1101|mesh-list
153542231|NCT01550146|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153542232|NCT01550146|Antiemetics|antiemetics|mesh-ancestor
153557483|NCT01619683|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
153557485|NCT01619761|Cyclophosphamide|cyclophosphamide|mesh-list
153542233|NCT01550146|Autonomic Agents|autonomic agents|mesh-ancestor
153542234|NCT01550146|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153542235|NCT01550146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153542236|NCT01550146|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153542237|NCT01550146|Glucocorticoids|glucocorticoids|mesh-ancestor
153542238|NCT01550146|Hormones|hormones|mesh-ancestor
153542239|NCT01550146|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153542240|NCT01550146|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153542241|NCT01550146|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153542242|NCT01550146|Protease Inhibitors|protease inhibitors|mesh-ancestor
153542243|NCT01550146|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153542244|NCT01550146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153542245|NCT01550302|Bupivacaine|bupivacaine|mesh-list
153542246|NCT01550302|Anesthetics, Local|anesthetics, local|mesh-ancestor
153542247|NCT01550302|Anesthetics|anesthetics|mesh-ancestor
153542248|NCT01550302|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153542249|NCT01550302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153542250|NCT01550302|Sensory System Agents|sensory system agents|mesh-ancestor
153542251|NCT01550302|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153542255|NCT01550354|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153542256|NCT01550354|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153542257|NCT01550354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153542258|NCT01550354|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153542274|NCT01550419|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153542275|NCT01550419|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
153542276|NCT01550419|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153542277|NCT01550445|Prednisolone|prednisolone|mesh-list
153542278|NCT01550445|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153542279|NCT01550445|Glucocorticoids|glucocorticoids|mesh-ancestor
153542280|NCT01550445|Hormones|hormones|mesh-ancestor
153542281|NCT01550445|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153542282|NCT01550445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153542283|NCT01550445|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153542284|NCT01550445|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153542285|NCT01550640|Remifentanil|remifentanil|mesh-list
153542286|NCT01550640|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153542287|NCT01550640|Narcotics|narcotics|mesh-ancestor
153542333|NCT01550458|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153542334|NCT01550458|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153542335|NCT01550458|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153542336|NCT01550458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153542337|NCT01550458|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153542338|NCT01550458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153542339|NCT01550458|Vasodilator Agents|vasodilator agents|mesh-ancestor
153542340|NCT01550458|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
153542341|NCT01550458|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153542342|NCT01550458|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153542343|NCT01551147|Montelukast|montelukast|mesh-list
153542344|NCT01551147|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153542346|NCT01551147|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
153542347|NCT01551147|Hormone Antagonists|hormone antagonists|mesh-ancestor
153542386|NCT01551368|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153542387|NCT01551368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153542388|NCT01551368|Vasodilator Agents|vasodilator agents|mesh-ancestor
153542389|NCT01551394|Gentamicins|gentamicins|mesh-list
153542391|NCT01551394|Ampicillin|ampicillin|mesh-list
153542392|NCT01551394|Cefotaxime|cefotaxime|mesh-list
153542393|NCT01551394|Cefoxitin|cefoxitin|mesh-list
153542394|NCT01551394|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153542399|NCT01551459|Sunitinib|sunitinib|mesh-list
153542452|NCT01551641|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153542453|NCT01551641|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153542454|NCT01551641|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153557538|NCT01620112|Analgesics|analgesics|mesh-ancestor
153542455|NCT01551641|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153542456|NCT01551641|Growth Substances|growth substances|mesh-ancestor
153542457|NCT01551641|Growth Inhibitors|growth inhibitors|mesh-ancestor
153542458|NCT01551641|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153542460|NCT01551667|Immunologic Factors|immunologic factors|mesh-ancestor
153542461|NCT01551667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153542462|NCT01551680|Iniparib|iniparib|mesh-list
153542463|NCT01551680|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
153542464|NCT01551680|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153542465|NCT01551680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153542466|NCT01551680|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153542468|NCT01551719|Vancomycin|vancomycin|mesh-list
153542512|NCT01552018|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153542513|NCT01552044|Spironolactone|spironolactone|mesh-list
153542514|NCT01552044|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
153542515|NCT01552044|Hormone Antagonists|hormone antagonists|mesh-ancestor
153542516|NCT01552044|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153542518|NCT01552044|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
153542519|NCT01552044|Diuretics|diuretics|mesh-ancestor
153542520|NCT01552044|Natriuretic Agents|natriuretic agents|mesh-ancestor
153542522|NCT01552122|Cholecalciferol|cholecalciferol|mesh-list
153542523|NCT01552122|Alendronate|alendronate|mesh-list
153542524|NCT01552122|Calcium Carbonate|calcium carbonate|mesh-list
153542525|NCT01552122|Calcium|calcium|mesh-list
153542526|NCT01552122|Vitamins|vitamins|mesh-ancestor
153542527|NCT01552122|Micronutrients|micronutrients|mesh-ancestor
153542528|NCT01552122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153542529|NCT01552122|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153542530|NCT01552122|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153542531|NCT01552122|Antacids|antacids|mesh-ancestor
153542532|NCT01552122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153542533|NCT01552122|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153542534|NCT01552148|Morphine|morphine|mesh-list
153542535|NCT01552148|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153542536|NCT01552148|Narcotics|narcotics|mesh-ancestor
153542566|NCT01552629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153542569|NCT01552629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153542570|NCT01552629|Antifungal Agents|antifungal agents|mesh-ancestor
153542571|NCT01552629|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153542572|NCT01552629|Dermatologic Agents|dermatologic agents|mesh-ancestor
153542573|NCT01552629|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153542574|NCT01552629|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
153542575|NCT01552668|Fidaxomicin|fidaxomicin|mesh-list
153542576|NCT01552668|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153542577|NCT01552668|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153542578|NCT01552798|Aspirin|aspirin|mesh-list
153542579|NCT01552798|Acetaminophen|acetaminophen|mesh-list
153542581|NCT01552798|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153542628|NCT01552993|Sensory System Agents|sensory system agents|mesh-ancestor
153542629|NCT01552993|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153542630|NCT01552993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153542631|NCT01552993|Antipyretics|antipyretics|mesh-ancestor
153542632|NCT01553006|Cefditoren pivoxil|cefditoren pivoxil|mesh-list
153542633|NCT01553006|Cefditoren|cefditoren|mesh-list
153542634|NCT01553006|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153542635|NCT01553006|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153542636|NCT01553019|Gemcitabine|gemcitabine|mesh-list
153542637|NCT01553019|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153542638|NCT01553019|Antimetabolites|antimetabolites|mesh-ancestor
153542639|NCT01553019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153542640|NCT01553019|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153542641|NCT01553123|Ulipristal acetate|ulipristal acetate|mesh-list
153542642|NCT01553123|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
153542643|NCT01553123|Contraceptive Agents|contraceptive agents|mesh-ancestor
153542644|NCT01553123|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153542645|NCT01553123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153542646|NCT01553123|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
153542647|NCT01553357|Dexamethasone|dexamethasone|mesh-list
153542680|NCT01553500|(1-6)-alpha-glucomannan|(1-6)-alpha-glucomannan|mesh-list
153542681|NCT01553500|Cathartics|cathartics|mesh-ancestor
153542682|NCT01553500|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153542683|NCT01553617|Hydroxyethyl Starch Derivatives|hydroxyethyl starch derivatives|mesh-list
153542685|NCT01553617|Blood Substitutes|blood substitutes|mesh-ancestor
153542686|NCT01553721|Udenafil|udenafil|mesh-list
153542687|NCT01553721|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
153542746|NCT01554111|Picosulfate sodium|picosulfate sodium|mesh-list
153542747|NCT01554111|Cathartics|cathartics|mesh-ancestor
153542748|NCT01554111|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153542750|NCT01554124|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153542751|NCT01554124|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153618984|NCT01981369|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153542752|NCT01554254|Angiotensin I (1-7)|angiotensin i (1-7)|mesh-list
153542753|NCT01554254|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153542754|NCT01554254|Vasodilator Agents|vasodilator agents|mesh-ancestor
153542755|NCT01554345|Vitamin E|vitamin e|mesh-list
153542813|NCT01554852|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153542814|NCT01554852|Glucocorticoids|glucocorticoids|mesh-ancestor
153542815|NCT01554852|Hormones|hormones|mesh-ancestor
153542816|NCT01554852|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153542817|NCT01554852|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153542818|NCT01554852|Protease Inhibitors|protease inhibitors|mesh-ancestor
153542819|NCT01554852|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153542820|NCT01554852|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153542821|NCT01554852|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153542822|NCT01554852|Growth Substances|growth substances|mesh-ancestor
153542823|NCT01554852|Growth Inhibitors|growth inhibitors|mesh-ancestor
153542824|NCT01554852|Leprostatic Agents|leprostatic agents|mesh-ancestor
153542825|NCT01554852|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153542826|NCT01554852|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153542827|NCT01554852|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
153542828|NCT01554930|Methylprednisolone|methylprednisolone|mesh-list
153542830|NCT01554930|Immunoglobulins|immunoglobulins|mesh-list
153542831|NCT01554930|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153542832|NCT01554930|Antiemetics|antiemetics|mesh-ancestor
153542835|NCT01554930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153542836|NCT01554930|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153542838|NCT01554930|Hormones|hormones|mesh-ancestor
153542839|NCT01554930|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153542840|NCT01554930|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
153542841|NCT01554930|Protective Agents|protective agents|mesh-ancestor
153542842|NCT01554930|Immunologic Factors|immunologic factors|mesh-ancestor
153542843|NCT01554930|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
153542844|NCT01554930|Diuretics|diuretics|mesh-ancestor
153542845|NCT01554930|Natriuretic Agents|natriuretic agents|mesh-ancestor
153542846|NCT01554969|Capecitabine|capecitabine|mesh-list
153542847|NCT01554969|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153542848|NCT01554969|Antimetabolites|antimetabolites|mesh-ancestor
153542849|NCT01554969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153542850|NCT01554969|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153542851|NCT01554995|Linezolid|linezolid|mesh-list
153542852|NCT01554995|Delpazolid|delpazolid|mesh-list
153542853|NCT01554995|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153542854|NCT01554995|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153542855|NCT01554995|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
153542856|NCT01554995|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153542857|NCT01554995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153542858|NCT01555008|(2S,3R,4R,5S,6R)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2H-pyran-3,4,5-triol|(2s,3r,4r,5s,6r)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2h-pyran-3,4,5-triol|mesh-list
153542859|NCT01555008|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
153542860|NCT01555008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153542861|NCT01555008|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153542862|NCT01555008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153542863|NCT01555060|Ferrous gluconate|ferrous gluconate|mesh-list
153542864|NCT01555060|Hematinics|hematinics|mesh-ancestor
153542865|NCT01555099|Budesonide|budesonide|mesh-list
153542866|NCT01555099|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153542867|NCT01555099|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153542868|NCT01555099|Autonomic Agents|autonomic agents|mesh-ancestor
153542871|NCT01555099|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153542904|NCT01555398|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153542905|NCT01555398|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153542906|NCT01555398|Antimetabolites|antimetabolites|mesh-ancestor
153542907|NCT01555398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153542908|NCT01555398|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153542909|NCT01555476|Ibuprofen|ibuprofen|mesh-list
153542910|NCT01555476|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153542911|NCT01555476|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153542912|NCT01555476|Analgesics|analgesics|mesh-ancestor
153542913|NCT01555476|Sensory System Agents|sensory system agents|mesh-ancestor
153542914|NCT01555476|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153542915|NCT01555476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153542916|NCT01555476|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153542917|NCT01555476|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153542918|NCT01555476|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153542960|NCT01555814|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
153542961|NCT01555814|Antidepressive Agents|antidepressive agents|mesh-ancestor
153542962|NCT01555853|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
153542963|NCT01555853|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153542964|NCT01555866|Isavuconazole|isavuconazole|mesh-list
153542965|NCT01555866|Antifungal Agents|antifungal agents|mesh-ancestor
153542966|NCT01555866|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153542967|NCT01555879|Abatacept|abatacept|mesh-list
153542968|NCT01555879|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153486220|NCT03229499|Anastrozole|anastrozole|mesh-list
153543025|NCT01556334|Erythromycin Estolate|erythromycin estolate|mesh-list
153543026|NCT01556334|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
153543027|NCT01556334|Erythromycin stearate|erythromycin stearate|mesh-list
153543028|NCT01556334|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153543029|NCT01556334|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153557755|NCT01621386|Prednisone|prednisone|mesh-list
153543030|NCT01556334|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153543031|NCT01556334|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
153543032|NCT01556334|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153543033|NCT01556334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153543034|NCT01556477|Lenalidomide|lenalidomide|mesh-list
153543035|NCT01556477|Azacitidine|azacitidine|mesh-list
153543036|NCT01556477|Immunologic Factors|immunologic factors|mesh-ancestor
153543038|NCT01556477|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153543087|NCT05847257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153543089|NCT05847257|Hormone Antagonists|hormone antagonists|mesh-ancestor
153543090|NCT05847257|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153543091|NCT05847257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153543092|NCT05847257|Micronutrients|micronutrients|mesh-ancestor
153543094|NCT05847205|Hirudins|hirudins|mesh-list
153543095|NCT05847205|Antithrombins|antithrombins|mesh-ancestor
153543096|NCT05847205|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
153543097|NCT05847205|Protease Inhibitors|protease inhibitors|mesh-ancestor
153543098|NCT05847205|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153543099|NCT05847205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153543100|NCT05847205|Anticoagulants|anticoagulants|mesh-ancestor
153543101|NCT05847205|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153543102|NCT05847205|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153543103|NCT05847088|Dexamethasone|dexamethasone|mesh-list
153543104|NCT05847088|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153543105|NCT05847088|Antiemetics|antiemetics|mesh-ancestor
153543106|NCT05847088|Autonomic Agents|autonomic agents|mesh-ancestor
153543107|NCT05847088|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153543108|NCT05847088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153543109|NCT05847088|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153543110|NCT05847088|Glucocorticoids|glucocorticoids|mesh-ancestor
153543111|NCT05847088|Hormones|hormones|mesh-ancestor
153543112|NCT05847088|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153543115|NCT05847049|Nepafenac|nepafenac|mesh-list
153543116|NCT05847049|Aflibercept|aflibercept|mesh-list
153543117|NCT05847049|Eplerenone|eplerenone|mesh-list
153543118|NCT05847049|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153543119|NCT05847049|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153543120|NCT05847049|Growth Substances|growth substances|mesh-ancestor
153543126|NCT05847049|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153543127|NCT05847049|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
153543130|NCT05847049|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153543131|NCT05847049|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153543132|NCT05847049|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153543133|NCT05847049|Analgesics|analgesics|mesh-ancestor
153543134|NCT05847049|Sensory System Agents|sensory system agents|mesh-ancestor
153543135|NCT05847049|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153543136|NCT05847049|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153543137|NCT05847049|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153543138|NCT05846867|Leucovorin|leucovorin|mesh-list
153543139|NCT05846867|Fluorouracil|fluorouracil|mesh-list
153543142|NCT05846867|Calcium|calcium|mesh-list
153543143|NCT05846867|Levoleucovorin|levoleucovorin|mesh-list
153543144|NCT05846867|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153543145|NCT05846867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153543146|NCT05846867|Antimetabolites|antimetabolites|mesh-ancestor
153543147|NCT05846867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153557767|NCT01621386|Hormone Antagonists|hormone antagonists|mesh-ancestor
153543148|NCT05846867|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153543149|NCT05846867|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153543150|NCT05846867|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153543151|NCT05846867|Immunologic Factors|immunologic factors|mesh-ancestor
153543152|NCT05846867|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
153543153|NCT05846867|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153543154|NCT05846867|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153543155|NCT05846867|Antidotes|antidotes|mesh-ancestor
153543156|NCT05846867|Protective Agents|protective agents|mesh-ancestor
153543157|NCT05846867|Vitamin B Complex|vitamin b complex|mesh-ancestor
153543158|NCT05846867|Vitamins|vitamins|mesh-ancestor
153543159|NCT05846867|Micronutrients|micronutrients|mesh-ancestor
153543171|NCT05840692|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
153543172|NCT05840692|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153543174|NCT05840692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153543176|NCT05840692|Serotonin Agents|serotonin agents|mesh-ancestor
153543177|NCT05840692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153543178|NCT05840653|Psychotropic Drugs|psychotropic drugs|mesh-list
153543179|NCT05840640|Lenograstim|lenograstim|mesh-list
153543180|NCT05840640|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153543181|NCT05840640|Immunologic Factors|immunologic factors|mesh-ancestor
153543233|NCT05840328|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153543234|NCT05840328|Analgesics|analgesics|mesh-ancestor
153543235|NCT05840328|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
153543236|NCT05840328|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153543237|NCT05840328|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153543238|NCT05840328|Adrenergic Agents|adrenergic agents|mesh-ancestor
153543239|NCT05840328|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153543240|NCT05840328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153543241|NCT05840172|Benzocaine|benzocaine|mesh-list
153543242|NCT05840172|Anesthetics, Local|anesthetics, local|mesh-ancestor
153543243|NCT05840172|Anesthetics|anesthetics|mesh-ancestor
153543244|NCT05840172|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153543245|NCT05840172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153543247|NCT05840172|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153543248|NCT05840094|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
153543249|NCT05840094|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
153543251|NCT05839548|Epinephrine|epinephrine|mesh-list
153543290|NCT05839236|Atorvastatin|atorvastatin|mesh-list
153543291|NCT05839236|Calcium|calcium|mesh-list
153543292|NCT05839236|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153543293|NCT05839236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153543294|NCT05839236|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153543295|NCT05839236|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153543296|NCT05839236|Antimetabolites|antimetabolites|mesh-ancestor
153543297|NCT05839236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153543298|NCT05839236|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153543299|NCT05839236|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
153543300|NCT05839236|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153543301|NCT05839197|Apatinib|apatinib|mesh-list
153543302|NCT05839197|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153543303|NCT05839197|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153543304|NCT05839197|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153543305|NCT05839197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153543306|NCT05838846|Milrinone|milrinone|mesh-list
153543307|NCT05838846|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
153543308|NCT05838846|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153543309|NCT05838846|Vasodilator Agents|vasodilator agents|mesh-ancestor
153543310|NCT05838846|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
153557806|NCT01621698|Bupivacaine|bupivacaine|mesh-list
153543311|NCT05838846|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
153543312|NCT05838846|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153543341|NCT05805683|Salmon calcitonin|salmon calcitonin|mesh-list
153543342|NCT05805683|Calcitonin Gene-Related Peptide|calcitonin gene-related peptide|mesh-list
153543344|NCT05805683|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153543345|NCT05805683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153543346|NCT05805683|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153543347|NCT05805683|Vasodilator Agents|vasodilator agents|mesh-ancestor
153543348|NCT05686005|Tranexamic Acid|tranexamic acid|mesh-list
153618987|NCT01981447|Lacosamide|lacosamide|mesh-list
153543349|NCT05686005|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
153543350|NCT05686005|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153543351|NCT05686005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153543352|NCT05686005|Hemostatics|hemostatics|mesh-ancestor
153543353|NCT05686005|Coagulants|coagulants|mesh-ancestor
153543354|NCT05585112|Lidocaine|lidocaine|mesh-list
153543355|NCT05585112|Carticaine|carticaine|mesh-list
153543356|NCT05585112|Anesthetics, Local|anesthetics, local|mesh-ancestor
153543357|NCT05585112|Anesthetics|anesthetics|mesh-ancestor
153543358|NCT05585112|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153543359|NCT05585112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153543360|NCT05585112|Sensory System Agents|sensory system agents|mesh-ancestor
153543361|NCT05585112|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153543362|NCT05585112|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153543363|NCT05585112|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
153543364|NCT05585112|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153543365|NCT05585112|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153543383|NCT05527470|Cisplatin|cisplatin|mesh-list
153543384|NCT05527470|Gemcitabine|gemcitabine|mesh-list
153543385|NCT05527470|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153543386|NCT05527470|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153543387|NCT05527470|Antimetabolites|antimetabolites|mesh-ancestor
153543388|NCT05527470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153543389|NCT05439356|Colchicine|colchicine|mesh-list
153543390|NCT05439356|Gout Suppressants|gout suppressants|mesh-ancestor
153543392|NCT05439356|Tubulin Modulators|tubulin modulators|mesh-ancestor
153543393|NCT05439356|Antimitotic Agents|antimitotic agents|mesh-ancestor
153543394|NCT05439356|Mitosis Modulators|mitosis modulators|mesh-ancestor
153543395|NCT05439356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153543396|NCT05439356|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153543397|NCT05323487|Bumetanide|bumetanide|mesh-list
153543398|NCT05323487|Diuretics|diuretics|mesh-ancestor
153543399|NCT05323487|Natriuretic Agents|natriuretic agents|mesh-ancestor
153543400|NCT05323487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153543401|NCT05323487|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
153543402|NCT05323487|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153543403|NCT05323487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153543404|NCT05266807|Vancomycin|vancomycin|mesh-list
153557822|NCT01621698|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
153543405|NCT05266807|Fidaxomicin|fidaxomicin|mesh-list
153543406|NCT05266807|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153543407|NCT05266807|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153543434|NCT05095259|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153543435|NCT05095259|Hormones|hormones|mesh-ancestor
153543436|NCT05095259|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153543437|NCT05049278|Phenylephrine|phenylephrine|mesh-list
153543438|NCT05049278|Oxymetazoline|oxymetazoline|mesh-list
153543439|NCT05049278|Norepinephrine|norepinephrine|mesh-list
153543440|NCT05049278|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
153543501|NCT04895592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153543502|NCT04895592|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153543503|NCT04895592|Glucocorticoids|glucocorticoids|mesh-ancestor
153543504|NCT04895592|Hormones|hormones|mesh-ancestor
153543505|NCT04895592|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153543506|NCT04895592|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153543508|NCT04895592|Protease Inhibitors|protease inhibitors|mesh-ancestor
153543509|NCT04895592|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153543510|NCT04895592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153543511|NCT04895592|Dermatologic Agents|dermatologic agents|mesh-ancestor
153543512|NCT04861103|Enoxaparin|enoxaparin|mesh-list
153543513|NCT04861103|Anticoagulants|anticoagulants|mesh-ancestor
153543514|NCT04861103|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153543515|NCT04861103|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153543516|NCT04861103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153543518|NCT04843761|Phentolamine|phentolamine|mesh-list
153543519|NCT04843761|Vasoactive Intestinal Peptide|vasoactive intestinal peptide|mesh-list
153543520|NCT04843761|Antimetabolites|antimetabolites|mesh-ancestor
153543521|NCT04843761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153543522|NCT04843761|Antiviral Agents|antiviral agents|mesh-ancestor
153543523|NCT04843761|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153543524|NCT04843761|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
153543549|NCT04559880|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
153543550|NCT04559880|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153543551|NCT04559880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153543552|NCT04559880|Hemostatics|hemostatics|mesh-ancestor
153543553|NCT04559880|Coagulants|coagulants|mesh-ancestor
153543554|NCT04542369|Carboplatin|carboplatin|mesh-list
153543555|NCT04542369|Etoposide|etoposide|mesh-list
153543556|NCT04542369|Tislelizumab|tislelizumab|mesh-list
153543557|NCT04542369|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153543558|NCT04542369|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153543559|NCT04542369|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153543560|NCT04542369|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153543561|NCT04542369|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153543562|NCT04542369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153543563|NCT04542369|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153543610|NCT04305444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153543611|NCT04305444|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153543612|NCT04305444|Immunologic Factors|immunologic factors|mesh-ancestor
153543613|NCT04305444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153543614|NCT04305444|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153543615|NCT04305444|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153543616|NCT04305444|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153543673|NCT04175262|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153543674|NCT04175262|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153543675|NCT04175262|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153543676|NCT04175262|Growth Substances|growth substances|mesh-ancestor
153543677|NCT04175262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153543678|NCT04175262|Growth Inhibitors|growth inhibitors|mesh-ancestor
153543679|NCT04175262|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153543739|NCT03776864|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153543740|NCT03776864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153543741|NCT03776864|Immunologic Factors|immunologic factors|mesh-ancestor
153543742|NCT03776864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153543743|NCT03762759|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
153543744|NCT03762759|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
153543745|NCT03762759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153543747|NCT03675412|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
153543748|NCT03675412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153543749|NCT03675412|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
153543750|NCT03675412|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153543751|NCT03675412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153543752|NCT03675412|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
153543753|NCT03675412|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
153543754|NCT03675412|Purinergic Agents|purinergic agents|mesh-ancestor
153543755|NCT03675412|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153543756|NCT03664180|Heparin|heparin|mesh-list
153543757|NCT03664180|Calcium heparin|calcium heparin|mesh-list
153543760|NCT03664180|Enoxaparin sodium|enoxaparin sodium|mesh-list
153543761|NCT03664180|Bivalirudin|bivalirudin|mesh-list
153543762|NCT03664180|Anticoagulants|anticoagulants|mesh-ancestor
153543763|NCT03664180|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153543789|NCT03652870|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
153543790|NCT03652870|Antidepressive Agents|antidepressive agents|mesh-ancestor
153543791|NCT03652870|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153543792|NCT03652870|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
153543793|NCT03652870|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
153543794|NCT03652870|Adrenergic Agents|adrenergic agents|mesh-ancestor
153543795|NCT03634852|Moxifloxacin|moxifloxacin|mesh-list
153543796|NCT03634852|Dexamethasone|dexamethasone|mesh-list
153543797|NCT03634852|Triamcinolone|triamcinolone|mesh-list
153543798|NCT03634852|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
153543799|NCT03634852|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
153543800|NCT03634852|Ophthalmic Solutions|ophthalmic solutions|mesh-list
153543801|NCT03634852|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
153543848|NCT03552575|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
153543849|NCT03552575|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153543850|NCT03552575|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
153543851|NCT03552575|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
153543852|NCT03552575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153543853|NCT03528902|Tamoxifen|tamoxifen|mesh-list
153543907|NCT03321526|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153543908|NCT03321526|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153543909|NCT03321526|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153543910|NCT03321526|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153543911|NCT03321526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153543912|NCT03321526|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153543913|NCT03321526|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153543914|NCT03321526|Adrenergic Agents|adrenergic agents|mesh-ancestor
153543915|NCT03321526|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153543916|NCT03321526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153543917|NCT03321526|Sympathomimetics|sympathomimetics|mesh-ancestor
153543918|NCT03321526|Autonomic Agents|autonomic agents|mesh-ancestor
153543919|NCT03321526|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153543920|NCT03321526|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
153543921|NCT03321526|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
153543962|NCT03153111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153557887|NCT01622361|Doxorubicin|doxorubicin|mesh-list
153543963|NCT03153111|Endothelin B Receptor Antagonists|endothelin b receptor antagonists|mesh-ancestor
153543965|NCT03126435|Paclitaxel|paclitaxel|mesh-list
153543966|NCT03126435|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153543967|NCT03126435|Antimetabolites|antimetabolites|mesh-ancestor
153543970|NCT03126435|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153543971|NCT03126435|Tubulin Modulators|tubulin modulators|mesh-ancestor
153543972|NCT03126435|Antimitotic Agents|antimitotic agents|mesh-ancestor
153543973|NCT03126435|Mitosis Modulators|mitosis modulators|mesh-ancestor
153543974|NCT03084939|Capecitabine|capecitabine|mesh-list
153543975|NCT03084939|Trastuzumab|trastuzumab|mesh-list
153543976|NCT03084939|Lapatinib|lapatinib|mesh-list
153543977|NCT03084939|Maytansine|maytansine|mesh-list
153543978|NCT03084939|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
153543979|NCT03084939|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153543980|NCT03084939|Antimetabolites|antimetabolites|mesh-ancestor
153543981|NCT03084939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153543982|NCT03084939|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153543983|NCT03084939|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153543984|NCT03084939|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153543991|NCT03084939|Immunotoxins|immunotoxins|mesh-ancestor
153544012|NCT02947347|Rituximab|rituximab|mesh-list
153544013|NCT02947347|Ibrutinib|ibrutinib|mesh-list
153544014|NCT02947347|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153544015|NCT02947347|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153544016|NCT02947347|Immunologic Factors|immunologic factors|mesh-ancestor
153544017|NCT02947347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153544018|NCT02947347|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153544019|NCT02947347|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153544020|NCT02947347|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153544021|NCT02947347|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153544022|NCT02947347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153544023|NCT02870907|Cyclophosphamide|cyclophosphamide|mesh-list
153544024|NCT02870907|Thiotepa|thiotepa|mesh-list
153544025|NCT02870907|Carboplatin|carboplatin|mesh-list
153544026|NCT02870907|Etoposide|etoposide|mesh-list
153544027|NCT02870907|Etoposide phosphate|etoposide phosphate|mesh-list
153544028|NCT02870907|Vincristine|vincristine|mesh-list
153544029|NCT02870907|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153544030|NCT02870907|Immunologic Factors|immunologic factors|mesh-ancestor
153544031|NCT02870907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153544032|NCT02870907|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153544033|NCT02870907|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153544037|NCT02870907|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153544038|NCT02870907|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153544039|NCT02870907|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153544040|NCT02870907|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153544041|NCT02870907|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153544042|NCT02870907|Tubulin Modulators|tubulin modulators|mesh-ancestor
153544043|NCT02870907|Antimitotic Agents|antimitotic agents|mesh-ancestor
153544044|NCT02870907|Mitosis Modulators|mitosis modulators|mesh-ancestor
153544046|NCT02823574|Ipilimumab|ipilimumab|mesh-list
153544047|NCT02823574|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153544048|NCT02823574|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153544052|NCT02641028|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
153544053|NCT02641028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153544054|NCT02641028|Sensory System Agents|sensory system agents|mesh-ancestor
153544055|NCT02641028|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153544056|NCT02525796|Eplerenone|eplerenone|mesh-list
153544057|NCT02525796|Amiloride|amiloride|mesh-list
153544058|NCT02525796|Cinacalcet|cinacalcet|mesh-list
153544059|NCT02525796|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
153544061|NCT02525796|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153544062|NCT02525796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153544064|NCT02525796|Diuretics|diuretics|mesh-ancestor
153544065|NCT02525796|Natriuretic Agents|natriuretic agents|mesh-ancestor
153544066|NCT02525796|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153544067|NCT02525796|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153544068|NCT02525796|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
153544069|NCT02525796|Acid Sensing Ion Channel Blockers|acid sensing ion channel blockers|mesh-ancestor
153544070|NCT02525796|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153544071|NCT02525796|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153544072|NCT02525796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153544073|NCT02525796|Epithelial Sodium Channel Blockers|epithelial sodium channel blockers|mesh-ancestor
153544074|NCT02360280|Midazolam|midazolam|mesh-list
153544075|NCT02360280|Ketamine|ketamine|mesh-list
153544076|NCT02360280|Analgesics|analgesics|mesh-ancestor
153544077|NCT02360280|Sensory System Agents|sensory system agents|mesh-ancestor
153544078|NCT02360280|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153544079|NCT02360280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153544080|NCT02360280|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
153544093|NCT02360280|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153544094|NCT02360280|GABA Modulators|gaba modulators|mesh-ancestor
153544095|NCT02360280|GABA Agents|gaba agents|mesh-ancestor
153544096|NCT02201251|Topiramate|topiramate|mesh-list
153544097|NCT02201251|Levetiracetam|levetiracetam|mesh-list
153544098|NCT02201251|Anticonvulsants|anticonvulsants|mesh-ancestor
153544099|NCT02201251|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153544100|NCT02201251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153544101|NCT02201251|Nootropic Agents|nootropic agents|mesh-ancestor
153544102|NCT02174575|Sevoflurane|sevoflurane|mesh-list
153544103|NCT02174575|Desflurane|desflurane|mesh-list
153544104|NCT02174575|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153544105|NCT02174575|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
153544106|NCT02174575|Anesthetics, General|anesthetics, general|mesh-ancestor
153544158|NCT00713323|Sensory System Agents|sensory system agents|mesh-ancestor
153544178|NCT00713193|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153544179|NCT00713193|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
153544181|NCT00710554|Analgesics|analgesics|mesh-ancestor
153544182|NCT00710554|Sensory System Agents|sensory system agents|mesh-ancestor
153544183|NCT00710554|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153544184|NCT00710554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153544186|NCT00710424|Analgesics|analgesics|mesh-ancestor
153544187|NCT00710424|Sensory System Agents|sensory system agents|mesh-ancestor
153544188|NCT00710424|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153544204|NCT01556672|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153544205|NCT01556672|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153544206|NCT01556698|Nitric Oxide|nitric oxide|mesh-list
153544207|NCT01556698|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153544208|NCT01556698|Autonomic Agents|autonomic agents|mesh-ancestor
153544209|NCT01556698|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153544210|NCT01556698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153544211|NCT01556698|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153544212|NCT01556698|Respiratory System Agents|respiratory system agents|mesh-ancestor
153544213|NCT01556698|Free Radical Scavengers|free radical scavengers|mesh-ancestor
153544214|NCT01556698|Antioxidants|antioxidants|mesh-ancestor
153544215|NCT01556698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153557924|NCT01622439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153544216|NCT01556698|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153544217|NCT01556698|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
153544218|NCT01556698|Vasodilator Agents|vasodilator agents|mesh-ancestor
153544219|NCT01556698|Gasotransmitters|gasotransmitters|mesh-ancestor
153544220|NCT01556698|Protective Agents|protective agents|mesh-ancestor
153544221|NCT01556737|Genistein|genistein|mesh-list
153357558|NCT04272320|Sensory System Agents|sensory system agents|mesh-ancestor
153544223|NCT01556737|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
153544224|NCT01556737|Protective Agents|protective agents|mesh-ancestor
153544225|NCT01556737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153544226|NCT01556737|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153544227|NCT01556737|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153544228|NCT01556737|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153544229|NCT01556737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153544230|NCT01556737|Phytoestrogens|phytoestrogens|mesh-ancestor
153544231|NCT01556737|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
153544232|NCT01556737|Estrogens|estrogens|mesh-ancestor
153544233|NCT01556737|Hormones|hormones|mesh-ancestor
153544234|NCT01556737|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153544235|NCT01556815|Sorafenib|sorafenib|mesh-list
153544236|NCT01556815|Chlorotrianisene|chlorotrianisene|mesh-list
153544237|NCT01556815|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153544238|NCT01556815|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153544239|NCT01556815|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153544240|NCT01556815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153544241|NCT01556815|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
153544242|NCT01556815|Estrogens|estrogens|mesh-ancestor
153544243|NCT01556815|Hormones|hormones|mesh-ancestor
153544244|NCT01556815|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153544245|NCT01556815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153544246|NCT01556815|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153544247|NCT01556867|Anti-Infective Agents, Local|anti-infective agents, local|mesh-list
153544248|NCT01556867|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153544249|NCT01557075|Atorvastatin|atorvastatin|mesh-list
153544250|NCT01557075|Pravastatin|pravastatin|mesh-list
153544251|NCT01557075|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-list
153544252|NCT01557075|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153544253|NCT01557075|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153544254|NCT01557075|Antimetabolites|antimetabolites|mesh-ancestor
153544255|NCT01557075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153544256|NCT01557075|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153544257|NCT01557075|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153544259|NCT01557114|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153544260|NCT01557114|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153544261|NCT01557114|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153544262|NCT01557114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153544264|NCT01557127|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153544288|NCT01557153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153544289|NCT01557153|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153544290|NCT01557153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153544291|NCT01557153|Vasodilator Agents|vasodilator agents|mesh-ancestor
153544292|NCT01557257|Naltrexone|naltrexone|mesh-list
153544293|NCT01557257|Oxycodone|oxycodone|mesh-list
153544294|NCT01557257|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
153544295|NCT01557257|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
153544296|NCT01557257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153544297|NCT01557257|Sensory System Agents|sensory system agents|mesh-ancestor
153557940|NCT01622439|Mitosis Modulators|mitosis modulators|mesh-ancestor
153544298|NCT01557257|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153544299|NCT01557257|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153544300|NCT01557257|Narcotics|narcotics|mesh-ancestor
153544301|NCT01557257|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153544302|NCT01557257|Analgesics|analgesics|mesh-ancestor
153544303|NCT01557270|Dexmedetomidine|dexmedetomidine|mesh-list
153544304|NCT01557270|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153544305|NCT01557270|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153544306|NCT01557270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153544307|NCT01557270|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153544308|NCT01557270|Analgesics|analgesics|mesh-ancestor
153544309|NCT01557270|Sensory System Agents|sensory system agents|mesh-ancestor
153811010|NCT00353067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153357560|NCT01277744|Cisplatin|cisplatin|mesh-list
153357561|NCT01277744|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153357562|NCT01277822|Losartan|losartan|mesh-list
153544310|NCT01557270|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153544311|NCT01557270|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
153544312|NCT01557270|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153544317|NCT01557335|Aspirin|aspirin|mesh-list
153544335|NCT01557335|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
153544336|NCT01557335|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
153544337|NCT01557335|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
153544339|NCT01557335|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153544340|NCT01557335|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
153544341|NCT01557335|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153544342|NCT01557335|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
153544343|NCT01557374|Abatacept|abatacept|mesh-list
153544344|NCT01557374|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153544345|NCT01557374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153544346|NCT01557374|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153544347|NCT01557374|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153544348|NCT01557374|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153544349|NCT01557374|Immunologic Factors|immunologic factors|mesh-ancestor
153544350|NCT01557374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153544351|NCT01557374|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153544352|NCT01557439|Levocetirizine|levocetirizine|mesh-list
153544353|NCT01557439|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
153544354|NCT01557439|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
153544355|NCT01557439|Histamine Antagonists|histamine antagonists|mesh-ancestor
153544356|NCT01557439|Histamine Agents|histamine agents|mesh-ancestor
153544357|NCT01557439|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153544358|NCT01557439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153544359|NCT01557439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153544360|NCT01557478|Melatonin|melatonin|mesh-list
153544361|NCT01557478|Antioxidants|antioxidants|mesh-ancestor
153544362|NCT01557478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153544363|NCT01557478|Protective Agents|protective agents|mesh-ancestor
153811011|NCT00323219|Moxifloxacin|moxifloxacin|mesh-list
153811012|NCT00323219|Cefazolin|cefazolin|mesh-list
153811013|NCT00323219|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153357563|NCT01277822|Amlodipine|amlodipine|mesh-list
153668020|NCT00030576|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153544364|NCT01557478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153544378|NCT01557712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153544379|NCT01557712|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
153544380|NCT01557712|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153544381|NCT01557712|Anesthetics, General|anesthetics, general|mesh-ancestor
153544382|NCT01557712|Anesthetics|anesthetics|mesh-ancestor
153544383|NCT01557712|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153544384|NCT01557712|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
153544385|NCT01557712|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
153544386|NCT01557712|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153544387|NCT01557712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153544388|NCT01557712|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
153544389|NCT01557712|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153544390|NCT01557712|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153544391|NCT01557712|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
153544392|NCT01557712|Antidepressive Agents|antidepressive agents|mesh-ancestor
153544393|NCT01557712|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153544394|NCT01557764|Trastuzumab|trastuzumab|mesh-list
153544395|NCT01557764|Lapatinib|lapatinib|mesh-list
153544396|NCT01557764|Antibodies|antibodies|mesh-list
153544397|NCT01557764|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
153544398|NCT01557764|Immunologic Factors|immunologic factors|mesh-ancestor
153544399|NCT01557764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153544400|NCT01557764|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153544401|NCT01557764|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153544402|NCT01557764|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153544403|NCT01557764|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153544404|NCT01557764|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153544405|NCT01557764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153544406|NCT01557816|Naproxen|naproxen|mesh-list
153544407|NCT01557816|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153544408|NCT01557816|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153544410|NCT01557816|Sensory System Agents|sensory system agents|mesh-ancestor
153544415|NCT01557816|Gout Suppressants|gout suppressants|mesh-ancestor
153544416|NCT01557816|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153544417|NCT01557816|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153544418|NCT01557816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153544419|NCT01557829|Silicon|silicon|mesh-list
153544420|NCT01557829|Trace Elements|trace elements|mesh-ancestor
153544421|NCT01557829|Micronutrients|micronutrients|mesh-ancestor
153544422|NCT01557829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153544423|NCT01557907|Insulin|insulin|mesh-list
153544424|NCT01557907|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
153544425|NCT01557907|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153544426|NCT01557907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153544427|NCT01557985|Bupivacaine|bupivacaine|mesh-list
153544428|NCT01557985|Anesthetics, Local|anesthetics, local|mesh-ancestor
153544429|NCT01557985|Anesthetics|anesthetics|mesh-ancestor
153544430|NCT01557985|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153544431|NCT01557985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153544432|NCT01557985|Sensory System Agents|sensory system agents|mesh-ancestor
153544433|NCT01557985|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153544434|NCT01558011|Docetaxel|docetaxel|mesh-list
153544435|NCT01558011|Capecitabine|capecitabine|mesh-list
153544436|NCT01558011|Oxaliplatin|oxaliplatin|mesh-list
153544437|NCT01558011|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153544438|NCT01558011|Tubulin Modulators|tubulin modulators|mesh-ancestor
153544439|NCT01558011|Antimitotic Agents|antimitotic agents|mesh-ancestor
153544440|NCT01558011|Mitosis Modulators|mitosis modulators|mesh-ancestor
153557986|NCT01622790|Antimetabolites|antimetabolites|mesh-ancestor
153544441|NCT01558011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153544442|NCT01558011|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153544444|NCT01558167|Rituximab|rituximab|mesh-list
153544445|NCT01558167|Lenalidomide|lenalidomide|mesh-list
153544446|NCT01558167|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
153544447|NCT01558167|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153544448|NCT01558167|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153544449|NCT01558167|Immunologic Factors|immunologic factors|mesh-ancestor
153544450|NCT01558167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153544451|NCT01558167|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153544453|NCT01558167|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153544454|NCT01558167|Growth Substances|growth substances|mesh-ancestor
153544455|NCT01558167|Growth Inhibitors|growth inhibitors|mesh-ancestor
153544456|NCT01558167|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153544457|NCT01558167|Alkylating Agents|alkylating agents|mesh-ancestor
153544458|NCT01558167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153544459|NCT01558193|Vitamins|vitamins|mesh-list
153544460|NCT01558193|Evening primrose oil|evening primrose oil|mesh-list
153544461|NCT01558193|Micronutrients|micronutrients|mesh-ancestor
153544462|NCT01558193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153544463|NCT01558193|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153544464|NCT01558193|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153544465|NCT01558193|Analgesics|analgesics|mesh-ancestor
153544466|NCT01558193|Sensory System Agents|sensory system agents|mesh-ancestor
153544467|NCT01558193|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153544468|NCT01558193|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153544469|NCT01558193|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153544470|NCT01558193|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153544471|NCT01558193|Antimetabolites|antimetabolites|mesh-ancestor
153544472|NCT01558193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153544473|NCT01558193|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153544474|NCT01558193|Dermatologic Agents|dermatologic agents|mesh-ancestor
153544475|NCT01558245|Kallikreins|kallikreins|mesh-list
153544476|NCT01558245|Coagulants|coagulants|mesh-ancestor
153544477|NCT01558245|Fertility Agents, Male|fertility agents, male|mesh-ancestor
153544478|NCT01558245|Fertility Agents|fertility agents|mesh-ancestor
153544481|NCT01558310|Ustekinumab|ustekinumab|mesh-list
153544482|NCT01558310|Dermatologic Agents|dermatologic agents|mesh-ancestor
153544483|NCT01558336|Praziquantel|praziquantel|mesh-list
153544484|NCT01558336|Anthelmintics|anthelmintics|mesh-ancestor
153544485|NCT01558336|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153544486|NCT01558336|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153544487|NCT01558375|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
153544489|NCT01558453|Oxaliplatin|oxaliplatin|mesh-list
153544490|NCT01558453|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153544492|NCT01558466|Vasodilator Agents|vasodilator agents|mesh-ancestor
153544493|NCT01558466|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
153544494|NCT01558466|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
153544495|NCT01558466|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153558031|NCT01623206|Natriuretic Agents|natriuretic agents|mesh-ancestor
153544496|NCT01558466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153544497|NCT01558466|Urological Agents|urological agents|mesh-ancestor
153544498|NCT01558622|Dexketoprofen trometamol|dexketoprofen trometamol|mesh-list
153544499|NCT01558622|Ketoprofen|ketoprofen|mesh-list
153544500|NCT01558622|Meperidine|meperidine|mesh-list
153544501|NCT01558622|Tramadol|tramadol|mesh-list
153544502|NCT01558622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153544503|NCT01558622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153544504|NCT01558622|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153544505|NCT01558622|Narcotics|narcotics|mesh-ancestor
153544506|NCT01558622|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153544508|NCT01558622|Sensory System Agents|sensory system agents|mesh-ancestor
153544509|NCT01558622|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153544510|NCT01558622|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153544511|NCT01558622|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153544512|NCT01558622|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153544513|NCT01558622|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153544514|NCT01558622|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153544515|NCT01558622|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153544516|NCT01558622|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153544517|NCT01558648|Analgesics|analgesics|mesh-list
153544538|NCT01558830|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153544539|NCT01558830|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153544540|NCT01558830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153544542|NCT01558869|Oxaliplatin|oxaliplatin|mesh-list
153544543|NCT01558869|Irinotecan|irinotecan|mesh-list
153544544|NCT01558869|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153544545|NCT01558869|Antimetabolites|antimetabolites|mesh-ancestor
153618990|NCT01981447|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153544546|NCT01558869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153544547|NCT01558869|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153544548|NCT01558869|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
153544549|NCT01558869|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153544550|NCT01558869|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153544553|NCT01558934|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
153544554|NCT01558934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153544555|NCT01558934|Sensory System Agents|sensory system agents|mesh-ancestor
153544556|NCT01558934|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153544557|NCT01558934|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
153544558|NCT01558934|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153544559|NCT01558934|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153544560|NCT01558934|Adrenergic Agents|adrenergic agents|mesh-ancestor
153544561|NCT01558934|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153544572|NCT01558986|Cefazolin|cefazolin|mesh-list
153544584|NCT01559051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153544585|NCT01559142|Infliximab|infliximab|mesh-list
153544586|NCT01559142|Azathioprine|azathioprine|mesh-list
153544587|NCT01559142|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
153544588|NCT01559142|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153544589|NCT01559142|Dermatologic Agents|dermatologic agents|mesh-ancestor
153544590|NCT01559142|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153544591|NCT01559142|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153544592|NCT01559142|Antimetabolites|antimetabolites|mesh-ancestor
153544593|NCT01559142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153544594|NCT01559142|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153544595|NCT01559142|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153544596|NCT01559142|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153558093|NCT01623635|Sensory System Agents|sensory system agents|mesh-ancestor
153544598|NCT01559142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153544599|NCT01559272|Paliperidone Palmitate|paliperidone palmitate|mesh-list
153544600|NCT01559272|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153544601|NCT01559272|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153544602|NCT01559272|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153544603|NCT01559272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153544604|NCT01559272|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153544605|NCT01559272|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
153544606|NCT01559272|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153544607|NCT01559272|Serotonin Agents|serotonin agents|mesh-ancestor
153544608|NCT01559272|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153544609|NCT01559272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153544610|NCT01559272|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
153544611|NCT01559272|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
153544628|NCT01559298|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153544629|NCT01559298|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153544630|NCT01559298|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153544631|NCT01559298|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153544632|NCT01559298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153544633|NCT01559298|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153544634|NCT01559298|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153544635|NCT01559298|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153544636|NCT01559298|Antipyretics|antipyretics|mesh-ancestor
153544637|NCT01559298|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
153544638|NCT01559298|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
153544639|NCT01559298|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
153544686|NCT01559740|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153544687|NCT01559753|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
153544688|NCT01559753|Amoxicillin|amoxicillin|mesh-list
153544689|NCT01559753|Ceftriaxone|ceftriaxone|mesh-list
153544690|NCT01559753|Tobramycin|tobramycin|mesh-list
153618991|NCT01981447|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153544691|NCT01559753|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
153544692|NCT01559753|Clavulanic Acids|clavulanic acids|mesh-list
153544693|NCT01559753|Clavulanic Acid|clavulanic acid|mesh-list
153544694|NCT01559753|Cefotaxime|cefotaxime|mesh-list
153544695|NCT01559753|Cefoxitin|cefoxitin|mesh-list
153544696|NCT01559753|Netilmicin|netilmicin|mesh-list
153544697|NCT01559753|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153544698|NCT01559753|Third Generation Cephalosporins|third generation cephalosporins|mesh-ancestor
153544699|NCT01559753|Beta Lactam Antibiotics|beta lactam antibiotics|mesh-ancestor
153544700|NCT01559753|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
153558133|NCT01623921|Analgesics|analgesics|mesh-ancestor
153544701|NCT01559753|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153544702|NCT01559753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153544703|NCT01559753|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
153811016|NCT00323219|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153544743|NCT05569668|Tubulin Modulators|tubulin modulators|mesh-ancestor
153544744|NCT05569668|Antimitotic Agents|antimitotic agents|mesh-ancestor
153544745|NCT05569668|Mitosis Modulators|mitosis modulators|mesh-ancestor
153544747|NCT05569655|Furosemide|furosemide|mesh-list
153544748|NCT05569655|Tolvaptan|tolvaptan|mesh-list
153544749|NCT05569655|Diuretics|diuretics|mesh-ancestor
153544750|NCT05569655|Natriuretic Agents|natriuretic agents|mesh-ancestor
153544751|NCT05569655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153544752|NCT05569655|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
153544753|NCT05569655|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153544754|NCT05569655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153544755|NCT05569655|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
153544756|NCT05569590|Hydrogen Peroxide|hydrogen peroxide|mesh-list
153544757|NCT05569590|Propolis|propolis|mesh-list
153544758|NCT05569590|Fluorides|fluorides|mesh-list
153544759|NCT05569590|Fluorides, Topical|fluorides, topical|mesh-list
153544760|NCT05569590|Cariostatic Agents|cariostatic agents|mesh-ancestor
153544761|NCT05569590|Protective Agents|protective agents|mesh-ancestor
153544762|NCT05569590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153544763|NCT05569590|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
153544764|NCT05569590|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153544765|NCT05569577|Estrogens|estrogens|mesh-list
153544766|NCT05569577|Dydrogesterone|dydrogesterone|mesh-list
153544767|NCT05569577|Hormones|hormones|mesh-ancestor
153544768|NCT05569577|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153544769|NCT05569577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153544770|NCT05569577|Progestins|progestins|mesh-ancestor
153544771|NCT05569031|Lofexidine|lofexidine|mesh-list
153544772|NCT05569031|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
153544773|NCT05569031|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
153544774|NCT05569031|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153544775|NCT05569031|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153544776|NCT05569031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153544777|NCT05569031|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153544780|NCT05569031|Antidepressive Agents|antidepressive agents|mesh-ancestor
153544781|NCT05569031|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153544782|NCT05569031|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153544783|NCT05569031|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
153544784|NCT05569031|Sensory System Agents|sensory system agents|mesh-ancestor
153544785|NCT05569031|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153544786|NCT05569031|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
153544787|NCT05569031|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153544788|NCT05569031|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153544789|NCT05569031|Adrenergic Agents|adrenergic agents|mesh-ancestor
153544791|NCT05564741|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153544792|NCT05564741|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153544793|NCT05564741|Adrenergic Agents|adrenergic agents|mesh-ancestor
153544794|NCT05564741|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153544795|NCT05564741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153544796|NCT05564741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153544797|NCT05564741|Sympathomimetics|sympathomimetics|mesh-ancestor
153544798|NCT05564741|Autonomic Agents|autonomic agents|mesh-ancestor
153544799|NCT05564741|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153544800|NCT05564741|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
153544801|NCT05522582|Methotrexate|methotrexate|mesh-list
153544802|NCT05522582|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
153544803|NCT05522582|Antibodies|antibodies|mesh-list
153544804|NCT05522582|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
153544805|NCT05522582|Immunologic Factors|immunologic factors|mesh-ancestor
153544806|NCT05522582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153544807|NCT05522582|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
153544808|NCT05522582|Abortifacient Agents|abortifacient agents|mesh-ancestor
153544809|NCT05522582|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153544811|NCT05522582|Antimetabolites|antimetabolites|mesh-ancestor
153357566|NCT01277822|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153544820|NCT05522582|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153544821|NCT05491304|Dexamethasone|dexamethasone|mesh-list
153544822|NCT05491304|Etoposide|etoposide|mesh-list
153544823|NCT05491304|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153544824|NCT05491304|Antiemetics|antiemetics|mesh-ancestor
153544825|NCT05491304|Autonomic Agents|autonomic agents|mesh-ancestor
153544826|NCT05491304|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153544827|NCT05491304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153544828|NCT05491304|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153544829|NCT05491304|Glucocorticoids|glucocorticoids|mesh-ancestor
153544830|NCT05491304|Hormones|hormones|mesh-ancestor
153544831|NCT05491304|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153544881|NCT04496999|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153544882|NCT04496999|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153544883|NCT04496999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153544884|NCT04298853|Morphine|morphine|mesh-list
153544885|NCT04298853|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153544886|NCT04298853|Narcotics|narcotics|mesh-ancestor
153544887|NCT04298853|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153544888|NCT04298853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153544890|NCT04298853|Sensory System Agents|sensory system agents|mesh-ancestor
153544892|NCT04232683|Tamsulosin|tamsulosin|mesh-list
153544943|NCT03813121|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153544944|NCT03813121|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153544945|NCT03813121|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153544946|NCT03813121|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153544947|NCT03813121|GABA Modulators|gaba modulators|mesh-ancestor
153544948|NCT03813121|GABA Agents|gaba agents|mesh-ancestor
153544949|NCT03710590|Nicotine|nicotine|mesh-list
153544950|NCT03710590|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
153544951|NCT03710590|Autonomic Agents|autonomic agents|mesh-ancestor
153544952|NCT03710590|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153544953|NCT03710590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153544954|NCT03710590|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
153544955|NCT03710590|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
153545007|NCT02917772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153811017|NCT00323219|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153545008|NCT02713373|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
153545009|NCT02713373|Pembrolizumab|pembrolizumab|mesh-list
153545010|NCT02713373|Cetuximab|cetuximab|mesh-list
153545011|NCT02713373|Antibodies|antibodies|mesh-list
153545012|NCT02713373|Immunoglobulins|immunoglobulins|mesh-list
153545013|NCT02713373|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
153545014|NCT02713373|Immunologic Factors|immunologic factors|mesh-ancestor
153545015|NCT02713373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153545016|NCT02713373|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153545017|NCT02713373|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153545018|NCT02713373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153545066|NCT02179749|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153545067|NCT02179749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153545068|NCT02179749|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
153545069|NCT02179749|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
153545070|NCT02179749|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
153545071|NCT02179749|Contraceptive Agents|contraceptive agents|mesh-ancestor
153545072|NCT02179749|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
153488397|NCT02222610|Ranibizumab|ranibizumab|mesh-list
153545133|NCT01564576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153545134|NCT01564823|Metronidazole|metronidazole|mesh-list
153545135|NCT01564823|Adalimumab|adalimumab|mesh-list
153545136|NCT01564823|Azathioprine|azathioprine|mesh-list
153545137|NCT01564823|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
153558235|NCT01624441|Epirubicin|epirubicin|mesh-list
153545138|NCT01564823|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153545139|NCT01564823|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153811018|NCT00323219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153357567|NCT01277822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153545140|NCT01564823|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153545141|NCT01564823|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153545142|NCT01564823|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153545143|NCT01564823|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153545144|NCT01564823|Antimetabolites|antimetabolites|mesh-ancestor
153545145|NCT01564823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153545193|NCT01566890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153545194|NCT01567072|Ibuprofen|ibuprofen|mesh-list
153545195|NCT01567072|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153545196|NCT01567072|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153545197|NCT01567072|Analgesics|analgesics|mesh-ancestor
153545198|NCT01567072|Sensory System Agents|sensory system agents|mesh-ancestor
153545201|NCT01567072|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153545256|NCT01569685|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153545257|NCT01569685|Serotonin Agents|serotonin agents|mesh-ancestor
153545258|NCT01569685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153545259|NCT01569685|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
153545260|NCT01569685|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
153545261|NCT01570049|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
153545262|NCT01570049|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153545263|NCT01570049|Alkylating Agents|alkylating agents|mesh-ancestor
153545264|NCT01570049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153545320|NCT06309719|Viscosupplements|viscosupplements|mesh-ancestor
153545321|NCT06309719|Protective Agents|protective agents|mesh-ancestor
153545323|NCT06309589|Ergocalciferols|ergocalciferols|mesh-list
153545324|NCT06309589|Cholecalciferol|cholecalciferol|mesh-list
153545325|NCT06309589|Vitamins|vitamins|mesh-list
153545326|NCT06309589|Micronutrients|micronutrients|mesh-ancestor
153545327|NCT06309589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153545328|NCT06309589|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153545329|NCT06309589|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153545330|NCT06309485|Sorafenib|sorafenib|mesh-list
153545331|NCT06309485|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153545332|NCT06309485|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153811020|NCT00323375|Chloroquine|chloroquine|mesh-list
153545335|NCT06309472|Mirtazapine|mirtazapine|mesh-list
153545383|NCT06308887|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153545384|NCT06308887|Glucocorticoids|glucocorticoids|mesh-ancestor
153545385|NCT06308887|Hormones|hormones|mesh-ancestor
153545386|NCT06308887|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153545387|NCT06308887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153545388|NCT06308887|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153545389|NCT06308887|Immunologic Factors|immunologic factors|mesh-ancestor
153545390|NCT06308887|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153545391|NCT06308887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153545392|NCT06308731|Caffeine|caffeine|mesh-list
153558242|NCT01624493|Carboplatin|carboplatin|mesh-list
153558243|NCT01624493|Gemcitabine|gemcitabine|mesh-list
153545393|NCT06308731|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
153545394|NCT06308731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153545395|NCT06308731|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
153545396|NCT06308731|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153545397|NCT06308731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153545398|NCT06308731|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
153545402|NCT06308679|Empagliflozin|empagliflozin|mesh-list
153545439|NCT06308367|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153545440|NCT06308367|Antimetabolites|antimetabolites|mesh-ancestor
153545441|NCT06308367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153545442|NCT06308367|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153545443|NCT06308107|Diazoxide|diazoxide|mesh-list
153545444|NCT06308107|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153545445|NCT06308107|Vasodilator Agents|vasodilator agents|mesh-ancestor
153545447|NCT06308068|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153545448|NCT06307808|Abatacept|abatacept|mesh-list
153545449|NCT06307808|Tacrolimus|tacrolimus|mesh-list
153545450|NCT06307808|Calcineurin Inhibitors|calcineurin inhibitors|mesh-list
153545501|NCT06305299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153545502|NCT06305299|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153545503|NCT06305299|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153545504|NCT06305299|Alkylating Agents|alkylating agents|mesh-ancestor
153545505|NCT06305299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153545506|NCT06305299|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153545507|NCT06305299|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153545508|NCT06305299|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153545509|NCT06305299|Antimetabolites|antimetabolites|mesh-ancestor
153545568|NCT06304896|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
153545569|NCT06304896|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153545570|NCT06304896|Gout Suppressants|gout suppressants|mesh-ancestor
153545571|NCT06304896|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153545572|NCT06304896|Tubulin Modulators|tubulin modulators|mesh-ancestor
153545573|NCT06304896|Antimitotic Agents|antimitotic agents|mesh-ancestor
153545574|NCT06304896|Mitosis Modulators|mitosis modulators|mesh-ancestor
153545575|NCT06304896|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153618994|NCT01981460|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153545576|NCT06304896|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
153545577|NCT06304896|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
153545578|NCT06304896|Adrenergic Agents|adrenergic agents|mesh-ancestor
153545579|NCT06304896|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153545580|NCT06304896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153545581|NCT06304896|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153545583|NCT06304896|Protective Agents|protective agents|mesh-ancestor
153545584|NCT06304896|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153545592|NCT06304779|Lidocaine|lidocaine|mesh-list
153545631|NCT06304324|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153545691|NCT06303583|Paclitaxel|paclitaxel|mesh-list
153545692|NCT06303583|Carboplatin|carboplatin|mesh-list
153545693|NCT06303583|Tislelizumab|tislelizumab|mesh-list
153545694|NCT06303583|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153545695|NCT06303583|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153545696|NCT06303583|Tubulin Modulators|tubulin modulators|mesh-ancestor
153545697|NCT06303583|Antimitotic Agents|antimitotic agents|mesh-ancestor
153545698|NCT06303583|Mitosis Modulators|mitosis modulators|mesh-ancestor
153545699|NCT06303583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153545701|NCT06303531|Ferrous fumarate|ferrous fumarate|mesh-list
153545760|NCT06301724|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153545761|NCT06301724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153558289|NCT01624857|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153545762|NCT06301724|Sensory System Agents|sensory system agents|mesh-ancestor
153545763|NCT06301724|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153545764|NCT06301724|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153545765|NCT06301724|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
153545766|NCT06301724|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153545767|NCT06301724|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153545769|NCT06301711|Lidocaine|lidocaine|mesh-list
153811021|NCT00323375|Amebicides|amebicides|mesh-ancestor
153811022|NCT00323375|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153619038|NCT01981811|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153619039|NCT01981811|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
153619040|NCT01981811|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
153619042|NCT01981889|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153619043|NCT01981889|Glucocorticoids|glucocorticoids|mesh-ancestor
153619044|NCT01981889|Hormones|hormones|mesh-ancestor
153619045|NCT01981889|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153619048|NCT01981889|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153619103|NCT01982578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153619105|NCT01982578|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
153619106|NCT01982578|Estrogens|estrogens|mesh-ancestor
153619107|NCT01982578|Hormones|hormones|mesh-ancestor
153619109|NCT01982734|Curcumin|curcumin|mesh-list
153619171|NCT01982929|Autonomic Agents|autonomic agents|mesh-ancestor
153619172|NCT01982929|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153619173|NCT01982929|Respiratory System Agents|respiratory system agents|mesh-ancestor
153619174|NCT01982929|Mydriatics|mydriatics|mesh-ancestor
153619175|NCT01982929|Sympathomimetics|sympathomimetics|mesh-ancestor
153619176|NCT01982929|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
153619177|NCT01983124|Vemurafenib|vemurafenib|mesh-list
153619178|NCT01983124|Fotemustine|fotemustine|mesh-list
153619179|NCT01983124|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153619180|NCT01983124|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153619181|NCT01983124|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153619182|NCT01983124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153619183|NCT01983137|Oxycodone|oxycodone|mesh-list
153619235|NCT01983527|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
153619236|NCT01983527|Prednisolone phosphate|prednisolone phosphate|mesh-list
153619237|NCT01983527|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153619238|NCT01983527|Antiemetics|antiemetics|mesh-ancestor
153619239|NCT01983527|Autonomic Agents|autonomic agents|mesh-ancestor
153619240|NCT01983527|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153619241|NCT01983527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153619242|NCT01983527|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153619244|NCT01983527|Hormones|hormones|mesh-ancestor
153619245|NCT01983527|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153619246|NCT01983527|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
153619247|NCT01983527|Protective Agents|protective agents|mesh-ancestor
153619248|NCT01983527|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153619249|NCT01983527|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153619250|NCT01983540|Vaccines|vaccines|mesh-list
153619251|NCT01983540|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
153619252|NCT01983540|Immunologic Factors|immunologic factors|mesh-ancestor
153619253|NCT01983540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153619254|NCT01983657|Molgramostim|molgramostim|mesh-list
153619255|NCT01983657|Sargramostim|sargramostim|mesh-list
153619256|NCT01983657|Immunologic Factors|immunologic factors|mesh-ancestor
153619257|NCT01983657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153619258|NCT01983657|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153619259|NCT01983722|Stiripentol|stiripentol|mesh-list
153619260|NCT01983722|Anticonvulsants|anticonvulsants|mesh-ancestor
153619262|NCT01983735|Amlodipine|amlodipine|mesh-list
153619263|NCT01983735|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153619264|NCT01983735|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153619265|NCT01983735|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153619266|NCT01983735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153619267|NCT01983735|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153619269|NCT01983735|Vasodilator Agents|vasodilator agents|mesh-ancestor
153619277|NCT01983761|Mycophenolic Acid|mycophenolic acid|mesh-list
153619278|NCT01983761|Fludarabine|fludarabine|mesh-list
153619279|NCT01983761|Fludarabine phosphate|fludarabine phosphate|mesh-list
153619280|NCT01983761|Melphalan|melphalan|mesh-list
153619281|NCT01983761|Busulfan|busulfan|mesh-list
153619282|NCT01983761|Clofarabine|clofarabine|mesh-list
153619283|NCT01983761|Tacrolimus|tacrolimus|mesh-list
153619284|NCT01983761|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153619285|NCT01983761|Immunologic Factors|immunologic factors|mesh-ancestor
153619286|NCT01983761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153619287|NCT01983761|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153619288|NCT01983761|Antimetabolites|antimetabolites|mesh-ancestor
153619289|NCT01983761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153619290|NCT01983761|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153619291|NCT01983761|Antiviral Agents|antiviral agents|mesh-ancestor
153619292|NCT01983761|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153619339|NCT01984073|Niacin|niacin|mesh-list
153619340|NCT01984073|Niacinamide|niacinamide|mesh-list
153619341|NCT01984073|Nicotinic Acids|nicotinic acids|mesh-list
153619342|NCT01984073|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153619343|NCT01984073|Antimetabolites|antimetabolites|mesh-ancestor
153619344|NCT01984073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153619345|NCT01984073|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153619346|NCT01984073|Vasodilator Agents|vasodilator agents|mesh-ancestor
153619347|NCT01984073|Vitamin B Complex|vitamin b complex|mesh-ancestor
153619348|NCT01984073|Vitamins|vitamins|mesh-ancestor
153619349|NCT01984073|Micronutrients|micronutrients|mesh-ancestor
153619350|NCT01984073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153619403|NCT01984372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153619404|NCT01984463|Fentanyl|fentanyl|mesh-list
153619405|NCT01984463|Morphine|morphine|mesh-list
153619406|NCT01984463|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153619407|NCT01984463|Narcotics|narcotics|mesh-ancestor
153619408|NCT01984463|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153619409|NCT01984463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153619411|NCT01984463|Sensory System Agents|sensory system agents|mesh-ancestor
153619412|NCT01984463|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153619413|NCT01984463|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153619414|NCT01984463|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153619470|NCT01984931|Antifoaming Agents|antifoaming agents|mesh-ancestor
153619471|NCT01984931|Emollients|emollients|mesh-ancestor
153619472|NCT01984931|Dermatologic Agents|dermatologic agents|mesh-ancestor
153619473|NCT01984931|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153619474|NCT01984931|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153619475|NCT01984931|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153619476|NCT01984931|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153619477|NCT01984931|GABA Modulators|gaba modulators|mesh-ancestor
153619478|NCT01984931|GABA Agents|gaba agents|mesh-ancestor
153619479|NCT01984931|Anticonvulsants|anticonvulsants|mesh-ancestor
153619480|NCT01984931|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153619481|NCT01984931|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
153619482|NCT01984931|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
153619483|NCT01985061|Busulfan|busulfan|mesh-list
153619531|NCT01985477|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153619532|NCT01985477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153619533|NCT01985477|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153619534|NCT01985477|Glucocorticoids|glucocorticoids|mesh-ancestor
153619535|NCT01985477|Hormones|hormones|mesh-ancestor
153558351|NCT01625520|Hormones|hormones|mesh-ancestor
153619536|NCT01985477|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153619537|NCT01985477|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153619538|NCT01985477|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153619539|NCT01985477|Immunologic Factors|immunologic factors|mesh-ancestor
153619540|NCT01985477|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153619541|NCT01985477|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153619542|NCT01985477|Growth Substances|growth substances|mesh-ancestor
153619543|NCT01985477|Growth Inhibitors|growth inhibitors|mesh-ancestor
153619544|NCT01985477|Keratolytic Agents|keratolytic agents|mesh-ancestor
153619545|NCT01985477|Dermatologic Agents|dermatologic agents|mesh-ancestor
153619546|NCT01985594|Nifedipine|nifedipine|mesh-list
153619547|NCT01985594|Progesterone|progesterone|mesh-list
153619548|NCT01985594|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153619587|NCT01985750|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
153619588|NCT01985750|Antitubercular Agents|antitubercular agents|mesh-ancestor
153619589|NCT01985750|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153619590|NCT01985750|Antimetabolites|antimetabolites|mesh-ancestor
153619591|NCT01985750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153619592|NCT01985789|Diphenhydramine|diphenhydramine|mesh-list
153619594|NCT01985789|Cetirizine|cetirizine|mesh-list
153619595|NCT01985789|Desloratadine|desloratadine|mesh-list
153619596|NCT01985789|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
153619597|NCT01985789|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153619598|NCT01985789|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153619599|NCT01985789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153619600|NCT01985789|Anesthetics, Local|anesthetics, local|mesh-ancestor
153619601|NCT01985789|Anesthetics|anesthetics|mesh-ancestor
153619602|NCT01985789|Sensory System Agents|sensory system agents|mesh-ancestor
153619647|NCT01985854|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153619648|NCT01985854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153619649|NCT01985854|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153619650|NCT01985854|Anesthetics, General|anesthetics, general|mesh-ancestor
153619651|NCT01985854|Anesthetics|anesthetics|mesh-ancestor
153619652|NCT01985854|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
153619653|NCT01985893|Trastuzumab|trastuzumab|mesh-list
153619654|NCT01985893|Lapatinib|lapatinib|mesh-list
153619655|NCT01985893|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153619656|NCT01985893|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153619657|NCT01985893|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153619658|NCT01985893|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153619659|NCT01985893|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153619661|NCT01986036|Calcium|calcium|mesh-list
153619708|NCT01986283|Narcotics|narcotics|mesh-ancestor
153357585|NCT00748826|Dermatologic Agents|dermatologic agents|mesh-ancestor
153619709|NCT01986283|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153619710|NCT01986283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153619711|NCT01986283|Analgesics|analgesics|mesh-ancestor
153619712|NCT01986283|Sensory System Agents|sensory system agents|mesh-ancestor
153619713|NCT01986283|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153619714|NCT01986309|Lidocaine|lidocaine|mesh-list
153619715|NCT01986309|Anesthetics, Local|anesthetics, local|mesh-ancestor
153619716|NCT01986309|Anesthetics|anesthetics|mesh-ancestor
153619717|NCT01986309|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153619718|NCT01986309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153619719|NCT01986309|Sensory System Agents|sensory system agents|mesh-ancestor
153619720|NCT01986309|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153619721|NCT01986309|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153619769|NCT01986582|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153619770|NCT01986582|Nasal Decongestants|nasal decongestants|mesh-ancestor
153619771|NCT01986582|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
153619772|NCT01986582|Respiratory System Agents|respiratory system agents|mesh-ancestor
153619773|NCT01986582|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
153619774|NCT01986582|Mydriatics|mydriatics|mesh-ancestor
153619775|NCT01986582|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
153811040|NCT00353145|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153357586|NCT00748826|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153357587|NCT00748826|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153619776|NCT01986582|Protective Agents|protective agents|mesh-ancestor
153619778|NCT01986608|Anticonvulsants|anticonvulsants|mesh-ancestor
153619779|NCT01986608|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
153619780|NCT01986608|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153619783|NCT01986660|Ibuprofen|ibuprofen|mesh-list
153619829|NCT01986894|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153619830|NCT01986894|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153619831|NCT01986894|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153619832|NCT01986894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153619833|NCT01986894|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153619834|NCT01986894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153619898|NCT01987297|Immunologic Factors|immunologic factors|mesh-ancestor
153619899|NCT01987297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153619900|NCT01987297|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153619901|NCT01987297|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153619902|NCT01987297|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153619903|NCT01987297|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153619904|NCT01987297|Keratolytic Agents|keratolytic agents|mesh-ancestor
153619905|NCT01987297|Dermatologic Agents|dermatologic agents|mesh-ancestor
153619906|NCT01987310|Atorvastatin|atorvastatin|mesh-list
153619907|NCT01987310|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153619908|NCT01987310|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153619909|NCT01987310|Antimetabolites|antimetabolites|mesh-ancestor
153619959|NCT01988298|Acetaminophen|acetaminophen|mesh-list
153619960|NCT01988298|Ibuprofen|ibuprofen|mesh-list
153619961|NCT01988298|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153619962|NCT01988298|Analgesics|analgesics|mesh-ancestor
153619963|NCT01988298|Sensory System Agents|sensory system agents|mesh-ancestor
153619964|NCT01988298|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153619965|NCT01988298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153619967|NCT01988298|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153619968|NCT01988298|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153620025|NCT01988831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153620026|NCT01988831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153620027|NCT01988831|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153620028|NCT01988831|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153620029|NCT01988831|Vasodilator Agents|vasodilator agents|mesh-ancestor
153620030|NCT01988896|Atezolizumab|atezolizumab|mesh-list
153620031|NCT01988896|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153620032|NCT01988896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153620034|NCT01988896|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153620035|NCT01988961|Golimumab|golimumab|mesh-list
153620036|NCT01988961|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
153620037|NCT01988961|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153620083|NCT01989312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153620084|NCT01989312|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153620085|NCT01989312|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153620086|NCT01989312|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153620087|NCT01989312|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153620088|NCT01989312|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153620153|NCT01989845|Rivaroxaban|rivaroxaban|mesh-list
153620154|NCT01989845|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
153620155|NCT01989845|Antithrombins|antithrombins|mesh-ancestor
153620156|NCT01989845|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
153620157|NCT01989845|Protease Inhibitors|protease inhibitors|mesh-ancestor
153620158|NCT01989845|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153620159|NCT01989845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153558442|NCT01626339|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153620160|NCT01989845|Anticoagulants|anticoagulants|mesh-ancestor
153620163|NCT01989897|Phenol|phenol|mesh-list
153620220|NCT01990118|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153620222|NCT01990118|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153620223|NCT01990118|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
153620290|NCT01990781|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153620291|NCT01990781|Glucocorticoids|glucocorticoids|mesh-ancestor
153620292|NCT01990781|Hormones|hormones|mesh-ancestor
153620293|NCT01990781|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153620294|NCT01990781|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153620295|NCT01990781|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153620296|NCT01990781|Protease Inhibitors|protease inhibitors|mesh-ancestor
153620297|NCT01990781|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153620356|NCT01991158|Pegaspargase|pegaspargase|mesh-list
153620357|NCT01991158|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153620358|NCT01991158|Antiemetics|antiemetics|mesh-ancestor
153620359|NCT01991158|Autonomic Agents|autonomic agents|mesh-ancestor
153620360|NCT01991158|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153620361|NCT01991158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153620362|NCT01991158|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153620363|NCT01991158|Glucocorticoids|glucocorticoids|mesh-ancestor
153620364|NCT01991158|Hormones|hormones|mesh-ancestor
153620365|NCT01991158|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153620366|NCT01991158|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153620369|NCT01991158|Antimetabolites|antimetabolites|mesh-ancestor
153620420|NCT01991327|Fertility Agents, Female|fertility agents, female|mesh-ancestor
153620421|NCT01991327|Fertility Agents|fertility agents|mesh-ancestor
153620422|NCT01991327|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153620423|NCT01991327|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
153620424|NCT01991327|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
153620425|NCT01991561|Aluminum Hydroxide|aluminum hydroxide|mesh-list
153620426|NCT01991561|Vaccines|vaccines|mesh-list
153620427|NCT01991561|Immunologic Factors|immunologic factors|mesh-ancestor
153620428|NCT01991561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153620429|NCT01991561|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153620430|NCT01991561|Antacids|antacids|mesh-ancestor
153702373|NCT00283036|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153357601|NCT01274624|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153815053|NCT00454272|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153357602|NCT01274624|Growth Substances|growth substances|mesh-ancestor
153357603|NCT01274624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153357604|NCT01274624|Growth Inhibitors|growth inhibitors|mesh-ancestor
153357605|NCT01274624|Antimetabolites|antimetabolites|mesh-ancestor
153357606|NCT01274624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153620431|NCT01991561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153620433|NCT01991574|Calcium|calcium|mesh-list
153620434|NCT01991574|Calcium acetate|calcium acetate|mesh-list
153620435|NCT01991574|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153620436|NCT01991574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153620437|NCT01991574|Chelating Agents|chelating agents|mesh-ancestor
153558492|NCT01626911|Heparin|heparin|mesh-list
153620438|NCT01991574|Sequestering Agents|sequestering agents|mesh-ancestor
153620439|NCT01991574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153620440|NCT01991587|Vaccines|vaccines|mesh-list
153620441|NCT01991587|Immunologic Factors|immunologic factors|mesh-ancestor
153620442|NCT01991587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153620443|NCT01991626|Iron|iron|mesh-list
153620444|NCT01991626|Trace Elements|trace elements|mesh-list
153620445|NCT01991626|Micronutrients|micronutrients|mesh-list
153620446|NCT01991626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153620447|NCT01991678|Etirinotecan pegol|etirinotecan pegol|mesh-list
153620448|NCT01991678|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153620449|NCT01991678|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153620450|NCT01991678|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153620451|NCT01991678|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153620463|NCT01992133|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153620464|NCT01992133|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153620466|NCT01992198|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
153620467|NCT01992198|Metronidazole|metronidazole|mesh-list
153620468|NCT01992198|Meropenem|meropenem|mesh-list
153620469|NCT01992198|Cefoperazone|cefoperazone|mesh-list
153620470|NCT01992198|Sulperazone|sulperazone|mesh-list
153620471|NCT01992198|Somatostatin|somatostatin|mesh-list
153620472|NCT01992198|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
153620473|NCT01992198|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153620528|NCT01992562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153620529|NCT01992562|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
153620530|NCT01992562|Protective Agents|protective agents|mesh-ancestor
153357607|NCT01274624|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153357608|NCT01274624|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153357609|NCT01274624|Immunologic Factors|immunologic factors|mesh-ancestor
153620532|NCT01992562|Analgesics|analgesics|mesh-ancestor
153620533|NCT01992562|Sensory System Agents|sensory system agents|mesh-ancestor
153620534|NCT01992562|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153620536|NCT01992588|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
153620537|NCT01992588|Insulin Aspart|insulin aspart|mesh-list
153620538|NCT01992588|Insulin, Long-Acting|insulin, long-acting|mesh-list
153620539|NCT01992588|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
153620540|NCT01992588|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153620541|NCT01992588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153620542|NCT01992601|Telmisartan|telmisartan|mesh-list
153620592|NCT01993212|Hormones|hormones|mesh-ancestor
153620593|NCT01993212|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153620594|NCT01993212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153620595|NCT01993212|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
153620596|NCT01993212|Hormone Antagonists|hormone antagonists|mesh-ancestor
153620597|NCT01993212|Fertility Agents, Female|fertility agents, female|mesh-ancestor
153620598|NCT01993212|Fertility Agents|fertility agents|mesh-ancestor
153620599|NCT01993212|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153620600|NCT01993212|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
153620601|NCT01993212|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
153620602|NCT01993225|Enclomiphene|enclomiphene|mesh-list
153620603|NCT01993225|Testosterone|testosterone|mesh-list
153620604|NCT01993225|Androgens|androgens|mesh-ancestor
153620605|NCT01993225|Hormones|hormones|mesh-ancestor
153620650|NCT01993472|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153620651|NCT01993472|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153620652|NCT01993472|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153620653|NCT01993472|Analgesics|analgesics|mesh-ancestor
153620654|NCT01993472|Sensory System Agents|sensory system agents|mesh-ancestor
153620655|NCT01993472|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153620656|NCT01993472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153620657|NCT01993472|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153620658|NCT01993472|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153620659|NCT01993472|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153620660|NCT01993472|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153620661|NCT01993472|Antiviral Agents|antiviral agents|mesh-ancestor
153620662|NCT01993472|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153620663|NCT01993537|Vitamin D|vitamin d|mesh-list
153620664|NCT01993537|Vitamins|vitamins|mesh-ancestor
153620712|NCT01994070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153620713|NCT01994096|Caspofungin|caspofungin|mesh-list
153620714|NCT01994096|Antifungal Agents|antifungal agents|mesh-ancestor
153620715|NCT01994096|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153620716|NCT01994096|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153620717|NCT01994096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153620718|NCT01994265|Warfarin|warfarin|mesh-list
153620780|NCT01994668|GABA Agents|gaba agents|mesh-ancestor
153620781|NCT01994668|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153620782|NCT01994668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153620783|NCT01994733|Calcium, Dietary|calcium, dietary|mesh-list
153620784|NCT01994733|Calcium Carbonate|calcium carbonate|mesh-list
153620785|NCT01994733|Calcium|calcium|mesh-list
153620786|NCT01994733|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153620787|NCT01994733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153620846|NCT01995019|Antiemetics|antiemetics|mesh-ancestor
153620847|NCT01995019|Autonomic Agents|autonomic agents|mesh-ancestor
153620848|NCT01995019|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153620849|NCT01995019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153620850|NCT01995019|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153620851|NCT01995019|Glucocorticoids|glucocorticoids|mesh-ancestor
153620852|NCT01995019|Hormones|hormones|mesh-ancestor
153620853|NCT01995019|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153620854|NCT01995019|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
153620855|NCT01995019|Protective Agents|protective agents|mesh-ancestor
153620856|NCT01995019|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153620857|NCT01995019|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153620858|NCT01995032|Metformin|metformin|mesh-list
153620859|NCT01995032|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153620860|NCT01995032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153620861|NCT01995058|Prednisone|prednisone|mesh-list
153620862|NCT01995058|Abiraterone Acetate|abiraterone acetate|mesh-list
153620863|NCT01995058|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153620902|NCT01995292|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153620903|NCT01995331|Cyclosporine|cyclosporine|mesh-list
153620905|NCT01995331|Cyclosporins|cyclosporins|mesh-list
153620906|NCT01995331|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153620907|NCT01995331|Immunologic Factors|immunologic factors|mesh-ancestor
153620908|NCT01995331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153620909|NCT01995331|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153620967|NCT01995890|Analgesics|analgesics|mesh-ancestor
153620968|NCT01995890|Sensory System Agents|sensory system agents|mesh-ancestor
153620969|NCT01995890|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153620970|NCT01995890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153620971|NCT01995890|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153620972|NCT01995890|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153620974|NCT01996085|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
153620975|NCT01996085|Telmisartan|telmisartan|mesh-list
153620977|NCT01996085|Nebivolol|nebivolol|mesh-list
153620978|NCT01996085|Indapamide|indapamide|mesh-list
153620979|NCT01996085|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153620980|NCT01996085|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153620981|NCT01996085|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153620986|NCT01996085|Diuretics|diuretics|mesh-ancestor
153621030|NCT01996306|Vitamin B Complex|vitamin b complex|mesh-ancestor
153621031|NCT01996306|Vitamins|vitamins|mesh-ancestor
153621032|NCT01996306|Micronutrients|micronutrients|mesh-ancestor
153621033|NCT01996358|Rocuronium|rocuronium|mesh-list
153621034|NCT01996358|Succinylcholine|succinylcholine|mesh-list
153621035|NCT01996358|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
153811068|NCT00353340|Acetylcysteine|acetylcysteine|mesh-list
153621036|NCT01996358|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
153357620|NCT00761930|Fluorides|fluorides|mesh-list
153621037|NCT01996358|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
153621038|NCT01996358|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153621039|NCT01996358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153621040|NCT01996358|Neuromuscular Depolarizing Agents|neuromuscular depolarizing agents|mesh-ancestor
153621042|NCT01996384|Anesthetics, Local|anesthetics, local|mesh-ancestor
153621043|NCT01996384|Anesthetics|anesthetics|mesh-ancestor
153621044|NCT01996384|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153621053|NCT01996423|Vitamin D|vitamin d|mesh-list
153621088|NCT01996475|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153621089|NCT01996475|Serotonin Agents|serotonin agents|mesh-ancestor
153621090|NCT01996475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153621091|NCT01996475|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
153621092|NCT01996475|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
153621093|NCT01996475|Parasympatholytics|parasympatholytics|mesh-ancestor
153621094|NCT01996475|Autonomic Agents|autonomic agents|mesh-ancestor
153621098|NCT01996475|Cholinergic Agents|cholinergic agents|mesh-ancestor
153621154|NCT01996735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153621155|NCT01996735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153621156|NCT01996761|Cerebrolysin|cerebrolysin|mesh-list
153621157|NCT01996761|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
153621158|NCT01996761|Protective Agents|protective agents|mesh-ancestor
153621159|NCT01996761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153621160|NCT01996761|Nootropic Agents|nootropic agents|mesh-ancestor
153621161|NCT01996891|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
153621162|NCT01996930|Silver Nitrate|silver nitrate|mesh-list
153811069|NCT00353340|N-monoacetylcystine|n-monoacetylcystine|mesh-list
153357621|NCT00761930|Sodium Fluoride|sodium fluoride|mesh-list
153621163|NCT01996930|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
153621164|NCT01996930|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153621165|NCT01997099|Diazepam|diazepam|mesh-list
153621166|NCT01997099|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153621217|NCT01997255|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153621218|NCT01997255|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153621219|NCT01997255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153621220|NCT01997255|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153621221|NCT01997255|Immunologic Factors|immunologic factors|mesh-ancestor
153621222|NCT01997255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153621223|NCT01997255|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153621224|NCT01997294|Atorvastatin|atorvastatin|mesh-list
153621283|NCT01997788|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153621284|NCT01997788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153621285|NCT01997788|Analgesics|analgesics|mesh-ancestor
153621286|NCT01997788|Sensory System Agents|sensory system agents|mesh-ancestor
153621287|NCT01997788|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153621288|NCT01997801|Ketamine|ketamine|mesh-list
153621289|NCT01997801|Analgesics|analgesics|mesh-ancestor
153621290|NCT01997801|Sensory System Agents|sensory system agents|mesh-ancestor
153621291|NCT01997801|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153621292|NCT01997801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153621348|NCT01998165|Analgesics|analgesics|mesh-ancestor
153621349|NCT01998165|Sensory System Agents|sensory system agents|mesh-ancestor
153621350|NCT01998165|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153621351|NCT01998217|Flurbiprofen|flurbiprofen|mesh-list
153621352|NCT01998217|Remifentanil|remifentanil|mesh-list
153621353|NCT01998217|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153621354|NCT01998217|Narcotics|narcotics|mesh-ancestor
153621355|NCT01998217|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153621356|NCT01998217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153621357|NCT01998217|Analgesics|analgesics|mesh-ancestor
153621414|NCT01998503|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153621415|NCT01998503|Immunologic Factors|immunologic factors|mesh-ancestor
153621416|NCT01998503|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153621417|NCT01998503|Alkylating Agents|alkylating agents|mesh-ancestor
153621418|NCT01998503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153621419|NCT01998503|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153621421|NCT01998685|Midazolam|midazolam|mesh-list
153621485|NCT01998789|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153621486|NCT01998789|Immunologic Factors|immunologic factors|mesh-ancestor
153621487|NCT01998789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153621488|NCT01998789|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
153621489|NCT01998789|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153811073|NCT00353340|Respiratory System Agents|respiratory system agents|mesh-ancestor
153811074|NCT00353340|Free Radical Scavengers|free radical scavengers|mesh-ancestor
153811075|NCT00353340|Antioxidants|antioxidants|mesh-ancestor
153357626|NCT00761930|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153811076|NCT00353340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153357627|NCT00761930|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
153357628|NCT00761930|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153621491|NCT01998789|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
153621492|NCT01998789|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153621494|NCT01999153|Ropivacaine|ropivacaine|mesh-list
153621551|NCT01999673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153621552|NCT01999673|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153621553|NCT01999673|Immunologic Factors|immunologic factors|mesh-ancestor
153621554|NCT01999673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153621555|NCT01999686|Metformin|metformin|mesh-list
153621556|NCT01999686|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153621557|NCT01999686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153621558|NCT01999738|Folic Acid|folic acid|mesh-list
153621559|NCT01999738|Hematinics|hematinics|mesh-ancestor
153621560|NCT01999738|Vitamin B Complex|vitamin b complex|mesh-ancestor
153621561|NCT01999738|Vitamins|vitamins|mesh-ancestor
153621562|NCT01999738|Micronutrients|micronutrients|mesh-ancestor
153621563|NCT01999738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153621564|NCT01999829|Caffeine|caffeine|mesh-list
153621565|NCT01999829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153621566|NCT01999829|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
153621567|NCT01999829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153621568|NCT01999829|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
153621569|NCT01999829|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153621571|NCT01999829|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
153621605|NCT02000193|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153621606|NCT02000193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153621608|NCT02000206|Alfentanil|alfentanil|mesh-list
153621609|NCT02000206|Propofol|propofol|mesh-list
153621610|NCT02000206|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153621611|NCT02000206|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153811077|NCT00353340|Protective Agents|protective agents|mesh-ancestor
153811078|NCT00353340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153621612|NCT02000206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153621613|NCT02000206|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153621614|NCT02000206|Anesthetics, General|anesthetics, general|mesh-ancestor
153621615|NCT02000206|Anesthetics|anesthetics|mesh-ancestor
153621668|NCT02000674|Succinylcholine|succinylcholine|mesh-list
153621669|NCT02000674|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
153621670|NCT02000674|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
153621671|NCT02000674|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
153621672|NCT02000674|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153621673|NCT02000674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153621674|NCT02000674|Neuromuscular Depolarizing Agents|neuromuscular depolarizing agents|mesh-ancestor
153621675|NCT02000700|Canagliflozin|canagliflozin|mesh-list
153621676|NCT02000700|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
153621731|NCT02001168|Docetaxel|docetaxel|mesh-list
153621732|NCT02001168|Pemetrexed|pemetrexed|mesh-list
153621733|NCT02001168|Cisplatin|cisplatin|mesh-list
153621734|NCT02001168|Endostatins|endostatins|mesh-list
153621735|NCT02001168|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153621736|NCT02001168|Tubulin Modulators|tubulin modulators|mesh-ancestor
153621737|NCT02001168|Antimitotic Agents|antimitotic agents|mesh-ancestor
153621738|NCT02001168|Mitosis Modulators|mitosis modulators|mesh-ancestor
153621739|NCT02001168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153621740|NCT02001168|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153621745|NCT02001168|Growth Substances|growth substances|mesh-ancestor
153621797|NCT02001311|Dermatologic Agents|dermatologic agents|mesh-ancestor
153621798|NCT02001363|Liraglutide|liraglutide|mesh-list
153621799|NCT02001363|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
153621800|NCT02001363|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153621801|NCT02001363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153621802|NCT02001363|Incretins|incretins|mesh-ancestor
153621803|NCT02001363|Hormones|hormones|mesh-ancestor
153621867|NCT02001883|Antimetabolites|antimetabolites|mesh-ancestor
153621868|NCT02001883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153621869|NCT02001883|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153621870|NCT02001883|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
153621871|NCT02001883|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153621872|NCT02001883|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153621874|NCT02001896|Gemcitabine|gemcitabine|mesh-list
153621875|NCT02001896|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
153621876|NCT02001896|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153621877|NCT02001896|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153621878|NCT02001896|Antimetabolites|antimetabolites|mesh-ancestor
153621879|NCT02001896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153621880|NCT02001896|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153621881|NCT02001896|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153621882|NCT02001896|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153621883|NCT02001909|Neomycin|neomycin|mesh-list
153621884|NCT02001909|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153621885|NCT02001909|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153621920|NCT02001974|Mitosis Modulators|mitosis modulators|mesh-ancestor
153621921|NCT02001974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153621922|NCT02002000|Vitamin D|vitamin d|mesh-list
153621923|NCT02002000|Cholecalciferol|cholecalciferol|mesh-list
153621924|NCT02002000|Vitamins|vitamins|mesh-ancestor
153621925|NCT02002000|Micronutrients|micronutrients|mesh-ancestor
153621926|NCT02002000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153621927|NCT02002000|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153621928|NCT02002000|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153621929|NCT02001103|Memantine|memantine|mesh-list
153621930|NCT02001103|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
153621986|NCT02002247|Selenious Acid|selenious acid|mesh-list
153621987|NCT02002247|Sodium Selenite|sodium selenite|mesh-list
153811079|NCT00353340|Antidotes|antidotes|mesh-ancestor
153811080|NCT00323843|Isoproterenol|isoproterenol|mesh-list
153357631|NCT00761930|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153621988|NCT02002247|Antioxidants|antioxidants|mesh-ancestor
153621989|NCT02002247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153621990|NCT02002247|Protective Agents|protective agents|mesh-ancestor
153621991|NCT02002247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153621992|NCT02002247|Trace Elements|trace elements|mesh-ancestor
153621993|NCT02002247|Micronutrients|micronutrients|mesh-ancestor
153621994|NCT02002260|Levonorgestrel|levonorgestrel|mesh-list
153621995|NCT02002260|Ethinyl Estradiol|ethinyl estradiol|mesh-list
153621997|NCT02002260|Contraceptives, Oral|contraceptives, oral|mesh-list
153621998|NCT02002260|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-list
153622000|NCT02002260|Estrogens|estrogens|mesh-ancestor
153622001|NCT02002260|Hormones|hormones|mesh-ancestor
153622003|NCT02002260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153622042|NCT02002390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153622044|NCT02002403|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
153622045|NCT02002403|Hormone Antagonists|hormone antagonists|mesh-ancestor
153622046|NCT02002403|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153622047|NCT02002403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153622048|NCT02002442|Chlorhexidine|chlorhexidine|mesh-list
153622049|NCT02002442|Cetylpyridinium|cetylpyridinium|mesh-list
153622050|NCT02002442|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
153622051|NCT02002442|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153622052|NCT02002442|Disinfectants|disinfectants|mesh-ancestor
153622053|NCT02002598|Dexamethasone|dexamethasone|mesh-list
153622054|NCT02002598|Dexamethasone acetate|dexamethasone acetate|mesh-list
153622056|NCT02002598|BB 1101|bb 1101|mesh-list
153622107|NCT02002715|Autonomic Agents|autonomic agents|mesh-ancestor
153622108|NCT02002715|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153622109|NCT02002715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153622110|NCT02002715|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153622111|NCT02002715|Respiratory System Agents|respiratory system agents|mesh-ancestor
153622112|NCT02002715|Glucocorticoids|glucocorticoids|mesh-ancestor
153622113|NCT02002715|Hormones|hormones|mesh-ancestor
153622114|NCT02002715|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153622172|NCT02001818|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
153622173|NCT02001818|Imatinib Mesylate|imatinib mesylate|mesh-list
153622174|NCT02001818|Nilotinib|nilotinib|mesh-list
153622175|NCT02001818|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153622176|NCT02001818|Antiviral Agents|antiviral agents|mesh-ancestor
153811086|NCT00323843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153811087|NCT00323843|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153622178|NCT02001818|Immunologic Factors|immunologic factors|mesh-ancestor
153622182|NCT02001818|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153622243|NCT02004171|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153622244|NCT02004171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153622245|NCT02004171|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
153622246|NCT02004171|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
153622247|NCT02004171|Cholinergic Agents|cholinergic agents|mesh-ancestor
153622248|NCT02004171|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153622249|NCT02004171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153622250|NCT02004184|Pemetrexed|pemetrexed|mesh-list
153622251|NCT02004184|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153622308|NCT02004574|Hormones|hormones|mesh-ancestor
153622309|NCT02004574|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153622310|NCT02004574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153622311|NCT02004574|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153622312|NCT02004574|Respiratory System Agents|respiratory system agents|mesh-ancestor
153622313|NCT02004574|Dermatologic Agents|dermatologic agents|mesh-ancestor
153622314|NCT02004652|Prucalopride|prucalopride|mesh-list
153622315|NCT02004652|Laxatives|laxatives|mesh-ancestor
153622316|NCT02004652|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153622317|NCT02004652|Serotonin 5-HT4 Receptor Agonists|serotonin 5-ht4 receptor agonists|mesh-ancestor
153622318|NCT02004652|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
153622319|NCT02004652|Serotonin Agents|serotonin agents|mesh-ancestor
153622320|NCT02004652|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153622321|NCT02004652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153622322|NCT02004652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153622323|NCT02004769|Docetaxel|docetaxel|mesh-list
153622324|NCT02004769|Capecitabine|capecitabine|mesh-list
153622367|NCT02005107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153622368|NCT02005107|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
153622369|NCT02005107|Antidepressive Agents|antidepressive agents|mesh-ancestor
153622370|NCT02005107|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153622371|NCT02005120|Bevacizumab|bevacizumab|mesh-list
153622372|NCT02005120|Endostatins|endostatins|mesh-list
153622373|NCT02005120|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153622374|NCT02005120|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153622375|NCT02005120|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153622376|NCT02005120|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153622429|NCT02005575|Anesthetics, Local|anesthetics, local|mesh-ancestor
153622430|NCT02005575|Anesthetics|anesthetics|mesh-ancestor
153622431|NCT02005575|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153622433|NCT02005588|Iron|iron|mesh-list
153622434|NCT02005588|Ferrous fumarate|ferrous fumarate|mesh-list
153622435|NCT02005588|Iron Chelating Agents|iron chelating agents|mesh-list
153622436|NCT02005588|Trace Elements|trace elements|mesh-ancestor
153622437|NCT02005588|Micronutrients|micronutrients|mesh-ancestor
153622438|NCT02005588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153622439|NCT02005588|Chelating Agents|chelating agents|mesh-ancestor
153622440|NCT02005588|Sequestering Agents|sequestering agents|mesh-ancestor
153622441|NCT02005588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153622442|NCT02005653|Doxycycline|doxycycline|mesh-list
153622443|NCT02005653|Albendazole|albendazole|mesh-list
153622444|NCT02005653|Diethylcarbamazine|diethylcarbamazine|mesh-list
153622445|NCT02005653|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153622446|NCT02005653|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153622447|NCT02005653|Antimalarials|antimalarials|mesh-ancestor
153622448|NCT02005653|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153622449|NCT02005653|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153622450|NCT02005653|Anthelmintics|anthelmintics|mesh-ancestor
153622451|NCT02005653|Anticestodal Agents|anticestodal agents|mesh-ancestor
153622452|NCT02005653|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
153622453|NCT02005653|Tubulin Modulators|tubulin modulators|mesh-ancestor
153622454|NCT02005653|Antimitotic Agents|antimitotic agents|mesh-ancestor
153622455|NCT02005653|Mitosis Modulators|mitosis modulators|mesh-ancestor
153622456|NCT02005653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153622457|NCT02005653|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153811089|NCT00323843|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153622458|NCT02005653|Filaricides|filaricides|mesh-ancestor
153811090|NCT00323843|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153811091|NCT00323843|Respiratory System Agents|respiratory system agents|mesh-ancestor
153622461|NCT02005653|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153622462|NCT02005718|Cholecalciferol|cholecalciferol|mesh-list
153622463|NCT02005718|Vitamin D|vitamin d|mesh-list
153622464|NCT02005718|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153622465|NCT02005718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153622470|NCT02005757|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153622471|NCT02005757|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153622473|NCT02005757|Sensory System Agents|sensory system agents|mesh-ancestor
153622474|NCT02005757|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153622475|NCT02005757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153622476|NCT02005757|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153622477|NCT02005757|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153622478|NCT02005757|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153622479|NCT02005757|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153622480|NCT02005757|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153622481|NCT02005757|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153622482|NCT02005757|Antimalarials|antimalarials|mesh-ancestor
153622483|NCT02005757|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153622484|NCT02005757|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153622485|NCT02005757|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153622487|NCT02005757|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153622525|NCT02005848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153622526|NCT02005848|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
153622527|NCT02005848|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
153622528|NCT02006043|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
153622529|NCT02006043|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153622530|NCT02006043|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153622531|NCT02006043|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153622532|NCT02006043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153622533|NCT02006043|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153622534|NCT02006173|Lidocaine|lidocaine|mesh-list
153811092|NCT00323843|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
153622535|NCT02006173|Anesthetics, Local|anesthetics, local|mesh-ancestor
153622536|NCT02006173|Anesthetics|anesthetics|mesh-ancestor
153622537|NCT02006173|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153622538|NCT02006173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153622539|NCT02006173|Sensory System Agents|sensory system agents|mesh-ancestor
153622540|NCT02006173|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153622541|NCT02006173|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153622542|NCT02006173|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
153622579|NCT05970900|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153622580|NCT05970900|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153622581|NCT05970900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153622582|NCT05970900|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153622583|NCT05970822|Azacitidine|azacitidine|mesh-list
153622584|NCT05970822|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153622585|NCT05970822|Antimetabolites|antimetabolites|mesh-ancestor
153622586|NCT05970822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153622587|NCT05970822|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153622588|NCT05970822|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153811094|NCT00323843|Protective Agents|protective agents|mesh-ancestor
153622589|NCT05970705|Trifluridine|trifluridine|mesh-list
153811095|NCT00331851|Metformin|metformin|mesh-list
153811096|NCT00331851|Insulin Glargine|insulin glargine|mesh-list
153357643|NCT01275014|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153357644|NCT01275014|Glucocorticoids|glucocorticoids|mesh-ancestor
153622591|NCT05970705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153622592|NCT05970705|Antiviral Agents|antiviral agents|mesh-ancestor
153622593|NCT05970705|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153622594|NCT05970679|Atorvastatin|atorvastatin|mesh-list
153622595|NCT05970679|Ezetimibe|ezetimibe|mesh-list
153622596|NCT05970679|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153622597|NCT05970679|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153622598|NCT05970679|Antimetabolites|antimetabolites|mesh-ancestor
153622599|NCT05970679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153622600|NCT05970679|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153622602|NCT05970679|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153622631|NCT05969990|Antidepressive Agents|antidepressive agents|mesh-ancestor
153622632|NCT05969990|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153622633|NCT05969899|Bevacizumab|bevacizumab|mesh-list
153622634|NCT05969899|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153622635|NCT05969899|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153622636|NCT05969899|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153622637|NCT05969899|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153622638|NCT05969899|Growth Substances|growth substances|mesh-ancestor
153622639|NCT05969899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153622640|NCT05969899|Growth Inhibitors|growth inhibitors|mesh-ancestor
153622641|NCT05969847|Capecitabine|capecitabine|mesh-list
153622642|NCT05969847|Oxaliplatin|oxaliplatin|mesh-list
153622643|NCT05969847|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153622644|NCT05969847|Antimetabolites|antimetabolites|mesh-ancestor
153622645|NCT05969847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153622688|NCT05969392|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
153622689|NCT05969392|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153622690|NCT05969392|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153622691|NCT05969392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153357649|NCT01275248|Ondansetron|ondansetron|mesh-list
153357650|NCT01275248|Antiemetics|antiemetics|mesh-ancestor
153357651|NCT01275248|Autonomic Agents|autonomic agents|mesh-ancestor
153357652|NCT01275248|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153357653|NCT01275248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153622692|NCT05969184|Trastuzumab|trastuzumab|mesh-list
153622693|NCT05969184|Pertuzumab|pertuzumab|mesh-list
153622694|NCT05969184|Letrozole|letrozole|mesh-list
153622695|NCT05969184|Exemestane|exemestane|mesh-list
153622696|NCT05969184|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153622697|NCT05969184|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153622698|NCT05969184|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
153622699|NCT05969184|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153622700|NCT05969184|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153622701|NCT05969184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153622702|NCT05969184|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
153622703|NCT05969184|Hormone Antagonists|hormone antagonists|mesh-ancestor
153622704|NCT05969184|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153622705|NCT05969184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153622744|NCT05968846|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
153622745|NCT05968846|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153622746|NCT05968846|Trace Elements|trace elements|mesh-ancestor
153622747|NCT05968846|Micronutrients|micronutrients|mesh-ancestor
153622748|NCT05968846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153622749|NCT05968651|Oxytocin|oxytocin|mesh-list
153622750|NCT05968651|Oxytocics|oxytocics|mesh-ancestor
153811102|NCT00331851|Incretins|incretins|mesh-ancestor
153622751|NCT05968651|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153622752|NCT05968651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153622753|NCT05968001|Obinutuzumab|obinutuzumab|mesh-list
153622754|NCT05968001|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153622755|NCT05968001|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153622756|NCT05967936|Bupivacaine|bupivacaine|mesh-list
153622757|NCT05967936|Anesthetics, Local|anesthetics, local|mesh-ancestor
153622758|NCT05967936|Anesthetics|anesthetics|mesh-ancestor
153622760|NCT05967936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153622806|NCT05967377|Protective Agents|protective agents|mesh-ancestor
153622807|NCT05967377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153622808|NCT05967377|Vitamin B Complex|vitamin b complex|mesh-ancestor
153622810|NCT05967377|Micronutrients|micronutrients|mesh-ancestor
153622811|NCT05967377|Antimetabolites|antimetabolites|mesh-ancestor
153622812|NCT05967377|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153622813|NCT05967377|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153622814|NCT05967377|Immunologic Factors|immunologic factors|mesh-ancestor
153622815|NCT05967377|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
153622816|NCT05967377|Abortifacient Agents|abortifacient agents|mesh-ancestor
153622817|NCT05967377|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153622818|NCT05967377|Dermatologic Agents|dermatologic agents|mesh-ancestor
153622819|NCT05967377|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153622820|NCT05967377|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153622821|NCT05967377|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153622822|NCT05967156|Empagliflozin|empagliflozin|mesh-list
153622823|NCT05967156|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
153622824|NCT05967156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153622825|NCT05967156|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153811110|NCT00331890|Lipotropic Agents|lipotropic agents|mesh-ancestor
153622826|NCT05967156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153622827|NCT05966818|Dapagliflozin|dapagliflozin|mesh-list
153357654|NCT01275248|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153357655|NCT01275248|Antipruritics|antipruritics|mesh-ancestor
153357656|NCT01275248|Dermatologic Agents|dermatologic agents|mesh-ancestor
153357657|NCT01275248|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
153357658|NCT01275248|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153622828|NCT05966818|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
153622856|NCT05951387|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153622857|NCT05951387|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
153622858|NCT05951387|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153622859|NCT05951387|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153622860|NCT05951387|Adrenergic Agents|adrenergic agents|mesh-ancestor
153622861|NCT05951387|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153622925|NCT05783544|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153622926|NCT05783544|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153622927|NCT05783544|Immunologic Factors|immunologic factors|mesh-ancestor
153622928|NCT05783544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153622929|NCT05783544|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153622930|NCT05760677|Metformin|metformin|mesh-list
153622931|NCT05760677|Pioglitazone|pioglitazone|mesh-list
153622932|NCT05760677|Orlistat|orlistat|mesh-list
153622933|NCT05760677|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153622935|NCT05760677|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153622987|NCT05687253|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
153622989|NCT05687253|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153622990|NCT05687253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153622991|NCT05683821|Nicotine|nicotine|mesh-list
153622992|NCT05683821|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
153622993|NCT05683821|Autonomic Agents|autonomic agents|mesh-ancestor
153622994|NCT05683821|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153622995|NCT05683821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153622996|NCT05683821|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
153622997|NCT05683821|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
153622998|NCT05683821|Cholinergic Agents|cholinergic agents|mesh-ancestor
153622999|NCT05683821|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153623000|NCT05683821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153623001|NCT05680805|Metformin|metformin|mesh-list
153623002|NCT05680805|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153623003|NCT05680805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153623004|NCT05637970|Hemostatics|hemostatics|mesh-list
153623005|NCT05637970|Coagulants|coagulants|mesh-ancestor
153623006|NCT05561543|Peppermint oil|peppermint oil|mesh-list
153623007|NCT05561543|Antiemetics|antiemetics|mesh-ancestor
153623008|NCT05561543|Autonomic Agents|autonomic agents|mesh-ancestor
153623009|NCT05561543|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153623010|NCT05561543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153623011|NCT05561543|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153623012|NCT05561543|Parasympatholytics|parasympatholytics|mesh-ancestor
153623013|NCT05555823|Repaglinide|repaglinide|mesh-list
153623014|NCT05555823|Celecoxib|celecoxib|mesh-list
153623015|NCT05555823|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153623016|NCT05555823|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153623017|NCT05555823|Analgesics|analgesics|mesh-ancestor
153623018|NCT05555823|Sensory System Agents|sensory system agents|mesh-ancestor
153623019|NCT05555823|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153623020|NCT05555823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153623021|NCT05555823|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153623022|NCT05555823|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153623026|NCT05555823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153623027|NCT05555823|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153623028|NCT05501886|Fulvestrant|fulvestrant|mesh-list
153623029|NCT05501886|Palbociclib|palbociclib|mesh-list
153623030|NCT05501886|Gedatolisib|gedatolisib|mesh-list
153623031|NCT05501886|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153623033|NCT05501886|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
153623034|NCT05501886|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
153623035|NCT05501886|Hormone Antagonists|hormone antagonists|mesh-ancestor
153623036|NCT05501886|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153623037|NCT05501886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153623038|NCT05501886|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153623039|NCT05501886|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153668021|NCT00030576|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153623040|NCT05501886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153623041|NCT05493371|Empagliflozin|empagliflozin|mesh-list
153623042|NCT05493371|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
153623043|NCT05493371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153623044|NCT05493371|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153623045|NCT05493371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153623046|NCT05488366|Pembrolizumab|pembrolizumab|mesh-list
153623047|NCT05488366|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153623048|NCT05488366|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153623049|NCT05488366|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153558762|NCT01628055|gamma-Globulins|gamma-globulins|mesh-list
153623050|NCT05488366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153623051|NCT05474560|Allopurinol|allopurinol|mesh-list
153623053|NCT05474560|Antimetabolites|antimetabolites|mesh-ancestor
153623054|NCT05474560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153623055|NCT05474560|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153623059|NCT05474560|Antioxidants|antioxidants|mesh-ancestor
153623067|NCT05469893|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153623068|NCT05469893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153623069|NCT05469893|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153623070|NCT05469893|Glucocorticoids|glucocorticoids|mesh-ancestor
153623071|NCT05469893|Hormones|hormones|mesh-ancestor
153623072|NCT05469893|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153623073|NCT05469893|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153623074|NCT05469893|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153623075|NCT05469893|Immunologic Factors|immunologic factors|mesh-ancestor
153623076|NCT05469893|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153623077|NCT05469893|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153623078|NCT05469893|Growth Substances|growth substances|mesh-ancestor
153623079|NCT05469893|Growth Inhibitors|growth inhibitors|mesh-ancestor
153623080|NCT05468957|Hemostatics|hemostatics|mesh-list
153623081|NCT05468957|Coagulants|coagulants|mesh-ancestor
153623127|NCT05413343|Beta Lactam Antibiotics|beta lactam antibiotics|mesh-ancestor
153623128|NCT05413343|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153623129|NCT05413343|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153623130|NCT05413343|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
153623131|NCT05413343|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153811115|NCT00331890|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153668022|NCT00030576|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153623132|NCT05413343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153623133|NCT05375929|Abrocitinib|abrocitinib|mesh-list
153623134|NCT05375929|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153623135|NCT05375929|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153623136|NCT05375929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153623137|NCT05319899|Tetrathiomolybdate|tetrathiomolybdate|mesh-list
153623138|NCT05319899|Choline|choline|mesh-list
153623139|NCT05319899|Omeprazole|omeprazole|mesh-list
153623140|NCT05319899|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
153623141|NCT05319899|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153623142|NCT05319899|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
153623143|NCT05319899|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153623144|NCT05319899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153623147|NCT05319899|Antimetabolites|antimetabolites|mesh-ancestor
153623182|NCT05291221|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153623183|NCT05291221|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153623184|NCT05291221|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
153623185|NCT05291221|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153623186|NCT05291221|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153623187|NCT05291221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153623188|NCT05291221|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153623189|NCT05291221|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153623190|NCT05291221|Analgesics|analgesics|mesh-ancestor
153623246|NCT05077683|Anticoagulants|anticoagulants|mesh-ancestor
153623247|NCT05076942|Cisplatin|cisplatin|mesh-list
153623248|NCT05076942|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153623249|NCT05022147|Dopamine|dopamine|mesh-list
153623250|NCT05022147|Dopamine Agonists|dopamine agonists|mesh-list
153623251|NCT05022147|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
153623252|NCT05022147|Sympathomimetics|sympathomimetics|mesh-ancestor
153623253|NCT05022147|Autonomic Agents|autonomic agents|mesh-ancestor
153623254|NCT05022147|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153623255|NCT05022147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153623256|NCT05022147|Dopamine Agents|dopamine agents|mesh-ancestor
153623266|NCT05005299|Venetoclax|venetoclax|mesh-list
153623312|NCT04914195|Leuprolide|leuprolide|mesh-list
153623313|NCT04914195|Fertility Agents, Female|fertility agents, female|mesh-ancestor
153623314|NCT04914195|Fertility Agents|fertility agents|mesh-ancestor
153623315|NCT04914195|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153623316|NCT04914195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153623317|NCT04914195|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153623318|NCT04914195|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153623319|NCT04901299|Fulvestrant|fulvestrant|mesh-list
153623320|NCT04901299|Neratinib|neratinib|mesh-list
153623321|NCT04901299|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153623322|NCT04901299|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153623323|NCT04901299|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
153623324|NCT04901299|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
153623325|NCT04901299|Hormone Antagonists|hormone antagonists|mesh-ancestor
153623326|NCT04901299|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153623327|NCT04901299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153623330|NCT04901299|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153623367|NCT04840342|Eplerenone|eplerenone|mesh-list
153623368|NCT04840342|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153623369|NCT04840342|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153623370|NCT04840342|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153623371|NCT04840342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153623372|NCT04840342|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153623373|NCT04840342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153623375|NCT04840342|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
153623376|NCT04840342|Hormone Antagonists|hormone antagonists|mesh-ancestor
153623427|NCT04742491|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153623428|NCT04742491|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153623429|NCT04741945|Metformin|metformin|mesh-list
153623430|NCT04741945|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153623431|NCT04741945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153623432|NCT04736433|Valsartan|valsartan|mesh-list
153623433|NCT04736433|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
153623434|NCT04736433|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
153623435|NCT04736433|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153623436|NCT04736433|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
153623437|NCT04736433|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
153623491|NCT04667572|Micronutrients|micronutrients|mesh-ancestor
153623492|NCT04667572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153623493|NCT04667572|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
153623494|NCT04667572|Dermatologic Agents|dermatologic agents|mesh-ancestor
153623495|NCT04651166|Tranexamic Acid|tranexamic acid|mesh-list
153623496|NCT04651166|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
153623497|NCT04651166|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153623498|NCT04651166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153623499|NCT04651166|Hemostatics|hemostatics|mesh-ancestor
153623500|NCT04651166|Coagulants|coagulants|mesh-ancestor
153623501|NCT04642547|Lenvatinib|lenvatinib|mesh-list
153623502|NCT04642547|Gefitinib|gefitinib|mesh-list
153623503|NCT04642547|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153623504|NCT04642547|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153623505|NCT04642547|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153623506|NCT04642547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153623507|NCT04642547|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153623508|NCT04539314|Dexmedetomidine|dexmedetomidine|mesh-list
153623509|NCT04539314|Bupivacaine|bupivacaine|mesh-list
153623547|NCT04508894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153623549|NCT04508894|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153623550|NCT04508894|Anesthetics, General|anesthetics, general|mesh-ancestor
153623551|NCT04508894|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
153623552|NCT04508894|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
153623553|NCT04506125|Chrysarobin|chrysarobin|mesh-list
153623614|NCT04396990|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153623615|NCT04396990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153623616|NCT04396990|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153623618|NCT04364555|Clobetasol|clobetasol|mesh-list
153623619|NCT04364555|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153623620|NCT04364555|Glucocorticoids|glucocorticoids|mesh-ancestor
153623621|NCT04364555|Hormones|hormones|mesh-ancestor
153623622|NCT04364555|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153623623|NCT04364555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153623624|NCT04324606|Acetaminophen|acetaminophen|mesh-list
153623676|NCT04250948|Antimetabolites|antimetabolites|mesh-ancestor
153623677|NCT04250948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153623678|NCT04250948|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153623679|NCT04243122|Aspirin|aspirin|mesh-list
153623680|NCT04243122|Apixaban|apixaban|mesh-list
153623681|NCT04243122|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153623682|NCT04243122|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153623683|NCT04243122|Analgesics|analgesics|mesh-ancestor
153623684|NCT04243122|Sensory System Agents|sensory system agents|mesh-ancestor
153623685|NCT04243122|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153623686|NCT04243122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153623687|NCT04243122|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153623688|NCT04243122|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153623689|NCT04243122|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153623690|NCT04243122|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153623691|NCT04243122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153623692|NCT04243122|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153623693|NCT04243122|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153623732|NCT04122196|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153623733|NCT04122196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153623734|NCT04122196|Anticonvulsants|anticonvulsants|mesh-ancestor
153623735|NCT04122196|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153357661|NCT01275248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153357662|NCT00756236|Metoprolol|metoprolol|mesh-list
153623736|NCT04122196|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153623737|NCT04122196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153623738|NCT04122196|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153623739|NCT04122196|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153623740|NCT04122196|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153623797|NCT04040946|Lipotropic Agents|lipotropic agents|mesh-ancestor
153623798|NCT04040946|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153623799|NCT04040946|Antimetabolites|antimetabolites|mesh-ancestor
153623800|NCT04040946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153623801|NCT04040946|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153623802|NCT04040946|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153623803|NCT04040946|Nootropic Agents|nootropic agents|mesh-ancestor
153623804|NCT04038099|Lidocaine|lidocaine|mesh-list
153623805|NCT04038099|Anesthetics, Local|anesthetics, local|mesh-ancestor
153623806|NCT04038099|Anesthetics|anesthetics|mesh-ancestor
153623807|NCT04038099|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153623808|NCT04038099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153623809|NCT04038099|Sensory System Agents|sensory system agents|mesh-ancestor
153623817|NCT04034238|LMB-100|lmb-100|mesh-list
153623858|NCT03978442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153623859|NCT03978442|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
153623860|NCT03978442|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153623861|NCT03978442|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153558891|NCT01629225|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153623862|NCT03956966|Dexamethasone|dexamethasone|mesh-list
153623863|NCT03956966|Bupivacaine|bupivacaine|mesh-list
153623864|NCT03956966|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153623865|NCT03956966|Antiemetics|antiemetics|mesh-ancestor
153623866|NCT03956966|Autonomic Agents|autonomic agents|mesh-ancestor
153623867|NCT03956966|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153357665|NCT00756236|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153357666|NCT00756236|Sympatholytics|sympatholytics|mesh-ancestor
153623868|NCT03956966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153623869|NCT03956966|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153623870|NCT03956966|Glucocorticoids|glucocorticoids|mesh-ancestor
153623871|NCT03956966|Hormones|hormones|mesh-ancestor
153623872|NCT03956966|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153623873|NCT03956966|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153623874|NCT03956966|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153623875|NCT03956966|Anesthetics, Local|anesthetics, local|mesh-ancestor
153623876|NCT03956966|Anesthetics|anesthetics|mesh-ancestor
153623877|NCT03956966|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153623878|NCT03956966|Sensory System Agents|sensory system agents|mesh-ancestor
153623879|NCT03956056|Poly I-C|poly i-c|mesh-list
153623880|NCT03956056|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
153623882|NCT03956056|Interferon Inducers|interferon inducers|mesh-ancestor
153623883|NCT03956056|Immunologic Factors|immunologic factors|mesh-ancestor
153623884|NCT03956056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153623905|NCT03948867|Hydroxyurea|hydroxyurea|mesh-list
153623906|NCT03948867|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153623907|NCT03948867|Antisickling Agents|antisickling agents|mesh-ancestor
153623908|NCT03948867|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153623909|NCT03948867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153623910|NCT03948867|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153623911|NCT03936829|Cyclophosphamide|cyclophosphamide|mesh-list
153623912|NCT03936829|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153623913|NCT03936829|Immunologic Factors|immunologic factors|mesh-ancestor
153623914|NCT03936829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153811124|NCT01059773|Antimetabolites|antimetabolites|mesh-ancestor
153357667|NCT00756236|Autonomic Agents|autonomic agents|mesh-ancestor
153623915|NCT03936829|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153357668|NCT00756236|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153623916|NCT03936829|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153623917|NCT03936829|Alkylating Agents|alkylating agents|mesh-ancestor
153623918|NCT03936829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153623919|NCT03936829|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153623965|NCT03859024|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153623966|NCT03859024|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153623967|NCT03859024|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153623968|NCT03859024|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
153623969|NCT03859024|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
153623970|NCT03859024|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153623971|NCT03859024|Antimanic Agents|antimanic agents|mesh-ancestor
153623972|NCT03830866|Carboplatin|carboplatin|mesh-list
153623974|NCT03830866|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153623975|NCT03830866|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153623976|NCT03794388|Pregabalin|pregabalin|mesh-list
153623977|NCT03794388|Capsaicin|capsaicin|mesh-list
153623978|NCT03794388|Analgesics|analgesics|mesh-ancestor
153623979|NCT03794388|Sensory System Agents|sensory system agents|mesh-ancestor
153623980|NCT03794388|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153623981|NCT03794388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153623983|NCT03794388|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153623984|NCT03794388|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153624019|NCT03573024|Venetoclax|venetoclax|mesh-list
153624020|NCT03573024|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153624021|NCT03573024|Antimetabolites|antimetabolites|mesh-ancestor
153558917|NCT01629394|Neostigmine|neostigmine|mesh-list
153811125|NCT01059773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153624091|NCT03149770|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153624093|NCT03095235|Vitamins|vitamins|mesh-ancestor
153624094|NCT03095235|Micronutrients|micronutrients|mesh-ancestor
153624095|NCT03095235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153624096|NCT03095235|Vitamin B Complex|vitamin b complex|mesh-ancestor
153624097|NCT03095235|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
153624098|NCT03095235|Dermatologic Agents|dermatologic agents|mesh-ancestor
153624099|NCT03012971|Dexmedetomidine|dexmedetomidine|mesh-list
153624100|NCT03012971|Morphine|morphine|mesh-list
153624116|NCT02960659|Metformin|metformin|mesh-list
153624159|NCT02913196|Antimitotic Agents|antimitotic agents|mesh-ancestor
153624160|NCT02913196|Mitosis Modulators|mitosis modulators|mesh-ancestor
153624161|NCT02913196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153624162|NCT02913196|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153624163|NCT02913196|Glucocorticoids|glucocorticoids|mesh-ancestor
153624164|NCT02913196|Hormones|hormones|mesh-ancestor
153624165|NCT02913196|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153624226|NCT02582775|Mycophenolic Acid|mycophenolic acid|mesh-list
153624227|NCT02582775|Cyclophosphamide|cyclophosphamide|mesh-list
153624228|NCT02582775|Busulfan|busulfan|mesh-list
153624229|NCT02582775|Fludarabine|fludarabine|mesh-list
153624230|NCT02582775|Fludarabine phosphate|fludarabine phosphate|mesh-list
153624231|NCT02582775|Tacrolimus|tacrolimus|mesh-list
153624232|NCT02582775|Thymoglobulin|thymoglobulin|mesh-list
153624233|NCT02582775|Antilymphocyte Serum|antilymphocyte serum|mesh-list
153624234|NCT02582775|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153624235|NCT02582775|Immunologic Factors|immunologic factors|mesh-ancestor
153624236|NCT02582775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153624237|NCT02582775|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153624238|NCT02582775|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153624239|NCT02582775|Alkylating Agents|alkylating agents|mesh-ancestor
153624240|NCT02582775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153624241|NCT02582775|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153811128|NCT01059773|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153624242|NCT02582775|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153624243|NCT02582775|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153811129|NCT01059773|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153811130|NCT01059773|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153624286|NCT02253316|Dexamethasone|dexamethasone|mesh-list
153624287|NCT02253316|Dexamethasone acetate|dexamethasone acetate|mesh-list
153624288|NCT02253316|Lenalidomide|lenalidomide|mesh-list
153624290|NCT02253316|BB 1101|bb 1101|mesh-list
153624291|NCT02253316|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153624292|NCT02253316|Antiemetics|antiemetics|mesh-ancestor
153624293|NCT02253316|Autonomic Agents|autonomic agents|mesh-ancestor
153624294|NCT02253316|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153624295|NCT02253316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153624296|NCT02253316|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153624297|NCT02253316|Glucocorticoids|glucocorticoids|mesh-ancestor
153624298|NCT02253316|Hormones|hormones|mesh-ancestor
153624299|NCT02253316|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153624300|NCT02253316|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153624310|NCT02169089|Spironolactone|spironolactone|mesh-list
153624344|NCT00601198|Protective Agents|protective agents|mesh-ancestor
153558921|NCT01629394|Cholinergic Agents|cholinergic agents|mesh-ancestor
153624345|NCT00601198|Vitamin B Complex|vitamin b complex|mesh-ancestor
153624346|NCT00601198|Vitamins|vitamins|mesh-ancestor
153624347|NCT00601198|Micronutrients|micronutrients|mesh-ancestor
153624348|NCT00601198|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
153624349|NCT02006498|Silymarin|silymarin|mesh-list
153624350|NCT02006498|Antioxidants|antioxidants|mesh-ancestor
153624352|NCT02006498|Protective Agents|protective agents|mesh-ancestor
153624412|NCT02007161|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153624413|NCT02007161|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153624414|NCT02007161|Analgesics|analgesics|mesh-ancestor
153624415|NCT02007161|Sensory System Agents|sensory system agents|mesh-ancestor
153624416|NCT02007161|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153624417|NCT02007161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153624418|NCT02007161|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153624419|NCT02007161|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153624420|NCT02007161|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153624421|NCT02007161|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153624422|NCT02007161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153624431|NCT02007330|Lidocaine|lidocaine|mesh-list
153624472|NCT02007629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153624473|NCT02007746|Liver Extracts|liver extracts|mesh-list
153624474|NCT02007746|Hematinics|hematinics|mesh-ancestor
153624475|NCT02007798|Dexmedetomidine|dexmedetomidine|mesh-list
153624476|NCT02007798|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153624477|NCT02007798|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153624478|NCT02007798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153624479|NCT02007798|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153624480|NCT02007798|Analgesics|analgesics|mesh-ancestor
153624481|NCT02007798|Sensory System Agents|sensory system agents|mesh-ancestor
153624482|NCT02007798|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153624483|NCT02007798|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
153624484|NCT02007798|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153624485|NCT02007798|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153624486|NCT02007798|Adrenergic Agents|adrenergic agents|mesh-ancestor
153624487|NCT02007798|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153624488|NCT02007798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153624489|NCT02007837|Aspirin|aspirin|mesh-list
153624490|NCT02007837|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153624525|NCT02007928|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153624526|NCT02007928|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153624527|NCT02007928|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
153624528|NCT02007928|Dopamine Agents|dopamine agents|mesh-ancestor
153624529|NCT02007928|Antiemetics|antiemetics|mesh-ancestor
153624530|NCT02007928|Autonomic Agents|autonomic agents|mesh-ancestor
153624531|NCT02007928|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153624532|NCT02007928|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153624533|NCT02007928|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
153624534|NCT02007928|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153624535|NCT02007928|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153624536|NCT02007928|Antidepressive Agents|antidepressive agents|mesh-ancestor
153624537|NCT02007928|Dopamine Agonists|dopamine agonists|mesh-ancestor
153624538|NCT02007928|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
153624539|NCT02007928|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
153624540|NCT02007928|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
153624541|NCT02007928|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
153624543|NCT02008006|Etoposide|etoposide|mesh-list
153624544|NCT02008006|Melphalan|melphalan|mesh-list
153624545|NCT02008006|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
153624546|NCT02008006|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153624547|NCT02008006|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153624548|NCT02008006|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153624549|NCT02008006|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153624550|NCT02008006|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153624551|NCT02008006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153624552|NCT02008006|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153624553|NCT02008006|Antimetabolites|antimetabolites|mesh-ancestor
153624554|NCT02008006|Antiviral Agents|antiviral agents|mesh-ancestor
153624555|NCT02008006|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153624556|NCT02008006|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153624557|NCT02008006|Immunologic Factors|immunologic factors|mesh-ancestor
153624558|NCT02008006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153624559|NCT02008006|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153624563|NCT02008019|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
153624564|NCT02008019|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153811135|NCT00353379|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153357674|NCT00756236|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153624565|NCT02008019|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153624567|NCT02008019|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153624634|NCT02008422|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153624635|NCT02008422|Growth Substances|growth substances|mesh-ancestor
153624636|NCT02008422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153624637|NCT02008422|Growth Inhibitors|growth inhibitors|mesh-ancestor
153624638|NCT02008461|Botulinum Toxins|botulinum toxins|mesh-list
153624639|NCT02008461|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
153624640|NCT02008461|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153624641|NCT02008461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153624642|NCT02008461|Cholinergic Agents|cholinergic agents|mesh-ancestor
153624643|NCT02008461|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153624644|NCT02008461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153624645|NCT02008578|Immunoglobulins|immunoglobulins|mesh-list
153624646|NCT02008578|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
153624647|NCT02008578|Antibodies|antibodies|mesh-list
153624648|NCT02008578|Immunologic Factors|immunologic factors|mesh-ancestor
153624649|NCT02008578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153624650|NCT02008734|Palbociclib|palbociclib|mesh-list
153624651|NCT02008734|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153624652|NCT02008734|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153624689|NCT02008981|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153624690|NCT02008981|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153624691|NCT02008981|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153624692|NCT02008981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153624693|NCT02008981|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153624694|NCT02008981|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153624695|NCT02008981|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153624697|NCT02008981|Antioxidants|antioxidants|mesh-ancestor
153624698|NCT02008981|Protective Agents|protective agents|mesh-ancestor
153624699|NCT02009007|Phenylephrine|phenylephrine|mesh-list
153624700|NCT02009007|Dopamine|dopamine|mesh-list
153624701|NCT02009007|Oxymetazoline|oxymetazoline|mesh-list
153624702|NCT02009007|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
153624703|NCT02009007|Mydriatics|mydriatics|mesh-ancestor
153624704|NCT02009007|Autonomic Agents|autonomic agents|mesh-ancestor
153624705|NCT02009007|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153624706|NCT02009007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153624707|NCT02009007|Sympathomimetics|sympathomimetics|mesh-ancestor
153624708|NCT02009007|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
153624709|NCT02009007|Nasal Decongestants|nasal decongestants|mesh-ancestor
153624710|NCT02009007|Respiratory System Agents|respiratory system agents|mesh-ancestor
153624711|NCT02009007|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
153624712|NCT02009007|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153624713|NCT02009007|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153624714|NCT02009007|Adrenergic Agents|adrenergic agents|mesh-ancestor
153624740|NCT05778461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153624741|NCT05778461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153624742|NCT05778305|Dexmedetomidine|dexmedetomidine|mesh-list
153624743|NCT05778305|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153624744|NCT05778305|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153624745|NCT05778305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153624805|NCT05777369|Tubulin Modulators|tubulin modulators|mesh-ancestor
153624806|NCT05777369|Antimitotic Agents|antimitotic agents|mesh-ancestor
153624807|NCT05777369|Mitosis Modulators|mitosis modulators|mesh-ancestor
153624809|NCT05777369|Sensory System Agents|sensory system agents|mesh-ancestor
153624810|NCT05777369|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153624811|NCT05777369|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153811138|NCT00353379|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153811139|NCT00353379|Adrenergic Agents|adrenergic agents|mesh-ancestor
153357677|NCT00762320|Lopinavir|lopinavir|mesh-list
153624812|NCT05777369|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153624813|NCT05777369|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153624814|NCT05777122|Lidocaine|lidocaine|mesh-list
153624815|NCT05777122|Anesthetics, Local|anesthetics, local|mesh-ancestor
153624816|NCT05777122|Anesthetics|anesthetics|mesh-ancestor
153624817|NCT05777122|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153624818|NCT05777122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153624819|NCT05777122|Sensory System Agents|sensory system agents|mesh-ancestor
153624820|NCT05777122|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153624865|NCT05121168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153624866|NCT05121168|Sensory System Agents|sensory system agents|mesh-ancestor
153624867|NCT05121168|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153624868|NCT05091905|Ropivacaine|ropivacaine|mesh-list
153624869|NCT05091905|Anesthetics, Local|anesthetics, local|mesh-list
153624870|NCT05091905|Anesthetics|anesthetics|mesh-list
153624871|NCT05091905|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153624872|NCT05091905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153624873|NCT05091905|Sensory System Agents|sensory system agents|mesh-ancestor
153624874|NCT05091905|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153624875|NCT04983589|Pilocarpine|pilocarpine|mesh-list
153624876|NCT04983589|Miotics|miotics|mesh-ancestor
153624877|NCT04983589|Autonomic Agents|autonomic agents|mesh-ancestor
153624878|NCT04983589|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153624885|NCT04861922|Heparin|heparin|mesh-list
153815054|NCT00454272|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153357678|NCT00762320|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
153624953|NCT04364984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153624954|NCT04364984|Protease Inhibitors|protease inhibitors|mesh-ancestor
153624956|NCT04278833|Triamcinolone|triamcinolone|mesh-list
153624957|NCT04278833|Betamethasone|betamethasone|mesh-list
153624958|NCT04278833|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153624959|NCT04278833|Antiemetics|antiemetics|mesh-ancestor
153624960|NCT04278833|Autonomic Agents|autonomic agents|mesh-ancestor
153624961|NCT04278833|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153624962|NCT04278833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153624963|NCT04278833|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153624964|NCT04278833|Glucocorticoids|glucocorticoids|mesh-ancestor
153624965|NCT04278833|Hormones|hormones|mesh-ancestor
153559019|NCT01630057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153624966|NCT04278833|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153624967|NCT04278833|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153625012|NCT04050280|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153625013|NCT04050280|Antimetabolites|antimetabolites|mesh-ancestor
153625014|NCT04050280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153625015|NCT04050280|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153625016|NCT04050280|Antiviral Agents|antiviral agents|mesh-ancestor
153625017|NCT04050280|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153625083|NCT03737968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153625096|NCT03556202|Mirikizumab|mirikizumab|mesh-list
153625097|NCT03556202|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153625098|NCT03556202|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153625099|NCT03556202|Analgesics|analgesics|mesh-ancestor
153625100|NCT03556202|Sensory System Agents|sensory system agents|mesh-ancestor
153625101|NCT03556202|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153625102|NCT03556202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153625103|NCT03556202|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153625104|NCT03556202|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153811141|NCT00353379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153625105|NCT03556202|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
153625106|NCT03556202|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153625107|NCT03480438|Blinatumomab|blinatumomab|mesh-list
153625145|NCT03329508|Protective Agents|protective agents|mesh-ancestor
153625146|NCT03329508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153625147|NCT03329508|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
153625148|NCT03329508|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
153625149|NCT03329508|Dopamine Agonists|dopamine agonists|mesh-ancestor
153625150|NCT03329508|Dopamine Agents|dopamine agents|mesh-ancestor
153625151|NCT03329508|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153625152|NCT03329508|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
153625153|NCT03329508|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153625154|NCT03329508|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
153625155|NCT03281304|Tofacitinib|tofacitinib|mesh-list
153625156|NCT03281304|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
153625157|NCT03281304|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153625158|NCT03281304|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153625159|NCT03281304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153625160|NCT03153319|Adalimumab|adalimumab|mesh-list
153625204|NCT02432963|Vaccines|vaccines|mesh-list
153625205|NCT02432963|Immunologic Factors|immunologic factors|mesh-ancestor
153625206|NCT02432963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153625207|NCT02432963|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153625208|NCT02432963|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153625209|NCT02432963|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153625210|NCT02432963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153625211|NCT02358538|Ganaxolone|ganaxolone|mesh-list
153625212|NCT02358538|Neurosteroids|neurosteroids|mesh-ancestor
153625213|NCT02358538|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153625214|NCT02358538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153625215|NCT02358538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153625216|NCT02358538|GABA Modulators|gaba modulators|mesh-ancestor
153625217|NCT02358538|GABA Agents|gaba agents|mesh-ancestor
153625218|NCT02349906|Treosulfan|treosulfan|mesh-list
153625219|NCT02349906|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153625220|NCT02349906|Alkylating Agents|alkylating agents|mesh-ancestor
153625221|NCT02349906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153625222|NCT02349906|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153625223|NCT02336087|Metformin|metformin|mesh-list
153625224|NCT02336087|Paclitaxel|paclitaxel|mesh-list
153625225|NCT02336087|Gemcitabine|gemcitabine|mesh-list
153625226|NCT02336087|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
153625227|NCT02336087|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153625253|NCT02048150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153625254|NCT02038452|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
153625255|NCT02038452|Methylprednisolone|methylprednisolone|mesh-list
153559082|NCT01630538|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153559108|NCT01630655|Felodipine|felodipine|mesh-list
153625256|NCT02038452|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
153625257|NCT02038452|Prednisolone|prednisolone|mesh-list
153625258|NCT02038452|Prednisolone acetate|prednisolone acetate|mesh-list
153625259|NCT02038452|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
153625260|NCT02038452|Prednisolone phosphate|prednisolone phosphate|mesh-list
153625261|NCT02038452|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153625262|NCT02038452|Antiemetics|antiemetics|mesh-ancestor
153625263|NCT02038452|Autonomic Agents|autonomic agents|mesh-ancestor
153625264|NCT02038452|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153625265|NCT02038452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153625266|NCT02038452|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153625267|NCT02038452|Glucocorticoids|glucocorticoids|mesh-ancestor
153625268|NCT02038452|Hormones|hormones|mesh-ancestor
153625270|NCT02038452|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
153625312|NCT01163357|Fludarabine|fludarabine|mesh-list
153625313|NCT01163357|Fludarabine phosphate|fludarabine phosphate|mesh-list
153625314|NCT01163357|Bortezomib|bortezomib|mesh-list
153625315|NCT01163357|Melphalan|melphalan|mesh-list
153625316|NCT01163357|Tacrolimus|tacrolimus|mesh-list
153625317|NCT01163357|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153625318|NCT01163357|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153625319|NCT01163357|Antimetabolites|antimetabolites|mesh-ancestor
153625320|NCT01163357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153625321|NCT01163357|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153625322|NCT01163357|Immunologic Factors|immunologic factors|mesh-ancestor
153625323|NCT01163357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153625324|NCT01163357|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
153625325|NCT01163357|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153625326|NCT01163357|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153625327|NCT01163357|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153625328|NCT01163357|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153625329|NCT01163357|Antifungal Agents|antifungal agents|mesh-ancestor
153357681|NCT00762320|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153625330|NCT01163357|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153625331|NCT01163357|Alkylating Agents|alkylating agents|mesh-ancestor
153625332|NCT01163357|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153625333|NCT00967005|Acetylcysteine|acetylcysteine|mesh-list
153625334|NCT00967005|N-monoacetylcystine|n-monoacetylcystine|mesh-list
153625335|NCT00967005|Antiviral Agents|antiviral agents|mesh-ancestor
153625336|NCT00967005|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153625337|NCT00967005|Expectorants|expectorants|mesh-ancestor
153625338|NCT00967005|Respiratory System Agents|respiratory system agents|mesh-ancestor
153625339|NCT00967005|Free Radical Scavengers|free radical scavengers|mesh-ancestor
153625340|NCT00967005|Antioxidants|antioxidants|mesh-ancestor
153625341|NCT00967005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153625342|NCT00967005|Protective Agents|protective agents|mesh-ancestor
153625344|NCT00967005|Antidotes|antidotes|mesh-ancestor
153625355|NCT00538031|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153625356|NCT00538031|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153625357|NCT00538031|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153625358|NCT00538031|Analgesics|analgesics|mesh-ancestor
153625359|NCT00538031|Sensory System Agents|sensory system agents|mesh-ancestor
153559122|NCT01630733|Docetaxel|docetaxel|mesh-list
153625360|NCT00538031|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153625361|NCT00538031|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153625362|NCT00538031|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
153625363|NCT00538031|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153625364|NCT00538031|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153625365|NCT00203996|Pioglitazone|pioglitazone|mesh-list
153625366|NCT00203996|Leuprolide|leuprolide|mesh-list
153625367|NCT00203996|Estrogens|estrogens|mesh-list
153625368|NCT00203996|Progestins|progestins|mesh-list
153625369|NCT00203996|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153625370|NCT00203996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153625371|NCT00203996|Fertility Agents, Female|fertility agents, female|mesh-ancestor
153625372|NCT00203996|Fertility Agents|fertility agents|mesh-ancestor
153625373|NCT00203996|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153625374|NCT00203996|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153625412|NCT03581877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153625413|NCT02009410|Pancrelipase|pancrelipase|mesh-list
153625414|NCT02009410|Pancreatin|pancreatin|mesh-list
153625415|NCT02009410|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153625416|NCT02009436|Azacitidine|azacitidine|mesh-list
153625417|NCT02009436|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153625418|NCT02009436|Antimetabolites|antimetabolites|mesh-ancestor
153625419|NCT02009436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153625420|NCT02009436|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153625421|NCT02009436|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153625422|NCT02009462|Polymethyl Methacrylate|polymethyl methacrylate|mesh-list
153625423|NCT02009462|Vasodilator Agents|vasodilator agents|mesh-ancestor
153625476|NCT02009787|Micronutrients|micronutrients|mesh-ancestor
153625477|NCT02009787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153625478|NCT02009787|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153625480|NCT02009943|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
153625481|NCT02009943|Hematinics|hematinics|mesh-ancestor
153625482|NCT02010164|Ubiquinone|ubiquinone|mesh-list
153625483|NCT02010164|Coenzyme Q10|coenzyme q10|mesh-list
153625484|NCT02010164|Micronutrients|micronutrients|mesh-ancestor
153625485|NCT02010164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153625486|NCT02010164|Vitamins|vitamins|mesh-ancestor
153625487|NCT02010411|Alpha 1-Antitrypsin|alpha 1-antitrypsin|mesh-list
153625488|NCT02010411|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
153625489|NCT02010411|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
153625490|NCT02010411|Protease Inhibitors|protease inhibitors|mesh-ancestor
153625491|NCT02010411|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153625492|NCT02010411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153625493|NCT02010437|Sodium Tetradecyl Sulfate|sodium tetradecyl sulfate|mesh-list
153625494|NCT02010437|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
153625495|NCT02010437|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
153625530|NCT02010944|Cholinergic Agents|cholinergic agents|mesh-ancestor
153625531|NCT02010944|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153625532|NCT02010944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153625533|NCT02010944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153625534|NCT02010944|Urological Agents|urological agents|mesh-ancestor
153625535|NCT02010944|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
153625536|NCT02010944|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
153625537|NCT02010944|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153625538|NCT02010944|Adrenergic Agents|adrenergic agents|mesh-ancestor
153625539|NCT02010957|Etomidate|etomidate|mesh-list
153625540|NCT02010957|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153625541|NCT02010957|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153625542|NCT02010957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153625543|NCT02010957|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153625544|NCT02010957|Anesthetics, General|anesthetics, general|mesh-ancestor
153811153|NCT00324194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153357688|NCT00762320|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153357689|NCT00244712|Tenofovir|tenofovir|mesh-list
153357690|NCT00244712|Lamivudine|lamivudine|mesh-list
153357691|NCT00244712|Emtricitabine|emtricitabine|mesh-list
153357692|NCT00244712|Abacavir|abacavir|mesh-list
153625545|NCT02010957|Anesthetics|anesthetics|mesh-ancestor
153625546|NCT02010970|Itraconazole|itraconazole|mesh-list
153625547|NCT02010970|Diltiazem|diltiazem|mesh-list
153625548|NCT02010970|Calcium Channel Blockers|calcium channel blockers|mesh-list
153625549|NCT02010970|Midazolam|midazolam|mesh-list
153625550|NCT02010970|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153625551|NCT02010970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153625552|NCT02010970|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153625553|NCT02010970|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153625554|NCT02010970|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153625555|NCT02010970|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153625556|NCT02010970|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153625557|NCT02010970|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153625560|NCT02010970|Anesthetics|anesthetics|mesh-ancestor
153625572|NCT02010970|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153625573|NCT02010970|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
153625574|NCT02010970|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153625575|NCT02010970|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153625576|NCT02010970|Vasodilator Agents|vasodilator agents|mesh-ancestor
153625582|NCT02011191|Biotin|biotin|mesh-list
153625638|NCT02011737|Adrenergic Agents|adrenergic agents|mesh-ancestor
153625639|NCT02011737|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153625640|NCT02011737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153625641|NCT02011737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153625642|NCT02011737|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153625643|NCT02011737|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153625644|NCT02011737|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153625645|NCT02011737|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153625646|NCT02011737|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153625647|NCT02011750|Valproic Acid|valproic acid|mesh-list
153625648|NCT02011750|Anticonvulsants|anticonvulsants|mesh-ancestor
153625649|NCT02011750|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153625650|NCT02011750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153625651|NCT02011750|GABA Agents|gaba agents|mesh-ancestor
153625652|NCT02011750|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153625653|NCT02011750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153625654|NCT02011750|Antimanic Agents|antimanic agents|mesh-ancestor
153625656|NCT02011750|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153625657|NCT02011750|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153625658|NCT02011828|Ergocalciferols|ergocalciferols|mesh-list
153625659|NCT02011828|Vitamin D|vitamin d|mesh-list
153625662|NCT02011828|Vitamins|vitamins|mesh-ancestor
153625690|NCT02011958|Amebicides|amebicides|mesh-ancestor
153625691|NCT02011958|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153625692|NCT02011958|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153625693|NCT02011958|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153625694|NCT02011958|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153625695|NCT02011958|Antifungal Agents|antifungal agents|mesh-ancestor
153625696|NCT02011958|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153625697|NCT02012036|Aminolevulinic Acid|aminolevulinic acid|mesh-list
153625757|NCT02012244|Fentanyl|fentanyl|mesh-list
153625758|NCT02012244|Anesthetics|anesthetics|mesh-list
153625759|NCT02012244|Anesthetics, Local|anesthetics, local|mesh-list
153625760|NCT02012244|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153625761|NCT02012244|Narcotics|narcotics|mesh-ancestor
153625762|NCT02012244|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153625763|NCT02012244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153625764|NCT02012244|Analgesics|analgesics|mesh-ancestor
153625765|NCT02012244|Sensory System Agents|sensory system agents|mesh-ancestor
153625766|NCT02012244|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153625773|NCT02012322|Ubiquinone|ubiquinone|mesh-list
153625823|NCT02012738|8-chloro-cyclic adenosine monophosphate|8-chloro-cyclic adenosine monophosphate|mesh-list
153625824|NCT02012738|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153625825|NCT02012738|Immunologic Factors|immunologic factors|mesh-ancestor
153625826|NCT02012738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153625827|NCT02012777|Propranolol|propranolol|mesh-list
153625828|NCT02012777|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
153625829|NCT02012777|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
153625830|NCT02012777|Adrenergic Agents|adrenergic agents|mesh-ancestor
153625831|NCT02012777|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153625832|NCT02012777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153625833|NCT02012777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153625834|NCT02012777|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153625835|NCT02012777|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153625836|NCT02012777|Vasodilator Agents|vasodilator agents|mesh-ancestor
153625837|NCT02012920|Seviteronel|seviteronel|mesh-list
153625838|NCT02012920|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153625839|NCT02012920|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153625840|NCT02012920|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153625841|NCT02012920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153625842|NCT02012933|Amifampridine|amifampridine|mesh-list
153625849|NCT02012946|Simendan|simendan|mesh-list
153625874|NCT02013102|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153625875|NCT02013102|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153625876|NCT02013115|Budesonide|budesonide|mesh-list
153625877|NCT02013115|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153625878|NCT02013115|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153625879|NCT02013115|Autonomic Agents|autonomic agents|mesh-ancestor
153625880|NCT02013115|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153625881|NCT02013115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153625882|NCT02013115|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153625883|NCT02013115|Respiratory System Agents|respiratory system agents|mesh-ancestor
153625885|NCT02013115|Hormones|hormones|mesh-ancestor
153625886|NCT02013115|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153625887|NCT02013219|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
153625888|NCT02013219|Atezolizumab|atezolizumab|mesh-list
153625889|NCT02013219|Alectinib|alectinib|mesh-list
153625890|NCT02013219|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153625891|NCT02013219|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153625892|NCT02013219|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153625893|NCT02013219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153625894|NCT02013219|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153625895|NCT02013219|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153625896|NCT02013219|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153625897|NCT02013232|Aripiprazole|aripiprazole|mesh-list
153625898|NCT02013232|Antidepressive Agents|antidepressive agents|mesh-ancestor
153625899|NCT02013232|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153625923|NCT02013271|Antimitotic Agents|antimitotic agents|mesh-ancestor
153625924|NCT02013271|Mitosis Modulators|mitosis modulators|mesh-ancestor
153625925|NCT02013271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153625926|NCT02013362|Folic Acid|folic acid|mesh-list
153625927|NCT02013362|Vitamin B 12|vitamin b 12|mesh-list
153625928|NCT02013362|Hydroxocobalamin|hydroxocobalamin|mesh-list
153625929|NCT02013362|Vitamins|vitamins|mesh-ancestor
153625930|NCT02013362|Micronutrients|micronutrients|mesh-ancestor
153625931|NCT02013362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153625932|NCT02013362|Hematinics|hematinics|mesh-ancestor
153625933|NCT02013362|Vitamin B Complex|vitamin b complex|mesh-ancestor
153625934|NCT02013453|Paclitaxel|paclitaxel|mesh-list
153625935|NCT02013453|Carboplatin|carboplatin|mesh-list
153625936|NCT02013453|Fluorouracil|fluorouracil|mesh-list
153625937|NCT02013453|Pemetrexed|pemetrexed|mesh-list
153625938|NCT02013453|Omeprazole|omeprazole|mesh-list
153625939|NCT02013453|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153625940|NCT02013453|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153625941|NCT02013453|Tubulin Modulators|tubulin modulators|mesh-ancestor
153625978|NCT02013856|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153625979|NCT02013869|Anesthetics|anesthetics|mesh-list
153625980|NCT02013869|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153625981|NCT02013869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153625982|NCT02013895|Technetium Tc 99m DTPA-galactosyl-human serum albumin|technetium tc 99m dtpa-galactosyl-human serum albumin|mesh-list
153625983|NCT02013895|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
153625984|NCT02013895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153625985|NCT02013960|Misoprostol|misoprostol|mesh-list
153625986|NCT02013960|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
153625987|NCT02013960|Abortifacient Agents|abortifacient agents|mesh-ancestor
153625988|NCT02013960|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153625989|NCT02013960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153625990|NCT02013960|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
153625991|NCT02013960|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153811162|NCT00353691|Glimepiride|glimepiride|mesh-list
153625992|NCT02013960|Oxytocics|oxytocics|mesh-ancestor
153357697|NCT00244712|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153625993|NCT02013986|Midazolam|midazolam|mesh-list
153625994|NCT02013986|Propofol|propofol|mesh-list
153625995|NCT02013986|Etomidate|etomidate|mesh-list
153626001|NCT02013986|Anesthetics|anesthetics|mesh-ancestor
153626034|NCT02013089|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153626035|NCT02013089|Growth Substances|growth substances|mesh-ancestor
153626036|NCT02013089|Growth Inhibitors|growth inhibitors|mesh-ancestor
153626037|NCT02014103|Tacrolimus|tacrolimus|mesh-list
153626038|NCT02014103|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153626039|NCT02014103|Immunologic Factors|immunologic factors|mesh-ancestor
153626040|NCT02014103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153626041|NCT02014103|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
153626042|NCT02014103|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153626043|NCT02014103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153626044|NCT02014259|Semaglutide|semaglutide|mesh-list
153626045|NCT02014259|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
153626046|NCT02014259|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153626047|NCT02014259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153626048|NCT02014337|Mifepristone|mifepristone|mesh-list
153626049|NCT02014337|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
153626050|NCT02014337|Abortifacient Agents|abortifacient agents|mesh-ancestor
153559362|NCT01632189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153559363|NCT01632371|Paclitaxel|paclitaxel|mesh-list
153559364|NCT01632371|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
153626051|NCT02014337|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153626052|NCT02014337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153626053|NCT02014337|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
153626054|NCT02014337|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
153626055|NCT02014337|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
153626056|NCT02014337|Contraceptive Agents|contraceptive agents|mesh-ancestor
153626057|NCT02014337|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
153626058|NCT02014337|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
153626059|NCT02014337|Hormone Antagonists|hormone antagonists|mesh-ancestor
153626060|NCT02014337|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153626061|NCT02014337|Luteolytic Agents|luteolytic agents|mesh-ancestor
153626062|NCT02014337|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
153626063|NCT02014337|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
153626064|NCT02014428|Hyaluronic Acid|hyaluronic acid|mesh-list
153626065|NCT02014428|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153626073|NCT02014454|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
153626074|NCT02014454|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
153626075|NCT02014454|Adrenergic Agents|adrenergic agents|mesh-ancestor
153626076|NCT02014454|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153626077|NCT02014454|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153626078|NCT02014454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153626079|NCT02014454|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153626080|NCT02014454|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153811164|NCT00353691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153626081|NCT02014454|Vasodilator Agents|vasodilator agents|mesh-ancestor
153626082|NCT02014506|Cyclophosphamide|cyclophosphamide|mesh-list
153626083|NCT02014506|Fludarabine|fludarabine|mesh-list
153626084|NCT02014506|Antilymphocyte Serum|antilymphocyte serum|mesh-list
153626085|NCT02014506|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153626134|NCT02014558|Hormone Antagonists|hormone antagonists|mesh-ancestor
153626135|NCT02014558|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153626136|NCT02014558|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
153626137|NCT02014558|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153626138|NCT02014558|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153626139|NCT02014558|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153626140|NCT02014623|Immunomodulating Agents|immunomodulating agents|mesh-list
153626141|NCT02014623|Histamine Antagonists|histamine antagonists|mesh-list
153626142|NCT02014623|Immunologic Factors|immunologic factors|mesh-ancestor
153626200|NCT02014922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153626201|NCT02014922|Vitamins|vitamins|mesh-ancestor
153626202|NCT02014922|Micronutrients|micronutrients|mesh-ancestor
153626203|NCT02015156|Trastuzumab|trastuzumab|mesh-list
153626204|NCT02015156|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153626205|NCT02015156|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153626206|NCT02015169|Lapatinib|lapatinib|mesh-list
153626207|NCT02015169|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153626208|NCT02015169|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153626209|NCT02015169|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153626210|NCT02015169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153626211|NCT02015169|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153626212|NCT02015182|Bupivacaine|bupivacaine|mesh-list
153626213|NCT02015182|Anesthetics, Local|anesthetics, local|mesh-ancestor
153626214|NCT02015182|Anesthetics|anesthetics|mesh-ancestor
153626215|NCT02015182|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153782662|NCT00413738|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153626216|NCT02015182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153626217|NCT02015182|Sensory System Agents|sensory system agents|mesh-ancestor
153626218|NCT02015182|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153626256|NCT02015403|Respiratory System Agents|respiratory system agents|mesh-ancestor
153626257|NCT02015403|Free Radical Scavengers|free radical scavengers|mesh-ancestor
153626258|NCT02015403|Antioxidants|antioxidants|mesh-ancestor
153626259|NCT02015403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153626260|NCT02015403|Protective Agents|protective agents|mesh-ancestor
153626261|NCT02015403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153626262|NCT02015403|Antidotes|antidotes|mesh-ancestor
153626263|NCT02015494|Hemagglutinins|hemagglutinins|mesh-list
153626264|NCT02015494|Immunologic Factors|immunologic factors|mesh-ancestor
153626265|NCT02015494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153626266|NCT02015494|Agglutinins|agglutinins|mesh-ancestor
153626267|NCT02015494|Coagulants|coagulants|mesh-ancestor
153626268|NCT02015507|Ciprofloxacin|ciprofloxacin|mesh-list
153626270|NCT02015507|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153626271|NCT02015507|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153626272|NCT02015507|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153626273|NCT02015507|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153626274|NCT02015507|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153626275|NCT02015507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153626276|NCT02015507|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153626277|NCT02015507|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
153626278|NCT02015507|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153626279|NCT02015507|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
153626280|NCT02015507|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153626281|NCT02015559|Protective Agents|protective agents|mesh-list
153626282|NCT02015559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153626283|NCT02015598|Carbocysteine|carbocysteine|mesh-list
153357698|NCT00244712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153626284|NCT02015598|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
153626285|NCT02015598|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153626286|NCT02015598|Expectorants|expectorants|mesh-ancestor
153626287|NCT02015598|Respiratory System Agents|respiratory system agents|mesh-ancestor
153626288|NCT02015650|Fluorouracil|fluorouracil|mesh-list
153626289|NCT02015650|Cetuximab|cetuximab|mesh-list
153626298|NCT02015650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153626299|NCT02015650|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153626300|NCT02015650|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153626301|NCT02015650|Alkylating Agents|alkylating agents|mesh-ancestor
153626302|NCT02015650|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153626303|NCT02015650|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153626304|NCT02015728|Etoposide|etoposide|mesh-list
153626305|NCT02015728|Everolimus|everolimus|mesh-list
153626306|NCT02015728|Temozolomide|temozolomide|mesh-list
153626307|NCT02015728|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
153626308|NCT02015728|Sorafenib|sorafenib|mesh-list
153626309|NCT02015728|Dasatinib|dasatinib|mesh-list
153626310|NCT02015728|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153626311|NCT02015728|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153626312|NCT02015728|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153626313|NCT02015728|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153626314|NCT02015728|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153626315|NCT02015728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153626316|NCT02015728|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
153626317|NCT02015728|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153626318|NCT02015728|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153626319|NCT02015728|Immunologic Factors|immunologic factors|mesh-ancestor
153626320|NCT02015728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153626321|NCT02015728|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153626322|NCT02015728|Alkylating Agents|alkylating agents|mesh-ancestor
153626346|NCT02015988|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153626347|NCT02016001|Fluorides|fluorides|mesh-list
153626348|NCT02016001|Cariostatic Agents|cariostatic agents|mesh-ancestor
153626349|NCT02016001|Protective Agents|protective agents|mesh-ancestor
153626350|NCT02016001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153626351|NCT02016157|Moxifloxacin|moxifloxacin|mesh-list
153626352|NCT02016157|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153626353|NCT02016157|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153626354|NCT02016157|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153626355|NCT02016157|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153626356|NCT02016157|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153626357|NCT02016157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153626358|NCT02016157|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153626359|NCT02016196|Rifaximin|rifaximin|mesh-list
153626360|NCT02016196|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153626361|NCT02016196|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153626362|NCT02016196|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153626363|NCT02016209|Paclitaxel|paclitaxel|mesh-list
153626389|NCT02016274|Paclitaxel|paclitaxel|mesh-list
153626401|NCT02016287|Antimitotic Agents|antimitotic agents|mesh-ancestor
153626402|NCT02016287|Mitosis Modulators|mitosis modulators|mesh-ancestor
153626403|NCT02016287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153626404|NCT02016365|Doxycycline|doxycycline|mesh-list
153626405|NCT02016365|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
153626406|NCT02016365|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153626407|NCT02016365|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153626408|NCT02016365|Antimalarials|antimalarials|mesh-ancestor
153626409|NCT02016365|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153626410|NCT02016365|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153626411|NCT02016365|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
153811169|NCT00332046|Antiemetics|antiemetics|mesh-ancestor
153626412|NCT02016365|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153626413|NCT02016391|Dexmedetomidine|dexmedetomidine|mesh-list
153357699|NCT00244712|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153626414|NCT02016391|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153626415|NCT02016391|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153626416|NCT02016391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153626417|NCT02016391|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153626419|NCT02016391|Sensory System Agents|sensory system agents|mesh-ancestor
153626420|NCT02016391|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153626421|NCT02016391|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
153559514|NCT01633970|Oxaliplatin|oxaliplatin|mesh-list
153626422|NCT02016391|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153626423|NCT02016391|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153626424|NCT02016391|Adrenergic Agents|adrenergic agents|mesh-ancestor
153626425|NCT02016391|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153626426|NCT02016391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153626427|NCT02016417|Cisplatin|cisplatin|mesh-list
153626428|NCT02016417|Gemcitabine|gemcitabine|mesh-list
153626448|NCT02016443|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
153626449|NCT02016443|Parasympatholytics|parasympatholytics|mesh-ancestor
153626450|NCT02016443|Autonomic Agents|autonomic agents|mesh-ancestor
153626451|NCT02016443|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
153626452|NCT02016443|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153626453|NCT02016443|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153626454|NCT02016443|Adrenergic Agents|adrenergic agents|mesh-ancestor
153626455|NCT02016443|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153626456|NCT02016443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153626457|NCT02016495|Thioctic Acid|thioctic acid|mesh-list
153626458|NCT02016495|Antioxidants|antioxidants|mesh-ancestor
153626459|NCT02016495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153626460|NCT02016495|Protective Agents|protective agents|mesh-ancestor
153626461|NCT02016495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153626462|NCT02016495|Vitamin B Complex|vitamin b complex|mesh-ancestor
153626464|NCT02016495|Micronutrients|micronutrients|mesh-ancestor
153626465|NCT02016547|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
153626466|NCT02016547|Abciximab|abciximab|mesh-list
153626467|NCT02016547|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153626468|NCT02016547|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153626469|NCT02016547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153626470|NCT02016547|Anticoagulants|anticoagulants|mesh-ancestor
153626471|NCT02016547|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153626472|NCT02016664|Ketamine|ketamine|mesh-list
153626473|NCT02016664|Analgesics|analgesics|mesh-ancestor
153626497|NCT02016846|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
153626498|NCT02016846|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153626499|NCT02016846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153626500|NCT02016846|Incretins|incretins|mesh-ancestor
153626501|NCT02016846|Hormones|hormones|mesh-ancestor
153626502|NCT02016846|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153626503|NCT02016911|Semaglutide|semaglutide|mesh-list
153626504|NCT02016911|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
153626505|NCT02016911|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153626506|NCT02016911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153626507|NCT02016976|Midazolam|midazolam|mesh-list
153626508|NCT02016976|Meperidine|meperidine|mesh-list
153626509|NCT02016976|Analgesics|analgesics|mesh-list
153626510|NCT02016976|Sensory System Agents|sensory system agents|mesh-ancestor
153626511|NCT02016976|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153626512|NCT02016976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153626513|NCT02016976|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153626555|NCT02017392|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
153626556|NCT02017392|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153626557|NCT02017392|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153626558|NCT02017392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153626560|NCT02017405|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
153626561|NCT02017405|Antibodies|antibodies|mesh-list
153626562|NCT02017405|Immunologic Factors|immunologic factors|mesh-ancestor
153626563|NCT02017405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153626564|NCT02017457|Azacitidine|azacitidine|mesh-list
153815057|NCT00344825|Alemtuzumab|alemtuzumab|mesh-list
153626565|NCT02017457|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153626567|NCT02017457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153626568|NCT02017457|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153626569|NCT02017457|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153626570|NCT02017561|Metformin|metformin|mesh-list
153626571|NCT02017561|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153626572|NCT02017561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153626573|NCT02017600|Fluorouracil|fluorouracil|mesh-list
153626574|NCT02017600|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153626575|NCT02017600|Antimetabolites|antimetabolites|mesh-ancestor
153626576|NCT02017600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153626577|NCT02017600|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153626578|NCT02017600|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153626579|NCT02017600|Immunologic Factors|immunologic factors|mesh-ancestor
153626580|NCT02017600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153626581|NCT02017613|Tenalisib|tenalisib|mesh-list
153626582|NCT02017613|Phosphoinositide-3 Kinase Inhibitors|phosphoinositide-3 kinase inhibitors|mesh-ancestor
153626599|NCT02018055|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153626600|NCT02018055|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153626601|NCT02018055|Analgesics|analgesics|mesh-ancestor
153626602|NCT02018055|Sensory System Agents|sensory system agents|mesh-ancestor
153626603|NCT02018055|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153626604|NCT02018055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153626605|NCT02018055|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153626607|NCT02018055|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153626608|NCT02018055|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153626609|NCT02018055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153626610|NCT02018055|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153910753|NCT02780479|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153910754|NCT02780479|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153910755|NCT02780479|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153910756|NCT05252923|Glucuronyl glucosamine glycan sulfate|glucuronyl glucosamine glycan sulfate|mesh-list
153910757|NCT05252923|Anticoagulants|anticoagulants|mesh-ancestor
153910758|NCT05252923|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153910759|NCT05252923|Antimetabolites|antimetabolites|mesh-ancestor
153910760|NCT05252923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153910761|NCT05252923|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153910762|NCT05252923|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153910763|NCT05252923|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153910764|NCT05252923|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153452466|NCT01846104|Immunologic Factors|immunologic factors|mesh-ancestor
153910765|NCT05252923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153910766|NCT05097079|rimabotulinumtoxinB|rimabotulinumtoxinb|mesh-list
153910767|NCT05097079|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
153910768|NCT05097079|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
153910769|NCT05097079|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
153910770|NCT05097079|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153910771|NCT05097079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153910772|NCT05097079|Cholinergic Agents|cholinergic agents|mesh-ancestor
153910773|NCT05097079|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153910774|NCT05097079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153910775|NCT05097079|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
153910776|NCT05097079|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153910777|NCT02779387|Goserelin|goserelin|mesh-list
153811172|NCT00332046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153357700|NCT00244712|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153357701|NCT00725270|Mifepristone|mifepristone|mesh-list
153910778|NCT02779387|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153910779|NCT02779387|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153910781|NCT04228315|Antimalarials|antimalarials|mesh-ancestor
153910782|NCT04228315|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153910783|NCT04228315|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153452500|NCT01803282|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153452501|NCT01844778|Tobramycin|tobramycin|mesh-list
153452502|NCT01844778|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153452503|NCT01844778|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153452504|NCT01802580|Fluocinonide|fluocinonide|mesh-list
153452505|NCT01802580|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153452506|NCT01802580|Glucocorticoids|glucocorticoids|mesh-ancestor
153452507|NCT01802580|Hormones|hormones|mesh-ancestor
153452508|NCT01802580|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153452509|NCT01802580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153452510|NCT01802580|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
153452511|NCT01611090|Rituximab|rituximab|mesh-list
153452512|NCT01611090|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
153452513|NCT01611090|Ibrutinib|ibrutinib|mesh-list
153452514|NCT01611090|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153452515|NCT01611090|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153452516|NCT01611090|Immunologic Factors|immunologic factors|mesh-ancestor
153452517|NCT01611090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153452518|NCT01611090|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153452519|NCT01611090|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153452522|NCT01611090|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153452523|NCT01611090|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153452525|NCT01844700|Risperidone|risperidone|mesh-list
153452526|NCT01844700|Aripiprazole|aripiprazole|mesh-list
153452527|NCT01844700|Quetiapine Fumarate|quetiapine fumarate|mesh-list
153452528|NCT01844700|Ziprasidone|ziprasidone|mesh-list
153452529|NCT01844700|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153452530|NCT01844700|Serotonin Agents|serotonin agents|mesh-ancestor
153452531|NCT01844700|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153452533|NCT01844700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153910784|NCT04228315|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153910785|NCT04228393|Mercaptopurine|mercaptopurine|mesh-list
153910786|NCT04228393|Antimetabolites|antimetabolites|mesh-ancestor
153559737|NCT01634958|Antacids|antacids|mesh-ancestor
153910787|NCT04228393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153910788|NCT04228393|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153910789|NCT04228393|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153910790|NCT04228393|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153910791|NCT04228393|Immunologic Factors|immunologic factors|mesh-ancestor
153910792|NCT04228393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153910793|NCT04228393|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153910794|NCT04228393|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153910795|NCT02779777|Tipifarnib|tipifarnib|mesh-list
153910796|NCT02779777|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153910797|NCT01880359|Nimorazole|nimorazole|mesh-list
153910798|NCT01880359|Antitrichomonal Agents|antitrichomonal agents|mesh-ancestor
153910799|NCT01880359|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153910800|NCT01880359|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153910801|NCT01880359|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153910802|NCT05338489|Itraconazole|itraconazole|mesh-list
153910803|NCT05338489|Rifampin|rifampin|mesh-list
153910804|NCT05338489|Antifungal Agents|antifungal agents|mesh-ancestor
153910805|NCT05338489|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153910806|NCT05338489|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
153910807|NCT05338489|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153910808|NCT05338489|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153910809|NCT05338489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153910810|NCT05338489|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153910811|NCT05338489|Hormone Antagonists|hormone antagonists|mesh-ancestor
153910812|NCT05338489|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153910813|NCT05338489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153910814|NCT05338489|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
153910815|NCT05338489|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
153910816|NCT05338489|Antitubercular Agents|antitubercular agents|mesh-ancestor
153910817|NCT05338489|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153910818|NCT05338489|Leprostatic Agents|leprostatic agents|mesh-ancestor
153910819|NCT05338489|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153910820|NCT05338489|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
153910821|NCT05338489|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
153910822|NCT05338489|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
153910823|NCT05338489|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
153452543|NCT01844700|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
153452544|NCT01844700|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
153452545|NCT01844700|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
153452546|NCT01844076|Quinacrine|quinacrine|mesh-list
153452547|NCT01844076|Capecitabine|capecitabine|mesh-list
153452548|NCT01844076|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153452549|NCT01844076|Antimetabolites|antimetabolites|mesh-ancestor
153452550|NCT01844076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153452551|NCT01844076|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153452552|NCT01844076|Anticestodal Agents|anticestodal agents|mesh-ancestor
153452553|NCT01844076|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
153452554|NCT01844076|Anthelmintics|anthelmintics|mesh-ancestor
153452555|NCT01844076|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153452556|NCT01844076|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153452557|NCT01844076|Antimalarials|antimalarials|mesh-ancestor
153452562|NCT01826448|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153452563|NCT01826448|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153626612|NCT02018055|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153626614|NCT02018055|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
153626615|NCT02018055|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
153626616|NCT02018055|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
153626617|NCT02018055|Purinergic Agents|purinergic agents|mesh-ancestor
153626618|NCT02018055|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153626619|NCT02018081|Levofloxacin|levofloxacin|mesh-list
153626620|NCT02018081|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
153626621|NCT02018081|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153357702|NCT00725270|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
153626622|NCT02018081|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153626623|NCT02018081|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153626624|NCT02018081|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153626625|NCT02018081|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153626626|NCT02018081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153626627|NCT02018081|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153463442|NCT04844268|Vaccines|vaccines|mesh-list
153452564|NCT01826448|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153452565|NCT01826448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153452566|NCT01826370|Linagliptin|linagliptin|mesh-list
153452567|NCT01826370|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153452568|NCT01826370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153452569|NCT01826370|Incretins|incretins|mesh-ancestor
153452570|NCT01826370|Hormones|hormones|mesh-ancestor
153452571|NCT01826370|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153452572|NCT01826370|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
153452573|NCT01826370|Protease Inhibitors|protease inhibitors|mesh-ancestor
153452574|NCT01826370|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153452575|NCT01826370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153452576|NCT01799226|Triclosan|triclosan|mesh-list
153452577|NCT01799226|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
153910824|NCT05338489|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
153910825|NCT05338489|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
153910827|NCT05266417|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153910828|NCT05266417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153910829|NCT02779465|Vitamin D|vitamin d|mesh-list
153910830|NCT02779465|Cholecalciferol|cholecalciferol|mesh-list
153910831|NCT02779465|Vitamins|vitamins|mesh-ancestor
153910832|NCT02779465|Micronutrients|micronutrients|mesh-ancestor
153910833|NCT02779465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153559869|NCT01635829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153559870|NCT01635829|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
153559874|NCT01635946|Isavuconazole|isavuconazole|mesh-list
153559925|NCT01636128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153559926|NCT01636128|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153559927|NCT01636128|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153559928|NCT01636128|Analgesics|analgesics|mesh-ancestor
153782666|NCT02211391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153559929|NCT01636128|Sensory System Agents|sensory system agents|mesh-ancestor
153910834|NCT02779465|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153910835|NCT02779465|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153910836|NCT02776189|Midazolam|midazolam|mesh-list
153910837|NCT02776189|Dexmedetomidine|dexmedetomidine|mesh-list
153910838|NCT02776189|Propofol|propofol|mesh-list
153910839|NCT02776189|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153910840|NCT02776189|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153910841|NCT02776189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153910842|NCT02776189|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153910843|NCT02776189|Analgesics|analgesics|mesh-ancestor
153910844|NCT02776189|Sensory System Agents|sensory system agents|mesh-ancestor
153626628|NCT02018081|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
153910845|NCT02776189|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153811176|NCT00332046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153910846|NCT02776189|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
153910847|NCT02776189|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153910848|NCT02776189|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153910849|NCT02776189|Adrenergic Agents|adrenergic agents|mesh-ancestor
153910850|NCT02776189|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153910851|NCT02776189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153910853|NCT02776189|Anesthetics, General|anesthetics, general|mesh-ancestor
153910855|NCT02776189|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153910856|NCT02776189|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153910857|NCT02776189|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153910858|NCT02776189|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153452588|NCT01824342|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153452589|NCT01824342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153910860|NCT02776189|GABA Agents|gaba agents|mesh-ancestor
153910861|NCT01194258|Insulin|insulin|mesh-list
153910862|NCT01194258|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
153910863|NCT01194258|Insulin Glargine|insulin glargine|mesh-list
153910864|NCT01194258|Insulin Aspart|insulin aspart|mesh-list
153910865|NCT01194258|Insulin Lispro|insulin lispro|mesh-list
153910866|NCT01194258|Insulin glulisine|insulin glulisine|mesh-list
153910867|NCT01194258|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153910868|NCT01194258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153910869|NCT04883437|Obinutuzumab|obinutuzumab|mesh-list
153559931|NCT01636128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153559932|NCT01636128|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153559933|NCT01636128|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153559934|NCT01636128|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153559935|NCT01636141|Dapansutrile|dapansutrile|mesh-list
153559984|NCT01636336|Progestins|progestins|mesh-ancestor
153559985|NCT01636336|Hormones|hormones|mesh-ancestor
153559986|NCT01636336|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153559987|NCT01636401|Bromides|bromides|mesh-list
153559988|NCT01636401|Anticonvulsants|anticonvulsants|mesh-ancestor
153559989|NCT01636505|Cetrorelix|cetrorelix|mesh-list
153559990|NCT01636505|Buserelin|buserelin|mesh-list
153559991|NCT01636505|Ganirelix|ganirelix|mesh-list
153559992|NCT01636505|Fertility Agents, Female|fertility agents, female|mesh-ancestor
153559993|NCT01636505|Fertility Agents|fertility agents|mesh-ancestor
153559994|NCT01636505|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153559995|NCT01636505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153910870|NCT04883437|Acalabrutinib|acalabrutinib|mesh-list
153910871|NCT04883437|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-list
153910872|NCT04883437|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153452591|NCT01823328|Etomidate|etomidate|mesh-list
153452592|NCT01823328|Analgesics|analgesics|mesh-ancestor
153452593|NCT01823328|Sensory System Agents|sensory system agents|mesh-ancestor
153452602|NCT01823328|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
153357705|NCT00725270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153452603|NCT01823328|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153452604|NCT01823328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153452605|NCT01823328|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153452607|NCT01840410|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153452608|NCT01840410|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153452609|NCT01840410|Growth Substances|growth substances|mesh-ancestor
153452610|NCT01840410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153452611|NCT01840410|Growth Inhibitors|growth inhibitors|mesh-ancestor
153452612|NCT01840410|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153452614|NCT01797432|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
153452615|NCT01797432|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
153452616|NCT01797432|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
153452617|NCT01797432|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153910873|NCT04883437|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153910874|NCT04883437|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153910875|NCT04883437|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153910876|NCT04883437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153910877|NCT02775877|Letrozole|letrozole|mesh-list
153910878|NCT02775877|Clomiphene|clomiphene|mesh-list
153910879|NCT02775877|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153910880|NCT02775877|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
153910881|NCT02775877|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153910882|NCT02775877|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153910883|NCT02775877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153910884|NCT02775877|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
153910885|NCT02775877|Hormone Antagonists|hormone antagonists|mesh-ancestor
153820684|NCT00464763|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153626629|NCT02018081|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153626630|NCT02018094|Iodine|iodine|mesh-list
153626631|NCT02018094|Chlorhexidine|chlorhexidine|mesh-list
153626632|NCT02018094|Povidone-Iodine|povidone-iodine|mesh-list
153626633|NCT02018094|Metronidazole|metronidazole|mesh-list
153910886|NCT02775877|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153910887|NCT02775877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153910888|NCT02775877|Fertility Agents, Female|fertility agents, female|mesh-ancestor
153910890|NCT02775877|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153910891|NCT02775877|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
153910892|NCT02775877|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
153910893|NCT02777671|Gliclazide|gliclazide|mesh-list
153910894|NCT02777671|Eslicarbazepine acetate|eslicarbazepine acetate|mesh-list
153910895|NCT02777671|Anticonvulsants|anticonvulsants|mesh-ancestor
153910896|NCT02777671|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
153910897|NCT02777671|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153910898|NCT02777671|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153910899|NCT02777671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153452618|NCT01797432|Glucocorticoids|glucocorticoids|mesh-ancestor
153452619|NCT01797432|Hormones|hormones|mesh-ancestor
153560001|NCT01636557|Vitamin K|vitamin k|mesh-list
153560002|NCT01636557|Midazolam|midazolam|mesh-list
153782667|NCT04562311|Tislelizumab|tislelizumab|mesh-list
153560003|NCT01636557|Caffeine|caffeine|mesh-list
153560004|NCT01636557|Omeprazole|omeprazole|mesh-list
153560005|NCT01636557|Warfarin|warfarin|mesh-list
153560006|NCT01636557|Vitamins|vitamins|mesh-ancestor
153452620|NCT01797432|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153452621|NCT01797432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153452622|NCT01797432|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153452623|NCT01797432|Immunologic Factors|immunologic factors|mesh-ancestor
153452624|NCT01797432|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153452625|NCT01797432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153452626|NCT01797120|Everolimus|everolimus|mesh-list
153452627|NCT01797120|MTOR Inhibitors|mtor inhibitors|mesh-list
153452628|NCT01797120|Fulvestrant|fulvestrant|mesh-list
153452629|NCT01797120|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153452630|NCT01797120|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153452631|NCT01797120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153452632|NCT01797120|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153452633|NCT01797120|Immunologic Factors|immunologic factors|mesh-ancestor
153452634|NCT01797120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153452635|NCT01797120|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153452636|NCT01797120|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153452637|NCT01797120|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
153452639|NCT01797120|Hormone Antagonists|hormone antagonists|mesh-ancestor
153452640|NCT01797120|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153452641|NCT01796964|Aflibercept|aflibercept|mesh-list
153452642|NCT01796964|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153910900|NCT02777671|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153910901|NCT02777671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153910902|NCT02778919|Leuprolide|leuprolide|mesh-list
153910903|NCT02778919|Fertility Agents, Female|fertility agents, female|mesh-ancestor
153910904|NCT02778919|Fertility Agents|fertility agents|mesh-ancestor
153910905|NCT02778919|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153910906|NCT02778919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153910907|NCT02778919|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153910908|NCT02778919|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153910909|NCT02779153|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
153910910|NCT02779153|Hormones|hormones|mesh-ancestor
153910911|NCT02779153|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153910912|NCT02779153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153910913|NCT04226443|Midazolam|midazolam|mesh-list
153910914|NCT04226443|Remifentanil|remifentanil|mesh-list
153910915|NCT04226443|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153910916|NCT04226443|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153357708|NCT00725270|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
153910917|NCT04226443|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153910918|NCT04226443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153910919|NCT04226443|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153910920|NCT04226443|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153910921|NCT04226443|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153910922|NCT04226443|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153910923|NCT04226443|Anesthetics, General|anesthetics, general|mesh-ancestor
153910924|NCT04226443|Anesthetics|anesthetics|mesh-ancestor
153910925|NCT04226443|GABA Modulators|gaba modulators|mesh-ancestor
153910926|NCT04226443|GABA Agents|gaba agents|mesh-ancestor
153910927|NCT04226443|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153560016|NCT01636557|Anesthetics, General|anesthetics, general|mesh-ancestor
153560017|NCT01636557|Anesthetics|anesthetics|mesh-ancestor
153560018|NCT01636557|GABA Modulators|gaba modulators|mesh-ancestor
153560027|NCT01636557|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
153560028|NCT01636557|Purinergic Agents|purinergic agents|mesh-ancestor
153560029|NCT01636557|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
153560030|NCT01636557|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153560031|NCT01636557|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
153560032|NCT01636557|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
153910928|NCT04226443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153910929|NCT04226443|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153910930|NCT04226443|Narcotics|narcotics|mesh-ancestor
153910931|NCT04226443|Analgesics|analgesics|mesh-ancestor
153910932|NCT04226443|Sensory System Agents|sensory system agents|mesh-ancestor
153910933|NCT04226443|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153910934|NCT02776891|Citric Acid|citric acid|mesh-list
153910935|NCT02776891|Sodium Citrate|sodium citrate|mesh-list
153910936|NCT02776891|Gallium citrate|gallium citrate|mesh-list
153910937|NCT02776891|Anticoagulants|anticoagulants|mesh-ancestor
153910938|NCT02776891|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
153811182|NCT00324467|Prednisone|prednisone|mesh-list
153357709|NCT00725270|Contraceptive Agents|contraceptive agents|mesh-ancestor
153910939|NCT02776891|Chelating Agents|chelating agents|mesh-ancestor
153910940|NCT02776891|Sequestering Agents|sequestering agents|mesh-ancestor
153910941|NCT02776891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153910942|NCT02776891|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
153910943|NCT02776813|Rituximab|rituximab|mesh-list
153452675|NCT01794780|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
153452676|NCT01794780|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153452677|NCT01794780|Vasodilator Agents|vasodilator agents|mesh-ancestor
153452678|NCT01794780|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
153452679|NCT01794780|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
153452680|NCT01794780|Purinergic Agents|purinergic agents|mesh-ancestor
153452682|NCT01838616|Tapentadol|tapentadol|mesh-list
153452683|NCT01838616|Naloxone|naloxone|mesh-list
153452684|NCT01838616|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153452685|NCT01838616|Narcotics|narcotics|mesh-ancestor
153452686|NCT01838616|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153452687|NCT01838616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153452688|NCT01838616|Analgesics|analgesics|mesh-ancestor
153452689|NCT01838616|Sensory System Agents|sensory system agents|mesh-ancestor
153452690|NCT01838616|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153452691|NCT01838616|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
153452692|NCT01838616|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
153560040|NCT01636570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153560041|NCT01636570|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153560042|NCT01636570|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153560043|NCT01636596|Insulin Lispro|insulin lispro|mesh-list
153560044|NCT01636596|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153560045|NCT01636596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153560046|NCT01636609|Cytarabine|cytarabine|mesh-list
153452693|NCT01838616|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153452694|NCT01838616|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153910947|NCT02776813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153910948|NCT02776813|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153910949|NCT05157997|Casirivimab and imdevimab drug combination|casirivimab and imdevimab drug combination|mesh-list
153910950|NCT05157997|Antibodies|antibodies|mesh-list
153910951|NCT05157997|Immunologic Factors|immunologic factors|mesh-ancestor
153910952|NCT05157997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153910953|NCT05157997|Antiviral Agents|antiviral agents|mesh-ancestor
153910954|NCT05157997|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153910955|NCT02773147|Pyridoxine|pyridoxine|mesh-list
153910956|NCT02773147|Vitamin B 12|vitamin b 12|mesh-list
153910957|NCT02773147|Hydroxocobalamin|hydroxocobalamin|mesh-list
153910958|NCT02773147|Hematinics|hematinics|mesh-ancestor
153910959|NCT02773147|Vitamin B Complex|vitamin b complex|mesh-ancestor
153910960|NCT02773147|Vitamins|vitamins|mesh-ancestor
153811183|NCT00324467|Cyclophosphamide|cyclophosphamide|mesh-list
153910962|NCT02773147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153910963|NCT02773927|Metformin|metformin|mesh-list
153910964|NCT02773927|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153910965|NCT02773927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153910966|NCT02773459|Capecitabine|capecitabine|mesh-list
153910967|NCT02773459|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153910968|NCT02773459|Antimetabolites|antimetabolites|mesh-ancestor
153910969|NCT02773459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153910970|NCT02773459|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153910971|NCT02773381|Semaglutide|semaglutide|mesh-list
153910972|NCT02773381|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
153910973|NCT02773381|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153910974|NCT02773381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153910975|NCT04818229|Moxifloxacin|moxifloxacin|mesh-list
153910976|NCT04818229|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
153452695|NCT01838616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153452696|NCT01838616|Adrenergic Agents|adrenergic agents|mesh-ancestor
153452697|NCT01838616|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153452698|NCT01794000|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
153452699|NCT01794000|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153452701|NCT01609218|Antidotes|antidotes|mesh-ancestor
153452702|NCT01609218|Protective Agents|protective agents|mesh-ancestor
153452703|NCT01609218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153452704|NCT04580472|Clindamycin|clindamycin|mesh-list
153452705|NCT04580472|Clindamycin palmitate|clindamycin palmitate|mesh-list
153452706|NCT04580472|Clindamycin phosphate|clindamycin phosphate|mesh-list
153560150|NCT01636999|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153560207|NCT01637259|Darunavir|darunavir|mesh-list
153560208|NCT01637259|Fosamprenavir|fosamprenavir|mesh-list
153560209|NCT01637259|HIV Protease Inhibitors|hiv protease inhibitors|mesh-list
153560210|NCT01637259|Tenofovir|tenofovir|mesh-list
153560211|NCT01637259|Lamivudine|lamivudine|mesh-list
153560212|NCT01637259|Emtricitabine|emtricitabine|mesh-list
153560213|NCT01637259|Zidovudine|zidovudine|mesh-list
153560214|NCT01637259|Maraviroc|maraviroc|mesh-list
153560215|NCT01637259|Abacavir|abacavir|mesh-list
153560216|NCT01637259|Dideoxynucleosides|dideoxynucleosides|mesh-list
153560217|NCT01637259|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-list
153560218|NCT01637259|Protease Inhibitors|protease inhibitors|mesh-list
153560220|NCT01637259|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153452707|NCT04580472|Cephalexin|cephalexin|mesh-list
153452708|NCT04580472|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153452709|NCT04580472|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153452710|NCT04580472|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
153452711|NCT04580472|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153452712|NCT04580472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153452713|NCT01611558|Ipilimumab|ipilimumab|mesh-list
153452714|NCT01611558|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153452715|NCT01611558|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153452716|NCT01611558|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153452717|NCT01611558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153452718|NCT01818726|Deferasirox|deferasirox|mesh-list
153452720|NCT01818726|Chelating Agents|chelating agents|mesh-ancestor
153452721|NCT01818726|Sequestering Agents|sequestering agents|mesh-ancestor
153452722|NCT01818726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153452723|NCT01818336|Amoxicillin|amoxicillin|mesh-list
153452724|NCT01818336|Penicillins|penicillins|mesh-list
153452725|NCT01818336|Penicillin G|penicillin g|mesh-list
153452726|NCT01818336|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153910977|NCT04818229|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153910978|NCT04818229|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153910979|NCT04818229|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153910980|NCT04818229|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153910981|NCT04818229|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153910982|NCT04818229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153910983|NCT04818229|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153910984|NCT04818229|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
153910985|NCT04818229|Contraceptive Agents|contraceptive agents|mesh-ancestor
153910986|NCT04818229|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153910987|NCT04818229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153452727|NCT01818336|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153452728|NCT01818258|Ritonavir|ritonavir|mesh-list
153910988|NCT04818229|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
153910989|NCT04818229|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
153910990|NCT04818229|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
153910991|NCT04771741|Acetaminophen|acetaminophen|mesh-list
153910992|NCT04771741|Ketorolac|ketorolac|mesh-list
153910993|NCT04771741|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
153910994|NCT04771741|Meloxicam|meloxicam|mesh-list
153910995|NCT04771741|Pregabalin|pregabalin|mesh-list
153910996|NCT04771741|Cyclobenzaprine|cyclobenzaprine|mesh-list
153910997|NCT04771741|Analgesics|analgesics|mesh-ancestor
153910998|NCT04771741|Sensory System Agents|sensory system agents|mesh-ancestor
153626636|NCT02018094|Teicoplanin|teicoplanin|mesh-list
153626637|NCT02018094|Povidone|povidone|mesh-list
153463708|NCT02666742|Aspirin|aspirin|mesh-list
153910999|NCT04771741|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153911000|NCT04771741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153911001|NCT04771741|Anticonvulsants|anticonvulsants|mesh-ancestor
153560227|NCT01637259|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153560228|NCT01637259|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153560229|NCT01637259|Antimetabolites|antimetabolites|mesh-ancestor
153560230|NCT01637259|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
153560231|NCT01637259|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
153560232|NCT01637259|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
153560233|NCT01637376|Temoporfin|temoporfin|mesh-list
153911002|NCT04771741|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153911003|NCT04771741|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153911004|NCT04771741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153911005|NCT04771741|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153911006|NCT04771741|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153911007|NCT04771741|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153911008|NCT04771741|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153911009|NCT04771741|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153911010|NCT04771741|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153911011|NCT04771741|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153911012|NCT04771741|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153911013|NCT04771741|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153911014|NCT04771741|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153911015|NCT04771741|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153911016|NCT04771741|Antipyretics|antipyretics|mesh-ancestor
153911017|NCT04771741|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
153452740|NCT01818258|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153452741|NCT01818258|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
153452742|NCT01818258|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153452743|NCT01818258|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153452744|NCT01818258|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153452745|NCT01818258|Antimetabolites|antimetabolites|mesh-ancestor
153452746|NCT01817790|Fluticasone|fluticasone|mesh-list
153452747|NCT01817790|Xhance|xhance|mesh-list
153452748|NCT01817790|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153452749|NCT01817790|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153452750|NCT01817790|Autonomic Agents|autonomic agents|mesh-ancestor
153452751|NCT01817790|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153452752|NCT01817790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153452753|NCT01817790|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153452754|NCT01817790|Respiratory System Agents|respiratory system agents|mesh-ancestor
153452755|NCT01817790|Dermatologic Agents|dermatologic agents|mesh-ancestor
153452756|NCT01817790|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
153452757|NCT01793688|Ampicillin|ampicillin|mesh-list
153452758|NCT01793688|Sulbactam|sulbactam|mesh-list
153452759|NCT01793688|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153452760|NCT01793688|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153911018|NCT04771741|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
153911019|NCT04771741|Antidepressive Agents|antidepressive agents|mesh-ancestor
153911020|NCT04771741|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
153911022|NCT02772601|Metoprolol|metoprolol|mesh-list
153911023|NCT02772601|Midazolam|midazolam|mesh-list
153911024|NCT02772601|Caffeine|caffeine|mesh-list
153911025|NCT02772601|Omeprazole|omeprazole|mesh-list
153911026|NCT02772601|Warfarin|warfarin|mesh-list
153911027|NCT02772601|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153911028|NCT02772601|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153911029|NCT02772601|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153911030|NCT02772601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153911031|NCT02772601|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153911032|NCT02772601|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153911033|NCT02772601|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153911034|NCT02772601|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153911035|NCT02772601|Anesthetics, General|anesthetics, general|mesh-ancestor
153911036|NCT02772601|Anesthetics|anesthetics|mesh-ancestor
153911037|NCT02772601|GABA Modulators|gaba modulators|mesh-ancestor
153560270|NCT01637545|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153560271|NCT01637545|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153560272|NCT01637545|Serotonin Agents|serotonin agents|mesh-ancestor
153560273|NCT01637545|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153560274|NCT01637545|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153560275|NCT01637558|Ritonavir|ritonavir|mesh-list
153560276|NCT01637558|Lopinavir|lopinavir|mesh-list
153560277|NCT01637558|Nevirapine|nevirapine|mesh-list
153560283|NCT01637558|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153782670|NCT00234689|Naltrexone|naltrexone|mesh-list
153911038|NCT02772601|GABA Agents|gaba agents|mesh-ancestor
153911039|NCT02772601|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153911040|NCT02772601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153911041|NCT02772601|Anticoagulants|anticoagulants|mesh-ancestor
153911042|NCT02772601|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
153911043|NCT02772601|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
153911044|NCT02772601|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153626638|NCT02018094|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
153911045|NCT02772601|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
153911046|NCT02772601|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
153911047|NCT02772601|Purinergic Agents|purinergic agents|mesh-ancestor
153911048|NCT02772601|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
153911049|NCT02772601|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153911050|NCT02772601|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
153452764|NCT01792830|Metformin|metformin|mesh-list
153911051|NCT02772601|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153911052|NCT02772601|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153911053|NCT02772601|Sympatholytics|sympatholytics|mesh-ancestor
153911054|NCT02772601|Autonomic Agents|autonomic agents|mesh-ancestor
153911055|NCT02772601|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153911056|NCT02772601|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
153911057|NCT02772601|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
153911058|NCT02772601|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
153911059|NCT02772601|Adrenergic Agents|adrenergic agents|mesh-ancestor
153911060|NCT02772211|Cycloserine|cycloserine|mesh-list
153911061|NCT02772211|Ketamine|ketamine|mesh-list
153911062|NCT02772211|Analgesics|analgesics|mesh-ancestor
153911063|NCT02772211|Sensory System Agents|sensory system agents|mesh-ancestor
153911064|NCT02772211|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153911065|NCT02772211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153911066|NCT02772211|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
153911067|NCT02772211|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153911068|NCT02772211|Anesthetics, General|anesthetics, general|mesh-ancestor
153911069|NCT02772211|Anesthetics|anesthetics|mesh-ancestor
153911070|NCT02772211|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153911071|NCT02772211|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
153452793|NCT04414566|Mitosis Modulators|mitosis modulators|mesh-ancestor
153452794|NCT04414566|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153452795|NCT04414566|Immunologic Factors|immunologic factors|mesh-ancestor
153452796|NCT04414566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153452797|NCT01791894|Arsenic Trioxide|arsenic trioxide|mesh-list
153452798|NCT01791894|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153452799|NCT04592016|Diclofenac|diclofenac|mesh-list
153452800|NCT04592016|Coal Tar|coal tar|mesh-list
153452801|NCT04592016|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153452802|NCT04592016|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153452803|NCT04592016|Analgesics|analgesics|mesh-ancestor
153452804|NCT04592016|Sensory System Agents|sensory system agents|mesh-ancestor
153452805|NCT04592016|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153452806|NCT04592016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153452807|NCT04592016|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153452808|NCT04592016|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153452809|NCT04592016|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153452810|NCT04592016|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153452811|NCT04592016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153452812|NCT04592016|Keratolytic Agents|keratolytic agents|mesh-ancestor
153452813|NCT04592016|Dermatologic Agents|dermatologic agents|mesh-ancestor
153452814|NCT01837680|Insulin|insulin|mesh-list
153452815|NCT01837680|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
153452816|NCT01837680|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153560311|NCT01637636|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
153560312|NCT01637636|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
153560313|NCT01637636|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
153560314|NCT01637636|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
153452817|NCT01837680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153452818|NCT01836276|Varenicline|varenicline|mesh-list
153452819|NCT01836276|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
153452820|NCT01836276|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
153911072|NCT02772211|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
153911073|NCT02772211|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153911074|NCT02772211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153911075|NCT02772211|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
153911076|NCT02772211|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153911077|NCT02772211|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
153911078|NCT02772211|Antitubercular Agents|antitubercular agents|mesh-ancestor
153911079|NCT02772211|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153911080|NCT02772211|Antimetabolites|antimetabolites|mesh-ancestor
153911081|NCT04225195|Amphotericin B|amphotericin b|mesh-list
153911082|NCT04225195|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
153911083|NCT04225195|Cholesteryl sulfate|cholesteryl sulfate|mesh-list
153911084|NCT04225195|Amebicides|amebicides|mesh-ancestor
153911085|NCT04225195|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153911086|NCT04225195|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153911087|NCT04225195|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153911088|NCT04225195|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153911089|NCT04225195|Antifungal Agents|antifungal agents|mesh-ancestor
153911090|NCT04225195|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
153452821|NCT01836276|Cholinergic Agents|cholinergic agents|mesh-ancestor
153911091|NCT04225195|Protease Inhibitors|protease inhibitors|mesh-ancestor
153911092|NCT04225195|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153911093|NCT04225195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153911094|NCT04225195|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
153911095|NCT04225195|Protective Agents|protective agents|mesh-ancestor
153811193|NCT00324467|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153911096|NCT04225195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153911097|NCT04225195|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153911099|NCT02771509|Mitosis Modulators|mitosis modulators|mesh-ancestor
153911100|NCT02771509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153911101|NCT02696941|Metformin|metformin|mesh-list
153911102|NCT02696941|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
153911103|NCT02696941|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153911104|NCT02696941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153560320|NCT01637636|Hormone Antagonists|hormone antagonists|mesh-ancestor
153560321|NCT01637636|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153560322|NCT01637636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153560323|NCT01637636|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
153560324|NCT01637675|Tanshinone|tanshinone|mesh-list
153560325|NCT01637675|Sildenafil Citrate|sildenafil citrate|mesh-list
153560362|NCT01637766|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153560363|NCT01637766|Immunologic Factors|immunologic factors|mesh-ancestor
153560364|NCT01637766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153560365|NCT01637818|Acetaminophen|acetaminophen|mesh-list
153911105|NCT02696941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153911106|NCT02767375|Fluorouracil|fluorouracil|mesh-list
153911107|NCT02767375|Oxaliplatin|oxaliplatin|mesh-list
153911108|NCT02767375|Antimetabolites|antimetabolites|mesh-ancestor
153911109|NCT02767375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153911110|NCT02767375|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153911111|NCT02767375|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153911112|NCT02767375|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153911113|NCT02767375|Immunologic Factors|immunologic factors|mesh-ancestor
153911114|NCT02767375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153911115|NCT02767219|Dexamethasone|dexamethasone|mesh-list
153911116|NCT02767219|Bevacizumab|bevacizumab|mesh-list
153452848|NCT01836198|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153452849|NCT01836198|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153452850|NCT01836198|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
153452851|NCT01836198|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153452852|NCT01836198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153452853|NCT01836198|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
153452854|NCT01836198|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153452855|NCT01836198|Antifungal Agents|antifungal agents|mesh-ancestor
153452856|NCT01836198|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
153452857|NCT01836198|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153452858|NCT01836198|Hormone Antagonists|hormone antagonists|mesh-ancestor
153452859|NCT01836198|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153452860|NCT01836198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153357710|NCT00725270|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
153452861|NCT01836198|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153452862|NCT01836198|Antimetabolites|antimetabolites|mesh-ancestor
153452863|NCT01836198|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153452864|NCT01836198|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
153452865|NCT01816074|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
153452866|NCT01816074|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
153452867|NCT01816074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153911118|NCT02767219|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153463829|NCT02983422|Purinergic Agents|purinergic agents|mesh-ancestor
153911119|NCT02767219|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153911120|NCT02767219|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153911121|NCT02767219|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153911122|NCT02767219|Growth Substances|growth substances|mesh-ancestor
153911123|NCT02767219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153911124|NCT02767219|Growth Inhibitors|growth inhibitors|mesh-ancestor
153560431|NCT01638247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153560432|NCT01638247|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153560433|NCT01638247|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153560434|NCT01638247|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
153560435|NCT01638247|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
153560436|NCT01638247|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153560437|NCT01638247|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
153560438|NCT01638247|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153560439|NCT01638247|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153560440|NCT01638247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153911125|NCT02767219|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153911126|NCT02767219|Antiemetics|antiemetics|mesh-ancestor
153911127|NCT02767219|Autonomic Agents|autonomic agents|mesh-ancestor
153911128|NCT02767219|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153911129|NCT02767219|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153911130|NCT02767219|Glucocorticoids|glucocorticoids|mesh-ancestor
153911132|NCT02767219|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153911133|NCT02767219|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153911134|NCT02767219|Antimetabolites|antimetabolites|mesh-ancestor
153911135|NCT02767219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153911136|NCT02767219|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153911137|NCT02767219|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153911138|NCT02767219|Immunologic Factors|immunologic factors|mesh-ancestor
153911140|NCT02771587|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
153911142|NCT02771587|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153911143|NCT02771587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153911144|NCT02771743|Cyclophosphamide|cyclophosphamide|mesh-list
153911145|NCT02771743|Ifosfamide|ifosfamide|mesh-list
153452868|NCT01816074|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
153452869|NCT01816074|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153452870|NCT01816074|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153452871|NCT01816074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153452872|NCT01816074|Dopamine Agents|dopamine agents|mesh-ancestor
153452873|NCT01816074|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153452874|NCT01815918|Hydrocortisone|hydrocortisone|mesh-list
153452875|NCT01815918|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153452876|NCT01789320|Triamcinolone|triamcinolone|mesh-list
153452877|NCT01789320|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
153452878|NCT01789320|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
153452879|NCT01789320|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
153452880|NCT01789320|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153452881|NCT01789320|Glucocorticoids|glucocorticoids|mesh-ancestor
153452882|NCT01789320|Hormones|hormones|mesh-ancestor
153452883|NCT01789320|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153452884|NCT01789320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153560487|NCT01638403|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
153420868|NCT03149887|Sensory System Agents|sensory system agents|mesh-ancestor
153560488|NCT01638403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153560542|NCT01638715|Dermatologic Agents|dermatologic agents|mesh-ancestor
153560543|NCT01638715|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153560544|NCT01638715|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153560545|NCT01638715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153560546|NCT01638715|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153560547|NCT01638767|Contraceptive Agents|contraceptive agents|mesh-list
153560548|NCT01638767|NuvaRing|nuvaring|mesh-list
153560549|NCT01638767|Contraceptives, Oral|contraceptives, oral|mesh-list
153560550|NCT01638767|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153560551|NCT01638767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153560552|NCT01638767|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
153560553|NCT01638767|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
153560554|NCT01638780|Resveratrol|resveratrol|mesh-list
153560555|NCT01638780|Antioxidants|antioxidants|mesh-ancestor
153452885|NCT01789320|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153452886|NCT01789320|Immunologic Factors|immunologic factors|mesh-ancestor
153452887|NCT01789320|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153452888|NCT01789320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153811198|NCT00324467|Alkylating Agents|alkylating agents|mesh-ancestor
153452889|NCT01788228|Vaccines|vaccines|mesh-list
153452890|NCT01788228|Immunologic Factors|immunologic factors|mesh-ancestor
153452891|NCT01788228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153452893|NCT01607346|Anticonvulsants|anticonvulsants|mesh-ancestor
153452894|NCT01607346|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153560558|NCT01638780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153560559|NCT01638780|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153452895|NCT01607346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153452896|NCT01815138|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
153452897|NCT01815138|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153452898|NCT01815138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153452899|NCT01606800|Ribavirin|ribavirin|mesh-list
153452900|NCT01606800|Interferon alpha-2|interferon alpha-2|mesh-list
153452901|NCT01606800|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
153452902|NCT01606800|Antimetabolites|antimetabolites|mesh-ancestor
153452903|NCT01606800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153911146|NCT02771743|Carboplatin|carboplatin|mesh-list
153911147|NCT02771743|Doxorubicin|doxorubicin|mesh-list
153911148|NCT02771743|Etoposide|etoposide|mesh-list
153911149|NCT02771743|Interleukin-2|interleukin-2|mesh-list
153911150|NCT02771743|Isotretinoin|isotretinoin|mesh-list
153911151|NCT02771743|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153911152|NCT02771743|Immunologic Factors|immunologic factors|mesh-ancestor
153911153|NCT02771743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153911154|NCT02771743|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153911155|NCT02771743|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153911156|NCT02771743|Alkylating Agents|alkylating agents|mesh-ancestor
153911157|NCT02771743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153911158|NCT02771743|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153815058|NCT00344825|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153911159|NCT02771743|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153911160|NCT02771743|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153911161|NCT02771743|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153911162|NCT02771743|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153911163|NCT02771743|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153911164|NCT02771743|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153911165|NCT02771743|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153911166|NCT02771743|Analgesics|analgesics|mesh-ancestor
153911167|NCT02771743|Sensory System Agents|sensory system agents|mesh-ancestor
153911168|NCT02771743|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153911169|NCT02771743|Dermatologic Agents|dermatologic agents|mesh-ancestor
153911170|NCT02762851|Vaccines|vaccines|mesh-list
153911171|NCT02762851|Immunologic Factors|immunologic factors|mesh-ancestor
153911172|NCT02762851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153911173|NCT02767063|Pioglitazone|pioglitazone|mesh-list
153911174|NCT02767063|Avelumab|avelumab|mesh-list
153911175|NCT02767063|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153911176|NCT02767063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153911177|NCT02767063|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153911178|NCT02767063|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153911179|NCT04224103|Nitric Oxide|nitric oxide|mesh-list
153911180|NCT04224103|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153911181|NCT04224103|Autonomic Agents|autonomic agents|mesh-ancestor
153911182|NCT04224103|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153911183|NCT04224103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153452906|NCT01606800|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153452908|NCT01814748|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153452909|NCT01814748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153452910|NCT01814670|Botulinum Toxins|botulinum toxins|mesh-list
153452911|NCT01814670|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
153560560|NCT01638780|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153452912|NCT01814670|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
153452913|NCT01814670|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
153452914|NCT01814670|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153452915|NCT01814670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153452916|NCT01814670|Cholinergic Agents|cholinergic agents|mesh-ancestor
153452917|NCT01814670|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153452918|NCT01814670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153452919|NCT01814670|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
153452920|NCT01814670|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153452921|NCT01814046|Aldesleukin|aldesleukin|mesh-list
153452922|NCT01814046|Cyclophosphamide|cyclophosphamide|mesh-list
153452923|NCT01814046|Fludarabine|fludarabine|mesh-list
153452924|NCT01814046|Interleukin-2|interleukin-2|mesh-list
153452925|NCT01814046|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153911184|NCT04224103|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153911185|NCT04224103|Respiratory System Agents|respiratory system agents|mesh-ancestor
153911186|NCT04224103|Free Radical Scavengers|free radical scavengers|mesh-ancestor
153911187|NCT04224103|Antioxidants|antioxidants|mesh-ancestor
153911188|NCT04224103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153911189|NCT04224103|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153911190|NCT04224103|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
153911191|NCT04224103|Vasodilator Agents|vasodilator agents|mesh-ancestor
153911192|NCT04224103|Gasotransmitters|gasotransmitters|mesh-ancestor
153911193|NCT04224103|Protective Agents|protective agents|mesh-ancestor
153911194|NCT02766439|Etanercept|etanercept|mesh-list
153911195|NCT02766439|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153911196|NCT02766439|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153911197|NCT02766439|Analgesics|analgesics|mesh-ancestor
153911198|NCT02766439|Sensory System Agents|sensory system agents|mesh-ancestor
153911199|NCT02766439|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153815059|NCT00344825|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153911200|NCT02766439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153911201|NCT02766439|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153911202|NCT02766439|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153911203|NCT02766439|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153911204|NCT02766439|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153911205|NCT02766439|Immunologic Factors|immunologic factors|mesh-ancestor
153911206|NCT02765971|Picosulfate sodium|picosulfate sodium|mesh-list
153911207|NCT02765971|Cathartics|cathartics|mesh-ancestor
153911208|NCT02765971|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153911209|NCT02765815|Ketorolac|ketorolac|mesh-list
153911210|NCT02765815|Epinephrine|epinephrine|mesh-list
153911211|NCT02765815|Racepinephrine|racepinephrine|mesh-list
153911212|NCT02765815|Morphine|morphine|mesh-list
153626639|NCT02018094|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153626640|NCT02018094|Disinfectants|disinfectants|mesh-ancestor
153626641|NCT02018094|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153626642|NCT02018094|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153626643|NCT02018094|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153626644|NCT02018094|Trace Elements|trace elements|mesh-ancestor
153626645|NCT02018094|Micronutrients|micronutrients|mesh-ancestor
153626646|NCT02018094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153626647|NCT02018094|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
153626648|NCT02018094|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153626649|NCT02018094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153626650|NCT02018094|Plasma Substitutes|plasma substitutes|mesh-ancestor
153560567|NCT01638858|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153560568|NCT01638936|Indatuximab ravtansine|indatuximab ravtansine|mesh-list
153560590|NCT01638962|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153560591|NCT01638962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153560592|NCT01638962|Antipyretics|antipyretics|mesh-ancestor
153626651|NCT02018094|Blood Substitutes|blood substitutes|mesh-ancestor
153626652|NCT02018094|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
153626653|NCT02018133|Vitamin D|vitamin d|mesh-list
153626654|NCT02018133|Ergocalciferols|ergocalciferols|mesh-list
153626655|NCT02018133|Vitamins|vitamins|mesh-ancestor
153626656|NCT02018133|Micronutrients|micronutrients|mesh-ancestor
153626657|NCT02018133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153626658|NCT02018133|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153626659|NCT02018133|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153911214|NCT02765815|Epinephryl borate|epinephryl borate|mesh-list
153911215|NCT02765815|Anesthetics, Local|anesthetics, local|mesh-ancestor
153911216|NCT02765815|Anesthetics|anesthetics|mesh-ancestor
153911217|NCT02765815|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153452926|NCT01814046|Immunologic Factors|immunologic factors|mesh-ancestor
153911218|NCT02765815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153911219|NCT02765815|Sensory System Agents|sensory system agents|mesh-ancestor
153911220|NCT02765815|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153911221|NCT02765815|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153911222|NCT02765815|Narcotics|narcotics|mesh-ancestor
153911223|NCT02765815|Analgesics|analgesics|mesh-ancestor
153911224|NCT02765815|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153911225|NCT02765815|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153911226|NCT02765815|Adrenergic Agents|adrenergic agents|mesh-ancestor
153911227|NCT02765815|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153911228|NCT02765815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153911229|NCT02765815|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
153911230|NCT02765815|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153911231|NCT02765815|Autonomic Agents|autonomic agents|mesh-ancestor
153911232|NCT02765815|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153911233|NCT02765815|Respiratory System Agents|respiratory system agents|mesh-ancestor
153911234|NCT02765815|Mydriatics|mydriatics|mesh-ancestor
153911235|NCT02765815|Sympathomimetics|sympathomimetics|mesh-ancestor
153911236|NCT02765815|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
153911237|NCT02765815|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153911238|NCT02765815|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153911239|NCT02765815|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153452961|NCT01813422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153452962|NCT01813422|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
153452963|NCT01813422|Protease Inhibitors|protease inhibitors|mesh-ancestor
153452964|NCT01813422|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153452965|NCT01813422|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153452966|NCT01786668|Tofacitinib|tofacitinib|mesh-list
153452967|NCT01786668|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
153452968|NCT01786668|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153452969|NCT01786668|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153452970|NCT01786668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153452971|NCT04414254|Cefprozil|cefprozil|mesh-list
153452972|NCT04414254|Beta Lactam Antibiotics|beta lactam antibiotics|mesh-ancestor
153452973|NCT04414254|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153452974|NCT04414254|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153452975|NCT01770912|Triamcinolone|triamcinolone|mesh-list
153452976|NCT01770912|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
153452977|NCT01770912|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
153452978|NCT01770912|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
153452979|NCT01770912|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153911240|NCT02765815|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153911241|NCT02765815|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153911242|NCT02765815|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153811200|NCT00324467|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153811201|NCT00324467|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153911244|NCT02765347|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153560655|NCT01639326|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153911245|NCT02765347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153911246|NCT02770885|Dulaglutide|dulaglutide|mesh-list
153911247|NCT02770885|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
153911248|NCT02770885|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153911249|NCT02770885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153911250|NCT02770651|Everolimus|everolimus|mesh-list
153911251|NCT02770651|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
153911252|NCT02770651|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153911253|NCT02770651|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153911254|NCT02770651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153911255|NCT02770651|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153911256|NCT02770651|Immunologic Factors|immunologic factors|mesh-ancestor
153911257|NCT02770651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153911258|NCT02770651|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153911259|NCT02770729|Moxifloxacin|moxifloxacin|mesh-list
153911260|NCT02770729|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
153911261|NCT02770729|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153911262|NCT02770729|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153911263|NCT02770729|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153811202|NCT00324467|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153911265|NCT02770729|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153911266|NCT02770729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153911267|NCT02770729|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153911268|NCT02770729|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
153911269|NCT02770729|Contraceptive Agents|contraceptive agents|mesh-ancestor
153911270|NCT02770729|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153911279|NCT02770105|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153911280|NCT02770105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153911281|NCT02770105|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
153911282|NCT02770105|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
153911283|NCT02770105|Purinergic Agents|purinergic agents|mesh-ancestor
153911284|NCT02770105|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153911286|NCT02769793|Benserazide|benserazide|mesh-list
153911287|NCT02769793|Benserazide, levodopa drug combination|benserazide, levodopa drug combination|mesh-list
153911288|NCT02769793|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
153911289|NCT02769793|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
153911290|NCT02769793|Dopamine Agents|dopamine agents|mesh-ancestor
153911291|NCT02769793|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153911292|NCT02769793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153911293|NCT02769793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153453017|NCT01810380|Antidepressive Agents|antidepressive agents|mesh-ancestor
153453018|NCT01810380|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153453019|NCT01810380|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153453020|NCT01810380|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153453021|NCT01810380|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153453022|NCT01810380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153453024|NCT01810380|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153453025|NCT01810380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153453026|NCT01810380|Dopamine Agonists|dopamine agonists|mesh-ancestor
153453029|NCT01810302|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153453030|NCT01810302|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153453031|NCT01810302|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153453032|NCT01810302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153453033|NCT01810302|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153453034|NCT01810302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153453035|NCT01810302|Vasodilator Agents|vasodilator agents|mesh-ancestor
153453036|NCT01783938|Nivolumab|nivolumab|mesh-list
153453037|NCT01783938|Ipilimumab|ipilimumab|mesh-list
153453038|NCT01783938|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153453039|NCT01783938|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153453040|NCT01783938|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153453041|NCT01783938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153453042|NCT01768572|Hydroxychloroquine|hydroxychloroquine|mesh-list
153453043|NCT01768572|Sulfasalazine|sulfasalazine|mesh-list
153453044|NCT01768572|Methotrexate|methotrexate|mesh-list
153453045|NCT01768572|Leflunomide|leflunomide|mesh-list
153560663|NCT01639456|Immunologic Factors|immunologic factors|mesh-ancestor
153453046|NCT01768572|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
153453047|NCT01768572|Abortifacient Agents|abortifacient agents|mesh-ancestor
153911294|NCT02769793|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153911296|NCT02769325|Atropine|atropine|mesh-list
153911297|NCT02769325|Morphine|morphine|mesh-list
153911298|NCT02769325|Propofol|propofol|mesh-list
153911299|NCT02769325|Sevoflurane|sevoflurane|mesh-list
153560670|NCT01639456|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153911300|NCT02769325|Rocuronium|rocuronium|mesh-list
153911301|NCT02769325|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153911302|NCT02769325|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153911303|NCT02769325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153911304|NCT02769325|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153911305|NCT02769325|Anesthetics, General|anesthetics, general|mesh-ancestor
153911306|NCT02769325|Anesthetics|anesthetics|mesh-ancestor
153911307|NCT02769325|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153911308|NCT02769325|Narcotics|narcotics|mesh-ancestor
153911309|NCT02769325|Analgesics|analgesics|mesh-ancestor
153911310|NCT02769325|Sensory System Agents|sensory system agents|mesh-ancestor
153911311|NCT02769325|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153911312|NCT02769325|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153911313|NCT02769325|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
153911314|NCT02769325|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153911315|NCT02769325|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153911316|NCT02769325|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153911317|NCT02769325|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153911318|NCT02769325|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153911319|NCT02769325|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153911320|NCT02769325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153911321|NCT02769325|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
153911322|NCT02769325|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
153911323|NCT02769325|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
153911324|NCT02769325|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153911325|NCT02769325|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153453048|NCT01768572|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153453049|NCT01768572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153453050|NCT01768572|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153453051|NCT01768572|Antimetabolites|antimetabolites|mesh-ancestor
153453052|NCT01768572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153453053|NCT01768572|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153626660|NCT02018159|Menotropins|menotropins|mesh-list
153626661|NCT02018159|Fertility Agents, Female|fertility agents, female|mesh-ancestor
153626662|NCT02018159|Fertility Agents|fertility agents|mesh-ancestor
153626663|NCT02018159|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153626664|NCT02018159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153626665|NCT02018250|Benzyl Alcohol|benzyl alcohol|mesh-list
153626666|NCT02018250|Anesthetics, Local|anesthetics, local|mesh-ancestor
153626667|NCT02018250|Anesthetics|anesthetics|mesh-ancestor
153626668|NCT02018250|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153626669|NCT02018250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153626670|NCT02018250|Sensory System Agents|sensory system agents|mesh-ancestor
153626671|NCT02018250|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153626672|NCT02018276|Lidocaine|lidocaine|mesh-list
153811204|NCT00324467|Autonomic Agents|autonomic agents|mesh-ancestor
153811205|NCT00324467|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153626674|NCT02018276|Anesthetics|anesthetics|mesh-ancestor
153626675|NCT02018276|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153626676|NCT02018276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153626677|NCT02018276|Sensory System Agents|sensory system agents|mesh-ancestor
153626678|NCT02018276|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153626679|NCT02018276|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153626680|NCT02018276|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
153626681|NCT02018276|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153626682|NCT02018276|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153560671|NCT01639456|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153560672|NCT01639456|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153626683|NCT02018276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153626685|NCT02018289|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
153626686|NCT02018289|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153626687|NCT02018289|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
153453054|NCT01768572|Dermatologic Agents|dermatologic agents|mesh-ancestor
153453055|NCT01768572|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153453056|NCT01768572|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153453057|NCT01768572|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153453058|NCT01768572|Immunologic Factors|immunologic factors|mesh-ancestor
153453059|NCT01768572|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153453060|NCT01768572|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153453061|NCT01768572|Antimalarials|antimalarials|mesh-ancestor
153453062|NCT01768572|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153453063|NCT01768572|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153453064|NCT01768572|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153911326|NCT02769325|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153911327|NCT02769325|Autonomic Agents|autonomic agents|mesh-ancestor
153911328|NCT02769325|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153911329|NCT02769325|Respiratory System Agents|respiratory system agents|mesh-ancestor
153911330|NCT02769325|Mydriatics|mydriatics|mesh-ancestor
153911331|NCT02769325|Parasympatholytics|parasympatholytics|mesh-ancestor
153911332|NCT02769325|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
153911333|NCT02769325|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
153911334|NCT02769325|Cholinergic Agents|cholinergic agents|mesh-ancestor
153911335|NCT02769325|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153911337|NCT02770261|Candesartan cilexetil|candesartan cilexetil|mesh-list
153911338|NCT02770261|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
153911339|NCT02770261|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153911340|NCT02770261|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153911341|NCT02770261|Antimetabolites|antimetabolites|mesh-ancestor
153911342|NCT02770261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153911343|NCT02770261|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153911344|NCT02770261|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
153911345|NCT02770261|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153911346|NCT02770261|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153911347|NCT02770261|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
153911348|NCT02770261|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
153911350|NCT04224649|Hyaluronic Acid|hyaluronic acid|mesh-list
153911351|NCT04224649|Anesthetics, Local|anesthetics, local|mesh-ancestor
153911352|NCT04224649|Anesthetics|anesthetics|mesh-ancestor
153911353|NCT04224649|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153911354|NCT04224649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153911355|NCT04224649|Sensory System Agents|sensory system agents|mesh-ancestor
153911356|NCT04224649|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153911357|NCT04224649|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153911358|NCT04224649|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
153911359|NCT04224649|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153911360|NCT04224649|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153911361|NCT04224649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153911362|NCT04224649|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153911363|NCT04224649|Immunologic Factors|immunologic factors|mesh-ancestor
153911364|NCT04224649|Viscosupplements|viscosupplements|mesh-ancestor
153911365|NCT04224649|Protective Agents|protective agents|mesh-ancestor
153911366|NCT02769169|Ranibizumab|ranibizumab|mesh-list
153911367|NCT02769169|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153911368|NCT02769169|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153911369|NCT02769169|Growth Substances|growth substances|mesh-ancestor
153911370|NCT02769169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153911371|NCT02769169|Growth Inhibitors|growth inhibitors|mesh-ancestor
153911372|NCT02769169|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153911374|NCT02769013|Anthelmintics|anthelmintics|mesh-ancestor
153911375|NCT02769013|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153560710|NCT01639794|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
153911376|NCT02769013|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153911378|NCT02768545|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153911379|NCT02768545|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153911380|NCT02768545|Antimetabolites|antimetabolites|mesh-ancestor
153911381|NCT02768545|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153911382|NCT02768545|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153453106|NCT01809132|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153453108|NCT01809132|Hormones|hormones|mesh-ancestor
153453109|NCT01809132|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153453110|NCT01809132|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
153453111|NCT01809132|Protective Agents|protective agents|mesh-ancestor
153453112|NCT01809132|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153453113|NCT01809132|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153453114|NCT01809132|Trace Elements|trace elements|mesh-ancestor
153453115|NCT01809132|Micronutrients|micronutrients|mesh-ancestor
153453116|NCT01809132|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
153453117|NCT01809132|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153453118|NCT01809132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153453119|NCT01809132|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153453120|NCT01809132|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
153453121|NCT01809132|Vasodilator Agents|vasodilator agents|mesh-ancestor
153453122|NCT01809132|Free Radical Scavengers|free radical scavengers|mesh-ancestor
153453123|NCT01809132|Antioxidants|antioxidants|mesh-ancestor
153453124|NCT01809132|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153453125|NCT01809132|Astringents|astringents|mesh-ancestor
153453126|NCT01809132|Dermatologic Agents|dermatologic agents|mesh-ancestor
153453127|NCT01766778|Metformin|metformin|mesh-list
153453128|NCT01766778|Vildagliptin|vildagliptin|mesh-list
153453129|NCT01766778|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153453130|NCT01766778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153453131|NCT01766778|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
153453132|NCT01766778|Protease Inhibitors|protease inhibitors|mesh-ancestor
153453133|NCT01766778|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153453134|NCT01766778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153453135|NCT01808196|Losartan|losartan|mesh-list
153453136|NCT01808196|Angiotensin II|angiotensin ii|mesh-list
153453137|NCT01808196|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-list
153453138|NCT01808196|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153911383|NCT02764723|Bupivacaine|bupivacaine|mesh-list
153911384|NCT02764723|Ropivacaine|ropivacaine|mesh-list
153911385|NCT02764723|Anesthetics, Local|anesthetics, local|mesh-ancestor
153911386|NCT02764723|Anesthetics|anesthetics|mesh-ancestor
153911387|NCT02764723|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153911388|NCT02764723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153911389|NCT02764723|Sensory System Agents|sensory system agents|mesh-ancestor
153911390|NCT02764723|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153453139|NCT01808196|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153911391|NCT04664959|Denosumab|denosumab|mesh-list
153911392|NCT04664959|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153560722|NCT01639885|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153560723|NCT01639885|Antiviral Agents|antiviral agents|mesh-ancestor
153560724|NCT01639885|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153560725|NCT01639885|Immunologic Factors|immunologic factors|mesh-ancestor
153560726|NCT01639885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153560727|NCT01639898|Dexamethasone|dexamethasone|mesh-list
153560728|NCT01639898|Dexamethasone acetate|dexamethasone acetate|mesh-list
153560729|NCT01639898|Lenalidomide|lenalidomide|mesh-list
153560730|NCT01639898|BB 1101|bb 1101|mesh-list
153911393|NCT04664959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153911394|NCT00951496|Paclitaxel|paclitaxel|mesh-list
153911395|NCT00951496|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
153911396|NCT00951496|Bevacizumab|bevacizumab|mesh-list
153911397|NCT00951496|Cisplatin|cisplatin|mesh-list
153911398|NCT00951496|Carboplatin|carboplatin|mesh-list
153911399|NCT00951496|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
153911400|NCT00951496|Endothelial Growth Factors|endothelial growth factors|mesh-list
153911401|NCT00951496|Antibodies|antibodies|mesh-list
153911402|NCT00951496|Immunoglobulins|immunoglobulins|mesh-list
153911403|NCT00951496|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
153911404|NCT00951496|Immunoglobulin G|immunoglobulin g|mesh-list
153911405|NCT00951496|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153911406|NCT00951496|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153911407|NCT00951496|Tubulin Modulators|tubulin modulators|mesh-ancestor
153911408|NCT00951496|Antimitotic Agents|antimitotic agents|mesh-ancestor
153911409|NCT00951496|Mitosis Modulators|mitosis modulators|mesh-ancestor
153911410|NCT00951496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153911411|NCT00951496|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153911412|NCT00951496|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153911413|NCT00951496|Growth Substances|growth substances|mesh-ancestor
153911414|NCT00951496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153911415|NCT00951496|Growth Inhibitors|growth inhibitors|mesh-ancestor
153911416|NCT00951496|Immunologic Factors|immunologic factors|mesh-ancestor
153911417|NCT02764411|Brimonidine Tartrate|brimonidine tartrate|mesh-list
153911418|NCT02764411|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153911419|NCT02764411|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
153911420|NCT02764411|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153911421|NCT02764411|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153911422|NCT02764411|Adrenergic Agents|adrenergic agents|mesh-ancestor
153911423|NCT02764411|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153911424|NCT02764411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153453148|NCT01782690|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
153453149|NCT01782690|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153453150|NCT01782690|Antimetabolites|antimetabolites|mesh-ancestor
153453151|NCT01782690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153453152|NCT01782690|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153560753|NCT01640743|Prednisolone|prednisolone|mesh-list
153560754|NCT01640743|Prednisolone acetate|prednisolone acetate|mesh-list
153560755|NCT01640743|Everolimus|everolimus|mesh-list
153560756|NCT01640743|Tacrolimus|tacrolimus|mesh-list
153560757|NCT01640743|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
153560759|NCT01640743|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153560760|NCT01640743|Immunologic Factors|immunologic factors|mesh-ancestor
153560761|NCT01640743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153560762|NCT01640743|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
153560763|NCT01640743|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153560764|NCT01640743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153560765|NCT01640743|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
153560766|NCT01640743|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153560816|NCT01642979|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153560817|NCT01642979|Immunologic Factors|immunologic factors|mesh-ancestor
153560819|NCT01642979|Antifungal Agents|antifungal agents|mesh-ancestor
153453153|NCT01782690|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153453154|NCT01782690|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153453155|NCT01782690|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153453157|NCT01766310|Hematinics|hematinics|mesh-ancestor
153453158|NCT01766310|Vitamin B Complex|vitamin b complex|mesh-ancestor
153453159|NCT01766310|Vitamins|vitamins|mesh-ancestor
153453160|NCT01766310|Micronutrients|micronutrients|mesh-ancestor
153453161|NCT01766310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153453162|NCT01782222|Rotigotine|rotigotine|mesh-list
153453163|NCT01782222|Dopamine Agonists|dopamine agonists|mesh-ancestor
153453164|NCT01782222|Dopamine Agents|dopamine agents|mesh-ancestor
153453165|NCT01782222|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153453166|NCT01782222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153453167|NCT01782222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153453168|NCT01807182|Aldesleukin|aldesleukin|mesh-list
153453169|NCT01807182|Cyclophosphamide|cyclophosphamide|mesh-list
153453170|NCT01807182|Fludarabine|fludarabine|mesh-list
153453171|NCT01807182|Fludarabine phosphate|fludarabine phosphate|mesh-list
153453172|NCT01807182|Interleukin-2|interleukin-2|mesh-list
153911425|NCT02764411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153911426|NCT02768077|Melatonin|melatonin|mesh-list
153911428|NCT02768077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153911430|NCT02768077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153915514|NCT00616213|Lenograstim|lenograstim|mesh-list
153911431|NCT02768077|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153911432|NCT01193244|Prednisone|prednisone|mesh-list
153911433|NCT01193244|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153911434|NCT01193244|Glucocorticoids|glucocorticoids|mesh-ancestor
153911435|NCT01193244|Hormones|hormones|mesh-ancestor
153911436|NCT01193244|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153911437|NCT01193244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153911438|NCT01193244|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153911439|NCT01193244|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153911440|NCT04224337|Doxorubicin|doxorubicin|mesh-list
153911441|NCT04224337|Durvalumab|durvalumab|mesh-list
153911442|NCT04224337|Ifosfamide|ifosfamide|mesh-list
153911443|NCT04224337|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153911444|NCT04224337|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153911445|NCT04224337|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153911446|NCT04224337|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153911447|NCT04224337|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153911448|NCT04224337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153560825|NCT01642979|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153560826|NCT01642979|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153560827|NCT01642979|Antinematodal Agents|antinematodal agents|mesh-ancestor
153560828|NCT01642979|Anthelmintics|anthelmintics|mesh-ancestor
153560829|NCT01642979|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153560830|NCT01643031|Clopidogrel|clopidogrel|mesh-list
153560831|NCT01643031|Ticagrelor|ticagrelor|mesh-list
153782674|NCT00234689|Sensory System Agents|sensory system agents|mesh-ancestor
153560840|NCT01643434|Clonidine|clonidine|mesh-list
153560873|NCT01645839|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153453173|NCT01807182|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153453174|NCT01807182|Immunologic Factors|immunologic factors|mesh-ancestor
153911449|NCT04224337|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153911450|NCT04224337|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153911451|NCT04224337|Alkylating Agents|alkylating agents|mesh-ancestor
153911452|NCT02764021|Hypoglycemic Agents|hypoglycemic agents|mesh-list
153911453|NCT02764021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153911454|NCT02762617|Tenofovir|tenofovir|mesh-list
153911455|NCT02762617|Antiviral Agents|antiviral agents|mesh-ancestor
153911456|NCT02762617|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153911457|NCT02762617|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153911458|NCT02762617|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153911459|NCT02762617|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153911460|NCT02762617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153911461|NCT02762617|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153911462|NCT02762617|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153911463|NCT01192152|Metformin|metformin|mesh-list
153911464|NCT01192152|Saxagliptin|saxagliptin|mesh-list
153911465|NCT01192152|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153911466|NCT01192152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153911467|NCT01192152|Incretins|incretins|mesh-ancestor
153911468|NCT01192152|Hormones|hormones|mesh-ancestor
153911469|NCT01192152|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153911470|NCT01192152|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
153453198|NCT01780974|Protective Agents|protective agents|mesh-ancestor
153453199|NCT01780974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153453200|NCT01780974|Vitamin B Complex|vitamin b complex|mesh-ancestor
153453201|NCT01780974|Vitamins|vitamins|mesh-ancestor
153453202|NCT01780974|Micronutrients|micronutrients|mesh-ancestor
153453203|NCT01780662|Gemcitabine|gemcitabine|mesh-list
153453204|NCT01780662|Brentuximab Vedotin|brentuximab vedotin|mesh-list
153453205|NCT01780662|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
153453206|NCT01780662|Antibodies|antibodies|mesh-list
153453207|NCT01780662|Immunoglobulins|immunoglobulins|mesh-list
153453208|NCT01780662|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
153453209|NCT01780662|Immunoconjugates|immunoconjugates|mesh-list
153453210|NCT01780662|Immunologic Factors|immunologic factors|mesh-ancestor
153560886|NCT01646437|Micronutrients|micronutrients|mesh-ancestor
153560887|NCT01646437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153560888|NCT01646437|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153560889|NCT01646437|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153560890|NCT01646437|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153560891|NCT01646437|Analgesics|analgesics|mesh-ancestor
153560892|NCT01646437|Sensory System Agents|sensory system agents|mesh-ancestor
153560924|NCT01647880|Immunologic Factors|immunologic factors|mesh-ancestor
153560925|NCT01647880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153560926|NCT01647880|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153560927|NCT01648218|Insulin|insulin|mesh-list
153560928|NCT01648218|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
153560929|NCT01648218|Insulin Glargine|insulin glargine|mesh-list
153560930|NCT01648218|Insulin Aspart|insulin aspart|mesh-list
153453211|NCT01780662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153453212|NCT01780662|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153453213|NCT01780662|Antimetabolites|antimetabolites|mesh-ancestor
153453214|NCT01780662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153453215|NCT01780662|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153453216|NCT01780662|Immunotoxins|immunotoxins|mesh-ancestor
153453217|NCT01780506|Elvitegravir, Cobicistat, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|elvitegravir, cobicistat, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
153453219|NCT01780506|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153453220|NCT01780506|Antiviral Agents|antiviral agents|mesh-ancestor
153453221|NCT01780506|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153453222|NCT01762800|Fluticasone|fluticasone|mesh-list
153453224|NCT01762800|Bromides|bromides|mesh-list
153453225|NCT01762800|Tiotropium Bromide|tiotropium bromide|mesh-list
153453226|NCT01762800|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
153453227|NCT01762800|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
153453228|NCT01762800|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153626688|NCT02018289|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153626689|NCT02018289|Antimetabolites|antimetabolites|mesh-ancestor
153626690|NCT02018289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153626691|NCT02018289|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153626692|NCT02018328|Curcumin|curcumin|mesh-list
153626693|NCT02018328|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153626694|NCT02018328|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153626695|NCT02018328|Analgesics|analgesics|mesh-ancestor
153626696|NCT02018328|Sensory System Agents|sensory system agents|mesh-ancestor
153626697|NCT02018328|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153626698|NCT02018328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153626699|NCT02018328|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153626700|NCT02018328|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153626701|NCT02018328|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153626702|NCT02018328|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153626703|NCT02018328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153626704|NCT02018367|Proflavine|proflavine|mesh-list
153626705|NCT02018367|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
153626706|NCT02018367|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153626707|NCT02018419|Vaccines|vaccines|mesh-list
153626708|NCT02018419|Immunologic Factors|immunologic factors|mesh-ancestor
153626709|NCT02018419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153626710|NCT02018523|Lenalidomide|lenalidomide|mesh-list
153453229|NCT01762800|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153560943|NCT01648465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153560944|NCT01648465|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153560945|NCT01648465|Immunologic Factors|immunologic factors|mesh-ancestor
153560946|NCT01648465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153560947|NCT01648465|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153560948|NCT01648777|Bupivacaine|bupivacaine|mesh-list
153560949|NCT01648777|Anesthetics, Local|anesthetics, local|mesh-ancestor
153560950|NCT01648777|Anesthetics|anesthetics|mesh-ancestor
153560971|NCT01650012|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153453230|NCT01762800|Autonomic Agents|autonomic agents|mesh-ancestor
153811216|NCT00324467|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153811217|NCT00324467|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153811218|NCT00324467|Tubulin Modulators|tubulin modulators|mesh-ancestor
153911471|NCT01192152|Protease Inhibitors|protease inhibitors|mesh-ancestor
153911472|NCT01192152|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153911473|NCT01192152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153911474|NCT02758249|Propofol|propofol|mesh-list
153911476|NCT02758249|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153453231|NCT01762800|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153453232|NCT01762800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153911477|NCT02758249|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153911478|NCT02758249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153911479|NCT02758249|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153911480|NCT02758249|Anesthetics, General|anesthetics, general|mesh-ancestor
153911481|NCT02758249|Anesthetics|anesthetics|mesh-ancestor
153911482|NCT02758249|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153911483|NCT02758249|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
153911484|NCT02758405|Fentanyl|fentanyl|mesh-list
153911485|NCT02758405|Bupivacaine|bupivacaine|mesh-list
153911486|NCT02758405|Anesthetics, Local|anesthetics, local|mesh-ancestor
153911487|NCT02758405|Anesthetics|anesthetics|mesh-ancestor
153911488|NCT02758405|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153911489|NCT02758405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153911490|NCT02758405|Sensory System Agents|sensory system agents|mesh-ancestor
153911491|NCT02758405|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153911492|NCT02758405|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153911493|NCT02758405|Narcotics|narcotics|mesh-ancestor
153911494|NCT02758405|Analgesics|analgesics|mesh-ancestor
153911495|NCT02758405|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153911496|NCT02758405|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153911497|NCT02758405|Anesthetics, General|anesthetics, general|mesh-ancestor
153911498|NCT02758327|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
153911499|NCT02758327|Ophthalmic Solutions|ophthalmic solutions|mesh-list
153911500|NCT02758327|Lubricant Eye Drops|lubricant eye drops|mesh-list
153911501|NCT02758327|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
153911502|NCT02758327|Laxatives|laxatives|mesh-ancestor
153911503|NCT02758327|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153911504|NCT02763475|Cyclophosphamide|cyclophosphamide|mesh-list
153911505|NCT02763475|Fludarabine|fludarabine|mesh-list
153560982|NCT01650129|Biphasic Insulins|biphasic insulins|mesh-list
153560983|NCT01650129|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153560984|NCT01650129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153560985|NCT01650181|Thioctic Acid|thioctic acid|mesh-list
153560986|NCT01650181|Selenium|selenium|mesh-list
153560987|NCT01650181|Metformin|metformin|mesh-list
153560988|NCT01650181|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153560990|NCT01650181|Antioxidants|antioxidants|mesh-ancestor
153561029|NCT01650428|Growth Inhibitors|growth inhibitors|mesh-ancestor
153561030|NCT01650428|Antimetabolites|antimetabolites|mesh-ancestor
153561031|NCT01650428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153561092|NCT01650662|Cyclosporins|cyclosporins|mesh-list
153911506|NCT02763475|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153911507|NCT02763475|Immunologic Factors|immunologic factors|mesh-ancestor
153911508|NCT02763475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153911509|NCT02763475|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153911510|NCT02763475|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153911511|NCT02763475|Alkylating Agents|alkylating agents|mesh-ancestor
153453239|NCT01762800|Cholinergic Agents|cholinergic agents|mesh-ancestor
153453240|NCT01762800|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153453241|NCT01762800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153453242|NCT01762800|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
153453243|NCT01762800|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
153453244|NCT01762800|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153453245|NCT01762800|Adrenergic Agents|adrenergic agents|mesh-ancestor
153453246|NCT01762800|Anticonvulsants|anticonvulsants|mesh-ancestor
153453247|NCT01762800|Glucocorticoids|glucocorticoids|mesh-ancestor
153453249|NCT01762800|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153453250|NCT01762800|Sympathomimetics|sympathomimetics|mesh-ancestor
153453251|NCT01778010|Cocaine|cocaine|mesh-list
153453252|NCT01778010|Modafinil|modafinil|mesh-list
153453253|NCT01778010|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
153453254|NCT01778010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153453255|NCT01778010|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
153911512|NCT02763475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153911513|NCT02763475|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153911514|NCT02763475|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153911515|NCT02762383|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
153911516|NCT02762383|Antiviral Agents|antiviral agents|mesh-ancestor
153911517|NCT02762383|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153911518|NCT02758015|Betaine|betaine|mesh-list
153811223|NCT00324467|Sensory System Agents|sensory system agents|mesh-ancestor
153357734|NCT00762710|Prazosin|prazosin|mesh-list
153911519|NCT02758015|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153911520|NCT02758015|Lipotropic Agents|lipotropic agents|mesh-ancestor
153911521|NCT02758015|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153911522|NCT02758015|Antimetabolites|antimetabolites|mesh-ancestor
153911523|NCT02758015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153561099|NCT01650662|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153561100|NCT01650662|Dermatologic Agents|dermatologic agents|mesh-ancestor
153561101|NCT01650662|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153561102|NCT01650662|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
153561103|NCT01650727|Rituximab|rituximab|mesh-list
153561116|NCT01650740|Analgesics|analgesics|mesh-ancestor
153561153|NCT01651169|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
153561154|NCT01651169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153561155|NCT01651169|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
153561156|NCT01651169|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153561157|NCT01651169|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153561159|NCT01651169|Dopamine Agents|dopamine agents|mesh-ancestor
153911524|NCT02758015|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153911525|NCT02757703|Terlipressin|terlipressin|mesh-list
153911526|NCT02757703|Pantoprazole|pantoprazole|mesh-list
153911527|NCT02757703|Somatostatin|somatostatin|mesh-list
153911528|NCT02757703|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
153911529|NCT02757703|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153911530|NCT02757703|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
153911531|NCT02757703|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153911532|NCT02757703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153911533|NCT02757703|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153911534|NCT02757703|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
153911535|NCT02757703|Hormones|hormones|mesh-ancestor
153911536|NCT02757703|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153911537|NCT02757703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153911538|NCT02763007|Pioglitazone|pioglitazone|mesh-list
153911539|NCT02763007|Alogliptin|alogliptin|mesh-list
153911540|NCT02763007|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153911541|NCT02763007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153911542|NCT02763007|Incretins|incretins|mesh-ancestor
153911543|NCT02763007|Hormones|hormones|mesh-ancestor
153911544|NCT02763007|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153911545|NCT02763007|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
153911546|NCT02763007|Protease Inhibitors|protease inhibitors|mesh-ancestor
153911547|NCT02763007|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153911548|NCT02763007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153911549|NCT00635323|Capecitabine|capecitabine|mesh-list
153911550|NCT00635323|Irinotecan|irinotecan|mesh-list
153911551|NCT00635323|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153911552|NCT00635323|Antimetabolites|antimetabolites|mesh-ancestor
153911553|NCT00635323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153911554|NCT00635323|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153911555|NCT00635323|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
153915638|NCT00615745|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153911556|NCT00635323|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153911557|NCT00635323|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153911558|NCT01191840|Vancomycin|vancomycin|mesh-list
153911559|NCT01191840|Cefazolin|cefazolin|mesh-list
153911560|NCT01191840|Daptomycin|daptomycin|mesh-list
153911561|NCT01191840|Cloxacillin|cloxacillin|mesh-list
153911562|NCT01191840|Oxacillin|oxacillin|mesh-list
153911563|NCT01191840|Nafcillin|nafcillin|mesh-list
153911564|NCT01191840|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153911565|NCT01191840|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153911566|NCT02752555|Antioxidants|antioxidants|mesh-list
153911567|NCT02752555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153911568|NCT02752555|Protective Agents|protective agents|mesh-ancestor
153561219|NCT01651390|Mitosis Modulators|mitosis modulators|mesh-ancestor
153561220|NCT01651390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153561221|NCT01651390|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153561222|NCT01651390|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153561223|NCT01651390|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153561224|NCT01651390|Antifungal Agents|antifungal agents|mesh-ancestor
153561225|NCT01651390|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153561226|NCT01651390|Immunologic Factors|immunologic factors|mesh-ancestor
153561227|NCT01651390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153561228|NCT01651416|Lumefantrine|lumefantrine|mesh-list
153561229|NCT01651416|Artemether|artemether|mesh-list
153561230|NCT01651416|Pyrimethamine|pyrimethamine|mesh-list
153561231|NCT01651416|Piperaquine|piperaquine|mesh-list
153911569|NCT02752555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153911570|NCT00624546|Lansoprazole|lansoprazole|mesh-list
153453296|NCT01777152|Prednisone|prednisone|mesh-list
153453297|NCT01777152|Cyclophosphamide|cyclophosphamide|mesh-list
153453298|NCT01777152|Doxorubicin|doxorubicin|mesh-list
153453299|NCT01777152|Vincristine|vincristine|mesh-list
153453300|NCT01777152|Brentuximab Vedotin|brentuximab vedotin|mesh-list
153357736|NCT00762710|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
153453302|NCT01777152|Immunologic Factors|immunologic factors|mesh-ancestor
153453303|NCT01777152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153453304|NCT01777152|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153453305|NCT01777152|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153453306|NCT01777152|Alkylating Agents|alkylating agents|mesh-ancestor
153453307|NCT01777152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153453308|NCT01777152|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153453309|NCT01777152|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153453310|NCT01777152|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153453311|NCT01777152|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153453312|NCT01777152|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153453313|NCT01777152|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153453314|NCT01777152|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153453316|NCT01777152|Hormones|hormones|mesh-ancestor
153453317|NCT01777152|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153911571|NCT00624546|Dexlansoprazole|dexlansoprazole|mesh-list
153911572|NCT00624546|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
153911573|NCT00624546|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153911574|NCT00624546|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
153911575|NCT00624546|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153911576|NCT00624546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153911577|NCT02757469|Drospirenone|drospirenone|mesh-list
153911578|NCT02757469|Ethinyl Estradiol|ethinyl estradiol|mesh-list
153911579|NCT02757469|Drospirenone and ethinyl estradiol combination|drospirenone and ethinyl estradiol combination|mesh-list
153911580|NCT02757469|Estradiol|estradiol|mesh-list
153911581|NCT02757469|Estrogens|estrogens|mesh-ancestor
153911582|NCT02757469|Hormones|hormones|mesh-ancestor
153911583|NCT02757469|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153911584|NCT02757469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153911585|NCT02757469|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
153911586|NCT02757469|Contraceptive Agents|contraceptive agents|mesh-ancestor
153911587|NCT02757469|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153911588|NCT02757469|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
153911589|NCT02757469|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
153911590|NCT02757469|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
153811229|NCT00324467|Serotonin Agents|serotonin agents|mesh-ancestor
153811230|NCT00324467|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153357737|NCT00762710|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
153357738|NCT00762710|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
153911591|NCT02757469|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
153911592|NCT02757469|Hormone Antagonists|hormone antagonists|mesh-ancestor
153911593|NCT02757469|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
153911594|NCT02757469|Diuretics|diuretics|mesh-ancestor
153911595|NCT02757469|Natriuretic Agents|natriuretic agents|mesh-ancestor
153911596|NCT02757391|Aldesleukin|aldesleukin|mesh-list
153911597|NCT02757391|Cyclophosphamide|cyclophosphamide|mesh-list
153911598|NCT02757391|Pembrolizumab|pembrolizumab|mesh-list
153911599|NCT02757391|Interleukin-2|interleukin-2|mesh-list
153911600|NCT02757391|Immunologic Factors|immunologic factors|mesh-list
153911601|NCT02757391|Immunomodulating Agents|immunomodulating agents|mesh-list
153911602|NCT02757391|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153911603|NCT02757391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153453333|NCT01733316|Cysteamine|cysteamine|mesh-list
153911604|NCT02757391|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153911605|NCT02757391|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153911606|NCT02757391|Alkylating Agents|alkylating agents|mesh-ancestor
153911607|NCT02757391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153911608|NCT02757391|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153911609|NCT02757391|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153911610|NCT02757391|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153911611|NCT02757391|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153911612|NCT02757391|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153911614|NCT02757391|Sensory System Agents|sensory system agents|mesh-ancestor
153911615|NCT02757391|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153911616|NCT02757391|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153911617|NCT02757391|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153911618|NCT02757391|Antiviral Agents|antiviral agents|mesh-ancestor
153911619|NCT02757391|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153911620|NCT02757079|Melatonin|melatonin|mesh-list
153911621|NCT02757079|Antioxidants|antioxidants|mesh-ancestor
153911622|NCT02757079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153911623|NCT02757079|Protective Agents|protective agents|mesh-ancestor
153453351|NCT01732770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153453353|NCT01774968|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153453354|NCT01774968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153453355|NCT01732536|Mometasone Furoate|mometasone furoate|mesh-list
153453356|NCT01732536|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153453357|NCT01732536|Dermatologic Agents|dermatologic agents|mesh-ancestor
153453358|NCT01732536|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
153453359|NCT01755702|Acetaminophen|acetaminophen|mesh-list
153453360|NCT01755702|Ibuprofen|ibuprofen|mesh-list
153453361|NCT01755702|Caffeine|caffeine|mesh-list
153453362|NCT01755702|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153453363|NCT01755702|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153453364|NCT01755702|Analgesics|analgesics|mesh-ancestor
153453365|NCT01755702|Sensory System Agents|sensory system agents|mesh-ancestor
153453366|NCT01755702|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153453367|NCT01755702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153453368|NCT01755702|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153453369|NCT01755702|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153453370|NCT01755702|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153453371|NCT01755702|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153453372|NCT01755702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153453373|NCT01755702|Antipyretics|antipyretics|mesh-ancestor
153561248|NCT01651481|Respiratory System Agents|respiratory system agents|mesh-ancestor
153561255|NCT01651481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153561256|NCT01651481|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
153561257|NCT01651481|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
153561258|NCT01651481|Histamine Antagonists|histamine antagonists|mesh-ancestor
153561259|NCT01651481|Histamine Agents|histamine agents|mesh-ancestor
153561260|NCT01651481|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153561261|NCT01651520|Flumazenil|flumazenil|mesh-list
153561262|NCT01651520|Antidotes|antidotes|mesh-ancestor
153561263|NCT01651520|Protective Agents|protective agents|mesh-ancestor
153561264|NCT01651520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153561265|NCT01651520|GABA Modulators|gaba modulators|mesh-ancestor
153561266|NCT01651520|GABA Agents|gaba agents|mesh-ancestor
153561267|NCT01651520|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153561268|NCT01651520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153453374|NCT01755702|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
153453375|NCT01755702|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
153453376|NCT01755702|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
153453377|NCT01755702|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
153453378|NCT01755702|Purinergic Agents|purinergic agents|mesh-ancestor
153453379|NCT01755702|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153453380|NCT01732458|Ondansetron|ondansetron|mesh-list
153811233|NCT00324467|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153911624|NCT02757079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153911625|NCT02757079|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153911626|NCT02768389|Bevacizumab|bevacizumab|mesh-list
153911627|NCT02768389|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153911628|NCT02768389|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153911629|NCT02768389|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153911630|NCT02768389|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153911631|NCT02768389|Growth Substances|growth substances|mesh-ancestor
153911632|NCT02768389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153911633|NCT02768389|Growth Inhibitors|growth inhibitors|mesh-ancestor
153911634|NCT04529005|Angiotensin II|angiotensin ii|mesh-list
153911635|NCT04529005|Giapreza|giapreza|mesh-list
153911636|NCT04529005|Angiotensinogen|angiotensinogen|mesh-list
153453381|NCT01732458|Aprepitant|aprepitant|mesh-list
153911637|NCT04529005|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
153911638|NCT04529005|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
153911639|NCT04529005|Protease Inhibitors|protease inhibitors|mesh-ancestor
153911640|NCT04529005|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153911641|NCT04529005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153911642|NCT05357040|Nitrous Oxide|nitrous oxide|mesh-list
153911643|NCT05357040|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
153911644|NCT05357040|Anesthetics, General|anesthetics, general|mesh-ancestor
153911645|NCT05357040|Anesthetics|anesthetics|mesh-ancestor
153911646|NCT05357040|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153911647|NCT05357040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153911648|NCT05357040|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153911649|NCT05357040|Analgesics|analgesics|mesh-ancestor
153911650|NCT05357040|Sensory System Agents|sensory system agents|mesh-ancestor
153911651|NCT05357040|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153911652|NCT00943072|Aflibercept|aflibercept|mesh-list
153911653|NCT00943072|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153911654|NCT00943072|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153911655|NCT00943072|Growth Substances|growth substances|mesh-ancestor
153911656|NCT00943072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153911657|NCT00943072|Growth Inhibitors|growth inhibitors|mesh-ancestor
153911658|NCT00943072|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153911659|NCT04222855|Diltiazem|diltiazem|mesh-list
153911660|NCT04222855|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153911661|NCT04222855|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153453402|NCT01708902|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153453404|NCT01708902|Protease Inhibitors|protease inhibitors|mesh-ancestor
153453405|NCT01708902|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153453406|NCT01708902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153453407|NCT01755546|Buprenorphine|buprenorphine|mesh-list
153453408|NCT01755546|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153453409|NCT01755546|Narcotics|narcotics|mesh-ancestor
153453410|NCT01755546|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153453411|NCT01755546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153453412|NCT01755546|Analgesics|analgesics|mesh-ancestor
153453413|NCT01755546|Sensory System Agents|sensory system agents|mesh-ancestor
153453414|NCT01755546|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153453415|NCT01755546|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
153453416|NCT04413864|Dexmedetomidine|dexmedetomidine|mesh-list
153453417|NCT04413864|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153453418|NCT04413864|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153453419|NCT04413864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153453420|NCT04413864|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153453421|NCT04413864|Analgesics|analgesics|mesh-ancestor
153453422|NCT04413864|Sensory System Agents|sensory system agents|mesh-ancestor
153453423|NCT04413864|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153453424|NCT04413864|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
153453425|NCT04413864|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153911666|NCT04222855|Vasodilator Agents|vasodilator agents|mesh-ancestor
153911667|NCT00942994|Amlodipine|amlodipine|mesh-list
153911668|NCT00942994|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
153911669|NCT00942994|Aliskiren|aliskiren|mesh-list
153911670|NCT00942994|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153911671|NCT00942994|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153911672|NCT00942994|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153911673|NCT00942994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153911674|NCT00942994|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153911675|NCT00942994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153911676|NCT00942994|Vasodilator Agents|vasodilator agents|mesh-ancestor
153911678|NCT00942994|Natriuretic Agents|natriuretic agents|mesh-ancestor
153911679|NCT00942994|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
153911680|NCT00942994|Renin Inhibitors|renin inhibitors|mesh-ancestor
153911681|NCT00942994|Protease Inhibitors|protease inhibitors|mesh-ancestor
153911682|NCT00942994|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153911683|NCT04268602|Anesthetics|anesthetics|mesh-list
153626711|NCT02018523|Immunologic Factors|immunologic factors|mesh-ancestor
153911685|NCT04268602|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153911686|NCT04268602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153911687|NCT04268602|Sensory System Agents|sensory system agents|mesh-ancestor
153911688|NCT04268602|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153911689|NCT04314336|Coal Tar|coal tar|mesh-list
153911690|NCT04314336|Keratolytic Agents|keratolytic agents|mesh-ancestor
153911691|NCT04314336|Dermatologic Agents|dermatologic agents|mesh-ancestor
153911692|NCT00624702|Maleic acid|maleic acid|mesh-list
153911693|NCT00624702|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153911694|NCT00624702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153911695|NCT02756377|Chlorhexidine|chlorhexidine|mesh-list
153911696|NCT02756377|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
153453426|NCT04413864|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153453427|NCT04413864|Adrenergic Agents|adrenergic agents|mesh-ancestor
153453428|NCT04413864|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153561298|NCT01651962|Fentanyl|fentanyl|mesh-list
153561299|NCT01651962|Terbutaline|terbutaline|mesh-list
153561300|NCT01651962|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153561301|NCT01651962|Narcotics|narcotics|mesh-ancestor
153561302|NCT01651962|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153561303|NCT01651962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153561304|NCT01651962|Analgesics|analgesics|mesh-ancestor
153561305|NCT01651962|Sensory System Agents|sensory system agents|mesh-ancestor
153453429|NCT04413864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153453430|NCT01755234|Propofol|propofol|mesh-list
153453431|NCT01755234|Sevoflurane|sevoflurane|mesh-list
153453432|NCT01755234|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153453433|NCT01755234|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153453434|NCT01755234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153453435|NCT01755234|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153453436|NCT01755234|Anesthetics, General|anesthetics, general|mesh-ancestor
153453437|NCT01755234|Anesthetics|anesthetics|mesh-ancestor
153453438|NCT01755234|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153453439|NCT01755234|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
153453440|NCT01730586|Paclitaxel|paclitaxel|mesh-list
153453441|NCT01730586|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
153453442|NCT01730586|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153453443|NCT01730586|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153453444|NCT01730586|Tubulin Modulators|tubulin modulators|mesh-ancestor
153453445|NCT01730586|Antimitotic Agents|antimitotic agents|mesh-ancestor
153453446|NCT01730586|Mitosis Modulators|mitosis modulators|mesh-ancestor
153453447|NCT01730586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153453449|NCT01755156|Insulin Glargine|insulin glargine|mesh-list
153453450|NCT01755156|Glimepiride|glimepiride|mesh-list
153911697|NCT02756377|Cetylpyridinium|cetylpyridinium|mesh-list
153911698|NCT02756377|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
153911699|NCT02756377|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153911700|NCT02756377|Disinfectants|disinfectants|mesh-ancestor
153911701|NCT02756377|Dermatologic Agents|dermatologic agents|mesh-ancestor
153911702|NCT02752477|Anesthetics|anesthetics|mesh-list
153911703|NCT02752477|Anesthetics, General|anesthetics, general|mesh-list
153911704|NCT02752477|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153911705|NCT02752477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153911706|NCT04204096|Vaccines|vaccines|mesh-list
153911707|NCT04204096|Immunologic Factors|immunologic factors|mesh-ancestor
153911708|NCT04204096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153911709|NCT05376852|Decitabine|decitabine|mesh-list
153911710|NCT05376852|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153911711|NCT05376852|Antimetabolites|antimetabolites|mesh-ancestor
153911712|NCT05376852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153911713|NCT05376852|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153911714|NCT05376852|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153561352|NCT01652014|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153561353|NCT01652014|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153782679|NCT04561960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153561355|NCT01652118|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153561356|NCT01652118|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153561357|NCT01652118|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
153561358|NCT01652118|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153561359|NCT01652118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153911718|NCT00061282|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153911720|NCT00061282|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
153453451|NCT01755156|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153911721|NCT00061282|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153911722|NCT00061282|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153911723|NCT00061282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153911724|NCT00061282|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153911725|NCT00061282|Hormone Antagonists|hormone antagonists|mesh-ancestor
153911726|NCT00061282|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153911727|NCT00061282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153911728|NCT00061282|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
153911744|NCT02855632|Immunologic Factors|immunologic factors|mesh-ancestor
153911745|NCT04220281|Nitroglycerin|nitroglycerin|mesh-list
153453477|NCT01605396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153453478|NCT01605396|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
153453479|NCT01605396|Hormone Antagonists|hormone antagonists|mesh-ancestor
153453480|NCT01605396|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153453481|NCT01605396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153453482|NCT01730118|Mitogens|mitogens|mesh-list
153453483|NCT01730118|Mitosis Modulators|mitosis modulators|mesh-ancestor
153453484|NCT01730118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153453485|NCT01730040|Atorvastatin|atorvastatin|mesh-list
153453486|NCT01730040|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
153453487|NCT01730040|Ezetimibe|ezetimibe|mesh-list
153453488|NCT01730040|Alirocumab|alirocumab|mesh-list
153453489|NCT01730040|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153453490|NCT01730040|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153453491|NCT01730040|Antimetabolites|antimetabolites|mesh-ancestor
153453492|NCT01730040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153453493|NCT01730040|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153453494|NCT01730040|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
153453495|NCT01730040|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153453496|NCT01730040|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
153453497|NCT01730040|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
153561416|NCT01652326|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153561417|NCT01652326|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153561418|NCT01652326|Anesthetics, General|anesthetics, general|mesh-ancestor
153561419|NCT01652326|Anesthetics|anesthetics|mesh-ancestor
153561420|NCT01652326|GABA Modulators|gaba modulators|mesh-ancestor
153561421|NCT01652326|GABA Agents|gaba agents|mesh-ancestor
153561422|NCT01652326|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153561423|NCT01652326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153453498|NCT01730040|Protease Inhibitors|protease inhibitors|mesh-ancestor
153453499|NCT01706328|Fluticasone|fluticasone|mesh-list
153453500|NCT01706328|Xhance|xhance|mesh-list
153911746|NCT04220281|Propofol|propofol|mesh-list
153811235|NCT00324467|Anesthetics|anesthetics|mesh-ancestor
153811236|NCT00324467|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
153911747|NCT04220281|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153561474|NCT01652417|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
153911748|NCT04220281|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153911749|NCT04220281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153911750|NCT04220281|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153911751|NCT04220281|Anesthetics, General|anesthetics, general|mesh-ancestor
153911752|NCT04220281|Anesthetics|anesthetics|mesh-ancestor
153911753|NCT04220281|Vasodilator Agents|vasodilator agents|mesh-ancestor
153911754|NCT02751619|Lidocaine|lidocaine|mesh-list
153911755|NCT02751619|Anesthetics, Local|anesthetics, local|mesh-ancestor
153911756|NCT02751619|Anesthetics|anesthetics|mesh-ancestor
153911757|NCT02751619|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153911758|NCT02751619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153911759|NCT02751619|Sensory System Agents|sensory system agents|mesh-ancestor
153911760|NCT02751619|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153911761|NCT02751619|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153911762|NCT02751619|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
153911763|NCT02751619|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153911764|NCT02751619|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153911765|NCT02751619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153911766|NCT02751541|Sunscreening Agents|sunscreening agents|mesh-list
153911767|NCT02751541|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
153911768|NCT02751541|Protective Agents|protective agents|mesh-ancestor
153453502|NCT01706328|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
153453503|NCT01706328|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153453504|NCT01706328|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153453505|NCT01706328|Autonomic Agents|autonomic agents|mesh-ancestor
153453506|NCT01706328|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153453507|NCT01706328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153453508|NCT01706328|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153453509|NCT01706328|Respiratory System Agents|respiratory system agents|mesh-ancestor
153453510|NCT01706328|Dermatologic Agents|dermatologic agents|mesh-ancestor
153453511|NCT01706328|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
153453512|NCT01706328|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
153453513|NCT01706328|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
153561475|NCT01652417|Protective Agents|protective agents|mesh-ancestor
153561476|NCT01652417|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153561477|NCT01652417|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153561478|NCT01652534|Amantadine|amantadine|mesh-list
153561514|NCT01652586|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
153561515|NCT01652586|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153561516|NCT01652586|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153453514|NCT01706328|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153811237|NCT00324467|Histamine Antagonists|histamine antagonists|mesh-ancestor
153453515|NCT01706328|Adrenergic Agents|adrenergic agents|mesh-ancestor
153453516|NCT01706328|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153453517|NCT01706328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153453518|NCT01706328|Tocolytic Agents|tocolytic agents|mesh-ancestor
153453519|NCT01706328|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153453520|NCT01706250|Salicylic Acid|salicylic acid|mesh-list
153453521|NCT01706250|Salicylates|salicylates|mesh-list
153453522|NCT01706250|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153453523|NCT01706250|Antifungal Agents|antifungal agents|mesh-ancestor
153453524|NCT01706250|Keratolytic Agents|keratolytic agents|mesh-ancestor
153911769|NCT02751541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153911770|NCT02751541|Dermatologic Agents|dermatologic agents|mesh-ancestor
153911771|NCT02755753|Lansoprazole|lansoprazole|mesh-list
153911772|NCT02755753|Dexlansoprazole|dexlansoprazole|mesh-list
153911773|NCT02755753|Rebamipide|rebamipide|mesh-list
153911774|NCT02755753|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
153911775|NCT02755753|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153911776|NCT02755753|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
153911777|NCT02755753|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153911778|NCT02755753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153911779|NCT02755753|Antioxidants|antioxidants|mesh-ancestor
153911780|NCT02755753|Protective Agents|protective agents|mesh-ancestor
153911781|NCT02755753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153911782|NCT02755909|Anesthetics|anesthetics|mesh-list
153911783|NCT02755909|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153911784|NCT02755909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153911785|NCT02761291|Valganciclovir|valganciclovir|mesh-list
153911786|NCT02761291|Gemcitabine|gemcitabine|mesh-list
153911787|NCT02761291|Valproic Acid|valproic acid|mesh-list
153911788|NCT02761291|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153911789|NCT02761291|Antimetabolites|antimetabolites|mesh-ancestor
153911790|NCT02761291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153911791|NCT02761291|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153561536|NCT01652599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153561539|NCT01652599|Hormones|hormones|mesh-ancestor
153561565|NCT01652820|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153561567|NCT01652820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153561568|NCT01652820|Tubulin Modulators|tubulin modulators|mesh-ancestor
153561569|NCT01652820|Antimitotic Agents|antimitotic agents|mesh-ancestor
153561570|NCT01652820|Mitosis Modulators|mitosis modulators|mesh-ancestor
153561571|NCT01652859|Amphotericin B|amphotericin b|mesh-list
153561572|NCT01652859|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
153561573|NCT01652859|Amebicides|amebicides|mesh-ancestor
153561574|NCT01652859|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153561575|NCT01652859|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153561576|NCT01652859|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153561577|NCT01652859|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153561578|NCT01652859|Antifungal Agents|antifungal agents|mesh-ancestor
153561579|NCT01652898|Esmolol|esmolol|mesh-list
153453525|NCT01706250|Dermatologic Agents|dermatologic agents|mesh-ancestor
153453533|NCT01706250|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153911792|NCT02761291|Anticonvulsants|anticonvulsants|mesh-ancestor
153911793|NCT02761291|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153911795|NCT02761291|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153911796|NCT02761291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153911797|NCT02761291|Antimanic Agents|antimanic agents|mesh-ancestor
153911798|NCT02761291|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153911799|NCT02761291|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153911800|NCT02761291|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153911801|NCT02761291|Antiviral Agents|antiviral agents|mesh-ancestor
153911802|NCT02761291|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153911804|NCT01187550|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153911805|NCT01187550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153911806|NCT02855866|Acetaminophen|acetaminophen|mesh-list
153911807|NCT02855866|Dexamethasone|dexamethasone|mesh-list
153911808|NCT02855866|Cortisone|cortisone|mesh-list
153911809|NCT02855866|Dexamethasone acetate|dexamethasone acetate|mesh-list
153911810|NCT02855866|BB 1101|bb 1101|mesh-list
153911811|NCT02855866|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153911812|NCT02855866|Antiemetics|antiemetics|mesh-ancestor
153911813|NCT02855866|Autonomic Agents|autonomic agents|mesh-ancestor
153911814|NCT02855866|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153911815|NCT02855866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153911817|NCT02855866|Glucocorticoids|glucocorticoids|mesh-ancestor
153911818|NCT02855866|Hormones|hormones|mesh-ancestor
153453549|NCT01729728|Adrenergic Agents|adrenergic agents|mesh-ancestor
153453550|NCT01729728|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153453551|NCT01728324|Ribavirin|ribavirin|mesh-list
153453552|NCT01728324|Antimetabolites|antimetabolites|mesh-ancestor
153453553|NCT01728324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153453554|NCT01728324|Antiviral Agents|antiviral agents|mesh-ancestor
153453555|NCT01728324|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153453556|NCT01728246|Acetaminophen|acetaminophen|mesh-list
153453557|NCT01728246|Tramadol|tramadol|mesh-list
153453558|NCT01728246|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153453559|NCT01728246|Analgesics|analgesics|mesh-ancestor
153453560|NCT01728246|Sensory System Agents|sensory system agents|mesh-ancestor
153357742|NCT00762710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153453561|NCT01728246|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153453562|NCT01728246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153453563|NCT01728246|Antipyretics|antipyretics|mesh-ancestor
153453564|NCT01728246|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153453565|NCT01728246|Narcotics|narcotics|mesh-ancestor
153453566|NCT01728246|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153453567|NCT04414020|Progesterone|progesterone|mesh-list
153453568|NCT04414020|Progestins|progestins|mesh-ancestor
153453569|NCT04414020|Hormones|hormones|mesh-ancestor
153453570|NCT04414020|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153453571|NCT04414020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153453572|NCT01705236|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
153453573|NCT01705236|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
153453574|NCT01705236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153453575|NCT01705236|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153453576|NCT01705236|Immunologic Factors|immunologic factors|mesh-ancestor
153453577|NCT01705236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153453578|NCT01751802|Ecopipam|ecopipam|mesh-list
153911819|NCT02855866|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153911820|NCT02855866|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153911821|NCT02855866|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153911822|NCT02855866|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153911823|NCT02855866|Analgesics|analgesics|mesh-ancestor
153911824|NCT02855866|Sensory System Agents|sensory system agents|mesh-ancestor
153911825|NCT02855866|Antipyretics|antipyretics|mesh-ancestor
153911826|NCT02855866|Protease Inhibitors|protease inhibitors|mesh-ancestor
153911827|NCT02855866|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153911828|NCT02855866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153911829|NCT02751307|Metformin|metformin|mesh-list
153911830|NCT02751307|Clozapine|clozapine|mesh-list
153911831|NCT02751307|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153911832|NCT02751307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153453579|NCT01751802|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153911833|NCT02751307|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153911834|NCT02751307|Serotonin Agents|serotonin agents|mesh-ancestor
153911835|NCT02751307|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153911836|NCT02751307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153911837|NCT02751307|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153911838|NCT02751307|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153911839|NCT02751307|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153911840|NCT02751307|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153911841|NCT02751307|GABA Antagonists|gaba antagonists|mesh-ancestor
153911842|NCT02751307|GABA Agents|gaba agents|mesh-ancestor
153911844|NCT00638209|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
153911845|NCT00638209|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153911846|NCT00638209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153911847|NCT05429671|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
153911848|NCT05429671|Gentamicins|gentamicins|mesh-list
153911849|NCT05429671|Tobramycin|tobramycin|mesh-list
153561675|NCT01653457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153561676|NCT01653457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153420890|NCT02159352|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153561677|NCT01653457|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
153561678|NCT01653457|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
153561679|NCT01653470|Leucovorin|leucovorin|mesh-list
153561680|NCT01653470|Paclitaxel|paclitaxel|mesh-list
153561681|NCT01653470|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
153911850|NCT05429671|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153911851|NCT05429671|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
153911852|NCT05429671|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153911853|NCT05429671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153911854|NCT01186770|Methylnaltrexone|methylnaltrexone|mesh-list
153911855|NCT01186770|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
153911856|NCT01186770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153911857|NCT01186770|Sensory System Agents|sensory system agents|mesh-ancestor
153911858|NCT01186770|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153911859|NCT02754817|Liraglutide|liraglutide|mesh-list
153911860|NCT02754817|Xultophy|xultophy|mesh-list
153911861|NCT02754817|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153911862|NCT02754817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153453593|NCT01703286|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153453594|NCT01703286|Immunologic Factors|immunologic factors|mesh-ancestor
153453595|NCT01703286|Incretins|incretins|mesh-ancestor
153453596|NCT01703286|Hormones|hormones|mesh-ancestor
153811242|NCT00332085|Picolinic acid|picolinic acid|mesh-list
153811243|NCT00332085|Trace Elements|trace elements|mesh-ancestor
153811244|NCT00332085|Micronutrients|micronutrients|mesh-ancestor
153357745|NCT00756548|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153357746|NCT00243074|Cediranib|cediranib|mesh-list
153453597|NCT01703286|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153453598|NCT01703286|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
153453600|NCT01703286|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153453601|NCT01703286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153453602|NCT01727700|Aripiprazole|aripiprazole|mesh-list
153453603|NCT01727700|Antidepressive Agents|antidepressive agents|mesh-ancestor
153453604|NCT01727700|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153453605|NCT01727700|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153453606|NCT01727700|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153453607|NCT01727700|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153453608|NCT01727700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153453609|NCT01727700|Dopamine Agonists|dopamine agonists|mesh-ancestor
153453610|NCT01727700|Dopamine Agents|dopamine agents|mesh-ancestor
153453611|NCT01727700|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153561726|NCT01653717|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153561727|NCT01653717|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153561728|NCT01653717|Alkylating Agents|alkylating agents|mesh-ancestor
153561729|NCT01653717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153561730|NCT01653717|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153561731|NCT01653717|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153561732|NCT01653717|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153561734|NCT01653977|Vasoconstrictor Agents|vasoconstrictor agents|mesh-list
153453612|NCT01727700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153453613|NCT01727700|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
153453614|NCT01727700|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
153453615|NCT01727700|Serotonin Agents|serotonin agents|mesh-ancestor
153453616|NCT01727700|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
153453617|NCT01727700|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153453618|NCT01727700|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
153453619|NCT01727700|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
153453620|NCT01725282|Quetiapine Fumarate|quetiapine fumarate|mesh-list
153453621|NCT01725282|Antidepressive Agents|antidepressive agents|mesh-ancestor
153453622|NCT01725282|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153453623|NCT01725282|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153453624|NCT01725282|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153453625|NCT01725282|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153453626|NCT01725282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153911863|NCT02754817|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
153911864|NCT02754817|Incretins|incretins|mesh-ancestor
153911865|NCT02754817|Hormones|hormones|mesh-ancestor
153911866|NCT02754817|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153911867|NCT04230031|Daratumumab|daratumumab|mesh-list
153911868|NCT04230031|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153911869|NCT01186458|Rituximab|rituximab|mesh-list
153911870|NCT01186458|Fludarabine|fludarabine|mesh-list
153911871|NCT01186458|Bortezomib|bortezomib|mesh-list
153911872|NCT01186458|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153911873|NCT01186458|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153911874|NCT01186458|Immunologic Factors|immunologic factors|mesh-ancestor
153911875|NCT01186458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153911876|NCT01186458|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153911878|NCT01185366|Sunitinib|sunitinib|mesh-list
153911879|NCT01185366|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
153911880|NCT01185366|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153911881|NCT01185366|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153911882|NCT01185366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153911883|NCT01185366|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153911884|NCT01185366|Immunologic Factors|immunologic factors|mesh-ancestor
153911885|NCT01185366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153911886|NCT01185366|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153911887|NCT01185366|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153911888|NCT01185366|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153911889|NCT01185366|Growth Substances|growth substances|mesh-ancestor
153911890|NCT01185366|Growth Inhibitors|growth inhibitors|mesh-ancestor
153911891|NCT01185288|Adalimumab|adalimumab|mesh-list
153911892|NCT01185288|Methotrexate|methotrexate|mesh-list
153911893|NCT01185288|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
153911894|NCT01185288|Abortifacient Agents|abortifacient agents|mesh-ancestor
153911895|NCT01185288|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153911896|NCT01185288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153561788|NCT01654211|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
153561789|NCT01654211|Protease Inhibitors|protease inhibitors|mesh-ancestor
153561790|NCT01654211|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153561791|NCT01654211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153561792|NCT01654211|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153561793|NCT01654211|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153561794|NCT01654211|Antiviral Agents|antiviral agents|mesh-ancestor
153561795|NCT01654211|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153561799|NCT01654367|Zoledronic Acid|zoledronic acid|mesh-list
153782684|NCT04561921|Sensory System Agents|sensory system agents|mesh-ancestor
153911897|NCT01185288|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153911898|NCT01185288|Antimetabolites|antimetabolites|mesh-ancestor
153911899|NCT01185288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153911900|NCT01185288|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153911901|NCT01185288|Dermatologic Agents|dermatologic agents|mesh-ancestor
153453633|NCT01725126|Hormones|hormones|mesh-ancestor
153453634|NCT01725126|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153453635|NCT01751724|Caffeine|caffeine|mesh-list
153453636|NCT01751724|Caffeine citrate|caffeine citrate|mesh-list
153453637|NCT01751724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153453638|NCT01751724|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
153453639|NCT01751724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153453640|NCT01751724|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
153453641|NCT01751724|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153453642|NCT01751724|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
153453643|NCT01751724|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
153453644|NCT01751724|Purinergic Agents|purinergic agents|mesh-ancestor
153453645|NCT01751724|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153453646|NCT01751646|Vitamin D|vitamin d|mesh-list
153453647|NCT01751646|Ergocalciferols|ergocalciferols|mesh-list
153453648|NCT01751646|Cholecalciferol|cholecalciferol|mesh-list
153453649|NCT01751646|Vitamins|vitamins|mesh-list
153453650|NCT01751646|Micronutrients|micronutrients|mesh-ancestor
153453651|NCT01751646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153453652|NCT01751646|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153453653|NCT01751646|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153453654|NCT01751568|Raltegravir Potassium|raltegravir potassium|mesh-list
153453655|NCT01751568|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153453656|NCT01751568|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153453657|NCT01751568|Antiviral Agents|antiviral agents|mesh-ancestor
153453658|NCT01751568|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153453659|NCT01751568|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
153453660|NCT01751568|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
153453661|NCT01751568|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153453662|NCT01751568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153453663|NCT01751178|Ethanol|ethanol|mesh-list
153453664|NCT01751178|Chlorhexidine|chlorhexidine|mesh-list
153911902|NCT01185288|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153911903|NCT01185288|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153911904|NCT01185288|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153911905|NCT01185288|Immunologic Factors|immunologic factors|mesh-ancestor
153911906|NCT01185288|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153911907|NCT01185288|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153911908|NCT01185288|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
153911909|NCT01185288|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153911910|NCT01184118|Fluticasone|fluticasone|mesh-list
153911911|NCT01184118|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153911912|NCT01184118|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153911913|NCT01184118|Autonomic Agents|autonomic agents|mesh-ancestor
153911914|NCT01184118|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153911915|NCT01184118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153911916|NCT01184118|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153911917|NCT01184118|Respiratory System Agents|respiratory system agents|mesh-ancestor
153911918|NCT01184118|Dermatologic Agents|dermatologic agents|mesh-ancestor
153911919|NCT01184118|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
153911921|NCT01183884|Isotretinoin|isotretinoin|mesh-list
153911922|NCT01183884|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153911923|NCT01183884|Keratolytic Agents|keratolytic agents|mesh-ancestor
153911924|NCT01183884|Dermatologic Agents|dermatologic agents|mesh-ancestor
153911925|NCT05344248|Antibodies|antibodies|mesh-list
153911926|NCT05344248|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
153911927|NCT05344248|Immunologic Factors|immunologic factors|mesh-ancestor
153911928|NCT05344248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153911929|NCT01191762|Sevelamer|sevelamer|mesh-list
153561806|NCT01654367|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
153911930|NCT01191762|Chelating Agents|chelating agents|mesh-ancestor
153911931|NCT01191762|Sequestering Agents|sequestering agents|mesh-ancestor
153911932|NCT01191762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153911933|NCT04315974|Rivaroxaban|rivaroxaban|mesh-list
153911934|NCT04315974|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
153911935|NCT04315974|Antithrombins|antithrombins|mesh-ancestor
153911936|NCT04315974|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
153911938|NCT04315974|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153911939|NCT04315974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153911940|NCT04315974|Anticoagulants|anticoagulants|mesh-ancestor
153911941|NCT02855788|Leucovorin|leucovorin|mesh-list
153911942|NCT02855788|Paclitaxel|paclitaxel|mesh-list
153911943|NCT02855788|Oxaliplatin|oxaliplatin|mesh-list
153911944|NCT02855788|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153911945|NCT02855788|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153453676|NCT01606254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153453677|NCT01606254|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153464857|NCT00168324|BB 1101|bb 1101|mesh-list
153453678|NCT01606254|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
153453679|NCT01606254|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153453680|NCT01606254|Serotonin Agents|serotonin agents|mesh-ancestor
153453681|NCT01606254|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153453682|NCT01606254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153453683|NCT01606254|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
153453684|NCT01606254|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
153453685|NCT01606254|Dopamine Agents|dopamine agents|mesh-ancestor
153453686|NCT01723254|Immunoglobulin E|immunoglobulin e|mesh-list
153453687|NCT01723254|Immunologic Factors|immunologic factors|mesh-ancestor
153453688|NCT01723254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153453689|NCT01722162|Bevacizumab|bevacizumab|mesh-list
153453690|NCT01722162|Capecitabine|capecitabine|mesh-list
153453691|NCT01722162|Levocetirizine|levocetirizine|mesh-list
153453692|NCT01722162|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153453693|NCT01722162|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153453694|NCT01722162|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153453695|NCT01722162|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153453696|NCT01722162|Growth Substances|growth substances|mesh-ancestor
153453697|NCT01722162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153453698|NCT01722162|Growth Inhibitors|growth inhibitors|mesh-ancestor
153453699|NCT01722162|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153453700|NCT01722162|Antimetabolites|antimetabolites|mesh-ancestor
153453701|NCT01722162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153453702|NCT01722162|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
153811249|NCT00332085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153453703|NCT01722162|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
153911946|NCT02855788|Tubulin Modulators|tubulin modulators|mesh-ancestor
153911947|NCT02855788|Antimitotic Agents|antimitotic agents|mesh-ancestor
153911948|NCT02855788|Mitosis Modulators|mitosis modulators|mesh-ancestor
153911949|NCT02855788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153911950|NCT02855788|Antidotes|antidotes|mesh-ancestor
153911951|NCT02855788|Protective Agents|protective agents|mesh-ancestor
153911952|NCT02855788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153911953|NCT02855788|Vitamin B Complex|vitamin b complex|mesh-ancestor
153911954|NCT02855788|Vitamins|vitamins|mesh-ancestor
153911955|NCT02855788|Micronutrients|micronutrients|mesh-ancestor
153911956|NCT01190514|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
153911957|NCT01190514|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
153561817|NCT01654497|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
153561818|NCT01654497|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153561819|NCT01654497|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153561820|NCT01654497|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
153561821|NCT01654497|Protective Agents|protective agents|mesh-ancestor
153911958|NCT01190514|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153911959|NCT01190514|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153911960|NCT01190514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153911961|NCT01190514|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153911962|NCT01190514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153911963|NCT01190514|Antidepressive Agents|antidepressive agents|mesh-ancestor
153911964|NCT01190514|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153911966|NCT01190436|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153911967|NCT01190436|Sympatholytics|sympatholytics|mesh-ancestor
153911968|NCT01190436|Autonomic Agents|autonomic agents|mesh-ancestor
153911969|NCT01190436|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153911970|NCT01190436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153911971|NCT01190436|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
153911972|NCT01190436|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
153911973|NCT01190436|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
153911974|NCT01190436|Adrenergic Agents|adrenergic agents|mesh-ancestor
153911975|NCT01190436|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153911976|NCT01190436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153911977|NCT02852122|Choline|choline|mesh-list
153911978|NCT02852122|Lipotropic Agents|lipotropic agents|mesh-ancestor
153911979|NCT02852122|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153911980|NCT02852122|Antimetabolites|antimetabolites|mesh-ancestor
153911981|NCT02852122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153911982|NCT02852122|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153911983|NCT02852122|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153911984|NCT02852122|Nootropic Agents|nootropic agents|mesh-ancestor
153911985|NCT01035255|Enalapril|enalapril|mesh-list
153911986|NCT01035255|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
153911987|NCT01035255|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
153911988|NCT01035255|Protease Inhibitors|protease inhibitors|mesh-ancestor
153911989|NCT01035255|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153453721|NCT01701258|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153453722|NCT01701258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153453723|NCT01701258|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153453724|NCT01701258|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
153453725|NCT01701258|Dopamine Agents|dopamine agents|mesh-ancestor
153453726|NCT01701258|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153453727|NCT01701258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153453728|NCT01701258|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
153453729|NCT01701258|Antidepressive Agents|antidepressive agents|mesh-ancestor
153453730|NCT01700946|Cytarabine|cytarabine|mesh-list
153453731|NCT01700946|Aldesleukin|aldesleukin|mesh-list
153453732|NCT01700946|Dexamethasone|dexamethasone|mesh-list
153453733|NCT01700946|Hydrocortisone|hydrocortisone|mesh-list
153453734|NCT01700946|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
153561874|NCT01654913|Sensory System Agents|sensory system agents|mesh-ancestor
153782686|NCT04561921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153561875|NCT01654913|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153561876|NCT01654913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153561877|NCT01654913|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153561878|NCT01654913|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153561879|NCT01654939|Rifaximin|rifaximin|mesh-list
153561880|NCT01654939|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153561883|NCT01654965|Topotecan|topotecan|mesh-list
153453735|NCT01700946|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
153453736|NCT01700946|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
153453737|NCT01700946|Cyclophosphamide|cyclophosphamide|mesh-list
153453738|NCT01700946|Rituximab|rituximab|mesh-list
153453739|NCT01700946|Methotrexate|methotrexate|mesh-list
153453740|NCT01700946|Etoposide|etoposide|mesh-list
153453741|NCT01700946|Vincristine|vincristine|mesh-list
153453742|NCT01700946|Asparaginase|asparaginase|mesh-list
153453743|NCT01700946|Interleukin-2|interleukin-2|mesh-list
153453744|NCT01700946|Mercaptopurine|mercaptopurine|mesh-list
153453745|NCT01700946|Mitoxantrone|mitoxantrone|mesh-list
153453746|NCT01700946|Clofarabine|clofarabine|mesh-list
153453747|NCT01700946|Vinblastine|vinblastine|mesh-list
153453748|NCT01700946|Pegaspargase|pegaspargase|mesh-list
153453749|NCT01700946|Teniposide|teniposide|mesh-list
153453750|NCT01700946|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153453751|NCT01700946|Immunologic Factors|immunologic factors|mesh-ancestor
153453752|NCT01700946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153453753|NCT01700946|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153453754|NCT01700946|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153453755|NCT01700946|Alkylating Agents|alkylating agents|mesh-ancestor
153453756|NCT01700946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153453757|NCT01700946|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153453758|NCT01700946|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153453759|NCT01700946|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153911990|NCT01035255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153911991|NCT01035255|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153911992|NCT01035255|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
153911993|NCT00602524|Pilocarpine|pilocarpine|mesh-list
153911994|NCT00602524|Miotics|miotics|mesh-ancestor
153911995|NCT00602524|Autonomic Agents|autonomic agents|mesh-ancestor
153911996|NCT00602524|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153911997|NCT00602524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153911998|NCT00602524|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
153811251|NCT00324506|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153911999|NCT00602524|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
153912000|NCT00602524|Cholinergic Agents|cholinergic agents|mesh-ancestor
153561926|NCT01655095|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
153561927|NCT01655095|Serotonin Agents|serotonin agents|mesh-ancestor
153561928|NCT01655095|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153561929|NCT01655095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153561930|NCT01655095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153561931|NCT01655095|Cathartics|cathartics|mesh-ancestor
153561932|NCT01655108|Minoxidil|minoxidil|mesh-list
153561933|NCT01655108|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153561934|NCT01655108|Vasodilator Agents|vasodilator agents|mesh-ancestor
153561982|NCT01655303|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
153561983|NCT01655303|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
153561984|NCT01655303|Adrenergic Agents|adrenergic agents|mesh-ancestor
153912001|NCT00602524|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153912002|NCT00602524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153912003|NCT01189890|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
153912004|NCT01189890|Glimepiride|glimepiride|mesh-list
153912005|NCT01189890|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153912006|NCT01189890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153912007|NCT01189890|Incretins|incretins|mesh-ancestor
153912008|NCT01189890|Hormones|hormones|mesh-ancestor
153912009|NCT01189890|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153912010|NCT01189890|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
153912011|NCT01189890|Protease Inhibitors|protease inhibitors|mesh-ancestor
153912012|NCT01189890|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153912013|NCT01189890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153912014|NCT01189890|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153912015|NCT01189890|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153912017|NCT01189812|Lithium Carbonate|lithium carbonate|mesh-list
153912018|NCT01189812|Citalopram|citalopram|mesh-list
153912019|NCT01189812|Antidepressive Agents|antidepressive agents|mesh-ancestor
153912020|NCT01189812|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153912021|NCT01189812|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153912022|NCT01189812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153912023|NCT01189812|Antimanic Agents|antimanic agents|mesh-ancestor
153912024|NCT01189812|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153912025|NCT01189812|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153453760|NCT01700946|Antiemetics|antiemetics|mesh-ancestor
153453761|NCT01700946|Autonomic Agents|autonomic agents|mesh-ancestor
153626712|NCT02018523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153453762|NCT01700946|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153453763|NCT01700946|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153453764|NCT01700946|Glucocorticoids|glucocorticoids|mesh-ancestor
153453765|NCT01700946|Hormones|hormones|mesh-ancestor
153453766|NCT01700946|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153453767|NCT01700946|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153453768|NCT01700946|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153453769|NCT01700946|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
153453770|NCT01700946|Abortifacient Agents|abortifacient agents|mesh-ancestor
153453771|NCT01700946|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153453772|NCT01700946|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153453773|NCT01700946|Antimetabolites|antimetabolites|mesh-ancestor
153453774|NCT01700946|Dermatologic Agents|dermatologic agents|mesh-ancestor
153453775|NCT01700946|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153453776|NCT01700946|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153453777|NCT01700946|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153453778|NCT01700946|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153453779|NCT01700946|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153453780|NCT01700946|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153453781|NCT01700946|Antiviral Agents|antiviral agents|mesh-ancestor
153453782|NCT01700946|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153453783|NCT01700946|Tubulin Modulators|tubulin modulators|mesh-ancestor
153453784|NCT01700946|Antimitotic Agents|antimitotic agents|mesh-ancestor
153453785|NCT01700946|Mitosis Modulators|mitosis modulators|mesh-ancestor
153453786|NCT01700946|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153453787|NCT01700946|Analgesics|analgesics|mesh-ancestor
153453788|NCT01700946|Sensory System Agents|sensory system agents|mesh-ancestor
153562005|NCT01655316|Vasodilator Agents|vasodilator agents|mesh-ancestor
153562035|NCT01655706|Aripiprazole|aripiprazole|mesh-list
153562036|NCT01655706|Escitalopram|escitalopram|mesh-list
153562037|NCT01655706|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
153562038|NCT01655706|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153562039|NCT01655706|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153562040|NCT01655706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153562041|NCT01655706|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153562042|NCT01655706|Serotonin Agents|serotonin agents|mesh-ancestor
153453789|NCT01700946|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153912026|NCT01189812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153912027|NCT01189812|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
153912028|NCT01189812|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153912029|NCT01189812|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153912030|NCT01189812|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153912031|NCT01189812|Serotonin Agents|serotonin agents|mesh-ancestor
153912032|NCT01189812|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
153912033|NCT01189500|Tamoxifen|tamoxifen|mesh-list
153912034|NCT01189500|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
153912035|NCT01189500|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
153912036|NCT01189500|Hormone Antagonists|hormone antagonists|mesh-ancestor
153811253|NCT00324506|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
153357748|NCT00243074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153912037|NCT01189500|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153453790|NCT01700946|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153453791|NCT01748994|Pioglitazone|pioglitazone|mesh-list
153453795|NCT01721070|Sufentanil|sufentanil|mesh-list
153912038|NCT01189500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153912039|NCT01189500|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153912040|NCT01189500|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153912041|NCT01189500|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
153912043|NCT01189500|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153912044|NCT01189500|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
153912045|NCT01189500|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153912046|NCT01189500|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153357749|NCT00243074|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153912047|NCT01189500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153912049|NCT01189500|Antidepressive Agents|antidepressive agents|mesh-ancestor
153912050|NCT01189500|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153912051|NCT00938860|Cyclosporine|cyclosporine|mesh-list
153912052|NCT00938860|Tacrolimus|tacrolimus|mesh-list
153912053|NCT00938860|Cyclosporins|cyclosporins|mesh-list
153453809|NCT01721070|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153453810|NCT01721070|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
153453811|NCT01721070|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153453812|NCT01721070|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153453813|NCT01721070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153453814|NCT01721070|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153453815|NCT01721070|Hormone Antagonists|hormone antagonists|mesh-ancestor
153453816|NCT01721070|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153453817|NCT01721070|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
153453818|NCT01748292|Ranibizumab|ranibizumab|mesh-list
153562043|NCT01655706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153562044|NCT01655706|Antidepressive Agents|antidepressive agents|mesh-ancestor
153562045|NCT01655706|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153562046|NCT01655706|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153562047|NCT01655706|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153562048|NCT01655706|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153562049|NCT01655706|Dopamine Agonists|dopamine agonists|mesh-ancestor
153453819|NCT01748292|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153453820|NCT01748292|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153453821|NCT01748292|Growth Substances|growth substances|mesh-ancestor
153453822|NCT01748292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153453823|NCT01748292|Growth Inhibitors|growth inhibitors|mesh-ancestor
153453825|NCT01720602|Letrozole|letrozole|mesh-list
153453827|NCT01720602|Vorinostat|vorinostat|mesh-list
153453828|NCT01720602|Exemestane|exemestane|mesh-list
153453829|NCT01720602|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
153453830|NCT01720602|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153912064|NCT00604396|Insulin|insulin|mesh-list
153912065|NCT00604396|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
153912066|NCT00604396|Insulin Detemir|insulin detemir|mesh-list
153912067|NCT00604396|Isophane Insulin, Human|isophane insulin, human|mesh-list
153912071|NCT00604396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153912072|NCT00938470|Docetaxel|docetaxel|mesh-list
153912073|NCT00938470|Capecitabine|capecitabine|mesh-list
153912074|NCT00938470|Fluorouracil|fluorouracil|mesh-list
153912075|NCT00938470|Oxaliplatin|oxaliplatin|mesh-list
153912076|NCT00938470|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153912077|NCT00938470|Tubulin Modulators|tubulin modulators|mesh-ancestor
153912078|NCT00938470|Antimitotic Agents|antimitotic agents|mesh-ancestor
153912079|NCT00938470|Mitosis Modulators|mitosis modulators|mesh-ancestor
153912080|NCT00938470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153912081|NCT00938470|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153912082|NCT00938470|Antimetabolites|antimetabolites|mesh-ancestor
153912083|NCT00938470|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153912084|NCT00938470|Immunologic Factors|immunologic factors|mesh-ancestor
153912085|NCT00938470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153912086|NCT00602680|Donepezil|donepezil|mesh-list
153912087|NCT00602680|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
153912088|NCT00602680|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153912089|NCT00602680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153912090|NCT00602680|Cholinergic Agents|cholinergic agents|mesh-ancestor
153912091|NCT00602680|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153453831|NCT01720602|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
153453832|NCT01720602|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153453833|NCT01720602|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153453834|NCT01720602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153453835|NCT01720602|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
153465085|NCT00088218|Antiviral Agents|antiviral agents|mesh-ancestor
153453836|NCT01720602|Hormone Antagonists|hormone antagonists|mesh-ancestor
153702374|NCT00283036|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
153453837|NCT01720602|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153453838|NCT01720602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153453839|NCT01720602|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153453840|NCT01720602|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
153453841|NCT01720602|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
153453842|NCT01746732|Moxifloxacin|moxifloxacin|mesh-list
153562094|NCT01655862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153782687|NCT04561921|Anesthetics|anesthetics|mesh-ancestor
153562096|NCT01655862|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153562097|NCT01655862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153562098|NCT01655862|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
153562099|NCT01655862|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153562100|NCT01655875|Plerixafor|plerixafor|mesh-list
153562107|NCT01655914|Flumazenil|flumazenil|mesh-list
153453843|NCT01746732|Evacetrapib|evacetrapib|mesh-list
153453844|NCT01746732|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
153453845|NCT01746732|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153453846|NCT01746732|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153453847|NCT01746732|Antimetabolites|antimetabolites|mesh-ancestor
153453848|NCT01746732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153453849|NCT01746732|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153453850|NCT01746732|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153453851|NCT01746732|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153453852|NCT01746732|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153453853|NCT01746732|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153453854|NCT01746732|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153453855|NCT01746732|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153453856|NCT01746732|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
153453857|NCT01746732|Contraceptive Agents|contraceptive agents|mesh-ancestor
153453858|NCT01746732|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153912092|NCT00602680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153912093|NCT00602680|Nootropic Agents|nootropic agents|mesh-ancestor
153912094|NCT00938392|Vaccines|vaccines|mesh-list
153912095|NCT00938392|Immunologic Factors|immunologic factors|mesh-ancestor
153912096|NCT00938392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153912097|NCT02851888|Ropivacaine|ropivacaine|mesh-list
153912098|NCT02851888|Anesthetics|anesthetics|mesh-ancestor
153912099|NCT02851888|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153912100|NCT02851888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153912101|NCT02851888|Anesthetics, Local|anesthetics, local|mesh-ancestor
153357752|NCT00241358|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153912102|NCT02851888|Sensory System Agents|sensory system agents|mesh-ancestor
153912103|NCT02851888|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153912104|NCT05381428|Indomethacin|indomethacin|mesh-list
153912105|NCT05381428|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153912106|NCT05381428|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153912107|NCT05381428|Analgesics|analgesics|mesh-ancestor
153912108|NCT05381428|Sensory System Agents|sensory system agents|mesh-ancestor
153912109|NCT05381428|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153912110|NCT05381428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153912111|NCT05381428|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153912113|NCT05381428|Gout Suppressants|gout suppressants|mesh-ancestor
153912114|NCT05381428|Tocolytic Agents|tocolytic agents|mesh-ancestor
153912115|NCT05381428|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153912116|NCT05381428|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153912117|NCT05381428|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153912118|NCT05381428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153912120|NCT01022853|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153912121|NCT01022853|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153912122|NCT01022853|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153912123|NCT01022853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153912124|NCT00937768|Leuprolide|leuprolide|mesh-list
153562114|NCT01655914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153562115|NCT01655927|Tranexamic Acid|tranexamic acid|mesh-list
153562116|NCT01655927|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
153562117|NCT01655927|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153562118|NCT01655927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153562119|NCT01655927|Hemostatics|hemostatics|mesh-ancestor
153562120|NCT01655927|Coagulants|coagulants|mesh-ancestor
153562121|NCT01655966|Vitamin D|vitamin d|mesh-list
153562122|NCT01655966|Interferons|interferons|mesh-list
153562127|NCT01655966|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153562128|NCT01655966|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153912125|NCT00937768|Goserelin|goserelin|mesh-list
153912126|NCT00937768|Fertility Agents, Female|fertility agents, female|mesh-ancestor
153912127|NCT00937768|Fertility Agents|fertility agents|mesh-ancestor
153912128|NCT00937768|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153912129|NCT00937768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153453878|NCT01745094|Mirabegron|mirabegron|mesh-list
153453879|NCT01745094|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
153465156|NCT00194532|Beta Lactam Antibiotics|beta lactam antibiotics|mesh-ancestor
153453880|NCT01745094|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
153453881|NCT01745094|Cholinergic Agents|cholinergic agents|mesh-ancestor
153453882|NCT01745094|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153453883|NCT01745094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153453884|NCT01745094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153453885|NCT01745094|Urological Agents|urological agents|mesh-ancestor
153453886|NCT01745094|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
153453887|NCT01745094|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
153811259|NCT00332124|Choline|choline|mesh-list
153453888|NCT01745094|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153453889|NCT01745094|Adrenergic Agents|adrenergic agents|mesh-ancestor
153453890|NCT01717326|Ribavirin|ribavirin|mesh-list
153453891|NCT01717326|Grazoprevir|grazoprevir|mesh-list
153453892|NCT01717326|Antimetabolites|antimetabolites|mesh-ancestor
153453893|NCT01717326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153453894|NCT01717326|Antiviral Agents|antiviral agents|mesh-ancestor
153453895|NCT01717326|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153453896|NCT01744782|Cysteamine|cysteamine|mesh-list
153453897|NCT01744782|Cystine Depleting Agents|cystine depleting agents|mesh-ancestor
153453898|NCT01744782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153453900|NCT01604850|Antiviral Agents|antiviral agents|mesh-ancestor
153453901|NCT01604850|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153453902|NCT01742286|Ceritinib|ceritinib|mesh-list
153912137|NCT00631228|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153912138|NCT00631228|Immunologic Factors|immunologic factors|mesh-ancestor
153912139|NCT00631228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153912140|NCT00631228|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153912143|NCT05381038|Irinotecan|irinotecan|mesh-list
153912144|NCT05381038|Azacitidine|azacitidine|mesh-list
153912145|NCT05381038|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153912146|NCT05381038|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153912147|NCT05381038|Tubulin Modulators|tubulin modulators|mesh-ancestor
153912148|NCT05381038|Antimitotic Agents|antimitotic agents|mesh-ancestor
153912149|NCT05381038|Mitosis Modulators|mitosis modulators|mesh-ancestor
153912150|NCT05381038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153912151|NCT05381038|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
153912152|NCT05381038|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153912153|NCT05381038|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153912154|NCT05381038|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153912155|NCT05381038|Antimetabolites|antimetabolites|mesh-ancestor
153912156|NCT05380960|Fibrin fragment D|fibrin fragment d|mesh-list
153912157|NCT05380960|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
153453909|NCT01716234|Antifungal Agents|antifungal agents|mesh-ancestor
153453910|NCT01716234|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153453911|NCT01716234|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
153453912|NCT01716234|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153453913|NCT01716234|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153453914|NCT01716234|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
153453915|NCT01716234|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153453916|NCT01716234|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153562132|NCT01655966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153562133|NCT01655992|Capecitabine|capecitabine|mesh-list
153562134|NCT01655992|Tegafur|tegafur|mesh-list
153562135|NCT01655992|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153562136|NCT01655992|Antimetabolites|antimetabolites|mesh-ancestor
153562137|NCT01655992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153562138|NCT01655992|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153562139|NCT01656005|Beclomethasone|beclomethasone|mesh-list
153562140|NCT01656005|Carvedilol|carvedilol|mesh-list
153453917|NCT01716234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153453918|NCT01716234|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153453919|NCT01716234|Hormone Antagonists|hormone antagonists|mesh-ancestor
153453920|NCT01716234|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153453921|NCT01716234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153453922|NCT01716156|Ribavirin|ribavirin|mesh-list
153453923|NCT01716156|Grazoprevir|grazoprevir|mesh-list
153453924|NCT01716156|Antimetabolites|antimetabolites|mesh-ancestor
153453925|NCT01716156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153453926|NCT01716156|Antiviral Agents|antiviral agents|mesh-ancestor
153357753|NCT00241358|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153357754|NCT00241358|Antiviral Agents|antiviral agents|mesh-ancestor
153357755|NCT00241358|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153357756|NCT00778310|Methylphenidate|methylphenidate|mesh-list
153453927|NCT01716156|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153453928|NCT01739790|Acetylcysteine|acetylcysteine|mesh-list
153453929|NCT01739790|N-monoacetylcystine|n-monoacetylcystine|mesh-list
153453930|NCT01739790|Antiviral Agents|antiviral agents|mesh-ancestor
153912165|NCT01189266|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153912166|NCT01189266|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
153912167|NCT01189266|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153912168|NCT01189266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153912169|NCT01189032|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
153912170|NCT01189032|Ophthalmic Solutions|ophthalmic solutions|mesh-list
153912171|NCT01188798|Methotrexate|methotrexate|mesh-list
153912172|NCT01188798|Pentostatin|pentostatin|mesh-list
153912173|NCT01188798|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
153912174|NCT01188798|Abortifacient Agents|abortifacient agents|mesh-ancestor
153912175|NCT01188798|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153912176|NCT01188798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153562141|NCT01656005|Bisoprolol|bisoprolol|mesh-list
153562142|NCT01656005|Formoterol Fumarate|formoterol fumarate|mesh-list
153562143|NCT01656005|Tiotropium Bromide|tiotropium bromide|mesh-list
153562144|NCT01656005|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153562145|NCT01656005|Autonomic Agents|autonomic agents|mesh-ancestor
153562146|NCT01656005|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153562147|NCT01656005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153562148|NCT01656005|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153562149|NCT01656005|Respiratory System Agents|respiratory system agents|mesh-ancestor
153562150|NCT01656005|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
153562151|NCT01656005|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
153562152|NCT01656005|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153562153|NCT01656005|Adrenergic Agents|adrenergic agents|mesh-ancestor
153562154|NCT01656005|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153562155|NCT01656005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153562156|NCT01656005|Parasympatholytics|parasympatholytics|mesh-ancestor
153562158|NCT01656005|Cholinergic Agents|cholinergic agents|mesh-ancestor
153912177|NCT01188798|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153912178|NCT01188798|Antimetabolites|antimetabolites|mesh-ancestor
153912179|NCT01188798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153912180|NCT01188798|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153912181|NCT01188798|Dermatologic Agents|dermatologic agents|mesh-ancestor
153912182|NCT01188798|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153912183|NCT01188798|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153912184|NCT01188798|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153912185|NCT01188798|Immunologic Factors|immunologic factors|mesh-ancestor
153912186|NCT01188798|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153912187|NCT01188798|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153811261|NCT00332124|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153811262|NCT00332124|Antimetabolites|antimetabolites|mesh-ancestor
153811263|NCT00332124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153811264|NCT00332124|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153912188|NCT01188798|Adenosine Deaminase Inhibitors|adenosine deaminase inhibitors|mesh-ancestor
153912189|NCT01183104|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
153912191|NCT01183104|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153912192|NCT01183104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153453931|NCT01739790|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153453932|NCT01739790|Expectorants|expectorants|mesh-ancestor
153453933|NCT01739790|Respiratory System Agents|respiratory system agents|mesh-ancestor
153453934|NCT01739790|Free Radical Scavengers|free radical scavengers|mesh-ancestor
153453935|NCT01739790|Antioxidants|antioxidants|mesh-ancestor
153453936|NCT01739790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153453937|NCT01739790|Protective Agents|protective agents|mesh-ancestor
153453938|NCT01739790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153453939|NCT01739790|Antidotes|antidotes|mesh-ancestor
153453940|NCT01696032|Paclitaxel|paclitaxel|mesh-list
153453941|NCT01696032|Carboplatin|carboplatin|mesh-list
153453942|NCT01696032|Gemcitabine|gemcitabine|mesh-list
153453943|NCT01696032|Doxorubicin|doxorubicin|mesh-list
153453944|NCT01696032|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
153453945|NCT01696032|Topotecan|topotecan|mesh-list
153453946|NCT01696032|Guadecitabine|guadecitabine|mesh-list
153453947|NCT01696032|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153453948|NCT01696032|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153453949|NCT01696032|Tubulin Modulators|tubulin modulators|mesh-ancestor
153453950|NCT01696032|Antimitotic Agents|antimitotic agents|mesh-ancestor
153453951|NCT01696032|Mitosis Modulators|mitosis modulators|mesh-ancestor
153453952|NCT01696032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153453953|NCT01696032|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153453954|NCT01696032|Antimetabolites|antimetabolites|mesh-ancestor
153453955|NCT01696032|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153453956|NCT01696032|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153453957|NCT01696032|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153453958|NCT01696032|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153912193|NCT01183104|Incretins|incretins|mesh-ancestor
153912194|NCT01183104|Hormones|hormones|mesh-ancestor
153912195|NCT01183104|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153912196|NCT01183104|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
153912197|NCT01183104|Protease Inhibitors|protease inhibitors|mesh-ancestor
153912198|NCT01183104|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153912199|NCT01183104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153912200|NCT01183104|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153562178|NCT01656018|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153562179|NCT01656018|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153562180|NCT01656018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153562181|NCT01656018|Antiviral Agents|antiviral agents|mesh-ancestor
153562182|NCT01656018|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153562183|NCT01656018|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153562185|NCT01656057|Acetaminophen|acetaminophen|mesh-list
153912201|NCT01183104|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153912202|NCT01183104|Immunologic Factors|immunologic factors|mesh-ancestor
153912204|NCT02885688|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153912205|NCT02885688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153912206|NCT00950248|Idebenone|idebenone|mesh-list
153912207|NCT00950248|Antioxidants|antioxidants|mesh-ancestor
153912208|NCT00950248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153912209|NCT00950248|Protective Agents|protective agents|mesh-ancestor
153453959|NCT01696032|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
153453960|NCT01695954|Ritonavir|ritonavir|mesh-list
153912210|NCT00950248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153912211|NCT00950170|Factor VIII|factor viii|mesh-list
153912212|NCT00950170|Coagulants|coagulants|mesh-ancestor
153912213|NCT00604864|Infliximab|infliximab|mesh-list
153912214|NCT00604864|Antibodies|antibodies|mesh-list
153912215|NCT00604864|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
153912217|NCT00604864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153912218|NCT00604864|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
153912219|NCT00604864|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153912220|NCT00604864|Dermatologic Agents|dermatologic agents|mesh-ancestor
153912221|NCT00604864|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153562190|NCT01656057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153562191|NCT01656057|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153912222|NCT00604864|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153811266|NCT00332124|Nootropic Agents|nootropic agents|mesh-ancestor
153357758|NCT00778310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153357759|NCT00778310|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
153357760|NCT00778310|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153357761|NCT00778310|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153357762|NCT00778310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153357763|NCT00778310|Dopamine Agents|dopamine agents|mesh-ancestor
153912223|NCT01227824|Raltegravir Potassium|raltegravir potassium|mesh-list
153912224|NCT01227824|Dolutegravir|dolutegravir|mesh-list
153912225|NCT01227824|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153912226|NCT01227824|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153912227|NCT01227824|Antiviral Agents|antiviral agents|mesh-ancestor
153912228|NCT01227824|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153912229|NCT01227824|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
153912230|NCT01227824|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
153912231|NCT01227824|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153912232|NCT01227824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153912233|NCT00949702|Vemurafenib|vemurafenib|mesh-list
153453980|NCT01695954|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
153453981|NCT01695954|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
153820685|NCT00464763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153562192|NCT01656057|Analgesics|analgesics|mesh-ancestor
153562193|NCT01656057|Sensory System Agents|sensory system agents|mesh-ancestor
153562194|NCT01656057|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153562195|NCT01656057|Antipyretics|antipyretics|mesh-ancestor
153562196|NCT01656057|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153562197|NCT01656057|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153562198|NCT01656057|Antimetabolites|antimetabolites|mesh-ancestor
153562213|NCT01656109|Protease Inhibitors|protease inhibitors|mesh-ancestor
153453982|NCT01695954|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
153453983|NCT01695954|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153811267|NCT04714554|Erythromycin|erythromycin|mesh-list
153811268|NCT04714554|Erythromycin Estolate|erythromycin estolate|mesh-list
153811269|NCT04714554|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
153811270|NCT04714554|Erythromycin stearate|erythromycin stearate|mesh-list
153811271|NCT04714554|Relugolix|relugolix|mesh-list
153811272|NCT04714554|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153811273|NCT04714554|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153811274|NCT04714554|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153453985|NCT01695954|Antimetabolites|antimetabolites|mesh-ancestor
153453986|NCT01695954|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153453987|NCT01694706|Omeprazole|omeprazole|mesh-list
153453988|NCT01694706|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
153453989|NCT01694706|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153453990|NCT01694706|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
153453991|NCT01694706|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153453992|NCT01694706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153453993|NCT01715298|Glycopyrrolate|glycopyrrolate|mesh-list
153453994|NCT01715298|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153880044|NCT02158091|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153453995|NCT01715298|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
153453996|NCT01715298|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
153811275|NCT04714554|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
153357764|NCT00778310|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153453997|NCT01715298|Cholinergic Agents|cholinergic agents|mesh-ancestor
153453998|NCT01715298|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153453999|NCT01715298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153454000|NCT01715298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153454001|NCT01739400|Macitentan|macitentan|mesh-list
153454002|NCT01739400|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
153454003|NCT01739400|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
153912240|NCT01034631|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153912241|NCT01034631|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153880045|NCT02158091|Alkylating Agents|alkylating agents|mesh-ancestor
153562219|NCT01656109|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153562221|NCT01656122|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153562222|NCT01656122|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153562223|NCT01656122|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153562224|NCT01656122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153562225|NCT01656122|Antiviral Agents|antiviral agents|mesh-ancestor
153562226|NCT01656122|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153562227|NCT01656122|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153562228|NCT01656122|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153562271|NCT01656668|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153562272|NCT01656668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153562273|NCT01656668|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153562274|NCT01656668|Respiratory System Agents|respiratory system agents|mesh-ancestor
153562275|NCT01656668|Vasodilator Agents|vasodilator agents|mesh-ancestor
153562276|NCT01656720|Methoxamine|methoxamine|mesh-list
153562277|NCT01656720|Sympathomimetics|sympathomimetics|mesh-ancestor
153562278|NCT01656720|Autonomic Agents|autonomic agents|mesh-ancestor
153912242|NCT01034631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153912243|NCT01034631|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153912244|NCT01034631|Immunologic Factors|immunologic factors|mesh-ancestor
153912245|NCT01034631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153912246|NCT01034631|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153912247|NCT01227668|Aripiprazole|aripiprazole|mesh-list
153912248|NCT01227668|Antidepressive Agents|antidepressive agents|mesh-ancestor
153912249|NCT01227668|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153912250|NCT01227668|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153912251|NCT01227668|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153912252|NCT01227668|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153912253|NCT01227668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153912254|NCT01227668|Dopamine Agonists|dopamine agonists|mesh-ancestor
153912255|NCT01227668|Dopamine Agents|dopamine agents|mesh-ancestor
153912256|NCT01227668|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153912258|NCT01227668|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
153811276|NCT04714554|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153357766|NCT03801278|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153912259|NCT01227668|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
153912260|NCT01227668|Serotonin Agents|serotonin agents|mesh-ancestor
153912261|NCT01227668|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
153912262|NCT01227668|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153912263|NCT01227668|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
153454004|NCT01739400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153454005|NCT01739400|Endothelin B Receptor Antagonists|endothelin b receptor antagonists|mesh-ancestor
153454007|NCT01712178|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
153454008|NCT01712178|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153454009|NCT01712178|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153454011|NCT01693068|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153454012|NCT01693068|Alkylating Agents|alkylating agents|mesh-ancestor
153562279|NCT01656720|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153562280|NCT01656720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153562281|NCT01656720|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
153562282|NCT01656720|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
153562283|NCT01656720|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153562284|NCT01656720|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153562285|NCT01656720|Adrenergic Agents|adrenergic agents|mesh-ancestor
153562286|NCT01656720|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153562287|NCT01656720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153562288|NCT01656798|Sildenafil Citrate|sildenafil citrate|mesh-list
153562289|NCT01656798|Citric Acid|citric acid|mesh-list
153562290|NCT01656798|Sodium Citrate|sodium citrate|mesh-list
153454013|NCT01693068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153454014|NCT01693068|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153454015|NCT01691898|Rituximab|rituximab|mesh-list
153454016|NCT01691898|Obinutuzumab|obinutuzumab|mesh-list
153454017|NCT01691898|Polatuzumab vedotin|polatuzumab vedotin|mesh-list
153454018|NCT01691898|Pinatuzumab vedotin|pinatuzumab vedotin|mesh-list
153454019|NCT01691898|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153454020|NCT01691898|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153454021|NCT01691898|Immunologic Factors|immunologic factors|mesh-ancestor
153454022|NCT01691898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153454023|NCT01691898|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153454024|NCT01691898|Immunoconjugates|immunoconjugates|mesh-ancestor
153454025|NCT01711866|Rotigotine|rotigotine|mesh-list
153454026|NCT01711866|Dopamine Agonists|dopamine agonists|mesh-ancestor
153454027|NCT01711866|Dopamine Agents|dopamine agents|mesh-ancestor
153454028|NCT01711866|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153454029|NCT01711866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153454030|NCT01711866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153454032|NCT01691508|Prednisolone|prednisolone|mesh-list
153454033|NCT01691508|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153912264|NCT01227668|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
153912265|NCT01227512|Tolvaptan|tolvaptan|mesh-list
153912266|NCT01227512|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
153912267|NCT01227512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153912268|NCT01227512|Natriuretic Agents|natriuretic agents|mesh-ancestor
153912269|NCT01227512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153912270|NCT01227278|Benralizumab|benralizumab|mesh-list
153912271|NCT01227278|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153912272|NCT01227278|Respiratory System Agents|respiratory system agents|mesh-ancestor
153912273|NCT01227044|Naltrexone|naltrexone|mesh-list
153912274|NCT01227044|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
153562387|NCT01657240|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
153562388|NCT01657240|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
153562389|NCT01657240|Histamine Antagonists|histamine antagonists|mesh-ancestor
153562390|NCT01657240|Histamine Agents|histamine agents|mesh-ancestor
153562391|NCT01657240|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153562392|NCT01657240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153562393|NCT01657318|Anti-Infective Agents, Local|anti-infective agents, local|mesh-list
153562394|NCT01657318|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153562395|NCT01657331|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
153562397|NCT01657331|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153562398|NCT01657331|Alkylating Agents|alkylating agents|mesh-ancestor
153562399|NCT01657331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153562400|NCT01657331|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153562401|NCT01657331|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153562402|NCT01657331|Immunotoxins|immunotoxins|mesh-ancestor
153880054|NCT01460654|Alendronate|alendronate|mesh-list
153912275|NCT01227044|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
153912276|NCT01227044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153912277|NCT01227044|Sensory System Agents|sensory system agents|mesh-ancestor
153811278|NCT04714554|Androgen Antagonists|androgen antagonists|mesh-ancestor
153454034|NCT01691508|Glucocorticoids|glucocorticoids|mesh-ancestor
153912278|NCT01227044|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153357767|NCT03801278|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153357768|NCT01247285|Fluoxetine|fluoxetine|mesh-list
153912279|NCT01034163|Panobinostat|panobinostat|mesh-list
153912280|NCT01034163|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153912281|NCT01034163|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
153912282|NCT01034163|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153912283|NCT01034163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153912284|NCT01162122|Vaccines|vaccines|mesh-list
153912285|NCT01162122|Immunologic Factors|immunologic factors|mesh-ancestor
153912286|NCT01162122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153912287|NCT01033071|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
153912288|NCT01033071|Olmesartan|olmesartan|mesh-list
153912289|NCT01033071|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
153912290|NCT01033071|Chlorthalidone|chlorthalidone|mesh-list
153912291|NCT01033071|Azilsartan medoxomil|azilsartan medoxomil|mesh-list
153912292|NCT01033071|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153912293|NCT01033071|Diuretics|diuretics|mesh-ancestor
153912294|NCT01033071|Natriuretic Agents|natriuretic agents|mesh-ancestor
153912295|NCT01033071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153912296|NCT01033071|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
153912297|NCT01033071|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153912298|NCT01033071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153912299|NCT01033071|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
153912300|NCT01033071|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
153811279|NCT04714554|Hormone Antagonists|hormone antagonists|mesh-ancestor
153811280|NCT04714554|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153912301|NCT01032915|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
153912302|NCT01032915|Immunologic Factors|immunologic factors|mesh-ancestor
153562426|NCT01657448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153562428|NCT01657487|Xhance|xhance|mesh-list
153562429|NCT01657487|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
153562430|NCT01657487|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
153562431|NCT01657487|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153562432|NCT01657487|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153562433|NCT01657487|Autonomic Agents|autonomic agents|mesh-ancestor
153562434|NCT01657487|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153562435|NCT01657487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153562436|NCT01657487|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153562437|NCT01657487|Respiratory System Agents|respiratory system agents|mesh-ancestor
153562438|NCT01657487|Dermatologic Agents|dermatologic agents|mesh-ancestor
153562439|NCT01657487|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
153912303|NCT01032915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153912304|NCT01161498|Talimogene laherparepvec|talimogene laherparepvec|mesh-list
153912305|NCT01161498|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153454049|NCT01688466|Immunologic Factors|immunologic factors|mesh-ancestor
153454050|NCT01688466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153454051|NCT01688466|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153454052|NCT01688466|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153454053|NCT01688466|Growth Substances|growth substances|mesh-ancestor
153454054|NCT01688466|Growth Inhibitors|growth inhibitors|mesh-ancestor
153454055|NCT01688466|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153454056|NCT01682148|Botulinum Toxins|botulinum toxins|mesh-list
153454057|NCT01682148|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
153454058|NCT01682148|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
153454059|NCT01682148|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
153454060|NCT01682148|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153454061|NCT01682148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153454062|NCT01682148|Cholinergic Agents|cholinergic agents|mesh-ancestor
153454063|NCT01682148|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153454064|NCT01682148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153454065|NCT01682148|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
153454066|NCT01682148|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153454067|NCT01681992|Vaccines|vaccines|mesh-list
153454068|NCT01681992|Immunologic Factors|immunologic factors|mesh-ancestor
153454069|NCT01681992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153454070|NCT01737840|Pantoprazole|pantoprazole|mesh-list
153912306|NCT01161498|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153912307|NCT02873559|Testosterone|testosterone|mesh-list
153912308|NCT02873559|Androgens|androgens|mesh-ancestor
153912309|NCT02873559|Hormones|hormones|mesh-ancestor
153562453|NCT01657578|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
153562454|NCT01657578|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153562469|NCT01657747|Parasympatholytics|parasympatholytics|mesh-ancestor
153562470|NCT01657747|Autonomic Agents|autonomic agents|mesh-ancestor
153562471|NCT01657747|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153562472|NCT01657747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153562473|NCT01657747|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
153562474|NCT01657747|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
153562475|NCT01657747|Cholinergic Agents|cholinergic agents|mesh-ancestor
153562476|NCT01657747|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153562477|NCT01657747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153562478|NCT01657812|Dexmedetomidine|dexmedetomidine|mesh-list
153562479|NCT01657812|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153562480|NCT01657812|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153562481|NCT01657812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153562482|NCT01657812|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153562483|NCT01657812|Analgesics|analgesics|mesh-ancestor
153562484|NCT01657812|Sensory System Agents|sensory system agents|mesh-ancestor
153562485|NCT01657812|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153562488|NCT01657812|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153912310|NCT02873559|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153912311|NCT02873559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153912312|NCT01029795|Glyburide|glyburide|mesh-list
153912313|NCT01029795|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153912314|NCT01029795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153912315|NCT02885454|Simeprevir|simeprevir|mesh-list
153912316|NCT02885454|Odalasvir|odalasvir|mesh-list
153912317|NCT02885454|Drospirenone|drospirenone|mesh-list
153912318|NCT02885454|Ethinyl Estradiol|ethinyl estradiol|mesh-list
153912319|NCT02885454|Drospirenone and ethinyl estradiol combination|drospirenone and ethinyl estradiol combination|mesh-list
153912320|NCT02885454|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
153912321|NCT02885454|Hormone Antagonists|hormone antagonists|mesh-ancestor
153912322|NCT02885454|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153912323|NCT02885454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153912324|NCT02885454|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
153912325|NCT02885454|Diuretics|diuretics|mesh-ancestor
153912326|NCT02885454|Natriuretic Agents|natriuretic agents|mesh-ancestor
153912327|NCT02885454|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
153912328|NCT02885454|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
153912329|NCT02885454|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
153912330|NCT02885454|Contraceptive Agents|contraceptive agents|mesh-ancestor
153912331|NCT02885454|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153912332|NCT02885454|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
153912333|NCT02885454|Estrogens|estrogens|mesh-ancestor
153912334|NCT02885454|Hormones|hormones|mesh-ancestor
153912335|NCT02885454|Antiviral Agents|antiviral agents|mesh-ancestor
153912336|NCT02885454|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153912337|NCT02885454|Protease Inhibitors|protease inhibitors|mesh-ancestor
153912338|NCT02885454|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153912339|NCT02885454|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153912341|NCT01032837|Antiviral Agents|antiviral agents|mesh-ancestor
153912342|NCT01032837|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153912343|NCT01032837|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153912344|NCT01032837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153912345|NCT01180296|Progesterone|progesterone|mesh-list
153912346|NCT01180296|Progestins|progestins|mesh-ancestor
153912347|NCT01180296|Hormones|hormones|mesh-ancestor
153912348|NCT01180296|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153912349|NCT01180296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153562492|NCT01657825|Isavuconazole|isavuconazole|mesh-list
153562518|NCT01657851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153562519|NCT01657851|Urological Agents|urological agents|mesh-ancestor
153562520|NCT01657851|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
153562521|NCT01657851|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153562522|NCT01657851|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153562523|NCT01657851|Hormone Antagonists|hormone antagonists|mesh-ancestor
153562524|NCT01657851|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153562525|NCT01657864|Lamotrigine|lamotrigine|mesh-list
153562526|NCT01657864|Anticonvulsants|anticonvulsants|mesh-ancestor
153562527|NCT01657864|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153912350|NCT01160640|Metronidazole|metronidazole|mesh-list
153912351|NCT01160640|Doxycycline|doxycycline|mesh-list
153912358|NCT01160640|Third Generation Cephalosporins|third generation cephalosporins|mesh-ancestor
153454103|NCT01687296|Glucocorticoids|glucocorticoids|mesh-ancestor
153454104|NCT01687296|Hormones|hormones|mesh-ancestor
153454105|NCT01687296|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153454106|NCT01687296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153454107|NCT01687296|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153454108|NCT01687296|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153454109|NCT01687296|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153454110|NCT01687296|Autonomic Agents|autonomic agents|mesh-ancestor
153454111|NCT01687296|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153454112|NCT01687296|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153357769|NCT01247285|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
153454113|NCT01687296|Respiratory System Agents|respiratory system agents|mesh-ancestor
153454114|NCT01687296|Dermatologic Agents|dermatologic agents|mesh-ancestor
153454115|NCT01687296|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
153454116|NCT01687296|Tocolytic Agents|tocolytic agents|mesh-ancestor
153454117|NCT01687296|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153454118|NCT01687296|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
153454119|NCT01687296|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
153454120|NCT01687296|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153454121|NCT01687296|Adrenergic Agents|adrenergic agents|mesh-ancestor
153454122|NCT01687296|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153454123|NCT01687296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153454124|NCT01568892|Dolutegravir|dolutegravir|mesh-list
153454125|NCT01568892|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
153454126|NCT01568892|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
153454127|NCT01568892|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153454128|NCT01568892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153454129|NCT01568892|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153912359|NCT01160640|Beta Lactam Antibiotics|beta lactam antibiotics|mesh-ancestor
153912360|NCT01160484|Lenalidomide|lenalidomide|mesh-list
153912361|NCT01160484|Bortezomib|bortezomib|mesh-list
153912362|NCT01160484|Immunologic Factors|immunologic factors|mesh-ancestor
153912363|NCT01160484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153562538|NCT01657890|Antifungal Agents|antifungal agents|mesh-ancestor
153562539|NCT01657890|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153782689|NCT04561921|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153782690|NCT04561921|Anticonvulsants|anticonvulsants|mesh-ancestor
153562540|NCT01657929|Aluminum Hydroxide|aluminum hydroxide|mesh-list
153562541|NCT01657929|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153562542|NCT01657929|Immunologic Factors|immunologic factors|mesh-ancestor
153562543|NCT01657929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153562545|NCT01657929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153562546|NCT01657929|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153562547|NCT01657955|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
153562548|NCT01657955|Chlorambucil|chlorambucil|mesh-list
153562557|NCT01657513|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153562563|NCT01657513|Analgesics|analgesics|mesh-ancestor
153912364|NCT01160484|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153912365|NCT01160484|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153912366|NCT01160484|Growth Substances|growth substances|mesh-ancestor
153912367|NCT01160484|Growth Inhibitors|growth inhibitors|mesh-ancestor
153912368|NCT01160484|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153912369|NCT01032291|Lenalidomide|lenalidomide|mesh-list
153912370|NCT01032291|Cetuximab|cetuximab|mesh-list
153912371|NCT01032291|Immunologic Factors|immunologic factors|mesh-ancestor
153912372|NCT01032291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153912373|NCT01032291|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153912374|NCT01032291|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153912375|NCT01032291|Growth Substances|growth substances|mesh-ancestor
153912376|NCT01032291|Growth Inhibitors|growth inhibitors|mesh-ancestor
153912377|NCT01032291|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153912378|NCT01032291|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153912379|NCT01159938|Insulin Lispro|insulin lispro|mesh-list
153912380|NCT01159938|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153912381|NCT01159938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153912382|NCT02873871|Hemostatics|hemostatics|mesh-list
153912383|NCT02873871|Coagulants|coagulants|mesh-ancestor
153912384|NCT04301739|Paclitaxel|paclitaxel|mesh-list
153912385|NCT04301739|Cyclophosphamide|cyclophosphamide|mesh-list
153912386|NCT04301739|Carboplatin|carboplatin|mesh-list
153912387|NCT04301739|Doxorubicin|doxorubicin|mesh-list
153454130|NCT01568892|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153454131|NCT01568892|Antiviral Agents|antiviral agents|mesh-ancestor
153454132|NCT01568892|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153454133|NCT01568112|Aspirin|aspirin|mesh-list
153454134|NCT01568112|Dimethyl Fumarate|dimethyl fumarate|mesh-list
153357770|NCT01247285|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153454135|NCT01568112|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153454136|NCT01568112|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153454137|NCT01568112|Analgesics|analgesics|mesh-ancestor
153454138|NCT01568112|Sensory System Agents|sensory system agents|mesh-ancestor
153454139|NCT01568112|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153454140|NCT01568112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153562568|NCT01657513|Immunologic Factors|immunologic factors|mesh-ancestor
153562569|NCT01657981|Darexaban|darexaban|mesh-list
153562570|NCT01657981|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
153562571|NCT01657981|Antithrombins|antithrombins|mesh-ancestor
153562572|NCT01657981|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
153562573|NCT01657981|Protease Inhibitors|protease inhibitors|mesh-ancestor
153562574|NCT01657981|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153562575|NCT01657981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153562576|NCT01657981|Anticoagulants|anticoagulants|mesh-ancestor
153454141|NCT01568112|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153454142|NCT01568112|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153454143|NCT01568112|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153454144|NCT01568112|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153454145|NCT01568112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153454146|NCT01568112|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153454147|NCT01568112|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153454148|NCT01568112|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153454149|NCT01568112|Antipyretics|antipyretics|mesh-ancestor
153454150|NCT01568112|Dermatologic Agents|dermatologic agents|mesh-ancestor
153454151|NCT01568112|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153912388|NCT04301739|Epirubicin|epirubicin|mesh-list
153912389|NCT04301739|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153912390|NCT04301739|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153912391|NCT04301739|Tubulin Modulators|tubulin modulators|mesh-ancestor
153912392|NCT04301739|Antimitotic Agents|antimitotic agents|mesh-ancestor
153912393|NCT04301739|Mitosis Modulators|mitosis modulators|mesh-ancestor
153912394|NCT04301739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153562604|NCT01658124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153912395|NCT04301739|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153912396|NCT04301739|Immunologic Factors|immunologic factors|mesh-ancestor
153912397|NCT04301739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153912398|NCT04301739|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153912399|NCT04301739|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153912400|NCT04301739|Alkylating Agents|alkylating agents|mesh-ancestor
153912401|NCT04301739|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153912402|NCT04301739|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153912403|NCT04301739|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153912404|NCT04301739|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153912405|NCT04301739|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153912406|NCT04301583|Proanthocyanidin|proanthocyanidin|mesh-list
153912407|NCT04301583|Procyanidin|procyanidin|mesh-list
153912408|NCT04301583|Antioxidants|antioxidants|mesh-ancestor
153912409|NCT04301583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153912410|NCT04301583|Protective Agents|protective agents|mesh-ancestor
153912411|NCT04301583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153562605|NCT01658124|Hemostatics|hemostatics|mesh-ancestor
153562606|NCT01658124|Coagulants|coagulants|mesh-ancestor
153562607|NCT01658176|Exemestane|exemestane|mesh-list
153562608|NCT01658176|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153562609|NCT01658176|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
153562610|NCT01658176|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153562611|NCT01658176|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153562612|NCT01658176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153562613|NCT01658176|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
153562614|NCT01658176|Hormone Antagonists|hormone antagonists|mesh-ancestor
153562617|NCT01658202|Nicotine|nicotine|mesh-list
153912412|NCT04301583|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153912413|NCT04301583|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153912414|NCT04301583|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153912415|NCT01021683|Itraconazole|itraconazole|mesh-list
153912416|NCT01021683|Antifungal Agents|antifungal agents|mesh-ancestor
153912417|NCT01021683|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153454152|NCT01568112|Immunologic Factors|immunologic factors|mesh-ancestor
153912418|NCT01021683|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
153912419|NCT01021683|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153912420|NCT01021683|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153912421|NCT01021683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153912422|NCT01021683|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153912423|NCT01021683|Hormone Antagonists|hormone antagonists|mesh-ancestor
153912424|NCT01021683|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153912425|NCT01021683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153912426|NCT01021683|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
153912427|NCT04625725|Cilgavimab and tixagevimab drug combination|cilgavimab and tixagevimab drug combination|mesh-list
153912428|NCT04625725|Antiviral Agents|antiviral agents|mesh-ancestor
153912430|NCT01021215|Celecoxib|celecoxib|mesh-list
153912431|NCT01021215|Zileuton|zileuton|mesh-list
153912432|NCT01021215|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153912433|NCT01021215|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153912434|NCT01021215|Analgesics|analgesics|mesh-ancestor
153912435|NCT01021215|Sensory System Agents|sensory system agents|mesh-ancestor
153912436|NCT01021215|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153912437|NCT01021215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153454183|NCT01686828|Testosterone|testosterone|mesh-list
153454184|NCT01686828|Testosterone undecanoate|testosterone undecanoate|mesh-list
153454185|NCT01686828|Testosterone enanthate|testosterone enanthate|mesh-list
153454186|NCT01686828|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
153454187|NCT01686828|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153454188|NCT01686828|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
153454189|NCT01686828|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153562660|NCT01658358|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153562661|NCT01658410|cyclo(Trp-Asp-Pro-Val-Leu)|cyclo(trp-asp-pro-val-leu)|mesh-list
153562662|NCT01658410|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153562663|NCT01658410|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
153562664|NCT01658410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153562665|NCT01658449|Hyaluronic Acid|hyaluronic acid|mesh-list
153562666|NCT01658449|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153562667|NCT01658449|Immunologic Factors|immunologic factors|mesh-ancestor
153562668|NCT01658449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153562669|NCT01658449|Viscosupplements|viscosupplements|mesh-ancestor
153562670|NCT01658449|Protective Agents|protective agents|mesh-ancestor
153562671|NCT01658462|Docetaxel|docetaxel|mesh-list
153454190|NCT01686828|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153454191|NCT01686828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153454192|NCT01686828|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
153454193|NCT01686828|Hormone Antagonists|hormone antagonists|mesh-ancestor
153454194|NCT01686828|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153454195|NCT01686828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153454196|NCT01686828|Androgens|androgens|mesh-ancestor
153454197|NCT01686828|Hormones|hormones|mesh-ancestor
153454198|NCT01686828|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153454199|NCT01686828|Anabolic Agents|anabolic agents|mesh-ancestor
153454200|NCT01603602|Botulinum Toxins|botulinum toxins|mesh-list
153454201|NCT01603602|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
153454202|NCT01603602|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
153454203|NCT01603602|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
153454204|NCT01603602|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153454205|NCT01603602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153454206|NCT01603602|Cholinergic Agents|cholinergic agents|mesh-ancestor
153454207|NCT01603602|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153454208|NCT01603602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153454209|NCT01603602|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
153454210|NCT01603602|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153454211|NCT01684878|Paclitaxel|paclitaxel|mesh-list
153454212|NCT01684878|Gemcitabine|gemcitabine|mesh-list
153454213|NCT01684878|Topotecan|topotecan|mesh-list
153454214|NCT01684878|Pertuzumab|pertuzumab|mesh-list
153454215|NCT01684878|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153454216|NCT01684878|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153454217|NCT01684878|Tubulin Modulators|tubulin modulators|mesh-ancestor
153912438|NCT01021215|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153912439|NCT01021215|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153912440|NCT01021215|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
153811286|NCT00419471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153912441|NCT01021215|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153912442|NCT01021215|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153912443|NCT01021215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153912444|NCT01021215|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
153912445|NCT01021215|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
153912446|NCT01021215|Hormone Antagonists|hormone antagonists|mesh-ancestor
153562690|NCT01658553|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153562692|NCT01658774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153562693|NCT01658774|Anthelmintics|anthelmintics|mesh-ancestor
153562694|NCT01658774|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153562695|NCT01658774|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153562696|NCT01658774|Anticestodal Agents|anticestodal agents|mesh-ancestor
153562697|NCT01658774|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
153562698|NCT01658774|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153562699|NCT01658774|Tubulin Modulators|tubulin modulators|mesh-ancestor
153562700|NCT01658774|Antimitotic Agents|antimitotic agents|mesh-ancestor
153562701|NCT01658774|Mitosis Modulators|mitosis modulators|mesh-ancestor
153912447|NCT01021215|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153912448|NCT02760979|Denosumab|denosumab|mesh-list
153912449|NCT02760979|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153912450|NCT02760979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153912451|NCT02873325|Antiviral Agents|antiviral agents|mesh-list
153912452|NCT02873325|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153912453|NCT02760901|Acetylcysteine|acetylcysteine|mesh-list
153912455|NCT02760901|Acetazolamide|acetazolamide|mesh-list
153912456|NCT02760901|N-monoacetylcystine|n-monoacetylcystine|mesh-list
153912457|NCT02760901|Antiviral Agents|antiviral agents|mesh-ancestor
153912458|NCT02760901|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153912459|NCT02760901|Expectorants|expectorants|mesh-ancestor
153912460|NCT02760901|Respiratory System Agents|respiratory system agents|mesh-ancestor
153912461|NCT02760901|Free Radical Scavengers|free radical scavengers|mesh-ancestor
153912462|NCT02760901|Antioxidants|antioxidants|mesh-ancestor
153912463|NCT02760901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153912464|NCT02760901|Protective Agents|protective agents|mesh-ancestor
153912465|NCT02760901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153912466|NCT02760901|Antidotes|antidotes|mesh-ancestor
153912467|NCT02760901|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
153912468|NCT02760901|Diuretics|diuretics|mesh-ancestor
153912469|NCT02760901|Natriuretic Agents|natriuretic agents|mesh-ancestor
153912470|NCT02760901|Anticonvulsants|anticonvulsants|mesh-ancestor
153562715|NCT01658891|Respiratory System Agents|respiratory system agents|mesh-ancestor
153562722|NCT01658891|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153912471|NCT02760901|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
153454218|NCT01684878|Antimitotic Agents|antimitotic agents|mesh-ancestor
153454219|NCT01684878|Mitosis Modulators|mitosis modulators|mesh-ancestor
153454220|NCT01684878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153454221|NCT01684878|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153357772|NCT01247285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153454223|NCT01684878|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
153454224|NCT01684878|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153454225|NCT01684878|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153454226|NCT01684878|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153454227|NCT01684722|Vitamin D|vitamin d|mesh-list
153454229|NCT01684722|Cholecalciferol|cholecalciferol|mesh-list
153454230|NCT01684722|Vitamins|vitamins|mesh-list
153454231|NCT01684722|Micronutrients|micronutrients|mesh-ancestor
153454232|NCT01684722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153454233|NCT01684722|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153454234|NCT01684722|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153454235|NCT01592292|Adalimumab|adalimumab|mesh-list
153454236|NCT01592292|Infliximab|infliximab|mesh-list
153454237|NCT01592292|Etanercept|etanercept|mesh-list
153454238|NCT01592292|Rituximab|rituximab|mesh-list
153454239|NCT01592292|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153454240|NCT01592292|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153454241|NCT01592292|Immunologic Factors|immunologic factors|mesh-ancestor
153454242|NCT01592292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153454243|NCT01592292|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153562723|NCT01658891|Glucocorticoids|glucocorticoids|mesh-ancestor
153562724|NCT01658891|Hormones|hormones|mesh-ancestor
153562725|NCT01658891|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153562726|NCT01659008|Estradiol|estradiol|mesh-list
153562727|NCT01659008|Estrogens|estrogens|mesh-ancestor
153562728|NCT01659008|Hormones|hormones|mesh-ancestor
153562729|NCT01659008|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153562730|NCT01659008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153562731|NCT01659047|Idelalisib|idelalisib|mesh-list
153562732|NCT01659047|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153454244|NCT01592292|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
153454245|NCT01592292|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153454246|NCT01592292|Dermatologic Agents|dermatologic agents|mesh-ancestor
153454247|NCT01592292|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153454248|NCT01592292|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153912472|NCT02760901|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153912473|NCT00635713|Fulvestrant|fulvestrant|mesh-list
153912474|NCT00635713|Anastrozole|anastrozole|mesh-list
153912475|NCT00635713|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153912476|NCT00635713|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153912477|NCT00635713|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
153912478|NCT00635713|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
153912479|NCT00635713|Hormone Antagonists|hormone antagonists|mesh-ancestor
153912480|NCT00635713|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153912481|NCT00635713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153912482|NCT00635713|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
153912483|NCT00635713|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153912484|NCT00635713|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153454249|NCT01592292|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153912485|NCT00635713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153912486|NCT02760823|Thioctic Acid|thioctic acid|mesh-list
153912487|NCT02760823|Antioxidants|antioxidants|mesh-ancestor
153912488|NCT02760823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153912489|NCT02760823|Protective Agents|protective agents|mesh-ancestor
153912490|NCT02760823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153912491|NCT02760823|Vitamin B Complex|vitamin b complex|mesh-ancestor
153912492|NCT02760823|Vitamins|vitamins|mesh-ancestor
153912493|NCT02760823|Micronutrients|micronutrients|mesh-ancestor
153912494|NCT01020747|Bevacizumab|bevacizumab|mesh-list
153912495|NCT01020747|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153912496|NCT01020747|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153562735|NCT01659086|Vaccines|vaccines|mesh-list
153562736|NCT01659086|Immunologic Factors|immunologic factors|mesh-ancestor
153562737|NCT01659086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153562738|NCT01659099|Prednisone|prednisone|mesh-list
153562739|NCT01659099|Cyclophosphamide|cyclophosphamide|mesh-list
153562740|NCT01659099|Rituximab|rituximab|mesh-list
153562741|NCT01659099|Doxorubicin|doxorubicin|mesh-list
153562742|NCT01659099|Vincristine|vincristine|mesh-list
153562743|NCT01659099|Obinutuzumab|obinutuzumab|mesh-list
153562744|NCT01659099|Bleomycin|bleomycin|mesh-list
153562745|NCT01659099|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153562746|NCT01659099|Immunologic Factors|immunologic factors|mesh-ancestor
153562747|NCT01659099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153562748|NCT01659099|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153562749|NCT01659099|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153562773|NCT01659242|Methotrexate|methotrexate|mesh-list
153912497|NCT01020747|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153912498|NCT01020747|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153912499|NCT01020747|Growth Substances|growth substances|mesh-ancestor
153912500|NCT01020747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153912501|NCT01020747|Growth Inhibitors|growth inhibitors|mesh-ancestor
153912502|NCT02754739|Pravastatin|pravastatin|mesh-list
153912503|NCT02754739|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153912504|NCT02754739|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153912505|NCT02754739|Antimetabolites|antimetabolites|mesh-ancestor
153912506|NCT02754739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153912507|NCT02754739|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153912508|NCT02754739|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
153912509|NCT02754739|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153912511|NCT01031979|Mydriatics|mydriatics|mesh-ancestor
153912512|NCT01031979|Autonomic Agents|autonomic agents|mesh-ancestor
153912513|NCT01031979|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153454263|NCT01565850|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
153454264|NCT01565850|Protease Inhibitors|protease inhibitors|mesh-ancestor
153454265|NCT01565850|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
153811287|NCT00419471|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153454266|NCT01565850|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153454267|NCT01565694|Solifenacin Succinate|solifenacin succinate|mesh-list
153454268|NCT01565694|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
153454269|NCT01565694|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
153454270|NCT01565694|Cholinergic Agents|cholinergic agents|mesh-ancestor
153454271|NCT01565694|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153562785|NCT01659242|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153562786|NCT01659242|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153562787|NCT01659242|Immunologic Factors|immunologic factors|mesh-ancestor
153562788|NCT01659242|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153562789|NCT01659242|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153562790|NCT01659242|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153562791|NCT01659242|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153562792|NCT01659242|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153562793|NCT01659242|Analgesics|analgesics|mesh-ancestor
153562794|NCT01659242|Sensory System Agents|sensory system agents|mesh-ancestor
153562795|NCT01659242|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153562796|NCT01659242|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153562797|NCT01659242|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153562798|NCT01659281|Artesunate|artesunate|mesh-list
153562799|NCT01659281|Mefloquine|mefloquine|mesh-list
153562800|NCT01659281|Antimalarials|antimalarials|mesh-ancestor
153562801|NCT01659281|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153562802|NCT01659281|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153454272|NCT01565694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153454273|NCT01565694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153454274|NCT01565694|Urological Agents|urological agents|mesh-ancestor
153454275|NCT01543152|Cyclophosphamide|cyclophosphamide|mesh-list
153454276|NCT01543152|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153454277|NCT01543152|Immunologic Factors|immunologic factors|mesh-ancestor
153454278|NCT01543152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153454279|NCT01543152|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153454280|NCT01543152|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153454281|NCT01543152|Alkylating Agents|alkylating agents|mesh-ancestor
153454282|NCT01543152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153454283|NCT01543152|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153454284|NCT01543152|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153454286|NCT01565148|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153454287|NCT01565148|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153454288|NCT01565148|Growth Substances|growth substances|mesh-ancestor
153454289|NCT01565148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153454290|NCT01565148|Growth Inhibitors|growth inhibitors|mesh-ancestor
153454291|NCT01565148|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153912514|NCT01031979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153912515|NCT01031979|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
153912516|NCT01031979|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
153912517|NCT01031979|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
153811288|NCT00419471|Serotonin Agents|serotonin agents|mesh-ancestor
153912518|NCT01031979|Adrenergic Agents|adrenergic agents|mesh-ancestor
153912519|NCT01031979|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153912520|NCT01031979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153912521|NCT01031979|Urological Agents|urological agents|mesh-ancestor
153912523|NCT02753803|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153912524|NCT02753803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153562818|NCT01659346|Protective Agents|protective agents|mesh-ancestor
153562819|NCT01659346|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153562820|NCT01659346|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153562821|NCT01659346|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153562822|NCT01659346|Vasodilator Agents|vasodilator agents|mesh-ancestor
153562823|NCT01659346|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
153562824|NCT01659346|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
153562825|NCT01659359|Lidocaine|lidocaine|mesh-list
153562826|NCT01659359|Anesthetics, Local|anesthetics, local|mesh-ancestor
153562827|NCT01659359|Anesthetics|anesthetics|mesh-ancestor
153562828|NCT01659359|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153562830|NCT01659359|Sensory System Agents|sensory system agents|mesh-ancestor
153912525|NCT04219579|Antithrombins|antithrombins|mesh-list
153912526|NCT04219579|Antithrombin III|antithrombin iii|mesh-list
153912527|NCT04219579|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
153912528|NCT04219579|Protease Inhibitors|protease inhibitors|mesh-ancestor
153912530|NCT04219579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153912531|NCT04219579|Anticoagulants|anticoagulants|mesh-ancestor
153912532|NCT00635401|Varenicline|varenicline|mesh-list
153912533|NCT00635401|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
153912534|NCT00635401|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
153912535|NCT00635401|Cholinergic Agents|cholinergic agents|mesh-ancestor
153912536|NCT00635401|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153912537|NCT00635401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153912538|NCT00635401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153912539|NCT02753725|Fentanyl|fentanyl|mesh-list
153912540|NCT02753725|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153912541|NCT02753725|Narcotics|narcotics|mesh-ancestor
153912542|NCT02753725|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153454293|NCT04410354|Antimetabolites|antimetabolites|mesh-ancestor
153454294|NCT04410354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153454295|NCT04410354|Antiviral Agents|antiviral agents|mesh-ancestor
153454296|NCT04410354|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153454297|NCT01564758|Linezolid|linezolid|mesh-list
153454298|NCT01564758|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153454299|NCT01564758|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153454300|NCT01564758|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
153454301|NCT01564758|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153454302|NCT01564758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153454303|NCT01589094|Gemcitabine|gemcitabine|mesh-list
153454304|NCT01589094|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153454305|NCT01589094|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153454306|NCT01589094|Antimetabolites|antimetabolites|mesh-ancestor
153454307|NCT01589094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153454309|NCT01563354|Pasireotide|pasireotide|mesh-list
153454310|NCT01563354|Somatostatin|somatostatin|mesh-list
153454311|NCT01563354|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
153454312|NCT01563354|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153454313|NCT01563354|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153454314|NCT01563354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153454315|NCT01563354|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153454316|NCT01563354|Immunologic Factors|immunologic factors|mesh-ancestor
153454317|NCT01563354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153454318|NCT01563354|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153454319|NCT01563354|Hormones|hormones|mesh-ancestor
153454320|NCT01563354|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153454321|NCT03027960|Empagliflozin|empagliflozin|mesh-list
153562849|NCT01659372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153562851|NCT01659437|Streptomycin|streptomycin|mesh-list
153562852|NCT01659437|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153562853|NCT01659437|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153562854|NCT01659437|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
153562855|NCT01659437|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153562856|NCT01659437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153562857|NCT01659437|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
153562858|NCT01659437|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153562859|NCT01659476|Methacholine Chloride|methacholine chloride|mesh-list
153562860|NCT01659476|Miotics|miotics|mesh-ancestor
153454322|NCT03027960|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
153454323|NCT03027960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153912543|NCT02753725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153912544|NCT02753725|Analgesics|analgesics|mesh-ancestor
153912545|NCT02753725|Sensory System Agents|sensory system agents|mesh-ancestor
153912546|NCT02753725|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153912547|NCT02753725|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153912548|NCT02753725|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153912549|NCT02753725|Anesthetics, General|anesthetics, general|mesh-ancestor
153912550|NCT02753725|Anesthetics|anesthetics|mesh-ancestor
153912551|NCT01020123|Glipizide|glipizide|mesh-list
153912552|NCT01020123|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153912553|NCT01020123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153912554|NCT04300959|Cisplatin|cisplatin|mesh-list
153912555|NCT04300959|Gemcitabine|gemcitabine|mesh-list
153912556|NCT04300959|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153912557|NCT04300959|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153912558|NCT04300959|Antimetabolites|antimetabolites|mesh-ancestor
153357774|NCT01247285|Serotonin Agents|serotonin agents|mesh-ancestor
153912559|NCT04300959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153912560|NCT02760355|Ribavirin|ribavirin|mesh-list
153562865|NCT01659476|Bronchoconstrictor Agents|bronchoconstrictor agents|mesh-ancestor
153562866|NCT01659476|Respiratory System Agents|respiratory system agents|mesh-ancestor
153912561|NCT02760355|Sofosbuvir|sofosbuvir|mesh-list
153912562|NCT02760355|Ledipasvir|ledipasvir|mesh-list
153912563|NCT02760355|Antimetabolites|antimetabolites|mesh-ancestor
153912564|NCT02760355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153912565|NCT02760355|Antiviral Agents|antiviral agents|mesh-ancestor
153912566|NCT02760355|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153912567|NCT01028391|Metformin|metformin|mesh-list
153912568|NCT01028391|Pioglitazone|pioglitazone|mesh-list
153912569|NCT01028391|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
153912570|NCT01028391|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153912571|NCT01028391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153912572|NCT01028391|Incretins|incretins|mesh-ancestor
153912573|NCT01028391|Hormones|hormones|mesh-ancestor
153912574|NCT01028391|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153912575|NCT01028391|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
153912577|NCT01028391|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153912578|NCT01028391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153912579|NCT01179672|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
153562867|NCT01659476|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
153562868|NCT01659476|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
153562869|NCT01659476|Cholinergic Agents|cholinergic agents|mesh-ancestor
153562870|NCT01659476|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153562871|NCT01659476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153562872|NCT01659515|Arbekacin|arbekacin|mesh-list
153562873|NCT01659515|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153912580|NCT01179672|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
153912581|NCT01179672|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153912582|NCT01179672|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153912583|NCT01179672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153454357|NCT01538472|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153454358|NCT01562028|Bevacizumab|bevacizumab|mesh-list
153454359|NCT01562028|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
153454360|NCT01562028|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153912585|NCT01179672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153912586|NCT01179672|Analgesics|analgesics|mesh-ancestor
153912587|NCT01179672|Sensory System Agents|sensory system agents|mesh-ancestor
153912588|NCT01179672|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153912589|NCT01179672|Antidepressive Agents|antidepressive agents|mesh-ancestor
153912590|NCT01179672|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153912591|NCT01179672|Dopamine Agents|dopamine agents|mesh-ancestor
153912592|NCT04301349|Misoprostol|misoprostol|mesh-list
153811289|NCT00419471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153811290|NCT00426348|Valsartan|valsartan|mesh-list
153912593|NCT04301349|Dinoprostone|dinoprostone|mesh-list
153912594|NCT04301349|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
153912595|NCT04301349|Abortifacient Agents|abortifacient agents|mesh-ancestor
153912596|NCT04301349|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153912597|NCT04301349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153912598|NCT04301349|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
153912599|NCT04301349|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153912600|NCT04301349|Oxytocics|oxytocics|mesh-ancestor
153912601|NCT02753647|Prednisone|prednisone|mesh-list
153912602|NCT02753647|Cyclophosphamide|cyclophosphamide|mesh-list
153912603|NCT02753647|Rituximab|rituximab|mesh-list
153912604|NCT02753647|Doxorubicin|doxorubicin|mesh-list
153912605|NCT02753647|Vincristine|vincristine|mesh-list
153912606|NCT02753647|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153912607|NCT02753647|Immunologic Factors|immunologic factors|mesh-ancestor
153912608|NCT02753647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153454361|NCT01562028|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153454362|NCT01562028|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153454363|NCT01562028|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153454364|NCT01562028|Growth Substances|growth substances|mesh-ancestor
153454365|NCT01562028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153454366|NCT01562028|Growth Inhibitors|growth inhibitors|mesh-ancestor
153454367|NCT01562028|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153562900|NCT01659827|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153562901|NCT01659827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153562902|NCT01659827|Sensory System Agents|sensory system agents|mesh-ancestor
153562903|NCT01659827|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153562904|NCT01659892|Montelukast|montelukast|mesh-list
153562905|NCT01659892|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153562906|NCT01659892|Respiratory System Agents|respiratory system agents|mesh-ancestor
153562907|NCT01659892|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
153562908|NCT01659892|Hormone Antagonists|hormone antagonists|mesh-ancestor
153562909|NCT01659892|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153562910|NCT01659892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153782695|NCT04561921|Tocolytic Agents|tocolytic agents|mesh-ancestor
153782696|NCT04561921|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153562911|NCT01659892|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
153454368|NCT01562028|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153454369|NCT01562028|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153454370|NCT01562028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153454371|NCT04767828|Capecitabine|capecitabine|mesh-list
153454372|NCT04767828|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153454373|NCT04767828|Antimetabolites|antimetabolites|mesh-ancestor
153454374|NCT04767828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153454375|NCT04767828|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153454376|NCT01585584|Protease Inhibitors|protease inhibitors|mesh-list
153454377|NCT01585584|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153454378|NCT01585584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153562915|NCT01659905|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153562916|NCT01659905|Respiratory System Agents|respiratory system agents|mesh-ancestor
153562917|NCT01659905|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
153562918|NCT01659905|Hormone Antagonists|hormone antagonists|mesh-ancestor
153454380|NCT01537068|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
153454387|NCT01537068|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153454388|NCT01585428|Aldesleukin|aldesleukin|mesh-list
153454389|NCT01585428|Cyclophosphamide|cyclophosphamide|mesh-list
153454390|NCT01585428|Fludarabine|fludarabine|mesh-list
153454391|NCT01585428|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153454392|NCT01585428|Immunologic Factors|immunologic factors|mesh-ancestor
153454393|NCT01585428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153454394|NCT01585428|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153912609|NCT02753647|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153912610|NCT02753647|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153912611|NCT02753647|Alkylating Agents|alkylating agents|mesh-ancestor
153912612|NCT02753647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153912613|NCT02753647|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153912614|NCT02753647|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153912615|NCT02753647|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153912616|NCT02753647|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153912617|NCT02753647|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153912618|NCT02753647|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153912619|NCT02753647|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153912620|NCT02753647|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153912621|NCT02753647|Glucocorticoids|glucocorticoids|mesh-ancestor
153562919|NCT01659905|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153562921|NCT01659905|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
153562922|NCT01659905|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
153562924|NCT01659918|Montelukast|montelukast|mesh-list
153912639|NCT01179516|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153912640|NCT01179516|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153912641|NCT01179516|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153912642|NCT01179516|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153912643|NCT01179516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153912644|NCT01179516|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
153912645|NCT01179516|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153454398|NCT01585428|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153454399|NCT01585428|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153454401|NCT01585428|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153454402|NCT01585428|Antiviral Agents|antiviral agents|mesh-ancestor
153454403|NCT01585428|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153454405|NCT01585272|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
153454406|NCT01585272|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153454407|NCT01585272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153454408|NCT01585272|Cholinergic Agents|cholinergic agents|mesh-ancestor
153454409|NCT01585272|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153454410|NCT01585272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153454411|NCT01585272|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
153811291|NCT00426348|Probucol|probucol|mesh-list
153454412|NCT01585272|Protective Agents|protective agents|mesh-ancestor
153454413|NCT01560780|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
153454414|NCT01560780|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153454415|NCT01585038|Efavirenz|efavirenz|mesh-list
153454416|NCT01585038|Rilpivirine|rilpivirine|mesh-list
153454417|NCT01585038|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153465991|NCT05266794|Selenium|selenium|mesh-list
153454418|NCT01585038|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153454419|NCT01585038|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153454420|NCT01585038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153454422|NCT01585038|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153454423|NCT01585038|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
153454424|NCT01585038|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153454425|NCT01585038|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
153562943|NCT01659931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153562944|NCT01659944|Metoprolol|metoprolol|mesh-list
153562945|NCT01659944|Eliglustat|eliglustat|mesh-list
153562946|NCT01659944|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153562947|NCT01659944|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153562948|NCT01659944|Sympatholytics|sympatholytics|mesh-ancestor
153562949|NCT01659944|Autonomic Agents|autonomic agents|mesh-ancestor
153562950|NCT01659944|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153420922|NCT02995915|Dopamine Agents|dopamine agents|mesh-ancestor
153562955|NCT01659944|Adrenergic Agents|adrenergic agents|mesh-ancestor
153454431|NCT01559844|Ribavirin|ribavirin|mesh-list
153912646|NCT01179516|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153912647|NCT01179516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153912648|NCT01179516|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153912649|NCT01179516|Serotonin Agents|serotonin agents|mesh-ancestor
153912650|NCT01179516|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
153912651|NCT01179516|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
153912652|NCT01179516|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
153912653|NCT01179516|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153912654|NCT00635791|Sorafenib|sorafenib|mesh-list
153912655|NCT00635791|Vorinostat|vorinostat|mesh-list
153912656|NCT00635791|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153912657|NCT00635791|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153912658|NCT00635791|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153912659|NCT00635791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153912660|NCT00635791|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
153912661|NCT02760121|Acetazolamide|acetazolamide|mesh-list
153912662|NCT02760121|Methazolamide|methazolamide|mesh-list
153912663|NCT02760121|Anticonvulsants|anticonvulsants|mesh-ancestor
153912664|NCT02760121|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
153912665|NCT02760121|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153912666|NCT02760121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153912667|NCT02760121|Diuretics|diuretics|mesh-ancestor
153912668|NCT02760121|Natriuretic Agents|natriuretic agents|mesh-ancestor
153912669|NCT02760121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153912670|NCT05215873|Misoprostol|misoprostol|mesh-list
153912671|NCT05215873|Oxytocin|oxytocin|mesh-list
153912672|NCT05215873|Oxytocics|oxytocics|mesh-ancestor
153912673|NCT05215873|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153912674|NCT05215873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153912675|NCT05215873|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
153912676|NCT05215873|Abortifacient Agents|abortifacient agents|mesh-ancestor
153912677|NCT05215873|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
153912678|NCT05215873|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153912679|NCT02759887|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
153912680|NCT02759887|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
153912681|NCT02759887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153912682|NCT02750917|Etoricoxib|etoricoxib|mesh-list
153912683|NCT02750917|Lornoxicam|lornoxicam|mesh-list
153912684|NCT02750917|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153912685|NCT02750917|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153912686|NCT02750917|Analgesics|analgesics|mesh-ancestor
153912687|NCT02750917|Sensory System Agents|sensory system agents|mesh-ancestor
153912688|NCT02750917|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153912689|NCT02750917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153454444|NCT01559454|Methadone|methadone|mesh-list
153454445|NCT01559454|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
153454446|NCT01559454|Naloxone|naloxone|mesh-list
153454447|NCT01559454|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153454449|NCT01559454|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153454450|NCT01559454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153454451|NCT01559454|Analgesics|analgesics|mesh-ancestor
153454452|NCT01559454|Sensory System Agents|sensory system agents|mesh-ancestor
153562978|NCT01660295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153562979|NCT01660295|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
153454453|NCT01559454|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153454454|NCT01559454|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
153454455|NCT01559454|Antitussive Agents|antitussive agents|mesh-ancestor
153454456|NCT01559454|Respiratory System Agents|respiratory system agents|mesh-ancestor
153454457|NCT01583166|Epinephrine|epinephrine|mesh-list
153454458|NCT01583166|Bupivacaine|bupivacaine|mesh-list
153454459|NCT01583166|Anesthetics, Local|anesthetics, local|mesh-ancestor
153454460|NCT01583166|Anesthetics|anesthetics|mesh-ancestor
153454461|NCT01583166|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153454462|NCT01583166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153454463|NCT01583166|Sensory System Agents|sensory system agents|mesh-ancestor
153466026|NCT05266560|Propofol|propofol|mesh-list
153454464|NCT01583166|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153454465|NCT01583166|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153454466|NCT01583166|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153912690|NCT02750917|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153912691|NCT02750917|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153912692|NCT02750917|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
153912693|NCT02750917|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153912694|NCT02750917|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153912695|NCT02750917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153912696|NCT02750995|Azacitidine|azacitidine|mesh-list
153912697|NCT02750995|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153912698|NCT02750995|Antimetabolites|antimetabolites|mesh-ancestor
153912699|NCT02750995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153912700|NCT02750995|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153912701|NCT02750995|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153912702|NCT01027845|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
153912703|NCT01027845|Immunologic Factors|immunologic factors|mesh-ancestor
153912704|NCT01027845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153912705|NCT04221919|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
153912706|NCT04221919|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
153912707|NCT04221919|Adrenergic Agents|adrenergic agents|mesh-ancestor
153912708|NCT04221919|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153912709|NCT04221919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153912710|NCT04221919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153912711|NCT04299633|Calcium|calcium|mesh-list
153912712|NCT04299633|Sevelamer|sevelamer|mesh-list
153912713|NCT04299633|Calcium acetate|calcium acetate|mesh-list
153912714|NCT04299633|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153912715|NCT04299633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153912716|NCT04299633|Chelating Agents|chelating agents|mesh-ancestor
153912717|NCT04299633|Sequestering Agents|sequestering agents|mesh-ancestor
153454467|NCT01583166|Adrenergic Agents|adrenergic agents|mesh-ancestor
153454472|NCT01583166|Autonomic Agents|autonomic agents|mesh-ancestor
153912718|NCT04299633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153912719|NCT02695459|Everolimus|everolimus|mesh-list
153912720|NCT02695459|Cisplatin|cisplatin|mesh-list
153912721|NCT02695459|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
153912722|NCT02695459|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153912723|NCT02695459|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153912724|NCT02695459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153912725|NCT02695459|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153912726|NCT02695459|Immunologic Factors|immunologic factors|mesh-ancestor
153912727|NCT02695459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153563016|NCT01660399|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153563017|NCT01660399|Tubulin Modulators|tubulin modulators|mesh-ancestor
153563018|NCT01660399|Antimitotic Agents|antimitotic agents|mesh-ancestor
153563019|NCT01660399|Mitosis Modulators|mitosis modulators|mesh-ancestor
153563020|NCT01660399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153563021|NCT01660477|Ritonavir|ritonavir|mesh-list
153563022|NCT01660477|Lopinavir|lopinavir|mesh-list
153563023|NCT01660477|Isavuconazole|isavuconazole|mesh-list
153912728|NCT02695459|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153912729|NCT04288713|Eculizumab|eculizumab|mesh-list
153912730|NCT04288713|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
153912731|NCT04288713|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153912732|NCT04288713|Immunologic Factors|immunologic factors|mesh-ancestor
153912733|NCT04288713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153912735|NCT01030341|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
153912736|NCT01030341|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153912737|NCT01030341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153912738|NCT02750293|Cholecalciferol|cholecalciferol|mesh-list
153912739|NCT02750293|Vitamin D|vitamin d|mesh-list
153454496|NCT01582308|Protease Inhibitors|protease inhibitors|mesh-ancestor
153454497|NCT01582308|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153454498|NCT01582308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153454499|NCT01558674|Torsemide|torsemide|mesh-list
153454500|NCT01558674|Furosemide|furosemide|mesh-list
153454501|NCT01558674|Diuretics|diuretics|mesh-ancestor
153454502|NCT01558674|Natriuretic Agents|natriuretic agents|mesh-ancestor
153454503|NCT01558674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153454504|NCT01558674|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
153454505|NCT01558674|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153912740|NCT02750293|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153912741|NCT02750293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153912742|NCT02750293|Vitamins|vitamins|mesh-ancestor
153912743|NCT02750293|Micronutrients|micronutrients|mesh-ancestor
153912744|NCT02750293|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153912745|NCT04217785|Ophthalmic Solutions|ophthalmic solutions|mesh-list
153912746|NCT04217785|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
153912747|NCT01026831|Timolol|timolol|mesh-list
153912753|NCT01026831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153912754|NCT01026831|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153912755|NCT01026831|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153912761|NCT02750137|Tetracaine|tetracaine|mesh-list
153563028|NCT01660477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153563029|NCT01660477|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153563030|NCT01660477|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153563031|NCT01660477|Antiviral Agents|antiviral agents|mesh-ancestor
153563032|NCT01660477|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153563033|NCT01660477|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
153563034|NCT01660477|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153563035|NCT01660477|Antifungal Agents|antifungal agents|mesh-ancestor
153563036|NCT01660542|Docetaxel|docetaxel|mesh-list
153563037|NCT01660542|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153563038|NCT01660542|Tubulin Modulators|tubulin modulators|mesh-ancestor
153912762|NCT02750137|Anesthetics, Local|anesthetics, local|mesh-ancestor
153912763|NCT02750137|Anesthetics|anesthetics|mesh-ancestor
153912764|NCT02750137|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153912765|NCT02750137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153912766|NCT02750137|Sensory System Agents|sensory system agents|mesh-ancestor
153912767|NCT02750137|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153912768|NCT02760043|Dexamethasone|dexamethasone|mesh-list
153912769|NCT02760043|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153912770|NCT02760043|Antiemetics|antiemetics|mesh-ancestor
153912771|NCT02760043|Autonomic Agents|autonomic agents|mesh-ancestor
153912772|NCT02760043|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153912773|NCT02760043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153912774|NCT02760043|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153912775|NCT02760043|Glucocorticoids|glucocorticoids|mesh-ancestor
153912776|NCT02760043|Hormones|hormones|mesh-ancestor
153912777|NCT02760043|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153912778|NCT02760043|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153912779|NCT02760043|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153912780|NCT02750059|Tenofovir|tenofovir|mesh-list
153912781|NCT02750059|Lamivudine|lamivudine|mesh-list
153912782|NCT02750059|Efavirenz|efavirenz|mesh-list
153912783|NCT02750059|Telmisartan|telmisartan|mesh-list
153912784|NCT02750059|Antiviral Agents|antiviral agents|mesh-ancestor
153912785|NCT02750059|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153912786|NCT02750059|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153912787|NCT02750059|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153912788|NCT02750059|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153912789|NCT02750059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153912790|NCT02750059|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153912791|NCT02750059|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153912792|NCT02750059|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153912793|NCT02750059|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
153454507|NCT01558674|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153912794|NCT02750059|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
153912795|NCT02750059|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
153912796|NCT02750059|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153912797|NCT02750059|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
153912798|NCT02750059|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
153912799|NCT02750059|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
153912800|NCT02750059|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
153912801|NCT02749825|Goserelin|goserelin|mesh-list
153912802|NCT02749825|Triptorelin Pamoate|triptorelin pamoate|mesh-list
153454560|NCT01534182|Antiviral Agents|antiviral agents|mesh-ancestor
153454561|NCT01534182|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153454562|NCT01534182|Immunologic Factors|immunologic factors|mesh-ancestor
153454563|NCT01534182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153454564|NCT01534182|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
153454565|NCT01534182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153454566|NCT01534182|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153563060|NCT01660750|Immunologic Factors|immunologic factors|mesh-ancestor
153563061|NCT01660750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153563062|NCT01660750|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153563063|NCT01660750|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153563064|NCT01660750|Alkylating Agents|alkylating agents|mesh-ancestor
153563065|NCT01660750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153563066|NCT01660750|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153563067|NCT01660750|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153563068|NCT01660750|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153563069|NCT01660750|Antiemetics|antiemetics|mesh-ancestor
153563070|NCT01660750|Autonomic Agents|autonomic agents|mesh-ancestor
153454567|NCT01534182|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153454568|NCT01534182|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153454570|NCT01579812|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153454571|NCT01579812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153454572|NCT01579578|Paclitaxel|paclitaxel|mesh-list
153454573|NCT01579578|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153454574|NCT01579578|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153454575|NCT01579578|Tubulin Modulators|tubulin modulators|mesh-ancestor
153454576|NCT01579578|Antimitotic Agents|antimitotic agents|mesh-ancestor
153563072|NCT01660750|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153454577|NCT01579578|Mitosis Modulators|mitosis modulators|mesh-ancestor
153454578|NCT01579578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153912803|NCT02749825|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153912804|NCT02749825|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153912805|NCT02749825|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153912806|NCT02749825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153912807|NCT02749825|Luteolytic Agents|luteolytic agents|mesh-ancestor
153912808|NCT02749825|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
153912809|NCT02749825|Contraceptive Agents|contraceptive agents|mesh-ancestor
153912810|NCT02749825|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
153912811|NCT02758873|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
153912813|NCT02758873|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153912814|NCT02758873|Autonomic Agents|autonomic agents|mesh-ancestor
153912815|NCT02758873|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153912816|NCT02758873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153912817|NCT02758873|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153912818|NCT02758873|Respiratory System Agents|respiratory system agents|mesh-ancestor
153912819|NCT02758873|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
153912820|NCT02758873|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
153912821|NCT02758873|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153912822|NCT02758873|Adrenergic Agents|adrenergic agents|mesh-ancestor
153912823|NCT02758873|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153912824|NCT02758873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153912825|NCT02758873|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
153912826|NCT02758873|Hormone Antagonists|hormone antagonists|mesh-ancestor
153912827|NCT02758873|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153912828|NCT02758873|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
153912829|NCT02758873|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
153912830|NCT02749747|Sulpiride|sulpiride|mesh-list
153357776|NCT01247285|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
153912831|NCT02749747|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153912832|NCT02749747|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153912833|NCT02749747|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153912834|NCT02749747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153912835|NCT02749747|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153912836|NCT02749747|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
153912837|NCT02749747|Dopamine Agents|dopamine agents|mesh-ancestor
153912838|NCT02749747|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153912839|NCT02749747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153912840|NCT02749747|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
153912841|NCT02749747|Antidepressive Agents|antidepressive agents|mesh-ancestor
153912842|NCT02749591|Botulinum Toxins|botulinum toxins|mesh-list
153912843|NCT02749591|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
153912844|NCT02749591|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
153912845|NCT02749591|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
153912846|NCT02749591|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153912847|NCT02749591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153912848|NCT02749591|Cholinergic Agents|cholinergic agents|mesh-ancestor
153563073|NCT01660750|Glucocorticoids|glucocorticoids|mesh-ancestor
153563074|NCT01660750|Hormones|hormones|mesh-ancestor
153563077|NCT01660854|Proguanil|proguanil|mesh-list
153563078|NCT01660854|Atovaquone, proguanil drug combination|atovaquone, proguanil drug combination|mesh-list
153912849|NCT02749591|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153912850|NCT02749591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153912851|NCT02749591|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
153912852|NCT02749591|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153912854|NCT04359979|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
153912855|NCT04359979|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
153454615|NCT01577160|Serotonin Agents|serotonin agents|mesh-ancestor
153454616|NCT01577160|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153454617|NCT01577160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153454618|NCT01577160|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
153454619|NCT01577160|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
153454620|NCT01577160|Dopamine Agents|dopamine agents|mesh-ancestor
153454622|NCT01554618|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
153454623|NCT01554618|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153454624|NCT01554618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153454625|NCT01554618|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
153811293|NCT00426348|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
153811294|NCT00426348|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
153454627|NCT01554618|Hormones|hormones|mesh-ancestor
153454628|NCT01554618|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153454629|NCT01531998|Dexamethasone|dexamethasone|mesh-list
153454630|NCT01531998|Lenalidomide|lenalidomide|mesh-list
153563084|NCT01660854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153563085|NCT01660867|Dexamethasone|dexamethasone|mesh-list
153454631|NCT01531998|Bortezomib|bortezomib|mesh-list
153454632|NCT01531998|Siltuximab|siltuximab|mesh-list
153454633|NCT01531998|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153454634|NCT01531998|Antiemetics|antiemetics|mesh-ancestor
153454635|NCT01531998|Autonomic Agents|autonomic agents|mesh-ancestor
153454636|NCT01531998|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153454637|NCT01531998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153454638|NCT01531998|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153454639|NCT01531998|Glucocorticoids|glucocorticoids|mesh-ancestor
153454640|NCT01531998|Hormones|hormones|mesh-ancestor
153454641|NCT01531998|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153454642|NCT01531998|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153454643|NCT01531998|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153454644|NCT01531998|Immunologic Factors|immunologic factors|mesh-ancestor
153454645|NCT01531998|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153454646|NCT01531998|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153454647|NCT01531998|Growth Substances|growth substances|mesh-ancestor
153454648|NCT01531998|Growth Inhibitors|growth inhibitors|mesh-ancestor
153563086|NCT01660867|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153563087|NCT01660867|Antiemetics|antiemetics|mesh-ancestor
153563088|NCT01660867|Autonomic Agents|autonomic agents|mesh-ancestor
153563089|NCT01660867|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153563090|NCT01660867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153563091|NCT01660867|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153563092|NCT01660867|Glucocorticoids|glucocorticoids|mesh-ancestor
153563093|NCT01660867|Hormones|hormones|mesh-ancestor
153563094|NCT01660867|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153563095|NCT01660867|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153454649|NCT01553916|Lithium Carbonate|lithium carbonate|mesh-list
153454650|NCT01553916|Antidepressive Agents|antidepressive agents|mesh-ancestor
153454651|NCT01553916|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153912856|NCT04359979|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
153912857|NCT04359979|Adrenergic Agents|adrenergic agents|mesh-ancestor
153912858|NCT04359979|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153912859|NCT04359979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153912860|NCT04359979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153563104|NCT01660919|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153912861|NCT04359979|Urological Agents|urological agents|mesh-ancestor
153912862|NCT04180813|Linagliptin|linagliptin|mesh-list
153912863|NCT04180813|Acarbose|acarbose|mesh-list
153912864|NCT04180813|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153912865|NCT04180813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153912866|NCT04180813|Incretins|incretins|mesh-ancestor
153912867|NCT04180813|Hormones|hormones|mesh-ancestor
153912868|NCT04180813|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153912869|NCT04180813|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
153912870|NCT04180813|Protease Inhibitors|protease inhibitors|mesh-ancestor
153912871|NCT04180813|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153912872|NCT04180813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153912873|NCT04180813|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
153912874|NCT04116775|Pembrolizumab|pembrolizumab|mesh-list
153912875|NCT04116775|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153912876|NCT04116775|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153912877|NCT04116775|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153912878|NCT04116775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153912879|NCT03913741|Tisotumab vedotin|tisotumab vedotin|mesh-list
153912880|NCT03913741|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153912881|NCT03913741|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153912882|NCT02749123|Lidocaine|lidocaine|mesh-list
153912883|NCT02749123|Menthol|menthol|mesh-list
153912884|NCT02749123|Anesthetics, Local|anesthetics, local|mesh-ancestor
153912885|NCT02749123|Anesthetics|anesthetics|mesh-ancestor
153912886|NCT02749123|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153912887|NCT02749123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153912888|NCT02749123|Sensory System Agents|sensory system agents|mesh-ancestor
153912889|NCT02749123|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153454652|NCT01553916|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153454653|NCT01553916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153454654|NCT01553916|Antimanic Agents|antimanic agents|mesh-ancestor
153454655|NCT01553916|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153454656|NCT01553916|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153454657|NCT01553916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153563105|NCT01660945|Ezetimibe, Simvastatin Drug Combination|ezetimibe, simvastatin drug combination|mesh-list
153563106|NCT01660945|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153563107|NCT01660945|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153563108|NCT01660945|Antimetabolites|antimetabolites|mesh-ancestor
153563109|NCT01660945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153563110|NCT01660945|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153563111|NCT01660997|Dexamethasone|dexamethasone|mesh-list
153563114|NCT01660997|Antiemetics|antiemetics|mesh-ancestor
153563115|NCT01660997|Autonomic Agents|autonomic agents|mesh-ancestor
153563116|NCT01660997|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153454658|NCT01553136|Varenicline|varenicline|mesh-list
153454659|NCT01553136|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
153454660|NCT01553136|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
153454661|NCT01553136|Cholinergic Agents|cholinergic agents|mesh-ancestor
153454662|NCT01553136|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153454663|NCT01553136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153454664|NCT01553136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153454665|NCT01552902|Methylphenidate|methylphenidate|mesh-list
153454666|NCT01552902|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
153454667|NCT01552902|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
153454668|NCT01552902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153454669|NCT01552902|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
153454670|NCT01552902|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153454671|NCT01552902|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153454672|NCT01552902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153454674|NCT01552902|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153563125|NCT01660997|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153454675|NCT02072928|Botulinum Toxins|botulinum toxins|mesh-list
153454676|NCT02072928|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
153454677|NCT02072928|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
153454678|NCT02072928|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
153454679|NCT02072928|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153454680|NCT02072928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153454681|NCT02072928|Cholinergic Agents|cholinergic agents|mesh-ancestor
153454682|NCT02072928|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153454683|NCT02072928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153454684|NCT02072928|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
153454685|NCT02072928|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153912890|NCT02749123|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153912891|NCT02749123|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
153912892|NCT02749123|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153912893|NCT02749123|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153912894|NCT02749123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153912895|NCT02749123|Antipruritics|antipruritics|mesh-ancestor
153912896|NCT02749123|Dermatologic Agents|dermatologic agents|mesh-ancestor
153912898|NCT00635557|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153912899|NCT02748265|Epoprostenol|epoprostenol|mesh-list
153912900|NCT02748265|Phenylephrine|phenylephrine|mesh-list
153912901|NCT02748265|Oxymetazoline|oxymetazoline|mesh-list
153912902|NCT02748265|Tezosentan|tezosentan|mesh-list
153912903|NCT02748265|Propofol|propofol|mesh-list
153912904|NCT02748265|Sevoflurane|sevoflurane|mesh-list
153811295|NCT00426348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153912906|NCT02748265|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153912907|NCT02748265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153912908|NCT02748265|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153912909|NCT02748265|Anesthetics, General|anesthetics, general|mesh-ancestor
153912910|NCT02748265|Anesthetics|anesthetics|mesh-ancestor
153912911|NCT02748265|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153563126|NCT01660997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153563127|NCT01661101|Omeprazole|omeprazole|mesh-list
153563128|NCT01661101|Dabigatran|dabigatran|mesh-list
153563129|NCT01661101|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
153912912|NCT02748265|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
153912913|NCT02748265|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
153912914|NCT02748265|Mydriatics|mydriatics|mesh-ancestor
153912915|NCT02748265|Autonomic Agents|autonomic agents|mesh-ancestor
153912916|NCT02748265|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153912917|NCT02748265|Sympathomimetics|sympathomimetics|mesh-ancestor
153912918|NCT02748265|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
153912919|NCT02748265|Nasal Decongestants|nasal decongestants|mesh-ancestor
153912920|NCT02748265|Respiratory System Agents|respiratory system agents|mesh-ancestor
153912921|NCT02748265|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
153912922|NCT02748265|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153912924|NCT02748265|Adrenergic Agents|adrenergic agents|mesh-ancestor
153912925|NCT02748265|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153912926|NCT02748265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153454686|NCT01529346|Ibuprofen|ibuprofen|mesh-list
153454687|NCT01529346|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153454688|NCT01529346|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153454689|NCT01529346|Analgesics|analgesics|mesh-ancestor
153454690|NCT01529346|Sensory System Agents|sensory system agents|mesh-ancestor
153454691|NCT01529346|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153454692|NCT01529346|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153454693|NCT01529346|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153454694|NCT01529346|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153454695|NCT01529346|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153454696|NCT01529346|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153454697|NCT01529346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153454698|NCT01529268|Cysteamine|cysteamine|mesh-list
153454699|NCT01529268|Cystine Depleting Agents|cystine depleting agents|mesh-ancestor
153454700|NCT01529268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153454701|NCT01529112|Lenvatinib|lenvatinib|mesh-list
153454702|NCT01529112|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153454703|NCT01529112|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153454704|NCT01529112|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153702375|NCT00283036|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
153454705|NCT01529112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153563147|NCT01661257|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153563156|NCT01661296|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
153563157|NCT01661296|Anthelmintics|anthelmintics|mesh-ancestor
153563158|NCT01661309|Vitamin B 12|vitamin b 12|mesh-list
153563159|NCT01661309|Vitamins|vitamins|mesh-ancestor
153563160|NCT01661309|Micronutrients|micronutrients|mesh-ancestor
153563161|NCT01661309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153563162|NCT01661309|Vitamin B Complex|vitamin b complex|mesh-ancestor
153563163|NCT01661322|Aspirin|aspirin|mesh-list
153563164|NCT01661322|Clopidogrel|clopidogrel|mesh-list
153563165|NCT01661322|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153563166|NCT01661322|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153563167|NCT01661322|Analgesics|analgesics|mesh-ancestor
153563168|NCT01661322|Sensory System Agents|sensory system agents|mesh-ancestor
153454706|NCT01575054|Botulinum Toxins|botulinum toxins|mesh-list
153454707|NCT01575054|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
153454708|NCT01575054|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
153454709|NCT01575054|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
153454710|NCT01575054|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153454711|NCT01575054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153563181|NCT01661322|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
153454712|NCT01575054|Cholinergic Agents|cholinergic agents|mesh-ancestor
153454713|NCT01575054|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153454714|NCT01575054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153454715|NCT01575054|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
153454716|NCT01575054|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153454718|NCT01528254|Vildagliptin|vildagliptin|mesh-list
153454719|NCT01528254|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153454722|NCT01528254|Protease Inhibitors|protease inhibitors|mesh-ancestor
153912927|NCT02748265|Protective Agents|protective agents|mesh-ancestor
153912928|NCT02748265|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153912929|NCT02748265|Vasodilator Agents|vasodilator agents|mesh-ancestor
153912930|NCT01015833|Doxorubicin|doxorubicin|mesh-list
153912931|NCT01015833|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
153912932|NCT01015833|Sorafenib|sorafenib|mesh-list
153912933|NCT01015833|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153912934|NCT01015833|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153912935|NCT01015833|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153912936|NCT01015833|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153912937|NCT01015833|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153912938|NCT01015833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153912939|NCT01015833|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153912940|NCT03523273|Liraglutide|liraglutide|mesh-list
153912941|NCT03523273|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
153912942|NCT03523273|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153912943|NCT03523273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153912944|NCT03523273|Incretins|incretins|mesh-ancestor
153912945|NCT03523273|Hormones|hormones|mesh-ancestor
153912946|NCT03523273|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153912947|NCT02695381|Etodolac|etodolac|mesh-list
153912948|NCT02695381|Lidocaine|lidocaine|mesh-list
153912949|NCT02695381|Anesthetics, Local|anesthetics, local|mesh-ancestor
153912950|NCT02695381|Anesthetics|anesthetics|mesh-ancestor
153912951|NCT02695381|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153912952|NCT02695381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153912953|NCT02695381|Sensory System Agents|sensory system agents|mesh-ancestor
153912954|NCT02695381|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153912955|NCT02695381|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153912956|NCT02695381|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
153912957|NCT02695381|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153912958|NCT02695381|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153912959|NCT02695381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153912960|NCT02695381|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153563182|NCT01661322|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
153563183|NCT01661322|Purinergic Agents|purinergic agents|mesh-ancestor
153563185|NCT01661335|Dexamethasone|dexamethasone|mesh-list
153912962|NCT02695381|Analgesics|analgesics|mesh-ancestor
153912963|NCT02695381|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153912964|NCT02695381|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153454724|NCT01528254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153454725|NCT01526148|Quetiapine Fumarate|quetiapine fumarate|mesh-list
153454726|NCT01526148|Lithium Carbonate|lithium carbonate|mesh-list
153454727|NCT01526148|Antidepressive Agents|antidepressive agents|mesh-ancestor
153454728|NCT01526148|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153454729|NCT01526148|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153454730|NCT01526148|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153454731|NCT01526148|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153454732|NCT01526148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153811296|NCT00426348|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153454733|NCT01526148|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153454734|NCT01526148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153454736|NCT01525602|Paclitaxel|paclitaxel|mesh-list
153454737|NCT01525602|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153454738|NCT01525602|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153454739|NCT01525602|Tubulin Modulators|tubulin modulators|mesh-ancestor
153454740|NCT01525602|Antimitotic Agents|antimitotic agents|mesh-ancestor
153454750|NCT01549002|Sensory System Agents|sensory system agents|mesh-ancestor
153454751|NCT01549002|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153454752|NCT01549002|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153454753|NCT01549002|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153454754|NCT01549002|Anesthetics, General|anesthetics, general|mesh-ancestor
153454756|NCT01548768|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-list
153454757|NCT01548768|Antirheumatic Agents|antirheumatic agents|mesh-list
153454758|NCT01548768|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153454759|NCT01572792|Bromides|bromides|mesh-list
153454760|NCT01572792|Formoterol Fumarate|formoterol fumarate|mesh-list
153454761|NCT01572792|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153454762|NCT01572792|Autonomic Agents|autonomic agents|mesh-ancestor
153454763|NCT01572792|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153454764|NCT01572792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153454765|NCT01572792|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153454766|NCT01572792|Respiratory System Agents|respiratory system agents|mesh-ancestor
153454767|NCT01572792|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
153454768|NCT01572792|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
153454769|NCT01572792|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153454770|NCT01572792|Adrenergic Agents|adrenergic agents|mesh-ancestor
153454771|NCT01572792|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153454772|NCT01572792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153454773|NCT01572792|Anticonvulsants|anticonvulsants|mesh-ancestor
153454774|NCT01547598|Timolol|timolol|mesh-list
153912984|NCT02655523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153912985|NCT02655523|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153912986|NCT02655523|Glucocorticoids|glucocorticoids|mesh-ancestor
153912987|NCT02655523|Hormones|hormones|mesh-ancestor
153563191|NCT01661335|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153563195|NCT01661335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153563196|NCT01661335|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153782701|NCT04561687|Montelukast|montelukast|mesh-list
153563197|NCT01661335|Glucocorticoids|glucocorticoids|mesh-ancestor
153563198|NCT01661335|Hormones|hormones|mesh-ancestor
153782702|NCT04561687|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153563199|NCT01661335|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153563200|NCT01661335|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153563201|NCT01661335|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153563202|NCT01661335|Protease Inhibitors|protease inhibitors|mesh-ancestor
153912988|NCT02655523|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153912989|NCT02655523|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153912990|NCT02655523|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153912991|NCT02655523|Anesthetics, Local|anesthetics, local|mesh-ancestor
153912992|NCT02655523|Anesthetics|anesthetics|mesh-ancestor
153912993|NCT02655523|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153912994|NCT02655523|Sensory System Agents|sensory system agents|mesh-ancestor
153912995|NCT02644291|Mebendazole|mebendazole|mesh-list
153912996|NCT02644291|Piperazine|piperazine|mesh-list
153912997|NCT02644291|Piperazine citrate|piperazine citrate|mesh-list
153912998|NCT02644291|DMP 777|dmp 777|mesh-list
153912999|NCT02644291|Antinematodal Agents|antinematodal agents|mesh-ancestor
153913000|NCT02644291|Anthelmintics|anthelmintics|mesh-ancestor
153913001|NCT02644291|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153913002|NCT02644291|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153913003|NCT02644291|Tubulin Modulators|tubulin modulators|mesh-ancestor
153913004|NCT02644291|Antimitotic Agents|antimitotic agents|mesh-ancestor
153913005|NCT02644291|Mitosis Modulators|mitosis modulators|mesh-ancestor
153913006|NCT02644291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153913007|NCT02644291|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153913008|NCT02644291|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153913009|NCT01015677|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
153913010|NCT01015677|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
153913011|NCT01015677|Estradiol|estradiol|mesh-list
153913012|NCT01015677|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
153913013|NCT01015677|Estrogens|estrogens|mesh-ancestor
153913014|NCT01015677|Hormones|hormones|mesh-ancestor
153913015|NCT01015677|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153913016|NCT01015677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153913017|NCT01015677|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
153913018|NCT01015677|Contraceptive Agents|contraceptive agents|mesh-ancestor
153913019|NCT01015677|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153913020|NCT01015677|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
153913021|NCT02281981|Curcumin|curcumin|mesh-list
153913022|NCT02281981|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153913024|NCT02281981|Analgesics|analgesics|mesh-ancestor
153913025|NCT02281981|Sensory System Agents|sensory system agents|mesh-ancestor
153454785|NCT01547598|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153454786|NCT01547598|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153454787|NCT01547286|Methacholine Chloride|methacholine chloride|mesh-list
153454788|NCT01547286|Miotics|miotics|mesh-ancestor
153454789|NCT01547286|Autonomic Agents|autonomic agents|mesh-ancestor
153454790|NCT01547286|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153454791|NCT01547286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153454792|NCT01547286|Parasympathomimetics|parasympathomimetics|mesh-ancestor
153454793|NCT01547286|Bronchoconstrictor Agents|bronchoconstrictor agents|mesh-ancestor
153454794|NCT01547286|Respiratory System Agents|respiratory system agents|mesh-ancestor
153454795|NCT01547286|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
153454796|NCT01547286|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
153454797|NCT01547286|Cholinergic Agents|cholinergic agents|mesh-ancestor
153454798|NCT01547286|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153454799|NCT01547286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153454801|NCT01524978|Vemurafenib|vemurafenib|mesh-list
153454802|NCT01524978|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153454803|NCT01524978|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153454804|NCT01524978|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153454805|NCT01524978|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153563205|NCT01661335|Antipruritics|antipruritics|mesh-ancestor
153563206|NCT01661335|Dermatologic Agents|dermatologic agents|mesh-ancestor
153563207|NCT01661335|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
153563208|NCT01661335|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153820686|NCT00464763|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153913028|NCT02281981|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153913029|NCT02281981|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153913030|NCT02281981|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153913031|NCT02281981|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153913032|NCT02281981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153913033|NCT04297839|Heparin|heparin|mesh-list
153913034|NCT04297839|Calcium heparin|calcium heparin|mesh-list
153913035|NCT04297839|Citric Acid|citric acid|mesh-list
153913036|NCT04297839|Sodium Citrate|sodium citrate|mesh-list
153913037|NCT04297839|Anticoagulants|anticoagulants|mesh-ancestor
153913038|NCT04297839|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
153913039|NCT04297839|Chelating Agents|chelating agents|mesh-ancestor
153913040|NCT04297839|Sequestering Agents|sequestering agents|mesh-ancestor
153913041|NCT04297839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153913042|NCT04297839|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153913043|NCT04297839|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153913044|NCT02751151|Aminolevulinic Acid|aminolevulinic acid|mesh-list
153913045|NCT02751151|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
153913046|NCT02751151|Dermatologic Agents|dermatologic agents|mesh-ancestor
153913047|NCT04216459|Cholecalciferol|cholecalciferol|mesh-list
153913048|NCT04216459|Vitamin D|vitamin d|mesh-list
153913049|NCT04216459|Thiamine|thiamine|mesh-list
153913050|NCT04216459|Vitamins|vitamins|mesh-ancestor
153913051|NCT04216459|Micronutrients|micronutrients|mesh-ancestor
153357780|NCT01247285|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153913052|NCT04216459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153913053|NCT04216459|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153913054|NCT04216459|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153913055|NCT04216459|Vitamin B Complex|vitamin b complex|mesh-ancestor
153913057|NCT04216771|Idarubicin|idarubicin|mesh-list
153913058|NCT04216771|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153913059|NCT04216771|Antimetabolites|antimetabolites|mesh-ancestor
153913060|NCT04216771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153913061|NCT04216771|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153913062|NCT04216771|Antiviral Agents|antiviral agents|mesh-ancestor
153913063|NCT04216771|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153913064|NCT04216771|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153913065|NCT04216771|Immunologic Factors|immunologic factors|mesh-ancestor
153913066|NCT04216771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153913067|NCT04216771|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153913068|NCT04216771|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153913069|NCT04216771|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153913070|NCT04216771|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153913071|NCT00636259|Bicalutamide|bicalutamide|mesh-list
153913072|NCT00636259|Androgen Antagonists|androgen antagonists|mesh-ancestor
153913073|NCT00636259|Hormone Antagonists|hormone antagonists|mesh-ancestor
153913074|NCT00636259|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153454835|NCT01546038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153454836|NCT01546038|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153454837|NCT01546038|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153454838|NCT01546038|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153454839|NCT01546038|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153454841|NCT01571232|Bevacizumab|bevacizumab|mesh-list
153454842|NCT01571232|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153454843|NCT01571232|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153454844|NCT01571232|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153454845|NCT01571232|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153454846|NCT01571232|Growth Substances|growth substances|mesh-ancestor
153454847|NCT01571232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153563220|NCT01661530|Vitamin E|vitamin e|mesh-list
153563221|NCT01661530|Vitamins|vitamins|mesh-ancestor
153454848|NCT01571232|Growth Inhibitors|growth inhibitors|mesh-ancestor
153466532|NCT00309738|Simvastatin|simvastatin|mesh-list
153454867|NCT01522950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153454868|NCT01522950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153454870|NCT01522950|Sympatholytics|sympatholytics|mesh-ancestor
153454871|NCT01522950|Autonomic Agents|autonomic agents|mesh-ancestor
153913102|NCT02735395|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153913103|NCT02735395|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153913104|NCT02735395|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153913105|NCT02735395|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153913107|NCT02741947|Benserazide|benserazide|mesh-list
153913108|NCT02741947|Benserazide, levodopa drug combination|benserazide, levodopa drug combination|mesh-list
153913109|NCT02741947|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
153913110|NCT02741947|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
153913111|NCT02741947|Dopamine Agents|dopamine agents|mesh-ancestor
153913112|NCT02741947|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153913113|NCT02741947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153454874|NCT01522950|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
153454875|NCT01522950|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
153454876|NCT01522404|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
153454877|NCT01522404|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
153454878|NCT01522404|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153454879|NCT01522404|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153454880|NCT01522404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153454881|NCT01522404|Adrenergic Agents|adrenergic agents|mesh-ancestor
153811301|NCT00426348|Protective Agents|protective agents|mesh-ancestor
153811302|NCT00426348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153357781|NCT01247285|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153454882|NCT01522404|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153454883|NCT01522404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153454886|NCT01570686|Protease Inhibitors|protease inhibitors|mesh-ancestor
153454887|NCT01570686|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153454888|NCT01570686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153454889|NCT01543776|Abiraterone Acetate|abiraterone acetate|mesh-list
153454890|NCT01543776|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153454891|NCT01543776|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153454892|NCT01543776|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153454893|NCT01543776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153913130|NCT02735317|Gentamicins|gentamicins|mesh-list
153913131|NCT02735317|Dexamethasone|dexamethasone|mesh-list
153913132|NCT02735317|Procaine|procaine|mesh-list
153913133|NCT02735317|Vitamins|vitamins|mesh-ancestor
153913134|NCT02735317|Micronutrients|micronutrients|mesh-ancestor
153913135|NCT02735317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153454894|NCT01543776|Hormone Antagonists|hormone antagonists|mesh-ancestor
153454895|NCT01543776|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153454896|NCT01543776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153454897|NCT01543776|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153454898|NCT01518192|Doxycycline|doxycycline|mesh-list
153454899|NCT01518192|Cefuroxime|cefuroxime|mesh-list
153454900|NCT01518192|Cefuroxime axetil|cefuroxime axetil|mesh-list
153454901|NCT01518192|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153454902|NCT01518192|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153454903|NCT01518192|Antimalarials|antimalarials|mesh-ancestor
153454904|NCT01518192|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153454905|NCT01518192|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153454906|NCT01517802|Prednisone|prednisone|mesh-list
153454907|NCT01517802|Abiraterone Acetate|abiraterone acetate|mesh-list
153454908|NCT01517802|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153454909|NCT01517802|Glucocorticoids|glucocorticoids|mesh-ancestor
153454910|NCT01517802|Hormones|hormones|mesh-ancestor
153454911|NCT01517802|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153454912|NCT01517802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153454913|NCT01517802|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153913150|NCT02735317|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153913151|NCT02735317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153913153|NCT02735317|Anesthetics, Local|anesthetics, local|mesh-ancestor
153913154|NCT02735317|Anesthetics|anesthetics|mesh-ancestor
153454914|NCT01517802|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153454915|NCT01517802|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153454916|NCT01517802|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153454917|NCT01517802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153454918|NCT01517802|Hormone Antagonists|hormone antagonists|mesh-ancestor
153454919|NCT01517802|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153454920|NCT04714710|Canrenoic Acid|canrenoic acid|mesh-list
153454921|NCT04714710|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
153454922|NCT04714710|Hormone Antagonists|hormone antagonists|mesh-ancestor
153454923|NCT04714710|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153454924|NCT04714710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153454925|NCT04714710|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
153454926|NCT04714710|Diuretics|diuretics|mesh-ancestor
153454927|NCT04714710|Natriuretic Agents|natriuretic agents|mesh-ancestor
153454928|NCT01520922|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
153454929|NCT01520922|Ofatumumab|ofatumumab|mesh-list
153454930|NCT01520922|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153454931|NCT01520922|Alkylating Agents|alkylating agents|mesh-ancestor
153454932|NCT01520922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153454933|NCT01520922|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153454934|NCT01517412|Metformin|metformin|mesh-list
153454935|NCT01517412|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153454937|NCT01489956|Monatide (IMS 3015)|monatide (ims 3015)|mesh-list
153454938|NCT01489956|Freund's Adjuvant|freund's adjuvant|mesh-list
153454939|NCT01489956|Keyhole-limpet hemocyanin|keyhole-limpet hemocyanin|mesh-list
153454940|NCT01489956|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153454941|NCT01489956|Immunologic Factors|immunologic factors|mesh-ancestor
153454942|NCT01489956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153454944|NCT01516008|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153454945|NCT01516008|Narcotics|narcotics|mesh-ancestor
153454946|NCT01516008|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153454947|NCT01516008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153913155|NCT02735317|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153913156|NCT02735317|Sensory System Agents|sensory system agents|mesh-ancestor
153913157|NCT02739529|genexol-PM|genexol-pm|mesh-list
153913158|NCT02739529|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153913159|NCT02739529|Tubulin Modulators|tubulin modulators|mesh-ancestor
153913160|NCT02739529|Antimitotic Agents|antimitotic agents|mesh-ancestor
153913161|NCT02739529|Mitosis Modulators|mitosis modulators|mesh-ancestor
153913162|NCT02739529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153913163|NCT02738983|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
153913164|NCT02738983|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153913165|NCT02738983|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153913166|NCT02738983|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153913167|NCT02738983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153913168|NCT02738983|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153913169|NCT02739061|Fluvoxamine|fluvoxamine|mesh-list
153913170|NCT02739061|Sertraline|sertraline|mesh-list
153913171|NCT02739061|Antidepressive Agents|antidepressive agents|mesh-ancestor
153913172|NCT02739061|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153913173|NCT02739061|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
153913174|NCT02739061|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153913175|NCT02739061|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153913176|NCT02739061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153913177|NCT02739061|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153913178|NCT02739061|Serotonin Agents|serotonin agents|mesh-ancestor
153913179|NCT02739061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153913180|NCT02739061|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153913181|NCT02739061|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153913182|NCT02739061|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153913183|NCT02739061|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
153913184|NCT02739061|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
153913185|NCT02739061|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153913186|NCT02739061|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153913187|NCT02739061|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
153913188|NCT02745925|Ibuprofen|ibuprofen|mesh-list
153913189|NCT02745925|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153913190|NCT02745925|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153913191|NCT02745925|Analgesics|analgesics|mesh-ancestor
153454953|NCT01516008|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153454954|NCT01516008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153454955|NCT01516008|Adrenergic Agents|adrenergic agents|mesh-ancestor
153454956|NCT01516008|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153454957|NCT01489254|Glatiramer Acetate|glatiramer acetate|mesh-list
153454959|NCT01489254|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153454960|NCT01489254|Immunologic Factors|immunologic factors|mesh-ancestor
153454961|NCT01489254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153454962|NCT01489254|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153454963|NCT01489254|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153454964|NCT01489020|Immunomodulating Agents|immunomodulating agents|mesh-list
153454965|NCT01489020|Immunologic Factors|immunologic factors|mesh-ancestor
153454966|NCT01489020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153454967|NCT01514682|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
153454968|NCT01514448|Everolimus|everolimus|mesh-list
153454969|NCT01514448|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
153454970|NCT01514448|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153454971|NCT01514448|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153454972|NCT01514448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153454973|NCT01514448|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153454974|NCT01514448|Immunologic Factors|immunologic factors|mesh-ancestor
153454975|NCT01514448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153454976|NCT01514448|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153454977|NCT01514370|Interferons|interferons|mesh-list
153913193|NCT02745925|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153913194|NCT02745925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153913195|NCT02745925|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153913196|NCT02745925|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153913197|NCT02745925|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153913198|NCT02745925|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153913199|NCT02745925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153913200|NCT04374253|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
153913201|NCT04374253|Immunologic Factors|immunologic factors|mesh-ancestor
153913202|NCT04374253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153913203|NCT02738905|Rifaximin|rifaximin|mesh-list
153913204|NCT02738905|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153913205|NCT02738905|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153913206|NCT02738905|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153913207|NCT02745691|Gefitinib|gefitinib|mesh-list
153913208|NCT02745691|Crizotinib|crizotinib|mesh-list
153913209|NCT02745691|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153913210|NCT02745691|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153913211|NCT02745691|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153913212|NCT02745691|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153454978|NCT01514370|Interferon-beta|interferon-beta|mesh-list
153454979|NCT01514370|Interferon beta-1a|interferon beta-1a|mesh-list
153913213|NCT02745691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153913214|NCT02745769|Ramucirumab|ramucirumab|mesh-list
153913215|NCT02745769|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153913216|NCT02745769|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153913217|NCT02745769|Growth Substances|growth substances|mesh-ancestor
153913218|NCT02745769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153913219|NCT02745769|Growth Inhibitors|growth inhibitors|mesh-ancestor
153913220|NCT02745769|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153913221|NCT02737813|Bupivacaine|bupivacaine|mesh-list
153913222|NCT02737813|Anesthetics, Local|anesthetics, local|mesh-ancestor
153913223|NCT02737813|Anesthetics|anesthetics|mesh-ancestor
153913224|NCT02737813|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153913225|NCT02737813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153913226|NCT02737813|Sensory System Agents|sensory system agents|mesh-ancestor
153913227|NCT02737813|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153913228|NCT00636415|Morphine|morphine|mesh-list
153913229|NCT00636415|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153913230|NCT00636415|Narcotics|narcotics|mesh-ancestor
153913231|NCT00636415|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153913232|NCT00636415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153811305|NCT00353808|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153913233|NCT00636415|Analgesics|analgesics|mesh-ancestor
153811306|NCT00353808|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
153913234|NCT00636415|Sensory System Agents|sensory system agents|mesh-ancestor
153913235|NCT00636415|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153913236|NCT02733835|Remifentanil|remifentanil|mesh-list
153913237|NCT02733835|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153913238|NCT02733835|Narcotics|narcotics|mesh-ancestor
153455001|NCT01519674|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
153455002|NCT01519674|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
153455003|NCT01519674|Biphasic Insulins|biphasic insulins|mesh-list
153455004|NCT01519674|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
153455005|NCT01519674|Insulin, Isophane|insulin, isophane|mesh-list
153455006|NCT01519674|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153455007|NCT01519674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153455008|NCT01519674|Incretins|incretins|mesh-ancestor
153455009|NCT01519674|Hormones|hormones|mesh-ancestor
153455010|NCT01519674|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153455011|NCT01519674|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
153455012|NCT01519674|Protease Inhibitors|protease inhibitors|mesh-ancestor
153455013|NCT01519674|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153455014|NCT01519674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153455015|NCT01519518|Heparin|heparin|mesh-list
153455016|NCT01519518|Calcium heparin|calcium heparin|mesh-list
153455017|NCT01519518|Bivalirudin|bivalirudin|mesh-list
153455018|NCT01519518|Anticoagulants|anticoagulants|mesh-ancestor
153455019|NCT01519518|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153455020|NCT01519518|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153455021|NCT01519518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153455022|NCT01519518|Antithrombins|antithrombins|mesh-ancestor
153455023|NCT01519518|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
153455024|NCT01519518|Protease Inhibitors|protease inhibitors|mesh-ancestor
153455027|NCT01518972|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153455028|NCT01518972|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
153455029|NCT01518972|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
153455030|NCT01518972|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
153455031|NCT01518972|Adrenergic Agents|adrenergic agents|mesh-ancestor
153455032|NCT01518972|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153913239|NCT02733835|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153913240|NCT02733835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153913241|NCT02733835|Analgesics|analgesics|mesh-ancestor
153913242|NCT02733835|Sensory System Agents|sensory system agents|mesh-ancestor
153913243|NCT02733835|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153913244|NCT02737423|Vitamin D|vitamin d|mesh-list
153913245|NCT02737423|Cholecalciferol|cholecalciferol|mesh-list
153913246|NCT02737423|Vitamins|vitamins|mesh-ancestor
153913247|NCT02737423|Micronutrients|micronutrients|mesh-ancestor
153913248|NCT02737423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153913249|NCT02737423|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153811307|NCT00353808|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153913250|NCT02737423|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153913252|NCT02733679|Pioglitazone|pioglitazone|mesh-list
153913253|NCT02733679|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153913254|NCT02733679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153913255|NCT02744131|Metformin|metformin|mesh-list
153913256|NCT02744131|Cyproterone Acetate|cyproterone acetate|mesh-list
153913257|NCT02744131|Contraceptive Agents|contraceptive agents|mesh-list
153913258|NCT02744131|Contraceptives, Oral|contraceptives, oral|mesh-list
153913259|NCT02744131|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-list
153913260|NCT02744131|Estradiol|estradiol|mesh-list
153913261|NCT02744131|Cyproterone|cyproterone|mesh-list
153913262|NCT02744131|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153913263|NCT02744131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153913264|NCT02744131|Estrogens|estrogens|mesh-ancestor
153913265|NCT02744131|Hormones|hormones|mesh-ancestor
153913266|NCT02744131|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153913267|NCT02744131|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153913268|NCT02744131|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
153913269|NCT02744131|Androgen Antagonists|androgen antagonists|mesh-ancestor
153913270|NCT02744131|Hormone Antagonists|hormone antagonists|mesh-ancestor
153913271|NCT02744131|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153913272|NCT02744131|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
153913273|NCT02743975|Bevacizumab|bevacizumab|mesh-list
153913274|NCT02743975|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153913275|NCT02743975|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153913276|NCT02743975|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153913277|NCT02743975|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153913278|NCT02743975|Growth Substances|growth substances|mesh-ancestor
153913279|NCT02743975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153913280|NCT02743975|Growth Inhibitors|growth inhibitors|mesh-ancestor
153455043|NCT04672512|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153455044|NCT04672512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153455045|NCT04672512|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153455046|NCT04672512|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153455047|NCT01512108|Liraglutide|liraglutide|mesh-list
153455048|NCT01512108|Hypoglycemic Agents|hypoglycemic agents|mesh-list
153455049|NCT01512108|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
153455050|NCT01512108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153455051|NCT01512108|Incretins|incretins|mesh-ancestor
153455052|NCT01512108|Hormones|hormones|mesh-ancestor
153455053|NCT01512108|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153455054|NCT01486758|Azithromycin|azithromycin|mesh-list
153455055|NCT01486758|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153455056|NCT01486758|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153455057|NCT01463982|Capecitabine|capecitabine|mesh-list
153455058|NCT01463982|Irinotecan|irinotecan|mesh-list
153455059|NCT01463982|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153455060|NCT01463982|Antimetabolites|antimetabolites|mesh-ancestor
153455061|NCT01463982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153455062|NCT01463982|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153455063|NCT01463982|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
153455064|NCT01463982|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153455065|NCT01463982|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153455066|NCT01510158|Allopurinol|allopurinol|mesh-list
153455067|NCT01510158|Lesinurad|lesinurad|mesh-list
153466975|NCT00410826|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153913282|NCT02743663|Bronchodilator Agents|bronchodilator agents|mesh-list
153913283|NCT02743663|Autonomic Agents|autonomic agents|mesh-ancestor
153913284|NCT02743663|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153913285|NCT02743663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153913286|NCT02743663|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153913287|NCT02743663|Respiratory System Agents|respiratory system agents|mesh-ancestor
153913288|NCT02743663|Tocolytic Agents|tocolytic agents|mesh-ancestor
153913289|NCT02743663|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153913290|NCT02743663|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
153913291|NCT02743663|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
153913292|NCT02743663|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153913293|NCT02743663|Adrenergic Agents|adrenergic agents|mesh-ancestor
153913294|NCT02743663|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153913295|NCT02743663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153913296|NCT02733445|Dasatinib|dasatinib|mesh-list
153913297|NCT02733445|Nilotinib|nilotinib|mesh-list
153913298|NCT02733445|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153913299|NCT02733445|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153913300|NCT02733445|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153913301|NCT02733445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153913302|NCT02733445|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153455074|NCT01510158|Antioxidants|antioxidants|mesh-ancestor
153913303|NCT02731105|Clindamycin|clindamycin|mesh-list
153913304|NCT02731105|Clindamycin palmitate|clindamycin palmitate|mesh-list
153913305|NCT02731105|Clindamycin phosphate|clindamycin phosphate|mesh-list
153913306|NCT02731105|Adapalene, Benzoyl Peroxide Drug Combination|adapalene, benzoyl peroxide drug combination|mesh-list
153913307|NCT02731105|Tretinoin|tretinoin|mesh-list
153913308|NCT02731105|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153913309|NCT02731105|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153913310|NCT02731105|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
153913311|NCT02731105|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153913312|NCT02731105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153913313|NCT02731105|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153913314|NCT02731105|Keratolytic Agents|keratolytic agents|mesh-ancestor
153913315|NCT02731105|Dermatologic Agents|dermatologic agents|mesh-ancestor
153913316|NCT02731105|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153913317|NCT02731105|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153913318|NCT02731105|Analgesics|analgesics|mesh-ancestor
153913319|NCT02731105|Sensory System Agents|sensory system agents|mesh-ancestor
153913320|NCT02731105|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153913321|NCT02731105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153913322|NCT02731105|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153913323|NCT02731105|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153913324|NCT02743429|Dinutuximab|dinutuximab|mesh-list
153913325|NCT02743429|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153913326|NCT02730949|Folic Acid|folic acid|mesh-list
153913327|NCT02730949|Inositol|inositol|mesh-list
153913328|NCT02730949|Hematinics|hematinics|mesh-ancestor
153455091|NCT01484496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153455093|NCT01509846|Immunologic Factors|immunologic factors|mesh-ancestor
153455094|NCT01509846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153455095|NCT01462344|Fluticasone|fluticasone|mesh-list
153455096|NCT01462344|Xhance|xhance|mesh-list
153455097|NCT01462344|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
153455098|NCT01462344|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153455099|NCT01462344|Autonomic Agents|autonomic agents|mesh-ancestor
153455100|NCT01462344|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153455101|NCT01462344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153455102|NCT01462344|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153455103|NCT01462344|Respiratory System Agents|respiratory system agents|mesh-ancestor
153455104|NCT01462344|Glucocorticoids|glucocorticoids|mesh-ancestor
153455105|NCT01462344|Hormones|hormones|mesh-ancestor
153455106|NCT01462344|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153455107|NCT01462344|Sympathomimetics|sympathomimetics|mesh-ancestor
153455108|NCT01462344|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153455109|NCT01462344|Dermatologic Agents|dermatologic agents|mesh-ancestor
153455110|NCT01462344|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
153455111|NCT01462266|Metformin|metformin|mesh-list
153455112|NCT01462266|Insulin Glargine|insulin glargine|mesh-list
153455113|NCT01462266|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
153455114|NCT01462266|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153455115|NCT01462266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153913337|NCT04205929|Sensory System Agents|sensory system agents|mesh-ancestor
153913338|NCT04205929|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153913339|NCT04205929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153913340|NCT04205929|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153913341|NCT04205929|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153913342|NCT04205929|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153913343|NCT04205929|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153913344|NCT04205929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153913345|NCT00636493|Fluocinolone Acetonide|fluocinolone acetonide|mesh-list
153913346|NCT00636493|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153913347|NCT00636493|Glucocorticoids|glucocorticoids|mesh-ancestor
153913348|NCT00636493|Hormones|hormones|mesh-ancestor
153913349|NCT00636493|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153913350|NCT00636493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153913351|NCT02730481|Paclitaxel|paclitaxel|mesh-list
153455117|NCT01462266|Hormones|hormones|mesh-ancestor
153455118|NCT01462266|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153455119|NCT01462266|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
153455120|NCT01462266|Protease Inhibitors|protease inhibitors|mesh-ancestor
153455121|NCT01462266|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153455122|NCT01462266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153455123|NCT04087590|Glycopyrrolate|glycopyrrolate|mesh-list
153455125|NCT04087590|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153455126|NCT04087590|Autonomic Agents|autonomic agents|mesh-ancestor
153455127|NCT04087590|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153455128|NCT04087590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153455129|NCT04087590|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153455130|NCT04087590|Respiratory System Agents|respiratory system agents|mesh-ancestor
153455131|NCT04087590|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
153455132|NCT04087590|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
153455133|NCT04087590|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153913364|NCT02730091|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153913365|NCT02730091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153913366|NCT02730091|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
153913367|NCT02730091|Hormone Antagonists|hormone antagonists|mesh-ancestor
153913368|NCT02730091|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153913369|NCT02730091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153455134|NCT04087590|Adrenergic Agents|adrenergic agents|mesh-ancestor
153455135|NCT04087590|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153455136|NCT04087590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153455137|NCT04087590|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153455138|NCT04087590|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
153455139|NCT04087590|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
153455140|NCT04087590|Cholinergic Agents|cholinergic agents|mesh-ancestor
153455141|NCT01508676|Diclofenac|diclofenac|mesh-list
153455142|NCT01508676|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
153455143|NCT01508676|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
153811309|NCT00353808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153455144|NCT01508676|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153455145|NCT01508676|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153455146|NCT01508676|Analgesics|analgesics|mesh-ancestor
153455147|NCT01508676|Sensory System Agents|sensory system agents|mesh-ancestor
153455148|NCT01508676|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153455149|NCT01508676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153455150|NCT01508676|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153563291|NCT01662193|Calcium Carbonate|calcium carbonate|mesh-list
153455151|NCT01508676|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153455152|NCT01508676|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153455153|NCT01508676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153455154|NCT02985372|Cytarabine|cytarabine|mesh-list
153455155|NCT02985372|Decitabine|decitabine|mesh-list
153455156|NCT02985372|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153455157|NCT02985372|Antimetabolites|antimetabolites|mesh-ancestor
153455158|NCT02985372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153455159|NCT02985372|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153455161|NCT02985372|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153913380|NCT02742805|Micronutrients|micronutrients|mesh-ancestor
153913381|NCT02742805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153913382|NCT02742805|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153913383|NCT02742805|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153913384|NCT02742805|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
153913385|NCT02742805|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153913386|NCT02742805|Respiratory System Agents|respiratory system agents|mesh-ancestor
153913387|NCT02690389|Flumazenil|flumazenil|mesh-list
153913388|NCT02690389|Antidotes|antidotes|mesh-ancestor
153913389|NCT02690389|Protective Agents|protective agents|mesh-ancestor
153913390|NCT02690389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153913391|NCT02690389|GABA Modulators|gaba modulators|mesh-ancestor
153913392|NCT02690389|GABA Agents|gaba agents|mesh-ancestor
153913393|NCT02690389|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153913394|NCT02690389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153913395|NCT02732197|Thiopental|thiopental|mesh-list
153913396|NCT02732197|Anticonvulsants|anticonvulsants|mesh-ancestor
153913397|NCT02732197|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153913398|NCT02732197|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153913399|NCT02732197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153913400|NCT02732197|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153455166|NCT02985216|Pregabalin|pregabalin|mesh-list
153455167|NCT02985216|Analgesics|analgesics|mesh-ancestor
153455168|NCT02985216|Sensory System Agents|sensory system agents|mesh-ancestor
153455169|NCT02985216|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153455170|NCT02985216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153455171|NCT02985216|Anticonvulsants|anticonvulsants|mesh-ancestor
153455172|NCT02985216|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153455173|NCT02985216|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153455174|NCT02985216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153455175|NCT02985216|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153455176|NCT02985216|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153455177|NCT02985216|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153455178|NCT02985216|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153455179|NCT02985216|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153455181|NCT01461096|Immunologic Factors|immunologic factors|mesh-ancestor
153455182|NCT01461096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153455183|NCT01480674|Trastuzumab|trastuzumab|mesh-list
153455184|NCT01480674|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153455185|NCT01480674|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153455186|NCT01506882|Levetiracetam|levetiracetam|mesh-list
153455187|NCT01506882|Anticonvulsants|anticonvulsants|mesh-ancestor
153455188|NCT01506882|Nootropic Agents|nootropic agents|mesh-ancestor
153455189|NCT01506726|Salicylic Acid|salicylic acid|mesh-list
153455190|NCT01506726|Salicylsalicylic acid|salicylsalicylic acid|mesh-list
153455191|NCT01506726|Salicylates|salicylates|mesh-list
153455192|NCT01506726|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153913425|NCT02729467|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153913426|NCT02729467|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153455193|NCT01506726|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153455195|NCT01506726|Sensory System Agents|sensory system agents|mesh-ancestor
153455196|NCT01506726|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153455197|NCT01506726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153455198|NCT01506726|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153455199|NCT01506726|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153455200|NCT01506726|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153455201|NCT01506726|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153455202|NCT01506726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153455203|NCT01506726|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153455204|NCT01506726|Antifungal Agents|antifungal agents|mesh-ancestor
153455205|NCT01506726|Keratolytic Agents|keratolytic agents|mesh-ancestor
153455206|NCT01506726|Dermatologic Agents|dermatologic agents|mesh-ancestor
153913434|NCT02729467|Antitubercular Agents|antitubercular agents|mesh-ancestor
153913435|NCT02729467|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153913436|NCT02729467|Leprostatic Agents|leprostatic agents|mesh-ancestor
153913437|NCT02729467|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153913438|NCT02729467|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
153913439|NCT02729467|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
153913440|NCT02729467|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
153455210|NCT01505634|Imipenem|imipenem|mesh-list
153455211|NCT01505634|Relebactam|relebactam|mesh-list
153455212|NCT01505634|Cilastatin|cilastatin|mesh-list
153455214|NCT01505634|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153455215|NCT01505634|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153455216|NCT01505634|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153455217|NCT01505634|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153455218|NCT01505634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153455219|NCT01505634|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153455220|NCT01505634|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
153455221|NCT01505634|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153455222|NCT01505634|Protease Inhibitors|protease inhibitors|mesh-ancestor
153455223|NCT01505634|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
153455225|NCT01460628|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
153455226|NCT01460628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153455227|NCT01460628|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
153455228|NCT01460628|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
153455229|NCT01460628|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
153913454|NCT02721433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153913455|NCT02721043|Lenalidomide|lenalidomide|mesh-list
153913456|NCT02721043|Vaccines|vaccines|mesh-list
153913457|NCT02721043|Poly ICLC|poly iclc|mesh-list
153913458|NCT02721043|Immunologic Factors|immunologic factors|mesh-ancestor
153913459|NCT02721043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153913460|NCT02721043|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153455230|NCT01460628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153455231|NCT01480596|Belimumab|belimumab|mesh-list
153455232|NCT01480596|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153455233|NCT01480596|Immunologic Factors|immunologic factors|mesh-ancestor
153455234|NCT01480596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153455236|NCT01459614|Docetaxel|docetaxel|mesh-list
153455237|NCT01459614|Capecitabine|capecitabine|mesh-list
153455238|NCT01459614|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153455239|NCT01459614|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153455240|NCT01459614|Antimetabolites|antimetabolites|mesh-ancestor
153455241|NCT01459614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153563338|NCT01662622|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
153455242|NCT01459614|Tubulin Modulators|tubulin modulators|mesh-ancestor
153455243|NCT01459614|Antimitotic Agents|antimitotic agents|mesh-ancestor
153455244|NCT01459614|Mitosis Modulators|mitosis modulators|mesh-ancestor
153455245|NCT01458522|Lacosamide|lacosamide|mesh-list
153455246|NCT01458522|Fosphenytoin|fosphenytoin|mesh-list
153455247|NCT01458522|Anticonvulsants|anticonvulsants|mesh-ancestor
153455248|NCT01458522|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
153455249|NCT01458522|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153455250|NCT01458522|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153455251|NCT01458522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153455253|NCT03026946|Alitretinoin|alitretinoin|mesh-list
153455254|NCT03026946|Cyclosporins|cyclosporins|mesh-list
153455255|NCT03026946|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153455256|NCT03026946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153455257|NCT03026946|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153455258|NCT03026946|Immunologic Factors|immunologic factors|mesh-ancestor
153913461|NCT02721043|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153913462|NCT02721043|Growth Substances|growth substances|mesh-ancestor
153913463|NCT02721043|Growth Inhibitors|growth inhibitors|mesh-ancestor
153913464|NCT02721043|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153913466|NCT02728843|Deferiprone|deferiprone|mesh-list
153913467|NCT02728843|Iron Chelating Agents|iron chelating agents|mesh-ancestor
153913468|NCT02728843|Chelating Agents|chelating agents|mesh-ancestor
153913469|NCT02728843|Sequestering Agents|sequestering agents|mesh-ancestor
153913470|NCT02728843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153913471|NCT02726503|Lenvatinib|lenvatinib|mesh-list
153913472|NCT02726503|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153913473|NCT02726503|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153913474|NCT02726503|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153913475|NCT02726503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153913476|NCT02720965|Anesthetics|anesthetics|mesh-list
153913477|NCT02720965|Anesthetics, Local|anesthetics, local|mesh-list
153913478|NCT02720965|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153913479|NCT02720965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153913480|NCT02720965|Sensory System Agents|sensory system agents|mesh-ancestor
153913481|NCT02720965|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153913482|NCT02726737|Lidocaine|lidocaine|mesh-list
153913483|NCT02726737|Anesthetics, Local|anesthetics, local|mesh-ancestor
153913484|NCT02726737|Anesthetics|anesthetics|mesh-ancestor
153913485|NCT02726737|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153913486|NCT02726737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153913487|NCT02726737|Sensory System Agents|sensory system agents|mesh-ancestor
153913488|NCT02726737|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153913489|NCT02726737|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153455259|NCT03026946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153455260|NCT03026946|Antifungal Agents|antifungal agents|mesh-ancestor
153455261|NCT03026946|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153455262|NCT03026946|Dermatologic Agents|dermatologic agents|mesh-ancestor
153455263|NCT03026946|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153455264|NCT03026946|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
153455265|NCT03026946|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153455266|NCT01458210|Dulaglutide|dulaglutide|mesh-list
153455267|NCT01458210|Moxifloxacin|moxifloxacin|mesh-list
153455268|NCT01458210|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
153455269|NCT01458210|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
153455270|NCT01458210|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153455271|NCT01458210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153455272|NCT01458210|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153455273|NCT01458210|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153455274|NCT01458210|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153455275|NCT01458210|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153455276|NCT01458210|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153455277|NCT01458210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153455278|NCT01458210|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153455279|NCT01458210|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
153455280|NCT01458210|Contraceptive Agents|contraceptive agents|mesh-ancestor
153455281|NCT01458210|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153455282|NCT01458210|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
153455283|NCT01458210|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
153455284|NCT01458210|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
153455285|NCT06175377|Aspirin|aspirin|mesh-list
153455286|NCT06175377|Clopidogrel|clopidogrel|mesh-list
153455287|NCT06175377|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153455288|NCT06175377|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153455289|NCT06175377|Analgesics|analgesics|mesh-ancestor
153455290|NCT06175377|Sensory System Agents|sensory system agents|mesh-ancestor
153357783|NCT03806582|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153913490|NCT02726737|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
153913491|NCT02726737|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153913492|NCT02726737|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153913493|NCT02726737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153913495|NCT02720575|Vitamins|vitamins|mesh-ancestor
153913496|NCT02720575|Micronutrients|micronutrients|mesh-ancestor
153455291|NCT06175377|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153913497|NCT02720575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153913498|NCT02720575|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153913499|NCT02720341|Armin|armin|mesh-list
153913500|NCT02720341|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
153913501|NCT02720341|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153913502|NCT02720341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153913503|NCT02720341|Cholinergic Agents|cholinergic agents|mesh-ancestor
153913504|NCT02720341|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153913505|NCT02720341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153913507|NCT02728453|Glimepiride|glimepiride|mesh-list
153913508|NCT02728453|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
153913509|NCT02728453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153913510|NCT02728453|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153913511|NCT02728453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153913512|NCT02728453|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153913513|NCT02728453|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153913514|NCT02728453|Immunologic Factors|immunologic factors|mesh-ancestor
153913515|NCT02728687|Mannitol|mannitol|mesh-list
153913516|NCT02728687|Menthol|menthol|mesh-list
153913517|NCT02728687|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
153913518|NCT02728687|Diuretics|diuretics|mesh-ancestor
153913519|NCT02728687|Natriuretic Agents|natriuretic agents|mesh-ancestor
153913520|NCT02728687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153913521|NCT02728687|Antipruritics|antipruritics|mesh-ancestor
153913522|NCT02728687|Dermatologic Agents|dermatologic agents|mesh-ancestor
153913523|NCT02726269|Ofloxacin|ofloxacin|mesh-list
153913524|NCT02726269|Levofloxacin|levofloxacin|mesh-list
153913525|NCT02726269|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
153913526|NCT02726269|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153913527|NCT02726269|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153913528|NCT02726269|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153913529|NCT02726269|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153455298|NCT06175377|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153455299|NCT06175377|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153455300|NCT06175377|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153455301|NCT06175377|Antipyretics|antipyretics|mesh-ancestor
153455302|NCT06175377|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
153455303|NCT06175377|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
153455304|NCT06175377|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
153455305|NCT06175377|Purinergic Agents|purinergic agents|mesh-ancestor
153455306|NCT06175377|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153455308|NCT06175156|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153455309|NCT06175156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153455311|NCT06175117|Ferrous succinate|ferrous succinate|mesh-list
153455312|NCT06175117|Hematinics|hematinics|mesh-ancestor
153455313|NCT06175117|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153455314|NCT06174935|Atropine|atropine|mesh-list
153455315|NCT06174935|Ophthalmic Solutions|ophthalmic solutions|mesh-list
153455316|NCT06174935|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153455317|NCT06174935|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153811312|NCT00353808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153357784|NCT03806582|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153455319|NCT06174935|Autonomic Agents|autonomic agents|mesh-ancestor
153455320|NCT06174935|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153455321|NCT06174935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153455322|NCT06174935|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153455323|NCT06174935|Respiratory System Agents|respiratory system agents|mesh-ancestor
153455324|NCT06174935|Mydriatics|mydriatics|mesh-ancestor
153455325|NCT06174935|Parasympatholytics|parasympatholytics|mesh-ancestor
153455326|NCT06174935|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
153455327|NCT06174935|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
153455328|NCT06174935|Cholinergic Agents|cholinergic agents|mesh-ancestor
153913530|NCT02726269|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153913531|NCT02726269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153913532|NCT02726269|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153811313|NCT00324623|Cyclophosphamide|cyclophosphamide|mesh-list
153811314|NCT00324623|Fludarabine|fludarabine|mesh-list
153913533|NCT02726269|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
153913534|NCT02726269|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153913536|NCT02694289|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153918715|NCT01176773|Protective Agents|protective agents|mesh-ancestor
153913537|NCT02694289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153913539|NCT02719795|Anesthetics, Local|anesthetics, local|mesh-ancestor
153913540|NCT02719795|Anesthetics|anesthetics|mesh-ancestor
153913541|NCT02719795|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153913542|NCT02719795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153913543|NCT02719795|Sensory System Agents|sensory system agents|mesh-ancestor
153913544|NCT02719795|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153913545|NCT02726347|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
153913546|NCT02726347|Immunologic Factors|immunologic factors|mesh-ancestor
153913547|NCT02726347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153913548|NCT02726035|Naltrexone|naltrexone|mesh-list
153913549|NCT02726035|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
153913550|NCT02726035|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
153913551|NCT02726035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153913552|NCT02726035|Sensory System Agents|sensory system agents|mesh-ancestor
153913553|NCT02726035|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153913554|NCT02719405|Caseins|caseins|mesh-list
153913555|NCT02719405|Chelating Agents|chelating agents|mesh-ancestor
153913556|NCT02719405|Sequestering Agents|sequestering agents|mesh-ancestor
153913557|NCT02719405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153913558|NCT02725255|Albendazole|albendazole|mesh-list
153455329|NCT06174935|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153455330|NCT06174935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153455331|NCT06174935|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
153455332|NCT06174922|Itraconazole|itraconazole|mesh-list
153455333|NCT06174922|Prednisolone|prednisolone|mesh-list
153455334|NCT06174922|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153455336|NCT06174922|Hormones|hormones|mesh-ancestor
153455337|NCT06174922|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153455338|NCT06174922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153455339|NCT06174922|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153455340|NCT06174922|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153455341|NCT06174922|Antifungal Agents|antifungal agents|mesh-ancestor
153455342|NCT06174922|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153455343|NCT06174922|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
153455344|NCT06174922|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153455345|NCT06174922|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153455346|NCT06174922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153455347|NCT06174922|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153455348|NCT06174922|Hormone Antagonists|hormone antagonists|mesh-ancestor
153455349|NCT06174922|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
153455350|NCT06174909|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
153455351|NCT06174909|Calcium|calcium|mesh-list
153455352|NCT06174909|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153455353|NCT06174909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153455354|NCT06174909|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153455355|NCT06174792|Drospirenone|drospirenone|mesh-list
153455356|NCT06174792|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
153455357|NCT06174792|Hormone Antagonists|hormone antagonists|mesh-ancestor
153357785|NCT03806582|Adrenergic Agents|adrenergic agents|mesh-ancestor
153455358|NCT06174792|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153455359|NCT06174792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153455361|NCT06174792|Diuretics|diuretics|mesh-ancestor
153913559|NCT02725255|Anthelmintics|anthelmintics|mesh-ancestor
153913560|NCT02725255|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153913561|NCT02725255|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153913562|NCT02725255|Anticestodal Agents|anticestodal agents|mesh-ancestor
153913563|NCT02725255|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
153913564|NCT02725255|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153913565|NCT02725255|Tubulin Modulators|tubulin modulators|mesh-ancestor
153913566|NCT02725255|Antimitotic Agents|antimitotic agents|mesh-ancestor
153913567|NCT02725255|Mitosis Modulators|mitosis modulators|mesh-ancestor
153913568|NCT02725255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153913569|NCT02725255|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153913570|NCT02719015|Pembrolizumab|pembrolizumab|mesh-list
153913571|NCT02719015|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153913572|NCT02719015|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153913573|NCT02719015|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153913588|NCT02718547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153913589|NCT02718547|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153913590|NCT02718547|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153913591|NCT02718547|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
153913592|NCT02718547|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153811315|NCT00324623|Fludarabine phosphate|fludarabine phosphate|mesh-list
153913593|NCT02718547|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153913594|NCT02725099|Ticagrelor|ticagrelor|mesh-list
153913595|NCT02725099|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153913596|NCT02725099|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
153913597|NCT02725099|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
153455369|NCT06174285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153455370|NCT06174285|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153455371|NCT06174012|Listerine|listerine|mesh-list
153455372|NCT06174012|Fluorides|fluorides|mesh-list
153455373|NCT06174012|Sodium Fluoride|sodium fluoride|mesh-list
153455374|NCT06174012|Cariostatic Agents|cariostatic agents|mesh-ancestor
153455375|NCT06174012|Protective Agents|protective agents|mesh-ancestor
153455376|NCT06174012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153455377|NCT06174012|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
153455378|NCT06174012|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153455379|NCT06173986|Paclitaxel|paclitaxel|mesh-list
153455380|NCT06173986|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
153455381|NCT06173986|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153455382|NCT06173986|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153455383|NCT06173986|Tubulin Modulators|tubulin modulators|mesh-ancestor
153455385|NCT06173986|Mitosis Modulators|mitosis modulators|mesh-ancestor
153455386|NCT06173986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153455387|NCT06173986|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153455388|NCT06173934|Insulin|insulin|mesh-list
153455389|NCT06173934|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
153455390|NCT06173934|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153913598|NCT02725099|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
153455391|NCT06173934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153455392|NCT06173778|Semaglutide|semaglutide|mesh-list
153455393|NCT06173778|Nicotine|nicotine|mesh-list
153455394|NCT06173778|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
153455395|NCT06173778|Autonomic Agents|autonomic agents|mesh-ancestor
153455396|NCT06173778|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153455397|NCT06173778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153455398|NCT06173778|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
153455399|NCT06173778|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
153455400|NCT06173778|Cholinergic Agents|cholinergic agents|mesh-ancestor
153455401|NCT06173778|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153455402|NCT06173778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153455403|NCT06173778|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
153455404|NCT06173778|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153455405|NCT06166654|Metolazone|metolazone|mesh-list
153455406|NCT06166654|Acetazolamide|acetazolamide|mesh-list
153455407|NCT06166654|Diuretics|diuretics|mesh-list
153455408|NCT06166654|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-list
153455409|NCT06166654|Natriuretic Agents|natriuretic agents|mesh-ancestor
153455410|NCT06166654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153455411|NCT06166654|Anticonvulsants|anticonvulsants|mesh-ancestor
153455412|NCT06166654|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
153455413|NCT06166654|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153913638|NCT01224821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153913639|NCT01224821|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153913640|NCT02684851|Fibrinolytic Agents|fibrinolytic agents|mesh-list
153913641|NCT02684851|Tranexamic Acid|tranexamic acid|mesh-list
153913642|NCT02684851|Antifibrinolytic Agents|antifibrinolytic agents|mesh-list
153455414|NCT06166654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153455415|NCT06166654|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153455416|NCT06166654|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153455417|NCT06166654|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
153455418|NCT06155331|Cyclophosphamide|cyclophosphamide|mesh-list
153455420|NCT06155331|Fenofibrate|fenofibrate|mesh-list
153455421|NCT06155331|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153455422|NCT06155331|Immunologic Factors|immunologic factors|mesh-ancestor
153455423|NCT06155331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153455424|NCT06155331|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153455425|NCT06155331|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153455426|NCT06155331|Alkylating Agents|alkylating agents|mesh-ancestor
153455427|NCT06155331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153455428|NCT06155331|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153455429|NCT06155331|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153455430|NCT06155331|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153455431|NCT06155331|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153455432|NCT06155331|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153455433|NCT06155331|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153455434|NCT06155331|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153455435|NCT06155331|Antimetabolites|antimetabolites|mesh-ancestor
153913643|NCT02684851|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153913644|NCT02684851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153913645|NCT02684851|Hemostatics|hemostatics|mesh-ancestor
153913646|NCT02684851|Coagulants|coagulants|mesh-ancestor
153563427|NCT01663077|Clozapine|clozapine|mesh-list
153913647|NCT01224431|Lidocaine|lidocaine|mesh-list
153913648|NCT01224431|Anesthetics, Local|anesthetics, local|mesh-ancestor
153913649|NCT01224431|Anesthetics|anesthetics|mesh-ancestor
153913650|NCT01224431|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153913651|NCT01224431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153811317|NCT00324623|Immunologic Factors|immunologic factors|mesh-ancestor
153913652|NCT01224431|Sensory System Agents|sensory system agents|mesh-ancestor
153913653|NCT01224431|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153913654|NCT01224431|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153913655|NCT01224431|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
153913656|NCT01224431|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153913657|NCT01224431|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153913658|NCT01224431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153913659|NCT02716129|Morphine|morphine|mesh-list
153913660|NCT02716129|Nalbuphine|nalbuphine|mesh-list
153913661|NCT02716129|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153913662|NCT02716129|Narcotics|narcotics|mesh-ancestor
153913663|NCT02716129|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153913664|NCT02716129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153913665|NCT02716129|Analgesics|analgesics|mesh-ancestor
153455436|NCT06155331|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153455437|NCT06131905|Magnesium Sulfate|magnesium sulfate|mesh-list
153455439|NCT06131905|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153455440|NCT06131905|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153455441|NCT06131905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153455442|NCT06131905|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153455443|NCT06131905|Anesthetics, General|anesthetics, general|mesh-ancestor
153455444|NCT06131905|Anesthetics|anesthetics|mesh-ancestor
153455445|NCT06131905|Analgesics|analgesics|mesh-ancestor
153455446|NCT06131905|Sensory System Agents|sensory system agents|mesh-ancestor
153455448|NCT06131905|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153455449|NCT06131905|Anticonvulsants|anticonvulsants|mesh-ancestor
153455450|NCT06131905|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153455451|NCT06131905|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153455452|NCT06131905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153455453|NCT06131905|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153455454|NCT06131905|Tocolytic Agents|tocolytic agents|mesh-ancestor
153455455|NCT06131905|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153455456|NCT06078904|Colchicine|colchicine|mesh-list
153455457|NCT06078904|Gout Suppressants|gout suppressants|mesh-ancestor
153455458|NCT06078904|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153913667|NCT02716129|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153913668|NCT02718079|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
153913669|NCT02718079|Acetylcysteine|acetylcysteine|mesh-list
153913670|NCT02718079|Mannitol|mannitol|mesh-list
153913671|NCT02718079|N-monoacetylcystine|n-monoacetylcystine|mesh-list
153913672|NCT02718079|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153913673|NCT02718079|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
153913674|NCT02718079|Diuretics|diuretics|mesh-ancestor
153913675|NCT02718079|Natriuretic Agents|natriuretic agents|mesh-ancestor
153913676|NCT02718079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153913677|NCT02718079|Antiviral Agents|antiviral agents|mesh-ancestor
153913678|NCT02718079|Expectorants|expectorants|mesh-ancestor
153913679|NCT02718079|Respiratory System Agents|respiratory system agents|mesh-ancestor
153913680|NCT02718079|Free Radical Scavengers|free radical scavengers|mesh-ancestor
153913681|NCT02718079|Antioxidants|antioxidants|mesh-ancestor
153913682|NCT02718079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153913683|NCT02718079|Protective Agents|protective agents|mesh-ancestor
153913684|NCT02718079|Antidotes|antidotes|mesh-ancestor
153913685|NCT02717923|Capecitabine|capecitabine|mesh-list
153913686|NCT02717923|Cetuximab|cetuximab|mesh-list
153913687|NCT02717923|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153913688|NCT02717923|Antimetabolites|antimetabolites|mesh-ancestor
153913689|NCT02717923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153913690|NCT02717923|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153913691|NCT02717923|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153913692|NCT02724163|Cytarabine|cytarabine|mesh-list
153455459|NCT06078904|Tubulin Modulators|tubulin modulators|mesh-ancestor
153455465|NCT06061926|Antacids|antacids|mesh-ancestor
153913693|NCT02724163|Cyclophosphamide|cyclophosphamide|mesh-list
153913694|NCT02724163|Busulfan|busulfan|mesh-list
153913695|NCT02724163|Fludarabine|fludarabine|mesh-list
153913706|NCT02724163|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153913708|NCT02724163|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153913709|NCT02724163|Antimetabolites|antimetabolites|mesh-ancestor
153913710|NCT02724163|Antiviral Agents|antiviral agents|mesh-ancestor
153913711|NCT02724163|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153913712|NCT02724163|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153913713|NCT02724163|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153913714|NCT02724163|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153913715|NCT02724163|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153913716|NCT02724163|Analgesics|analgesics|mesh-ancestor
153913717|NCT02724163|Sensory System Agents|sensory system agents|mesh-ancestor
153455487|NCT06034314|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153455488|NCT05896163|Obinutuzumab|obinutuzumab|mesh-list
153455489|NCT05896163|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153455490|NCT05896163|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153455491|NCT05894603|Ritonavir|ritonavir|mesh-list
153455492|NCT05894603|Nirmatrelvir|nirmatrelvir|mesh-list
153455493|NCT05894603|Nirmatrelvir and ritonavir drug combination|nirmatrelvir and ritonavir drug combination|mesh-list
153455494|NCT05894603|Molnupiravir|molnupiravir|mesh-list
153455495|NCT05894603|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
153455496|NCT05894603|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
153455499|NCT05894603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153455500|NCT05894603|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153455501|NCT05894603|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153455502|NCT05894603|Antiviral Agents|antiviral agents|mesh-ancestor
153455503|NCT05894603|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153913725|NCT02723461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153913727|NCT02715193|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153913728|NCT02715193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153913729|NCT01223027|Sorafenib|sorafenib|mesh-list
153913730|NCT01223027|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153913731|NCT01223027|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153913732|NCT01223027|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153913733|NCT01223027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153811318|NCT00324623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153913734|NCT02714959|Aldesleukin|aldesleukin|mesh-list
153455504|NCT05894603|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
153455505|NCT05894603|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153455506|NCT05890963|Ibalizumab|ibalizumab|mesh-list
153455507|NCT05890963|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153455508|NCT05890963|Antiviral Agents|antiviral agents|mesh-ancestor
153455509|NCT05890963|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153455510|NCT05890963|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153455511|NCT05877430|Pembrolizumab|pembrolizumab|mesh-list
153455512|NCT05877430|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153455513|NCT05877430|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153455514|NCT05877430|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153455523|NCT05846724|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153455524|NCT05846724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153455525|NCT05846724|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153455526|NCT05846724|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153913735|NCT02714959|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153913736|NCT02714959|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153913737|NCT02714959|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153913738|NCT02714959|Antiviral Agents|antiviral agents|mesh-ancestor
153913739|NCT02714959|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153913740|NCT02714725|Dexmedetomidine|dexmedetomidine|mesh-list
153913741|NCT02714725|Propofol|propofol|mesh-list
153913742|NCT02714725|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153913743|NCT02714725|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153913744|NCT02714725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153811319|NCT00324623|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153357787|NCT03806582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153913745|NCT02714725|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153913746|NCT02714725|Analgesics|analgesics|mesh-ancestor
153913747|NCT02714725|Sensory System Agents|sensory system agents|mesh-ancestor
153913748|NCT02714725|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153913749|NCT02714725|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
153913750|NCT02714725|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153913751|NCT02714725|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153913752|NCT02714725|Adrenergic Agents|adrenergic agents|mesh-ancestor
153913753|NCT02714725|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153913754|NCT02714725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153913755|NCT02714725|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153913756|NCT02714725|Anesthetics, General|anesthetics, general|mesh-ancestor
153913757|NCT02714725|Anesthetics|anesthetics|mesh-ancestor
153913758|NCT01015287|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
153913759|NCT01015287|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153913760|NCT02714179|Acetaminophen|acetaminophen|mesh-list
153913761|NCT02714179|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153913762|NCT02714179|Analgesics|analgesics|mesh-ancestor
153913763|NCT02714179|Sensory System Agents|sensory system agents|mesh-ancestor
153913764|NCT02714179|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153913765|NCT02714179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153913766|NCT02714179|Antipyretics|antipyretics|mesh-ancestor
153913768|NCT01015131|Antiviral Agents|antiviral agents|mesh-ancestor
153913769|NCT01015131|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153913770|NCT02723383|Baclofen|baclofen|mesh-list
153913771|NCT02723383|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
153455563|NCT05786365|Anesthetics|anesthetics|mesh-ancestor
153455565|NCT05786365|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
153455566|NCT05786365|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
153455567|NCT05786365|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153455568|NCT05786365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153455570|NCT05773846|Anesthetics, Local|anesthetics, local|mesh-ancestor
153455571|NCT05773846|Anesthetics|anesthetics|mesh-ancestor
153455572|NCT05773846|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153455574|NCT05773846|Sensory System Agents|sensory system agents|mesh-ancestor
153455575|NCT05773846|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153913793|NCT05269537|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153913794|NCT05269537|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153913795|NCT05269537|Anesthetics, General|anesthetics, general|mesh-ancestor
153913796|NCT05269537|Oxytocics|oxytocics|mesh-ancestor
153913797|NCT05269537|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153913798|NCT05269537|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
153913799|NCT05269537|Sympathomimetics|sympathomimetics|mesh-ancestor
153913800|NCT05269537|Autonomic Agents|autonomic agents|mesh-ancestor
153913801|NCT05269537|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
153913802|NCT05269537|Adrenergic Agents|adrenergic agents|mesh-ancestor
153913803|NCT05269537|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153913804|NCT05269537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153913805|NCT01222715|Sirolimus|sirolimus|mesh-list
153563500|NCT01664013|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
153455579|NCT05763953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153563504|NCT01664013|Cholinergic Agents|cholinergic agents|mesh-ancestor
153455580|NCT05763953|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153455581|NCT05763953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153455582|NCT05757063|Dexmedetomidine|dexmedetomidine|mesh-list
153455584|NCT05757063|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153455585|NCT05757063|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153455586|NCT05757063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153811321|NCT00324623|Alkylating Agents|alkylating agents|mesh-ancestor
153357790|NCT03806582|Autonomic Agents|autonomic agents|mesh-ancestor
153357791|NCT03806582|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153357792|NCT03806582|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
153357793|NCT00779558|Heparin|heparin|mesh-list
153357794|NCT00779558|Calcium heparin|calcium heparin|mesh-list
153357795|NCT00779558|Anticoagulants|anticoagulants|mesh-ancestor
153357796|NCT00779558|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153811322|NCT00324623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153811323|NCT00324623|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153811324|NCT00324623|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153455590|NCT05757063|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153913812|NCT01222715|Antibodies|antibodies|mesh-list
153913813|NCT01222715|Immunoglobulins|immunoglobulins|mesh-list
153913814|NCT01222715|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
153913815|NCT01222715|Immunoglobulin G|immunoglobulin g|mesh-list
153913816|NCT01222715|Endothelial Growth Factors|endothelial growth factors|mesh-list
153913817|NCT01222715|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153913818|NCT01222715|Immunologic Factors|immunologic factors|mesh-ancestor
153913819|NCT01222715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153913821|NCT01222715|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153913828|NCT01222715|Growth Substances|growth substances|mesh-ancestor
153913829|NCT01222715|Growth Inhibitors|growth inhibitors|mesh-ancestor
153913830|NCT01222715|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153913831|NCT01222715|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153913832|NCT01222715|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153913833|NCT01222715|Antifungal Agents|antifungal agents|mesh-ancestor
153913834|NCT01222715|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153913835|NCT01222715|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153913836|NCT01222715|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153913837|NCT01222715|Tubulin Modulators|tubulin modulators|mesh-ancestor
153913838|NCT01222715|Antimitotic Agents|antimitotic agents|mesh-ancestor
153913839|NCT01222715|Mitosis Modulators|mitosis modulators|mesh-ancestor
153913840|NCT02723071|Ocrelizumab|ocrelizumab|mesh-list
153811325|NCT00324623|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153811327|NCT00324779|Rituximab|rituximab|mesh-list
153357797|NCT00779558|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153357798|NCT00779558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153357799|NCT01301183|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
153357800|NCT01301183|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
153811328|NCT00324779|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153811329|NCT00324779|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153811330|NCT00324779|Immunologic Factors|immunologic factors|mesh-ancestor
153811331|NCT00324779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153913841|NCT02723071|Immunologic Factors|immunologic factors|mesh-ancestor
153468060|NCT00556452|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153455618|NCT05660213|Growth Substances|growth substances|mesh-ancestor
153455619|NCT05660213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153455620|NCT05660213|Growth Inhibitors|growth inhibitors|mesh-ancestor
153455621|NCT05660213|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153455622|NCT05660213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153455623|NCT05660213|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153455624|NCT05660213|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153455625|NCT05658562|Loncastuximab tesirine|loncastuximab tesirine|mesh-list
153455626|NCT05658562|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153418608|NCT02941640|beta-Endorphin|beta-endorphin|mesh-list
153455627|NCT05658562|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153455629|NCT05643794|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153913847|NCT02722759|Sensory System Agents|sensory system agents|mesh-ancestor
153913848|NCT02722759|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153913849|NCT02722759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153913850|NCT02722759|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153913851|NCT02722759|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153913852|NCT02722447|Rivaroxaban|rivaroxaban|mesh-list
153913853|NCT02722447|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
153913854|NCT02722447|Antithrombins|antithrombins|mesh-ancestor
153913855|NCT02722447|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
153913856|NCT02722447|Protease Inhibitors|protease inhibitors|mesh-ancestor
153913857|NCT02722447|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153913858|NCT02722447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153913860|NCT01222403|Vaccines|vaccines|mesh-list
153913866|NCT02722369|Carboplatin|carboplatin|mesh-list
153913867|NCT02722369|Gemcitabine|gemcitabine|mesh-list
153913868|NCT02722369|Etoposide|etoposide|mesh-list
153913869|NCT02722369|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153913870|NCT02722369|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153913871|NCT02722369|Antimetabolites|antimetabolites|mesh-ancestor
153913872|NCT02722369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153913873|NCT02722369|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153913874|NCT02722369|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153913876|NCT02722369|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153913877|NCT02722369|Antimalarials|antimalarials|mesh-ancestor
153913879|NCT02722369|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153913880|NCT02722369|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153913881|NCT02722369|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153913883|NCT01222247|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153913884|NCT01222247|Glucocorticoids|glucocorticoids|mesh-ancestor
153913885|NCT01222247|Hormones|hormones|mesh-ancestor
153913886|NCT01222247|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153913887|NCT01222247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153913888|NCT01222247|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153468251|NCT06299371|Paclitaxel|paclitaxel|mesh-list
153913889|NCT01222247|Respiratory System Agents|respiratory system agents|mesh-ancestor
153913890|NCT01014975|Fibrinolysin|fibrinolysin|mesh-list
153913891|NCT01014975|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153913892|NCT01014975|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153455660|NCT05414500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153455661|NCT05367960|BPN14770|bpn14770|mesh-list
153913898|NCT03982537|Expectorants|expectorants|mesh-ancestor
153913899|NCT03982537|Respiratory System Agents|respiratory system agents|mesh-ancestor
153913900|NCT03982537|Free Radical Scavengers|free radical scavengers|mesh-ancestor
153913901|NCT03982537|Antioxidants|antioxidants|mesh-ancestor
153913902|NCT03982537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153913903|NCT03982537|Protective Agents|protective agents|mesh-ancestor
153913904|NCT03982537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153913905|NCT03982537|Antidotes|antidotes|mesh-ancestor
153913906|NCT05260593|Vitamins|vitamins|mesh-list
153913907|NCT05260593|Hydroxocobalamin|hydroxocobalamin|mesh-list
153455674|NCT05289349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153455675|NCT05289349|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153455676|NCT05289349|Anesthetics, General|anesthetics, general|mesh-ancestor
153455677|NCT05289349|Anesthetics|anesthetics|mesh-ancestor
153455690|NCT05183048|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153455691|NCT05174052|Dapagliflozin|dapagliflozin|mesh-list
153455692|NCT05174052|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
153455693|NCT05174052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153811332|NCT00324779|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153811333|NCT00324818|Azithromycin|azithromycin|mesh-list
153357802|NCT01301183|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
153455695|NCT05174052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153455698|NCT05150938|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
153563512|NCT01664065|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153913908|NCT05260593|Vitamin B 12|vitamin b 12|mesh-list
153913909|NCT05260593|Vitamin B Complex|vitamin b complex|mesh-list
153913910|NCT05260593|Micronutrients|micronutrients|mesh-ancestor
153913911|NCT05260593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153913912|NCT05260593|Hematinics|hematinics|mesh-ancestor
153913913|NCT02713477|Insulin|insulin|mesh-list
153913914|NCT02713477|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
153913915|NCT02713477|Insulin Glargine|insulin glargine|mesh-list
153913916|NCT02713477|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153913917|NCT02713477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153913918|NCT01014585|Milnacipran|milnacipran|mesh-list
153913919|NCT01014585|Levomilnacipran|levomilnacipran|mesh-list
153913920|NCT01014585|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
153913921|NCT01014585|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153913922|NCT01014585|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153913923|NCT01014585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153913924|NCT01014585|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153913925|NCT01014585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153913926|NCT01014585|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153913927|NCT01014585|Analgesics|analgesics|mesh-ancestor
153913928|NCT01014585|Sensory System Agents|sensory system agents|mesh-ancestor
153468381|NCT06297681|Dapagliflozin|dapagliflozin|mesh-list
153913929|NCT01014585|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153913930|NCT01014585|Antidepressive Agents|antidepressive agents|mesh-ancestor
153811334|NCT00324818|Metronidazole|metronidazole|mesh-list
153811335|NCT00324818|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153455701|NCT05150938|Rivaroxaban|rivaroxaban|mesh-list
153455702|NCT05150938|Vitamins|vitamins|mesh-ancestor
153455703|NCT05150938|Micronutrients|micronutrients|mesh-ancestor
153455716|NCT05150938|Coagulants|coagulants|mesh-ancestor
153455717|NCT05110001|Chlorhexidine|chlorhexidine|mesh-list
153455718|NCT05110001|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
153455719|NCT05110001|Natamycin|natamycin|mesh-list
153455720|NCT05110001|Moxifloxacin|moxifloxacin|mesh-list
153455721|NCT05110001|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
153455722|NCT05110001|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153455723|NCT05110001|Disinfectants|disinfectants|mesh-ancestor
153913931|NCT01014585|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153913932|NCT00611143|Atorvastatin|atorvastatin|mesh-list
153913933|NCT00611143|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153913934|NCT00611143|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153913935|NCT00611143|Antimetabolites|antimetabolites|mesh-ancestor
153913936|NCT00611143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153913937|NCT00611143|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153913938|NCT00611143|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
153913939|NCT00611143|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153913940|NCT02712619|Metformin|metformin|mesh-list
153913941|NCT02712619|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153913942|NCT02712619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153913943|NCT01220609|Epothilones|epothilones|mesh-list
153913944|NCT01220609|Tubulin Modulators|tubulin modulators|mesh-ancestor
153913946|NCT01220609|Mitosis Modulators|mitosis modulators|mesh-ancestor
153913947|NCT01220609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153913948|NCT01220609|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153913949|NCT02713087|Phenylephrine|phenylephrine|mesh-list
153913950|NCT02713087|Oxymetazoline|oxymetazoline|mesh-list
153913951|NCT02713087|Ephedrine|ephedrine|mesh-list
153913952|NCT02713087|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
153913953|NCT02713087|Mydriatics|mydriatics|mesh-ancestor
153455725|NCT05110001|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153455726|NCT05110001|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153455727|NCT05110001|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153455728|NCT05110001|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153913954|NCT02713087|Autonomic Agents|autonomic agents|mesh-ancestor
153913955|NCT02713087|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153913956|NCT02713087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153913957|NCT02713087|Sympathomimetics|sympathomimetics|mesh-ancestor
153913958|NCT02713087|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
153913959|NCT02713087|Nasal Decongestants|nasal decongestants|mesh-ancestor
153913960|NCT02713087|Respiratory System Agents|respiratory system agents|mesh-ancestor
153913961|NCT02713087|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
153913962|NCT02713087|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153913963|NCT02713087|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153913964|NCT02713087|Adrenergic Agents|adrenergic agents|mesh-ancestor
153913965|NCT02713087|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153811336|NCT00324818|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153357805|NCT01301183|Hormones|hormones|mesh-ancestor
153913966|NCT02713087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153913967|NCT02713087|Protective Agents|protective agents|mesh-ancestor
153913968|NCT02713087|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
153913970|NCT02722603|Tramadol|tramadol|mesh-list
153913971|NCT02722603|Analgesics|analgesics|mesh-ancestor
153913972|NCT02722603|Sensory System Agents|sensory system agents|mesh-ancestor
153913973|NCT02722603|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153468515|NCT06285396|Ephedrine|ephedrine|mesh-list
153455747|NCT05031234|Sensory System Agents|sensory system agents|mesh-ancestor
153455748|NCT05031234|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153455749|NCT05005260|Bupivacaine|bupivacaine|mesh-list
153455750|NCT05005260|Anesthetics, Local|anesthetics, local|mesh-ancestor
153913981|NCT02722603|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
153913982|NCT02722603|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153913983|NCT02722603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153913985|NCT02722603|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153913986|NCT02722603|Narcotics|narcotics|mesh-ancestor
153913987|NCT02712697|Prednisone|prednisone|mesh-list
153913988|NCT02712697|Hormones|hormones|mesh-list
153913989|NCT02712697|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153913990|NCT02712697|Glucocorticoids|glucocorticoids|mesh-ancestor
153913991|NCT02712697|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153913992|NCT02712697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153455769|NCT04964947|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153455770|NCT04964947|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153455772|NCT04964466|Anticoagulants|anticoagulants|mesh-ancestor
153455773|NCT04964466|Angiogenesis Inducing Agents|angiogenesis inducing agents|mesh-ancestor
153455774|NCT04964466|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153455775|NCT04964466|Growth Substances|growth substances|mesh-ancestor
153455776|NCT04964466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153455778|NCT04938557|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
153455779|NCT04938557|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153455780|NCT04938557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153455781|NCT04937881|Tenofovir|tenofovir|mesh-list
153455782|NCT04937881|Antiviral Agents|antiviral agents|mesh-ancestor
153455783|NCT04937881|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153811337|NCT00324818|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153455785|NCT04937881|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153455786|NCT04937881|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153455787|NCT04937881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153455788|NCT04937881|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153455789|NCT04937881|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153455790|NCT04842604|Azacitidine|azacitidine|mesh-list
153455791|NCT04842604|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153455792|NCT04842604|Antimetabolites|antimetabolites|mesh-ancestor
153455793|NCT04842604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153455794|NCT04842604|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153563557|NCT01664676|Liraglutide|liraglutide|mesh-list
153563562|NCT01664676|Hormones|hormones|mesh-ancestor
153455795|NCT04842604|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153455796|NCT04789668|Atezolizumab|atezolizumab|mesh-list
153455797|NCT04789668|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153455798|NCT04789668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153913993|NCT02712697|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153913994|NCT02712697|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153913995|NCT01220297|Mycophenolic Acid|mycophenolic acid|mesh-list
153913997|NCT01220297|Cyclophosphamide|cyclophosphamide|mesh-list
153913998|NCT01220297|Carmustine|carmustine|mesh-list
153913999|NCT01220297|Etoposide|etoposide|mesh-list
153914000|NCT01220297|Etoposide phosphate|etoposide phosphate|mesh-list
153914001|NCT01220297|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153914002|NCT01220297|Immunologic Factors|immunologic factors|mesh-ancestor
153914003|NCT01220297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153455799|NCT04789668|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153914004|NCT01220297|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153914005|NCT01220297|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153914006|NCT01220297|Alkylating Agents|alkylating agents|mesh-ancestor
153914007|NCT01220297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153914008|NCT01220297|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153811338|NCT00324818|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153914010|NCT01220297|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153914011|NCT01220297|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153914012|NCT01220297|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153914013|NCT01220297|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153914014|NCT01220297|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153914015|NCT01220297|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
153914016|NCT01220297|Antitubercular Agents|antitubercular agents|mesh-ancestor
153914017|NCT01220297|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153914018|NCT01220297|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153914019|NCT01220297|Antifungal Agents|antifungal agents|mesh-ancestor
153914020|NCT02712775|Minocycline|minocycline|mesh-list
153914021|NCT02712775|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153914022|NCT02712775|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153914023|NCT04318847|Ondansetron|ondansetron|mesh-list
153914024|NCT04318847|Antiemetics|antiemetics|mesh-ancestor
153914025|NCT04318847|Autonomic Agents|autonomic agents|mesh-ancestor
153914026|NCT04318847|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153914027|NCT04318847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153914028|NCT04318847|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153914029|NCT04318847|Antipruritics|antipruritics|mesh-ancestor
153914030|NCT04318847|Dermatologic Agents|dermatologic agents|mesh-ancestor
153914031|NCT04318847|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
153914032|NCT04318847|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153914033|NCT04318847|Serotonin Agents|serotonin agents|mesh-ancestor
153914034|NCT04318847|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153455811|NCT04778514|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153811339|NCT00324974|Lansoprazole|lansoprazole|mesh-list
153357806|NCT01301183|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153357807|NCT01301183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153455812|NCT04778514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153455813|NCT04778514|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
153455814|NCT04756401|Dexamethasone|dexamethasone|mesh-list
153455815|NCT04756401|Dexamethasone acetate|dexamethasone acetate|mesh-list
153455816|NCT04756401|Daratumumab|daratumumab|mesh-list
153455817|NCT04756401|Ichthammol|ichthammol|mesh-list
153455818|NCT04756401|BB 1101|bb 1101|mesh-list
153455831|NCT04756401|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153455832|NCT04756401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153455833|NCT04756401|Dermatologic Agents|dermatologic agents|mesh-ancestor
153455837|NCT04642391|Cosyntropin|cosyntropin|mesh-list
153914035|NCT04318847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153914036|NCT02721511|Furosemide|furosemide|mesh-list
153914037|NCT02721511|Diuretics|diuretics|mesh-ancestor
153914038|NCT02721511|Natriuretic Agents|natriuretic agents|mesh-ancestor
153914039|NCT02721511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153914040|NCT02721511|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
153914041|NCT02721511|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153914042|NCT02721511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153914043|NCT02712307|Penicillins|penicillins|mesh-list
153914044|NCT02712307|Penicillin V|penicillin v|mesh-list
153914045|NCT02712307|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153914046|NCT02712307|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153914047|NCT02708251|Lidocaine|lidocaine|mesh-list
153914048|NCT02708251|Nitroglycerin|nitroglycerin|mesh-list
153914049|NCT02708251|Anesthetics, Local|anesthetics, local|mesh-ancestor
153914050|NCT02708251|Anesthetics|anesthetics|mesh-ancestor
153914051|NCT02708251|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153914052|NCT02708251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153914053|NCT02708251|Sensory System Agents|sensory system agents|mesh-ancestor
153914054|NCT02708251|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153914055|NCT02708251|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153914056|NCT02708251|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
153811340|NCT00324974|Dexlansoprazole|dexlansoprazole|mesh-list
153914670|NCT05342857|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153455839|NCT04642391|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153455840|NCT04642391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153455841|NCT04613518|Deucravacitinib|deucravacitinib|mesh-list
153455842|NCT04613518|Dermatologic Agents|dermatologic agents|mesh-ancestor
153455844|NCT04613518|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153455845|NCT04613518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153455847|NCT04588727|Ticagrelor|ticagrelor|mesh-list
153455856|NCT04588727|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153455857|NCT04588727|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153455858|NCT04588727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153455859|NCT04588727|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153455860|NCT04588727|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153455861|NCT04588727|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153455862|NCT04588727|Antipyretics|antipyretics|mesh-ancestor
153914059|NCT02708251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153914060|NCT02708251|Vasodilator Agents|vasodilator agents|mesh-ancestor
153914061|NCT02708173|Vaccines|vaccines|mesh-list
153914062|NCT02708173|Immunologic Factors|immunologic factors|mesh-ancestor
153914063|NCT02708173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153914064|NCT00611611|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
153914065|NCT00611611|Immunologic Factors|immunologic factors|mesh-ancestor
153914066|NCT00611611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153914067|NCT00612625|Glucagon|glucagon|mesh-list
153914068|NCT00612625|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
153914069|NCT00612625|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153914070|NCT00612625|Hormones|hormones|mesh-ancestor
153914071|NCT00612625|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153811342|NCT00324974|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153811343|NCT00324974|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
153455863|NCT04588727|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
153455864|NCT04588727|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
153455865|NCT04588727|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
153455866|NCT04588727|Purinergic Agents|purinergic agents|mesh-ancestor
153455867|NCT04588727|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153455869|NCT04564547|Antiviral Agents|antiviral agents|mesh-ancestor
153455870|NCT04564547|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153455871|NCT04564547|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153455872|NCT04564547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153914098|NCT02711449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153914099|NCT02711449|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153914100|NCT02711449|Glucocorticoids|glucocorticoids|mesh-ancestor
153820712|NCT01050530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153811344|NCT00324974|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153914671|NCT04264624|Erythritol|erythritol|mesh-list
153455880|NCT04559607|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153455881|NCT04515329|Cyclosporine|cyclosporine|mesh-list
153455882|NCT04515329|Lubricant Eye Drops|lubricant eye drops|mesh-list
153455883|NCT04515329|Cyclosporins|cyclosporins|mesh-list
153455884|NCT04515329|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153455885|NCT04515329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153455886|NCT04515329|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153455888|NCT04515329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153455889|NCT04515329|Antifungal Agents|antifungal agents|mesh-ancestor
153455890|NCT04515329|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153455891|NCT04515329|Dermatologic Agents|dermatologic agents|mesh-ancestor
153455892|NCT04515329|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153914672|NCT04264624|Vasodilator Agents|vasodilator agents|mesh-ancestor
153455894|NCT04515329|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
153455895|NCT04515329|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
153455896|NCT04508621|Cyclobenzaprine|cyclobenzaprine|mesh-list
153455897|NCT04508621|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
153455898|NCT04508621|Antidepressive Agents|antidepressive agents|mesh-ancestor
153455899|NCT04508621|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153455900|NCT04508621|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
153455901|NCT04508621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153455902|NCT04508621|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
153455903|NCT04508621|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153455904|NCT04508621|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153455905|NCT04508621|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153455906|NCT04506554|Nivolumab|nivolumab|mesh-list
153455915|NCT04498117|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153455916|NCT04498117|Tubulin Modulators|tubulin modulators|mesh-ancestor
153455917|NCT04498117|Antimitotic Agents|antimitotic agents|mesh-ancestor
153455918|NCT04498117|Mitosis Modulators|mitosis modulators|mesh-ancestor
153455919|NCT04498117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153455920|NCT04498117|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153455921|NCT04359017|Lidocaine|lidocaine|mesh-list
153914143|NCT02707393|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
153914144|NCT02707393|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153455923|NCT04359017|Anesthetics|anesthetics|mesh-ancestor
153455924|NCT04359017|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153455925|NCT04359017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153455926|NCT04359017|Sensory System Agents|sensory system agents|mesh-ancestor
153455927|NCT04359017|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153455928|NCT04359017|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153455929|NCT04359017|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
153455930|NCT04359017|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153455931|NCT04359017|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153455932|NCT04359017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153455933|NCT04273776|Zolpidem|zolpidem|mesh-list
153455934|NCT04273776|Suvorexant|suvorexant|mesh-list
153455935|NCT04273776|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
153455936|NCT04273776|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153455937|NCT04273776|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153455938|NCT04273776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153455939|NCT04273776|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
153455941|NCT04273776|GABA Agents|gaba agents|mesh-ancestor
153455943|NCT04273776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153820688|NCT00464763|Sensory System Agents|sensory system agents|mesh-ancestor
153920371|NCT06332014|Denosumab|denosumab|mesh-list
153914189|NCT02711683|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153914190|NCT02711683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153914191|NCT02711683|Cholinergic Agents|cholinergic agents|mesh-ancestor
153914192|NCT02711683|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153914193|NCT02711683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153914194|NCT02711683|Nootropic Agents|nootropic agents|mesh-ancestor
153914195|NCT02711683|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153914196|NCT02711683|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
153914197|NCT02711683|Protective Agents|protective agents|mesh-ancestor
153455976|NCT04197687|Antibodies|antibodies|mesh-list
153455977|NCT04197687|Immunoglobulins|immunoglobulins|mesh-list
153455978|NCT04197687|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
153455979|NCT04197687|Sargramostim|sargramostim|mesh-list
153455980|NCT04197687|Immunoconjugates|immunoconjugates|mesh-list
153455981|NCT04197687|Immunologic Factors|immunologic factors|mesh-ancestor
153455982|NCT04197687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153455983|NCT04197687|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153455984|NCT04197687|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153455985|NCT04197687|Tubulin Modulators|tubulin modulators|mesh-ancestor
153455986|NCT04197687|Antimitotic Agents|antimitotic agents|mesh-ancestor
153455987|NCT04197687|Mitosis Modulators|mitosis modulators|mesh-ancestor
153455988|NCT04197687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153455989|NCT04197687|Immunotoxins|immunotoxins|mesh-ancestor
153455990|NCT04186494|Liraglutide|liraglutide|mesh-list
153455991|NCT04186494|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
153455992|NCT04186494|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153455993|NCT04186494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153455994|NCT04186494|Incretins|incretins|mesh-ancestor
153469212|NCT05418088|Fludarabine|fludarabine|mesh-list
153455995|NCT04186494|Hormones|hormones|mesh-ancestor
153455997|NCT04155541|Dacomitinib|dacomitinib|mesh-list
153456005|NCT04115319|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153914199|NCT05079061|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
153914200|NCT05079061|Abortifacient Agents|abortifacient agents|mesh-ancestor
153914201|NCT05079061|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153914202|NCT05079061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153914203|NCT05079061|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
153914204|NCT05079061|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153914205|NCT05079061|Oxytocics|oxytocics|mesh-ancestor
153914206|NCT00605020|Insulin|insulin|mesh-list
153914207|NCT00605020|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
153914208|NCT00605020|Insulin Aspart|insulin aspart|mesh-list
153914209|NCT00605020|Insulin, Long-Acting|insulin, long-acting|mesh-list
153914210|NCT00605020|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
153914211|NCT00605020|Insulin Detemir|insulin detemir|mesh-list
153914212|NCT00605020|Biphasic Insulins|biphasic insulins|mesh-list
153914213|NCT00605020|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153914214|NCT00605020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153914215|NCT02707081|Lidocaine|lidocaine|mesh-list
153914216|NCT02707081|Anesthetics, Local|anesthetics, local|mesh-ancestor
153914217|NCT02707081|Anesthetics|anesthetics|mesh-ancestor
153914218|NCT02707081|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153914219|NCT02707081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153914220|NCT02707081|Sensory System Agents|sensory system agents|mesh-ancestor
153914221|NCT02707081|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153914222|NCT02707081|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153914223|NCT02707081|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
153914224|NCT02707081|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153914225|NCT02707081|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153456006|NCT04115319|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153456007|NCT04115319|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153456008|NCT04115319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153456010|NCT04110132|Anesthetics, Local|anesthetics, local|mesh-ancestor
153456011|NCT04110132|Anesthetics|anesthetics|mesh-ancestor
153456012|NCT04110132|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153456013|NCT04110132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153456014|NCT04110132|Sensory System Agents|sensory system agents|mesh-ancestor
153456015|NCT04110132|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153456016|NCT04105270|Carboplatin|carboplatin|mesh-list
153456017|NCT04105270|Pemetrexed|pemetrexed|mesh-list
153456018|NCT04105270|Durvalumab|durvalumab|mesh-list
153456019|NCT04105270|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153914226|NCT02707081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153914227|NCT00605098|Ritonavir|ritonavir|mesh-list
153914228|NCT00605098|Lopinavir|lopinavir|mesh-list
153914229|NCT00605098|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
153914230|NCT00605098|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
153914231|NCT00605098|Protease Inhibitors|protease inhibitors|mesh-ancestor
153914232|NCT00605098|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153914233|NCT00605098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153914234|NCT00605098|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153914235|NCT00605098|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153914236|NCT00605098|Antiviral Agents|antiviral agents|mesh-ancestor
153914237|NCT00605098|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153914238|NCT00605098|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
153914239|NCT00605098|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153914240|NCT02711215|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
153914241|NCT02711215|Mirtazapine|mirtazapine|mesh-list
153914242|NCT02711215|Citalopram|citalopram|mesh-list
153914243|NCT02711215|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
153563575|NCT01664754|Carboplatin|carboplatin|mesh-list
153914244|NCT02711215|Escitalopram|escitalopram|mesh-list
153563576|NCT01664754|Pemetrexed|pemetrexed|mesh-list
153563577|NCT01664754|Exemestane|exemestane|mesh-list
153914245|NCT02711215|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
153914246|NCT02711215|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153914247|NCT02711215|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153914248|NCT02711215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153914249|NCT02711215|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153914250|NCT02711215|Serotonin Agents|serotonin agents|mesh-ancestor
153914251|NCT02711215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153914252|NCT02711215|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153914253|NCT02711215|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
153914254|NCT02711215|Antidepressive Agents|antidepressive agents|mesh-ancestor
153914255|NCT02711215|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153914256|NCT02711215|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
153914257|NCT02711215|Analgesics|analgesics|mesh-ancestor
153914258|NCT02711215|Sensory System Agents|sensory system agents|mesh-ancestor
153914259|NCT02711215|Dopamine Agents|dopamine agents|mesh-ancestor
153914260|NCT02711215|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
153914261|NCT02711215|Histamine Antagonists|histamine antagonists|mesh-ancestor
153914262|NCT02711215|Histamine Agents|histamine agents|mesh-ancestor
153914263|NCT02711215|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153914264|NCT02711215|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153914265|NCT02711215|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153914266|NCT02711215|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
153914267|NCT02711215|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
153914268|NCT02711215|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
153914269|NCT02711215|Adrenergic Agents|adrenergic agents|mesh-ancestor
153914270|NCT02711215|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
153914271|NCT02711215|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153914272|NCT02711215|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
153456020|NCT04105270|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153914273|NCT00603772|Tretinoin|tretinoin|mesh-list
153914274|NCT00603772|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153914275|NCT00603772|Keratolytic Agents|keratolytic agents|mesh-ancestor
153914276|NCT00603772|Dermatologic Agents|dermatologic agents|mesh-ancestor
153914277|NCT02706769|Acetaminophen|acetaminophen|mesh-list
153914278|NCT02706769|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153914279|NCT02706769|Analgesics|analgesics|mesh-ancestor
153914280|NCT02706769|Sensory System Agents|sensory system agents|mesh-ancestor
153914281|NCT02706769|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153914282|NCT02706769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153914283|NCT02706769|Antipyretics|antipyretics|mesh-ancestor
153914284|NCT05044117|Capecitabine|capecitabine|mesh-list
153456067|NCT03837353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153456068|NCT03832010|Triamcinolone|triamcinolone|mesh-list
153456069|NCT03832010|Hydrocortisone|hydrocortisone|mesh-list
153456070|NCT03832010|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153456071|NCT03832010|Glucocorticoids|glucocorticoids|mesh-ancestor
153456072|NCT03832010|Hormones|hormones|mesh-ancestor
153456073|NCT03832010|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153456074|NCT03832010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153456075|NCT03812393|Neratinib|neratinib|mesh-list
153456076|NCT03812393|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153456078|NCT03812393|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153456079|NCT03812393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153456080|NCT03794583|Treprostinil|treprostinil|mesh-list
153456081|NCT03794583|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153456082|NCT03774732|Paclitaxel|paclitaxel|mesh-list
153456083|NCT03774732|Cisplatin|cisplatin|mesh-list
153456084|NCT03774732|Carboplatin|carboplatin|mesh-list
153456085|NCT03774732|Pembrolizumab|pembrolizumab|mesh-list
153456086|NCT03774732|Pemetrexed|pemetrexed|mesh-list
153456087|NCT03774732|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153456088|NCT03774732|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153456089|NCT03774732|Tubulin Modulators|tubulin modulators|mesh-ancestor
153456090|NCT03774732|Antimitotic Agents|antimitotic agents|mesh-ancestor
153456091|NCT03774732|Mitosis Modulators|mitosis modulators|mesh-ancestor
153456092|NCT03774732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153456093|NCT03774732|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153456094|NCT03774732|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153456095|NCT03774732|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153914285|NCT05044117|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153914286|NCT05044117|Antimetabolites|antimetabolites|mesh-ancestor
153914287|NCT05044117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153914288|NCT05044117|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153914289|NCT03961165|Scopolamine|scopolamine|mesh-list
153914290|NCT03961165|Bromides|bromides|mesh-list
153914291|NCT03961165|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
153914292|NCT03961165|Anticonvulsants|anticonvulsants|mesh-ancestor
153914293|NCT03961165|Parasympatholytics|parasympatholytics|mesh-ancestor
153914294|NCT03961165|Autonomic Agents|autonomic agents|mesh-ancestor
153914296|NCT03961165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153914297|NCT03961165|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
153914298|NCT03961165|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
153456096|NCT03774732|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153456097|NCT03774732|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153914299|NCT03961165|Cholinergic Agents|cholinergic agents|mesh-ancestor
153914300|NCT03961165|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153914301|NCT03961165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153914302|NCT03961165|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153914303|NCT03961165|Antiemetics|antiemetics|mesh-ancestor
153914304|NCT03961165|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153914305|NCT03961165|Mydriatics|mydriatics|mesh-ancestor
153914306|NCT02706535|Itraconazole|itraconazole|mesh-list
153914307|NCT02706535|Rifampin|rifampin|mesh-list
153914308|NCT02706535|Antifungal Agents|antifungal agents|mesh-ancestor
153914309|NCT02706535|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153914310|NCT02706535|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
153914311|NCT02706535|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153914312|NCT02706535|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153914313|NCT02706535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153914314|NCT02706535|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153914315|NCT02706535|Hormone Antagonists|hormone antagonists|mesh-ancestor
153914316|NCT02706535|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153914317|NCT02706535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153914318|NCT02706535|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
153914319|NCT02706535|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
153914320|NCT02706535|Antitubercular Agents|antitubercular agents|mesh-ancestor
153914321|NCT02706535|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153914322|NCT02706535|Leprostatic Agents|leprostatic agents|mesh-ancestor
153914323|NCT02706535|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153914324|NCT02706535|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
153914325|NCT02706535|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
153914326|NCT02706535|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
153456113|NCT03725059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153456114|NCT03725059|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153456115|NCT03725059|Immunologic Factors|immunologic factors|mesh-ancestor
153456116|NCT03725059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153456117|NCT03725059|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153563587|NCT01664754|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153563588|NCT01664754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153563589|NCT01664819|Antioxidants|antioxidants|mesh-list
153563590|NCT01664819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153563591|NCT01664819|Protective Agents|protective agents|mesh-ancestor
153563592|NCT01664819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153563593|NCT01664845|Metformin|metformin|mesh-list
153563594|NCT01664845|Ribavirin|ribavirin|mesh-list
153563595|NCT01664845|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153563596|NCT01664845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153563597|NCT01664845|Antimetabolites|antimetabolites|mesh-ancestor
153563598|NCT01664845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153563599|NCT01664845|Antiviral Agents|antiviral agents|mesh-ancestor
153456118|NCT03725059|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153456119|NCT03725059|Alkylating Agents|alkylating agents|mesh-ancestor
153456120|NCT03725059|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153456121|NCT03725059|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153456122|NCT03725059|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153456124|NCT03725059|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153456125|NCT03725059|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153456126|NCT03725059|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153456127|NCT03695237|Leuprolide|leuprolide|mesh-list
153456128|NCT03695237|Fertility Agents, Female|fertility agents, female|mesh-ancestor
153456129|NCT03695237|Fertility Agents|fertility agents|mesh-ancestor
153456130|NCT03695237|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153456131|NCT03695237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153456132|NCT03695237|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153914333|NCT00612157|Eszopiclone|eszopiclone|mesh-list
153914334|NCT00612157|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153914335|NCT00612157|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153914336|NCT00612157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153914337|NCT00936598|Zolpidem|zolpidem|mesh-list
153914338|NCT00936598|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
153914339|NCT00936598|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153914340|NCT00936598|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153914341|NCT00936598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153914342|NCT00936598|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
153914343|NCT00936598|GABA Agonists|gaba agonists|mesh-ancestor
153914344|NCT00936598|GABA Agents|gaba agents|mesh-ancestor
153914345|NCT00936598|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153914346|NCT00936598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153914347|NCT01025817|Mycophenolic Acid|mycophenolic acid|mesh-list
153914348|NCT01025817|Everolimus|everolimus|mesh-list
153914349|NCT01025817|Tacrolimus|tacrolimus|mesh-list
153914350|NCT01025817|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153914351|NCT01025817|Immunologic Factors|immunologic factors|mesh-ancestor
153563601|NCT01664871|Fluorides|fluorides|mesh-list
153563602|NCT01664871|Cariostatic Agents|cariostatic agents|mesh-ancestor
153563603|NCT01664871|Protective Agents|protective agents|mesh-ancestor
153563604|NCT01664871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153563605|NCT01664936|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
153563606|NCT01664936|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
153563607|NCT01664936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153563608|NCT01665066|Nicotine|nicotine|mesh-list
153563609|NCT01665066|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
153563621|NCT01665079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153563622|NCT01665079|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153563623|NCT01665079|Anesthetics, General|anesthetics, general|mesh-ancestor
153563624|NCT01665079|Anesthetics|anesthetics|mesh-ancestor
153563625|NCT01665196|Deoxyglucose|deoxyglucose|mesh-list
153563626|NCT01665196|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
153563632|NCT01665209|Morphine|morphine|mesh-list
153456138|NCT03665597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153456139|NCT03607656|Docetaxel|docetaxel|mesh-list
153456141|NCT03607656|Oxaliplatin|oxaliplatin|mesh-list
153456142|NCT03607656|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153456143|NCT03607656|Tubulin Modulators|tubulin modulators|mesh-ancestor
153456144|NCT03607656|Antimitotic Agents|antimitotic agents|mesh-ancestor
153456145|NCT03607656|Mitosis Modulators|mitosis modulators|mesh-ancestor
153456146|NCT03607656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153456147|NCT03607656|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153456148|NCT03607656|Antimetabolites|antimetabolites|mesh-ancestor
153456149|NCT03586609|Cytarabine|cytarabine|mesh-list
153456150|NCT03586609|Azacitidine|azacitidine|mesh-list
153456151|NCT03586609|2-chloro-3'-deoxyadenosine|2-chloro-3'-deoxyadenosine|mesh-list
153456152|NCT03586609|Venetoclax|venetoclax|mesh-list
153456153|NCT03586609|Cladribine|cladribine|mesh-list
153456154|NCT03586609|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153456155|NCT03586609|Antimetabolites|antimetabolites|mesh-ancestor
153456171|NCT03584373|Sensory System Agents|sensory system agents|mesh-ancestor
153456172|NCT03584373|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153456173|NCT03584373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153456174|NCT03584373|Antipyretics|antipyretics|mesh-ancestor
153456175|NCT03584373|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153914384|NCT04300881|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
153914385|NCT04300881|Hormone Antagonists|hormone antagonists|mesh-ancestor
153456177|NCT03584373|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153456178|NCT03584373|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153456179|NCT03584373|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153456180|NCT03584373|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153456182|NCT03584373|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153456183|NCT03584373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153456184|NCT03582124|Panitumumab|panitumumab|mesh-list
153456185|NCT03582124|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153456186|NCT03582124|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153456187|NCT03569839|Propofol|propofol|mesh-list
153456188|NCT03569839|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153456189|NCT03569839|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153456190|NCT03569839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153456191|NCT03569839|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153456192|NCT03569839|Anesthetics, General|anesthetics, general|mesh-ancestor
153456193|NCT03569839|Anesthetics|anesthetics|mesh-ancestor
153456194|NCT03558789|Lactoferrin|lactoferrin|mesh-list
153456195|NCT03558789|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153456196|NCT03523858|Ocrelizumab|ocrelizumab|mesh-list
153914386|NCT04300881|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153456202|NCT03409718|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
153456203|NCT03409718|Histamine Antagonists|histamine antagonists|mesh-ancestor
153456204|NCT03409718|Histamine Agents|histamine agents|mesh-ancestor
153456205|NCT03409718|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153456206|NCT03409718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153456207|NCT03409718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153456208|NCT03409718|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
153456209|NCT03409718|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153456210|NCT03409718|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153456211|NCT03404778|Cimetidine|cimetidine|mesh-list
153456212|NCT03404778|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
153914405|NCT00611689|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153914406|NCT05264077|Midazolam|midazolam|mesh-list
153914407|NCT05264077|Dexmedetomidine|dexmedetomidine|mesh-list
153914409|NCT05264077|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153914410|NCT05264077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153914411|NCT05264077|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153914412|NCT05264077|Analgesics|analgesics|mesh-ancestor
153914434|NCT01010217|Cyclophosphamide|cyclophosphamide|mesh-list
153914435|NCT01010217|Melphalan|melphalan|mesh-list
153914436|NCT01010217|Thiotepa|thiotepa|mesh-list
153914437|NCT01010217|Rituximab|rituximab|mesh-list
153914438|NCT01010217|Fludarabine|fludarabine|mesh-list
153914439|NCT01010217|Fludarabine phosphate|fludarabine phosphate|mesh-list
153914440|NCT01010217|Tacrolimus|tacrolimus|mesh-list
153914441|NCT01010217|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153914442|NCT01010217|Immunologic Factors|immunologic factors|mesh-ancestor
153914443|NCT01010217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153914444|NCT01010217|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153914445|NCT01010217|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153456235|NCT03335839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153456236|NCT03245658|Nabiximols|nabiximols|mesh-list
153456237|NCT03245658|Analgesics|analgesics|mesh-ancestor
153456238|NCT03245658|Sensory System Agents|sensory system agents|mesh-ancestor
153456239|NCT03245658|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153456240|NCT03245658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153456241|NCT03223220|Midazolam|midazolam|mesh-list
153456242|NCT03223220|Ketamine|ketamine|mesh-list
153456243|NCT03223220|Analgesics|analgesics|mesh-ancestor
153456244|NCT03223220|Sensory System Agents|sensory system agents|mesh-ancestor
153456245|NCT03223220|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153626713|NCT02018523|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153626714|NCT02018523|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153626715|NCT02018523|Growth Substances|growth substances|mesh-ancestor
153456255|NCT03223220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153456256|NCT03223220|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153456257|NCT03223220|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153456259|NCT03223220|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153914446|NCT01010217|Alkylating Agents|alkylating agents|mesh-ancestor
153914447|NCT01010217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153914448|NCT01010217|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153914449|NCT01010217|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153914450|NCT01010217|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153914451|NCT01010217|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153914452|NCT01010217|Antimetabolites|antimetabolites|mesh-ancestor
153914453|NCT01010217|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153914454|NCT01010217|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
153914455|NCT01010217|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153914456|NCT01010217|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153914457|NCT01010217|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
153914458|NCT01010217|Antitubercular Agents|antitubercular agents|mesh-ancestor
153914459|NCT01010217|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153914460|NCT00604006|Spironolactone|spironolactone|mesh-list
153914461|NCT00604006|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
153914462|NCT00604006|Hormone Antagonists|hormone antagonists|mesh-ancestor
153914463|NCT00604006|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153914464|NCT00604006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153914465|NCT00604006|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
153914466|NCT00604006|Diuretics|diuretics|mesh-ancestor
153914467|NCT00604006|Natriuretic Agents|natriuretic agents|mesh-ancestor
153914468|NCT00604084|Ivermectin|ivermectin|mesh-list
153914469|NCT00604084|Permethrin|permethrin|mesh-list
153456260|NCT03223220|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153456261|NCT03223220|GABA Modulators|gaba modulators|mesh-ancestor
153456262|NCT03223220|GABA Agents|gaba agents|mesh-ancestor
153456263|NCT03148327|Durvalumab|durvalumab|mesh-list
153456264|NCT03148327|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153456265|NCT03148327|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153456266|NCT02969083|Cisplatin|cisplatin|mesh-list
153914476|NCT05379478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153914477|NCT04267042|Budesonide|budesonide|mesh-list
153914478|NCT04267042|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153914479|NCT04267042|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153914480|NCT04267042|Autonomic Agents|autonomic agents|mesh-ancestor
153914481|NCT04267042|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153914483|NCT04267042|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153914484|NCT04267042|Respiratory System Agents|respiratory system agents|mesh-ancestor
153914485|NCT04267042|Glucocorticoids|glucocorticoids|mesh-ancestor
153914486|NCT04267042|Hormones|hormones|mesh-ancestor
153914487|NCT04267042|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153456279|NCT02943590|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153456280|NCT02773238|Deoxyglucose|deoxyglucose|mesh-list
153456281|NCT02773238|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
153456282|NCT02773238|Technetium Tc 99m Sulfur Colloid|technetium tc 99m sulfur colloid|mesh-list
153456283|NCT02773238|Technetium Tc 99m Aggregated Albumin|technetium tc 99m aggregated albumin|mesh-list
153456284|NCT02773238|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
153456285|NCT02773238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153456297|NCT02630628|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153456298|NCT02630628|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153456299|NCT02630628|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
153914488|NCT01217957|Dexamethasone|dexamethasone|mesh-list
153914489|NCT01217957|Lenalidomide|lenalidomide|mesh-list
153914490|NCT01217957|Ixazomib|ixazomib|mesh-list
153914491|NCT01217957|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153914492|NCT01217957|Antiemetics|antiemetics|mesh-ancestor
153914493|NCT01217957|Autonomic Agents|autonomic agents|mesh-ancestor
153914494|NCT01217957|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153914495|NCT01217957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153914496|NCT01217957|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153914497|NCT01217957|Glucocorticoids|glucocorticoids|mesh-ancestor
153914498|NCT01217957|Hormones|hormones|mesh-ancestor
153914499|NCT01217957|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153914500|NCT01217957|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153914501|NCT01217957|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153563699|NCT01665404|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153563700|NCT01665404|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153914502|NCT01217957|Immunologic Factors|immunologic factors|mesh-ancestor
153914503|NCT01217957|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153469890|NCT04053478|Phenylephrine|phenylephrine|mesh-list
153914504|NCT01217957|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153563701|NCT01665404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153914505|NCT01217957|Growth Substances|growth substances|mesh-ancestor
153914506|NCT01217957|Growth Inhibitors|growth inhibitors|mesh-ancestor
153914507|NCT01217957|Protease Inhibitors|protease inhibitors|mesh-ancestor
153914508|NCT01217957|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153563704|NCT01665404|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153563705|NCT01665404|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153456300|NCT02630628|Antitubercular Agents|antitubercular agents|mesh-ancestor
153456301|NCT02630628|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153456302|NCT02630628|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153456303|NCT02619253|Pembrolizumab|pembrolizumab|mesh-list
153456304|NCT02619253|Vorinostat|vorinostat|mesh-list
153456305|NCT02619253|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153456306|NCT02619253|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153456307|NCT02619253|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153456321|NCT02476786|Goserelin|goserelin|mesh-list
153456322|NCT02476786|Exemestane|exemestane|mesh-list
153456323|NCT02476786|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
153914509|NCT01217957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153914510|NCT01217801|Ondansetron|ondansetron|mesh-list
153914511|NCT01217801|Antiemetics|antiemetics|mesh-ancestor
153914512|NCT01217801|Autonomic Agents|autonomic agents|mesh-ancestor
153914513|NCT01217801|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153914514|NCT01217801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153914515|NCT01217801|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153914516|NCT01217801|Antipruritics|antipruritics|mesh-ancestor
153914517|NCT01217801|Dermatologic Agents|dermatologic agents|mesh-ancestor
153914518|NCT01217801|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
153914519|NCT01217801|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153914520|NCT01217801|Serotonin Agents|serotonin agents|mesh-ancestor
153914521|NCT01217801|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153914522|NCT01217801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153914526|NCT00935818|Antidepressive Agents|antidepressive agents|mesh-ancestor
153914527|NCT00935818|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153914528|NCT00935818|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
153914529|NCT00935818|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153914530|NCT00935818|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153456324|NCT02476786|Hormone Antagonists|hormone antagonists|mesh-ancestor
153456325|NCT02476786|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153456326|NCT02476786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153456327|NCT02476786|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153456328|NCT02476786|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153456329|NCT02476786|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
153456330|NCT02476786|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
153456332|NCT02476786|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
153456334|NCT02476786|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153456335|NCT02476786|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153456336|NCT02476786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153456338|NCT02400255|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153456339|NCT02263729|Losartan|losartan|mesh-list
153456340|NCT02263729|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153456341|NCT02263729|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153456352|NCT02161783|Alkylating Agents|alkylating agents|mesh-ancestor
153456353|NCT02161783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153456354|NCT02161783|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153456355|NCT02161783|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153456357|NCT01868438|Pyronaridine|pyronaridine|mesh-list
153456358|NCT01868438|Pyronaridine tetraphosphate, artesunate drug combination|pyronaridine tetraphosphate, artesunate drug combination|mesh-list
153456359|NCT01868438|Antimalarials|antimalarials|mesh-ancestor
153456360|NCT01868438|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153456361|NCT01868438|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153456362|NCT01868438|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153456363|NCT01868438|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153456364|NCT01868438|Antiviral Agents|antiviral agents|mesh-ancestor
153456365|NCT01868438|Schistosomicides|schistosomicides|mesh-ancestor
153456366|NCT01868438|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
153456367|NCT01868438|Anthelmintics|anthelmintics|mesh-ancestor
153456368|NCT01554046|Methylphenidate|methylphenidate|mesh-list
153456369|NCT01554046|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
153456370|NCT01554046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153563715|NCT01665417|Docetaxel|docetaxel|mesh-list
153456371|NCT01554046|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
153456372|NCT01554046|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153456373|NCT01554046|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153456374|NCT01554046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153456375|NCT01554046|Dopamine Agents|dopamine agents|mesh-ancestor
153563720|NCT01665417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153563721|NCT01665469|Lycopene|lycopene|mesh-list
153456376|NCT01554046|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153456377|NCT01208662|Dexamethasone|dexamethasone|mesh-list
153456378|NCT01208662|Lenalidomide|lenalidomide|mesh-list
153456379|NCT01208662|Bortezomib|bortezomib|mesh-list
153456380|NCT01208662|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153456381|NCT01208662|Antiemetics|antiemetics|mesh-ancestor
153914557|NCT01216163|Sensory System Agents|sensory system agents|mesh-ancestor
153914558|NCT01216163|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153914559|NCT01216163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153914560|NCT01216163|Antipyretics|antipyretics|mesh-ancestor
153914561|NCT01216163|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153914562|NCT01216163|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153914563|NCT01216163|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153914564|NCT01216163|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153914565|NCT01216163|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153914568|NCT05260255|Ergocalciferols|ergocalciferols|mesh-list
153914569|NCT05260255|Vitamins|vitamins|mesh-ancestor
153914570|NCT05260255|Micronutrients|micronutrients|mesh-ancestor
153914571|NCT05260255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153914572|NCT05260255|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153914573|NCT05260255|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153914574|NCT00612469|Chlorhexidine|chlorhexidine|mesh-list
153914575|NCT00612469|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
153914576|NCT00612469|Listerine|listerine|mesh-list
153914577|NCT00612469|Vancomycin|vancomycin|mesh-list
153914578|NCT00612469|Fluorides|fluorides|mesh-list
153914579|NCT00612469|Sodium Fluoride|sodium fluoride|mesh-list
153914580|NCT00612469|Cariostatic Agents|cariostatic agents|mesh-ancestor
153914581|NCT00612469|Protective Agents|protective agents|mesh-ancestor
153914582|NCT00612469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153914583|NCT00612469|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
153914584|NCT00612469|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153914585|NCT00612469|Disinfectants|disinfectants|mesh-ancestor
153914586|NCT00612469|Dermatologic Agents|dermatologic agents|mesh-ancestor
153914587|NCT00612469|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153914588|NCT00933244|Vitamin D|vitamin d|mesh-list
153914589|NCT00933244|Ergocalciferols|ergocalciferols|mesh-list
153914590|NCT00933244|Cholecalciferol|cholecalciferol|mesh-list
153914591|NCT00933244|Vitamins|vitamins|mesh-list
153914592|NCT00933244|Micronutrients|micronutrients|mesh-ancestor
153456383|NCT01208662|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153563722|NCT01665469|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153456384|NCT01208662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153456385|NCT01208662|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153456401|NCT01457118|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153456402|NCT01457118|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153456403|NCT01457118|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153815096|NCT00344942|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153815097|NCT00344942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153563723|NCT01665469|Antioxidants|antioxidants|mesh-ancestor
153563724|NCT01665469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153563725|NCT01665469|Protective Agents|protective agents|mesh-ancestor
153563726|NCT01665469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153563727|NCT01665469|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
153563728|NCT01665469|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
153882690|NCT01580163|Methadone|methadone|mesh-list
153815098|NCT00344942|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153815099|NCT00344942|Immunologic Factors|immunologic factors|mesh-ancestor
153815100|NCT00344942|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153815101|NCT00344942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153815102|NCT00454350|1 alpha-hydroxyergocalciferol|1 alpha-hydroxyergocalciferol|mesh-list
153815104|NCT00454350|Micronutrients|micronutrients|mesh-ancestor
153815105|NCT00454350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153815106|NCT00454350|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153815107|NCT00454389|Ranibizumab|ranibizumab|mesh-list
153815108|NCT00454389|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153815109|NCT00454389|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153815110|NCT00454389|Growth Substances|growth substances|mesh-ancestor
153815111|NCT00454389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153815112|NCT00454389|Growth Inhibitors|growth inhibitors|mesh-ancestor
153815113|NCT00454389|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153815114|NCT00344981|Tenofovir|tenofovir|mesh-list
153815115|NCT00344981|Hydroxyurea|hydroxyurea|mesh-list
153456404|NCT01457118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153456406|NCT01501110|N-monoacetylcystine|n-monoacetylcystine|mesh-list
153456407|NCT01501110|Antiviral Agents|antiviral agents|mesh-ancestor
153456408|NCT01501110|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153456409|NCT01501110|Expectorants|expectorants|mesh-ancestor
153456410|NCT01501110|Respiratory System Agents|respiratory system agents|mesh-ancestor
153456424|NCT01476696|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153815117|NCT00344981|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153815118|NCT00344981|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153815119|NCT00344981|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153815120|NCT00344981|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153815121|NCT00344981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153815122|NCT00344981|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153815123|NCT00344981|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153815124|NCT00344981|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153815125|NCT00344981|Antisickling Agents|antisickling agents|mesh-ancestor
153815126|NCT00448266|Cyclophosphamide|cyclophosphamide|mesh-list
153815127|NCT00448266|Thiotepa|thiotepa|mesh-list
153563731|NCT01664507|Racepinephrine|racepinephrine|mesh-list
153563748|NCT01665586|Dexmedetomidine|dexmedetomidine|mesh-list
153563749|NCT01665586|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153563750|NCT01665586|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153563751|NCT01665586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153563752|NCT01665586|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153563753|NCT01665586|Analgesics|analgesics|mesh-ancestor
153563754|NCT01665586|Sensory System Agents|sensory system agents|mesh-ancestor
153563755|NCT01665586|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153815128|NCT00448266|Carboplatin|carboplatin|mesh-list
153815129|NCT00448266|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153815130|NCT00448266|Immunologic Factors|immunologic factors|mesh-ancestor
153815131|NCT00448266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153815132|NCT00448266|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153815133|NCT00448266|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153815134|NCT00448266|Alkylating Agents|alkylating agents|mesh-ancestor
153815135|NCT00448266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153815136|NCT00448266|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153456426|NCT01455012|Dopamine Agonists|dopamine agonists|mesh-ancestor
153456427|NCT01455012|Dopamine Agents|dopamine agents|mesh-ancestor
153456428|NCT01455012|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153456429|NCT01455012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153456430|NCT01455012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153456431|NCT01454778|Paclitaxel|paclitaxel|mesh-list
153456432|NCT01454778|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153456433|NCT01454778|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153456436|NCT01454778|Mitosis Modulators|mitosis modulators|mesh-ancestor
153456437|NCT01454778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153456439|NCT01454076|Rifampin|rifampin|mesh-list
153456440|NCT01454076|Ketoconazole|ketoconazole|mesh-list
153456441|NCT01454076|Ixazomib|ixazomib|mesh-list
153456442|NCT01454076|Glycine|glycine|mesh-list
153456443|NCT01454076|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153456444|NCT01454076|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153456445|NCT01454076|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
153456446|NCT01454076|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153456447|NCT01454076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153456448|NCT01454076|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
153456449|NCT01454076|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153456450|NCT01454076|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
153456451|NCT01454076|Antitubercular Agents|antitubercular agents|mesh-ancestor
153456452|NCT01454076|Leprostatic Agents|leprostatic agents|mesh-ancestor
153456453|NCT01454076|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153456454|NCT01454076|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
153456455|NCT01454076|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
153456456|NCT01454076|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
153456457|NCT01454076|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
153563774|NCT01665742|Vitamin E|vitamin e|mesh-list
153782708|NCT04561687|Respiratory System Agents|respiratory system agents|mesh-ancestor
153782709|NCT04561687|Glucocorticoids|glucocorticoids|mesh-ancestor
153563793|NCT01666041|Fenofibrate|fenofibrate|mesh-list
153563794|NCT01666041|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153563795|NCT01666041|Antimetabolites|antimetabolites|mesh-ancestor
153563796|NCT01666041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153563797|NCT01666041|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153815137|NCT00448266|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153815138|NCT00454545|Atorvastatin|atorvastatin|mesh-list
153811700|NCT00327080|Acetylcholine|acetylcholine|mesh-list
153815139|NCT00454545|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153815140|NCT00454545|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153815141|NCT00454545|Antimetabolites|antimetabolites|mesh-ancestor
153815142|NCT00454545|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153815143|NCT00454545|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153815144|NCT00454545|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
153815145|NCT00454545|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153815146|NCT00345059|Gemcitabine|gemcitabine|mesh-list
153815147|NCT00345059|Capecitabine|capecitabine|mesh-list
153815148|NCT00345059|Docetaxel|docetaxel|mesh-list
153815150|NCT00345059|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153815151|NCT00345059|Antimetabolites|antimetabolites|mesh-ancestor
153815152|NCT00345059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153815153|NCT00345059|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153815154|NCT00345059|Tubulin Modulators|tubulin modulators|mesh-ancestor
153815155|NCT00345059|Antimitotic Agents|antimitotic agents|mesh-ancestor
153815156|NCT00345059|Mitosis Modulators|mitosis modulators|mesh-ancestor
153815157|NCT00345059|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153815158|NCT00345098|Amibegron|amibegron|mesh-list
153815159|NCT00345098|Amibegron hydrochloride|amibegron hydrochloride|mesh-list
153815160|NCT00345098|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
153815161|NCT00345098|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153815162|NCT00345098|Adrenergic Agents|adrenergic agents|mesh-ancestor
153815163|NCT00345098|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153815164|NCT00345098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153815165|NCT00345098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153815166|NCT00345098|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
153815167|NCT00448305|Paclitaxel|paclitaxel|mesh-list
153815168|NCT00448305|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
153815169|NCT00448305|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153456458|NCT01454076|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
153456459|NCT01454076|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
153456460|NCT01454076|Antifungal Agents|antifungal agents|mesh-ancestor
153456461|NCT01454076|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
153456462|NCT01454076|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153456463|NCT01454076|Hormone Antagonists|hormone antagonists|mesh-ancestor
153456464|NCT01454076|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153563818|NCT01666223|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153563819|NCT01666236|Triamcinolone|triamcinolone|mesh-list
153563820|NCT01666236|Ranibizumab|ranibizumab|mesh-list
153563821|NCT01666236|Verteporfin|verteporfin|mesh-list
153563822|NCT01666236|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153563830|NCT01666236|Hormones|hormones|mesh-ancestor
153563835|NCT01666249|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
153563836|NCT01666249|Antibodies|antibodies|mesh-list
153563837|NCT01666249|Immunologic Factors|immunologic factors|mesh-ancestor
153563838|NCT01666249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153563839|NCT01666262|Vaccines|vaccines|mesh-list
153563840|NCT01666262|Immunologic Factors|immunologic factors|mesh-ancestor
153563841|NCT01666262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153563842|NCT01666301|Darbepoetin alfa|darbepoetin alfa|mesh-list
153456465|NCT01454076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153456466|NCT01454076|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153456467|NCT01454076|Protease Inhibitors|protease inhibitors|mesh-ancestor
153456468|NCT01454076|Glycine Agents|glycine agents|mesh-ancestor
153456469|NCT01454076|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153456470|NCT01453998|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
153456471|NCT01453998|Immunologic Factors|immunologic factors|mesh-ancestor
153456472|NCT01453998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153815170|NCT00448305|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153815171|NCT00448305|Tubulin Modulators|tubulin modulators|mesh-ancestor
153815172|NCT00448305|Antimitotic Agents|antimitotic agents|mesh-ancestor
153815173|NCT00448305|Mitosis Modulators|mitosis modulators|mesh-ancestor
153815174|NCT00448305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153815175|NCT00345137|omega-N-Methylarginine|omega-n-methylarginine|mesh-list
153815176|NCT00345137|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153815177|NCT00345137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153815179|NCT00448383|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
153815180|NCT00448383|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153815181|NCT00448383|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153815182|NCT00448461|Heparin|heparin|mesh-list
153815183|NCT00448461|Bivalirudin|bivalirudin|mesh-list
153815184|NCT00448461|Anticoagulants|anticoagulants|mesh-ancestor
153815185|NCT00448461|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153815186|NCT00448461|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153815187|NCT00448461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153815188|NCT00448461|Antithrombins|antithrombins|mesh-ancestor
153815189|NCT00448461|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
153815190|NCT00448461|Protease Inhibitors|protease inhibitors|mesh-ancestor
153815191|NCT00448461|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153815192|NCT00454662|Amlodipine|amlodipine|mesh-list
153815193|NCT00454662|Olmesartan|olmesartan|mesh-list
153815194|NCT00454662|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
153815195|NCT00454662|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153815196|NCT00454662|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153815197|NCT00454662|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153815198|NCT00454662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153563851|NCT01666379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153563852|NCT01666379|Analgesics|analgesics|mesh-ancestor
153563853|NCT01666379|Sensory System Agents|sensory system agents|mesh-ancestor
153563854|NCT01666379|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153563855|NCT01666379|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153563856|NCT01666379|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153563891|NCT01666587|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153563892|NCT01666587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153563893|NCT01666587|Protective Agents|protective agents|mesh-ancestor
153563894|NCT01666587|Hormone Antagonists|hormone antagonists|mesh-ancestor
153815199|NCT00454662|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153815200|NCT00454662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153815201|NCT00454662|Vasodilator Agents|vasodilator agents|mesh-ancestor
153815202|NCT00454662|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
153815203|NCT00454662|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
153815204|NCT00345644|Risedronic Acid|risedronic acid|mesh-list
153815205|NCT00345644|Etidronic Acid|etidronic acid|mesh-list
153815206|NCT00345644|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153815207|NCT00345644|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153815208|NCT00345644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153815209|NCT00345644|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153815210|NCT00345644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153815211|NCT00345644|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153815212|NCT00454701|Alefacept|alefacept|mesh-list
153815213|NCT00454701|Dermatologic Agents|dermatologic agents|mesh-ancestor
153815214|NCT00454701|Immunologic Factors|immunologic factors|mesh-ancestor
153815215|NCT00454701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153815216|NCT00345761|Bevacizumab|bevacizumab|mesh-list
153815217|NCT00345761|Capecitabine|capecitabine|mesh-list
153815218|NCT00345761|Oxaliplatin|oxaliplatin|mesh-list
153815219|NCT00345761|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153815220|NCT00345761|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153815221|NCT00345761|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153815222|NCT00345761|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153815223|NCT00345761|Growth Substances|growth substances|mesh-ancestor
153815224|NCT00345761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153815225|NCT00345761|Growth Inhibitors|growth inhibitors|mesh-ancestor
153626728|NCT02018601|Acetaminophen|acetaminophen|mesh-list
153626729|NCT02018601|Dexketoprofen trometamol|dexketoprofen trometamol|mesh-list
153626730|NCT02018601|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153626731|NCT02018601|Analgesics|analgesics|mesh-ancestor
153626732|NCT02018601|Sensory System Agents|sensory system agents|mesh-ancestor
153626733|NCT02018601|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153456518|NCT01499160|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153456519|NCT01499160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153456520|NCT01499160|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153456521|NCT01499160|Immunologic Factors|immunologic factors|mesh-ancestor
153456522|NCT01499160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153456523|NCT01499160|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153456524|NCT01499160|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
153456525|NCT01499160|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153456526|NCT01499160|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
153456527|NCT01499160|Hormone Antagonists|hormone antagonists|mesh-ancestor
153456528|NCT01499160|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153456529|NCT01499160|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153456530|NCT01498068|Interferons|interferons|mesh-list
153456531|NCT01498068|Ribavirin|ribavirin|mesh-list
153456532|NCT01498068|Interferon-alpha|interferon-alpha|mesh-list
153456533|NCT01498068|Interferon alpha-2|interferon alpha-2|mesh-list
153456534|NCT01498068|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
153456535|NCT01498068|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153456536|NCT01498068|Antiviral Agents|antiviral agents|mesh-ancestor
153456537|NCT01498068|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153456538|NCT01498068|Antimetabolites|antimetabolites|mesh-ancestor
153456539|NCT01498068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153456540|NCT01498068|Immunologic Factors|immunologic factors|mesh-ancestor
153456541|NCT01498068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153456542|NCT01497366|Sofosbuvir|sofosbuvir|mesh-list
153815227|NCT00345761|Antimetabolites|antimetabolites|mesh-ancestor
153815228|NCT00345761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153815229|NCT00345800|Sodium Oxybate|sodium oxybate|mesh-list
153815230|NCT00345800|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153815231|NCT00345800|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153815232|NCT00345800|Anesthetics, General|anesthetics, general|mesh-ancestor
153563914|NCT01666678|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153815234|NCT00345800|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153815235|NCT00345800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153815236|NCT00454740|Solifenacin Succinate|solifenacin succinate|mesh-list
153815237|NCT00454740|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
153815238|NCT00454740|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
153456543|NCT01497366|Antiviral Agents|antiviral agents|mesh-ancestor
153456544|NCT01497366|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153812006|NCT00432549|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153456545|NCT01475838|Elvitegravir, Cobicistat, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|elvitegravir, cobicistat, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
153456547|NCT01475838|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153456548|NCT01475838|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153456549|NCT01475838|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153456550|NCT01451814|Nicotine|nicotine|mesh-list
153456551|NCT01451814|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
153456552|NCT01451814|Autonomic Agents|autonomic agents|mesh-ancestor
153456553|NCT01451814|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153456554|NCT01451814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153456555|NCT01451814|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
153456556|NCT01451814|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
153456557|NCT01451814|Cholinergic Agents|cholinergic agents|mesh-ancestor
153456558|NCT01451814|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153456559|NCT01451814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153456560|NCT01496430|Azilsartan medoxomil|azilsartan medoxomil|mesh-list
153456561|NCT01496430|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
153456562|NCT01496430|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
153456563|NCT01496430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153456564|NCT04408326|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
153456565|NCT04408326|Angiotensin II|angiotensin ii|mesh-list
153456566|NCT04408326|Giapreza|giapreza|mesh-list
153456567|NCT04408326|Angiotensinogen|angiotensinogen|mesh-list
153456568|NCT04408326|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153815252|NCT03276858|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153815253|NCT03276858|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153815254|NCT03276858|Anesthetics, General|anesthetics, general|mesh-ancestor
153815255|NCT03276858|Anesthetics|anesthetics|mesh-ancestor
153815256|NCT03276858|GABA Modulators|gaba modulators|mesh-ancestor
153815257|NCT03276858|GABA Agents|gaba agents|mesh-ancestor
153815258|NCT03276858|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153815259|NCT03276858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153815260|NCT00421187|Amphotericin B|amphotericin b|mesh-list
153815261|NCT00421187|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
153815262|NCT00421187|Amebicides|amebicides|mesh-ancestor
153812186|NCT01055028|Paclitaxel|paclitaxel|mesh-list
153815264|NCT00421187|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153815265|NCT00421187|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153815266|NCT00421187|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153815267|NCT00421187|Antifungal Agents|antifungal agents|mesh-ancestor
153815268|NCT00454896|Solifenacin Succinate|solifenacin succinate|mesh-list
153815269|NCT00454896|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
153815270|NCT00454896|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
153815271|NCT00454896|Cholinergic Agents|cholinergic agents|mesh-ancestor
153815272|NCT00454896|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153815273|NCT00454896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153815274|NCT00454896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153815275|NCT00454896|Urological Agents|urological agents|mesh-ancestor
153815276|NCT00346190|Alendronate|alendronate|mesh-list
153815277|NCT00346190|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153815278|NCT00346190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153456569|NCT04408326|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
153563934|NCT01666691|CKD732|ckd732|mesh-list
153456570|NCT04408326|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
153456571|NCT04408326|Protease Inhibitors|protease inhibitors|mesh-ancestor
153456572|NCT04408326|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153456573|NCT04408326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153456574|NCT01474746|Sertraline|sertraline|mesh-list
153456575|NCT01474746|Antidepressive Agents|antidepressive agents|mesh-ancestor
153456576|NCT01474746|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153456577|NCT01474746|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
153456578|NCT01474746|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153456579|NCT01474746|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153456580|NCT01474746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153456581|NCT01474746|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153456582|NCT01474746|Serotonin Agents|serotonin agents|mesh-ancestor
153456583|NCT01474746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153456584|NCT01450800|Nitrofurantoin|nitrofurantoin|mesh-list
153456585|NCT01450800|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
153456586|NCT01450800|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153456587|NCT01450800|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153456589|NCT01474512|Dermatologic Agents|dermatologic agents|mesh-ancestor
153456590|NCT02985606|Caffeine|caffeine|mesh-list
153456591|NCT02985606|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
153456592|NCT02985606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153456593|NCT02985606|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
153456594|NCT02985606|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153456600|NCT01473732|Mycophenolic Acid|mycophenolic acid|mesh-list
153815279|NCT00346229|Doxorubicin|doxorubicin|mesh-list
153815280|NCT00346229|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
153815281|NCT00346229|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153815282|NCT00346229|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153815283|NCT00346229|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153815284|NCT00346229|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153815285|NCT00346229|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153820689|NCT00464763|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153815286|NCT00346229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153815287|NCT00346385|Lorvotuzumab mertansine|lorvotuzumab mertansine|mesh-list
153815288|NCT00346385|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153815289|NCT00346385|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153815290|NCT00346385|Immunotoxins|immunotoxins|mesh-ancestor
153815291|NCT00346385|Immunoconjugates|immunoconjugates|mesh-ancestor
153815292|NCT00346385|Immunologic Factors|immunologic factors|mesh-ancestor
153815293|NCT00346385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153815294|NCT00346385|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153815295|NCT00448578|Quetiapine Fumarate|quetiapine fumarate|mesh-list
153815296|NCT00448578|Antidepressive Agents|antidepressive agents|mesh-ancestor
153815297|NCT00448578|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153815298|NCT00448578|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153815299|NCT00448578|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153815300|NCT00448578|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153815301|NCT00448578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153815302|NCT00346463|Allopurinol|allopurinol|mesh-list
153815303|NCT00346463|Antimetabolites|antimetabolites|mesh-ancestor
153815304|NCT00346463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153815305|NCT00346463|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153815307|NCT00346463|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153563946|NCT01666756|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153782711|NCT04561687|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153563947|NCT01666756|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153563948|NCT01666756|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153563950|NCT01666769|Micafungin|micafungin|mesh-list
153815308|NCT00346463|Free Radical Scavengers|free radical scavengers|mesh-ancestor
153815318|NCT00455091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153815320|NCT00455091|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153815321|NCT00455091|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153815322|NCT00455091|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153815323|NCT00346580|Nelfinavir|nelfinavir|mesh-list
153815324|NCT00346580|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
153815325|NCT00346580|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
153456615|NCT01473732|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153456616|NCT01473732|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153456617|NCT01450098|Evacetrapib|evacetrapib|mesh-list
153456618|NCT01450098|Propyl Gallate|propyl gallate|mesh-list
153456619|NCT01450098|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153456620|NCT01450098|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153456621|NCT01450098|Antimetabolites|antimetabolites|mesh-ancestor
153456622|NCT01450098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153456623|NCT01450098|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153456624|NCT01450098|Antioxidants|antioxidants|mesh-ancestor
153456625|NCT01450098|Protective Agents|protective agents|mesh-ancestor
153456626|NCT01450098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153456627|NCT01449630|Celecoxib|celecoxib|mesh-list
153456628|NCT01449630|LY3031207|ly3031207|mesh-list
153456629|NCT01449630|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153456630|NCT01449630|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153456631|NCT01449630|Analgesics|analgesics|mesh-ancestor
153456632|NCT01449630|Sensory System Agents|sensory system agents|mesh-ancestor
153456633|NCT01449630|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153456634|NCT01449630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153456635|NCT01449630|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153456636|NCT01449630|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153456637|NCT01449630|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
153456638|NCT01449630|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153456639|NCT01449630|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153456640|NCT01449630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153456641|NCT01449630|Prostaglandin Antagonists|prostaglandin antagonists|mesh-ancestor
153456642|NCT01449630|Hormone Antagonists|hormone antagonists|mesh-ancestor
153456643|NCT01449630|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153470561|NCT00114101|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153815326|NCT00346580|Protease Inhibitors|protease inhibitors|mesh-ancestor
153815327|NCT00346580|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153815328|NCT00346580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153815329|NCT00346580|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153815330|NCT00346580|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153815331|NCT00346580|Antiviral Agents|antiviral agents|mesh-ancestor
153815332|NCT00346580|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153815333|NCT00346619|Nelfinavir|nelfinavir|mesh-list
153815334|NCT00346619|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
153815335|NCT00346619|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
153815337|NCT00346619|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153815338|NCT00346619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153815339|NCT00346619|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153815340|NCT00346619|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153456662|NCT01449006|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
153470623|NCT02129478|Serotonin Agents|serotonin agents|mesh-ancestor
153815355|NCT02959658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153815356|NCT04698213|Avelumab|avelumab|mesh-list
153815357|NCT04698213|Axitinib|axitinib|mesh-list
153815358|NCT04698213|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153815368|NCT02273817|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
153815369|NCT00346853|Fomepizole|fomepizole|mesh-list
153815370|NCT00346853|Antidotes|antidotes|mesh-ancestor
153815371|NCT00346853|Protective Agents|protective agents|mesh-ancestor
153815372|NCT00346853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153456663|NCT01449006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153456665|NCT01449006|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153456666|NCT01449006|Antiviral Agents|antiviral agents|mesh-ancestor
153456667|NCT01449006|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153456668|NCT01449006|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
153456669|NCT01491672|Everolimus|everolimus|mesh-list
153456670|NCT01491672|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
153456671|NCT01491672|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153456672|NCT01491672|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153456673|NCT01491672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153456674|NCT01491672|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153456675|NCT01491672|Immunologic Factors|immunologic factors|mesh-ancestor
153456676|NCT01491672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153456677|NCT01491672|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153456678|NCT01447446|Ribavirin|ribavirin|mesh-list
153456679|NCT01447446|Interferon-alpha|interferon-alpha|mesh-list
153456680|NCT01447446|Interferon alpha-2|interferon alpha-2|mesh-list
153456681|NCT01447446|Interferon-alfa-1b|interferon-alfa-1b|mesh-list
153456682|NCT01447446|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
153456683|NCT01447446|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
153456684|NCT01447446|Antimetabolites|antimetabolites|mesh-ancestor
153456685|NCT01447446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153456686|NCT01447446|Antiviral Agents|antiviral agents|mesh-ancestor
153456687|NCT01447446|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153456688|NCT01447446|Immunologic Factors|immunologic factors|mesh-ancestor
153456689|NCT01447446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153456690|NCT01447446|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153456691|NCT01471782|Blinatumomab|blinatumomab|mesh-list
153456692|NCT01471782|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153815373|NCT00346853|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153815374|NCT00346853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153815375|NCT00346970|Niacin|niacin|mesh-list
153815376|NCT00346970|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153815377|NCT00346970|Antimetabolites|antimetabolites|mesh-ancestor
153815378|NCT00346970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153815379|NCT00346970|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153815380|NCT00346970|Vasodilator Agents|vasodilator agents|mesh-ancestor
153815381|NCT00346970|Vitamin B Complex|vitamin b complex|mesh-ancestor
153815382|NCT00346970|Vitamins|vitamins|mesh-ancestor
153815383|NCT00346970|Micronutrients|micronutrients|mesh-ancestor
153815384|NCT00346970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153815385|NCT00455130|Mannitol|mannitol|mesh-list
153815386|NCT00455130|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
153815388|NCT00455130|Natriuretic Agents|natriuretic agents|mesh-ancestor
153815389|NCT00455130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153815391|NCT00347048|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153815392|NCT00347048|Immunologic Factors|immunologic factors|mesh-ancestor
153815393|NCT00347048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153815394|NCT00347048|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
153815395|NCT00347048|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153815396|NCT00347048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153815397|NCT00347087|Irbesartan|irbesartan|mesh-list
153815398|NCT00347087|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153815399|NCT00347087|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
153815400|NCT00347087|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
153456693|NCT01490580|Atropine|atropine|mesh-list
153456694|NCT01490580|Sufentanil|sufentanil|mesh-list
153456695|NCT01490580|Propofol|propofol|mesh-list
153456696|NCT01490580|Atracurium|atracurium|mesh-list
153456697|NCT01490580|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153456698|NCT01490580|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153456699|NCT01490580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153456700|NCT01490580|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153456701|NCT01490580|Anesthetics, General|anesthetics, general|mesh-ancestor
153456702|NCT01490580|Anesthetics|anesthetics|mesh-ancestor
153456703|NCT01490580|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153456704|NCT01490580|Narcotics|narcotics|mesh-ancestor
153456705|NCT01490580|Analgesics|analgesics|mesh-ancestor
153456706|NCT01490580|Sensory System Agents|sensory system agents|mesh-ancestor
153456707|NCT01490580|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153456708|NCT01490580|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153456709|NCT01490580|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153456710|NCT01490580|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153456711|NCT01490580|Autonomic Agents|autonomic agents|mesh-ancestor
153456712|NCT01490580|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153815401|NCT00347087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153815402|NCT00347165|Bevacizumab|bevacizumab|mesh-list
153815403|NCT00347165|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153815404|NCT00347165|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153815405|NCT00347165|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153815406|NCT00347165|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153815407|NCT00347165|Growth Substances|growth substances|mesh-ancestor
153815408|NCT00347165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153815409|NCT00347165|Growth Inhibitors|growth inhibitors|mesh-ancestor
153815410|NCT00347204|Ketorolac|ketorolac|mesh-list
153815411|NCT00347204|Nepafenac|nepafenac|mesh-list
153815412|NCT00347204|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153815413|NCT00347204|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153815414|NCT00347204|Analgesics|analgesics|mesh-ancestor
153815415|NCT00347204|Sensory System Agents|sensory system agents|mesh-ancestor
153815416|NCT00347204|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153815417|NCT00347204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153815418|NCT00347204|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153815419|NCT00347204|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153815420|NCT00347204|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153815421|NCT00347204|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153815422|NCT00347204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153563998|NCT01667445|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153563999|NCT01667445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153564000|NCT01667445|Analgesics|analgesics|mesh-ancestor
153564001|NCT01667445|Sensory System Agents|sensory system agents|mesh-ancestor
153564002|NCT01667445|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153564003|NCT01667484|Adderall|adderall|mesh-list
153564004|NCT01667484|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
153564005|NCT01667484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153564006|NCT01667497|4-Aminopyridine|4-aminopyridine|mesh-list
153564007|NCT01667497|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
153564011|NCT01667523|Capsaicin|capsaicin|mesh-list
153815423|NCT00455286|Methylprednisolone|methylprednisolone|mesh-list
153815424|NCT00455286|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
153815425|NCT00455286|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
153815426|NCT00455286|Prednisolone|prednisolone|mesh-list
153815427|NCT00455286|Prednisolone acetate|prednisolone acetate|mesh-list
153815428|NCT00455286|Methotrexate|methotrexate|mesh-list
153815429|NCT00455286|Temozolomide|temozolomide|mesh-list
153815430|NCT00455286|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
153815431|NCT00455286|Prednisolone phosphate|prednisolone phosphate|mesh-list
153815432|NCT00455286|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
153815433|NCT00455286|Abortifacient Agents|abortifacient agents|mesh-ancestor
153815434|NCT00455286|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153456713|NCT01490580|Respiratory System Agents|respiratory system agents|mesh-ancestor
153456714|NCT01490580|Mydriatics|mydriatics|mesh-ancestor
153456727|NCT01490190|NuvaRing|nuvaring|mesh-list
153815435|NCT00455286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153815436|NCT00455286|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153815437|NCT00455286|Antimetabolites|antimetabolites|mesh-ancestor
153815438|NCT00455286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153815439|NCT00455286|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153815440|NCT00455286|Dermatologic Agents|dermatologic agents|mesh-ancestor
153815441|NCT00455286|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153815442|NCT00455286|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153815443|NCT00455286|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153815444|NCT00455286|Immunologic Factors|immunologic factors|mesh-ancestor
153815445|NCT00455286|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153815446|NCT00455286|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153815447|NCT00455286|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153815448|NCT00455286|Alkylating Agents|alkylating agents|mesh-ancestor
153815449|NCT00455286|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153815450|NCT00455286|Antiemetics|antiemetics|mesh-ancestor
153815451|NCT00455286|Autonomic Agents|autonomic agents|mesh-ancestor
153815452|NCT00455286|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153815453|NCT00455286|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153456749|NCT01446042|Anabolic Agents|anabolic agents|mesh-ancestor
153456750|NCT01445886|Calcitriol|calcitriol|mesh-list
153456751|NCT01445886|Calcipotriene|calcipotriene|mesh-list
153456752|NCT01445886|Dermatologic Agents|dermatologic agents|mesh-ancestor
153456753|NCT01445886|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153456754|NCT01445886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153456755|NCT01445886|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
153456756|NCT01445886|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153456757|NCT01445886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153456758|NCT01445886|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
153456759|NCT01445886|Vitamins|vitamins|mesh-ancestor
153456760|NCT01445886|Micronutrients|micronutrients|mesh-ancestor
153456761|NCT01445886|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153456762|NCT01470612|Tofacitinib|tofacitinib|mesh-list
153456763|NCT01470612|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
153456764|NCT01470612|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153456765|NCT01470612|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153812820|NCT00330785|Amlodipine|amlodipine|mesh-list
153456766|NCT01470612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153456768|NCT04073316|Rivaroxaban|rivaroxaban|mesh-list
153456769|NCT04073316|Anticoagulants|anticoagulants|mesh-ancestor
153456770|NCT04073316|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
153456771|NCT04073316|Antithrombins|antithrombins|mesh-ancestor
153456772|NCT04073316|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
153456773|NCT04073316|Protease Inhibitors|protease inhibitors|mesh-ancestor
153456774|NCT04073316|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153456775|NCT04073316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153456776|NCT04089852|Nitrous Oxide|nitrous oxide|mesh-list
153456777|NCT04089852|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
153456778|NCT04089852|Anesthetics, General|anesthetics, general|mesh-ancestor
153456779|NCT04089852|Anesthetics|anesthetics|mesh-ancestor
153815454|NCT00455286|Glucocorticoids|glucocorticoids|mesh-ancestor
153815455|NCT00455286|Hormones|hormones|mesh-ancestor
153815456|NCT00455286|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153815457|NCT00455286|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
153815458|NCT00455286|Protective Agents|protective agents|mesh-ancestor
153815459|NCT00455286|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153815460|NCT00455364|Voriconazole|voriconazole|mesh-list
153815461|NCT00455364|Antifungal Agents|antifungal agents|mesh-ancestor
153470805|NCT05175768|Antimetabolites|antimetabolites|mesh-ancestor
153815462|NCT00455364|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153815463|NCT00455364|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
153815464|NCT00455364|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153815465|NCT00455364|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153815466|NCT00455364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153456780|NCT04089852|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153456786|NCT03026244|Vitamin D|vitamin d|mesh-list
153815467|NCT00455364|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153815468|NCT00455364|Hormone Antagonists|hormone antagonists|mesh-ancestor
153815469|NCT00455364|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153812852|NCT00330824|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153815470|NCT00455364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153815471|NCT00455364|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
153815472|NCT00347399|Bevacizumab|bevacizumab|mesh-list
153815473|NCT00347399|Verteporfin|verteporfin|mesh-list
153815474|NCT00347399|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153815475|NCT00347399|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153815476|NCT00347399|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153815477|NCT00347399|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153815478|NCT00347399|Growth Substances|growth substances|mesh-ancestor
153815479|NCT00347399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153815480|NCT00347399|Growth Inhibitors|growth inhibitors|mesh-ancestor
153815482|NCT00347399|Dermatologic Agents|dermatologic agents|mesh-ancestor
153815483|NCT00455442|Mifepristone|mifepristone|mesh-list
153815484|NCT00455442|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
153815492|NCT00455442|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
153815493|NCT00455442|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
153456794|NCT03026244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153456797|NCT01470144|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153456798|NCT01470144|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153456799|NCT01470144|Vasodilator Agents|vasodilator agents|mesh-ancestor
153456800|NCT01443858|Meclizine|meclizine|mesh-list
153456801|NCT01443858|Nicotine|nicotine|mesh-list
153456802|NCT01443858|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
153456803|NCT01443858|Autonomic Agents|autonomic agents|mesh-ancestor
153456804|NCT01443858|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153456805|NCT01443858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153456806|NCT01443858|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
153456807|NCT01443858|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
153456808|NCT01443858|Cholinergic Agents|cholinergic agents|mesh-ancestor
153456809|NCT01443858|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153456810|NCT01443858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153456811|NCT01443858|Antiemetics|antiemetics|mesh-ancestor
153456812|NCT01443858|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153456813|NCT01443858|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
153456814|NCT01443858|Histamine Antagonists|histamine antagonists|mesh-ancestor
153456815|NCT01443858|Histamine Agents|histamine agents|mesh-ancestor
153456816|NCT01443858|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
153456817|NCT01443858|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
153456819|NCT01443078|Gemcitabine|gemcitabine|mesh-list
153815494|NCT00455442|Hormone Antagonists|hormone antagonists|mesh-ancestor
153815495|NCT00455442|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153815496|NCT00455442|Luteolytic Agents|luteolytic agents|mesh-ancestor
153815497|NCT00455442|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
153815498|NCT00455442|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
153815499|NCT00347555|Aluminum phosphate|aluminum phosphate|mesh-list
153815500|NCT00347555|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153815501|NCT00347555|Immunologic Factors|immunologic factors|mesh-ancestor
153815502|NCT00347555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153815503|NCT00347555|Antacids|antacids|mesh-ancestor
153815504|NCT00347555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153815505|NCT00347555|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153815506|NCT00455637|Botulinum Toxins|botulinum toxins|mesh-list
153815507|NCT00455637|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
153815508|NCT00455637|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
153815509|NCT00455637|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
153815510|NCT00455637|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153815511|NCT00455637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153815512|NCT00455637|Cholinergic Agents|cholinergic agents|mesh-ancestor
153815513|NCT00455637|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153815514|NCT00455637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153815515|NCT00455637|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
153456820|NCT01443078|Docetaxel|docetaxel|mesh-list
153456821|NCT01443078|Pemetrexed|pemetrexed|mesh-list
153456822|NCT01443078|Vinorelbine|vinorelbine|mesh-list
153456823|NCT01443078|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153456824|NCT01443078|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153456825|NCT01443078|Antimetabolites|antimetabolites|mesh-ancestor
153456826|NCT01443078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153456827|NCT01443078|Tubulin Modulators|tubulin modulators|mesh-ancestor
153456828|NCT01443078|Antimitotic Agents|antimitotic agents|mesh-ancestor
153456829|NCT01443078|Mitosis Modulators|mitosis modulators|mesh-ancestor
153456830|NCT01443078|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153456831|NCT01443078|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153456832|NCT01443078|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153456833|NCT01443078|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153456834|NCT01439880|Evolocumab|evolocumab|mesh-list
153456835|NCT01439880|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
153456836|NCT01439880|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153456837|NCT01439880|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153456838|NCT01439880|Antimetabolites|antimetabolites|mesh-ancestor
153456839|NCT01439880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153456840|NCT01439880|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
153456841|NCT01439880|Protease Inhibitors|protease inhibitors|mesh-ancestor
153456842|NCT01439880|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153456843|NCT01439880|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153456844|NCT01469364|Aztreonam|aztreonam|mesh-list
153456845|NCT01469364|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153456846|NCT01469364|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153456847|NCT01439568|Carboplatin|carboplatin|mesh-list
153456848|NCT01439568|Etoposide|etoposide|mesh-list
153456849|NCT01439568|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153456850|NCT01439568|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153815516|NCT00455637|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153815517|NCT00347750|Lopinavir|lopinavir|mesh-list
153815518|NCT00347750|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
153815519|NCT00347750|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
153815520|NCT00347750|Protease Inhibitors|protease inhibitors|mesh-ancestor
153815521|NCT00347750|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153815522|NCT00347750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153815523|NCT00347750|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153815524|NCT00347750|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153815525|NCT00347750|Antiviral Agents|antiviral agents|mesh-ancestor
153815526|NCT00347750|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153456851|NCT01439568|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153456852|NCT01439568|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153815527|NCT00347750|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
153815528|NCT00347750|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153815529|NCT00347828|Moxifloxacin|moxifloxacin|mesh-list
153815530|NCT00347828|Gatifloxacin|gatifloxacin|mesh-list
153815531|NCT00347828|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
153815532|NCT00347828|Ophthalmic Solutions|ophthalmic solutions|mesh-list
153815533|NCT00347828|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153815534|NCT00347828|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153815535|NCT00347828|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153815536|NCT00347828|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153815537|NCT00347828|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153815538|NCT00347828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153815539|NCT00347828|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153815540|NCT00347867|Sildenafil Citrate|sildenafil citrate|mesh-list
153815541|NCT00347867|Vasodilator Agents|vasodilator agents|mesh-ancestor
153815542|NCT00347867|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
153815543|NCT00347867|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
153815544|NCT00347867|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153815545|NCT00347867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153815546|NCT00347867|Urological Agents|urological agents|mesh-ancestor
153815547|NCT00449202|Oleoyl-estrone|oleoyl-estrone|mesh-list
153815548|NCT00449202|Estrone|estrone|mesh-list
153815549|NCT00449202|Estrogens|estrogens|mesh-ancestor
153815550|NCT00449202|Hormones|hormones|mesh-ancestor
153815551|NCT00449202|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153815552|NCT00449202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153815553|NCT00449202|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
153815554|NCT00455715|Sildenafil Citrate|sildenafil citrate|mesh-list
153815555|NCT00455715|Vasodilator Agents|vasodilator agents|mesh-ancestor
153815556|NCT00455715|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
153815557|NCT00455715|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
153456864|NCT01468818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153456865|NCT01468818|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153456866|NCT01468818|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153456867|NCT01468818|Alkylating Agents|alkylating agents|mesh-ancestor
153456868|NCT01468818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153456869|NCT01468818|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153456870|NCT01468818|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153456872|NCT01442376|Palonosetron|palonosetron|mesh-list
153456873|NCT01442376|Antiemetics|antiemetics|mesh-ancestor
153456874|NCT01442376|Autonomic Agents|autonomic agents|mesh-ancestor
153456875|NCT01442376|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153456876|NCT01442376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153456877|NCT01442376|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153456878|NCT01442376|Antipruritics|antipruritics|mesh-ancestor
153456879|NCT01442376|Dermatologic Agents|dermatologic agents|mesh-ancestor
153456880|NCT01442376|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
153456881|NCT01442376|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153456882|NCT01442376|Serotonin Agents|serotonin agents|mesh-ancestor
153813001|NCT00431262|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153456883|NCT01442376|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153456884|NCT01442376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153456885|NCT01442064|Ranibizumab|ranibizumab|mesh-list
153456886|NCT01442064|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153456887|NCT01442064|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153815558|NCT00455715|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153815559|NCT00455715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153815560|NCT00455715|Urological Agents|urological agents|mesh-ancestor
153815561|NCT00455754|Esomeprazole|esomeprazole|mesh-list
153815562|NCT00455754|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
153815563|NCT00455754|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153815564|NCT00455754|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
153815565|NCT00455754|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153815566|NCT00455754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153815567|NCT00347984|Ophthalmic Solutions|ophthalmic solutions|mesh-list
153815568|NCT00347984|Lubricant Eye Drops|lubricant eye drops|mesh-list
153815569|NCT00347984|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
153815571|NCT00348023|Bimatoprost|bimatoprost|mesh-list
153815572|NCT00348023|Travoprost|travoprost|mesh-list
153815573|NCT00348023|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
153815574|NCT00348023|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
153815575|NCT00348023|Adrenergic Agents|adrenergic agents|mesh-ancestor
153815577|NCT00348023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153815578|NCT00348023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153815579|NCT00348023|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153815580|NCT00348023|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153815581|NCT00348062|Bimatoprost|bimatoprost|mesh-list
153815582|NCT00348062|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153815583|NCT00348101|Enoximone|enoximone|mesh-list
153815584|NCT00348101|Esmolol|esmolol|mesh-list
153815585|NCT00348101|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
153815586|NCT00348101|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
153815587|NCT00348101|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
153815588|NCT00348101|Adrenergic Agents|adrenergic agents|mesh-ancestor
153815589|NCT00348101|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153815590|NCT00348101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153815591|NCT00348101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153815593|NCT00348101|Vasodilator Agents|vasodilator agents|mesh-ancestor
153815594|NCT00348101|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
153815595|NCT00348101|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
153815596|NCT00348101|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153815597|NCT00348101|Protective Agents|protective agents|mesh-ancestor
153815598|NCT00455832|Ribavirin|ribavirin|mesh-list
153815599|NCT00455832|Antimetabolites|antimetabolites|mesh-ancestor
153815600|NCT00455832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153815601|NCT00455832|Antiviral Agents|antiviral agents|mesh-ancestor
153815602|NCT00455832|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153815603|NCT00455871|Ranibizumab|ranibizumab|mesh-list
153815604|NCT00455871|Verteporfin|verteporfin|mesh-list
153815605|NCT00455871|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153815606|NCT00455871|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153815607|NCT00455871|Growth Substances|growth substances|mesh-ancestor
153456912|NCT01441440|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153456913|NCT03026478|Betamethasone|betamethasone|mesh-list
153456914|NCT03026478|Betamethasone Valerate|betamethasone valerate|mesh-list
153456915|NCT03026478|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
153456916|NCT03026478|Betamethasone benzoate|betamethasone benzoate|mesh-list
153456917|NCT03026478|Clobetasol|clobetasol|mesh-list
153456918|NCT03026478|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
153456919|NCT03026478|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153456920|NCT03026478|Glucocorticoids|glucocorticoids|mesh-ancestor
153456921|NCT03026478|Hormones|hormones|mesh-ancestor
153456922|NCT03026478|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153456923|NCT03026478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153456924|NCT03026478|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153456925|NCT03026478|Respiratory System Agents|respiratory system agents|mesh-ancestor
153456926|NCT04066764|Nadroparin|nadroparin|mesh-list
153456927|NCT04066764|Warfarin|warfarin|mesh-list
153456928|NCT04066764|Rivaroxaban|rivaroxaban|mesh-list
153456929|NCT04066764|Anticoagulants|anticoagulants|mesh-ancestor
153456930|NCT04066764|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
153456931|NCT04066764|Antithrombins|antithrombins|mesh-ancestor
153456932|NCT04066764|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
153456933|NCT04066764|Protease Inhibitors|protease inhibitors|mesh-ancestor
153456934|NCT04066764|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153456935|NCT04066764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153456936|NCT04066764|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153456937|NCT04066764|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153456938|NCT01437540|Bromides|bromides|mesh-list
153456939|NCT01437540|Formoterol Fumarate|formoterol fumarate|mesh-list
153456940|NCT01437540|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153456941|NCT01437540|Autonomic Agents|autonomic agents|mesh-ancestor
153456942|NCT01437540|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153456943|NCT01437540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153456944|NCT01437540|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153815608|NCT00455871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153815609|NCT00455871|Growth Inhibitors|growth inhibitors|mesh-ancestor
153815610|NCT00455871|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153815611|NCT00455871|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
153815612|NCT00455871|Dermatologic Agents|dermatologic agents|mesh-ancestor
153815613|NCT00449280|Sirolimus|sirolimus|mesh-list
153815614|NCT00449280|Sorafenib|sorafenib|mesh-list
153815615|NCT00449280|Temsirolimus|temsirolimus|mesh-list
153815616|NCT00449280|MTOR Inhibitors|mtor inhibitors|mesh-list
153815617|NCT00449280|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153815618|NCT00449280|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153815619|NCT00449280|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153815620|NCT00449280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153815621|NCT00449280|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153815622|NCT00449280|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153815623|NCT00449280|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153815624|NCT00449280|Antifungal Agents|antifungal agents|mesh-ancestor
153815625|NCT00449280|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153815626|NCT00449280|Immunologic Factors|immunologic factors|mesh-ancestor
153815627|NCT00449280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153815628|NCT00455910|Thalidomide|thalidomide|mesh-list
153815629|NCT00455910|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153815630|NCT00455910|Immunologic Factors|immunologic factors|mesh-ancestor
153815631|NCT00455910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153815632|NCT00455910|Leprostatic Agents|leprostatic agents|mesh-ancestor
153815633|NCT00455910|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153815634|NCT00455910|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153815635|NCT00455910|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153815636|NCT00455910|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153815637|NCT00455910|Growth Substances|growth substances|mesh-ancestor
153815638|NCT00455910|Growth Inhibitors|growth inhibitors|mesh-ancestor
153815639|NCT00455910|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153815640|NCT00348296|Immunoglobulins|immunoglobulins|mesh-list
153815641|NCT00348296|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
153456945|NCT01437540|Respiratory System Agents|respiratory system agents|mesh-ancestor
153456946|NCT01437540|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
153456947|NCT01437540|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
153456948|NCT01437540|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153456949|NCT01437540|Adrenergic Agents|adrenergic agents|mesh-ancestor
153456950|NCT01437540|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153456951|NCT01437540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153564156|NCT01668498|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153564157|NCT01668498|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153564158|NCT01668498|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153564163|NCT01668550|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153564164|NCT01668550|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153564165|NCT01668550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153564166|NCT01668615|Tretinoin|tretinoin|mesh-list
153564167|NCT01668615|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153564168|NCT01668615|Keratolytic Agents|keratolytic agents|mesh-ancestor
153564169|NCT01668615|Dermatologic Agents|dermatologic agents|mesh-ancestor
153564170|NCT01668680|Celecoxib|celecoxib|mesh-list
153564171|NCT01668680|Capecitabine|capecitabine|mesh-list
153456952|NCT01437540|Anticonvulsants|anticonvulsants|mesh-ancestor
153456953|NCT01420536|Salicylic Acid|salicylic acid|mesh-list
153456954|NCT01420536|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153456955|NCT01420536|Antifungal Agents|antifungal agents|mesh-ancestor
153456956|NCT01420536|Keratolytic Agents|keratolytic agents|mesh-ancestor
153456957|NCT01420536|Dermatologic Agents|dermatologic agents|mesh-ancestor
153456958|NCT01420068|Aliskiren|aliskiren|mesh-list
153456959|NCT01420068|Renin Inhibitors|renin inhibitors|mesh-ancestor
153456960|NCT01420068|Protease Inhibitors|protease inhibitors|mesh-ancestor
153456961|NCT01420068|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153456962|NCT01420068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153456963|NCT01467492|Interferons|interferons|mesh-list
153456964|NCT01467492|Ribavirin|ribavirin|mesh-list
153456965|NCT01467492|Interferon-alpha|interferon-alpha|mesh-list
153456966|NCT01467492|Interferon alpha-2|interferon alpha-2|mesh-list
153456967|NCT01467492|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
153456968|NCT01467492|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153456969|NCT01467492|Antiviral Agents|antiviral agents|mesh-ancestor
153456970|NCT01467492|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153456971|NCT01467492|Antimetabolites|antimetabolites|mesh-ancestor
153456972|NCT01467492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153456973|NCT01467492|Immunologic Factors|immunologic factors|mesh-ancestor
153456974|NCT01467492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153456975|NCT01466790|Ribavirin|ribavirin|mesh-list
153815642|NCT00348296|Antibodies|antibodies|mesh-list
153815643|NCT00348296|gamma-Globulins|gamma-globulins|mesh-list
153815644|NCT00348296|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
153815645|NCT00348296|Immunologic Factors|immunologic factors|mesh-ancestor
153815646|NCT00348296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153815647|NCT00449319|Daunorubicin|daunorubicin|mesh-list
153815648|NCT00449319|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153815649|NCT00449319|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153815650|NCT00449319|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153815651|NCT00449319|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153815652|NCT00449319|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153456976|NCT01466790|Sofosbuvir|sofosbuvir|mesh-list
153564177|NCT01668680|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
153564178|NCT01668680|Abortifacient Agents|abortifacient agents|mesh-ancestor
153564179|NCT01668680|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153564180|NCT01668680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153564181|NCT01668680|Dermatologic Agents|dermatologic agents|mesh-ancestor
153564182|NCT01668680|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153564218|NCT01668927|Potassium Citrate|potassium citrate|mesh-list
153564219|NCT01668927|Lansoprazole|lansoprazole|mesh-list
153564220|NCT01668927|Bismuth|bismuth|mesh-list
153564221|NCT01668927|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
153564222|NCT01668927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153564223|NCT01668927|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153456977|NCT01466790|Simeprevir|simeprevir|mesh-list
153456978|NCT01466790|Antimetabolites|antimetabolites|mesh-ancestor
153456980|NCT01466790|Antiviral Agents|antiviral agents|mesh-ancestor
153815653|NCT00449319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153815654|NCT00348335|Cyclosporine|cyclosporine|mesh-list
153815655|NCT00348335|Cyclosporins|cyclosporins|mesh-list
153815656|NCT00348335|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153815657|NCT00348335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153815658|NCT00348335|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153815659|NCT00348335|Immunologic Factors|immunologic factors|mesh-ancestor
153815660|NCT00348335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153815661|NCT00348335|Antifungal Agents|antifungal agents|mesh-ancestor
153815662|NCT00348335|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153815663|NCT00348335|Dermatologic Agents|dermatologic agents|mesh-ancestor
153815664|NCT00348335|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153815665|NCT00348335|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
153815666|NCT00348413|Methylprednisolone|methylprednisolone|mesh-list
153815667|NCT00348413|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
153815668|NCT00348413|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
153815669|NCT00348413|Prednisolone|prednisolone|mesh-list
153815670|NCT00348413|Prednisolone acetate|prednisolone acetate|mesh-list
153815671|NCT00348413|Methotrexate|methotrexate|mesh-list
153815672|NCT00348413|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
153815673|NCT00348413|Prednisolone phosphate|prednisolone phosphate|mesh-list
153815674|NCT00348413|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
153815675|NCT00348413|Abortifacient Agents|abortifacient agents|mesh-ancestor
153815676|NCT00348413|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153815677|NCT00348413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153815678|NCT00348413|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153815679|NCT00348413|Antimetabolites|antimetabolites|mesh-ancestor
153815680|NCT00348413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153815681|NCT00348413|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153456989|NCT01418352|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153456990|NCT01418352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153456991|NCT01418352|Dopamine Agonists|dopamine agonists|mesh-ancestor
153456992|NCT01418352|Dopamine Agents|dopamine agents|mesh-ancestor
153456993|NCT01418352|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153456994|NCT01418352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153456995|NCT01418352|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
153456996|NCT01418352|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
153456997|NCT01418352|Serotonin Agents|serotonin agents|mesh-ancestor
153456998|NCT01418352|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
153456999|NCT01418352|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153457000|NCT01418352|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
153457001|NCT01418352|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
153457003|NCT01436370|Immunologic Factors|immunologic factors|mesh-ancestor
153457004|NCT01436370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153457005|NCT01465464|Orantinib|orantinib|mesh-list
153457006|NCT01465464|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153457007|NCT01465464|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153457008|NCT01465464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153457009|NCT01417104|Aliskiren|aliskiren|mesh-list
153564241|NCT01669044|Dexmedetomidine|dexmedetomidine|mesh-list
153457010|NCT01417104|Renin Inhibitors|renin inhibitors|mesh-ancestor
153457011|NCT01417104|Protease Inhibitors|protease inhibitors|mesh-ancestor
153457012|NCT01417104|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153457013|NCT01417104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153457014|NCT01465386|Bortezomib|bortezomib|mesh-list
153457015|NCT01465386|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153457016|NCT01465230|Lenalidomide|lenalidomide|mesh-list
153457017|NCT01465230|Immunologic Factors|immunologic factors|mesh-ancestor
153457018|NCT01465230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153457019|NCT01465230|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153457020|NCT01465230|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153457021|NCT01465230|Growth Substances|growth substances|mesh-ancestor
153564242|NCT01669044|Propofol|propofol|mesh-list
153457022|NCT01465230|Growth Inhibitors|growth inhibitors|mesh-ancestor
153457023|NCT01465230|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153457024|NCT01435122|Axitinib|axitinib|mesh-list
153457025|NCT01435122|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153815682|NCT00348413|Dermatologic Agents|dermatologic agents|mesh-ancestor
153815683|NCT00348413|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153815684|NCT00348413|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153815685|NCT00348413|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153815686|NCT00348413|Immunologic Factors|immunologic factors|mesh-ancestor
153815687|NCT00348413|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153815688|NCT00348413|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153815690|NCT00348413|Antiemetics|antiemetics|mesh-ancestor
153815691|NCT00348413|Autonomic Agents|autonomic agents|mesh-ancestor
153815692|NCT00348413|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153815693|NCT00348413|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153815694|NCT00348413|Glucocorticoids|glucocorticoids|mesh-ancestor
153815695|NCT00348413|Hormones|hormones|mesh-ancestor
153815696|NCT00348413|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153815697|NCT00348413|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
153815698|NCT00348413|Protective Agents|protective agents|mesh-ancestor
153815699|NCT00348413|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153815700|NCT00348452|Celecoxib|celecoxib|mesh-list
153815701|NCT00348452|Tramadol|tramadol|mesh-list
153815702|NCT00348452|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153815703|NCT00348452|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153815704|NCT00348452|Analgesics|analgesics|mesh-ancestor
153815705|NCT00348452|Sensory System Agents|sensory system agents|mesh-ancestor
153815706|NCT00348452|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153815707|NCT00348452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153815708|NCT00348452|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153815709|NCT00348452|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153457035|NCT01393158|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153457036|NCT01393158|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153457038|NCT01393158|Sensory System Agents|sensory system agents|mesh-ancestor
153457039|NCT01393158|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153457040|NCT01393158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153457041|NCT01393158|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153457042|NCT01393158|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153815717|NCT00449397|Quetiapine Fumarate|quetiapine fumarate|mesh-list
153815718|NCT00449397|Antidepressive Agents|antidepressive agents|mesh-ancestor
153815719|NCT00449397|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153815720|NCT00449397|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153815721|NCT00449397|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153815722|NCT00449397|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153815723|NCT00449397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153815724|NCT00348491|Lumiracoxib|lumiracoxib|mesh-list
153815725|NCT00348491|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
153815726|NCT00348491|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153815727|NCT00348491|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153815728|NCT00348491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153815729|NCT00348491|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153457043|NCT01393158|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
153457044|NCT01393158|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
153457045|NCT01393158|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153457046|NCT01393158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153457047|NCT01413360|Vitamins|vitamins|mesh-list
153457048|NCT01413360|Ascorbic Acid|ascorbic acid|mesh-list
153457049|NCT01413360|Micronutrients|micronutrients|mesh-ancestor
153457050|NCT01413360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153457051|NCT01413360|Antioxidants|antioxidants|mesh-ancestor
153457052|NCT01413360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153457053|NCT01413360|Protective Agents|protective agents|mesh-ancestor
153457054|NCT01392378|Acetaminophen|acetaminophen|mesh-list
153457055|NCT01392378|Ibuprofen|ibuprofen|mesh-list
153457056|NCT01392378|Vaccines|vaccines|mesh-list
153457057|NCT01392378|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
153457058|NCT01392378|Immunologic Factors|immunologic factors|mesh-ancestor
153457059|NCT01392378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153457060|NCT01392378|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153457061|NCT01392378|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153457062|NCT01392378|Analgesics|analgesics|mesh-ancestor
153457063|NCT01392378|Sensory System Agents|sensory system agents|mesh-ancestor
153457064|NCT01392378|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153457065|NCT01392378|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153457066|NCT01392378|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153457067|NCT01392378|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153457068|NCT01392378|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153457069|NCT01392378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153457070|NCT01392378|Antipyretics|antipyretics|mesh-ancestor
153457071|NCT01412424|Octreotide|octreotide|mesh-list
153815734|NCT00348491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153815735|NCT00348491|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153815736|NCT00348491|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153815738|NCT03274323|Latanoprost|latanoprost|mesh-list
153815739|NCT03274323|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
153815740|NCT03274323|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
153815741|NCT03274323|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153815742|NCT00348530|Verapamil|verapamil|mesh-list
153815743|NCT00348530|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153815744|NCT00348530|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153815745|NCT00348530|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153815746|NCT00348530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153815747|NCT00348530|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153815748|NCT00348530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153815749|NCT00348530|Vasodilator Agents|vasodilator agents|mesh-ancestor
153815750|NCT00449436|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-list
153815751|NCT00449436|HIV Protease Inhibitors|hiv protease inhibitors|mesh-list
153815752|NCT00449436|Protease Inhibitors|protease inhibitors|mesh-list
153815753|NCT00449436|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153815754|NCT00449436|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153815755|NCT00449436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153815756|NCT00449436|Antiviral Agents|antiviral agents|mesh-ancestor
153815757|NCT00449436|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153815758|NCT00449436|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
153815772|NCT00448734|Mitosis Modulators|mitosis modulators|mesh-ancestor
153815773|NCT00448734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153815774|NCT00348725|Metformin|metformin|mesh-list
153815775|NCT00348725|Fenofibrate|fenofibrate|mesh-list
153457093|NCT01432626|3-Iodobenzylguanidine|3-iodobenzylguanidine|mesh-list
153457094|NCT01432626|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153457095|NCT01432626|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153457096|NCT01432626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153457097|NCT01432626|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
153457098|NCT01391130|Sunitinib|sunitinib|mesh-list
153457099|NCT01391130|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153457100|NCT01391130|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153457101|NCT01391130|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153457102|NCT01391130|Growth Substances|growth substances|mesh-ancestor
153457103|NCT01391130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153457104|NCT01391130|Growth Inhibitors|growth inhibitors|mesh-ancestor
153457105|NCT01391130|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153457106|NCT01391130|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153457107|NCT01391130|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153457108|NCT01410240|Hemostatics|hemostatics|mesh-list
153457109|NCT01410240|Coagulants|coagulants|mesh-ancestor
153457110|NCT01408914|Rifampin|rifampin|mesh-list
153457111|NCT01408914|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
153564345|NCT01669499|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153457112|NCT01408914|Antitubercular Agents|antitubercular agents|mesh-ancestor
153457113|NCT01408914|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153457114|NCT01408914|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153457115|NCT01408914|Leprostatic Agents|leprostatic agents|mesh-ancestor
153457116|NCT01408914|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153457117|NCT01408914|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153815777|NCT00348725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153815778|NCT00348725|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153815779|NCT00348725|Antimetabolites|antimetabolites|mesh-ancestor
153815780|NCT00348725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153815781|NCT00348725|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153815782|NCT00348764|Polidocanol|polidocanol|mesh-list
153564346|NCT01669499|Protease Inhibitors|protease inhibitors|mesh-ancestor
153564347|NCT01669499|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153564348|NCT01669499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153564349|NCT01669707|Endostar protein|endostar protein|mesh-list
153564350|NCT01669707|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153564351|NCT01669707|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153564352|NCT01669707|Growth Substances|growth substances|mesh-ancestor
153564366|NCT01669967|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153564367|NCT01669967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153564368|NCT01669967|Sensory System Agents|sensory system agents|mesh-ancestor
153564369|NCT01669967|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153564370|NCT01669967|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153564371|NCT01669967|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
153564372|NCT01669967|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153564373|NCT01669967|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153564374|NCT01669967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153564375|NCT01669967|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
153815783|NCT00348764|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
153815785|NCT03276156|Apatinib|apatinib|mesh-list
153815786|NCT03276156|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153815787|NCT03276156|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153815788|NCT03276156|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153815789|NCT03276156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153815790|NCT00456144|Hormones|hormones|mesh-list
153815791|NCT00456144|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153815792|NCT00456144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153815793|NCT00348920|Bupivacaine|bupivacaine|mesh-list
153815794|NCT00348920|Anesthetics, Local|anesthetics, local|mesh-ancestor
153815795|NCT00348920|Anesthetics|anesthetics|mesh-ancestor
153815796|NCT00348920|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153815797|NCT00348920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153815798|NCT00348920|Sensory System Agents|sensory system agents|mesh-ancestor
153815799|NCT00348920|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153815800|NCT00449514|Tamoxifen|tamoxifen|mesh-list
153815801|NCT00449514|Clomiphene|clomiphene|mesh-list
153815802|NCT00449514|Enclomiphene|enclomiphene|mesh-list
153815804|NCT00449514|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
153815805|NCT00449514|Hormone Antagonists|hormone antagonists|mesh-ancestor
153914593|NCT00933244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153457129|NCT04044222|Isophosphamide mustard|isophosphamide mustard|mesh-list
153815806|NCT00449514|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153815807|NCT00449514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153815808|NCT00449514|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153815809|NCT00449514|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153815810|NCT00449514|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
153815811|NCT00449514|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
153815812|NCT00449514|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153815813|NCT00449514|Fertility Agents, Female|fertility agents, female|mesh-ancestor
153815814|NCT00449514|Fertility Agents|fertility agents|mesh-ancestor
153815815|NCT00449514|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153815816|NCT00348998|Bevacizumab|bevacizumab|mesh-list
153815817|NCT00348998|Goserelin|goserelin|mesh-list
153457130|NCT04044222|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153457143|NCT01429584|Anesthetics|anesthetics|mesh-ancestor
153457144|NCT01429584|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153457145|NCT01429584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153457146|NCT01429584|Sensory System Agents|sensory system agents|mesh-ancestor
153457147|NCT01429584|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153457148|NCT01405950|Clonidine|clonidine|mesh-list
153457149|NCT01405950|Tizanidine|tizanidine|mesh-list
153457150|NCT01405950|Analgesics|analgesics|mesh-ancestor
153457151|NCT01405950|Sensory System Agents|sensory system agents|mesh-ancestor
153457152|NCT01405950|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153457153|NCT01405950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153815818|NCT00348998|Bicalutamide|bicalutamide|mesh-list
153815819|NCT00348998|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153815820|NCT00348998|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153471590|NCT04515615|Oxaliplatin|oxaliplatin|mesh-list
153815821|NCT00348998|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153815822|NCT00348998|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153815823|NCT00348998|Growth Substances|growth substances|mesh-ancestor
153815824|NCT00348998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153815825|NCT00348998|Growth Inhibitors|growth inhibitors|mesh-ancestor
153815826|NCT00348998|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153815827|NCT00348998|Androgen Antagonists|androgen antagonists|mesh-ancestor
153815828|NCT00348998|Hormone Antagonists|hormone antagonists|mesh-ancestor
153564378|NCT01669967|Autonomic Agents|autonomic agents|mesh-ancestor
153815829|NCT00348998|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153815831|NCT00449553|Pioglitazone|pioglitazone|mesh-list
153815833|NCT00449553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153815834|NCT00349076|Oxaliplatin|oxaliplatin|mesh-list
153815835|NCT00349076|Fluorouracil|fluorouracil|mesh-list
153815836|NCT00349076|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153815837|NCT00349076|Antimetabolites|antimetabolites|mesh-ancestor
153815838|NCT00349076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153815839|NCT00349076|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153815840|NCT00349076|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153457155|NCT01405950|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
153457169|NCT01405560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153457172|NCT01428882|Midazolam|midazolam|mesh-list
153457173|NCT01428882|Propofol|propofol|mesh-list
153457174|NCT01428882|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153815856|NCT00456339|Clavulanic Acid|clavulanic acid|mesh-list
153815857|NCT00456339|Clavulanic Acids|clavulanic acids|mesh-list
153815858|NCT00456339|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
153815859|NCT00456339|Prednisolone|prednisolone|mesh-list
153815860|NCT00456339|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153815861|NCT00456339|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153626749|NCT02018757|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153626750|NCT02018757|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153626751|NCT02018783|Listerine|listerine|mesh-list
153626752|NCT02018783|Sodium Fluoride|sodium fluoride|mesh-list
153626753|NCT02018783|Cariostatic Agents|cariostatic agents|mesh-ancestor
153626754|NCT02018783|Protective Agents|protective agents|mesh-ancestor
153626755|NCT02018783|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153626756|NCT02018783|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
153815862|NCT00456339|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153815863|NCT00456339|Glucocorticoids|glucocorticoids|mesh-ancestor
153815864|NCT00456339|Hormones|hormones|mesh-ancestor
153815865|NCT00456339|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153815866|NCT00456339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153815867|NCT00456339|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153815868|NCT00456339|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153815869|NCT00456339|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
153815870|NCT00456339|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153815871|NCT00456339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153815872|NCT00421421|Dutasteride|dutasteride|mesh-list
153815873|NCT00421421|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
153815874|NCT00421421|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153815875|NCT00421421|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153815876|NCT00421421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153815877|NCT00421421|Hormone Antagonists|hormone antagonists|mesh-ancestor
153457209|NCT03814200|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153457210|NCT03814200|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153457211|NCT03814200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153457212|NCT03814200|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
153457213|NCT03814200|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
153457214|NCT03814200|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
153815878|NCT00421421|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153815879|NCT00421421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153815880|NCT00421460|Methyltestosterone|methyltestosterone|mesh-list
153815881|NCT00421460|Testosterone|testosterone|mesh-list
153815882|NCT00421460|Testosterone undecanoate|testosterone undecanoate|mesh-list
153815883|NCT00421460|Testosterone enanthate|testosterone enanthate|mesh-list
153815884|NCT00421460|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
153815885|NCT00421460|Androgens|androgens|mesh-ancestor
153815886|NCT00421460|Hormones|hormones|mesh-ancestor
153815887|NCT00421460|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153815888|NCT00421460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153564395|NCT01670370|Antimetabolites|antimetabolites|mesh-ancestor
153815889|NCT00421460|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153815890|NCT00421460|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153815891|NCT00421460|Anabolic Agents|anabolic agents|mesh-ancestor
153815892|NCT03274167|Gabapentin|gabapentin|mesh-list
153815893|NCT03274167|Analgesics|analgesics|mesh-ancestor
153815894|NCT03274167|Sensory System Agents|sensory system agents|mesh-ancestor
153815895|NCT03274167|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153815896|NCT03274167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153815897|NCT03274167|Anticonvulsants|anticonvulsants|mesh-ancestor
153815898|NCT03274167|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153457231|NCT01403610|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153457232|NCT01403610|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153457233|NCT01403610|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153457234|NCT01403610|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153457235|NCT01403610|Growth Substances|growth substances|mesh-ancestor
153457236|NCT01403610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153457237|NCT01403610|Growth Inhibitors|growth inhibitors|mesh-ancestor
153457238|NCT01403610|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153457239|NCT01403610|Alkylating Agents|alkylating agents|mesh-ancestor
153457240|NCT01403610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153457241|NCT01402986|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
153457242|NCT01402986|Immunologic Factors|immunologic factors|mesh-ancestor
153457243|NCT01402986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153457244|NCT01389102|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
153457247|NCT01389102|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
153457248|NCT01389102|Estrogens|estrogens|mesh-ancestor
153457249|NCT01389102|Hormones|hormones|mesh-ancestor
153457250|NCT01389102|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153457251|NCT01389102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153457252|NCT01389102|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
153457253|NCT01389102|Contraceptive Agents|contraceptive agents|mesh-ancestor
153815912|NCT00349583|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153564417|NCT01670578|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153564418|NCT01670578|Immunologic Factors|immunologic factors|mesh-ancestor
153564419|NCT01670578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153564420|NCT01670578|Viscosupplements|viscosupplements|mesh-ancestor
153564421|NCT01670578|Protective Agents|protective agents|mesh-ancestor
153564422|NCT01670812|Methylprednisolone|methylprednisolone|mesh-list
153564423|NCT01670812|Rituximab|rituximab|mesh-list
153564424|NCT01670812|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153564425|NCT01670812|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153564426|NCT01670812|Immunologic Factors|immunologic factors|mesh-ancestor
153564427|NCT01670812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153815913|NCT00349583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153815914|NCT00349583|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153815915|NCT00349583|Immunologic Factors|immunologic factors|mesh-ancestor
153815916|NCT00349583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153815917|NCT00349583|Antifungal Agents|antifungal agents|mesh-ancestor
153815918|NCT00349583|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153815919|NCT00349583|Dermatologic Agents|dermatologic agents|mesh-ancestor
153815920|NCT00349583|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153815921|NCT00349583|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
153815922|NCT00349739|Anecortave|anecortave|mesh-list
153815923|NCT00349739|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153815924|NCT00349739|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153815925|NCT00349739|Growth Substances|growth substances|mesh-ancestor
153815926|NCT00349739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153815927|NCT00349739|Growth Inhibitors|growth inhibitors|mesh-ancestor
153815928|NCT00349739|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153815929|NCT00456729|Metronidazole|metronidazole|mesh-list
153815930|NCT00456729|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153815931|NCT00456729|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153457254|NCT01389102|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153815932|NCT00456729|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153815933|NCT00456729|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153815934|NCT00450099|Bupivacaine|bupivacaine|mesh-list
153815935|NCT00450099|Anesthetics, Local|anesthetics, local|mesh-ancestor
153815936|NCT00450099|Anesthetics|anesthetics|mesh-ancestor
153815937|NCT00450099|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153815938|NCT00450099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153815939|NCT00450099|Sensory System Agents|sensory system agents|mesh-ancestor
153815940|NCT00450099|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153815941|NCT00450138|Cisplatin|cisplatin|mesh-list
153815942|NCT00450138|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153815943|NCT00350051|Prednisone|prednisone|mesh-list
153564457|NCT01673308|Lenalidomide|lenalidomide|mesh-list
153815944|NCT00350051|Sagopilone|sagopilone|mesh-list
153815945|NCT00350051|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153815946|NCT00350051|Glucocorticoids|glucocorticoids|mesh-ancestor
153815947|NCT00350051|Hormones|hormones|mesh-ancestor
153815948|NCT00350051|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153815950|NCT00350051|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153815951|NCT00350051|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153815952|NCT00350090|Epoetin Alfa|epoetin alfa|mesh-list
153815953|NCT00350090|Hematinics|hematinics|mesh-ancestor
153815954|NCT04699110|Adenosine|adenosine|mesh-list
153815955|NCT04699110|Epinephrine|epinephrine|mesh-list
153815956|NCT04699110|Racepinephrine|racepinephrine|mesh-list
153815957|NCT04699110|Epinephryl borate|epinephryl borate|mesh-list
153815958|NCT04699110|Analgesics|analgesics|mesh-ancestor
153564458|NCT01673308|Immunologic Factors|immunologic factors|mesh-ancestor
153564459|NCT01673308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153815959|NCT04699110|Sensory System Agents|sensory system agents|mesh-ancestor
153815960|NCT04699110|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153457276|NCT01388790|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153457277|NCT01388478|Pramipexole|pramipexole|mesh-list
153564460|NCT01673308|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153564461|NCT01673308|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153564462|NCT01673308|Growth Substances|growth substances|mesh-ancestor
153564463|NCT01673308|Growth Inhibitors|growth inhibitors|mesh-ancestor
153564464|NCT01673308|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153564465|NCT01673737|Vemurafenib|vemurafenib|mesh-list
153564466|NCT01673737|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153564467|NCT01673737|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153782716|NCT04561687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153815967|NCT04699110|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153815968|NCT04699110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153815969|NCT04699110|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153815970|NCT04699110|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153815971|NCT04699110|Adrenergic Agents|adrenergic agents|mesh-ancestor
153815972|NCT04699110|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
153815973|NCT04699110|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153815974|NCT04699110|Autonomic Agents|autonomic agents|mesh-ancestor
153457290|NCT01400958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153457291|NCT01400958|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
153457292|NCT01400958|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
153457293|NCT01400958|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
153457330|NCT01422720|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
153457332|NCT01422720|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153457333|NCT01422720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153457334|NCT01387932|Doxorubicin|doxorubicin|mesh-list
153457335|NCT01387932|Ethiodized Oil|ethiodized oil|mesh-list
153457336|NCT01387932|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153457337|NCT01387932|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153457338|NCT01387932|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153457339|NCT01387932|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153457340|NCT01387932|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153457341|NCT01387932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153816001|NCT00350480|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
153816002|NCT00350480|Contraceptives, Oral|contraceptives, oral|mesh-list
153816003|NCT00350480|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-list
153816004|NCT00350480|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
153816005|NCT00350480|Contraceptive Agents|contraceptive agents|mesh-ancestor
153816006|NCT00350480|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153816007|NCT00350480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153816008|NCT00350480|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
153816009|NCT00350480|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
153816010|NCT00350480|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153816011|NCT00350480|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153816012|NCT00350597|Molgramostim|molgramostim|mesh-list
153816013|NCT00350597|Sargramostim|sargramostim|mesh-list
153816014|NCT00350597|Immunologic Factors|immunologic factors|mesh-ancestor
153816015|NCT00350597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153816016|NCT00350597|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153816017|NCT00350753|Bevacizumab|bevacizumab|mesh-list
153816018|NCT00350753|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
153816019|NCT00350753|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153816020|NCT00350753|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153816021|NCT00350753|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153816022|NCT00350753|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153816023|NCT00350753|Growth Substances|growth substances|mesh-ancestor
153816024|NCT00350753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153816025|NCT00350753|Growth Inhibitors|growth inhibitors|mesh-ancestor
153457342|NCT04413786|Oxytocin|oxytocin|mesh-list
153457343|NCT04413786|Oxytocics|oxytocics|mesh-ancestor
153457344|NCT04413786|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153457345|NCT04413786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153457346|NCT01422408|Fluocinonide|fluocinonide|mesh-list
153816037|NCT00457119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153816038|NCT00457119|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153816039|NCT00350948|Doxorubicin|doxorubicin|mesh-list
153816040|NCT00350948|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
153816041|NCT00350948|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153816042|NCT00350948|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153816043|NCT00350948|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153816044|NCT00350948|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153816045|NCT00350948|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153816046|NCT00350948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153782717|NCT04561687|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
153816047|NCT00450567|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
153816048|NCT00450567|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
153816049|NCT00450567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153816050|NCT00421538|Nadroparin|nadroparin|mesh-list
153816051|NCT00421538|Calcium|calcium|mesh-list
153816052|NCT00421538|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153457370|NCT01387074|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
153457371|NCT01387074|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153457372|NCT01387074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153457373|NCT01387074|Cholinergic Agents|cholinergic agents|mesh-ancestor
153457374|NCT01387074|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153457375|NCT01387074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153457385|NCT01386606|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
153457386|NCT01386606|Androgens|androgens|mesh-ancestor
153457387|NCT01386606|Hormones|hormones|mesh-ancestor
153457388|NCT01386606|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153457389|NCT01386606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153457390|NCT01386606|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153457391|NCT01386606|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153457392|NCT01386606|Anabolic Agents|anabolic agents|mesh-ancestor
153457393|NCT01386606|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
153457394|NCT01386606|Hormone Antagonists|hormone antagonists|mesh-ancestor
153457395|NCT01386606|Fertility Agents, Female|fertility agents, female|mesh-ancestor
153457397|NCT01386606|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153816053|NCT00421538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153816054|NCT00421538|Anticoagulants|anticoagulants|mesh-ancestor
153816055|NCT00421538|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153816056|NCT00421538|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153816057|NCT00421538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153816059|NCT00351026|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153816060|NCT00351026|Narcotics|narcotics|mesh-ancestor
153816061|NCT00351026|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153816062|NCT00351026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153816063|NCT00351026|Analgesics|analgesics|mesh-ancestor
153816064|NCT00351026|Sensory System Agents|sensory system agents|mesh-ancestor
153816065|NCT00351026|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153816066|NCT00351026|Antitussive Agents|antitussive agents|mesh-ancestor
153816067|NCT00351026|Respiratory System Agents|respiratory system agents|mesh-ancestor
153816068|NCT00351104|Ketoprofen|ketoprofen|mesh-list
153816069|NCT00351104|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153816070|NCT00351104|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153816071|NCT00351104|Analgesics|analgesics|mesh-ancestor
153816072|NCT00351104|Sensory System Agents|sensory system agents|mesh-ancestor
153816073|NCT00351104|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153816074|NCT00351104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153816075|NCT00351104|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153816076|NCT00351104|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153816077|NCT00351104|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153816078|NCT00351104|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153914675|NCT04188691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153457398|NCT01386606|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
153457399|NCT01386606|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
153457400|NCT01385748|Clonidine|clonidine|mesh-list
153457401|NCT01385748|Analgesics|analgesics|mesh-ancestor
153457402|NCT01385748|Sensory System Agents|sensory system agents|mesh-ancestor
153457403|NCT01385748|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153816081|NCT00351143|Xhance|xhance|mesh-list
153816082|NCT00351143|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
153816083|NCT00351143|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153816084|NCT00351143|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153816085|NCT00351143|Autonomic Agents|autonomic agents|mesh-ancestor
153816086|NCT00351143|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153816087|NCT00351143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153816088|NCT00351143|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153816089|NCT00351143|Respiratory System Agents|respiratory system agents|mesh-ancestor
153816090|NCT00351143|Dermatologic Agents|dermatologic agents|mesh-ancestor
153816091|NCT00351143|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
153816092|NCT00351143|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
153816093|NCT00351143|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
153457413|NCT01385748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153457414|NCT01397448|Rabeprazole|rabeprazole|mesh-list
153457415|NCT01397448|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
153457416|NCT01397448|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153457417|NCT01397448|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
153457418|NCT01397448|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153457419|NCT01397448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153457420|NCT01384734|Ritonavir|ritonavir|mesh-list
153626767|NCT02018965|Vitamin B Complex|vitamin b complex|mesh-list
153626768|NCT02018965|Micronutrients|micronutrients|mesh-ancestor
153626769|NCT02018965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153626770|NCT02018965|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153626771|NCT02018965|Antimetabolites|antimetabolites|mesh-ancestor
153472424|NCT04355598|Sensory System Agents|sensory system agents|mesh-ancestor
153816094|NCT00351143|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153816095|NCT00351143|Adrenergic Agents|adrenergic agents|mesh-ancestor
153816096|NCT00351143|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153816097|NCT00351143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153816098|NCT00457470|Rucaparib|rucaparib|mesh-list
153816099|NCT00457470|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
153816100|NCT00457470|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153816101|NCT00457470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153816102|NCT00457470|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153816103|NCT00457509|Vaccines|vaccines|mesh-list
153816104|NCT00457509|Immunologic Factors|immunologic factors|mesh-ancestor
153816105|NCT00457509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153816106|NCT00450645|Heparin|heparin|mesh-list
153816107|NCT00450645|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
153816108|NCT00450645|Tinzaparin|tinzaparin|mesh-list
153816109|NCT00450645|Dalteparin|dalteparin|mesh-list
153816110|NCT00450645|Anticoagulants|anticoagulants|mesh-ancestor
153816111|NCT00450645|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153816113|NCT00450645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153816114|NCT00351182|Doxycycline|doxycycline|mesh-list
153816115|NCT00351182|Telithromycin|telithromycin|mesh-list
153457435|NCT01384734|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153457436|NCT01384734|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153457437|NCT01384734|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153457438|NCT01384734|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
153457439|NCT01384734|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
153457440|NCT01384734|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
153457441|NCT01384734|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
153457443|NCT01396512|Immunologic Factors|immunologic factors|mesh-ancestor
153457444|NCT01396512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153564524|NCT01677039|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
153457445|NCT01396434|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
153457446|NCT01396434|Immunologic Factors|immunologic factors|mesh-ancestor
153457447|NCT01396434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153457449|NCT01383954|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153457450|NCT01383954|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153457451|NCT01383954|Analgesics|analgesics|mesh-ancestor
153457452|NCT01383954|Sensory System Agents|sensory system agents|mesh-ancestor
153457453|NCT01383954|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153736471|NCT02397720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153736472|NCT02397720|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153736473|NCT02397720|Antimetabolites|antimetabolites|mesh-ancestor
153736474|NCT02397720|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153736475|NCT02289209|Pembrolizumab|pembrolizumab|mesh-list
153736476|NCT02289209|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153736477|NCT02289209|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153736478|NCT02289209|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153736479|NCT02289209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153736536|NCT01701986|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153736537|NCT01701986|Alkylating Agents|alkylating agents|mesh-ancestor
153736538|NCT01701986|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153736539|NCT01701986|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153736540|NCT01696734|Domperidone|domperidone|mesh-list
153736541|NCT01696734|Antiemetics|antiemetics|mesh-ancestor
153736542|NCT01696734|Autonomic Agents|autonomic agents|mesh-ancestor
153736543|NCT01696734|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153736544|NCT01696734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153736545|NCT01696734|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153736546|NCT01696734|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
153736547|NCT01696734|Dopamine Agents|dopamine agents|mesh-ancestor
153736548|NCT01696734|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153736549|NCT01696734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153736551|NCT01665144|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
153736552|NCT01665144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153736553|NCT01665144|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153736554|NCT01665144|Immunologic Factors|immunologic factors|mesh-ancestor
153736555|NCT01665144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153736556|NCT01602666|Carboplatin|carboplatin|mesh-list
153736557|NCT01602666|Etoposide|etoposide|mesh-list
153736591|NCT01527149|Alkylating Agents|alkylating agents|mesh-ancestor
153736592|NCT01527149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153736593|NCT01527149|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153736594|NCT01527149|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153736595|NCT01527149|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153736597|NCT01527149|Autonomic Agents|autonomic agents|mesh-ancestor
153736598|NCT01527149|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153736599|NCT01527149|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153736600|NCT01527149|Glucocorticoids|glucocorticoids|mesh-ancestor
153564559|NCT01678053|Botulinum Toxins|botulinum toxins|mesh-list
153564560|NCT01678053|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
153564561|NCT01678053|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
153564562|NCT01678053|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
153564563|NCT01678053|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
153564564|NCT01678053|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153564565|NCT01678053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153564566|NCT01678053|Cholinergic Agents|cholinergic agents|mesh-ancestor
153564567|NCT01678053|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153564568|NCT01678053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153564569|NCT01678053|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
153736601|NCT01527149|Hormones|hormones|mesh-ancestor
153736656|NCT00390793|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153736657|NCT00390793|Immunologic Factors|immunologic factors|mesh-ancestor
153736658|NCT00390793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153736659|NCT00390793|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153736660|NCT00390793|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153736661|NCT00390793|Alkylating Agents|alkylating agents|mesh-ancestor
153736662|NCT00390793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153736663|NCT00390793|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153736664|NCT00390793|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153736665|NCT00390793|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153736719|NCT06182891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153736720|NCT06182800|Bevacizumab|bevacizumab|mesh-list
153736722|NCT06182800|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153736723|NCT06182800|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153736724|NCT06182800|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153736790|NCT06182098|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153736791|NCT06182098|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
153736792|NCT06182098|Histamine Antagonists|histamine antagonists|mesh-ancestor
153736793|NCT06182098|Histamine Agents|histamine agents|mesh-ancestor
153736794|NCT06182098|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153736795|NCT06182098|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
153736796|NCT06182098|Antipruritics|antipruritics|mesh-ancestor
153736797|NCT06182098|Dermatologic Agents|dermatologic agents|mesh-ancestor
153736798|NCT06182098|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153736799|NCT06182098|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153736800|NCT06182098|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153736801|NCT06182098|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
153736855|NCT06181422|Lactoferrin|lactoferrin|mesh-list
153736856|NCT06181422|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153736857|NCT06181422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153736858|NCT06181422|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153736859|NCT06181396|Oxytocin|oxytocin|mesh-list
153736860|NCT06181396|Oxytocics|oxytocics|mesh-ancestor
153736861|NCT06181396|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153736862|NCT06181396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153736863|NCT06181188|Midazolam|midazolam|mesh-list
153736864|NCT06181188|Fentanyl|fentanyl|mesh-list
153736865|NCT06181188|Ketamine|ketamine|mesh-list
153736866|NCT06181188|Analgesics|analgesics|mesh-ancestor
153736867|NCT06181188|Sensory System Agents|sensory system agents|mesh-ancestor
153736868|NCT06181188|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153564572|NCT01678053|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
153564573|NCT01678053|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153564574|NCT01678937|Cyclosporine|cyclosporine|mesh-list
153564575|NCT01678937|Sirolimus|sirolimus|mesh-list
153564576|NCT01678937|Mycophenolic Acid|mycophenolic acid|mesh-list
153880096|NCT02876107|Antimitotic Agents|antimitotic agents|mesh-ancestor
153880097|NCT02876107|Mitosis Modulators|mitosis modulators|mesh-ancestor
153564577|NCT01678937|Temsirolimus|temsirolimus|mesh-list
153564578|NCT01678937|MTOR Inhibitors|mtor inhibitors|mesh-list
153564580|NCT01678937|Cyclosporins|cyclosporins|mesh-list
153564581|NCT01678937|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153564587|NCT01678937|Antifungal Agents|antifungal agents|mesh-ancestor
153736869|NCT06181188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153736870|NCT06181188|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
153736871|NCT06181188|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153736872|NCT06181188|Anesthetics, General|anesthetics, general|mesh-ancestor
153736873|NCT06181188|Anesthetics|anesthetics|mesh-ancestor
153736874|NCT06181188|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153736875|NCT06181188|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
153736881|NCT06181188|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153736909|NCT06181019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153736910|NCT06181019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153736911|NCT06181019|Urological Agents|urological agents|mesh-ancestor
153736912|NCT06181006|Pirtobrutinib|pirtobrutinib|mesh-list
153736913|NCT06181006|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153736914|NCT06181006|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153736915|NCT06181006|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153736916|NCT06181006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153736917|NCT06180980|Pirtobrutinib|pirtobrutinib|mesh-list
153736918|NCT06180980|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153736919|NCT06180980|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153736920|NCT06180980|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153736922|NCT06180967|Midazolam|midazolam|mesh-list
153736969|NCT06180941|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153736970|NCT06180876|Propofol|propofol|mesh-list
153736971|NCT06180876|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153736972|NCT06180876|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153736973|NCT06180876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153736974|NCT06180876|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153736975|NCT06180876|Anesthetics, General|anesthetics, general|mesh-ancestor
153737038|NCT06172400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153737039|NCT06172400|Sensory System Agents|sensory system agents|mesh-ancestor
153737040|NCT06172400|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153737042|NCT06171152|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
153737043|NCT06171152|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153737044|NCT06171152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153737045|NCT06171152|Incretins|incretins|mesh-ancestor
153737046|NCT06171152|Hormones|hormones|mesh-ancestor
153737047|NCT06171152|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153737048|NCT06163820|Bevacizumab|bevacizumab|mesh-list
153737101|NCT06061146|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153737102|NCT06061146|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153737104|NCT06059456|Immunologic Factors|immunologic factors|mesh-ancestor
153737105|NCT06059456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153737106|NCT06010719|Amoxicillin|amoxicillin|mesh-list
153737107|NCT06010719|Azithromycin|azithromycin|mesh-list
153737108|NCT06010719|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153564602|NCT01679041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153737109|NCT06010719|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153564603|NCT01679041|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153737110|NCT05979311|Tenofovir|tenofovir|mesh-list
153737111|NCT05979311|Lamivudine|lamivudine|mesh-list
153737112|NCT05979311|Emtricitabine|emtricitabine|mesh-list
153737113|NCT05979311|Dolutegravir|dolutegravir|mesh-list
153737165|NCT05839314|Antifungal Agents|antifungal agents|mesh-ancestor
153737166|NCT05839314|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153564604|NCT01679041|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153564605|NCT01679041|Alkylating Agents|alkylating agents|mesh-ancestor
153564606|NCT01679041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153564607|NCT01679041|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153564610|NCT01679093|Dexamethasone|dexamethasone|mesh-list
153737167|NCT05839314|Dermatologic Agents|dermatologic agents|mesh-ancestor
153737168|NCT05839314|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153737169|NCT05839314|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
153737170|NCT05822765|Epinephrine|epinephrine|mesh-list
153737171|NCT05822765|Racepinephrine|racepinephrine|mesh-list
153737172|NCT05822765|Epinephryl borate|epinephryl borate|mesh-list
153737237|NCT05717153|Ornithine Decarboxylase Inhibitors|ornithine decarboxylase inhibitors|mesh-ancestor
153737238|NCT05717153|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153737239|NCT05717153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153737241|NCT05701917|Calcium heparin|calcium heparin|mesh-list
153737242|NCT05701917|Rivaroxaban|rivaroxaban|mesh-list
153737243|NCT05701917|Apixaban|apixaban|mesh-list
153737244|NCT05701917|Warfarin|warfarin|mesh-list
153737245|NCT05701917|Anticoagulants|anticoagulants|mesh-ancestor
153737246|NCT05701917|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153737247|NCT05701917|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153737248|NCT05701917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153737249|NCT05701917|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
153737250|NCT05701917|Antithrombins|antithrombins|mesh-ancestor
153737251|NCT05701917|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
153574279|NCT01699204|Antioxidants|antioxidants|mesh-ancestor
153737257|NCT05671653|Semaglutide|semaglutide|mesh-list
153737297|NCT05514509|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
153737298|NCT05514509|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153737299|NCT05514509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153737300|NCT05514509|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153737301|NCT05514509|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153737302|NCT05514509|Antiviral Agents|antiviral agents|mesh-ancestor
153737303|NCT05514509|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153737304|NCT05511337|Citric Acid|citric acid|mesh-list
153737305|NCT05511337|Sodium Citrate|sodium citrate|mesh-list
153737306|NCT05511337|Anticoagulants|anticoagulants|mesh-ancestor
153737307|NCT05511337|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
153737308|NCT05511337|Chelating Agents|chelating agents|mesh-ancestor
153737309|NCT05511337|Sequestering Agents|sequestering agents|mesh-ancestor
153737310|NCT05511337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153737311|NCT05511025|Acetaminophen|acetaminophen|mesh-list
153737312|NCT05511025|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153737313|NCT05511025|Analgesics|analgesics|mesh-ancestor
153737314|NCT05511025|Sensory System Agents|sensory system agents|mesh-ancestor
153737315|NCT05511025|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153737316|NCT05511025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153737317|NCT05511025|Antipyretics|antipyretics|mesh-ancestor
153737318|NCT05498610|Semaglutide|semaglutide|mesh-list
153737319|NCT05498610|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
153564623|NCT01679093|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153564624|NCT01679093|Antipruritics|antipruritics|mesh-ancestor
153564625|NCT01679093|Dermatologic Agents|dermatologic agents|mesh-ancestor
153564626|NCT01679093|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
153564627|NCT01679093|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153564628|NCT01679093|Serotonin Agents|serotonin agents|mesh-ancestor
153564629|NCT01679093|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153564630|NCT01679093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153737350|NCT05374525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153737351|NCT05374525|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153564682|NCT05596669|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153564683|NCT05596669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153737352|NCT05374525|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153737353|NCT05374525|Antiviral Agents|antiviral agents|mesh-ancestor
153737354|NCT05374525|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153737355|NCT05339529|Glycine|glycine|mesh-list
153737356|NCT05339529|Thymalfasin|thymalfasin|mesh-list
153737357|NCT05339529|Glycine Agents|glycine agents|mesh-ancestor
153737358|NCT05339529|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153737359|NCT05339529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153737415|NCT05318443|Antimitotic Agents|antimitotic agents|mesh-ancestor
153737416|NCT05318443|Mitosis Modulators|mitosis modulators|mesh-ancestor
153737417|NCT05318443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153737418|NCT05318443|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153737419|NCT05318443|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153737420|NCT05318443|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153737422|NCT05318443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153737423|NCT05318443|Growth Inhibitors|growth inhibitors|mesh-ancestor
153737424|NCT05316662|Semaglutide|semaglutide|mesh-list
153737425|NCT05316662|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
153737426|NCT05316662|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153737427|NCT05316662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153737428|NCT05302388|Diphenhydramine|diphenhydramine|mesh-list
153737429|NCT05302388|Promethazine|promethazine|mesh-list
153737431|NCT05302388|Prednisolone|prednisolone|mesh-list
153737432|NCT05302388|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
153737433|NCT05302388|Methylprednisolone|methylprednisolone|mesh-list
153737434|NCT05302388|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
153737435|NCT05302388|Prednisolone acetate|prednisolone acetate|mesh-list
153737468|NCT05266846|Bevacizumab|bevacizumab|mesh-list
153737469|NCT05266846|Pembrolizumab|pembrolizumab|mesh-list
153737470|NCT05266846|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153737471|NCT05266846|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153737472|NCT05266846|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153737473|NCT05266846|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153737474|NCT05266846|Growth Substances|growth substances|mesh-ancestor
153737475|NCT05266846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153737476|NCT05266846|Growth Inhibitors|growth inhibitors|mesh-ancestor
153737477|NCT05266846|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153737478|NCT05266846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153737480|NCT05259696|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153737481|NCT05259696|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153737482|NCT05236647|Morphine|morphine|mesh-list
153737483|NCT05236647|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153737484|NCT05236647|Narcotics|narcotics|mesh-ancestor
153737485|NCT05236647|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153737486|NCT05236647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153737487|NCT05236647|Analgesics|analgesics|mesh-ancestor
153737488|NCT05236647|Sensory System Agents|sensory system agents|mesh-ancestor
153737489|NCT05236647|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153737490|NCT05230615|Semaglutide|semaglutide|mesh-list
153737491|NCT05230615|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
153737518|NCT05172050|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
153737519|NCT05172050|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
153737520|NCT05172050|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153737521|NCT05134441|Calcium, Dietary|calcium, dietary|mesh-list
153737522|NCT05134441|Calcium|calcium|mesh-list
153737523|NCT05134441|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153737524|NCT05134441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153737526|NCT05131828|Metformin|metformin|mesh-list
153737586|NCT05041907|Immunoglobulins|immunoglobulins|mesh-list
153737587|NCT05041907|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
153737588|NCT05041907|Immunologic Factors|immunologic factors|mesh-ancestor
153737589|NCT05041907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153737590|NCT05041907|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153737591|NCT05041907|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
153737592|NCT05041907|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
153737593|NCT05041907|Protease Inhibitors|protease inhibitors|mesh-ancestor
153737594|NCT05041907|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153737595|NCT05041907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153737596|NCT05041907|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153737597|NCT05041907|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153564717|NCT05596552|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153564718|NCT05596552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153564719|NCT05596552|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153564720|NCT05596552|Narcotics|narcotics|mesh-ancestor
153564721|NCT05596552|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153564722|NCT05596552|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153737598|NCT05041907|Antiviral Agents|antiviral agents|mesh-ancestor
153737599|NCT05041907|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153737600|NCT05041907|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
153737601|NCT05041907|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153737602|NCT05041907|Antimalarials|antimalarials|mesh-ancestor
153737603|NCT05041907|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153737604|NCT05041907|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153737605|NCT05041907|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153737606|NCT05041907|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
153737607|NCT05041907|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153737608|NCT05041907|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153737609|NCT05041907|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153737610|NCT05041907|Serotonin Agents|serotonin agents|mesh-ancestor
153737632|NCT04924062|Cisplatin|cisplatin|mesh-list
153737633|NCT04924062|Gemcitabine|gemcitabine|mesh-list
153737634|NCT04924062|Pembrolizumab|pembrolizumab|mesh-list
153737635|NCT04924062|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153737636|NCT04924062|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153737637|NCT04924062|Antimetabolites|antimetabolites|mesh-ancestor
153737638|NCT04924062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153737639|NCT04924062|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153737640|NCT04924062|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153737641|NCT04912856|Ezogabine|ezogabine|mesh-list
153737642|NCT04912856|Anticonvulsants|anticonvulsants|mesh-ancestor
153737643|NCT04912856|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153737644|NCT04912856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153737646|NCT04898023|Antioxidants|antioxidants|mesh-ancestor
153737647|NCT04898023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153737648|NCT04898023|Protective Agents|protective agents|mesh-ancestor
153737649|NCT04898023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153737650|NCT04898023|Vitamins|vitamins|mesh-ancestor
153737651|NCT04898023|Micronutrients|micronutrients|mesh-ancestor
153737652|NCT04886323|Itraconazole|itraconazole|mesh-list
153737653|NCT04886323|Antifungal Agents|antifungal agents|mesh-ancestor
153564792|NCT05557253|Anesthetics|anesthetics|mesh-list
153564793|NCT05557253|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153564794|NCT05557253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153564795|NCT05539924|Vitamin B 12|vitamin b 12|mesh-list
153564796|NCT05539924|Pregabalin|pregabalin|mesh-list
153564797|NCT05539924|Gabapentin|gabapentin|mesh-list
153564807|NCT05539924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153564808|NCT05539924|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153782754|NCT02211625|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153564809|NCT05539924|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153564810|NCT05539924|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153782755|NCT00234923|Ritonavir|ritonavir|mesh-list
153564811|NCT05539924|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153564812|NCT05539924|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153564813|NCT05539924|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
153564814|NCT05539924|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
153564816|NCT05539924|Antimanic Agents|antimanic agents|mesh-ancestor
153737654|NCT04886323|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153737682|NCT04857164|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153737683|NCT04857164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153737684|NCT04826484|Bupivacaine|bupivacaine|mesh-list
153737685|NCT04826484|Anesthetics, Local|anesthetics, local|mesh-ancestor
153737687|NCT04826484|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153737688|NCT04826484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153737689|NCT04826484|Sensory System Agents|sensory system agents|mesh-ancestor
153737690|NCT04826484|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153737691|NCT04818216|Niacinamide|niacinamide|mesh-list
153737692|NCT04818216|Niacin|niacin|mesh-list
153737693|NCT04818216|Nicotinic Acids|nicotinic acids|mesh-list
153737745|NCT04635423|Vaccines|vaccines|mesh-list
153737746|NCT04635423|Immunologic Factors|immunologic factors|mesh-ancestor
153737747|NCT04635423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153737748|NCT04584008|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
153737749|NCT04584008|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153737750|NCT04584008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153737751|NCT04584008|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153737752|NCT04565483|Benralizumab|benralizumab|mesh-list
153737753|NCT04565483|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153737754|NCT04565483|Respiratory System Agents|respiratory system agents|mesh-ancestor
153737755|NCT04555044|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
153737756|NCT04555044|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
153737757|NCT04555044|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
153737758|NCT04555044|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
153737759|NCT04542278|Prednisone|prednisone|mesh-list
153737760|NCT04542278|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153737761|NCT04542278|Glucocorticoids|glucocorticoids|mesh-ancestor
153737762|NCT04542278|Hormones|hormones|mesh-ancestor
153737802|NCT04486352|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
153564822|NCT05514782|Dermatologic Agents|dermatologic agents|mesh-ancestor
153564823|NCT05479370|Vaccines|vaccines|mesh-list
153564824|NCT05479370|Immunologic Factors|immunologic factors|mesh-ancestor
153564825|NCT05479370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153564826|NCT05433402|Chlorpromazine|chlorpromazine|mesh-list
153564827|NCT05433402|Antiemetics|antiemetics|mesh-ancestor
153564828|NCT05433402|Autonomic Agents|autonomic agents|mesh-ancestor
153564829|NCT05433402|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153564830|NCT05433402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153564831|NCT05433402|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153564832|NCT05433402|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153564855|NCT05057949|Rifampin|rifampin|mesh-list
153737803|NCT04486352|Letrozole|letrozole|mesh-list
153737804|NCT04486352|Maytansine|maytansine|mesh-list
153737805|NCT04486352|Talazoparib|talazoparib|mesh-list
153737806|NCT04486352|Ipatasertib|ipatasertib|mesh-list
153737807|NCT04486352|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
153737808|NCT04486352|Inavolisib|inavolisib|mesh-list
153564868|NCT05057949|Antitubercular Agents|antitubercular agents|mesh-ancestor
153737809|NCT04486352|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153737810|NCT04486352|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153737811|NCT04486352|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153737812|NCT04486352|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153737813|NCT04486352|Growth Substances|growth substances|mesh-ancestor
153737814|NCT04486352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153737815|NCT04486352|Growth Inhibitors|growth inhibitors|mesh-ancestor
153737816|NCT04486352|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153737817|NCT04486352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153737818|NCT04486352|Immunologic Factors|immunologic factors|mesh-ancestor
153737819|NCT04486352|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
153737820|NCT04486352|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153737821|NCT04486352|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153737822|NCT04486352|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
153737823|NCT04486352|Hormone Antagonists|hormone antagonists|mesh-ancestor
153737824|NCT04486352|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153737825|NCT04486352|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153737826|NCT04486352|Tubulin Modulators|tubulin modulators|mesh-ancestor
153564869|NCT05057949|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153564870|NCT05057949|Leprostatic Agents|leprostatic agents|mesh-ancestor
153564871|NCT05057949|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153564872|NCT05057949|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
153564873|NCT05057949|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
153782756|NCT00234923|Lopinavir|lopinavir|mesh-list
153782757|NCT00234923|Lamivudine|lamivudine|mesh-list
153782758|NCT00234923|Zidovudine|zidovudine|mesh-list
153782759|NCT00234923|Lamivudine, zidovudine drug combination|lamivudine, zidovudine drug combination|mesh-list
153782760|NCT00234923|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
153782761|NCT00234923|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
153782762|NCT00234923|Protease Inhibitors|protease inhibitors|mesh-ancestor
153782763|NCT00234923|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153782768|NCT00234923|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153782769|NCT00234923|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
153737827|NCT04486352|Antimitotic Agents|antimitotic agents|mesh-ancestor
153737829|NCT04486352|Immunotoxins|immunotoxins|mesh-ancestor
153737901|NCT04375605|Docetaxel|docetaxel|mesh-list
153737902|NCT04375605|Fluorouracil|fluorouracil|mesh-list
153737903|NCT04375605|Oxaliplatin|oxaliplatin|mesh-list
153737904|NCT04375605|Calcium|calcium|mesh-list
153737905|NCT04375605|Levoleucovorin|levoleucovorin|mesh-list
153737906|NCT04375605|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153737907|NCT04375605|Tubulin Modulators|tubulin modulators|mesh-ancestor
153737908|NCT04375605|Antimitotic Agents|antimitotic agents|mesh-ancestor
153737909|NCT04375605|Mitosis Modulators|mitosis modulators|mesh-ancestor
153737910|NCT04375605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153737969|NCT04271735|Vitamin B Complex|vitamin b complex|mesh-ancestor
153737970|NCT04271735|Vitamins|vitamins|mesh-ancestor
153737971|NCT04271735|Micronutrients|micronutrients|mesh-ancestor
153737972|NCT04271735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153737973|NCT04271735|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153737974|NCT04271735|Antimetabolites|antimetabolites|mesh-ancestor
153737975|NCT04271735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153737976|NCT04271735|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153737977|NCT04271735|Vasodilator Agents|vasodilator agents|mesh-ancestor
153737978|NCT04271384|Nivolumab|nivolumab|mesh-list
153737980|NCT04271384|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153738035|NCT04094012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153738036|NCT04094012|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153738037|NCT04094012|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
153738038|NCT04094012|Leprostatic Agents|leprostatic agents|mesh-ancestor
153738039|NCT04082364|Trastuzumab|trastuzumab|mesh-list
153738040|NCT04082364|Margetuximab|margetuximab|mesh-list
153738041|NCT04082364|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153738042|NCT04082364|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153738043|NCT04072497|Vaccines|vaccines|mesh-list
153738044|NCT04072497|Immunologic Factors|immunologic factors|mesh-ancestor
153738045|NCT04072497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153738097|NCT03918252|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153738098|NCT03918252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153738099|NCT03912831|Cyclophosphamide|cyclophosphamide|mesh-list
153738100|NCT03912831|Fludarabine|fludarabine|mesh-list
153738101|NCT03912831|Interleukin-2|interleukin-2|mesh-list
153564884|NCT04901312|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153564885|NCT04886297|Resveratrol|resveratrol|mesh-list
153564886|NCT04886297|Antioxidants|antioxidants|mesh-ancestor
153564887|NCT04886297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153564888|NCT04886297|Protective Agents|protective agents|mesh-ancestor
153564889|NCT04886297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153564890|NCT04886297|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153564891|NCT04886297|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153564892|NCT04810793|Amoxicillin|amoxicillin|mesh-list
153564893|NCT04810793|Levofloxacin|levofloxacin|mesh-list
153564894|NCT04810793|Ofloxacin|ofloxacin|mesh-list
153564895|NCT04810793|Tetracycline|tetracycline|mesh-list
153738102|NCT03912831|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153738103|NCT03912831|Immunologic Factors|immunologic factors|mesh-ancestor
153738104|NCT03912831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153738105|NCT03912831|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153738106|NCT03912831|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153738161|NCT03646994|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153738162|NCT03646994|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153738164|NCT03646994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153738165|NCT03646994|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153738167|NCT03646968|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153738168|NCT03646968|Tubulin Modulators|tubulin modulators|mesh-ancestor
153738169|NCT03646968|Antimitotic Agents|antimitotic agents|mesh-ancestor
153738170|NCT03646968|Mitosis Modulators|mitosis modulators|mesh-ancestor
153738171|NCT03646968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153738172|NCT03637660|Penicillins|penicillins|mesh-list
153738173|NCT03637660|Penicillin G Benzathine|penicillin g benzathine|mesh-list
153564915|NCT04810793|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153738174|NCT03637660|Penicillin G|penicillin g|mesh-list
153738225|NCT03300557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153738226|NCT03300557|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
153738227|NCT03300557|Hormone Antagonists|hormone antagonists|mesh-ancestor
153738228|NCT03300557|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153738229|NCT03300557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153738230|NCT03256981|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-list
153738231|NCT03256981|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153738232|NCT03256981|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153738233|NCT03256981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153738234|NCT03203850|Deferasirox|deferasirox|mesh-list
153738235|NCT03203850|Iron Chelating Agents|iron chelating agents|mesh-ancestor
153738239|NCT03123783|Nivolumab|nivolumab|mesh-list
153738284|NCT02913274|Antimitotic Agents|antimitotic agents|mesh-ancestor
153738285|NCT02913274|Mitosis Modulators|mitosis modulators|mesh-ancestor
153738286|NCT02913274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153738287|NCT02847624|Tolvaptan|tolvaptan|mesh-list
153738288|NCT02847624|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
153738356|NCT02399215|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153738357|NCT02399215|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153738358|NCT02399215|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153564916|NCT04810793|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
153564917|NCT04797832|Ferric gluconate|ferric gluconate|mesh-list
153564919|NCT04684511|Rofecoxib|rofecoxib|mesh-list
153564920|NCT04684511|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
153564921|NCT04684511|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153564922|NCT04684511|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153564923|NCT04684511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153564924|NCT04684511|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153564925|NCT04684511|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153738359|NCT02399215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153738360|NCT02365649|Upadacitinib|upadacitinib|mesh-list
153738361|NCT02365649|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
153738362|NCT02365649|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153738363|NCT02365649|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153738423|NCT01955460|Interleukin-2|interleukin-2|mesh-list
153738424|NCT01955460|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153738425|NCT01955460|Immunologic Factors|immunologic factors|mesh-ancestor
153738426|NCT01955460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153738427|NCT01955460|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153738428|NCT01955460|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153738429|NCT01955460|Alkylating Agents|alkylating agents|mesh-ancestor
153738430|NCT01955460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153738432|NCT01955460|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153738433|NCT01955460|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153738434|NCT01955460|Antimetabolites|antimetabolites|mesh-ancestor
153738435|NCT01955460|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153738436|NCT01955460|Analgesics|analgesics|mesh-ancestor
153738437|NCT01955460|Sensory System Agents|sensory system agents|mesh-ancestor
153738438|NCT01955460|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153738439|NCT01955460|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153738440|NCT01955460|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153738441|NCT01955460|Antiviral Agents|antiviral agents|mesh-ancestor
153738442|NCT01955460|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153738443|NCT01902173|Trametinib|trametinib|mesh-list
153738444|NCT01902173|Dabrafenib|dabrafenib|mesh-list
153738445|NCT01902173|Dimethyl Sulfoxide|dimethyl sulfoxide|mesh-list
153738446|NCT01902173|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153738447|NCT01902173|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153738448|NCT01902173|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153738449|NCT01902173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153738450|NCT01902173|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
153738451|NCT01902173|Protective Agents|protective agents|mesh-ancestor
153738452|NCT01902173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153738453|NCT01902173|Free Radical Scavengers|free radical scavengers|mesh-ancestor
153738454|NCT01902173|Antioxidants|antioxidants|mesh-ancestor
153738455|NCT01805297|Aflibercept|aflibercept|mesh-list
153738456|NCT01805297|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153738457|NCT01805297|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153738458|NCT01805297|Growth Substances|growth substances|mesh-ancestor
153738459|NCT01805297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153738460|NCT01805297|Growth Inhibitors|growth inhibitors|mesh-ancestor
153738461|NCT01805297|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153738462|NCT01756456|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
153738464|NCT01756456|Mitosis Modulators|mitosis modulators|mesh-ancestor
153738465|NCT01756456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153738466|NCT01744704|Mitogens|mitogens|mesh-list
153738467|NCT01744704|Mitosis Modulators|mitosis modulators|mesh-ancestor
153738529|NCT01336803|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
153738530|NCT01336803|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
153738531|NCT01206465|Fluorouracil|fluorouracil|mesh-list
153738532|NCT01206465|Antimetabolites|antimetabolites|mesh-ancestor
153738533|NCT01206465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153738534|NCT01206465|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153738535|NCT01206465|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153738536|NCT01206465|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153564947|NCT04231838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153575562|NCT01707251|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153738537|NCT01206465|Immunologic Factors|immunologic factors|mesh-ancestor
153738538|NCT01206465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153738539|NCT00979693|Psilocybin|psilocybin|mesh-list
153738540|NCT00979693|Hallucinogens|hallucinogens|mesh-ancestor
153738541|NCT00979693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153738542|NCT00979693|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153738543|NCT00801489|Cytarabine|cytarabine|mesh-list
153738589|NCT00642434|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153738590|NCT00642434|Vasodilator Agents|vasodilator agents|mesh-ancestor
153738591|NCT00642434|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
153738592|NCT00642434|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
153738593|NCT00508963|Antimony Sodium Gluconate|antimony sodium gluconate|mesh-list
153738594|NCT00508963|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153738595|NCT00508963|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153738596|NCT00508963|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153738597|NCT00508963|Schistosomicides|schistosomicides|mesh-ancestor
153738598|NCT00508963|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
153738599|NCT00508963|Anthelmintics|anthelmintics|mesh-ancestor
153738600|NCT00318981|Methylphenidate|methylphenidate|mesh-list
153738601|NCT00318981|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
153738602|NCT00318981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153738603|NCT00318981|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
153738607|NCT00318981|Dopamine Agents|dopamine agents|mesh-ancestor
153738649|NCT00004192|Glucocorticoids|glucocorticoids|mesh-ancestor
153738651|NCT00004192|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153738652|NCT00004192|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
153738653|NCT00004192|Protective Agents|protective agents|mesh-ancestor
153738654|NCT00004192|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153738655|NCT00004112|Prednisone|prednisone|mesh-list
153738656|NCT00004112|Prednisolone|prednisolone|mesh-list
153738657|NCT00004112|Cyclophosphamide|cyclophosphamide|mesh-list
153738658|NCT00004112|Rituximab|rituximab|mesh-list
153738659|NCT00004112|Doxorubicin|doxorubicin|mesh-list
153738660|NCT00004112|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
153738661|NCT00004112|Vincristine|vincristine|mesh-list
153738662|NCT00004112|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153738663|NCT00004112|Immunologic Factors|immunologic factors|mesh-ancestor
153738664|NCT00004112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153738665|NCT00004112|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153564964|NCT04068246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153564965|NCT04063033|Ferric gluconate|ferric gluconate|mesh-list
153564966|NCT04063033|Hematinics|hematinics|mesh-ancestor
153564967|NCT04002258|Antipsychotic Agents|antipsychotic agents|mesh-list
153564968|NCT04002258|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153564969|NCT04002258|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153738666|NCT00004112|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153738667|NCT00004112|Alkylating Agents|alkylating agents|mesh-ancestor
153738668|NCT00004112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153738669|NCT00004112|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153738670|NCT00004112|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153738671|NCT00004112|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153738672|NCT00004112|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153738673|NCT00004112|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153738674|NCT00004112|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153738675|NCT00004112|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153738676|NCT00004112|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153738694|NCT00469885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153738696|NCT00469924|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
153738697|NCT00469924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153738698|NCT00469924|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
153738699|NCT00469924|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153738700|NCT00469924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153738701|NCT00469924|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
153738702|NCT00469924|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
153738703|NCT00469924|Purinergic Agents|purinergic agents|mesh-ancestor
153738704|NCT00469924|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153738705|NCT00157677|Fibrin fragment D|fibrin fragment d|mesh-list
153738706|NCT00157677|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
153738707|NCT00157677|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153738708|NCT00157677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153738709|NCT00157677|Hemostatics|hemostatics|mesh-ancestor
153738710|NCT00157677|Coagulants|coagulants|mesh-ancestor
153738711|NCT00470041|Lamivudine|lamivudine|mesh-list
153738712|NCT00470041|Zidovudine|zidovudine|mesh-list
153738713|NCT00470041|Antiviral Agents|antiviral agents|mesh-list
153738714|NCT00470041|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153738715|NCT00470041|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153738716|NCT00470041|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153738717|NCT00470041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153738718|NCT00470041|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153738719|NCT00470041|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153738720|NCT00470041|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153738721|NCT00470041|Antimetabolites|antimetabolites|mesh-ancestor
153738722|NCT00157716|Pyridoxal|pyridoxal|mesh-list
153738723|NCT00157716|Pyridoxal Phosphate|pyridoxal phosphate|mesh-list
153738724|NCT00157716|Vitamin B Complex|vitamin b complex|mesh-ancestor
153738728|NCT00470197|Cytarabine|cytarabine|mesh-list
153738729|NCT00470197|Mitoxantrone|mitoxantrone|mesh-list
153738730|NCT00470197|Alvocidib|alvocidib|mesh-list
153564996|NCT03749174|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153564997|NCT03749174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153564998|NCT03722927|Bupivacaine|bupivacaine|mesh-list
153564999|NCT03722927|Anesthetics, Local|anesthetics, local|mesh-ancestor
153565000|NCT03722927|Anesthetics|anesthetics|mesh-ancestor
153565001|NCT03722927|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153565002|NCT03722927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153565003|NCT03722927|Sensory System Agents|sensory system agents|mesh-ancestor
153565004|NCT03722927|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153565005|NCT03578198|Rituximab|rituximab|mesh-list
153565006|NCT03578198|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153782782|NCT00234962|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
153782783|NCT00234962|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
153565007|NCT03578198|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153474720|NCT00717288|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153738731|NCT00470197|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153738732|NCT00470197|Antimetabolites|antimetabolites|mesh-ancestor
153738733|NCT00470197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153738734|NCT00470197|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153738735|NCT00470197|Antiviral Agents|antiviral agents|mesh-ancestor
153738736|NCT00470197|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153738737|NCT00470197|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153738738|NCT00470197|Immunologic Factors|immunologic factors|mesh-ancestor
153738739|NCT00470197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153738741|NCT00470197|Sensory System Agents|sensory system agents|mesh-ancestor
153738742|NCT00470197|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153738743|NCT00470197|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153738749|NCT00470314|N-Methylaspartate|n-methylaspartate|mesh-list
153738791|NCT00470665|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153738792|NCT00470665|Immunologic Factors|immunologic factors|mesh-ancestor
153738793|NCT00470665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153738794|NCT00470743|Ibuprofen|ibuprofen|mesh-list
153738795|NCT00470743|Indomethacin|indomethacin|mesh-list
153738796|NCT00470743|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153738797|NCT00470743|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153738798|NCT00470743|Analgesics|analgesics|mesh-ancestor
153738799|NCT00470743|Sensory System Agents|sensory system agents|mesh-ancestor
153738800|NCT00470743|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153738801|NCT00470743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153738802|NCT00470743|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153738803|NCT00470743|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153738804|NCT00470743|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153738805|NCT00470743|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153738806|NCT00470743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153738807|NCT00470743|Gout Suppressants|gout suppressants|mesh-ancestor
153738808|NCT00470743|Tocolytic Agents|tocolytic agents|mesh-ancestor
153738809|NCT00470743|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153738810|NCT00470821|Melatonin|melatonin|mesh-list
153738811|NCT00470821|Antioxidants|antioxidants|mesh-ancestor
153738813|NCT00470821|Protective Agents|protective agents|mesh-ancestor
153738844|NCT05350592|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
153738845|NCT05350592|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153738846|NCT05350592|Adrenergic Agents|adrenergic agents|mesh-ancestor
153738847|NCT05350592|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153782784|NCT00234962|Protease Inhibitors|protease inhibitors|mesh-ancestor
153782785|NCT00234962|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153420962|NCT03185546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153420963|NCT02186652|Pantoprazole|pantoprazole|mesh-list
153420964|NCT02186652|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
153420965|NCT02186652|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153782786|NCT00234962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153782788|NCT00234962|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153782789|NCT00234962|Antiviral Agents|antiviral agents|mesh-ancestor
153782790|NCT00234962|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153782796|NCT04551703|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153565011|NCT03554200|Empagliflozin|empagliflozin|mesh-list
153738848|NCT05350592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153738849|NCT05350592|Protective Agents|protective agents|mesh-ancestor
153738850|NCT00471055|Capsaicin|capsaicin|mesh-list
153738851|NCT00471055|Antipruritics|antipruritics|mesh-ancestor
153738852|NCT00471055|Dermatologic Agents|dermatologic agents|mesh-ancestor
153738853|NCT00471055|Sensory System Agents|sensory system agents|mesh-ancestor
153738854|NCT00471055|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153738855|NCT00471055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153738856|NCT00471094|Lansoprazole|lansoprazole|mesh-list
153738857|NCT00471094|Dexlansoprazole|dexlansoprazole|mesh-list
153738858|NCT00471094|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
153738859|NCT00471094|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153738860|NCT00471094|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
153738861|NCT00471094|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153738862|NCT00471094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153738863|NCT00157872|Naproxen|naproxen|mesh-list
153738864|NCT00157872|Rofecoxib|rofecoxib|mesh-list
153738865|NCT00157872|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153738866|NCT00157872|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153738867|NCT00157872|Analgesics|analgesics|mesh-ancestor
153738868|NCT00157872|Sensory System Agents|sensory system agents|mesh-ancestor
153738869|NCT00157872|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153565019|NCT03517176|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153565020|NCT03517176|Tubulin Modulators|tubulin modulators|mesh-ancestor
153565021|NCT03517176|Antimitotic Agents|antimitotic agents|mesh-ancestor
153565022|NCT03517176|Mitosis Modulators|mitosis modulators|mesh-ancestor
153565023|NCT03517176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153565024|NCT03517176|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153565025|NCT03517176|Antimetabolites|antimetabolites|mesh-ancestor
153565026|NCT03512964|Tenofovir|tenofovir|mesh-list
153565027|NCT03512964|Emtricitabine|emtricitabine|mesh-list
153565028|NCT03512964|Dolutegravir|dolutegravir|mesh-list
153565029|NCT03512964|Emtricitabine tenofovir alafenamide|emtricitabine tenofovir alafenamide|mesh-list
153565030|NCT03512964|Antiviral Agents|antiviral agents|mesh-ancestor
153565031|NCT03512964|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153565032|NCT03512964|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153565033|NCT03512964|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153565034|NCT03512964|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153565035|NCT03512964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153565036|NCT03512964|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153565037|NCT03512964|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153565040|NCT03476109|Omalizumab|omalizumab|mesh-list
153738870|NCT00157872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153738871|NCT00157872|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153738872|NCT00157872|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153738873|NCT00157872|Gout Suppressants|gout suppressants|mesh-ancestor
153738874|NCT00157872|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153738875|NCT00157872|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153738876|NCT00157872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153738877|NCT00157872|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
153738879|NCT03271255|Apatinib|apatinib|mesh-list
153738883|NCT03271255|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153738884|NCT03271255|Growth Substances|growth substances|mesh-ancestor
153738885|NCT03271255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153738886|NCT03271255|Growth Inhibitors|growth inhibitors|mesh-ancestor
153738887|NCT03271255|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153738888|NCT03271255|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153738889|NCT03271255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153738890|NCT00471289|Paclitaxel|paclitaxel|mesh-list
153738891|NCT00471289|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153738892|NCT00471289|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153565056|NCT03366974|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153565057|NCT03366974|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153782798|NCT04551703|Adrenergic Agents|adrenergic agents|mesh-ancestor
153782799|NCT04551703|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153782800|NCT04551703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153782801|NCT04551703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153782802|NCT04551703|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
153782803|NCT04551703|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153782804|NCT04551703|Autonomic Agents|autonomic agents|mesh-ancestor
153782805|NCT04551703|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153782806|NCT04551703|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153782807|NCT04551703|Respiratory System Agents|respiratory system agents|mesh-ancestor
153565059|NCT03366974|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153565060|NCT03366974|Anesthetics, General|anesthetics, general|mesh-ancestor
153565061|NCT03366974|Anesthetics|anesthetics|mesh-ancestor
153565062|NCT03366974|GABA Modulators|gaba modulators|mesh-ancestor
153565063|NCT03366974|GABA Agents|gaba agents|mesh-ancestor
153565064|NCT03366974|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153565065|NCT03366974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153738893|NCT00471289|Tubulin Modulators|tubulin modulators|mesh-ancestor
153738894|NCT00471289|Antimitotic Agents|antimitotic agents|mesh-ancestor
153738895|NCT00471289|Mitosis Modulators|mitosis modulators|mesh-ancestor
153738896|NCT00471289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153738946|NCT00471523|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153738947|NCT00471523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153738948|NCT00471523|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
153738949|NCT00471523|Hormone Antagonists|hormone antagonists|mesh-ancestor
153738950|NCT00471523|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153738951|NCT00471523|Fertility Agents, Female|fertility agents, female|mesh-ancestor
153738952|NCT00471523|Fertility Agents|fertility agents|mesh-ancestor
153738953|NCT00471523|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153738954|NCT00471523|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
153738955|NCT00471523|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
153738956|NCT00471562|Angiotensin I (1-7)|angiotensin i (1-7)|mesh-list
153738957|NCT00471562|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153738958|NCT00471562|Vasodilator Agents|vasodilator agents|mesh-ancestor
153738959|NCT00471640|Dexamethasone|dexamethasone|mesh-list
153738960|NCT00471640|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153738961|NCT00471640|Antiemetics|antiemetics|mesh-ancestor
153738962|NCT00471640|Autonomic Agents|autonomic agents|mesh-ancestor
153738963|NCT00471640|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153738964|NCT00471640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153738965|NCT00471640|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153738966|NCT00471640|Glucocorticoids|glucocorticoids|mesh-ancestor
153738967|NCT00471640|Hormones|hormones|mesh-ancestor
153738968|NCT00471640|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153738969|NCT00471640|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153738970|NCT00471640|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153738971|NCT00471679|Ethanol|ethanol|mesh-list
153738972|NCT00471679|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
153565085|NCT03119038|Ketorolac|ketorolac|mesh-list
153565086|NCT03119038|Clonidine|clonidine|mesh-list
153565087|NCT03119038|Epinephrine|epinephrine|mesh-list
153565088|NCT03119038|Bupivacaine|bupivacaine|mesh-list
153565089|NCT03119038|Ropivacaine|ropivacaine|mesh-list
153565090|NCT03119038|Anesthetics, Local|anesthetics, local|mesh-ancestor
153565091|NCT03119038|Anesthetics|anesthetics|mesh-ancestor
153565092|NCT03119038|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153565093|NCT03119038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153565094|NCT03119038|Sensory System Agents|sensory system agents|mesh-ancestor
153565095|NCT03119038|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153565096|NCT03119038|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153565097|NCT03119038|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153565098|NCT03119038|Adrenergic Agents|adrenergic agents|mesh-ancestor
153565099|NCT03119038|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153738973|NCT00471679|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153738974|NCT00471679|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153738975|NCT00471679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153738976|NCT00149604|Raloxifene Hydrochloride|raloxifene hydrochloride|mesh-list
153738977|NCT00149604|Estrogens|estrogens|mesh-list
153738978|NCT00149604|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
153738979|NCT00149604|Hormones|hormones|mesh-ancestor
153474968|NCT00743574|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
153457454|NCT01383954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153738980|NCT00149604|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153738981|NCT00149604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153738982|NCT00149604|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
153738983|NCT00149604|Hormone Antagonists|hormone antagonists|mesh-ancestor
153738984|NCT00149604|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
153738986|NCT00149604|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153738988|NCT00471952|Rizatriptan|rizatriptan|mesh-list
153738989|NCT00471952|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
153738990|NCT00471952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153738991|NCT00471952|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
153739040|NCT00336466|Epoetin Alfa|epoetin alfa|mesh-list
153739041|NCT00336466|Hematinics|hematinics|mesh-ancestor
153739042|NCT00472381|Insulin|insulin|mesh-list
153739043|NCT00472381|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153739044|NCT00472381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153739045|NCT00472459|Methyl 5-aminolevulinate|methyl 5-aminolevulinate|mesh-list
153739046|NCT00472459|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
153739047|NCT00472459|Dermatologic Agents|dermatologic agents|mesh-ancestor
153739048|NCT00336739|Cinacalcet|cinacalcet|mesh-list
153739049|NCT00336739|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153739050|NCT00336739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153739051|NCT00336739|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
153739052|NCT00336739|Hormone Antagonists|hormone antagonists|mesh-ancestor
153739053|NCT00336739|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153565121|NCT03099265|Oxaliplatin|oxaliplatin|mesh-list
153565122|NCT03099265|Irinotecan|irinotecan|mesh-list
153565123|NCT03099265|Antimetabolites|antimetabolites|mesh-ancestor
153782808|NCT04551703|Mydriatics|mydriatics|mesh-ancestor
153782809|NCT04551703|Sympathomimetics|sympathomimetics|mesh-ancestor
153782810|NCT04551703|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
153782811|NCT00235001|Verapamil|verapamil|mesh-list
153782812|NCT00235001|Trandolapril|trandolapril|mesh-list
153782813|NCT00235001|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153782814|NCT00235001|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153782815|NCT00235001|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153565124|NCT03099265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153565133|NCT03099265|Antidotes|antidotes|mesh-ancestor
153739054|NCT00424151|Rituximab|rituximab|mesh-list
153739055|NCT00424151|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153739056|NCT00424151|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153739057|NCT00424151|Immunologic Factors|immunologic factors|mesh-ancestor
153739058|NCT00424151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153739059|NCT00424151|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153739060|NCT00472810|Mitomycins|mitomycins|mesh-list
153739061|NCT00472810|Mitomycin|mitomycin|mesh-list
153739062|NCT00472810|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153739063|NCT00472810|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153739064|NCT00472810|Alkylating Agents|alkylating agents|mesh-ancestor
153739065|NCT00472810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153739089|NCT00337090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153739090|NCT00337090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153739091|NCT00337090|Urological Agents|urological agents|mesh-ancestor
153739093|NCT05262452|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153739094|NCT00337246|Cyclophosphamide|cyclophosphamide|mesh-list
153739095|NCT00337246|Rituximab|rituximab|mesh-list
153739096|NCT00337246|Fludarabine|fludarabine|mesh-list
153739097|NCT00337246|Fludarabine phosphate|fludarabine phosphate|mesh-list
153739098|NCT00337246|Mitoxantrone|mitoxantrone|mesh-list
153739099|NCT00337246|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153739100|NCT00337246|Immunologic Factors|immunologic factors|mesh-ancestor
153739101|NCT00337246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153739102|NCT00337246|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153739103|NCT00337246|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153739104|NCT00337246|Alkylating Agents|alkylating agents|mesh-ancestor
153739105|NCT00337246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153739106|NCT00337246|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153739107|NCT00337246|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153739108|NCT00337246|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153739110|NCT00337246|Antimetabolites|antimetabolites|mesh-ancestor
153739142|NCT00473239|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153739143|NCT00473239|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153739144|NCT00149916|Mycophenolic Acid|mycophenolic acid|mesh-list
153739145|NCT00149916|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153739146|NCT00149916|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153739147|NCT00149916|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
153739148|NCT00149916|Antitubercular Agents|antitubercular agents|mesh-ancestor
153739149|NCT00149916|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153739150|NCT00149916|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153739151|NCT00149916|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153739152|NCT00149916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153739153|NCT00337441|Epoetin Alfa|epoetin alfa|mesh-list
153739154|NCT00337441|Hematinics|hematinics|mesh-ancestor
153739155|NCT00337519|Alemtuzumab|alemtuzumab|mesh-list
153739156|NCT00337519|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153739157|NCT00337519|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153739158|NCT00337558|Solifenacin Succinate|solifenacin succinate|mesh-list
153739159|NCT00337558|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
153739160|NCT00337558|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
153739161|NCT00337558|Cholinergic Agents|cholinergic agents|mesh-ancestor
153739162|NCT00337558|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153739163|NCT00337558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153739165|NCT00337558|Urological Agents|urological agents|mesh-ancestor
153739193|NCT00509158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153739194|NCT00509158|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153739195|NCT00405080|Rifampin|rifampin|mesh-list
153739197|NCT00405080|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
153739198|NCT00405080|Antitubercular Agents|antitubercular agents|mesh-ancestor
153565152|NCT02975037|Antifungal Agents|antifungal agents|mesh-ancestor
153739199|NCT00405080|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153739200|NCT00405080|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153739201|NCT00405080|Leprostatic Agents|leprostatic agents|mesh-ancestor
153565166|NCT02931890|Antimitotic Agents|antimitotic agents|mesh-ancestor
153739202|NCT00405080|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153739203|NCT00405080|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153739204|NCT00405080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153739205|NCT00405080|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
153739206|NCT00405080|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
153739207|NCT00405080|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
153739208|NCT00405080|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
153739209|NCT00405080|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
153739210|NCT00405080|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
153739211|NCT00405080|Antiemetics|antiemetics|mesh-ancestor
153739212|NCT00405080|Autonomic Agents|autonomic agents|mesh-ancestor
153739213|NCT00405080|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153576245|NCT01711437|Vitamins|vitamins|mesh-ancestor
153739214|NCT00405080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153739215|NCT00405080|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153739216|NCT00405080|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
153739217|NCT00405080|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153739218|NCT00158496|Interferons|interferons|mesh-list
153739219|NCT00158496|Ribavirin|ribavirin|mesh-list
153739220|NCT00158496|Interferon-alpha|interferon-alpha|mesh-list
153739221|NCT00158496|Interferon alpha-2|interferon alpha-2|mesh-list
153739230|NCT00337792|Midazolam|midazolam|mesh-list
153739235|NCT00337792|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153739236|NCT00337792|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153739237|NCT00337792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153739238|NCT00337792|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153739239|NCT00337792|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153739240|NCT00337792|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153739241|NCT00337792|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153739242|NCT00337792|Anesthetics, General|anesthetics, general|mesh-ancestor
153739243|NCT00337792|Anesthetics|anesthetics|mesh-ancestor
153739244|NCT00337792|GABA Modulators|gaba modulators|mesh-ancestor
153739245|NCT00337792|GABA Agents|gaba agents|mesh-ancestor
153739246|NCT00337792|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153739247|NCT00337792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153739248|NCT00337792|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153739249|NCT00337792|Narcotics|narcotics|mesh-ancestor
153739250|NCT00337792|Analgesics|analgesics|mesh-ancestor
153739251|NCT00337792|Sensory System Agents|sensory system agents|mesh-ancestor
153739252|NCT00337792|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153739253|NCT00337792|Anticonvulsants|anticonvulsants|mesh-ancestor
153739254|NCT00337792|Antiemetics|antiemetics|mesh-ancestor
153739255|NCT00337792|Autonomic Agents|autonomic agents|mesh-ancestor
153739256|NCT00337792|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153739257|NCT00405119|Esomeprazole|esomeprazole|mesh-list
153739258|NCT00405119|Ranitidine|ranitidine|mesh-list
153565167|NCT02931890|Mitosis Modulators|mitosis modulators|mesh-ancestor
153565168|NCT02931890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153739259|NCT00405119|Ranitidine bismuth citrate|ranitidine bismuth citrate|mesh-list
153739260|NCT00405119|Loxtidine|loxtidine|mesh-list
153739261|NCT00405119|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
153739262|NCT00405119|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153739263|NCT00405119|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
153739286|NCT00509431|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153739287|NCT00509431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153739288|NCT00509431|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153739289|NCT00509431|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153739290|NCT00509431|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153739291|NCT00509431|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153739292|NCT00509431|Antifungal Agents|antifungal agents|mesh-ancestor
153739293|NCT00509431|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153739294|NCT00509431|Immunologic Factors|immunologic factors|mesh-ancestor
153739295|NCT00509431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153739297|NCT00509470|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
153739298|NCT00509470|Telmisartan|telmisartan|mesh-list
153739299|NCT00509470|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153739300|NCT00509470|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153739301|NCT00509470|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153739302|NCT00509470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153739303|NCT00509470|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153739304|NCT00509470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153739305|NCT00509470|Vasodilator Agents|vasodilator agents|mesh-ancestor
153739306|NCT00509470|Diuretics|diuretics|mesh-ancestor
153739307|NCT00509470|Natriuretic Agents|natriuretic agents|mesh-ancestor
153739308|NCT00509470|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
153739309|NCT00509470|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
153739310|NCT00509470|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
153739311|NCT00405158|Acetaminophen|acetaminophen|mesh-list
153739312|NCT00405158|Antipyretics|antipyretics|mesh-list
153739313|NCT00405158|Penicillins|penicillins|mesh-list
153739314|NCT00405158|Floxacillin|floxacillin|mesh-list
153739316|NCT00405158|Oxytocin|oxytocin|mesh-list
153739317|NCT00405158|Oxytocics|oxytocics|mesh-ancestor
153739318|NCT00405158|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153739319|NCT00405158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153739326|NCT00150072|Imatinib Mesylate|imatinib mesylate|mesh-list
153739327|NCT00150072|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153739328|NCT00150072|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153739329|NCT00150072|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153739330|NCT00150072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153739331|NCT00150072|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153739332|NCT02953366|Mometasone Furoate|mometasone furoate|mesh-list
153739333|NCT02953366|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153739334|NCT02953366|Dermatologic Agents|dermatologic agents|mesh-ancestor
153739335|NCT02953366|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
153739336|NCT00150111|Rituximab|rituximab|mesh-list
153739337|NCT00150111|Methimazole|methimazole|mesh-list
153739338|NCT00150111|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153739339|NCT00150111|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153739340|NCT00150111|Immunologic Factors|immunologic factors|mesh-ancestor
153739341|NCT00150111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153739342|NCT00150111|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153739343|NCT00150111|Antithyroid Agents|antithyroid agents|mesh-ancestor
153739344|NCT00150111|Hormone Antagonists|hormone antagonists|mesh-ancestor
153782822|NCT00235001|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153782823|NCT00235001|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153782824|NCT04551781|Prednisone|prednisone|mesh-list
153782825|NCT04551781|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153782826|NCT04551781|Glucocorticoids|glucocorticoids|mesh-ancestor
153739345|NCT00150111|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153739346|NCT02953210|Dexamethasone|dexamethasone|mesh-list
153739348|NCT02953210|Lidocaine|lidocaine|mesh-list
153739349|NCT02953210|Clonidine|clonidine|mesh-list
153739350|NCT02953210|Midazolam|midazolam|mesh-list
153739351|NCT02953210|Fentanyl|fentanyl|mesh-list
153739352|NCT02953210|Ketamine|ketamine|mesh-list
153739353|NCT02953210|Ondansetron|ondansetron|mesh-list
153739354|NCT02953210|Bupivacaine|bupivacaine|mesh-list
153739355|NCT02953210|Propofol|propofol|mesh-list
153739356|NCT02953210|Isoflurane|isoflurane|mesh-list
153739357|NCT02953210|Ranitidine|ranitidine|mesh-list
153739358|NCT02953210|Ranitidine bismuth citrate|ranitidine bismuth citrate|mesh-list
153739359|NCT02953210|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
153739360|NCT02953210|Rocuronium|rocuronium|mesh-list
153739361|NCT02953210|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153739362|NCT02953210|Antiemetics|antiemetics|mesh-ancestor
153739363|NCT02953210|Autonomic Agents|autonomic agents|mesh-ancestor
153739364|NCT02953210|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153576386|NCT01711931|Everolimus|everolimus|mesh-list
153739367|NCT02953210|Glucocorticoids|glucocorticoids|mesh-ancestor
153739368|NCT02953210|Hormones|hormones|mesh-ancestor
153739369|NCT02953210|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153739370|NCT02953210|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153739371|NCT02953210|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153739372|NCT02953210|Anesthetics, Local|anesthetics, local|mesh-ancestor
153739374|NCT02953210|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153739375|NCT02953210|Sensory System Agents|sensory system agents|mesh-ancestor
153739376|NCT02953210|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153739377|NCT02953210|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
153739378|NCT02953210|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153739379|NCT02953210|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153739380|NCT02953210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153739381|NCT02953210|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153565196|NCT02549677|Epirubicin|epirubicin|mesh-list
153565197|NCT02549677|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153739382|NCT02953210|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153739383|NCT02953210|Anesthetics, General|anesthetics, general|mesh-ancestor
153565198|NCT02549677|Immunologic Factors|immunologic factors|mesh-ancestor
153739384|NCT02953210|Analgesics|analgesics|mesh-ancestor
153739385|NCT02953210|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
153739386|NCT02953210|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
153565199|NCT02549677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153565200|NCT02549677|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153565201|NCT02549677|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153565202|NCT02549677|Alkylating Agents|alkylating agents|mesh-ancestor
153565203|NCT02549677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153565204|NCT02549677|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153565205|NCT02549677|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153565206|NCT02549677|Tubulin Modulators|tubulin modulators|mesh-ancestor
153565207|NCT02549677|Antimitotic Agents|antimitotic agents|mesh-ancestor
153565208|NCT02549677|Mitosis Modulators|mitosis modulators|mesh-ancestor
153565209|NCT02549677|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153565219|NCT02450253|Urological Agents|urological agents|mesh-ancestor
153565221|NCT02257970|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153565222|NCT02257970|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153739387|NCT02953210|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
153739388|NCT02953210|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153739389|NCT02953210|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153739390|NCT02953210|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153739391|NCT02953210|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153739392|NCT02953210|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153739393|NCT02953210|GABA Modulators|gaba modulators|mesh-ancestor
153739414|NCT02953210|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153739415|NCT02953210|Adrenergic Agents|adrenergic agents|mesh-ancestor
153739416|NCT02953210|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
153739417|NCT02953210|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
153739418|NCT02953210|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
153739419|NCT02953210|Histamine Antagonists|histamine antagonists|mesh-ancestor
153739420|NCT02953210|Histamine Agents|histamine agents|mesh-ancestor
153739421|NCT00509743|Diclofenac|diclofenac|mesh-list
153739422|NCT00509743|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153739423|NCT00509743|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153739424|NCT00509743|Analgesics|analgesics|mesh-ancestor
153739425|NCT00509743|Sensory System Agents|sensory system agents|mesh-ancestor
153739426|NCT00509743|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153739427|NCT00509743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153739428|NCT00509743|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153739429|NCT00509743|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153739430|NCT00509743|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153739473|NCT00158574|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153739474|NCT00158574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153739475|NCT00158574|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
153739476|NCT00158574|Leprostatic Agents|leprostatic agents|mesh-ancestor
153739477|NCT00158574|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153739480|NCT00338221|Glycine Agents|glycine agents|mesh-ancestor
153739481|NCT00338221|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153739482|NCT00338221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153739483|NCT00338221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153739484|NCT00338299|Epoetin Alfa|epoetin alfa|mesh-list
153739485|NCT00338299|Hematinics|hematinics|mesh-ancestor
153739486|NCT00510016|Clonidine|clonidine|mesh-list
153739487|NCT00510016|Analgesics|analgesics|mesh-ancestor
153565227|NCT02257970|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153565228|NCT02257970|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153565229|NCT02257970|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153565230|NCT02257970|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153565231|NCT02257970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153565232|NCT05838248|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
153565233|NCT05838248|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153565234|NCT05838105|Progesterone|progesterone|mesh-list
153565235|NCT05838105|Progestins|progestins|mesh-ancestor
153565236|NCT05838105|Hormones|hormones|mesh-ancestor
153565237|NCT05838105|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153565238|NCT05838105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153565239|NCT05838066|Docetaxel|docetaxel|mesh-list
153739488|NCT00510016|Sensory System Agents|sensory system agents|mesh-ancestor
153739489|NCT00510016|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153739490|NCT00510016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153739491|NCT00510016|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153739492|NCT00510016|Sympatholytics|sympatholytics|mesh-ancestor
153739493|NCT00510016|Autonomic Agents|autonomic agents|mesh-ancestor
153739527|NCT02953015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153739528|NCT02953015|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
153739529|NCT02953015|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153739530|NCT02953015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153739531|NCT02953015|Cholinergic Agents|cholinergic agents|mesh-ancestor
153739532|NCT02953015|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153739533|NCT00473005|Capecitabine|capecitabine|mesh-list
153739534|NCT00473005|Everolimus|everolimus|mesh-list
153739535|NCT00473005|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153739536|NCT00473005|Antimetabolites|antimetabolites|mesh-ancestor
153739537|NCT00473005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153739538|NCT00473005|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153739539|NCT00473005|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
153739540|NCT00473005|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153739541|NCT00473005|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153739542|NCT00473005|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153739543|NCT00473005|Immunologic Factors|immunologic factors|mesh-ancestor
153739544|NCT00473005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153739545|NCT00158652|Carboplatin|carboplatin|mesh-list
153739546|NCT00158652|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153739547|NCT00338650|Adalimumab|adalimumab|mesh-list
153739548|NCT00338650|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
153739549|NCT00338650|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153739550|NCT00338650|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153739551|NCT00158691|Amifostine|amifostine|mesh-list
153739552|NCT00158691|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
153739553|NCT00158691|Protective Agents|protective agents|mesh-ancestor
153739554|NCT00158691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153739555|NCT00338767|Fluoxetine|fluoxetine|mesh-list
153739556|NCT00338767|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
153739569|NCT00339001|Epoetin Alfa|epoetin alfa|mesh-list
153739570|NCT00339001|Hematinics|hematinics|mesh-ancestor
153739571|NCT00150306|Sertraline|sertraline|mesh-list
153739572|NCT00150306|Antidepressive Agents|antidepressive agents|mesh-ancestor
153565264|NCT05836831|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153565265|NCT05836831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153739573|NCT00150306|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153739574|NCT00150306|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
153739575|NCT00150306|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153739576|NCT00150306|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153565266|NCT05836831|Hemostatics|hemostatics|mesh-ancestor
153565267|NCT05836831|Coagulants|coagulants|mesh-ancestor
153565268|NCT05836545|Midazolam|midazolam|mesh-list
153565269|NCT05836545|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153565270|NCT05836545|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153565271|NCT05836545|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153565272|NCT05836545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153565273|NCT05836545|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153565274|NCT05836545|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153565275|NCT05836545|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153565276|NCT05836545|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153565277|NCT05836545|Anesthetics, General|anesthetics, general|mesh-ancestor
153739577|NCT00150306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153739578|NCT00150306|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153739579|NCT00150306|Serotonin Agents|serotonin agents|mesh-ancestor
153739580|NCT00150306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153739581|NCT00510172|Epoprostenol|epoprostenol|mesh-list
153739582|NCT00510172|Tezosentan|tezosentan|mesh-list
153739583|NCT00510172|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153739584|NCT00510172|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153739585|NCT00510172|Vasodilator Agents|vasodilator agents|mesh-ancestor
153739586|NCT00420901|Sildenafil Citrate|sildenafil citrate|mesh-list
153739587|NCT00420901|Vasodilator Agents|vasodilator agents|mesh-ancestor
153739588|NCT00420901|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
153739589|NCT00420901|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
153739590|NCT00420901|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153739591|NCT00420901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153739592|NCT00420901|Urological Agents|urological agents|mesh-ancestor
153739619|NCT00339118|Cyclophosphamide|cyclophosphamide|mesh-list
153739620|NCT00339118|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153739621|NCT00339118|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153739622|NCT00339118|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153565281|NCT05836545|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153739623|NCT00339118|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153739624|NCT00339118|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153739625|NCT00339118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153739626|NCT00339118|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153739627|NCT00339118|Immunologic Factors|immunologic factors|mesh-ancestor
153739628|NCT00339118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153739629|NCT00339118|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153739630|NCT00339118|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153739631|NCT00339118|Alkylating Agents|alkylating agents|mesh-ancestor
153739632|NCT00339118|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153739633|NCT00339157|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
153739634|NCT00339157|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153739635|NCT00339196|Azacitidine|azacitidine|mesh-list
153739636|NCT00339196|Tretinoin|tretinoin|mesh-list
153739637|NCT00339196|Valproic Acid|valproic acid|mesh-list
153739638|NCT00339196|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153739639|NCT00339196|Antimetabolites|antimetabolites|mesh-ancestor
153739640|NCT00339196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153739641|NCT00339196|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153739642|NCT00339196|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153739643|NCT00339196|Keratolytic Agents|keratolytic agents|mesh-ancestor
153739644|NCT00339196|Dermatologic Agents|dermatologic agents|mesh-ancestor
153565282|NCT05836545|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153565283|NCT05836441|Tacrolimus|tacrolimus|mesh-list
153565284|NCT05836441|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153565285|NCT05836441|Immunologic Factors|immunologic factors|mesh-ancestor
153739645|NCT00339196|Anticonvulsants|anticonvulsants|mesh-ancestor
153739646|NCT00339196|GABA Agents|gaba agents|mesh-ancestor
153739666|NCT00510211|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153739668|NCT00510211|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
153739669|NCT00510211|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153739670|NCT00510211|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153739671|NCT00510211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153739672|NCT00510211|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153739673|NCT00510211|Serotonin Agents|serotonin agents|mesh-ancestor
153739674|NCT00150423|Pregabalin|pregabalin|mesh-list
153739675|NCT00150423|Analgesics|analgesics|mesh-ancestor
153739676|NCT00150423|Sensory System Agents|sensory system agents|mesh-ancestor
153739677|NCT00150423|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153739678|NCT00150423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153739679|NCT00150423|Anticonvulsants|anticonvulsants|mesh-ancestor
153739680|NCT00150423|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153739681|NCT00150423|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153739682|NCT00150423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153739683|NCT00150423|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153739684|NCT00150423|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153739685|NCT00150423|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153739686|NCT00150423|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153739687|NCT00150423|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153739688|NCT00510250|Sorafenib|sorafenib|mesh-list
153739689|NCT00510250|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153739690|NCT00510250|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153739691|NCT00510250|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153739692|NCT00510250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153739693|NCT00510367|Cyclophosphamide|cyclophosphamide|mesh-list
153739694|NCT00510367|Doxorubicin|doxorubicin|mesh-list
153739695|NCT00510367|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
153739696|NCT00510367|Fluorouracil|fluorouracil|mesh-list
153739697|NCT00510367|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153739705|NCT00510367|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153739706|NCT00510367|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153739707|NCT00510367|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153739708|NCT00510367|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153739709|NCT00510367|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153739710|NCT00510367|Antimetabolites|antimetabolites|mesh-ancestor
153739711|NCT00510367|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153739712|NCT00158847|Fluticasone|fluticasone|mesh-list
153739713|NCT00158847|Xhance|xhance|mesh-list
153739714|NCT00158847|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
153739715|NCT00158847|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153739716|NCT00158847|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153739717|NCT00158847|Autonomic Agents|autonomic agents|mesh-ancestor
153739718|NCT00158847|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153739719|NCT00158847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153739720|NCT00158847|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153739721|NCT00158847|Respiratory System Agents|respiratory system agents|mesh-ancestor
153739722|NCT00158847|Dermatologic Agents|dermatologic agents|mesh-ancestor
153739723|NCT00158847|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
153739724|NCT00158847|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
153739725|NCT00158847|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
153739726|NCT00158847|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153739727|NCT00158847|Adrenergic Agents|adrenergic agents|mesh-ancestor
153739728|NCT00158847|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153565316|NCT05797558|Hormone Antagonists|hormone antagonists|mesh-ancestor
153565318|NCT05797558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153739729|NCT00158847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153739731|NCT00339586|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153739732|NCT00339586|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153739733|NCT00339586|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153739734|NCT00339586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153739735|NCT00339586|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153739736|NCT00158886|Topotecan|topotecan|mesh-list
153739737|NCT00158886|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
153739745|NCT00510406|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
153739746|NCT00510406|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
153739747|NCT00510406|Adrenergic Agents|adrenergic agents|mesh-ancestor
153739748|NCT00510406|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153739749|NCT00510406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153739750|NCT00510406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153739751|NCT00510406|Urological Agents|urological agents|mesh-ancestor
153739752|NCT00510406|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
153739753|NCT00510406|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
153739754|NCT00510406|Cholinergic Agents|cholinergic agents|mesh-ancestor
153739755|NCT00165555|Sodium thiosulfate|sodium thiosulfate|mesh-list
153739756|NCT00165555|Antidotes|antidotes|mesh-ancestor
153739757|NCT00165555|Protective Agents|protective agents|mesh-ancestor
153739758|NCT00165555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153739759|NCT00165555|Antioxidants|antioxidants|mesh-ancestor
153739760|NCT00165555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153739761|NCT00165555|Antitubercular Agents|antitubercular agents|mesh-ancestor
153739762|NCT00165555|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153565331|NCT05786820|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153739763|NCT00165555|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153739764|NCT00165555|Chelating Agents|chelating agents|mesh-ancestor
153739765|NCT00165555|Sequestering Agents|sequestering agents|mesh-ancestor
153739766|NCT00150579|Amphetamine|amphetamine|mesh-list
153739767|NCT00150579|Dextroamphetamine|dextroamphetamine|mesh-list
153739768|NCT00150579|Adderall|adderall|mesh-list
153739769|NCT00150579|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
153739770|NCT00150579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153565332|NCT05781308|Paclitaxel|paclitaxel|mesh-list
153782835|NCT02214004|Trastuzumab|trastuzumab|mesh-list
153782843|NCT02214004|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
153782844|NCT02214004|Hormone Antagonists|hormone antagonists|mesh-ancestor
153782845|NCT02214004|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153782846|NCT02214004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153782848|NCT00235079|Gout Suppressants|gout suppressants|mesh-ancestor
153782849|NCT00235079|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153782850|NCT00235079|Tubulin Modulators|tubulin modulators|mesh-ancestor
153782851|NCT00235079|Antimitotic Agents|antimitotic agents|mesh-ancestor
153782852|NCT00235079|Mitosis Modulators|mitosis modulators|mesh-ancestor
153782853|NCT00235079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153782854|NCT00235079|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153739771|NCT00150579|Sympathomimetics|sympathomimetics|mesh-ancestor
153739772|NCT00150579|Autonomic Agents|autonomic agents|mesh-ancestor
153739773|NCT00150579|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153739791|NCT00150657|Carboplatin|carboplatin|mesh-list
153739792|NCT00150657|Gemcitabine|gemcitabine|mesh-list
153739793|NCT00150657|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153739794|NCT00150657|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153739795|NCT00150657|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153739796|NCT00150657|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153739797|NCT00150657|Growth Substances|growth substances|mesh-ancestor
153739798|NCT00150657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153739799|NCT00150657|Growth Inhibitors|growth inhibitors|mesh-ancestor
153739800|NCT00150657|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153739801|NCT00150657|Antimetabolites|antimetabolites|mesh-ancestor
153739802|NCT00150657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153739803|NCT00511771|Tegaserod|tegaserod|mesh-list
153739804|NCT00511771|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
153739805|NCT00511771|Serotonin Agents|serotonin agents|mesh-ancestor
153739806|NCT00511771|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153739807|NCT00511771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153739808|NCT00511771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153739809|NCT00165594|N-(3-chloro-7-indolyl)-1,4-benzenedisulphonamide|n-(3-chloro-7-indolyl)-1,4-benzenedisulphonamide|mesh-list
153739810|NCT00165594|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153739811|NCT00165594|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
153739812|NCT00165594|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153739813|NCT00165594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153739814|NCT00511849|Paclitaxel|paclitaxel|mesh-list
153739815|NCT00511849|Carboplatin|carboplatin|mesh-list
153739816|NCT00511849|Sunitinib|sunitinib|mesh-list
153739817|NCT00511849|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153739818|NCT00511849|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153739819|NCT00511849|Tubulin Modulators|tubulin modulators|mesh-ancestor
153739820|NCT00511849|Antimitotic Agents|antimitotic agents|mesh-ancestor
153739821|NCT00511849|Mitosis Modulators|mitosis modulators|mesh-ancestor
153739822|NCT00511849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153739829|NCT00511849|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153739830|NCT00510640|Sunitinib|sunitinib|mesh-list
153739831|NCT00510640|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153739832|NCT00510640|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153739833|NCT00510640|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153739834|NCT00510640|Growth Substances|growth substances|mesh-ancestor
153739835|NCT00510640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153739836|NCT00510640|Growth Inhibitors|growth inhibitors|mesh-ancestor
153739837|NCT00510640|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153880119|NCT02760407|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
153565333|NCT05781308|Bevacizumab|bevacizumab|mesh-list
153883969|NCT02273765|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
153739838|NCT00510640|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153739839|NCT00510640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153739840|NCT00150696|Risedronic Acid|risedronic acid|mesh-list
153739841|NCT00150696|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153739842|NCT00150696|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153739843|NCT00150696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153739844|NCT00150696|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153739845|NCT00150696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153739846|NCT00150696|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153739847|NCT00165633|Vitamin K 2|vitamin k 2|mesh-list
153739848|NCT00165633|Menatetrenone|menatetrenone|mesh-list
153739849|NCT00165633|Hemostatics|hemostatics|mesh-ancestor
153739850|NCT00165633|Coagulants|coagulants|mesh-ancestor
153739851|NCT00165633|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
153739852|NCT00165633|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153739853|NCT00165633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153739854|NCT00165633|Vitamins|vitamins|mesh-ancestor
153739855|NCT00165633|Micronutrients|micronutrients|mesh-ancestor
153739876|NCT04695925|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153739877|NCT04695925|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153739878|NCT04695925|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153739879|NCT04695925|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153739880|NCT00511069|Bortezomib|bortezomib|mesh-list
153739881|NCT00511069|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153739882|NCT00165750|Donepezil|donepezil|mesh-list
153739883|NCT00165750|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
153739884|NCT00165750|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153739885|NCT00165750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153739886|NCT00165750|Cholinergic Agents|cholinergic agents|mesh-ancestor
153739887|NCT00165750|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153739888|NCT00165750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153739889|NCT00165750|Nootropic Agents|nootropic agents|mesh-ancestor
153739890|NCT00511225|Cholecalciferol|cholecalciferol|mesh-list
153739891|NCT00511225|Vitamin D|vitamin d|mesh-list
153739892|NCT00511225|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153739893|NCT00511225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153739895|NCT00511225|Micronutrients|micronutrients|mesh-ancestor
153739896|NCT00511225|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153739897|NCT00150774|Levetiracetam|levetiracetam|mesh-list
153739898|NCT00150774|Anticonvulsants|anticonvulsants|mesh-ancestor
153739899|NCT00150774|Nootropic Agents|nootropic agents|mesh-ancestor
153739900|NCT00511303|Imatinib Mesylate|imatinib mesylate|mesh-list
153739901|NCT00511303|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153739902|NCT00511303|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153739903|NCT00511303|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153739904|NCT00511303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153739905|NCT00511303|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153739907|NCT00165828|Anticonvulsants|anticonvulsants|mesh-ancestor
153739908|NCT00165828|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153739909|NCT00165828|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153739910|NCT00165828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153739911|NCT00165828|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153739912|NCT00165828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153739913|NCT00511498|Sildenafil Citrate|sildenafil citrate|mesh-list
153739914|NCT00511498|Vasodilator Agents|vasodilator agents|mesh-ancestor
153739915|NCT00511498|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
153565334|NCT05781308|Atezolizumab|atezolizumab|mesh-list
153565337|NCT05781308|Tubulin Modulators|tubulin modulators|mesh-ancestor
153739916|NCT00511498|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
153739917|NCT00511498|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153739918|NCT00511498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153739919|NCT00511498|Urological Agents|urological agents|mesh-ancestor
153739920|NCT00511576|Docetaxel|docetaxel|mesh-list
153739921|NCT00511576|Mocetinostat|mocetinostat|mesh-list
153739922|NCT00511576|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153739923|NCT00511576|Tubulin Modulators|tubulin modulators|mesh-ancestor
153739924|NCT00511576|Antimitotic Agents|antimitotic agents|mesh-ancestor
153739925|NCT00511576|Mitosis Modulators|mitosis modulators|mesh-ancestor
153739926|NCT00511576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153739927|NCT00511576|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
153739928|NCT00511576|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153739929|NCT00511654|Midazolam|midazolam|mesh-list
153739930|NCT00511654|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153739931|NCT00511654|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153739932|NCT00511654|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153739933|NCT00511654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153739934|NCT00511654|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153739935|NCT00511654|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153739936|NCT00511654|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153739937|NCT00511654|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153739938|NCT00511654|Anesthetics, General|anesthetics, general|mesh-ancestor
153739939|NCT00511654|Anesthetics|anesthetics|mesh-ancestor
153739940|NCT00511654|GABA Modulators|gaba modulators|mesh-ancestor
153739941|NCT00511654|GABA Agents|gaba agents|mesh-ancestor
153739942|NCT00511654|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153739958|NCT02951806|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153739959|NCT02951806|Narcotics|narcotics|mesh-ancestor
153739960|NCT02951806|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153739961|NCT02951806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153739962|NCT02951806|Analgesics|analgesics|mesh-ancestor
153739963|NCT02951806|Sensory System Agents|sensory system agents|mesh-ancestor
153739964|NCT02951806|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153739965|NCT02951806|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153739966|NCT02951806|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153739967|NCT02951806|Anesthetics, General|anesthetics, general|mesh-ancestor
153739968|NCT02951806|Anesthetics|anesthetics|mesh-ancestor
153739969|NCT00512980|Prednisone|prednisone|mesh-list
153739970|NCT00512980|Gemcitabine|gemcitabine|mesh-list
153739971|NCT00512980|Doxorubicin|doxorubicin|mesh-list
153782857|NCT00260988|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
153739972|NCT00512980|Vinblastine|vinblastine|mesh-list
153739973|NCT00512980|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153739974|NCT00512980|Antimetabolites|antimetabolites|mesh-ancestor
153739975|NCT00512980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153739976|NCT00512980|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153739977|NCT00512980|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153739978|NCT00512980|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153739979|NCT00512980|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153739980|NCT00512980|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153739981|NCT00512980|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153739982|NCT00512980|Glucocorticoids|glucocorticoids|mesh-ancestor
153739983|NCT00512980|Hormones|hormones|mesh-ancestor
153739984|NCT00512980|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153739985|NCT00512980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153740006|NCT00150891|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153740007|NCT00150891|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153740008|NCT00150891|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
153740009|NCT00150891|Antitubercular Agents|antitubercular agents|mesh-ancestor
153565378|NCT05597254|Micronutrients|micronutrients|mesh-ancestor
153740010|NCT00150891|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153740011|NCT00150891|Antimetabolites|antimetabolites|mesh-ancestor
153740012|NCT00150891|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153740014|NCT00513058|Lapatinib|lapatinib|mesh-list
153740015|NCT00513058|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153740016|NCT00513058|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153740017|NCT00513058|Tubulin Modulators|tubulin modulators|mesh-ancestor
153740018|NCT00513058|Antimitotic Agents|antimitotic agents|mesh-ancestor
153740019|NCT00513058|Mitosis Modulators|mitosis modulators|mesh-ancestor
153740020|NCT00513058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153740021|NCT00513058|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153740022|NCT00513058|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153740023|NCT00513058|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153740024|NCT02951962|Amlodipine|amlodipine|mesh-list
153740025|NCT02951962|Telmisartan|telmisartan|mesh-list
153740026|NCT02951962|Telmisartan amlodipine combination|telmisartan amlodipine combination|mesh-list
153740027|NCT02951962|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
153740028|NCT02951962|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153740029|NCT02951962|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153740030|NCT02951962|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153740031|NCT02951962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153740032|NCT02951962|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153740033|NCT02951962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153740034|NCT02951962|Vasodilator Agents|vasodilator agents|mesh-ancestor
153740035|NCT02951962|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153565379|NCT05597254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153565381|NCT05576415|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
153565382|NCT05576415|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
153565383|NCT05576415|Cholinergic Agents|cholinergic agents|mesh-ancestor
153565384|NCT05576415|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153565385|NCT05576415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153565386|NCT05576415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153565387|NCT05324761|Pregabalin|pregabalin|mesh-list
153565388|NCT05324761|Gabapentin|gabapentin|mesh-list
153565389|NCT05324761|Analgesics|analgesics|mesh-ancestor
153740036|NCT02951962|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153740047|NCT00513253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153740048|NCT00513253|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153740050|NCT00513487|Methacholine Chloride|methacholine chloride|mesh-list
153740051|NCT00513487|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153740052|NCT00513487|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153740053|NCT00513487|Autonomic Agents|autonomic agents|mesh-ancestor
153740054|NCT00513487|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153740055|NCT00513487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153740056|NCT00513487|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153740057|NCT00513487|Respiratory System Agents|respiratory system agents|mesh-ancestor
153740058|NCT00513487|Dermatologic Agents|dermatologic agents|mesh-ancestor
153740059|NCT00513487|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
153740060|NCT00513487|Miotics|miotics|mesh-ancestor
153740083|NCT00513643|Insulin|insulin|mesh-list
153740108|NCT00151047|Capecitabine|capecitabine|mesh-list
153740109|NCT00151047|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153740110|NCT00151047|Tubulin Modulators|tubulin modulators|mesh-ancestor
153740111|NCT00151047|Antimitotic Agents|antimitotic agents|mesh-ancestor
153740112|NCT00151047|Mitosis Modulators|mitosis modulators|mesh-ancestor
153740113|NCT00151047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153577129|NCT01715701|Iodine|iodine|mesh-list
153740114|NCT00151047|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153740115|NCT00151047|Antimetabolites|antimetabolites|mesh-ancestor
153740116|NCT00513955|Prednisolone|prednisolone|mesh-list
153740117|NCT00513955|Cyclophosphamide|cyclophosphamide|mesh-list
153740118|NCT00513955|Doxorubicin|doxorubicin|mesh-list
153740119|NCT00513955|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
153740120|NCT00513955|Vincristine|vincristine|mesh-list
153740121|NCT00513955|Bortezomib|bortezomib|mesh-list
153740122|NCT00513955|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153740123|NCT00513955|Immunologic Factors|immunologic factors|mesh-ancestor
153740124|NCT00513955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153740125|NCT00513955|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153782873|NCT04550338|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153782874|NCT04550338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153782875|NCT04550338|Hemostatics|hemostatics|mesh-ancestor
153782876|NCT04550338|Coagulants|coagulants|mesh-ancestor
153782877|NCT04550611|Immunoglobulins|immunoglobulins|mesh-list
153782878|NCT04550611|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
153565402|NCT05324761|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
153565403|NCT05324761|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
153565404|NCT05324761|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153565406|NCT05317403|Cytarabine|cytarabine|mesh-list
153565407|NCT05317403|Fludarabine|fludarabine|mesh-list
153740126|NCT00513955|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153740127|NCT00513955|Alkylating Agents|alkylating agents|mesh-ancestor
153565431|NCT05288829|Immunologic Factors|immunologic factors|mesh-ancestor
153740128|NCT00513955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153740129|NCT00513955|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153740130|NCT00513955|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153740131|NCT00513955|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153740132|NCT00513955|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153740133|NCT00513955|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153740134|NCT00513955|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153740135|NCT00513955|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153740136|NCT00513955|Tubulin Modulators|tubulin modulators|mesh-ancestor
153740137|NCT00513955|Antimitotic Agents|antimitotic agents|mesh-ancestor
153740138|NCT00513955|Mitosis Modulators|mitosis modulators|mesh-ancestor
153740139|NCT00513955|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153740140|NCT00513955|Glucocorticoids|glucocorticoids|mesh-ancestor
153740141|NCT00513955|Hormones|hormones|mesh-ancestor
153740142|NCT00513955|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153740143|NCT00513955|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153740145|NCT00513994|Vasodilator Agents|vasodilator agents|mesh-ancestor
153740146|NCT00514072|Vaccines|vaccines|mesh-list
153740148|NCT00514072|Immunologic Factors|immunologic factors|mesh-ancestor
153740149|NCT00514072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153740150|NCT00514072|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153740151|NCT00514111|Interferons|interferons|mesh-list
153740152|NCT00514111|Ribavirin|ribavirin|mesh-list
153740153|NCT00514111|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153740154|NCT00514111|Antiviral Agents|antiviral agents|mesh-ancestor
153740155|NCT00514111|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153740156|NCT00514111|Antimetabolites|antimetabolites|mesh-ancestor
153740157|NCT00514111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153740158|NCT00151086|Vinorelbine|vinorelbine|mesh-list
153740159|NCT00151086|Estramustine|estramustine|mesh-list
153740160|NCT00151086|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153740161|NCT00151086|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153740162|NCT00151086|Tubulin Modulators|tubulin modulators|mesh-ancestor
153740163|NCT00151086|Antimitotic Agents|antimitotic agents|mesh-ancestor
153740164|NCT00151086|Mitosis Modulators|mitosis modulators|mesh-ancestor
153740169|NCT00514228|Sunitinib|sunitinib|mesh-list
153740201|NCT00514891|Vitamin A|vitamin a|mesh-list
153740202|NCT00514891|Vitamins|vitamins|mesh-ancestor
153740203|NCT00514891|Micronutrients|micronutrients|mesh-ancestor
153740204|NCT00514891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153740205|NCT00514969|Imatinib Mesylate|imatinib mesylate|mesh-list
153740206|NCT00514969|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153740207|NCT00514969|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153740209|NCT00514969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153740210|NCT00514969|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153740211|NCT02950948|Progesterone|progesterone|mesh-list
153740212|NCT02950948|Progestins|progestins|mesh-ancestor
153740213|NCT02950948|Hormones|hormones|mesh-ancestor
153740214|NCT02950948|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153740261|NCT00151203|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153740263|NCT04620200|Ipilimumab|ipilimumab|mesh-list
153740264|NCT04620200|Immunomodulating Agents|immunomodulating agents|mesh-list
153740265|NCT04620200|Immunologic Factors|immunologic factors|mesh-list
153740271|NCT00515593|Hormones|hormones|mesh-list
153740331|NCT00515944|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153740332|NCT00151242|Cytarabine|cytarabine|mesh-list
153740333|NCT00151242|Etoposide|etoposide|mesh-list
153740334|NCT00151242|Idarubicin|idarubicin|mesh-list
153740335|NCT00151242|Tretinoin|tretinoin|mesh-list
153740336|NCT00151242|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153740337|NCT00151242|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153740338|NCT00151242|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153740339|NCT00151242|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153740340|NCT00151242|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153740341|NCT00151242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153740342|NCT00151242|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153740343|NCT00151242|Antimetabolites|antimetabolites|mesh-ancestor
153740344|NCT00151242|Antiviral Agents|antiviral agents|mesh-ancestor
153740345|NCT00151242|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153740346|NCT00151242|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153740347|NCT00151242|Immunologic Factors|immunologic factors|mesh-ancestor
153740348|NCT00151242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153740391|NCT02950168|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
153740392|NCT02950168|Protease Inhibitors|protease inhibitors|mesh-ancestor
153740393|NCT02950168|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153740394|NCT02950168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153740395|NCT02950168|Anticoagulants|anticoagulants|mesh-ancestor
153740396|NCT04695223|Arsenic Trioxide|arsenic trioxide|mesh-list
153740397|NCT04695223|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153740398|NCT00166491|Insulin|insulin|mesh-list
153740399|NCT00166491|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153565453|NCT05210517|Uricosuric Agents|uricosuric agents|mesh-ancestor
153565454|NCT05210517|Gout Suppressants|gout suppressants|mesh-ancestor
153565455|NCT05210517|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153782884|NCT00235196|Anti-Infective Agents|anti-infective agents|mesh-list
153782885|NCT00235196|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
153782886|NCT00261027|Exemestane|exemestane|mesh-list
153782887|NCT00261027|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153782888|NCT00261027|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
153782889|NCT00261027|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153565478|NCT05032118|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153565505|NCT04505878|Vitamins|vitamins|mesh-ancestor
153740400|NCT00166491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153740401|NCT00508885|Niacinamide|niacinamide|mesh-list
153740402|NCT00508885|Niacin|niacin|mesh-list
153740403|NCT00508885|Nicotinic Acids|nicotinic acids|mesh-list
153740404|NCT00508885|Vitamin B Complex|vitamin b complex|mesh-ancestor
153740405|NCT00508885|Vitamins|vitamins|mesh-ancestor
153740406|NCT00508885|Micronutrients|micronutrients|mesh-ancestor
153740407|NCT00508885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153740408|NCT00508885|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153740409|NCT00508885|Antimetabolites|antimetabolites|mesh-ancestor
153740410|NCT00508885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153740411|NCT00508885|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153740412|NCT00508885|Vasodilator Agents|vasodilator agents|mesh-ancestor
153740413|NCT02953405|Clopidogrel|clopidogrel|mesh-list
153740415|NCT02953405|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
153740416|NCT02953405|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
153740417|NCT02953405|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
153740418|NCT02953405|Purinergic Agents|purinergic agents|mesh-ancestor
153740419|NCT02953405|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153740420|NCT02953405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153740421|NCT02953405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153740422|NCT00516802|Olaparib|olaparib|mesh-list
153740423|NCT00516802|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
153740424|NCT00516802|Dacarbazine|dacarbazine|mesh-list
153740425|NCT00516802|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153740428|NCT00516802|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153740430|NCT05861466|Ranibizumab|ranibizumab|mesh-list
153740431|NCT05861466|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153740432|NCT05861466|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153740433|NCT05861466|Growth Substances|growth substances|mesh-ancestor
153740434|NCT05861466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153740435|NCT05861466|Growth Inhibitors|growth inhibitors|mesh-ancestor
153740436|NCT05861466|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153740437|NCT05861310|Metronidazole|metronidazole|mesh-list
153740438|NCT05861310|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153740439|NCT05861310|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153740492|NCT05860699|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
153740493|NCT05860699|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153740494|NCT05860699|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153740495|NCT05860699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153740497|NCT05860335|Paclitaxel|paclitaxel|mesh-list
153740498|NCT05860335|Nedaplatin|nedaplatin|mesh-list
153740499|NCT05860335|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153740500|NCT05860335|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153740501|NCT05860335|Tubulin Modulators|tubulin modulators|mesh-ancestor
153740502|NCT05860335|Antimitotic Agents|antimitotic agents|mesh-ancestor
153740503|NCT05860335|Mitosis Modulators|mitosis modulators|mesh-ancestor
153740504|NCT05860335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153740505|NCT05860244|Albuterol|albuterol|mesh-list
153740506|NCT05860244|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153740507|NCT05860244|Autonomic Agents|autonomic agents|mesh-ancestor
153740508|NCT05860244|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153740509|NCT05860244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153565546|NCT04257448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153565547|NCT04257448|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153565548|NCT04257448|Antimetabolites|antimetabolites|mesh-ancestor
153565549|NCT04257448|Immunologic Factors|immunologic factors|mesh-ancestor
153565550|NCT04257448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153565551|NCT04257448|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153565552|NCT04257448|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153565553|NCT04257448|Growth Substances|growth substances|mesh-ancestor
153565554|NCT04257448|Growth Inhibitors|growth inhibitors|mesh-ancestor
153565555|NCT04257448|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153740510|NCT05860244|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153740511|NCT05860244|Respiratory System Agents|respiratory system agents|mesh-ancestor
153740512|NCT05860244|Tocolytic Agents|tocolytic agents|mesh-ancestor
153740513|NCT05860244|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153740514|NCT05860244|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
153740515|NCT05860244|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
153740516|NCT05860244|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153740517|NCT05860244|Adrenergic Agents|adrenergic agents|mesh-ancestor
153740518|NCT05860244|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153740542|NCT05860153|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153740543|NCT05860153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153740544|NCT05860114|Givinostat hydrochloride|givinostat hydrochloride|mesh-list
153740545|NCT05860114|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
153740546|NCT05860114|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153740547|NCT05860114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153740549|NCT05860062|Calcium|calcium|mesh-list
153740550|NCT05860062|Vitamins|vitamins|mesh-ancestor
153740551|NCT05860062|Micronutrients|micronutrients|mesh-ancestor
153740552|NCT05860062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153740553|NCT05860062|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153740554|NCT05860062|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153740555|NCT05860010|Epinephrine|epinephrine|mesh-list
153740556|NCT05860010|Dexmedetomidine|dexmedetomidine|mesh-list
153740557|NCT05860010|Bupivacaine|bupivacaine|mesh-list
153740558|NCT05860010|Anesthetics, Local|anesthetics, local|mesh-ancestor
153740559|NCT05860010|Anesthetics|anesthetics|mesh-ancestor
153740560|NCT05860010|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153740561|NCT05860010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153740562|NCT05860010|Sensory System Agents|sensory system agents|mesh-ancestor
153740563|NCT05860010|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153740589|NCT05859750|Paclitaxel|paclitaxel|mesh-list
153740594|NCT05859750|Antimitotic Agents|antimitotic agents|mesh-ancestor
153740595|NCT05859750|Mitosis Modulators|mitosis modulators|mesh-ancestor
153740596|NCT05859750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153565557|NCT04257448|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153565558|NCT04257448|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
153565559|NCT03959566|Moxifloxacin|moxifloxacin|mesh-list
153420974|NCT06289257|Cholecalciferol|cholecalciferol|mesh-list
153420975|NCT06289257|Vitamins|vitamins|mesh-list
153420976|NCT06289257|Micronutrients|micronutrients|mesh-ancestor
153565560|NCT03959566|Bedaquiline|bedaquiline|mesh-list
153782903|NCT00235235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153782926|NCT00268359|Growth Substances|growth substances|mesh-ancestor
153782927|NCT00268359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153782928|NCT00268359|Growth Inhibitors|growth inhibitors|mesh-ancestor
153782929|NCT00268359|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
153782930|NCT00268359|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153782931|NCT00268359|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153565561|NCT03959566|Midazolam|midazolam|mesh-list
153782932|NCT00268359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153782933|NCT00235274|Secretin|secretin|mesh-list
153782934|NCT00235274|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153782935|NCT00235274|Hormones|hormones|mesh-ancestor
153782936|NCT00235274|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153740597|NCT05859750|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153740598|NCT05859750|Antimetabolites|antimetabolites|mesh-ancestor
153740599|NCT05858918|Clopidogrel|clopidogrel|mesh-list
153740600|NCT05858918|Ticagrelor|ticagrelor|mesh-list
153740601|NCT05858918|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153740602|NCT05858918|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
153740603|NCT05858918|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
153740605|NCT05858918|Purinergic Agents|purinergic agents|mesh-ancestor
153740658|NCT05731596|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153740659|NCT05731596|Micronutrients|micronutrients|mesh-ancestor
153740660|NCT05731596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153740685|NCT05678114|Inositol|inositol|mesh-list
153740730|NCT05491278|Sensory System Agents|sensory system agents|mesh-ancestor
153740731|NCT05491278|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153740732|NCT05457582|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-list
153740734|NCT05457582|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153740735|NCT05457582|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153740736|NCT05457582|Antimetabolites|antimetabolites|mesh-ancestor
153740737|NCT05457582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153740738|NCT05457582|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153740739|NCT05457582|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153740796|NCT05110170|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153577818|NCT01719835|Antiemetics|antiemetics|mesh-ancestor
153740799|NCT04971499|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153740800|NCT04971499|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153740801|NCT04971499|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153740802|NCT04971499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153740803|NCT04971499|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153740804|NCT04918017|Esomeprazole|esomeprazole|mesh-list
153740805|NCT04918017|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
153740806|NCT04918017|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
153740807|NCT04918017|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153740808|NCT04918017|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153740809|NCT04918017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153740810|NCT04898231|Methylprednisolone|methylprednisolone|mesh-list
153740811|NCT04898231|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
153740854|NCT04831736|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153782937|NCT00235274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153782938|NCT00268398|Leucovorin|leucovorin|mesh-list
153782939|NCT00268398|Folic Acid|folic acid|mesh-list
153782940|NCT00268398|Fluorouracil|fluorouracil|mesh-list
153782941|NCT00268398|Oxaliplatin|oxaliplatin|mesh-list
153782942|NCT00268398|Irinotecan|irinotecan|mesh-list
153782943|NCT00268398|Levoleucovorin|levoleucovorin|mesh-list
153740855|NCT04831736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153740856|NCT04831736|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
153740857|NCT04831736|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153740858|NCT04831736|Anesthetics, General|anesthetics, general|mesh-ancestor
153740860|NCT04831736|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153740861|NCT04831736|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
153740862|NCT04831736|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
153740863|NCT04831736|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153740864|NCT04831736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153740865|NCT04830462|Rifampin|rifampin|mesh-list
153740915|NCT04634162|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153740916|NCT04634162|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
153740917|NCT04634162|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
153740919|NCT04634162|Purinergic Agents|purinergic agents|mesh-ancestor
153740920|NCT04634162|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153740921|NCT04634162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153740922|NCT04634162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153740923|NCT04616196|Cetuximab|cetuximab|mesh-list
153740924|NCT04616196|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153740925|NCT04616196|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153740926|NCT04583956|Remdesivir|remdesivir|mesh-list
153740927|NCT04583956|Antimetabolites|antimetabolites|mesh-ancestor
153740928|NCT04583956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153740929|NCT04583956|Antiviral Agents|antiviral agents|mesh-ancestor
153740930|NCT04583956|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153740931|NCT04541407|Temozolomide|temozolomide|mesh-list
153740932|NCT04541407|Osimertinib|osimertinib|mesh-list
153740933|NCT04541407|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153740934|NCT04541407|Alkylating Agents|alkylating agents|mesh-ancestor
153740935|NCT04541407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153740936|NCT04541407|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153740937|NCT04541407|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153740938|NCT04541407|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153740939|NCT04541407|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153740940|NCT04552795|Lamivudine|lamivudine|mesh-list
153740960|NCT04463680|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
153740961|NCT04463680|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
153740962|NCT04463680|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
153740963|NCT04463680|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
153740964|NCT04438655|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
153565666|NCT01333514|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
153565667|NCT01333514|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153565668|NCT01333514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153565669|NCT02098512|Brentuximab Vedotin|brentuximab vedotin|mesh-list
153565670|NCT02098512|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153565671|NCT02098512|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153565672|NCT02098512|Immunotoxins|immunotoxins|mesh-ancestor
153565673|NCT02098512|Immunoconjugates|immunoconjugates|mesh-ancestor
153565674|NCT02098512|Immunologic Factors|immunologic factors|mesh-ancestor
153565675|NCT02098512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153565676|NCT02066636|Nivolumab|nivolumab|mesh-list
153740965|NCT04438655|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153740966|NCT04304014|Sulfalene|sulfalene|mesh-list
153740967|NCT04304014|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153740968|NCT04304014|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
153740969|NCT04304014|Antimalarials|antimalarials|mesh-ancestor
153740970|NCT04304014|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153740971|NCT04304014|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153740972|NCT04300231|Hydromorphone|hydromorphone|mesh-list
153740973|NCT04300231|Bupivacaine|bupivacaine|mesh-list
153740974|NCT04300231|Anesthetics, Local|anesthetics, local|mesh-ancestor
153740975|NCT04300231|Anesthetics|anesthetics|mesh-ancestor
153740976|NCT04300231|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153741018|NCT03896880|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153741019|NCT03896880|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
153741020|NCT03896880|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
153741021|NCT03896880|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153741022|NCT03896880|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153741023|NCT03896880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153741024|NCT03896880|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153741025|NCT03896880|Hormone Antagonists|hormone antagonists|mesh-ancestor
153741026|NCT03896880|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153741027|NCT03896880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153741028|NCT03896880|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
153741077|NCT03195270|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
153741078|NCT03195270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153741080|NCT03172754|Axitinib|axitinib|mesh-list
153741081|NCT03172754|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153741082|NCT03172754|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153741083|NCT03172754|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153741084|NCT03172754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153741085|NCT03172754|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153741086|NCT03172754|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153741087|NCT03123913|Methyltestosterone|methyltestosterone|mesh-list
153741088|NCT03123913|Testosterone|testosterone|mesh-list
153741089|NCT03123913|Testosterone undecanoate|testosterone undecanoate|mesh-list
153741090|NCT03123913|Testosterone enanthate|testosterone enanthate|mesh-list
153741091|NCT03123913|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
153741092|NCT03123913|Androgens|androgens|mesh-ancestor
153741093|NCT03123913|Hormones|hormones|mesh-ancestor
153741094|NCT03123913|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153741095|NCT03123913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153565686|NCT01486264|Botulinum Toxins|botulinum toxins|mesh-list
153565687|NCT01486264|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
153565688|NCT01486264|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
153565689|NCT01486264|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
153565690|NCT01486264|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153565691|NCT01486264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153565692|NCT01486264|Cholinergic Agents|cholinergic agents|mesh-ancestor
153565695|NCT01486264|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
153565696|NCT01486264|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153565698|NCT01299480|Immunologic Factors|immunologic factors|mesh-ancestor
153565699|NCT01299480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153565700|NCT01681446|Interferons|interferons|mesh-list
153741096|NCT03123913|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153741098|NCT03123913|Anabolic Agents|anabolic agents|mesh-ancestor
153741099|NCT03039985|Lithium Carbonate|lithium carbonate|mesh-list
153741100|NCT03039985|Antidepressive Agents|antidepressive agents|mesh-ancestor
153741101|NCT03039985|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153741102|NCT03039985|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153741103|NCT03039985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153741104|NCT03039985|Antimanic Agents|antimanic agents|mesh-ancestor
153741105|NCT03039985|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153741106|NCT03039985|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153741107|NCT03039985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153741108|NCT03007238|Aldesleukin|aldesleukin|mesh-list
153741109|NCT03007238|Interleukin-2|interleukin-2|mesh-list
153741119|NCT03007238|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153741120|NCT02902198|Quinine|quinine|mesh-list
153741121|NCT02902198|Antimalarials|antimalarials|mesh-ancestor
153741122|NCT02902198|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153741123|NCT02902198|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153741124|NCT02902198|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153741125|NCT02902198|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
153741126|NCT02902198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153741127|NCT02902198|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
153741128|NCT02902198|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153741129|NCT02902198|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153741130|NCT02902198|Analgesics|analgesics|mesh-ancestor
153741182|NCT02172651|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153741183|NCT02144857|Cyclosporine|cyclosporine|mesh-list
153741185|NCT02144857|Apremilast|apremilast|mesh-list
153741186|NCT02144857|Ustekinumab|ustekinumab|mesh-list
153741187|NCT02144857|Cyclosporins|cyclosporins|mesh-list
153741188|NCT02144857|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153741251|NCT00176254|Paclitaxel|paclitaxel|mesh-list
153741252|NCT00176254|Carboplatin|carboplatin|mesh-list
153741253|NCT00176254|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153741254|NCT00176254|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153741255|NCT00176254|Tubulin Modulators|tubulin modulators|mesh-ancestor
153741256|NCT00176254|Antimitotic Agents|antimitotic agents|mesh-ancestor
153741257|NCT00176254|Mitosis Modulators|mitosis modulators|mesh-ancestor
153741258|NCT00176254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153741259|NCT02949895|Etoposide|etoposide|mesh-list
153741260|NCT02949895|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153741261|NCT02949895|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153741262|NCT02949895|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153741263|NCT02949895|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153741264|NCT02949895|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153741265|NCT02949895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153741266|NCT02949583|Chlorhexidine|chlorhexidine|mesh-list
153741267|NCT02949583|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
153741268|NCT02949583|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153741269|NCT02949583|Disinfectants|disinfectants|mesh-ancestor
153741270|NCT00516841|Volociximab|volociximab|mesh-list
153741306|NCT00516958|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153741307|NCT00516958|Disinfectants|disinfectants|mesh-ancestor
153741308|NCT00517114|Rabeprazole|rabeprazole|mesh-list
153741309|NCT00517114|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
153741377|NCT00166686|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153741378|NCT00166686|Sympatholytics|sympatholytics|mesh-ancestor
153741379|NCT00166686|Autonomic Agents|autonomic agents|mesh-ancestor
153741380|NCT00166686|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
153741381|NCT00166686|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153741446|NCT02949232|Glucocorticoids|glucocorticoids|mesh-ancestor
153741447|NCT02949232|Hormones|hormones|mesh-ancestor
153741448|NCT02949232|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153741449|NCT02949232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153741450|NCT02949232|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153741451|NCT02949232|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153741452|NCT00518908|Sevoflurane|sevoflurane|mesh-list
153741453|NCT00518908|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153741454|NCT00518908|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
153741455|NCT00518908|Anesthetics, General|anesthetics, general|mesh-ancestor
153741456|NCT00518908|Anesthetics|anesthetics|mesh-ancestor
153741457|NCT00518908|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153741509|NCT02949349|Prednisolone|prednisolone|mesh-list
153741510|NCT02949349|Azathioprine|azathioprine|mesh-list
153741511|NCT02949349|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153741512|NCT02949349|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153741513|NCT02949349|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
153741514|NCT02949349|Antitubercular Agents|antitubercular agents|mesh-ancestor
153741515|NCT02949349|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153741516|NCT02949349|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153741517|NCT02949349|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153741519|NCT02949349|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153741574|NCT00519298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153741575|NCT00519298|Nootropic Agents|nootropic agents|mesh-ancestor
153741577|NCT00519337|Vitamins|vitamins|mesh-ancestor
153741578|NCT00519337|Micronutrients|micronutrients|mesh-ancestor
153741579|NCT00519337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153741580|NCT00519337|Antioxidants|antioxidants|mesh-ancestor
153741581|NCT00519337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153741582|NCT00519337|Protective Agents|protective agents|mesh-ancestor
153741583|NCT00151749|Colesevelam Hydrochloride|colesevelam hydrochloride|mesh-list
153741584|NCT00151749|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153741585|NCT00151749|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153565813|NCT06223880|Bupropion|bupropion|mesh-list
153741637|NCT00151827|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153741638|NCT00151827|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153741639|NCT00151827|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
153741640|NCT00151827|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
153741641|NCT00151827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153741642|NCT00151827|Diuretics|diuretics|mesh-ancestor
153741643|NCT00151827|Natriuretic Agents|natriuretic agents|mesh-ancestor
153741644|NCT00151827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153741645|NCT00151827|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
153741646|NCT00151827|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153741647|NCT00519805|Dalteparin|dalteparin|mesh-list
153741648|NCT00519805|Tinzaparin|tinzaparin|mesh-list
153741649|NCT00519805|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
153741650|NCT00519805|Anticoagulants|anticoagulants|mesh-ancestor
153741651|NCT00519805|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153741652|NCT00519805|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153741653|NCT00519805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153741654|NCT02948881|Ibandronic Acid|ibandronic acid|mesh-list
153741655|NCT02948881|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153741656|NCT02948881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153741657|NCT04457180|Repaglinide|repaglinide|mesh-list
153741658|NCT04457180|Apatinib|apatinib|mesh-list
153741659|NCT04457180|Bupropion|bupropion|mesh-list
153741660|NCT04457180|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153741661|NCT04457180|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153741662|NCT04457180|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153741663|NCT04457180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153741664|NCT04457180|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
153741665|NCT04457180|Antidepressive Agents|antidepressive agents|mesh-ancestor
153741666|NCT04457180|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153741667|NCT04457180|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
153741668|NCT04457180|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153741669|NCT04457180|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153741674|NCT04457180|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153741675|NCT04457180|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153741677|NCT00520000|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
153741678|NCT00520000|Paclitaxel|paclitaxel|mesh-list
153741679|NCT00520000|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153741680|NCT00520000|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153741685|NCT00151944|Mesalamine|mesalamine|mesh-list
153741739|NCT00152022|Sympathomimetics|sympathomimetics|mesh-ancestor
153741740|NCT00152022|Autonomic Agents|autonomic agents|mesh-ancestor
153741742|NCT00152022|Dopamine Agents|dopamine agents|mesh-ancestor
153741743|NCT00152022|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153741744|NCT00152022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153741745|NCT00152022|Adrenergic Agents|adrenergic agents|mesh-ancestor
153741746|NCT00152022|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
153741747|NCT00152022|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153741748|NCT00152022|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153565856|NCT06223659|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153565864|NCT06223477|Vitamins|vitamins|mesh-ancestor
153741749|NCT00152022|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
153741750|NCT00520819|Antioxidants|antioxidants|mesh-list
153741751|NCT00520819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153741752|NCT00520819|Protective Agents|protective agents|mesh-ancestor
153741753|NCT00520819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153741754|NCT00520897|Raltegravir Potassium|raltegravir potassium|mesh-list
153741755|NCT00520897|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153741794|NCT00521170|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153741795|NCT00521170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153741796|NCT00521170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153741797|NCT00521248|Morphine|morphine|mesh-list
153741798|NCT00521248|Buprenorphine|buprenorphine|mesh-list
153741799|NCT00521248|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153741800|NCT00521248|Narcotics|narcotics|mesh-ancestor
153741801|NCT00521248|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153741802|NCT00521248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153741858|NCT03458923|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
153741859|NCT03458923|Ranibizumab|ranibizumab|mesh-list
153741860|NCT03458923|Endothelial Growth Factors|endothelial growth factors|mesh-list
153741861|NCT03458923|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153741862|NCT03458923|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153741863|NCT03458923|Growth Substances|growth substances|mesh-ancestor
153741864|NCT03458923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153741865|NCT03458923|Growth Inhibitors|growth inhibitors|mesh-ancestor
153741866|NCT03458923|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153741867|NCT03458923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153741869|NCT03458923|Analgesics|analgesics|mesh-ancestor
153741923|NCT00152178|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153741924|NCT00152178|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153741926|NCT00152178|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153741927|NCT00152178|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
153741928|NCT00152178|Abortifacient Agents|abortifacient agents|mesh-ancestor
153741929|NCT00152178|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153741930|NCT00152178|Dermatologic Agents|dermatologic agents|mesh-ancestor
153741931|NCT00152178|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153741932|NCT00152178|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153741985|NCT04726553|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153741986|NCT04726553|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153741988|NCT04726553|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153741989|NCT04726553|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153741990|NCT04726553|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153741991|NCT04726553|Immunologic Factors|immunologic factors|mesh-ancestor
153741992|NCT04726553|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153741993|NCT04726553|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153741994|NCT04726553|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153741995|NCT04726553|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
153741996|NCT04726553|Antitubercular Agents|antitubercular agents|mesh-ancestor
153741997|NCT04726553|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153741998|NCT04726553|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153741999|NCT04726553|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153742000|NCT04726553|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153742002|NCT02947945|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153742003|NCT02947945|Respiratory System Agents|respiratory system agents|mesh-ancestor
153565879|NCT06223074|Prednisolone phosphate|prednisolone phosphate|mesh-list
153565880|NCT06223074|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153742042|NCT02951728|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153742043|NCT02951728|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153742044|NCT02951728|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153742045|NCT02951728|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153742046|NCT02951728|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153742047|NCT02951728|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153742048|NCT02951728|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153742049|NCT02951728|Glucocorticoids|glucocorticoids|mesh-ancestor
153742108|NCT00523666|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
153742109|NCT00523666|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153742110|NCT00523666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153742111|NCT00523666|Cholinergic Agents|cholinergic agents|mesh-ancestor
153742112|NCT00523666|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153742178|NCT00524095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153742179|NCT00524095|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153742180|NCT00524095|Respiratory System Agents|respiratory system agents|mesh-ancestor
153742181|NCT00524095|Dermatologic Agents|dermatologic agents|mesh-ancestor
153742182|NCT00524095|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
153742183|NCT00524095|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153742184|NCT00524095|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153742185|NCT00512629|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
153742186|NCT00512629|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
153742245|NCT00512824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153742246|NCT00512824|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153742248|NCT00512863|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
153742249|NCT00512863|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153742250|NCT00512863|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153742251|NCT00524407|Epoetin Alfa|epoetin alfa|mesh-list
153742252|NCT00524407|Hematinics|hematinics|mesh-ancestor
153742253|NCT00525889|Sirolimus|sirolimus|mesh-list
153742254|NCT00525889|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153742255|NCT00525889|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153742256|NCT00525889|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153742257|NCT00525889|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153742258|NCT00525889|Antifungal Agents|antifungal agents|mesh-ancestor
153742305|NCT00167817|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153742306|NCT00167817|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
153742307|NCT00167817|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
153565904|NCT06222801|Antiviral Agents|antiviral agents|mesh-ancestor
153565905|NCT06222801|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153565906|NCT06222723|Ribavirin|ribavirin|mesh-list
153742308|NCT02947711|Diltiazem|diltiazem|mesh-list
153742309|NCT02947711|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153742310|NCT02947711|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153742311|NCT02947711|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153742312|NCT02947711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153742313|NCT02947711|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153742314|NCT02947711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153742315|NCT02947711|Vasodilator Agents|vasodilator agents|mesh-ancestor
153742316|NCT03845348|Ketoconazole|ketoconazole|mesh-list
153742317|NCT03845348|Antifungal Agents|antifungal agents|mesh-ancestor
153742318|NCT03845348|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153742319|NCT03845348|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
153742328|NCT04723563|Heparin|heparin|mesh-list
153742361|NCT00526006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153742363|NCT02946814|Sodium Fluoride|sodium fluoride|mesh-list
153742364|NCT02946814|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
153742365|NCT02946814|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153742366|NCT02946814|Cariostatic Agents|cariostatic agents|mesh-ancestor
153742367|NCT02946814|Protective Agents|protective agents|mesh-ancestor
153742430|NCT02947672|Antiemetics|antiemetics|mesh-ancestor
153742431|NCT02947672|Autonomic Agents|autonomic agents|mesh-ancestor
153742432|NCT02947672|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153742433|NCT02947672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153742434|NCT02947672|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153742436|NCT02947672|Hormones|hormones|mesh-ancestor
153742437|NCT02947672|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153742438|NCT02947672|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153565996|NCT06192160|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153742439|NCT02947672|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153742440|NCT03539627|Azilsartan medoxomil|azilsartan medoxomil|mesh-list
153742441|NCT03539627|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
153742442|NCT03539627|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
153742443|NCT03539627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153742444|NCT02946268|Ropivacaine|ropivacaine|mesh-list
153742445|NCT02946268|Anesthetics, Local|anesthetics, local|mesh-ancestor
153742446|NCT02946268|Anesthetics|anesthetics|mesh-ancestor
153565997|NCT06192160|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153565998|NCT06192160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153565999|NCT06192160|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
153566000|NCT06192160|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
153566001|NCT06192160|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
153566002|NCT06192160|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
153566003|NCT06192160|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
153566004|NCT06192160|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
153566005|NCT06192160|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
153566006|NCT06192160|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153742447|NCT02946268|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153566021|NCT06144944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153742448|NCT02946268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153742449|NCT02946268|Sensory System Agents|sensory system agents|mesh-ancestor
153742450|NCT02946268|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153742451|NCT00168051|Factor VIII|factor viii|mesh-list
153742485|NCT00526318|Dermatologic Agents|dermatologic agents|mesh-ancestor
153742486|NCT00526318|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
153742487|NCT04693312|Methylprednisolone|methylprednisolone|mesh-list
153742488|NCT04693312|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
153742489|NCT04693312|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
153742490|NCT04693312|Prednisolone|prednisolone|mesh-list
153742491|NCT04693312|Prednisolone acetate|prednisolone acetate|mesh-list
153742492|NCT04693312|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
153742493|NCT04693312|Prednisolone phosphate|prednisolone phosphate|mesh-list
153742494|NCT04693312|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153742495|NCT04693312|Antiemetics|antiemetics|mesh-ancestor
153742496|NCT04693312|Autonomic Agents|autonomic agents|mesh-ancestor
153742497|NCT04693312|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153742498|NCT04693312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153742499|NCT04693312|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153742500|NCT04693312|Glucocorticoids|glucocorticoids|mesh-ancestor
153742501|NCT04693312|Hormones|hormones|mesh-ancestor
153742503|NCT04693312|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
153742544|NCT03186755|Protective Agents|protective agents|mesh-ancestor
153742545|NCT03186755|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153742547|NCT03186755|Analgesics|analgesics|mesh-ancestor
153742548|NCT03186755|Sensory System Agents|sensory system agents|mesh-ancestor
153742549|NCT03186755|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153742550|NCT03186755|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153742551|NCT03186755|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153742552|NCT03186755|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
153742553|NCT03186755|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
153742554|NCT03186755|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
153742555|NCT03186755|Histamine Antagonists|histamine antagonists|mesh-ancestor
153742556|NCT03186755|Histamine Agents|histamine agents|mesh-ancestor
153742557|NCT03186755|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153742558|NCT03186755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153742559|NCT00525616|Rituximab|rituximab|mesh-list
153742560|NCT00525616|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153742600|NCT00527020|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
153742601|NCT00527020|Autonomic Agents|autonomic agents|mesh-ancestor
153742602|NCT00527020|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153742603|NCT00527020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153742604|NCT00527020|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
153742605|NCT00527020|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
153742606|NCT00527020|Cholinergic Agents|cholinergic agents|mesh-ancestor
153742607|NCT00527020|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153742608|NCT00527020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153742662|NCT02945956|Antiviral Agents|antiviral agents|mesh-ancestor
153742663|NCT02945956|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153742664|NCT00527137|Darbepoetin alfa|darbepoetin alfa|mesh-list
153742665|NCT00527137|Hematinics|hematinics|mesh-ancestor
153742666|NCT02945839|Topiramate|topiramate|mesh-list
153742667|NCT02945839|Anticonvulsants|anticonvulsants|mesh-ancestor
153742668|NCT02945839|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153742669|NCT02945839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153742670|NCT02957786|Varenicline|varenicline|mesh-list
153742671|NCT02957786|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
153742681|NCT03109964|Surgiflo|surgiflo|mesh-list
153742728|NCT00173667|Vasodilator Agents|vasodilator agents|mesh-ancestor
153742729|NCT00173667|Tocolytic Agents|tocolytic agents|mesh-ancestor
153742730|NCT00173667|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153742731|NCT00516685|Monatide (IMS 3015)|monatide (ims 3015)|mesh-list
153742732|NCT00516685|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153742733|NCT00516685|Immunologic Factors|immunologic factors|mesh-ancestor
153742734|NCT00516685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153742735|NCT03458689|Analgesics|analgesics|mesh-list
153742795|NCT02448095|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153742796|NCT02448095|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153742797|NCT02448095|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153742798|NCT02448095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153742799|NCT02448095|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153742800|NCT00168402|Botulinum Toxins|botulinum toxins|mesh-list
153742801|NCT00168402|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
153742802|NCT00168402|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
153742803|NCT00168402|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
153742804|NCT00168402|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153742805|NCT00168402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153742806|NCT00168402|Cholinergic Agents|cholinergic agents|mesh-ancestor
153742807|NCT00168402|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153742808|NCT00168402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153742809|NCT00168402|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
153742810|NCT00168402|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153742811|NCT00529594|Etoricoxib|etoricoxib|mesh-list
153742848|NCT00529867|Lumefantrine|lumefantrine|mesh-list
153742849|NCT00529867|Artemether|artemether|mesh-list
153742850|NCT00529867|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
153742851|NCT00529867|Antimalarials|antimalarials|mesh-ancestor
153742852|NCT00529867|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153742853|NCT00529867|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153742854|NCT00529867|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153742855|NCT00168441|Botulinum Toxins|botulinum toxins|mesh-list
153742856|NCT00168441|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
153742857|NCT00168441|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
153742858|NCT00168441|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
153742859|NCT00168441|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153742860|NCT00168441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153742861|NCT00168441|Cholinergic Agents|cholinergic agents|mesh-ancestor
153742878|NCT00527449|Docetaxel|docetaxel|mesh-list
153742908|NCT04692376|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153742909|NCT00527683|Vigabatrin|vigabatrin|mesh-list
153742910|NCT00527683|Anticonvulsants|anticonvulsants|mesh-ancestor
153742911|NCT00527683|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153742912|NCT00527683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153742913|NCT00527683|GABA Agents|gaba agents|mesh-ancestor
153742914|NCT00527683|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153742915|NCT00527683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153742916|NCT00173901|Ceftazidime|ceftazidime|mesh-list
153742917|NCT00173901|Third Generation Cephalosporins|third generation cephalosporins|mesh-ancestor
153742973|NCT00144677|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
153742974|NCT00144677|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153742975|NCT00144677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153742976|NCT00144677|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153742977|NCT00144677|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153742978|NCT00144677|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153742979|NCT00144677|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153742980|NCT00144677|Antifungal Agents|antifungal agents|mesh-ancestor
153742981|NCT00531076|Bevacizumab|bevacizumab|mesh-list
153742982|NCT00531076|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153742983|NCT00531076|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153742984|NCT00531076|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153742985|NCT00531076|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153742986|NCT00531076|Growth Substances|growth substances|mesh-ancestor
153742987|NCT00531076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153742988|NCT00531076|Growth Inhibitors|growth inhibitors|mesh-ancestor
153742990|NCT00531115|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153742991|NCT00531115|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153742992|NCT00144716|Insect Repellents|insect repellents|mesh-list
153742993|NCT00144716|Protective Agents|protective agents|mesh-ancestor
153742994|NCT00144716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153742995|NCT00531193|3-(4-amino-3-methylbenzyl)-7-(2-furyl)-3H-(1,2,3)triazolo(4,5-d)pyrimidine-5-amine|3-(4-amino-3-methylbenzyl)-7-(2-furyl)-3h-(1,2,3)triazolo(4,5-d)pyrimidine-5-amine|mesh-list
153742996|NCT00531193|SCH 442416|sch 442416|mesh-list
153742997|NCT00531193|Adenosine A2 Receptor Antagonists|adenosine a2 receptor antagonists|mesh-ancestor
153742998|NCT00531193|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
153742999|NCT00531193|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
153743000|NCT00531193|Purinergic Agents|purinergic agents|mesh-ancestor
153743001|NCT00531193|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153743004|NCT00144755|Darbepoetin alfa|darbepoetin alfa|mesh-list
153743014|NCT00531310|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153743015|NCT00531310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153743016|NCT00531310|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153743017|NCT00531310|Immunologic Factors|immunologic factors|mesh-ancestor
153743018|NCT00531310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153743019|NCT00531310|Alkylating Agents|alkylating agents|mesh-ancestor
153743020|NCT00531310|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153743021|NCT00531310|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153743022|NCT00407862|Losartan|losartan|mesh-list
153566094|NCT06009055|Anesthetics|anesthetics|mesh-ancestor
153566095|NCT06007508|Insulin Glargine|insulin glargine|mesh-list
153566096|NCT06007508|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153566097|NCT06007508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153566098|NCT05995535|Lofexidine|lofexidine|mesh-list
153743023|NCT00407862|Telmisartan|telmisartan|mesh-list
153743025|NCT00407862|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153743076|NCT00528073|Rifaximin|rifaximin|mesh-list
153743077|NCT00528073|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153743078|NCT00528073|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153743079|NCT00528073|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153743080|NCT00528151|Curcumin|curcumin|mesh-list
153743081|NCT00528151|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153743082|NCT00528151|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153743083|NCT00528151|Analgesics|analgesics|mesh-ancestor
153743084|NCT00528151|Sensory System Agents|sensory system agents|mesh-ancestor
153743085|NCT00528151|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153743138|NCT00168636|Vitamins|vitamins|mesh-ancestor
153743139|NCT00168636|Micronutrients|micronutrients|mesh-ancestor
153743140|NCT00168636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153743141|NCT00144989|Cisplatin|cisplatin|mesh-list
153743142|NCT00144989|Irinotecan|irinotecan|mesh-list
153743143|NCT00144989|Etoposide|etoposide|mesh-list
153743144|NCT00144989|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153743145|NCT00144989|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
153743146|NCT00144989|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153743147|NCT00144989|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153743148|NCT00144989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153743149|NCT00144989|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153743150|NCT00144989|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153743200|NCT00145028|Carboplatin|carboplatin|mesh-list
153743201|NCT00145028|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153743202|NCT00528814|Hand Sanitizers|hand sanitizers|mesh-list
153743203|NCT00528814|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
153743204|NCT00528814|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153743205|NCT00528814|Disinfectants|disinfectants|mesh-ancestor
153743206|NCT00168753|Alefacept|alefacept|mesh-list
153743207|NCT00168753|Dermatologic Agents|dermatologic agents|mesh-ancestor
153743208|NCT00168753|Immunologic Factors|immunologic factors|mesh-ancestor
153743209|NCT00168753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153743210|NCT00528892|Raltegravir Potassium|raltegravir potassium|mesh-list
153743211|NCT00528892|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153743212|NCT00528892|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153743213|NCT00528892|Antiviral Agents|antiviral agents|mesh-ancestor
153743214|NCT00528892|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153743215|NCT00528892|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
153743262|NCT02944357|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153743264|NCT02944357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153743265|NCT02944357|Immunologic Factors|immunologic factors|mesh-ancestor
153743266|NCT02944357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153743267|NCT02944396|Paclitaxel|paclitaxel|mesh-list
153743268|NCT02944396|Carboplatin|carboplatin|mesh-list
153743269|NCT02944396|Nivolumab|nivolumab|mesh-list
153743270|NCT02944396|Pemetrexed|pemetrexed|mesh-list
153743271|NCT02944396|Veliparib|veliparib|mesh-list
153743272|NCT02944396|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153743274|NCT02944396|Tubulin Modulators|tubulin modulators|mesh-ancestor
153743323|NCT00168870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153743324|NCT00168870|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153743325|NCT00168870|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153743392|NCT00531856|Carbon Monoxide|carbon monoxide|mesh-list
153743393|NCT00531856|Antimetabolites|antimetabolites|mesh-ancestor
153566119|NCT05995535|Adrenergic Agents|adrenergic agents|mesh-ancestor
153566120|NCT05995535|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153566122|NCT05995535|Autonomic Agents|autonomic agents|mesh-ancestor
153566123|NCT05994287|Aspirin|aspirin|mesh-list
153566124|NCT05994287|Celecoxib|celecoxib|mesh-list
153566125|NCT05994287|Ketorolac|ketorolac|mesh-list
153566126|NCT05994287|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153566127|NCT05994287|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153566128|NCT05994287|Analgesics|analgesics|mesh-ancestor
153566157|NCT05992428|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153566158|NCT05992428|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
153743394|NCT00531856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153743395|NCT00531856|Gasotransmitters|gasotransmitters|mesh-ancestor
153743396|NCT00531856|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153743397|NCT00531856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153743398|NCT00531895|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
153743399|NCT00531895|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
153743405|NCT00531895|Analgesics|analgesics|mesh-ancestor
153743457|NCT05319301|Antioxidants|antioxidants|mesh-ancestor
153743458|NCT05319301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153743459|NCT05319301|Protective Agents|protective agents|mesh-ancestor
153743460|NCT05319301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153743461|NCT05319301|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153743463|NCT00169065|Clozapine|clozapine|mesh-list
153743464|NCT00169065|Antiemetics|antiemetics|mesh-ancestor
153743465|NCT00169065|Autonomic Agents|autonomic agents|mesh-ancestor
153743466|NCT00169065|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153743467|NCT00169065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153743468|NCT00169065|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153743469|NCT00169065|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153743470|NCT00169065|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153743471|NCT00169065|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153743472|NCT00169065|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153743473|NCT00169065|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
153743474|NCT00169065|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153743475|NCT00169065|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153743511|NCT02942680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153743512|NCT02942680|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153743513|NCT02942680|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153743514|NCT02942680|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153743516|NCT00174564|Oxaliplatin|oxaliplatin|mesh-list
153743519|NCT02276911|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153743520|NCT02276911|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153743521|NCT02276911|Analgesics|analgesics|mesh-ancestor
153743522|NCT02276911|Sensory System Agents|sensory system agents|mesh-ancestor
153743523|NCT02276911|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153566159|NCT05992428|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
153743524|NCT02276911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153743571|NCT02942758|Pioglitazone|pioglitazone|mesh-list
153743572|NCT02942758|Azacitidine|azacitidine|mesh-list
153743573|NCT02942758|Tretinoin|tretinoin|mesh-list
153743574|NCT02942758|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153743575|NCT02942758|Antimetabolites|antimetabolites|mesh-ancestor
153743576|NCT02942758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153743577|NCT02942758|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153743578|NCT02942758|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153743579|NCT02942758|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153743581|NCT02942758|Keratolytic Agents|keratolytic agents|mesh-ancestor
153743636|NCT00174642|Insulin glulisine|insulin glulisine|mesh-list
153743637|NCT00174642|Secretagogues|secretagogues|mesh-list
153743638|NCT00174642|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153743639|NCT00174642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153743640|NCT00174681|Insulin Glargine|insulin glargine|mesh-list
153743641|NCT00174681|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153743642|NCT00174681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153743643|NCT00146042|Erythromycin|erythromycin|mesh-list
153743644|NCT00146042|Erythromycin Estolate|erythromycin estolate|mesh-list
153743645|NCT00146042|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
153743646|NCT00146042|Erythromycin stearate|erythromycin stearate|mesh-list
153743647|NCT00146042|Docetaxel|docetaxel|mesh-list
153566160|NCT05992428|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153566161|NCT05992428|Adrenergic Agents|adrenergic agents|mesh-ancestor
153566162|NCT05992428|Urological Agents|urological agents|mesh-ancestor
153566163|NCT05992428|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
153566164|NCT05992428|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
153880136|NCT02741570|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153880137|NCT02730416|Paclitaxel|paclitaxel|mesh-list
153743648|NCT00146042|Trastuzumab|trastuzumab|mesh-list
153743649|NCT00146042|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153743650|NCT00146042|Tubulin Modulators|tubulin modulators|mesh-ancestor
153743651|NCT00146042|Antimitotic Agents|antimitotic agents|mesh-ancestor
153743652|NCT00146042|Mitosis Modulators|mitosis modulators|mesh-ancestor
153743695|NCT00174720|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153743696|NCT00174720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153743697|NCT00174720|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
153743698|NCT02942212|Nicotine|nicotine|mesh-list
153743699|NCT02942212|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
153743700|NCT02942212|Autonomic Agents|autonomic agents|mesh-ancestor
153743701|NCT02942212|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153743702|NCT02942212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153743703|NCT02942212|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
153743704|NCT02942212|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
153743709|NCT00146120|Idarubicin|idarubicin|mesh-list
153743759|NCT00174759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153743760|NCT00174759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153743761|NCT00146237|Phenytoin|phenytoin|mesh-list
153743762|NCT00146237|Anticonvulsants|anticonvulsants|mesh-ancestor
153743763|NCT00146237|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
153743764|NCT00146237|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153743765|NCT00146237|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153743766|NCT00146237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153743767|NCT00146237|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
153880138|NCT02730416|Carboplatin|carboplatin|mesh-list
153880139|NCT02730416|Nintedanib|nintedanib|mesh-list
153566165|NCT05992428|Cholinergic Agents|cholinergic agents|mesh-ancestor
153566166|NCT05991401|Clarithromycin|clarithromycin|mesh-list
153566167|NCT05991401|Rifampin|rifampin|mesh-list
153566168|NCT05991401|DA-8010|da-8010|mesh-list
153566169|NCT05991401|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153566170|NCT05991401|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153566171|NCT05991401|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
153566172|NCT05991401|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153566173|NCT05991401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153566174|NCT05991401|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
153566175|NCT05991401|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153566176|NCT05991401|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
153566177|NCT05991401|Antitubercular Agents|antitubercular agents|mesh-ancestor
153566178|NCT05991401|Leprostatic Agents|leprostatic agents|mesh-ancestor
153566179|NCT05991401|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153566180|NCT05991401|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
153566186|NCT05991401|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
153743768|NCT00146237|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
153743769|NCT02277067|Misoprostol|misoprostol|mesh-list
153743770|NCT02277067|Carbetocin|carbetocin|mesh-list
153743771|NCT02277067|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
153743772|NCT02277067|Abortifacient Agents|abortifacient agents|mesh-ancestor
153743773|NCT02277067|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153743774|NCT02277067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153743775|NCT02277067|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
153743776|NCT02277067|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153743777|NCT02277067|Oxytocics|oxytocics|mesh-ancestor
153743778|NCT00146276|Gemcitabine|gemcitabine|mesh-list
153743779|NCT00146276|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153743780|NCT00146276|Antimetabolites|antimetabolites|mesh-ancestor
153743781|NCT00146276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153743782|NCT00146276|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153743791|NCT02940808|Caffeine|caffeine|mesh-list
153743806|NCT00174876|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153743807|NCT00174876|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153743808|NCT00174876|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153743809|NCT00174876|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153743810|NCT00174876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153743811|NCT00174876|Dopamine Agonists|dopamine agonists|mesh-ancestor
153743812|NCT00174876|Dopamine Agents|dopamine agents|mesh-ancestor
153743813|NCT00174876|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153743814|NCT00174876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153743815|NCT00174876|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
153782967|NCT00235313|Cholinergic Agents|cholinergic agents|mesh-ancestor
153782968|NCT00235313|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153782969|NCT00235313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153782970|NCT04549012|Tranexamic Acid|tranexamic acid|mesh-list
153782971|NCT04549012|Oxytocin|oxytocin|mesh-list
153782972|NCT04549012|Oxytocics|oxytocics|mesh-ancestor
153782973|NCT04549012|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153782974|NCT04549012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153566198|NCT05899127|Remifentanil|remifentanil|mesh-list
153566199|NCT05899127|Dsuvia|dsuvia|mesh-list
153566200|NCT05899127|Propofol|propofol|mesh-list
153566201|NCT05899127|Etomidate|etomidate|mesh-list
153566202|NCT05899127|Rocuronium|rocuronium|mesh-list
153566203|NCT05899127|Anesthetics, Local|anesthetics, local|mesh-ancestor
153566204|NCT05899127|Anesthetics|anesthetics|mesh-ancestor
153566205|NCT05899127|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153566206|NCT05899127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153566207|NCT05899127|Sensory System Agents|sensory system agents|mesh-ancestor
153743816|NCT00174876|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
153743817|NCT00174876|Serotonin Agents|serotonin agents|mesh-ancestor
153743818|NCT00174876|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
153743819|NCT00174876|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153743820|NCT00174876|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
153743864|NCT00146549|Mitosis Modulators|mitosis modulators|mesh-ancestor
153743865|NCT00146549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153743866|NCT00146549|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153743867|NCT02940535|Triptorelin Pamoate|triptorelin pamoate|mesh-list
153743868|NCT02940535|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
153743869|NCT02940535|Menotropins|menotropins|mesh-list
153743870|NCT02940535|Luteolytic Agents|luteolytic agents|mesh-ancestor
153743871|NCT02940535|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
153743873|NCT02940535|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153743874|NCT02940535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153743875|NCT02940535|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
153743927|NCT00146627|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153743928|NCT00146627|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153743929|NCT00146627|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153743930|NCT00146627|Ornithine Decarboxylase Inhibitors|ornithine decarboxylase inhibitors|mesh-ancestor
153743931|NCT00146627|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153743932|NCT00146627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153743933|NCT00169533|Lapatinib|lapatinib|mesh-list
153743934|NCT00169533|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153743935|NCT00169533|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153743936|NCT00169533|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153743937|NCT00169533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153743938|NCT00169533|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153743990|NCT00169572|Hormones|hormones|mesh-ancestor
153743991|NCT00169572|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153743992|NCT00169572|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153743993|NCT00169572|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153743994|NCT00169572|Antipruritics|antipruritics|mesh-ancestor
153743995|NCT00169572|Dermatologic Agents|dermatologic agents|mesh-ancestor
153743996|NCT00169572|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
153743997|NCT00169572|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153581037|NCT01749072|Ifosfamide|ifosfamide|mesh-list
153743998|NCT00169572|Serotonin Agents|serotonin agents|mesh-ancestor
153743999|NCT00169572|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153744000|NCT00169572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153566254|NCT05753956|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153566255|NCT05753956|Serotonin Agents|serotonin agents|mesh-ancestor
153566256|NCT05753956|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153566257|NCT05753956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153566258|NCT05753956|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
153566259|NCT05745480|Analgesics, Opioid|analgesics, opioid|mesh-list
153566260|NCT05745480|Narcotics|narcotics|mesh-ancestor
153566261|NCT05745480|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153566262|NCT05745480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153566263|NCT05745480|Analgesics|analgesics|mesh-ancestor
153782975|NCT04549012|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
153782976|NCT04549012|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153744001|NCT00169572|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
153744003|NCT00146783|Sulfadoxine|sulfadoxine|mesh-list
153744047|NCT02943655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153744048|NCT02943655|Progestins|progestins|mesh-ancestor
153744050|NCT02943655|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153744051|NCT00175227|Furosemide|furosemide|mesh-list
153744052|NCT00175227|Mannitol|mannitol|mesh-list
153744053|NCT00175227|Diuretics|diuretics|mesh-ancestor
153744054|NCT00175227|Natriuretic Agents|natriuretic agents|mesh-ancestor
153744060|NCT02940262|Edetic Acid|edetic acid|mesh-list
153744113|NCT02939248|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153744114|NCT02939248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153744115|NCT02939248|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
153744116|NCT02938975|Permethrin|permethrin|mesh-list
153744117|NCT02938975|Insect Repellents|insect repellents|mesh-list
153744118|NCT02938975|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153744119|NCT02938975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153744120|NCT02938975|Protective Agents|protective agents|mesh-ancestor
153744121|NCT02938975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153744122|NCT02939092|Chlorhexidine|chlorhexidine|mesh-list
153744123|NCT02939092|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
153744124|NCT02939092|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153744125|NCT02939092|Disinfectants|disinfectants|mesh-ancestor
153744126|NCT00175305|Octreotide|octreotide|mesh-list
153744127|NCT00175305|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153744128|NCT00175305|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153744129|NCT00175305|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153744130|NCT02938741|Thymoglobulin|thymoglobulin|mesh-list
153744131|NCT02938741|Immunologic Factors|immunologic factors|mesh-ancestor
153744132|NCT02938741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153744133|NCT02938741|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153744134|NCT00407589|Besifloxacin|besifloxacin|mesh-list
153744135|NCT00407589|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153744136|NCT00407589|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153744137|NCT00407589|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153744138|NCT00407589|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153744139|NCT00407589|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153744140|NCT00407589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153744141|NCT00407589|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153744142|NCT02938546|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
153744143|NCT02938546|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
153744144|NCT02938546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153782989|NCT00268515|Azathioprine|azathioprine|mesh-list
153782990|NCT00268515|Tacrolimus|tacrolimus|mesh-list
153782991|NCT00268515|Cyclosporins|cyclosporins|mesh-list
153566266|NCT05732961|Luspatercept|luspatercept|mesh-list
153566267|NCT05732961|Hematinics|hematinics|mesh-ancestor
153566268|NCT05706870|Clobetasol|clobetasol|mesh-list
153566269|NCT05706870|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153566270|NCT05706870|Glucocorticoids|glucocorticoids|mesh-ancestor
153566271|NCT05706870|Hormones|hormones|mesh-ancestor
153566272|NCT05706870|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153566286|NCT05655689|Vancomycin|vancomycin|mesh-list
153744154|NCT02938468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153744155|NCT02938468|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153744156|NCT02938468|Glucocorticoids|glucocorticoids|mesh-ancestor
153744157|NCT02938468|Hormones|hormones|mesh-ancestor
153566287|NCT05655689|Gentamicins|gentamicins|mesh-list
153744158|NCT02938468|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153744159|NCT02938468|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153744160|NCT02938468|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153581271|NCT01750099|Narcotics|narcotics|mesh-ancestor
153744221|NCT00147680|Carboplatin|carboplatin|mesh-list
153744222|NCT00147680|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153744223|NCT00147680|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153744224|NCT00147680|Tubulin Modulators|tubulin modulators|mesh-ancestor
153744225|NCT00147680|Antimitotic Agents|antimitotic agents|mesh-ancestor
153744226|NCT00147680|Mitosis Modulators|mitosis modulators|mesh-ancestor
153744227|NCT00147680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153744228|NCT02940184|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
153744229|NCT02940184|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153744230|NCT02940184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153744231|NCT02940184|Incretins|incretins|mesh-ancestor
153744232|NCT02940184|Hormones|hormones|mesh-ancestor
153744233|NCT02940184|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153744234|NCT02940184|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
153744235|NCT02940184|Protease Inhibitors|protease inhibitors|mesh-ancestor
153744236|NCT02940184|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153744237|NCT02940184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153744238|NCT03458143|Ketamine|ketamine|mesh-list
153744239|NCT03458143|Remifentanil|remifentanil|mesh-list
153744240|NCT03458143|Analgesics|analgesics|mesh-ancestor
153744272|NCT05273671|Sensory System Agents|sensory system agents|mesh-ancestor
153744273|NCT05273671|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153744274|NCT05273671|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
153744275|NCT05273671|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153744276|NCT05273671|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153744277|NCT05273671|Adrenergic Agents|adrenergic agents|mesh-ancestor
153566288|NCT05655689|Ceftazidime|ceftazidime|mesh-list
153566289|NCT05655689|Natamycin|natamycin|mesh-list
153566290|NCT05655689|Voriconazole|voriconazole|mesh-list
153566291|NCT05655689|Ophthalmic Solutions|ophthalmic solutions|mesh-list
153566292|NCT05655689|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
153566293|NCT05655689|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153566294|NCT05655689|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153566295|NCT05655689|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153566296|NCT05655689|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153566297|NCT05655689|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153566305|NCT05655689|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153566306|NCT05655689|Hormone Antagonists|hormone antagonists|mesh-ancestor
153566307|NCT05655689|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153566308|NCT05655689|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
153566309|NCT05655689|Third Generation Cephalosporins|third generation cephalosporins|mesh-ancestor
153744278|NCT05273671|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153744279|NCT05273671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153744338|NCT00147875|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153744339|NCT00147875|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153744341|NCT00147875|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153744342|NCT00147875|Glucocorticoids|glucocorticoids|mesh-ancestor
153744344|NCT00147875|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153744345|NCT00147875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153744346|NCT00147875|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153744347|NCT00147875|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153744348|NCT00147875|Tubulin Modulators|tubulin modulators|mesh-ancestor
153744349|NCT00147875|Antimitotic Agents|antimitotic agents|mesh-ancestor
153744350|NCT00147875|Mitosis Modulators|mitosis modulators|mesh-ancestor
153744351|NCT00169923|Rosiglitazone|rosiglitazone|mesh-list
153744352|NCT00169923|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153744353|NCT00169923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153744354|NCT00147914|Amoxicillin|amoxicillin|mesh-list
153744355|NCT00147914|Clavulanic Acid|clavulanic acid|mesh-list
153744356|NCT00147914|Clavulanic Acids|clavulanic acids|mesh-list
153744357|NCT00147914|Cefdinir|cefdinir|mesh-list
153744359|NCT00147914|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153744390|NCT00175617|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
153744391|NCT00175617|Diuretics|diuretics|mesh-ancestor
153744392|NCT00175617|Natriuretic Agents|natriuretic agents|mesh-ancestor
153744393|NCT00175617|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153744394|NCT00175617|Vasodilator Agents|vasodilator agents|mesh-ancestor
153744395|NCT02930707|Magnesium Sulfate|magnesium sulfate|mesh-list
153744396|NCT02930707|Bupivacaine|bupivacaine|mesh-list
153744397|NCT02930707|Anesthetics, Local|anesthetics, local|mesh-ancestor
153744398|NCT02930707|Anesthetics|anesthetics|mesh-ancestor
153744399|NCT02930707|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153744400|NCT02930707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153744401|NCT02930707|Sensory System Agents|sensory system agents|mesh-ancestor
153744402|NCT02930707|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153744403|NCT02930707|Analgesics|analgesics|mesh-ancestor
153744404|NCT02930707|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153744405|NCT02930707|Anticonvulsants|anticonvulsants|mesh-ancestor
153566323|NCT05539053|Antiviral Agents|antiviral agents|mesh-ancestor
153566324|NCT05539053|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153566325|NCT05539053|Expectorants|expectorants|mesh-ancestor
153566326|NCT05539053|Respiratory System Agents|respiratory system agents|mesh-ancestor
153566327|NCT05539053|Free Radical Scavengers|free radical scavengers|mesh-ancestor
153566328|NCT05539053|Antioxidants|antioxidants|mesh-ancestor
153566329|NCT05539053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153566330|NCT05539053|Protective Agents|protective agents|mesh-ancestor
153566331|NCT05539053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153782992|NCT00268515|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153782993|NCT00268515|Glucocorticoids|glucocorticoids|mesh-ancestor
153782994|NCT00268515|Hormones|hormones|mesh-ancestor
153782996|NCT00268515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153744406|NCT02930707|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153359823|NCT03810417|Antibodies|antibodies|mesh-list
153744408|NCT02930707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153744409|NCT02930707|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153744411|NCT02930707|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153744444|NCT00175695|Anticoagulants|anticoagulants|mesh-ancestor
153744445|NCT00175695|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153744446|NCT00175695|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153744447|NCT00175695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153744448|NCT00175695|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153744515|NCT04689412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153744516|NCT04689412|Protective Agents|protective agents|mesh-ancestor
153744517|NCT04689412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153744518|NCT04689412|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153744519|NCT04689412|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153744520|NCT00148460|Tenecteplase|tenecteplase|mesh-list
153744521|NCT00148460|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153744522|NCT00148460|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153744523|NCT00148460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153744524|NCT00170196|Prednisone|prednisone|mesh-list
153744525|NCT00170196|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153744579|NCT00148499|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153744580|NCT00148499|Expectorants|expectorants|mesh-ancestor
153744581|NCT00148499|Respiratory System Agents|respiratory system agents|mesh-ancestor
153744582|NCT03457597|Pioglitazone|pioglitazone|mesh-list
153744583|NCT03457597|Tolbutamide|tolbutamide|mesh-list
153566339|NCT05536011|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
153566340|NCT05536011|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153566341|NCT05536011|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153566342|NCT05536011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153566343|NCT05536011|Dopamine Agents|dopamine agents|mesh-ancestor
153566344|NCT05536011|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153566345|NCT05536011|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
153566346|NCT05536011|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
153566347|NCT05536011|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
153566348|NCT05536011|Sympathomimetics|sympathomimetics|mesh-ancestor
153566349|NCT05536011|Autonomic Agents|autonomic agents|mesh-ancestor
153566350|NCT05536011|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153566351|NCT05536011|Adrenergic Agents|adrenergic agents|mesh-ancestor
153566352|NCT05536011|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
153566353|NCT05536011|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153566354|NCT05536011|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153566355|NCT05536011|Anesthetics, General|anesthetics, general|mesh-ancestor
153566356|NCT05536011|Anesthetics|anesthetics|mesh-ancestor
153566382|NCT05466279|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153566383|NCT05466279|GABA Modulators|gaba modulators|mesh-ancestor
153566384|NCT05466279|GABA Agents|gaba agents|mesh-ancestor
153566385|NCT05466279|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153744584|NCT03457597|Metoprolol|metoprolol|mesh-list
153744585|NCT03457597|Midazolam|midazolam|mesh-list
153566388|NCT05457257|Olaparib|olaparib|mesh-list
153566389|NCT05457257|Abiraterone Acetate|abiraterone acetate|mesh-list
153744586|NCT03457597|Omeprazole|omeprazole|mesh-list
153744587|NCT03457597|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153744588|NCT03457597|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153744647|NCT02928679|Hormones|hormones|mesh-ancestor
153744648|NCT02928679|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153744649|NCT02928601|Ondansetron|ondansetron|mesh-list
153744650|NCT02928601|Antiemetics|antiemetics|mesh-ancestor
153744651|NCT02928601|Autonomic Agents|autonomic agents|mesh-ancestor
153744652|NCT02928601|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153744653|NCT02928601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153744654|NCT02928601|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153744655|NCT02928601|Antipruritics|antipruritics|mesh-ancestor
153744656|NCT02928601|Dermatologic Agents|dermatologic agents|mesh-ancestor
153744657|NCT02928601|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
153744658|NCT02928601|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153744659|NCT02928601|Serotonin Agents|serotonin agents|mesh-ancestor
153744660|NCT02928601|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153744661|NCT02928601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153744707|NCT02927587|Propofol|propofol|mesh-list
153744708|NCT02927587|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153744710|NCT02927587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153744711|NCT02927587|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153744712|NCT02927587|Anesthetics, General|anesthetics, general|mesh-ancestor
153744713|NCT02927587|Anesthetics|anesthetics|mesh-ancestor
153744714|NCT00148850|Pioglitazone|pioglitazone|mesh-list
153744715|NCT00148850|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153744716|NCT00148850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153744717|NCT02927353|Adalimumab|adalimumab|mesh-list
153744772|NCT00149084|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153744773|NCT00149084|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153744774|NCT00149084|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
153744775|NCT00149084|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153744776|NCT00149084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153744777|NCT00149084|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
153744778|NCT00149084|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153744779|NCT00149084|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
153744780|NCT00149084|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153744781|NCT00149084|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
153566421|NCT05438602|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
153744782|NCT00170469|Aluminum Hydroxide|aluminum hydroxide|mesh-list
153744783|NCT00170469|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153744784|NCT00170469|Immunologic Factors|immunologic factors|mesh-ancestor
153744785|NCT00170469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153744786|NCT00170469|Antacids|antacids|mesh-ancestor
153744787|NCT00170469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153744788|NCT00170469|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153744789|NCT00149123|Hydrocortisone|hydrocortisone|mesh-list
153744790|NCT00149123|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153744826|NCT00149240|Cholinergic Agents|cholinergic agents|mesh-ancestor
153744827|NCT00149240|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153744828|NCT00149240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153744829|NCT00149240|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
153744830|NCT00149240|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153744831|NCT02925247|Anticoagulants|anticoagulants|mesh-list
153744832|NCT00170664|Paclitaxel|paclitaxel|mesh-list
153744833|NCT00170664|Carboplatin|carboplatin|mesh-list
153744834|NCT00170664|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153744835|NCT00170664|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153744836|NCT00170664|Tubulin Modulators|tubulin modulators|mesh-ancestor
153744837|NCT00170664|Antimitotic Agents|antimitotic agents|mesh-ancestor
153744838|NCT00170664|Mitosis Modulators|mitosis modulators|mesh-ancestor
153744839|NCT00170664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153744841|NCT00170742|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153744844|NCT02917525|Vitamin K|vitamin k|mesh-list
153744884|NCT02917018|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
153744885|NCT02917018|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153744886|NCT02917018|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153744887|NCT02917018|Adrenergic Agents|adrenergic agents|mesh-ancestor
153744888|NCT02917018|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153744889|NCT02917018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153744890|NCT00170859|Everolimus|everolimus|mesh-list
153744891|NCT00170859|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
153744893|NCT00170859|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153744946|NCT02916238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153744947|NCT02916238|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
153744948|NCT02916238|Antidepressive Agents|antidepressive agents|mesh-ancestor
153744949|NCT02916238|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153744950|NCT02916238|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
153744951|NCT02916238|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153744952|NCT02916238|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153744953|NCT00149708|Hormones|hormones|mesh-list
153744954|NCT00149708|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153744955|NCT00149708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153744956|NCT00163761|Gemcitabine|gemcitabine|mesh-list
153744957|NCT00163761|Vinorelbine|vinorelbine|mesh-list
153744958|NCT00163761|Ifosfamide|ifosfamide|mesh-list
153744959|NCT00163761|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153744960|NCT00163761|Antimetabolites|antimetabolites|mesh-ancestor
153744961|NCT00163761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153744962|NCT00163761|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153744963|NCT00163761|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153744964|NCT00163761|Tubulin Modulators|tubulin modulators|mesh-ancestor
153744965|NCT00163761|Antimitotic Agents|antimitotic agents|mesh-ancestor
153744966|NCT00163761|Mitosis Modulators|mitosis modulators|mesh-ancestor
153744967|NCT00163761|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153744969|NCT02916160|Valsartan|valsartan|mesh-list
153744995|NCT00149864|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153744996|NCT00149864|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
153744997|NCT00149864|Antitubercular Agents|antitubercular agents|mesh-ancestor
153744998|NCT00149864|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153744999|NCT00149864|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153745000|NCT00149864|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153745001|NCT00149864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153745002|NCT00149903|Mycophenolic Acid|mycophenolic acid|mesh-list
153745003|NCT00149903|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153745004|NCT00149903|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153745056|NCT05785234|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153745057|NCT05785234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153745058|NCT05785234|Analgesics|analgesics|mesh-ancestor
153745059|NCT05785234|Sensory System Agents|sensory system agents|mesh-ancestor
153745060|NCT05785234|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153745061|NCT05785234|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153745062|NCT05785234|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153745063|NCT05785234|Anesthetics, General|anesthetics, general|mesh-ancestor
153745064|NCT05785234|Anesthetics|anesthetics|mesh-ancestor
153745065|NCT05785208|Osimertinib|osimertinib|mesh-list
153745066|NCT05785208|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153745067|NCT05785208|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153745068|NCT05785208|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153745069|NCT05785208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153745070|NCT05785208|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153745071|NCT05785026|Menthol|menthol|mesh-list
153745072|NCT05785026|Antipruritics|antipruritics|mesh-ancestor
153745073|NCT05785026|Dermatologic Agents|dermatologic agents|mesh-ancestor
153745074|NCT05784987|Rituximab|rituximab|mesh-list
153745075|NCT05784987|Etoposide|etoposide|mesh-list
153745076|NCT05784987|Lenalidomide|lenalidomide|mesh-list
153745077|NCT05784987|Mitoxantrone|mitoxantrone|mesh-list
153745078|NCT05784987|Ifosfamide|ifosfamide|mesh-list
153745079|NCT05784987|Isophosphamide mustard|isophosphamide mustard|mesh-list
153745080|NCT05784987|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153745081|NCT05784987|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153745082|NCT05784987|Immunologic Factors|immunologic factors|mesh-ancestor
153566451|NCT06235424|Del Nido cardioplegia solution|del nido cardioplegia solution|mesh-list
153566452|NCT06235424|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
153566453|NCT06235411|Psilocybin|psilocybin|mesh-list
153566454|NCT06235411|Hallucinogens|hallucinogens|mesh-ancestor
153566455|NCT06235411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153566456|NCT06235411|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153566457|NCT06235294|Folic Acid|folic acid|mesh-list
153566458|NCT06235294|Resveratrol|resveratrol|mesh-list
153566459|NCT06235294|Hematinics|hematinics|mesh-ancestor
153745083|NCT05784987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153745084|NCT05784987|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153745085|NCT05784987|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153745086|NCT05784987|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153745087|NCT05784987|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153745099|NCT05784519|Ophthalmic Solutions|ophthalmic solutions|mesh-list
153745100|NCT05784519|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
153745101|NCT05784467|Methamphetamine|methamphetamine|mesh-list
153745102|NCT05784467|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
153745103|NCT05784467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153745104|NCT05784467|Sympathomimetics|sympathomimetics|mesh-ancestor
153745105|NCT05784467|Autonomic Agents|autonomic agents|mesh-ancestor
153745106|NCT05784467|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153745107|NCT05784467|Dopamine Agents|dopamine agents|mesh-ancestor
153745108|NCT05784467|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153745109|NCT05784467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153745110|NCT05784467|Adrenergic Agents|adrenergic agents|mesh-ancestor
153745111|NCT05784467|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
153745161|NCT05634577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153745162|NCT05634577|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153745164|NCT05616260|Anticonvulsants|anticonvulsants|mesh-ancestor
153745165|NCT05616260|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
153745166|NCT05616260|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153745167|NCT05616260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153745168|NCT05616260|Diuretics|diuretics|mesh-ancestor
153745169|NCT05616260|Natriuretic Agents|natriuretic agents|mesh-ancestor
153745170|NCT05616260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153745171|NCT05611034|Oxaliplatin|oxaliplatin|mesh-list
153745172|NCT05611034|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153745173|NCT05592509|Vitamins|vitamins|mesh-list
153745174|NCT05592509|Micronutrients|micronutrients|mesh-ancestor
153745175|NCT05592509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153745176|NCT05582213|Anesthetics|anesthetics|mesh-list
153745177|NCT05582213|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153566465|NCT06235294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153566466|NCT06235294|Protective Agents|protective agents|mesh-ancestor
153566467|NCT06235294|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153566468|NCT06235294|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153566471|NCT06235216|Sacituzumab govitecan|sacituzumab govitecan|mesh-list
153566472|NCT06235216|Immunoconjugates|immunoconjugates|mesh-ancestor
153566493|NCT06235099|Trace Elements|trace elements|mesh-ancestor
153566494|NCT06235099|Micronutrients|micronutrients|mesh-ancestor
153566495|NCT06235099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153566496|NCT06235086|Dulaglutide|dulaglutide|mesh-list
153745178|NCT05582213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153745179|NCT05550597|Fentanyl|fentanyl|mesh-list
153745180|NCT05550597|Bupivacaine|bupivacaine|mesh-list
153745181|NCT05550597|Anesthetics, Local|anesthetics, local|mesh-ancestor
153745182|NCT05550597|Anesthetics|anesthetics|mesh-ancestor
153745183|NCT05550597|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153745188|NCT05550597|Narcotics|narcotics|mesh-ancestor
153745207|NCT05334017|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153745208|NCT05334017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153745209|NCT05334017|Sensory System Agents|sensory system agents|mesh-ancestor
153745210|NCT05334017|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153745211|NCT05334017|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
153745212|NCT05334017|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
153745213|NCT05334017|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153745214|NCT05334017|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153745215|NCT05334017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153745216|NCT05334017|Dopamine Agents|dopamine agents|mesh-ancestor
153745217|NCT05334017|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153745218|NCT05334017|Nasal Decongestants|nasal decongestants|mesh-ancestor
153745219|NCT05334017|Respiratory System Agents|respiratory system agents|mesh-ancestor
153745220|NCT05292339|Triamcinolone|triamcinolone|mesh-list
153745221|NCT05292339|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
153745222|NCT05292339|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
153745263|NCT05157867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153566517|NCT06234813|Thrombin|thrombin|mesh-list
153566518|NCT06234813|Thromboplastin|thromboplastin|mesh-list
153566519|NCT06234813|Hemostatics|hemostatics|mesh-ancestor
153566520|NCT06234813|Coagulants|coagulants|mesh-ancestor
153783040|NCT00268554|Dipyridamole|dipyridamole|mesh-list
153566528|NCT06234813|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153566529|NCT06234813|Hormone Antagonists|hormone antagonists|mesh-ancestor
153566530|NCT06234813|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153566531|NCT06234813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153566532|NCT06234813|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
153566533|NCT06234813|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
153566535|NCT06234748|Carboplatin|carboplatin|mesh-list
153566536|NCT06234748|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153566537|NCT06234722|Nicotine|nicotine|mesh-list
153566538|NCT06234722|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
153566539|NCT06234722|Autonomic Agents|autonomic agents|mesh-ancestor
153566540|NCT06234722|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153566541|NCT06234722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153566542|NCT06234722|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
153566543|NCT06234722|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
153566544|NCT06234722|Cholinergic Agents|cholinergic agents|mesh-ancestor
153566545|NCT06234722|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153745264|NCT05131386|Trabectedin|trabectedin|mesh-list
153745265|NCT05131386|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153745266|NCT05131386|Alkylating Agents|alkylating agents|mesh-ancestor
153745267|NCT05131386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153745268|NCT05131386|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153745269|NCT05129332|Vitamin E|vitamin e|mesh-list
153745270|NCT05129332|Vitamins|vitamins|mesh-ancestor
153745271|NCT05129332|Micronutrients|micronutrients|mesh-ancestor
153745272|NCT05129332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153745273|NCT05129332|Antioxidants|antioxidants|mesh-ancestor
153745275|NCT05129332|Protective Agents|protective agents|mesh-ancestor
153745325|NCT04933630|Sympathomimetics|sympathomimetics|mesh-ancestor
153745326|NCT04933630|Autonomic Agents|autonomic agents|mesh-ancestor
153745327|NCT04933630|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153745398|NCT04532918|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153745399|NCT04532918|Dermatologic Agents|dermatologic agents|mesh-ancestor
153745400|NCT04532918|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153745401|NCT04532918|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
153745402|NCT04532918|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
153745403|NCT04532918|Antitubercular Agents|antitubercular agents|mesh-ancestor
153745404|NCT04532918|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153745468|NCT04335669|Tubulin Modulators|tubulin modulators|mesh-ancestor
153745469|NCT04335669|Antimitotic Agents|antimitotic agents|mesh-ancestor
153745470|NCT04335669|Mitosis Modulators|mitosis modulators|mesh-ancestor
153745471|NCT04335669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153745472|NCT04335669|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153745473|NCT04335669|Immunologic Factors|immunologic factors|mesh-ancestor
153745474|NCT04335669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153745475|NCT04335669|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153745534|NCT04015596|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153745535|NCT04015596|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153745537|NCT04015596|Sensory System Agents|sensory system agents|mesh-ancestor
153745538|NCT04015596|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153745539|NCT04015596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153745540|NCT04015596|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153745599|NCT03460314|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153745601|NCT03460210|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
153745602|NCT03460210|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
153745603|NCT03460210|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153745604|NCT03460210|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153745605|NCT03460210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153745606|NCT03460210|Adrenergic Agents|adrenergic agents|mesh-ancestor
153745607|NCT03460210|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153745616|NCT03440879|Goserelin|goserelin|mesh-list
153745663|NCT03249792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153745664|NCT03132675|Pembrolizumab|pembrolizumab|mesh-list
153745665|NCT03132675|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153745666|NCT03132675|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153745667|NCT03132675|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153745668|NCT03132675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153745669|NCT03110744|Palbociclib|palbociclib|mesh-list
153745670|NCT03110744|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153745671|NCT03110744|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153745672|NCT03110744|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153745727|NCT02406209|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153745728|NCT02406209|Glucocorticoids|glucocorticoids|mesh-ancestor
153745729|NCT02406209|Hormones|hormones|mesh-ancestor
153745730|NCT02406209|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153745731|NCT02406209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153745732|NCT02406209|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153745733|NCT02406209|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153745734|NCT02406209|Antiemetics|antiemetics|mesh-ancestor
153745735|NCT02406209|Autonomic Agents|autonomic agents|mesh-ancestor
153745736|NCT02406209|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153745737|NCT02406209|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153745738|NCT02406209|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
153745739|NCT02406209|Protective Agents|protective agents|mesh-ancestor
153745740|NCT02295722|Gemcitabine|gemcitabine|mesh-list
153745788|NCT00635700|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153745789|NCT00635700|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153745790|NCT00635700|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
153745791|NCT00635700|Dopamine Agents|dopamine agents|mesh-ancestor
153745793|NCT00582075|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153745794|NCT00582075|Alkylating Agents|alkylating agents|mesh-ancestor
153745795|NCT00582075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153745796|NCT00582075|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153745797|NCT00558961|Imatinib Mesylate|imatinib mesylate|mesh-list
153745798|NCT00558961|Chlorambucil|chlorambucil|mesh-list
153745799|NCT00558961|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153745800|NCT00558961|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153745801|NCT00558961|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153745802|NCT00558961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153745803|NCT00558961|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153745804|NCT00558961|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153745805|NCT00558961|Alkylating Agents|alkylating agents|mesh-ancestor
153745807|NCT00326456|Carboplatin|carboplatin|mesh-list
153745808|NCT00326456|Doxorubicin|doxorubicin|mesh-list
153745809|NCT00326456|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
153745810|NCT00326456|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153745811|NCT00326456|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153745812|NCT00326456|Tubulin Modulators|tubulin modulators|mesh-ancestor
153745813|NCT00326456|Antimitotic Agents|antimitotic agents|mesh-ancestor
153745814|NCT00326456|Mitosis Modulators|mitosis modulators|mesh-ancestor
153745815|NCT00326456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153745816|NCT00326456|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153745820|NCT00149942|Mycophenolic Acid|mycophenolic acid|mesh-list
153745831|NCT00149981|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153745832|NCT00149981|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153745833|NCT00149981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153745834|NCT00149981|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153745835|NCT00149981|Immunologic Factors|immunologic factors|mesh-ancestor
153745836|NCT00149981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153745837|NCT00149981|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153745838|NCT02915731|Vitamin A|vitamin a|mesh-list
153745842|NCT02915809|Vaccines|vaccines|mesh-list
153745895|NCT02914015|Morphine|morphine|mesh-list
153745896|NCT02914015|Ropivacaine|ropivacaine|mesh-list
153745897|NCT02914015|Anesthetics, Local|anesthetics, local|mesh-list
153745898|NCT02914015|Anesthetics|anesthetics|mesh-list
153745899|NCT02914015|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153745900|NCT02914015|Narcotics|narcotics|mesh-ancestor
153745901|NCT02914015|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153745902|NCT02914015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153745903|NCT02914015|Analgesics|analgesics|mesh-ancestor
153745904|NCT02914015|Sensory System Agents|sensory system agents|mesh-ancestor
153745905|NCT02914015|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153745906|NCT00171093|Valsartan|valsartan|mesh-list
153745907|NCT00171093|Simvastatin|simvastatin|mesh-list
153745958|NCT00171132|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153745960|NCT00171132|Autonomic Agents|autonomic agents|mesh-ancestor
153745961|NCT00171132|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153745962|NCT00171132|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
153745963|NCT00171132|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
153745964|NCT00171132|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
153745965|NCT00171132|Adrenergic Agents|adrenergic agents|mesh-ancestor
153745966|NCT00171132|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153745967|NCT02913859|Androgen Antagonists|androgen antagonists|mesh-list
153745968|NCT02913859|Hormone Antagonists|hormone antagonists|mesh-ancestor
153745969|NCT02913859|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153745970|NCT02913859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153745972|NCT00150137|Antithyroid Agents|antithyroid agents|mesh-ancestor
153745973|NCT00150137|Hormone Antagonists|hormone antagonists|mesh-ancestor
153745974|NCT00150137|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153745975|NCT00150137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153745976|NCT00150215|Olanzapine|olanzapine|mesh-list
153745977|NCT00150215|Antiemetics|antiemetics|mesh-ancestor
153745978|NCT00150215|Autonomic Agents|autonomic agents|mesh-ancestor
153745979|NCT00150215|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153746009|NCT02913430|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
153746010|NCT02913430|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153746012|NCT02913430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153746014|NCT02913469|Metoclopramide|metoclopramide|mesh-list
153746015|NCT02913469|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153746016|NCT02913469|Narcotics|narcotics|mesh-ancestor
153746017|NCT02913469|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153746018|NCT02913469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153746019|NCT02913469|Analgesics|analgesics|mesh-ancestor
153746020|NCT02913469|Sensory System Agents|sensory system agents|mesh-ancestor
153746021|NCT02913469|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153566606|NCT06234345|Beclomethasone|beclomethasone|mesh-list
153746022|NCT02913469|Antiemetics|antiemetics|mesh-ancestor
153746023|NCT02913469|Autonomic Agents|autonomic agents|mesh-ancestor
153746024|NCT02913469|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153746025|NCT02913469|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
153746026|NCT02913469|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
153746027|NCT02913469|Dopamine Agents|dopamine agents|mesh-ancestor
153746028|NCT02913469|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153746062|NCT02913118|Azithromycin|azithromycin|mesh-list
153746063|NCT02913118|Doxycycline|doxycycline|mesh-list
153746064|NCT02913118|Minocycline|minocycline|mesh-list
153746065|NCT02913118|Cephalosporins|cephalosporins|mesh-list
153746066|NCT02913118|Fluoroquinolones|fluoroquinolones|mesh-list
153746067|NCT02913118|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153746068|NCT02913118|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153746069|NCT02913118|Antimalarials|antimalarials|mesh-ancestor
153746070|NCT02913118|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153746071|NCT02913118|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153746072|NCT02913118|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153746129|NCT02912182|Antiemetics|antiemetics|mesh-ancestor
153746130|NCT02912182|Autonomic Agents|autonomic agents|mesh-ancestor
153746131|NCT02912182|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153746132|NCT02912182|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153746133|NCT02912182|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
153746134|NCT02912182|Protective Agents|protective agents|mesh-ancestor
153746135|NCT02912182|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153746136|NCT02912182|Respiratory System Agents|respiratory system agents|mesh-ancestor
153746137|NCT02912026|Olorofim|olorofim|mesh-list
153746138|NCT02912026|Antifungal Agents|antifungal agents|mesh-ancestor
153746139|NCT02912026|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153746141|NCT02911870|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153746142|NCT02911870|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153746143|NCT02911870|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153746144|NCT02911870|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153746145|NCT02911870|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153746146|NCT02911870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153746147|NCT02911870|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153746148|NCT02843230|Bevacizumab|bevacizumab|mesh-list
153746149|NCT02843230|Temozolomide|temozolomide|mesh-list
153746150|NCT02843230|Lomustine|lomustine|mesh-list
153746151|NCT02843230|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153746152|NCT02843230|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153746153|NCT02843230|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153746155|NCT02843230|Growth Substances|growth substances|mesh-ancestor
153746175|NCT00150527|Hormones|hormones|mesh-ancestor
153746176|NCT00150527|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153746177|NCT00150527|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153746178|NCT00150527|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153746179|NCT00150527|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
153746180|NCT00150527|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153746181|NCT00150527|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153746182|NCT00150527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153746183|NCT00150527|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153746184|NCT00150527|Serotonin Agents|serotonin agents|mesh-ancestor
153746185|NCT00150527|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
153746186|NCT00150527|Antidepressive Agents|antidepressive agents|mesh-ancestor
153746187|NCT00150527|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153746188|NCT00171327|Valsartan|valsartan|mesh-list
153746189|NCT00171327|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153746190|NCT00171327|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
153746191|NCT00171327|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
153746192|NCT00171327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153746193|NCT02911597|Naltrexone|naltrexone|mesh-list
153746194|NCT02911597|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
153746195|NCT02911597|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
153746196|NCT02911597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153746197|NCT02911597|Sensory System Agents|sensory system agents|mesh-ancestor
153746198|NCT02911597|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153746221|NCT00150605|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153746222|NCT00150605|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153746224|NCT00150605|Sensory System Agents|sensory system agents|mesh-ancestor
153746225|NCT00150605|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153746226|NCT00150605|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153746227|NCT00150605|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153746228|NCT00150605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153746229|NCT00150605|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
153746230|NCT00150605|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
153746231|NCT00171405|Aliskiren|aliskiren|mesh-list
153746232|NCT00171405|Renin Inhibitors|renin inhibitors|mesh-ancestor
153746233|NCT00171405|Protease Inhibitors|protease inhibitors|mesh-ancestor
153746234|NCT00171405|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153746235|NCT00171405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153746236|NCT02910778|Ticagrelor|ticagrelor|mesh-list
153746237|NCT02910778|Atorvastatin|atorvastatin|mesh-list
153746238|NCT02910778|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153746239|NCT02910778|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153746240|NCT02910778|Antimetabolites|antimetabolites|mesh-ancestor
153746241|NCT02910778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153746242|NCT02910778|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153746243|NCT02910778|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
153746244|NCT02910778|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153746245|NCT02910778|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153746246|NCT02910778|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
153746247|NCT02910778|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
153746248|NCT02910778|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
153746249|NCT02910778|Purinergic Agents|purinergic agents|mesh-ancestor
153566764|NCT06233565|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153746250|NCT02910778|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153746251|NCT02910778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153746252|NCT00164112|Azithromycin|azithromycin|mesh-list
153746253|NCT00164112|Levofloxacin|levofloxacin|mesh-list
153746254|NCT00164112|Telithromycin|telithromycin|mesh-list
153746255|NCT00164112|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153482237|NCT01432236|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153746256|NCT00164112|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153746257|NCT00164112|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
153746258|NCT00164112|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153746259|NCT00164112|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153746260|NCT00164112|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153746261|NCT00164112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153746321|NCT03782740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153746323|NCT03782740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153746324|NCT03782740|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153746325|NCT00532168|Ritonavir|ritonavir|mesh-list
153746326|NCT00532168|Lopinavir|lopinavir|mesh-list
153746327|NCT00532168|Atazanavir Sulfate|atazanavir sulfate|mesh-list
153746328|NCT00532168|Tenofovir|tenofovir|mesh-list
153746329|NCT00532168|Emtricitabine|emtricitabine|mesh-list
153746330|NCT00532168|Efavirenz|efavirenz|mesh-list
153746331|NCT00532168|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
153746332|NCT00532168|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
153746333|NCT00532168|Protease Inhibitors|protease inhibitors|mesh-ancestor
153746334|NCT00532168|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153746335|NCT00532168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153746336|NCT00532168|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153746337|NCT00532168|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153746338|NCT00532168|Antiviral Agents|antiviral agents|mesh-ancestor
153746339|NCT00532168|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153746340|NCT00532168|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
153746341|NCT00532168|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153746342|NCT00532168|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153746343|NCT00532168|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153746344|NCT00532168|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
153746345|NCT00532168|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
153746346|NCT00532168|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
153746347|NCT00532168|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
153746348|NCT00532168|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
153746349|NCT00532207|Teriparatide|teriparatide|mesh-list
153746350|NCT00532207|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153746351|NCT00532207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153746352|NCT00532207|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153746353|NCT04723836|Riboflavin|riboflavin|mesh-list
153746354|NCT04723836|Vitamins|vitamins|mesh-ancestor
153746355|NCT04723836|Micronutrients|micronutrients|mesh-ancestor
153746356|NCT04723836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153746358|NCT04723836|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
153746359|NCT04723836|Dermatologic Agents|dermatologic agents|mesh-ancestor
153746360|NCT00150995|Tetrathiomolybdate|tetrathiomolybdate|mesh-list
153746361|NCT00150995|Chelating Agents|chelating agents|mesh-ancestor
153746362|NCT00150995|Sequestering Agents|sequestering agents|mesh-ancestor
153783061|NCT00268593|Glucocorticoids|glucocorticoids|mesh-ancestor
153783063|NCT00268593|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153783064|NCT00268593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153783065|NCT00268593|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153783066|NCT04555525|Sarecycline|sarecycline|mesh-list
153746363|NCT00150995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153746364|NCT00150995|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153746365|NCT00150995|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153746366|NCT00150995|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153746367|NCT00150995|Growth Substances|growth substances|mesh-ancestor
153746368|NCT00150995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153746369|NCT00150995|Growth Inhibitors|growth inhibitors|mesh-ancestor
153746370|NCT00150995|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153746371|NCT00532246|Raloxifene Hydrochloride|raloxifene hydrochloride|mesh-list
153746372|NCT00532246|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
153746373|NCT00532246|Hormone Antagonists|hormone antagonists|mesh-ancestor
153746374|NCT00532246|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153746375|NCT00532246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153746413|NCT00171522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153746414|NCT00171522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153746415|NCT00151073|Zoledronic Acid|zoledronic acid|mesh-list
153746416|NCT00151073|Docetaxel|docetaxel|mesh-list
153746417|NCT00151073|Estramustine|estramustine|mesh-list
153746418|NCT00151073|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153746419|NCT00151073|Tubulin Modulators|tubulin modulators|mesh-ancestor
153746420|NCT00151073|Antimitotic Agents|antimitotic agents|mesh-ancestor
153746421|NCT00151073|Mitosis Modulators|mitosis modulators|mesh-ancestor
153746422|NCT00151073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153746423|NCT00151073|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153746424|NCT00151073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153746425|NCT00151073|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153746426|NCT00151073|Alkylating Agents|alkylating agents|mesh-ancestor
153746427|NCT00151073|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153746428|NCT00171561|Valsartan|valsartan|mesh-list
153746429|NCT00171561|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
153746430|NCT00171561|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153746431|NCT00171561|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
153746432|NCT00171561|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
153746433|NCT00171561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153746434|NCT00171561|Diuretics|diuretics|mesh-ancestor
153746435|NCT00171561|Natriuretic Agents|natriuretic agents|mesh-ancestor
153746436|NCT00171561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153746437|NCT00171561|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
153746439|NCT00151112|Anesthetics|anesthetics|mesh-list
153746457|NCT00171600|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
153746458|NCT00171600|Protease Inhibitors|protease inhibitors|mesh-ancestor
153746459|NCT00171600|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153746460|NCT00171600|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
153746461|NCT00171600|Protective Agents|protective agents|mesh-ancestor
153746462|NCT00171600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153746464|NCT05467384|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153746466|NCT05467384|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153746467|NCT05467384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153746468|NCT05467384|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153746469|NCT05467384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153746470|NCT05467384|Vasodilator Agents|vasodilator agents|mesh-ancestor
153746471|NCT05467189|Paclitaxel|paclitaxel|mesh-list
153746472|NCT05467189|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
153746473|NCT05467189|Busulfan|busulfan|mesh-list
153746474|NCT05467189|Lapatinib|lapatinib|mesh-list
153746475|NCT05467189|Afatinib|afatinib|mesh-list
153746476|NCT05467189|Crizotinib|crizotinib|mesh-list
153746477|NCT05467189|Ceritinib|ceritinib|mesh-list
153746478|NCT05467189|Antineoplastic Agents|antineoplastic agents|mesh-list
153746479|NCT05467189|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153746480|NCT05467189|Tubulin Modulators|tubulin modulators|mesh-ancestor
153746481|NCT05467189|Antimitotic Agents|antimitotic agents|mesh-ancestor
153746482|NCT05467189|Mitosis Modulators|mitosis modulators|mesh-ancestor
153746483|NCT05467189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153746484|NCT05467189|Alkylating Agents|alkylating agents|mesh-ancestor
153746485|NCT05467189|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153746486|NCT05467189|Immunologic Factors|immunologic factors|mesh-ancestor
153746487|NCT05467189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153746488|NCT05467189|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153746489|NCT05467189|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153746499|NCT05466604|Autonomic Agents|autonomic agents|mesh-ancestor
153746500|NCT05466604|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153746501|NCT05466604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153746502|NCT05466604|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153746503|NCT05466604|Glucocorticoids|glucocorticoids|mesh-ancestor
153746504|NCT05466604|Hormones|hormones|mesh-ancestor
153746505|NCT05466604|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153746506|NCT05466604|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153746507|NCT05466604|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153746508|NCT04723875|Paclitaxel|paclitaxel|mesh-list
153746509|NCT04723875|Docetaxel|docetaxel|mesh-list
153746510|NCT04723875|Carboplatin|carboplatin|mesh-list
153746511|NCT04723875|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153746512|NCT04723875|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153746513|NCT04723875|Tubulin Modulators|tubulin modulators|mesh-ancestor
153746514|NCT04723875|Antimitotic Agents|antimitotic agents|mesh-ancestor
153746515|NCT04723875|Mitosis Modulators|mitosis modulators|mesh-ancestor
153746516|NCT04723875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153746518|NCT05466019|Docetaxel|docetaxel|mesh-list
153746519|NCT05466019|Oxaliplatin|oxaliplatin|mesh-list
153783067|NCT04555525|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153783068|NCT04555525|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153783069|NCT04555525|Dermatologic Agents|dermatologic agents|mesh-ancestor
153783070|NCT00261183|Melatonin|melatonin|mesh-list
153783071|NCT00261183|Antioxidants|antioxidants|mesh-ancestor
153746520|NCT05466019|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153746521|NCT05466019|Tubulin Modulators|tubulin modulators|mesh-ancestor
153746554|NCT00532519|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153746555|NCT00532519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153746556|NCT00532519|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153746557|NCT00532519|Serotonin Agents|serotonin agents|mesh-ancestor
153746558|NCT00532519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153746559|NCT00532519|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
153746561|NCT00532519|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153746620|NCT00171756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153746621|NCT00171756|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153746622|NCT00171756|Sympatholytics|sympatholytics|mesh-ancestor
153746623|NCT00171756|Autonomic Agents|autonomic agents|mesh-ancestor
153746624|NCT00171756|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153746625|NCT00171756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153746626|NCT00171756|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
153746627|NCT00171756|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
153746628|NCT00171756|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
153746629|NCT00171756|Adrenergic Agents|adrenergic agents|mesh-ancestor
153746630|NCT00171756|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153746631|NCT00171795|Rivastigmine|rivastigmine|mesh-list
153746632|NCT00171795|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
153746633|NCT00171795|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153746634|NCT00171795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153746635|NCT00171795|Cholinergic Agents|cholinergic agents|mesh-ancestor
153746636|NCT00171795|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153746637|NCT00171795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153746638|NCT00171795|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
153746639|NCT00171795|Protective Agents|protective agents|mesh-ancestor
153746641|NCT00151541|Adapalene|adapalene|mesh-list
153746642|NCT00151541|Benzoyl Peroxide|benzoyl peroxide|mesh-list
153746643|NCT00151541|Dermatologic Agents|dermatologic agents|mesh-ancestor
153746644|NCT00151541|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153746645|NCT00151541|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153746646|NCT00151541|Analgesics|analgesics|mesh-ancestor
153746647|NCT00151541|Sensory System Agents|sensory system agents|mesh-ancestor
153746648|NCT00151541|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153746649|NCT00151541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153746650|NCT00151541|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153746662|NCT00151580|Antimetabolites|antimetabolites|mesh-ancestor
153746663|NCT00151580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153746664|NCT00151580|Antiviral Agents|antiviral agents|mesh-ancestor
153746665|NCT00151580|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153880155|NCT02703610|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153746666|NCT00171912|Imatinib Mesylate|imatinib mesylate|mesh-list
153746667|NCT00171912|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153746668|NCT00171912|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153746669|NCT00171912|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153746670|NCT00171912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153746671|NCT00171912|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153746672|NCT00151619|Amlodipine|amlodipine|mesh-list
153746679|NCT00151619|Vasodilator Agents|vasodilator agents|mesh-ancestor
153746723|NCT05293600|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153746724|NCT05293600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153746725|NCT05293600|Anticonvulsants|anticonvulsants|mesh-ancestor
153746726|NCT05293600|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
153746727|NCT05293600|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153746729|NCT05293600|Natriuretic Agents|natriuretic agents|mesh-ancestor
153746730|NCT05293600|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153746731|NCT05293600|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153746732|NCT05293600|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153746736|NCT05293600|Serotonin Agents|serotonin agents|mesh-ancestor
153746737|NCT05293600|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
153746738|NCT05293600|Antidepressive Agents|antidepressive agents|mesh-ancestor
153746739|NCT00151697|Insulin Aspart|insulin aspart|mesh-list
153746740|NCT00151697|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
153746741|NCT00151697|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153746742|NCT00151697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153746743|NCT00532714|Capecitabine|capecitabine|mesh-list
153746744|NCT00532714|Irinotecan|irinotecan|mesh-list
153746745|NCT00532714|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153746746|NCT00532714|Antimetabolites|antimetabolites|mesh-ancestor
153746747|NCT00532714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153746748|NCT00532714|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153746749|NCT00532714|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
153746750|NCT00532714|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153746751|NCT00532714|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153746752|NCT00151736|Etodolac|etodolac|mesh-list
153746753|NCT00151736|Chlorambucil|chlorambucil|mesh-list
153746754|NCT00151736|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153746755|NCT00151736|Alkylating Agents|alkylating agents|mesh-ancestor
153746757|NCT00151736|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153746761|NCT00151736|Sensory System Agents|sensory system agents|mesh-ancestor
153746762|NCT00151736|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153746763|NCT00151736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153746764|NCT00151736|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153746765|NCT00151736|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153746766|NCT00151736|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
153746767|NCT00151736|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153746768|NCT00151736|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153746769|NCT00171990|Famciclovir|famciclovir|mesh-list
153746770|NCT00171990|Antiviral Agents|antiviral agents|mesh-ancestor
153746771|NCT00171990|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153746772|NCT00171990|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153746773|NCT00171990|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153746774|NCT00171990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153746775|NCT00406094|Montelukast|montelukast|mesh-list
153746776|NCT00406094|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153746777|NCT00406094|Respiratory System Agents|respiratory system agents|mesh-ancestor
153746778|NCT00406094|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
153746779|NCT00406094|Hormone Antagonists|hormone antagonists|mesh-ancestor
153746780|NCT00406094|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153746781|NCT00406094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153746782|NCT00406094|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
153746783|NCT00406094|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
153746784|NCT00406094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153746786|NCT00164736|Lopinavir|lopinavir|mesh-list
153746787|NCT00164736|Lamivudine|lamivudine|mesh-list
153746788|NCT00164736|Zidovudine|zidovudine|mesh-list
153746789|NCT00164736|Nevirapine|nevirapine|mesh-list
153746804|NCT00164736|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
153746805|NCT00164736|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
153746807|NCT00532909|Capecitabine|capecitabine|mesh-list
153746808|NCT00532909|Oxaliplatin|oxaliplatin|mesh-list
153746809|NCT00532909|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153746810|NCT00532909|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153746811|NCT00532909|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153746812|NCT00532909|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153746813|NCT00532909|Growth Substances|growth substances|mesh-ancestor
153746814|NCT00532909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153746815|NCT00532909|Growth Inhibitors|growth inhibitors|mesh-ancestor
153746816|NCT00532909|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153746817|NCT00532909|Antimetabolites|antimetabolites|mesh-ancestor
153746818|NCT00532909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153746819|NCT00172068|Vitamin D|vitamin d|mesh-list
153746820|NCT00172068|Zoledronic Acid|zoledronic acid|mesh-list
153746821|NCT00172068|Calcium|calcium|mesh-list
153746822|NCT00172068|Vitamins|vitamins|mesh-ancestor
153746823|NCT00172068|Micronutrients|micronutrients|mesh-ancestor
153746824|NCT00172068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153746825|NCT00172068|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153746855|NCT00164775|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
153746856|NCT00164775|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153746857|NCT00164775|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153746858|NCT00164775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153746860|NCT00164775|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153746861|NCT00164775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153746862|NCT00533026|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
153746863|NCT00533026|Warfarin|warfarin|mesh-list
153746864|NCT00533026|Anticoagulants|anticoagulants|mesh-ancestor
153746865|NCT00533026|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
153746915|NCT00152204|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153746916|NCT00152204|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153746917|NCT00152204|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153746918|NCT00152204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153746919|NCT00152204|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
153746920|NCT00533065|Donepezil|donepezil|mesh-list
153746921|NCT00533065|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
153746922|NCT00533065|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153746923|NCT00533065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153783072|NCT00261183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153783073|NCT00261183|Protective Agents|protective agents|mesh-ancestor
153746924|NCT00533065|Cholinergic Agents|cholinergic agents|mesh-ancestor
153746925|NCT00533065|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153783074|NCT00261183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153746926|NCT00533065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153746927|NCT00533065|Nootropic Agents|nootropic agents|mesh-ancestor
153746928|NCT00152243|Tegafur|tegafur|mesh-list
153746929|NCT00152243|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153746930|NCT00152243|Antimetabolites|antimetabolites|mesh-ancestor
153746931|NCT00152243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153746932|NCT00152243|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153746933|NCT00172107|Parathyroid Hormone|parathyroid hormone|mesh-list
153746934|NCT00172107|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153746935|NCT00172107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153746936|NCT00152282|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
153746938|NCT00152282|Hormones|hormones|mesh-ancestor
153746964|NCT00164931|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
153746965|NCT00164931|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153746966|NCT00164931|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
153746967|NCT00164931|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153746968|NCT00164931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153746969|NCT00152438|Progesterone|progesterone|mesh-list
153746970|NCT00152438|Progestins|progestins|mesh-ancestor
153746971|NCT00152438|Hormones|hormones|mesh-ancestor
153746972|NCT00152438|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153746973|NCT00152438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153746975|NCT00164970|Hydroxocobalamin|hydroxocobalamin|mesh-list
153746976|NCT00164970|Vitamins|vitamins|mesh-ancestor
153746977|NCT00164970|Micronutrients|micronutrients|mesh-ancestor
153746978|NCT00164970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153746979|NCT00164970|Vitamin B Complex|vitamin b complex|mesh-ancestor
153746980|NCT00164970|Hematinics|hematinics|mesh-ancestor
153746981|NCT02937844|Cyclophosphamide|cyclophosphamide|mesh-list
153746982|NCT02937844|Fludarabine|fludarabine|mesh-list
153746983|NCT02937844|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153746984|NCT02937844|Immunologic Factors|immunologic factors|mesh-ancestor
153746985|NCT02937844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153746986|NCT02937844|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153746987|NCT02937844|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153870568|NCT01081782|Ceralifimod|ceralifimod|mesh-list
153746988|NCT02937844|Alkylating Agents|alkylating agents|mesh-ancestor
153746989|NCT02937844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153746990|NCT02937844|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153746991|NCT02937844|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153746992|NCT02937415|Antioxidants|antioxidants|mesh-list
153746993|NCT02937415|Carbon Monoxide|carbon monoxide|mesh-list
153747009|NCT00152594|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153747010|NCT00152594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153747011|NCT00152594|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
153747012|NCT00407199|Quetiapine Fumarate|quetiapine fumarate|mesh-list
153747019|NCT00152633|Losartan|losartan|mesh-list
153747077|NCT00165048|Sensory System Agents|sensory system agents|mesh-ancestor
153747078|NCT00165048|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153747079|NCT00165048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153747080|NCT00165048|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153747081|NCT00165048|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153747082|NCT04690270|Sumatriptan|sumatriptan|mesh-list
153747083|NCT04690270|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
153747084|NCT04690270|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
153747085|NCT04690270|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
153747086|NCT04690270|Serotonin Agents|serotonin agents|mesh-ancestor
153747087|NCT04690270|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153747088|NCT04690270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153747089|NCT04690270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153747090|NCT00165087|Doxorubicin|doxorubicin|mesh-list
153747091|NCT00165087|Dexrazoxane|dexrazoxane|mesh-list
153747092|NCT00165087|Asparaginase|asparaginase|mesh-list
153747093|NCT00165087|Razoxane|razoxane|mesh-list
153747094|NCT00165087|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153747095|NCT00165087|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153747097|NCT00165087|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153747132|NCT00152828|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153747133|NCT00152828|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153747134|NCT00152828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153747135|NCT02935933|Dexmedetomidine|dexmedetomidine|mesh-list
153747136|NCT02935933|Morphine|morphine|mesh-list
153747137|NCT02935933|Bupivacaine|bupivacaine|mesh-list
153747138|NCT02935933|Anesthetics, Local|anesthetics, local|mesh-ancestor
153747139|NCT02935933|Anesthetics|anesthetics|mesh-ancestor
153747140|NCT02935933|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153747141|NCT02935933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153747142|NCT02935933|Sensory System Agents|sensory system agents|mesh-ancestor
153747143|NCT02935933|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153747144|NCT02935933|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153747145|NCT02935933|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153747146|NCT02935933|Analgesics|analgesics|mesh-ancestor
153747147|NCT02935933|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
153747148|NCT02935933|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153747149|NCT02935933|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153747150|NCT02935933|Adrenergic Agents|adrenergic agents|mesh-ancestor
153747151|NCT02935933|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153747152|NCT02935933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153747153|NCT02935933|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153747154|NCT02935933|Narcotics|narcotics|mesh-ancestor
153747155|NCT00152867|Dexamethasone|dexamethasone|mesh-list
153747156|NCT00152867|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153747157|NCT00152867|Antiemetics|antiemetics|mesh-ancestor
153747158|NCT00152867|Autonomic Agents|autonomic agents|mesh-ancestor
153747159|NCT00152867|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153747160|NCT00152867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153747161|NCT00152867|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153747162|NCT00152867|Glucocorticoids|glucocorticoids|mesh-ancestor
153747176|NCT02935972|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
153747177|NCT02935972|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153747178|NCT02935972|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153747179|NCT02935972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153747181|NCT02935972|Anticonvulsants|anticonvulsants|mesh-ancestor
153747182|NCT02935972|Antiemetics|antiemetics|mesh-ancestor
153747183|NCT02935972|Autonomic Agents|autonomic agents|mesh-ancestor
153747184|NCT02935972|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153747185|NCT02935972|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153747186|NCT02935972|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
153747187|NCT02935972|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
153747188|NCT02935972|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153747189|NCT02935972|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153747190|NCT02935972|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153747191|NCT02935972|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153747192|NCT02935972|Anesthetics, General|anesthetics, general|mesh-ancestor
153747193|NCT02935972|GABA Modulators|gaba modulators|mesh-ancestor
153747194|NCT02935972|GABA Agents|gaba agents|mesh-ancestor
153747233|NCT00152945|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
153747234|NCT00152945|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
153747235|NCT00152945|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
153747236|NCT00152945|Protective Agents|protective agents|mesh-ancestor
153747237|NCT00152945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153747238|NCT02935114|Hydrogen Peroxide|hydrogen peroxide|mesh-list
153747239|NCT02935114|Carbamide Peroxide|carbamide peroxide|mesh-list
153747240|NCT02935114|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
153747241|NCT02935114|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153747243|NCT02935231|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
153747244|NCT02935231|Autonomic Agents|autonomic agents|mesh-ancestor
153747245|NCT02935231|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153747246|NCT02935231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153747247|NCT02935231|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
153747248|NCT02935231|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
153747249|NCT02935231|Cholinergic Agents|cholinergic agents|mesh-ancestor
153747250|NCT02935231|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153747251|NCT02935231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153747252|NCT00172380|Docetaxel|docetaxel|mesh-list
153747253|NCT00172380|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153747254|NCT00172380|Tubulin Modulators|tubulin modulators|mesh-ancestor
153747255|NCT00172380|Antimitotic Agents|antimitotic agents|mesh-ancestor
153747256|NCT00172380|Mitosis Modulators|mitosis modulators|mesh-ancestor
153747257|NCT00172380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153747258|NCT00152984|Tiotropium Bromide|tiotropium bromide|mesh-list
153747259|NCT00152984|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153747260|NCT00152984|Autonomic Agents|autonomic agents|mesh-ancestor
153747261|NCT00152984|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153747278|NCT02935075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153747280|NCT02935075|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153747281|NCT02935075|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
153747282|NCT02935075|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153747283|NCT02935075|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
153747343|NCT00153296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153747344|NCT00153296|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153747345|NCT00153296|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153747347|NCT00153296|Sensory System Agents|sensory system agents|mesh-ancestor
153747348|NCT00153296|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153747349|NCT00153296|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153747350|NCT00153296|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153747351|NCT00153296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153747352|NCT00153296|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
153747353|NCT00153296|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
153747354|NCT02934295|Antibodies|antibodies|mesh-list
153747355|NCT02934295|Immunologic Factors|immunologic factors|mesh-ancestor
153747356|NCT02934295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153747357|NCT02934022|Maraviroc|maraviroc|mesh-list
153747358|NCT02934022|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
153747359|NCT02934022|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
153747360|NCT02934022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153747361|NCT02934022|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153747362|NCT02934022|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153747363|NCT02934022|Antiviral Agents|antiviral agents|mesh-ancestor
153747364|NCT02934022|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153747365|NCT02934022|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
153747366|NCT02934061|Tizanidine|tizanidine|mesh-list
153747367|NCT02934061|Analgesics|analgesics|mesh-ancestor
153747368|NCT02934061|Sensory System Agents|sensory system agents|mesh-ancestor
153747369|NCT02934061|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153747370|NCT02934061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153747382|NCT02934217|Cyclosporine|cyclosporine|mesh-list
153747389|NCT02934217|Antifungal Agents|antifungal agents|mesh-ancestor
153747390|NCT02934217|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153747391|NCT02934217|Dermatologic Agents|dermatologic agents|mesh-ancestor
153747392|NCT02934217|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153783075|NCT00261183|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153783076|NCT00268632|Risedronic Acid|risedronic acid|mesh-list
153783077|NCT00268632|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153783078|NCT00268632|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153747393|NCT02934217|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
153747394|NCT00165360|Temozolomide|temozolomide|mesh-list
153747395|NCT00165360|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153747396|NCT00165360|Alkylating Agents|alkylating agents|mesh-ancestor
153747397|NCT00165360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153747454|NCT02933593|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153747455|NCT02933593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153747456|NCT02933593|Vasodilator Agents|vasodilator agents|mesh-ancestor
153747457|NCT02933593|Tocolytic Agents|tocolytic agents|mesh-ancestor
153747458|NCT02933593|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153747459|NCT02933593|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
153747460|NCT02933593|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
153747461|NCT02933593|Adrenergic Agents|adrenergic agents|mesh-ancestor
153747519|NCT00165516|Antitubercular Agents|antitubercular agents|mesh-ancestor
153747520|NCT00165516|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153747521|NCT00165516|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153747522|NCT00165516|Chelating Agents|chelating agents|mesh-ancestor
153747523|NCT00165516|Sequestering Agents|sequestering agents|mesh-ancestor
153747524|NCT04642378|Insulin|insulin|mesh-list
153747525|NCT04642378|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
153747526|NCT04642378|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153747528|NCT00407784|Eplerenone|eplerenone|mesh-list
153747587|NCT00180102|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153747588|NCT00180102|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153747589|NCT04690309|Insulin|insulin|mesh-list
153747590|NCT04690309|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
153747591|NCT04690309|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153747592|NCT04690309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153747593|NCT00153881|Carboplatin|carboplatin|mesh-list
153747594|NCT00153881|Docetaxel|docetaxel|mesh-list
153747595|NCT00153881|Capecitabine|capecitabine|mesh-list
153747658|NCT02925130|Respiratory System Agents|respiratory system agents|mesh-ancestor
153747659|NCT02925130|Tocolytic Agents|tocolytic agents|mesh-ancestor
153747660|NCT02925130|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153747661|NCT02925130|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
153747662|NCT02925130|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
153747663|NCT02925130|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153747664|NCT02925130|Adrenergic Agents|adrenergic agents|mesh-ancestor
153747665|NCT02925130|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153747666|NCT02925130|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153747667|NCT02924974|Lidocaine|lidocaine|mesh-list
153747668|NCT02924974|Morphine|morphine|mesh-list
153747669|NCT02924974|Anesthetics, Local|anesthetics, local|mesh-ancestor
153747670|NCT02924974|Anesthetics|anesthetics|mesh-ancestor
153747671|NCT02924974|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153747672|NCT02924974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153747673|NCT02924974|Sensory System Agents|sensory system agents|mesh-ancestor
153747674|NCT02924974|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153747713|NCT02924506|Analgesics|analgesics|mesh-ancestor
153747714|NCT02924506|Sensory System Agents|sensory system agents|mesh-ancestor
153747715|NCT02924506|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153747716|NCT02924506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153747717|NCT02924506|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153747718|NCT02924506|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153884808|NCT00595140|Hormones|hormones|mesh-ancestor
153747719|NCT02924506|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
153747720|NCT02924506|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153747721|NCT02924506|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153747777|NCT02923687|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
153747778|NCT02923687|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153747779|NCT02923687|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153747780|NCT02923687|Analgesics|analgesics|mesh-ancestor
153747846|NCT02922283|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153747847|NCT02922283|Analgesics|analgesics|mesh-ancestor
153747848|NCT02922283|Sensory System Agents|sensory system agents|mesh-ancestor
153747849|NCT02922283|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153747850|NCT02922283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153747851|NCT04705454|Loncastuximab tesirine|loncastuximab tesirine|mesh-list
153747852|NCT04705454|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153747853|NCT04705454|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153747855|NCT02922166|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
153747856|NCT02922166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153747857|NCT02922166|Natriuretic Agents|natriuretic agents|mesh-ancestor
153747858|NCT02922166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153747859|NCT02922127|Contraceptive Agents|contraceptive agents|mesh-list
153747860|NCT02922127|Ulipristal acetate|ulipristal acetate|mesh-list
153747861|NCT02922127|Contraceptives, Oral|contraceptives, oral|mesh-list
153747862|NCT02922127|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-list
153747863|NCT02922127|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153747902|NCT00188136|Alkylating Agents|alkylating agents|mesh-ancestor
153747903|NCT00188136|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153747905|NCT00406250|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153747909|NCT00406250|Growth Substances|growth substances|mesh-ancestor
153747973|NCT00180882|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153747974|NCT00180882|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153747975|NCT00180882|Immunologic Factors|immunologic factors|mesh-ancestor
153747976|NCT00180882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153747977|NCT00180882|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153747978|NCT00180921|Imatinib Mesylate|imatinib mesylate|mesh-list
153747979|NCT00180921|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153747980|NCT00180921|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153747981|NCT00180921|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153747982|NCT00180921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153747983|NCT00180921|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153747984|NCT02920489|Sufentanil|sufentanil|mesh-list
153747985|NCT02920489|Dsuvia|dsuvia|mesh-list
153747986|NCT02920489|Ropivacaine|ropivacaine|mesh-list
153747987|NCT02920489|Anesthetics, Local|anesthetics, local|mesh-ancestor
153747988|NCT02920489|Anesthetics|anesthetics|mesh-ancestor
153747989|NCT02920489|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153747990|NCT02920489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153747991|NCT02920489|Sensory System Agents|sensory system agents|mesh-ancestor
153747994|NCT02920489|Narcotics|narcotics|mesh-ancestor
153748030|NCT00154700|Micronutrients|micronutrients|mesh-ancestor
153748031|NCT00154700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153748032|NCT04688983|Imatinib Mesylate|imatinib mesylate|mesh-list
153748033|NCT04688983|Blinatumomab|blinatumomab|mesh-list
153748035|NCT04688983|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153748036|NCT04688983|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153748037|NCT04688983|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153748038|NCT04688983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153748039|NCT04688983|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153748041|NCT02920060|Valproic Acid|valproic acid|mesh-list
153748042|NCT02920060|Anticonvulsants|anticonvulsants|mesh-ancestor
153748043|NCT02920060|Nootropic Agents|nootropic agents|mesh-ancestor
153748044|NCT02920060|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153748045|NCT02920060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153748046|NCT02920060|GABA Agents|gaba agents|mesh-ancestor
153748047|NCT02920060|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153748048|NCT02920060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153748049|NCT02920060|Antimanic Agents|antimanic agents|mesh-ancestor
153748050|NCT02920060|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153748051|NCT02920060|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153748052|NCT02920060|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153748053|NCT00154739|Gemcitabine|gemcitabine|mesh-list
153748054|NCT00154739|Epirubicin|epirubicin|mesh-list
153748055|NCT00154739|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153748056|NCT00154739|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153748057|NCT00154739|Antimetabolites|antimetabolites|mesh-ancestor
153748080|NCT00154895|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153748081|NCT00154895|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153748082|NCT00181116|Levetiracetam|levetiracetam|mesh-list
153748083|NCT00181116|Anticonvulsants|anticonvulsants|mesh-ancestor
153748084|NCT00181116|Nootropic Agents|nootropic agents|mesh-ancestor
153748086|NCT02918812|Lidocaine|lidocaine|mesh-list
153748087|NCT02918812|Anesthetics, Local|anesthetics, local|mesh-ancestor
153748088|NCT02918812|Anesthetics|anesthetics|mesh-ancestor
153748089|NCT02918812|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153748090|NCT02918812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153748092|NCT02918812|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153748093|NCT02918812|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153748094|NCT02918812|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
153748095|NCT02918812|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153748096|NCT02918812|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153748097|NCT02918812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153748098|NCT02918812|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153748099|NCT02918812|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153748101|NCT02918812|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153748103|NCT02918812|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153748104|NCT02918812|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153748105|NCT02918110|Misoprostol|misoprostol|mesh-list
153783083|NCT04554979|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
153783084|NCT04554979|Hydroxychloroquine|hydroxychloroquine|mesh-list
153783085|NCT04554979|Anticoagulants|anticoagulants|mesh-list
153783086|NCT04554979|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153783087|NCT04554979|Antimalarials|antimalarials|mesh-ancestor
153783088|NCT04554979|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153748106|NCT02918110|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
153748107|NCT02918110|Abortifacient Agents|abortifacient agents|mesh-ancestor
153748108|NCT02918110|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153748109|NCT02918110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153748110|NCT02918110|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
153748111|NCT02918110|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153748112|NCT02918110|Oxytocics|oxytocics|mesh-ancestor
153748113|NCT00181272|Azithromycin|azithromycin|mesh-list
153748114|NCT00181272|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153748115|NCT00181272|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153748121|NCT02910076|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153748122|NCT02910076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153748123|NCT02910076|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153748124|NCT02910115|Oxytocin|oxytocin|mesh-list
153748125|NCT02910115|Oxytocics|oxytocics|mesh-ancestor
153748126|NCT02910115|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153748127|NCT02910115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153748128|NCT00188565|Celecoxib|celecoxib|mesh-list
153748129|NCT00188565|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153748130|NCT00188565|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153748131|NCT00188565|Analgesics|analgesics|mesh-ancestor
153748184|NCT02939833|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153748185|NCT02939833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153748186|NCT02939833|Sensory System Agents|sensory system agents|mesh-ancestor
153748187|NCT02939833|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153748188|NCT00188604|Selenious Acid|selenious acid|mesh-list
153748189|NCT00188604|Sodium Selenite|sodium selenite|mesh-list
153748190|NCT00188604|Trace Elements|trace elements|mesh-ancestor
153748191|NCT00188604|Micronutrients|micronutrients|mesh-ancestor
153748192|NCT00188604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153748194|NCT00155402|Hemostatics|hemostatics|mesh-ancestor
153748195|NCT00155402|Coagulants|coagulants|mesh-ancestor
153748246|NCT00533416|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153748247|NCT00533416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153748249|NCT00155558|Fluorouracil|fluorouracil|mesh-list
153748250|NCT00155558|Antimetabolites|antimetabolites|mesh-ancestor
153748251|NCT00155558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153748252|NCT00155558|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153748253|NCT00155558|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153748254|NCT00155558|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153748255|NCT00155558|Immunologic Factors|immunologic factors|mesh-ancestor
153748256|NCT00155558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153748257|NCT00155558|Antidotes|antidotes|mesh-ancestor
153748258|NCT00155558|Protective Agents|protective agents|mesh-ancestor
153748260|NCT00155558|Vitamins|vitamins|mesh-ancestor
153748261|NCT00155558|Micronutrients|micronutrients|mesh-ancestor
153748262|NCT00533455|Gabapentin|gabapentin|mesh-list
153748263|NCT00533455|Analgesics|analgesics|mesh-ancestor
153748264|NCT00533455|Sensory System Agents|sensory system agents|mesh-ancestor
153748265|NCT00533455|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153748266|NCT00533455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153748267|NCT00533455|Anticonvulsants|anticonvulsants|mesh-ancestor
153748268|NCT00533455|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153748269|NCT00533455|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153748270|NCT00533455|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153748271|NCT00533455|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153748272|NCT00533455|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
153783089|NCT04554979|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153783090|NCT04554979|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153783091|NCT04554979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153783092|NCT04554979|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153783093|NCT00235703|Anti-Infective Agents|anti-infective agents|mesh-list
153783094|NCT00235703|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
153783095|NCT00261222|Amodiaquine|amodiaquine|mesh-list
153748273|NCT00533455|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
153748274|NCT00533455|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153748275|NCT00533455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153748276|NCT00533455|Antimanic Agents|antimanic agents|mesh-ancestor
153748277|NCT00533533|Docetaxel|docetaxel|mesh-list
153748278|NCT00533533|Oxaliplatin|oxaliplatin|mesh-list
153748279|NCT00533533|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153748280|NCT00533533|Tubulin Modulators|tubulin modulators|mesh-ancestor
153748281|NCT00533533|Antimitotic Agents|antimitotic agents|mesh-ancestor
153748286|NCT00533611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153748287|NCT00533611|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153748288|NCT00533611|Antimetabolites|antimetabolites|mesh-ancestor
153748289|NCT00533611|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153748290|NCT00533611|Vasodilator Agents|vasodilator agents|mesh-ancestor
153748291|NCT00533611|Vitamin B Complex|vitamin b complex|mesh-ancestor
153748293|NCT00533611|Micronutrients|micronutrients|mesh-ancestor
153748294|NCT04575844|Liraglutide|liraglutide|mesh-list
153748295|NCT04575844|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
153748296|NCT04575844|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153748297|NCT04575844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153748298|NCT04575844|Incretins|incretins|mesh-ancestor
153748299|NCT04575844|Hormones|hormones|mesh-ancestor
153748300|NCT04575844|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153748302|NCT00155714|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-list
153748303|NCT00155714|Vasodilator Agents|vasodilator agents|mesh-ancestor
153748304|NCT00155714|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
153748305|NCT00155714|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153748306|NCT00155714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153748307|NCT00155714|Urological Agents|urological agents|mesh-ancestor
153748308|NCT00181740|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
153748309|NCT00181740|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
153748310|NCT00181740|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153748311|NCT00181740|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153748312|NCT00181740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153748313|NCT00181740|Adrenergic Agents|adrenergic agents|mesh-ancestor
153748314|NCT00181740|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153748315|NCT00181740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153748316|NCT00181779|Aripiprazole|aripiprazole|mesh-list
153748317|NCT00181779|Antidepressive Agents|antidepressive agents|mesh-ancestor
153748318|NCT00181779|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153748319|NCT00181779|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153748320|NCT00181779|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153783113|NCT00268671|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153783114|NCT00268671|Tubulin Modulators|tubulin modulators|mesh-ancestor
153783115|NCT00268671|Antimitotic Agents|antimitotic agents|mesh-ancestor
153783116|NCT00268671|Mitosis Modulators|mitosis modulators|mesh-ancestor
153783117|NCT00268671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153783118|NCT04554433|Ethanol|ethanol|mesh-list
153783119|NCT04554433|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
153783120|NCT04554433|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153783121|NCT04554433|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153783122|NCT04554433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153783123|NCT04721054|Lidocaine|lidocaine|mesh-list
153783124|NCT04721054|Bupivacaine|bupivacaine|mesh-list
153748324|NCT00181779|Dopamine Agents|dopamine agents|mesh-ancestor
153748325|NCT00181779|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153748326|NCT00181779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153748327|NCT00181779|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
153748329|NCT00181779|Serotonin Agents|serotonin agents|mesh-ancestor
153748330|NCT00181779|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
153748331|NCT00181779|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153748332|NCT00181779|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
153748333|NCT00181779|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
153748334|NCT00533923|Cyclosporine|cyclosporine|mesh-list
153748335|NCT00533923|Cyclophosphamide|cyclophosphamide|mesh-list
153748336|NCT00533923|Fludarabine|fludarabine|mesh-list
153748337|NCT00533923|Alemtuzumab|alemtuzumab|mesh-list
153748338|NCT00533923|Cyclosporins|cyclosporins|mesh-list
153748339|NCT00533923|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153748340|NCT00533923|Immunologic Factors|immunologic factors|mesh-ancestor
153748341|NCT00533923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153748342|NCT00533923|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153748343|NCT00533923|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153748377|NCT00181818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153748378|NCT00181818|Dopamine Agents|dopamine agents|mesh-ancestor
153748379|NCT00181818|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153748380|NCT00181818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153748381|NCT00181818|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
153748382|NCT00181818|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153748383|NCT00181818|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153748384|NCT04462627|Antibodies|antibodies|mesh-list
153748385|NCT04462627|Immunologic Factors|immunologic factors|mesh-ancestor
153748386|NCT04462627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153748387|NCT00406601|Sorafenib|sorafenib|mesh-list
153748388|NCT00406601|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153748389|NCT00406601|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153748390|NCT00406601|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153748391|NCT00406601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153748392|NCT00409305|Betahistine|betahistine|mesh-list
153748393|NCT00409305|Vasodilator Agents|vasodilator agents|mesh-ancestor
153748394|NCT00409305|Histamine Agonists|histamine agonists|mesh-ancestor
153748395|NCT00409305|Histamine Agents|histamine agents|mesh-ancestor
153748396|NCT00409305|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153783125|NCT04721054|Anesthetics|anesthetics|mesh-list
153748397|NCT00409305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153748398|NCT00409305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153748399|NCT00406679|Acetaminophen|acetaminophen|mesh-list
153783126|NCT04721054|Anesthetics, Local|anesthetics, local|mesh-ancestor
153421019|NCT06288841|Sensory System Agents|sensory system agents|mesh-ancestor
153421020|NCT06288841|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153421021|NCT06288490|Calcium Carbonate|calcium carbonate|mesh-list
153421022|NCT06288490|Calcium|calcium|mesh-list
153421023|NCT06288490|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153421024|NCT06288490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153421025|NCT06288490|Antacids|antacids|mesh-ancestor
153783127|NCT04721054|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153783128|NCT04721054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153748400|NCT00406679|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
153748401|NCT00406679|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153748402|NCT00406679|Analgesics|analgesics|mesh-ancestor
153748403|NCT00406679|Sensory System Agents|sensory system agents|mesh-ancestor
153748406|NCT00406679|Antipyretics|antipyretics|mesh-ancestor
153748420|NCT00181896|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153748421|NCT04686448|Fentanyl|fentanyl|mesh-list
153748422|NCT04686448|Ketamine|ketamine|mesh-list
153748423|NCT04686448|Propofol|propofol|mesh-list
153748424|NCT04686448|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153748425|NCT04686448|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153748426|NCT04686448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153748427|NCT04686448|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153748428|NCT04686448|Anesthetics, General|anesthetics, general|mesh-ancestor
153748429|NCT04686448|Anesthetics|anesthetics|mesh-ancestor
153748430|NCT04686448|Analgesics|analgesics|mesh-ancestor
153748431|NCT04686448|Sensory System Agents|sensory system agents|mesh-ancestor
153748432|NCT04686448|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153748433|NCT04686448|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
153748434|NCT04686448|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
153748435|NCT04686448|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
153748436|NCT04686448|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153748437|NCT04686448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153748438|NCT04686448|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153748439|NCT04686448|Narcotics|narcotics|mesh-ancestor
153748440|NCT04686448|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153748441|NCT00181935|Olanzapine|olanzapine|mesh-list
153748442|NCT00181935|Risperidone|risperidone|mesh-list
153748443|NCT00181935|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153748444|NCT00181935|Serotonin Agents|serotonin agents|mesh-ancestor
153748445|NCT00181935|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153748446|NCT00181935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153748447|NCT00181935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153748448|NCT00181935|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153748450|NCT00181935|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153748451|NCT00181935|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153748452|NCT00181935|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
153748453|NCT00181935|Dopamine Agents|dopamine agents|mesh-ancestor
153748460|NCT00181935|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153748461|NCT00409383|Paclitaxel|paclitaxel|mesh-list
153748462|NCT00409383|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
153748463|NCT00409383|Temozolomide|temozolomide|mesh-list
153748464|NCT00409383|Oblimersen|oblimersen|mesh-list
153748465|NCT00409383|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153748466|NCT00409383|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153748467|NCT00409383|Tubulin Modulators|tubulin modulators|mesh-ancestor
153585531|NCT01767454|Ipilimumab|ipilimumab|mesh-list
153748468|NCT00409383|Antimitotic Agents|antimitotic agents|mesh-ancestor
153783129|NCT04721054|Sensory System Agents|sensory system agents|mesh-ancestor
153783130|NCT04721054|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153783131|NCT04721054|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153783132|NCT04721054|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
153783133|NCT04721054|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153783134|NCT04721054|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153748469|NCT00409383|Mitosis Modulators|mitosis modulators|mesh-ancestor
153748524|NCT00182013|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153748525|NCT00182013|Antidepressive Agents|antidepressive agents|mesh-ancestor
153748526|NCT00182052|Rosiglitazone|rosiglitazone|mesh-list
153748527|NCT00182052|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153748528|NCT00182052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153748593|NCT00156299|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153748594|NCT00156299|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153748595|NCT00156299|Lipotropic Agents|lipotropic agents|mesh-ancestor
153748596|NCT00156299|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153748598|NCT00156299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153748599|NCT00156299|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153748600|NCT00156299|Nootropic Agents|nootropic agents|mesh-ancestor
153748601|NCT00156299|Analgesics|analgesics|mesh-ancestor
153783137|NCT02212639|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153748606|NCT00535951|Panobinostat|panobinostat|mesh-list
153748660|NCT00408525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153748661|NCT00408525|Nootropic Agents|nootropic agents|mesh-ancestor
153748662|NCT05469529|Dexmedetomidine|dexmedetomidine|mesh-list
153748663|NCT05469529|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153748664|NCT05469529|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153748665|NCT05469529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153748666|NCT05469529|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153748668|NCT05469529|Sensory System Agents|sensory system agents|mesh-ancestor
153748671|NCT05469529|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153748725|NCT00536419|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
153748726|NCT00536419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153748727|NCT00536419|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
153748728|NCT00536419|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153748729|NCT00536419|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153748730|NCT00536419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153748731|NCT00536419|Dopamine Agents|dopamine agents|mesh-ancestor
153748732|NCT00536419|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153748733|NCT00189150|Mycophenolic Acid|mycophenolic acid|mesh-list
153748734|NCT00189150|Valganciclovir|valganciclovir|mesh-list
153748735|NCT00189150|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153748736|NCT00189150|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153748737|NCT00189150|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
153748738|NCT00189150|Antitubercular Agents|antitubercular agents|mesh-ancestor
153748739|NCT00189150|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153748740|NCT00189150|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153748741|NCT00189150|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153748742|NCT00189150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153748743|NCT00189150|Antiviral Agents|antiviral agents|mesh-ancestor
153748744|NCT00156689|Levetiracetam|levetiracetam|mesh-list
153783138|NCT02212639|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
153783139|NCT02212639|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153783140|NCT02212639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153783141|NCT02212639|Protective Agents|protective agents|mesh-ancestor
153783142|NCT02212639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153783143|NCT02212756|Metformin|metformin|mesh-list
153783144|NCT02212756|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153783145|NCT02212756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153783146|NCT02212795|Levofloxacin|levofloxacin|mesh-list
153748745|NCT00156689|Anticonvulsants|anticonvulsants|mesh-ancestor
153748746|NCT00156689|Nootropic Agents|nootropic agents|mesh-ancestor
153748748|NCT00536614|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153748749|NCT00536614|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153748750|NCT05468164|Omeprazole|omeprazole|mesh-list
153748751|NCT05468164|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
153748752|NCT05468164|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153748771|NCT00182364|Calcium heparin|calcium heparin|mesh-list
153748772|NCT00182364|Dalteparin|dalteparin|mesh-list
153748773|NCT00182364|Tinzaparin|tinzaparin|mesh-list
153748774|NCT00182364|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
153748775|NCT00182364|Anticoagulants|anticoagulants|mesh-ancestor
153748776|NCT00182364|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153748777|NCT00182364|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153748779|NCT00536653|Calcium, Dietary|calcium, dietary|mesh-list
153748843|NCT00182442|Antidepressive Agents|antidepressive agents|mesh-ancestor
153748844|NCT00536770|Calcitriol|calcitriol|mesh-list
153748845|NCT00536770|Gemcitabine|gemcitabine|mesh-list
153748846|NCT00536770|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
153748847|NCT00536770|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153748911|NCT00189501|Cinacalcet|cinacalcet|mesh-list
153748913|NCT00189501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153748914|NCT00189501|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
153748915|NCT00189501|Hormone Antagonists|hormone antagonists|mesh-ancestor
153748916|NCT00189501|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153748917|NCT00157118|Protein C|protein c|mesh-list
153748918|NCT00157118|Anticoagulants|anticoagulants|mesh-ancestor
153748919|NCT00157118|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153748920|NCT00157118|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153781934|NCT04557475|Sensory System Agents|sensory system agents|mesh-ancestor
153748921|NCT00157118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153748922|NCT00189579|Trastuzumab|trastuzumab|mesh-list
153748923|NCT00189579|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153748924|NCT00189579|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153748926|NCT00157235|Tiotropium Bromide|tiotropium bromide|mesh-list
153748927|NCT00157235|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153748928|NCT00157235|Autonomic Agents|autonomic agents|mesh-ancestor
153748929|NCT00157235|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153748930|NCT00157235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153748931|NCT00157235|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153748932|NCT00157235|Respiratory System Agents|respiratory system agents|mesh-ancestor
153748934|NCT00157235|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
153748961|NCT00182559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153748962|NCT00182559|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
153748963|NCT00182559|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153748964|NCT00182559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153748965|NCT00182559|Antifungal Agents|antifungal agents|mesh-ancestor
153748966|NCT00182559|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153748967|NCT00182559|Dermatologic Agents|dermatologic agents|mesh-ancestor
153748968|NCT00182559|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153748970|NCT00425568|Androgens|androgens|mesh-ancestor
153748971|NCT00425568|Hormones|hormones|mesh-ancestor
153748972|NCT00425568|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153748973|NCT00425568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153748974|NCT00157508|Nitroaspirin|nitroaspirin|mesh-list
153748975|NCT00157508|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153748976|NCT00157508|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153748977|NCT00157508|Analgesics|analgesics|mesh-ancestor
153748978|NCT00157508|Sensory System Agents|sensory system agents|mesh-ancestor
153748979|NCT00157508|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153748980|NCT00157508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153748981|NCT00157508|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153748982|NCT00157508|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153748984|NCT00157508|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153748985|NCT00157508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153748986|NCT00157508|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153748987|NCT00157508|Cysteine Proteinase Inhibitors|cysteine proteinase inhibitors|mesh-ancestor
153748989|NCT00157508|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153748990|NCT00189618|Aspirin|aspirin|mesh-list
153749003|NCT00189618|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153749004|NCT00189618|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153749005|NCT00189618|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153749006|NCT00189618|Antipyretics|antipyretics|mesh-ancestor
153749007|NCT00189618|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
153749008|NCT00189618|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
153749009|NCT00189618|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
153749010|NCT00189618|Purinergic Agents|purinergic agents|mesh-ancestor
153749011|NCT00189618|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153749012|NCT00406796|Ranibizumab|ranibizumab|mesh-list
153749013|NCT00406796|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153749014|NCT00406796|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153749015|NCT00406796|Growth Substances|growth substances|mesh-ancestor
153749067|NCT00534586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153749069|NCT00534586|Anesthetics, General|anesthetics, general|mesh-ancestor
153749070|NCT00534586|Anesthetics|anesthetics|mesh-ancestor
153749071|NCT00534586|Analgesics|analgesics|mesh-ancestor
153749072|NCT00534586|Sensory System Agents|sensory system agents|mesh-ancestor
153749073|NCT00534586|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153749074|NCT00534586|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
153749075|NCT00534586|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
153749076|NCT00534586|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
153749077|NCT00534586|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153749078|NCT00534586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153749079|NCT00534586|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153749080|NCT00534586|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
153749081|NCT00534586|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153749083|NCT00534586|Antidepressive Agents|antidepressive agents|mesh-ancestor
153749084|NCT00534586|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153749085|NCT00534625|Zileuton|zileuton|mesh-list
153749086|NCT00534625|Hydroxyurea|hydroxyurea|mesh-list
153749087|NCT00534625|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153749088|NCT00534625|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153749089|NCT00534625|Analgesics|analgesics|mesh-ancestor
153749090|NCT00534625|Sensory System Agents|sensory system agents|mesh-ancestor
153749091|NCT00534625|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153749117|NCT04106830|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
153749118|NCT04106830|Antitubercular Agents|antitubercular agents|mesh-ancestor
153749119|NCT04106830|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153749120|NCT04106830|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153749121|NCT04106830|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153749122|NCT04106830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153749123|NCT04106830|Antimetabolites|antimetabolites|mesh-ancestor
153749124|NCT04106830|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153749125|NCT04106830|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153749126|NCT00189657|Irinotecan|irinotecan|mesh-list
153749127|NCT00189657|Fluorouracil|fluorouracil|mesh-list
153749128|NCT00189657|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
153749129|NCT00189657|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153749130|NCT00189657|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153749131|NCT00189657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153749132|NCT00189657|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153749133|NCT00189657|Antimetabolites|antimetabolites|mesh-ancestor
153749134|NCT00189657|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153749135|NCT00189657|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153749136|NCT00189657|Immunologic Factors|immunologic factors|mesh-ancestor
153749137|NCT00189657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153749170|NCT00157547|Antidepressive Agents|antidepressive agents|mesh-ancestor
153749171|NCT00157547|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153749172|NCT00157547|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
153749173|NCT00157547|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153749174|NCT00157547|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153749175|NCT00157547|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
153749176|NCT00157547|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153749177|NCT00157547|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153749178|NCT00157547|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153749179|NCT00157547|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
153749180|NCT00157547|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
153749181|NCT00157547|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
153749183|NCT04061161|Tiotropium Bromide|tiotropium bromide|mesh-list
153749184|NCT04061161|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153749185|NCT04061161|Autonomic Agents|autonomic agents|mesh-ancestor
153749186|NCT04061161|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153749187|NCT04061161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153749188|NCT04061161|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153749189|NCT04061161|Respiratory System Agents|respiratory system agents|mesh-ancestor
153749190|NCT04061161|Parasympatholytics|parasympatholytics|mesh-ancestor
153749191|NCT04061161|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
153749192|NCT04061161|Cholinergic Agents|cholinergic agents|mesh-ancestor
153749193|NCT04061161|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153749194|NCT04061161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153749195|NCT04061161|Anticonvulsants|anticonvulsants|mesh-ancestor
153749196|NCT00157586|Manidipine|manidipine|mesh-list
153749197|NCT00157586|Delapril|delapril|mesh-list
153749198|NCT00157586|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153749199|NCT00157586|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153749273|NCT00157898|Ertapenem|ertapenem|mesh-list
153749274|NCT00157898|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153749275|NCT00157898|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153749276|NCT00157898|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153749277|NCT00157898|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153749278|NCT00157898|Third Generation Cephalosporins|third generation cephalosporins|mesh-ancestor
153749279|NCT00157898|Beta Lactam Antibiotics|beta lactam antibiotics|mesh-ancestor
153749280|NCT03669523|Denosumab|denosumab|mesh-list
153749281|NCT03669523|Nivolumab|nivolumab|mesh-list
153749336|NCT00158132|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153749337|NCT00158132|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153749339|NCT00158132|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
153749340|NCT00158132|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
153749341|NCT00158132|Antiviral Agents|antiviral agents|mesh-ancestor
153749342|NCT00158132|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153749343|NCT00158132|Dopamine Agents|dopamine agents|mesh-ancestor
153749344|NCT00158132|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153749345|NCT00158132|Analgesics|analgesics|mesh-ancestor
153749346|NCT00158132|Sensory System Agents|sensory system agents|mesh-ancestor
153749347|NCT00158132|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153749348|NCT00158171|Folic Acid|folic acid|mesh-list
153749349|NCT00158171|Nicotine|nicotine|mesh-list
153880169|NCT02703610|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153749350|NCT00158171|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
153749351|NCT00158171|Autonomic Agents|autonomic agents|mesh-ancestor
153749352|NCT00158171|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153749353|NCT00158171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153749354|NCT00158171|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
153749355|NCT00158171|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
153749356|NCT00158171|Cholinergic Agents|cholinergic agents|mesh-ancestor
153749357|NCT00158171|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153749358|NCT00158171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153749359|NCT00158171|Hematinics|hematinics|mesh-ancestor
153749360|NCT00158171|Vitamin B Complex|vitamin b complex|mesh-ancestor
153749361|NCT00158171|Vitamins|vitamins|mesh-ancestor
153749362|NCT00158171|Micronutrients|micronutrients|mesh-ancestor
153749363|NCT03370783|Ethanol|ethanol|mesh-list
153749364|NCT03370783|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
153749365|NCT03370783|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153749366|NCT03370783|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153749383|NCT00183222|Ondansetron|ondansetron|mesh-list
153749384|NCT00183222|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
153749385|NCT00183222|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
153749386|NCT00183222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153749387|NCT00183222|Sensory System Agents|sensory system agents|mesh-ancestor
153749388|NCT00183222|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153749389|NCT00183222|Antiemetics|antiemetics|mesh-ancestor
153749390|NCT00183222|Autonomic Agents|autonomic agents|mesh-ancestor
153749451|NCT05169229|Tobramycin|tobramycin|mesh-list
153749452|NCT05169229|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153749453|NCT05169229|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153749456|NCT00538018|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153749520|NCT00538603|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153749521|NCT00538603|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153749522|NCT00538603|Tubulin Modulators|tubulin modulators|mesh-ancestor
153749523|NCT00538603|Antimitotic Agents|antimitotic agents|mesh-ancestor
153749524|NCT00538603|Mitosis Modulators|mitosis modulators|mesh-ancestor
153749526|NCT00538603|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153749593|NCT00537121|Fluorouracil|fluorouracil|mesh-list
153880170|NCT02661035|Mycophenolic Acid|mycophenolic acid|mesh-list
153880171|NCT02661035|Cyclophosphamide|cyclophosphamide|mesh-list
153880172|NCT02661035|Fludarabine|fludarabine|mesh-list
153880173|NCT02661035|Allopurinol|allopurinol|mesh-list
153880174|NCT02661035|Tacrolimus|tacrolimus|mesh-list
153749594|NCT00537121|Irinotecan|irinotecan|mesh-list
153749596|NCT00537121|Calcium|calcium|mesh-list
153749597|NCT00537121|Levoleucovorin|levoleucovorin|mesh-list
153749598|NCT00537121|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153749599|NCT00537121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153749600|NCT00537121|Antimetabolites|antimetabolites|mesh-ancestor
153749601|NCT00537121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153749658|NCT00183612|Autonomic Agents|autonomic agents|mesh-ancestor
153749659|NCT00183612|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153749660|NCT00183612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153749661|NCT00183612|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153749662|NCT00183612|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153749663|NCT00183612|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153749664|NCT00183612|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153749665|NCT00183612|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153749666|NCT00183612|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
153749667|NCT00183612|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153749668|NCT00183612|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153749669|NCT00183612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153749670|NCT00183612|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153749671|NCT00183612|Serotonin Agents|serotonin agents|mesh-ancestor
153749717|NCT00159146|Vasodilator Agents|vasodilator agents|mesh-ancestor
153749718|NCT00537667|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
153749719|NCT00537667|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153749720|NCT00538876|Decitabine|decitabine|mesh-list
153749789|NCT00539968|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153749790|NCT00183846|Irinotecan|irinotecan|mesh-list
153749791|NCT00183846|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
153749792|NCT00183846|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153749793|NCT00183846|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153749794|NCT00183846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153749795|NCT00183846|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153749796|NCT00540085|Rocuronium|rocuronium|mesh-list
153749797|NCT00540085|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
153749798|NCT00540085|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
153749799|NCT00540085|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
153749800|NCT00540085|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153749801|NCT00540085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153749802|NCT00540202|Lumefantrine|lumefantrine|mesh-list
153749803|NCT00540202|Artemether|artemether|mesh-list
153749848|NCT00183924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153749849|NCT00183924|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153749850|NCT00183924|Alkylating Agents|alkylating agents|mesh-ancestor
153749851|NCT00183924|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153749853|NCT00159302|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153749854|NCT00159302|Autonomic Agents|autonomic agents|mesh-ancestor
153749855|NCT00159302|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153749856|NCT00159302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153749912|NCT00540787|Sympatholytics|sympatholytics|mesh-ancestor
153749913|NCT00540787|Autonomic Agents|autonomic agents|mesh-ancestor
153749914|NCT00540787|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153749915|NCT00540787|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
153749916|NCT00540787|Antimalarials|antimalarials|mesh-ancestor
153749917|NCT00540787|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153749981|NCT00541177|Respiratory System Agents|respiratory system agents|mesh-ancestor
153749983|NCT00541177|Parasympatholytics|parasympatholytics|mesh-ancestor
153749984|NCT00541177|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
153749985|NCT00541177|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
153749986|NCT00541177|Cholinergic Agents|cholinergic agents|mesh-ancestor
153749987|NCT00541177|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153749988|NCT00541177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153749989|NCT00541216|Ephedrine|ephedrine|mesh-list
153749990|NCT00541216|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
153749991|NCT00541216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153749992|NCT00541216|Sympathomimetics|sympathomimetics|mesh-ancestor
153749993|NCT00541216|Autonomic Agents|autonomic agents|mesh-ancestor
153749994|NCT00541216|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153750041|NCT00541489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153750042|NCT00541489|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
153750057|NCT00408798|Botulinum Toxins|botulinum toxins|mesh-list
153750058|NCT00408798|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
153750059|NCT00408798|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
153750060|NCT00408798|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
153750061|NCT00408798|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153486096|NCT04189757|Acalabrutinib|acalabrutinib|mesh-list
153816116|NCT00351182|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153816117|NCT00351182|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153816118|NCT00351182|Antimalarials|antimalarials|mesh-ancestor
153816119|NCT00351182|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153816120|NCT00351182|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153816121|NCT00457860|Immunotoxin HA22|immunotoxin ha22|mesh-list
153750062|NCT00408798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153750063|NCT00408798|Cholinergic Agents|cholinergic agents|mesh-ancestor
153750065|NCT00408798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153750066|NCT00408798|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
153750067|NCT00408798|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153750068|NCT00541723|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
153750069|NCT00541723|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
153750070|NCT00541723|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153750071|NCT00541723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153750072|NCT00541723|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
153750073|NCT00541723|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153750074|NCT00541723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153750075|NCT00541723|Cholinergic Agents|cholinergic agents|mesh-ancestor
153750077|NCT00159614|Rolofylline|rolofylline|mesh-list
153750121|NCT00190515|Micronutrients|micronutrients|mesh-ancestor
153750122|NCT00159692|Amlodipine|amlodipine|mesh-list
153750123|NCT00159692|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153750124|NCT00159692|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153750125|NCT00159692|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153750126|NCT00159692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153750127|NCT00159692|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153750128|NCT00159692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153750129|NCT00159692|Vasodilator Agents|vasodilator agents|mesh-ancestor
153750130|NCT00542074|Ethanol|ethanol|mesh-list
153750131|NCT00542074|Emollients|emollients|mesh-list
153750132|NCT00542074|Dermatologic Agents|dermatologic agents|mesh-ancestor
153750133|NCT00542074|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
153750134|NCT00542074|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153750182|NCT00542347|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153750183|NCT00542347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153750184|NCT00190554|Cisplatin|cisplatin|mesh-list
153750185|NCT00190554|Fluorouracil|fluorouracil|mesh-list
153750186|NCT00190554|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153750187|NCT00190554|Antimetabolites|antimetabolites|mesh-ancestor
153750188|NCT00190554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153750189|NCT00190554|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153750190|NCT00190554|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153750191|NCT00190554|Immunologic Factors|immunologic factors|mesh-ancestor
153750192|NCT00190554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153750193|NCT00159770|Olanzapine|olanzapine|mesh-list
153750194|NCT00159770|Risperidone|risperidone|mesh-list
153750195|NCT00159770|Quetiapine Fumarate|quetiapine fumarate|mesh-list
153750196|NCT00159770|Ziprasidone|ziprasidone|mesh-list
153750197|NCT00159770|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153750198|NCT00159770|Serotonin Agents|serotonin agents|mesh-ancestor
153750239|NCT00184041|Pegaspargase|pegaspargase|mesh-list
153750240|NCT00184041|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153750241|NCT00184041|Glucocorticoids|glucocorticoids|mesh-ancestor
153750242|NCT00184041|Hormones|hormones|mesh-ancestor
153750243|NCT00184041|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153750244|NCT00184041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153750245|NCT00184041|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153750246|NCT00184041|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153750247|NCT00184041|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
153750248|NCT00184041|Abortifacient Agents|abortifacient agents|mesh-ancestor
153750249|NCT00184041|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153750250|NCT00184041|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153750251|NCT00184041|Antimetabolites|antimetabolites|mesh-ancestor
153750252|NCT00184041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153750253|NCT00184041|Dermatologic Agents|dermatologic agents|mesh-ancestor
153750254|NCT00184041|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153750255|NCT00184041|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153750256|NCT00184041|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153750257|NCT00184041|Immunologic Factors|immunologic factors|mesh-ancestor
153750258|NCT00184041|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153750259|NCT00184041|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153750260|NCT00184041|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153750261|NCT00184041|Alkylating Agents|alkylating agents|mesh-ancestor
153750262|NCT00184041|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153783150|NCT02212795|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153783151|NCT02212795|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153783152|NCT02212795|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153783153|NCT02212795|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153750263|NCT00184041|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153750272|NCT00543049|Sunitinib|sunitinib|mesh-list
153750284|NCT00190632|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153750285|NCT00190632|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153750286|NCT00190632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153750287|NCT00190632|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153750288|NCT00190632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153750290|NCT00190632|Sensory System Agents|sensory system agents|mesh-ancestor
153750293|NCT00190632|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153750350|NCT00159887|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153750351|NCT00159887|Urological Agents|urological agents|mesh-ancestor
153750353|NCT00543361|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153750354|NCT00543361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153750355|NCT00190788|Drotrecogin alfa activated|drotrecogin alfa activated|mesh-list
153750356|NCT00190788|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153750357|NCT00543634|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
153750358|NCT00543634|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
153750359|NCT00543634|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
153750360|NCT00543634|Contraceptive Agents|contraceptive agents|mesh-ancestor
153750361|NCT00543634|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153750362|NCT00543634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153750412|NCT00160043|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153750413|NCT00160043|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153750414|NCT00160043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153750415|NCT00544063|Oxaliplatin|oxaliplatin|mesh-list
153750416|NCT00544063|Irinotecan|irinotecan|mesh-list
153750417|NCT00544063|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153750418|NCT00544063|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
153750419|NCT00544063|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153750420|NCT00544063|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153750421|NCT00544063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153750422|NCT00544180|Risedronic Acid|risedronic acid|mesh-list
153750423|NCT00544180|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153750424|NCT00544180|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153750425|NCT00544180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153750426|NCT00544180|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153750427|NCT00544180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153750464|NCT00190866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153750465|NCT00190866|Analgesics|analgesics|mesh-ancestor
153750466|NCT00190866|Sensory System Agents|sensory system agents|mesh-ancestor
153750467|NCT00190866|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153750468|NCT00190866|Antidepressive Agents|antidepressive agents|mesh-ancestor
153750469|NCT00190866|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153750470|NCT00190866|Dopamine Agents|dopamine agents|mesh-ancestor
153750471|NCT00160160|Eprosartan|eprosartan|mesh-list
153750472|NCT00160160|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153750473|NCT00160160|Angiotensin II Type 2 Receptor Blockers|angiotensin ii type 2 receptor blockers|mesh-ancestor
153750474|NCT00160160|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
153750475|NCT00160160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153750476|NCT00544570|Cyclophosphamide|cyclophosphamide|mesh-list
153750477|NCT00544570|Melphalan|melphalan|mesh-list
153750478|NCT00544570|Carmustine|carmustine|mesh-list
153750479|NCT00544570|Etoposide|etoposide|mesh-list
153750480|NCT00544570|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153750481|NCT00544570|Immunologic Factors|immunologic factors|mesh-ancestor
153750482|NCT00544570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153885028|NCT02272517|Antidepressive Agents|antidepressive agents|mesh-ancestor
153750483|NCT00544570|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153750484|NCT00544570|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153750485|NCT00544570|Alkylating Agents|alkylating agents|mesh-ancestor
153750486|NCT00544570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153750487|NCT00544570|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153750488|NCT00544570|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153750489|NCT00544570|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153750490|NCT00544570|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153750491|NCT00544570|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153750492|NCT00544570|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153750493|NCT00190905|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
153750500|NCT00190905|Analgesics|analgesics|mesh-ancestor
153750505|NCT00190905|Dopamine Agents|dopamine agents|mesh-ancestor
153750506|NCT00544609|Sorafenib|sorafenib|mesh-list
153750507|NCT00544609|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153750508|NCT00544609|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153750509|NCT00544609|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153750510|NCT00544609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153750511|NCT00544687|Mometasone Furoate|mometasone furoate|mesh-list
153750512|NCT00544687|Nortriptyline|nortriptyline|mesh-list
153750513|NCT00544687|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153750514|NCT00544687|Dermatologic Agents|dermatologic agents|mesh-ancestor
153750515|NCT00544687|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
153750516|NCT00544687|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
153750517|NCT00544687|Antidepressive Agents|antidepressive agents|mesh-ancestor
153750518|NCT00544687|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153750519|NCT00544687|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
153750520|NCT00544687|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153750521|NCT00544687|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153750522|NCT00544687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153750523|NCT00544687|Adrenergic Agents|adrenergic agents|mesh-ancestor
153750524|NCT00544687|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153750525|NCT00544687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153750526|NCT00160238|Betahistine|betahistine|mesh-list
153750527|NCT00160238|Vasodilator Agents|vasodilator agents|mesh-ancestor
153750528|NCT00160238|Histamine Agonists|histamine agonists|mesh-ancestor
153750529|NCT00160238|Histamine Agents|histamine agents|mesh-ancestor
153750554|NCT02963181|Adrenergic Agents|adrenergic agents|mesh-ancestor
153750555|NCT02963181|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153750556|NCT02963181|Urological Agents|urological agents|mesh-ancestor
153750559|NCT00544999|Daunorubicin|daunorubicin|mesh-list
153750560|NCT00544999|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153750561|NCT00544999|Antimetabolites|antimetabolites|mesh-ancestor
153750562|NCT00544999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153750563|NCT00544999|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153750621|NCT00160394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153750622|NCT00160394|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153750623|NCT00160394|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153750624|NCT00160394|Dermatologic Agents|dermatologic agents|mesh-ancestor
153750625|NCT00191022|Paroxetine|paroxetine|mesh-list
153750626|NCT00191022|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
153750627|NCT00191022|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153750628|NCT00191022|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153750629|NCT00191022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153750630|NCT00191022|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153750631|NCT00191022|Serotonin Agents|serotonin agents|mesh-ancestor
153750632|NCT00191022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153750633|NCT00191022|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
153750634|NCT00191022|Antidepressive Agents|antidepressive agents|mesh-ancestor
153750635|NCT00191022|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153750636|NCT00191022|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
153750637|NCT00191022|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153461934|NCT05241054|Acetaminophen|acetaminophen|mesh-list
153750638|NCT00191022|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153750639|NCT00545389|Mesalamine|mesalamine|mesh-list
153750640|NCT00545389|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153750647|NCT00545389|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153750673|NCT00545935|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153750674|NCT00545935|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153750675|NCT00545935|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153750676|NCT00545935|Antiviral Agents|antiviral agents|mesh-ancestor
153750677|NCT00545935|Schistosomicides|schistosomicides|mesh-ancestor
153750678|NCT00545935|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
153750679|NCT00545935|Anthelmintics|anthelmintics|mesh-ancestor
153750680|NCT00160511|Levetiracetam|levetiracetam|mesh-list
153750681|NCT00160511|Anticonvulsants|anticonvulsants|mesh-ancestor
153750682|NCT00160511|Nootropic Agents|nootropic agents|mesh-ancestor
153750683|NCT00191061|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
153750684|NCT00191061|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
153750685|NCT00191061|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153750686|NCT00191061|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153750687|NCT00191061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153750688|NCT00191061|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153750689|NCT00191061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153750690|NCT00191061|Analgesics|analgesics|mesh-ancestor
153750691|NCT00191061|Sensory System Agents|sensory system agents|mesh-ancestor
153750692|NCT00191061|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153462145|NCT01929330|Dutasteride|dutasteride|mesh-list
153750693|NCT00191061|Antidepressive Agents|antidepressive agents|mesh-ancestor
153750694|NCT00191061|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153750695|NCT00191061|Dopamine Agents|dopamine agents|mesh-ancestor
153750696|NCT00160550|Levetiracetam|levetiracetam|mesh-list
153750697|NCT00160550|Anticonvulsants|anticonvulsants|mesh-ancestor
153750698|NCT00160550|Nootropic Agents|nootropic agents|mesh-ancestor
153750699|NCT00160589|Levocetirizine|levocetirizine|mesh-list
153750700|NCT00160589|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
153750701|NCT00160589|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
153750702|NCT00160589|Histamine Antagonists|histamine antagonists|mesh-ancestor
153750703|NCT00160589|Histamine Agents|histamine agents|mesh-ancestor
153750704|NCT00160589|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153750707|NCT00546130|polysaccharide-K|polysaccharide-k|mesh-list
153750715|NCT00546130|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153750716|NCT00546130|Immunologic Factors|immunologic factors|mesh-ancestor
153750717|NCT00546130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153750718|NCT00546130|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153750719|NCT00546130|Antiviral Agents|antiviral agents|mesh-ancestor
153750720|NCT00546130|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153750721|NCT00546130|Interferon Inducers|interferon inducers|mesh-ancestor
153750722|NCT00546130|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
153750723|NCT00546130|Protective Agents|protective agents|mesh-ancestor
153750725|NCT00191178|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
153750726|NCT00191178|Insulin Glargine|insulin glargine|mesh-list
153750727|NCT00191178|Insulin Lispro|insulin lispro|mesh-list
153462271|NCT00632736|Ropinirole|ropinirole|mesh-list
153462429|NCT00982020|Olanzapine|olanzapine|mesh-list
153750729|NCT00191178|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153750730|NCT00191178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153750731|NCT00191178|Heparin Antagonists|heparin antagonists|mesh-ancestor
153750775|NCT00191256|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153750776|NCT00191256|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153750777|NCT00191256|Tubulin Modulators|tubulin modulators|mesh-ancestor
153750778|NCT00191256|Antimitotic Agents|antimitotic agents|mesh-ancestor
153750779|NCT00191256|Mitosis Modulators|mitosis modulators|mesh-ancestor
153750780|NCT00191256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153750781|NCT00191256|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153750782|NCT00191256|Antimetabolites|antimetabolites|mesh-ancestor
153750840|NCT00547183|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153750841|NCT00547183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153750842|NCT00547183|Urological Agents|urological agents|mesh-ancestor
153750844|NCT00184626|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
153750845|NCT00184626|Metformin|metformin|mesh-list
153750846|NCT00184626|Insulin Glargine|insulin glargine|mesh-list
153750847|NCT00184626|Insulin Aspart|insulin aspart|mesh-list
153750848|NCT00184626|Biphasic Insulins|biphasic insulins|mesh-list
153750849|NCT00184626|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153750850|NCT00184626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153750851|NCT00547417|Tadalafil|tadalafil|mesh-list
153750852|NCT00547417|Vasodilator Agents|vasodilator agents|mesh-ancestor
153750853|NCT00547417|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
153750854|NCT00547417|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
153750855|NCT00547417|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153750856|NCT00547417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153750857|NCT00547417|Urological Agents|urological agents|mesh-ancestor
153750858|NCT00191295|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
153750859|NCT00191295|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
153750860|NCT00191295|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153750861|NCT00191295|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153750862|NCT00191295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153750863|NCT00191295|Adrenergic Agents|adrenergic agents|mesh-ancestor
153750864|NCT00191295|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153750866|NCT00547495|Tadalafil|tadalafil|mesh-list
153750887|NCT00547573|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
153750888|NCT00547573|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
153750889|NCT00547573|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153750890|NCT00547573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153750891|NCT00547573|Urological Agents|urological agents|mesh-ancestor
153750892|NCT00191373|Gemcitabine|gemcitabine|mesh-list
153750893|NCT00191373|Trastuzumab|trastuzumab|mesh-list
153750956|NCT00191412|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153750957|NCT00191412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153750958|NCT00191412|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153750959|NCT00191412|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153750960|NCT00548002|Levofloxacin|levofloxacin|mesh-list
153750961|NCT00548002|Trovafloxacin|trovafloxacin|mesh-list
153750962|NCT00548002|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
153750963|NCT00548002|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153750964|NCT00548002|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153750965|NCT00548002|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153750966|NCT00548002|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153750967|NCT00548002|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153750968|NCT00548002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153750969|NCT00548002|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153751015|NCT00548509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153751017|NCT00548509|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153751018|NCT00548509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153751019|NCT00548509|Hemostatics|hemostatics|mesh-ancestor
153751020|NCT00548509|Coagulants|coagulants|mesh-ancestor
153751021|NCT00548704|Dexrazoxane|dexrazoxane|mesh-list
153751022|NCT00548704|Razoxane|razoxane|mesh-list
153751023|NCT00548704|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153751024|NCT00548704|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
153751033|NCT00184899|Heparin|heparin|mesh-list
153426047|NCT01550510|Irinotecan|irinotecan|mesh-list
153751080|NCT00548938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153751081|NCT00548938|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153751082|NCT00161330|Amoxicillin|amoxicillin|mesh-list
153751083|NCT00161330|Ceftriaxone|ceftriaxone|mesh-list
153751084|NCT00161330|Clavulanic Acids|clavulanic acids|mesh-list
153751085|NCT00161330|Clavulanic Acid|clavulanic acid|mesh-list
153751086|NCT00161330|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153751087|NCT00161330|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153751088|NCT00161330|Third Generation Cephalosporins|third generation cephalosporins|mesh-ancestor
153751089|NCT00161330|Beta Lactam Antibiotics|beta lactam antibiotics|mesh-ancestor
153751144|NCT00184977|Respiratory System Agents|respiratory system agents|mesh-ancestor
153751145|NCT00184977|Dermatologic Agents|dermatologic agents|mesh-ancestor
153751146|NCT00184977|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
153751147|NCT00184977|Antiviral Agents|antiviral agents|mesh-ancestor
153751148|NCT00184977|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153751149|NCT00184977|Expectorants|expectorants|mesh-ancestor
153751214|NCT00191763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153751215|NCT00161564|Rituximab|rituximab|mesh-list
153751216|NCT00161564|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153751217|NCT00161564|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153751218|NCT00161564|Immunologic Factors|immunologic factors|mesh-ancestor
153751219|NCT00161564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153751220|NCT00161564|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153751221|NCT00185055|Valsartan|valsartan|mesh-list
153751222|NCT00185055|Olmesartan|olmesartan|mesh-list
153751223|NCT00185055|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
153751224|NCT00185055|Irbesartan|irbesartan|mesh-list
153751277|NCT00161681|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153751278|NCT00161681|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
153751279|NCT00161681|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
153751280|NCT00161681|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
153751281|NCT00161681|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
153751282|NCT02963454|Simendan|simendan|mesh-list
153751283|NCT02963454|Dobutamine|dobutamine|mesh-list
153751284|NCT02963454|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
153751285|NCT02963454|Vasodilator Agents|vasodilator agents|mesh-ancestor
153751286|NCT02963454|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
153751287|NCT02963454|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
153751288|NCT02963454|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153751289|NCT02963454|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153751290|NCT02963454|Protective Agents|protective agents|mesh-ancestor
153751291|NCT02963454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153751292|NCT02963454|Sympathomimetics|sympathomimetics|mesh-ancestor
153751293|NCT02963454|Autonomic Agents|autonomic agents|mesh-ancestor
153751294|NCT02963454|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153751295|NCT02963454|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
153751331|NCT00161720|Protein C|protein c|mesh-list
153751332|NCT00161720|Anticoagulants|anticoagulants|mesh-ancestor
153751333|NCT00161720|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153751334|NCT00161720|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153751335|NCT00161720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153751336|NCT00185133|Amlodipine|amlodipine|mesh-list
153751337|NCT00185133|Olmesartan|olmesartan|mesh-list
153751338|NCT00185133|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
153751339|NCT00185133|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153463542|NCT05027100|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
153463543|NCT05027100|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153463544|NCT05027100|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153463545|NCT05027100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153463546|NCT05027100|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153463547|NCT05027100|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153463548|NCT01458600|Diclofenac|diclofenac|mesh-list
153463679|NCT02680314|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153751340|NCT00185133|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153751341|NCT00185133|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153751342|NCT00185133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153751343|NCT00185133|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153751344|NCT00185133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153751345|NCT00185133|Vasodilator Agents|vasodilator agents|mesh-ancestor
153751346|NCT00185133|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
153751347|NCT00185133|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
153751348|NCT00551005|Celecoxib|celecoxib|mesh-list
153751388|NCT00551122|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153751389|NCT00551122|Immunologic Factors|immunologic factors|mesh-ancestor
153751390|NCT00551122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153751391|NCT00551122|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153751392|NCT00551122|Alkylating Agents|alkylating agents|mesh-ancestor
153751394|NCT00551239|Fludarabine|fludarabine|mesh-list
153751395|NCT00551239|Fludarabine phosphate|fludarabine phosphate|mesh-list
153751396|NCT00551239|Pixantrone|pixantrone|mesh-list
153751397|NCT00551239|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153751453|NCT00551590|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
153463993|NCT05578950|Itraconazole|itraconazole|mesh-list
153463994|NCT05578950|Terbinafine|terbinafine|mesh-list
153751455|NCT00551590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153751457|NCT00551590|Hormones|hormones|mesh-ancestor
153751458|NCT00551590|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153751459|NCT00551590|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
153751460|NCT00551590|Protease Inhibitors|protease inhibitors|mesh-ancestor
153751517|NCT00161993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153751518|NCT00185328|Estradiol|estradiol|mesh-list
153751519|NCT00185328|Estrogens|estrogens|mesh-ancestor
153751520|NCT00185328|Hormones|hormones|mesh-ancestor
153751521|NCT00185328|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153751522|NCT00185328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153751524|NCT00162110|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153751526|NCT00552370|Insulin Glargine|insulin glargine|mesh-list
153751580|NCT00552682|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153751581|NCT00552682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153751583|NCT00552682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153751585|NCT00552682|Sensory System Agents|sensory system agents|mesh-ancestor
153751586|NCT00552682|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153751587|NCT00552682|Antidepressive Agents|antidepressive agents|mesh-ancestor
153751588|NCT00552682|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153751589|NCT00552682|Dopamine Agents|dopamine agents|mesh-ancestor
153751590|NCT04652089|Simvastatin|simvastatin|mesh-list
153751591|NCT04652089|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153751592|NCT04652089|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153751593|NCT04652089|Antimetabolites|antimetabolites|mesh-ancestor
153421039|NCT06288373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153421040|NCT06288360|Paclitaxel|paclitaxel|mesh-list
153421041|NCT06288360|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
153421042|NCT06288360|Cisplatin|cisplatin|mesh-list
153751594|NCT04652089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153751595|NCT04652089|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153751596|NCT04652089|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
153751597|NCT04652089|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153751598|NCT04609306|Hydrogen Peroxide|hydrogen peroxide|mesh-list
153751599|NCT04609306|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
153751633|NCT00162383|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153751634|NCT00162383|Antimalarials|antimalarials|mesh-ancestor
153751635|NCT00162383|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153751636|NCT00162383|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153751637|NCT00162383|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153751638|NCT00162383|Leprostatic Agents|leprostatic agents|mesh-ancestor
153751639|NCT00162383|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153751640|NCT00162383|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153751641|NCT00162383|Sympatholytics|sympatholytics|mesh-ancestor
153751642|NCT00162383|Autonomic Agents|autonomic agents|mesh-ancestor
153751643|NCT00162383|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153751644|NCT00162383|Adrenergic Agents|adrenergic agents|mesh-ancestor
153751694|NCT00162461|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
153751695|NCT00162461|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
153751697|NCT00185562|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
153751698|NCT00185562|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153751699|NCT00185562|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153751700|NCT00162656|Cyclophosphamide|cyclophosphamide|mesh-list
153464452|NCT04773756|Sofosbuvir|sofosbuvir|mesh-list
153751701|NCT00162656|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153751702|NCT00162656|Immunologic Factors|immunologic factors|mesh-ancestor
153751703|NCT00162656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153751704|NCT00162656|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153751757|NCT00185835|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153751758|NCT00185835|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153751759|NCT00185835|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153751760|NCT00185835|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153751761|NCT00185835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153751762|NCT00162968|Escitalopram|escitalopram|mesh-list
153751763|NCT00162968|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
153751764|NCT00162968|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153751765|NCT00162968|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153751766|NCT00162968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153751767|NCT00162968|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153421043|NCT06288360|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153464826|NCT00051168|Travoprost|travoprost|mesh-list
153751768|NCT00162968|Serotonin Agents|serotonin agents|mesh-ancestor
153751769|NCT00162968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153751770|NCT03970330|Naltrexone|naltrexone|mesh-list
153751771|NCT03970330|Norethindrone|norethindrone|mesh-list
153751772|NCT03970330|Norethindrone Acetate|norethindrone acetate|mesh-list
153421044|NCT06288360|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153751773|NCT03970330|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
153751774|NCT03970330|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
153751775|NCT03970330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153751776|NCT03970330|Sensory System Agents|sensory system agents|mesh-ancestor
153751777|NCT03970330|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153751778|NCT03970330|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
153751779|NCT03970330|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
153751780|NCT03970330|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
153751781|NCT03970330|Contraceptive Agents|contraceptive agents|mesh-ancestor
153751782|NCT03970330|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153751783|NCT03970330|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
153751784|NCT03970330|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
153751800|NCT00163046|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153751801|NCT00163046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153751802|NCT00163046|Antimanic Agents|antimanic agents|mesh-ancestor
153751804|NCT00185952|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153751805|NCT00185952|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153751806|NCT00185952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153751807|NCT00185952|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153751863|NCT00163202|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153751865|NCT00163202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153751866|NCT00163202|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153751867|NCT00163202|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
153751868|NCT00163202|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153751869|NCT03318952|Lidocaine|lidocaine|mesh-list
153751870|NCT03318952|Anesthetics, Local|anesthetics, local|mesh-list
153751871|NCT03318952|Carticaine|carticaine|mesh-list
153751872|NCT03318952|Anesthetics|anesthetics|mesh-list
153751873|NCT03318952|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153751874|NCT03318952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153751882|NCT00192660|Ritonavir|ritonavir|mesh-list
153751926|NCT00163241|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153751927|NCT00163241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153751929|NCT00163241|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153751930|NCT00163241|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
153751948|NCT00163319|Hormones|hormones|mesh-ancestor
153751993|NCT00163397|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153751994|NCT00163397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153751995|NCT00163397|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
153751996|NCT00163436|Ciclesonide|ciclesonide|mesh-list
153751997|NCT00163436|Glucocorticoids|glucocorticoids|mesh-ancestor
153751998|NCT00163436|Hormones|hormones|mesh-ancestor
153751999|NCT00163436|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153752000|NCT00163436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153752059|NCT00553072|Magnesium Sulfate|magnesium sulfate|mesh-list
153752060|NCT00553072|Analgesics|analgesics|mesh-ancestor
153752061|NCT00553072|Sensory System Agents|sensory system agents|mesh-ancestor
153752062|NCT00553072|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153752063|NCT00553072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153752064|NCT00553072|Anesthetics|anesthetics|mesh-ancestor
153752065|NCT00553072|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153752126|NCT05807776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153752127|NCT05807776|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153752130|NCT05807659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153752131|NCT05807659|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153752132|NCT05807659|Immunologic Factors|immunologic factors|mesh-ancestor
153465107|NCT00091260|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153465108|NCT00091260|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153752133|NCT05807659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153752134|NCT05807659|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153752135|NCT05807659|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153752136|NCT05807659|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153752137|NCT05807542|Paclitaxel|paclitaxel|mesh-list
153752138|NCT05807542|Carboplatin|carboplatin|mesh-list
153752139|NCT05807542|Tislelizumab|tislelizumab|mesh-list
153752140|NCT05807542|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153752141|NCT05807542|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153752142|NCT05807542|Tubulin Modulators|tubulin modulators|mesh-ancestor
153752184|NCT05807100|Keratolytic Agents|keratolytic agents|mesh-ancestor
153752185|NCT05807100|Dermatologic Agents|dermatologic agents|mesh-ancestor
153752189|NCT05781698|Mesalamine|mesalamine|mesh-list
153752190|NCT05781698|Fenofibrate|fenofibrate|mesh-list
153752191|NCT05781698|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153752192|NCT05781698|Antimetabolites|antimetabolites|mesh-ancestor
153752193|NCT05781698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153752194|NCT05781698|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153752195|NCT05781698|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153752196|NCT05781698|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153752197|NCT05781698|Analgesics|analgesics|mesh-ancestor
153752198|NCT05781698|Sensory System Agents|sensory system agents|mesh-ancestor
153752199|NCT05781698|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153465457|NCT00225498|Olanzapine|olanzapine|mesh-list
153752200|NCT05781698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153752202|NCT05781698|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153752203|NCT05709509|Aspirin|aspirin|mesh-list
153752244|NCT05674513|Contraceptive Agents|contraceptive agents|mesh-ancestor
153752245|NCT05674513|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153752246|NCT05674513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153752247|NCT05674513|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
153752248|NCT05644340|Methamphetamine|methamphetamine|mesh-list
153752249|NCT05644340|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
153752250|NCT05644340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153752251|NCT05644340|Sympathomimetics|sympathomimetics|mesh-ancestor
153752252|NCT05644340|Autonomic Agents|autonomic agents|mesh-ancestor
153752253|NCT05644340|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153752262|NCT05627947|Cyclosporine|cyclosporine|mesh-list
153752308|NCT05464654|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
153752310|NCT05464654|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153752311|NCT05464654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153752312|NCT05267873|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
153752313|NCT05267873|Vortioxetine|vortioxetine|mesh-list
153752318|NCT05267873|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153752374|NCT04716699|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153752375|NCT04716699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153752376|NCT04716699|Sensory System Agents|sensory system agents|mesh-ancestor
153752377|NCT04716699|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153752378|NCT04716699|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153752379|NCT04716699|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
153752380|NCT04716699|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153752381|NCT04716699|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153752382|NCT04716699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153752439|NCT04531176|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153752440|NCT04531176|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153752441|NCT04531176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153752442|NCT04531176|Dopamine Agents|dopamine agents|mesh-ancestor
153752443|NCT04531176|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153752444|NCT04531176|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
153752445|NCT04531176|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153752446|NCT04531176|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153752503|NCT03729245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153752504|NCT03729245|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153752505|NCT03729245|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153752506|NCT03729245|Growth Substances|growth substances|mesh-ancestor
153752507|NCT03729245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153466108|NCT00330876|Pitavastatin|pitavastatin|mesh-list
153752508|NCT03729245|Growth Inhibitors|growth inhibitors|mesh-ancestor
153752509|NCT03729245|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153752510|NCT03729245|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153752512|NCT03712397|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
153752513|NCT03712397|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153752514|NCT03712397|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153752515|NCT03712397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153752516|NCT03712397|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153752518|NCT03557918|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153752519|NCT03544099|Pembrolizumab|pembrolizumab|mesh-list
153752520|NCT03544099|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153752521|NCT03544099|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153752522|NCT03544099|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153752523|NCT03544099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153752524|NCT03528408|Nivolumab|nivolumab|mesh-list
153752525|NCT03528408|Ipilimumab|ipilimumab|mesh-list
153752554|NCT03406299|Antidotes|antidotes|mesh-ancestor
153752555|NCT03406299|Protective Agents|protective agents|mesh-ancestor
153752556|NCT03406299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153752557|NCT03406299|Vitamin B Complex|vitamin b complex|mesh-ancestor
153752558|NCT03406299|Vitamins|vitamins|mesh-ancestor
153752559|NCT03406299|Micronutrients|micronutrients|mesh-ancestor
153752560|NCT03396445|Paclitaxel|paclitaxel|mesh-list
153752561|NCT03396445|Carboplatin|carboplatin|mesh-list
153752562|NCT03396445|Pembrolizumab|pembrolizumab|mesh-list
153752563|NCT03396445|Pemetrexed|pemetrexed|mesh-list
153752564|NCT03396445|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153752565|NCT03396445|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153752566|NCT03396445|Tubulin Modulators|tubulin modulators|mesh-ancestor
153752567|NCT03396445|Antimitotic Agents|antimitotic agents|mesh-ancestor
153752568|NCT03396445|Mitosis Modulators|mitosis modulators|mesh-ancestor
153752569|NCT03396445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153752570|NCT03396445|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153752616|NCT03330028|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
153752617|NCT03330028|Antipruritics|antipruritics|mesh-ancestor
153752618|NCT03330028|Dermatologic Agents|dermatologic agents|mesh-ancestor
153752619|NCT03330028|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
153752620|NCT03330028|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
153752621|NCT03311555|Docetaxel|docetaxel|mesh-list
153752622|NCT03311555|Androgens|androgens|mesh-list
153752623|NCT03311555|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153752624|NCT03311555|Tubulin Modulators|tubulin modulators|mesh-ancestor
153752625|NCT03311555|Antimitotic Agents|antimitotic agents|mesh-ancestor
153752626|NCT03311555|Mitosis Modulators|mitosis modulators|mesh-ancestor
153752627|NCT03311555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153752677|NCT02401035|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153752678|NCT02401035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153752679|NCT02153944|Propranolol|propranolol|mesh-list
153752680|NCT02153944|Methylphenidate|methylphenidate|mesh-list
153752681|NCT02153944|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
153752682|NCT02153944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153752683|NCT02153944|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
153752684|NCT02153944|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153752685|NCT02153944|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153752742|NCT01075971|Sensory System Agents|sensory system agents|mesh-ancestor
153752743|NCT01075971|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153752744|NCT01075971|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
153752745|NCT00775749|Nicotine|nicotine|mesh-list
153752746|NCT00775749|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
153752747|NCT00775749|Autonomic Agents|autonomic agents|mesh-ancestor
153752748|NCT00775749|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153752750|NCT00775749|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
153752808|NCT00193011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153752809|NCT00193011|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153752810|NCT00193011|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153752811|NCT00193011|Tubulin Modulators|tubulin modulators|mesh-ancestor
153752812|NCT00193011|Antimitotic Agents|antimitotic agents|mesh-ancestor
153752813|NCT00193011|Mitosis Modulators|mitosis modulators|mesh-ancestor
153752814|NCT00193011|Antimetabolites|antimetabolites|mesh-ancestor
153752815|NCT00193011|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153752816|NCT00193011|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
153752817|NCT00193011|Abortifacient Agents|abortifacient agents|mesh-ancestor
153752818|NCT00193011|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153752819|NCT00193011|Dermatologic Agents|dermatologic agents|mesh-ancestor
153752871|NCT00163982|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153752872|NCT00163982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153783154|NCT02212795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153783155|NCT02212795|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153752873|NCT00163982|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153752874|NCT00163982|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
153752875|NCT00163982|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153752876|NCT00193323|Gemcitabine|gemcitabine|mesh-list
153590016|NCT01810809|Hylan|hylan|mesh-list
153752878|NCT00193323|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153752879|NCT00193323|Antimetabolites|antimetabolites|mesh-ancestor
153752880|NCT00193323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153752881|NCT00193323|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153752882|NCT00193323|Tubulin Modulators|tubulin modulators|mesh-ancestor
153752883|NCT00193323|Antimitotic Agents|antimitotic agents|mesh-ancestor
153752884|NCT00193323|Mitosis Modulators|mitosis modulators|mesh-ancestor
153752885|NCT00193362|Paclitaxel|paclitaxel|mesh-list
153752886|NCT00193362|Vinorelbine|vinorelbine|mesh-list
153752887|NCT00193362|Carboplatin|carboplatin|mesh-list
153752888|NCT00193362|Gemcitabine|gemcitabine|mesh-list
153752889|NCT00193362|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153752890|NCT00193362|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153752891|NCT00193362|Tubulin Modulators|tubulin modulators|mesh-ancestor
153752892|NCT00193362|Antimitotic Agents|antimitotic agents|mesh-ancestor
153752893|NCT00193362|Mitosis Modulators|mitosis modulators|mesh-ancestor
153752894|NCT00193362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153752895|NCT00193362|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153752896|NCT00193362|Antimetabolites|antimetabolites|mesh-ancestor
153752918|NCT05077969|Famotidine|famotidine|mesh-list
153752919|NCT05077969|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153752920|NCT05077969|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153752921|NCT05077969|Analgesics|analgesics|mesh-ancestor
153752922|NCT05077969|Sensory System Agents|sensory system agents|mesh-ancestor
153752923|NCT05077969|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153752924|NCT05077969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153752925|NCT05077969|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153752926|NCT05077969|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153752927|NCT05077969|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
153752984|NCT04977232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153752986|NCT04974814|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
153752987|NCT04974814|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153752988|NCT04974814|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153467445|NCT00535782|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153880195|NCT02661035|Antioxidants|antioxidants|mesh-ancestor
153880196|NCT02661035|Protective Agents|protective agents|mesh-ancestor
153880197|NCT02627846|Lidocaine|lidocaine|mesh-list
153880198|NCT02627846|Epinephrine|epinephrine|mesh-list
153880199|NCT02627846|Racepinephrine|racepinephrine|mesh-list
153880200|NCT02627846|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
153752989|NCT04974814|Antimetabolites|antimetabolites|mesh-ancestor
153752990|NCT04974814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153752991|NCT04974814|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153752992|NCT04974814|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
153752993|NCT04974814|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153752994|NCT00164411|Vaccines|vaccines|mesh-list
153752995|NCT00164411|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
153752996|NCT00164411|Immunologic Factors|immunologic factors|mesh-ancestor
153752997|NCT00164411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153752998|NCT00193635|Mycophenolic Acid|mycophenolic acid|mesh-list
153753043|NCT00176241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153753044|NCT00176241|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153753045|NCT00176241|Antimetabolites|antimetabolites|mesh-ancestor
153753046|NCT00164801|Diltiazem|diltiazem|mesh-list
153753047|NCT00164801|Baclofen|baclofen|mesh-list
153753048|NCT00164801|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
153753049|NCT00164801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153753050|NCT00164801|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
153753051|NCT00164801|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153753052|NCT00164801|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
153753053|NCT00164801|GABA Agonists|gaba agonists|mesh-ancestor
153753054|NCT00164801|GABA Agents|gaba agents|mesh-ancestor
153753055|NCT00164801|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153753056|NCT00164801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153753057|NCT00164801|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153753058|NCT00164801|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153753059|NCT00164801|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153753060|NCT00164801|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153753061|NCT00164801|Vasodilator Agents|vasodilator agents|mesh-ancestor
153753062|NCT00176280|Dexamethasone|dexamethasone|mesh-list
153753063|NCT00176280|Sargramostim|sargramostim|mesh-list
153753064|NCT00176280|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153753065|NCT00176280|Antiemetics|antiemetics|mesh-ancestor
153753066|NCT00176280|Autonomic Agents|autonomic agents|mesh-ancestor
153753067|NCT00176280|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153753068|NCT00176280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153753090|NCT04723940|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
153753091|NCT00164840|Esomeprazole|esomeprazole|mesh-list
153753092|NCT00164840|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
153753093|NCT00164840|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153753094|NCT00164840|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
153753095|NCT00164840|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153753096|NCT00164840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153753098|NCT04641247|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
153753099|NCT04641247|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153753100|NCT04641247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153753101|NCT04641247|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153753102|NCT04635007|Misoprostol|misoprostol|mesh-list
153590189|NCT01812018|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153753103|NCT04635007|Tranexamic Acid|tranexamic acid|mesh-list
153753104|NCT04635007|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
153753105|NCT04635007|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153753107|NCT04635007|Hemostatics|hemostatics|mesh-ancestor
153753144|NCT00165035|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153753145|NCT00165035|Tubulin Modulators|tubulin modulators|mesh-ancestor
153753146|NCT00165035|Antimitotic Agents|antimitotic agents|mesh-ancestor
153753147|NCT00165035|Mitosis Modulators|mitosis modulators|mesh-ancestor
153753148|NCT00165035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153753149|NCT00165074|Calfactant|calfactant|mesh-list
153753150|NCT00165074|Pulmonary Surfactants|pulmonary surfactants|mesh-ancestor
153753151|NCT00165074|Respiratory System Agents|respiratory system agents|mesh-ancestor
153753152|NCT04307953|Saracatinib|saracatinib|mesh-list
153753153|NCT04307953|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153753154|NCT04307953|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153753155|NCT04307953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153753156|NCT04297267|Gemcitabine|gemcitabine|mesh-list
153753157|NCT04297267|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153753158|NCT04297267|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153753159|NCT04297267|Antimetabolites|antimetabolites|mesh-ancestor
153753161|NCT00176475|Rituximab|rituximab|mesh-list
153753201|NCT00176553|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
153753202|NCT00176553|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
153753203|NCT00176553|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153753204|NCT00176553|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153753205|NCT00176553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153880202|NCT02627846|Epinephryl borate|epinephryl borate|mesh-list
153813720|NCT00436839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153813721|NCT00436839|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153813722|NCT00436839|Glucocorticoids|glucocorticoids|mesh-ancestor
153813723|NCT00436839|Hormones|hormones|mesh-ancestor
153813724|NCT00436839|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153753206|NCT00176553|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153753207|NCT00176553|Narcotics|narcotics|mesh-ancestor
153753208|NCT00176553|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153753209|NCT00176553|Analgesics|analgesics|mesh-ancestor
153753210|NCT00176553|Sensory System Agents|sensory system agents|mesh-ancestor
153753211|NCT00176553|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153753212|NCT00165308|Tamoxifen|tamoxifen|mesh-list
153753213|NCT00165308|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
153753214|NCT00165308|Hormone Antagonists|hormone antagonists|mesh-ancestor
153753215|NCT00165308|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153753216|NCT00165308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153753217|NCT00165308|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153753218|NCT00165308|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153753219|NCT00165308|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
153753220|NCT00165308|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
153753221|NCT00165308|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153753222|NCT00165347|Vatalanib|vatalanib|mesh-list
153753251|NCT04082650|Vitamin D|vitamin d|mesh-list
153753252|NCT04082650|Vitamins|vitamins|mesh-ancestor
153753253|NCT04082650|Micronutrients|micronutrients|mesh-ancestor
153753254|NCT04082650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153753255|NCT04082650|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153753256|NCT00176787|Capecitabine|capecitabine|mesh-list
153753257|NCT00176787|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153753258|NCT00176787|Antimetabolites|antimetabolites|mesh-ancestor
153468527|NCT06285396|Respiratory System Agents|respiratory system agents|mesh-ancestor
153753259|NCT00176787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153753260|NCT00176787|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153783156|NCT02212795|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
153753262|NCT00176943|Toll-Like Receptor Agonists|toll-like receptor agonists|mesh-ancestor
153753263|NCT00176943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153753264|NCT00176943|Immunomodulating Agents|immunomodulating agents|mesh-ancestor
153753265|NCT00176943|Immunologic Factors|immunologic factors|mesh-ancestor
153753269|NCT00176943|Interferon Inducers|interferon inducers|mesh-ancestor
153753309|NCT04682899|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153753310|NCT04682899|Antitubercular Agents|antitubercular agents|mesh-ancestor
153753311|NCT03789916|Aspirin|aspirin|mesh-list
153753312|NCT03789916|Ticagrelor|ticagrelor|mesh-list
153753313|NCT03789916|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153753314|NCT03789916|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
153753315|NCT03789916|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
153753316|NCT03789916|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
153753317|NCT03789916|Purinergic Agents|purinergic agents|mesh-ancestor
153753373|NCT00177099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153753374|NCT00177099|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
153753375|NCT00177099|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153753376|NCT00177099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153753377|NCT03413800|Dexamethasone|dexamethasone|mesh-list
153753378|NCT03413800|Lenalidomide|lenalidomide|mesh-list
153753379|NCT03413800|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153753380|NCT03413800|Antiemetics|antiemetics|mesh-ancestor
153753381|NCT03413800|Autonomic Agents|autonomic agents|mesh-ancestor
153753382|NCT03413800|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153753383|NCT03413800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153753384|NCT03413800|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153753385|NCT03413800|Glucocorticoids|glucocorticoids|mesh-ancestor
153753386|NCT03413800|Hormones|hormones|mesh-ancestor
153468989|NCT05701189|Immunoglobulins|immunoglobulins|mesh-list
153468990|NCT05701189|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
153468991|NCT05701189|Antibodies|antibodies|mesh-list
153753387|NCT03413800|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153753388|NCT03413800|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153753398|NCT00537862|Mycophenolic Acid|mycophenolic acid|mesh-list
153753430|NCT00194649|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153753431|NCT00194649|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
153753432|NCT00194649|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153753433|NCT00194649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153753434|NCT00166244|Mycophenolic Acid|mycophenolic acid|mesh-list
153753435|NCT00166244|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153753436|NCT00166244|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153753437|NCT00166244|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
153753438|NCT00166244|Antitubercular Agents|antitubercular agents|mesh-ancestor
153753439|NCT00166244|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153753440|NCT00166244|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153753441|NCT00166244|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153753442|NCT00166244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153753443|NCT00177138|Alemtuzumab|alemtuzumab|mesh-list
153753444|NCT00177138|Tacrolimus|tacrolimus|mesh-list
153753445|NCT00177138|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153753446|NCT00177138|Immunologic Factors|immunologic factors|mesh-ancestor
153753447|NCT00177138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153753448|NCT00177138|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
153753449|NCT00177138|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153753482|NCT00166400|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153753483|NCT00166400|Sympatholytics|sympatholytics|mesh-ancestor
153753484|NCT00166400|Autonomic Agents|autonomic agents|mesh-ancestor
153753485|NCT00166400|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153753486|NCT00166400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153753487|NCT00166400|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
153753488|NCT00166400|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
153753489|NCT00166400|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
153753490|NCT00166400|Adrenergic Agents|adrenergic agents|mesh-ancestor
153753491|NCT00166400|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153753492|NCT00166400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153753493|NCT02042287|Metronidazole|metronidazole|mesh-list
153753494|NCT02042287|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153626907|NCT02019524|Vaccines|vaccines|mesh-list
153753495|NCT02042287|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153753496|NCT02042287|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153753497|NCT02042287|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153753498|NCT05296213|Calcium|calcium|mesh-list
153753499|NCT05296213|Fluorides|fluorides|mesh-list
153753500|NCT05296213|Caseins|caseins|mesh-list
153753501|NCT05296213|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153753502|NCT05296213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153753503|NCT05296213|Cariostatic Agents|cariostatic agents|mesh-ancestor
153753504|NCT05296213|Protective Agents|protective agents|mesh-ancestor
153753505|NCT05296213|Chelating Agents|chelating agents|mesh-ancestor
153753506|NCT05296213|Sequestering Agents|sequestering agents|mesh-ancestor
153753507|NCT05296213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153753508|NCT00166478|Sulindac sulfone|sulindac sulfone|mesh-list
153753509|NCT00166478|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153753510|NCT00166478|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
153753511|NCT00166478|Protective Agents|protective agents|mesh-ancestor
153753512|NCT00166478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153753513|NCT00166478|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153753514|NCT00166478|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153753517|NCT00166478|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153753522|NCT00166478|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153753523|NCT05282875|Immunosuppressive Agents|immunosuppressive agents|mesh-list
153753524|NCT05282875|Immunologic Factors|immunologic factors|mesh-ancestor
153753525|NCT05282875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153753526|NCT00194766|Temozolomide|temozolomide|mesh-list
153753527|NCT00194766|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153753528|NCT00194766|Alkylating Agents|alkylating agents|mesh-ancestor
153753529|NCT00194766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153753589|NCT05124067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153753590|NCT05124067|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153753591|NCT05124067|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153753592|NCT05124067|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153753593|NCT05124067|Analgesics|analgesics|mesh-ancestor
153753594|NCT05124067|Sensory System Agents|sensory system agents|mesh-ancestor
153753595|NCT05124067|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
153753596|NCT05124067|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153753597|NCT05124067|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153753598|NCT05124067|Adrenergic Agents|adrenergic agents|mesh-ancestor
153753599|NCT05124067|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153753605|NCT00194883|Hormones|hormones|mesh-list
153753652|NCT00177372|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
153753653|NCT00177372|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
153753654|NCT00177372|Contraceptive Agents|contraceptive agents|mesh-ancestor
153753655|NCT00177372|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
153753656|NCT00177372|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
153627156|NCT02020980|Botulinum Toxins|botulinum toxins|mesh-list
153683229|NCT00403780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153683230|NCT00403780|Anticonvulsants|anticonvulsants|mesh-ancestor
153421048|NCT06288360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153421050|NCT06288334|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
153421051|NCT06288334|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
153421052|NCT06288334|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
153421054|NCT06288334|Histamine Agents|histamine agents|mesh-ancestor
153683231|NCT00403780|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153683232|NCT00403780|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153683233|NCT00403780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153683234|NCT00403780|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153683235|NCT00403780|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153683236|NCT00403780|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153683237|NCT00403780|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153683238|NCT00403780|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153683239|NCT00046514|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
153683240|NCT00046514|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153683241|NCT00403819|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
153683242|NCT00403819|Laxatives|laxatives|mesh-ancestor
153683287|NCT00080340|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153683289|NCT00132184|Vitamins|vitamins|mesh-ancestor
153683290|NCT00132184|Micronutrients|micronutrients|mesh-ancestor
153683291|NCT00132184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153683292|NCT00132184|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153683293|NCT00132379|Docetaxel|docetaxel|mesh-list
153683294|NCT00132379|Naptumomab estafenatox|naptumomab estafenatox|mesh-list
153683295|NCT00132379|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153683296|NCT00132379|Tubulin Modulators|tubulin modulators|mesh-ancestor
153683297|NCT00132379|Antimitotic Agents|antimitotic agents|mesh-ancestor
153683298|NCT00132379|Mitosis Modulators|mitosis modulators|mesh-ancestor
153683352|NCT00080418|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153683353|NCT00080418|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153683354|NCT00080418|Tubulin Modulators|tubulin modulators|mesh-ancestor
153683355|NCT00080418|Antimitotic Agents|antimitotic agents|mesh-ancestor
153683356|NCT00080418|Mitosis Modulators|mitosis modulators|mesh-ancestor
153683357|NCT00080418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153683358|NCT00132925|Triamcinolone|triamcinolone|mesh-list
153683359|NCT00132925|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153683360|NCT00132925|Glucocorticoids|glucocorticoids|mesh-ancestor
153683361|NCT00132925|Hormones|hormones|mesh-ancestor
153683363|NCT00132925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153683416|NCT00133237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153683417|NCT00133237|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153683418|NCT00133237|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153683419|NCT00133237|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153683420|NCT00133237|Antifungal Agents|antifungal agents|mesh-ancestor
153683421|NCT00133237|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153683422|NCT00133237|Immunologic Factors|immunologic factors|mesh-ancestor
153683423|NCT00133237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153683424|NCT00399672|Interferons|interferons|mesh-list
153520359|NCT06162949|Amoxicillin|amoxicillin|mesh-list
153683425|NCT00399672|Ribavirin|ribavirin|mesh-list
153683426|NCT00399672|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153683427|NCT00399672|Antiviral Agents|antiviral agents|mesh-ancestor
153683428|NCT00399672|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153683429|NCT00399672|Antimetabolites|antimetabolites|mesh-ancestor
153683430|NCT00399672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153683431|NCT00133276|Escitalopram|escitalopram|mesh-list
153683432|NCT00133276|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
153683433|NCT00133276|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153683434|NCT00133276|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153683435|NCT00133276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153683436|NCT00133276|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153683437|NCT00133276|Serotonin Agents|serotonin agents|mesh-ancestor
153683438|NCT00133276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153683439|NCT00131755|Diazoxide|diazoxide|mesh-list
153683440|NCT00131755|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153683441|NCT00131755|Vasodilator Agents|vasodilator agents|mesh-ancestor
153683463|NCT00080496|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
153683464|NCT00080496|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153683465|NCT00080496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153683466|NCT00080496|Protease Inhibitors|protease inhibitors|mesh-ancestor
153683467|NCT00133354|Anastrozole|anastrozole|mesh-list
153683468|NCT00133354|Hormones|hormones|mesh-list
153683469|NCT00133354|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153683470|NCT00133354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153683471|NCT00133354|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153683472|NCT00133354|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153683473|NCT00133354|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
153683474|NCT00133354|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153683523|NCT00080613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153683524|NCT00080613|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
153683525|NCT00080613|Hormone Antagonists|hormone antagonists|mesh-ancestor
153683526|NCT00047021|Cytarabine|cytarabine|mesh-list
153683527|NCT00047021|Mitoxantrone|mitoxantrone|mesh-list
153683528|NCT00047021|Sargramostim|sargramostim|mesh-list
153683529|NCT00047021|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153683530|NCT00047021|Antimetabolites|antimetabolites|mesh-ancestor
153683531|NCT00047021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153683592|NCT00047099|Tubulin Modulators|tubulin modulators|mesh-ancestor
153683593|NCT00047099|Antimitotic Agents|antimitotic agents|mesh-ancestor
153683594|NCT00047099|Mitosis Modulators|mitosis modulators|mesh-ancestor
153683595|NCT00047099|Antimetabolites|antimetabolites|mesh-ancestor
153683596|NCT00047099|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153683597|NCT00047099|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153683598|NCT00047099|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153683599|NCT00047099|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153683600|NCT00047099|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153683601|NCT00047099|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
153683602|NCT00047099|Hormone Antagonists|hormone antagonists|mesh-ancestor
153683603|NCT00047099|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153683604|NCT00047099|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153683605|NCT00047099|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
153683606|NCT00047099|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
153683607|NCT00047099|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153683609|NCT00133822|Sertraline|sertraline|mesh-list
153683610|NCT00133822|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153683611|NCT00133822|Serotonin Agents|serotonin agents|mesh-ancestor
153683612|NCT00133822|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153683615|NCT00133822|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153426206|NCT03665155|Daratumumab|daratumumab|mesh-list
153426207|NCT03665155|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153426208|NCT00477230|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-list
153426209|NCT00448682|Leucovorin|leucovorin|mesh-list
153426210|NCT00448682|Docetaxel|docetaxel|mesh-list
153683644|NCT00047138|Doxorubicin|doxorubicin|mesh-list
153683645|NCT00047138|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
153683646|NCT00047138|Etoposide|etoposide|mesh-list
153683647|NCT00047138|Vincristine|vincristine|mesh-list
153627841|NCT02025491|Amphotericin B|amphotericin b|mesh-list
153683648|NCT00047138|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153683649|NCT00047138|Immunologic Factors|immunologic factors|mesh-ancestor
153683650|NCT00047138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153683651|NCT00047138|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153683652|NCT00047138|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153683653|NCT00047138|Alkylating Agents|alkylating agents|mesh-ancestor
153683654|NCT00047138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153683655|NCT00047138|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153683656|NCT00047138|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153683657|NCT00047138|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153683658|NCT00047138|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153683659|NCT00047138|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153683660|NCT00047138|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153683661|NCT00047138|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153683662|NCT00047138|Tubulin Modulators|tubulin modulators|mesh-ancestor
153683663|NCT00047138|Antimitotic Agents|antimitotic agents|mesh-ancestor
153683664|NCT00047138|Mitosis Modulators|mitosis modulators|mesh-ancestor
153683665|NCT00047138|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153683696|NCT00080847|Tubulin Modulators|tubulin modulators|mesh-ancestor
153683697|NCT00080847|Antimitotic Agents|antimitotic agents|mesh-ancestor
153683698|NCT00080847|Mitosis Modulators|mitosis modulators|mesh-ancestor
153683699|NCT00134173|Atorvastatin|atorvastatin|mesh-list
153683700|NCT00134173|Torcetrapib|torcetrapib|mesh-list
153683701|NCT00134173|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153683703|NCT00134173|Antimetabolites|antimetabolites|mesh-ancestor
153683704|NCT00134173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153683705|NCT00134173|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153683706|NCT00134173|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
153683707|NCT00134173|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153683708|NCT00047177|Oxaliplatin|oxaliplatin|mesh-list
153683709|NCT00047177|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153683710|NCT00134212|Epinephrine|epinephrine|mesh-list
153683711|NCT00134212|Norepinephrine|norepinephrine|mesh-list
153885269|NCT00598962|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153885270|NCT00598962|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153683712|NCT00134212|Dopexamine|dopexamine|mesh-list
153683713|NCT00134212|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153683715|NCT00134212|Adrenergic Agents|adrenergic agents|mesh-ancestor
153683716|NCT00134212|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153683717|NCT00134212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153683718|NCT00134212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153683719|NCT00134212|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
153683720|NCT00134212|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153683721|NCT00134212|Autonomic Agents|autonomic agents|mesh-ancestor
153683722|NCT00134212|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153683723|NCT00134212|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153683724|NCT00134212|Respiratory System Agents|respiratory system agents|mesh-ancestor
153683725|NCT00134212|Mydriatics|mydriatics|mesh-ancestor
153683726|NCT00134212|Sympathomimetics|sympathomimetics|mesh-ancestor
153683743|NCT00080925|Fludarabine|fludarabine|mesh-list
153683744|NCT00080925|Fludarabine phosphate|fludarabine phosphate|mesh-list
153683745|NCT00080925|Etoposide|etoposide|mesh-list
153683746|NCT00080925|Vincristine|vincristine|mesh-list
153683747|NCT00080925|Cyclosporins|cyclosporins|mesh-list
153683748|NCT00080925|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153683749|NCT00080925|Immunologic Factors|immunologic factors|mesh-ancestor
153683750|NCT00080925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153683751|NCT00080925|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153683752|NCT00080925|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153683753|NCT00080925|Alkylating Agents|alkylating agents|mesh-ancestor
153683754|NCT00080925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153683755|NCT00080925|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153683756|NCT00080925|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153683757|NCT00080925|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153683758|NCT00080925|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153683759|NCT00080925|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153683760|NCT00080925|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153683761|NCT00080925|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153683762|NCT00080925|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153683763|NCT00080925|Glucocorticoids|glucocorticoids|mesh-ancestor
153683764|NCT00080925|Hormones|hormones|mesh-ancestor
153683765|NCT00080925|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153683766|NCT00080925|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153683767|NCT00080925|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153683768|NCT00080925|Antimetabolites|antimetabolites|mesh-ancestor
153683769|NCT00080925|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153683790|NCT00047255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153683791|NCT00047255|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153683792|NCT00134368|Etanercept|etanercept|mesh-list
153683793|NCT00134368|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153683794|NCT00134368|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153683795|NCT00134368|Analgesics|analgesics|mesh-ancestor
153683796|NCT00134368|Sensory System Agents|sensory system agents|mesh-ancestor
153683797|NCT00134368|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153332022|NCT03960658|Ketamine|ketamine|mesh-list
153683798|NCT00134368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153683799|NCT00134368|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153683800|NCT00134368|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153683801|NCT00134368|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153683802|NCT00134368|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153683803|NCT00134368|Immunologic Factors|immunologic factors|mesh-ancestor
153683804|NCT00134485|Atorvastatin|atorvastatin|mesh-list
153683805|NCT00134485|Torcetrapib|torcetrapib|mesh-list
153683806|NCT00134485|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153683807|NCT00134485|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153683847|NCT00134641|Vinorelbine|vinorelbine|mesh-list
153683848|NCT00134641|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153683849|NCT00134641|Antimetabolites|antimetabolites|mesh-ancestor
153683850|NCT00134641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153683851|NCT00134641|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153683852|NCT00134641|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153683853|NCT00134641|Tubulin Modulators|tubulin modulators|mesh-ancestor
153683854|NCT00134641|Antimitotic Agents|antimitotic agents|mesh-ancestor
153683855|NCT00134641|Mitosis Modulators|mitosis modulators|mesh-ancestor
153683856|NCT00134680|Trastuzumab|trastuzumab|mesh-list
153683857|NCT00134680|Letrozole|letrozole|mesh-list
153683858|NCT00134680|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153683859|NCT00134680|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153683860|NCT00134680|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
153683861|NCT00134680|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153683862|NCT00134680|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153683863|NCT00134680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153683864|NCT00134680|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
153683902|NCT00134914|Sensory System Agents|sensory system agents|mesh-ancestor
153683903|NCT00134914|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153683904|NCT00134914|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
153683906|NCT00134953|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
153683907|NCT00134953|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153683908|NCT00134953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153683909|NCT00134953|Cholinergic Agents|cholinergic agents|mesh-ancestor
153683910|NCT00134953|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153683912|NCT00134953|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
153683969|NCT00135187|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153683971|NCT00145093|Trace Elements|trace elements|mesh-ancestor
153683972|NCT00145093|Micronutrients|micronutrients|mesh-ancestor
153332023|NCT03960658|Analgesics|analgesics|mesh-ancestor
153332024|NCT03960658|Sensory System Agents|sensory system agents|mesh-ancestor
153783159|NCT00261261|Midazolam|midazolam|mesh-list
153683973|NCT00145093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153683974|NCT00047450|Citalopram|citalopram|mesh-list
153683975|NCT00047450|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
153683976|NCT00047450|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153683977|NCT00047450|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153683978|NCT00047450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153683979|NCT00047450|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153683980|NCT00047450|Serotonin Agents|serotonin agents|mesh-ancestor
153683981|NCT00047450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153683982|NCT00047450|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
153683983|NCT00047450|Antidepressive Agents|antidepressive agents|mesh-ancestor
153628602|NCT02031367|Hormones|hormones|mesh-ancestor
153683984|NCT00047450|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153683985|NCT00081237|Oxaliplatin|oxaliplatin|mesh-list
153683986|NCT00081237|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153683987|NCT00145171|Apomorphine|apomorphine|mesh-list
153683988|NCT00145171|Emetics|emetics|mesh-ancestor
153683989|NCT00145171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153683990|NCT00145171|Autonomic Agents|autonomic agents|mesh-ancestor
153683991|NCT00145171|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153684020|NCT00145405|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153684021|NCT00145405|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153684022|NCT00145444|Olanzapine|olanzapine|mesh-list
153684023|NCT00145444|Ziprasidone|ziprasidone|mesh-list
153684024|NCT00145444|Antiemetics|antiemetics|mesh-ancestor
153684025|NCT00145444|Autonomic Agents|autonomic agents|mesh-ancestor
153684026|NCT00145444|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153684027|NCT00145444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153520953|NCT05389995|Sequestering Agents|sequestering agents|mesh-ancestor
153684028|NCT00145444|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153684029|NCT00145444|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153684030|NCT00145444|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153684031|NCT00145444|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153684032|NCT00145444|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153684082|NCT00145639|Doxorubicin|doxorubicin|mesh-list
153684084|NCT00145639|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153684085|NCT00145639|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153684086|NCT00145639|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153684087|NCT00145639|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153684088|NCT00145639|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153684089|NCT00145639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153684090|NCT00145639|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153684091|NCT00145639|Alkylating Agents|alkylating agents|mesh-ancestor
153684092|NCT00047567|Zonisamide|zonisamide|mesh-list
153332058|NCT05313958|Sorafenib|sorafenib|mesh-list
153332088|NCT03633526|VX-659|vx-659|mesh-list
153684093|NCT00047567|Anticonvulsants|anticonvulsants|mesh-ancestor
153684094|NCT00047567|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153684095|NCT00047567|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153684096|NCT00047567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153684141|NCT00146146|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
153684142|NCT00146146|Hormone Antagonists|hormone antagonists|mesh-ancestor
153684143|NCT00146146|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153684144|NCT00146146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153684145|NCT00146146|Androgens|androgens|mesh-ancestor
153684146|NCT00146146|Hormones|hormones|mesh-ancestor
153684147|NCT00146146|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153684148|NCT00146146|Anabolic Agents|anabolic agents|mesh-ancestor
153684149|NCT00146146|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
153684150|NCT00146224|Epoetin Alfa|epoetin alfa|mesh-list
153684151|NCT00146224|Hematinics|hematinics|mesh-ancestor
153684153|NCT00081549|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153684205|NCT02957890|Vaccines|vaccines|mesh-list
153684206|NCT02957890|Immunologic Factors|immunologic factors|mesh-ancestor
153684207|NCT02957890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153684208|NCT00146575|Sirolimus|sirolimus|mesh-list
153684209|NCT00146575|Paclitaxel|paclitaxel|mesh-list
153684210|NCT00146575|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153684211|NCT00146575|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153684212|NCT00146575|Tubulin Modulators|tubulin modulators|mesh-ancestor
153684213|NCT00146575|Antimitotic Agents|antimitotic agents|mesh-ancestor
153684214|NCT00146575|Mitosis Modulators|mitosis modulators|mesh-ancestor
153684215|NCT00146575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153684268|NCT00042978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153684269|NCT00405730|Ketorolac|ketorolac|mesh-list
153684270|NCT00405730|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
153684271|NCT00405730|Nepafenac|nepafenac|mesh-list
153684272|NCT00405730|Ophthalmic Solutions|ophthalmic solutions|mesh-list
153684273|NCT00405730|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
153684274|NCT00405730|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153684275|NCT00405730|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153684276|NCT00405730|Analgesics|analgesics|mesh-ancestor
153684277|NCT00405730|Sensory System Agents|sensory system agents|mesh-ancestor
153684278|NCT00405730|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153684279|NCT00405730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153684280|NCT00405730|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153684281|NCT00405730|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153684282|NCT00405730|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153684283|NCT00405730|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153684284|NCT00405730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153684285|NCT00405769|Red yeast rice|red yeast rice|mesh-list
153684287|NCT00405769|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153684325|NCT00146926|Ketamine|ketamine|mesh-list
153684326|NCT00146926|Anesthetics, Local|anesthetics, local|mesh-ancestor
153684327|NCT00146926|Anesthetics|anesthetics|mesh-ancestor
153684328|NCT00146926|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153684329|NCT00146926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153629195|NCT02043314|Isoniazid|isoniazid|mesh-list
153684330|NCT00146926|Sensory System Agents|sensory system agents|mesh-ancestor
153684331|NCT00146926|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153684332|NCT00146926|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153684392|NCT00147355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153684393|NCT00147355|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153684394|NCT00147355|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153684395|NCT00147355|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153684396|NCT00147355|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153684397|NCT00147355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153684399|NCT00147355|Antiemetics|antiemetics|mesh-ancestor
153684400|NCT00147355|Autonomic Agents|autonomic agents|mesh-ancestor
153684401|NCT00147355|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153684402|NCT00147355|Antipruritics|antipruritics|mesh-ancestor
153684403|NCT00147355|Dermatologic Agents|dermatologic agents|mesh-ancestor
153684404|NCT00147355|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
153684405|NCT00147355|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153521322|NCT04338204|Tofacitinib|tofacitinib|mesh-list
153684406|NCT00147355|Serotonin Agents|serotonin agents|mesh-ancestor
153684407|NCT00147355|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153684408|NCT00147355|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
153684409|NCT00147355|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
153684410|NCT00147355|Dopamine Agents|dopamine agents|mesh-ancestor
153684447|NCT04725682|Tacrolimus|tacrolimus|mesh-list
153684448|NCT04725682|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153684449|NCT04725682|Immunologic Factors|immunologic factors|mesh-ancestor
153684450|NCT04725682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153684451|NCT04725682|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
153684452|NCT04725682|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153684453|NCT04725682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153684454|NCT00147511|Linezolid|linezolid|mesh-list
153684455|NCT00147511|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153684456|NCT00147511|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153684457|NCT00147511|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
153684458|NCT00147511|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153684459|NCT00147511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153684460|NCT00043095|Gemcitabine|gemcitabine|mesh-list
153684461|NCT00043095|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153684462|NCT00043095|Antimetabolites|antimetabolites|mesh-ancestor
153684463|NCT00043095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153684464|NCT00043095|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153684465|NCT00048230|Bortezomib|bortezomib|mesh-list
153684466|NCT00048230|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153684467|NCT00147589|Eplerenone|eplerenone|mesh-list
153684468|NCT00147589|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
153684469|NCT00147589|Hormone Antagonists|hormone antagonists|mesh-ancestor
153684470|NCT00147589|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153684471|NCT00147589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153684472|NCT00147589|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
153684473|NCT00147589|Diuretics|diuretics|mesh-ancestor
153684474|NCT00147589|Natriuretic Agents|natriuretic agents|mesh-ancestor
153332141|NCT04467424|Anesthetics, General|anesthetics, general|mesh-ancestor
153684475|NCT00147589|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153684476|NCT00397332|Alefacept|alefacept|mesh-list
153684477|NCT00397332|Dermatologic Agents|dermatologic agents|mesh-ancestor
153684478|NCT00397332|Immunologic Factors|immunologic factors|mesh-ancestor
153684479|NCT00397332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153684480|NCT00147628|Sildenafil Citrate|sildenafil citrate|mesh-list
153684481|NCT00147628|Citric Acid|citric acid|mesh-list
153684482|NCT00147628|Sodium Citrate|sodium citrate|mesh-list
153684483|NCT00147628|Anticoagulants|anticoagulants|mesh-ancestor
153684485|NCT00147628|Chelating Agents|chelating agents|mesh-ancestor
153684486|NCT00147628|Sequestering Agents|sequestering agents|mesh-ancestor
153684487|NCT00147628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153684488|NCT00147628|Vasodilator Agents|vasodilator agents|mesh-ancestor
153684489|NCT00147628|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
153684490|NCT00147628|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
153684491|NCT00147628|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153629355|NCT02044627|Antimetabolites|antimetabolites|mesh-ancestor
153684492|NCT00147628|Urological Agents|urological agents|mesh-ancestor
153684493|NCT00147667|Erythromycin|erythromycin|mesh-list
153684494|NCT00147667|Erythromycin Estolate|erythromycin estolate|mesh-list
153684550|NCT00147979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153684551|NCT00148018|Dexamethasone|dexamethasone|mesh-list
153684552|NCT00148018|Bortezomib|bortezomib|mesh-list
153684553|NCT00148018|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153684554|NCT00148018|Antiemetics|antiemetics|mesh-ancestor
153684555|NCT00148018|Autonomic Agents|autonomic agents|mesh-ancestor
153684556|NCT00148018|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153521493|NCT03845075|Metoprolol|metoprolol|mesh-list
153684557|NCT00148018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153684558|NCT00148018|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153684559|NCT00148018|Glucocorticoids|glucocorticoids|mesh-ancestor
153684560|NCT00148018|Hormones|hormones|mesh-ancestor
153684564|NCT00081822|Cytarabine|cytarabine|mesh-list
153684612|NCT00148291|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153684613|NCT00148330|Triamcinolone|triamcinolone|mesh-list
153684614|NCT00148330|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153684615|NCT00148330|Glucocorticoids|glucocorticoids|mesh-ancestor
153684616|NCT00148330|Hormones|hormones|mesh-ancestor
153684617|NCT00148330|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153684618|NCT00148330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153684619|NCT00405808|Rimonabant|rimonabant|mesh-list
153684620|NCT00405808|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
153684621|NCT00405808|Cannabinoid Receptor Antagonists|cannabinoid receptor antagonists|mesh-ancestor
153684622|NCT00405808|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
153684623|NCT00405808|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153684624|NCT00405808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153684625|NCT00405808|Hormones|hormones|mesh-ancestor
153684626|NCT00405808|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153684627|NCT00405808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153684628|NCT00081900|N(1),N(11)-diethylnorspermine|n(1),n(11)-diethylnorspermine|mesh-list
153684629|NCT00081900|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153684630|NCT00081900|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153684631|NCT00405847|Dexmedetomidine|dexmedetomidine|mesh-list
153684632|NCT00405847|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153684633|NCT00405847|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153684634|NCT00405847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153684635|NCT00405847|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153684636|NCT00405847|Analgesics|analgesics|mesh-ancestor
153684637|NCT00405847|Sensory System Agents|sensory system agents|mesh-ancestor
153684638|NCT00405847|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153684654|NCT00148408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153684655|NCT00048503|Tipifarnib|tipifarnib|mesh-list
153684656|NCT00048503|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153684657|NCT00148447|Escitalopram|escitalopram|mesh-list
153684658|NCT00148447|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
153684659|NCT00148447|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153684661|NCT00148447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153684662|NCT00148447|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153684663|NCT00148447|Serotonin Agents|serotonin agents|mesh-ancestor
153684664|NCT00148447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153684665|NCT00043134|Decitabine|decitabine|mesh-list
153684666|NCT00043134|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153684667|NCT00043134|Antimetabolites|antimetabolites|mesh-ancestor
153684668|NCT00043134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153684669|NCT00043134|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153684670|NCT00043134|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153684671|NCT00148564|Olanzapine|olanzapine|mesh-list
153684672|NCT00148564|Ziprasidone|ziprasidone|mesh-list
153684673|NCT00148564|Antiemetics|antiemetics|mesh-ancestor
153684674|NCT00148564|Autonomic Agents|autonomic agents|mesh-ancestor
153684675|NCT00148564|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153684702|NCT00048659|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
153684703|NCT00048659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153684704|NCT00148681|Paclitaxel|paclitaxel|mesh-list
153684705|NCT00148681|Vinorelbine|vinorelbine|mesh-list
153684706|NCT00148681|Cyclophosphamide|cyclophosphamide|mesh-list
153684707|NCT00148681|Doxorubicin|doxorubicin|mesh-list
153684708|NCT00148681|Trastuzumab|trastuzumab|mesh-list
153629680|NCT02046720|Propofol|propofol|mesh-list
153684709|NCT00148681|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153684710|NCT00148681|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153684711|NCT00148681|Tubulin Modulators|tubulin modulators|mesh-ancestor
153684712|NCT00148681|Antimitotic Agents|antimitotic agents|mesh-ancestor
153684713|NCT00148681|Mitosis Modulators|mitosis modulators|mesh-ancestor
153684714|NCT00148681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153684715|NCT00148681|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153684716|NCT00148681|Immunologic Factors|immunologic factors|mesh-ancestor
153684717|NCT00148681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153684718|NCT00148681|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153684719|NCT00148681|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153684720|NCT00148681|Alkylating Agents|alkylating agents|mesh-ancestor
153684721|NCT00148681|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153684722|NCT00148681|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153684723|NCT00148681|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153684724|NCT00148681|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153684725|NCT00148681|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153684726|NCT00148681|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153684727|NCT00148720|Capecitabine|capecitabine|mesh-list
153684728|NCT00148720|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153684729|NCT00148720|Antimetabolites|antimetabolites|mesh-ancestor
153684730|NCT00148720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153684731|NCT00148720|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153684732|NCT00148837|Interferons|interferons|mesh-list
153684733|NCT00148837|Ribavirin|ribavirin|mesh-list
153684734|NCT00148837|Interferon-alpha|interferon-alpha|mesh-list
153684735|NCT00148837|Interferon alpha-2|interferon alpha-2|mesh-list
153684736|NCT00148837|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
153684737|NCT00148837|Prazosin|prazosin|mesh-list
153684739|NCT00148837|Antiviral Agents|antiviral agents|mesh-ancestor
153684740|NCT00148837|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153684741|NCT00148837|Antimetabolites|antimetabolites|mesh-ancestor
153629798|NCT02047175|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153684742|NCT00148837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153684743|NCT00148837|Immunologic Factors|immunologic factors|mesh-ancestor
153684744|NCT00148837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153684745|NCT00148837|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153684746|NCT00148837|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
153684747|NCT00148837|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
153684748|NCT00148837|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
153684749|NCT00148837|Adrenergic Agents|adrenergic agents|mesh-ancestor
153684750|NCT00148837|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153684751|NCT00148876|Capecitabine|capecitabine|mesh-list
153684752|NCT00148876|Trastuzumab|trastuzumab|mesh-list
153684753|NCT00148876|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153684754|NCT00148876|Antimetabolites|antimetabolites|mesh-ancestor
153684755|NCT00148876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153684756|NCT00148876|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153684757|NCT00148876|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153684758|NCT00148915|Ibandronic Acid|ibandronic acid|mesh-list
153684759|NCT00148915|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153684760|NCT00148915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153684761|NCT00149110|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
153684762|NCT00149110|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
153684763|NCT00149110|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153684764|NCT00149110|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153684765|NCT00149110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153684766|NCT00149110|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153684782|NCT00048776|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153332267|NCT01042795|Sunitinib|sunitinib|mesh-list
153684783|NCT00048776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153684784|NCT00048776|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153684785|NCT00048776|Respiratory System Agents|respiratory system agents|mesh-ancestor
153684786|NCT00048776|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153684787|NCT00048776|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153684788|NCT00048776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153684849|NCT00149617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153684850|NCT00043329|Interferon-gamma|interferon-gamma|mesh-list
153684851|NCT00043329|Antiviral Agents|antiviral agents|mesh-ancestor
153684852|NCT00043329|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153684853|NCT00149656|Selenium|selenium|mesh-list
153684854|NCT00149656|Antioxidants|antioxidants|mesh-ancestor
153684855|NCT00149656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153684856|NCT00149656|Protective Agents|protective agents|mesh-ancestor
153684857|NCT00149656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153684858|NCT00149656|Trace Elements|trace elements|mesh-ancestor
153684859|NCT00149656|Micronutrients|micronutrients|mesh-ancestor
153684860|NCT00082095|Doxorubicin|doxorubicin|mesh-list
153684861|NCT00082095|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
153684862|NCT00082095|Capecitabine|capecitabine|mesh-list
153684870|NCT00082095|Antimetabolites|antimetabolites|mesh-ancestor
153684911|NCT00149968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153684912|NCT04725448|Paclitaxel|paclitaxel|mesh-list
153684913|NCT04725448|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
153684914|NCT04725448|Bevacizumab|bevacizumab|mesh-list
153684915|NCT04725448|Carboplatin|carboplatin|mesh-list
153684916|NCT04725448|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153684917|NCT04725448|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153684918|NCT04725448|Tubulin Modulators|tubulin modulators|mesh-ancestor
153684919|NCT04725448|Antimitotic Agents|antimitotic agents|mesh-ancestor
153684928|NCT00405925|Lamivudine|lamivudine|mesh-list
153684974|NCT00150085|Antifungal Agents|antifungal agents|mesh-ancestor
153684975|NCT00150085|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153684976|NCT00150085|Dermatologic Agents|dermatologic agents|mesh-ancestor
153684977|NCT00150085|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153684978|NCT00150085|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
153684980|NCT00082251|Simvastatin|simvastatin|mesh-list
153684981|NCT00082251|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153684982|NCT00082251|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153684983|NCT00082251|Antimetabolites|antimetabolites|mesh-ancestor
153684984|NCT00082251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153684985|NCT00082251|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153684986|NCT00082251|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
153684990|NCT00082251|Vitamins|vitamins|mesh-ancestor
153685036|NCT00150358|Vasodilator Agents|vasodilator agents|mesh-ancestor
153685037|NCT00150358|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
153332289|NCT01011413|Efavirenz|efavirenz|mesh-list
153685038|NCT00150358|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
153685039|NCT00150358|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153685040|NCT00150358|Urological Agents|urological agents|mesh-ancestor
153685041|NCT00049361|Thalidomide|thalidomide|mesh-list
153685042|NCT00049361|Temozolomide|temozolomide|mesh-list
153685043|NCT00049361|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153685044|NCT00049361|Alkylating Agents|alkylating agents|mesh-ancestor
153685045|NCT00049361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153685046|NCT00049361|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153685047|NCT00049361|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153685048|NCT00049361|Immunologic Factors|immunologic factors|mesh-ancestor
153685097|NCT00049439|Lomustine|lomustine|mesh-list
153685098|NCT00049439|Etoposide|etoposide|mesh-list
153685099|NCT00049439|Procarbazine|procarbazine|mesh-list
153685100|NCT00049439|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153685101|NCT00049439|Immunologic Factors|immunologic factors|mesh-ancestor
153685102|NCT00049439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153685103|NCT00049439|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153685104|NCT00049439|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153685105|NCT00049439|Alkylating Agents|alkylating agents|mesh-ancestor
153685106|NCT00049439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153685107|NCT00049439|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153685161|NCT00049634|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153685162|NCT00049634|Antimetabolites|antimetabolites|mesh-ancestor
153685163|NCT00049634|Dermatologic Agents|dermatologic agents|mesh-ancestor
153685164|NCT00049634|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153685165|NCT00049634|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153685166|NCT00049634|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153685167|NCT00049634|Antifungal Agents|antifungal agents|mesh-ancestor
153685168|NCT00049634|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153685169|NCT00049634|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
153685171|NCT00151060|Etoposide|etoposide|mesh-list
153630273|NCT00005976|NSC 366140|nsc 366140|mesh-list
153685172|NCT00151060|Estramustine|estramustine|mesh-list
153685173|NCT00151060|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153685174|NCT00151060|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153685175|NCT00151060|Tubulin Modulators|tubulin modulators|mesh-ancestor
153685176|NCT00151060|Antimitotic Agents|antimitotic agents|mesh-ancestor
153685177|NCT00151060|Mitosis Modulators|mitosis modulators|mesh-ancestor
153685178|NCT00151060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153685179|NCT00151060|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153685180|NCT00151060|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153685181|NCT00151060|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153685182|NCT00151060|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153685183|NCT00151060|Alkylating Agents|alkylating agents|mesh-ancestor
153685184|NCT00151060|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153685185|NCT00151138|Atenolol|atenolol|mesh-list
153685186|NCT00151138|Lisinopril|lisinopril|mesh-list
153332381|NCT01106833|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153332382|NCT01106833|Glucocorticoids|glucocorticoids|mesh-ancestor
153332383|NCT01106833|Hormones|hormones|mesh-ancestor
153332384|NCT01106833|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153332385|NCT01106833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153685187|NCT00151138|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
153685188|NCT00151138|Protease Inhibitors|protease inhibitors|mesh-ancestor
153685189|NCT00151138|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153685190|NCT00151138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153685191|NCT00151138|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153685192|NCT00151138|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
153685193|NCT00151138|Protective Agents|protective agents|mesh-ancestor
153685205|NCT00082485|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
153685206|NCT00082485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153685207|NCT00082485|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
153685208|NCT00082485|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153685209|NCT00082485|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
153685210|NCT00082485|GABA Agonists|gaba agonists|mesh-ancestor
153685211|NCT00082485|GABA Agents|gaba agents|mesh-ancestor
153685212|NCT00082485|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153685213|NCT00082485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153685214|NCT00151255|Cytarabine|cytarabine|mesh-list
153685215|NCT00151255|Mitoxantrone|mitoxantrone|mesh-list
153685216|NCT00151255|Idarubicin|idarubicin|mesh-list
153685217|NCT00151255|Tretinoin|tretinoin|mesh-list
153685218|NCT00151255|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153685219|NCT00151255|Antimetabolites|antimetabolites|mesh-ancestor
153685220|NCT00151255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153685221|NCT00151255|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153685261|NCT00151450|Pregabalin|pregabalin|mesh-list
153685262|NCT00151450|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
153685263|NCT00151450|Analgesics|analgesics|mesh-ancestor
153685264|NCT00151450|Sensory System Agents|sensory system agents|mesh-ancestor
153685265|NCT00151450|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153685266|NCT00151450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153332438|NCT04322968|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153685267|NCT00151450|Anticonvulsants|anticonvulsants|mesh-ancestor
153685268|NCT00151450|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153685269|NCT00151450|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153685270|NCT00151450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153685271|NCT00151450|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153685272|NCT00151450|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153685321|NCT00406003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153685322|NCT00406003|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
153685323|NCT00406003|Antidepressive Agents|antidepressive agents|mesh-ancestor
153685324|NCT00406003|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153685325|NCT00406003|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
153685326|NCT00406003|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153685327|NCT00406003|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153685328|NCT00049829|Zoledronic Acid|zoledronic acid|mesh-list
153685329|NCT00049829|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153685330|NCT00049829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153685331|NCT00406042|Prednisolone|prednisolone|mesh-list
153685340|NCT00406042|Hormones|hormones|mesh-ancestor
153685382|NCT00151528|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153685383|NCT00151528|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153685384|NCT00151528|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153685385|NCT00397787|Sunitinib|sunitinib|mesh-list
153685386|NCT00397787|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153685387|NCT00397787|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153685388|NCT00397787|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153685389|NCT00397787|Growth Substances|growth substances|mesh-ancestor
153685390|NCT00397787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153685391|NCT00397787|Growth Inhibitors|growth inhibitors|mesh-ancestor
153685392|NCT00397787|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153685393|NCT00397787|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153685394|NCT00397787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153685395|NCT00082602|Galantamine|galantamine|mesh-list
153685396|NCT00082602|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
153685397|NCT00082602|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153685398|NCT00082602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153685399|NCT00082602|Cholinergic Agents|cholinergic agents|mesh-ancestor
153685400|NCT00082602|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153685401|NCT00082602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153685402|NCT00082602|Parasympathomimetics|parasympathomimetics|mesh-ancestor
153685403|NCT00082602|Autonomic Agents|autonomic agents|mesh-ancestor
153685404|NCT00082602|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153685405|NCT00082602|Nootropic Agents|nootropic agents|mesh-ancestor
153685406|NCT00151567|Tamsulosin|tamsulosin|mesh-list
153685407|NCT00151567|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
153685408|NCT00151567|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
153685409|NCT00151567|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
153685410|NCT00151567|Adrenergic Agents|adrenergic agents|mesh-ancestor
153685411|NCT00151567|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153685412|NCT00151567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153685413|NCT00151567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153685421|NCT00397826|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
153685422|NCT00397826|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153685423|NCT00151684|Diazoxide|diazoxide|mesh-list
153685424|NCT00151684|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153685425|NCT00151684|Vasodilator Agents|vasodilator agents|mesh-ancestor
153685426|NCT00151762|Colesevelam Hydrochloride|colesevelam hydrochloride|mesh-list
153685427|NCT00151762|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153685428|NCT00151762|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153685429|NCT00151762|Antimetabolites|antimetabolites|mesh-ancestor
153685430|NCT00151762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153685431|NCT00151762|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153685432|NCT00151801|Interferons|interferons|mesh-list
153685433|NCT00151801|Interferon-beta|interferon-beta|mesh-list
153685434|NCT00151801|Interferon beta-1a|interferon beta-1a|mesh-list
153685435|NCT00151801|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153685436|NCT00151801|Antiviral Agents|antiviral agents|mesh-ancestor
153685437|NCT00151801|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153685479|NCT00049946|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153685480|NCT00049946|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
153685481|NCT00049946|Dopamine Agents|dopamine agents|mesh-ancestor
153685483|NCT00152035|Dextroamphetamine|dextroamphetamine|mesh-list
153685484|NCT00152035|Adderall|adderall|mesh-list
153685485|NCT00152035|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
153685486|NCT00152035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153685487|NCT00152035|Sympathomimetics|sympathomimetics|mesh-ancestor
153685488|NCT00152035|Autonomic Agents|autonomic agents|mesh-ancestor
153332460|NCT04323592|Methylprednisolone|methylprednisolone|mesh-list
153685489|NCT00152035|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153685490|NCT00152035|Dopamine Agents|dopamine agents|mesh-ancestor
153685544|NCT00152386|Certolizumab Pegol|certolizumab pegol|mesh-list
153685545|NCT00152386|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
153685546|NCT00152386|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153685547|NCT00152386|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153685548|NCT00152386|Immunologic Factors|immunologic factors|mesh-ancestor
153685549|NCT00152386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153685550|NCT00152386|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153685551|NCT00082836|Rituximab|rituximab|mesh-list
153685552|NCT00082836|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153685553|NCT00082836|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153685554|NCT00082836|Immunologic Factors|immunologic factors|mesh-ancestor
153685555|NCT00082836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153685556|NCT00082836|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153685557|NCT00152425|Certolizumab Pegol|certolizumab pegol|mesh-list
153685558|NCT00152425|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
153685559|NCT00152425|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153685560|NCT00152425|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153685561|NCT00152425|Immunologic Factors|immunologic factors|mesh-ancestor
153685562|NCT00152425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153685563|NCT00152425|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153685564|NCT00152542|Nitric Oxide|nitric oxide|mesh-list
153631127|NCT00006174|Letrozole|letrozole|mesh-list
153685565|NCT00152542|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153685566|NCT00152542|Autonomic Agents|autonomic agents|mesh-ancestor
153685567|NCT00152542|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153685595|NCT00152581|Interferon alpha-2|interferon alpha-2|mesh-list
153685596|NCT00152581|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
153522514|NCT05353361|Tubulin Modulators|tubulin modulators|mesh-ancestor
153685597|NCT00152581|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153685598|NCT00152581|Antiviral Agents|antiviral agents|mesh-ancestor
153685599|NCT00152581|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153685600|NCT00152581|Antimetabolites|antimetabolites|mesh-ancestor
153685601|NCT00152581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153685602|NCT00152581|Immunologic Factors|immunologic factors|mesh-ancestor
153685603|NCT00152581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153685604|NCT00152620|Dexamethasone|dexamethasone|mesh-list
153685605|NCT00152620|Methylprednisolone|methylprednisolone|mesh-list
153685659|NCT00082914|Denileukin diftitox|denileukin diftitox|mesh-list
153685660|NCT00082914|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153685662|NCT00152815|Antioxidants|antioxidants|mesh-list
153685663|NCT00152815|Vitamins|vitamins|mesh-ancestor
153685664|NCT00152815|Micronutrients|micronutrients|mesh-ancestor
153685665|NCT00152815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153685666|NCT00152815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153685667|NCT00152815|Protective Agents|protective agents|mesh-ancestor
153685668|NCT00043719|Vitamin D|vitamin d|mesh-list
153685669|NCT00043719|Nitroglycerin|nitroglycerin|mesh-list
153685670|NCT00043719|Calcium|calcium|mesh-list
153685671|NCT00043719|Vitamins|vitamins|mesh-ancestor
153685672|NCT00043719|Micronutrients|micronutrients|mesh-ancestor
153685673|NCT00043719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153685674|NCT00043719|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153332488|NCT01047241|Anesthetics, General|anesthetics, general|mesh-ancestor
153332489|NCT01047241|Anesthetics|anesthetics|mesh-ancestor
153421071|NCT06287944|Sirolimus|sirolimus|mesh-list
153685675|NCT00043719|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153685676|NCT00043719|Vasodilator Agents|vasodilator agents|mesh-ancestor
153685677|NCT00152854|Acetaminophen|acetaminophen|mesh-list
153685678|NCT00152854|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153685679|NCT00152854|Analgesics|analgesics|mesh-ancestor
153685680|NCT00152854|Sensory System Agents|sensory system agents|mesh-ancestor
153685681|NCT00152854|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153685682|NCT00152854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153685683|NCT00152854|Antipyretics|antipyretics|mesh-ancestor
153685684|NCT00050297|N-(6-methoxy-5-(2-methoxyphenoxy)-2-(pyrimidin-2-yl)pyrimidin-4-yl)-2-phenylethenesulfonamide|n-(6-methoxy-5-(2-methoxyphenoxy)-2-(pyrimidin-2-yl)pyrimidin-4-yl)-2-phenylethenesulfonamide|mesh-list
153685685|NCT00050297|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
153685686|NCT00050297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153685689|NCT00152893|Trace Elements|trace elements|mesh-ancestor
153685703|NCT00152932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153685704|NCT00083031|Cyclophosphamide|cyclophosphamide|mesh-list
153685705|NCT00083031|Bevacizumab|bevacizumab|mesh-list
153685706|NCT00083031|Methotrexate|methotrexate|mesh-list
153685707|NCT00083031|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153685708|NCT00083031|Immunologic Factors|immunologic factors|mesh-ancestor
153685709|NCT00083031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153685710|NCT00083031|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153685711|NCT00083031|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153685712|NCT00083031|Alkylating Agents|alkylating agents|mesh-ancestor
153685714|NCT00083031|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153685763|NCT00050414|Dexamethasone|dexamethasone|mesh-list
153685764|NCT00050414|Trabectedin|trabectedin|mesh-list
153685765|NCT00050414|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153685766|NCT00050414|Antiemetics|antiemetics|mesh-ancestor
153685767|NCT00050414|Autonomic Agents|autonomic agents|mesh-ancestor
153685769|NCT00050414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153685770|NCT00050414|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153685771|NCT00050414|Glucocorticoids|glucocorticoids|mesh-ancestor
153685772|NCT00050414|Hormones|hormones|mesh-ancestor
153685773|NCT00050414|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153685775|NCT00050414|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153685776|NCT00050414|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153685777|NCT00050414|Alkylating Agents|alkylating agents|mesh-ancestor
153685778|NCT00050414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153685779|NCT00153127|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
153685780|NCT00153127|Laxatives|laxatives|mesh-ancestor
153685781|NCT00153127|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153685782|NCT00083109|Suramin|suramin|mesh-list
153685783|NCT00083109|Fluorouracil|fluorouracil|mesh-list
153685784|NCT00083109|Antimetabolites|antimetabolites|mesh-ancestor
153685785|NCT00083109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153685786|NCT00083109|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153685787|NCT00083109|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153685792|NCT00083109|Anthelmintics|anthelmintics|mesh-ancestor
153685811|NCT00153283|Sensory System Agents|sensory system agents|mesh-ancestor
153685812|NCT00153283|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153685813|NCT00153283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153685814|NCT00153283|Anticonvulsants|anticonvulsants|mesh-ancestor
153685815|NCT00153283|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153685816|NCT00153283|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153685817|NCT00153283|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153685818|NCT00153283|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153685819|NCT00153283|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
153332519|NCT03018821|Entecavir|entecavir|mesh-list
153522736|NCT03887650|Dexamethasone|dexamethasone|mesh-list
153685820|NCT00153283|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
153685821|NCT00153283|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153685822|NCT00153283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153685823|NCT00153283|Antimanic Agents|antimanic agents|mesh-ancestor
153685824|NCT00050531|Interferons|interferons|mesh-list
153685825|NCT00050531|Interferon-alpha|interferon-alpha|mesh-list
153685826|NCT00050531|Interferon alpha-2|interferon alpha-2|mesh-list
153685827|NCT00050531|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
153685828|NCT00050531|Interferon-alfa-1b|interferon-alfa-1b|mesh-list
153685829|NCT00050531|Imatinib Mesylate|imatinib mesylate|mesh-list
153685830|NCT00050531|Molgramostim|molgramostim|mesh-list
153685831|NCT00050531|Sargramostim|sargramostim|mesh-list
153685842|NCT00083148|Irinotecan|irinotecan|mesh-list
153631645|NCT00005878|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153685863|NCT00083187|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153685865|NCT00153634|Ciprofloxacin|ciprofloxacin|mesh-list
153685866|NCT00153634|Meropenem|meropenem|mesh-list
153685867|NCT00153634|Tazobactam|tazobactam|mesh-list
153685868|NCT00153634|Piperacillin|piperacillin|mesh-list
153685869|NCT00153634|Tobramycin|tobramycin|mesh-list
153685870|NCT00153634|Clavulanic Acid|clavulanic acid|mesh-list
153685871|NCT00153634|Amikacin|amikacin|mesh-list
153685872|NCT00153634|Ceftazidime|ceftazidime|mesh-list
153685873|NCT00153634|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
153685874|NCT00153634|Ticarcillin|ticarcillin|mesh-list
153685875|NCT00153634|Ticarcillin-clavulanic acid|ticarcillin-clavulanic acid|mesh-list
153685876|NCT00153634|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153685877|NCT00153634|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153685878|NCT00153634|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153685879|NCT00153634|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153685880|NCT00153634|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153685881|NCT00153634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153685882|NCT00153634|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153685883|NCT00153634|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
153685884|NCT00153634|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153685885|NCT00153634|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
153685886|NCT00153634|Third Generation Cephalosporins|third generation cephalosporins|mesh-ancestor
153685887|NCT00153634|Beta Lactam Antibiotics|beta lactam antibiotics|mesh-ancestor
153685888|NCT00050609|Tadalafil|tadalafil|mesh-list
153685889|NCT00050609|Vasodilator Agents|vasodilator agents|mesh-ancestor
153685890|NCT00050609|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
153685891|NCT00050609|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
153685895|NCT00153673|Celecoxib|celecoxib|mesh-list
153685909|NCT00050648|Cyclosporins|cyclosporins|mesh-list
153685911|NCT00050648|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153685912|NCT00050648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153685913|NCT00050648|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153685914|NCT00050648|Immunologic Factors|immunologic factors|mesh-ancestor
153685915|NCT00050648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153685916|NCT00050648|Antifungal Agents|antifungal agents|mesh-ancestor
153685917|NCT00050648|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153685918|NCT00050648|Dermatologic Agents|dermatologic agents|mesh-ancestor
153685919|NCT00050648|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153685920|NCT00050648|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
153685921|NCT00153868|Darbepoetin alfa|darbepoetin alfa|mesh-list
153685922|NCT00153868|Hematinics|hematinics|mesh-ancestor
153685923|NCT00153907|Capecitabine|capecitabine|mesh-list
153685924|NCT00153907|Vinorelbine|vinorelbine|mesh-list
153685925|NCT00153907|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153685926|NCT00153907|Antimetabolites|antimetabolites|mesh-ancestor
153332531|NCT03866434|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153685927|NCT00153907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153685928|NCT00153907|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153685929|NCT00153907|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153685930|NCT00153907|Tubulin Modulators|tubulin modulators|mesh-ancestor
153685940|NCT00153946|Edaravone|edaravone|mesh-list
153685964|NCT00154180|Estradiol|estradiol|mesh-list
153685965|NCT00154180|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
153685966|NCT00154180|Estrogens|estrogens|mesh-list
153685967|NCT00154180|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
153685968|NCT00154180|Progesterone|progesterone|mesh-list
153685969|NCT00154180|Hormones|hormones|mesh-ancestor
153685970|NCT00154180|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153522885|NCT03233347|Nivolumab|nivolumab|mesh-list
153685971|NCT00154180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153685972|NCT00154180|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
153685973|NCT00154180|Contraceptive Agents|contraceptive agents|mesh-ancestor
153685974|NCT00154180|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153685975|NCT00154180|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
153685976|NCT00154180|Progestins|progestins|mesh-ancestor
153685977|NCT00154219|Lumiracoxib|lumiracoxib|mesh-list
153686022|NCT00154336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153686023|NCT00154336|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153686024|NCT00154336|Dermatologic Agents|dermatologic agents|mesh-ancestor
153686025|NCT00154336|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153686026|NCT00154336|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153686027|NCT00154336|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153686028|NCT00154336|Immunologic Factors|immunologic factors|mesh-ancestor
153686029|NCT00154336|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153686030|NCT00154336|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153686031|NCT00154336|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153686032|NCT00154336|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153686033|NCT00050804|Sertraline|sertraline|mesh-list
153686034|NCT00050804|Antidepressive Agents|antidepressive agents|mesh-ancestor
153686035|NCT00050804|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153686036|NCT00050804|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
153686037|NCT00050804|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153686038|NCT00050804|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153686039|NCT00050804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153686040|NCT00050804|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153686041|NCT00050804|Serotonin Agents|serotonin agents|mesh-ancestor
153686043|NCT00043914|Lamotrigine|lamotrigine|mesh-list
153686073|NCT00050843|Thalidomide|thalidomide|mesh-list
153686074|NCT00050843|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153686075|NCT00050843|Immunologic Factors|immunologic factors|mesh-ancestor
153686076|NCT00050843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153686077|NCT00050843|Leprostatic Agents|leprostatic agents|mesh-ancestor
153686078|NCT00050843|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153686079|NCT00050843|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153686080|NCT00050843|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153686081|NCT00050843|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153686082|NCT00050843|Growth Substances|growth substances|mesh-ancestor
153686083|NCT00050843|Growth Inhibitors|growth inhibitors|mesh-ancestor
153686084|NCT00050843|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153686085|NCT00406237|Tigecycline|tigecycline|mesh-list
153686086|NCT00406237|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153686087|NCT00406237|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153686088|NCT00406237|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
153686089|NCT00406237|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153686091|NCT00406432|Paroxetine|paroxetine|mesh-list
153686129|NCT00154687|Antimetabolites|antimetabolites|mesh-ancestor
153686130|NCT00154687|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153686131|NCT00154687|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153686133|NCT00154687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153686134|NCT00083460|Thalidomide|thalidomide|mesh-list
153686135|NCT00083460|Dexamethasone|dexamethasone|mesh-list
153686136|NCT00083460|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153686137|NCT00083460|Antiemetics|antiemetics|mesh-ancestor
153686139|NCT00083460|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153686140|NCT00083460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153686141|NCT00083460|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153686142|NCT00083460|Glucocorticoids|glucocorticoids|mesh-ancestor
153686143|NCT00083460|Hormones|hormones|mesh-ancestor
153686144|NCT00083460|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153686156|NCT00154726|Paclitaxel|paclitaxel|mesh-list
153686189|NCT00043953|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153686190|NCT00043953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153686191|NCT00043953|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153686192|NCT00043953|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153686193|NCT00043953|Antiviral Agents|antiviral agents|mesh-ancestor
153686194|NCT00043953|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153686195|NCT00043953|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
153686196|NCT00043953|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153686197|NCT00043953|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153686198|NCT00043953|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153686199|NCT00043953|Antimetabolites|antimetabolites|mesh-ancestor
153686200|NCT00154882|Paclitaxel|paclitaxel|mesh-list
153686201|NCT00154882|Cisplatin|cisplatin|mesh-list
153686202|NCT00154882|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153686203|NCT00154882|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153686204|NCT00154882|Tubulin Modulators|tubulin modulators|mesh-ancestor
153686205|NCT00154882|Antimitotic Agents|antimitotic agents|mesh-ancestor
153686206|NCT00154882|Mitosis Modulators|mitosis modulators|mesh-ancestor
153686207|NCT00154882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153686208|NCT00051077|Ribavirin|ribavirin|mesh-list
153686209|NCT00051077|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
153686210|NCT00051077|Adefovir|adefovir|mesh-list
153686211|NCT00051077|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
153686212|NCT00051077|Antimetabolites|antimetabolites|mesh-ancestor
153686213|NCT00051077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153686214|NCT00051077|Antiviral Agents|antiviral agents|mesh-ancestor
153686215|NCT00051077|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153686216|NCT00051077|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153686217|NCT00051077|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153686218|NCT00051077|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153686233|NCT00051116|Growth Substances|growth substances|mesh-ancestor
153686234|NCT00051116|Growth Inhibitors|growth inhibitors|mesh-ancestor
153686235|NCT00051116|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153686236|NCT00155272|Thalidomide|thalidomide|mesh-list
153686237|NCT00155272|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153686238|NCT00155272|Immunologic Factors|immunologic factors|mesh-ancestor
153686239|NCT00155272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153686240|NCT00155272|Leprostatic Agents|leprostatic agents|mesh-ancestor
153686241|NCT00155272|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153686242|NCT00155272|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153686243|NCT00155272|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153686244|NCT00155272|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153686245|NCT00155272|Growth Substances|growth substances|mesh-ancestor
153686246|NCT00155272|Growth Inhibitors|growth inhibitors|mesh-ancestor
153686296|NCT00083538|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153686297|NCT00083538|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153686298|NCT00083538|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153686300|NCT00083538|Growth Inhibitors|growth inhibitors|mesh-ancestor
153686301|NCT00083577|Thalidomide|thalidomide|mesh-list
153686302|NCT00083577|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153632669|NCT02890069|Everolimus|everolimus|mesh-list
153686303|NCT00083577|Immunologic Factors|immunologic factors|mesh-ancestor
153686304|NCT00083577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153686359|NCT00156403|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153686360|NCT00156403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153686362|NCT00051272|Bupropion|bupropion|mesh-list
153686363|NCT00051272|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
153686364|NCT00051272|Antidepressive Agents|antidepressive agents|mesh-ancestor
153686365|NCT00051272|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153686366|NCT00051272|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
153686367|NCT00051272|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153686368|NCT00051272|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153686369|NCT00051272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153686370|NCT00051272|Dopamine Agents|dopamine agents|mesh-ancestor
153686371|NCT00051272|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153686372|NCT00051272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153686373|NCT00051272|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
153686374|NCT00051272|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153686375|NCT00051272|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153686376|NCT00044187|Sibutramine|sibutramine|mesh-list
153686377|NCT00044187|Antidepressive Agents|antidepressive agents|mesh-ancestor
153686378|NCT00044187|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153686379|NCT00044187|Appetite Depressants|appetite depressants|mesh-ancestor
153332672|NCT04332094|Antimalarials|antimalarials|mesh-ancestor
153332673|NCT04332094|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153686380|NCT00044187|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
153686381|NCT00156520|Aminocaproic Acid|aminocaproic acid|mesh-list
153686382|NCT00156520|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
153686383|NCT00156520|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153686384|NCT00156520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153686385|NCT00156520|Hemostatics|hemostatics|mesh-ancestor
153686386|NCT00156520|Coagulants|coagulants|mesh-ancestor
153686387|NCT00083694|Thalidomide|thalidomide|mesh-list
153686388|NCT00083694|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153686389|NCT00083694|Immunologic Factors|immunologic factors|mesh-ancestor
153686390|NCT00083694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153686391|NCT00083694|Leprostatic Agents|leprostatic agents|mesh-ancestor
153686398|NCT00083694|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153686399|NCT00051389|Fosinopril|fosinopril|mesh-list
153686400|NCT00051389|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
153686401|NCT00051389|Protease Inhibitors|protease inhibitors|mesh-ancestor
153686402|NCT00051389|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153686403|NCT00051389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153686404|NCT00051389|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153686405|NCT00156949|Epoetin Alfa|epoetin alfa|mesh-list
153686406|NCT00156949|Hematinics|hematinics|mesh-ancestor
153686408|NCT00156988|Silver Sulfadiazine|silver sulfadiazine|mesh-list
153686409|NCT00156988|Cerium nitrate|cerium nitrate|mesh-list
153686410|NCT00156988|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153686411|NCT00156988|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153686412|NCT00156988|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153686413|NCT00156988|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153686414|NCT00156988|Coccidiostats|coccidiostats|mesh-ancestor
153686415|NCT00156988|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
153686416|NCT00157066|Ergocalciferols|ergocalciferols|mesh-list
153523334|NCT04169347|Vitamin B Complex|vitamin b complex|mesh-ancestor
153686418|NCT00157066|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153686419|NCT00157066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153686420|NCT00157066|Vitamins|vitamins|mesh-ancestor
153686421|NCT00157066|Micronutrients|micronutrients|mesh-ancestor
153686452|NCT00157378|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
153686453|NCT00406861|Montelukast|montelukast|mesh-list
153686454|NCT00406861|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153686455|NCT00406861|Respiratory System Agents|respiratory system agents|mesh-ancestor
153686456|NCT00406861|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
153686457|NCT00406861|Hormone Antagonists|hormone antagonists|mesh-ancestor
153686458|NCT00406861|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153686459|NCT00406861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153686460|NCT00406861|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
153686461|NCT00406861|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
153686463|NCT00044265|Ramipril|ramipril|mesh-list
153686514|NCT00157729|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
153686515|NCT00157729|Protease Inhibitors|protease inhibitors|mesh-ancestor
153686516|NCT00157729|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153686517|NCT00157729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153686518|NCT00157729|Vitamin B Complex|vitamin b complex|mesh-ancestor
153686520|NCT00157729|Micronutrients|micronutrients|mesh-ancestor
153686521|NCT00157729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153686522|NCT00051545|Seocalcitol|seocalcitol|mesh-list
153686523|NCT00051545|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153686524|NCT00051545|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153686525|NCT00051545|Immunologic Factors|immunologic factors|mesh-ancestor
153686526|NCT00051545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153686527|NCT00157885|Artesunate|artesunate|mesh-list
153686528|NCT00157885|Amodiaquine|amodiaquine|mesh-list
153686529|NCT00157885|Antimalarials|antimalarials|mesh-ancestor
153686530|NCT00157885|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153686531|NCT00157885|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153686532|NCT00157885|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153686533|NCT00157885|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153686534|NCT00157885|Antiviral Agents|antiviral agents|mesh-ancestor
153686535|NCT00157885|Schistosomicides|schistosomicides|mesh-ancestor
153686536|NCT00157885|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
153686538|NCT00158002|Topiramate|topiramate|mesh-list
153686539|NCT00158002|Anticonvulsants|anticonvulsants|mesh-ancestor
153686540|NCT00158002|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153686541|NCT00158002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153686542|NCT00158041|Amifostine|amifostine|mesh-list
153686543|NCT00158041|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
153686544|NCT00158041|Protective Agents|protective agents|mesh-ancestor
153686546|NCT00051584|Gemcitabine|gemcitabine|mesh-list
153686560|NCT00044382|Immunologic Factors|immunologic factors|mesh-ancestor
153686561|NCT00044382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153686562|NCT00044382|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153633157|NCT00006154|Ritonavir|ritonavir|mesh-list
153686563|NCT00044382|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153686564|NCT00044382|Growth Substances|growth substances|mesh-ancestor
153686565|NCT00044382|Growth Inhibitors|growth inhibitors|mesh-ancestor
153686566|NCT00044382|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153686629|NCT00158548|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153686630|NCT00158548|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153686631|NCT00158548|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153686632|NCT00158548|Antiviral Agents|antiviral agents|mesh-ancestor
153686633|NCT00158548|Schistosomicides|schistosomicides|mesh-ancestor
153686634|NCT00158548|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
153686635|NCT00158548|Anthelmintics|anthelmintics|mesh-ancestor
153686636|NCT00158548|Amebicides|amebicides|mesh-ancestor
153686637|NCT00158548|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153686638|NCT00158587|Primaquine|primaquine|mesh-list
153686639|NCT00158587|Antimalarials|antimalarials|mesh-ancestor
153686640|NCT00158587|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153686641|NCT00158587|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153686642|NCT00158587|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153686643|NCT00158704|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
153686644|NCT00158704|Antiviral Agents|antiviral agents|mesh-ancestor
153686645|NCT00158704|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153686646|NCT00158704|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153332746|NCT01126255|Progestins|progestins|mesh-ancestor
153332747|NCT01126255|Hormones|hormones|mesh-ancestor
153686647|NCT00158704|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153686648|NCT00158704|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153686649|NCT00158704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153686650|NCT00158782|Lapatinib|lapatinib|mesh-list
153686651|NCT00158782|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153686652|NCT00158782|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153686653|NCT00158782|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153686654|NCT00158782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153686676|NCT05568147|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153686678|NCT05568147|Analgesics|analgesics|mesh-ancestor
153686679|NCT05568147|Sensory System Agents|sensory system agents|mesh-ancestor
153686680|NCT05568147|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153686681|NCT05568147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153686690|NCT05568147|Antipyretics|antipyretics|mesh-ancestor
153686744|NCT05567718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153686745|NCT00052013|Vatalanib|vatalanib|mesh-list
153686746|NCT00052013|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153686747|NCT00052013|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153686748|NCT00052013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153686749|NCT00159445|Gemcitabine|gemcitabine|mesh-list
153686750|NCT00159445|Capecitabine|capecitabine|mesh-list
153686751|NCT00159445|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153686752|NCT00159445|Antimetabolites|antimetabolites|mesh-ancestor
153686753|NCT00159445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153686754|NCT00159445|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153686755|NCT00044460|Rosiglitazone|rosiglitazone|mesh-list
153686756|NCT00044460|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153686757|NCT00044460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153686758|NCT00159484|Celecoxib|celecoxib|mesh-list
153686759|NCT00159484|Epothilone B|epothilone b|mesh-list
153686760|NCT00159484|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153686761|NCT00159484|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153686762|NCT00159484|Analgesics|analgesics|mesh-ancestor
153686763|NCT00159484|Sensory System Agents|sensory system agents|mesh-ancestor
153633477|NCT00007683|Aspirin|aspirin|mesh-list
153686764|NCT00159484|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153686765|NCT00159484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153686767|NCT00159484|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153686768|NCT00159484|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
153686769|NCT00159484|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153686771|NCT00159484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153686772|NCT00159484|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153686773|NCT00159484|Tubulin Modulators|tubulin modulators|mesh-ancestor
153686774|NCT00159484|Antimitotic Agents|antimitotic agents|mesh-ancestor
153686775|NCT00159484|Mitosis Modulators|mitosis modulators|mesh-ancestor
153686776|NCT00052052|Interferons|interferons|mesh-list
153686777|NCT00052052|Interferon-gamma|interferon-gamma|mesh-list
153686778|NCT00052052|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153686779|NCT00052052|Antiviral Agents|antiviral agents|mesh-ancestor
153686783|NCT00159679|Sensory System Agents|sensory system agents|mesh-ancestor
153332766|NCT01169467|Analgesics|analgesics|mesh-ancestor
153686784|NCT00159679|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153686785|NCT00159679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153686786|NCT00159679|Anticonvulsants|anticonvulsants|mesh-ancestor
153686787|NCT00159679|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153686788|NCT00159679|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153686789|NCT00159679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153686790|NCT00159679|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153686791|NCT00159679|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153686792|NCT00159679|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153686793|NCT00159679|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153686794|NCT00159679|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153686795|NCT00159718|Amlodipine|amlodipine|mesh-list
153523752|NCT02220426|Xenon|xenon|mesh-list
153686796|NCT00159718|Atorvastatin|atorvastatin|mesh-list
153686797|NCT00159718|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153686798|NCT00159718|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153686799|NCT00159718|Antimetabolites|antimetabolites|mesh-ancestor
153686800|NCT00159718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153686801|NCT00159718|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153686810|NCT00159757|Ziprasidone|ziprasidone|mesh-list
153686835|NCT00052169|Antimitotic Agents|antimitotic agents|mesh-ancestor
153686836|NCT00052169|Mitosis Modulators|mitosis modulators|mesh-ancestor
153686837|NCT00052169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153686838|NCT00052169|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153686839|NCT00052169|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153686840|NCT00052169|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153686841|NCT00159952|Insulin|insulin|mesh-list
153686842|NCT00159952|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153686843|NCT00159952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153686844|NCT00052208|Gefitinib|gefitinib|mesh-list
153686845|NCT00052208|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153686846|NCT00052208|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153686898|NCT05567484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153686899|NCT05567484|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153686900|NCT05567484|Hormone Antagonists|hormone antagonists|mesh-ancestor
153686901|NCT05567484|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153686902|NCT05567484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153686903|NCT05567484|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
153686904|NCT00160264|Vitamin D|vitamin d|mesh-list
153686905|NCT00160264|Lactulose|lactulose|mesh-list
153686906|NCT00160264|Calcium|calcium|mesh-list
153686907|NCT00160264|Vitamins|vitamins|mesh-ancestor
153686908|NCT00160264|Micronutrients|micronutrients|mesh-ancestor
153686909|NCT00160264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153686910|NCT00160264|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153686911|NCT00160264|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153686912|NCT00160264|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153686913|NCT00160342|Methyltestosterone|methyltestosterone|mesh-list
153686914|NCT00160342|Estrogens|estrogens|mesh-list
153686915|NCT00160342|Estrogens, Esterified (USP)|estrogens, esterified (usp)|mesh-list
153686916|NCT00160342|Estrone|estrone|mesh-list
153686917|NCT00160342|Testosterone|testosterone|mesh-list
153686918|NCT00160342|Testosterone undecanoate|testosterone undecanoate|mesh-list
153686919|NCT00160342|Testosterone enanthate|testosterone enanthate|mesh-list
153686920|NCT00160342|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
153686921|NCT00160342|Hormones|hormones|mesh-ancestor
153686922|NCT00160342|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153686923|NCT00160342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153686924|NCT00160342|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153686925|NCT00160342|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153686926|NCT00160342|Anabolic Agents|anabolic agents|mesh-ancestor
153686927|NCT00160342|Androgens|androgens|mesh-ancestor
153686928|NCT00052364|Oxaliplatin|oxaliplatin|mesh-list
153686929|NCT00052364|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153686930|NCT00052403|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
153686931|NCT00052403|Antibodies|antibodies|mesh-list
153686932|NCT00052403|Immunoglobulins|immunoglobulins|mesh-list
153686938|NCT00052403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153686939|NCT00052403|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153686940|NCT00052403|Mitosis Modulators|mitosis modulators|mesh-ancestor
153686941|NCT00052403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153686942|NCT00160498|Lercanidipine|lercanidipine|mesh-list
153686943|NCT00160498|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153686944|NCT00160498|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153686945|NCT00160498|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153687003|NCT00160966|Antifungal Agents|antifungal agents|mesh-ancestor
153687004|NCT00160966|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153687005|NCT00160966|Dermatologic Agents|dermatologic agents|mesh-ancestor
153687006|NCT00160966|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153687007|NCT00160966|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
153687008|NCT00160966|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153687009|NCT00160966|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153687010|NCT00160966|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153687011|NCT00160966|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
153687012|NCT00160966|Antitubercular Agents|antitubercular agents|mesh-ancestor
153687013|NCT00160966|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153687014|NCT00052559|Bevacizumab|bevacizumab|mesh-list
153687015|NCT00052559|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
153687016|NCT00052559|Fluorouracil|fluorouracil|mesh-list
153687017|NCT00052559|Antibodies|antibodies|mesh-list
153687018|NCT00052559|Immunoglobulins|immunoglobulins|mesh-list
153687019|NCT00052559|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
153687020|NCT00052559|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153687021|NCT00052559|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153687022|NCT00052559|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153687023|NCT00052559|Growth Substances|growth substances|mesh-ancestor
153687024|NCT00052559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153687058|NCT00161200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153687059|NCT00161200|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
153332833|NCT03809182|Dexmedetomidine|dexmedetomidine|mesh-list
153687060|NCT00161200|Histamine Antagonists|histamine antagonists|mesh-ancestor
153687061|NCT00161200|Histamine Agents|histamine agents|mesh-ancestor
153687062|NCT00161200|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153687063|NCT00161200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153687065|NCT00161239|Methotrexate|methotrexate|mesh-list
153687066|NCT00161239|Asparaginase|asparaginase|mesh-list
153687067|NCT00161239|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153687068|NCT00161239|Glucocorticoids|glucocorticoids|mesh-ancestor
153687069|NCT00161239|Hormones|hormones|mesh-ancestor
153687070|NCT00161239|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153687071|NCT00161239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153687072|NCT00161239|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153687073|NCT00161239|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153687074|NCT00161239|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
153687075|NCT00161239|Abortifacient Agents|abortifacient agents|mesh-ancestor
153687076|NCT00161239|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153687077|NCT00161239|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153687078|NCT00161239|Antimetabolites|antimetabolites|mesh-ancestor
153687079|NCT00161239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153687080|NCT00161239|Dermatologic Agents|dermatologic agents|mesh-ancestor
153687081|NCT00161239|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153687082|NCT00161239|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153687083|NCT00161239|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153687084|NCT00161239|Immunologic Factors|immunologic factors|mesh-ancestor
153687085|NCT00161239|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153687086|NCT00161239|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153687087|NCT00161278|Paclitaxel|paclitaxel|mesh-list
153687088|NCT00161278|Carboplatin|carboplatin|mesh-list
153687089|NCT00161278|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153687090|NCT00161278|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153687097|NCT00044616|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153687098|NCT00044616|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153687099|NCT00044616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153687100|NCT00044616|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153687102|NCT00044616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153687103|NCT00044616|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
153687117|NCT00161434|Valacyclovir|valacyclovir|mesh-list
153687164|NCT00044733|Immunologic Factors|immunologic factors|mesh-ancestor
153687165|NCT00044733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153687166|NCT00052949|Imatinib Mesylate|imatinib mesylate|mesh-list
153687167|NCT00052949|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153687168|NCT00052949|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153687169|NCT00052949|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153687170|NCT00052949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153687172|NCT00161902|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
153687173|NCT00161902|Hemostatics|hemostatics|mesh-ancestor
153687174|NCT00161902|Coagulants|coagulants|mesh-ancestor
153687175|NCT00053027|Rituximab|rituximab|mesh-list
153687176|NCT00053027|Cladribine|cladribine|mesh-list
153687177|NCT00053027|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153687178|NCT00053027|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153687179|NCT00053027|Immunologic Factors|immunologic factors|mesh-ancestor
153687180|NCT00053027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153687181|NCT00053027|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153687182|NCT00053027|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153687183|NCT00161980|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
153687184|NCT00161980|Hemostatics|hemostatics|mesh-ancestor
153687185|NCT00161980|Coagulants|coagulants|mesh-ancestor
153687186|NCT00162019|Factor VIII|factor viii|mesh-list
153687187|NCT00162019|Coagulants|coagulants|mesh-ancestor
153634375|NCT00008281|Calcium|calcium|mesh-list
153687189|NCT00162214|Dasatinib|dasatinib|mesh-list
153687190|NCT00162214|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153687191|NCT00162214|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153687192|NCT00162214|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153687193|NCT00162214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153687194|NCT00162214|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153687195|NCT00162214|Antifungal Agents|antifungal agents|mesh-ancestor
153687196|NCT00162214|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153687209|NCT00407056|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153687210|NCT00407056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153687212|NCT00405457|Cyclosporins|cyclosporins|mesh-list
153687213|NCT00405457|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153687214|NCT00405457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153687215|NCT00405457|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153687216|NCT00405457|Immunologic Factors|immunologic factors|mesh-ancestor
153687217|NCT00405457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153687218|NCT00405457|Antifungal Agents|antifungal agents|mesh-ancestor
153687219|NCT00405457|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153687220|NCT00405457|Dermatologic Agents|dermatologic agents|mesh-ancestor
153687221|NCT00405457|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153687222|NCT00405457|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
153687223|NCT00053105|Cytarabine|cytarabine|mesh-list
153687224|NCT00053105|Methylprednisolone|methylprednisolone|mesh-list
153687225|NCT00053105|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
153687226|NCT00053105|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
153687227|NCT00053105|Prednisolone|prednisolone|mesh-list
153687266|NCT00053144|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
153687267|NCT00053144|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153687268|NCT00053144|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153687269|NCT00053144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153687270|NCT00053144|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153687272|NCT00053144|Antimetabolites|antimetabolites|mesh-ancestor
153687273|NCT00053144|Antiviral Agents|antiviral agents|mesh-ancestor
153687274|NCT00053144|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153687275|NCT00053144|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153687276|NCT00053144|Immunologic Factors|immunologic factors|mesh-ancestor
153687277|NCT00053144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153687279|NCT00162487|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153687280|NCT00162487|Autonomic Agents|autonomic agents|mesh-ancestor
153687281|NCT00162487|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153687282|NCT00162487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153332927|NCT04498351|Magnesium Sulfate|magnesium sulfate|mesh-list
153687283|NCT00162487|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153687284|NCT00162487|Respiratory System Agents|respiratory system agents|mesh-ancestor
153687285|NCT00162487|Tocolytic Agents|tocolytic agents|mesh-ancestor
153687286|NCT00162487|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153687287|NCT00162487|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
153687288|NCT00162487|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
153687289|NCT00162487|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153687290|NCT00162487|Adrenergic Agents|adrenergic agents|mesh-ancestor
153687291|NCT00162487|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153634635|NCT00000421|Prednisone|prednisone|mesh-list
153687292|NCT00162487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153687293|NCT00162526|Tocopherols|tocopherols|mesh-list
153687294|NCT00162526|Vitamin E|vitamin e|mesh-list
153687295|NCT00162526|Tocotrienols|tocotrienols|mesh-list
153687296|NCT00162526|alpha-Tocopherol|alpha-tocopherol|mesh-list
153687297|NCT00162526|Antioxidants|antioxidants|mesh-ancestor
153687298|NCT00162526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153687299|NCT00162526|Protective Agents|protective agents|mesh-ancestor
153687301|NCT00162526|Vitamins|vitamins|mesh-ancestor
153687306|NCT00162565|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153687307|NCT00162565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153687308|NCT00162565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153687310|NCT00162604|Cefuroxime axetil|cefuroxime axetil|mesh-list
153687311|NCT00162604|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153687312|NCT00162604|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153687313|NCT00162643|Ritonavir|ritonavir|mesh-list
153687314|NCT00162643|Lopinavir|lopinavir|mesh-list
153687315|NCT00162643|Lamivudine|lamivudine|mesh-list
153687316|NCT00162643|Zidovudine|zidovudine|mesh-list
153687317|NCT00162643|Efavirenz|efavirenz|mesh-list
153687369|NCT00162760|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153687370|NCT00162760|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153687371|NCT00162760|Growth Substances|growth substances|mesh-ancestor
153687372|NCT00162760|Growth Inhibitors|growth inhibitors|mesh-ancestor
153687373|NCT00162760|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153687374|NCT00162799|Triflusal|triflusal|mesh-list
153687375|NCT00162799|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153687376|NCT00044811|Fexofenadine|fexofenadine|mesh-list
153687377|NCT00044811|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
153687378|NCT00044811|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
153687379|NCT00044811|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
153687380|NCT00044811|Histamine Antagonists|histamine antagonists|mesh-ancestor
153687381|NCT00044811|Histamine Agents|histamine agents|mesh-ancestor
153687382|NCT00044811|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153687383|NCT00044811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153687384|NCT00044811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153687385|NCT00162877|Esomeprazole|esomeprazole|mesh-list
153687386|NCT00162877|Rabeprazole|rabeprazole|mesh-list
153687387|NCT00162877|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
153687388|NCT00162877|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153687389|NCT00162877|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
153687390|NCT00162877|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153687391|NCT00162877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153687392|NCT00162916|Citalopram|citalopram|mesh-list
153687393|NCT00162916|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
153687394|NCT00162916|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153687416|NCT00163111|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153332983|NCT03746002|Furosemide|furosemide|mesh-list
153687417|NCT00163111|Antifungal Agents|antifungal agents|mesh-ancestor
153687418|NCT00163111|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
153687419|NCT00163111|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153687420|NCT00163111|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153687421|NCT00163111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153687422|NCT00163111|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153687423|NCT00163111|Hormone Antagonists|hormone antagonists|mesh-ancestor
153687424|NCT00163111|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153687425|NCT00163111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153687476|NCT04731038|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153687477|NCT04731038|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153687478|NCT04731038|Tubulin Modulators|tubulin modulators|mesh-ancestor
153687479|NCT04731038|Antimitotic Agents|antimitotic agents|mesh-ancestor
153687480|NCT04731038|Mitosis Modulators|mitosis modulators|mesh-ancestor
153687481|NCT04731038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153687482|NCT00163462|Ciclesonide|ciclesonide|mesh-list
153687483|NCT00163462|Glucocorticoids|glucocorticoids|mesh-ancestor
153687484|NCT00163462|Hormones|hormones|mesh-ancestor
153687485|NCT00163462|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153687486|NCT00163462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153687487|NCT00163462|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
153687488|NCT00053300|Thalidomide|thalidomide|mesh-list
153687489|NCT00053300|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153687490|NCT00053300|Immunologic Factors|immunologic factors|mesh-ancestor
153687491|NCT00053300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153687492|NCT00053300|Leprostatic Agents|leprostatic agents|mesh-ancestor
153687532|NCT02970383|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153687533|NCT00163969|Ketamine|ketamine|mesh-list
153687535|NCT00163969|Sensory System Agents|sensory system agents|mesh-ancestor
153687536|NCT00163969|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153687537|NCT00163969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153687538|NCT00163969|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
153687539|NCT00163969|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153687540|NCT00163969|Anesthetics, General|anesthetics, general|mesh-ancestor
153687541|NCT00163969|Anesthetics|anesthetics|mesh-ancestor
153687542|NCT00163969|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153687543|NCT00163969|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
153687544|NCT00163969|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
153687545|NCT00163969|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153687546|NCT00163969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153687547|NCT00164008|Zoledronic Acid|zoledronic acid|mesh-list
153687548|NCT00164008|Pamidronate|pamidronate|mesh-list
153687549|NCT00164008|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153687550|NCT00164008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153687551|NCT00164047|Nitrous Oxide|nitrous oxide|mesh-list
153687552|NCT00164047|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
153687553|NCT00164047|Anesthetics, General|anesthetics, general|mesh-ancestor
153687554|NCT00164047|Anesthetics|anesthetics|mesh-ancestor
153687583|NCT00164242|Autonomic Agents|autonomic agents|mesh-ancestor
153687584|NCT00164242|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153687585|NCT00164242|Nootropic Agents|nootropic agents|mesh-ancestor
153687586|NCT00162955|Valsartan|valsartan|mesh-list
153634832|NCT00000526|Flecainide|flecainide|mesh-list
153687587|NCT00162955|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153475856|NCT00837252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153333039|NCT01926236|Vitamins|vitamins|mesh-ancestor
153687588|NCT00162955|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
153687589|NCT00162955|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
153687590|NCT00162955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153687591|NCT00164281|Isoniazid|isoniazid|mesh-list
153687592|NCT00164281|Antitubercular Agents|antitubercular agents|mesh-ancestor
153687593|NCT00164281|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153687650|NCT00164710|Schistosomicides|schistosomicides|mesh-ancestor
153687651|NCT00164710|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
153687652|NCT00164710|Anthelmintics|anthelmintics|mesh-ancestor
153687653|NCT00164710|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153687654|NCT00164710|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153687655|NCT00164710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153687656|NCT00164710|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
153687657|NCT00164710|Leprostatic Agents|leprostatic agents|mesh-ancestor
153687658|NCT00164710|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153687659|NCT00045045|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
153687660|NCT00045045|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
153687661|NCT00045045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153687662|NCT00164749|Curcumin|curcumin|mesh-list
153687663|NCT00164749|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153687664|NCT00164749|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153687665|NCT00164749|Analgesics|analgesics|mesh-ancestor
153687670|NCT00164749|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153687709|NCT00045123|Gamma Secretase Inhibitors and Modulators|gamma secretase inhibitors and modulators|mesh-ancestor
153687710|NCT00045123|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153687711|NCT00045123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153687712|NCT00164866|Omeprazole|omeprazole|mesh-list
153687713|NCT00164866|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
153635135|NCT00000742|Zidovudine|zidovudine|mesh-list
153687714|NCT00164866|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153687715|NCT00164866|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
153687716|NCT00164866|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153687717|NCT00164866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153687718|NCT00407212|Maleic acid|maleic acid|mesh-list
153687719|NCT00407212|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153687720|NCT00407212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153687721|NCT00165139|Cyclophosphamide|cyclophosphamide|mesh-list
153687722|NCT00165139|Melphalan|melphalan|mesh-list
153687723|NCT00165139|Ifosfamide|ifosfamide|mesh-list
153687724|NCT00165139|Carboplatin|carboplatin|mesh-list
153687725|NCT00165139|Etoposide|etoposide|mesh-list
153687726|NCT00165139|Vincristine|vincristine|mesh-list
153687727|NCT00165139|Doxorubicin|doxorubicin|mesh-list
153687728|NCT00165139|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
153687764|NCT00165178|Cytarabine|cytarabine|mesh-list
153687765|NCT00165178|Dexamethasone|dexamethasone|mesh-list
153687766|NCT00165178|Prednisone|prednisone|mesh-list
153687767|NCT00165178|Hydrocortisone|hydrocortisone|mesh-list
153687768|NCT00165178|Doxorubicin|doxorubicin|mesh-list
153687769|NCT00165178|Methotrexate|methotrexate|mesh-list
153687770|NCT00165178|Vincristine|vincristine|mesh-list
153687771|NCT00165178|Asparaginase|asparaginase|mesh-list
153687836|NCT00053885|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153687837|NCT00053885|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153635306|NCT00000826|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
153687838|NCT00053885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153687839|NCT00165334|Cetuximab|cetuximab|mesh-list
153687840|NCT00165334|Vinorelbine|vinorelbine|mesh-list
153687841|NCT00165334|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153687904|NCT00165685|Antidepressive Agents|antidepressive agents|mesh-ancestor
153687905|NCT00165685|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153687906|NCT00165685|Appetite Depressants|appetite depressants|mesh-ancestor
153687907|NCT00165685|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
153687908|NCT00045279|Interferons|interferons|mesh-list
153687975|NCT00166426|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
153687976|NCT00166426|Protective Agents|protective agents|mesh-ancestor
153687977|NCT00166426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153687978|NCT00166426|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153687979|NCT00166426|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153687980|NCT00166426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153687981|NCT00166426|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153688044|NCT00054392|Tubulin Modulators|tubulin modulators|mesh-ancestor
153688045|NCT00054392|Antimitotic Agents|antimitotic agents|mesh-ancestor
153688046|NCT00054392|Mitosis Modulators|mitosis modulators|mesh-ancestor
153688047|NCT00054392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153688048|NCT00054392|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153688049|NCT00054392|Antimetabolites|antimetabolites|mesh-ancestor
153688050|NCT00166816|Cyclosporine|cyclosporine|mesh-list
153688051|NCT00166816|Sirolimus|sirolimus|mesh-list
153688052|NCT00166816|Tacrolimus|tacrolimus|mesh-list
153688053|NCT00166816|Cyclosporins|cyclosporins|mesh-list
153688054|NCT00166816|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153688055|NCT00166816|Immunologic Factors|immunologic factors|mesh-ancestor
153688056|NCT00166816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153688057|NCT00166816|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
153688058|NCT00166816|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153688059|NCT00166816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153688060|NCT00166816|Antifungal Agents|antifungal agents|mesh-ancestor
153688061|NCT00166816|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153688062|NCT00166816|Dermatologic Agents|dermatologic agents|mesh-ancestor
153688063|NCT00166816|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153688064|NCT00166816|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153688065|NCT00166816|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153688066|NCT00166816|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153688067|NCT04723732|Chlorhexidine|chlorhexidine|mesh-list
153688068|NCT04723732|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
153688069|NCT04723732|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
153688070|NCT04723732|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153688071|NCT04723732|Disinfectants|disinfectants|mesh-ancestor
153688072|NCT04723732|Dermatologic Agents|dermatologic agents|mesh-ancestor
153524988|NCT01468740|Prednisone|prednisone|mesh-list
153688073|NCT00054431|Imatinib Mesylate|imatinib mesylate|mesh-list
153688074|NCT00054431|Decitabine|decitabine|mesh-list
153688075|NCT00054431|Azacitidine|azacitidine|mesh-list
153688076|NCT00054431|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153688077|NCT00054431|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153688078|NCT00054431|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153688083|NCT00054470|Trastuzumab|trastuzumab|mesh-list
153688084|NCT00054470|Tipifarnib|tipifarnib|mesh-list
153688085|NCT00054470|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153688086|NCT00054470|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153688087|NCT00054548|Paclitaxel|paclitaxel|mesh-list
153688088|NCT00054548|Oblimersen|oblimersen|mesh-list
153688089|NCT00054548|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153688090|NCT00054548|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153688091|NCT00054548|Tubulin Modulators|tubulin modulators|mesh-ancestor
153688092|NCT00054548|Antimitotic Agents|antimitotic agents|mesh-ancestor
153635487|NCT00000940|Antiviral Agents|antiviral agents|mesh-ancestor
153688093|NCT00054548|Mitosis Modulators|mitosis modulators|mesh-ancestor
153688094|NCT00054548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153688095|NCT00045513|Fludarabine|fludarabine|mesh-list
153688096|NCT00045513|Fludarabine phosphate|fludarabine phosphate|mesh-list
153688097|NCT00045513|7-hydroxystaurosporine|7-hydroxystaurosporine|mesh-list
153688098|NCT00045513|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153688099|NCT00045513|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153688100|NCT00045513|Antimetabolites|antimetabolites|mesh-ancestor
153688101|NCT00045513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153688102|NCT00045513|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153688103|NCT00045513|Immunologic Factors|immunologic factors|mesh-ancestor
153688104|NCT00045513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153688105|NCT00045513|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153688106|NCT00045513|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153688108|NCT00167401|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153688109|NCT00167401|Tubulin Modulators|tubulin modulators|mesh-ancestor
153688110|NCT00167401|Antimitotic Agents|antimitotic agents|mesh-ancestor
153688111|NCT00167401|Mitosis Modulators|mitosis modulators|mesh-ancestor
153688112|NCT00167401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153688113|NCT00167479|Risperidone|risperidone|mesh-list
153688114|NCT00167479|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153688125|NCT00054587|Cyclophosphamide|cyclophosphamide|mesh-list
153688126|NCT00054587|Docetaxel|docetaxel|mesh-list
153688127|NCT00054587|Fluorouracil|fluorouracil|mesh-list
153688128|NCT00054587|Trastuzumab|trastuzumab|mesh-list
153688129|NCT00054587|Epirubicin|epirubicin|mesh-list
153688130|NCT00054587|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153688131|NCT00054587|Immunologic Factors|immunologic factors|mesh-ancestor
153688132|NCT00054587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153688133|NCT00054587|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153688134|NCT00054587|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153688135|NCT00054587|Alkylating Agents|alkylating agents|mesh-ancestor
153688136|NCT00054587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153688137|NCT00054587|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153688152|NCT00167518|Hormones|hormones|mesh-ancestor
153688186|NCT00167713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153688187|NCT00167713|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153688188|NCT00167713|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153688189|NCT00167713|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153688190|NCT00167713|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153688191|NCT00167713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153333135|NCT03011905|Acetaminophen|acetaminophen|mesh-list
153688192|NCT00167791|Rituximab|rituximab|mesh-list
153688193|NCT00167791|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153688194|NCT00167791|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153688195|NCT00167791|Immunologic Factors|immunologic factors|mesh-ancestor
153688196|NCT00167791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153688197|NCT00167791|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153688198|NCT00045591|Celecoxib|celecoxib|mesh-list
153688199|NCT00045591|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153688200|NCT00045591|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153688246|NCT00168181|Cholinergic Agents|cholinergic agents|mesh-ancestor
153688247|NCT00168181|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153688248|NCT00168181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153688250|NCT00407251|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153688251|NCT00407251|Tubulin Modulators|tubulin modulators|mesh-ancestor
153688252|NCT00407251|Antimitotic Agents|antimitotic agents|mesh-ancestor
153688253|NCT00407251|Mitosis Modulators|mitosis modulators|mesh-ancestor
153688254|NCT00407251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153688255|NCT00045669|Imatinib Mesylate|imatinib mesylate|mesh-list
153688256|NCT00045669|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153688257|NCT00045669|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153688258|NCT00045669|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153688259|NCT00045669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153688261|NCT00407290|Neostigmine|neostigmine|mesh-list
153688303|NCT00168532|Trimethoprim|trimethoprim|mesh-list
153688304|NCT00168532|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
153688305|NCT00168532|Sulfamethoxazole|sulfamethoxazole|mesh-list
153688306|NCT00168532|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
153688307|NCT00168532|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153688308|NCT00168532|Antimalarials|antimalarials|mesh-ancestor
153688309|NCT00168532|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153688310|NCT00168532|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153688311|NCT00168532|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153688312|NCT00168532|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153688313|NCT00168532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153688369|NCT00168922|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
153688370|NCT00168922|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153688371|NCT00168922|Alkylating Agents|alkylating agents|mesh-ancestor
153688372|NCT00168922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153688373|NCT00168922|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153688374|NCT00054938|Aspirin|aspirin|mesh-list
153688375|NCT00054938|Ramipril|ramipril|mesh-list
153688376|NCT00054938|Pravastatin|pravastatin|mesh-list
153688377|NCT00054938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153688378|NCT00054938|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153688434|NCT00169039|Autonomic Agents|autonomic agents|mesh-ancestor
153688435|NCT00169039|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153688436|NCT00169039|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153688437|NCT00169039|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
153688438|NCT00169039|Dopamine Agents|dopamine agents|mesh-ancestor
153688440|NCT00169078|Amebicides|amebicides|mesh-ancestor
153688441|NCT00169078|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153688442|NCT00169078|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153688443|NCT00169078|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153688444|NCT00169078|Antimalarials|antimalarials|mesh-ancestor
153688445|NCT00169078|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153688447|NCT00054977|Antimetabolites|antimetabolites|mesh-ancestor
153333142|NCT03011905|Autonomic Agents|autonomic agents|mesh-ancestor
153688497|NCT00169468|Bortezomib|bortezomib|mesh-list
153688498|NCT00169468|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153688499|NCT00169468|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153688500|NCT00169468|Immunologic Factors|immunologic factors|mesh-ancestor
153688501|NCT00169468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153688502|NCT00169468|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153688503|NCT00169546|Fluticasone|fluticasone|mesh-list
153688504|NCT00169546|Xhance|xhance|mesh-list
153688505|NCT00169546|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
153688506|NCT00169546|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153688507|NCT00169546|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153688508|NCT00169546|Autonomic Agents|autonomic agents|mesh-ancestor
153688509|NCT00169546|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153688510|NCT00169546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153688511|NCT00169546|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153688512|NCT00169546|Respiratory System Agents|respiratory system agents|mesh-ancestor
153688521|NCT00398372|Rituximab|rituximab|mesh-list
153688555|NCT00407680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153688556|NCT00169819|Abciximab|abciximab|mesh-list
153688557|NCT00169819|Anticoagulants|anticoagulants|mesh-ancestor
153688558|NCT00169819|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153688559|NCT00055133|Paclitaxel|paclitaxel|mesh-list
153688560|NCT00055133|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153688561|NCT00055133|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153688562|NCT00055133|Tubulin Modulators|tubulin modulators|mesh-ancestor
153688563|NCT00055133|Antimitotic Agents|antimitotic agents|mesh-ancestor
153688564|NCT00055133|Mitosis Modulators|mitosis modulators|mesh-ancestor
153688565|NCT00055133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153688566|NCT00170053|Sirolimus|sirolimus|mesh-list
153688567|NCT00170053|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153688575|NCT00055250|Gemcitabine|gemcitabine|mesh-list
153688619|NCT00055367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153688621|NCT00170677|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
153688622|NCT00170677|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153688623|NCT00170677|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153688624|NCT00170677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153688625|NCT00170677|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153688626|NCT00170755|Darifenacin|darifenacin|mesh-list
153688627|NCT00170755|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
153688628|NCT00170755|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
153688629|NCT00170755|Cholinergic Agents|cholinergic agents|mesh-ancestor
153688630|NCT00170755|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153688631|NCT00170755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153688632|NCT00170755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153688633|NCT00170755|Urological Agents|urological agents|mesh-ancestor
153688634|NCT00170794|Everolimus|everolimus|mesh-list
153688635|NCT00170794|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
153688675|NCT00170989|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153688677|NCT00171028|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153688678|NCT00171028|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
153688679|NCT00171028|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
153688680|NCT00171028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153688681|NCT00055484|Zonisamide|zonisamide|mesh-list
153688682|NCT00055484|Anticonvulsants|anticonvulsants|mesh-ancestor
153688684|NCT00055484|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153688688|NCT00171067|Valsartan|valsartan|mesh-list
153688736|NCT00171418|Serotonin Agents|serotonin agents|mesh-ancestor
153688737|NCT00171418|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153688738|NCT00171418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153688739|NCT00171418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153688740|NCT00171457|Tegaserod|tegaserod|mesh-list
153688742|NCT00171457|Serotonin Agents|serotonin agents|mesh-ancestor
153688743|NCT00171457|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153688744|NCT00171457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153688745|NCT00171457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153688746|NCT00055562|Lenalidomide|lenalidomide|mesh-list
153688747|NCT00055562|Immunologic Factors|immunologic factors|mesh-ancestor
153688797|NCT04920981|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153688798|NCT04920981|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153688799|NCT00055640|Prednisone|prednisone|mesh-list
153688800|NCT00055640|Cyclophosphamide|cyclophosphamide|mesh-list
153688801|NCT00055640|Rituximab|rituximab|mesh-list
153688802|NCT00055640|Doxorubicin|doxorubicin|mesh-list
153688803|NCT00055640|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
153688804|NCT00055640|Vincristine|vincristine|mesh-list
153688805|NCT00055640|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153688806|NCT00055640|Immunologic Factors|immunologic factors|mesh-ancestor
153688807|NCT00055640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153688808|NCT00055640|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153688809|NCT00055640|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153688810|NCT00055640|Alkylating Agents|alkylating agents|mesh-ancestor
153688811|NCT00055640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153688812|NCT00055640|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153688813|NCT00055640|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153688814|NCT00055640|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153688815|NCT00055640|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153688816|NCT00055640|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153688817|NCT00055640|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153688818|NCT00055640|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153688819|NCT00055640|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153688820|NCT00055640|Glucocorticoids|glucocorticoids|mesh-ancestor
153688821|NCT00055640|Hormones|hormones|mesh-ancestor
153688822|NCT00055640|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153688823|NCT00055640|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153688824|NCT00055640|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153688825|NCT00055640|Tubulin Modulators|tubulin modulators|mesh-ancestor
153688826|NCT00055640|Antimitotic Agents|antimitotic agents|mesh-ancestor
153688827|NCT00055640|Mitosis Modulators|mitosis modulators|mesh-ancestor
153688828|NCT00171652|Diclofenac|diclofenac|mesh-list
153688839|NCT00171652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153688841|NCT00171691|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153688842|NCT00171691|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153688843|NCT00171691|Analgesics|analgesics|mesh-ancestor
153688844|NCT00171691|Sensory System Agents|sensory system agents|mesh-ancestor
153688845|NCT00171691|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153688846|NCT00171691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153688847|NCT00171691|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153688848|NCT00171691|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153688849|NCT00171691|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153636588|NCT00000531|Sotalol|sotalol|mesh-list
153688850|NCT00171691|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153333219|NCT01178827|Oxybutynin|oxybutynin|mesh-list
153688900|NCT00171964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153688902|NCT00172003|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153688903|NCT00172003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153688904|NCT00055718|Silymarin|silymarin|mesh-list
153688905|NCT00055718|Antioxidants|antioxidants|mesh-ancestor
153688906|NCT00055718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153688907|NCT00055718|Protective Agents|protective agents|mesh-ancestor
153688908|NCT00055718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153688966|NCT00055913|Antibodies|antibodies|mesh-list
153688967|NCT00055913|Immunoglobulins|immunoglobulins|mesh-list
153688968|NCT00055913|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
153688969|NCT00055913|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153688970|NCT00055913|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153688971|NCT00055913|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153688972|NCT00055913|Growth Substances|growth substances|mesh-ancestor
153525895|NCT05077332|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
153688973|NCT00055913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153688974|NCT00055913|Growth Inhibitors|growth inhibitors|mesh-ancestor
153688975|NCT00055913|Immunologic Factors|immunologic factors|mesh-ancestor
153688976|NCT00055913|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153688977|NCT00055913|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153688978|NCT00055913|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153689028|NCT00046020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153689029|NCT00046020|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153333228|NCT01178827|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153333229|NCT01178827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153333230|NCT01178827|Urological Agents|urological agents|mesh-ancestor
153783171|NCT00261261|GABA Agents|gaba agents|mesh-ancestor
153333231|NCT01178827|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
153333232|NCT01178827|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153333233|NCT01135537|Thymoglobulin|thymoglobulin|mesh-list
153333234|NCT01135537|Antilymphocyte Serum|antilymphocyte serum|mesh-list
153689030|NCT00046020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153689031|NCT00046020|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
153689032|NCT00046020|Antidepressive Agents|antidepressive agents|mesh-ancestor
153689033|NCT00046020|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153689034|NCT00173875|Gefitinib|gefitinib|mesh-list
153689035|NCT00173875|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153689036|NCT00173875|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153689037|NCT00173875|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153689038|NCT00173875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153689039|NCT00173875|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153689040|NCT00174226|Buspirone|buspirone|mesh-list
153689041|NCT00174226|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
153689042|NCT00174226|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
153689043|NCT00174226|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153689044|NCT00174226|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153689045|NCT00174226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153689046|NCT00174226|Adrenergic Agents|adrenergic agents|mesh-ancestor
153689047|NCT00174226|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153689048|NCT00174226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153689049|NCT00174226|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153689050|NCT00174226|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153689051|NCT00174226|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153689052|NCT00174226|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153689053|NCT00174226|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
153689054|NCT00174226|Serotonin Agents|serotonin agents|mesh-ancestor
153333268|NCT00980330|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153689055|NCT00174304|Amlodipine|amlodipine|mesh-list
153689070|NCT00174304|Vasodilator Agents|vasodilator agents|mesh-ancestor
153689071|NCT00174343|Exemestane|exemestane|mesh-list
153689072|NCT00174343|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153689073|NCT00174343|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
153689074|NCT00174343|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153689075|NCT00174343|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153689076|NCT00174343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153689077|NCT00174343|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
153689078|NCT00174343|Hormone Antagonists|hormone antagonists|mesh-ancestor
153689079|NCT00174343|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153689080|NCT00174343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153689081|NCT00174499|Nicotine|nicotine|mesh-list
153689082|NCT00174499|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
153689083|NCT00174499|Autonomic Agents|autonomic agents|mesh-ancestor
153689084|NCT00174499|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153689085|NCT00174499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153689086|NCT00174499|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
153689091|NCT00174538|Codeine|codeine|mesh-list
153689126|NCT00056225|Pyridoxal|pyridoxal|mesh-list
153689127|NCT00056225|Pyridoxine|pyridoxine|mesh-list
153689128|NCT00056225|Vitamin B Complex|vitamin b complex|mesh-list
153333269|NCT01138735|Adapalene|adapalene|mesh-list
153333272|NCT01138735|Dermatologic Agents|dermatologic agents|mesh-ancestor
153689129|NCT00056225|Micronutrients|micronutrients|mesh-ancestor
153689130|NCT00056225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153689131|NCT00174616|Capecitabine|capecitabine|mesh-list
153689132|NCT00174616|Oxaliplatin|oxaliplatin|mesh-list
153689133|NCT00174616|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153689134|NCT00174616|Antimetabolites|antimetabolites|mesh-ancestor
153689135|NCT00174616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153689136|NCT00174616|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153689137|NCT00174655|Cyclophosphamide|cyclophosphamide|mesh-list
153689138|NCT00174655|Docetaxel|docetaxel|mesh-list
153689139|NCT00174655|Doxorubicin|doxorubicin|mesh-list
153689140|NCT00174655|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
153689141|NCT00174655|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153689142|NCT00174655|Immunologic Factors|immunologic factors|mesh-ancestor
153689143|NCT00174655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153689144|NCT00174655|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153689162|NCT00174733|Hormones|hormones|mesh-ancestor
153689186|NCT02963779|Sensory System Agents|sensory system agents|mesh-ancestor
153689187|NCT02963779|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153689188|NCT02963779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153689189|NCT02963779|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153689190|NCT02963779|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153689191|NCT02963779|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
153689192|NCT02963779|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
153689193|NCT02963779|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153689194|NCT02963779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153689195|NCT00046176|Lamivudine|lamivudine|mesh-list
153689196|NCT00046176|Abacavir|abacavir|mesh-list
153689248|NCT00175396|Ascorbic Acid|ascorbic acid|mesh-list
153689249|NCT00175396|Leuprolide|leuprolide|mesh-list
153689250|NCT00175396|Methyltestosterone|methyltestosterone|mesh-list
153689251|NCT00175396|Flutamide|flutamide|mesh-list
153689252|NCT00175396|Bicalutamide|bicalutamide|mesh-list
153689253|NCT00175396|Nilutamide|nilutamide|mesh-list
153689254|NCT00175396|Buserelin|buserelin|mesh-list
153689255|NCT00175396|Androgens|androgens|mesh-list
153333303|NCT00987272|Ophthalmic Solutions|ophthalmic solutions|mesh-list
153689256|NCT00175396|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
153689257|NCT00175396|Fertility Agents, Female|fertility agents, female|mesh-ancestor
153689258|NCT00175396|Fertility Agents|fertility agents|mesh-ancestor
153689259|NCT00175396|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153689260|NCT00175396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153689315|NCT00175747|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153689316|NCT00175747|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153689317|NCT00175747|Autonomic Agents|autonomic agents|mesh-ancestor
153689318|NCT00175747|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153689319|NCT00175747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153689320|NCT00175747|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153689321|NCT00175747|Respiratory System Agents|respiratory system agents|mesh-ancestor
153333304|NCT00987272|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153689322|NCT00175747|Glucocorticoids|glucocorticoids|mesh-ancestor
153689323|NCT00175747|Hormones|hormones|mesh-ancestor
153689324|NCT00175747|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153689325|NCT04493619|Carboplatin|carboplatin|mesh-list
153689326|NCT04493619|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153689327|NCT00056576|Zonisamide|zonisamide|mesh-list
153689328|NCT00056576|Anticonvulsants|anticonvulsants|mesh-ancestor
153689329|NCT00056576|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153689330|NCT00056576|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153689331|NCT00056576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153689332|NCT00056576|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153689333|NCT00056576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153689334|NCT00175903|Carbamazepine|carbamazepine|mesh-list
153689335|NCT00175903|Levetiracetam|levetiracetam|mesh-list
153689336|NCT00175903|Valproic Acid|valproic acid|mesh-list
153689337|NCT00175903|Anticonvulsants|anticonvulsants|mesh-ancestor
153689338|NCT00175903|Nootropic Agents|nootropic agents|mesh-ancestor
153689339|NCT00175903|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153689340|NCT00175903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153689341|NCT00175903|GABA Agents|gaba agents|mesh-ancestor
153689342|NCT00175903|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153689343|NCT00175903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153689344|NCT00175903|Antimanic Agents|antimanic agents|mesh-ancestor
153689359|NCT00056654|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153689360|NCT00056654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153689361|NCT00056654|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153689362|NCT00056654|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153689363|NCT00175981|Sildenafil Citrate|sildenafil citrate|mesh-list
153689364|NCT00175981|Fluvoxamine|fluvoxamine|mesh-list
153689365|NCT00175981|Vasodilator Agents|vasodilator agents|mesh-ancestor
153689366|NCT00175981|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
153689426|NCT00176293|Hormones|hormones|mesh-ancestor
153689427|NCT00176293|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153689428|NCT00176293|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153689429|NCT00176293|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153689430|NCT00176293|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153689431|NCT00176293|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153689432|NCT00176293|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153689433|NCT00176293|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153689434|NCT00176293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153689435|NCT00056693|Sunitinib|sunitinib|mesh-list
153689436|NCT00056693|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153689437|NCT00056693|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153689438|NCT00056693|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153689484|NCT00176527|Interferon-alpha|interferon-alpha|mesh-list
153689485|NCT00176527|Interferon alpha-2|interferon alpha-2|mesh-list
153689486|NCT00176527|Docetaxel|docetaxel|mesh-list
153689487|NCT00176527|Estramustine|estramustine|mesh-list
153689488|NCT00176527|Isotretinoin|isotretinoin|mesh-list
153689489|NCT00176527|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153689490|NCT00176527|Tubulin Modulators|tubulin modulators|mesh-ancestor
153689491|NCT00176527|Antimitotic Agents|antimitotic agents|mesh-ancestor
153689492|NCT00176527|Mitosis Modulators|mitosis modulators|mesh-ancestor
153333340|NCT04552808|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153333341|NCT01927406|Timolol|timolol|mesh-list
153689493|NCT00176527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153689494|NCT00176527|Antiviral Agents|antiviral agents|mesh-ancestor
153689495|NCT00176527|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153689496|NCT00176527|Immunologic Factors|immunologic factors|mesh-ancestor
153689497|NCT00176527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153689498|NCT00176527|Dermatologic Agents|dermatologic agents|mesh-ancestor
153689499|NCT00176527|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153689500|NCT00176527|Alkylating Agents|alkylating agents|mesh-ancestor
153689501|NCT00176527|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153689503|NCT00398489|Cyclophosphamide|cyclophosphamide|mesh-list
153689540|NCT00176761|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153689541|NCT00176761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153689542|NCT00176995|Eflornithine|eflornithine|mesh-list
153689543|NCT00176995|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153689544|NCT00176995|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
153689545|NCT00176995|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153689546|NCT00176995|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153689547|NCT00176995|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153689548|NCT00176995|Ornithine Decarboxylase Inhibitors|ornithine decarboxylase inhibitors|mesh-ancestor
153689549|NCT00176995|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153689550|NCT00176995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153689551|NCT00423527|Levetiracetam|levetiracetam|mesh-list
153689552|NCT00423527|Anticonvulsants|anticonvulsants|mesh-ancestor
153689553|NCT00423527|Nootropic Agents|nootropic agents|mesh-ancestor
153689598|NCT00056810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153689599|NCT00177853|Celecoxib|celecoxib|mesh-list
153689600|NCT00177853|Irinotecan|irinotecan|mesh-list
153689601|NCT00177853|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
153689602|NCT00177853|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153689603|NCT00177853|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153689604|NCT00177853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153689605|NCT00177853|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153689606|NCT00177853|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153689661|NCT00408187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153689662|NCT00408187|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153689663|NCT00408187|Immunologic Factors|immunologic factors|mesh-ancestor
153637734|NCT00005834|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153689664|NCT00408187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153689666|NCT00408187|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153333364|NCT01927484|Antimetabolites|antimetabolites|mesh-ancestor
153689667|NCT00408187|Dermatologic Agents|dermatologic agents|mesh-ancestor
153689668|NCT00408187|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153689669|NCT00408187|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
153689724|NCT00179023|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153689725|NCT00179023|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153689726|NCT00179023|Ganglionic Blockers|ganglionic blockers|mesh-ancestor
153689727|NCT00179023|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
153689728|NCT00179023|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
153689729|NCT00179023|Cholinergic Agents|cholinergic agents|mesh-ancestor
153689730|NCT00179023|Vasodilator Agents|vasodilator agents|mesh-ancestor
153689731|NCT00057005|Cyclophosphamide|cyclophosphamide|mesh-list
153689732|NCT00057005|Alemtuzumab|alemtuzumab|mesh-list
153689733|NCT00057005|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153689734|NCT00057005|Immunologic Factors|immunologic factors|mesh-ancestor
153689735|NCT00057005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153689736|NCT00057005|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153689737|NCT00057005|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153689738|NCT00057005|Alkylating Agents|alkylating agents|mesh-ancestor
153689739|NCT00057005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153689782|NCT00408382|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
153689783|NCT00408382|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153689785|NCT00057122|Rifapentine|rifapentine|mesh-list
153689786|NCT00057122|Isoniazid|isoniazid|mesh-list
153689787|NCT00057122|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
153689788|NCT00057122|Antitubercular Agents|antitubercular agents|mesh-ancestor
153689789|NCT00057122|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153689790|NCT00057122|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153689791|NCT00057122|Leprostatic Agents|leprostatic agents|mesh-ancestor
153689792|NCT00057122|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153689793|NCT00057122|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153689794|NCT00057122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153689795|NCT00057122|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
153689796|NCT00057122|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
153689797|NCT00057122|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
153689798|NCT00057122|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
153689799|NCT00057122|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
153689838|NCT00179764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153689839|NCT00179764|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153689840|NCT00179764|Immunologic Factors|immunologic factors|mesh-ancestor
153689841|NCT00179764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153689842|NCT00179764|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153689843|NCT00179764|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153689844|NCT00179764|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153689845|NCT00179881|Thalidomide|thalidomide|mesh-list
153689846|NCT00179881|Carboplatin|carboplatin|mesh-list
153689847|NCT00179881|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153689848|NCT00179881|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153689849|NCT00179881|Immunologic Factors|immunologic factors|mesh-ancestor
153689860|NCT00180037|Ubiquinone|ubiquinone|mesh-list
153689899|NCT00180310|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153689900|NCT00180310|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153689901|NCT00180310|Immunologic Factors|immunologic factors|mesh-ancestor
153689902|NCT00180310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153689903|NCT00057278|Gabapentin|gabapentin|mesh-list
153689904|NCT00057278|Analgesics|analgesics|mesh-ancestor
153689905|NCT00057278|Sensory System Agents|sensory system agents|mesh-ancestor
153689906|NCT00057278|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153689907|NCT00057278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153689908|NCT00057278|Anticonvulsants|anticonvulsants|mesh-ancestor
153689909|NCT00057278|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153689910|NCT00057278|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153689911|NCT00057278|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153689912|NCT00057278|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153689913|NCT00057278|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
153689958|NCT04729491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153689960|NCT00057356|Conivaptan|conivaptan|mesh-list
153689961|NCT00057356|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
153689962|NCT00057356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153689963|NCT00057356|Natriuretic Agents|natriuretic agents|mesh-ancestor
153689965|NCT00181012|Lidocaine|lidocaine|mesh-list
153690023|NCT00181675|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153690024|NCT00181675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153690025|NCT00181675|Parasympathomimetics|parasympathomimetics|mesh-ancestor
153690027|NCT00181675|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153690028|NCT00181675|Nootropic Agents|nootropic agents|mesh-ancestor
153690029|NCT00181870|Carbamazepine|carbamazepine|mesh-list
153690030|NCT00181870|Anticonvulsants|anticonvulsants|mesh-ancestor
153690031|NCT00181870|Antimanic Agents|antimanic agents|mesh-ancestor
153690032|NCT00181870|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153690033|NCT00181870|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153690034|NCT00181870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153690085|NCT00408538|Antiviral Agents|antiviral agents|mesh-ancestor
153690086|NCT00408655|Sirolimus|sirolimus|mesh-list
153527033|NCT00411138|Paclitaxel|paclitaxel|mesh-list
153690087|NCT00408655|Paclitaxel|paclitaxel|mesh-list
153690088|NCT00408655|Carboplatin|carboplatin|mesh-list
153690089|NCT00408655|Temsirolimus|temsirolimus|mesh-list
153690090|NCT00408655|MTOR Inhibitors|mtor inhibitors|mesh-list
153690091|NCT00408655|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153690092|NCT00408655|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153690093|NCT00408655|Tubulin Modulators|tubulin modulators|mesh-ancestor
153690094|NCT00408655|Antimitotic Agents|antimitotic agents|mesh-ancestor
153690095|NCT00408655|Mitosis Modulators|mitosis modulators|mesh-ancestor
153690096|NCT00408655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153690109|NCT00182455|Topiramate|topiramate|mesh-list
153690148|NCT00182650|Immunologic Factors|immunologic factors|mesh-ancestor
153690149|NCT00182650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153690150|NCT00182650|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153690151|NCT00182650|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153638084|NCT00009178|Fluoxetine|fluoxetine|mesh-list
153690152|NCT00182650|Antimetabolites|antimetabolites|mesh-ancestor
153690153|NCT00182650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153690154|NCT00182650|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153690155|NCT00182650|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153690156|NCT00182650|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153690157|NCT00182650|Antiviral Agents|antiviral agents|mesh-ancestor
153690213|NCT00183235|Serotonin Agents|serotonin agents|mesh-ancestor
153690214|NCT00183235|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
153690215|NCT00183235|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153690216|NCT00183235|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
153690217|NCT00183235|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
153690218|NCT00057512|Masoprocol|masoprocol|mesh-list
153690219|NCT00057512|Antioxidants|antioxidants|mesh-ancestor
153690220|NCT00057512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153690221|NCT00057512|Protective Agents|protective agents|mesh-ancestor
153690222|NCT00057512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153690223|NCT00057512|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
153690224|NCT00057512|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153690276|NCT00183820|Antimetabolites|antimetabolites|mesh-ancestor
153690277|NCT02969720|Titanium dioxide|titanium dioxide|mesh-list
153690278|NCT02969720|Sunscreening Agents|sunscreening agents|mesh-ancestor
153690279|NCT02969720|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
153690280|NCT02969720|Protective Agents|protective agents|mesh-ancestor
153690281|NCT02969720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153690282|NCT02969720|Dermatologic Agents|dermatologic agents|mesh-ancestor
153690283|NCT02969720|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
153690284|NCT00183859|Irinotecan|irinotecan|mesh-list
153690285|NCT00183859|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
153690290|NCT00183898|Capecitabine|capecitabine|mesh-list
153690341|NCT00184015|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153690342|NCT00184015|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153690343|NCT00184015|Growth Substances|growth substances|mesh-ancestor
153690344|NCT00184015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153690345|NCT00184015|Growth Inhibitors|growth inhibitors|mesh-ancestor
153690347|NCT00184171|Bismuth|bismuth|mesh-list
153690348|NCT00184171|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153690349|NCT00184171|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153690350|NCT00184171|Autonomic Agents|autonomic agents|mesh-ancestor
153690351|NCT00184171|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153333489|NCT05506410|Cytarabine|cytarabine|mesh-list
153690352|NCT00184171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153690353|NCT00184171|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153690403|NCT00058253|Antimitotic Agents|antimitotic agents|mesh-ancestor
153690404|NCT00058253|Mitosis Modulators|mitosis modulators|mesh-ancestor
153690405|NCT00058253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153690406|NCT00046800|Lurtotecan|lurtotecan|mesh-list
153690407|NCT00046800|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153690408|NCT00058292|Cytarabine|cytarabine|mesh-list
153690409|NCT00058292|Rituximab|rituximab|mesh-list
153690410|NCT00058292|Etoposide|etoposide|mesh-list
153690411|NCT00058292|Etoposide phosphate|etoposide phosphate|mesh-list
153690412|NCT00058292|Melphalan|melphalan|mesh-list
153333490|NCT05506410|Prednisone|prednisone|mesh-list
153690413|NCT00058292|Carmustine|carmustine|mesh-list
153690414|NCT00058292|Lenograstim|lenograstim|mesh-list
153690415|NCT00058292|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153690416|NCT00058292|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153690417|NCT00058292|Immunologic Factors|immunologic factors|mesh-ancestor
153690418|NCT00058292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153690419|NCT00058292|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153638201|NCT00009880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153690420|NCT00058292|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153690421|NCT00058292|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153690422|NCT00058292|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153690423|NCT00058292|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153690424|NCT00058292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153690425|NCT00058292|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153690426|NCT00058292|Antimetabolites|antimetabolites|mesh-ancestor
153690427|NCT00058292|Antiviral Agents|antiviral agents|mesh-ancestor
153690428|NCT00058292|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153690429|NCT00058292|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153690430|NCT00058292|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153690431|NCT00058292|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153690432|NCT00058292|Alkylating Agents|alkylating agents|mesh-ancestor
153690449|NCT00184912|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153690450|NCT00184951|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
153690452|NCT00184951|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153690453|NCT00184951|Antimetabolites|antimetabolites|mesh-ancestor
153690454|NCT00184951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153690455|NCT00184951|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153690456|NCT00184951|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
153690457|NCT00184951|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153690458|NCT00184990|Pimagedine|pimagedine|mesh-list
153690459|NCT00184990|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153690460|NCT00184990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153690461|NCT00058331|Epoetin Alfa|epoetin alfa|mesh-list
153690462|NCT00058331|Hematinics|hematinics|mesh-ancestor
153690464|NCT00185068|Olmesartan|olmesartan|mesh-list
153690508|NCT00185185|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
153690509|NCT00185185|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
153690511|NCT00185185|Adrenergic Agents|adrenergic agents|mesh-ancestor
153690512|NCT00185185|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153690513|NCT00185224|Ethinyl Estradiol-Norgestrel Combination|ethinyl estradiol-norgestrel combination|mesh-list
153690514|NCT00185224|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
153690515|NCT00185224|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
153690516|NCT00185224|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
153690517|NCT00185224|Contraceptive Agents|contraceptive agents|mesh-ancestor
153690518|NCT00185224|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153690526|NCT00185302|Entinostat|entinostat|mesh-list
153690566|NCT00185575|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153333515|NCT05506332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153690567|NCT00185575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153690568|NCT00185575|Analgesics|analgesics|mesh-ancestor
153690569|NCT00185575|Sensory System Agents|sensory system agents|mesh-ancestor
153690570|NCT00185575|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153690571|NCT00185575|Antidepressive Agents|antidepressive agents|mesh-ancestor
153690572|NCT00185575|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153690573|NCT00185575|Dopamine Agents|dopamine agents|mesh-ancestor
153638419|NCT00011362|Hormones|hormones|mesh-ancestor
153690574|NCT03731832|Dexamethasone|dexamethasone|mesh-list
153690575|NCT03731832|Cyclophosphamide|cyclophosphamide|mesh-list
153690576|NCT03731832|Pomalidomide|pomalidomide|mesh-list
153690577|NCT03731832|Ixazomib|ixazomib|mesh-list
153690578|NCT03731832|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153690579|NCT03731832|Immunologic Factors|immunologic factors|mesh-ancestor
153690580|NCT03731832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153690581|NCT03731832|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153690582|NCT03731832|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153690583|NCT03731832|Alkylating Agents|alkylating agents|mesh-ancestor
153690625|NCT00186277|Tubulin Modulators|tubulin modulators|mesh-ancestor
153690626|NCT00186277|Antimitotic Agents|antimitotic agents|mesh-ancestor
153690627|NCT00186277|Mitosis Modulators|mitosis modulators|mesh-ancestor
153690628|NCT00186277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153690629|NCT00186316|Immunoglobulin Idiotypes|immunoglobulin idiotypes|mesh-list
153690630|NCT00186316|Immunologic Factors|immunologic factors|mesh-ancestor
153690631|NCT00186316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153690632|NCT00058682|Anidulafungin|anidulafungin|mesh-list
153690633|NCT00058682|Antifungal Agents|antifungal agents|mesh-ancestor
153690634|NCT00058682|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153690635|NCT00186589|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
153690636|NCT00186589|Immunologic Factors|immunologic factors|mesh-ancestor
153690637|NCT00186589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153690638|NCT00186706|Selenium|selenium|mesh-list
153690639|NCT00186706|Antioxidants|antioxidants|mesh-ancestor
153690687|NCT00186979|Gefitinib|gefitinib|mesh-list
153690688|NCT00186979|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
153333583|NCT04120454|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
153690689|NCT00186979|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153690690|NCT00186979|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153690691|NCT00186979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153690692|NCT00186979|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153690693|NCT00186979|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153690694|NCT00186979|Tubulin Modulators|tubulin modulators|mesh-ancestor
153690695|NCT00186979|Antimitotic Agents|antimitotic agents|mesh-ancestor
153690696|NCT00186979|Mitosis Modulators|mitosis modulators|mesh-ancestor
153638520|NCT00005945|Cytarabine|cytarabine|mesh-list
153690697|NCT00186979|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153690698|NCT00186979|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153690699|NCT00186979|Third Generation Cephalosporins|third generation cephalosporins|mesh-ancestor
153690700|NCT00186979|Beta Lactam Antibiotics|beta lactam antibiotics|mesh-ancestor
153690701|NCT00186979|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153690702|NCT00186979|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153690704|NCT00187057|Dexamethasone|dexamethasone|mesh-list
153690705|NCT00187057|Prednisone|prednisone|mesh-list
153690706|NCT00187057|Cyclophosphamide|cyclophosphamide|mesh-list
153690707|NCT00187057|Doxorubicin|doxorubicin|mesh-list
153333584|NCT04120454|Pembrolizumab|pembrolizumab|mesh-list
153333586|NCT04120454|Antibodies|antibodies|mesh-list
153690708|NCT00187057|Methotrexate|methotrexate|mesh-list
153690709|NCT00187057|Etoposide|etoposide|mesh-list
153690710|NCT00187057|Vincristine|vincristine|mesh-list
153690711|NCT00187057|Daunorubicin|daunorubicin|mesh-list
153690712|NCT00187057|Asparaginase|asparaginase|mesh-list
153690713|NCT00187057|Mercaptopurine|mercaptopurine|mesh-list
153690714|NCT00187057|Vinblastine|vinblastine|mesh-list
153690715|NCT00187057|Procarbazine|procarbazine|mesh-list
153690736|NCT00187057|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153690737|NCT00187057|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153690738|NCT00187057|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
153690739|NCT00187057|Abortifacient Agents|abortifacient agents|mesh-ancestor
153690740|NCT00187057|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153690741|NCT00187057|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153690742|NCT00187057|Antimetabolites|antimetabolites|mesh-ancestor
153690743|NCT00187057|Dermatologic Agents|dermatologic agents|mesh-ancestor
153690744|NCT00187057|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153690745|NCT00187057|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153690746|NCT00187057|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153690748|NCT00187057|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153690749|NCT00187057|Tubulin Modulators|tubulin modulators|mesh-ancestor
153690750|NCT00187057|Antimitotic Agents|antimitotic agents|mesh-ancestor
153690751|NCT00187057|Mitosis Modulators|mitosis modulators|mesh-ancestor
153690752|NCT00046917|Irinotecan|irinotecan|mesh-list
153690796|NCT00187447|Sensory System Agents|sensory system agents|mesh-ancestor
153690797|NCT00187447|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153690798|NCT00187447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153690799|NCT00187447|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153690800|NCT00187447|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153690801|NCT00187447|Gout Suppressants|gout suppressants|mesh-ancestor
153690802|NCT00187447|Tocolytic Agents|tocolytic agents|mesh-ancestor
153690803|NCT00187447|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153690804|NCT00187447|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153690805|NCT00187447|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153690806|NCT00187447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153690810|NCT00187525|Memantine|memantine|mesh-list
153690859|NCT00058955|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153690860|NCT00058955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153690861|NCT00058955|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153690862|NCT00187759|Cephalexin|cephalexin|mesh-list
153690863|NCT00187759|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153690864|NCT00187759|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153690865|NCT00187798|Metformin|metformin|mesh-list
153333613|NCT00966641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153690866|NCT00187798|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153690867|NCT00187798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153690868|NCT00058994|Anecortave|anecortave|mesh-list
153690869|NCT00058994|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153690870|NCT00058994|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153690922|NCT00188227|Anesthetics|anesthetics|mesh-ancestor
153690923|NCT00188227|GABA Modulators|gaba modulators|mesh-ancestor
153690924|NCT00188227|GABA Agents|gaba agents|mesh-ancestor
153690925|NCT00188227|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153690926|NCT00188227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153690927|NCT00188227|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153690928|NCT00188227|Narcotics|narcotics|mesh-ancestor
153690930|NCT00188227|Sensory System Agents|sensory system agents|mesh-ancestor
153690931|NCT00188227|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153690932|NCT00188266|Fluorouracil|fluorouracil|mesh-list
153690933|NCT00188266|Cisplatin|cisplatin|mesh-list
153690934|NCT00188266|Antimetabolites|antimetabolites|mesh-ancestor
153690935|NCT00188266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153690936|NCT00188266|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153690937|NCT00188266|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153690982|NCT00409318|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153690983|NCT00409318|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153690984|NCT00409318|Analgesics|analgesics|mesh-ancestor
153690985|NCT00409318|Sensory System Agents|sensory system agents|mesh-ancestor
153690986|NCT00409318|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153690987|NCT00409318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153690988|NCT00409318|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153690989|NCT00409318|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153690990|NCT00409318|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153690991|NCT00409318|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153690992|NCT00409318|Immunologic Factors|immunologic factors|mesh-ancestor
153691044|NCT00059306|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153691045|NCT00059306|Analgesics|analgesics|mesh-ancestor
153691046|NCT00059306|Sensory System Agents|sensory system agents|mesh-ancestor
153691047|NCT00059306|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153691048|NCT00059306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153691049|NCT00059306|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153691050|NCT00059306|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153691051|NCT00059306|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153691052|NCT00059306|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153691053|NCT00059306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153691054|NCT00059306|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153691055|NCT00059306|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153691056|NCT00059306|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153691057|NCT00059306|Antipyretics|antipyretics|mesh-ancestor
153691106|NCT00189358|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153691107|NCT00189358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153638862|NCT00014404|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153691108|NCT00189358|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153691109|NCT00189358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153333651|NCT00971789|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153333652|NCT00971789|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153691110|NCT00189358|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
153691111|NCT00189358|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
153691112|NCT00189358|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153691113|NCT00189358|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153691114|NCT00189358|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153691115|NCT00189358|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153691116|NCT00189358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153691117|NCT00189397|Azathioprine|azathioprine|mesh-list
153691118|NCT00189397|Antimetabolites|antimetabolites|mesh-ancestor
153691126|NCT00189514|Pramlintide|pramlintide|mesh-list
153691161|NCT00189748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153691162|NCT00189748|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
153691163|NCT00189748|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153691164|NCT00189748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153691179|NCT00189826|Tacrolimus|tacrolimus|mesh-list
153691229|NCT00190099|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153691230|NCT00047268|Cytarabine|cytarabine|mesh-list
153691231|NCT00047268|Mercaptopurine|mercaptopurine|mesh-list
153691232|NCT00047268|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153691233|NCT00047268|Antimetabolites|antimetabolites|mesh-ancestor
153691234|NCT00047268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153691235|NCT00047268|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153691236|NCT00047268|Antiviral Agents|antiviral agents|mesh-ancestor
153691237|NCT00047268|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153691238|NCT00047268|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153691239|NCT00047268|Immunologic Factors|immunologic factors|mesh-ancestor
153691240|NCT00047268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153691241|NCT00047268|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153691242|NCT00047268|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153691243|NCT00190294|Misoprostol|misoprostol|mesh-list
153691244|NCT00190294|Mifepristone|mifepristone|mesh-list
153691245|NCT00190294|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
153691246|NCT00190294|Abortifacient Agents|abortifacient agents|mesh-ancestor
153691247|NCT00190294|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153691248|NCT00190294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153691249|NCT00190294|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
153691281|NCT00190333|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153691282|NCT00190333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153691283|NCT00190333|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153691284|NCT00190333|Serotonin Agents|serotonin agents|mesh-ancestor
153691285|NCT00190333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153691286|NCT00190372|Hypnotics and Sedatives|hypnotics and sedatives|mesh-list
153691287|NCT00190372|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153691288|NCT00190372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153691289|NCT00190411|Celiprolol|celiprolol|mesh-list
153691290|NCT00190411|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153691291|NCT00190411|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153691342|NCT00190606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153691343|NCT00190606|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153691344|NCT00190606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153691345|NCT00190606|Analgesics|analgesics|mesh-ancestor
153691346|NCT00190606|Sensory System Agents|sensory system agents|mesh-ancestor
153691348|NCT00190606|Antidepressive Agents|antidepressive agents|mesh-ancestor
153691349|NCT00190606|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153691350|NCT00190606|Dopamine Agents|dopamine agents|mesh-ancestor
153691351|NCT00190645|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
153691352|NCT00190645|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
153691353|NCT00190645|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153691354|NCT00190645|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153333692|NCT04122560|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153691355|NCT00190645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153691356|NCT00190645|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153691357|NCT00190645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153691358|NCT00190645|Analgesics|analgesics|mesh-ancestor
153691359|NCT00190645|Sensory System Agents|sensory system agents|mesh-ancestor
153691394|NCT00190879|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153691395|NCT00190879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153691397|NCT00190918|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153691398|NCT00190918|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153691399|NCT00190918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153691400|NCT00190918|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153691401|NCT00190918|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153691402|NCT00190957|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
153691403|NCT00190957|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
153691404|NCT00190957|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153691405|NCT00190957|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153691406|NCT00190957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153691407|NCT00190957|Adrenergic Agents|adrenergic agents|mesh-ancestor
153691408|NCT00190957|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153691409|NCT00190957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153691410|NCT00190996|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
153691411|NCT00190996|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
153691412|NCT00190996|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153691413|NCT00190996|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153691415|NCT00190996|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153691441|NCT02922894|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153691442|NCT02922894|Serotonin Agents|serotonin agents|mesh-ancestor
153691443|NCT02922894|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
153691444|NCT02922894|Antidepressive Agents|antidepressive agents|mesh-ancestor
153691445|NCT00191230|Carboplatin|carboplatin|mesh-list
153691446|NCT00191230|Gemcitabine|gemcitabine|mesh-list
153691447|NCT00191230|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153691448|NCT00191230|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153691449|NCT00191230|Antimetabolites|antimetabolites|mesh-ancestor
153691450|NCT00191230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153691451|NCT00191347|Gemcitabine|gemcitabine|mesh-list
153691453|NCT00191347|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153691454|NCT00191347|Antimetabolites|antimetabolites|mesh-ancestor
153691455|NCT00191347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153691499|NCT00191542|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153691500|NCT00191542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153691501|NCT00059735|N-(3-chloro-7-indolyl)-1,4-benzenedisulphonamide|n-(3-chloro-7-indolyl)-1,4-benzenedisulphonamide|mesh-list
153691502|NCT00059735|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153691503|NCT00059735|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
153691504|NCT00059735|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153528474|NCT01478503|Mirabegron|mirabegron|mesh-list
153691505|NCT00059735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153691506|NCT00191581|Insulin|insulin|mesh-list
153691507|NCT00191581|Insulin Lispro|insulin lispro|mesh-list
153333707|NCT05501340|Molgramostim|molgramostim|mesh-list
153691508|NCT00191581|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
153691509|NCT00191581|Isophane insulin, insulin lispro drug combination 50:50|isophane insulin, insulin lispro drug combination 50:50|mesh-list
153691510|NCT00191581|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153691511|NCT00191581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153691512|NCT00191620|Gemcitabine|gemcitabine|mesh-list
153691551|NCT00191932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153691552|NCT00191932|Analgesics|analgesics|mesh-ancestor
153691555|NCT00191932|Antidepressive Agents|antidepressive agents|mesh-ancestor
153691556|NCT00191932|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153691557|NCT00191932|Dopamine Agents|dopamine agents|mesh-ancestor
153691558|NCT00059813|Interferons|interferons|mesh-list
153691559|NCT00059813|Interferon-alpha|interferon-alpha|mesh-list
153691561|NCT00059813|Oblimersen|oblimersen|mesh-list
153691617|NCT00047580|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153691618|NCT00047580|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153691619|NCT00047580|Adrenergic Agents|adrenergic agents|mesh-ancestor
153691620|NCT00047580|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153691621|NCT00047580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153691622|NCT02968901|Tadalafil|tadalafil|mesh-list
153691623|NCT02968901|Macitentan|macitentan|mesh-list
153691624|NCT02968901|Vasodilator Agents|vasodilator agents|mesh-ancestor
153691626|NCT02968901|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
153691684|NCT00193024|Tubulin Modulators|tubulin modulators|mesh-ancestor
153691685|NCT00193024|Antimitotic Agents|antimitotic agents|mesh-ancestor
153691686|NCT00193024|Mitosis Modulators|mitosis modulators|mesh-ancestor
153691687|NCT00193024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153691688|NCT00193024|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153691689|NCT00193024|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153691690|NCT00193024|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153691691|NCT00193024|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153691692|NCT00193102|Thalidomide|thalidomide|mesh-list
153691693|NCT00193102|Capecitabine|capecitabine|mesh-list
153691694|NCT00193102|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153691695|NCT00193102|Antimetabolites|antimetabolites|mesh-ancestor
153691696|NCT00193102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153691697|NCT00193102|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153639183|NCT00015964|Gefitinib|gefitinib|mesh-list
153691698|NCT00193102|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153691708|NCT00193141|Paclitaxel|paclitaxel|mesh-list
153691743|NCT00193531|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153691744|NCT00193531|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153691745|NCT00193531|Tubulin Modulators|tubulin modulators|mesh-ancestor
153691746|NCT00193531|Antimitotic Agents|antimitotic agents|mesh-ancestor
153691747|NCT00193531|Mitosis Modulators|mitosis modulators|mesh-ancestor
153691748|NCT00193531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153691749|NCT00193531|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153691750|NCT00193531|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153691751|NCT00193531|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153691753|NCT00193570|Topotecan|topotecan|mesh-list
153691754|NCT00193570|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153691755|NCT00193570|Tubulin Modulators|tubulin modulators|mesh-ancestor
153691805|NCT00193648|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153691806|NCT00193648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153691807|NCT00193726|Ethinyl Estradiol|ethinyl estradiol|mesh-list
153691808|NCT00193726|Estradiol|estradiol|mesh-list
153691809|NCT00193726|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
153691810|NCT00193726|Estrogens|estrogens|mesh-ancestor
153691811|NCT00193726|Hormones|hormones|mesh-ancestor
153691812|NCT00193726|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153691813|NCT00193726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153691814|NCT00193726|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
153691815|NCT00193726|Contraceptive Agents|contraceptive agents|mesh-ancestor
153691816|NCT00193726|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153691817|NCT00193726|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
153691818|NCT00193726|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
153691819|NCT00193726|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
153691820|NCT00193882|Cisplatin|cisplatin|mesh-list
153691821|NCT00193882|Fluorouracil|fluorouracil|mesh-list
153691822|NCT00193882|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153691824|NCT00193882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153691826|NCT00193882|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153691827|NCT00193882|Immunologic Factors|immunologic factors|mesh-ancestor
153691828|NCT00193882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153691829|NCT00060242|Fosbretabulin|fosbretabulin|mesh-list
153691830|NCT00060242|Combretastatin|combretastatin|mesh-list
153691831|NCT00060242|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153691832|NCT00060242|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153691833|NCT00060242|Tubulin Modulators|tubulin modulators|mesh-ancestor
153691834|NCT00060242|Antimitotic Agents|antimitotic agents|mesh-ancestor
153691835|NCT00060242|Mitosis Modulators|mitosis modulators|mesh-ancestor
153691836|NCT00060242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153691837|NCT00193921|Cisplatin|cisplatin|mesh-list
153691847|NCT00193921|Mitosis Modulators|mitosis modulators|mesh-ancestor
153691848|NCT00194038|Aripiprazole|aripiprazole|mesh-list
153691849|NCT00194038|Antidepressive Agents|antidepressive agents|mesh-ancestor
153691850|NCT00194038|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153691851|NCT00194038|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153691852|NCT00194038|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153691853|NCT00194038|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153691854|NCT00194038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153691855|NCT00194038|Dopamine Agonists|dopamine agonists|mesh-ancestor
153691856|NCT00194038|Dopamine Agents|dopamine agents|mesh-ancestor
153691857|NCT00194038|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153691858|NCT00194038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153691859|NCT00194038|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
153691860|NCT00194038|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
153691866|NCT00060359|Paclitaxel|paclitaxel|mesh-list
153691905|NCT00194623|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
153691906|NCT00194623|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153691907|NCT00194623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153691908|NCT00194623|Cholinergic Agents|cholinergic agents|mesh-ancestor
153691909|NCT00194623|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153691910|NCT00194623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153691911|NCT00194623|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
153691912|NCT00194623|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153691913|NCT00194740|Docetaxel|docetaxel|mesh-list
153691914|NCT00194740|Vinorelbine|vinorelbine|mesh-list
153691915|NCT00194740|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153691916|NCT00194740|Tubulin Modulators|tubulin modulators|mesh-ancestor
153691917|NCT00194740|Antimitotic Agents|antimitotic agents|mesh-ancestor
153691918|NCT00194740|Mitosis Modulators|mitosis modulators|mesh-ancestor
153691919|NCT00194740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153691920|NCT00194740|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153691921|NCT00194818|Mesalamine|mesalamine|mesh-list
153691932|NCT00194935|Topotecan|topotecan|mesh-list
153691961|NCT00194974|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
153691962|NCT00194974|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
153691963|NCT00194974|Sympathomimetics|sympathomimetics|mesh-ancestor
153691964|NCT00194974|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
153691965|NCT00194974|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
153692031|NCT00084240|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
153692032|NCT00084240|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153692033|NCT00084240|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153692034|NCT00084240|Amebicides|amebicides|mesh-ancestor
153692035|NCT00084240|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153692036|NCT00084240|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153692037|NCT00084240|Antimalarials|antimalarials|mesh-ancestor
153692038|NCT00084240|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153692039|NCT00084240|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153639496|NCT00017134|Fenretinide|fenretinide|mesh-list
153692040|NCT00084240|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153692041|NCT00084240|Analgesics|analgesics|mesh-ancestor
153692042|NCT00084240|Sensory System Agents|sensory system agents|mesh-ancestor
153692043|NCT00084240|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153692044|NCT00084240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153692045|NCT00084240|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153692046|NCT00084240|Filaricides|filaricides|mesh-ancestor
153692047|NCT00084240|Antinematodal Agents|antinematodal agents|mesh-ancestor
153692048|NCT00084240|Anthelmintics|anthelmintics|mesh-ancestor
153692049|NCT00084240|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153692050|NCT00084240|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153692051|NCT00084240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153692052|NCT00084240|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
153692053|NCT00195598|Paroxetine|paroxetine|mesh-list
153692054|NCT00195598|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
153692055|NCT00195598|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
153692056|NCT00195598|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153692057|NCT00195598|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153692058|NCT00195598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153692060|NCT00195598|Serotonin Agents|serotonin agents|mesh-ancestor
153692072|NCT00195637|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
153692073|NCT00195637|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
153692074|NCT00195637|Immunologic Factors|immunologic factors|mesh-ancestor
153692075|NCT00195637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153692076|NCT00195754|Valproic Acid|valproic acid|mesh-list
153692077|NCT00195754|Anticonvulsants|anticonvulsants|mesh-ancestor
153692078|NCT00195754|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153692079|NCT00195754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153692081|NCT00195754|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153692082|NCT00195754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153692083|NCT00195754|Antimanic Agents|antimanic agents|mesh-ancestor
153692084|NCT00195754|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153692085|NCT00195754|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153692133|NCT00195871|Mitosis Modulators|mitosis modulators|mesh-ancestor
153692134|NCT00195871|Antiviral Agents|antiviral agents|mesh-ancestor
153692135|NCT00195871|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153692136|NCT00195871|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153692137|NCT00195910|Morphine|morphine|mesh-list
153692138|NCT00195910|Hydromorphone|hydromorphone|mesh-list
153692139|NCT00195910|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153692140|NCT00195910|Narcotics|narcotics|mesh-ancestor
153692141|NCT00195910|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153692142|NCT00195910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153692143|NCT00195910|Analgesics|analgesics|mesh-ancestor
153692144|NCT00195910|Sensory System Agents|sensory system agents|mesh-ancestor
153692145|NCT00195910|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153692146|NCT00195988|Mycophenolic Acid|mycophenolic acid|mesh-list
153692147|NCT00195988|Tacrolimus|tacrolimus|mesh-list
153692148|NCT00195988|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153692191|NCT00196378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153692192|NCT00196417|Heparin|heparin|mesh-list
153692193|NCT00196417|Certoparin|certoparin|mesh-list
153692194|NCT00196417|Anticoagulants|anticoagulants|mesh-ancestor
153692195|NCT00196417|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153692196|NCT00196417|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153692197|NCT00196417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153692198|NCT00060554|Heparin|heparin|mesh-list
153692199|NCT00060554|PENTA|penta|mesh-list
153692259|NCT00196768|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153692260|NCT00084396|Letrozole|letrozole|mesh-list
153692261|NCT00084396|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153692262|NCT00084396|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
153692263|NCT00084396|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153692264|NCT00084396|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153692265|NCT00084396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153692267|NCT00084396|Hormone Antagonists|hormone antagonists|mesh-ancestor
153692268|NCT00084396|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153692269|NCT00084396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153692270|NCT00196846|Goserelin|goserelin|mesh-list
153692271|NCT00196846|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153692272|NCT00196846|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153692273|NCT00060632|Sirolimus|sirolimus|mesh-list
153692274|NCT00060632|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153692275|NCT00060632|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153692276|NCT00060632|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153692277|NCT00060632|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153692278|NCT00060632|Antifungal Agents|antifungal agents|mesh-ancestor
153692279|NCT00060632|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153692312|NCT00197080|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
153692313|NCT00197080|Dopamine Agonists|dopamine agonists|mesh-ancestor
153692314|NCT00197080|Dopamine Agents|dopamine agents|mesh-ancestor
153692315|NCT00197080|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153692316|NCT00197080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153692317|NCT00197080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153692318|NCT00060671|Rituximab|rituximab|mesh-list
153692319|NCT00060671|Pixantrone|pixantrone|mesh-list
153692320|NCT00060671|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153692321|NCT00060671|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153692322|NCT00060671|Immunologic Factors|immunologic factors|mesh-ancestor
153692323|NCT00060671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153692324|NCT00060671|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153692325|NCT00060671|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153692326|NCT00060671|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153692368|NCT02962999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153692369|NCT00084513|Trastuzumab|trastuzumab|mesh-list
153692370|NCT00084513|Imatinib Mesylate|imatinib mesylate|mesh-list
153692371|NCT00084513|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153692372|NCT00084513|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153692373|NCT00084513|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153692374|NCT00084513|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153692375|NCT00084513|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153692376|NCT00084513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153692377|NCT00084591|Capecitabine|capecitabine|mesh-list
153692378|NCT00084591|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153692379|NCT00084591|Antimetabolites|antimetabolites|mesh-ancestor
153692380|NCT00084591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153692381|NCT00084591|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153333910|NCT04128878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153692382|NCT00197548|Folic Acid|folic acid|mesh-list
153692383|NCT00197548|Vitamin B Complex|vitamin b complex|mesh-list
153692384|NCT00197548|Vitamins|vitamins|mesh-ancestor
153333911|NCT04128878|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153333912|NCT04128878|Sympatholytics|sympatholytics|mesh-ancestor
153692424|NCT00084669|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153692425|NCT00084669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153692426|NCT00084669|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
153692427|NCT00084669|Antidepressive Agents|antidepressive agents|mesh-ancestor
153692428|NCT00084669|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153692429|NCT00084669|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
153692430|NCT00084669|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153692431|NCT00084669|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153692487|NCT00198094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153692488|NCT00198094|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153692489|NCT00198094|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153692490|NCT00198094|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153692491|NCT00198094|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153692492|NCT00198094|GABA Modulators|gaba modulators|mesh-ancestor
153692493|NCT00198094|GABA Agents|gaba agents|mesh-ancestor
153692494|NCT00198172|Epirubicin|epirubicin|mesh-list
153692495|NCT00198172|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153692496|NCT00198172|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153692497|NCT00198172|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153692498|NCT00198172|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153692499|NCT00198172|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153692500|NCT00198172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153692501|NCT00198250|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
153692502|NCT00198250|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
153692503|NCT00198250|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153692504|NCT00198250|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153692511|NCT00084708|Calcitriol|calcitriol|mesh-list
153692540|NCT00198367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153692541|NCT00198367|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153692542|NCT00198367|Tubulin Modulators|tubulin modulators|mesh-ancestor
153692543|NCT00198367|Antimitotic Agents|antimitotic agents|mesh-ancestor
153692544|NCT00198367|Mitosis Modulators|mitosis modulators|mesh-ancestor
153692546|NCT00198445|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153692547|NCT00198445|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153692548|NCT00198445|Analgesics|analgesics|mesh-ancestor
153692549|NCT00198445|Sensory System Agents|sensory system agents|mesh-ancestor
153692550|NCT00198445|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153692551|NCT00198445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153692552|NCT00198445|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153692553|NCT00198445|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153692554|NCT00048399|Fludarabine|fludarabine|mesh-list
153692555|NCT00048399|Alemtuzumab|alemtuzumab|mesh-list
153692556|NCT00048399|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153692557|NCT00048399|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153692558|NCT00060905|Valproic Acid|valproic acid|mesh-list
153692559|NCT00060905|Anticonvulsants|anticonvulsants|mesh-ancestor
153692560|NCT00060905|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153692561|NCT00060905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153692562|NCT00060905|GABA Agents|gaba agents|mesh-ancestor
153692563|NCT00060905|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153333945|NCT04128020|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153333947|NCT04128020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153692590|NCT00198523|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153692591|NCT00198523|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153692592|NCT00198562|Losartan|losartan|mesh-list
153692593|NCT00198562|Amlodipine|amlodipine|mesh-list
153692594|NCT00198562|Antihypertensive Agents|antihypertensive agents|mesh-list
153692595|NCT00198562|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153692596|NCT00198562|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153692597|NCT00198562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153692598|NCT00198562|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153692599|NCT00198562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153692600|NCT00198562|Vasodilator Agents|vasodilator agents|mesh-ancestor
153692601|NCT00198562|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153692602|NCT00198562|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
153692603|NCT00198562|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
153692604|NCT00409942|Torsemide|torsemide|mesh-list
153692605|NCT00409942|Furosemide|furosemide|mesh-list
153692606|NCT00409942|Diuretics|diuretics|mesh-ancestor
153692607|NCT00409942|Natriuretic Agents|natriuretic agents|mesh-ancestor
153692608|NCT00409942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153692645|NCT00084825|Tubulin Modulators|tubulin modulators|mesh-ancestor
153692646|NCT00084825|Antimitotic Agents|antimitotic agents|mesh-ancestor
153692647|NCT00084825|Mitosis Modulators|mitosis modulators|mesh-ancestor
153692648|NCT00084825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153692649|NCT00084825|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153692650|NCT00084825|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153692651|NCT00084825|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153692652|NCT00048477|omega-N-Methylarginine|omega-n-methylarginine|mesh-list
153692653|NCT00048477|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153462334|NCT00630786|Conatumumab|conatumumab|mesh-list
153640114|NCT04971343|Antibodies|antibodies|mesh-list
153692654|NCT00048477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153692655|NCT00199147|Cytarabine|cytarabine|mesh-list
153692656|NCT00199147|Fludarabine|fludarabine|mesh-list
153692657|NCT00199147|Etoposide|etoposide|mesh-list
153692658|NCT00199147|Idarubicin|idarubicin|mesh-list
153692659|NCT00199147|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153692660|NCT00199147|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153692661|NCT00199147|Antimetabolites|antimetabolites|mesh-ancestor
153692662|NCT00199147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153692663|NCT00199147|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153692664|NCT00199147|Immunologic Factors|immunologic factors|mesh-ancestor
153692665|NCT00199147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153692666|NCT00199147|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153692667|NCT00199147|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153692668|NCT00199147|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153692669|NCT00199147|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153692695|NCT00199186|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153692696|NCT00199186|Glucocorticoids|glucocorticoids|mesh-ancestor
153692697|NCT00199186|Hormones|hormones|mesh-ancestor
153692698|NCT00199186|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153692699|NCT00199186|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153333963|NCT00981227|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153333964|NCT00981227|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153333965|NCT00981227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153692700|NCT00199186|Protease Inhibitors|protease inhibitors|mesh-ancestor
153692701|NCT00199186|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153692702|NCT00199186|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
153692703|NCT00199186|Abortifacient Agents|abortifacient agents|mesh-ancestor
153692704|NCT00199186|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153692705|NCT00199186|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153692706|NCT00199186|Antimetabolites|antimetabolites|mesh-ancestor
153692707|NCT00199186|Dermatologic Agents|dermatologic agents|mesh-ancestor
153692708|NCT00199186|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153692709|NCT00199186|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153692710|NCT00199186|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153692711|NCT00199186|Tubulin Modulators|tubulin modulators|mesh-ancestor
153692712|NCT00199186|Antimitotic Agents|antimitotic agents|mesh-ancestor
153692721|NCT00199225|Moxifloxacin|moxifloxacin|mesh-list
153692749|NCT00199576|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
153692750|NCT00199576|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
153692751|NCT00199576|Prednisolone|prednisolone|mesh-list
153692752|NCT00199576|Prednisolone acetate|prednisolone acetate|mesh-list
153692753|NCT00199576|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
153692754|NCT00199576|Prednisolone phosphate|prednisolone phosphate|mesh-list
153692755|NCT00199576|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153692756|NCT00199576|Antiemetics|antiemetics|mesh-ancestor
153692757|NCT00199576|Autonomic Agents|autonomic agents|mesh-ancestor
153692758|NCT00199576|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153692759|NCT00199576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153692760|NCT00199576|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153692761|NCT00199576|Glucocorticoids|glucocorticoids|mesh-ancestor
153692762|NCT00199576|Hormones|hormones|mesh-ancestor
153692763|NCT00199576|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153692764|NCT00199576|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
153692765|NCT00199576|Protective Agents|protective agents|mesh-ancestor
153692766|NCT00199576|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153692767|NCT00199576|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153692768|NCT00084942|Gemcitabine|gemcitabine|mesh-list
153692769|NCT00084942|Capecitabine|capecitabine|mesh-list
153692770|NCT00084942|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153692771|NCT00084942|Antimetabolites|antimetabolites|mesh-ancestor
153692772|NCT00084942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153692773|NCT00084942|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153692774|NCT02968394|Omalizumab|omalizumab|mesh-list
153692775|NCT02968394|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
153692776|NCT02968394|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153692777|NCT02968394|Respiratory System Agents|respiratory system agents|mesh-ancestor
153692778|NCT00199771|Dextrans|dextrans|mesh-list
153692782|NCT00084981|Decitabine|decitabine|mesh-list
153692795|NCT00084981|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153692796|NCT00084981|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153692797|NCT00084981|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153692798|NCT00199966|Valproic Acid|valproic acid|mesh-list
153692799|NCT00199966|Anticonvulsants|anticonvulsants|mesh-ancestor
153692800|NCT00199966|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153692801|NCT00199966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153692802|NCT00199966|GABA Agents|gaba agents|mesh-ancestor
153692803|NCT00199966|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153692804|NCT00199966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153692861|NCT00200473|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153692862|NCT00200473|Vasodilator Agents|vasodilator agents|mesh-ancestor
153692863|NCT00200473|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
153692864|NCT00200473|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
153692865|NCT00200473|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153692866|NCT00200473|Adrenergic Agents|adrenergic agents|mesh-ancestor
153692867|NCT00200473|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153640483|NCT00387374|Antibodies|antibodies|mesh-list
153692868|NCT00200473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153692869|NCT00200473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153692871|NCT02962804|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153692872|NCT02962804|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153692873|NCT02962804|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153692874|NCT02962804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153692875|NCT00048555|Galiximab|galiximab|mesh-list
153692876|NCT00048555|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153692877|NCT00048555|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153692878|NCT00200512|Apomorphine|apomorphine|mesh-list
153692879|NCT00200512|Emetics|emetics|mesh-ancestor
153692880|NCT00200512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153692881|NCT00200512|Autonomic Agents|autonomic agents|mesh-ancestor
153692882|NCT00200512|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153692883|NCT00200512|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153692884|NCT00200512|Dopamine Agonists|dopamine agonists|mesh-ancestor
153692885|NCT00200512|Dopamine Agents|dopamine agents|mesh-ancestor
153692886|NCT00200512|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153692887|NCT00200512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153692888|NCT00200551|Cyclosporine|cyclosporine|mesh-list
153692889|NCT00200551|Mycophenolic Acid|mycophenolic acid|mesh-list
153692890|NCT00200551|Cyclosporins|cyclosporins|mesh-list
153692891|NCT00200551|Antilymphocyte Serum|antilymphocyte serum|mesh-list
153692892|NCT00200551|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153692893|NCT00200551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153692901|NCT00200551|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
153692902|NCT00200551|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153692903|NCT00200551|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153692904|NCT00200551|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
153692905|NCT00200551|Antitubercular Agents|antitubercular agents|mesh-ancestor
153692906|NCT00200551|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153692907|NCT00061256|Vitamin D|vitamin d|mesh-list
153692908|NCT00061256|Alendronate|alendronate|mesh-list
153692910|NCT00061256|Calcium|calcium|mesh-list
153692911|NCT00061256|Vitamins|vitamins|mesh-ancestor
153692912|NCT00061256|Micronutrients|micronutrients|mesh-ancestor
153692913|NCT00061256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153692914|NCT00061256|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153692915|NCT00061256|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153692916|NCT00061256|Antacids|antacids|mesh-ancestor
153462807|NCT04129008|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153692917|NCT00061256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153692919|NCT00200590|Acetaminophen|acetaminophen|mesh-list
153692920|NCT00200590|Morphine|morphine|mesh-list
153692921|NCT00200590|Nalbuphine|nalbuphine|mesh-list
153334026|NCT02979548|Ondansetron|ondansetron|mesh-list
153692922|NCT00200590|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153692923|NCT00200590|Narcotics|narcotics|mesh-ancestor
153692924|NCT00200590|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153692925|NCT00200590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153692926|NCT00200590|Analgesics|analgesics|mesh-ancestor
153692927|NCT00200590|Sensory System Agents|sensory system agents|mesh-ancestor
153692928|NCT00200590|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153692929|NCT00200590|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153692930|NCT00200590|Antipyretics|antipyretics|mesh-ancestor
153692931|NCT00200629|Adenosine|adenosine|mesh-list
153692948|NCT00048594|Autonomic Agents|autonomic agents|mesh-ancestor
153692949|NCT00048594|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153692950|NCT00048594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153692951|NCT00048594|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153692952|NCT00048594|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
153692953|NCT00048594|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153692954|NCT00048594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153692955|NCT00200941|Topiramate|topiramate|mesh-list
153692956|NCT00200941|Anticonvulsants|anticonvulsants|mesh-ancestor
153692957|NCT00200941|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153692958|NCT00200941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153692959|NCT00201253|Dimercaprol|dimercaprol|mesh-list
153692960|NCT00201253|Chelating Agents|chelating agents|mesh-ancestor
153692961|NCT00201253|Sequestering Agents|sequestering agents|mesh-ancestor
153692962|NCT00201253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153641158|NCT00847171|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153693008|NCT00410449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153693009|NCT00410449|Protective Agents|protective agents|mesh-ancestor
153693010|NCT00410449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153693011|NCT00410449|Vitamins|vitamins|mesh-ancestor
153693012|NCT00410449|Micronutrients|micronutrients|mesh-ancestor
153693013|NCT00061451|Gemcitabine|gemcitabine|mesh-list
153693014|NCT00061451|Pemetrexed|pemetrexed|mesh-list
153693015|NCT00061451|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153693016|NCT00061451|Antimetabolites|antimetabolites|mesh-ancestor
153693017|NCT00061451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153693018|NCT00061451|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153693019|NCT00061451|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153693020|NCT00061451|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153693021|NCT00061451|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153693022|NCT00410527|Meropenem|meropenem|mesh-list
153693023|NCT00410527|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153693024|NCT00410527|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153693025|NCT00048750|Micafungin|micafungin|mesh-list
153693026|NCT00048750|Antifungal Agents|antifungal agents|mesh-ancestor
153693027|NCT00048750|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153693028|NCT00221416|Aripiprazole|aripiprazole|mesh-list
153693029|NCT00221416|Antidepressive Agents|antidepressive agents|mesh-ancestor
153693030|NCT00221416|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153693031|NCT00221416|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153693032|NCT00221416|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153641511|NCT00276250|Abatacept|abatacept|mesh-list
153693033|NCT00221416|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153693034|NCT00221416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153693035|NCT00221416|Dopamine Agonists|dopamine agonists|mesh-ancestor
153693036|NCT00221416|Dopamine Agents|dopamine agents|mesh-ancestor
153693037|NCT00221416|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153693038|NCT00221416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153693046|NCT00221494|Pindolol|pindolol|mesh-list
153693051|NCT00221494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153334057|NCT04393610|Anesthetics|anesthetics|mesh-ancestor
153334068|NCT04393610|Narcotics|narcotics|mesh-ancestor
153693052|NCT00221494|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153693054|NCT00221494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153693055|NCT00221494|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
153693056|NCT00221494|Antidepressive Agents|antidepressive agents|mesh-ancestor
153693057|NCT00221494|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153693058|NCT00221494|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
153693059|NCT00221494|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
153693060|NCT00221494|Adrenergic Agents|adrenergic agents|mesh-ancestor
153693061|NCT00221494|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153693062|NCT00221494|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153693063|NCT00221494|Vasodilator Agents|vasodilator agents|mesh-ancestor
153693065|NCT00221611|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
153693066|NCT00221611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153693067|NCT00221611|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
153693068|NCT00221611|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153693069|NCT00221611|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
153693070|NCT00221611|GABA Agonists|gaba agonists|mesh-ancestor
153693071|NCT00221611|GABA Agents|gaba agents|mesh-ancestor
153693072|NCT00221611|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153693073|NCT00221611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153693074|NCT00221650|Ribavirin|ribavirin|mesh-list
153693075|NCT00221650|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
153693077|NCT00221650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153693078|NCT00221650|Antiviral Agents|antiviral agents|mesh-ancestor
153693079|NCT00221650|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153693080|NCT00221689|Baclofen|baclofen|mesh-list
153693081|NCT00221689|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
153693095|NCT02968121|Dopamine Agonists|dopamine agonists|mesh-ancestor
153693096|NCT02968121|Dopamine Agents|dopamine agents|mesh-ancestor
153693097|NCT00412789|Epothilone B|epothilone b|mesh-list
153693098|NCT00412789|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153693099|NCT00412789|Tubulin Modulators|tubulin modulators|mesh-ancestor
153693100|NCT00412789|Antimitotic Agents|antimitotic agents|mesh-ancestor
153693101|NCT00412789|Mitosis Modulators|mitosis modulators|mesh-ancestor
153693102|NCT00412789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153693103|NCT00048828|Olanzapine|olanzapine|mesh-list
153693104|NCT00048828|Clozapine|clozapine|mesh-list
153693105|NCT00048828|Antiemetics|antiemetics|mesh-ancestor
153693106|NCT00048828|Autonomic Agents|autonomic agents|mesh-ancestor
153693107|NCT00048828|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153693157|NCT00221962|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
153693158|NCT00221962|Serotonin Agents|serotonin agents|mesh-ancestor
153693159|NCT00221962|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
153693160|NCT00221962|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153693161|NCT00221962|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
153693162|NCT00221962|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
153693164|NCT02968160|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
153693165|NCT02968160|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153693166|NCT02968160|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153693167|NCT02968160|Antimetabolites|antimetabolites|mesh-ancestor
153693221|NCT00222547|Tubulin Modulators|tubulin modulators|mesh-ancestor
153693222|NCT00222547|Antimitotic Agents|antimitotic agents|mesh-ancestor
153530185|NCT01489566|Mitomycin|mitomycin|mesh-list
153693224|NCT00086034|Motexafin gadolinium|motexafin gadolinium|mesh-list
153693225|NCT00086034|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153693226|NCT00086034|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
153693227|NCT00086034|Dermatologic Agents|dermatologic agents|mesh-ancestor
153693228|NCT02968082|Scopolamine|scopolamine|mesh-list
153463121|NCT02952222|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153693229|NCT02968082|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
153693230|NCT02968082|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153693231|NCT02968082|Antiemetics|antiemetics|mesh-ancestor
153693232|NCT02968082|Autonomic Agents|autonomic agents|mesh-ancestor
153693233|NCT02968082|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153693234|NCT02968082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153693235|NCT02968082|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153693281|NCT00061763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153693282|NCT00223054|Cyclosporine|cyclosporine|mesh-list
153693283|NCT00223054|Sirolimus|sirolimus|mesh-list
153693284|NCT00223054|Everolimus|everolimus|mesh-list
153693285|NCT00223054|Tacrolimus|tacrolimus|mesh-list
153693286|NCT00223054|Cyclosporins|cyclosporins|mesh-list
153693287|NCT00223054|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153693288|NCT00223054|Immunologic Factors|immunologic factors|mesh-ancestor
153693289|NCT00223054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153693290|NCT00223054|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
153693291|NCT00223054|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153693292|NCT00223054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153693293|NCT00223054|Antifungal Agents|antifungal agents|mesh-ancestor
153693294|NCT00223054|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153693295|NCT00223054|Dermatologic Agents|dermatologic agents|mesh-ancestor
153693341|NCT00085449|Fludarabine phosphate|fludarabine phosphate|mesh-list
153693342|NCT00085449|Melphalan|melphalan|mesh-list
153693343|NCT00085449|Alemtuzumab|alemtuzumab|mesh-list
153693344|NCT00085449|Cyclosporins|cyclosporins|mesh-list
153693345|NCT00085449|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153693346|NCT00085449|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153693347|NCT00085449|Antimetabolites|antimetabolites|mesh-ancestor
153693348|NCT00085449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153693349|NCT00085449|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153334091|NCT03820466|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153334092|NCT03820466|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153334093|NCT03820466|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153334094|NCT03820466|Antipyretics|antipyretics|mesh-ancestor
153334095|NCT03820466|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153334096|NCT03820466|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153334098|NCT03820466|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153334099|NCT03820466|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
153334100|NCT03826004|Clemastine|clemastine|mesh-list
153334101|NCT03826004|Antipruritics|antipruritics|mesh-ancestor
153334102|NCT03826004|Dermatologic Agents|dermatologic agents|mesh-ancestor
153886025|NCT02893280|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153886026|NCT02893280|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153886027|NCT02893280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153427029|NCT00001940|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
153427030|NCT03907033|Bupivacaine|bupivacaine|mesh-list
153427031|NCT03907033|Anesthetics, Local|anesthetics, local|mesh-ancestor
153693350|NCT00085449|Immunologic Factors|immunologic factors|mesh-ancestor
153693351|NCT00085449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153693352|NCT00085449|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153693353|NCT00085449|Antifungal Agents|antifungal agents|mesh-ancestor
153693354|NCT00085449|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153693355|NCT00085449|Dermatologic Agents|dermatologic agents|mesh-ancestor
153693356|NCT00085449|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153693357|NCT00085449|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
153693358|NCT00085449|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153642695|NCT00006155|Carboplatin|carboplatin|mesh-list
153693359|NCT00085449|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
153693360|NCT00085449|Antitubercular Agents|antitubercular agents|mesh-ancestor
153693361|NCT00085449|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153693362|NCT00085449|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153693363|NCT00085449|Alkylating Agents|alkylating agents|mesh-ancestor
153693364|NCT00085449|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153693379|NCT00223717|Aspirin|aspirin|mesh-list
153693395|NCT00223717|Nitroglycerin|nitroglycerin|mesh-list
153693396|NCT00223717|Dipyridamole|dipyridamole|mesh-list
153693397|NCT00223717|Carbidopa|carbidopa|mesh-list
153693398|NCT00223717|Aspirin, Dipyridamole Drug Combination|aspirin, dipyridamole drug combination|mesh-list
153693399|NCT00223717|Tamsulosin|tamsulosin|mesh-list
153693400|NCT00223717|Aliskiren|aliskiren|mesh-list
153693401|NCT00223717|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153693402|NCT00223717|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153693403|NCT00223717|Analgesics|analgesics|mesh-ancestor
153693404|NCT00223717|Sensory System Agents|sensory system agents|mesh-ancestor
153693405|NCT00223717|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153693406|NCT00223717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153693407|NCT00223717|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153693408|NCT00223717|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153693409|NCT00223717|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153693410|NCT00223717|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153693411|NCT00223717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153693412|NCT00223717|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153693413|NCT00223717|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153693414|NCT00223717|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153693415|NCT00223717|Antipyretics|antipyretics|mesh-ancestor
153693416|NCT00223717|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153693417|NCT00223717|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153693418|NCT00223717|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
153693419|NCT00223717|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
153693420|NCT00223717|Vasodilator Agents|vasodilator agents|mesh-ancestor
153693421|NCT00223717|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
153693422|NCT00223717|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
153693438|NCT00223717|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
153693439|NCT00223717|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
153693440|NCT00223717|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
153693441|NCT00223717|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
153693442|NCT00223717|Dopamine Agents|dopamine agents|mesh-ancestor
153693443|NCT00223717|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
153693444|NCT00223717|Renin Inhibitors|renin inhibitors|mesh-ancestor
153693445|NCT00223717|Protease Inhibitors|protease inhibitors|mesh-ancestor
153693446|NCT00223717|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153693447|NCT00223717|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153693448|NCT00223717|Tocolytic Agents|tocolytic agents|mesh-ancestor
153693449|NCT00223717|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153693450|NCT00223717|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
153334103|NCT03826004|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
153693452|NCT00223717|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153693497|NCT00224146|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
153693498|NCT00224146|Cholinergic Agents|cholinergic agents|mesh-ancestor
153693499|NCT00224146|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153693500|NCT00224146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153693501|NCT00224146|Urological Agents|urological agents|mesh-ancestor
153693502|NCT00061997|Inositol|inositol|mesh-list
153693503|NCT00061997|Vitamin B Complex|vitamin b complex|mesh-ancestor
153693504|NCT00061997|Vitamins|vitamins|mesh-ancestor
153693505|NCT00061997|Micronutrients|micronutrients|mesh-ancestor
153693506|NCT00061997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153693507|NCT00224185|Dimercaprol|dimercaprol|mesh-list
153693508|NCT00224185|Chelating Agents|chelating agents|mesh-ancestor
153693509|NCT00224185|Sequestering Agents|sequestering agents|mesh-ancestor
153693510|NCT00224185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153693511|NCT00062036|Aldesleukin|aldesleukin|mesh-list
153693512|NCT00062036|Cyclophosphamide|cyclophosphamide|mesh-list
153693513|NCT00062036|Fludarabine|fludarabine|mesh-list
153693514|NCT00062036|Fludarabine phosphate|fludarabine phosphate|mesh-list
153693515|NCT00062036|Interleukin-2|interleukin-2|mesh-list
153693516|NCT00062036|Freund's Adjuvant|freund's adjuvant|mesh-list
153463377|NCT01455870|Exenatide|exenatide|mesh-list
153693517|NCT00062036|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153693518|NCT00062036|Immunologic Factors|immunologic factors|mesh-ancestor
153693519|NCT00062036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153693520|NCT00062036|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153693521|NCT00062036|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153693522|NCT00062036|Alkylating Agents|alkylating agents|mesh-ancestor
153693523|NCT00062036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153693524|NCT00062036|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153693525|NCT00062036|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153693526|NCT00062036|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153643225|NCT04728880|Remdesivir|remdesivir|mesh-list
153693542|NCT00224302|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153693543|NCT00224302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153693544|NCT00224302|Analgesics|analgesics|mesh-ancestor
153693545|NCT00224302|Sensory System Agents|sensory system agents|mesh-ancestor
153693546|NCT00224302|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153693547|NCT00224302|Antidepressive Agents|antidepressive agents|mesh-ancestor
153693548|NCT00224302|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153693549|NCT00224302|Dopamine Agents|dopamine agents|mesh-ancestor
153693551|NCT00062075|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153693552|NCT00062075|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153693553|NCT00062075|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
153693554|NCT00062075|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153693555|NCT00062075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153693556|NCT00224419|Nicotine|nicotine|mesh-list
153693601|NCT00095082|Insulin Aspart|insulin aspart|mesh-list
153693602|NCT00095082|Insulin Detemir|insulin detemir|mesh-list
153693603|NCT00095082|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153693604|NCT00095082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153693605|NCT00062231|Amoxicillin|amoxicillin|mesh-list
153783177|NCT00235820|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153334133|NCT01222195|Growth Inhibitors|growth inhibitors|mesh-ancestor
153693606|NCT00062231|Moxifloxacin|moxifloxacin|mesh-list
153693607|NCT00062231|Ciprofloxacin|ciprofloxacin|mesh-list
153693608|NCT00062231|Clavulanic Acid|clavulanic acid|mesh-list
153693609|NCT00062231|Clavulanic Acids|clavulanic acids|mesh-list
153693610|NCT00062231|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
153693611|NCT00062231|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
153693612|NCT00062231|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153693613|NCT00062231|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153693614|NCT00062231|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153693615|NCT00062231|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153693616|NCT00062231|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153693618|NCT00062231|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153693657|NCT00224809|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153693658|NCT00224809|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153693659|NCT00224809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153693660|NCT00224809|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153693661|NCT00224809|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153693662|NCT00224809|Antipyretics|antipyretics|mesh-ancestor
153643513|NCT00094978|Alvocidib|alvocidib|mesh-list
153693663|NCT00224809|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
153693664|NCT00224809|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
153693665|NCT00224809|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
153693666|NCT00224809|Purinergic Agents|purinergic agents|mesh-ancestor
153693667|NCT00224809|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153693668|NCT00224809|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
153693669|NCT00224809|Hormone Antagonists|hormone antagonists|mesh-ancestor
153693670|NCT00224809|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153914704|NCT00609544|Rilonacept|rilonacept|mesh-list
153693671|NCT00224809|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
153693672|NCT00224809|Diuretics|diuretics|mesh-ancestor
153693673|NCT00224809|Natriuretic Agents|natriuretic agents|mesh-ancestor
153643713|NCT00006275|Vitamins|vitamins|mesh-ancestor
153693674|NCT00224809|Protease Inhibitors|protease inhibitors|mesh-ancestor
153693675|NCT00062270|Gemcitabine|gemcitabine|mesh-list
153693676|NCT00062270|Docetaxel|docetaxel|mesh-list
153693677|NCT00062270|Gefitinib|gefitinib|mesh-list
153693678|NCT00062270|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153693709|NCT00413179|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153693710|NCT00413179|Fertility Agents, Female|fertility agents, female|mesh-ancestor
153693711|NCT00413179|Fertility Agents|fertility agents|mesh-ancestor
153693712|NCT00413179|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153693713|NCT00413179|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
153693714|NCT00413179|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
153693715|NCT00413257|Nefopam|nefopam|mesh-list
153693716|NCT00413257|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153693717|NCT00413257|Analgesics|analgesics|mesh-ancestor
153693718|NCT00413257|Sensory System Agents|sensory system agents|mesh-ancestor
153693719|NCT00413257|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153693720|NCT00413257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153693721|NCT00095316|Caspofungin|caspofungin|mesh-list
153693722|NCT00095316|Antifungal Agents|antifungal agents|mesh-ancestor
153693723|NCT00095316|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153693724|NCT00095316|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153643881|NCT00390273|Metformin|metformin|mesh-list
153693725|NCT00095316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153693726|NCT00225043|Phenylephrine|phenylephrine|mesh-list
153693727|NCT00225043|Epinephrine|epinephrine|mesh-list
153693728|NCT00225043|Oxymetazoline|oxymetazoline|mesh-list
153693729|NCT00225043|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153693730|NCT00225043|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153693731|NCT00225043|Adrenergic Agents|adrenergic agents|mesh-ancestor
153693732|NCT00225043|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153693733|NCT00225043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153693734|NCT00225043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153693735|NCT00225043|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
153693736|NCT00225043|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153693737|NCT00225043|Autonomic Agents|autonomic agents|mesh-ancestor
153693738|NCT00225043|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153693739|NCT00225043|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153693741|NCT00225043|Mydriatics|mydriatics|mesh-ancestor
153693749|NCT00225121|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153693750|NCT00225121|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153693752|NCT00225121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153693753|NCT00095355|Valproic Acid|valproic acid|mesh-list
153693754|NCT00095355|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153693755|NCT00095355|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153693756|NCT00095355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153693757|NCT00095355|Antimanic Agents|antimanic agents|mesh-ancestor
153693758|NCT00095355|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153693759|NCT00095355|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153693760|NCT00095355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153693761|NCT00095355|Anticonvulsants|anticonvulsants|mesh-ancestor
153693763|NCT00095355|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153693764|NCT00225160|Acetylcarnitine|acetylcarnitine|mesh-list
153693765|NCT00225160|Vitamin B Complex|vitamin b complex|mesh-ancestor
153693766|NCT00225160|Vitamins|vitamins|mesh-ancestor
153693767|NCT00225160|Micronutrients|micronutrients|mesh-ancestor
153693768|NCT00225160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153693769|NCT00225160|Nootropic Agents|nootropic agents|mesh-ancestor
153693770|NCT00225238|Esomeprazole|esomeprazole|mesh-list
153693803|NCT00095433|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153693804|NCT00095433|Growth Substances|growth substances|mesh-ancestor
153693805|NCT00095433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153693806|NCT00095433|Growth Inhibitors|growth inhibitors|mesh-ancestor
153693807|NCT00095433|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153693808|NCT00225355|Rosiglitazone|rosiglitazone|mesh-list
153693809|NCT00225355|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153693810|NCT00225355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153693811|NCT00225433|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
153693813|NCT00225433|Hormones|hormones|mesh-ancestor
153693814|NCT00225433|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153693815|NCT00225433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153693816|NCT00225433|Hormone Antagonists|hormone antagonists|mesh-ancestor
153693817|NCT00095472|omega-N-Methylarginine|omega-n-methylarginine|mesh-list
153693818|NCT00095472|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153693819|NCT00095472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153693820|NCT02962258|Amlodipine|amlodipine|mesh-list
153693857|NCT00095511|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153693858|NCT00095511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153693859|NCT00095511|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
153693860|NCT00095511|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
153693861|NCT00095511|Serotonin Agents|serotonin agents|mesh-ancestor
153693862|NCT00095511|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
153693863|NCT00095511|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153693864|NCT00095511|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
153693865|NCT00095511|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
153693866|NCT00225589|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
153693867|NCT00225589|Calcium|calcium|mesh-list
153693868|NCT00225589|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153693869|NCT00225589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153693870|NCT00225589|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153693871|NCT00225589|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153693872|NCT00225589|Antimetabolites|antimetabolites|mesh-ancestor
153693874|NCT00225589|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153693913|NCT00225862|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153693914|NCT00225862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153693915|NCT00225862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153693916|NCT00095706|Bevacizumab|bevacizumab|mesh-list
153693917|NCT00095706|Trastuzumab|trastuzumab|mesh-list
153693918|NCT00095706|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153693919|NCT00095706|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153693920|NCT00095706|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153693921|NCT00095706|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153693922|NCT00095706|Growth Substances|growth substances|mesh-ancestor
153693923|NCT00095706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153693924|NCT00095706|Growth Inhibitors|growth inhibitors|mesh-ancestor
153693925|NCT00225901|Mitogens|mitogens|mesh-list
153693926|NCT00225901|Mitosis Modulators|mitosis modulators|mesh-ancestor
153693927|NCT00225901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153693928|NCT00225979|Octreotide|octreotide|mesh-list
153693972|NCT00226096|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
153693973|NCT00226096|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
153693974|NCT00226096|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
153693975|NCT00226096|Adrenergic Agents|adrenergic agents|mesh-ancestor
153693976|NCT00226096|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153693977|NCT00226096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153693979|NCT00226096|Sensory System Agents|sensory system agents|mesh-ancestor
153693980|NCT00226096|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
153693981|NCT00226096|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153693982|NCT00226096|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153693983|NCT00226096|Vasodilator Agents|vasodilator agents|mesh-ancestor
153693984|NCT00226096|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
153693985|NCT00226096|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
153693986|NCT00226096|Protective Agents|protective agents|mesh-ancestor
153693987|NCT00226096|Sympathomimetics|sympathomimetics|mesh-ancestor
153693988|NCT00226096|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
153693989|NCT00226096|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
153693990|NCT00226096|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153693991|NCT00226096|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153693992|NCT00226096|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153693993|NCT00226096|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
153693994|NCT00226096|Serotonin Agents|serotonin agents|mesh-ancestor
153693995|NCT00226096|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
153693996|NCT00226096|Protease Inhibitors|protease inhibitors|mesh-ancestor
153693997|NCT00226096|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153694095|NCT00226564|Sensory System Agents|sensory system agents|mesh-ancestor
153694096|NCT00226564|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153694097|NCT00226564|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153694098|NCT00226564|Anesthetics, General|anesthetics, general|mesh-ancestor
153694100|NCT00062699|Calcitriol|calcitriol|mesh-list
153694101|NCT00062699|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153694102|NCT00062699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153694103|NCT00062699|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
153694104|NCT00062699|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153694105|NCT00062699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153694107|NCT00062699|Vitamins|vitamins|mesh-ancestor
153694108|NCT00062699|Micronutrients|micronutrients|mesh-ancestor
153694109|NCT00062699|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153694110|NCT00226798|Capecitabine|capecitabine|mesh-list
153694111|NCT00226798|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153694112|NCT00226798|Antimetabolites|antimetabolites|mesh-ancestor
153694113|NCT00226798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153694114|NCT00226798|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153694115|NCT00399243|Sumatriptan|sumatriptan|mesh-list
153694116|NCT00399243|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
153463494|NCT01893294|Gemcitabine|gemcitabine|mesh-list
153694117|NCT00399243|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
153694118|NCT00399243|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
153694120|NCT00399243|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153694123|NCT00226837|Nitrous Oxide|nitrous oxide|mesh-list
153694141|NCT00226915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153694143|NCT00095862|Interferon-alpha|interferon-alpha|mesh-list
153694144|NCT00095862|Cyclophosphamide|cyclophosphamide|mesh-list
153694145|NCT00095862|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153694146|NCT00095862|Immunologic Factors|immunologic factors|mesh-ancestor
153694147|NCT00095862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153694148|NCT00095862|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153694149|NCT00095862|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153694150|NCT00095862|Alkylating Agents|alkylating agents|mesh-ancestor
153694151|NCT00095862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153694152|NCT00095862|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153694153|NCT00095862|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153694154|NCT00095862|Antiviral Agents|antiviral agents|mesh-ancestor
153694155|NCT00095862|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153694156|NCT00226954|Zoledronic Acid|zoledronic acid|mesh-list
153694157|NCT00226954|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153694158|NCT00226954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153694159|NCT00227032|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
153694160|NCT00227032|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153694161|NCT00227032|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153694162|NCT00227032|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153694163|NCT00227032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153694164|NCT00227032|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153694165|NCT00095901|Capecitabine|capecitabine|mesh-list
153694166|NCT00095901|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153694167|NCT00095901|Antimetabolites|antimetabolites|mesh-ancestor
153334244|NCT02965976|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
153694168|NCT00095901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153694169|NCT00095901|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153694184|NCT00227461|Nootropic Agents|nootropic agents|mesh-ancestor
153694185|NCT00227500|Pravastatin|pravastatin|mesh-list
153694186|NCT00227500|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153694187|NCT00227500|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153694188|NCT00227500|Antimetabolites|antimetabolites|mesh-ancestor
153694189|NCT00227500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153914824|NCT04298775|Morphine|morphine|mesh-list
153694190|NCT00227500|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153694191|NCT00227500|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
153694192|NCT00227500|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153694193|NCT00096096|Mycophenolic Acid|mycophenolic acid|mesh-list
153694194|NCT00096096|Tacrolimus|tacrolimus|mesh-list
153531162|NCT01495104|Valproic Acid|valproic acid|mesh-list
153694195|NCT00096096|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153694196|NCT00096096|Immunologic Factors|immunologic factors|mesh-ancestor
153694197|NCT00096096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153694198|NCT00096096|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
153694199|NCT00096096|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153694200|NCT00096096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153694201|NCT00096096|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153694202|NCT00096096|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153694203|NCT00096096|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
153694204|NCT00096096|Antitubercular Agents|antitubercular agents|mesh-ancestor
153694205|NCT00096096|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153694206|NCT00096096|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153694208|NCT04721899|Vitamins|vitamins|mesh-ancestor
153694209|NCT04721899|Micronutrients|micronutrients|mesh-ancestor
153694210|NCT04721899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153694211|NCT04721899|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153694213|NCT00062972|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
153694214|NCT00062972|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153694216|NCT00062972|Cholinergic Agents|cholinergic agents|mesh-ancestor
153694225|NCT00227656|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153694226|NCT00227656|Antimetabolites|antimetabolites|mesh-ancestor
153694227|NCT00227656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153694228|NCT00227656|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153694229|NCT00227656|Antiviral Agents|antiviral agents|mesh-ancestor
153694230|NCT00227656|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153694231|NCT00227656|Immunologic Factors|immunologic factors|mesh-ancestor
153694232|NCT00227656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153694233|NCT00227695|Rituximab|rituximab|mesh-list
153694234|NCT00227695|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153694235|NCT00227695|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153694236|NCT00227695|Immunologic Factors|immunologic factors|mesh-ancestor
153694237|NCT00227695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153694238|NCT00227695|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153694240|NCT00227734|Oxaliplatin|oxaliplatin|mesh-list
153694241|NCT00227734|Cetuximab|cetuximab|mesh-list
153694242|NCT00227734|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153694280|NCT00096291|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
153694281|NCT00096291|Doxorubicin|doxorubicin|mesh-list
153694282|NCT00096291|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
153694283|NCT00096291|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153694284|NCT00096291|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153694285|NCT00096291|Tubulin Modulators|tubulin modulators|mesh-ancestor
153694286|NCT00096291|Antimitotic Agents|antimitotic agents|mesh-ancestor
153694287|NCT00096291|Mitosis Modulators|mitosis modulators|mesh-ancestor
153694288|NCT00096291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153694289|NCT00096291|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153694346|NCT00228046|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153645862|NCT00112138|Anticonvulsants|anticonvulsants|mesh-ancestor
153694347|NCT00228046|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153694350|NCT00063089|gamma-Globulins|gamma-globulins|mesh-list
153694351|NCT00063089|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
153694352|NCT00063089|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
153694353|NCT00063089|Immunologic Factors|immunologic factors|mesh-ancestor
153694354|NCT00063089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153694355|NCT00228163|Teriflunomide|teriflunomide|mesh-list
153694356|NCT00228163|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153694357|NCT00228163|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153694411|NCT00228358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153694412|NCT00228358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153694413|NCT00228358|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153694414|NCT00228358|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153694415|NCT00228358|Analgesics|analgesics|mesh-ancestor
153694416|NCT00228358|Sensory System Agents|sensory system agents|mesh-ancestor
153694417|NCT00228358|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153694418|NCT00228358|Immunoconjugates|immunoconjugates|mesh-ancestor
153694419|NCT00228397|Temsirolimus|temsirolimus|mesh-list
153694420|NCT00228397|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
153694421|NCT00228397|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153694422|NCT00228397|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153694423|NCT00228397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153694424|NCT00228397|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153694425|NCT00228397|Immunologic Factors|immunologic factors|mesh-ancestor
153694426|NCT00228397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153694427|NCT00228397|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153694469|NCT00075621|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153694470|NCT00228865|Insulin|insulin|mesh-list
153694471|NCT00228865|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
153694472|NCT00228865|Insulin, Isophane|insulin, isophane|mesh-list
153694473|NCT00228865|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153694474|NCT00228865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153694475|NCT00228904|Insulin|insulin|mesh-list
153694476|NCT00228904|Insulin Lispro|insulin lispro|mesh-list
153694477|NCT00228904|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
153694478|NCT00228904|Insulin Aspart|insulin aspart|mesh-list
153694479|NCT00228904|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153694480|NCT00228904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153694481|NCT00228982|Vancomycin|vancomycin|mesh-list
153694482|NCT00228982|Ceftobiprole|ceftobiprole|mesh-list
153694483|NCT00228982|Ceftobiprole medocaril|ceftobiprole medocaril|mesh-list
153694484|NCT00228982|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153694485|NCT00228982|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153694486|NCT00229060|Doripenem|doripenem|mesh-list
153694487|NCT00229060|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153694488|NCT00229060|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153694489|NCT00229138|Tacrolimus|tacrolimus|mesh-list
153694490|NCT00229138|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153694491|NCT00229138|Immunologic Factors|immunologic factors|mesh-ancestor
153694492|NCT00229138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153694493|NCT00229138|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
153694494|NCT00229138|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153694495|NCT00229138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153694496|NCT00063323|Bupropion|bupropion|mesh-list
153694497|NCT00063323|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
153694498|NCT00063323|Antidepressive Agents|antidepressive agents|mesh-ancestor
153694499|NCT00063323|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153694504|NCT00063323|Dopamine Agents|dopamine agents|mesh-ancestor
153694513|NCT00229216|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153694514|NCT00229216|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153694515|NCT00229216|Antitrichomonal Agents|antitrichomonal agents|mesh-ancestor
153694516|NCT00229216|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153694517|NCT00229216|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153694519|NCT02967653|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153694520|NCT02967653|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153694522|NCT02967653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153694523|NCT02967653|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153694524|NCT02967653|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
153694525|NCT02967653|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153694526|NCT00229333|Escitalopram|escitalopram|mesh-list
153694527|NCT00229333|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
153694528|NCT00229333|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153694529|NCT00229333|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153694530|NCT00229333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153694531|NCT00229333|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153694532|NCT00229333|Serotonin Agents|serotonin agents|mesh-ancestor
153694533|NCT00229333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153694563|NCT00075699|Alkylating Agents|alkylating agents|mesh-ancestor
153694564|NCT00075699|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153694565|NCT00075699|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153694566|NCT00229567|Lidocaine|lidocaine|mesh-list
153694567|NCT00229567|Ketamine|ketamine|mesh-list
153694568|NCT00229567|Anesthetics, Local|anesthetics, local|mesh-ancestor
153694569|NCT00229567|Anesthetics|anesthetics|mesh-ancestor
153694570|NCT00229567|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153694571|NCT00229567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153694572|NCT00229567|Sensory System Agents|sensory system agents|mesh-ancestor
153694573|NCT00229567|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153694574|NCT00229567|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153694575|NCT00229567|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
153694576|NCT00229567|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153694577|NCT00229567|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153694578|NCT00229567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153694580|NCT00229567|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
153694593|NCT02967341|Ciprofloxacin|ciprofloxacin|mesh-list
153694619|NCT00413608|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153694620|NCT00413608|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
153694621|NCT00413608|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
153694622|NCT00413608|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
153694623|NCT00413608|Purinergic Agents|purinergic agents|mesh-ancestor
153694624|NCT00413608|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153694625|NCT00413608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153694626|NCT00413608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153694627|NCT00229918|Triamcinolone|triamcinolone|mesh-list
153694628|NCT00229918|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
153694629|NCT00229918|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
153694630|NCT00229918|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
153694631|NCT00229918|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153694632|NCT00229918|Glucocorticoids|glucocorticoids|mesh-ancestor
153694678|NCT00230035|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153694679|NCT00230035|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153694680|NCT00230035|Antimetabolites|antimetabolites|mesh-ancestor
153694681|NCT00230035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153694682|NCT00230035|Dermatologic Agents|dermatologic agents|mesh-ancestor
153694683|NCT00230035|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153694684|NCT00230035|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153694685|NCT00230035|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153694686|NCT00230035|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153694687|NCT00230035|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
153694688|NCT00230035|Antitubercular Agents|antitubercular agents|mesh-ancestor
153694741|NCT00230542|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153694742|NCT00230542|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153694743|NCT00230542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153694744|NCT00230542|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153694745|NCT00230542|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153694746|NCT00063479|Zoledronic Acid|zoledronic acid|mesh-list
153694747|NCT00063479|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153694748|NCT00063479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153694749|NCT00097032|Risperidone|risperidone|mesh-list
153694750|NCT00097032|Quetiapine Fumarate|quetiapine fumarate|mesh-list
153694751|NCT00097032|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153694752|NCT00097032|Serotonin Agents|serotonin agents|mesh-ancestor
153694753|NCT00097032|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153694754|NCT00097032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153694755|NCT00097032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153694756|NCT00097032|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153694757|NCT00097032|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153694758|NCT00097032|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153694759|NCT00097032|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153694794|NCT00075738|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153694795|NCT00075738|Antidotes|antidotes|mesh-ancestor
153694796|NCT00075738|Protective Agents|protective agents|mesh-ancestor
153334356|NCT04124822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153334357|NCT04124822|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153694797|NCT00075738|Vitamin B Complex|vitamin b complex|mesh-ancestor
153694799|NCT00075738|Micronutrients|micronutrients|mesh-ancestor
153694800|NCT00230698|Topiramate|topiramate|mesh-list
153694801|NCT00230698|Anticonvulsants|anticonvulsants|mesh-ancestor
153694802|NCT00230698|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153694803|NCT00230698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153694804|NCT00230776|Pregabalin|pregabalin|mesh-list
153694805|NCT00230776|Analgesics|analgesics|mesh-ancestor
153694806|NCT00230776|Sensory System Agents|sensory system agents|mesh-ancestor
153694809|NCT00230776|Anticonvulsants|anticonvulsants|mesh-ancestor
153694859|NCT02967380|Protective Agents|protective agents|mesh-ancestor
153694860|NCT02967380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153694861|NCT02967380|Chelating Agents|chelating agents|mesh-ancestor
153694862|NCT02967380|Sequestering Agents|sequestering agents|mesh-ancestor
153694863|NCT02967380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153694864|NCT02967380|Iron Chelating Agents|iron chelating agents|mesh-ancestor
153781922|NCT00259662|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
153781923|NCT00259662|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153531888|NCT01499446|Xhance|xhance|mesh-list
153694865|NCT00075855|Testosterone|testosterone|mesh-list
153694866|NCT00075855|Androgens|androgens|mesh-ancestor
153694868|NCT00075855|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153694869|NCT00075855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153694870|NCT00063596|Vitamin A|vitamin a|mesh-list
153694871|NCT00063596|Vitamins|vitamins|mesh-ancestor
153694872|NCT00063596|Micronutrients|micronutrients|mesh-ancestor
153694873|NCT00063596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153694874|NCT00231244|Sirolimus|sirolimus|mesh-list
153694875|NCT00231244|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153694876|NCT00231244|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153694877|NCT00231244|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153694878|NCT00231244|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153694879|NCT00231244|Antifungal Agents|antifungal agents|mesh-ancestor
153694880|NCT00231244|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153694881|NCT00231244|Immunologic Factors|immunologic factors|mesh-ancestor
153694882|NCT00231244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153694887|NCT00231517|Morphine|morphine|mesh-list
153694906|NCT00231595|Anticonvulsants|anticonvulsants|mesh-ancestor
153694907|NCT00231595|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153694908|NCT00231595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153694909|NCT00231634|Topiramate|topiramate|mesh-list
153694910|NCT00231634|Anticonvulsants|anticonvulsants|mesh-ancestor
153694911|NCT00231634|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153694912|NCT00231634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153694974|NCT00097227|Tubulin Modulators|tubulin modulators|mesh-ancestor
153694975|NCT00097227|Antimitotic Agents|antimitotic agents|mesh-ancestor
153694976|NCT00097227|Mitosis Modulators|mitosis modulators|mesh-ancestor
153694977|NCT00097227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153694978|NCT00097227|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153694979|NCT00232336|Quetiapine Fumarate|quetiapine fumarate|mesh-list
153694980|NCT00232336|Antidepressive Agents|antidepressive agents|mesh-ancestor
153694981|NCT00232336|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153694982|NCT00232336|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153694983|NCT00232336|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153694984|NCT00232336|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153694985|NCT00232336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153694986|NCT00232375|Insulin|insulin|mesh-list
153695035|NCT00232531|Nicotinic Acids|nicotinic acids|mesh-list
153695036|NCT00232531|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153695037|NCT00232531|Antimetabolites|antimetabolites|mesh-ancestor
153695038|NCT00232531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153695039|NCT00232531|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153695040|NCT00232531|Vasodilator Agents|vasodilator agents|mesh-ancestor
153695041|NCT00232531|Vitamin B Complex|vitamin b complex|mesh-ancestor
153695042|NCT00232531|Vitamins|vitamins|mesh-ancestor
153695043|NCT00232531|Micronutrients|micronutrients|mesh-ancestor
153695044|NCT00232531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153695045|NCT00232570|Quetiapine Fumarate|quetiapine fumarate|mesh-list
153695046|NCT00232570|Antidepressive Agents|antidepressive agents|mesh-ancestor
153695047|NCT00232570|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153695048|NCT00232570|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153695049|NCT00232570|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153695050|NCT00232570|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153695051|NCT00232570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153695052|NCT00097266|Haloperidol|haloperidol|mesh-list
153695053|NCT00097266|Aripiprazole|aripiprazole|mesh-list
153695054|NCT00097266|Haloperidol decanoate|haloperidol decanoate|mesh-list
153695055|NCT00097266|Antidepressive Agents|antidepressive agents|mesh-ancestor
153695056|NCT00097266|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153695057|NCT00097266|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153695058|NCT00097266|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153695086|NCT00232648|Budesonide|budesonide|mesh-list
153695087|NCT00232648|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153695088|NCT00232648|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153695089|NCT00232648|Autonomic Agents|autonomic agents|mesh-ancestor
153695090|NCT00232648|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153647147|NCT00120367|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153695091|NCT00232648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153695092|NCT00232648|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153695093|NCT00232648|Respiratory System Agents|respiratory system agents|mesh-ancestor
153695094|NCT00232648|Glucocorticoids|glucocorticoids|mesh-ancestor
153695096|NCT00232648|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153695097|NCT00232687|Aripiprazole|aripiprazole|mesh-list
153695098|NCT00232687|Antidepressive Agents|antidepressive agents|mesh-ancestor
153695099|NCT00232687|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153695100|NCT00232687|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153695101|NCT00232687|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153334428|NCT02564952|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153334429|NCT02564952|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
153695102|NCT00232687|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153695103|NCT00232687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153695104|NCT00232687|Dopamine Agonists|dopamine agonists|mesh-ancestor
153695105|NCT00232687|Dopamine Agents|dopamine agents|mesh-ancestor
153695106|NCT00232687|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153695110|NCT00232687|Serotonin Agents|serotonin agents|mesh-ancestor
153695143|NCT02958566|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153695144|NCT02958566|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153695145|NCT02958566|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
153695146|NCT02958566|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153695147|NCT02958566|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153695148|NCT02958566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153695149|NCT02958566|Analgesics|analgesics|mesh-ancestor
153695150|NCT02958566|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
153695151|NCT02958566|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153695152|NCT02958566|Anesthetics, General|anesthetics, general|mesh-ancestor
153695153|NCT02958566|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
153695154|NCT02958566|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
153695155|NCT02958566|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153695156|NCT02958566|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153695157|NCT02958566|Narcotics|narcotics|mesh-ancestor
153695158|NCT02958566|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153695159|NCT02958566|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153695160|NCT02958566|Antipyretics|antipyretics|mesh-ancestor
153695161|NCT02958566|Anticonvulsants|anticonvulsants|mesh-ancestor
153695162|NCT02958566|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153695163|NCT02958566|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153695164|NCT02958566|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153695165|NCT02958566|Antimanic Agents|antimanic agents|mesh-ancestor
153695166|NCT02958566|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153695167|NCT02958566|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153695168|NCT02958566|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153695184|NCT00097344|Toremifene|toremifene|mesh-list
153695191|NCT00097344|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-list
153695192|NCT00097344|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153695193|NCT00097344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153695194|NCT00097344|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153695195|NCT00097344|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
153695196|NCT00097344|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153695197|NCT00097344|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153695198|NCT00097344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153695199|NCT00097344|Hormone Antagonists|hormone antagonists|mesh-ancestor
153695200|NCT00097344|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153695201|NCT00097344|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
153334457|NCT01454804|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153334471|NCT05504382|Naproxen|naproxen|mesh-list
153695202|NCT00097344|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153695203|NCT00232882|Atenolol|atenolol|mesh-list
153695204|NCT00232882|Candesartan|candesartan|mesh-list
153695205|NCT00232882|Candesartan cilexetil|candesartan cilexetil|mesh-list
153695206|NCT00232882|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-list
153695207|NCT00232882|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153695208|NCT00232882|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
153695209|NCT00232882|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
153695210|NCT00232882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153695211|NCT00232882|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153695212|NCT00232882|Sympatholytics|sympatholytics|mesh-ancestor
153695213|NCT00232882|Autonomic Agents|autonomic agents|mesh-ancestor
153695214|NCT00232882|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153695215|NCT00232882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153695216|NCT00232882|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
153695217|NCT00232882|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
153695218|NCT00232882|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
153695219|NCT00232882|Adrenergic Agents|adrenergic agents|mesh-ancestor
153647645|NCT00009204|Dopamine Agents|dopamine agents|mesh-ancestor
153695220|NCT00232882|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153695230|NCT00413686|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153695231|NCT00413686|Antimetabolites|antimetabolites|mesh-ancestor
153695232|NCT00413686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153695233|NCT00413686|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153695234|NCT00233038|Ethanol|ethanol|mesh-list
153695235|NCT00233038|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
153695236|NCT00233038|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153695237|NCT00233038|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153695238|NCT00233038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153695239|NCT00097383|Epirubicin|epirubicin|mesh-list
153695240|NCT00097383|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153695241|NCT00097383|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153695242|NCT00097383|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153695243|NCT00097383|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153695244|NCT00097383|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153695245|NCT00097383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153695246|NCT00233155|Capsaicin|capsaicin|mesh-list
153695247|NCT00233155|Antipruritics|antipruritics|mesh-ancestor
153695248|NCT00233155|Dermatologic Agents|dermatologic agents|mesh-ancestor
153695249|NCT00233155|Sensory System Agents|sensory system agents|mesh-ancestor
153695250|NCT00233155|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153695251|NCT00233155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153695252|NCT00064142|Halofuginone|halofuginone|mesh-list
153695253|NCT00064142|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153695254|NCT00064142|Coccidiostats|coccidiostats|mesh-ancestor
153695255|NCT00064142|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153695256|NCT00064142|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153695257|NCT00064142|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153695258|NCT00064142|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
153695259|NCT00064142|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153695260|NCT00064142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153695261|NCT00064142|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153695262|NCT00064142|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153695271|NCT00064181|Calcium|calcium|mesh-list
153695272|NCT00064181|Levoleucovorin|levoleucovorin|mesh-list
153695273|NCT00064181|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153695274|NCT00064181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153695275|NCT00064181|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153695276|NCT00064181|Antimetabolites|antimetabolites|mesh-ancestor
153695277|NCT00064181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153695278|NCT00064181|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153695279|NCT00064181|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153695280|NCT00064181|Immunologic Factors|immunologic factors|mesh-ancestor
153695281|NCT00064181|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
153695282|NCT00064181|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153695283|NCT00064181|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153695284|NCT00064181|Antidotes|antidotes|mesh-ancestor
153695285|NCT00064181|Protective Agents|protective agents|mesh-ancestor
153695286|NCT00064181|Vitamin B Complex|vitamin b complex|mesh-ancestor
153695288|NCT00064181|Micronutrients|micronutrients|mesh-ancestor
153695289|NCT00064181|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153695290|NCT00064181|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153695291|NCT00064181|Analgesics|analgesics|mesh-ancestor
153695292|NCT00064181|Sensory System Agents|sensory system agents|mesh-ancestor
153695293|NCT00064181|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153695294|NCT00064181|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153695295|NCT00064181|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153695296|NCT00064181|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
153695297|NCT00064181|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153695298|NCT00233545|Miltefosine|miltefosine|mesh-list
153695299|NCT00233545|Antifungal Agents|antifungal agents|mesh-ancestor
153695300|NCT00233545|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153695301|NCT00233545|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153695302|NCT00233545|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153695303|NCT00233545|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153695304|NCT00233584|Budesonide|budesonide|mesh-list
153695305|NCT00233584|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153695306|NCT00233584|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153695307|NCT00233584|Autonomic Agents|autonomic agents|mesh-ancestor
153334535|NCT05563350|Midazolam|midazolam|mesh-list
153334536|NCT05563350|Omeprazole|omeprazole|mesh-list
153334537|NCT05563350|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153334538|NCT05563350|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153695308|NCT00233584|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153695309|NCT00233584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153695310|NCT00233584|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153695311|NCT00233584|Respiratory System Agents|respiratory system agents|mesh-ancestor
153695312|NCT00233584|Glucocorticoids|glucocorticoids|mesh-ancestor
153695313|NCT00233584|Hormones|hormones|mesh-ancestor
153695314|NCT00233584|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153695315|NCT00233623|Leucovorin|leucovorin|mesh-list
153695316|NCT00233623|Fluorouracil|fluorouracil|mesh-list
153695317|NCT00233623|Irinotecan|irinotecan|mesh-list
153695318|NCT00233623|Gefitinib|gefitinib|mesh-list
153695319|NCT00233623|Antimetabolites|antimetabolites|mesh-ancestor
153695320|NCT00233623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153695321|NCT00233623|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153695322|NCT00233623|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153695323|NCT00233623|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153695324|NCT00233623|Immunologic Factors|immunologic factors|mesh-ancestor
153695325|NCT00233623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153695326|NCT00233623|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
153695327|NCT00233623|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153695328|NCT00233623|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153695329|NCT00233623|Antidotes|antidotes|mesh-ancestor
153695330|NCT00233623|Protective Agents|protective agents|mesh-ancestor
153695331|NCT00233623|Vitamin B Complex|vitamin b complex|mesh-ancestor
153695332|NCT00233623|Vitamins|vitamins|mesh-ancestor
153695333|NCT00233623|Micronutrients|micronutrients|mesh-ancestor
153695334|NCT00233623|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153695335|NCT00233623|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153695336|NCT00064220|Soblidotin|soblidotin|mesh-list
153695338|NCT00233779|Sirolimus|sirolimus|mesh-list
153695357|NCT00233818|Antifungal Agents|antifungal agents|mesh-ancestor
153334564|NCT02564718|Protease Inhibitors|protease inhibitors|mesh-ancestor
153334565|NCT02564718|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153334566|NCT02564718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153334567|NCT02564718|Anticoagulants|anticoagulants|mesh-ancestor
153334568|NCT01453946|Budesonide|budesonide|mesh-list
153334569|NCT01453946|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153334570|NCT01453946|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153334571|NCT01453946|Autonomic Agents|autonomic agents|mesh-ancestor
153334572|NCT01453946|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153334573|NCT01453946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153334574|NCT01453946|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153334575|NCT01453946|Respiratory System Agents|respiratory system agents|mesh-ancestor
153334576|NCT01453946|Glucocorticoids|glucocorticoids|mesh-ancestor
153334577|NCT01453946|Hormones|hormones|mesh-ancestor
153334578|NCT01453946|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153334579|NCT01455896|Exenatide|exenatide|mesh-list
153334580|NCT01455896|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
153334581|NCT01455896|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153334582|NCT01455896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153334583|NCT01455896|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
153695358|NCT00233818|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153695359|NCT00233818|Immunologic Factors|immunologic factors|mesh-ancestor
153695360|NCT00233818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153695361|NCT00076206|Temsirolimus|temsirolimus|mesh-list
153695362|NCT00076206|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
153695363|NCT00076206|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153695364|NCT00076206|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153695365|NCT00076206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153695366|NCT00076206|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153695367|NCT00076206|Immunologic Factors|immunologic factors|mesh-ancestor
153695368|NCT00076206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153695369|NCT00076206|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153695370|NCT00233896|Beclomethasone|beclomethasone|mesh-list
153695371|NCT00233896|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153695372|NCT00233896|Glucocorticoids|glucocorticoids|mesh-ancestor
153695373|NCT00233896|Hormones|hormones|mesh-ancestor
153695374|NCT00233896|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153695375|NCT00233896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153695376|NCT00233896|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153695377|NCT00233896|Respiratory System Agents|respiratory system agents|mesh-ancestor
153695378|NCT00233935|Epigallocatechin gallate|epigallocatechin gallate|mesh-list
153695379|NCT00233935|Antioxidants|antioxidants|mesh-ancestor
153695380|NCT00233935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153695381|NCT00233935|Protective Agents|protective agents|mesh-ancestor
153695382|NCT00233935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153695383|NCT00233935|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
153695384|NCT00233935|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
153695385|NCT00233935|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153695386|NCT00233935|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
153695387|NCT00234091|Ritonavir|ritonavir|mesh-list
153695388|NCT00234091|Lopinavir|lopinavir|mesh-list
153695389|NCT00234091|Nelfinavir|nelfinavir|mesh-list
153695390|NCT00234091|Lamivudine|lamivudine|mesh-list
153695391|NCT00234091|Zidovudine|zidovudine|mesh-list
153695392|NCT00234091|Nevirapine|nevirapine|mesh-list
153695398|NCT00234091|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153695399|NCT00234091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153695400|NCT00234091|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153695401|NCT00234091|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153695402|NCT00234091|Antiviral Agents|antiviral agents|mesh-ancestor
153695403|NCT00234091|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153695404|NCT00234091|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
153695405|NCT00234091|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153695406|NCT00234091|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153695407|NCT00234091|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153695408|NCT00234091|Antimetabolites|antimetabolites|mesh-ancestor
153334599|NCT05560542|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153695409|NCT00234091|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
153695410|NCT00234091|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
153695411|NCT00234091|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
153695412|NCT00234091|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
153695413|NCT00234091|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
153695414|NCT04721704|Amoxicillin|amoxicillin|mesh-list
153695415|NCT04721704|Metronidazole|metronidazole|mesh-list
153695416|NCT04721704|Clarithromycin|clarithromycin|mesh-list
153695417|NCT04721704|Omeprazole|omeprazole|mesh-list
153695418|NCT04721704|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153695419|NCT04721704|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153695447|NCT00234403|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153695448|NCT00234403|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153695449|NCT00234403|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153695450|NCT00234403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153334661|NCT03780010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153695451|NCT00064415|Formoterol Fumarate|formoterol fumarate|mesh-list
153695452|NCT00064415|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
153695453|NCT00064415|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153695454|NCT00064415|Autonomic Agents|autonomic agents|mesh-ancestor
153695455|NCT00064415|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153695456|NCT00064415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153695457|NCT00064415|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153695458|NCT00064415|Respiratory System Agents|respiratory system agents|mesh-ancestor
153463828|NCT02983422|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
153695459|NCT00064415|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
153695460|NCT00064415|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
153695461|NCT00064415|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153695462|NCT00064415|Adrenergic Agents|adrenergic agents|mesh-ancestor
153695463|NCT00064415|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153695464|NCT00064415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153695465|NCT00234442|Gefitinib|gefitinib|mesh-list
153695466|NCT00234442|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153695467|NCT00234442|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153695468|NCT00234442|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153695469|NCT00234442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153695470|NCT00234442|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153695471|NCT00076323|Primaquine|primaquine|mesh-list
153695495|NCT00234637|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
153695496|NCT00234637|Protective Agents|protective agents|mesh-ancestor
153695497|NCT00234676|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
153695498|NCT00234676|Estrogens|estrogens|mesh-ancestor
153695499|NCT00234676|Hormones|hormones|mesh-ancestor
153695500|NCT00234676|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153695501|NCT00234676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153695502|NCT00076362|Octreotide|octreotide|mesh-list
153695503|NCT00076362|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153695504|NCT00076362|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153695505|NCT00076362|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153695506|NCT00234871|Verapamil|verapamil|mesh-list
153695507|NCT00234871|Amlodipine|amlodipine|mesh-list
153695508|NCT00234871|Benazepril|benazepril|mesh-list
153695509|NCT00234871|Trandolapril|trandolapril|mesh-list
153695510|NCT00234871|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153695511|NCT00234871|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153695512|NCT00234871|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153695513|NCT00234871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153695514|NCT00234871|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153695515|NCT00234871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153695516|NCT00234871|Vasodilator Agents|vasodilator agents|mesh-ancestor
153695517|NCT00234871|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153695518|NCT00234871|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
153695519|NCT00234871|Protease Inhibitors|protease inhibitors|mesh-ancestor
153695520|NCT00234871|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153695521|NCT00234910|Ritonavir|ritonavir|mesh-list
153334662|NCT03826550|Diclofenac|diclofenac|mesh-list
153695522|NCT00234910|Lopinavir|lopinavir|mesh-list
153695524|NCT00234910|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
153695525|NCT00234910|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
153695526|NCT00234910|Protease Inhibitors|protease inhibitors|mesh-ancestor
153695527|NCT00234910|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153695537|NCT00234949|Cephalexin|cephalexin|mesh-list
153695538|NCT00234949|Cefdinir|cefdinir|mesh-list
153695539|NCT00234949|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153695540|NCT00234949|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153695541|NCT00234949|Third Generation Cephalosporins|third generation cephalosporins|mesh-ancestor
153695542|NCT00234949|Beta Lactam Antibiotics|beta lactam antibiotics|mesh-ancestor
153695543|NCT00234988|Sibutramine|sibutramine|mesh-list
153695544|NCT00234988|Antidepressive Agents|antidepressive agents|mesh-ancestor
153695545|NCT00234988|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153695546|NCT00234988|Appetite Depressants|appetite depressants|mesh-ancestor
153695547|NCT00234988|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
153695548|NCT00400491|Vitamin D|vitamin d|mesh-list
153695549|NCT00400491|Ergocalciferols|ergocalciferols|mesh-list
153695550|NCT00400491|Cholecalciferol|cholecalciferol|mesh-list
153695551|NCT00400491|Vitamins|vitamins|mesh-list
153695552|NCT00400491|Micronutrients|micronutrients|mesh-ancestor
153695553|NCT00400491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153695554|NCT00400491|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153695555|NCT00400491|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153695557|NCT00235105|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
153695558|NCT00235105|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153695559|NCT00235105|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153695560|NCT00235144|Sirolimus|sirolimus|mesh-list
153695561|NCT00235144|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153695562|NCT00235144|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153695563|NCT00235144|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153695564|NCT00235144|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153334673|NCT03826550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153695565|NCT00235144|Antifungal Agents|antifungal agents|mesh-ancestor
153695566|NCT00235144|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153695567|NCT00235144|Immunologic Factors|immunologic factors|mesh-ancestor
153695568|NCT00235144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153695583|NCT00235222|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153695584|NCT00235261|Dexamethasone|dexamethasone|mesh-list
153695585|NCT00235261|Pregabalin|pregabalin|mesh-list
153695586|NCT00235261|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153695587|NCT00235261|Antiemetics|antiemetics|mesh-ancestor
153695588|NCT00235261|Autonomic Agents|autonomic agents|mesh-ancestor
153695589|NCT00235261|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153695590|NCT00235261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153695591|NCT00235261|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153695592|NCT00235261|Glucocorticoids|glucocorticoids|mesh-ancestor
153695593|NCT00235261|Hormones|hormones|mesh-ancestor
153695594|NCT00235261|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153695595|NCT00235261|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153695596|NCT00235261|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153695597|NCT00235261|Analgesics|analgesics|mesh-ancestor
153695598|NCT00235261|Sensory System Agents|sensory system agents|mesh-ancestor
153695599|NCT00235261|Anticonvulsants|anticonvulsants|mesh-ancestor
153695600|NCT00235261|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153695601|NCT00235261|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153695602|NCT00235261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153695603|NCT00235261|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153695604|NCT00235261|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153695605|NCT00235261|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153695606|NCT00235261|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153695607|NCT00235261|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153695608|NCT00235300|Thymoglobulin|thymoglobulin|mesh-list
153695609|NCT00235300|Antilymphocyte Serum|antilymphocyte serum|mesh-list
153695610|NCT00235300|Basiliximab|basiliximab|mesh-list
153695611|NCT00235300|Immunologic Factors|immunologic factors|mesh-ancestor
153695612|NCT00235300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153695613|NCT00235300|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153695614|NCT00064649|Finasteride|finasteride|mesh-list
153695615|NCT00064649|Alfuzosin|alfuzosin|mesh-list
153695616|NCT00064649|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
153695617|NCT00064649|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153695618|NCT00064649|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153695621|NCT00064649|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153915222|NCT00848731|Autonomic Agents|autonomic agents|mesh-ancestor
153695622|NCT00064649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153695623|NCT00064649|Urological Agents|urological agents|mesh-ancestor
153695624|NCT00064649|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
153695625|NCT00064649|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
153695626|NCT00064649|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
153695627|NCT00064649|Adrenergic Agents|adrenergic agents|mesh-ancestor
153695628|NCT00064649|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153695630|NCT00097734|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153695632|NCT00064727|Rosiglitazone|rosiglitazone|mesh-list
153695684|NCT00414037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153695685|NCT00236275|Telbivudine|telbivudine|mesh-list
153695686|NCT00236275|Antiviral Agents|antiviral agents|mesh-ancestor
153695687|NCT00236275|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153695688|NCT00236275|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153695689|NCT00236275|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153695690|NCT00236275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153695691|NCT00236353|Risperidone|risperidone|mesh-list
153695692|NCT00236353|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153532661|NCT01503216|Vitamins|vitamins|mesh-ancestor
153695749|NCT00076401|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153695750|NCT00076401|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
153695751|NCT00076401|Dermatologic Agents|dermatologic agents|mesh-ancestor
153695753|NCT00236548|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153695754|NCT00236548|Serotonin Agents|serotonin agents|mesh-ancestor
153695755|NCT00236548|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153695756|NCT00236548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153695757|NCT00236548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153695758|NCT00236548|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153695759|NCT00236548|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153695760|NCT00236548|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153695761|NCT00236548|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153695762|NCT00236548|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
153695763|NCT00236548|Dopamine Agents|dopamine agents|mesh-ancestor
153695764|NCT00236587|Risperidone|risperidone|mesh-list
153695765|NCT00236587|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153695766|NCT00236587|Serotonin Agents|serotonin agents|mesh-ancestor
153695767|NCT00236587|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153695808|NCT00236782|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153695809|NCT00236782|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
153695810|NCT00236782|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
153695811|NCT00236782|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
153880336|NCT02199184|Etoposide|etoposide|mesh-list
153421179|NCT06263491|Rituximab|rituximab|mesh-list
153695813|NCT00097968|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
153695814|NCT00097968|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153695815|NCT00097968|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153695816|NCT00097968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153695817|NCT00097968|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153695818|NCT00097968|Immunologic Factors|immunologic factors|mesh-ancestor
153695819|NCT00097968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153695820|NCT00097968|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153695821|NCT00236821|Levofloxacin|levofloxacin|mesh-list
153695822|NCT00236821|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
153695823|NCT00236821|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153695824|NCT00236821|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153695825|NCT00236821|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153695826|NCT00236821|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153695827|NCT00236821|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153695828|NCT00236821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153695829|NCT00236821|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153695830|NCT00236821|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
153695831|NCT00236821|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153695832|NCT00236860|Topiramate|topiramate|mesh-list
153695833|NCT00236860|Anticonvulsants|anticonvulsants|mesh-ancestor
153695834|NCT00236860|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153695835|NCT00236860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153695836|NCT00065117|Leucovorin|leucovorin|mesh-list
153695837|NCT00065117|Fluorouracil|fluorouracil|mesh-list
153695850|NCT00065117|Micronutrients|micronutrients|mesh-ancestor
153695851|NCT00237016|Doxycycline|doxycycline|mesh-list
153695852|NCT00237016|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153695853|NCT00237016|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153695854|NCT00237016|Antimalarials|antimalarials|mesh-ancestor
153695855|NCT00237016|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153695856|NCT00237016|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153695858|NCT00237133|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153695859|NCT00237133|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
153695860|NCT00237133|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153695861|NCT00237133|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153695862|NCT00237133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153695863|NCT00237133|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
153695864|NCT00237133|Hormone Antagonists|hormone antagonists|mesh-ancestor
153695865|NCT00237133|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153695866|NCT00237133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153695868|NCT00237172|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153695869|NCT00237172|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153695870|NCT00237172|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153695871|NCT00237172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153695872|NCT00237172|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153695873|NCT00237211|Letrozole|letrozole|mesh-list
153695874|NCT00237211|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153695875|NCT00237211|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
153695876|NCT00237211|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153334719|NCT04281420|Niacin|niacin|mesh-list
153695877|NCT00237211|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153695878|NCT00237211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153695893|NCT00237250|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153695894|NCT00237250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153695895|NCT00237250|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
153695896|NCT00237250|Protease Inhibitors|protease inhibitors|mesh-ancestor
153695897|NCT00237250|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153695898|NCT00237250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153695899|NCT00237289|Topiramate|topiramate|mesh-list
153695900|NCT00237289|Anticonvulsants|anticonvulsants|mesh-ancestor
153695901|NCT00237289|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153695902|NCT00237289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153695903|NCT00237328|Heparin|heparin|mesh-list
153695904|NCT00237328|Anticoagulants|anticoagulants|mesh-ancestor
153695905|NCT00237328|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153695906|NCT00237328|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153695952|NCT00237484|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
153695953|NCT00237484|Infliximab|infliximab|mesh-list
153695954|NCT00237484|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153695955|NCT00237484|Antiviral Agents|antiviral agents|mesh-ancestor
153695956|NCT00237484|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153695957|NCT00237484|Antimetabolites|antimetabolites|mesh-ancestor
153695958|NCT00237484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153695959|NCT00237484|Immunologic Factors|immunologic factors|mesh-ancestor
153695960|NCT00237484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153695961|NCT00237484|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
153695962|NCT00237484|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153695963|NCT00237484|Dermatologic Agents|dermatologic agents|mesh-ancestor
153695964|NCT00237484|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153695965|NCT00237484|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153695966|NCT00237523|Iodine|iodine|mesh-list
153695967|NCT00237523|Cadexomer iodine|cadexomer iodine|mesh-list
153695968|NCT00237523|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
153695969|NCT00237523|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153695970|NCT00237523|Trace Elements|trace elements|mesh-ancestor
153695971|NCT00237523|Micronutrients|micronutrients|mesh-ancestor
153695972|NCT00237523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153695973|NCT00098124|Milnacipran|milnacipran|mesh-list
153695974|NCT00098124|Levomilnacipran|levomilnacipran|mesh-list
153695975|NCT00098124|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
153695976|NCT00098124|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153695977|NCT00098124|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153915299|NCT02703571|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153695978|NCT00098124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153695979|NCT00098124|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153695980|NCT00098124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153695981|NCT00098124|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153695982|NCT00098124|Analgesics|analgesics|mesh-ancestor
153695983|NCT00098124|Sensory System Agents|sensory system agents|mesh-ancestor
153650355|NCT00028873|Docetaxel|docetaxel|mesh-list
153695984|NCT00098124|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153695985|NCT00098124|Antidepressive Agents|antidepressive agents|mesh-ancestor
153695986|NCT00098124|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153695991|NCT00065351|Immunologic Factors|immunologic factors|mesh-ancestor
153695992|NCT00065351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153695993|NCT00065351|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153695994|NCT00065351|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153695995|NCT00065351|Growth Substances|growth substances|mesh-ancestor
153695996|NCT00065351|Growth Inhibitors|growth inhibitors|mesh-ancestor
153695997|NCT00065351|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153695998|NCT04709770|Simethicone|simethicone|mesh-list
153695999|NCT04709770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153696000|NCT04709770|Antifoaming Agents|antifoaming agents|mesh-ancestor
153696001|NCT04709770|Emollients|emollients|mesh-ancestor
153696002|NCT04709770|Dermatologic Agents|dermatologic agents|mesh-ancestor
153696003|NCT04709731|Ponatinib|ponatinib|mesh-list
153696004|NCT04709731|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153696005|NCT04709731|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153696006|NCT04709731|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153696008|NCT04709731|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153696009|NCT00398684|Nevirapine|nevirapine|mesh-list
153696010|NCT00398684|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153696011|NCT00398684|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153696012|NCT00398684|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153696013|NCT00398684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153696014|NCT00398684|Antiviral Agents|antiviral agents|mesh-ancestor
153696015|NCT00398684|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153696016|NCT00398684|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153696017|NCT00398684|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153696018|NCT00398684|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
153696019|NCT00398684|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
153696020|NCT00076440|Leuprolide|leuprolide|mesh-list
153696021|NCT00076440|Fertility Agents, Female|fertility agents, female|mesh-ancestor
153696022|NCT00076440|Fertility Agents|fertility agents|mesh-ancestor
153696023|NCT00076440|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153696032|NCT00237874|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153696033|NCT00237874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153696034|NCT00237874|Dopamine Agonists|dopamine agonists|mesh-ancestor
153696035|NCT00237874|Dopamine Agents|dopamine agents|mesh-ancestor
153696036|NCT00237874|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153696037|NCT00237874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153696038|NCT00237874|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
153696039|NCT00237874|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
153696040|NCT00237874|Serotonin Agents|serotonin agents|mesh-ancestor
153696041|NCT00237874|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
153696042|NCT00237874|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153696043|NCT00237874|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
153696044|NCT00237874|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
153696045|NCT00237913|Olanzapine|olanzapine|mesh-list
153696046|NCT00237913|Risperidone|risperidone|mesh-list
153696047|NCT00237913|Aripiprazole|aripiprazole|mesh-list
153696048|NCT00237913|Quetiapine Fumarate|quetiapine fumarate|mesh-list
153696049|NCT00237913|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153696050|NCT00237913|Serotonin Agents|serotonin agents|mesh-ancestor
153334757|NCT01450124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153334758|NCT01450124|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153334759|NCT01450124|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153915365|NCT01012713|Vitamins|vitamins|mesh-ancestor
153696051|NCT00237913|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153650991|NCT00031954|Antimetabolites|antimetabolites|mesh-ancestor
153696052|NCT00237913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153696053|NCT00237913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153696054|NCT00237913|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153696055|NCT00237913|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153696056|NCT00237913|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153696057|NCT00237913|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153696058|NCT00237913|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
153696059|NCT00237913|Dopamine Agents|dopamine agents|mesh-ancestor
153696060|NCT00237913|Antiemetics|antiemetics|mesh-ancestor
153696061|NCT00237913|Autonomic Agents|autonomic agents|mesh-ancestor
153696062|NCT00237913|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153696063|NCT00237913|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153696064|NCT00237913|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
153696065|NCT00237913|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153696066|NCT00237913|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153360722|NCT01368263|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
153651082|NCT00000596|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153360723|NCT01368263|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153696067|NCT00237913|Antidepressive Agents|antidepressive agents|mesh-ancestor
153696068|NCT00237913|Dopamine Agonists|dopamine agonists|mesh-ancestor
153696069|NCT00237913|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
153696070|NCT00237913|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
153696071|NCT00237913|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
153696072|NCT00237913|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
153696073|NCT00237952|Chelating Agents|chelating agents|mesh-list
153696074|NCT00237952|Sequestering Agents|sequestering agents|mesh-ancestor
153696075|NCT00237952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153696077|NCT00098241|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
153696078|NCT00098241|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153696079|NCT00098241|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153696080|NCT00098241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153696081|NCT00098241|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153696082|NCT00098241|Immunologic Factors|immunologic factors|mesh-ancestor
153696083|NCT00098241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153696084|NCT00098241|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153696085|NCT04721119|Anesthetics|anesthetics|mesh-list
153696086|NCT04721119|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153696087|NCT04721119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153696088|NCT00238147|Carboplatin|carboplatin|mesh-list
153696089|NCT00238147|Docetaxel|docetaxel|mesh-list
153696090|NCT00238147|Capecitabine|capecitabine|mesh-list
153696091|NCT00238147|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153696092|NCT00238147|Tubulin Modulators|tubulin modulators|mesh-ancestor
153696094|NCT00238147|Mitosis Modulators|mitosis modulators|mesh-ancestor
153696114|NCT00238225|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153696116|NCT00238225|Hormones|hormones|mesh-ancestor
153696117|NCT00238225|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153696118|NCT00238225|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153696119|NCT00238225|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153696120|NCT00238225|Antifungal Agents|antifungal agents|mesh-ancestor
153696121|NCT00238225|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153696122|NCT00238225|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
153696123|NCT00238225|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153696124|NCT00238225|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153696125|NCT00238225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153696126|NCT00238225|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153696127|NCT00238225|Hormone Antagonists|hormone antagonists|mesh-ancestor
153696128|NCT00238225|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
153696129|NCT00238225|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153696130|NCT00238225|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
153696131|NCT00238225|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153696132|NCT00238225|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
153696133|NCT00238225|Vitamins|vitamins|mesh-ancestor
153696134|NCT00238225|Micronutrients|micronutrients|mesh-ancestor
153651364|NCT00033436|Antimetabolites|antimetabolites|mesh-ancestor
153651365|NCT00033436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153651366|NCT00033436|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153651367|NCT00033436|Vasodilator Agents|vasodilator agents|mesh-ancestor
153696135|NCT00238225|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153696136|NCT00076518|Fenofibrate|fenofibrate|mesh-list
153696137|NCT00076518|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153696162|NCT00238459|Antiviral Agents|antiviral agents|mesh-ancestor
153696163|NCT00238459|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153696164|NCT00238498|Vildagliptin|vildagliptin|mesh-list
153696165|NCT00238498|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153696166|NCT00238498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153696167|NCT00238498|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
153696168|NCT00238498|Protease Inhibitors|protease inhibitors|mesh-ancestor
153696169|NCT00238498|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153696170|NCT00238498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153696171|NCT00238537|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
153696172|NCT00238537|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153696173|NCT00238537|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153696174|NCT00238537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153696175|NCT00098319|Folic Acid|folic acid|mesh-list
153696176|NCT00098319|Hematinics|hematinics|mesh-ancestor
153696177|NCT00098319|Vitamin B Complex|vitamin b complex|mesh-ancestor
153696178|NCT00098319|Vitamins|vitamins|mesh-ancestor
153696179|NCT00098319|Micronutrients|micronutrients|mesh-ancestor
153696180|NCT00098319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153696181|NCT00238732|Bazedoxifene|bazedoxifene|mesh-list
153334841|NCT04066426|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153696182|NCT00238732|Estrogens|estrogens|mesh-list
153696183|NCT00238732|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
153696184|NCT00238732|Hormones|hormones|mesh-ancestor
153696185|NCT00238732|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153651368|NCT00000635|Trifluridine|trifluridine|mesh-list
153696187|NCT00238732|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
153696188|NCT00238732|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
153696209|NCT00065624|Vitamins|vitamins|mesh-ancestor
153696210|NCT00065624|Micronutrients|micronutrients|mesh-ancestor
153696211|NCT00238966|Mycophenolic Acid|mycophenolic acid|mesh-list
153696212|NCT00238966|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153696213|NCT00238966|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153696214|NCT00238966|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
153696215|NCT00238966|Antitubercular Agents|antitubercular agents|mesh-ancestor
153696216|NCT00238966|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153696217|NCT00238966|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153696218|NCT00238966|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153696219|NCT00238966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153696220|NCT00239044|Mycophenolic Acid|mycophenolic acid|mesh-list
153696221|NCT00239044|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153696222|NCT00239044|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153696223|NCT00239044|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
153696224|NCT00239044|Antitubercular Agents|antitubercular agents|mesh-ancestor
153696225|NCT00239044|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153696226|NCT00239044|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153696227|NCT00239044|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153696228|NCT00239044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153696229|NCT00098358|Zileuton|zileuton|mesh-list
153696230|NCT00098358|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153696231|NCT00098358|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153696232|NCT00098358|Analgesics|analgesics|mesh-ancestor
153696233|NCT00098358|Sensory System Agents|sensory system agents|mesh-ancestor
153696234|NCT00098358|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153696235|NCT00098358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153696236|NCT00098358|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153696237|NCT00098358|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153696238|NCT00098358|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
153696239|NCT00098358|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153696240|NCT00098358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153334886|NCT04051684|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153696241|NCT00098358|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
153696248|NCT00239083|Antitubercular Agents|antitubercular agents|mesh-ancestor
153696250|NCT00239083|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153696251|NCT00239083|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153696252|NCT00239083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153696253|NCT00239161|Levofloxacin|levofloxacin|mesh-list
153696254|NCT00239161|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
153334887|NCT04840238|Cholecalciferol|cholecalciferol|mesh-list
153696255|NCT00239161|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153696256|NCT00239161|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153696257|NCT00239161|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153696258|NCT00239161|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153696259|NCT00239161|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153696260|NCT00239161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153696261|NCT00239161|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153696262|NCT00239161|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
153696263|NCT00239161|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153696264|NCT00239200|Lapatinib|lapatinib|mesh-list
153696265|NCT00239200|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153696266|NCT00239200|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153696267|NCT00239200|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153696268|NCT00239200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153696269|NCT00239200|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153696270|NCT02961829|Niacinamide|niacinamide|mesh-list
153696271|NCT02961829|Dolutegravir|dolutegravir|mesh-list
153696273|NCT02961829|Auranofin|auranofin|mesh-list
153696274|NCT02961829|Vaccines|vaccines|mesh-list
153696275|NCT02961829|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-list
153696276|NCT02961829|Immunologic Factors|immunologic factors|mesh-ancestor
153696277|NCT02961829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153696278|NCT02961829|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
153696291|NCT02961829|Micronutrients|micronutrients|mesh-ancestor
153696292|NCT02961829|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153696293|NCT00239239|Darbepoetin alfa|darbepoetin alfa|mesh-list
153696294|NCT00239239|Hematinics|hematinics|mesh-ancestor
153696296|NCT00414349|Sensory System Agents|sensory system agents|mesh-ancestor
153696297|NCT00414349|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153696298|NCT00414349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153696299|NCT00065741|Silymarin|silymarin|mesh-list
153696300|NCT00065741|Antioxidants|antioxidants|mesh-ancestor
153781925|NCT04557943|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153696357|NCT00239434|Respiratory System Agents|respiratory system agents|mesh-ancestor
153696358|NCT00239434|Parasympatholytics|parasympatholytics|mesh-ancestor
153696359|NCT00239434|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
153696360|NCT00239434|Cholinergic Agents|cholinergic agents|mesh-ancestor
153696361|NCT00239434|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153696362|NCT00239434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153696363|NCT00239434|Anticonvulsants|anticonvulsants|mesh-ancestor
153696421|NCT00239707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153696423|NCT00239746|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153696424|NCT00239746|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153696425|NCT00239746|Analgesics|analgesics|mesh-ancestor
153696426|NCT00239746|Sensory System Agents|sensory system agents|mesh-ancestor
153696427|NCT00239746|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153696428|NCT00239746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153696429|NCT00239746|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153334917|NCT01457690|Tocopherols|tocopherols|mesh-list
153696482|NCT00240058|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153696483|NCT00240058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153696484|NCT00240058|Protective Agents|protective agents|mesh-ancestor
153696485|NCT00240058|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153696486|NCT00240058|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153696487|NCT00240058|Free Radical Scavengers|free radical scavengers|mesh-ancestor
153696488|NCT00240058|Antioxidants|antioxidants|mesh-ancestor
153696489|NCT00240058|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
153696490|NCT00240058|Vasodilator Agents|vasodilator agents|mesh-ancestor
153696491|NCT00240058|Gasotransmitters|gasotransmitters|mesh-ancestor
153696492|NCT00098553|Everolimus|everolimus|mesh-list
153696493|NCT00098553|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
153696494|NCT00098553|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153696495|NCT00098553|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153696496|NCT00098553|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153696497|NCT00098553|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153696498|NCT00098553|Immunologic Factors|immunologic factors|mesh-ancestor
153696540|NCT00240409|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153696541|NCT00240448|Valsartan|valsartan|mesh-list
153696542|NCT00240448|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
153696543|NCT00240448|Telmisartan|telmisartan|mesh-list
153696544|NCT00240448|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153696545|NCT00240448|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
153696546|NCT00240448|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
153696547|NCT00240448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153696548|NCT00240448|Diuretics|diuretics|mesh-ancestor
153696549|NCT00240448|Natriuretic Agents|natriuretic agents|mesh-ancestor
153696550|NCT00240448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153696551|NCT00240448|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
153696552|NCT00240448|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153696553|NCT00098631|Lapatinib|lapatinib|mesh-list
153696554|NCT00098631|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153696555|NCT00098631|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153696556|NCT00098631|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153696557|NCT00098631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153696558|NCT00098631|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153696560|NCT00240604|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153696561|NCT00240604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153696562|NCT00076791|Tenofovir|tenofovir|mesh-list
153696563|NCT00076791|Emtricitabine|emtricitabine|mesh-list
153334969|NCT01187017|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153696564|NCT00076791|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
153696565|NCT00076791|Antiviral Agents|antiviral agents|mesh-ancestor
153696566|NCT00076791|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153696567|NCT00076791|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153696568|NCT00076791|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153696569|NCT00076791|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153696570|NCT00076791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153696580|NCT00240760|Memantine|memantine|mesh-list
153696581|NCT00240760|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
153696582|NCT00240760|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
153696583|NCT00240760|Dopamine Agents|dopamine agents|mesh-ancestor
153696584|NCT00240760|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153696585|NCT00240760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153696586|NCT00240760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153696587|NCT00240760|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
153696588|NCT00240760|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
153696589|NCT00066092|Lenograstim|lenograstim|mesh-list
153696643|NCT00076869|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
153696644|NCT00076869|Caspofungin|caspofungin|mesh-list
153696645|NCT00076869|Amebicides|amebicides|mesh-ancestor
153696646|NCT00076869|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153696647|NCT00076869|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153696648|NCT00076869|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153696649|NCT00076869|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153652172|NCT02971306|Antioxidants|antioxidants|mesh-ancestor
153696650|NCT00076869|Antifungal Agents|antifungal agents|mesh-ancestor
153696651|NCT00076869|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153696652|NCT00076869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153696653|NCT00066248|Cyproheptadine|cyproheptadine|mesh-list
153696654|NCT00066248|Megestrol|megestrol|mesh-list
153696655|NCT00066248|Megestrol Acetate|megestrol acetate|mesh-list
153696656|NCT00066248|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
153696657|NCT00066248|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
153696658|NCT00066248|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
153696659|NCT00066248|Contraceptive Agents|contraceptive agents|mesh-ancestor
153696660|NCT00066248|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153696661|NCT00066248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153696662|NCT00066248|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
153696663|NCT00066248|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
153696664|NCT00066248|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153696665|NCT00066248|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153696666|NCT00066248|Appetite Stimulants|appetite stimulants|mesh-ancestor
153696667|NCT00066248|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
153696692|NCT00241189|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153696693|NCT00241189|Immunologic Factors|immunologic factors|mesh-ancestor
153696694|NCT00241189|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153696695|NCT00241189|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153696696|NCT00241189|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153696697|NCT00241189|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153335007|NCT01451918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153696698|NCT00241189|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153696699|NCT00241189|Antifungal Agents|antifungal agents|mesh-ancestor
153696700|NCT00066326|Imatinib Mesylate|imatinib mesylate|mesh-list
153696701|NCT00066326|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153696702|NCT00066326|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153696703|NCT00066326|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153696704|NCT00066326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153696705|NCT00066326|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153696706|NCT00241345|Valganciclovir|valganciclovir|mesh-list
153696707|NCT00241345|Ganciclovir|ganciclovir|mesh-list
153696708|NCT00241345|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
153696709|NCT00241345|Antiviral Agents|antiviral agents|mesh-ancestor
153696748|NCT00098982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153696749|NCT00098982|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153696750|NCT00098982|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153696751|NCT00098982|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153696752|NCT00098982|Immunologic Factors|immunologic factors|mesh-ancestor
153696753|NCT00098982|Antidotes|antidotes|mesh-ancestor
153696754|NCT00098982|Protective Agents|protective agents|mesh-ancestor
153696755|NCT00098982|Vitamin B Complex|vitamin b complex|mesh-ancestor
153696757|NCT00098982|Micronutrients|micronutrients|mesh-ancestor
153696759|NCT00241618|Ribavirin|ribavirin|mesh-list
153696760|NCT00241618|Interferon-alpha|interferon-alpha|mesh-list
153696761|NCT00241618|Interferon alpha-2|interferon alpha-2|mesh-list
153696762|NCT00241618|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153696763|NCT00241618|Antiviral Agents|antiviral agents|mesh-ancestor
153696764|NCT00241618|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153696765|NCT00241618|Antimetabolites|antimetabolites|mesh-ancestor
153696766|NCT00241618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153696767|NCT00241618|Immunologic Factors|immunologic factors|mesh-ancestor
153696768|NCT00241618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153696769|NCT00066482|Cyclophosphamide|cyclophosphamide|mesh-list
153696770|NCT00066482|Cisplatin|cisplatin|mesh-list
153696771|NCT00066482|Etoposide|etoposide|mesh-list
153696772|NCT00066482|Bleomycin|bleomycin|mesh-list
153696773|NCT00066482|Lenograstim|lenograstim|mesh-list
153696774|NCT00066482|Mesna|mesna|mesh-list
153696775|NCT00066482|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153696776|NCT00066482|Immunologic Factors|immunologic factors|mesh-ancestor
153696777|NCT00066482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153696778|NCT00066482|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153696780|NCT00066482|Alkylating Agents|alkylating agents|mesh-ancestor
153696795|NCT00099060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153696796|NCT00099060|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153696797|NCT00066599|Voriconazole|voriconazole|mesh-list
153696798|NCT00066599|Antifungal Agents|antifungal agents|mesh-ancestor
153696799|NCT00066599|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153696800|NCT00066599|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
153696801|NCT00066599|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153696802|NCT00066599|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153696803|NCT00066599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153696804|NCT00066599|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153696805|NCT00066599|Hormone Antagonists|hormone antagonists|mesh-ancestor
153696806|NCT00066599|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153696807|NCT00066599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153696808|NCT00066599|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
153696809|NCT00242008|Rotigotine|rotigotine|mesh-list
153696810|NCT00242008|Dopamine Agonists|dopamine agonists|mesh-ancestor
153696811|NCT00242008|Dopamine Agents|dopamine agents|mesh-ancestor
153696812|NCT00242008|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153696813|NCT00242008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153696814|NCT00242008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153696846|NCT00242203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153696847|NCT00242203|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153696849|NCT00242203|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153696850|NCT00242203|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153335036|NCT05495958|Vitamins|vitamins|mesh-ancestor
153696852|NCT00242203|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153696853|NCT00242203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153696854|NCT00077025|Gefitinib|gefitinib|mesh-list
153696913|NCT00066794|Sargramostim|sargramostim|mesh-list
153696914|NCT00066794|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153696915|NCT00066794|Antimetabolites|antimetabolites|mesh-ancestor
153696916|NCT00066794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153696917|NCT00066794|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153696918|NCT00066794|Antiviral Agents|antiviral agents|mesh-ancestor
153696981|NCT00066989|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
153696982|NCT00066989|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
153696983|NCT00066989|Immunologic Factors|immunologic factors|mesh-ancestor
153696984|NCT00066989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153696985|NCT00243178|Clopidogrel|clopidogrel|mesh-list
153696986|NCT00243178|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153696987|NCT00243178|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
153696988|NCT00243178|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
153696989|NCT00243178|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
153696990|NCT00243178|Purinergic Agents|purinergic agents|mesh-ancestor
153697043|NCT00244153|Hormones|hormones|mesh-ancestor
153534011|NCT01508923|Liraglutide|liraglutide|mesh-list
153697044|NCT00244153|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153697045|NCT00244153|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153697046|NCT00244153|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153697047|NCT00244153|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153697049|NCT00244153|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153697050|NCT00244153|Analgesics|analgesics|mesh-ancestor
153697051|NCT00244153|Sensory System Agents|sensory system agents|mesh-ancestor
153697052|NCT02967029|Remifentanil|remifentanil|mesh-list
153697053|NCT02967029|Esmolol|esmolol|mesh-list
153697054|NCT02967029|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153697055|NCT02967029|Narcotics|narcotics|mesh-ancestor
153697056|NCT02967029|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153697057|NCT02967029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153697058|NCT02967029|Analgesics|analgesics|mesh-ancestor
153697059|NCT02967029|Sensory System Agents|sensory system agents|mesh-ancestor
153697060|NCT02967029|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153697061|NCT02967029|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
153697062|NCT02967029|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
153697097|NCT00244309|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153697099|NCT00244348|Oxaliplatin|oxaliplatin|mesh-list
153697100|NCT00244348|Antimetabolites|antimetabolites|mesh-ancestor
153697101|NCT00244348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153697102|NCT00244348|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153697103|NCT00244348|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153697104|NCT00244348|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153697105|NCT00244348|Immunologic Factors|immunologic factors|mesh-ancestor
153697106|NCT00244348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153697107|NCT00077220|Paclitaxel|paclitaxel|mesh-list
153697108|NCT00077220|Carboplatin|carboplatin|mesh-list
153880337|NCT02199184|Vincristine|vincristine|mesh-list
153880339|NCT02199184|Ofatumumab|ofatumumab|mesh-list
153697160|NCT00099489|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153697161|NCT00067262|Valproic Acid|valproic acid|mesh-list
153697162|NCT00067262|Anticonvulsants|anticonvulsants|mesh-ancestor
153697163|NCT00067262|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153697164|NCT00067262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153697165|NCT00067262|GABA Agents|gaba agents|mesh-ancestor
153697166|NCT00067262|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153697167|NCT00067262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153697168|NCT00067262|Antimanic Agents|antimanic agents|mesh-ancestor
153697169|NCT00067262|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153652730|NCT00038233|Leprostatic Agents|leprostatic agents|mesh-ancestor
153697170|NCT00067262|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153697172|NCT00244738|Castor Oil|castor oil|mesh-list
153697222|NCT00067340|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
153697223|NCT00067340|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153697225|NCT00245206|Olanzapine|olanzapine|mesh-list
153697226|NCT00245206|Risperidone|risperidone|mesh-list
153697227|NCT00245206|Aripiprazole|aripiprazole|mesh-list
153697228|NCT00245206|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153697229|NCT00245206|Serotonin Agents|serotonin agents|mesh-ancestor
153697230|NCT00245206|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153697231|NCT00245206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153697232|NCT00245206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153697233|NCT00245206|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153697234|NCT00245206|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153697236|NCT00245206|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153697284|NCT00245440|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153697285|NCT00400608|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
153697286|NCT00400608|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153697287|NCT00400608|Autonomic Agents|autonomic agents|mesh-ancestor
153697288|NCT00400608|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153697289|NCT00400608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153697290|NCT00400608|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153697291|NCT00400608|Respiratory System Agents|respiratory system agents|mesh-ancestor
153697292|NCT00400608|Glucocorticoids|glucocorticoids|mesh-ancestor
153697293|NCT00400608|Hormones|hormones|mesh-ancestor
153697294|NCT00400608|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153697295|NCT00400608|Sympathomimetics|sympathomimetics|mesh-ancestor
153697296|NCT00245596|Sildenafil Citrate|sildenafil citrate|mesh-list
153697297|NCT00245596|Vasodilator Agents|vasodilator agents|mesh-ancestor
153697298|NCT00245596|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
153697299|NCT00245596|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
153697300|NCT00245596|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153335063|NCT01458470|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
153697301|NCT00245596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153697302|NCT00245596|Urological Agents|urological agents|mesh-ancestor
153697339|NCT00245791|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
153697340|NCT00245791|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153697341|NCT00245791|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153697342|NCT00245791|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153697343|NCT00245791|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153697344|NCT00245791|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153697345|NCT00245791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153697346|NCT00245791|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153697347|NCT00245791|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
153697348|NCT00245791|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153697350|NCT00400647|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153697398|NCT00246103|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153697399|NCT00246103|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153697400|NCT00246142|Botulinum Toxins|botulinum toxins|mesh-list
153697401|NCT00246142|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
153697402|NCT00246142|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
153697403|NCT00246142|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
153697404|NCT00246142|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153697466|NCT00424801|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
153697467|NCT00424801|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
153697468|NCT00424801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153697470|NCT00424801|Natriuretic Agents|natriuretic agents|mesh-ancestor
153697471|NCT00424801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153697472|NCT00424801|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
153335096|NCT01458626|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153697473|NCT00424801|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153697474|NCT00424801|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
153697475|NCT00424801|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
153697476|NCT00424801|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
153697477|NCT00424801|Adrenergic Agents|adrenergic agents|mesh-ancestor
153697478|NCT00424801|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153697525|NCT04728516|Pantoprazole|pantoprazole|mesh-list
153697526|NCT04728516|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153697527|NCT04728516|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153697528|NCT04728516|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
153697529|NCT04728516|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153697530|NCT04728516|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
153697531|NCT04728516|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153697532|NCT04728516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153697533|NCT00400998|Fluticasone|fluticasone|mesh-list
153697535|NCT00400998|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153697536|NCT00400998|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153697537|NCT00400998|Autonomic Agents|autonomic agents|mesh-ancestor
153697539|NCT00400998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153697540|NCT00400998|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153697541|NCT00400998|Respiratory System Agents|respiratory system agents|mesh-ancestor
153697542|NCT00400998|Dermatologic Agents|dermatologic agents|mesh-ancestor
153697543|NCT00400998|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
153697544|NCT00247078|Antivenins|antivenins|mesh-list
153697545|NCT00247078|Immunologic Factors|immunologic factors|mesh-ancestor
153697546|NCT00247078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153697547|NCT00247117|Metformin|metformin|mesh-list
153697548|NCT00247117|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153697549|NCT00247117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153697550|NCT00099606|Dasatinib|dasatinib|mesh-list
153697551|NCT00099606|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153697552|NCT00099606|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153697553|NCT00099606|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153653510|NCT00016419|Cyclosporine|cyclosporine|mesh-list
153697554|NCT00099606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153697555|NCT00099606|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153697571|NCT00247585|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153697572|NCT00247585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153697573|NCT00099645|Mifepristone|mifepristone|mesh-list
153335117|NCT00377806|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153697574|NCT00099645|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
153697575|NCT00099645|Abortifacient Agents|abortifacient agents|mesh-ancestor
153697576|NCT00099645|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153697577|NCT00099645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153697578|NCT00099645|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
153697579|NCT00099645|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
153697580|NCT00099645|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
153697581|NCT00099645|Contraceptive Agents|contraceptive agents|mesh-ancestor
153697582|NCT00099645|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
153697583|NCT00099645|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
153697584|NCT00099645|Hormone Antagonists|hormone antagonists|mesh-ancestor
153697586|NCT00099645|Luteolytic Agents|luteolytic agents|mesh-ancestor
153697626|NCT00099684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153697627|NCT00099684|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153697628|NCT00067730|Drotrecogin alfa activated|drotrecogin alfa activated|mesh-list
153697629|NCT00067730|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153697630|NCT00248053|Curcumin|curcumin|mesh-list
153697631|NCT00248053|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153697632|NCT00248053|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153697633|NCT00248053|Analgesics|analgesics|mesh-ancestor
153697634|NCT00248053|Sensory System Agents|sensory system agents|mesh-ancestor
153697651|NCT00248131|Octreotide|octreotide|mesh-list
153697689|NCT00248482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153697690|NCT00248482|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153915734|NCT02699827|Anesthetics, Local|anesthetics, local|mesh-ancestor
153697691|NCT00248482|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153697692|NCT00248482|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153697693|NCT00103233|Trastuzumab|trastuzumab|mesh-list
153697694|NCT00103233|Vinorelbine|vinorelbine|mesh-list
153697695|NCT00103233|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153697696|NCT00103233|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153697697|NCT00103233|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153697698|NCT00103233|Tubulin Modulators|tubulin modulators|mesh-ancestor
153654092|NCT00397072|Sagopilone|sagopilone|mesh-list
153697699|NCT00103233|Antimitotic Agents|antimitotic agents|mesh-ancestor
153697700|NCT00103233|Mitosis Modulators|mitosis modulators|mesh-ancestor
153697751|NCT00249223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153697752|NCT00249223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153697753|NCT00249223|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153697754|NCT00249223|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153697755|NCT00249223|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153697756|NCT00249223|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153697757|NCT00249223|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
153697758|NCT00249223|Dopamine Agents|dopamine agents|mesh-ancestor
153697759|NCT00099840|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
153697760|NCT00099840|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153697761|NCT02967224|Insulin|insulin|mesh-list
153697762|NCT02967224|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
153697763|NCT02967224|Insulin Glargine|insulin glargine|mesh-list
153697764|NCT02967224|Insulin Detemir|insulin detemir|mesh-list
153697765|NCT02967224|Insulin, Isophane|insulin, isophane|mesh-list
153697766|NCT02967224|Isophane Insulin, Human|isophane insulin, human|mesh-list
153697767|NCT02967224|Isophane insulin, beef|isophane insulin, beef|mesh-list
153697768|NCT02967224|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153697769|NCT02967224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153697771|NCT00099918|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153697772|NCT00099918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153697773|NCT00099918|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
153697774|NCT00099918|Protease Inhibitors|protease inhibitors|mesh-ancestor
153697776|NCT00099918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153697777|NCT00249574|Buprenorphine|buprenorphine|mesh-list
153697778|NCT00249574|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
153697779|NCT00249574|Naloxone|naloxone|mesh-list
153697780|NCT00249574|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153697796|NCT00249730|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153697797|NCT00249730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153697798|NCT00249730|Urological Agents|urological agents|mesh-ancestor
153697800|NCT00249847|Estrogens|estrogens|mesh-list
153697801|NCT00249847|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
153697802|NCT00249847|Hormones|hormones|mesh-ancestor
153697803|NCT00249847|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153697804|NCT00249847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153697805|NCT00249847|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
153697806|NCT00249847|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153697807|NCT00249847|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153697808|NCT00249847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153697809|NCT00249847|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153697810|NCT00249847|Serotonin Agents|serotonin agents|mesh-ancestor
153697811|NCT00249847|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
153697812|NCT00249847|Antidepressive Agents|antidepressive agents|mesh-ancestor
153697813|NCT00249847|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153697814|NCT00249847|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
153697815|NCT00249847|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153335136|NCT02559414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153697817|NCT00249886|Citalopram|citalopram|mesh-list
153697848|NCT00250042|Arsenic Trioxide|arsenic trioxide|mesh-list
153697849|NCT00250042|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153697850|NCT00250042|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153697851|NCT00250042|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153697852|NCT00250042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153697853|NCT00250042|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153697854|NCT00068315|Rituximab|rituximab|mesh-list
153697855|NCT00068315|Fludarabine|fludarabine|mesh-list
153697856|NCT00068315|Fludarabine phosphate|fludarabine phosphate|mesh-list
153697857|NCT00068315|Bortezomib|bortezomib|mesh-list
153697858|NCT00068315|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153697859|NCT00068315|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153697860|NCT00068315|Immunologic Factors|immunologic factors|mesh-ancestor
153697861|NCT00068315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153697862|NCT00068315|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153697905|NCT00068432|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153697906|NCT00068432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153697907|NCT00068432|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153697908|NCT00068432|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153697909|NCT00068432|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
153697910|NCT00068432|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153697911|NCT00068432|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153697912|NCT00250237|Haloperidol|haloperidol|mesh-list
153697913|NCT00250237|Haloperidol decanoate|haloperidol decanoate|mesh-list
153697914|NCT00250237|Antiemetics|antiemetics|mesh-ancestor
153697915|NCT00250237|Autonomic Agents|autonomic agents|mesh-ancestor
153655432|NCT00047749|Ziconotide|ziconotide|mesh-list
153697917|NCT00250237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153697918|NCT00250237|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153655520|NCT00048646|Progesterone|progesterone|mesh-list
153697919|NCT00250237|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153697920|NCT00250237|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153697921|NCT00250237|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153697922|NCT00250237|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153697961|NCT00250354|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
153697962|NCT00250354|Dopamine Agents|dopamine agents|mesh-ancestor
153697963|NCT00250393|Istradefylline|istradefylline|mesh-list
153697964|NCT00250393|Adenosine A2 Receptor Antagonists|adenosine a2 receptor antagonists|mesh-ancestor
153697965|NCT00250393|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
153697966|NCT00250393|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
153697967|NCT00250393|Purinergic Agents|purinergic agents|mesh-ancestor
153697968|NCT00250393|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153655758|NCT00050362|Rofecoxib|rofecoxib|mesh-list
153697969|NCT00250393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153697970|NCT00250393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153697971|NCT02961634|Ciclopirox|ciclopirox|mesh-list
153697972|NCT02961634|Antifungal Agents|antifungal agents|mesh-ancestor
153697973|NCT02961634|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153697974|NCT02966717|Rituximab|rituximab|mesh-list
153698023|NCT00068549|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153698024|NCT00068549|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153698025|NCT00068549|Antimetabolites|antimetabolites|mesh-ancestor
153698026|NCT00068549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153698027|NCT04720183|Sulfasalazine|sulfasalazine|mesh-list
153698028|NCT04720183|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153698029|NCT04720183|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153698030|NCT04720183|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153698032|NCT04720183|Sensory System Agents|sensory system agents|mesh-ancestor
153698033|NCT04720183|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153698034|NCT04720183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153698035|NCT04720183|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153698036|NCT04720183|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153698038|NCT00250978|Bevacizumab|bevacizumab|mesh-list
153698082|NCT00100074|Respiratory System Agents|respiratory system agents|mesh-ancestor
153698083|NCT00068744|Fluorouracil|fluorouracil|mesh-list
153335157|NCT04713904|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
153698084|NCT00068744|Mitomycins|mitomycins|mesh-list
153698085|NCT00068744|Mitomycin|mitomycin|mesh-list
153698086|NCT00068744|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153698087|NCT00068744|Antimetabolites|antimetabolites|mesh-ancestor
153656002|NCT00052273|Capecitabine|capecitabine|mesh-list
153698088|NCT00068744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153698089|NCT00068744|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153698090|NCT00068744|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153698092|NCT00068744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153698093|NCT00068744|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153698094|NCT00068744|Alkylating Agents|alkylating agents|mesh-ancestor
153698095|NCT00068744|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153698096|NCT00068744|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153698097|NCT00100113|Vanoxerine|vanoxerine|mesh-list
153698098|NCT00100113|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
153698099|NCT00100113|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153698100|NCT00100113|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153698137|NCT02966522|Leprostatic Agents|leprostatic agents|mesh-ancestor
153698138|NCT02966522|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153698139|NCT02966522|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153698140|NCT02966522|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153698141|NCT02966522|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153698142|NCT02966522|Growth Substances|growth substances|mesh-ancestor
153698143|NCT02966522|Growth Inhibitors|growth inhibitors|mesh-ancestor
153698145|NCT00251485|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153656316|NCT00054340|Alkylating Agents|alkylating agents|mesh-ancestor
153698146|NCT00251485|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153698148|NCT00100152|Gamma Secretase Inhibitors and Modulators|gamma secretase inhibitors and modulators|mesh-ancestor
153698199|NCT00251602|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
153698200|NCT00251602|Cholinergic Agents|cholinergic agents|mesh-ancestor
153698201|NCT02961166|Immunoglobulins|immunoglobulins|mesh-list
153698202|NCT02961166|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
153698204|NCT02961166|Immunologic Factors|immunologic factors|mesh-ancestor
153698205|NCT02961166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153698206|NCT00103818|Gaboxadol|gaboxadol|mesh-list
153698207|NCT00103818|Analgesics|analgesics|mesh-ancestor
153698208|NCT00103818|Sensory System Agents|sensory system agents|mesh-ancestor
153698209|NCT00103818|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153698210|NCT00103818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153698211|NCT00103818|Anticonvulsants|anticonvulsants|mesh-ancestor
153698212|NCT00103818|GABA Agonists|gaba agonists|mesh-ancestor
153698213|NCT00103818|GABA Agents|gaba agents|mesh-ancestor
153698260|NCT00399074|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153698261|NCT00399074|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153698262|NCT00399074|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153698263|NCT00399074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153698264|NCT00399074|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
153698266|NCT00100308|Anticoagulants|anticoagulants|mesh-ancestor
153698267|NCT00100308|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153698268|NCT00100308|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153698269|NCT00100308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153698270|NCT00251953|Metformin|metformin|mesh-list
153698271|NCT00251953|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153698272|NCT00251953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153335192|NCT05029856|Vaccines|vaccines|mesh-list
153698321|NCT00252343|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153698322|NCT00252343|Adrenergic Agents|adrenergic agents|mesh-ancestor
153698323|NCT00252343|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153698324|NCT00252343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153698325|NCT00252343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153698326|NCT00252343|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
153698327|NCT00252421|Nitroglycerin|nitroglycerin|mesh-list
153698328|NCT00252421|Vasodilator Agents|vasodilator agents|mesh-ancestor
153698330|NCT00252655|Tacrolimus|tacrolimus|mesh-list
153698384|NCT00253123|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153698386|NCT00253123|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
153698387|NCT00253123|Dopamine Agents|dopamine agents|mesh-ancestor
153698388|NCT00253162|Risperidone|risperidone|mesh-list
153698389|NCT00253162|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153698390|NCT00253162|Serotonin Agents|serotonin agents|mesh-ancestor
153698391|NCT00253162|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153698392|NCT00253162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153698393|NCT00253162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153698394|NCT00253162|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153698395|NCT00253162|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153698396|NCT00253162|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153698397|NCT00253162|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153698398|NCT00253162|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
153698399|NCT00253162|Dopamine Agents|dopamine agents|mesh-ancestor
153698400|NCT00253201|Galantamine|galantamine|mesh-list
153698401|NCT00253201|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
153698443|NCT00253552|Busulfan|busulfan|mesh-list
153698444|NCT00253552|Methotrexate|methotrexate|mesh-list
153698445|NCT00253552|Etoposide|etoposide|mesh-list
153698446|NCT00253552|Cyclosporins|cyclosporins|mesh-list
153698447|NCT00253552|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153698448|NCT00253552|Immunologic Factors|immunologic factors|mesh-ancestor
153698449|NCT00253552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153698450|NCT00253552|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153698451|NCT00253552|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153698452|NCT00253552|Alkylating Agents|alkylating agents|mesh-ancestor
153698453|NCT00253552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153698454|NCT00253552|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153698455|NCT00253552|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153698456|NCT00253552|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
153698458|NCT00253552|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153698459|NCT00253552|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153698460|NCT00253552|Antimetabolites|antimetabolites|mesh-ancestor
153657438|NCT06192784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153698461|NCT00253552|Dermatologic Agents|dermatologic agents|mesh-ancestor
153698498|NCT00104130|Mitosis Modulators|mitosis modulators|mesh-ancestor
153698499|NCT00104130|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153698500|NCT00104130|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153698501|NCT00254020|Citalopram|citalopram|mesh-list
153698502|NCT00254020|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
153698503|NCT00254020|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153698504|NCT00254020|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153698505|NCT00254020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153335225|NCT01453400|Analgesics|analgesics|mesh-ancestor
153698506|NCT00254020|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153698507|NCT00254020|Serotonin Agents|serotonin agents|mesh-ancestor
153698508|NCT00254020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153698509|NCT00254020|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
153698557|NCT00254449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153698558|NCT00104286|Troxacitabine|troxacitabine|mesh-list
153698559|NCT00104286|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153698560|NCT00104286|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153698561|NCT00104286|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153698562|NCT00104286|Antiviral Agents|antiviral agents|mesh-ancestor
153698563|NCT00104286|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153335243|NCT05025644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153698565|NCT00254800|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
153698566|NCT00254800|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
153698567|NCT00254800|Levonorgestrel|levonorgestrel|mesh-list
153698568|NCT00254800|Ethinyl Estradiol|ethinyl estradiol|mesh-list
153698569|NCT00254800|Estradiol|estradiol|mesh-list
153698570|NCT00254800|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
153698571|NCT00254800|Estrogens|estrogens|mesh-ancestor
153698572|NCT00254800|Hormones|hormones|mesh-ancestor
153698589|NCT00104403|Casopitant|casopitant|mesh-list
153698618|NCT00254878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153698619|NCT00254878|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
153698620|NCT00254878|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153698621|NCT00254878|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153698622|NCT00254878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153698626|NCT00254917|Immunologic Factors|immunologic factors|mesh-ancestor
153698627|NCT00254917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153698629|NCT00254956|Glucocorticoids|glucocorticoids|mesh-ancestor
153698680|NCT00255463|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153698681|NCT00255463|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153698682|NCT00255463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153698684|NCT00255463|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153698685|NCT00255463|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
153698686|NCT00255463|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153698687|NCT00255463|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
153698688|NCT00255463|Hormone Antagonists|hormone antagonists|mesh-ancestor
153698689|NCT00255463|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153698690|NCT00255463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153698691|NCT00255502|Metoprolol|metoprolol|mesh-list
153698692|NCT00255502|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153698693|NCT00255502|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153657819|NCT05472779|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
153657825|NCT05455424|Niraparib|niraparib|mesh-list
153657826|NCT05455424|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
153657827|NCT05455424|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153698694|NCT00255502|Sympatholytics|sympatholytics|mesh-ancestor
153698695|NCT00255502|Autonomic Agents|autonomic agents|mesh-ancestor
153698696|NCT00255502|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153698697|NCT00255502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153698698|NCT00255502|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
153698699|NCT00255502|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
153698700|NCT00255502|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
153698733|NCT00070148|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153698734|NCT00070148|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153698735|NCT00070148|Appetite Stimulants|appetite stimulants|mesh-ancestor
153698736|NCT00070148|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
153698737|NCT00070148|Androgens|androgens|mesh-ancestor
153698738|NCT00070148|Hormones|hormones|mesh-ancestor
153915930|NCT04318223|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153698739|NCT00070148|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153698740|NCT00070148|Anabolic Agents|anabolic agents|mesh-ancestor
153698741|NCT00100581|Interferons|interferons|mesh-list
153698742|NCT00100581|Ritonavir|ritonavir|mesh-list
153698743|NCT00100581|Tenofovir|tenofovir|mesh-list
153698744|NCT00100581|Ribavirin|ribavirin|mesh-list
153698745|NCT00100581|Interferon-alpha|interferon-alpha|mesh-list
153698746|NCT00100581|Lamivudine|lamivudine|mesh-list
153698747|NCT00100581|Interferon alpha-2|interferon alpha-2|mesh-list
153698748|NCT00100581|Efavirenz|efavirenz|mesh-list
153698749|NCT00100581|Lopinavir|lopinavir|mesh-list
153698750|NCT00100581|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
153698773|NCT00070187|Interferons|interferons|mesh-list
153698795|NCT00070187|Immunologic Factors|immunologic factors|mesh-ancestor
153698796|NCT00070187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153698797|NCT00070187|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153698798|NCT00070187|Antifungal Agents|antifungal agents|mesh-ancestor
153698799|NCT00070187|Dermatologic Agents|dermatologic agents|mesh-ancestor
153698800|NCT00070187|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153698801|NCT00070187|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
153698802|NCT00070187|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153698803|NCT00070187|Alkylating Agents|alkylating agents|mesh-ancestor
153698804|NCT00070187|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153698805|NCT00070187|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153698806|NCT00070187|Analgesics|analgesics|mesh-ancestor
153698807|NCT00070187|Sensory System Agents|sensory system agents|mesh-ancestor
153698808|NCT00070187|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153698809|NCT00070187|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153698810|NCT00070187|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153698811|NCT00415246|Triptorelin Pamoate|triptorelin pamoate|mesh-list
153698812|NCT00415246|Luteolytic Agents|luteolytic agents|mesh-ancestor
153698848|NCT00104598|Antidepressive Agents|antidepressive agents|mesh-ancestor
153698849|NCT00104598|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153698850|NCT00104598|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
153698851|NCT00104598|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153698852|NCT00104598|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153698853|NCT00104598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153698854|NCT00104598|Dopamine Agents|dopamine agents|mesh-ancestor
153698855|NCT00104598|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153698856|NCT00104598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153698857|NCT00104598|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
153698858|NCT00104598|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153698859|NCT00104598|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153698860|NCT00256321|Celecoxib|celecoxib|mesh-list
153698861|NCT00256321|Capecitabine|capecitabine|mesh-list
153698862|NCT00256321|Oxaliplatin|oxaliplatin|mesh-list
153698863|NCT00256321|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153698864|NCT00256321|Antimetabolites|antimetabolites|mesh-ancestor
153698865|NCT00256321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153698866|NCT00256321|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153698867|NCT00256321|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153698868|NCT00256321|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153698869|NCT00256321|Analgesics|analgesics|mesh-ancestor
153698870|NCT00256321|Sensory System Agents|sensory system agents|mesh-ancestor
153698871|NCT00256321|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153698892|NCT00100737|Rituximab|rituximab|mesh-list
153698896|NCT00100737|Immunologic Factors|immunologic factors|mesh-ancestor
153658204|NCT04508400|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153698897|NCT00100737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153698898|NCT00100737|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153698899|NCT00100737|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153698900|NCT00100737|Analgesics|analgesics|mesh-ancestor
153698901|NCT00100737|Sensory System Agents|sensory system agents|mesh-ancestor
153698902|NCT00100737|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153698903|NCT00070343|Dacarbazine|dacarbazine|mesh-list
153698905|NCT00070343|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153698906|NCT00070343|Alkylating Agents|alkylating agents|mesh-ancestor
153781927|NCT04557943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153698958|NCT00100776|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153698959|NCT00100776|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153698960|NCT00100776|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153698961|NCT00100776|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153698962|NCT00100776|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153698963|NCT00100776|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
153698964|NCT00100776|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153464721|NCT01897116|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153698965|NCT00100776|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153698966|NCT00100776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153698967|NCT00100776|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153698969|NCT00070538|Cytarabine|cytarabine|mesh-list
153698970|NCT00070538|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153698971|NCT00070538|Antimetabolites|antimetabolites|mesh-ancestor
153698972|NCT00070538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153698973|NCT00070538|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153698974|NCT00070538|Antiviral Agents|antiviral agents|mesh-ancestor
153698975|NCT00070538|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153698976|NCT00070538|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153699009|NCT00100854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153699010|NCT00100854|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153699011|NCT00100854|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153699012|NCT00100854|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
153335304|NCT02880020|Ipilimumab|ipilimumab|mesh-list
153699013|NCT00100854|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
153699014|NCT00100854|Hormone Antagonists|hormone antagonists|mesh-ancestor
153699015|NCT00100854|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153699016|NCT00100854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153699017|NCT00257140|Levofloxacin|levofloxacin|mesh-list
153699072|NCT00070655|Vitamins|vitamins|mesh-ancestor
153699073|NCT00070655|Micronutrients|micronutrients|mesh-ancestor
153699074|NCT00070655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153699075|NCT00070655|Anticoagulants|anticoagulants|mesh-ancestor
153699076|NCT00070655|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
153699077|NCT00070655|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153699078|NCT00070655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153699079|NCT00070655|Hemostatics|hemostatics|mesh-ancestor
153699080|NCT00070655|Coagulants|coagulants|mesh-ancestor
153699081|NCT00070655|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
153699086|NCT00257530|Imiquimod|imiquimod|mesh-list
153699137|NCT00257959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153699138|NCT00257959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153699139|NCT00257959|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153699140|NCT00257959|Vasodilator Agents|vasodilator agents|mesh-ancestor
153699141|NCT00257959|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
153699142|NCT00257959|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153699143|NCT00257959|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153699144|NCT00257959|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
153699145|NCT00257959|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153699146|NCT00257959|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153699147|NCT00257959|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
153699148|NCT00257959|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
153699149|NCT00257959|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
153699150|NCT00257959|Sympatholytics|sympatholytics|mesh-ancestor
153699151|NCT00257959|Autonomic Agents|autonomic agents|mesh-ancestor
153699152|NCT00257959|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153699153|NCT00070733|Methyltestosterone|methyltestosterone|mesh-list
153699154|NCT00070733|Testosterone|testosterone|mesh-list
153699191|NCT00258232|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153699192|NCT00258232|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
153699193|NCT00258232|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153699194|NCT00258232|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153699195|NCT00258232|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153699196|NCT00258232|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153699197|NCT00258232|Analgesics|analgesics|mesh-ancestor
153699198|NCT00258232|Sensory System Agents|sensory system agents|mesh-ancestor
153699199|NCT00258232|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153781928|NCT04557943|Viscosupplements|viscosupplements|mesh-ancestor
153335381|NCT01890902|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153699200|NCT00258232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153699201|NCT00258232|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153699202|NCT00258232|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153699203|NCT00258232|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
153699204|NCT00258232|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153699205|NCT00258271|Cytarabine|cytarabine|mesh-list
153699206|NCT00258271|Imatinib Mesylate|imatinib mesylate|mesh-list
153699207|NCT00258271|Cladribine|cladribine|mesh-list
153699208|NCT00258271|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153699209|NCT00258271|Antimetabolites|antimetabolites|mesh-ancestor
153699245|NCT00258622|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153699246|NCT00258622|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153462077|NCT01929252|Dexmedetomidine|dexmedetomidine|mesh-list
153699247|NCT00258622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153699249|NCT00423761|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153699250|NCT00423761|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153699251|NCT00423761|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153699252|NCT00423761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153699253|NCT00423761|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153699254|NCT00423761|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153699255|NCT00423761|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153699256|NCT00423761|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153699257|NCT00423761|Anesthetics, General|anesthetics, general|mesh-ancestor
153699258|NCT00423761|Anesthetics|anesthetics|mesh-ancestor
153699259|NCT00423761|GABA Modulators|gaba modulators|mesh-ancestor
153699306|NCT00104988|Thalidomide|thalidomide|mesh-list
153699307|NCT00104988|Temozolomide|temozolomide|mesh-list
153699308|NCT00104988|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153699309|NCT00104988|Alkylating Agents|alkylating agents|mesh-ancestor
153699310|NCT00104988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153699311|NCT00104988|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153699312|NCT00104988|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153699313|NCT00104988|Immunologic Factors|immunologic factors|mesh-ancestor
153699314|NCT00104988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153699315|NCT00104988|Leprostatic Agents|leprostatic agents|mesh-ancestor
153699316|NCT00104988|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153699317|NCT00104988|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153699318|NCT00104988|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153699319|NCT00104988|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153699320|NCT00104988|Growth Substances|growth substances|mesh-ancestor
153699321|NCT00104988|Growth Inhibitors|growth inhibitors|mesh-ancestor
153699322|NCT00415402|Vitamin D|vitamin d|mesh-list
153699323|NCT00415402|Cholecalciferol|cholecalciferol|mesh-list
153699324|NCT00415402|Vitamins|vitamins|mesh-ancestor
153699325|NCT00415402|Micronutrients|micronutrients|mesh-ancestor
153699326|NCT00415402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153699327|NCT00415402|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153699329|NCT00259402|Fluorouracil|fluorouracil|mesh-list
153699357|NCT00259636|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153699358|NCT00259636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153699359|NCT00259636|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153335407|NCT04423926|Mitosis Modulators|mitosis modulators|mesh-ancestor
153699360|NCT00259636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153699361|NCT00259675|Carboplatin|carboplatin|mesh-list
153699362|NCT00259675|Gemcitabine|gemcitabine|mesh-list
153699363|NCT00259675|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153699364|NCT00259675|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153699365|NCT00259675|Antimetabolites|antimetabolites|mesh-ancestor
153699366|NCT00259675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153699367|NCT00105105|Mifepristone|mifepristone|mesh-list
153699368|NCT00105105|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
153699369|NCT00105105|Abortifacient Agents|abortifacient agents|mesh-ancestor
153699370|NCT00105105|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153699371|NCT00105105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153699372|NCT00105105|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
153699373|NCT00105105|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
153699374|NCT00105105|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
153699375|NCT00105105|Contraceptive Agents|contraceptive agents|mesh-ancestor
153699376|NCT00105105|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
153699377|NCT00105105|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
153699385|NCT00071240|Hormones|hormones|mesh-list
153659242|NCT00064402|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
153699405|NCT00259792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153699406|NCT00105144|Caspofungin|caspofungin|mesh-list
153699408|NCT00105144|Antifungal Agents|antifungal agents|mesh-ancestor
153699409|NCT00105144|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153699410|NCT00105144|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153699411|NCT00105144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153699412|NCT00259870|Olanzapine|olanzapine|mesh-list
153699471|NCT00105300|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153699472|NCT00260416|Abciximab|abciximab|mesh-list
153699473|NCT00260416|Anticoagulants|anticoagulants|mesh-ancestor
153699474|NCT00260416|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153699475|NCT00260611|Docetaxel|docetaxel|mesh-list
153699476|NCT00260611|Oxaliplatin|oxaliplatin|mesh-list
153699477|NCT00260611|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153699478|NCT00260611|Tubulin Modulators|tubulin modulators|mesh-ancestor
153699479|NCT00260611|Antimitotic Agents|antimitotic agents|mesh-ancestor
153335429|NCT01479010|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153699480|NCT00260611|Mitosis Modulators|mitosis modulators|mesh-ancestor
153699481|NCT00260611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153699482|NCT00424086|Vaccines|vaccines|mesh-list
153699486|NCT00101205|Etoposide|etoposide|mesh-list
153699535|NCT00261352|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153699536|NCT00261391|Marimastat|marimastat|mesh-list
153699537|NCT00261391|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153699538|NCT00261391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153699539|NCT00071942|Metronidazole|metronidazole|mesh-list
153699540|NCT00071942|Vaccines|vaccines|mesh-list
153699541|NCT00071942|Immunologic Factors|immunologic factors|mesh-ancestor
153699542|NCT00071942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153699543|NCT00071942|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153699544|NCT00071942|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153699545|NCT00071942|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153699546|NCT00071942|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153699599|NCT00261703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153699600|NCT00261703|Antimetabolites|antimetabolites|mesh-ancestor
153699601|NCT00261703|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153699602|NCT00261703|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153335439|NCT02558400|Ophthalmic Solutions|ophthalmic solutions|mesh-list
153699603|NCT00261703|Immunologic Factors|immunologic factors|mesh-ancestor
153699604|NCT00261703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153699605|NCT00261742|Penicillins|penicillins|mesh-list
153699606|NCT00261742|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153699607|NCT00261742|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153699608|NCT00072059|Epoetin Alfa|epoetin alfa|mesh-list
153699609|NCT00072059|Hematinics|hematinics|mesh-ancestor
153699664|NCT00261976|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153699665|NCT00261976|Dermatologic Agents|dermatologic agents|mesh-ancestor
153699666|NCT00261976|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153699667|NCT00261976|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153699668|NCT00072137|Metronidazole|metronidazole|mesh-list
153699669|NCT00072137|Molgramostim|molgramostim|mesh-list
153699670|NCT00072137|Vaccines|vaccines|mesh-list
153699671|NCT00072137|Sargramostim|sargramostim|mesh-list
153699672|NCT00072137|Adjuvants, Vaccine|adjuvants, vaccine|mesh-list
153699673|NCT00072137|Immunologic Factors|immunologic factors|mesh-ancestor
153699674|NCT00072137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153699675|NCT00072137|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153699676|NCT00072137|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153699677|NCT00072137|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153699678|NCT00072137|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153699679|NCT00072137|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153699680|NCT00072137|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153699681|NCT00262015|Vaccines|vaccines|mesh-list
153699682|NCT00262015|Immunologic Factors|immunologic factors|mesh-ancestor
153699683|NCT00262015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153699684|NCT00262054|Heparin|heparin|mesh-list
153699685|NCT00262054|Calcium heparin|calcium heparin|mesh-list
153699686|NCT00262054|Bivalirudin|bivalirudin|mesh-list
153699687|NCT00262054|Anticoagulants|anticoagulants|mesh-ancestor
153699688|NCT00262054|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153699689|NCT00262054|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153699690|NCT00262054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153699691|NCT00262054|Antithrombins|antithrombins|mesh-ancestor
153699692|NCT00262054|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
153699714|NCT00262210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153699715|NCT00262210|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153496537|NCT00002322|Zidovudine|zidovudine|mesh-list
153699716|NCT00262210|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153699717|NCT00262210|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153699718|NCT00262210|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153699719|NCT00262210|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153699720|NCT00262210|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153699721|NCT00262210|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153699722|NCT00262210|Glucocorticoids|glucocorticoids|mesh-ancestor
153699723|NCT00262210|Hormones|hormones|mesh-ancestor
153699724|NCT00262210|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153699725|NCT00262210|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153699726|NCT00262210|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153699773|NCT00262405|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153699774|NCT00262405|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
153699775|NCT00262405|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153699776|NCT00262405|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
153699777|NCT00262405|Hormone Antagonists|hormone antagonists|mesh-ancestor
153699778|NCT00262483|Ribavirin|ribavirin|mesh-list
153699779|NCT00262483|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
153699780|NCT00262483|Antimetabolites|antimetabolites|mesh-ancestor
153699781|NCT00262483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153699782|NCT00262483|Antiviral Agents|antiviral agents|mesh-ancestor
153699783|NCT00262483|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153699784|NCT00262561|Aspirin|aspirin|mesh-list
153699785|NCT00262561|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153699786|NCT00262561|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153699787|NCT00262561|Analgesics|analgesics|mesh-ancestor
153699788|NCT00262561|Sensory System Agents|sensory system agents|mesh-ancestor
153699789|NCT00262561|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153699790|NCT00262561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153699791|NCT00262561|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153699792|NCT00262561|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153699793|NCT00262561|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153699799|NCT00262561|Antipyretics|antipyretics|mesh-ancestor
153699826|NCT00263068|Dopamine Agonists|dopamine agonists|mesh-ancestor
153699827|NCT00263068|Dopamine Agents|dopamine agents|mesh-ancestor
153699828|NCT00263068|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153699829|NCT00263068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153699830|NCT00263068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153699831|NCT00101634|Paliperidone Palmitate|paliperidone palmitate|mesh-list
153699832|NCT00101634|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153699833|NCT00101634|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153699834|NCT00101634|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153699835|NCT00101634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153699836|NCT00101634|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153699837|NCT00101634|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
153699838|NCT00101634|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153699839|NCT00101634|Serotonin Agents|serotonin agents|mesh-ancestor
153699840|NCT00101634|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153699842|NCT00101634|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
153699883|NCT00263302|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153699884|NCT00263302|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153699885|NCT00263458|Buprenorphine|buprenorphine|mesh-list
153699886|NCT00263458|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153699887|NCT00263458|Narcotics|narcotics|mesh-ancestor
153699888|NCT00263458|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153699889|NCT00263458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153699890|NCT00263458|Analgesics|analgesics|mesh-ancestor
153335503|NCT01406860|Histamine Antagonists|histamine antagonists|mesh-ancestor
153699891|NCT00263458|Sensory System Agents|sensory system agents|mesh-ancestor
153699950|NCT04709029|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153699951|NCT04709029|Glucocorticoids|glucocorticoids|mesh-ancestor
153699952|NCT04709029|Hormones|hormones|mesh-ancestor
153781930|NCT04557475|Aspirin|aspirin|mesh-list
153699953|NCT04709029|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153699954|NCT04709029|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153699955|NCT04709029|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153699956|NCT04709029|Protease Inhibitors|protease inhibitors|mesh-ancestor
153699957|NCT04709029|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153699958|NCT04709029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153659867|NCT00070642|Alkylating Agents|alkylating agents|mesh-ancestor
153700014|NCT00265018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153700015|NCT00265018|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153700016|NCT00265018|Tubulin Modulators|tubulin modulators|mesh-ancestor
153700017|NCT00265018|Antimitotic Agents|antimitotic agents|mesh-ancestor
153700018|NCT00265018|Mitosis Modulators|mitosis modulators|mesh-ancestor
153700019|NCT00265135|Siltuximab|siltuximab|mesh-list
153700020|NCT00265135|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153700021|NCT00106197|Bupropion|bupropion|mesh-list
153700022|NCT00106197|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
153700077|NCT00265642|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153700078|NCT00265642|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
153700079|NCT00265642|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
153700080|NCT00265642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153700081|NCT00265915|Rituximab|rituximab|mesh-list
153700082|NCT00265915|Sargramostim|sargramostim|mesh-list
153700083|NCT00265915|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153700084|NCT00265915|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153700085|NCT00265915|Immunologic Factors|immunologic factors|mesh-ancestor
153700086|NCT00265915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153700087|NCT00265915|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153700088|NCT00265993|Enoxaparin|enoxaparin|mesh-list
153700138|NCT00102141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153700139|NCT00102141|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
153700141|NCT00102141|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153700142|NCT00102141|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
153700143|NCT00102141|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
153700144|NCT00102141|Hormone Antagonists|hormone antagonists|mesh-ancestor
153700145|NCT00102141|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
153700147|NCT00102141|Natriuretic Agents|natriuretic agents|mesh-ancestor
153700148|NCT00102141|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
153700149|NCT00102141|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
153700150|NCT00266344|Gaboxadol|gaboxadol|mesh-list
153700151|NCT00266344|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153700152|NCT00266344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153700153|NCT00266344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153700154|NCT00266344|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153700155|NCT00266344|Analgesics|analgesics|mesh-ancestor
153700156|NCT00266344|Sensory System Agents|sensory system agents|mesh-ancestor
153700157|NCT00266344|Anticonvulsants|anticonvulsants|mesh-ancestor
153700158|NCT00266344|GABA Agonists|gaba agonists|mesh-ancestor
153700159|NCT00266344|GABA Agents|gaba agents|mesh-ancestor
153700160|NCT00266539|Fentanyl|fentanyl|mesh-list
153700161|NCT00266539|Morphine|morphine|mesh-list
153700190|NCT00102219|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153700191|NCT00102219|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153700192|NCT00102219|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153700193|NCT00102219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153700194|NCT00102219|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153700195|NCT00102219|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153700196|NCT01349569|Lenalidomide|lenalidomide|mesh-list
153700197|NCT01349569|Vaccines|vaccines|mesh-list
153700198|NCT01349569|Immunologic Factors|immunologic factors|mesh-ancestor
153700199|NCT01349569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153700200|NCT01349569|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153700201|NCT01349569|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153700202|NCT01349569|Growth Substances|growth substances|mesh-ancestor
153700203|NCT01349569|Growth Inhibitors|growth inhibitors|mesh-ancestor
153700205|NCT00267163|Donepezil|donepezil|mesh-list
153537224|NCT05368090|Autonomic Agents|autonomic agents|mesh-ancestor
153700250|NCT00106548|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
153700251|NCT00106548|Abortifacient Agents|abortifacient agents|mesh-ancestor
153700252|NCT00106548|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153700253|NCT00106548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153700254|NCT00106548|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153700255|NCT00106548|Antimetabolites|antimetabolites|mesh-ancestor
153700256|NCT00106548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153700257|NCT00106548|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153700258|NCT00106548|Dermatologic Agents|dermatologic agents|mesh-ancestor
153700259|NCT00106548|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153700260|NCT00106548|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153700311|NCT00268177|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153700312|NCT00268177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153700313|NCT00268177|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153700314|NCT00268177|Respiratory System Agents|respiratory system agents|mesh-ancestor
153700315|NCT00268177|Dermatologic Agents|dermatologic agents|mesh-ancestor
153700316|NCT00268177|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
153700317|NCT00268177|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
153700318|NCT00268177|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
153700319|NCT00268177|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153700320|NCT00268177|Adrenergic Agents|adrenergic agents|mesh-ancestor
153700321|NCT00268177|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153700322|NCT00268177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153700371|NCT00268255|Enzyme Inhibitors|enzyme inhibitors|mesh-list
153700372|NCT00268255|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153700373|NCT00268255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153700374|NCT00268255|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153700375|NCT00102414|Gemcitabine|gemcitabine|mesh-list
153700376|NCT00102414|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153700377|NCT00102414|Antimetabolites|antimetabolites|mesh-ancestor
153700378|NCT00102414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153700379|NCT00102414|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153700380|NCT00268333|Leucovorin|leucovorin|mesh-list
153700381|NCT00268333|Fluorouracil|fluorouracil|mesh-list
153700382|NCT00268333|Oxaliplatin|oxaliplatin|mesh-list
153700383|NCT00268333|Calcium|calcium|mesh-list
153700384|NCT00268333|Levoleucovorin|levoleucovorin|mesh-list
153700385|NCT00268333|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153700386|NCT00268333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153335631|NCT05499234|Narcotics|narcotics|mesh-ancestor
153700387|NCT00268333|Antimetabolites|antimetabolites|mesh-ancestor
153700388|NCT00268333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153700389|NCT00268333|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153700390|NCT00268333|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153700391|NCT00268333|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153700392|NCT00268333|Immunologic Factors|immunologic factors|mesh-ancestor
153700396|NCT00268333|Vitamins|vitamins|mesh-ancestor
153700424|NCT00268372|Mitosis Modulators|mitosis modulators|mesh-ancestor
153700425|NCT00268372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153700426|NCT00268372|Antimetabolites|antimetabolites|mesh-ancestor
153700427|NCT00268372|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153700428|NCT00268372|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153700429|NCT00268372|Immunologic Factors|immunologic factors|mesh-ancestor
153700430|NCT00268372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153700431|NCT00268411|Gemcitabine|gemcitabine|mesh-list
153700432|NCT00268411|Oxaliplatin|oxaliplatin|mesh-list
153700433|NCT00268411|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153700434|NCT00268411|Antimetabolites|antimetabolites|mesh-ancestor
153700435|NCT00268411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153700436|NCT00268411|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153700437|NCT00073736|Cytarabine|cytarabine|mesh-list
153700438|NCT00073736|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153335657|NCT05599126|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153700439|NCT00073736|Antimetabolites|antimetabolites|mesh-ancestor
153700440|NCT00073736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153700481|NCT00073814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153700482|NCT00073814|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153700483|NCT00073814|Respiratory System Agents|respiratory system agents|mesh-ancestor
153700484|NCT00073814|Tocolytic Agents|tocolytic agents|mesh-ancestor
153700485|NCT00073814|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153700486|NCT00073814|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
153700487|NCT00073814|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
153700488|NCT00073814|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153700489|NCT00073814|Adrenergic Agents|adrenergic agents|mesh-ancestor
153700490|NCT00073814|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153700491|NCT00073814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153700492|NCT00102453|Pentoxifylline|pentoxifylline|mesh-list
153700493|NCT00102453|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
153700494|NCT00102453|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153700495|NCT00102453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153700496|NCT00102453|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153700497|NCT00102453|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
153700498|NCT00102453|Protective Agents|protective agents|mesh-ancestor
153700499|NCT00102453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153700500|NCT00102453|Vasodilator Agents|vasodilator agents|mesh-ancestor
153700501|NCT00102453|Free Radical Scavengers|free radical scavengers|mesh-ancestor
153700502|NCT00102453|Antioxidants|antioxidants|mesh-ancestor
153700503|NCT00268567|Prednisone|prednisone|mesh-list
153700504|NCT00268567|Leflunomide|leflunomide|mesh-list
153700505|NCT00268567|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153700506|NCT00268567|Glucocorticoids|glucocorticoids|mesh-ancestor
153700507|NCT00268567|Hormones|hormones|mesh-ancestor
153700527|NCT00268684|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153700529|NCT00106821|Tiotropium Bromide|tiotropium bromide|mesh-list
153700530|NCT00106821|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153700531|NCT00106821|Autonomic Agents|autonomic agents|mesh-ancestor
153700532|NCT00106821|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153700533|NCT00106821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153700534|NCT00106821|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153700535|NCT00106821|Respiratory System Agents|respiratory system agents|mesh-ancestor
153700536|NCT00106821|Parasympatholytics|parasympatholytics|mesh-ancestor
153700537|NCT00106821|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
153660863|NCT00078481|Idebenone|idebenone|mesh-list
153700538|NCT00106821|Cholinergic Agents|cholinergic agents|mesh-ancestor
153700539|NCT00106821|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153335695|NCT01662648|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153700540|NCT00106821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153700589|NCT00268957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153700590|NCT00073970|Celecoxib|celecoxib|mesh-list
153700591|NCT00073970|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153700592|NCT00073970|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153700593|NCT00073970|Analgesics|analgesics|mesh-ancestor
153700594|NCT00073970|Sensory System Agents|sensory system agents|mesh-ancestor
153700595|NCT00073970|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153916309|NCT04223661|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153700596|NCT00073970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153700597|NCT00073970|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153700598|NCT00073970|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153700599|NCT00073970|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
153700600|NCT00073970|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153700601|NCT00073970|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153700602|NCT00073970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153700603|NCT00102492|Casopitant|casopitant|mesh-list
153700647|NCT00269542|Micronutrients|micronutrients|mesh-ancestor
153700648|NCT00269542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153700649|NCT00269542|Hematinics|hematinics|mesh-ancestor
153700650|NCT00269542|Vitamins|vitamins|mesh-ancestor
153700651|NCT00269620|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
153700652|NCT00269620|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
153700653|NCT00269620|Ethinyl Estradiol|ethinyl estradiol|mesh-list
153700654|NCT00269620|Etonogestrel|etonogestrel|mesh-list
153700655|NCT00269620|NuvaRing|nuvaring|mesh-list
153700656|NCT00269620|Norelgestromin|norelgestromin|mesh-list
153700657|NCT00269620|Ortho Evra|ortho evra|mesh-list
153700658|NCT00269620|Contraceptive Agents|contraceptive agents|mesh-list
153700659|NCT00269620|Estradiol|estradiol|mesh-list
153700660|NCT00269620|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
153700661|NCT00269620|Estrogens|estrogens|mesh-ancestor
153700662|NCT00269620|Hormones|hormones|mesh-ancestor
153700663|NCT00269620|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153700664|NCT00269620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153700665|NCT00269620|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
153700666|NCT00269620|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153700667|NCT00269620|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
153700670|NCT00074204|Carboplatin|carboplatin|mesh-list
153700703|NCT00269737|Analgesics|analgesics|mesh-ancestor
153700704|NCT00269737|Sensory System Agents|sensory system agents|mesh-ancestor
153700705|NCT00269737|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153700706|NCT00269737|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153700707|NCT00269737|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153700708|NCT00269737|Anesthetics, General|anesthetics, general|mesh-ancestor
153700709|NCT00269737|Anesthetics|anesthetics|mesh-ancestor
153700710|NCT00269776|Methylphenidate|methylphenidate|mesh-list
153335696|NCT01662648|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153700711|NCT00269776|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
153700712|NCT00269776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153700713|NCT00269776|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
153700714|NCT00269776|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153700715|NCT00269776|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153700716|NCT00269776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153463032|NCT03820518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153700717|NCT00269776|Dopamine Agents|dopamine agents|mesh-ancestor
153700718|NCT00269776|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153700719|NCT00269815|Methylphenidate|methylphenidate|mesh-list
153700722|NCT00269815|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
153700760|NCT00102609|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153700761|NCT00102609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153700762|NCT00102609|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153700763|NCT00102609|Glucocorticoids|glucocorticoids|mesh-ancestor
153700764|NCT00102609|Hormones|hormones|mesh-ancestor
153700765|NCT00102609|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153700766|NCT00102609|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153700767|NCT00102609|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153700768|NCT00102609|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153700769|NCT00102609|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153700770|NCT00102609|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153700771|NCT00102609|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153700772|NCT00102609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153700773|NCT00102609|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153700774|NCT00102609|Alkylating Agents|alkylating agents|mesh-ancestor
153700775|NCT00269932|Levofloxacin|levofloxacin|mesh-list
153700776|NCT00269932|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
153700777|NCT00269932|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153700778|NCT00269932|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153700779|NCT00269932|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153700780|NCT00269932|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153700810|NCT00270127|Hematinics|hematinics|mesh-ancestor
153700811|NCT00270166|Epoetin Alfa|epoetin alfa|mesh-list
153700812|NCT00270166|Hematinics|hematinics|mesh-ancestor
153700813|NCT00074399|Nevirapine|nevirapine|mesh-list
153700814|NCT00074399|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153700815|NCT00074399|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153700817|NCT00074399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153700818|NCT00074399|Antiviral Agents|antiviral agents|mesh-ancestor
153335744|NCT05488860|Hormones|hormones|mesh-ancestor
153700819|NCT00074399|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153700879|NCT00074438|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153700880|NCT00074438|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153700881|NCT00074438|Immunologic Factors|immunologic factors|mesh-ancestor
153700882|NCT00074438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153700883|NCT00074438|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153700884|NCT00074438|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
153700885|NCT00074438|Abortifacient Agents|abortifacient agents|mesh-ancestor
153700886|NCT00074438|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153700887|NCT00074438|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153700888|NCT00074438|Antimetabolites|antimetabolites|mesh-ancestor
153700889|NCT00074438|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153700890|NCT00074438|Dermatologic Agents|dermatologic agents|mesh-ancestor
153700891|NCT00074438|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153700892|NCT00074438|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153700893|NCT00074438|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153700936|NCT00107523|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153700937|NCT00107523|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153700938|NCT00107523|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153700939|NCT00107523|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153700940|NCT00107523|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153700941|NCT00107523|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153700942|NCT00107523|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153700943|NCT00107523|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
153700944|NCT00416377|Prednisolone|prednisolone|mesh-list
153700945|NCT00416377|Doxorubicin|doxorubicin|mesh-list
153700946|NCT00416377|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
153700947|NCT00416377|Bleomycin|bleomycin|mesh-list
153700999|NCT00271414|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153701000|NCT00271414|Anesthetics, General|anesthetics, general|mesh-ancestor
153701001|NCT00271414|Anesthetics|anesthetics|mesh-ancestor
153701002|NCT00271453|Fentanyl|fentanyl|mesh-list
153537978|NCT01526122|Antipyretics|antipyretics|mesh-ancestor
153701003|NCT00271453|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153701004|NCT00271453|Narcotics|narcotics|mesh-ancestor
153701005|NCT00271453|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153701006|NCT00271453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153701007|NCT00271453|Analgesics|analgesics|mesh-ancestor
153701008|NCT00271453|Sensory System Agents|sensory system agents|mesh-ancestor
153701009|NCT00271453|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153701010|NCT00271453|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153701011|NCT00271453|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153701012|NCT00271453|Anesthetics, General|anesthetics, general|mesh-ancestor
153701013|NCT00271453|Anesthetics|anesthetics|mesh-ancestor
153701062|NCT00272584|Serotonin Agents|serotonin agents|mesh-ancestor
153701063|NCT00272584|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153701064|NCT00272584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153701065|NCT00272584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153701066|NCT00272584|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153701067|NCT00272584|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153701068|NCT00272584|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153701069|NCT00272584|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153701070|NCT00272584|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
153701071|NCT00272584|Dopamine Agents|dopamine agents|mesh-ancestor
153701125|NCT00272935|Estrogens, conjugated synthetic A|estrogens, conjugated synthetic a|mesh-list
153701127|NCT00272935|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153701128|NCT00272935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153701129|NCT00273013|Montelukast|montelukast|mesh-list
153701130|NCT00273013|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153701131|NCT00273013|Respiratory System Agents|respiratory system agents|mesh-ancestor
153701132|NCT00273013|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
153701133|NCT00273013|Hormone Antagonists|hormone antagonists|mesh-ancestor
153701134|NCT00273013|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153701135|NCT00273013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153701136|NCT00273013|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
153701137|NCT00273013|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
153701138|NCT00273013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153701139|NCT00107835|Lidocaine|lidocaine|mesh-list
153701182|NCT00273442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153701183|NCT00273442|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153701184|NCT00273442|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153701185|NCT00273442|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
153701187|NCT00401427|Vinorelbine|vinorelbine|mesh-list
153701188|NCT00401427|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153701189|NCT00401427|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153701190|NCT00401427|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153701191|NCT00401427|Tubulin Modulators|tubulin modulators|mesh-ancestor
153701192|NCT00401427|Antimitotic Agents|antimitotic agents|mesh-ancestor
153701193|NCT00401427|Mitosis Modulators|mitosis modulators|mesh-ancestor
153701194|NCT00401427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153701195|NCT00273481|Timolol|timolol|mesh-list
153701196|NCT00273481|Dorzolamide|dorzolamide|mesh-list
153701197|NCT00273481|Latanoprost|latanoprost|mesh-list
153701198|NCT00273481|Maleic acid|maleic acid|mesh-list
153701199|NCT00273481|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153701240|NCT00273949|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153701241|NCT00273988|Nevirapine|nevirapine|mesh-list
153701242|NCT00273988|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153701243|NCT00273988|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153701244|NCT00273988|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153701245|NCT00273988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153701246|NCT00273988|Antiviral Agents|antiviral agents|mesh-ancestor
153701247|NCT00273988|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153701248|NCT00273988|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153701249|NCT00273988|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153701250|NCT00273988|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
153701251|NCT00273988|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
153701252|NCT00274027|Bromides|bromides|mesh-list
153701253|NCT00274027|Tiotropium Bromide|tiotropium bromide|mesh-list
153701300|NCT00274144|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153701301|NCT00274144|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
153701302|NCT00274144|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
153701303|NCT00274144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153701304|NCT00108186|Celecoxib|celecoxib|mesh-list
153701305|NCT00108186|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153701306|NCT00108186|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153701307|NCT00108186|Analgesics|analgesics|mesh-ancestor
153701308|NCT00108186|Sensory System Agents|sensory system agents|mesh-ancestor
153701309|NCT00108186|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153701361|NCT00274534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153701362|NCT00274534|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
153701363|NCT00274534|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
153701364|NCT00274534|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153701365|NCT00274534|Adrenergic Agents|adrenergic agents|mesh-ancestor
153701366|NCT00274573|Bromides|bromides|mesh-list
153701367|NCT00274573|Tiotropium Bromide|tiotropium bromide|mesh-list
153701368|NCT00274573|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153701369|NCT00274573|Autonomic Agents|autonomic agents|mesh-ancestor
153701426|NCT00277225|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153701427|NCT00277225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153701428|NCT00277225|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153701429|NCT00277225|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153701430|NCT00277225|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153701431|NCT00277225|Immunologic Factors|immunologic factors|mesh-ancestor
153701432|NCT00277225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153701433|NCT00277225|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153701434|NCT00277264|Tiotropium Bromide|tiotropium bromide|mesh-list
153701435|NCT00277264|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153701436|NCT00277264|Autonomic Agents|autonomic agents|mesh-ancestor
153701437|NCT00277264|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153701438|NCT00277264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153701439|NCT00277264|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153701440|NCT00277264|Respiratory System Agents|respiratory system agents|mesh-ancestor
153701441|NCT00277264|Parasympatholytics|parasympatholytics|mesh-ancestor
153701442|NCT00277264|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
153701443|NCT00277264|Cholinergic Agents|cholinergic agents|mesh-ancestor
153701446|NCT00108420|Prazosin|prazosin|mesh-list
153701480|NCT00108498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153701481|NCT00108498|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153701482|NCT00108498|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153701483|NCT00108498|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153701484|NCT00108498|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
153701485|NCT00108498|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
153701486|NCT00108498|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
153701487|NCT00108498|Adrenergic Agents|adrenergic agents|mesh-ancestor
153701488|NCT00108498|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
153701489|NCT00108498|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153701543|NCT00277693|Natriuretic Agents|natriuretic agents|mesh-ancestor
153701544|NCT00108576|Valproic Acid|valproic acid|mesh-list
153701545|NCT00108576|Anticonvulsants|anticonvulsants|mesh-ancestor
153701546|NCT00108576|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153701547|NCT00108576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153701548|NCT00108576|GABA Agents|gaba agents|mesh-ancestor
153701549|NCT00108576|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153701550|NCT00108576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153701551|NCT00108576|Antimanic Agents|antimanic agents|mesh-ancestor
153701552|NCT00108576|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153701553|NCT00108576|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153701554|NCT00108576|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153701555|NCT00075491|Fenretinide|fenretinide|mesh-list
153701556|NCT00075491|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153701557|NCT00075491|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
153701558|NCT00075491|Protective Agents|protective agents|mesh-ancestor
153701559|NCT00075491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153701561|NCT00108615|Pioglitazone|pioglitazone|mesh-list
153701562|NCT00108615|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153701563|NCT00108615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153335908|NCT01182610|Antimetabolites|antimetabolites|mesh-ancestor
153701564|NCT00278122|Paclitaxel|paclitaxel|mesh-list
153701565|NCT00278122|Sargramostim|sargramostim|mesh-list
153701566|NCT00278122|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153701598|NCT00278278|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153701599|NCT00278278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153701600|NCT00278278|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153701601|NCT00278278|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
153701602|NCT00278278|Abortifacient Agents|abortifacient agents|mesh-ancestor
153701603|NCT00278278|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153701604|NCT00278278|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153701606|NCT00278278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153701607|NCT00278278|Dermatologic Agents|dermatologic agents|mesh-ancestor
153701608|NCT00278278|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153701609|NCT00278278|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153701610|NCT00278278|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153701611|NCT00278278|Immunologic Factors|immunologic factors|mesh-ancestor
153701612|NCT00278278|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153701613|NCT00278278|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153701614|NCT00278278|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153701622|NCT00108771|Fentanyl|fentanyl|mesh-list
153701651|NCT00278824|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153701652|NCT00278824|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153701653|NCT00278824|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153701654|NCT00278824|Anesthetics, General|anesthetics, general|mesh-ancestor
153701655|NCT00278824|Anesthetics|anesthetics|mesh-ancestor
153701656|NCT00278941|Quetiapine Fumarate|quetiapine fumarate|mesh-list
153701657|NCT00278941|Antidepressive Agents|antidepressive agents|mesh-ancestor
153701658|NCT00278941|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153701659|NCT00278941|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153701660|NCT00278941|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153701661|NCT00278941|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153701662|NCT00278941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153701663|NCT00279019|Tiotropium Bromide|tiotropium bromide|mesh-list
153701664|NCT00279019|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153701665|NCT00279019|Autonomic Agents|autonomic agents|mesh-ancestor
153662226|NCT00139243|Leucovorin|leucovorin|mesh-list
153701666|NCT00279019|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153701667|NCT00279019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153701668|NCT00279019|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153701669|NCT00279019|Respiratory System Agents|respiratory system agents|mesh-ancestor
153701670|NCT00279019|Parasympatholytics|parasympatholytics|mesh-ancestor
153701675|NCT00108849|Estradiol|estradiol|mesh-list
153701704|NCT00109044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153701705|NCT00279448|Tamoxifen|tamoxifen|mesh-list
153701706|NCT00279448|Exemestane|exemestane|mesh-list
153701707|NCT00279448|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
153701708|NCT00279448|Hormone Antagonists|hormone antagonists|mesh-ancestor
153701709|NCT00279448|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153701710|NCT00279448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153335964|NCT02317276|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
153701711|NCT00279448|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153701712|NCT00279448|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153701713|NCT00279448|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
153701714|NCT00279448|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
153662466|NCT00140725|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153701715|NCT00279448|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153701716|NCT00279448|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
153701717|NCT00279448|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153701718|NCT00279448|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153701719|NCT00279448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153701721|NCT00075959|Antioxidants|antioxidants|mesh-ancestor
153701722|NCT00075959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153701723|NCT00075959|Protective Agents|protective agents|mesh-ancestor
153701724|NCT00075959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153701725|NCT00279487|Gabapentin|gabapentin|mesh-list
153701726|NCT00279487|Analgesics|analgesics|mesh-ancestor
153701727|NCT00279487|Sensory System Agents|sensory system agents|mesh-ancestor
153701728|NCT00279487|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153701729|NCT00279487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153701730|NCT00279487|Anticonvulsants|anticonvulsants|mesh-ancestor
153701731|NCT00279487|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153701732|NCT00279487|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153701733|NCT00279487|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153701734|NCT00279487|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153701735|NCT00279487|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
153701736|NCT00279487|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
153701737|NCT00279487|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153701739|NCT00279487|Antimanic Agents|antimanic agents|mesh-ancestor
153701740|NCT00279565|Interferons|interferons|mesh-list
153701741|NCT00279565|Ribavirin|ribavirin|mesh-list
153701742|NCT00279565|Interferon-alpha|interferon-alpha|mesh-list
153701743|NCT00279565|Interferon alpha-2|interferon alpha-2|mesh-list
153701744|NCT00279565|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
153701745|NCT00279565|Buprenorphine|buprenorphine|mesh-list
153701746|NCT00279565|Methadone|methadone|mesh-list
153701747|NCT00279565|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153701748|NCT00279565|Antiviral Agents|antiviral agents|mesh-ancestor
153538724|NCT01529320|Hormones|hormones|mesh-ancestor
153701749|NCT00279565|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153701750|NCT00279565|Antimetabolites|antimetabolites|mesh-ancestor
153701751|NCT00279565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153701752|NCT00279565|Immunologic Factors|immunologic factors|mesh-ancestor
153701804|NCT00416767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153701805|NCT00416767|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153336010|NCT02287636|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
153783204|NCT00235859|Adalimumab|adalimumab|mesh-list
153701806|NCT00416767|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153701807|NCT00416767|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153701808|NCT00416767|Immunologic Factors|immunologic factors|mesh-ancestor
153701809|NCT00416767|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
153701811|NCT00416767|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153701812|NCT00416767|Antidotes|antidotes|mesh-ancestor
153701813|NCT00416767|Protective Agents|protective agents|mesh-ancestor
153701814|NCT00416767|Vitamin B Complex|vitamin b complex|mesh-ancestor
153701815|NCT00416767|Vitamins|vitamins|mesh-ancestor
153701816|NCT00416767|Micronutrients|micronutrients|mesh-ancestor
153701817|NCT00076115|Risperidone|risperidone|mesh-list
153701818|NCT00076115|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153701819|NCT00076115|Serotonin Agents|serotonin agents|mesh-ancestor
153701820|NCT00076115|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153701821|NCT00076115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153701822|NCT00076115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153701823|NCT00076115|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153701824|NCT00076115|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153701825|NCT00076115|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153701826|NCT00076115|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153701827|NCT00076115|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
153701828|NCT00076115|Dopamine Agents|dopamine agents|mesh-ancestor
153701829|NCT00109239|Bevacizumab|bevacizumab|mesh-list
153701841|NCT00280033|Antacids|antacids|mesh-ancestor
153701853|NCT00076232|Antiviral Agents|antiviral agents|mesh-ancestor
153701854|NCT00076232|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153701855|NCT00280423|Casopitant|casopitant|mesh-list
153701856|NCT00280423|Antiemetics|antiemetics|mesh-ancestor
153701857|NCT00280423|Autonomic Agents|autonomic agents|mesh-ancestor
153701858|NCT00280423|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153916632|NCT00994461|Celecoxib|celecoxib|mesh-list
153701859|NCT00280423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153701860|NCT00280423|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153701861|NCT00280423|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
153701862|NCT00280423|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153701863|NCT00280423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153701865|NCT00109356|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153701866|NCT00280462|Nifedipine|nifedipine|mesh-list
153701867|NCT00280462|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153701868|NCT00280462|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153701873|NCT00280462|Tocolytic Agents|tocolytic agents|mesh-ancestor
153701909|NCT00280618|Oxaliplatin|oxaliplatin|mesh-list
153701910|NCT00280618|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153701911|NCT00416845|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
153701912|NCT00416845|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
153701913|NCT00416845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153701914|NCT00416845|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153701915|NCT00416845|Immunologic Factors|immunologic factors|mesh-ancestor
153701916|NCT00416845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153701917|NCT00280696|Levetiracetam|levetiracetam|mesh-list
153701918|NCT00280696|Anticonvulsants|anticonvulsants|mesh-ancestor
153463443|NCT04844268|Immunologic Factors|immunologic factors|mesh-ancestor
153463444|NCT04844268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153336047|NCT05484648|Analgesics|analgesics|mesh-ancestor
153662759|NCT00142948|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
153662760|NCT00142948|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
153701920|NCT00076388|Docetaxel|docetaxel|mesh-list
153701921|NCT00076388|Gefitinib|gefitinib|mesh-list
153701922|NCT00076388|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153701923|NCT00076388|Tubulin Modulators|tubulin modulators|mesh-ancestor
153701924|NCT00076388|Antimitotic Agents|antimitotic agents|mesh-ancestor
153701925|NCT00076388|Mitosis Modulators|mitosis modulators|mesh-ancestor
153701926|NCT00076388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153701927|NCT00076388|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153701928|NCT00076388|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153701929|NCT00076388|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153701930|NCT00280774|Memantine|memantine|mesh-list
153701931|NCT00280774|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
153701932|NCT00280774|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
153701933|NCT00280774|Dopamine Agents|dopamine agents|mesh-ancestor
153701934|NCT00280774|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153701935|NCT00280774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153701936|NCT00280774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153701937|NCT00280774|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
153701938|NCT00280774|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
153701939|NCT00109551|Folic Acid|folic acid|mesh-list
153701940|NCT00109551|Zinc Sulfate|zinc sulfate|mesh-list
153701941|NCT00109551|Hematinics|hematinics|mesh-ancestor
153701952|NCT00280930|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153701953|NCT00280930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153701954|NCT00280930|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
153701955|NCT00280930|Hormone Antagonists|hormone antagonists|mesh-ancestor
153701956|NCT00280930|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153701957|NCT00280930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153701959|NCT00280969|Atazanavir Sulfate|atazanavir sulfate|mesh-list
153701960|NCT00280969|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153701961|NCT00280969|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153701962|NCT00280969|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153701963|NCT00280969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153701964|NCT00280969|Antiviral Agents|antiviral agents|mesh-ancestor
153701965|NCT00280969|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153701966|NCT00280969|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
153701967|NCT00280969|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153701968|NCT00280969|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
153702006|NCT04730297|Sensory System Agents|sensory system agents|mesh-ancestor
153702007|NCT04730297|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153702008|NCT04730297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153702009|NCT04730297|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153336066|NCT02137096|Alkylating Agents|alkylating agents|mesh-ancestor
153702010|NCT04730297|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153702011|NCT04730297|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153702012|NCT04730297|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153702013|NCT04730297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153702014|NCT04730297|Antipyretics|antipyretics|mesh-ancestor
153702015|NCT04730297|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153702016|NCT04730297|Narcotics|narcotics|mesh-ancestor
153702017|NCT04730297|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153702018|NCT04730297|Antitussive Agents|antitussive agents|mesh-ancestor
153702021|NCT00399269|Hematinics|hematinics|mesh-ancestor
153702022|NCT00281281|Vancomycin|vancomycin|mesh-list
153702023|NCT00281281|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153702024|NCT00281281|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153702025|NCT00109785|Idoxuridine|idoxuridine|mesh-list
153702026|NCT00109785|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
153702027|NCT00109785|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
153702028|NCT00109785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153702029|NCT00109785|Antiviral Agents|antiviral agents|mesh-ancestor
153702030|NCT00109785|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153662970|NCT00144118|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
153702031|NCT00109785|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153702032|NCT00109785|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153702033|NCT00281476|Simvastatin|simvastatin|mesh-list
153702034|NCT00281476|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153702035|NCT00281476|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153702036|NCT00281476|Antimetabolites|antimetabolites|mesh-ancestor
153702037|NCT00281476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153702038|NCT00281476|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153702039|NCT00281476|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
153702040|NCT00281476|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153702041|NCT00416923|Rituximab|rituximab|mesh-list
153702042|NCT00416923|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153702043|NCT00416923|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153702044|NCT00416923|Immunologic Factors|immunologic factors|mesh-ancestor
153702045|NCT00416923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153702046|NCT00416923|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153702047|NCT00416962|Oseltamivir|oseltamivir|mesh-list
153702048|NCT00416962|Amantadine|amantadine|mesh-list
153702049|NCT00416962|Antiviral Agents|antiviral agents|mesh-ancestor
153702050|NCT00416962|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153702051|NCT00416962|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153702052|NCT00416962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153702053|NCT00416962|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
153702054|NCT00416962|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
153702055|NCT00416962|Dopamine Agents|dopamine agents|mesh-ancestor
153702056|NCT00416962|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153702057|NCT00416962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153702058|NCT00416962|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153702059|NCT00416962|Analgesics|analgesics|mesh-ancestor
153702060|NCT00416962|Sensory System Agents|sensory system agents|mesh-ancestor
153702061|NCT00416962|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153702062|NCT00109824|Decitabine|decitabine|mesh-list
153702063|NCT00109824|Azacitidine|azacitidine|mesh-list
153702064|NCT00109824|Valproic Acid|valproic acid|mesh-list
153702065|NCT00109824|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153702066|NCT00109824|Antimetabolites|antimetabolites|mesh-ancestor
153336140|NCT01006018|Incretins|incretins|mesh-ancestor
153702067|NCT00109824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153702068|NCT00109824|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153702069|NCT00109824|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153702070|NCT00109824|Anticonvulsants|anticonvulsants|mesh-ancestor
153702071|NCT00109824|GABA Agents|gaba agents|mesh-ancestor
153702072|NCT00109824|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153702073|NCT00109824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153702074|NCT00109824|Antimanic Agents|antimanic agents|mesh-ancestor
153702075|NCT00109824|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153702076|NCT00109824|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153702083|NCT00109941|Enkephalin, Methionine|enkephalin, methionine|mesh-list
153702084|NCT00109941|Narcotics|narcotics|mesh-ancestor
153702085|NCT00109941|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153702086|NCT00109941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153702087|NCT00109941|Analgesics|analgesics|mesh-ancestor
153702088|NCT00109941|Sensory System Agents|sensory system agents|mesh-ancestor
153702089|NCT00109941|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153702090|NCT00109941|Mitosis Modulators|mitosis modulators|mesh-ancestor
153702091|NCT00109941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153702092|NCT00109941|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153702093|NCT00281593|Telmisartan|telmisartan|mesh-list
153702094|NCT00281593|Ramipril|ramipril|mesh-list
153702095|NCT00281593|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153702096|NCT00281593|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
153702097|NCT00281593|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
153702098|NCT00281593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153702099|NCT00281593|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
153702138|NCT00281788|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153702139|NCT00281788|Tubulin Modulators|tubulin modulators|mesh-ancestor
153702140|NCT00281788|Antimitotic Agents|antimitotic agents|mesh-ancestor
153702141|NCT00281788|Mitosis Modulators|mitosis modulators|mesh-ancestor
153702142|NCT00281788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153702143|NCT00281788|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153702144|NCT00281788|Antimetabolites|antimetabolites|mesh-ancestor
153702145|NCT00281866|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
153702146|NCT00281866|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153702147|NCT00281866|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153702148|NCT00281866|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153702150|NCT00281866|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153702201|NCT00110058|Antitubercular Agents|antitubercular agents|mesh-ancestor
153702202|NCT00110058|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153702203|NCT00110058|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153702204|NCT00110058|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153702205|NCT00281944|Leucovorin|leucovorin|mesh-list
153702206|NCT00281944|Fluorouracil|fluorouracil|mesh-list
153702207|NCT00281944|Oxaliplatin|oxaliplatin|mesh-list
153702208|NCT00281944|Calcium|calcium|mesh-list
153702209|NCT00281944|Levoleucovorin|levoleucovorin|mesh-list
153702210|NCT00281944|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153702211|NCT00281944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153702212|NCT00281944|Antimetabolites|antimetabolites|mesh-ancestor
153702267|NCT00282100|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153702268|NCT00282100|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153702269|NCT00282100|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153702270|NCT00282100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153702271|NCT00282100|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153702272|NCT00282139|Aripiprazole|aripiprazole|mesh-list
153702273|NCT00282139|Antidepressive Agents|antidepressive agents|mesh-ancestor
153702274|NCT00282139|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153702275|NCT00282139|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153702276|NCT00282139|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153702277|NCT00282139|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153702278|NCT00282139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153702279|NCT00282139|Dopamine Agonists|dopamine agonists|mesh-ancestor
153702280|NCT00282139|Dopamine Agents|dopamine agents|mesh-ancestor
153702281|NCT00282139|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153702282|NCT00282139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153702283|NCT00282139|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
153702284|NCT00282139|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
153702285|NCT00282139|Serotonin Agents|serotonin agents|mesh-ancestor
153702289|NCT00282139|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
153702319|NCT00282217|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153702320|NCT00282217|Antifungal Agents|antifungal agents|mesh-ancestor
153702321|NCT00282217|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153702322|NCT00282217|Immunologic Factors|immunologic factors|mesh-ancestor
153702323|NCT00282217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153702324|NCT00282451|Insulin|insulin|mesh-list
153702325|NCT00282451|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
153702326|NCT00282451|Insulin Aspart|insulin aspart|mesh-list
153702327|NCT00282451|Insulin, Long-Acting|insulin, long-acting|mesh-list
153663390|NCT01806090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153461704|NCT05158062|Mitosis Modulators|mitosis modulators|mesh-ancestor
153461705|NCT05158062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153461706|NCT05158062|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153461707|NCT05158062|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153461710|NCT05158062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153360265|NCT01355705|Analgesics|analgesics|mesh-ancestor
153360266|NCT01355705|Sensory System Agents|sensory system agents|mesh-ancestor
153820333|NCT00471588|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
153820334|NCT00471588|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
153820335|NCT00471588|Antidepressive Agents|antidepressive agents|mesh-ancestor
153360338|NCT01274897|Lactitol|lactitol|mesh-list
153336238|NCT01973062|Rituximab|rituximab|mesh-list
153820337|NCT00463359|Toll-Like Receptor Agonists|toll-like receptor agonists|mesh-ancestor
153820339|NCT00463359|Immunomodulating Agents|immunomodulating agents|mesh-ancestor
153820340|NCT00463359|Immunologic Factors|immunologic factors|mesh-ancestor
153360367|NCT04155164|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153665382|NCT00130026|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153820387|NCT00433043|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153360414|NCT00806234|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
153360458|NCT03678506|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
153360459|NCT03678506|Antithrombins|antithrombins|mesh-ancestor
153360460|NCT03678506|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
153360461|NCT03678506|Protease Inhibitors|protease inhibitors|mesh-ancestor
153360462|NCT03678506|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153360463|NCT03678506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153360464|NCT03678506|Anticoagulants|anticoagulants|mesh-ancestor
153360466|NCT00844298|Nilotinib|nilotinib|mesh-list
153666176|NCT00020358|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153360484|NCT01276301|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
153360485|NCT01276301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153360486|NCT01276301|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153360487|NCT01276301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153360488|NCT01276301|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153360489|NCT01276301|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153360548|NCT02193815|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
153360549|NCT02193815|Vitamins|vitamins|mesh-ancestor
153820586|NCT04702685|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153360575|NCT01331213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153360576|NCT01331213|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153360587|NCT01332071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153360588|NCT01277159|Dexamethasone|dexamethasone|mesh-list
153360594|NCT01277159|Autonomic Agents|autonomic agents|mesh-ancestor
153360610|NCT01277159|Sensory System Agents|sensory system agents|mesh-ancestor
153360611|NCT01277159|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
153360612|NCT01362959|Nicotine|nicotine|mesh-list
153360613|NCT01362959|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
153360614|NCT01362959|Autonomic Agents|autonomic agents|mesh-ancestor
153360615|NCT01362959|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153360616|NCT01362959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153360617|NCT01362959|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
153360618|NCT01362959|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
153336283|NCT00932152|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153336285|NCT00932152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153336286|NCT00932152|Sensory System Agents|sensory system agents|mesh-ancestor
153336287|NCT00932152|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153336288|NCT00932152|Autonomic Agents|autonomic agents|mesh-ancestor
153336289|NCT00932152|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153336290|NCT01916590|Bupivacaine|bupivacaine|mesh-list
153336291|NCT01916590|Anesthetics, Local|anesthetics, local|mesh-ancestor
153336292|NCT01916590|Anesthetics|anesthetics|mesh-ancestor
153336293|NCT01916590|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153336295|NCT01916590|Sensory System Agents|sensory system agents|mesh-ancestor
153360619|NCT01362959|Cholinergic Agents|cholinergic agents|mesh-ancestor
153626804|NCT02019095|Sequestering Agents|sequestering agents|mesh-ancestor
153820618|NCT00464451|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153820620|NCT00464451|Sensory System Agents|sensory system agents|mesh-ancestor
153820621|NCT00464451|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153820622|NCT00464451|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
153820623|NCT00464451|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153820624|NCT00464451|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153820625|NCT00464451|Adrenergic Agents|adrenergic agents|mesh-ancestor
153820626|NCT00464451|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153820627|NCT00464451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153820628|NCT00433940|Prednisolone|prednisolone|mesh-list
153820629|NCT00433940|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153820630|NCT00433940|Glucocorticoids|glucocorticoids|mesh-ancestor
153820631|NCT00433940|Hormones|hormones|mesh-ancestor
153702329|NCT00282451|Biphasic Insulins|biphasic insulins|mesh-list
153360621|NCT01362959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153360622|NCT01332461|Fluticasone|fluticasone|mesh-list
153360624|NCT01332461|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
153360625|NCT01332461|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153360626|NCT01332461|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153360627|NCT01332461|Autonomic Agents|autonomic agents|mesh-ancestor
153360628|NCT01332461|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153360629|NCT01332461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153360638|NCT01332461|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153360649|NCT03608696|Narcotics|narcotics|mesh-ancestor
153360650|NCT03608696|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153820665|NCT00434096|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153820666|NCT00434096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153820667|NCT01050569|Nicotine|nicotine|mesh-list
153702330|NCT00282451|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153360667|NCT04311710|Ipilimumab|ipilimumab|mesh-list
153360668|NCT04311710|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153421208|NCT06175403|Antimetabolites|antimetabolites|mesh-ancestor
153357583|NCT00748826|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
153357584|NCT00748826|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153811065|NCT00323804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153811067|NCT00323804|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153811107|NCT00331851|Immunologic Factors|immunologic factors|mesh-ancestor
153811108|NCT00331890|Choline|choline|mesh-list
153811109|NCT00331890|Cytidine Diphosphate Choline|cytidine diphosphate choline|mesh-list
153702377|NCT00110370|Insulin Glargine|insulin glargine|mesh-list
153702378|NCT00110370|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153702379|NCT00110370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153702381|NCT00283114|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153702382|NCT00283114|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153702383|NCT00076856|Temozolomide|temozolomide|mesh-list
153336354|NCT03626454|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153336356|NCT03626454|Sympathomimetics|sympathomimetics|mesh-ancestor
153702384|NCT00076856|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153702385|NCT00076856|Alkylating Agents|alkylating agents|mesh-ancestor
153702386|NCT00076856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153702387|NCT00076856|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153702388|NCT00283192|Sertraline|sertraline|mesh-list
153702389|NCT00283192|Antidepressive Agents|antidepressive agents|mesh-ancestor
153702390|NCT00283192|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153702391|NCT00283192|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
153702392|NCT00283192|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153702393|NCT00283192|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153702395|NCT00283192|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153702419|NCT00283543|Temozolomide|temozolomide|mesh-list
153702420|NCT00283543|Carmustine|carmustine|mesh-list
153702421|NCT00283543|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153702422|NCT00283543|Alkylating Agents|alkylating agents|mesh-ancestor
153702423|NCT00283543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153702424|NCT00283543|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153702425|NCT00283621|Doxorubicin|doxorubicin|mesh-list
153702426|NCT00283621|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
153702427|NCT00283621|Ifosfamide|ifosfamide|mesh-list
153702428|NCT00283621|Darbepoetin alfa|darbepoetin alfa|mesh-list
153702429|NCT00283621|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153702430|NCT00283621|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153702431|NCT00283621|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153702432|NCT00283621|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153702433|NCT00283621|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153702434|NCT00283621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153702435|NCT00283621|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153702436|NCT00283621|Alkylating Agents|alkylating agents|mesh-ancestor
153702437|NCT00283621|Hematinics|hematinics|mesh-ancestor
153702438|NCT00283660|Zinc Oxide|zinc oxide|mesh-list
153702439|NCT00283660|Dermatologic Agents|dermatologic agents|mesh-ancestor
153702440|NCT00283660|Sunscreening Agents|sunscreening agents|mesh-ancestor
153702441|NCT00283660|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
153702442|NCT00283660|Protective Agents|protective agents|mesh-ancestor
153702443|NCT00283660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153702444|NCT00077051|Tetrahydrouridine|tetrahydrouridine|mesh-list
153702445|NCT00077051|Antimetabolites|antimetabolites|mesh-ancestor
153702446|NCT00077051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153702447|NCT00283699|Albendazole|albendazole|mesh-list
153702448|NCT00283699|Anthelmintics|anthelmintics|mesh-ancestor
153702449|NCT00283699|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153702463|NCT00283777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153702464|NCT00283777|Iron Chelating Agents|iron chelating agents|mesh-ancestor
153702465|NCT00283777|Chelating Agents|chelating agents|mesh-ancestor
153702466|NCT00283777|Sequestering Agents|sequestering agents|mesh-ancestor
153702467|NCT00283777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153702468|NCT00110448|Aspirin|aspirin|mesh-list
153702469|NCT00110448|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153702470|NCT00110448|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153702471|NCT00110448|Analgesics|analgesics|mesh-ancestor
153702472|NCT00110448|Sensory System Agents|sensory system agents|mesh-ancestor
153702473|NCT00110448|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153702474|NCT00110448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153702475|NCT00110448|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153702476|NCT00110448|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153702477|NCT00110448|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153702478|NCT00110448|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153702479|NCT00110448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153702480|NCT00110448|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153702518|NCT00077168|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
153702519|NCT00077168|Hormone Antagonists|hormone antagonists|mesh-ancestor
153702520|NCT00077168|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153702521|NCT00077168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153702522|NCT00077168|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153702523|NCT00077168|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153702524|NCT00077168|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
153702525|NCT00077168|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
153702526|NCT00077168|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153702527|NCT00077168|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
153702528|NCT00077168|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153702529|NCT00077168|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153702531|NCT00110604|Hematinics|hematinics|mesh-ancestor
153702532|NCT00110604|Vitamin B Complex|vitamin b complex|mesh-ancestor
153702535|NCT00110604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153702536|NCT00284752|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
153702537|NCT00284752|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153702571|NCT00284947|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153539564|NCT01534169|Hormones|hormones|mesh-ancestor
153702572|NCT00284947|Antiemetics|antiemetics|mesh-ancestor
153702573|NCT00284947|Autonomic Agents|autonomic agents|mesh-ancestor
153702574|NCT00284947|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153702575|NCT00284947|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153702576|NCT00284947|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
153702577|NCT00284947|Protective Agents|protective agents|mesh-ancestor
153702578|NCT00284947|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153702579|NCT00284947|Immunologic Factors|immunologic factors|mesh-ancestor
153702580|NCT00110682|Imiquimod|imiquimod|mesh-list
153702581|NCT00110682|Toll-Like Receptor Agonists|toll-like receptor agonists|mesh-ancestor
153702582|NCT00110682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153702583|NCT00110682|Immunomodulating Agents|immunomodulating agents|mesh-ancestor
153702584|NCT00110682|Immunologic Factors|immunologic factors|mesh-ancestor
153702588|NCT00110682|Interferon Inducers|interferon inducers|mesh-ancestor
153702629|NCT00285181|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153702630|NCT00285181|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153702631|NCT00285181|Antimetabolites|antimetabolites|mesh-ancestor
153702632|NCT00285181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153702633|NCT00285181|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153702634|NCT00285181|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
153702635|NCT00285181|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153702636|NCT00285298|Pentoxifylline|pentoxifylline|mesh-list
153702646|NCT00285298|Antioxidants|antioxidants|mesh-ancestor
153702695|NCT00285766|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
153702696|NCT00285766|Protective Agents|protective agents|mesh-ancestor
153702697|NCT00285766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153702698|NCT00285805|Rosiglitazone|rosiglitazone|mesh-list
153702699|NCT00285805|Amiloride|amiloride|mesh-list
153702700|NCT00285805|Furosemide|furosemide|mesh-list
153702701|NCT00285805|Diuretics|diuretics|mesh-ancestor
153702702|NCT00285805|Natriuretic Agents|natriuretic agents|mesh-ancestor
153702703|NCT00285805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153702704|NCT00285805|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
153702705|NCT00285805|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153702706|NCT00285805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153702707|NCT00285805|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153702708|NCT00285805|Acid Sensing Ion Channel Blockers|acid sensing ion channel blockers|mesh-ancestor
153702709|NCT00285805|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153702751|NCT00286117|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153702752|NCT00286117|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
153702753|NCT00286117|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153702754|NCT00286117|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153702755|NCT00286117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153702756|NCT00110916|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
153702757|NCT00110916|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153702758|NCT00077558|Fludarabine|fludarabine|mesh-list
153702759|NCT00077558|Fludarabine phosphate|fludarabine phosphate|mesh-list
153702760|NCT00077558|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153702761|NCT00077558|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153702762|NCT00077558|Antimetabolites|antimetabolites|mesh-ancestor
153702763|NCT00077558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153702764|NCT00077558|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153702765|NCT00077558|Immunologic Factors|immunologic factors|mesh-ancestor
153702766|NCT00077558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153702767|NCT00286273|Heparin|heparin|mesh-list
153702768|NCT00286273|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
153702769|NCT00286273|Tinzaparin|tinzaparin|mesh-list
153702807|NCT00286585|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153702808|NCT00286585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153702809|NCT00286585|Anesthetics, General|anesthetics, general|mesh-ancestor
153702810|NCT00111072|Dexamethasone|dexamethasone|mesh-list
153702811|NCT00111072|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153702812|NCT00111072|Antiemetics|antiemetics|mesh-ancestor
153702813|NCT00111072|Autonomic Agents|autonomic agents|mesh-ancestor
153702814|NCT00111072|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153336493|NCT01606150|Sensory System Agents|sensory system agents|mesh-ancestor
153702815|NCT00111072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153702816|NCT00111072|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153702817|NCT00111072|Glucocorticoids|glucocorticoids|mesh-ancestor
153702818|NCT00111072|Hormones|hormones|mesh-ancestor
153702819|NCT00111072|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153702820|NCT00111072|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153702821|NCT00111072|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153702822|NCT00286624|Cyclosporine|cyclosporine|mesh-list
153702823|NCT00286624|Everolimus|everolimus|mesh-list
153702824|NCT00286624|Cyclosporins|cyclosporins|mesh-list
153702825|NCT00286624|Antilymphocyte Serum|antilymphocyte serum|mesh-list
153702826|NCT00286624|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153702827|NCT00286624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153702828|NCT00286624|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153702829|NCT00286624|Immunologic Factors|immunologic factors|mesh-ancestor
153702830|NCT00286624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153702831|NCT00286624|Antifungal Agents|antifungal agents|mesh-ancestor
153702832|NCT00286624|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153702833|NCT00286624|Dermatologic Agents|dermatologic agents|mesh-ancestor
153702834|NCT00286624|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153702835|NCT00286624|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
153702836|NCT00286624|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
153702837|NCT00286624|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153702838|NCT00286624|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153702839|NCT00077597|Epoetin Alfa|epoetin alfa|mesh-list
153702849|NCT00286780|Antispermatogenic Agents|antispermatogenic agents|mesh-ancestor
153702850|NCT00286780|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
153702851|NCT00111111|Etanercept|etanercept|mesh-list
153702852|NCT00111111|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153702853|NCT00111111|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153702854|NCT00111111|Analgesics|analgesics|mesh-ancestor
153702855|NCT00111111|Sensory System Agents|sensory system agents|mesh-ancestor
153702856|NCT00111111|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153702857|NCT00111111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153702858|NCT00111111|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153702911|NCT00111189|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
153702912|NCT00111189|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
153702913|NCT00111189|Dopamine Agents|dopamine agents|mesh-ancestor
153702914|NCT00077792|Enoxaparin|enoxaparin|mesh-list
153702915|NCT00077792|Enoxaparin sodium|enoxaparin sodium|mesh-list
153702916|NCT00077792|Anticoagulants|anticoagulants|mesh-ancestor
153702917|NCT00077792|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153702918|NCT00077792|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153702919|NCT00077792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153702920|NCT00111267|Vitamins|vitamins|mesh-list
153702921|NCT00111267|Folic Acid|folic acid|mesh-list
153702922|NCT00111267|Hydroxocobalamin|hydroxocobalamin|mesh-list
153702923|NCT00111267|Vitamin B 12|vitamin b 12|mesh-list
153702924|NCT00111267|Vitamin B Complex|vitamin b complex|mesh-list
153702925|NCT00111267|Micronutrients|micronutrients|mesh-ancestor
153702926|NCT00111267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153702927|NCT00111267|Hematinics|hematinics|mesh-ancestor
153702928|NCT00286936|Zolpidem|zolpidem|mesh-list
153702929|NCT00286936|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
153702934|NCT00286936|GABA Agonists|gaba agonists|mesh-ancestor
153702969|NCT00287209|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
153702970|NCT00287209|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153702971|NCT00287209|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153702972|NCT00287209|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
153702973|NCT00287209|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
153702974|NCT00287209|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
153702976|NCT00077948|Enoximone|enoximone|mesh-list
153702977|NCT00077948|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153702978|NCT00077948|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153702979|NCT00077948|Sympatholytics|sympatholytics|mesh-ancestor
153702980|NCT00077948|Autonomic Agents|autonomic agents|mesh-ancestor
153702981|NCT00077948|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153702982|NCT00077948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153702983|NCT00077948|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
153702984|NCT00077948|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
153702985|NCT00077948|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
153702986|NCT00077948|Adrenergic Agents|adrenergic agents|mesh-ancestor
153702995|NCT00111345|Daunorubicin|daunorubicin|mesh-list
153703023|NCT00287326|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153703024|NCT00287326|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153703025|NCT00287326|Adrenergic Agents|adrenergic agents|mesh-ancestor
153703026|NCT00287326|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153703027|NCT00287326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153703029|NCT00287443|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153703030|NCT00287443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153703031|NCT00077987|Sunitinib|sunitinib|mesh-list
153703032|NCT00077987|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153703033|NCT00077987|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153703034|NCT00077987|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153703035|NCT00077987|Growth Substances|growth substances|mesh-ancestor
153703036|NCT00077987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153703037|NCT00077987|Growth Inhibitors|growth inhibitors|mesh-ancestor
153703041|NCT00287521|Timolol|timolol|mesh-list
153703080|NCT00287794|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
153703081|NCT00287794|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153703082|NCT00287794|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153703083|NCT00287794|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153703084|NCT00287794|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153336587|NCT05482074|Olaparib|olaparib|mesh-list
153703085|NCT00287794|Anesthetics, General|anesthetics, general|mesh-ancestor
153703086|NCT00287794|Anesthetics|anesthetics|mesh-ancestor
153703087|NCT00287794|GABA Modulators|gaba modulators|mesh-ancestor
153703088|NCT00287794|GABA Agents|gaba agents|mesh-ancestor
153703089|NCT00287794|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153703090|NCT00287911|Topotecan|topotecan|mesh-list
153703091|NCT00287911|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153703092|NCT00287911|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
153540074|NCT01537107|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
153703093|NCT00287911|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153703094|NCT00287911|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153703095|NCT00287911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153703096|NCT00287950|Cyclophosphamide|cyclophosphamide|mesh-list
153703097|NCT00287950|Carboplatin|carboplatin|mesh-list
153703098|NCT00287950|Etoposide|etoposide|mesh-list
153703099|NCT00287950|Vincristine|vincristine|mesh-list
153703100|NCT00287950|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153703101|NCT00287950|Immunologic Factors|immunologic factors|mesh-ancestor
153703102|NCT00287950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153703103|NCT00287950|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153703104|NCT00287950|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153703105|NCT00287950|Alkylating Agents|alkylating agents|mesh-ancestor
153703107|NCT00287950|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153703128|NCT00288184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153703129|NCT00288184|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153703130|NCT00288184|Gout Suppressants|gout suppressants|mesh-ancestor
153703131|NCT00288184|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153703132|NCT00288184|Free Radical Scavengers|free radical scavengers|mesh-ancestor
153703134|NCT00288184|Protective Agents|protective agents|mesh-ancestor
153703135|NCT00288184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153703137|NCT00288223|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153703138|NCT00288223|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153703139|NCT00288262|Melatonin|melatonin|mesh-list
153703140|NCT00288262|Antioxidants|antioxidants|mesh-ancestor
153703141|NCT00288262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153703142|NCT00288262|Protective Agents|protective agents|mesh-ancestor
153703143|NCT00288262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153703144|NCT00288262|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153703146|NCT00288379|Formoterol Fumarate|formoterol fumarate|mesh-list
153703147|NCT00288379|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153703148|NCT00288379|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153703149|NCT00288379|Autonomic Agents|autonomic agents|mesh-ancestor
153703150|NCT00288379|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153703155|NCT00288379|Hormones|hormones|mesh-ancestor
153703181|NCT00399425|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153703182|NCT00399425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153703183|NCT00288535|Sirolimus|sirolimus|mesh-list
153703184|NCT00288535|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153703186|NCT00288535|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153703187|NCT00288535|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153703188|NCT00288535|Antifungal Agents|antifungal agents|mesh-ancestor
153703189|NCT00288535|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153703190|NCT00288535|Immunologic Factors|immunologic factors|mesh-ancestor
153703191|NCT00288535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153703242|NCT00289354|Picolinic acid|picolinic acid|mesh-list
153703243|NCT00289354|Trace Elements|trace elements|mesh-ancestor
153703245|NCT00289354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153336602|NCT00678574|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153703246|NCT00289354|Vitamin B Complex|vitamin b complex|mesh-ancestor
153703247|NCT00289354|Vitamins|vitamins|mesh-ancestor
153703248|NCT00289354|Iron Chelating Agents|iron chelating agents|mesh-ancestor
153703249|NCT00289354|Chelating Agents|chelating agents|mesh-ancestor
153703250|NCT00289354|Sequestering Agents|sequestering agents|mesh-ancestor
153703251|NCT00289354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153703252|NCT00289510|Vaccines|vaccines|mesh-list
153703253|NCT00289510|Immunologic Factors|immunologic factors|mesh-ancestor
153703254|NCT00289510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153703255|NCT00289588|Mupirocin|mupirocin|mesh-list
153703256|NCT00289588|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153703257|NCT00289588|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153703258|NCT00289588|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
153703259|NCT00289588|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153703260|NCT00289588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153703261|NCT00289627|Ipilimumab|ipilimumab|mesh-list
153703262|NCT00289627|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153703263|NCT00289627|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153703297|NCT00112086|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153703298|NCT00112086|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153703299|NCT00112086|Tubulin Modulators|tubulin modulators|mesh-ancestor
153703300|NCT00112086|Antimitotic Agents|antimitotic agents|mesh-ancestor
153703301|NCT00112086|Mitosis Modulators|mitosis modulators|mesh-ancestor
153703302|NCT00112086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153703303|NCT00290173|Ritodrine|ritodrine|mesh-list
153703304|NCT00290173|Sympathomimetics|sympathomimetics|mesh-ancestor
153703305|NCT00290173|Autonomic Agents|autonomic agents|mesh-ancestor
153703306|NCT00290173|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153703307|NCT00290173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153703308|NCT00290173|Tocolytic Agents|tocolytic agents|mesh-ancestor
153703309|NCT00290173|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153703310|NCT00290173|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
153703358|NCT00290641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153703359|NCT00290641|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153703360|NCT00290641|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153703361|NCT00290641|Alkylating Agents|alkylating agents|mesh-ancestor
153703362|NCT00290641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153703363|NCT00290641|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153703365|NCT00290641|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153703366|NCT00290641|Antimetabolites|antimetabolites|mesh-ancestor
153703367|NCT00290641|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153336631|NCT00542542|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153336632|NCT00542542|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153336633|NCT00542542|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153703368|NCT00290641|Antifungal Agents|antifungal agents|mesh-ancestor
153703369|NCT00290641|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153703370|NCT00290641|Dermatologic Agents|dermatologic agents|mesh-ancestor
153703371|NCT00290641|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
153703372|NCT00290641|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153703373|NCT00290641|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
153703374|NCT00290641|Antitubercular Agents|antitubercular agents|mesh-ancestor
153703375|NCT00290641|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153703376|NCT00290680|Celecoxib|celecoxib|mesh-list
153703377|NCT00290680|Bortezomib|bortezomib|mesh-list
153703378|NCT00290680|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153703379|NCT00290680|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153703380|NCT00290680|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153703381|NCT00290680|Analgesics|analgesics|mesh-ancestor
153703382|NCT00290680|Sensory System Agents|sensory system agents|mesh-ancestor
153703383|NCT00290680|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153703384|NCT00290680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153703385|NCT00290680|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153703386|NCT00290680|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153703387|NCT00290680|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
153703388|NCT00290680|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153703389|NCT00290680|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153703390|NCT00290680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153703396|NCT02960815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153703397|NCT02960815|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153703398|NCT02960815|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153703399|NCT02960815|Interferon Inducers|interferon inducers|mesh-ancestor
153703400|NCT00112281|omega-N-Methylarginine|omega-n-methylarginine|mesh-list
153703401|NCT00112281|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153703402|NCT00112281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153703403|NCT00290719|Irinotecan|irinotecan|mesh-list
153703404|NCT00290719|Gefitinib|gefitinib|mesh-list
153703405|NCT00290719|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153703406|NCT00290719|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
153703407|NCT00290719|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153703408|NCT00290719|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153703409|NCT00290719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153703410|NCT00290719|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153703411|NCT00290719|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153703412|NCT00290836|Thrombin|thrombin|mesh-list
153703413|NCT00290836|Aprotinin|aprotinin|mesh-list
153703414|NCT00290836|Hemostatics|hemostatics|mesh-ancestor
153703415|NCT00290836|Coagulants|coagulants|mesh-ancestor
153703416|NCT00290836|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
153703417|NCT00290836|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
153703418|NCT00290836|Protease Inhibitors|protease inhibitors|mesh-ancestor
153703447|NCT00291109|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153703448|NCT00291109|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
153703449|NCT00291109|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153703450|NCT00291109|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153703451|NCT00291109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153703452|NCT00291109|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
153703453|NCT00291109|Hormone Antagonists|hormone antagonists|mesh-ancestor
153703454|NCT00291109|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153703455|NCT00291109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153703457|NCT00291148|Paroxetine|paroxetine|mesh-list
153703460|NCT00291148|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153703461|NCT00291148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153703462|NCT00291148|Anticonvulsants|anticonvulsants|mesh-ancestor
153703463|NCT00291148|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153703503|NCT00112476|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153703504|NCT00112476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153703505|NCT00112476|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153703506|NCT00112476|Immunologic Factors|immunologic factors|mesh-ancestor
153703507|NCT00112476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153703508|NCT00112476|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153703509|NCT00112476|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153703510|NCT00112476|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153703511|NCT00112476|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153703515|NCT00291538|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153703516|NCT00291616|Interferons|interferons|mesh-list
153703517|NCT00291616|Interferon-alpha|interferon-alpha|mesh-list
153703564|NCT00291850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153703565|NCT00112554|Cytarabine|cytarabine|mesh-list
153703566|NCT00112554|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153703567|NCT00112554|Antimetabolites|antimetabolites|mesh-ancestor
153703568|NCT00112554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153703634|NCT00275119|Oxaliplatin|oxaliplatin|mesh-list
153703635|NCT00275119|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153703636|NCT00275119|Antimetabolites|antimetabolites|mesh-ancestor
153703637|NCT00275119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153703638|NCT00275119|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153703639|NCT00275119|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153703640|NCT00275119|Immunologic Factors|immunologic factors|mesh-ancestor
153703641|NCT00275119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153703642|NCT00275080|Decitabine|decitabine|mesh-list
153703643|NCT00275080|Azacitidine|azacitidine|mesh-list
153703644|NCT00275080|Vorinostat|vorinostat|mesh-list
153703645|NCT00275080|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153703646|NCT00275080|Antimetabolites|antimetabolites|mesh-ancestor
153703647|NCT00275080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153336704|NCT00623974|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153703648|NCT00275080|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153703649|NCT00275080|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153703650|NCT00275080|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
153703651|NCT00078962|Gemcitabine|gemcitabine|mesh-list
153703652|NCT00078962|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153703653|NCT00078962|Antimetabolites|antimetabolites|mesh-ancestor
153703655|NCT00078962|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153703686|NCT00102765|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153703687|NCT00102765|Respiratory System Agents|respiratory system agents|mesh-ancestor
153703688|NCT00102765|Dermatologic Agents|dermatologic agents|mesh-ancestor
153703689|NCT00102765|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
153703690|NCT00102765|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
153703691|NCT00102765|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
153540672|NCT01540500|Serotonin Agents|serotonin agents|mesh-ancestor
153703693|NCT00102765|Adrenergic Agents|adrenergic agents|mesh-ancestor
153703694|NCT00102765|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153703695|NCT00102765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153703696|NCT00102765|Glucocorticoids|glucocorticoids|mesh-ancestor
153703697|NCT00102765|Hormones|hormones|mesh-ancestor
153703698|NCT00102765|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153703699|NCT00102765|Sympathomimetics|sympathomimetics|mesh-ancestor
153703700|NCT00130390|Nitazoxanide|nitazoxanide|mesh-list
153703701|NCT00130390|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153703702|NCT00130390|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153703703|NCT00130312|Glucuronyl glucosamine glycan sulfate|glucuronyl glucosamine glycan sulfate|mesh-list
153703704|NCT00130312|Anticoagulants|anticoagulants|mesh-ancestor
153703705|NCT00130312|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153703706|NCT00130312|Antimetabolites|antimetabolites|mesh-ancestor
153703709|NCT00130312|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153703710|NCT00130312|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153703711|NCT00130312|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153703712|NCT00130312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153703713|NCT00130234|Omalizumab|omalizumab|mesh-list
153703714|NCT00130234|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
153703715|NCT00130234|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153703716|NCT00130234|Respiratory System Agents|respiratory system agents|mesh-ancestor
153703726|NCT00119301|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153703727|NCT00119301|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153703728|NCT00119301|Antimetabolites|antimetabolites|mesh-ancestor
153703729|NCT00119301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153703730|NCT00119301|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153703731|NCT00119301|Dermatologic Agents|dermatologic agents|mesh-ancestor
153703732|NCT00119301|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153703733|NCT00119301|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153703735|NCT00119301|Immunologic Factors|immunologic factors|mesh-ancestor
153703736|NCT00119301|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153703737|NCT00119301|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153703738|NCT00119301|Antidotes|antidotes|mesh-ancestor
153703739|NCT00119301|Protective Agents|protective agents|mesh-ancestor
153703789|NCT00130195|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153703790|NCT00130195|Antiviral Agents|antiviral agents|mesh-ancestor
153703791|NCT00130195|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153703792|NCT00130195|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153703793|NCT00130195|Tubulin Modulators|tubulin modulators|mesh-ancestor
153703794|NCT00130195|Antimitotic Agents|antimitotic agents|mesh-ancestor
153703795|NCT00130195|Mitosis Modulators|mitosis modulators|mesh-ancestor
153336781|NCT00421954|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
153703796|NCT00130195|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153703797|NCT00130195|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153703798|NCT00130195|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153703799|NCT00130195|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153703800|NCT00130195|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153703801|NCT00394303|Insulin|insulin|mesh-list
153703802|NCT00394303|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153703803|NCT00394303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153336811|NCT00000772|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153703804|NCT00119340|Cyclosporine|cyclosporine|mesh-list
153703805|NCT00119340|Mycophenolic Acid|mycophenolic acid|mesh-list
153703806|NCT00119340|Fludarabine|fludarabine|mesh-list
153703807|NCT00119340|Fludarabine phosphate|fludarabine phosphate|mesh-list
153703808|NCT00119340|Cyclosporins|cyclosporins|mesh-list
153703809|NCT00119340|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153703810|NCT00119340|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153703842|NCT00079157|Sargramostim|sargramostim|mesh-list
153703843|NCT00079157|Freund's Adjuvant|freund's adjuvant|mesh-list
153703844|NCT00079157|Immunologic Factors|immunologic factors|mesh-ancestor
153703845|NCT00079157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153703846|NCT00079157|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153703848|NCT00130000|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
153703849|NCT00130000|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153703851|NCT00130000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153703852|NCT00079235|Sirolimus|sirolimus|mesh-list
153703853|NCT00079235|Temsirolimus|temsirolimus|mesh-list
153703854|NCT00079235|MTOR Inhibitors|mtor inhibitors|mesh-list
153703855|NCT00079235|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153703856|NCT00079235|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153703857|NCT00079235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153703858|NCT00079235|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153703859|NCT00079235|Immunologic Factors|immunologic factors|mesh-ancestor
153703860|NCT00079235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153703861|NCT00079235|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153703862|NCT00079235|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153703863|NCT00079235|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153703864|NCT00079235|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153703897|NCT00129727|Mitosis Modulators|mitosis modulators|mesh-ancestor
153703898|NCT00129727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153703899|NCT00129727|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153703900|NCT00129727|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153703901|NCT00129727|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153703902|NCT00129727|Growth Substances|growth substances|mesh-ancestor
153703903|NCT00129727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153703904|NCT00129727|Growth Inhibitors|growth inhibitors|mesh-ancestor
153703905|NCT00129688|Amikacin|amikacin|mesh-list
153703906|NCT00129688|Cloxacillin|cloxacillin|mesh-list
153703907|NCT00129688|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153703908|NCT00129688|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153703909|NCT00079352|Gemcitabine|gemcitabine|mesh-list
153703910|NCT00079352|Irinotecan|irinotecan|mesh-list
153703911|NCT00079352|Alvocidib|alvocidib|mesh-list
153703958|NCT00298324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153336814|NCT00000772|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153703959|NCT00298324|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153703960|NCT00298324|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153703961|NCT00298324|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153465990|NCT05266794|Thioctic Acid|thioctic acid|mesh-list
153703963|NCT00298324|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153703964|NCT00298324|Immunologic Factors|immunologic factors|mesh-ancestor
153703965|NCT00298324|Antifungal Agents|antifungal agents|mesh-ancestor
153703966|NCT00298324|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153703967|NCT00298324|Dermatologic Agents|dermatologic agents|mesh-ancestor
153703968|NCT00298324|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153703969|NCT00298324|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
153703970|NCT00298324|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153703971|NCT00298324|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
153703972|NCT00298324|Antitubercular Agents|antitubercular agents|mesh-ancestor
153703973|NCT00298324|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153703974|NCT00079430|Paclitaxel|paclitaxel|mesh-list
153703975|NCT00079430|Bevacizumab|bevacizumab|mesh-list
153703976|NCT00079430|Carboplatin|carboplatin|mesh-list
153703977|NCT00079430|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
153703978|NCT00079430|Antibodies|antibodies|mesh-list
153703979|NCT00079430|Immunoglobulins|immunoglobulins|mesh-list
153703980|NCT00079430|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
153703981|NCT00079430|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153703982|NCT00079430|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153703983|NCT00079430|Tubulin Modulators|tubulin modulators|mesh-ancestor
153703984|NCT00079430|Antimitotic Agents|antimitotic agents|mesh-ancestor
153703985|NCT00079430|Mitosis Modulators|mitosis modulators|mesh-ancestor
153703986|NCT00079430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153703987|NCT00079430|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153703988|NCT00079430|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153703990|NCT00079430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153703991|NCT00079430|Growth Inhibitors|growth inhibitors|mesh-ancestor
153703992|NCT00079430|Immunologic Factors|immunologic factors|mesh-ancestor
153703993|NCT00298597|Epoetin Alfa|epoetin alfa|mesh-list
153703994|NCT00298597|Hematinics|hematinics|mesh-ancestor
153703996|NCT00298636|Analgesics|analgesics|mesh-ancestor
153703997|NCT00298636|Sensory System Agents|sensory system agents|mesh-ancestor
153703998|NCT00298636|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153703999|NCT00298636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153704000|NCT00298636|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153704001|NCT00298636|Vasodilator Agents|vasodilator agents|mesh-ancestor
153704002|NCT00298636|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
153704003|NCT00298636|Purinergic Agonists|purinergic agonists|mesh-ancestor
153704004|NCT00298636|Purinergic Agents|purinergic agents|mesh-ancestor
153704005|NCT00298636|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153704006|NCT00298636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153704007|NCT00086112|Risperidone|risperidone|mesh-list
153704008|NCT00086112|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153704009|NCT00086112|Serotonin Agents|serotonin agents|mesh-ancestor
153704010|NCT00086112|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153704011|NCT00086112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153704012|NCT00086112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153704015|NCT00086112|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153704016|NCT00086112|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153336861|NCT00000796|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153704046|NCT00298714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153704047|NCT00079508|Bivalirudin|bivalirudin|mesh-list
153704048|NCT00079508|Antithrombins|antithrombins|mesh-ancestor
153704049|NCT00079508|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
153704050|NCT00079508|Protease Inhibitors|protease inhibitors|mesh-ancestor
153704051|NCT00079508|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153704052|NCT00079508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153704053|NCT00079508|Anticoagulants|anticoagulants|mesh-ancestor
153704054|NCT00298870|Isoniazid|isoniazid|mesh-list
153704055|NCT00298870|Antitubercular Agents|antitubercular agents|mesh-ancestor
153704056|NCT00298870|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153704057|NCT00298870|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153704058|NCT00298870|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
153704059|NCT00298870|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153704061|NCT00298870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153704062|NCT00298870|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153704064|NCT00298909|Niacinamide|niacinamide|mesh-list
153704065|NCT00298909|Nicotinic Acids|nicotinic acids|mesh-list
153704066|NCT00298909|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153704067|NCT00298909|Antimetabolites|antimetabolites|mesh-ancestor
153704068|NCT00298909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153704069|NCT00298909|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153541045|NCT01542424|Insulin Detemir|insulin detemir|mesh-list
153704070|NCT00298909|Vasodilator Agents|vasodilator agents|mesh-ancestor
153704071|NCT00298909|Vitamin B Complex|vitamin b complex|mesh-ancestor
153704072|NCT00298909|Vitamins|vitamins|mesh-ancestor
153704073|NCT00298909|Micronutrients|micronutrients|mesh-ancestor
153704074|NCT00298909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153704092|NCT00299065|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153704093|NCT00299065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153704094|NCT00299065|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
153704095|NCT00299065|Hormone Antagonists|hormone antagonists|mesh-ancestor
153704096|NCT00299065|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153704097|NCT00079586|Heparin|heparin|mesh-list
153704098|NCT00079586|Bivalirudin|bivalirudin|mesh-list
153704099|NCT00079586|Anticoagulants|anticoagulants|mesh-ancestor
153704100|NCT00079586|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153704101|NCT00079586|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153704102|NCT00079586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153704103|NCT00079586|Antithrombins|antithrombins|mesh-ancestor
153704104|NCT00079586|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
153704105|NCT00079586|Protease Inhibitors|protease inhibitors|mesh-ancestor
153704106|NCT00079586|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153704107|NCT00418132|Thalidomide|thalidomide|mesh-list
153704108|NCT00418132|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153704109|NCT00418132|Immunologic Factors|immunologic factors|mesh-ancestor
153336878|NCT00000796|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153704110|NCT00418132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153704111|NCT00418132|Leprostatic Agents|leprostatic agents|mesh-ancestor
153704112|NCT00418132|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153704113|NCT00418132|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153704114|NCT00418132|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153704115|NCT00418132|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153704116|NCT00418132|Growth Substances|growth substances|mesh-ancestor
153704117|NCT00418132|Growth Inhibitors|growth inhibitors|mesh-ancestor
153704118|NCT00418132|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153704119|NCT00119613|Darbepoetin alfa|darbepoetin alfa|mesh-list
153704139|NCT00299611|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153704140|NCT00299611|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
153704141|NCT00299611|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153704142|NCT00299611|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153704143|NCT00299611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153704144|NCT00299611|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153704146|NCT00299611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153704147|NCT00299611|Anticonvulsants|anticonvulsants|mesh-ancestor
153704148|NCT00299611|Nootropic Agents|nootropic agents|mesh-ancestor
153704149|NCT00299650|Cisatracurium|cisatracurium|mesh-list
153704150|NCT00299650|Atracurium|atracurium|mesh-list
153704151|NCT00299650|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
153704152|NCT00299650|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
153704153|NCT00299650|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153704154|NCT00299650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153704155|NCT00299650|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
153336918|NCT00268450|Paclitaxel|paclitaxel|mesh-list
153704156|NCT00299650|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
153704157|NCT00299650|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
153704158|NCT00299650|Cholinergic Agents|cholinergic agents|mesh-ancestor
153704160|NCT00299650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153704162|NCT04727853|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
153704163|NCT04727853|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153704164|NCT04727853|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153704165|NCT04727853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153704166|NCT04727853|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153704167|NCT00299806|Aliskiren|aliskiren|mesh-list
153704168|NCT00299806|Renin Inhibitors|renin inhibitors|mesh-ancestor
153917351|NCT00642577|Vitamins|vitamins|mesh-ancestor
153704169|NCT00299806|Protease Inhibitors|protease inhibitors|mesh-ancestor
153704170|NCT00299806|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153704182|NCT00299884|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153704183|NCT00299884|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153704184|NCT00299884|Antimetabolites|antimetabolites|mesh-ancestor
153704185|NCT00299884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153704186|NCT00299884|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153704187|NCT00299884|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
153704188|NCT00299884|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153704189|NCT00119652|Quetiapine Fumarate|quetiapine fumarate|mesh-list
153704191|NCT00119652|Antidepressive Agents|antidepressive agents|mesh-ancestor
153704192|NCT00119652|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153704243|NCT00418171|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153704245|NCT00418171|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153704247|NCT00418171|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153704248|NCT00418171|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
153704249|NCT00418171|Dopamine Agents|dopamine agents|mesh-ancestor
153704250|NCT00119691|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
153704251|NCT00119691|Natriuretic Agents|natriuretic agents|mesh-ancestor
153704252|NCT00119691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153704253|NCT00300040|Chrysarobin|chrysarobin|mesh-list
153704254|NCT00300040|HBOC 201|hboc 201|mesh-list
153704255|NCT00300040|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153704256|NCT00300040|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153704257|NCT00300040|Analgesics|analgesics|mesh-ancestor
153704258|NCT00300040|Sensory System Agents|sensory system agents|mesh-ancestor
153704259|NCT00300040|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153704260|NCT00300040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153704261|NCT00300040|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153704262|NCT00300040|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153704263|NCT00300040|Blood Substitutes|blood substitutes|mesh-ancestor
153704264|NCT00079820|Vaccines|vaccines|mesh-list
153704265|NCT00079820|Immunologic Factors|immunologic factors|mesh-ancestor
153704266|NCT00079820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153704267|NCT00300079|Brinzolamide|brinzolamide|mesh-list
153704268|NCT00300079|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
153704269|NCT00300079|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153704270|NCT00300079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153704271|NCT00300118|Budesonide|budesonide|mesh-list
153704272|NCT00300118|Mesalamine|mesalamine|mesh-list
153704273|NCT00300118|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153704274|NCT00300118|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153704275|NCT00300118|Autonomic Agents|autonomic agents|mesh-ancestor
153704284|NCT00300118|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153704285|NCT00300118|Analgesics|analgesics|mesh-ancestor
153704286|NCT00300118|Sensory System Agents|sensory system agents|mesh-ancestor
153704287|NCT00300118|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153704288|NCT00119730|Rituximab|rituximab|mesh-list
153704289|NCT00119730|Fludarabine|fludarabine|mesh-list
153704290|NCT00119730|Mitoxantrone|mitoxantrone|mesh-list
153704291|NCT00119730|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153704292|NCT00119730|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153704293|NCT00119730|Immunologic Factors|immunologic factors|mesh-ancestor
153541285|NCT01544140|Midazolam|midazolam|mesh-list
153704294|NCT00119730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153704295|NCT00119730|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153704296|NCT00119730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153704297|NCT00119730|Analgesics|analgesics|mesh-ancestor
153704298|NCT00119730|Sensory System Agents|sensory system agents|mesh-ancestor
153704299|NCT00119730|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153704300|NCT00119730|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153704301|NCT00119730|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153704302|NCT00119730|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153704303|NCT00300196|Ancrod|ancrod|mesh-list
153704304|NCT00300196|Anticoagulants|anticoagulants|mesh-ancestor
153704305|NCT00300196|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153546708|NCT05993234|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153546709|NCT05993234|Immunoconjugates|immunoconjugates|mesh-ancestor
153546710|NCT05993234|Immunologic Factors|immunologic factors|mesh-ancestor
153704327|NCT00300352|Vitamin B Complex|vitamin b complex|mesh-ancestor
153704328|NCT00300352|Vitamins|vitamins|mesh-ancestor
153704329|NCT00300352|Micronutrients|micronutrients|mesh-ancestor
153704330|NCT00300352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153704331|NCT00300508|Anastrozole|anastrozole|mesh-list
153704333|NCT00300508|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153704393|NCT00080054|Dermatologic Agents|dermatologic agents|mesh-ancestor
153704394|NCT04718233|Sildenafil Citrate|sildenafil citrate|mesh-list
153704395|NCT04718233|Vasodilator Agents|vasodilator agents|mesh-ancestor
153704396|NCT04718233|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
153704397|NCT04718233|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
153704398|NCT04718233|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153704399|NCT04718233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153704400|NCT04718233|Urological Agents|urological agents|mesh-ancestor
153704401|NCT00119886|Botulinum Toxins|botulinum toxins|mesh-list
153704402|NCT00119886|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
153704403|NCT00119886|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153704404|NCT00119886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153704405|NCT00119886|Cholinergic Agents|cholinergic agents|mesh-ancestor
153704406|NCT00119886|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153704407|NCT00119886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153704409|NCT00300937|Coenzyme Q10|coenzyme q10|mesh-list
153704410|NCT00300937|Micronutrients|micronutrients|mesh-ancestor
153704411|NCT00300937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153704412|NCT00300937|Vitamins|vitamins|mesh-ancestor
153337005|NCT00000838|Didanosine|didanosine|mesh-list
153704413|NCT00418249|Ammonium trichloro(dioxoethylene-O,O'-)tellurate|ammonium trichloro(dioxoethylene-o,o'-)tellurate|mesh-list
153704414|NCT00418249|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153704415|NCT00418249|Immunologic Factors|immunologic factors|mesh-ancestor
153704416|NCT00418249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153704417|NCT00418249|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153704418|NCT00418249|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
153704439|NCT00301093|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153704440|NCT00301093|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153704441|NCT00301093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153704443|NCT00301171|Fluticasone|fluticasone|mesh-list
153704444|NCT00301171|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153704445|NCT00301171|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153704446|NCT00301171|Autonomic Agents|autonomic agents|mesh-ancestor
153704447|NCT00301171|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153704448|NCT00301171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153704449|NCT00301171|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153337006|NCT00000838|Stavudine|stavudine|mesh-list
153337007|NCT00000838|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153704450|NCT00301171|Respiratory System Agents|respiratory system agents|mesh-ancestor
153704451|NCT00301171|Dermatologic Agents|dermatologic agents|mesh-ancestor
153704452|NCT00301171|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
153704454|NCT00301210|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153704455|NCT00301210|Narcotics|narcotics|mesh-ancestor
153704456|NCT00301210|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153704457|NCT00301210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153704458|NCT00301210|Analgesics|analgesics|mesh-ancestor
153704459|NCT00301210|Sensory System Agents|sensory system agents|mesh-ancestor
153704460|NCT00301210|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153704461|NCT00080327|Aripiprazole|aripiprazole|mesh-list
153704462|NCT00080327|Antidepressive Agents|antidepressive agents|mesh-ancestor
153704463|NCT00080327|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153704464|NCT00080327|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153704465|NCT00080327|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153704466|NCT00080327|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153704467|NCT00080327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153704468|NCT00080327|Dopamine Agonists|dopamine agonists|mesh-ancestor
153704469|NCT00080327|Dopamine Agents|dopamine agents|mesh-ancestor
153704470|NCT00080327|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153704483|NCT00301405|Leprostatic Agents|leprostatic agents|mesh-ancestor
153704484|NCT00301405|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153704485|NCT00301405|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153704486|NCT00301405|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153704487|NCT00301405|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153704488|NCT00301405|Growth Substances|growth substances|mesh-ancestor
153704489|NCT00301405|Growth Inhibitors|growth inhibitors|mesh-ancestor
153704490|NCT00301405|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153704492|NCT00301483|HBOC 201|hboc 201|mesh-list
153704493|NCT00301483|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153704494|NCT00301483|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153704495|NCT00301483|Analgesics|analgesics|mesh-ancestor
153704546|NCT00080444|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153704547|NCT00080444|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
153704548|NCT00086736|Eflornithine|eflornithine|mesh-list
153704549|NCT00086736|Bicalutamide|bicalutamide|mesh-list
153704550|NCT00086736|Androgen Antagonists|androgen antagonists|mesh-ancestor
153704551|NCT00086736|Hormone Antagonists|hormone antagonists|mesh-ancestor
153337037|NCT00020722|Thiotepa|thiotepa|mesh-list
153704552|NCT00086736|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153704553|NCT00086736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153704554|NCT00086736|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153704555|NCT00086736|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
153704556|NCT00086736|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153704608|NCT00086775|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153704609|NCT00086775|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153704610|NCT00086775|Antimetabolites|antimetabolites|mesh-ancestor
153704611|NCT00086775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153704612|NCT00086775|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153704614|NCT00086892|Cetuximab|cetuximab|mesh-list
153704615|NCT00086892|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153704616|NCT00086892|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153704617|NCT00292708|Cefmetazole|cefmetazole|mesh-list
153704618|NCT00292708|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153704619|NCT00292708|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153704620|NCT00086931|Capecitabine|capecitabine|mesh-list
153704621|NCT00086931|Oxaliplatin|oxaliplatin|mesh-list
153704622|NCT00086931|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153704623|NCT00086931|Antimetabolites|antimetabolites|mesh-ancestor
153704624|NCT00086931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153704625|NCT00086931|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153704626|NCT00292747|Ibuprofen|ibuprofen|mesh-list
153704627|NCT00292747|Drotaverin|drotaverin|mesh-list
153704628|NCT00292747|Papaverine|papaverine|mesh-list
153704663|NCT00201721|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153704664|NCT00201721|Adenosine Deaminase Inhibitors|adenosine deaminase inhibitors|mesh-ancestor
153704665|NCT00201721|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153704667|NCT00201799|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
153704668|NCT00201799|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153704669|NCT00201799|Dermatologic Agents|dermatologic agents|mesh-ancestor
153704670|NCT00201799|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153704671|NCT00201799|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153704672|NCT00080678|Docetaxel|docetaxel|mesh-list
153704673|NCT00080678|Imatinib Mesylate|imatinib mesylate|mesh-list
153704674|NCT00080678|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153704675|NCT00080678|Tubulin Modulators|tubulin modulators|mesh-ancestor
153704682|NCT00086970|Ifosfamide|ifosfamide|mesh-list
153704727|NCT00120120|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153704728|NCT00120120|Growth Substances|growth substances|mesh-ancestor
153704729|NCT00120120|Growth Inhibitors|growth inhibitors|mesh-ancestor
153704730|NCT00120120|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153704731|NCT00202189|Budesonide|budesonide|mesh-list
153704735|NCT00202189|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153704736|NCT00202189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153704737|NCT00202189|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153704738|NCT00202189|Respiratory System Agents|respiratory system agents|mesh-ancestor
153704740|NCT00202189|Hormones|hormones|mesh-ancestor
153704741|NCT00202189|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153704742|NCT00202228|Riboflavin|riboflavin|mesh-list
153704743|NCT00202228|Thiamine|thiamine|mesh-list
153704744|NCT00202228|Vitamin B Complex|vitamin b complex|mesh-ancestor
153704745|NCT00202228|Vitamins|vitamins|mesh-ancestor
153704746|NCT00202228|Micronutrients|micronutrients|mesh-ancestor
153704747|NCT00202228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153704748|NCT00202228|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
153546762|NCT05948891|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153546763|NCT05948891|Autonomic Agents|autonomic agents|mesh-ancestor
153546764|NCT05948891|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153546765|NCT05948891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153546766|NCT05948891|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153546767|NCT05948891|Respiratory System Agents|respiratory system agents|mesh-ancestor
153783216|NCT00235859|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153546768|NCT05948891|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
153704749|NCT00202228|Dermatologic Agents|dermatologic agents|mesh-ancestor
153704750|NCT00087009|Rituximab|rituximab|mesh-list
153704751|NCT00087009|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153704752|NCT00087009|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153704753|NCT00087009|Immunologic Factors|immunologic factors|mesh-ancestor
153704754|NCT00087009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153704755|NCT00087009|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153704756|NCT00306319|Moxifloxacin|moxifloxacin|mesh-list
153704757|NCT00306319|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153704758|NCT00306319|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153704759|NCT00306319|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153704760|NCT00306319|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153704769|NCT00306358|Vitamin B Complex|vitamin b complex|mesh-ancestor
153704770|NCT00306358|Hematinics|hematinics|mesh-ancestor
153704771|NCT00306397|Sirolimus|sirolimus|mesh-list
153704772|NCT00306397|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153704773|NCT00306397|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153704774|NCT00306397|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153704775|NCT00306397|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153704776|NCT00306397|Antifungal Agents|antifungal agents|mesh-ancestor
153704777|NCT00306397|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153704778|NCT00306397|Immunologic Factors|immunologic factors|mesh-ancestor
153704779|NCT00306397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153704780|NCT00418600|1 alpha-hydroxyergocalciferol|1 alpha-hydroxyergocalciferol|mesh-list
153704833|NCT00087087|Pemetrexed|pemetrexed|mesh-list
153704834|NCT00087087|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153704835|NCT00087087|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153704836|NCT00087087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153704837|NCT00087087|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153704838|NCT00087087|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153704839|NCT00301795|Rituximab|rituximab|mesh-list
153704840|NCT00301795|Oblimersen|oblimersen|mesh-list
153704841|NCT00301795|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153704842|NCT00301795|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153704843|NCT00301795|Immunologic Factors|immunologic factors|mesh-ancestor
153704844|NCT00301795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153704845|NCT00301795|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153704846|NCT00080990|Leucovorin|leucovorin|mesh-list
153704847|NCT00080990|Fluorouracil|fluorouracil|mesh-list
153704848|NCT00080990|Oxaliplatin|oxaliplatin|mesh-list
153704849|NCT00080990|Alvocidib|alvocidib|mesh-list
153704850|NCT00080990|Calcium|calcium|mesh-list
153704851|NCT00080990|Levoleucovorin|levoleucovorin|mesh-list
153337135|NCT02344472|Pertuzumab|pertuzumab|mesh-list
153704852|NCT00080990|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153704853|NCT00080990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153704854|NCT00080990|Antimetabolites|antimetabolites|mesh-ancestor
153704855|NCT00080990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153704856|NCT00080990|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153704857|NCT00080990|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153704863|NCT00080990|Vitamins|vitamins|mesh-ancestor
153704885|NCT00301912|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153704886|NCT00301912|Immunologic Factors|immunologic factors|mesh-ancestor
153704887|NCT00301912|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153704888|NCT00301912|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153704889|NCT00301912|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
153704890|NCT00301912|Alkylating Agents|alkylating agents|mesh-ancestor
153704891|NCT00301912|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153704892|NCT00301912|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153704893|NCT00301951|Mycophenolic Acid|mycophenolic acid|mesh-list
153546780|NCT05948891|Hormones|hormones|mesh-ancestor
153546781|NCT05948891|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153546782|NCT05946941|Deucravacitinib|deucravacitinib|mesh-list
153546783|NCT05946941|Dermatologic Agents|dermatologic agents|mesh-ancestor
153704959|NCT00087165|Glucocorticoids|glucocorticoids|mesh-ancestor
153704960|NCT00087165|Hormones|hormones|mesh-ancestor
153546785|NCT05946941|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153546786|NCT05946941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153546787|NCT05936528|Lactoferrin|lactoferrin|mesh-list
153546788|NCT05936528|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153546789|NCT05929794|Metronidazole|metronidazole|mesh-list
153546790|NCT05929794|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153546791|NCT05929794|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153878204|NCT04775550|Dexamethasone|dexamethasone|mesh-list
153704968|NCT00302341|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153704969|NCT00302341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153704970|NCT00302341|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
153704983|NCT00302419|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153704984|NCT00302419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153704985|NCT00302497|Basiliximab|basiliximab|mesh-list
153704986|NCT00302497|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153704987|NCT00302497|Immunologic Factors|immunologic factors|mesh-ancestor
153704988|NCT00302497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153704989|NCT00081107|Epothilones|epothilones|mesh-list
153704990|NCT00081107|Desoxyepothilone B|desoxyepothilone b|mesh-list
153705036|NCT00081302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153705038|NCT00302653|Rasburicase|rasburicase|mesh-list
153705039|NCT00302653|Gout Suppressants|gout suppressants|mesh-ancestor
153705040|NCT00302653|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153705041|NCT00418288|Glucagon|glucagon|mesh-list
153542026|NCT01548911|Gemtuzumab|gemtuzumab|mesh-list
153705042|NCT00418288|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
153705043|NCT00418288|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153705044|NCT00418288|Hormones|hormones|mesh-ancestor
153546806|NCT05922930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153705046|NCT00418288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153705048|NCT00418327|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
153705049|NCT00418327|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153705050|NCT00418327|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153705051|NCT00418327|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153705052|NCT00418327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153337174|NCT00000868|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153337175|NCT00000868|Immunologic Factors|immunologic factors|mesh-ancestor
153705053|NCT00418327|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153705054|NCT00087282|Irinotecan|irinotecan|mesh-list
153705055|NCT00087282|Alvocidib|alvocidib|mesh-list
153705056|NCT00087282|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
153705057|NCT00087282|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153705058|NCT00087282|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153705059|NCT00087282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153705060|NCT00087282|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153705061|NCT00087282|Growth Inhibitors|growth inhibitors|mesh-ancestor
153705062|NCT00087282|Growth Substances|growth substances|mesh-ancestor
153705063|NCT00087282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153705064|NCT00087282|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153705065|NCT00418366|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
153705066|NCT00418366|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153705068|NCT00418366|Incretins|incretins|mesh-ancestor
153705072|NCT00418366|Protease Inhibitors|protease inhibitors|mesh-ancestor
153705073|NCT00418366|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153705074|NCT00418366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153705075|NCT00120315|Esomeprazole|esomeprazole|mesh-list
153705076|NCT00120315|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
153705077|NCT00120315|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153705078|NCT00120315|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
153705079|NCT00120315|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153705080|NCT00120315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153705081|NCT00081380|Valproic Acid|valproic acid|mesh-list
153705082|NCT00081380|Quetiapine Fumarate|quetiapine fumarate|mesh-list
153705083|NCT00081380|Antipsychotic Agents|antipsychotic agents|mesh-list
153705084|NCT00081380|Antidepressive Agents|antidepressive agents|mesh-ancestor
153705085|NCT00081380|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153705086|NCT00081380|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153705087|NCT00081380|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153705088|NCT00081380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153705128|NCT00303004|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
153705129|NCT00303004|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
153705130|NCT00303004|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153705146|NCT00081575|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153705148|NCT00087399|Gabapentin|gabapentin|mesh-list
153705149|NCT00087399|Antidepressive Agents|antidepressive agents|mesh-list
153705150|NCT00087399|Analgesics|analgesics|mesh-ancestor
153705151|NCT00087399|Sensory System Agents|sensory system agents|mesh-ancestor
153705152|NCT00087399|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153705153|NCT00087399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153705154|NCT00087399|Anticonvulsants|anticonvulsants|mesh-ancestor
153705155|NCT00087399|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153705156|NCT00087399|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153705157|NCT00087399|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153705158|NCT00087399|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153705160|NCT00087399|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
153705167|NCT00081614|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153705168|NCT00081614|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153705169|NCT00081614|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153705170|NCT00081614|Growth Substances|growth substances|mesh-ancestor
153705171|NCT00081614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153705172|NCT00081614|Growth Inhibitors|growth inhibitors|mesh-ancestor
153705173|NCT00081614|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153705174|NCT00081614|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153705175|NCT00081614|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153705176|NCT00081614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153705177|NCT00303277|Simvastatin|simvastatin|mesh-list
153705178|NCT00303277|Pravastatin|pravastatin|mesh-list
153705179|NCT00303277|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153705180|NCT00303277|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153705181|NCT00303277|Antimetabolites|antimetabolites|mesh-ancestor
153705226|NCT00303589|Lactams|lactams|mesh-list
153705227|NCT00303589|beta-Lactams|beta-lactams|mesh-list
153705228|NCT00303589|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153705229|NCT00303589|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153705230|NCT00081848|Metronidazole|metronidazole|mesh-list
153705231|NCT00081848|Celecoxib|celecoxib|mesh-list
153705232|NCT00081848|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153705233|NCT00081848|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153705234|NCT00081848|Analgesics|analgesics|mesh-ancestor
153705235|NCT00081848|Sensory System Agents|sensory system agents|mesh-ancestor
153705236|NCT00081848|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153705237|NCT00081848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153705238|NCT00081848|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153705289|NCT00081887|Antimetabolites|antimetabolites|mesh-ancestor
153705290|NCT00081887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153705291|NCT00081887|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153705298|NCT00304018|Prednisone|prednisone|mesh-list
153705299|NCT00304018|Fludarabine|fludarabine|mesh-list
153705300|NCT00304018|Fludarabine phosphate|fludarabine phosphate|mesh-list
153705301|NCT00304018|Etoposide|etoposide|mesh-list
153705302|NCT00304018|Busulfan|busulfan|mesh-list
153705303|NCT00304018|Tacrolimus|tacrolimus|mesh-list
153705304|NCT00304018|Antilymphocyte Serum|antilymphocyte serum|mesh-list
153705305|NCT00304018|Sargramostim|sargramostim|mesh-list
153705306|NCT00304018|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153705307|NCT00304018|Glucocorticoids|glucocorticoids|mesh-ancestor
153705308|NCT00304018|Hormones|hormones|mesh-ancestor
153546822|NCT05900895|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153546823|NCT05900895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153546824|NCT05900895|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
153546825|NCT05900895|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153705345|NCT00304252|Interferon beta-1a|interferon beta-1a|mesh-list
153705346|NCT00304252|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153337225|NCT00001864|Atropine|atropine|mesh-list
153705347|NCT00304252|Antiviral Agents|antiviral agents|mesh-ancestor
153705348|NCT00304252|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153705349|NCT00304252|Immunologic Factors|immunologic factors|mesh-ancestor
153705350|NCT00304252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153705351|NCT00304252|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153705353|NCT00120471|Antiviral Agents|antiviral agents|mesh-ancestor
153705354|NCT00120471|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153705355|NCT00120471|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153705356|NCT00120471|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153705357|NCT00120471|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153705358|NCT00120471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153705359|NCT00120471|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153705360|NCT00120471|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153705361|NCT00082043|Dutasteride|dutasteride|mesh-list
153705362|NCT00082043|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
153705363|NCT00082043|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153705364|NCT00082043|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153705365|NCT00082043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153705366|NCT00082043|Hormone Antagonists|hormone antagonists|mesh-ancestor
153705367|NCT00082043|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153705368|NCT00082043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153705369|NCT00304291|Mitoxantrone|mitoxantrone|mesh-list
153705370|NCT00304291|Analgesics|analgesics|mesh-ancestor
153705371|NCT00304291|Sensory System Agents|sensory system agents|mesh-ancestor
153705372|NCT00304291|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153705386|NCT00082082|Immunologic Factors|immunologic factors|mesh-ancestor
153705387|NCT00082082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153705388|NCT00304447|Gemtuzumab|gemtuzumab|mesh-list
153705389|NCT00304447|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153705390|NCT00304447|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153705391|NCT00304447|Immunotoxins|immunotoxins|mesh-ancestor
153705392|NCT00304447|Immunoconjugates|immunoconjugates|mesh-ancestor
153705393|NCT00304447|Immunologic Factors|immunologic factors|mesh-ancestor
153705394|NCT00304447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153705395|NCT00087711|Gemcitabine|gemcitabine|mesh-list
153705396|NCT00087711|Pemetrexed|pemetrexed|mesh-list
153705397|NCT00087711|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153705398|NCT00087711|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153705399|NCT00087711|Antimetabolites|antimetabolites|mesh-ancestor
153705400|NCT00087711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153705401|NCT00087711|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153705434|NCT00082199|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153705435|NCT00082199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153705436|NCT00082199|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
153705437|NCT00082199|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
153705438|NCT00082199|Serotonin Agents|serotonin agents|mesh-ancestor
153705439|NCT00082199|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
153705440|NCT00082199|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153705441|NCT00082199|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
153705442|NCT00082199|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
153705443|NCT00120510|Lamivudine|lamivudine|mesh-list
153705444|NCT00120510|Zidovudine|zidovudine|mesh-list
153705445|NCT00120510|Efavirenz|efavirenz|mesh-list
153705446|NCT00120510|Lamivudine, zidovudine drug combination|lamivudine, zidovudine drug combination|mesh-list
153705447|NCT00120510|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153705448|NCT00120510|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153705449|NCT00120510|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153705450|NCT00120510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153705451|NCT00120510|Antiviral Agents|antiviral agents|mesh-ancestor
153705452|NCT00120510|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153705453|NCT00120510|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153705484|NCT00082277|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153705485|NCT00082277|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153705486|NCT00082277|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
153705487|NCT00082277|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153705488|NCT00082277|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153705489|NCT00082277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153705490|NCT00082277|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
153705491|NCT00082277|Hormone Antagonists|hormone antagonists|mesh-ancestor
153705492|NCT00082277|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153705493|NCT00082277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153705494|NCT00082277|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153705495|NCT00082277|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153705496|NCT00082277|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153705497|NCT00082277|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153705499|NCT00305266|Immunologic Factors|immunologic factors|mesh-ancestor
153705500|NCT00305266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153705501|NCT00082316|Capsaicin|capsaicin|mesh-list
153705502|NCT00082316|Antipruritics|antipruritics|mesh-ancestor
153705503|NCT00082316|Dermatologic Agents|dermatologic agents|mesh-ancestor
153705504|NCT00082316|Sensory System Agents|sensory system agents|mesh-ancestor
153705505|NCT00082316|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153705506|NCT00082316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153705519|NCT00305422|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153705520|NCT00305422|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153705521|NCT00305422|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153705522|NCT00305422|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
153705523|NCT00305422|Dopamine Agents|dopamine agents|mesh-ancestor
153705528|NCT00305461|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153705529|NCT00305461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153705530|NCT00305461|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
153705531|NCT00082394|Atazanavir Sulfate|atazanavir sulfate|mesh-list
153705532|NCT00082394|Lamivudine, zidovudine drug combination|lamivudine, zidovudine drug combination|mesh-list
153705533|NCT00082394|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
153705534|NCT00082394|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
153705535|NCT00082394|Protease Inhibitors|protease inhibitors|mesh-ancestor
153705536|NCT00082394|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153705537|NCT00082394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153705538|NCT00082394|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153705539|NCT00082394|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153705540|NCT00082394|Antiviral Agents|antiviral agents|mesh-ancestor
153705541|NCT00082394|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153705542|NCT00082394|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153705543|NCT00082394|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153705544|NCT00305500|Escitalopram|escitalopram|mesh-list
153705545|NCT00305500|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
153705546|NCT00305500|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153705547|NCT00305500|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153705548|NCT00305500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153705552|NCT00305539|Adalimumab|adalimumab|mesh-list
153705559|NCT00305734|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153705560|NCT00305734|Antimetabolites|antimetabolites|mesh-ancestor
153546858|NCT05893862|Moxifloxacin|moxifloxacin|mesh-list
153546859|NCT05893862|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153546860|NCT05893862|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153546861|NCT05893862|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153546862|NCT05893862|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153546863|NCT05893862|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153546864|NCT05893862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153546865|NCT05893862|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153546869|NCT05889624|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153705625|NCT00306748|Linaclotide|linaclotide|mesh-list
153705626|NCT00306748|Guanylyl Cyclase C Agonists|guanylyl cyclase c agonists|mesh-ancestor
153705627|NCT00306748|Enzyme Activators|enzyme activators|mesh-ancestor
153705628|NCT00306748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153705629|NCT00306748|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153705630|NCT00082784|Bortezomib|bortezomib|mesh-list
153705631|NCT00082784|Alvocidib|alvocidib|mesh-list
153705632|NCT00082784|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153705633|NCT00082784|Growth Inhibitors|growth inhibitors|mesh-ancestor
153705634|NCT00082784|Growth Substances|growth substances|mesh-ancestor
153542622|NCT01552967|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153705635|NCT00082784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153705636|NCT00082784|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153705637|NCT00082784|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153705638|NCT00082784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153705639|NCT00306826|Pioglitazone|pioglitazone|mesh-list
153705640|NCT00306826|Simvastatin|simvastatin|mesh-list
153705641|NCT00306826|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153705642|NCT00306826|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153705643|NCT00306826|Antimetabolites|antimetabolites|mesh-ancestor
153705644|NCT00306826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153705645|NCT00306826|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153705646|NCT00306826|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
153705647|NCT00306826|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153705648|NCT00306826|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153705650|NCT00082823|Aflibercept|aflibercept|mesh-list
153705661|NCT00087945|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153705666|NCT00087945|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153705667|NCT00087945|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153705668|NCT00087945|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153705669|NCT00087945|Antimetabolites|antimetabolites|mesh-ancestor
153705671|NCT00082862|Interferon-alpha|interferon-alpha|mesh-list
153705682|NCT00307099|Meropenem|meropenem|mesh-list
153705724|NCT00120744|Serotonin Agents|serotonin agents|mesh-ancestor
153705725|NCT00120744|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153705726|NCT00120744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153705727|NCT00083057|Paclitaxel|paclitaxel|mesh-list
153705728|NCT00083057|Gefitinib|gefitinib|mesh-list
153337320|NCT00000178|Prednisone|prednisone|mesh-list
153337323|NCT00000178|Hormones|hormones|mesh-ancestor
153705729|NCT00083057|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153705742|NCT00307606|Prednisolone acetate|prednisolone acetate|mesh-list
153705743|NCT00307606|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
153705744|NCT00307606|Prednisolone phosphate|prednisolone phosphate|mesh-list
153705745|NCT00307606|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153705746|NCT00307606|Antiemetics|antiemetics|mesh-ancestor
153705747|NCT00307606|Autonomic Agents|autonomic agents|mesh-ancestor
153705748|NCT00307606|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153705749|NCT00307606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153705750|NCT00307606|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153705751|NCT00307606|Glucocorticoids|glucocorticoids|mesh-ancestor
153705752|NCT00307606|Hormones|hormones|mesh-ancestor
153705753|NCT00307606|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153705754|NCT00307606|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
153705755|NCT00307606|Protective Agents|protective agents|mesh-ancestor
153705779|NCT00307645|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153705780|NCT00307645|Glucocorticoids|glucocorticoids|mesh-ancestor
153705781|NCT00307645|Hormones|hormones|mesh-ancestor
153546883|NCT05886049|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153705791|NCT00307645|Autonomic Agents|autonomic agents|mesh-ancestor
153705813|NCT00120783|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153705815|NCT00307723|Gemcitabine|gemcitabine|mesh-list
153705816|NCT00307723|Fluorouracil|fluorouracil|mesh-list
153705817|NCT00307723|Oxaliplatin|oxaliplatin|mesh-list
153705818|NCT00307723|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153705819|NCT00307723|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153705837|NCT00120822|Vitamin B Complex|vitamin b complex|mesh-ancestor
153705838|NCT00120822|Vitamins|vitamins|mesh-ancestor
153705839|NCT00120822|Micronutrients|micronutrients|mesh-ancestor
153705840|NCT00120822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153705841|NCT00083213|Aflibercept|aflibercept|mesh-list
153705842|NCT00083213|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153705843|NCT00083213|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153705844|NCT00083213|Growth Substances|growth substances|mesh-ancestor
153705858|NCT00418678|Nabilone|nabilone|mesh-list
153705859|NCT00418678|Antiemetics|antiemetics|mesh-ancestor
153705860|NCT00418678|Autonomic Agents|autonomic agents|mesh-ancestor
153705861|NCT00418678|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153705862|NCT00418678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153705863|NCT00418678|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153705864|NCT00418678|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153705865|NCT00418678|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153705866|NCT00418678|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153705867|NCT00418678|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153705868|NCT00120861|Interferons|interferons|mesh-list
153705869|NCT00120861|Ribavirin|ribavirin|mesh-list
153705870|NCT00120861|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153705871|NCT00120861|Antiviral Agents|antiviral agents|mesh-ancestor
153705872|NCT00120861|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153705873|NCT00120861|Antimetabolites|antimetabolites|mesh-ancestor
153705875|NCT00418756|Nilotinib|nilotinib|mesh-list
153705918|NCT00308425|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153705919|NCT00308425|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153705920|NCT00308425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153705921|NCT00308425|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153337360|NCT00000196|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
153337361|NCT00000196|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
153705922|NCT00308425|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
153705923|NCT00308425|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
153705925|NCT00308503|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153705926|NCT00308503|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153705983|NCT00309049|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153705984|NCT00309088|Tacrolimus|tacrolimus|mesh-list
153705985|NCT00309088|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153705986|NCT00309088|Immunologic Factors|immunologic factors|mesh-ancestor
153705987|NCT00309088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153705988|NCT00309088|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
153705989|NCT00309088|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153705990|NCT00309088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153705998|NCT00120978|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153705999|NCT00120978|Respiratory System Agents|respiratory system agents|mesh-ancestor
153706000|NCT00120978|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153706001|NCT00120978|Dermatologic Agents|dermatologic agents|mesh-ancestor
153706002|NCT00120978|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
153706003|NCT00309205|Dapivirine|dapivirine|mesh-list
153706004|NCT00309205|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153706005|NCT00309205|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153706006|NCT00309205|Antiviral Agents|antiviral agents|mesh-ancestor
153706008|NCT00309283|Somatostatin|somatostatin|mesh-list
153706032|NCT04727502|Analgesics|analgesics|mesh-ancestor
153706033|NCT04727502|Sensory System Agents|sensory system agents|mesh-ancestor
153706034|NCT04727502|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153706035|NCT04727502|Antidepressive Agents|antidepressive agents|mesh-ancestor
153706036|NCT04727502|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153706037|NCT04727502|Dopamine Agents|dopamine agents|mesh-ancestor
153706038|NCT00309361|Phentolamine|phentolamine|mesh-list
153706039|NCT00309361|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
153706040|NCT00309361|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
153706041|NCT00309361|Adrenergic Agents|adrenergic agents|mesh-ancestor
153706042|NCT00309361|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153706043|NCT00309361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153706044|NCT00309361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153706045|NCT00309361|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153706047|NCT00088491|Antiemetics|antiemetics|mesh-ancestor
153706048|NCT00088491|Autonomic Agents|autonomic agents|mesh-ancestor
153706049|NCT00088491|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153706050|NCT00088491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153706051|NCT00088491|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153706052|NCT00088491|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153546914|NCT05838599|Toll-Like Receptor Agonists|toll-like receptor agonists|mesh-ancestor
153546915|NCT05838599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153546916|NCT05838599|Immunomodulating Agents|immunomodulating agents|mesh-ancestor
153546917|NCT05838599|Immunologic Factors|immunologic factors|mesh-ancestor
153546918|NCT05838599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153546919|NCT05838599|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153546920|NCT05838599|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153706059|NCT00088491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153706060|NCT00088491|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153706061|NCT00088491|Serotonin Agents|serotonin agents|mesh-ancestor
153706063|NCT00309517|Edrecolomab|edrecolomab|mesh-list
153706064|NCT00309517|Antidotes|antidotes|mesh-ancestor
153706065|NCT00309517|Protective Agents|protective agents|mesh-ancestor
153706066|NCT00309517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153706067|NCT00309517|Vitamin B Complex|vitamin b complex|mesh-ancestor
153706073|NCT00121017|Lopinavir|lopinavir|mesh-list
153706074|NCT00121017|Tenofovir|tenofovir|mesh-list
153706075|NCT00121017|Emtricitabine|emtricitabine|mesh-list
153706076|NCT00121017|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
153706077|NCT00121017|Efavirenz|efavirenz|mesh-list
153706078|NCT00121017|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
153706079|NCT00121017|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
153706080|NCT00121017|Protease Inhibitors|protease inhibitors|mesh-ancestor
153706081|NCT00121017|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153706082|NCT00121017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153706083|NCT00121017|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153706084|NCT00121017|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153706085|NCT00121017|Antiviral Agents|antiviral agents|mesh-ancestor
153706132|NCT00309634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153706133|NCT00309712|Simvastatin|simvastatin|mesh-list
153706134|NCT00309712|Fenofibrate|fenofibrate|mesh-list
153706135|NCT00309712|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153706136|NCT00309712|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153706137|NCT00309712|Antimetabolites|antimetabolites|mesh-ancestor
153706138|NCT00309712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153706139|NCT00309712|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153706140|NCT00309712|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
153706141|NCT00309712|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153706142|NCT00121056|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
153706143|NCT00121056|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153706144|NCT00309790|Sildenafil Citrate|sildenafil citrate|mesh-list
153706145|NCT00309790|Vasodilator Agents|vasodilator agents|mesh-ancestor
153706146|NCT00309790|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
153706147|NCT00309790|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
153706148|NCT00309790|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153706149|NCT00309790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153706150|NCT00309790|Urological Agents|urological agents|mesh-ancestor
153706152|NCT00418873|Zotepine|zotepine|mesh-list
153706153|NCT00418873|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153706154|NCT00418873|Serotonin Agents|serotonin agents|mesh-ancestor
153706155|NCT00418873|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153546923|NCT05836584|Leucovorin|leucovorin|mesh-list
153706193|NCT00083681|Cyclophosphamide|cyclophosphamide|mesh-list
153706194|NCT00083681|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153706195|NCT00083681|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153706196|NCT00083681|Antiemetics|antiemetics|mesh-ancestor
153706197|NCT00083681|Autonomic Agents|autonomic agents|mesh-ancestor
153706198|NCT00083681|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153706199|NCT00083681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153706200|NCT00083681|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153706201|NCT00083681|Glucocorticoids|glucocorticoids|mesh-ancestor
153706294|NCT00309673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153706296|NCT00310843|Nevirapine|nevirapine|mesh-list
153337437|NCT00000964|Antiviral Agents|antiviral agents|mesh-ancestor
153337455|NCT00000226|Buprenorphine|buprenorphine|mesh-list
153706297|NCT00310843|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153706298|NCT00310843|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153706299|NCT00310843|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153706361|NCT00088959|Analgesics|analgesics|mesh-ancestor
153706362|NCT00088959|Sensory System Agents|sensory system agents|mesh-ancestor
153706363|NCT00088959|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153706364|NCT00088959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153706365|NCT00088959|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153706366|NCT00088959|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153918104|NCT01179737|Nilotinib|nilotinib|mesh-list
153706368|NCT00088959|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153706369|NCT05568017|Edotreotide|edotreotide|mesh-list
153706370|NCT05568017|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
153706371|NCT05568017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153706372|NCT00311389|Timolol|timolol|mesh-list
153706373|NCT00311389|Travoprost|travoprost|mesh-list
153706374|NCT00311389|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
153706375|NCT00311389|Latanoprost|latanoprost|mesh-list
153706408|NCT00311467|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153706409|NCT00311545|Siltuximab|siltuximab|mesh-list
153706410|NCT00311545|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153706411|NCT00089037|Sirolimus|sirolimus|mesh-list
153706412|NCT00089037|Methotrexate|methotrexate|mesh-list
153706413|NCT00089037|Tacrolimus|tacrolimus|mesh-list
153706414|NCT00089037|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
153706415|NCT00089037|Abortifacient Agents|abortifacient agents|mesh-ancestor
153706416|NCT00089037|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153706417|NCT00089037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153706418|NCT00089037|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153706419|NCT00089037|Antimetabolites|antimetabolites|mesh-ancestor
153706420|NCT00089037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153706421|NCT00089037|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153706422|NCT00089037|Dermatologic Agents|dermatologic agents|mesh-ancestor
153706434|NCT00311740|Valsartan|valsartan|mesh-list
153706468|NCT00121446|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153706469|NCT00121446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153706470|NCT00121446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153706471|NCT00121446|Anticoagulants|anticoagulants|mesh-ancestor
153706472|NCT00121446|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153706473|NCT00121446|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153706474|NCT00311974|Dihydralazine|dihydralazine|mesh-list
153706475|NCT00311974|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153706477|NCT00312013|Anticoagulants|anticoagulants|mesh-ancestor
153706478|NCT00312013|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153706479|NCT00312013|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153706480|NCT00312013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153706481|NCT00121524|Atropine|atropine|mesh-list
153706530|NCT00089115|Immunologic Factors|immunologic factors|mesh-ancestor
153706531|NCT00089115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153706532|NCT00089115|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153706533|NCT00312325|Prednisolone|prednisolone|mesh-list
153706534|NCT00312325|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153706535|NCT00312325|Glucocorticoids|glucocorticoids|mesh-ancestor
153543534|NCT04699604|Levocetirizine|levocetirizine|mesh-list
153706537|NCT00312325|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153706538|NCT00312325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153706539|NCT00312325|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153337459|NCT00000226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153706540|NCT00312325|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153706542|NCT05567471|Immunologic Factors|immunologic factors|mesh-ancestor
153706543|NCT05567471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153706544|NCT00089154|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
153706545|NCT00089154|Antibodies|antibodies|mesh-list
153706546|NCT00089154|Immunoglobulins|immunoglobulins|mesh-list
153706547|NCT00089154|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
153706548|NCT00089154|Immunologic Factors|immunologic factors|mesh-ancestor
153706549|NCT00089154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153706550|NCT00089154|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153706551|NCT00312481|Ascorbic Acid|ascorbic acid|mesh-list
153706552|NCT00312481|Magnesium citrate|magnesium citrate|mesh-list
153706582|NCT00312520|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153706583|NCT00312520|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153706584|NCT00089193|Sargramostim|sargramostim|mesh-list
153706585|NCT00089193|Freund's Adjuvant|freund's adjuvant|mesh-list
153706586|NCT00089193|Immunologic Factors|immunologic factors|mesh-ancestor
153706587|NCT00089193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153706588|NCT00089193|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153706589|NCT00293098|Deferiprone|deferiprone|mesh-list
153337477|NCT02549196|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
153706590|NCT00293098|Iron Chelating Agents|iron chelating agents|mesh-ancestor
153706591|NCT00293098|Chelating Agents|chelating agents|mesh-ancestor
153706592|NCT00293098|Sequestering Agents|sequestering agents|mesh-ancestor
153706593|NCT00293098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153706594|NCT00293176|Donepezil|donepezil|mesh-list
153706595|NCT00293176|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
153706602|NCT00121563|Thalidomide|thalidomide|mesh-list
153706643|NCT00121563|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153706644|NCT00293332|Bevacizumab|bevacizumab|mesh-list
153706645|NCT00293332|Carboplatin|carboplatin|mesh-list
153706646|NCT00293332|Docetaxel|docetaxel|mesh-list
153706647|NCT00293332|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153706648|NCT00293332|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153706649|NCT00293332|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153706650|NCT00293332|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153706651|NCT00293332|Growth Substances|growth substances|mesh-ancestor
153706652|NCT00293332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153706654|NCT00293332|Tubulin Modulators|tubulin modulators|mesh-ancestor
153706655|NCT00293332|Antimitotic Agents|antimitotic agents|mesh-ancestor
153706656|NCT00293332|Mitosis Modulators|mitosis modulators|mesh-ancestor
153706657|NCT00293332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153706703|NCT00293644|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
153706704|NCT00293644|Histamine Antagonists|histamine antagonists|mesh-ancestor
153706705|NCT00293644|Histamine Agents|histamine agents|mesh-ancestor
153706706|NCT00293644|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153706707|NCT00293644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153706708|NCT00293761|Travoprost|travoprost|mesh-list
153706709|NCT00293761|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153706710|NCT00293800|Timolol|timolol|mesh-list
153706711|NCT00293800|Travoprost|travoprost|mesh-list
153706712|NCT00293800|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
153706713|NCT00293800|Latanoprost|latanoprost|mesh-list
153706714|NCT00293800|Ophthalmic Solutions|ophthalmic solutions|mesh-list
153706715|NCT00293800|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
153706716|NCT00293800|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
153706717|NCT00293800|Adrenergic Agents|adrenergic agents|mesh-ancestor
153706718|NCT00293800|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153706719|NCT00293800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153706720|NCT00293800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153706721|NCT00293800|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153706759|NCT05567081|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
153706760|NCT05567081|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
153706761|NCT05567081|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153706762|NCT05567081|Glucocorticoids|glucocorticoids|mesh-ancestor
153706763|NCT05567081|Hormones|hormones|mesh-ancestor
153543746|NCT03675412|Caffeine|caffeine|mesh-list
153706764|NCT05567081|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153706765|NCT05567081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153706767|NCT05567081|Immunologic Factors|immunologic factors|mesh-ancestor
153706768|NCT05567081|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153706769|NCT05567081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153706770|NCT00294112|Remestemcel-l|remestemcel-l|mesh-list
153706771|NCT00294112|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153706772|NCT00294112|Antiviral Agents|antiviral agents|mesh-ancestor
153706773|NCT00294112|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153706774|NCT00417898|Aspirin|aspirin|mesh-list
153546974|NCT05822583|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153706775|NCT00417898|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153706776|NCT00417898|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153706777|NCT00417898|Analgesics|analgesics|mesh-ancestor
153706778|NCT00417898|Sensory System Agents|sensory system agents|mesh-ancestor
153706779|NCT00417898|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153706780|NCT00417898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153706781|NCT00417898|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153706782|NCT00417898|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153706783|NCT00417898|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153706784|NCT00417898|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153706785|NCT00417898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153706786|NCT00417898|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153706787|NCT00417898|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153706788|NCT00417898|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153706789|NCT00417898|Antipyretics|antipyretics|mesh-ancestor
153706790|NCT00294190|Topotecan|topotecan|mesh-list
153706791|NCT00294190|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
153706792|NCT00294190|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153706793|NCT00294190|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153706794|NCT00294190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153706795|NCT00294190|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153706796|NCT02960503|Azithromycin|azithromycin|mesh-list
153706797|NCT02960503|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153706798|NCT02960503|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153706799|NCT00294385|Gemcitabine|gemcitabine|mesh-list
153706800|NCT00294385|Docetaxel|docetaxel|mesh-list
153706801|NCT00294385|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153706803|NCT00294385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153706804|NCT00294385|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153706805|NCT00294385|Tubulin Modulators|tubulin modulators|mesh-ancestor
153706806|NCT00294385|Antimitotic Agents|antimitotic agents|mesh-ancestor
153706807|NCT00294385|Mitosis Modulators|mitosis modulators|mesh-ancestor
153706808|NCT00294463|Tibolone|tibolone|mesh-list
153706809|NCT00294463|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
153706810|NCT00294463|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
153706812|NCT00294463|Medroxyprogesterone|medroxyprogesterone|mesh-list
153706813|NCT00294463|Estradiol|estradiol|mesh-list
153706814|NCT00294463|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
153706815|NCT00294463|Progesterone|progesterone|mesh-list
153706816|NCT00294463|Estrogens|estrogens|mesh-ancestor
153706849|NCT00089349|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
153706850|NCT00089349|Immunologic Factors|immunologic factors|mesh-ancestor
153706851|NCT00089349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153706852|NCT00089349|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153706853|NCT00089349|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
153706854|NCT00089349|Abortifacient Agents|abortifacient agents|mesh-ancestor
153706855|NCT00089349|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153706856|NCT00089349|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153706857|NCT00089349|Antimetabolites|antimetabolites|mesh-ancestor
153706858|NCT00089349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153706859|NCT00089349|Dermatologic Agents|dermatologic agents|mesh-ancestor
153706860|NCT00089349|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153706861|NCT00089349|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153706862|NCT00089349|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153706863|NCT00089349|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153706864|NCT00089349|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153706904|NCT00294892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153706905|NCT00294892|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153706906|NCT00294892|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153706907|NCT00294892|Analgesics|analgesics|mesh-ancestor
153706908|NCT00294892|Sensory System Agents|sensory system agents|mesh-ancestor
153706911|NCT00294892|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153706912|NCT00089427|Temozolomide|temozolomide|mesh-list
153706914|NCT00089427|Alkylating Agents|alkylating agents|mesh-ancestor
153706967|NCT00295555|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
153706968|NCT00295555|Adrenergic Agents|adrenergic agents|mesh-ancestor
153706969|NCT00295555|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153706970|NCT00295555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153706971|NCT00295555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153706972|NCT00295594|Tacrolimus|tacrolimus|mesh-list
153706973|NCT00295594|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153706974|NCT00295594|Immunologic Factors|immunologic factors|mesh-ancestor
153706975|NCT00295594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153706976|NCT00295594|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
153706977|NCT00295594|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153706978|NCT00295594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153706979|NCT00121875|Hormones|hormones|mesh-list
153706980|NCT00121875|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153706981|NCT00121875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153706982|NCT00295672|Vinorelbine|vinorelbine|mesh-list
153543964|NCT03126435|Gemcitabine|gemcitabine|mesh-list
153706985|NCT00295672|Tubulin Modulators|tubulin modulators|mesh-ancestor
153337527|NCT00000994|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153706986|NCT00295672|Antimitotic Agents|antimitotic agents|mesh-ancestor
153706987|NCT00295672|Mitosis Modulators|mitosis modulators|mesh-ancestor
153707021|NCT00295945|Anesthetics, Local|anesthetics, local|mesh-ancestor
153707022|NCT00295945|Anesthetics|anesthetics|mesh-ancestor
153707023|NCT00295945|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153707024|NCT00295945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153707025|NCT00295945|Sensory System Agents|sensory system agents|mesh-ancestor
153707026|NCT00295945|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153707027|NCT00295945|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153707028|NCT00295945|Narcotics|narcotics|mesh-ancestor
153707029|NCT00295945|Analgesics|analgesics|mesh-ancestor
153707030|NCT00295945|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153707031|NCT00295945|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153707033|NCT00121914|Ethanol|ethanol|mesh-list
153707086|NCT00296062|Growth Inhibitors|growth inhibitors|mesh-ancestor
153707087|NCT00296062|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153707088|NCT00296062|Antimetabolites|antimetabolites|mesh-ancestor
153707089|NCT00296062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153707090|NCT00296062|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
153707091|NCT00296062|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153707092|NCT00296062|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153707093|NCT00296179|Zolpidem|zolpidem|mesh-list
153707094|NCT00296179|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
153707096|NCT00296179|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153707097|NCT00296179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153707098|NCT00296179|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
153707099|NCT00296179|GABA Agonists|gaba agonists|mesh-ancestor
153707100|NCT00296179|GABA Agents|gaba agents|mesh-ancestor
153707101|NCT00296179|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153707102|NCT00296179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153707103|NCT00296218|Irbesartan|irbesartan|mesh-list
153707141|NCT00296530|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153707142|NCT00296530|Adrenergic Agents|adrenergic agents|mesh-ancestor
153707143|NCT00296530|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153707144|NCT00296530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153707145|NCT00296530|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
153707146|NCT00296530|Hormone Antagonists|hormone antagonists|mesh-ancestor
153707147|NCT00296530|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153707148|NCT00296530|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
153707149|NCT00296530|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
153707151|NCT00296530|Hormones|hormones|mesh-ancestor
153707152|NCT00296530|Sympathomimetics|sympathomimetics|mesh-ancestor
153707153|NCT00090012|Olanzapine|olanzapine|mesh-list
153707154|NCT00090012|Quetiapine Fumarate|quetiapine fumarate|mesh-list
153707201|NCT00296686|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153707202|NCT00296686|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153707203|NCT00296686|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153707204|NCT00296686|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153707205|NCT00122070|Quetiapine Fumarate|quetiapine fumarate|mesh-list
153707206|NCT00122070|Antidepressive Agents|antidepressive agents|mesh-ancestor
153707207|NCT00122070|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153707208|NCT00122070|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153707209|NCT00122070|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153337556|NCT02904954|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153337570|NCT03244020|Aspirin|aspirin|mesh-list
153707210|NCT00122070|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153707211|NCT00122070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153707212|NCT00296803|Clopidogrel|clopidogrel|mesh-list
153707213|NCT00296803|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153707263|NCT00297505|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
153707264|NCT00297505|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153707265|NCT00297505|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153707266|NCT00297505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153707267|NCT00297505|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153707268|NCT00297505|Serotonin Agents|serotonin agents|mesh-ancestor
153707269|NCT00297505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153707270|NCT00297505|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
153707271|NCT00297505|Antidepressive Agents|antidepressive agents|mesh-ancestor
153707272|NCT00297505|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153707273|NCT00297544|Sildenafil Citrate|sildenafil citrate|mesh-list
153707274|NCT00297544|Vasodilator Agents|vasodilator agents|mesh-ancestor
153707275|NCT00297544|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
153707276|NCT00297544|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
153707277|NCT00297544|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153707278|NCT00297544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153707279|NCT00297544|Urological Agents|urological agents|mesh-ancestor
153707280|NCT00297583|Insulin glulisine|insulin glulisine|mesh-list
153707281|NCT00297583|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153707282|NCT00297583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153707283|NCT00297661|Sirolimus|sirolimus|mesh-list
153707284|NCT00297661|Paclitaxel|paclitaxel|mesh-list
153707285|NCT00297661|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153707286|NCT00297661|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153707287|NCT00297661|Tubulin Modulators|tubulin modulators|mesh-ancestor
153707288|NCT00297661|Antimitotic Agents|antimitotic agents|mesh-ancestor
153707289|NCT00297661|Mitosis Modulators|mitosis modulators|mesh-ancestor
153707290|NCT00297661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153707291|NCT00297661|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153707292|NCT00297661|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153707293|NCT00297661|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153707294|NCT00297661|Antifungal Agents|antifungal agents|mesh-ancestor
153707295|NCT00297661|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153707296|NCT00297661|Immunologic Factors|immunologic factors|mesh-ancestor
153707298|NCT00090207|Ondansetron|ondansetron|mesh-list
153707300|NCT00090207|Antiemetics|antiemetics|mesh-ancestor
153707301|NCT00090207|Autonomic Agents|autonomic agents|mesh-ancestor
153707302|NCT00090207|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153707303|NCT00090207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153707305|NCT00090207|Antipruritics|antipruritics|mesh-ancestor
153707306|NCT00090207|Dermatologic Agents|dermatologic agents|mesh-ancestor
153707307|NCT00090207|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
153707308|NCT00090207|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153707309|NCT00090207|Serotonin Agents|serotonin agents|mesh-ancestor
153707310|NCT00090207|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153707311|NCT00090207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153707312|NCT00090207|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
153707313|NCT00297739|Risperidone|risperidone|mesh-list
153707314|NCT00297739|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153707315|NCT00297739|Serotonin Agents|serotonin agents|mesh-ancestor
153707316|NCT00297739|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153707317|NCT00297739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153707318|NCT00297739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153707356|NCT00122226|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
153707357|NCT00122226|Protease Inhibitors|protease inhibitors|mesh-ancestor
153707358|NCT00122226|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153707359|NCT00122226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153707360|NCT00122226|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153707361|NCT00122226|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153707362|NCT00122226|Antiviral Agents|antiviral agents|mesh-ancestor
153707363|NCT00122226|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153707364|NCT00122226|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
153707365|NCT00122226|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153707366|NCT00122226|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153707367|NCT00122226|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153707369|NCT00122226|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
153707370|NCT00122226|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
153707412|NCT00322543|Dermatologic Agents|dermatologic agents|mesh-ancestor
153707413|NCT00322543|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153707414|NCT00322543|Immunologic Factors|immunologic factors|mesh-ancestor
153707415|NCT00322543|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
153707416|NCT00322543|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153707417|NCT00322543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153707418|NCT00313963|Magnesium Sulfate|magnesium sulfate|mesh-list
153707419|NCT00313963|Analgesics|analgesics|mesh-ancestor
153707424|NCT00313963|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153707425|NCT00313963|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153707426|NCT00313963|Anticonvulsants|anticonvulsants|mesh-ancestor
153707427|NCT00313963|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153707428|NCT00313963|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153707429|NCT00313963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153707430|NCT00313963|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153707432|NCT00313963|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153707465|NCT00322660|Epinephryl borate|epinephryl borate|mesh-list
153707473|NCT00322660|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153707474|NCT00322660|Autonomic Agents|autonomic agents|mesh-ancestor
153707475|NCT00322660|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153707476|NCT00322660|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153707477|NCT00322660|Respiratory System Agents|respiratory system agents|mesh-ancestor
153707478|NCT00322660|Mydriatics|mydriatics|mesh-ancestor
153707479|NCT00322660|Sympathomimetics|sympathomimetics|mesh-ancestor
153707480|NCT00322660|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
153707481|NCT00322699|Dihematoporphyrin Ether|dihematoporphyrin ether|mesh-list
153707482|NCT00322699|Hematoporphyrin Derivative|hematoporphyrin derivative|mesh-list
153707483|NCT00322699|Trioxsalen|trioxsalen|mesh-list
153707484|NCT00322699|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153707485|NCT00322699|Dermatologic Agents|dermatologic agents|mesh-ancestor
153707486|NCT00322699|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
153337608|NCT00001024|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153337609|NCT00001024|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153707487|NCT00322972|Azithromycin|azithromycin|mesh-list
153707488|NCT00322972|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153707517|NCT00323011|Vitamins|vitamins|mesh-ancestor
153707518|NCT00323011|Micronutrients|micronutrients|mesh-ancestor
153707519|NCT00323011|Hematinics|hematinics|mesh-ancestor
153707520|NCT00323011|Anticoagulants|anticoagulants|mesh-ancestor
153707521|NCT00323011|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153707522|NCT00323011|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153707523|NCT00323206|Interleukin-12|interleukin-12|mesh-list
153707524|NCT00323206|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153707525|NCT00323206|Immunologic Factors|immunologic factors|mesh-ancestor
153707526|NCT00323206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153547081|NCT05775159|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153707584|NCT00122499|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
153707585|NCT00122499|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
153707587|NCT00122499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153707588|NCT00122499|Urological Agents|urological agents|mesh-ancestor
153707590|NCT00312598|Antidepressive Agents|antidepressive agents|mesh-ancestor
153707591|NCT00312598|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153707592|NCT00312598|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153707593|NCT00312598|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153707594|NCT00312598|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153707596|NCT00312598|Dopamine Agonists|dopamine agonists|mesh-ancestor
153707597|NCT00312598|Dopamine Agents|dopamine agents|mesh-ancestor
153707598|NCT00312598|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153707599|NCT00312598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153707600|NCT00312598|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
153707601|NCT00312598|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
153707602|NCT00312598|Serotonin Agents|serotonin agents|mesh-ancestor
153707603|NCT00312598|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
153707605|NCT00312598|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
153707606|NCT00312598|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
153707607|NCT00312754|Atazanavir Sulfate|atazanavir sulfate|mesh-list
153707608|NCT00312754|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
153707609|NCT00312754|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
153707610|NCT00312754|Protease Inhibitors|protease inhibitors|mesh-ancestor
153707611|NCT00312754|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153707612|NCT00312754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153707613|NCT00312754|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153707614|NCT00312754|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153707615|NCT00312754|Antiviral Agents|antiviral agents|mesh-ancestor
153707616|NCT00312754|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153707617|NCT00312871|Epoetin Alfa|epoetin alfa|mesh-list
153707618|NCT00312871|Hematinics|hematinics|mesh-ancestor
153707619|NCT00090675|Gefitinib|gefitinib|mesh-list
153707623|NCT00090675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153707624|NCT00090675|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153707625|NCT00312988|Gemcitabine|gemcitabine|mesh-list
153707627|NCT00312988|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153707628|NCT00312988|Antimetabolites|antimetabolites|mesh-ancestor
153337632|NCT00001042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153707629|NCT00312988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153707630|NCT00312988|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153707631|NCT00312988|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
153707632|NCT00312988|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153707633|NCT00312988|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153707634|NCT00122538|Lamivudine|lamivudine|mesh-list
153707635|NCT00122538|Efavirenz|efavirenz|mesh-list
153707636|NCT00122538|Didanosine|didanosine|mesh-list
153707637|NCT00122538|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153707638|NCT00122538|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153707639|NCT00122538|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153707640|NCT00122538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153707641|NCT00122538|Antiviral Agents|antiviral agents|mesh-ancestor
153707642|NCT00122538|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153707643|NCT00122538|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153707644|NCT00122538|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153707648|NCT00122538|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
153707649|NCT00122538|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
153707650|NCT00122538|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
153707651|NCT00122538|Antimetabolites|antimetabolites|mesh-ancestor
153707652|NCT00313105|Lobeline|lobeline|mesh-list
153707653|NCT00313105|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
153707654|NCT00313105|Autonomic Agents|autonomic agents|mesh-ancestor
153707655|NCT00313105|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153707656|NCT00313105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153707661|NCT00313105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153707662|NCT00313105|Respiratory System Agents|respiratory system agents|mesh-ancestor
153707663|NCT00313183|Pramlintide|pramlintide|mesh-list
153707664|NCT00313183|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153707665|NCT00313183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153707666|NCT06003270|Quercetin|quercetin|mesh-list
153707667|NCT06003270|Antioxidants|antioxidants|mesh-ancestor
153707668|NCT06003270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153707669|NCT06003270|Protective Agents|protective agents|mesh-ancestor
153707670|NCT06003270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153707671|NCT06002854|Insulin|insulin|mesh-list
153707672|NCT06002854|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
153707673|NCT06002854|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153707674|NCT06002854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153707731|NCT06001151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153544709|NCT01559974|Micronutrients|micronutrients|mesh-ancestor
153707732|NCT06001151|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153707733|NCT06001151|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153707735|NCT06000917|Carboplatin|carboplatin|mesh-list
153707736|NCT06000917|Trastuzumab|trastuzumab|mesh-list
153707737|NCT06000917|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153707738|NCT06000917|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153707750|NCT06000137|Sufentanil|sufentanil|mesh-list
153707776|NCT06000137|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153707777|NCT06000137|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153707778|NCT06000137|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153707779|NCT06000033|Disitamab vedotin|disitamab vedotin|mesh-list
153707780|NCT06000033|Immunoconjugates|immunoconjugates|mesh-ancestor
153707781|NCT06000033|Immunologic Factors|immunologic factors|mesh-ancestor
153707782|NCT06000033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153707783|NCT05999942|Amikacin|amikacin|mesh-list
153707784|NCT05999942|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153707785|NCT05999942|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153707786|NCT05999890|Tapentadol|tapentadol|mesh-list
153707787|NCT05999890|Analgesics|analgesics|mesh-ancestor
153707788|NCT05999890|Sensory System Agents|sensory system agents|mesh-ancestor
153707789|NCT05999890|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153707790|NCT05999890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153707791|NCT05999890|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153707792|NCT05999890|Narcotics|narcotics|mesh-ancestor
153707838|NCT05999383|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153707839|NCT05999383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153707840|NCT05999331|N-Methylaspartate|n-methylaspartate|mesh-list
153707841|NCT05999331|Excitatory Amino Acid Agonists|excitatory amino acid agonists|mesh-ancestor
153707844|NCT05999331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153707886|NCT05998525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153707887|NCT05998421|Aspirin|aspirin|mesh-list
153707888|NCT05998421|Heparin|heparin|mesh-list
153707889|NCT05998421|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153707890|NCT05998421|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153707891|NCT05998421|Analgesics|analgesics|mesh-ancestor
153707892|NCT05998421|Sensory System Agents|sensory system agents|mesh-ancestor
153707893|NCT05998421|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153708025|NCT05996588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153708026|NCT05996588|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153708027|NCT05996588|Anesthetics, General|anesthetics, general|mesh-ancestor
153708028|NCT05996588|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153708029|NCT05996549|Vaccines|vaccines|mesh-list
153708030|NCT05996549|Immunologic Factors|immunologic factors|mesh-ancestor
153708031|NCT05996549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153708032|NCT05996484|Paclitaxel|paclitaxel|mesh-list
153708033|NCT05996484|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
153708034|NCT05996484|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153708035|NCT05996484|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153708036|NCT05996484|Tubulin Modulators|tubulin modulators|mesh-ancestor
153708037|NCT05996484|Antimitotic Agents|antimitotic agents|mesh-ancestor
153708038|NCT05996484|Mitosis Modulators|mitosis modulators|mesh-ancestor
153708039|NCT05996484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153708040|NCT05996445|Pembrolizumab|pembrolizumab|mesh-list
153708041|NCT05996445|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153708042|NCT05996445|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153708043|NCT05996445|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153708044|NCT05996445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153708046|NCT05996406|Venetoclax|venetoclax|mesh-list
153708047|NCT05996406|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153708048|NCT05996406|Antiemetics|antiemetics|mesh-ancestor
153708049|NCT05996406|Autonomic Agents|autonomic agents|mesh-ancestor
153708050|NCT05996406|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153708051|NCT05996406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153708052|NCT05996406|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153708053|NCT05996406|Glucocorticoids|glucocorticoids|mesh-ancestor
153708054|NCT05996406|Hormones|hormones|mesh-ancestor
153708070|NCT05996393|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153708071|NCT05996393|Dermatologic Agents|dermatologic agents|mesh-ancestor
153708072|NCT05996393|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153708073|NCT05996393|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
153708074|NCT05996224|Hyaluronic Acid|hyaluronic acid|mesh-list
153708075|NCT05996224|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153708076|NCT05996224|Immunologic Factors|immunologic factors|mesh-ancestor
153337739|NCT02548962|Antiemetics|antiemetics|mesh-ancestor
153708077|NCT05996224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153708078|NCT05996224|Viscosupplements|viscosupplements|mesh-ancestor
153708079|NCT05996224|Protective Agents|protective agents|mesh-ancestor
153708080|NCT05995392|Spironolactone|spironolactone|mesh-list
153708081|NCT05995392|Ophthalmic Solutions|ophthalmic solutions|mesh-list
153708082|NCT05995392|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
153708083|NCT05995392|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
153708084|NCT05995392|Hormone Antagonists|hormone antagonists|mesh-ancestor
153708085|NCT05995392|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153708086|NCT05995392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153708087|NCT05995392|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
153708088|NCT05995392|Diuretics|diuretics|mesh-ancestor
153708089|NCT05995392|Natriuretic Agents|natriuretic agents|mesh-ancestor
153708090|NCT05995314|Caffeine|caffeine|mesh-list
153708091|NCT05995314|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
153708092|NCT05995314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153708093|NCT05995314|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
153708094|NCT05995314|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153708095|NCT05995314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153708096|NCT05995314|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
153708097|NCT05995314|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
153708098|NCT05995314|Purinergic Agents|purinergic agents|mesh-ancestor
153708116|NCT05990985|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153708117|NCT05990985|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153708118|NCT05990985|Alkylating Agents|alkylating agents|mesh-ancestor
153708119|NCT05990985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153708120|NCT05990985|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153708121|NCT05990985|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153708122|NCT05990985|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153708123|NCT05990985|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153708182|NCT05966246|Serotonin 5-HT4 Receptor Agonists|serotonin 5-ht4 receptor agonists|mesh-ancestor
153708183|NCT05966246|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
153708184|NCT05966246|Serotonin Agents|serotonin agents|mesh-ancestor
153708185|NCT05966246|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153708186|NCT05966246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153708187|NCT05952713|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
153708189|NCT05952713|Vortioxetine|vortioxetine|mesh-list
153708190|NCT05952713|Mirtazapine|mirtazapine|mesh-list
153708191|NCT05952713|Agomelatine|agomelatine|mesh-list
153708192|NCT05952713|Citalopram|citalopram|mesh-list
153708193|NCT05952713|Fluoxetine|fluoxetine|mesh-list
153708194|NCT05952713|Paroxetine|paroxetine|mesh-list
153708195|NCT05952713|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
153708196|NCT05952713|Sertraline|sertraline|mesh-list
153708197|NCT05952713|Antidepressive Agents|antidepressive agents|mesh-list
153708198|NCT05952713|Reboxetine|reboxetine|mesh-list
153708242|NCT05925023|Antifungal Agents|antifungal agents|mesh-ancestor
153708243|NCT05925023|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153708244|NCT05925023|Immunologic Factors|immunologic factors|mesh-ancestor
153708245|NCT05925023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153708246|NCT05905419|Analgesics, Opioid|analgesics, opioid|mesh-list
153708247|NCT05905419|Narcotics|narcotics|mesh-ancestor
153337758|NCT00000274|Flupenthixol|flupenthixol|mesh-list
153708248|NCT05905419|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153708249|NCT05905419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153708250|NCT05905419|Analgesics|analgesics|mesh-ancestor
153708251|NCT05905419|Sensory System Agents|sensory system agents|mesh-ancestor
153708252|NCT05905419|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153708253|NCT05894928|Cholestyramine Resin|cholestyramine resin|mesh-list
153708254|NCT05894928|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153708255|NCT05894928|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153708256|NCT05894928|Antimetabolites|antimetabolites|mesh-ancestor
153708258|NCT05894928|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153708304|NCT05826964|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153708305|NCT05826964|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153708306|NCT05826964|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153708307|NCT05826964|Immunologic Factors|immunologic factors|mesh-ancestor
153708308|NCT05826964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153708309|NCT05826964|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153708310|NCT05826964|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
153708378|NCT05721027|Glucocorticoids|glucocorticoids|mesh-ancestor
153708429|NCT05688098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153708430|NCT05688098|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153708431|NCT05688098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153708432|NCT05688098|Vasodilator Agents|vasodilator agents|mesh-ancestor
153547163|NCT05734625|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153547164|NCT05734625|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
153547165|NCT05734625|Protective Agents|protective agents|mesh-ancestor
153708436|NCT05688085|Irbesartan|irbesartan|mesh-list
153708437|NCT05688085|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153708438|NCT05688085|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153708439|NCT05688085|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153708440|NCT05688085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153708446|NCT05686863|Remifentanil|remifentanil|mesh-list
153708488|NCT05620862|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153708489|NCT05620862|Tubulin Modulators|tubulin modulators|mesh-ancestor
153708490|NCT05620862|Antimitotic Agents|antimitotic agents|mesh-ancestor
153708491|NCT05620862|Mitosis Modulators|mitosis modulators|mesh-ancestor
153708492|NCT05620862|Analgesics|analgesics|mesh-ancestor
153708493|NCT05620862|Sensory System Agents|sensory system agents|mesh-ancestor
153708494|NCT05620862|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153708495|NCT05620862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153708496|NCT05620862|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153708497|NCT05617859|Lenvatinib|lenvatinib|mesh-list
153708498|NCT05617859|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153708499|NCT05617859|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153708500|NCT05617859|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153708501|NCT05617859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153708503|NCT05579574|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
153708543|NCT05512039|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
153708544|NCT05512039|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153708545|NCT05512039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153708546|NCT05512039|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
153708548|NCT05512039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153708549|NCT05512039|Cholinergic Agents|cholinergic agents|mesh-ancestor
153708550|NCT05512039|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153708551|NCT05488457|Oxytocin|oxytocin|mesh-list
153708552|NCT05488457|Oxytocics|oxytocics|mesh-ancestor
153708553|NCT05488457|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153708554|NCT05488457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153708555|NCT05480865|Sotorasib|sotorasib|mesh-list
153918618|NCT00610792|Doxorubicin|doxorubicin|mesh-list
153708599|NCT05424445|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153708600|NCT05424445|Oxytocics|oxytocics|mesh-ancestor
153708601|NCT05407636|Aflibercept|aflibercept|mesh-list
153708602|NCT05407636|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153708603|NCT05407636|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153708604|NCT05407636|Growth Substances|growth substances|mesh-ancestor
153708605|NCT05407636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153708606|NCT05407636|Growth Inhibitors|growth inhibitors|mesh-ancestor
153708607|NCT05407636|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153708613|NCT05405452|Ethyl Chloride|ethyl chloride|mesh-list
153708614|NCT05405452|Anesthetics|anesthetics|mesh-ancestor
153708615|NCT05405452|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153708655|NCT05375903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153708656|NCT05375903|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153708657|NCT05375903|Interferon Inducers|interferon inducers|mesh-ancestor
153708658|NCT05346354|Ravulizumab|ravulizumab|mesh-list
153708659|NCT05346354|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
153708662|NCT05346354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153708664|NCT05342519|Temsirolimus|temsirolimus|mesh-list
153708665|NCT05342519|MTOR Inhibitors|mtor inhibitors|mesh-list
153708666|NCT05342519|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153708667|NCT05342519|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153708668|NCT05342519|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153708669|NCT05342519|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153708670|NCT05342519|Antifungal Agents|antifungal agents|mesh-ancestor
153708714|NCT05331664|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153708715|NCT05331664|Respiratory System Agents|respiratory system agents|mesh-ancestor
153708716|NCT05331664|Mydriatics|mydriatics|mesh-ancestor
153708717|NCT05331664|Parasympatholytics|parasympatholytics|mesh-ancestor
153708718|NCT05331664|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
153708719|NCT05331664|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
153708720|NCT05331664|Cholinergic Agents|cholinergic agents|mesh-ancestor
153708721|NCT05331664|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153708722|NCT05331664|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
153708723|NCT05331664|Antimalarials|antimalarials|mesh-ancestor
153708724|NCT05331664|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153708725|NCT05331664|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153708726|NCT05331664|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153708727|NCT05331664|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
153708777|NCT05190471|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153708778|NCT05190471|Antimetabolites|antimetabolites|mesh-ancestor
153708779|NCT05190471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153337808|NCT01188577|Autonomic Agents|autonomic agents|mesh-ancestor
153708780|NCT05190471|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153708781|NCT05190471|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153708782|NCT05137067|Cisplatin|cisplatin|mesh-list
153708783|NCT05137067|Docetaxel|docetaxel|mesh-list
153708784|NCT05137067|Antineoplastic Agents|antineoplastic agents|mesh-list
153708785|NCT05137067|Tubulin Modulators|tubulin modulators|mesh-ancestor
153708786|NCT05137067|Antimitotic Agents|antimitotic agents|mesh-ancestor
153708787|NCT05137067|Mitosis Modulators|mitosis modulators|mesh-ancestor
153708788|NCT05137067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153708789|NCT05111912|Liraglutide|liraglutide|mesh-list
153708790|NCT05111912|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-list
153708791|NCT05111912|Glucagon|glucagon|mesh-list
153708792|NCT05111912|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
153708793|NCT05111912|Incretins|incretins|mesh-ancestor
153708794|NCT05111912|Hormones|hormones|mesh-ancestor
153708795|NCT05111912|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153708796|NCT05111912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153708833|NCT05063734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153708834|NCT05063734|Growth Inhibitors|growth inhibitors|mesh-ancestor
153708835|NCT05063734|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153708836|NCT05060822|Pirfenidone|pirfenidone|mesh-list
153708837|NCT05060822|Analgesics|analgesics|mesh-ancestor
153708838|NCT05060822|Sensory System Agents|sensory system agents|mesh-ancestor
153708839|NCT05060822|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153708840|NCT05060822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153708896|NCT04938765|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153708899|NCT04935931|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
153708900|NCT04935931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153708901|NCT04935931|Sensory System Agents|sensory system agents|mesh-ancestor
153708902|NCT04935931|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153708903|NCT04926181|Androgens|androgens|mesh-list
153708904|NCT04926181|Hormones|hormones|mesh-ancestor
153708905|NCT04926181|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153708906|NCT04926181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153708907|NCT04921189|Ascorbic Acid|ascorbic acid|mesh-list
153708908|NCT04921189|Thiamine|thiamine|mesh-list
153708959|NCT04872790|Rituximab|rituximab|mesh-list
153708960|NCT04872790|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
153708961|NCT04872790|Methotrexate|methotrexate|mesh-list
153708962|NCT04872790|Venetoclax|venetoclax|mesh-list
153708963|NCT04872790|Dasatinib|dasatinib|mesh-list
153708964|NCT04872790|Blinatumomab|blinatumomab|mesh-list
153708965|NCT04872790|Antibodies|antibodies|mesh-list
153708966|NCT04872790|Immunoglobulins|immunoglobulins|mesh-list
153708967|NCT04872790|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
153708968|NCT04872790|Muromonab-CD3|muromonab-cd3|mesh-list
153708969|NCT04872790|Antibodies, Bispecific|antibodies, bispecific|mesh-list
153708970|NCT04872790|Immunologic Factors|immunologic factors|mesh-ancestor
153708971|NCT04872790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153708972|NCT04872790|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153708973|NCT04872790|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153708974|NCT04872790|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153708975|NCT04872790|Glucocorticoids|glucocorticoids|mesh-ancestor
153708977|NCT04872790|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153708978|NCT04872790|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153708979|NCT04872790|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
153708980|NCT04872790|Abortifacient Agents|abortifacient agents|mesh-ancestor
153708981|NCT04872790|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153708982|NCT04872790|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153708983|NCT04872790|Antimetabolites|antimetabolites|mesh-ancestor
153709010|NCT04722172|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153337833|NCT00000292|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153709011|NCT04722172|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153709012|NCT04722172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153709013|NCT04712942|Azacitidine|azacitidine|mesh-list
153709014|NCT04712942|Pevonedistat|pevonedistat|mesh-list
153709015|NCT04712942|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153709016|NCT04712942|Antimetabolites|antimetabolites|mesh-ancestor
153709017|NCT04712942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153709018|NCT04712942|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153709019|NCT04712942|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153709020|NCT04708145|Aflibercept|aflibercept|mesh-list
153709072|NCT04647084|Lidocaine|lidocaine|mesh-list
153709073|NCT04647084|Anesthetics, Local|anesthetics, local|mesh-ancestor
153709074|NCT04647084|Anesthetics|anesthetics|mesh-ancestor
153709075|NCT04647084|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153709076|NCT04647084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153709077|NCT04647084|Sensory System Agents|sensory system agents|mesh-ancestor
153709078|NCT04647084|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153709079|NCT04647084|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153709080|NCT04647084|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
153709081|NCT04647084|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153709082|NCT04647084|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153709083|NCT04647084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153709085|NCT04630002|Darunavir|darunavir|mesh-list
153709086|NCT04630002|Etravirine|etravirine|mesh-list
153709087|NCT04630002|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
153709088|NCT04630002|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
153709089|NCT04630002|Protease Inhibitors|protease inhibitors|mesh-ancestor
153709090|NCT04630002|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153709091|NCT04630002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153709092|NCT04630002|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153547191|NCT05719883|Sirolimus|sirolimus|mesh-list
153547192|NCT05719883|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153547193|NCT05719883|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153547194|NCT05719883|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153547195|NCT05719883|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153547196|NCT05719883|Antifungal Agents|antifungal agents|mesh-ancestor
153547197|NCT05719883|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153547198|NCT05719883|Immunologic Factors|immunologic factors|mesh-ancestor
153709094|NCT04630002|Antiviral Agents|antiviral agents|mesh-ancestor
153709095|NCT04630002|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153709096|NCT04630002|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
153709097|NCT04630002|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153709098|NCT04630002|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153709100|NCT04605393|Dronabinol|dronabinol|mesh-list
153709117|NCT04566133|Trametinib|trametinib|mesh-list
153709118|NCT04566133|Antimalarials|antimalarials|mesh-ancestor
153709119|NCT04566133|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153709120|NCT04566133|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153709121|NCT04566133|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153709122|NCT04566133|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153709123|NCT04566133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153709124|NCT04566133|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153709125|NCT04566133|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153709183|NCT04434664|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
153709184|NCT04434664|Adrenergic Agents|adrenergic agents|mesh-ancestor
153709185|NCT04434664|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153709186|NCT04430192|Pluvicto|pluvicto|mesh-list
153709187|NCT04430192|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
153709188|NCT04430192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153709189|NCT04419272|Methylphenidate|methylphenidate|mesh-list
153709190|NCT04419272|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
153709191|NCT04419272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153709192|NCT04419272|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
153709193|NCT04419272|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153709194|NCT04419272|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153709196|NCT04419272|Dopamine Agents|dopamine agents|mesh-ancestor
153709244|NCT04246697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153709245|NCT04246697|Sensory System Agents|sensory system agents|mesh-ancestor
153709246|NCT04246697|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153709248|NCT04246697|Narcotics|narcotics|mesh-ancestor
153709249|NCT04246697|Analgesics|analgesics|mesh-ancestor
153709250|NCT04246697|Anticonvulsants|anticonvulsants|mesh-ancestor
153709251|NCT04246697|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153709252|NCT04246697|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153709310|NCT04222023|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
153709311|NCT04222023|Antibodies|antibodies|mesh-list
153709312|NCT04222023|gamma-Globulins|gamma-globulins|mesh-list
153709313|NCT04222023|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
153709314|NCT04222023|Immunologic Factors|immunologic factors|mesh-ancestor
153709315|NCT04222023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153709316|NCT04198649|Azithromycin|azithromycin|mesh-list
153709317|NCT04198649|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153709318|NCT04198649|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153709319|NCT04177706|Ketamine|ketamine|mesh-list
153709320|NCT04177706|Analgesics|analgesics|mesh-ancestor
153709321|NCT04177706|Sensory System Agents|sensory system agents|mesh-ancestor
153709374|NCT04090879|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
153709375|NCT04090879|Autonomic Agents|autonomic agents|mesh-ancestor
153709376|NCT04090879|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153709377|NCT04090879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153709378|NCT04090879|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
153709379|NCT04090879|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
153709380|NCT04090879|Cholinergic Agents|cholinergic agents|mesh-ancestor
153709381|NCT04090879|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153709382|NCT04090879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153709383|NCT04039867|Gemcitabine|gemcitabine|mesh-list
153709384|NCT04039867|Oxaliplatin|oxaliplatin|mesh-list
153709385|NCT04039867|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153709386|NCT04039867|Antimetabolites|antimetabolites|mesh-ancestor
153709387|NCT04039867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153709388|NCT04039867|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153709389|NCT04029038|Cyclophosphamide|cyclophosphamide|mesh-list
153709390|NCT04029038|Fludarabine|fludarabine|mesh-list
153709391|NCT04029038|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153709432|NCT03840915|Docetaxel|docetaxel|mesh-list
153709434|NCT03840915|Carboplatin|carboplatin|mesh-list
153709435|NCT03840915|Gemcitabine|gemcitabine|mesh-list
153709436|NCT03840915|Pemetrexed|pemetrexed|mesh-list
153709437|NCT03840915|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153709438|NCT03840915|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153709439|NCT03840915|Tubulin Modulators|tubulin modulators|mesh-ancestor
153709440|NCT03840915|Antimitotic Agents|antimitotic agents|mesh-ancestor
153709441|NCT03840915|Mitosis Modulators|mitosis modulators|mesh-ancestor
153709442|NCT03840915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153337882|NCT02548650|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153709443|NCT03840915|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153709444|NCT03840915|Antimetabolites|antimetabolites|mesh-ancestor
153709445|NCT03840915|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153709446|NCT03840915|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153709447|NCT03840915|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153709490|NCT03765788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153709491|NCT03765788|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153709493|NCT03760822|Paclitaxel|paclitaxel|mesh-list
153709494|NCT03760822|Ramucirumab|ramucirumab|mesh-list
153709495|NCT03760822|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153709496|NCT03760822|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153709497|NCT03760822|Tubulin Modulators|tubulin modulators|mesh-ancestor
153709498|NCT03760822|Antimitotic Agents|antimitotic agents|mesh-ancestor
153709499|NCT03760822|Mitosis Modulators|mitosis modulators|mesh-ancestor
153709500|NCT03760822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153709501|NCT03760822|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153709502|NCT03760822|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153709503|NCT03760822|Growth Substances|growth substances|mesh-ancestor
153709504|NCT03760822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153709505|NCT03760822|Growth Inhibitors|growth inhibitors|mesh-ancestor
153709506|NCT03754725|Deferiprone|deferiprone|mesh-list
153709507|NCT03754725|Iron Chelating Agents|iron chelating agents|mesh-ancestor
153709508|NCT03754725|Chelating Agents|chelating agents|mesh-ancestor
153709509|NCT03754725|Sequestering Agents|sequestering agents|mesh-ancestor
153709510|NCT03754725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153709511|NCT03731923|Liver Extracts|liver extracts|mesh-list
153709541|NCT03649230|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153709542|NCT03649230|Serotonin Agents|serotonin agents|mesh-ancestor
153709543|NCT03649230|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153709544|NCT03649230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153709545|NCT03626545|Docetaxel|docetaxel|mesh-list
153709546|NCT03626545|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153709547|NCT03626545|Tubulin Modulators|tubulin modulators|mesh-ancestor
153709548|NCT03626545|Antimitotic Agents|antimitotic agents|mesh-ancestor
153709549|NCT03626545|Mitosis Modulators|mitosis modulators|mesh-ancestor
153709550|NCT03626545|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153709551|NCT03620201|Atezolizumab|atezolizumab|mesh-list
153709552|NCT03620201|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153709553|NCT03620201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153709554|NCT03620201|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153709556|NCT03584711|Panitumumab|panitumumab|mesh-list
153709599|NCT03463057|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153709600|NCT03463057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153709601|NCT03463057|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153709602|NCT03463057|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153709603|NCT03460756|Ganaxolone|ganaxolone|mesh-list
153878782|NCT03534713|Paclitaxel|paclitaxel|mesh-list
153709604|NCT03460756|Neurosteroids|neurosteroids|mesh-ancestor
153709605|NCT03460756|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153709606|NCT03460756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153709607|NCT03460756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153709608|NCT03460756|GABA Modulators|gaba modulators|mesh-ancestor
153709609|NCT03460756|GABA Agents|gaba agents|mesh-ancestor
153709610|NCT03443999|Sirolimus|sirolimus|mesh-list
153709611|NCT03443999|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153709612|NCT03443999|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153709613|NCT03443999|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153709657|NCT03331731|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153709658|NCT03331731|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153709659|NCT03331731|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153337925|NCT00000316|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153709660|NCT03331731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153709661|NCT03322995|Fluorouracil|fluorouracil|mesh-list
153709662|NCT03322995|Antimetabolites|antimetabolites|mesh-ancestor
153709663|NCT03322995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153709664|NCT03322995|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153709665|NCT03322995|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153709666|NCT03322995|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153709667|NCT03322995|Immunologic Factors|immunologic factors|mesh-ancestor
153709668|NCT03322995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153709670|NCT03319498|Mineral Oil|mineral oil|mesh-list
153546640|NCT06003179|Fludarabine|fludarabine|mesh-list
153709671|NCT03319498|Antiemetics|antiemetics|mesh-ancestor
153709672|NCT03319498|Autonomic Agents|autonomic agents|mesh-ancestor
153709673|NCT03319498|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153709674|NCT03319498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153709675|NCT03319498|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153709676|NCT03319498|Parasympatholytics|parasympatholytics|mesh-ancestor
153709677|NCT03319498|Emollients|emollients|mesh-ancestor
153709709|NCT03259074|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
153709710|NCT03259074|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153709711|NCT03259074|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153709712|NCT03246074|Paclitaxel|paclitaxel|mesh-list
153709713|NCT03246074|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153709714|NCT03246074|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153709715|NCT03246074|Tubulin Modulators|tubulin modulators|mesh-ancestor
153709716|NCT03246074|Antimitotic Agents|antimitotic agents|mesh-ancestor
153709717|NCT03246074|Mitosis Modulators|mitosis modulators|mesh-ancestor
153709718|NCT03246074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153709719|NCT03216967|Everolimus|everolimus|mesh-list
153709720|NCT03216967|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
153709721|NCT03216967|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153709722|NCT03216967|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153709724|NCT03216967|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153709767|NCT02959619|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153709768|NCT02959619|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153709769|NCT02959619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153709770|NCT02912715|Paclitaxel|paclitaxel|mesh-list
153709771|NCT02912715|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153709772|NCT02912715|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153709773|NCT02912715|Tubulin Modulators|tubulin modulators|mesh-ancestor
153337940|NCT01026623|Temsirolimus|temsirolimus|mesh-list
153709774|NCT02912715|Antimitotic Agents|antimitotic agents|mesh-ancestor
153709775|NCT02912715|Mitosis Modulators|mitosis modulators|mesh-ancestor
153709776|NCT02912715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153709777|NCT02886962|Vitamin K|vitamin k|mesh-list
153709833|NCT02703220|Anticonvulsants|anticonvulsants|mesh-ancestor
153709834|NCT02703220|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
153709835|NCT02703220|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153709836|NCT02703220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153709837|NCT02703220|Diuretics|diuretics|mesh-ancestor
153709838|NCT02703220|Natriuretic Agents|natriuretic agents|mesh-ancestor
153709839|NCT02703220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153709840|NCT02703220|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
153709841|NCT02703220|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153709897|NCT02355379|Fluorouracil|fluorouracil|mesh-list
153546871|NCT05889624|Analgesics|analgesics|mesh-ancestor
153709898|NCT02355379|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153709899|NCT02355379|Antimetabolites|antimetabolites|mesh-ancestor
153709900|NCT02355379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153709901|NCT02355379|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153709902|NCT02355379|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153709903|NCT02355379|Immunologic Factors|immunologic factors|mesh-ancestor
153709904|NCT02355379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153709905|NCT02157974|Exenatide|exenatide|mesh-list
153709906|NCT02157974|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
153709907|NCT02157974|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153709908|NCT02157974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153709915|NCT02140255|Raltegravir Potassium|raltegravir potassium|mesh-list
153709916|NCT02140255|Nevirapine|nevirapine|mesh-list
153918897|NCT05907902|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153709917|NCT02140255|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-list
153709948|NCT02046395|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
153709949|NCT02046395|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
153709950|NCT02046395|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
153709951|NCT02046395|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
153709953|NCT02046395|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153709954|NCT02046395|Urological Agents|urological agents|mesh-ancestor
153709955|NCT02037126|Diphenhydramine|diphenhydramine|mesh-list
153709956|NCT02037126|Promethazine|promethazine|mesh-list
153709957|NCT02037126|Psilocybin|psilocybin|mesh-list
153709958|NCT02037126|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
153709959|NCT02037126|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153710011|NCT01367301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153710013|NCT01220583|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153710014|NCT01166594|Bevacizumab|bevacizumab|mesh-list
153710015|NCT01166594|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153710016|NCT01166594|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153710017|NCT01166594|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153710018|NCT01166594|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153710019|NCT01166594|Growth Substances|growth substances|mesh-ancestor
153337987|NCT00001108|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153710020|NCT01166594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153338013|NCT00380224|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153710021|NCT01166594|Growth Inhibitors|growth inhibitors|mesh-ancestor
153710022|NCT00871013|Thalidomide|thalidomide|mesh-list
153710023|NCT00871013|Dexamethasone|dexamethasone|mesh-list
153710024|NCT00871013|Cyclophosphamide|cyclophosphamide|mesh-list
153710025|NCT00871013|Melphalan|melphalan|mesh-list
153710026|NCT00871013|Doxorubicin|doxorubicin|mesh-list
153710027|NCT00871013|Etoposide|etoposide|mesh-list
153710028|NCT00871013|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
153710029|NCT00871013|Bortezomib|bortezomib|mesh-list
153710030|NCT00871013|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153710031|NCT00871013|Immunologic Factors|immunologic factors|mesh-ancestor
153710032|NCT00871013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153710065|NCT00585650|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153710066|NCT00585650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153710067|NCT00585650|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153710068|NCT00585650|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153710069|NCT00585650|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153710070|NCT00585650|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153710071|NCT00585650|Immunologic Factors|immunologic factors|mesh-ancestor
153710072|NCT00172029|Zoledronic Acid|zoledronic acid|mesh-list
153710073|NCT00172029|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153710074|NCT00172029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153710075|NCT00039130|Leucovorin|leucovorin|mesh-list
153710076|NCT00039130|Cytarabine|cytarabine|mesh-list
153710077|NCT00039130|Dexamethasone|dexamethasone|mesh-list
153710078|NCT00039130|Prednisone|prednisone|mesh-list
153710079|NCT00039130|Cyclophosphamide|cyclophosphamide|mesh-list
153710128|NCT00039130|Tubulin Modulators|tubulin modulators|mesh-ancestor
153710129|NCT00039130|Antimitotic Agents|antimitotic agents|mesh-ancestor
153710130|NCT00039130|Mitosis Modulators|mitosis modulators|mesh-ancestor
153710131|NCT00039130|Gout Suppressants|gout suppressants|mesh-ancestor
153710132|NCT00039130|Free Radical Scavengers|free radical scavengers|mesh-ancestor
153710133|NCT00039130|Antioxidants|antioxidants|mesh-ancestor
153710134|NCT00002889|Leuprolide|leuprolide|mesh-list
153710135|NCT00002889|Goserelin|goserelin|mesh-list
153710136|NCT00002889|Flutamide|flutamide|mesh-list
153710137|NCT00002889|Fertility Agents, Female|fertility agents, female|mesh-ancestor
153710138|NCT00002889|Fertility Agents|fertility agents|mesh-ancestor
153710139|NCT00002889|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153710140|NCT00002889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153710141|NCT00002889|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153338014|NCT00380224|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153710142|NCT00002889|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153710143|NCT00002889|Androgen Antagonists|androgen antagonists|mesh-ancestor
153710145|NCT00002889|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153710148|NCT00122577|Tenofovir|tenofovir|mesh-list
153710149|NCT00122577|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
153710150|NCT00122577|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
153710151|NCT00122577|Protease Inhibitors|protease inhibitors|mesh-ancestor
153710152|NCT00122577|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153710153|NCT00122577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153710154|NCT00122577|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153710155|NCT00122577|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153710156|NCT00122577|Antiviral Agents|antiviral agents|mesh-ancestor
153710157|NCT00122577|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153710176|NCT00425074|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153710177|NCT00425074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153710178|NCT00425074|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153710180|NCT00425074|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153710181|NCT00425074|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153710182|NCT00425074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153710183|NCT00425074|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153710184|NCT00425074|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153710185|NCT00425074|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153710186|NCT00425074|Antipyretics|antipyretics|mesh-ancestor
153710187|NCT00425152|Leucovorin|leucovorin|mesh-list
153710188|NCT00425152|Levamisole|levamisole|mesh-list
153710189|NCT00425152|Fluorouracil|fluorouracil|mesh-list
153710190|NCT00425152|Calcium|calcium|mesh-list
153710191|NCT00425152|Levoleucovorin|levoleucovorin|mesh-list
153710211|NCT00314314|Insulin|insulin|mesh-list
153710237|NCT04984070|Natriuretic Agents|natriuretic agents|mesh-ancestor
153710238|NCT04984070|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
153710239|NCT04984070|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
153710240|NCT04984070|Estrogens|estrogens|mesh-ancestor
153710241|NCT04984070|Hormones|hormones|mesh-ancestor
153710242|NCT00314509|Ciclesonide|ciclesonide|mesh-list
153710243|NCT00314509|Formoterol Fumarate|formoterol fumarate|mesh-list
153710244|NCT00314509|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153710245|NCT00314509|Autonomic Agents|autonomic agents|mesh-ancestor
153710246|NCT00314509|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153710247|NCT00314509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153710248|NCT00314509|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153338061|NCT00380380|Protease Inhibitors|protease inhibitors|mesh-ancestor
153710249|NCT00314509|Respiratory System Agents|respiratory system agents|mesh-ancestor
153710301|NCT00314704|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153710302|NCT00314704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153710303|NCT00314704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153710304|NCT00314704|Sympathomimetics|sympathomimetics|mesh-ancestor
153710305|NCT00314704|Autonomic Agents|autonomic agents|mesh-ancestor
153710306|NCT00314704|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153710307|NCT00314704|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
153710308|NCT00314704|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
153710309|NCT00314704|Dopamine Agents|dopamine agents|mesh-ancestor
153710365|NCT00314743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153710366|NCT00314743|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
153710368|NCT00314782|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153710369|NCT00314782|Tubulin Modulators|tubulin modulators|mesh-ancestor
153710370|NCT00314782|Antimitotic Agents|antimitotic agents|mesh-ancestor
153710371|NCT00314782|Mitosis Modulators|mitosis modulators|mesh-ancestor
153710372|NCT00314782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153710373|NCT00122655|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-list
153710374|NCT00122655|HIV Protease Inhibitors|hiv protease inhibitors|mesh-list
153710428|NCT00313456|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153710429|NCT00313534|Masoprocol|masoprocol|mesh-list
153710430|NCT00313534|Antioxidants|antioxidants|mesh-ancestor
153710431|NCT00313534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153710432|NCT00313534|Protective Agents|protective agents|mesh-ancestor
153710433|NCT00313534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153710434|NCT00313534|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
153710435|NCT00313534|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153710436|NCT00313534|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153710437|NCT00313534|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153710438|NCT00313534|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153710491|NCT00122772|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153710492|NCT00091338|Freund's Adjuvant|freund's adjuvant|mesh-list
153710493|NCT00091338|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153710494|NCT00091338|Immunologic Factors|immunologic factors|mesh-ancestor
153710496|NCT00122811|Perindopril|perindopril|mesh-list
153710497|NCT00122811|Indapamide|indapamide|mesh-list
153710498|NCT00122811|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
153710499|NCT00122811|Protease Inhibitors|protease inhibitors|mesh-ancestor
153710500|NCT00122811|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153710501|NCT00122811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153338097|NCT00001132|Antiviral Agents|antiviral agents|mesh-ancestor
153710502|NCT00122811|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153710503|NCT00122811|Diuretics|diuretics|mesh-ancestor
153710504|NCT00122811|Natriuretic Agents|natriuretic agents|mesh-ancestor
153710505|NCT00122811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153710506|NCT00122811|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
153710507|NCT00122811|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153710508|NCT00122850|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
153710509|NCT00122850|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
153710510|NCT00122850|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
153710511|NCT00122850|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153710512|NCT00122850|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153710513|NCT00122850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153710514|NCT00122850|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153710515|NCT00122850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153710516|NCT00122850|Analgesics|analgesics|mesh-ancestor
153710532|NCT00091377|Paclitaxel|paclitaxel|mesh-list
153710536|NCT00091377|Tubulin Modulators|tubulin modulators|mesh-ancestor
153710537|NCT00091377|Antimitotic Agents|antimitotic agents|mesh-ancestor
153710538|NCT00091377|Mitosis Modulators|mitosis modulators|mesh-ancestor
153710539|NCT00091377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153710540|NCT03897868|Losartan|losartan|mesh-list
153710541|NCT03897868|Amlodipine|amlodipine|mesh-list
153710542|NCT03897868|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153710543|NCT03897868|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153547216|NCT05687058|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153710544|NCT03897868|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153710545|NCT03897868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153710546|NCT03897868|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153710552|NCT00122889|Allicin|allicin|mesh-list
153710599|NCT03690544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153710600|NCT03690544|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153710601|NCT03690544|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153710602|NCT03690544|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
153710603|NCT03690544|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
153710604|NCT03690544|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153710605|NCT03690544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153710606|NCT00314977|Cyclophosphamide|cyclophosphamide|mesh-list
153710607|NCT00314977|Docetaxel|docetaxel|mesh-list
153710608|NCT00314977|Doxorubicin|doxorubicin|mesh-list
153710609|NCT00314977|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
153710610|NCT00314977|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153710611|NCT00314977|Immunologic Factors|immunologic factors|mesh-ancestor
153710612|NCT00314977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153710613|NCT00314977|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153710614|NCT00314977|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153710615|NCT00314977|Alkylating Agents|alkylating agents|mesh-ancestor
153338133|NCT00002020|Zidovudine|zidovudine|mesh-list
153710616|NCT00314977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153710617|NCT00314977|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153710618|NCT00314977|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153710619|NCT00314977|Tubulin Modulators|tubulin modulators|mesh-ancestor
153710652|NCT00419146|Eicosapentaenoic acid ethyl ester|eicosapentaenoic acid ethyl ester|mesh-list
153710653|NCT00419146|Micronutrients|micronutrients|mesh-ancestor
153710654|NCT00419146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153710655|NCT00419146|Antioxidants|antioxidants|mesh-ancestor
153710656|NCT00419146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153710657|NCT00419146|Protective Agents|protective agents|mesh-ancestor
153710658|NCT00419146|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153710659|NCT00419146|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153710660|NCT02965196|Dexamethasone|dexamethasone|mesh-list
153710716|NCT03031483|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
153710717|NCT03031483|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153710718|NCT00091650|Olanzapine|olanzapine|mesh-list
153710719|NCT00091650|Antiemetics|antiemetics|mesh-ancestor
153710720|NCT00091650|Autonomic Agents|autonomic agents|mesh-ancestor
153710721|NCT00091650|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153710722|NCT00091650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153710723|NCT00091650|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153710724|NCT00091650|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153710725|NCT00091650|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153710734|NCT01691833|Vitamin D|vitamin d|mesh-list
153710780|NCT00327691|Antimetabolites|antimetabolites|mesh-ancestor
153710781|NCT00327691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153710782|NCT00327691|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153710783|NCT00327691|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
153710784|NCT00327691|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153710785|NCT03913832|Sirolimus|sirolimus|mesh-list
153710786|NCT03913832|Paclitaxel|paclitaxel|mesh-list
153710787|NCT03913832|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153710788|NCT03913832|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153710789|NCT03913832|Tubulin Modulators|tubulin modulators|mesh-ancestor
153710790|NCT03913832|Antimitotic Agents|antimitotic agents|mesh-ancestor
153710791|NCT03913832|Mitosis Modulators|mitosis modulators|mesh-ancestor
153710792|NCT03913832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153710793|NCT03913832|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153710794|NCT03913832|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153710837|NCT00092001|Growth Inhibitors|growth inhibitors|mesh-ancestor
153710838|NCT00092001|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153710839|NCT00092001|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153710840|NCT00092001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153710841|NCT03883919|Vitamin D|vitamin d|mesh-list
153710842|NCT03883919|Leucovorin|leucovorin|mesh-list
153710843|NCT03883919|Fluorouracil|fluorouracil|mesh-list
153710844|NCT03883919|Irinotecan|irinotecan|mesh-list
153710845|NCT03883919|Vitamins|vitamins|mesh-ancestor
153710906|NCT00315367|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153710907|NCT00315367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153710908|NCT00315367|Cholinergic Agents|cholinergic agents|mesh-ancestor
153710909|NCT00315367|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153710910|NCT00315367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153710911|NCT00315367|Nootropic Agents|nootropic agents|mesh-ancestor
153710912|NCT00315484|Epoetin Alfa|epoetin alfa|mesh-list
153710913|NCT00315484|Darbepoetin alfa|darbepoetin alfa|mesh-list
153710914|NCT00315484|Hematinics|hematinics|mesh-ancestor
153710915|NCT00315523|Levocetirizine|levocetirizine|mesh-list
153710916|NCT00315523|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
153710917|NCT00315523|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
153710923|NCT00092196|Aprepitant|aprepitant|mesh-list
153710970|NCT00315874|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
153710971|NCT00315913|Propranolol|propranolol|mesh-list
153710972|NCT00315913|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
153710973|NCT00315913|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
153710974|NCT00315913|Adrenergic Agents|adrenergic agents|mesh-ancestor
153710976|NCT00315913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153710977|NCT00315913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153710978|NCT00315913|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153710979|NCT00315913|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153710980|NCT00315913|Vasodilator Agents|vasodilator agents|mesh-ancestor
153710981|NCT00092313|Acetaminophen|acetaminophen|mesh-list
153710982|NCT00092313|Rofecoxib|rofecoxib|mesh-list
153710983|NCT00092313|Oxycodone|oxycodone|mesh-list
153710984|NCT00092313|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153710985|NCT00092313|Analgesics|analgesics|mesh-ancestor
153710986|NCT00092313|Sensory System Agents|sensory system agents|mesh-ancestor
153710987|NCT00092313|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153710988|NCT00092313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153710989|NCT00092313|Antipyretics|antipyretics|mesh-ancestor
153710990|NCT00092313|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153710991|NCT00092313|Narcotics|narcotics|mesh-ancestor
153710992|NCT00092313|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153710993|NCT00092313|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
153710994|NCT00092313|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153710995|NCT00092313|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153710996|NCT00092313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153710997|NCT00092313|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153710998|NCT00092313|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153710999|NCT00092313|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153711000|NCT00399971|Immunomodulating Agents|immunomodulating agents|mesh-list
153711015|NCT00123552|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153711016|NCT00123552|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153711017|NCT00123552|Antiviral Agents|antiviral agents|mesh-ancestor
153711018|NCT00123552|Schistosomicides|schistosomicides|mesh-ancestor
153711019|NCT00123552|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
153711020|NCT00123552|Anthelmintics|anthelmintics|mesh-ancestor
153711021|NCT00123552|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153711022|NCT00123552|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153711023|NCT00123552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153711024|NCT00123552|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
153711026|NCT03352427|Dasatinib|dasatinib|mesh-list
153711027|NCT03352427|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
153711070|NCT00316810|Immunologic Factors|immunologic factors|mesh-ancestor
153711071|NCT00316810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153338199|NCT00000358|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
153711072|NCT00316810|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153711073|NCT00092391|Vaccines|vaccines|mesh-list
153711074|NCT00092391|Immunologic Factors|immunologic factors|mesh-ancestor
153711075|NCT00092391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153711076|NCT00316849|Sirolimus|sirolimus|mesh-list
153711077|NCT00316849|Temozolomide|temozolomide|mesh-list
153711078|NCT00316849|Temsirolimus|temsirolimus|mesh-list
153711079|NCT00316849|MTOR Inhibitors|mtor inhibitors|mesh-list
153711080|NCT00316849|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153711081|NCT00316849|Alkylating Agents|alkylating agents|mesh-ancestor
153711133|NCT00123669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153711134|NCT00123669|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
153711135|NCT00123669|Hormone Antagonists|hormone antagonists|mesh-ancestor
153711137|NCT00317200|Bevacizumab|bevacizumab|mesh-list
153711138|NCT00317200|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153711139|NCT00317200|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153711140|NCT00317200|Tubulin Modulators|tubulin modulators|mesh-ancestor
153711141|NCT00317200|Antimitotic Agents|antimitotic agents|mesh-ancestor
153711142|NCT00317200|Mitosis Modulators|mitosis modulators|mesh-ancestor
153547221|NCT05679258|Immunologic Factors|immunologic factors|mesh-ancestor
153547222|NCT05679258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153547223|NCT05671757|Daratumumab|daratumumab|mesh-list
153547224|NCT05671757|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
153711200|NCT00092508|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153711201|NCT00092508|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153711258|NCT00328939|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153711259|NCT00328939|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153711260|NCT00328939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153711261|NCT00328939|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
153711262|NCT00328939|Antithrombins|antithrombins|mesh-ancestor
153711263|NCT00328939|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
153711264|NCT00328939|Protease Inhibitors|protease inhibitors|mesh-ancestor
153711265|NCT00328939|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153711266|NCT00328978|Quetiapine Fumarate|quetiapine fumarate|mesh-list
153711267|NCT00328978|Antidepressive Agents|antidepressive agents|mesh-ancestor
153711268|NCT00328978|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153711269|NCT00328978|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153711270|NCT00328978|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153711320|NCT00329368|Immunologic Factors|immunologic factors|mesh-ancestor
153711321|NCT00329368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153711322|NCT00329368|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153711323|NCT00329368|Analgesics|analgesics|mesh-ancestor
153711324|NCT00329368|Sensory System Agents|sensory system agents|mesh-ancestor
153711325|NCT00329368|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153711326|NCT00329368|Hematinics|hematinics|mesh-ancestor
153419788|NCT03054103|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153419789|NCT03054103|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153711384|NCT00123903|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153711385|NCT00123903|Vasodilator Agents|vasodilator agents|mesh-ancestor
153711386|NCT00123903|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
153338207|NCT00000376|Antidepressive Agents|antidepressive agents|mesh-ancestor
153338208|NCT00000376|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153711387|NCT00123903|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
153711388|NCT00123903|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
153711389|NCT00123903|Protease Inhibitors|protease inhibitors|mesh-ancestor
153711390|NCT00123903|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153711391|NCT00123903|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
153711392|NCT00329680|Evening primrose oil|evening primrose oil|mesh-list
153711393|NCT00329680|Antioxidants|antioxidants|mesh-list
153711394|NCT00329680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153711441|NCT00330148|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153711442|NCT00330148|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153711443|NCT00330148|Ornithine Decarboxylase Inhibitors|ornithine decarboxylase inhibitors|mesh-ancestor
153711444|NCT00330148|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153711445|NCT00330148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153711446|NCT00093093|Interferons|interferons|mesh-list
153711448|NCT00093093|Interferon-alpha|interferon-alpha|mesh-list
153711459|NCT00330304|Isoniazid|isoniazid|mesh-list
153711508|NCT00083993|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153711509|NCT00083993|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153711511|NCT00083993|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153711512|NCT00083993|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153711513|NCT00083993|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153711514|NCT00083993|Antifungal Agents|antifungal agents|mesh-ancestor
153711515|NCT00323791|Gemcitabine|gemcitabine|mesh-list
153711516|NCT00323791|Imatinib Mesylate|imatinib mesylate|mesh-list
153711517|NCT00323791|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153711518|NCT00323791|Antimetabolites|antimetabolites|mesh-ancestor
153711519|NCT00323791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153711520|NCT00323791|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153711521|NCT00323791|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153711522|NCT00323791|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153711569|NCT00317629|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153711570|NCT00317629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153419802|NCT03043274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153711637|NCT00317746|Serotonin Agents|serotonin agents|mesh-ancestor
153711638|NCT00317746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153711639|NCT00317746|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
153711640|NCT00317746|Antidepressive Agents|antidepressive agents|mesh-ancestor
153711641|NCT00317746|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153711642|NCT00317785|Cyclosporine|cyclosporine|mesh-list
153711644|NCT00317785|Mycophenolic Acid|mycophenolic acid|mesh-list
153711645|NCT00317785|Cyclophosphamide|cyclophosphamide|mesh-list
153711646|NCT00317785|Methotrexate|methotrexate|mesh-list
153338280|NCT00001282|Antiviral Agents|antiviral agents|mesh-ancestor
153338281|NCT00001282|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153711647|NCT00317785|Tacrolimus|tacrolimus|mesh-list
153711648|NCT00317785|Cyclosporins|cyclosporins|mesh-list
153711649|NCT00317785|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153711650|NCT00317785|Immunologic Factors|immunologic factors|mesh-ancestor
153711651|NCT00317785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153711652|NCT00317785|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153711653|NCT00317785|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153711654|NCT00317785|Alkylating Agents|alkylating agents|mesh-ancestor
153711655|NCT00317785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153711656|NCT00317785|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153711657|NCT00317785|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153711686|NCT00093288|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153711687|NCT00093288|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153711688|NCT00324454|Levetiracetam|levetiracetam|mesh-list
153711690|NCT00324454|Nootropic Agents|nootropic agents|mesh-ancestor
153711691|NCT00317902|Epoetin Alfa|epoetin alfa|mesh-list
153711692|NCT00317902|Hematinics|hematinics|mesh-ancestor
153711693|NCT00317980|Meglumine Antimoniate|meglumine antimoniate|mesh-list
153711694|NCT00317980|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153711695|NCT00317980|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153711697|NCT00324571|Calcium|calcium|mesh-list
153711752|NCT00324766|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153711753|NCT00324766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153711754|NCT00324766|Protective Agents|protective agents|mesh-ancestor
153711755|NCT00324766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153711756|NCT00084578|Rosiglitazone|rosiglitazone|mesh-list
153711757|NCT00084578|Celecoxib|celecoxib|mesh-list
153711758|NCT00084578|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153711818|NCT00084695|Methylprednisolone|methylprednisolone|mesh-list
153711819|NCT00084695|Cyclophosphamide|cyclophosphamide|mesh-list
153711820|NCT00084695|Melphalan|melphalan|mesh-list
153711821|NCT00084695|Busulfan|busulfan|mesh-list
153711822|NCT00084695|Fludarabine|fludarabine|mesh-list
153711823|NCT00084695|Fludarabine phosphate|fludarabine phosphate|mesh-list
153711824|NCT00084695|Antilymphocyte Serum|antilymphocyte serum|mesh-list
153711825|NCT00084695|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153711826|NCT00084695|Immunologic Factors|immunologic factors|mesh-ancestor
153711827|NCT00084695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153711828|NCT00084695|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153711829|NCT00084695|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153711830|NCT00084695|Alkylating Agents|alkylating agents|mesh-ancestor
153711831|NCT00084695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153338282|NCT00001282|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153711880|NCT00325429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153711882|NCT00093522|Fludarabine phosphate|fludarabine phosphate|mesh-list
153711883|NCT00093522|Keyhole-limpet hemocyanin|keyhole-limpet hemocyanin|mesh-list
153711884|NCT00093522|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153711885|NCT00093522|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153338305|NCT01195597|Nicotine|nicotine|mesh-list
153711886|NCT00093522|Antimetabolites|antimetabolites|mesh-ancestor
153711887|NCT00093522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153711944|NCT00093561|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
153711945|NCT00093561|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153711946|NCT00084890|Carboplatin|carboplatin|mesh-list
153711947|NCT00084890|Docetaxel|docetaxel|mesh-list
153711948|NCT00084890|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153711949|NCT00084890|Tubulin Modulators|tubulin modulators|mesh-ancestor
153711950|NCT00084890|Antimitotic Agents|antimitotic agents|mesh-ancestor
153711951|NCT00084890|Mitosis Modulators|mitosis modulators|mesh-ancestor
153711952|NCT00084890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153711953|NCT00318838|Azimilide|azimilide|mesh-list
153711954|NCT00318838|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153711955|NCT00318838|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153712006|NCT00318955|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153712007|NCT00318955|Anesthetics, General|anesthetics, general|mesh-ancestor
153712010|NCT00325936|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153712011|NCT00325936|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153712012|NCT00325936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153712015|NCT00318994|Meropenem|meropenem|mesh-list
153712075|NCT00093639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153712076|NCT00093639|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153712077|NCT00093639|Immunologic Factors|immunologic factors|mesh-ancestor
153712078|NCT00093639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153712079|NCT00093639|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153712080|NCT00093639|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153712081|NCT00319150|Epoetin Alfa|epoetin alfa|mesh-list
153712082|NCT00319150|Hematinics|hematinics|mesh-ancestor
153712083|NCT00326053|Budesonide|budesonide|mesh-list
153712139|NCT00319267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153712140|NCT00085280|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
153712141|NCT00085280|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153712142|NCT00085280|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153712143|NCT00085280|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153712144|NCT00085280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153712145|NCT00085280|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153712146|NCT00326248|Casopitant|casopitant|mesh-list
153712147|NCT00326248|Antiemetics|antiemetics|mesh-ancestor
153712148|NCT00326248|Autonomic Agents|autonomic agents|mesh-ancestor
153549155|NCT04342975|Niacin|niacin|mesh-list
153712201|NCT00093678|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153712202|NCT00093678|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153712203|NCT00093678|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
153712204|NCT00093678|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153712205|NCT00093678|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153712206|NCT00093678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153712207|NCT00319345|Mannitol|mannitol|mesh-list
153712208|NCT00319345|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
153712209|NCT00319345|Diuretics|diuretics|mesh-ancestor
153712210|NCT00319345|Natriuretic Agents|natriuretic agents|mesh-ancestor
153712211|NCT00319345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153712212|NCT00419536|Panobinostat|panobinostat|mesh-list
153712213|NCT00419536|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153712214|NCT00419536|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
153712215|NCT00419536|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153712216|NCT00419536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153712217|NCT00326404|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
153712218|NCT00326404|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
153712219|NCT00326404|Ethinyl Estradiol|ethinyl estradiol|mesh-list
153712256|NCT00124332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153712257|NCT00124332|Hormones|hormones|mesh-ancestor
153712258|NCT00124332|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153712259|NCT00124332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153712260|NCT00085553|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
153712324|NCT00320047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153712325|NCT04708639|Alectinib|alectinib|mesh-list
153712326|NCT04708639|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153712327|NCT04708639|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153712328|NCT04708639|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153712329|NCT04708639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153712330|NCT00085826|Sulindac sulfone|sulindac sulfone|mesh-list
153712331|NCT00085826|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153712332|NCT00085826|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
153712333|NCT00085826|Protective Agents|protective agents|mesh-ancestor
153712334|NCT00085826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153712335|NCT00085826|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153712336|NCT00085826|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153712337|NCT00085826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153712338|NCT00085826|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153712339|NCT00085826|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153712340|NCT00085826|Analgesics|analgesics|mesh-ancestor
153712341|NCT00085826|Sensory System Agents|sensory system agents|mesh-ancestor
153712342|NCT00085826|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153712343|NCT00085826|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153712344|NCT00085826|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153712345|NCT00320125|Calcium|calcium|mesh-list
153712346|NCT00320125|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153712347|NCT00320125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153712372|NCT00320359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153712373|NCT00320359|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
153712375|NCT00093912|Clevidipine|clevidipine|mesh-list
153712376|NCT00093912|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153712377|NCT00093912|Vasodilator Agents|vasodilator agents|mesh-ancestor
153712378|NCT00093912|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
153712379|NCT00093912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153712380|NCT00093912|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153712381|NCT00093912|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153712382|NCT00093912|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153712383|NCT00093912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153712384|NCT00327145|Amlodipine|amlodipine|mesh-list
153712385|NCT00327145|Valsartan|valsartan|mesh-list
153712386|NCT00327145|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
153712387|NCT00327145|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153712388|NCT00327145|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153712389|NCT00327145|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153712393|NCT00327145|Vasodilator Agents|vasodilator agents|mesh-ancestor
153338336|NCT03110562|Dexamethasone|dexamethasone|mesh-list
153712426|NCT00093951|Protective Agents|protective agents|mesh-ancestor
153712427|NCT00093951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153712428|NCT00093951|GABA Antagonists|gaba antagonists|mesh-ancestor
153712430|NCT00093951|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153712431|NCT00093951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153712494|NCT00320983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153712496|NCT00086177|Progestins|progestins|mesh-ancestor
153712497|NCT00086177|Hormones|hormones|mesh-ancestor
153712498|NCT00086177|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153712499|NCT00086177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153712500|NCT00094146|Octreotide|octreotide|mesh-list
153712501|NCT00094146|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153712502|NCT00094146|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153712503|NCT00094146|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153712504|NCT00086255|Tiagabine|tiagabine|mesh-list
153712505|NCT00086255|Anticonvulsants|anticonvulsants|mesh-ancestor
153712506|NCT00086255|GABA Uptake Inhibitors|gaba uptake inhibitors|mesh-ancestor
153712507|NCT00086255|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153712508|NCT00086255|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153712509|NCT00086255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153712510|NCT00086255|GABA Agents|gaba agents|mesh-ancestor
153712511|NCT00086255|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153712512|NCT00086255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153712513|NCT00321178|Clarithromycin|clarithromycin|mesh-list
153712514|NCT00321178|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153712515|NCT00321178|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153712516|NCT00321178|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
153712517|NCT00321178|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153712518|NCT00321178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153712519|NCT00321178|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
153712520|NCT00321178|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153712521|NCT00124527|Capecitabine|capecitabine|mesh-list
153549528|NCT04062656|Leucovorin|leucovorin|mesh-list
153712522|NCT00124527|Irofulven|irofulven|mesh-list
153712523|NCT00124527|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153712524|NCT00124527|Antimetabolites|antimetabolites|mesh-ancestor
153879094|NCT06080256|Alirocumab|alirocumab|mesh-list
153712535|NCT00086294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153712536|NCT00086294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153712537|NCT00086294|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153712538|NCT00086294|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153712539|NCT00086294|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153712599|NCT00419653|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153712600|NCT00419653|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153712601|NCT00419653|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
153712602|NCT00419653|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153712603|NCT00419653|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153712604|NCT00419653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153712605|NCT00419653|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153712607|NCT00419653|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
153712608|NCT00419653|Dopamine Agents|dopamine agents|mesh-ancestor
153712609|NCT00419653|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
153712610|NCT00419653|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
153712611|NCT00419653|Antidepressive Agents|antidepressive agents|mesh-ancestor
153712612|NCT00094341|Etanercept|etanercept|mesh-list
153712613|NCT00094341|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153712614|NCT00094341|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153712615|NCT00094341|Analgesics|analgesics|mesh-ancestor
153712616|NCT00094341|Sensory System Agents|sensory system agents|mesh-ancestor
153712617|NCT00094341|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153712618|NCT00094341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153712619|NCT00094341|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153712620|NCT00094341|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153712621|NCT00094341|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153712622|NCT00094341|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153712648|NCT00321490|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
153712649|NCT00321490|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153712650|NCT00321490|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153712651|NCT00321490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153712652|NCT00321490|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153712654|NCT00321490|Sensory System Agents|sensory system agents|mesh-ancestor
153712655|NCT00321490|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153712656|NCT00321490|Dopamine Agents|dopamine agents|mesh-ancestor
153712708|NCT00124566|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153712709|NCT00124566|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153712710|NCT00124566|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153712711|NCT00124566|Alkylating Agents|alkylating agents|mesh-ancestor
153712712|NCT00321724|Cediranib|cediranib|mesh-list
153712713|NCT00321724|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153712714|NCT00321724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153712715|NCT00321724|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153712716|NCT00321724|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153712717|NCT00086645|Dexetimide|dexetimide|mesh-list
153712718|NCT00086645|Citalopram|citalopram|mesh-list
153712719|NCT00086645|Escitalopram|escitalopram|mesh-list
153712720|NCT00086645|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
153712721|NCT00086645|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153712722|NCT00086645|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153712723|NCT00086645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153712724|NCT00086645|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153712725|NCT00086645|Serotonin Agents|serotonin agents|mesh-ancestor
153712738|NCT00321802|Simvastatin|simvastatin|mesh-list
153712764|NCT00086801|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
153712765|NCT00086801|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153712766|NCT00086801|Antimetabolites|antimetabolites|mesh-ancestor
153712767|NCT00086801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153712768|NCT00086801|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153712769|NCT00086801|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153712770|NCT00086801|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153712771|NCT00086801|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153712772|NCT00086801|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153712773|NCT00086801|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
153712779|NCT00124644|Etoposide|etoposide|mesh-list
153712827|NCT00124683|Dopamine Agents|dopamine agents|mesh-ancestor
153712828|NCT00124683|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
153712829|NCT00124683|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153712830|NCT00124683|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153712831|NCT04717063|Hydrogen Peroxide|hydrogen peroxide|mesh-list
153712832|NCT04717063|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
153712833|NCT04717063|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153712834|NCT00086879|Temozolomide|temozolomide|mesh-list
153712836|NCT00086879|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
153712838|NCT00086879|Alkylating Agents|alkylating agents|mesh-ancestor
153712840|NCT00086879|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153712888|NCT00087035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153712889|NCT00087035|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153712890|NCT00087035|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153712891|NCT00087035|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153712892|NCT00322075|Insulin Glargine|insulin glargine|mesh-list
153712893|NCT00322075|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153712894|NCT00322075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153712896|NCT00322114|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153712897|NCT00322114|Antioxidants|antioxidants|mesh-ancestor
153712898|NCT00322114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153712899|NCT00322114|Protective Agents|protective agents|mesh-ancestor
153712900|NCT00322114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153712901|NCT00322114|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
153712902|NCT00322114|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
153712903|NCT00322114|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153712904|NCT00087074|Sirolimus|sirolimus|mesh-list
153712905|NCT00087074|Temsirolimus|temsirolimus|mesh-list
153712906|NCT00087074|MTOR Inhibitors|mtor inhibitors|mesh-list
153712944|NCT00332293|Contraceptive Agents|contraceptive agents|mesh-ancestor
153712945|NCT00332293|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153712946|NCT00332293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153712947|NCT00332293|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
153712948|NCT00332293|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
153712949|NCT00332293|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
153712950|NCT00087191|Motexafin lutetium|motexafin lutetium|mesh-list
153712951|NCT00087191|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
153712952|NCT00087191|Dermatologic Agents|dermatologic agents|mesh-ancestor
153712953|NCT00094692|Atropine|atropine|mesh-list
153712954|NCT00094692|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153712955|NCT00094692|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153712956|NCT00094692|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153712957|NCT00094692|Autonomic Agents|autonomic agents|mesh-ancestor
153712958|NCT00094692|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153712959|NCT00094692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153712960|NCT00094692|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153712961|NCT00094692|Respiratory System Agents|respiratory system agents|mesh-ancestor
153712962|NCT00094692|Mydriatics|mydriatics|mesh-ancestor
153712963|NCT00094692|Parasympatholytics|parasympatholytics|mesh-ancestor
153712964|NCT00094692|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
153712965|NCT00094692|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
153712966|NCT00094692|Cholinergic Agents|cholinergic agents|mesh-ancestor
153712967|NCT00094692|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153549989|NCT03677830|Acetaminophen|acetaminophen|mesh-list
153712968|NCT00094692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153712969|NCT05181007|Valproic Acid|valproic acid|mesh-list
153712970|NCT05181007|Anticonvulsants|anticonvulsants|mesh-ancestor
153712971|NCT05181007|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153712972|NCT05181007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153712973|NCT05181007|GABA Agents|gaba agents|mesh-ancestor
153712974|NCT05181007|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153712975|NCT05181007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153712976|NCT05181007|Antimanic Agents|antimanic agents|mesh-ancestor
153712977|NCT05181007|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153712978|NCT05181007|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153712979|NCT05181007|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153360724|NCT01368263|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153712980|NCT00124839|Naltrexone|naltrexone|mesh-list
153712981|NCT00124839|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
153712982|NCT00124839|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
153712983|NCT00124839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153338435|NCT00002068|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153712984|NCT00124839|Sensory System Agents|sensory system agents|mesh-ancestor
153712985|NCT00124839|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153712986|NCT00087269|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
153713048|NCT00330655|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
153713049|NCT00330772|Aspirin|aspirin|mesh-list
153713050|NCT00330772|Clopidogrel|clopidogrel|mesh-list
153713051|NCT00330772|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153713052|NCT00330772|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153713053|NCT00330772|Analgesics|analgesics|mesh-ancestor
153713054|NCT00330772|Sensory System Agents|sensory system agents|mesh-ancestor
153713055|NCT00330772|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153713056|NCT00330772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153713057|NCT00330772|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153713058|NCT00330772|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153713059|NCT00330772|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153713060|NCT00330772|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153713061|NCT00330772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153713062|NCT00330772|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153713063|NCT00330772|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153713064|NCT00330772|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153713065|NCT00330772|Antipyretics|antipyretics|mesh-ancestor
153713066|NCT00330772|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
153713103|NCT00331084|BB 1101|bb 1101|mesh-list
153713104|NCT00331084|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153713105|NCT00331084|Antiemetics|antiemetics|mesh-ancestor
153713106|NCT00331084|Autonomic Agents|autonomic agents|mesh-ancestor
153713107|NCT00331084|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153919503|NCT00999804|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
153713109|NCT00331084|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153713110|NCT00331084|Glucocorticoids|glucocorticoids|mesh-ancestor
153713112|NCT00331084|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153713113|NCT00331084|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153713114|NCT00331084|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153713115|NCT00331084|Protease Inhibitors|protease inhibitors|mesh-ancestor
153713116|NCT00331084|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153713117|NCT00331084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153713118|NCT00331084|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153713119|NCT00331084|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153713120|NCT00331084|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153713121|NCT00331084|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
153713157|NCT00087542|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153713158|NCT00087542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153713159|NCT00331240|Timolol|timolol|mesh-list
153713160|NCT00331240|Travoprost|travoprost|mesh-list
153713161|NCT00331240|Lubricant Eye Drops|lubricant eye drops|mesh-list
153713162|NCT00331240|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
153713163|NCT00331240|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
153713164|NCT00331240|Adrenergic Agents|adrenergic agents|mesh-ancestor
153713165|NCT00331240|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153713166|NCT00331240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153713167|NCT00331240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153713168|NCT00331240|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153713220|NCT00124995|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153713221|NCT00124995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153713222|NCT00124995|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153713223|NCT00124995|Respiratory System Agents|respiratory system agents|mesh-ancestor
153713224|NCT00124995|Sympathomimetics|sympathomimetics|mesh-ancestor
153338490|NCT00001354|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153713225|NCT00124995|Tocolytic Agents|tocolytic agents|mesh-ancestor
153713226|NCT00124995|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153713227|NCT00124995|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
153713228|NCT00124995|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
153713229|NCT00124995|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153713230|NCT00124995|Adrenergic Agents|adrenergic agents|mesh-ancestor
153713231|NCT00124995|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153713232|NCT00124995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153713233|NCT00331708|Artesunate|artesunate|mesh-list
153713234|NCT00331708|Pyrimethamine|pyrimethamine|mesh-list
153713235|NCT00331708|Sulfadoxine|sulfadoxine|mesh-list
153713236|NCT00331708|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
153713237|NCT00331708|Antimalarials|antimalarials|mesh-ancestor
153713238|NCT00331708|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153713239|NCT00331708|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153713278|NCT00331786|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153713279|NCT00331786|Autonomic Agents|autonomic agents|mesh-ancestor
153713280|NCT00331786|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153713338|NCT00331981|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153713339|NCT00331981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153713340|NCT00331981|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
153713341|NCT00331981|Antidepressive Agents|antidepressive agents|mesh-ancestor
153713343|NCT00126633|Gemcitabine|gemcitabine|mesh-list
153713344|NCT00126633|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153713345|NCT00126633|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153713346|NCT00126633|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153713347|NCT00126633|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153713348|NCT00126633|Growth Substances|growth substances|mesh-ancestor
153713349|NCT00126633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153713350|NCT00126633|Growth Inhibitors|growth inhibitors|mesh-ancestor
153713351|NCT00126633|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153713352|NCT00126633|Antimetabolites|antimetabolites|mesh-ancestor
153713365|NCT02965274|Fluoxetine|fluoxetine|mesh-list
153713395|NCT00332137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153713397|NCT00126789|Fentanyl|fentanyl|mesh-list
153713398|NCT00126789|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153713399|NCT00126789|Narcotics|narcotics|mesh-ancestor
153713400|NCT00126789|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153713401|NCT00126789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153713402|NCT00126789|Analgesics|analgesics|mesh-ancestor
153713403|NCT00126789|Sensory System Agents|sensory system agents|mesh-ancestor
153713404|NCT00126789|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153713405|NCT00126789|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153713406|NCT00126789|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153713407|NCT00126789|Anesthetics, General|anesthetics, general|mesh-ancestor
153713408|NCT00126789|Anesthetics|anesthetics|mesh-ancestor
153713409|NCT05831969|Lenalidomide|lenalidomide|mesh-list
153713410|NCT05831969|Immunologic Factors|immunologic factors|mesh-ancestor
153713411|NCT05831969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153713412|NCT05831969|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153713413|NCT05831969|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153713414|NCT05831969|Growth Substances|growth substances|mesh-ancestor
153713415|NCT05831969|Growth Inhibitors|growth inhibitors|mesh-ancestor
153713416|NCT05831969|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153713418|NCT05831761|Analgesics|analgesics|mesh-list
153713419|NCT05831761|Anesthetics, Local|anesthetics, local|mesh-ancestor
153713420|NCT05831761|Anesthetics|anesthetics|mesh-ancestor
153713421|NCT05831761|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153713422|NCT05831761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153713423|NCT05831761|Sensory System Agents|sensory system agents|mesh-ancestor
153713424|NCT05831761|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153713442|NCT05831566|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
153713443|NCT05831566|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
153713444|NCT05831566|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153713445|NCT05831566|Adrenergic Agents|adrenergic agents|mesh-ancestor
153713446|NCT05831566|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153713447|NCT05831566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153713448|NCT05831462|Ticagrelor|ticagrelor|mesh-list
153713449|NCT05831462|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153713450|NCT05831462|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
153713451|NCT05831462|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
153713452|NCT05831462|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
153713453|NCT05831462|Purinergic Agents|purinergic agents|mesh-ancestor
153713454|NCT05831462|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153713505|NCT05776017|Immunologic Factors|immunologic factors|mesh-ancestor
153713506|NCT05776017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153713507|NCT05776017|Antacids|antacids|mesh-ancestor
153713508|NCT05776017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153338527|NCT00000496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153338541|NCT00002086|Zidovudine|zidovudine|mesh-list
153713509|NCT05776017|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153713510|NCT05665270|Prednisolone|prednisolone|mesh-list
153713511|NCT05665270|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
153713512|NCT05665270|Methylprednisolone|methylprednisolone|mesh-list
153713513|NCT05665270|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
153713514|NCT05665270|Prednisolone acetate|prednisolone acetate|mesh-list
153713515|NCT05665270|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
153713516|NCT05665270|Prednisolone phosphate|prednisolone phosphate|mesh-list
153713517|NCT05665270|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153713518|NCT05665270|Glucocorticoids|glucocorticoids|mesh-ancestor
153713519|NCT05665270|Hormones|hormones|mesh-ancestor
153713520|NCT05665270|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153713521|NCT05665270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153713522|NCT05665270|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153713560|NCT05546359|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153713561|NCT05546359|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
153713562|NCT05546359|Dopamine Agents|dopamine agents|mesh-ancestor
153713563|NCT05546359|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153713564|NCT05546359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153713565|NCT05546359|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
153713566|NCT05546359|Antidepressive Agents|antidepressive agents|mesh-ancestor
153713567|NCT05413330|Triamcinolone|triamcinolone|mesh-list
153713568|NCT05413330|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
153713569|NCT05413330|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
153713570|NCT05413330|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
153713571|NCT05413330|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153713572|NCT05413330|Glucocorticoids|glucocorticoids|mesh-ancestor
153713573|NCT05413330|Hormones|hormones|mesh-ancestor
153713574|NCT05413330|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153713575|NCT05413330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153713576|NCT05413330|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153713618|NCT05243940|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
153713619|NCT05243940|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
153713620|NCT05243940|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153713622|NCT05198544|Hyaluronic Acid|hyaluronic acid|mesh-list
153713623|NCT05198544|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153713624|NCT05198544|Immunologic Factors|immunologic factors|mesh-ancestor
153713625|NCT05198544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153713626|NCT05198544|Viscosupplements|viscosupplements|mesh-ancestor
153713627|NCT05198544|Protective Agents|protective agents|mesh-ancestor
153713638|NCT05141474|Aldesleukin|aldesleukin|mesh-list
153713639|NCT05141474|Cyclophosphamide|cyclophosphamide|mesh-list
153713678|NCT05097261|Anesthetics|anesthetics|mesh-ancestor
153713679|NCT05097261|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153713680|NCT05097261|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
153713681|NCT05097261|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
153713682|NCT05097261|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153713683|NCT05097261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153338554|NCT00002086|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153713684|NCT05037032|Naltrexone|naltrexone|mesh-list
153713685|NCT05037032|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
153713686|NCT05037032|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
153713744|NCT04334876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153713745|NCT04231214|Tiotropium Bromide|tiotropium bromide|mesh-list
153713746|NCT04231214|Olodaterol|olodaterol|mesh-list
153713747|NCT04231214|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153713748|NCT04231214|Autonomic Agents|autonomic agents|mesh-ancestor
153713749|NCT04231214|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153713750|NCT04231214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153713751|NCT04231214|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153713752|NCT04231214|Respiratory System Agents|respiratory system agents|mesh-ancestor
153713753|NCT04231214|Parasympatholytics|parasympatholytics|mesh-ancestor
153713754|NCT04231214|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
153338576|NCT00001384|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153713755|NCT04231214|Cholinergic Agents|cholinergic agents|mesh-ancestor
153713756|NCT04231214|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153713757|NCT04231214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153713758|NCT04229095|Suvorexant|suvorexant|mesh-list
153713759|NCT04229095|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
153713760|NCT04229095|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153713761|NCT04229095|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153713762|NCT04229095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153713798|NCT04006288|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
153713799|NCT04006288|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
153713800|NCT04006288|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
153713801|NCT04006288|Purinergic Agents|purinergic agents|mesh-ancestor
153713802|NCT04006288|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153713803|NCT04006288|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
153713804|NCT04006288|Antithrombins|antithrombins|mesh-ancestor
153713805|NCT04006288|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
153713806|NCT04006288|Protease Inhibitors|protease inhibitors|mesh-ancestor
153713807|NCT04006288|Anticoagulants|anticoagulants|mesh-ancestor
153713808|NCT03979131|Avelumab|avelumab|mesh-list
153713809|NCT03979131|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153713810|NCT03979131|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153713811|NCT03952273|Sirolimus|sirolimus|mesh-list
153713812|NCT03952273|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153713813|NCT03952273|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153713814|NCT03952273|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153713815|NCT03952273|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153713816|NCT03952273|Antifungal Agents|antifungal agents|mesh-ancestor
153713817|NCT03952273|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153713818|NCT03952273|Immunologic Factors|immunologic factors|mesh-ancestor
153713819|NCT03952273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153713820|NCT03843645|Anesthetics|anesthetics|mesh-list
153713821|NCT03843645|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153713822|NCT03843645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153713823|NCT03728881|Vaccines|vaccines|mesh-list
153713824|NCT03728881|Immunologic Factors|immunologic factors|mesh-ancestor
153713825|NCT03728881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153713826|NCT03711253|Tenofovir|tenofovir|mesh-list
153713827|NCT03711253|Emtricitabine|emtricitabine|mesh-list
153713828|NCT03711253|Antiviral Agents|antiviral agents|mesh-ancestor
153713829|NCT03711253|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153713832|NCT03711253|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153713842|NCT03643822|Autonomic Agents|autonomic agents|mesh-ancestor
153713843|NCT03643822|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153713844|NCT03643822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153713845|NCT03643822|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153713846|NCT03643822|Glucocorticoids|glucocorticoids|mesh-ancestor
153713848|NCT03643822|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153713849|NCT03643822|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153713850|NCT03643822|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153713851|NCT03643822|Protease Inhibitors|protease inhibitors|mesh-ancestor
153713852|NCT03643822|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153713853|NCT03643822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153713854|NCT03643822|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153713855|NCT03643822|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153713856|NCT03643822|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153713857|NCT03643822|Analgesics|analgesics|mesh-ancestor
153713858|NCT03643822|Sensory System Agents|sensory system agents|mesh-ancestor
153713859|NCT03643822|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
153713860|NCT03643822|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153713861|NCT03643822|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153713862|NCT03643822|Adrenergic Agents|adrenergic agents|mesh-ancestor
153713864|NCT03603964|Guadecitabine|guadecitabine|mesh-list
153713893|NCT03495921|Temozolomide|temozolomide|mesh-list
153713894|NCT03495921|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
153713896|NCT03495921|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153713897|NCT03495921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153713898|NCT03495921|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153713899|NCT03495921|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153713900|NCT03495921|Alkylating Agents|alkylating agents|mesh-ancestor
153713901|NCT03495921|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153713902|NCT03191864|Fluticasone|fluticasone|mesh-list
153713904|NCT03191864|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153713905|NCT03191864|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153713906|NCT03191864|Autonomic Agents|autonomic agents|mesh-ancestor
153713907|NCT03191864|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153713908|NCT03191864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153713909|NCT03191864|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153713910|NCT03191864|Respiratory System Agents|respiratory system agents|mesh-ancestor
153713911|NCT03191864|Dermatologic Agents|dermatologic agents|mesh-ancestor
153713912|NCT03191864|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
153713913|NCT03123978|Niclosamide|niclosamide|mesh-list
153713914|NCT03123978|Anticestodal Agents|anticestodal agents|mesh-ancestor
153713915|NCT03123978|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
153713916|NCT03123978|Anthelmintics|anthelmintics|mesh-ancestor
153713917|NCT03123978|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153713918|NCT03123978|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153713919|NCT03123978|Antinematodal Agents|antinematodal agents|mesh-ancestor
153713941|NCT03002103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153713942|NCT03002103|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153713943|NCT03002103|Antimetabolites|antimetabolites|mesh-ancestor
153713945|NCT02898207|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
153713946|NCT02898207|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153713947|NCT02898207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153713948|NCT02898207|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153713949|NCT02682485|Metronidazole|metronidazole|mesh-list
153713950|NCT02682485|Ciprofloxacin|ciprofloxacin|mesh-list
153713951|NCT02682485|Neomycin|neomycin|mesh-list
153713952|NCT02682485|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153713953|NCT02682485|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153713954|NCT02682485|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153713955|NCT02682485|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153713956|NCT02682485|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153713957|NCT02682485|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153338604|NCT00002098|Didanosine|didanosine|mesh-list
153713958|NCT02682485|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153713959|NCT02682485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153713960|NCT02682485|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153713961|NCT02682485|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
153713962|NCT02682485|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153713992|NCT02304458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153713993|NCT02219373|Oxcarbazepine|oxcarbazepine|mesh-list
153713994|NCT02219373|Gabapentin|gabapentin|mesh-list
153713995|NCT02219373|Analgesics|analgesics|mesh-ancestor
153713996|NCT02219373|Sensory System Agents|sensory system agents|mesh-ancestor
153713997|NCT02219373|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153713998|NCT02219373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153713999|NCT02219373|Anticonvulsants|anticonvulsants|mesh-ancestor
153714056|NCT01958021|Hormone Antagonists|hormone antagonists|mesh-ancestor
153714057|NCT01958021|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153714058|NCT01958021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153714060|NCT01946477|Daratumumab|daratumumab|mesh-list
153714061|NCT01946477|Pomalidomide|pomalidomide|mesh-list
153714062|NCT01946477|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153714063|NCT01946477|Antiemetics|antiemetics|mesh-ancestor
153714064|NCT01946477|Autonomic Agents|autonomic agents|mesh-ancestor
153714065|NCT01946477|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153714066|NCT01946477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153714067|NCT01946477|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153714068|NCT01946477|Glucocorticoids|glucocorticoids|mesh-ancestor
153714118|NCT05952050|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153714119|NCT05952050|Analgesics|analgesics|mesh-ancestor
153714120|NCT05952050|Sensory System Agents|sensory system agents|mesh-ancestor
153714121|NCT05952050|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153714122|NCT05952050|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
153714123|NCT05952050|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153714124|NCT05952050|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153879311|NCT05721755|Paclitaxel|paclitaxel|mesh-list
153879312|NCT05721755|Cisplatin|cisplatin|mesh-list
153879313|NCT05721755|Carboplatin|carboplatin|mesh-list
153879314|NCT05721755|Pembrolizumab|pembrolizumab|mesh-list
153879315|NCT05721755|Fluorouracil|fluorouracil|mesh-list
153879316|NCT05721755|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
153879317|NCT05721755|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153879318|NCT05721755|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153879319|NCT05721755|Tubulin Modulators|tubulin modulators|mesh-ancestor
153714125|NCT05952050|Adrenergic Agents|adrenergic agents|mesh-ancestor
153714126|NCT05952050|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153714188|NCT05951309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153714189|NCT05947435|Tranexamic Acid|tranexamic acid|mesh-list
153714190|NCT05947435|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
153714191|NCT05947435|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153714192|NCT05947435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153714193|NCT05947435|Hemostatics|hemostatics|mesh-ancestor
153714194|NCT05947435|Coagulants|coagulants|mesh-ancestor
153338613|NCT00002098|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153714195|NCT05936671|Remifentanil|remifentanil|mesh-list
153714196|NCT05936671|Anesthetics|anesthetics|mesh-list
153714197|NCT05936671|Sevoflurane|sevoflurane|mesh-list
153714198|NCT05936671|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153714254|NCT05794997|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153714255|NCT05794997|Vasodilator Agents|vasodilator agents|mesh-ancestor
153714256|NCT05794997|Antioxidants|antioxidants|mesh-ancestor
153714257|NCT05794997|Protective Agents|protective agents|mesh-ancestor
153714258|NCT05794997|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153714259|NCT05794997|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153714260|NCT05794997|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153714261|NCT05794997|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
153714262|NCT05794997|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
153714263|NCT05794997|Sympatholytics|sympatholytics|mesh-ancestor
153714264|NCT05794997|Autonomic Agents|autonomic agents|mesh-ancestor
153714265|NCT05794997|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153714266|NCT05794997|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
153714267|NCT05742399|Hyaluronic Acid|hyaluronic acid|mesh-list
153714314|NCT05635370|Free Radical Scavengers|free radical scavengers|mesh-ancestor
153714315|NCT05635370|Antioxidants|antioxidants|mesh-ancestor
153714316|NCT05635370|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153714317|NCT05635370|Autonomic Agents|autonomic agents|mesh-ancestor
153714318|NCT05635370|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153714319|NCT05635370|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153714320|NCT05635370|Respiratory System Agents|respiratory system agents|mesh-ancestor
153714321|NCT05635370|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153714322|NCT05635370|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153714323|NCT05635370|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
153714324|NCT05635370|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
153714325|NCT05635357|Letrozole|letrozole|mesh-list
153714326|NCT05635357|Anastrozole|anastrozole|mesh-list
153714327|NCT05635357|Exemestane|exemestane|mesh-list
153714328|NCT05635357|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153714329|NCT05635357|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
153714330|NCT05635357|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153714371|NCT05457855|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
153714372|NCT05457855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153714374|NCT05379491|Guanylyl Cyclase C Agonists|guanylyl cyclase c agonists|mesh-ancestor
153714375|NCT05379491|Enzyme Activators|enzyme activators|mesh-ancestor
153714376|NCT05379491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153714377|NCT05379491|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153714378|NCT05376111|Azacitidine|azacitidine|mesh-list
153714379|NCT05376111|Venetoclax|venetoclax|mesh-list
153714380|NCT05376111|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153714382|NCT05376111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153714383|NCT05376111|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153714384|NCT05376111|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153714385|NCT05322902|Propofol|propofol|mesh-list
153714386|NCT05322902|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153714387|NCT05322902|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153714388|NCT05322902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153714389|NCT05322902|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153714390|NCT05322902|Anesthetics, General|anesthetics, general|mesh-ancestor
153714391|NCT05322902|Anesthetics|anesthetics|mesh-ancestor
153714392|NCT05291299|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
153714393|NCT05242458|Ustekinumab|ustekinumab|mesh-list
153714394|NCT05242458|Dermatologic Agents|dermatologic agents|mesh-ancestor
153338710|NCT00000580|Immunologic Factors|immunologic factors|mesh-ancestor
153714395|NCT05170893|Ubiquinone|ubiquinone|mesh-list
153714396|NCT05170893|Coenzyme Q10|coenzyme q10|mesh-list
153338711|NCT00000580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153714397|NCT05170893|Micronutrients|micronutrients|mesh-ancestor
153714418|NCT05125276|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153714423|NCT05125276|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153714424|NCT05125276|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153714425|NCT05125276|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153714426|NCT05125276|Antipyretics|antipyretics|mesh-ancestor
153714427|NCT05083780|Hydroxychloroquine|hydroxychloroquine|mesh-list
153714428|NCT05083780|Chlorphenesin|chlorphenesin|mesh-list
153714482|NCT05049902|Natriuretic Agents|natriuretic agents|mesh-ancestor
153714483|NCT05049902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153714485|NCT05049902|Respiratory System Agents|respiratory system agents|mesh-ancestor
153714486|NCT05026593|Carboplatin|carboplatin|mesh-list
153714487|NCT05026593|Etoposide|etoposide|mesh-list
153714488|NCT05026593|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153714489|NCT05026593|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153714490|NCT05026593|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153714491|NCT05026593|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153714492|NCT05026593|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153714493|NCT05026593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153714494|NCT04971109|Tecovirimat|tecovirimat|mesh-list
153714495|NCT04971109|Antiviral Agents|antiviral agents|mesh-ancestor
153714496|NCT04971109|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153714497|NCT04957485|Tecovirimat|tecovirimat|mesh-list
153714499|NCT04957485|Antiviral Agents|antiviral agents|mesh-ancestor
153714501|NCT04833959|Panitumumab|panitumumab|mesh-list
153714541|NCT04608448|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153714542|NCT04608448|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153714543|NCT04608448|Antifungal Agents|antifungal agents|mesh-ancestor
153714544|NCT04608448|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153714545|NCT04608448|Immunologic Factors|immunologic factors|mesh-ancestor
153714546|NCT04608448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153879365|NCT05621174|Dopamine Agents|dopamine agents|mesh-ancestor
153879366|NCT05621174|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153879367|NCT05579977|Semaglutide|semaglutide|mesh-list
153879368|NCT05579977|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
153879369|NCT05579977|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153714548|NCT04608448|Dermatologic Agents|dermatologic agents|mesh-ancestor
153714549|NCT04562285|Antibodies|antibodies|mesh-list
153714550|NCT04562285|Immunologic Factors|immunologic factors|mesh-ancestor
153714551|NCT04562285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153714552|NCT04528004|Niacinamide|niacinamide|mesh-list
153714553|NCT04528004|Niacin|niacin|mesh-list
153714554|NCT04528004|Nicotinic Acids|nicotinic acids|mesh-list
153714555|NCT04528004|Vitamin B Complex|vitamin b complex|mesh-ancestor
153714556|NCT04528004|Vitamins|vitamins|mesh-ancestor
153714557|NCT04528004|Micronutrients|micronutrients|mesh-ancestor
153714558|NCT04528004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153714559|NCT04528004|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153714582|NCT04485039|Sevelamer|sevelamer|mesh-list
153714603|NCT04313790|Calcium heparin|calcium heparin|mesh-list
153714604|NCT04313790|Anticoagulants|anticoagulants|mesh-ancestor
153714605|NCT04313790|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153714606|NCT04313790|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153714607|NCT04313790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153714608|NCT04293393|Paclitaxel|paclitaxel|mesh-list
153714609|NCT04293393|Docetaxel|docetaxel|mesh-list
153714610|NCT04293393|Cyclophosphamide|cyclophosphamide|mesh-list
153714611|NCT04293393|Doxorubicin|doxorubicin|mesh-list
153714612|NCT04293393|Letrozole|letrozole|mesh-list
153714613|NCT04293393|Leuprolide|leuprolide|mesh-list
153714614|NCT04293393|Goserelin|goserelin|mesh-list
153714615|NCT04293393|Taxane|taxane|mesh-list
153919596|NCT00003236|ISIS 5132|isis 5132|mesh-list
153714616|NCT04293393|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153714618|NCT04293393|Tubulin Modulators|tubulin modulators|mesh-ancestor
153714619|NCT04293393|Antimitotic Agents|antimitotic agents|mesh-ancestor
153714620|NCT04293393|Mitosis Modulators|mitosis modulators|mesh-ancestor
153714621|NCT04293393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153714622|NCT04293393|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153714623|NCT04293393|Immunologic Factors|immunologic factors|mesh-ancestor
153714624|NCT04293393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153714625|NCT04293393|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153714626|NCT04293393|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153714629|NCT04293393|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153714654|NCT04153487|Vitamins|vitamins|mesh-ancestor
153714655|NCT04153487|Micronutrients|micronutrients|mesh-ancestor
153714656|NCT04153487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153714657|NCT04153487|Antioxidants|antioxidants|mesh-ancestor
153714658|NCT04153487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153714660|NCT04153032|Diltiazem|diltiazem|mesh-list
153714720|NCT03431831|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153714721|NCT03431831|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
153714722|NCT03431831|Antidepressive Agents|antidepressive agents|mesh-ancestor
153714723|NCT03431831|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153714724|NCT03431831|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
153714725|NCT03431831|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153714726|NCT03431831|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153714727|NCT03431831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153714728|NCT03431831|Dopamine Agents|dopamine agents|mesh-ancestor
153714729|NCT03431831|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153714730|NCT03431831|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
153714731|NCT03431831|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153714732|NCT03431831|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153714733|NCT03426891|Pembrolizumab|pembrolizumab|mesh-list
153338738|NCT00001498|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153714734|NCT03426891|Temozolomide|temozolomide|mesh-list
153714735|NCT03426891|Vorinostat|vorinostat|mesh-list
153714736|NCT03426891|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-list
153714737|NCT03426891|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153714802|NCT02953834|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153714803|NCT02953834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153714804|NCT02849639|Scopolamine|scopolamine|mesh-list
153714805|NCT02849639|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
153714806|NCT02849639|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153714807|NCT02849639|Antiemetics|antiemetics|mesh-ancestor
153714808|NCT02849639|Autonomic Agents|autonomic agents|mesh-ancestor
153714809|NCT02849639|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153714810|NCT02849639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153714811|NCT02849639|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153714812|NCT02849639|Mydriatics|mydriatics|mesh-ancestor
153714813|NCT02849639|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
153714814|NCT02849639|Cholinergic Agents|cholinergic agents|mesh-ancestor
153714815|NCT02849639|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153714816|NCT02849639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153714817|NCT02849639|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
153714818|NCT02849639|Parasympatholytics|parasympatholytics|mesh-ancestor
153714858|NCT02326805|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153714859|NCT02326805|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153714860|NCT02326805|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153714861|NCT02326805|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153714862|NCT01952782|Naloxone|naloxone|mesh-list
153714863|NCT01952782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153714864|NCT01952782|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
153714865|NCT01952782|Sensory System Agents|sensory system agents|mesh-ancestor
153714866|NCT01952782|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153714867|NCT01423812|Ritonavir|ritonavir|mesh-list
153714868|NCT01423812|Darunavir|darunavir|mesh-list
153714869|NCT01423812|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
153714870|NCT01423812|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
153714871|NCT01423812|Protease Inhibitors|protease inhibitors|mesh-ancestor
153714918|NCT00859781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153714919|NCT00859781|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
153714920|NCT00792740|Givinostat hydrochloride|givinostat hydrochloride|mesh-list
153919597|NCT00003236|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153714921|NCT00792740|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
153714922|NCT00792740|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153714923|NCT00792740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153714924|NCT00729300|Disulfiram|disulfiram|mesh-list
153714925|NCT00729300|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
153714926|NCT00729300|Acetaldehyde Dehydrogenase Inhibitors|acetaldehyde dehydrogenase inhibitors|mesh-ancestor
153547251|NCT05636592|Immunologic Factors|immunologic factors|mesh-ancestor
153714935|NCT00856947|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153714936|NCT00655993|Simvastatin|simvastatin|mesh-list
153714937|NCT00655993|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153714938|NCT00655993|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153714939|NCT00655993|Antimetabolites|antimetabolites|mesh-ancestor
153714940|NCT00655993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153714941|NCT00655993|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153338790|NCT00002122|Azithromycin|azithromycin|mesh-list
153714942|NCT00655993|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
153714943|NCT00655993|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153714944|NCT00125151|Complement C1 Inhibitor Protein|complement c1 inhibitor protein|mesh-list
153714962|NCT00087854|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153714963|NCT00087854|Antiviral Agents|antiviral agents|mesh-ancestor
153714964|NCT00087854|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153714965|NCT00087854|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153714966|NCT00087854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153714967|NCT04715620|Niraparib|niraparib|mesh-list
153714968|NCT04715620|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
153714969|NCT04715620|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153714970|NCT04715620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153714971|NCT04715620|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153879421|NCT05314933|Deoxyglucose|deoxyglucose|mesh-list
153714973|NCT00125229|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
153714974|NCT00125229|Diuretics|diuretics|mesh-ancestor
153714975|NCT00125229|Natriuretic Agents|natriuretic agents|mesh-ancestor
153714976|NCT00125229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153714977|NCT00126906|Pyrimethamine|pyrimethamine|mesh-list
153714978|NCT00126906|Sulfadoxine|sulfadoxine|mesh-list
153714979|NCT00126906|Antimalarials|antimalarials|mesh-ancestor
153714980|NCT00126906|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153714981|NCT00126906|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153714982|NCT00126906|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153715016|NCT00088088|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153715017|NCT00088088|Tubulin Modulators|tubulin modulators|mesh-ancestor
153715018|NCT00088088|Antimitotic Agents|antimitotic agents|mesh-ancestor
153715019|NCT00088088|Mitosis Modulators|mitosis modulators|mesh-ancestor
153715020|NCT00088088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153715022|NCT00125307|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153715023|NCT00125307|Immunologic Factors|immunologic factors|mesh-ancestor
153715024|NCT00125307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153715025|NCT00125307|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
153715026|NCT00125307|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153715027|NCT00125307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153715028|NCT00127023|Vaccines|vaccines|mesh-list
153715029|NCT00127023|Immunologic Factors|immunologic factors|mesh-ancestor
153715030|NCT00127023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153715031|NCT00332761|Amlodipine, atorvastatin drug combination|amlodipine, atorvastatin drug combination|mesh-list
153715032|NCT00332761|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153715033|NCT00332761|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153715034|NCT00332761|Antimetabolites|antimetabolites|mesh-ancestor
153338818|NCT01027559|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153880437|NCT01752049|Timolol|timolol|mesh-list
153715035|NCT00332761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153715036|NCT00332761|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153715037|NCT00332761|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153715038|NCT00332761|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153715039|NCT00332761|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153715040|NCT00332761|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153715041|NCT00332761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153338842|NCT00000628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153715042|NCT00332761|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
153715043|NCT00332761|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153715044|NCT00332995|Dapivirine|dapivirine|mesh-list
153715058|NCT00333034|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153715059|NCT00333034|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153715060|NCT00333034|Immunologic Factors|immunologic factors|mesh-ancestor
153715061|NCT00088478|Olanzapine|olanzapine|mesh-list
153715062|NCT00088478|Antiemetics|antiemetics|mesh-ancestor
153715063|NCT00088478|Autonomic Agents|autonomic agents|mesh-ancestor
153715064|NCT00088478|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153715077|NCT00125346|Tobramycin|tobramycin|mesh-list
153715126|NCT00125424|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153715127|NCT00125424|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153715128|NCT00125424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153715129|NCT00125424|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153715130|NCT00125424|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153715131|NCT00125424|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153715195|NCT00421018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153715196|NCT00421018|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
153715197|NCT00421018|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
153715198|NCT00421018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153715200|NCT00421096|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153715201|NCT00421096|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153715202|NCT00421096|Antimetabolites|antimetabolites|mesh-ancestor
153715203|NCT00421096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153715204|NCT00089063|Sargramostim|sargramostim|mesh-list
153715205|NCT00089063|Monatide (IMS 3015)|monatide (ims 3015)|mesh-list
153715206|NCT00089063|Freund's Adjuvant|freund's adjuvant|mesh-list
153715207|NCT00089063|Immunologic Factors|immunologic factors|mesh-ancestor
153715208|NCT00089063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153715254|NCT00334321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153715255|NCT00334360|Dexmedetomidine|dexmedetomidine|mesh-list
153715257|NCT00334360|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153715258|NCT00334360|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153715259|NCT00334360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153715260|NCT00334360|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153715261|NCT00334360|Analgesics|analgesics|mesh-ancestor
153715262|NCT00334360|Sensory System Agents|sensory system agents|mesh-ancestor
153715263|NCT00334360|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153715264|NCT00334360|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
153715265|NCT00334360|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153715266|NCT00334360|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153715268|NCT00334360|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153715269|NCT00334360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153715270|NCT00334360|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153715271|NCT00334360|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153715272|NCT00334360|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153715273|NCT00334360|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
153715274|NCT00334360|Serotonin Agents|serotonin agents|mesh-ancestor
153715275|NCT00334399|Miglitol|miglitol|mesh-list
153715276|NCT00334399|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153715277|NCT00334399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153715278|NCT00334399|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153715279|NCT00334399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153715280|NCT00334399|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
153715281|NCT00334438|Rituximab|rituximab|mesh-list
153715282|NCT00334438|Bortezomib|bortezomib|mesh-list
153715283|NCT00334438|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
153715284|NCT00334438|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153715295|NCT00334477|Urological Agents|urological agents|mesh-ancestor
153715296|NCT04715269|Alprazolam|alprazolam|mesh-list
153715297|NCT04715269|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153715298|NCT04715269|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153715299|NCT04715269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153715300|NCT04715269|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153715313|NCT00089258|Antibodies|antibodies|mesh-list
153715365|NCT00334672|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153715366|NCT00334672|Antimetabolites|antimetabolites|mesh-ancestor
153715367|NCT00334672|Dermatologic Agents|dermatologic agents|mesh-ancestor
153715368|NCT00334672|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153715369|NCT00334672|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153715370|NCT00334672|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153715371|NCT00334672|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153715372|NCT00334672|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153715373|NCT00334672|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153715374|NCT00334672|Antifungal Agents|antifungal agents|mesh-ancestor
153715375|NCT00334672|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153715381|NCT00089453|Dexamethasone|dexamethasone|mesh-list
153715429|NCT00334789|Isotretinoin|isotretinoin|mesh-list
153715430|NCT00334789|Vitamins|vitamins|mesh-ancestor
153715431|NCT00334789|Micronutrients|micronutrients|mesh-ancestor
153715432|NCT00334789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153715433|NCT00334789|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153715434|NCT00334789|Keratolytic Agents|keratolytic agents|mesh-ancestor
153715435|NCT00334789|Dermatologic Agents|dermatologic agents|mesh-ancestor
153715436|NCT00334789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153715437|NCT00334789|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
153715438|NCT00334789|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153715439|NCT00334867|Cyclophosphamide|cyclophosphamide|mesh-list
153715494|NCT00334906|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153715495|NCT00334906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153715496|NCT00334906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153715497|NCT00334906|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
153715498|NCT00334906|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
153715499|NCT00089570|Terlipressin|terlipressin|mesh-list
153715500|NCT00089570|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153715501|NCT00089570|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
153715503|NCT00342862|Dermatologic Agents|dermatologic agents|mesh-ancestor
153715504|NCT00342862|Immunologic Factors|immunologic factors|mesh-ancestor
153715505|NCT00342862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153338871|NCT00002134|Antiviral Agents|antiviral agents|mesh-ancestor
153715506|NCT00089687|Vanoxerine|vanoxerine|mesh-list
153715507|NCT00089687|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
153715508|NCT00089687|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153715509|NCT00089687|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153715510|NCT00089687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153715511|NCT00089687|Dopamine Agents|dopamine agents|mesh-ancestor
153715512|NCT00089687|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153715513|NCT00089687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153715546|NCT00343096|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153715547|NCT00343096|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153715548|NCT00343096|GABA Modulators|gaba modulators|mesh-ancestor
153715550|NCT00343096|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153715551|NCT00343096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153715552|NCT00335179|Imiquimod|imiquimod|mesh-list
153715553|NCT00335179|Toll-Like Receptor Agonists|toll-like receptor agonists|mesh-ancestor
153715554|NCT00335179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153715555|NCT00335179|Immunomodulating Agents|immunomodulating agents|mesh-ancestor
153715612|NCT00343369|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153715613|NCT00343369|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153715614|NCT00343369|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153715615|NCT00343369|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153715616|NCT00343369|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153715617|NCT00343369|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153715618|NCT00343369|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
153715619|NCT00343369|Abortifacient Agents|abortifacient agents|mesh-ancestor
153715620|NCT00343369|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153715621|NCT00343369|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153715622|NCT00343369|Antimetabolites|antimetabolites|mesh-ancestor
153715623|NCT00343369|Dermatologic Agents|dermatologic agents|mesh-ancestor
153715624|NCT00343369|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153715626|NCT00343369|Antiviral Agents|antiviral agents|mesh-ancestor
153715669|NCT00343759|Lapatinib|lapatinib|mesh-list
153715670|NCT00343759|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153715671|NCT00343759|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153715672|NCT00343759|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153715673|NCT00343759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153715674|NCT00343759|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153715676|NCT00127920|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153715677|NCT00127920|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153715678|NCT00127920|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153715679|NCT00127920|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153715680|NCT00127920|Growth Substances|growth substances|mesh-ancestor
153715681|NCT00127920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153715732|NCT00402636|Temsirolimus|temsirolimus|mesh-list
153715733|NCT00402636|MTOR Inhibitors|mtor inhibitors|mesh-list
153715734|NCT00402636|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153715735|NCT00402636|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153715736|NCT00402636|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153338921|NCT00000658|Antiemetics|antiemetics|mesh-ancestor
153715737|NCT00402636|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153715738|NCT00402636|Antifungal Agents|antifungal agents|mesh-ancestor
153715739|NCT00402636|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153715740|NCT00402636|Immunologic Factors|immunologic factors|mesh-ancestor
153715741|NCT00402636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153715742|NCT00402636|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153715743|NCT00402636|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153715744|NCT00402636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153879481|NCT05112952|Lazertinib|lazertinib|mesh-list
153715745|NCT00344110|Aliskiren|aliskiren|mesh-list
153715746|NCT00344110|Renin Inhibitors|renin inhibitors|mesh-ancestor
153715795|NCT00344422|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153715796|NCT00344422|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153715797|NCT00344422|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153715798|NCT00344422|Protease Inhibitors|protease inhibitors|mesh-ancestor
153715799|NCT00344422|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153715801|NCT00344422|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153715860|NCT04715503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153715861|NCT00344617|Bevacizumab|bevacizumab|mesh-list
153715862|NCT00344617|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153715863|NCT00344617|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153715864|NCT00344617|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153715865|NCT00344617|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153715866|NCT00344617|Growth Substances|growth substances|mesh-ancestor
153715867|NCT00344617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153715868|NCT00344617|Growth Inhibitors|growth inhibitors|mesh-ancestor
153715869|NCT00127998|Artesunate|artesunate|mesh-list
153715870|NCT00127998|Chloroquine|chloroquine|mesh-list
153715871|NCT00127998|Lumefantrine|lumefantrine|mesh-list
153715872|NCT00127998|Artemether|artemether|mesh-list
153715873|NCT00127998|Pyrimethamine|pyrimethamine|mesh-list
153715874|NCT00127998|Sulfadoxine|sulfadoxine|mesh-list
153715875|NCT00127998|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
153715876|NCT00127998|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
153715877|NCT00127998|Amodiaquine|amodiaquine|mesh-list
153715913|NCT00344695|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
153715914|NCT00344695|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153715915|NCT00344695|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153715917|NCT00128037|Mitomycin|mitomycin|mesh-list
153715918|NCT00128037|Vindesine|vindesine|mesh-list
153715919|NCT00128037|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153715920|NCT00128037|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153715921|NCT00128037|Alkylating Agents|alkylating agents|mesh-ancestor
153715922|NCT00128037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153715923|NCT00128037|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153715977|NCT00090194|Antibodies|antibodies|mesh-list
153715979|NCT00090194|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
153715981|NCT00090194|Immunologic Factors|immunologic factors|mesh-ancestor
153715982|NCT00090194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153715983|NCT00345163|Bevacizumab|bevacizumab|mesh-list
153715984|NCT00345163|Irinotecan|irinotecan|mesh-list
153715985|NCT00345163|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153715986|NCT00345163|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153715987|NCT00345163|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153715988|NCT00345163|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153715989|NCT00345163|Growth Substances|growth substances|mesh-ancestor
153715990|NCT00345163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153715991|NCT00345163|Growth Inhibitors|growth inhibitors|mesh-ancestor
153715992|NCT00345163|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
153715993|NCT00345163|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153715994|NCT00345163|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153715995|NCT00345163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153715996|NCT00345202|Atorvastatin|atorvastatin|mesh-list
153715997|NCT00345202|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153715998|NCT00345202|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153715999|NCT00345202|Antimetabolites|antimetabolites|mesh-ancestor
153716000|NCT00345202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153716001|NCT00345202|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153716002|NCT00345202|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
153716003|NCT00345202|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153716004|NCT00335647|Fluphenazine|fluphenazine|mesh-list
153716005|NCT00335647|Fluphenazine depot|fluphenazine depot|mesh-list
153716006|NCT00335647|Fluphenazine enanthate|fluphenazine enanthate|mesh-list
153716007|NCT00335647|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153716021|NCT00128154|Iron Chelating Agents|iron chelating agents|mesh-ancestor
153716022|NCT00128154|Chelating Agents|chelating agents|mesh-ancestor
153716023|NCT00128154|Sequestering Agents|sequestering agents|mesh-ancestor
153716024|NCT00128154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153716025|NCT00335686|Lopinavir|lopinavir|mesh-list
153716026|NCT00335686|Nevirapine|nevirapine|mesh-list
153716029|NCT00335686|Protease Inhibitors|protease inhibitors|mesh-ancestor
153716030|NCT00335686|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153716031|NCT00335686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153716032|NCT00335686|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153716033|NCT00335686|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153716034|NCT00335686|Antiviral Agents|antiviral agents|mesh-ancestor
153716035|NCT00335686|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153716036|NCT00335686|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
153716037|NCT00335686|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153716038|NCT00335686|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153716039|NCT00335686|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153716040|NCT00335686|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
153716041|NCT00335686|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
153716042|NCT00128232|Octreotide|octreotide|mesh-list
153716043|NCT00128232|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153716044|NCT00128232|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153716046|NCT04708249|Inositol|inositol|mesh-list
153716047|NCT04708249|Vitamin B Complex|vitamin b complex|mesh-ancestor
153716048|NCT04708249|Vitamins|vitamins|mesh-ancestor
153339029|NCT00000694|Zidovudine|zidovudine|mesh-list
153716049|NCT04708249|Micronutrients|micronutrients|mesh-ancestor
153716050|NCT04708249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153716051|NCT00090272|Ertapenem|ertapenem|mesh-list
153716052|NCT00090272|Cefotetan|cefotetan|mesh-list
153716053|NCT00090272|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153716065|NCT00128271|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153716066|NCT00128271|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153716067|NCT00090311|Quetiapine Fumarate|quetiapine fumarate|mesh-list
153716068|NCT00090311|Antidepressive Agents|antidepressive agents|mesh-ancestor
153716069|NCT00090311|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153716070|NCT00090311|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153716071|NCT00090311|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153716072|NCT00090311|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153716073|NCT00090311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153716074|NCT02959762|Vitamins|vitamins|mesh-list
153716075|NCT02959762|Vitamin K|vitamin k|mesh-list
153716076|NCT02959762|Vitamin K 2|vitamin k 2|mesh-list
153716077|NCT02959762|Menaquinone 7|menaquinone 7|mesh-list
153716078|NCT02959762|Micronutrients|micronutrients|mesh-ancestor
153716079|NCT02959762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153716080|NCT02959762|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
153716125|NCT00346294|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153716126|NCT00346294|Analgesics|analgesics|mesh-ancestor
153716127|NCT00346294|Sensory System Agents|sensory system agents|mesh-ancestor
153716128|NCT00346294|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153716129|NCT00346294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153716130|NCT00346294|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153716131|NCT00346294|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153716132|NCT00346294|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153716133|NCT00346294|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153716134|NCT00346294|Immunologic Factors|immunologic factors|mesh-ancestor
153716135|NCT00346489|Fluorouracil|fluorouracil|mesh-list
153716137|NCT00346489|Mitomycin|mitomycin|mesh-list
153716138|NCT00346489|Antimetabolites|antimetabolites|mesh-ancestor
153716139|NCT00346489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153716140|NCT00346489|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153716141|NCT00346489|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153716142|NCT00346489|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153716143|NCT00346489|Immunologic Factors|immunologic factors|mesh-ancestor
153716144|NCT00346489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153716145|NCT00346489|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153716149|NCT00125814|Interferons|interferons|mesh-list
153716179|NCT02957994|Tenofovir|tenofovir|mesh-list
153716180|NCT02957994|Antiviral Agents|antiviral agents|mesh-ancestor
153716181|NCT02957994|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153716182|NCT02957994|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153716183|NCT02957994|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153716184|NCT02957994|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153716185|NCT02957994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153716186|NCT02957994|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153716188|NCT00346645|Bortezomib|bortezomib|mesh-list
153716246|NCT00126009|Amisulpride|amisulpride|mesh-list
153716247|NCT00126009|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153716248|NCT00126009|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153339067|NCT00002164|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
153716249|NCT00126009|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153716250|NCT00126009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153716251|NCT00126009|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153716252|NCT00126009|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
153716253|NCT00126009|Dopamine Agents|dopamine agents|mesh-ancestor
153716254|NCT00126009|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153716255|NCT00126009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153716256|NCT00126009|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
153716257|NCT00126009|Antidepressive Agents|antidepressive agents|mesh-ancestor
153716258|NCT00346918|Sirolimus|sirolimus|mesh-list
153716259|NCT00346918|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153716260|NCT00346918|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153716261|NCT00346918|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153716262|NCT00346918|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153716263|NCT00346918|Antifungal Agents|antifungal agents|mesh-ancestor
153716264|NCT00346918|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153716265|NCT00346918|Immunologic Factors|immunologic factors|mesh-ancestor
153716267|NCT00346957|Hydrocortisone|hydrocortisone|mesh-list
153716299|NCT00347113|Albendazole|albendazole|mesh-list
153716300|NCT00347113|Praziquantel|praziquantel|mesh-list
153716301|NCT00347113|Anthelmintics|anthelmintics|mesh-ancestor
153716302|NCT00347113|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153716303|NCT00347113|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153716304|NCT00347113|Anticestodal Agents|anticestodal agents|mesh-ancestor
153716305|NCT00347113|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
153716306|NCT00347113|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153716307|NCT00347113|Tubulin Modulators|tubulin modulators|mesh-ancestor
153716308|NCT00347113|Antimitotic Agents|antimitotic agents|mesh-ancestor
153716309|NCT00347113|Mitosis Modulators|mitosis modulators|mesh-ancestor
153716311|NCT00347113|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153716363|NCT00402558|Analgesics|analgesics|mesh-ancestor
153716365|NCT00402558|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153716367|NCT00402558|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153716368|NCT00347386|Zinc Sulfate|zinc sulfate|mesh-list
153716369|NCT00347386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153716370|NCT00347386|Astringents|astringents|mesh-ancestor
153716371|NCT00347386|Dermatologic Agents|dermatologic agents|mesh-ancestor
153716373|NCT00347425|Risperidone|risperidone|mesh-list
153716374|NCT00347425|Aripiprazole|aripiprazole|mesh-list
153716375|NCT00347425|Quetiapine Fumarate|quetiapine fumarate|mesh-list
153716376|NCT00347425|Ziprasidone|ziprasidone|mesh-list
153716377|NCT00347425|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153716378|NCT00347425|Serotonin Agents|serotonin agents|mesh-ancestor
153716379|NCT00347425|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153716425|NCT00347503|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153716426|NCT00347503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153716427|NCT00347503|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153339078|NCT00000706|Antimetabolites|antimetabolites|mesh-ancestor
153716428|NCT00347503|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153716429|NCT00347503|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153716430|NCT00347503|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153716431|NCT00347503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153716433|NCT00347542|Vitamins|vitamins|mesh-ancestor
153716434|NCT00347542|Micronutrients|micronutrients|mesh-ancestor
153716435|NCT00347542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153716436|NCT00347542|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153339116|NCT00002170|Protease Inhibitors|protease inhibitors|mesh-ancestor
153716437|NCT00091052|Sargramostim|sargramostim|mesh-list
153716438|NCT00091052|Immunologic Factors|immunologic factors|mesh-ancestor
153716439|NCT00091052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153716440|NCT00347581|Methamphetamine|methamphetamine|mesh-list
153716441|NCT00347581|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
153716442|NCT00347581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153716443|NCT00347581|Sympathomimetics|sympathomimetics|mesh-ancestor
153716444|NCT00347581|Autonomic Agents|autonomic agents|mesh-ancestor
153716445|NCT00347581|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153716446|NCT00347581|Dopamine Agents|dopamine agents|mesh-ancestor
153716478|NCT00126243|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153716479|NCT00126243|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153716480|NCT00126243|Immunologic Factors|immunologic factors|mesh-ancestor
153716481|NCT00126243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153716482|NCT00126243|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153716483|NCT00426439|Chloroquine|chloroquine|mesh-list
153716484|NCT00426439|Lumefantrine|lumefantrine|mesh-list
153716485|NCT00426439|Artemether|artemether|mesh-list
153716486|NCT00426439|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
153716487|NCT00426439|Amebicides|amebicides|mesh-ancestor
153716488|NCT00426439|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153716489|NCT00426439|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153716490|NCT00426439|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153716491|NCT00426439|Antimalarials|antimalarials|mesh-ancestor
153716492|NCT00426439|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153716493|NCT00426478|Amlodipine|amlodipine|mesh-list
153716494|NCT00426478|Valsartan|valsartan|mesh-list
153716537|NCT04705129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153716539|NCT00126321|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153716540|NCT00126321|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153716541|NCT00126321|Immunologic Factors|immunologic factors|mesh-ancestor
153716542|NCT00126321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153716543|NCT00426595|Omeprazole|omeprazole|mesh-list
153716544|NCT00426595|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
153716545|NCT00426595|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153716546|NCT00426595|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
153716547|NCT00426595|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153716548|NCT00426595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153716549|NCT00426673|Brivaracetam|brivaracetam|mesh-list
153716550|NCT00426673|Anticonvulsants|anticonvulsants|mesh-ancestor
153716589|NCT00091286|Monatide (IMS 3015)|monatide (ims 3015)|mesh-list
153716590|NCT00091286|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153716591|NCT00091286|Immunologic Factors|immunologic factors|mesh-ancestor
153716592|NCT00091286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153716593|NCT00126399|Doxycycline|doxycycline|mesh-list
153339117|NCT00002170|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153716594|NCT00126399|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153716595|NCT00126399|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153716596|NCT00126399|Antimalarials|antimalarials|mesh-ancestor
153716597|NCT00126399|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153716598|NCT00126399|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153716599|NCT01058395|Minocycline|minocycline|mesh-list
153716600|NCT01058395|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153716601|NCT01058395|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153716602|NCT00091325|Epigallocatechin gallate|epigallocatechin gallate|mesh-list
153716603|NCT00091325|Antioxidants|antioxidants|mesh-ancestor
153716604|NCT00091325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153716605|NCT00091325|Protective Agents|protective agents|mesh-ancestor
153716606|NCT00091325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153716607|NCT00091325|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
153716646|NCT00426829|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153716647|NCT00426829|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153716648|NCT00426829|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153716649|NCT00426829|Growth Substances|growth substances|mesh-ancestor
153547300|NCT05614089|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
153716653|NCT00426946|Antidepressive Agents|antidepressive agents|mesh-ancestor
153716654|NCT00426946|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153716655|NCT00426946|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
153716656|NCT00426946|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153716657|NCT00426946|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153716658|NCT00426946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153716659|NCT00426946|Adrenergic Agents|adrenergic agents|mesh-ancestor
153716660|NCT00426946|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153716661|NCT00426946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153716662|NCT00091598|Ambrisentan|ambrisentan|mesh-list
153716663|NCT00091598|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153716664|NCT00426985|Ketoprofen|ketoprofen|mesh-list
153716665|NCT00426985|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153716666|NCT00426985|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153716667|NCT00426985|Analgesics|analgesics|mesh-ancestor
153716668|NCT00426985|Sensory System Agents|sensory system agents|mesh-ancestor
153716669|NCT00426985|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153716670|NCT00426985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153716671|NCT00426985|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153716692|NCT00427492|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153716693|NCT00427570|Fluorouracil|fluorouracil|mesh-list
153716694|NCT00427570|Vincristine|vincristine|mesh-list
153716695|NCT00427570|Semustine|semustine|mesh-list
153716696|NCT00427570|BCG Vaccine|bcg vaccine|mesh-list
153716697|NCT00427570|Antimetabolites|antimetabolites|mesh-ancestor
153716698|NCT00427570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153716699|NCT00427570|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153716700|NCT00427570|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153716701|NCT00427570|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153716702|NCT00427570|Immunologic Factors|immunologic factors|mesh-ancestor
153716716|NCT00427882|Alfuzosin|alfuzosin|mesh-list
153716755|NCT00428194|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153716756|NCT00428194|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153339155|NCT00000730|Sulfamethoxazole|sulfamethoxazole|mesh-list
153716757|NCT00428194|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153716758|NCT00428194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153716759|NCT03769467|Pembrolizumab|pembrolizumab|mesh-list
153716760|NCT03769467|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153716825|NCT00428350|Quetiapine Fumarate|quetiapine fumarate|mesh-list
153716826|NCT00428350|Antidepressive Agents|antidepressive agents|mesh-ancestor
153879625|NCT04640779|Salicylates|salicylates|mesh-list
153879626|NCT04640779|Choline|choline|mesh-list
153879627|NCT04640779|Lipotropic Agents|lipotropic agents|mesh-ancestor
153879628|NCT04640779|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153879629|NCT04640779|Antimetabolites|antimetabolites|mesh-ancestor
153879630|NCT04640779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153879631|NCT04640779|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153879632|NCT04640779|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153879633|NCT04640779|Nootropic Agents|nootropic agents|mesh-ancestor
153879634|NCT04640779|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153716827|NCT00428350|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153716828|NCT00428350|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153716829|NCT00428350|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153716830|NCT00428350|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153716831|NCT00428350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153716833|NCT00428428|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
153716834|NCT00428428|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153716835|NCT00428428|Adrenergic Agents|adrenergic agents|mesh-ancestor
153716836|NCT00428428|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153716837|NCT00428428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153716838|NCT00428428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153716839|NCT00428428|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153716840|NCT00428428|Autonomic Agents|autonomic agents|mesh-ancestor
153716841|NCT00428428|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153716842|NCT00428428|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153716843|NCT00428428|Respiratory System Agents|respiratory system agents|mesh-ancestor
153716844|NCT00428428|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
153716845|NCT00428428|Sympathomimetics|sympathomimetics|mesh-ancestor
153716846|NCT00428428|Protective Agents|protective agents|mesh-ancestor
153716848|NCT00092339|Rofecoxib|rofecoxib|mesh-list
153716849|NCT00092339|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
153716873|NCT00092378|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153716874|NCT00092378|Analgesics|analgesics|mesh-ancestor
153716875|NCT00092378|Sensory System Agents|sensory system agents|mesh-ancestor
153716876|NCT00092378|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153716877|NCT00092378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153716878|NCT00092378|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153716879|NCT00092378|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153716880|NCT00092378|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153716881|NCT00092378|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153339200|NCT00002176|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153339201|NCT00002176|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
153716882|NCT00092378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153716883|NCT00092378|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
153716884|NCT00092846|Lovastatin|lovastatin|mesh-list
153716885|NCT00092846|L 647318|l 647318|mesh-list
153716886|NCT00092846|Dihydromevinolin|dihydromevinolin|mesh-list
153716887|NCT00092846|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153716888|NCT00092846|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153716889|NCT00092846|Antimetabolites|antimetabolites|mesh-ancestor
153716890|NCT00092846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153716891|NCT00092846|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153716892|NCT00092846|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
153716893|NCT00092846|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153716895|NCT00092924|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153716896|NCT00093002|Fulvestrant|fulvestrant|mesh-list
153716897|NCT00093002|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153716898|NCT00093002|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153716899|NCT00093002|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
153716900|NCT00093002|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
153716901|NCT00093002|Hormone Antagonists|hormone antagonists|mesh-ancestor
153716902|NCT00093002|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153716903|NCT00093002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153716904|NCT00093119|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
153716905|NCT00093119|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153716906|NCT00093158|Anticoagulants|anticoagulants|mesh-list
153716912|NCT00093158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153716913|NCT03501498|Loperamide|loperamide|mesh-list
153716914|NCT03501498|Antidiarrheals|antidiarrheals|mesh-list
153716915|NCT03501498|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153716916|NCT05561049|Thalidomide|thalidomide|mesh-list
153716917|NCT05561049|Dexamethasone|dexamethasone|mesh-list
153716918|NCT05561049|Bortezomib|bortezomib|mesh-list
153716919|NCT05561049|Daratumumab|daratumumab|mesh-list
153716920|NCT05561049|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153716921|NCT05561049|Antiemetics|antiemetics|mesh-ancestor
153716922|NCT05561049|Autonomic Agents|autonomic agents|mesh-ancestor
153716923|NCT05561049|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153716924|NCT05561049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153716925|NCT05561049|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153716926|NCT05561049|Glucocorticoids|glucocorticoids|mesh-ancestor
153716927|NCT05561049|Hormones|hormones|mesh-ancestor
153716928|NCT05561049|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153716929|NCT05561049|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153716930|NCT05561049|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153716931|NCT05561049|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153716932|NCT05561049|Immunologic Factors|immunologic factors|mesh-ancestor
153716949|NCT03448107|Fluorides|fluorides|mesh-list
153716968|NCT00093353|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153716969|NCT00093353|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153716971|NCT00093509|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
153716972|NCT00093509|Ifosfamide|ifosfamide|mesh-list
153716973|NCT00093509|Isophosphamide mustard|isophosphamide mustard|mesh-list
153716974|NCT00093509|Mesna|mesna|mesh-list
153716975|NCT00093509|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153716976|NCT00093509|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153716977|NCT00093509|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153716978|NCT00093509|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153716979|NCT00093509|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153716980|NCT00093509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153469281|NCT05298423|Mitosis Modulators|mitosis modulators|mesh-ancestor
153716981|NCT00093509|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153716982|NCT00093509|Alkylating Agents|alkylating agents|mesh-ancestor
153716983|NCT00093509|Protective Agents|protective agents|mesh-ancestor
153716984|NCT00093509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153716985|NCT00093548|Vaccines|vaccines|mesh-list
153716986|NCT00093548|Sargramostim|sargramostim|mesh-list
153716987|NCT00093548|Adjuvants, Vaccine|adjuvants, vaccine|mesh-list
153716988|NCT00093548|Immunologic Factors|immunologic factors|mesh-ancestor
153716989|NCT00093548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153717022|NCT00093587|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153339288|NCT01152697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153339289|NCT01152697|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
153339291|NCT00002188|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153339292|NCT00002188|Dermatologic Agents|dermatologic agents|mesh-ancestor
153339293|NCT00002332|Thymopentin|thymopentin|mesh-list
153339294|NCT00002332|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153339295|NCT00002332|Immunologic Factors|immunologic factors|mesh-ancestor
153339296|NCT00002332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153339297|NCT03011281|Tofacitinib|tofacitinib|mesh-list
153339298|NCT03011281|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
153339299|NCT03011281|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153339300|NCT03011281|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153339301|NCT03011281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153339302|NCT00002194|Clarithromycin|clarithromycin|mesh-list
153339307|NCT00002194|Nevirapine|nevirapine|mesh-list
153717023|NCT00093587|Antifungal Agents|antifungal agents|mesh-ancestor
153554034|NCT01596075|Cannabidiol|cannabidiol|mesh-list
153717024|NCT00093587|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153717025|NCT00093587|Dermatologic Agents|dermatologic agents|mesh-ancestor
153717026|NCT00093587|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
153717027|NCT00093626|Sorafenib|sorafenib|mesh-list
153717028|NCT00093626|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153717029|NCT00093626|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153339320|NCT00002194|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
153717030|NCT00093626|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153717031|NCT00093626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153717037|NCT05543109|Anesthetics|anesthetics|mesh-list
153717038|NCT05543109|Sevoflurane|sevoflurane|mesh-list
153717039|NCT05543109|Anesthetics, Local|anesthetics, local|mesh-list
153717040|NCT05543109|Rocuronium|rocuronium|mesh-list
153717081|NCT01055314|Vincristine|vincristine|mesh-list
153717082|NCT01055314|Etoposide phosphate|etoposide phosphate|mesh-list
153717083|NCT01055314|Podophyllotoxin|podophyllotoxin|mesh-list
153717084|NCT01055314|Camptothecin|camptothecin|mesh-list
153717085|NCT01055314|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
153717086|NCT01055314|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153717087|NCT01055314|Immunologic Factors|immunologic factors|mesh-ancestor
153717088|NCT01055314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153717089|NCT01055314|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153717090|NCT01055314|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153717091|NCT01055314|Alkylating Agents|alkylating agents|mesh-ancestor
153717092|NCT01055314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153717093|NCT01055314|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153717094|NCT01055314|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153717095|NCT01055314|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153717141|NCT00093860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153717142|NCT00093860|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153717143|NCT00093860|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153717144|NCT00093860|Vasodilator Agents|vasodilator agents|mesh-ancestor
153717146|NCT00402909|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153717147|NCT00402909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153717148|NCT02823366|Fenofibrate|fenofibrate|mesh-list
153717149|NCT02823366|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153717150|NCT02823366|Antimetabolites|antimetabolites|mesh-ancestor
153717151|NCT02823366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153717152|NCT02823366|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153717153|NCT00093977|Darbepoetin alfa|darbepoetin alfa|mesh-list
153717154|NCT00093977|Hematinics|hematinics|mesh-ancestor
153339321|NCT00002194|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
153339322|NCT00002194|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153339323|NCT04756622|Acetylcysteine|acetylcysteine|mesh-list
153339327|NCT04756622|Expectorants|expectorants|mesh-ancestor
153879673|NCT04370509|Axitinib|axitinib|mesh-list
153717155|NCT00094289|Disulfiram|disulfiram|mesh-list
153717156|NCT00094289|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
153717157|NCT00094289|Acetaldehyde Dehydrogenase Inhibitors|acetaldehyde dehydrogenase inhibitors|mesh-ancestor
153717158|NCT00094289|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153717159|NCT00094289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153717160|NCT00094367|Lamivudine|lamivudine|mesh-list
153717161|NCT00094367|Abacavir|abacavir|mesh-list
153717162|NCT00094367|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153339374|NCT02403986|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153717163|NCT00094367|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153717192|NCT00094523|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153717193|NCT00094523|Antiviral Agents|antiviral agents|mesh-ancestor
153717194|NCT00094523|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153717195|NCT00428701|Esomeprazole|esomeprazole|mesh-list
153717196|NCT00428701|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
153717197|NCT00428701|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153717198|NCT00428701|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
153717199|NCT00428701|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153717200|NCT00428701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153717201|NCT00428818|Doxycycline|doxycycline|mesh-list
153717202|NCT00428818|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
153717203|NCT00428818|Trimethoprim|trimethoprim|mesh-list
153717205|NCT00428818|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153717206|NCT00428818|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153717207|NCT00428818|Antimalarials|antimalarials|mesh-ancestor
153717208|NCT00428818|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153717209|NCT00428818|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153717247|NCT00403338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153717248|NCT00095069|Gaboxadol|gaboxadol|mesh-list
153717249|NCT00095069|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153717250|NCT00095069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153717251|NCT00095069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153717252|NCT00095069|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153717253|NCT00095069|Analgesics|analgesics|mesh-ancestor
153717254|NCT00095069|Sensory System Agents|sensory system agents|mesh-ancestor
153717255|NCT00095069|Anticonvulsants|anticonvulsants|mesh-ancestor
153717256|NCT00095069|GABA Agonists|gaba agonists|mesh-ancestor
153717257|NCT00095069|GABA Agents|gaba agents|mesh-ancestor
153717258|NCT00403533|Atorvastatin|atorvastatin|mesh-list
153717259|NCT00403533|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153717260|NCT00403533|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153717261|NCT00403533|Antimetabolites|antimetabolites|mesh-ancestor
153717262|NCT00403533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153717263|NCT00403533|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153717264|NCT00403533|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
153717265|NCT00403533|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153717266|NCT00095225|Bevacizumab|bevacizumab|mesh-list
153717281|NCT01054729|Sofosbuvir|sofosbuvir|mesh-list
153717301|NCT00429091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153717302|NCT00429091|Adrenergic Agents|adrenergic agents|mesh-ancestor
153717303|NCT00429091|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153717304|NCT00429091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153717305|NCT00095459|Bevacizumab|bevacizumab|mesh-list
153717306|NCT00095459|Sorafenib|sorafenib|mesh-list
153717307|NCT00095459|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153717308|NCT00095459|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153339380|NCT00002212|Bexarotene|bexarotene|mesh-list
153717309|NCT00095459|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153717367|NCT00429520|Viscosupplements|viscosupplements|mesh-ancestor
153717368|NCT00429520|Protective Agents|protective agents|mesh-ancestor
153717369|NCT00429559|Gemcitabine|gemcitabine|mesh-list
153717370|NCT00429559|Topotecan|topotecan|mesh-list
153717371|NCT00429559|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153717372|NCT00429559|Antimetabolites|antimetabolites|mesh-ancestor
153717373|NCT00429559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153717374|NCT00429559|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153717375|NCT00429559|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
153717376|NCT00429559|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153717377|NCT00429559|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153717378|NCT00095810|Aripiprazole|aripiprazole|mesh-list
153717379|NCT00095810|Antidepressive Agents|antidepressive agents|mesh-ancestor
153717380|NCT00095810|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153717381|NCT00095810|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153717382|NCT00095810|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153717383|NCT00095810|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153717384|NCT00095810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153717385|NCT00095810|Dopamine Agonists|dopamine agonists|mesh-ancestor
153717386|NCT00095810|Dopamine Agents|dopamine agents|mesh-ancestor
153717421|NCT00429676|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
153717422|NCT00429715|Aluminum sulfate|aluminum sulfate|mesh-list
153717429|NCT00095927|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153717430|NCT00095927|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153717431|NCT00095927|Tubulin Modulators|tubulin modulators|mesh-ancestor
153717432|NCT00095927|Antimitotic Agents|antimitotic agents|mesh-ancestor
153717433|NCT00095927|Mitosis Modulators|mitosis modulators|mesh-ancestor
153717434|NCT00095927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153717435|NCT00095927|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
153717482|NCT00429871|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153717483|NCT00429871|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153717484|NCT00429871|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153717485|NCT00429871|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153717486|NCT00095966|Gemcitabine|gemcitabine|mesh-list
153717488|NCT00095966|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153717489|NCT00095966|Antimetabolites|antimetabolites|mesh-ancestor
153717490|NCT00095966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153717491|NCT00095966|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153717492|NCT00095966|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153717493|NCT00095966|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153717494|NCT01803594|Nicotinic Acids|nicotinic acids|mesh-list
153717495|NCT01803594|Niacin|niacin|mesh-list
153717496|NCT01803594|Niacinamide|niacinamide|mesh-list
153717543|NCT00096083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153717544|NCT00096083|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153717545|NCT00096083|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153339393|NCT00002362|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153339397|NCT00002362|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
153717546|NCT00096083|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153717547|NCT00096083|Immunologic Factors|immunologic factors|mesh-ancestor
153717548|NCT00096083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153717550|NCT01726452|Paclitaxel|paclitaxel|mesh-list
153717551|NCT01726452|Docetaxel|docetaxel|mesh-list
153554568|NCT01598337|Sensory System Agents|sensory system agents|mesh-ancestor
153717553|NCT01726452|Capecitabine|capecitabine|mesh-list
153717554|NCT01726452|Fluorouracil|fluorouracil|mesh-list
153717555|NCT01726452|Oxaliplatin|oxaliplatin|mesh-list
153717556|NCT01726452|Epirubicin|epirubicin|mesh-list
153717557|NCT01726452|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153717558|NCT01726452|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153717559|NCT01726452|Tubulin Modulators|tubulin modulators|mesh-ancestor
153717560|NCT01726452|Antimitotic Agents|antimitotic agents|mesh-ancestor
153717601|NCT00096473|Cholinergic Agents|cholinergic agents|mesh-ancestor
153717602|NCT00096473|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153717603|NCT00096473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153717604|NCT00096473|Nootropic Agents|nootropic agents|mesh-ancestor
153717605|NCT00130494|Zoledronic Acid|zoledronic acid|mesh-list
153717606|NCT00130494|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153717607|NCT00130494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153717609|NCT00096512|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153717610|NCT00096512|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153717611|NCT00096512|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153717612|NCT00096512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153717613|NCT00096551|Metronidazole|metronidazole|mesh-list
153717614|NCT00096551|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153879736|NCT04026009|Vaccines|vaccines|mesh-list
153717619|NCT00095186|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153717620|NCT00130572|Pimecrolimus|pimecrolimus|mesh-list
153717658|NCT00096668|Mitosis Modulators|mitosis modulators|mesh-ancestor
153717659|NCT00096668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153717660|NCT00430846|Brentuximab Vedotin|brentuximab vedotin|mesh-list
153717661|NCT00430846|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153717662|NCT00430846|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153717663|NCT00430846|Immunotoxins|immunotoxins|mesh-ancestor
153717664|NCT00430846|Immunoconjugates|immunoconjugates|mesh-ancestor
153717723|NCT00096863|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153717724|NCT00096863|Serotonin Agents|serotonin agents|mesh-ancestor
153717725|NCT00130767|Finasteride|finasteride|mesh-list
153717726|NCT00130767|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
153469456|NCT05034562|Anticoagulants|anticoagulants|mesh-ancestor
153717727|NCT00130767|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153717728|NCT00130767|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153717729|NCT00130767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153717730|NCT00130767|Hormone Antagonists|hormone antagonists|mesh-ancestor
153717731|NCT00130767|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153717732|NCT00130767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153717733|NCT00130767|Urological Agents|urological agents|mesh-ancestor
153717735|NCT00431080|Docetaxel|docetaxel|mesh-list
153717736|NCT00431080|Cyclophosphamide|cyclophosphamide|mesh-list
153717737|NCT00431080|Epirubicin|epirubicin|mesh-list
153717738|NCT00431080|Fluorouracil|fluorouracil|mesh-list
153717739|NCT00431080|Lenograstim|lenograstim|mesh-list
153717740|NCT00431080|Mitogens|mitogens|mesh-list
153717741|NCT00431080|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153717742|NCT00431080|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153717743|NCT00431080|Tubulin Modulators|tubulin modulators|mesh-ancestor
153717744|NCT00431080|Antimitotic Agents|antimitotic agents|mesh-ancestor
153717745|NCT00431080|Mitosis Modulators|mitosis modulators|mesh-ancestor
153717746|NCT00431080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153717748|NCT00431080|Immunologic Factors|immunologic factors|mesh-ancestor
153717775|NCT00431119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153717776|NCT00431119|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153717777|NCT00097019|Bevacizumab|bevacizumab|mesh-list
153717778|NCT00097019|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153717779|NCT00097019|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153879748|NCT03927690|Growth Substances|growth substances|mesh-ancestor
153879749|NCT03927690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153879750|NCT03927690|Growth Inhibitors|growth inhibitors|mesh-ancestor
153879752|NCT03833921|Prednisone|prednisone|mesh-list
153717780|NCT00097019|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153717781|NCT00097019|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153717782|NCT00097019|Growth Substances|growth substances|mesh-ancestor
153717783|NCT00097019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153717784|NCT00097019|Growth Inhibitors|growth inhibitors|mesh-ancestor
153717785|NCT00431197|Ketoconazole|ketoconazole|mesh-list
153717786|NCT00431197|Testosterone|testosterone|mesh-list
153717787|NCT00431197|Antifungal Agents|antifungal agents|mesh-ancestor
153717788|NCT00431197|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153717789|NCT00431197|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
153717790|NCT00431197|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153717791|NCT00431197|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153717792|NCT00431197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153717793|NCT00431197|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153717794|NCT00431197|Hormone Antagonists|hormone antagonists|mesh-ancestor
153717795|NCT00431197|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153717796|NCT00431197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153717797|NCT00431197|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
153717798|NCT00431197|Androgens|androgens|mesh-ancestor
153717799|NCT00431197|Hormones|hormones|mesh-ancestor
153717800|NCT00431236|Dexamethasone|dexamethasone|mesh-list
153717801|NCT00431236|Ondansetron|ondansetron|mesh-list
153717802|NCT00431236|Casopitant|casopitant|mesh-list
153717803|NCT00431236|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153717804|NCT00431236|Antiemetics|antiemetics|mesh-ancestor
153717805|NCT00431236|Autonomic Agents|autonomic agents|mesh-ancestor
153717806|NCT00431236|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153717807|NCT00431236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153717808|NCT00431236|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153717809|NCT00431236|Glucocorticoids|glucocorticoids|mesh-ancestor
153717810|NCT00431236|Hormones|hormones|mesh-ancestor
153717813|NCT00431236|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153717814|NCT00431236|Antipruritics|antipruritics|mesh-ancestor
153717815|NCT00431236|Dermatologic Agents|dermatologic agents|mesh-ancestor
153717816|NCT00431236|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
153717817|NCT00431236|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153717818|NCT00431236|Serotonin Agents|serotonin agents|mesh-ancestor
153717819|NCT00431236|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153717820|NCT00431236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153717821|NCT00431236|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
153717822|NCT00431275|Tremelimumab|tremelimumab|mesh-list
153717824|NCT00431275|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153717825|NCT00431275|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153717826|NCT00431275|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153717827|NCT00431275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153717828|NCT00431353|Valganciclovir|valganciclovir|mesh-list
153717829|NCT00431353|Ganciclovir|ganciclovir|mesh-list
153717830|NCT00431353|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
153717831|NCT00431353|Antiviral Agents|antiviral agents|mesh-ancestor
153717832|NCT00431353|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153717833|NCT00431353|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153717834|NCT00431353|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153717835|NCT00431353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153717836|NCT00130845|Octreotide|octreotide|mesh-list
153717837|NCT00130845|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153717838|NCT00130845|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153717839|NCT00130845|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153717840|NCT00431392|Atropine|atropine|mesh-list
153717841|NCT00431392|Propranolol|propranolol|mesh-list
153717842|NCT00431392|Phenylephrine|phenylephrine|mesh-list
153717843|NCT00431392|Oxymetazoline|oxymetazoline|mesh-list
153717844|NCT00431392|omega-N-Methylarginine|omega-n-methylarginine|mesh-list
153717846|NCT00431392|Mydriatics|mydriatics|mesh-ancestor
153717847|NCT00431392|Autonomic Agents|autonomic agents|mesh-ancestor
153717848|NCT00431392|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153717849|NCT00431392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153360725|NCT01368263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153717850|NCT00431392|Sympathomimetics|sympathomimetics|mesh-ancestor
153717851|NCT00431392|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
153554868|NCT05540184|Antimetabolites|antimetabolites|mesh-ancestor
153717852|NCT00431392|Nasal Decongestants|nasal decongestants|mesh-ancestor
153717853|NCT00431392|Respiratory System Agents|respiratory system agents|mesh-ancestor
153717854|NCT00431392|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
153717855|NCT00431392|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153717856|NCT00431392|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153717857|NCT00431392|Adrenergic Agents|adrenergic agents|mesh-ancestor
153717858|NCT00431392|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153717914|NCT04727073|Spironolactone|spironolactone|mesh-list
153717915|NCT04727073|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
153717916|NCT04727073|Hormone Antagonists|hormone antagonists|mesh-ancestor
153339521|NCT01942694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153339522|NCT01942694|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153717917|NCT04727073|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153717918|NCT04727073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153717919|NCT04727073|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
153717920|NCT04727073|Diuretics|diuretics|mesh-ancestor
153717921|NCT04727073|Natriuretic Agents|natriuretic agents|mesh-ancestor
153717922|NCT00432016|Zidovudine|zidovudine|mesh-list
153717923|NCT00432016|Antimetabolites|antimetabolites|mesh-ancestor
153717924|NCT00432016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153545821|NCT06300099|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153717925|NCT00432016|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153717926|NCT00432016|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153717927|NCT00432016|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153717928|NCT00432016|Antiviral Agents|antiviral agents|mesh-ancestor
153717929|NCT00432016|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153717930|NCT00432016|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153717931|NCT00432016|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153717932|NCT01052077|Antidepressive Agents|antidepressive agents|mesh-list
153717933|NCT01052077|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153717935|NCT00131040|Hemostatics|hemostatics|mesh-ancestor
153339568|NCT05751850|Vitamins|vitamins|mesh-ancestor
153717936|NCT00131040|Coagulants|coagulants|mesh-ancestor
153717937|NCT00131040|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
153717938|NCT00131040|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
153717939|NCT00131040|Protease Inhibitors|protease inhibitors|mesh-ancestor
153717961|NCT01052038|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153717962|NCT01052038|Protease Inhibitors|protease inhibitors|mesh-ancestor
153717963|NCT01052038|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153717964|NCT01052038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153717965|NCT00432055|Botulinum Toxins|botulinum toxins|mesh-list
153717966|NCT00432055|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
153717967|NCT00432055|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
153717968|NCT00432055|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
153717969|NCT00432055|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153717970|NCT00432055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153717971|NCT00432055|Cholinergic Agents|cholinergic agents|mesh-ancestor
153717972|NCT00432055|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153717973|NCT00432055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153717974|NCT00432055|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
153717975|NCT00432055|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153717976|NCT04711044|Menthol|menthol|mesh-list
153717977|NCT04711044|Histamine|histamine|mesh-list
153717978|NCT04711044|Antipruritics|antipruritics|mesh-ancestor
153717979|NCT04711044|Dermatologic Agents|dermatologic agents|mesh-ancestor
153717980|NCT04711044|Histamine Agonists|histamine agonists|mesh-ancestor
153717981|NCT04711044|Histamine Agents|histamine agents|mesh-ancestor
153717982|NCT04711044|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153717983|NCT04711044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153717984|NCT04711044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153717985|NCT01051960|Ambrisentan|ambrisentan|mesh-list
153717986|NCT01051960|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153339569|NCT05751850|Micronutrients|micronutrients|mesh-ancestor
153717987|NCT00432367|Artesunate|artesunate|mesh-list
153717988|NCT00432367|Pyrimethamine|pyrimethamine|mesh-list
153717989|NCT00432367|Sulfadoxine|sulfadoxine|mesh-list
153717990|NCT00432367|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
153717997|NCT00432367|Antiviral Agents|antiviral agents|mesh-ancestor
153717998|NCT00432367|Schistosomicides|schistosomicides|mesh-ancestor
153717999|NCT00432367|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
153718000|NCT00432367|Anthelmintics|anthelmintics|mesh-ancestor
153718001|NCT00432367|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153718002|NCT00432367|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153718003|NCT00432367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153718004|NCT00432367|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
153718006|NCT00097760|Immunologic Factors|immunologic factors|mesh-ancestor
153718007|NCT00097760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153718008|NCT00432406|Infliximab|infliximab|mesh-list
153718009|NCT00432406|Etanercept|etanercept|mesh-list
153718010|NCT00432406|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
153718011|NCT00432406|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153718012|NCT00432406|Dermatologic Agents|dermatologic agents|mesh-ancestor
153718013|NCT00432406|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153718014|NCT00432406|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153718015|NCT00432406|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153718016|NCT00432406|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153718017|NCT00432406|Analgesics|analgesics|mesh-ancestor
153718018|NCT00432406|Sensory System Agents|sensory system agents|mesh-ancestor
153718052|NCT02273518|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153718054|NCT00432757|Antipruritics|antipruritics|mesh-ancestor
153718055|NCT00432757|Dermatologic Agents|dermatologic agents|mesh-ancestor
153718056|NCT00432757|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
153718057|NCT00432757|Histamine Antagonists|histamine antagonists|mesh-ancestor
153718058|NCT00432757|Histamine Agents|histamine agents|mesh-ancestor
153718062|NCT00432757|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
153718064|NCT00432796|Tinzaparin|tinzaparin|mesh-list
153718117|NCT00131274|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153718118|NCT00131274|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153718119|NCT00131274|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153718120|NCT00131274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153718121|NCT00131274|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153718122|NCT00098033|Clofarabine|clofarabine|mesh-list
153718123|NCT00098033|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153718124|NCT00098033|Antimetabolites|antimetabolites|mesh-ancestor
153718125|NCT00098033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153718126|NCT00098033|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153718127|NCT00403065|Dexamethasone|dexamethasone|mesh-list
153718128|NCT00403065|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153718129|NCT00403065|Antiemetics|antiemetics|mesh-ancestor
153718130|NCT00403065|Autonomic Agents|autonomic agents|mesh-ancestor
153339610|NCT03009877|Narcotics|narcotics|mesh-ancestor
153339611|NCT03009877|Analgesics|analgesics|mesh-ancestor
153339612|NCT03009877|Sensory System Agents|sensory system agents|mesh-ancestor
153339613|NCT03009877|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153339614|NCT03009877|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
153718131|NCT00403065|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153718132|NCT00403065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153718133|NCT00403065|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153718134|NCT00403065|Glucocorticoids|glucocorticoids|mesh-ancestor
153718135|NCT00403065|Hormones|hormones|mesh-ancestor
153718136|NCT00403065|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153718137|NCT00403065|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153718138|NCT00403065|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153718139|NCT00098111|Azathioprine|azathioprine|mesh-list
153718140|NCT00098111|Antimetabolites|antimetabolites|mesh-ancestor
153718211|NCT00131391|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
153718212|NCT00131391|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
153718213|NCT00131391|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153718214|NCT00131391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153718216|NCT00131391|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153718217|NCT00131391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153718218|NCT00433459|Prednisone|prednisone|mesh-list
153718219|NCT00433459|Prednisolone|prednisolone|mesh-list
153718220|NCT00433459|Cyclophosphamide|cyclophosphamide|mesh-list
153718221|NCT00433459|Dacarbazine|dacarbazine|mesh-list
153718222|NCT00433459|Vincristine|vincristine|mesh-list
153718223|NCT00433459|Procarbazine|procarbazine|mesh-list
153547392|NCT05538247|Tocolytic Agents|tocolytic agents|mesh-ancestor
153547393|NCT05538247|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153547394|NCT05538247|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153547395|NCT05538247|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153547396|NCT05538247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153547397|NCT05537220|Acetylcysteine|acetylcysteine|mesh-list
153718227|NCT00433459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153718229|NCT00433459|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153718230|NCT00433459|Alkylating Agents|alkylating agents|mesh-ancestor
153339632|NCT00002398|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153718231|NCT00433459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153718232|NCT00433459|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153718233|NCT00433459|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153547448|NCT05491616|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153718260|NCT00433576|Antioxidants|antioxidants|mesh-ancestor
153718261|NCT00433576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153718262|NCT00433576|Protective Agents|protective agents|mesh-ancestor
153718263|NCT00433576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153718264|NCT00433576|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153718265|NCT00433576|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153718266|NCT00433615|Epoetin Alfa|epoetin alfa|mesh-list
153718267|NCT00433615|Hematinics|hematinics|mesh-ancestor
153718268|NCT00098384|Rifaximin|rifaximin|mesh-list
153718269|NCT00098384|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153718270|NCT00098384|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153718271|NCT00098384|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153718272|NCT00433732|Naproxen|naproxen|mesh-list
153718273|NCT00433732|Sumatriptan|sumatriptan|mesh-list
153718274|NCT00433732|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153339633|NCT00002398|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153339635|NCT00002398|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153339645|NCT00997139|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153339646|NCT00997139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153339647|NCT00997139|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
153718275|NCT00433732|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153718276|NCT00433732|Analgesics|analgesics|mesh-ancestor
153718277|NCT00433732|Sensory System Agents|sensory system agents|mesh-ancestor
153718278|NCT00433732|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153718279|NCT00433732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153718291|NCT00098423|Cytarabine|cytarabine|mesh-list
153718305|NCT01050790|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153718307|NCT01050790|Growth Substances|growth substances|mesh-ancestor
153718308|NCT01050790|Growth Inhibitors|growth inhibitors|mesh-ancestor
153718309|NCT01050790|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153718310|NCT01050790|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153718311|NCT01050790|Antimetabolites|antimetabolites|mesh-ancestor
153718312|NCT01050790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153718313|NCT01050790|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153718315|NCT00433927|Folic Acid|folic acid|mesh-list
153718316|NCT00433927|Bevacizumab|bevacizumab|mesh-list
153718317|NCT00433927|Cetuximab|cetuximab|mesh-list
153718318|NCT00433927|Irinotecan|irinotecan|mesh-list
153718319|NCT00433927|Levoleucovorin|levoleucovorin|mesh-list
153718320|NCT00433927|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153718321|NCT00433927|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153718322|NCT00433927|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153718323|NCT00433927|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153718331|NCT00433927|Antidotes|antidotes|mesh-ancestor
153718360|NCT00098501|Temsirolimus|temsirolimus|mesh-list
153718361|NCT00098501|MTOR Inhibitors|mtor inhibitors|mesh-list
153718363|NCT00098501|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153718364|NCT00098501|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153718365|NCT00098501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153718366|NCT00098501|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153718367|NCT00098501|Immunologic Factors|immunologic factors|mesh-ancestor
153718427|NCT00098579|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153919708|NCT00643825|Temozolomide|temozolomide|mesh-list
153919709|NCT00643825|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153919710|NCT00643825|Alkylating Agents|alkylating agents|mesh-ancestor
153718492|NCT00434239|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153718493|NCT00434239|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153718494|NCT00434239|Growth Substances|growth substances|mesh-ancestor
153718495|NCT00434239|Growth Inhibitors|growth inhibitors|mesh-ancestor
153718496|NCT00434239|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153718497|NCT01057147|Rebamipide|rebamipide|mesh-list
153547482|NCT05457959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153547483|NCT05457959|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153547484|NCT05457959|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153547485|NCT05457959|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153547486|NCT05457959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153547487|NCT05457959|Interferon Inducers|interferon inducers|mesh-ancestor
153718501|NCT01057147|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153339662|NCT00002236|Protease Inhibitors|protease inhibitors|mesh-ancestor
153718503|NCT01057147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153718504|NCT01057147|Protective Agents|protective agents|mesh-ancestor
153718507|NCT00099125|Irinotecan|irinotecan|mesh-list
153718534|NCT01051414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153718535|NCT00434317|Zoledronic Acid|zoledronic acid|mesh-list
153718536|NCT00434317|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153718537|NCT00434317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153718604|NCT00403728|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153718605|NCT00403728|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
153718606|NCT00403806|Dexamethasone|dexamethasone|mesh-list
153718607|NCT00403806|Dexamethasone acetate|dexamethasone acetate|mesh-list
153718608|NCT00403806|BB 1101|bb 1101|mesh-list
153718609|NCT00403806|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153718610|NCT00403806|Antiemetics|antiemetics|mesh-ancestor
153718611|NCT00403806|Autonomic Agents|autonomic agents|mesh-ancestor
153718612|NCT00403806|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153718613|NCT00403806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153718669|NCT00099749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153919713|NCT04178863|Timolol|timolol|mesh-list
153718670|NCT00132093|Eplerenone|eplerenone|mesh-list
153718671|NCT00132093|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
153718672|NCT00132093|Hormone Antagonists|hormone antagonists|mesh-ancestor
153718673|NCT00132093|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153718674|NCT00132093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153718675|NCT00132093|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
153718676|NCT00132093|Diuretics|diuretics|mesh-ancestor
153718677|NCT00132093|Natriuretic Agents|natriuretic agents|mesh-ancestor
153718678|NCT00132093|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153718679|NCT00099788|Ranolazine|ranolazine|mesh-list
153718680|NCT00099788|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153718681|NCT00099788|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153718682|NCT00099788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153718683|NCT00099866|Metformin|metformin|mesh-list
153718684|NCT00099866|Vildagliptin|vildagliptin|mesh-list
153718685|NCT00099866|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153718686|NCT00099866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153718687|NCT00099866|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
153718688|NCT00099866|Protease Inhibitors|protease inhibitors|mesh-ancestor
153718689|NCT00099866|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153718691|NCT00099905|Vildagliptin|vildagliptin|mesh-list
153718692|NCT00099905|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153718693|NCT00099905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153718694|NCT00099905|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
153718695|NCT00099905|Protease Inhibitors|protease inhibitors|mesh-ancestor
153718696|NCT00099905|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153718697|NCT00099905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153718698|NCT00132210|Interferons|interferons|mesh-list
153718699|NCT00132210|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153718700|NCT00132210|Antiviral Agents|antiviral agents|mesh-ancestor
153718701|NCT00132210|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153339719|NCT00002410|Protease Inhibitors|protease inhibitors|mesh-ancestor
153718702|NCT00099944|Glimepiride|glimepiride|mesh-list
153718707|NCT00099944|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153718709|NCT00099944|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
153718710|NCT00099944|Protease Inhibitors|protease inhibitors|mesh-ancestor
153718711|NCT00099944|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153718712|NCT00099944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153718713|NCT04333914|Avdoralimab|avdoralimab|mesh-list
153718714|NCT04333914|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153718715|NCT04333914|Antiviral Agents|antiviral agents|mesh-ancestor
153718716|NCT04333914|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153718717|NCT00100100|Modafinil|modafinil|mesh-list
153718718|NCT00100100|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
153718719|NCT00100100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153919756|NCT05336968|Ketorolac|ketorolac|mesh-list
153718720|NCT00100100|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
153718721|NCT00100100|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
153718722|NCT00100100|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
153718723|NCT00100100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153718727|NCT00100139|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153718728|NCT00100139|Tubulin Modulators|tubulin modulators|mesh-ancestor
153718729|NCT00100139|Antimitotic Agents|antimitotic agents|mesh-ancestor
153718730|NCT00100139|Mitosis Modulators|mitosis modulators|mesh-ancestor
153718731|NCT00100139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153718732|NCT00100412|Phenylephrine|phenylephrine|mesh-list
153718755|NCT04244058|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
153718756|NCT04244058|Antiviral Agents|antiviral agents|mesh-ancestor
153718757|NCT04244058|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153718758|NCT04244058|Dopamine Agents|dopamine agents|mesh-ancestor
153718759|NCT04244058|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153718760|NCT04244058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153718761|NCT04244058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153718762|NCT04244058|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153718763|NCT04244058|Analgesics|analgesics|mesh-ancestor
153718764|NCT04244058|Sensory System Agents|sensory system agents|mesh-ancestor
153718818|NCT04728659|Hormone Antagonists|hormone antagonists|mesh-ancestor
153718820|NCT00132600|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
153718821|NCT00132600|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153718822|NCT00132600|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153718823|NCT00132639|Docetaxel|docetaxel|mesh-list
153718824|NCT00132639|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153718890|NCT00100958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153718892|NCT00101075|Capecitabine|capecitabine|mesh-list
153718893|NCT00101075|Oxaliplatin|oxaliplatin|mesh-list
153718894|NCT00101075|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153718895|NCT00101075|Antimetabolites|antimetabolites|mesh-ancestor
153339752|NCT01243567|Timolol|timolol|mesh-list
153339753|NCT01243567|Bimatoprost|bimatoprost|mesh-list
153718952|NCT00133029|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153718953|NCT00135408|Budesonide|budesonide|mesh-list
153547497|NCT05456191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153547499|NCT05453968|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
153547500|NCT05453968|Protease Inhibitors|protease inhibitors|mesh-ancestor
153719020|NCT00133185|Natriuretic Agents|natriuretic agents|mesh-ancestor
153719021|NCT00133185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153547506|NCT05438420|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153547507|NCT05438420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153547508|NCT05432804|Temozolomide|temozolomide|mesh-list
153547509|NCT05432804|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153547510|NCT05432804|Alkylating Agents|alkylating agents|mesh-ancestor
153719022|NCT00133185|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
153719023|NCT00133185|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153719025|NCT00135603|Clavulanic Acid|clavulanic acid|mesh-list
153719026|NCT00135603|Clavulanic Acids|clavulanic acids|mesh-list
153719028|NCT00135603|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153719078|NCT00135720|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153719079|NCT00135720|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153719080|NCT00135720|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153719081|NCT00135720|Immunologic Factors|immunologic factors|mesh-ancestor
153719082|NCT00101894|Panitumumab|panitumumab|mesh-list
153719083|NCT00101894|Motesanib diphosphate|motesanib diphosphate|mesh-list
153547518|NCT05425979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153547523|NCT05421858|Antifungal Agents|antifungal agents|mesh-ancestor
153547524|NCT05421858|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153547525|NCT05421858|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
153719101|NCT00133341|Analgesics|analgesics|mesh-ancestor
153719126|NCT00102167|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153719127|NCT00102167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153719130|NCT00135876|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
153719131|NCT00135876|Anticoagulants|anticoagulants|mesh-ancestor
153719132|NCT00135876|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153719133|NCT00135876|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153719134|NCT00135876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153719135|NCT00102206|Ritonavir|ritonavir|mesh-list
153719136|NCT00102206|Lopinavir|lopinavir|mesh-list
153719137|NCT00102206|Saquinavir|saquinavir|mesh-list
153719138|NCT00102206|Tenofovir|tenofovir|mesh-list
153719139|NCT00102206|Lamivudine|lamivudine|mesh-list
153719140|NCT00102206|Emtricitabine|emtricitabine|mesh-list
153719141|NCT00102206|Zidovudine|zidovudine|mesh-list
153719142|NCT00102206|Abacavir|abacavir|mesh-list
153719143|NCT00102206|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
153719144|NCT00102206|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
153719148|NCT00102206|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153719186|NCT00135525|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
153719187|NCT00135525|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153719188|NCT00135525|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153719190|NCT00403962|Vestipitant|vestipitant|mesh-list
153719191|NCT00403962|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
153719192|NCT00403962|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153719193|NCT00403962|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153548925|NCT04530565|Mesna|mesna|mesh-list
153719194|NCT00403962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153719195|NCT00403962|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153719196|NCT00403962|Serotonin Agents|serotonin agents|mesh-ancestor
153719197|NCT00403962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153719243|NCT00102557|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153719245|NCT00102557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153719246|NCT00102557|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153339801|NCT00002266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153549249|NCT04278768|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153549250|NCT04260529|Pembrolizumab|pembrolizumab|mesh-list
153549251|NCT04260529|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153549252|NCT04260529|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153549253|NCT04260529|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153549254|NCT04260529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153549310|NCT04199026|Ifosfamide|ifosfamide|mesh-list
153719247|NCT00102635|Fenretinide|fenretinide|mesh-list
153719248|NCT00102635|Lonafarnib|lonafarnib|mesh-list
153719249|NCT00102635|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153719250|NCT00102635|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
153719252|NCT00102635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153719253|NCT00102635|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153719254|NCT00102635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153719255|NCT00133419|Vitamins|vitamins|mesh-list
153719256|NCT00133419|Vitamin A|vitamin a|mesh-list
153719257|NCT00133419|Zinc|zinc|mesh-list
153719258|NCT00133419|Trace Elements|trace elements|mesh-list
153719259|NCT00133419|Micronutrients|micronutrients|mesh-list
153719260|NCT00133419|Retinol palmitate|retinol palmitate|mesh-list
153719261|NCT00133419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153719262|NCT00133419|Antioxidants|antioxidants|mesh-ancestor
153719263|NCT00133419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153719264|NCT00133419|Protective Agents|protective agents|mesh-ancestor
153719265|NCT00133419|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
153550263|NCT03386578|Antiviral Agents|antiviral agents|mesh-ancestor
153550570|NCT02829268|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
153550571|NCT02829268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153550572|NCT02829268|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
153550573|NCT02829268|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153550583|NCT02747004|Tamoxifen|tamoxifen|mesh-list
153550767|NCT02465060|Tubulin Modulators|tubulin modulators|mesh-ancestor
153719266|NCT00133419|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153719267|NCT00102674|Cangrelor|cangrelor|mesh-list
153719268|NCT00102674|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153719269|NCT00102674|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
153719270|NCT00102674|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
153719271|NCT00102674|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
153719272|NCT00102674|Purinergic Agents|purinergic agents|mesh-ancestor
153719273|NCT00102674|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153719274|NCT00102674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153719275|NCT00102674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153719277|NCT00135993|Dopamine Agonists|dopamine agonists|mesh-ancestor
153719278|NCT00135993|Dopamine Agents|dopamine agents|mesh-ancestor
153719279|NCT00135993|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153719280|NCT00135993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153719281|NCT00135993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153719282|NCT00102713|Valproic Acid|valproic acid|mesh-list
153551372|NCT01571388|Dacomitinib|dacomitinib|mesh-list
153719283|NCT00102713|Anticonvulsants|anticonvulsants|mesh-ancestor
153719284|NCT00102713|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153719285|NCT00102713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153339841|NCT00002272|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153719286|NCT00102713|GABA Agents|gaba agents|mesh-ancestor
153339922|NCT01421810|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153719287|NCT00102713|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153719288|NCT00102713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153719289|NCT00102713|Antimanic Agents|antimanic agents|mesh-ancestor
153719290|NCT00102713|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153719291|NCT00102713|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153719343|NCT00102908|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153719344|NCT00401024|Imatinib Mesylate|imatinib mesylate|mesh-list
153551753|NCT01573013|Iron|iron|mesh-list
153719345|NCT00401024|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153719346|NCT00401024|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153719347|NCT00401024|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153719348|NCT00401024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153719349|NCT00401024|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153719351|NCT00136266|Vitamins|vitamins|mesh-list
153719352|NCT00136266|Vitamin A|vitamin a|mesh-list
153719353|NCT00136266|Ferrous fumarate|ferrous fumarate|mesh-list
153719354|NCT00136266|Micronutrients|micronutrients|mesh-ancestor
153719356|NCT00136266|Trace Elements|trace elements|mesh-ancestor
153719405|NCT00136383|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153719407|NCT00103103|Leucovorin|leucovorin|mesh-list
153719408|NCT00103103|Fluorouracil|fluorouracil|mesh-list
153719409|NCT00103103|Bortezomib|bortezomib|mesh-list
153719410|NCT00103103|Calcium|calcium|mesh-list
153719411|NCT00103103|Levoleucovorin|levoleucovorin|mesh-list
153551795|NCT01573377|Androgen Antagonists|androgen antagonists|mesh-ancestor
153719412|NCT00103103|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153719413|NCT00103103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153719414|NCT00103103|Antimetabolites|antimetabolites|mesh-ancestor
153719415|NCT00103103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153719416|NCT00103103|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153719417|NCT00103103|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153719418|NCT00103103|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153719419|NCT00103103|Immunologic Factors|immunologic factors|mesh-ancestor
153719420|NCT00103103|Antidotes|antidotes|mesh-ancestor
153719421|NCT00103103|Protective Agents|protective agents|mesh-ancestor
153719422|NCT00103103|Vitamin B Complex|vitamin b complex|mesh-ancestor
153719466|NCT00103298|Melphalan|melphalan|mesh-list
153719468|NCT00103298|Levoleucovorin|levoleucovorin|mesh-list
153719469|NCT00103298|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153719471|NCT00103298|Antimetabolites|antimetabolites|mesh-ancestor
153719472|NCT00103298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153719473|NCT00103298|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153719474|NCT00103298|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153719475|NCT00103298|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153719476|NCT00103298|Immunologic Factors|immunologic factors|mesh-ancestor
153719478|NCT00103298|Protective Agents|protective agents|mesh-ancestor
153719479|NCT00103298|Vitamin B Complex|vitamin b complex|mesh-ancestor
153719480|NCT00103298|Vitamins|vitamins|mesh-ancestor
153719481|NCT00103298|Micronutrients|micronutrients|mesh-ancestor
153719482|NCT00103298|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153719483|NCT00103298|Alkylating Agents|alkylating agents|mesh-ancestor
153719524|NCT00136539|Immunologic Factors|immunologic factors|mesh-ancestor
153719525|NCT00136539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153719526|NCT00136539|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153719527|NCT00136539|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153719528|NCT00136539|Alkylating Agents|alkylating agents|mesh-ancestor
153719529|NCT00136539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153719530|NCT00136539|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153719537|NCT00103571|Olanzapine|olanzapine|mesh-list
153719589|NCT00103727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153719590|NCT00103727|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153719591|NCT00103727|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153719592|NCT00103727|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153719593|NCT00103727|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153719594|NCT00103727|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
153719595|NCT00103727|Dopamine Agents|dopamine agents|mesh-ancestor
153719596|NCT00103766|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
153719597|NCT00103766|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153719598|NCT00103766|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153719599|NCT00103766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153719600|NCT00103805|Levodopa|levodopa|mesh-list
153719602|NCT00103805|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
153719603|NCT00103805|Dopamine Agents|dopamine agents|mesh-ancestor
153719604|NCT00103805|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153719605|NCT00103805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153719606|NCT00103805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153719607|NCT00404040|Lactulose|lactulose|mesh-list
153719608|NCT00404040|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
153919887|NCT04287387|Dapagliflozin|dapagliflozin|mesh-list
153719644|NCT04729088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153719645|NCT04729088|Vasodilator Agents|vasodilator agents|mesh-ancestor
153719713|NCT00136968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153719714|NCT00136968|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153719715|NCT00136968|Hormone Antagonists|hormone antagonists|mesh-ancestor
153719716|NCT00136968|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153719717|NCT00136968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153719718|NCT00136968|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
153719781|NCT00104663|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
153719782|NCT00104663|Anthelmintics|anthelmintics|mesh-ancestor
153719783|NCT00104663|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153719784|NCT00104663|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153719785|NCT00104663|Antimalarials|antimalarials|mesh-ancestor
153719786|NCT00104663|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153719787|NCT00104663|Antinematodal Agents|antinematodal agents|mesh-ancestor
153719788|NCT00104663|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153719789|NCT00104663|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153719790|NCT00104663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153719791|NCT00104741|Triptorelin Pamoate|triptorelin pamoate|mesh-list
153552854|NCT01583972|Vitamin A|vitamin a|mesh-list
153719794|NCT00104741|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
153719795|NCT00104741|Contraceptive Agents|contraceptive agents|mesh-ancestor
153719796|NCT00104741|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153719827|NCT00104819|Antibodies|antibodies|mesh-list
153719837|NCT00137202|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153719838|NCT00137202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153719840|NCT00137202|Antipruritics|antipruritics|mesh-ancestor
153719841|NCT00137202|Dermatologic Agents|dermatologic agents|mesh-ancestor
153719842|NCT00137202|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
153719843|NCT00137202|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153719844|NCT00137202|Serotonin Agents|serotonin agents|mesh-ancestor
153719845|NCT00137202|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153719846|NCT00137202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153719847|NCT00137202|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
153719848|NCT00137202|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153719849|NCT00137202|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153719850|NCT00137202|Anesthetics, Local|anesthetics, local|mesh-ancestor
153719851|NCT00137202|Anesthetics|anesthetics|mesh-ancestor
153719852|NCT00137202|Sensory System Agents|sensory system agents|mesh-ancestor
153719853|NCT00137202|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
153719854|NCT00137202|Histamine Antagonists|histamine antagonists|mesh-ancestor
153719855|NCT00137202|Histamine Agents|histamine agents|mesh-ancestor
153719856|NCT00137202|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
153719857|NCT00104975|Fludarabine|fludarabine|mesh-list
153719858|NCT00104975|Fludarabine phosphate|fludarabine phosphate|mesh-list
153719859|NCT00104975|Melphalan|melphalan|mesh-list
153719860|NCT00104975|Alemtuzumab|alemtuzumab|mesh-list
153719861|NCT00104975|Thiotepa|thiotepa|mesh-list
153719862|NCT00104975|Tacrolimus|tacrolimus|mesh-list
153719863|NCT00104975|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153553529|NCT01593332|Immunologic Factors|immunologic factors|mesh-ancestor
153719864|NCT00104975|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153719865|NCT00104975|Antimetabolites|antimetabolites|mesh-ancestor
153719866|NCT00104975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153719883|NCT00134706|Carboplatin|carboplatin|mesh-list
153719884|NCT00134706|Docetaxel|docetaxel|mesh-list
153719885|NCT00134706|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153719886|NCT00134706|Tubulin Modulators|tubulin modulators|mesh-ancestor
153719887|NCT00134706|Antimitotic Agents|antimitotic agents|mesh-ancestor
153719888|NCT00134706|Mitosis Modulators|mitosis modulators|mesh-ancestor
153719889|NCT00134706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153719890|NCT00137397|Tolterodine Tartrate|tolterodine tartrate|mesh-list
153719898|NCT00134745|Estradiol|estradiol|mesh-list
153719951|NCT00105326|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
153553804|NCT01594879|Levonorgestrel|levonorgestrel|mesh-list
153719952|NCT00105326|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153719953|NCT00105326|Serotonin Agents|serotonin agents|mesh-ancestor
153719954|NCT00105326|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153340002|NCT01003769|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153719955|NCT00105326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153719956|NCT00105326|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
153719957|NCT00105326|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
153719958|NCT00105326|Dopamine Agents|dopamine agents|mesh-ancestor
153719959|NCT00137553|Pyrimethamine|pyrimethamine|mesh-list
153719960|NCT00137553|Sulfadoxine|sulfadoxine|mesh-list
153719961|NCT00137553|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
153719962|NCT00137553|Antimalarials|antimalarials|mesh-ancestor
153719963|NCT00137553|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153719964|NCT00137553|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153719965|NCT00137553|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153719966|NCT00137553|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153719967|NCT00137553|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153719968|NCT00137553|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153553839|NCT01595009|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
153719969|NCT00137553|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
153719970|NCT00105404|Triamcinolone|triamcinolone|mesh-list
153719971|NCT00105404|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
153719972|NCT00105404|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
153719973|NCT00105404|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
153719974|NCT00105404|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153719976|NCT00105404|Hormones|hormones|mesh-ancestor
153719996|NCT00135018|Celecoxib|celecoxib|mesh-list
153719997|NCT00135018|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153719998|NCT00135018|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153719999|NCT00135018|Analgesics|analgesics|mesh-ancestor
153720000|NCT00135018|Sensory System Agents|sensory system agents|mesh-ancestor
153720001|NCT00135018|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153720002|NCT00135018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153720003|NCT00135018|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153720004|NCT00135018|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153720005|NCT00135018|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
153720006|NCT00135018|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153720007|NCT00135018|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153720008|NCT00135018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153720009|NCT00137709|Lamotrigine|lamotrigine|mesh-list
153720059|NCT04702048|Growth Substances|growth substances|mesh-ancestor
153720060|NCT04702048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153720061|NCT04702048|Growth Inhibitors|growth inhibitors|mesh-ancestor
153720062|NCT04702048|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153720063|NCT00434629|Tositumomab I-131|tositumomab i-131|mesh-list
153720066|NCT00135057|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
153720067|NCT00135057|Insulin Glargine|insulin glargine|mesh-list
153720068|NCT00135057|Insulin glulisine|insulin glulisine|mesh-list
153720069|NCT00135057|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153720070|NCT00135057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153720071|NCT00434668|Cisplatin|cisplatin|mesh-list
153720072|NCT00434668|Docetaxel|docetaxel|mesh-list
153720073|NCT00434668|Vinorelbine|vinorelbine|mesh-list
153720074|NCT00434668|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153720075|NCT00434668|Tubulin Modulators|tubulin modulators|mesh-ancestor
153720118|NCT00434863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153720120|NCT00434863|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153468706|NCT06172257|Dexamethasone acetate|dexamethasone acetate|mesh-list
153720121|NCT00434863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153720122|NCT00434863|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
153720123|NCT00434863|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153720124|NCT00434941|Capecitabine|capecitabine|mesh-list
153720125|NCT00434941|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153720185|NCT00435292|Sensory System Agents|sensory system agents|mesh-ancestor
153720186|NCT00435292|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153720187|NCT00435292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153720188|NCT00435292|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153720189|NCT00435292|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153720190|NCT00435292|Gout Suppressants|gout suppressants|mesh-ancestor
153340065|NCT00002476|Dermatologic Agents|dermatologic agents|mesh-ancestor
153720191|NCT00435292|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153720192|NCT00435292|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153720193|NCT00435292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153720194|NCT00435331|Verapamil|verapamil|mesh-list
153720195|NCT00435331|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153554738|NCT01599364|Antiviral Agents|antiviral agents|mesh-ancestor
153720196|NCT00435331|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153720197|NCT00435331|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153720198|NCT00435331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153720199|NCT00435331|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153720200|NCT00435331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153720243|NCT00142467|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153720244|NCT00142467|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153720245|NCT00142467|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153720246|NCT00142467|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153720247|NCT00142467|Growth Substances|growth substances|mesh-ancestor
153554848|NCT05688046|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153554884|NCT05473195|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153720248|NCT00142467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153720249|NCT00142467|Growth Inhibitors|growth inhibitors|mesh-ancestor
153720250|NCT00142467|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153720251|NCT00142467|Antimetabolites|antimetabolites|mesh-ancestor
153720252|NCT00142467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153720253|NCT00435955|Rituximab|rituximab|mesh-list
153720305|NCT00138060|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153720306|NCT00138060|Immunologic Factors|immunologic factors|mesh-ancestor
153340103|NCT01004705|Sensory System Agents|sensory system agents|mesh-ancestor
153340104|NCT01004705|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153340128|NCT01004939|PENTA|penta|mesh-list
153555144|NCT05704959|Plasma Substitutes|plasma substitutes|mesh-ancestor
153720307|NCT00138060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153720308|NCT00138060|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
153720309|NCT00138060|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153720372|NCT00436423|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153720373|NCT00436423|Antimetabolites|antimetabolites|mesh-ancestor
153720374|NCT00436423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153720375|NCT00436423|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153720376|NCT00436579|Sorafenib|sorafenib|mesh-list
153720377|NCT00436579|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153720378|NCT00436579|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153720379|NCT00436579|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153720380|NCT00436579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153720381|NCT00436657|Cisplatin|cisplatin|mesh-list
153720382|NCT00436657|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153720383|NCT00106418|Romidepsin|romidepsin|mesh-list
153720384|NCT00106418|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153919980|NCT00970281|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153919981|NCT00970281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153919982|NCT00970281|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153919983|NCT00970281|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153919984|NCT00970281|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153720385|NCT00106418|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153720386|NCT00106418|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
153720428|NCT00437359|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
153555354|NCT03499899|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153720429|NCT00437359|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153720430|NCT00437476|Ribavirin|ribavirin|mesh-list
153720431|NCT00437476|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
153720432|NCT00437476|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-list
153720433|NCT00437476|Antimetabolites|antimetabolites|mesh-ancestor
153720434|NCT00437476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153720435|NCT00437476|Antiviral Agents|antiviral agents|mesh-ancestor
153720436|NCT00437476|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153720437|NCT00437476|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153720438|NCT00437476|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153720439|NCT00437554|Glimepiride|glimepiride|mesh-list
153720440|NCT00437554|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153340133|NCT01004939|Protease Inhibitors|protease inhibitors|mesh-ancestor
153340134|NCT01004939|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153340136|NCT01004939|Anticoagulants|anticoagulants|mesh-ancestor
153720441|NCT00437554|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153720442|NCT00437554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153720443|NCT00437554|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153720444|NCT00437554|Immunologic Factors|immunologic factors|mesh-ancestor
153720445|NCT00437632|Caffeine|caffeine|mesh-list
153720446|NCT00437632|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
153720447|NCT00437632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153720448|NCT00437632|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
153720480|NCT03278665|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153720481|NCT03278665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153720482|NCT00401219|Estrogens|estrogens|mesh-list
153720483|NCT00401219|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
153720484|NCT00401219|Progestins|progestins|mesh-list
153720485|NCT00401219|Hormones|hormones|mesh-ancestor
153720486|NCT00401219|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153720487|NCT00401219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153720488|NCT04701463|Calcium|calcium|mesh-list
153555803|NCT01602874|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153720489|NCT04701463|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153720490|NCT04701463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153720491|NCT00438139|Dronabinol|dronabinol|mesh-list
153720492|NCT00438139|Hallucinogens|hallucinogens|mesh-ancestor
153720493|NCT00438139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153720494|NCT00438139|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153720495|NCT00438139|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153720538|NCT03279757|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153720539|NCT03279757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153340179|NCT00002494|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
153340180|NCT00002494|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
153720540|NCT03279757|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153720541|NCT03279757|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153720542|NCT03279757|Adrenergic Agents|adrenergic agents|mesh-ancestor
153720543|NCT03279757|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153720544|NCT03279757|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
153720545|NCT03279757|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153720546|NCT03279757|Autonomic Agents|autonomic agents|mesh-ancestor
153720547|NCT03279757|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153720604|NCT00438841|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153919986|NCT00970281|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153720605|NCT00438841|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153720606|NCT00438841|Growth Substances|growth substances|mesh-ancestor
153720607|NCT00438841|Growth Inhibitors|growth inhibitors|mesh-ancestor
153720608|NCT00438958|Lenograstim|lenograstim|mesh-list
153556189|NCT01612273|Triflusal|triflusal|mesh-list
153720610|NCT00438958|Immunologic Factors|immunologic factors|mesh-ancestor
153720611|NCT00438958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153720612|NCT00107003|Lapatinib|lapatinib|mesh-list
153720613|NCT00107003|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153720614|NCT00107003|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153720615|NCT00107003|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153720616|NCT00107003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153720617|NCT00107003|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153720664|NCT00439543|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153720665|NCT00439543|Vasodilator Agents|vasodilator agents|mesh-ancestor
153720666|NCT00107237|Everolimus|everolimus|mesh-list
153720667|NCT00107237|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
153720668|NCT00107237|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153720669|NCT00107237|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153340236|NCT00002506|Antiviral Agents|antiviral agents|mesh-ancestor
153720670|NCT00107237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153720671|NCT00107237|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153720672|NCT00107237|Immunologic Factors|immunologic factors|mesh-ancestor
153720673|NCT00107237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153720674|NCT00107237|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153720675|NCT00439699|Memantine|memantine|mesh-list
153720676|NCT00439699|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
153720677|NCT00439699|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
153720678|NCT00439699|Dopamine Agents|dopamine agents|mesh-ancestor
153720679|NCT00439699|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153720681|NCT00439699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153720723|NCT00138177|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153720724|NCT00138177|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153720725|NCT00138177|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153720726|NCT00138177|Immunologic Factors|immunologic factors|mesh-ancestor
153720727|NCT00138177|Antidotes|antidotes|mesh-ancestor
153720728|NCT00138177|Protective Agents|protective agents|mesh-ancestor
153720729|NCT00138177|Vitamin B Complex|vitamin b complex|mesh-ancestor
153720730|NCT00138177|Vitamins|vitamins|mesh-ancestor
153720731|NCT00138177|Micronutrients|micronutrients|mesh-ancestor
153720732|NCT00138177|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
153720733|NCT00138177|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153720734|NCT03279601|Capecitabine|capecitabine|mesh-list
153720735|NCT03279601|Temozolomide|temozolomide|mesh-list
153720737|NCT03279601|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153720738|NCT03279601|Antimetabolites|antimetabolites|mesh-ancestor
153720739|NCT03279601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153720740|NCT03279601|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153720741|NCT03279601|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153720778|NCT00439972|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
153720779|NCT00439972|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
153720781|NCT00440128|Casopitant|casopitant|mesh-list
153557401|NCT01619163|Prednisolone|prednisolone|mesh-list
153720782|NCT00440128|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153720783|NCT00440128|Tubulin Modulators|tubulin modulators|mesh-ancestor
153720784|NCT00440128|Antimitotic Agents|antimitotic agents|mesh-ancestor
153720785|NCT00440128|Mitosis Modulators|mitosis modulators|mesh-ancestor
153720786|NCT00440128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153720787|NCT00440128|Antiemetics|antiemetics|mesh-ancestor
153720788|NCT00440128|Autonomic Agents|autonomic agents|mesh-ancestor
153720789|NCT00440128|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153720791|NCT00440128|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153720843|NCT00440245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153557855|NCT01621893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153720844|NCT00440245|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153720845|NCT00440245|Respiratory System Agents|respiratory system agents|mesh-ancestor
153720846|NCT00440245|Tocolytic Agents|tocolytic agents|mesh-ancestor
153720847|NCT00440245|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153720848|NCT00440245|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
153720849|NCT00440245|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
153720850|NCT00440245|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153720851|NCT00440245|Adrenergic Agents|adrenergic agents|mesh-ancestor
153340298|NCT00002524|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
153720852|NCT00440245|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153720853|NCT00440245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153720855|NCT00440284|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153720856|NCT00440284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153720857|NCT00142779|Fluoxetine|fluoxetine|mesh-list
153720858|NCT00142779|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
153720859|NCT00142779|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153720860|NCT00142779|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153720861|NCT00142779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153720862|NCT00142779|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153720863|NCT00142779|Serotonin Agents|serotonin agents|mesh-ancestor
153720864|NCT00142779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153720865|NCT00142779|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
153720866|NCT00142779|Antidepressive Agents|antidepressive agents|mesh-ancestor
153720867|NCT00142779|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153720868|NCT00142779|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
153720869|NCT00142779|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153720870|NCT00142779|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153720871|NCT00440323|Zolpidem|zolpidem|mesh-list
153720872|NCT00440323|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
153720873|NCT00440323|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153720874|NCT00440323|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153720875|NCT00440323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153720876|NCT00440323|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
153720877|NCT00440323|GABA Agonists|gaba agonists|mesh-ancestor
153720878|NCT00440323|GABA Agents|gaba agents|mesh-ancestor
153720879|NCT00440323|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153720880|NCT00440323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153720881|NCT00440440|Testosterone|testosterone|mesh-list
153720882|NCT00440440|Androgens|androgens|mesh-ancestor
153720883|NCT00440440|Hormones|hormones|mesh-ancestor
153720884|NCT00440440|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153340374|NCT00002536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153720885|NCT00440440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153720886|NCT00142896|Morphine|morphine|mesh-list
153720887|NCT00142896|Tramadol|tramadol|mesh-list
153720888|NCT00142896|Naloxone|naloxone|mesh-list
153720889|NCT00142896|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153720890|NCT00142896|Narcotics|narcotics|mesh-ancestor
153720891|NCT00142896|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153720892|NCT00142896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153720893|NCT00142896|Analgesics|analgesics|mesh-ancestor
153720894|NCT00142896|Sensory System Agents|sensory system agents|mesh-ancestor
153720895|NCT00142896|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153720934|NCT00440869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153720935|NCT00440869|Protective Agents|protective agents|mesh-ancestor
153720936|NCT00440869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153720937|NCT00440869|Antidotes|antidotes|mesh-ancestor
153720938|NCT00441025|Alemtuzumab|alemtuzumab|mesh-list
153720939|NCT00441025|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153720940|NCT00441025|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153720941|NCT00441181|Travoprost|travoprost|mesh-list
153720942|NCT00441181|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153720943|NCT00441298|Tenofovir|tenofovir|mesh-list
153720944|NCT00441298|Antiviral Agents|antiviral agents|mesh-ancestor
153720996|NCT00107822|Anesthetics, Local|anesthetics, local|mesh-ancestor
153720997|NCT00107822|Anesthetics|anesthetics|mesh-ancestor
153720998|NCT00107822|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153720999|NCT00107822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153721000|NCT00107822|Sensory System Agents|sensory system agents|mesh-ancestor
153721001|NCT00107822|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153721002|NCT00107822|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153721003|NCT00107822|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
153721004|NCT00107822|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153721005|NCT00107822|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153721006|NCT00107822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153721008|NCT03279328|Emollients|emollients|mesh-ancestor
153721009|NCT03279328|Dermatologic Agents|dermatologic agents|mesh-ancestor
153721010|NCT00142974|Tegaserod|tegaserod|mesh-list
153721011|NCT00142974|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
153721012|NCT00142974|Serotonin Agents|serotonin agents|mesh-ancestor
153721013|NCT00142974|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153721015|NCT00142974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153560489|NCT01638624|Propofol|propofol|mesh-list
153721049|NCT00441961|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
153721050|NCT00441961|Abortifacient Agents|abortifacient agents|mesh-ancestor
153721051|NCT00441961|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153721052|NCT00441961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153721053|NCT00441961|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153721054|NCT00441961|Antimetabolites|antimetabolites|mesh-ancestor
153721055|NCT00441961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153721056|NCT00441961|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153721112|NCT00442273|Ophthalmic Solutions|ophthalmic solutions|mesh-list
153721113|NCT00442273|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
153721114|NCT00442312|Brimonidine Tartrate, Timolol Maleate Drug Combination|brimonidine tartrate, timolol maleate drug combination|mesh-list
153721115|NCT00442312|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
153721116|NCT00442312|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
153721117|NCT00442312|Adrenergic Agents|adrenergic agents|mesh-ancestor
153721118|NCT00442312|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153721119|NCT00442312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153721120|NCT00442312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153721121|NCT00442312|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
153721122|NCT00442312|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153721123|NCT00442312|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153721172|NCT00442819|Protective Agents|protective agents|mesh-ancestor
153721173|NCT00442819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153721174|NCT00108251|Eplerenone|eplerenone|mesh-list
153721175|NCT00108251|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
153721176|NCT00108251|Hormone Antagonists|hormone antagonists|mesh-ancestor
153721177|NCT00108251|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153721178|NCT00108251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153721179|NCT00108251|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
153721181|NCT00108251|Natriuretic Agents|natriuretic agents|mesh-ancestor
153721182|NCT00108251|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153721183|NCT00443170|Rosiglitazone|rosiglitazone|mesh-list
153721184|NCT00443170|Flurbiprofen|flurbiprofen|mesh-list
153721185|NCT00443170|Midazolam|midazolam|mesh-list
153721186|NCT00443170|Caffeine|caffeine|mesh-list
153721187|NCT00443170|Omeprazole|omeprazole|mesh-list
153721188|NCT00443170|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153721231|NCT00108368|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153721232|NCT00108368|Serotonin Agents|serotonin agents|mesh-ancestor
153561365|NCT01652183|Acetaminophen|acetaminophen|mesh-list
153721233|NCT00108368|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153721234|NCT00108368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153721235|NCT00108368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153721236|NCT00108368|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153721237|NCT00108368|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153721238|NCT00108368|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153721239|NCT00108368|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153721240|NCT00108368|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
153721241|NCT00108368|Dopamine Agents|dopamine agents|mesh-ancestor
153721242|NCT00108368|Antiemetics|antiemetics|mesh-ancestor
153721243|NCT00108368|Autonomic Agents|autonomic agents|mesh-ancestor
153561809|NCT01654497|HU 211|hu 211|mesh-list
153721244|NCT00108368|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153721249|NCT00108446|Lidocaine|lidocaine|mesh-list
153721290|NCT00443482|Respiratory System Agents|respiratory system agents|mesh-ancestor
153721291|NCT00443482|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
153721292|NCT00443482|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
153721293|NCT00443482|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153721294|NCT00443482|Adrenergic Agents|adrenergic agents|mesh-ancestor
153721295|NCT00443482|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153721296|NCT00443482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153721297|NCT00443521|Triamcinolone|triamcinolone|mesh-list
153721298|NCT00443521|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
153721299|NCT00443521|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
153721300|NCT00443521|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
153721354|NCT00443794|Ramipril|ramipril|mesh-list
153721355|NCT00443794|Simvastatin|simvastatin|mesh-list
153721356|NCT00443794|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-list
153721357|NCT00443794|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153721358|NCT00443794|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153721359|NCT00443794|Analgesics|analgesics|mesh-ancestor
153721371|NCT00443794|Antipyretics|antipyretics|mesh-ancestor
153721421|NCT00444184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153721422|NCT00444184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153340462|NCT05749900|Antimetabolites|antimetabolites|mesh-ancestor
153340463|NCT05749900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153721423|NCT00444184|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153340464|NCT05749900|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153340465|NCT05749900|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153340466|NCT05749666|Prednisolone|prednisolone|mesh-list
153340467|NCT05749666|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
153340468|NCT05749666|Methylprednisolone|methylprednisolone|mesh-list
153340470|NCT05749666|Prednisolone acetate|prednisolone acetate|mesh-list
153721424|NCT00444184|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153721426|NCT00444223|Cariostatic Agents|cariostatic agents|mesh-ancestor
153721427|NCT00444223|Protective Agents|protective agents|mesh-ancestor
153721428|NCT00444223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153721429|NCT03275701|Abacavir, dolutegravir, and lamivudine drug combination|abacavir, dolutegravir, and lamivudine drug combination|mesh-list
153721430|NCT03275701|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153721431|NCT03275701|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153721432|NCT03275701|Antiviral Agents|antiviral agents|mesh-ancestor
153562218|NCT01656109|Antiviral Agents|antiviral agents|mesh-ancestor
153562408|NCT01657409|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
153721433|NCT03275701|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153721434|NCT00451360|Diacerein|diacerein|mesh-list
153558456|NCT01626469|Captopril|captopril|mesh-list
153721435|NCT00451360|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153721436|NCT00451399|Metformin|metformin|mesh-list
153721437|NCT00451399|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153721438|NCT00451399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153721440|NCT00108797|Coagulants|coagulants|mesh-ancestor
153721476|NCT00139035|Immunologic Factors|immunologic factors|mesh-ancestor
153721477|NCT00139035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153721478|NCT00139035|Antifungal Agents|antifungal agents|mesh-ancestor
153721479|NCT00139035|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153721480|NCT00139035|Dermatologic Agents|dermatologic agents|mesh-ancestor
153721481|NCT00139035|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153721482|NCT00139035|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
153721483|NCT00451672|Bromocriptine|bromocriptine|mesh-list
153340506|NCT02940509|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153340507|NCT02940509|Anesthetics, General|anesthetics, general|mesh-ancestor
153340509|NCT02940509|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153340510|NCT02940509|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
153340511|NCT02940509|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
153340512|NCT02940509|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153340513|NCT02940509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153340514|NCT02940509|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153721485|NCT00451672|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
153721486|NCT00451672|Hormone Antagonists|hormone antagonists|mesh-ancestor
153721487|NCT00451672|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153721488|NCT00451672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153721489|NCT00451672|Dopamine Agonists|dopamine agonists|mesh-ancestor
153721490|NCT00451672|Dopamine Agents|dopamine agents|mesh-ancestor
153721491|NCT00451672|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153721492|NCT00451672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153721493|NCT00108875|BIRC5 protein, human|birc5 protein, human|mesh-list
153721494|NCT00108875|Cysteine Proteinase Inhibitors|cysteine proteinase inhibitors|mesh-ancestor
153721495|NCT00108875|Protease Inhibitors|protease inhibitors|mesh-ancestor
153721496|NCT00108875|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153721497|NCT00108875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153721498|NCT00451711|Amphotericin B|amphotericin b|mesh-list
153721499|NCT00451711|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
153721500|NCT00451711|Amebicides|amebicides|mesh-ancestor
153721501|NCT00451711|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153721502|NCT00451711|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153721503|NCT00451711|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153721504|NCT00451711|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153340531|NCT04094207|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153721521|NCT00451750|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153562892|NCT01659788|Ubiquinone|ubiquinone|mesh-list
153721522|NCT00451828|Simvastatin|simvastatin|mesh-list
153920103|NCT02862873|Serotonin Agents|serotonin agents|mesh-ancestor
153721523|NCT00451828|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153721526|NCT00451828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153721527|NCT00451828|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153721528|NCT00451828|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
153721529|NCT00451828|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153721530|NCT00451867|Mycophenolic Acid|mycophenolic acid|mesh-list
153721531|NCT00451867|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153721532|NCT00451867|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153721533|NCT00451867|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
153721534|NCT00451867|Antitubercular Agents|antitubercular agents|mesh-ancestor
153721535|NCT00451867|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153721536|NCT00451867|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153721537|NCT00451867|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153721538|NCT00451867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153721539|NCT00143091|Sertraline|sertraline|mesh-list
153721540|NCT00143091|Antidepressive Agents|antidepressive agents|mesh-ancestor
153721542|NCT00143091|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
153721572|NCT00108992|Sensory System Agents|sensory system agents|mesh-ancestor
153721573|NCT00108992|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153721574|NCT00108992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153721575|NCT00108992|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153721576|NCT00108992|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153721577|NCT00108992|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153721578|NCT00108992|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153721579|NCT00108992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153721580|NCT00143130|Pregabalin|pregabalin|mesh-list
153721581|NCT00143130|Analgesics|analgesics|mesh-ancestor
153721582|NCT00143130|Sensory System Agents|sensory system agents|mesh-ancestor
153721583|NCT00143130|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153563458|NCT01663558|Imiquimod|imiquimod|mesh-list
153721584|NCT00143130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153721630|NCT03275116|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153721631|NCT03275116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153721632|NCT03275116|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153721633|NCT03275116|Respiratory System Agents|respiratory system agents|mesh-ancestor
153721634|NCT03275116|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
153721635|NCT03275116|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
153721636|NCT03275116|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153721637|NCT03275116|Adrenergic Agents|adrenergic agents|mesh-ancestor
153721638|NCT03275116|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153721639|NCT03275116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153563682|NCT01665248|Listerine|listerine|mesh-list
153721640|NCT03275116|Parasympatholytics|parasympatholytics|mesh-ancestor
153721641|NCT03275116|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
153721642|NCT03275116|Cholinergic Agents|cholinergic agents|mesh-ancestor
153721643|NCT03275116|Anticonvulsants|anticonvulsants|mesh-ancestor
153721649|NCT00109148|Hormones|hormones|mesh-ancestor
153721687|NCT00109187|Respiratory System Agents|respiratory system agents|mesh-ancestor
153721688|NCT00452608|Atorvastatin|atorvastatin|mesh-list
153721689|NCT00452608|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153721690|NCT00452608|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153721691|NCT00452608|Antimetabolites|antimetabolites|mesh-ancestor
153721692|NCT00452608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153721693|NCT00452608|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153721694|NCT00452608|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
153721751|NCT00109382|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153721752|NCT00109382|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153563901|NCT01666665|Metformin|metformin|mesh-list
153721753|NCT00109382|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153721754|NCT00109382|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153721755|NCT00109382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153340581|NCT01804790|Capecitabine|capecitabine|mesh-list
153721756|NCT00109382|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153721817|NCT00453778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153721818|NCT00453778|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153721819|NCT00453778|Respiratory System Agents|respiratory system agents|mesh-ancestor
153721820|NCT00453778|Dermatologic Agents|dermatologic agents|mesh-ancestor
153721821|NCT00453778|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
153721822|NCT00109616|Chlorhexidine|chlorhexidine|mesh-list
153721823|NCT00109616|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
153721824|NCT00109616|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
153721825|NCT00109616|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
153721826|NCT00109616|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153721827|NCT00109616|Disinfectants|disinfectants|mesh-ancestor
153920166|NCT04175587|Tretinoin|tretinoin|mesh-list
153721828|NCT00109616|Dermatologic Agents|dermatologic agents|mesh-ancestor
153721829|NCT00453856|Pyrimethamine|pyrimethamine|mesh-list
153721830|NCT00453856|Sulfadoxine|sulfadoxine|mesh-list
153721831|NCT00453856|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
153721832|NCT00453856|Antimalarials|antimalarials|mesh-ancestor
153721833|NCT00453856|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153721834|NCT00453856|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153721835|NCT00453856|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153721836|NCT00453856|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153721840|NCT00454168|Sargramostim|sargramostim|mesh-list
153721873|NCT00454480|Melphalan|melphalan|mesh-list
153721874|NCT00454480|Busulfan|busulfan|mesh-list
153340624|NCT04868708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153721875|NCT00454480|Daunorubicin|daunorubicin|mesh-list
153721876|NCT00454480|Alemtuzumab|alemtuzumab|mesh-list
153721877|NCT00454480|Clofarabine|clofarabine|mesh-list
153721878|NCT00454480|Arsenic Trioxide|arsenic trioxide|mesh-list
153721879|NCT00454480|Gemtuzumab|gemtuzumab|mesh-list
153721880|NCT00454480|Tipifarnib|tipifarnib|mesh-list
153721881|NCT00454480|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153721882|NCT00454480|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153721883|NCT00454480|Antimetabolites|antimetabolites|mesh-ancestor
153721884|NCT00454480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153721885|NCT00454480|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153721886|NCT00454480|Immunologic Factors|immunologic factors|mesh-ancestor
153721887|NCT00454480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153721888|NCT00454480|Antiviral Agents|antiviral agents|mesh-ancestor
153721889|NCT00454480|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153721890|NCT00454480|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153721891|NCT00454480|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153721892|NCT00454480|Alkylating Agents|alkylating agents|mesh-ancestor
153564579|NCT01678937|Tacrolimus|tacrolimus|mesh-list
153721893|NCT00454480|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153721894|NCT00454480|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153721895|NCT00454480|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153721896|NCT00454480|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153721897|NCT00454480|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153721899|NCT00454480|Immunoconjugates|immunoconjugates|mesh-ancestor
153721900|NCT00110006|Prednisone|prednisone|mesh-list
153721924|NCT00110006|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153340654|NCT00002548|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153721925|NCT00110006|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153721926|NCT00110006|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153721927|NCT00110006|Tubulin Modulators|tubulin modulators|mesh-ancestor
153721928|NCT00110006|Antimitotic Agents|antimitotic agents|mesh-ancestor
153564694|NCT05596669|Narcotics|narcotics|mesh-ancestor
153721929|NCT00110006|Mitosis Modulators|mitosis modulators|mesh-ancestor
153721930|NCT00110006|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
153721932|NCT00454519|Mitomycin|mitomycin|mesh-list
153721933|NCT00454519|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153721934|NCT00454519|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153721935|NCT00454519|Alkylating Agents|alkylating agents|mesh-ancestor
153721936|NCT00454519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153721937|NCT00454519|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153721938|NCT00454519|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153721939|NCT00112749|Infliximab|infliximab|mesh-list
153721940|NCT00112749|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
153721941|NCT00112749|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153721942|NCT00112749|Dermatologic Agents|dermatologic agents|mesh-ancestor
153721943|NCT00112749|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153721944|NCT00112749|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153721945|NCT00110045|Caspofungin|caspofungin|mesh-list
153721946|NCT00110045|Antifungal Agents|antifungal agents|mesh-ancestor
153721947|NCT00110045|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153721950|NCT00454714|Sildenafil Citrate|sildenafil citrate|mesh-list
153721973|NCT00454831|Chelating Agents|chelating agents|mesh-ancestor
153721975|NCT00454831|Hemostatics|hemostatics|mesh-ancestor
153721976|NCT00454831|Coagulants|coagulants|mesh-ancestor
153721977|NCT00110123|Fotemustine|fotemustine|mesh-list
153721978|NCT00110123|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153721979|NCT00455026|Remifentanil|remifentanil|mesh-list
153721980|NCT00455026|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153721981|NCT00455026|Narcotics|narcotics|mesh-ancestor
153721982|NCT00455026|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153721983|NCT00455026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153721984|NCT00455026|Analgesics|analgesics|mesh-ancestor
153721985|NCT00455026|Sensory System Agents|sensory system agents|mesh-ancestor
153782787|NCT00234962|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153565138|NCT02975037|Clarithromycin|clarithromycin|mesh-list
153721986|NCT00455026|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153721987|NCT00143325|Varenicline|varenicline|mesh-list
153721988|NCT00143325|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
153721989|NCT00143325|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
153721990|NCT00143325|Cholinergic Agents|cholinergic agents|mesh-ancestor
153721991|NCT00143325|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153721992|NCT00143325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153721993|NCT00143325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153721994|NCT00112983|Eculizumab|eculizumab|mesh-list
153722028|NCT02273791|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
153340705|NCT00002566|Carboplatin|carboplatin|mesh-list
153722029|NCT02273791|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
153722030|NCT02273791|Hormone Antagonists|hormone antagonists|mesh-ancestor
153722031|NCT02273791|Fertility Agents, Female|fertility agents, female|mesh-ancestor
153722032|NCT02273791|Fertility Agents|fertility agents|mesh-ancestor
153722033|NCT02273791|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
153565225|NCT02257970|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153565226|NCT02257970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153722034|NCT02273791|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
153722035|NCT00110240|Vildagliptin|vildagliptin|mesh-list
153722037|NCT00110240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153722038|NCT00110240|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
153722039|NCT00110240|Protease Inhibitors|protease inhibitors|mesh-ancestor
153722040|NCT00110240|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153722041|NCT00110240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153722043|NCT00455416|Allicin|allicin|mesh-list
153722044|NCT00455416|Resveratrol|resveratrol|mesh-list
153722045|NCT00455416|Quercetin|quercetin|mesh-list
153722046|NCT00455416|Antioxidants|antioxidants|mesh-ancestor
153722047|NCT00455416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153722048|NCT00455416|Protective Agents|protective agents|mesh-ancestor
153722049|NCT00455416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153722050|NCT00455416|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153722052|NCT00455416|Trace Elements|trace elements|mesh-ancestor
153722081|NCT00401492|Antimitotic Agents|antimitotic agents|mesh-ancestor
153722082|NCT00401492|Mitosis Modulators|mitosis modulators|mesh-ancestor
153722083|NCT00455806|Amoxicillin|amoxicillin|mesh-list
153722084|NCT00455806|Moxifloxacin|moxifloxacin|mesh-list
153722085|NCT00455806|Esomeprazole|esomeprazole|mesh-list
153722086|NCT00455806|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153340718|NCT00002566|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153340724|NCT00002572|Aldesleukin|aldesleukin|mesh-list
153722087|NCT00455806|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153565380|NCT05576415|Varenicline|varenicline|mesh-list
153722088|NCT00455806|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153722089|NCT00455806|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153722090|NCT00455806|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153722091|NCT00455806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153722092|NCT00455806|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153722093|NCT00455806|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
153722094|NCT00455806|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153722095|NCT00455806|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
153722096|NCT00455845|Levonorgestrel|levonorgestrel|mesh-list
153722097|NCT00455845|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
153722098|NCT00455845|Contraceptive Agents|contraceptive agents|mesh-ancestor
153565447|NCT05210517|Empagliflozin|empagliflozin|mesh-list
153722099|NCT00455845|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153722100|NCT00455845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153722101|NCT00455845|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
153722102|NCT00455845|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
153722103|NCT00455845|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
153722133|NCT00143949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153722134|NCT00143949|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
153722135|NCT00143949|Protease Inhibitors|protease inhibitors|mesh-ancestor
153722136|NCT00143949|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153722137|NCT00456235|Mycophenolic Acid|mycophenolic acid|mesh-list
153722138|NCT00456235|Cyclosporine|cyclosporine|mesh-list
153722139|NCT00456235|Tacrolimus|tacrolimus|mesh-list
153722140|NCT00456235|Cyclosporins|cyclosporins|mesh-list
153722141|NCT00456235|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153722142|NCT00456235|Immunologic Factors|immunologic factors|mesh-ancestor
153722156|NCT00456313|Fluticasone|fluticasone|mesh-list
153722197|NCT00110669|Prednisone|prednisone|mesh-list
153722198|NCT00110669|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153722199|NCT00110669|Glucocorticoids|glucocorticoids|mesh-ancestor
153722200|NCT00110669|Hormones|hormones|mesh-ancestor
153722201|NCT00110669|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153722202|NCT00110669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153722203|NCT00110669|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153722204|NCT00110669|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153722262|NCT00110747|Tetracaine|tetracaine|mesh-list
153722263|NCT00110747|Anesthetics, Local|anesthetics, local|mesh-ancestor
153722264|NCT00110747|Anesthetics|anesthetics|mesh-ancestor
153722265|NCT00110747|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153722266|NCT00110747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153722267|NCT00110747|Sensory System Agents|sensory system agents|mesh-ancestor
153722268|NCT00110747|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153722269|NCT00110747|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153722270|NCT00110747|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
153722271|NCT00110747|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153722322|NCT00457483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153722323|NCT00457483|Diuretics|diuretics|mesh-ancestor
153722324|NCT00457483|Natriuretic Agents|natriuretic agents|mesh-ancestor
153722325|NCT00457483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153722326|NCT00457483|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
153722327|NCT00457483|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153722328|NCT00110864|Insulin|insulin|mesh-list
153722329|NCT00110864|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153566071|NCT06023641|Alkylating Agents|alkylating agents|mesh-ancestor
153722330|NCT00110864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153722331|NCT00457678|Dexamethasone|dexamethasone|mesh-list
153722332|NCT00457678|Ranibizumab|ranibizumab|mesh-list
153722333|NCT00457678|Verteporfin|verteporfin|mesh-list
153722334|NCT00457678|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153722335|NCT00457678|Antiemetics|antiemetics|mesh-ancestor
153722336|NCT00457678|Autonomic Agents|autonomic agents|mesh-ancestor
153722337|NCT00457678|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153722338|NCT00457678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153722339|NCT00457678|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153722340|NCT00457678|Glucocorticoids|glucocorticoids|mesh-ancestor
153722342|NCT00457678|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153722343|NCT00457678|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153722344|NCT00457678|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153722345|NCT00457678|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153722372|NCT00110903|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153722373|NCT00110903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153722374|NCT00110903|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153722375|NCT00110903|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153722376|NCT00110903|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153722377|NCT00110903|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153722378|NCT00110903|Immunologic Factors|immunologic factors|mesh-ancestor
153722379|NCT00144144|Calcium Channel Blockers|calcium channel blockers|mesh-list
153722380|NCT00144144|Angiotensin II|angiotensin ii|mesh-list
153722382|NCT00144144|Calcium|calcium|mesh-list
153722383|NCT00144144|Angiotensinogen|angiotensinogen|mesh-list
153782997|NCT00268515|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153722384|NCT00144144|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-list
153722385|NCT00144144|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153722386|NCT00144144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153722387|NCT00144144|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
153722388|NCT00144144|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
153722389|NCT00144144|Protease Inhibitors|protease inhibitors|mesh-ancestor
153722390|NCT00144144|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153722391|NCT00144144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153722392|NCT00144144|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153722393|NCT00465673|Doxorubicin|doxorubicin|mesh-list
153722394|NCT00465673|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
153722395|NCT00465673|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153722396|NCT00465673|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153722397|NCT00465673|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153722398|NCT00465673|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153722399|NCT00465673|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153722400|NCT00465673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153722401|NCT00144183|Zidovudine|zidovudine|mesh-list
153722416|NCT00465751|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153722417|NCT00110981|Etanercept|etanercept|mesh-list
153722418|NCT00110981|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153722419|NCT00110981|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153722420|NCT00110981|Analgesics|analgesics|mesh-ancestor
153722421|NCT00110981|Sensory System Agents|sensory system agents|mesh-ancestor
153722422|NCT00110981|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153722423|NCT00110981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153722424|NCT00110981|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153722425|NCT00110981|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153722480|NCT00466180|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
153722481|NCT00466219|Interferons|interferons|mesh-list
153722482|NCT00466219|Ribavirin|ribavirin|mesh-list
153722483|NCT00466219|Interferon-alpha|interferon-alpha|mesh-list
153722484|NCT00466219|Interferon alpha-2|interferon alpha-2|mesh-list
153722485|NCT00466219|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
153722486|NCT00466219|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153722487|NCT00466219|Antiviral Agents|antiviral agents|mesh-ancestor
153722488|NCT00466219|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153722489|NCT00466219|Antimetabolites|antimetabolites|mesh-ancestor
153722490|NCT00466219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153722491|NCT00466219|Immunologic Factors|immunologic factors|mesh-ancestor
153722492|NCT00466219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153722543|NCT00111137|Hematinics|hematinics|mesh-ancestor
153722544|NCT00347854|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
153722545|NCT00347854|Ophthalmic Solutions|ophthalmic solutions|mesh-list
153722546|NCT00347854|Lubricant Eye Drops|lubricant eye drops|mesh-list
153722547|NCT00347854|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
153722548|NCT00347854|Laxatives|laxatives|mesh-ancestor
153722549|NCT00347854|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153559578|NCT01634321|Fertility Agents|fertility agents|mesh-ancestor
153722551|NCT00347971|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153722552|NCT00347971|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153722553|NCT00347971|Immunologic Factors|immunologic factors|mesh-ancestor
153722554|NCT00347971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153722555|NCT00347971|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153722556|NCT00113958|Cinacalcet|cinacalcet|mesh-list
153722557|NCT00113958|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153722558|NCT00113958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153722559|NCT00113958|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
153722560|NCT00113958|Hormone Antagonists|hormone antagonists|mesh-ancestor
153722561|NCT00113958|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153722562|NCT00348010|Tramadol|tramadol|mesh-list
153722563|NCT00348010|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153722564|NCT00348010|Narcotics|narcotics|mesh-ancestor
153722565|NCT00348010|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153722566|NCT00348010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153722567|NCT00348010|Analgesics|analgesics|mesh-ancestor
153722568|NCT00348010|Sensory System Agents|sensory system agents|mesh-ancestor
153722569|NCT00348010|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153722570|NCT00144417|Moxifloxacin|moxifloxacin|mesh-list
153722571|NCT00144417|Rifampin|rifampin|mesh-list
153722572|NCT00144417|Isoniazid|isoniazid|mesh-list
153722573|NCT00144417|Pyrazinamide|pyrazinamide|mesh-list
153722574|NCT00144417|Ethambutol|ethambutol|mesh-list
153722575|NCT00144417|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153722576|NCT00144417|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153722577|NCT00144417|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153722582|NCT00144417|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
153722583|NCT00144417|Antitubercular Agents|antitubercular agents|mesh-ancestor
153722584|NCT00144417|Leprostatic Agents|leprostatic agents|mesh-ancestor
153722585|NCT00144417|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153722586|NCT00144417|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
153722587|NCT00144417|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
153722588|NCT00144417|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
153722589|NCT00144417|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
153722590|NCT00144417|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
153722591|NCT00144417|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
153722592|NCT00144417|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
153722593|NCT00144417|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153722595|NCT00144417|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153722596|NCT00111215|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
153722597|NCT00111215|Tranexamic Acid|tranexamic acid|mesh-list
153722598|NCT00111215|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
153722599|NCT00111215|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153722600|NCT00111215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153722635|NCT00348244|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153722636|NCT00348244|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
153722637|NCT00348244|Protective Agents|protective agents|mesh-ancestor
153722638|NCT00348244|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153722639|NCT00348244|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153722641|NCT00348244|Sensory System Agents|sensory system agents|mesh-ancestor
153722642|NCT00348244|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153722643|NCT00348244|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153722644|NCT00348244|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153722645|NCT00348244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153722646|NCT00348322|Ophthalmic Solutions|ophthalmic solutions|mesh-list
153722647|NCT00348322|Lubricant Eye Drops|lubricant eye drops|mesh-list
153722648|NCT00348322|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
153722649|NCT00348361|Fluticasone|fluticasone|mesh-list
153722650|NCT00348361|Xhance|xhance|mesh-list
153722651|NCT00348361|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153722652|NCT00348361|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153722653|NCT00348361|Autonomic Agents|autonomic agents|mesh-ancestor
153722655|NCT00348361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153722657|NCT00348361|Respiratory System Agents|respiratory system agents|mesh-ancestor
153722658|NCT00348361|Dermatologic Agents|dermatologic agents|mesh-ancestor
153722659|NCT00348361|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
153722660|NCT00348400|Brimonidine Tartrate|brimonidine tartrate|mesh-list
153722661|NCT00348400|Dorzolamide|dorzolamide|mesh-list
153722662|NCT00348400|Latanoprost|latanoprost|mesh-list
153722663|NCT00348400|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
153722664|NCT00348400|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
153722665|NCT00348400|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153722666|NCT00348400|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
153341013|NCT01895348|Analgesics|analgesics|mesh-ancestor
153722667|NCT00348400|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153722668|NCT00348400|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153722676|NCT00144456|Hydroxycholecalciferols|hydroxycholecalciferols|mesh-list
153722677|NCT00144456|Eldecalcitol|eldecalcitol|mesh-list
153722678|NCT00144456|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153722679|NCT00144456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153722680|NCT00144456|Vitamins|vitamins|mesh-ancestor
153722681|NCT00144456|Micronutrients|micronutrients|mesh-ancestor
153722682|NCT00348439|Fibrinolysin|fibrinolysin|mesh-list
153722683|NCT00348439|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153722684|NCT00348439|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153722685|NCT00348439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153722686|NCT00348517|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
153722687|NCT00348517|Ophthalmic Solutions|ophthalmic solutions|mesh-list
153722688|NCT00348517|Lubricant Eye Drops|lubricant eye drops|mesh-list
153722689|NCT00348517|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
153722690|NCT00348517|Laxatives|laxatives|mesh-ancestor
153722691|NCT00348517|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153722692|NCT00348634|Tegaserod|tegaserod|mesh-list
153722693|NCT00348634|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
153722694|NCT00348634|Serotonin Agents|serotonin agents|mesh-ancestor
153722695|NCT00348634|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153722696|NCT00348634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153722698|NCT00348712|Insulin|insulin|mesh-list
153722731|NCT00111371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153722733|NCT00349180|Enoxaparin sodium|enoxaparin sodium|mesh-list
153722734|NCT00349180|Anticoagulants|anticoagulants|mesh-ancestor
153722735|NCT00349180|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153722736|NCT00349180|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153722737|NCT00349180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153722738|NCT00421369|Sertraline|sertraline|mesh-list
153722739|NCT00421369|Reboxetine|reboxetine|mesh-list
153722740|NCT00421369|Antidepressive Agents|antidepressive agents|mesh-ancestor
153341066|NCT01107236|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153341067|NCT01107236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153341068|NCT01107236|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153722765|NCT04729140|Ivermectin|ivermectin|mesh-list
153722796|NCT00349258|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153722797|NCT00349258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153722798|NCT00349258|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153722799|NCT00349258|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153722800|NCT00349375|Simvastatin|simvastatin|mesh-list
153722801|NCT00349375|Fenofibrate|fenofibrate|mesh-list
153722802|NCT00349375|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153722804|NCT00349375|Antimetabolites|antimetabolites|mesh-ancestor
153722805|NCT00349375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153722806|NCT00349375|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153722807|NCT00349375|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
153722808|NCT00349375|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153722809|NCT00349453|Deferiprone|deferiprone|mesh-list
153722810|NCT00349453|Deferoxamine|deferoxamine|mesh-list
153722811|NCT00349453|Iron Chelating Agents|iron chelating agents|mesh-ancestor
153722812|NCT00349453|Chelating Agents|chelating agents|mesh-ancestor
153722813|NCT00349453|Sequestering Agents|sequestering agents|mesh-ancestor
153722815|NCT00349453|Siderophores|siderophores|mesh-ancestor
153722854|NCT00111644|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153722855|NCT00111644|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153722857|NCT00350038|Ciprofibrate|ciprofibrate|mesh-list
153722859|NCT00350038|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
153722860|NCT00350038|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
153722861|NCT00350038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153722862|NCT00350038|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153722863|NCT00350038|Antimetabolites|antimetabolites|mesh-ancestor
153722864|NCT00350038|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153722865|NCT00350077|Vitamins|vitamins|mesh-list
153722866|NCT00350077|Ascorbic Acid|ascorbic acid|mesh-list
153722867|NCT00350077|Micronutrients|micronutrients|mesh-ancestor
153722868|NCT00350077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153722870|NCT00350077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153722871|NCT00350077|Protective Agents|protective agents|mesh-ancestor
153722872|NCT00114153|Carboplatin|carboplatin|mesh-list
153722911|NCT00404781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153722912|NCT00404781|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153722913|NCT00404781|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153722915|NCT00404781|Antipyretics|antipyretics|mesh-ancestor
153722922|NCT00404781|Autonomic Agents|autonomic agents|mesh-ancestor
153722980|NCT00350662|Deferoxamine|deferoxamine|mesh-list
153722981|NCT00350662|Iron Chelating Agents|iron chelating agents|mesh-ancestor
153920376|NCT06331845|Paclitaxel|paclitaxel|mesh-list
153722982|NCT00350662|Chelating Agents|chelating agents|mesh-ancestor
153722983|NCT00350662|Sequestering Agents|sequestering agents|mesh-ancestor
153722984|NCT00350662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153722985|NCT00350662|Siderophores|siderophores|mesh-ancestor
153722986|NCT00350818|Azacitidine|azacitidine|mesh-list
153722987|NCT00350818|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153722988|NCT00350818|Antimetabolites|antimetabolites|mesh-ancestor
153722989|NCT00350818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153722990|NCT00350818|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153723042|NCT00351052|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153723043|NCT00351052|Dermatologic Agents|dermatologic agents|mesh-ancestor
153723045|NCT00351052|Immunologic Factors|immunologic factors|mesh-ancestor
153723046|NCT00351052|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
153723047|NCT00351052|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153723048|NCT00351052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153723050|NCT00401609|Gemcitabine|gemcitabine|mesh-list
153723051|NCT00401609|Etoposide|etoposide|mesh-list
153723052|NCT00401609|Vinorelbine|vinorelbine|mesh-list
153723053|NCT00401609|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153723054|NCT00401609|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153723055|NCT00401609|Antimetabolites|antimetabolites|mesh-ancestor
153723056|NCT00401609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153723057|NCT00401609|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153723058|NCT00401609|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153723059|NCT00401609|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153723060|NCT00401609|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153723061|NCT00401609|Tubulin Modulators|tubulin modulators|mesh-ancestor
153723062|NCT00401609|Antimitotic Agents|antimitotic agents|mesh-ancestor
153723063|NCT00401609|Mitosis Modulators|mitosis modulators|mesh-ancestor
153723064|NCT00351091|Risedronic Acid|risedronic acid|mesh-list
153723065|NCT00351091|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153723066|NCT00351091|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153723067|NCT00351091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153723068|NCT00351091|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153723069|NCT00351091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153723070|NCT00351091|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153723071|NCT00351130|Amlodipine|amlodipine|mesh-list
153723072|NCT00351130|Valsartan|valsartan|mesh-list
153723073|NCT00351130|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153723074|NCT00351130|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153723075|NCT00351130|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153332129|NCT04467424|Anesthetics|anesthetics|mesh-ancestor
153723079|NCT00351130|Vasodilator Agents|vasodilator agents|mesh-ancestor
153723080|NCT00351130|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
153723081|NCT00351130|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
153341194|NCT00002734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153723082|NCT00351169|Quetiapine Fumarate|quetiapine fumarate|mesh-list
153723084|NCT00351169|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
153723085|NCT00351169|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153723086|NCT00351169|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153723088|NCT00351169|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153723144|NCT00114387|Antioxidants|antioxidants|mesh-ancestor
153723145|NCT00114387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153723146|NCT00114387|Protective Agents|protective agents|mesh-ancestor
153723147|NCT00114387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153723148|NCT00114387|Vitamins|vitamins|mesh-ancestor
153723149|NCT00114387|Micronutrients|micronutrients|mesh-ancestor
153723150|NCT00351364|Montelukast|montelukast|mesh-list
153723151|NCT00351364|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153723152|NCT00351364|Respiratory System Agents|respiratory system agents|mesh-ancestor
153723154|NCT00351364|Hormone Antagonists|hormone antagonists|mesh-ancestor
153723155|NCT00351364|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153723156|NCT00351364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153723157|NCT00351364|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
153332495|NCT01047241|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153723158|NCT00351364|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
153723159|NCT00351364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153723160|NCT00351403|Ribavirin|ribavirin|mesh-list
153723161|NCT00351403|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
153723162|NCT00351403|Antimetabolites|antimetabolites|mesh-ancestor
153723163|NCT00351403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153723164|NCT00351403|Antiviral Agents|antiviral agents|mesh-ancestor
153723197|NCT00351871|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
153723198|NCT00351871|Antimetabolites|antimetabolites|mesh-ancestor
153723199|NCT00351871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153341218|NCT00002740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153341219|NCT00002740|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153723200|NCT00351871|Antiviral Agents|antiviral agents|mesh-ancestor
153723201|NCT00351871|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153723202|NCT00351910|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
153723204|NCT00351910|Quetiapine Fumarate|quetiapine fumarate|mesh-list
153723205|NCT00351910|Citalopram|citalopram|mesh-list
153723206|NCT00351910|Bupropion|bupropion|mesh-list
153723207|NCT00351910|Fluoxetine|fluoxetine|mesh-list
153723208|NCT00351910|Paroxetine|paroxetine|mesh-list
153723209|NCT00351910|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
153332617|NCT04290676|Dexamethasone|dexamethasone|mesh-list
153723260|NCT00112619|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
153723262|NCT00112619|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153723263|NCT00112619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153723264|NCT00112619|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153723265|NCT00352261|Esomeprazole|esomeprazole|mesh-list
153723266|NCT00352261|Lansoprazole|lansoprazole|mesh-list
153723267|NCT00352261|Dexlansoprazole|dexlansoprazole|mesh-list
153723268|NCT00352261|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
153723269|NCT00352261|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153723327|NCT00352378|Immunologic Factors|immunologic factors|mesh-ancestor
153723328|NCT00352378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153332687|NCT01167829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153723329|NCT00352378|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153723330|NCT00352378|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153723331|NCT00352378|Alkylating Agents|alkylating agents|mesh-ancestor
153723332|NCT00352378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153723333|NCT00352378|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153723334|NCT00352378|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153723335|NCT00352378|Tubulin Modulators|tubulin modulators|mesh-ancestor
153723336|NCT00352378|Antimitotic Agents|antimitotic agents|mesh-ancestor
153723337|NCT00352378|Mitosis Modulators|mitosis modulators|mesh-ancestor
153723338|NCT00352378|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153723339|NCT00352378|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153723340|NCT00352378|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153723342|NCT00352378|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153723343|NCT00352378|Antimetabolites|antimetabolites|mesh-ancestor
153723344|NCT00352495|Carboplatin|carboplatin|mesh-list
153723345|NCT00352495|Vinblastine|vinblastine|mesh-list
153723346|NCT00352495|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153723381|NCT00352651|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153332994|NCT04089982|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
153341265|NCT00002752|Antibodies|antibodies|mesh-list
153723382|NCT00352651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153723384|NCT00352651|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153723385|NCT00352651|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153723386|NCT00352651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153723387|NCT00352651|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153723388|NCT00352651|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153341295|NCT05167175|Glucocorticoids|glucocorticoids|mesh-ancestor
153723389|NCT00352651|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153723390|NCT00352651|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153723391|NCT00352651|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153723392|NCT00112775|Imatinib Mesylate|imatinib mesylate|mesh-list
153723393|NCT00112775|Dasatinib|dasatinib|mesh-list
153723394|NCT00112775|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153920461|NCT06331468|Cisplatin|cisplatin|mesh-list
153723395|NCT00112775|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153723396|NCT00112775|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153723397|NCT00112775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153723398|NCT00112775|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153723432|NCT00112853|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153723433|NCT00112853|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153723434|NCT00112853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153723436|NCT00353002|Tetracaine|tetracaine|mesh-list
153723437|NCT00353002|Anesthetics, Local|anesthetics, local|mesh-ancestor
153723438|NCT00353002|Anesthetics|anesthetics|mesh-ancestor
153723439|NCT00353002|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153723440|NCT00353002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153723441|NCT00353002|Sensory System Agents|sensory system agents|mesh-ancestor
153723442|NCT00353002|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153723443|NCT00353002|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153723444|NCT00353002|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
153723445|NCT00353002|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153723446|NCT00353002|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153723447|NCT00353002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153723448|NCT00353041|Lidocaine|lidocaine|mesh-list
153723449|NCT00353041|Anesthetics, Local|anesthetics, local|mesh-ancestor
153723450|NCT00353041|Anesthetics|anesthetics|mesh-ancestor
153723451|NCT00353041|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153723452|NCT00353041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153723453|NCT00353041|Sensory System Agents|sensory system agents|mesh-ancestor
153723454|NCT00353041|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153723460|NCT00353080|Risedronic Acid|risedronic acid|mesh-list
153723480|NCT00353665|Memantine|memantine|mesh-list
153723481|NCT00353665|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
153723482|NCT00353665|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
153723483|NCT00353665|Dopamine Agents|dopamine agents|mesh-ancestor
153723484|NCT00353665|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153723485|NCT00353665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153920498|NCT06331208|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153920499|NCT06331208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153920541|NCT06331000|Ivacaftor|ivacaftor|mesh-list
153723486|NCT00353665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153723487|NCT00353665|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
153723488|NCT00353665|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
153723489|NCT00353665|Anticonvulsants|anticonvulsants|mesh-ancestor
153723490|NCT00353665|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
153723545|NCT00354523|Dacarbazine|dacarbazine|mesh-list
153723546|NCT00354523|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153723547|NCT00354523|Antimetabolites|antimetabolites|mesh-ancestor
153341315|NCT00002590|Vincristine|vincristine|mesh-list
153341316|NCT00002590|Daunorubicin|daunorubicin|mesh-list
153723548|NCT00354523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153723549|NCT00354523|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153723550|NCT00354523|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153723551|NCT00354523|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153723552|NCT00354523|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153723553|NCT00354523|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153723554|NCT00354523|Alkylating Agents|alkylating agents|mesh-ancestor
153723555|NCT00114933|Ritonavir|ritonavir|mesh-list
153723604|NCT00113594|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153723605|NCT00113594|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153723606|NCT00113594|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153341336|NCT00002590|Hormones|hormones|mesh-ancestor
153341342|NCT00002590|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153341343|NCT00002590|Antimetabolites|antimetabolites|mesh-ancestor
153341344|NCT00002590|Dermatologic Agents|dermatologic agents|mesh-ancestor
153341345|NCT00002590|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153341346|NCT00002590|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153341347|NCT00002590|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153341348|NCT00002590|Antiviral Agents|antiviral agents|mesh-ancestor
153341349|NCT00002590|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153341350|NCT00002590|Antidotes|antidotes|mesh-ancestor
153341351|NCT00002590|Protective Agents|protective agents|mesh-ancestor
153341352|NCT00002590|Vitamin B Complex|vitamin b complex|mesh-ancestor
153333448|NCT04759742|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153723607|NCT00113594|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153723608|NCT00113594|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153723609|NCT00113594|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
153723610|NCT00113594|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153920542|NCT06331000|Elexacaftor|elexacaftor|mesh-list
153920543|NCT06331000|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
153469301|NCT05285358|Mitosis Modulators|mitosis modulators|mesh-ancestor
153469303|NCT05285358|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153920544|NCT06331000|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153920545|NCT06331000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153920546|NCT06330935|Tranexamic Acid|tranexamic acid|mesh-list
153723611|NCT00113594|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153920566|NCT06330662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153920567|NCT06330662|Viscosupplements|viscosupplements|mesh-ancestor
153469328|NCT05203913|Nivolumab|nivolumab|mesh-list
153469329|NCT05203913|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153469330|NCT05203913|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153469331|NCT05203913|Tubulin Modulators|tubulin modulators|mesh-ancestor
153723612|NCT00113594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153723613|NCT00113594|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153723616|NCT00426049|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
153723617|NCT00426049|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153723618|NCT00426049|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153723619|NCT00426049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153723620|NCT00426049|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153723621|NCT00426049|Immunologic Factors|immunologic factors|mesh-ancestor
153723622|NCT00426049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153723623|NCT00426049|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153723624|NCT00115089|Beclomethasone|beclomethasone|mesh-list
153723625|NCT00115089|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153723626|NCT00115089|Glucocorticoids|glucocorticoids|mesh-ancestor
153723627|NCT00115089|Hormones|hormones|mesh-ancestor
153723628|NCT00115089|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153723629|NCT00115089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153333636|NCT00971633|Ondansetron|ondansetron|mesh-list
153723630|NCT00115089|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153723631|NCT00115089|Respiratory System Agents|respiratory system agents|mesh-ancestor
153723632|NCT00115128|Lenograstim|lenograstim|mesh-list
153723633|NCT00115128|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153723634|NCT00115128|Immunologic Factors|immunologic factors|mesh-ancestor
153341361|NCT00002788|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153341362|NCT00002788|Immunologic Factors|immunologic factors|mesh-ancestor
153723635|NCT00115128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153723636|NCT00115167|Darbepoetin alfa|darbepoetin alfa|mesh-list
153723637|NCT00115167|Hematinics|hematinics|mesh-ancestor
153723639|NCT00115245|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
153723642|NCT00115245|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153723643|NCT00115245|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153723644|NCT00115245|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153723645|NCT00115245|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153723646|NCT00115245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153723647|NCT01059526|Ecallantide|ecallantide|mesh-list
153723648|NCT01059526|Analgesics|analgesics|mesh-ancestor
153723649|NCT01059526|Sensory System Agents|sensory system agents|mesh-ancestor
153723650|NCT01059526|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153723651|NCT01059526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153469332|NCT05203913|Antimitotic Agents|antimitotic agents|mesh-ancestor
153723652|NCT01059526|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153723653|NCT01059526|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153723654|NCT01059526|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153723655|NCT01059526|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153723656|NCT00444340|Etanercept|etanercept|mesh-list
153723657|NCT00444340|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153723658|NCT00444340|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153723659|NCT00444340|Analgesics|analgesics|mesh-ancestor
153723660|NCT00444340|Sensory System Agents|sensory system agents|mesh-ancestor
153723661|NCT00444340|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153723662|NCT00444340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153723691|NCT00444379|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
153723693|NCT00444418|Naloxone|naloxone|mesh-list
153723694|NCT00444418|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
153723695|NCT00444418|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
153723696|NCT00444418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153723697|NCT00444418|Sensory System Agents|sensory system agents|mesh-ancestor
153723698|NCT00444418|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153723699|NCT00444574|Methylphenidate|methylphenidate|mesh-list
153723700|NCT00444574|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
153723701|NCT00444574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153723702|NCT00444574|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
153723703|NCT00444574|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153723704|NCT00444574|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153723705|NCT00444574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153723706|NCT00444574|Dopamine Agents|dopamine agents|mesh-ancestor
153723707|NCT00444574|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153723708|NCT00444652|Enoxaparin|enoxaparin|mesh-list
153723709|NCT00444652|Anticoagulants|anticoagulants|mesh-ancestor
153723710|NCT00444652|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153723711|NCT00444652|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153723712|NCT00444652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153723713|NCT04699903|Antibodies|antibodies|mesh-list
153723714|NCT04699903|Immunoglobulin G|immunoglobulin g|mesh-list
153723715|NCT04699903|Immunologic Factors|immunologic factors|mesh-ancestor
153723716|NCT04699903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153723717|NCT00444808|Calcitonin|calcitonin|mesh-list
153723718|NCT00444808|Salmon calcitonin|salmon calcitonin|mesh-list
153723738|NCT00444886|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
153723739|NCT00444886|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
153723740|NCT00444886|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
153723741|NCT00444886|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153723742|NCT00444886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153723743|NCT00444886|Cholinergic Agents|cholinergic agents|mesh-ancestor
153723744|NCT00444886|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153723745|NCT00444886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153723746|NCT00444886|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
153723747|NCT00444886|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153723749|NCT05594121|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153723750|NCT05594121|Narcotics|narcotics|mesh-ancestor
153723751|NCT05594121|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153723752|NCT05594121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153723753|NCT05594121|Analgesics|analgesics|mesh-ancestor
153723754|NCT05594121|Sensory System Agents|sensory system agents|mesh-ancestor
153341431|NCT04330300|Fosinopril|fosinopril|mesh-list
153341433|NCT04330300|Nitrendipine|nitrendipine|mesh-list
153341434|NCT04330300|Bendroflumethiazide|bendroflumethiazide|mesh-list
153341435|NCT04330300|Chlorothiazide|chlorothiazide|mesh-list
153341436|NCT04330300|Nifedipine|nifedipine|mesh-list
153341437|NCT04330300|Calcium Channel Blockers|calcium channel blockers|mesh-list
153341438|NCT04330300|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-list
153341439|NCT04330300|Diuretics|diuretics|mesh-list
153341440|NCT04330300|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
153341441|NCT04330300|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153341442|NCT04330300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153341443|NCT04330300|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153341453|NCT04330300|Tocolytic Agents|tocolytic agents|mesh-ancestor
153723755|NCT05594121|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153723756|NCT05594121|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
153723757|NCT00115362|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
153723758|NCT00115362|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
153723788|NCT00445081|Dermatologic Agents|dermatologic agents|mesh-ancestor
153723789|NCT00445081|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153723790|NCT00445081|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
153723791|NCT00113906|Melatonin|melatonin|mesh-list
153723792|NCT00113906|Antioxidants|antioxidants|mesh-ancestor
153723793|NCT00113906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153723794|NCT00113906|Protective Agents|protective agents|mesh-ancestor
153723795|NCT00113906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153723796|NCT00113906|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153723797|NCT00113945|Cinacalcet|cinacalcet|mesh-list
153723798|NCT00113945|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153723799|NCT00113945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153723800|NCT00113945|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
153723801|NCT00113945|Hormone Antagonists|hormone antagonists|mesh-ancestor
153723803|NCT00445159|Treprostinil|treprostinil|mesh-list
153723847|NCT00445900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153723848|NCT00445900|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153723849|NCT00445900|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153723850|NCT00445900|Alkylating Agents|alkylating agents|mesh-ancestor
153723851|NCT00445900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153723852|NCT00445900|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153723853|NCT00445900|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153723854|NCT00445900|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153723855|NCT00445900|Glucocorticoids|glucocorticoids|mesh-ancestor
153723856|NCT00445900|Hormones|hormones|mesh-ancestor
153334584|NCT01455896|Incretins|incretins|mesh-ancestor
153723857|NCT00445900|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153723858|NCT00445900|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153723859|NCT00445900|Leprostatic Agents|leprostatic agents|mesh-ancestor
153723860|NCT00445900|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153723861|NCT00445900|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153723862|NCT00445900|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153723863|NCT00445900|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153723864|NCT00445900|Growth Substances|growth substances|mesh-ancestor
153723865|NCT00445900|Growth Inhibitors|growth inhibitors|mesh-ancestor
153723866|NCT00115479|Insulin|insulin|mesh-list
153723867|NCT00115479|Benzocaine|benzocaine|mesh-list
153723868|NCT00115479|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153723869|NCT00115479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153723870|NCT00115479|Anesthetics, Local|anesthetics, local|mesh-ancestor
153723875|NCT00446017|Milrinone|milrinone|mesh-list
153920612|NCT06330337|Mitosis Modulators|mitosis modulators|mesh-ancestor
153920613|NCT06330337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153920614|NCT06330337|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153920615|NCT06330337|Alkylating Agents|alkylating agents|mesh-ancestor
153920616|NCT06330220|Aflibercept|aflibercept|mesh-list
153920617|NCT06330220|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153920618|NCT06330220|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153920619|NCT06330220|Growth Substances|growth substances|mesh-ancestor
153920620|NCT06330220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153723895|NCT00446017|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153723896|NCT00446017|Vasodilator Agents|vasodilator agents|mesh-ancestor
153334760|NCT03751124|Norethindrone|norethindrone|mesh-list
153723897|NCT00446017|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
153723898|NCT00446017|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
153723899|NCT00446017|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153723900|NCT00446017|Protective Agents|protective agents|mesh-ancestor
153723901|NCT00446173|Cyclophosphamide|cyclophosphamide|mesh-list
153723903|NCT00446173|Sargramostim|sargramostim|mesh-list
153723904|NCT00446173|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153723905|NCT00446173|Immunologic Factors|immunologic factors|mesh-ancestor
153723906|NCT00446173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153723907|NCT00446173|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153723908|NCT00446173|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153723909|NCT00446173|Alkylating Agents|alkylating agents|mesh-ancestor
153723910|NCT00446173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153723911|NCT00446173|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153723912|NCT00446173|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153723913|NCT00446212|Propofol|propofol|mesh-list
153723914|NCT00446212|Desflurane|desflurane|mesh-list
153723915|NCT00446212|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153723916|NCT00446212|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153723917|NCT00446212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153723918|NCT00446212|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153723919|NCT00446212|Anesthetics, General|anesthetics, general|mesh-ancestor
153723920|NCT00446212|Anesthetics|anesthetics|mesh-ancestor
153723921|NCT00446212|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
153723922|NCT00446329|Cinacalcet|cinacalcet|mesh-list
153723928|NCT00446368|Everolimus|everolimus|mesh-list
153723942|NCT00401765|Mitosis Modulators|mitosis modulators|mesh-ancestor
153723943|NCT00401765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153723944|NCT00115518|Cetuximab|cetuximab|mesh-list
153723945|NCT00115518|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153335049|NCT04011592|Anesthetics|anesthetics|mesh-ancestor
153723947|NCT00446524|Amlodipine|amlodipine|mesh-list
153723948|NCT00446524|Valsartan|valsartan|mesh-list
153723949|NCT00446524|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153723950|NCT00446524|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153723951|NCT00446524|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153723952|NCT00446524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153723953|NCT00446524|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153723954|NCT00446524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153723955|NCT00446524|Vasodilator Agents|vasodilator agents|mesh-ancestor
153469398|NCT05085028|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153335201|NCT05495100|Mitoxantrone|mitoxantrone|mesh-list
153335221|NCT01453400|Aspirin|aspirin|mesh-list
153469399|NCT05085028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153469400|NCT05083637|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
153469401|NCT05080790|Zoledronic Acid|zoledronic acid|mesh-list
153469402|NCT05080790|Interleukin-2|interleukin-2|mesh-list
153469403|NCT05080790|Dinutuximab|dinutuximab|mesh-list
153469404|NCT05080790|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153469406|NCT05080790|Analgesics|analgesics|mesh-ancestor
153469407|NCT05080790|Sensory System Agents|sensory system agents|mesh-ancestor
153920647|NCT06330077|Ifenprodil|ifenprodil|mesh-list
153723956|NCT00446524|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
153723957|NCT00446524|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
153723958|NCT00446602|Epoetin Alfa|epoetin alfa|mesh-list
153723959|NCT00446602|Hematinics|hematinics|mesh-ancestor
153723960|NCT05589753|Acetazolamide|acetazolamide|mesh-list
153723961|NCT05589753|Anticonvulsants|anticonvulsants|mesh-ancestor
153723962|NCT05589753|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
153723963|NCT05589753|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153335507|NCT01406860|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
153335508|NCT01406860|Antipruritics|antipruritics|mesh-ancestor
153723964|NCT05589753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153723965|NCT05589753|Diuretics|diuretics|mesh-ancestor
153723966|NCT05589753|Natriuretic Agents|natriuretic agents|mesh-ancestor
153723967|NCT05589753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153723968|NCT00114179|Bevacizumab|bevacizumab|mesh-list
153723969|NCT00114179|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
153723970|NCT00114179|Gemcitabine|gemcitabine|mesh-list
153723971|NCT00114179|Capecitabine|capecitabine|mesh-list
153341562|NCT03852797|Ketamine|ketamine|mesh-list
153723972|NCT00114179|Antibodies|antibodies|mesh-list
153723973|NCT00114179|Immunoglobulins|immunoglobulins|mesh-list
153723974|NCT00114179|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
153920669|NCT06329921|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
153335660|NCT05599126|GABA Modulators|gaba modulators|mesh-ancestor
153920671|NCT06329921|Anticoagulants|anticoagulants|mesh-ancestor
153920672|NCT06329921|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153920673|NCT06329921|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153920674|NCT06329921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153920675|NCT06329895|Dabigatran|dabigatran|mesh-list
153920676|NCT06329895|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
153920677|NCT06329895|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153920678|NCT06329895|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153920679|NCT06329895|Antimetabolites|antimetabolites|mesh-ancestor
153922571|NCT04673942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153922572|NCT04673942|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153922573|NCT04673942|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153922575|NCT04673448|Dostarlimab|dostarlimab|mesh-list
153922576|NCT04673448|Immunoglobulins|immunoglobulins|mesh-list
153922577|NCT04673448|Immunoglobulin G|immunoglobulin g|mesh-list
153922578|NCT04673448|Immunologic Factors|immunologic factors|mesh-ancestor
153922579|NCT04673448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153922580|NCT04673448|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
153922581|NCT04673448|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153922582|NCT04673448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153922583|NCT04673448|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153471324|NCT05764746|Schistosomicides|schistosomicides|mesh-ancestor
153723975|NCT00114179|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153723976|NCT00114179|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153723977|NCT00114179|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153723978|NCT00114179|Growth Substances|growth substances|mesh-ancestor
153723979|NCT00114179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153336199|NCT05475444|Antimetabolites|antimetabolites|mesh-ancestor
153723980|NCT00114179|Growth Inhibitors|growth inhibitors|mesh-ancestor
153723981|NCT00114179|Immunologic Factors|immunologic factors|mesh-ancestor
153723982|NCT00114179|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153723983|NCT00114179|Antimetabolites|antimetabolites|mesh-ancestor
153723984|NCT00114179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153723985|NCT00446680|Mannitol|mannitol|mesh-list
153723987|NCT00446680|Diuretics|diuretics|mesh-ancestor
153723988|NCT00446680|Natriuretic Agents|natriuretic agents|mesh-ancestor
153723989|NCT00446680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153723990|NCT00114257|Decitabine|decitabine|mesh-list
153723991|NCT00114257|Romidepsin|romidepsin|mesh-list
153723992|NCT00114257|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153723993|NCT00114257|Antimetabolites|antimetabolites|mesh-ancestor
153723994|NCT00114257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153723995|NCT00114257|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153723996|NCT00114257|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153723997|NCT00114257|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153723998|NCT00114257|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
153723999|NCT00404937|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
153724000|NCT00404937|Tobramycin, Dexamethasone Drug Combination|tobramycin, dexamethasone drug combination|mesh-list
153724001|NCT00404937|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153724002|NCT00404937|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153724003|NCT00404937|Glucocorticoids|glucocorticoids|mesh-ancestor
153724004|NCT00404937|Hormones|hormones|mesh-ancestor
153724005|NCT00404937|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153724006|NCT00404937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153724007|NCT00404937|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
153724021|NCT00114374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153724022|NCT00114374|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153724024|NCT00114374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153724025|NCT00446953|Betamethasone|betamethasone|mesh-list
153724026|NCT00446953|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153724027|NCT00446953|Glucocorticoids|glucocorticoids|mesh-ancestor
153724028|NCT00446953|Hormones|hormones|mesh-ancestor
153724029|NCT00446953|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153724030|NCT00446953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153724031|NCT00446953|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153724032|NCT00446953|Respiratory System Agents|respiratory system agents|mesh-ancestor
153724033|NCT00447031|Triamcinolone|triamcinolone|mesh-list
153724034|NCT00447031|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
153724035|NCT00447031|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
153724036|NCT00447031|Bevacizumab|bevacizumab|mesh-list
153724037|NCT00447031|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
153724038|NCT00447031|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153724039|NCT00447031|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153724040|NCT00447031|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153724041|NCT00447031|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153724042|NCT00447031|Growth Substances|growth substances|mesh-ancestor
153724043|NCT00447031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153724044|NCT00447031|Growth Inhibitors|growth inhibitors|mesh-ancestor
153724045|NCT00447031|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153724046|NCT00447031|Glucocorticoids|glucocorticoids|mesh-ancestor
153724047|NCT00447031|Hormones|hormones|mesh-ancestor
153336767|NCT00379522|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
153724048|NCT00447031|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153724065|NCT00115635|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153336970|NCT00177970|Immunoglobulins|immunoglobulins|mesh-list
153724067|NCT00115635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153724068|NCT00115635|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153724069|NCT00115635|Tubulin Modulators|tubulin modulators|mesh-ancestor
153724070|NCT00115635|Antimitotic Agents|antimitotic agents|mesh-ancestor
153724071|NCT00115635|Mitosis Modulators|mitosis modulators|mesh-ancestor
153724072|NCT00447304|Moxifloxacin|moxifloxacin|mesh-list
153724073|NCT00447304|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153724074|NCT00447304|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153724075|NCT00447304|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153724076|NCT00447304|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153724077|NCT00447304|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153878325|NCT04551885|Fludarabine|fludarabine|mesh-list
153724128|NCT00447967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153724129|NCT00447967|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153724131|NCT00447967|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153724132|NCT00447967|Immunologic Factors|immunologic factors|mesh-ancestor
153920732|NCT06329752|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153920733|NCT06329752|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153920734|NCT06329752|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
153920735|NCT06329752|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153920736|NCT06329752|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153920737|NCT06329752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153469507|NCT04913675|Antiviral Agents|antiviral agents|mesh-ancestor
153469508|NCT04913675|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153469509|NCT04902027|Mitoxantrone|mitoxantrone|mesh-list
153469510|NCT04902027|Analgesics|analgesics|mesh-ancestor
153469511|NCT04902027|Sensory System Agents|sensory system agents|mesh-ancestor
153469512|NCT04902027|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153724133|NCT00447967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153724134|NCT00447967|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
153724135|NCT00447967|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153337405|NCT00000208|Narcotics|narcotics|mesh-ancestor
153724136|NCT00447967|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153724137|NCT00447967|Antidotes|antidotes|mesh-ancestor
153724138|NCT00447967|Protective Agents|protective agents|mesh-ancestor
153724139|NCT00447967|Vitamin B Complex|vitamin b complex|mesh-ancestor
153724141|NCT00447967|Micronutrients|micronutrients|mesh-ancestor
153724142|NCT00401856|Eplerenone|eplerenone|mesh-list
153724143|NCT00401856|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
153724144|NCT00401856|Hormone Antagonists|hormone antagonists|mesh-ancestor
153724145|NCT00401856|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153724146|NCT00401856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153724147|NCT00401856|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
153724148|NCT00401856|Diuretics|diuretics|mesh-ancestor
153337487|NCT00000988|Stavudine|stavudine|mesh-list
153337554|NCT02904954|Durvalumab|durvalumab|mesh-list
153724149|NCT00401856|Natriuretic Agents|natriuretic agents|mesh-ancestor
153724150|NCT00401856|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153724151|NCT00448240|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
153724157|NCT00448396|Epothilone B|epothilone b|mesh-list
153724177|NCT05553678|Midazolam|midazolam|mesh-list
153724178|NCT05553678|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153724179|NCT05553678|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153724180|NCT05553678|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153724181|NCT05553678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153724182|NCT05553678|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153724183|NCT05553678|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153724184|NCT05553678|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153724185|NCT05553678|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153724186|NCT05553678|Anesthetics, General|anesthetics, general|mesh-ancestor
153724187|NCT05553678|Anesthetics|anesthetics|mesh-ancestor
153561245|NCT01651481|Montelukast|montelukast|mesh-list
153724188|NCT05553678|GABA Modulators|gaba modulators|mesh-ancestor
153724189|NCT05553678|GABA Agents|gaba agents|mesh-ancestor
153724198|NCT03276520|Ethanol|ethanol|mesh-list
153724240|NCT00448981|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153724242|NCT03276325|Dexamethasone|dexamethasone|mesh-list
153724243|NCT03276325|Nalbuphine|nalbuphine|mesh-list
153724244|NCT03276325|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153337973|NCT01189279|Bimatoprost|bimatoprost|mesh-list
153724245|NCT03276325|Antiemetics|antiemetics|mesh-ancestor
153341723|NCT01059929|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153724246|NCT03276325|Autonomic Agents|autonomic agents|mesh-ancestor
153337975|NCT00001108|Ritonavir|ritonavir|mesh-list
153724247|NCT03276325|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153724248|NCT03276325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153724249|NCT03276325|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153724251|NCT03276325|Hormones|hormones|mesh-ancestor
153724252|NCT03276325|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153724305|NCT00449137|Antidotes|antidotes|mesh-ancestor
153724306|NCT00449137|Protective Agents|protective agents|mesh-ancestor
153724307|NCT00449137|Vitamin B Complex|vitamin b complex|mesh-ancestor
153724308|NCT00449137|Vitamins|vitamins|mesh-ancestor
153724309|NCT00449137|Micronutrients|micronutrients|mesh-ancestor
153724310|NCT00449254|Oleoyl-estrone|oleoyl-estrone|mesh-list
153338049|NCT02535000|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153724311|NCT00449254|Estrone|estrone|mesh-list
153724312|NCT00449254|Estrogens|estrogens|mesh-ancestor
153724313|NCT00449254|Hormones|hormones|mesh-ancestor
153724314|NCT00449254|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153724315|NCT00449254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153724316|NCT00449254|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
153724370|NCT00449527|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153724371|NCT00449527|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153724372|NCT00449527|Autonomic Agents|autonomic agents|mesh-ancestor
153724373|NCT00449527|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153724374|NCT00449527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153724375|NCT00449527|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153724376|NCT00449527|Respiratory System Agents|respiratory system agents|mesh-ancestor
153724377|NCT00449527|Glucocorticoids|glucocorticoids|mesh-ancestor
153724378|NCT00449527|Hormones|hormones|mesh-ancestor
153724379|NCT00449527|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153724380|NCT00449527|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
153724381|NCT00449527|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
153724382|NCT00449527|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153338130|NCT00000340|Pemoline|pemoline|mesh-list
153724383|NCT00449527|Adrenergic Agents|adrenergic agents|mesh-ancestor
153724384|NCT00449527|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153724385|NCT00449527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153724386|NCT00449683|Terazosin|terazosin|mesh-list
153724387|NCT00449683|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
153724388|NCT00449683|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
153724389|NCT00449683|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
153724395|NCT00449722|Mesalamine|mesalamine|mesh-list
153724422|NCT04699279|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153724423|NCT04699279|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153724424|NCT04699279|Antimetabolites|antimetabolites|mesh-ancestor
153724425|NCT04699279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153724426|NCT04699279|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153724427|NCT04699279|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
153724428|NCT04699279|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153724429|NCT00450307|Antibodies|antibodies|mesh-list
153724430|NCT00450307|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
153724431|NCT00450307|Sargramostim|sargramostim|mesh-list
153724432|NCT00450307|Immunologic Factors|immunologic factors|mesh-ancestor
153724433|NCT00450307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153724434|NCT03276013|Pembrolizumab|pembrolizumab|mesh-list
153724435|NCT03276013|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153724436|NCT03276013|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153724437|NCT03276013|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153724438|NCT03276013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153338172|NCT01229527|Analgesics|analgesics|mesh-ancestor
153724440|NCT00450736|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153724441|NCT00450736|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153724442|NCT00450736|Analgesics|analgesics|mesh-ancestor
153724443|NCT00450736|Sensory System Agents|sensory system agents|mesh-ancestor
153724444|NCT00450736|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153724472|NCT05536362|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
153724473|NCT05536362|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153724474|NCT05536362|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153338225|NCT00001228|Antiviral Agents|antiviral agents|mesh-ancestor
153338240|NCT01894334|Edaravone|edaravone|mesh-list
153724476|NCT00450853|Granisetron|granisetron|mesh-list
153724477|NCT00450853|Antiemetics|antiemetics|mesh-ancestor
153724478|NCT00450853|Autonomic Agents|autonomic agents|mesh-ancestor
153724479|NCT00450853|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153724480|NCT00450853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153724481|NCT00450853|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153724482|NCT00450853|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
153724483|NCT00450853|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153724487|NCT00450892|Docetaxel|docetaxel|mesh-list
153724534|NCT00458458|Fertility Agents, Female|fertility agents, female|mesh-ancestor
153724535|NCT00458458|Fertility Agents|fertility agents|mesh-ancestor
153724536|NCT00458458|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153724537|NCT00458458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153724538|NCT00458458|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153724539|NCT00458458|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153338406|NCT00002062|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153724540|NCT00458458|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
153469572|NCT04817969|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
153469573|NCT04817969|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153469574|NCT04817969|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153469575|NCT04798781|Pembrolizumab|pembrolizumab|mesh-list
153920819|NCT06325943|Immunologic Factors|immunologic factors|mesh-ancestor
153920820|NCT06325943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153920821|NCT06325943|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153920836|NCT06314620|Heparin|heparin|mesh-list
153878326|NCT04551885|Avelumab|avelumab|mesh-list
153341794|NCT01063049|Cathartics|cathartics|mesh-ancestor
153724542|NCT00458458|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
153724543|NCT00458458|Contraceptive Agents|contraceptive agents|mesh-ancestor
153724544|NCT00458458|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
153724545|NCT00458458|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
153724546|NCT00458614|Lansoprazole|lansoprazole|mesh-list
153724547|NCT00458614|Dexlansoprazole|dexlansoprazole|mesh-list
153724548|NCT00458614|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
153724549|NCT00458614|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153724550|NCT00458614|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
153724551|NCT00458614|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153724553|NCT00458731|Bevacizumab|bevacizumab|mesh-list
153724588|NCT00459004|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
153338580|NCT01151761|Cisplatin|cisplatin|mesh-list
153724589|NCT00459004|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153724590|NCT00459004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153724591|NCT00459004|Hormones|hormones|mesh-ancestor
153724592|NCT00459004|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153724593|NCT00459004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153724594|NCT00459160|Antihypertensive Agents|antihypertensive agents|mesh-list
153724595|NCT00115583|cyclo(Trp-Asp-Pro-Val-Leu)|cyclo(trp-asp-pro-val-leu)|mesh-list
153724596|NCT00115583|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153724597|NCT00115583|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
153724598|NCT00115583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153724599|NCT00115622|Fluticasone|fluticasone|mesh-list
153724600|NCT00115622|Xhance|xhance|mesh-list
153724601|NCT00115622|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153724602|NCT00115622|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153724603|NCT00115622|Autonomic Agents|autonomic agents|mesh-ancestor
153724604|NCT00115622|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153724605|NCT00115622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153724606|NCT00115622|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153338657|NCT00002104|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153724607|NCT00115622|Respiratory System Agents|respiratory system agents|mesh-ancestor
153724608|NCT00115622|Dermatologic Agents|dermatologic agents|mesh-ancestor
153724609|NCT00115622|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
153724610|NCT00459511|Hydrocortisone|hydrocortisone|mesh-list
153724611|NCT00459511|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153724637|NCT00401804|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153724640|NCT00401804|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153724641|NCT00401804|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153724642|NCT00401804|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153724643|NCT00401804|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153724644|NCT00401804|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153724645|NCT00401804|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153724646|NCT00401804|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153724647|NCT00401804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153724648|NCT00459940|Pioglitazone|pioglitazone|mesh-list
153724649|NCT00459940|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153724650|NCT00459940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153724651|NCT00460057|Alendronate|alendronate|mesh-list
153724652|NCT00460057|Diphosphonates|diphosphonates|mesh-list
153783251|NCT02213224|Amlodipine|amlodipine|mesh-list
153783252|NCT02213224|Telmisartan|telmisartan|mesh-list
153724653|NCT00460057|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153915873|NCT00628719|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153724654|NCT00460057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153724655|NCT00401921|Minocycline|minocycline|mesh-list
153724656|NCT00401921|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153724657|NCT00401921|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153724658|NCT00460174|Bevacizumab|bevacizumab|mesh-list
153724659|NCT00460174|Gemcitabine|gemcitabine|mesh-list
153724660|NCT00460174|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153724661|NCT00460174|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153724664|NCT00460174|Growth Substances|growth substances|mesh-ancestor
153724684|NCT00115817|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
153724685|NCT00115817|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153724687|NCT00460369|Lumefantrine|lumefantrine|mesh-list
153724688|NCT00460369|Artemether|artemether|mesh-list
153724689|NCT00460369|Pyrimethamine|pyrimethamine|mesh-list
153724690|NCT00460369|Sulfadoxine|sulfadoxine|mesh-list
153724691|NCT00460369|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
153724692|NCT00460369|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
153724693|NCT00460369|Amodiaquine|amodiaquine|mesh-list
153724694|NCT00460369|Antimalarials|antimalarials|mesh-ancestor
153724695|NCT00460369|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153724696|NCT00460369|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153724697|NCT00460369|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153724698|NCT00460369|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153724699|NCT00460369|Antiviral Agents|antiviral agents|mesh-ancestor
153724700|NCT00460369|Schistosomicides|schistosomicides|mesh-ancestor
153724701|NCT00460369|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
153724702|NCT00460369|Anthelmintics|anthelmintics|mesh-ancestor
153338832|NCT00001570|Vinblastine|vinblastine|mesh-list
153724703|NCT00460369|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153724704|NCT00460369|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153724705|NCT00460369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153724706|NCT00460369|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
153724707|NCT00460447|Gemtuzumab|gemtuzumab|mesh-list
153724708|NCT00460447|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153724709|NCT00460447|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153724710|NCT00460447|Immunotoxins|immunotoxins|mesh-ancestor
153724711|NCT00460447|Immunoconjugates|immunoconjugates|mesh-ancestor
153561774|NCT01654185|Letrozole|letrozole|mesh-list
153724712|NCT00460447|Immunologic Factors|immunologic factors|mesh-ancestor
153724713|NCT00460447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153724714|NCT00460642|Cetrorelix|cetrorelix|mesh-list
153724715|NCT00460642|Fertility Agents, Female|fertility agents, female|mesh-ancestor
153724716|NCT00460642|Fertility Agents|fertility agents|mesh-ancestor
153724717|NCT00460642|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153724725|NCT00460759|Moxifloxacin|moxifloxacin|mesh-list
153338867|NCT01661790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153338868|NCT01661790|Growth Inhibitors|growth inhibitors|mesh-ancestor
153338869|NCT00002134|Ganciclovir|ganciclovir|mesh-list
153724726|NCT00460759|Rifapentine|rifapentine|mesh-list
153724727|NCT00460759|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153724728|NCT00460759|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153724729|NCT00460759|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153724730|NCT00460759|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153724731|NCT00460759|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153724732|NCT00460759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153724733|NCT00460759|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153724734|NCT00460759|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
153724735|NCT00460759|Antitubercular Agents|antitubercular agents|mesh-ancestor
153724736|NCT00460759|Leprostatic Agents|leprostatic agents|mesh-ancestor
153724737|NCT00460837|Picosulfate sodium|picosulfate sodium|mesh-list
153724738|NCT00460837|Cathartics|cathartics|mesh-ancestor
153724787|NCT00461344|Tubulin Modulators|tubulin modulators|mesh-ancestor
153724788|NCT00461344|Antimitotic Agents|antimitotic agents|mesh-ancestor
153339009|NCT00000670|Zidovudine|zidovudine|mesh-list
153339010|NCT00000670|Probenecid|probenecid|mesh-list
153339011|NCT00000670|Antimetabolites|antimetabolites|mesh-ancestor
153724789|NCT00461344|Mitosis Modulators|mitosis modulators|mesh-ancestor
153724790|NCT00461344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153724791|NCT00461344|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153724792|NCT00461344|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153724793|NCT00461344|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153724794|NCT00461344|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153724795|NCT03273634|Lansoprazole|lansoprazole|mesh-list
153724796|NCT03273634|Dexlansoprazole|dexlansoprazole|mesh-list
153724797|NCT03273634|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
153724798|NCT03273634|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153724799|NCT03273634|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
153724800|NCT03273634|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153724801|NCT03273634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153724803|NCT03273595|Cyclophosphamide|cyclophosphamide|mesh-list
153724804|NCT03273595|Trastuzumab|trastuzumab|mesh-list
153724805|NCT03273595|Epirubicin|epirubicin|mesh-list
153724806|NCT03273595|Lapatinib|lapatinib|mesh-list
153724807|NCT03273595|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153724808|NCT03273595|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153724809|NCT03273595|Tubulin Modulators|tubulin modulators|mesh-ancestor
153920967|NCT06208462|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153724838|NCT03273556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153724839|NCT04728308|Bupivacaine|bupivacaine|mesh-list
153339204|NCT00002176|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153724841|NCT04728308|Anesthetics|anesthetics|mesh-ancestor
153724842|NCT04728308|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153724843|NCT04728308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153724844|NCT04728308|Sensory System Agents|sensory system agents|mesh-ancestor
153341904|NCT03187834|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153724845|NCT04728308|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153724846|NCT00461422|Ganirelix|ganirelix|mesh-list
153724847|NCT00461422|Hormone Antagonists|hormone antagonists|mesh-ancestor
153724848|NCT00461422|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153339261|NCT02167217|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
153724849|NCT00461422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153724850|NCT04697992|Vitamins|vitamins|mesh-list
153724851|NCT04697992|Ascorbic Acid|ascorbic acid|mesh-list
153724901|NCT00116064|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153920995|NCT06191744|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153920996|NCT06191744|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153469764|NCT04473911|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153469765|NCT04473911|Antifungal Agents|antifungal agents|mesh-ancestor
153724902|NCT00116064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153724903|NCT04728035|Irinotecan|irinotecan|mesh-list
153724904|NCT04728035|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
153724905|NCT04728035|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153724906|NCT04728035|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153724907|NCT04728035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153724908|NCT04728035|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153724909|NCT00461890|Naltrexone|naltrexone|mesh-list
153724910|NCT00461890|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
153339370|NCT02403986|Anesthetics|anesthetics|mesh-ancestor
153724912|NCT00461890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153724913|NCT00461890|Sensory System Agents|sensory system agents|mesh-ancestor
153724914|NCT00461890|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153724915|NCT00461968|Simvastatin|simvastatin|mesh-list
153724916|NCT00461968|Ezetimibe|ezetimibe|mesh-list
153724917|NCT00461968|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153724918|NCT00461968|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153724919|NCT00461968|Antimetabolites|antimetabolites|mesh-ancestor
153724920|NCT00461968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153724921|NCT00461968|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153724922|NCT00461968|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
153724923|NCT00461968|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153724924|NCT00116103|Tacrolimus|tacrolimus|mesh-list
153724925|NCT00116103|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153724926|NCT00116103|Immunologic Factors|immunologic factors|mesh-ancestor
153724927|NCT00116103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153724931|NCT02956252|Anesthetics|anesthetics|mesh-list
153724947|NCT00116181|Sensory System Agents|sensory system agents|mesh-ancestor
153724948|NCT00116181|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153724949|NCT00116181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153724950|NCT00116181|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153724951|NCT00116181|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153724952|NCT00116181|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153724953|NCT00116181|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153724954|NCT00116181|Immunologic Factors|immunologic factors|mesh-ancestor
153724956|NCT00462397|Carboplatin|carboplatin|mesh-list
153724957|NCT00462397|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153724958|NCT00462397|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153724959|NCT00462397|Tubulin Modulators|tubulin modulators|mesh-ancestor
153341959|NCT00002890|Lintuzumab|lintuzumab|mesh-list
153724960|NCT00462397|Antimitotic Agents|antimitotic agents|mesh-ancestor
153724961|NCT00462397|Mitosis Modulators|mitosis modulators|mesh-ancestor
153724962|NCT00462397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153724963|NCT00462475|Hormones|hormones|mesh-list
153724964|NCT00462475|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153724965|NCT00462475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153724966|NCT00462553|Gemcitabine|gemcitabine|mesh-list
153724968|NCT00462553|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153724969|NCT00462553|Antimetabolites|antimetabolites|mesh-ancestor
153724970|NCT00462553|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153724971|NCT00462553|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153724972|NCT00462553|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153724973|NCT00462553|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153724974|NCT00462553|Growth Substances|growth substances|mesh-ancestor
153724975|NCT00462553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153724976|NCT00462553|Growth Inhibitors|growth inhibitors|mesh-ancestor
153724977|NCT00462553|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153724978|NCT00462553|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153724979|NCT00462592|Budesonide|budesonide|mesh-list
153724980|NCT00462592|Montelukast|montelukast|mesh-list
153724981|NCT00462592|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153724986|NCT00462592|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153724987|NCT00462592|Respiratory System Agents|respiratory system agents|mesh-ancestor
153724989|NCT00462592|Hormones|hormones|mesh-ancestor
153340059|NCT00002476|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153340060|NCT00002476|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153340061|NCT00002476|Immunologic Factors|immunologic factors|mesh-ancestor
153724990|NCT00462592|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153724991|NCT00462592|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
153724993|NCT00462592|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
153724994|NCT00462592|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
153724995|NCT00462592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153724996|NCT00405015|Rosiglitazone|rosiglitazone|mesh-list
153724997|NCT00405015|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153724998|NCT00405015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153724999|NCT00462631|Paclitaxel|paclitaxel|mesh-list
153725000|NCT00462631|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
153725001|NCT00462631|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153725002|NCT00462631|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153725003|NCT00462631|Tubulin Modulators|tubulin modulators|mesh-ancestor
153725004|NCT00462631|Antimitotic Agents|antimitotic agents|mesh-ancestor
153725005|NCT00462631|Mitosis Modulators|mitosis modulators|mesh-ancestor
153725006|NCT00462631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153725007|NCT00462787|Dexamethasone|dexamethasone|mesh-list
153725008|NCT00462787|Topotecan|topotecan|mesh-list
153725009|NCT00462787|Vinorelbine|vinorelbine|mesh-list
153340254|NCT02165111|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153340255|NCT02165111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153340256|NCT02165111|Cholinergic Agents|cholinergic agents|mesh-ancestor
153340257|NCT02165111|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153340258|NCT02165111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153340259|NCT02165111|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
153340264|NCT05750290|Irinotecan|irinotecan|mesh-list
153340269|NCT05750290|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153725011|NCT00462787|Clofarabine|clofarabine|mesh-list
153340375|NCT01203319|Vaccines|vaccines|mesh-list
153725012|NCT00462787|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153725013|NCT00462787|Antiemetics|antiemetics|mesh-ancestor
153725014|NCT00462787|Autonomic Agents|autonomic agents|mesh-ancestor
153725015|NCT00462787|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153725016|NCT00462787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153725017|NCT00462787|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153725018|NCT00462787|Glucocorticoids|glucocorticoids|mesh-ancestor
153725019|NCT00462787|Hormones|hormones|mesh-ancestor
153725021|NCT00462787|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153725026|NCT00462787|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153725027|NCT00462787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153725028|NCT00462787|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153725029|NCT00462787|Tubulin Modulators|tubulin modulators|mesh-ancestor
153725030|NCT00462787|Antimitotic Agents|antimitotic agents|mesh-ancestor
153725031|NCT00462787|Mitosis Modulators|mitosis modulators|mesh-ancestor
153725032|NCT00462787|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153725033|NCT00462787|Alkylating Agents|alkylating agents|mesh-ancestor
153725034|NCT00462787|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153725035|NCT00462787|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153725036|NCT00462787|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153725037|NCT00462787|Antimetabolites|antimetabolites|mesh-ancestor
153342025|NCT00002920|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
153725038|NCT00463021|1 alpha-hydroxyergocalciferol|1 alpha-hydroxyergocalciferol|mesh-list
153725039|NCT00463021|Vitamins|vitamins|mesh-ancestor
153725041|NCT00463021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153725042|NCT00463021|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153725043|NCT00116259|Aripiprazole|aripiprazole|mesh-list
153725044|NCT00116259|Antidepressive Agents|antidepressive agents|mesh-ancestor
153725045|NCT00116259|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153725046|NCT00116259|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153725047|NCT00116259|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153725048|NCT00116259|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153725049|NCT00116259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153725050|NCT00116259|Dopamine Agonists|dopamine agonists|mesh-ancestor
153725051|NCT00116259|Dopamine Agents|dopamine agents|mesh-ancestor
153725052|NCT00116259|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153921144|NCT06107413|Growth Substances|growth substances|mesh-ancestor
153725053|NCT00116259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153725054|NCT00116259|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
153725055|NCT00116259|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
153725056|NCT00116259|Serotonin Agents|serotonin agents|mesh-ancestor
153340598|NCT01313702|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153725057|NCT00116259|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
153725058|NCT00116259|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153725059|NCT00116259|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
153725060|NCT00116259|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
153360726|NCT01368263|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
153360727|NCT01368263|Hormone Antagonists|hormone antagonists|mesh-ancestor
153725062|NCT00116324|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153725063|NCT00116324|Respiratory System Agents|respiratory system agents|mesh-ancestor
153725064|NCT00116324|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
153725065|NCT00116324|Hormone Antagonists|hormone antagonists|mesh-ancestor
153725066|NCT00116324|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153725067|NCT00116324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153725068|NCT00116324|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
153725069|NCT00116324|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
153725070|NCT00116324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153725071|NCT00116402|Fluticasone|fluticasone|mesh-list
153725072|NCT00116402|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
153725073|NCT00116402|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153725074|NCT00116402|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153725075|NCT00116402|Autonomic Agents|autonomic agents|mesh-ancestor
153340687|NCT00002554|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153340761|NCT00002578|Vitamins|vitamins|mesh-ancestor
153340856|NCT00002608|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
153725076|NCT00116402|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153725077|NCT00116402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153725078|NCT00116402|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153725079|NCT00116402|Respiratory System Agents|respiratory system agents|mesh-ancestor
153725080|NCT00116402|Dermatologic Agents|dermatologic agents|mesh-ancestor
153725081|NCT00116402|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
153725082|NCT00116402|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
153725083|NCT00116402|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
153725084|NCT00116402|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153725085|NCT00116402|Adrenergic Agents|adrenergic agents|mesh-ancestor
153725086|NCT00116402|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153342135|NCT01214317|Mitoxantrone|mitoxantrone|mesh-list
153725087|NCT00116402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153725088|NCT00463723|Ophthalmic Solutions|ophthalmic solutions|mesh-list
153725089|NCT00463723|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
153725091|NCT00463762|Cefoperazone|cefoperazone|mesh-list
153725092|NCT00463762|Sulperazone|sulperazone|mesh-list
153725093|NCT00463762|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153725094|NCT00463762|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153725095|NCT00463762|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
153725096|NCT00463762|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153725097|NCT00463762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153725098|NCT00463762|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
153725099|NCT00116480|Misoprostol|misoprostol|mesh-list
153725100|NCT00116480|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
153725101|NCT00116480|Abortifacient Agents|abortifacient agents|mesh-ancestor
153725102|NCT00116480|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153725103|NCT00116480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153725104|NCT00116480|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
153725105|NCT00116480|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153725106|NCT00116480|Oxytocics|oxytocics|mesh-ancestor
153341193|NCT00002734|Mitosis Modulators|mitosis modulators|mesh-ancestor
153725107|NCT00463879|Galantamine|galantamine|mesh-list
153725108|NCT00463879|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
153725109|NCT00463879|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153725110|NCT00463879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153725111|NCT00463879|Cholinergic Agents|cholinergic agents|mesh-ancestor
153725112|NCT00463879|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153342198|NCT01572662|Fludarabine|fludarabine|mesh-list
153725113|NCT00463879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153725114|NCT00463879|Parasympathomimetics|parasympathomimetics|mesh-ancestor
153725115|NCT00463879|Autonomic Agents|autonomic agents|mesh-ancestor
153725116|NCT00463879|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153725117|NCT00463879|Nootropic Agents|nootropic agents|mesh-ancestor
153725118|NCT00463918|Varenicline|varenicline|mesh-list
153725119|NCT00463918|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
153725120|NCT00463918|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
153725121|NCT00463918|Cholinergic Agents|cholinergic agents|mesh-ancestor
153725122|NCT00463918|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153725123|NCT00463918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153725124|NCT00463918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153725125|NCT00463957|Sildenafil Citrate|sildenafil citrate|mesh-list
153725127|NCT00463957|Vasodilator Agents|vasodilator agents|mesh-ancestor
153725128|NCT00463957|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
153725129|NCT00463957|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
153725130|NCT00463957|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153725135|NCT00464035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153725136|NCT00116454|Ethiodized Oil|ethiodized oil|mesh-list
153725137|NCT00116454|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153725138|NCT00464191|Escitalopram|escitalopram|mesh-list
153725139|NCT00464191|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
153341396|NCT04783792|Vitamins|vitamins|mesh-ancestor
153725140|NCT00464191|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153725141|NCT00464191|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153725142|NCT00464191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153725143|NCT00464191|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153725144|NCT00464191|Serotonin Agents|serotonin agents|mesh-ancestor
153725145|NCT00464191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153725198|NCT00116675|Immunomodulating Agents|immunomodulating agents|mesh-ancestor
153725199|NCT00116675|Immunologic Factors|immunologic factors|mesh-ancestor
153725200|NCT00116675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153725201|NCT00464776|Aliskiren|aliskiren|mesh-list
153725202|NCT00464776|Renin Inhibitors|renin inhibitors|mesh-ancestor
153725203|NCT00464776|Protease Inhibitors|protease inhibitors|mesh-ancestor
153725204|NCT00464776|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153725205|NCT00464776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153725206|NCT00116532|Escitalopram|escitalopram|mesh-list
153725207|NCT00116532|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
153725208|NCT00116532|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153725209|NCT00116532|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153725210|NCT00116532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153725211|NCT00116532|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153725212|NCT00116532|Serotonin Agents|serotonin agents|mesh-ancestor
153725213|NCT00116532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153725214|NCT00464854|Insulin Aspart|insulin aspart|mesh-list
153725215|NCT00464854|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153725216|NCT00464854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153725217|NCT00464893|Catumaxomab|catumaxomab|mesh-list
153725218|NCT00464893|Antibodies, Bispecific|antibodies, bispecific|mesh-list
153725219|NCT00464893|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153725220|NCT00464893|Immunologic Factors|immunologic factors|mesh-ancestor
153725221|NCT00464893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153725222|NCT00464932|Vasoactive Intestinal Peptide|vasoactive intestinal peptide|mesh-list
153725223|NCT00464932|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153725224|NCT00464932|Vasodilator Agents|vasodilator agents|mesh-ancestor
153725225|NCT00464932|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
153725227|NCT00464932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153725241|NCT00116870|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
153725242|NCT00116870|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153725244|NCT00465205|Antiviral Agents|antiviral agents|mesh-ancestor
153725245|NCT00465205|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153725246|NCT00465244|Levetiracetam|levetiracetam|mesh-list
153725247|NCT00465244|Lorazepam|lorazepam|mesh-list
153725248|NCT00465244|Anticonvulsants|anticonvulsants|mesh-ancestor
153725249|NCT00465244|Nootropic Agents|nootropic agents|mesh-ancestor
153725250|NCT00465244|Antiemetics|antiemetics|mesh-ancestor
153725251|NCT00465244|Autonomic Agents|autonomic agents|mesh-ancestor
153725252|NCT00465244|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153725253|NCT00465244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153725254|NCT00465244|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153725255|NCT00465244|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153725256|NCT00465244|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153725257|NCT00465244|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153725258|NCT00465244|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153725259|NCT00465244|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153725260|NCT00465244|GABA Modulators|gaba modulators|mesh-ancestor
153725261|NCT00465244|GABA Agents|gaba agents|mesh-ancestor
153725262|NCT00465244|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153725263|NCT00465244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153725264|NCT00465283|Donepezil|donepezil|mesh-list
153725265|NCT00465283|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
153725266|NCT00465283|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153725267|NCT00465283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153725268|NCT00465283|Cholinergic Agents|cholinergic agents|mesh-ancestor
153341861|NCT03836014|Dexamethasone acetate|dexamethasone acetate|mesh-list
153341862|NCT03836014|Lenalidomide|lenalidomide|mesh-list
153725269|NCT00465283|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153725270|NCT00465283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153725289|NCT00116948|Histamine Agents|histamine agents|mesh-ancestor
153725290|NCT00116948|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153725291|NCT00116948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153921275|NCT06075147|Aflibercept|aflibercept|mesh-list
153725292|NCT00116948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153725293|NCT00116948|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
153725294|NCT00116948|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153725297|NCT03272503|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153725298|NCT03272503|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153725299|NCT03272503|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153725300|NCT03272503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153725301|NCT03272503|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153725302|NCT03272503|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
153725303|NCT03272503|Dopamine Agents|dopamine agents|mesh-ancestor
153725304|NCT03272503|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153725305|NCT03272503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153725306|NCT03272503|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
153725307|NCT00465439|Lidocaine|lidocaine|mesh-list
153725308|NCT00465439|Epinephrine|epinephrine|mesh-list
153725341|NCT00116727|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153725342|NCT00116727|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153725343|NCT00116727|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153725344|NCT00116727|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153725345|NCT00116727|Immunologic Factors|immunologic factors|mesh-ancestor
153725346|NCT00473551|Sirolimus|sirolimus|mesh-list
153725347|NCT00473551|Cyclophosphamide|cyclophosphamide|mesh-list
153725348|NCT00473551|Rituximab|rituximab|mesh-list
153725349|NCT00473551|Fludarabine|fludarabine|mesh-list
153342221|NCT01258153|MEN 11420|men 11420|mesh-list
153725350|NCT00473551|Fludarabine phosphate|fludarabine phosphate|mesh-list
153725351|NCT00473551|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153725407|NCT00474136|Sensory System Agents|sensory system agents|mesh-ancestor
153725408|NCT00474136|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153725409|NCT00474136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153725410|NCT00474136|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153725411|NCT00474136|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153725412|NCT00474136|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153725413|NCT00474136|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153725414|NCT00474136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153725415|NCT00117104|Darbepoetin alfa|darbepoetin alfa|mesh-list
153725416|NCT00117104|Hematinics|hematinics|mesh-ancestor
153725417|NCT03270709|Vitamin D|vitamin d|mesh-list
153725418|NCT03270709|Cholecalciferol|cholecalciferol|mesh-list
153725419|NCT03270709|Vitamins|vitamins|mesh-ancestor
153725420|NCT03270709|Micronutrients|micronutrients|mesh-ancestor
153725421|NCT03270709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153725422|NCT03270709|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153725423|NCT03270709|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153725424|NCT03270553|Metformin|metformin|mesh-list
153725425|NCT03270553|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153725426|NCT03270553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153725428|NCT00117182|Mannitol|mannitol|mesh-list
153725429|NCT00117182|Bromides|bromides|mesh-list
153725430|NCT00117182|Albuterol|albuterol|mesh-list
153725431|NCT00117182|Ipratropium|ipratropium|mesh-list
153725432|NCT00117182|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153725433|NCT00117182|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153725434|NCT00117182|Autonomic Agents|autonomic agents|mesh-ancestor
153725435|NCT00117182|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153725436|NCT00117182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153725437|NCT00117182|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153725438|NCT00117182|Respiratory System Agents|respiratory system agents|mesh-ancestor
153725452|NCT00117182|Diuretics|diuretics|mesh-ancestor
153725453|NCT00117182|Natriuretic Agents|natriuretic agents|mesh-ancestor
153725454|NCT00117182|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
153725455|NCT00117182|Cholinergic Agents|cholinergic agents|mesh-ancestor
153725456|NCT00116922|Metformin|metformin|mesh-list
153343648|NCT00003262|Hormones|hormones|mesh-ancestor
153343924|NCT00003994|Protective Agents|protective agents|mesh-ancestor
153344018|NCT00003328|Porfiromycin|porfiromycin|mesh-list
153725458|NCT00116922|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153725459|NCT00116922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153725460|NCT00116961|Dexamethasone|dexamethasone|mesh-list
153725461|NCT00116961|Bortezomib|bortezomib|mesh-list
153725462|NCT00116961|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153725463|NCT00116961|Antiemetics|antiemetics|mesh-ancestor
153725465|NCT00116961|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153725466|NCT00116961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153562510|NCT01657851|Tamsulosin|tamsulosin|mesh-list
153342436|NCT00003424|Tamoxifen|tamoxifen|mesh-list
153725467|NCT00116961|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153725468|NCT00116961|Glucocorticoids|glucocorticoids|mesh-ancestor
153725469|NCT00116961|Hormones|hormones|mesh-ancestor
153725470|NCT00116961|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153725471|NCT00116961|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153344503|NCT00003868|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153725472|NCT00116961|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153725473|NCT00474721|Acetaminophen|acetaminophen|mesh-list
153725474|NCT00474721|Ibuprofen|ibuprofen|mesh-list
153725475|NCT00474721|Codeine|codeine|mesh-list
153725476|NCT00474721|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153725477|NCT00474721|Analgesics|analgesics|mesh-ancestor
153725478|NCT00474721|Sensory System Agents|sensory system agents|mesh-ancestor
153725479|NCT00474721|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153725480|NCT00474721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153725481|NCT00474721|Antipyretics|antipyretics|mesh-ancestor
153725482|NCT00474721|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153725489|NCT00474721|Narcotics|narcotics|mesh-ancestor
153725495|NCT00117260|Ethinyl estradiol, levonorgestrel drug combination|ethinyl estradiol, levonorgestrel drug combination|mesh-list
153725498|NCT00117260|Hormones|hormones|mesh-ancestor
153725499|NCT00117260|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153725500|NCT00117260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153725501|NCT00117260|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
153725502|NCT00117260|Contraceptive Agents|contraceptive agents|mesh-ancestor
153725503|NCT00117260|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153725504|NCT00117260|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
153725505|NCT00117260|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
153725506|NCT00117260|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
153725507|NCT00117260|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
153725556|NCT00475189|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
153725557|NCT00475189|Contraceptive Agents|contraceptive agents|mesh-ancestor
153725558|NCT00475189|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153725559|NCT00475189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153725560|NCT00475189|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
153344914|NCT05042817|Analgesics|analgesics|mesh-ancestor
153725561|NCT00475189|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
153725562|NCT00475189|Contraceptives, Oral, Sequential|contraceptives, oral, sequential|mesh-ancestor
153725563|NCT00475189|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
153725565|NCT00475189|Hormones|hormones|mesh-ancestor
153345236|NCT00199056|Tubulin Modulators|tubulin modulators|mesh-ancestor
153345391|NCT00004162|Antimetabolites|antimetabolites|mesh-ancestor
153725566|NCT00475189|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153725568|NCT00117377|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153725569|NCT00117377|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153725570|NCT00117377|Analgesics|analgesics|mesh-ancestor
153725571|NCT00117377|Sensory System Agents|sensory system agents|mesh-ancestor
153342486|NCT00003436|Abortifacient Agents|abortifacient agents|mesh-ancestor
153725572|NCT00117377|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153725573|NCT00117377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153725575|NCT00117377|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153725608|NCT00475696|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153725609|NCT00475696|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153725610|NCT00475696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153725611|NCT00475696|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153346369|NCT00004582|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
153346656|NCT04753112|Valsartan|valsartan|mesh-list
153725612|NCT00475696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153725613|NCT00475696|Analgesics|analgesics|mesh-ancestor
153725614|NCT00475696|Sensory System Agents|sensory system agents|mesh-ancestor
153725615|NCT00475696|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153725616|NCT00475696|Antidepressive Agents|antidepressive agents|mesh-ancestor
153725617|NCT00475696|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153725618|NCT00475696|Dopamine Agents|dopamine agents|mesh-ancestor
153725619|NCT00117455|Lenograstim|lenograstim|mesh-list
153346831|NCT00151814|Olmesartan|olmesartan|mesh-list
153346914|NCT03015857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153346918|NCT03015857|Narcotics|narcotics|mesh-ancestor
153725620|NCT00117455|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153725622|NCT00117455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153725623|NCT03270007|Vinorelbine|vinorelbine|mesh-list
153725665|NCT00475969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153725666|NCT00475969|Analgesics|analgesics|mesh-ancestor
153725667|NCT00475969|Sensory System Agents|sensory system agents|mesh-ancestor
153725668|NCT00475969|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153346996|NCT01072643|Analgesics|analgesics|mesh-ancestor
153725669|NCT00475969|Antidepressive Agents|antidepressive agents|mesh-ancestor
153347133|NCT02176031|Prednisolone|prednisolone|mesh-list
153347404|NCT00262730|Poly ICLC|poly iclc|mesh-list
153725671|NCT00475969|Dopamine Agents|dopamine agents|mesh-ancestor
153725672|NCT00476164|Rituximab|rituximab|mesh-list
153725673|NCT00476164|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153725674|NCT00476164|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153725675|NCT00476164|Immunologic Factors|immunologic factors|mesh-ancestor
153725676|NCT00476164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153725677|NCT00476164|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153725678|NCT00402077|Pramlintide|pramlintide|mesh-list
153725679|NCT00402077|Phentermine|phentermine|mesh-list
153725680|NCT00402077|Sibutramine|sibutramine|mesh-list
153725681|NCT00402077|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
153725682|NCT00402077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153725683|NCT00402077|Appetite Depressants|appetite depressants|mesh-ancestor
153725684|NCT00402077|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
153347734|NCT01084265|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
153725686|NCT00402077|Autonomic Agents|autonomic agents|mesh-ancestor
153725687|NCT00402077|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153725688|NCT00402077|Adrenergic Agents|adrenergic agents|mesh-ancestor
153725689|NCT00402077|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153725690|NCT00402077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153725691|NCT00402077|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153725692|NCT00402077|Antidepressive Agents|antidepressive agents|mesh-ancestor
153725693|NCT00402077|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153725694|NCT00476359|Lopinavir|lopinavir|mesh-list
153725695|NCT00476359|Saquinavir|saquinavir|mesh-list
153725711|NCT00117494|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153725712|NCT00117494|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153725714|NCT00117494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153725715|NCT00117494|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153878327|NCT04551885|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153725716|NCT00117494|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
153725717|NCT00117494|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153725718|NCT00117533|Ribavirin|ribavirin|mesh-list
153725719|NCT00117533|Interferon alpha-2|interferon alpha-2|mesh-list
153725720|NCT00117533|Antimetabolites|antimetabolites|mesh-ancestor
153725721|NCT00117533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153725722|NCT00117533|Antiviral Agents|antiviral agents|mesh-ancestor
153725723|NCT00117533|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153725724|NCT00117533|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153725725|NCT00117234|Darbepoetin alfa|darbepoetin alfa|mesh-list
153725726|NCT00117234|Hematinics|hematinics|mesh-ancestor
153725727|NCT00117611|Omalizumab|omalizumab|mesh-list
153725728|NCT00117611|Antibodies|antibodies|mesh-list
153725729|NCT00117611|Immunologic Factors|immunologic factors|mesh-ancestor
153470181|NCT03340896|Antimetabolites|antimetabolites|mesh-ancestor
153725730|NCT00117611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153725731|NCT00117611|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
153725732|NCT00117611|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153725733|NCT00117611|Respiratory System Agents|respiratory system agents|mesh-ancestor
153725734|NCT03277261|Teriflunomide|teriflunomide|mesh-list
153725735|NCT03277261|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153725736|NCT03277261|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153725737|NCT03277261|Analgesics|analgesics|mesh-ancestor
153725738|NCT03277261|Sensory System Agents|sensory system agents|mesh-ancestor
153725739|NCT03277261|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153725740|NCT03277261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153342588|NCT00003034|Doxorubicin|doxorubicin|mesh-list
153878328|NCT04551885|Immunologic Factors|immunologic factors|mesh-ancestor
153348113|NCT00183092|Quinacrine|quinacrine|mesh-list
153725757|NCT00117689|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
153725758|NCT00117689|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153725759|NCT00117689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153725760|NCT00117689|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153725761|NCT00117689|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153725762|NCT00117689|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
153725763|NCT00117689|Antitubercular Agents|antitubercular agents|mesh-ancestor
153725764|NCT00117689|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153725765|NCT00117689|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153348353|NCT00186446|Bupropion|bupropion|mesh-list
153725766|NCT00117273|Levonorgestrel|levonorgestrel|mesh-list
153725767|NCT00117273|Ethinyl Estradiol|ethinyl estradiol|mesh-list
153725769|NCT00117273|Estrogens|estrogens|mesh-ancestor
153725770|NCT00117273|Hormones|hormones|mesh-ancestor
153725771|NCT00117273|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153725772|NCT00117273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153725773|NCT00117273|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
153725774|NCT00117273|Contraceptive Agents|contraceptive agents|mesh-ancestor
153725775|NCT00117273|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153348468|NCT00278876|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153725776|NCT00117273|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
153725777|NCT00117273|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
153725778|NCT00117273|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
153725779|NCT00117273|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
153725780|NCT00476710|Colesevelam Hydrochloride|colesevelam hydrochloride|mesh-list
153725781|NCT00476710|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153725782|NCT00476710|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153725783|NCT00476710|Antimetabolites|antimetabolites|mesh-ancestor
153725784|NCT00476710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153725785|NCT00476710|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153725801|NCT00117767|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153725802|NCT00117767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153725803|NCT03277066|Diclofenac|diclofenac|mesh-list
153725804|NCT03277066|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153725805|NCT03277066|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153725806|NCT03277066|Analgesics|analgesics|mesh-ancestor
153725807|NCT03277066|Sensory System Agents|sensory system agents|mesh-ancestor
153921414|NCT05988632|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153921415|NCT05988632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153921426|NCT05987124|Defibrotide|defibrotide|mesh-list
153921427|NCT05987124|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153921428|NCT05987124|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153921429|NCT05987124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153921430|NCT05987124|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153921431|NCT05983302|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
153921432|NCT05983302|Hemostatics|hemostatics|mesh-ancestor
153921433|NCT05983302|Coagulants|coagulants|mesh-ancestor
153725808|NCT03277066|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153725809|NCT03277066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153725810|NCT03277066|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153725811|NCT03277066|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153725812|NCT03277066|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153725813|NCT03277066|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153725814|NCT03277066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153725816|NCT00117923|Toll-Like Receptor Agonists|toll-like receptor agonists|mesh-ancestor
153725817|NCT00117923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153725818|NCT00117923|Immunomodulating Agents|immunomodulating agents|mesh-ancestor
153348863|NCT00296192|Rotigotine|rotigotine|mesh-list
153725819|NCT00117923|Immunologic Factors|immunologic factors|mesh-ancestor
153725820|NCT00117923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153725822|NCT00117351|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153725823|NCT00118196|Azacitidine|azacitidine|mesh-list
153725824|NCT00118196|Arsenic Trioxide|arsenic trioxide|mesh-list
153725825|NCT00118196|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153725826|NCT00118196|Antimetabolites|antimetabolites|mesh-ancestor
153348946|NCT00230126|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
153348947|NCT00230126|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153725827|NCT00118196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153725828|NCT00118196|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153725829|NCT00118196|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153725830|NCT00118235|Bevacizumab|bevacizumab|mesh-list
153725831|NCT00118235|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
153725832|NCT00118235|Irinotecan|irinotecan|mesh-list
153725833|NCT00118235|Antibodies|antibodies|mesh-list
153725834|NCT00118235|Immunoglobulins|immunoglobulins|mesh-list
153349099|NCT01156571|Clopidogrel|clopidogrel|mesh-list
153725835|NCT00118235|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
153725836|NCT00118235|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153725838|NCT00118235|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153725839|NCT00118235|Growth Substances|growth substances|mesh-ancestor
153725840|NCT00118235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153725841|NCT00118235|Growth Inhibitors|growth inhibitors|mesh-ancestor
153725842|NCT00118235|Immunologic Factors|immunologic factors|mesh-ancestor
153725843|NCT00118235|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
153725844|NCT00118235|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153725846|NCT00118235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153725847|NCT00118313|Imiquimod|imiquimod|mesh-list
153725848|NCT00118313|Sargramostim|sargramostim|mesh-list
153725849|NCT00118313|Freund's Adjuvant|freund's adjuvant|mesh-list
153725850|NCT00118313|Dimethyl Sulfoxide|dimethyl sulfoxide|mesh-list
153725851|NCT00118313|Immunologic Factors|immunologic factors|mesh-ancestor
153725852|NCT00118313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153725853|NCT00118313|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153349286|NCT01453075|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153349383|NCT02099006|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153725854|NCT00118313|Toll-Like Receptor Agonists|toll-like receptor agonists|mesh-ancestor
153725855|NCT00118313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153725856|NCT00118313|Immunomodulating Agents|immunomodulating agents|mesh-ancestor
153725891|NCT00476983|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153725892|NCT00476983|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
153916447|NCT00628953|Esomeprazole|esomeprazole|mesh-list
153725893|NCT00476983|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153725894|NCT00476983|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153725895|NCT00476983|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153725897|NCT00477061|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153725898|NCT00477061|Narcotics|narcotics|mesh-ancestor
153725899|NCT00477061|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153921441|NCT05964335|Nalbuphine|nalbuphine|mesh-list
153725900|NCT00477061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153725902|NCT00477061|Sensory System Agents|sensory system agents|mesh-ancestor
153725903|NCT00477061|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153725904|NCT00477217|Zoledronic Acid|zoledronic acid|mesh-list
153725905|NCT00477217|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153725906|NCT00477217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153725907|NCT00477373|Valproic Acid|valproic acid|mesh-list
153725908|NCT00477373|Anticonvulsants|anticonvulsants|mesh-ancestor
153725909|NCT00477373|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153725910|NCT00477373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153725911|NCT00477373|GABA Agents|gaba agents|mesh-ancestor
153725912|NCT00477373|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153725913|NCT00477373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153725914|NCT00477373|Antimanic Agents|antimanic agents|mesh-ancestor
153725915|NCT00477373|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153725916|NCT00477373|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153725917|NCT00477373|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153725918|NCT00477763|Cyclosporine|cyclosporine|mesh-list
153562954|NCT01659944|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
153725919|NCT00477763|Cyclosporins|cyclosporins|mesh-list
153725934|NCT00477802|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153725935|NCT00477802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153725936|NCT00477802|Cholinergic Agents|cholinergic agents|mesh-ancestor
153725937|NCT00477802|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153725938|NCT00477802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153725939|NCT00477802|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
153725940|NCT00477802|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153725941|NCT00477880|Cetuximab|cetuximab|mesh-list
153725942|NCT00477880|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153342771|NCT00003088|Mitosis Modulators|mitosis modulators|mesh-ancestor
153916472|NCT02868801|Pregabalin|pregabalin|mesh-list
153725943|NCT00477880|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153350057|NCT00310466|Immunologic Factors|immunologic factors|mesh-ancestor
153350058|NCT00310466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153725944|NCT00118820|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
153725945|NCT00118820|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153725947|NCT00477997|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153725948|NCT00477997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153725949|NCT00478075|Bortezomib|bortezomib|mesh-list
153725950|NCT00478075|Samarium Sm-153 lexidronam|samarium sm-153 lexidronam|mesh-list
153725951|NCT00478075|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153725952|NCT00478075|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153350165|NCT00365144|Growth Inhibitors|growth inhibitors|mesh-ancestor
153725954|NCT00478075|Sensory System Agents|sensory system agents|mesh-ancestor
153725955|NCT00478075|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153725956|NCT00478075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153725957|NCT00117078|Darbepoetin alfa|darbepoetin alfa|mesh-list
153725958|NCT00117078|Hematinics|hematinics|mesh-ancestor
153725960|NCT00478114|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153725961|NCT00478114|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153725962|NCT00478114|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153725963|NCT00478114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153725964|NCT00478270|Ibandronic Acid|ibandronic acid|mesh-list
153725967|NCT00478504|Letrozole|letrozole|mesh-list
153725973|NCT00478504|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
153725974|NCT00478504|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153725975|NCT00478504|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153725976|NCT00478504|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
153725977|NCT00478504|Hormone Antagonists|hormone antagonists|mesh-ancestor
153350280|NCT02525874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153350281|NCT01794572|Melphalan|melphalan|mesh-list
153350282|NCT01794572|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153350290|NCT00392444|Sunitinib|sunitinib|mesh-list
153725978|NCT00478504|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153725979|NCT00478504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153725980|NCT00478504|Fertility Agents, Female|fertility agents, female|mesh-ancestor
153725981|NCT00478504|Fertility Agents|fertility agents|mesh-ancestor
153350444|NCT05901389|Sensory System Agents|sensory system agents|mesh-ancestor
153725982|NCT00478504|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153725983|NCT00478504|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
153725984|NCT00478504|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
153725985|NCT00117468|Progesterone|progesterone|mesh-list
153725986|NCT00117468|Progestins|progestins|mesh-ancestor
153350557|NCT05833139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153878329|NCT04551885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153725988|NCT00117468|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153725989|NCT00117468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153725993|NCT03271879|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153726027|NCT00118976|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153726028|NCT00118976|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
153726029|NCT00118976|Protective Agents|protective agents|mesh-ancestor
153726030|NCT00118976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153726031|NCT00478816|Vaccines|vaccines|mesh-list
153726032|NCT00478816|Immunologic Factors|immunologic factors|mesh-ancestor
153726033|NCT00478816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153726034|NCT00478855|Piperacillin|piperacillin|mesh-list
153726035|NCT00478855|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
153726036|NCT00478855|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153726037|NCT00478855|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153726038|NCT00478855|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
153726039|NCT00478855|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153726040|NCT00478855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153726041|NCT00117546|Methyldopa|methyldopa|mesh-list
153350857|NCT04621929|Topiramate|topiramate|mesh-list
153726042|NCT00117546|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153726043|NCT00117546|Sympatholytics|sympatholytics|mesh-ancestor
153726044|NCT00117546|Autonomic Agents|autonomic agents|mesh-ancestor
153726045|NCT00117546|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153350952|NCT04218773|Sympathomimetics|sympathomimetics|mesh-ancestor
153726046|NCT00117546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153726047|NCT00117546|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
153726048|NCT00117546|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153726049|NCT00117546|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153726050|NCT00117546|Adrenergic Agents|adrenergic agents|mesh-ancestor
153726051|NCT00117546|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153726053|NCT00479206|Artesunate|artesunate|mesh-list
153726076|NCT00119132|Anthelmintics|anthelmintics|mesh-ancestor
153726077|NCT00119132|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153726078|NCT00119132|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153726079|NCT00119132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153726080|NCT00119132|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
153726081|NCT00479323|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
153726083|NCT00479323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153726084|NCT00479362|Aspirin|aspirin|mesh-list
153726085|NCT00479362|Warfarin|warfarin|mesh-list
153726086|NCT00479362|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153726087|NCT00479362|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153726088|NCT00479362|Analgesics|analgesics|mesh-ancestor
153726089|NCT00479362|Sensory System Agents|sensory system agents|mesh-ancestor
153726090|NCT00479362|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153726091|NCT00479362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153351525|NCT05300802|Sensory System Agents|sensory system agents|mesh-ancestor
153726133|NCT00479752|Oxaliplatin|oxaliplatin|mesh-list
153726134|NCT00479752|Cetuximab|cetuximab|mesh-list
153726135|NCT00479752|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153726136|NCT00479752|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153726137|NCT00119249|Sorafenib|sorafenib|mesh-list
153726138|NCT00119249|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153726139|NCT00119249|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153351667|NCT00407966|Cytarabine|cytarabine|mesh-list
153726140|NCT00119249|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153342915|NCT00063362|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153726141|NCT00119249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153726142|NCT00479908|Sildenafil Citrate|sildenafil citrate|mesh-list
153726143|NCT00479908|Nitroglycerin|nitroglycerin|mesh-list
153726144|NCT00479908|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153726145|NCT00479908|Vasodilator Agents|vasodilator agents|mesh-ancestor
153726196|NCT00480181|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153726197|NCT00480181|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153726198|NCT00480181|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153726199|NCT00480298|Methylprednisolone|methylprednisolone|mesh-list
153726200|NCT00480298|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
153921534|NCT05857384|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
153351746|NCT05294328|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
153921535|NCT05857384|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
153921536|NCT05857384|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153921538|NCT05857384|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153726201|NCT00480298|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
153726202|NCT00480298|Prednisolone|prednisolone|mesh-list
153726203|NCT00480298|Prednisolone acetate|prednisolone acetate|mesh-list
153726204|NCT00480298|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
153726205|NCT00480298|Prednisolone phosphate|prednisolone phosphate|mesh-list
153726206|NCT00480298|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153726207|NCT00480298|Antiemetics|antiemetics|mesh-ancestor
153726208|NCT00480298|Autonomic Agents|autonomic agents|mesh-ancestor
153726209|NCT00480298|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153351831|NCT05143502|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153726257|NCT00480571|Dopamine Agents|dopamine agents|mesh-ancestor
153726259|NCT00480610|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153726260|NCT00480610|Immunologic Factors|immunologic factors|mesh-ancestor
153726261|NCT00480610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153726262|NCT00480610|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
153726263|NCT00480610|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153726264|NCT00480610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153726265|NCT00480649|Fluticasone|fluticasone|mesh-list
153726267|NCT00480649|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
153726268|NCT00480649|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153726269|NCT00480649|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153726270|NCT00480649|Autonomic Agents|autonomic agents|mesh-ancestor
153726271|NCT00480649|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153726272|NCT00480649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153726273|NCT00480649|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153726317|NCT05236998|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
153726318|NCT05236998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153726319|NCT05236998|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153726320|NCT05236998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153726321|NCT05236998|Incretins|incretins|mesh-ancestor
153726322|NCT05236998|Hormones|hormones|mesh-ancestor
153726323|NCT05236998|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153726324|NCT05236998|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
153726325|NCT05236998|Protease Inhibitors|protease inhibitors|mesh-ancestor
153726326|NCT05236998|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153726327|NCT01240096|Mirtazapine|mirtazapine|mesh-list
153726328|NCT01240096|Antidepressive Agents|antidepressive agents|mesh-ancestor
153726329|NCT01240096|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153726330|NCT01240096|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
153726331|NCT01240096|Histamine Antagonists|histamine antagonists|mesh-ancestor
153726332|NCT01240096|Histamine Agents|histamine agents|mesh-ancestor
153726333|NCT01240096|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153343024|NCT01063829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153726334|NCT01240096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153726335|NCT01240096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153726336|NCT01240096|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153352022|NCT05236530|Respiratory System Agents|respiratory system agents|mesh-ancestor
153726337|NCT01240096|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153726338|NCT01240096|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153726339|NCT01240096|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
153726340|NCT01240096|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
153726341|NCT01240096|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
153726342|NCT01240096|Adrenergic Agents|adrenergic agents|mesh-ancestor
153726344|NCT01240096|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153726358|NCT00119756|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
153726359|NCT00119756|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
153352114|NCT00462020|Ampicillin|ampicillin|mesh-list
153352115|NCT00462020|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
153726360|NCT00119756|Dopamine Agents|dopamine agents|mesh-ancestor
153726361|NCT01240174|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
153726362|NCT01240174|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153726363|NCT01240252|Insulin|insulin|mesh-list
153726364|NCT01240252|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
153726365|NCT01240252|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153726366|NCT01240252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153726367|NCT00117780|Insulin|insulin|mesh-list
153726368|NCT00117780|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
153726370|NCT00117780|Insulin Detemir|insulin detemir|mesh-list
153726371|NCT00117780|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153726372|NCT00117780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153726373|NCT01240408|Lenvatinib|lenvatinib|mesh-list
153726374|NCT01240408|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153726375|NCT01240408|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153726376|NCT01240408|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153726377|NCT01240408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153726378|NCT00481273|Azacitidine|azacitidine|mesh-list
153726379|NCT00481273|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153726380|NCT00481273|Antimetabolites|antimetabolites|mesh-ancestor
153726381|NCT00481273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153726382|NCT00481273|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153726383|NCT00481273|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153726384|NCT00481312|Midazolam|midazolam|mesh-list
153726385|NCT00481312|Dexmedetomidine|dexmedetomidine|mesh-list
153726386|NCT00481312|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153726387|NCT00481312|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153726388|NCT00481312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153726389|NCT00481312|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153726390|NCT00481312|Analgesics|analgesics|mesh-ancestor
153726391|NCT00481312|Sensory System Agents|sensory system agents|mesh-ancestor
153726395|NCT00481312|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153878330|NCT04551885|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153726399|NCT00481312|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153726400|NCT00481312|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153726401|NCT00481312|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153726402|NCT00481312|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153726403|NCT00481312|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153726404|NCT00481312|Anesthetics, General|anesthetics, general|mesh-ancestor
153726405|NCT00481312|Anesthetics|anesthetics|mesh-ancestor
153726406|NCT00481312|GABA Modulators|gaba modulators|mesh-ancestor
153726407|NCT00481312|GABA Agents|gaba agents|mesh-ancestor
153726408|NCT00481429|Rosiglitazone|rosiglitazone|mesh-list
153726409|NCT00481429|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153352574|NCT00475904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153726410|NCT00481429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153726411|NCT00119990|Dialysis Solutions|dialysis solutions|mesh-list
153726412|NCT00119990|Icodextrin|icodextrin|mesh-list
153726413|NCT00119990|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
153352718|NCT00489086|Tazarotene|tazarotene|mesh-list
153726414|NCT00481624|Epoetin Alfa|epoetin alfa|mesh-list
153726415|NCT00481624|Ferric gluconate|ferric gluconate|mesh-list
153726416|NCT00481624|Hematinics|hematinics|mesh-ancestor
153726417|NCT00117897|Lenograstim|lenograstim|mesh-list
153726461|NCT00481819|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153726462|NCT00481819|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153726463|NCT00481819|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153726464|NCT00481819|Antiemetics|antiemetics|mesh-ancestor
153726465|NCT00481819|Autonomic Agents|autonomic agents|mesh-ancestor
153343108|NCT00002812|Cyclophosphamide|cyclophosphamide|mesh-list
153352827|NCT00552422|Domperidone|domperidone|mesh-list
153352828|NCT00552422|Antiemetics|antiemetics|mesh-ancestor
153352862|NCT02208037|Maraviroc|maraviroc|mesh-list
153726466|NCT00481819|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153726467|NCT00481819|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153726468|NCT00481819|Glucocorticoids|glucocorticoids|mesh-ancestor
153726469|NCT00481819|Hormones|hormones|mesh-ancestor
153726470|NCT00481819|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153353066|NCT01469767|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153726471|NCT00481819|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
153726473|NCT00481819|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153726474|NCT02958059|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
153726475|NCT02958059|Cefoxitin|cefoxitin|mesh-list
153726476|NCT02958059|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153726477|NCT00481975|Rimonabant|rimonabant|mesh-list
153726478|NCT00481975|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
153726479|NCT00481975|Cannabinoid Receptor Antagonists|cannabinoid receptor antagonists|mesh-ancestor
153726480|NCT00481975|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
153726481|NCT00481975|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153726482|NCT00481975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153726483|NCT00481975|Hormones|hormones|mesh-ancestor
153726484|NCT00481975|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153726485|NCT00481975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153726486|NCT00482209|Misoprostol|misoprostol|mesh-list
153726487|NCT00482209|Mifepristone|mifepristone|mesh-list
153726488|NCT00482209|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
153726506|NCT00482209|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
153726507|NCT00117936|Mitogens|mitogens|mesh-list
153726508|NCT00117936|Mitosis Modulators|mitosis modulators|mesh-ancestor
153726509|NCT00117936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153726510|NCT00482248|Omalizumab|omalizumab|mesh-list
153353490|NCT02520726|Sertraline|sertraline|mesh-list
153726511|NCT00482248|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
153726512|NCT00482248|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153726513|NCT00482248|Respiratory System Agents|respiratory system agents|mesh-ancestor
153726514|NCT00120185|Interleukin-2|interleukin-2|mesh-list
153726575|NCT00120380|Vasodilator Agents|vasodilator agents|mesh-ancestor
153726576|NCT00483028|Donepezil|donepezil|mesh-list
153726577|NCT00483028|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
153726578|NCT00483028|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153726579|NCT00483028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153726580|NCT00483028|Cholinergic Agents|cholinergic agents|mesh-ancestor
153921621|NCT05767034|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
153726581|NCT00483028|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153726582|NCT00483028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153726584|NCT00118014|Sertraline|sertraline|mesh-list
153726637|NCT00120497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153353728|NCT01505179|Ranolazine|ranolazine|mesh-list
153726638|NCT00483145|Methyl 5-aminolevulinate|methyl 5-aminolevulinate|mesh-list
153726639|NCT00483145|Aminolevulinic Acid|aminolevulinic acid|mesh-list
153726640|NCT00483145|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
153726641|NCT00483145|Dermatologic Agents|dermatologic agents|mesh-ancestor
153726643|NCT00483301|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
153726704|NCT00483964|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153726705|NCT00483964|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153726706|NCT00483964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153726707|NCT00483964|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153354057|NCT01519063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153726710|NCT00484003|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153726711|NCT00484003|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153726712|NCT00484003|Analgesics|analgesics|mesh-ancestor
153726713|NCT00484003|Sensory System Agents|sensory system agents|mesh-ancestor
153726766|NCT00484237|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153726767|NCT00484237|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153726768|NCT00484237|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153726769|NCT00484237|Immunologic Factors|immunologic factors|mesh-ancestor
153726770|NCT00120692|Epoetin Alfa|epoetin alfa|mesh-list
153726771|NCT00120692|Darbepoetin alfa|darbepoetin alfa|mesh-list
153726772|NCT00120692|Hematinics|hematinics|mesh-ancestor
153726773|NCT00484432|Doxorubicin|doxorubicin|mesh-list
153343223|NCT00002818|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153726774|NCT00484432|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153726834|NCT00120809|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153726835|NCT00120809|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153726836|NCT00120809|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153726837|NCT00120809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153354483|NCT04730648|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-list
153354484|NCT04730648|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153726838|NCT00120809|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
153726839|NCT00484900|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
153726840|NCT00484900|Antimalarials|antimalarials|mesh-ancestor
153726841|NCT00484900|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153726842|NCT00484900|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153726843|NCT00484900|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153726846|NCT01241383|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
153726847|NCT01241383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153726848|NCT00485056|Pioglitazone|pioglitazone|mesh-list
153726849|NCT00485056|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153726850|NCT00485056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153726851|NCT00120887|Atorvastatin|atorvastatin|mesh-list
153726853|NCT00120887|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153726854|NCT00120887|Antimetabolites|antimetabolites|mesh-ancestor
153726885|NCT02274181|Fertility Agents, Female|fertility agents, female|mesh-ancestor
153726886|NCT02274181|Fertility Agents|fertility agents|mesh-ancestor
153726887|NCT02274181|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153726888|NCT02274181|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
153726889|NCT02274181|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
153726890|NCT01241422|Montelukast|montelukast|mesh-list
153726891|NCT01241422|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153726892|NCT01241422|Respiratory System Agents|respiratory system agents|mesh-ancestor
153726893|NCT01241422|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
153726894|NCT01241422|Hormone Antagonists|hormone antagonists|mesh-ancestor
153726895|NCT01241422|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153726896|NCT01241422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153726946|NCT01241773|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153354765|NCT04856228|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153354774|NCT00605384|Tenofovir|tenofovir|mesh-list
153726947|NCT01241773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153726948|NCT01241773|Antiviral Agents|antiviral agents|mesh-ancestor
153726949|NCT01241773|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153726950|NCT01241773|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
153726951|NCT01241773|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153726952|NCT01241773|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
153726953|NCT01241773|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
153727011|NCT00121394|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153727013|NCT00486343|Zileuton|zileuton|mesh-list
153727014|NCT00486343|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153727070|NCT00486694|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
153727071|NCT00486694|Antimalarials|antimalarials|mesh-ancestor
153354848|NCT04527770|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153354849|NCT04527770|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153354850|NCT04527770|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153354851|NCT04527770|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153354852|NCT04527770|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153727072|NCT00486694|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153727073|NCT00486694|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153727074|NCT00486694|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153921668|NCT05736549|Autonomic Agents|autonomic agents|mesh-ancestor
153727075|NCT00486694|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153727076|NCT00486694|Antiviral Agents|antiviral agents|mesh-ancestor
153727077|NCT00486694|Schistosomicides|schistosomicides|mesh-ancestor
153727135|NCT00119184|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153727136|NCT00119184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153727138|NCT00487123|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
153727139|NCT00487123|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153354939|NCT00670982|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153727140|NCT00487123|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
153727141|NCT00487123|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
153727142|NCT00487123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153727144|NCT00487123|Natriuretic Agents|natriuretic agents|mesh-ancestor
153727145|NCT00487123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153727146|NCT00487123|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
153727147|NCT00487123|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153727148|NCT00487591|Simvastatin|simvastatin|mesh-list
153727149|NCT00487591|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153727151|NCT00487591|Antimetabolites|antimetabolites|mesh-ancestor
153727189|NCT00488215|Laxatives|laxatives|mesh-ancestor
153727190|NCT00488215|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153727191|NCT00488215|Serotonin 5-HT4 Receptor Agonists|serotonin 5-ht4 receptor agonists|mesh-ancestor
153727192|NCT00488215|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
153727193|NCT00488215|Serotonin Agents|serotonin agents|mesh-ancestor
153727194|NCT00488215|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153878331|NCT04551885|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153727195|NCT00488215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153727254|NCT00145275|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153727255|NCT00145275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153727256|NCT00488995|Tremelimumab|tremelimumab|mesh-list
153727257|NCT00488995|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153727258|NCT00489073|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
153727259|NCT00489073|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
153355102|NCT01585207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153355103|NCT03007303|Olanzapine|olanzapine|mesh-list
153727260|NCT00489073|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153727261|NCT00489073|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153727262|NCT00489073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153727263|NCT00489073|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153727264|NCT00489073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153727265|NCT00489073|Analgesics|analgesics|mesh-ancestor
153727266|NCT00489073|Sensory System Agents|sensory system agents|mesh-ancestor
153727267|NCT00489073|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153921692|NCT05725135|Anesthetics|anesthetics|mesh-ancestor
153727268|NCT00489073|Antidepressive Agents|antidepressive agents|mesh-ancestor
153727269|NCT00489073|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153727270|NCT00489073|Dopamine Agents|dopamine agents|mesh-ancestor
153727271|NCT00489151|Lamivudine|lamivudine|mesh-list
153727310|NCT00489229|Protease Inhibitors|protease inhibitors|mesh-ancestor
153727311|NCT00489229|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153727312|NCT00489229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153727313|NCT00489229|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153727322|NCT01242631|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153727323|NCT01242631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153727324|NCT01242631|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153727325|NCT01242631|Immunologic Factors|immunologic factors|mesh-ancestor
153727326|NCT01242631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153727327|NCT01242631|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153355297|NCT00623714|Dermatologic Agents|dermatologic agents|mesh-ancestor
153355298|NCT00623714|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
153355299|NCT02174822|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
153355300|NCT02174822|Paroxetine|paroxetine|mesh-list
153355301|NCT02174822|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
153355302|NCT02174822|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153355303|NCT02174822|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153355304|NCT02174822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153355305|NCT02174822|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153387710|NCT00000765|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153727376|NCT00489775|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153878332|NCT04551885|Alkylating Agents|alkylating agents|mesh-ancestor
153727377|NCT00489775|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153727378|NCT00489775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153727379|NCT00489775|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153727380|NCT00489775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153727382|NCT00489775|Sensory System Agents|sensory system agents|mesh-ancestor
153727383|NCT00489775|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153727384|NCT00489775|Antidepressive Agents|antidepressive agents|mesh-ancestor
153727385|NCT00489775|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153727386|NCT00489775|Dopamine Agents|dopamine agents|mesh-ancestor
153727387|NCT00489775|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
153727388|NCT00489775|Serotonin Agents|serotonin agents|mesh-ancestor
153727409|NCT00490087|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
153727411|NCT01243060|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
153727412|NCT01243060|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153727413|NCT01243060|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153727414|NCT01243060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153727415|NCT01243060|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
153727416|NCT01243060|GABA Agonists|gaba agonists|mesh-ancestor
153727417|NCT01243060|GABA Agents|gaba agents|mesh-ancestor
153727418|NCT01243060|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153421648|NCT05603104|Ketamine|ketamine|mesh-list
153727419|NCT01243060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153727421|NCT00490204|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
153727422|NCT00490204|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
153727423|NCT00490204|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
153727424|NCT00490204|Histamine Antagonists|histamine antagonists|mesh-ancestor
153727425|NCT00490204|Histamine Agents|histamine agents|mesh-ancestor
153727426|NCT00490204|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153727427|NCT00490204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153727428|NCT00490204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153727429|NCT00122096|Valdecoxib|valdecoxib|mesh-list
153727430|NCT00122096|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
153727431|NCT00122096|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153355414|NCT03000127|Hormones|hormones|mesh-ancestor
153727436|NCT00122096|Analgesics|analgesics|mesh-ancestor
153727437|NCT00122096|Sensory System Agents|sensory system agents|mesh-ancestor
153727438|NCT00122096|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153727439|NCT00122096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153727440|NCT00122096|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153727441|NCT00122096|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153727442|NCT00490243|Budesonide|budesonide|mesh-list
153727443|NCT00490243|Formoterol Fumarate|formoterol fumarate|mesh-list
153727446|NCT00490243|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153727447|NCT00490243|Autonomic Agents|autonomic agents|mesh-ancestor
153727448|NCT00490243|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153355463|NCT02247505|Tamsulosin|tamsulosin|mesh-list
153355464|NCT02247505|Vasodilator Agents|vasodilator agents|mesh-ancestor
153355465|NCT02247505|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
153355466|NCT02247505|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
153727449|NCT00490243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153727450|NCT00490243|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153727451|NCT00490243|Respiratory System Agents|respiratory system agents|mesh-ancestor
153727454|NCT00490243|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153727455|NCT00490243|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
153727456|NCT00490243|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
153727457|NCT00490243|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153727458|NCT00490243|Adrenergic Agents|adrenergic agents|mesh-ancestor
153727459|NCT00490243|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153727460|NCT00490243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153727461|NCT00490243|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
153727462|NCT00490243|Hormone Antagonists|hormone antagonists|mesh-ancestor
153727463|NCT00490243|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
153727464|NCT00490243|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
153783440|NCT00236249|Lidocaine|lidocaine|mesh-list
153727497|NCT00122291|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153727498|NCT00490789|Sirolimus|sirolimus|mesh-list
153727499|NCT00490789|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153727500|NCT00490789|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153727501|NCT00490789|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153727502|NCT00490789|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153727503|NCT00490789|Antifungal Agents|antifungal agents|mesh-ancestor
153727504|NCT00490789|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153727505|NCT00490789|Immunologic Factors|immunologic factors|mesh-ancestor
153727506|NCT00490789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153727507|NCT00490828|Hydrocortisone|hydrocortisone|mesh-list
153727508|NCT00490828|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
153727509|NCT00490828|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
153727510|NCT00490828|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
153727511|NCT00490828|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153727512|NCT00490867|Thioctic Acid|thioctic acid|mesh-list
153727513|NCT00490867|Antioxidants|antioxidants|mesh-ancestor
153343477|NCT00003214|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153727514|NCT00490867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153727518|NCT00490867|Vitamins|vitamins|mesh-ancestor
153727555|NCT00145665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153727558|NCT00491725|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153727559|NCT00491725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153727560|NCT00491803|Sildenafil Citrate|sildenafil citrate|mesh-list
153727561|NCT00491803|Vasodilator Agents|vasodilator agents|mesh-ancestor
153727562|NCT00491803|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
153727563|NCT00491803|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
153727564|NCT00491803|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153727565|NCT00491803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153727566|NCT00491803|Urological Agents|urological agents|mesh-ancestor
153727567|NCT00122603|Saquinavir|saquinavir|mesh-list
153727568|NCT00122603|Fosamprenavir|fosamprenavir|mesh-list
153727569|NCT00122603|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
153727570|NCT00122603|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
153727571|NCT00122603|Protease Inhibitors|protease inhibitors|mesh-ancestor
153727572|NCT00122603|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153355623|NCT00631358|Hormones|hormones|mesh-ancestor
153355659|NCT00687674|Dexamethasone|dexamethasone|mesh-list
153355660|NCT00687674|Lenalidomide|lenalidomide|mesh-list
153355661|NCT00687674|Sorafenib|sorafenib|mesh-list
153355662|NCT00687674|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153355663|NCT00687674|Antiemetics|antiemetics|mesh-ancestor
153355664|NCT00687674|Autonomic Agents|autonomic agents|mesh-ancestor
153355665|NCT00687674|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153355666|NCT00687674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153343503|NCT00003232|Clodronic Acid|clodronic acid|mesh-list
153355667|NCT00687674|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153355668|NCT00687674|Glucocorticoids|glucocorticoids|mesh-ancestor
153355669|NCT00687674|Hormones|hormones|mesh-ancestor
153727574|NCT00122603|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153727610|NCT00492388|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153727611|NCT00492388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153727612|NCT00492388|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
153727613|NCT00492388|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153727614|NCT00492388|Anesthetics, General|anesthetics, general|mesh-ancestor
153727615|NCT00492388|Anesthetics|anesthetics|mesh-ancestor
153727616|NCT00492388|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153727617|NCT00492388|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
153727618|NCT00492388|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
153727619|NCT00492388|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153727620|NCT00492388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153355735|NCT00588536|Leucovorin|leucovorin|mesh-list
153355801|NCT02221219|Analgesics|analgesics|mesh-ancestor
153727622|NCT01243528|Vitamins|vitamins|mesh-ancestor
153727623|NCT01243528|Micronutrients|micronutrients|mesh-ancestor
153727624|NCT01243528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153727625|NCT01243528|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153727626|NCT00492427|Epoetin Alfa|epoetin alfa|mesh-list
153727627|NCT00492427|Hematinics|hematinics|mesh-ancestor
153727628|NCT00492466|Interferons|interferons|mesh-list
153727629|NCT00492466|Interferon-beta|interferon-beta|mesh-list
153727630|NCT00492466|Interferon beta-1a|interferon beta-1a|mesh-list
153564693|NCT05596669|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153727631|NCT00492466|Methylprednisolone|methylprednisolone|mesh-list
153727633|NCT00492466|Antiviral Agents|antiviral agents|mesh-ancestor
153727634|NCT00492466|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153727635|NCT00492466|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153727636|NCT00492466|Antiemetics|antiemetics|mesh-ancestor
153727637|NCT00492466|Autonomic Agents|autonomic agents|mesh-ancestor
153727638|NCT00492466|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153727639|NCT00492466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153727640|NCT00492466|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153355920|NCT01790282|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153727641|NCT00492466|Glucocorticoids|glucocorticoids|mesh-ancestor
153727642|NCT00492466|Hormones|hormones|mesh-ancestor
153727643|NCT00492466|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153727650|NCT00492505|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153727651|NCT00492505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153727652|NCT00492505|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153727653|NCT00492505|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153727655|NCT00492505|Hormone Antagonists|hormone antagonists|mesh-ancestor
153355957|NCT00692978|Xhance|xhance|mesh-list
153355958|NCT00692978|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153355959|NCT00692978|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153727656|NCT00492505|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153727658|NCT00492505|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153727716|NCT00493129|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153727717|NCT00493129|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153727718|NCT00493129|Analgesics|analgesics|mesh-ancestor
153727719|NCT00493129|Sensory System Agents|sensory system agents|mesh-ancestor
153727720|NCT00493129|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153727721|NCT00493129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153727722|NCT00126542|Bevacizumab|bevacizumab|mesh-list
153727723|NCT00126542|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
153727724|NCT00126542|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
153727725|NCT00126542|Antibodies|antibodies|mesh-list
153727726|NCT00126542|Immunoglobulins|immunoglobulins|mesh-list
153727727|NCT00126542|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
153727728|NCT00126542|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153727729|NCT00126542|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153727730|NCT00126542|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153727731|NCT00126542|Growth Substances|growth substances|mesh-ancestor
153727732|NCT00126542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153727733|NCT00126542|Growth Inhibitors|growth inhibitors|mesh-ancestor
153356065|NCT00696488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153356066|NCT00696488|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153727734|NCT00126542|Immunologic Factors|immunologic factors|mesh-ancestor
153727735|NCT00126542|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153727736|NCT00126542|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153727767|NCT00493363|Antimalarials|antimalarials|mesh-ancestor
153727768|NCT00493363|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153727769|NCT00493363|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153727770|NCT00493363|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153727771|NCT00493363|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153727772|NCT00493363|Antiviral Agents|antiviral agents|mesh-ancestor
153727773|NCT00493363|Schistosomicides|schistosomicides|mesh-ancestor
153727774|NCT00493363|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
153727775|NCT00493363|Anthelmintics|anthelmintics|mesh-ancestor
153727776|NCT00126698|Ciprofloxacin|ciprofloxacin|mesh-list
153727777|NCT00126698|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
153727778|NCT00126698|Trimethoprim|trimethoprim|mesh-list
153727779|NCT00126698|Sulfamethoxazole|sulfamethoxazole|mesh-list
153727780|NCT00126698|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153727781|NCT00126698|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153727782|NCT00126698|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153727783|NCT00126698|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153727785|NCT00126698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153343658|NCT00003700|Leucovorin|leucovorin|mesh-list
153727786|NCT00126698|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153727787|NCT00126698|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
153727790|NCT00126698|Antimalarials|antimalarials|mesh-ancestor
153727821|NCT00493480|Vasodilator Agents|vasodilator agents|mesh-ancestor
153727822|NCT00493480|Antioxidants|antioxidants|mesh-ancestor
153727823|NCT00493480|Protective Agents|protective agents|mesh-ancestor
153727824|NCT00493480|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153356204|NCT04345094|Hydroquinone|hydroquinone|mesh-list
153727827|NCT00493480|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
153727828|NCT00493480|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
153727829|NCT01243996|Ibuprofen|ibuprofen|mesh-list
153727830|NCT01243996|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153727831|NCT01243996|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153727832|NCT01243996|Analgesics|analgesics|mesh-ancestor
153727833|NCT01243996|Sensory System Agents|sensory system agents|mesh-ancestor
153727834|NCT01243996|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153727835|NCT01243996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153727836|NCT01243996|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153727837|NCT01243996|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153727838|NCT01243996|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153727839|NCT01243996|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153727840|NCT01243996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153727841|NCT01244113|Propofol|propofol|mesh-list
153727842|NCT01244113|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153727843|NCT01244113|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153356385|NCT01235897|Trastuzumab|trastuzumab|mesh-list
153727844|NCT01244113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153343695|NCT00003700|Protective Agents|protective agents|mesh-ancestor
153727845|NCT01244113|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153727846|NCT01244113|Anesthetics, General|anesthetics, general|mesh-ancestor
153727847|NCT01244113|Anesthetics|anesthetics|mesh-ancestor
153727848|NCT00405249|Dexelvucitabine|dexelvucitabine|mesh-list
153727849|NCT00405249|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153727850|NCT00405249|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153727851|NCT00405249|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153727864|NCT00493987|Hormones|hormones|mesh-ancestor
153727865|NCT00493987|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153727866|NCT00493987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153356491|NCT00704912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153356492|NCT00704912|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
153356493|NCT00704912|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153356526|NCT00666848|Enalapril|enalapril|mesh-list
153727867|NCT00493987|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153727869|NCT00493987|Anabolic Agents|anabolic agents|mesh-ancestor
153727870|NCT00493987|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
153727871|NCT00493987|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153727872|NCT00493987|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153727873|NCT00493987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153727874|NCT00493987|Hormone Antagonists|hormone antagonists|mesh-ancestor
153727875|NCT00494104|Vitamin D|vitamin d|mesh-list
153727876|NCT00494104|Vitamins|vitamins|mesh-ancestor
153727877|NCT00494104|Micronutrients|micronutrients|mesh-ancestor
153727878|NCT00494104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153921873|NCT05644561|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153921874|NCT05644561|Immunologic Factors|immunologic factors|mesh-ancestor
153921875|NCT05644561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153921880|NCT05615844|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
153921881|NCT05615844|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153727923|NCT00126971|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153727924|NCT00126971|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153727925|NCT00126971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153727932|NCT01244230|Histamine Antagonists|histamine antagonists|mesh-ancestor
153727933|NCT01244230|Histamine Agents|histamine agents|mesh-ancestor
153727934|NCT01244230|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153727935|NCT01244230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153727936|NCT01244230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153727937|NCT01244269|Methylphenidate|methylphenidate|mesh-list
153727938|NCT01244269|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
153727939|NCT01244269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153343752|NCT00003712|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153343756|NCT00003268|Cytarabine|cytarabine|mesh-list
153727940|NCT01244269|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
153727941|NCT01244269|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153727942|NCT01244269|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153727943|NCT01244269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153727944|NCT01244269|Dopamine Agents|dopamine agents|mesh-ancestor
153727945|NCT01244269|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153727947|NCT00127010|Immunologic Factors|immunologic factors|mesh-ancestor
153727948|NCT00127010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153727969|NCT00127049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153727970|NCT00127049|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153727971|NCT00127049|Alkylating Agents|alkylating agents|mesh-ancestor
153727972|NCT00494884|Vildagliptin|vildagliptin|mesh-list
153727973|NCT00494884|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153727974|NCT00494884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153727976|NCT00494884|Protease Inhibitors|protease inhibitors|mesh-ancestor
153545847|NCT06299891|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
153545848|NCT06299891|Sympathomimetics|sympathomimetics|mesh-ancestor
153545849|NCT06299891|Autonomic Agents|autonomic agents|mesh-ancestor
153545850|NCT06299891|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153728046|NCT00495352|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153728047|NCT00495352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153728048|NCT00495352|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
153356845|NCT01298063|Afatinib|afatinib|mesh-list
153356846|NCT01298063|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153728049|NCT00495352|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153728050|NCT00495352|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153728053|NCT00495547|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153728113|NCT00496444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153728114|NCT00496444|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153728115|NCT00496444|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153728187|NCT04599894|Analgesics|analgesics|mesh-ancestor
153728188|NCT04599894|Sensory System Agents|sensory system agents|mesh-ancestor
153728189|NCT04599894|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153728190|NCT04599894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153343789|NCT00384124|Toll-Like Receptor Agonists|toll-like receptor agonists|mesh-ancestor
153728256|NCT00127868|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153728331|NCT00146523|Contraceptive Agents|contraceptive agents|mesh-ancestor
153356874|NCT02322242|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153356875|NCT02322242|Glucocorticoids|glucocorticoids|mesh-ancestor
153728332|NCT00146523|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
153728334|NCT00146523|Hormone Antagonists|hormone antagonists|mesh-ancestor
153728335|NCT00146523|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153728336|NCT00146523|Luteolytic Agents|luteolytic agents|mesh-ancestor
153728337|NCT00146523|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
153728338|NCT00146523|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
153728340|NCT00402623|Antioxidants|antioxidants|mesh-ancestor
153728341|NCT00402623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153356925|NCT02992496|GABA Modulators|gaba modulators|mesh-ancestor
153728343|NCT00402623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153728344|NCT00402662|Everolimus|everolimus|mesh-list
153728345|NCT00402662|Imatinib Mesylate|imatinib mesylate|mesh-list
153728346|NCT00402662|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
153728347|NCT00402662|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153728348|NCT00402662|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153728349|NCT00402662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153728350|NCT00402662|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153728385|NCT01245166|Metformin|metformin|mesh-list
153728386|NCT01245166|Acarbose|acarbose|mesh-list
153728387|NCT01245166|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153728388|NCT01245166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153728389|NCT01245166|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
153728390|NCT01245166|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153728391|NCT01245166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153728392|NCT00146601|Fulvestrant|fulvestrant|mesh-list
153728393|NCT00146601|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153728394|NCT00146601|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153728395|NCT00146601|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
153728398|NCT00146601|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153728400|NCT00498589|Methotrexate|methotrexate|mesh-list
153728401|NCT00498589|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
153728402|NCT00498589|Abortifacient Agents|abortifacient agents|mesh-ancestor
153728403|NCT00498589|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153470694|NCT04747236|Romidepsin|romidepsin|mesh-list
153728404|NCT00498589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153728405|NCT00498589|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153728406|NCT00498589|Antimetabolites|antimetabolites|mesh-ancestor
153728436|NCT00498901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153728437|NCT00498901|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
153728438|NCT00498901|Hormone Antagonists|hormone antagonists|mesh-ancestor
153728439|NCT00498901|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153728440|NCT00498901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153728441|NCT00498901|Fertility Agents, Female|fertility agents, female|mesh-ancestor
153728442|NCT00498901|Fertility Agents|fertility agents|mesh-ancestor
153728443|NCT00498901|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153728444|NCT00498901|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153728445|NCT00498979|Interferons|interferons|mesh-list
153728446|NCT00498979|Interferon-alpha|interferon-alpha|mesh-list
153728447|NCT00498979|Interferon alpha-2|interferon alpha-2|mesh-list
153728448|NCT00498979|Antimony Sodium Gluconate|antimony sodium gluconate|mesh-list
153728449|NCT00498979|Dacarbazine|dacarbazine|mesh-list
153728450|NCT00498979|Vinblastine|vinblastine|mesh-list
153357014|NCT01278446|Chelating Agents|chelating agents|mesh-ancestor
153357015|NCT01278446|Sequestering Agents|sequestering agents|mesh-ancestor
153357016|NCT01278446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153357017|NCT02339558|Nivolumab|nivolumab|mesh-list
153357018|NCT02339558|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153357019|NCT02339558|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153357020|NCT02339558|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153728451|NCT00498979|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153728452|NCT00498979|Antiviral Agents|antiviral agents|mesh-ancestor
153728496|NCT00499018|Cyclophosphamide|cyclophosphamide|mesh-list
153728497|NCT00499018|Vincristine|vincristine|mesh-list
153728498|NCT00499018|Doxorubicin|doxorubicin|mesh-list
153728499|NCT00499018|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
153728500|NCT00499018|Lenograstim|lenograstim|mesh-list
153728501|NCT00499018|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153728503|NCT00499018|Immunologic Factors|immunologic factors|mesh-ancestor
153728504|NCT00499018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153728505|NCT00499018|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153917128|NCT02684305|Oxytocin|oxytocin|mesh-list
153728506|NCT00499018|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153728508|NCT00499018|Hormones|hormones|mesh-ancestor
153728509|NCT00499018|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153728510|NCT00499018|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153728511|NCT00499018|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153728512|NCT00499018|Antimetabolites|antimetabolites|mesh-ancestor
153728513|NCT00499018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153728514|NCT00499018|Antiviral Agents|antiviral agents|mesh-ancestor
153728515|NCT00499018|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153728516|NCT00499018|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153728517|NCT00499018|Analgesics|analgesics|mesh-ancestor
153728547|NCT00127985|Autonomic Agents|autonomic agents|mesh-ancestor
153728548|NCT00127985|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153728549|NCT00127985|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153728550|NCT00127985|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
153921962|NCT05564377|Leucovorin|leucovorin|mesh-list
153728551|NCT00127985|Protective Agents|protective agents|mesh-ancestor
153728552|NCT00424164|Tamoxifen|tamoxifen|mesh-list
153728553|NCT00424164|Lapatinib|lapatinib|mesh-list
153728554|NCT00424164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153357167|NCT01275170|Midazolam|midazolam|mesh-list
153728561|NCT00424164|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
153728562|NCT00424164|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
153728563|NCT00424164|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153357869|NCT01214057|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153357870|NCT01214057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153357871|NCT01214057|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153357872|NCT01214057|Anesthetics, General|anesthetics, general|mesh-ancestor
153357873|NCT01214057|Anesthetics|anesthetics|mesh-ancestor
153357874|NCT01214057|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153357875|NCT01214057|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
153357876|NCT01214057|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153728564|NCT00424164|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153728565|NCT00424164|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153728566|NCT00424164|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153728568|NCT00499135|Sunitinib|sunitinib|mesh-list
153728569|NCT00499135|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153728570|NCT00499135|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153728571|NCT00499135|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153728572|NCT00499135|Growth Substances|growth substances|mesh-ancestor
153728573|NCT00499135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153728574|NCT00499135|Growth Inhibitors|growth inhibitors|mesh-ancestor
153728575|NCT00499135|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153728576|NCT00499135|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153728577|NCT00499135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153728578|NCT00499135|Antiviral Agents|antiviral agents|mesh-ancestor
153728579|NCT00499135|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153728580|NCT01245361|Infliximab|infliximab|mesh-list
153728581|NCT01245361|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
153728582|NCT01245361|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153728583|NCT01245361|Dermatologic Agents|dermatologic agents|mesh-ancestor
153728584|NCT01245361|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153728585|NCT01245361|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153728586|NCT00424203|Cyclophosphamide|cyclophosphamide|mesh-list
153728587|NCT00424203|Doxorubicin|doxorubicin|mesh-list
153728588|NCT00424203|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
153728589|NCT00424203|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153728590|NCT00424203|Immunologic Factors|immunologic factors|mesh-ancestor
153728591|NCT00424203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153728592|NCT00424203|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153728593|NCT00424203|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153728594|NCT00424203|Alkylating Agents|alkylating agents|mesh-ancestor
153728595|NCT00424203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153728596|NCT00424203|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153728597|NCT00424203|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153728598|NCT00424203|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153728599|NCT00424203|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153728600|NCT00424203|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153358037|NCT03805178|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153358038|NCT03805178|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153728601|NCT00424203|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153728602|NCT01245556|Ipilimumab|ipilimumab|mesh-list
153728603|NCT01245556|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153728604|NCT01245556|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153728605|NCT01245556|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153728606|NCT01245556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153728607|NCT00499525|Paclitaxel|paclitaxel|mesh-list
153728608|NCT00499525|Sorafenib|sorafenib|mesh-list
153358079|NCT03804866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153358080|NCT01251575|Cyclosporine|cyclosporine|mesh-list
153358081|NCT01251575|Sirolimus|sirolimus|mesh-list
153358082|NCT01251575|Mycophenolic Acid|mycophenolic acid|mesh-list
153358083|NCT01251575|Fludarabine|fludarabine|mesh-list
153358084|NCT01251575|Fludarabine phosphate|fludarabine phosphate|mesh-list
153358085|NCT01251575|Cyclosporins|cyclosporins|mesh-list
153358086|NCT01251575|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153358087|NCT01251575|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153358088|NCT01251575|Antimetabolites|antimetabolites|mesh-ancestor
153358089|NCT01251575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153358090|NCT01251575|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153358091|NCT01251575|Immunologic Factors|immunologic factors|mesh-ancestor
153358120|NCT01306175|Digoxin|digoxin|mesh-list
153728629|NCT00499837|Protein C Inhibitor|protein c inhibitor|mesh-list
153728630|NCT00499837|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
153728631|NCT00499837|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
153728632|NCT00499837|Protease Inhibitors|protease inhibitors|mesh-ancestor
153728633|NCT00499837|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153728634|NCT00499837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153358121|NCT01306175|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153728636|NCT00499876|Antimalarials|antimalarials|mesh-ancestor
153728637|NCT00499876|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153728638|NCT00499876|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153728639|NCT00499876|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153728640|NCT00146718|Pyrimethamine|pyrimethamine|mesh-list
153728641|NCT00146718|Sulfadoxine|sulfadoxine|mesh-list
153728642|NCT00146718|Amodiaquine|amodiaquine|mesh-list
153728643|NCT00146718|Antimalarials|antimalarials|mesh-ancestor
153728644|NCT00146718|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153728645|NCT00146718|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153728646|NCT00146718|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153728647|NCT00146718|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153728648|NCT00146718|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153358153|NCT01216397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153728649|NCT00146718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153728651|NCT00499993|Lanreotide|lanreotide|mesh-list
153728674|NCT04710914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153728676|NCT00500344|Ranibizumab|ranibizumab|mesh-list
153728677|NCT00500344|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153728678|NCT00500344|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153728679|NCT00500344|Growth Substances|growth substances|mesh-ancestor
153358195|NCT00783614|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153358196|NCT00783614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153358197|NCT00783614|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153358198|NCT00783614|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153358199|NCT00783614|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153358201|NCT00783614|Antiviral Agents|antiviral agents|mesh-ancestor
153358202|NCT00783614|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153358203|NCT01252745|Methyltestosterone|methyltestosterone|mesh-list
153358204|NCT01252745|Testosterone|testosterone|mesh-list
153358205|NCT01252745|Testosterone undecanoate|testosterone undecanoate|mesh-list
153783462|NCT04547335|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153358206|NCT01252745|Testosterone enanthate|testosterone enanthate|mesh-list
153358207|NCT01252745|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
153358208|NCT01252745|Androgens|androgens|mesh-ancestor
153358209|NCT01252745|Hormones|hormones|mesh-ancestor
153728680|NCT00500344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153728681|NCT00500344|Growth Inhibitors|growth inhibitors|mesh-ancestor
153728682|NCT00500344|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153728683|NCT00146835|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
153728684|NCT00146835|Immunologic Factors|immunologic factors|mesh-ancestor
153728685|NCT00146835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153728688|NCT01245868|Anesthetics, Local|anesthetics, local|mesh-ancestor
153728689|NCT01245868|Anesthetics|anesthetics|mesh-ancestor
153728690|NCT01245868|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153728691|NCT01245868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153728692|NCT01245868|Sensory System Agents|sensory system agents|mesh-ancestor
153728693|NCT01245868|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153728694|NCT01245868|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153728695|NCT01245868|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
153728725|NCT01245946|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153728726|NCT01245946|Dermatologic Agents|dermatologic agents|mesh-ancestor
153728727|NCT00146913|Interferons|interferons|mesh-list
153728728|NCT00146913|Imatinib Mesylate|imatinib mesylate|mesh-list
153728729|NCT00146913|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153728730|NCT00146913|Antiviral Agents|antiviral agents|mesh-ancestor
153728731|NCT00146913|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153728739|NCT00501241|ATI 7505|ati 7505|mesh-list
153358309|NCT00769886|Adrenergic Agents|adrenergic agents|mesh-ancestor
153358310|NCT00769886|Nasal Decongestants|nasal decongestants|mesh-ancestor
153358311|NCT00769886|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
153358312|NCT00769886|Respiratory System Agents|respiratory system agents|mesh-ancestor
153358313|NCT00794144|Olopatadine Hydrochloride|olopatadine hydrochloride|mesh-list
153358314|NCT00794144|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153728740|NCT00501241|Serotonin 5-HT4 Receptor Agonists|serotonin 5-ht4 receptor agonists|mesh-ancestor
153728741|NCT00501241|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
153728743|NCT00501241|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153728744|NCT00501241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153358331|NCT01309451|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153728745|NCT00501241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153728746|NCT01246180|Diclofenac|diclofenac|mesh-list
153358332|NCT01309451|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153783480|NCT00236288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153783481|NCT00236288|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
153783482|NCT00236288|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153783483|NCT00236288|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153783484|NCT04547296|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
153783486|NCT00236327|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153783487|NCT00236327|Narcotics|narcotics|mesh-ancestor
153728754|NCT01246180|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153728768|NCT05561972|Immunologic Factors|immunologic factors|mesh-ancestor
153728769|NCT05561972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153728770|NCT05561972|Viscosupplements|viscosupplements|mesh-ancestor
153728771|NCT05561972|Protective Agents|protective agents|mesh-ancestor
153728773|NCT02274610|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153728774|NCT02274610|Tubulin Modulators|tubulin modulators|mesh-ancestor
153728775|NCT02274610|Antimitotic Agents|antimitotic agents|mesh-ancestor
153728776|NCT02274610|Mitosis Modulators|mitosis modulators|mesh-ancestor
153728777|NCT02274610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153728778|NCT00501397|Ketoconazole|ketoconazole|mesh-list
153728779|NCT00501397|Antifungal Agents|antifungal agents|mesh-ancestor
153728780|NCT00501397|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153728781|NCT00501397|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
153728782|NCT00501397|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153728783|NCT00501397|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153358432|NCT01339091|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153728784|NCT00501397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153728785|NCT00501397|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153728786|NCT00501397|Hormone Antagonists|hormone antagonists|mesh-ancestor
153728787|NCT00501397|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153728788|NCT00501397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153728789|NCT00501397|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
153728790|NCT00501514|Hormones|hormones|mesh-list
153358433|NCT01339091|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153358434|NCT01339091|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
153358435|NCT01339091|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153358436|NCT01339091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153358437|NCT01339247|Halofantrine|halofantrine|mesh-list
153358438|NCT01339247|Paroxetine|paroxetine|mesh-list
153358439|NCT01339247|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
153358440|NCT01339247|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153358456|NCT00772772|Vitamin D|vitamin d|mesh-list
153728792|NCT00501514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153728793|NCT00147186|Hylan|hylan|mesh-list
153728794|NCT00147186|Viscosupplements|viscosupplements|mesh-ancestor
153728795|NCT00147186|Protective Agents|protective agents|mesh-ancestor
153728796|NCT00147186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153728797|NCT00501748|Rituximab|rituximab|mesh-list
153728798|NCT00501748|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153728799|NCT00501748|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153728800|NCT00501748|Immunologic Factors|immunologic factors|mesh-ancestor
153728801|NCT00501748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153728805|NCT00501787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153728806|NCT00147264|Telmisartan|telmisartan|mesh-list
153728807|NCT00147264|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153728808|NCT00147264|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
153728809|NCT00147264|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
153728810|NCT00147264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153728811|NCT00501904|Metformin|metformin|mesh-list
153728812|NCT00501904|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153728813|NCT00501904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153728814|NCT00501982|Poractant alfa|poractant alfa|mesh-list
153728815|NCT00501982|Pulmonary Surfactants|pulmonary surfactants|mesh-ancestor
153728816|NCT00501982|Respiratory System Agents|respiratory system agents|mesh-ancestor
153728817|NCT00147303|Sarpogrelate|sarpogrelate|mesh-list
153728818|NCT00147303|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153728819|NCT00147303|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153728820|NCT00147303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153728821|NCT00147303|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153728822|NCT00147303|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153728823|NCT00147303|Serotonin Agents|serotonin agents|mesh-ancestor
153922051|NCT05371054|Prednisone|prednisone|mesh-list
153728825|NCT00147303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153728826|NCT00502060|Cediranib|cediranib|mesh-list
153728827|NCT00502060|Gefitinib|gefitinib|mesh-list
153728828|NCT00502060|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153728855|NCT00502294|Immunologic Factors|immunologic factors|mesh-ancestor
153344004|NCT00003754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153728856|NCT00502294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153728857|NCT00502411|Doxorubicin|doxorubicin|mesh-list
153358607|NCT00789776|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153358608|NCT00789776|Alkylating Agents|alkylating agents|mesh-ancestor
153358609|NCT00789776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153358610|NCT00789776|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153728858|NCT00502411|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
153728859|NCT00502411|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153728860|NCT00502411|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153728861|NCT00502411|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153728862|NCT00502411|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153728863|NCT00502411|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153728864|NCT00502411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153728865|NCT00502528|cyclo(Trp-Asp-Pro-Val-Leu)|cyclo(trp-asp-pro-val-leu)|mesh-list
153728878|NCT00147381|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153728880|NCT00502567|Docetaxel|docetaxel|mesh-list
153728881|NCT00502567|Fluorouracil|fluorouracil|mesh-list
153728882|NCT00502567|Oxaliplatin|oxaliplatin|mesh-list
153728883|NCT00502567|Irinotecan|irinotecan|mesh-list
153728884|NCT00502567|Pemetrexed|pemetrexed|mesh-list
153728901|NCT00502567|Protective Agents|protective agents|mesh-ancestor
153728902|NCT00502567|Vitamin B Complex|vitamin b complex|mesh-ancestor
153728903|NCT00502567|Vitamins|vitamins|mesh-ancestor
153728904|NCT00502567|Micronutrients|micronutrients|mesh-ancestor
153358701|NCT01342523|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153358702|NCT01342523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153358703|NCT01342523|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
153358704|NCT01342523|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
153358705|NCT01342523|Cholinergic Agents|cholinergic agents|mesh-ancestor
153358706|NCT01342523|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153358707|NCT01342523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153358708|NCT01342757|Temozolomide|temozolomide|mesh-list
153358709|NCT01342757|Vorinostat|vorinostat|mesh-list
153358710|NCT01342757|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153358711|NCT01342757|Alkylating Agents|alkylating agents|mesh-ancestor
153358712|NCT01342757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153358713|NCT01342757|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153728908|NCT00502567|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153728909|NCT05561231|Pyrithione zinc|pyrithione zinc|mesh-list
153728910|NCT05561231|Keratolytic Agents|keratolytic agents|mesh-ancestor
153728911|NCT05561231|Dermatologic Agents|dermatologic agents|mesh-ancestor
153728912|NCT00502684|Etodolac|etodolac|mesh-list
153728913|NCT00502684|Propranolol|propranolol|mesh-list
153728914|NCT00502684|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
153728915|NCT00502684|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
153358740|NCT02199743|Serotonin Agents|serotonin agents|mesh-ancestor
153358741|NCT02199743|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
153358742|NCT00776594|Bevacizumab|bevacizumab|mesh-list
153358743|NCT00776594|Bicalutamide|bicalutamide|mesh-list
153358744|NCT00776594|Androgens|androgens|mesh-list
153358745|NCT00776594|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153358746|NCT00776594|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153358747|NCT00776594|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153358748|NCT00776594|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153358749|NCT00776594|Growth Substances|growth substances|mesh-ancestor
153358750|NCT00776594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153358751|NCT00776594|Growth Inhibitors|growth inhibitors|mesh-ancestor
153358752|NCT00776594|Hormones|hormones|mesh-ancestor
153358753|NCT00776594|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153358754|NCT00776594|Androgen Antagonists|androgen antagonists|mesh-ancestor
153358755|NCT00776594|Hormone Antagonists|hormone antagonists|mesh-ancestor
153358756|NCT00777062|Naltrexone|naltrexone|mesh-list
153358757|NCT00777062|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
153783494|NCT00236327|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153728916|NCT00502684|Adrenergic Agents|adrenergic agents|mesh-ancestor
153728917|NCT00502684|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153728918|NCT00502684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153728919|NCT00502684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153728921|NCT00502684|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153728922|NCT00502684|Vasodilator Agents|vasodilator agents|mesh-ancestor
153728923|NCT00502684|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153728924|NCT00502684|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153783500|NCT00236366|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153783501|NCT00236366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153783502|NCT00236366|Analgesics|analgesics|mesh-ancestor
153783503|NCT00236366|Sensory System Agents|sensory system agents|mesh-ancestor
153783504|NCT00236366|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153783505|NCT00236366|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153728945|NCT00502879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153728958|NCT00503152|Protease Inhibitors|protease inhibitors|mesh-ancestor
153728959|NCT00503152|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153728960|NCT00503347|Bavituximab|bavituximab|mesh-list
153728961|NCT00503347|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153358821|NCT06214468|Antimetabolites|antimetabolites|mesh-ancestor
153358859|NCT06214078|Niacin|niacin|mesh-list
153728964|NCT00503386|Granisetron|granisetron|mesh-list
153728965|NCT00503386|Antiemetics|antiemetics|mesh-ancestor
153728966|NCT00503386|Autonomic Agents|autonomic agents|mesh-ancestor
153728967|NCT00503386|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153728968|NCT00503386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153728969|NCT00503386|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153728970|NCT00503386|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
153358905|NCT06213935|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
153358906|NCT06213935|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
153358907|NCT06213857|Silymarin|silymarin|mesh-list
153358908|NCT06213857|Antioxidants|antioxidants|mesh-ancestor
153358909|NCT06213857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153358910|NCT06213857|Protective Agents|protective agents|mesh-ancestor
153358911|NCT06213857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153358912|NCT06213727|Ophthalmic Solutions|ophthalmic solutions|mesh-list
153344161|NCT00004042|Immunologic Factors|immunologic factors|mesh-ancestor
153358913|NCT06213727|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
153358914|NCT06213662|Botulinum Toxins|botulinum toxins|mesh-list
153728971|NCT00503386|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153728972|NCT00503386|Serotonin Agents|serotonin agents|mesh-ancestor
153728983|NCT00503503|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153728984|NCT00503503|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153728985|NCT00503503|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153728986|NCT00503503|Immunologic Factors|immunologic factors|mesh-ancestor
153728987|NCT00503542|Metronidazole|metronidazole|mesh-list
153728988|NCT00503542|Clindamycin|clindamycin|mesh-list
153728989|NCT00503542|Clindamycin palmitate|clindamycin palmitate|mesh-list
153728990|NCT00503542|Clindamycin phosphate|clindamycin phosphate|mesh-list
153728991|NCT00503542|Fluconazole|fluconazole|mesh-list
153728992|NCT00503542|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153728993|NCT00503542|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153358929|NCT06213610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153728999|NCT00503542|Antifungal Agents|antifungal agents|mesh-ancestor
153729000|NCT00503542|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
153729001|NCT00503542|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153729002|NCT00503542|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153358977|NCT06212973|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153358978|NCT06212973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153783511|NCT04547179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153358979|NCT06212973|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153358980|NCT06212973|Respiratory System Agents|respiratory system agents|mesh-ancestor
153358981|NCT06212973|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
153358983|NCT06212973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153358984|NCT06212973|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
153344247|NCT00384826|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153729004|NCT00503542|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153729006|NCT00503542|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
153729007|NCT00503542|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
153729008|NCT00147615|Eplerenone|eplerenone|mesh-list
153358999|NCT06212934|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153359000|NCT06212934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153359001|NCT06212830|Acetaminophen|acetaminophen|mesh-list
153359002|NCT06212830|Gabapentin|gabapentin|mesh-list
153359003|NCT06212830|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153359004|NCT06212830|Analgesics|analgesics|mesh-ancestor
153359005|NCT06212830|Sensory System Agents|sensory system agents|mesh-ancestor
153359006|NCT06212830|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153359007|NCT06212830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153359008|NCT06212830|Antipyretics|antipyretics|mesh-ancestor
153359009|NCT06212830|Anticonvulsants|anticonvulsants|mesh-ancestor
153359010|NCT06212830|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153359011|NCT06212830|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153359012|NCT06212830|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153359013|NCT06212830|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153359014|NCT06212830|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
153729009|NCT00147615|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
153729010|NCT00147615|Hormone Antagonists|hormone antagonists|mesh-ancestor
153729011|NCT00147615|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153729025|NCT01246804|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153729026|NCT01246804|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153729027|NCT01246804|Antiviral Agents|antiviral agents|mesh-ancestor
153729028|NCT01246804|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153729029|NCT01246804|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
153729030|NCT01246804|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
153729031|NCT01246804|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153729032|NCT01246804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153729033|NCT00147654|Tamsulosin|tamsulosin|mesh-list
153344267|NCT00003364|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153729034|NCT00147654|Tolterodine Tartrate|tolterodine tartrate|mesh-list
153729035|NCT00147654|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
153729036|NCT00147654|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
153729037|NCT00147654|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
153359074|NCT06209606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153359075|NCT06209606|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153359076|NCT06209606|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153359077|NCT06209606|Growth Substances|growth substances|mesh-ancestor
153359078|NCT06209606|Growth Inhibitors|growth inhibitors|mesh-ancestor
153359079|NCT06209606|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153783512|NCT04547179|Analgesics|analgesics|mesh-ancestor
153359080|NCT06209606|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153729038|NCT00147654|Adrenergic Agents|adrenergic agents|mesh-ancestor
153729039|NCT00147654|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153729040|NCT00147654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153729083|NCT00503620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153729084|NCT00503620|Cholinergic Agents|cholinergic agents|mesh-ancestor
153729085|NCT00503620|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153729086|NCT00503620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153729087|NCT00503620|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
153359111|NCT06200194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153359112|NCT06174688|Botulinum Toxins|botulinum toxins|mesh-list
153359113|NCT06174688|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
153359114|NCT06174688|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
153359115|NCT06174688|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
153359116|NCT06174688|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153359117|NCT06174688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153359118|NCT06174688|Cholinergic Agents|cholinergic agents|mesh-ancestor
153359119|NCT06174688|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153359125|NCT06108830|Propofol|propofol|mesh-list
153729089|NCT00503659|Methacholine Chloride|methacholine chloride|mesh-list
153729090|NCT00503659|Miotics|miotics|mesh-ancestor
153729091|NCT00503659|Autonomic Agents|autonomic agents|mesh-ancestor
153729092|NCT00503659|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153729093|NCT00503659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153729094|NCT00503659|Parasympathomimetics|parasympathomimetics|mesh-ancestor
153729095|NCT00503659|Bronchoconstrictor Agents|bronchoconstrictor agents|mesh-ancestor
153729096|NCT00503659|Respiratory System Agents|respiratory system agents|mesh-ancestor
153344305|NCT00004840|Hormones|hormones|mesh-list
153729097|NCT00503659|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
153729098|NCT00503659|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
153729099|NCT00503659|Cholinergic Agents|cholinergic agents|mesh-ancestor
153729100|NCT00503659|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153729101|NCT00503659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153729102|NCT04063163|Carboplatin|carboplatin|mesh-list
153729103|NCT04063163|Etoposide|etoposide|mesh-list
153729104|NCT04063163|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153729105|NCT04063163|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153729106|NCT04063163|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153729107|NCT04063163|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153729108|NCT04063163|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153729109|NCT04063163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153729110|NCT00503815|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
153729112|NCT00503815|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153359191|NCT05899465|Hemostatics|hemostatics|mesh-ancestor
153359192|NCT05899465|Coagulants|coagulants|mesh-ancestor
153359193|NCT05885074|Empagliflozin|empagliflozin|mesh-list
153359194|NCT05885074|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
153359195|NCT05885074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153359198|NCT05869591|Apixaban|apixaban|mesh-list
153729113|NCT01247077|Selenium|selenium|mesh-list
153729114|NCT01247077|Antioxidants|antioxidants|mesh-ancestor
153729115|NCT01247077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153729116|NCT01247077|Protective Agents|protective agents|mesh-ancestor
153729117|NCT01247077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153729121|NCT03990467|Piperacillin|piperacillin|mesh-list
153729122|NCT03990467|Amikacin|amikacin|mesh-list
153729123|NCT03990467|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153729124|NCT03990467|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153729125|NCT03990467|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
153729126|NCT03990467|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153729127|NCT03990467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153729128|NCT01247311|Vitamin D|vitamin d|mesh-list
153729129|NCT01247311|Ergocalciferols|ergocalciferols|mesh-list
153729130|NCT01247311|Cholecalciferol|cholecalciferol|mesh-list
153729131|NCT01247311|Vitamins|vitamins|mesh-list
153729132|NCT01247311|Micronutrients|micronutrients|mesh-ancestor
153359234|NCT05776524|Antimetabolites|antimetabolites|mesh-ancestor
153359235|NCT05747794|Paclitaxel|paclitaxel|mesh-list
153359236|NCT05747794|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153359237|NCT05747794|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153359239|NCT05747794|Antimitotic Agents|antimitotic agents|mesh-ancestor
153359240|NCT05747794|Mitosis Modulators|mitosis modulators|mesh-ancestor
153359241|NCT05747794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153359242|NCT05737693|Midazolam|midazolam|mesh-list
153359243|NCT05737693|Ketamine|ketamine|mesh-list
153359244|NCT05737693|Analgesics|analgesics|mesh-ancestor
153359245|NCT05737693|Sensory System Agents|sensory system agents|mesh-ancestor
153359246|NCT05737693|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153359247|NCT05737693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153359248|NCT05737693|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
153359249|NCT05737693|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153359250|NCT05737693|Anesthetics, General|anesthetics, general|mesh-ancestor
153359251|NCT05737693|Anesthetics|anesthetics|mesh-ancestor
153359252|NCT05737693|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153359253|NCT05737693|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
153359254|NCT05737693|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
153359255|NCT05737693|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153359256|NCT05737693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153359257|NCT05737693|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153421843|NCT05431595|Antimanic Agents|antimanic agents|mesh-ancestor
153421844|NCT05430152|Naltrexone|naltrexone|mesh-list
153421845|NCT05430152|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
153421846|NCT05430152|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
153421847|NCT05430152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153729143|NCT00147771|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153729144|NCT00147771|Interferon Inducers|interferon inducers|mesh-ancestor
153729146|NCT00503932|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153729148|NCT00503932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153729149|NCT00503932|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153729151|NCT03981146|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153729152|NCT03981146|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153729153|NCT03981146|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153729154|NCT03981146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153729161|NCT01247857|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153729162|NCT04331730|Aflibercept|aflibercept|mesh-list
153729163|NCT04331730|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153729164|NCT04331730|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153729165|NCT04331730|Growth Substances|growth substances|mesh-ancestor
153729166|NCT04331730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153729167|NCT04331730|Growth Inhibitors|growth inhibitors|mesh-ancestor
153729168|NCT04331730|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153729169|NCT01248091|Nitroprusside|nitroprusside|mesh-list
153359310|NCT05643651|Micronutrients|micronutrients|mesh-ancestor
153359311|NCT05643651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153359312|NCT05643651|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153359314|NCT05643651|Analgesics|analgesics|mesh-ancestor
153729172|NCT01248091|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
153729173|NCT01248091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153729174|NCT00503971|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
153729176|NCT00503971|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153729177|NCT00503971|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153729178|NCT00503971|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153359335|NCT05643651|Protease Inhibitors|protease inhibitors|mesh-ancestor
153359336|NCT05643651|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
153359338|NCT05643651|Coagulants|coagulants|mesh-ancestor
153359339|NCT05623319|Pembrolizumab|pembrolizumab|mesh-list
153359340|NCT05623319|Olaparib|olaparib|mesh-list
153359341|NCT05623319|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153359369|NCT05497557|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
153783525|NCT00236444|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153359370|NCT05497557|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153359371|NCT05497557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153359372|NCT05497557|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153359373|NCT05497557|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153359374|NCT05497557|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153359375|NCT05464966|Insulin|insulin|mesh-list
153359376|NCT05464966|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153729181|NCT00503971|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
153729182|NCT01248325|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
153729183|NCT02274961|Pantoprazole|pantoprazole|mesh-list
153729184|NCT02274961|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
153729185|NCT02274961|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153729186|NCT02274961|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
153729187|NCT02274961|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153729188|NCT02274961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153729189|NCT02275039|Gemcitabine|gemcitabine|mesh-list
153729191|NCT02275039|Immunologic Factors|immunologic factors|mesh-ancestor
153359400|NCT05400369|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
153359402|NCT05400369|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153359403|NCT05400369|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153359404|NCT05400369|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153359405|NCT05400369|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153359406|NCT05400369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153359407|NCT05400369|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153359408|NCT05400369|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
153359409|NCT05400369|Contraceptive Agents|contraceptive agents|mesh-ancestor
153359410|NCT05400369|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153359411|NCT05400369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153359412|NCT05400369|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
153359413|NCT05400369|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
153359414|NCT05400369|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
153359415|NCT05362760|Fulvestrant|fulvestrant|mesh-list
153359422|NCT05362760|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153359424|NCT05362760|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153359425|NCT05362760|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153359426|NCT05362760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153359427|NCT05356104|Exenatide|exenatide|mesh-list
153359428|NCT05356104|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
153359429|NCT05356104|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153729206|NCT01248403|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153729207|NCT01248403|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153729208|NCT01248403|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153729209|NCT01248403|Immunologic Factors|immunologic factors|mesh-ancestor
153729210|NCT01248403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153729211|NCT01248442|Cholecalciferol|cholecalciferol|mesh-list
153359434|NCT05356104|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153729212|NCT01248442|Vitamin D|vitamin d|mesh-list
153729213|NCT01248442|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153729214|NCT01248442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153729216|NCT01248442|Micronutrients|micronutrients|mesh-ancestor
153729217|NCT01248442|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153729219|NCT01248481|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
153729254|NCT00504127|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153729255|NCT00504127|Gout Suppressants|gout suppressants|mesh-ancestor
153729256|NCT00504127|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153729257|NCT00504127|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153729258|NCT00504127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153359498|NCT05079230|Venetoclax|venetoclax|mesh-list
153729259|NCT00504127|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
153729260|NCT00504205|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-list
153729261|NCT00504205|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153729262|NCT00504205|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153729263|NCT00504205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153729264|NCT01249690|Thalidomide|thalidomide|mesh-list
153729265|NCT01249690|Dexamethasone|dexamethasone|mesh-list
153729266|NCT01249690|Dexamethasone acetate|dexamethasone acetate|mesh-list
153729267|NCT01249690|Bortezomib|bortezomib|mesh-list
153729268|NCT01249690|Pirarubicin|pirarubicin|mesh-list
153359499|NCT05079230|Magrolimab|magrolimab|mesh-list
153359505|NCT05079230|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153359506|NCT05077904|Alprazolam|alprazolam|mesh-list
153359507|NCT05077904|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153359508|NCT05077904|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153359522|NCT05032235|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153359523|NCT05032235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153359524|NCT05032235|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153359525|NCT05028062|Naltrexone|naltrexone|mesh-list
153359526|NCT05028062|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
153359527|NCT05028062|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
153359528|NCT05028062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153344566|NCT00004900|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153344567|NCT00004900|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153359529|NCT05028062|Sensory System Agents|sensory system agents|mesh-ancestor
153359530|NCT05028062|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153359531|NCT05024032|Tirzepatide|tirzepatide|mesh-list
153359532|NCT05024032|Incretins|incretins|mesh-ancestor
153359533|NCT05024032|Hormones|hormones|mesh-ancestor
153359534|NCT05024032|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153359535|NCT05024032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153359536|NCT05004350|Fluorouracil|fluorouracil|mesh-list
153359537|NCT05004350|Irinotecan|irinotecan|mesh-list
153359571|NCT04858009|Antimitotic Agents|antimitotic agents|mesh-ancestor
153359572|NCT04858009|Mitosis Modulators|mitosis modulators|mesh-ancestor
153359573|NCT04858009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153359607|NCT04674254|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153359608|NCT04674254|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153359609|NCT04674254|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153359610|NCT04674254|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153729436|NCT04725942|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153729437|NCT04725942|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153729459|NCT03890952|Growth Inhibitors|growth inhibitors|mesh-ancestor
153729460|NCT03890952|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153729461|NCT03890952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153729462|NCT03868722|Venetoclax|venetoclax|mesh-list
153729463|NCT03868722|Acalabrutinib|acalabrutinib|mesh-list
153729464|NCT03868722|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153729465|NCT03868722|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153729466|NCT03868722|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153729467|NCT03868722|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153729468|NCT03868722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153729472|NCT00139152|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
153729473|NCT00139152|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153729474|NCT00139152|Respiratory System Agents|respiratory system agents|mesh-ancestor
153729475|NCT02824523|Aspirin|aspirin|mesh-list
153729476|NCT02824523|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153729477|NCT02824523|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153729510|NCT00139230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153471004|NCT00614484|Paclitaxel|paclitaxel|mesh-list
153729511|NCT00139230|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153729512|NCT00139230|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153729513|NCT00139230|Immunologic Factors|immunologic factors|mesh-ancestor
153729514|NCT00139230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153729515|NCT00139230|Antidotes|antidotes|mesh-ancestor
153729516|NCT00139230|Protective Agents|protective agents|mesh-ancestor
153729517|NCT00139230|Vitamin B Complex|vitamin b complex|mesh-ancestor
153729518|NCT00139230|Vitamins|vitamins|mesh-ancestor
153729519|NCT00139230|Micronutrients|micronutrients|mesh-ancestor
153729520|NCT00139230|Tubulin Modulators|tubulin modulators|mesh-ancestor
153729521|NCT00139230|Antimitotic Agents|antimitotic agents|mesh-ancestor
153729522|NCT00139230|Mitosis Modulators|mitosis modulators|mesh-ancestor
153729523|NCT00139230|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153729524|NCT00139230|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153729525|NCT00139230|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153729526|NCT00139230|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153729527|NCT00139230|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153729541|NCT00139269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153729544|NCT02065154|Immunologic Factors|immunologic factors|mesh-ancestor
153729545|NCT02065154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153729546|NCT02065154|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153729547|NCT02065154|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153729548|NCT02065154|Alkylating Agents|alkylating agents|mesh-ancestor
153729601|NCT00139581|Pimecrolimus|pimecrolimus|mesh-list
153729608|NCT00139581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153729609|NCT00139581|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153729618|NCT03500913|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153729620|NCT00139620|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
153729624|NCT00139620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153729625|NCT00139620|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153729627|NCT00130481|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153363921|NCT01574183|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153363922|NCT01574183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153363971|NCT01728818|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153363974|NCT01728974|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153363975|NCT01728974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153363976|NCT03407300|Docetaxel|docetaxel|mesh-list
153363977|NCT03407300|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153363978|NCT03407300|Tubulin Modulators|tubulin modulators|mesh-ancestor
153363979|NCT03407300|Antimitotic Agents|antimitotic agents|mesh-ancestor
153363980|NCT03407300|Mitosis Modulators|mitosis modulators|mesh-ancestor
153363982|NCT01722968|Paclitaxel|paclitaxel|mesh-list
153363996|NCT04379180|Bosentan|bosentan|mesh-list
153729628|NCT00130481|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153729629|NCT00130481|Antimetabolites|antimetabolites|mesh-ancestor
153729630|NCT00130481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153729631|NCT00130481|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153729632|NCT00130481|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
153729633|NCT00130481|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153729635|NCT00139698|Olmesartan|olmesartan|mesh-list
153729636|NCT00139698|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153729637|NCT00139698|Diuretics|diuretics|mesh-ancestor
153729638|NCT00139698|Natriuretic Agents|natriuretic agents|mesh-ancestor
153729639|NCT00139698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153729640|NCT00139698|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
153729641|NCT00139698|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153922284|NCT05053971|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153729642|NCT00139698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153729643|NCT00139698|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
153729644|NCT00139698|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
153729646|NCT00130676|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
153729647|NCT00130676|Abortifacient Agents|abortifacient agents|mesh-ancestor
153729649|NCT00130676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153729650|NCT00130676|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
153729651|NCT00130676|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
153729652|NCT00130676|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
153729653|NCT00130676|Contraceptive Agents|contraceptive agents|mesh-ancestor
153729654|NCT00130676|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
153729655|NCT00130676|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
153729656|NCT00130676|Hormone Antagonists|hormone antagonists|mesh-ancestor
153366791|NCT02447718|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
153366792|NCT02447718|Immunologic Factors|immunologic factors|mesh-ancestor
153366793|NCT02447718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153366794|NCT03016442|Dinoprostone|dinoprostone|mesh-list
153366795|NCT03016442|Oxytocics|oxytocics|mesh-ancestor
153366796|NCT03016442|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153366797|NCT03016442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153344691|NCT05776212|Protective Agents|protective agents|mesh-ancestor
153366832|NCT00964496|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153366833|NCT00964496|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153366834|NCT00964496|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153366835|NCT00964496|Growth Substances|growth substances|mesh-ancestor
153366836|NCT00964496|Growth Inhibitors|growth inhibitors|mesh-ancestor
153366837|NCT00964496|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153367050|NCT00974480|Dermatologic Agents|dermatologic agents|mesh-ancestor
153367051|NCT00975650|Testosterone|testosterone|mesh-list
153367052|NCT00975650|Androgens|androgens|mesh-ancestor
153367085|NCT03018236|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
153367086|NCT03018236|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153367088|NCT03018236|Dopamine Agents|dopamine agents|mesh-ancestor
153729657|NCT00130676|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153729658|NCT00130676|Luteolytic Agents|luteolytic agents|mesh-ancestor
153729659|NCT00130676|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
153729660|NCT00130676|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
153729661|NCT00404274|Casopitant|casopitant|mesh-list
153729662|NCT00404274|Warfarin|warfarin|mesh-list
153783863|NCT02214979|Ramipril|ramipril|mesh-list
153783864|NCT02214979|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153783865|NCT02214979|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
153783866|NCT02214979|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
153783867|NCT02214979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153783868|NCT02214979|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
153783870|NCT02214979|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153783871|NCT00237341|Fentanyl|fentanyl|mesh-list
153783872|NCT00237341|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153783873|NCT00237341|Narcotics|narcotics|mesh-ancestor
153783874|NCT00237341|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153783875|NCT00237341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153783876|NCT00237341|Analgesics|analgesics|mesh-ancestor
153344733|NCT05775770|Insulin|insulin|mesh-list
153783877|NCT00237341|Sensory System Agents|sensory system agents|mesh-ancestor
153783878|NCT00237341|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153368621|NCT02557035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153368622|NCT02557035|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153368623|NCT02557035|Glucocorticoids|glucocorticoids|mesh-ancestor
153368625|NCT02557035|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153368626|NCT02557035|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153368627|NCT02557035|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153368628|NCT02557035|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
153368629|NCT02557035|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153368630|NCT02557035|Serotonin Agents|serotonin agents|mesh-ancestor
153368631|NCT02557035|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153368632|NCT02557035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153368633|NCT04341207|Azithromycin|azithromycin|mesh-list
153783926|NCT00237536|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153783927|NCT00237536|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153783928|NCT02215720|Sirolimus|sirolimus|mesh-list
153783929|NCT02215720|Cetuximab|cetuximab|mesh-list
153783930|NCT02215720|Temsirolimus|temsirolimus|mesh-list
153783931|NCT02215720|MTOR Inhibitors|mtor inhibitors|mesh-list
153783932|NCT02215720|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153783934|NCT02215720|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153783935|NCT02215720|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153783956|NCT02215798|Antidepressive Agents|antidepressive agents|mesh-ancestor
153783957|NCT02215798|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153368635|NCT04341207|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153783958|NCT02215798|Dopamine Agents|dopamine agents|mesh-ancestor
153783959|NCT02215018|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
153783960|NCT02215057|Lidocaine|lidocaine|mesh-list
153783961|NCT02215057|Anesthetics|anesthetics|mesh-list
153783962|NCT02215057|Anesthetics, Local|anesthetics, local|mesh-ancestor
153783963|NCT02215057|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153783964|NCT02215057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153783965|NCT02215057|Sensory System Agents|sensory system agents|mesh-ancestor
153783966|NCT02215057|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153783968|NCT02215057|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
153783970|NCT02215057|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153783971|NCT02215057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153783972|NCT00269685|Vasopressins|vasopressins|mesh-list
153783973|NCT00269685|Arginine Vasopressin|arginine vasopressin|mesh-list
153783974|NCT00269685|Hemostatics|hemostatics|mesh-ancestor
153783975|NCT00269685|Coagulants|coagulants|mesh-ancestor
153368943|NCT02410278|Dimethyl Fumarate|dimethyl fumarate|mesh-list
153368944|NCT02410278|Montelukast|montelukast|mesh-list
153368945|NCT02410278|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153368946|NCT02410278|Respiratory System Agents|respiratory system agents|mesh-ancestor
153368947|NCT02410278|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
153368948|NCT02410278|Hormone Antagonists|hormone antagonists|mesh-ancestor
153368949|NCT02410278|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153368950|NCT02410278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153368951|NCT02410278|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
153368952|NCT02410278|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
153368953|NCT02410278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153368955|NCT02410278|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153368956|NCT02410278|Immunologic Factors|immunologic factors|mesh-ancestor
153368957|NCT01181258|Methylprednisolone|methylprednisolone|mesh-list
153368958|NCT01181258|Cyclophosphamide|cyclophosphamide|mesh-list
153368959|NCT01181258|Rituximab|rituximab|mesh-list
153368960|NCT01181258|Fludarabine|fludarabine|mesh-list
153368961|NCT01181258|Interleukin-2|interleukin-2|mesh-list
153368962|NCT01181258|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153783976|NCT00269685|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
153783978|NCT00269685|Natriuretic Agents|natriuretic agents|mesh-ancestor
153784007|NCT00269724|Cholinergic Agents|cholinergic agents|mesh-ancestor
153784008|NCT00269724|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153784009|NCT00269724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153784016|NCT04710017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153784017|NCT04710017|Hemostatics|hemostatics|mesh-ancestor
153784018|NCT04710017|Coagulants|coagulants|mesh-ancestor
153784019|NCT04710017|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
153784020|NCT04710017|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
153784021|NCT04710017|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
153369534|NCT04366713|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153369536|NCT04366713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153369537|NCT04366713|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153369538|NCT04366713|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153369539|NCT04366713|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153369540|NCT04366713|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153369541|NCT04366713|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153784023|NCT04710017|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153784024|NCT04710017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153784025|NCT04710017|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
153784026|NCT04710017|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
153784027|NCT04710017|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
153784028|NCT04710017|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153784029|NCT04710017|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153784031|NCT04538521|Nicotinic Acids|nicotinic acids|mesh-list
153784032|NCT04538521|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153369851|NCT05418361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153370099|NCT03524937|Protective Agents|protective agents|mesh-ancestor
153370100|NCT03524937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153370101|NCT03524937|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153370102|NCT03505710|Trastuzumab|trastuzumab|mesh-list
153370103|NCT03505710|Trastuzumab deruxtecan|trastuzumab deruxtecan|mesh-list
153784034|NCT04538521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153784036|NCT04538521|Vasodilator Agents|vasodilator agents|mesh-ancestor
153784037|NCT04538521|Vitamin B Complex|vitamin b complex|mesh-ancestor
153784048|NCT00269763|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153784049|NCT00269763|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153784050|NCT00269763|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153784051|NCT00269763|Anesthetics, General|anesthetics, general|mesh-ancestor
153784052|NCT00269763|Anesthetics|anesthetics|mesh-ancestor
153784053|NCT00237575|Gemcitabine|gemcitabine|mesh-list
153784054|NCT00237575|Sargramostim|sargramostim|mesh-list
153784055|NCT00237575|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153370393|NCT05220813|Lidocaine|lidocaine|mesh-list
153370394|NCT05220813|Bupivacaine|bupivacaine|mesh-list
153344880|NCT05252598|Psilocybin|psilocybin|mesh-list
153370396|NCT05220813|Anesthetics|anesthetics|mesh-ancestor
153370397|NCT05220813|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153370398|NCT05220813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153370425|NCT01284296|Sensory System Agents|sensory system agents|mesh-ancestor
153370426|NCT01284296|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153370427|NCT01284296|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153370428|NCT01284296|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
153370429|NCT01284296|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153370430|NCT01284296|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153370431|NCT01284296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153370432|NCT01284296|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153370433|NCT01284296|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153370434|NCT01284296|Analgesics|analgesics|mesh-ancestor
153370435|NCT01284296|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153784062|NCT00269802|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
153784063|NCT00269802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153784064|NCT00269802|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
153784065|NCT00269802|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153784066|NCT00269802|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153784067|NCT00269802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153370438|NCT00364143|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
153370439|NCT00364143|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153370440|NCT00364143|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153370441|NCT00364143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153370442|NCT00364143|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153370553|NCT00365001|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
153370554|NCT00365001|Abortifacient Agents|abortifacient agents|mesh-ancestor
153370555|NCT00365001|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153370556|NCT00365001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153370557|NCT00365001|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153370558|NCT00365001|Antimetabolites|antimetabolites|mesh-ancestor
153370559|NCT00365001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153370602|NCT02377479|Letrozole|letrozole|mesh-list
153370603|NCT02377479|Clomiphene|clomiphene|mesh-list
153370604|NCT02377479|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153370605|NCT02377479|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
153370606|NCT02377479|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153370608|NCT02377479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153370676|NCT00003407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153370677|NCT00003407|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153784104|NCT00414128|Cyclophosphamide|cyclophosphamide|mesh-list
153784139|NCT00414245|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153784140|NCT00414245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153784142|NCT00269880|Abciximab|abciximab|mesh-list
153784143|NCT00269880|Anticoagulants|anticoagulants|mesh-ancestor
153784144|NCT00269880|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153784145|NCT00269880|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153371067|NCT02600715|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153371068|NCT02600715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153371069|NCT02600715|Analgesics|analgesics|mesh-ancestor
153371070|NCT02600715|Sensory System Agents|sensory system agents|mesh-ancestor
153371191|NCT01742117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153371192|NCT01742117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153371193|NCT02613897|Dapagliflozin|dapagliflozin|mesh-list
153784151|NCT00269958|Epoetin Alfa|epoetin alfa|mesh-list
153784152|NCT00269958|Hematinics|hematinics|mesh-ancestor
153784153|NCT02215876|Cyclophosphamide|cyclophosphamide|mesh-list
153784154|NCT02215876|Doxorubicin|doxorubicin|mesh-list
153371306|NCT01246076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153784155|NCT02215876|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153784156|NCT02215876|Immunologic Factors|immunologic factors|mesh-ancestor
153784157|NCT02215876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153784158|NCT02215876|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153784159|NCT02215876|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153784160|NCT02215876|Alkylating Agents|alkylating agents|mesh-ancestor
153784161|NCT02215876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153784162|NCT02215876|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153784163|NCT02215876|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153784164|NCT02215876|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153784165|NCT02215876|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153784166|NCT02215876|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153371382|NCT04425239|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
153371383|NCT04425239|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153371384|NCT04425239|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153371386|NCT04425239|Protective Agents|protective agents|mesh-ancestor
153371387|NCT04425239|Vitamin B Complex|vitamin b complex|mesh-ancestor
153371389|NCT04425239|Micronutrients|micronutrients|mesh-ancestor
153371390|NCT04425239|Hematinics|hematinics|mesh-ancestor
153371391|NCT04425239|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153371392|NCT01309802|Botulinum Toxins|botulinum toxins|mesh-list
153371420|NCT04379999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153371421|NCT04379999|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153371422|NCT04379999|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153371423|NCT04379999|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153371424|NCT04379999|Antipyretics|antipyretics|mesh-ancestor
153371425|NCT04379999|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153371426|NCT04379999|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153784183|NCT00262392|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153784184|NCT00262392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153784186|NCT04537780|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153784187|NCT04537780|Respiratory System Agents|respiratory system agents|mesh-ancestor
153784188|NCT04537780|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
153922358|NCT04934722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153922359|NCT04930094|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
153922360|NCT04930094|Immunologic Factors|immunologic factors|mesh-ancestor
153922361|NCT04930094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153784189|NCT04537780|Hormone Antagonists|hormone antagonists|mesh-ancestor
153784190|NCT04537780|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153784191|NCT04537780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153784192|NCT04537780|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
153784193|NCT04537780|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
153784194|NCT04537780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153784196|NCT00237887|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
153784197|NCT00237887|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153784198|NCT00237887|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153784199|NCT02215993|Ticagrelor|ticagrelor|mesh-list
153784200|NCT02215993|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
153784201|NCT02215993|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153784202|NCT02215993|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
153784203|NCT02215993|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
153784204|NCT02215993|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
153784205|NCT02215993|Purinergic Agents|purinergic agents|mesh-ancestor
153784206|NCT02215993|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153784207|NCT02215993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153371428|NCT04379999|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153371429|NCT04379999|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
153344984|NCT04041128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153784208|NCT02215993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153784209|NCT02216149|Capecitabine|capecitabine|mesh-list
153784227|NCT00238004|Vasodilator Agents|vasodilator agents|mesh-ancestor
153784228|NCT00262548|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
153784229|NCT00262548|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153784230|NCT00262548|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153784231|NCT00262548|Antimetabolites|antimetabolites|mesh-ancestor
153784232|NCT00262548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153784233|NCT00262548|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153784234|NCT00262548|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
153784235|NCT00262548|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153784236|NCT00238043|Epoetin Alfa|epoetin alfa|mesh-list
153784237|NCT00238043|Hematinics|hematinics|mesh-ancestor
153784238|NCT00415584|Cinacalcet|cinacalcet|mesh-list
153784239|NCT00415584|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153784240|NCT00415584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153784241|NCT00415584|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
153784242|NCT00415584|Hormone Antagonists|hormone antagonists|mesh-ancestor
153784243|NCT00415584|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153784244|NCT04536922|Aldesleukin|aldesleukin|mesh-list
153784245|NCT04536922|Cyclophosphamide|cyclophosphamide|mesh-list
153784246|NCT04536922|Pembrolizumab|pembrolizumab|mesh-list
153784247|NCT04536922|Fludarabine|fludarabine|mesh-list
153784248|NCT04536922|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153784249|NCT04536922|Immunologic Factors|immunologic factors|mesh-ancestor
153784250|NCT04536922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153922403|NCT04893785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153922404|NCT04893785|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153784251|NCT04536922|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153784252|NCT04536922|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153784253|NCT04536922|Alkylating Agents|alkylating agents|mesh-ancestor
153784254|NCT04536922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153784255|NCT04536922|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153371435|NCT03009422|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
153371436|NCT03009422|Anthelmintics|anthelmintics|mesh-ancestor
153371437|NCT05730621|Aspirin|aspirin|mesh-list
153371438|NCT05730621|Sarpogrelate|sarpogrelate|mesh-list
153372063|NCT01766219|Thioctic Acid|thioctic acid|mesh-list
153784276|NCT00238160|Fluorouracil|fluorouracil|mesh-list
153784277|NCT00238160|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153345033|NCT03493490|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153345036|NCT03493490|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153784278|NCT00238160|Antimetabolites|antimetabolites|mesh-ancestor
153784279|NCT00238160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153784280|NCT00238160|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153784281|NCT00238160|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153784282|NCT00238160|Immunologic Factors|immunologic factors|mesh-ancestor
153784283|NCT00238160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153784284|NCT00415701|Hydrocortisone|hydrocortisone|mesh-list
153784285|NCT00415701|Propofol|propofol|mesh-list
153784286|NCT00415701|Etomidate|etomidate|mesh-list
153784287|NCT00415701|Cosyntropin|cosyntropin|mesh-list
153784288|NCT00415701|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153784289|NCT00415701|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153784290|NCT00415701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153784291|NCT00415701|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153784292|NCT00415701|Anesthetics, General|anesthetics, general|mesh-ancestor
153784293|NCT00415701|Anesthetics|anesthetics|mesh-ancestor
153784294|NCT00415701|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153784295|NCT00415701|Hormones|hormones|mesh-ancestor
153784296|NCT00415701|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153784297|NCT02961998|Celecoxib|celecoxib|mesh-list
153784298|NCT02961998|Sorafenib|sorafenib|mesh-list
153784299|NCT02961998|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153784300|NCT02961998|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153784301|NCT02961998|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153784302|NCT02961998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153784303|NCT02961998|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153784304|NCT02961998|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153784305|NCT02961998|Analgesics|analgesics|mesh-ancestor
153784306|NCT02961998|Sensory System Agents|sensory system agents|mesh-ancestor
153784307|NCT02961998|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153784310|NCT02961998|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153784311|NCT02961998|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
153784312|NCT02961998|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153784313|NCT04536415|Oseltamivir|oseltamivir|mesh-list
153784314|NCT04536415|Antiviral Agents|antiviral agents|mesh-ancestor
153784315|NCT04536415|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153784316|NCT04536415|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153784317|NCT04536415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153784318|NCT00262587|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
153784319|NCT00262587|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153784320|NCT00262587|Autonomic Agents|autonomic agents|mesh-ancestor
153784321|NCT00262587|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153784322|NCT00262587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153784323|NCT00262587|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153784324|NCT00262587|Respiratory System Agents|respiratory system agents|mesh-ancestor
153784325|NCT00262587|Glucocorticoids|glucocorticoids|mesh-ancestor
153784326|NCT00262587|Hormones|hormones|mesh-ancestor
153784327|NCT00262587|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153784328|NCT00262587|Sympathomimetics|sympathomimetics|mesh-ancestor
153784329|NCT00238199|Calcitriol|calcitriol|mesh-list
153784330|NCT00238199|Docetaxel|docetaxel|mesh-list
153784331|NCT00238199|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153784332|NCT00238199|Tubulin Modulators|tubulin modulators|mesh-ancestor
153784333|NCT00238199|Antimitotic Agents|antimitotic agents|mesh-ancestor
153784334|NCT00238199|Mitosis Modulators|mitosis modulators|mesh-ancestor
153784335|NCT00238199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153784336|NCT00238199|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153784337|NCT00238199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153784338|NCT00238199|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
153784339|NCT00238199|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153784340|NCT00238199|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
153784341|NCT00238199|Vitamins|vitamins|mesh-ancestor
153784342|NCT00238199|Micronutrients|micronutrients|mesh-ancestor
153784351|NCT04536493|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153784352|NCT04536493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153784353|NCT04536493|Sensory System Agents|sensory system agents|mesh-ancestor
153784354|NCT04536493|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153784355|NCT04536493|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153784356|NCT04536493|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
153784357|NCT04536493|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153784358|NCT04536493|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153784359|NCT04536493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153784360|NCT04536493|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153922480|NCT04793646|Antioxidants|antioxidants|mesh-ancestor
153922492|NCT04786210|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153784361|NCT04536493|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153784362|NCT04536493|Adrenergic Agents|adrenergic agents|mesh-ancestor
153784363|NCT04536493|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153784364|NCT04536493|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
153784365|NCT04536493|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153784366|NCT04536493|Autonomic Agents|autonomic agents|mesh-ancestor
153784367|NCT04536493|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153784368|NCT04536493|Respiratory System Agents|respiratory system agents|mesh-ancestor
153784370|NCT04536493|Sympathomimetics|sympathomimetics|mesh-ancestor
153784371|NCT04536493|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
153784372|NCT04536181|Prednisone|prednisone|mesh-list
153784373|NCT04536181|Prednisolone|prednisolone|mesh-list
153784374|NCT04536181|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153784400|NCT02216227|Plasma Substitutes|plasma substitutes|mesh-ancestor
153784401|NCT02216227|Blood Substitutes|blood substitutes|mesh-ancestor
153784402|NCT02216227|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
153784403|NCT02216227|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153784404|NCT02216227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153784405|NCT00238277|Temozolomide|temozolomide|mesh-list
153784406|NCT00238277|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153784407|NCT00238277|Alkylating Agents|alkylating agents|mesh-ancestor
153784408|NCT00238277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153784409|NCT00238277|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153784410|NCT02216266|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
153784411|NCT02216266|Physostigmine|physostigmine|mesh-list
153784412|NCT02216266|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
153784413|NCT02216266|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153784414|NCT02216266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153784415|NCT02216266|Cholinergic Agents|cholinergic agents|mesh-ancestor
153784416|NCT02216266|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153784417|NCT02216266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153784418|NCT02216266|Miotics|miotics|mesh-ancestor
153784419|NCT02216266|Autonomic Agents|autonomic agents|mesh-ancestor
153784420|NCT02216266|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153784421|NCT00238316|Letrozole|letrozole|mesh-list
153784422|NCT00238316|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153784424|NCT00238316|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153784425|NCT00238316|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153784426|NCT00238316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153784445|NCT04535518|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153784446|NCT04535518|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153922493|NCT04786210|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153784447|NCT04535518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153784448|NCT04535518|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153784449|NCT04535518|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153784450|NCT04535518|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153784451|NCT04535518|Antipyretics|antipyretics|mesh-ancestor
153784452|NCT04535518|Immunologic Factors|immunologic factors|mesh-ancestor
153784453|NCT04535518|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
153784454|NCT04535518|Dermatologic Agents|dermatologic agents|mesh-ancestor
153784455|NCT04535518|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153784457|NCT02216383|Carbetocin|carbetocin|mesh-list
153784458|NCT02216383|Syntometrine|syntometrine|mesh-list
153784508|NCT00238667|Anticoagulants|anticoagulants|mesh-list
153784509|NCT00238667|Clopidogrel|clopidogrel|mesh-list
153784510|NCT00238667|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153784511|NCT00238667|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153784512|NCT00238667|Analgesics|analgesics|mesh-ancestor
153784513|NCT00238667|Sensory System Agents|sensory system agents|mesh-ancestor
153784514|NCT00238667|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153784515|NCT00238667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153784516|NCT00238667|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153784517|NCT00238667|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153784572|NCT00263094|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
153784573|NCT00263094|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153784574|NCT00263094|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153784575|NCT00263094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153784576|NCT00263094|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153345259|NCT00198978|Lenograstim|lenograstim|mesh-list
153784577|NCT00263094|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153784578|NCT00263094|Analgesics|analgesics|mesh-ancestor
153784579|NCT00263094|Sensory System Agents|sensory system agents|mesh-ancestor
153784580|NCT00263094|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153784581|NCT00263094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153784582|NCT00263094|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153784583|NCT00263094|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153784584|NCT00238784|Budesonide|budesonide|mesh-list
153784585|NCT00238784|Formoterol Fumarate|formoterol fumarate|mesh-list
153784586|NCT00238784|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153784587|NCT00238784|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153784588|NCT00238784|Autonomic Agents|autonomic agents|mesh-ancestor
153372131|NCT04351724|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
153784594|NCT00238784|Hormones|hormones|mesh-ancestor
153784595|NCT00238784|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153784596|NCT00238784|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
153784597|NCT00238784|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
153784598|NCT00238784|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153784599|NCT00238784|Adrenergic Agents|adrenergic agents|mesh-ancestor
153784600|NCT00238784|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153784601|NCT00238784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153784602|NCT00263133|Sertraline|sertraline|mesh-list
153784603|NCT00263133|Antidepressive Agents|antidepressive agents|mesh-ancestor
153784604|NCT00263133|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153784610|NCT00263133|Serotonin Agents|serotonin agents|mesh-ancestor
153784611|NCT00263133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153922524|NCT04752033|Morphine|morphine|mesh-list
153784613|NCT04533724|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153784614|NCT04533724|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153784615|NCT04533724|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153784616|NCT04533724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153784617|NCT04533724|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153784618|NCT04533724|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
153784619|NCT04533724|Dopamine Agents|dopamine agents|mesh-ancestor
153784620|NCT04533724|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153784621|NCT04533724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153784622|NCT04533724|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
153784623|NCT04533724|Antidepressive Agents|antidepressive agents|mesh-ancestor
153784624|NCT00238901|Basiliximab|basiliximab|mesh-list
153784625|NCT00238901|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153784626|NCT00238901|Immunologic Factors|immunologic factors|mesh-ancestor
153784627|NCT00238901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153784628|NCT00238940|Mycophenolic Acid|mycophenolic acid|mesh-list
153784629|NCT00238940|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153784630|NCT00238940|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153784631|NCT00238940|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
153784632|NCT00238940|Antitubercular Agents|antitubercular agents|mesh-ancestor
153784633|NCT00238940|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153784634|NCT00238940|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153784635|NCT00238940|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153784654|NCT00239018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153784655|NCT04532671|Ether|ether|mesh-list
153784656|NCT04532671|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
153784658|NCT04532671|Anesthetics|anesthetics|mesh-ancestor
153784659|NCT04532671|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153784660|NCT04532671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153784661|NCT00239057|Mycophenolic Acid|mycophenolic acid|mesh-list
153784662|NCT00239057|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153784663|NCT00239057|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153784664|NCT00239057|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
153784665|NCT00239057|Antitubercular Agents|antitubercular agents|mesh-ancestor
153784666|NCT00239057|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153784667|NCT00239057|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153784668|NCT00239057|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153345376|NCT00004162|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
153784669|NCT00239057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153784670|NCT00238082|Beclomethasone|beclomethasone|mesh-list
153784671|NCT00238082|Norflurane|norflurane|mesh-list
153784672|NCT00238082|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153784673|NCT00238082|Glucocorticoids|glucocorticoids|mesh-ancestor
153922537|NCT04742101|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153922538|NCT04742101|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153922539|NCT04730622|Mitogens|mitogens|mesh-list
153922540|NCT04730622|Mitosis Modulators|mitosis modulators|mesh-ancestor
153922541|NCT04730622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153922542|NCT04711252|Palbociclib|palbociclib|mesh-list
153922570|NCT04673942|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
153784675|NCT00238082|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153784676|NCT00238082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153784677|NCT00238082|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153784678|NCT00238082|Respiratory System Agents|respiratory system agents|mesh-ancestor
153784679|NCT00238082|Anesthetics|anesthetics|mesh-ancestor
153784680|NCT00238082|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153784681|NCT02217007|Calcium, Dietary|calcium, dietary|mesh-list
153784682|NCT02217007|Acamprosate|acamprosate|mesh-list
153784697|NCT05897372|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
153784698|NCT05897372|Protective Agents|protective agents|mesh-ancestor
153784699|NCT05897372|Vasodilator Agents|vasodilator agents|mesh-ancestor
153784700|NCT05897372|Free Radical Scavengers|free radical scavengers|mesh-ancestor
153784701|NCT05897372|Antioxidants|antioxidants|mesh-ancestor
153784702|NCT05897294|Voriconazole|voriconazole|mesh-list
153784703|NCT05897294|Antifungal Agents|antifungal agents|mesh-ancestor
153784704|NCT05897294|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153784705|NCT05897294|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
153784706|NCT05897294|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153784707|NCT05897294|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153784708|NCT05897294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153784709|NCT05897294|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153784710|NCT05897294|Hormone Antagonists|hormone antagonists|mesh-ancestor
153784711|NCT05897294|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153784712|NCT05897294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153784713|NCT05897294|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
153784752|NCT05896605|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153784753|NCT05896605|Immunologic Factors|immunologic factors|mesh-ancestor
153784754|NCT05896605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153784755|NCT05896605|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153784756|NCT05896553|Oxytocin|oxytocin|mesh-list
153784757|NCT05896553|Oxytocics|oxytocics|mesh-ancestor
153784758|NCT05896553|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153784759|NCT05896553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153784760|NCT05896462|Povidone-Iodine|povidone-iodine|mesh-list
153784761|NCT05896462|Povidone|povidone|mesh-list
153784762|NCT05896462|Plasma Substitutes|plasma substitutes|mesh-ancestor
153784763|NCT05896462|Blood Substitutes|blood substitutes|mesh-ancestor
153784764|NCT05896462|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
153784765|NCT05896462|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153784766|NCT05896449|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
153784767|NCT05896449|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
153345404|NCT00004984|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153345406|NCT00004174|Paclitaxel|paclitaxel|mesh-list
153784768|NCT05896449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153784769|NCT05896319|Hyaluronic Acid|hyaluronic acid|mesh-list
153784770|NCT05896319|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153784771|NCT05896319|Immunologic Factors|immunologic factors|mesh-ancestor
153784772|NCT05896319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153784773|NCT05896319|Viscosupplements|viscosupplements|mesh-ancestor
153784774|NCT05896319|Protective Agents|protective agents|mesh-ancestor
153784775|NCT05896059|Tislelizumab|tislelizumab|mesh-list
153784776|NCT05896059|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153784777|NCT05896059|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153784778|NCT05895942|Imatinib Mesylate|imatinib mesylate|mesh-list
153784779|NCT05895942|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153784780|NCT05895942|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153784781|NCT05895942|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153784782|NCT05895942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153784783|NCT05895942|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153784784|NCT05876715|Nivolumab|nivolumab|mesh-list
153471394|NCT05581797|Hallucinogens|hallucinogens|mesh-ancestor
153471395|NCT05581797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153471396|NCT05581797|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153922622|NCT04620382|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153922623|NCT04620382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153922624|NCT04620382|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
153922626|NCT04620382|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153784785|NCT05876715|Ipilimumab|ipilimumab|mesh-list
153784786|NCT05876715|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153784787|NCT05876715|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153784790|NCT05853120|Doxycycline|doxycycline|mesh-list
153784792|NCT05853120|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153784793|NCT05853120|Antimalarials|antimalarials|mesh-ancestor
153784794|NCT05853120|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153784795|NCT05853120|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153784797|NCT05841160|Ecopipam|ecopipam|mesh-list
153784798|NCT05841160|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153784799|NCT05841160|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153784800|NCT05841160|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153784801|NCT05841160|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153784802|NCT05841160|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153784803|NCT05841160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153784804|NCT05841160|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153784805|NCT05841160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153784806|NCT05841160|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153784807|NCT05841160|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153784808|NCT05841160|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153784809|NCT05841160|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153784810|NCT05841160|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
153784811|NCT05841160|Dopamine Agents|dopamine agents|mesh-ancestor
153784812|NCT05841160|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153784813|NCT05815758|Ketotifen|ketotifen|mesh-list
153784814|NCT05815758|Brimonidine Tartrate|brimonidine tartrate|mesh-list
153784815|NCT05815758|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
153784816|NCT05815758|Ophthalmic Solutions|ophthalmic solutions|mesh-list
153784817|NCT05815758|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153784818|NCT05815758|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
153784819|NCT05815758|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153784820|NCT05815758|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153784821|NCT05815758|Adrenergic Agents|adrenergic agents|mesh-ancestor
153784822|NCT05815758|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153784823|NCT05815758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153784824|NCT05815758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153784825|NCT05815758|Antipruritics|antipruritics|mesh-ancestor
153784828|NCT05815758|Histamine Antagonists|histamine antagonists|mesh-ancestor
153372454|NCT01779167|Leprostatic Agents|leprostatic agents|mesh-ancestor
153784830|NCT05815758|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
153784831|NCT05694533|Midazolam|midazolam|mesh-list
153784832|NCT05694533|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153784833|NCT05694533|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153922631|NCT04616560|Trastuzumab|trastuzumab|mesh-list
153784834|NCT05694533|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153784835|NCT05694533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153784836|NCT05694533|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153784837|NCT05694533|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153784838|NCT05694533|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153784839|NCT05694533|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153784840|NCT05694533|Anesthetics, General|anesthetics, general|mesh-ancestor
153784841|NCT05694533|Anesthetics|anesthetics|mesh-ancestor
153784842|NCT05694533|GABA Modulators|gaba modulators|mesh-ancestor
153784843|NCT05694533|GABA Agents|gaba agents|mesh-ancestor
153784844|NCT05694533|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153784845|NCT05694533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153784846|NCT05681390|Tislelizumab|tislelizumab|mesh-list
153784847|NCT05681390|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153784848|NCT05681390|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153784850|NCT05669547|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153784851|NCT05669547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153784852|NCT05669079|Decitabine|decitabine|mesh-list
153784853|NCT05669079|Epoetin Alfa|epoetin alfa|mesh-list
153784854|NCT05669079|Lenograstim|lenograstim|mesh-list
153784855|NCT05669079|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153784856|NCT05669079|Antimetabolites|antimetabolites|mesh-ancestor
153784857|NCT05669079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153784858|NCT05669079|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153784859|NCT05669079|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153784860|NCT05669079|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153784870|NCT05586373|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153784871|NCT05586373|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153784872|NCT05586373|Analgesics|analgesics|mesh-ancestor
153784873|NCT05586373|Sensory System Agents|sensory system agents|mesh-ancestor
153784874|NCT05586373|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153784875|NCT05586373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153784876|NCT05586373|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153784877|NCT05586373|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153784878|NCT05586373|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153784879|NCT05586373|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153784880|NCT05586373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153784881|NCT05586373|Antipyretics|antipyretics|mesh-ancestor
153784882|NCT05434546|Pregnanolone|pregnanolone|mesh-list
153784883|NCT05434546|Anesthetics|anesthetics|mesh-ancestor
153784884|NCT05434546|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153784885|NCT05434546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153784887|NCT05250791|Anesthetics, Local|anesthetics, local|mesh-ancestor
153784888|NCT05250791|Anesthetics|anesthetics|mesh-ancestor
153372545|NCT01786967|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
153784890|NCT05250791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153784919|NCT04933383|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153784920|NCT04933383|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153784921|NCT04933383|Autonomic Agents|autonomic agents|mesh-ancestor
153784922|NCT04933383|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153784923|NCT04933383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153784924|NCT04933383|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153784925|NCT04933383|Respiratory System Agents|respiratory system agents|mesh-ancestor
153784926|NCT04933383|Glucocorticoids|glucocorticoids|mesh-ancestor
153784927|NCT04933383|Hormones|hormones|mesh-ancestor
153784928|NCT04933383|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153784929|NCT04923776|Carboplatin|carboplatin|mesh-list
153784930|NCT04923776|Etoposide|etoposide|mesh-list
153784931|NCT04923776|Atezolizumab|atezolizumab|mesh-list
153784932|NCT04923776|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153784933|NCT04923776|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153784934|NCT04923776|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153784935|NCT04923776|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153784936|NCT04923776|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153784937|NCT04923776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153784938|NCT04923776|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153784939|NCT04923776|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153784940|NCT04582266|Remdesivir|remdesivir|mesh-list
153784941|NCT04582266|Antimetabolites|antimetabolites|mesh-ancestor
153784942|NCT04582266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153784943|NCT04582266|Antiviral Agents|antiviral agents|mesh-ancestor
153784944|NCT04582266|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153784945|NCT04528134|Listerine|listerine|mesh-list
153784946|NCT04528134|Fluorides|fluorides|mesh-list
153784947|NCT04528134|Sodium Fluoride|sodium fluoride|mesh-list
153784948|NCT04528134|Fluorides, Topical|fluorides, topical|mesh-list
153784949|NCT04528134|Cariostatic Agents|cariostatic agents|mesh-ancestor
153784950|NCT04528134|Protective Agents|protective agents|mesh-ancestor
153784951|NCT04528134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153784952|NCT04528134|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
153784953|NCT04528134|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153784954|NCT04521920|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
153922684|NCT04525014|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153785005|NCT04026958|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153785007|NCT03939182|Abexinostat|abexinostat|mesh-list
153785008|NCT03939182|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153785009|NCT03939182|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153785010|NCT03939182|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153785011|NCT03939182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153785012|NCT03939182|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
153785023|NCT03878589|Oxytocin|oxytocin|mesh-list
153785024|NCT03878589|Oxytocics|oxytocics|mesh-ancestor
153785025|NCT03878589|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153785026|NCT03878589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153785027|NCT03813836|Pembrolizumab|pembrolizumab|mesh-list
153785028|NCT03813836|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153785029|NCT03813836|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153785030|NCT03813836|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153785031|NCT03813836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153785032|NCT03730649|Sulforaphane|sulforaphane|mesh-list
153785033|NCT03730649|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
153785040|NCT03598426|Dexamethasone|dexamethasone|mesh-list
153785051|NCT03598426|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153785052|NCT03521037|Rucaparib|rucaparib|mesh-list
153922714|NCT04439253|Crizotinib|crizotinib|mesh-list
153785053|NCT03521037|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
153785054|NCT03521037|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153785055|NCT03521037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153785056|NCT03521037|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153785057|NCT03499444|Rucaparib|rucaparib|mesh-list
153785058|NCT03499444|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
153785059|NCT03499444|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153785060|NCT03499444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153785061|NCT03499444|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153785062|NCT03494322|Cetuximab|cetuximab|mesh-list
153785063|NCT03494322|Avelumab|avelumab|mesh-list
153785064|NCT03494322|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153785065|NCT03494322|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153785066|NCT03441633|Rivaroxaban|rivaroxaban|mesh-list
153785067|NCT03441633|Apixaban|apixaban|mesh-list
153785068|NCT03441633|Dabigatran|dabigatran|mesh-list
153785069|NCT03441633|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
153785070|NCT03441633|Antithrombins|antithrombins|mesh-ancestor
153785071|NCT03441633|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
153785072|NCT03441633|Protease Inhibitors|protease inhibitors|mesh-ancestor
153785073|NCT03441633|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153785074|NCT03441633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153785075|NCT03441633|Anticoagulants|anticoagulants|mesh-ancestor
153785076|NCT03397394|Rucaparib|rucaparib|mesh-list
153785101|NCT03053440|Ibrutinib|ibrutinib|mesh-list
153785102|NCT03053440|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153785103|NCT03053440|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153785104|NCT03053440|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153785105|NCT03053440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153785106|NCT03053440|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153785107|NCT02986100|Rucaparib|rucaparib|mesh-list
153785108|NCT02986100|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
153785109|NCT02986100|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153785110|NCT02986100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153785111|NCT02986100|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153785112|NCT02952534|Rucaparib|rucaparib|mesh-list
153785113|NCT02952534|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
153785114|NCT02952534|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153785115|NCT02952534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153785116|NCT02952534|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153785117|NCT02949934|Tolcapone|tolcapone|mesh-list
153785118|NCT02949934|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
153785119|NCT02949934|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
153785121|NCT02949934|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153785122|NCT02949934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153785123|NCT02935634|Nivolumab|nivolumab|mesh-list
153785124|NCT02935634|Ipilimumab|ipilimumab|mesh-list
153785125|NCT02935634|Relatlimab|relatlimab|mesh-list
153785126|NCT02935634|Rucaparib|rucaparib|mesh-list
153785152|NCT02740712|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153785153|NCT02740712|Anesthetics, General|anesthetics, general|mesh-ancestor
153785154|NCT02740712|Anesthetics|anesthetics|mesh-ancestor
153785155|NCT02740712|GABA Modulators|gaba modulators|mesh-ancestor
153785156|NCT02740712|GABA Agents|gaba agents|mesh-ancestor
153785157|NCT02740712|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153922751|NCT04438382|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153785158|NCT02740712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153785159|NCT02740712|Anticoagulants|anticoagulants|mesh-ancestor
153785160|NCT02740712|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
153785161|NCT02740712|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
153785162|NCT02740712|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153785163|NCT02740712|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
153785164|NCT02740712|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
153785165|NCT02740712|Purinergic Agents|purinergic agents|mesh-ancestor
153785166|NCT02740712|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
153785167|NCT02740712|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153785168|NCT02740712|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
153785169|NCT02740712|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153785170|NCT02740712|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
153785171|NCT02740712|Protective Agents|protective agents|mesh-ancestor
153785172|NCT02740712|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
153785173|NCT02740712|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153785174|NCT02740712|Hemostatics|hemostatics|mesh-ancestor
153785175|NCT02740712|Coagulants|coagulants|mesh-ancestor
153785176|NCT02740712|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
153785177|NCT02740712|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153785178|NCT02684578|Metformin|metformin|mesh-list
153785179|NCT02684578|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153785180|NCT02684578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153785181|NCT02580305|Memantine|memantine|mesh-list
153785182|NCT02580305|Donepezil|donepezil|mesh-list
153785183|NCT02580305|1-((2-bromophenyl)sulfonyl)-5-methoxy-3-((4-methyl-1-piperazinyl)methyl)-1H-indole dimesylate monohydrate|1-((2-bromophenyl)sulfonyl)-5-methoxy-3-((4-methyl-1-piperazinyl)methyl)-1h-indole dimesylate monohydrate|mesh-list
153785184|NCT02580305|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
153785185|NCT02580305|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153785189|NCT02580305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153785191|NCT02580305|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
153785193|NCT02580305|Dopamine Agents|dopamine agents|mesh-ancestor
153785194|NCT02580305|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
153785195|NCT02580305|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
153785196|NCT02580305|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153785197|NCT02580305|Serotonin Agents|serotonin agents|mesh-ancestor
153785198|NCT02279394|Dexamethasone|dexamethasone|mesh-list
153785199|NCT02279394|Lenalidomide|lenalidomide|mesh-list
153785200|NCT02279394|Elotuzumab|elotuzumab|mesh-list
153785201|NCT02279394|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153785202|NCT02279394|Antiemetics|antiemetics|mesh-ancestor
153785203|NCT02279394|Autonomic Agents|autonomic agents|mesh-ancestor
153785204|NCT02279394|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153785205|NCT02279394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153785206|NCT02279394|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153785207|NCT02279394|Glucocorticoids|glucocorticoids|mesh-ancestor
153785208|NCT02279394|Hormones|hormones|mesh-ancestor
153785209|NCT02279394|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153785210|NCT02279394|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153785211|NCT02279394|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153785212|NCT02279394|Immunologic Factors|immunologic factors|mesh-ancestor
153785213|NCT02279394|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153785214|NCT02279394|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153785215|NCT02279394|Growth Substances|growth substances|mesh-ancestor
153785216|NCT02279394|Growth Inhibitors|growth inhibitors|mesh-ancestor
153785217|NCT02229578|Lidocaine|lidocaine|mesh-list
153785218|NCT02229578|Anesthetics, Local|anesthetics, local|mesh-ancestor
153785219|NCT02229578|Anesthetics|anesthetics|mesh-ancestor
153785220|NCT02229578|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153785221|NCT02229578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153785222|NCT02229578|Sensory System Agents|sensory system agents|mesh-ancestor
153785223|NCT02229578|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153785227|NCT02229578|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153785228|NCT02229578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153785229|NCT01821781|Fludarabine|fludarabine|mesh-list
153785230|NCT01821781|Melphalan|melphalan|mesh-list
153785231|NCT01821781|Alemtuzumab|alemtuzumab|mesh-list
153785232|NCT01821781|Thiotepa|thiotepa|mesh-list
153785233|NCT01821781|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153785234|NCT01821781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153785235|NCT01821781|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153785236|NCT01821781|Immunologic Factors|immunologic factors|mesh-ancestor
153785237|NCT01821781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153785238|NCT01821781|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153785239|NCT01821781|Alkylating Agents|alkylating agents|mesh-ancestor
153785240|NCT01821781|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153785241|NCT01821781|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153785242|NCT01555463|Azelaic acid|azelaic acid|mesh-list
153785243|NCT01555463|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153785244|NCT01555463|Dermatologic Agents|dermatologic agents|mesh-ancestor
153785245|NCT01482715|Rucaparib|rucaparib|mesh-list
153785246|NCT01482715|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
153785247|NCT01482715|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153785248|NCT01482715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153785249|NCT01482715|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153785250|NCT01257919|Azelaic acid|azelaic acid|mesh-list
153785254|NCT00915837|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
153785255|NCT00915837|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
153785256|NCT00915837|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
153785257|NCT00915837|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153785258|NCT00915837|Glucocorticoids|glucocorticoids|mesh-ancestor
153785259|NCT00915837|Hormones|hormones|mesh-ancestor
153785260|NCT00915837|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153785263|NCT00915837|Immunologic Factors|immunologic factors|mesh-ancestor
153785265|NCT00915837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153785267|NCT00239096|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153785268|NCT00239096|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153785269|NCT00239096|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
153785270|NCT00239096|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
153785271|NCT00239096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153785272|NCT04532554|Hormones|hormones|mesh-list
153785273|NCT04532554|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153785274|NCT04532554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153785275|NCT04532281|Carbamide Peroxide|carbamide peroxide|mesh-list
153785276|NCT04532281|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
153785277|NCT04532281|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153785278|NCT02217163|Dexamethasone|dexamethasone|mesh-list
153785279|NCT02217163|Cyclophosphamide|cyclophosphamide|mesh-list
153785280|NCT02217163|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153785281|NCT02217163|Immunologic Factors|immunologic factors|mesh-ancestor
153785282|NCT02217163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153785283|NCT02217163|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153785284|NCT02217163|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153785285|NCT02217163|Alkylating Agents|alkylating agents|mesh-ancestor
153785286|NCT02217163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153785312|NCT04531423|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153785313|NCT04531423|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153785314|NCT04531423|Immunologic Factors|immunologic factors|mesh-ancestor
153785315|NCT04531423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153785316|NCT04531423|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153785317|NCT04531423|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153785318|NCT04531423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153785319|NCT04531423|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153785320|NCT04531423|Serotonin Agents|serotonin agents|mesh-ancestor
153785321|NCT00239252|Interferons|interferons|mesh-list
153785322|NCT00239252|Interferon alfacon-1|interferon alfacon-1|mesh-list
153785323|NCT00239252|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153785324|NCT00239252|Antiviral Agents|antiviral agents|mesh-ancestor
153785325|NCT00239252|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153471591|NCT04515615|Tegafur|tegafur|mesh-list
153785326|NCT00263406|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
153785327|NCT00263406|Protease Inhibitors|protease inhibitors|mesh-ancestor
153785328|NCT00263406|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153785329|NCT00263406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153785330|NCT04531267|Calcium|calcium|mesh-list
153785333|NCT04531228|Lenvatinib|lenvatinib|mesh-list
153785363|NCT00414323|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153785365|NCT00414323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153785366|NCT00414323|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153785367|NCT00414323|Antidepressive Agents|antidepressive agents|mesh-ancestor
153785368|NCT00414323|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153785369|NCT00414323|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
153785370|NCT00414323|Analgesics|analgesics|mesh-ancestor
153785371|NCT00414323|Sensory System Agents|sensory system agents|mesh-ancestor
153785372|NCT00414323|Dopamine Agents|dopamine agents|mesh-ancestor
153785373|NCT00263484|Zoledronic Acid|zoledronic acid|mesh-list
153785374|NCT00263484|Thalidomide|thalidomide|mesh-list
153785375|NCT00263484|Dexamethasone|dexamethasone|mesh-list
153785376|NCT00263484|Dexamethasone acetate|dexamethasone acetate|mesh-list
153785377|NCT00263484|BB 1101|bb 1101|mesh-list
153785378|NCT00263484|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153785379|NCT00263484|Antiemetics|antiemetics|mesh-ancestor
153785380|NCT00263484|Autonomic Agents|autonomic agents|mesh-ancestor
153785381|NCT00263484|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153785382|NCT00263484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153785383|NCT00263484|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153785384|NCT00263484|Glucocorticoids|glucocorticoids|mesh-ancestor
153785385|NCT00263484|Hormones|hormones|mesh-ancestor
153785386|NCT00263484|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153785387|NCT00263484|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153785388|NCT00263484|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153785389|NCT00263484|Protease Inhibitors|protease inhibitors|mesh-ancestor
153785390|NCT00263484|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153785391|NCT00263484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153785392|NCT00263484|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153785393|NCT00263484|Immunologic Factors|immunologic factors|mesh-ancestor
153785394|NCT00263484|Leprostatic Agents|leprostatic agents|mesh-ancestor
153785395|NCT00263484|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153785396|NCT00263484|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153785397|NCT00263484|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153785399|NCT00263484|Growth Substances|growth substances|mesh-ancestor
153785402|NCT02217319|Sevoflurane|sevoflurane|mesh-list
153785403|NCT02217319|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153785404|NCT02217319|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
153785405|NCT02217319|Anesthetics, General|anesthetics, general|mesh-ancestor
153785406|NCT02217319|Anesthetics|anesthetics|mesh-ancestor
153785407|NCT02217319|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153345719|NCT00005056|Immunologic Factors|immunologic factors|mesh-ancestor
153345722|NCT00004252|Leucovorin|leucovorin|mesh-list
153785408|NCT02217319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153785409|NCT00263601|Immunomodulating Agents|immunomodulating agents|mesh-list
153785410|NCT00263601|Immunologic Factors|immunologic factors|mesh-ancestor
153785411|NCT00263601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153785412|NCT02217514|Midazolam|midazolam|mesh-list
153785413|NCT02217514|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153785414|NCT02217514|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153785415|NCT02217514|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153785416|NCT02217514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153785417|NCT02217514|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153785418|NCT02217514|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153785419|NCT02217514|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153785420|NCT02217514|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153785421|NCT02217514|Anesthetics, General|anesthetics, general|mesh-ancestor
153785422|NCT02217514|Anesthetics|anesthetics|mesh-ancestor
153785423|NCT02217514|GABA Modulators|gaba modulators|mesh-ancestor
153785424|NCT02217514|GABA Agents|gaba agents|mesh-ancestor
153785425|NCT02217514|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153785426|NCT02217514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153785428|NCT02217553|Vitamin D|vitamin d|mesh-list
153785451|NCT02217631|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153785452|NCT02217631|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
153785453|NCT02217631|Protective Agents|protective agents|mesh-ancestor
153785454|NCT02217670|Metformin|metformin|mesh-list
153785455|NCT02217670|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153785456|NCT02217670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153785457|NCT00239291|Gefitinib|gefitinib|mesh-list
153785458|NCT00239291|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153785459|NCT00239291|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153785460|NCT00239291|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153785461|NCT00239291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153785462|NCT00239291|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153785463|NCT00263640|Immunomodulating Agents|immunomodulating agents|mesh-list
153785464|NCT00263640|Immunologic Factors|immunologic factors|mesh-ancestor
153785465|NCT00263640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153785466|NCT02217826|Octreotide|octreotide|mesh-list
153785467|NCT02217826|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153785468|NCT02217826|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153785469|NCT02217826|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153785470|NCT00239330|Atorvastatin|atorvastatin|mesh-list
153785471|NCT00239330|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
153785479|NCT02218021|Oxycodone|oxycodone|mesh-list
153785504|NCT00239408|Tiotropium Bromide|tiotropium bromide|mesh-list
153785505|NCT00239408|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153785506|NCT00239408|Autonomic Agents|autonomic agents|mesh-ancestor
153785507|NCT00239408|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153785508|NCT00239408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153785509|NCT00239408|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153785510|NCT00239408|Respiratory System Agents|respiratory system agents|mesh-ancestor
153785511|NCT00239408|Parasympatholytics|parasympatholytics|mesh-ancestor
153785512|NCT00239408|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
153785513|NCT00239408|Cholinergic Agents|cholinergic agents|mesh-ancestor
153785514|NCT00239408|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153785515|NCT00239408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153785516|NCT00239408|Anticonvulsants|anticonvulsants|mesh-ancestor
153785517|NCT02218177|Ranibizumab|ranibizumab|mesh-list
153785518|NCT02218177|Aflibercept|aflibercept|mesh-list
153785519|NCT02218177|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153785520|NCT02218177|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153785521|NCT02218177|Growth Substances|growth substances|mesh-ancestor
153785522|NCT02218177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153785523|NCT02218177|Growth Inhibitors|growth inhibitors|mesh-ancestor
153785524|NCT02218177|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153785525|NCT00263718|Betamethasone|betamethasone|mesh-list
153785526|NCT00263718|Betamethasone Valerate|betamethasone valerate|mesh-list
153785527|NCT00263718|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
153785528|NCT00263718|Betamethasone benzoate|betamethasone benzoate|mesh-list
153785529|NCT00263718|Calcipotriene|calcipotriene|mesh-list
153785530|NCT00263718|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
153785531|NCT00263718|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153785532|NCT00263718|Glucocorticoids|glucocorticoids|mesh-ancestor
153785533|NCT00263718|Hormones|hormones|mesh-ancestor
153785534|NCT00263718|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153785535|NCT00263718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153785536|NCT00263718|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153785537|NCT00263718|Respiratory System Agents|respiratory system agents|mesh-ancestor
153785538|NCT00263718|Dermatologic Agents|dermatologic agents|mesh-ancestor
153785539|NCT02218645|Brotizolam|brotizolam|mesh-list
153785540|NCT02218645|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153785542|NCT02218645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153785543|NCT02218684|Telmisartan|telmisartan|mesh-list
153785544|NCT02218684|Lacidipine|lacidipine|mesh-list
153785545|NCT02218684|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153785546|NCT02218684|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
153785547|NCT02218684|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
153785548|NCT02218684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153785549|NCT02218684|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153785550|NCT02218684|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153785551|NCT02218684|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153785552|NCT02218684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153785553|NCT02278861|Tretinoin|tretinoin|mesh-list
153785554|NCT02278861|Isotretinoin|isotretinoin|mesh-list
153785555|NCT02278861|Sunscreening Agents|sunscreening agents|mesh-list
153785556|NCT02278861|Dermatologic Agents|dermatologic agents|mesh-ancestor
153785557|NCT02278861|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153785558|NCT02278861|Keratolytic Agents|keratolytic agents|mesh-ancestor
153785559|NCT02278861|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
153785560|NCT02278861|Protective Agents|protective agents|mesh-ancestor
153785563|NCT01642030|Hydromorphone|hydromorphone|mesh-list
153785565|NCT01642030|Narcotics|narcotics|mesh-ancestor
153785566|NCT01642030|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153785567|NCT01642030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153785568|NCT01642030|Analgesics|analgesics|mesh-ancestor
153785569|NCT01642030|Sensory System Agents|sensory system agents|mesh-ancestor
153332079|NCT01006655|Beclomethasone|beclomethasone|mesh-list
153785570|NCT01642030|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153785571|NCT01642030|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
153785572|NCT00263796|Oxytocin|oxytocin|mesh-list
153785573|NCT00263796|Oxytocics|oxytocics|mesh-ancestor
153785581|NCT01642108|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153785582|NCT01642108|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
153785583|NCT01642108|Protease Inhibitors|protease inhibitors|mesh-ancestor
153785584|NCT01642108|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153785585|NCT01642108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153785586|NCT00250185|Acetylcholine|acetylcholine|mesh-list
153785587|NCT00250185|Vasodilator Agents|vasodilator agents|mesh-ancestor
153785588|NCT00250185|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
153785589|NCT00250185|Cholinergic Agents|cholinergic agents|mesh-ancestor
153785590|NCT00250185|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153785591|NCT00250185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153785592|NCT00250185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153785593|NCT00239486|Pramipexole|pramipexole|mesh-list
153785594|NCT00239486|Dexpramipexole|dexpramipexole|mesh-list
153785595|NCT00239486|Antioxidants|antioxidants|mesh-ancestor
153785596|NCT00239486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153785597|NCT00239486|Protective Agents|protective agents|mesh-ancestor
153785598|NCT00239486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153785599|NCT00239486|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
153785600|NCT00239486|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
153785601|NCT00239486|Dopamine Agonists|dopamine agonists|mesh-ancestor
153785602|NCT00239486|Dopamine Agents|dopamine agents|mesh-ancestor
153785603|NCT00239486|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153785604|NCT01642966|Ticagrelor|ticagrelor|mesh-list
153785605|NCT01642966|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
153785606|NCT01642966|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153785607|NCT01642966|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
153785608|NCT01642966|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
153785609|NCT01642966|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
153785610|NCT01642966|Purinergic Agents|purinergic agents|mesh-ancestor
153471709|NCT03282799|Contraceptive Agents|contraceptive agents|mesh-ancestor
153785611|NCT01642966|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153785612|NCT01642966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153785613|NCT01642966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153785614|NCT01643083|Rifaximin|rifaximin|mesh-list
153785618|NCT01643278|Ipilimumab|ipilimumab|mesh-list
153785619|NCT01643278|Dasatinib|dasatinib|mesh-list
153785620|NCT01643278|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153785621|NCT01643278|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153785622|NCT01643278|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153785623|NCT01643278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153785624|NCT01643278|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153785625|NCT01643278|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153785626|NCT01643278|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153785627|NCT01643629|Minoxidil|minoxidil|mesh-list
153785628|NCT01643629|Finasteride|finasteride|mesh-list
153785629|NCT01643629|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153785630|NCT01643629|Vasodilator Agents|vasodilator agents|mesh-ancestor
153785631|NCT01643629|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
153785632|NCT01643629|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153785633|NCT01643629|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153785634|NCT01643629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153785635|NCT01643629|Hormone Antagonists|hormone antagonists|mesh-ancestor
153785636|NCT01643629|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153785637|NCT01643629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153785638|NCT01643629|Urological Agents|urological agents|mesh-ancestor
153785639|NCT01644253|Rituximab|rituximab|mesh-list
153785640|NCT01644253|Obinutuzumab|obinutuzumab|mesh-list
153785641|NCT01644253|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
153785642|NCT01644253|Idelalisib|idelalisib|mesh-list
153332081|NCT01006655|Glucocorticoids|glucocorticoids|mesh-ancestor
153785643|NCT01644253|Immunoglobulin G|immunoglobulin g|mesh-list
153785644|NCT01644253|Ibrutinib|ibrutinib|mesh-list
153785645|NCT01644253|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153785646|NCT01644253|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153785647|NCT01644253|Immunologic Factors|immunologic factors|mesh-ancestor
153785648|NCT01644253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153785649|NCT01644253|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153785650|NCT01644253|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153785658|NCT01644799|Immunologic Factors|immunologic factors|mesh-ancestor
153785659|NCT01644799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153785660|NCT01644799|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153785661|NCT01644799|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153785662|NCT01644799|Growth Substances|growth substances|mesh-ancestor
153785663|NCT01644799|Growth Inhibitors|growth inhibitors|mesh-ancestor
153785664|NCT01644799|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153785665|NCT01644799|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153785666|NCT01644799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153785667|NCT01644838|Promethazine|promethazine|mesh-list
153922941|NCT04164082|Gemcitabine|gemcitabine|mesh-list
153785668|NCT01644838|Diphenhydramine|diphenhydramine|mesh-list
153785669|NCT01644838|Scopolamine|scopolamine|mesh-list
153785670|NCT01644838|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153785671|NCT01644838|Antiemetics|antiemetics|mesh-ancestor
153785672|NCT01644838|Autonomic Agents|autonomic agents|mesh-ancestor
153785718|NCT04528888|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153785719|NCT04528888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153785720|NCT01645384|Atorvastatin|atorvastatin|mesh-list
153785721|NCT01645384|Calcium|calcium|mesh-list
153785722|NCT01645384|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153785723|NCT01645384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153785724|NCT01645384|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153785725|NCT01645384|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153785726|NCT01645384|Antimetabolites|antimetabolites|mesh-ancestor
153785727|NCT01645384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153785728|NCT01645384|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153785729|NCT01645384|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
153785775|NCT01646281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153785777|NCT01646554|Aflibercept|aflibercept|mesh-list
153785778|NCT01646554|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153785779|NCT01646554|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153785780|NCT01646554|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153785781|NCT01646554|Growth Substances|growth substances|mesh-ancestor
153785782|NCT01646554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153785783|NCT01646554|Growth Inhibitors|growth inhibitors|mesh-ancestor
153785784|NCT00250263|Immunomodulating Agents|immunomodulating agents|mesh-list
153785785|NCT00250263|Immunologic Factors|immunologic factors|mesh-ancestor
153785786|NCT00250263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153785787|NCT00264069|Antipsychotic Agents|antipsychotic agents|mesh-list
153785788|NCT00264069|Antidepressive Agents|antidepressive agents|mesh-list
153785789|NCT00264069|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153785790|NCT00264069|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153785791|NCT00264069|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153785792|NCT00264069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153785793|NCT01646788|Paclitaxel|paclitaxel|mesh-list
153785794|NCT01646788|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153785795|NCT01646788|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153785796|NCT01646788|Tubulin Modulators|tubulin modulators|mesh-ancestor
153785797|NCT01646788|Antimitotic Agents|antimitotic agents|mesh-ancestor
153785798|NCT01646788|Mitosis Modulators|mitosis modulators|mesh-ancestor
153345913|NCT00004300|Dopamine Agonists|dopamine agonists|mesh-ancestor
153785799|NCT01646788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153785800|NCT01647256|Nikkomycin|nikkomycin|mesh-list
153785801|NCT01647256|Antifungal Agents|antifungal agents|mesh-ancestor
153785802|NCT01647256|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153785803|NCT01647256|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153785804|NCT01647256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153785805|NCT00239954|Escitalopram|escitalopram|mesh-list
153785817|NCT04528927|Antimalarials|antimalarials|mesh-ancestor
153785818|NCT04528927|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153785819|NCT04528927|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153785820|NCT04720287|Bupivacaine|bupivacaine|mesh-list
153785821|NCT04720287|Neostigmine|neostigmine|mesh-list
153785822|NCT04720287|Anesthetics, Local|anesthetics, local|mesh-ancestor
153785823|NCT04720287|Anesthetics|anesthetics|mesh-ancestor
153785824|NCT04720287|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153785825|NCT04720287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153785826|NCT04720287|Sensory System Agents|sensory system agents|mesh-ancestor
153785827|NCT04720287|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153785828|NCT04720287|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
153785829|NCT04720287|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153785830|NCT04720287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153785831|NCT04720287|Cholinergic Agents|cholinergic agents|mesh-ancestor
153785832|NCT04720287|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153785833|NCT04720287|Parasympathomimetics|parasympathomimetics|mesh-ancestor
153785834|NCT04720287|Autonomic Agents|autonomic agents|mesh-ancestor
153785835|NCT00239993|Glatiramer Acetate|glatiramer acetate|mesh-list
153785836|NCT00239993|(T,G)-A-L|(t,g)-a-l|mesh-list
153785837|NCT00239993|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153785838|NCT00239993|Immunologic Factors|immunologic factors|mesh-ancestor
153785839|NCT00239993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153785840|NCT00239993|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153785841|NCT00239993|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153785842|NCT00264108|Epoetin Alfa|epoetin alfa|mesh-list
153785843|NCT00264108|Darbepoetin alfa|darbepoetin alfa|mesh-list
153785844|NCT00264108|Hematinics|hematinics|mesh-ancestor
153785845|NCT01647412|Curcumin|curcumin|mesh-list
153785846|NCT01647412|Hormones|hormones|mesh-list
153785847|NCT01647412|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153785848|NCT01647412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153785849|NCT01647412|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153785850|NCT01647412|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153785851|NCT01647412|Analgesics|analgesics|mesh-ancestor
153346021|NCT00385450|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
153785858|NCT01647412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153785859|NCT01647529|Ganciclovir|ganciclovir|mesh-list
153785860|NCT01647529|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
153785861|NCT01647529|Antiviral Agents|antiviral agents|mesh-ancestor
153785862|NCT01647529|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153785863|NCT01647529|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153785864|NCT01647529|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153785865|NCT01647529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153785866|NCT00240032|Cetirizine|cetirizine|mesh-list
153785867|NCT00240032|Glatiramer Acetate|glatiramer acetate|mesh-list
153785868|NCT00240032|(T,G)-A-L|(t,g)-a-l|mesh-list
153785869|NCT00240032|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
153785870|NCT00240032|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
153785871|NCT00240032|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
153785872|NCT00240032|Histamine Antagonists|histamine antagonists|mesh-ancestor
153785873|NCT00240032|Histamine Agents|histamine agents|mesh-ancestor
153785874|NCT00240032|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153785875|NCT00240032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153785914|NCT01647685|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153785915|NCT01647685|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153785916|NCT00240266|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
153785917|NCT00240266|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153785918|NCT00240266|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153785919|NCT00240266|Antimetabolites|antimetabolites|mesh-ancestor
153785920|NCT00240266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153785921|NCT00240266|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153785922|NCT00240266|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
153785923|NCT00240266|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153785924|NCT01648036|Heparin|heparin|mesh-list
153785925|NCT01648036|Calcium heparin|calcium heparin|mesh-list
153785926|NCT01648036|Dalteparin|dalteparin|mesh-list
153785927|NCT01648036|Tinzaparin|tinzaparin|mesh-list
153785928|NCT01648036|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
153785929|NCT01648036|Anticoagulants|anticoagulants|mesh-ancestor
153785930|NCT01648036|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153785931|NCT01648036|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153785932|NCT01648036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153785933|NCT00240305|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
153785934|NCT00240305|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153785935|NCT00240305|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153785936|NCT00240305|Antimetabolites|antimetabolites|mesh-ancestor
153785937|NCT00240305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153785938|NCT00240305|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153785939|NCT00240305|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
153785940|NCT00240305|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153785941|NCT01648231|Losartan|losartan|mesh-list
153785942|NCT01648231|Amlodipine|amlodipine|mesh-list
153785943|NCT01648231|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153785944|NCT01648231|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153785945|NCT01648231|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153785946|NCT01648231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153785953|NCT00264186|Norepinephrine|norepinephrine|mesh-list
153785954|NCT00264186|Nitroglycerin|nitroglycerin|mesh-list
153785955|NCT00264186|Acetylcholine|acetylcholine|mesh-list
153785956|NCT00264186|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153785957|NCT00264186|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153785958|NCT00264186|Adrenergic Agents|adrenergic agents|mesh-ancestor
153785959|NCT00264186|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153785960|NCT00264186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153785961|NCT00264186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153785962|NCT00264186|Sympathomimetics|sympathomimetics|mesh-ancestor
153785963|NCT00264186|Autonomic Agents|autonomic agents|mesh-ancestor
153785964|NCT00264186|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153785965|NCT00264186|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
153785966|NCT00264186|Vasodilator Agents|vasodilator agents|mesh-ancestor
153785967|NCT00264186|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
153785968|NCT00264186|Cholinergic Agents|cholinergic agents|mesh-ancestor
153785969|NCT00240422|Telmisartan|telmisartan|mesh-list
153785971|NCT00240422|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153785972|NCT00240422|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
153785973|NCT00240422|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
153785974|NCT00240422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153785975|NCT00240422|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
153785976|NCT00240422|Protease Inhibitors|protease inhibitors|mesh-ancestor
153785977|NCT00240422|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153785978|NCT00264225|Codeine|codeine|mesh-list
153785979|NCT00264225|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153785980|NCT00264225|Narcotics|narcotics|mesh-ancestor
153785981|NCT00264225|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153785982|NCT00264225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153785983|NCT00264225|Analgesics|analgesics|mesh-ancestor
153785984|NCT00264225|Sensory System Agents|sensory system agents|mesh-ancestor
153785985|NCT00264225|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153785986|NCT00264225|Antitussive Agents|antitussive agents|mesh-ancestor
153785995|NCT02279563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153785996|NCT02279563|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153785997|NCT02279563|Respiratory System Agents|respiratory system agents|mesh-ancestor
153785998|NCT02279563|Dermatologic Agents|dermatologic agents|mesh-ancestor
153785999|NCT02279563|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
153786000|NCT02279563|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
153786001|NCT02279563|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153786002|NCT02279563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153786003|NCT02279563|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
153786004|NCT02279563|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
153786005|NCT02279563|Histamine Antagonists|histamine antagonists|mesh-ancestor
153786006|NCT02279563|Histamine Agents|histamine agents|mesh-ancestor
153786007|NCT02279563|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153786008|NCT02279758|Metformin|metformin|mesh-list
153786009|NCT02279758|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153346101|NCT01217749|Ofatumumab|ofatumumab|mesh-list
153786010|NCT02279758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153786011|NCT01649245|Interferons|interferons|mesh-list
153332452|NCT00958919|Naloxone|naloxone|mesh-list
153786012|NCT01649245|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153332453|NCT00958919|Endorphins|endorphins|mesh-list
153786013|NCT01649245|Antiviral Agents|antiviral agents|mesh-ancestor
153786014|NCT01649245|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153786016|NCT01649284|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153786017|NCT01649284|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153786018|NCT01649284|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153786020|NCT01649284|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153786044|NCT01649635|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153786045|NCT01649635|Glucocorticoids|glucocorticoids|mesh-ancestor
153786046|NCT01649635|Hormones|hormones|mesh-ancestor
153786047|NCT01649635|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153786048|NCT01649635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153786049|NCT01649635|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153786050|NCT01649635|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153786051|NCT01649635|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153786052|NCT01649635|Immunologic Factors|immunologic factors|mesh-ancestor
153786053|NCT01649635|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153786054|NCT01649635|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153786055|NCT01649635|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153786056|NCT01649635|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153786057|NCT01649635|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153786058|NCT01649635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153786059|NCT01649635|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
153786060|NCT01649635|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153786061|NCT00250536|Nandrolone Decanoate|nandrolone decanoate|mesh-list
153786062|NCT00250536|Nandrolone|nandrolone|mesh-list
153786063|NCT00250536|Nandrolone phenpropionate|nandrolone phenpropionate|mesh-list
153786064|NCT00250536|Androgens|androgens|mesh-ancestor
153786065|NCT00250536|Hormones|hormones|mesh-ancestor
153786066|NCT00250536|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153923053|NCT03969004|Cemiplimab|cemiplimab|mesh-list
153786067|NCT00250536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153786068|NCT00250536|Anabolic Agents|anabolic agents|mesh-ancestor
153786069|NCT00250536|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153786070|NCT00240617|Naproxen|naproxen|mesh-list
153786071|NCT00240617|Sumatriptan|sumatriptan|mesh-list
153786072|NCT00240617|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153786073|NCT00240617|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153786074|NCT00240617|Analgesics|analgesics|mesh-ancestor
153786075|NCT00240617|Sensory System Agents|sensory system agents|mesh-ancestor
153786076|NCT00240617|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153786083|NCT00240617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153786084|NCT00240617|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
153786085|NCT00240617|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
153786086|NCT00240617|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
153786087|NCT00240617|Serotonin Agents|serotonin agents|mesh-ancestor
153332526|NCT03018821|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153786088|NCT00240617|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153786089|NCT01649830|Temozolomide|temozolomide|mesh-list
153786090|NCT01649830|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153786092|NCT01649830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153786093|NCT01649830|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153786095|NCT00240656|Captopril|captopril|mesh-list
153786096|NCT00240656|Spironolactone|spironolactone|mesh-list
153786097|NCT00240656|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
153786098|NCT00240656|Hormone Antagonists|hormone antagonists|mesh-ancestor
153786099|NCT00240656|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153346152|NCT00004444|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153786100|NCT00240656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153786101|NCT00240656|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
153786102|NCT00240656|Diuretics|diuretics|mesh-ancestor
153786103|NCT00240656|Natriuretic Agents|natriuretic agents|mesh-ancestor
153786104|NCT00240656|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
153786110|NCT00240656|Antioxidants|antioxidants|mesh-ancestor
153786130|NCT00250575|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153786131|NCT00250575|GABA Antagonists|gaba antagonists|mesh-ancestor
153786132|NCT00250575|GABA Agents|gaba agents|mesh-ancestor
153786133|NCT00240695|Galantamine|galantamine|mesh-list
153786134|NCT00240695|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
153786135|NCT00240695|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153786136|NCT00240695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153786137|NCT00240695|Cholinergic Agents|cholinergic agents|mesh-ancestor
153786138|NCT00240695|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153786139|NCT00240695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153786140|NCT00240695|Parasympathomimetics|parasympathomimetics|mesh-ancestor
153786141|NCT00240695|Autonomic Agents|autonomic agents|mesh-ancestor
153786142|NCT00240695|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153786143|NCT00240695|Nootropic Agents|nootropic agents|mesh-ancestor
153786145|NCT00240734|Hematinics|hematinics|mesh-ancestor
153786146|NCT04720248|Dipyrone|dipyrone|mesh-list
153786147|NCT04720248|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153786188|NCT04708821|Ophthalmic Solutions|ophthalmic solutions|mesh-list
153786189|NCT04708821|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153786190|NCT04708821|Antiemetics|antiemetics|mesh-ancestor
153786191|NCT04708821|Autonomic Agents|autonomic agents|mesh-ancestor
153786192|NCT04708821|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153786193|NCT04708821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153786194|NCT04708821|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153786195|NCT04708821|Glucocorticoids|glucocorticoids|mesh-ancestor
153786196|NCT04708821|Hormones|hormones|mesh-ancestor
153786197|NCT04708821|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153786198|NCT04708821|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153786199|NCT04708821|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153786200|NCT04708821|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
153786201|NCT04708821|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
153786202|NCT04708821|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153786203|NCT04708821|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153786204|NCT04708821|Analgesics|analgesics|mesh-ancestor
153786205|NCT04708821|Sensory System Agents|sensory system agents|mesh-ancestor
153786206|NCT04708821|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153786207|NCT04708821|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
153786208|NCT04708821|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
153786209|NCT04708821|Histamine Antagonists|histamine antagonists|mesh-ancestor
153786210|NCT04708821|Histamine Agents|histamine agents|mesh-ancestor
153786211|NCT04708821|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153786212|NCT04708821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153786213|NCT00240812|Ibuprofen|ibuprofen|mesh-list
153786214|NCT00240812|Pseudoephedrine|pseudoephedrine|mesh-list
153786215|NCT00240812|Ephedrine|ephedrine|mesh-list
153786216|NCT00240812|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153786217|NCT00240812|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153786218|NCT00240812|Analgesics|analgesics|mesh-ancestor
153786219|NCT00240812|Sensory System Agents|sensory system agents|mesh-ancestor
153786220|NCT00240812|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153786227|NCT00240812|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153786228|NCT00240812|Autonomic Agents|autonomic agents|mesh-ancestor
153786229|NCT00240812|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153786230|NCT00240812|Respiratory System Agents|respiratory system agents|mesh-ancestor
153786231|NCT00240812|Nasal Decongestants|nasal decongestants|mesh-ancestor
153786232|NCT00240812|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
153786233|NCT00240812|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
153786234|NCT00240812|Sympathomimetics|sympathomimetics|mesh-ancestor
153332678|NCT05314270|Copper|copper|mesh-list
153346205|NCT01289275|Nicotine|nicotine|mesh-list
153332751|NCT01126255|Glucocorticoids|glucocorticoids|mesh-ancestor
153786235|NCT00240812|Adrenergic Agents|adrenergic agents|mesh-ancestor
153786236|NCT00240812|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153786237|NCT01688518|Lidocaine|lidocaine|mesh-list
153786238|NCT01688518|Tetracaine|tetracaine|mesh-list
153786239|NCT01688518|Anesthetics, Local|anesthetics, local|mesh-ancestor
153786240|NCT01688518|Anesthetics|anesthetics|mesh-ancestor
153786241|NCT01688518|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153786242|NCT01688518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153786243|NCT01688518|Sensory System Agents|sensory system agents|mesh-ancestor
153786244|NCT01688518|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153786245|NCT01688518|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153786246|NCT01688518|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
153786247|NCT01688518|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153786248|NCT01688518|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153786249|NCT01688518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153786250|NCT00240851|Acetaminophen|acetaminophen|mesh-list
153786251|NCT00240851|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153786252|NCT00240851|Analgesics|analgesics|mesh-ancestor
153786253|NCT00240851|Sensory System Agents|sensory system agents|mesh-ancestor
153786254|NCT00240851|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153786255|NCT00240851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153786256|NCT00240851|Antipyretics|antipyretics|mesh-ancestor
153786257|NCT00240929|Palivizumab|palivizumab|mesh-list
153786258|NCT00240929|Antiviral Agents|antiviral agents|mesh-ancestor
153786259|NCT00240929|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153786260|NCT00250692|Nitrous Oxide|nitrous oxide|mesh-list
153786261|NCT00250692|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
153786263|NCT00250692|Anesthetics|anesthetics|mesh-ancestor
153786264|NCT00250692|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153786265|NCT00250692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153786266|NCT00250692|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153786267|NCT00250692|Analgesics|analgesics|mesh-ancestor
153786268|NCT00250692|Sensory System Agents|sensory system agents|mesh-ancestor
153786269|NCT00250692|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153786271|NCT01688791|Carboplatin|carboplatin|mesh-list
153786272|NCT01688791|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153786273|NCT01688791|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153786274|NCT01688791|Tubulin Modulators|tubulin modulators|mesh-ancestor
153786275|NCT01688791|Antimitotic Agents|antimitotic agents|mesh-ancestor
153786276|NCT01688791|Mitosis Modulators|mitosis modulators|mesh-ancestor
153786277|NCT01688791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153786279|NCT01688947|Analgesics|analgesics|mesh-ancestor
153786280|NCT01688947|Sensory System Agents|sensory system agents|mesh-ancestor
153786281|NCT01688947|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153786282|NCT01688947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153786283|NCT01688947|Anticonvulsants|anticonvulsants|mesh-ancestor
153786284|NCT01688947|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153786285|NCT01688947|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153786286|NCT01688947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153786287|NCT01688947|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153786288|NCT01688947|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153786292|NCT00241007|Valsartan|valsartan|mesh-list
153786310|NCT00241046|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
153786311|NCT00241046|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153786312|NCT00241046|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153786313|NCT00241046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153786314|NCT00241046|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
153786315|NCT00241046|Hormone Antagonists|hormone antagonists|mesh-ancestor
153786316|NCT00241046|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153786317|NCT00241046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153786318|NCT01689259|Cyclobenzaprine|cyclobenzaprine|mesh-list
153786319|NCT01689259|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
153786320|NCT01689259|Antidepressive Agents|antidepressive agents|mesh-ancestor
153786321|NCT01689259|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153786322|NCT01689259|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
153786323|NCT01689259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153786324|NCT01689259|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
153786325|NCT01689259|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153786327|NCT01689259|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153786329|NCT01689298|Carbetocin|carbetocin|mesh-list
153786330|NCT01689298|Oxytocics|oxytocics|mesh-ancestor
153786331|NCT01689298|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153786332|NCT01689298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153786333|NCT00241085|Valsartan|valsartan|mesh-list
153786334|NCT00241085|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153786335|NCT00241085|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
153786336|NCT00241085|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
153786337|NCT00241085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153786338|NCT00241124|Valsartan|valsartan|mesh-list
153786339|NCT00241124|Lisinopril|lisinopril|mesh-list
153786351|NCT00241163|Hemostatics|hemostatics|mesh-ancestor
153786352|NCT00241163|Coagulants|coagulants|mesh-ancestor
153786353|NCT02277106|Brexanolone|brexanolone|mesh-list
153786354|NCT02277106|Neurosteroids|neurosteroids|mesh-ancestor
153786355|NCT02277106|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153786356|NCT02277106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153786357|NCT02277106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153786358|NCT02277106|GABA Modulators|gaba modulators|mesh-ancestor
153786359|NCT02277106|GABA Agents|gaba agents|mesh-ancestor
153786360|NCT00241241|Interferons|interferons|mesh-list
153786361|NCT00241241|Interferon-alpha|interferon-alpha|mesh-list
153786362|NCT00241241|Interferon alpha-2|interferon alpha-2|mesh-list
153786363|NCT00241241|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
153786364|NCT00241241|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153786365|NCT00241241|Antiviral Agents|antiviral agents|mesh-ancestor
153786367|NCT00241241|Immunologic Factors|immunologic factors|mesh-ancestor
153786413|NCT02218762|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153786414|NCT02218762|Respiratory System Agents|respiratory system agents|mesh-ancestor
153786415|NCT02218762|Dermatologic Agents|dermatologic agents|mesh-ancestor
153786416|NCT02218762|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
153786417|NCT02218762|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
153786418|NCT02218762|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
153786419|NCT02218762|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153786420|NCT02218762|Adrenergic Agents|adrenergic agents|mesh-ancestor
153786421|NCT02218762|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153786422|NCT02218762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153786423|NCT02218762|Glucocorticoids|glucocorticoids|mesh-ancestor
153786424|NCT02218762|Hormones|hormones|mesh-ancestor
153786425|NCT02218762|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153786426|NCT02218762|Sympathomimetics|sympathomimetics|mesh-ancestor
153786427|NCT00264459|Immunomodulating Agents|immunomodulating agents|mesh-list
153786428|NCT00264459|Immunologic Factors|immunologic factors|mesh-list
153786429|NCT00264459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153786430|NCT00241514|Esomeprazole|esomeprazole|mesh-list
153786431|NCT00241514|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
153786432|NCT00241514|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153786433|NCT00241514|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
153786434|NCT00241514|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153786435|NCT00241514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153786461|NCT00264615|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153786462|NCT00264615|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153786463|NCT00264615|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153786464|NCT00264615|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153786466|NCT02219191|Atorvastatin|atorvastatin|mesh-list
153786467|NCT02219191|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153786468|NCT02219191|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153786469|NCT02219191|Antimetabolites|antimetabolites|mesh-ancestor
153786470|NCT02219191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153786471|NCT02219191|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153786472|NCT02219191|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
153786473|NCT02219191|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153786474|NCT02219191|Vasodilator Agents|vasodilator agents|mesh-ancestor
153786475|NCT04529512|Dexamethasone|dexamethasone|mesh-list
153786476|NCT04529512|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153786477|NCT04529512|Antiemetics|antiemetics|mesh-ancestor
153786478|NCT04529512|Autonomic Agents|autonomic agents|mesh-ancestor
153786479|NCT04529512|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153786480|NCT04529512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153786481|NCT04529512|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153786482|NCT04529512|Glucocorticoids|glucocorticoids|mesh-ancestor
153786483|NCT04529512|Hormones|hormones|mesh-ancestor
153786484|NCT04529512|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153786485|NCT04529512|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153786486|NCT04529512|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153786487|NCT00241670|Aminolevulinic Acid|aminolevulinic acid|mesh-list
153786488|NCT00241670|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
153786489|NCT00241670|Dermatologic Agents|dermatologic agents|mesh-ancestor
153786491|NCT02219737|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
153786492|NCT02219737|Carboplatin|carboplatin|mesh-list
153786493|NCT02219737|Etoposide|etoposide|mesh-list
153786494|NCT02219737|Etoposide phosphate|etoposide phosphate|mesh-list
153786504|NCT02219737|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153786505|NCT02219737|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153923253|NCT03480776|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153786506|NCT02219737|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153786507|NCT02219737|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153786508|NCT02219737|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153786509|NCT02219737|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153786510|NCT02219737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153786511|NCT02219737|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153786512|NCT02219737|Alkylating Agents|alkylating agents|mesh-ancestor
153786513|NCT02219737|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153786514|NCT02219737|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153786515|NCT02219737|Keratolytic Agents|keratolytic agents|mesh-ancestor
153786516|NCT02219737|Dermatologic Agents|dermatologic agents|mesh-ancestor
153786517|NCT02219737|Tubulin Modulators|tubulin modulators|mesh-ancestor
153786518|NCT02219737|Antimitotic Agents|antimitotic agents|mesh-ancestor
153786519|NCT02219737|Mitosis Modulators|mitosis modulators|mesh-ancestor
153786520|NCT02219893|Immunotoxins|immunotoxins|mesh-list
153786521|NCT02219893|MOC31PE immunotoxin|moc31pe immunotoxin|mesh-list
153786522|NCT02219893|Immunoconjugates|immunoconjugates|mesh-ancestor
153786523|NCT02219893|Immunologic Factors|immunologic factors|mesh-ancestor
153786524|NCT02219893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153786525|NCT02212951|Insulin Lispro|insulin lispro|mesh-list
153786526|NCT02212951|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153786527|NCT02212951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153786528|NCT02210806|Albuterol|albuterol|mesh-list
153786529|NCT02210806|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153786530|NCT02210806|Autonomic Agents|autonomic agents|mesh-ancestor
153786531|NCT02210806|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153332982|NCT03746002|Metolazone|metolazone|mesh-list
153786532|NCT02210806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153786546|NCT00264654|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153372837|NCT01267292|Buspirone|buspirone|mesh-list
153786547|NCT00264654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153786548|NCT00264654|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153786549|NCT00264654|Serotonin Agents|serotonin agents|mesh-ancestor
153786550|NCT00264654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153786551|NCT00264654|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
153786552|NCT00264654|Antidepressive Agents|antidepressive agents|mesh-ancestor
153786553|NCT00264654|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153786554|NCT00264654|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
153786555|NCT00264654|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153786556|NCT00264654|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153786557|NCT02219659|Midazolam|midazolam|mesh-list
153786558|NCT02219659|Fentanyl|fentanyl|mesh-list
153786559|NCT02219659|Propofol|propofol|mesh-list
153786560|NCT02219659|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153786561|NCT02219659|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153786562|NCT02219659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153786563|NCT02219659|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153786564|NCT02219659|Anesthetics, General|anesthetics, general|mesh-ancestor
153786565|NCT02219659|Anesthetics|anesthetics|mesh-ancestor
153786566|NCT02219659|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153786567|NCT02219659|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153786568|NCT02219659|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153786569|NCT02219659|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153786570|NCT02219659|GABA Modulators|gaba modulators|mesh-ancestor
153786571|NCT02219659|GABA Agents|gaba agents|mesh-ancestor
153786572|NCT02219659|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153786573|NCT02219659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153786575|NCT02219659|Narcotics|narcotics|mesh-ancestor
153786576|NCT02219659|Analgesics|analgesics|mesh-ancestor
153786577|NCT02219659|Sensory System Agents|sensory system agents|mesh-ancestor
153786578|NCT02219659|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153786588|NCT02212015|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153786589|NCT02212015|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153786590|NCT02212015|Tubulin Modulators|tubulin modulators|mesh-ancestor
153786591|NCT02212015|Antimitotic Agents|antimitotic agents|mesh-ancestor
153786592|NCT02212015|Mitosis Modulators|mitosis modulators|mesh-ancestor
153786593|NCT02212015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153786594|NCT04720859|Canagliflozin|canagliflozin|mesh-list
153786595|NCT04720859|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
153786596|NCT04720859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153786597|NCT04720859|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153786598|NCT04720859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153786599|NCT02961842|Ephedrine|ephedrine|mesh-list
153786600|NCT02961842|Fentanyl|fentanyl|mesh-list
153786601|NCT02961842|Bupivacaine|bupivacaine|mesh-list
153786602|NCT02961842|Anesthetics, Local|anesthetics, local|mesh-ancestor
153786603|NCT02961842|Anesthetics|anesthetics|mesh-ancestor
153786604|NCT02961842|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153786605|NCT02961842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153786606|NCT02961842|Sensory System Agents|sensory system agents|mesh-ancestor
153372881|NCT01797575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153786607|NCT02961842|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153786609|NCT02961842|Narcotics|narcotics|mesh-ancestor
153786610|NCT02961842|Analgesics|analgesics|mesh-ancestor
153786611|NCT02961842|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153786612|NCT02961842|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153786613|NCT02961842|Anesthetics, General|anesthetics, general|mesh-ancestor
153786614|NCT02961842|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
153786615|NCT02961842|Sympathomimetics|sympathomimetics|mesh-ancestor
153786616|NCT02961842|Autonomic Agents|autonomic agents|mesh-ancestor
153786617|NCT02961842|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
153786618|NCT02961842|Adrenergic Agents|adrenergic agents|mesh-ancestor
153786619|NCT02961842|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153786620|NCT02961842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153786621|NCT00272805|Carvedilol|carvedilol|mesh-list
153786622|NCT00272805|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
153786623|NCT00272805|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
153786625|NCT00272805|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153786626|NCT00272805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153346462|NCT01341301|Alkylating Agents|alkylating agents|mesh-ancestor
153786627|NCT00272805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153786628|NCT00272805|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153786629|NCT00272805|Antioxidants|antioxidants|mesh-ancestor
153786630|NCT00272805|Protective Agents|protective agents|mesh-ancestor
153786631|NCT00272805|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153786632|NCT00272805|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153786633|NCT00272805|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153786634|NCT00272805|Vasodilator Agents|vasodilator agents|mesh-ancestor
153786635|NCT00272805|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
153786636|NCT00272805|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
153786637|NCT00242177|Pioglitazone|pioglitazone|mesh-list
153786638|NCT00242177|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153786639|NCT00242177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153786641|NCT00264927|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
153786642|NCT00264927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153786643|NCT00264927|Natriuretic Agents|natriuretic agents|mesh-ancestor
153786644|NCT00264927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153786645|NCT00242372|Insulin|insulin|mesh-list
153786646|NCT00242372|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153786647|NCT00242372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153786648|NCT00265005|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
153786649|NCT00265005|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153786650|NCT00265005|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153786651|NCT00265005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153786652|NCT00242411|Budesonide|budesonide|mesh-list
153786653|NCT00242411|Formoterol Fumarate|formoterol fumarate|mesh-list
153786654|NCT00242411|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153786655|NCT00242411|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153786656|NCT00242411|Autonomic Agents|autonomic agents|mesh-ancestor
153786657|NCT00242411|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153786658|NCT00242411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153786659|NCT00242411|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153786661|NCT00242411|Glucocorticoids|glucocorticoids|mesh-ancestor
153786662|NCT00242411|Hormones|hormones|mesh-ancestor
153786663|NCT00242411|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153786664|NCT00242411|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
153786665|NCT00242411|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
153786666|NCT00242411|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153786667|NCT00242411|Adrenergic Agents|adrenergic agents|mesh-ancestor
153786668|NCT00242411|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153786669|NCT00242411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153786670|NCT02962037|Melatonin|melatonin|mesh-list
153786671|NCT02962037|Antioxidants|antioxidants|mesh-ancestor
153372956|NCT01335620|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
153372957|NCT01335932|Ganciclovir|ganciclovir|mesh-list
153786673|NCT02962037|Protective Agents|protective agents|mesh-ancestor
153786674|NCT02962037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153346531|NCT00102518|Serotonin Agents|serotonin agents|mesh-ancestor
153786675|NCT02962037|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153786676|NCT00282399|Decitabine|decitabine|mesh-list
153786677|NCT00282399|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153333122|NCT01175395|Glucocorticoids|glucocorticoids|mesh-ancestor
153786678|NCT00282399|Antimetabolites|antimetabolites|mesh-ancestor
153333123|NCT01175395|Hormones|hormones|mesh-ancestor
153333196|NCT01177735|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153786679|NCT00282399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153786680|NCT00282399|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153786681|NCT00282399|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153786682|NCT00242450|Metoclopramide|metoclopramide|mesh-list
153786683|NCT00242450|Antiemetics|antiemetics|mesh-ancestor
153786684|NCT00242450|Autonomic Agents|autonomic agents|mesh-ancestor
153786685|NCT00242450|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153786686|NCT00242450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153786690|NCT00242450|Dopamine Agents|dopamine agents|mesh-ancestor
153786701|NCT00273039|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
153786702|NCT00273039|Antidepressive Agents|antidepressive agents|mesh-ancestor
153786703|NCT00273039|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153786704|NCT00273039|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
153786705|NCT00273039|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153786706|NCT00273039|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153786707|NCT00242528|Zoledronic Acid|zoledronic acid|mesh-list
153786708|NCT00242528|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153786709|NCT00242528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153786710|NCT00242606|Lamotrigine|lamotrigine|mesh-list
153786711|NCT00242606|Levetiracetam|levetiracetam|mesh-list
153786712|NCT00242606|Anticonvulsants|anticonvulsants|mesh-ancestor
153923310|NCT03290079|Pembrolizumab|pembrolizumab|mesh-list
153923311|NCT03290079|Lenvatinib|lenvatinib|mesh-list
153923312|NCT03290079|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153923313|NCT03290079|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153923314|NCT03290079|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153786713|NCT00242606|Nootropic Agents|nootropic agents|mesh-ancestor
153786714|NCT00242606|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153786715|NCT00242606|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153786716|NCT00242606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153786717|NCT00242606|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153786718|NCT00242606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153786719|NCT00242606|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153786720|NCT00242606|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153786721|NCT00242606|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153786722|NCT00242606|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153786723|NCT00242606|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153786724|NCT00242762|Docetaxel|docetaxel|mesh-list
153786725|NCT00242762|Gefitinib|gefitinib|mesh-list
153786726|NCT00242762|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153786749|NCT00242879|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153786750|NCT00242879|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
153786751|NCT00242879|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153786752|NCT00282594|Insulin|insulin|mesh-list
153786753|NCT00282594|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153786754|NCT00282594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153786755|NCT00242918|Docetaxel|docetaxel|mesh-list
153786756|NCT00242918|Gefitinib|gefitinib|mesh-list
153786757|NCT00242918|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153786758|NCT00242918|Tubulin Modulators|tubulin modulators|mesh-ancestor
153786759|NCT00242918|Antimitotic Agents|antimitotic agents|mesh-ancestor
153786760|NCT00242918|Mitosis Modulators|mitosis modulators|mesh-ancestor
153786761|NCT00242918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153786762|NCT00242918|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153786763|NCT00242918|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153786764|NCT00242918|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153786765|NCT00273312|Epothilone B|epothilone b|mesh-list
153786766|NCT00273312|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153786767|NCT00273312|Tubulin Modulators|tubulin modulators|mesh-ancestor
153786768|NCT00273312|Antimitotic Agents|antimitotic agents|mesh-ancestor
153786769|NCT00273312|Mitosis Modulators|mitosis modulators|mesh-ancestor
153786770|NCT00273312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153786771|NCT00242996|Cyclophosphamide|cyclophosphamide|mesh-list
153786772|NCT00242996|Carmustine|carmustine|mesh-list
153786773|NCT00242996|Rituximab|rituximab|mesh-list
153786774|NCT00242996|Etoposide|etoposide|mesh-list
153786775|NCT00242996|Sargramostim|sargramostim|mesh-list
153786776|NCT00242996|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153786777|NCT00242996|Immunologic Factors|immunologic factors|mesh-ancestor
153786778|NCT00242996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153786793|NCT00273390|Dermatologic Agents|dermatologic agents|mesh-ancestor
153786794|NCT00273390|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153786795|NCT00273390|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153786796|NCT00243035|Bortezomib|bortezomib|mesh-list
153786797|NCT00243035|Tipifarnib|tipifarnib|mesh-list
153786798|NCT00243035|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153786799|NCT00243113|Docetaxel|docetaxel|mesh-list
153786800|NCT00243113|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153786801|NCT00243113|Tubulin Modulators|tubulin modulators|mesh-ancestor
153786802|NCT00243113|Antimitotic Agents|antimitotic agents|mesh-ancestor
153786803|NCT00243113|Mitosis Modulators|mitosis modulators|mesh-ancestor
153786804|NCT00243113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153786859|NCT00273546|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153786861|NCT00273546|Antimitotic Agents|antimitotic agents|mesh-ancestor
153786862|NCT00273546|Mitosis Modulators|mitosis modulators|mesh-ancestor
153786863|NCT00273546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153786864|NCT00283101|Dacetuzumab|dacetuzumab|mesh-list
153786865|NCT00283101|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153786866|NCT00283101|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153786867|NCT00243737|Artesunate|artesunate|mesh-list
153786868|NCT00243737|Mefloquine|mefloquine|mesh-list
153786869|NCT00243737|Antimalarials|antimalarials|mesh-ancestor
153786870|NCT00243737|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153786871|NCT00243737|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153786872|NCT00243737|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153786873|NCT00243737|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153786874|NCT00243737|Antiviral Agents|antiviral agents|mesh-ancestor
153786875|NCT00243737|Schistosomicides|schistosomicides|mesh-ancestor
153786876|NCT00243737|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
153786877|NCT00243737|Anthelmintics|anthelmintics|mesh-ancestor
153786878|NCT00273702|Acetylcysteine|acetylcysteine|mesh-list
153786879|NCT00273702|N-monoacetylcystine|n-monoacetylcystine|mesh-list
153786880|NCT00273702|Antiviral Agents|antiviral agents|mesh-ancestor
153786881|NCT00273702|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153786882|NCT00273702|Expectorants|expectorants|mesh-ancestor
153786913|NCT00283179|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
153786914|NCT00283179|Dopamine Agents|dopamine agents|mesh-ancestor
153786915|NCT00283179|Antidepressive Agents|antidepressive agents|mesh-ancestor
153786916|NCT00283179|Dopamine Agonists|dopamine agonists|mesh-ancestor
153786917|NCT00283179|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
153786918|NCT00283179|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
153786919|NCT00283179|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
153786920|NCT00283179|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
153786921|NCT00243854|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
153786922|NCT00243854|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153786923|NCT00243854|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153786924|NCT00243854|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153786925|NCT00243854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153786926|NCT00243854|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153786927|NCT00273741|Methylphenidate|methylphenidate|mesh-list
153786928|NCT00273741|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
153786929|NCT00273741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153786930|NCT00273741|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
153786931|NCT00273741|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153786932|NCT00273741|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153786933|NCT00273741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153786935|NCT00273741|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153786936|NCT02279134|Paclitaxel|paclitaxel|mesh-list
153786937|NCT02279134|Nedaplatin|nedaplatin|mesh-list
153786938|NCT02279134|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153786939|NCT02279134|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153786955|NCT00244127|Prednisone|prednisone|mesh-list
153786956|NCT00244127|Cyclophosphamide|cyclophosphamide|mesh-list
153786957|NCT00244127|Rituximab|rituximab|mesh-list
153786958|NCT00244127|Vincristine|vincristine|mesh-list
153786959|NCT00244127|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153786960|NCT00244127|Immunologic Factors|immunologic factors|mesh-ancestor
153923339|NCT03124355|Bromides|bromides|mesh-list
153786961|NCT00244127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153786962|NCT00244127|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153786963|NCT00244127|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153786964|NCT00244127|Alkylating Agents|alkylating agents|mesh-ancestor
153786965|NCT00244127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153787016|NCT00244322|Gamma Secretase Inhibitors and Modulators|gamma secretase inhibitors and modulators|mesh-ancestor
153787017|NCT00244322|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153787018|NCT00244322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153787020|NCT00244361|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153787021|NCT00244361|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153787022|NCT00244361|Immunologic Factors|immunologic factors|mesh-ancestor
153787023|NCT00244361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153787024|NCT00244361|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153787025|NCT00274014|Tiotropium Bromide|tiotropium bromide|mesh-list
153787026|NCT00274014|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153787027|NCT00274014|Autonomic Agents|autonomic agents|mesh-ancestor
153787028|NCT00274014|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153787029|NCT00274014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153787030|NCT00274014|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153787031|NCT00274014|Respiratory System Agents|respiratory system agents|mesh-ancestor
153787032|NCT00274014|Parasympatholytics|parasympatholytics|mesh-ancestor
153787033|NCT00274014|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
153787034|NCT00274014|Cholinergic Agents|cholinergic agents|mesh-ancestor
153787035|NCT00274014|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153787036|NCT00274014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153787066|NCT00274053|Cholinergic Agents|cholinergic agents|mesh-ancestor
153787067|NCT00274053|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153787068|NCT00274053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153787069|NCT00417183|Triptorelin Pamoate|triptorelin pamoate|mesh-list
153787070|NCT00417183|Ganirelix|ganirelix|mesh-list
153787071|NCT00417183|Luteolytic Agents|luteolytic agents|mesh-ancestor
153787072|NCT00417183|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
153787073|NCT00417183|Contraceptive Agents|contraceptive agents|mesh-ancestor
153787074|NCT00417183|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153787075|NCT00417183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153787076|NCT00417183|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
153787077|NCT00417183|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153787078|NCT00417183|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153787079|NCT00417183|Hormone Antagonists|hormone antagonists|mesh-ancestor
153787080|NCT00417183|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153787081|NCT00244517|Remifentanil|remifentanil|mesh-list
153787082|NCT00244517|Sevoflurane|sevoflurane|mesh-list
153787083|NCT00244517|Desflurane|desflurane|mesh-list
153787084|NCT00244517|Isoflurane|isoflurane|mesh-list
153787085|NCT00244517|Anesthetics|anesthetics|mesh-ancestor
153787086|NCT00244517|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153787087|NCT00244517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153787088|NCT00244517|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153787089|NCT00244517|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
153787116|NCT00244556|Antimetabolites|antimetabolites|mesh-ancestor
153787117|NCT00244556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153787118|NCT00244556|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153787119|NCT00244556|Dermatologic Agents|dermatologic agents|mesh-ancestor
153787120|NCT00244556|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153787121|NCT00244556|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153787122|NCT00244556|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153787123|NCT00244556|Immunologic Factors|immunologic factors|mesh-ancestor
153787124|NCT00244556|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153787125|NCT00244556|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153881875|NCT01601730|Dexetimide|dexetimide|mesh-list
153787127|NCT00244556|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153787179|NCT00244946|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153787180|NCT00244946|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153787181|NCT00244946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153787182|NCT00244946|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153787184|NCT00244946|Antiviral Agents|antiviral agents|mesh-ancestor
153787185|NCT00244946|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153787186|NCT00244946|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153787187|NCT00244946|Immunologic Factors|immunologic factors|mesh-ancestor
153787188|NCT00244946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153787189|NCT00244946|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153787190|NCT00244946|Alkylating Agents|alkylating agents|mesh-ancestor
153787191|NCT00244946|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153787192|NCT00245024|Sulindac|sulindac|mesh-list
153787193|NCT00245024|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153333645|NCT00971633|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153333661|NCT05510778|Charcoal|charcoal|mesh-list
153787194|NCT00245024|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153787195|NCT00245024|Analgesics|analgesics|mesh-ancestor
153787196|NCT00245024|Sensory System Agents|sensory system agents|mesh-ancestor
153787230|NCT00245141|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153787231|NCT00245141|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153787232|NCT00416637|Bevacizumab|bevacizumab|mesh-list
153787233|NCT00416637|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153787234|NCT00416637|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153787235|NCT00416637|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153787236|NCT00416637|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153787237|NCT00416637|Growth Substances|growth substances|mesh-ancestor
153787238|NCT00416637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153787239|NCT00416637|Growth Inhibitors|growth inhibitors|mesh-ancestor
153787240|NCT00245258|Sildenafil Citrate|sildenafil citrate|mesh-list
153787241|NCT00245258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153787242|NCT00245258|Vasodilator Agents|vasodilator agents|mesh-ancestor
153787243|NCT00245258|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
153346797|NCT00052910|Vitamins|vitamins|mesh-ancestor
153787244|NCT00245258|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
153787245|NCT00245258|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153787246|NCT00245258|Urological Agents|urological agents|mesh-ancestor
153787247|NCT02961803|Biotin|biotin|mesh-list
153923376|NCT02929589|Ibuprofen|ibuprofen|mesh-list
153787250|NCT02961803|Micronutrients|micronutrients|mesh-ancestor
153787251|NCT02961803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153787252|NCT00245297|Factor VIII|factor viii|mesh-list
153787253|NCT00245297|Coagulants|coagulants|mesh-ancestor
153787254|NCT00274404|Valacyclovir|valacyclovir|mesh-list
153787255|NCT00274404|Antiviral Agents|antiviral agents|mesh-ancestor
153787256|NCT00274404|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153787257|NCT00283764|Latanoprost|latanoprost|mesh-list
153787258|NCT00283764|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
153787259|NCT00283764|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
153787260|NCT00245336|Thrombin|thrombin|mesh-list
153787261|NCT00245336|Hemostatics|hemostatics|mesh-ancestor
153787262|NCT00245336|Coagulants|coagulants|mesh-ancestor
153787263|NCT00274443|Carboplatin|carboplatin|mesh-list
153787264|NCT00274443|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
153787265|NCT00274443|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153787266|NCT00245375|Acetaminophen|acetaminophen|mesh-list
153787272|NCT00245375|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153787273|NCT00245375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153787274|NCT00245375|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153787275|NCT00245375|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153787276|NCT00245375|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153787277|NCT00245375|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153787278|NCT00245375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153787279|NCT00245375|Antipyretics|antipyretics|mesh-ancestor
153787338|NCT00274638|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
153787339|NCT00274638|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153787341|NCT00274677|Anticonvulsants|anticonvulsants|mesh-ancestor
153787342|NCT00274677|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153787343|NCT00274677|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153787344|NCT00274677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153333797|NCT00955487|Nitric Oxide|nitric oxide|mesh-list
153787345|NCT00274677|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153787346|NCT00274677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153787347|NCT00274677|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153787348|NCT00274677|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153787349|NCT00274677|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153787350|NCT00274677|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153787351|NCT00274677|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153787352|NCT00245921|Levonorgestrel|levonorgestrel|mesh-list
153787354|NCT00245921|Estradiol|estradiol|mesh-list
153787394|NCT00246194|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153787395|NCT00246194|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153787396|NCT00246194|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153787397|NCT00246194|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153346840|NCT01314001|Varenicline|varenicline|mesh-list
153787398|NCT00246194|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
153787399|NCT00246194|Dopamine Agents|dopamine agents|mesh-ancestor
153787400|NCT00284232|Insulin|insulin|mesh-list
153787401|NCT00284232|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153787402|NCT00284232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153787403|NCT00246233|Methylphenidate|methylphenidate|mesh-list
153787404|NCT00246233|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
153787410|NCT00246233|Dopamine Agents|dopamine agents|mesh-ancestor
153787459|NCT00284271|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153787460|NCT00284271|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153787461|NCT00284271|Alkylating Agents|alkylating agents|mesh-ancestor
153787462|NCT00284271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153787463|NCT00284271|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153787464|NCT00284271|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153787465|NCT00284271|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153787466|NCT00284271|Glucocorticoids|glucocorticoids|mesh-ancestor
153787467|NCT00284271|Hormones|hormones|mesh-ancestor
153787469|NCT00284271|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153787522|NCT00416676|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153787523|NCT00416676|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153787524|NCT00416676|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153787525|NCT00416676|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153787526|NCT00416676|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153787527|NCT00416676|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153787528|NCT00416676|Tubulin Modulators|tubulin modulators|mesh-ancestor
153787529|NCT00416676|Antimitotic Agents|antimitotic agents|mesh-ancestor
153787530|NCT00416676|Mitosis Modulators|mitosis modulators|mesh-ancestor
153787531|NCT00246623|Hypoglycemic Agents|hypoglycemic agents|mesh-list
153787532|NCT00246623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153787534|NCT00284427|Vitamins|vitamins|mesh-ancestor
153787583|NCT00247052|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153787585|NCT00247052|Sensory System Agents|sensory system agents|mesh-ancestor
153787586|NCT00247052|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153787587|NCT00247052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153787588|NCT00247052|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153787589|NCT00247052|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153787590|NCT00247052|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153787593|NCT00277602|Riluzole|riluzole|mesh-list
153787648|NCT00247247|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
153787649|NCT00247247|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153787650|NCT00247247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153787651|NCT00277758|Interferons|interferons|mesh-list
153787652|NCT00277758|Ribavirin|ribavirin|mesh-list
153787653|NCT00277758|Interferon-alpha|interferon-alpha|mesh-list
153787654|NCT00277758|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
153787655|NCT00277758|Interleukin-2|interleukin-2|mesh-list
153787657|NCT00277758|Antiviral Agents|antiviral agents|mesh-ancestor
153787658|NCT00277758|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153787659|NCT00277758|Antimetabolites|antimetabolites|mesh-ancestor
153787660|NCT00277758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153787661|NCT00277758|Immunologic Factors|immunologic factors|mesh-ancestor
153787662|NCT00277758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153787663|NCT00277758|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153787664|NCT00277758|Analgesics|analgesics|mesh-ancestor
153787665|NCT00277758|Sensory System Agents|sensory system agents|mesh-ancestor
153787666|NCT00277758|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153787667|NCT00247364|Levetiracetam|levetiracetam|mesh-list
153787668|NCT00247364|Anticonvulsants|anticonvulsants|mesh-ancestor
153787669|NCT00247364|Nootropic Agents|nootropic agents|mesh-ancestor
153787670|NCT00247403|Deoxyglucose|deoxyglucose|mesh-list
153787671|NCT00247403|Antimetabolites|antimetabolites|mesh-ancestor
153787672|NCT00247403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153787673|NCT00247403|Antiviral Agents|antiviral agents|mesh-ancestor
153787674|NCT00247403|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153787675|NCT00424814|Ritonavir|ritonavir|mesh-list
153787694|NCT00284973|Monatide (IMS 3015)|monatide (ims 3015)|mesh-list
153787695|NCT00284973|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153787696|NCT00284973|Immunologic Factors|immunologic factors|mesh-ancestor
153787697|NCT00284973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153787699|NCT00247481|Gefitinib|gefitinib|mesh-list
153787700|NCT00247481|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153787701|NCT00247481|Tubulin Modulators|tubulin modulators|mesh-ancestor
153787702|NCT00247481|Antimitotic Agents|antimitotic agents|mesh-ancestor
153787703|NCT00247481|Mitosis Modulators|mitosis modulators|mesh-ancestor
153787704|NCT00247481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153787705|NCT00247481|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153923407|NCT02870738|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153787706|NCT00247481|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153787707|NCT00247481|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153787708|NCT00247559|Botulinum Toxins|botulinum toxins|mesh-list
153787709|NCT00247559|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
153787710|NCT00247559|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
153787711|NCT00247559|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
153334173|NCT01142947|Hormones|hormones|mesh-ancestor
153787712|NCT00247559|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153787713|NCT00247559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153787714|NCT00247559|Cholinergic Agents|cholinergic agents|mesh-ancestor
153787715|NCT00247559|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153787716|NCT00247559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153787717|NCT00247559|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
153787718|NCT00247559|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153787719|NCT00285051|Ondansetron|ondansetron|mesh-list
153787720|NCT00285051|Antiemetics|antiemetics|mesh-ancestor
153787721|NCT00285051|Autonomic Agents|autonomic agents|mesh-ancestor
153787722|NCT00285051|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153787723|NCT00285051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153787724|NCT00285051|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153787725|NCT00285051|Antipruritics|antipruritics|mesh-ancestor
153787726|NCT00285051|Dermatologic Agents|dermatologic agents|mesh-ancestor
153787727|NCT00285051|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
153787732|NCT00247715|Pantoprazole|pantoprazole|mesh-list
153787733|NCT00247715|Ranitidine|ranitidine|mesh-list
153787734|NCT00247715|Ranitidine bismuth citrate|ranitidine bismuth citrate|mesh-list
153787735|NCT00247715|Magnesium Oxide|magnesium oxide|mesh-list
153787736|NCT00247715|Aluminum Hydroxide|aluminum hydroxide|mesh-list
153787737|NCT00247715|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
153787738|NCT00247715|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153787739|NCT00247715|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
153787740|NCT00247715|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153787741|NCT00247715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153787742|NCT00247715|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
153787743|NCT00247715|Histamine Antagonists|histamine antagonists|mesh-ancestor
153787744|NCT00247715|Histamine Agents|histamine agents|mesh-ancestor
153787745|NCT00247715|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153787746|NCT00247715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153787747|NCT00247715|Antacids|antacids|mesh-ancestor
153787748|NCT00247715|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153787749|NCT00247715|Immunologic Factors|immunologic factors|mesh-ancestor
153787750|NCT00285090|Calcium, Dietary|calcium, dietary|mesh-list
153787751|NCT00285090|Vitamin D|vitamin d|mesh-list
153787752|NCT00285090|Ergocalciferols|ergocalciferols|mesh-list
153787753|NCT00285090|Cholecalciferol|cholecalciferol|mesh-list
153787754|NCT00285090|Vitamins|vitamins|mesh-list
153787755|NCT00285090|Calcium|calcium|mesh-list
153787756|NCT00285090|Micronutrients|micronutrients|mesh-ancestor
153787757|NCT00285090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153787758|NCT00285090|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153787759|NCT00285090|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153787760|NCT00417222|Olmesartan|olmesartan|mesh-list
153787761|NCT00417222|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
153787780|NCT00247910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153787781|NCT00247910|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
153787782|NCT00247910|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153787783|NCT00247910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153787784|NCT00278187|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
153787785|NCT00278187|Volociximab|volociximab|mesh-list
153787786|NCT00278187|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153787787|NCT00278187|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153787788|NCT00278187|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153334255|NCT04393220|Nivolumab|nivolumab|mesh-list
153334323|NCT04392128|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153787789|NCT00278187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153787790|NCT00278187|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153787791|NCT00278187|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153787792|NCT00278187|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153787793|NCT00278187|Growth Substances|growth substances|mesh-ancestor
153787794|NCT00278187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153787795|NCT00278187|Growth Inhibitors|growth inhibitors|mesh-ancestor
153346966|NCT04780061|Vitamin K 2|vitamin k 2|mesh-list
153787796|NCT00247988|Carboplatin|carboplatin|mesh-list
153787797|NCT00247988|Docetaxel|docetaxel|mesh-list
153787798|NCT00247988|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153787799|NCT00247988|Tubulin Modulators|tubulin modulators|mesh-ancestor
153787800|NCT00247988|Antimitotic Agents|antimitotic agents|mesh-ancestor
153787801|NCT00247988|Mitosis Modulators|mitosis modulators|mesh-ancestor
153787802|NCT00247988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153787803|NCT00248144|Famciclovir|famciclovir|mesh-list
153787804|NCT00248144|Antiviral Agents|antiviral agents|mesh-ancestor
153787805|NCT00248144|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153787806|NCT00248144|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153787807|NCT00248144|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153787808|NCT00248144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153787809|NCT00278265|Methotrexate|methotrexate|mesh-list
153787810|NCT00278265|Fludarabine phosphate|fludarabine phosphate|mesh-list
153787811|NCT00278265|Fludarabine|fludarabine|mesh-list
153787813|NCT00278265|Abortifacient Agents|abortifacient agents|mesh-ancestor
153787816|NCT00278265|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153787818|NCT00278265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153787820|NCT00278265|Dermatologic Agents|dermatologic agents|mesh-ancestor
153787821|NCT00278265|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153787822|NCT00278265|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153787823|NCT00278265|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153787824|NCT00278265|Immunologic Factors|immunologic factors|mesh-ancestor
153787825|NCT00278265|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153787826|NCT00278265|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153787827|NCT00248183|Naluzotan|naluzotan|mesh-list
153787828|NCT00248183|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
153787829|NCT00248183|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
153787830|NCT00248183|Serotonin Agents|serotonin agents|mesh-ancestor
153787831|NCT00248183|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153787832|NCT00248183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153787833|NCT00248183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153787834|NCT00278343|Cediranib|cediranib|mesh-list
153787835|NCT00278343|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153787836|NCT00278343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153787837|NCT00278343|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153787838|NCT00278343|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153787839|NCT00248261|Ziprasidone|ziprasidone|mesh-list
153787840|NCT00248261|Sertraline|sertraline|mesh-list
153787841|NCT00248261|Antidepressive Agents|antidepressive agents|mesh-ancestor
153787842|NCT00248261|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153787843|NCT00248261|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
153787844|NCT00248261|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153787858|NCT00248300|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153787859|NCT00248300|Disinfectants|disinfectants|mesh-ancestor
153787861|NCT00278382|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153334397|NCT03821168|Growth Inhibitors|growth inhibitors|mesh-ancestor
153787862|NCT00278382|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153787863|NCT00278382|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153787864|NCT00278382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153787865|NCT00248339|Ribavirin|ribavirin|mesh-list
153787866|NCT00248339|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
153787867|NCT00248339|Epoetin Alfa|epoetin alfa|mesh-list
153787868|NCT00248339|Antimetabolites|antimetabolites|mesh-ancestor
153787869|NCT00248339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153787870|NCT00248339|Antiviral Agents|antiviral agents|mesh-ancestor
153787871|NCT00248339|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153787872|NCT00248339|Hematinics|hematinics|mesh-ancestor
153787873|NCT00278421|Prednisone|prednisone|mesh-list
153787874|NCT00278421|Cyclophosphamide|cyclophosphamide|mesh-list
153787875|NCT00278421|Rituximab|rituximab|mesh-list
153787876|NCT00278421|Doxorubicin|doxorubicin|mesh-list
153787877|NCT00278421|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
153787878|NCT00278421|Vincristine|vincristine|mesh-list
153787879|NCT00278421|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153787880|NCT00278421|Immunologic Factors|immunologic factors|mesh-ancestor
153787881|NCT00278421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153787895|NCT00278421|Hormones|hormones|mesh-ancestor
153787908|NCT00248456|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153787909|NCT00248456|Glucocorticoids|glucocorticoids|mesh-ancestor
153787910|NCT00248456|Hormones|hormones|mesh-ancestor
153787911|NCT00248456|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153787912|NCT00248456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153787913|NCT00248456|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153787914|NCT00248456|Respiratory System Agents|respiratory system agents|mesh-ancestor
153787915|NCT00248456|Dermatologic Agents|dermatologic agents|mesh-ancestor
153787916|NCT00278460|Gemcitabine|gemcitabine|mesh-list
153787917|NCT00278460|Docetaxel|docetaxel|mesh-list
153787918|NCT00278460|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153787919|NCT00278460|Antimetabolites|antimetabolites|mesh-ancestor
153787920|NCT00278460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153787922|NCT00278460|Tubulin Modulators|tubulin modulators|mesh-ancestor
153787923|NCT00278460|Antimitotic Agents|antimitotic agents|mesh-ancestor
153787924|NCT00278460|Mitosis Modulators|mitosis modulators|mesh-ancestor
153787925|NCT00248729|Midazolam|midazolam|mesh-list
153787926|NCT00248729|Etomidate|etomidate|mesh-list
153787927|NCT00248729|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153787928|NCT00248729|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153787929|NCT00248729|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153787930|NCT00248729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153787931|NCT00248729|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153347079|NCT00118352|Cyclosporine|cyclosporine|mesh-list
153787932|NCT00248729|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153787933|NCT00248729|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153787934|NCT00248729|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153787935|NCT00248729|Anesthetics, General|anesthetics, general|mesh-ancestor
153787936|NCT00248729|Anesthetics|anesthetics|mesh-ancestor
153334473|NCT05504382|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153787937|NCT00248729|GABA Modulators|gaba modulators|mesh-ancestor
153787938|NCT00248729|GABA Agents|gaba agents|mesh-ancestor
153787939|NCT00248729|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153787940|NCT00248729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153787941|NCT00278694|Oxaliplatin|oxaliplatin|mesh-list
153787946|NCT00248963|Estrogens|estrogens|mesh-ancestor
153787947|NCT00248963|Hormones|hormones|mesh-ancestor
153787948|NCT00248963|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153787949|NCT00248963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153787950|NCT00248963|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
153787951|NCT00248963|Contraceptive Agents|contraceptive agents|mesh-ancestor
153787952|NCT00248963|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153787953|NCT00248963|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
153787954|NCT00248963|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
153787955|NCT00248963|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
153787956|NCT00248963|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
153787957|NCT00249041|Etanercept|etanercept|mesh-list
153787958|NCT00249041|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153787959|NCT00249041|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153787960|NCT00249041|Analgesics|analgesics|mesh-ancestor
153787961|NCT00249041|Sensory System Agents|sensory system agents|mesh-ancestor
153787962|NCT00249041|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153787963|NCT00249041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153787964|NCT00249041|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153787965|NCT00249041|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153787966|NCT00249041|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153787967|NCT00249041|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153787969|NCT00285519|Doxazosin|doxazosin|mesh-list
153787970|NCT00285519|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153787971|NCT00285519|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
153787972|NCT00285519|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
153787973|NCT00285519|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
153787974|NCT00285519|Adrenergic Agents|adrenergic agents|mesh-ancestor
153787975|NCT00285519|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153787976|NCT00285519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153787977|NCT00285519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153787986|NCT00278772|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153787987|NCT00278772|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153787988|NCT00278772|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153787989|NCT00249119|Risperidone|risperidone|mesh-list
153787990|NCT00249119|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153787991|NCT00249119|Serotonin Agents|serotonin agents|mesh-ancestor
153787992|NCT00249119|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153787993|NCT00249119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153787994|NCT00249119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153787995|NCT00249119|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153787996|NCT00249119|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153787997|NCT00249119|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153787998|NCT00249119|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153787999|NCT00249119|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
153788000|NCT00249119|Dopamine Agents|dopamine agents|mesh-ancestor
153788001|NCT00285597|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
153788002|NCT00285597|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
153788003|NCT00285597|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153788004|NCT00249158|Risperidone|risperidone|mesh-list
153788005|NCT00249158|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153788006|NCT00249158|Serotonin Agents|serotonin agents|mesh-ancestor
153334474|NCT05504382|Analgesics|analgesics|mesh-ancestor
153418832|NCT02956070|Hormones|hormones|mesh-ancestor
153788007|NCT00249158|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153788008|NCT00249158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153788009|NCT00249158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153788010|NCT00249158|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153788011|NCT00249158|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153788012|NCT00249158|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153788013|NCT00249158|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153788029|NCT00249197|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
153788030|NCT00249197|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153788032|NCT00278967|Cathartics|cathartics|mesh-ancestor
153788033|NCT00278967|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153788034|NCT00278967|Laxatives|laxatives|mesh-ancestor
153788036|NCT00249236|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153347146|NCT02176031|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153788037|NCT00249236|Serotonin Agents|serotonin agents|mesh-ancestor
153788038|NCT00249236|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153788039|NCT00249236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153788040|NCT00249236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153788041|NCT00249236|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153788042|NCT00249236|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153788043|NCT00249236|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153788044|NCT00249236|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153788045|NCT00249236|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
153788046|NCT00249236|Dopamine Agents|dopamine agents|mesh-ancestor
153788047|NCT00285675|Calcitriol|calcitriol|mesh-list
153788048|NCT00285675|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153788049|NCT00285675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153788050|NCT00285675|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
153788051|NCT00285675|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153788052|NCT00285675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153788053|NCT00285675|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
153788054|NCT00285675|Vitamins|vitamins|mesh-ancestor
153788055|NCT00285675|Micronutrients|micronutrients|mesh-ancestor
153788056|NCT00285675|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153788057|NCT02215096|GSK2636771|gsk2636771|mesh-list
153788058|NCT02215096|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153788059|NCT02215096|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153788072|NCT00249353|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153788073|NCT00249353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153788074|NCT00249353|Dopamine Agents|dopamine agents|mesh-ancestor
153788075|NCT00249353|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153788077|NCT00249431|Antidepressive Agents|antidepressive agents|mesh-ancestor
153788078|NCT00249431|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153788079|NCT00249431|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
153788080|NCT00249431|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153788081|NCT00249431|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153347177|NCT03014297|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
153334547|NCT05563350|GABA Modulators|gaba modulators|mesh-ancestor
153788082|NCT00249431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153788083|NCT00249431|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153788084|NCT00249431|Serotonin Agents|serotonin agents|mesh-ancestor
153788085|NCT00249431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153788086|NCT00249509|Bupropion|bupropion|mesh-list
153788087|NCT00249509|Nefazodone|nefazodone|mesh-list
153788088|NCT00249509|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
153788125|NCT00249587|Respiratory System Agents|respiratory system agents|mesh-ancestor
153923606|NCT01081262|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153788126|NCT00279123|Pantoprazole|pantoprazole|mesh-list
153788127|NCT00279123|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
153788128|NCT00279123|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153788129|NCT00279123|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
153788130|NCT00279123|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153788131|NCT00279123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153788132|NCT00279162|Betamethasone|betamethasone|mesh-list
153788133|NCT00279162|Calcipotriene|calcipotriene|mesh-list
153788134|NCT00279162|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153788135|NCT00279162|Glucocorticoids|glucocorticoids|mesh-ancestor
153788137|NCT00279162|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153788138|NCT00279162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153788139|NCT00279162|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153422965|NCT05406050|Vitamin D|vitamin d|mesh-list
153788141|NCT00279162|Dermatologic Agents|dermatologic agents|mesh-ancestor
153347178|NCT03014297|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153788143|NCT00249704|Ergocalciferols|ergocalciferols|mesh-list
153788144|NCT00249704|Cholecalciferol|cholecalciferol|mesh-list
153788145|NCT00249704|Vitamins|vitamins|mesh-list
153788146|NCT00249704|Micronutrients|micronutrients|mesh-ancestor
153788147|NCT00249704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153788148|NCT00249704|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153788149|NCT00249704|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153788150|NCT00249782|Metronidazole|metronidazole|mesh-list
153788151|NCT00249782|Dapsone|dapsone|mesh-list
153788152|NCT00249782|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153334622|NCT05560308|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153788153|NCT00249782|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153334623|NCT05560308|Tubulin Modulators|tubulin modulators|mesh-ancestor
153788154|NCT00249782|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153334697|NCT04391582|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153788155|NCT00249782|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153788156|NCT00249782|Antimalarials|antimalarials|mesh-ancestor
153347237|NCT01317667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153788161|NCT00279240|Metformin|metformin|mesh-list
153788163|NCT00279240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153788164|NCT00249860|Interferons|interferons|mesh-list
153788165|NCT00249860|Ribavirin|ribavirin|mesh-list
153788166|NCT00249860|Interferon-beta|interferon-beta|mesh-list
153788167|NCT00249860|Interferon beta-1a|interferon beta-1a|mesh-list
153788168|NCT00249860|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153788169|NCT00249860|Antiviral Agents|antiviral agents|mesh-ancestor
153788170|NCT00249860|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153788171|NCT00249860|Antimetabolites|antimetabolites|mesh-ancestor
153788172|NCT00249860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153788174|NCT00249860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153788175|NCT00249860|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153788176|NCT00249899|Atorvastatin|atorvastatin|mesh-list
153788177|NCT00249899|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
153788178|NCT00249899|Simvastatin|simvastatin|mesh-list
153788179|NCT00249899|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-list
153788180|NCT00249899|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153788181|NCT00249899|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153788182|NCT00249899|Antimetabolites|antimetabolites|mesh-ancestor
153788183|NCT00249899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153788184|NCT00249899|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153788186|NCT00249938|Colesevelam Hydrochloride|colesevelam hydrochloride|mesh-list
153788187|NCT00249938|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153788188|NCT00249938|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153788189|NCT00249938|Antimetabolites|antimetabolites|mesh-ancestor
153788190|NCT00249938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153788191|NCT00249938|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153788192|NCT00249977|Capecitabine|capecitabine|mesh-list
153788193|NCT00249977|Irinotecan|irinotecan|mesh-list
153788207|NCT00279435|Visilizumab|visilizumab|mesh-list
153788208|NCT00279435|Immunologic Factors|immunologic factors|mesh-ancestor
153788209|NCT00279435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153788210|NCT00286026|Azithromycin|azithromycin|mesh-list
153788211|NCT00286026|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153788212|NCT00286026|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153788213|NCT00250172|Rolipram|rolipram|mesh-list
153788214|NCT00250172|Antidepressive Agents|antidepressive agents|mesh-ancestor
153788215|NCT00250172|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153788216|NCT00250172|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
153788217|NCT00250172|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
153788218|NCT00250172|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153788219|NCT00250172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153788220|NCT02961608|Tacrolimus|tacrolimus|mesh-list
153788221|NCT02961608|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153788222|NCT02961608|Immunologic Factors|immunologic factors|mesh-ancestor
153788223|NCT02961608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153788224|NCT02961608|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
153788225|NCT02961608|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153788226|NCT02961608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153788227|NCT00286104|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
153334698|NCT04391582|Coccidiostats|coccidiostats|mesh-ancestor
153788228|NCT00286104|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153788230|NCT00286143|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153788231|NCT00286143|Narcotics|narcotics|mesh-ancestor
153788256|NCT00250562|Valsartan|valsartan|mesh-list
153788258|NCT00250562|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153347309|NCT00123110|Leuprolide|leuprolide|mesh-list
153788259|NCT00250562|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
153788260|NCT00250562|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
153788261|NCT00250562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153788262|NCT00250562|Diuretics|diuretics|mesh-ancestor
153788263|NCT00250562|Natriuretic Agents|natriuretic agents|mesh-ancestor
153788264|NCT00250562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153788265|NCT00250562|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
153788266|NCT00250562|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153788267|NCT02960880|Rivaroxaban|rivaroxaban|mesh-list
153788268|NCT02960880|Phenprocoumon|phenprocoumon|mesh-list
153788269|NCT02960880|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
153788270|NCT02960880|Antithrombins|antithrombins|mesh-ancestor
153788271|NCT02960880|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
153788272|NCT02960880|Protease Inhibitors|protease inhibitors|mesh-ancestor
153788316|NCT00286416|Respiratory System Agents|respiratory system agents|mesh-ancestor
153788317|NCT00250874|Docetaxel|docetaxel|mesh-list
153788318|NCT00250874|Doxorubicin|doxorubicin|mesh-list
153788319|NCT00250874|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
153788320|NCT00250874|Trastuzumab|trastuzumab|mesh-list
153788321|NCT00250874|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153788322|NCT00250874|Tubulin Modulators|tubulin modulators|mesh-ancestor
153788323|NCT00250874|Antimitotic Agents|antimitotic agents|mesh-ancestor
153788324|NCT00250874|Mitosis Modulators|mitosis modulators|mesh-ancestor
153788325|NCT00250874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153788326|NCT00250874|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153788327|NCT00250874|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153788328|NCT00250874|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153788329|NCT00250874|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153788330|NCT00250874|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153788331|NCT00279825|Levodopa|levodopa|mesh-list
153788332|NCT00279825|Carbidopa|carbidopa|mesh-list
153788333|NCT00279825|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
153788335|NCT00279825|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
153788336|NCT00279825|Dopamine Agents|dopamine agents|mesh-ancestor
153788337|NCT00279825|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153788338|NCT00279825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153788339|NCT00279825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153788340|NCT00279825|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
153788341|NCT00279825|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153788342|NCT00279825|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153788343|NCT00279825|Immunologic Factors|immunologic factors|mesh-ancestor
153788344|NCT00279825|Dopamine Agonists|dopamine agonists|mesh-ancestor
153788356|NCT00250991|Eptifibatide|eptifibatide|mesh-list
153788360|NCT00250991|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153788361|NCT00286611|Amifostine|amifostine|mesh-list
153788362|NCT00286611|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
153788363|NCT00286611|Protective Agents|protective agents|mesh-ancestor
153788364|NCT00286611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153788365|NCT00416832|Prednisone|prednisone|mesh-list
153788366|NCT00416832|Cyclophosphamide|cyclophosphamide|mesh-list
153788367|NCT00416832|Dacarbazine|dacarbazine|mesh-list
153788368|NCT00416832|Doxorubicin|doxorubicin|mesh-list
153788369|NCT00416832|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
153788370|NCT00416832|Etoposide|etoposide|mesh-list
153788371|NCT00416832|Vincristine|vincristine|mesh-list
153788372|NCT00416832|Procarbazine|procarbazine|mesh-list
153788373|NCT00416832|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153788374|NCT00416832|Immunologic Factors|immunologic factors|mesh-ancestor
153788375|NCT00416832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153788376|NCT00416832|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153788377|NCT00416832|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153788378|NCT00416832|Alkylating Agents|alkylating agents|mesh-ancestor
153788379|NCT00416832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153334920|NCT01457690|alpha-Tocopherol|alpha-tocopherol|mesh-list
153334921|NCT01457690|Antioxidants|antioxidants|mesh-ancestor
153334922|NCT01457690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153334923|NCT01457690|Protective Agents|protective agents|mesh-ancestor
153334924|NCT01457690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153334925|NCT01457690|Vitamins|vitamins|mesh-ancestor
153334926|NCT01457690|Micronutrients|micronutrients|mesh-ancestor
153334927|NCT01451060|Ephedrine|ephedrine|mesh-list
153788401|NCT00251030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153788402|NCT00251030|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
153788403|NCT00251030|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
153788404|NCT00251030|Protease Inhibitors|protease inhibitors|mesh-ancestor
153788405|NCT00251030|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153788406|NCT00251030|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153788407|NCT00251030|Antiviral Agents|antiviral agents|mesh-ancestor
153788408|NCT00251030|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153788410|NCT00286689|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153788411|NCT00286689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153788412|NCT02961491|3-Iodobenzylguanidine|3-iodobenzylguanidine|mesh-list
153788413|NCT02961491|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153788414|NCT02961491|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153788415|NCT02961491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153788416|NCT02961491|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
153788417|NCT01640002|Bromides|bromides|mesh-list
153788418|NCT01640002|Propantheline|propantheline|mesh-list
153788419|NCT01640002|Anticonvulsants|anticonvulsants|mesh-ancestor
153788420|NCT01640002|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
153788421|NCT01640002|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153788422|NCT01640002|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
153472624|NCT04344756|Heparin|heparin|mesh-list
153788423|NCT01640002|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
153788424|NCT01640002|Cholinergic Agents|cholinergic agents|mesh-ancestor
153788425|NCT01640002|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153788426|NCT01640002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153788427|NCT01640002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153788434|NCT00279903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153788435|NCT00279903|Cholinergic Agents|cholinergic agents|mesh-ancestor
153788436|NCT00279903|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153788437|NCT00279903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153788438|NCT00279903|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
153788439|NCT00279903|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153788440|NCT00279903|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153788441|NCT01640275|Propofol|propofol|mesh-list
153788442|NCT01640275|Isoflurane|isoflurane|mesh-list
153788443|NCT01640275|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153788444|NCT01640275|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153788445|NCT01640275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153788446|NCT01640275|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153788447|NCT01640275|Anesthetics, General|anesthetics, general|mesh-ancestor
153788448|NCT01640275|Anesthetics|anesthetics|mesh-ancestor
153788449|NCT01640275|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
153788450|NCT04529356|Acetaminophen|acetaminophen|mesh-list
153788451|NCT04529356|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153347414|NCT04262934|Vitamins|vitamins|mesh-ancestor
153788452|NCT04529356|Analgesics|analgesics|mesh-ancestor
153788453|NCT04529356|Sensory System Agents|sensory system agents|mesh-ancestor
153788454|NCT04529356|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153788455|NCT04529356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153788456|NCT04529356|Antipyretics|antipyretics|mesh-ancestor
153788457|NCT01640665|Capecitabine|capecitabine|mesh-list
153347415|NCT04262934|Micronutrients|micronutrients|mesh-ancestor
153788484|NCT01640782|Protective Agents|protective agents|mesh-ancestor
153788485|NCT01640782|Vitamin B Complex|vitamin b complex|mesh-ancestor
153788486|NCT01640782|Vitamins|vitamins|mesh-ancestor
153788487|NCT01640782|Micronutrients|micronutrients|mesh-ancestor
153788488|NCT00251186|Capecitabine|capecitabine|mesh-list
153788489|NCT00251186|Cetuximab|cetuximab|mesh-list
153374333|NCT04738773|Naltrexone|naltrexone|mesh-list
153788490|NCT00251186|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153788491|NCT00251186|Antimetabolites|antimetabolites|mesh-ancestor
153788492|NCT00251186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153788493|NCT00251186|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153788494|NCT00251186|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153788495|NCT01641250|Cytarabine|cytarabine|mesh-list
153788496|NCT01641250|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153788497|NCT01641250|Antimetabolites|antimetabolites|mesh-ancestor
153788498|NCT01641250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153788499|NCT01641250|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153788500|NCT01641250|Antiviral Agents|antiviral agents|mesh-ancestor
153788501|NCT01641250|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153788502|NCT01641250|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153788503|NCT01641250|Immunologic Factors|immunologic factors|mesh-ancestor
153788504|NCT01641250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153788505|NCT01641289|Acetaminophen|acetaminophen|mesh-list
153788506|NCT01641289|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153788507|NCT01641289|Analgesics|analgesics|mesh-ancestor
153788508|NCT01641289|Sensory System Agents|sensory system agents|mesh-ancestor
153788509|NCT01641289|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153788510|NCT01641289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153788511|NCT01641289|Antipyretics|antipyretics|mesh-ancestor
153788512|NCT01641406|Cyclophosphamide|cyclophosphamide|mesh-list
153788513|NCT01641406|Bevacizumab|bevacizumab|mesh-list
153788514|NCT01641406|Docetaxel|docetaxel|mesh-list
153788515|NCT01641406|Capecitabine|capecitabine|mesh-list
153788516|NCT01641406|Trastuzumab|trastuzumab|mesh-list
153788528|NCT01641406|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153788529|NCT01641406|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153788530|NCT01641406|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153788531|NCT01641406|Growth Substances|growth substances|mesh-ancestor
153788532|NCT01641406|Growth Inhibitors|growth inhibitors|mesh-ancestor
153788533|NCT01641406|Tubulin Modulators|tubulin modulators|mesh-ancestor
153788534|NCT01641406|Antimitotic Agents|antimitotic agents|mesh-ancestor
153788535|NCT01641406|Mitosis Modulators|mitosis modulators|mesh-ancestor
153788536|NCT01641406|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153788537|NCT01641406|Antimetabolites|antimetabolites|mesh-ancestor
153788538|NCT01641406|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153788539|NCT01641406|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153788540|NCT01641406|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153788541|NCT01641406|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153788542|NCT01641406|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153788543|NCT01641523|Polymethyl Methacrylate|polymethyl methacrylate|mesh-list
153788544|NCT01641523|Vasodilator Agents|vasodilator agents|mesh-ancestor
153788545|NCT01641523|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
153788546|NCT01641523|Protective Agents|protective agents|mesh-ancestor
153473074|NCT03018756|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153788547|NCT01641523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153374340|NCT03833063|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
153788550|NCT01641796|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153335020|NCT01188109|Antimetabolites|antimetabolites|mesh-ancestor
153335022|NCT01458236|Beraprost|beraprost|mesh-list
153788551|NCT01641796|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153788552|NCT01641796|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153788553|NCT00280098|Docetaxel|docetaxel|mesh-list
153788554|NCT00280098|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153788555|NCT00280098|Tubulin Modulators|tubulin modulators|mesh-ancestor
153788556|NCT00280098|Antimitotic Agents|antimitotic agents|mesh-ancestor
153788557|NCT00280098|Mitosis Modulators|mitosis modulators|mesh-ancestor
153788571|NCT01685827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153788572|NCT05140096|Fluconazole|fluconazole|mesh-list
153788573|NCT05140096|Isavuconazole|isavuconazole|mesh-list
153788574|NCT05140096|Acalabrutinib|acalabrutinib|mesh-list
153788575|NCT05140096|Antifungal Agents|antifungal agents|mesh-ancestor
153788576|NCT05140096|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153788577|NCT05140096|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
153788578|NCT05140096|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153788579|NCT05140096|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153788580|NCT05140096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153788581|NCT05140096|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153788582|NCT05140096|Hormone Antagonists|hormone antagonists|mesh-ancestor
153788583|NCT05140096|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153788584|NCT05140096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153788585|NCT05140096|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
153788586|NCT05140096|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
153788587|NCT05140096|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153788588|NCT05140096|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153788589|NCT05140096|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153788590|NCT00251459|Ranibizumab|ranibizumab|mesh-list
153788591|NCT00251459|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153788592|NCT00251459|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153788593|NCT00251459|Growth Substances|growth substances|mesh-ancestor
153788620|NCT00280176|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153788621|NCT00280176|Immunologic Factors|immunologic factors|mesh-ancestor
153788622|NCT00280176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153788623|NCT00280215|Losartan|losartan|mesh-list
153788624|NCT00280215|Lisinopril|lisinopril|mesh-list
153788625|NCT00280215|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-list
153335093|NCT01458626|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153788626|NCT00280215|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
153788627|NCT00280215|Enzyme Inhibitors|enzyme inhibitors|mesh-list
153788628|NCT00280215|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153788629|NCT00280215|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153788630|NCT00280215|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
153788631|NCT00280215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153788633|NCT00280215|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
153788634|NCT00280215|Protective Agents|protective agents|mesh-ancestor
153788635|NCT00280215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153788636|NCT00251498|Cetuximab|cetuximab|mesh-list
153788637|NCT00251498|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153788638|NCT00251498|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153788639|NCT02271334|Albuterol|albuterol|mesh-list
153788640|NCT02271334|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153788641|NCT02271334|Autonomic Agents|autonomic agents|mesh-ancestor
153788642|NCT02271334|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153788643|NCT02271334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153788644|NCT02271334|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153788667|NCT00280371|Respiratory System Agents|respiratory system agents|mesh-ancestor
153788668|NCT00280371|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
153788669|NCT00280371|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
153788670|NCT00280371|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153788671|NCT00280371|Adrenergic Agents|adrenergic agents|mesh-ancestor
153788672|NCT00280371|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153788673|NCT00280371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153788674|NCT00251654|Anesthetics|anesthetics|mesh-list
153788675|NCT00251654|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153788676|NCT00251654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153788677|NCT00286923|Topiramate|topiramate|mesh-list
153788678|NCT00286923|Anticonvulsants|anticonvulsants|mesh-ancestor
153788679|NCT00286923|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153788680|NCT00286923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153788681|NCT00251732|Antidepressive Agents|antidepressive agents|mesh-list
153788682|NCT00251732|Nortriptyline|nortriptyline|mesh-list
153788683|NCT00251732|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-list
153788684|NCT00251732|Rabeprazole|rabeprazole|mesh-list
153788685|NCT00251732|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
153788686|NCT00251732|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153788687|NCT00251732|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
153788688|NCT00251732|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153788689|NCT00251732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153788690|NCT00251732|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153788691|NCT00251732|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
153788692|NCT00251732|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153788693|NCT00251732|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153788712|NCT00251888|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
153788713|NCT00251888|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153788714|NCT00251888|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153788715|NCT00251888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153788716|NCT00251966|Esomeprazole|esomeprazole|mesh-list
153788717|NCT00251966|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
153788718|NCT00251966|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153788719|NCT00251966|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
153788720|NCT00251966|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153473380|NCT03005184|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153788721|NCT00251966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153788722|NCT00252044|Pergolide|pergolide|mesh-list
153788723|NCT00252044|Dopamine Agonists|dopamine agonists|mesh-ancestor
153788724|NCT00252044|Dopamine Agents|dopamine agents|mesh-ancestor
153788725|NCT00252044|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153788726|NCT00252044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153788727|NCT00252044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153788728|NCT01805284|Linezolid|linezolid|mesh-list
153788729|NCT01805284|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153788730|NCT01805284|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153788731|NCT01805284|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
153788732|NCT01805284|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153788733|NCT01805284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153788734|NCT00280605|Alfuzosin|alfuzosin|mesh-list
153788735|NCT00280605|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
153788736|NCT00280605|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
153788737|NCT00280605|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
153788738|NCT00280605|Adrenergic Agents|adrenergic agents|mesh-ancestor
153788739|NCT00280605|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153788740|NCT00280605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153788741|NCT00280605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153788742|NCT00280605|Urological Agents|urological agents|mesh-ancestor
153788743|NCT01134601|Capecitabine|capecitabine|mesh-list
153788744|NCT01134601|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153788745|NCT01134601|Antimetabolites|antimetabolites|mesh-ancestor
153788746|NCT01134601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153788747|NCT01134601|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153788748|NCT00252122|Ketamine|ketamine|mesh-list
153788749|NCT00252122|Analgesics|analgesics|mesh-ancestor
153788750|NCT00252122|Sensory System Agents|sensory system agents|mesh-ancestor
153788751|NCT00252122|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153788752|NCT00252122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153788753|NCT00252122|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
153788754|NCT00252122|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153788755|NCT00252122|Anesthetics, General|anesthetics, general|mesh-ancestor
153788757|NCT00252122|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153788758|NCT00252122|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
153788759|NCT00252122|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
153788760|NCT00252122|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153788761|NCT00252122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153788762|NCT00287157|Tizanidine|tizanidine|mesh-list
153788763|NCT00287157|Analgesics|analgesics|mesh-ancestor
153788764|NCT00287157|Sensory System Agents|sensory system agents|mesh-ancestor
153788765|NCT00287157|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153788766|NCT00287157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153788767|NCT00287157|Anticonvulsants|anticonvulsants|mesh-ancestor
153788768|NCT00287157|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
153788769|NCT00287157|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
153788770|NCT00287157|Parasympatholytics|parasympatholytics|mesh-ancestor
153788771|NCT00287157|Autonomic Agents|autonomic agents|mesh-ancestor
153335242|NCT05025644|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153788772|NCT00287157|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
153788773|NCT00287157|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153788774|NCT00287157|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153788775|NCT00287157|Adrenergic Agents|adrenergic agents|mesh-ancestor
153788776|NCT00287157|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153788777|NCT00287157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153788778|NCT00280644|Leflunomide|leflunomide|mesh-list
153788779|NCT00280644|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153788780|NCT00280644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153788781|NCT00280644|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153788782|NCT00280644|Immunologic Factors|immunologic factors|mesh-ancestor
153788783|NCT00280644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153788784|NCT00252200|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
153788785|NCT00252200|Natriuretic Agents|natriuretic agents|mesh-ancestor
153788786|NCT00252200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153788787|NCT00252278|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
153788788|NCT00252278|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
153788789|NCT00252278|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153788790|NCT00252278|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153473553|NCT02978976|Hormones|hormones|mesh-ancestor
153788791|NCT00252278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153788792|NCT00252278|Adrenergic Agents|adrenergic agents|mesh-ancestor
153788793|NCT00252278|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153788794|NCT00252278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153788796|NCT00252317|Trandolapril|trandolapril|mesh-list
153347744|NCT01084499|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153347746|NCT01084499|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
153788797|NCT00252317|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
153473621|NCT02974920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153788798|NCT00252317|Protease Inhibitors|protease inhibitors|mesh-ancestor
153788799|NCT00252317|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153788800|NCT00252317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153788801|NCT00252317|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153788803|NCT00252356|Amibegron hydrochloride|amibegron hydrochloride|mesh-list
153788804|NCT00252356|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
153788805|NCT00252356|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153788806|NCT00252356|Adrenergic Agents|adrenergic agents|mesh-ancestor
153788807|NCT00252356|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153788808|NCT00252356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153788811|NCT02753998|Paclitaxel|paclitaxel|mesh-list
153788827|NCT02754154|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153788828|NCT02754154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153788829|NCT00252434|Methamphetamine|methamphetamine|mesh-list
153788830|NCT00252434|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
153788831|NCT00252434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153788832|NCT00252434|Sympathomimetics|sympathomimetics|mesh-ancestor
153788833|NCT00252434|Autonomic Agents|autonomic agents|mesh-ancestor
153788834|NCT00252434|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153788836|NCT00252434|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153788837|NCT00252434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153788838|NCT00252434|Adrenergic Agents|adrenergic agents|mesh-ancestor
153788839|NCT00252434|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
153788840|NCT00252434|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153347817|NCT01332721|Bevacizumab|bevacizumab|mesh-list
153788841|NCT00252434|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153788842|NCT00252434|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
153788843|NCT00280839|Topiramate|topiramate|mesh-list
153788844|NCT00280839|Anticonvulsants|anticonvulsants|mesh-ancestor
153788845|NCT00280839|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153788846|NCT00280839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153788847|NCT00280878|Rituximab|rituximab|mesh-list
153788848|NCT00280878|Gemcitabine|gemcitabine|mesh-list
153473630|NCT02974920|Antipyretics|antipyretics|mesh-ancestor
153788880|NCT01680250|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153788881|NCT01680250|Immunologic Factors|immunologic factors|mesh-ancestor
153788882|NCT01680250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153788883|NCT00280956|Natalizumab|natalizumab|mesh-list
153788884|NCT00280956|Immunologic Factors|immunologic factors|mesh-ancestor
153788885|NCT00280956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153788886|NCT02279875|Rifampin|rifampin|mesh-list
153788887|NCT02279875|Isoniazid|isoniazid|mesh-list
153788888|NCT02279875|Linezolid|linezolid|mesh-list
153788889|NCT02279875|Pyrazinamide|pyrazinamide|mesh-list
153473680|NCT02641782|Isotretinoin|isotretinoin|mesh-list
153473681|NCT02641782|Antibodies|antibodies|mesh-list
153788890|NCT02279875|Ethambutol|ethambutol|mesh-list
153788891|NCT02279875|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
153788892|NCT02279875|Antitubercular Agents|antitubercular agents|mesh-ancestor
153788893|NCT02279875|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153788894|NCT02279875|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153788895|NCT02279875|Leprostatic Agents|leprostatic agents|mesh-ancestor
153788896|NCT02279875|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153788897|NCT02279875|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153788898|NCT02279875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153788899|NCT02279875|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
153788900|NCT02279875|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
153788901|NCT02279875|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
153788902|NCT02279875|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
153788903|NCT02279875|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
153788904|NCT02279875|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
153788905|NCT02279875|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
153788906|NCT02279875|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153788907|NCT02279875|Antimetabolites|antimetabolites|mesh-ancestor
153788908|NCT02279875|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153788923|NCT00287352|Amantadine|amantadine|mesh-list
153788924|NCT00287352|Olanzapine|olanzapine|mesh-list
153788926|NCT00287352|Autonomic Agents|autonomic agents|mesh-ancestor
153788927|NCT00287352|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153788928|NCT00287352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153788929|NCT00287352|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153788930|NCT00287352|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153788931|NCT00287352|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153788932|NCT00287352|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153788933|NCT00287352|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153788934|NCT00287352|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
153788935|NCT00287352|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153788936|NCT00287352|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153788937|NCT00287352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153473722|NCT04769076|Paclitaxel|paclitaxel|mesh-list
153788938|NCT00287352|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153788940|NCT00287352|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
153788941|NCT00287352|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
153788942|NCT00287352|Antiviral Agents|antiviral agents|mesh-ancestor
153788943|NCT00287352|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153788944|NCT00287352|Dopamine Agents|dopamine agents|mesh-ancestor
153788945|NCT00287352|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153347944|NCT00176930|Busulfan|busulfan|mesh-list
153788946|NCT00287352|Analgesics|analgesics|mesh-ancestor
153788947|NCT00287352|Sensory System Agents|sensory system agents|mesh-ancestor
153788948|NCT04823962|Molgramostim|molgramostim|mesh-list
153788949|NCT04823962|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153788950|NCT00252668|Etanercept|etanercept|mesh-list
153788951|NCT00252668|Methotrexate|methotrexate|mesh-list
153788952|NCT00252668|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
153788953|NCT00252668|Abortifacient Agents|abortifacient agents|mesh-ancestor
153788954|NCT00252668|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153788955|NCT00252668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153788956|NCT00252668|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153788957|NCT00252668|Antimetabolites|antimetabolites|mesh-ancestor
153788960|NCT00252668|Dermatologic Agents|dermatologic agents|mesh-ancestor
153788964|NCT00252668|Immunologic Factors|immunologic factors|mesh-ancestor
153788965|NCT00252668|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153788966|NCT00252668|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153788967|NCT00252668|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153788968|NCT00252668|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153788969|NCT00252668|Analgesics|analgesics|mesh-ancestor
153788970|NCT00252668|Sensory System Agents|sensory system agents|mesh-ancestor
153788971|NCT00252668|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153788972|NCT00252668|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153788973|NCT00252668|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153788974|NCT02271997|Ferrous fumarate|ferrous fumarate|mesh-list
153788975|NCT02271997|Ferrous gluconate|ferrous gluconate|mesh-list
153788976|NCT02271997|Trace Elements|trace elements|mesh-ancestor
153788977|NCT02271997|Micronutrients|micronutrients|mesh-ancestor
153788978|NCT02271997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153788979|NCT02271997|Hematinics|hematinics|mesh-ancestor
153788980|NCT00287391|Rabeprazole|rabeprazole|mesh-list
153788981|NCT00287391|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
153788982|NCT00287391|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153788983|NCT00287391|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
153788984|NCT00287391|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153788985|NCT00287391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153788986|NCT00252707|Docetaxel|docetaxel|mesh-list
153788987|NCT00252707|Gefitinib|gefitinib|mesh-list
153788988|NCT00252707|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153788989|NCT00252707|Tubulin Modulators|tubulin modulators|mesh-ancestor
153788990|NCT00252707|Antimitotic Agents|antimitotic agents|mesh-ancestor
153788991|NCT00252707|Mitosis Modulators|mitosis modulators|mesh-ancestor
153788992|NCT00252707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153788993|NCT00252707|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153788994|NCT00252707|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153788995|NCT00252707|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153788997|NCT01680406|Lumefantrine|lumefantrine|mesh-list
153788998|NCT01680406|Artemether|artemether|mesh-list
153335464|NCT05493618|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153788999|NCT01680406|Primaquine|primaquine|mesh-list
153789000|NCT01680406|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
153789002|NCT01680406|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153789003|NCT01680406|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153789004|NCT01680406|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153789005|NCT01680406|Antimalarials|antimalarials|mesh-ancestor
153789006|NCT01680406|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153789007|NCT00287430|Hormones|hormones|mesh-list
153789008|NCT00287430|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153789009|NCT00287430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153789010|NCT01680679|Vaccines|vaccines|mesh-list
153789011|NCT01680679|Immunologic Factors|immunologic factors|mesh-ancestor
153789012|NCT01680679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153789013|NCT01680718|Vasopressins|vasopressins|mesh-list
153789014|NCT01680718|Arginine Vasopressin|arginine vasopressin|mesh-list
153789015|NCT01680718|Oxytocin|oxytocin|mesh-list
153789016|NCT01680718|Oxytocics|oxytocics|mesh-ancestor
153789017|NCT01680718|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153789018|NCT01680718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153789019|NCT01680718|Hemostatics|hemostatics|mesh-ancestor
153789020|NCT01680718|Coagulants|coagulants|mesh-ancestor
153789021|NCT01680718|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
153789022|NCT01680718|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
153789023|NCT01680718|Natriuretic Agents|natriuretic agents|mesh-ancestor
153789024|NCT01680796|Dexamethasone|dexamethasone|mesh-list
153789025|NCT01680796|Bortezomib|bortezomib|mesh-list
153789026|NCT01680796|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153789027|NCT01680796|Antiemetics|antiemetics|mesh-ancestor
153789028|NCT01680796|Autonomic Agents|autonomic agents|mesh-ancestor
153789029|NCT01680796|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153789030|NCT01680796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153347978|NCT01441843|GABA Agents|gaba agents|mesh-ancestor
153789049|NCT00252785|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153789050|NCT00252785|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
153789051|NCT00252785|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
153789052|NCT00252785|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153789053|NCT00252785|Adrenergic Agents|adrenergic agents|mesh-ancestor
153789054|NCT00252785|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153789055|NCT00252785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153789056|NCT00252785|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
153789057|NCT00252785|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153789058|NCT00252785|Vasodilator Agents|vasodilator agents|mesh-ancestor
153789059|NCT00252785|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
153789060|NCT00252785|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
153789061|NCT00252785|Purinergic Agents|purinergic agents|mesh-ancestor
153789062|NCT01680913|Anesthetics|anesthetics|mesh-list
153789063|NCT01680913|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153789064|NCT01680913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153789065|NCT01680952|Mycophenolic Acid|mycophenolic acid|mesh-list
153789066|NCT01680952|Sirolimus|sirolimus|mesh-list
153789067|NCT01680952|Tacrolimus|tacrolimus|mesh-list
153789068|NCT01680952|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153789069|NCT01680952|Immunologic Factors|immunologic factors|mesh-ancestor
153789070|NCT01680952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153789071|NCT01680952|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
153789098|NCT00252824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153789099|NCT00281190|Dimercaprol|dimercaprol|mesh-list
153789100|NCT00281190|Chelating Agents|chelating agents|mesh-ancestor
153789101|NCT00281190|Sequestering Agents|sequestering agents|mesh-ancestor
153789102|NCT00281190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153789103|NCT00252863|Fluticasone|fluticasone|mesh-list
153789104|NCT00252863|Xhance|xhance|mesh-list
153789105|NCT00252863|Budesonide|budesonide|mesh-list
153789106|NCT00252863|Theophylline|theophylline|mesh-list
153789107|NCT00252863|Albuterol|albuterol|mesh-list
153789108|NCT00252863|Terbutaline|terbutaline|mesh-list
153789109|NCT00252863|Formoterol Fumarate|formoterol fumarate|mesh-list
153789110|NCT00252863|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
153789111|NCT00252863|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
153789112|NCT00252863|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
153789113|NCT00252863|Montelukast|montelukast|mesh-list
153789114|NCT00252863|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153348005|NCT00128180|Prednisolone acetate|prednisolone acetate|mesh-list
153789115|NCT00252863|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153789116|NCT00252863|Autonomic Agents|autonomic agents|mesh-ancestor
153789117|NCT00252863|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153789118|NCT00252863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153789119|NCT00252863|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153789120|NCT00252863|Respiratory System Agents|respiratory system agents|mesh-ancestor
153789121|NCT00252863|Dermatologic Agents|dermatologic agents|mesh-ancestor
153789122|NCT00252863|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
153789123|NCT00252863|Glucocorticoids|glucocorticoids|mesh-ancestor
153789124|NCT00252863|Hormones|hormones|mesh-ancestor
153789125|NCT00252863|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153789127|NCT00252863|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
153789144|NCT00252863|Sympathomimetics|sympathomimetics|mesh-ancestor
153789145|NCT01681537|Cytarabine|cytarabine|mesh-list
153789146|NCT01681537|Etoposide|etoposide|mesh-list
153789147|NCT01681537|Mitoxantrone|mitoxantrone|mesh-list
153789148|NCT01681537|Lenalidomide|lenalidomide|mesh-list
153789149|NCT01681537|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153789150|NCT01681537|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153789151|NCT01681537|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153789152|NCT01681537|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153789153|NCT01681537|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153789154|NCT01681537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153789155|NCT01681537|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153789156|NCT01681537|Antimetabolites|antimetabolites|mesh-ancestor
153789157|NCT01681537|Antiviral Agents|antiviral agents|mesh-ancestor
153789158|NCT01681537|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153789159|NCT01681537|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153789160|NCT01681537|Immunologic Factors|immunologic factors|mesh-ancestor
153789161|NCT01681537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153789162|NCT01681537|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153375538|NCT02770365|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153789200|NCT02279914|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153789203|NCT00281307|Vitamin E|vitamin e|mesh-list
153789204|NCT00281307|Tocotrienols|tocotrienols|mesh-list
153789205|NCT00281307|alpha-Tocopherol|alpha-tocopherol|mesh-list
153789206|NCT00281307|Antioxidants|antioxidants|mesh-ancestor
153789207|NCT00281307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153789208|NCT00281307|Protective Agents|protective agents|mesh-ancestor
153789209|NCT00281307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153789210|NCT00281307|Vitamins|vitamins|mesh-ancestor
153789211|NCT00281307|Micronutrients|micronutrients|mesh-ancestor
153789212|NCT01682746|Dihematoporphyrin Ether|dihematoporphyrin ether|mesh-list
153375723|NCT01461824|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
153375724|NCT01461824|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
153375725|NCT01461824|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
153375726|NCT01461824|Contraceptive Agents|contraceptive agents|mesh-ancestor
153375727|NCT01461824|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153375728|NCT01461824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153375729|NCT01461824|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
153375730|NCT01461824|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
153375731|NCT01461824|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
153376032|NCT06194214|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153376034|NCT06194214|Protective Agents|protective agents|mesh-ancestor
153789213|NCT01682746|Trioxsalen|trioxsalen|mesh-list
153789214|NCT01682746|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153419421|NCT04395196|Choline|choline|mesh-list
153789215|NCT01682746|Dermatologic Agents|dermatologic agents|mesh-ancestor
153789216|NCT01682746|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
153789217|NCT00287664|Terlipressin|terlipressin|mesh-list
153789218|NCT00287664|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153789219|NCT00287664|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
153789220|NCT01682902|Insulin|insulin|mesh-list
153789221|NCT01682902|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
153789222|NCT01682902|Insulin Aspart|insulin aspart|mesh-list
153789223|NCT01682902|Insulin, Long-Acting|insulin, long-acting|mesh-list
153789224|NCT01682902|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
153335692|NCT01890200|Antiviral Agents|antiviral agents|mesh-ancestor
153789225|NCT01682902|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153789226|NCT01682902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153789229|NCT01683175|Vinorelbine|vinorelbine|mesh-list
153789246|NCT01683253|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153789247|NCT01683253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153789248|NCT01683253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153789249|NCT01683253|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
153789250|NCT01683253|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153789251|NCT01683253|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
153789252|NCT01683253|Sympathomimetics|sympathomimetics|mesh-ancestor
153789253|NCT01683253|Autonomic Agents|autonomic agents|mesh-ancestor
153789254|NCT01683253|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153789255|NCT01683253|Protective Agents|protective agents|mesh-ancestor
153789256|NCT01683292|Apomorphine|apomorphine|mesh-list
153789257|NCT01683292|Emetics|emetics|mesh-ancestor
153789258|NCT01683292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153789259|NCT01683292|Autonomic Agents|autonomic agents|mesh-ancestor
153789260|NCT01683292|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153789261|NCT01683292|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153789262|NCT01683292|Dopamine Agonists|dopamine agonists|mesh-ancestor
153789263|NCT01683292|Dopamine Agents|dopamine agents|mesh-ancestor
153789264|NCT01683292|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153376038|NCT06194201|Caspofungin|caspofungin|mesh-list
153789265|NCT01683292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153789267|NCT00253058|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
153789268|NCT00253058|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
153789269|NCT00253058|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
153789277|NCT01683682|Nintedanib|nintedanib|mesh-list
153789294|NCT00287742|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153789295|NCT00287742|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153789296|NCT00287742|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
153789297|NCT00287742|Dopamine Agents|dopamine agents|mesh-ancestor
153789298|NCT04527562|Colchicine|colchicine|mesh-list
153789299|NCT04527562|Gout Suppressants|gout suppressants|mesh-ancestor
153789300|NCT04527562|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153789301|NCT04527562|Tubulin Modulators|tubulin modulators|mesh-ancestor
153789303|NCT04527562|Mitosis Modulators|mitosis modulators|mesh-ancestor
153789304|NCT04527562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153789305|NCT04527562|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153789306|NCT01684072|Vaccines|vaccines|mesh-list
153789307|NCT01684072|Immunologic Factors|immunologic factors|mesh-ancestor
153789308|NCT01684072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153789309|NCT01684111|Vinorelbine|vinorelbine|mesh-list
153789310|NCT01684111|Nintedanib|nintedanib|mesh-list
153789311|NCT01684111|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153789312|NCT01684111|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153789313|NCT01684111|Tubulin Modulators|tubulin modulators|mesh-ancestor
153789314|NCT01684111|Antimitotic Agents|antimitotic agents|mesh-ancestor
153789315|NCT01684111|Mitosis Modulators|mitosis modulators|mesh-ancestor
153789316|NCT01684111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153789317|NCT01684111|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153789318|NCT01684111|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153789319|NCT00253136|Risperidone|risperidone|mesh-list
153474135|NCT00603408|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153789320|NCT00253136|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153789321|NCT00253136|Serotonin Agents|serotonin agents|mesh-ancestor
153789322|NCT00253136|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153789323|NCT00253136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153789337|NCT01684306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153789338|NCT00287781|Lidocaine|lidocaine|mesh-list
153789339|NCT00287781|Anesthetics, Local|anesthetics, local|mesh-ancestor
153789340|NCT00287781|Anesthetics|anesthetics|mesh-ancestor
153789341|NCT00287781|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153789342|NCT00287781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153789343|NCT00287781|Sensory System Agents|sensory system agents|mesh-ancestor
153789344|NCT00287781|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153789345|NCT00287781|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153789346|NCT00287781|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
153789347|NCT00287781|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153789348|NCT00287781|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153789349|NCT00287781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153789350|NCT00416871|Interferons|interferons|mesh-list
153789351|NCT00416871|Interferon-alpha|interferon-alpha|mesh-list
153789352|NCT00416871|Aldesleukin|aldesleukin|mesh-list
153789353|NCT00416871|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153789354|NCT00416871|Antiviral Agents|antiviral agents|mesh-ancestor
153789355|NCT00416871|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153789356|NCT00416871|Immunologic Factors|immunologic factors|mesh-ancestor
153377416|NCT04640545|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153789357|NCT00416871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153789358|NCT00416871|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153789359|NCT00416871|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153789360|NCT01684657|Asenapine|asenapine|mesh-list
153789361|NCT01684657|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153789362|NCT01684657|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153789387|NCT01684774|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153789388|NCT01684774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153789389|NCT01684774|Sensory System Agents|sensory system agents|mesh-ancestor
153789390|NCT01684774|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153789391|NCT02279992|Carboplatin|carboplatin|mesh-list
153789392|NCT02279992|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
153789393|NCT02279992|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153789394|NCT02279992|Vasodilator Agents|vasodilator agents|mesh-ancestor
153789395|NCT02279992|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
153789396|NCT02279992|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
153789397|NCT02279992|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153789398|NCT02279992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153789399|NCT02279992|Urological Agents|urological agents|mesh-ancestor
153789400|NCT00253175|Topiramate|topiramate|mesh-list
153789401|NCT00253175|Anticonvulsants|anticonvulsants|mesh-ancestor
153789402|NCT00253175|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153789403|NCT00253175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153789404|NCT00287820|Olanzapine|olanzapine|mesh-list
153789405|NCT00287820|Risperidone|risperidone|mesh-list
153789407|NCT00287820|Serotonin Agents|serotonin agents|mesh-ancestor
153789409|NCT00287820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153789410|NCT00287820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153789411|NCT00287820|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153789412|NCT00287820|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153789413|NCT00287820|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153789414|NCT00287820|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153789415|NCT00287820|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
153789416|NCT00287820|Dopamine Agents|dopamine agents|mesh-ancestor
153789417|NCT00287820|Antiemetics|antiemetics|mesh-ancestor
153789418|NCT00287820|Autonomic Agents|autonomic agents|mesh-ancestor
153789419|NCT00287820|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153789420|NCT00287820|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153789421|NCT00287820|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
153789422|NCT00287820|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153789423|NCT00287820|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153789425|NCT02272348|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153789426|NCT02272348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153789427|NCT00253214|Galantamine|galantamine|mesh-list
153789428|NCT00253214|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
153789429|NCT00253214|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153789430|NCT00253214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153789431|NCT00253214|Cholinergic Agents|cholinergic agents|mesh-ancestor
153789432|NCT00253214|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153789433|NCT00253214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153789434|NCT00253214|Parasympathomimetics|parasympathomimetics|mesh-ancestor
153789435|NCT00253214|Autonomic Agents|autonomic agents|mesh-ancestor
153348280|NCT05306405|Misoprostol|misoprostol|mesh-list
153789436|NCT00253214|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153789437|NCT00253214|Nootropic Agents|nootropic agents|mesh-ancestor
153789439|NCT00287859|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
153789477|NCT04527679|Lenvatinib|lenvatinib|mesh-list
153789478|NCT04527679|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153789479|NCT04527679|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153789480|NCT04527679|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153789481|NCT04527679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153789482|NCT01685281|Metadoxine|metadoxine|mesh-list
153789483|NCT01685281|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
153789484|NCT00417066|Triptorelin Pamoate|triptorelin pamoate|mesh-list
153789485|NCT00417066|Ganirelix|ganirelix|mesh-list
153789486|NCT00417066|Luteolytic Agents|luteolytic agents|mesh-ancestor
153789487|NCT00417066|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
153789488|NCT00417066|Contraceptive Agents|contraceptive agents|mesh-ancestor
153789489|NCT00417066|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153789490|NCT00417066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153789491|NCT00417066|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
153474554|NCT00691002|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153789492|NCT00417066|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153789493|NCT00417066|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153789494|NCT00417066|Hormone Antagonists|hormone antagonists|mesh-ancestor
153789495|NCT00417066|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153789497|NCT01685398|Ophthalmic Solutions|ophthalmic solutions|mesh-list
153789498|NCT01685398|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
153789499|NCT01685398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153789500|NCT01685398|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
153789501|NCT01685398|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
153789502|NCT01685398|Adrenergic Agents|adrenergic agents|mesh-ancestor
153789503|NCT01685398|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153789504|NCT01685398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153789505|NCT01685398|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153789506|NCT01685398|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153789507|NCT01685515|Decitabine|decitabine|mesh-list
153348311|NCT05272397|Methylphenidate|methylphenidate|mesh-list
153789508|NCT01685515|Tetrahydrouridine|tetrahydrouridine|mesh-list
153789509|NCT01685515|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153789510|NCT01685515|Antimetabolites|antimetabolites|mesh-ancestor
153789513|NCT01685515|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153789516|NCT00281502|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153789517|NCT00281502|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153789519|NCT00253331|Vasodilator Agents|vasodilator agents|mesh-ancestor
153789520|NCT00253487|Temozolomide|temozolomide|mesh-list
153789521|NCT00253487|Busulfan|busulfan|mesh-list
153335985|NCT01662492|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153789522|NCT00253487|O(6)-benzylguanine|o(6)-benzylguanine|mesh-list
153789523|NCT00253487|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153789524|NCT00253487|Alkylating Agents|alkylating agents|mesh-ancestor
153789525|NCT00253487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153789526|NCT00253487|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153789527|NCT00253487|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153789528|NCT00253487|Immunologic Factors|immunologic factors|mesh-ancestor
153789529|NCT00253487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153789530|NCT00253487|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153789531|NCT00253487|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153789532|NCT00281619|Mycophenolic Acid|mycophenolic acid|mesh-list
153789533|NCT00281619|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153789534|NCT00281619|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153789535|NCT00281619|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
153789536|NCT00281619|Antitubercular Agents|antitubercular agents|mesh-ancestor
153789537|NCT00281619|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153789538|NCT00281619|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153789539|NCT00281619|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153789540|NCT00281619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153789541|NCT04527211|Ivermectin|ivermectin|mesh-list
153789544|NCT00253526|Bevacizumab|bevacizumab|mesh-list
153789564|NCT01686217|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153789565|NCT01686217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153789566|NCT01686217|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153789567|NCT01686217|Immunologic Factors|immunologic factors|mesh-ancestor
153789568|NCT01686217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153789569|NCT01686217|Vitamin B Complex|vitamin b complex|mesh-ancestor
153789570|NCT01686217|Vitamins|vitamins|mesh-ancestor
153789571|NCT01686217|Micronutrients|micronutrients|mesh-ancestor
153789572|NCT00253565|Capecitabine|capecitabine|mesh-list
153789573|NCT00253565|Imatinib Mesylate|imatinib mesylate|mesh-list
153789574|NCT00253565|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153789575|NCT00253565|Antimetabolites|antimetabolites|mesh-ancestor
153789576|NCT00253565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153789577|NCT00253565|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153789578|NCT00253565|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153789579|NCT00253565|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153789580|NCT00253565|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153789581|NCT01686529|Bevacizumab|bevacizumab|mesh-list
153789582|NCT01686529|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153789583|NCT01686529|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153789584|NCT01686529|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153789585|NCT01686529|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153789586|NCT01686529|Growth Substances|growth substances|mesh-ancestor
153789587|NCT01686529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153789588|NCT01686529|Growth Inhibitors|growth inhibitors|mesh-ancestor
153789589|NCT01686607|Itraconazole|itraconazole|mesh-list
153789590|NCT01686607|Fluconazole|fluconazole|mesh-list
153789591|NCT01686607|Voriconazole|voriconazole|mesh-list
153789592|NCT01686607|Amphotericin B|amphotericin b|mesh-list
153789593|NCT01686607|Caspofungin|caspofungin|mesh-list
153789594|NCT01686607|Micafungin|micafungin|mesh-list
153789595|NCT01686607|Antifungal Agents|antifungal agents|mesh-list
153789597|NCT01686607|Miconazole|miconazole|mesh-list
153789606|NCT01686607|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153789607|NCT01686607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153789608|NCT01686607|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
153789609|NCT01686607|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
153789610|NCT01686607|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
153789611|NCT01686607|Amebicides|amebicides|mesh-ancestor
153789613|NCT01686607|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153789614|NCT01686607|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153789615|NCT01686607|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
153789616|NCT01686802|Ibuprofen|ibuprofen|mesh-list
153789617|NCT01686802|Morphine|morphine|mesh-list
153789618|NCT01686802|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153789619|NCT01686802|Narcotics|narcotics|mesh-ancestor
153789666|NCT00281931|Immunologic Factors|immunologic factors|mesh-ancestor
153789667|NCT00281931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153789668|NCT00281931|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153789669|NCT00281931|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153789670|NCT00281931|Alkylating Agents|alkylating agents|mesh-ancestor
153789671|NCT00281931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153789672|NCT00281931|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153789673|NCT00281931|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153336136|NCT01006018|Pioglitazone|pioglitazone|mesh-list
153789674|NCT00281931|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153789675|NCT00281931|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153789677|NCT01687348|Lidocaine|lidocaine|mesh-list
153789678|NCT01687348|Anesthetics, Local|anesthetics, local|mesh-ancestor
153789680|NCT01687348|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153789681|NCT01687348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153789682|NCT01687348|Sensory System Agents|sensory system agents|mesh-ancestor
153789683|NCT01687348|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153789684|NCT01687348|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153789686|NCT01687348|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153789687|NCT01687348|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153789688|NCT01687348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153789689|NCT01687426|Brimonidine Tartrate|brimonidine tartrate|mesh-list
153789690|NCT01687426|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153789691|NCT01687426|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
153789692|NCT01687426|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153789693|NCT01687426|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153789694|NCT01687426|Adrenergic Agents|adrenergic agents|mesh-ancestor
153789695|NCT01687426|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153789696|NCT01687426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153789697|NCT01687426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153789698|NCT01687582|Liraglutide|liraglutide|mesh-list
153789699|NCT01687582|Exenatide|exenatide|mesh-list
153789702|NCT01687582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153789703|NCT01687582|Incretins|incretins|mesh-ancestor
153789704|NCT01687582|Hormones|hormones|mesh-ancestor
153789705|NCT01687582|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153789706|NCT01687582|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
153789707|NCT01687699|Spironolactone|spironolactone|mesh-list
153789708|NCT01687699|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
153789709|NCT01687699|Hormone Antagonists|hormone antagonists|mesh-ancestor
153789710|NCT01687699|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153348362|NCT00186446|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153789711|NCT01687699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153789712|NCT01687699|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
153789714|NCT01687699|Natriuretic Agents|natriuretic agents|mesh-ancestor
153789715|NCT00287937|Paclitaxel|paclitaxel|mesh-list
153789716|NCT00287937|Carboplatin|carboplatin|mesh-list
153789717|NCT00287937|Vorinostat|vorinostat|mesh-list
153789719|NCT00287937|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153789720|NCT00287937|Tubulin Modulators|tubulin modulators|mesh-ancestor
153789721|NCT00287937|Antimitotic Agents|antimitotic agents|mesh-ancestor
153789722|NCT00287937|Mitosis Modulators|mitosis modulators|mesh-ancestor
153789723|NCT00287937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153789724|NCT00287937|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
153789725|NCT00287937|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153789726|NCT01687894|Vasopressins|vasopressins|mesh-list
153789727|NCT01687894|Arginine Vasopressin|arginine vasopressin|mesh-list
153789728|NCT01687894|Propofol|propofol|mesh-list
153789729|NCT01687894|Anesthetics, Intravenous|anesthetics, intravenous|mesh-list
153789730|NCT01687894|Anesthetics|anesthetics|mesh-list
153789731|NCT01687894|Sevoflurane|sevoflurane|mesh-list
153789732|NCT01687894|Anesthetics, General|anesthetics, general|mesh-list
153789733|NCT01687894|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153789734|NCT01687894|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153789735|NCT01687894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153789742|NCT01687894|Natriuretic Agents|natriuretic agents|mesh-ancestor
153789743|NCT00287976|Irinotecan|irinotecan|mesh-list
153789744|NCT00287976|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
153789745|NCT00287976|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153789746|NCT00287976|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153789747|NCT00287976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153789748|NCT00287976|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153789749|NCT01688089|Levodopa|levodopa|mesh-list
153789750|NCT01688089|Carbidopa|carbidopa|mesh-list
153789751|NCT01688089|Entacapone|entacapone|mesh-list
153789752|NCT01688089|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
153789753|NCT01688089|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
153789754|NCT01688089|Dopamine Agents|dopamine agents|mesh-ancestor
153789755|NCT01688089|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153789756|NCT01688089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153789757|NCT01688089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153789758|NCT01688089|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
153789759|NCT01688089|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153789760|NCT01688089|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
153789761|NCT01688206|Atezolizumab|atezolizumab|mesh-list
153789762|NCT01688206|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153789793|NCT00288249|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153789794|NCT00288249|Tubulin Modulators|tubulin modulators|mesh-ancestor
153789795|NCT00288249|Antimitotic Agents|antimitotic agents|mesh-ancestor
153789796|NCT00288249|Mitosis Modulators|mitosis modulators|mesh-ancestor
153789797|NCT00288249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153789798|NCT00254033|Methylphenidate|methylphenidate|mesh-list
153789799|NCT00254033|Dextroamphetamine|dextroamphetamine|mesh-list
153789800|NCT00254033|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
153789801|NCT00254033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153789802|NCT00254033|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
153789803|NCT00254033|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153789805|NCT00254033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153789806|NCT00254033|Dopamine Agents|dopamine agents|mesh-ancestor
153789807|NCT00254033|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153789808|NCT01600573|Topotecan|topotecan|mesh-list
153789809|NCT01600573|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
153789810|NCT01600573|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153789811|NCT01600573|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153789812|NCT01600573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153789813|NCT01600573|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153789814|NCT01600612|Oxytocin|oxytocin|mesh-list
153789815|NCT01600612|Carbetocin|carbetocin|mesh-list
153789816|NCT01600612|Oxytocics|oxytocics|mesh-ancestor
153789817|NCT01600612|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153789818|NCT01600612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153789819|NCT01600768|Lactams|lactams|mesh-list
153336284|NCT00932152|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153789820|NCT01600768|beta-Lactams|beta-lactams|mesh-list
153789821|NCT01600768|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153789836|NCT00288444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153789837|NCT00288444|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153789838|NCT00417573|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
153789839|NCT00417573|Immunologic Factors|immunologic factors|mesh-ancestor
153789840|NCT00417573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153789841|NCT00415064|Dexamethasone|dexamethasone|mesh-list
153789842|NCT00415064|Lenalidomide|lenalidomide|mesh-list
153789843|NCT00415064|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153789844|NCT00415064|Antiemetics|antiemetics|mesh-ancestor
153789845|NCT00415064|Autonomic Agents|autonomic agents|mesh-ancestor
153789846|NCT00415064|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153789847|NCT00415064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153789848|NCT00415064|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153789849|NCT00415064|Glucocorticoids|glucocorticoids|mesh-ancestor
153789850|NCT00415064|Hormones|hormones|mesh-ancestor
153789851|NCT00415064|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153789852|NCT00415064|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153789854|NCT00415064|Immunologic Factors|immunologic factors|mesh-ancestor
153789855|NCT00415064|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153789856|NCT00415064|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153789857|NCT00415064|Growth Substances|growth substances|mesh-ancestor
153789858|NCT00415064|Growth Inhibitors|growth inhibitors|mesh-ancestor
153789859|NCT00415103|Aprepitant|aprepitant|mesh-list
153789860|NCT00415103|Palonosetron|palonosetron|mesh-list
153789861|NCT00415103|Granisetron|granisetron|mesh-list
153789862|NCT00415103|Antiemetics|antiemetics|mesh-ancestor
153789863|NCT00415103|Autonomic Agents|autonomic agents|mesh-ancestor
153789864|NCT00415103|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153789865|NCT00415103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153789866|NCT00415103|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153789879|NCT00417729|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
153474769|NCT00726414|Quinine|quinine|mesh-list
153789881|NCT00417729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153789882|NCT00417729|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153789883|NCT00417729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153789885|NCT00254189|Ethinyl Estradiol|ethinyl estradiol|mesh-list
153789886|NCT00254189|Estradiol|estradiol|mesh-list
153789887|NCT00254189|Estrogens|estrogens|mesh-ancestor
153789888|NCT00254189|Hormones|hormones|mesh-ancestor
153789889|NCT00254189|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153789890|NCT00254189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153789891|NCT00254189|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
153789892|NCT00254189|Contraceptive Agents|contraceptive agents|mesh-ancestor
153789893|NCT00254189|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153789894|NCT00254189|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
153789895|NCT00254189|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
153336359|NCT03626454|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
153789896|NCT00254189|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
153336434|NCT00843310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153789930|NCT01601002|Histamine Antagonists|histamine antagonists|mesh-ancestor
153789931|NCT01601002|Histamine Agents|histamine agents|mesh-ancestor
153789932|NCT01601002|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153789933|NCT01601002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153789934|NCT01601002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153789935|NCT01601002|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153789936|NCT01601002|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153789937|NCT01601002|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153789938|NCT01601002|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
153789939|NCT01601002|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
153789940|NCT01601002|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
153789941|NCT01601002|Adrenergic Agents|adrenergic agents|mesh-ancestor
153789942|NCT01601002|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
153789943|NCT01601002|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153789944|NCT01601002|Serotonin Agents|serotonin agents|mesh-ancestor
153789945|NCT01601002|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
153789946|NCT00288561|Ranibizumab|ranibizumab|mesh-list
153789947|NCT00288561|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153789948|NCT00288561|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153789950|NCT00288561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153789951|NCT00288561|Growth Inhibitors|growth inhibitors|mesh-ancestor
153789952|NCT00288561|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153789954|NCT01607086|Anticonvulsants|anticonvulsants|mesh-ancestor
153789965|NCT01607125|Vortioxetine|vortioxetine|mesh-list
153789975|NCT01607125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153789976|NCT01607125|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153789977|NCT01607125|Serotonin Agents|serotonin agents|mesh-ancestor
153789978|NCT01607125|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
153789979|NCT01607125|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
153789980|NCT01607125|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
153789981|NCT01607125|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153789982|NCT00254345|Polymethyl Methacrylate|polymethyl methacrylate|mesh-list
153789983|NCT00254345|Vasodilator Agents|vasodilator agents|mesh-ancestor
153789984|NCT00254345|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
153789985|NCT00254345|Protective Agents|protective agents|mesh-ancestor
153789986|NCT00254345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153789987|NCT00254618|Mesalamine|mesalamine|mesh-list
153789988|NCT00254618|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153789989|NCT00254618|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153789990|NCT00254618|Analgesics|analgesics|mesh-ancestor
153789991|NCT00254618|Sensory System Agents|sensory system agents|mesh-ancestor
153789992|NCT00254618|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153789993|NCT00254618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153789994|NCT00254618|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153789995|NCT00254618|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153790026|NCT02482753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153790027|NCT02482753|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
153790028|NCT02482753|Hormone Antagonists|hormone antagonists|mesh-ancestor
153790029|NCT02482753|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153790030|NCT02482753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153790031|NCT00254735|Quetiapine Fumarate|quetiapine fumarate|mesh-list
153790032|NCT00254735|Clomipramine|clomipramine|mesh-list
153790033|NCT00254735|Antidepressive Agents|antidepressive agents|mesh-ancestor
153790034|NCT00254735|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153790035|NCT00254735|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153790036|NCT00254735|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153790037|NCT00254735|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153790038|NCT00254735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153790039|NCT00254735|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
153790041|NCT00254735|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153790042|NCT00254735|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153790043|NCT00254735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153790044|NCT00254735|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153790046|NCT00288873|Cholecalciferol|cholecalciferol|mesh-list
153790047|NCT00288873|Vitamin D|vitamin d|mesh-list
153790048|NCT00288873|Ergocalciferols|ergocalciferols|mesh-list
153790049|NCT00288873|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153790050|NCT00288873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153790051|NCT00288873|Vitamins|vitamins|mesh-ancestor
153790052|NCT00288873|Micronutrients|micronutrients|mesh-ancestor
153790053|NCT00288873|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153790054|NCT01608139|Curcumin|curcumin|mesh-list
153790055|NCT01608139|Sorafenib|sorafenib|mesh-list
153790056|NCT01608139|Vorinostat|vorinostat|mesh-list
153790057|NCT01608139|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153790058|NCT01608139|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153790059|NCT01608139|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153790062|NCT01608139|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153790065|NCT01608139|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153790066|NCT01608139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153790067|NCT01608139|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153790069|NCT01608139|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
153790070|NCT01607671|Timolol|timolol|mesh-list
153790071|NCT01607671|Maleic acid|maleic acid|mesh-list
153790072|NCT01607671|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153790073|NCT01607671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153790074|NCT01607671|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
153790075|NCT01607671|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
153790076|NCT01607671|Adrenergic Agents|adrenergic agents|mesh-ancestor
153790077|NCT01607671|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153790078|NCT01607671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153790079|NCT01607671|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153790080|NCT01607671|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153790081|NCT00288951|Travoprost|travoprost|mesh-list
153790082|NCT00288951|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153790083|NCT00254774|Valproic Acid|valproic acid|mesh-list
153790084|NCT00254774|Quetiapine Fumarate|quetiapine fumarate|mesh-list
153790085|NCT00254774|Antidepressive Agents|antidepressive agents|mesh-ancestor
153790086|NCT00254774|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153790087|NCT00254774|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153790088|NCT00254774|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153790089|NCT00254774|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153474983|NCT00743730|Analgesics|analgesics|mesh-ancestor
153790090|NCT00254774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153790091|NCT00254774|Anticonvulsants|anticonvulsants|mesh-ancestor
153790092|NCT00254774|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153790093|NCT00254774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153790094|NCT00254774|GABA Agents|gaba agents|mesh-ancestor
153790095|NCT00254774|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153790096|NCT00254774|Antimanic Agents|antimanic agents|mesh-ancestor
153790097|NCT01608334|Fentanyl|fentanyl|mesh-list
153790098|NCT01608334|Sufentanil|sufentanil|mesh-list
153790099|NCT01608334|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153790107|NCT01608334|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153790108|NCT01608334|Anesthetics, General|anesthetics, general|mesh-ancestor
153790109|NCT01608334|Anesthetics|anesthetics|mesh-ancestor
153790110|NCT01608373|Lidocaine|lidocaine|mesh-list
153336583|NCT01530880|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153790111|NCT01608373|Anesthetics, Local|anesthetics, local|mesh-ancestor
153790112|NCT01608373|Anesthetics|anesthetics|mesh-ancestor
153790113|NCT01608373|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153790114|NCT01608373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153348682|NCT01165541|Histamine Agents|histamine agents|mesh-ancestor
153790115|NCT01608373|Sensory System Agents|sensory system agents|mesh-ancestor
153790116|NCT01608373|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153790117|NCT01608373|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153790118|NCT01608373|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
153790119|NCT01608373|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153790120|NCT01608373|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153790121|NCT01608373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153790122|NCT01608412|Everolimus|everolimus|mesh-list
153790123|NCT01608412|Tacrolimus|tacrolimus|mesh-list
153379688|NCT03003416|Hormones|hormones|mesh-ancestor
153790160|NCT02273440|Theophylline|theophylline|mesh-list
153790161|NCT02273440|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153790162|NCT02273440|Autonomic Agents|autonomic agents|mesh-ancestor
153790163|NCT02273440|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153790164|NCT02273440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153790165|NCT02273440|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153790166|NCT02273440|Respiratory System Agents|respiratory system agents|mesh-ancestor
153790167|NCT02273440|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
153790168|NCT02273440|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153790169|NCT02273440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153790170|NCT02273440|Vasodilator Agents|vasodilator agents|mesh-ancestor
153790171|NCT02273440|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
153790172|NCT02273440|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
153790186|NCT01588756|Goralatide|goralatide|mesh-list
153790219|NCT00255242|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153790220|NCT00255242|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153790221|NCT00255242|Antimetabolites|antimetabolites|mesh-ancestor
153790222|NCT00255242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153790223|NCT00255242|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153790224|NCT00255242|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
153790225|NCT00255242|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153790226|NCT00270114|Epoetin Alfa|epoetin alfa|mesh-list
153790227|NCT00270114|Hematinics|hematinics|mesh-ancestor
153790228|NCT00107380|Prednisone|prednisone|mesh-list
153790229|NCT00107380|Cyclophosphamide|cyclophosphamide|mesh-list
153790230|NCT00107380|Rituximab|rituximab|mesh-list
153790231|NCT00107380|Doxorubicin|doxorubicin|mesh-list
153790232|NCT00107380|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
153790233|NCT00107380|Vincristine|vincristine|mesh-list
153790234|NCT00107380|Tositumomab I-131|tositumomab i-131|mesh-list
153348712|NCT00287222|Growth Substances|growth substances|mesh-ancestor
153790235|NCT00107380|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153790236|NCT00107380|Immunologic Factors|immunologic factors|mesh-ancestor
153379695|NCT02988869|Autonomic Agents|autonomic agents|mesh-ancestor
153790237|NCT00107380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153790239|NCT00107380|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153790274|NCT04054531|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153790275|NCT04054531|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153790276|NCT00289263|Paclitaxel|paclitaxel|mesh-list
153790277|NCT00289263|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153790278|NCT00289263|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153790279|NCT00289263|Tubulin Modulators|tubulin modulators|mesh-ancestor
153790280|NCT00289263|Antimitotic Agents|antimitotic agents|mesh-ancestor
153790281|NCT00289263|Mitosis Modulators|mitosis modulators|mesh-ancestor
153790282|NCT00289263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153790283|NCT00255437|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
153790284|NCT00255437|Hematinics|hematinics|mesh-ancestor
153790285|NCT00255437|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
153790286|NCT00255437|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
153790287|NCT00255476|Gefitinib|gefitinib|mesh-list
153790288|NCT00255476|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153790289|NCT00255476|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153790290|NCT00255476|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153790291|NCT00255476|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153790292|NCT00255476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153790293|NCT00270270|Epoetin Alfa|epoetin alfa|mesh-list
153379778|NCT01887587|Antimitotic Agents|antimitotic agents|mesh-ancestor
153379987|NCT02931045|Ticagrelor|ticagrelor|mesh-list
153790295|NCT04512118|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
153790326|NCT00289419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153790327|NCT00289419|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153790328|NCT00289419|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153790329|NCT00289419|Adrenergic Agents|adrenergic agents|mesh-ancestor
153790330|NCT00289419|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153790331|NCT00289419|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
153790332|NCT00289419|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153790333|NCT00289419|Autonomic Agents|autonomic agents|mesh-ancestor
153790334|NCT00289419|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153790335|NCT00289419|Respiratory System Agents|respiratory system agents|mesh-ancestor
153790336|NCT00289419|Mydriatics|mydriatics|mesh-ancestor
153790337|NCT00289419|Sympathomimetics|sympathomimetics|mesh-ancestor
153336885|NCT00000796|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153790340|NCT00255554|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
153790341|NCT00255554|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153790342|NCT00255554|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153475088|NCT00761202|Glycerol|glycerol|mesh-list
153790343|NCT00255554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153790344|NCT00255554|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153790345|NCT00255554|Serotonin Agents|serotonin agents|mesh-ancestor
153790346|NCT00255554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153790349|NCT00270348|Hormones|hormones|mesh-ancestor
153790377|NCT00255710|Antimetabolites|antimetabolites|mesh-ancestor
153790378|NCT00255710|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
153790379|NCT00255710|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153790380|NCT00255710|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153790381|NCT00255710|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
153790382|NCT00255710|Antitubercular Agents|antitubercular agents|mesh-ancestor
153790383|NCT00255710|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153790384|NCT00255710|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153790385|NCT00270426|Benazepril|benazepril|mesh-list
153790386|NCT00270426|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
153790387|NCT00270426|Protease Inhibitors|protease inhibitors|mesh-ancestor
153790388|NCT00270426|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153790389|NCT00270426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153790390|NCT00270426|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153790391|NCT00255749|Epoetin Alfa|epoetin alfa|mesh-list
153790392|NCT00255749|Hematinics|hematinics|mesh-ancestor
153790393|NCT04482361|Antibodies|antibodies|mesh-list
153790394|NCT04482361|Immunologic Factors|immunologic factors|mesh-ancestor
153790395|NCT04482361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153790397|NCT00270543|Fluorouracil|fluorouracil|mesh-list
153790398|NCT00270543|Docetaxel|docetaxel|mesh-list
153790399|NCT00270543|Antimetabolites|antimetabolites|mesh-ancestor
153348773|NCT01138475|Vitamins|vitamins|mesh-ancestor
153790400|NCT00270543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153790401|NCT00270543|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153790402|NCT00270543|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153790403|NCT00270543|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153790404|NCT00270543|Immunologic Factors|immunologic factors|mesh-ancestor
153790405|NCT00270543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153790406|NCT00270543|Antidotes|antidotes|mesh-ancestor
153790424|NCT00270582|Docetaxel|docetaxel|mesh-list
153790425|NCT00270582|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153790426|NCT00270582|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153790427|NCT00270582|Antimetabolites|antimetabolites|mesh-ancestor
153790428|NCT00270582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153790429|NCT00270582|Tubulin Modulators|tubulin modulators|mesh-ancestor
153790430|NCT00270582|Antimitotic Agents|antimitotic agents|mesh-ancestor
153790431|NCT00270582|Mitosis Modulators|mitosis modulators|mesh-ancestor
153790433|NCT01600456|Antidepressive Agents|antidepressive agents|mesh-ancestor
153790434|NCT01600456|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153790435|NCT01600456|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
153790436|NCT01600456|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153790437|NCT01600456|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153790438|NCT01600456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153790439|NCT01600456|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153790440|NCT01600456|Serotonin Agents|serotonin agents|mesh-ancestor
153790441|NCT01600456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153790442|NCT00289809|Ifosfamide|ifosfamide|mesh-list
153790443|NCT00289809|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153790444|NCT00289809|Alkylating Agents|alkylating agents|mesh-ancestor
153790445|NCT00289809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153790446|NCT00289809|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153790447|NCT00256100|PENTA|penta|mesh-list
153790448|NCT00256100|Fondaparinux|fondaparinux|mesh-list
153790449|NCT00256100|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
153790450|NCT00256100|Antithrombins|antithrombins|mesh-ancestor
153790451|NCT00256100|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
153790452|NCT00256100|Protease Inhibitors|protease inhibitors|mesh-ancestor
153790453|NCT00256100|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153790454|NCT00256100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153790455|NCT00256100|Anticoagulants|anticoagulants|mesh-ancestor
153790465|NCT01609192|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153790466|NCT01609192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153790467|NCT01609192|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153790468|NCT01609387|Tocopherols|tocopherols|mesh-list
153790469|NCT01609387|Antioxidants|antioxidants|mesh-ancestor
153790470|NCT01609387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153790471|NCT01609387|Protective Agents|protective agents|mesh-ancestor
153790472|NCT01609387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153790473|NCT01609387|Vitamins|vitamins|mesh-ancestor
153790474|NCT01609387|Micronutrients|micronutrients|mesh-ancestor
153790475|NCT00256178|Simvastatin|simvastatin|mesh-list
153790476|NCT00256178|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153790477|NCT00256178|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153790478|NCT00256178|Antimetabolites|antimetabolites|mesh-ancestor
153790479|NCT00256178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153790480|NCT00256178|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153348904|NCT00298610|Adrenergic Agents|adrenergic agents|mesh-ancestor
153475230|NCT00785772|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
153790481|NCT00256178|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
153336959|NCT00000814|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
153790483|NCT02488408|Cytarabine|cytarabine|mesh-list
153790484|NCT02488408|Decitabine|decitabine|mesh-list
153790485|NCT02488408|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153336960|NCT02661932|Letrozole|letrozole|mesh-list
153790486|NCT02488408|Antimetabolites|antimetabolites|mesh-ancestor
153337034|NCT00014560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153790487|NCT02488408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153790488|NCT02488408|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153790489|NCT02488408|Antiviral Agents|antiviral agents|mesh-ancestor
153790490|NCT02488408|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153790491|NCT02488408|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153790492|NCT02488408|Immunologic Factors|immunologic factors|mesh-ancestor
153790493|NCT02488408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153790494|NCT02488408|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153790495|NCT00270777|Promethazine|promethazine|mesh-list
153790496|NCT00270777|Diphenhydramine|diphenhydramine|mesh-list
153790497|NCT00270777|Hydrocortisone|hydrocortisone|mesh-list
153790498|NCT00270777|Epinephrine|epinephrine|mesh-list
153790501|NCT00270777|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153790502|NCT00270777|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153790503|NCT00270777|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153348933|NCT00215930|Tubulin Modulators|tubulin modulators|mesh-ancestor
153790504|NCT00270777|Adrenergic Agents|adrenergic agents|mesh-ancestor
153380197|NCT02476058|Antipruritics|antipruritics|mesh-ancestor
153790505|NCT00270777|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153790506|NCT00270777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153790507|NCT00270777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153790508|NCT00270777|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
153790509|NCT00270777|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153790510|NCT00270777|Autonomic Agents|autonomic agents|mesh-ancestor
153790511|NCT00270777|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153790512|NCT00270777|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153790513|NCT00270777|Respiratory System Agents|respiratory system agents|mesh-ancestor
153790514|NCT00270777|Mydriatics|mydriatics|mesh-ancestor
153790515|NCT00270777|Sympathomimetics|sympathomimetics|mesh-ancestor
153790516|NCT00270777|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
153790517|NCT00270777|Antipruritics|antipruritics|mesh-ancestor
153790518|NCT00270777|Dermatologic Agents|dermatologic agents|mesh-ancestor
153790519|NCT00270777|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
153790520|NCT00270777|Histamine Antagonists|histamine antagonists|mesh-ancestor
153790521|NCT00270777|Histamine Agents|histamine agents|mesh-ancestor
153790522|NCT00270777|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
153790523|NCT00270777|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
153790524|NCT00270777|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153420313|NCT00375050|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
153790525|NCT00270777|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153790526|NCT00270777|Anesthetics, Local|anesthetics, local|mesh-ancestor
153790527|NCT00270777|Anesthetics|anesthetics|mesh-ancestor
153790528|NCT00270777|Sensory System Agents|sensory system agents|mesh-ancestor
153790529|NCT00270777|Antiemetics|antiemetics|mesh-ancestor
153790530|NCT00270777|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153790531|NCT00256256|Glucagon|glucagon|mesh-list
153790544|NCT00256334|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153790545|NCT01609855|Scopolamine|scopolamine|mesh-list
153790546|NCT01609855|Bromides|bromides|mesh-list
153790547|NCT01609855|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
153790551|NCT01609855|Autonomic Agents|autonomic agents|mesh-ancestor
153790552|NCT01609855|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153790553|NCT01609855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153790554|NCT01609855|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153790555|NCT01609855|Mydriatics|mydriatics|mesh-ancestor
153790556|NCT01609855|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
153790557|NCT01609855|Cholinergic Agents|cholinergic agents|mesh-ancestor
153790558|NCT01609855|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153790559|NCT01609855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153790561|NCT01609855|Parasympatholytics|parasympatholytics|mesh-ancestor
153790562|NCT00270816|Interferons|interferons|mesh-list
153475303|NCT00789750|Colesevelam Hydrochloride|colesevelam hydrochloride|mesh-list
153337108|NCT00001810|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
153790563|NCT00270816|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153790564|NCT00270816|Antiviral Agents|antiviral agents|mesh-ancestor
153790565|NCT00270816|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153790566|NCT00290004|Motexafin gadolinium|motexafin gadolinium|mesh-list
153790567|NCT00290004|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153790568|NCT00290004|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
153790569|NCT00290004|Dermatologic Agents|dermatologic agents|mesh-ancestor
153790570|NCT01609816|Dasatinib|dasatinib|mesh-list
153790571|NCT01609816|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153790572|NCT01609816|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153790573|NCT01609816|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153790574|NCT01609816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153790575|NCT01609816|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153790586|NCT00290082|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153790587|NCT00290082|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153790588|NCT00290082|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153790589|NCT00290082|Anesthetics, General|anesthetics, general|mesh-ancestor
153790590|NCT00290082|Anesthetics|anesthetics|mesh-ancestor
153790591|NCT00290082|GABA Modulators|gaba modulators|mesh-ancestor
153790592|NCT00290082|GABA Agents|gaba agents|mesh-ancestor
153790593|NCT00290082|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153790594|NCT00290082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153790595|NCT00290082|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153790596|NCT00290082|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
153790597|NCT00290082|Dopamine Agents|dopamine agents|mesh-ancestor
153790598|NCT00256646|Rosiglitazone|rosiglitazone|mesh-list
153790599|NCT00256646|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153790600|NCT00256646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153790601|NCT02270437|Epinephrine|epinephrine|mesh-list
153790602|NCT02270437|Racepinephrine|racepinephrine|mesh-list
153790603|NCT02270437|Fentanyl|fentanyl|mesh-list
153790604|NCT02270437|Ropivacaine|ropivacaine|mesh-list
153790605|NCT02270437|Epinephryl borate|epinephryl borate|mesh-list
153790606|NCT02270437|Anesthetics, Local|anesthetics, local|mesh-ancestor
153790607|NCT02270437|Anesthetics|anesthetics|mesh-ancestor
153790608|NCT02270437|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153790609|NCT02270437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153790610|NCT02270437|Sensory System Agents|sensory system agents|mesh-ancestor
153790611|NCT02270437|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153790612|NCT02270437|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153790639|NCT02270788|Cytarabine|cytarabine|mesh-list
153790640|NCT02270788|Hydrocortisone|hydrocortisone|mesh-list
153790641|NCT02270788|Methotrexate|methotrexate|mesh-list
153337180|NCT05586464|Bismuth|bismuth|mesh-list
153790642|NCT02270788|Sorafenib|sorafenib|mesh-list
153790643|NCT02270788|Crenolanib|crenolanib|mesh-list
153790644|NCT02270788|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
153790645|NCT02270788|Abortifacient Agents|abortifacient agents|mesh-ancestor
153790646|NCT02270788|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153790647|NCT02270788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153790648|NCT02270788|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153790649|NCT02270788|Antimetabolites|antimetabolites|mesh-ancestor
153790650|NCT02270788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153790651|NCT02270788|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153790652|NCT02270788|Dermatologic Agents|dermatologic agents|mesh-ancestor
153790654|NCT02270788|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153790655|NCT02270788|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153790656|NCT02270788|Immunologic Factors|immunologic factors|mesh-ancestor
153790657|NCT02270788|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153790658|NCT02270788|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153790659|NCT02270788|Antiviral Agents|antiviral agents|mesh-ancestor
153790660|NCT02270788|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153790661|NCT02270788|Antidotes|antidotes|mesh-ancestor
153790662|NCT02270788|Protective Agents|protective agents|mesh-ancestor
153790663|NCT02270788|Vitamin B Complex|vitamin b complex|mesh-ancestor
153790664|NCT02270788|Vitamins|vitamins|mesh-ancestor
153790665|NCT02270788|Micronutrients|micronutrients|mesh-ancestor
153790666|NCT02270788|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153790667|NCT02270788|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153790668|NCT02270827|Hydrocortisone|hydrocortisone|mesh-list
153790669|NCT02270827|Aminophylline|aminophylline|mesh-list
153790670|NCT02270827|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153790671|NCT02270827|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153790672|NCT02270827|Autonomic Agents|autonomic agents|mesh-ancestor
153790681|NCT02270827|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
153475344|NCT00793650|Bortezomib|bortezomib|mesh-list
153475373|NCT00795366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153349010|NCT01149785|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153790682|NCT02270827|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
153790683|NCT02270827|Purinergic Agents|purinergic agents|mesh-ancestor
153790684|NCT02270827|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153790685|NCT02270827|Protective Agents|protective agents|mesh-ancestor
153790687|NCT00290121|Antiemetics|antiemetics|mesh-ancestor
153790688|NCT00290121|Autonomic Agents|autonomic agents|mesh-ancestor
153790689|NCT00290121|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153790690|NCT00290121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153790691|NCT00290121|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153790692|NCT00290121|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153790693|NCT00290121|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153790694|NCT00290121|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153790696|NCT00290121|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
153790697|NCT00290121|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153790698|NCT00290121|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153790699|NCT00290121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153790700|NCT00290121|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153790701|NCT00290121|Serotonin Agents|serotonin agents|mesh-ancestor
153790702|NCT04709744|Vitamin D|vitamin d|mesh-list
153790703|NCT04709744|Ergocalciferols|ergocalciferols|mesh-list
153790704|NCT04709744|Cholecalciferol|cholecalciferol|mesh-list
153790705|NCT04709744|Vitamins|vitamins|mesh-list
153790729|NCT00271050|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
153790730|NCT00271050|Immunologic Factors|immunologic factors|mesh-ancestor
153790731|NCT00271050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153790732|NCT02271646|Bupivacaine|bupivacaine|mesh-list
153790733|NCT02271646|Anesthetics, Local|anesthetics, local|mesh-ancestor
153790734|NCT02271646|Anesthetics|anesthetics|mesh-ancestor
153790735|NCT02271646|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153790736|NCT02271646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153790737|NCT02271646|Sensory System Agents|sensory system agents|mesh-ancestor
153790738|NCT02271646|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153790739|NCT02271802|Butyric Acid|butyric acid|mesh-list
153790740|NCT02271802|Histamine Antagonists|histamine antagonists|mesh-ancestor
153790741|NCT02271802|Histamine Agents|histamine agents|mesh-ancestor
153790742|NCT02271802|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153790743|NCT02271802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153790744|NCT02271802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153790745|NCT02271958|Mifepristone|mifepristone|mesh-list
153790746|NCT02271958|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
153790748|NCT02271958|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153790749|NCT02271958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153790750|NCT02271958|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
153790751|NCT02271958|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
153349027|NCT01173029|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153349079|NCT03465527|Prednisolone|prednisolone|mesh-list
153790752|NCT02271958|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
153790753|NCT02271958|Contraceptive Agents|contraceptive agents|mesh-ancestor
153380773|NCT01928693|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
153790754|NCT02271958|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
153790755|NCT02271958|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
153790756|NCT02271958|Hormone Antagonists|hormone antagonists|mesh-ancestor
153790757|NCT02271958|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153790758|NCT02271958|Luteolytic Agents|luteolytic agents|mesh-ancestor
153790759|NCT02271958|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
153790760|NCT02271958|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
153790761|NCT00257036|Levofloxacin|levofloxacin|mesh-list
153790762|NCT00257036|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
153790766|NCT00257036|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153790767|NCT00257036|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153790768|NCT00257036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153790769|NCT00257036|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153790770|NCT00257036|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
153790771|NCT00257036|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153790772|NCT00257075|Risperidone|risperidone|mesh-list
153790773|NCT00257075|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153790774|NCT00257075|Serotonin Agents|serotonin agents|mesh-ancestor
153790775|NCT00257075|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153790776|NCT00257075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153790777|NCT00257075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153790778|NCT00257075|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153790779|NCT00257075|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153380921|NCT01951391|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153380922|NCT02342886|Moxifloxacin|moxifloxacin|mesh-list
153380924|NCT02342886|Isoniazid|isoniazid|mesh-list
153790780|NCT00257075|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153790781|NCT00257075|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153790782|NCT00257075|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
153790783|NCT00257075|Dopamine Agents|dopamine agents|mesh-ancestor
153790784|NCT02272270|Minocycline|minocycline|mesh-list
153790785|NCT02272270|Temozolomide|temozolomide|mesh-list
153790786|NCT02272270|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153790787|NCT02272270|Alkylating Agents|alkylating agents|mesh-ancestor
153337314|NCT00000160|Xenon|xenon|mesh-list
153349100|NCT01156571|Cangrelor|cangrelor|mesh-list
153790788|NCT02272270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153790815|NCT02272660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153790816|NCT02272660|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153790817|NCT02272660|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153790818|NCT02272660|Analgesics|analgesics|mesh-ancestor
153790819|NCT02272660|Sensory System Agents|sensory system agents|mesh-ancestor
153475427|NCT00801138|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153790820|NCT02272660|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153790821|NCT02272660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153790822|NCT02272660|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153790823|NCT02272660|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153790824|NCT02272699|Paclitaxel|paclitaxel|mesh-list
153790825|NCT02272699|Nimotuzumab|nimotuzumab|mesh-list
153790826|NCT02272699|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153790827|NCT02272699|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153790828|NCT02272699|Tubulin Modulators|tubulin modulators|mesh-ancestor
153790829|NCT02272699|Antimitotic Agents|antimitotic agents|mesh-ancestor
153790830|NCT02272699|Mitosis Modulators|mitosis modulators|mesh-ancestor
153790831|NCT02272699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153790832|NCT02272699|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153790833|NCT02272738|Paclitaxel|paclitaxel|mesh-list
153790834|NCT02272738|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
153790835|NCT02272738|Gemcitabine|gemcitabine|mesh-list
153790836|NCT02272738|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153790838|NCT02272738|Tubulin Modulators|tubulin modulators|mesh-ancestor
153790864|NCT00257270|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153790865|NCT00257270|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153790866|NCT00257270|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153790867|NCT00257270|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
153790868|NCT00257270|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
153790869|NCT00257270|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153790870|NCT00257270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153790871|NCT00257270|Antimanic Agents|antimanic agents|mesh-ancestor
153790872|NCT00290394|Rosiglitazone|rosiglitazone|mesh-list
153790873|NCT00290394|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153790874|NCT00290394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153790875|NCT00257348|Docetaxel|docetaxel|mesh-list
153790876|NCT00257348|Capecitabine|capecitabine|mesh-list
153790877|NCT00257348|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153790878|NCT00257348|Tubulin Modulators|tubulin modulators|mesh-ancestor
153790879|NCT00257348|Antimitotic Agents|antimitotic agents|mesh-ancestor
153790880|NCT00257348|Mitosis Modulators|mitosis modulators|mesh-ancestor
153790882|NCT00257348|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153790883|NCT00257348|Antimetabolites|antimetabolites|mesh-ancestor
153790884|NCT02273128|Calcitonin|calcitonin|mesh-list
153790885|NCT02273128|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153790886|NCT02273128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153790887|NCT02273128|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153790888|NCT00257387|Cyclosporine|cyclosporine|mesh-list
153790889|NCT00257387|Cyclosporins|cyclosporins|mesh-list
153790890|NCT00257387|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153790912|NCT00416325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153790913|NCT00416325|Protective Agents|protective agents|mesh-ancestor
153790914|NCT00416325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153790915|NCT00416325|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
153790916|NCT00416325|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
153790917|NCT00416325|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153790918|NCT00257465|Vaccines|vaccines|mesh-list
153790919|NCT00257465|Immunologic Factors|immunologic factors|mesh-ancestor
153790920|NCT00257465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153790921|NCT01601899|Tenofovir|tenofovir|mesh-list
153790922|NCT01601899|Lamivudine|lamivudine|mesh-list
153790923|NCT01601899|Efavirenz|efavirenz|mesh-list
153790924|NCT01601899|Stavudine|stavudine|mesh-list
153790925|NCT01601899|Antiviral Agents|antiviral agents|mesh-ancestor
153790926|NCT01601899|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153790927|NCT01601899|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153790928|NCT01601899|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153790929|NCT01601899|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153790930|NCT01601899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153790932|NCT01601899|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153790933|NCT01601899|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
153790934|NCT01601899|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153790935|NCT01601899|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
153790936|NCT01601899|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
153337412|NCT00001930|Amantadine|amantadine|mesh-list
153790937|NCT01601899|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
153790938|NCT01601899|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
153790939|NCT01601899|Antimetabolites|antimetabolites|mesh-ancestor
153790940|NCT01601938|Selenium|selenium|mesh-list
153790941|NCT01601938|Antioxidants|antioxidants|mesh-ancestor
153790942|NCT01601938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153790943|NCT01601938|Protective Agents|protective agents|mesh-ancestor
153783371|NCT04552444|Biapenem|biapenem|mesh-list
153790944|NCT01601938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153790945|NCT01601938|Trace Elements|trace elements|mesh-ancestor
153790950|NCT01602250|Ropivacaine|ropivacaine|mesh-list
153790951|NCT01602250|Levobupivacaine|levobupivacaine|mesh-list
153790952|NCT01602250|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
153790953|NCT01602250|Anesthetics, Local|anesthetics, local|mesh-ancestor
153790954|NCT01602250|Anesthetics|anesthetics|mesh-ancestor
153790955|NCT01602250|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153790956|NCT01602250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153790957|NCT01602250|Sensory System Agents|sensory system agents|mesh-ancestor
153790958|NCT01602250|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153790959|NCT01602250|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
153790960|NCT01602250|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
153790961|NCT01602250|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
153420618|NCT00375284|Antioxidants|antioxidants|mesh-ancestor
153790962|NCT00257582|Cetirizine|cetirizine|mesh-list
153790963|NCT00257582|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
153791011|NCT00290628|Antifungal Agents|antifungal agents|mesh-ancestor
153791012|NCT00290628|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153791013|NCT00290628|Dermatologic Agents|dermatologic agents|mesh-ancestor
153791014|NCT00290628|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
153791015|NCT00290628|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153791016|NCT00290628|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
153791017|NCT00290628|Antitubercular Agents|antitubercular agents|mesh-ancestor
153791018|NCT00290628|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153791019|NCT00290628|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153791020|NCT00290628|Antiemetics|antiemetics|mesh-ancestor
153791021|NCT00290628|Autonomic Agents|autonomic agents|mesh-ancestor
153791022|NCT00290628|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153791023|NCT00290628|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153791024|NCT00290628|Glucocorticoids|glucocorticoids|mesh-ancestor
153791025|NCT00290628|Hormones|hormones|mesh-ancestor
153791026|NCT00290628|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153791027|NCT00290628|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
153791028|NCT00290628|Protective Agents|protective agents|mesh-ancestor
153791029|NCT01602523|Budesonide|budesonide|mesh-list
153791030|NCT01602523|Formoterol Fumarate|formoterol fumarate|mesh-list
153381383|NCT05738681|Acetylcysteine|acetylcysteine|mesh-list
153791032|NCT01602523|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153791033|NCT01602523|Autonomic Agents|autonomic agents|mesh-ancestor
153791034|NCT01602523|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153791035|NCT01602523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153791036|NCT01602523|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153791037|NCT01602523|Respiratory System Agents|respiratory system agents|mesh-ancestor
153791038|NCT01602523|Glucocorticoids|glucocorticoids|mesh-ancestor
153791039|NCT01602523|Hormones|hormones|mesh-ancestor
153791040|NCT01602523|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153791041|NCT01602523|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
153791042|NCT01602523|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
153791043|NCT01602523|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153791052|NCT01602640|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153791053|NCT01602640|Narcotics|narcotics|mesh-ancestor
153791054|NCT01602640|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153791055|NCT01602640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153791056|NCT01602640|Analgesics|analgesics|mesh-ancestor
153791058|NCT01602640|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153791059|NCT01602640|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153791060|NCT01602640|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153791061|NCT01602640|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153791062|NCT01602640|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153791063|NCT01602640|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153791064|NCT01602640|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153791065|NCT01602640|Anesthetics, General|anesthetics, general|mesh-ancestor
153791066|NCT01602640|Anesthetics|anesthetics|mesh-ancestor
153791067|NCT01602640|GABA Modulators|gaba modulators|mesh-ancestor
153791068|NCT01602640|GABA Agents|gaba agents|mesh-ancestor
153791069|NCT01602640|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153791070|NCT01602640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153791071|NCT00290667|Prednisone|prednisone|mesh-list
153791072|NCT00290667|Cyclophosphamide|cyclophosphamide|mesh-list
153791073|NCT00290667|Rituximab|rituximab|mesh-list
153791074|NCT00290667|Doxorubicin|doxorubicin|mesh-list
153791075|NCT00290667|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
153791102|NCT01602757|Anesthetics, Local|anesthetics, local|mesh-ancestor
153791103|NCT01602757|Anesthetics|anesthetics|mesh-ancestor
153791104|NCT01602757|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153791105|NCT01602757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153791106|NCT01602757|Sensory System Agents|sensory system agents|mesh-ancestor
153791107|NCT01602757|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153791108|NCT01602757|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153791109|NCT01602757|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
153791110|NCT01602757|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153791111|NCT01602757|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153791112|NCT01602757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153791113|NCT02961101|Decitabine|decitabine|mesh-list
153791114|NCT02961101|Antibodies|antibodies|mesh-list
153791115|NCT02961101|Immunologic Factors|immunologic factors|mesh-ancestor
153791116|NCT02961101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153791117|NCT02961101|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153420687|NCT03122587|Vitamins|vitamins|mesh-ancestor
153420688|NCT03122587|Micronutrients|micronutrients|mesh-ancestor
153791118|NCT02961101|Antimetabolites|antimetabolites|mesh-ancestor
153420689|NCT03122587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153420690|NCT03122587|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153791119|NCT02961101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153791120|NCT02961101|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153791121|NCT02961101|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153420691|NCT02161146|Olopatadine Hydrochloride|olopatadine hydrochloride|mesh-list
153791122|NCT01602913|Paroxetine|paroxetine|mesh-list
153420697|NCT02161146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153791123|NCT01602913|Pravastatin|pravastatin|mesh-list
153791124|NCT01602913|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
153791125|NCT01602913|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153381637|NCT02899325|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
153791126|NCT01602913|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153791127|NCT01602913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153791128|NCT01602913|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153791146|NCT00257699|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153791147|NCT00257699|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153791148|NCT00257699|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153791149|NCT00257699|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153791150|NCT00257699|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153791151|NCT00257699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153791152|NCT00257699|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153791153|NCT00257699|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
153791154|NCT00257699|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153791155|NCT01603030|Moxifloxacin|moxifloxacin|mesh-list
153791156|NCT01603030|Prednisolone|prednisolone|mesh-list
153791157|NCT01603030|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
153791158|NCT01603030|Methylprednisolone|methylprednisolone|mesh-list
153791159|NCT01603030|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
153791160|NCT01603030|Prednisolone acetate|prednisolone acetate|mesh-list
153791161|NCT01603030|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
153791162|NCT01603030|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
153791163|NCT01603030|Prednisolone phosphate|prednisolone phosphate|mesh-list
153791164|NCT01603030|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153791165|NCT01603030|Glucocorticoids|glucocorticoids|mesh-ancestor
153791166|NCT01603030|Hormones|hormones|mesh-ancestor
153791167|NCT01603030|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153791168|NCT01603030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153791169|NCT01603030|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153791170|NCT01603030|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153791171|NCT01603030|Antiemetics|antiemetics|mesh-ancestor
153791172|NCT01603030|Autonomic Agents|autonomic agents|mesh-ancestor
153791173|NCT01603030|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153791174|NCT01603030|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153791175|NCT01603030|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
153791176|NCT01603030|Protective Agents|protective agents|mesh-ancestor
153791177|NCT01603030|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153791178|NCT01603030|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153791179|NCT01603030|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153791180|NCT01603030|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153791182|NCT01603030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153791183|NCT01603030|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
153791184|NCT01603030|Contraceptive Agents|contraceptive agents|mesh-ancestor
153791185|NCT01603030|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153791186|NCT01603030|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
153791187|NCT01603030|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
153791188|NCT01603030|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
153791189|NCT01603108|Rifaximin|rifaximin|mesh-list
153381836|NCT03282669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153791191|NCT01603108|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153791192|NCT01603108|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153791193|NCT00290823|Albendazole|albendazole|mesh-list
153791194|NCT00290823|Dexamethasone|dexamethasone|mesh-list
153791195|NCT00290823|Omeprazole|omeprazole|mesh-list
153791196|NCT00290823|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153791197|NCT00290823|Antiemetics|antiemetics|mesh-ancestor
153791198|NCT00290823|Autonomic Agents|autonomic agents|mesh-ancestor
153791199|NCT00290823|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153791200|NCT00290823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153791201|NCT00290823|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153791202|NCT00290823|Glucocorticoids|glucocorticoids|mesh-ancestor
153791203|NCT00290823|Hormones|hormones|mesh-ancestor
153791204|NCT00290823|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153791205|NCT00290823|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153791206|NCT00290823|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153791207|NCT00290823|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
153791208|NCT00290823|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
153791209|NCT00290823|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153791210|NCT00290823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153791211|NCT00290823|Anthelmintics|anthelmintics|mesh-ancestor
153791212|NCT00290823|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153349349|NCT03549650|Anticoagulants|anticoagulants|mesh-ancestor
153791213|NCT00290823|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153791214|NCT00290823|Anticestodal Agents|anticestodal agents|mesh-ancestor
153791225|NCT01603186|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153791226|NCT01603186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153791227|NCT00271284|Insulin|insulin|mesh-list
153791228|NCT00271284|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
153791229|NCT00271284|Insulin Glargine|insulin glargine|mesh-list
153791230|NCT00271284|Insulin Detemir|insulin detemir|mesh-list
153791231|NCT00271284|Insulin glulisine|insulin glulisine|mesh-list
153791232|NCT00271284|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153337710|NCT04331470|Antimalarials|antimalarials|mesh-ancestor
153791234|NCT00257816|Topotecan|topotecan|mesh-list
153791235|NCT00257816|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153791236|NCT00257816|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
153791237|NCT00257816|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153791238|NCT00257816|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153791239|NCT00257816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153791241|NCT00271323|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153791242|NCT00271323|Tubulin Modulators|tubulin modulators|mesh-ancestor
153791243|NCT00271323|Antimitotic Agents|antimitotic agents|mesh-ancestor
153791244|NCT00271323|Mitosis Modulators|mitosis modulators|mesh-ancestor
153791245|NCT00271323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153791246|NCT01603342|Clopidogrel|clopidogrel|mesh-list
153791247|NCT01603342|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153791248|NCT01603342|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
153791281|NCT01603498|Glucocorticoids|glucocorticoids|mesh-ancestor
153791283|NCT01603498|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153791284|NCT01603498|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153791285|NCT01603498|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153791286|NCT01603498|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
153791287|NCT01603498|Protective Agents|protective agents|mesh-ancestor
153791288|NCT01603654|Ascorbic Acid|ascorbic acid|mesh-list
153791290|NCT01603654|Picosulfate sodium|picosulfate sodium|mesh-list
153791291|NCT01603654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153791292|NCT01603654|Antioxidants|antioxidants|mesh-ancestor
153791293|NCT01603654|Protective Agents|protective agents|mesh-ancestor
153791294|NCT01603654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153791295|NCT01603654|Vitamins|vitamins|mesh-ancestor
153791296|NCT01603654|Micronutrients|micronutrients|mesh-ancestor
153791297|NCT01603654|Cathartics|cathartics|mesh-ancestor
153791330|NCT06302426|Pembrolizumab|pembrolizumab|mesh-list
153791331|NCT06302426|Nivolumab|nivolumab|mesh-list
153791332|NCT06302426|Atezolizumab|atezolizumab|mesh-list
153791333|NCT06302426|Durvalumab|durvalumab|mesh-list
153791334|NCT06302426|Avelumab|avelumab|mesh-list
153791335|NCT06302426|Cemiplimab|cemiplimab|mesh-list
153791336|NCT06302426|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153791337|NCT06302426|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153791338|NCT06302426|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153791339|NCT06302426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153791340|NCT06302335|Povidone-Iodine|povidone-iodine|mesh-list
153791341|NCT06302335|Povidone|povidone|mesh-list
153791342|NCT06302335|Plasma Substitutes|plasma substitutes|mesh-ancestor
153791343|NCT06302335|Blood Substitutes|blood substitutes|mesh-ancestor
153791344|NCT06302335|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
153791345|NCT06302335|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153791346|NCT06302218|Ropivacaine|ropivacaine|mesh-list
153791347|NCT06302218|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
153791359|NCT06302062|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153791360|NCT06302062|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153791361|NCT06302062|Alkylating Agents|alkylating agents|mesh-ancestor
153791362|NCT06302062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153791363|NCT06302062|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153791364|NCT06302062|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153791365|NCT06302062|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153791366|NCT06302062|Analgesics|analgesics|mesh-ancestor
153791367|NCT06302062|Sensory System Agents|sensory system agents|mesh-ancestor
153791368|NCT06302062|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153791369|NCT06302049|Esomeprazole|esomeprazole|mesh-list
153791370|NCT06302049|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
153791371|NCT06302049|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153791372|NCT06302049|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
153791373|NCT06302049|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153791374|NCT06302049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153791375|NCT06301880|Milrinone|milrinone|mesh-list
153791376|NCT06301880|Nitroglycerin|nitroglycerin|mesh-list
153791377|NCT06301880|Vasodilator Agents|vasodilator agents|mesh-list
153791378|NCT06301880|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
153791379|NCT06301880|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153791380|NCT06301880|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
153791381|NCT06301880|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
153791382|NCT06301880|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153791383|NCT06301880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153337934|NCT00001990|Antimalarials|antimalarials|mesh-ancestor
153475834|NCT00834678|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153475835|NCT00834678|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153349481|NCT01457521|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153475836|NCT00834678|Alkylating Agents|alkylating agents|mesh-ancestor
153874529|NCT04550351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153874530|NCT01640691|Vaccines|vaccines|mesh-list
153874531|NCT01640691|Immunologic Factors|immunologic factors|mesh-ancestor
153874532|NCT01640691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153874533|NCT01643889|Moxifloxacin|moxifloxacin|mesh-list
153874534|NCT01643889|Domperidone|domperidone|mesh-list
153874535|NCT01643889|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153791385|NCT06301880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153791386|NCT06301828|Endostar protein|endostar protein|mesh-list
153791387|NCT06301828|Endostatins|endostatins|mesh-list
153791388|NCT06301828|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153791389|NCT06301828|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153791398|NCT06301802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153791399|NCT06301789|Bupivacaine|bupivacaine|mesh-list
153349539|NCT01482091|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153791400|NCT06301789|Anesthetics, Local|anesthetics, local|mesh-ancestor
153791401|NCT06301789|Anesthetics|anesthetics|mesh-ancestor
153791402|NCT06301789|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153791403|NCT06301789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153791404|NCT06301789|Sensory System Agents|sensory system agents|mesh-ancestor
153791405|NCT06301789|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153791406|NCT06301776|Ticagrelor|ticagrelor|mesh-list
153791407|NCT06301776|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153791408|NCT06301776|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
153791409|NCT06301776|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
153791410|NCT06301776|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
153791411|NCT06301776|Purinergic Agents|purinergic agents|mesh-ancestor
153791412|NCT06301776|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153791413|NCT06301776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153791414|NCT06301776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153349540|NCT01482091|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153349541|NCT01482091|Anesthetics, General|anesthetics, general|mesh-ancestor
153791415|NCT06301529|Canagliflozin|canagliflozin|mesh-list
153791416|NCT06301529|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
153791417|NCT06301529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153791418|NCT06301529|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153791419|NCT06301529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153791420|NCT06301399|Rituximab|rituximab|mesh-list
153791421|NCT06301399|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
153791422|NCT06301399|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153349582|NCT05075330|Sensory System Agents|sensory system agents|mesh-ancestor
153791423|NCT06301399|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153791424|NCT06301399|Immunologic Factors|immunologic factors|mesh-ancestor
153791425|NCT06301399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153791441|NCT06301373|Abortifacient Agents|abortifacient agents|mesh-ancestor
153791442|NCT06301373|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153791443|NCT06301373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153791444|NCT06301373|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153791445|NCT06301373|Antimetabolites|antimetabolites|mesh-ancestor
153382377|NCT01992185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153791446|NCT06301373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153791447|NCT06301373|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153791448|NCT06301373|Dermatologic Agents|dermatologic agents|mesh-ancestor
153791449|NCT06301373|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153791450|NCT06301373|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153791451|NCT06301373|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153791452|NCT06301373|Immunologic Factors|immunologic factors|mesh-ancestor
153791453|NCT06301373|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153791454|NCT06301373|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153791455|NCT06301373|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153791456|NCT06301334|Bupivacaine|bupivacaine|mesh-list
153791457|NCT06301334|Anesthetics, Local|anesthetics, local|mesh-ancestor
153791458|NCT06301334|Anesthetics|anesthetics|mesh-ancestor
153791459|NCT06301334|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153791460|NCT06301334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153791461|NCT06301334|Sensory System Agents|sensory system agents|mesh-ancestor
153791462|NCT06301334|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153791463|NCT06301308|Lidocaine|lidocaine|mesh-list
153791464|NCT06301308|Anesthetics, Local|anesthetics, local|mesh-ancestor
153791465|NCT06301308|Anesthetics|anesthetics|mesh-ancestor
153791466|NCT06301308|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153791467|NCT06301308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153791468|NCT06301308|Sensory System Agents|sensory system agents|mesh-ancestor
153349584|NCT02108288|Carteolol|carteolol|mesh-list
153791469|NCT06301308|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153791470|NCT06301308|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153791471|NCT06301308|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
153791472|NCT06301308|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153791475|NCT06301282|Levodopa|levodopa|mesh-list
153791480|NCT06301282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153791481|NCT06301282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153791482|NCT06301256|Tirzepatide|tirzepatide|mesh-list
153791483|NCT06301256|Incretins|incretins|mesh-ancestor
153791484|NCT06301256|Hormones|hormones|mesh-ancestor
153791485|NCT06301256|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153791486|NCT06301256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153791487|NCT06301204|Tranexamic Acid|tranexamic acid|mesh-list
153791488|NCT06301204|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
153791489|NCT06301204|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153791490|NCT06301204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153791491|NCT06301204|Hemostatics|hemostatics|mesh-ancestor
153791493|NCT06301191|Semaglutide|semaglutide|mesh-list
153791494|NCT06301191|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
153791495|NCT06301191|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
153791496|NCT06301191|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153791497|NCT06301191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153791498|NCT06301191|Protease Inhibitors|protease inhibitors|mesh-ancestor
153791499|NCT06301191|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153791500|NCT06301191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153791501|NCT06301061|Pregabalin|pregabalin|mesh-list
153791502|NCT06301061|Gabapentin|gabapentin|mesh-list
153791503|NCT06301061|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
153791504|NCT06301061|Amitriptyline|amitriptyline|mesh-list
153791505|NCT06301061|Analgesics|analgesics|mesh-ancestor
153791506|NCT06301061|Sensory System Agents|sensory system agents|mesh-ancestor
153791507|NCT06301061|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153791508|NCT06301061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153791509|NCT06301061|Anticonvulsants|anticonvulsants|mesh-ancestor
153791521|NCT06301061|Antimanic Agents|antimanic agents|mesh-ancestor
153791522|NCT06301061|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
153791523|NCT06301061|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153791525|NCT06301061|Dopamine Agents|dopamine agents|mesh-ancestor
153791526|NCT06301061|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
153791527|NCT06301061|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153791528|NCT06301061|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
153791529|NCT06301061|Adrenergic Agents|adrenergic agents|mesh-ancestor
153791531|NCT06300970|Lumefantrine|lumefantrine|mesh-list
153791532|NCT06300970|Artemether|artemether|mesh-list
153791533|NCT06300970|Amodiaquine|amodiaquine|mesh-list
153791534|NCT06300970|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
153791535|NCT06300970|Antimalarials|antimalarials|mesh-ancestor
153791536|NCT06300970|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153791537|NCT06300970|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153791538|NCT06300970|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153791539|NCT06300970|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153791540|NCT06300970|Antiviral Agents|antiviral agents|mesh-ancestor
153791541|NCT06300970|Schistosomicides|schistosomicides|mesh-ancestor
153791542|NCT06300970|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
153791543|NCT06300970|Anthelmintics|anthelmintics|mesh-ancestor
153791544|NCT06300944|Analgesics|analgesics|mesh-list
153791545|NCT06300944|Esketamine|esketamine|mesh-list
153791546|NCT06300944|Sensory System Agents|sensory system agents|mesh-ancestor
153791547|NCT06300944|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153791548|NCT06300944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153791549|NCT06300944|Antidepressive Agents|antidepressive agents|mesh-ancestor
153791550|NCT06300944|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153791551|NCT06300502|Deoxycholic Acid|deoxycholic acid|mesh-list
153791552|NCT06300502|Polidocanol|polidocanol|mesh-list
153791553|NCT06300502|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
153791554|NCT06300502|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
153791555|NCT06300502|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
153791556|NCT06300502|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153791557|NCT06300489|Capecitabine|capecitabine|mesh-list
153791558|NCT06300489|Irinotecan|irinotecan|mesh-list
153791559|NCT06300489|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153791562|NCT06300489|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153791563|NCT06300489|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
153791564|NCT06300489|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153791565|NCT06300489|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153791566|NCT06300346|Pregabalin|pregabalin|mesh-list
153791567|NCT06300346|Propofol|propofol|mesh-list
153791568|NCT06300346|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153791569|NCT06300346|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153791571|NCT06300346|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153791630|NCT06300138|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
153791631|NCT06300138|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153791633|NCT06300138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153791634|NCT06300138|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153791635|NCT06300138|Hormone Antagonists|hormone antagonists|mesh-ancestor
153874553|NCT04550078|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153874554|NCT04550078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153874555|NCT04550078|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153349693|NCT01159067|Chelating Agents|chelating agents|mesh-ancestor
153874556|NCT04550078|Antacids|antacids|mesh-ancestor
153874557|NCT04550078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153874559|NCT01205035|Ranibizumab|ranibizumab|mesh-list
153791636|NCT06300138|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153791638|NCT06300138|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
153791639|NCT06299852|Trastuzumab|trastuzumab|mesh-list
153791640|NCT06299852|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
153791641|NCT06299852|Maytansine|maytansine|mesh-list
153791642|NCT06299852|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153791643|NCT06299852|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153791644|NCT06299852|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153791645|NCT06299852|Tubulin Modulators|tubulin modulators|mesh-ancestor
153791646|NCT06299852|Antimitotic Agents|antimitotic agents|mesh-ancestor
153791647|NCT06299852|Mitosis Modulators|mitosis modulators|mesh-ancestor
153791648|NCT06299852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153791649|NCT06299852|Immunotoxins|immunotoxins|mesh-ancestor
153791650|NCT06299852|Immunoconjugates|immunoconjugates|mesh-ancestor
153791651|NCT06299852|Immunologic Factors|immunologic factors|mesh-ancestor
153791690|NCT06294561|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153791692|NCT06294561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153791693|NCT06294561|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153791694|NCT06294561|Hormone Antagonists|hormone antagonists|mesh-ancestor
153791695|NCT06294561|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153791696|NCT06294561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153791697|NCT06294561|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
153791698|NCT06294561|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153791699|NCT06294561|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153791700|NCT06294561|Antiviral Agents|antiviral agents|mesh-ancestor
153791701|NCT06294561|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
153791702|NCT06294561|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
153791726|NCT06293807|Sensory System Agents|sensory system agents|mesh-ancestor
153791727|NCT06293807|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153791728|NCT06293807|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153791729|NCT06293807|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
153791730|NCT06293807|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153791731|NCT06293807|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153791732|NCT06293807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153791733|NCT06293807|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153791734|NCT06293807|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153791735|NCT06293807|Adrenergic Agents|adrenergic agents|mesh-ancestor
153791736|NCT06293807|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153791737|NCT06293807|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
153791738|NCT06293807|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153791739|NCT06293807|Autonomic Agents|autonomic agents|mesh-ancestor
153791740|NCT06293807|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153791787|NCT06279234|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153791788|NCT06279234|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153791789|NCT06279234|Anesthetics, General|anesthetics, general|mesh-ancestor
153791790|NCT06279234|Anesthetics|anesthetics|mesh-ancestor
153791791|NCT06279234|GABA Modulators|gaba modulators|mesh-ancestor
153791792|NCT06279234|GABA Agents|gaba agents|mesh-ancestor
153791793|NCT06279234|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153874570|NCT04549844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153791794|NCT06279234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153791795|NCT06279234|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153791798|NCT06279234|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153791799|NCT06279234|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
153791800|NCT06279234|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153791801|NCT06279234|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
153791802|NCT06279234|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153791803|NCT06279234|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
153791804|NCT06277674|Pemetrexed|pemetrexed|mesh-list
153791805|NCT06277674|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153791806|NCT06277674|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153791807|NCT06277674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153791808|NCT06277674|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153791809|NCT06277674|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153791810|NCT06239467|Trastuzumab|trastuzumab|mesh-list
153791811|NCT06239467|Fulvestrant|fulvestrant|mesh-list
153791813|NCT06239467|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153791834|NCT06218303|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153791835|NCT06218303|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153791836|NCT06218303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153791837|NCT06218303|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
153791838|NCT06218303|Hormone Antagonists|hormone antagonists|mesh-ancestor
153791839|NCT06218303|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153791840|NCT06218303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153791841|NCT06218303|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153791842|NCT06218303|Interferon Inducers|interferon inducers|mesh-ancestor
153791843|NCT06218303|Immunologic Factors|immunologic factors|mesh-ancestor
153791845|NCT06208410|Capecitabine|capecitabine|mesh-list
153791846|NCT06208410|Fulvestrant|fulvestrant|mesh-list
153791847|NCT06208410|Fluzoparib|fluzoparib|mesh-list
153791848|NCT06208410|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153791849|NCT06208410|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153791850|NCT06208410|Tubulin Modulators|tubulin modulators|mesh-ancestor
153791851|NCT06208410|Antimitotic Agents|antimitotic agents|mesh-ancestor
153415301|NCT02206620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153791853|NCT06208410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153791854|NCT06208410|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153791855|NCT06208410|Antimetabolites|antimetabolites|mesh-ancestor
153791856|NCT06208410|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153791857|NCT06208410|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
153791858|NCT06208410|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
153791859|NCT06208410|Hormone Antagonists|hormone antagonists|mesh-ancestor
153791879|NCT06184373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153791880|NCT06184373|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153791881|NCT06184373|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153791883|NCT06171100|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
153791884|NCT06171100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153791885|NCT06171100|Natriuretic Agents|natriuretic agents|mesh-ancestor
153791886|NCT06171100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153791887|NCT06164275|Doxorubicin|doxorubicin|mesh-list
153791888|NCT06164275|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
153791889|NCT06164275|Daunorubicin|daunorubicin|mesh-list
153791890|NCT06164275|Pembrolizumab|pembrolizumab|mesh-list
153791891|NCT06164275|Dacarbazine|dacarbazine|mesh-list
153791892|NCT06164275|Vinblastine|vinblastine|mesh-list
153791893|NCT06164275|Imidazole|imidazole|mesh-list
153791894|NCT06164275|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153349744|NCT01184885|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153791895|NCT06164275|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153338385|NCT01231399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153791896|NCT06164275|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153791897|NCT06164275|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153791898|NCT06164275|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153791899|NCT06164275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153791900|NCT06164275|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153791901|NCT06164275|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153791902|NCT06164275|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153791903|NCT06164275|Alkylating Agents|alkylating agents|mesh-ancestor
153791904|NCT06164275|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153791905|NCT06164275|Tubulin Modulators|tubulin modulators|mesh-ancestor
153791906|NCT06164275|Antimitotic Agents|antimitotic agents|mesh-ancestor
153791907|NCT06164275|Mitosis Modulators|mitosis modulators|mesh-ancestor
153791921|NCT06162455|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153791922|NCT06162455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153791923|NCT06162455|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153791924|NCT06162455|Respiratory System Agents|respiratory system agents|mesh-ancestor
153791925|NCT06162455|Free Radical Scavengers|free radical scavengers|mesh-ancestor
153791927|NCT06162455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153791928|NCT06162455|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153791929|NCT06162455|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
153791930|NCT06162455|Vasodilator Agents|vasodilator agents|mesh-ancestor
153791931|NCT06162455|Gasotransmitters|gasotransmitters|mesh-ancestor
153791932|NCT06162455|Protective Agents|protective agents|mesh-ancestor
153791933|NCT06159283|Immunoglobulins|immunoglobulins|mesh-list
153791934|NCT06159283|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
153791935|NCT06159283|Antibodies|antibodies|mesh-list
153791936|NCT06159283|Immunologic Factors|immunologic factors|mesh-ancestor
153791937|NCT06159283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153791938|NCT06152575|Dexamethasone|dexamethasone|mesh-list
153791940|NCT06152575|Pomalidomide|pomalidomide|mesh-list
153791941|NCT06152575|Elotuzumab|elotuzumab|mesh-list
153791942|NCT06152575|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153791943|NCT06152575|Antiemetics|antiemetics|mesh-ancestor
153791944|NCT06152575|Autonomic Agents|autonomic agents|mesh-ancestor
153791972|NCT06136598|Glucocorticoids|glucocorticoids|mesh-ancestor
153791973|NCT06136598|Hormones|hormones|mesh-ancestor
153791974|NCT06136598|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153791975|NCT06136598|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153791976|NCT06136598|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153791977|NCT06136598|Protease Inhibitors|protease inhibitors|mesh-ancestor
153791978|NCT06136598|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153383286|NCT01748942|Dermatologic Agents|dermatologic agents|mesh-ancestor
153791980|NCT06128330|Tranexamic Acid|tranexamic acid|mesh-list
153791981|NCT06128330|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
153791982|NCT06128330|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153791983|NCT06128330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153791984|NCT06128330|Hemostatics|hemostatics|mesh-ancestor
153791985|NCT06128330|Coagulants|coagulants|mesh-ancestor
153791986|NCT06123026|Cabergoline|cabergoline|mesh-list
153791987|NCT06123026|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
153791988|NCT06123026|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
153791989|NCT06123026|Dopamine Agonists|dopamine agonists|mesh-ancestor
153791990|NCT06123026|Dopamine Agents|dopamine agents|mesh-ancestor
153791991|NCT06123026|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153791992|NCT06123026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153791993|NCT06123026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153791994|NCT06120491|Abiraterone Acetate|abiraterone acetate|mesh-list
153791995|NCT06120491|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153791996|NCT06120491|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153791997|NCT06120491|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153791998|NCT06120491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153791999|NCT06120491|Hormone Antagonists|hormone antagonists|mesh-ancestor
153792017|NCT06045221|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
153792018|NCT06045221|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153792019|NCT06045221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153792021|NCT06040099|Durvalumab|durvalumab|mesh-list
153792022|NCT06040099|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153792023|NCT06040099|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153792024|NCT06040099|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153874614|NCT04529187|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153874615|NCT04529187|Analgesics|analgesics|mesh-ancestor
153874616|NCT04529187|Sensory System Agents|sensory system agents|mesh-ancestor
153792025|NCT06040099|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153792026|NCT06040099|Growth Substances|growth substances|mesh-ancestor
153792027|NCT06040099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153792028|NCT06040099|Growth Inhibitors|growth inhibitors|mesh-ancestor
153792030|NCT06031883|Ketamine|ketamine|mesh-list
153792031|NCT06031883|Analgesics|analgesics|mesh-ancestor
153792032|NCT06031883|Sensory System Agents|sensory system agents|mesh-ancestor
153792033|NCT06031883|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153792034|NCT06031883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153792035|NCT06031883|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
153792036|NCT06031883|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153792037|NCT06031883|Anesthetics, General|anesthetics, general|mesh-ancestor
153792038|NCT06031883|Anesthetics|anesthetics|mesh-ancestor
153792039|NCT06031883|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153792040|NCT06031883|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
153792041|NCT06031883|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
153792042|NCT06031883|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153792043|NCT06031883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153792044|NCT06031883|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153792045|NCT06031883|Narcotics|narcotics|mesh-ancestor
153792046|NCT06031883|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153792047|NCT06012695|Temozolomide|temozolomide|mesh-list
153792048|NCT06012695|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153792049|NCT06012695|Alkylating Agents|alkylating agents|mesh-ancestor
153792051|NCT06012695|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153792056|NCT06012240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153792057|NCT06012240|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153383705|NCT00355589|Protease Inhibitors|protease inhibitors|mesh-ancestor
153792059|NCT06009107|Fludarabine|fludarabine|mesh-list
153792060|NCT06009107|Fludarabine phosphate|fludarabine phosphate|mesh-list
153792061|NCT06009107|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153792062|NCT06009107|Immunologic Factors|immunologic factors|mesh-ancestor
153792063|NCT06009107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153792064|NCT06009107|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153792065|NCT06009107|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153349930|NCT00305942|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153792066|NCT06009107|Alkylating Agents|alkylating agents|mesh-ancestor
153792067|NCT06009107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153792068|NCT06009107|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153874617|NCT04529187|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153874618|NCT04529187|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
153874619|NCT04529187|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153874620|NCT04529187|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153874621|NCT04529187|Adrenergic Agents|adrenergic agents|mesh-ancestor
153874622|NCT04529187|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153874623|NCT04529187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153874624|NCT04529187|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153874625|NCT04529187|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153874626|NCT04529187|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153874627|NCT04529187|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153874628|NCT04529187|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153874629|NCT04529187|Anesthetics, General|anesthetics, general|mesh-ancestor
153792069|NCT06009107|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153792070|NCT06009107|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153792071|NCT06009107|Antimetabolites|antimetabolites|mesh-ancestor
153792072|NCT05989126|Aflibercept|aflibercept|mesh-list
153792073|NCT05989126|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153792074|NCT05989126|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153792075|NCT05989126|Growth Substances|growth substances|mesh-ancestor
153792076|NCT05989126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153792077|NCT05989126|Growth Inhibitors|growth inhibitors|mesh-ancestor
153792078|NCT05989126|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153792107|NCT05955170|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153792108|NCT05955170|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153350025|NCT05344404|Vasodilator Agents|vasodilator agents|mesh-ancestor
153792109|NCT05955170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153792110|NCT05946811|Macitentan|macitentan|mesh-list
153792111|NCT05946811|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
153792112|NCT05946811|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
153792113|NCT05946811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153792114|NCT05946811|Endothelin B Receptor Antagonists|endothelin b receptor antagonists|mesh-ancestor
153792115|NCT05937789|Vitamin D|vitamin d|mesh-list
153792116|NCT05937789|Vitamins|vitamins|mesh-ancestor
153792117|NCT05937789|Micronutrients|micronutrients|mesh-ancestor
153792118|NCT05937789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153792119|NCT05937789|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153792120|NCT05916950|Calcium|calcium|mesh-list
153792121|NCT05916950|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153792122|NCT05916950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153792123|NCT05900206|Paclitaxel|paclitaxel|mesh-list
153792124|NCT05900206|Docetaxel|docetaxel|mesh-list
153792125|NCT05900206|Cyclophosphamide|cyclophosphamide|mesh-list
153792126|NCT05900206|Carboplatin|carboplatin|mesh-list
153792127|NCT05900206|Trastuzumab|trastuzumab|mesh-list
153792128|NCT05900206|Letrozole|letrozole|mesh-list
153792129|NCT05900206|Epirubicin|epirubicin|mesh-list
153792130|NCT05900206|Pertuzumab|pertuzumab|mesh-list
153792131|NCT05900206|Trastuzumab deruxtecan|trastuzumab deruxtecan|mesh-list
153792132|NCT05900206|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153792133|NCT05900206|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153792134|NCT05900206|Tubulin Modulators|tubulin modulators|mesh-ancestor
153792135|NCT05900206|Antimitotic Agents|antimitotic agents|mesh-ancestor
153792153|NCT05900206|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153792154|NCT05900206|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153874639|NCT02214368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153874640|NCT02214368|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153874641|NCT02214368|Anesthetics, General|anesthetics, general|mesh-ancestor
153874642|NCT02214368|Anesthetics|anesthetics|mesh-ancestor
153874643|NCT01204294|Metformin|metformin|mesh-list
153874644|NCT01204294|Linagliptin|linagliptin|mesh-list
153421116|NCT06287320|Immunologic Factors|immunologic factors|mesh-ancestor
153874645|NCT01204294|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153415356|NCT05342376|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153415357|NCT05342376|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153415358|NCT05342376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153415359|NCT05342376|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153792155|NCT05900206|Immunoconjugates|immunoconjugates|mesh-ancestor
153792156|NCT05869955|Cyclophosphamide|cyclophosphamide|mesh-list
153792157|NCT05869955|Fludarabine|fludarabine|mesh-list
153792158|NCT05869955|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153792159|NCT05869955|Immunologic Factors|immunologic factors|mesh-ancestor
153792160|NCT05869955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153792161|NCT05869955|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153792162|NCT05869955|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153792163|NCT05869955|Alkylating Agents|alkylating agents|mesh-ancestor
153792164|NCT05869955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153792165|NCT05869955|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153792166|NCT05869955|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153792167|NCT05816785|Cetuximab|cetuximab|mesh-list
153792168|NCT05816785|Imatinib Mesylate|imatinib mesylate|mesh-list
153792169|NCT05816785|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153792170|NCT05816785|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153792171|NCT05816785|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153792172|NCT05816785|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153792173|NCT05816785|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153792174|NCT05816785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153792175|NCT05796167|Pimavanserin|pimavanserin|mesh-list
153792176|NCT05796167|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
153792177|NCT05796167|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
153792178|NCT05796167|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153792179|NCT05796167|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153792180|NCT05796167|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153792181|NCT05796167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153792182|NCT05796167|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153792196|NCT05776875|Growth Inhibitors|growth inhibitors|mesh-ancestor
153792197|NCT05776875|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153792198|NCT05776875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153792200|NCT05768854|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153792201|NCT05768854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153350091|NCT00315146|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153350127|NCT00316862|Irinotecan|irinotecan|mesh-list
153792202|NCT05767021|Mirikizumab|mirikizumab|mesh-list
153792203|NCT05767021|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153792204|NCT05767021|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153792205|NCT05767021|Analgesics|analgesics|mesh-ancestor
153792206|NCT05767021|Sensory System Agents|sensory system agents|mesh-ancestor
153792207|NCT05767021|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153792208|NCT05767021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153792209|NCT05767021|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153792210|NCT05767021|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153874646|NCT01204294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153874647|NCT01204294|Incretins|incretins|mesh-ancestor
153874648|NCT01204294|Hormones|hormones|mesh-ancestor
153874649|NCT01204294|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153874651|NCT01204294|Protease Inhibitors|protease inhibitors|mesh-ancestor
153874652|NCT01204294|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153792211|NCT05767021|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
153792212|NCT05767021|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153792213|NCT05756166|Interferons|interferons|mesh-list
153792214|NCT05756166|Interferon-alpha|interferon-alpha|mesh-list
153792215|NCT05756166|Interferon alpha-2|interferon alpha-2|mesh-list
153792216|NCT05756166|poly(I).poly(c12,U)|poly(i).poly(c12,u)|mesh-list
153792217|NCT05756166|Celecoxib|celecoxib|mesh-list
153792218|NCT05756166|Pembrolizumab|pembrolizumab|mesh-list
153792219|NCT05756166|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153792220|NCT05756166|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153792221|NCT05756166|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153792222|NCT05756166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153792223|NCT05756166|Antiviral Agents|antiviral agents|mesh-ancestor
153792224|NCT05756166|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153792225|NCT05756166|Immunologic Factors|immunologic factors|mesh-ancestor
153792226|NCT05756166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153792227|NCT05756166|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153792228|NCT05756166|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153792229|NCT05756166|Analgesics|analgesics|mesh-ancestor
153792230|NCT05756166|Sensory System Agents|sensory system agents|mesh-ancestor
153792236|NCT05756166|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153792237|NCT05753007|Cannabidiol|cannabidiol|mesh-list
153792238|NCT05753007|Anticonvulsants|anticonvulsants|mesh-ancestor
153792239|NCT05743036|Cetuximab|cetuximab|mesh-list
153792240|NCT05743036|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153792241|NCT05743036|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153792242|NCT05739136|Norethindrone|norethindrone|mesh-list
153792243|NCT05739136|Norethindrone Acetate|norethindrone acetate|mesh-list
153792244|NCT05739136|Estradiol|estradiol|mesh-list
153792245|NCT05739136|Relugolix|relugolix|mesh-list
153792246|NCT05739136|Estrogens|estrogens|mesh-ancestor
153792247|NCT05739136|Hormones|hormones|mesh-ancestor
153792248|NCT05739136|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153792249|NCT05739136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153792250|NCT05739136|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
153792251|NCT05739136|Contraceptive Agents|contraceptive agents|mesh-ancestor
153792252|NCT05739136|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153792253|NCT05739136|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
153792254|NCT05739136|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
153792255|NCT05739136|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
153792256|NCT05739136|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
153792257|NCT05739136|Androgen Antagonists|androgen antagonists|mesh-ancestor
153415380|NCT04776096|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153415381|NCT04776096|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153415382|NCT04776096|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
153415383|NCT04776096|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
153415384|NCT04776096|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
153415385|NCT04776096|Histamine Antagonists|histamine antagonists|mesh-ancestor
153415386|NCT04776096|Histamine Agents|histamine agents|mesh-ancestor
153384465|NCT03357393|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153415387|NCT04776096|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153415388|NCT04776096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153415389|NCT02203032|Ustekinumab|ustekinumab|mesh-list
153415390|NCT02203032|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
153415391|NCT02203032|Dermatologic Agents|dermatologic agents|mesh-ancestor
153415392|NCT02203032|Immunologic Factors|immunologic factors|mesh-ancestor
153415394|NCT02169414|Levodopa|levodopa|mesh-list
153792258|NCT05739136|Hormone Antagonists|hormone antagonists|mesh-ancestor
153792259|NCT05739123|Relugolix|relugolix|mesh-list
153792260|NCT05739123|Androgen Antagonists|androgen antagonists|mesh-ancestor
153792261|NCT05739123|Hormone Antagonists|hormone antagonists|mesh-ancestor
153792262|NCT05739123|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153792263|NCT05739123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153792264|NCT05727176|Futibatinib|futibatinib|mesh-list
153792265|NCT05727176|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153792266|NCT05720988|Azacitidine|azacitidine|mesh-list
153792267|NCT05720988|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153792268|NCT05720988|Antimetabolites|antimetabolites|mesh-ancestor
153792269|NCT05720988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153792270|NCT05720988|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153792277|NCT05720273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153350266|NCT00369746|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153792278|NCT05720273|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
153792279|NCT05720273|Vitamins|vitamins|mesh-ancestor
153792280|NCT05720273|Micronutrients|micronutrients|mesh-ancestor
153792281|NCT05720273|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153384565|NCT02363946|Antiemetics|antiemetics|mesh-ancestor
153792282|NCT05710237|Risperidone|risperidone|mesh-list
153792283|NCT05710237|Psilocybin|psilocybin|mesh-list
153792284|NCT05710237|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153792285|NCT05710237|Serotonin Agents|serotonin agents|mesh-ancestor
153792286|NCT05710237|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153792287|NCT05710237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153792288|NCT05710237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153792289|NCT05710237|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153792290|NCT05710237|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153792291|NCT05710237|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153792292|NCT05710237|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153792293|NCT05710237|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
153792294|NCT05710237|Dopamine Agents|dopamine agents|mesh-ancestor
153792295|NCT05710237|Hallucinogens|hallucinogens|mesh-ancestor
153792296|NCT05708300|Vaccines|vaccines|mesh-list
153792297|NCT05708300|Immunologic Factors|immunologic factors|mesh-ancestor
153792298|NCT05708300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153792299|NCT05696626|Fulvestrant|fulvestrant|mesh-list
153792300|NCT05696626|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153792301|NCT05696626|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153792304|NCT05696626|Hormone Antagonists|hormone antagonists|mesh-ancestor
153792305|NCT05696626|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153874663|NCT01182181|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153874664|NCT01182181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153874665|NCT01181986|Exenatide|exenatide|mesh-list
153874666|NCT01181986|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
153874667|NCT01181986|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153874668|NCT01181986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153792306|NCT05696626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153792308|NCT05686408|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
153792309|NCT05686408|Antidepressive Agents|antidepressive agents|mesh-ancestor
153792311|NCT05671900|Gemcitabine|gemcitabine|mesh-list
153792312|NCT05671900|Docetaxel|docetaxel|mesh-list
153792315|NCT05671900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153792316|NCT05671900|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153792317|NCT05671900|Tubulin Modulators|tubulin modulators|mesh-ancestor
153792318|NCT05671900|Antimitotic Agents|antimitotic agents|mesh-ancestor
153792319|NCT05671900|Mitosis Modulators|mitosis modulators|mesh-ancestor
153792320|NCT05664750|Immunoglobulins|immunoglobulins|mesh-list
153792321|NCT05664750|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
153792322|NCT05664750|Antibodies|antibodies|mesh-list
153792323|NCT05664750|Immunologic Factors|immunologic factors|mesh-ancestor
153792324|NCT05664750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153792325|NCT05662332|Insulin|insulin|mesh-list
153792326|NCT05662332|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
153792327|NCT05662332|Insulin Glargine|insulin glargine|mesh-list
153792328|NCT05662332|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153792329|NCT05662332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153792330|NCT05660525|Nicotine|nicotine|mesh-list
153792331|NCT05660525|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
153350300|NCT02528214|Prednisone|prednisone|mesh-list
153792332|NCT05660525|Autonomic Agents|autonomic agents|mesh-ancestor
153792333|NCT05660525|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153792334|NCT05660525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153792335|NCT05660525|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
153792336|NCT05660525|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
153792337|NCT05660525|Cholinergic Agents|cholinergic agents|mesh-ancestor
153792338|NCT05660525|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153792339|NCT05660525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153792340|NCT05645107|Immunoglobulins|immunoglobulins|mesh-list
153792341|NCT05645107|gamma-Globulins|gamma-globulins|mesh-list
153792342|NCT05645107|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
153792343|NCT05645107|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
153792344|NCT05645107|Immunologic Factors|immunologic factors|mesh-ancestor
153792345|NCT05645107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153792362|NCT05552144|Sodium Fluoride|sodium fluoride|mesh-list
153792363|NCT05552144|Cariostatic Agents|cariostatic agents|mesh-ancestor
153792364|NCT05552144|Protective Agents|protective agents|mesh-ancestor
153792365|NCT05552144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153792366|NCT05552144|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
153792367|NCT05552144|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153792368|NCT05546879|Bevacizumab|bevacizumab|mesh-list
153792369|NCT05546879|Atezolizumab|atezolizumab|mesh-list
153415401|NCT02169414|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153415402|NCT02169414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153415404|NCT02169414|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
153415405|NCT02169414|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153415406|NCT02169414|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
153415407|NCT02201940|Sofosbuvir|sofosbuvir|mesh-list
153415409|NCT02201940|Velpatasvir|velpatasvir|mesh-list
153792370|NCT05546879|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153792372|NCT05546879|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153792373|NCT05546879|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153792374|NCT05546879|Growth Substances|growth substances|mesh-ancestor
153792375|NCT05546879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153792376|NCT05546879|Growth Inhibitors|growth inhibitors|mesh-ancestor
153792377|NCT05546879|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153792378|NCT05546879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153792380|NCT05546853|Oxaliplatin|oxaliplatin|mesh-list
153792381|NCT05546853|Irinotecan|irinotecan|mesh-list
153792382|NCT05546853|Calcium|calcium|mesh-list
153792383|NCT05546853|Levoleucovorin|levoleucovorin|mesh-list
153792384|NCT05546853|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153792385|NCT05546853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153792386|NCT05546853|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153792387|NCT05546853|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
153792388|NCT05546853|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153792389|NCT05546853|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153792390|NCT05546853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153792391|NCT05546853|Antidotes|antidotes|mesh-ancestor
153792392|NCT05546853|Protective Agents|protective agents|mesh-ancestor
153792393|NCT05546853|Vitamin B Complex|vitamin b complex|mesh-ancestor
153792394|NCT05546853|Vitamins|vitamins|mesh-ancestor
153792395|NCT05546853|Micronutrients|micronutrients|mesh-ancestor
153792396|NCT05541341|Tisagenlecleucel|tisagenlecleucel|mesh-list
153792397|NCT05541341|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153792398|NCT05541341|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153792399|NCT05523895|Pimavanserin|pimavanserin|mesh-list
153792400|NCT05523895|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
153792401|NCT05523895|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
153792402|NCT05523895|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153792403|NCT05523895|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153350370|NCT05902078|Eldecalcitol|eldecalcitol|mesh-list
153792404|NCT05523895|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153792405|NCT05523895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153792406|NCT05523895|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153792407|NCT05523895|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
153792408|NCT05523895|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153792409|NCT05523895|Serotonin Agents|serotonin agents|mesh-ancestor
153792410|NCT05523895|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153874689|NCT01181167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153874690|NCT01181167|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
153874691|NCT01181167|Antithrombins|antithrombins|mesh-ancestor
153874692|NCT01181167|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
153874693|NCT01181167|Protease Inhibitors|protease inhibitors|mesh-ancestor
153874694|NCT01181167|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153874695|NCT04548557|Immunoglobulins|immunoglobulins|mesh-list
153874696|NCT04548557|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
153874697|NCT04548557|Antibodies|antibodies|mesh-list
153874698|NCT04548557|gamma-Globulins|gamma-globulins|mesh-list
153874700|NCT04548557|Immunologic Factors|immunologic factors|mesh-ancestor
153874701|NCT04548557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153874702|NCT01181128|Factor VIII|factor viii|mesh-list
153792411|NCT05523895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153792412|NCT05519085|Dexamethasone|dexamethasone|mesh-list
153792413|NCT05519085|Bortezomib|bortezomib|mesh-list
153792414|NCT05519085|Pomalidomide|pomalidomide|mesh-list
153792415|NCT05519085|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153792416|NCT05519085|Antiemetics|antiemetics|mesh-ancestor
153792417|NCT05519085|Autonomic Agents|autonomic agents|mesh-ancestor
153792418|NCT05519085|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153792419|NCT05519085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153792420|NCT05519085|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153792421|NCT05519085|Glucocorticoids|glucocorticoids|mesh-ancestor
153792422|NCT05519085|Hormones|hormones|mesh-ancestor
153350393|NCT05901766|Trace Elements|trace elements|mesh-list
153350395|NCT05901701|Salicylic Acid|salicylic acid|mesh-list
153792423|NCT05519085|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153792424|NCT05519085|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153792425|NCT05519085|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153792426|NCT05519085|Immunologic Factors|immunologic factors|mesh-ancestor
153792427|NCT05519085|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153792428|NCT05519085|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153792429|NCT05519085|Growth Substances|growth substances|mesh-ancestor
153792440|NCT05508074|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
153792441|NCT05508074|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
153792442|NCT05508074|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153792443|NCT05508074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153792444|NCT05508074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153792445|NCT05508074|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
153792446|NCT05508074|Protective Agents|protective agents|mesh-ancestor
153792447|NCT05497206|Metronidazole|metronidazole|mesh-list
153792448|NCT05497206|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153792449|NCT05497206|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153792450|NCT05497206|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153792451|NCT05497206|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153792452|NCT05490680|Sildenafil Citrate|sildenafil citrate|mesh-list
153792453|NCT05490680|Vasodilator Agents|vasodilator agents|mesh-ancestor
153792454|NCT05490680|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
153792455|NCT05490680|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
153792456|NCT05490680|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153792457|NCT05490680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153350451|NCT05901194|Lenvatinib|lenvatinib|mesh-list
153792458|NCT05490680|Urological Agents|urological agents|mesh-ancestor
153792460|NCT05482789|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
153792461|NCT05482789|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153792462|NCT05482789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153792463|NCT05482789|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
153792464|NCT05482789|Incretins|incretins|mesh-ancestor
153792466|NCT05482789|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153792467|NCT05473234|Amoxicillin|amoxicillin|mesh-list
153792468|NCT05473234|Azithromycin|azithromycin|mesh-list
153792469|NCT05473234|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153792470|NCT05473234|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153792483|NCT05417269|Dimethyl Fumarate|dimethyl fumarate|mesh-list
153792484|NCT05417269|Dermatologic Agents|dermatologic agents|mesh-ancestor
153792485|NCT05417269|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153792486|NCT05417269|Immunologic Factors|immunologic factors|mesh-ancestor
153792487|NCT05417269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153792488|NCT05411744|Vitamin B 6|vitamin b 6|mesh-list
153792489|NCT05411744|Pyridoxal|pyridoxal|mesh-list
153792490|NCT05411744|Pyridoxine|pyridoxine|mesh-list
153792491|NCT05411744|Isoniazid|isoniazid|mesh-list
153792492|NCT05411744|Rifapentine|rifapentine|mesh-list
153792493|NCT05411744|Vitamins|vitamins|mesh-ancestor
153792494|NCT05411744|Micronutrients|micronutrients|mesh-ancestor
153792495|NCT05411744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153792496|NCT05411744|Vitamin B Complex|vitamin b complex|mesh-ancestor
153792497|NCT05411744|Antitubercular Agents|antitubercular agents|mesh-ancestor
153792498|NCT05411744|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153792499|NCT05411744|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153792500|NCT05411744|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
153338981|NCT04389554|Fibrin fragment D|fibrin fragment d|mesh-list
153792501|NCT05411744|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153792502|NCT05411744|Antimetabolites|antimetabolites|mesh-ancestor
153792503|NCT05411744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153792504|NCT05411744|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153792505|NCT05411744|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
153792506|NCT05411744|Leprostatic Agents|leprostatic agents|mesh-ancestor
153792507|NCT05411094|Durvalumab|durvalumab|mesh-list
153792508|NCT05411094|Olaparib|olaparib|mesh-list
153792509|NCT05411094|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
153792510|NCT05411094|Immunoglobulins|immunoglobulins|mesh-list
153792511|NCT05411094|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
153792512|NCT05411094|Immunoglobulin G|immunoglobulin g|mesh-list
153792513|NCT05411094|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153792514|NCT05411094|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153792515|NCT05411094|Immunologic Factors|immunologic factors|mesh-ancestor
153792516|NCT05411094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153792517|NCT05411094|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153792518|NCT05411094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153792519|NCT05406713|Pembrolizumab|pembrolizumab|mesh-list
153469175|NCT05452772|Vitamins|vitamins|mesh-ancestor
153792520|NCT05406713|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153792521|NCT05406713|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153792522|NCT05406713|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153792523|NCT05406713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153792525|NCT05387603|Edotreotide lutetium LU-177|edotreotide lutetium lu-177|mesh-list
153350524|NCT05837000|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153792526|NCT05387603|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153792527|NCT05387603|Antimetabolites|antimetabolites|mesh-ancestor
153792528|NCT05387603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153792529|NCT05387603|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153792530|NCT05387603|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
153415444|NCT03043807|Antimitotic Agents|antimitotic agents|mesh-ancestor
153415445|NCT03043807|Mitosis Modulators|mitosis modulators|mesh-ancestor
153415446|NCT03043807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153876454|NCT01195675|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153792531|NCT05361993|Aripiprazole|aripiprazole|mesh-list
153792532|NCT05361993|Antidepressive Agents|antidepressive agents|mesh-ancestor
153792533|NCT05361993|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153792534|NCT05361993|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153792535|NCT05361993|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153792536|NCT05361993|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153792537|NCT05361993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153792538|NCT05361993|Dopamine Agonists|dopamine agonists|mesh-ancestor
153792539|NCT05361993|Dopamine Agents|dopamine agents|mesh-ancestor
153792540|NCT05361993|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153792541|NCT05361993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153792542|NCT05361993|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
153792543|NCT05361993|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
153792544|NCT05361993|Serotonin Agents|serotonin agents|mesh-ancestor
153792545|NCT05361993|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
153350606|NCT05672173|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153792546|NCT05361993|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153792547|NCT05361993|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
153792548|NCT05361993|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
153792549|NCT05337137|Bevacizumab|bevacizumab|mesh-list
153792608|NCT05213481|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
153792609|NCT05213481|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153792610|NCT05192889|Leucovorin|leucovorin|mesh-list
153792611|NCT05192889|Cytarabine|cytarabine|mesh-list
153792612|NCT05192889|Dexamethasone|dexamethasone|mesh-list
153792613|NCT05192889|Hydrocortisone|hydrocortisone|mesh-list
153792614|NCT05192889|Cyclophosphamide|cyclophosphamide|mesh-list
153792615|NCT05192889|Methotrexate|methotrexate|mesh-list
153792616|NCT05192889|Etoposide|etoposide|mesh-list
153792617|NCT05192889|Vincristine|vincristine|mesh-list
153792618|NCT05192889|Venetoclax|venetoclax|mesh-list
153792619|NCT05192889|Asparaginase|asparaginase|mesh-list
153792620|NCT05192889|Dasatinib|dasatinib|mesh-list
153792621|NCT05192889|Mercaptopurine|mercaptopurine|mesh-list
153792622|NCT05192889|Pegaspargase|pegaspargase|mesh-list
153792623|NCT05192889|Blinatumomab|blinatumomab|mesh-list
153792624|NCT05192889|Navitoclax|navitoclax|mesh-list
153792625|NCT05192889|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153792626|NCT05192889|Immunologic Factors|immunologic factors|mesh-ancestor
153792627|NCT05192889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153883204|NCT01689896|Hormones|hormones|mesh-ancestor
153792629|NCT05192889|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153792630|NCT05192889|Alkylating Agents|alkylating agents|mesh-ancestor
153350657|NCT05427474|Antimanic Agents|antimanic agents|mesh-ancestor
153874712|NCT04547894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153874713|NCT01641315|Immunoglobulins|immunoglobulins|mesh-list
153874714|NCT01641315|Immunologic Factors|immunologic factors|mesh-ancestor
153874715|NCT01641315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153792631|NCT05192889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153792632|NCT05192889|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153792633|NCT05192889|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153792634|NCT05192889|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153792636|NCT05192889|Autonomic Agents|autonomic agents|mesh-ancestor
153792637|NCT05192889|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153792638|NCT05192889|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153792639|NCT05192889|Glucocorticoids|glucocorticoids|mesh-ancestor
153792640|NCT05192889|Hormones|hormones|mesh-ancestor
153792641|NCT05192889|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153792644|NCT05192889|Abortifacient Agents|abortifacient agents|mesh-ancestor
153792653|NCT05192889|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153792654|NCT05192889|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153792655|NCT05192889|Antiviral Agents|antiviral agents|mesh-ancestor
153792656|NCT05192889|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153792657|NCT05192889|Antidotes|antidotes|mesh-ancestor
153792658|NCT05192889|Protective Agents|protective agents|mesh-ancestor
153792659|NCT05192889|Vitamin B Complex|vitamin b complex|mesh-ancestor
153792660|NCT05192889|Vitamins|vitamins|mesh-ancestor
153792661|NCT05192889|Micronutrients|micronutrients|mesh-ancestor
153792662|NCT05192889|Tubulin Modulators|tubulin modulators|mesh-ancestor
153792663|NCT05192889|Antimitotic Agents|antimitotic agents|mesh-ancestor
153792664|NCT05192889|Mitosis Modulators|mitosis modulators|mesh-ancestor
153792665|NCT05192889|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153792666|NCT05192889|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153792667|NCT05191264|Analgesics|analgesics|mesh-list
153792668|NCT05191264|Sensory System Agents|sensory system agents|mesh-ancestor
153792669|NCT05191264|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153792670|NCT05191264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153792671|NCT05155709|Azacitidine|azacitidine|mesh-list
153792672|NCT05155709|Venetoclax|venetoclax|mesh-list
153792673|NCT05155709|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153792674|NCT05155709|Antimetabolites|antimetabolites|mesh-ancestor
153792675|NCT05155709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153792676|NCT05155709|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153792677|NCT05155709|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153792678|NCT05082896|Anesthetics|anesthetics|mesh-list
153792679|NCT05082896|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153792680|NCT05082896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153792681|NCT05070247|Pembrolizumab|pembrolizumab|mesh-list
153792682|NCT05070247|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153415453|NCT03043807|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153415454|NCT03043807|Hormone Antagonists|hormone antagonists|mesh-ancestor
153415455|NCT03043807|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153415456|NCT03043807|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153415457|NCT03043807|Androgen Antagonists|androgen antagonists|mesh-ancestor
153415458|NCT02609828|Tanezumab|tanezumab|mesh-list
153475837|NCT00835224|Midodrine|midodrine|mesh-list
153874736|NCT01641510|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
153792684|NCT05070247|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153792685|NCT05070247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153792686|NCT05064878|Fenfluramine|fenfluramine|mesh-list
153792693|NCT05064878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153792694|NCT05044819|Cannabidiol|cannabidiol|mesh-list
153792695|NCT05044819|Anticonvulsants|anticonvulsants|mesh-ancestor
153792696|NCT05015686|Vaccines|vaccines|mesh-list
153792697|NCT05015686|Immunologic Factors|immunologic factors|mesh-ancestor
153792698|NCT05015686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153792699|NCT05011058|Valganciclovir|valganciclovir|mesh-list
153792700|NCT05011058|Antiviral Agents|antiviral agents|mesh-ancestor
153792701|NCT05011058|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153792702|NCT04997980|Amiodarone|amiodarone|mesh-list
153792703|NCT04997980|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153792704|NCT04997980|Vasodilator Agents|vasodilator agents|mesh-ancestor
153792705|NCT04997980|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
153792715|NCT04980404|Decitabine|decitabine|mesh-list
153792755|NCT04906395|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153792756|NCT04906395|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153792757|NCT04906395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153792758|NCT04906395|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
153792759|NCT04906395|Hormone Antagonists|hormone antagonists|mesh-ancestor
153792760|NCT04906395|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153792761|NCT04906395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153792762|NCT04906395|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153792763|NCT04906395|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
153792764|NCT04906395|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
153792765|NCT04906395|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153792766|NCT04905563|Acetaminophen|acetaminophen|mesh-list
153792767|NCT04905563|Ibuprofen|ibuprofen|mesh-list
153792768|NCT04905563|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
153792769|NCT04905563|Hydrocodone|hydrocodone|mesh-list
153792770|NCT04905563|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153792771|NCT04905563|Analgesics|analgesics|mesh-ancestor
153792772|NCT04905563|Sensory System Agents|sensory system agents|mesh-ancestor
153792773|NCT04905563|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153421453|NCT05896228|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
153792774|NCT04905563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153792776|NCT04905563|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153874738|NCT01641510|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
153874739|NCT01641510|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
153874740|NCT01641510|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
153874741|NCT01641510|Purinergic Agents|purinergic agents|mesh-ancestor
153874742|NCT01641510|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153874743|NCT01641510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153874744|NCT01641510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153874745|NCT04547621|Temozolomide|temozolomide|mesh-list
153874746|NCT04547621|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153415459|NCT02609828|Analgesics|analgesics|mesh-ancestor
153415460|NCT02609828|Sensory System Agents|sensory system agents|mesh-ancestor
153415461|NCT02609828|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153415462|NCT02609828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153415463|NCT05588557|Bupivacaine|bupivacaine|mesh-list
153415464|NCT05588557|Anesthetics, Local|anesthetics, local|mesh-ancestor
153792777|NCT04905563|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153792778|NCT04905563|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153792779|NCT04905563|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153792780|NCT04905563|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153792782|NCT04905563|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153792799|NCT04886531|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153792800|NCT04886531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153792801|NCT04886531|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153792802|NCT04886531|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153792803|NCT04886531|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153792804|NCT04881032|Temozolomide|temozolomide|mesh-list
153792805|NCT04881032|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153792806|NCT04881032|Alkylating Agents|alkylating agents|mesh-ancestor
153792807|NCT04881032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153792808|NCT04881032|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153792809|NCT04870112|Carboplatin|carboplatin|mesh-list
153792810|NCT04870112|Etoposide|etoposide|mesh-list
153792811|NCT04870112|Durvalumab|durvalumab|mesh-list
153792812|NCT04870112|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153792813|NCT04870112|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153792814|NCT04870112|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153792815|NCT04870112|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153792816|NCT04870112|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153792817|NCT04870112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153792818|NCT04870112|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153792819|NCT04841668|Metformin|metformin|mesh-list
153792820|NCT04841668|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153792821|NCT04841668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153385150|NCT02354586|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153792822|NCT04834427|Ketamine|ketamine|mesh-list
153792823|NCT04834427|Esketamine|esketamine|mesh-list
153792824|NCT04834427|Analgesics|analgesics|mesh-ancestor
153792825|NCT04834427|Sensory System Agents|sensory system agents|mesh-ancestor
153792826|NCT04834427|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153792827|NCT04834427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153792828|NCT04834427|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
153792829|NCT04834427|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153792830|NCT04834427|Anesthetics, General|anesthetics, general|mesh-ancestor
153792831|NCT04834427|Anesthetics|anesthetics|mesh-ancestor
153792832|NCT04834427|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153415465|NCT05588557|Anesthetics|anesthetics|mesh-ancestor
153415466|NCT05588557|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153415467|NCT05588557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153415468|NCT05588557|Sensory System Agents|sensory system agents|mesh-ancestor
153415469|NCT05588557|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153415470|NCT01632306|Leucovorin|leucovorin|mesh-list
153415471|NCT01632306|Paclitaxel|paclitaxel|mesh-list
153415472|NCT01632306|Gemcitabine|gemcitabine|mesh-list
153415473|NCT01632306|Fluorouracil|fluorouracil|mesh-list
153415474|NCT01632306|Oxaliplatin|oxaliplatin|mesh-list
153415475|NCT01632306|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153415476|NCT01632306|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153792833|NCT04834427|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
153792835|NCT04834427|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153792836|NCT04834427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153792837|NCT04834427|Antidepressive Agents|antidepressive agents|mesh-ancestor
153792838|NCT04834427|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153792839|NCT04738942|Vedolizumab|vedolizumab|mesh-list
153792840|NCT04738942|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153792841|NCT04729114|Dexamethasone|dexamethasone|mesh-list
153792842|NCT04729114|Prednisone|prednisone|mesh-list
153792843|NCT04729114|Docetaxel|docetaxel|mesh-list
153792844|NCT04729114|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153792845|NCT04729114|Antiemetics|antiemetics|mesh-ancestor
153792846|NCT04729114|Autonomic Agents|autonomic agents|mesh-ancestor
153792847|NCT04729114|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153792848|NCT04729114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153792849|NCT04729114|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153792852|NCT04729114|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153792853|NCT04729114|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153792854|NCT04729114|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153792855|NCT04729114|Tubulin Modulators|tubulin modulators|mesh-ancestor
153792856|NCT04729114|Antimitotic Agents|antimitotic agents|mesh-ancestor
153792857|NCT04729114|Mitosis Modulators|mitosis modulators|mesh-ancestor
153792858|NCT04729114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153792859|NCT04716894|Itraconazole|itraconazole|mesh-list
153792860|NCT04716894|Antifungal Agents|antifungal agents|mesh-ancestor
153792861|NCT04716894|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153792862|NCT04716894|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
153792864|NCT04716894|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153792865|NCT04716894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153792866|NCT04716894|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153339368|NCT02403986|Lidocaine|lidocaine|mesh-list
153792874|NCT04678869|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153792875|NCT04678869|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153792876|NCT04678869|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153350946|NCT04218773|Synephrine|synephrine|mesh-list
153792877|NCT04678869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153792878|NCT04678869|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153874747|NCT04547621|Alkylating Agents|alkylating agents|mesh-ancestor
153874748|NCT04547621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153874749|NCT04547621|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153792879|NCT04678869|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
153792880|NCT04678869|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153792883|NCT04652544|Vitamins|vitamins|mesh-ancestor
153792884|NCT04652544|Micronutrients|micronutrients|mesh-ancestor
153792885|NCT04652544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153792886|NCT04652544|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153792887|NCT04652544|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153792888|NCT04644068|Paclitaxel|paclitaxel|mesh-list
153792889|NCT04644068|Carboplatin|carboplatin|mesh-list
153792890|NCT04644068|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153792891|NCT04644068|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153792892|NCT04644068|Tubulin Modulators|tubulin modulators|mesh-ancestor
153792893|NCT04644068|Antimitotic Agents|antimitotic agents|mesh-ancestor
153792894|NCT04644068|Mitosis Modulators|mitosis modulators|mesh-ancestor
153792895|NCT04644068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153792896|NCT04587427|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
153792897|NCT04587427|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153792922|NCT04551950|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153792923|NCT04551950|Growth Substances|growth substances|mesh-ancestor
153792924|NCT04551950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153792925|NCT04551950|Growth Inhibitors|growth inhibitors|mesh-ancestor
153792926|NCT04542135|Sulindac|sulindac|mesh-list
153792927|NCT04542135|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153792928|NCT04542135|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153792929|NCT04542135|Analgesics|analgesics|mesh-ancestor
153792930|NCT04542135|Sensory System Agents|sensory system agents|mesh-ancestor
153792931|NCT04542135|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153792932|NCT04542135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153792933|NCT04542135|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153792934|NCT04542135|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153792935|NCT04542135|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153792936|NCT04542135|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153792937|NCT04542135|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153792938|NCT04542135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153792939|NCT04537897|Midazolam|midazolam|mesh-list
153792940|NCT04537897|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153792941|NCT04537897|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153792942|NCT04537897|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153792943|NCT04537897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153792945|NCT04537897|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153792946|NCT04537897|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153792947|NCT04537897|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153792948|NCT04537897|Anesthetics, General|anesthetics, general|mesh-ancestor
153792954|NCT04489147|Metformin|metformin|mesh-list
153792969|NCT04420884|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153415495|NCT02201784|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153415496|NCT02201784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153415497|NCT02201784|Sensory System Agents|sensory system agents|mesh-ancestor
153415498|NCT02201784|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153415499|NCT05587933|Parasympatholytics|parasympatholytics|mesh-list
153415500|NCT05587933|Autonomic Agents|autonomic agents|mesh-ancestor
153415501|NCT05587933|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153792970|NCT04420884|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153792971|NCT04420884|Immunologic Factors|immunologic factors|mesh-ancestor
153792972|NCT04420884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153792973|NCT04409795|Metformin|metformin|mesh-list
153792974|NCT04409795|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
153792975|NCT04409795|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153792976|NCT04409795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153792977|NCT04409795|Incretins|incretins|mesh-ancestor
153792978|NCT04409795|Hormones|hormones|mesh-ancestor
153792979|NCT04409795|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153385709|NCT03026348|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153792980|NCT04409795|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
153792981|NCT04409795|Protease Inhibitors|protease inhibitors|mesh-ancestor
153792982|NCT04409795|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153792983|NCT04409795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153792984|NCT04396574|Lasmiditan|lasmiditan|mesh-list
153792985|NCT04396574|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
153792986|NCT04396574|Serotonin Agents|serotonin agents|mesh-ancestor
153792987|NCT04396574|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153792988|NCT04396574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153792989|NCT04396574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153792990|NCT04270409|Acetaminophen|acetaminophen|mesh-list
153792991|NCT04270409|Diphenhydramine|diphenhydramine|mesh-list
153792992|NCT04270409|Promethazine|promethazine|mesh-list
153792993|NCT04270409|Dexamethasone|dexamethasone|mesh-list
153792994|NCT04270409|Methylprednisolone|methylprednisolone|mesh-list
153792995|NCT04270409|Lenalidomide|lenalidomide|mesh-list
153792996|NCT04270409|Montelukast|montelukast|mesh-list
153792997|NCT04270409|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153792998|NCT04270409|Antiemetics|antiemetics|mesh-ancestor
153792999|NCT04270409|Autonomic Agents|autonomic agents|mesh-ancestor
153793000|NCT04270409|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153793013|NCT04270409|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153793014|NCT04270409|Analgesics|analgesics|mesh-ancestor
153793015|NCT04270409|Sensory System Agents|sensory system agents|mesh-ancestor
153793016|NCT04270409|Antipyretics|antipyretics|mesh-ancestor
153793017|NCT04270409|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
153793018|NCT04270409|Protective Agents|protective agents|mesh-ancestor
153339587|NCT00002230|Antisickling Agents|antisickling agents|mesh-ancestor
153793019|NCT04270409|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153793020|NCT04270409|Respiratory System Agents|respiratory system agents|mesh-ancestor
153793021|NCT04270409|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
153793022|NCT04270409|Hormone Antagonists|hormone antagonists|mesh-ancestor
153793023|NCT04270409|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
153874776|NCT01203787|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153874777|NCT01203787|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153876584|NCT01177384|Acarbose|acarbose|mesh-list
153793024|NCT04270409|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
153793025|NCT04270409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153793027|NCT04270409|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153793028|NCT04270409|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153793029|NCT04270409|Anesthetics, Local|anesthetics, local|mesh-ancestor
153793031|NCT04270409|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
153793032|NCT04270409|Histamine Antagonists|histamine antagonists|mesh-ancestor
153793033|NCT04270409|Histamine Agents|histamine agents|mesh-ancestor
153793034|NCT04270409|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153793035|NCT04270409|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
153793036|NCT04270409|Antipruritics|antipruritics|mesh-ancestor
153793037|NCT04270409|Dermatologic Agents|dermatologic agents|mesh-ancestor
153793038|NCT04253626|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
153793039|NCT04253626|Hematinics|hematinics|mesh-ancestor
153793040|NCT04253626|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
153793041|NCT04253626|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
153793042|NCT04251715|Leucovorin|leucovorin|mesh-list
153793043|NCT04251715|Dexamethasone|dexamethasone|mesh-list
153793058|NCT04251715|Hormones|hormones|mesh-ancestor
153793059|NCT04251715|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153793060|NCT04251715|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153793061|NCT04251715|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153793062|NCT04251715|Protease Inhibitors|protease inhibitors|mesh-ancestor
153793063|NCT04251715|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153793064|NCT04251715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153793065|NCT04251715|Antimetabolites|antimetabolites|mesh-ancestor
153421605|NCT05689047|Artesunate|artesunate|mesh-list
153793066|NCT04251715|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153793067|NCT04251715|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153793068|NCT04251715|Immunologic Factors|immunologic factors|mesh-ancestor
153793069|NCT04251715|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
153793070|NCT04251715|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153793071|NCT04251715|Antidotes|antidotes|mesh-ancestor
153793072|NCT04251715|Protective Agents|protective agents|mesh-ancestor
153793073|NCT04251715|Vitamin B Complex|vitamin b complex|mesh-ancestor
153793074|NCT04251715|Vitamins|vitamins|mesh-ancestor
153793075|NCT04251715|Micronutrients|micronutrients|mesh-ancestor
153793076|NCT04232553|Mirikizumab|mirikizumab|mesh-list
153793077|NCT04232553|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153793078|NCT04232553|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153385960|NCT02749227|Hormones|hormones|mesh-ancestor
153793079|NCT04232553|Analgesics|analgesics|mesh-ancestor
153793080|NCT04232553|Sensory System Agents|sensory system agents|mesh-ancestor
153793081|NCT04232553|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153793082|NCT04232553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153793083|NCT04232553|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153793084|NCT04232553|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153874780|NCT04547504|Pembrolizumab|pembrolizumab|mesh-list
153793086|NCT04232553|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153360728|NCT01368263|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153360729|NCT01368263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153793105|NCT04209686|Pembrolizumab|pembrolizumab|mesh-list
153793106|NCT04209686|Olaparib|olaparib|mesh-list
153793107|NCT04209686|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153793108|NCT04209686|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153793109|NCT04209686|Tubulin Modulators|tubulin modulators|mesh-ancestor
153793110|NCT04209686|Antimitotic Agents|antimitotic agents|mesh-ancestor
153793111|NCT04209686|Mitosis Modulators|mitosis modulators|mesh-ancestor
153793112|NCT04209686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153793113|NCT04209686|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153793114|NCT04209686|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153793115|NCT04209686|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
153793116|NCT04209686|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153793117|NCT04198428|Analgesics, Opioid|analgesics, opioid|mesh-list
153793118|NCT04198428|Narcotics|narcotics|mesh-ancestor
153793119|NCT04198428|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153386011|NCT01880840|Histamine Antagonists|histamine antagonists|mesh-ancestor
153793120|NCT04198428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153793122|NCT04198428|Sensory System Agents|sensory system agents|mesh-ancestor
153793123|NCT04198428|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153793124|NCT04184622|Tirzepatide|tirzepatide|mesh-list
153793125|NCT04184622|Incretins|incretins|mesh-ancestor
153793126|NCT04184622|Hormones|hormones|mesh-ancestor
153793130|NCT04151940|Immunologic Factors|immunologic factors|mesh-ancestor
153793152|NCT04076462|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153793153|NCT04076462|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153793154|NCT04076462|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153793156|NCT04015700|Vaccines|vaccines|mesh-list
153793157|NCT04015700|Immunologic Factors|immunologic factors|mesh-ancestor
153793158|NCT04015700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153793159|NCT04015700|Keratolytic Agents|keratolytic agents|mesh-ancestor
153793160|NCT04015700|Dermatologic Agents|dermatologic agents|mesh-ancestor
153793161|NCT04009681|Pembrolizumab|pembrolizumab|mesh-list
153793162|NCT04009681|Cetuximab|cetuximab|mesh-list
153793163|NCT04009681|Antibodies|antibodies|mesh-list
153793164|NCT04009681|Immunologic Factors|immunologic factors|mesh-ancestor
153793165|NCT04009681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153793166|NCT04009681|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153793167|NCT04009681|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153793168|NCT04009681|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153386291|NCT01223001|Dopamine Agents|dopamine agents|mesh-ancestor
153793169|NCT04009681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153793170|NCT03984565|Cannabidiol|cannabidiol|mesh-list
153793171|NCT03984565|Anticonvulsants|anticonvulsants|mesh-ancestor
153793172|NCT03972657|Cemiplimab|cemiplimab|mesh-list
153415521|NCT02018263|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153415523|NCT02168946|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
153415524|NCT02168946|Meropenem|meropenem|mesh-list
153415525|NCT02168946|Vaborbactam|vaborbactam|mesh-list
153415526|NCT02168946|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
153415527|NCT02168946|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-list
153415528|NCT02168946|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153351202|NCT00392834|Leucovorin|leucovorin|mesh-list
153415529|NCT02168946|Antitubercular Agents|antitubercular agents|mesh-ancestor
153874787|NCT01645254|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153874788|NCT01645254|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153793173|NCT03972657|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153793174|NCT03972657|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153793191|NCT03917381|Docetaxel|docetaxel|mesh-list
153793192|NCT03917381|Pembrolizumab|pembrolizumab|mesh-list
153793193|NCT03917381|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153793204|NCT03828201|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
153793205|NCT03828201|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153793206|NCT03828201|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153793207|NCT03828201|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153793208|NCT03828201|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153793209|NCT03828201|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153793210|NCT03828201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153793211|NCT03828201|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153793212|NCT03828201|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
153793213|NCT03828201|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153793214|NCT03828201|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
153793215|NCT03828201|Antitubercular Agents|antitubercular agents|mesh-ancestor
153793216|NCT03828201|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153793217|NCT03828201|Leprostatic Agents|leprostatic agents|mesh-ancestor
153793218|NCT03795194|Clavulanic Acid|clavulanic acid|mesh-list
153793219|NCT03795194|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
153793220|NCT03795194|Clavulanic Acids|clavulanic acids|mesh-list
153793222|NCT03795194|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
153793223|NCT03795194|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153793224|NCT03795194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153793225|NCT03795194|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153793226|NCT03795194|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153793227|NCT03763396|Ketoconazole|ketoconazole|mesh-list
153793228|NCT03763396|Posaconazole|posaconazole|mesh-list
153793249|NCT03756896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153793250|NCT03756896|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153793251|NCT03756896|Glucocorticoids|glucocorticoids|mesh-ancestor
153793253|NCT03756896|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153793254|NCT03756896|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153793255|NCT03756896|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153793256|NCT03756896|Immunologic Factors|immunologic factors|mesh-ancestor
153793257|NCT03756896|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153793258|NCT03756896|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153793259|NCT03756896|Growth Substances|growth substances|mesh-ancestor
153874789|NCT01181011|Amlodipine|amlodipine|mesh-list
153793260|NCT03756896|Growth Inhibitors|growth inhibitors|mesh-ancestor
153793261|NCT03727139|Rasagiline|rasagiline|mesh-list
153793262|NCT03727139|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
153793263|NCT03727139|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153793264|NCT03727139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153793265|NCT03727139|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
153793266|NCT03727139|Protective Agents|protective agents|mesh-ancestor
153793267|NCT03727139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153793268|NCT03719430|Doxorubicin|doxorubicin|mesh-list
153793269|NCT03719430|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153793270|NCT03719430|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153793271|NCT03719430|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153793272|NCT03719430|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153793273|NCT03719430|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153386601|NCT00378183|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153386637|NCT00896025|Antiviral Agents|antiviral agents|mesh-ancestor
153793274|NCT03719430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153793275|NCT03704363|Infliximab|infliximab|mesh-list
153793276|NCT03704363|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
153793277|NCT03704363|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153793278|NCT03704363|Dermatologic Agents|dermatologic agents|mesh-ancestor
153793281|NCT03612713|Oxycodone|oxycodone|mesh-list
153793292|NCT03564821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153793293|NCT03519945|Mirikizumab|mirikizumab|mesh-list
153793294|NCT03519945|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153793295|NCT03519945|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153386780|NCT01941615|Contraceptive Agents|contraceptive agents|mesh-ancestor
153793298|NCT03519945|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153793299|NCT03519945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153793300|NCT03519945|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153793301|NCT03519945|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153793302|NCT03519945|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
153793303|NCT03519945|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153793304|NCT03456076|Carboplatin|carboplatin|mesh-list
153793305|NCT03456076|Gemcitabine|gemcitabine|mesh-list
153793306|NCT03456076|Pemetrexed|pemetrexed|mesh-list
153793307|NCT03456076|Vinorelbine|vinorelbine|mesh-list
153793308|NCT03456076|Alectinib|alectinib|mesh-list
153793311|NCT03456076|Antimetabolites|antimetabolites|mesh-ancestor
153793351|NCT03322215|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153793352|NCT03322215|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
153793353|NCT03322215|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
153793354|NCT03322215|Hormone Antagonists|hormone antagonists|mesh-ancestor
153793355|NCT03322215|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153793356|NCT03322215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153793357|NCT03322215|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153793358|NCT03322215|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153415539|NCT02168478|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153415540|NCT02168478|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153415543|NCT02168478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153415545|NCT00367874|Valproic Acid|valproic acid|mesh-list
153415546|NCT00367874|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153415547|NCT00367874|Narcotics|narcotics|mesh-ancestor
153415548|NCT00367874|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153415549|NCT00367874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153415550|NCT00367874|Analgesics|analgesics|mesh-ancestor
153415551|NCT00367874|Sensory System Agents|sensory system agents|mesh-ancestor
153415552|NCT00367874|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153415553|NCT00367874|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
153415554|NCT00367874|Anticonvulsants|anticonvulsants|mesh-ancestor
153793363|NCT03189446|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153387208|NCT00357773|Azithromycin|azithromycin|mesh-list
153793373|NCT03070392|Ipilimumab|ipilimumab|mesh-list
153793410|NCT02972840|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153793411|NCT02972840|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153793412|NCT02972840|Alkylating Agents|alkylating agents|mesh-ancestor
153793413|NCT02972840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153793414|NCT02972840|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153793415|NCT02972840|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153793416|NCT02972840|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153793417|NCT02921282|Dopamine|dopamine|mesh-list
153793418|NCT02921282|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
153793419|NCT02921282|Sympathomimetics|sympathomimetics|mesh-ancestor
153793420|NCT02921282|Autonomic Agents|autonomic agents|mesh-ancestor
153793421|NCT02921282|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153793422|NCT02921282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153793423|NCT02921282|Dopamine Agents|dopamine agents|mesh-ancestor
153793424|NCT02921282|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153793425|NCT02921282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153793426|NCT02921282|Protective Agents|protective agents|mesh-ancestor
153793427|NCT02763566|Letrozole|letrozole|mesh-list
153793428|NCT02763566|Fulvestrant|fulvestrant|mesh-list
153793429|NCT02763566|Anastrozole|anastrozole|mesh-list
153793430|NCT02763566|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153793431|NCT02763566|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
153793432|NCT02763566|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153793433|NCT02763566|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153793435|NCT02763566|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
153793460|NCT02464696|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153793461|NCT02464696|Glucocorticoids|glucocorticoids|mesh-ancestor
153793462|NCT02464696|Hormones|hormones|mesh-ancestor
153793463|NCT02464696|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153793464|NCT02464696|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
153351468|NCT00405704|Trimethoprim|trimethoprim|mesh-list
153793466|NCT02464696|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153793467|NCT02464696|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153874813|NCT02214602|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153874814|NCT02214602|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153874815|NCT02214602|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153874816|NCT02214602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153874817|NCT01646580|Ciclopirox|ciclopirox|mesh-list
153874818|NCT01646580|Antifungal Agents|antifungal agents|mesh-ancestor
153793527|NCT02156895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153793528|NCT02128906|Docetaxel|docetaxel|mesh-list
153793529|NCT02128906|Cetuximab|cetuximab|mesh-list
153793530|NCT02128906|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153793531|NCT02128906|Tubulin Modulators|tubulin modulators|mesh-ancestor
153793532|NCT02128906|Antimitotic Agents|antimitotic agents|mesh-ancestor
153793533|NCT02128906|Mitosis Modulators|mitosis modulators|mesh-ancestor
153793536|NCT02101775|Gemcitabine|gemcitabine|mesh-list
153793572|NCT00861705|Doxorubicin|doxorubicin|mesh-list
153793573|NCT00861705|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
153793574|NCT00861705|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
153793575|NCT00861705|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
153793577|NCT00861705|Immunoglobulins|immunoglobulins|mesh-list
153793578|NCT00861705|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
153793579|NCT00861705|Immunoglobulin G|immunoglobulin g|mesh-list
153793580|NCT00861705|Endothelial Growth Factors|endothelial growth factors|mesh-list
153351533|NCT05299476|Bevacizumab|bevacizumab|mesh-list
153793581|NCT00861705|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153793582|NCT00861705|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153793583|NCT00861705|Tubulin Modulators|tubulin modulators|mesh-ancestor
153793584|NCT00861705|Antimitotic Agents|antimitotic agents|mesh-ancestor
153793585|NCT00861705|Mitosis Modulators|mitosis modulators|mesh-ancestor
153793586|NCT00861705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153793587|NCT00861705|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153793588|NCT00861705|Immunologic Factors|immunologic factors|mesh-ancestor
153793630|NCT00588770|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
153793631|NCT00588770|Cisplatin|cisplatin|mesh-list
153793633|NCT00588770|Docetaxel|docetaxel|mesh-list
153793634|NCT00588770|Fluorouracil|fluorouracil|mesh-list
153793635|NCT00588770|Endothelial Growth Factors|endothelial growth factors|mesh-list
153793636|NCT00588770|Antibodies|antibodies|mesh-list
153793637|NCT00588770|Immunoglobulins|immunoglobulins|mesh-list
153793638|NCT00588770|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
153793639|NCT00588770|Immunoglobulin G|immunoglobulin g|mesh-list
153793640|NCT00588770|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153793641|NCT00588770|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153793642|NCT00588770|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153415560|NCT00367874|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153415562|NCT00367562|Valsartan|valsartan|mesh-list
153793643|NCT00588770|Growth Substances|growth substances|mesh-ancestor
153793644|NCT00588770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153793645|NCT00588770|Growth Inhibitors|growth inhibitors|mesh-ancestor
153793646|NCT00588770|Immunologic Factors|immunologic factors|mesh-ancestor
153793692|NCT00334815|Etoposide phosphate|etoposide phosphate|mesh-list
153793693|NCT00334815|Podophyllotoxin|podophyllotoxin|mesh-list
153793694|NCT00334815|Endothelial Growth Factors|endothelial growth factors|mesh-list
153793696|NCT00334815|Immunoglobulins|immunoglobulins|mesh-list
153793697|NCT00334815|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
153793698|NCT00334815|Lenograstim|lenograstim|mesh-list
153793699|NCT00334815|Immunoglobulin G|immunoglobulin g|mesh-list
153793700|NCT00334815|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153793701|NCT00334815|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153793702|NCT00334815|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153793704|NCT00334815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153793705|NCT00334815|Growth Inhibitors|growth inhibitors|mesh-ancestor
153793706|NCT00334815|Immunologic Factors|immunologic factors|mesh-ancestor
153793754|NCT00070499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153793755|NCT00070499|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153793756|NCT00257972|Aripiprazole|aripiprazole|mesh-list
153793757|NCT00257972|Antidepressive Agents|antidepressive agents|mesh-ancestor
153793758|NCT00257972|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153793759|NCT00257972|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153793760|NCT00257972|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153793761|NCT00257972|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153793762|NCT00257972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153793763|NCT00257972|Dopamine Agonists|dopamine agonists|mesh-ancestor
153793764|NCT00257972|Dopamine Agents|dopamine agents|mesh-ancestor
153793765|NCT00257972|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153793766|NCT00257972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153793767|NCT00257972|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
153793812|NCT00258089|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153793813|NCT00290901|Celecoxib|celecoxib|mesh-list
153793814|NCT00290901|Tramadol|tramadol|mesh-list
153793815|NCT00290901|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153793816|NCT00290901|Narcotics|narcotics|mesh-ancestor
153793817|NCT00290901|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153793818|NCT00290901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153793820|NCT00290901|Sensory System Agents|sensory system agents|mesh-ancestor
153793821|NCT00290901|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153793822|NCT00290901|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153874839|NCT01645410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153874840|NCT01645410|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153874841|NCT01645410|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
153874842|NCT01645410|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153874843|NCT04546334|Magnesium Sulfate|magnesium sulfate|mesh-list
153874844|NCT04546334|Analgesics|analgesics|mesh-ancestor
153874845|NCT04546334|Sensory System Agents|sensory system agents|mesh-ancestor
153874846|NCT04546334|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153874847|NCT04546334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153874848|NCT04546334|Anesthetics|anesthetics|mesh-ancestor
153793823|NCT00290901|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153793824|NCT00290901|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153793825|NCT00290901|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153793826|NCT00290901|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
153793827|NCT00290901|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153793828|NCT00290901|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153793829|NCT00290901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153793831|NCT00258245|Vitamins|vitamins|mesh-list
153793832|NCT00258245|Ascorbic Acid|ascorbic acid|mesh-list
153469367|NCT05111860|Bevacizumab|bevacizumab|mesh-list
153793833|NCT00258245|Thalidomide|thalidomide|mesh-list
153793866|NCT00258245|Antioxidants|antioxidants|mesh-ancestor
153793867|NCT00258245|Protective Agents|protective agents|mesh-ancestor
153793868|NCT00258245|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153793869|NCT00258245|Immunologic Factors|immunologic factors|mesh-ancestor
153793870|NCT00258245|Leprostatic Agents|leprostatic agents|mesh-ancestor
153793871|NCT00258245|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153793872|NCT00258245|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153793873|NCT00258245|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153793877|NCT00271440|Chlorhexidine|chlorhexidine|mesh-list
153793935|NCT00290979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153793936|NCT00258479|Modafinil|modafinil|mesh-list
153793937|NCT00258479|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
153793938|NCT00258479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153793939|NCT00258479|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
153793940|NCT00258479|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
153793941|NCT00258479|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
153793942|NCT00258479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153793943|NCT00271518|Hormones|hormones|mesh-list
153793944|NCT00271518|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153793945|NCT00271518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153793946|NCT01340014|Timolol|timolol|mesh-list
153793947|NCT01340014|Dorzolamide|dorzolamide|mesh-list
153793948|NCT01340014|Ophthalmic Solutions|ophthalmic solutions|mesh-list
153793994|NCT01339273|Sensory System Agents|sensory system agents|mesh-ancestor
153793995|NCT01339273|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153793996|NCT04709315|Choline|choline|mesh-list
153793997|NCT04709315|Rocuronium|rocuronium|mesh-list
153793998|NCT04709315|Succinylcholine|succinylcholine|mesh-list
153793999|NCT04709315|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
153794000|NCT04709315|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
153794006|NCT04709315|Antimetabolites|antimetabolites|mesh-ancestor
153794063|NCT00291369|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
153794064|NCT00291369|Medroxyprogesterone|medroxyprogesterone|mesh-list
153794065|NCT00291369|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153794066|NCT00291369|Antiviral Agents|antiviral agents|mesh-ancestor
153794067|NCT00291369|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153794135|NCT00259142|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153794137|NCT00259142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153794138|NCT00259142|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
153794139|NCT00259181|Chlorhexidine|chlorhexidine|mesh-list
153794140|NCT00259181|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
153794141|NCT00259181|Polymethyl Methacrylate|polymethyl methacrylate|mesh-list
153794142|NCT00259181|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
153794143|NCT00259181|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153794144|NCT00259181|Disinfectants|disinfectants|mesh-ancestor
153794145|NCT00259181|Dermatologic Agents|dermatologic agents|mesh-ancestor
153794146|NCT00259181|Vasodilator Agents|vasodilator agents|mesh-ancestor
153794147|NCT00259181|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
153794148|NCT00259181|Protective Agents|protective agents|mesh-ancestor
153794149|NCT00259181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153794190|NCT00272025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153794191|NCT04709081|Itraconazole|itraconazole|mesh-list
153794193|NCT04709081|Midazolam|midazolam|mesh-list
153794194|NCT04709081|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153794195|NCT04709081|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153794196|NCT04709081|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153794197|NCT04709081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153794198|NCT04709081|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153794199|NCT04709081|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153794200|NCT04709081|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153794201|NCT04709081|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153794204|NCT04709081|GABA Modulators|gaba modulators|mesh-ancestor
153794205|NCT04709081|GABA Agents|gaba agents|mesh-ancestor
153794206|NCT04709081|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153794220|NCT00272064|Insulin|insulin|mesh-list
153794250|NCT00291915|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153794251|NCT00291915|Dermatologic Agents|dermatologic agents|mesh-ancestor
153415602|NCT02244164|Protease Inhibitors|protease inhibitors|mesh-ancestor
153415603|NCT02244164|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153415604|NCT02244164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153874863|NCT04546256|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153874864|NCT04546256|Autonomic Agents|autonomic agents|mesh-ancestor
153874865|NCT04546256|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153351876|NCT05246046|Anticonvulsants|anticonvulsants|mesh-ancestor
153874866|NCT04546256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153876856|NCT06047860|Interleukin-2|interleukin-2|mesh-list
153417639|NCT00372008|Hormones|hormones|mesh-ancestor
153794252|NCT00291915|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153794253|NCT00291915|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153794254|NCT00291915|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153794255|NCT00291915|Immunologic Factors|immunologic factors|mesh-ancestor
153794256|NCT00291915|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153794257|NCT00291915|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153794258|NCT00291915|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
153794259|NCT00291915|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153794261|NCT00259766|Terbutaline|terbutaline|mesh-list
153794262|NCT00259766|Formoterol Fumarate|formoterol fumarate|mesh-list
153794263|NCT00259766|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153794264|NCT00259766|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153794265|NCT00259766|Autonomic Agents|autonomic agents|mesh-ancestor
153794266|NCT00259766|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153794267|NCT00259766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153794307|NCT00259883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153794308|NCT00259883|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153794309|NCT00259883|Serotonin Agents|serotonin agents|mesh-ancestor
153794310|NCT00259883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153794311|NCT00259883|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
153351959|NCT05238948|Midazolam|midazolam|mesh-list
153794312|NCT00259883|Antidepressive Agents|antidepressive agents|mesh-ancestor
153794313|NCT00259883|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153794314|NCT00259883|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
153794315|NCT00259883|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153794316|NCT00259883|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153794317|NCT00272415|Temozolomide|temozolomide|mesh-list
153794318|NCT00272415|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153794319|NCT00272415|Alkylating Agents|alkylating agents|mesh-ancestor
153794320|NCT00272415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153794321|NCT00272415|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153794322|NCT00259922|Alvimopan|alvimopan|mesh-list
153794323|NCT00259922|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153794324|NCT00272454|Aspirin|aspirin|mesh-list
153794325|NCT00272454|Cilostazol|cilostazol|mesh-list
153794326|NCT00272454|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153794327|NCT00272454|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153794328|NCT00272454|Analgesics|analgesics|mesh-ancestor
153794329|NCT00272454|Sensory System Agents|sensory system agents|mesh-ancestor
153794355|NCT00292266|Immunologic Factors|immunologic factors|mesh-ancestor
153794356|NCT00292266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153874877|NCT04546256|Glucocorticoids|glucocorticoids|mesh-ancestor
153794358|NCT00292266|Antiviral Agents|antiviral agents|mesh-ancestor
153794359|NCT00292266|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153794360|NCT00260039|Vaccines|vaccines|mesh-list
153794361|NCT00260039|Immunologic Factors|immunologic factors|mesh-ancestor
153794362|NCT00260039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153794363|NCT00292344|Rifaximin|rifaximin|mesh-list
153469542|NCT04898894|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153469543|NCT04898894|Dermatologic Agents|dermatologic agents|mesh-ancestor
153469544|NCT04898894|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153469545|NCT04898894|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153469546|NCT04898894|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153794365|NCT00292344|Antidiarrheals|antidiarrheals|mesh-list
153794366|NCT00292344|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153794367|NCT00292344|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153794368|NCT00292344|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153794369|NCT00417768|Plasminogen|plasminogen|mesh-list
153794370|NCT00417768|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
153340868|NCT04160000|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-list
153794371|NCT00417768|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153794372|NCT00417768|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153794373|NCT00417768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153794374|NCT00272610|Vitamin A|vitamin a|mesh-list
153794375|NCT00272610|Vitamins|vitamins|mesh-ancestor
153794376|NCT00272610|Micronutrients|micronutrients|mesh-ancestor
153794377|NCT00272610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153794378|NCT00260351|Vaccines|vaccines|mesh-list
153794379|NCT00260351|Immunologic Factors|immunologic factors|mesh-ancestor
153794380|NCT00260351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153794381|NCT00272688|Levodopa|levodopa|mesh-list
153794382|NCT00272688|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
153794401|NCT00260624|Serotonin Agents|serotonin agents|mesh-ancestor
153794402|NCT00260624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153794403|NCT00292695|Ifosfamide|ifosfamide|mesh-list
153794404|NCT00292695|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153794405|NCT00292695|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153794406|NCT00292695|Alkylating Agents|alkylating agents|mesh-ancestor
153794407|NCT00292695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153794408|NCT00292734|Zolpidem|zolpidem|mesh-list
153794409|NCT00292734|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
153794410|NCT00292734|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153352061|NCT00411398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153794411|NCT00292734|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153794465|NCT00298506|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153794466|NCT00298506|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153794467|NCT00298506|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
153415619|NCT02152670|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153813759|NCT00437229|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153415620|NCT02152670|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
153415621|NCT02152670|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153415623|NCT02028806|Oxaliplatin|oxaliplatin|mesh-list
153415625|NCT02028806|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153415626|NCT02028806|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
153415627|NCT02028806|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153415628|NCT02028806|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153415629|NCT02028806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153415630|NCT02028806|Antidotes|antidotes|mesh-ancestor
153415631|NCT02028806|Protective Agents|protective agents|mesh-ancestor
153415632|NCT02028806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153874886|NCT01645449|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153794468|NCT00298506|Antitubercular Agents|antitubercular agents|mesh-ancestor
153794469|NCT00298506|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153794470|NCT00298506|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153794471|NCT00424892|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
153794472|NCT00424892|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
153794473|NCT00424892|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153794474|NCT00424892|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153794476|NCT00424892|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153794525|NCT01330459|Anesthetics|anesthetics|mesh-ancestor
153794526|NCT01330459|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153794527|NCT01330459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153794528|NCT01330459|Sensory System Agents|sensory system agents|mesh-ancestor
153794529|NCT01330459|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153794531|NCT01330459|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
153794532|NCT01330459|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153794533|NCT01330459|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153794534|NCT01330459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153794535|NCT01330459|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153794536|NCT01330459|Analgesics|analgesics|mesh-ancestor
153794588|NCT01330381|Serotonin Agents|serotonin agents|mesh-ancestor
153794589|NCT01330381|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153794590|NCT01330381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153794591|NCT01330381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153794592|NCT00261092|Oxaliplatin|oxaliplatin|mesh-list
153794593|NCT00261092|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153794594|NCT00293124|Imatinib Mesylate|imatinib mesylate|mesh-list
153341176|NCT00002722|Antidotes|antidotes|mesh-ancestor
153794595|NCT00293124|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153794596|NCT00293124|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153794597|NCT00293124|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153794598|NCT00293124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153794599|NCT00293124|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153794600|NCT01330108|Ambrisentan|ambrisentan|mesh-list
153794601|NCT01330108|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153794602|NCT00261131|Botulinum Toxins|botulinum toxins|mesh-list
153794603|NCT00261131|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
153794640|NCT00261326|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153794641|NCT00293163|Hylan|hylan|mesh-list
153794642|NCT00293163|Viscosupplements|viscosupplements|mesh-ancestor
153794643|NCT00293163|Protective Agents|protective agents|mesh-ancestor
153794644|NCT00293163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153794645|NCT00261365|Ipilimumab|ipilimumab|mesh-list
153794646|NCT00261365|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153794647|NCT00261365|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153794648|NCT00261365|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153794649|NCT00261365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153794650|NCT00293280|Lomustine|lomustine|mesh-list
153794651|NCT00293280|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153794652|NCT00293280|Alkylating Agents|alkylating agents|mesh-ancestor
153794653|NCT00293280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153794654|NCT00293280|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153794655|NCT00298779|Bortezomib|bortezomib|mesh-list
153794656|NCT00298779|Omeprazole|omeprazole|mesh-list
153794657|NCT00298779|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153794658|NCT00298779|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
153794659|NCT00298779|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153794660|NCT00298779|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
153794661|NCT00298779|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153794662|NCT00298779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153794663|NCT00261482|Ethinyl Estradiol|ethinyl estradiol|mesh-list
153794664|NCT00261482|Norelgestromin|norelgestromin|mesh-list
153794665|NCT00261482|Estradiol|estradiol|mesh-list
153794666|NCT00261482|Estrogens|estrogens|mesh-ancestor
153341250|NCT01049945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153794668|NCT00261482|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153794669|NCT00261482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153794684|NCT00298857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153794685|NCT00298857|Antimanic Agents|antimanic agents|mesh-ancestor
153794686|NCT00298857|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153794687|NCT00298857|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153469873|NCT04108026|Durvalumab|durvalumab|mesh-list
153794688|NCT00298857|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153794689|NCT00261560|Acetaminophen|acetaminophen|mesh-list
153794690|NCT00261560|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153794691|NCT00261560|Analgesics|analgesics|mesh-ancestor
153794692|NCT00261560|Sensory System Agents|sensory system agents|mesh-ancestor
153794693|NCT00261560|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153794694|NCT00261560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153794695|NCT00261560|Antipyretics|antipyretics|mesh-ancestor
153794696|NCT00261599|Midazolam|midazolam|mesh-list
153794697|NCT00261599|Fospropofol|fospropofol|mesh-list
153794698|NCT00261599|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153794699|NCT00261599|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153794700|NCT00261599|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153469913|NCT04053478|Coagulants|coagulants|mesh-ancestor
153794701|NCT00261599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153794703|NCT00261599|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153794704|NCT00261599|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153794705|NCT00261599|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153794707|NCT00261599|Anesthetics|anesthetics|mesh-ancestor
153794738|NCT00298974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153794740|NCT00298974|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153794741|NCT00298974|Narcotics|narcotics|mesh-ancestor
153794742|NCT00298974|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153794743|NCT00298974|Antitussive Agents|antitussive agents|mesh-ancestor
153415634|NCT02028806|Vitamins|vitamins|mesh-ancestor
153415635|NCT02028806|Micronutrients|micronutrients|mesh-ancestor
153415636|NCT01756118|Dactolisib|dactolisib|mesh-list
153415637|NCT01756118|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153415638|NCT04339712|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
153415639|NCT04339712|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153415640|NCT02656160|4-Aminopyridine|4-aminopyridine|mesh-list
153415641|NCT02656160|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
153469975|NCT03945591|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153415642|NCT02656160|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153415643|NCT02656160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153415644|NCT02657252|Polidocanol|polidocanol|mesh-list
153415645|NCT02657252|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
153415646|NCT02657252|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
153415647|NCT04740086|Calcium|calcium|mesh-list
153415648|NCT04740086|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153794744|NCT00298974|Respiratory System Agents|respiratory system agents|mesh-ancestor
153794745|NCT00298974|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153794746|NCT00298974|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153794748|NCT00293436|Celecoxib|celecoxib|mesh-list
153794803|NCT00293475|Antioxidants|antioxidants|mesh-ancestor
153794804|NCT00293475|Antitubercular Agents|antitubercular agents|mesh-ancestor
153794805|NCT00293475|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153794806|NCT00293475|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153794807|NCT00293475|Chelating Agents|chelating agents|mesh-ancestor
153794808|NCT00293475|Sequestering Agents|sequestering agents|mesh-ancestor
153794809|NCT00261911|Sibutramine|sibutramine|mesh-list
153794810|NCT00261911|Antidepressive Agents|antidepressive agents|mesh-ancestor
153794811|NCT00261911|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153794812|NCT00261911|Appetite Depressants|appetite depressants|mesh-ancestor
153794813|NCT00261911|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
153794815|NCT00299013|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
153341326|NCT00002590|Alkylating Agents|alkylating agents|mesh-ancestor
153794816|NCT00299013|Methylprednisolone|methylprednisolone|mesh-list
153794864|NCT00299208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153794865|NCT00299208|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
153794866|NCT00299208|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153794867|NCT00299208|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153794868|NCT00299208|Analgesics|analgesics|mesh-ancestor
153794869|NCT00299208|Sensory System Agents|sensory system agents|mesh-ancestor
153794870|NCT00418119|Epoetin Alfa|epoetin alfa|mesh-list
153794871|NCT00418119|Hematinics|hematinics|mesh-ancestor
153794872|NCT00293592|Dexamethasone|dexamethasone|mesh-list
153794873|NCT00293592|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153794874|NCT00293592|Antiemetics|antiemetics|mesh-ancestor
153794875|NCT00293592|Autonomic Agents|autonomic agents|mesh-ancestor
153794876|NCT00293592|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153794877|NCT00293592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153794878|NCT00293592|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153794879|NCT00293592|Glucocorticoids|glucocorticoids|mesh-ancestor
153794880|NCT00293592|Hormones|hormones|mesh-ancestor
153794925|NCT00299286|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153794926|NCT00299286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153794927|NCT00299286|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153794929|NCT00293787|Travoprost|travoprost|mesh-list
153794930|NCT00293787|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
153794931|NCT00293787|Latanoprost|latanoprost|mesh-list
153794932|NCT00293787|Ophthalmic Solutions|ophthalmic solutions|mesh-list
153794933|NCT00293787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153475838|NCT00835224|Sympathomimetics|sympathomimetics|mesh-ancestor
153874913|NCT04545788|Cycloserine|cycloserine|mesh-list
153874914|NCT04545788|Bedaquiline|bedaquiline|mesh-list
153874915|NCT04545788|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153874916|NCT04545788|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153470207|NCT03338621|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
153874917|NCT04545788|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
153874918|NCT04545788|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153874919|NCT04545788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153876944|NCT06046105|Sensory System Agents|sensory system agents|mesh-ancestor
153794934|NCT00293787|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
153794935|NCT00293787|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
153352323|NCT00533546|Anticoagulants|anticoagulants|mesh-ancestor
153794936|NCT00293787|Adrenergic Agents|adrenergic agents|mesh-ancestor
153794937|NCT00293787|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153794941|NCT00299364|Tibolone|tibolone|mesh-list
153794986|NCT00262808|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153794987|NCT00262808|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153794988|NCT00262808|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153794989|NCT00262808|Immunologic Factors|immunologic factors|mesh-ancestor
153794990|NCT00262808|Antidotes|antidotes|mesh-ancestor
153795057|NCT06259630|Cholinergic Agents|cholinergic agents|mesh-ancestor
153795058|NCT06259630|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153795059|NCT06259630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153795060|NCT06259565|Dexmedetomidine|dexmedetomidine|mesh-list
153795061|NCT06259565|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153470274|NCT03151499|BI 409306|bi 409306|mesh-list
153470275|NCT03151499|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
153795062|NCT06259565|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153795063|NCT06259565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153795064|NCT06259565|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153795065|NCT06259565|Analgesics|analgesics|mesh-ancestor
153795066|NCT06259565|Sensory System Agents|sensory system agents|mesh-ancestor
153795067|NCT06259565|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153795068|NCT06259565|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
153795069|NCT06259565|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153795070|NCT06259565|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153795071|NCT06259565|Adrenergic Agents|adrenergic agents|mesh-ancestor
153795072|NCT06259565|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153795111|NCT06259175|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
153795112|NCT06259175|Protease Inhibitors|protease inhibitors|mesh-ancestor
153795113|NCT06259175|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153795114|NCT06259175|Diuretics|diuretics|mesh-ancestor
153795115|NCT06259175|Natriuretic Agents|natriuretic agents|mesh-ancestor
153795116|NCT06259175|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
153795117|NCT06259149|Calcium|calcium|mesh-list
153795118|NCT06259149|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153795119|NCT06259149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153795120|NCT06259097|Misoprostol|misoprostol|mesh-list
153795121|NCT06259097|Oxytocin|oxytocin|mesh-list
153795122|NCT06259097|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
153795123|NCT06259097|Abortifacient Agents|abortifacient agents|mesh-ancestor
153795129|NCT06258967|Propofol|propofol|mesh-list
153795173|NCT06258265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153795174|NCT06258265|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153795175|NCT06258265|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
153795176|NCT06258265|Contraceptive Agents|contraceptive agents|mesh-ancestor
153795177|NCT06258265|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153795178|NCT06258265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153795179|NCT06258265|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
153795181|NCT06258265|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
153795182|NCT06258226|Estazolam|estazolam|mesh-list
153795183|NCT06258226|Anticonvulsants|anticonvulsants|mesh-ancestor
153795184|NCT06258226|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153795185|NCT06258226|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153795232|NCT06257966|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
153795233|NCT06257966|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
153795234|NCT06257966|Incretins|incretins|mesh-ancestor
153795235|NCT06257966|Hormones|hormones|mesh-ancestor
153795236|NCT06257966|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153795237|NCT06257706|Vedolizumab|vedolizumab|mesh-list
153795238|NCT06257706|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153795239|NCT06257537|Diclofenac|diclofenac|mesh-list
153795240|NCT06257537|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153795241|NCT06257537|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153795290|NCT06243263|Anesthetics, Local|anesthetics, local|mesh-ancestor
153795291|NCT06243263|Anesthetics|anesthetics|mesh-ancestor
153795292|NCT06243263|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153795293|NCT06243263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153795294|NCT06243263|Sensory System Agents|sensory system agents|mesh-ancestor
153795295|NCT06243263|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153795296|NCT06233942|Tislelizumab|tislelizumab|mesh-list
153795297|NCT06233942|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153795298|NCT06233942|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153795299|NCT06225349|Magnesium citrate|magnesium citrate|mesh-list
153795300|NCT06225349|Magnesium Oxide|magnesium oxide|mesh-list
153795302|NCT06225349|Cathartics|cathartics|mesh-ancestor
153795353|NCT06059118|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153795354|NCT06059118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153795356|NCT06059118|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153795357|NCT06059118|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153795358|NCT06059118|Anabolic Agents|anabolic agents|mesh-ancestor
153795422|NCT05974267|Antimalarials|antimalarials|mesh-ancestor
153795423|NCT05974267|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153795424|NCT05974267|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153795425|NCT05974267|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153795426|NCT05974267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153795427|NCT05974267|Antimetabolites|antimetabolites|mesh-ancestor
153795428|NCT05966727|Cholestyramine Resin|cholestyramine resin|mesh-list
153795429|NCT05966727|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153795430|NCT05966727|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153795431|NCT05966727|Antimetabolites|antimetabolites|mesh-ancestor
153795432|NCT05966727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153795433|NCT05966727|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153795435|NCT05964647|Lorazepam|lorazepam|mesh-list
153795436|NCT05964647|Olanzapine|olanzapine|mesh-list
153795437|NCT05964647|Antiemetics|antiemetics|mesh-ancestor
153795438|NCT05964647|Autonomic Agents|autonomic agents|mesh-ancestor
153795442|NCT05964647|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153795480|NCT05873881|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153795481|NCT05873881|Vitamin B Complex|vitamin b complex|mesh-ancestor
153795482|NCT05873881|Vitamins|vitamins|mesh-ancestor
153795483|NCT05873881|Micronutrients|micronutrients|mesh-ancestor
153415669|NCT02684942|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153874930|NCT02756013|Mitosis Modulators|mitosis modulators|mesh-ancestor
153795484|NCT05873881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153795485|NCT05873465|Midazolam|midazolam|mesh-list
153795486|NCT05873465|Fentanyl|fentanyl|mesh-list
153342077|NCT01214083|Expectorants|expectorants|mesh-ancestor
153795487|NCT05873465|Propofol|propofol|mesh-list
153795488|NCT05873465|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153795489|NCT05873465|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153470479|NCT01822314|Mitosis Modulators|mitosis modulators|mesh-ancestor
153795490|NCT05873465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153795491|NCT05873465|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153795492|NCT05873465|Anesthetics, General|anesthetics, general|mesh-ancestor
153795493|NCT05873465|Anesthetics|anesthetics|mesh-ancestor
153795494|NCT05873465|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153795495|NCT05873465|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153795496|NCT05873465|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153795497|NCT05873465|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153795498|NCT05873465|GABA Modulators|gaba modulators|mesh-ancestor
153795499|NCT05873465|GABA Agents|gaba agents|mesh-ancestor
153795500|NCT05873465|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153795501|NCT05873465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153795502|NCT05873465|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153795503|NCT05873465|Narcotics|narcotics|mesh-ancestor
153795504|NCT05873465|Analgesics|analgesics|mesh-ancestor
153795505|NCT05873465|Sensory System Agents|sensory system agents|mesh-ancestor
153795506|NCT05873465|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153795507|NCT05867914|Nitric Oxide|nitric oxide|mesh-list
153795515|NCT05867914|Antioxidants|antioxidants|mesh-ancestor
153795527|NCT05835999|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153795528|NCT05835999|Immunologic Factors|immunologic factors|mesh-ancestor
153795529|NCT05835999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153795530|NCT05835999|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153795531|NCT05786599|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
153795532|NCT05786599|Methadone|methadone|mesh-list
153795533|NCT05786599|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
153795534|NCT05786599|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153795535|NCT05786599|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153795536|NCT05786599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153795537|NCT05786599|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153795538|NCT05786599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153795539|NCT05786599|Analgesics|analgesics|mesh-ancestor
153795540|NCT05786599|Sensory System Agents|sensory system agents|mesh-ancestor
153795541|NCT05786599|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153795542|NCT05786599|Antidepressive Agents|antidepressive agents|mesh-ancestor
153795543|NCT05786599|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153795544|NCT05786599|Dopamine Agents|dopamine agents|mesh-ancestor
153795545|NCT05786599|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153795546|NCT05786599|Narcotics|narcotics|mesh-ancestor
153795547|NCT05786599|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153795548|NCT05786599|Antitussive Agents|antitussive agents|mesh-ancestor
153795578|NCT05741372|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153795579|NCT05741372|Antimetabolites|antimetabolites|mesh-ancestor
153795580|NCT05741372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153795581|NCT05741372|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153795582|NCT05741372|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
153795583|NCT05741372|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153795584|NCT05741372|Diuretics|diuretics|mesh-ancestor
153352629|NCT00480740|Analgesics|analgesics|mesh-ancestor
153795585|NCT05741372|Natriuretic Agents|natriuretic agents|mesh-ancestor
153795586|NCT05741372|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
153874931|NCT02756013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153874932|NCT01680042|Phenytoin|phenytoin|mesh-list
153874933|NCT01680042|Anticonvulsants|anticonvulsants|mesh-ancestor
153795587|NCT05741372|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153795588|NCT05741372|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153795589|NCT05741372|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
153795590|NCT05741372|Protective Agents|protective agents|mesh-ancestor
153795591|NCT05739682|Anti-Infective Agents|anti-infective agents|mesh-list
153795592|NCT05739682|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
153795593|NCT05739682|Epinephrine|epinephrine|mesh-list
153795594|NCT05739682|Anesthetics|anesthetics|mesh-list
153795595|NCT05739682|Carticaine|carticaine|mesh-list
153795596|NCT05739682|Anesthetics, Local|anesthetics, local|mesh-list
153795597|NCT05739682|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153795598|NCT05739682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153795599|NCT05739682|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153795600|NCT05739682|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153795601|NCT05739682|Adrenergic Agents|adrenergic agents|mesh-ancestor
153795602|NCT05739682|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153795603|NCT05739682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153795604|NCT05739682|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
153795605|NCT05739682|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153470614|NCT02129478|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153795606|NCT05739682|Autonomic Agents|autonomic agents|mesh-ancestor
153795607|NCT05739682|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153795619|NCT05722002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153795620|NCT05722002|Antipyretics|antipyretics|mesh-ancestor
153795621|NCT05711082|Dopamine|dopamine|mesh-list
153795622|NCT05711082|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
153795623|NCT05711082|Sympathomimetics|sympathomimetics|mesh-ancestor
153795624|NCT05711082|Autonomic Agents|autonomic agents|mesh-ancestor
153795625|NCT05711082|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153795626|NCT05711082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153795627|NCT05711082|Dopamine Agents|dopamine agents|mesh-ancestor
153795628|NCT05711082|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153795629|NCT05711082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153795630|NCT05711082|Protective Agents|protective agents|mesh-ancestor
153795631|NCT05700695|Lactulose|lactulose|mesh-list
153795632|NCT05700695|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153795633|NCT05681481|Prednisone|prednisone|mesh-list
153795634|NCT05681481|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153470664|NCT05362188|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153795635|NCT05681481|Glucocorticoids|glucocorticoids|mesh-ancestor
153795678|NCT05540145|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153795680|NCT05540145|Antimitotic Agents|antimitotic agents|mesh-ancestor
153795681|NCT05540145|Mitosis Modulators|mitosis modulators|mesh-ancestor
153795682|NCT05540145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153795683|NCT05540145|Immunologic Factors|immunologic factors|mesh-ancestor
153795684|NCT05540145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153795685|NCT05525273|Trametinib|trametinib|mesh-list
153795686|NCT05525273|Dabrafenib|dabrafenib|mesh-list
153795740|NCT05444946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153795741|NCT05444946|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153795742|NCT05444946|Hormone Antagonists|hormone antagonists|mesh-ancestor
153795743|NCT05444946|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
153795745|NCT05419011|Immunologic Factors|immunologic factors|mesh-ancestor
153352678|NCT00544778|Dexrazoxane|dexrazoxane|mesh-list
153795746|NCT05419011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153795747|NCT05403580|Olanzapine|olanzapine|mesh-list
153795748|NCT05403580|Antiemetics|antiemetics|mesh-ancestor
153795749|NCT05403580|Autonomic Agents|autonomic agents|mesh-ancestor
153795750|NCT05403580|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153795751|NCT05403580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153795752|NCT05403580|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153795753|NCT05403580|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153795754|NCT05403580|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153795755|NCT05403580|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153795763|NCT05402293|Lidocaine|lidocaine|mesh-list
153795796|NCT05379179|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153795797|NCT05379179|Anesthetics, General|anesthetics, general|mesh-ancestor
153795798|NCT05379179|Anesthetics|anesthetics|mesh-ancestor
153795799|NCT05379179|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153795800|NCT05379179|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
153795801|NCT05379179|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
153795802|NCT05379179|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153795803|NCT05379179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153795804|NCT05379179|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153795805|NCT05379179|Narcotics|narcotics|mesh-ancestor
153795806|NCT05379179|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153795807|NCT05366166|Cisplatin|cisplatin|mesh-list
153795808|NCT05366166|Pembrolizumab|pembrolizumab|mesh-list
153795809|NCT05366166|Olaparib|olaparib|mesh-list
153795810|NCT05366166|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153795812|NCT05366166|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153795855|NCT05270057|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153795856|NCT05270057|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153795857|NCT05270057|Alkylating Agents|alkylating agents|mesh-ancestor
153795858|NCT05270057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153795859|NCT05270057|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153795860|NCT05270057|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153795861|NCT05270057|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153795862|NCT05270057|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153795863|NCT05270057|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153795920|NCT05189457|Leuprolide|leuprolide|mesh-list
153795921|NCT05189457|Triptorelin Pamoate|triptorelin pamoate|mesh-list
153415688|NCT02660918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153415690|NCT02660918|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153415691|NCT00367315|Lumiracoxib|lumiracoxib|mesh-list
153415692|NCT00367315|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
153877052|NCT06044480|Hormones|hormones|mesh-ancestor
153795922|NCT05189457|Hormones|hormones|mesh-list
153795923|NCT05189457|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
153795924|NCT05189457|Relugolix|relugolix|mesh-list
153795925|NCT05189457|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153795926|NCT05189457|Tubulin Modulators|tubulin modulators|mesh-ancestor
153795927|NCT05189457|Antimitotic Agents|antimitotic agents|mesh-ancestor
153795928|NCT05189457|Mitosis Modulators|mitosis modulators|mesh-ancestor
153795929|NCT05189457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153342451|NCT00003004|Paclitaxel|paclitaxel|mesh-list
153795930|NCT05189457|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153795931|NCT05189457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153795932|NCT05189457|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153795933|NCT05189457|Fertility Agents, Female|fertility agents, female|mesh-ancestor
153795935|NCT05189457|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153795936|NCT05189457|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153795937|NCT05189457|Luteolytic Agents|luteolytic agents|mesh-ancestor
153795938|NCT05189457|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
153795939|NCT05189457|Contraceptive Agents|contraceptive agents|mesh-ancestor
153352721|NCT00489866|Aripiprazole|aripiprazole|mesh-list
153795940|NCT05189457|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
153795941|NCT05189457|Androgen Antagonists|androgen antagonists|mesh-ancestor
153795982|NCT05043116|Cholecalciferol|cholecalciferol|mesh-list
153795983|NCT05043116|Vitamins|vitamins|mesh-ancestor
153795989|NCT05038839|Pamiparib|pamiparib|mesh-list
153796034|NCT04947085|Anesthetics|anesthetics|mesh-ancestor
153796035|NCT04947085|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153796036|NCT04947085|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
153796037|NCT04947085|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
153796038|NCT04947085|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153796039|NCT04947085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153796040|NCT04920565|Polymyxins|polymyxins|mesh-list
153796041|NCT04920565|Polymyxin B|polymyxin b|mesh-list
153796042|NCT04920565|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153796043|NCT04920565|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153796049|NCT04902040|Pembrolizumab|pembrolizumab|mesh-list
153796050|NCT04902040|Nivolumab|nivolumab|mesh-list
153796051|NCT04902040|Atezolizumab|atezolizumab|mesh-list
153796052|NCT04902040|Durvalumab|durvalumab|mesh-list
153796053|NCT04902040|Avelumab|avelumab|mesh-list
153796054|NCT04902040|Immunoglobulins|immunoglobulins|mesh-list
153796055|NCT04902040|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
153796056|NCT04902040|Immunoglobulin G|immunoglobulin g|mesh-list
153796057|NCT04902040|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153796058|NCT04902040|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153796059|NCT04902040|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153796060|NCT04902040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153796061|NCT04902040|Immunologic Factors|immunologic factors|mesh-ancestor
153796062|NCT04902040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153796063|NCT04892277|Cyclophosphamide|cyclophosphamide|mesh-list
153796068|NCT04892277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153796069|NCT04892277|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153796070|NCT04892277|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153796071|NCT04892277|Alkylating Agents|alkylating agents|mesh-ancestor
153874950|NCT01680081|Vasodilator Agents|vasodilator agents|mesh-ancestor
153874951|NCT01680081|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
153874952|NCT01680081|Purinergic Agonists|purinergic agonists|mesh-ancestor
153874953|NCT01680081|Purinergic Agents|purinergic agents|mesh-ancestor
153470934|NCT00612222|Interleukin-2|interleukin-2|mesh-list
153874954|NCT01680081|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153796072|NCT04892277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153796073|NCT04892277|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153796074|NCT04892277|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153796075|NCT04865653|Lysergic Acid Diethylamide|lysergic acid diethylamide|mesh-list
153796076|NCT04865653|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
153796077|NCT04865653|Hallucinogens|hallucinogens|mesh-ancestor
153796078|NCT04865653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153796079|NCT04865653|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153796080|NCT04865653|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153796081|NCT04865653|Serotonin Agents|serotonin agents|mesh-ancestor
153796082|NCT04865653|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153796083|NCT04865653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153796084|NCT04865653|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
153470980|NCT04304274|Anesthetics|anesthetics|mesh-ancestor
153796085|NCT04847206|N-Methyl-3,4-methylenedioxyamphetamine|n-methyl-3,4-methylenedioxyamphetamine|mesh-list
153796086|NCT04847206|3,4-Methylenedioxyamphetamine|3,4-methylenedioxyamphetamine|mesh-list
153796087|NCT04847206|Hallucinogens|hallucinogens|mesh-ancestor
153796088|NCT04847206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153796089|NCT04847206|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153796090|NCT04847206|Serotonin Agents|serotonin agents|mesh-ancestor
153796091|NCT04847206|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153796092|NCT04847206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153796112|NCT04814875|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
153796113|NCT04814875|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153796114|NCT04814875|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153796115|NCT04814875|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153796116|NCT04814875|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153796117|NCT04814875|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153796118|NCT04814875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153796119|NCT04809051|Metronidazole|metronidazole|mesh-list
153796120|NCT04809051|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153796121|NCT04809051|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153796122|NCT04809051|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153796123|NCT04809051|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153796124|NCT04798339|Darbepoetin alfa|darbepoetin alfa|mesh-list
153796125|NCT04798339|Hematinics|hematinics|mesh-ancestor
153796126|NCT04777409|Semaglutide|semaglutide|mesh-list
153471032|NCT04142502|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153796127|NCT04777409|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
153796128|NCT04777409|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153796129|NCT04777409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153796130|NCT04772547|Vigabatrin|vigabatrin|mesh-list
153796131|NCT04772547|Anticonvulsants|anticonvulsants|mesh-ancestor
153796132|NCT04772547|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153796134|NCT04772547|GABA Agents|gaba agents|mesh-ancestor
153796166|NCT04599634|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153796167|NCT04599634|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153415718|NCT05441761|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153796168|NCT04597411|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
153796169|NCT04597411|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
153796170|NCT04597411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153796171|NCT04448977|Ocrelizumab|ocrelizumab|mesh-list
153796172|NCT04448977|Immunologic Factors|immunologic factors|mesh-ancestor
153796173|NCT04448977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153796174|NCT04432831|Faricimab|faricimab|mesh-list
153796175|NCT04432831|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153796176|NCT04432831|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153796177|NCT04432831|Growth Substances|growth substances|mesh-ancestor
153796178|NCT04432831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153796179|NCT04432831|Growth Inhibitors|growth inhibitors|mesh-ancestor
153796180|NCT04432831|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153796181|NCT04428372|Mannitol|mannitol|mesh-list
153796182|NCT04428372|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
153796183|NCT04428372|Diuretics|diuretics|mesh-ancestor
153796184|NCT04428372|Natriuretic Agents|natriuretic agents|mesh-ancestor
153796222|NCT04291599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153796223|NCT04291599|Analgesics|analgesics|mesh-ancestor
153796224|NCT04291599|Sensory System Agents|sensory system agents|mesh-ancestor
153796225|NCT04291599|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153796226|NCT04291599|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153796227|NCT04291599|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153796228|NCT04291599|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153471087|NCT00618540|Alkylating Agents|alkylating agents|mesh-ancestor
153796229|NCT04291599|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153796230|NCT04291599|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153796231|NCT04291599|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153352865|NCT02208037|Bortezomib|bortezomib|mesh-list
153796232|NCT04291599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153796233|NCT04207086|Pembrolizumab|pembrolizumab|mesh-list
153796234|NCT04207086|Lenvatinib|lenvatinib|mesh-list
153796235|NCT04207086|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153796236|NCT04207086|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153796237|NCT04207086|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153796238|NCT04207086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153796239|NCT04207086|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153796240|NCT04207086|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153796241|NCT04191135|Carboplatin|carboplatin|mesh-list
153796242|NCT04191135|Gemcitabine|gemcitabine|mesh-list
153796243|NCT04191135|Pembrolizumab|pembrolizumab|mesh-list
153796244|NCT04191135|Olaparib|olaparib|mesh-list
153796245|NCT04191135|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153796246|NCT04191135|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153796247|NCT04191135|Antimetabolites|antimetabolites|mesh-ancestor
153796248|NCT04191135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153796249|NCT04191135|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153796250|NCT04191135|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153796251|NCT04191135|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
153471179|NCT01107457|Ixekizumab|ixekizumab|mesh-list
153796253|NCT04104139|Trifluridine|trifluridine|mesh-list
153796264|NCT04067726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153796265|NCT04067726|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153415719|NCT05441761|Antimetabolites|antimetabolites|mesh-ancestor
153415720|NCT05441761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153415721|NCT05441761|Analgesics|analgesics|mesh-ancestor
153415727|NCT05587621|Ezetimibe|ezetimibe|mesh-list
153796266|NCT04067726|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153796336|NCT03805789|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153796337|NCT03805789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153796338|NCT03805789|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
153796339|NCT03805789|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
153796340|NCT03781128|Lysergic Acid Diethylamide|lysergic acid diethylamide|mesh-list
153796341|NCT03781128|Hallucinogens|hallucinogens|mesh-ancestor
153796342|NCT03781128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153796343|NCT03781128|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153796344|NCT03781128|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153796345|NCT03781128|Serotonin Agents|serotonin agents|mesh-ancestor
153796346|NCT03781128|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153796394|NCT03670056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153796397|NCT03622788|Antilymphocyte Serum|antilymphocyte serum|mesh-list
153796398|NCT03622788|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153796399|NCT03622788|Immunologic Factors|immunologic factors|mesh-ancestor
153796400|NCT03622788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153796461|NCT03522168|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
153352964|NCT00555464|Prednisone|prednisone|mesh-list
153796462|NCT03522168|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
153796463|NCT03522168|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
153796464|NCT03522168|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
153796465|NCT03514017|Pembrolizumab|pembrolizumab|mesh-list
153796466|NCT03514017|Ibrutinib|ibrutinib|mesh-list
153796467|NCT03514017|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153796468|NCT03514017|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153796469|NCT03514017|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153796470|NCT03514017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153796471|NCT03514017|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153796472|NCT03514017|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153796473|NCT03514017|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153796474|NCT03435003|Dexamethasone|dexamethasone|mesh-list
153796475|NCT03435003|Fentanyl|fentanyl|mesh-list
153796476|NCT03435003|Scopolamine|scopolamine|mesh-list
153796477|NCT03435003|Dexmedetomidine|dexmedetomidine|mesh-list
153796478|NCT03435003|Ondansetron|ondansetron|mesh-list
153796479|NCT03435003|Aprepitant|aprepitant|mesh-list
153796480|NCT03435003|Metoclopramide|metoclopramide|mesh-list
153796481|NCT03435003|Prochlorperazine|prochlorperazine|mesh-list
153796482|NCT03435003|Propofol|propofol|mesh-list
153874983|NCT04541732|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153796514|NCT03435003|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153796515|NCT03435003|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
153796516|NCT03435003|Antipruritics|antipruritics|mesh-ancestor
153796517|NCT03435003|Dermatologic Agents|dermatologic agents|mesh-ancestor
153796518|NCT03435003|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
153343047|NCT00072566|Growth Substances|growth substances|mesh-ancestor
153796519|NCT03435003|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153796520|NCT03435003|Serotonin Agents|serotonin agents|mesh-ancestor
153796521|NCT03435003|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
153796522|NCT03435003|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
153796523|NCT03435003|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
153796524|NCT03435003|Dopamine Agents|dopamine agents|mesh-ancestor
153796525|NCT03435003|Mydriatics|mydriatics|mesh-ancestor
153796526|NCT03435003|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
153796577|NCT03214510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153796578|NCT03214510|Sensory System Agents|sensory system agents|mesh-ancestor
153796579|NCT03214510|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153796580|NCT03214510|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153796581|NCT03214510|Narcotics|narcotics|mesh-ancestor
153796582|NCT03214510|Analgesics|analgesics|mesh-ancestor
153796583|NCT03214510|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153796584|NCT03214510|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153796585|NCT03214510|Anesthetics, General|anesthetics, general|mesh-ancestor
153796586|NCT03179995|Octreotide|octreotide|mesh-list
153796587|NCT03179995|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153796588|NCT03179995|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153796589|NCT03179995|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153796590|NCT03148418|Bevacizumab|bevacizumab|mesh-list
153796591|NCT03148418|Atezolizumab|atezolizumab|mesh-list
153796593|NCT03148418|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153796636|NCT02951052|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153796637|NCT02951052|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153796638|NCT02951052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153796639|NCT02951052|Antiviral Agents|antiviral agents|mesh-ancestor
153796640|NCT02951052|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153796641|NCT02951052|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153796642|NCT02951052|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153796643|NCT02951052|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
153796644|NCT02951052|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
153796645|NCT02848040|Bile Acids and Salts|bile acids and salts|mesh-list
153796646|NCT02848040|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153796697|NCT02606305|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153796698|NCT02606305|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153796699|NCT02606305|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153796700|NCT02606305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153796701|NCT02606305|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153471219|NCT05766436|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153796702|NCT02606305|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153796703|NCT02606305|Tubulin Modulators|tubulin modulators|mesh-ancestor
153796704|NCT02606305|Antimitotic Agents|antimitotic agents|mesh-ancestor
153796705|NCT02606305|Mitosis Modulators|mitosis modulators|mesh-ancestor
153796706|NCT02606305|Immunoconjugates|immunoconjugates|mesh-ancestor
153796707|NCT02606305|Immunologic Factors|immunologic factors|mesh-ancestor
153796708|NCT02567175|Domperidone|domperidone|mesh-list
153796709|NCT02567175|Antiemetics|antiemetics|mesh-ancestor
153415738|NCT05587621|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153796760|NCT02542293|Mitosis Modulators|mitosis modulators|mesh-ancestor
153796761|NCT02542293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153796762|NCT02542293|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153796763|NCT02542293|Antimetabolites|antimetabolites|mesh-ancestor
153796764|NCT02542293|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153796765|NCT02542293|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153796766|NCT02542293|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153796767|NCT02542293|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153796768|NCT02530463|Nivolumab|nivolumab|mesh-list
153796769|NCT02530463|Ipilimumab|ipilimumab|mesh-list
153796770|NCT02530463|Azacitidine|azacitidine|mesh-list
153796771|NCT02530463|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153796772|NCT02530463|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153471234|NCT05766176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153796773|NCT02530463|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153471235|NCT05766085|Dexamethasone|dexamethasone|mesh-list
153353025|NCT00435812|Vaccines|vaccines|mesh-list
153796774|NCT02530463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153796775|NCT02530463|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153796776|NCT02530463|Antimetabolites|antimetabolites|mesh-ancestor
153796777|NCT02530463|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153796778|NCT02522715|Prednisone|prednisone|mesh-list
153796779|NCT02522715|Cortisone|cortisone|mesh-list
153796780|NCT02522715|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153796813|NCT02206984|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
153796814|NCT02206984|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
153796815|NCT02206984|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153796816|NCT02206984|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
153796817|NCT02206984|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
153796818|NCT02206984|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153796819|NCT02206984|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153796820|NCT02206984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153796821|NCT01976182|Cyclophosphamide|cyclophosphamide|mesh-list
153796822|NCT01976182|Methotrexate|methotrexate|mesh-list
153796823|NCT01976182|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153796824|NCT01976182|Immunologic Factors|immunologic factors|mesh-ancestor
153796825|NCT01976182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153796826|NCT01976182|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153796827|NCT01976182|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153796828|NCT01976182|Alkylating Agents|alkylating agents|mesh-ancestor
153796829|NCT01976182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153796830|NCT01976182|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153796831|NCT01976182|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153796832|NCT01976182|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
153875009|NCT04544306|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
153875011|NCT04544228|Bupivacaine|bupivacaine|mesh-list
153875012|NCT04544228|Neostigmine|neostigmine|mesh-list
153875013|NCT04544228|Anesthetics, Local|anesthetics, local|mesh-ancestor
153875014|NCT04544228|Anesthetics|anesthetics|mesh-ancestor
153875015|NCT04544228|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153875016|NCT04544228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153875017|NCT04544228|Sensory System Agents|sensory system agents|mesh-ancestor
153875018|NCT04544228|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153875019|NCT04544228|Analgesics|analgesics|mesh-ancestor
153875020|NCT04544228|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
153875021|NCT04544228|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153875022|NCT04544228|Anesthetics, General|anesthetics, general|mesh-ancestor
153471290|NCT05765110|Sympathomimetics|sympathomimetics|mesh-ancestor
153353064|NCT01469767|Glucocorticoids|glucocorticoids|mesh-ancestor
153353065|NCT01469767|Hormones|hormones|mesh-ancestor
153353069|NCT03246620|Diazepam|diazepam|mesh-list
153875024|NCT04544228|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
153796833|NCT01976182|Abortifacient Agents|abortifacient agents|mesh-ancestor
153796834|NCT01976182|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153796835|NCT01976182|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153796836|NCT01976182|Antimetabolites|antimetabolites|mesh-ancestor
153796837|NCT01976182|Dermatologic Agents|dermatologic agents|mesh-ancestor
153796838|NCT01976182|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153796839|NCT01976182|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153796841|NCT01940094|Prednisone|prednisone|mesh-list
153796855|NCT01862991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153796856|NCT01862991|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
153796857|NCT01862991|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153796858|NCT01862991|Oxytocics|oxytocics|mesh-ancestor
153796859|NCT01862991|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153796860|NCT01862991|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
153796861|NCT01862991|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153796862|NCT01862991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153796863|NCT01862991|Protective Agents|protective agents|mesh-ancestor
153796864|NCT01862991|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
153796865|NCT01862991|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
153796866|NCT01862991|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
153796867|NCT01862991|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
153796868|NCT01862991|Contraceptive Agents|contraceptive agents|mesh-ancestor
153796869|NCT01862991|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
153796870|NCT01862991|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
153796871|NCT01862991|Hormone Antagonists|hormone antagonists|mesh-ancestor
153796872|NCT01862991|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153796873|NCT01862991|Luteolytic Agents|luteolytic agents|mesh-ancestor
153796874|NCT01862991|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
153796905|NCT01701674|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153796906|NCT01701674|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153796907|NCT01701674|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153796908|NCT01701674|Antiviral Agents|antiviral agents|mesh-ancestor
153796909|NCT01701674|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153353115|NCT01470859|Antioxidants|antioxidants|mesh-ancestor
153796911|NCT01672255|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
153796912|NCT01672255|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153796913|NCT01672255|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153796915|NCT01672255|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153471367|NCT05715931|Leucovorin|leucovorin|mesh-list
153796966|NCT00876772|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153796968|NCT00876772|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153796969|NCT00876772|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153796970|NCT00876772|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153796971|NCT00876772|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
153796972|NCT00876772|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153796973|NCT00876772|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153796974|NCT00876772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153796975|NCT00876772|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153796976|NCT00876772|Serotonin Agents|serotonin agents|mesh-ancestor
153797030|NCT00263198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153797031|NCT00263198|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
153797032|NCT00263198|Hormone Antagonists|hormone antagonists|mesh-ancestor
153797033|NCT00263198|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153797034|NCT00263198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153797035|NCT00263198|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153343653|NCT00003262|Tubulin Modulators|tubulin modulators|mesh-ancestor
153797037|NCT00294099|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153797038|NCT00294099|Immunologic Factors|immunologic factors|mesh-ancestor
153797039|NCT00294099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153797040|NCT00294099|Antacids|antacids|mesh-ancestor
153797041|NCT00294099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153797042|NCT00294099|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153797043|NCT00299676|Galantamine|galantamine|mesh-list
153797044|NCT00299676|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
153797045|NCT00299676|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153797046|NCT00299676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153797047|NCT00299676|Cholinergic Agents|cholinergic agents|mesh-ancestor
153471377|NCT05715931|Antidotes|antidotes|mesh-ancestor
153797048|NCT00299676|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153797049|NCT00299676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153797050|NCT00299676|Parasympathomimetics|parasympathomimetics|mesh-ancestor
153797051|NCT00299676|Autonomic Agents|autonomic agents|mesh-ancestor
153797052|NCT00299676|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153797053|NCT00299676|Nootropic Agents|nootropic agents|mesh-ancestor
153797054|NCT00263276|Metformin|metformin|mesh-list
153797055|NCT00263276|Dapagliflozin|dapagliflozin|mesh-list
153797056|NCT00263276|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153797057|NCT00263276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153797058|NCT00263276|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
153797059|NCT00263276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153797060|NCT00299754|Misoprostol|misoprostol|mesh-list
153797069|NCT00263315|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
153797070|NCT00263315|Amebicides|amebicides|mesh-ancestor
153797071|NCT00263315|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153797072|NCT00263315|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153797073|NCT00263315|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153797074|NCT00263315|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153797075|NCT00263315|Antifungal Agents|antifungal agents|mesh-ancestor
153797076|NCT00417807|Imatinib Mesylate|imatinib mesylate|mesh-list
153797077|NCT00417807|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153797078|NCT00417807|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153797079|NCT00417807|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153797080|NCT00417807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153797082|NCT00263354|Oxaliplatin|oxaliplatin|mesh-list
153797131|NCT00294255|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153415773|NCT00367861|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153415774|NCT00367861|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153415775|NCT00367861|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153415776|NCT00367861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153415777|NCT00367861|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153353260|NCT05021094|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
153415778|NCT02666846|Ibuprofen|ibuprofen|mesh-list
153415779|NCT02666846|Diclofenac|diclofenac|mesh-list
153471434|NCT05133258|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153415781|NCT02666846|Methyl salicylate|methyl salicylate|mesh-list
153415782|NCT02666846|Menthol|menthol|mesh-list
153415783|NCT02666846|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153797132|NCT00294255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153797133|NCT00294255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153797135|NCT00294255|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153797136|NCT00294255|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153797137|NCT00294255|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153797138|NCT00294255|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
153797139|NCT00294255|Dopamine Agents|dopamine agents|mesh-ancestor
153797140|NCT00263705|Capecitabine|capecitabine|mesh-list
153797141|NCT00263705|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153797142|NCT00263705|Antimetabolites|antimetabolites|mesh-ancestor
153797143|NCT00263705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153797144|NCT00263705|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153797145|NCT00263744|Aluminum Hydroxide|aluminum hydroxide|mesh-list
153797146|NCT00263744|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153797147|NCT00263744|Immunologic Factors|immunologic factors|mesh-ancestor
153797148|NCT00263744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153797186|NCT00300339|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
153797187|NCT00300339|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
153797189|NCT00300339|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153797190|NCT00300339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153797191|NCT00300339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153797192|NCT00264173|Valproic Acid|valproic acid|mesh-list
153797193|NCT00264173|Anticonvulsants|anticonvulsants|mesh-ancestor
153797194|NCT00264173|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153797195|NCT00264173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153797196|NCT00264173|GABA Agents|gaba agents|mesh-ancestor
153797197|NCT00264173|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153797198|NCT00264173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153797199|NCT00264173|Antimanic Agents|antimanic agents|mesh-ancestor
153797200|NCT00264173|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153797201|NCT00264173|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153797202|NCT00264173|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153797203|NCT00264212|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
153797204|NCT00264212|Irbesartan|irbesartan|mesh-list
153797205|NCT00264212|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153797206|NCT00264212|Diuretics|diuretics|mesh-ancestor
153797207|NCT00264212|Natriuretic Agents|natriuretic agents|mesh-ancestor
153797208|NCT00264212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153797209|NCT00264212|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
153797210|NCT00264212|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153797211|NCT00264212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153797212|NCT00264212|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
153797213|NCT00264212|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
153797214|NCT00300378|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
153797222|NCT00300378|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153797227|NCT00294567|Calcium Channel Blockers|calcium channel blockers|mesh-list
153797228|NCT00294567|Calcium|calcium|mesh-list
153797229|NCT00294567|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153797230|NCT00294567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153797231|NCT00294567|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153797232|NCT00294567|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153353425|NCT00446264|Antifungal Agents|antifungal agents|mesh-ancestor
153797233|NCT00294567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153797234|NCT00294567|Vasodilator Agents|vasodilator agents|mesh-ancestor
153471501|NCT04908176|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153797235|NCT00294606|Phenylephrine|phenylephrine|mesh-list
153797236|NCT00294606|Oxymetazoline|oxymetazoline|mesh-list
153797237|NCT00294606|Norepinephrine|norepinephrine|mesh-list
153875039|NCT01646736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153875040|NCT01646736|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153875042|NCT04542005|Albuterol|albuterol|mesh-list
153875052|NCT04542005|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
153797239|NCT00294606|Mydriatics|mydriatics|mesh-ancestor
153797240|NCT00294606|Autonomic Agents|autonomic agents|mesh-ancestor
153797241|NCT00294606|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153797242|NCT00294606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153797243|NCT00294606|Sympathomimetics|sympathomimetics|mesh-ancestor
153797244|NCT00294606|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
153797245|NCT00294606|Nasal Decongestants|nasal decongestants|mesh-ancestor
153797246|NCT00294606|Respiratory System Agents|respiratory system agents|mesh-ancestor
153797247|NCT00294606|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
153797248|NCT00294606|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153797249|NCT00294606|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153797250|NCT00294606|Adrenergic Agents|adrenergic agents|mesh-ancestor
153797275|NCT00264407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153797276|NCT00300573|Dexelvucitabine|dexelvucitabine|mesh-list
153797277|NCT00300573|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153797278|NCT00300573|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153797279|NCT00300573|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153797280|NCT00300573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153797281|NCT00300573|Antiviral Agents|antiviral agents|mesh-ancestor
153797282|NCT00300573|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153797283|NCT00300573|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153797284|NCT00300573|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153797285|NCT00264446|Eniluracil|eniluracil|mesh-list
153797286|NCT00264446|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153797287|NCT00264446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153797288|NCT00264485|Fentanyl|fentanyl|mesh-list
153797289|NCT00264485|Morphine|morphine|mesh-list
153797290|NCT00264485|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153797291|NCT00264485|Narcotics|narcotics|mesh-ancestor
153797292|NCT00264485|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153797293|NCT00264485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153797294|NCT00264485|Analgesics|analgesics|mesh-ancestor
153797295|NCT00264485|Sensory System Agents|sensory system agents|mesh-ancestor
153797299|NCT00264485|Anesthetics, General|anesthetics, general|mesh-ancestor
153343873|NCT00003730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153797328|NCT00300729|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153797330|NCT00300729|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
153797331|NCT00300729|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153797332|NCT00300729|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153797333|NCT00300729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153797334|NCT00264719|Metoclopramide|metoclopramide|mesh-list
153797335|NCT00264719|Antiemetics|antiemetics|mesh-ancestor
153797336|NCT00264719|Autonomic Agents|autonomic agents|mesh-ancestor
153797337|NCT00264719|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153875053|NCT04542005|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153797338|NCT00264719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153797339|NCT00264719|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153797340|NCT00264719|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
153797342|NCT00264719|Dopamine Agents|dopamine agents|mesh-ancestor
153797343|NCT00264719|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153797344|NCT00264719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153797345|NCT00264914|Satavaptan|satavaptan|mesh-list
153797346|NCT00264914|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
153797347|NCT00264914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153353597|NCT03326180|Anesthetics|anesthetics|mesh-ancestor
153797348|NCT00264914|Natriuretic Agents|natriuretic agents|mesh-ancestor
153797349|NCT00264914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153797350|NCT00264953|Prednisone|prednisone|mesh-list
153797351|NCT00264953|Etoposide|etoposide|mesh-list
153797352|NCT00264953|Vincristine|vincristine|mesh-list
153797353|NCT00264953|Doxorubicin|doxorubicin|mesh-list
153797354|NCT00264953|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
153797355|NCT00264953|Bleomycin|bleomycin|mesh-list
153797356|NCT00264953|Vinblastine|vinblastine|mesh-list
153797357|NCT00264953|Procarbazine|procarbazine|mesh-list
153797358|NCT00264953|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153797359|NCT00264953|Glucocorticoids|glucocorticoids|mesh-ancestor
153797360|NCT00264953|Hormones|hormones|mesh-ancestor
153797368|NCT00264953|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153797369|NCT00264953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153797370|NCT00264953|Tubulin Modulators|tubulin modulators|mesh-ancestor
153797371|NCT00264953|Antimitotic Agents|antimitotic agents|mesh-ancestor
153797372|NCT00264953|Mitosis Modulators|mitosis modulators|mesh-ancestor
153797373|NCT00264953|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153797374|NCT00300846|Aripiprazole|aripiprazole|mesh-list
153797375|NCT00300846|Antidepressive Agents|antidepressive agents|mesh-ancestor
153797376|NCT00300846|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153797377|NCT00300846|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153797378|NCT00300846|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153797379|NCT00300846|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153797380|NCT00300846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153797381|NCT00300846|Dopamine Agonists|dopamine agonists|mesh-ancestor
153797382|NCT00300846|Dopamine Agents|dopamine agents|mesh-ancestor
153797383|NCT00300846|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153797384|NCT00300846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153797385|NCT00300846|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
153415801|NCT02643979|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153415802|NCT02643979|Anesthetics, General|anesthetics, general|mesh-ancestor
153415803|NCT02643979|Anesthetics|anesthetics|mesh-ancestor
153415804|NCT02643979|Analgesics|analgesics|mesh-ancestor
153415805|NCT02643979|Sensory System Agents|sensory system agents|mesh-ancestor
153415806|NCT02643979|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153415807|NCT02643979|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
153415808|NCT02643979|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
153415809|NCT02643979|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
153415810|NCT02643979|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153415816|NCT05587231|Hormones|hormones|mesh-ancestor
153875073|NCT01646853|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153797386|NCT00300846|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
153797387|NCT00300846|Serotonin Agents|serotonin agents|mesh-ancestor
153797388|NCT00300846|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
153797389|NCT00300846|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153797390|NCT00300846|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
153353701|NCT02124512|Rifaximin|rifaximin|mesh-list
153797391|NCT00300846|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
153797392|NCT00294996|Doxorubicin|doxorubicin|mesh-list
153797393|NCT00294996|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153797394|NCT00294996|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153797395|NCT00294996|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153797396|NCT00294996|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153797397|NCT00294996|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153797412|NCT00265031|Alkylating Agents|alkylating agents|mesh-ancestor
153797413|NCT00265031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153797414|NCT00265031|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153797415|NCT00265031|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153797416|NCT00265031|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153797417|NCT00265031|Glucocorticoids|glucocorticoids|mesh-ancestor
153797418|NCT00265031|Hormones|hormones|mesh-ancestor
153797419|NCT00265031|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153797420|NCT00265031|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153797421|NCT00265031|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153797422|NCT00265031|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153797473|NCT00418275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153797474|NCT00265304|Ketoprofen|ketoprofen|mesh-list
153797475|NCT00265304|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153344022|NCT00004024|Sargramostim|sargramostim|mesh-list
153797476|NCT00265304|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153797477|NCT00265304|Analgesics|analgesics|mesh-ancestor
153471866|NCT01715285|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153797478|NCT00265304|Sensory System Agents|sensory system agents|mesh-ancestor
153797479|NCT00265304|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153797480|NCT00265304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153797481|NCT00265304|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153797482|NCT00265304|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153797483|NCT00265304|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153797484|NCT00265304|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153783419|NCT00261612|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153797485|NCT00265304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153797486|NCT00295191|Dialysis Solutions|dialysis solutions|mesh-list
153797530|NCT00265772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153797531|NCT00265772|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153797532|NCT00265772|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153797534|NCT00265811|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153797535|NCT00265811|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153797537|NCT00295308|Analgesics|analgesics|mesh-ancestor
153797538|NCT00295308|Sensory System Agents|sensory system agents|mesh-ancestor
153797539|NCT00295308|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153797540|NCT00295308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153797541|NCT00295308|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153797542|NCT00295308|Sympatholytics|sympatholytics|mesh-ancestor
153797543|NCT00295308|Autonomic Agents|autonomic agents|mesh-ancestor
153797544|NCT00295308|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
153797545|NCT00295308|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153797546|NCT00295308|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153797586|NCT00295386|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153797587|NCT00295386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153797588|NCT00301236|Dexmethylphenidate Hydrochloride|dexmethylphenidate hydrochloride|mesh-list
153797589|NCT00301236|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
153797590|NCT00301236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153797591|NCT00301236|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
153471964|NCT00079417|Iodine|iodine|mesh-list
153797592|NCT00301236|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153797593|NCT00301236|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153797594|NCT00301236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153797595|NCT00301236|Dopamine Agents|dopamine agents|mesh-ancestor
153797596|NCT00301236|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153797645|NCT00301392|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153797646|NCT00301392|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153797647|NCT00415844|Levodopa|levodopa|mesh-list
153471969|NCT00079417|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153797650|NCT00415844|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
153797651|NCT00415844|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
153797652|NCT00415844|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
153797653|NCT00415844|Dopamine Agents|dopamine agents|mesh-ancestor
153797654|NCT00415844|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153797655|NCT00415844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153797656|NCT00415844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153353778|NCT02514174|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153353779|NCT02514174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153797657|NCT00415844|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
153797658|NCT00415844|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153797659|NCT00415844|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
153797660|NCT00415844|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153797661|NCT00415844|Immunologic Factors|immunologic factors|mesh-ancestor
153797662|NCT00415844|Dopamine Agonists|dopamine agonists|mesh-ancestor
153797705|NCT00295542|Sympatholytics|sympatholytics|mesh-ancestor
153797706|NCT00295542|Autonomic Agents|autonomic agents|mesh-ancestor
153797707|NCT00295542|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153797708|NCT00295542|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
153797709|NCT00295542|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
153415830|NCT02645617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153415831|NCT02645617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153415832|NCT02694601|Caffeine|caffeine|mesh-list
153415833|NCT02694601|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
153797710|NCT00295542|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
153797711|NCT00295542|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153797712|NCT00295542|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
153797713|NCT00295542|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
153797714|NCT00266318|Interferons|interferons|mesh-list
153797715|NCT00266318|Ribavirin|ribavirin|mesh-list
153797716|NCT00266318|Interferon alfacon-1|interferon alfacon-1|mesh-list
153797766|NCT00301587|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153797767|NCT00301587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153797768|NCT00301587|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
153797769|NCT00301587|Contraceptive Agents|contraceptive agents|mesh-ancestor
153344320|NCT00004852|Antimetabolites|antimetabolites|mesh-ancestor
153797770|NCT00301587|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153797771|NCT00301587|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
153797773|NCT00301587|Vitamin B Complex|vitamin b complex|mesh-ancestor
153797774|NCT00301587|Vitamins|vitamins|mesh-ancestor
153797775|NCT00301587|Micronutrients|micronutrients|mesh-ancestor
153797776|NCT00301587|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
153797777|NCT00301587|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
153797778|NCT00301587|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
153797779|NCT00301587|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153797780|NCT00301587|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153797781|NCT00301587|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153797782|NCT00301587|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153797783|NCT00301587|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153797784|NCT00301587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153797785|NCT00301587|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153797786|NCT00301587|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
153797787|NCT00266591|Topiramate|topiramate|mesh-list
153797815|NCT00266669|Vasodilator Agents|vasodilator agents|mesh-ancestor
153797816|NCT00266747|Amibegron|amibegron|mesh-list
153797817|NCT00266747|Amibegron hydrochloride|amibegron hydrochloride|mesh-list
153797818|NCT00266747|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
153797819|NCT00266747|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153797820|NCT00266747|Adrenergic Agents|adrenergic agents|mesh-ancestor
153797821|NCT00266747|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153797822|NCT00266747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153797823|NCT00266747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153797824|NCT00266747|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
153797825|NCT00266786|Ketorolac|ketorolac|mesh-list
153797826|NCT00266786|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
153797827|NCT00266786|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153797828|NCT00266786|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153797829|NCT00266786|Analgesics|analgesics|mesh-ancestor
153797830|NCT00266786|Sensory System Agents|sensory system agents|mesh-ancestor
153797838|NCT00295815|Lomustine|lomustine|mesh-list
153797870|NCT00296010|Cyclophosphamide|cyclophosphamide|mesh-list
153797871|NCT00296010|Doxorubicin|doxorubicin|mesh-list
153797872|NCT00296010|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
153797873|NCT00296010|Methotrexate|methotrexate|mesh-list
153797874|NCT00296010|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153797875|NCT00296010|Immunologic Factors|immunologic factors|mesh-ancestor
153797876|NCT00296010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153875100|NCT01681134|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
153875101|NCT01681134|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153877243|NCT06010810|Coagulants|coagulants|mesh-ancestor
153877244|NCT06009653|Tirzepatide|tirzepatide|mesh-list
153875102|NCT01681134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153875103|NCT04543916|Irinotecan|irinotecan|mesh-list
153797877|NCT00296010|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153797878|NCT00296010|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153797879|NCT00296010|Alkylating Agents|alkylating agents|mesh-ancestor
153797881|NCT00296010|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153797933|NCT00301782|Tubulin Modulators|tubulin modulators|mesh-ancestor
153797934|NCT00301782|Antimitotic Agents|antimitotic agents|mesh-ancestor
153797935|NCT00301782|Mitosis Modulators|mitosis modulators|mesh-ancestor
153797936|NCT00301782|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153797937|NCT00267332|Modafinil|modafinil|mesh-list
153797938|NCT00267332|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
153797939|NCT00267332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153797940|NCT00267332|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
153797941|NCT00267332|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
153797942|NCT00267332|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
153797943|NCT00267332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153797944|NCT04718649|Celecoxib|celecoxib|mesh-list
153797994|NCT00296127|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153797995|NCT00296127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153797996|NCT00296127|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153797997|NCT00296127|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153797998|NCT00296127|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
153353853|NCT01510327|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
153797999|NCT00296127|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153798000|NCT00296127|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153472147|NCT04374006|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
153798001|NCT00296127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153798003|NCT00296205|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153798004|NCT00296205|Immunologic Factors|immunologic factors|mesh-ancestor
153798056|NCT00416039|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153798057|NCT00416039|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153798058|NCT00416039|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153798059|NCT00416039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153798060|NCT00416039|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153798061|NCT00416039|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153798062|NCT00416039|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153798063|NCT00416039|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153798064|NCT00416039|Anesthetics, General|anesthetics, general|mesh-ancestor
153798065|NCT00416039|Anesthetics|anesthetics|mesh-ancestor
153798066|NCT00416039|GABA Modulators|gaba modulators|mesh-ancestor
153798067|NCT00416039|GABA Agents|gaba agents|mesh-ancestor
153798068|NCT00416039|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153798069|NCT00416039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153798070|NCT00296478|Progesterone|progesterone|mesh-list
153798071|NCT00296478|Progestins|progestins|mesh-ancestor
153798072|NCT00296478|Hormones|hormones|mesh-ancestor
153798112|NCT00302289|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
153798113|NCT00302289|Purinergic Agents|purinergic agents|mesh-ancestor
153798114|NCT00302289|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153798115|NCT00296634|Aluminum Hydroxide|aluminum hydroxide|mesh-list
153798116|NCT00296634|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153472183|NCT04370262|Famotidine|famotidine|mesh-list
153472184|NCT04370262|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
153798117|NCT00296634|Immunologic Factors|immunologic factors|mesh-ancestor
153798118|NCT00296634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153798119|NCT00296634|Antacids|antacids|mesh-ancestor
153353898|NCT00115700|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153798120|NCT00296634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153798121|NCT00296634|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153798122|NCT00268619|Ramipril|ramipril|mesh-list
153798123|NCT00268619|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
153798124|NCT00268619|Protease Inhibitors|protease inhibitors|mesh-ancestor
153798125|NCT00268619|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153798126|NCT00268619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153798127|NCT00268619|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153798128|NCT00296712|Dexetimide|dexetimide|mesh-list
153798129|NCT00296712|Citalopram|citalopram|mesh-list
153798130|NCT00296712|Bupropion|bupropion|mesh-list
153798131|NCT00296712|Escitalopram|escitalopram|mesh-list
153798132|NCT00296712|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
153798133|NCT00296712|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153798134|NCT00296712|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153344698|NCT05776186|Sensory System Agents|sensory system agents|mesh-ancestor
153798135|NCT00296712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153344768|NCT00004126|Paclitaxel|paclitaxel|mesh-list
153798136|NCT00296712|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153798137|NCT00296712|Serotonin Agents|serotonin agents|mesh-ancestor
153798138|NCT00296712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153798139|NCT00296712|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
153798140|NCT00296712|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
153798141|NCT00296712|Parasympatholytics|parasympatholytics|mesh-ancestor
153798142|NCT00296712|Autonomic Agents|autonomic agents|mesh-ancestor
153798146|NCT00296712|Cholinergic Agents|cholinergic agents|mesh-ancestor
153798150|NCT00296712|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
153798151|NCT00296712|Dopamine Agents|dopamine agents|mesh-ancestor
153798152|NCT00296712|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
153798153|NCT00296712|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153798154|NCT00296712|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153798155|NCT00268697|Ezetimibe|ezetimibe|mesh-list
153798156|NCT00268697|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153798157|NCT00268697|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153798158|NCT00268697|Antimetabolites|antimetabolites|mesh-ancestor
153798159|NCT00268697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153798160|NCT00268697|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153798213|NCT00268814|Antitussive Agents|antitussive agents|mesh-ancestor
153798214|NCT00268814|Respiratory System Agents|respiratory system agents|mesh-ancestor
153798215|NCT00302484|Zoledronic Acid|zoledronic acid|mesh-list
153798216|NCT00302484|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153415850|NCT02690948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153415851|NCT02698735|Gentamicins|gentamicins|mesh-list
153415852|NCT02698735|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153415853|NCT02698735|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153353958|NCT00561002|Vaccines|vaccines|mesh-list
153415854|NCT02698735|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
153415855|NCT02698735|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153415856|NCT02698735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153415857|NCT02691416|Propofol|propofol|mesh-list
153415858|NCT02691416|Sevoflurane|sevoflurane|mesh-list
153415859|NCT02691416|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153415860|NCT02691416|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153798217|NCT00302484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153798218|NCT00296868|Ascorbic Acid|ascorbic acid|mesh-list
153798219|NCT00296868|Vitamins|vitamins|mesh-ancestor
153798220|NCT00296868|Micronutrients|micronutrients|mesh-ancestor
153798221|NCT00296868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153798222|NCT00296868|Antioxidants|antioxidants|mesh-ancestor
153798223|NCT00296868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153798224|NCT00296868|Protective Agents|protective agents|mesh-ancestor
153798225|NCT00268970|Paclitaxel|paclitaxel|mesh-list
153798226|NCT00268970|Satraplatin|satraplatin|mesh-list
153798227|NCT00268970|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153472414|NCT04356144|Hemostatics|hemostatics|mesh-ancestor
153472415|NCT04356144|Coagulants|coagulants|mesh-ancestor
153472416|NCT04355598|Lidocaine|lidocaine|mesh-list
153472417|NCT04355598|Nitroglycerin|nitroglycerin|mesh-list
153798228|NCT00268970|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153798233|NCT00296946|Bromides|bromides|mesh-list
153798271|NCT00269126|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153798272|NCT00269126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153798273|NCT00269126|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153798274|NCT00269126|Respiratory System Agents|respiratory system agents|mesh-ancestor
153798275|NCT00269126|Dermatologic Agents|dermatologic agents|mesh-ancestor
153798276|NCT00269126|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
153798339|NCT00418353|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153798340|NCT00418353|Glucocorticoids|glucocorticoids|mesh-ancestor
153798341|NCT00418353|Hormones|hormones|mesh-ancestor
153798342|NCT00418353|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153798343|NCT00418353|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153798344|NCT00418353|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153798345|NCT00418353|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153798346|NCT00418353|Respiratory System Agents|respiratory system agents|mesh-ancestor
153798347|NCT00418353|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153798348|NCT00418392|Minocycline|minocycline|mesh-list
153798349|NCT00418392|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153798350|NCT00418392|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153798351|NCT00269555|Genistein|genistein|mesh-list
153798352|NCT00269555|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
153798353|NCT00269555|Protective Agents|protective agents|mesh-ancestor
153798354|NCT00269555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153344926|NCT04895566|Immunologic Factors|immunologic factors|mesh-ancestor
153344929|NCT04779320|Vedolizumab|vedolizumab|mesh-list
153798355|NCT00269555|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153798356|NCT00269555|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153798357|NCT00269555|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153472502|NCT04353336|Antinematodal Agents|antinematodal agents|mesh-ancestor
153798358|NCT00269555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153798388|NCT00269672|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
153798389|NCT00269672|Immunologic Factors|immunologic factors|mesh-ancestor
153798390|NCT00269672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153798391|NCT00302835|Analgesics|analgesics|mesh-list
153798392|NCT00302835|Sensory System Agents|sensory system agents|mesh-ancestor
153798393|NCT00302835|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153798394|NCT00302835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153798395|NCT00269750|Oxybutynin|oxybutynin|mesh-list
153798396|NCT00269750|Parasympatholytics|parasympatholytics|mesh-ancestor
153798397|NCT00269750|Autonomic Agents|autonomic agents|mesh-ancestor
153798398|NCT00269750|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153875124|NCT02214992|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153875125|NCT04528095|Clozapine|clozapine|mesh-list
153875126|NCT04528095|Amisulpride|amisulpride|mesh-list
153875127|NCT04528095|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153877277|NCT05966376|Hemostatics|hemostatics|mesh-list
153875128|NCT04528095|Serotonin Agents|serotonin agents|mesh-ancestor
153798399|NCT00269750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153798400|NCT00269750|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
153798401|NCT00269750|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
153472629|NCT04344756|Anticoagulants|anticoagulants|mesh-ancestor
153472630|NCT04344756|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153798402|NCT00269750|Cholinergic Agents|cholinergic agents|mesh-ancestor
153798403|NCT00269750|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153798404|NCT00269750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153798405|NCT00269750|Urological Agents|urological agents|mesh-ancestor
153798406|NCT00269789|Methylphenidate|methylphenidate|mesh-list
153798441|NCT00269867|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
153798443|NCT00269867|Dermatologic Agents|dermatologic agents|mesh-ancestor
153798444|NCT00269867|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153798445|NCT00269867|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153798446|NCT00269906|Abciximab|abciximab|mesh-list
153798447|NCT00269906|Anticoagulants|anticoagulants|mesh-ancestor
153798448|NCT00269906|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153798449|NCT00269945|Epoetin Alfa|epoetin alfa|mesh-list
153798450|NCT00269945|Hematinics|hematinics|mesh-ancestor
153798451|NCT00269984|Epoetin Alfa|epoetin alfa|mesh-list
153798452|NCT00269984|Hematinics|hematinics|mesh-ancestor
153798453|NCT00297336|Topiramate|topiramate|mesh-list
153360185|NCT00802100|Olanzapine|olanzapine|mesh-list
153798454|NCT00297336|Anticonvulsants|anticonvulsants|mesh-ancestor
153798455|NCT00297336|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153798456|NCT00297336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153798457|NCT00270023|Epoetin Alfa|epoetin alfa|mesh-list
153798458|NCT00270023|Hematinics|hematinics|mesh-ancestor
153798459|NCT00297375|Acetaminophen|acetaminophen|mesh-list
153798460|NCT00297375|Tramadol|tramadol|mesh-list
153798461|NCT00297375|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153798462|NCT00297375|Analgesics|analgesics|mesh-ancestor
153798463|NCT00297375|Sensory System Agents|sensory system agents|mesh-ancestor
153798501|NCT00270491|Tubulin Modulators|tubulin modulators|mesh-ancestor
153798502|NCT00270491|Antimitotic Agents|antimitotic agents|mesh-ancestor
153798503|NCT00270491|Mitosis Modulators|mitosis modulators|mesh-ancestor
153354053|NCT01519063|Naltrexone|naltrexone|mesh-list
153354054|NCT01519063|Memantine|memantine|mesh-list
153354077|NCT00634166|Miconazole|miconazole|mesh-list
153798504|NCT00270491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153798505|NCT00270491|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153798506|NCT00270491|Antimetabolites|antimetabolites|mesh-ancestor
153798507|NCT00270530|Pyrimethamine|pyrimethamine|mesh-list
153798508|NCT00270530|Sulfadoxine|sulfadoxine|mesh-list
153798509|NCT00270530|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
153798510|NCT00270530|Antimalarials|antimalarials|mesh-ancestor
153798511|NCT00270530|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153798512|NCT00270530|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153798513|NCT00270530|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153798518|NCT00297765|Tacrolimus|tacrolimus|mesh-list
153798561|NCT00297960|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153798562|NCT00297960|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
153798563|NCT00297960|Dopamine Agents|dopamine agents|mesh-ancestor
153798564|NCT00270881|Cytarabine|cytarabine|mesh-list
153798565|NCT00270881|Cyclophosphamide|cyclophosphamide|mesh-list
153798566|NCT00270881|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153798567|NCT00270881|Immunologic Factors|immunologic factors|mesh-ancestor
153472858|NCT04332978|Fluticasone|fluticasone|mesh-list
153798568|NCT00270881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153798569|NCT00270881|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153798570|NCT00270881|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153798571|NCT00270881|Alkylating Agents|alkylating agents|mesh-ancestor
153798572|NCT00270881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153798573|NCT00270881|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153798574|NCT00270881|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153798575|NCT00270881|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153798576|NCT00270881|Antimetabolites|antimetabolites|mesh-ancestor
153798577|NCT00270881|Antiviral Agents|antiviral agents|mesh-ancestor
153798578|NCT00270881|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153798580|NCT00298194|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
153798581|NCT00298194|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153798582|NCT00298194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153798583|NCT00298194|Cholinergic Agents|cholinergic agents|mesh-ancestor
153345154|NCT00199095|Idarubicin|idarubicin|mesh-list
153345227|NCT00199056|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153345228|NCT00199056|Antimetabolites|antimetabolites|mesh-ancestor
153798584|NCT00298194|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153798585|NCT00298194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153798586|NCT00298194|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153798587|NCT00418548|Etanercept|etanercept|mesh-list
153798588|NCT00418548|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153798589|NCT00418548|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153798590|NCT00418548|Analgesics|analgesics|mesh-ancestor
153798591|NCT00418548|Sensory System Agents|sensory system agents|mesh-ancestor
153472959|NCT03035214|Dexamethasone|dexamethasone|mesh-list
153798598|NCT00418548|Immunologic Factors|immunologic factors|mesh-ancestor
153798599|NCT00418587|Vitamin D|vitamin d|mesh-list
153798600|NCT00418587|Ergocalciferols|ergocalciferols|mesh-list
153798601|NCT00418587|Cholecalciferol|cholecalciferol|mesh-list
153798602|NCT00418587|Vitamins|vitamins|mesh-list
153798603|NCT00418587|Micronutrients|micronutrients|mesh-ancestor
153798604|NCT00418587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153798605|NCT00418587|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153798607|NCT00416273|Bortezomib|bortezomib|mesh-list
153345308|NCT00109395|Anesthetics, General|anesthetics, general|mesh-ancestor
153798659|NCT00306540|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153798660|NCT00306540|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153798661|NCT00306540|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153798662|NCT00306540|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153798663|NCT00306540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153798664|NCT00271271|Gemcitabine|gemcitabine|mesh-list
153798665|NCT00271271|Vinorelbine|vinorelbine|mesh-list
153415882|NCT05502211|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153415883|NCT05502211|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153415884|NCT05502211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153418071|NCT02779166|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153798667|NCT00271271|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153798668|NCT00271271|Antimetabolites|antimetabolites|mesh-ancestor
153798669|NCT00271271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153798670|NCT00271271|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153798671|NCT00271271|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153798672|NCT00271271|Tubulin Modulators|tubulin modulators|mesh-ancestor
153798673|NCT00271271|Antimitotic Agents|antimitotic agents|mesh-ancestor
153798674|NCT00271271|Mitosis Modulators|mitosis modulators|mesh-ancestor
153798675|NCT00306618|2-Methoxyestradiol|2-methoxyestradiol|mesh-list
153798676|NCT00306618|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153798677|NCT00306618|Tubulin Modulators|tubulin modulators|mesh-ancestor
153798678|NCT00306618|Antimitotic Agents|antimitotic agents|mesh-ancestor
153798679|NCT00306618|Mitosis Modulators|mitosis modulators|mesh-ancestor
153798680|NCT00306618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153798682|NCT00271349|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153798683|NCT00271349|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153798684|NCT00271349|Autonomic Agents|autonomic agents|mesh-ancestor
153798685|NCT00271349|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153798686|NCT00271349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153798690|NCT00271349|Hormones|hormones|mesh-ancestor
153798702|NCT00306696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153473246|NCT03009474|Antimetabolites|antimetabolites|mesh-ancestor
153473247|NCT03009474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153798703|NCT00306696|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
153798704|NCT00306696|Hormone Antagonists|hormone antagonists|mesh-ancestor
153798705|NCT00306696|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153798706|NCT00306696|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
153798707|NCT00306696|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153798708|NCT00306696|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
153798710|NCT00271427|Antioxidants|antioxidants|mesh-ancestor
153798711|NCT00271427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153798712|NCT00271427|Protective Agents|protective agents|mesh-ancestor
153798713|NCT00271427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153798714|NCT00271427|Trace Elements|trace elements|mesh-ancestor
153798715|NCT00271427|Micronutrients|micronutrients|mesh-ancestor
153798716|NCT00271466|Fentanyl|fentanyl|mesh-list
153798717|NCT00271466|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153345310|NCT00109395|GABA Modulators|gaba modulators|mesh-ancestor
153798718|NCT00271466|Narcotics|narcotics|mesh-ancestor
153798719|NCT00271466|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153798720|NCT00271466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153798721|NCT00271466|Analgesics|analgesics|mesh-ancestor
153798722|NCT00271466|Sensory System Agents|sensory system agents|mesh-ancestor
153798723|NCT00271466|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153798724|NCT00271466|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153875145|NCT04528056|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153875146|NCT04528056|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153473391|NCT03002844|Pemetrexed|pemetrexed|mesh-list
153875147|NCT04528056|Analgesics|analgesics|mesh-ancestor
153875148|NCT04528056|Sensory System Agents|sensory system agents|mesh-ancestor
153875149|NCT04528056|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153875150|NCT04528056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153875151|NCT04528056|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153798725|NCT00271466|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153798728|NCT00306735|Palonosetron|palonosetron|mesh-list
153798749|NCT00306774|Vitamins|vitamins|mesh-ancestor
153798750|NCT00306774|Micronutrients|micronutrients|mesh-ancestor
153798751|NCT00306774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153798752|NCT00306774|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153798753|NCT00306774|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153798754|NCT00306813|Lenalidomide|lenalidomide|mesh-list
153798755|NCT00306813|Immunologic Factors|immunologic factors|mesh-ancestor
153798756|NCT00306813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153798757|NCT00306813|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153798758|NCT00306813|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153798759|NCT00306813|Growth Substances|growth substances|mesh-ancestor
153798760|NCT00306813|Growth Inhibitors|growth inhibitors|mesh-ancestor
153798761|NCT00306813|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153798762|NCT00271973|Oxycodone|oxycodone|mesh-list
153798763|NCT00271973|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153473543|NCT02980926|Sensory System Agents|sensory system agents|mesh-ancestor
153813799|NCT00335270|Ritonavir|ritonavir|mesh-list
153798765|NCT00271973|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153798766|NCT00271973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153798767|NCT00271973|Analgesics|analgesics|mesh-ancestor
153798768|NCT00271973|Sensory System Agents|sensory system agents|mesh-ancestor
153798769|NCT00271973|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153798770|NCT00306969|Bexarotene|bexarotene|mesh-list
153798771|NCT00306969|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153798772|NCT00272012|Insulin glulisine|insulin glulisine|mesh-list
153798773|NCT00272012|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153354320|NCT01569451|Glatiramer Acetate|glatiramer acetate|mesh-list
153798799|NCT00307203|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
153798800|NCT00307203|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153798801|NCT00307203|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153798802|NCT00307203|Dopamine Agents|dopamine agents|mesh-ancestor
153798803|NCT00307203|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
153798804|NCT00307203|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153798805|NCT00307203|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153798806|NCT00272090|Insulin Glargine|insulin glargine|mesh-list
153798807|NCT00272090|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153798808|NCT00272090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153798809|NCT00272207|Nabilone|nabilone|mesh-list
153798810|NCT00272207|Antiemetics|antiemetics|mesh-ancestor
153798811|NCT00272207|Autonomic Agents|autonomic agents|mesh-ancestor
153798812|NCT00272207|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153798813|NCT00272207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153798814|NCT00272207|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153798815|NCT00272207|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153798817|NCT00272207|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153798818|NCT00272207|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153798819|NCT00307515|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
153798820|NCT00307515|Hemostatics|hemostatics|mesh-ancestor
153798821|NCT00307515|Coagulants|coagulants|mesh-ancestor
153798822|NCT00272285|Granisetron|granisetron|mesh-list
153798823|NCT00272285|Ramosetron|ramosetron|mesh-list
153798824|NCT00272285|Antiemetics|antiemetics|mesh-ancestor
153798825|NCT00272285|Autonomic Agents|autonomic agents|mesh-ancestor
153798826|NCT00272285|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153473928|NCT00585780|Prazosin|prazosin|mesh-list
153798827|NCT00272285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153798831|NCT00272285|Serotonin Agents|serotonin agents|mesh-ancestor
153798845|NCT00272324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153798846|NCT00272324|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153798847|NCT00272324|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153798848|NCT00272324|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153798849|NCT00272324|Antipyretics|antipyretics|mesh-ancestor
153798850|NCT00307593|Infliximab|infliximab|mesh-list
153798851|NCT00307593|Rituximab|rituximab|mesh-list
153798852|NCT00307593|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153798853|NCT00307593|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153798854|NCT00307593|Immunologic Factors|immunologic factors|mesh-ancestor
153798855|NCT00307593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153798856|NCT00307593|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153798857|NCT00307593|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
153798858|NCT00307593|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153798859|NCT00307593|Dermatologic Agents|dermatologic agents|mesh-ancestor
153798860|NCT00307593|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153798861|NCT00307632|Ethinyl Estradiol|ethinyl estradiol|mesh-list
153798862|NCT00307632|Estradiol|estradiol|mesh-list
153798863|NCT00307632|Estrogens|estrogens|mesh-ancestor
153798864|NCT00307632|Hormones|hormones|mesh-ancestor
153798866|NCT00307632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153798900|NCT00307671|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153798901|NCT00307671|Alkylating Agents|alkylating agents|mesh-ancestor
153798902|NCT00307671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153798903|NCT00307671|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153798904|NCT00307671|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153798905|NCT00307671|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153798906|NCT00307671|Glucocorticoids|glucocorticoids|mesh-ancestor
153798907|NCT00307671|Hormones|hormones|mesh-ancestor
153798908|NCT00307671|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153798909|NCT00307671|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153798910|NCT00307671|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
153798911|NCT00307671|Abortifacient Agents|abortifacient agents|mesh-ancestor
153875164|NCT04543565|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153875166|NCT01647555|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153875167|NCT01647555|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153875190|NCT01681563|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153798912|NCT00307671|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153798913|NCT00307671|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153798958|NCT00272636|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153798959|NCT00272636|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153798960|NCT00272636|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
153798961|NCT00272636|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
153798962|NCT00272636|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
153798964|NCT00281970|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153798965|NCT00281970|Tubulin Modulators|tubulin modulators|mesh-ancestor
153798966|NCT00281970|Antimitotic Agents|antimitotic agents|mesh-ancestor
153798967|NCT00281970|Mitosis Modulators|mitosis modulators|mesh-ancestor
153798968|NCT00281970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153798969|NCT00272675|Chlorhexidine|chlorhexidine|mesh-list
153798970|NCT00272675|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
153798971|NCT00272675|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
153798972|NCT00272675|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153798973|NCT00272675|Disinfectants|disinfectants|mesh-ancestor
153798974|NCT00272675|Dermatologic Agents|dermatologic agents|mesh-ancestor
153799014|NCT00272831|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
153799015|NCT00272831|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153799016|NCT00416468|Valsartan|valsartan|mesh-list
153799017|NCT00416468|Aliskiren|aliskiren|mesh-list
153474120|NCT00603018|Fluoxetine|fluoxetine|mesh-list
153799018|NCT00416468|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153799019|NCT00416468|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
153799020|NCT00416468|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
153799021|NCT00416468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153799022|NCT00416468|Renin Inhibitors|renin inhibitors|mesh-ancestor
153345595|NCT00005038|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153799023|NCT00416468|Protease Inhibitors|protease inhibitors|mesh-ancestor
153799074|NCT00273026|Xhance|xhance|mesh-list
153799077|NCT00273026|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153799078|NCT00273026|Autonomic Agents|autonomic agents|mesh-ancestor
153799079|NCT00273026|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153799080|NCT00273026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153799081|NCT00273026|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153799082|NCT00273026|Respiratory System Agents|respiratory system agents|mesh-ancestor
153799083|NCT00273026|Dermatologic Agents|dermatologic agents|mesh-ancestor
153799084|NCT00273026|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
153799085|NCT00273026|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
153799086|NCT00273026|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
153799088|NCT00273026|Adrenergic Agents|adrenergic agents|mesh-ancestor
153799089|NCT00273026|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153345671|NCT00022490|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153345674|NCT00386230|Zidovudine|zidovudine|mesh-list
153799132|NCT00418782|Analgesics|analgesics|mesh-ancestor
153875191|NCT01681563|Immunologic Factors|immunologic factors|mesh-ancestor
153875192|NCT01681563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153875193|NCT01681563|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153875194|NCT01681563|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153799133|NCT00418782|Sensory System Agents|sensory system agents|mesh-ancestor
153799134|NCT00418782|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153799135|NCT00418782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153799136|NCT00418782|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153799137|NCT00418782|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153799200|NCT00273533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153799202|NCT00273611|Vitamin D|vitamin d|mesh-list
153799203|NCT00273611|Vitamins|vitamins|mesh-ancestor
153799204|NCT00273611|Micronutrients|micronutrients|mesh-ancestor
153799270|NCT00273962|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153799271|NCT00273962|Respiratory System Agents|respiratory system agents|mesh-ancestor
153799272|NCT00273962|Tocolytic Agents|tocolytic agents|mesh-ancestor
153799273|NCT00273962|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153799274|NCT00273962|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
153799275|NCT00273962|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
153799276|NCT00273962|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153799277|NCT00273962|Adrenergic Agents|adrenergic agents|mesh-ancestor
153799278|NCT00273962|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153799279|NCT00273962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153799280|NCT00273962|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
153799281|NCT00273962|Cholinergic Agents|cholinergic agents|mesh-ancestor
153799283|NCT00274001|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153799284|NCT00274001|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153799285|NCT00274001|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153799286|NCT00274001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153799287|NCT00274001|Antiviral Agents|antiviral agents|mesh-ancestor
153799288|NCT00274001|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153799289|NCT00274001|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153799290|NCT00274001|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153799291|NCT00274001|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
153799292|NCT00274001|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
153799293|NCT00274040|Tiotropium Bromide|tiotropium bromide|mesh-list
153883009|NCT02271399|Antipyretics|antipyretics|mesh-ancestor
153799294|NCT00274040|Ipratropium|ipratropium|mesh-list
153799295|NCT00274040|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153799317|NCT00308451|Micronutrients|micronutrients|mesh-ancestor
153799318|NCT00308451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153799319|NCT00308451|Vitamin B Complex|vitamin b complex|mesh-ancestor
153799320|NCT00308451|Vitamins|vitamins|mesh-ancestor
153799321|NCT00308451|Iron Chelating Agents|iron chelating agents|mesh-ancestor
153799322|NCT00308451|Chelating Agents|chelating agents|mesh-ancestor
153799323|NCT00308451|Sequestering Agents|sequestering agents|mesh-ancestor
153799324|NCT00308451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153799325|NCT00274079|Tiotropium Bromide|tiotropium bromide|mesh-list
153799326|NCT00274079|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153799327|NCT00274079|Autonomic Agents|autonomic agents|mesh-ancestor
153799328|NCT00274079|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153799329|NCT00274079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153799330|NCT00274079|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153799331|NCT00274079|Respiratory System Agents|respiratory system agents|mesh-ancestor
153418135|NCT02906696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153418137|NCT02785406|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
153418138|NCT02785406|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153418139|NCT02785406|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153799333|NCT00274079|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
153799334|NCT00274079|Cholinergic Agents|cholinergic agents|mesh-ancestor
153799335|NCT00274079|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153799336|NCT00274079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153799337|NCT00274118|Telmisartan|telmisartan|mesh-list
153799338|NCT00274118|Enalapril|enalapril|mesh-list
153799339|NCT00274118|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153799340|NCT00274118|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
153799341|NCT00274118|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
153799342|NCT00274118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153799343|NCT00274118|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
153799344|NCT00274118|Protease Inhibitors|protease inhibitors|mesh-ancestor
153799345|NCT00274118|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153799346|NCT00308490|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
153799347|NCT00308490|Hematinics|hematinics|mesh-ancestor
153799348|NCT00416585|Isotretinoin|isotretinoin|mesh-list
153799359|NCT00308529|Growth Inhibitors|growth inhibitors|mesh-ancestor
153799360|NCT00308529|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
153799361|NCT00308529|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153799362|NCT00308529|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153799363|NCT00308529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153799364|NCT00274235|Pyrimethamine|pyrimethamine|mesh-list
153799365|NCT00274235|Sulfadoxine|sulfadoxine|mesh-list
153799366|NCT00274235|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
153799368|NCT00274235|Antimalarials|antimalarials|mesh-ancestor
153799426|NCT00274391|Diuretics|diuretics|mesh-ancestor
153799427|NCT00274391|Natriuretic Agents|natriuretic agents|mesh-ancestor
153799428|NCT00274391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153354686|NCT01537315|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153474851|NCT00733356|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
153799429|NCT00274391|Acid Sensing Ion Channel Blockers|acid sensing ion channel blockers|mesh-ancestor
153799430|NCT00274391|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153799431|NCT00274391|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153799432|NCT00274391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153799433|NCT00274391|Epithelial Sodium Channel Blockers|epithelial sodium channel blockers|mesh-ancestor
153799434|NCT00274391|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
153799435|NCT00274430|Dexamethasone|dexamethasone|mesh-list
153799436|NCT00274430|Tadalafil|tadalafil|mesh-list
153799437|NCT00274430|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153799438|NCT00274430|Antiemetics|antiemetics|mesh-ancestor
153799439|NCT00274430|Autonomic Agents|autonomic agents|mesh-ancestor
153799440|NCT00274430|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153799441|NCT00274430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153799442|NCT00274430|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153799443|NCT00274430|Glucocorticoids|glucocorticoids|mesh-ancestor
153799444|NCT00274430|Hormones|hormones|mesh-ancestor
153799445|NCT00274430|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153799446|NCT00274430|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153875199|NCT01681563|Adenosine Deaminase Inhibitors|adenosine deaminase inhibitors|mesh-ancestor
153875200|NCT01681563|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153875201|NCT01681680|Metformin|metformin|mesh-list
153875202|NCT01681680|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153875203|NCT01681680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153875204|NCT01647633|Calcium|calcium|mesh-list
153875205|NCT01647633|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153875206|NCT01647633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153875207|NCT01647672|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
153799447|NCT00274430|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153799448|NCT00274430|Vasodilator Agents|vasodilator agents|mesh-ancestor
153799449|NCT00274430|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
153799450|NCT00274430|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
153799451|NCT00274430|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153799452|NCT00274430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153799453|NCT00274430|Urological Agents|urological agents|mesh-ancestor
153799454|NCT00274547|Tiotropium Bromide|tiotropium bromide|mesh-list
153799467|NCT00308763|Nicotine|nicotine|mesh-list
153799468|NCT00308763|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
153799469|NCT00308763|Autonomic Agents|autonomic agents|mesh-ancestor
153799470|NCT00308763|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153799471|NCT00308763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153799472|NCT00308763|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
153799473|NCT00308763|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
153799474|NCT00308763|Cholinergic Agents|cholinergic agents|mesh-ancestor
153475219|NCT00785772|Gabapentin|gabapentin|mesh-list
153799475|NCT00308763|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153799478|NCT00308763|Antidepressive Agents|antidepressive agents|mesh-ancestor
153799532|NCT00274859|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153799534|NCT00274859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153799535|NCT00274859|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153799536|NCT00274898|Celecoxib|celecoxib|mesh-list
153799537|NCT00274898|Docetaxel|docetaxel|mesh-list
153799538|NCT00274898|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153799539|NCT00274898|Tubulin Modulators|tubulin modulators|mesh-ancestor
153799540|NCT00274898|Antimitotic Agents|antimitotic agents|mesh-ancestor
153799541|NCT00274898|Mitosis Modulators|mitosis modulators|mesh-ancestor
153799542|NCT00274898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153799594|NCT00315003|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153799595|NCT00277550|Tegaserod|tegaserod|mesh-list
153783432|NCT04547608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153783433|NCT04547608|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153354708|NCT00584948|Dopamine Agents|dopamine agents|mesh-ancestor
153354710|NCT00584948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153354713|NCT00584948|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
153799596|NCT00277550|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
153799597|NCT00277550|Serotonin Agents|serotonin agents|mesh-ancestor
153799598|NCT00277550|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153799599|NCT00277550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153799600|NCT00277550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153799601|NCT00277589|Iodine|iodine|mesh-list
153799602|NCT00277589|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
153799603|NCT00277589|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153475460|NCT00803010|Tacrolimus|tacrolimus|mesh-list
153475580|NCT00814788|Everolimus|everolimus|mesh-list
153799604|NCT00277589|Trace Elements|trace elements|mesh-ancestor
153799605|NCT00277589|Micronutrients|micronutrients|mesh-ancestor
153799606|NCT00277589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153799607|NCT00315042|Penicillins|penicillins|mesh-list
153799608|NCT00315042|Telithromycin|telithromycin|mesh-list
153799609|NCT00315042|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153799610|NCT00315042|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153799611|NCT00277667|Quetiapine Fumarate|quetiapine fumarate|mesh-list
153799612|NCT00277667|Antidepressive Agents|antidepressive agents|mesh-ancestor
153799613|NCT00277667|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153799614|NCT00277667|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153799615|NCT00277667|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153799618|NCT00315081|Bromocriptine|bromocriptine|mesh-list
153799648|NCT00278018|Immunologic Factors|immunologic factors|mesh-ancestor
153799649|NCT00278018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153799650|NCT00309270|Alemtuzumab|alemtuzumab|mesh-list
153799651|NCT00309270|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153799652|NCT00309270|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153799653|NCT00315276|Modafinil|modafinil|mesh-list
153799654|NCT00315276|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
153799655|NCT00315276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153799656|NCT00315276|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
153799657|NCT00315276|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
153799658|NCT00315276|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
153799659|NCT00315276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153799660|NCT00309309|Rosiglitazone|rosiglitazone|mesh-list
153799709|NCT00278330|Alvocidib|alvocidib|mesh-list
153799710|NCT00278330|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153799711|NCT00278330|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
153799712|NCT00278330|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153799713|NCT00278330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153799714|NCT00278330|Growth Inhibitors|growth inhibitors|mesh-ancestor
153799715|NCT00278330|Growth Substances|growth substances|mesh-ancestor
153475584|NCT00814788|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153354717|NCT00605072|Candesartan cilexetil|candesartan cilexetil|mesh-list
153354718|NCT00605072|Lisinopril|lisinopril|mesh-list
153354719|NCT00605072|Nifedipine|nifedipine|mesh-list
153354720|NCT00605072|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153354721|NCT00605072|Diuretics|diuretics|mesh-ancestor
153354722|NCT00605072|Natriuretic Agents|natriuretic agents|mesh-ancestor
153354723|NCT00605072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153354724|NCT00605072|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
153354725|NCT00605072|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153354726|NCT00605072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153354727|NCT00605072|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153799716|NCT00278330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153799717|NCT00278330|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153799718|NCT00315510|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
153799719|NCT00315510|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153799720|NCT00315510|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153799721|NCT00315510|Antimetabolites|antimetabolites|mesh-ancestor
153799722|NCT00315510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153799723|NCT00315510|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153799725|NCT00315510|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153799767|NCT00278408|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153799768|NCT00278408|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153799769|NCT00278408|Tubulin Modulators|tubulin modulators|mesh-ancestor
153799770|NCT00278408|Antimitotic Agents|antimitotic agents|mesh-ancestor
153799771|NCT00278408|Mitosis Modulators|mitosis modulators|mesh-ancestor
153799772|NCT00315666|Memantine|memantine|mesh-list
153799773|NCT00315666|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
153799774|NCT00315666|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
153799775|NCT00315666|Dopamine Agents|dopamine agents|mesh-ancestor
153415958|NCT05470465|Antidepressive Agents|antidepressive agents|mesh-ancestor
153415959|NCT05470465|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153415960|NCT05470465|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
153799776|NCT00315666|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153799777|NCT00315666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153799778|NCT00315666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153799779|NCT00315666|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
153799780|NCT00315666|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
153799781|NCT00315744|Fluticasone|fluticasone|mesh-list
153799783|NCT00315744|Albuterol|albuterol|mesh-list
153799827|NCT00309660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153799828|NCT00315900|Valproic Acid|valproic acid|mesh-list
153799829|NCT00315900|Quetiapine Fumarate|quetiapine fumarate|mesh-list
153799830|NCT00315900|Antidepressive Agents|antidepressive agents|mesh-ancestor
153799831|NCT00315900|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153799832|NCT00315900|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153799833|NCT00315900|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153799834|NCT00315900|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153475629|NCT04900116|Bupivacaine|bupivacaine|mesh-list
153799835|NCT00315900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153799837|NCT00315900|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153799838|NCT00315900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153799888|NCT00279344|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153799889|NCT00279344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153799890|NCT00279344|Analgesics|analgesics|mesh-ancestor
153799891|NCT00279344|Sensory System Agents|sensory system agents|mesh-ancestor
153799892|NCT00279344|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153799893|NCT00279344|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153799894|NCT00279344|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153799895|NCT00279344|Anesthetics, General|anesthetics, general|mesh-ancestor
153799896|NCT00279344|Anesthetics|anesthetics|mesh-ancestor
153799897|NCT00418860|Aspirin|aspirin|mesh-list
153799898|NCT00418860|Clopidogrel|clopidogrel|mesh-list
153799899|NCT00418860|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153799900|NCT00418860|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153799901|NCT00418860|Analgesics|analgesics|mesh-ancestor
153799902|NCT00418860|Sensory System Agents|sensory system agents|mesh-ancestor
153799903|NCT00418860|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153799904|NCT00418860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153799946|NCT00279422|Immunologic Factors|immunologic factors|mesh-ancestor
153799947|NCT00279422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153799948|NCT00309894|Ketoconazole|ketoconazole|mesh-list
153799949|NCT00309894|Hydrocortisone|hydrocortisone|mesh-list
153799950|NCT00309894|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
153799951|NCT00309894|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
153799952|NCT00309894|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
153799953|NCT00309894|Sargramostim|sargramostim|mesh-list
153799954|NCT00309894|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153799955|NCT00309894|Immunologic Factors|immunologic factors|mesh-ancestor
153475675|NCT00821964|Tubulin Modulators|tubulin modulators|mesh-ancestor
153799956|NCT00309894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153799957|NCT00309894|Antifungal Agents|antifungal agents|mesh-ancestor
153799958|NCT00309894|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153799959|NCT00309894|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
153799960|NCT00309894|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153799961|NCT00309894|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153799962|NCT00309894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153799963|NCT00309894|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153799964|NCT00309894|Hormone Antagonists|hormone antagonists|mesh-ancestor
153799965|NCT00309894|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153799966|NCT00309894|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
153800000|NCT00279617|Anticonvulsants|anticonvulsants|mesh-ancestor
153800001|NCT00279617|Nootropic Agents|nootropic agents|mesh-ancestor
153800003|NCT00310011|Gemcitabine|gemcitabine|mesh-list
153800004|NCT00310011|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153800005|NCT00310011|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153800006|NCT00310011|Tubulin Modulators|tubulin modulators|mesh-ancestor
153800007|NCT00310011|Antimitotic Agents|antimitotic agents|mesh-ancestor
153800008|NCT00310011|Mitosis Modulators|mitosis modulators|mesh-ancestor
153800009|NCT00310011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153800010|NCT00310011|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153800011|NCT00310011|Antimetabolites|antimetabolites|mesh-ancestor
153800012|NCT00316407|Paclitaxel|paclitaxel|mesh-list
153800013|NCT00316407|Carboplatin|carboplatin|mesh-list
153800014|NCT00316407|Lapatinib|lapatinib|mesh-list
153800015|NCT00316407|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153800016|NCT00316407|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153475848|NCT00835224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153475849|NCT00835926|Vaccines|vaccines|mesh-list
153800017|NCT00316407|Tubulin Modulators|tubulin modulators|mesh-ancestor
153800018|NCT00316407|Antimitotic Agents|antimitotic agents|mesh-ancestor
153800019|NCT00316407|Mitosis Modulators|mitosis modulators|mesh-ancestor
153800020|NCT00316407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153800021|NCT00316407|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153800022|NCT00316407|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153800023|NCT00316407|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153800025|NCT00310089|Docetaxel|docetaxel|mesh-list
153800026|NCT00310089|Doxorubicin|doxorubicin|mesh-list
153800027|NCT00310089|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
153800028|NCT00310089|Cediranib|cediranib|mesh-list
153800029|NCT00310089|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153800030|NCT00310089|Immunologic Factors|immunologic factors|mesh-ancestor
153800031|NCT00310089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153415982|NCT05351762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153415983|NCT05351762|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153415984|NCT02708641|Pembrolizumab|pembrolizumab|mesh-list
153415985|NCT02708641|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153415986|NCT02708641|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153415987|NCT02708641|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153415988|NCT02708641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153415989|NCT02710981|Sildenafil Citrate|sildenafil citrate|mesh-list
153415990|NCT02710981|Clomiphene|clomiphene|mesh-list
153415991|NCT02710981|Enclomiphene|enclomiphene|mesh-list
153415992|NCT02710981|Zuclomiphene|zuclomiphene|mesh-list
153415994|NCT02710981|Vasodilator Agents|vasodilator agents|mesh-ancestor
153800032|NCT00310089|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153800042|NCT00310089|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153800043|NCT00310089|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153800044|NCT00310089|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153800045|NCT00310089|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153354728|NCT00605072|Sympatholytics|sympatholytics|mesh-ancestor
153800046|NCT00279734|Abatacept|abatacept|mesh-list
153800047|NCT00279734|Vaccines|vaccines|mesh-list
153800048|NCT00279734|Immunologic Factors|immunologic factors|mesh-ancestor
153800049|NCT00279734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153800050|NCT00279734|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153800051|NCT00279734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153800052|NCT00279734|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153800053|NCT00279734|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153800054|NCT00279734|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153800055|NCT00279734|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153800056|NCT00310128|Cytarabine|cytarabine|mesh-list
153800057|NCT00310128|Methylprednisolone|methylprednisolone|mesh-list
153800058|NCT00310128|Rituximab|rituximab|mesh-list
153800059|NCT00310128|Etoposide|etoposide|mesh-list
153800060|NCT00310128|Antibodies|antibodies|mesh-list
153800098|NCT00316563|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153800099|NCT00316563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153800101|NCT00316563|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153800102|NCT00416819|Leucovorin|leucovorin|mesh-list
153800103|NCT00416819|Cytarabine|cytarabine|mesh-list
153800104|NCT00416819|Rituximab|rituximab|mesh-list
153476059|NCT00882102|Immunologic Factors|immunologic factors|mesh-ancestor
153476060|NCT00882102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153800106|NCT00416819|Etoposide|etoposide|mesh-list
153800107|NCT00416819|Temozolomide|temozolomide|mesh-list
153800108|NCT00416819|Etoposide phosphate|etoposide phosphate|mesh-list
153800109|NCT00416819|Levoleucovorin|levoleucovorin|mesh-list
153800110|NCT00416819|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153800111|NCT00416819|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153800112|NCT00416819|Immunologic Factors|immunologic factors|mesh-ancestor
153800113|NCT00416819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153800114|NCT00416819|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153800115|NCT00416819|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
153800116|NCT00416819|Abortifacient Agents|abortifacient agents|mesh-ancestor
153800117|NCT00416819|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153800118|NCT00416819|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153800119|NCT00416819|Antimetabolites|antimetabolites|mesh-ancestor
153800120|NCT00416819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153800121|NCT00416819|Dermatologic Agents|dermatologic agents|mesh-ancestor
153800122|NCT00416819|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153800147|NCT00280007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153800148|NCT00280007|Growth Inhibitors|growth inhibitors|mesh-ancestor
153800150|NCT00316680|Immunologic Factors|immunologic factors|mesh-ancestor
153800151|NCT00316680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153800152|NCT00280046|Insulin Aspart|insulin aspart|mesh-list
153875275|NCT01648608|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153875276|NCT01648608|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153415998|NCT02710981|Urological Agents|urological agents|mesh-ancestor
153800153|NCT00280046|Biphasic Insulins|biphasic insulins|mesh-list
153800154|NCT00280046|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153800155|NCT00280046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153800156|NCT00310323|Levomethorphan|levomethorphan|mesh-list
153800157|NCT00310323|Dextromethorphan|dextromethorphan|mesh-list
153800212|NCT00310518|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153800213|NCT00310518|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153800214|NCT00310518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153800215|NCT00310518|Antiviral Agents|antiviral agents|mesh-ancestor
153354735|NCT00605072|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153354736|NCT00605072|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
153354737|NCT00605072|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
153354738|NCT00605072|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153354739|NCT00605072|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153354741|NCT00605072|Tocolytic Agents|tocolytic agents|mesh-ancestor
153354742|NCT00605072|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153354744|NCT00605072|Protease Inhibitors|protease inhibitors|mesh-ancestor
153346864|NCT00257894|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
153800216|NCT00280436|Casopitant|casopitant|mesh-list
153800217|NCT00280436|Antiemetics|antiemetics|mesh-ancestor
153800218|NCT00280436|Autonomic Agents|autonomic agents|mesh-ancestor
153800219|NCT00280436|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153800220|NCT00280436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153800221|NCT00280436|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153800222|NCT00280436|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
153800223|NCT00280436|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153800224|NCT00280436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153800225|NCT00280514|Moxifloxacin|moxifloxacin|mesh-list
153800226|NCT00280514|Cefpirome|cefpirome|mesh-list
153800227|NCT00280514|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153800228|NCT00280514|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153800229|NCT00280514|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153800230|NCT00280514|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153800231|NCT00280514|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153800232|NCT00280514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153800233|NCT00280514|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153800234|NCT00280514|Beta Lactam Antibiotics|beta lactam antibiotics|mesh-ancestor
153800260|NCT00419172|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
153800261|NCT00419172|Antitubercular Agents|antitubercular agents|mesh-ancestor
153800262|NCT00419172|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153800263|NCT00419172|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153800265|NCT00419172|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153800266|NCT00419172|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153800328|NCT00281255|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153800329|NCT00281255|Free Radical Scavengers|free radical scavengers|mesh-ancestor
153800330|NCT00281255|Antioxidants|antioxidants|mesh-ancestor
153800331|NCT00281255|Protective Agents|protective agents|mesh-ancestor
153800332|NCT00281255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153800333|NCT00281255|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
153800334|NCT00281255|Sympathomimetics|sympathomimetics|mesh-ancestor
153800335|NCT00281255|Autonomic Agents|autonomic agents|mesh-ancestor
153415999|NCT02710981|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
153800336|NCT00281255|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153800337|NCT00281255|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
153800338|NCT00281255|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
153800339|NCT00281255|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153800340|NCT00281255|Adrenergic Agents|adrenergic agents|mesh-ancestor
153800341|NCT00281255|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153800342|NCT00317187|Vaccines|vaccines|mesh-list
153800343|NCT00317187|Immunologic Factors|immunologic factors|mesh-ancestor
153800344|NCT00317187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153800345|NCT00310908|Tramadol|tramadol|mesh-list
153800346|NCT00310908|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153800347|NCT00310908|Narcotics|narcotics|mesh-ancestor
153800348|NCT00310908|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153800349|NCT00310908|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153800350|NCT00310908|Analgesics|analgesics|mesh-ancestor
153800351|NCT00310908|Sensory System Agents|sensory system agents|mesh-ancestor
153800352|NCT00310908|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153800354|NCT00281489|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153800376|NCT00416897|Antiemetics|antiemetics|mesh-ancestor
153424266|NCT03233737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153800377|NCT00416897|Autonomic Agents|autonomic agents|mesh-ancestor
153800378|NCT00416897|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153800379|NCT00416897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153800380|NCT00416897|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153800381|NCT00416897|Glucocorticoids|glucocorticoids|mesh-ancestor
153800383|NCT00416897|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153800384|NCT00416897|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153800385|NCT00416897|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153800386|NCT00417014|Prednisolone|prednisolone|mesh-list
153800387|NCT00417014|Vinblastine|vinblastine|mesh-list
153800388|NCT00417014|Procarbazine|procarbazine|mesh-list
153800389|NCT00417014|Chlorambucil|chlorambucil|mesh-list
153800390|NCT00417014|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153800391|NCT00417014|Glucocorticoids|glucocorticoids|mesh-ancestor
153800392|NCT00417014|Hormones|hormones|mesh-ancestor
153800393|NCT00417014|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153800394|NCT00417014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153476240|NCT00905580|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153800412|NCT00417053|Melphalan|melphalan|mesh-list
153800432|NCT00417053|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153800433|NCT00417053|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153800434|NCT00417053|Tubulin Modulators|tubulin modulators|mesh-ancestor
153800435|NCT00417053|Antimitotic Agents|antimitotic agents|mesh-ancestor
153800436|NCT00417053|Mitosis Modulators|mitosis modulators|mesh-ancestor
153800437|NCT00281567|Tiotropium Bromide|tiotropium bromide|mesh-list
153800438|NCT00281567|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153347013|NCT01076231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153800439|NCT00281567|Autonomic Agents|autonomic agents|mesh-ancestor
153800440|NCT00281567|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153800441|NCT00281567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153800442|NCT00281567|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153800443|NCT00281567|Respiratory System Agents|respiratory system agents|mesh-ancestor
153800444|NCT00281567|Parasympatholytics|parasympatholytics|mesh-ancestor
153800449|NCT00317499|Etanercept|etanercept|mesh-list
153800491|NCT00281645|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153800492|NCT00281645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153800493|NCT00317577|Timolol|timolol|mesh-list
153875277|NCT01648608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153875278|NCT01648608|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
153418202|NCT02888665|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153800494|NCT00317577|Brimonidine Tartrate|brimonidine tartrate|mesh-list
153800495|NCT00317577|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
153800496|NCT00317577|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
153800497|NCT00317577|Adrenergic Agents|adrenergic agents|mesh-ancestor
153800498|NCT00317577|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153800499|NCT00317577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153800500|NCT00317577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153800501|NCT00317577|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153800502|NCT00317577|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153800503|NCT00317577|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
153800504|NCT00317577|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153354746|NCT00605072|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
153354747|NCT00605072|Protective Agents|protective agents|mesh-ancestor
153354748|NCT00585104|Simendan|simendan|mesh-list
153354749|NCT00585104|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
153354750|NCT00585104|Vasodilator Agents|vasodilator agents|mesh-ancestor
153354751|NCT00585104|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
153354752|NCT00585104|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
153354753|NCT00585104|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153354754|NCT00585104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153354757|NCT00585182|Enoxaparin|enoxaparin|mesh-list
153800505|NCT00317577|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153800506|NCT00317655|Ibuprofen|ibuprofen|mesh-list
153800507|NCT00317655|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153800508|NCT00317655|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153800509|NCT00317655|Analgesics|analgesics|mesh-ancestor
153800510|NCT00317655|Sensory System Agents|sensory system agents|mesh-ancestor
153800511|NCT00317655|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153800512|NCT00317655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153800513|NCT00317655|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153800540|NCT00317733|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153800541|NCT00317733|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153800542|NCT00317733|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153800543|NCT00317733|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153800544|NCT00317733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153800545|NCT00311337|Bortezomib|bortezomib|mesh-list
153800546|NCT00311337|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153800548|NCT00317811|Bortezomib|bortezomib|mesh-list
153800549|NCT00317811|Melphalan|melphalan|mesh-list
153800550|NCT00317811|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153800551|NCT00317811|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153800552|NCT00317811|Alkylating Agents|alkylating agents|mesh-ancestor
153800603|NCT00282503|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153800604|NCT00282503|Glucocorticoids|glucocorticoids|mesh-ancestor
153800605|NCT00282503|Hormones|hormones|mesh-ancestor
153800606|NCT00282503|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153800607|NCT00282503|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
153800608|NCT00282503|Protective Agents|protective agents|mesh-ancestor
153800609|NCT00282503|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153800610|NCT00282503|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153800611|NCT00282503|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
153800612|NCT00282503|Dermatologic Agents|dermatologic agents|mesh-ancestor
153800613|NCT00317928|Metformin|metformin|mesh-list
153800614|NCT00317928|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153800664|NCT00318201|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153476426|NCT00931164|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153476427|NCT00931164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153800665|NCT00318201|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153800666|NCT00318201|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153800667|NCT00318201|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
153800668|NCT00318201|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153800669|NCT00311688|Interleukin-2|interleukin-2|mesh-list
153800670|NCT00311688|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153800671|NCT00311688|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153800672|NCT00311688|Analgesics|analgesics|mesh-ancestor
153800673|NCT00311688|Sensory System Agents|sensory system agents|mesh-ancestor
153800674|NCT00311688|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153800675|NCT00311688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153800676|NCT00283478|Gemcitabine|gemcitabine|mesh-list
153354787|NCT00586196|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
153800677|NCT00283478|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153800678|NCT00283478|Antimetabolites|antimetabolites|mesh-ancestor
153800679|NCT00283478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153800680|NCT00283478|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153800682|NCT00318318|Estrogens|estrogens|mesh-ancestor
153800720|NCT00318552|Meropenem|meropenem|mesh-list
153800721|NCT00318552|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153800722|NCT00318552|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153800723|NCT00283751|Insulin|insulin|mesh-list
153800724|NCT00283751|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
153800725|NCT00283751|Insulin Glargine|insulin glargine|mesh-list
153800726|NCT00283751|Insulin Detemir|insulin detemir|mesh-list
153800727|NCT00283751|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153800728|NCT00283751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153800730|NCT00318630|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153800731|NCT00318630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153800732|NCT00283790|Zolpidem|zolpidem|mesh-list
153800733|NCT00283790|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
153800734|NCT00283790|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153800735|NCT00283790|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153800736|NCT00283790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153800737|NCT00283790|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
153800738|NCT00283790|GABA Agonists|gaba agonists|mesh-ancestor
153800739|NCT00283790|GABA Agents|gaba agents|mesh-ancestor
153800740|NCT00283790|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153800741|NCT00283790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153800742|NCT00318669|Paroxetine|paroxetine|mesh-list
153875301|NCT01682421|Glucocorticoids|glucocorticoids|mesh-ancestor
153800743|NCT00318669|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
153800771|NCT00311961|Hormones|hormones|mesh-ancestor
153800772|NCT00311961|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153800773|NCT00311961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153800774|NCT00311961|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153800775|NCT00311961|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153800776|NCT00311961|Antiemetics|antiemetics|mesh-ancestor
153800777|NCT00311961|Autonomic Agents|autonomic agents|mesh-ancestor
153476512|NCT00943800|Antiviral Agents|antiviral agents|mesh-ancestor
153800778|NCT00311961|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153354788|NCT00586196|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153354789|NCT00586196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153354790|NCT00586196|Cholinergic Agents|cholinergic agents|mesh-ancestor
153354791|NCT00586196|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153354792|NCT00586196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153354793|NCT00586196|Nootropic Agents|nootropic agents|mesh-ancestor
153354794|NCT00605696|Insulin|insulin|mesh-list
153354795|NCT00605696|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153424367|NCT00422864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153424368|NCT00422864|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153424369|NCT00422864|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153424376|NCT00422864|Vitamins|vitamins|mesh-ancestor
153800779|NCT00311961|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153800837|NCT00284024|Antiemetics|antiemetics|mesh-ancestor
153800838|NCT00284024|Autonomic Agents|autonomic agents|mesh-ancestor
153800839|NCT00284024|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153880760|NCT06031090|Clonidine|clonidine|mesh-list
153354796|NCT00605696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153800840|NCT00284024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153800841|NCT00284024|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153800842|NCT00284024|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
153800843|NCT00284024|Dopamine Agents|dopamine agents|mesh-ancestor
153800844|NCT00284024|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153800845|NCT00284024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153800846|NCT00284258|Irinotecan|irinotecan|mesh-list
153875302|NCT01682421|Hormones|hormones|mesh-ancestor
153416027|NCT02659501|Analgesics|analgesics|mesh-ancestor
153800847|NCT00284258|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
153800848|NCT00284258|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153800849|NCT00284258|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153800850|NCT00284258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153800851|NCT00284258|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153800852|NCT00318786|Insulin Aspart|insulin aspart|mesh-list
153800853|NCT00318786|Biphasic Insulins|biphasic insulins|mesh-list
153800854|NCT00318786|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153800855|NCT00318786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153800856|NCT00284336|Cyclophosphamide|cyclophosphamide|mesh-list
153800857|NCT00284336|Doxorubicin|doxorubicin|mesh-list
153800858|NCT00284336|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
153800859|NCT00284336|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153800860|NCT00284336|Immunologic Factors|immunologic factors|mesh-ancestor
153800861|NCT00284336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153476581|NCT00957684|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153800862|NCT00284336|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153800863|NCT00284336|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153800883|NCT00318825|Anesthetics, General|anesthetics, general|mesh-ancestor
153800884|NCT00318825|Anesthetics|anesthetics|mesh-ancestor
153800885|NCT00318825|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153800886|NCT00318825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153800887|NCT00318825|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153800888|NCT00318825|Analgesics|analgesics|mesh-ancestor
153800889|NCT00318825|Sensory System Agents|sensory system agents|mesh-ancestor
153800890|NCT00318825|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153800891|NCT00284531|Daclizumab|daclizumab|mesh-list
153800892|NCT00284531|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153800893|NCT00284531|Immunologic Factors|immunologic factors|mesh-ancestor
153800894|NCT00284531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153800895|NCT00312273|Aminophylline|aminophylline|mesh-list
153800896|NCT00312273|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153354797|NCT00587132|Secretin|secretin|mesh-list
153354798|NCT00587132|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153354799|NCT00587132|Hormones|hormones|mesh-ancestor
153354800|NCT00587132|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153354801|NCT00587132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153354802|NCT00587678|Simvastatin|simvastatin|mesh-list
153354803|NCT00587678|Ezetimibe|ezetimibe|mesh-list
153354804|NCT00587678|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153354805|NCT00587678|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153354806|NCT00587678|Antimetabolites|antimetabolites|mesh-ancestor
153354807|NCT00587678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153354808|NCT00587678|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153800897|NCT00312273|Autonomic Agents|autonomic agents|mesh-ancestor
153800944|NCT00319059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153800945|NCT00312507|Pulmonary Surfactants|pulmonary surfactants|mesh-list
153800946|NCT00312507|Respiratory System Agents|respiratory system agents|mesh-ancestor
153800947|NCT00312546|Enfuvirtide|enfuvirtide|mesh-list
153800948|NCT00312546|Valproic Acid|valproic acid|mesh-list
153800949|NCT00312546|Anticonvulsants|anticonvulsants|mesh-ancestor
153800950|NCT00312546|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153476611|NCT00973752|Prednisone|prednisone|mesh-list
153800951|NCT00312546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153800952|NCT00312546|GABA Agents|gaba agents|mesh-ancestor
153800953|NCT00312546|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153800954|NCT00312546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153800955|NCT00312546|Antimanic Agents|antimanic agents|mesh-ancestor
153347542|NCT01323517|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153800956|NCT00312546|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153800957|NCT00312546|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153875314|NCT01682499|Analgesics|analgesics|mesh-ancestor
153800958|NCT00312546|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153800959|NCT00312546|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
153800960|NCT00312546|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
153800961|NCT00312546|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153800962|NCT00312546|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153800963|NCT00312546|Antiviral Agents|antiviral agents|mesh-ancestor
153800964|NCT00312546|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153800965|NCT00425009|Metformin|metformin|mesh-list
153476661|NCT00974376|Analgesics|analgesics|mesh-ancestor
153800967|NCT00425009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153800969|NCT00319215|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153800970|NCT00319215|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153800971|NCT00319215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153800972|NCT00285155|Bupropion|bupropion|mesh-list
153800973|NCT00285155|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
153800974|NCT00285155|Antidepressive Agents|antidepressive agents|mesh-ancestor
153800975|NCT00285155|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153800976|NCT00285155|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
153800977|NCT00285155|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153800978|NCT00285155|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153800979|NCT00285155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153800980|NCT00285155|Dopamine Agents|dopamine agents|mesh-ancestor
153800981|NCT00285155|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153800982|NCT00285155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153800983|NCT00285155|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
153800984|NCT00285155|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153800985|NCT00285155|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153800986|NCT00319293|Metformin|metformin|mesh-list
153800987|NCT00319293|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153800988|NCT00319293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153800989|NCT00319332|Tositumomab I-131|tositumomab i-131|mesh-list
153800990|NCT00319332|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153800991|NCT00285350|Mycophenolic Acid|mycophenolic acid|mesh-list
153800992|NCT00285350|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153800993|NCT00285350|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153800994|NCT00285350|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
153800995|NCT00285350|Antitubercular Agents|antitubercular agents|mesh-ancestor
153800996|NCT00285350|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153800997|NCT00285350|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153800998|NCT00285350|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153800999|NCT00285350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153801000|NCT00285389|Dexamethasone|dexamethasone|mesh-list
153801001|NCT00285389|Cyclophosphamide|cyclophosphamide|mesh-list
153801029|NCT00285389|Mitosis Modulators|mitosis modulators|mesh-ancestor
153801030|NCT00285389|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153801031|NCT00285389|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153354815|NCT04545008|Acetylcysteine|acetylcysteine|mesh-list
153801032|NCT00285389|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153801033|NCT00285389|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153801034|NCT00285428|Veltuzumab|veltuzumab|mesh-list
153801035|NCT00285428|Antibodies|antibodies|mesh-list
153801036|NCT00285428|Immunologic Factors|immunologic factors|mesh-ancestor
153801037|NCT00285428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153801038|NCT00285428|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153801039|NCT00312819|Disulfiram|disulfiram|mesh-list
153801040|NCT00312819|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
153476736|NCT00987558|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153801041|NCT00312819|Acetaldehyde Dehydrogenase Inhibitors|acetaldehyde dehydrogenase inhibitors|mesh-ancestor
153801042|NCT00312819|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153801043|NCT00312819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153801044|NCT00319488|Budesonide|budesonide|mesh-list
153801045|NCT00319488|Albuterol|albuterol|mesh-list
153801046|NCT00319488|Montelukast|montelukast|mesh-list
153801047|NCT00319488|Leukotriene Antagonists|leukotriene antagonists|mesh-list
153801048|NCT00319488|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153801049|NCT00319488|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153801086|NCT00285662|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153801087|NCT00285662|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153801088|NCT00285662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153801089|NCT00285662|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
153801090|NCT00319566|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
153801091|NCT00319566|Medroxyprogesterone|medroxyprogesterone|mesh-list
153801092|NCT00319566|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
153801093|NCT00319566|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
153801094|NCT00319566|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
153801095|NCT00319566|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
153801096|NCT00319566|Contraceptive Agents|contraceptive agents|mesh-ancestor
153801097|NCT00319566|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153801098|NCT00319566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153801099|NCT00319566|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
153801100|NCT00319566|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
153801101|NCT00319566|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
153476760|NCT00991458|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153801102|NCT00319566|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153801103|NCT00319566|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153801104|NCT00319566|Estrogens|estrogens|mesh-ancestor
153801106|NCT00319566|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153801107|NCT00319605|Levetiracetam|levetiracetam|mesh-list
153801108|NCT00319605|Anticonvulsants|anticonvulsants|mesh-ancestor
153801109|NCT00319605|Nootropic Agents|nootropic agents|mesh-ancestor
153801110|NCT00313053|Vincristine|vincristine|mesh-list
153801111|NCT00313053|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153801112|NCT00313053|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153801113|NCT00313053|Tubulin Modulators|tubulin modulators|mesh-ancestor
153801114|NCT00313053|Antimitotic Agents|antimitotic agents|mesh-ancestor
153801115|NCT00313053|Mitosis Modulators|mitosis modulators|mesh-ancestor
153801116|NCT00313053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153801117|NCT00285896|Glucagon|glucagon|mesh-list
153875365|NCT01682772|Olaparib|olaparib|mesh-list
153801118|NCT00285896|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
153801119|NCT00285896|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153801123|NCT00285896|Incretins|incretins|mesh-ancestor
153801124|NCT00319683|Eniluracil|eniluracil|mesh-list
153801125|NCT00319683|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153801126|NCT00319683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153801127|NCT00286052|Naloxone|naloxone|mesh-list
153801128|NCT00286052|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
153801129|NCT00286052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153801130|NCT00286052|Sensory System Agents|sensory system agents|mesh-ancestor
153801131|NCT00286052|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153801132|NCT00319761|Calcitriol|calcitriol|mesh-list
153354820|NCT04545008|Expectorants|expectorants|mesh-ancestor
153801134|NCT00319761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153801186|NCT00319800|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153801187|NCT00319800|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153801188|NCT00313131|Metronidazole|metronidazole|mesh-list
153801189|NCT00313131|Fluconazole|fluconazole|mesh-list
153801190|NCT00313131|Clotrimazole|clotrimazole|mesh-list
153801191|NCT00313131|Miconazole|miconazole|mesh-list
153801192|NCT00313131|Tinidazole|tinidazole|mesh-list
153801193|NCT00313131|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153354832|NCT04545008|Histamine Agents|histamine agents|mesh-ancestor
153354833|NCT04545008|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153801194|NCT00313131|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153801195|NCT00313131|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153801196|NCT00313131|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153801197|NCT00313131|Antifungal Agents|antifungal agents|mesh-ancestor
153801250|NCT00286403|Dopamine Agents|dopamine agents|mesh-ancestor
153801251|NCT00286403|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153801252|NCT00286403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153801253|NCT00313287|Clevudine|clevudine|mesh-list
153801254|NCT00313287|Antiviral Agents|antiviral agents|mesh-ancestor
153801255|NCT00313287|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153801256|NCT00286481|Simvastatin|simvastatin|mesh-list
153801257|NCT00286481|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153801258|NCT00286481|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153347838|NCT01384591|Antioxidants|antioxidants|mesh-ancestor
153801259|NCT00286481|Antimetabolites|antimetabolites|mesh-ancestor
153801264|NCT00320034|Albuterol|albuterol|mesh-list
153801312|NCT00320268|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153801313|NCT00320268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153801315|NCT00417404|Vitamin A|vitamin a|mesh-list
153801316|NCT00417404|Retinol palmitate|retinol palmitate|mesh-list
153801317|NCT00417404|Micronutrients|micronutrients|mesh-ancestor
153801318|NCT00417404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153801319|NCT00417404|Antioxidants|antioxidants|mesh-ancestor
153354834|NCT04527770|Dexamethasone|dexamethasone|mesh-list
153354835|NCT04527770|Midazolam|midazolam|mesh-list
153354836|NCT04527770|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153354838|NCT04527770|Autonomic Agents|autonomic agents|mesh-ancestor
153354839|NCT04527770|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153354840|NCT04527770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153354841|NCT04527770|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153354842|NCT04527770|Glucocorticoids|glucocorticoids|mesh-ancestor
153354843|NCT04527770|Hormones|hormones|mesh-ancestor
153354844|NCT04527770|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153354845|NCT04527770|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153354846|NCT04527770|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153354847|NCT04527770|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153801320|NCT00417404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153801322|NCT00417404|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
153801323|NCT00417404|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153801324|NCT00417443|Clonidine|clonidine|mesh-list
153801325|NCT00417443|Analgesics|analgesics|mesh-ancestor
153801326|NCT00417443|Sensory System Agents|sensory system agents|mesh-ancestor
153801327|NCT00417443|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153875371|NCT01649037|Epinephrine|epinephrine|mesh-list
153801329|NCT00417443|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153801330|NCT00417443|Sympatholytics|sympatholytics|mesh-ancestor
153801331|NCT00417443|Autonomic Agents|autonomic agents|mesh-ancestor
153347916|NCT01043393|Desoximetasone|desoximetasone|mesh-list
153801332|NCT00417443|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
153801333|NCT00417443|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153801334|NCT00417443|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153801335|NCT00417443|Adrenergic Agents|adrenergic agents|mesh-ancestor
153801336|NCT00417443|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153801337|NCT00417443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153801359|NCT00320307|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153801360|NCT00320307|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153801361|NCT00320307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153801362|NCT00320307|Antiviral Agents|antiviral agents|mesh-ancestor
153801363|NCT00320307|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153801364|NCT00320307|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153801365|NCT00320307|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153801426|NCT00287300|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
153801427|NCT00287300|Anthelmintics|anthelmintics|mesh-ancestor
153801428|NCT00287300|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153801429|NCT00287300|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153476987|NCT01015170|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
153801430|NCT00287300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153354860|NCT01798940|Pioglitazone|pioglitazone|mesh-list
153354861|NCT01798940|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153354862|NCT01798940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153354863|NCT00609128|Olopatadine Hydrochloride|olopatadine hydrochloride|mesh-list
153354864|NCT00609128|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153801431|NCT00287300|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
153801433|NCT00287378|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
153801434|NCT00287378|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153801435|NCT00287378|Respiratory System Agents|respiratory system agents|mesh-ancestor
153801436|NCT00320580|Ethinyl Estradiol|ethinyl estradiol|mesh-list
153801437|NCT00320580|Norelgestromin|norelgestromin|mesh-list
153801438|NCT00320580|Estradiol|estradiol|mesh-list
153801439|NCT00320580|Estrogens|estrogens|mesh-ancestor
153801440|NCT00320580|Hormones|hormones|mesh-ancestor
153801441|NCT00320580|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153801442|NCT00320580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153801443|NCT00320580|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
153801444|NCT00320580|Contraceptive Agents|contraceptive agents|mesh-ancestor
153801445|NCT00320580|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153801446|NCT00320580|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
153801447|NCT00320580|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
153801448|NCT00320580|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
153801450|NCT00320619|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
153801451|NCT00320619|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153801452|NCT00320619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153801453|NCT00320619|Hemostatics|hemostatics|mesh-ancestor
153801454|NCT00320619|Coagulants|coagulants|mesh-ancestor
153801455|NCT00287456|Insulin|insulin|mesh-list
153801456|NCT00287456|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
153801457|NCT00287456|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153801470|NCT00287495|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153801471|NCT00287495|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153801472|NCT00287495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153801473|NCT00320658|Aluminum Hydroxide|aluminum hydroxide|mesh-list
153801474|NCT00320658|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153801475|NCT00320658|Immunologic Factors|immunologic factors|mesh-ancestor
153801476|NCT00320658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153801477|NCT00320658|Antacids|antacids|mesh-ancestor
153477038|NCT04147416|Propofol|propofol|mesh-list
153801478|NCT00320658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153477039|NCT04147416|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153801479|NCT00320658|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153801481|NCT00287534|Anastrozole|anastrozole|mesh-list
153801482|NCT00287534|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
153801483|NCT00287534|Hormone Antagonists|hormone antagonists|mesh-ancestor
153801484|NCT00287534|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153354916|NCT00611468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153354917|NCT00611468|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153354918|NCT00611468|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
153354919|NCT00611468|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153354920|NCT00670202|Fasudil|fasudil|mesh-list
153354921|NCT00670202|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153354922|NCT00670202|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153424567|NCT04036292|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
153424579|NCT00377390|Omalizumab|omalizumab|mesh-list
153801485|NCT00287534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153801486|NCT00287534|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153801487|NCT00287534|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153801495|NCT00320697|Bupropion|bupropion|mesh-list
153801523|NCT00320736|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
153801524|NCT00320736|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153801525|NCT00320736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153801526|NCT00320736|Cholinergic Agents|cholinergic agents|mesh-ancestor
153801527|NCT00320736|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153801528|NCT00320736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153801529|NCT00320736|Parasympathomimetics|parasympathomimetics|mesh-ancestor
153801530|NCT00320736|Autonomic Agents|autonomic agents|mesh-ancestor
153801531|NCT00320736|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153801532|NCT00320736|Nootropic Agents|nootropic agents|mesh-ancestor
153801533|NCT00287768|Docetaxel|docetaxel|mesh-list
153801534|NCT00287768|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153801535|NCT00287768|Tubulin Modulators|tubulin modulators|mesh-ancestor
153801536|NCT00287768|Antimitotic Agents|antimitotic agents|mesh-ancestor
153416155|NCT03889106|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153416156|NCT00368329|Carboplatin|carboplatin|mesh-list
153416157|NCT00368329|Capecitabine|capecitabine|mesh-list
153416158|NCT00368329|Fluorouracil|fluorouracil|mesh-list
153416159|NCT00368329|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
153416160|NCT00368329|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153416161|NCT00368329|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153416162|NCT00368329|Antimetabolites|antimetabolites|mesh-ancestor
153416163|NCT00368329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153416164|NCT00368329|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153416166|NCT00368329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153416167|NCT00368329|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
153416168|NCT02670343|Methyltestosterone|methyltestosterone|mesh-list
153416170|NCT02670343|Testosterone undecanoate|testosterone undecanoate|mesh-list
153801538|NCT00287768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153801539|NCT00320775|Aflibercept|aflibercept|mesh-list
153801540|NCT00320775|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153801541|NCT00320775|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153801542|NCT00320775|Growth Substances|growth substances|mesh-ancestor
153801543|NCT00320775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153801544|NCT00320775|Growth Inhibitors|growth inhibitors|mesh-ancestor
153801545|NCT00320775|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153354925|NCT00670202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153801546|NCT00320814|Aflibercept|aflibercept|mesh-list
153801547|NCT00320814|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153801572|NCT00287924|Methotrexate|methotrexate|mesh-list
153801573|NCT00287924|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
153801574|NCT00287924|Abortifacient Agents|abortifacient agents|mesh-ancestor
153801575|NCT00287924|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153801576|NCT00287924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153801577|NCT00287924|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153801578|NCT00287924|Antimetabolites|antimetabolites|mesh-ancestor
153801579|NCT00287924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153801580|NCT00287924|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153801581|NCT00287924|Dermatologic Agents|dermatologic agents|mesh-ancestor
153801582|NCT00287924|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153801583|NCT00287924|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153801584|NCT00287924|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153801585|NCT00287924|Immunologic Factors|immunologic factors|mesh-ancestor
153801586|NCT00287924|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153801587|NCT00287924|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153801588|NCT00287963|Topotecan|topotecan|mesh-list
153801589|NCT00287963|Vinorelbine|vinorelbine|mesh-list
153801590|NCT00287963|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
153801591|NCT00287963|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153801592|NCT00287963|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153801593|NCT00287963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153801594|NCT00287963|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153801595|NCT00287963|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153801596|NCT00287963|Tubulin Modulators|tubulin modulators|mesh-ancestor
153801597|NCT00287963|Antimitotic Agents|antimitotic agents|mesh-ancestor
153801598|NCT00287963|Mitosis Modulators|mitosis modulators|mesh-ancestor
153801599|NCT00320892|Atropine|atropine|mesh-list
153801601|NCT00320892|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153801602|NCT00320892|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153801603|NCT00320892|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153801605|NCT00320892|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153801606|NCT00320892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153801611|NCT00320892|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
153801612|NCT00320892|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
153801613|NCT00320892|Cholinergic Agents|cholinergic agents|mesh-ancestor
153801614|NCT00320892|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153801615|NCT00320892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153801616|NCT00320892|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
153801617|NCT00288002|Cyclophosphamide|cyclophosphamide|mesh-list
153801619|NCT00288002|Capecitabine|capecitabine|mesh-list
153801620|NCT00288002|Trastuzumab|trastuzumab|mesh-list
153801621|NCT00288002|Epirubicin|epirubicin|mesh-list
153875424|NCT04542629|Trace Elements|trace elements|mesh-list
153875425|NCT04542629|Rituximab|rituximab|mesh-list
153875426|NCT04542629|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153875427|NCT04542629|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153875428|NCT04542629|Immunologic Factors|immunologic factors|mesh-ancestor
153877570|NCT05653401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153801623|NCT00288002|Immunologic Factors|immunologic factors|mesh-ancestor
153801624|NCT00288002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153801625|NCT00288002|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153801626|NCT00288002|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153801627|NCT00288002|Alkylating Agents|alkylating agents|mesh-ancestor
153801628|NCT00288002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153801629|NCT00288002|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153801630|NCT00288002|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153801631|NCT00288002|Tubulin Modulators|tubulin modulators|mesh-ancestor
153801632|NCT00288002|Antimitotic Agents|antimitotic agents|mesh-ancestor
153801633|NCT00288002|Mitosis Modulators|mitosis modulators|mesh-ancestor
153801634|NCT00288002|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153801635|NCT00288002|Antimetabolites|antimetabolites|mesh-ancestor
153801636|NCT00288002|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153801637|NCT00288002|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153801638|NCT00288002|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153801639|NCT00288002|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153801640|NCT00288002|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153801641|NCT00322569|Pimecrolimus|pimecrolimus|mesh-list
153801642|NCT00322569|Paclitaxel|paclitaxel|mesh-list
153801643|NCT00322569|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
153801644|NCT00322569|Tacrolimus|tacrolimus|mesh-list
153801645|NCT00322569|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153801646|NCT00322569|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153801647|NCT00322569|Tubulin Modulators|tubulin modulators|mesh-ancestor
153801649|NCT00322569|Mitosis Modulators|mitosis modulators|mesh-ancestor
153801650|NCT00322569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153801651|NCT00322569|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153801653|NCT00322569|Analgesics|analgesics|mesh-ancestor
153801654|NCT00322569|Sensory System Agents|sensory system agents|mesh-ancestor
153801655|NCT00322569|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153801656|NCT00322569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153801657|NCT00322569|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153801658|NCT00322569|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153801659|NCT00322569|Dermatologic Agents|dermatologic agents|mesh-ancestor
153875429|NCT04542629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153801660|NCT00322569|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153801661|NCT00322569|Immunologic Factors|immunologic factors|mesh-ancestor
153801662|NCT00322569|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
153801663|NCT00322569|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153801664|NCT00288041|Paclitaxel|paclitaxel|mesh-list
153801665|NCT00288041|Carboplatin|carboplatin|mesh-list
153801666|NCT00288041|Bortezomib|bortezomib|mesh-list
153801667|NCT00288041|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153801668|NCT00288041|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153801669|NCT00288041|Tubulin Modulators|tubulin modulators|mesh-ancestor
153801670|NCT00288041|Antimitotic Agents|antimitotic agents|mesh-ancestor
153801671|NCT00288041|Mitosis Modulators|mitosis modulators|mesh-ancestor
153801672|NCT00288041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153801673|NCT00320970|Candesartan|candesartan|mesh-list
153801674|NCT00320970|Candesartan cilexetil|candesartan cilexetil|mesh-list
153801675|NCT00320970|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153801696|NCT00288197|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153801697|NCT00288197|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
153801698|NCT00288197|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153801699|NCT00288197|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153801700|NCT00288197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153801701|NCT00288197|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153801702|NCT00288197|Hormone Antagonists|hormone antagonists|mesh-ancestor
153801703|NCT00288197|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153348286|NCT05306405|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153801704|NCT00288197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153801705|NCT00288197|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
153801706|NCT00288236|Rimonabant|rimonabant|mesh-list
153801707|NCT00288236|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
153801708|NCT00288236|Cannabinoid Receptor Antagonists|cannabinoid receptor antagonists|mesh-ancestor
153801709|NCT00288236|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
153801751|NCT00288431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153801753|NCT00321165|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153801754|NCT00321165|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
153801755|NCT00321165|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153801756|NCT00322803|1-(4-chlorophenyl)-4-piperidin-1-yl-1,5-dihydroimidazol-2-one|1-(4-chlorophenyl)-4-piperidin-1-yl-1,5-dihydroimidazol-2-one|mesh-list
153801765|NCT00322803|GABA Agents|gaba agents|mesh-ancestor
153801818|NCT00288548|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153875444|NCT02215733|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
153477302|NCT05822323|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153801819|NCT00288548|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153801820|NCT00288548|Sympatholytics|sympatholytics|mesh-ancestor
153801821|NCT00288548|Autonomic Agents|autonomic agents|mesh-ancestor
153801822|NCT00288548|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153801823|NCT00288548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153801824|NCT00288548|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
153801825|NCT00288548|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
153801826|NCT00288548|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
153801827|NCT00288548|Adrenergic Agents|adrenergic agents|mesh-ancestor
153355014|NCT00672932|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
153355015|NCT00672932|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153355016|NCT00672932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153355017|NCT02513550|Ixekizumab|ixekizumab|mesh-list
153355018|NCT02513550|Dermatologic Agents|dermatologic agents|mesh-ancestor
153355019|NCT00673712|Analgesics, Opioid|analgesics, opioid|mesh-list
153801828|NCT00288548|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153801829|NCT00288548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153801830|NCT00321477|Casopitant|casopitant|mesh-list
153801831|NCT00321477|Antiemetics|antiemetics|mesh-ancestor
153801832|NCT00321477|Autonomic Agents|autonomic agents|mesh-ancestor
153801833|NCT00321477|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153801834|NCT00321477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153801835|NCT00321477|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153801836|NCT00321477|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
153801837|NCT00321477|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153801838|NCT00321477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153801839|NCT00321516|Aripiprazole|aripiprazole|mesh-list
153801840|NCT00321516|Antidepressive Agents|antidepressive agents|mesh-ancestor
153801841|NCT00321516|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153801842|NCT00321516|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153801843|NCT00321516|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153801844|NCT00321516|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153801845|NCT00321516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153801846|NCT00321516|Dopamine Agonists|dopamine agonists|mesh-ancestor
153801857|NCT06140277|Chitosan|chitosan|mesh-list
153801858|NCT06140277|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153801859|NCT06140277|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153801860|NCT06140277|Antimetabolites|antimetabolites|mesh-ancestor
153801861|NCT06140277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153801862|NCT06140277|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153801863|NCT06140277|Chelating Agents|chelating agents|mesh-ancestor
153801864|NCT06140277|Sequestering Agents|sequestering agents|mesh-ancestor
153801865|NCT06140277|Hemostatics|hemostatics|mesh-ancestor
153801866|NCT06140277|Coagulants|coagulants|mesh-ancestor
153801867|NCT06140251|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
153801868|NCT06140251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153801869|NCT06140251|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153801870|NCT06140251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153801871|NCT06140238|Parecoxib|parecoxib|mesh-list
153801872|NCT06140238|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
153801873|NCT06140238|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153801874|NCT06140238|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153801875|NCT06140238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153416199|NCT02731820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153416200|NCT02731820|Antacids|antacids|mesh-ancestor
153416201|NCT02731820|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153355020|NCT00673712|Narcotics|narcotics|mesh-ancestor
153355021|NCT00673712|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153355022|NCT00673712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153355023|NCT00673712|Analgesics|analgesics|mesh-ancestor
153355024|NCT00673712|Sensory System Agents|sensory system agents|mesh-ancestor
153355026|NCT04062032|Aspirin|aspirin|mesh-list
153477360|NCT05821153|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153801876|NCT06140238|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153801877|NCT06140238|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153801878|NCT06140238|Analgesics|analgesics|mesh-ancestor
153477361|NCT05821062|Aspirin|aspirin|mesh-list
153801879|NCT06140238|Sensory System Agents|sensory system agents|mesh-ancestor
153801880|NCT06140238|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153801881|NCT06140238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153801882|NCT06140238|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153801883|NCT06140238|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153801884|NCT06140095|Atorvastatin|atorvastatin|mesh-list
153801885|NCT06140095|Evolocumab|evolocumab|mesh-list
153801886|NCT06140095|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153801887|NCT06140095|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153801888|NCT06140095|Antimetabolites|antimetabolites|mesh-ancestor
153801899|NCT06139952|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153801900|NCT06139952|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153801901|NCT06139952|Antimetabolites|antimetabolites|mesh-ancestor
153801902|NCT06139952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153801903|NCT06139952|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153801904|NCT06139952|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
153801905|NCT06139952|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153801906|NCT06139952|Antiviral Agents|antiviral agents|mesh-ancestor
153477386|NCT05817162|Anesthetics, Local|anesthetics, local|mesh-ancestor
153801907|NCT06139952|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153801909|NCT06139952|Respiratory System Agents|respiratory system agents|mesh-ancestor
153801910|NCT06139952|Free Radical Scavengers|free radical scavengers|mesh-ancestor
153801911|NCT06139952|Antioxidants|antioxidants|mesh-ancestor
153801912|NCT06139952|Protective Agents|protective agents|mesh-ancestor
153801913|NCT06139952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153801914|NCT06139952|Antidotes|antidotes|mesh-ancestor
153801915|NCT06139926|Dexmedetomidine|dexmedetomidine|mesh-list
153801920|NCT06139926|Analgesics|analgesics|mesh-ancestor
153801957|NCT06139211|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
153801958|NCT06139211|Bevacizumab|bevacizumab|mesh-list
153801959|NCT06139211|Gemcitabine|gemcitabine|mesh-list
153801960|NCT06139211|Capecitabine|capecitabine|mesh-list
153801961|NCT06139211|Fluorouracil|fluorouracil|mesh-list
153801962|NCT06139211|Oxaliplatin|oxaliplatin|mesh-list
153801963|NCT06139211|Irinotecan|irinotecan|mesh-list
153801964|NCT06139211|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153801965|NCT06139211|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153801966|NCT06139211|Tubulin Modulators|tubulin modulators|mesh-ancestor
153801967|NCT06139211|Antimitotic Agents|antimitotic agents|mesh-ancestor
153801968|NCT06139211|Mitosis Modulators|mitosis modulators|mesh-ancestor
153416202|NCT02731820|Diuretics|diuretics|mesh-ancestor
153801969|NCT06139211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153801970|NCT06139211|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153801971|NCT06139211|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153801972|NCT06139211|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153801973|NCT06139211|Growth Substances|growth substances|mesh-ancestor
153801974|NCT06139211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153801975|NCT06139211|Growth Inhibitors|growth inhibitors|mesh-ancestor
153802013|NCT06138769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153802014|NCT06138574|Dexmedetomidine|dexmedetomidine|mesh-list
153802015|NCT06138574|Remifentanil|remifentanil|mesh-list
153802016|NCT06138574|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153802017|NCT06138574|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153802018|NCT06138574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153802019|NCT06138574|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153802020|NCT06138574|Analgesics|analgesics|mesh-ancestor
153802021|NCT06138574|Sensory System Agents|sensory system agents|mesh-ancestor
153477449|NCT05557877|Analgesics|analgesics|mesh-ancestor
153477450|NCT05557877|Sensory System Agents|sensory system agents|mesh-ancestor
153802022|NCT06138574|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153802023|NCT06138574|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
153802024|NCT06138574|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153802025|NCT06138574|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153802026|NCT06138574|Adrenergic Agents|adrenergic agents|mesh-ancestor
153802027|NCT06138574|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153802073|NCT06129916|Buprenorphine|buprenorphine|mesh-list
153802074|NCT06129916|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153802075|NCT06129916|Narcotics|narcotics|mesh-ancestor
153802076|NCT06129916|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153802077|NCT06129916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153802078|NCT06129916|Analgesics|analgesics|mesh-ancestor
153802079|NCT06129916|Sensory System Agents|sensory system agents|mesh-ancestor
153802080|NCT06129916|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153802081|NCT06129916|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
153802082|NCT06103617|Penicillamine|penicillamine|mesh-list
153802083|NCT06103617|Antidotes|antidotes|mesh-ancestor
153802084|NCT06103617|Protective Agents|protective agents|mesh-ancestor
153802085|NCT06103617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153802086|NCT06103617|Chelating Agents|chelating agents|mesh-ancestor
153802087|NCT06103617|Sequestering Agents|sequestering agents|mesh-ancestor
153802088|NCT06103617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153802089|NCT06103617|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153802090|NCT06096025|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
153802091|NCT06096025|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153416229|NCT02733757|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153802093|NCT06083480|N-monoacetylcystine|n-monoacetylcystine|mesh-list
153802094|NCT06083480|Glycine|glycine|mesh-list
153802095|NCT06083480|Antiviral Agents|antiviral agents|mesh-ancestor
153802096|NCT06083480|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153802097|NCT06083480|Expectorants|expectorants|mesh-ancestor
153802098|NCT06083480|Respiratory System Agents|respiratory system agents|mesh-ancestor
153802099|NCT06083480|Free Radical Scavengers|free radical scavengers|mesh-ancestor
153802100|NCT06083480|Antioxidants|antioxidants|mesh-ancestor
153802123|NCT06053853|Antitoxins|antitoxins|mesh-list
153802124|NCT06053853|Diphtheria Antitoxin|diphtheria antitoxin|mesh-list
153802125|NCT06053853|Immunologic Factors|immunologic factors|mesh-ancestor
153802126|NCT06053853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153802127|NCT06020144|Tofacitinib|tofacitinib|mesh-list
153802128|NCT06020144|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
153802129|NCT06020144|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153802130|NCT06020144|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153802131|NCT06020144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153802132|NCT06002490|Aspirin|aspirin|mesh-list
153802133|NCT06002490|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153802134|NCT06002490|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153802135|NCT06002490|Analgesics|analgesics|mesh-ancestor
153802185|NCT05863312|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153802186|NCT05863312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153802187|NCT05863312|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153802188|NCT05863312|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153802189|NCT05863312|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153802190|NCT05863312|GABA Modulators|gaba modulators|mesh-ancestor
153802191|NCT05863312|GABA Agents|gaba agents|mesh-ancestor
153802192|NCT05863312|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153802193|NCT05863312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153802194|NCT05848375|Levobupivacaine|levobupivacaine|mesh-list
153802195|NCT05848375|Ropivacaine|ropivacaine|mesh-list
153802196|NCT05848375|Anesthetics, Local|anesthetics, local|mesh-ancestor
153802198|NCT05848375|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153802199|NCT05848375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153802200|NCT05848375|Sensory System Agents|sensory system agents|mesh-ancestor
153416230|NCT02733757|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153416231|NCT02733757|Adrenergic Agents|adrenergic agents|mesh-ancestor
153416232|NCT02733757|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153416233|NCT02733757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153416234|NCT00368264|Infliximab|infliximab|mesh-list
153416237|NCT00368264|Dermatologic Agents|dermatologic agents|mesh-ancestor
153802201|NCT05848375|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153802202|NCT05834036|Amoxicillin|amoxicillin|mesh-list
153355108|NCT03007303|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153355109|NCT03007303|Serotonin Agents|serotonin agents|mesh-ancestor
153355110|NCT03007303|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153355111|NCT03007303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153355112|NCT03007303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153355113|NCT03007303|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153355114|NCT03007303|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153355115|NCT03007303|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153355116|NCT03007303|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
153355117|NCT03007303|Dopamine Agents|dopamine agents|mesh-ancestor
153802203|NCT05834036|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153802204|NCT05834036|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153802205|NCT05826912|Minocycline|minocycline|mesh-list
153802206|NCT05826912|Candesartan|candesartan|mesh-list
153802207|NCT05826912|Candesartan cilexetil|candesartan cilexetil|mesh-list
153802208|NCT05826912|Atorvastatin|atorvastatin|mesh-list
153802209|NCT05826912|Calcium|calcium|mesh-list
153802210|NCT05826912|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153802211|NCT05826912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153802212|NCT05826912|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153802213|NCT05826912|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153802214|NCT05826912|Antimetabolites|antimetabolites|mesh-ancestor
153802215|NCT05826912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153802229|NCT05799144|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153802230|NCT05799144|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153802231|NCT05799144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153802232|NCT05781542|MEDI9197|medi9197|mesh-list
153802233|NCT05781542|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153802234|NCT05781542|Immunologic Factors|immunologic factors|mesh-ancestor
153802235|NCT05781542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153802236|NCT05781217|Goserelin|goserelin|mesh-list
153802237|NCT05781217|Triptorelin Pamoate|triptorelin pamoate|mesh-list
153802238|NCT05781217|Leuprolide|leuprolide|mesh-list
153802240|NCT05781217|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153802294|NCT05638217|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153802295|NCT05597098|Cantharidin|cantharidin|mesh-list
153802296|NCT05597098|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153802297|NCT05597098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153802298|NCT05585151|Evolocumab|evolocumab|mesh-list
153802299|NCT05585151|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
153348878|NCT00297596|Oxaliplatin|oxaliplatin|mesh-list
153802300|NCT05585151|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153802301|NCT05585151|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153802302|NCT05585151|Antimetabolites|antimetabolites|mesh-ancestor
153802303|NCT05585151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153802304|NCT05585151|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
153802305|NCT05585151|Protease Inhibitors|protease inhibitors|mesh-ancestor
153875499|NCT01201759|Analgesics|analgesics|mesh-ancestor
153875500|NCT01201759|Sensory System Agents|sensory system agents|mesh-ancestor
153416265|NCT03609008|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153355134|NCT01585441|Urological Agents|urological agents|mesh-ancestor
153355135|NCT00617942|Paclitaxel|paclitaxel|mesh-list
153416266|NCT03609008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153802306|NCT05585151|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153802307|NCT05585151|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153477743|NCT04716296|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
153477744|NCT04716296|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153802308|NCT05585125|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
153802309|NCT05585125|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
153802310|NCT05585125|Adrenergic Agents|adrenergic agents|mesh-ancestor
153802311|NCT05585125|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153802312|NCT05585125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153802313|NCT05585125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153802315|NCT05541497|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
153802316|NCT05541497|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
153802317|NCT05541497|Cholinergic Agents|cholinergic agents|mesh-ancestor
153802318|NCT05541497|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153802320|NCT05541497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153802342|NCT05313620|Infliximab|infliximab|mesh-list
153802343|NCT05313620|Golimumab|golimumab|mesh-list
153802344|NCT05313620|Tofacitinib|tofacitinib|mesh-list
153802345|NCT05313620|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
153802346|NCT05313620|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153802347|NCT05313620|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153802348|NCT05313620|Dermatologic Agents|dermatologic agents|mesh-ancestor
153802409|NCT05194397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153802410|NCT05194397|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153802411|NCT05194397|Antimetabolites|antimetabolites|mesh-ancestor
153802412|NCT05194397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153802413|NCT05194397|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153802414|NCT05194397|Vasodilator Agents|vasodilator agents|mesh-ancestor
153802415|NCT05114096|Betamethasone|betamethasone|mesh-list
153802416|NCT05114096|Betamethasone Valerate|betamethasone valerate|mesh-list
153802417|NCT05114096|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
153802418|NCT05114096|Betamethasone benzoate|betamethasone benzoate|mesh-list
153802419|NCT05114096|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
153802420|NCT05114096|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153802421|NCT05114096|Glucocorticoids|glucocorticoids|mesh-ancestor
153802422|NCT05114096|Hormones|hormones|mesh-ancestor
153802423|NCT05114096|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153802424|NCT05114096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153802425|NCT05114096|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153416267|NCT03609008|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153416268|NCT03609008|Respiratory System Agents|respiratory system agents|mesh-ancestor
153416269|NCT03609008|Parasympatholytics|parasympatholytics|mesh-ancestor
153416270|NCT03609008|Vasodilator Agents|vasodilator agents|mesh-ancestor
153416271|NCT02734238|Methyltestosterone|methyltestosterone|mesh-list
153416272|NCT02734238|Testosterone|testosterone|mesh-list
153416273|NCT02734238|Testosterone undecanoate|testosterone undecanoate|mesh-list
153416274|NCT02734238|Testosterone enanthate|testosterone enanthate|mesh-list
153355170|NCT00619190|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
153355171|NCT00619190|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
153355172|NCT00619190|Serotonin Agents|serotonin agents|mesh-ancestor
153355173|NCT00619190|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
153355174|NCT00619190|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153355175|NCT00619190|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
153355176|NCT00619190|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
153883924|NCT00591708|Sodium Citrate|sodium citrate|mesh-list
153416275|NCT02734238|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
153416276|NCT02734238|Androgens|androgens|mesh-ancestor
153416277|NCT02734238|Hormones|hormones|mesh-ancestor
153416278|NCT02734238|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153416279|NCT02734238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153416280|NCT02734238|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153802426|NCT05114096|Respiratory System Agents|respiratory system agents|mesh-ancestor
153802427|NCT05036291|Sotorasib|sotorasib|mesh-list
153802428|NCT05036291|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153802429|NCT05036291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153802430|NCT05036291|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153802431|NCT05036291|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153802432|NCT04981860|Povidone-Iodine|povidone-iodine|mesh-list
153802433|NCT04981860|Povidone|povidone|mesh-list
153802434|NCT04981860|Plasma Substitutes|plasma substitutes|mesh-ancestor
153802435|NCT04981860|Blood Substitutes|blood substitutes|mesh-ancestor
153802436|NCT04981860|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
153802437|NCT04981860|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153802438|NCT04979910|Ixekizumab|ixekizumab|mesh-list
153802439|NCT04979910|Dermatologic Agents|dermatologic agents|mesh-ancestor
153802440|NCT04889664|Ketamine|ketamine|mesh-list
153802441|NCT04889664|Analgesics|analgesics|mesh-ancestor
153802442|NCT04889664|Sensory System Agents|sensory system agents|mesh-ancestor
153802443|NCT04889664|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153802448|NCT04889664|Anesthetics|anesthetics|mesh-ancestor
153802449|NCT04889664|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153802450|NCT04889664|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
153802451|NCT04889664|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
153802452|NCT04889664|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153802453|NCT04889664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153802454|NCT04827992|Analgesics, Opioid|analgesics, opioid|mesh-list
153802455|NCT04827992|Narcotics|narcotics|mesh-ancestor
153802456|NCT04827992|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153802457|NCT04827992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153802458|NCT04827992|Analgesics|analgesics|mesh-ancestor
153802459|NCT04827992|Sensory System Agents|sensory system agents|mesh-ancestor
153802460|NCT04827992|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153802461|NCT04740671|Ranibizumab|ranibizumab|mesh-list
153802462|NCT04740671|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153802463|NCT04740671|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153802464|NCT04740671|Growth Substances|growth substances|mesh-ancestor
153802507|NCT04679012|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153802508|NCT04679012|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153802509|NCT04679012|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153355190|NCT00619970|Rifaximin|rifaximin|mesh-list
153875531|NCT01649466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153875532|NCT01200589|Rituximab|rituximab|mesh-list
153875533|NCT01200589|Ofatumumab|ofatumumab|mesh-list
153875534|NCT01200589|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
153875535|NCT01200589|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153875536|NCT01200589|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153875537|NCT01200589|Immunologic Factors|immunologic factors|mesh-ancestor
153875538|NCT01200589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153875539|NCT01200589|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153875540|NCT01683552|Fexofenadine|fexofenadine|mesh-list
153875541|NCT01683552|Prednisone|prednisone|mesh-list
153875542|NCT01683552|Aprepitant|aprepitant|mesh-list
153875543|NCT01683552|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153875544|NCT01683552|Glucocorticoids|glucocorticoids|mesh-ancestor
153875545|NCT01683552|Hormones|hormones|mesh-ancestor
153875546|NCT01683552|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153875547|NCT01683552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153875548|NCT01683552|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153802510|NCT04679012|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153802511|NCT04679012|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153802512|NCT04679012|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153802513|NCT04679012|Glucocorticoids|glucocorticoids|mesh-ancestor
153802515|NCT04679012|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153802516|NCT04679012|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153802518|NCT04679012|Immunoconjugates|immunoconjugates|mesh-ancestor
153802519|NCT04612790|Benralizumab|benralizumab|mesh-list
153802520|NCT04612790|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153802521|NCT04612790|Respiratory System Agents|respiratory system agents|mesh-ancestor
153802522|NCT04602377|Pembrolizumab|pembrolizumab|mesh-list
153802523|NCT04602377|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153802524|NCT04602377|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153802525|NCT04602377|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153349090|NCT03418805|Analgesics|analgesics|mesh-ancestor
153802526|NCT04602377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153802527|NCT04579380|Trastuzumab|trastuzumab|mesh-list
153802528|NCT04579380|Fulvestrant|fulvestrant|mesh-list
153349162|NCT00301028|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153802529|NCT04579380|Tucatinib|tucatinib|mesh-list
153802530|NCT04579380|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153802531|NCT04579380|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153802532|NCT04579380|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153802533|NCT04579380|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
153802534|NCT04579380|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
153802535|NCT04579380|Hormone Antagonists|hormone antagonists|mesh-ancestor
153802536|NCT04579380|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153802537|NCT04579380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153802538|NCT04579380|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153802539|NCT04579380|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153802540|NCT04579380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153802542|NCT04572295|Exemestane|exemestane|mesh-list
153802543|NCT04572295|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153802544|NCT04572295|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153802545|NCT04572295|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
153802546|NCT04572295|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
153802547|NCT04572295|Hormone Antagonists|hormone antagonists|mesh-ancestor
153802606|NCT04495088|Vitamin B Complex|vitamin b complex|mesh-ancestor
153802608|NCT04495088|Micronutrients|micronutrients|mesh-ancestor
153802609|NCT04495088|Hematinics|hematinics|mesh-ancestor
153802610|NCT04421560|Rituximab|rituximab|mesh-list
153802611|NCT04421560|Pembrolizumab|pembrolizumab|mesh-list
153802612|NCT04421560|Ibrutinib|ibrutinib|mesh-list
153802613|NCT04421560|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153802614|NCT04421560|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153802615|NCT04421560|Immunologic Factors|immunologic factors|mesh-ancestor
153802616|NCT04421560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153802617|NCT04421560|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153802618|NCT04421560|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153802619|NCT04421560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153802620|NCT04421560|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153802621|NCT04421560|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153875550|NCT01683552|Antiemetics|antiemetics|mesh-ancestor
153802623|NCT04405167|Dexamethasone|dexamethasone|mesh-list
153802624|NCT04405167|Lenalidomide|lenalidomide|mesh-list
153802625|NCT04405167|Ixazomib|ixazomib|mesh-list
153802626|NCT04405167|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153802627|NCT04405167|Antiemetics|antiemetics|mesh-ancestor
153478112|NCT01093794|Incretins|incretins|mesh-ancestor
153802629|NCT04405167|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153802630|NCT04405167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153802631|NCT04405167|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153355267|NCT02924714|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153355268|NCT00678470|Alefacept|alefacept|mesh-list
153802633|NCT04405167|Hormones|hormones|mesh-ancestor
153802634|NCT04405167|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153802635|NCT04405167|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153802653|NCT04338763|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153802654|NCT04338763|Antimetabolites|antimetabolites|mesh-ancestor
153802655|NCT04338763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153802656|NCT04338763|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153802657|NCT04268771|Rituximab|rituximab|mesh-list
153802658|NCT04268771|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153802659|NCT04268771|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153802660|NCT04268771|Immunologic Factors|immunologic factors|mesh-ancestor
153802661|NCT04268771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153802662|NCT04268771|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153802663|NCT04253145|Atezolizumab|atezolizumab|mesh-list
153802664|NCT04253145|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153802665|NCT04253145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153802666|NCT04253145|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153802667|NCT04253145|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153802713|NCT04085744|Mometasone Furoate|mometasone furoate|mesh-list
153802714|NCT04085744|Lidocaine|lidocaine|mesh-list
153802715|NCT04085744|Anesthetics, Local|anesthetics, local|mesh-ancestor
153802716|NCT04085744|Anesthetics|anesthetics|mesh-ancestor
153802717|NCT04085744|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153802718|NCT04085744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153802719|NCT04085744|Sensory System Agents|sensory system agents|mesh-ancestor
153802720|NCT04085744|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153802721|NCT04085744|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153802722|NCT04085744|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
153802723|NCT04085744|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153416299|NCT02736175|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153416300|NCT00369356|Prednisone|prednisone|mesh-list
153416301|NCT00369356|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153416302|NCT00369356|Glucocorticoids|glucocorticoids|mesh-ancestor
153416303|NCT00369356|Hormones|hormones|mesh-ancestor
153875551|NCT01683552|Autonomic Agents|autonomic agents|mesh-ancestor
153875552|NCT01683552|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153875553|NCT01683552|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153802724|NCT04085744|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153802725|NCT04085744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153355306|NCT02174822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153355307|NCT02174822|Analgesics|analgesics|mesh-ancestor
153355308|NCT02174822|Sensory System Agents|sensory system agents|mesh-ancestor
153355309|NCT02174822|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153355310|NCT02174822|Antidepressive Agents|antidepressive agents|mesh-ancestor
153355311|NCT02174822|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153355312|NCT02174822|Dopamine Agents|dopamine agents|mesh-ancestor
153355313|NCT02174822|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
153355314|NCT02174822|Serotonin Agents|serotonin agents|mesh-ancestor
153355315|NCT02174822|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
153355316|NCT02174822|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
153355317|NCT02174822|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153355318|NCT02174822|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153355319|NCT00624416|Prednisolone|prednisolone|mesh-list
153478238|NCT01103934|Xhance|xhance|mesh-list
153802726|NCT04085744|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153802728|NCT04085744|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
153802765|NCT03961919|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153802766|NCT03961919|Alkylating Agents|alkylating agents|mesh-ancestor
153802768|NCT03947385|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153802769|NCT03947385|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153802770|NCT03947385|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153802771|NCT03947385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153802772|NCT03947385|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153802773|NCT03942328|Bevacizumab|bevacizumab|mesh-list
153802774|NCT03942328|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
153802775|NCT03942328|Atezolizumab|atezolizumab|mesh-list
153802829|NCT03901339|Sacituzumab govitecan|sacituzumab govitecan|mesh-list
153802830|NCT03901339|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153802831|NCT03901339|Antimetabolites|antimetabolites|mesh-ancestor
153802832|NCT03901339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153802833|NCT03901339|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153802834|NCT03901339|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153802835|NCT03901339|Tubulin Modulators|tubulin modulators|mesh-ancestor
153802836|NCT03901339|Antimitotic Agents|antimitotic agents|mesh-ancestor
153802837|NCT03901339|Mitosis Modulators|mitosis modulators|mesh-ancestor
153802838|NCT03901339|Immunoconjugates|immunoconjugates|mesh-ancestor
153802839|NCT03901339|Immunologic Factors|immunologic factors|mesh-ancestor
153478258|NCT01105650|Cyclophosphamide|cyclophosphamide|mesh-list
153802840|NCT03901339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153802841|NCT03885713|Adalimumab|adalimumab|mesh-list
153802842|NCT03885713|Infliximab|infliximab|mesh-list
153802843|NCT03885713|Golimumab|golimumab|mesh-list
153802844|NCT03885713|Ustekinumab|ustekinumab|mesh-list
153802845|NCT03885713|Vedolizumab|vedolizumab|mesh-list
153802846|NCT03885713|Tofacitinib|tofacitinib|mesh-list
153802847|NCT03885713|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
153802848|NCT03885713|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153802849|NCT03885713|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153802850|NCT03885713|Dermatologic Agents|dermatologic agents|mesh-ancestor
153802851|NCT03885713|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153802881|NCT03784677|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153802882|NCT03784677|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153802883|NCT03784677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153802884|NCT03718065|Lofexidine|lofexidine|mesh-list
153802885|NCT03718065|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153802886|NCT03718065|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
153355324|NCT00624416|Cortisone|cortisone|mesh-list
153355325|NCT00624416|Isoproterenol|isoproterenol|mesh-list
153355326|NCT00624416|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
153355328|NCT00624416|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153355329|NCT00624416|Glucocorticoids|glucocorticoids|mesh-ancestor
153355330|NCT00624416|Hormones|hormones|mesh-ancestor
153355331|NCT00624416|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153355332|NCT00624416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153355333|NCT00624416|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153355334|NCT00624416|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153355335|NCT00624416|Antiemetics|antiemetics|mesh-ancestor
153355336|NCT00624416|Autonomic Agents|autonomic agents|mesh-ancestor
153355337|NCT00624416|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153355338|NCT00624416|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153355339|NCT00624416|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
153425055|NCT03565328|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153802887|NCT03718065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153802888|NCT03718065|Sensory System Agents|sensory system agents|mesh-ancestor
153803011|NCT03441048|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153803012|NCT03441048|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153803013|NCT03414983|Leucovorin|leucovorin|mesh-list
153803014|NCT03414983|Bevacizumab|bevacizumab|mesh-list
153803015|NCT03414983|Nivolumab|nivolumab|mesh-list
153803016|NCT03414983|Fluorouracil|fluorouracil|mesh-list
153803017|NCT03414983|Oxaliplatin|oxaliplatin|mesh-list
153803018|NCT03414983|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153803019|NCT03414983|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153803020|NCT03414983|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153803022|NCT03414983|Growth Substances|growth substances|mesh-ancestor
153803023|NCT03414983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153803024|NCT03414983|Growth Inhibitors|growth inhibitors|mesh-ancestor
153803025|NCT03414983|Antimetabolites|antimetabolites|mesh-ancestor
153803026|NCT03414983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153803027|NCT03414983|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153803028|NCT03414983|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153803029|NCT03414983|Immunologic Factors|immunologic factors|mesh-ancestor
153803030|NCT03414983|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153803031|NCT03414983|Antidotes|antidotes|mesh-ancestor
153803032|NCT03414983|Protective Agents|protective agents|mesh-ancestor
153803033|NCT03414983|Vitamin B Complex|vitamin b complex|mesh-ancestor
153803034|NCT03414983|Vitamins|vitamins|mesh-ancestor
153803035|NCT03414983|Micronutrients|micronutrients|mesh-ancestor
153803036|NCT03396575|Cyclophosphamide|cyclophosphamide|mesh-list
153803037|NCT03396575|Fludarabine|fludarabine|mesh-list
153803038|NCT03396575|Vaccines|vaccines|mesh-list
153803039|NCT03396575|Immunologic Factors|immunologic factors|mesh-ancestor
153803056|NCT03288974|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153355340|NCT00624416|Protective Agents|protective agents|mesh-ancestor
153355341|NCT00624416|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
153355342|NCT00624416|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153355343|NCT00624416|Adrenergic Agents|adrenergic agents|mesh-ancestor
153355344|NCT00624416|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153355345|NCT00624416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153355346|NCT00624416|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153355347|NCT00624416|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153355348|NCT00624416|Respiratory System Agents|respiratory system agents|mesh-ancestor
153355349|NCT00624416|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
153355350|NCT00624416|Sympathomimetics|sympathomimetics|mesh-ancestor
153355351|NCT00626210|Modafinil|modafinil|mesh-list
153355352|NCT00626210|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
153355353|NCT00626210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153355354|NCT00626210|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
153355355|NCT00626210|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
153355356|NCT00626210|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
153355357|NCT00626210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153355358|NCT00653276|Cyclosporine|cyclosporine|mesh-list
153355359|NCT00653276|Ezetimibe|ezetimibe|mesh-list
153425101|NCT01163084|Leuprolide|leuprolide|mesh-list
153803057|NCT03288974|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153803058|NCT03288974|Growth Substances|growth substances|mesh-ancestor
153875572|NCT01649544|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
153803060|NCT03288974|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153803061|NCT03272477|Tamoxifen|tamoxifen|mesh-list
153803062|NCT03272477|Paclitaxel|paclitaxel|mesh-list
153803063|NCT03272477|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
153803064|NCT03272477|Cyclophosphamide|cyclophosphamide|mesh-list
153803065|NCT03272477|Trastuzumab|trastuzumab|mesh-list
153803066|NCT03272477|Letrozole|letrozole|mesh-list
153803067|NCT03272477|Epirubicin|epirubicin|mesh-list
153803068|NCT03272477|Pertuzumab|pertuzumab|mesh-list
153803069|NCT03272477|Anastrozole|anastrozole|mesh-list
153803070|NCT03272477|Exemestane|exemestane|mesh-list
153803071|NCT03272477|Goserelin|goserelin|mesh-list
153803072|NCT03272477|Leuprolide|leuprolide|mesh-list
153803073|NCT03272477|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153803117|NCT03080974|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153803118|NCT03080974|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153803119|NCT03080974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153803120|NCT03059563|Varenicline|varenicline|mesh-list
153803121|NCT03059563|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
153803122|NCT03059563|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
153803123|NCT03059563|Cholinergic Agents|cholinergic agents|mesh-ancestor
153803124|NCT03059563|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153803125|NCT03059563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153803126|NCT03059563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153803127|NCT03004287|Thalidomide|thalidomide|mesh-list
153803128|NCT03004287|Dexamethasone|dexamethasone|mesh-list
153803129|NCT03004287|Cyclophosphamide|cyclophosphamide|mesh-list
153803131|NCT03004287|Doxorubicin|doxorubicin|mesh-list
153803132|NCT03004287|Etoposide|etoposide|mesh-list
153803133|NCT03004287|Lenalidomide|lenalidomide|mesh-list
153803134|NCT03004287|Bortezomib|bortezomib|mesh-list
153803135|NCT03004287|Daratumumab|daratumumab|mesh-list
153803136|NCT03004287|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153803137|NCT03004287|Immunologic Factors|immunologic factors|mesh-ancestor
153803138|NCT03004287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153803139|NCT03004287|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153803140|NCT03004287|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153803141|NCT03004287|Alkylating Agents|alkylating agents|mesh-ancestor
153803142|NCT03004287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153803143|NCT03004287|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153803144|NCT03004287|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153803145|NCT03004287|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153875573|NCT01649544|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
153875574|NCT01649544|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
153875575|NCT04528290|Ozanimod|ozanimod|mesh-list
153875576|NCT04528290|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
153355360|NCT00653276|Cyclosporins|cyclosporins|mesh-list
153355361|NCT00653276|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153355362|NCT00653276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153355363|NCT00653276|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153355364|NCT00653276|Immunologic Factors|immunologic factors|mesh-ancestor
153355365|NCT00653276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153884148|NCT01601912|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
153884149|NCT01601912|Cholinergic Agents|cholinergic agents|mesh-ancestor
153884150|NCT01601912|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
153875581|NCT01179334|Sildenafil Citrate|sildenafil citrate|mesh-list
153803165|NCT03004287|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153803166|NCT02986659|Metformin|metformin|mesh-list
153803167|NCT02986659|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153803168|NCT02986659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153803169|NCT02837978|Methotrexate|methotrexate|mesh-list
153478465|NCT02410512|Atezolizumab|atezolizumab|mesh-list
153803170|NCT02837978|Tacrolimus|tacrolimus|mesh-list
153803171|NCT02837978|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
153803172|NCT02837978|Abortifacient Agents|abortifacient agents|mesh-ancestor
153803173|NCT02837978|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153803174|NCT02837978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153803175|NCT02837978|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153803176|NCT02837978|Antimetabolites|antimetabolites|mesh-ancestor
153803177|NCT02837978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153803178|NCT02837978|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153803179|NCT02837978|Dermatologic Agents|dermatologic agents|mesh-ancestor
153803180|NCT02837978|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153803181|NCT02837978|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153803182|NCT02837978|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153803183|NCT02837978|Immunologic Factors|immunologic factors|mesh-ancestor
153803184|NCT02837978|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153803185|NCT02837978|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153803186|NCT02837978|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
153803187|NCT02743806|Vedolizumab|vedolizumab|mesh-list
153803188|NCT02743806|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153803189|NCT02668653|Cytarabine|cytarabine|mesh-list
153803213|NCT02652052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153803214|NCT02652052|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153803215|NCT02652052|Antioxidants|antioxidants|mesh-ancestor
153803216|NCT02652052|Protective Agents|protective agents|mesh-ancestor
153803217|NCT02652052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153803218|NCT02615119|Isoproterenol|isoproterenol|mesh-list
153803219|NCT02615119|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
153478520|NCT01130844|Sensory System Agents|sensory system agents|mesh-ancestor
153478541|NCT01135368|Lansoprazole|lansoprazole|mesh-list
153803220|NCT02615119|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153803221|NCT02615119|Adrenergic Agents|adrenergic agents|mesh-ancestor
153803222|NCT02615119|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153803223|NCT02615119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153803224|NCT02615119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153803225|NCT02615119|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153416336|NCT00367627|Antimitotic Agents|antimitotic agents|mesh-ancestor
153416337|NCT00367627|Mitosis Modulators|mitosis modulators|mesh-ancestor
153355366|NCT00653276|Antifungal Agents|antifungal agents|mesh-ancestor
153355367|NCT00653276|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153425142|NCT01139996|Clonidine|clonidine|mesh-list
153416338|NCT00367627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153416339|NCT00367627|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153416340|NCT05443789|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
153416341|NCT05443789|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153803275|NCT02143050|Trametinib|trametinib|mesh-list
153803276|NCT02143050|Dabrafenib|dabrafenib|mesh-list
153803277|NCT02143050|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153803278|NCT02143050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153803279|NCT02143050|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153803280|NCT02143050|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153803281|NCT02143050|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153803282|NCT02143050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153803283|NCT01957956|Temozolomide|temozolomide|mesh-list
153803284|NCT01957956|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153803285|NCT01957956|Alkylating Agents|alkylating agents|mesh-ancestor
153803286|NCT01957956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153803287|NCT01957956|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153803288|NCT01863550|Dexamethasone|dexamethasone|mesh-list
153803289|NCT01863550|Dexamethasone acetate|dexamethasone acetate|mesh-list
153803290|NCT01863550|Lenalidomide|lenalidomide|mesh-list
153803291|NCT01863550|Bortezomib|bortezomib|mesh-list
153803292|NCT01863550|Ichthammol|ichthammol|mesh-list
153803293|NCT01863550|BB 1101|bb 1101|mesh-list
153803294|NCT01863550|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153803295|NCT01863550|Antiemetics|antiemetics|mesh-ancestor
153803322|NCT00321633|Mitosis Modulators|mitosis modulators|mesh-ancestor
153803323|NCT00321633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153803324|NCT00288782|Mirtazapine|mirtazapine|mesh-list
153803325|NCT00288782|Antidepressive Agents|antidepressive agents|mesh-ancestor
153803326|NCT00288782|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153803327|NCT00288782|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
153803328|NCT00288782|Histamine Antagonists|histamine antagonists|mesh-ancestor
153803329|NCT00288782|Histamine Agents|histamine agents|mesh-ancestor
153803330|NCT00288782|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153803331|NCT00288782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153875587|NCT01179334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153875588|NCT01179334|Urological Agents|urological agents|mesh-ancestor
153875589|NCT01179334|Enzyme Activators|enzyme activators|mesh-ancestor
153803332|NCT00288782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153416357|NCT05442931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153355390|NCT00683852|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153355391|NCT00683852|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
153355392|NCT00683852|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
153355393|NCT03006835|Clopidogrel|clopidogrel|mesh-list
153355394|NCT03006835|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153355395|NCT03006835|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
153355396|NCT03006835|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
153355397|NCT03006835|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
153803333|NCT00288782|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153803334|NCT00288782|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153478619|NCT01146834|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153478620|NCT01146834|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153803335|NCT00288782|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153803336|NCT00288782|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
153803337|NCT00288782|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
153803338|NCT00288782|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
153803339|NCT00288782|Adrenergic Agents|adrenergic agents|mesh-ancestor
153803340|NCT00288782|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
153803341|NCT00288782|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153803342|NCT00288782|Serotonin Agents|serotonin agents|mesh-ancestor
153803343|NCT00288782|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
153803344|NCT01059825|Metformin|metformin|mesh-list
153803368|NCT00321750|Immunologic Factors|immunologic factors|mesh-ancestor
153803369|NCT00321750|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
153803370|NCT00321750|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153803371|NCT00321750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153803372|NCT00321945|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
153803373|NCT00321945|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-list
153803374|NCT00321945|Protease Inhibitors|protease inhibitors|mesh-ancestor
153803375|NCT00321945|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153803376|NCT00321945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153803377|NCT00323076|Fluoroazomycin arabinoside|fluoroazomycin arabinoside|mesh-list
153803378|NCT00323076|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
153803379|NCT00323076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153803380|NCT00323154|Nalbuphine|nalbuphine|mesh-list
153803381|NCT00323154|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153803382|NCT00323154|Narcotics|narcotics|mesh-ancestor
153478669|NCT01163214|Sensory System Agents|sensory system agents|mesh-ancestor
153803384|NCT00323154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153803385|NCT00323154|Analgesics|analgesics|mesh-ancestor
153803386|NCT00323154|Sensory System Agents|sensory system agents|mesh-ancestor
153803387|NCT00323154|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153803388|NCT00289250|Artesunate|artesunate|mesh-list
153803389|NCT00289250|Pyrimethamine|pyrimethamine|mesh-list
153803390|NCT00289250|Sulfadoxine|sulfadoxine|mesh-list
153803391|NCT00289250|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
153803392|NCT00289250|Antimalarials|antimalarials|mesh-ancestor
153803393|NCT00289250|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153803394|NCT00289250|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153803395|NCT00289250|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153803396|NCT00289250|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153803412|NCT00323505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153355407|NCT03006757|Dermatologic Agents|dermatologic agents|mesh-ancestor
153803414|NCT00289406|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153803415|NCT00289406|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153416358|NCT05442931|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153416359|NCT05442931|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153803416|NCT00289406|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153803417|NCT00289406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153803418|NCT00289406|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153803419|NCT00289406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153803420|NCT00289406|Vasodilator Agents|vasodilator agents|mesh-ancestor
153803421|NCT00323544|Tenofovir|tenofovir|mesh-list
153803422|NCT00323544|Lamivudine|lamivudine|mesh-list
153803423|NCT00323544|Emtricitabine|emtricitabine|mesh-list
153349979|NCT00343460|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153803424|NCT00323544|Zidovudine|zidovudine|mesh-list
153803425|NCT00323544|Lamivudine, zidovudine drug combination|lamivudine, zidovudine drug combination|mesh-list
153803426|NCT00323544|Antiviral Agents|antiviral agents|mesh-ancestor
153803427|NCT00323544|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153803471|NCT00323583|Protective Agents|protective agents|mesh-ancestor
153803472|NCT00323583|Vitamin B Complex|vitamin b complex|mesh-ancestor
153803474|NCT00323583|Micronutrients|micronutrients|mesh-ancestor
153803475|NCT00289601|Eptifibatide|eptifibatide|mesh-list
153803476|NCT00289601|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153803477|NCT00323778|Hyaluronic Acid|hyaluronic acid|mesh-list
153803478|NCT00323778|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153803479|NCT00323778|Immunologic Factors|immunologic factors|mesh-ancestor
153803480|NCT00323778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153803481|NCT00323778|Viscosupplements|viscosupplements|mesh-ancestor
153803482|NCT00323778|Protective Agents|protective agents|mesh-ancestor
153803483|NCT00323817|Z 338|z 338|mesh-list
153803484|NCT00323817|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
153803485|NCT00323817|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153803486|NCT00323817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153803487|NCT00323817|Cholinergic Agents|cholinergic agents|mesh-ancestor
153803488|NCT00323817|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153478705|NCT01170390|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
153803489|NCT00323817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153803490|NCT00323817|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153355444|NCT03006211|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153355445|NCT03006211|Analgesics|analgesics|mesh-ancestor
153355446|NCT03006211|Sensory System Agents|sensory system agents|mesh-ancestor
153355447|NCT03006211|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153355448|NCT03006211|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153355449|NCT03006211|Autonomic Agents|autonomic agents|mesh-ancestor
153355450|NCT03006211|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153355453|NCT03006211|Antioxidants|antioxidants|mesh-ancestor
153803492|NCT00289835|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
153350055|NCT01793948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153803493|NCT00289835|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153803494|NCT00289835|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153803495|NCT00289835|Tubulin Modulators|tubulin modulators|mesh-ancestor
153803520|NCT00303264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153803521|NCT00290069|Sirolimus|sirolimus|mesh-list
153803522|NCT00290069|Tacrolimus|tacrolimus|mesh-list
153803523|NCT00290069|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153803524|NCT00290069|Immunologic Factors|immunologic factors|mesh-ancestor
153875607|NCT01178671|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153875608|NCT01178671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153875609|NCT01178671|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153875610|NCT01178671|Serotonin Agents|serotonin agents|mesh-ancestor
153875611|NCT01178671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153875612|NCT01178671|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
153875613|NCT01178671|Histamine Antagonists|histamine antagonists|mesh-ancestor
153875614|NCT01178671|Histamine Agents|histamine agents|mesh-ancestor
153875615|NCT01178671|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153875616|NCT01178671|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153875617|NCT01178671|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153875618|NCT01178671|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
153875619|NCT01178671|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
153875620|NCT01178671|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
153803525|NCT00290069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153803526|NCT00290069|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
153803527|NCT00290069|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153803528|NCT00290069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153803529|NCT00290069|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153803530|NCT00290069|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153803531|NCT00290069|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153803532|NCT00290069|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153803533|NCT00290069|Antifungal Agents|antifungal agents|mesh-ancestor
153803534|NCT04718259|Midazolam|midazolam|mesh-list
153803535|NCT04718259|Bupivacaine|bupivacaine|mesh-list
153803536|NCT04718259|Anesthetics, Local|anesthetics, local|mesh-ancestor
153803537|NCT04718259|Anesthetics|anesthetics|mesh-ancestor
153803538|NCT04718259|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153803539|NCT04718259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153416361|NCT05442931|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153803540|NCT04718259|Sensory System Agents|sensory system agents|mesh-ancestor
153803541|NCT04718259|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153416362|NCT05442931|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153416363|NCT05442931|Anesthetics|anesthetics|mesh-ancestor
153416364|NCT05442931|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153803571|NCT00323973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153803572|NCT00324012|Docetaxel|docetaxel|mesh-list
153803573|NCT00324012|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153350129|NCT00316862|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
153803574|NCT00324012|Tubulin Modulators|tubulin modulators|mesh-ancestor
153803575|NCT00324012|Antimitotic Agents|antimitotic agents|mesh-ancestor
153803576|NCT00324012|Mitosis Modulators|mitosis modulators|mesh-ancestor
153803577|NCT00324012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153803579|NCT00290264|Formoterol Fumarate|formoterol fumarate|mesh-list
153803580|NCT00290264|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153803581|NCT00290264|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153803582|NCT00290264|Autonomic Agents|autonomic agents|mesh-ancestor
153803583|NCT00290264|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153803584|NCT00290264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153803585|NCT00290264|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153803586|NCT00290264|Respiratory System Agents|respiratory system agents|mesh-ancestor
153803587|NCT00290264|Glucocorticoids|glucocorticoids|mesh-ancestor
153803588|NCT00290264|Hormones|hormones|mesh-ancestor
153803589|NCT00290264|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153803590|NCT00290264|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
153803591|NCT00290264|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
153803592|NCT00290264|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153803593|NCT00290264|Adrenergic Agents|adrenergic agents|mesh-ancestor
153803594|NCT00290264|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153416365|NCT05442931|Tocolytic Agents|tocolytic agents|mesh-ancestor
153416366|NCT05442931|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153416367|NCT05442931|Vasodilator Agents|vasodilator agents|mesh-ancestor
153416368|NCT05439499|Letrozole|letrozole|mesh-list
153416369|NCT05439499|Anastrozole|anastrozole|mesh-list
153416370|NCT05439499|Goserelin|goserelin|mesh-list
153416371|NCT05439499|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153416372|NCT05439499|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
153416373|NCT05439499|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153478815|NCT01188876|Hematinics|hematinics|mesh-ancestor
153803595|NCT00290264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153803597|NCT00324051|Antiemetics|antiemetics|mesh-ancestor
153803598|NCT00324051|Autonomic Agents|autonomic agents|mesh-ancestor
153803599|NCT00324051|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153803600|NCT00324051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153803601|NCT00324051|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153803602|NCT00324051|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153803603|NCT00324051|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153803604|NCT00324051|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153803605|NCT00324051|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153803607|NCT00324051|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153803608|NCT00324051|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153803609|NCT00324051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153803610|NCT00324051|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153803611|NCT00324051|Serotonin Agents|serotonin agents|mesh-ancestor
153803612|NCT00303381|Interferons|interferons|mesh-list
153803613|NCT00303381|Interferon-beta|interferon-beta|mesh-list
153803614|NCT00303381|Interferon beta-1a|interferon beta-1a|mesh-list
153803615|NCT00303381|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153803616|NCT00303381|Antiviral Agents|antiviral agents|mesh-ancestor
153803617|NCT00303381|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153803618|NCT00303381|Immunologic Factors|immunologic factors|mesh-ancestor
153803619|NCT00303381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153355577|NCT03005665|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
153421656|NCT05603104|Antidepressive Agents|antidepressive agents|mesh-list
153421657|NCT05603104|Escitalopram|escitalopram|mesh-list
153421658|NCT05603104|Analgesics|analgesics|mesh-ancestor
153421659|NCT05603104|Sensory System Agents|sensory system agents|mesh-ancestor
153355578|NCT03005665|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153355579|NCT03005665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153355586|NCT00630734|Ritonavir|ritonavir|mesh-list
153478859|NCT01198158|Growth Inhibitors|growth inhibitors|mesh-ancestor
153478860|NCT01198158|Immunologic Factors|immunologic factors|mesh-ancestor
153478861|NCT01198158|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
153803620|NCT00303381|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153803621|NCT00290420|Chloroquine|chloroquine|mesh-list
153803622|NCT00290420|Amebicides|amebicides|mesh-ancestor
153803623|NCT00290420|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153803624|NCT00290420|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153803625|NCT00290420|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153803626|NCT00290420|Antimalarials|antimalarials|mesh-ancestor
153803627|NCT00290420|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153803628|NCT00303420|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
153803636|NCT00303537|Metformin|metformin|mesh-list
153803660|NCT00303615|Anastrozole|anastrozole|mesh-list
153803661|NCT00303615|Fluoxymesterone|fluoxymesterone|mesh-list
153803662|NCT00303615|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153803663|NCT00303615|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153803664|NCT00303615|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
153803665|NCT00303615|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153803666|NCT00303615|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153803667|NCT00303615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153803668|NCT00303615|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
153803669|NCT00303615|Hormone Antagonists|hormone antagonists|mesh-ancestor
153803670|NCT00303615|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153875624|NCT01178671|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
153875625|NCT04532060|Anti-Infective Agents|anti-infective agents|mesh-list
153875626|NCT04532060|Nystatin|nystatin|mesh-list
153875627|NCT04532060|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
153875628|NCT04532060|Antifungal Agents|antifungal agents|mesh-ancestor
153875629|NCT04532060|Ionophores|ionophores|mesh-ancestor
153803671|NCT00303615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153803672|NCT00303615|Anabolic Agents|anabolic agents|mesh-ancestor
153803673|NCT00303615|Hormones|hormones|mesh-ancestor
153803674|NCT00324324|Moxifloxacin|moxifloxacin|mesh-list
153803675|NCT00324324|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
153803676|NCT00324324|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153803677|NCT00324324|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153803678|NCT00324324|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153803679|NCT00324324|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153803680|NCT00324324|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153803681|NCT00324324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153803682|NCT00324324|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153803683|NCT00324324|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
153803690|NCT00291122|Celecoxib|celecoxib|mesh-list
153803706|NCT00324363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153803707|NCT00324363|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
153803708|NCT00324363|Incretins|incretins|mesh-ancestor
153803709|NCT00324363|Hormones|hormones|mesh-ancestor
153803710|NCT00324363|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153803711|NCT00303732|Everolimus|everolimus|mesh-list
153803712|NCT00303732|Vatalanib|vatalanib|mesh-list
153355596|NCT00630734|Antiviral Agents|antiviral agents|mesh-ancestor
153355597|NCT00630734|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153355598|NCT00630734|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
153355600|NCT00630734|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153803713|NCT00303732|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
153803714|NCT00303732|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153803715|NCT00303732|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153803716|NCT00303732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153803717|NCT00303732|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153803718|NCT00303732|Immunologic Factors|immunologic factors|mesh-ancestor
153803719|NCT00303732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153803720|NCT00303732|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153803721|NCT00303771|Leucovorin|leucovorin|mesh-list
153803722|NCT00303771|Fluorouracil|fluorouracil|mesh-list
153803723|NCT00303771|Irinotecan|irinotecan|mesh-list
153803724|NCT00303771|Calcium|calcium|mesh-list
153803725|NCT00303771|Levoleucovorin|levoleucovorin|mesh-list
153803726|NCT00303771|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153803727|NCT00303771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153803728|NCT00303771|Antimetabolites|antimetabolites|mesh-ancestor
153803729|NCT00303771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153803730|NCT00303771|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153803731|NCT00303771|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153803737|NCT00303771|Antidotes|antidotes|mesh-ancestor
153803757|NCT00303810|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153803758|NCT00303810|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153803759|NCT00303810|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
153803760|NCT00303810|Abortifacient Agents|abortifacient agents|mesh-ancestor
153803761|NCT00303810|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153803762|NCT00303810|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153803763|NCT00303810|Antimetabolites|antimetabolites|mesh-ancestor
153803764|NCT00303810|Dermatologic Agents|dermatologic agents|mesh-ancestor
153803765|NCT00303810|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153803766|NCT00303810|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153803767|NCT00303810|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153803768|NCT00303810|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153803769|NCT00303810|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153803770|NCT00303810|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153875633|NCT01649739|Vasodilator Agents|vasodilator agents|mesh-ancestor
153803771|NCT00303810|Tubulin Modulators|tubulin modulators|mesh-ancestor
153803772|NCT00303810|Antimitotic Agents|antimitotic agents|mesh-ancestor
153355611|NCT05644249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153355612|NCT00686582|Smallpox and monkeypox vaccine modified vaccinia ankara-bavarian nordic|smallpox and monkeypox vaccine modified vaccinia ankara-bavarian nordic|mesh-list
153803773|NCT00303810|Mitosis Modulators|mitosis modulators|mesh-ancestor
153803774|NCT00324480|Vorinostat|vorinostat|mesh-list
153803775|NCT00324480|Alvocidib|alvocidib|mesh-list
153803776|NCT00324480|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153803777|NCT00324480|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
153803778|NCT00324480|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153803779|NCT00324480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153803780|NCT00324480|Growth Inhibitors|growth inhibitors|mesh-ancestor
153479040|NCT01231230|Xhance|xhance|mesh-list
153803782|NCT00324480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153803783|NCT00324480|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153803803|NCT00324519|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
153803804|NCT00324519|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153803805|NCT00324519|Oxytocics|oxytocics|mesh-ancestor
153803806|NCT00291746|Esomeprazole|esomeprazole|mesh-list
153803807|NCT00291746|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
153803808|NCT00291746|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153479094|NCT01236378|Immunologic Factors|immunologic factors|mesh-ancestor
153803809|NCT00291746|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
153803810|NCT00291746|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153803811|NCT00291746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153803812|NCT00303927|Capecitabine|capecitabine|mesh-list
153803813|NCT00303927|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153803814|NCT00303927|Antimetabolites|antimetabolites|mesh-ancestor
153803815|NCT00303927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153803816|NCT00303927|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153803817|NCT00419484|Pioglitazone|pioglitazone|mesh-list
153803818|NCT00419484|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153803819|NCT00419484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153803820|NCT00291785|Leucovorin|leucovorin|mesh-list
153803821|NCT00291785|Folic Acid|folic acid|mesh-list
153803822|NCT00291785|Fluorouracil|fluorouracil|mesh-list
153803823|NCT00291785|Levoleucovorin|levoleucovorin|mesh-list
153803860|NCT00291980|Vaccines|vaccines|mesh-list
153803861|NCT00291980|Immunologic Factors|immunologic factors|mesh-ancestor
153803862|NCT00291980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153803863|NCT00324597|Gemcitabine|gemcitabine|mesh-list
153803864|NCT00324597|Motesanib diphosphate|motesanib diphosphate|mesh-list
153803865|NCT00324597|Imetelstat|imetelstat|mesh-list
153803866|NCT00324597|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153803867|NCT00324597|Antimetabolites|antimetabolites|mesh-ancestor
153803869|NCT00324597|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153803927|NCT00324831|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153803928|NCT00324831|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153355642|NCT02248753|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153355643|NCT02248753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153355644|NCT02248753|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
153355645|NCT02248753|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153355646|NCT02248753|Protective Agents|protective agents|mesh-ancestor
153355647|NCT02248753|Vasodilator Agents|vasodilator agents|mesh-ancestor
153355648|NCT02248753|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
153803929|NCT00324831|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153803930|NCT00324831|Glucocorticoids|glucocorticoids|mesh-ancestor
153803931|NCT00324831|Hormones|hormones|mesh-ancestor
153803932|NCT00324831|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153803933|NCT00324831|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153803934|NCT00324831|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153803935|NCT00324831|Tubulin Modulators|tubulin modulators|mesh-ancestor
153803936|NCT00324831|Antimitotic Agents|antimitotic agents|mesh-ancestor
153803937|NCT00324831|Mitosis Modulators|mitosis modulators|mesh-ancestor
153803939|NCT00292253|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153803940|NCT00292253|Immunologic Factors|immunologic factors|mesh-ancestor
153803941|NCT00292253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153803942|NCT00292253|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153803943|NCT00292253|Antiviral Agents|antiviral agents|mesh-ancestor
153803944|NCT00292253|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153803945|NCT00304434|Oseltamivir|oseltamivir|mesh-list
153350508|NCT05877326|Anesthetics|anesthetics|mesh-list
153803946|NCT00304434|Probenecid|probenecid|mesh-list
153803947|NCT00304434|Antiviral Agents|antiviral agents|mesh-ancestor
153803948|NCT00304434|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153803949|NCT00304434|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153803950|NCT00304434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153350569|NCT05821296|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
153803951|NCT00304434|Uricosuric Agents|uricosuric agents|mesh-ancestor
153803952|NCT00304434|Gout Suppressants|gout suppressants|mesh-ancestor
153803970|NCT00292409|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
153803971|NCT00292409|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
153803972|NCT00304473|Quetiapine Fumarate|quetiapine fumarate|mesh-list
153803973|NCT00304473|Antidepressive Agents|antidepressive agents|mesh-ancestor
153803974|NCT00304473|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153803975|NCT00304473|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153803976|NCT00304473|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153803977|NCT00304473|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153803978|NCT00304473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153803979|NCT00292448|Tiotropium Bromide|tiotropium bromide|mesh-list
153803980|NCT00292448|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153803981|NCT00292448|Autonomic Agents|autonomic agents|mesh-ancestor
153803982|NCT00292448|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153803983|NCT00292448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153803984|NCT00292448|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153803985|NCT00292448|Respiratory System Agents|respiratory system agents|mesh-ancestor
153803986|NCT00292448|Parasympatholytics|parasympatholytics|mesh-ancestor
153803987|NCT00292448|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
153803988|NCT00292448|Cholinergic Agents|cholinergic agents|mesh-ancestor
153803989|NCT00292448|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153803990|NCT00292448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153355685|NCT00687908|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153355687|NCT00687908|Sensory System Agents|sensory system agents|mesh-ancestor
153355688|NCT00687908|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153355690|NCT00687908|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153803991|NCT00324948|Alprostadil|alprostadil|mesh-list
153803992|NCT00324948|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153803993|NCT00324948|Vasodilator Agents|vasodilator agents|mesh-ancestor
153803994|NCT00324948|Urological Agents|urological agents|mesh-ancestor
153804019|NCT00292526|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
153804020|NCT00292526|Protease Inhibitors|protease inhibitors|mesh-ancestor
153804021|NCT00292526|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153350570|NCT05821296|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153804022|NCT00292526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153416403|NCT00368719|Tacrolimus|tacrolimus|mesh-list
153416404|NCT00368719|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153416405|NCT00368719|Immunologic Factors|immunologic factors|mesh-ancestor
153479265|NCT01275300|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153875644|NCT04532333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153875645|NCT04532333|Antithrombins|antithrombins|mesh-ancestor
153875646|NCT04532333|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
153875647|NCT04532333|Protease Inhibitors|protease inhibitors|mesh-ancestor
153875648|NCT04532333|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153875649|NCT01649895|Cycloserine|cycloserine|mesh-list
153875650|NCT01649895|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
153875651|NCT01649895|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153875652|NCT01649895|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
153804023|NCT00292526|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153804024|NCT00418509|Mometasone Furoate|mometasone furoate|mesh-list
153804025|NCT00418509|Formoterol Fumarate|formoterol fumarate|mesh-list
153804026|NCT00418509|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153804027|NCT00418509|Autonomic Agents|autonomic agents|mesh-ancestor
153804028|NCT00418509|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153804029|NCT00418509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153804030|NCT00418509|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153804031|NCT00418509|Respiratory System Agents|respiratory system agents|mesh-ancestor
153804032|NCT00418509|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
153804033|NCT00418509|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
153804034|NCT00418509|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153804035|NCT00418509|Adrenergic Agents|adrenergic agents|mesh-ancestor
153804036|NCT00418509|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153804037|NCT00418509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153804038|NCT00418509|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153804039|NCT00418509|Dermatologic Agents|dermatologic agents|mesh-ancestor
153804040|NCT00418509|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
153804041|NCT00292721|Celecoxib|celecoxib|mesh-list
153804042|NCT00292721|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153804043|NCT00292721|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153804060|NCT00292799|Metformin|metformin|mesh-list
153804064|NCT00292799|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153804065|NCT00292799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153804066|NCT00292799|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
153804067|NCT00292799|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153804068|NCT00304629|Galantamine|galantamine|mesh-list
153804069|NCT00304629|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
153804070|NCT00304629|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153804130|NCT00293228|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153804131|NCT00293228|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153804132|NCT00293228|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
153804133|NCT00293228|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153804134|NCT00293228|Antimetabolites|antimetabolites|mesh-ancestor
153479285|NCT01276314|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153804135|NCT00293228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153355763|NCT03977233|Irinotecan|irinotecan|mesh-list
153804136|NCT00293228|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153804138|NCT00293345|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153804139|NCT00293345|Antimetabolites|antimetabolites|mesh-ancestor
153804140|NCT00293345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153804141|NCT00293345|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153804142|NCT00293501|Tinzaparin|tinzaparin|mesh-list
153804143|NCT00293501|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
153804144|NCT00293501|Dalteparin|dalteparin|mesh-list
153804145|NCT00293501|Anticoagulants|anticoagulants|mesh-ancestor
153804146|NCT00293501|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153804147|NCT00293501|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153804148|NCT00293501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153804155|NCT00293657|Lornoxicam|lornoxicam|mesh-list
153804183|NCT00293735|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153804184|NCT00293735|Sympathomimetics|sympathomimetics|mesh-ancestor
153804185|NCT00293735|Autonomic Agents|autonomic agents|mesh-ancestor
153804186|NCT00293735|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153804187|NCT00293735|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
153804188|NCT00293735|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
153804189|NCT00304980|Lumefantrine|lumefantrine|mesh-list
153804190|NCT00304980|Artemether|artemether|mesh-list
153804191|NCT00304980|Pyrimethamine|pyrimethamine|mesh-list
153355816|NCT00593450|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153355817|NCT00593450|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153387713|NCT00000243|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153355818|NCT00593450|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153355819|NCT00593450|Growth Substances|growth substances|mesh-ancestor
153355820|NCT00593450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153355821|NCT00593450|Growth Inhibitors|growth inhibitors|mesh-ancestor
153355822|NCT00631748|Quetiapine Fumarate|quetiapine fumarate|mesh-list
153355823|NCT00631748|Antidepressive Agents|antidepressive agents|mesh-ancestor
153355824|NCT00631748|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153355825|NCT00631748|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153355826|NCT00631748|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153355877|NCT00595790|Vaccines|vaccines|mesh-list
153804192|NCT00304980|Sulfadoxine|sulfadoxine|mesh-list
153804193|NCT00304980|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
153804194|NCT00304980|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
153804196|NCT00304980|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153804197|NCT00304980|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153804198|NCT00304980|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153804199|NCT00304980|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153804242|NCT00294086|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
153804243|NCT00294086|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
153804244|NCT00294086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153804246|NCT00325689|Aripiprazole|aripiprazole|mesh-list
153804247|NCT00325689|Quetiapine Fumarate|quetiapine fumarate|mesh-list
153804248|NCT00325689|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153804249|NCT00325689|Serotonin Agents|serotonin agents|mesh-ancestor
153804250|NCT00325689|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153804251|NCT00325689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153804306|NCT00305331|Dopamine Agents|dopamine agents|mesh-ancestor
153804307|NCT00305331|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153804308|NCT00305331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153804309|NCT00325767|Albuterol|albuterol|mesh-list
153804310|NCT00325767|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153804311|NCT00325767|Autonomic Agents|autonomic agents|mesh-ancestor
153804312|NCT00325767|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153804313|NCT00325767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153804314|NCT00325767|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153804315|NCT00325767|Respiratory System Agents|respiratory system agents|mesh-ancestor
153355883|NCT00595946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153355884|NCT00597038|Dasatinib|dasatinib|mesh-list
153355885|NCT00597038|Dacarbazine|dacarbazine|mesh-list
153355886|NCT00597038|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153355887|NCT00597038|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153355888|NCT00597038|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153355889|NCT00597038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153355890|NCT00597038|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153355891|NCT00597038|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153355892|NCT00597038|Alkylating Agents|alkylating agents|mesh-ancestor
153355893|NCT00597428|Lubiprostone|lubiprostone|mesh-list
153387714|NCT00000243|Narcotics|narcotics|mesh-ancestor
153884645|NCT00593463|Antimetabolites|antimetabolites|mesh-ancestor
153884646|NCT00593463|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153884647|NCT00593463|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153884648|NCT00592410|Insulin|insulin|mesh-list
153884649|NCT00592410|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
153355894|NCT00597428|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
153804316|NCT00325767|Tocolytic Agents|tocolytic agents|mesh-ancestor
153804318|NCT00325767|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
153804319|NCT00325767|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
153804320|NCT00325767|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153804321|NCT00325767|Adrenergic Agents|adrenergic agents|mesh-ancestor
153804322|NCT00325767|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153804323|NCT00325767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153804324|NCT00294359|Bevacizumab|bevacizumab|mesh-list
153804325|NCT00294359|Capecitabine|capecitabine|mesh-list
153804326|NCT00294359|Mitomycins|mitomycins|mesh-list
153804327|NCT00294359|Mitomycin|mitomycin|mesh-list
153804328|NCT00294359|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153804329|NCT00294359|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153804330|NCT00294359|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153804331|NCT00294359|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153804354|NCT00305370|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153479370|NCT01293396|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153804355|NCT00305370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153804356|NCT00305370|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
153804357|NCT00305370|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
153804358|NCT00305370|Serotonin Agents|serotonin agents|mesh-ancestor
153804359|NCT00305370|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
153804360|NCT00305370|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153804361|NCT00305370|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
153804362|NCT00305370|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
153804363|NCT00325806|Ramipril|ramipril|mesh-list
153804369|NCT00305409|Sulfalene|sulfalene|mesh-list
153804418|NCT00294944|Idazoxan|idazoxan|mesh-list
153804419|NCT00294944|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
153804420|NCT00294944|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
153804421|NCT00294944|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
153804422|NCT00294944|Adrenergic Agents|adrenergic agents|mesh-ancestor
153804423|NCT00294944|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153804424|NCT00294944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153804425|NCT00294944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153804426|NCT00326157|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
153479402|NCT01301742|Empagliflozin|empagliflozin|mesh-list
153355902|NCT00597818|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153355903|NCT00597818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153355904|NCT00597818|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153355905|NCT00597896|Pramipexole|pramipexole|mesh-list
153355906|NCT00597896|Dexpramipexole|dexpramipexole|mesh-list
153355907|NCT00597896|Antioxidants|antioxidants|mesh-ancestor
153355908|NCT00597896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153355909|NCT00597896|Protective Agents|protective agents|mesh-ancestor
153355910|NCT00597896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153355911|NCT00597896|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
153355912|NCT00597896|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
153355913|NCT00597896|Dopamine Agonists|dopamine agonists|mesh-ancestor
153355914|NCT00597896|Dopamine Agents|dopamine agents|mesh-ancestor
153355915|NCT00597896|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153355916|NCT01790282|Estradiol|estradiol|mesh-list
153355917|NCT01790282|Progesterone|progesterone|mesh-list
153355921|NCT01790282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153355922|NCT01790282|Progestins|progestins|mesh-ancestor
153804430|NCT00326157|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153804432|NCT00295100|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
153804433|NCT00295100|Hormone Antagonists|hormone antagonists|mesh-ancestor
153804434|NCT00295100|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153804435|NCT00295100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153804436|NCT00295100|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153804437|NCT00295100|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153804438|NCT00295100|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
153804439|NCT00295100|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
153804440|NCT00295100|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153804441|NCT00326235|Buspirone|buspirone|mesh-list
153804466|NCT00295373|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153804467|NCT00295373|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153804468|NCT00295373|Antimetabolites|antimetabolites|mesh-ancestor
153416441|NCT03122509|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153875690|NCT04531748|Toremifene|toremifene|mesh-list
153804470|NCT00295373|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153804471|NCT00295373|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
153804472|NCT00295373|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153804473|NCT00295412|Quetiapine Fumarate|quetiapine fumarate|mesh-list
153804474|NCT00295412|Antidepressive Agents|antidepressive agents|mesh-ancestor
153804475|NCT00295412|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153804476|NCT00295412|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153804477|NCT00295412|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153804478|NCT00295412|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153804479|NCT00295412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153804480|NCT00326352|Remifentanil|remifentanil|mesh-list
153804481|NCT00326352|Propofol|propofol|mesh-list
153804482|NCT00326352|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153804483|NCT00326352|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153804484|NCT00326352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153804522|NCT00326391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153804523|NCT00326391|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
153804524|NCT00326391|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153804525|NCT00326391|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153804526|NCT00326391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153804527|NCT00326391|Dopamine Agents|dopamine agents|mesh-ancestor
153804528|NCT00326391|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153804529|NCT00295685|Antacids|antacids|mesh-list
153804530|NCT00295685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153804531|NCT00295685|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153804532|NCT00306150|Aprotinin|aprotinin|mesh-list
153804533|NCT00306150|Hemostatics|hemostatics|mesh-ancestor
153804534|NCT00306150|Coagulants|coagulants|mesh-ancestor
153804535|NCT00306150|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
153804536|NCT00306150|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
153804537|NCT00306150|Protease Inhibitors|protease inhibitors|mesh-ancestor
153804538|NCT00306150|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153351098|NCT02903381|Nivolumab|nivolumab|mesh-list
153804539|NCT00306150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153804541|NCT00417911|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153804542|NCT00326469|Lanreotide|lanreotide|mesh-list
153804543|NCT00326469|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153804544|NCT00417950|Acarbose|acarbose|mesh-list
153804545|NCT00417950|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
153804546|NCT00417950|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153804548|NCT00417950|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153804570|NCT00295841|Immunologic Factors|immunologic factors|mesh-ancestor
153804571|NCT00295841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153804573|NCT00326664|Maleic acid|maleic acid|mesh-list
153804574|NCT00326664|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153804575|NCT00326664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153804576|NCT00326664|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153804577|NCT00326664|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153804579|NCT00295919|Fenretinide|fenretinide|mesh-list
153804580|NCT00295919|Antifungal Agents|antifungal agents|mesh-ancestor
153416444|NCT03113695|Immunologic Factors|immunologic factors|mesh-ancestor
153416445|NCT03113695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153804581|NCT00295919|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153804582|NCT00295919|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
153804633|NCT00418067|Paclitaxel|paclitaxel|mesh-list
153804634|NCT00418067|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153804635|NCT00418067|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153804636|NCT00418067|Tubulin Modulators|tubulin modulators|mesh-ancestor
153804637|NCT00418067|Antimitotic Agents|antimitotic agents|mesh-ancestor
153804638|NCT00418067|Mitosis Modulators|mitosis modulators|mesh-ancestor
153804639|NCT00418067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153804640|NCT00418067|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153804641|NCT00418067|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153804642|NCT00418067|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153804643|NCT00418067|Antifungal Agents|antifungal agents|mesh-ancestor
153804644|NCT00418067|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153804645|NCT00418067|Immunologic Factors|immunologic factors|mesh-ancestor
153355938|NCT00639158|Ezetimibe|ezetimibe|mesh-list
153355939|NCT00639158|Fenofibric acid|fenofibric acid|mesh-list
153355940|NCT00639158|Fenofibrate|fenofibrate|mesh-list
153355941|NCT00639158|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153355945|NCT00639158|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153355946|NCT00639158|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
153355947|NCT00639158|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153355948|NCT00639158|Lipotropic Agents|lipotropic agents|mesh-ancestor
153355949|NCT00639158|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153425708|NCT00661466|Anesthetics, Local|anesthetics, local|mesh-ancestor
153425709|NCT00661466|Anesthetics|anesthetics|mesh-ancestor
153425710|NCT00661466|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153425711|NCT00661466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153355950|NCT00639158|Nootropic Agents|nootropic agents|mesh-ancestor
153355951|NCT02248987|Antipsychotic Agents|antipsychotic agents|mesh-list
153355953|NCT02248987|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153355954|NCT02248987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153355955|NCT02248987|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153355956|NCT00692978|Fluticasone|fluticasone|mesh-list
153355960|NCT00692978|Autonomic Agents|autonomic agents|mesh-ancestor
153425712|NCT00661466|Sensory System Agents|sensory system agents|mesh-ancestor
153425713|NCT00661466|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153804646|NCT00418067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153804647|NCT00296309|Tacrolimus|tacrolimus|mesh-list
153804648|NCT00296309|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153804649|NCT00296309|Immunologic Factors|immunologic factors|mesh-ancestor
153804650|NCT00296309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153804651|NCT00296309|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
153804652|NCT00296309|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153804653|NCT00296309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153804654|NCT00296348|Mycophenolic Acid|mycophenolic acid|mesh-list
153804655|NCT00296348|Tacrolimus|tacrolimus|mesh-list
153804656|NCT00296348|Daclizumab|daclizumab|mesh-list
153804657|NCT00296348|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153804658|NCT00296348|Immunologic Factors|immunologic factors|mesh-ancestor
153804659|NCT00296348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153804680|NCT00326820|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153804681|NCT00326820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153804682|NCT00296465|Citric Acid|citric acid|mesh-list
153804683|NCT00296465|Sodium Citrate|sodium citrate|mesh-list
153804684|NCT00296465|Clomiphene|clomiphene|mesh-list
153804685|NCT00296465|Enclomiphene|enclomiphene|mesh-list
153804686|NCT00296465|Zuclomiphene|zuclomiphene|mesh-list
153804687|NCT00296465|Hormones|hormones|mesh-list
153804688|NCT00296465|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
153804689|NCT00296465|Anticoagulants|anticoagulants|mesh-ancestor
153804690|NCT00296465|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
153804691|NCT00296465|Chelating Agents|chelating agents|mesh-ancestor
153804692|NCT00296465|Sequestering Agents|sequestering agents|mesh-ancestor
153804693|NCT00296465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153804694|NCT00296465|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153804695|NCT00296465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153804696|NCT00296465|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
153804697|NCT00296465|Hormone Antagonists|hormone antagonists|mesh-ancestor
153804698|NCT00296465|Fertility Agents, Female|fertility agents, female|mesh-ancestor
153804699|NCT00296465|Fertility Agents|fertility agents|mesh-ancestor
153804700|NCT00296465|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153804733|NCT00296777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153804734|NCT00296777|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
153804735|NCT00296777|Antidepressive Agents|antidepressive agents|mesh-ancestor
153804736|NCT00296777|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153804737|NCT00296777|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
153804738|NCT00296777|Dopamine Agents|dopamine agents|mesh-ancestor
153355961|NCT00692978|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153355962|NCT00692978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153355963|NCT00692978|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153355964|NCT00692978|Respiratory System Agents|respiratory system agents|mesh-ancestor
153355965|NCT00692978|Dermatologic Agents|dermatologic agents|mesh-ancestor
153355966|NCT00692978|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
153355968|NCT00601718|Carboplatin|carboplatin|mesh-list
153355969|NCT00601718|Etoposide|etoposide|mesh-list
153355970|NCT00601718|Etoposide phosphate|etoposide phosphate|mesh-list
153355971|NCT00601718|Ifosfamide|ifosfamide|mesh-list
153355972|NCT00601718|Vorinostat|vorinostat|mesh-list
153355973|NCT00601718|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153355974|NCT00601718|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153355975|NCT00601718|Immunologic Factors|immunologic factors|mesh-ancestor
153355976|NCT00601718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153884780|NCT01606241|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153884781|NCT02270918|Apixaban|apixaban|mesh-list
153804739|NCT00296777|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
153804740|NCT00296777|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153804744|NCT00296777|Adrenergic Agents|adrenergic agents|mesh-ancestor
153804745|NCT00296894|Adalimumab|adalimumab|mesh-list
153804746|NCT00296894|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
153804747|NCT00296894|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153804748|NCT00296894|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153804749|NCT00296933|Bupropion|bupropion|mesh-list
153479592|NCT01324128|Iron|iron|mesh-list
153804751|NCT00296933|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
153804752|NCT00296933|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153804753|NCT00296933|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153804754|NCT00296933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153804755|NCT00296933|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153804757|NCT00296933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153804758|NCT00296933|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
153804759|NCT00296933|Antidepressive Agents|antidepressive agents|mesh-ancestor
153804760|NCT00296933|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153804777|NCT00297011|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153804778|NCT00297011|Glucocorticoids|glucocorticoids|mesh-ancestor
153804779|NCT00297011|Hormones|hormones|mesh-ancestor
153804780|NCT00297011|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153804781|NCT00297011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153804782|NCT00327093|Bevacizumab|bevacizumab|mesh-list
153804783|NCT00327093|Cetuximab|cetuximab|mesh-list
153804784|NCT00327093|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153804785|NCT00327093|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153804842|NCT04392531|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153804843|NCT04392531|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
153804845|NCT00297323|Anticonvulsants|anticonvulsants|mesh-ancestor
153804846|NCT00297323|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153804847|NCT00297323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153804848|NCT00327288|Docetaxel|docetaxel|mesh-list
153804849|NCT00327288|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153804850|NCT00327288|Tubulin Modulators|tubulin modulators|mesh-ancestor
153804851|NCT00327288|Antimitotic Agents|antimitotic agents|mesh-ancestor
153804852|NCT00327288|Mitosis Modulators|mitosis modulators|mesh-ancestor
153355977|NCT00601718|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153355978|NCT00601718|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153355979|NCT00601718|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153355980|NCT00601718|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153783445|NCT00236249|Sensory System Agents|sensory system agents|mesh-ancestor
153355981|NCT00601718|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153804853|NCT00327288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153875702|NCT04531748|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153875703|NCT04531748|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153875704|NCT01177813|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
153875705|NCT01177813|Empagliflozin|empagliflozin|mesh-list
153875706|NCT01177813|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153875707|NCT01177813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153875708|NCT01177813|Incretins|incretins|mesh-ancestor
153875709|NCT01177813|Hormones|hormones|mesh-ancestor
153875710|NCT01177813|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153875711|NCT01177813|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
153875712|NCT01177813|Protease Inhibitors|protease inhibitors|mesh-ancestor
153804854|NCT04333134|Fluzoparib|fluzoparib|mesh-list
153804856|NCT04333134|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153804902|NCT00297947|Antidepressive Agents|antidepressive agents|mesh-ancestor
153416463|NCT05444738|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153804903|NCT00297947|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153804904|NCT00297947|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153804905|NCT00297947|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153804906|NCT00297947|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153351469|NCT00405704|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
153804907|NCT00297947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153804908|NCT04718714|Midazolam|midazolam|mesh-list
153804910|NCT04718714|Propofol|propofol|mesh-list
153804911|NCT04718714|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153804912|NCT04718714|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153804913|NCT04718714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153804914|NCT04718714|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153804915|NCT04718714|Analgesics|analgesics|mesh-ancestor
153804916|NCT04718714|Sensory System Agents|sensory system agents|mesh-ancestor
153804917|NCT04718714|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153804918|NCT04718714|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
153804919|NCT04718714|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153804920|NCT04718714|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153804921|NCT04718714|Adrenergic Agents|adrenergic agents|mesh-ancestor
153804922|NCT04718714|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153804923|NCT04718714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153804924|NCT04718714|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153804925|NCT04718714|Anesthetics, General|anesthetics, general|mesh-ancestor
153804926|NCT04718714|Anesthetics|anesthetics|mesh-ancestor
153804927|NCT04718714|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153804928|NCT04718714|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153804929|NCT04718714|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153804930|NCT04718714|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153804931|NCT04718714|GABA Modulators|gaba modulators|mesh-ancestor
153804943|NCT00298025|Fertility Agents|fertility agents|mesh-ancestor
153804944|NCT00298025|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153804945|NCT00298181|polysaccharide-K|polysaccharide-k|mesh-list
153804946|NCT00298181|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153804947|NCT00298181|Immunologic Factors|immunologic factors|mesh-ancestor
153804948|NCT00298181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153804949|NCT00298181|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153804950|NCT00298181|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153804951|NCT00298181|Antiviral Agents|antiviral agents|mesh-ancestor
153804952|NCT00298181|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153804953|NCT00298181|Interferon Inducers|interferon inducers|mesh-ancestor
153804954|NCT00298181|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
153804955|NCT00298181|Protective Agents|protective agents|mesh-ancestor
153416464|NCT05444738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153416466|NCT05243953|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153416467|NCT05243953|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153416468|NCT05243953|Autonomic Agents|autonomic agents|mesh-ancestor
153416469|NCT05243953|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153416470|NCT05243953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153416472|NCT05243953|Respiratory System Agents|respiratory system agents|mesh-ancestor
153416473|NCT05243953|Parasympatholytics|parasympatholytics|mesh-ancestor
153416474|NCT05243953|Vasodilator Agents|vasodilator agents|mesh-ancestor
153416475|NCT02757313|Dronabinol|dronabinol|mesh-list
153416476|NCT02757313|Hallucinogens|hallucinogens|mesh-ancestor
153416477|NCT02757313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153416478|NCT02757313|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153804956|NCT05458089|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
153804957|NCT05458089|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
153804958|NCT05458089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153804959|NCT03754140|Polidocanol|polidocanol|mesh-list
153804960|NCT03754140|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
153804961|NCT03754140|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
153804962|NCT00298415|Paclitaxel|paclitaxel|mesh-list
153804963|NCT00298415|Vinorelbine|vinorelbine|mesh-list
153804964|NCT00298415|Carboplatin|carboplatin|mesh-list
153804965|NCT00298415|Gemcitabine|gemcitabine|mesh-list
153804966|NCT00298415|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
153356032|NCT00646646|Dexmedetomidine|dexmedetomidine|mesh-list
153804967|NCT00298415|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153804978|NCT00298454|Furosemide|furosemide|mesh-list
153804992|NCT00298571|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153804993|NCT00298571|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153804994|NCT00298571|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153804995|NCT00298571|Adrenergic Agents|adrenergic agents|mesh-ancestor
153804996|NCT00298571|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153804997|NCT00298571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153804998|NCT00298571|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
153804999|NCT00298571|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153805000|NCT00298571|Autonomic Agents|autonomic agents|mesh-ancestor
153805001|NCT00298571|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153805002|NCT00298571|Respiratory System Agents|respiratory system agents|mesh-ancestor
153805003|NCT00298571|Mydriatics|mydriatics|mesh-ancestor
153805004|NCT00298571|Sympathomimetics|sympathomimetics|mesh-ancestor
153805005|NCT00298571|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
153805006|NCT00298688|Gefitinib|gefitinib|mesh-list
153805007|NCT00298688|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153805008|NCT00298688|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153805049|NCT00299234|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153805050|NCT00299234|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153805051|NCT00299234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153805052|NCT00299234|Adrenergic Agents|adrenergic agents|mesh-ancestor
153805053|NCT00299234|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153805054|NCT00299234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153805055|NCT00299351|Romidepsin|romidepsin|mesh-list
153805056|NCT00299351|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153805057|NCT00299351|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153805058|NCT00299351|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
153805059|NCT00299351|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153805060|NCT00299351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153805109|NCT00300014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153875722|NCT04315831|Sensory System Agents|sensory system agents|mesh-ancestor
153875723|NCT04315831|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153875724|NCT04315831|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
153805111|NCT00300131|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
153421683|NCT05603104|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153421684|NCT05603104|GABA Antagonists|gaba antagonists|mesh-ancestor
153356067|NCT00696488|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153356068|NCT00696488|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153356069|NCT00696488|Immunologic Factors|immunologic factors|mesh-ancestor
153356070|NCT00696488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153356071|NCT00648908|4-Aminopyridine|4-aminopyridine|mesh-list
153356072|NCT00648908|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
153356073|NCT00648908|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153356075|NCT00650078|Prednisone|prednisone|mesh-list
153356076|NCT00650078|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153356077|NCT00650078|Glucocorticoids|glucocorticoids|mesh-ancestor
153356078|NCT00650078|Hormones|hormones|mesh-ancestor
153356079|NCT00650078|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153805112|NCT00300131|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153805113|NCT00300131|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153805114|NCT00300131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153805115|NCT00300131|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153805116|NCT00300131|Immunologic Factors|immunologic factors|mesh-ancestor
153805117|NCT00300131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153805118|NCT00300131|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153805119|NCT01785459|Prochlorperazine|prochlorperazine|mesh-list
153805120|NCT01785459|Bupivacaine|bupivacaine|mesh-list
153805121|NCT01785459|Anesthetics, Local|anesthetics, local|mesh-ancestor
153805122|NCT01785459|Anesthetics|anesthetics|mesh-ancestor
153805123|NCT01785459|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153805124|NCT01785459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153805125|NCT01785459|Sensory System Agents|sensory system agents|mesh-ancestor
153805126|NCT01785459|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153805127|NCT01785459|Antiemetics|antiemetics|mesh-ancestor
153805128|NCT01785459|Autonomic Agents|autonomic agents|mesh-ancestor
153805129|NCT01785459|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153479800|NCT06244212|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153479802|NCT06244121|Pyridoxine|pyridoxine|mesh-list
153479803|NCT06244121|Vitamin B Complex|vitamin b complex|mesh-ancestor
153479804|NCT06244121|Vitamins|vitamins|mesh-ancestor
153479805|NCT06244121|Micronutrients|micronutrients|mesh-ancestor
153479822|NCT06243822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153479832|NCT06243679|Immunomodulating Agents|immunomodulating agents|mesh-list
153479833|NCT06243679|Immunologic Factors|immunologic factors|mesh-ancestor
153479834|NCT06243679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153805130|NCT01785459|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153351689|NCT00408200|Sotalol|sotalol|mesh-list
153805131|NCT01785459|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153805132|NCT01785459|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153805161|NCT00300404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153805162|NCT01539447|Naproxen|naproxen|mesh-list
153805163|NCT01539447|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153805164|NCT01539447|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153805165|NCT01539447|Analgesics|analgesics|mesh-ancestor
153805166|NCT01539447|Sensory System Agents|sensory system agents|mesh-ancestor
153805167|NCT01539447|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153805168|NCT01539447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153805169|NCT01539447|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153805170|NCT01539447|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153805171|NCT01539447|Gout Suppressants|gout suppressants|mesh-ancestor
153805172|NCT01539447|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153805173|NCT01539447|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153356088|NCT01799486|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153356089|NCT01799486|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153356090|NCT01799486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153356091|NCT00650546|Exenatide|exenatide|mesh-list
153356092|NCT00650546|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
153356093|NCT00650546|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153356094|NCT00650546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153356095|NCT00650546|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
153356096|NCT00650546|Incretins|incretins|mesh-ancestor
153356097|NCT00650546|Hormones|hormones|mesh-ancestor
153805174|NCT01539447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153805175|NCT00300443|Bimatoprost|bimatoprost|mesh-list
153805176|NCT00300443|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153805177|NCT00300560|Colistin|colistin|mesh-list
153805178|NCT00300560|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153805179|NCT00300560|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153805180|NCT00327522|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
153805181|NCT00327522|Immunologic Factors|immunologic factors|mesh-ancestor
153805182|NCT00327522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153805184|NCT00300716|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
153805211|NCT00300833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153805212|NCT00300833|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153805214|NCT00300911|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153805215|NCT00300911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153805216|NCT00327678|Rituximab|rituximab|mesh-list
153805217|NCT00327678|Imatinib Mesylate|imatinib mesylate|mesh-list
153805218|NCT00327678|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153805219|NCT00327678|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153805220|NCT00327678|Immunologic Factors|immunologic factors|mesh-ancestor
153805221|NCT00327678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153805222|NCT00327678|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153805223|NCT00327678|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153805224|NCT00327678|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153805225|NCT00327678|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153805226|NCT00327678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153805227|NCT00300950|Gemcitabine|gemcitabine|mesh-list
153805228|NCT00300950|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153805229|NCT00300950|Antimetabolites|antimetabolites|mesh-ancestor
153805230|NCT00300950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153805231|NCT00300950|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153805232|NCT00327756|Ubiquinone|ubiquinone|mesh-list
153805233|NCT00327756|Coenzyme Q10|coenzyme q10|mesh-list
153805234|NCT00327756|Micronutrients|micronutrients|mesh-ancestor
153805235|NCT00327756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153805236|NCT00327756|Vitamins|vitamins|mesh-ancestor
153805237|NCT00301106|Interleukin-12|interleukin-12|mesh-list
153805238|NCT00301106|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153805246|NCT00301145|Varenicline|varenicline|mesh-list
153805257|NCT00301223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153805258|NCT00301223|Anticonvulsants|anticonvulsants|mesh-ancestor
153805259|NCT00301223|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153805260|NCT00301223|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153479910|NCT06243133|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153805261|NCT00301223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153805262|NCT00301223|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153805263|NCT00301223|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153805264|NCT00301223|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153805265|NCT00301223|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153805266|NCT00301223|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153805269|NCT00301301|Cisplatin|cisplatin|mesh-list
153805270|NCT00301301|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153805271|NCT00301301|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153805272|NCT00301301|Immunologic Factors|immunologic factors|mesh-ancestor
153805313|NCT00301613|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153805314|NCT00301613|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153805315|NCT00301613|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153805316|NCT00301613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153805317|NCT00301652|Mycophenolic Acid|mycophenolic acid|mesh-list
153805318|NCT00301652|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153805319|NCT00301652|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153805320|NCT00301652|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
153805321|NCT00301652|Antitubercular Agents|antitubercular agents|mesh-ancestor
153416492|NCT02379806|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153805322|NCT00301652|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153805323|NCT00301652|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153805324|NCT00301652|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153805325|NCT00301652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153805326|NCT00301730|Aldesleukin|aldesleukin|mesh-list
153805327|NCT00301730|Paclitaxel|paclitaxel|mesh-list
153805328|NCT00301730|Trastuzumab|trastuzumab|mesh-list
153805329|NCT00301730|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153805330|NCT00301730|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153805331|NCT00301730|Tubulin Modulators|tubulin modulators|mesh-ancestor
153805332|NCT00301730|Antimitotic Agents|antimitotic agents|mesh-ancestor
153805333|NCT00301730|Mitosis Modulators|mitosis modulators|mesh-ancestor
153805334|NCT00301730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153805335|NCT00301730|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153805336|NCT00301730|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153805337|NCT00301730|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153805338|NCT00301730|Antiviral Agents|antiviral agents|mesh-ancestor
153805339|NCT00301730|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153805340|NCT00301847|Sorafenib|sorafenib|mesh-list
153805341|NCT00301847|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153805342|NCT00301847|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153805343|NCT00301847|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153805344|NCT00301847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153805345|NCT00327990|Alendronate|alendronate|mesh-list
153805346|NCT00327990|Ibandronic Acid|ibandronic acid|mesh-list
153805347|NCT00327990|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153805349|NCT00301886|Zoledronic Acid|zoledronic acid|mesh-list
153805350|NCT00301886|Ibandronic Acid|ibandronic acid|mesh-list
153805351|NCT00301886|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153805352|NCT00301886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153805353|NCT00301925|Cyclophosphamide|cyclophosphamide|mesh-list
153805354|NCT00301925|Capecitabine|capecitabine|mesh-list
153805355|NCT00301925|Fluorouracil|fluorouracil|mesh-list
153805356|NCT00301925|Methotrexate|methotrexate|mesh-list
153805357|NCT00301925|Epirubicin|epirubicin|mesh-list
153805358|NCT00301925|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153805359|NCT00301925|Immunologic Factors|immunologic factors|mesh-ancestor
153805360|NCT00301925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153805361|NCT00301925|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153805362|NCT00301925|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153805363|NCT00301925|Alkylating Agents|alkylating agents|mesh-ancestor
153805364|NCT00301925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153805365|NCT00301925|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153805366|NCT00301925|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153805367|NCT00301925|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153805368|NCT00301925|Antimetabolites|antimetabolites|mesh-ancestor
153875771|NCT01684683|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153805369|NCT00301925|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
153805370|NCT00301925|Abortifacient Agents|abortifacient agents|mesh-ancestor
153805371|NCT00301925|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153805372|NCT00301925|Dermatologic Agents|dermatologic agents|mesh-ancestor
153805373|NCT00301925|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153805374|NCT00301925|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153805375|NCT00301925|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153805376|NCT00301925|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153805377|NCT00301925|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153805378|NCT00301925|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153805379|NCT00328029|Busulfan|busulfan|mesh-list
153805380|NCT00328029|Alkylating Agents|alkylating agents|mesh-ancestor
153805381|NCT00328029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153805382|NCT00328029|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153805387|NCT00328029|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153805388|NCT00302354|Methylphenidate|methylphenidate|mesh-list
153805389|NCT00302354|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
153805390|NCT00302354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153805391|NCT00302354|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
153805392|NCT00302354|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153805393|NCT00302354|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153805394|NCT00302354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153805395|NCT00302354|Dopamine Agents|dopamine agents|mesh-ancestor
153805396|NCT00302354|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153805398|NCT00302393|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
153805399|NCT00302393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153805400|NCT00302393|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
153805401|NCT00302393|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153805402|NCT00302393|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153805403|NCT00302393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153805404|NCT00302393|Dopamine Agents|dopamine agents|mesh-ancestor
153805405|NCT00302393|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153805406|NCT00328107|Hemagglutinins|hemagglutinins|mesh-list
153805440|NCT00302627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153805441|NCT00302627|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153875772|NCT01684683|Respiratory System Agents|respiratory system agents|mesh-ancestor
153875773|NCT01684683|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
153356250|NCT01194479|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153356251|NCT01194479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153356252|NCT01230593|Tobramycin|tobramycin|mesh-list
153880835|NCT06027567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153880836|NCT06027528|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
153880837|NCT06027528|Hemostatics|hemostatics|mesh-ancestor
153880838|NCT06027528|Coagulants|coagulants|mesh-ancestor
153880839|NCT06027099|Tizanidine|tizanidine|mesh-list
153880840|NCT06027099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153880841|NCT06027099|Analgesics|analgesics|mesh-ancestor
153880842|NCT06027099|Sensory System Agents|sensory system agents|mesh-ancestor
153880843|NCT06027099|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153880844|NCT06027099|Anticonvulsants|anticonvulsants|mesh-ancestor
153421699|NCT05556512|Tirzepatide|tirzepatide|mesh-list
153426068|NCT00556400|Contraceptive Agents|contraceptive agents|mesh-list
153875774|NCT01684683|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153875775|NCT01684683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153875776|NCT01684683|Vasodilator Agents|vasodilator agents|mesh-ancestor
153416521|NCT00961142|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153416522|NCT00961142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153416523|NCT00961142|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153805442|NCT00302627|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153805444|NCT00302627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153805445|NCT00302627|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153805506|NCT00302822|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153805507|NCT00302822|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
153805508|NCT00302822|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
153805509|NCT00302822|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
153805510|NCT00302822|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
153805511|NCT00302822|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
153805512|NCT00302822|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
153805513|NCT00302822|Protease Inhibitors|protease inhibitors|mesh-ancestor
153805514|NCT00302822|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
153805515|NCT00302822|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
153805516|NCT00302822|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
153805517|NCT00328458|Epothilones|epothilones|mesh-list
153805518|NCT00328458|Epothilone B|epothilone b|mesh-list
153805519|NCT00328458|Tubulin Modulators|tubulin modulators|mesh-ancestor
153805520|NCT00328458|Antimitotic Agents|antimitotic agents|mesh-ancestor
153805521|NCT00328458|Mitosis Modulators|mitosis modulators|mesh-ancestor
153805522|NCT00328458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153805523|NCT00328458|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153805524|NCT00303017|Naproxen|naproxen|mesh-list
153805525|NCT00303017|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153805526|NCT00303017|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153805556|NCT00328497|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153805557|NCT00328497|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153805558|NCT00328497|Growth Substances|growth substances|mesh-ancestor
153805559|NCT00328497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153805560|NCT00328497|Growth Inhibitors|growth inhibitors|mesh-ancestor
153805561|NCT00328497|Tubulin Modulators|tubulin modulators|mesh-ancestor
153805562|NCT00328497|Antimitotic Agents|antimitotic agents|mesh-ancestor
153805563|NCT00328497|Mitosis Modulators|mitosis modulators|mesh-ancestor
153805564|NCT00328497|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153805565|NCT00303290|Interferons|interferons|mesh-list
153805566|NCT00303290|Cytarabine|cytarabine|mesh-list
153480034|NCT06070701|Morphine|morphine|mesh-list
153805567|NCT00303290|Interferon-alpha|interferon-alpha|mesh-list
153805568|NCT00303290|Interferon alpha-2|interferon alpha-2|mesh-list
153805569|NCT00303290|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
153805570|NCT00303290|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153805571|NCT00303290|Antiviral Agents|antiviral agents|mesh-ancestor
153805572|NCT00303290|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153805573|NCT00303290|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153805574|NCT00303290|Antimetabolites|antimetabolites|mesh-ancestor
153352139|NCT04241640|Nefopam|nefopam|mesh-list
153805576|NCT00303290|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153805610|NCT00419835|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153805611|NCT00419835|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153805612|NCT00419835|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
153805613|NCT00419835|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
153356253|NCT01230593|Tobramycin, Dexamethasone Drug Combination|tobramycin, dexamethasone drug combination|mesh-list
153356255|NCT01230593|Dexamethasone acetate|dexamethasone acetate|mesh-list
153356256|NCT01230593|BB 1101|bb 1101|mesh-list
153356257|NCT01230593|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153356258|NCT01230593|Antiemetics|antiemetics|mesh-ancestor
153356259|NCT01230593|Autonomic Agents|autonomic agents|mesh-ancestor
153356260|NCT01230593|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153805614|NCT00419835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153805615|NCT00419835|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
153805616|NCT00419835|Protease Inhibitors|protease inhibitors|mesh-ancestor
153805617|NCT00419835|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153805618|NCT00328809|Spironolactone|spironolactone|mesh-list
153805619|NCT00328809|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
153805620|NCT00328809|Hormone Antagonists|hormone antagonists|mesh-ancestor
153805621|NCT00328809|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153805622|NCT00328809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153805623|NCT00328809|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
153805624|NCT00328809|Diuretics|diuretics|mesh-ancestor
153805625|NCT00328809|Natriuretic Agents|natriuretic agents|mesh-ancestor
153805626|NCT00420030|Abciximab|abciximab|mesh-list
153805627|NCT00420030|Anticoagulants|anticoagulants|mesh-ancestor
153805628|NCT00420030|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153805629|NCT00303758|Leucovorin|leucovorin|mesh-list
153805630|NCT00303758|Gemcitabine|gemcitabine|mesh-list
153480066|NCT06022003|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153805631|NCT00303758|Fluorouracil|fluorouracil|mesh-list
153805632|NCT00303758|Calcium|calcium|mesh-list
153805633|NCT00303758|Levoleucovorin|levoleucovorin|mesh-list
153805634|NCT00303758|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153805635|NCT00303758|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153805636|NCT00303758|Antimetabolites|antimetabolites|mesh-ancestor
153805638|NCT00303758|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153805657|NCT00303836|Interleukin-2|interleukin-2|mesh-list
153805658|NCT00303836|Freund's Adjuvant|freund's adjuvant|mesh-list
153805659|NCT00303836|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153805660|NCT00303836|Immunologic Factors|immunologic factors|mesh-ancestor
153805661|NCT00303836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153805662|NCT00303836|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153805663|NCT00303836|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153805664|NCT00303836|Alkylating Agents|alkylating agents|mesh-ancestor
153805665|NCT00303836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153805666|NCT00303836|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153805667|NCT00303836|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153805668|NCT00303836|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153805669|NCT00303836|Antimetabolites|antimetabolites|mesh-ancestor
153805670|NCT00303836|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153805671|NCT00303836|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153805672|NCT00303836|Analgesics|analgesics|mesh-ancestor
153805673|NCT00303836|Sensory System Agents|sensory system agents|mesh-ancestor
153805674|NCT00303836|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153805675|NCT00303836|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153805676|NCT00303836|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153805677|NCT00303836|Antiviral Agents|antiviral agents|mesh-ancestor
153805678|NCT00303836|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153805679|NCT00303992|Trastuzumab|trastuzumab|mesh-list
153805680|NCT00303992|Irinotecan|irinotecan|mesh-list
153805681|NCT00303992|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153805682|NCT00303992|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153805683|NCT00303992|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
153805684|NCT00303992|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153875777|NCT01684683|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
153875778|NCT01684683|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
153875779|NCT01684683|Purinergic Agents|purinergic agents|mesh-ancestor
153356264|NCT01230593|Hormones|hormones|mesh-ancestor
153875780|NCT01684683|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153875782|NCT01684800|Hemostatics|hemostatics|mesh-ancestor
153805685|NCT00303992|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153805687|NCT00304226|Amlodipine|amlodipine|mesh-list
153805701|NCT00332319|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153805702|NCT00332319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153805703|NCT00332319|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153805704|NCT00332319|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
153356277|NCT01195025|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153805705|NCT00332319|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153805706|NCT00332319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153805707|NCT00304382|Vaccines|vaccines|mesh-list
153805708|NCT00304382|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
153805709|NCT00304382|Immunologic Factors|immunologic factors|mesh-ancestor
153805710|NCT00304382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153805711|NCT00304421|Rabeprazole|rabeprazole|mesh-list
153805712|NCT00304421|Pantoprazole|pantoprazole|mesh-list
153805713|NCT00304421|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
153805714|NCT00304421|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153805715|NCT00304421|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
153805716|NCT00304421|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153805717|NCT00304421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153805718|NCT00332397|Sirolimus|sirolimus|mesh-list
153805719|NCT00332397|Temsirolimus|temsirolimus|mesh-list
153805720|NCT00332397|MTOR Inhibitors|mtor inhibitors|mesh-list
153805721|NCT00332397|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153352288|NCT00531518|Aripiprazole|aripiprazole|mesh-list
153805722|NCT00332397|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153805723|NCT00332397|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153805749|NCT00304538|Glucagon|glucagon|mesh-list
153805750|NCT00304538|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153805751|NCT00304538|Hormones|hormones|mesh-ancestor
153356278|NCT01195025|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153356279|NCT01195025|Analgesics|analgesics|mesh-ancestor
153356280|NCT01195025|Sensory System Agents|sensory system agents|mesh-ancestor
153356281|NCT01195025|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153421706|NCT05554406|Daunorubicin|daunorubicin|mesh-list
153783448|NCT00236249|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
153356283|NCT01195025|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153356287|NCT00703664|Bortezomib|bortezomib|mesh-list
153805752|NCT00304538|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153805753|NCT00304538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153805754|NCT00420498|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
153805755|NCT00420498|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
153805756|NCT00420498|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153805757|NCT00420498|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153875796|NCT04531163|Protective Agents|protective agents|mesh-ancestor
153805758|NCT00420498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153805759|NCT00420498|Adrenergic Agents|adrenergic agents|mesh-ancestor
153805760|NCT00420498|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153805761|NCT00420498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153805762|NCT00328965|Lacidipine|lacidipine|mesh-list
153805763|NCT00328965|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153805764|NCT00328965|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153805765|NCT00328965|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153805766|NCT00328965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153805767|NCT00328965|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153805768|NCT00328965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153805769|NCT00304616|Olanzapine|olanzapine|mesh-list
153805770|NCT00304616|Risperidone|risperidone|mesh-list
153805771|NCT00304616|Aripiprazole|aripiprazole|mesh-list
153805772|NCT00304616|Quetiapine Fumarate|quetiapine fumarate|mesh-list
153805773|NCT00304616|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153805795|NCT00304616|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
153805796|NCT00304616|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
153352433|NCT00538616|Anesthetics, General|anesthetics, general|mesh-ancestor
153805798|NCT00332436|Brimonidine Tartrate|brimonidine tartrate|mesh-list
153356304|NCT00658736|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153805799|NCT00332436|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
153805800|NCT00332436|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
153805801|NCT00332436|Adrenergic Agents|adrenergic agents|mesh-ancestor
153805802|NCT00332436|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153805803|NCT00332436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153805804|NCT00332436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153805805|NCT00332436|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153805856|NCT00332631|Antiviral Agents|antiviral agents|mesh-ancestor
153805857|NCT00332631|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153805858|NCT00332631|Expectorants|expectorants|mesh-ancestor
153805859|NCT00332631|Respiratory System Agents|respiratory system agents|mesh-ancestor
153805860|NCT00332631|Free Radical Scavengers|free radical scavengers|mesh-ancestor
153805861|NCT00332631|Antioxidants|antioxidants|mesh-ancestor
153805862|NCT00332631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153805863|NCT00332631|Protective Agents|protective agents|mesh-ancestor
153805864|NCT00332631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153805865|NCT00332631|Antidotes|antidotes|mesh-ancestor
153805866|NCT00304772|Fluconazole|fluconazole|mesh-list
153805867|NCT00304772|Micafungin|micafungin|mesh-list
153805868|NCT00304772|Antifungal Agents|antifungal agents|mesh-ancestor
153805869|NCT00304772|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153805871|NCT00304772|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153805872|NCT00304772|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153805873|NCT00304772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153805880|NCT00304811|Vancomycin|vancomycin|mesh-list
153805912|NCT00304850|Ketamine|ketamine|mesh-list
153805914|NCT00304850|Sensory System Agents|sensory system agents|mesh-ancestor
153805915|NCT00304850|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153805916|NCT00304850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153805917|NCT00304850|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
153805918|NCT00304850|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153805919|NCT00304850|Anesthetics, General|anesthetics, general|mesh-ancestor
153805928|NCT00329316|Hormones|hormones|mesh-ancestor
153805975|NCT00332904|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
153805976|NCT00332904|Diuretics|diuretics|mesh-ancestor
153805977|NCT00332904|Natriuretic Agents|natriuretic agents|mesh-ancestor
153805978|NCT00329394|Ketamine|ketamine|mesh-list
153805979|NCT00329394|Analgesics|analgesics|mesh-ancestor
153805980|NCT00329394|Sensory System Agents|sensory system agents|mesh-ancestor
153805981|NCT00329394|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153805982|NCT00329394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153805983|NCT00329394|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
153805984|NCT00329394|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153805985|NCT00329394|Anesthetics, General|anesthetics, general|mesh-ancestor
153805986|NCT00329394|Anesthetics|anesthetics|mesh-ancestor
153805987|NCT00329394|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153805988|NCT00329394|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
153805989|NCT00329394|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
153805990|NCT00329394|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153805991|NCT00329394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153805992|NCT00305396|Sirolimus|sirolimus|mesh-list
153805993|NCT00305396|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153805994|NCT00305396|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153805995|NCT00305396|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153805996|NCT00305396|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153805997|NCT00305396|Antifungal Agents|antifungal agents|mesh-ancestor
153806026|NCT00329511|Autonomic Agents|autonomic agents|mesh-ancestor
153806027|NCT00329511|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
153806028|NCT00329511|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153806029|NCT00329511|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153806031|NCT00329511|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153806032|NCT00329511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153416578|NCT04338919|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153416579|NCT04338919|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153416580|NCT04338919|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153875834|NCT04527666|Anticoagulants|anticoagulants|mesh-list
153875835|NCT04530500|Androgens|androgens|mesh-list
153806033|NCT00305513|Caffeine|caffeine|mesh-list
153806034|NCT00305513|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
153806035|NCT00305513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153806036|NCT00305513|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
153806037|NCT00305513|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153806038|NCT00305513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153806039|NCT00305513|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
153806040|NCT00305513|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
153806041|NCT00305513|Purinergic Agents|purinergic agents|mesh-ancestor
153806042|NCT00305513|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153806044|NCT00333021|Fondaparinux|fondaparinux|mesh-list
153806045|NCT00333021|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
153806046|NCT00333021|Antithrombins|antithrombins|mesh-ancestor
153806047|NCT00333021|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
153806048|NCT00333021|Protease Inhibitors|protease inhibitors|mesh-ancestor
153806049|NCT00333021|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153806050|NCT00333021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153806051|NCT00333021|Anticoagulants|anticoagulants|mesh-ancestor
153806052|NCT00333021|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153806053|NCT00333021|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153806054|NCT00305552|Thalidomide|thalidomide|mesh-list
153806055|NCT00305552|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153806056|NCT00305552|Immunologic Factors|immunologic factors|mesh-ancestor
153806057|NCT00305552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153806058|NCT00305552|Leprostatic Agents|leprostatic agents|mesh-ancestor
153806059|NCT00305552|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153806060|NCT00305552|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153806064|NCT00305552|Growth Inhibitors|growth inhibitors|mesh-ancestor
153806065|NCT00305552|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153806066|NCT00329589|Bortezomib|bortezomib|mesh-list
153806067|NCT00329589|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153806068|NCT00305591|N-Methylaspartate|n-methylaspartate|mesh-list
153806069|NCT00305591|Excitatory Amino Acid Agonists|excitatory amino acid agonists|mesh-ancestor
153806070|NCT00305591|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
153806071|NCT00305591|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153806072|NCT00305591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153806073|NCT00305591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153806074|NCT00333060|Ophthalmic Solutions|ophthalmic solutions|mesh-list
153806075|NCT00333060|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
153806076|NCT00305630|Triamcinolone|triamcinolone|mesh-list
153806077|NCT00305630|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
153806078|NCT00305630|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
153875836|NCT04530500|Hormones|hormones|mesh-ancestor
153875837|NCT04530500|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153875838|NCT04530500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153875839|NCT01685658|Acetaminophen|acetaminophen|mesh-list
153875840|NCT01685658|Ketoprofen|ketoprofen|mesh-list
153875841|NCT01685658|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153480482|NCT05594095|Fulvestrant|fulvestrant|mesh-list
153875842|NCT01685658|Analgesics|analgesics|mesh-ancestor
153875843|NCT01685658|Sensory System Agents|sensory system agents|mesh-ancestor
153875844|NCT01685658|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153875845|NCT01685658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153875846|NCT01685658|Antipyretics|antipyretics|mesh-ancestor
153806079|NCT00305630|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
153806080|NCT00305630|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153806081|NCT00305630|Glucocorticoids|glucocorticoids|mesh-ancestor
153806082|NCT00305630|Hormones|hormones|mesh-ancestor
153806083|NCT00305630|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153806084|NCT00305630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153806085|NCT00305630|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153806086|NCT00305630|Immunologic Factors|immunologic factors|mesh-ancestor
153806087|NCT00305630|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153806088|NCT00305630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153806090|NCT00329628|Rivaroxaban|rivaroxaban|mesh-list
153806091|NCT00329628|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
153806092|NCT00329628|Antithrombins|antithrombins|mesh-ancestor
153806093|NCT00329628|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
153806094|NCT00329628|Protease Inhibitors|protease inhibitors|mesh-ancestor
153806095|NCT00329628|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153480520|NCT05543785|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153806096|NCT00329628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153806097|NCT00329628|Anticoagulants|anticoagulants|mesh-ancestor
153806098|NCT00329628|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153806099|NCT00329628|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153806100|NCT00305669|Sargramostim|sargramostim|mesh-list
153356572|NCT00667004|Protease Inhibitors|protease inhibitors|mesh-ancestor
153356573|NCT00667004|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153356574|NCT00667004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153356575|NCT00667004|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
153356576|NCT00667004|Protective Agents|protective agents|mesh-ancestor
153356577|NCT00667004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153880846|NCT06027099|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
153880847|NCT06027099|Parasympatholytics|parasympatholytics|mesh-ancestor
153880848|NCT06027099|Autonomic Agents|autonomic agents|mesh-ancestor
153356578|NCT00667004|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153356579|NCT01204853|Sitaxsentan|sitaxsentan|mesh-list
153356580|NCT01204853|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
153806102|NCT00305669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153806103|NCT00305708|Fludarabine|fludarabine|mesh-list
153806104|NCT00305708|Fludarabine phosphate|fludarabine phosphate|mesh-list
153806105|NCT00305708|Busulfan|busulfan|mesh-list
153806106|NCT00305708|Antilymphocyte Serum|antilymphocyte serum|mesh-list
153806107|NCT00305708|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153806108|NCT00305708|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153806109|NCT00305708|Antimetabolites|antimetabolites|mesh-ancestor
153806110|NCT00305708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153806111|NCT00305708|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153806112|NCT00305708|Immunologic Factors|immunologic factors|mesh-ancestor
153806113|NCT00305708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153806114|NCT00305708|Alkylating Agents|alkylating agents|mesh-ancestor
153806115|NCT00305708|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153806116|NCT00305708|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153806117|NCT00305747|3,3'-diindolylmethane|3,3'-diindolylmethane|mesh-list
153806118|NCT00305747|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
153806119|NCT00305747|Protective Agents|protective agents|mesh-ancestor
153806120|NCT00305747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153806121|NCT00305747|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153806122|NCT00333255|Nepafenac|nepafenac|mesh-list
153806123|NCT00333255|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153806124|NCT00333255|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153806125|NCT00333255|Analgesics|analgesics|mesh-ancestor
153806126|NCT00333255|Sensory System Agents|sensory system agents|mesh-ancestor
153806127|NCT00333255|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153806149|NCT00305825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153806150|NCT00305825|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
153806151|NCT00305825|Hormone Antagonists|hormone antagonists|mesh-ancestor
153806152|NCT00305825|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153806153|NCT00333294|Vinorelbine|vinorelbine|mesh-list
153806154|NCT00333294|Gefitinib|gefitinib|mesh-list
153806155|NCT00333294|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153806156|NCT00333294|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153806157|NCT00333294|Tubulin Modulators|tubulin modulators|mesh-ancestor
153806158|NCT00333294|Antimitotic Agents|antimitotic agents|mesh-ancestor
153806159|NCT00333294|Mitosis Modulators|mitosis modulators|mesh-ancestor
153806160|NCT00333294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153416605|NCT00369889|Growth Inhibitors|growth inhibitors|mesh-ancestor
153352732|NCT00489866|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
153806161|NCT00333294|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153806162|NCT00333294|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153806163|NCT00333294|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153806165|NCT00305903|Rivastigmine|rivastigmine|mesh-list
153806166|NCT00305903|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
153806167|NCT00305903|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
153806168|NCT00305903|Dopamine Agents|dopamine agents|mesh-ancestor
153806169|NCT00305903|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153806170|NCT00305903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153806171|NCT00305903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153356586|NCT04386122|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153356587|NCT04386122|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153356589|NCT04386122|Sensory System Agents|sensory system agents|mesh-ancestor
153356590|NCT04386122|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153356591|NCT04386122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153806172|NCT00305903|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
153806173|NCT00305903|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
153806174|NCT00305903|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
153806193|NCT00306020|Narcotics|narcotics|mesh-ancestor
153806194|NCT00306020|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153806195|NCT00306020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153806196|NCT00306020|Analgesics|analgesics|mesh-ancestor
153806197|NCT00306020|Sensory System Agents|sensory system agents|mesh-ancestor
153806198|NCT00306020|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153806199|NCT00306137|Aprotinin|aprotinin|mesh-list
153806200|NCT00306137|Hemostatics|hemostatics|mesh-ancestor
153806201|NCT00306137|Coagulants|coagulants|mesh-ancestor
153806202|NCT00306137|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
153806203|NCT00306137|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
153806204|NCT00306137|Protease Inhibitors|protease inhibitors|mesh-ancestor
153806205|NCT00306137|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153806206|NCT00306137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153806207|NCT00329940|Letrozole|letrozole|mesh-list
153806208|NCT00329940|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153806209|NCT00329940|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
153806210|NCT00329940|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153806211|NCT00329940|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153480731|NCT05226663|Fluorides|fluorides|mesh-list
153806212|NCT00329940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153806213|NCT00329940|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
153806214|NCT00329940|Hormone Antagonists|hormone antagonists|mesh-ancestor
153806215|NCT00329940|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153806216|NCT00329940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153806217|NCT00306176|Rosiglitazone|rosiglitazone|mesh-list
153806218|NCT00306176|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153416606|NCT00369889|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153416607|NCT00369889|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153416608|NCT00369889|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153806219|NCT00306176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153806221|NCT00333372|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
153806222|NCT00333372|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153806223|NCT00333372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153806224|NCT00333372|Cholinergic Agents|cholinergic agents|mesh-ancestor
153806233|NCT00333450|Immunologic Factors|immunologic factors|mesh-ancestor
153806234|NCT00333450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153806236|NCT00306254|N-(4-chlorophenyl)-N-(2-fluoro-4-(2-oxopyridin-1(2H)-yl)phenyl)-4-methoxypyrrolidiine-1,2-dicarboxamide|n-(4-chlorophenyl)-n-(2-fluoro-4-(2-oxopyridin-1(2h)-yl)phenyl)-4-methoxypyrrolidiine-1,2-dicarboxamide|mesh-list
153806237|NCT00306254|Anticoagulants|anticoagulants|mesh-ancestor
153806238|NCT00306254|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153480741|NCT05195918|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153806239|NCT00306254|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153806240|NCT00306254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153806241|NCT00306254|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
153356612|NCT02995304|Analgesics|analgesics|mesh-ancestor
153356613|NCT02995304|Sensory System Agents|sensory system agents|mesh-ancestor
153356614|NCT02995304|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153426532|NCT03714919|Acetaminophen|acetaminophen|mesh-list
153426533|NCT03714919|Dexmedetomidine|dexmedetomidine|mesh-list
153426534|NCT03714919|Ketamine|ketamine|mesh-list
153806242|NCT00306254|Antithrombins|antithrombins|mesh-ancestor
153806243|NCT00306254|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
153806244|NCT00306254|Protease Inhibitors|protease inhibitors|mesh-ancestor
153806245|NCT00306254|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153806246|NCT00333489|Valsartan|valsartan|mesh-list
153806257|NCT03275558|Sunitinib|sunitinib|mesh-list
153806292|NCT00333645|Caspofungin|caspofungin|mesh-list
153806293|NCT00333645|Antifungal Agents|antifungal agents|mesh-ancestor
153806294|NCT00333645|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153806295|NCT00333645|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153806296|NCT00333645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153806297|NCT00451100|Glycopyrrolate|glycopyrrolate|mesh-list
153806298|NCT00451100|Neostigmine|neostigmine|mesh-list
153806299|NCT00451100|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
153806300|NCT00451100|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153806301|NCT00451100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153806302|NCT00451100|Cholinergic Agents|cholinergic agents|mesh-ancestor
153806303|NCT00451100|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153806304|NCT00451100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153806305|NCT00451100|Parasympathomimetics|parasympathomimetics|mesh-ancestor
153806306|NCT00451100|Autonomic Agents|autonomic agents|mesh-ancestor
153352884|NCT02208037|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153806308|NCT00451100|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153806351|NCT00451139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153806352|NCT00451139|Antimetabolites|antimetabolites|mesh-ancestor
153806353|NCT00330486|Acamprosate|acamprosate|mesh-list
153806354|NCT00330486|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
153806355|NCT00451373|Vancomycin|vancomycin|mesh-list
153806356|NCT00451373|Daptomycin|daptomycin|mesh-list
153806357|NCT00451373|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153806358|NCT00451373|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153806359|NCT00333723|Rosiglitazone|rosiglitazone|mesh-list
153806360|NCT00333723|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153806361|NCT00333723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153806362|NCT00451412|Heparin|heparin|mesh-list
153806363|NCT00451412|Calcium heparin|calcium heparin|mesh-list
153806364|NCT00451412|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
153806365|NCT00451412|Tinzaparin|tinzaparin|mesh-list
153806366|NCT00451412|Dalteparin|dalteparin|mesh-list
153806367|NCT00451412|Certoparin|certoparin|mesh-list
153806368|NCT00451412|Anticoagulants|anticoagulants|mesh-ancestor
153806369|NCT00451412|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153806370|NCT00451412|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153806371|NCT00451412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153806372|NCT00451490|Agomelatine|agomelatine|mesh-list
153875862|NCT04530578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153875863|NCT01685853|Bisacodyl|bisacodyl|mesh-list
153875864|NCT01685853|Cathartics|cathartics|mesh-ancestor
153806373|NCT00451490|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153806374|NCT00451490|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153806375|NCT00451490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153806376|NCT00330525|Sibutramine|sibutramine|mesh-list
153806377|NCT00330525|Antidepressive Agents|antidepressive agents|mesh-ancestor
153806378|NCT00330525|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153806379|NCT00330525|Appetite Depressants|appetite depressants|mesh-ancestor
153806380|NCT00330525|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
153806381|NCT00333918|Bromfenac|bromfenac|mesh-list
153806392|NCT00451568|Metformin|metformin|mesh-list
153806397|NCT00451646|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
153806398|NCT00451646|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
153806399|NCT00451724|Ketamine|ketamine|mesh-list
153806400|NCT00451724|Analgesics|analgesics|mesh-ancestor
153806401|NCT00451724|Sensory System Agents|sensory system agents|mesh-ancestor
153806402|NCT00451724|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153806403|NCT00451724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153806404|NCT00451724|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
153806405|NCT00451724|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153806406|NCT00451724|Anesthetics, General|anesthetics, general|mesh-ancestor
153806407|NCT00451724|Anesthetics|anesthetics|mesh-ancestor
153806408|NCT00451724|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153806409|NCT00451724|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
153806410|NCT00451724|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
153806411|NCT00451724|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153806413|NCT00451763|Bevacizumab|bevacizumab|mesh-list
153806456|NCT00451997|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153806457|NCT00330993|Misoprostol|misoprostol|mesh-list
153806458|NCT00330993|Mifepristone|mifepristone|mesh-list
153353031|NCT05081466|Micronutrients|micronutrients|mesh-ancestor
153806459|NCT00330993|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
153806460|NCT00330993|Abortifacient Agents|abortifacient agents|mesh-ancestor
153806461|NCT00330993|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153806462|NCT00330993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153806463|NCT00330993|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
153806464|NCT00330993|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153806465|NCT00330993|Oxytocics|oxytocics|mesh-ancestor
153806466|NCT00330993|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
153806467|NCT00330993|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
153481000|NCT04548349|Benzoyl Peroxide|benzoyl peroxide|mesh-list
153806468|NCT00330993|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
153806469|NCT00330993|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
153806470|NCT00330993|Contraceptive Agents|contraceptive agents|mesh-ancestor
153806471|NCT00330993|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
153875865|NCT01685853|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153356639|NCT00725504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153356647|NCT03830684|Baicalein|baicalein|mesh-list
153416640|NCT05441150|Anesthetics|anesthetics|mesh-ancestor
153806472|NCT00330993|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
153806473|NCT00330993|Hormone Antagonists|hormone antagonists|mesh-ancestor
153806474|NCT00330993|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153806475|NCT00330993|Luteolytic Agents|luteolytic agents|mesh-ancestor
153806476|NCT00330993|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
153806477|NCT00330993|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
153806478|NCT00452075|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
153806479|NCT00452075|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153806480|NCT00452075|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153806481|NCT00452075|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153806485|NCT00331071|Ortho Evra|ortho evra|mesh-list
153806498|NCT00333996|Glucocorticoids|glucocorticoids|mesh-ancestor
153806499|NCT00333996|Hormones|hormones|mesh-ancestor
153806500|NCT00333996|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153806501|NCT00333996|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153806502|NCT00333996|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153806503|NCT00452192|Telmisartan|telmisartan|mesh-list
153806504|NCT00452192|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153806505|NCT00452192|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
153806506|NCT00452192|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
153806507|NCT00452192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153806508|NCT00334035|Quetiapine Fumarate|quetiapine fumarate|mesh-list
153806509|NCT00334035|Antidepressive Agents|antidepressive agents|mesh-ancestor
153806510|NCT00334035|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153806511|NCT00334035|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153806512|NCT00334035|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153806513|NCT00334035|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153806514|NCT00334035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153806515|NCT00334152|Casopitant|casopitant|mesh-list
153806516|NCT00334152|Antiemetics|antiemetics|mesh-ancestor
153806517|NCT00334152|Autonomic Agents|autonomic agents|mesh-ancestor
153806518|NCT00334152|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153806519|NCT00334152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153806520|NCT00334152|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153806524|NCT04698512|Sirolimus|sirolimus|mesh-list
153806546|NCT00334347|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153806547|NCT00334347|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153806549|NCT00334386|Diuretics|diuretics|mesh-list
153806550|NCT00334386|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-list
153806551|NCT00334386|Natriuretic Agents|natriuretic agents|mesh-ancestor
153806552|NCT00334386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153806553|NCT00334386|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153806554|NCT00334386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153806555|NCT00334386|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153806556|NCT00452231|Cycloserine|cycloserine|mesh-list
153806557|NCT00452231|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
153806558|NCT00452231|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153806559|NCT00452231|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
153806560|NCT00452231|Antitubercular Agents|antitubercular agents|mesh-ancestor
153806561|NCT00452231|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153806562|NCT00452231|Antimetabolites|antimetabolites|mesh-ancestor
153416661|NCT05438810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153806563|NCT00452231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153806564|NCT00334425|Menotropins|menotropins|mesh-list
153806565|NCT00334425|Fertility Agents, Female|fertility agents, female|mesh-ancestor
153806566|NCT00334425|Fertility Agents|fertility agents|mesh-ancestor
153806567|NCT00334425|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153806568|NCT00334425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153806569|NCT03275207|Dexmedetomidine|dexmedetomidine|mesh-list
153806570|NCT03275207|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153356758|NCT01296191|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153356759|NCT01296191|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153356760|NCT01296191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153356761|NCT01296191|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153356762|NCT01244711|Quetiapine Fumarate|quetiapine fumarate|mesh-list
153356763|NCT01244711|Antidepressive Agents|antidepressive agents|mesh-ancestor
153356764|NCT01244711|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153356765|NCT01244711|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153356766|NCT01244711|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153356767|NCT01244711|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153356768|NCT01244711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153356769|NCT01210079|Gabapentin|gabapentin|mesh-list
153356770|NCT01210079|Analgesics|analgesics|mesh-ancestor
153356771|NCT01210079|Sensory System Agents|sensory system agents|mesh-ancestor
153356784|NCT01245647|Naltrexone|naltrexone|mesh-list
153806571|NCT03275207|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153806572|NCT03275207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153806573|NCT03275207|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153806574|NCT03275207|Analgesics|analgesics|mesh-ancestor
153806575|NCT03275207|Sensory System Agents|sensory system agents|mesh-ancestor
153806576|NCT03275207|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153806577|NCT03275207|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
153806578|NCT03275207|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153806579|NCT03275207|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153806580|NCT03275207|Adrenergic Agents|adrenergic agents|mesh-ancestor
153806582|NCT03275207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153806583|NCT00334464|Warfarin|warfarin|mesh-list
153806584|NCT00334464|Anticoagulants|anticoagulants|mesh-ancestor
153806585|NCT03275012|Morphine|morphine|mesh-list
153806586|NCT03275012|Gabapentin|gabapentin|mesh-list
153806587|NCT03275012|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153806588|NCT03275012|Narcotics|narcotics|mesh-ancestor
153806589|NCT03275012|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153806590|NCT03275012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153806591|NCT03275012|Analgesics|analgesics|mesh-ancestor
153806592|NCT03275012|Sensory System Agents|sensory system agents|mesh-ancestor
153806593|NCT03275012|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153806594|NCT03275012|Anticonvulsants|anticonvulsants|mesh-ancestor
153806595|NCT03275012|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153806596|NCT03275012|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153806597|NCT03275012|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153806598|NCT03275012|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
153806599|NCT03275012|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
153806600|NCT03275012|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153806601|NCT03275012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153356786|NCT01245647|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
153356787|NCT01245647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153356788|NCT01245647|Sensory System Agents|sensory system agents|mesh-ancestor
153356789|NCT01245647|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153356790|NCT00708110|Dolutegravir|dolutegravir|mesh-list
153356791|NCT00708110|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
153806602|NCT03275012|Antimanic Agents|antimanic agents|mesh-ancestor
153875892|NCT02887534|Tizanidine|tizanidine|mesh-list
153875893|NCT02887534|Analgesics|analgesics|mesh-ancestor
153875894|NCT02887534|Sensory System Agents|sensory system agents|mesh-ancestor
153875895|NCT02887534|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153875896|NCT02887534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153875897|NCT02887534|Anticonvulsants|anticonvulsants|mesh-ancestor
153875898|NCT02887534|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
153875899|NCT02887534|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
153875900|NCT02887534|Parasympatholytics|parasympatholytics|mesh-ancestor
153875901|NCT02887534|Autonomic Agents|autonomic agents|mesh-ancestor
153875902|NCT02887534|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
153875903|NCT02887534|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153875904|NCT02887534|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153875905|NCT02887534|Adrenergic Agents|adrenergic agents|mesh-ancestor
153875906|NCT02887534|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153806603|NCT00334503|Miglitol|miglitol|mesh-list
153806604|NCT00334503|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153806605|NCT00334503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153806606|NCT00334503|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153806607|NCT00334503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153806608|NCT00334503|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
153806609|NCT00334581|Irbesartan|irbesartan|mesh-list
153806610|NCT00334581|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153806628|NCT00334698|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
153806629|NCT00334698|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
153806630|NCT00334698|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
153806631|NCT00334698|Histamine Antagonists|histamine antagonists|mesh-ancestor
153806632|NCT00334698|Histamine Agents|histamine agents|mesh-ancestor
153806633|NCT00334698|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153806634|NCT00334698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153806635|NCT00334698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153806636|NCT00334698|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153806637|NCT00334698|Autonomic Agents|autonomic agents|mesh-ancestor
153806638|NCT00334698|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153806639|NCT00334698|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153806640|NCT00334698|Respiratory System Agents|respiratory system agents|mesh-ancestor
153806641|NCT00334698|Nasal Decongestants|nasal decongestants|mesh-ancestor
153806642|NCT00334698|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
153806643|NCT00334698|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
153426722|NCT00000920|Zidovudine|zidovudine|mesh-list
153806644|NCT00334698|Sympathomimetics|sympathomimetics|mesh-ancestor
153806653|NCT00334854|Ifosfamide|ifosfamide|mesh-list
153806683|NCT00452855|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153806684|NCT00452855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153806685|NCT00452855|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153806686|NCT00452855|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
153806687|NCT00452855|Anesthetics, General|anesthetics, general|mesh-ancestor
153806688|NCT00452855|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153806689|NCT00452855|Narcotics|narcotics|mesh-ancestor
153806690|NCT00452855|Analgesics|analgesics|mesh-ancestor
153806691|NCT00452855|Sensory System Agents|sensory system agents|mesh-ancestor
153806692|NCT00452855|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153806694|NCT00335088|Moxifloxacin|moxifloxacin|mesh-list
153806695|NCT00335088|Povidone-Iodine|povidone-iodine|mesh-list
153806696|NCT00335088|Povidone|povidone|mesh-list
153806697|NCT00335088|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153806698|NCT00335088|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153806699|NCT00335088|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153806706|NCT00335088|Trace Elements|trace elements|mesh-ancestor
153806743|NCT00453050|Immunologic Factors|immunologic factors|mesh-ancestor
153806744|NCT00453050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153806745|NCT00453050|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153806747|NCT00453050|Interferon Inducers|interferon inducers|mesh-ancestor
153806748|NCT00335400|Anesthetics|anesthetics|mesh-list
153806749|NCT00335400|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153806750|NCT00335400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153806751|NCT00420615|Epothilone B|epothilone b|mesh-list
153806752|NCT00420615|Epothilones|epothilones|mesh-list
153806754|NCT00420615|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
153806755|NCT00420615|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153806757|NCT00420615|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153806758|NCT00420615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153806759|NCT00420615|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153806760|NCT00420615|Tubulin Modulators|tubulin modulators|mesh-ancestor
153806761|NCT00420615|Antimitotic Agents|antimitotic agents|mesh-ancestor
153806762|NCT00420615|Mitosis Modulators|mitosis modulators|mesh-ancestor
153806763|NCT00453167|Paclitaxel|paclitaxel|mesh-list
153806764|NCT00453167|Gemcitabine|gemcitabine|mesh-list
153806765|NCT00453167|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153806766|NCT00453167|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153806767|NCT00453167|Tubulin Modulators|tubulin modulators|mesh-ancestor
153806768|NCT00453167|Antimitotic Agents|antimitotic agents|mesh-ancestor
153806769|NCT00453167|Mitosis Modulators|mitosis modulators|mesh-ancestor
153806794|NCT00335439|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
153806795|NCT00335439|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153806796|NCT00335439|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153806797|NCT00335439|Analgesics|analgesics|mesh-ancestor
153806798|NCT00335439|Sensory System Agents|sensory system agents|mesh-ancestor
153806799|NCT00335439|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153806800|NCT00335439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153806801|NCT00335439|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153806802|NCT00335439|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153806803|NCT00335439|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153806804|NCT00335439|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153806805|NCT00335439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153481477|NCT03338205|Ketamine|ketamine|mesh-list
153806808|NCT00453401|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153806809|NCT00453401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153806810|NCT00335673|Irbesartan|irbesartan|mesh-list
153806811|NCT00335673|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153806812|NCT00335673|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
153806813|NCT00335673|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
153806814|NCT00335673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153806815|NCT00453635|Carboplatin|carboplatin|mesh-list
153356833|NCT01297595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153356834|NCT01297595|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153416673|NCT05451121|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153416674|NCT05451121|Adrenergic Agents|adrenergic agents|mesh-ancestor
153416675|NCT05451121|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153416676|NCT05451121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153416677|NCT05451121|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153416678|NCT05451121|Anesthetics, General|anesthetics, general|mesh-ancestor
153416679|NCT05451121|Anesthetics|anesthetics|mesh-ancestor
153416680|NCT04967443|Prazosin|prazosin|mesh-list
153416681|NCT04967443|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153416683|NCT04967443|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
153806816|NCT00453635|Docetaxel|docetaxel|mesh-list
153806817|NCT00453635|Trastuzumab|trastuzumab|mesh-list
153806818|NCT00453635|Vinorelbine|vinorelbine|mesh-list
153806819|NCT00453635|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153806820|NCT00453635|Tubulin Modulators|tubulin modulators|mesh-ancestor
153806821|NCT00453635|Antimitotic Agents|antimitotic agents|mesh-ancestor
153806822|NCT00453635|Mitosis Modulators|mitosis modulators|mesh-ancestor
153806823|NCT00453635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153353409|NCT01495585|Lonafarnib|lonafarnib|mesh-list
153806833|NCT00336141|Vorinostat|vorinostat|mesh-list
153806834|NCT00336141|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153806835|NCT00336141|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
153806836|NCT00336141|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153806837|NCT00336141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153806838|NCT00336219|Pantoprazole|pantoprazole|mesh-list
153806839|NCT00336219|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
153806840|NCT00336219|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153806841|NCT00336219|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
153806842|NCT00336219|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153806843|NCT00336219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153806844|NCT00453908|Alfuzosin|alfuzosin|mesh-list
153806845|NCT00453908|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
153806846|NCT00453908|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
153806847|NCT00453908|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
153806848|NCT00453908|Adrenergic Agents|adrenergic agents|mesh-ancestor
153806849|NCT00453908|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153806852|NCT00453908|Urological Agents|urological agents|mesh-ancestor
153806889|NCT00336453|Immunologic Factors|immunologic factors|mesh-ancestor
153806890|NCT00336453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153806891|NCT00336453|Coagulants|coagulants|mesh-ancestor
153806892|NCT00336531|Itraconazole|itraconazole|mesh-list
153806893|NCT00336531|Antifungal Agents|antifungal agents|mesh-ancestor
153806894|NCT00336531|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153806895|NCT00336531|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
153806896|NCT00336531|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153353479|NCT01496131|Goserelin|goserelin|mesh-list
153806897|NCT00336531|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153356840|NCT01276730|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153356842|NCT01276730|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153356843|NCT01276730|Keratolytic Agents|keratolytic agents|mesh-ancestor
153356844|NCT01276730|Dermatologic Agents|dermatologic agents|mesh-ancestor
153356847|NCT01298063|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153356848|NCT01298063|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153356849|NCT01298063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153356850|NCT01298063|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153356851|NCT02999594|Tramadol|tramadol|mesh-list
153356852|NCT02999594|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153356853|NCT02999594|Narcotics|narcotics|mesh-ancestor
153885788|NCT01171183|Adrenergic Agents|adrenergic agents|mesh-ancestor
153426825|NCT00000950|Vitamins|vitamins|mesh-ancestor
153875926|NCT04530617|Protease Inhibitors|protease inhibitors|mesh-ancestor
153416704|NCT02230956|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153806898|NCT00336531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153806900|NCT00336531|Hormone Antagonists|hormone antagonists|mesh-ancestor
153806901|NCT00336531|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153806902|NCT00336531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153806903|NCT00336531|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
153806904|NCT00322062|Ascorbic Acid|ascorbic acid|mesh-list
153806905|NCT00322062|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
153806906|NCT00322062|Antioxidants|antioxidants|mesh-ancestor
153806907|NCT00322062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153806908|NCT00322062|Protective Agents|protective agents|mesh-ancestor
153806909|NCT00322062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153806910|NCT00322062|Vitamins|vitamins|mesh-ancestor
153806911|NCT00322062|Micronutrients|micronutrients|mesh-ancestor
153806912|NCT00322062|Laxatives|laxatives|mesh-ancestor
153806913|NCT00322062|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153806934|NCT03274817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153806935|NCT03274817|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
153806937|NCT03274817|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153806938|NCT03274817|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
153806940|NCT00230204|Immunologic Factors|immunologic factors|mesh-ancestor
153806941|NCT00230204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153806942|NCT00230321|Darbepoetin alfa|darbepoetin alfa|mesh-list
153806943|NCT00230321|Hematinics|hematinics|mesh-ancestor
153806944|NCT00230399|Celecoxib|celecoxib|mesh-list
153806945|NCT00230399|Capecitabine|capecitabine|mesh-list
153806946|NCT00230399|Irinotecan|irinotecan|mesh-list
153806947|NCT00230399|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153806995|NCT00336882|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153806996|NCT00336882|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153806997|NCT00336882|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153806998|NCT00336882|GABA Modulators|gaba modulators|mesh-ancestor
153806999|NCT00336882|GABA Agents|gaba agents|mesh-ancestor
153807000|NCT00336882|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153807001|NCT00336882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153807003|NCT00336921|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
153807004|NCT00336921|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
153416705|NCT05447936|Vitamin D|vitamin d|mesh-list
153356854|NCT02999594|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153356855|NCT02999594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153356856|NCT02999594|Analgesics|analgesics|mesh-ancestor
153356857|NCT02999594|Sensory System Agents|sensory system agents|mesh-ancestor
153356858|NCT02999594|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153356859|NCT01298219|Lubiprostone|lubiprostone|mesh-list
153426841|NCT00000218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153426842|NCT00000218|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
153416706|NCT05447936|Vitamins|vitamins|mesh-ancestor
153416709|NCT05447936|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153807005|NCT00336921|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
153807006|NCT00336921|Adrenergic Agents|adrenergic agents|mesh-ancestor
153807007|NCT00336921|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153807008|NCT00336921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153807009|NCT00336921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153807052|NCT00306644|Rosiglitazone|rosiglitazone|mesh-list
153807053|NCT00306644|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153807054|NCT00306644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153807055|NCT00306683|Diazoxide|diazoxide|mesh-list
153807056|NCT00306683|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153807057|NCT00306683|Vasodilator Agents|vasodilator agents|mesh-ancestor
153807058|NCT00306722|Fospropofol|fospropofol|mesh-list
153807059|NCT00306722|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153807060|NCT00306722|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153807061|NCT00306722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153807062|NCT00337389|Leucovorin|leucovorin|mesh-list
153807063|NCT00337389|Bevacizumab|bevacizumab|mesh-list
153807118|NCT00307307|Vitamin B Complex|vitamin b complex|mesh-ancestor
153807119|NCT00307307|Vitamins|vitamins|mesh-ancestor
153807120|NCT00307307|Micronutrients|micronutrients|mesh-ancestor
153807121|NCT00307307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153807122|NCT00337623|Prednisolone|prednisolone|mesh-list
153807123|NCT00337623|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153807124|NCT00337623|Glucocorticoids|glucocorticoids|mesh-ancestor
153353767|NCT01653912|Tubulin Modulators|tubulin modulators|mesh-ancestor
153807125|NCT00337623|Hormones|hormones|mesh-ancestor
153807126|NCT00337623|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153807127|NCT00337623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153807128|NCT00337623|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153807129|NCT00337623|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153807130|NCT00337701|Enfuvirtide|enfuvirtide|mesh-list
153807132|NCT00337701|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
153807133|NCT00337701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153807135|NCT00337701|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153807136|NCT00337701|Antiviral Agents|antiviral agents|mesh-ancestor
153807137|NCT00337701|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153356860|NCT01298219|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
153356861|NCT01298219|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153356862|NCT01298219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153356863|NCT01276886|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
153356864|NCT01276886|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153356865|NCT02322242|Dexamethasone|dexamethasone|mesh-list
153356866|NCT02322242|Dexamethasone acetate|dexamethasone acetate|mesh-list
153356867|NCT02322242|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
153807138|NCT00307463|Antihypertensive Agents|antihypertensive agents|mesh-list
153807139|NCT00337740|Propranolol|propranolol|mesh-list
153807140|NCT00337740|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
153807141|NCT00337740|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
153807142|NCT00337740|Adrenergic Agents|adrenergic agents|mesh-ancestor
153807143|NCT00337740|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153807144|NCT00337740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153807145|NCT00337740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153807146|NCT00337740|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153875952|NCT04536662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153875953|NCT04536662|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153875954|NCT04536662|Glucocorticoids|glucocorticoids|mesh-ancestor
153875955|NCT04536662|Hormones|hormones|mesh-ancestor
153875956|NCT04536662|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153875957|NCT04536662|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153875958|NCT04536662|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153875959|NCT01686321|Rituximab|rituximab|mesh-list
153875960|NCT01686321|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
153416710|NCT04739384|Ticagrelor|ticagrelor|mesh-list
153807147|NCT00337740|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153807148|NCT00337740|Vasodilator Agents|vasodilator agents|mesh-ancestor
153807150|NCT00307502|Lopinavir|lopinavir|mesh-list
153807158|NCT00307502|Nevirapine|nevirapine|mesh-list
153807159|NCT00307502|Tipranavir|tipranavir|mesh-list
153807160|NCT00307502|Efavirenz|efavirenz|mesh-list
153807161|NCT00307502|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
153807162|NCT00307502|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
153807163|NCT00307502|Protease Inhibitors|protease inhibitors|mesh-ancestor
153807164|NCT00307502|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153807165|NCT00307502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153807166|NCT00307502|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153807167|NCT00307502|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153807168|NCT00307502|Antiviral Agents|antiviral agents|mesh-ancestor
153807169|NCT00307502|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153807170|NCT00307502|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
153807171|NCT00307502|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153807172|NCT00307502|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153807173|NCT00307502|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153807174|NCT00307502|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
153356890|NCT02993588|Protective Agents|protective agents|mesh-ancestor
153356891|NCT02993588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153356892|NCT02993588|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153807175|NCT00307502|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
153807176|NCT00307502|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
153807177|NCT00307502|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
153807178|NCT00307502|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
153807180|NCT00307502|Antitubercular Agents|antitubercular agents|mesh-ancestor
153807181|NCT00307502|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153807182|NCT00307580|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
153807183|NCT00307580|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153807205|NCT00337545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153807206|NCT00337545|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153807207|NCT00307775|Estradiol|estradiol|mesh-list
153807208|NCT00307775|Estrogens|estrogens|mesh-ancestor
153807209|NCT00307775|Hormones|hormones|mesh-ancestor
153807210|NCT00307775|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153807211|NCT00307775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153807212|NCT00307814|Epoetin Alfa|epoetin alfa|mesh-list
153807213|NCT00307814|Hematinics|hematinics|mesh-ancestor
153807214|NCT00341055|Epoetin Alfa|epoetin alfa|mesh-list
153807215|NCT00341055|Hematinics|hematinics|mesh-ancestor
153807216|NCT00338052|Ethinyl Estradiol|ethinyl estradiol|mesh-list
153807217|NCT00338052|Norethindrone|norethindrone|mesh-list
153807218|NCT00338052|Norethindrone Acetate|norethindrone acetate|mesh-list
153416744|NCT05449028|Antacids|antacids|mesh-ancestor
153807221|NCT00338052|Hormones|hormones|mesh-ancestor
153807222|NCT00338052|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153807223|NCT00338052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153807224|NCT00338052|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
153807225|NCT00338052|Contraceptive Agents|contraceptive agents|mesh-ancestor
153807226|NCT00338052|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153807227|NCT00338052|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
153807228|NCT00338052|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
153807229|NCT00338052|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
153807230|NCT00338052|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
153807231|NCT00338091|Losartan|losartan|mesh-list
153807232|NCT00338091|Benazepril|benazepril|mesh-list
153807233|NCT00338091|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153807234|NCT00338091|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153807235|NCT00338091|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
153807250|NCT00308048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153807251|NCT00308048|Immunologic Factors|immunologic factors|mesh-ancestor
153807252|NCT00308048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153807253|NCT00338130|Temozolomide|temozolomide|mesh-list
153807254|NCT00338130|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153807255|NCT00338130|Alkylating Agents|alkylating agents|mesh-ancestor
153807256|NCT00338130|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153807257|NCT00338130|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153807258|NCT00308126|Hydroxyethyl Starch Derivatives|hydroxyethyl starch derivatives|mesh-list
153807259|NCT00308126|Plasma Substitutes|plasma substitutes|mesh-ancestor
153807260|NCT00308126|Blood Substitutes|blood substitutes|mesh-ancestor
153356921|NCT02992496|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153356922|NCT02992496|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153356923|NCT02992496|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153356924|NCT02992496|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153356926|NCT02992496|GABA Agents|gaba agents|mesh-ancestor
153356928|NCT00729482|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
153356929|NCT00729482|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153356930|NCT00729482|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153807261|NCT00308165|Topotecan|topotecan|mesh-list
153807262|NCT00308165|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
153807263|NCT00308165|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153807264|NCT00308165|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153807265|NCT00308165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153807266|NCT00308165|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153807267|NCT00418769|Nilotinib|nilotinib|mesh-list
153807268|NCT00418769|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153807269|NCT00418769|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153807270|NCT00418769|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153807271|NCT00418769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153807272|NCT00425334|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
153353842|NCT01510327|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153353852|NCT01510327|Antipyretics|antipyretics|mesh-ancestor
153807273|NCT00338247|Capecitabine|capecitabine|mesh-list
153807274|NCT00338247|Lapatinib|lapatinib|mesh-list
153807275|NCT00338247|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153807276|NCT00338247|Antimetabolites|antimetabolites|mesh-ancestor
153807277|NCT00338247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153807290|NCT00308321|Glucocorticoids|glucocorticoids|mesh-ancestor
153807291|NCT00308321|Hormones|hormones|mesh-ancestor
153807292|NCT00308321|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153875968|NCT01686321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153875969|NCT01199731|Etravirine|etravirine|mesh-list
153875972|NCT01199731|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153807293|NCT00308321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153807294|NCT00308321|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153807295|NCT00308321|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153807296|NCT00308321|Antiemetics|antiemetics|mesh-ancestor
153807297|NCT00308321|Autonomic Agents|autonomic agents|mesh-ancestor
153807298|NCT00308321|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153807299|NCT00308321|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153807300|NCT00308321|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
153807301|NCT00308321|Protective Agents|protective agents|mesh-ancestor
153807302|NCT00308360|Valproic Acid|valproic acid|mesh-list
153807303|NCT00308360|Risperidone|risperidone|mesh-list
153356941|NCT01278056|Deferasirox|deferasirox|mesh-list
153356942|NCT01278056|Iron Chelating Agents|iron chelating agents|mesh-ancestor
153356943|NCT01278056|Chelating Agents|chelating agents|mesh-ancestor
153356944|NCT01278056|Sequestering Agents|sequestering agents|mesh-ancestor
153356945|NCT01278056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153356946|NCT02992652|Allopurinol|allopurinol|mesh-list
153356947|NCT02992652|Antimetabolites|antimetabolites|mesh-ancestor
153783456|NCT04547452|Immunologic Factors|immunologic factors|mesh-ancestor
153783457|NCT04547452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153807304|NCT00308360|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153807305|NCT00308360|Serotonin Agents|serotonin agents|mesh-ancestor
153807306|NCT00308360|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153807307|NCT00308360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153807308|NCT00308360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153807309|NCT00308360|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153807310|NCT00308360|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153807311|NCT00308360|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153807312|NCT00308360|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153807313|NCT00308360|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
153807314|NCT00308360|Dopamine Agents|dopamine agents|mesh-ancestor
153807315|NCT00308360|Anticonvulsants|anticonvulsants|mesh-ancestor
153807316|NCT00308360|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153807317|NCT00308360|GABA Agents|gaba agents|mesh-ancestor
153807318|NCT00308360|Antimanic Agents|antimanic agents|mesh-ancestor
153807319|NCT00341250|Aluminum Hydroxide|aluminum hydroxide|mesh-list
153807320|NCT00341250|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153807321|NCT00341250|Immunologic Factors|immunologic factors|mesh-ancestor
153807322|NCT00341250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153807323|NCT00341250|Antacids|antacids|mesh-ancestor
153807324|NCT00341250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153807330|NCT00308438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153807332|NCT00308477|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153807333|NCT00308477|Antiemetics|antiemetics|mesh-ancestor
153807334|NCT00308477|Autonomic Agents|autonomic agents|mesh-ancestor
153807335|NCT00308477|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153807336|NCT00308477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153807338|NCT00308477|Glucocorticoids|glucocorticoids|mesh-ancestor
153807339|NCT00308477|Hormones|hormones|mesh-ancestor
153807340|NCT00308477|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153807341|NCT00308477|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153807342|NCT00308477|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153807343|NCT00308594|Dexamethasone|dexamethasone|mesh-list
153807344|NCT00308594|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153807345|NCT00308594|Antiemetics|antiemetics|mesh-ancestor
153807346|NCT00308594|Autonomic Agents|autonomic agents|mesh-ancestor
153807347|NCT00308594|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153807387|NCT00309218|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153807388|NCT00309218|Glucocorticoids|glucocorticoids|mesh-ancestor
153807389|NCT00309218|Hormones|hormones|mesh-ancestor
153807390|NCT00309218|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153807392|NCT00309218|Protective Agents|protective agents|mesh-ancestor
153356966|NCT01270724|Antimetabolites|antimetabolites|mesh-ancestor
153807393|NCT00309218|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153807394|NCT00309218|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153807395|NCT00309335|Phentolamine|phentolamine|mesh-list
153807396|NCT00309335|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
153807397|NCT00309335|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
153807398|NCT00309335|Adrenergic Agents|adrenergic agents|mesh-ancestor
153807399|NCT00309335|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153807400|NCT00309335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153807401|NCT00309335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153807402|NCT00309335|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153807403|NCT00309374|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
153807404|NCT00309374|Simvastatin|simvastatin|mesh-list
153807405|NCT00309374|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153807441|NCT00309530|Immunologic Factors|immunologic factors|mesh-ancestor
153807442|NCT00309530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153807443|NCT00309530|Antiviral Agents|antiviral agents|mesh-ancestor
153807444|NCT00309530|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153807445|NCT00309569|Cyclophosphamide|cyclophosphamide|mesh-list
153807446|NCT00309569|Fluorouracil|fluorouracil|mesh-list
153807447|NCT00309569|Methotrexate|methotrexate|mesh-list
153807448|NCT00309569|Epirubicin|epirubicin|mesh-list
153807449|NCT00309569|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153807450|NCT00309569|Immunologic Factors|immunologic factors|mesh-ancestor
153807451|NCT00309569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153807452|NCT00309569|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153807453|NCT00309569|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153807458|NCT00309569|Antimetabolites|antimetabolites|mesh-ancestor
153807503|NCT00338793|Prednisolone|prednisolone|mesh-list
153807504|NCT00338793|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153807505|NCT00338793|Glucocorticoids|glucocorticoids|mesh-ancestor
153807506|NCT00338793|Hormones|hormones|mesh-ancestor
153807507|NCT00338793|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153807508|NCT00338793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153807509|NCT00338793|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153356997|NCT00711464|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
153356998|NCT00711464|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
153356999|NCT00711464|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
153357000|NCT00711464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153357001|NCT01278290|Triptorelin Pamoate|triptorelin pamoate|mesh-list
153357002|NCT01278290|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
153357003|NCT01278290|Luteolytic Agents|luteolytic agents|mesh-ancestor
153357004|NCT01278290|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
153357005|NCT01278290|Contraceptive Agents|contraceptive agents|mesh-ancestor
153357006|NCT01278290|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153357007|NCT01278290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153357008|NCT01278290|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
153357009|NCT01278290|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153357010|NCT01278290|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153357012|NCT01278290|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153357013|NCT01278446|Caseins|caseins|mesh-list
153880866|NCT06014073|Alkylating Agents|alkylating agents|mesh-ancestor
153880867|NCT06014073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153807510|NCT00338793|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153807511|NCT00418847|Miglustat|miglustat|mesh-list
153807512|NCT00418847|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153416754|NCT04738526|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153416755|NCT04738526|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153416756|NCT04738526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153416757|NCT04738526|Antimanic Agents|antimanic agents|mesh-ancestor
153807513|NCT00418847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153807514|NCT00418847|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153807515|NCT00418847|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153807516|NCT00418847|Antiviral Agents|antiviral agents|mesh-ancestor
153807517|NCT00418847|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153807518|NCT00418847|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
153807519|NCT00418847|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153807520|NCT00418847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153807521|NCT00309881|Prednisone|prednisone|mesh-list
153807522|NCT00309881|Cyclophosphamide|cyclophosphamide|mesh-list
153807523|NCT00309881|Rituximab|rituximab|mesh-list
153807524|NCT00309881|Doxorubicin|doxorubicin|mesh-list
153807525|NCT00309881|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
153807526|NCT00309881|Vincristine|vincristine|mesh-list
153482411|NCT01479270|Epinephrine|epinephrine|mesh-list
153807527|NCT00309881|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153807552|NCT00309920|Doxorubicin|doxorubicin|mesh-list
153807553|NCT00309920|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
153807554|NCT00309920|Fluorouracil|fluorouracil|mesh-list
153807556|NCT00309920|Darbepoetin alfa|darbepoetin alfa|mesh-list
153807557|NCT00309920|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153807558|NCT00309920|Immunologic Factors|immunologic factors|mesh-ancestor
153807559|NCT00309920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153807560|NCT00309920|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153807561|NCT00309920|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153807562|NCT00309920|Alkylating Agents|alkylating agents|mesh-ancestor
153807563|NCT00309920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153807564|NCT00309920|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153807565|NCT00309920|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153807566|NCT00309920|Tubulin Modulators|tubulin modulators|mesh-ancestor
153807567|NCT00309920|Antimitotic Agents|antimitotic agents|mesh-ancestor
153807568|NCT00309920|Mitosis Modulators|mitosis modulators|mesh-ancestor
153807569|NCT00309920|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153807570|NCT00309920|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153807571|NCT00309920|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153807572|NCT00309920|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153354141|NCT03258320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153354145|NCT01797926|Losartan|losartan|mesh-list
153807573|NCT00309920|Antimetabolites|antimetabolites|mesh-ancestor
153807603|NCT00338910|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153807604|NCT00338910|Autonomic Agents|autonomic agents|mesh-ancestor
153807605|NCT00338910|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153807606|NCT00338910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153807607|NCT00338910|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153482590|NCT01523496|Vitamin D|vitamin d|mesh-list
153807608|NCT00338910|Respiratory System Agents|respiratory system agents|mesh-ancestor
153807609|NCT00338910|Glucocorticoids|glucocorticoids|mesh-ancestor
153807611|NCT00338910|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153807612|NCT00338910|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153807613|NCT00338910|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153807614|NCT00338910|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153807615|NCT00338910|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153807617|NCT00310232|Hematinics|hematinics|mesh-ancestor
153807637|NCT00339066|Sertraline|sertraline|mesh-list
153807659|NCT00310583|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153807660|NCT00310583|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153807661|NCT00421044|Epothilone B|epothilone b|mesh-list
153807662|NCT00421044|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153807663|NCT00421044|Tubulin Modulators|tubulin modulators|mesh-ancestor
153807664|NCT00421044|Antimitotic Agents|antimitotic agents|mesh-ancestor
153807665|NCT00421044|Mitosis Modulators|mitosis modulators|mesh-ancestor
153807666|NCT00421044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153807668|NCT00425217|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153807669|NCT00425217|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153807670|NCT00425217|Immunologic Factors|immunologic factors|mesh-ancestor
153807671|NCT00425217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153354366|NCT01529827|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153807722|NCT00421122|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
153807723|NCT00421122|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153482689|NCT06114953|Mycophenolic Acid|mycophenolic acid|mesh-list
153807724|NCT00421122|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153807725|NCT00421122|Autonomic Agents|autonomic agents|mesh-ancestor
153807726|NCT00421122|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153807727|NCT00421122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153807728|NCT00421122|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153807729|NCT00421122|Respiratory System Agents|respiratory system agents|mesh-ancestor
153807730|NCT00421122|Glucocorticoids|glucocorticoids|mesh-ancestor
153807732|NCT00421122|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153807734|NCT00421122|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
153807779|NCT00342381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153807780|NCT00311558|Interferons|interferons|mesh-list
153807781|NCT00311558|Interferon-alpha|interferon-alpha|mesh-list
153807782|NCT00311558|Interferon alpha-2|interferon alpha-2|mesh-list
153807783|NCT00311558|Antimony Sodium Gluconate|antimony sodium gluconate|mesh-list
153807784|NCT00311558|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153807785|NCT00311558|Antiviral Agents|antiviral agents|mesh-ancestor
153807786|NCT00311558|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153807787|NCT00311558|Immunologic Factors|immunologic factors|mesh-ancestor
153807788|NCT00311558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153807789|NCT00311558|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153807790|NCT00311558|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153807791|NCT00311558|Schistosomicides|schistosomicides|mesh-ancestor
153807792|NCT00311558|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
153807793|NCT00311558|Anthelmintics|anthelmintics|mesh-ancestor
153807794|NCT00418925|Dronabinol|dronabinol|mesh-list
153807795|NCT00418925|Hallucinogens|hallucinogens|mesh-ancestor
153876037|NCT01687140|Antimetabolites|antimetabolites|mesh-ancestor
153416804|NCT05448781|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153416805|NCT05448781|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153416806|NCT05448781|Tubulin Modulators|tubulin modulators|mesh-ancestor
153416807|NCT05448781|Antimitotic Agents|antimitotic agents|mesh-ancestor
153416808|NCT05448781|Mitosis Modulators|mitosis modulators|mesh-ancestor
153416809|NCT05448781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153416810|NCT05448781|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153807796|NCT00418925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153807797|NCT00418925|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153807798|NCT00418925|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153807799|NCT00418925|Analgesics|analgesics|mesh-ancestor
153807800|NCT00418925|Sensory System Agents|sensory system agents|mesh-ancestor
153807801|NCT00418925|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153807802|NCT00418925|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
153807803|NCT00418925|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
153807831|NCT00311636|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153807832|NCT00311636|Tubulin Modulators|tubulin modulators|mesh-ancestor
153807833|NCT00311636|Antimitotic Agents|antimitotic agents|mesh-ancestor
153807834|NCT00311636|Mitosis Modulators|mitosis modulators|mesh-ancestor
153807835|NCT00311636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153807836|NCT00311636|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153807837|NCT00311636|Immunologic Factors|immunologic factors|mesh-ancestor
153807838|NCT00311636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153807839|NCT00311636|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153807840|NCT00311636|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153807841|NCT00311636|Alkylating Agents|alkylating agents|mesh-ancestor
153807842|NCT00311636|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153807843|NCT00311636|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153807844|NCT00311636|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153807845|NCT00311636|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153807846|NCT00311636|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153807887|NCT00342849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153807889|NCT00342849|Sequestering Agents|sequestering agents|mesh-ancestor
153807890|NCT00342849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153807892|NCT00312104|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
153807893|NCT00312104|Insulin Glargine|insulin glargine|mesh-list
153807894|NCT00312104|Insulin Aspart|insulin aspart|mesh-list
153807895|NCT00312104|Insulin Detemir|insulin detemir|mesh-list
153807896|NCT00312104|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153807897|NCT00312104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153807898|NCT00312143|Mycophenolic Acid|mycophenolic acid|mesh-list
153807899|NCT00312143|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153807900|NCT00312143|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153807901|NCT00312143|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
153807902|NCT00312143|Antitubercular Agents|antitubercular agents|mesh-ancestor
153876038|NCT01687140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153876039|NCT04535960|Liraglutide|liraglutide|mesh-list
153876040|NCT04535960|Empagliflozin|empagliflozin|mesh-list
153876041|NCT04535960|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
153876042|NCT04535960|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153876043|NCT04535960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153876044|NCT04535960|Incretins|incretins|mesh-ancestor
153876046|NCT04535960|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153807903|NCT00312143|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153807904|NCT00312143|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153807905|NCT00312143|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153807906|NCT00312143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153807907|NCT00343005|Aluminum Hydroxide|aluminum hydroxide|mesh-list
153807908|NCT00343005|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153807909|NCT00343005|Immunologic Factors|immunologic factors|mesh-ancestor
153807910|NCT00343005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153807911|NCT00343005|Antacids|antacids|mesh-ancestor
153807912|NCT00343005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153807936|NCT00312260|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
153807938|NCT00312260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153807939|NCT00312260|Antimanic Agents|antimanic agents|mesh-ancestor
153807940|NCT00312260|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
153807941|NCT00312260|Antidepressive Agents|antidepressive agents|mesh-ancestor
153354513|NCT01532089|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
153807942|NCT00312260|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153807943|NCT00312260|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
153354586|NCT05245448|Immunologic Factors|immunologic factors|mesh-ancestor
153807944|NCT00312260|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153807945|NCT00312260|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153807946|NCT00312260|Adrenergic Agents|adrenergic agents|mesh-ancestor
153807947|NCT00312299|Polymethyl Methacrylate|polymethyl methacrylate|mesh-list
153807948|NCT00312299|Vasodilator Agents|vasodilator agents|mesh-ancestor
153807949|NCT00312299|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
153807992|NCT00312650|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153807993|NCT00312650|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153807994|NCT00312650|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153807995|NCT00312650|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153807996|NCT00312650|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153807997|NCT00343200|Sildenafil Citrate|sildenafil citrate|mesh-list
153807998|NCT00343200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153807999|NCT00343200|Vasodilator Agents|vasodilator agents|mesh-ancestor
153808000|NCT00343200|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
153808001|NCT00343200|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
153808002|NCT00343200|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153808003|NCT00343200|Urological Agents|urological agents|mesh-ancestor
153808004|NCT00312806|Pantoprazole|pantoprazole|mesh-list
153416827|NCT02535247|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153416828|NCT02535247|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153808056|NCT00347724|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153808057|NCT00347724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153808058|NCT00347724|Analgesics|analgesics|mesh-ancestor
153808059|NCT00347724|Sensory System Agents|sensory system agents|mesh-ancestor
153808060|NCT00347724|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153808061|NCT00313157|Metoprolol|metoprolol|mesh-list
153808062|NCT00313157|Verapamil|verapamil|mesh-list
153808063|NCT00313157|Carvedilol|carvedilol|mesh-list
153808064|NCT00313157|Diltiazem|diltiazem|mesh-list
153808065|NCT00313157|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153808066|NCT00313157|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153808067|NCT00313157|Sympatholytics|sympatholytics|mesh-ancestor
153808120|NCT00425126|Hematinics|hematinics|mesh-ancestor
153808121|NCT00343551|Aliskiren|aliskiren|mesh-list
153808122|NCT00343551|Renin Inhibitors|renin inhibitors|mesh-ancestor
153808123|NCT00343551|Protease Inhibitors|protease inhibitors|mesh-ancestor
153808124|NCT00343551|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153808125|NCT00343551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153808126|NCT00343629|Sulindac|sulindac|mesh-list
153808127|NCT00343629|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153808128|NCT00343629|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153808129|NCT00343629|Analgesics|analgesics|mesh-ancestor
153808130|NCT00343629|Sensory System Agents|sensory system agents|mesh-ancestor
153808131|NCT00343629|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153808132|NCT00343629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153808133|NCT00343629|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153808134|NCT00343629|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153808135|NCT00343629|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153808136|NCT00343629|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153808137|NCT00343629|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153808138|NCT00343629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153808139|NCT00343668|Irinotecan|irinotecan|mesh-list
153808140|NCT00343668|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
153808141|NCT00343668|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153808142|NCT00343668|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153808143|NCT00343668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153808144|NCT00343668|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153808145|NCT00343707|Paroxetine|paroxetine|mesh-list
153808146|NCT00343707|Vestipitant|vestipitant|mesh-list
153416829|NCT02535247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153416830|NCT04417920|Mitomycins|mitomycins|mesh-list
153416831|NCT04417920|Mitomycin|mitomycin|mesh-list
153416832|NCT04417920|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153416833|NCT04417920|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153416834|NCT04417920|Alkylating Agents|alkylating agents|mesh-ancestor
153416835|NCT04417920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153416836|NCT04417920|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153416837|NCT04417920|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153416838|NCT02626130|Tremelimumab|tremelimumab|mesh-list
153416839|NCT02626130|Ipilimumab|ipilimumab|mesh-list
153876068|NCT01687491|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153876069|NCT01687491|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153876070|NCT01687491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153876071|NCT04530227|Paclitaxel|paclitaxel|mesh-list
153876072|NCT04530227|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
153808147|NCT00343707|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
153808148|NCT00343707|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153808149|NCT00343707|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153808150|NCT00343707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153808151|NCT00343707|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153808152|NCT00343707|Serotonin Agents|serotonin agents|mesh-ancestor
153808153|NCT00343707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153808154|NCT00343707|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
153808155|NCT00343707|Antidepressive Agents|antidepressive agents|mesh-ancestor
153808157|NCT00343707|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
153357042|NCT01278602|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153808158|NCT00343707|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153808159|NCT00343707|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153808160|NCT00343707|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
153808161|NCT00313391|Risperidone|risperidone|mesh-list
153808162|NCT00313391|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153808163|NCT00313391|Serotonin Agents|serotonin agents|mesh-ancestor
153808164|NCT00313391|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153808165|NCT00313391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153354740|NCT00605072|Vasodilator Agents|vasodilator agents|mesh-ancestor
153808166|NCT00313391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153808167|NCT00313391|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153808168|NCT00313391|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153808169|NCT00313391|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153808170|NCT00313391|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153808171|NCT00313391|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
153808172|NCT00313391|Dopamine Agents|dopamine agents|mesh-ancestor
153808173|NCT00348153|Adalimumab|adalimumab|mesh-list
153808174|NCT00348153|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
153808175|NCT00348153|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153808176|NCT00348153|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153808177|NCT00313508|Vidarabine|vidarabine|mesh-list
153808178|NCT00313508|Fludarabine|fludarabine|mesh-list
153808179|NCT00313508|Fludarabine phosphate|fludarabine phosphate|mesh-list
153808180|NCT00313508|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153808181|NCT00313508|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153808182|NCT00313508|Antimetabolites|antimetabolites|mesh-ancestor
153808183|NCT00313508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153808184|NCT00313508|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153808198|NCT00313547|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
153808199|NCT00313547|Protease Inhibitors|protease inhibitors|mesh-ancestor
153808200|NCT00313547|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153808201|NCT00348192|Donepezil|donepezil|mesh-list
153808202|NCT00348192|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
153808203|NCT00348192|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153808204|NCT00348192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153808205|NCT00348192|Cholinergic Agents|cholinergic agents|mesh-ancestor
153808206|NCT00348192|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153808207|NCT00348192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153808208|NCT00348192|Nootropic Agents|nootropic agents|mesh-ancestor
153808209|NCT00313625|Methotrexate|methotrexate|mesh-list
153808210|NCT00313625|Melphalan|melphalan|mesh-list
153808211|NCT00313625|Busulfan|busulfan|mesh-list
153808212|NCT00313625|Tacrolimus|tacrolimus|mesh-list
153808213|NCT00313625|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
153808214|NCT00313625|Abortifacient Agents|abortifacient agents|mesh-ancestor
153808215|NCT00313625|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153808216|NCT00313625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153808217|NCT00313625|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153808218|NCT00313625|Antimetabolites|antimetabolites|mesh-ancestor
153808219|NCT00313625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153808220|NCT00313625|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153808221|NCT00313625|Dermatologic Agents|dermatologic agents|mesh-ancestor
153808222|NCT00313625|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153808223|NCT00313625|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153808224|NCT00313625|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153808225|NCT00313625|Immunologic Factors|immunologic factors|mesh-ancestor
153808226|NCT00313625|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153808243|NCT00313859|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153808245|NCT00313859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153808246|NCT00313859|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153808247|NCT00313859|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
153808248|NCT00313859|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153808250|NCT00348231|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153808251|NCT00348231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153808252|NCT00313898|Sildenafil Citrate|sildenafil citrate|mesh-list
153808253|NCT00313898|Vasodilator Agents|vasodilator agents|mesh-ancestor
153808254|NCT00313898|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
153808255|NCT00313898|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
153808305|NCT00344253|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153808306|NCT00344253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153357050|NCT00712244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153357051|NCT00712244|Viscosupplements|viscosupplements|mesh-ancestor
153808307|NCT00344253|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153808308|NCT00344253|Antimetabolites|antimetabolites|mesh-ancestor
153808309|NCT00344253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153808310|NCT00344253|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153808311|NCT00344253|Dermatologic Agents|dermatologic agents|mesh-ancestor
153808312|NCT00344253|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153808313|NCT00344253|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153808314|NCT00344253|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153808315|NCT00344253|Immunologic Factors|immunologic factors|mesh-ancestor
153808316|NCT00344253|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153354959|NCT00612716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153808317|NCT00344253|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153808319|NCT00344253|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153808321|NCT00314405|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153808322|NCT00314405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153808323|NCT04715295|Azithromycin|azithromycin|mesh-list
153808324|NCT04715295|Doxycycline|doxycycline|mesh-list
153808325|NCT04715295|Hydroxychloroquine|hydroxychloroquine|mesh-list
153808326|NCT04715295|Rivaroxaban|rivaroxaban|mesh-list
153808327|NCT04715295|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153808328|NCT04715295|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153808330|NCT04715295|Antithrombins|antithrombins|mesh-ancestor
153808355|NCT00348504|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153808356|NCT00348504|Adrenergic Agents|adrenergic agents|mesh-ancestor
153808357|NCT00348504|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153808359|NCT00314561|Rosiglitazone|rosiglitazone|mesh-list
153808360|NCT00314561|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153808361|NCT00314561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153808362|NCT00344409|Darbepoetin alfa|darbepoetin alfa|mesh-list
153808363|NCT00344409|Hematinics|hematinics|mesh-ancestor
153808364|NCT00348582|Ketorolac|ketorolac|mesh-list
153808365|NCT00348582|Nepafenac|nepafenac|mesh-list
153808366|NCT00348582|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153808367|NCT00348582|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153808368|NCT00348582|Analgesics|analgesics|mesh-ancestor
153808369|NCT00348582|Sensory System Agents|sensory system agents|mesh-ancestor
153808370|NCT00348582|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153808371|NCT00348582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153808372|NCT00348582|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153808373|NCT00348582|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153808410|NCT00344526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153808411|NCT00344526|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153808412|NCT00344526|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153808413|NCT00344526|Immunologic Factors|immunologic factors|mesh-ancestor
153808414|NCT00344565|Modafinil|modafinil|mesh-list
153808415|NCT00344565|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
153808416|NCT00344565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153808421|NCT00314873|Imatinib Mesylate|imatinib mesylate|mesh-list
153808478|NCT00344760|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153808479|NCT00344760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153808480|NCT00344760|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153808481|NCT00344760|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153808482|NCT00344760|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
153808483|NCT00344760|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153808484|NCT00344760|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
153808485|NCT00344760|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
153808486|NCT00344760|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
153808487|NCT00344760|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
153808488|NCT00344760|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
153808489|NCT00344760|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
153808490|NCT00348894|Reboxetine|reboxetine|mesh-list
153808491|NCT00348894|Antidepressive Agents|antidepressive agents|mesh-ancestor
153808535|NCT00349128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153808536|NCT00349128|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153355106|NCT03007303|Ziprasidone|ziprasidone|mesh-list
153808537|NCT00315848|Buprenorphine|buprenorphine|mesh-list
153808538|NCT00315848|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153808539|NCT00315848|Narcotics|narcotics|mesh-ancestor
153808540|NCT00315848|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153808541|NCT00315848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153808543|NCT00315848|Sensory System Agents|sensory system agents|mesh-ancestor
153808544|NCT00315848|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153808545|NCT00315848|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
153808546|NCT00349206|Sirolimus|sirolimus|mesh-list
153808547|NCT00349206|Sorafenib|sorafenib|mesh-list
153808548|NCT00349206|Temsirolimus|temsirolimus|mesh-list
153808549|NCT00349206|MTOR Inhibitors|mtor inhibitors|mesh-list
153808550|NCT00349206|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153808551|NCT00349206|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153808552|NCT00349206|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153808553|NCT00349206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153808554|NCT00349206|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153808555|NCT00349206|Immunologic Factors|immunologic factors|mesh-ancestor
153808556|NCT00349206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153808557|NCT00349206|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153808558|NCT00349206|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153808559|NCT00349206|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153808560|NCT00349206|Antifungal Agents|antifungal agents|mesh-ancestor
153808561|NCT00315887|Buprenorphine|buprenorphine|mesh-list
153808562|NCT00315887|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153808563|NCT00315887|Narcotics|narcotics|mesh-ancestor
153808580|NCT00421434|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
153808581|NCT00421434|Interferon-alpha|interferon-alpha|mesh-list
153808582|NCT00421434|Nitazoxanide|nitazoxanide|mesh-list
153808583|NCT00421434|Antimetabolites|antimetabolites|mesh-ancestor
153808584|NCT00421434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153357083|NCT01271660|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153357090|NCT00731588|Biotin|biotin|mesh-list
153808585|NCT00421434|Antiviral Agents|antiviral agents|mesh-ancestor
153808586|NCT00421434|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153808587|NCT00421434|Immunologic Factors|immunologic factors|mesh-ancestor
153808588|NCT00421434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153808589|NCT00421434|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153808590|NCT00315965|Nitric Oxide|nitric oxide|mesh-list
153808591|NCT00315965|Carbon Monoxide|carbon monoxide|mesh-list
153808592|NCT00315965|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153808593|NCT00315965|Autonomic Agents|autonomic agents|mesh-ancestor
153808594|NCT00315965|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153355186|NCT01590979|Ranolazine|ranolazine|mesh-list
153808640|NCT06165146|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153808641|NCT06165146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153808642|NCT06165042|Methamphetamine|methamphetamine|mesh-list
153808643|NCT06165042|Fluorides|fluorides|mesh-list
153808644|NCT06165042|Fluorides, Topical|fluorides, topical|mesh-list
153808645|NCT06165042|Cariostatic Agents|cariostatic agents|mesh-ancestor
153808646|NCT06165042|Protective Agents|protective agents|mesh-ancestor
153808647|NCT06165042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153427558|NCT03782233|Bromides|bromides|mesh-list
153808648|NCT06165042|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
153808650|NCT06165042|Autonomic Agents|autonomic agents|mesh-ancestor
153808651|NCT06165042|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153808652|NCT06165042|Dopamine Agents|dopamine agents|mesh-ancestor
153808653|NCT06165042|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153808654|NCT06165042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153808655|NCT06165042|Adrenergic Agents|adrenergic agents|mesh-ancestor
153808656|NCT06165042|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
153808657|NCT06165042|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153808658|NCT06165042|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153808659|NCT06165042|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
153808660|NCT06164834|Esomeprazole|esomeprazole|mesh-list
153808661|NCT06164834|Clopidogrel|clopidogrel|mesh-list
153808662|NCT06164834|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153808663|NCT06164834|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
153808664|NCT06164834|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
153808665|NCT06164834|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
153808666|NCT06164834|Purinergic Agents|purinergic agents|mesh-ancestor
153808667|NCT06164834|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153808668|NCT06164834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153808683|NCT06164535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153808684|NCT06164379|Spironolactone|spironolactone|mesh-list
153808685|NCT06164379|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
153808686|NCT06164379|Hormone Antagonists|hormone antagonists|mesh-ancestor
153355327|NCT00624416|Prednisolone phosphate|prednisolone phosphate|mesh-list
153808687|NCT06164379|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153808688|NCT06164379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153808689|NCT06164379|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
153808690|NCT06164379|Diuretics|diuretics|mesh-ancestor
153808691|NCT06164379|Natriuretic Agents|natriuretic agents|mesh-ancestor
153808692|NCT06164327|Rituximab|rituximab|mesh-list
153808693|NCT06164327|Carboplatin|carboplatin|mesh-list
153808694|NCT06164327|Gemcitabine|gemcitabine|mesh-list
153808744|NCT06163755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153808746|NCT06163755|Glucocorticoids|glucocorticoids|mesh-ancestor
153808747|NCT06163755|Hormones|hormones|mesh-ancestor
153808748|NCT06163755|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153808749|NCT06163755|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
153808750|NCT06163755|Protective Agents|protective agents|mesh-ancestor
153808751|NCT06163755|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153808752|NCT06163755|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153808753|NCT06158412|Tretinoin|tretinoin|mesh-list
153808754|NCT06158412|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153808755|NCT06158412|Keratolytic Agents|keratolytic agents|mesh-ancestor
153808756|NCT06158412|Dermatologic Agents|dermatologic agents|mesh-ancestor
153808757|NCT06158399|Azacitidine|azacitidine|mesh-list
153808758|NCT06158399|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153808759|NCT06158399|Antimetabolites|antimetabolites|mesh-ancestor
153808760|NCT06158399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153808761|NCT06158399|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153416893|NCT00370370|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153808763|NCT06153394|Enoxaparin|enoxaparin|mesh-list
153808764|NCT06153394|Dalteparin|dalteparin|mesh-list
153808765|NCT06153394|Tinzaparin|tinzaparin|mesh-list
153808766|NCT06153394|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
153808767|NCT06153394|Enoxaparin sodium|enoxaparin sodium|mesh-list
153808768|NCT06153394|Anticoagulants|anticoagulants|mesh-ancestor
153808769|NCT06153394|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153808770|NCT06153394|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153808771|NCT06153394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153808772|NCT06151080|Lenalidomide|lenalidomide|mesh-list
153808773|NCT06151080|Immunologic Factors|immunologic factors|mesh-ancestor
153808774|NCT06151080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153808777|NCT06151080|Growth Substances|growth substances|mesh-ancestor
153808788|NCT06105684|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153808789|NCT06105684|Antimetabolites|antimetabolites|mesh-ancestor
153808790|NCT06105684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153808791|NCT06105684|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153808793|NCT06024174|Adagrasib|adagrasib|mesh-list
153808794|NCT06024174|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153808795|NCT06024174|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153808796|NCT06004830|Spironolactone|spironolactone|mesh-list
153808797|NCT06004830|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
153808798|NCT06004830|Hormone Antagonists|hormone antagonists|mesh-ancestor
153808799|NCT06004830|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153808800|NCT06004830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153808801|NCT06004830|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
153808802|NCT06004830|Diuretics|diuretics|mesh-ancestor
153808803|NCT06004830|Natriuretic Agents|natriuretic agents|mesh-ancestor
153808804|NCT05980806|N-(cyanomethyl)-4-(2-((4-(4-morpholinyl)phenyl)amino)-4-pyrimidinyl)benzamide|n-(cyanomethyl)-4-(2-((4-(4-morpholinyl)phenyl)amino)-4-pyrimidinyl)benzamide|mesh-list
153808805|NCT05980806|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153808806|NCT05980806|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153808807|NCT05980806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153808808|NCT05965570|Clarithromycin|clarithromycin|mesh-list
153808809|NCT05965570|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153808810|NCT05965570|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153808811|NCT05965570|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
153876136|NCT04529525|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153357156|NCT00722072|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153357157|NCT00722072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153357158|NCT00722072|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153886567|NCT00600639|Tocolytic Agents|tocolytic agents|mesh-ancestor
153886568|NCT00600639|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153886583|NCT00600873|Dopamine Agonists|dopamine agonists|mesh-ancestor
153886584|NCT00600873|Dopamine Agents|dopamine agents|mesh-ancestor
153886585|NCT00600873|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153886586|NCT00598611|Loratadine|loratadine|mesh-list
153886587|NCT00598611|Desloratadine|desloratadine|mesh-list
153886588|NCT00598611|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
153876137|NCT02216409|Magrolimab|magrolimab|mesh-list
153876138|NCT02216409|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153876139|NCT02216409|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153876140|NCT05126121|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
153876141|NCT05126121|Amoxicillin|amoxicillin|mesh-list
153876142|NCT05126121|Clarithromycin|clarithromycin|mesh-list
153876143|NCT05126121|Levofloxacin|levofloxacin|mesh-list
153876144|NCT05126121|Ofloxacin|ofloxacin|mesh-list
153876145|NCT05126121|Tetracycline|tetracycline|mesh-list
153876146|NCT05126121|Tinidazole|tinidazole|mesh-list
153876147|NCT05126121|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
153876148|NCT05126121|Furazolidone|furazolidone|mesh-list
153876149|NCT05126121|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153876150|NCT05126121|Antitubercular Agents|antitubercular agents|mesh-ancestor
153876151|NCT05126121|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
153808813|NCT05965570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153808814|NCT05965570|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
153808815|NCT05965570|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153808816|NCT05930613|Certolizumab Pegol|certolizumab pegol|mesh-list
153808817|NCT05930613|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
153808823|NCT05903807|FAPI-46|fapi-46|mesh-list
153808827|NCT05879146|Gamma Secretase Inhibitors and Modulators|gamma secretase inhibitors and modulators|mesh-ancestor
153808828|NCT05879146|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153808829|NCT05879146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153808830|NCT05849779|Sevoflurane|sevoflurane|mesh-list
153808831|NCT05849779|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153808832|NCT05849779|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
153808833|NCT05849779|Anesthetics, General|anesthetics, general|mesh-ancestor
153355400|NCT03006835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153355476|NCT02248129|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
153808835|NCT05849779|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153808836|NCT05849779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153427635|NCT00000506|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153886627|NCT01325493|Sensory System Agents|sensory system agents|mesh-ancestor
153886628|NCT01325493|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153886629|NCT01325493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153886630|NCT01325493|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
153427647|NCT00000512|Dihydromevinolin|dihydromevinolin|mesh-list
153427659|NCT00000512|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
153427660|NCT00000512|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153427661|NCT00000512|Sequestering Agents|sequestering agents|mesh-ancestor
153427662|NCT00380822|Miglitol|miglitol|mesh-list
153427663|NCT00380822|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153427664|NCT00380822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153427665|NCT00380822|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153427666|NCT00380822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153427667|NCT00380822|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
153886631|NCT01325493|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153808887|NCT05717400|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153808888|NCT05704647|Nivolumab|nivolumab|mesh-list
153808889|NCT05704647|Relatlimab|relatlimab|mesh-list
153808890|NCT05704647|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153808891|NCT05704647|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153808892|NCT05704647|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153808893|NCT05704647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153808894|NCT05696977|Cyclosporine|cyclosporine|mesh-list
153808895|NCT05696977|Cyclosporins|cyclosporins|mesh-list
153808896|NCT05696977|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153808897|NCT05696977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153808898|NCT05696977|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153808899|NCT05696977|Immunologic Factors|immunologic factors|mesh-ancestor
153808900|NCT05696977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153808901|NCT05696977|Antifungal Agents|antifungal agents|mesh-ancestor
153808902|NCT05696977|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153808903|NCT05696977|Dermatologic Agents|dermatologic agents|mesh-ancestor
153355477|NCT02248129|Telmisartan|telmisartan|mesh-list
153808942|NCT05661669|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153808943|NCT05661669|Anesthetics, General|anesthetics, general|mesh-ancestor
153808944|NCT05661669|Anesthetics|anesthetics|mesh-ancestor
153808945|NCT05661669|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153808946|NCT05661669|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
153808947|NCT05661669|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
153808948|NCT05661669|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153808949|NCT05661669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153808950|NCT05625776|Capsaicin|capsaicin|mesh-list
153808951|NCT05625776|Antipruritics|antipruritics|mesh-ancestor
153808952|NCT05625776|Dermatologic Agents|dermatologic agents|mesh-ancestor
153808953|NCT05625776|Sensory System Agents|sensory system agents|mesh-ancestor
153808954|NCT05625776|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153808955|NCT05625776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153808957|NCT05590260|Trace Elements|trace elements|mesh-ancestor
153808958|NCT05590260|Micronutrients|micronutrients|mesh-ancestor
153808959|NCT05590260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153357159|NCT00722072|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
153357160|NCT00722072|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
153357161|NCT00722072|Hormone Antagonists|hormone antagonists|mesh-ancestor
153808960|NCT05567315|Anesthetics|anesthetics|mesh-list
153808961|NCT05567315|Anesthetics, Local|anesthetics, local|mesh-list
153808962|NCT05567315|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153808963|NCT05567315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153808964|NCT05567315|Sensory System Agents|sensory system agents|mesh-ancestor
153808965|NCT05567315|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153808966|NCT05541484|Dapagliflozin|dapagliflozin|mesh-list
153808967|NCT05541484|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
153808968|NCT05541484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153808969|NCT05541484|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153808970|NCT05541484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153808971|NCT05483491|Aldesleukin|aldesleukin|mesh-list
153808972|NCT05483491|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153808973|NCT05483491|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153808974|NCT05483491|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153808975|NCT05483491|Antiviral Agents|antiviral agents|mesh-ancestor
153808976|NCT05483491|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153808977|NCT05479123|Timolol|timolol|mesh-list
153808978|NCT05479123|Propranolol|propranolol|mesh-list
153808980|NCT05479123|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
153808981|NCT05479123|Adrenergic Agents|adrenergic agents|mesh-ancestor
153808982|NCT05479123|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153355627|NCT02248753|Metoprolol|metoprolol|mesh-list
153808983|NCT05479123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153808984|NCT05479123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153808985|NCT05479123|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153808986|NCT05479123|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153808987|NCT05479123|Vasodilator Agents|vasodilator agents|mesh-ancestor
153808988|NCT05461820|Methimazole|methimazole|mesh-list
153808989|NCT05461820|Antithyroid Agents|antithyroid agents|mesh-ancestor
153808990|NCT05461820|Hormone Antagonists|hormone antagonists|mesh-ancestor
153808991|NCT05461820|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153808992|NCT05461820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153808993|NCT05425862|Talazoparib|talazoparib|mesh-list
153416924|NCT00370591|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153416925|NCT00370591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153416926|NCT03956173|Hypoglycemic Agents|hypoglycemic agents|mesh-list
153416927|NCT03956173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153416928|NCT00371527|Ipratropium|ipratropium|mesh-list
153416929|NCT00371527|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153416930|NCT00371527|Autonomic Agents|autonomic agents|mesh-ancestor
153416931|NCT00371527|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153808994|NCT05425862|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
153808995|NCT05425862|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153808996|NCT05425862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153483593|NCT01428089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153808999|NCT05413551|Antitubercular Agents|antitubercular agents|mesh-ancestor
153809000|NCT05413551|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153809001|NCT05413551|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153809002|NCT05413551|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
153809003|NCT05413551|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153809004|NCT05413551|Antimetabolites|antimetabolites|mesh-ancestor
153809006|NCT05413551|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153809024|NCT05394337|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153809025|NCT05394337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153809026|NCT05394337|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153809027|NCT05394337|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153809028|NCT05372887|Cyclobenzaprine|cyclobenzaprine|mesh-list
153809029|NCT05372887|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
153809030|NCT05372887|Antidepressive Agents|antidepressive agents|mesh-ancestor
153809031|NCT05372887|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153809032|NCT05372887|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
153809033|NCT05372887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153809034|NCT05372887|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
153809035|NCT05372887|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153809036|NCT05372887|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153809037|NCT05372887|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153809038|NCT05371964|Imetelstat|imetelstat|mesh-list
153809039|NCT05371964|Motesanib diphosphate|motesanib diphosphate|mesh-list
153809040|NCT05371964|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153809041|NCT05371964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153809042|NCT05371964|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153809044|NCT05340790|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
153809045|NCT05317936|Venetoclax|venetoclax|mesh-list
153809075|NCT05285813|Anesthetics|anesthetics|mesh-ancestor
153809076|NCT05285813|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
153809077|NCT05285813|Histamine Antagonists|histamine antagonists|mesh-ancestor
153809078|NCT05285813|Histamine Agents|histamine agents|mesh-ancestor
153809079|NCT05285813|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153809080|NCT05285813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153809081|NCT05285813|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
153809082|NCT05285813|Antipruritics|antipruritics|mesh-ancestor
153357846|NCT03806036|Vitamin D|vitamin d|mesh-list
153809083|NCT05285813|Dermatologic Agents|dermatologic agents|mesh-ancestor
153876167|NCT02218658|Brotizolam|brotizolam|mesh-list
153809084|NCT05271552|Dexmedetomidine|dexmedetomidine|mesh-list
153416936|NCT00371527|Cholinergic Agents|cholinergic agents|mesh-ancestor
153416937|NCT00371527|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153809085|NCT05271552|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153809086|NCT05271552|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153809087|NCT05271552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153809088|NCT05271552|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153809089|NCT05271552|Analgesics|analgesics|mesh-ancestor
153809090|NCT05271552|Sensory System Agents|sensory system agents|mesh-ancestor
153809091|NCT05271552|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153809092|NCT05271552|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
153809132|NCT05183841|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153809133|NCT05183841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153809134|NCT05183841|Sympathomimetics|sympathomimetics|mesh-ancestor
153809135|NCT05183841|Tocolytic Agents|tocolytic agents|mesh-ancestor
153809136|NCT05183841|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153809137|NCT05183841|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
153809138|NCT05183841|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
153809139|NCT05183841|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153809140|NCT05183841|Adrenergic Agents|adrenergic agents|mesh-ancestor
153809141|NCT05159934|Nicotine|nicotine|mesh-list
153809142|NCT05159934|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
153809143|NCT05159934|Autonomic Agents|autonomic agents|mesh-ancestor
153809144|NCT05159934|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153809194|NCT04773873|Lithium Carbonate|lithium carbonate|mesh-list
153809195|NCT04773873|Antidepressive Agents|antidepressive agents|mesh-ancestor
153809196|NCT04773873|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153809197|NCT04773873|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153809198|NCT04773873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153809199|NCT04773873|Antimanic Agents|antimanic agents|mesh-ancestor
153809200|NCT04773873|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153809201|NCT04773873|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153809202|NCT04773873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153355777|NCT02219503|Ritonavir|ritonavir|mesh-list
153809204|NCT04771156|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153809205|NCT04771156|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153809255|NCT04523207|Hormone Antagonists|hormone antagonists|mesh-ancestor
153809256|NCT04523207|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153809257|NCT04523207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153809258|NCT04497870|Peppermint oil|peppermint oil|mesh-list
153809259|NCT04497870|Menthol|menthol|mesh-list
153809260|NCT04497870|Antipruritics|antipruritics|mesh-ancestor
153809261|NCT04497870|Dermatologic Agents|dermatologic agents|mesh-ancestor
153809262|NCT04497870|Antiemetics|antiemetics|mesh-ancestor
153809263|NCT04497870|Autonomic Agents|autonomic agents|mesh-ancestor
153809264|NCT04497870|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153809265|NCT04497870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153809266|NCT04497870|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153809267|NCT04497870|Parasympatholytics|parasympatholytics|mesh-ancestor
153809268|NCT04455815|Gabexate|gabexate|mesh-list
153809269|NCT04455815|Camostat|camostat|mesh-list
153809270|NCT04455815|Protease Inhibitors|protease inhibitors|mesh-ancestor
153809271|NCT04455815|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153809272|NCT04455815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153809273|NCT04455815|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
153809274|NCT04455815|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
153809275|NCT04455815|Anticoagulants|anticoagulants|mesh-ancestor
153809276|NCT04402073|Vincristine|vincristine|mesh-list
153809277|NCT04402073|Lomustine|lomustine|mesh-list
153809278|NCT04402073|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153809280|NCT04402073|Tubulin Modulators|tubulin modulators|mesh-ancestor
153809281|NCT04402073|Antimitotic Agents|antimitotic agents|mesh-ancestor
153809282|NCT04402073|Mitosis Modulators|mitosis modulators|mesh-ancestor
153357861|NCT03806036|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
153357862|NCT00780026|Insulin|insulin|mesh-list
153809283|NCT04402073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153809284|NCT04402073|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153809285|NCT04402073|Alkylating Agents|alkylating agents|mesh-ancestor
153809286|NCT04209543|Progesterone|progesterone|mesh-list
153809287|NCT04209543|Progestins|progestins|mesh-ancestor
153809289|NCT04209543|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153809290|NCT04209543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153809291|NCT04158739|Cytarabine|cytarabine|mesh-list
153809292|NCT04158739|Antibodies|antibodies|mesh-list
153809293|NCT04158739|Immunoglobulins|immunoglobulins|mesh-list
153809294|NCT04158739|Antibodies, Bispecific|antibodies, bispecific|mesh-list
153809295|NCT04158739|Immunologic Factors|immunologic factors|mesh-ancestor
153809296|NCT04158739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153809297|NCT04158739|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153809299|NCT04158739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153809300|NCT04158739|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153809301|NCT04158739|Antiviral Agents|antiviral agents|mesh-ancestor
153809302|NCT04158739|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153809303|NCT04158739|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153809304|NCT04147325|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
153809358|NCT04011410|Antimalarials|antimalarials|mesh-ancestor
153809359|NCT04011410|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153809360|NCT04011410|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153809361|NCT04011410|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153809362|NCT04011410|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153809363|NCT04011410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153809364|NCT04011410|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153809365|NCT03964051|Omalizumab|omalizumab|mesh-list
153809366|NCT03964051|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
153809367|NCT03964051|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153809368|NCT03964051|Respiratory System Agents|respiratory system agents|mesh-ancestor
153809369|NCT03835520|Immunomodulating Agents|immunomodulating agents|mesh-list
153809370|NCT03835520|Immunologic Factors|immunologic factors|mesh-ancestor
153809371|NCT03835520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153809372|NCT03793478|Cytarabine|cytarabine|mesh-list
153809373|NCT03793478|Fludarabine|fludarabine|mesh-list
153809374|NCT03793478|Etoposide|etoposide|mesh-list
153809375|NCT03793478|Quizartinib|quizartinib|mesh-list
153809376|NCT03793478|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153809377|NCT03793478|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153809378|NCT03793478|Antimetabolites|antimetabolites|mesh-ancestor
153809380|NCT03793478|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153809415|NCT03579446|Hydrocodone|hydrocodone|mesh-list
153809416|NCT03579446|Levorphanol|levorphanol|mesh-list
153809417|NCT03579446|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153809418|NCT03579446|Narcotics|narcotics|mesh-ancestor
153809419|NCT03579446|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153416952|NCT04027322|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153809420|NCT03579446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153809421|NCT03579446|Analgesics|analgesics|mesh-ancestor
153809422|NCT03579446|Sensory System Agents|sensory system agents|mesh-ancestor
153357898|NCT03809312|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153357899|NCT03809312|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153357900|NCT03809312|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153880911|NCT05856994|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
153357901|NCT03809312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153357902|NCT03809312|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
153357903|NCT01247363|Globalagliatin|globalagliatin|mesh-list
153357904|NCT01247363|Enzyme Activators|enzyme activators|mesh-ancestor
153886797|NCT02877355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153809423|NCT03579446|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153809424|NCT03579446|Antitussive Agents|antitussive agents|mesh-ancestor
153809425|NCT03579446|Respiratory System Agents|respiratory system agents|mesh-ancestor
153809426|NCT03579446|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153809427|NCT03537508|Vaccines|vaccines|mesh-list
153809428|NCT03537508|Immunologic Factors|immunologic factors|mesh-ancestor
153809429|NCT03537508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153809430|NCT03424018|Natriuretic Peptide, C-Type|natriuretic peptide, c-type|mesh-list
153355999|NCT00601796|Dermatologic Agents|dermatologic agents|mesh-ancestor
153809431|NCT03424018|Natriuretic Agents|natriuretic agents|mesh-ancestor
153809432|NCT03424018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153809434|NCT03405155|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153809435|NCT03405155|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153809436|NCT03405155|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153809437|NCT03405155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153809438|NCT03383692|Ritonavir|ritonavir|mesh-list
153809439|NCT03383692|Itraconazole|itraconazole|mesh-list
153809440|NCT03383692|Trastuzumab deruxtecan|trastuzumab deruxtecan|mesh-list
153809441|NCT03383692|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
153809442|NCT03383692|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
153809443|NCT03383692|Protease Inhibitors|protease inhibitors|mesh-ancestor
153809444|NCT03383692|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153809445|NCT03383692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153809446|NCT03383692|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153809447|NCT03383692|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153809448|NCT03383692|Antiviral Agents|antiviral agents|mesh-ancestor
153809449|NCT03383692|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153809450|NCT03383692|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
153809451|NCT03383692|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153809452|NCT03383692|Antifungal Agents|antifungal agents|mesh-ancestor
153809453|NCT03383692|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
153809454|NCT03383692|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153809455|NCT03383692|Hormone Antagonists|hormone antagonists|mesh-ancestor
153809456|NCT03383692|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153809457|NCT03383692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153809458|NCT03383692|Immunoconjugates|immunoconjugates|mesh-ancestor
153809459|NCT03383692|Immunologic Factors|immunologic factors|mesh-ancestor
153809461|NCT03342196|Melphalan|melphalan|mesh-list
153809462|NCT03342196|Thiotepa|thiotepa|mesh-list
153809463|NCT03342196|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153809464|NCT03342196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153809465|NCT03342196|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153809466|NCT03342196|Immunologic Factors|immunologic factors|mesh-ancestor
153809467|NCT03342196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153809471|NCT03330132|Hemagglutinins|hemagglutinins|mesh-list
153809509|NCT03206671|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153809510|NCT03206671|Glucocorticoids|glucocorticoids|mesh-ancestor
153809512|NCT03206671|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153809513|NCT03206671|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153809514|NCT03206671|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153809515|NCT03206671|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153809516|NCT03206671|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153809517|NCT03206671|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153809518|NCT03206671|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153809519|NCT03206671|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
153809520|NCT03206671|Abortifacient Agents|abortifacient agents|mesh-ancestor
153809521|NCT03206671|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153809522|NCT03206671|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153809523|NCT03206671|Antimetabolites|antimetabolites|mesh-ancestor
153809524|NCT03206671|Dermatologic Agents|dermatologic agents|mesh-ancestor
153809525|NCT03206671|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153809526|NCT03206671|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153809527|NCT03206671|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153809528|NCT03206671|Antiviral Agents|antiviral agents|mesh-ancestor
153809529|NCT03206671|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153809530|NCT03206671|Tubulin Modulators|tubulin modulators|mesh-ancestor
153809531|NCT03206671|Antimitotic Agents|antimitotic agents|mesh-ancestor
153809532|NCT03206671|Mitosis Modulators|mitosis modulators|mesh-ancestor
153809533|NCT03161431|Pembrolizumab|pembrolizumab|mesh-list
153809534|NCT03161431|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153809535|NCT03161431|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153809536|NCT03161431|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153809537|NCT03161431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153809538|NCT03048019|Tirofiban|tirofiban|mesh-list
153809539|NCT03048019|Cangrelor|cangrelor|mesh-list
153809543|NCT03048019|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153809548|NCT03048019|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153809549|NCT03048019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153809550|NCT03006705|Capecitabine|capecitabine|mesh-list
153809551|NCT03006705|Tegafur|tegafur|mesh-list
153809552|NCT03006705|Nivolumab|nivolumab|mesh-list
153809553|NCT03006705|Oxaliplatin|oxaliplatin|mesh-list
153809554|NCT03006705|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153809555|NCT03006705|Antimetabolites|antimetabolites|mesh-ancestor
153809556|NCT03006705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153809557|NCT03006705|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153809558|NCT03006705|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153809559|NCT03006705|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153809560|NCT02998645|Cyclosporine|cyclosporine|mesh-list
153809561|NCT02998645|Cyclosporins|cyclosporins|mesh-list
153809562|NCT02998645|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153809563|NCT02998645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153809572|NCT02917720|Nilotinib|nilotinib|mesh-list
153809605|NCT02710734|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153809606|NCT02710734|Alkylating Agents|alkylating agents|mesh-ancestor
153809607|NCT02710734|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153809608|NCT02710734|Tubulin Modulators|tubulin modulators|mesh-ancestor
153809609|NCT02710734|Antimitotic Agents|antimitotic agents|mesh-ancestor
153813887|NCT00437697|Tinzaparin|tinzaparin|mesh-list
153483869|NCT01559064|Immunologic Factors|immunologic factors|mesh-ancestor
153483870|NCT01559064|Viscosupplements|viscosupplements|mesh-ancestor
153483871|NCT01559064|Protective Agents|protective agents|mesh-ancestor
153483872|NCT01559922|Polymethyl Methacrylate|polymethyl methacrylate|mesh-list
153483873|NCT01559922|Vasodilator Agents|vasodilator agents|mesh-ancestor
153483874|NCT01559922|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
153483875|NCT01559922|Protective Agents|protective agents|mesh-ancestor
153483876|NCT01559922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153809612|NCT02580994|Pembrolizumab|pembrolizumab|mesh-list
153809613|NCT02580994|Etoposide|etoposide|mesh-list
153809614|NCT02580994|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153886834|NCT01321008|Hormones|hormones|mesh-ancestor
153809615|NCT02580994|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153809616|NCT02580994|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153809617|NCT02580994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153809618|NCT02580994|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153809619|NCT02580994|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153809620|NCT02580994|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153809621|NCT02580994|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153809622|NCT02543567|Smallpox and monkeypox vaccine modified vaccinia ankara-bavarian nordic|smallpox and monkeypox vaccine modified vaccinia ankara-bavarian nordic|mesh-list
153809623|NCT02543567|Antiviral Agents|antiviral agents|mesh-ancestor
153809624|NCT02543567|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153809625|NCT02530489|Paclitaxel|paclitaxel|mesh-list
153809626|NCT02530489|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
153809627|NCT02530489|Atezolizumab|atezolizumab|mesh-list
153809628|NCT02530489|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
153809629|NCT02530489|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153809630|NCT02530489|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153809631|NCT02530489|Tubulin Modulators|tubulin modulators|mesh-ancestor
153809632|NCT02530489|Antimitotic Agents|antimitotic agents|mesh-ancestor
153809633|NCT02530489|Mitosis Modulators|mitosis modulators|mesh-ancestor
153809634|NCT02530489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153809635|NCT02530489|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153809636|NCT02530489|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153876185|NCT01198795|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153876186|NCT01198795|Serotonin Agents|serotonin agents|mesh-ancestor
153876188|NCT02278913|Insulin|insulin|mesh-list
153809637|NCT02530489|Immunologic Factors|immunologic factors|mesh-ancestor
153809638|NCT02530489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153809639|NCT02223377|Morphine|morphine|mesh-list
153809640|NCT02223377|Hydromorphone|hydromorphone|mesh-list
153809641|NCT02223377|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153809642|NCT02223377|Narcotics|narcotics|mesh-ancestor
153809643|NCT02223377|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153809644|NCT02223377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153809645|NCT02223377|Analgesics|analgesics|mesh-ancestor
153809646|NCT02223377|Sensory System Agents|sensory system agents|mesh-ancestor
153809647|NCT02223377|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153809648|NCT02094261|Osimertinib|osimertinib|mesh-list
153809652|NCT02094261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153809653|NCT02094261|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153356225|NCT01284335|Temozolomide|temozolomide|mesh-list
153809654|NCT01697527|Aldesleukin|aldesleukin|mesh-list
153809655|NCT01697527|Cyclophosphamide|cyclophosphamide|mesh-list
153809656|NCT01697527|Fludarabine|fludarabine|mesh-list
153809657|NCT01697527|Fludarabine phosphate|fludarabine phosphate|mesh-list
153809658|NCT01697527|Interleukin-2|interleukin-2|mesh-list
153809659|NCT01697527|Vaccines|vaccines|mesh-list
153809660|NCT01697527|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
153809661|NCT01697527|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153809662|NCT01697527|Immunologic Factors|immunologic factors|mesh-ancestor
153809663|NCT01697527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153809664|NCT01697527|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153809665|NCT01697527|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153809666|NCT01697527|Alkylating Agents|alkylating agents|mesh-ancestor
153809689|NCT01632007|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153809690|NCT01632007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153809692|NCT01524926|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153809693|NCT01524926|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153809694|NCT01524926|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153809695|NCT01524926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153809696|NCT01524926|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153809697|NCT01402271|Paclitaxel|paclitaxel|mesh-list
153809698|NCT01402271|Carboplatin|carboplatin|mesh-list
153809699|NCT01402271|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153809700|NCT01402271|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153809701|NCT01402271|Tubulin Modulators|tubulin modulators|mesh-ancestor
153483939|NCT01569126|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
153483940|NCT01569126|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153483941|NCT01569126|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153483946|NCT01569126|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
153483947|NCT01569126|Antidepressive Agents|antidepressive agents|mesh-ancestor
153483948|NCT01569126|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153483949|NCT01569126|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
153809703|NCT01402271|Mitosis Modulators|mitosis modulators|mesh-ancestor
153809704|NCT01402271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153809705|NCT01387295|Capecitabine|capecitabine|mesh-list
153809706|NCT01387295|Oxaliplatin|oxaliplatin|mesh-list
153809745|NCT00679029|Immunologic Factors|immunologic factors|mesh-ancestor
153809746|NCT00679029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153809747|NCT00679029|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153416966|NCT00371072|Alkylating Agents|alkylating agents|mesh-ancestor
153809748|NCT00679029|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153809749|NCT00679029|Alkylating Agents|alkylating agents|mesh-ancestor
153809750|NCT00679029|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153809751|NCT00679029|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153809752|NCT00679029|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153809753|NCT00679029|Growth Substances|growth substances|mesh-ancestor
153809754|NCT00679029|Growth Inhibitors|growth inhibitors|mesh-ancestor
153809755|NCT00679029|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153809756|NCT00679029|Antimetabolites|antimetabolites|mesh-ancestor
153809757|NCT00679029|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153809758|NCT00679029|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153809759|NCT00679029|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153809760|NCT00679029|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153809761|NCT00519116|Sirolimus|sirolimus|mesh-list
153809762|NCT00519116|Tacrolimus|tacrolimus|mesh-list
153809763|NCT00519116|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153483954|NCT01569828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153483955|NCT01577706|Alprazolam|alprazolam|mesh-list
153483956|NCT01577706|Dextroamphetamine|dextroamphetamine|mesh-list
153483957|NCT01577706|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153483958|NCT01577706|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153813888|NCT00437697|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
153813889|NCT00437697|Anticoagulants|anticoagulants|mesh-ancestor
153813890|NCT00437697|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153809764|NCT00519116|Immunologic Factors|immunologic factors|mesh-ancestor
153809765|NCT00519116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153809766|NCT00519116|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
153809767|NCT00519116|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153809768|NCT00519116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153809769|NCT00519116|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153809770|NCT00519116|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153809771|NCT00519116|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153809772|NCT00519116|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153809773|NCT00519116|Antifungal Agents|antifungal agents|mesh-ancestor
153809791|NCT00195429|Prednisone|prednisone|mesh-list
153809792|NCT00195429|Tacrolimus|tacrolimus|mesh-list
153809793|NCT00195429|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153809794|NCT00195429|Glucocorticoids|glucocorticoids|mesh-ancestor
153809795|NCT00195429|Hormones|hormones|mesh-ancestor
153809796|NCT00195429|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153809797|NCT00195429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153809798|NCT00195429|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153809799|NCT00195429|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153809800|NCT00195429|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153809801|NCT00195429|Immunologic Factors|immunologic factors|mesh-ancestor
153809802|NCT00195429|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
153809803|NCT00195429|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153809804|NCT00195429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153809805|NCT00195429|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153809806|NCT00195429|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153809807|NCT00195429|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153809808|NCT00195429|Antifungal Agents|antifungal agents|mesh-ancestor
153809809|NCT00349284|Ezetimibe|ezetimibe|mesh-list
153809810|NCT00349284|Fenofibrate|fenofibrate|mesh-list
153809811|NCT00349284|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153809812|NCT00349284|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153809813|NCT00349284|Antimetabolites|antimetabolites|mesh-ancestor
153809814|NCT00349284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153809815|NCT00349284|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153809816|NCT00316160|Bupropion|bupropion|mesh-list
153809817|NCT00316160|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
153809818|NCT00316160|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
153416967|NCT00371072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153357957|NCT00780962|Protective Agents|protective agents|mesh-ancestor
153416968|NCT00371072|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153809819|NCT00316160|Antidepressive Agents|antidepressive agents|mesh-ancestor
153809820|NCT00316160|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153484032|NCT05493540|Ibuprofen|ibuprofen|mesh-list
153809821|NCT00316160|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
153809822|NCT00316160|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153809823|NCT00316160|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153809831|NCT00316160|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
153809834|NCT00349362|Hormones|hormones|mesh-ancestor
153809835|NCT00349362|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153809836|NCT00349362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153809837|NCT00316238|Olanzapine|olanzapine|mesh-list
153809838|NCT00316238|Antiemetics|antiemetics|mesh-ancestor
153809839|NCT00316238|Autonomic Agents|autonomic agents|mesh-ancestor
153809840|NCT00316238|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153809841|NCT00316238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153809842|NCT00316238|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153809843|NCT00316238|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153809844|NCT00316238|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153809845|NCT00316238|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153809846|NCT00316238|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153809847|NCT00316238|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
153809848|NCT00316238|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153809849|NCT00316238|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153809850|NCT00316238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153809851|NCT00316238|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153809852|NCT00316238|Serotonin Agents|serotonin agents|mesh-ancestor
153809853|NCT00349401|Ketorolac|ketorolac|mesh-list
153809880|NCT00349440|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
153809881|NCT00316433|Oxaliplatin|oxaliplatin|mesh-list
153809883|NCT00316433|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153809884|NCT00316433|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
153809885|NCT00316433|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153809886|NCT00316433|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153809887|NCT00316433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153809888|NCT00349518|Dasatinib|dasatinib|mesh-list
153809889|NCT00349518|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153809890|NCT00349518|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153809891|NCT00349518|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153809892|NCT00349518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153809893|NCT00349518|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153809894|NCT00316472|Niacinamide|niacinamide|mesh-list
153876208|NCT02216552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153484049|NCT05672394|Lidocaine|lidocaine|mesh-list
153876209|NCT02216552|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153876210|NCT02216552|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153876211|NCT01198756|Vaccines|vaccines|mesh-list
153876212|NCT01198756|Immunologic Factors|immunologic factors|mesh-ancestor
153876213|NCT01198756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153876214|NCT02216487|Irinotecan|irinotecan|mesh-list
153876215|NCT02216487|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
153876216|NCT02216487|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153876217|NCT02216487|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153876220|NCT02218814|Bupivacaine|bupivacaine|mesh-list
153809896|NCT00316472|Nicotinic Acids|nicotinic acids|mesh-list
153809897|NCT00316472|Vitamin B Complex|vitamin b complex|mesh-ancestor
153809898|NCT00316472|Vitamins|vitamins|mesh-ancestor
153809899|NCT00316472|Micronutrients|micronutrients|mesh-ancestor
153809900|NCT00316472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153809901|NCT00316472|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153809902|NCT00316472|Antimetabolites|antimetabolites|mesh-ancestor
153809903|NCT00316472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153809932|NCT00349635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153809934|NCT00316745|Leucovorin|leucovorin|mesh-list
153809935|NCT00316745|Fluorouracil|fluorouracil|mesh-list
153809936|NCT00316745|Oxaliplatin|oxaliplatin|mesh-list
153809937|NCT00316745|Irinotecan|irinotecan|mesh-list
153809938|NCT00316745|Antimetabolites|antimetabolites|mesh-ancestor
153809939|NCT00316745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153809940|NCT00316745|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153809941|NCT00316745|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153809942|NCT00316745|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153809943|NCT00316745|Immunologic Factors|immunologic factors|mesh-ancestor
153809944|NCT00316745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153809945|NCT00316745|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
153809946|NCT00316745|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153809947|NCT00316745|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153809948|NCT00316745|Antidotes|antidotes|mesh-ancestor
153356518|NCT01241903|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153809949|NCT00316745|Protective Agents|protective agents|mesh-ancestor
153809950|NCT00316745|Vitamin B Complex|vitamin b complex|mesh-ancestor
153809951|NCT00316745|Vitamins|vitamins|mesh-ancestor
153809953|NCT00349674|Methotrexate|methotrexate|mesh-list
153809954|NCT00349674|Azathioprine|azathioprine|mesh-list
153809956|NCT00349674|Abortifacient Agents|abortifacient agents|mesh-ancestor
153809957|NCT00349674|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153809958|NCT00349674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153809959|NCT00349674|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153809960|NCT00349674|Antimetabolites|antimetabolites|mesh-ancestor
153809961|NCT00349674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153809962|NCT00349674|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153809977|NCT00344955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153809978|NCT00344955|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153809979|NCT00344955|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
153809980|NCT00344955|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153809981|NCT00316901|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
153809982|NCT00316901|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
153809983|NCT00316901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153809984|NCT00316940|Bortezomib|bortezomib|mesh-list
153809985|NCT00316940|Samarium Sm-153 lexidronam|samarium sm-153 lexidronam|mesh-list
153809986|NCT00316940|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153810039|NCT00317330|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
153810040|NCT00317330|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
153810041|NCT00317330|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
153810042|NCT00317330|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
153810043|NCT00317330|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
153810044|NCT00317330|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
153417005|NCT03886922|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153417006|NCT03886922|Autonomic Agents|autonomic agents|mesh-ancestor
153810046|NCT00317330|Antimetabolites|antimetabolites|mesh-ancestor
153810047|NCT00317330|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153810048|NCT00317408|Leucovorin|leucovorin|mesh-list
153810049|NCT00317408|Cytarabine|cytarabine|mesh-list
153810050|NCT00317408|Cyclosporine|cyclosporine|mesh-list
153810106|NCT00317408|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153810108|NCT00317408|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153810109|NCT00317408|Analgesics|analgesics|mesh-ancestor
153810110|NCT00317408|Sensory System Agents|sensory system agents|mesh-ancestor
153810111|NCT00317408|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153810112|NCT00317408|Tubulin Modulators|tubulin modulators|mesh-ancestor
153810113|NCT00317408|Antimitotic Agents|antimitotic agents|mesh-ancestor
153810114|NCT00317408|Mitosis Modulators|mitosis modulators|mesh-ancestor
153810115|NCT00317447|Prednisone|prednisone|mesh-list
153810116|NCT00317447|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153810117|NCT00317447|Glucocorticoids|glucocorticoids|mesh-ancestor
153810118|NCT00317447|Hormones|hormones|mesh-ancestor
153810119|NCT00317447|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153810120|NCT00317447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153810121|NCT00317447|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153810122|NCT00317447|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153428028|NCT00000692|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153428029|NCT00000692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153886975|NCT01169038|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153886976|NCT01169038|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153886977|NCT01169038|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
153886978|NCT01169038|Antitubercular Agents|antitubercular agents|mesh-ancestor
153886979|NCT01169038|Leprostatic Agents|leprostatic agents|mesh-ancestor
153886980|NCT01169038|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153886981|NCT01169038|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153358052|NCT01250717|Bicalutamide|bicalutamide|mesh-list
153886995|NCT00624754|Budesonide|budesonide|mesh-list
153810163|NCT00350181|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153810165|NCT00350181|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153810166|NCT00350181|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153810167|NCT00350181|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153810168|NCT00350181|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
153810169|NCT00350181|Antitubercular Agents|antitubercular agents|mesh-ancestor
153810170|NCT00350181|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153810171|NCT00350181|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153810172|NCT00350181|Antifungal Agents|antifungal agents|mesh-ancestor
153810173|NCT00317759|Fludarabine|fludarabine|mesh-list
153810174|NCT00317759|Fludarabine phosphate|fludarabine phosphate|mesh-list
153810175|NCT00317759|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153356743|NCT01244633|Ecopipam|ecopipam|mesh-list
153886851|NCT01320722|Vitamins|vitamins|mesh-list
153810176|NCT00317759|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153810222|NCT00317876|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153810223|NCT00317876|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153810224|NCT00317876|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
153810225|NCT00317876|Abortifacient Agents|abortifacient agents|mesh-ancestor
153810226|NCT00317876|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153358053|NCT01250717|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153358054|NCT01250717|Antiemetics|antiemetics|mesh-ancestor
153358055|NCT01250717|Autonomic Agents|autonomic agents|mesh-ancestor
153358056|NCT01250717|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153358058|NCT01250717|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153358059|NCT01250717|Glucocorticoids|glucocorticoids|mesh-ancestor
153358060|NCT01250717|Hormones|hormones|mesh-ancestor
153358061|NCT01250717|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153358062|NCT01250717|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153810227|NCT00317876|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153810228|NCT00317876|Antimetabolites|antimetabolites|mesh-ancestor
153810229|NCT00317876|Dermatologic Agents|dermatologic agents|mesh-ancestor
153810230|NCT00317876|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153810231|NCT00317876|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153810232|NCT00317876|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153810233|NCT00317876|Antifungal Agents|antifungal agents|mesh-ancestor
153810234|NCT00317876|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153810235|NCT00317876|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
153810236|NCT00317915|Irbesartan|irbesartan|mesh-list
153810237|NCT00317915|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153810238|NCT00317915|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
153810239|NCT00317915|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
153810240|NCT00317915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153810241|NCT00317954|Spironolactone|spironolactone|mesh-list
153810242|NCT00317954|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
153810243|NCT00317954|Hormone Antagonists|hormone antagonists|mesh-ancestor
153810247|NCT00317954|Diuretics|diuretics|mesh-ancestor
153810272|NCT00345696|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153810273|NCT00345696|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153810274|NCT00345696|Growth Substances|growth substances|mesh-ancestor
153810275|NCT00345696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153810276|NCT00345696|Growth Inhibitors|growth inhibitors|mesh-ancestor
153810277|NCT00345696|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153810278|NCT00345696|Antimetabolites|antimetabolites|mesh-ancestor
153810279|NCT00345696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153810280|NCT00350454|Sirolimus|sirolimus|mesh-list
153810281|NCT00350454|Temsirolimus|temsirolimus|mesh-list
153810282|NCT00350454|MTOR Inhibitors|mtor inhibitors|mesh-list
153810283|NCT00350454|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153810284|NCT00350454|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153484266|NCT01619982|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153484268|NCT01620216|Sorafenib|sorafenib|mesh-list
153810285|NCT00350454|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153810286|NCT00350454|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153810294|NCT00345735|Fentanyl|fentanyl|mesh-list
153810330|NCT00318422|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153358092|NCT01251575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153358093|NCT01251575|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153358094|NCT01251575|Antifungal Agents|antifungal agents|mesh-ancestor
153358095|NCT01251575|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153358096|NCT01251575|Dermatologic Agents|dermatologic agents|mesh-ancestor
153358097|NCT01251575|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153358098|NCT01251575|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
153358099|NCT01251575|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153358100|NCT01251575|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
153358101|NCT01251575|Antitubercular Agents|antitubercular agents|mesh-ancestor
153358102|NCT01251575|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153358103|NCT00782756|Bevacizumab|bevacizumab|mesh-list
153358104|NCT00782756|Temozolomide|temozolomide|mesh-list
153358106|NCT00782756|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153358107|NCT00782756|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153358108|NCT00782756|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153887017|NCT01114828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153887018|NCT01313312|Botulinum Toxins|botulinum toxins|mesh-list
153887020|NCT01313312|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
153810331|NCT00318422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153810332|NCT00318422|Incretins|incretins|mesh-ancestor
153810333|NCT00318422|Hormones|hormones|mesh-ancestor
153810334|NCT00318422|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153810335|NCT00318422|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153810336|NCT00318422|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153810337|NCT00318422|Immunologic Factors|immunologic factors|mesh-ancestor
153810338|NCT00318539|Quetiapine Fumarate|quetiapine fumarate|mesh-list
153810339|NCT00318539|Antidepressive Agents|antidepressive agents|mesh-ancestor
153810340|NCT00318539|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153810341|NCT00318539|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153810342|NCT00318539|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153810343|NCT00318539|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153810344|NCT00318539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153810345|NCT00346047|Buprenorphine|buprenorphine|mesh-list
153810346|NCT00346047|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153810347|NCT00346047|Narcotics|narcotics|mesh-ancestor
153484397|NCT01643616|Midazolam|midazolam|mesh-list
153810348|NCT00346047|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153810349|NCT00346047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153810351|NCT00346047|Sensory System Agents|sensory system agents|mesh-ancestor
153810352|NCT00346047|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153810353|NCT00346047|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
153810354|NCT00421200|Hydroxyethyl Starch Derivatives|hydroxyethyl starch derivatives|mesh-list
153810355|NCT00421200|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
153810356|NCT00421200|Plasma Substitutes|plasma substitutes|mesh-ancestor
153810357|NCT00421200|Blood Substitutes|blood substitutes|mesh-ancestor
153810358|NCT00318773|Sertraline|sertraline|mesh-list
153810359|NCT00318773|Antidepressive Agents|antidepressive agents|mesh-ancestor
153810360|NCT00318773|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153810373|NCT00318890|Mitosis Modulators|mitosis modulators|mesh-ancestor
153810374|NCT00318890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153810375|NCT00318890|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
153810376|NCT00318890|Protective Agents|protective agents|mesh-ancestor
153358109|NCT00782756|Growth Substances|growth substances|mesh-ancestor
153810377|NCT00318890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153810378|NCT00318968|Esomeprazole|esomeprazole|mesh-list
153810379|NCT00318968|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
153810380|NCT00318968|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153810381|NCT00318968|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
153810382|NCT00318968|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153810383|NCT00318968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153810384|NCT00319007|Sulindac|sulindac|mesh-list
153484450|NCT01652040|Testosterone|testosterone|mesh-list
153810385|NCT00319007|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153810386|NCT00319007|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153810430|NCT00319163|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
153810431|NCT00319202|Candesartan|candesartan|mesh-list
153810432|NCT00319202|Candesartan cilexetil|candesartan cilexetil|mesh-list
153810433|NCT00319202|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153810434|NCT00319202|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
153810435|NCT00319202|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
153810436|NCT00319202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153810437|NCT00421512|Bevacizumab|bevacizumab|mesh-list
153810439|NCT00421512|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153810440|NCT00421512|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153810441|NCT00421512|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153810442|NCT00421512|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153810443|NCT00421512|Growth Substances|growth substances|mesh-ancestor
153810444|NCT00421512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153810445|NCT00421512|Growth Inhibitors|growth inhibitors|mesh-ancestor
153810446|NCT00421512|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153810447|NCT00421512|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153810448|NCT00421512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153810449|NCT00319319|Mecamylamine|mecamylamine|mesh-list
153810451|NCT00319319|Ganglionic Blockers|ganglionic blockers|mesh-ancestor
153810452|NCT00319319|Autonomic Agents|autonomic agents|mesh-ancestor
153810453|NCT00319319|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153810454|NCT00319319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153810455|NCT00319319|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
153810456|NCT00319319|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
153810457|NCT00319319|Cholinergic Agents|cholinergic agents|mesh-ancestor
153810458|NCT00319319|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153810459|NCT00319319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153810460|NCT00346359|Methotrexate|methotrexate|mesh-list
153810461|NCT00346359|Fludarabine phosphate|fludarabine phosphate|mesh-list
153810462|NCT00346359|Fludarabine|fludarabine|mesh-list
153810463|NCT00346359|Busulfan|busulfan|mesh-list
153810464|NCT00346359|Tacrolimus|tacrolimus|mesh-list
153810468|NCT00346359|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153810469|NCT00346359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153810470|NCT00346359|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153810471|NCT00346359|Antimetabolites|antimetabolites|mesh-ancestor
153810472|NCT00346359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153484554|NCT01682538|Nitisinone|nitisinone|mesh-list
153810473|NCT00346359|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153810474|NCT00346359|Dermatologic Agents|dermatologic agents|mesh-ancestor
153810476|NCT00346359|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153810477|NCT00346359|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153810478|NCT00346359|Immunologic Factors|immunologic factors|mesh-ancestor
153810479|NCT00346359|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153810480|NCT00346359|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153810481|NCT00346359|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
153810482|NCT00346359|Alkylating Agents|alkylating agents|mesh-ancestor
153810483|NCT00346359|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153810484|NCT00346359|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153810485|NCT00319358|Antioxidants|antioxidants|mesh-list
153810486|NCT00319358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153810487|NCT00319358|Protective Agents|protective agents|mesh-ancestor
153810488|NCT00319358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153810489|NCT00319514|Docetaxel|docetaxel|mesh-list
153810490|NCT00319514|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153810491|NCT00319514|Tubulin Modulators|tubulin modulators|mesh-ancestor
153810492|NCT00319514|Antimitotic Agents|antimitotic agents|mesh-ancestor
153810493|NCT00319514|Mitosis Modulators|mitosis modulators|mesh-ancestor
153810494|NCT00319514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153810515|NCT00319709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153810516|NCT00319709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153417043|NCT02165202|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153417044|NCT02165202|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153417045|NCT02165202|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153358132|NCT01215929|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
153417046|NCT01628874|Lidocaine|lidocaine|mesh-list
153417047|NCT01628874|Lidocaine, Prilocaine Drug Combination|lidocaine, prilocaine drug combination|mesh-list
153417048|NCT01628874|Anesthetics, Local|anesthetics, local|mesh-ancestor
153417049|NCT01628874|Anesthetics|anesthetics|mesh-ancestor
153417050|NCT01628874|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153417051|NCT01628874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153876277|NCT01196416|Temozolomide|temozolomide|mesh-list
153876278|NCT01196416|Vinblastine|vinblastine|mesh-list
153876280|NCT01196416|Gamma Secretase Inhibitors and Modulators|gamma secretase inhibitors and modulators|mesh-list
153810517|NCT00319709|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
153810519|NCT00319787|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153810520|NCT00319787|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153810521|NCT00319787|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153810522|NCT00319787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153810523|NCT00319787|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153810524|NCT00319865|Thalidomide|thalidomide|mesh-list
153810551|NCT00319865|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153810552|NCT00319865|Growth Substances|growth substances|mesh-ancestor
153810553|NCT00319865|Growth Inhibitors|growth inhibitors|mesh-ancestor
153810554|NCT00320021|Pyridoxamine|pyridoxamine|mesh-list
153810555|NCT00320021|Vitamin B Complex|vitamin b complex|mesh-ancestor
153810556|NCT00320021|Vitamins|vitamins|mesh-ancestor
153810557|NCT00320021|Micronutrients|micronutrients|mesh-ancestor
153810558|NCT00320021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153810559|NCT00320060|Pyridoxamine|pyridoxamine|mesh-list
153810560|NCT00320060|Vitamin B Complex|vitamin b complex|mesh-ancestor
153810561|NCT00320060|Vitamins|vitamins|mesh-ancestor
153810562|NCT00320060|Micronutrients|micronutrients|mesh-ancestor
153810563|NCT00320060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153417680|NCT02192190|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153417681|NCT02192190|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
153417682|NCT02192190|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153417683|NCT02192190|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153417684|NCT02192190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153417685|NCT02748889|Carboplatin|carboplatin|mesh-list
153877081|NCT06043908|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153877082|NCT06043908|Dermatologic Agents|dermatologic agents|mesh-ancestor
153877083|NCT06043908|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153417846|NCT04061330|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153417925|NCT04737655|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153417926|NCT04737655|Glucocorticoids|glucocorticoids|mesh-ancestor
153417927|NCT04737655|Hormones|hormones|mesh-ancestor
153417928|NCT04737655|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153417929|NCT05063396|Analgesics, Opioid|analgesics, opioid|mesh-list
153417930|NCT05063396|Anesthetics|anesthetics|mesh-list
153417931|NCT05063396|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153417932|NCT05063396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153417933|NCT05063396|Narcotics|narcotics|mesh-ancestor
153358143|NCT01216397|Metformin|metformin|mesh-list
153417934|NCT05063396|Analgesics|analgesics|mesh-ancestor
153417935|NCT05063396|Sensory System Agents|sensory system agents|mesh-ancestor
153417936|NCT05063396|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153417937|NCT05055752|Aspirin|aspirin|mesh-list
153877216|NCT06034158|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
153877217|NCT06034158|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
153877219|NCT06018688|Osimertinib|osimertinib|mesh-list
153877220|NCT06018688|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153877221|NCT06018688|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153877222|NCT06018688|Analgesics|analgesics|mesh-ancestor
153814007|NCT00336401|Propofol|propofol|mesh-list
153417982|NCT01547468|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153814008|NCT00336401|Sevoflurane|sevoflurane|mesh-list
153357301|NCT01279694|Prednisone|prednisone|mesh-list
153357302|NCT01279694|Melphalan|melphalan|mesh-list
153357303|NCT01279694|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153357304|NCT01279694|Glucocorticoids|glucocorticoids|mesh-ancestor
153357305|NCT01279694|Hormones|hormones|mesh-ancestor
153357306|NCT01279694|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153357307|NCT01279694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153357308|NCT01279694|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153357309|NCT01279694|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153357310|NCT01279694|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153357311|NCT01279694|Alkylating Agents|alkylating agents|mesh-ancestor
153357312|NCT01279694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153810704|NCT00321113|Tacrolimus|tacrolimus|mesh-list
153810705|NCT00321113|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153810706|NCT00321113|Immunologic Factors|immunologic factors|mesh-ancestor
153810707|NCT00321113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153810708|NCT00321113|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
153810709|NCT00321113|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153810710|NCT00321113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153879411|NCT05387759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153814009|NCT00336401|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153887692|NCT00593099|Bupropion|bupropion|mesh-list
153877227|NCT06018688|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153877228|NCT06018688|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153877229|NCT06018688|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153814014|NCT00336401|Anesthetics|anesthetics|mesh-ancestor
153418026|NCT00372853|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153418027|NCT00372853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153418028|NCT00372853|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153418029|NCT00372853|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153877261|NCT05986331|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153877262|NCT05986331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153877263|NCT05984238|Semaglutide|semaglutide|mesh-list
153877264|NCT05984238|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
153877265|NCT05984238|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153814030|NCT00347490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153877268|NCT05975684|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
153418033|NCT00372853|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153418034|NCT00372853|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153418036|NCT02885636|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153418037|NCT02885636|Autonomic Agents|autonomic agents|mesh-ancestor
153418038|NCT02885636|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153814031|NCT00336674|Insulin|insulin|mesh-list
153887784|NCT00594737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153887785|NCT00594737|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
153887786|NCT00594737|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
153887788|NCT00595049|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153887842|NCT04326803|Vaccines|vaccines|mesh-list
153887843|NCT04326803|Immunologic Factors|immunologic factors|mesh-ancestor
153887844|NCT04326803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153887845|NCT00597233|Insulin|insulin|mesh-list
153887846|NCT00597233|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
153887847|NCT00597233|Insulin Aspart|insulin aspart|mesh-list
153887848|NCT00597233|Isophane Insulin, Human|isophane insulin, human|mesh-list
153428936|NCT00002504|Interferon-alpha|interferon-alpha|mesh-list
153428937|NCT00002504|Aldesleukin|aldesleukin|mesh-list
153428938|NCT00002504|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153428939|NCT00002504|Antiviral Agents|antiviral agents|mesh-ancestor
153357352|NCT00744380|GABA Modulators|gaba modulators|mesh-ancestor
153357353|NCT00744380|GABA Agents|gaba agents|mesh-ancestor
153357354|NCT00744692|Fludarabine|fludarabine|mesh-list
153357355|NCT00744692|Melphalan|melphalan|mesh-list
153357356|NCT00744692|Thiotepa|thiotepa|mesh-list
153810746|NCT00321230|Protective Agents|protective agents|mesh-ancestor
153810747|NCT00321230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153810748|NCT00321230|Vitamins|vitamins|mesh-ancestor
153810749|NCT00321230|Micronutrients|micronutrients|mesh-ancestor
153428940|NCT00002504|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153428941|NCT00002504|Immunologic Factors|immunologic factors|mesh-ancestor
153428942|NCT00002504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153428943|NCT00002504|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153428944|NCT00002504|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153428945|NCT02360059|Metformin|metformin|mesh-list
153428946|NCT02360059|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153428947|NCT02360059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153877295|NCT05944510|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153877296|NCT05944510|Analgesics|analgesics|mesh-ancestor
153877297|NCT05944510|Sensory System Agents|sensory system agents|mesh-ancestor
153877298|NCT05944510|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153877299|NCT05938907|Mitogens|mitogens|mesh-list
153877300|NCT05938907|Mitosis Modulators|mitosis modulators|mesh-ancestor
153358149|NCT01216397|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153358155|NCT04345406|Enalapril|enalapril|mesh-list
153877301|NCT05938907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153877302|NCT05934253|Chloroprocaine|chloroprocaine|mesh-list
153418065|NCT02779166|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153418068|NCT02779166|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153418069|NCT02779166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153418070|NCT02779166|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153418072|NCT02779166|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
153418073|NCT02779166|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153418074|NCT02779166|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153418075|NCT02779166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153418076|NCT00373165|Ganciclovir|ganciclovir|mesh-list
153814058|NCT00336791|Immunologic Factors|immunologic factors|mesh-ancestor
153887868|NCT00597389|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153814071|NCT00444561|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153814072|NCT00444561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153814073|NCT00444639|Triptorelin Pamoate|triptorelin pamoate|mesh-list
153814074|NCT00444639|Luteolytic Agents|luteolytic agents|mesh-ancestor
153814075|NCT00444639|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
153814076|NCT00444639|Contraceptive Agents|contraceptive agents|mesh-ancestor
153814081|NCT00444639|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153814082|NCT00336947|Tegafur|tegafur|mesh-list
153814083|NCT00336947|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153814084|NCT00336947|Antimetabolites|antimetabolites|mesh-ancestor
153814085|NCT00336947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153814086|NCT00336947|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153887946|NCT00598169|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153887948|NCT00598169|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153887949|NCT00598169|Immunologic Factors|immunologic factors|mesh-ancestor
153887950|NCT00598169|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153887951|NCT00598169|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153814107|NCT00337259|Antimetabolites|antimetabolites|mesh-ancestor
153814108|NCT00337259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153877372|NCT05885932|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153877373|NCT05885932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153429030|NCT02341495|Vitamins|vitamins|mesh-ancestor
153429031|NCT02341495|Micronutrients|micronutrients|mesh-ancestor
153429032|NCT02341495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153429033|NCT02341495|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153429034|NCT02341495|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153814110|NCT04699734|Lidocaine|lidocaine|mesh-list
153814111|NCT04699734|Anesthetics, Local|anesthetics, local|mesh-ancestor
153814112|NCT04699734|Anesthetics|anesthetics|mesh-ancestor
153814113|NCT04699734|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153814114|NCT04699734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153814115|NCT04699734|Sensory System Agents|sensory system agents|mesh-ancestor
153814116|NCT04699734|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153358156|NCT04345406|Captopril|captopril|mesh-list
153358157|NCT04345406|Amebicides|amebicides|mesh-ancestor
153358158|NCT04345406|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153887162|NCT01077739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153887163|NCT01077739|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153887165|NCT01077739|Antidotes|antidotes|mesh-ancestor
153429035|NCT02341495|Antimetabolites|antimetabolites|mesh-ancestor
153429036|NCT02341495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153429037|NCT02341495|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153877378|NCT05885932|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
153418142|NCT02785406|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153418143|NCT02785406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153418144|NCT02062489|Tamoxifen|tamoxifen|mesh-list
153420453|NCT03100123|Analgesics|analgesics|mesh-ancestor
153814117|NCT04699734|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153814118|NCT04699734|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
153429038|NCT02341495|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153814124|NCT00337298|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153814125|NCT00337298|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153814126|NCT00337298|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153814156|NCT00337493|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153814157|NCT00337493|Immunologic Factors|immunologic factors|mesh-ancestor
153814158|NCT00337493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153814159|NCT00337493|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
153814160|NCT00337493|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153814161|NCT00337493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153814162|NCT00337493|Antifungal Agents|antifungal agents|mesh-ancestor
153877382|NCT05885932|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153877383|NCT05885932|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153877384|NCT05885932|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153877385|NCT05885932|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153877386|NCT05885932|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153877387|NCT05885932|Antifungal Agents|antifungal agents|mesh-ancestor
153877388|NCT05885932|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153888023|NCT01062763|Natriuretic Agents|natriuretic agents|mesh-ancestor
153888024|NCT00599417|Broncho-Vaxom|broncho-vaxom|mesh-list
153888025|NCT00599417|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153888027|NCT00599417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153814167|NCT00337493|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153358159|NCT04345406|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153814168|NCT00337493|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
153814169|NCT00337493|Antitubercular Agents|antitubercular agents|mesh-ancestor
153814170|NCT00337493|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153877396|NCT05884671|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
153877397|NCT05884671|Dopamine Agents|dopamine agents|mesh-ancestor
153877398|NCT05884671|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153877399|NCT05884671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153877400|NCT05884671|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
153877401|NCT05884671|Antidepressive Agents|antidepressive agents|mesh-ancestor
153888078|NCT00600041|Pantoprazole|pantoprazole|mesh-list
153888079|NCT00600041|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
153418175|NCT02790788|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
153418177|NCT02790788|Prednisolone acetate|prednisolone acetate|mesh-list
153418178|NCT02790788|Hydrocortisone|hydrocortisone|mesh-list
153418179|NCT02790788|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
153418180|NCT02790788|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
153418181|NCT02790788|Prednisolone phosphate|prednisolone phosphate|mesh-list
153888091|NCT01326533|Hydroxychloroquine|hydroxychloroquine|mesh-list
153814286|NCT00338273|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
153368170|NCT02445807|Clobetasol|clobetasol|mesh-list
153368171|NCT02445807|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153368172|NCT02445807|Glucocorticoids|glucocorticoids|mesh-ancestor
153368173|NCT02445807|Hormones|hormones|mesh-ancestor
153368174|NCT02445807|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153368175|NCT02445807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153368176|NCT00362973|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
153368177|NCT00362973|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
153828250|NCT04515732|Sensory System Agents|sensory system agents|mesh-ancestor
153368275|NCT02435901|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153368277|NCT02437383|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
153368278|NCT02437383|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
153368279|NCT02437383|Adrenergic Agents|adrenergic agents|mesh-ancestor
153368280|NCT02437383|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153368281|NCT02437383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153368282|NCT02437383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153368283|NCT02437383|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153368284|NCT02437383|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153368285|NCT02437383|Vasodilator Agents|vasodilator agents|mesh-ancestor
153368286|NCT02385708|Chlorhexidine|chlorhexidine|mesh-list
153368287|NCT02385708|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
153368323|NCT03371108|Insulin Glargine|insulin glargine|mesh-list
153368324|NCT03371108|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153368325|NCT03371108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153368326|NCT01100606|Pancrelipase|pancrelipase|mesh-list
153368327|NCT01100606|Pancreatin|pancreatin|mesh-list
153368328|NCT01100606|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153828314|NCT01241097|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153828315|NCT01241097|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153828316|NCT01241097|Antimetabolites|antimetabolites|mesh-ancestor
153828317|NCT01241097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153828320|NCT01241097|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153828382|NCT01302964|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153368389|NCT02530281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153368390|NCT02530281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153368391|NCT03013634|Dexmedetomidine|dexmedetomidine|mesh-list
153368392|NCT03013634|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153368393|NCT03013634|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153368394|NCT03013634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153368395|NCT03013634|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153368396|NCT03013634|Analgesics|analgesics|mesh-ancestor
153368397|NCT03013634|Sensory System Agents|sensory system agents|mesh-ancestor
153368398|NCT03013634|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153368399|NCT03013634|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
153877418|NCT05845450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153877419|NCT05842213|Golimumab|golimumab|mesh-list
153877420|NCT05842213|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
153877421|NCT05842213|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
153877422|NCT05842213|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153877423|NCT05842213|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153877424|NCT05842213|Immunologic Factors|immunologic factors|mesh-ancestor
153418187|NCT02790788|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153418188|NCT02790788|Glucocorticoids|glucocorticoids|mesh-ancestor
153418189|NCT02790788|Hormones|hormones|mesh-ancestor
153418190|NCT02790788|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153828405|NCT01302691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153828406|NCT01302691|Vasodilator Agents|vasodilator agents|mesh-ancestor
153828407|NCT01302691|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153368414|NCT02980094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153368415|NCT02980094|Protective Agents|protective agents|mesh-ancestor
153368416|NCT02980094|Trace Elements|trace elements|mesh-ancestor
153368417|NCT03013322|Physostigmine|physostigmine|mesh-list
153368418|NCT03013322|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
153368419|NCT03013322|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153368420|NCT03013322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153368424|NCT03013322|Miotics|miotics|mesh-ancestor
153828410|NCT01302691|Diuretics|diuretics|mesh-ancestor
153828607|NCT00484926|Aspirin|aspirin|mesh-list
153829022|NCT00485810|Antiemetics|antiemetics|mesh-ancestor
153461735|NCT03193866|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153829098|NCT00485901|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153829099|NCT00485901|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153829100|NCT00485901|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
153829101|NCT00485901|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153829102|NCT00485901|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153829103|NCT00485901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153829105|NCT00485901|Serotonin Agents|serotonin agents|mesh-ancestor
153829106|NCT00485901|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
153829107|NCT00485901|Dopamine Agents|dopamine agents|mesh-ancestor
153829108|NCT00485901|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
153829109|NCT00490412|Vitamin D|vitamin d|mesh-list
153369194|NCT02407704|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153369195|NCT02407704|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153369196|NCT02407704|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153369197|NCT02407704|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153369198|NCT02407704|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153369199|NCT02407704|GABA Modulators|gaba modulators|mesh-ancestor
153369200|NCT02407704|GABA Agents|gaba agents|mesh-ancestor
153369201|NCT02581839|Dexamethasone|dexamethasone|mesh-list
153369202|NCT02581839|Dexamethasone acetate|dexamethasone acetate|mesh-list
153829180|NCT04511715|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153829191|NCT00486317|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153829192|NCT00486317|Vasodilator Agents|vasodilator agents|mesh-ancestor
153829194|NCT00490880|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153829195|NCT00490880|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153829196|NCT00490880|Antimetabolites|antimetabolites|mesh-ancestor
153829206|NCT00486213|Pyridoxine|pyridoxine|mesh-list
153829392|NCT01301092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153829393|NCT04510623|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
153829394|NCT04510623|Protease Inhibitors|protease inhibitors|mesh-ancestor
153418229|NCT02794844|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
153418230|NCT02794844|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153418231|NCT02794844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153418232|NCT02783443|Anesthetics|anesthetics|mesh-list
153418233|NCT02783443|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153418234|NCT02783443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153418235|NCT00373568|Miltefosine|miltefosine|mesh-list
153418236|NCT00373568|Antifungal Agents|antifungal agents|mesh-ancestor
153369513|NCT01159262|GABA Modulators|gaba modulators|mesh-ancestor
153369561|NCT00363753|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153369562|NCT00363753|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153369563|NCT00363753|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153369564|NCT00363753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153369565|NCT00363753|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153369566|NCT00363753|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153369567|NCT00363753|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153369568|NCT00363753|Antipyretics|antipyretics|mesh-ancestor
153358186|NCT00783614|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153358187|NCT00783614|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153358189|NCT00783614|Sensory System Agents|sensory system agents|mesh-ancestor
153428299|NCT00002330|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153428300|NCT00002330|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153428301|NCT00002330|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153428302|NCT00002330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153428303|NCT03740659|Levofloxacin|levofloxacin|mesh-list
153428305|NCT03740659|Dexamethasone|dexamethasone|mesh-list
153428306|NCT03740659|Dexamethasone acetate|dexamethasone acetate|mesh-list
153428307|NCT03740659|BB 1101|bb 1101|mesh-list
153428308|NCT03740659|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153428309|NCT03740659|Antiemetics|antiemetics|mesh-ancestor
153887266|NCT01076335|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153418238|NCT00373568|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153418239|NCT00373568|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153829605|NCT00487422|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153829606|NCT00487422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153829607|NCT00487422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153829608|NCT04697355|Beta Carotene|beta carotene|mesh-list
153829609|NCT04697355|Naringenin|naringenin|mesh-list
153829610|NCT04697355|Carotenoids|carotenoids|mesh-list
153829611|NCT04697355|Antioxidants|antioxidants|mesh-ancestor
153829613|NCT04697355|Protective Agents|protective agents|mesh-ancestor
153369676|NCT02517021|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153369677|NCT02517021|Antiemetics|antiemetics|mesh-ancestor
153369678|NCT02517021|Autonomic Agents|autonomic agents|mesh-ancestor
153877464|NCT05766631|Sensory System Agents|sensory system agents|mesh-ancestor
153877465|NCT05766631|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153877466|NCT05766631|Antitussive Agents|antitussive agents|mesh-ancestor
153877467|NCT05766631|Respiratory System Agents|respiratory system agents|mesh-ancestor
153877469|NCT05753306|Docetaxel|docetaxel|mesh-list
153877470|NCT05753306|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153877471|NCT05753306|Tubulin Modulators|tubulin modulators|mesh-ancestor
153810785|NCT00351975|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153357382|NCT00744848|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
153357383|NCT00744848|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153829797|NCT00487773|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153829800|NCT01299961|Abatacept|abatacept|mesh-list
153418248|NCT03002012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153418249|NCT03002012|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153418251|NCT03002012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153418252|NCT03002012|Antifungal Agents|antifungal agents|mesh-ancestor
153418253|NCT03002012|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153418254|NCT03002012|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
153418255|NCT03002012|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153418256|NCT03002012|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153369908|NCT04936841|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153877484|NCT05752734|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153877492|NCT05741905|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153877493|NCT05741905|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153877494|NCT05741905|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153877495|NCT05741905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153877496|NCT05741905|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153877499|NCT05717049|Theophylline|theophylline|mesh-list
153357385|NCT00744848|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153418266|NCT00373646|Leprostatic Agents|leprostatic agents|mesh-ancestor
153418267|NCT00373646|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153418268|NCT00373646|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153418269|NCT00373646|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153358190|NCT00783614|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153358191|NCT00783614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153418270|NCT00373646|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153418271|NCT00373646|Growth Substances|growth substances|mesh-ancestor
153420665|NCT02222922|Avelumab|avelumab|mesh-list
153877502|NCT05717049|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153370158|NCT02813356|Naloxegol|naloxegol|mesh-list
153370872|NCT01215344|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153370873|NCT01215344|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153370874|NCT01215344|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153370875|NCT01215344|Immunologic Factors|immunologic factors|mesh-ancestor
153830860|NCT01245452|Methotrexate|methotrexate|mesh-list
153830910|NCT01246622|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153830912|NCT01246622|Growth Inhibitors|growth inhibitors|mesh-ancestor
153830913|NCT01245530|Donepezil|donepezil|mesh-list
153830914|NCT01245530|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
153370957|NCT01721603|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153877582|NCT05653401|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153877583|NCT05653401|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153877584|NCT05653401|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153877585|NCT05653401|Anticonvulsants|anticonvulsants|mesh-ancestor
153877586|NCT05653401|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153877587|NCT05653401|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153830951|NCT01245803|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
153830952|NCT01245803|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153371145|NCT04743063|Eprosartan|eprosartan|mesh-list
153371146|NCT04743063|Angiotensin II|angiotensin ii|mesh-list
153371147|NCT04743063|Giapreza|giapreza|mesh-list
153371148|NCT04743063|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
153371149|NCT04743063|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-list
153371150|NCT04743063|Angiotensinogen|angiotensinogen|mesh-list
153371151|NCT04743063|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153371152|NCT04743063|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
153371153|NCT04743063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153371154|NCT04743063|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153371159|NCT04743063|Angiotensin II Type 2 Receptor Blockers|angiotensin ii type 2 receptor blockers|mesh-ancestor
153831090|NCT06039566|N-monoacetylcystine|n-monoacetylcystine|mesh-list
153831091|NCT06039566|Antiviral Agents|antiviral agents|mesh-ancestor
153831092|NCT06039566|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153831093|NCT06039566|Expectorants|expectorants|mesh-ancestor
153831094|NCT06039566|Respiratory System Agents|respiratory system agents|mesh-ancestor
153358214|NCT01252745|Anabolic Agents|anabolic agents|mesh-ancestor
153358215|NCT04278872|SJX-653|sjx-653|mesh-list
153877606|NCT05610657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153877607|NCT05600114|Cannabidiol|cannabidiol|mesh-list
153877608|NCT05600114|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
153877609|NCT05600114|Anticonvulsants|anticonvulsants|mesh-ancestor
153877610|NCT05599841|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
153877611|NCT05589220|Nicotine|nicotine|mesh-list
153877612|NCT05589220|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
153877613|NCT05589220|Autonomic Agents|autonomic agents|mesh-ancestor
153877614|NCT05589220|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153877615|NCT05589220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153877616|NCT05589220|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
153418393|NCT00374348|Dopamine Agents|dopamine agents|mesh-ancestor
153418394|NCT00374348|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153418395|NCT00374348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153418396|NCT00374348|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
153418397|NCT00374348|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
153418398|NCT00374348|Serotonin Agents|serotonin agents|mesh-ancestor
153418399|NCT00374348|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
153418400|NCT00374348|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153418401|NCT00374348|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
153877627|NCT05569811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153877628|NCT05569811|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
153877629|NCT05569811|Hormone Antagonists|hormone antagonists|mesh-ancestor
153372337|NCT02631057|Anticoagulants|anticoagulants|mesh-ancestor
153832363|NCT02954484|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153877639|NCT05525247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153877640|NCT05525247|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153877641|NCT05520814|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
153877642|NCT05520814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153877643|NCT05520814|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153877644|NCT05520814|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153877645|NCT05515796|Trastuzumab|trastuzumab|mesh-list
153877646|NCT05515796|Tislelizumab|tislelizumab|mesh-list
153832605|NCT01248494|Letrozole|letrozole|mesh-list
153418421|NCT02903407|Sensory System Agents|sensory system agents|mesh-ancestor
153418422|NCT02903407|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153418423|NCT02903407|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
153418424|NCT02903407|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153358223|NCT03807596|Viscosupplements|viscosupplements|mesh-ancestor
153358224|NCT03807596|Protective Agents|protective agents|mesh-ancestor
153418426|NCT02903407|Adrenergic Agents|adrenergic agents|mesh-ancestor
153418427|NCT02903407|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153418428|NCT02903407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153418429|NCT02903407|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153418430|NCT02903407|Anesthetics, General|anesthetics, general|mesh-ancestor
153418431|NCT02903407|Anesthetics|anesthetics|mesh-ancestor
153832765|NCT01248923|Dexamethasone|dexamethasone|mesh-list
153418432|NCT02903407|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153832897|NCT01249430|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153877654|NCT05511610|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153373210|NCT00367497|Hormones|hormones|mesh-ancestor
153877656|NCT05511610|Anesthetics, General|anesthetics, general|mesh-ancestor
153877658|NCT05511610|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153877666|NCT05509569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153877667|NCT05509569|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153877668|NCT05509569|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153877669|NCT05509569|Bradykinin B2 Receptor Antagonists|bradykinin b2 receptor antagonists|mesh-ancestor
153877670|NCT05509569|Bradykinin Receptor Antagonists|bradykinin receptor antagonists|mesh-ancestor
153877671|NCT05509569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153877715|NCT05418244|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153877716|NCT05418244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153877722|NCT05418244|Serotonin Agents|serotonin agents|mesh-ancestor
153877723|NCT05418244|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153418496|NCT03018925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153418497|NCT03019783|Atazanavir Sulfate|atazanavir sulfate|mesh-list
153418498|NCT03019783|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
153418499|NCT03019783|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
153844789|NCT05469035|Calcium heparin|calcium heparin|mesh-list
153844918|NCT05468450|Polidocanol|polidocanol|mesh-list
153418520|NCT03020095|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153418521|NCT03020095|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
153418522|NCT03020095|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153418523|NCT03020095|Antimetabolites|antimetabolites|mesh-ancestor
153877748|NCT05407662|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153877750|NCT05407662|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
153877751|NCT05407662|Diuretics|diuretics|mesh-ancestor
153877752|NCT05407662|Natriuretic Agents|natriuretic agents|mesh-ancestor
153877753|NCT05407662|Hormones|hormones|mesh-ancestor
153877754|NCT05403385|Carboplatin|carboplatin|mesh-list
153418530|NCT03021343|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153847539|NCT00550212|Neratinib|neratinib|mesh-list
153877815|NCT05358704|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153877816|NCT05358704|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153877817|NCT05358704|Immunologic Factors|immunologic factors|mesh-ancestor
153877818|NCT05358704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153877819|NCT05358704|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
153877820|NCT05358704|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153877821|NCT05358704|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153877822|NCT05358704|Antidotes|antidotes|mesh-ancestor
153877823|NCT05358704|Protective Agents|protective agents|mesh-ancestor
153877824|NCT05358704|Vitamin B Complex|vitamin b complex|mesh-ancestor
153877825|NCT05358704|Vitamins|vitamins|mesh-ancestor
153847701|NCT00550992|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153849682|NCT04346654|Dexamethasone|dexamethasone|mesh-list
153849786|NCT03949673|Analgesics|analgesics|mesh-ancestor
153390616|NCT02756611|Venetoclax|venetoclax|mesh-list
153390836|NCT00002649|Alkylating Agents|alkylating agents|mesh-ancestor
153851377|NCT05542667|Fluorides, Topical|fluorides, topical|mesh-list
153851759|NCT03730181|Leprostatic Agents|leprostatic agents|mesh-ancestor
153854149|NCT00558506|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153854279|NCT00559052|Pancrelipase|pancrelipase|mesh-list
153855262|NCT01221727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153855263|NCT01221727|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153855264|NCT01221181|Eculizumab|eculizumab|mesh-list
153855265|NCT01221181|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
153855266|NCT01221181|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153855267|NCT01221181|Immunologic Factors|immunologic factors|mesh-ancestor
153855268|NCT01221181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153856511|NCT02106546|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
153856596|NCT02092935|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153856597|NCT02092935|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153810858|NCT00322400|Mitosis Modulators|mitosis modulators|mesh-ancestor
153357440|NCT00746954|Acetazolamide|acetazolamide|mesh-list
153357441|NCT00746954|Buspirone|buspirone|mesh-list
153357442|NCT00746954|Anticonvulsants|anticonvulsants|mesh-ancestor
153357443|NCT00746954|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
153357444|NCT00746954|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153357445|NCT00746954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153357446|NCT00746954|Diuretics|diuretics|mesh-ancestor
153357447|NCT00746954|Natriuretic Agents|natriuretic agents|mesh-ancestor
153357448|NCT00746954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153357449|NCT00746954|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153357450|NCT00746954|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153357451|NCT00746954|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153357452|NCT00746954|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153357453|NCT00746954|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
153357454|NCT00746954|Serotonin Agents|serotonin agents|mesh-ancestor
153357455|NCT00746954|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153357456|NCT00752102|Calcitriol|calcitriol|mesh-list
153357457|NCT00752102|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153357458|NCT00752102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153860992|NCT04209205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153860994|NCT04129086|Analgesics|analgesics|mesh-ancestor
153401306|NCT02049307|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
153401307|NCT02049307|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
153401308|NCT02049307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153401310|NCT00355628|Citric Acid|citric acid|mesh-list
153401311|NCT00355628|Sodium Citrate|sodium citrate|mesh-list
153401312|NCT00355628|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153401313|NCT00355628|Narcotics|narcotics|mesh-ancestor
153401314|NCT00355628|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153401315|NCT00355628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153401316|NCT00355628|Analgesics|analgesics|mesh-ancestor
153401317|NCT00355628|Sensory System Agents|sensory system agents|mesh-ancestor
153401318|NCT00355628|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153401319|NCT00355628|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153401320|NCT00355628|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153401321|NCT00355628|Anesthetics, General|anesthetics, general|mesh-ancestor
153401322|NCT00355628|Anesthetics|anesthetics|mesh-ancestor
153401323|NCT00355628|Anticoagulants|anticoagulants|mesh-ancestor
153401324|NCT00355628|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
153401325|NCT00355628|Chelating Agents|chelating agents|mesh-ancestor
153861001|NCT04129086|Anesthetics|anesthetics|mesh-ancestor
153861002|NCT04129086|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153358229|NCT01253525|Paclitaxel|paclitaxel|mesh-list
153358230|NCT01253525|Ramucirumab|ramucirumab|mesh-list
153887323|NCT05320705|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
153887324|NCT05320705|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153887325|NCT05320705|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153887326|NCT05320705|Adrenergic Agents|adrenergic agents|mesh-ancestor
153887327|NCT05320705|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153887328|NCT05320705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153887329|NCT01104766|Aripiprazole|aripiprazole|mesh-list
153887330|NCT01104766|Cariprazine|cariprazine|mesh-list
153887331|NCT01104766|Antidepressive Agents|antidepressive agents|mesh-ancestor
153887332|NCT01104766|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153428365|NCT00002348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153428366|NCT02721277|SMOFlipid|smoflipid|mesh-list
153861003|NCT04129086|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
153861004|NCT04129086|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
153357459|NCT00752102|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
153357460|NCT00752102|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153357461|NCT00752102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153357462|NCT00752102|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
153357463|NCT00752102|Vitamins|vitamins|mesh-ancestor
153357464|NCT00752102|Micronutrients|micronutrients|mesh-ancestor
153357465|NCT00752102|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153357466|NCT00723632|Ribavirin|ribavirin|mesh-list
153357467|NCT00723632|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
153357468|NCT00723632|Antimetabolites|antimetabolites|mesh-ancestor
153861014|NCT03961438|Monophosphoryl lipid A|monophosphoryl lipid a|mesh-list
153401326|NCT00355628|Sequestering Agents|sequestering agents|mesh-ancestor
153401327|NCT00355628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153401329|NCT02049385|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153401330|NCT02049385|Vasodilator Agents|vasodilator agents|mesh-ancestor
153401331|NCT03717155|Carboplatin|carboplatin|mesh-list
153401332|NCT03717155|Gemcitabine|gemcitabine|mesh-list
153401333|NCT03717155|Cetuximab|cetuximab|mesh-list
153401334|NCT03717155|Avelumab|avelumab|mesh-list
153401335|NCT03717155|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153401336|NCT03717155|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153401337|NCT03717155|Antimetabolites|antimetabolites|mesh-ancestor
153401338|NCT03717155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153401339|NCT03717155|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153401340|NCT03655613|Nivolumab|nivolumab|mesh-list
153401341|NCT03655613|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153401342|NCT03655613|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153401343|NCT03655613|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153401344|NCT03655613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153401345|NCT03286829|Metoprolol|metoprolol|mesh-list
153401346|NCT03286829|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153401347|NCT03286829|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153401348|NCT03286829|Sympatholytics|sympatholytics|mesh-ancestor
153401349|NCT03286829|Autonomic Agents|autonomic agents|mesh-ancestor
153401350|NCT03286829|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153401351|NCT03286829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153401352|NCT03286829|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
153401356|NCT03286829|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153401357|NCT03286829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153401359|NCT02051335|Donepezil|donepezil|mesh-list
153401360|NCT02051335|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
153401361|NCT02051335|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
153401362|NCT02051335|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153401363|NCT02051335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153401364|NCT02051335|Cholinergic Agents|cholinergic agents|mesh-ancestor
153358231|NCT01253525|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153358233|NCT01253525|Tubulin Modulators|tubulin modulators|mesh-ancestor
153358234|NCT01253525|Antimitotic Agents|antimitotic agents|mesh-ancestor
153358235|NCT01253525|Mitosis Modulators|mitosis modulators|mesh-ancestor
153358236|NCT01253525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153358237|NCT01253525|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153401365|NCT02051335|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153401366|NCT02051335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153401367|NCT02051335|Nootropic Agents|nootropic agents|mesh-ancestor
153401368|NCT02051335|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153401387|NCT02300077|Analgesics|analgesics|mesh-ancestor
153401388|NCT02300077|Sensory System Agents|sensory system agents|mesh-ancestor
153401389|NCT02300077|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153401390|NCT02300077|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153401391|NCT02300077|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153401392|NCT02300077|Anesthetics, General|anesthetics, general|mesh-ancestor
153810860|NCT00322400|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153810861|NCT00322400|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153810862|NCT00352521|Bevacizumab|bevacizumab|mesh-list
153810863|NCT00352521|Irinotecan|irinotecan|mesh-list
153810864|NCT00352521|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153810865|NCT00352521|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153810866|NCT00352521|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153810867|NCT00352521|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153401393|NCT02300077|Anesthetics|anesthetics|mesh-ancestor
153401394|NCT02300077|Antitussive Agents|antitussive agents|mesh-ancestor
153401395|NCT02300077|Respiratory System Agents|respiratory system agents|mesh-ancestor
153401396|NCT03291197|Bupivacaine|bupivacaine|mesh-list
153401397|NCT03291197|Anesthetics, Local|anesthetics, local|mesh-ancestor
153401398|NCT03291197|Anesthetics|anesthetics|mesh-ancestor
153401399|NCT03291197|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153401400|NCT03291197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153401401|NCT03291197|Sensory System Agents|sensory system agents|mesh-ancestor
153401402|NCT03291197|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153401403|NCT00356096|Pramipexole|pramipexole|mesh-list
153401404|NCT00356096|Dexpramipexole|dexpramipexole|mesh-list
153401405|NCT00356096|Antioxidants|antioxidants|mesh-ancestor
153401406|NCT00356096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153401407|NCT00356096|Protective Agents|protective agents|mesh-ancestor
153861067|NCT03416179|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153861068|NCT03416179|Immunologic Factors|immunologic factors|mesh-ancestor
153861069|NCT03416179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153861070|NCT03416179|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153861071|NCT03416179|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153861072|NCT03416179|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153861073|NCT03416179|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153810868|NCT00352521|Growth Substances|growth substances|mesh-ancestor
153810869|NCT00352521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153810870|NCT00352521|Growth Inhibitors|growth inhibitors|mesh-ancestor
153810871|NCT00352521|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
153810872|NCT00352521|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153810873|NCT00352521|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153810874|NCT00352521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153810875|NCT00352599|Lovastatin|lovastatin|mesh-list
153810876|NCT00352599|L 647318|l 647318|mesh-list
153401408|NCT00356096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153401410|NCT00356096|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
153401411|NCT00356096|Dopamine Agonists|dopamine agonists|mesh-ancestor
153401412|NCT00356096|Dopamine Agents|dopamine agents|mesh-ancestor
153401413|NCT00356096|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153401414|NCT03243461|Temozolomide|temozolomide|mesh-list
153401415|NCT03243461|Valproic Acid|valproic acid|mesh-list
153401416|NCT03243461|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153401417|NCT03243461|Alkylating Agents|alkylating agents|mesh-ancestor
153401418|NCT03243461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153401419|NCT03243461|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153401420|NCT03243461|Anticonvulsants|anticonvulsants|mesh-ancestor
153401421|NCT03243461|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153401422|NCT03243461|GABA Agents|gaba agents|mesh-ancestor
153401423|NCT03243461|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153401424|NCT03243461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153401425|NCT03243461|Antimanic Agents|antimanic agents|mesh-ancestor
153401426|NCT03243461|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153401427|NCT03243461|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153401428|NCT03243461|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153401429|NCT03296345|Ketamine|ketamine|mesh-list
153861097|NCT02859792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153401453|NCT00376181|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
153401454|NCT00376181|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
153401455|NCT00376181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153401456|NCT04736693|Zoledronic Acid|zoledronic acid|mesh-list
153401457|NCT04736693|Raloxifene Hydrochloride|raloxifene hydrochloride|mesh-list
153401458|NCT04736693|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153401459|NCT04736693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153401460|NCT04736693|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
153401461|NCT04736693|Hormone Antagonists|hormone antagonists|mesh-ancestor
153401462|NCT04736693|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153401463|NCT04736693|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
153401464|NCT04736693|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
153401465|NCT04652414|Prednisone|prednisone|mesh-list
153401466|NCT04652414|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153401467|NCT04652414|Glucocorticoids|glucocorticoids|mesh-ancestor
153401468|NCT04652414|Hormones|hormones|mesh-ancestor
153401469|NCT04652414|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153401470|NCT04652414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153401472|NCT04652414|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153401473|NCT04736381|Mycophenolic Acid|mycophenolic acid|mesh-list
153401474|NCT04736381|Abatacept|abatacept|mesh-list
153401475|NCT04736381|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153861137|NCT01792934|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
153861138|NCT01792934|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153861139|NCT01792934|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153861140|NCT01792934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153861207|NCT00545207|Ibandronic Acid|ibandronic acid|mesh-list
153861208|NCT00545207|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153861209|NCT00545207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153861210|NCT00545246|Docetaxel|docetaxel|mesh-list
153861211|NCT00545246|Aflibercept|aflibercept|mesh-list
153358248|NCT05310968|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153358249|NCT05310968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153358250|NCT05310968|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153358251|NCT05310968|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153358252|NCT05310968|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153358253|NCT05310968|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153358254|NCT05310968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153358255|NCT05310968|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153358257|NCT05310968|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153358258|NCT05310968|Antipyretics|antipyretics|mesh-ancestor
153358259|NCT00768716|Acetaminophen|acetaminophen|mesh-list
153358260|NCT00768716|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153358261|NCT00768716|Analgesics|analgesics|mesh-ancestor
153887334|NCT01104766|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153887335|NCT01104766|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153887336|NCT01104766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153887337|NCT01104766|Dopamine Agonists|dopamine agonists|mesh-ancestor
153861212|NCT00545246|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153861213|NCT00545246|Tubulin Modulators|tubulin modulators|mesh-ancestor
153861214|NCT00545246|Antimitotic Agents|antimitotic agents|mesh-ancestor
153861215|NCT00545246|Mitosis Modulators|mitosis modulators|mesh-ancestor
153861216|NCT00545246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153861217|NCT00545246|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153861218|NCT00545246|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153401540|NCT02056171|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153401541|NCT02056171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153401543|NCT03312023|Ledipasvir, sofosbuvir drug combination|ledipasvir, sofosbuvir drug combination|mesh-list
153401544|NCT03312023|Ledipasvir|ledipasvir|mesh-list
153401545|NCT03312023|Antiviral Agents|antiviral agents|mesh-ancestor
153401546|NCT03312023|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153401547|NCT02342197|Triptorelin Pamoate|triptorelin pamoate|mesh-list
153401557|NCT02344225|Ketorolac|ketorolac|mesh-list
153401558|NCT02344225|Caffeine|caffeine|mesh-list
153401559|NCT02344225|Caffeine citrate|caffeine citrate|mesh-list
153401560|NCT02344225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153401561|NCT02344225|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153401562|NCT02344225|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153401563|NCT02344225|Analgesics|analgesics|mesh-ancestor
153401564|NCT02344225|Sensory System Agents|sensory system agents|mesh-ancestor
153861252|NCT00545558|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
153861253|NCT00545558|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153861275|NCT00545675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153861276|NCT00545675|Dopamine Agonists|dopamine agonists|mesh-ancestor
153861277|NCT00545675|Dopamine Agents|dopamine agents|mesh-ancestor
153861278|NCT00545675|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153861279|NCT00545675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153861280|NCT00545675|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
153861281|NCT00545675|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
153861282|NCT00545675|Serotonin Agents|serotonin agents|mesh-ancestor
153401615|NCT04624295|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153401616|NCT04624295|Antipyretics|antipyretics|mesh-ancestor
153401617|NCT03323801|Tretinoin|tretinoin|mesh-list
153401619|NCT03323801|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153401620|NCT03323801|Keratolytic Agents|keratolytic agents|mesh-ancestor
153401621|NCT03323801|Dermatologic Agents|dermatologic agents|mesh-ancestor
153401629|NCT02349685|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
153401631|NCT02352259|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153401640|NCT02397265|Insulin|insulin|mesh-list
153861319|NCT00546065|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153861320|NCT00546065|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
153861321|NCT00546065|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153861322|NCT00546065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153861324|NCT00546143|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
153861329|NCT00546143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153401649|NCT00375869|Darbepoetin alfa|darbepoetin alfa|mesh-list
153401650|NCT00375869|Hematinics|hematinics|mesh-ancestor
153401651|NCT03198221|Picosulfate sodium|picosulfate sodium|mesh-list
153401652|NCT03198221|Magnesium Oxide|magnesium oxide|mesh-list
153401653|NCT03198221|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
153358265|NCT00768716|Antipyretics|antipyretics|mesh-ancestor
153401654|NCT03198221|Citric Acid|citric acid|mesh-list
153401655|NCT03198221|Cathartics|cathartics|mesh-ancestor
153401656|NCT03198221|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153401657|NCT03198221|Antacids|antacids|mesh-ancestor
153401658|NCT03198221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153401659|NCT03198221|Anticoagulants|anticoagulants|mesh-ancestor
153401660|NCT03198221|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
153401661|NCT03198221|Chelating Agents|chelating agents|mesh-ancestor
153401662|NCT03198221|Sequestering Agents|sequestering agents|mesh-ancestor
153401663|NCT03198221|Laxatives|laxatives|mesh-ancestor
153401664|NCT03203681|Methyltestosterone|methyltestosterone|mesh-list
153401665|NCT03203681|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
153401666|NCT03203681|Testosterone|testosterone|mesh-list
153861345|NCT00560118|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153401668|NCT03203681|Testosterone enanthate|testosterone enanthate|mesh-list
153401669|NCT03203681|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153401670|NCT03203681|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153401671|NCT03203681|Anabolic Agents|anabolic agents|mesh-ancestor
153401673|NCT03203681|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153401674|NCT03203681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153401675|NCT03203681|Androgens|androgens|mesh-ancestor
153401718|NCT05992987|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153401719|NCT05992987|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153401720|NCT05992987|Vasodilator Agents|vasodilator agents|mesh-ancestor
153401721|NCT05992987|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
153401722|NCT05992987|Purinergic Agonists|purinergic agonists|mesh-ancestor
153401723|NCT05992987|Purinergic Agents|purinergic agents|mesh-ancestor
153401724|NCT05992987|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153401725|NCT05992987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153401726|NCT05992883|Triamcinolone|triamcinolone|mesh-list
153861395|NCT00546923|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153401754|NCT05992220|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153401755|NCT05992220|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153401756|NCT05992220|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153401757|NCT05992220|Growth Substances|growth substances|mesh-ancestor
153401758|NCT05992220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153861426|NCT00547547|Antimetabolites|antimetabolites|mesh-ancestor
153861427|NCT00547547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153861428|NCT00547547|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153861429|NCT00547547|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
153861430|NCT00547547|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153861431|NCT00547547|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153401851|NCT05987397|Antioxidants|antioxidants|mesh-ancestor
153401852|NCT05987397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153401853|NCT05987397|Protective Agents|protective agents|mesh-ancestor
153401854|NCT05987397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153401855|NCT05987397|Micronutrients|micronutrients|mesh-ancestor
153401857|NCT05987345|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
153401858|NCT05987345|Immunologic Factors|immunologic factors|mesh-ancestor
153401859|NCT05987345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153861624|NCT00549419|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153861626|NCT00549419|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
153861627|NCT00549419|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
153861628|NCT00549419|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
153401967|NCT05983055|Glucocorticoids|glucocorticoids|mesh-ancestor
153401968|NCT05983055|Hormones|hormones|mesh-ancestor
153401969|NCT05983055|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153401970|NCT05983055|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153401971|NCT05983055|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153401972|NCT05983055|Protease Inhibitors|protease inhibitors|mesh-ancestor
153401973|NCT05983055|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153401974|NCT05983055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153401975|NCT05970380|Anesthetics|anesthetics|mesh-list
153401976|NCT05970380|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153861678|NCT00549965|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153861679|NCT00549965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153861680|NCT00549965|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153861681|NCT00549965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153861682|NCT00549965|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153861684|NCT00550004|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153861685|NCT00550004|Antimetabolites|antimetabolites|mesh-ancestor
153402032|NCT05862233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153402033|NCT05862233|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153402034|NCT05862233|Immunologic Factors|immunologic factors|mesh-ancestor
153402035|NCT05862233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153402036|NCT05862233|Antifungal Agents|antifungal agents|mesh-ancestor
153402037|NCT05862233|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153402038|NCT05862233|Dermatologic Agents|dermatologic agents|mesh-ancestor
153402039|NCT05862233|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153402040|NCT05862233|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
153402041|NCT05856851|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
153402042|NCT05856851|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153402043|NCT05856851|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153402044|NCT05856851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153402045|NCT05840861|Quetiapine Fumarate|quetiapine fumarate|mesh-list
153402046|NCT05840861|Vortioxetine|vortioxetine|mesh-list
153402047|NCT05840861|Antidepressive Agents|antidepressive agents|mesh-ancestor
153402048|NCT05840861|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153402049|NCT05840861|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153402050|NCT05840861|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153402051|NCT05840861|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153402103|NCT05814640|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
153861762|NCT00550784|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
153861763|NCT00550784|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153861764|NCT00550784|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153861766|NCT00550901|Razoxane|razoxane|mesh-list
153861767|NCT00550901|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153861768|NCT00550901|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
153861769|NCT00550901|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153861770|NCT00550901|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153861789|NCT00551018|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153861791|NCT00551018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153861792|NCT00551018|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153861793|NCT00551018|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153861812|NCT01125761|BB 1101|bb 1101|mesh-list
153861813|NCT01125761|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153861814|NCT01125761|Antiemetics|antiemetics|mesh-ancestor
153861815|NCT01125761|Autonomic Agents|autonomic agents|mesh-ancestor
153402149|NCT05752409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153888627|NCT01091662|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153888628|NCT01091662|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153888629|NCT01091662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153888630|NCT01312961|Fluticasone|fluticasone|mesh-list
153402150|NCT05752409|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153402151|NCT05752409|Anesthetics, General|anesthetics, general|mesh-ancestor
153402152|NCT05752409|Anesthetics|anesthetics|mesh-ancestor
153402160|NCT05752409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153402161|NCT05752409|Antidepressive Agents|antidepressive agents|mesh-ancestor
153402168|NCT05746481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153402169|NCT05746481|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153402170|NCT05746481|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153402171|NCT05746481|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153402172|NCT05746481|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153402173|NCT05721937|Abrocitinib|abrocitinib|mesh-list
153402174|NCT05721937|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153402175|NCT05721937|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153402176|NCT05721937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153402177|NCT05715411|Methamphetamine|methamphetamine|mesh-list
153402178|NCT05715411|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
153402179|NCT05715411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153402180|NCT05715411|Sympathomimetics|sympathomimetics|mesh-ancestor
153402181|NCT05715411|Autonomic Agents|autonomic agents|mesh-ancestor
153402182|NCT05715411|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153402183|NCT05715411|Dopamine Agents|dopamine agents|mesh-ancestor
153888633|NCT01312961|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
153861860|NCT04640181|Enoxaparin|enoxaparin|mesh-list
153783469|NCT04547335|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
153783470|NCT00236288|Bupropion|bupropion|mesh-list
153783471|NCT00236288|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
153861861|NCT04640181|Rivaroxaban|rivaroxaban|mesh-list
153861862|NCT04640181|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
153861863|NCT04640181|Antithrombins|antithrombins|mesh-ancestor
153861865|NCT04640181|Protease Inhibitors|protease inhibitors|mesh-ancestor
153861889|NCT05186675|Epinephrine|epinephrine|mesh-list
153861890|NCT05186675|Racepinephrine|racepinephrine|mesh-list
153861891|NCT05186675|Epinephryl borate|epinephryl borate|mesh-list
153861892|NCT05186675|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153861893|NCT05186675|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153861894|NCT05186675|Adrenergic Agents|adrenergic agents|mesh-ancestor
153861895|NCT05186675|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153861896|NCT05186675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153861897|NCT05186675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153861898|NCT05186675|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
153861899|NCT05186675|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153861900|NCT05186675|Autonomic Agents|autonomic agents|mesh-ancestor
153861901|NCT05186675|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153861902|NCT05186675|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153861904|NCT05186675|Mydriatics|mydriatics|mesh-ancestor
153861933|NCT00559689|Glucocorticoids|glucocorticoids|mesh-ancestor
153861934|NCT00559689|Hormones|hormones|mesh-ancestor
153861935|NCT00559689|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153861936|NCT04629027|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
153861937|NCT04629027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153861938|NCT04629027|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153861939|NCT04629027|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153861940|NCT00561288|Acetaminophen|acetaminophen|mesh-list
153861941|NCT00561288|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153861942|NCT00561288|Analgesics|analgesics|mesh-ancestor
153402271|NCT05510427|Atezolizumab|atezolizumab|mesh-list
153402272|NCT05510427|Infigratinib|infigratinib|mesh-list
153402273|NCT05510427|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153402274|NCT05510427|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153402275|NCT05510427|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153402276|NCT05510427|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153861967|NCT04628559|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153861968|NCT04628559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153861969|NCT04628559|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153861970|NCT04628559|Analgesics|analgesics|mesh-ancestor
153861971|NCT04628559|Sensory System Agents|sensory system agents|mesh-ancestor
153783473|NCT00236288|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153783474|NCT00236288|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
153783475|NCT00236288|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153783476|NCT00236288|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153861981|NCT04628559|Anesthetics, General|anesthetics, general|mesh-ancestor
153861982|NCT04628559|Anesthetics|anesthetics|mesh-ancestor
153861983|NCT04628559|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
153861984|NCT04628559|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
153861985|NCT04683341|Tenofovir|tenofovir|mesh-list
153861986|NCT04683341|Antiviral Agents|antiviral agents|mesh-ancestor
153861987|NCT04683341|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153402327|NCT05450965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153402328|NCT05444582|Levonorgestrel|levonorgestrel|mesh-list
153402329|NCT05444582|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
153402330|NCT05444582|Contraceptive Agents|contraceptive agents|mesh-ancestor
153402331|NCT05444582|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153402332|NCT05444582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153402333|NCT05444582|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
153402334|NCT05444582|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
153402335|NCT05444582|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
153402336|NCT05442034|Mitogens|mitogens|mesh-list
153402337|NCT05442034|Mitosis Modulators|mitosis modulators|mesh-ancestor
153402338|NCT05442034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153402339|NCT05425875|Dimercaprol|dimercaprol|mesh-list
153402340|NCT05425875|Chelating Agents|chelating agents|mesh-ancestor
153862047|NCT01214239|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
153862049|NCT01214239|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153862050|NCT01214239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153862051|NCT01214044|Dexetimide|dexetimide|mesh-list
153862052|NCT01214044|Citalopram|citalopram|mesh-list
153862053|NCT01214044|Escitalopram|escitalopram|mesh-list
153402387|NCT05378555|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153862084|NCT04657107|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153862085|NCT04657107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153862086|NCT04657107|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
153402421|NCT05305105|Psilocybin|psilocybin|mesh-list
153402422|NCT05305105|Hallucinogens|hallucinogens|mesh-ancestor
153402423|NCT05305105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153402427|NCT05301361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153402428|NCT05301361|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
153402429|NCT05301361|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153402430|NCT05301361|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153402431|NCT05301361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153402432|NCT05301361|Dopamine Agents|dopamine agents|mesh-ancestor
153402433|NCT05301361|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153402434|NCT05280340|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
153429743|NCT00381914|Vitamin D|vitamin d|mesh-list
153862158|NCT04710719|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153358282|NCT01337687|Oxytocin|oxytocin|mesh-list
153862159|NCT04710719|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153862160|NCT04710719|Immunologic Factors|immunologic factors|mesh-ancestor
153862161|NCT04710719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153862162|NCT04710719|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153862163|NCT04710719|Glucocorticoids|glucocorticoids|mesh-ancestor
153862164|NCT04710719|Hormones|hormones|mesh-ancestor
153862165|NCT04710719|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153862166|NCT04710719|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153862167|NCT04627779|Flurbiprofen|flurbiprofen|mesh-list
153862168|NCT04627779|Flurbiprofen axetil|flurbiprofen axetil|mesh-list
153862169|NCT04627779|Analgesics|analgesics|mesh-ancestor
153402544|NCT05107453|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153402546|NCT05105841|Obinutuzumab|obinutuzumab|mesh-list
153402547|NCT05105841|Ibrutinib|ibrutinib|mesh-list
153862286|NCT02905994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153402622|NCT05053126|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153402623|NCT05053126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153402625|NCT05053126|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153402626|NCT05053126|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153402627|NCT05053126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153402628|NCT05053126|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153402629|NCT05053126|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153402630|NCT05053126|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153402631|NCT05053126|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153402632|NCT05053126|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153402633|NCT05053126|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153402634|NCT05053126|Narcotics|narcotics|mesh-ancestor
153402635|NCT05049616|Nifedipine|nifedipine|mesh-list
153402636|NCT05049616|Diuretics|diuretics|mesh-list
153402637|NCT05049616|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
153402638|NCT05049616|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153402639|NCT05049616|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153402783|NCT04865887|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153402785|NCT04864444|Primaquine|primaquine|mesh-list
153402786|NCT04864444|Piperaquine|piperaquine|mesh-list
153402787|NCT04864444|Artenimol|artenimol|mesh-list
153358290|NCT04351919|Antimalarials|antimalarials|mesh-ancestor
153358291|NCT04351919|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153887453|NCT01089361|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153887454|NCT01089361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153887455|NCT01089361|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
153887456|NCT01089361|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153862443|NCT04624269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153862444|NCT04624269|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153862446|NCT04652739|Lycopene|lycopene|mesh-list
153862447|NCT04652739|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153862517|NCT00562185|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153862518|NCT00562185|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153862519|NCT00562185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153862520|NCT00562224|Abexinostat|abexinostat|mesh-list
153862521|NCT00562224|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
153862522|NCT00562224|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153402869|NCT04729725|Immunologic Factors|immunologic factors|mesh-ancestor
153402870|NCT04729725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153402871|NCT04729725|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153402882|NCT04723004|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153402883|NCT04723004|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153402884|NCT04723004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153402885|NCT04698603|N,N-Dimethyltryptamine|n,n-dimethyltryptamine|mesh-list
153402886|NCT04698603|Hallucinogens|hallucinogens|mesh-ancestor
153402887|NCT04698603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153402888|NCT04698603|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153402889|NCT04698603|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153402890|NCT04698603|Serotonin Agents|serotonin agents|mesh-ancestor
153402891|NCT04698603|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153402892|NCT04698603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153402893|NCT04698603|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
153862535|NCT04623840|Urological Agents|urological agents|mesh-ancestor
153862536|NCT02902640|Trimethoprim|trimethoprim|mesh-list
153862537|NCT02902640|Sulfamethoxazole|sulfamethoxazole|mesh-list
153862538|NCT02902640|Phenylpropanolamine|phenylpropanolamine|mesh-list
153862539|NCT02902640|Guaifenesin|guaifenesin|mesh-list
153862540|NCT02902640|Chlorpheniramine, phenylpropanolamine drug combination|chlorpheniramine, phenylpropanolamine drug combination|mesh-list
153862559|NCT02902640|Appetite Depressants|appetite depressants|mesh-ancestor
153402931|NCT04640831|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153402932|NCT04640831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153402933|NCT04640831|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
153402934|NCT04610398|Dexamethasone|dexamethasone|mesh-list
153402935|NCT04610398|Dexamethasone acetate|dexamethasone acetate|mesh-list
153402936|NCT04610398|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153402937|NCT04610398|Antiemetics|antiemetics|mesh-ancestor
153862563|NCT02902640|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153862564|NCT02902640|Nasal Decongestants|nasal decongestants|mesh-ancestor
153862565|NCT02902640|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
153862566|NCT04624893|Polatuzumab vedotin|polatuzumab vedotin|mesh-list
153862648|NCT04622202|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153887462|NCT01089361|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153887463|NCT01089361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153887464|NCT01102972|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
153887465|NCT01102972|Atazanavir Sulfate|atazanavir sulfate|mesh-list
153887466|NCT01102972|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153887467|NCT01102972|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153887468|NCT01102972|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153887469|NCT01102972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153887470|NCT01102972|Antiviral Agents|antiviral agents|mesh-ancestor
153887471|NCT01102972|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153887472|NCT01102972|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153887473|NCT01102972|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153862649|NCT04622202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153862650|NCT04622202|Anticonvulsants|anticonvulsants|mesh-ancestor
153862651|NCT04622202|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153402998|NCT04497142|Anticonvulsants|anticonvulsants|mesh-ancestor
153402999|NCT04497142|Nootropic Agents|nootropic agents|mesh-ancestor
153403001|NCT04495257|Ipilimumab|ipilimumab|mesh-list
153403002|NCT04495257|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153403003|NCT04495257|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153403004|NCT04495257|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153403005|NCT04495257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153403006|NCT04477759|Atezolizumab|atezolizumab|mesh-list
153403007|NCT04477759|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153403008|NCT04477759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153403009|NCT04477759|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153403010|NCT04477759|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153403011|NCT04316702|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
153403012|NCT04316702|Analgesics|analgesics|mesh-ancestor
153403013|NCT04316702|Sensory System Agents|sensory system agents|mesh-ancestor
153403014|NCT04316702|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153403015|NCT04316702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153403016|NCT04316702|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153862660|NCT04622358|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
153862661|NCT04622358|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153862662|NCT04622358|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
153862663|NCT04622358|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153862664|NCT04622358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153862722|NCT01212757|Apremilast|apremilast|mesh-list
153862723|NCT01212757|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153862724|NCT01212757|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153862725|NCT01212757|Analgesics|analgesics|mesh-ancestor
153862726|NCT01212757|Sensory System Agents|sensory system agents|mesh-ancestor
153403076|NCT04256707|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153403077|NCT04249427|Erenumab|erenumab|mesh-list
153403078|NCT04249427|Calcitonin Gene-Related Peptide Receptor Antagonists|calcitonin gene-related peptide receptor antagonists|mesh-ancestor
153403079|NCT04249427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153403080|NCT04249427|Analgesics|analgesics|mesh-ancestor
153403081|NCT04249427|Sensory System Agents|sensory system agents|mesh-ancestor
153403082|NCT04249427|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153403083|NCT04249427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153862732|NCT01212757|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
153862733|NCT01212757|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153862734|NCT01212757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153862735|NCT01212757|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153862736|NCT01212757|Immunologic Factors|immunologic factors|mesh-ancestor
153862737|NCT01212757|Leprostatic Agents|leprostatic agents|mesh-ancestor
153862738|NCT01212757|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153862739|NCT01212757|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153862740|NCT01212757|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153862741|NCT01212757|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153358292|NCT04351919|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153358293|NCT04351919|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153358294|NCT04351919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153428548|NCT00002378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153358295|NCT04351919|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153428549|NCT00002378|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153403148|NCT04167111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153403149|NCT04167111|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153403150|NCT04167111|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153403151|NCT04139304|Prednisone|prednisone|mesh-list
153403152|NCT04139304|Cortisone|cortisone|mesh-list
153862785|NCT01190254|Asenapine|asenapine|mesh-list
153862786|NCT01190254|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153862787|NCT01190254|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153862788|NCT01190254|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153862789|NCT01190254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153862813|NCT04621110|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153862814|NCT04621110|Adrenergic Agents|adrenergic agents|mesh-ancestor
153862815|NCT04621110|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153862816|NCT04621110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153862817|NCT04621110|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
153862818|NCT04621110|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153862819|NCT04621110|Anesthetics, General|anesthetics, general|mesh-ancestor
153403220|NCT04109924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153403223|NCT04109924|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153403224|NCT04109924|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153403225|NCT04093596|Cyclophosphamide|cyclophosphamide|mesh-list
153358296|NCT00769886|Ketotifen|ketotifen|mesh-list
153358297|NCT00769886|Naphazoline|naphazoline|mesh-list
153358298|NCT00769886|Antipruritics|antipruritics|mesh-ancestor
153358299|NCT00769886|Dermatologic Agents|dermatologic agents|mesh-ancestor
153358300|NCT00769886|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
153358301|NCT00769886|Histamine Antagonists|histamine antagonists|mesh-ancestor
153358302|NCT00769886|Histamine Agents|histamine agents|mesh-ancestor
153358303|NCT00769886|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153358304|NCT00769886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153358305|NCT00769886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153358306|NCT00769886|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
153358307|NCT00769886|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153887497|NCT04306627|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153887498|NCT04306627|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153887499|NCT04306627|Antimetabolites|antimetabolites|mesh-ancestor
153887500|NCT04306627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153887501|NCT04306627|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153887502|NCT04306627|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
153887503|NCT04306627|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153887504|NCT04306627|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153887505|NCT04306627|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153887506|NCT04306627|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153428550|NCT00002378|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153403226|NCT04093596|Fludarabine|fludarabine|mesh-list
153403227|NCT04093596|Nirogacestat|nirogacestat|mesh-list
153403228|NCT04093596|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153403229|NCT04093596|Immunologic Factors|immunologic factors|mesh-ancestor
153403230|NCT04093596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153403231|NCT04093596|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153403232|NCT04093596|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153403233|NCT04093596|Alkylating Agents|alkylating agents|mesh-ancestor
153403234|NCT04093596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153403235|NCT04093596|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153862954|NCT02885740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153862955|NCT02885740|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153862956|NCT02885740|Vasodilator Agents|vasodilator agents|mesh-ancestor
153862957|NCT02885740|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
153862958|NCT02885740|Purinergic Agonists|purinergic agonists|mesh-ancestor
153862959|NCT02885740|Purinergic Agents|purinergic agents|mesh-ancestor
153862960|NCT02885740|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153862961|NCT02885740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153862962|NCT05309785|Canagliflozin|canagliflozin|mesh-list
153862965|NCT05309785|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153862986|NCT04619433|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153862987|NCT04619433|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153880941|NCT05842759|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153421798|NCT05468489|Etoposide|etoposide|mesh-list
153358315|NCT00794144|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153358316|NCT00794144|Analgesics|analgesics|mesh-ancestor
153358317|NCT00794144|Sensory System Agents|sensory system agents|mesh-ancestor
153358318|NCT00794144|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153358319|NCT00794144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153358320|NCT00794144|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153358321|NCT00794144|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153358322|NCT00794144|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
153358323|NCT00794144|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
153358324|NCT00794144|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
153428556|NCT00002378|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153428557|NCT00002378|Antimetabolites|antimetabolites|mesh-ancestor
153428558|NCT02589145|Pyridoxine|pyridoxine|mesh-list
153428559|NCT02589145|Dexamethasone|dexamethasone|mesh-list
153428560|NCT02589145|Rituximab|rituximab|mesh-list
153428561|NCT02589145|Gemcitabine|gemcitabine|mesh-list
153428562|NCT02589145|Lenalidomide|lenalidomide|mesh-list
153428563|NCT02589145|Melphalan|melphalan|mesh-list
153428564|NCT02589145|Busulfan|busulfan|mesh-list
153428565|NCT02589145|Vorinostat|vorinostat|mesh-list
153428566|NCT02589145|Enoxaparin|enoxaparin|mesh-list
153428567|NCT02589145|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153428568|NCT02589145|Antiemetics|antiemetics|mesh-ancestor
153862988|NCT04619433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153862989|NCT04619433|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153862990|NCT04619433|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153862991|NCT04619160|Propofol|propofol|mesh-list
153862992|NCT04619160|Sevoflurane|sevoflurane|mesh-list
153862993|NCT04619160|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153862994|NCT04619160|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153862995|NCT04619160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153862996|NCT04619160|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153862997|NCT04619160|Anesthetics, General|anesthetics, general|mesh-ancestor
153862998|NCT04619160|Anesthetics|anesthetics|mesh-ancestor
153863006|NCT01165684|Insulin Detemir|insulin detemir|mesh-list
153863007|NCT01165684|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153863008|NCT01165684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153863009|NCT01189201|Linagliptin|linagliptin|mesh-list
153863019|NCT01189201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153863020|NCT01189201|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
153863021|NCT01188811|Thioctic Acid|thioctic acid|mesh-list
153863022|NCT01188811|Antioxidants|antioxidants|mesh-ancestor
153863023|NCT01188811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153863024|NCT01188811|Protective Agents|protective agents|mesh-ancestor
153863056|NCT04618575|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
153863057|NCT04618575|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153863058|NCT04618536|Sunscreening Agents|sunscreening agents|mesh-list
153863059|NCT04618536|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
153863060|NCT04618536|Protective Agents|protective agents|mesh-ancestor
153863061|NCT04618536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153863062|NCT04618536|Dermatologic Agents|dermatologic agents|mesh-ancestor
153863063|NCT04651959|Favipiravir|favipiravir|mesh-list
153863064|NCT04651959|Antiviral Agents|antiviral agents|mesh-ancestor
153863101|NCT05421962|Fentanyl|fentanyl|mesh-list
153863170|NCT05376761|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153863171|NCT05376761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153863172|NCT04617561|Methylprednisolone|methylprednisolone|mesh-list
153863173|NCT04617561|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
153863174|NCT04617561|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
153863175|NCT04617561|Prednisolone|prednisolone|mesh-list
153863176|NCT04617561|Prednisolone acetate|prednisolone acetate|mesh-list
153887507|NCT04306627|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153887508|NCT04306627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153887509|NCT04306627|Vasodilator Agents|vasodilator agents|mesh-ancestor
153887510|NCT04306627|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
153887511|NCT04306627|Protease Inhibitors|protease inhibitors|mesh-ancestor
153887513|NCT04306471|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
153887514|NCT04306471|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153863177|NCT04617561|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
153863178|NCT04617561|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
153863179|NCT04617561|Prednisolone phosphate|prednisolone phosphate|mesh-list
153863180|NCT04617561|Glucocorticoids|glucocorticoids|mesh-list
153863181|NCT04617561|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153863182|NCT04617561|Antiemetics|antiemetics|mesh-ancestor
153863183|NCT04617561|Autonomic Agents|autonomic agents|mesh-ancestor
153863184|NCT04617561|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153863187|NCT04617561|Hormones|hormones|mesh-ancestor
153863199|NCT04617249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153863200|NCT05349383|Antineoplastic Agents|antineoplastic agents|mesh-list
153863201|NCT05349383|Antibodies|antibodies|mesh-list
153863202|NCT05349383|Immunoglobulins|immunoglobulins|mesh-list
153863203|NCT05349383|Immunoconjugates|immunoconjugates|mesh-list
153863204|NCT05349383|Immunomodulating Agents|immunomodulating agents|mesh-list
153863205|NCT05349383|Immunologic Factors|immunologic factors|mesh-ancestor
153863206|NCT05349383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153863207|NCT04617171|Benralizumab|benralizumab|mesh-list
153863208|NCT04617171|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153863209|NCT04617171|Respiratory System Agents|respiratory system agents|mesh-ancestor
153863210|NCT00557934|Dobutamine|dobutamine|mesh-list
153403601|NCT03240809|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
153403602|NCT03240809|Dermatologic Agents|dermatologic agents|mesh-ancestor
153403603|NCT03240809|Immunologic Factors|immunologic factors|mesh-ancestor
153403604|NCT03240809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153403606|NCT03192995|Anesthetics, Local|anesthetics, local|mesh-ancestor
153403607|NCT03192995|Anesthetics|anesthetics|mesh-ancestor
153403608|NCT03192995|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153358326|NCT00794144|Histamine Agents|histamine agents|mesh-ancestor
153358327|NCT00794144|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153358328|NCT00794144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153358329|NCT01309451|Dexamethasone|dexamethasone|mesh-list
153358330|NCT01309451|Bevacizumab|bevacizumab|mesh-list
153783488|NCT00236327|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153783489|NCT00236327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153783490|NCT00236327|Analgesics|analgesics|mesh-ancestor
153358333|NCT01309451|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153358334|NCT01309451|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153428583|NCT02589145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153428584|NCT02589145|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153428585|NCT02589145|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153428586|NCT02589145|Growth Substances|growth substances|mesh-ancestor
153428587|NCT02589145|Growth Inhibitors|growth inhibitors|mesh-ancestor
153428588|NCT02589145|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153428589|NCT02589145|Alkylating Agents|alkylating agents|mesh-ancestor
153428590|NCT02589145|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153428591|NCT02589145|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153428592|NCT02589145|Anticoagulants|anticoagulants|mesh-ancestor
153428593|NCT02589145|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153428594|NCT02589145|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153403609|NCT03192995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153403610|NCT03192995|Sensory System Agents|sensory system agents|mesh-ancestor
153403612|NCT03192995|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
153863273|NCT05153525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153863274|NCT04649892|Naltrexone|naltrexone|mesh-list
153863275|NCT04649892|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
153863276|NCT04649892|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
153403656|NCT03110926|Mitosis Modulators|mitosis modulators|mesh-ancestor
153403657|NCT03110926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153403658|NCT03110926|Antidotes|antidotes|mesh-ancestor
153403659|NCT03110926|Protective Agents|protective agents|mesh-ancestor
153403660|NCT03110926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153863300|NCT05125796|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153863301|NCT05125796|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153863302|NCT05125796|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153403788|NCT02525692|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153403790|NCT02514382|Dexamethasone acetate|dexamethasone acetate|mesh-list
153403791|NCT02514382|Bortezomib|bortezomib|mesh-list
153863419|NCT04713371|Immunologic Factors|immunologic factors|mesh-ancestor
153403802|NCT02514382|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153863619|NCT02104388|Ophthalmic Solutions|ophthalmic solutions|mesh-list
153863620|NCT04633044|Betaine|betaine|mesh-list
153863621|NCT04633044|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153863622|NCT04633044|Lipotropic Agents|lipotropic agents|mesh-ancestor
153863623|NCT04633044|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153863624|NCT04633044|Antimetabolites|antimetabolites|mesh-ancestor
153863625|NCT04633044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153863626|NCT04633044|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153863627|NCT04611438|Cannabidiol|cannabidiol|mesh-list
153863628|NCT04611438|Anticonvulsants|anticonvulsants|mesh-ancestor
153863629|NCT00563823|Vatalanib|vatalanib|mesh-list
153863630|NCT00563823|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153863631|NCT00563823|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153863632|NCT00563823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153863633|NCT00563862|Fluorouracil|fluorouracil|mesh-list
153863634|NCT00563862|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153863635|NCT00563862|Antimetabolites|antimetabolites|mesh-ancestor
153404016|NCT01476787|Growth Substances|growth substances|mesh-ancestor
153863636|NCT00563862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153863637|NCT00563862|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153863638|NCT00563862|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153863639|NCT00563862|Immunologic Factors|immunologic factors|mesh-ancestor
153863640|NCT00563862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153863671|NCT02081300|Testosterone|testosterone|mesh-list
153863672|NCT02081300|Testosterone undecanoate|testosterone undecanoate|mesh-list
153863673|NCT02081300|Testosterone enanthate|testosterone enanthate|mesh-list
153358338|NCT01309451|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153863674|NCT02081300|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
153863675|NCT02081300|Androgens|androgens|mesh-ancestor
153863676|NCT02081300|Hormones|hormones|mesh-ancestor
153863677|NCT02081300|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153863689|NCT02072954|Asenapine|asenapine|mesh-list
153863690|NCT02072954|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153863691|NCT02072954|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153863692|NCT02072954|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153404081|NCT00571714|Antimetabolites|antimetabolites|mesh-ancestor
153863720|NCT02057315|Analgesics|analgesics|mesh-ancestor
153863721|NCT02057315|Sensory System Agents|sensory system agents|mesh-ancestor
153863866|NCT01165138|Respiratory System Agents|respiratory system agents|mesh-ancestor
153863867|NCT01165138|Dermatologic Agents|dermatologic agents|mesh-ancestor
153863868|NCT01165138|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
153863870|NCT00561054|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153863871|NCT00561054|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153863872|NCT04206358|Molgramostim|molgramostim|mesh-list
153863873|NCT04206358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153863874|NCT00561093|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
153404274|NCT02358889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153404275|NCT02358889|Growth Inhibitors|growth inhibitors|mesh-ancestor
153404276|NCT02358889|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153863962|NCT04610502|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
153863963|NCT04610502|Antibodies|antibodies|mesh-list
153358347|NCT00771056|Hydroxychloroquine|hydroxychloroquine|mesh-list
153358348|NCT00771056|Antimalarials|antimalarials|mesh-ancestor
153358349|NCT00771056|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153358350|NCT00771056|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153358351|NCT00771056|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153358352|NCT00771056|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153358353|NCT00771056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153358354|NCT00771056|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153358355|NCT00795002|Cytarabine|cytarabine|mesh-list
153358356|NCT00795002|Mitoxantrone|mitoxantrone|mesh-list
153358357|NCT00795002|Alvocidib|alvocidib|mesh-list
153358358|NCT00795002|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153358359|NCT00795002|Antimetabolites|antimetabolites|mesh-ancestor
153887585|NCT02890719|Grazoprevir|grazoprevir|mesh-list
153887586|NCT02890719|Antimetabolites|antimetabolites|mesh-ancestor
153887587|NCT02890719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153887588|NCT02890719|Antiviral Agents|antiviral agents|mesh-ancestor
153887589|NCT02890719|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153887590|NCT04325061|Dexamethasone|dexamethasone|mesh-list
153887591|NCT04325061|Dexamethasone acetate|dexamethasone acetate|mesh-list
153887592|NCT04325061|BB 1101|bb 1101|mesh-list
153887593|NCT04325061|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153887594|NCT04325061|Antiemetics|antiemetics|mesh-ancestor
153887595|NCT04325061|Autonomic Agents|autonomic agents|mesh-ancestor
153428643|NCT00002420|Didanosine|didanosine|mesh-list
153863964|NCT04610502|Immunologic Factors|immunologic factors|mesh-ancestor
153863965|NCT04610502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153863966|NCT01164475|Plerixafor|plerixafor|mesh-list
153863967|NCT01164475|Lenograstim|lenograstim|mesh-list
153863975|NCT01164007|Bevacizumab|bevacizumab|mesh-list
153404419|NCT02112578|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
153404420|NCT00358280|Bupivacaine|bupivacaine|mesh-list
153404479|NCT05718661|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153404528|NCT02385097|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153404529|NCT02385097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153404530|NCT02385097|Sensory System Agents|sensory system agents|mesh-ancestor
153404531|NCT02385097|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153404532|NCT02387359|Plecanatide|plecanatide|mesh-list
153404533|NCT02387359|Guanylyl Cyclase C Agonists|guanylyl cyclase c agonists|mesh-ancestor
153404534|NCT02387359|Enzyme Activators|enzyme activators|mesh-ancestor
153404535|NCT02387359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153404536|NCT02387359|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153404537|NCT00355459|Doxycycline|doxycycline|mesh-list
153404538|NCT00355459|Tetracycline|tetracycline|mesh-list
153404539|NCT00355459|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153404540|NCT00355459|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153404548|NCT02393677|Ropivacaine|ropivacaine|mesh-list
153864142|NCT01847573|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153864143|NCT01847573|Coccidiostats|coccidiostats|mesh-ancestor
153864144|NCT01847573|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153864145|NCT01847573|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153864146|NCT01847573|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153864147|NCT01847573|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
153864148|NCT01847573|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153864158|NCT04609254|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153864161|NCT04609254|Sensory System Agents|sensory system agents|mesh-ancestor
153864162|NCT04609254|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153864164|NCT04609254|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153864177|NCT01846481|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
153864178|NCT01846481|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
153864183|NCT01846481|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153404597|NCT01721876|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153404598|NCT01721876|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153404599|NCT01721876|Immunologic Factors|immunologic factors|mesh-ancestor
153404600|NCT01721876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153404601|NCT03224585|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
153404602|NCT03224585|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153404604|NCT03423641|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153404605|NCT01112072|Riboflavin|riboflavin|mesh-list
153404606|NCT01112072|Vitamin B Complex|vitamin b complex|mesh-ancestor
153404607|NCT01112072|Vitamins|vitamins|mesh-ancestor
153428649|NCT00002420|Antisickling Agents|antisickling agents|mesh-ancestor
153358360|NCT00795002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153358361|NCT00795002|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153358362|NCT00795002|Antiviral Agents|antiviral agents|mesh-ancestor
153358363|NCT00795002|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153358364|NCT00795002|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153358365|NCT00795002|Immunologic Factors|immunologic factors|mesh-ancestor
153358366|NCT00795002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153358367|NCT00795002|Analgesics|analgesics|mesh-ancestor
153404608|NCT01112072|Micronutrients|micronutrients|mesh-ancestor
153404609|NCT01112072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153404610|NCT01112072|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
153404611|NCT01112072|Dermatologic Agents|dermatologic agents|mesh-ancestor
153404612|NCT04825795|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
153404613|NCT04825795|Protease Inhibitors|protease inhibitors|mesh-ancestor
153864494|NCT01516346|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153864495|NCT01303796|Decitabine|decitabine|mesh-list
153864496|NCT01303796|Sapacitabine|sapacitabine|mesh-list
153864497|NCT01303796|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153864498|NCT01303796|Antimetabolites|antimetabolites|mesh-ancestor
153404894|NCT04706897|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153404895|NCT04706897|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153404896|NCT04706897|Adrenergic Agents|adrenergic agents|mesh-ancestor
153404897|NCT04706897|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153404898|NCT04706897|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
153404899|NCT04706897|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153404900|NCT04706897|Anesthetics, General|anesthetics, general|mesh-ancestor
153404905|NCT00003213|Metoclopramide|metoclopramide|mesh-list
153405028|NCT03441269|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153864693|NCT01162135|Digoxin|digoxin|mesh-list
153864725|NCT04314505|Analgesics|analgesics|mesh-ancestor
153405289|NCT03279731|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153358380|NCT03802838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153358381|NCT03802838|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153358382|NCT03802838|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
153358383|NCT03802838|Dopamine Agents|dopamine agents|mesh-ancestor
153358384|NCT03802838|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153358385|NCT03802838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153358386|NCT03802838|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
153358387|NCT03802838|Antidepressive Agents|antidepressive agents|mesh-ancestor
153358388|NCT00772304|Azelastine|azelastine|mesh-list
153358389|NCT00772304|Olopatadine Hydrochloride|olopatadine hydrochloride|mesh-list
153358391|NCT00772304|Autonomic Agents|autonomic agents|mesh-ancestor
153405290|NCT03279731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153405291|NCT03279731|Incretins|incretins|mesh-ancestor
153405292|NCT03279731|Hormones|hormones|mesh-ancestor
153405293|NCT03279731|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153405762|NCT05920980|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
153405764|NCT05920980|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153405765|NCT05920980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153405767|NCT05920928|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153405768|NCT05920928|Antimetabolites|antimetabolites|mesh-ancestor
153405769|NCT05920928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153405770|NCT05920928|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153405771|NCT05920889|Semaglutide|semaglutide|mesh-list
153405773|NCT05920889|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153865363|NCT00565383|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153865364|NCT00565383|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153865366|NCT00565383|Anesthetics|anesthetics|mesh-ancestor
153865367|NCT04625426|Protective Agents|protective agents|mesh-list
153865368|NCT04625426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153865369|NCT04625114|Gabexate|gabexate|mesh-list
153865370|NCT04625114|Camostat|camostat|mesh-list
153865371|NCT04625114|Protease Inhibitors|protease inhibitors|mesh-ancestor
153865372|NCT04625114|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153865376|NCT04625114|Anticoagulants|anticoagulants|mesh-ancestor
153865448|NCT00567411|Brimonidine Tartrate|brimonidine tartrate|mesh-list
153865449|NCT00567411|Apraclonidine|apraclonidine|mesh-list
153865450|NCT00567411|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153865451|NCT00567411|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
153865452|NCT00567411|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153865453|NCT00567411|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153865454|NCT00567411|Adrenergic Agents|adrenergic agents|mesh-ancestor
153865455|NCT00567411|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153865456|NCT00567411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153865457|NCT00567411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153865459|NCT00562172|Insulin Glargine|insulin glargine|mesh-list
153358406|NCT00772304|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153358407|NCT00772304|Analgesics|analgesics|mesh-ancestor
153865460|NCT00562172|Glimepiride|glimepiride|mesh-list
153865461|NCT00562172|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153865462|NCT00562172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153865463|NCT00562172|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153865464|NCT00562172|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153865465|NCT00562172|Immunologic Factors|immunologic factors|mesh-ancestor
153405878|NCT05857514|Gout Suppressants|gout suppressants|mesh-ancestor
153405879|NCT05857514|Tocolytic Agents|tocolytic agents|mesh-ancestor
153405880|NCT05857514|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153405881|NCT05857514|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153405882|NCT05857514|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153405883|NCT05857514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153865632|NCT04622891|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
153865633|NCT04622891|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153865634|NCT04622579|Rituximab|rituximab|mesh-list
153865635|NCT04622579|Lenalidomide|lenalidomide|mesh-list
153865636|NCT04622579|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153865637|NCT04622579|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153865638|NCT04622579|Immunologic Factors|immunologic factors|mesh-ancestor
153865639|NCT04622579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153406058|NCT05558150|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153406157|NCT05237297|Aceclofenac|aceclofenac|mesh-list
153865722|NCT01151410|Enalapril|enalapril|mesh-list
153358425|NCT01338857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153358426|NCT01339013|Anesthetics|anesthetics|mesh-list
153358427|NCT01339013|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153358428|NCT01339013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153358429|NCT01339091|Vancomycin|vancomycin|mesh-list
153865723|NCT01151410|Aliskiren|aliskiren|mesh-list
153865727|NCT01151410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153406176|NCT05216952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153406249|NCT05103904|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153406250|NCT05103904|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153865807|NCT01151215|Anastrozole|anastrozole|mesh-list
153406401|NCT04608539|Iron isomaltoside 1000|iron isomaltoside 1000|mesh-list
153866314|NCT04616261|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
153866315|NCT04616261|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153866316|NCT04616261|Adrenergic Agents|adrenergic agents|mesh-ancestor
153866317|NCT04616261|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153866318|NCT04616261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153866319|NCT00563225|Insulin Glargine|insulin glargine|mesh-list
153866320|NCT00563225|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153866321|NCT00563225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153866322|NCT00571116|Arsenic Trioxide|arsenic trioxide|mesh-list
153406777|NCT03829371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153406778|NCT03829371|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153406779|NCT03829371|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153406781|NCT03785964|Gamma Secretase Inhibitors and Modulators|gamma secretase inhibitors and modulators|mesh-ancestor
153406782|NCT03785964|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153406783|NCT03785964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153866382|NCT00563342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153866384|NCT04583046|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153866386|NCT04582929|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
153866387|NCT04582929|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
153866388|NCT04582929|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153866389|NCT04582929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153866393|NCT04582929|Cholinergic Agents|cholinergic agents|mesh-ancestor
153406890|NCT03568318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153406892|NCT03550794|Thiamine|thiamine|mesh-list
153406893|NCT03550794|Vitamins|vitamins|mesh-ancestor
153406894|NCT03550794|Micronutrients|micronutrients|mesh-ancestor
153406895|NCT03550794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153406896|NCT03550794|Vitamin B Complex|vitamin b complex|mesh-ancestor
153406897|NCT03456102|Pravastatin|pravastatin|mesh-list
153406898|NCT03456102|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153406899|NCT03456102|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153406900|NCT03456102|Antimetabolites|antimetabolites|mesh-ancestor
153406952|NCT03243552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153406954|NCT03242278|Rivaroxaban|rivaroxaban|mesh-list
153866506|NCT00563771|Gout Suppressants|gout suppressants|mesh-ancestor
153866507|NCT00563771|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153866508|NCT04582032|Dexketoprofen trometamol|dexketoprofen trometamol|mesh-list
153887636|NCT01080391|Growth Substances|growth substances|mesh-ancestor
153887637|NCT01080391|Growth Inhibitors|growth inhibitors|mesh-ancestor
153887638|NCT01070329|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
153887639|NCT01070329|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
153887640|NCT01070329|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153887641|NCT01070329|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153887642|NCT01070329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153887643|NCT01070329|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153887644|NCT01070329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153866509|NCT04582032|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153866510|NCT04582032|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153866511|NCT04582032|Analgesics|analgesics|mesh-ancestor
153866512|NCT04582032|Sensory System Agents|sensory system agents|mesh-ancestor
153866513|NCT04582032|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153866515|NCT04582032|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153866516|NCT04582032|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153866518|NCT00563849|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153866519|NCT00563849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153866520|NCT00563849|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153866521|NCT00563849|Immunologic Factors|immunologic factors|mesh-ancestor
153866522|NCT00563849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153866523|NCT04581876|Paclitaxel|paclitaxel|mesh-list
153866524|NCT04581876|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
153866653|NCT00575523|Parasympatholytics|parasympatholytics|mesh-ancestor
153866654|NCT00575523|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
153866655|NCT00575523|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
153866656|NCT00575523|Cholinergic Agents|cholinergic agents|mesh-ancestor
153866657|NCT00575523|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153866658|NCT00575523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153866660|NCT01149421|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
153866661|NCT01149421|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153866662|NCT01149421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153866663|NCT00575601|Simvastatin|simvastatin|mesh-list
153866664|NCT00575601|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153866665|NCT00575601|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153866666|NCT00575601|Antimetabolites|antimetabolites|mesh-ancestor
153407111|NCT02359175|Anesthetics, Local|anesthetics, local|mesh-ancestor
153407112|NCT02359175|Anesthetics|anesthetics|mesh-ancestor
153407121|NCT02359175|Anesthetics, General|anesthetics, general|mesh-ancestor
153407122|NCT02359175|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153407123|NCT02359175|Antipyretics|antipyretics|mesh-ancestor
153407124|NCT02215980|Dexamethasone|dexamethasone|mesh-list
153407125|NCT02215980|Lenalidomide|lenalidomide|mesh-list
153358476|NCT00773786|Autonomic Agents|autonomic agents|mesh-ancestor
153407126|NCT02215980|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153407127|NCT02215980|Antiemetics|antiemetics|mesh-ancestor
153407128|NCT02215980|Autonomic Agents|autonomic agents|mesh-ancestor
153407129|NCT02215980|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153407130|NCT02215980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153407131|NCT02215980|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153407132|NCT02215980|Glucocorticoids|glucocorticoids|mesh-ancestor
153866782|NCT00565682|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153866783|NCT00565682|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153866784|NCT00565682|Analgesics|analgesics|mesh-ancestor
153866785|NCT00565682|Sensory System Agents|sensory system agents|mesh-ancestor
153866786|NCT00565682|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153866787|NCT00565682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153866788|NCT00565682|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153866789|NCT00565682|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153866790|NCT00565682|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
153866791|NCT00565682|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153866792|NCT00565682|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153866794|NCT00575952|Paclitaxel|paclitaxel|mesh-list
153866801|NCT00575952|Mitosis Modulators|mitosis modulators|mesh-ancestor
153866802|NCT00575952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153866803|NCT00575952|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153866804|NCT00575952|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153866805|NCT00575952|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153866806|NCT00575952|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153866807|NCT00573417|Modafinil|modafinil|mesh-list
153358479|NCT00773786|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153358480|NCT00773786|Respiratory System Agents|respiratory system agents|mesh-ancestor
153358481|NCT00773786|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
153358482|NCT00773786|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
153358483|NCT00773786|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153358484|NCT00773786|Adrenergic Agents|adrenergic agents|mesh-ancestor
153358485|NCT00773786|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153358486|NCT00773786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153358488|NCT01258049|Quinine|quinine|mesh-list
153358489|NCT01258049|Antimalarials|antimalarials|mesh-ancestor
153358490|NCT01258049|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153358491|NCT01258049|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153358492|NCT01258049|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153358493|NCT01258049|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
153358494|NCT01258049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153358495|NCT01258049|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
153358497|NCT01258049|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153358499|NCT01258049|Sensory System Agents|sensory system agents|mesh-ancestor
153887659|NCT04327427|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153887660|NCT04327427|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153866808|NCT00573417|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
153866816|NCT00573495|Protease Inhibitors|protease inhibitors|mesh-ancestor
153866817|NCT00573495|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153866818|NCT00573495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153866819|NCT00565955|Montelukast|montelukast|mesh-list
153866820|NCT00565955|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153866821|NCT00565955|Respiratory System Agents|respiratory system agents|mesh-ancestor
153866822|NCT00565955|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
153866823|NCT00565955|Hormone Antagonists|hormone antagonists|mesh-ancestor
153407332|NCT01124695|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
153407333|NCT01124695|Hormone Antagonists|hormone antagonists|mesh-ancestor
153407334|NCT01124695|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153407335|NCT01124695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153407336|NCT01124695|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153407337|NCT01124695|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153407338|NCT01124695|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
153407339|NCT01124695|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
153866859|NCT00576225|Mitosis Modulators|mitosis modulators|mesh-ancestor
153866860|NCT00576225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153866861|NCT04597931|Zoledronic Acid|zoledronic acid|mesh-list
153866862|NCT04597931|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153866863|NCT04597931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153866864|NCT00576459|Fluocinolone Acetonide|fluocinolone acetonide|mesh-list
153866865|NCT00576459|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153866866|NCT00576459|Glucocorticoids|glucocorticoids|mesh-ancestor
153866867|NCT00576459|Hormones|hormones|mesh-ancestor
153866870|NCT04597775|Hydroxychloroquine|hydroxychloroquine|mesh-list
153407360|NCT01079780|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153407361|NCT01079780|Growth Substances|growth substances|mesh-ancestor
153407362|NCT01079780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153358500|NCT03802214|Vedolizumab|vedolizumab|mesh-list
153358501|NCT03802214|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153358502|NCT03801746|Cyclosporine|cyclosporine|mesh-list
153358503|NCT03801746|Rifampin|rifampin|mesh-list
153866952|NCT00577161|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153866953|NCT00577161|Immunologic Factors|immunologic factors|mesh-ancestor
153866956|NCT00577161|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153866959|NCT00577161|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153866981|NCT04595942|Autonomic Agents|autonomic agents|mesh-ancestor
153866982|NCT04595942|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153866983|NCT04595942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153866984|NCT04595942|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
153866985|NCT04595942|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
153866986|NCT04595942|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153866987|NCT04595942|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153866988|NCT04595942|Adrenergic Agents|adrenergic agents|mesh-ancestor
153866989|NCT04595942|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153866990|NCT04595942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153407458|NCT00316888|Cisplatin|cisplatin|mesh-list
153867010|NCT04595318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153867011|NCT04595318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153867013|NCT00577668|Dexamethasone|dexamethasone|mesh-list
153867014|NCT00577668|Melphalan|melphalan|mesh-list
153867015|NCT00577668|Bortezomib|bortezomib|mesh-list
153867016|NCT00577668|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153867017|NCT00577668|Antiemetics|antiemetics|mesh-ancestor
153867023|NCT00577668|Hormones|hormones|mesh-ancestor
153407540|NCT00104884|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153867150|NCT00566891|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153407615|NCT00060346|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153407616|NCT00060346|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153407617|NCT00060346|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153407618|NCT00060346|Tubulin Modulators|tubulin modulators|mesh-ancestor
153407619|NCT00060346|Antimitotic Agents|antimitotic agents|mesh-ancestor
153407620|NCT00060346|Mitosis Modulators|mitosis modulators|mesh-ancestor
153407621|NCT00057954|Cyclosporine|cyclosporine|mesh-list
153407622|NCT00057954|Mycophenolic Acid|mycophenolic acid|mesh-list
153407623|NCT00057954|Methotrexate|methotrexate|mesh-list
153358525|NCT03801746|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
153358526|NCT03801746|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
153428755|NCT02487277|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153428756|NCT02487277|Tubulin Modulators|tubulin modulators|mesh-ancestor
153428757|NCT02487277|Antimitotic Agents|antimitotic agents|mesh-ancestor
153358527|NCT03801746|Uricosuric Agents|uricosuric agents|mesh-ancestor
153428758|NCT02487277|Mitosis Modulators|mitosis modulators|mesh-ancestor
153428759|NCT02487277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153428760|NCT02487277|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153407624|NCT00057954|Pentostatin|pentostatin|mesh-list
153407625|NCT00057954|Cyclosporins|cyclosporins|mesh-list
153407693|NCT00033657|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153407701|NCT00003389|Prednisone|prednisone|mesh-list
153867254|NCT00580242|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153867255|NCT04591457|Insulin|insulin|mesh-list
153867256|NCT04591457|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
153867267|NCT00580359|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153867268|NCT00580359|Antimetabolites|antimetabolites|mesh-ancestor
153867269|NCT00580359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153867270|NCT00580359|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153867271|NCT00580827|Disulfiram|disulfiram|mesh-list
153867307|NCT04590638|Sympathomimetics|sympathomimetics|mesh-ancestor
153867308|NCT04590638|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
153867309|NCT00567554|Paclitaxel|paclitaxel|mesh-list
153867310|NCT00567554|Docetaxel|docetaxel|mesh-list
153867311|NCT00567554|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
153867312|NCT00567554|Cyclophosphamide|cyclophosphamide|mesh-list
153867313|NCT00567554|Bevacizumab|bevacizumab|mesh-list
153867314|NCT00567554|Trastuzumab|trastuzumab|mesh-list
153867315|NCT00567554|Everolimus|everolimus|mesh-list
153867316|NCT00567554|Epirubicin|epirubicin|mesh-list
153867317|NCT00567554|Lapatinib|lapatinib|mesh-list
153867718|NCT00567060|Nootropic Agents|nootropic agents|mesh-ancestor
153867720|NCT00568217|Ibuprofen|ibuprofen|mesh-list
153408407|NCT03675581|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
153408408|NCT03675581|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
153408409|NCT03675581|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
153408410|NCT03675581|Contraceptives, Postcoital, Hormonal|contraceptives, postcoital, hormonal|mesh-ancestor
153408411|NCT03675581|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
153867997|NCT00570440|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
153867998|NCT00570440|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
153867999|NCT00570440|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
153868000|NCT00570479|Anecortave|anecortave|mesh-list
153868001|NCT00570479|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153868002|NCT00570479|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153868003|NCT00570479|Growth Substances|growth substances|mesh-ancestor
153868004|NCT00570479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153868005|NCT00570479|Growth Inhibitors|growth inhibitors|mesh-ancestor
153868037|NCT04580342|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153868038|NCT04580342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153868039|NCT04580342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153868040|NCT04580342|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153868041|NCT04580342|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153868042|NCT04580342|Vasodilator Agents|vasodilator agents|mesh-ancestor
153868043|NCT00571142|Bevacizumab|bevacizumab|mesh-list
153868123|NCT00571298|Sequestering Agents|sequestering agents|mesh-ancestor
153868124|NCT00571337|Infliximab|infliximab|mesh-list
153868183|NCT02883556|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153868184|NCT02883556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153868185|NCT00585000|Tremelimumab|tremelimumab|mesh-list
153868186|NCT00585000|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153408684|NCT04968522|Dextroamphetamine|dextroamphetamine|mesh-list
153408685|NCT04968522|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
153408686|NCT04968522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153408687|NCT04968522|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
153408688|NCT04968522|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153408689|NCT04968522|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153408690|NCT04968522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153408724|NCT02974712|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153408725|NCT02974712|Anesthetics, General|anesthetics, general|mesh-ancestor
153408726|NCT02974712|Anesthetics|anesthetics|mesh-ancestor
153408727|NCT02974556|Capecitabine|capecitabine|mesh-list
153408728|NCT02974556|Oxaliplatin|oxaliplatin|mesh-list
153408729|NCT02974556|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153408730|NCT02974556|Antimetabolites|antimetabolites|mesh-ancestor
153408731|NCT02974556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153408741|NCT03557333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153408744|NCT03557333|Sensory System Agents|sensory system agents|mesh-ancestor
153408745|NCT03557333|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153408747|NCT04818450|Analgesics|analgesics|mesh-ancestor
153408748|NCT04818450|Sensory System Agents|sensory system agents|mesh-ancestor
153408749|NCT04818450|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153408750|NCT04818450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153408751|NCT04818450|Anticonvulsants|anticonvulsants|mesh-ancestor
153408752|NCT04818450|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153408753|NCT04818450|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153408754|NCT04818450|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153408755|NCT04818450|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153408756|NCT04818450|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
153408757|NCT04818450|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
153408758|NCT04818450|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153408853|NCT01638000|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
153408854|NCT01638000|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
153408855|NCT01638000|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153408856|NCT01638000|Adrenergic Agents|adrenergic agents|mesh-ancestor
153408857|NCT04023695|Lidocaine|lidocaine|mesh-list
153408858|NCT04023695|Epinephrine|epinephrine|mesh-list
153408859|NCT04023695|Anesthetics, Local|anesthetics, local|mesh-ancestor
153408860|NCT04023695|Anesthetics|anesthetics|mesh-ancestor
153408861|NCT04023695|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153408874|NCT04023695|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
153408875|NCT04023695|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153408877|NCT04023695|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153408882|NCT04211909|Sofosbuvir|sofosbuvir|mesh-list
153868485|NCT00586365|Sensory System Agents|sensory system agents|mesh-ancestor
153868486|NCT00586365|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153868487|NCT00586365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153868488|NCT00586365|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153868489|NCT00586365|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153409000|NCT03504410|Antiviral Agents|antiviral agents|mesh-ancestor
153868544|NCT00586560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153868546|NCT00586560|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153868547|NCT00586560|Alkylating Agents|alkylating agents|mesh-ancestor
153868548|NCT00586560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153868549|NCT00586560|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153868550|NCT00586560|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153868551|NCT00574964|Temozolomide|temozolomide|mesh-list
153868552|NCT00574964|Carmustine|carmustine|mesh-list
153868553|NCT00574964|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153868554|NCT00574964|Alkylating Agents|alkylating agents|mesh-ancestor
153868556|NCT00574964|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153868652|NCT01137604|Bevacizumab|bevacizumab|mesh-list
153868653|NCT01137604|Lenvatinib|lenvatinib|mesh-list
153868654|NCT01137604|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153868655|NCT01137604|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153868656|NCT01137604|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153868657|NCT01137604|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153868675|NCT00198822|Antioxidants|antioxidants|mesh-ancestor
153868676|NCT00198822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153868703|NCT01137292|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153868704|NCT01137292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153868705|NCT01137292|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153409377|NCT00359125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153409378|NCT00359125|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
153868883|NCT00195507|Etanercept|etanercept|mesh-list
153409498|NCT04802382|Fibrin fragment D|fibrin fragment d|mesh-list
153409499|NCT04802382|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
153409500|NCT04802382|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153358556|NCT02199041|Methylprednisolone|methylprednisolone|mesh-list
153358557|NCT02199041|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
153358558|NCT02199041|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
153409501|NCT04802382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153869188|NCT04607525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153869189|NCT04607525|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153869190|NCT04607525|Analgesics|analgesics|mesh-ancestor
153869191|NCT04607525|Sensory System Agents|sensory system agents|mesh-ancestor
153869192|NCT04607525|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153869193|NCT04607525|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
153869194|NCT04607525|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153409893|NCT05496894|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153409894|NCT05496894|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153409895|NCT05496894|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153409897|NCT05496894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153409898|NCT02021604|Dihydroxyphenylalanine|dihydroxyphenylalanine|mesh-list
153409899|NCT02021604|Dopamine Agents|dopamine agents|mesh-ancestor
153409900|NCT02021604|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153409901|NCT02021604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153409902|NCT02021604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153869377|NCT04604054|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
153869378|NCT04604054|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153869379|NCT04604054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153869380|NCT00476229|Rituximab|rituximab|mesh-list
153869381|NCT00476229|Thymoglobulin|thymoglobulin|mesh-list
153869382|NCT00476229|Antilymphocyte Serum|antilymphocyte serum|mesh-list
153869383|NCT00476229|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153869384|NCT00476229|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153410055|NCT00003423|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153410056|NCT00003423|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153410057|NCT00003423|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153410058|NCT00003423|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153410059|NCT00003423|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153887791|NCT00595985|Sorafenib|sorafenib|mesh-list
153869494|NCT00565253|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153869574|NCT00473694|Rocuronium|rocuronium|mesh-list
153869575|NCT00473694|Vecuronium Bromide|vecuronium bromide|mesh-list
153410110|NCT04329585|GABA Agents|gaba agents|mesh-ancestor
153410111|NCT04329585|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153410112|NCT04329585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153410113|NCT00003279|Antibodies|antibodies|mesh-list
153410114|NCT00003279|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
153410115|NCT00003279|BCG Vaccine|bcg vaccine|mesh-list
153410116|NCT00003279|Immunologic Factors|immunologic factors|mesh-ancestor
153410117|NCT00003279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153869584|NCT00473694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153869585|NCT00473694|Cholinergic Agents|cholinergic agents|mesh-ancestor
153410189|NCT00002805|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153869649|NCT04571151|Dermatologic Agents|dermatologic agents|mesh-ancestor
153869650|NCT04571151|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
153869651|NCT01133977|Lenvatinib|lenvatinib|mesh-list
153869652|NCT01133977|Dacarbazine|dacarbazine|mesh-list
153869653|NCT01133977|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153869654|NCT01133977|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153869655|NCT01133977|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153869656|NCT01133977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153869657|NCT01133977|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153869684|NCT00583271|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153410224|NCT00003447|Tubulin Modulators|tubulin modulators|mesh-ancestor
153410225|NCT00003447|Antimitotic Agents|antimitotic agents|mesh-ancestor
153410226|NCT00003447|Mitosis Modulators|mitosis modulators|mesh-ancestor
153410227|NCT00003315|Amphotericin B|amphotericin b|mesh-list
153410228|NCT00003315|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
153410229|NCT00003315|Sargramostim|sargramostim|mesh-list
153410230|NCT00003315|Immunologic Factors|immunologic factors|mesh-ancestor
153410231|NCT00003315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153410232|NCT00003315|Amebicides|amebicides|mesh-ancestor
153410233|NCT00003315|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153410234|NCT00003315|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153410235|NCT00003315|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153410245|NCT00003465|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153410247|NCT00002823|Vinorelbine|vinorelbine|mesh-list
153410248|NCT00002823|Vinblastine|vinblastine|mesh-list
153410249|NCT00002823|Vindesine|vindesine|mesh-list
153410250|NCT00002823|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153410251|NCT00002823|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153410284|NCT00361621|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153410285|NCT00361621|Tubulin Modulators|tubulin modulators|mesh-ancestor
153410286|NCT00361621|Antimitotic Agents|antimitotic agents|mesh-ancestor
153410287|NCT00361621|Mitosis Modulators|mitosis modulators|mesh-ancestor
153410288|NCT00003327|Paclitaxel|paclitaxel|mesh-list
153869743|NCT02882893|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153869744|NCT02882893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153869745|NCT02882893|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
153869746|NCT02882893|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153869747|NCT02882893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153869748|NCT02882893|Cholinergic Agents|cholinergic agents|mesh-ancestor
153410295|NCT00003339|Interleukin-12|interleukin-12|mesh-list
153410296|NCT00003339|Freund's Adjuvant|freund's adjuvant|mesh-list
153410297|NCT00003339|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153410298|NCT00003339|Immunologic Factors|immunologic factors|mesh-ancestor
153410299|NCT00003339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153410300|NCT00003339|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153410301|NCT00003339|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153410302|NCT00003339|Growth Substances|growth substances|mesh-ancestor
153410303|NCT00003339|Growth Inhibitors|growth inhibitors|mesh-ancestor
153410322|NCT00002829|Antiviral Agents|antiviral agents|mesh-ancestor
153410323|NCT00002829|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153410325|NCT03614221|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153410326|NCT03614221|Immunologic Factors|immunologic factors|mesh-ancestor
153410327|NCT03614221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153410328|NCT03614221|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
153869781|NCT04570449|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153869782|NCT04570449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153869783|NCT04570449|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153869784|NCT04570449|Serotonin Agents|serotonin agents|mesh-ancestor
153869792|NCT00470847|Trastuzumab|trastuzumab|mesh-list
153410404|NCT00002835|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
153410405|NCT00002835|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153410406|NCT00002835|Analgesics|analgesics|mesh-ancestor
153869859|NCT04570254|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153869860|NCT04570254|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153869861|NCT04570254|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
153869862|NCT04570254|Vasodilator Agents|vasodilator agents|mesh-ancestor
153869863|NCT04570254|Free Radical Scavengers|free radical scavengers|mesh-ancestor
153869864|NCT04570254|Antiviral Agents|antiviral agents|mesh-ancestor
153869865|NCT04570254|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153869866|NCT04570254|Expectorants|expectorants|mesh-ancestor
153869867|NCT04570254|Respiratory System Agents|respiratory system agents|mesh-ancestor
153869868|NCT04570254|Antidotes|antidotes|mesh-ancestor
153410426|NCT00002847|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153410427|NCT00002847|Immunologic Factors|immunologic factors|mesh-ancestor
153410428|NCT00002847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153410429|NCT00002847|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153410430|NCT00002847|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153410492|NCT00002865|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153410493|NCT00002865|Antimetabolites|antimetabolites|mesh-ancestor
153410494|NCT00002865|Dermatologic Agents|dermatologic agents|mesh-ancestor
153410495|NCT00002865|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153410510|NCT00361309|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153410511|NCT00361309|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153410512|NCT00361309|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153410525|NCT00361387|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
153410526|NCT00361387|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153410527|NCT00361387|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153410528|NCT00361387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153410530|NCT00361387|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153410531|NCT00003369|Tirapazamine|tirapazamine|mesh-list
153410532|NCT00003369|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153410533|NCT04342351|Valsartan|valsartan|mesh-list
153410534|NCT04342351|Perindopril|perindopril|mesh-list
153410535|NCT04342351|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
153410536|NCT04342351|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153410537|NCT04342351|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
153410538|NCT04342351|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
153410539|NCT04342351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153870054|NCT01088529|Prednisone|prednisone|mesh-list
153870055|NCT01088529|Leuprolide|leuprolide|mesh-list
153870056|NCT01088529|Goserelin|goserelin|mesh-list
153870057|NCT01088529|Abiraterone Acetate|abiraterone acetate|mesh-list
153870058|NCT01088529|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153870059|NCT01088529|Glucocorticoids|glucocorticoids|mesh-ancestor
153870060|NCT01088529|Hormones|hormones|mesh-ancestor
153870061|NCT01088529|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153870062|NCT01088529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153870063|NCT01088529|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153410632|NCT03492463|Nicotine|nicotine|mesh-list
153870102|NCT04312204|Carboplatin|carboplatin|mesh-list
153870103|NCT04312204|Gemcitabine|gemcitabine|mesh-list
153870104|NCT04312204|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153870105|NCT04312204|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153870106|NCT04312204|Antimetabolites|antimetabolites|mesh-ancestor
153870107|NCT04312204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153870108|NCT04312282|Itraconazole|itraconazole|mesh-list
153870109|NCT04312282|Rifampin|rifampin|mesh-list
153870110|NCT04312282|Antifungal Agents|antifungal agents|mesh-ancestor
153870111|NCT04312282|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153870112|NCT04312282|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
153870113|NCT04312282|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153870114|NCT04312282|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153870115|NCT04312282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153410683|NCT00004833|Immunoglobulins|immunoglobulins|mesh-list
153410684|NCT00004833|Antibodies|antibodies|mesh-list
153410685|NCT00004833|gamma-Globulins|gamma-globulins|mesh-list
153410686|NCT00004833|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
153410687|NCT00004833|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
153410688|NCT00004833|Immunologic Factors|immunologic factors|mesh-ancestor
153410689|NCT00004833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153410691|NCT00003555|Amifostine|amifostine|mesh-list
153410693|NCT00003555|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153410694|NCT00003555|Tubulin Modulators|tubulin modulators|mesh-ancestor
153410695|NCT00003555|Antimitotic Agents|antimitotic agents|mesh-ancestor
153410696|NCT00003555|Mitosis Modulators|mitosis modulators|mesh-ancestor
153410697|NCT00003555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153410698|NCT00003555|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
153410699|NCT00003555|Protective Agents|protective agents|mesh-ancestor
153410700|NCT00003555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153410701|NCT00003963|Rituximab|rituximab|mesh-list
153410702|NCT00003963|Vinorelbine|vinorelbine|mesh-list
153410703|NCT00003963|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153410704|NCT00003963|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153410705|NCT00003963|Immunologic Factors|immunologic factors|mesh-ancestor
153410706|NCT00003963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153410707|NCT00003963|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153410784|NCT00003567|Alkylating Agents|alkylating agents|mesh-ancestor
153410785|NCT00003567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153410786|NCT00003567|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153410787|NCT00003567|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153410799|NCT00003573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153410800|NCT00003573|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153410801|NCT00003573|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153410802|NCT00003573|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153410803|NCT00003573|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153410804|NCT00003573|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153870283|NCT00588302|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153870287|NCT01084005|Incretins|incretins|mesh-ancestor
153410945|NCT00004011|Antimitotic Agents|antimitotic agents|mesh-ancestor
153410946|NCT00004011|Mitosis Modulators|mitosis modulators|mesh-ancestor
153410947|NCT00004011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153410948|NCT00004017|Antibodies|antibodies|mesh-list
153410949|NCT00004017|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
153410950|NCT00004017|Immunologic Factors|immunologic factors|mesh-ancestor
153410951|NCT00004017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153410952|NCT00004905|Interferons|interferons|mesh-list
153410953|NCT00004905|Cytarabine|cytarabine|mesh-list
153410954|NCT00004905|Interferon-alpha|interferon-alpha|mesh-list
153410955|NCT00004905|Cyclophosphamide|cyclophosphamide|mesh-list
153870449|NCT03452345|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
153870450|NCT03452345|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153870451|NCT03452345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153870453|NCT03452345|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153870454|NCT03452306|Metformin|metformin|mesh-list
153870455|NCT03452306|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153870456|NCT03452306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153870457|NCT01080300|Gabapentin|gabapentin|mesh-list
153870488|NCT01085097|Prednisolone acetate|prednisolone acetate|mesh-list
153870489|NCT01085097|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
153870490|NCT01085097|Prednisolone phosphate|prednisolone phosphate|mesh-list
153870491|NCT01085097|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153870492|NCT01085097|Glucocorticoids|glucocorticoids|mesh-ancestor
153411077|NCT00003639|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153411078|NCT00003639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153411079|NCT00003639|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153411080|NCT00003639|Alkylating Agents|alkylating agents|mesh-ancestor
153411117|NCT00004077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153411118|NCT00004077|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153411119|NCT00004077|Alkylating Agents|alkylating agents|mesh-ancestor
153411120|NCT00004083|Cisplatin|cisplatin|mesh-list
153411121|NCT00004083|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153870521|NCT04567290|Ticagrelor|ticagrelor|mesh-list
153870522|NCT04567290|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153870523|NCT04567290|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
153870524|NCT04567290|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
153870525|NCT04567290|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
153870526|NCT04567290|Purinergic Agents|purinergic agents|mesh-ancestor
153888969|NCT01294449|Autonomic Agents|autonomic agents|mesh-ancestor
153888970|NCT01294449|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153888971|NCT01294449|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153888972|NCT01294449|Glucocorticoids|glucocorticoids|mesh-ancestor
153888973|NCT01294449|Hormones|hormones|mesh-ancestor
153870527|NCT04567290|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153870528|NCT04567290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153870529|NCT04567290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153870530|NCT01084161|Morphine|morphine|mesh-list
153870531|NCT01084161|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153870532|NCT01084161|Narcotics|narcotics|mesh-ancestor
153870533|NCT01084161|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153870534|NCT01084161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153411122|NCT00004941|Infliximab|infliximab|mesh-list
153411123|NCT00004941|Antibodies|antibodies|mesh-list
153411124|NCT00004941|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
153411146|NCT00003657|Protective Agents|protective agents|mesh-ancestor
153411148|NCT00004089|Fluorouracil|fluorouracil|mesh-list
153411149|NCT00004089|Hydroxyurea|hydroxyurea|mesh-list
153411150|NCT00004089|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153411151|NCT00004089|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153411152|NCT00004089|Tubulin Modulators|tubulin modulators|mesh-ancestor
153411153|NCT00004089|Antimitotic Agents|antimitotic agents|mesh-ancestor
153411154|NCT00004089|Mitosis Modulators|mitosis modulators|mesh-ancestor
153358589|NCT02199041|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153358591|NCT02199041|Glucocorticoids|glucocorticoids|mesh-ancestor
153358593|NCT02199041|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153358594|NCT02199041|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
153887954|NCT00598169|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153887955|NCT00598169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153358595|NCT02199041|Protective Agents|protective agents|mesh-ancestor
153358596|NCT02199041|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153358597|NCT02199041|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153358598|NCT00789776|Mycophenolic Acid|mycophenolic acid|mesh-list
153358599|NCT00789776|Cyclophosphamide|cyclophosphamide|mesh-list
153411155|NCT00004089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153411156|NCT00004089|Antimetabolites|antimetabolites|mesh-ancestor
153411157|NCT00004089|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153411159|NCT00004089|Immunologic Factors|immunologic factors|mesh-ancestor
153870580|NCT03452267|Metformin|metformin|mesh-list
153870581|NCT03452267|Pioglitazone|pioglitazone|mesh-list
153870582|NCT03452267|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153870583|NCT03452267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153870586|NCT03451682|Procyanidin|procyanidin|mesh-list
153870587|NCT03451682|Antioxidants|antioxidants|mesh-ancestor
153870588|NCT03451682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153870589|NCT03451682|Protective Agents|protective agents|mesh-ancestor
153870590|NCT03451682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153870591|NCT04997382|Alectinib|alectinib|mesh-list
153870592|NCT04997382|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153870593|NCT04997382|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153870594|NCT04997382|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153870595|NCT04997382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153870596|NCT02210754|Menthol|menthol|mesh-list
153870597|NCT02210754|Nicotine|nicotine|mesh-list
153411203|NCT00003675|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153411204|NCT00003675|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153411205|NCT00003675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153411206|NCT00003675|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153411207|NCT00004137|Paclitaxel|paclitaxel|mesh-list
153411208|NCT00004137|Carboplatin|carboplatin|mesh-list
153411209|NCT00004137|Topotecan|topotecan|mesh-list
153411210|NCT00004137|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153411211|NCT00004137|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153411212|NCT00004137|Tubulin Modulators|tubulin modulators|mesh-ancestor
153411213|NCT00004137|Antimitotic Agents|antimitotic agents|mesh-ancestor
153411214|NCT00004137|Mitosis Modulators|mitosis modulators|mesh-ancestor
153411215|NCT00004137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153411216|NCT00004137|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
153411217|NCT00004137|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153411218|NCT00004137|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153411219|NCT00003681|Epoetin Alfa|epoetin alfa|mesh-list
153411220|NCT00003681|Amifostine|amifostine|mesh-list
153411221|NCT00003681|Hematinics|hematinics|mesh-ancestor
153411222|NCT00003681|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
153411223|NCT00003681|Protective Agents|protective agents|mesh-ancestor
153411224|NCT00003681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153411225|NCT00005007|Etanercept|etanercept|mesh-list
153870606|NCT02210754|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153870607|NCT02210754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153870608|NCT02210754|Antipruritics|antipruritics|mesh-ancestor
153870609|NCT02210754|Dermatologic Agents|dermatologic agents|mesh-ancestor
153870610|NCT02210754|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
153870611|NCT02210754|Protective Agents|protective agents|mesh-ancestor
153870612|NCT02210871|Semaglutide|semaglutide|mesh-list
153870613|NCT02210871|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
153411256|NCT00005013|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153411257|NCT00005013|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153870646|NCT04572542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153870679|NCT03450317|Analgesics|analgesics|mesh-ancestor
153870681|NCT03450317|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153870682|NCT03450317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153870683|NCT03450317|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153411277|NCT00005025|Antiviral Agents|antiviral agents|mesh-ancestor
153411278|NCT00005025|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153411279|NCT00005025|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153411280|NCT00005025|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153411281|NCT00005025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153411282|NCT00004179|Prednisone|prednisone|mesh-list
153358600|NCT00789776|Fludarabine|fludarabine|mesh-list
153358601|NCT00789776|Fludarabine phosphate|fludarabine phosphate|mesh-list
153358602|NCT00789776|Tacrolimus|tacrolimus|mesh-list
153411283|NCT00004179|Cyclophosphamide|cyclophosphamide|mesh-list
153411284|NCT00004179|Rituximab|rituximab|mesh-list
153411285|NCT00004179|Doxorubicin|doxorubicin|mesh-list
153411286|NCT00004179|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
153411287|NCT00004179|Vincristine|vincristine|mesh-list
153411288|NCT00004179|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153411289|NCT00004179|Immunologic Factors|immunologic factors|mesh-ancestor
153411290|NCT00004179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153411291|NCT00004179|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153411292|NCT00004179|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153411293|NCT00004179|Alkylating Agents|alkylating agents|mesh-ancestor
153430095|NCT04403516|Methylprednisolone|methylprednisolone|mesh-list
153411294|NCT00004179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153411295|NCT00004179|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153411296|NCT00004179|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153411297|NCT00004179|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153411298|NCT00004179|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153411299|NCT00004179|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153411300|NCT00004179|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153411301|NCT00004179|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153411302|NCT00004179|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153411304|NCT00004179|Hormones|hormones|mesh-ancestor
153411305|NCT00004179|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153411306|NCT00004179|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153411307|NCT00004179|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153870711|NCT04565184|Artemether|artemether|mesh-list
153870712|NCT04565184|Amodiaquine|amodiaquine|mesh-list
153870713|NCT04565184|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
153870714|NCT04565184|Amodiaquine, artesunate drug combination|amodiaquine, artesunate drug combination|mesh-list
153870715|NCT04565184|Antimalarials|antimalarials|mesh-ancestor
153870753|NCT03456947|Sensory System Agents|sensory system agents|mesh-ancestor
153870754|NCT03456947|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153870755|NCT03456947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153870756|NCT03456947|Anticonvulsants|anticonvulsants|mesh-ancestor
153870757|NCT03456947|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153870758|NCT03456947|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153870759|NCT03456947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153870760|NCT03456947|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153870761|NCT03456947|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153870762|NCT03456947|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153870763|NCT03456947|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153411369|NCT00004215|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153411370|NCT00004215|Antiviral Agents|antiviral agents|mesh-ancestor
153411371|NCT00004215|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153411372|NCT00004215|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153411379|NCT00004221|Paclitaxel|paclitaxel|mesh-list
153411438|NCT00385359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153411440|NCT00004233|Fluorouracil|fluorouracil|mesh-list
153411441|NCT00004233|Calcium|calcium|mesh-list
153411442|NCT00004233|Levoleucovorin|levoleucovorin|mesh-list
153411443|NCT00004233|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153411444|NCT00004233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153411445|NCT00004233|Antimetabolites|antimetabolites|mesh-ancestor
153411446|NCT00004233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153411447|NCT00004233|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153411448|NCT00004233|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153870863|NCT04560465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153411473|NCT00005061|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153411474|NCT00005061|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153411475|NCT00005061|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153411476|NCT00005061|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153411477|NCT00005061|Growth Substances|growth substances|mesh-ancestor
153411478|NCT00005061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153411479|NCT00005061|Growth Inhibitors|growth inhibitors|mesh-ancestor
153411481|NCT00004245|Sodium Salicylate|sodium salicylate|mesh-list
153411482|NCT00004245|Salicylsalicylic acid|salicylsalicylic acid|mesh-list
153411483|NCT00004245|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153870899|NCT00194987|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153870900|NCT00194987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153411500|NCT00004251|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
153870913|NCT00194792|Antimitotic Agents|antimitotic agents|mesh-ancestor
153870914|NCT00194792|Mitosis Modulators|mitosis modulators|mesh-ancestor
153870915|NCT00194792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153870916|NCT00194792|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153870917|NCT00194792|Antimetabolites|antimetabolites|mesh-ancestor
153870918|NCT00194792|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
153870919|NCT00194792|Abortifacient Agents|abortifacient agents|mesh-ancestor
153870920|NCT00194792|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153870921|NCT00194792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153870922|NCT00194792|Dermatologic Agents|dermatologic agents|mesh-ancestor
153870923|NCT00194792|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153870924|NCT00194792|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153870937|NCT00194792|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
153870938|NCT00194792|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153870940|NCT02486367|Ticagrelor|ticagrelor|mesh-list
153870941|NCT02486367|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153870942|NCT02486367|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
153870943|NCT02486367|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
153870944|NCT02486367|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
153870945|NCT02486367|Purinergic Agents|purinergic agents|mesh-ancestor
153870946|NCT02486367|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153411546|NCT00005073|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153411547|NCT00005073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153411548|NCT00004275|Hormones|hormones|mesh-list
153411549|NCT00004275|Oxandrolone|oxandrolone|mesh-list
153411550|NCT00004275|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153411551|NCT00004275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153411552|NCT00004275|Androgens|androgens|mesh-ancestor
153411553|NCT00004275|Anabolic Agents|anabolic agents|mesh-ancestor
153411554|NCT00003741|Antibodies|antibodies|mesh-list
153870949|NCT00194675|Testosterone|testosterone|mesh-list
153870983|NCT04563351|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153870985|NCT00192647|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
153870986|NCT00192647|Interferon alpha-2|interferon alpha-2|mesh-list
153358611|NCT00789776|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153358612|NCT00789776|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153358614|NCT00789776|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
153358615|NCT00789776|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153358616|NCT00789776|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153358617|NCT00789776|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
153358618|NCT00789776|Antitubercular Agents|antitubercular agents|mesh-ancestor
153358619|NCT00789776|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153358620|NCT00789776|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153358621|NCT03801590|Riboflavin|riboflavin|mesh-list
153358622|NCT03801590|Vitamin B Complex|vitamin b complex|mesh-ancestor
153358623|NCT03801590|Vitamins|vitamins|mesh-ancestor
153358624|NCT03801590|Micronutrients|micronutrients|mesh-ancestor
153358626|NCT03801590|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
153870987|NCT00192647|Antimetabolites|antimetabolites|mesh-ancestor
153870988|NCT00192647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153870989|NCT00192647|Antiviral Agents|antiviral agents|mesh-ancestor
153870990|NCT00192647|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153870991|NCT00192647|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153870992|NCT04563429|Vitamin A|vitamin a|mesh-list
153871308|NCT00479765|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153871309|NCT00479765|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153871310|NCT00479765|Tubulin Modulators|tubulin modulators|mesh-ancestor
153871311|NCT00479765|Antimitotic Agents|antimitotic agents|mesh-ancestor
153871312|NCT00479765|Mitosis Modulators|mitosis modulators|mesh-ancestor
153871313|NCT00479765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153871317|NCT00479687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153871318|NCT00479687|Viscosupplements|viscosupplements|mesh-ancestor
153871319|NCT00479687|Protective Agents|protective agents|mesh-ancestor
153871320|NCT00479336|Tolvaptan|tolvaptan|mesh-list
153871321|NCT00479336|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
153871322|NCT00479336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153871323|NCT00479336|Natriuretic Agents|natriuretic agents|mesh-ancestor
153871326|NCT00478244|Busulfan|busulfan|mesh-list
153889003|NCT01293123|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
153411970|NCT02469116|Mitosis Modulators|mitosis modulators|mesh-ancestor
153411971|NCT02469116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153411972|NCT00362960|Losartan|losartan|mesh-list
153411973|NCT00362960|Olmesartan|olmesartan|mesh-list
153411974|NCT00362960|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
153358628|NCT00775658|Olopatadine Hydrochloride|olopatadine hydrochloride|mesh-list
153358629|NCT00775658|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153358630|NCT00775658|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153358631|NCT00775658|Analgesics|analgesics|mesh-ancestor
153411975|NCT00362960|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153411976|NCT00362960|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153411977|NCT00362960|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
153358632|NCT00775658|Sensory System Agents|sensory system agents|mesh-ancestor
153358633|NCT00775658|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153358634|NCT00775658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153358635|NCT00775658|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153358636|NCT00775658|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153358637|NCT00775658|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
153358638|NCT00775658|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
153358639|NCT00775658|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
153888107|NCT00600587|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153429167|NCT00002570|Protective Agents|protective agents|mesh-ancestor
153872036|NCT01081769|Dopamine Agents|dopamine agents|mesh-ancestor
153872037|NCT04551768|Ribavirin|ribavirin|mesh-list
153872038|NCT04551768|Antimetabolites|antimetabolites|mesh-ancestor
153872039|NCT04551768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153872040|NCT04551768|Antiviral Agents|antiviral agents|mesh-ancestor
153872268|NCT00479232|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
153872269|NCT00478881|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
153872270|NCT00478881|Vasodilator Agents|vasodilator agents|mesh-ancestor
153413489|NCT02541565|Hormones|hormones|mesh-ancestor
153413490|NCT02541565|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153811358|NCT00325169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153811360|NCT00325169|Hormones|hormones|mesh-ancestor
153811361|NCT00325169|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153811362|NCT00325169|Sympathomimetics|sympathomimetics|mesh-ancestor
153811363|NCT00426543|Rituximab|rituximab|mesh-list
153811364|NCT00426543|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153811365|NCT00426543|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153811366|NCT00426543|Immunologic Factors|immunologic factors|mesh-ancestor
153811367|NCT00426543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153811368|NCT00426543|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153811369|NCT00325286|Carbamazepine|carbamazepine|mesh-list
153811391|NCT00325325|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153811392|NCT00325325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153811393|NCT00325325|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
153811394|NCT00325325|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153811395|NCT00325325|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153811396|NCT00354081|Vitamins|vitamins|mesh-list
153811397|NCT00354081|Folic Acid|folic acid|mesh-list
153811398|NCT00354081|Hydroxocobalamin|hydroxocobalamin|mesh-list
153811399|NCT00354081|Vitamin B 12|vitamin b 12|mesh-list
153811400|NCT00354081|Pyridoxine|pyridoxine|mesh-list
153811401|NCT00354081|Pyridoxal|pyridoxal|mesh-list
153358640|NCT00775658|Histamine Antagonists|histamine antagonists|mesh-ancestor
153358642|NCT00775658|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153358666|NCT04383548|Antibodies|antibodies|mesh-list
153811402|NCT00354081|Vitamin B 6|vitamin b 6|mesh-list
153811403|NCT00354081|Vitamin B Complex|vitamin b complex|mesh-list
153811404|NCT00354081|Micronutrients|micronutrients|mesh-ancestor
153811405|NCT00354081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153811406|NCT00354081|Hematinics|hematinics|mesh-ancestor
153811407|NCT00325637|Losartan|losartan|mesh-list
153811408|NCT00325637|Cilnidipine|cilnidipine|mesh-list
153811409|NCT00325637|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153811410|NCT00325637|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153430195|NCT01532635|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153414102|NCT02243202|Autonomic Agents|autonomic agents|mesh-ancestor
153811411|NCT00325637|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
153811412|NCT00325637|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
153414103|NCT02243202|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153414104|NCT02243202|Adrenergic Agents|adrenergic agents|mesh-ancestor
153414105|NCT02243202|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153430196|NCT00986947|Rituximab|rituximab|mesh-list
153811414|NCT00325637|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153811415|NCT00325637|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153811416|NCT00325637|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153811417|NCT00325637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153811418|NCT04714593|Cyclophosphamide|cyclophosphamide|mesh-list
153811419|NCT04714593|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153811420|NCT04714593|Immunologic Factors|immunologic factors|mesh-ancestor
153811421|NCT04714593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153811422|NCT04714593|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153873456|NCT04556279|Natriuretic Agents|natriuretic agents|mesh-ancestor
153873457|NCT02216331|Rifampin|rifampin|mesh-list
153873458|NCT02216331|Rifapentine|rifapentine|mesh-list
153873459|NCT02216331|Bedaquiline|bedaquiline|mesh-list
153873460|NCT02216331|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
153873461|NCT02216331|Antitubercular Agents|antitubercular agents|mesh-ancestor
153873462|NCT02216331|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153873463|NCT02216331|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153414129|NCT02560051|Ketoconazole|ketoconazole|mesh-list
153414130|NCT02560051|Docetaxel|docetaxel|mesh-list
153414131|NCT02560051|Doxorubicin|doxorubicin|mesh-list
153811423|NCT04714593|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153811424|NCT04714593|Alkylating Agents|alkylating agents|mesh-ancestor
153811425|NCT04714593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153811426|NCT04714593|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153811430|NCT00426582|Tubulin Modulators|tubulin modulators|mesh-ancestor
153811431|NCT00426582|Antimitotic Agents|antimitotic agents|mesh-ancestor
153811432|NCT00426582|Mitosis Modulators|mitosis modulators|mesh-ancestor
153873470|NCT02216331|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
153873471|NCT02216331|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
153873472|NCT02216331|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
153873473|NCT02216331|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
153873474|NCT04535817|Omalizumab|omalizumab|mesh-list
153429201|NCT00002576|Sensory System Agents|sensory system agents|mesh-ancestor
153429202|NCT00002582|Tamoxifen|tamoxifen|mesh-list
153429203|NCT00002582|Cyclophosphamide|cyclophosphamide|mesh-list
153429204|NCT00002582|Doxorubicin|doxorubicin|mesh-list
153429205|NCT00002582|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
153429206|NCT00002582|Fluorouracil|fluorouracil|mesh-list
153429207|NCT00002582|Methotrexate|methotrexate|mesh-list
153429208|NCT00002582|Leuprolide|leuprolide|mesh-list
153429209|NCT00002582|Goserelin|goserelin|mesh-list
153429210|NCT00002582|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153429211|NCT00002582|Immunologic Factors|immunologic factors|mesh-ancestor
153873475|NCT04535817|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
153873476|NCT04535817|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153873477|NCT04535817|Respiratory System Agents|respiratory system agents|mesh-ancestor
153873478|NCT04578236|Tretinoin|tretinoin|mesh-list
153873479|NCT04578236|Captopril|captopril|mesh-list
153811433|NCT00426582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153811434|NCT00354198|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
153811435|NCT00354198|Pentoxifylline|pentoxifylline|mesh-list
153811436|NCT00354198|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
153811437|NCT00354198|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153811438|NCT00354198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153811439|NCT00354198|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153811440|NCT00354198|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
153811441|NCT00354198|Protective Agents|protective agents|mesh-ancestor
153811442|NCT00354198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153811443|NCT00354198|Vasodilator Agents|vasodilator agents|mesh-ancestor
153811444|NCT00354198|Free Radical Scavengers|free radical scavengers|mesh-ancestor
153811445|NCT00354198|Antioxidants|antioxidants|mesh-ancestor
153811446|NCT00354198|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153811447|NCT00354198|Glucocorticoids|glucocorticoids|mesh-ancestor
153811448|NCT00354198|Hormones|hormones|mesh-ancestor
153811449|NCT00354198|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153811450|NCT00354198|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
153873500|NCT04542213|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
153873501|NCT04542213|Linagliptin|linagliptin|mesh-list
153873502|NCT04542213|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153873503|NCT04542213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153414198|NCT03777956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153414199|NCT02481505|Chloroprocaine|chloroprocaine|mesh-list
153873504|NCT04542213|Incretins|incretins|mesh-ancestor
153873505|NCT04542213|Hormones|hormones|mesh-ancestor
153873506|NCT04542213|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153358671|NCT01341977|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
153358673|NCT04351763|Verapamil|verapamil|mesh-list
153358674|NCT04351763|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153358675|NCT04351763|Vasodilator Agents|vasodilator agents|mesh-ancestor
153358676|NCT04351763|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
153358677|NCT04351763|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153358678|NCT04351763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153358679|NCT04351763|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153421819|NCT05434689|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153421820|NCT05434689|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153873507|NCT04542213|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
153873508|NCT04542213|Protease Inhibitors|protease inhibitors|mesh-ancestor
153873509|NCT04542213|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153873510|NCT04542213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153873511|NCT04542252|Cyclosporine|cyclosporine|mesh-list
153873512|NCT04542252|Cyclosporins|cyclosporins|mesh-list
153873513|NCT04542252|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153414206|NCT02563093|Vaccines|vaccines|mesh-list
153811457|NCT00325676|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153811458|NCT00325676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153811472|NCT00325793|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153414223|NCT02564029|GABA Agents|gaba agents|mesh-ancestor
153414224|NCT02564029|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153414225|NCT02564029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153414226|NCT05588336|Morphine|morphine|mesh-list
153414227|NCT05588336|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153414228|NCT05588336|Narcotics|narcotics|mesh-ancestor
153414229|NCT05588336|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153873539|NCT04532775|Antiemetics|antiemetics|mesh-ancestor
153873540|NCT04532775|Autonomic Agents|autonomic agents|mesh-ancestor
153873542|NCT04532775|Glucocorticoids|glucocorticoids|mesh-ancestor
153811473|NCT00325793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153811474|NCT00325793|Vasodilator Agents|vasodilator agents|mesh-ancestor
153811476|NCT00426621|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153811477|NCT00426621|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153811478|NCT00426621|Analgesics|analgesics|mesh-ancestor
153811479|NCT00426621|Sensory System Agents|sensory system agents|mesh-ancestor
153811480|NCT00426621|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153811481|NCT00426621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153811482|NCT00426621|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153811483|NCT00426621|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153811484|NCT00426621|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153811485|NCT00426621|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153811486|NCT00426621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153358698|NCT01342523|Nicotine|nicotine|mesh-list
153811487|NCT04714242|Ranibizumab|ranibizumab|mesh-list
153811488|NCT04714242|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153811489|NCT04714242|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153811490|NCT04714242|Growth Substances|growth substances|mesh-ancestor
153889080|NCT02872597|Methylprednisolone|methylprednisolone|mesh-list
153889081|NCT02872597|Prednisolone|prednisolone|mesh-list
153889082|NCT02872597|Albuterol|albuterol|mesh-list
153889083|NCT02872597|Ipratropium|ipratropium|mesh-list
153414270|NCT03926624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153414271|NCT03926624|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153414272|NCT03926624|Immunologic Factors|immunologic factors|mesh-ancestor
153811492|NCT04714242|Growth Inhibitors|growth inhibitors|mesh-ancestor
153811526|NCT00326027|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
153811527|NCT00326027|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153811528|NCT00326027|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
153811529|NCT00326027|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153414273|NCT03926624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153811530|NCT00326027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153811531|NCT01059318|Everolimus|everolimus|mesh-list
153414274|NCT03926624|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153873586|NCT04532736|Glucocorticoids|glucocorticoids|mesh-ancestor
153811532|NCT01059318|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
153811533|NCT01059318|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153811534|NCT01059318|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153811535|NCT01059318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153811536|NCT01059318|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153811588|NCT01058655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153811589|NCT01058655|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153811590|NCT01058655|Immunologic Factors|immunologic factors|mesh-ancestor
153811591|NCT01058655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153811592|NCT01058655|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153811593|NCT00326300|Methylphenidate|methylphenidate|mesh-list
153811594|NCT00326300|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
153811595|NCT00326300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153811596|NCT00326300|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
153811597|NCT00326300|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153811598|NCT00326300|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153811599|NCT00326300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153811600|NCT00326300|Dopamine Agents|dopamine agents|mesh-ancestor
153811601|NCT00326300|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153811644|NCT00326807|Sensory System Agents|sensory system agents|mesh-ancestor
153811645|NCT00326807|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153811646|NCT00354549|Bevacizumab|bevacizumab|mesh-list
153811647|NCT00354549|Carboplatin|carboplatin|mesh-list
153811648|NCT00354549|Gemcitabine|gemcitabine|mesh-list
153811649|NCT00354549|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
153811650|NCT00354549|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153811651|NCT00354549|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153811652|NCT00354549|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153811653|NCT00354549|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153414296|NCT03551210|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153414297|NCT03551210|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
153811654|NCT00354549|Growth Substances|growth substances|mesh-ancestor
153811655|NCT00354549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153811656|NCT00354549|Growth Inhibitors|growth inhibitors|mesh-ancestor
153811657|NCT00354549|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153811658|NCT00354549|Antimetabolites|antimetabolites|mesh-ancestor
153811659|NCT00354549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153811662|NCT00354549|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153811701|NCT00327080|Vasodilator Agents|vasodilator agents|mesh-ancestor
153811702|NCT00327080|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
153811703|NCT00327080|Cholinergic Agents|cholinergic agents|mesh-ancestor
153811704|NCT00327080|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153873639|NCT00579995|Free Radical Scavengers|free radical scavengers|mesh-ancestor
153873640|NCT00579995|Antioxidants|antioxidants|mesh-ancestor
153873641|NCT00579995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153873642|NCT00579995|Protective Agents|protective agents|mesh-ancestor
153873643|NCT00579995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153873644|NCT00579995|Antidotes|antidotes|mesh-ancestor
153873645|NCT04531371|Dexmedetomidine|dexmedetomidine|mesh-list
153873646|NCT04531371|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153873647|NCT04531371|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153873648|NCT04531371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153873649|NCT04531371|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153873650|NCT04531371|Analgesics|analgesics|mesh-ancestor
153873651|NCT04531371|Sensory System Agents|sensory system agents|mesh-ancestor
153873655|NCT04531371|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153811706|NCT00327080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153811707|NCT00327119|Panitumumab|panitumumab|mesh-list
153811708|NCT00327119|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153811709|NCT00327119|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153811710|NCT00426933|Vancomycin|vancomycin|mesh-list
153811711|NCT00426933|Daptomycin|daptomycin|mesh-list
153811712|NCT00426933|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153811713|NCT00426933|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153811714|NCT00327197|Prednisolone|prednisolone|mesh-list
153811715|NCT00327197|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153811716|NCT00327197|Glucocorticoids|glucocorticoids|mesh-ancestor
153811717|NCT00327197|Hormones|hormones|mesh-ancestor
153811719|NCT00327197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153811757|NCT00327353|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153811758|NCT00327353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153811759|NCT00327353|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153811760|NCT00327353|Respiratory System Agents|respiratory system agents|mesh-ancestor
153811761|NCT00327353|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
153811762|NCT00327353|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
153811763|NCT00327353|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153811764|NCT00327353|Adrenergic Agents|adrenergic agents|mesh-ancestor
153811765|NCT00327353|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153811766|NCT00327353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153811767|NCT00425841|Gemcitabine|gemcitabine|mesh-list
153811768|NCT00425841|Oxaliplatin|oxaliplatin|mesh-list
153811769|NCT00425841|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153811770|NCT00425841|Antimetabolites|antimetabolites|mesh-ancestor
153811771|NCT00425841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153811814|NCT00425997|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153783496|NCT00236327|Anesthetics|anesthetics|mesh-ancestor
153783497|NCT00236366|Fentanyl|fentanyl|mesh-list
153429317|NCT00002618|Cobalt|cobalt|mesh-list
153429318|NCT00002618|Cytarabine|cytarabine|mesh-list
153811815|NCT00425997|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153811816|NCT00425997|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153811817|NCT00425997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153811818|NCT00425997|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153811819|NCT00425997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153811820|NCT00425997|Vasodilator Agents|vasodilator agents|mesh-ancestor
153811821|NCT00425997|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
153811822|NCT00425997|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
153811823|NCT00425997|Diuretics|diuretics|mesh-ancestor
153811824|NCT00425997|Natriuretic Agents|natriuretic agents|mesh-ancestor
153811825|NCT00425997|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
153811874|NCT00432393|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153811875|NCT00432393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153811876|NCT00432393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153811877|NCT00432393|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
153811878|NCT00432393|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153811879|NCT00432393|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153811880|NCT00432393|Immunologic Factors|immunologic factors|mesh-ancestor
153811881|NCT00432393|Dopamine Agonists|dopamine agonists|mesh-ancestor
153811882|NCT05453045|Albendazole|albendazole|mesh-list
153811883|NCT05453045|Anthelmintics|anthelmintics|mesh-ancestor
153811884|NCT05453045|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153811885|NCT05453045|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153811935|NCT05354258|Praziquantel|praziquantel|mesh-list
153811936|NCT05354258|Antimalarials|antimalarials|mesh-ancestor
153811937|NCT05354258|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153811938|NCT05354258|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153811939|NCT05354258|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153811940|NCT05354258|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153811941|NCT05354258|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153811942|NCT05354258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153811943|NCT05354258|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
153811944|NCT05354258|Anthelmintics|anthelmintics|mesh-ancestor
153358343|NCT01309451|Glucocorticoids|glucocorticoids|mesh-ancestor
153811945|NCT05354258|Anticestodal Agents|anticestodal agents|mesh-ancestor
153811996|NCT02273505|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153811998|NCT02273505|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
153811999|NCT02273505|Vasodilator Agents|vasodilator agents|mesh-ancestor
153812000|NCT05210621|Ocrelizumab|ocrelizumab|mesh-list
153812001|NCT05210621|Immunologic Factors|immunologic factors|mesh-ancestor
153812002|NCT05210621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153812003|NCT00432549|Topiramate|topiramate|mesh-list
153812004|NCT00432549|Almotriptan|almotriptan|mesh-list
153812005|NCT00432549|Anticonvulsants|anticonvulsants|mesh-ancestor
153812007|NCT00432549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153812008|NCT00432549|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
153812009|NCT00432549|Serotonin Agents|serotonin agents|mesh-ancestor
153812010|NCT00432549|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153783498|NCT00236366|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153783499|NCT00236366|Narcotics|narcotics|mesh-ancestor
153880959|NCT05779007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153880960|NCT05779007|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153812011|NCT00432549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153873714|NCT04530903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153873715|NCT04530903|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153873716|NCT04530903|Sympatholytics|sympatholytics|mesh-ancestor
153873717|NCT04530903|Autonomic Agents|autonomic agents|mesh-ancestor
153414391|NCT04341727|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153414392|NCT04341727|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153414393|NCT04341727|Analgesics|analgesics|mesh-ancestor
153414394|NCT04341727|Sensory System Agents|sensory system agents|mesh-ancestor
153414395|NCT04341727|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153414396|NCT04341727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153414397|NCT04341727|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153414398|NCT04341727|Filaricides|filaricides|mesh-ancestor
153414399|NCT04341727|Antinematodal Agents|antinematodal agents|mesh-ancestor
153414400|NCT04341727|Anthelmintics|anthelmintics|mesh-ancestor
153414401|NCT00367094|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
153414402|NCT00367094|Benazepril|benazepril|mesh-list
153414403|NCT00367094|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153414404|NCT00367094|Diuretics|diuretics|mesh-ancestor
153430219|NCT00539617|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153430220|NCT00539617|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153812057|NCT00432627|Iron Chelating Agents|iron chelating agents|mesh-ancestor
153812058|NCT00432627|Chelating Agents|chelating agents|mesh-ancestor
153812059|NCT00432627|Sequestering Agents|sequestering agents|mesh-ancestor
153812060|NCT00432627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153812125|NCT01056510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153812127|NCT01056276|Bortezomib|bortezomib|mesh-list
153812128|NCT01056276|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
153812129|NCT01056276|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153812130|NCT01056276|Antiemetics|antiemetics|mesh-ancestor
153812131|NCT01056276|Autonomic Agents|autonomic agents|mesh-ancestor
153812132|NCT01056276|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153812133|NCT01056276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153812134|NCT01056276|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153414405|NCT00367094|Natriuretic Agents|natriuretic agents|mesh-ancestor
153414406|NCT00367094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153414407|NCT00367094|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
153414408|NCT00367094|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153414409|NCT00367094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153414410|NCT00367094|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
153873718|NCT04530903|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
153873719|NCT04530903|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153873720|NCT04530903|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153873721|NCT04530903|Adrenergic Agents|adrenergic agents|mesh-ancestor
153873722|NCT04530903|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153873723|NCT04530903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153873724|NCT04530903|Anesthetics, Local|anesthetics, local|mesh-ancestor
153873725|NCT04530903|Anesthetics|anesthetics|mesh-ancestor
153873726|NCT04530903|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153358765|NCT01318967|Natriuretic Agents|natriuretic agents|mesh-ancestor
153358766|NCT01318967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153358767|NCT01318967|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
153873727|NCT04530474|Ivermectin|ivermectin|mesh-list
153812136|NCT01056276|Hormones|hormones|mesh-ancestor
153812137|NCT01056276|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153812138|NCT01056276|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153812141|NCT01056276|Alkylating Agents|alkylating agents|mesh-ancestor
153812183|NCT00433173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153812184|NCT00433173|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
153812185|NCT00433173|Hormone Antagonists|hormone antagonists|mesh-ancestor
153812187|NCT01055028|Bevacizumab|bevacizumab|mesh-list
153812188|NCT01055028|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153812189|NCT01055028|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153812190|NCT01055028|Tubulin Modulators|tubulin modulators|mesh-ancestor
153812191|NCT01055028|Antimitotic Agents|antimitotic agents|mesh-ancestor
153812192|NCT01055028|Mitosis Modulators|mitosis modulators|mesh-ancestor
153812193|NCT01055028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153812194|NCT01055028|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153812195|NCT01055028|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153812196|NCT01055028|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153812197|NCT01055028|Growth Substances|growth substances|mesh-ancestor
153812240|NCT04703127|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
153812241|NCT04703127|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
153873753|NCT00625573|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
153889109|NCT02872597|Cholinergic Agents|cholinergic agents|mesh-ancestor
153889110|NCT02873065|Amoxicillin|amoxicillin|mesh-list
153430242|NCT00523939|Antimetabolites|antimetabolites|mesh-ancestor
153430243|NCT00523939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153889111|NCT02873065|Clarithromycin|clarithromycin|mesh-list
153873754|NCT00625573|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153873755|NCT04205851|Gimsilumab|gimsilumab|mesh-list
153873756|NCT04205851|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153873757|NCT04205851|Antiviral Agents|antiviral agents|mesh-ancestor
153873758|NCT04205851|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153873759|NCT02882113|Tacrolimus|tacrolimus|mesh-list
153873760|NCT02882113|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153873761|NCT02882113|Immunologic Factors|immunologic factors|mesh-ancestor
153873769|NCT01121536|Modafinil|modafinil|mesh-list
153812243|NCT04703127|Urological Agents|urological agents|mesh-ancestor
153812244|NCT00428883|Acetylcysteine|acetylcysteine|mesh-list
153812245|NCT00428883|N-monoacetylcystine|n-monoacetylcystine|mesh-list
153812246|NCT00428883|Antiviral Agents|antiviral agents|mesh-ancestor
153812247|NCT00428883|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153812248|NCT00428883|Expectorants|expectorants|mesh-ancestor
153812249|NCT00428883|Respiratory System Agents|respiratory system agents|mesh-ancestor
153812250|NCT00428883|Free Radical Scavengers|free radical scavengers|mesh-ancestor
153812251|NCT00428883|Antioxidants|antioxidants|mesh-ancestor
153812252|NCT00428883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153812253|NCT00428883|Protective Agents|protective agents|mesh-ancestor
153812302|NCT00327587|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153812303|NCT00327587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153812304|NCT00327587|Vasodilator Agents|vasodilator agents|mesh-ancestor
153812305|NCT00327587|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
153812306|NCT00327587|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
153812307|NCT00327587|Diuretics|diuretics|mesh-ancestor
153812308|NCT00327587|Natriuretic Agents|natriuretic agents|mesh-ancestor
153812309|NCT00327587|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
153812310|NCT00327665|Vaccines|vaccines|mesh-list
153812311|NCT00327665|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
153812312|NCT00327665|Immunologic Factors|immunologic factors|mesh-ancestor
153358775|NCT01348607|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
153358776|NCT01348607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153358777|NCT01348607|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
153358781|NCT01348607|Dopamine Agents|dopamine agents|mesh-ancestor
153812313|NCT00327665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153358716|NCT02199743|Haloperidol|haloperidol|mesh-list
153812314|NCT00433641|Sibutramine|sibutramine|mesh-list
153812315|NCT00433641|Antidepressive Agents|antidepressive agents|mesh-ancestor
153812320|NCT00429234|Dasatinib|dasatinib|mesh-list
153812360|NCT04704297|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153812361|NCT04704297|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153812362|NCT04704297|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153812363|NCT04704297|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153812364|NCT04704297|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153812365|NCT04704297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153812366|NCT04704297|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
153812367|NCT04704297|Antidepressive Agents|antidepressive agents|mesh-ancestor
153812368|NCT04704297|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153812369|NCT04704297|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
153812370|NCT04704297|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
153812371|NCT04704297|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153812372|NCT04704297|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
153414466|NCT02572609|Ambroxol|ambroxol|mesh-list
153812373|NCT04704297|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153812374|NCT04704297|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153812375|NCT04704297|Adrenergic Agents|adrenergic agents|mesh-ancestor
153812376|NCT04704297|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153812377|NCT00328211|Bile Acids and Salts|bile acids and salts|mesh-list
153358784|NCT01348607|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
153358785|NCT01348607|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
153358786|NCT06214572|Paclitaxel|paclitaxel|mesh-list
153358787|NCT06214572|Cisplatin|cisplatin|mesh-list
153358788|NCT06214572|Gemcitabine|gemcitabine|mesh-list
153358789|NCT06214572|Oxaliplatin|oxaliplatin|mesh-list
153358790|NCT06214572|Durvalumab|durvalumab|mesh-list
153358791|NCT06214572|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153358798|NCT06214572|Antimetabolites|antimetabolites|mesh-ancestor
153812378|NCT00328211|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153812379|NCT00328367|Aripiprazole|aripiprazole|mesh-list
153812380|NCT00328367|Antidepressive Agents|antidepressive agents|mesh-ancestor
153812381|NCT00328367|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153812382|NCT00328367|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153812409|NCT04703088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153812410|NCT00328718|Fluticasone|fluticasone|mesh-list
153812412|NCT00328718|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
153812413|NCT00328718|Montelukast|montelukast|mesh-list
153873798|NCT04554524|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153873799|NCT04554524|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153873800|NCT04554524|Tubulin Modulators|tubulin modulators|mesh-ancestor
153873801|NCT04554524|Antimitotic Agents|antimitotic agents|mesh-ancestor
153812414|NCT00328718|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153812415|NCT00328718|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153812416|NCT00328718|Autonomic Agents|autonomic agents|mesh-ancestor
153812417|NCT00328718|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153812418|NCT00328718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153812419|NCT00328718|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153812420|NCT00328718|Respiratory System Agents|respiratory system agents|mesh-ancestor
153812421|NCT00328718|Dermatologic Agents|dermatologic agents|mesh-ancestor
153812422|NCT00328718|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
153873822|NCT02217852|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
153873824|NCT02217852|Antihypertensive Agents|antihypertensive agents|mesh-list
153812423|NCT00328718|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
153812424|NCT00328718|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
153812426|NCT00328718|Adrenergic Agents|adrenergic agents|mesh-ancestor
153812427|NCT00328718|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153812428|NCT00328718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153812429|NCT00328718|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
153812430|NCT00328718|Hormone Antagonists|hormone antagonists|mesh-ancestor
153812432|NCT00328718|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
153358817|NCT06214468|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153358818|NCT06214468|Antipyretics|antipyretics|mesh-ancestor
153358819|NCT06214468|Vitamin B Complex|vitamin b complex|mesh-ancestor
153888529|NCT05644691|Dermatologic Agents|dermatologic agents|mesh-ancestor
153888530|NCT01093846|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
153888531|NCT01093846|Immunologic Factors|immunologic factors|mesh-ancestor
153888532|NCT01093846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153888533|NCT01093534|Solifenacin Succinate|solifenacin succinate|mesh-list
153888534|NCT01093534|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
153812459|NCT00429468|Respiratory System Agents|respiratory system agents|mesh-ancestor
153812460|NCT00429468|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153812461|NCT00429468|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153812462|NCT00429468|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153812463|NCT04702698|Peposertib|peposertib|mesh-list
153812465|NCT04702698|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153812466|NCT04702698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153812467|NCT00328874|Ubiquinone|ubiquinone|mesh-list
153812468|NCT00328874|Coenzyme Q10|coenzyme q10|mesh-list
153812469|NCT00328874|Micronutrients|micronutrients|mesh-ancestor
153812525|NCT00329147|Antidepressive Agents|antidepressive agents|mesh-ancestor
153889143|NCT00628225|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153430251|NCT00382538|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
153430252|NCT00382538|Abortifacient Agents|abortifacient agents|mesh-ancestor
153812526|NCT00329147|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153812527|NCT00329147|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
153812528|NCT00329147|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153812529|NCT00329147|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153812530|NCT00329147|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
153812531|NCT00329147|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
153812532|NCT00329147|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
153812533|NCT00329147|Adrenergic Agents|adrenergic agents|mesh-ancestor
153812534|NCT00329186|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
153812535|NCT00329186|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
153812536|NCT00329186|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
153812537|NCT00329186|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153812538|NCT00329186|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153812539|NCT00329186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153812540|NCT00329186|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153812541|NCT00329186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153812542|NCT00329186|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
153812543|NCT00329186|Antidepressive Agents|antidepressive agents|mesh-ancestor
153812544|NCT00329186|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153812545|NCT00434031|Cyclophosphamide|cyclophosphamide|mesh-list
153812548|NCT00434031|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
153812549|NCT00434031|Trastuzumab|trastuzumab|mesh-list
153812550|NCT00434031|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153358820|NCT06214468|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153358822|NCT06214468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153812551|NCT00434031|Immunologic Factors|immunologic factors|mesh-ancestor
153812552|NCT00434031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153812553|NCT00434031|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153812555|NCT00434031|Alkylating Agents|alkylating agents|mesh-ancestor
153812566|NCT00434031|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153812567|NCT00329225|Rosiglitazone|rosiglitazone|mesh-list
153812568|NCT00329225|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153812569|NCT00329225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153812570|NCT01050543|Neostigmine|neostigmine|mesh-list
153812571|NCT01050543|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
153873923|NCT01120093|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153873924|NCT01120093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153873925|NCT01120093|Anticonvulsants|anticonvulsants|mesh-ancestor
153873926|NCT00581009|Lithium Carbonate|lithium carbonate|mesh-list
153873927|NCT00581009|Sertraline|sertraline|mesh-list
153873928|NCT00581009|Antidepressive Agents|antidepressive agents|mesh-ancestor
153873929|NCT00581009|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153873930|NCT00581009|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
153873931|NCT00581009|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153414617|NCT02507011|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153414618|NCT02507011|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153812572|NCT01050543|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153812573|NCT01050543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153812574|NCT01050543|Cholinergic Agents|cholinergic agents|mesh-ancestor
153812575|NCT01050543|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153812576|NCT01050543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153812577|NCT01050543|Parasympathomimetics|parasympathomimetics|mesh-ancestor
153812578|NCT01050543|Autonomic Agents|autonomic agents|mesh-ancestor
153812579|NCT01050543|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153812580|NCT00329264|Quetiapine Fumarate|quetiapine fumarate|mesh-list
153812581|NCT00329264|Antidepressive Agents|antidepressive agents|mesh-ancestor
153812582|NCT00329264|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153812583|NCT00329264|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153414645|NCT05345210|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153414646|NCT05345210|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
153812584|NCT00329264|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153414649|NCT05345210|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153812585|NCT00329264|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153812586|NCT00329264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153812587|NCT00329381|Omalizumab|omalizumab|mesh-list
153812588|NCT00329381|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
153812589|NCT00329381|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
153812590|NCT00329381|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153812591|NCT00329381|Respiratory System Agents|respiratory system agents|mesh-ancestor
153359019|NCT06212648|Amlodipine|amlodipine|mesh-list
153812602|NCT00329459|Analgesics|analgesics|mesh-ancestor
153812603|NCT00329459|Sensory System Agents|sensory system agents|mesh-ancestor
153812604|NCT00329459|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153414763|NCT02513095|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
153414764|NCT02513095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153812605|NCT00329459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153812606|NCT00329459|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153812607|NCT00329459|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153812608|NCT00329459|Gout Suppressants|gout suppressants|mesh-ancestor
153812609|NCT00329459|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153812610|NCT00329459|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153812611|NCT00329459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153812612|NCT00329459|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
153874116|NCT02219178|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153874117|NCT02219178|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153874118|NCT02219178|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153874119|NCT02219178|Immunologic Factors|immunologic factors|mesh-ancestor
153358838|NCT06214169|Anesthetics, Local|anesthetics, local|mesh-ancestor
153358839|NCT06214169|Anesthetics|anesthetics|mesh-ancestor
153874120|NCT02219178|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153874121|NCT02219178|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153874122|NCT02219178|Growth Substances|growth substances|mesh-ancestor
153414820|NCT00364429|GABA Modulators|gaba modulators|mesh-ancestor
153414822|NCT02593903|Trimethoprim|trimethoprim|mesh-list
153414823|NCT02593903|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
153414824|NCT02593903|Sulfamethoxazole|sulfamethoxazole|mesh-list
153414825|NCT02593903|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
153414826|NCT02593903|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153414827|NCT02593903|Antimalarials|antimalarials|mesh-ancestor
153414828|NCT02593903|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153414829|NCT02593903|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153414830|NCT02593903|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153414831|NCT02593903|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153414832|NCT02593903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153414833|NCT02593903|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
153414834|NCT02593903|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
153414835|NCT02593903|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153414836|NCT02593903|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153414837|NCT02596867|Propranolol|propranolol|mesh-list
153414838|NCT02596867|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
153874139|NCT02219217|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153874140|NCT02219217|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
153874141|NCT02219217|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153874142|NCT04577378|Itraconazole|itraconazole|mesh-list
153812613|NCT00329459|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
153812614|NCT00329459|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
153812615|NCT00329459|Serotonin Agents|serotonin agents|mesh-ancestor
153812616|NCT00329459|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153812617|NCT00329498|Ascorbic Acid|ascorbic acid|mesh-list
153812618|NCT00329498|Antioxidants|antioxidants|mesh-ancestor
153812619|NCT00329498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153812620|NCT00329498|Protective Agents|protective agents|mesh-ancestor
153812621|NCT00329498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153812653|NCT00429975|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
153812654|NCT00429975|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153812655|NCT00429975|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153812656|NCT00429975|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153358847|NCT06214169|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153812657|NCT00429975|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153414851|NCT02597101|Incretins|incretins|mesh-ancestor
153414852|NCT02597101|Hormones|hormones|mesh-ancestor
153414853|NCT02597101|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153414854|NCT02597101|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
153414855|NCT02597101|Protease Inhibitors|protease inhibitors|mesh-ancestor
153812658|NCT00429975|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153812659|NCT00429975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153812660|NCT00429975|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153812661|NCT00429975|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
153812662|NCT00429975|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153812663|NCT00429975|Third Generation Cephalosporins|third generation cephalosporins|mesh-ancestor
153812664|NCT00429975|Beta Lactam Antibiotics|beta lactam antibiotics|mesh-ancestor
153812665|NCT00329615|Isophane Insulin, Human|isophane insulin, human|mesh-list
153812666|NCT00329615|Insulin, Isophane|insulin, isophane|mesh-list
153874200|NCT04553393|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153414917|NCT02608489|Hyaluronic Acid|hyaluronic acid|mesh-list
153874201|NCT04553393|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153874202|NCT02211846|Mirabegron|mirabegron|mesh-list
153874203|NCT02211846|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
153874204|NCT02211846|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
153874205|NCT02211846|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153874206|NCT02211846|Adrenergic Agents|adrenergic agents|mesh-ancestor
153874207|NCT02211846|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153874208|NCT02211846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153874209|NCT02211846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153874210|NCT02211846|Urological Agents|urological agents|mesh-ancestor
153874211|NCT02219646|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
153358869|NCT06214078|Vasodilator Agents|vasodilator agents|mesh-ancestor
153358870|NCT06213987|Tretinoin|tretinoin|mesh-list
153888578|NCT01092832|Hormone Antagonists|hormone antagonists|mesh-ancestor
153888579|NCT01092832|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153358872|NCT06213987|Keratolytic Agents|keratolytic agents|mesh-ancestor
153358873|NCT06213987|Dermatologic Agents|dermatologic agents|mesh-ancestor
153358874|NCT06213948|Mirtazapine|mirtazapine|mesh-list
153358875|NCT06213948|Antidepressive Agents|antidepressive agents|mesh-ancestor
153358876|NCT06213948|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153358877|NCT06213948|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
153358878|NCT06213948|Histamine Antagonists|histamine antagonists|mesh-ancestor
153358879|NCT06213948|Histamine Agents|histamine agents|mesh-ancestor
153358880|NCT06213948|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153874212|NCT02219646|Vasodilator Agents|vasodilator agents|mesh-ancestor
153874213|NCT02219646|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
153874214|NCT02219646|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
153874215|NCT02219646|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153874216|NCT02219646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153874217|NCT02219646|Urological Agents|urological agents|mesh-ancestor
153874218|NCT04553510|Bevacizumab|bevacizumab|mesh-list
153874219|NCT04553510|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153874220|NCT04553510|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153874221|NCT04553510|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153812667|NCT00329615|Isophane insulin, beef|isophane insulin, beef|mesh-list
153812668|NCT00329615|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153359091|NCT06202014|Capecitabine|capecitabine|mesh-list
153812669|NCT00329615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153812707|NCT00430170|Dipyridamole|dipyridamole|mesh-list
153812708|NCT00430170|Caffeine|caffeine|mesh-list
153812709|NCT00430170|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
153812710|NCT00430170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153812711|NCT00430170|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
153812712|NCT00430170|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153812713|NCT00430170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153812714|NCT00430170|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
153812715|NCT00430170|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
153812716|NCT00430170|Purinergic Agents|purinergic agents|mesh-ancestor
153874249|NCT01642134|Antipyretics|antipyretics|mesh-ancestor
153874250|NCT01642134|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
153414958|NCT05732155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153414960|NCT05732155|Serotonin Agents|serotonin agents|mesh-ancestor
153414961|NCT05732155|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153414962|NCT05732155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153414963|NCT05732155|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
153414964|NCT05732155|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153414965|NCT05732155|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153414966|NCT05732155|Adrenergic Agents|adrenergic agents|mesh-ancestor
153414967|NCT05528419|Valsartan|valsartan|mesh-list
153414968|NCT05528419|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
153414969|NCT05528419|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153414970|NCT05528419|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
153414971|NCT05528419|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
153414972|NCT05528419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153414973|NCT05480293|Ranibizumab|ranibizumab|mesh-list
153812717|NCT00430170|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153812718|NCT00430170|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153812719|NCT00430170|Vasodilator Agents|vasodilator agents|mesh-ancestor
153812720|NCT00330044|Carboplatin|carboplatin|mesh-list
153812721|NCT00330044|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153812722|NCT00430365|Lenalidomide|lenalidomide|mesh-list
153812723|NCT00430365|Immunologic Factors|immunologic factors|mesh-ancestor
153812724|NCT00430365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153874263|NCT00581789|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153874264|NCT00581789|Growth Substances|growth substances|mesh-ancestor
153874265|NCT00581789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153874266|NCT00581789|Growth Inhibitors|growth inhibitors|mesh-ancestor
153874267|NCT02213588|Antioxidants|antioxidants|mesh-list
153874268|NCT02213588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153874269|NCT02213588|Protective Agents|protective agents|mesh-ancestor
153874270|NCT02213588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153874271|NCT01642524|Dextrans|dextrans|mesh-list
153874272|NCT01642524|Anticoagulants|anticoagulants|mesh-ancestor
153874273|NCT01642524|Plasma Substitutes|plasma substitutes|mesh-ancestor
153874274|NCT01642524|Blood Substitutes|blood substitutes|mesh-ancestor
153874275|NCT02213783|Imipenem|imipenem|mesh-list
153414974|NCT05480293|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153414975|NCT05480293|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153414976|NCT05480293|Growth Substances|growth substances|mesh-ancestor
153812725|NCT00430365|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153812726|NCT00430365|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153812760|NCT00330278|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153812762|NCT00330317|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153812763|NCT00330317|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
153812764|NCT00330317|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153812765|NCT00330317|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153874306|NCT01117051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153874308|NCT02211417|Mineral Oil|mineral oil|mesh-list
153874309|NCT02211417|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153874310|NCT02211417|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153874311|NCT02211417|Analgesics|analgesics|mesh-ancestor
153874312|NCT02211417|Sensory System Agents|sensory system agents|mesh-ancestor
153874313|NCT02211417|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153874314|NCT02211417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153874315|NCT02211417|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153874316|NCT02211417|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153415018|NCT04143607|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153415020|NCT04143607|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153415021|NCT04143607|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153415022|NCT04802863|Imipenem|imipenem|mesh-list
153415023|NCT04802863|Cilastatin|cilastatin|mesh-list
153415024|NCT04802863|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153415025|NCT04802863|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153415026|NCT04802863|Protease Inhibitors|protease inhibitors|mesh-ancestor
153415027|NCT04802863|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153415028|NCT04802863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153415029|NCT04622839|Acetaminophen|acetaminophen|mesh-list
153415030|NCT04622839|Ibuprofen|ibuprofen|mesh-list
153415031|NCT04622839|Diclofenac|diclofenac|mesh-list
153415032|NCT04622839|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153358902|NCT06213935|Sympathomimetics|sympathomimetics|mesh-ancestor
153358903|NCT06213935|Autonomic Agents|autonomic agents|mesh-ancestor
153358904|NCT06213935|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153358915|NCT06213662|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
153358916|NCT06213662|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
153429760|NCT00002750|Melphalan|melphalan|mesh-list
153415033|NCT04622839|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153415034|NCT04622839|Analgesics|analgesics|mesh-ancestor
153415035|NCT04622839|Sensory System Agents|sensory system agents|mesh-ancestor
153812766|NCT00330317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153812767|NCT00330317|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
153812768|NCT00330317|Hormone Antagonists|hormone antagonists|mesh-ancestor
153812769|NCT00330317|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153812770|NCT00330317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153812771|NCT00430443|Annamycin|annamycin|mesh-list
153812772|NCT00430443|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153812773|NCT00430443|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153812774|NCT00330395|Caspofungin|caspofungin|mesh-list
153812775|NCT00330395|Antifungal Agents|antifungal agents|mesh-ancestor
153812776|NCT00330395|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153874322|NCT02211417|Emollients|emollients|mesh-ancestor
153874323|NCT02279121|Taurolidine|taurolidine|mesh-list
153874324|NCT02279121|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
153874325|NCT02279121|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153874326|NCT02279121|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
153874327|NCT02279121|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153874328|NCT02218164|Interferons|interferons|mesh-list
153874329|NCT02218164|Interferon-alpha|interferon-alpha|mesh-list
153874330|NCT02218164|Interferon alpha-2|interferon alpha-2|mesh-list
153874331|NCT02218164|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
153874332|NCT02218164|Capecitabine|capecitabine|mesh-list
153874333|NCT02218164|Fluorouracil|fluorouracil|mesh-list
153874334|NCT02218164|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153874335|NCT02218164|Antimetabolites|antimetabolites|mesh-ancestor
153874336|NCT02218164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153874337|NCT02218164|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153874338|NCT02218164|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153874339|NCT02218164|Immunologic Factors|immunologic factors|mesh-ancestor
153874340|NCT02218164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153874341|NCT02218164|Antiviral Agents|antiviral agents|mesh-ancestor
153874342|NCT02218164|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153874343|NCT04552067|Enoxaparin|enoxaparin|mesh-list
153874344|NCT04552067|Anticoagulants|anticoagulants|mesh-ancestor
153874345|NCT04552067|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153874346|NCT04552067|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153874347|NCT04552067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153874348|NCT01643187|Vitamins|vitamins|mesh-list
153874349|NCT01643187|Micronutrients|micronutrients|mesh-ancestor
153415052|NCT02619799|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153415055|NCT02619799|Anesthetics|anesthetics|mesh-ancestor
153812778|NCT00330395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153812779|NCT00434382|Fentanyl|fentanyl|mesh-list
153812780|NCT00434382|Sufentanil|sufentanil|mesh-list
153812781|NCT00434382|Remifentanil|remifentanil|mesh-list
153812782|NCT00434382|Alfentanil|alfentanil|mesh-list
153812783|NCT00434382|Propofol|propofol|mesh-list
153812784|NCT00434382|Sevoflurane|sevoflurane|mesh-list
153812785|NCT00434382|Desflurane|desflurane|mesh-list
153812786|NCT00434382|Isoflurane|isoflurane|mesh-list
153812787|NCT00434382|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153874363|NCT04551755|Ivermectin|ivermectin|mesh-list
153874364|NCT04551755|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153874365|NCT04551755|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153812791|NCT00434382|Anesthetics, General|anesthetics, general|mesh-ancestor
153812810|NCT00330746|Gemcitabine|gemcitabine|mesh-list
153812811|NCT00330746|Cetuximab|cetuximab|mesh-list
153874366|NCT04551755|Antimalarials|antimalarials|mesh-ancestor
153874367|NCT04551755|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153874368|NCT04551755|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153874369|NCT01643499|Leucovorin|leucovorin|mesh-list
153874370|NCT01643499|Fluorouracil|fluorouracil|mesh-list
153874371|NCT01643499|Oxaliplatin|oxaliplatin|mesh-list
153358919|NCT06213662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153358920|NCT06213662|Cholinergic Agents|cholinergic agents|mesh-ancestor
153415072|NCT04741165|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153415073|NCT04741165|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153415074|NCT04741165|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153415075|NCT04741165|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153415076|NCT04741165|Growth Substances|growth substances|mesh-ancestor
153415077|NCT04741165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153415078|NCT04741165|Growth Inhibitors|growth inhibitors|mesh-ancestor
153415079|NCT04741165|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153415080|NCT04741165|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153415081|NCT04741165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153415082|NCT02625181|Promethazine|promethazine|mesh-list
153415083|NCT02625181|Diphenhydramine|diphenhydramine|mesh-list
153415085|NCT02625181|Dexamethasone|dexamethasone|mesh-list
153415086|NCT02625181|Fentanyl|fentanyl|mesh-list
153415087|NCT02625181|Sufentanil|sufentanil|mesh-list
153415088|NCT02625181|Scopolamine|scopolamine|mesh-list
153415089|NCT02625181|Oxymorphone|oxymorphone|mesh-list
153415090|NCT02625181|Meperidine|meperidine|mesh-list
153415091|NCT02625181|Droperidol|droperidol|mesh-list
153415092|NCT02625181|Ketamine|ketamine|mesh-list
153415093|NCT02625181|Morphine|morphine|mesh-list
153415094|NCT02625181|Remifentanil|remifentanil|mesh-list
153415095|NCT02625181|Oxycodone|oxycodone|mesh-list
153415096|NCT02625181|Methadone|methadone|mesh-list
153415097|NCT02625181|Hydromorphone|hydromorphone|mesh-list
153812813|NCT00330746|Antimetabolites|antimetabolites|mesh-ancestor
153812814|NCT00330746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153812815|NCT00330746|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153812816|NCT00330746|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153359238|NCT05747794|Tubulin Modulators|tubulin modulators|mesh-ancestor
153812817|NCT01053741|Plasma-lyte 148|plasma-lyte 148|mesh-list
153874375|NCT01643499|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153874376|NCT01643499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153874377|NCT01643499|Antimetabolites|antimetabolites|mesh-ancestor
153874378|NCT01643499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153874379|NCT01643499|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153874380|NCT01643499|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153874381|NCT01643499|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153874382|NCT01643499|Immunologic Factors|immunologic factors|mesh-ancestor
153874383|NCT01643499|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
153874384|NCT01643499|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153874385|NCT01643499|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153874386|NCT01643499|Antidotes|antidotes|mesh-ancestor
153874387|NCT01643499|Protective Agents|protective agents|mesh-ancestor
153874388|NCT01643499|Vitamin B Complex|vitamin b complex|mesh-ancestor
153874389|NCT01643499|Vitamins|vitamins|mesh-ancestor
153874390|NCT01643499|Micronutrients|micronutrients|mesh-ancestor
153358921|NCT06213662|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153358922|NCT06213662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153358923|NCT06213662|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
153358924|NCT06213662|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153358925|NCT06213610|Perindopril|perindopril|mesh-list
153358926|NCT06213610|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
153358927|NCT06213610|Protease Inhibitors|protease inhibitors|mesh-ancestor
153358928|NCT06213610|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153421830|NCT05431595|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153358930|NCT06213610|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153358931|NCT06213519|Oxaliplatin|oxaliplatin|mesh-list
153429826|NCT01157533|Vancomycin|vancomycin|mesh-list
153874391|NCT01117012|Ivacaftor|ivacaftor|mesh-list
153874392|NCT01117012|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
153874393|NCT01117012|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153874394|NCT01117012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153874395|NCT01116739|Fluorides|fluorides|mesh-list
153874397|NCT01116739|Cariostatic Agents|cariostatic agents|mesh-ancestor
153874398|NCT01116739|Protective Agents|protective agents|mesh-ancestor
153415103|NCT02625181|Metoclopramide|metoclopramide|mesh-list
153415104|NCT02625181|Palonosetron|palonosetron|mesh-list
153415105|NCT02625181|Granisetron|granisetron|mesh-list
153415106|NCT02625181|Ramosetron|ramosetron|mesh-list
153415107|NCT02625181|Tropisetron|tropisetron|mesh-list
153415108|NCT02625181|Dolasetron|dolasetron|mesh-list
153415109|NCT02625181|Anesthetics|anesthetics|mesh-list
153415110|NCT02625181|Propofol|propofol|mesh-list
153415111|NCT02625181|Sevoflurane|sevoflurane|mesh-list
153415112|NCT02625181|Desflurane|desflurane|mesh-list
153415113|NCT02625181|Isoflurane|isoflurane|mesh-list
153415114|NCT02625181|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
153812818|NCT01053741|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
153812819|NCT01053741|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
153812821|NCT00330785|Amlodipine, atorvastatin drug combination|amlodipine, atorvastatin drug combination|mesh-list
153812822|NCT00330785|Atorvastatin|atorvastatin|mesh-list
153812823|NCT00330785|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153812824|NCT00330785|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153812825|NCT00330785|Antimetabolites|antimetabolites|mesh-ancestor
153812826|NCT00330785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153812827|NCT00330785|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153812828|NCT00330785|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
153812829|NCT00330785|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153812830|NCT00330785|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153812831|NCT00330785|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153812832|NCT00330785|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153812833|NCT00330785|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153812834|NCT00330785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153812835|NCT00330785|Vasodilator Agents|vasodilator agents|mesh-ancestor
153812836|NCT00330824|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
153812837|NCT00330824|Moxifloxacin|moxifloxacin|mesh-list
153812838|NCT00330824|Dexamethasone|dexamethasone|mesh-list
153812839|NCT00330824|Dexamethasone acetate|dexamethasone acetate|mesh-list
153812840|NCT00330824|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
153812841|NCT00330824|BB 1101|bb 1101|mesh-list
153812843|NCT00330824|Antiemetics|antiemetics|mesh-ancestor
153874405|NCT01640496|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153874406|NCT01640496|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153874408|NCT04551248|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
153874409|NCT04551248|Immunologic Factors|immunologic factors|mesh-ancestor
153874410|NCT04551248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153874411|NCT01640535|Cetirizine|cetirizine|mesh-list
153874412|NCT01640535|Montelukast|montelukast|mesh-list
153874413|NCT01640535|Levocetirizine|levocetirizine|mesh-list
153874414|NCT01640535|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153874415|NCT01640535|Respiratory System Agents|respiratory system agents|mesh-ancestor
153874416|NCT01640535|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
153415123|NCT02625181|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153415124|NCT02625181|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153415126|NCT02625181|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153415127|NCT02625181|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153415128|NCT02625181|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153415129|NCT02625181|Anesthetics, General|anesthetics, general|mesh-ancestor
153812850|NCT00330824|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153812851|NCT00330824|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153358933|NCT06213506|Vaccines|vaccines|mesh-list
153812853|NCT00330824|Protease Inhibitors|protease inhibitors|mesh-ancestor
153812854|NCT00330824|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153812855|NCT00330824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153812856|NCT00330824|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153812857|NCT00330824|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153812858|NCT00330824|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153415130|NCT02625181|Analgesics|analgesics|mesh-ancestor
153415131|NCT02625181|Sensory System Agents|sensory system agents|mesh-ancestor
153415132|NCT02625181|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
153415133|NCT02625181|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
153415134|NCT02625181|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
153415135|NCT02625181|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153415136|NCT02625181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153415137|NCT02625181|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153415138|NCT02625181|Narcotics|narcotics|mesh-ancestor
153415139|NCT02625181|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153415145|NCT02625181|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153415147|NCT02625181|Antitussive Agents|antitussive agents|mesh-ancestor
153415148|NCT02625181|Respiratory System Agents|respiratory system agents|mesh-ancestor
153415149|NCT02625181|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
153415150|NCT02625181|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153415151|NCT02625181|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153415152|NCT02625181|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153415153|NCT02625181|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
153415155|NCT02625181|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
153415156|NCT02625181|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
153415157|NCT02625181|Mydriatics|mydriatics|mesh-ancestor
153874417|NCT01640535|Hormone Antagonists|hormone antagonists|mesh-ancestor
153812859|NCT00330824|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
153812860|NCT00330824|Contraceptive Agents|contraceptive agents|mesh-ancestor
153812861|NCT00330824|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153812862|NCT00330824|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
153812863|NCT00330824|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
153358942|NCT06213116|Anesthetics, Local|anesthetics, local|mesh-ancestor
153358943|NCT06213116|Anesthetics|anesthetics|mesh-ancestor
153358944|NCT06213116|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153358945|NCT06213116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153358946|NCT06213116|Sensory System Agents|sensory system agents|mesh-ancestor
153358947|NCT06213116|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153358948|NCT06213116|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153358953|NCT06213077|Nitric Oxide|nitric oxide|mesh-list
153812864|NCT00330824|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
153812866|NCT00330902|Pyrimethamine|pyrimethamine|mesh-list
153812867|NCT00330902|Primaquine|primaquine|mesh-list
153812868|NCT00330902|Sulfadoxine|sulfadoxine|mesh-list
153812869|NCT00330902|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
153812870|NCT00330902|Antimalarials|antimalarials|mesh-ancestor
153812871|NCT00330902|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153874418|NCT01640535|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153874419|NCT01640535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153874420|NCT01640535|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
153874421|NCT01640535|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
153874422|NCT01640535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153874423|NCT01640535|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
153874425|NCT01640535|Histamine Antagonists|histamine antagonists|mesh-ancestor
153874426|NCT01640535|Histamine Agents|histamine agents|mesh-ancestor
153874427|NCT01640535|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153874428|NCT01640535|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
153874429|NCT04550858|Rebamipide|rebamipide|mesh-list
153874430|NCT04550858|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
153874431|NCT04550858|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153874432|NCT04550858|Antioxidants|antioxidants|mesh-ancestor
153874433|NCT04550858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153874434|NCT04550858|Protective Agents|protective agents|mesh-ancestor
153874435|NCT04550858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153874436|NCT04550858|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153874437|NCT01640574|Chloroquine|chloroquine|mesh-list
153874438|NCT01640574|Chloroquine diphosphate|chloroquine diphosphate|mesh-list
153874439|NCT01640574|Piperaquine|piperaquine|mesh-list
153874440|NCT01640574|Artenimol|artenimol|mesh-list
153812872|NCT00330902|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153812873|NCT00330902|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153812874|NCT00330902|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153812875|NCT00330902|Antiviral Agents|antiviral agents|mesh-ancestor
153812876|NCT00330902|Schistosomicides|schistosomicides|mesh-ancestor
153812877|NCT00330902|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
153812878|NCT00330902|Anthelmintics|anthelmintics|mesh-ancestor
153359313|NCT05643651|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153812894|NCT00330980|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153812895|NCT00330980|Antimetabolites|antimetabolites|mesh-ancestor
153812896|NCT00330980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153874441|NCT01640574|Artemisinins|artemisinins|mesh-list
153874442|NCT01640574|Amebicides|amebicides|mesh-ancestor
153874443|NCT01640574|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153874444|NCT01640574|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153874445|NCT01640574|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153874446|NCT01640574|Antimalarials|antimalarials|mesh-ancestor
153874447|NCT01640574|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153874448|NCT01640574|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153874449|NCT01640574|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153874450|NCT01640574|Analgesics|analgesics|mesh-ancestor
153415158|NCT02625181|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
153415159|NCT02625181|Cholinergic Agents|cholinergic agents|mesh-ancestor
153415160|NCT02625181|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
153812897|NCT00330980|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153812898|NCT00330980|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
153812899|NCT00330980|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153812900|NCT00430833|Candesartan|candesartan|mesh-list
153812901|NCT00430833|Candesartan cilexetil|candesartan cilexetil|mesh-list
153812902|NCT00430833|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153812903|NCT00430833|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
153812904|NCT00430833|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
153812905|NCT00430833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153415161|NCT02625181|Parasympatholytics|parasympatholytics|mesh-ancestor
153415162|NCT02625181|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
153812906|NCT00331058|Prednisolone|prednisolone|mesh-list
153415163|NCT02625181|Histamine Antagonists|histamine antagonists|mesh-ancestor
153415164|NCT02625181|Histamine Agents|histamine agents|mesh-ancestor
153415165|NCT02625181|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
153415166|NCT02625181|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
153415167|NCT02625181|Anesthetics, Local|anesthetics, local|mesh-ancestor
153415168|NCT02630017|Methylphenidate|methylphenidate|mesh-list
153415169|NCT02630017|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
153415170|NCT02630017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153415171|NCT02630017|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
153415172|NCT02630017|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153415173|NCT02630017|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153415174|NCT02630017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153415175|NCT02630017|Dopamine Agents|dopamine agents|mesh-ancestor
153415176|NCT02630017|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153415178|NCT02630719|Ophthalmic Solutions|ophthalmic solutions|mesh-list
153415179|NCT02630719|Lubricant Eye Drops|lubricant eye drops|mesh-list
153415180|NCT02630719|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
153415181|NCT02630719|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
153812907|NCT00331058|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153812908|NCT00331058|Glucocorticoids|glucocorticoids|mesh-ancestor
153812909|NCT00331058|Hormones|hormones|mesh-ancestor
153812910|NCT00331058|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153812911|NCT00331058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153812912|NCT00331058|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153812913|NCT00331058|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153812914|NCT00331097|Cyclophosphamide|cyclophosphamide|mesh-list
153874453|NCT01640574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153874454|NCT01640574|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153874455|NCT01640574|Filaricides|filaricides|mesh-ancestor
153874456|NCT01640574|Antinematodal Agents|antinematodal agents|mesh-ancestor
153874457|NCT01640574|Anthelmintics|anthelmintics|mesh-ancestor
153874458|NCT01116427|Abatacept|abatacept|mesh-list
153874459|NCT01116427|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153874460|NCT01116427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153874461|NCT01116427|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153874462|NCT01116427|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153874463|NCT01116427|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153874464|NCT01116427|Immunologic Factors|immunologic factors|mesh-ancestor
153874465|NCT01116427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153874466|NCT01116427|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153874467|NCT04529226|Haloperidol|haloperidol|mesh-list
153874468|NCT04529226|Pimozide|pimozide|mesh-list
153874469|NCT04529226|Olanzapine|olanzapine|mesh-list
153874470|NCT04529226|Risperidone|risperidone|mesh-list
153874471|NCT04529226|Haloperidol decanoate|haloperidol decanoate|mesh-list
153874472|NCT04529226|Clozapine|clozapine|mesh-list
153874473|NCT04529226|Amisulpride|amisulpride|mesh-list
153874474|NCT04529226|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153874475|NCT04529226|Serotonin Agents|serotonin agents|mesh-ancestor
153874476|NCT04529226|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153874477|NCT04529226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153812916|NCT00331097|Fluorouracil|fluorouracil|mesh-list
153812917|NCT00331097|Methotrexate|methotrexate|mesh-list
153812938|NCT00331097|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153812940|NCT00331214|Androgens|androgens|mesh-ancestor
153812941|NCT00331214|Hormones|hormones|mesh-ancestor
153812942|NCT00331214|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153812943|NCT00331214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153812944|NCT00434772|Glucagon|glucagon|mesh-list
153812945|NCT00434772|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153812946|NCT00434772|Hormones|hormones|mesh-ancestor
153812947|NCT00434772|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153812948|NCT00434772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153812949|NCT00431028|Ciprofloxacin|ciprofloxacin|mesh-list
153415205|NCT04159519|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153415206|NCT04159519|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153415207|NCT04159519|Autonomic Agents|autonomic agents|mesh-ancestor
153415208|NCT04159519|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153415209|NCT04159519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153415210|NCT04159519|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153415211|NCT04159519|Respiratory System Agents|respiratory system agents|mesh-ancestor
153359028|NCT06212648|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
153359030|NCT06212596|Prednisone|prednisone|mesh-list
153359031|NCT06212596|Cyclophosphamide|cyclophosphamide|mesh-list
153359032|NCT06212596|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153359033|NCT06212596|Immunologic Factors|immunologic factors|mesh-ancestor
153359034|NCT06212596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153359035|NCT06212596|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153359036|NCT06212596|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153359037|NCT06212596|Alkylating Agents|alkylating agents|mesh-ancestor
153359038|NCT06212596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153415212|NCT04159519|Glucocorticoids|glucocorticoids|mesh-ancestor
153415213|NCT04159519|Hormones|hormones|mesh-ancestor
153415214|NCT04159519|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153415215|NCT04159519|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
153415216|NCT04159519|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
153874481|NCT04529226|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153874483|NCT04529226|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
153874484|NCT04529226|Dopamine Agents|dopamine agents|mesh-ancestor
153874485|NCT04529226|Antiemetics|antiemetics|mesh-ancestor
153874486|NCT04529226|Autonomic Agents|autonomic agents|mesh-ancestor
153874487|NCT04529226|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153874488|NCT04529226|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153874489|NCT04529226|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
153874490|NCT04529226|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153874491|NCT04529226|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153874492|NCT04529226|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
153874493|NCT04529226|GABA Antagonists|gaba antagonists|mesh-ancestor
153874494|NCT04529226|GABA Agents|gaba agents|mesh-ancestor
153874495|NCT04529226|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
153874496|NCT04529226|Antidepressive Agents|antidepressive agents|mesh-ancestor
153874497|NCT04310683|Hormones|hormones|mesh-list
153812952|NCT00431028|Glucocorticoids|glucocorticoids|mesh-ancestor
153812953|NCT00431028|Hormones|hormones|mesh-ancestor
153812954|NCT00431028|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153812955|NCT00431028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153812956|NCT00431028|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153812957|NCT00431028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153874501|NCT04550702|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
153874502|NCT04550702|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
153874503|NCT04550702|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153874505|NCT04550702|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153874506|NCT04550702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153874507|NCT04550702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153874508|NCT04550702|Urological Agents|urological agents|mesh-ancestor
153874509|NCT01116232|Sirolimus|sirolimus|mesh-list
153874510|NCT01116232|Rituximab|rituximab|mesh-list
153874511|NCT01116232|Tacrolimus|tacrolimus|mesh-list
153415220|NCT04159519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153415221|NCT04159519|Tocolytic Agents|tocolytic agents|mesh-ancestor
153415222|NCT04159519|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153415223|NCT02634073|Lamivudine|lamivudine|mesh-list
153415224|NCT02634073|Sorbitol|sorbitol|mesh-list
153415225|NCT02634073|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153415226|NCT02634073|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153415227|NCT02634073|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153812958|NCT00431028|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153812959|NCT00431028|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153812960|NCT00431028|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153812961|NCT00431028|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153812962|NCT00431028|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153812963|NCT00431028|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
153812964|NCT00431028|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153812965|NCT00431106|Gemcitabine|gemcitabine|mesh-list
153812966|NCT00431106|Capecitabine|capecitabine|mesh-list
153415232|NCT02634073|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153415234|NCT02634073|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153415235|NCT00366691|Loteprednol Etabonate|loteprednol etabonate|mesh-list
153415236|NCT00366691|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
153415237|NCT00367393|Pimecrolimus|pimecrolimus|mesh-list
153812967|NCT00431106|Vinorelbine|vinorelbine|mesh-list
153812968|NCT00431106|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153812969|NCT00431106|Antimetabolites|antimetabolites|mesh-ancestor
153812970|NCT00431106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153812976|NCT00431145|Niacin|niacin|mesh-list
153812977|NCT00431145|Niacinamide|niacinamide|mesh-list
153812978|NCT00431145|Nicotinic Acids|nicotinic acids|mesh-list
153812979|NCT00431145|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153812980|NCT00431145|Antimetabolites|antimetabolites|mesh-ancestor
153812981|NCT00431145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153812982|NCT00431145|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153812983|NCT00431145|Vasodilator Agents|vasodilator agents|mesh-ancestor
153812984|NCT00431145|Vitamin B Complex|vitamin b complex|mesh-ancestor
153812986|NCT00431145|Micronutrients|micronutrients|mesh-ancestor
153812987|NCT00431145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153812988|NCT00331487|Pioglitazone|pioglitazone|mesh-list
153812989|NCT00331487|Rosiglitazone|rosiglitazone|mesh-list
153812990|NCT00331487|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153812991|NCT00331487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153812992|NCT00331526|Aldesleukin|aldesleukin|mesh-list
153812993|NCT00331526|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153812994|NCT00331526|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153874514|NCT01116232|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153874515|NCT01116232|Immunologic Factors|immunologic factors|mesh-ancestor
153874516|NCT01116232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153874517|NCT01116232|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153874518|NCT01116232|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153874519|NCT01116232|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
153874520|NCT01116232|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153874521|NCT01116232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153874522|NCT01116232|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153874523|NCT01116232|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153874524|NCT01116232|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153874525|NCT01116232|Antifungal Agents|antifungal agents|mesh-ancestor
153874526|NCT02214095|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
153874527|NCT04550351|Vaccines|vaccines|mesh-list
153874528|NCT04550351|Immunologic Factors|immunologic factors|mesh-ancestor
153415238|NCT00367393|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153415239|NCT00367393|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153812995|NCT00331526|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153812996|NCT00331526|Antiviral Agents|antiviral agents|mesh-ancestor
153812997|NCT00331526|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153812998|NCT00431262|Disulfiram|disulfiram|mesh-list
153812999|NCT00431262|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
153813000|NCT00431262|Acetaldehyde Dehydrogenase Inhibitors|acetaldehyde dehydrogenase inhibitors|mesh-ancestor
153813003|NCT00331604|Insulin|insulin|mesh-list
153813029|NCT00331838|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
153813030|NCT00331838|Enoxaparin sodium|enoxaparin sodium|mesh-list
153813031|NCT00331838|Anticoagulants|anticoagulants|mesh-ancestor
153813032|NCT00331838|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153813033|NCT00331838|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153813034|NCT00331838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153813035|NCT00431418|Sildenafil Citrate|sildenafil citrate|mesh-list
153813036|NCT00431418|Vasodilator Agents|vasodilator agents|mesh-ancestor
153415240|NCT00367393|Analgesics|analgesics|mesh-ancestor
153415241|NCT00367393|Sensory System Agents|sensory system agents|mesh-ancestor
153387802|NCT00000807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153387834|NCT00001713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153387836|NCT00000273|Morphine|morphine|mesh-list
153387837|NCT00000273|Oxycodone|oxycodone|mesh-list
153387838|NCT00000273|Buprenorphine|buprenorphine|mesh-list
153387839|NCT00000273|Methadone|methadone|mesh-list
153387840|NCT00000273|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153387841|NCT00000273|Narcotics|narcotics|mesh-ancestor
153387842|NCT00000273|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153387843|NCT00000273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153387844|NCT00000273|Analgesics|analgesics|mesh-ancestor
153387845|NCT00000273|Sensory System Agents|sensory system agents|mesh-ancestor
153387846|NCT00000273|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153387847|NCT00000273|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153387848|NCT00000273|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153387849|NCT00000273|Anesthetics, General|anesthetics, general|mesh-ancestor
153387884|NCT00000285|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
153813037|NCT00431418|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
153813038|NCT00431418|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
153813039|NCT00431418|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153813040|NCT00431418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153813041|NCT00431418|Urological Agents|urological agents|mesh-ancestor
153813042|NCT00331955|Doxorubicin|doxorubicin|mesh-list
153813043|NCT00331955|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
153813044|NCT00331955|Vorinostat|vorinostat|mesh-list
153813045|NCT00331955|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153813046|NCT00331955|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153813047|NCT00331955|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153813048|NCT00331955|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153813049|NCT00331955|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153387886|NCT00000285|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153387887|NCT00000285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153387888|NCT00000285|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
153387889|NCT00000285|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
153387922|NCT05362487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153387925|NCT00000291|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
153387926|NCT00000291|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
153387927|NCT00000291|Adrenergic Agents|adrenergic agents|mesh-ancestor
153813050|NCT00331955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153430111|NCT04403516|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
153430112|NCT04403516|Protective Agents|protective agents|mesh-ancestor
153889006|NCT01292187|Calcitonin Gene-Related Peptide|calcitonin gene-related peptide|mesh-list
153889008|NCT01292187|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153889009|NCT01292187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153889010|NCT01292187|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153889011|NCT01292187|Vasodilator Agents|vasodilator agents|mesh-ancestor
153430113|NCT01555489|Ascorbic Acid|ascorbic acid|mesh-list
153430115|NCT01555489|Micronutrients|micronutrients|mesh-ancestor
153430116|NCT01555489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153813051|NCT00331955|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
153813053|NCT00331994|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153359538|NCT05004350|Cetuximab|cetuximab|mesh-list
153359539|NCT05004350|Antimetabolites|antimetabolites|mesh-ancestor
153359550|NCT04899765|Vaccines|vaccines|mesh-list
153359560|NCT04891991|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153359561|NCT04873050|Semaglutide|semaglutide|mesh-list
153359562|NCT04873050|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
153387929|NCT00000291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153387991|NCT00001827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153387992|NCT00001827|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153387993|NCT00001827|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153387994|NCT00001827|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153387995|NCT00001827|Antiviral Agents|antiviral agents|mesh-ancestor
153387996|NCT00001827|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153387997|NCT00001827|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153387999|NCT01647516|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
153388000|NCT01647516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153388001|NCT01647516|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153388002|NCT01647516|Immunologic Factors|immunologic factors|mesh-ancestor
153359564|NCT04873050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153359565|NCT04858009|Paclitaxel|paclitaxel|mesh-list
153359566|NCT04858009|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
153359567|NCT04858009|Cisplatin|cisplatin|mesh-list
153359568|NCT04858009|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153359569|NCT04858009|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153813054|NCT00331994|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153359570|NCT04858009|Tubulin Modulators|tubulin modulators|mesh-ancestor
153388003|NCT01647516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153388004|NCT00001839|Cyclosporine|cyclosporine|mesh-list
153388062|NCT05347979|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153388063|NCT05347979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153388065|NCT00000909|Aldesleukin|aldesleukin|mesh-list
153388066|NCT00000909|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153388067|NCT00000909|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153388068|NCT00000909|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153388069|NCT00000909|Antiviral Agents|antiviral agents|mesh-ancestor
153388070|NCT00000909|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153388071|NCT00001863|Leflunomide|leflunomide|mesh-list
153388072|NCT00001863|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153388073|NCT00001863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153388074|NCT00001863|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153388075|NCT00001863|Immunologic Factors|immunologic factors|mesh-ancestor
153388076|NCT00001863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153388103|NCT00000939|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153388104|NCT00000939|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153388105|NCT00000939|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153388106|NCT00000939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153388107|NCT00000939|Antiviral Agents|antiviral agents|mesh-ancestor
153388108|NCT00000939|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153359082|NCT06209606|Autonomic Agents|autonomic agents|mesh-ancestor
153359083|NCT06209606|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153359084|NCT06209606|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153359085|NCT06209606|Glucocorticoids|glucocorticoids|mesh-ancestor
153359086|NCT06209606|Hormones|hormones|mesh-ancestor
153889046|NCT01021813|Suvorexant|suvorexant|mesh-list
153388109|NCT00000939|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
153388110|NCT00000939|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153388111|NCT00000939|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
153388112|NCT00000939|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
153813055|NCT00331994|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153813056|NCT00331994|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153813058|NCT00332033|Analgesics|analgesics|mesh-ancestor
153813059|NCT00332033|Sensory System Agents|sensory system agents|mesh-ancestor
153813060|NCT00332033|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153813061|NCT00332033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153813062|NCT00332033|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153813063|NCT00332033|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153813064|NCT00332033|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153813065|NCT00332033|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153813066|NCT00332033|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153813067|NCT00435279|Eszopiclone|eszopiclone|mesh-list
153813068|NCT00435279|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
153813069|NCT00435279|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
153813070|NCT00435279|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153813071|NCT00435279|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153388113|NCT00000939|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
153388114|NCT00000939|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
153388115|NCT00000939|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153388116|NCT00000939|Antisickling Agents|antisickling agents|mesh-ancestor
153388118|NCT00000939|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153388119|NCT00000939|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153388120|NCT00000945|Cidofovir|cidofovir|mesh-list
153388121|NCT00000945|Probenecid|probenecid|mesh-list
153388122|NCT00000945|Uricosuric Agents|uricosuric agents|mesh-ancestor
153388123|NCT00000945|Gout Suppressants|gout suppressants|mesh-ancestor
153388124|NCT00000945|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153388125|NCT00000945|Antiviral Agents|antiviral agents|mesh-ancestor
153388126|NCT00000945|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153388127|NCT00000945|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153813072|NCT00435279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153813074|NCT00435279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153813075|NCT00435279|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
153813076|NCT00435279|Antidepressive Agents|antidepressive agents|mesh-ancestor
153813077|NCT00435279|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153813078|NCT00435279|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153813079|NCT00435279|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153388158|NCT00001893|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153388159|NCT00001893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153388160|NCT00001893|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153388161|NCT00001893|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153388162|NCT00001893|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153388163|NCT00001893|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153388164|NCT00001893|Immunologic Factors|immunologic factors|mesh-ancestor
153388166|NCT00000981|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153388167|NCT00000981|Antiviral Agents|antiviral agents|mesh-ancestor
153388168|NCT00000981|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153388169|NCT02280096|4-Aminopyridine|4-aminopyridine|mesh-list
153388170|NCT02280096|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
153388171|NCT02280096|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153388195|NCT00000987|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153388197|NCT00000987|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153388198|NCT00000987|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153813081|NCT00332072|Bimatoprost|bimatoprost|mesh-list
153813082|NCT00332072|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
153813083|NCT00332072|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
153813084|NCT00332072|Adrenergic Agents|adrenergic agents|mesh-ancestor
153813085|NCT00332072|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153813086|NCT00332072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153813087|NCT00332072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153813088|NCT00332072|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153813089|NCT00332072|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153388199|NCT00000987|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153388200|NCT00001911|Interleukin-12|interleukin-12|mesh-list
153388201|NCT00001911|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153388202|NCT00001911|Immunologic Factors|immunologic factors|mesh-ancestor
153388203|NCT00001911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153388204|NCT00001911|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153388205|NCT00001911|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153388206|NCT00001911|Growth Substances|growth substances|mesh-ancestor
153388207|NCT00001911|Growth Inhibitors|growth inhibitors|mesh-ancestor
153388208|NCT00001911|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153388210|NCT00001929|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
153388211|NCT00001929|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
153388212|NCT00001929|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153388213|NCT00001929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153388214|NCT00001929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153388215|NCT00001929|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
153388216|NCT00001929|Protective Agents|protective agents|mesh-ancestor
153388217|NCT00358553|Insulin|insulin|mesh-list
153388218|NCT00358553|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153388219|NCT00358553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153388220|NCT00000993|Zidovudine|zidovudine|mesh-list
153388222|NCT00000993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153388223|NCT00000993|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153388250|NCT00001017|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153388251|NCT00001017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153388252|NCT00001017|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
153388253|NCT00001017|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
153388254|NCT00001017|Amebicides|amebicides|mesh-ancestor
153388255|NCT00001017|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153813091|NCT00431613|Gemcitabine|gemcitabine|mesh-list
153813092|NCT00431613|Docetaxel|docetaxel|mesh-list
153813093|NCT00431613|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153813094|NCT00431613|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153813095|NCT00431613|Antimetabolites|antimetabolites|mesh-ancestor
153813096|NCT00431613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153813097|NCT00431613|Tubulin Modulators|tubulin modulators|mesh-ancestor
153813098|NCT00431613|Antimitotic Agents|antimitotic agents|mesh-ancestor
153813099|NCT00431613|Mitosis Modulators|mitosis modulators|mesh-ancestor
153813100|NCT00332228|Naltrexone|naltrexone|mesh-list
153813101|NCT00332228|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
153388256|NCT00001017|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153388257|NCT00001017|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153388259|NCT02279862|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153388260|NCT02279862|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153388261|NCT02279862|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153388263|NCT00001965|Cyclosporine|cyclosporine|mesh-list
153388264|NCT00001965|Cyclosporins|cyclosporins|mesh-list
153388265|NCT00001965|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153388266|NCT00001965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153388267|NCT00001965|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153388268|NCT00001965|Immunologic Factors|immunologic factors|mesh-ancestor
153388269|NCT00001965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153388349|NCT00001059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153388350|NCT00001059|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153388351|NCT00001059|Tubulin Modulators|tubulin modulators|mesh-ancestor
153388352|NCT00001059|Antimitotic Agents|antimitotic agents|mesh-ancestor
153388353|NCT00001059|Mitosis Modulators|mitosis modulators|mesh-ancestor
153388355|NCT00001065|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
153388356|NCT00001065|Amebicides|amebicides|mesh-ancestor
153388357|NCT00001065|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153388358|NCT00001065|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153388359|NCT00001065|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153813104|NCT00332228|Sensory System Agents|sensory system agents|mesh-ancestor
153813105|NCT00332228|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153813106|NCT00431691|Nitroglycerin|nitroglycerin|mesh-list
153813107|NCT00431691|Vasodilator Agents|vasodilator agents|mesh-ancestor
153388360|NCT00001065|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153388362|NCT02977637|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
153388363|NCT02977637|Hematinics|hematinics|mesh-ancestor
153388364|NCT02977637|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
153388365|NCT02977637|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
153813108|NCT00332306|Lamivudine|lamivudine|mesh-list
153813109|NCT00332306|Efavirenz|efavirenz|mesh-list
153813110|NCT00332306|Nevirapine|nevirapine|mesh-list
153813111|NCT00332306|Didanosine|didanosine|mesh-list
153359130|NCT06108830|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153359131|NCT06108830|Anesthetics, General|anesthetics, general|mesh-ancestor
153359132|NCT06108830|Anesthetics|anesthetics|mesh-ancestor
153359133|NCT06108830|Antidepressive Agents|antidepressive agents|mesh-ancestor
153359134|NCT06108830|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153813112|NCT00332306|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153813113|NCT00332306|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153813120|NCT00332306|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
153813121|NCT00332306|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153813122|NCT00332306|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
153813123|NCT00332306|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
153388366|NCT00001995|Rifabutin|rifabutin|mesh-list
153388367|NCT00001995|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153388368|NCT00001995|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153388369|NCT00001995|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
153388370|NCT00001995|Antitubercular Agents|antitubercular agents|mesh-ancestor
153388371|NCT00002001|Zidovudine|zidovudine|mesh-list
153388372|NCT00002001|Didanosine|didanosine|mesh-list
153388373|NCT00002001|Zalcitabine|zalcitabine|mesh-list
153388374|NCT00002001|Antimetabolites|antimetabolites|mesh-ancestor
153388375|NCT00002001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153388376|NCT00002001|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153813125|NCT00332306|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
153813126|NCT00332306|Antimetabolites|antimetabolites|mesh-ancestor
153813127|NCT00332345|Timolol|timolol|mesh-list
153813128|NCT00332345|Brimonidine Tartrate|brimonidine tartrate|mesh-list
153813129|NCT00332345|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
153813130|NCT00332345|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
153813131|NCT00332345|Adrenergic Agents|adrenergic agents|mesh-ancestor
153813132|NCT00332345|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153813133|NCT00332345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153813134|NCT00332345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153813135|NCT00332345|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153813136|NCT00332345|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153813137|NCT00332345|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
153813138|NCT00332345|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153359148|NCT06089395|Vitamins|vitamins|mesh-ancestor
153359149|NCT06079775|Ceftibuten|ceftibuten|mesh-list
153359150|NCT06079775|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153359151|NCT06079775|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153359152|NCT06077721|Milrinone|milrinone|mesh-list
153359153|NCT06077721|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
153813139|NCT00332345|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153813140|NCT00332384|Timolol|timolol|mesh-list
153388377|NCT00002001|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153388378|NCT00002001|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153388379|NCT00002001|Antiviral Agents|antiviral agents|mesh-ancestor
153388380|NCT00002001|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153388381|NCT00002001|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153388382|NCT00002001|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153388383|NCT00002007|Zidovudine|zidovudine|mesh-list
153388384|NCT00002007|Sargramostim|sargramostim|mesh-list
153388385|NCT00002007|Antimetabolites|antimetabolites|mesh-ancestor
153388386|NCT00002007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153388406|NCT00001095|Antiviral Agents|antiviral agents|mesh-ancestor
153388407|NCT00001095|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153388408|NCT00001095|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153388409|NCT00001095|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153388410|NCT00001095|Antimetabolites|antimetabolites|mesh-ancestor
153388411|NCT00001095|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
153388412|NCT00001095|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
153388413|NCT00001095|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
153388414|NCT00001095|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
153388415|NCT00001095|Protease Inhibitors|protease inhibitors|mesh-ancestor
153388416|NCT00001095|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
153388417|NCT00001095|Antitubercular Agents|antitubercular agents|mesh-ancestor
153388418|NCT00001095|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153388419|NCT02294058|Interferons|interferons|mesh-list
153388420|NCT02294058|Interferon-beta|interferon-beta|mesh-list
153388421|NCT02294058|Interferon beta-1a|interferon beta-1a|mesh-list
153388423|NCT02294058|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153388424|NCT02294058|Antiviral Agents|antiviral agents|mesh-ancestor
153388425|NCT02294058|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153813141|NCT00332384|Brimonidine Tartrate|brimonidine tartrate|mesh-list
153813142|NCT00332384|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
153813143|NCT00332384|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
153813144|NCT00332384|Adrenergic Agents|adrenergic agents|mesh-ancestor
153813145|NCT00332384|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153813146|NCT00332384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153813147|NCT00332384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153813148|NCT00332384|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153813149|NCT00332384|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153359658|NCT04432376|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
153359659|NCT04432376|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153359660|NCT04432376|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153388426|NCT02294058|Immunologic Factors|immunologic factors|mesh-ancestor
153388427|NCT02294058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153388428|NCT02294058|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153388429|NCT02294058|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
153388430|NCT02294058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153388431|NCT02294058|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153388432|NCT00002013|Zidovudine|zidovudine|mesh-list
153388433|NCT00002013|Antimetabolites|antimetabolites|mesh-ancestor
153388434|NCT00002013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153388435|NCT00002013|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153388436|NCT00002013|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153388437|NCT00002013|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153388438|NCT00002013|Antiviral Agents|antiviral agents|mesh-ancestor
153388439|NCT00002013|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153388440|NCT00002013|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153359661|NCT04432376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153359663|NCT04432376|Hormone Antagonists|hormone antagonists|mesh-ancestor
153359664|NCT04432376|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153359665|NCT04432376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153359666|NCT04432376|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
153359667|NCT04432376|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
153359668|NCT04430426|Glycolic acid|glycolic acid|mesh-list
153813175|NCT00332735|Anesthetics, Local|anesthetics, local|mesh-ancestor
153388441|NCT00002013|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153388443|NCT00359333|Docetaxel|docetaxel|mesh-list
153388444|NCT00359333|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153388445|NCT00359333|Antimetabolites|antimetabolites|mesh-ancestor
153388475|NCT00001107|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153388476|NCT00002019|Amphotericin B|amphotericin b|mesh-list
153388477|NCT00002019|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
153388478|NCT00002019|Amebicides|amebicides|mesh-ancestor
153388479|NCT00002019|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153388480|NCT00002019|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153388481|NCT00002019|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153388482|NCT00002019|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153388483|NCT00002019|Antifungal Agents|antifungal agents|mesh-ancestor
153388484|NCT00002025|Ganciclovir|ganciclovir|mesh-list
153388485|NCT00002025|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
153388486|NCT00002025|Antiviral Agents|antiviral agents|mesh-ancestor
153783590|NCT00261729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153388487|NCT00002025|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153388488|NCT00002025|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153388489|NCT00002025|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153388588|NCT05031455|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153388589|NCT05031455|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153388661|NCT00002079|Antimetabolites|antimetabolites|mesh-ancestor
153388694|NCT00001407|Interferons|interferons|mesh-list
153813176|NCT00332735|Anesthetics|anesthetics|mesh-ancestor
153813177|NCT00332735|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153813178|NCT00332735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153813179|NCT00332735|Sensory System Agents|sensory system agents|mesh-ancestor
153813180|NCT00332735|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153813181|NCT00332774|Ketorolac|ketorolac|mesh-list
153813182|NCT00332774|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
153813183|NCT00332774|Nepafenac|nepafenac|mesh-list
153813184|NCT00332774|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
153388851|NCT00002127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153388852|NCT00002127|Leprostatic Agents|leprostatic agents|mesh-ancestor
153388853|NCT00002127|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153388854|NCT00002127|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153388855|NCT00002127|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153388856|NCT00002127|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153388857|NCT00002127|Growth Substances|growth substances|mesh-ancestor
153388858|NCT00002127|Growth Inhibitors|growth inhibitors|mesh-ancestor
153388859|NCT00002127|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153388860|NCT00001599|Thalidomide|thalidomide|mesh-list
153388861|NCT00001599|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153388863|NCT00001599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153388864|NCT00001599|Leprostatic Agents|leprostatic agents|mesh-ancestor
153388865|NCT00001599|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153388866|NCT00001599|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153388867|NCT00001599|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153388868|NCT00001599|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153388869|NCT00001599|Growth Substances|growth substances|mesh-ancestor
153388870|NCT00001599|Growth Inhibitors|growth inhibitors|mesh-ancestor
153388908|NCT00002295|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153388909|NCT00002295|Immunologic Factors|immunologic factors|mesh-ancestor
153388937|NCT00002307|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153388938|NCT00002307|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153783591|NCT00261729|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153783592|NCT00261729|Serotonin Agents|serotonin agents|mesh-ancestor
153388939|NCT00002307|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153388949|NCT00002313|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153388950|NCT00002313|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153388951|NCT00002313|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153388952|NCT00002313|Antifungal Agents|antifungal agents|mesh-ancestor
153388953|NCT00002313|Ionophores|ionophores|mesh-ancestor
153359155|NCT06077721|Vasodilator Agents|vasodilator agents|mesh-ancestor
153359156|NCT06077721|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
153359157|NCT06077721|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
153359158|NCT06077721|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153359159|NCT06077721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153359160|NCT06077721|Protective Agents|protective agents|mesh-ancestor
153388954|NCT00002313|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153388955|NCT00002157|Thalidomide|thalidomide|mesh-list
153388956|NCT00002157|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153388957|NCT00002157|Immunologic Factors|immunologic factors|mesh-ancestor
153388958|NCT00002157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153388959|NCT00002157|Leprostatic Agents|leprostatic agents|mesh-ancestor
153388960|NCT00002157|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153388972|NCT00002319|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153388973|NCT00002319|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153389110|NCT00002367|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153389330|NCT00002433|Interferons|interferons|mesh-list
153389331|NCT00002433|Interferon-gamma|interferon-gamma|mesh-list
153389332|NCT00002433|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153389333|NCT00002433|Antiviral Agents|antiviral agents|mesh-ancestor
153389334|NCT00002433|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153389335|NCT00002439|Alitretinoin|alitretinoin|mesh-list
153389336|NCT00002439|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153389337|NCT00002439|Dermatologic Agents|dermatologic agents|mesh-ancestor
153389339|NCT00002229|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
153389340|NCT00002229|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
153389607|NCT00002517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153783593|NCT00261729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153389918|NCT00002571|Micronutrients|micronutrients|mesh-ancestor
153389919|NCT00002571|Tubulin Modulators|tubulin modulators|mesh-ancestor
153390063|NCT00002241|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
153390064|NCT00002241|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153390065|NCT00002241|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153390066|NCT00002241|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153390067|NCT00002241|Antimetabolites|antimetabolites|mesh-ancestor
153390068|NCT05806853|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
153390069|NCT05806853|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
153390207|NCT05775237|Analgesics|analgesics|mesh-ancestor
153390208|NCT05775237|Sensory System Agents|sensory system agents|mesh-ancestor
153390209|NCT05775237|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153390210|NCT05775237|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153390211|NCT05775237|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153390233|NCT05751044|Glucocorticoids|glucocorticoids|mesh-ancestor
153390235|NCT05751044|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153390236|NCT05751044|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153390237|NCT05751044|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153390238|NCT05751044|Antimetabolites|antimetabolites|mesh-ancestor
153390239|NCT05751044|Antiviral Agents|antiviral agents|mesh-ancestor
153390240|NCT05751044|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153390241|NCT05751044|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153390242|NCT05751044|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153390243|NCT05751044|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153390244|NCT05709093|Azacitidine|azacitidine|mesh-list
153390245|NCT05709093|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153390291|NCT05414409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153390292|NCT05411575|Plerixafor|plerixafor|mesh-list
153390293|NCT05411575|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153390294|NCT05411575|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153390295|NCT05411575|Antiviral Agents|antiviral agents|mesh-ancestor
153390296|NCT05411575|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153390297|NCT05367401|Azacitidine|azacitidine|mesh-list
153783594|NCT00261729|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
153390298|NCT05367401|Magrolimab|magrolimab|mesh-list
153783595|NCT00261729|Antidepressive Agents|antidepressive agents|mesh-ancestor
153390307|NCT05297448|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153390308|NCT05297448|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153390310|NCT05161156|Tiotropium Bromide|tiotropium bromide|mesh-list
153390311|NCT05161156|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153390372|NCT04669210|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153390373|NCT04669210|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
153390374|NCT04669210|Antitubercular Agents|antitubercular agents|mesh-ancestor
153390375|NCT04669210|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153390376|NCT04669210|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153390377|NCT04655157|Nivolumab|nivolumab|mesh-list
153390528|NCT03636152|Amebicides|amebicides|mesh-ancestor
153390529|NCT03555916|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
153390530|NCT03555916|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
153390531|NCT03555916|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153390532|NCT03555916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153390533|NCT03555916|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
153390534|NCT03555916|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153390621|NCT02673359|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153390622|NCT02673359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153390623|NCT02624518|Gastrin-Releasing Peptide|gastrin-releasing peptide|mesh-list
153390624|NCT02624518|Bombesin|bombesin|mesh-list
153390625|NCT02624518|Gastrins|gastrins|mesh-list
153390626|NCT02624518|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153390702|NCT01323465|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153390703|NCT01323465|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153390704|NCT01323465|Leprostatic Agents|leprostatic agents|mesh-ancestor
153390705|NCT01323465|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153390706|NCT01323465|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
153390707|NCT01323465|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
153390740|NCT01322139|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153390741|NCT01322139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153390742|NCT01322139|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
153390743|NCT01322139|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
153390744|NCT01322139|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
153390793|NCT00005835|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
153390794|NCT00005835|Protective Agents|protective agents|mesh-ancestor
153390796|NCT00002643|Cyclophosphamide|cyclophosphamide|mesh-list
153390799|NCT00002643|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
153390800|NCT00002643|Etoposide|etoposide|mesh-list
153390801|NCT00002643|Vincristine|vincristine|mesh-list
153390802|NCT00002643|Topotecan|topotecan|mesh-list
153390803|NCT00002643|Amifostine|amifostine|mesh-list
153390804|NCT00002643|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153390805|NCT00002643|Immunologic Factors|immunologic factors|mesh-ancestor
153390806|NCT00002643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153390807|NCT00002643|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153390812|NCT00002643|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153390813|NCT00002643|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153390814|NCT00002643|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153390815|NCT00002643|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153390816|NCT00002643|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153390850|NCT00002649|Antiviral Agents|antiviral agents|mesh-ancestor
153390851|NCT00002649|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153390852|NCT03003871|Chlorhexidine|chlorhexidine|mesh-list
153390853|NCT03003871|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
153390854|NCT03003871|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
153390855|NCT03003871|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153391094|NCT01625923|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153391095|NCT01625923|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153391240|NCT01634191|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153391241|NCT01634191|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153391242|NCT01634191|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
153391243|NCT01634191|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
153391244|NCT01634191|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153391245|NCT01634191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153391246|NCT04005443|Radiopharmaceuticals|radiopharmaceuticals|mesh-list
153391253|NCT04266197|Vasodilator Agents|vasodilator agents|mesh-ancestor
153391254|NCT04266197|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
153391255|NCT04266197|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
153391263|NCT05669313|Protease Inhibitors|protease inhibitors|mesh-ancestor
153391264|NCT05669313|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153391265|NCT05669313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153391267|NCT04343963|Bromides|bromides|mesh-list
153391268|NCT04343963|Pyridostigmine Bromide|pyridostigmine bromide|mesh-list
153391269|NCT04343963|Anticonvulsants|anticonvulsants|mesh-ancestor
153391270|NCT04343963|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
153391328|NCT01636063|Oxytocics|oxytocics|mesh-ancestor
153391329|NCT01636063|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
153391397|NCT00382083|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
153391398|NCT00382083|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153391399|NCT00382083|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153461740|NCT03193866|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153391451|NCT04584749|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153391452|NCT04584749|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
153391453|NCT04584749|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153391454|NCT04584749|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153391455|NCT04584749|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153391457|NCT01644331|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
153391488|NCT03788291|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153391489|NCT03788291|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153391490|NCT03788291|Immunologic Factors|immunologic factors|mesh-ancestor
153391491|NCT03788291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153391492|NCT03788291|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153391493|NCT03788291|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153391494|NCT03788291|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153391619|NCT02975843|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153391620|NCT02975843|Glucocorticoids|glucocorticoids|mesh-ancestor
153391621|NCT02975843|Hormones|hormones|mesh-ancestor
153391622|NCT02975843|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153391623|NCT01655563|Tacrolimus|tacrolimus|mesh-list
153391624|NCT01655563|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153391625|NCT01655563|Immunologic Factors|immunologic factors|mesh-ancestor
153391626|NCT01655563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153391627|NCT01655563|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
153391628|NCT01655563|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153391844|NCT01919996|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153391845|NCT01919996|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153391846|NCT05735132|Lidocaine|lidocaine|mesh-list
153391847|NCT05735132|Anesthetics, Local|anesthetics, local|mesh-ancestor
153391848|NCT05735132|Anesthetics|anesthetics|mesh-ancestor
153391849|NCT05735132|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153889155|NCT01013701|Fluticasone|fluticasone|mesh-list
153391850|NCT05735132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153391851|NCT05735132|Sensory System Agents|sensory system agents|mesh-ancestor
153391852|NCT05735132|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153391853|NCT05735132|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153391854|NCT05735132|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
153391855|NCT05735132|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153391858|NCT01667029|Sulfasalazine|sulfasalazine|mesh-list
153391897|NCT00000333|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153391898|NCT00000333|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153391900|NCT00000339|Risperidone|risperidone|mesh-list
153391901|NCT00000339|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153391902|NCT00000339|Serotonin Agents|serotonin agents|mesh-ancestor
153391903|NCT00000339|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153392038|NCT00000441|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153392039|NCT00000441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153392041|NCT00000441|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153392042|NCT00000441|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153392044|NCT00000441|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153392045|NCT00000441|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153392046|NCT00000441|GABA Modulators|gaba modulators|mesh-ancestor
153392047|NCT00000441|GABA Agents|gaba agents|mesh-ancestor
153392048|NCT00000441|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153392049|NCT00000441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153392050|NCT00000441|Antimanic Agents|antimanic agents|mesh-ancestor
153392051|NCT00000441|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153392052|NCT00000441|Analgesics|analgesics|mesh-ancestor
153392422|NCT00000663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153392423|NCT00000669|Didanosine|didanosine|mesh-list
153392424|NCT00000669|Antimetabolites|antimetabolites|mesh-ancestor
153393173|NCT01715233|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153393174|NCT01715233|Tubulin Modulators|tubulin modulators|mesh-ancestor
153393175|NCT01715233|Antimitotic Agents|antimitotic agents|mesh-ancestor
153393176|NCT01715233|Mitosis Modulators|mitosis modulators|mesh-ancestor
153393177|NCT01715233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153393648|NCT00002955|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153393649|NCT00002955|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153393650|NCT00002955|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153393651|NCT00002961|Cyclosporine|cyclosporine|mesh-list
153393652|NCT00002961|Cyclophosphamide|cyclophosphamide|mesh-list
153393653|NCT00002961|Busulfan|busulfan|mesh-list
153393654|NCT00002961|Methotrexate|methotrexate|mesh-list
153393655|NCT00002961|Etoposide|etoposide|mesh-list
153393656|NCT00002961|Etoposide phosphate|etoposide phosphate|mesh-list
153393657|NCT00002961|Cyclosporins|cyclosporins|mesh-list
153393658|NCT00002961|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153393659|NCT00002961|Immunologic Factors|immunologic factors|mesh-ancestor
153393660|NCT00002961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153393661|NCT00002961|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153394171|NCT04172701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153394173|NCT01760785|Valproic Acid|valproic acid|mesh-list
153394174|NCT01760785|Anticonvulsants|anticonvulsants|mesh-ancestor
153394175|NCT01760785|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153394176|NCT01760785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153394177|NCT01760785|GABA Agents|gaba agents|mesh-ancestor
153394178|NCT01760785|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153394179|NCT01760785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153394180|NCT01760785|Antimanic Agents|antimanic agents|mesh-ancestor
153394632|NCT01796665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153394633|NCT01796665|Dermatologic Agents|dermatologic agents|mesh-ancestor
153394634|NCT01798225|Doxycycline|doxycycline|mesh-list
153394635|NCT01798225|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153394636|NCT01798225|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153394637|NCT01798225|Antimalarials|antimalarials|mesh-ancestor
153394638|NCT01798225|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153394639|NCT01798225|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153394640|NCT01800877|Phenylephrine|phenylephrine|mesh-list
153394641|NCT01800877|Dopamine|dopamine|mesh-list
153394642|NCT01800877|Vasopressins|vasopressins|mesh-list
153394643|NCT01800877|Epinephrine|epinephrine|mesh-list
153394644|NCT01800877|Norepinephrine|norepinephrine|mesh-list
153394645|NCT01800877|Vasoconstrictor Agents|vasoconstrictor agents|mesh-list
153394646|NCT01800877|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153394647|NCT01800877|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153394648|NCT01800877|Adrenergic Agents|adrenergic agents|mesh-ancestor
153395140|NCT02487563|Antimetabolites|antimetabolites|mesh-ancestor
153395141|NCT02487563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153395142|NCT02487563|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153395143|NCT02487563|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153395144|NCT02427737|Hypnotics and Sedatives|hypnotics and sedatives|mesh-list
153395145|NCT02427737|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153395146|NCT02427737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153395147|NCT02489357|Pembrolizumab|pembrolizumab|mesh-list
153395148|NCT02489357|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153395149|NCT02489357|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153395150|NCT02489357|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153395593|NCT04477733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153395594|NCT04477733|Analgesics|analgesics|mesh-ancestor
153395595|NCT04477733|Sensory System Agents|sensory system agents|mesh-ancestor
153395596|NCT04477733|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153395597|NCT04477733|Antitussive Agents|antitussive agents|mesh-ancestor
153395598|NCT04477733|Respiratory System Agents|respiratory system agents|mesh-ancestor
153395599|NCT04477733|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
153395600|NCT00558025|Pramipexole|pramipexole|mesh-list
153359206|NCT05869591|Anticoagulants|anticoagulants|mesh-ancestor
153359207|NCT05834738|Atrasentan|atrasentan|mesh-list
153395601|NCT00558025|Dexpramipexole|dexpramipexole|mesh-list
153395602|NCT00558025|Antioxidants|antioxidants|mesh-ancestor
153395645|NCT01834261|Oxytocics|oxytocics|mesh-ancestor
153395646|NCT01834261|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153395705|NCT00365183|Dermatologic Agents|dermatologic agents|mesh-ancestor
153395706|NCT01837069|Metoprolol|metoprolol|mesh-list
153395707|NCT01837069|Lisinopril|lisinopril|mesh-list
153395708|NCT01837069|Atorvastatin|atorvastatin|mesh-list
153395709|NCT01837069|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
153395710|NCT01837069|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153395711|NCT01837069|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153395712|NCT01837069|Antimetabolites|antimetabolites|mesh-ancestor
153395750|NCT02268955|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153395751|NCT02268955|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153395777|NCT05249153|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153395778|NCT05249153|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
153395779|NCT05249153|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153395780|NCT05249153|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153395781|NCT05249153|Adrenergic Agents|adrenergic agents|mesh-ancestor
153395782|NCT05249153|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153395783|NCT05249153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153395784|NCT05249153|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153359692|NCT04409834|Purinergic Agents|purinergic agents|mesh-ancestor
153359693|NCT04409834|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153359694|NCT04409834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153359695|NCT04409834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153359696|NCT04409834|Anticoagulants|anticoagulants|mesh-ancestor
153359697|NCT04409834|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153359698|NCT04409834|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153359699|NCT04340076|Ixekizumab|ixekizumab|mesh-list
153359700|NCT04340076|Brodalumab|brodalumab|mesh-list
153395786|NCT05249153|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153395787|NCT05249153|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153395788|NCT05249153|Anesthetics, General|anesthetics, general|mesh-ancestor
153430333|NCT00379015|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153430335|NCT00379015|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153430336|NCT00911053|Melatonin|melatonin|mesh-list
153430337|NCT00911053|Antioxidants|antioxidants|mesh-ancestor
153430338|NCT00911053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153430339|NCT00911053|Protective Agents|protective agents|mesh-ancestor
153430340|NCT00911053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153430341|NCT00911053|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153430342|NCT04713410|Prednisolone|prednisolone|mesh-list
153395789|NCT05249153|Anesthetics|anesthetics|mesh-ancestor
153395790|NCT02961257|Prednisone|prednisone|mesh-list
153395791|NCT02961257|Lenograstim|lenograstim|mesh-list
153395792|NCT02961257|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153395793|NCT02961257|Glucocorticoids|glucocorticoids|mesh-ancestor
153395794|NCT02961257|Hormones|hormones|mesh-ancestor
153395795|NCT02961257|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153395796|NCT02961257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153395797|NCT02961257|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153395798|NCT02961257|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153395799|NCT02961257|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153395800|NCT02961257|Immunologic Factors|immunologic factors|mesh-ancestor
153359701|NCT04340076|Dermatologic Agents|dermatologic agents|mesh-ancestor
153359702|NCT04332211|Pseudoephedrine|pseudoephedrine|mesh-list
153359704|NCT04332211|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153359705|NCT04332211|Autonomic Agents|autonomic agents|mesh-ancestor
153359706|NCT04332211|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153359707|NCT04332211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153359708|NCT04332211|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153359709|NCT04332211|Respiratory System Agents|respiratory system agents|mesh-ancestor
153395801|NCT02271217|4-Aminopyridine|4-aminopyridine|mesh-list
153395851|NCT02274792|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153395852|NCT02274792|Immunologic Factors|immunologic factors|mesh-ancestor
153395853|NCT02592629|Triamcinolone|triamcinolone|mesh-list
153395854|NCT02592629|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
153395855|NCT02592629|Lidocaine|lidocaine|mesh-list
153395856|NCT02592629|Ethyl Chloride|ethyl chloride|mesh-list
153395857|NCT02592629|Anesthetics, Local|anesthetics, local|mesh-ancestor
153395858|NCT02592629|Anesthetics|anesthetics|mesh-ancestor
153395859|NCT02592629|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153395860|NCT02592629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153395861|NCT02592629|Sensory System Agents|sensory system agents|mesh-ancestor
153783605|NCT00236561|Topiramate|topiramate|mesh-list
153395862|NCT02592629|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153395863|NCT02592629|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153395864|NCT02592629|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
153395865|NCT02592629|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153395866|NCT02592629|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153395867|NCT02592629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153395868|NCT02592629|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153395869|NCT02592629|Glucocorticoids|glucocorticoids|mesh-ancestor
153395871|NCT02592629|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153359215|NCT05782608|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153359217|NCT05782608|Sensory System Agents|sensory system agents|mesh-ancestor
153359218|NCT05782608|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153359219|NCT05782608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153430387|NCT00459121|Antimitotic Agents|antimitotic agents|mesh-ancestor
153359714|NCT04332211|Adrenergic Agents|adrenergic agents|mesh-ancestor
153395942|NCT00364481|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
153395944|NCT00364481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153395945|NCT02601833|Fluorides|fluorides|mesh-list
153395946|NCT02601833|Cariostatic Agents|cariostatic agents|mesh-ancestor
153395947|NCT02601833|Protective Agents|protective agents|mesh-ancestor
153395948|NCT02601833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153395949|NCT00553267|Amlodipine|amlodipine|mesh-list
153395950|NCT00553267|Telmisartan|telmisartan|mesh-list
153395984|NCT02604173|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153395986|NCT02604173|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
153395987|NCT02604173|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153396024|NCT00365339|Dopamine Agents|dopamine agents|mesh-ancestor
153396025|NCT00365339|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153396059|NCT05371301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153396061|NCT02285166|Antimetabolites|antimetabolites|mesh-ancestor
153396062|NCT02285166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153396063|NCT02285166|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153396064|NCT02605187|Acetaminophen|acetaminophen|mesh-list
153396065|NCT02605187|Ibuprofen|ibuprofen|mesh-list
153396066|NCT02605187|Morphine|morphine|mesh-list
153396258|NCT00551161|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
153396259|NCT00551161|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
153396260|NCT00551161|Dopamine Agents|dopamine agents|mesh-ancestor
153396261|NCT00551161|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153396262|NCT00551161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153396263|NCT00551161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153396328|NCT04801043|Protease Inhibitors|protease inhibitors|mesh-ancestor
153396329|NCT04801043|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153396330|NCT04801043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153396331|NCT04734197|Cyclosporine|cyclosporine|mesh-list
153396332|NCT04734197|Mycophenolic Acid|mycophenolic acid|mesh-list
153396333|NCT04734197|Betamethasone|betamethasone|mesh-list
153396334|NCT04734197|Betamethasone Valerate|betamethasone valerate|mesh-list
153396335|NCT04734197|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
153396336|NCT04734197|Betamethasone benzoate|betamethasone benzoate|mesh-list
153396337|NCT04734197|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
153396338|NCT04734197|Lifitegrast|lifitegrast|mesh-list
153396339|NCT04734197|Ophthalmic Solutions|ophthalmic solutions|mesh-list
153396340|NCT04734197|Cyclosporins|cyclosporins|mesh-list
153813202|NCT00332852|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153813203|NCT00332852|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153813204|NCT00332852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153813205|NCT00332852|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
153813206|NCT00332852|Hormone Antagonists|hormone antagonists|mesh-ancestor
153813207|NCT00332852|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153813208|NCT00332852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153396341|NCT04734197|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
153396342|NCT04734197|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153396343|NCT04734197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153396344|NCT04734197|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153396345|NCT04734197|Immunologic Factors|immunologic factors|mesh-ancestor
153396346|NCT04734197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153396347|NCT04734197|Antifungal Agents|antifungal agents|mesh-ancestor
153396348|NCT04734197|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153396349|NCT04734197|Dermatologic Agents|dermatologic agents|mesh-ancestor
153396350|NCT04734197|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153396351|NCT04734197|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
153396352|NCT04734197|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153396353|NCT04734197|Glucocorticoids|glucocorticoids|mesh-ancestor
153396354|NCT04734197|Hormones|hormones|mesh-ancestor
153396384|NCT00557401|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
153396386|NCT00557401|GABA Agents|gaba agents|mesh-ancestor
153396387|NCT00557401|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153396388|NCT00557401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153396389|NCT02264353|Donepezil|donepezil|mesh-list
153396390|NCT02264353|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
153396391|NCT02264353|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153396392|NCT02264353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153396393|NCT02264353|Cholinergic Agents|cholinergic agents|mesh-ancestor
153396394|NCT02264353|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153396395|NCT02264353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153813210|NCT00332891|Amibegron hydrochloride|amibegron hydrochloride|mesh-list
153813211|NCT00332891|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
153813212|NCT00332891|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153813213|NCT00332891|Adrenergic Agents|adrenergic agents|mesh-ancestor
153813214|NCT00332891|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153813215|NCT00332891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153813216|NCT00332891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153396709|NCT02303405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153396710|NCT02303405|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153396712|NCT02164955|Immunologic Factors|immunologic factors|mesh-ancestor
153396713|NCT02164955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153396714|NCT02164955|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153396715|NCT02164955|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153396716|NCT02164955|Growth Substances|growth substances|mesh-ancestor
153396717|NCT02164955|Growth Inhibitors|growth inhibitors|mesh-ancestor
153396718|NCT02164955|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153396720|NCT01943461|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
153396721|NCT01943461|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153396722|NCT01943461|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153396723|NCT01943461|Immunologic Factors|immunologic factors|mesh-ancestor
153396732|NCT00702481|Nimotuzumab|nimotuzumab|mesh-list
153397181|NCT03649061|Immunologic Factors|immunologic factors|mesh-ancestor
153397182|NCT03649061|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153397183|NCT03649061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153397184|NCT02265744|Antibodies|antibodies|mesh-list
153397185|NCT02265744|Immunologic Factors|immunologic factors|mesh-ancestor
153397186|NCT02265744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153397187|NCT05109143|Indomethacin|indomethacin|mesh-list
153397188|NCT05109143|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153397189|NCT05109143|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153399271|NCT01967641|Buprenorphine|buprenorphine|mesh-list
153399272|NCT01967641|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
153399273|NCT01967641|Naloxone|naloxone|mesh-list
153399274|NCT01967641|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153399275|NCT01967641|Narcotics|narcotics|mesh-ancestor
153399472|NCT02012192|Tubulin Modulators|tubulin modulators|mesh-ancestor
153399473|NCT02012192|Antimitotic Agents|antimitotic agents|mesh-ancestor
153399474|NCT02012192|Mitosis Modulators|mitosis modulators|mesh-ancestor
153399797|NCT02870309|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153399798|NCT02870309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153400413|NCT02363270|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153400414|NCT02363270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153400415|NCT02363270|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
153400416|NCT02363270|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153400417|NCT02363270|Anesthetics, General|anesthetics, general|mesh-ancestor
153400418|NCT02363270|Anesthetics|anesthetics|mesh-ancestor
153400419|NCT02363270|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153400420|NCT02363270|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
153400421|NCT02363270|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
153400709|NCT03145259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153400711|NCT00354692|Ferric gluconate|ferric gluconate|mesh-list
153400712|NCT00354692|Hematinics|hematinics|mesh-ancestor
153400713|NCT02989727|Lamotrigine|lamotrigine|mesh-list
153400714|NCT02989727|Anticonvulsants|anticonvulsants|mesh-ancestor
153400715|NCT02989727|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153400716|NCT02989727|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153400725|NCT02039947|Trametinib|trametinib|mesh-list
153400726|NCT02039947|Dabrafenib|dabrafenib|mesh-list
153400727|NCT02039947|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153400729|NCT02039947|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153403484|NCT03666065|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153403485|NCT03666065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153403486|NCT03654716|Cytarabine|cytarabine|mesh-list
153403487|NCT03654716|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153403488|NCT03654716|Antimetabolites|antimetabolites|mesh-ancestor
153359258|NCT05737693|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153359262|NCT05737693|GABA Modulators|gaba modulators|mesh-ancestor
153403489|NCT03654716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153403490|NCT03654716|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153403491|NCT03654716|Antiviral Agents|antiviral agents|mesh-ancestor
153403492|NCT03654716|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153403493|NCT03654716|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153403494|NCT03654716|Immunologic Factors|immunologic factors|mesh-ancestor
153403495|NCT03654716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153403496|NCT03629613|Antioxidants|antioxidants|mesh-list
153403497|NCT03629613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153403498|NCT03629613|Protective Agents|protective agents|mesh-ancestor
153403499|NCT03629613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153403500|NCT03532477|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
153403503|NCT03532477|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153403505|NCT03532477|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153359739|NCT04224480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153359742|NCT04201457|Dabrafenib|dabrafenib|mesh-list
153359743|NCT04201457|Dimethyl Sulfoxide|dimethyl sulfoxide|mesh-list
153359744|NCT04201457|Antimalarials|antimalarials|mesh-ancestor
153359745|NCT04201457|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153359746|NCT04201457|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153359747|NCT04201457|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153359748|NCT04201457|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153359749|NCT04201457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153428615|NCT02568007|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153428616|NCT02568007|Serotonin Agents|serotonin agents|mesh-ancestor
153428617|NCT02568007|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
153428618|NCT00002390|Abacavir|abacavir|mesh-list
153428619|NCT00002390|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153428620|NCT00002390|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153428621|NCT00002390|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153428622|NCT00002390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153428623|NCT00002390|Antiviral Agents|antiviral agents|mesh-ancestor
153428624|NCT00002390|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153428625|NCT00002390|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153428626|NCT00002390|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153428627|NCT00002396|Tenofovir|tenofovir|mesh-list
153428628|NCT00002396|Antiviral Agents|antiviral agents|mesh-ancestor
153428629|NCT00002396|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153428684|NCT03538015|Adrenergic Agents|adrenergic agents|mesh-ancestor
153428685|NCT03538015|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153428686|NCT03538015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153428687|NCT03538015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153428688|NCT03538015|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153359270|NCT05723601|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153359271|NCT05723601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153428689|NCT03538015|Antioxidants|antioxidants|mesh-ancestor
153428730|NCT05701436|Leucovorin|leucovorin|mesh-list
153431299|NCT06315283|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153431300|NCT06315283|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153431301|NCT06315283|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
153432882|NCT03421353|Paclitaxel|paclitaxel|mesh-list
153432883|NCT03421353|Carboplatin|carboplatin|mesh-list
153432884|NCT03421353|Gemcitabine|gemcitabine|mesh-list
153432885|NCT03421353|Durvalumab|durvalumab|mesh-list
153434215|NCT00001999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153434217|NCT00001999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153434219|NCT00002383|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
153889333|NCT01281189|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153434220|NCT00002383|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
153434221|NCT00002383|Protease Inhibitors|protease inhibitors|mesh-ancestor
153436012|NCT00003446|Levoleucovorin|levoleucovorin|mesh-list
153436013|NCT00003446|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153436014|NCT00003446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153813339|NCT00333281|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153359822|NCT03810417|Digoxin|digoxin|mesh-list
153438604|NCT00005612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153438605|NCT00005612|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153441238|NCT00004255|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153441239|NCT00004255|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153441240|NCT00004255|Antimetabolites|antimetabolites|mesh-ancestor
153441244|NCT00004255|Antiemetics|antiemetics|mesh-ancestor
153445417|NCT00000881|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153445418|NCT00000881|Antiviral Agents|antiviral agents|mesh-ancestor
153454079|NCT01737840|Histamine Antagonists|histamine antagonists|mesh-ancestor
153454080|NCT01737840|Histamine Agents|histamine agents|mesh-ancestor
153454479|NCT01582854|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
153454480|NCT01582854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153454481|NCT01582854|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
153454482|NCT01582854|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153454483|NCT01582854|Antioxidants|antioxidants|mesh-ancestor
153454484|NCT01582854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153454485|NCT01582854|Protective Agents|protective agents|mesh-ancestor
153454486|NCT01582854|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
153454487|NCT01582308|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
153454488|NCT01582308|Vildagliptin|vildagliptin|mesh-list
153454489|NCT01582308|Saxagliptin|saxagliptin|mesh-list
153454490|NCT01582308|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153456021|NCT04105270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153456022|NCT04105270|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153456023|NCT04105270|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153456024|NCT04105270|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153456026|NCT04073602|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153430474|NCT00379249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153889348|NCT01280721|Natriuretic Agents|natriuretic agents|mesh-ancestor
153889349|NCT01280721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153889350|NCT01087762|Certolizumab Pegol|certolizumab pegol|mesh-list
153889351|NCT01087762|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
153889352|NCT01087762|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153889353|NCT01087762|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153889354|NCT01087762|Immunologic Factors|immunologic factors|mesh-ancestor
153889355|NCT01087762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153456027|NCT04073602|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153456028|NCT04060277|Acetic Acid|acetic acid|mesh-list
153456029|NCT04060277|Letermovir|letermovir|mesh-list
153456030|NCT04060277|Vaccines|vaccines|mesh-list
153456031|NCT04060277|Immunologic Factors|immunologic factors|mesh-ancestor
153427821|NCT02973464|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153427822|NCT02973464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153456064|NCT03837353|Tubulin Modulators|tubulin modulators|mesh-ancestor
153456065|NCT03837353|Antimitotic Agents|antimitotic agents|mesh-ancestor
153456066|NCT03837353|Mitosis Modulators|mitosis modulators|mesh-ancestor
153456098|NCT03759366|Eculizumab|eculizumab|mesh-list
153456512|NCT01499940|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153456513|NCT01499160|Everolimus|everolimus|mesh-list
153456514|NCT01499160|Letrozole|letrozole|mesh-list
153820839|NCT02957630|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
153820841|NCT02957630|Hormones|hormones|mesh-ancestor
153360828|NCT01407575|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153360829|NCT01407575|Narcotics|narcotics|mesh-ancestor
153360830|NCT01407575|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153360831|NCT01407575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153360832|NCT01407575|Analgesics|analgesics|mesh-ancestor
153820861|NCT00434486|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153360857|NCT02203565|Eusol|eusol|mesh-list
153360858|NCT02203565|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
153360859|NCT02203565|Disinfectants|disinfectants|mesh-ancestor
153360860|NCT02203565|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153360861|NCT01375127|Tofacitinib|tofacitinib|mesh-list
153360862|NCT01375127|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
153360863|NCT01375127|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153360864|NCT01375127|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153820871|NCT00465192|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
153820872|NCT00465192|Contraceptive Agents|contraceptive agents|mesh-ancestor
153820875|NCT00434681|Acetaminophen|acetaminophen|mesh-list
153820881|NCT00434681|Antipyretics|antipyretics|mesh-ancestor
153359276|NCT05678959|Antibodies, Anti-Idiotypic|antibodies, anti-idiotypic|mesh-list
153359277|NCT05678959|Immunologic Factors|immunologic factors|mesh-ancestor
153359278|NCT05678959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153359279|NCT05674643|Acetaminophen|acetaminophen|mesh-list
153359280|NCT05674643|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153359281|NCT05674643|Analgesics|analgesics|mesh-ancestor
153359282|NCT05674643|Sensory System Agents|sensory system agents|mesh-ancestor
153359283|NCT05674643|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153359284|NCT05674643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153359285|NCT05674643|Antipyretics|antipyretics|mesh-ancestor
153359286|NCT05671510|Docetaxel|docetaxel|mesh-list
153359287|NCT05671510|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153430532|NCT00746239|Citalopram|citalopram|mesh-list
153820889|NCT00473070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153820890|NCT00473070|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
153360870|NCT00857714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153360871|NCT00857714|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153360893|NCT01376297|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153820923|NCT00473460|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153820927|NCT00473460|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
153820928|NCT00435305|Vancomycin|vancomycin|mesh-list
153820929|NCT00435305|Meropenem|meropenem|mesh-list
153820930|NCT00435305|Tazobactam|tazobactam|mesh-list
153820931|NCT00435305|Linezolid|linezolid|mesh-list
153360905|NCT00859508|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
153360906|NCT00859508|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
153360908|NCT00859508|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
153360909|NCT00859508|Estrogens|estrogens|mesh-ancestor
153360910|NCT00859508|Hormones|hormones|mesh-ancestor
153914678|NCT01215851|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153461784|NCT03163992|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153461785|NCT03163992|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153461834|NCT05244252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153461835|NCT05244252|Sensory System Agents|sensory system agents|mesh-ancestor
153461836|NCT05244252|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153461851|NCT05244018|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153461852|NCT05244018|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153461854|NCT02398500|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153360913|NCT00859508|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
153360914|NCT00859508|Contraceptive Agents|contraceptive agents|mesh-ancestor
153461856|NCT02398500|Growth Substances|growth substances|mesh-ancestor
153461857|NCT02398500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153461927|NCT05241132|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153461928|NCT05241132|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153461929|NCT05241132|Tubulin Modulators|tubulin modulators|mesh-ancestor
153461930|NCT05241132|Antimitotic Agents|antimitotic agents|mesh-ancestor
153461931|NCT05241132|Mitosis Modulators|mitosis modulators|mesh-ancestor
153461932|NCT05241132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153461933|NCT05241132|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153462030|NCT00637572|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
153462031|NCT00637572|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153359289|NCT05671510|Antimitotic Agents|antimitotic agents|mesh-ancestor
153359290|NCT05671510|Mitosis Modulators|mitosis modulators|mesh-ancestor
153359291|NCT05671510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153783523|NCT00236444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153359292|NCT05670236|Lidocaine|lidocaine|mesh-list
153430538|NCT00746239|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153430540|NCT00746239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153430541|NCT00746239|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
153430552|NCT04977674|Naltrexone|naltrexone|mesh-list
153462032|NCT00637572|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153462033|NCT00637572|Appetite Stimulants|appetite stimulants|mesh-ancestor
153462034|NCT00637572|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
153462036|NCT00637416|Dexlansoprazole|dexlansoprazole|mesh-list
153462037|NCT00637416|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
153462038|NCT00637416|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153462039|NCT00637416|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
153461723|NCT03193866|Alemtuzumab|alemtuzumab|mesh-list
153360919|NCT01377467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153820955|NCT00473616|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153820956|NCT00473616|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153462040|NCT00637416|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153462041|NCT00637416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153462042|NCT00636792|Rituximab|rituximab|mesh-list
153462043|NCT00636792|Bortezomib|bortezomib|mesh-list
153462044|NCT00636792|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
153462045|NCT00636792|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153462046|NCT00636792|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153462047|NCT00636792|Immunologic Factors|immunologic factors|mesh-ancestor
153462048|NCT00636792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153462049|NCT00636792|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153462050|NCT00636792|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153462051|NCT00636792|Alkylating Agents|alkylating agents|mesh-ancestor
153462052|NCT00636792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153360922|NCT02348762|Glycine|glycine|mesh-list
153360923|NCT02348762|Antiviral Agents|antiviral agents|mesh-ancestor
153360924|NCT02348762|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153360925|NCT02348762|Expectorants|expectorants|mesh-ancestor
153820957|NCT00473616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153820958|NCT00473616|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153820959|NCT00435851|Hormones|hormones|mesh-list
153360926|NCT02348762|Respiratory System Agents|respiratory system agents|mesh-ancestor
153430566|NCT04977674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153430567|NCT04977674|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
153359294|NCT05670236|Anesthetics|anesthetics|mesh-ancestor
153430568|NCT04977674|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
153430570|NCT00402883|Vitamin B 12|vitamin b 12|mesh-list
153430571|NCT00402883|Bevacizumab|bevacizumab|mesh-list
153430576|NCT00402883|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153430577|NCT00402883|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153430578|NCT00402883|Growth Substances|growth substances|mesh-ancestor
153430579|NCT00402883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153430580|NCT00402883|Growth Inhibitors|growth inhibitors|mesh-ancestor
153430581|NCT00402883|Vitamins|vitamins|mesh-ancestor
153430582|NCT00402883|Micronutrients|micronutrients|mesh-ancestor
153430583|NCT00402883|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153430584|NCT00402883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153889446|NCT01274637|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153820961|NCT00435851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153820962|NCT00436124|Oseltamivir|oseltamivir|mesh-list
153360929|NCT02348762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153360930|NCT02348762|Protective Agents|protective agents|mesh-ancestor
153462054|NCT00636636|Analgesics|analgesics|mesh-ancestor
153462055|NCT00636636|Sensory System Agents|sensory system agents|mesh-ancestor
153462056|NCT00636636|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153462057|NCT00636636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153462110|NCT00634920|Dermatologic Agents|dermatologic agents|mesh-ancestor
153462111|NCT00634920|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153462112|NCT00634920|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
153462132|NCT01923012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153462134|NCT01923012|Coagulants|coagulants|mesh-ancestor
153462135|NCT01923090|Finasteride|finasteride|mesh-list
153462136|NCT01923090|Dutasteride|dutasteride|mesh-list
153462137|NCT01923090|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
153462138|NCT01923090|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153820963|NCT00436124|Antiviral Agents|antiviral agents|mesh-ancestor
153820964|NCT00436124|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153820965|NCT00436124|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153889842|NCT01264965|Sensory System Agents|sensory system agents|mesh-ancestor
153430951|NCT04181203|Leuprolide|leuprolide|mesh-list
153462140|NCT01923090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153462141|NCT01923090|Hormone Antagonists|hormone antagonists|mesh-ancestor
153462142|NCT01923090|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153462143|NCT01923090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153462144|NCT01923090|Urological Agents|urological agents|mesh-ancestor
153462146|NCT01929330|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
153462147|NCT01929330|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153462148|NCT01929330|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153462192|NCT01923558|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153462193|NCT01923558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153462194|NCT01923558|Nootropic Agents|nootropic agents|mesh-ancestor
153462195|NCT01921218|Cyclosporine|cyclosporine|mesh-list
153462196|NCT01921218|Mycophenolic Acid|mycophenolic acid|mesh-list
153462197|NCT01921218|Prednisone|prednisone|mesh-list
153462198|NCT01921218|Abatacept|abatacept|mesh-list
153462199|NCT01921218|Tacrolimus|tacrolimus|mesh-list
153462200|NCT01921218|Cyclosporins|cyclosporins|mesh-list
153462201|NCT01921218|Calcineurin Inhibitors|calcineurin inhibitors|mesh-list
153462202|NCT01921218|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153462203|NCT01921218|Glucocorticoids|glucocorticoids|mesh-ancestor
153462204|NCT01921218|Hormones|hormones|mesh-ancestor
153462205|NCT01921218|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153462206|NCT01921218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153462207|NCT01921218|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153462208|NCT01921218|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153462209|NCT01921218|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153462210|NCT01921218|Immunologic Factors|immunologic factors|mesh-ancestor
153462211|NCT01921218|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153462212|NCT01921218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153360934|NCT02348762|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153462214|NCT01921218|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153462215|NCT01921218|Dermatologic Agents|dermatologic agents|mesh-ancestor
153462216|NCT01921218|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153462217|NCT01921218|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153462218|NCT01921218|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
153462219|NCT01921218|Antitubercular Agents|antitubercular agents|mesh-ancestor
153462220|NCT01921218|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153462221|NCT01921218|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153462222|NCT01921218|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153813622|NCT00334685|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153820720|NCT03272802|Riluzole|riluzole|mesh-list
153462251|NCT00988260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153462253|NCT00633126|Cephalosporins|cephalosporins|mesh-list
153462254|NCT00633126|Beta Lactam Antibiotics|beta lactam antibiotics|mesh-ancestor
153462255|NCT00633126|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153462256|NCT00633126|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153462257|NCT00989664|Tositumomab I-131|tositumomab i-131|mesh-list
153820970|NCT02957474|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
153820971|NCT02957474|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153462258|NCT00989664|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153462259|NCT01923870|Enclomiphene|enclomiphene|mesh-list
153462260|NCT01923870|Clomiphene|clomiphene|mesh-list
153462261|NCT01923870|Zuclomiphene|zuclomiphene|mesh-list
153462262|NCT01923870|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
153462263|NCT01923870|Hormone Antagonists|hormone antagonists|mesh-ancestor
153462353|NCT01920204|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153360049|NCT01349231|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
153360050|NCT01349231|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153360051|NCT01349231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153360052|NCT01350245|Mycophenolic Acid|mycophenolic acid|mesh-list
153813628|NCT00334685|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153813629|NCT00334685|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153813630|NCT00334685|Antidepressive Agents|antidepressive agents|mesh-ancestor
153914680|NCT01215851|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153813632|NCT00334685|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153462430|NCT00982020|Antiemetics|antiemetics|mesh-ancestor
153462431|NCT00982020|Autonomic Agents|autonomic agents|mesh-ancestor
153462432|NCT00982020|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153462433|NCT00982020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153462434|NCT00982020|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153462435|NCT00982020|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153462436|NCT00982020|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153462437|NCT00982020|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153462438|NCT00982020|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153462440|NCT00982020|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153462441|NCT00982020|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153462442|NCT00982020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153462443|NCT00982020|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153462444|NCT00982020|Serotonin Agents|serotonin agents|mesh-ancestor
153462476|NCT00980148|Doxycycline|doxycycline|mesh-list
153462477|NCT00980148|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153462478|NCT00980148|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153820972|NCT02957474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153360936|NCT01377623|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153461724|NCT03193866|Glatiramer Acetate|glatiramer acetate|mesh-list
153462481|NCT00980148|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153462482|NCT03064854|Paclitaxel|paclitaxel|mesh-list
153462483|NCT03064854|Carboplatin|carboplatin|mesh-list
153462484|NCT03064854|Gemcitabine|gemcitabine|mesh-list
153462485|NCT03064854|Pemetrexed|pemetrexed|mesh-list
153462486|NCT03064854|Spartalizumab|spartalizumab|mesh-list
153462487|NCT03064854|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153462488|NCT03064854|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153462489|NCT03064854|Tubulin Modulators|tubulin modulators|mesh-ancestor
153462490|NCT03064854|Antimitotic Agents|antimitotic agents|mesh-ancestor
153462491|NCT03064854|Mitosis Modulators|mitosis modulators|mesh-ancestor
153462492|NCT03064854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153462493|NCT03064854|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153462494|NCT03064854|Antimetabolites|antimetabolites|mesh-ancestor
153462495|NCT03064854|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153462496|NCT03064854|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153462497|NCT03064854|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153820973|NCT00465231|Fentanyl|fentanyl|mesh-list
153820974|NCT00465231|Bupivacaine|bupivacaine|mesh-list
153461725|NCT03193866|Dimethyl Fumarate|dimethyl fumarate|mesh-list
153461726|NCT03193866|Natalizumab|natalizumab|mesh-list
153889843|NCT01264965|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153430953|NCT04181203|Triptorelin Pamoate|triptorelin pamoate|mesh-list
153430954|NCT04181203|Hormones|hormones|mesh-list
153430955|NCT04181203|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153462498|NCT03064854|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153462538|NCT04395768|Antimalarials|antimalarials|mesh-ancestor
153462539|NCT04395768|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153462540|NCT04395768|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153462541|NCT04395768|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153462542|NCT04395768|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153462543|NCT04395768|Antioxidants|antioxidants|mesh-ancestor
153462544|NCT04395768|Protective Agents|protective agents|mesh-ancestor
153462545|NCT04395768|Vitamin B Complex|vitamin b complex|mesh-ancestor
153462546|NCT01927224|Nifurtimox|nifurtimox|mesh-list
153462547|NCT01927224|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
153462548|NCT01927224|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153462549|NCT01927224|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153462550|NCT01927224|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153462551|NCT01922154|Ranibizumab|ranibizumab|mesh-list
153462552|NCT01922154|Mitomycin|mitomycin|mesh-list
153462565|NCT03423342|Niacin|niacin|mesh-list
153462619|NCT03059004|Protective Agents|protective agents|mesh-ancestor
153462620|NCT03059004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153462621|NCT04554888|Doxepin|doxepin|mesh-list
153462622|NCT04554888|Histamine|histamine|mesh-list
153462623|NCT04554888|Histamine Agonists|histamine agonists|mesh-ancestor
153462624|NCT04554888|Histamine Agents|histamine agents|mesh-ancestor
153462625|NCT04554888|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153462626|NCT04554888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153462627|NCT04554888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153462628|NCT04554888|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
153462629|NCT04554888|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153462630|NCT04554888|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153462631|NCT04554888|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
153462632|NCT04554888|Antidepressive Agents|antidepressive agents|mesh-ancestor
153462633|NCT04554888|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153462634|NCT04554888|Histamine Antagonists|histamine antagonists|mesh-ancestor
153462635|NCT05601960|Sunscreening Agents|sunscreening agents|mesh-list
153462636|NCT05601960|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
153462637|NCT05601960|Protective Agents|protective agents|mesh-ancestor
153462664|NCT04124094|Respiratory System Agents|respiratory system agents|mesh-ancestor
153462665|NCT04124094|Dermatologic Agents|dermatologic agents|mesh-ancestor
153462666|NCT04124094|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
153462667|NCT04124094|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
153430956|NCT04181203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153430957|NCT04181203|Fertility Agents, Female|fertility agents, female|mesh-ancestor
153462668|NCT04124094|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
153462669|NCT04124094|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153462670|NCT04124094|Adrenergic Agents|adrenergic agents|mesh-ancestor
153462671|NCT04124094|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153462672|NCT04124094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153462673|NCT04124094|Glucocorticoids|glucocorticoids|mesh-ancestor
153462708|NCT04760262|Sensory System Agents|sensory system agents|mesh-ancestor
153462709|NCT04760262|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153359315|NCT05643651|Sensory System Agents|sensory system agents|mesh-ancestor
153359316|NCT05643651|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153359317|NCT05643651|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153359319|NCT05643651|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153462710|NCT03047928|Nivolumab|nivolumab|mesh-list
153462711|NCT03047928|Vaccines|vaccines|mesh-list
153462712|NCT03047928|Immunologic Factors|immunologic factors|mesh-ancestor
153462713|NCT03047928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153462714|NCT03047928|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153462715|NCT03047928|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153462716|NCT03047928|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153462717|NCT03047928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153462718|NCT05607810|Aflibercept|aflibercept|mesh-list
153462789|NCT04129710|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153462790|NCT04129710|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153820977|NCT00465231|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153360938|NCT01377623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153360939|NCT01377623|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153889849|NCT01264887|Tapentadol|tapentadol|mesh-list
153889850|NCT01264887|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153889851|NCT01264887|Narcotics|narcotics|mesh-ancestor
153430959|NCT04181203|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153462793|NCT04129710|Growth Inhibitors|growth inhibitors|mesh-ancestor
153462794|NCT04129710|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153462795|NCT04129710|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153462797|NCT03200808|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153462798|NCT03200808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153462799|NCT04129008|Aspirin|aspirin|mesh-list
153462800|NCT04129008|Indobufen|indobufen|mesh-list
153462801|NCT04129008|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153462835|NCT04120350|Dermatologic Agents|dermatologic agents|mesh-ancestor
153462836|NCT04120350|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153462837|NCT04120350|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153462838|NCT04120350|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153462839|NCT04120350|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153462840|NCT04120350|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153462841|NCT04120350|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153462855|NCT04127916|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153462856|NCT04127916|Alkylating Agents|alkylating agents|mesh-ancestor
153462857|NCT04127916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153462859|NCT05602428|Esketamine|esketamine|mesh-list
153462860|NCT05602428|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153462861|NCT05602428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153462862|NCT05602428|Antidepressive Agents|antidepressive agents|mesh-ancestor
153462870|NCT04127058|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153462871|NCT04127058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153462872|NCT04127058|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153462873|NCT03012360|Ciprofloxacin|ciprofloxacin|mesh-list
153462874|NCT03012360|Ceftriaxone|ceftriaxone|mesh-list
153462875|NCT03012360|Linezolid|linezolid|mesh-list
153462876|NCT03012360|Imipenem|imipenem|mesh-list
153462877|NCT03012360|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153462878|NCT03012360|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153462879|NCT03012360|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153462880|NCT03012360|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153462881|NCT03012360|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153462882|NCT03012360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153462883|NCT03012360|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153462884|NCT03012360|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
153462885|NCT03012360|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153462886|NCT03012360|Third Generation Cephalosporins|third generation cephalosporins|mesh-ancestor
153462888|NCT03012360|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
153462889|NCT04126668|Vorolanib|vorolanib|mesh-list
153813639|NCT00436371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153813640|NCT00436371|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153813641|NCT00436371|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
153813642|NCT00436371|Dopamine Agents|dopamine agents|mesh-ancestor
153813643|NCT00436371|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153813644|NCT00436371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153813645|NCT00436371|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
153813646|NCT00436371|Antidepressive Agents|antidepressive agents|mesh-ancestor
153813647|NCT00334763|Paclitaxel|paclitaxel|mesh-list
153813648|NCT00334763|Bevacizumab|bevacizumab|mesh-list
153360075|NCT01321151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153462931|NCT04394208|Antioxidants|antioxidants|mesh-ancestor
153462933|NCT04394208|Protective Agents|protective agents|mesh-ancestor
153463003|NCT03828474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153463005|NCT03828474|Natriuretic Agents|natriuretic agents|mesh-ancestor
153463006|NCT03828474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153463007|NCT03828084|Decitabine|decitabine|mesh-list
153820978|NCT00465231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153820979|NCT00465231|Sensory System Agents|sensory system agents|mesh-ancestor
153360940|NCT01377623|Analgesics|analgesics|mesh-ancestor
153889852|NCT01264887|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153430960|NCT04181203|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153430961|NCT04181203|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153463008|NCT03828084|Tetrahydrouridine|tetrahydrouridine|mesh-list
153463009|NCT03828084|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153463010|NCT03828084|Antimetabolites|antimetabolites|mesh-ancestor
153463011|NCT03828084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153463012|NCT03828084|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153463013|NCT03828084|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153463014|NCT04274166|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
153463015|NCT04274166|Immunologic Factors|immunologic factors|mesh-ancestor
153463016|NCT04274166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153463017|NCT02983734|Cycloserine|cycloserine|mesh-list
153359330|NCT05643651|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153359331|NCT05643651|Anticoagulants|anticoagulants|mesh-ancestor
153359332|NCT05643651|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
153359333|NCT05643651|Antithrombins|antithrombins|mesh-ancestor
153359334|NCT05643651|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
153889643|NCT01012219|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153889644|NCT01012219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153463018|NCT02983734|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
153463019|NCT02983734|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153463020|NCT02983734|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
153463021|NCT02983734|Antitubercular Agents|antitubercular agents|mesh-ancestor
153463022|NCT02983734|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153463023|NCT02983734|Antimetabolites|antimetabolites|mesh-ancestor
153463024|NCT02983734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153813649|NCT00334763|Carboplatin|carboplatin|mesh-list
153360076|NCT01321151|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153463025|NCT03821454|Capecitabine|capecitabine|mesh-list
153463026|NCT03821454|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153463059|NCT02955654|Serotonin Agents|serotonin agents|mesh-ancestor
153463060|NCT02955654|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
153463061|NCT02955654|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153463062|NCT02955654|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
153463063|NCT02955654|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
153463064|NCT04392648|Dexamethasone|dexamethasone|mesh-list
153463065|NCT04392648|Cyclophosphamide|cyclophosphamide|mesh-list
153463067|NCT04392648|Pomalidomide|pomalidomide|mesh-list
153463068|NCT04392648|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153463094|NCT03826602|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153463096|NCT03826602|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153463097|NCT03826602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153463098|NCT01453920|Ranibizumab|ranibizumab|mesh-list
153463099|NCT01453920|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153463100|NCT01453920|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153463101|NCT01453920|Growth Substances|growth substances|mesh-ancestor
153463102|NCT01453920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153463103|NCT01453920|Growth Inhibitors|growth inhibitors|mesh-ancestor
153463104|NCT01453920|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153463105|NCT03820908|Bisantrene|bisantrene|mesh-list
153463106|NCT03820908|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153463107|NCT03820908|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153463108|NCT02953548|Cannabidiol|cannabidiol|mesh-list
153889692|NCT01011673|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153889693|NCT01011439|Maleic acid|maleic acid|mesh-list
153889694|NCT01011439|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153889695|NCT01011439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153889697|NCT01311024|Immunologic Factors|immunologic factors|mesh-ancestor
153889698|NCT01311024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153889699|NCT02871193|Dexamethasone|dexamethasone|mesh-list
153889700|NCT02871193|Ropivacaine|ropivacaine|mesh-list
153430834|NCT00000277|Mazindol|mazindol|mesh-list
153430835|NCT00000277|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
153463109|NCT02953548|Anticonvulsants|anticonvulsants|mesh-ancestor
153463110|NCT02952222|Dexmedetomidine|dexmedetomidine|mesh-list
153463111|NCT02952222|Propofol|propofol|mesh-list
153463112|NCT02952222|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153820981|NCT00465231|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153360941|NCT01377623|Sensory System Agents|sensory system agents|mesh-ancestor
153360942|NCT01377623|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153463113|NCT02952222|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153463114|NCT02952222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153463115|NCT02952222|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153463117|NCT02952222|Sensory System Agents|sensory system agents|mesh-ancestor
153463118|NCT02952222|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153463137|NCT04391478|Urological Agents|urological agents|mesh-ancestor
153820721|NCT03272802|Edaravone|edaravone|mesh-list
153463165|NCT02983188|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153463166|NCT02983188|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153463167|NCT02983188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153463168|NCT02983188|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153463169|NCT01450176|Olopatadine Hydrochloride|olopatadine hydrochloride|mesh-list
153463170|NCT01450176|Bepotastine besilate|bepotastine besilate|mesh-list
153463171|NCT01450176|Ophthalmic Solutions|ophthalmic solutions|mesh-list
153463172|NCT01450176|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
153463173|NCT01450176|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153463298|NCT01451658|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
153463299|NCT01451658|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
153463300|NCT01451658|Adrenergic Agents|adrenergic agents|mesh-ancestor
153463301|NCT01451658|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153463302|NCT01451658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153463303|NCT01451658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153463304|NCT01451658|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153463305|NCT01451658|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153463306|NCT01451658|Vasodilator Agents|vasodilator agents|mesh-ancestor
153463307|NCT02851056|Lenograstim|lenograstim|mesh-list
153463308|NCT02851056|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153463309|NCT02851056|Immunologic Factors|immunologic factors|mesh-ancestor
153359342|NCT05623319|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153359343|NCT05623319|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153889744|NCT01005901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153889746|NCT02889549|Clopidogrel|clopidogrel|mesh-list
153889747|NCT02889549|Ticagrelor|ticagrelor|mesh-list
153889748|NCT02889549|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153889749|NCT02889549|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
153889750|NCT02889549|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
153463310|NCT02851056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153463539|NCT01893450|Antithyroid Agents|antithyroid agents|mesh-ancestor
153463540|NCT05027100|Irinotecan|irinotecan|mesh-list
153463541|NCT05027100|Tislelizumab|tislelizumab|mesh-list
153463680|NCT02680314|Immunologic Factors|immunologic factors|mesh-ancestor
153463681|NCT02680314|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153463682|NCT02680314|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153463683|NCT02680314|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
153463684|NCT02680314|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153463685|NCT02680314|Oxytocics|oxytocics|mesh-ancestor
153463686|NCT02707692|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
153463687|NCT02707692|Immunologic Factors|immunologic factors|mesh-ancestor
153463688|NCT02707692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153463689|NCT02706678|Tacrolimus|tacrolimus|mesh-list
153463690|NCT02706678|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153463691|NCT02706678|Immunologic Factors|immunologic factors|mesh-ancestor
153463692|NCT02706678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153463693|NCT02706678|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
153820982|NCT00465231|Narcotics|narcotics|mesh-ancestor
153889853|NCT01264887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153889854|NCT01264887|Analgesics|analgesics|mesh-ancestor
153463695|NCT02706678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153463844|NCT05585814|Growth Substances|growth substances|mesh-ancestor
153463845|NCT05585814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153463846|NCT05585814|Growth Inhibitors|growth inhibitors|mesh-ancestor
153463847|NCT05585814|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153463848|NCT05585814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153463849|NCT05585814|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153463852|NCT05585736|Autonomic Agents|autonomic agents|mesh-ancestor
153463853|NCT05585736|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153463854|NCT05585736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153463855|NCT01989780|Paclitaxel|paclitaxel|mesh-list
153463856|NCT01989780|Bevacizumab|bevacizumab|mesh-list
153463857|NCT01989780|Letrozole|letrozole|mesh-list
153463858|NCT01989780|Fulvestrant|fulvestrant|mesh-list
153463859|NCT01989780|Anastrozole|anastrozole|mesh-list
153813653|NCT00334763|Antimitotic Agents|antimitotic agents|mesh-ancestor
153463995|NCT05578950|Antifungal Agents|antifungal agents|mesh-ancestor
153464052|NCT02104986|Cisplatin|cisplatin|mesh-list
153464053|NCT02104986|Ifosfamide|ifosfamide|mesh-list
153464054|NCT02104986|Bleomycin|bleomycin|mesh-list
153464055|NCT02104986|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153464056|NCT02104986|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153464057|NCT02104986|Alkylating Agents|alkylating agents|mesh-ancestor
153464058|NCT02104986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153464059|NCT02104986|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153464060|NCT04757532|Methyltestosterone|methyltestosterone|mesh-list
153464061|NCT04757532|Anastrozole|anastrozole|mesh-list
153820985|NCT00465231|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153820986|NCT00465231|Anesthetics, General|anesthetics, general|mesh-ancestor
153820987|NCT00436241|Capecitabine|capecitabine|mesh-list
153820988|NCT00436241|Oxaliplatin|oxaliplatin|mesh-list
153820989|NCT00436241|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153464063|NCT04757532|Bupropion|bupropion|mesh-list
153464064|NCT04757532|Testosterone|testosterone|mesh-list
153464189|NCT00273624|Autonomic Agents|autonomic agents|mesh-ancestor
153464190|NCT00273624|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153464191|NCT00273624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153464192|NCT00273624|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153464193|NCT00273624|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153464194|NCT00273624|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153464195|NCT00273624|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153464196|NCT00273624|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153464197|NCT00273624|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
153889821|NCT01265823|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153889822|NCT01004185|Aminosalicylic Acid|aminosalicylic acid|mesh-list
153430936|NCT00000313|Serotonin Agents|serotonin agents|mesh-ancestor
153464198|NCT00273624|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153464199|NCT00273624|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153464200|NCT00273624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153464201|NCT00273624|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153464202|NCT00273624|Serotonin Agents|serotonin agents|mesh-ancestor
153464203|NCT01253070|Cytarabine|cytarabine|mesh-list
153464204|NCT01253070|Sorafenib|sorafenib|mesh-list
153464205|NCT01253070|Daunorubicin|daunorubicin|mesh-list
153464206|NCT01253070|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153464207|NCT01253070|Antimetabolites|antimetabolites|mesh-ancestor
153464217|NCT01253070|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153464218|NCT01253070|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153464220|NCT01212822|Leucovorin|leucovorin|mesh-list
153464221|NCT01212822|Bevacizumab|bevacizumab|mesh-list
153464222|NCT01212822|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
153464223|NCT01212822|Fluorouracil|fluorouracil|mesh-list
153464224|NCT01212822|Oxaliplatin|oxaliplatin|mesh-list
153464225|NCT01212822|Antibodies|antibodies|mesh-list
153464226|NCT01212822|Immunoglobulins|immunoglobulins|mesh-list
153464227|NCT01212822|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
153464228|NCT01212822|Levoleucovorin|levoleucovorin|mesh-list
153464229|NCT01212822|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153464243|NCT01212822|Vitamins|vitamins|mesh-ancestor
153820990|NCT00436241|Antimetabolites|antimetabolites|mesh-ancestor
153360947|NCT01377623|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153464244|NCT01212822|Micronutrients|micronutrients|mesh-ancestor
153464245|NCT00163566|Dihydrotestosterone|dihydrotestosterone|mesh-list
153464246|NCT00163566|Androgens|androgens|mesh-ancestor
153464247|NCT00163566|Hormones|hormones|mesh-ancestor
153464248|NCT00163566|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153464249|NCT00163566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153464250|NCT04705662|Lactulose|lactulose|mesh-list
153464251|NCT04705662|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153464252|NCT04782960|Bupivacaine|bupivacaine|mesh-list
153464253|NCT04782960|Anesthetics|anesthetics|mesh-list
153430938|NCT00000319|Buprenorphine|buprenorphine|mesh-list
153464254|NCT04782960|Anesthetics, Local|anesthetics, local|mesh-ancestor
153464255|NCT04782960|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153464256|NCT04782960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153464257|NCT04782960|Sensory System Agents|sensory system agents|mesh-ancestor
153464258|NCT04782960|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153464259|NCT01026012|Regadenoson|regadenoson|mesh-list
153464260|NCT01026012|Adenosine A2 Receptor Agonists|adenosine a2 receptor agonists|mesh-ancestor
153464261|NCT01026012|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
153464262|NCT01026012|Purinergic Agonists|purinergic agonists|mesh-ancestor
153464267|NCT02088216|Acetylcysteine|acetylcysteine|mesh-list
153464364|NCT04777968|Protective Agents|protective agents|mesh-ancestor
153464365|NCT04777968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153464366|NCT01722708|Metronidazole|metronidazole|mesh-list
153464367|NCT01722708|Clindamycin|clindamycin|mesh-list
153464368|NCT01722708|Clindamycin palmitate|clindamycin palmitate|mesh-list
153464369|NCT01722708|Clindamycin phosphate|clindamycin phosphate|mesh-list
153813654|NCT00334763|Mitosis Modulators|mitosis modulators|mesh-ancestor
153464370|NCT01722708|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153464371|NCT01722708|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153464372|NCT01722708|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153464373|NCT01722708|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153464374|NCT01722708|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
153464375|NCT01722708|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153360948|NCT01377623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153889855|NCT01264887|Sensory System Agents|sensory system agents|mesh-ancestor
153889856|NCT01264887|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153430963|NCT04181203|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
153464376|NCT01722708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153464378|NCT01711632|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153464379|NCT01711632|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153464380|NCT01711632|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153464381|NCT01711632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153464382|NCT04756206|Dutasteride|dutasteride|mesh-list
153464383|NCT04756206|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
153464384|NCT04756206|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153464398|NCT04779060|Hormones|hormones|mesh-ancestor
153464428|NCT05605314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153464429|NCT05605314|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153464431|NCT05605314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153464432|NCT05605314|Antifungal Agents|antifungal agents|mesh-ancestor
153464433|NCT05605314|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153464434|NCT05605314|Dermatologic Agents|dermatologic agents|mesh-ancestor
153464435|NCT05605314|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153464436|NCT05605314|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
153464437|NCT05605158|Pioglitazone|pioglitazone|mesh-list
153464438|NCT05605158|Empagliflozin|empagliflozin|mesh-list
153464439|NCT05605158|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153464440|NCT05605158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153464441|NCT05605158|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
153464442|NCT05605158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153359359|NCT05534243|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153359360|NCT05534243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153359362|NCT05498025|Antidotes|antidotes|mesh-ancestor
153359363|NCT05498025|Protective Agents|protective agents|mesh-ancestor
153359364|NCT05498025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153359365|NCT05497557|Sotorasib|sotorasib|mesh-list
153359366|NCT05497557|Omeprazole|omeprazole|mesh-list
153359367|NCT05497557|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
153783524|NCT00236444|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153464444|NCT04775238|Trace Elements|trace elements|mesh-ancestor
153464445|NCT04775238|Micronutrients|micronutrients|mesh-ancestor
153464446|NCT04775238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153464447|NCT05580042|Tofacitinib|tofacitinib|mesh-list
153820991|NCT00436241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153820992|NCT00436241|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153360949|NCT01486043|Metformin|metformin|mesh-list
153359379|NCT05444699|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
153360950|NCT01486043|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153464449|NCT05580042|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153464450|NCT05580042|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153464451|NCT05580042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153464453|NCT04773756|Antiviral Agents|antiviral agents|mesh-ancestor
153464454|NCT04773756|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153464455|NCT03012984|Dexmedetomidine|dexmedetomidine|mesh-list
153464498|NCT01896960|Anesthetics, General|anesthetics, general|mesh-ancestor
153464499|NCT00055692|Bevacizumab|bevacizumab|mesh-list
153464500|NCT00055692|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
153464501|NCT00055692|Antibodies|antibodies|mesh-list
153464502|NCT00055692|Immunoglobulins|immunoglobulins|mesh-list
153464503|NCT00055692|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
153464504|NCT00055692|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153464505|NCT00055692|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153464506|NCT00055692|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153464507|NCT00055692|Growth Substances|growth substances|mesh-ancestor
153464508|NCT00055692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153464509|NCT00055692|Growth Inhibitors|growth inhibitors|mesh-ancestor
153464510|NCT00055692|Immunologic Factors|immunologic factors|mesh-ancestor
153820993|NCT00481455|Temozolomide|temozolomide|mesh-list
153820994|NCT00481455|2-Methoxyestradiol|2-methoxyestradiol|mesh-list
153360951|NCT01486043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153360953|NCT01490723|Rituximab|rituximab|mesh-list
153464511|NCT04772352|Febuxostat|febuxostat|mesh-list
153464512|NCT04772352|Gout Suppressants|gout suppressants|mesh-ancestor
153464574|NCT02538744|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
153464575|NCT02538744|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
153464577|NCT00060528|Metronidazole|metronidazole|mesh-list
153464578|NCT00060528|Molgramostim|molgramostim|mesh-list
153464579|NCT00060528|Sargramostim|sargramostim|mesh-list
153464580|NCT00060528|Immunologic Factors|immunologic factors|mesh-ancestor
153464581|NCT00060528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153464611|NCT00063570|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153464684|NCT00074802|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153359380|NCT05444699|Methylprednisolone|methylprednisolone|mesh-list
153359381|NCT05444699|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
153359382|NCT05444699|Prednisolone acetate|prednisolone acetate|mesh-list
153359383|NCT05444699|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
153359384|NCT05444699|Prednisolone phosphate|prednisolone phosphate|mesh-list
153359385|NCT05444699|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153359386|NCT05444699|Glucocorticoids|glucocorticoids|mesh-ancestor
153359387|NCT05444699|Hormones|hormones|mesh-ancestor
153359388|NCT05444699|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153359389|NCT05444699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153359390|NCT05444699|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153359398|NCT05400369|Moxifloxacin|moxifloxacin|mesh-list
153464685|NCT00074802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153890048|NCT00624039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153464686|NCT00074802|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153464687|NCT00074802|Serotonin Agents|serotonin agents|mesh-ancestor
153813655|NCT00334763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153360082|NCT01350947|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153360083|NCT01350947|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153889857|NCT01264887|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
153430964|NCT04181203|Contraceptive Agents|contraceptive agents|mesh-ancestor
153464790|NCT00038610|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153464791|NCT00038610|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153464792|NCT00038610|Antiviral Agents|antiviral agents|mesh-ancestor
153464793|NCT00038610|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153464794|NCT00038610|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153464795|NCT00038610|Tubulin Modulators|tubulin modulators|mesh-ancestor
153464796|NCT00038610|Antimitotic Agents|antimitotic agents|mesh-ancestor
153464813|NCT00079326|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153464814|NCT00079326|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153813656|NCT00334763|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153813657|NCT00334763|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153813658|NCT00334763|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153813659|NCT00334763|Growth Substances|growth substances|mesh-ancestor
153360087|NCT01269047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153464816|NCT00079326|Antimitotic Agents|antimitotic agents|mesh-ancestor
153464817|NCT00079326|Mitosis Modulators|mitosis modulators|mesh-ancestor
153464818|NCT00079326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153464819|NCT01898052|Anesthetics|anesthetics|mesh-list
153464820|NCT01898052|Levobupivacaine|levobupivacaine|mesh-list
153464821|NCT01898052|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153464822|NCT01898052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153464823|NCT01898052|Anesthetics, Local|anesthetics, local|mesh-ancestor
153464824|NCT01898052|Sensory System Agents|sensory system agents|mesh-ancestor
153464848|NCT00167934|GABA Agents|gaba agents|mesh-ancestor
153464849|NCT00167934|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153464850|NCT00167934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153464851|NCT00167934|Antimanic Agents|antimanic agents|mesh-ancestor
153464852|NCT00167934|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153464853|NCT00167934|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153464854|NCT00167934|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153464855|NCT00168324|Dexamethasone|dexamethasone|mesh-list
153464856|NCT00168324|Dexamethasone acetate|dexamethasone acetate|mesh-list
153464878|NCT02091882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153464879|NCT02091882|Dopamine Agonists|dopamine agonists|mesh-ancestor
153464880|NCT02091882|Dopamine Agents|dopamine agents|mesh-ancestor
153464881|NCT02091882|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153890049|NCT00624039|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
153431068|NCT00000361|Methotrexate|methotrexate|mesh-list
153431069|NCT00000361|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
153464882|NCT02091882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153464883|NCT02091882|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
153359430|NCT05356104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153889858|NCT01264887|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153464885|NCT02091882|Serotonin Agents|serotonin agents|mesh-ancestor
153464886|NCT02091882|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
153464887|NCT02091882|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153464888|NCT02091882|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
153464889|NCT02091882|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
153464890|NCT00085254|Temozolomide|temozolomide|mesh-list
153464891|NCT00085254|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153464892|NCT00085254|Alkylating Agents|alkylating agents|mesh-ancestor
153464893|NCT00085254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153464894|NCT00085254|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153464895|NCT00253890|Trazodone|trazodone|mesh-list
153464896|NCT00253890|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153464897|NCT00253890|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153464898|NCT00253890|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153464899|NCT00253890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153464900|NCT00253890|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153464901|NCT00253890|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
153464902|NCT00253890|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153813660|NCT00334763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153813661|NCT00334763|Growth Inhibitors|growth inhibitors|mesh-ancestor
153360088|NCT01269047|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
153464906|NCT00253890|Serotonin Agents|serotonin agents|mesh-ancestor
153464907|NCT00253890|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
153464932|NCT00254592|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153464933|NCT00254592|Growth Substances|growth substances|mesh-ancestor
153464934|NCT00254592|Growth Inhibitors|growth inhibitors|mesh-ancestor
153464935|NCT00254592|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153464936|NCT00254592|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153464937|NCT00254592|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153464938|NCT00254592|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153465006|NCT00176202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153465007|NCT00176202|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153465008|NCT00176202|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153465009|NCT00176202|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153465010|NCT00176202|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
153465011|NCT00176202|Dopamine Agents|dopamine agents|mesh-ancestor
153465012|NCT00176202|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153465013|NCT00176202|GABA Agents|gaba agents|mesh-ancestor
153465014|NCT00176202|Antimanic Agents|antimanic agents|mesh-ancestor
153465015|NCT00176592|Glatiramer Acetate|glatiramer acetate|mesh-list
153465016|NCT00176592|Interferon beta-1b|interferon beta-1b|mesh-list
153359431|NCT05356104|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
153359432|NCT05356104|Incretins|incretins|mesh-ancestor
153359433|NCT05356104|Hormones|hormones|mesh-ancestor
153359435|NCT05354778|Hydrocortisone|hydrocortisone|mesh-list
153359436|NCT05354778|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
153465017|NCT00176592|(T,G)-A-L|(t,g)-a-l|mesh-list
153465033|NCT00176904|Busulfan|busulfan|mesh-list
153465081|NCT00088218|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153465082|NCT00088218|Antimetabolites|antimetabolites|mesh-ancestor
153465083|NCT00088218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153465091|NCT00189228|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
153465092|NCT00189228|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153465093|NCT00189228|Respiratory System Agents|respiratory system agents|mesh-ancestor
153465094|NCT00091260|Dexamethasone|dexamethasone|mesh-list
153465095|NCT00091260|Dexamethasone acetate|dexamethasone acetate|mesh-list
153465096|NCT00091260|Lenalidomide|lenalidomide|mesh-list
153465097|NCT00091260|BB 1101|bb 1101|mesh-list
153465098|NCT00091260|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153465099|NCT00091260|Antiemetics|antiemetics|mesh-ancestor
153465100|NCT00091260|Autonomic Agents|autonomic agents|mesh-ancestor
153820999|NCT00481455|Tubulin Modulators|tubulin modulators|mesh-ancestor
153360959|NCT01490723|Thymoglobulin|thymoglobulin|mesh-list
153465102|NCT00091260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153465103|NCT00091260|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153465104|NCT00091260|Glucocorticoids|glucocorticoids|mesh-ancestor
153465105|NCT00091260|Hormones|hormones|mesh-ancestor
153465106|NCT00091260|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153465109|NCT00091260|Protease Inhibitors|protease inhibitors|mesh-ancestor
153465110|NCT00091260|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153465111|NCT00091260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153465112|NCT00091260|Immunologic Factors|immunologic factors|mesh-ancestor
153465113|NCT00091260|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153465114|NCT00091260|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153465136|NCT00193596|Mitosis Modulators|mitosis modulators|mesh-ancestor
153465137|NCT00193596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153465138|NCT00193596|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153465139|NCT00193596|Antimetabolites|antimetabolites|mesh-ancestor
153465140|NCT00193596|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
153465213|NCT00267696|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153465214|NCT00267696|Antimetabolites|antimetabolites|mesh-ancestor
153465215|NCT00267696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153465217|NCT00195624|Alemtuzumab|alemtuzumab|mesh-list
153465218|NCT00195624|Cyclosporins|cyclosporins|mesh-list
153465219|NCT00195624|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153465226|NCT00195624|Dermatologic Agents|dermatologic agents|mesh-ancestor
153465227|NCT00195624|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153465228|NCT00195624|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
153465229|NCT00195624|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153821000|NCT00481455|Antimitotic Agents|antimitotic agents|mesh-ancestor
153821001|NCT00481455|Mitosis Modulators|mitosis modulators|mesh-ancestor
153360960|NCT01490723|Antilymphocyte Serum|antilymphocyte serum|mesh-list
153360961|NCT01490723|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
153360962|NCT01490723|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153889860|NCT01264887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153889861|NCT01264887|Adrenergic Agents|adrenergic agents|mesh-ancestor
153889862|NCT01264887|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153430967|NCT03521102|Hydromorphone|hydromorphone|mesh-list
153430968|NCT03521102|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153465284|NCT00205374|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153465285|NCT00205374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153465287|NCT00103194|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153465374|NCT00282282|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153465376|NCT00282828|Sertraline|sertraline|mesh-list
153465377|NCT00282828|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
153465378|NCT00282828|Antidepressive Agents|antidepressive agents|mesh-ancestor
153465379|NCT00282828|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153465380|NCT00282828|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
153465381|NCT00282828|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153465382|NCT00282828|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153465454|NCT00225420|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153465455|NCT00225420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153821002|NCT00481533|Oxytocin|oxytocin|mesh-list
153821003|NCT00481533|Ergonovine|ergonovine|mesh-list
153821004|NCT00481533|Oxytocics|oxytocics|mesh-ancestor
153821005|NCT00481533|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153889863|NCT01011283|Azacitidine|azacitidine|mesh-list
153889864|NCT01011283|Decitabine|decitabine|mesh-list
153465456|NCT00225420|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153465459|NCT00225498|Ziprasidone|ziprasidone|mesh-list
153465460|NCT00225498|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153465461|NCT00225498|Serotonin Agents|serotonin agents|mesh-ancestor
153465462|NCT00225498|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153465473|NCT00225498|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153465549|NCT01898676|Anticonvulsants|anticonvulsants|mesh-ancestor
153359493|NCT05164549|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153359494|NCT05164549|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
153359495|NCT05164549|Antitussive Agents|antitussive agents|mesh-ancestor
153359496|NCT05164549|Respiratory System Agents|respiratory system agents|mesh-ancestor
153359497|NCT05079230|Azacitidine|azacitidine|mesh-list
153421873|NCT05374603|Durvalumab|durvalumab|mesh-list
153359509|NCT05077904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153359510|NCT05077904|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153359511|NCT05077904|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153359512|NCT05077904|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153359513|NCT05077904|GABA Modulators|gaba modulators|mesh-ancestor
153359514|NCT05077904|GABA Agents|gaba agents|mesh-ancestor
153359515|NCT05077904|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153359516|NCT05077904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153359517|NCT05061134|Durvalumab|durvalumab|mesh-list
153890052|NCT00624039|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153431071|NCT00000361|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153431072|NCT00000361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153465550|NCT01898676|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153465551|NCT01898676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153421874|NCT05374603|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153421875|NCT05374603|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153465552|NCT01898676|GABA Agents|gaba agents|mesh-ancestor
153465553|NCT01898676|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153465636|NCT00234078|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153465637|NCT00118404|Fluoxetine|fluoxetine|mesh-list
153465638|NCT00118404|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
153465639|NCT00118404|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153465668|NCT00237666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153465669|NCT00237666|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153465670|NCT00237666|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153465671|NCT00237666|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153465672|NCT00237666|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153465673|NCT00237666|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
153465674|NCT00237666|Dopamine Agents|dopamine agents|mesh-ancestor
153465675|NCT00296322|Mitomycins|mitomycins|mesh-list
153465676|NCT00296322|Mitomycin|mitomycin|mesh-list
153465735|NCT04226352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153465736|NCT04226352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153465737|NCT04226352|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153465738|NCT04226352|Narcotics|narcotics|mesh-ancestor
153465739|NCT04226352|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153465740|NCT04226352|Analgesics|analgesics|mesh-ancestor
153465741|NCT04226352|Sensory System Agents|sensory system agents|mesh-ancestor
153889865|NCT01011283|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153430969|NCT03521102|Analgesics|analgesics|mesh-ancestor
153465743|NCT00300456|Simvastatin|simvastatin|mesh-list
153465744|NCT00300456|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153465745|NCT00300456|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153465746|NCT00300456|Antimetabolites|antimetabolites|mesh-ancestor
153465747|NCT00300456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153465780|NCT00241176|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
153465781|NCT00241176|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
153465834|NCT01899066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153421876|NCT05328908|Trifluridine|trifluridine|mesh-list
153421877|NCT05328908|Nivolumab|nivolumab|mesh-list
153421878|NCT05328908|Relatlimab|relatlimab|mesh-list
153421879|NCT05328908|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153431075|NCT00000361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153431077|NCT00000361|Dermatologic Agents|dermatologic agents|mesh-ancestor
153431078|NCT00000361|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153465835|NCT01899066|Growth Inhibitors|growth inhibitors|mesh-ancestor
153465837|NCT00127218|Atorvastatin|atorvastatin|mesh-list
153465838|NCT00127218|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
153465839|NCT00127218|Simvastatin|simvastatin|mesh-list
153465840|NCT00127218|Pravastatin|pravastatin|mesh-list
153465841|NCT00127218|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153465842|NCT00127218|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153465843|NCT00127218|Antimetabolites|antimetabolites|mesh-ancestor
153465844|NCT00127218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153465845|NCT00127218|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153465846|NCT00127218|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
153465847|NCT00127218|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153465848|NCT00127218|Vasodilator Agents|vasodilator agents|mesh-ancestor
153465849|NCT00127218|Vitamin B Complex|vitamin b complex|mesh-ancestor
153465850|NCT00127218|Vitamins|vitamins|mesh-ancestor
153465851|NCT00127218|Micronutrients|micronutrients|mesh-ancestor
153465852|NCT00127218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153465853|NCT00127530|4-Aminopyridine|4-aminopyridine|mesh-list
153465854|NCT00127530|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
153465855|NCT00127530|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153465856|NCT00127530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153465903|NCT00134004|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153465904|NCT00134004|Antimetabolites|antimetabolites|mesh-ancestor
153465905|NCT00134004|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
153465906|NCT00134004|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153465907|NCT00134004|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153465908|NCT00134004|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
153465909|NCT00134004|Antitubercular Agents|antitubercular agents|mesh-ancestor
153465910|NCT00134004|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153465911|NCT00134004|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153465912|NCT00135798|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
153465913|NCT00135798|Antiviral Agents|antiviral agents|mesh-ancestor
153889866|NCT01011283|Antimetabolites|antimetabolites|mesh-ancestor
153889867|NCT01011283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153465915|NCT02103114|Antithrombin III|antithrombin iii|mesh-list
153813671|NCT00334880|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153466008|NCT00142818|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
153466009|NCT00142818|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
153466010|NCT00142818|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
153466011|NCT00142818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153466012|NCT05266716|Methamphetamine|methamphetamine|mesh-list
153466013|NCT05266716|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
153466014|NCT05266716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153466015|NCT05266716|Sympathomimetics|sympathomimetics|mesh-ancestor
153359611|NCT04674254|Growth Substances|growth substances|mesh-ancestor
153359612|NCT04674254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153359613|NCT04674254|Growth Inhibitors|growth inhibitors|mesh-ancestor
153359614|NCT04665843|Atezolizumab|atezolizumab|mesh-list
153359615|NCT04665843|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153359618|NCT04665843|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153466016|NCT05266716|Autonomic Agents|autonomic agents|mesh-ancestor
153466017|NCT05266716|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153466018|NCT05266716|Dopamine Agents|dopamine agents|mesh-ancestor
153466084|NCT00324870|Growth Inhibitors|growth inhibitors|mesh-ancestor
153466097|NCT00328770|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153466098|NCT00328770|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153466099|NCT00328770|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153466100|NCT00328770|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153466101|NCT00328770|Antifungal Agents|antifungal agents|mesh-ancestor
153466102|NCT00328770|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153466103|NCT00328770|Immunologic Factors|immunologic factors|mesh-ancestor
153466104|NCT00328770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153466105|NCT04177680|Eicosapentaenoic acid ethyl ester|eicosapentaenoic acid ethyl ester|mesh-list
153466106|NCT04177680|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153466165|NCT00344370|Pitavastatin|pitavastatin|mesh-list
153466166|NCT00344370|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153466167|NCT00344370|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153466168|NCT00344370|Antimetabolites|antimetabolites|mesh-ancestor
153360963|NCT01490723|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153360964|NCT01490723|Immunologic Factors|immunologic factors|mesh-ancestor
153889868|NCT01011283|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153889869|NCT01011283|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153430970|NCT03521102|Sensory System Agents|sensory system agents|mesh-ancestor
153430971|NCT03521102|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153466170|NCT00344370|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153466171|NCT00344370|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
153466172|NCT00344370|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153466174|NCT00344682|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
153466175|NCT00344682|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
153466196|NCT01791114|Propranolol|propranolol|mesh-list
153466248|NCT00351936|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153466249|NCT00351936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153466250|NCT00351936|Dopamine Agonists|dopamine agonists|mesh-ancestor
153466251|NCT00351936|Dopamine Agents|dopamine agents|mesh-ancestor
153466252|NCT00351936|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153466253|NCT00351936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153466254|NCT00351936|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
153466255|NCT00351936|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
153359655|NCT04432376|Miconazole|miconazole|mesh-list
153359656|NCT04432376|Antifungal Agents|antifungal agents|mesh-ancestor
153890061|NCT05661240|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153466256|NCT00351936|Serotonin Agents|serotonin agents|mesh-ancestor
153466257|NCT00351936|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
153466258|NCT00351936|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153466276|NCT00353418|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
153466277|NCT00353418|Antimetabolites|antimetabolites|mesh-ancestor
153466279|NCT00353418|Antiviral Agents|antiviral agents|mesh-ancestor
153466332|NCT00354978|Bevacizumab|bevacizumab|mesh-list
153466333|NCT00354978|Fluorouracil|fluorouracil|mesh-list
153466334|NCT00354978|Irinotecan|irinotecan|mesh-list
153466335|NCT00354978|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153466336|NCT00354978|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153466337|NCT00354978|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153889870|NCT01263483|Inositol|inositol|mesh-list
153889871|NCT01263483|Alogliptin|alogliptin|mesh-list
153889872|NCT01263483|Voglibose|voglibose|mesh-list
153466339|NCT00354978|Growth Substances|growth substances|mesh-ancestor
153466340|NCT00354978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153466341|NCT00354978|Growth Inhibitors|growth inhibitors|mesh-ancestor
153466342|NCT00354978|Antimetabolites|antimetabolites|mesh-ancestor
153466343|NCT00354978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153466350|NCT00354978|Antidotes|antidotes|mesh-ancestor
153466440|NCT00549978|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
153466441|NCT00549978|Protective Agents|protective agents|mesh-ancestor
153466442|NCT00549978|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
153466443|NCT00549978|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
153466444|NCT00549978|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153466445|NCT00549978|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153466446|NCT00549978|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153466447|NCT00549978|Antimetabolites|antimetabolites|mesh-ancestor
153466448|NCT00549978|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153466450|NCT03983226|Carboplatin|carboplatin|mesh-list
153466451|NCT03983226|Gemcitabine|gemcitabine|mesh-list
153466452|NCT03983226|Doxorubicin|doxorubicin|mesh-list
153466453|NCT03983226|Niraparib|niraparib|mesh-list
153466454|NCT03983226|Taxane|taxane|mesh-list
153813674|NCT00334880|Dopamine Agents|dopamine agents|mesh-ancestor
153466455|NCT03983226|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153466521|NCT00305760|Vaccines|vaccines|mesh-list
153466522|NCT00305760|Immunologic Factors|immunologic factors|mesh-ancestor
153466523|NCT00305760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153890062|NCT05661240|Tubulin Modulators|tubulin modulators|mesh-ancestor
153466524|NCT00305760|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153466525|NCT00305760|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153466526|NCT00305760|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153466527|NCT00305760|Alkylating Agents|alkylating agents|mesh-ancestor
153466528|NCT00305760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153466529|NCT00305760|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153466530|NCT00305760|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153466531|NCT00305760|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153466550|NCT00363168|Growth Substances|growth substances|mesh-ancestor
153466551|NCT00363168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153466552|NCT00363168|Growth Inhibitors|growth inhibitors|mesh-ancestor
153466553|NCT00363168|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153466554|NCT00365274|Prednisone|prednisone|mesh-list
153466555|NCT00365274|Cyclophosphamide|cyclophosphamide|mesh-list
153466556|NCT00365274|Doxorubicin|doxorubicin|mesh-list
153466602|NCT00313560|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153466603|NCT00313560|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153466604|NCT00313560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153821010|NCT00481572|Norepinephrine|norepinephrine|mesh-list
153821011|NCT00481572|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153821012|NCT00481572|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153360967|NCT01490723|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
153889876|NCT01263483|Hormones|hormones|mesh-ancestor
153889877|NCT01263483|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153466607|NCT00314106|Cyclophosphamide|cyclophosphamide|mesh-list
153466608|NCT00314106|Fludarabine|fludarabine|mesh-list
153466609|NCT00314106|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153466610|NCT00314106|Immunologic Factors|immunologic factors|mesh-ancestor
153466611|NCT00314106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153466674|NCT00391716|Anticonvulsants|anticonvulsants|mesh-ancestor
153466675|NCT00391716|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153466676|NCT00391716|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153466677|NCT00391716|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153466678|NCT00391716|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153466679|NCT00391716|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
153466680|NCT00391716|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
153466681|NCT00391716|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153466682|NCT00391716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153466683|NCT00391716|Antimanic Agents|antimanic agents|mesh-ancestor
153466684|NCT00392496|Sunitinib|sunitinib|mesh-list
153466685|NCT00392496|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153466686|NCT00392496|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153466687|NCT00392496|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153466688|NCT00392496|Growth Substances|growth substances|mesh-ancestor
153466690|NCT00392496|Growth Inhibitors|growth inhibitors|mesh-ancestor
153813681|NCT00436761|Antilymphocyte Serum|antilymphocyte serum|mesh-list
153813682|NCT00436761|Sargramostim|sargramostim|mesh-list
153813683|NCT00436761|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153360098|NCT03800264|Autonomic Agents|autonomic agents|mesh-ancestor
153360099|NCT03800264|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153360100|NCT03800264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153360101|NCT03800264|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
153360102|NCT03800264|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
153360103|NCT03800264|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
153360104|NCT03800264|Adrenergic Agents|adrenergic agents|mesh-ancestor
153360105|NCT03800264|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153360106|NCT03800264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153360107|NCT01321541|Rituximab|rituximab|mesh-list
153360108|NCT01321541|Gemcitabine|gemcitabine|mesh-list
153360109|NCT01321541|Pixantrone|pixantrone|mesh-list
153466739|NCT00397878|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153466740|NCT00397878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153466742|NCT00400686|Hematinics|hematinics|mesh-ancestor
153466743|NCT00373386|Hormones|hormones|mesh-list
153466744|NCT00373386|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153466745|NCT00373386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153466746|NCT00374088|Acetylcysteine|acetylcysteine|mesh-list
153466747|NCT00374088|N-monoacetylcystine|n-monoacetylcystine|mesh-list
153466748|NCT00374088|Antiviral Agents|antiviral agents|mesh-ancestor
153466749|NCT00374088|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153466750|NCT00374088|Expectorants|expectorants|mesh-ancestor
153466770|NCT00377832|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153466771|NCT00377832|Analgesics|analgesics|mesh-ancestor
153466772|NCT00377832|Sensory System Agents|sensory system agents|mesh-ancestor
153466773|NCT00377832|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153466774|NCT00377832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153466775|NCT00377832|Antipyretics|antipyretics|mesh-ancestor
153466776|NCT00401778|Everolimus|everolimus|mesh-list
153466777|NCT00401778|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
153466778|NCT00401778|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153466779|NCT00401778|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153466795|NCT00405288|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
153466796|NCT00405288|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
153466798|NCT00405288|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153466799|NCT00405288|Anesthetics, Local|anesthetics, local|mesh-ancestor
153783527|NCT00236444|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153466800|NCT00405288|Anesthetics|anesthetics|mesh-ancestor
153466801|NCT00405288|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153783528|NCT00236444|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
153431079|NCT00000361|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153466802|NCT00405288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153466803|NCT00405288|Sensory System Agents|sensory system agents|mesh-ancestor
153813684|NCT00436761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153783529|NCT00236444|Dopamine Agents|dopamine agents|mesh-ancestor
153813685|NCT00436761|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153813686|NCT00436761|Immunologic Factors|immunologic factors|mesh-ancestor
153813687|NCT00436761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153813688|NCT00436761|Antifungal Agents|antifungal agents|mesh-ancestor
153813689|NCT00436761|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153466824|NCT00381810|Glucocorticoids|glucocorticoids|mesh-ancestor
153466825|NCT00381810|Hormones|hormones|mesh-ancestor
153466826|NCT00381810|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153466827|NCT00381810|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
153466828|NCT00381810|Protective Agents|protective agents|mesh-ancestor
153466829|NCT00381810|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
153466830|NCT00381810|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153821014|NCT00481572|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153821015|NCT00481572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153821016|NCT00481572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153466833|NCT00381810|Anesthetics|anesthetics|mesh-ancestor
153466834|NCT00381810|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
153466835|NCT00381810|Histamine Antagonists|histamine antagonists|mesh-ancestor
153466836|NCT00381810|Histamine Agents|histamine agents|mesh-ancestor
153466837|NCT00381810|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153466838|NCT00381810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153466839|NCT00381810|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
153466848|NCT00459732|Zinc Sulfate|zinc sulfate|mesh-list
153466849|NCT00459732|Trace Elements|trace elements|mesh-ancestor
153466850|NCT00459732|Micronutrients|micronutrients|mesh-ancestor
153466851|NCT00459732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153466852|NCT00459732|Astringents|astringents|mesh-ancestor
153466854|NCT00459810|Paclitaxel|paclitaxel|mesh-list
153466886|NCT00461292|Cholinergic Agents|cholinergic agents|mesh-ancestor
153466887|NCT00461292|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153466888|NCT00461292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153360110|NCT01321541|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153466889|NCT00461292|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
153466969|NCT00384774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153466970|NCT00384774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153466971|NCT00410826|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
153466972|NCT00410826|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153466973|NCT00410826|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153466999|NCT00464646|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153467000|NCT00464646|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153813697|NCT00436761|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153813698|NCT00436761|Glucocorticoids|glucocorticoids|mesh-ancestor
153360111|NCT01321541|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153360112|NCT01321541|Immunologic Factors|immunologic factors|mesh-ancestor
153360113|NCT01321541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153360114|NCT01321541|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153360115|NCT01321541|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153360116|NCT01321541|Antimetabolites|antimetabolites|mesh-ancestor
153360117|NCT01321541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153467001|NCT00464646|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153467002|NCT00464646|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153467003|NCT00385008|Naproxen|naproxen|mesh-list
153467063|NCT00411684|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
153467065|NCT00412074|Ergocalciferols|ergocalciferols|mesh-list
153467066|NCT00412074|Cholecalciferol|cholecalciferol|mesh-list
153467067|NCT00412074|Vitamins|vitamins|mesh-list
153467068|NCT00412074|Micronutrients|micronutrients|mesh-ancestor
153360972|NCT01490723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153889878|NCT01263483|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
153889879|NCT01263483|Protease Inhibitors|protease inhibitors|mesh-ancestor
153467071|NCT00412074|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153467072|NCT00412464|PENTA|penta|mesh-list
153467073|NCT00412464|Fondaparinux|fondaparinux|mesh-list
153467074|NCT00412464|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
153467075|NCT00412464|Antithrombins|antithrombins|mesh-ancestor
153467076|NCT00412464|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
153467077|NCT00412464|Protease Inhibitors|protease inhibitors|mesh-ancestor
153467105|NCT00413166|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153467106|NCT00413166|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153467107|NCT00413166|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153467108|NCT00413166|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153467109|NCT00413166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153467191|NCT00475878|Escitalopram|escitalopram|mesh-list
153467192|NCT00475878|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
153467193|NCT00475878|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153467194|NCT00475878|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153467195|NCT00475878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153467196|NCT00475878|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153467197|NCT00475878|Serotonin Agents|serotonin agents|mesh-ancestor
153467198|NCT00475878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153467199|NCT01795170|Pyridoxine|pyridoxine|mesh-list
153467200|NCT01795170|Vitamin B Complex|vitamin b complex|mesh-ancestor
153467265|NCT00424554|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153467266|NCT00424554|Alkylating Agents|alkylating agents|mesh-ancestor
153467267|NCT00424554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153467268|NCT00424554|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153467269|NCT00425802|Cyclosporine|cyclosporine|mesh-list
153467270|NCT00425802|Mycophenolic Acid|mycophenolic acid|mesh-list
153467271|NCT00425802|Cyclophosphamide|cyclophosphamide|mesh-list
153467272|NCT00425802|Rituximab|rituximab|mesh-list
153890064|NCT05661240|Mitosis Modulators|mitosis modulators|mesh-ancestor
153890065|NCT05661240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153431082|NCT00000361|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153467273|NCT00425802|Fludarabine|fludarabine|mesh-list
153467274|NCT00425802|Fludarabine phosphate|fludarabine phosphate|mesh-list
153467346|NCT00428922|Growth Substances|growth substances|mesh-ancestor
153467347|NCT00428922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153467364|NCT00533442|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
153467365|NCT00533442|Antitubercular Agents|antitubercular agents|mesh-ancestor
153467366|NCT00533442|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153467367|NCT00533442|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153467368|NCT00533442|Antifungal Agents|antifungal agents|mesh-ancestor
153821017|NCT00481572|Sympathomimetics|sympathomimetics|mesh-ancestor
153467370|NCT00533910|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153467371|NCT00533910|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153467372|NCT00533910|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153467373|NCT01954524|Sildenafil Citrate|sildenafil citrate|mesh-list
153467374|NCT01954524|Vasodilator Agents|vasodilator agents|mesh-ancestor
153467375|NCT01954524|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
153467376|NCT01954524|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
153467439|NCT00535782|Abortifacient Agents|abortifacient agents|mesh-ancestor
153467440|NCT00535782|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153467441|NCT00535782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153467442|NCT00535782|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153467443|NCT00535782|Antimetabolites|antimetabolites|mesh-ancestor
153467444|NCT00535782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153467446|NCT00535782|Dermatologic Agents|dermatologic agents|mesh-ancestor
153467447|NCT00535782|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153467448|NCT00535782|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153467449|NCT00535782|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153467450|NCT00535782|Immunologic Factors|immunologic factors|mesh-ancestor
153360118|NCT01321541|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153467451|NCT00535782|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153467530|NCT00538824|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153467531|NCT00538824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153467532|NCT00538824|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153467533|NCT00538824|Glucocorticoids|glucocorticoids|mesh-ancestor
153889889|NCT01263093|Clopidogrel|clopidogrel|mesh-list
153889890|NCT01263093|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153889891|NCT01263093|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
153889892|NCT01263093|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
153889893|NCT01263093|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
153430981|NCT00000763|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153430982|NCT00000763|Growth Substances|growth substances|mesh-ancestor
153783530|NCT00269217|Niacin|niacin|mesh-list
153783531|NCT00269217|Niacinamide|niacinamide|mesh-list
153890069|NCT01008553|Fentanyl|fentanyl|mesh-list
153890070|NCT01008553|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153467535|NCT00538824|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153467536|NCT00538824|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153467537|NCT00538824|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153467538|NCT00538824|Immunologic Factors|immunologic factors|mesh-ancestor
153467539|NCT00538824|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153467540|NCT00538824|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153467612|NCT00439296|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153467613|NCT00439296|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153467614|NCT00439296|Antimetabolites|antimetabolites|mesh-ancestor
153467615|NCT00439296|Dermatologic Agents|dermatologic agents|mesh-ancestor
153467616|NCT00439296|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153467617|NCT00439296|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153467618|NCT00439296|Antiviral Agents|antiviral agents|mesh-ancestor
153467619|NCT00439296|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153467621|NCT03117660|Vitamins|vitamins|mesh-ancestor
153467622|NCT03117660|Micronutrients|micronutrients|mesh-ancestor
153467623|NCT03117660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153467630|NCT00439374|Progestins|progestins|mesh-ancestor
153467694|NCT00504660|Thioguanine|thioguanine|mesh-list
153467695|NCT00504660|Temozolomide|temozolomide|mesh-list
153467696|NCT00504660|Lomustine|lomustine|mesh-list
153467697|NCT00504660|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153467698|NCT00504660|Antimetabolites|antimetabolites|mesh-ancestor
153467699|NCT00504660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153467714|NCT00505518|Psychotropic Drugs|psychotropic drugs|mesh-list
153467715|NCT00544908|Dasatinib|dasatinib|mesh-list
153467716|NCT00544908|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153467717|NCT00544908|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153467718|NCT00544908|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153467719|NCT00544908|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153467720|NCT00544908|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153467721|NCT00447330|Bevacizumab|bevacizumab|mesh-list
153467722|NCT00447330|Capecitabine|capecitabine|mesh-list
153467770|NCT00546156|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153467771|NCT00546156|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153467772|NCT00546156|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153467774|NCT00449046|Xhance|xhance|mesh-list
153467775|NCT00449046|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
153467776|NCT00449046|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153360975|NCT01490723|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153467777|NCT00449046|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153467779|NCT00449046|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153890071|NCT01008553|Narcotics|narcotics|mesh-ancestor
153431087|NCT06316830|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153431088|NCT06316830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153467780|NCT00449046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153467781|NCT00449046|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153467782|NCT00449046|Respiratory System Agents|respiratory system agents|mesh-ancestor
153467783|NCT00449046|Dermatologic Agents|dermatologic agents|mesh-ancestor
153467784|NCT00449046|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
153467786|NCT00449046|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
153467865|NCT00549822|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153467866|NCT00549822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153467867|NCT00549822|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
153467868|NCT00549822|Hormone Antagonists|hormone antagonists|mesh-ancestor
153813710|NCT00436800|Antimetabolites|antimetabolites|mesh-ancestor
153467869|NCT00549822|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153467905|NCT00518154|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153467906|NCT00518154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153467908|NCT00553098|Mycophenolic Acid|mycophenolic acid|mesh-list
153468039|NCT00527124|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153468040|NCT00527124|Glucocorticoids|glucocorticoids|mesh-ancestor
153468041|NCT00527124|Hormones|hormones|mesh-ancestor
153468042|NCT00527124|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153468043|NCT00527124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153468044|NCT00527124|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153468045|NCT00527124|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153468046|NCT00527124|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153468047|NCT00527592|Travoprost|travoprost|mesh-list
153468048|NCT00527592|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
153468049|NCT00527592|Latanoprost|latanoprost|mesh-list
153468050|NCT00527592|Ophthalmic Solutions|ophthalmic solutions|mesh-list
153468051|NCT00527592|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153468052|NCT00556452|Busulfan|busulfan|mesh-list
153468053|NCT00556452|Clofarabine|clofarabine|mesh-list
153431089|NCT06316830|Analgesics|analgesics|mesh-ancestor
153431090|NCT06316830|Sensory System Agents|sensory system agents|mesh-ancestor
153431091|NCT06316830|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153431092|NCT06316830|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
153431093|NCT06316596|Anesthetics|anesthetics|mesh-list
153431094|NCT06316596|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153431095|NCT06316596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153431096|NCT06316414|Omalizumab|omalizumab|mesh-list
153431097|NCT06316414|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
153431098|NCT06316414|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153431099|NCT06316414|Respiratory System Agents|respiratory system agents|mesh-ancestor
153431100|NCT06316336|Alfuzosin|alfuzosin|mesh-list
153431101|NCT06316336|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
153431102|NCT06316336|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
153468054|NCT00556452|Alkylating Agents|alkylating agents|mesh-ancestor
153468055|NCT00556452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153468056|NCT00556452|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153468057|NCT00556452|Immunologic Factors|immunologic factors|mesh-ancestor
153468103|NCT02319486|Carboplatin|carboplatin|mesh-list
153468104|NCT02319486|Etoposide|etoposide|mesh-list
153468105|NCT02319486|Vincristine|vincristine|mesh-list
153468106|NCT02319486|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153468107|NCT02319486|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153468108|NCT02319486|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153468109|NCT02319486|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153468110|NCT02319486|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153468111|NCT02319486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153821019|NCT00481572|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153889894|NCT01263093|Purinergic Agents|purinergic agents|mesh-ancestor
153889895|NCT01263093|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153430983|NCT00000763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153468112|NCT02319486|Tubulin Modulators|tubulin modulators|mesh-ancestor
153468113|NCT02319486|Antimitotic Agents|antimitotic agents|mesh-ancestor
153468114|NCT02319486|Mitosis Modulators|mitosis modulators|mesh-ancestor
153468115|NCT03271554|Alectinib|alectinib|mesh-list
153468116|NCT03271554|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153890079|NCT01008553|Anesthetics, General|anesthetics, general|mesh-ancestor
153890080|NCT01008553|Anesthetics|anesthetics|mesh-ancestor
153890081|NCT04901169|Angiotensin II|angiotensin ii|mesh-list
153890082|NCT04901169|Giapreza|giapreza|mesh-list
153890083|NCT04901169|Angiotensinogen|angiotensinogen|mesh-list
153890084|NCT04901169|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
153890085|NCT04901169|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
153890086|NCT04901169|Protease Inhibitors|protease inhibitors|mesh-ancestor
153890087|NCT04901169|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153890088|NCT04901169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153890089|NCT04479267|Prednisone|prednisone|mesh-list
153890090|NCT04479267|Methylprednisolone|methylprednisolone|mesh-list
153890091|NCT04479267|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
153890092|NCT04479267|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
153890093|NCT04479267|Prednisolone|prednisolone|mesh-list
153890094|NCT04479267|Prednisolone acetate|prednisolone acetate|mesh-list
153890095|NCT04479267|Hydrocortisone|hydrocortisone|mesh-list
153890096|NCT04479267|Cortisone|cortisone|mesh-list
153890097|NCT04479267|Cyclophosphamide|cyclophosphamide|mesh-list
153890098|NCT04479267|Rituximab|rituximab|mesh-list
153468117|NCT03271554|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153468118|NCT03271554|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153468119|NCT03271554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153468120|NCT05622162|Radiopharmaceuticals|radiopharmaceuticals|mesh-list
153468121|NCT05622162|18F-JK-PSMA-7|18f-jk-psma-7|mesh-list
153468136|NCT00561834|Growth Inhibitors|growth inhibitors|mesh-ancestor
153468137|NCT00561834|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153468138|NCT04388202|Sertraline|sertraline|mesh-list
153468139|NCT04388202|Escitalopram|escitalopram|mesh-list
153468140|NCT04388202|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
153468141|NCT04388202|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153468142|NCT04388202|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153468149|NCT02128230|Thalidomide|thalidomide|mesh-list
153468165|NCT02128230|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153468166|NCT02128230|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153468167|NCT02128230|Alkylating Agents|alkylating agents|mesh-ancestor
153468168|NCT02128230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153468169|NCT02128230|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153468170|NCT02128230|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153468171|NCT02128230|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153468172|NCT02128230|Antiemetics|antiemetics|mesh-ancestor
153468173|NCT02128230|Autonomic Agents|autonomic agents|mesh-ancestor
153821021|NCT00481572|Hemostatics|hemostatics|mesh-ancestor
153821022|NCT00481572|Coagulants|coagulants|mesh-ancestor
153821023|NCT00481572|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
153821024|NCT00481572|Natriuretic Agents|natriuretic agents|mesh-ancestor
153360128|NCT05201612|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153360129|NCT05201612|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153360130|NCT05201612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153360131|NCT05201612|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
153360132|NCT05201612|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153360133|NCT01271855|Glycerol|glycerol|mesh-list
153360134|NCT01271855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153360135|NCT01271855|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
153360136|NCT01271855|Protective Agents|protective agents|mesh-ancestor
153360137|NCT01354145|Celecoxib|celecoxib|mesh-list
153360138|NCT01354145|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153468231|NCT00564954|Methylphenidate|methylphenidate|mesh-list
153468232|NCT00564954|Dexmethylphenidate Hydrochloride|dexmethylphenidate hydrochloride|mesh-list
153468233|NCT00564954|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
153468234|NCT00564954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153813719|NCT00436839|Mitosis Modulators|mitosis modulators|mesh-ancestor
153813725|NCT00436839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153813726|NCT00436839|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153813727|NCT00436839|Analgesics|analgesics|mesh-ancestor
153890107|NCT04479267|Polatuzumab vedotin|polatuzumab vedotin|mesh-list
153468347|NCT06297954|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153468348|NCT06297954|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
153468349|NCT06297954|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
153468350|NCT06297954|Dopamine Agents|dopamine agents|mesh-ancestor
153468351|NCT06297954|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153468352|NCT06297954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153468353|NCT06297915|Lidocaine|lidocaine|mesh-list
153468354|NCT06297915|Ketamine|ketamine|mesh-list
153468355|NCT06297915|Anesthetics, Local|anesthetics, local|mesh-ancestor
153468356|NCT06297915|Anesthetics|anesthetics|mesh-ancestor
153889896|NCT01263093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153430984|NCT00000763|Growth Inhibitors|growth inhibitors|mesh-ancestor
153430985|NCT00380263|Pituitary Adenylate Cyclase-Activating Polypeptide|pituitary adenylate cyclase-activating polypeptide|mesh-list
153468406|NCT06297564|Hormones|hormones|mesh-list
153468407|NCT06297564|Progesterone|progesterone|mesh-list
153468408|NCT06297564|Hormone Antagonists|hormone antagonists|mesh-list
153468409|NCT06297564|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153468410|NCT06297564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153468411|NCT06297564|Progestins|progestins|mesh-ancestor
153468412|NCT06297512|Doxorubicin|doxorubicin|mesh-list
153468413|NCT06297512|Temozolomide|temozolomide|mesh-list
153468414|NCT06297512|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153468415|NCT06297512|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153468416|NCT06297512|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153468417|NCT06297512|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153468466|NCT06295562|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153468467|NCT06295562|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
153468468|NCT06295562|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
153468469|NCT06295562|Cholinergic Agents|cholinergic agents|mesh-ancestor
153468470|NCT06295562|Urological Agents|urological agents|mesh-ancestor
153468471|NCT06295562|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153468472|NCT06295562|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153468473|NCT06295562|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153468474|NCT06295562|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
153468475|NCT06295562|Serotonin Agents|serotonin agents|mesh-ancestor
153468476|NCT06295159|Nivolumab|nivolumab|mesh-list
153468477|NCT06295159|Ipilimumab|ipilimumab|mesh-list
153468478|NCT06295159|Relatlimab|relatlimab|mesh-list
153468479|NCT06295159|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153468480|NCT06295159|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153468481|NCT06295159|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153468482|NCT06295159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153468525|NCT06285396|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
153468526|NCT06285396|Nasal Decongestants|nasal decongestants|mesh-ancestor
153468528|NCT06285396|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
153468529|NCT06285396|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153468530|NCT06285396|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153468531|NCT06285396|Adrenergic Agents|adrenergic agents|mesh-ancestor
153468532|NCT06285396|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153468533|NCT06285396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153468534|NCT06285396|Protective Agents|protective agents|mesh-ancestor
153468535|NCT06285396|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
153468536|NCT06282848|Atropine|atropine|mesh-list
153468537|NCT06282848|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153468538|NCT06282848|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153360980|NCT01490723|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153360981|NCT01490723|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
153468539|NCT06282848|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153468545|NCT06282848|Mydriatics|mydriatics|mesh-ancestor
153468584|NCT06277609|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153468585|NCT06277609|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153468586|NCT06277609|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153468587|NCT06277609|Antipyretics|antipyretics|mesh-ancestor
153468588|NCT06277609|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
153468589|NCT06277050|Capecitabine|capecitabine|mesh-list
153468590|NCT06277050|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153468591|NCT06277050|Antimetabolites|antimetabolites|mesh-ancestor
153813742|NCT04716179|Testosterone|testosterone|mesh-list
153468592|NCT06277050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153468593|NCT06277050|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153468595|NCT06271395|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
153468596|NCT06271395|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153468597|NCT06271395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153468598|NCT06271395|Cholinergic Agents|cholinergic agents|mesh-ancestor
153468599|NCT06271395|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153468600|NCT06271395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153468640|NCT06236425|Fludarabine|fludarabine|mesh-list
153468641|NCT06236425|Interleukin-2|interleukin-2|mesh-list
153468642|NCT06236425|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153468643|NCT06236425|Immunologic Factors|immunologic factors|mesh-ancestor
153468644|NCT06236425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153468645|NCT06236425|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153468646|NCT06236425|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153468647|NCT06236425|Alkylating Agents|alkylating agents|mesh-ancestor
153468648|NCT06236425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153468675|NCT06207799|Lenalidomide|lenalidomide|mesh-list
153468676|NCT06207799|Melphalan|melphalan|mesh-list
153468677|NCT06207799|Busulfan|busulfan|mesh-list
153468678|NCT06207799|Immunologic Factors|immunologic factors|mesh-ancestor
153468679|NCT06207799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153468680|NCT06207799|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153468681|NCT06207799|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153468736|NCT06125340|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153890108|NCT04479267|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153468737|NCT06125340|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153468738|NCT06112314|Nivolumab|nivolumab|mesh-list
153468739|NCT06112314|Relatlimab|relatlimab|mesh-list
153468740|NCT06112314|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153468741|NCT06112314|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153468742|NCT06112314|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153468744|NCT06094998|Insulin|insulin|mesh-list
153468812|NCT06031233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153889897|NCT01263093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153889898|NCT01010971|Ciclesonide|ciclesonide|mesh-list
153889899|NCT01010971|Glucocorticoids|glucocorticoids|mesh-ancestor
153468814|NCT06018623|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153468815|NCT06018623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153468816|NCT05963022|Tirzepatide|tirzepatide|mesh-list
153468817|NCT05963022|Incretins|incretins|mesh-ancestor
153468818|NCT05963022|Hormones|hormones|mesh-ancestor
153468819|NCT05963022|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153468820|NCT05963022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153468822|NCT05962229|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
153468823|NCT05962229|Autonomic Agents|autonomic agents|mesh-ancestor
153468824|NCT05962229|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153468825|NCT05962229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153468826|NCT05962229|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
153468827|NCT05962229|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
153468828|NCT05962229|Cholinergic Agents|cholinergic agents|mesh-ancestor
153468829|NCT05962229|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153468844|NCT05950334|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153468845|NCT05948267|Lidocaine|lidocaine|mesh-list
153468846|NCT05948267|Fentanyl|fentanyl|mesh-list
153468847|NCT05948267|Ketamine|ketamine|mesh-list
153468848|NCT05948267|Propofol|propofol|mesh-list
153468880|NCT05931718|Hematinics|hematinics|mesh-ancestor
153468881|NCT05930938|Cetuximab|cetuximab|mesh-list
153468882|NCT05930938|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153468883|NCT05930938|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153468884|NCT05922904|Doxorubicin|doxorubicin|mesh-list
153468885|NCT05922904|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
153468886|NCT05922904|Pembrolizumab|pembrolizumab|mesh-list
153468887|NCT05922904|Dacarbazine|dacarbazine|mesh-list
153468888|NCT05922904|Brentuximab Vedotin|brentuximab vedotin|mesh-list
153468889|NCT05922904|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153468890|NCT05922904|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153468902|NCT05922904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153468904|NCT05901519|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153468905|NCT05901519|Glucocorticoids|glucocorticoids|mesh-ancestor
153468906|NCT05901519|Hormones|hormones|mesh-ancestor
153468970|NCT05742438|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153890109|NCT04479267|Immunologic Factors|immunologic factors|mesh-ancestor
153890110|NCT04479267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153468971|NCT05742438|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
153468972|NCT05742438|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153468973|NCT05742438|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153468974|NCT05742438|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153468975|NCT05742438|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153468976|NCT05742438|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153468977|NCT05742438|Analgesics|analgesics|mesh-ancestor
153821025|NCT00481572|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153821026|NCT00474006|Daunorubicin|daunorubicin|mesh-list
153821027|NCT00474006|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153889900|NCT01010971|Hormones|hormones|mesh-ancestor
153468979|NCT05742438|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153468981|NCT05742438|Adrenergic Agents|adrenergic agents|mesh-ancestor
153468982|NCT05742438|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153468983|NCT05742438|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153468984|NCT05742438|Narcotics|narcotics|mesh-ancestor
153468985|NCT05733923|Sodium Hypochlorite|sodium hypochlorite|mesh-list
153468986|NCT05733923|Eusol|eusol|mesh-list
153468987|NCT05733923|Disinfectants|disinfectants|mesh-ancestor
153468988|NCT05733923|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153468992|NCT05701189|gamma-Globulins|gamma-globulins|mesh-list
153468993|NCT05701189|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
153468994|NCT05701189|Immunologic Factors|immunologic factors|mesh-ancestor
153469032|NCT05671081|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153469033|NCT05671081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153469034|NCT05671081|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153469035|NCT05671081|Sensory System Agents|sensory system agents|mesh-ancestor
153469036|NCT05671081|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153469037|NCT05671081|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
153469038|NCT05671081|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153469039|NCT05671081|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153469040|NCT05671081|Adrenergic Agents|adrenergic agents|mesh-ancestor
153469041|NCT05671081|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153469042|NCT05671081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153469043|NCT05671081|Anesthetics|anesthetics|mesh-ancestor
153469044|NCT05671081|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153469045|NCT05671081|Anticonvulsants|anticonvulsants|mesh-ancestor
153469046|NCT05671081|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153469047|NCT05671081|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153469048|NCT05671081|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153469049|NCT05671081|Tocolytic Agents|tocolytic agents|mesh-ancestor
153469050|NCT05671081|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153469051|NCT05649722|Treprostinil|treprostinil|mesh-list
153469070|NCT05619172|Cetuximab|cetuximab|mesh-list
153469071|NCT05619172|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153469072|NCT05619172|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153469073|NCT05617677|Deucravacitinib|deucravacitinib|mesh-list
153469074|NCT05617677|Dermatologic Agents|dermatologic agents|mesh-ancestor
153469075|NCT05617677|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153469076|NCT05617677|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153469077|NCT05617677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153469078|NCT05611593|Finasteride|finasteride|mesh-list
153469087|NCT05591144|Prednisone|prednisone|mesh-list
153469088|NCT05591144|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153469089|NCT05591144|Glucocorticoids|glucocorticoids|mesh-ancestor
153469090|NCT05591144|Hormones|hormones|mesh-ancestor
153469091|NCT05591144|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153469092|NCT05591144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153469093|NCT05591144|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153469094|NCT05591144|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153469095|NCT05590676|Metformin|metformin|mesh-list
153469096|NCT05590676|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153469097|NCT05590676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153469098|NCT05567796|Semaglutide|semaglutide|mesh-list
153469099|NCT05567796|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
153469100|NCT05567796|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153469101|NCT05567796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153469102|NCT05564039|Dulaglutide|dulaglutide|mesh-list
153469103|NCT05564039|Tirzepatide|tirzepatide|mesh-list
153469104|NCT05564039|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
153469105|NCT05564039|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153469106|NCT05564039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153469107|NCT05564039|Incretins|incretins|mesh-ancestor
153469108|NCT05564039|Hormones|hormones|mesh-ancestor
153469109|NCT05564039|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153469110|NCT05562713|Denatonium|denatonium|mesh-list
153469111|NCT05562713|Aversive Agents|aversive agents|mesh-ancestor
153469116|NCT05562713|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153469117|NCT05555615|Pimavanserin|pimavanserin|mesh-list
153813743|NCT04716179|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153813744|NCT04716179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153813745|NCT04716179|Androgens|androgens|mesh-ancestor
153813746|NCT00437229|Dexamethasone|dexamethasone|mesh-list
153813747|NCT00437229|Dexamethasone acetate|dexamethasone acetate|mesh-list
153813748|NCT00437229|Ondansetron|ondansetron|mesh-list
153813749|NCT00437229|Casopitant|casopitant|mesh-list
153813750|NCT00437229|BB 1101|bb 1101|mesh-list
153813751|NCT00437229|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153813752|NCT00437229|Antiemetics|antiemetics|mesh-ancestor
153813753|NCT00437229|Autonomic Agents|autonomic agents|mesh-ancestor
153813754|NCT00437229|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153813755|NCT00437229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153360161|NCT02196857|Azacitidine|azacitidine|mesh-list
153469119|NCT05555615|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
153469120|NCT05555615|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153469121|NCT05555615|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153469122|NCT05555615|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153469123|NCT05555615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153469124|NCT05555615|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153469125|NCT05555615|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
153469126|NCT05555615|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153469127|NCT05555615|Serotonin Agents|serotonin agents|mesh-ancestor
153469128|NCT05555615|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153469129|NCT05555615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153469130|NCT05549297|Pembrolizumab|pembrolizumab|mesh-list
153469156|NCT05501054|Nivolumab|nivolumab|mesh-list
153626836|NCT02019290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153626837|NCT02019329|Risperidone|risperidone|mesh-list
153626838|NCT02019329|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153626839|NCT02019329|Serotonin Agents|serotonin agents|mesh-ancestor
153626840|NCT02019329|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153626841|NCT02019329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153626842|NCT02019329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153626843|NCT02019329|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153626844|NCT02019329|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153626845|NCT02019329|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153626846|NCT02019329|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153821028|NCT00474006|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153360982|NCT01490723|Antitubercular Agents|antitubercular agents|mesh-ancestor
153626850|NCT02019355|Calcipotriene|calcipotriene|mesh-list
153626851|NCT02019355|Petrolatum|petrolatum|mesh-list
153626852|NCT02019355|Antimetabolites|antimetabolites|mesh-ancestor
153626853|NCT02019355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153626854|NCT02019355|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153626861|NCT02019381|Vitamin D|vitamin d|mesh-list
153626891|NCT02019485|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153626892|NCT02019485|Narcotics|narcotics|mesh-ancestor
153626893|NCT02019485|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153626894|NCT02019485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153626895|NCT02019485|Analgesics|analgesics|mesh-ancestor
153626896|NCT02019485|Sensory System Agents|sensory system agents|mesh-ancestor
153626897|NCT02019485|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153626898|NCT02019485|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
153626899|NCT02019485|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153626900|NCT02019485|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153626901|NCT02019485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153626902|NCT02019485|Adrenergic Agents|adrenergic agents|mesh-ancestor
153626903|NCT02019485|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153626905|NCT02019524|Vitamin B Complex|vitamin b complex|mesh-list
153626906|NCT02019524|Molgramostim|molgramostim|mesh-list
153626908|NCT02019524|Sargramostim|sargramostim|mesh-list
153626909|NCT02019524|Immunologic Factors|immunologic factors|mesh-ancestor
153626910|NCT02019524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153626911|NCT02019524|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153626912|NCT02019524|Hematinics|hematinics|mesh-ancestor
153626913|NCT02019524|Vitamins|vitamins|mesh-ancestor
153626914|NCT02019524|Micronutrients|micronutrients|mesh-ancestor
153626915|NCT02019784|Rifaximin|rifaximin|mesh-list
153626916|NCT02019784|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153626917|NCT02019784|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153626918|NCT02019784|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153626940|NCT02019810|Protective Agents|protective agents|mesh-ancestor
153626942|NCT02019836|Vitamins|vitamins|mesh-ancestor
153626943|NCT02019836|Micronutrients|micronutrients|mesh-ancestor
153626944|NCT02019836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153626945|NCT02019836|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153626946|NCT02020005|Nicotine|nicotine|mesh-list
153626947|NCT02020005|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
153626948|NCT02020005|Autonomic Agents|autonomic agents|mesh-ancestor
153626949|NCT02020005|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153626950|NCT02020005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153626951|NCT02020005|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
153626952|NCT02020005|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
153626953|NCT02020005|Cholinergic Agents|cholinergic agents|mesh-ancestor
153626954|NCT02020005|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153626955|NCT02020005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153626998|NCT02020200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153626999|NCT02020200|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
153627001|NCT02020200|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153627002|NCT02020200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153627003|NCT02020200|Dopamine Agents|dopamine agents|mesh-ancestor
153881011|NCT05609240|Cefuroxime|cefuroxime|mesh-list
153881012|NCT05609240|Cefuroxime axetil|cefuroxime axetil|mesh-list
153627004|NCT02020200|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153627005|NCT02020213|Posaconazole|posaconazole|mesh-list
153627006|NCT02020213|Antifungal Agents|antifungal agents|mesh-ancestor
153627007|NCT02020213|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153627008|NCT02020213|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
153627009|NCT02020213|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153627010|NCT02020213|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153627011|NCT02020213|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
153627012|NCT02020213|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153627013|NCT02020213|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153627020|NCT02020330|Artemether|artemether|mesh-list
153627054|NCT02020603|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153627055|NCT02020603|Respiratory System Agents|respiratory system agents|mesh-ancestor
153627056|NCT02020603|Mydriatics|mydriatics|mesh-ancestor
153627057|NCT02020603|Sympathomimetics|sympathomimetics|mesh-ancestor
153627058|NCT02020603|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
153627059|NCT02020603|Coagulants|coagulants|mesh-ancestor
153627060|NCT02020681|Fluorides|fluorides|mesh-list
153627061|NCT02020681|Cariostatic Agents|cariostatic agents|mesh-ancestor
153627062|NCT02020681|Protective Agents|protective agents|mesh-ancestor
153627063|NCT02020681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153627064|NCT02018796|Misoprostol|misoprostol|mesh-list
153627065|NCT02018796|Mifepristone|mifepristone|mesh-list
153627066|NCT02018796|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
153627067|NCT02018796|Abortifacient Agents|abortifacient agents|mesh-ancestor
153627068|NCT02018796|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153627069|NCT02018796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153627070|NCT02018796|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
153627071|NCT02018796|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153627072|NCT02018796|Oxytocics|oxytocics|mesh-ancestor
153627073|NCT02018796|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
153627074|NCT02018796|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
153627075|NCT02018796|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
153627076|NCT02018796|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
153627077|NCT02018796|Contraceptive Agents|contraceptive agents|mesh-ancestor
153627078|NCT02018796|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
153627079|NCT02018796|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
153627080|NCT02018796|Hormone Antagonists|hormone antagonists|mesh-ancestor
153627081|NCT02018796|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153627082|NCT02018796|Luteolytic Agents|luteolytic agents|mesh-ancestor
153627083|NCT02018796|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
153627084|NCT02018796|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
153627085|NCT02021097|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
153627086|NCT02021097|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
153627087|NCT02021097|Levonorgestrel|levonorgestrel|mesh-list
153627088|NCT02021097|Ethinyl Estradiol|ethinyl estradiol|mesh-list
153627094|NCT02021097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153627095|NCT02021097|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
153627096|NCT02021097|Contraceptive Agents|contraceptive agents|mesh-ancestor
153821029|NCT00474006|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153627100|NCT02021097|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
153627101|NCT02021097|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
153627102|NCT02021110|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
153627103|NCT02021110|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
153890115|NCT04479267|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153627104|NCT02021110|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153627108|NCT02021201|Risperidone|risperidone|mesh-list
153627154|NCT02021409|Darbepoetin alfa|darbepoetin alfa|mesh-list
153627155|NCT02021409|Hematinics|hematinics|mesh-ancestor
153627157|NCT02020980|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
153627158|NCT02020980|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
153627159|NCT02020980|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
153627160|NCT02020980|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153627161|NCT02020980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153627162|NCT02020980|Cholinergic Agents|cholinergic agents|mesh-ancestor
153627163|NCT02020980|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153627164|NCT02020980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153627165|NCT02020980|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
153627166|NCT02020980|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153627167|NCT02021422|Fluorouracil|fluorouracil|mesh-list
153627214|NCT02021851|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153627215|NCT02021851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153627216|NCT02021851|Antipruritics|antipruritics|mesh-ancestor
153627217|NCT02021851|Dermatologic Agents|dermatologic agents|mesh-ancestor
153627218|NCT02021851|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
153627219|NCT02021851|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153627220|NCT02021851|Serotonin Agents|serotonin agents|mesh-ancestor
153627221|NCT02021851|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153627222|NCT02021851|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
153627223|NCT02021864|Vitamin D|vitamin d|mesh-list
153627224|NCT02021864|Cholecalciferol|cholecalciferol|mesh-list
153627225|NCT02021864|Vitamins|vitamins|mesh-ancestor
153627226|NCT02021864|Micronutrients|micronutrients|mesh-ancestor
153627227|NCT02021864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153627228|NCT02021864|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153627229|NCT02021864|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153627230|NCT02022163|Aluminum Hydroxide|aluminum hydroxide|mesh-list
153627231|NCT02022163|Vaccines|vaccines|mesh-list
153627232|NCT02022163|Immunologic Factors|immunologic factors|mesh-ancestor
153627233|NCT02022163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153627234|NCT02022163|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153627235|NCT02022163|Antacids|antacids|mesh-ancestor
153627236|NCT02022163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153627237|NCT02022163|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153627256|NCT02022254|Metformin|metformin|mesh-list
153627264|NCT02022293|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153627269|NCT02022293|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
153627270|NCT02022293|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153627272|NCT02022358|Folic Acid|folic acid|mesh-list
153627273|NCT02022358|Methotrexate|methotrexate|mesh-list
153627274|NCT02022358|Levoleucovorin|levoleucovorin|mesh-list
153627275|NCT02022358|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
153627276|NCT02022358|Abortifacient Agents|abortifacient agents|mesh-ancestor
153627290|NCT02022358|Antidotes|antidotes|mesh-ancestor
153627324|NCT02022488|GABA Modulators|gaba modulators|mesh-ancestor
153627325|NCT02022488|GABA Agents|gaba agents|mesh-ancestor
153627326|NCT02022488|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153627327|NCT02022488|Narcotics|narcotics|mesh-ancestor
153627328|NCT02022527|Aspirin|aspirin|mesh-list
153627329|NCT02022527|Salicylic Acid|salicylic acid|mesh-list
153627330|NCT02022527|Salicylates|salicylates|mesh-list
153627331|NCT02022527|Warfarin|warfarin|mesh-list
153627332|NCT02022527|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153627333|NCT02022527|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153627334|NCT02022527|Analgesics|analgesics|mesh-ancestor
153627335|NCT02022527|Sensory System Agents|sensory system agents|mesh-ancestor
153627336|NCT02022527|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153627337|NCT02022527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153627338|NCT02022527|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153627339|NCT02022527|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153627340|NCT02022527|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153627385|NCT02022852|Antimetabolites|antimetabolites|mesh-ancestor
153627386|NCT02022852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153627387|NCT02022852|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153783534|NCT00269217|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153627388|NCT02022917|Bevacizumab|bevacizumab|mesh-list
153627389|NCT02022917|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153627390|NCT02022917|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153627391|NCT02022917|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153627392|NCT02022917|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153627393|NCT02022917|Growth Substances|growth substances|mesh-ancestor
153627394|NCT02022917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153627395|NCT02022917|Growth Inhibitors|growth inhibitors|mesh-ancestor
153627396|NCT02022930|Triamcinolone|triamcinolone|mesh-list
153627397|NCT02022930|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
153627398|NCT02022930|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
153627399|NCT02022930|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
153627443|NCT02023359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153627444|NCT02023359|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153627445|NCT02023359|Immunologic Factors|immunologic factors|mesh-ancestor
153627446|NCT02023359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153627447|NCT02023359|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153627448|NCT02023359|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
153627449|NCT02023359|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153627450|NCT02023359|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
153627451|NCT02023359|Hormone Antagonists|hormone antagonists|mesh-ancestor
153430987|NCT00380263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153430988|NCT00380263|Vasodilator Agents|vasodilator agents|mesh-ancestor
153889901|NCT01010971|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153889902|NCT01010971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153889903|NCT01010971|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
153889904|NCT01306656|Vitamin D|vitamin d|mesh-list
153430989|NCT00380263|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153627453|NCT02023424|Glatiramer Acetate|glatiramer acetate|mesh-list
153627454|NCT02023424|(T,G)-A-L|(t,g)-a-l|mesh-list
153627455|NCT02023424|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153627456|NCT02023424|Immunologic Factors|immunologic factors|mesh-ancestor
153627457|NCT02023424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153627458|NCT02023424|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153627459|NCT02023424|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153627460|NCT02023450|Ritonavir|ritonavir|mesh-list
153627461|NCT02023450|Saquinavir|saquinavir|mesh-list
153627462|NCT02023450|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
153627463|NCT02023450|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
153627464|NCT02023450|Protease Inhibitors|protease inhibitors|mesh-ancestor
153627465|NCT02023450|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153627467|NCT02023450|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153627493|NCT02023567|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
153627494|NCT02023567|Serotonin Agents|serotonin agents|mesh-ancestor
153627495|NCT02023567|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153627496|NCT02023567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153627497|NCT02023567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153627498|NCT02023567|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153627499|NCT02023567|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153627500|NCT02023684|Lidocaine|lidocaine|mesh-list
153627501|NCT02023684|Ropivacaine|ropivacaine|mesh-list
153627502|NCT02023684|Anesthetics, Local|anesthetics, local|mesh-ancestor
153890116|NCT04479267|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153627503|NCT02023684|Anesthetics|anesthetics|mesh-ancestor
153627504|NCT02023684|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153627505|NCT02023684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153627506|NCT02023684|Sensory System Agents|sensory system agents|mesh-ancestor
153627507|NCT02023684|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153627508|NCT02023684|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153627550|NCT02023931|Sulforaphane|sulforaphane|mesh-list
153627551|NCT02023931|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
153627552|NCT02023931|Protective Agents|protective agents|mesh-ancestor
153627553|NCT02023931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153627554|NCT02023931|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153627556|NCT02024009|Paclitaxel|paclitaxel|mesh-list
153627557|NCT02024009|Gemcitabine|gemcitabine|mesh-list
153627558|NCT02024009|Capecitabine|capecitabine|mesh-list
153627559|NCT02024009|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153627560|NCT02024009|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153627561|NCT02024009|Tubulin Modulators|tubulin modulators|mesh-ancestor
153627562|NCT02024009|Antimitotic Agents|antimitotic agents|mesh-ancestor
153627563|NCT02024009|Mitosis Modulators|mitosis modulators|mesh-ancestor
153627565|NCT02024009|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153627612|NCT02024308|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153627613|NCT02024308|Antimetabolites|antimetabolites|mesh-ancestor
153627614|NCT02024308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153627615|NCT02024308|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153627616|NCT02024308|Immunologic Factors|immunologic factors|mesh-ancestor
153627617|NCT02024308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153627618|NCT02024308|Antiviral Agents|antiviral agents|mesh-ancestor
153627619|NCT02024308|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153889905|NCT01306656|Ergocalciferols|ergocalciferols|mesh-list
153889906|NCT01306656|Cholecalciferol|cholecalciferol|mesh-list
153889907|NCT01306656|Vitamins|vitamins|mesh-list
153627620|NCT02024334|Leflunomide|leflunomide|mesh-list
153627621|NCT02024334|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153627674|NCT02024568|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153627675|NCT02024568|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153627676|NCT02024594|Nitrous Oxide|nitrous oxide|mesh-list
153627677|NCT02024594|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
153627678|NCT02024594|Anesthetics, General|anesthetics, general|mesh-ancestor
153627679|NCT02024594|Anesthetics|anesthetics|mesh-ancestor
153627680|NCT02024594|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153627681|NCT02024594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153627682|NCT02024594|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153627683|NCT02024594|Analgesics|analgesics|mesh-ancestor
153627684|NCT02024594|Sensory System Agents|sensory system agents|mesh-ancestor
153627685|NCT02024594|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153627686|NCT02024633|Gemcitabine|gemcitabine|mesh-list
153627687|NCT02024633|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153627688|NCT02024633|Antimetabolites|antimetabolites|mesh-ancestor
153627689|NCT02024633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153627690|NCT02024633|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153627692|NCT02024659|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153627693|NCT02024659|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153627694|NCT02024659|Autonomic Agents|autonomic agents|mesh-ancestor
153627700|NCT02024659|Hormones|hormones|mesh-ancestor
153627726|NCT02024945|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
153627727|NCT02024945|Cholinergic Agents|cholinergic agents|mesh-ancestor
153627728|NCT02024945|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153627729|NCT02024945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153627730|NCT02024945|Urological Agents|urological agents|mesh-ancestor
153627731|NCT02024984|Clomiphene|clomiphene|mesh-list
153627732|NCT02024984|Enclomiphene|enclomiphene|mesh-list
153627733|NCT02024984|Zuclomiphene|zuclomiphene|mesh-list
153627734|NCT02024984|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
153627735|NCT02024984|Hormone Antagonists|hormone antagonists|mesh-ancestor
153627736|NCT02024984|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153627737|NCT02024984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153627738|NCT02024984|Fertility Agents, Female|fertility agents, female|mesh-ancestor
153627787|NCT02025218|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153627788|NCT02025218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153627789|NCT02025218|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153627790|NCT02025348|Metoprolol|metoprolol|mesh-list
153627791|NCT02025348|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153627792|NCT02025348|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153627793|NCT02025348|Sympatholytics|sympatholytics|mesh-ancestor
153627794|NCT02025348|Autonomic Agents|autonomic agents|mesh-ancestor
153627795|NCT02025348|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153627796|NCT02025348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153627797|NCT02025348|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
153627798|NCT02025348|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
153627799|NCT02025348|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
153627800|NCT02025348|Adrenergic Agents|adrenergic agents|mesh-ancestor
153627801|NCT02025348|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153627802|NCT02025348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153627803|NCT02025361|Lidocaine|lidocaine|mesh-list
153627804|NCT02025361|Anesthetics, Local|anesthetics, local|mesh-ancestor
153627840|NCT02025465|Vasodilator Agents|vasodilator agents|mesh-ancestor
153627842|NCT02025491|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
153627843|NCT02025491|Amebicides|amebicides|mesh-ancestor
153627844|NCT02025491|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153627845|NCT02025491|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153627846|NCT02025491|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153627847|NCT02025491|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153627848|NCT02025491|Antifungal Agents|antifungal agents|mesh-ancestor
153627849|NCT02025608|Pramipexole|pramipexole|mesh-list
153889908|NCT01306656|Micronutrients|micronutrients|mesh-ancestor
153889909|NCT01306656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153627852|NCT02025608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153627853|NCT02025608|Protective Agents|protective agents|mesh-ancestor
153627854|NCT02025608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153627855|NCT02025608|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
153627856|NCT02025608|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
153627857|NCT02025608|Dopamine Agonists|dopamine agonists|mesh-ancestor
153627858|NCT02025608|Dopamine Agents|dopamine agents|mesh-ancestor
153627859|NCT02025608|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153627861|NCT02025712|Exemestane|exemestane|mesh-list
153627862|NCT02025712|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
153627863|NCT02025712|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153627864|NCT02025712|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153627865|NCT02025712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153627866|NCT02025712|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153890119|NCT04479267|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153890120|NCT04479267|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153627867|NCT02025712|Immunologic Factors|immunologic factors|mesh-ancestor
153627868|NCT02025712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153627869|NCT02025712|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153627887|NCT02025855|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153627888|NCT02025855|Antitussive Agents|antitussive agents|mesh-ancestor
153627889|NCT02025855|Respiratory System Agents|respiratory system agents|mesh-ancestor
153627890|NCT02025868|Raltegravir Potassium|raltegravir potassium|mesh-list
153627891|NCT02025868|Darunavir|darunavir|mesh-list
153627892|NCT02025868|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
153627893|NCT02025868|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153627894|NCT02025868|Antiviral Agents|antiviral agents|mesh-ancestor
153627895|NCT02025868|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153627896|NCT02025868|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
153627897|NCT02025868|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
153627898|NCT02025868|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153627899|NCT02025868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153627900|NCT02025868|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
153627901|NCT02025868|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
153627902|NCT02025868|Protease Inhibitors|protease inhibitors|mesh-ancestor
153627903|NCT02025881|Cyclophosphamide|cyclophosphamide|mesh-list
153627904|NCT02025881|Thiotepa|thiotepa|mesh-list
153627905|NCT02025881|Carboplatin|carboplatin|mesh-list
153627906|NCT02025881|Etoposide|etoposide|mesh-list
153627907|NCT02025881|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153627908|NCT02025881|Immunologic Factors|immunologic factors|mesh-ancestor
153627909|NCT02025881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153627910|NCT02025881|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153627911|NCT02025881|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153627912|NCT02025881|Alkylating Agents|alkylating agents|mesh-ancestor
153627914|NCT02025881|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153627936|NCT02026050|Antiemetics|antiemetics|mesh-ancestor
153627937|NCT02026050|Autonomic Agents|autonomic agents|mesh-ancestor
153627938|NCT02026050|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153627939|NCT02026050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153627940|NCT02026050|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153627941|NCT02026050|Glucocorticoids|glucocorticoids|mesh-ancestor
153627942|NCT02026050|Hormones|hormones|mesh-ancestor
153627943|NCT02026050|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153627944|NCT02026050|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153627945|NCT02026050|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153627946|NCT02026050|Protease Inhibitors|protease inhibitors|mesh-ancestor
153627947|NCT02026050|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153627948|NCT02026050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153627949|NCT02026219|Clopidogrel|clopidogrel|mesh-list
153627950|NCT02026219|Ticagrelor|ticagrelor|mesh-list
153627951|NCT02026219|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153627994|NCT02026492|Cholinergic Agents|cholinergic agents|mesh-ancestor
153627995|NCT02026492|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153889910|NCT01306656|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153430991|NCT00000769|Interleukin-4|interleukin-4|mesh-list
153430992|NCT00000769|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153627998|NCT02026505|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153627999|NCT02026518|Vitamin D|vitamin d|mesh-list
153628000|NCT02026518|Cholecalciferol|cholecalciferol|mesh-list
153628001|NCT02026518|Vitamins|vitamins|mesh-ancestor
153628002|NCT02026518|Micronutrients|micronutrients|mesh-ancestor
153628003|NCT02026518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153628004|NCT02026518|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153628005|NCT02026518|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153628014|NCT02026765|Heparin|heparin|mesh-list
153628058|NCT02026921|Tubulin Modulators|tubulin modulators|mesh-ancestor
153628059|NCT02026921|Antimitotic Agents|antimitotic agents|mesh-ancestor
153628060|NCT02026921|Mitosis Modulators|mitosis modulators|mesh-ancestor
153628061|NCT02026921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153628062|NCT02026947|Sodium Benzoate|sodium benzoate|mesh-list
153628063|NCT02026947|Antifungal Agents|antifungal agents|mesh-ancestor
153628064|NCT02026947|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153628065|NCT02026973|Fulvestrant|fulvestrant|mesh-list
153628066|NCT02026973|Anastrozole|anastrozole|mesh-list
153628067|NCT02026973|Somatostatin|somatostatin|mesh-list
153628068|NCT02026973|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153628069|NCT02026973|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153628070|NCT02026973|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
153628071|NCT02026973|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
153628072|NCT02026973|Hormone Antagonists|hormone antagonists|mesh-ancestor
153628073|NCT02026973|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153628074|NCT02026973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153628115|NCT02027298|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153628116|NCT02027298|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153628117|NCT02027298|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153628118|NCT02027298|Immunologic Factors|immunologic factors|mesh-ancestor
153628119|NCT02027298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153628120|NCT02027298|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153783535|NCT00269217|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153628121|NCT02027324|Chlorhexidine|chlorhexidine|mesh-list
153628122|NCT02027324|Povidone-Iodine|povidone-iodine|mesh-list
153628123|NCT02027324|Povidone|povidone|mesh-list
153628124|NCT02027324|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
153628181|NCT02027493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153628182|NCT02027493|Immunologic Factors|immunologic factors|mesh-ancestor
153628183|NCT02027493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153628184|NCT02027532|Vancomycin|vancomycin|mesh-list
153628185|NCT02027532|Cefazolin|cefazolin|mesh-list
153628186|NCT02027532|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153628187|NCT02027532|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153628188|NCT02027675|Micronutrients|micronutrients|mesh-list
153628189|NCT02027675|Trace Elements|trace elements|mesh-list
153628190|NCT02027675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153628191|NCT02027753|Metformin|metformin|mesh-list
153628192|NCT02027753|Insulin Glargine|insulin glargine|mesh-list
153628193|NCT02027753|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
153628194|NCT02027753|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153628195|NCT02027753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153628196|NCT02027753|Protease Inhibitors|protease inhibitors|mesh-ancestor
153628197|NCT02027753|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153628198|NCT02027753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153628199|NCT02027792|Diclofenac|diclofenac|mesh-list
153628200|NCT02027792|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153628201|NCT02027792|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153628202|NCT02027792|Analgesics|analgesics|mesh-ancestor
153628203|NCT02027792|Sensory System Agents|sensory system agents|mesh-ancestor
153628204|NCT02027792|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153628205|NCT02027792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153628206|NCT02027792|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153628207|NCT02027792|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153628210|NCT02027792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153628211|NCT02027870|Sirolimus|sirolimus|mesh-list
153628212|NCT02027870|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153628213|NCT02027870|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153628216|NCT02027870|Antifungal Agents|antifungal agents|mesh-ancestor
153628220|NCT02027922|Sodium fluoride topical preparation|sodium fluoride topical preparation|mesh-list
153628221|NCT02027922|Cariostatic Agents|cariostatic agents|mesh-ancestor
153628222|NCT02027922|Protective Agents|protective agents|mesh-ancestor
153628223|NCT02027922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153628224|NCT02027961|Durvalumab|durvalumab|mesh-list
153890125|NCT04479267|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153628225|NCT02027961|Trametinib|trametinib|mesh-list
153628226|NCT02027961|Dabrafenib|dabrafenib|mesh-list
153628227|NCT02027961|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153628228|NCT02027961|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153628229|NCT02027961|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153628230|NCT02027961|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153628231|NCT02027961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153628232|NCT02027987|Valproic Acid|valproic acid|mesh-list
153628233|NCT02027987|Anticonvulsants|anticonvulsants|mesh-ancestor
153628234|NCT02027987|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153628235|NCT02027987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153628236|NCT02027987|GABA Agents|gaba agents|mesh-ancestor
153628237|NCT02027987|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153628238|NCT02027987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153628239|NCT02027987|Antimanic Agents|antimanic agents|mesh-ancestor
153628240|NCT02027987|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153628241|NCT02027987|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153628242|NCT02027987|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153628243|NCT02028026|Citalopram|citalopram|mesh-list
153628244|NCT02028026|Vilazodone Hydrochloride|vilazodone hydrochloride|mesh-list
153628245|NCT02028026|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
153628246|NCT02028026|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153628247|NCT02028026|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153628248|NCT02028026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153628257|NCT02028078|Insulin|insulin|mesh-list
153628262|NCT02028234|Pantoprazole|pantoprazole|mesh-list
153628263|NCT02028234|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
153628264|NCT02028234|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153628265|NCT02028234|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
153628266|NCT02028234|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153628267|NCT02028234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153628268|NCT02028260|Modafinil|modafinil|mesh-list
153628269|NCT02028260|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
153628270|NCT02028260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153628271|NCT02028260|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
153628272|NCT02028260|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
153628323|NCT02028533|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153628324|NCT02028533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153628325|NCT02028598|Sildenafil Citrate|sildenafil citrate|mesh-list
153890132|NCT04479267|Protective Agents|protective agents|mesh-ancestor
153628326|NCT02028598|Clomipramine|clomipramine|mesh-list
153628327|NCT02028598|Citric Acid|citric acid|mesh-list
153628328|NCT02028598|Sodium Citrate|sodium citrate|mesh-list
153628329|NCT02028598|Anticoagulants|anticoagulants|mesh-ancestor
153628330|NCT02028598|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
153628331|NCT02028598|Chelating Agents|chelating agents|mesh-ancestor
153628332|NCT02028598|Sequestering Agents|sequestering agents|mesh-ancestor
153821030|NCT00474006|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153821031|NCT00474006|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153889911|NCT01306656|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153628336|NCT02028598|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
153628337|NCT02028598|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153628338|NCT02028598|Urological Agents|urological agents|mesh-ancestor
153628339|NCT02028598|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
153628340|NCT02028598|Antidepressive Agents|antidepressive agents|mesh-ancestor
153628381|NCT02028910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153628382|NCT02028910|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153628383|NCT02028910|Antipruritics|antipruritics|mesh-ancestor
153628384|NCT02028910|Dermatologic Agents|dermatologic agents|mesh-ancestor
153628385|NCT02028910|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
153628386|NCT02028910|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153628387|NCT02028910|Serotonin Agents|serotonin agents|mesh-ancestor
153628388|NCT02028910|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153628389|NCT02028910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153628391|NCT02028923|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153628392|NCT02028923|Narcotics|narcotics|mesh-ancestor
153628393|NCT02028923|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153628394|NCT02028923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153628395|NCT02028923|Analgesics|analgesics|mesh-ancestor
153628396|NCT02028923|Sensory System Agents|sensory system agents|mesh-ancestor
153628397|NCT02028923|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153628398|NCT02028949|Idarubicin|idarubicin|mesh-list
153628399|NCT02028949|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153431171|NCT06315920|Analgesics|analgesics|mesh-ancestor
153431172|NCT06315920|Sensory System Agents|sensory system agents|mesh-ancestor
153431173|NCT06315920|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153431174|NCT06315920|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
153431175|NCT06315920|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153431176|NCT06315920|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153431177|NCT06315920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153431178|NCT06315920|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153431179|NCT06315920|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153431180|NCT06315881|Lobeline|lobeline|mesh-list
153431181|NCT06315881|Nicotine|nicotine|mesh-list
153431182|NCT06315881|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
153628400|NCT02028949|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153628401|NCT02028949|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153628402|NCT02028949|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153628403|NCT02028949|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153628404|NCT02028949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153628405|NCT02029105|Hyaluronic Acid|hyaluronic acid|mesh-list
153628406|NCT02029105|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153628407|NCT02029105|Immunologic Factors|immunologic factors|mesh-ancestor
153628409|NCT02029105|Viscosupplements|viscosupplements|mesh-ancestor
153628426|NCT02029118|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153628428|NCT02029118|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153628429|NCT02029118|Antipyretics|antipyretics|mesh-ancestor
153628430|NCT02029118|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153628431|NCT02029118|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153628432|NCT02029118|Antimetabolites|antimetabolites|mesh-ancestor
153628433|NCT02029118|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153628434|NCT02029118|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
153628435|NCT02029118|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153628436|NCT02029118|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153628486|NCT02029573|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
153628487|NCT02029573|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153628488|NCT02029573|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153430993|NCT00000769|Immunologic Factors|immunologic factors|mesh-ancestor
153628491|NCT02029586|Beta-lapachone|beta-lapachone|mesh-list
153628492|NCT02029586|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153628493|NCT02029586|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153628494|NCT02029586|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153628495|NCT02029586|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153628496|NCT02029586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153628497|NCT02029586|Antiviral Agents|antiviral agents|mesh-ancestor
153628498|NCT02029599|Acetaminophen|acetaminophen|mesh-list
153628499|NCT02029599|Methotrexate|methotrexate|mesh-list
153628500|NCT02029599|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
153628501|NCT02029599|Abortifacient Agents|abortifacient agents|mesh-ancestor
153628502|NCT02029599|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153628503|NCT02029599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153628504|NCT02029599|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153628505|NCT02029599|Antimetabolites|antimetabolites|mesh-ancestor
153628506|NCT02029599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153628507|NCT02029599|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153628508|NCT02029599|Dermatologic Agents|dermatologic agents|mesh-ancestor
153628509|NCT02029599|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153628512|NCT02029599|Immunologic Factors|immunologic factors|mesh-ancestor
153783536|NCT00269217|Antimetabolites|antimetabolites|mesh-ancestor
153431183|NCT06315881|Autonomic Agents|autonomic agents|mesh-ancestor
153628534|NCT02029625|Antimetabolites|antimetabolites|mesh-ancestor
153628535|NCT02029625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153628536|NCT02029625|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153628537|NCT02029625|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
153628538|NCT02029625|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153628539|NCT02029794|Acetic Acid|acetic acid|mesh-list
153628540|NCT02029794|Retinol acetate|retinol acetate|mesh-list
153628541|NCT02029794|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153628542|NCT02029794|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153628543|NCT02029794|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153628544|NCT02029794|Immunologic Factors|immunologic factors|mesh-ancestor
153628545|NCT02029794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153628546|NCT02029794|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
153628547|NCT02029794|Protective Agents|protective agents|mesh-ancestor
153628548|NCT02029794|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153628549|NCT02029898|Remifentanil|remifentanil|mesh-list
153628550|NCT02029898|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153628551|NCT02029898|Narcotics|narcotics|mesh-ancestor
153628552|NCT02029898|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153628553|NCT02029898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153628554|NCT02029898|Analgesics|analgesics|mesh-ancestor
153628555|NCT02029898|Sensory System Agents|sensory system agents|mesh-ancestor
153628556|NCT02029898|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153628557|NCT02029924|Insulin Lispro|insulin lispro|mesh-list
153628558|NCT02029924|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153628559|NCT02029924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153628561|NCT02029937|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
153628562|NCT02029937|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153628564|NCT02029950|Etoposide|etoposide|mesh-list
153628565|NCT02029950|Podophyllotoxin|podophyllotoxin|mesh-list
153628566|NCT02029950|Daunorubicin|daunorubicin|mesh-list
153889912|NCT01003639|Aspirin|aspirin|mesh-list
153889913|NCT01003639|Acetaminophen|acetaminophen|mesh-list
153430994|NCT00000769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153628569|NCT02029950|Pomalidomide|pomalidomide|mesh-list
153628570|NCT02029950|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153628571|NCT02029950|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153628574|NCT02029950|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153628575|NCT02029950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153628576|NCT02029950|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153628577|NCT02029950|Antimetabolites|antimetabolites|mesh-ancestor
153628578|NCT02029950|Antiviral Agents|antiviral agents|mesh-ancestor
153628579|NCT02029950|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153628580|NCT02029950|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153628581|NCT02029950|Immunologic Factors|immunologic factors|mesh-ancestor
153431208|NCT06315699|Histamine Agents|histamine agents|mesh-ancestor
153431209|NCT06315699|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153461760|NCT04130802|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153628582|NCT02029950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153628583|NCT02029950|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153628584|NCT02029950|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153628585|NCT02029950|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153628586|NCT02029950|Growth Substances|growth substances|mesh-ancestor
153628587|NCT02029950|Growth Inhibitors|growth inhibitors|mesh-ancestor
153628588|NCT02029950|Keratolytic Agents|keratolytic agents|mesh-ancestor
153628589|NCT02029950|Dermatologic Agents|dermatologic agents|mesh-ancestor
153628590|NCT02029950|Tubulin Modulators|tubulin modulators|mesh-ancestor
153628591|NCT02029950|Antimitotic Agents|antimitotic agents|mesh-ancestor
153628592|NCT02029950|Mitosis Modulators|mitosis modulators|mesh-ancestor
153628593|NCT02030561|Trastuzumab|trastuzumab|mesh-list
153628594|NCT02030561|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153628595|NCT02030561|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153628596|NCT02031367|Triamcinolone|triamcinolone|mesh-list
153628597|NCT02031367|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
153628598|NCT02031367|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
153628599|NCT02031367|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
153628600|NCT02031367|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153628601|NCT02031367|Glucocorticoids|glucocorticoids|mesh-ancestor
153628603|NCT02031367|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153628604|NCT02031367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153628605|NCT02031367|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153628606|NCT02031367|Immunologic Factors|immunologic factors|mesh-ancestor
153628607|NCT02031367|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153628609|NCT02031692|Cholecalciferol|cholecalciferol|mesh-list
153628613|NCT02031692|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153628614|NCT02031692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153628615|NCT02031692|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153628616|NCT02031692|Vitamins|vitamins|mesh-ancestor
153628617|NCT02031692|Micronutrients|micronutrients|mesh-ancestor
153628618|NCT02031692|Antacids|antacids|mesh-ancestor
153628619|NCT02031692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153628620|NCT02031692|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153628621|NCT02031991|Bevacizumab|bevacizumab|mesh-list
153628622|NCT02031991|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153628623|NCT02031991|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153628624|NCT02031991|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153628675|NCT02033733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153628676|NCT02034253|Risperidone|risperidone|mesh-list
153628677|NCT02034253|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153628678|NCT02034253|Serotonin Agents|serotonin agents|mesh-ancestor
153628679|NCT02034253|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153430995|NCT00000769|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153430998|NCT05440591|Dapagliflozin|dapagliflozin|mesh-list
153430999|NCT05440591|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153431000|NCT05440591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153628680|NCT02034253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153628682|NCT02034253|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153628683|NCT02034253|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153628684|NCT02034253|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153628685|NCT02034253|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153628686|NCT02034253|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
153628738|NCT02039453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153628739|NCT02039453|Analgesics|analgesics|mesh-ancestor
153628740|NCT02039453|Sensory System Agents|sensory system agents|mesh-ancestor
153628741|NCT02039453|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153628742|NCT02039453|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153628743|NCT02039453|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153628744|NCT02039453|Anesthetics, General|anesthetics, general|mesh-ancestor
153628745|NCT02039453|Anesthetics|anesthetics|mesh-ancestor
153628746|NCT02039492|Spironolactone|spironolactone|mesh-list
153628747|NCT02039492|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
153628748|NCT02039492|Hormone Antagonists|hormone antagonists|mesh-ancestor
153628749|NCT02039492|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153628750|NCT02039492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153628751|NCT02039492|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
153628752|NCT02039492|Diuretics|diuretics|mesh-ancestor
153628753|NCT02039492|Natriuretic Agents|natriuretic agents|mesh-ancestor
153628755|NCT02039869|Sucralfate|sucralfate|mesh-list
153628756|NCT02039869|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
153628757|NCT02039869|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
153628758|NCT02039869|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153628759|NCT02039869|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153628760|NCT02039869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153628761|NCT02040064|Gefitinib|gefitinib|mesh-list
153628762|NCT02040064|Tremelimumab|tremelimumab|mesh-list
153628763|NCT02040064|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153628764|NCT02040064|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153628765|NCT02040064|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153628766|NCT02040064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153628767|NCT02040064|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153628768|NCT02040142|Mitomycins|mitomycins|mesh-list
153628769|NCT02040142|Mitomycin|mitomycin|mesh-list
153628770|NCT02040142|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153628780|NCT02040220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153628782|NCT02040220|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153628783|NCT02040246|Metformin|metformin|mesh-list
153628784|NCT02040246|Repaglinide|repaglinide|mesh-list
153628785|NCT02040246|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153628786|NCT02040246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153628787|NCT02040285|Metoclopramide|metoclopramide|mesh-list
153628788|NCT02040285|Bisacodyl|bisacodyl|mesh-list
153628789|NCT02040285|Antiemetics|antiemetics|mesh-ancestor
153628790|NCT02040285|Autonomic Agents|autonomic agents|mesh-ancestor
153783537|NCT00269217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153431271|NCT06315322|Brivaracetam|brivaracetam|mesh-list
153431274|NCT06315309|Tacrolimus|tacrolimus|mesh-list
153628791|NCT02040285|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153628792|NCT02040285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153628793|NCT02040285|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153628794|NCT02040285|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
153628795|NCT02040285|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
153628796|NCT02040285|Dopamine Agents|dopamine agents|mesh-ancestor
153628797|NCT02040285|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153628799|NCT02040285|Cathartics|cathartics|mesh-ancestor
153628841|NCT02040454|Tubulin Modulators|tubulin modulators|mesh-ancestor
153628842|NCT02040454|Antimitotic Agents|antimitotic agents|mesh-ancestor
153628843|NCT02040454|Mitosis Modulators|mitosis modulators|mesh-ancestor
153628844|NCT02040454|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153628845|NCT02040571|Insulin|insulin|mesh-list
153628846|NCT02040571|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153628847|NCT02040571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153628848|NCT02040597|Beclomethasone|beclomethasone|mesh-list
153628871|NCT02040636|Vaccines|vaccines|mesh-list
153628901|NCT02040818|N-monoacetylcystine|n-monoacetylcystine|mesh-list
153628902|NCT02040818|Anticoagulants|anticoagulants|mesh-ancestor
153628903|NCT02040818|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153628904|NCT02040818|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153628905|NCT02040818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153628906|NCT02040818|Antiviral Agents|antiviral agents|mesh-ancestor
153628907|NCT02040818|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153628908|NCT02040818|Expectorants|expectorants|mesh-ancestor
153628909|NCT02040818|Respiratory System Agents|respiratory system agents|mesh-ancestor
153628910|NCT02040818|Free Radical Scavengers|free radical scavengers|mesh-ancestor
153628911|NCT02040818|Antioxidants|antioxidants|mesh-ancestor
153628912|NCT02040818|Protective Agents|protective agents|mesh-ancestor
153628913|NCT02040818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153628914|NCT02040818|Antidotes|antidotes|mesh-ancestor
153628915|NCT02040818|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153628916|NCT02040818|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
153628917|NCT02040818|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153628918|NCT02040831|Vaccines|vaccines|mesh-list
153628919|NCT02040831|Immunologic Factors|immunologic factors|mesh-ancestor
153628920|NCT02040831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153628955|NCT02040909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153628956|NCT02040909|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153628957|NCT02040909|Anesthetics, General|anesthetics, general|mesh-ancestor
153628958|NCT02040909|Anesthetics|anesthetics|mesh-ancestor
153628959|NCT02040935|Trastuzumab|trastuzumab|mesh-list
153628960|NCT02040935|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153628961|NCT02040935|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153628962|NCT02040987|Moxifloxacin|moxifloxacin|mesh-list
153628963|NCT02040987|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153628964|NCT02040987|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153628965|NCT02040987|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153628966|NCT02040987|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153628967|NCT02040987|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153628968|NCT02040987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153628969|NCT02040987|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153628970|NCT02041117|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
153628971|NCT02041117|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153628972|NCT02041117|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153628973|NCT02041117|Antimetabolites|antimetabolites|mesh-ancestor
153628974|NCT02041117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153821032|NCT00474006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153889955|NCT04297033|Dihydromevinolin|dihydromevinolin|mesh-list
153889956|NCT04297033|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153889957|NCT04297033|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153889958|NCT04297033|Antimetabolites|antimetabolites|mesh-ancestor
153431013|NCT00000337|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
153628976|NCT02041117|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
153628977|NCT02041117|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153628978|NCT02041143|Caseins|caseins|mesh-list
153628979|NCT02041143|Chelating Agents|chelating agents|mesh-ancestor
153628980|NCT02041143|Sequestering Agents|sequestering agents|mesh-ancestor
153628982|NCT02041273|Palbociclib|palbociclib|mesh-list
153629001|NCT02041351|Docetaxel|docetaxel|mesh-list
153629002|NCT02041351|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153629003|NCT02041351|Tubulin Modulators|tubulin modulators|mesh-ancestor
153629004|NCT02041351|Antimitotic Agents|antimitotic agents|mesh-ancestor
153629005|NCT02041351|Mitosis Modulators|mitosis modulators|mesh-ancestor
153629006|NCT02041351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153629007|NCT02041455|Amitriptyline|amitriptyline|mesh-list
153629008|NCT02041455|Melatonin|melatonin|mesh-list
153629009|NCT02041455|Antioxidants|antioxidants|mesh-ancestor
153629010|NCT02041455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153629011|NCT02041455|Protective Agents|protective agents|mesh-ancestor
153629012|NCT02041455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153629064|NCT02042027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153629065|NCT02042170|Hormones|hormones|mesh-list
153629066|NCT02042170|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153783538|NCT00269217|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153421902|NCT05273554|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153421903|NCT05273554|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153431335|NCT06314763|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153629067|NCT02042170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153629068|NCT02042196|Cetrorelix|cetrorelix|mesh-list
153629069|NCT02042196|Estradiol|estradiol|mesh-list
153629070|NCT02042196|Estrogens|estrogens|mesh-ancestor
153629071|NCT02042196|Hormones|hormones|mesh-ancestor
153629073|NCT02042196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153629130|NCT02042690|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153629131|NCT02042690|Glucocorticoids|glucocorticoids|mesh-ancestor
153821033|NCT04697745|Dexamethasone|dexamethasone|mesh-list
153360986|NCT01491113|Levetiracetam|levetiracetam|mesh-list
153431014|NCT00000337|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
153431015|NCT00000337|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153889959|NCT04297033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153889960|NCT04297033|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153889961|NCT04297033|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
153889962|NCT04297033|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153889963|NCT04294537|Anesthetics|anesthetics|mesh-list
153889964|NCT04294537|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153629133|NCT02042690|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153629135|NCT02042690|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153629136|NCT02042690|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
153629137|NCT02042690|Abortifacient Agents|abortifacient agents|mesh-ancestor
153629138|NCT02042690|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153629139|NCT02042690|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153629140|NCT02042690|Antimetabolites|antimetabolites|mesh-ancestor
153629141|NCT02042690|Dermatologic Agents|dermatologic agents|mesh-ancestor
153629142|NCT02042690|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153629143|NCT02042690|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153629144|NCT02042690|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153629145|NCT02042690|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153629146|NCT02042690|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153629147|NCT02042742|3,4-dihydroxyphenylethanol|3,4-dihydroxyphenylethanol|mesh-list
153629148|NCT02042742|Phenylethyl Alcohol|phenylethyl alcohol|mesh-list
153629150|NCT02042742|Antioxidants|antioxidants|mesh-ancestor
153629152|NCT02042742|Protective Agents|protective agents|mesh-ancestor
153629184|NCT02043223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153629185|NCT02043223|Antioxidants|antioxidants|mesh-ancestor
153629186|NCT02043223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153629187|NCT02043223|Protective Agents|protective agents|mesh-ancestor
153629188|NCT02043223|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
153629189|NCT02043223|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153629190|NCT02043288|Gemcitabine|gemcitabine|mesh-list
153629191|NCT02043288|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153629192|NCT02043288|Antimetabolites|antimetabolites|mesh-ancestor
153629193|NCT02043288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153629194|NCT02043288|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153629196|NCT02043314|Antitubercular Agents|antitubercular agents|mesh-ancestor
153629197|NCT02043314|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153629198|NCT02043314|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153629199|NCT02043314|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
153629200|NCT02043314|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153629201|NCT02043314|Antimetabolites|antimetabolites|mesh-ancestor
153629202|NCT02043314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153629203|NCT02043314|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153890369|NCT01297920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153890373|NCT01255761|Certolizumab Pegol|certolizumab pegol|mesh-list
153629205|NCT02043340|Dermatologic Agents|dermatologic agents|mesh-ancestor
153629235|NCT02043821|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153629236|NCT02043886|Acarbose|acarbose|mesh-list
153629237|NCT02043886|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
153431016|NCT00000337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153431017|NCT00000337|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
153629240|NCT02043886|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153629241|NCT02043886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153629242|NCT02043912|Haloperidol|haloperidol|mesh-list
153629243|NCT02043912|Haloperidol decanoate|haloperidol decanoate|mesh-list
153629244|NCT02043912|Antiemetics|antiemetics|mesh-ancestor
153629245|NCT02043912|Autonomic Agents|autonomic agents|mesh-ancestor
153629246|NCT02043912|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153629247|NCT02043912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153629248|NCT02043912|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153629249|NCT02043912|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153629250|NCT02043912|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153629251|NCT02043912|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153629252|NCT02043912|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153629253|NCT02043912|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
153629254|NCT02043912|Dopamine Agents|dopamine agents|mesh-ancestor
153629255|NCT02043912|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153629256|NCT02043912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153629288|NCT02044146|Purinergic Agents|purinergic agents|mesh-ancestor
153629289|NCT02044146|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153629290|NCT02044146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153629291|NCT02044146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153629292|NCT02044224|Dexmedetomidine|dexmedetomidine|mesh-list
153629293|NCT02044224|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153629294|NCT02044224|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153629295|NCT02044224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153629296|NCT02044224|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153629297|NCT02044224|Analgesics|analgesics|mesh-ancestor
153629299|NCT02044224|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153629300|NCT02044224|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
153629301|NCT02044224|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153629302|NCT02044224|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153629303|NCT02044224|Adrenergic Agents|adrenergic agents|mesh-ancestor
153629304|NCT02044224|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153629305|NCT02044224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153629306|NCT02044250|Aspirin|aspirin|mesh-list
153629307|NCT02044250|Clopidogrel|clopidogrel|mesh-list
153629308|NCT02044250|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153629309|NCT02044250|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153629310|NCT02044250|Analgesics|analgesics|mesh-ancestor
153431420|NCT06293963|Adrenergic Agents|adrenergic agents|mesh-ancestor
153629311|NCT02044250|Sensory System Agents|sensory system agents|mesh-ancestor
153629312|NCT02044250|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153629313|NCT02044250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153629314|NCT02044250|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153629315|NCT02044250|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153629316|NCT02044250|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153629317|NCT02044250|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153629318|NCT02044250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153821035|NCT04697745|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153821036|NCT04697745|Antiemetics|antiemetics|mesh-ancestor
153821037|NCT04697745|Autonomic Agents|autonomic agents|mesh-ancestor
153889966|NCT04295629|Anesthetics|anesthetics|mesh-list
153889967|NCT04295629|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153889968|NCT04295629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153629320|NCT02044250|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153629321|NCT02044250|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153629322|NCT02044250|Antipyretics|antipyretics|mesh-ancestor
153820722|NCT03272802|Free Radical Scavengers|free radical scavengers|mesh-ancestor
153629325|NCT02044250|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
153629326|NCT02044250|Purinergic Agents|purinergic agents|mesh-ancestor
153629327|NCT02044250|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153629328|NCT02044354|Docetaxel|docetaxel|mesh-list
153629329|NCT02044354|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153629330|NCT02044354|Tubulin Modulators|tubulin modulators|mesh-ancestor
153629331|NCT02044354|Antimitotic Agents|antimitotic agents|mesh-ancestor
153629332|NCT02044354|Mitosis Modulators|mitosis modulators|mesh-ancestor
153629333|NCT02044354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153629334|NCT02044549|Oxytocin|oxytocin|mesh-list
153629335|NCT02044549|Carbetocin|carbetocin|mesh-list
153629336|NCT02044549|Methylergonovine|methylergonovine|mesh-list
153629337|NCT02044549|Syntometrine|syntometrine|mesh-list
153629338|NCT02044549|Oxytocics|oxytocics|mesh-ancestor
153629339|NCT02044549|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153629340|NCT02044549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153629341|NCT02044601|Paclitaxel|paclitaxel|mesh-list
153629342|NCT02044601|Carboplatin|carboplatin|mesh-list
153629343|NCT02044601|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
153629344|NCT02044601|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153629345|NCT02044601|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153629346|NCT02044601|Tubulin Modulators|tubulin modulators|mesh-ancestor
153629347|NCT02044601|Antimitotic Agents|antimitotic agents|mesh-ancestor
153629348|NCT02044601|Mitosis Modulators|mitosis modulators|mesh-ancestor
153629349|NCT02044601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153629375|NCT02044952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153629376|NCT02044952|Antispermatogenic Agents|antispermatogenic agents|mesh-ancestor
153629377|NCT02044952|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
153629378|NCT02044952|Contraceptive Agents|contraceptive agents|mesh-ancestor
153629379|NCT02044952|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153629380|NCT02044952|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153629381|NCT02044952|Immunologic Factors|immunologic factors|mesh-ancestor
153890437|NCT01075282|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153890438|NCT01075282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153890441|NCT01075282|Immunologic Factors|immunologic factors|mesh-ancestor
153629382|NCT02044952|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153629383|NCT02044952|Alkylating Agents|alkylating agents|mesh-ancestor
153629384|NCT02044952|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153629385|NCT02044965|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
153629386|NCT02044965|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
153629387|NCT02044965|Trimethoprim|trimethoprim|mesh-list
153629388|NCT02044965|Sulfamethoxazole|sulfamethoxazole|mesh-list
153629389|NCT02044965|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153629391|NCT02044965|Antimalarials|antimalarials|mesh-ancestor
153629433|NCT02045056|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
153629434|NCT02045056|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153629435|NCT02045056|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153629436|NCT02045069|Ivermectin|ivermectin|mesh-list
153629437|NCT02045069|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153629438|NCT02045069|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153629439|NCT02045290|Metformin|metformin|mesh-list
153629440|NCT02045290|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153629441|NCT02045290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153629442|NCT02045368|Methotrexate|methotrexate|mesh-list
153629443|NCT02045368|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
153629444|NCT02045368|Abortifacient Agents|abortifacient agents|mesh-ancestor
153629445|NCT02045368|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153629446|NCT02045368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153629447|NCT02045368|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153629448|NCT02045368|Antimetabolites|antimetabolites|mesh-ancestor
153821038|NCT04697745|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153431018|NCT00000337|Protective Agents|protective agents|mesh-ancestor
153431019|NCT00000337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153629490|NCT02045797|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153629491|NCT02045797|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153629492|NCT02045797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153629493|NCT02045797|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153629494|NCT02045810|Levobupivacaine|levobupivacaine|mesh-list
153629495|NCT02045810|Anesthetics, Local|anesthetics, local|mesh-ancestor
153629496|NCT02045810|Anesthetics|anesthetics|mesh-ancestor
153629497|NCT02045810|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153629498|NCT02045810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153629499|NCT02045810|Sensory System Agents|sensory system agents|mesh-ancestor
153629500|NCT02045810|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153629501|NCT02045849|Itraconazole|itraconazole|mesh-list
153629502|NCT02045849|Gepotidacin|gepotidacin|mesh-list
153629503|NCT02045849|Antifungal Agents|antifungal agents|mesh-ancestor
153629504|NCT02045849|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153629548|NCT02045992|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153629549|NCT02045992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153629550|NCT02045992|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
153629551|NCT02045992|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
153629552|NCT02045992|Purinergic Agents|purinergic agents|mesh-ancestor
153629553|NCT02045992|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153629554|NCT02046044|Digoxin|digoxin|mesh-list
153629555|NCT02046044|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153629556|NCT02046044|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
153629557|NCT02046044|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153629558|NCT02046044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153629559|NCT02046044|Protective Agents|protective agents|mesh-ancestor
153629607|NCT02046486|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153629608|NCT02046486|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
153629609|NCT02046486|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
153629610|NCT02046486|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
153629611|NCT02046486|Purinergic Agents|purinergic agents|mesh-ancestor
153629612|NCT02046486|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153629614|NCT02046486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153629674|NCT02046668|Hormone Antagonists|hormone antagonists|mesh-ancestor
153629675|NCT02046668|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153629676|NCT02046668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153629677|NCT02046668|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
153629679|NCT02046668|Natriuretic Agents|natriuretic agents|mesh-ancestor
153629681|NCT02046720|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153629682|NCT02046720|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153629683|NCT02046720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153629684|NCT02046720|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153629685|NCT02046720|Anesthetics, General|anesthetics, general|mesh-ancestor
153629735|NCT02047006|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
153629736|NCT02047006|Antithrombins|antithrombins|mesh-ancestor
153629737|NCT02047006|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
153629738|NCT02047006|Protease Inhibitors|protease inhibitors|mesh-ancestor
153629739|NCT02047006|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153629740|NCT02047006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153629741|NCT02047006|Anticoagulants|anticoagulants|mesh-ancestor
153629742|NCT02047019|Candesartan|candesartan|mesh-list
153629743|NCT02047019|Candesartan cilexetil|candesartan cilexetil|mesh-list
153629744|NCT02047019|Nifedipine|nifedipine|mesh-list
153629745|NCT02047019|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153890495|NCT01293006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153890496|NCT01293006|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
153889969|NCT01306032|Cyclophosphamide|cyclophosphamide|mesh-list
153889970|NCT01306032|Veliparib|veliparib|mesh-list
153889971|NCT01306032|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153431020|NCT00000781|Zidovudine|zidovudine|mesh-list
153629746|NCT02047019|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
153629747|NCT02047019|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
153629748|NCT02047019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153629749|NCT02047019|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153629750|NCT02047019|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153629751|NCT02047019|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153629752|NCT02047019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153629754|NCT02047019|Tocolytic Agents|tocolytic agents|mesh-ancestor
153629755|NCT02047019|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153629787|NCT02047162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153629788|NCT02047162|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153629789|NCT02047162|Antidiarrheals|antidiarrheals|mesh-ancestor
153629791|NCT02047175|Amlodipine|amlodipine|mesh-list
153629792|NCT02047175|Telmisartan|telmisartan|mesh-list
153629793|NCT02047175|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
153629794|NCT02047175|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153629795|NCT02047175|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153629796|NCT02047175|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153629797|NCT02047175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153629799|NCT02047175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153629800|NCT02047175|Vasodilator Agents|vasodilator agents|mesh-ancestor
153629801|NCT02047175|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153629802|NCT02047175|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153629803|NCT02047175|Antimetabolites|antimetabolites|mesh-ancestor
153629804|NCT02047175|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153629805|NCT02047175|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
153629806|NCT02047175|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153629807|NCT02047175|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
153629808|NCT02047175|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
153629839|NCT00005823|Idarubicin|idarubicin|mesh-list
153629840|NCT00005823|Hydroxyurea|hydroxyurea|mesh-list
153629841|NCT00005823|Thioguanine|thioguanine|mesh-list
153881026|NCT05465317|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153881027|NCT05465317|Hormones|hormones|mesh-ancestor
153881028|NCT05465317|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153431527|NCT06128044|Fludarabine|fludarabine|mesh-list
153431528|NCT06128044|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153431537|NCT06120881|Metformin|metformin|mesh-list
153629842|NCT00005823|Tretinoin|tretinoin|mesh-list
153629843|NCT00005823|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153629844|NCT00005823|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153629845|NCT00005823|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153629846|NCT00005823|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153629847|NCT00005823|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153629848|NCT00005823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153629849|NCT00005823|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153629850|NCT00005823|Antimetabolites|antimetabolites|mesh-ancestor
153360990|NCT03839498|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153360991|NCT03839498|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153629852|NCT00005823|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153629853|NCT00005823|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153629854|NCT00005823|Immunologic Factors|immunologic factors|mesh-ancestor
153629855|NCT00005823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153629856|NCT00005823|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153629857|NCT00005823|Analgesics|analgesics|mesh-ancestor
153629858|NCT00005823|Sensory System Agents|sensory system agents|mesh-ancestor
153629859|NCT00005823|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153629860|NCT00005823|Antisickling Agents|antisickling agents|mesh-ancestor
153629861|NCT00005823|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153629862|NCT00005823|Keratolytic Agents|keratolytic agents|mesh-ancestor
153629863|NCT00005823|Dermatologic Agents|dermatologic agents|mesh-ancestor
153629864|NCT00005826|Rubitecan|rubitecan|mesh-list
153629865|NCT00005826|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153629866|NCT00005826|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
153629867|NCT00005826|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153629868|NCT00005826|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153629869|NCT00005826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153629870|NCT00005829|Gemcitabine|gemcitabine|mesh-list
153629882|NCT00005838|Tubulin Modulators|tubulin modulators|mesh-ancestor
153629883|NCT00005838|Antimitotic Agents|antimitotic agents|mesh-ancestor
153629884|NCT00005838|Mitosis Modulators|mitosis modulators|mesh-ancestor
153629885|NCT00005838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153629886|NCT00005841|Freund's Adjuvant|freund's adjuvant|mesh-list
153629887|NCT00005841|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153629888|NCT00005841|Immunologic Factors|immunologic factors|mesh-ancestor
153361432|NCT00877604|Antiviral Agents|antiviral agents|mesh-ancestor
153361433|NCT00877604|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153361434|NCT01508117|Axitinib|axitinib|mesh-list
153361435|NCT01508117|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153361436|NCT01508117|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153361437|NCT01508117|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153361438|NCT01508117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153361439|NCT00878228|Ondansetron|ondansetron|mesh-list
153361440|NCT00878228|Antiemetics|antiemetics|mesh-ancestor
153361441|NCT00878228|Autonomic Agents|autonomic agents|mesh-ancestor
153361442|NCT00878228|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153361443|NCT00878228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153361447|NCT00878228|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
153431568|NCT06097364|Hormones|hormones|mesh-ancestor
153629889|NCT00005841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153629890|NCT00005844|Oxaliplatin|oxaliplatin|mesh-list
153629891|NCT00005844|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153629892|NCT00005850|Gemcitabine|gemcitabine|mesh-list
153629893|NCT00005850|Fluoxetine|fluoxetine|mesh-list
153629894|NCT00005850|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153629895|NCT00005850|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153629896|NCT00005850|Antimetabolites|antimetabolites|mesh-ancestor
153629897|NCT00005850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153629898|NCT00005850|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
153629899|NCT00005850|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153629900|NCT00005850|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153629936|NCT00005862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153629937|NCT00005865|Vinorelbine|vinorelbine|mesh-list
153629938|NCT00005865|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153629939|NCT00005865|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153629940|NCT00005865|Tubulin Modulators|tubulin modulators|mesh-ancestor
153629941|NCT00005865|Antimitotic Agents|antimitotic agents|mesh-ancestor
153629942|NCT00005865|Mitosis Modulators|mitosis modulators|mesh-ancestor
153629943|NCT00005865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153629944|NCT00005868|Docetaxel|docetaxel|mesh-list
153629945|NCT00005868|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153629946|NCT00005868|Tubulin Modulators|tubulin modulators|mesh-ancestor
153629947|NCT00005868|Antimitotic Agents|antimitotic agents|mesh-ancestor
153629948|NCT00005868|Mitosis Modulators|mitosis modulators|mesh-ancestor
153629994|NCT00005886|Hormone Antagonists|hormone antagonists|mesh-ancestor
153629995|NCT00005886|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153629996|NCT00005886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153629997|NCT00005886|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153629998|NCT00005886|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153629999|NCT00005886|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
153630000|NCT00005886|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
153630001|NCT00005886|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153630002|NCT00005889|Glucagon|glucagon|mesh-list
153630003|NCT00005889|Glycerol|glycerol|mesh-list
153630004|NCT00005889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153630005|NCT00005889|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153630006|NCT00005889|Hormones|hormones|mesh-ancestor
153630007|NCT00005889|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153630008|NCT00005889|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
153630009|NCT00005889|Protective Agents|protective agents|mesh-ancestor
153362034|NCT05943080|Sympathomimetics|sympathomimetics|mesh-ancestor
153362035|NCT05943080|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
153362036|NCT05929495|Metformin|metformin|mesh-list
153362037|NCT05929495|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153362038|NCT05929495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153362509|NCT01401023|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153362510|NCT01401023|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
153362511|NCT01401023|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153362512|NCT01401023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153630010|NCT00005892|Cyclophosphamide|cyclophosphamide|mesh-list
153821039|NCT04697745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153821040|NCT04697745|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153630047|NCT00005898|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153630048|NCT00005898|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
153630049|NCT00005898|Protective Agents|protective agents|mesh-ancestor
153630050|NCT00386412|Valganciclovir|valganciclovir|mesh-list
153630051|NCT00386412|Antiviral Agents|antiviral agents|mesh-ancestor
153630052|NCT00386412|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153630053|NCT00386529|Aspirin|aspirin|mesh-list
153630054|NCT00386529|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153630055|NCT00386529|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153630056|NCT00386529|Analgesics|analgesics|mesh-ancestor
153630057|NCT00386529|Sensory System Agents|sensory system agents|mesh-ancestor
153630058|NCT00386529|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153630059|NCT00386529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153630068|NCT00386529|Antipyretics|antipyretics|mesh-ancestor
153630106|NCT00005934|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153630107|NCT00005934|Antimetabolites|antimetabolites|mesh-ancestor
153630108|NCT00005934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153630109|NCT00005934|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153630110|NCT00005934|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153630111|NCT00005940|Iodine|iodine|mesh-list
153630112|NCT00005940|Cyclosporine|cyclosporine|mesh-list
153630113|NCT00005940|Cyclophosphamide|cyclophosphamide|mesh-list
153630114|NCT00005940|Busulfan|busulfan|mesh-list
153630115|NCT00005940|Methotrexate|methotrexate|mesh-list
153630116|NCT00005940|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
153630117|NCT00005940|Cyclosporins|cyclosporins|mesh-list
153630118|NCT00005940|Antibodies|antibodies|mesh-list
153630119|NCT00005940|Immunoglobulins|immunoglobulins|mesh-list
153630120|NCT00005940|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
153630121|NCT00005940|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153630122|NCT00005940|Immunologic Factors|immunologic factors|mesh-ancestor
153630123|NCT00005940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153630124|NCT00005940|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153630125|NCT00005940|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153630160|NCT00005946|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153630161|NCT00005946|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153630162|NCT00005946|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153630163|NCT00005946|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153630164|NCT00005946|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153630165|NCT00005946|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153630166|NCT00005949|Aldesleukin|aldesleukin|mesh-list
153630167|NCT00005949|Interleukin-2|interleukin-2|mesh-list
153630168|NCT00005949|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153630169|NCT00005949|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153630170|NCT00005949|Analgesics|analgesics|mesh-ancestor
153630171|NCT00005949|Sensory System Agents|sensory system agents|mesh-ancestor
153630172|NCT00005949|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153362525|NCT01515995|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153362526|NCT01515995|Tocolytic Agents|tocolytic agents|mesh-ancestor
153362527|NCT01515995|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153362528|NCT01436045|Insulin glulisine|insulin glulisine|mesh-list
153362529|NCT01436045|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153362561|NCT02210195|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153630173|NCT00005949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153630174|NCT00005949|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153630175|NCT00005949|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153889972|NCT01306032|Immunologic Factors|immunologic factors|mesh-ancestor
153431023|NCT00000781|Zalcitabine|zalcitabine|mesh-list
153630177|NCT00005949|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153630178|NCT00005952|Temozolomide|temozolomide|mesh-list
153630179|NCT00005952|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153630180|NCT00005952|Alkylating Agents|alkylating agents|mesh-ancestor
153630216|NCT00005964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153630217|NCT00005964|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153630218|NCT00005964|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153630219|NCT00005964|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153630220|NCT00005964|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153630221|NCT00005964|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153630222|NCT00005964|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153630223|NCT00005964|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153630224|NCT00005964|Glucocorticoids|glucocorticoids|mesh-ancestor
153630225|NCT00005964|Hormones|hormones|mesh-ancestor
153630226|NCT00005964|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153630227|NCT00005964|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153630228|NCT00005964|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153630229|NCT00005964|Tubulin Modulators|tubulin modulators|mesh-ancestor
153630230|NCT00005964|Antimitotic Agents|antimitotic agents|mesh-ancestor
153630231|NCT00005964|Mitosis Modulators|mitosis modulators|mesh-ancestor
153630232|NCT00005967|Tipifarnib|tipifarnib|mesh-list
153630233|NCT00005967|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153630234|NCT00005970|Tamoxifen|tamoxifen|mesh-list
153630235|NCT00005970|Paclitaxel|paclitaxel|mesh-list
153630236|NCT00005970|Cyclophosphamide|cyclophosphamide|mesh-list
153630237|NCT00005970|Doxorubicin|doxorubicin|mesh-list
153630238|NCT00005970|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
153630239|NCT00005970|Trastuzumab|trastuzumab|mesh-list
153630240|NCT00005970|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
153630266|NCT00005970|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153630267|NCT00005970|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153630268|NCT00005970|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
153630269|NCT00005970|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
153630270|NCT00005970|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153630271|NCT00005970|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153914595|NCT00933244|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153362597|NCT00837590|Salicylsalicylic acid|salicylsalicylic acid|mesh-list
153362598|NCT00837590|Sodium Salicylate|sodium salicylate|mesh-list
153362599|NCT00837590|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153362600|NCT00837590|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153362602|NCT00837590|Sensory System Agents|sensory system agents|mesh-ancestor
153360993|NCT03839498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153360994|NCT01492673|Cyclophosphamide|cyclophosphamide|mesh-list
153889973|NCT01306032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153889974|NCT01306032|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153889975|NCT01306032|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153630274|NCT00005976|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153630275|NCT00005979|Leucovorin|leucovorin|mesh-list
153630276|NCT00005979|Fluorouracil|fluorouracil|mesh-list
153630331|NCT00005988|Cyclosporine|cyclosporine|mesh-list
153630332|NCT00005988|Methylprednisolone|methylprednisolone|mesh-list
153630333|NCT00005988|Cyclophosphamide|cyclophosphamide|mesh-list
153630334|NCT00005988|Methotrexate|methotrexate|mesh-list
153630335|NCT00005988|Cyclosporins|cyclosporins|mesh-list
153630336|NCT00005988|Levoleucovorin|levoleucovorin|mesh-list
153630337|NCT00005988|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153630338|NCT00005988|Immunologic Factors|immunologic factors|mesh-ancestor
153630339|NCT00005988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153630340|NCT00005988|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153630398|NCT00006000|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
153630399|NCT00006000|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153630400|NCT00006000|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153630401|NCT00006000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153630402|NCT00006003|Semaxinib|semaxinib|mesh-list
153630403|NCT00006003|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153630404|NCT00006003|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153630405|NCT00006003|Growth Substances|growth substances|mesh-ancestor
153630466|NCT00006015|Micronutrients|micronutrients|mesh-ancestor
153630468|NCT00006018|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153630469|NCT00006018|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153630470|NCT00006018|Tubulin Modulators|tubulin modulators|mesh-ancestor
153630471|NCT00006018|Antimitotic Agents|antimitotic agents|mesh-ancestor
153630472|NCT00006018|Mitosis Modulators|mitosis modulators|mesh-ancestor
153630473|NCT00006018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153630474|NCT00006021|Ascorbic Acid|ascorbic acid|mesh-list
153630475|NCT00006021|Arsenic Trioxide|arsenic trioxide|mesh-list
153630476|NCT00006021|Antioxidants|antioxidants|mesh-ancestor
153630477|NCT00006021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153630478|NCT00006021|Protective Agents|protective agents|mesh-ancestor
153630479|NCT00006021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153630480|NCT00006021|Vitamins|vitamins|mesh-ancestor
153363008|NCT02476422|Ibuprofen|ibuprofen|mesh-list
153630481|NCT00006021|Micronutrients|micronutrients|mesh-ancestor
153630525|NCT00006033|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153630526|NCT00006033|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153630527|NCT00006033|Immunologic Factors|immunologic factors|mesh-ancestor
153889976|NCT01306032|Alkylating Agents|alkylating agents|mesh-ancestor
153889977|NCT01306032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153889978|NCT01306032|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153630528|NCT00006033|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153630529|NCT00006033|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153630530|NCT00006033|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153630531|NCT00006033|Analgesics|analgesics|mesh-ancestor
153630532|NCT00006033|Sensory System Agents|sensory system agents|mesh-ancestor
153630533|NCT00006033|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153630534|NCT00006036|Lurtotecan|lurtotecan|mesh-list
153630535|NCT00006036|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153630536|NCT00006039|Interferons|interferons|mesh-list
153630537|NCT00006039|Interferon-alpha|interferon-alpha|mesh-list
153630590|NCT00386802|Clotrimazole|clotrimazole|mesh-list
153630591|NCT00386802|Miconazole|miconazole|mesh-list
153630592|NCT00386802|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153630593|NCT00386802|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
153630594|NCT00386802|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
153630595|NCT00386802|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153630596|NCT00386802|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153630597|NCT00386802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153630598|NCT00386802|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153630604|NCT00386841|Escitalopram|escitalopram|mesh-list
153630651|NCT05679336|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153630652|NCT05626725|Insulin|insulin|mesh-list
153630653|NCT05626725|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153630654|NCT05626725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153630655|NCT05597163|Atropine|atropine|mesh-list
153630656|NCT05597163|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153630657|NCT05597163|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153630658|NCT05597163|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153630659|NCT05597163|Autonomic Agents|autonomic agents|mesh-ancestor
153630660|NCT05597163|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153630661|NCT05597163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153630662|NCT05597163|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153630663|NCT05597163|Respiratory System Agents|respiratory system agents|mesh-ancestor
153630664|NCT05597163|Mydriatics|mydriatics|mesh-ancestor
153363779|NCT00910520|Cholinergic Agents|cholinergic agents|mesh-ancestor
153630665|NCT05597163|Parasympatholytics|parasympatholytics|mesh-ancestor
153630666|NCT05597163|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
153821043|NCT04697745|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153821044|NCT04697745|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153360996|NCT01492673|Topotecan|topotecan|mesh-list
153360997|NCT01492673|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153360998|NCT01492673|Immunologic Factors|immunologic factors|mesh-ancestor
153630667|NCT05597163|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
153630669|NCT05597163|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153630708|NCT04793685|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
153630709|NCT04793685|Adrenergic Agents|adrenergic agents|mesh-ancestor
153630710|NCT04793685|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153630711|NCT04793685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153630712|NCT04793685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153630713|NCT04552080|Amoxicillin|amoxicillin|mesh-list
153630714|NCT04552080|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153630715|NCT04552080|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153630716|NCT03834909|Tenofovir|tenofovir|mesh-list
153630717|NCT03834909|Emtricitabine|emtricitabine|mesh-list
153630718|NCT03834909|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
153630719|NCT03834909|Antiviral Agents|antiviral agents|mesh-ancestor
153630720|NCT03834909|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153630721|NCT03834909|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153630722|NCT03834909|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153630765|NCT03741933|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153630766|NCT03741933|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
153630767|NCT03741933|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
153630768|NCT03741933|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153630769|NCT03741933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153630770|NCT03002259|Dexamethasone|dexamethasone|mesh-list
153630771|NCT03002259|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153630772|NCT03002259|Antiemetics|antiemetics|mesh-ancestor
153630773|NCT03002259|Autonomic Agents|autonomic agents|mesh-ancestor
153630774|NCT03002259|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153630775|NCT03002259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153630776|NCT03002259|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153630777|NCT03002259|Glucocorticoids|glucocorticoids|mesh-ancestor
153630778|NCT03002259|Hormones|hormones|mesh-ancestor
153630779|NCT03002259|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153630780|NCT03002259|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153630823|NCT02373813|Etanercept|etanercept|mesh-list
153630824|NCT02373813|Methotrexate|methotrexate|mesh-list
153630825|NCT02373813|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
153630826|NCT02373813|Abortifacient Agents|abortifacient agents|mesh-ancestor
153630827|NCT02373813|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153630828|NCT02373813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153630829|NCT02373813|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153630830|NCT02373813|Antimetabolites|antimetabolites|mesh-ancestor
153630831|NCT02373813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153630890|NCT00006051|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153630891|NCT00006051|Antimetabolites|antimetabolites|mesh-ancestor
153363988|NCT01722968|Mitosis Modulators|mitosis modulators|mesh-ancestor
153363989|NCT01722968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153630892|NCT00006051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153630893|NCT00006051|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153630894|NCT00006051|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153630895|NCT00006051|Immunologic Factors|immunologic factors|mesh-ancestor
153630896|NCT00006051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153630897|NCT00006054|Cyclosporine|cyclosporine|mesh-list
153630898|NCT00006054|Prednisone|prednisone|mesh-list
153630899|NCT00006054|Methylprednisolone|methylprednisolone|mesh-list
153630900|NCT00006054|Cyclophosphamide|cyclophosphamide|mesh-list
153630901|NCT00006054|Busulfan|busulfan|mesh-list
153630902|NCT00006054|Methotrexate|methotrexate|mesh-list
153630903|NCT00006054|Etoposide|etoposide|mesh-list
153630904|NCT00006054|Cyclosporins|cyclosporins|mesh-list
153630905|NCT00006054|Antilymphocyte Serum|antilymphocyte serum|mesh-list
153630906|NCT00006054|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153630907|NCT00006054|Immunologic Factors|immunologic factors|mesh-ancestor
153630908|NCT00006054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153630909|NCT00006054|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153630910|NCT00006054|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153630911|NCT00006054|Alkylating Agents|alkylating agents|mesh-ancestor
153630912|NCT00006054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153630913|NCT00006054|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153630914|NCT00006054|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153630915|NCT00006054|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153630939|NCT00006054|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
153630940|NCT00006054|Protective Agents|protective agents|mesh-ancestor
153630941|NCT00006063|Pancrelipase|pancrelipase|mesh-list
153630942|NCT00006063|Pancreatin|pancreatin|mesh-list
153630943|NCT00006063|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153630944|NCT00006066|Aldesleukin|aldesleukin|mesh-list
153630945|NCT00006066|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153630946|NCT00006066|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153821045|NCT04697745|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153821046|NCT04697745|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153914596|NCT02709187|Candesartan|candesartan|mesh-list
153360999|NCT01492673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153361000|NCT01492673|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153630949|NCT00006066|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153630951|NCT00006072|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153630952|NCT00006072|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153630953|NCT00006072|Immunologic Factors|immunologic factors|mesh-ancestor
153630954|NCT00006072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153630955|NCT00006072|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153630956|NCT00006075|Chlorhexidine|chlorhexidine|mesh-list
153630957|NCT00006075|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
153630958|NCT00006075|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
153630959|NCT00006075|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153630996|NCT00006105|Protective Agents|protective agents|mesh-ancestor
153630997|NCT00006105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153364137|NCT03405584|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153364138|NCT03405584|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153364139|NCT03405584|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
153364140|NCT03405584|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153364141|NCT03405584|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
153364142|NCT03405584|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153630998|NCT00006108|Paclitaxel|paclitaxel|mesh-list
153630999|NCT00006108|Capecitabine|capecitabine|mesh-list
153631000|NCT00006108|Trastuzumab|trastuzumab|mesh-list
153631001|NCT00006108|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153631002|NCT00006108|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153631003|NCT00006108|Tubulin Modulators|tubulin modulators|mesh-ancestor
153631004|NCT00006108|Antimitotic Agents|antimitotic agents|mesh-ancestor
153631005|NCT00006108|Mitosis Modulators|mitosis modulators|mesh-ancestor
153631006|NCT00006108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153631007|NCT00006108|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153631059|NCT00006123|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153631060|NCT00006123|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153631061|NCT00006123|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153631062|NCT00006126|Cyclophosphamide|cyclophosphamide|mesh-list
153631063|NCT00006126|Busulfan|busulfan|mesh-list
153631064|NCT00006126|Fludarabine|fludarabine|mesh-list
153631065|NCT00006126|Fludarabine phosphate|fludarabine phosphate|mesh-list
153631066|NCT00006126|Etoposide|etoposide|mesh-list
153631067|NCT00006126|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153631068|NCT00006126|Immunologic Factors|immunologic factors|mesh-ancestor
153631069|NCT00006126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153631070|NCT00006126|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153631071|NCT00006126|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153631072|NCT00006126|Alkylating Agents|alkylating agents|mesh-ancestor
153631073|NCT00006126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153631074|NCT00006126|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153631075|NCT00006126|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153631076|NCT00006126|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153631077|NCT00006126|Antimetabolites|antimetabolites|mesh-ancestor
153631078|NCT00006126|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153431025|NCT00000781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153631081|NCT00006126|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153631082|NCT00006129|Testosterone|testosterone|mesh-list
153631083|NCT00006129|Androgens|androgens|mesh-ancestor
153631084|NCT00006129|Hormones|hormones|mesh-ancestor
153631085|NCT00006129|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153631086|NCT00006129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153365150|NCT04371146|Antidepressive Agents|antidepressive agents|mesh-ancestor
153365152|NCT04371146|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
153365312|NCT02244632|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153365313|NCT02244632|Growth Substances|growth substances|mesh-ancestor
153365314|NCT02244632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153365315|NCT02244632|Growth Inhibitors|growth inhibitors|mesh-ancestor
153365316|NCT02244632|Antimetabolites|antimetabolites|mesh-ancestor
153365318|NCT02244632|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153631087|NCT00006132|Acyclovir|acyclovir|mesh-list
153631088|NCT00006132|Antiviral Agents|antiviral agents|mesh-ancestor
153631089|NCT00006132|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153631090|NCT00006135|Acyclovir|acyclovir|mesh-list
153631091|NCT00006135|Antiviral Agents|antiviral agents|mesh-ancestor
153631092|NCT00006135|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153631094|NCT00006144|Lopinavir|lopinavir|mesh-list
153631095|NCT00006144|Emtricitabine|emtricitabine|mesh-list
153631096|NCT00006144|Stavudine|stavudine|mesh-list
153631098|NCT00006144|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
153631099|NCT00006144|Protease Inhibitors|protease inhibitors|mesh-ancestor
153631100|NCT00006144|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153631101|NCT00006144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153631102|NCT00006144|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153631103|NCT00006144|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153631104|NCT00006144|Antiviral Agents|antiviral agents|mesh-ancestor
153631105|NCT00006144|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153631106|NCT00006144|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
153631107|NCT00006144|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153631108|NCT00006144|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153631109|NCT00006144|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153631110|NCT00006144|Antimetabolites|antimetabolites|mesh-ancestor
153631111|NCT00006168|Methotrexate|methotrexate|mesh-list
153631112|NCT00006168|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
153631113|NCT00006168|Abortifacient Agents|abortifacient agents|mesh-ancestor
153631114|NCT00006168|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153631115|NCT00006168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153631116|NCT00006168|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153631117|NCT00006168|Antimetabolites|antimetabolites|mesh-ancestor
153631118|NCT00006168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153631119|NCT00006168|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153631120|NCT00006168|Dermatologic Agents|dermatologic agents|mesh-ancestor
153821047|NCT04697745|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153821048|NCT04697745|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153631121|NCT00006168|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153631122|NCT00006168|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153631123|NCT00006168|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153631124|NCT00006168|Immunologic Factors|immunologic factors|mesh-ancestor
153631125|NCT00006168|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153631126|NCT00006168|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153631128|NCT00006174|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153631129|NCT00006174|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
153631130|NCT00006174|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153631131|NCT00006174|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153631133|NCT00006174|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
153631135|NCT00006174|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153631136|NCT00006174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153631137|NCT00006180|Alendronate|alendronate|mesh-list
153631138|NCT00006180|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153631139|NCT00006180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153631140|NCT00006195|Olanzapine|olanzapine|mesh-list
153631141|NCT00006195|Risperidone|risperidone|mesh-list
153631142|NCT00006195|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153631143|NCT00006195|Serotonin Agents|serotonin agents|mesh-ancestor
153631144|NCT00006195|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153631152|NCT00006195|Dopamine Agents|dopamine agents|mesh-ancestor
153631198|NCT00006216|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
153631199|NCT00006216|Antiviral Agents|antiviral agents|mesh-ancestor
153631200|NCT00006216|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153631201|NCT00006216|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153631202|NCT00006216|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153631203|NCT00006216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153631204|NCT00006219|Clarithromycin|clarithromycin|mesh-list
153631205|NCT00006219|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
153631206|NCT00006219|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153631207|NCT00006219|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153631208|NCT00006219|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
153631209|NCT00006219|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153631210|NCT00006219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153631258|NCT00006246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153631259|NCT00006246|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153631260|NCT00006246|Immunologic Factors|immunologic factors|mesh-ancestor
153631261|NCT00006246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153361001|NCT01492673|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153361002|NCT01492673|Alkylating Agents|alkylating agents|mesh-ancestor
153889979|NCT01306032|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153431026|NCT00000781|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153631264|NCT00006246|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153631265|NCT00006249|Interferons|interferons|mesh-list
153631266|NCT00006249|Interferon-alpha|interferon-alpha|mesh-list
153631267|NCT00006249|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153631268|NCT00006249|Antiviral Agents|antiviral agents|mesh-ancestor
153631269|NCT00006249|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153631270|NCT00006249|Immunologic Factors|immunologic factors|mesh-ancestor
153631271|NCT00006249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153631272|NCT00006252|Cyclophosphamide|cyclophosphamide|mesh-list
153631273|NCT00006252|Fludarabine|fludarabine|mesh-list
153631274|NCT00006252|Fludarabine phosphate|fludarabine phosphate|mesh-list
153365708|NCT02486952|Cyclophosphamide|cyclophosphamide|mesh-list
153365709|NCT02486952|Rituximab|rituximab|mesh-list
153365711|NCT02486952|Doxorubicin|doxorubicin|mesh-list
153365712|NCT02486952|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
153365713|NCT02486952|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153365714|NCT02486952|Immunologic Factors|immunologic factors|mesh-ancestor
153365715|NCT02486952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153365716|NCT02486952|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153890874|NCT01036594|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153914647|NCT02709031|Diuretics|diuretics|mesh-ancestor
153365717|NCT02486952|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153365718|NCT02486952|Alkylating Agents|alkylating agents|mesh-ancestor
153631316|NCT00006261|Doxorubicin|doxorubicin|mesh-list
153631317|NCT00006261|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
153631318|NCT00006261|Fludarabine|fludarabine|mesh-list
153631319|NCT00006261|Fludarabine phosphate|fludarabine phosphate|mesh-list
153631320|NCT00006261|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153631321|NCT00006261|Immunologic Factors|immunologic factors|mesh-ancestor
153631322|NCT00006261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153631323|NCT00006261|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153631324|NCT00006261|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153631325|NCT00006261|Alkylating Agents|alkylating agents|mesh-ancestor
153631326|NCT00006261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153631327|NCT00006261|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153631328|NCT00006261|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153631329|NCT00006261|Tubulin Modulators|tubulin modulators|mesh-ancestor
153631330|NCT00006261|Antimitotic Agents|antimitotic agents|mesh-ancestor
153631331|NCT00006261|Mitosis Modulators|mitosis modulators|mesh-ancestor
153631332|NCT00006261|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153631333|NCT00006261|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153631334|NCT00006261|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153631335|NCT00006261|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153631336|NCT00006261|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153631337|NCT00006261|Antimetabolites|antimetabolites|mesh-ancestor
153631338|NCT00006264|Zidovudine|zidovudine|mesh-list
153631339|NCT00006264|Aldesleukin|aldesleukin|mesh-list
153631340|NCT00006264|Ganciclovir|ganciclovir|mesh-list
153631341|NCT00006264|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
153631342|NCT00006264|Antimetabolites|antimetabolites|mesh-ancestor
153631365|NCT00006270|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153631367|NCT00006276|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153631368|NCT00006276|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153631369|NCT00006276|Tubulin Modulators|tubulin modulators|mesh-ancestor
153631370|NCT00006276|Antimitotic Agents|antimitotic agents|mesh-ancestor
153631371|NCT00006276|Mitosis Modulators|mitosis modulators|mesh-ancestor
153631372|NCT00006276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153821049|NCT04697745|Analgesics|analgesics|mesh-ancestor
153821050|NCT04697745|Sensory System Agents|sensory system agents|mesh-ancestor
153821051|NCT04697745|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
153631429|NCT00006324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153631430|NCT00006324|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
153631431|NCT00006324|Contraceptive Agents|contraceptive agents|mesh-ancestor
153631432|NCT00006324|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153631433|NCT00006324|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
153365719|NCT02486952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153365720|NCT02486952|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153365721|NCT02486952|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153365722|NCT02486952|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153365723|NCT02486952|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153365724|NCT02486952|Glucocorticoids|glucocorticoids|mesh-ancestor
153365725|NCT02486952|Hormones|hormones|mesh-ancestor
153365726|NCT02486952|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153365727|NCT02486952|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153365728|NCT02486952|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153365729|NCT02486952|Tubulin Modulators|tubulin modulators|mesh-ancestor
153365730|NCT02486952|Antimitotic Agents|antimitotic agents|mesh-ancestor
153365731|NCT02486952|Mitosis Modulators|mitosis modulators|mesh-ancestor
153890906|NCT01268046|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153631434|NCT00006324|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
153631435|NCT00006324|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
153881036|NCT05405270|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153365756|NCT01641653|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153631436|NCT00006324|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
153631437|NCT00006324|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
153631438|NCT00006324|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153631439|NCT00006324|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153631440|NCT00006324|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
153631441|NCT00005824|Cyclophosphamide|cyclophosphamide|mesh-list
153631442|NCT00005824|Busulfan|busulfan|mesh-list
153631452|NCT00005827|Genistein|genistein|mesh-list
153631488|NCT00005839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153631489|NCT00005839|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153631490|NCT00005842|Trastuzumab|trastuzumab|mesh-list
153631491|NCT00005842|Tipifarnib|tipifarnib|mesh-list
153631492|NCT00005842|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153631493|NCT00005842|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153631494|NCT00005845|Tipifarnib|tipifarnib|mesh-list
153631495|NCT00005845|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153631496|NCT00005848|Tipifarnib|tipifarnib|mesh-list
153631497|NCT00005848|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153631498|NCT00005851|Cyclosporine|cyclosporine|mesh-list
153631499|NCT00005851|Mycophenolic Acid|mycophenolic acid|mesh-list
153631500|NCT00005851|Fludarabine|fludarabine|mesh-list
153631501|NCT00005851|Fludarabine phosphate|fludarabine phosphate|mesh-list
153631502|NCT00005851|Cyclosporins|cyclosporins|mesh-list
153631503|NCT00005851|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153631504|NCT00005851|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153631505|NCT00005851|Antimetabolites|antimetabolites|mesh-ancestor
153631506|NCT00005851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153631507|NCT00005851|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153631508|NCT00005851|Immunologic Factors|immunologic factors|mesh-ancestor
153631509|NCT00005851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153631510|NCT00005851|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153631511|NCT00005851|Antifungal Agents|antifungal agents|mesh-ancestor
153365757|NCT01641653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153365758|NCT01641653|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153365759|NCT01641653|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153365760|NCT01641653|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153365761|NCT01641653|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153365762|NCT01641653|Anesthetics, General|anesthetics, general|mesh-ancestor
153365763|NCT01641653|Anesthetics|anesthetics|mesh-ancestor
153365764|NCT01641653|GABA Modulators|gaba modulators|mesh-ancestor
153365765|NCT01641653|GABA Agents|gaba agents|mesh-ancestor
153365766|NCT01641653|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153365767|NCT01641653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153365768|NCT01600703|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
153365769|NCT01600703|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153365770|NCT01600703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153365771|NCT01600703|Incretins|incretins|mesh-ancestor
153365772|NCT01600703|Hormones|hormones|mesh-ancestor
153890943|NCT01033942|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153631512|NCT00005851|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153631513|NCT00005851|Dermatologic Agents|dermatologic agents|mesh-ancestor
153631520|NCT00005854|Cyclosporine|cyclosporine|mesh-list
153631537|NCT00005854|Antimetabolites|antimetabolites|mesh-ancestor
153631538|NCT00005854|Dermatologic Agents|dermatologic agents|mesh-ancestor
153631539|NCT00005854|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153631540|NCT00005854|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153631541|NCT00005854|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153631542|NCT00005854|Antifungal Agents|antifungal agents|mesh-ancestor
153631543|NCT00005854|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153631544|NCT00005854|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
153631546|NCT00005857|Trastuzumab|trastuzumab|mesh-list
153889980|NCT01306032|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
153431027|NCT00000781|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153631548|NCT00005857|Tubulin Modulators|tubulin modulators|mesh-ancestor
153631549|NCT00005857|Antimitotic Agents|antimitotic agents|mesh-ancestor
153631550|NCT00005857|Mitosis Modulators|mitosis modulators|mesh-ancestor
153631551|NCT00005857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153631552|NCT00005857|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153631554|NCT00005860|Oxaliplatin|oxaliplatin|mesh-list
153631555|NCT00005860|Floxuridine|floxuridine|mesh-list
153631556|NCT00005860|Calcium|calcium|mesh-list
153631557|NCT00005860|Levoleucovorin|levoleucovorin|mesh-list
153631558|NCT00005860|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153631559|NCT00005860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153631560|NCT00005860|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153631561|NCT00005860|Antidotes|antidotes|mesh-ancestor
153631562|NCT00005860|Protective Agents|protective agents|mesh-ancestor
153631563|NCT00005860|Vitamin B Complex|vitamin b complex|mesh-ancestor
153631564|NCT00005860|Vitamins|vitamins|mesh-ancestor
153631565|NCT00005860|Micronutrients|micronutrients|mesh-ancestor
153631566|NCT00005860|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153631567|NCT00005860|Antimetabolites|antimetabolites|mesh-ancestor
153631568|NCT00005860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153631569|NCT00005863|Cytarabine|cytarabine|mesh-list
153631570|NCT00005863|Fludarabine|fludarabine|mesh-list
153631571|NCT00005863|Fludarabine phosphate|fludarabine phosphate|mesh-list
153631572|NCT00005863|Etoposide|etoposide|mesh-list
153365773|NCT01600703|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153365774|NCT01600703|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
153365775|NCT01600703|Protease Inhibitors|protease inhibitors|mesh-ancestor
153365776|NCT01600703|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153365777|NCT01600703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153365778|NCT02450526|Botulinum Toxins|botulinum toxins|mesh-list
153365779|NCT02450526|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
153365780|NCT02450526|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
153631573|NCT00005863|Daunorubicin|daunorubicin|mesh-list
153631574|NCT00005863|Tretinoin|tretinoin|mesh-list
153631575|NCT00005863|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153631578|NCT00005863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153631579|NCT00005863|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153631581|NCT00005863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153631582|NCT00005863|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153631583|NCT00005863|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153631584|NCT00005863|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153631585|NCT00005863|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153631586|NCT00005863|Antiviral Agents|antiviral agents|mesh-ancestor
153631587|NCT00005863|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153631588|NCT00005863|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153631589|NCT00005863|Keratolytic Agents|keratolytic agents|mesh-ancestor
153631639|NCT00005878|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153631640|NCT00005878|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153631641|NCT00005878|Analgesics|analgesics|mesh-ancestor
153631642|NCT00005878|Sensory System Agents|sensory system agents|mesh-ancestor
153631643|NCT00005878|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153631644|NCT00005878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153631646|NCT00005878|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153631647|NCT00005878|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
153631649|NCT00005878|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153631704|NCT00386503|Amodiaquine|amodiaquine|mesh-list
153631705|NCT00386503|Antimalarials|antimalarials|mesh-ancestor
153821052|NCT04697745|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153821053|NCT04697745|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153889981|NCT01306032|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153431028|NCT00000781|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153431029|NCT00000781|Antiviral Agents|antiviral agents|mesh-ancestor
153631706|NCT00386503|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153631707|NCT00386503|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153631708|NCT00386503|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153631709|NCT00386503|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153631711|NCT00386503|Schistosomicides|schistosomicides|mesh-ancestor
153631712|NCT00386503|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
153631713|NCT00386503|Anthelmintics|anthelmintics|mesh-ancestor
153631714|NCT00386581|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
153631715|NCT00386581|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
153631716|NCT00386581|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153631717|NCT00386581|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153631718|NCT00386581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153631719|NCT00386581|Adrenergic Agents|adrenergic agents|mesh-ancestor
153631720|NCT00386581|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153631762|NCT00005935|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
153631763|NCT00005935|Antitubercular Agents|antitubercular agents|mesh-ancestor
153631764|NCT00005935|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153631766|NCT00006348|Antiemetics|antiemetics|mesh-ancestor
153631767|NCT00006348|Autonomic Agents|autonomic agents|mesh-ancestor
153631768|NCT00006348|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153631769|NCT00006348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153631770|NCT00006348|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153631771|NCT00006348|Antipruritics|antipruritics|mesh-ancestor
153631772|NCT00006348|Dermatologic Agents|dermatologic agents|mesh-ancestor
153631773|NCT00006348|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
153631774|NCT00006348|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153631775|NCT00006348|Serotonin Agents|serotonin agents|mesh-ancestor
153631776|NCT00006348|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153631777|NCT00006348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153631778|NCT00005938|Exatecan|exatecan|mesh-list
153631779|NCT00005938|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
153889982|NCT01263015|Lamivudine|lamivudine|mesh-list
153889983|NCT01263015|Abacavir|abacavir|mesh-list
153889984|NCT01263015|Dideoxynucleosides|dideoxynucleosides|mesh-list
153631781|NCT00005938|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153631782|NCT00005938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153631783|NCT00005938|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153631784|NCT00005941|Cyclosporine|cyclosporine|mesh-list
153631785|NCT00005941|Mycophenolic Acid|mycophenolic acid|mesh-list
153631786|NCT00005941|Fludarabine|fludarabine|mesh-list
153631787|NCT00005941|Fludarabine phosphate|fludarabine phosphate|mesh-list
153631788|NCT00005941|Cyclosporins|cyclosporins|mesh-list
153631789|NCT00005941|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153631790|NCT00005941|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153631791|NCT00005941|Antimetabolites|antimetabolites|mesh-ancestor
153631792|NCT00005941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153631793|NCT00005941|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153631794|NCT00005941|Immunologic Factors|immunologic factors|mesh-ancestor
153631795|NCT00005941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153631796|NCT00005941|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153820723|NCT03272802|Antioxidants|antioxidants|mesh-ancestor
153631801|NCT00005941|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
153631802|NCT00005941|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153631803|NCT00005941|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
153631804|NCT00005941|Antitubercular Agents|antitubercular agents|mesh-ancestor
153631805|NCT00005941|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153631807|NCT00005944|Fluorouracil|fluorouracil|mesh-list
153631808|NCT00005944|Mitomycins|mitomycins|mesh-list
153631809|NCT00005944|Mitomycin|mitomycin|mesh-list
153631810|NCT00005944|Calcium|calcium|mesh-list
153366755|NCT01016678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153366756|NCT01016678|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153366757|NCT01016678|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153366758|NCT01016678|Gout Suppressants|gout suppressants|mesh-ancestor
153366759|NCT01016678|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153631811|NCT00005944|Levoleucovorin|levoleucovorin|mesh-list
153631812|NCT00005944|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153631813|NCT00005944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153631814|NCT00005944|Antimetabolites|antimetabolites|mesh-ancestor
153631820|NCT00005944|Antidotes|antidotes|mesh-ancestor
153631862|NCT00005959|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153631863|NCT00005959|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153631864|NCT00005959|Glucocorticoids|glucocorticoids|mesh-ancestor
153631865|NCT00005959|Hormones|hormones|mesh-ancestor
153631866|NCT00005959|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153631867|NCT00005959|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153631868|NCT00005959|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153631869|NCT00005959|Tubulin Modulators|tubulin modulators|mesh-ancestor
153631870|NCT00005959|Antimitotic Agents|antimitotic agents|mesh-ancestor
153631871|NCT00005959|Mitosis Modulators|mitosis modulators|mesh-ancestor
153631872|NCT00387738|Histamine|histamine|mesh-list
153631873|NCT00387738|Histamine Agonists|histamine agonists|mesh-ancestor
153631874|NCT00387738|Histamine Agents|histamine agents|mesh-ancestor
153631875|NCT00387738|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153631876|NCT00387738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153631877|NCT00387738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153631878|NCT00005965|Bryostatin 1|bryostatin 1|mesh-list
153631879|NCT00005965|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153631919|NCT00005977|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
153631920|NCT00005977|Methotrexate|methotrexate|mesh-list
153631921|NCT00005977|Etoposide|etoposide|mesh-list
153631922|NCT00005977|Vincristine|vincristine|mesh-list
153631923|NCT00005977|Lenograstim|lenograstim|mesh-list
153631924|NCT00005977|Levoleucovorin|levoleucovorin|mesh-list
153631925|NCT00005977|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153366767|NCT01016834|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
153366768|NCT01016834|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
153366769|NCT01016834|Serotonin Agents|serotonin agents|mesh-ancestor
153366770|NCT01016834|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153366771|NCT01016834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153366772|NCT01016834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153366773|NCT04923594|Mazindol|mazindol|mesh-list
153366774|NCT04923594|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
153366775|NCT04923594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153366776|NCT04923594|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
153366777|NCT04923594|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153631926|NCT00005977|Immunologic Factors|immunologic factors|mesh-ancestor
153631927|NCT00005977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153631928|NCT00005977|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153631929|NCT00005977|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153631930|NCT00005977|Alkylating Agents|alkylating agents|mesh-ancestor
153631931|NCT00005977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153631932|NCT00005977|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153631933|NCT00005977|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153631934|NCT00005977|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153631935|NCT00005977|Antiemetics|antiemetics|mesh-ancestor
153631979|NCT00005986|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153631980|NCT00005986|Immunologic Factors|immunologic factors|mesh-ancestor
153631981|NCT00005986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153631982|NCT00005986|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153631983|NCT00005986|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153631984|NCT00005986|Alkylating Agents|alkylating agents|mesh-ancestor
153631985|NCT00005986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153631986|NCT00005986|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153631987|NCT00005986|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153631988|NCT00005986|Antiviral Agents|antiviral agents|mesh-ancestor
153631989|NCT00005986|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153631990|NCT00005989|Tipifarnib|tipifarnib|mesh-list
153631991|NCT00005989|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153631992|NCT00005998|Cytarabine|cytarabine|mesh-list
153631993|NCT00005998|Dexamethasone|dexamethasone|mesh-list
153631994|NCT00005998|Cyclophosphamide|cyclophosphamide|mesh-list
153631995|NCT00005998|Carmustine|carmustine|mesh-list
153632038|NCT00006001|Growth Inhibitors|growth inhibitors|mesh-ancestor
153632039|NCT00006001|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153632040|NCT00006001|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153632041|NCT00006001|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153632042|NCT00006001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153632043|NCT00006007|Gemcitabine|gemcitabine|mesh-list
153632044|NCT00006007|Pemetrexed|pemetrexed|mesh-list
153632045|NCT00006007|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153632046|NCT00006007|Antimetabolites|antimetabolites|mesh-ancestor
153632047|NCT00006007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153632048|NCT00006007|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153821056|NCT04697745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153821057|NCT00481689|Ciprofloxacin|ciprofloxacin|mesh-list
153632100|NCT00006019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153366782|NCT04923594|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
153366783|NCT04923594|Dopamine Agents|dopamine agents|mesh-ancestor
153366784|NCT00961532|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
153366785|NCT00961532|Hemostatics|hemostatics|mesh-ancestor
153367087|NCT03018236|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153367094|NCT00982592|Levoleucovorin|levoleucovorin|mesh-list
153432044|NCT05469204|Acetaminophen|acetaminophen|mesh-list
153432045|NCT05469204|Digoxin|digoxin|mesh-list
153432046|NCT05469204|Midazolam|midazolam|mesh-list
153432047|NCT05469204|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
153432048|NCT05469204|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153432049|NCT05469204|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153432050|NCT05469204|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153432051|NCT05469204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153632101|NCT00006019|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153632102|NCT00006019|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153632103|NCT00006022|Aldesleukin|aldesleukin|mesh-list
153632104|NCT00006022|Bryostatin 1|bryostatin 1|mesh-list
153632105|NCT00006022|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153632106|NCT00006022|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153632107|NCT00006022|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153632165|NCT00006034|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153632166|NCT00006034|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153632167|NCT00006034|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153632168|NCT00006034|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153632169|NCT00006034|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153632170|NCT00006034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153632171|NCT00006034|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153632172|NCT00006034|Immunologic Factors|immunologic factors|mesh-ancestor
153632173|NCT00006034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153632174|NCT00006037|Fluorouracil|fluorouracil|mesh-list
153632175|NCT00006037|Irinotecan|irinotecan|mesh-list
153632176|NCT00006037|Antimetabolites|antimetabolites|mesh-ancestor
153632177|NCT00006037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153632178|NCT00006037|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153632179|NCT00006037|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153632180|NCT00006037|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153632181|NCT00006037|Immunologic Factors|immunologic factors|mesh-ancestor
153632182|NCT00006037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153632183|NCT00006037|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
153632184|NCT00006037|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153632185|NCT00006037|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153632186|NCT00006040|Etoposide|etoposide|mesh-list
153632187|NCT00006040|Antibodies|antibodies|mesh-list
153632188|NCT00006040|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
153632189|NCT00006040|Immunologic Factors|immunologic factors|mesh-ancestor
153632190|NCT00006040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153632191|NCT00006040|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153632213|NCT00006363|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153632214|NCT00006363|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153632215|NCT00006363|Immunologic Factors|immunologic factors|mesh-ancestor
153632216|NCT00006363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153632217|NCT00006363|Alkylating Agents|alkylating agents|mesh-ancestor
153632218|NCT00006363|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153632219|NCT00006363|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153632220|NCT00006363|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153367095|NCT00982592|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153367141|NCT00988832|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
153367142|NCT00988832|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153367143|NCT00988832|Dermatologic Agents|dermatologic agents|mesh-ancestor
153367144|NCT00988832|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153367145|NCT00988832|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153367147|NCT01023776|Immunologic Factors|immunologic factors|mesh-ancestor
153367148|NCT01023776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153367149|NCT00989768|Botulinum Toxins|botulinum toxins|mesh-list
153881050|NCT05263908|Ritonavir|ritonavir|mesh-list
153367150|NCT00989768|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
153367151|NCT00989768|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
153367152|NCT00989768|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
153367153|NCT00989768|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153367154|NCT00989768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153632221|NCT00006363|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153632222|NCT00006363|Analgesics|analgesics|mesh-ancestor
153632223|NCT00006363|Sensory System Agents|sensory system agents|mesh-ancestor
153632224|NCT00006363|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153632273|NCT00006381|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153632274|NCT00006381|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153632275|NCT00006381|Analgesics|analgesics|mesh-ancestor
153632276|NCT00006381|Sensory System Agents|sensory system agents|mesh-ancestor
153632277|NCT00006381|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153632278|NCT00006381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153632279|NCT00006381|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153632280|NCT00006381|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153632281|NCT00006381|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
153632282|NCT00006381|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153632283|NCT00006381|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153632284|NCT00006381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153632285|NCT00006384|Interferons|interferons|mesh-list
153632286|NCT00006384|Interferon-alpha|interferon-alpha|mesh-list
153632287|NCT00006384|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153632288|NCT00006384|Antiviral Agents|antiviral agents|mesh-ancestor
153632289|NCT00006384|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153632290|NCT00006384|Immunologic Factors|immunologic factors|mesh-ancestor
153632291|NCT00006384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153632292|NCT00386815|Pemetrexed|pemetrexed|mesh-list
153632326|NCT03996148|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153632327|NCT03996148|Analgesics|analgesics|mesh-ancestor
153367155|NCT00989768|Cholinergic Agents|cholinergic agents|mesh-ancestor
153367156|NCT00989768|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153367157|NCT00989768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153367158|NCT00989768|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
153367159|NCT00989768|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153367161|NCT00990236|Enoxaparin sodium|enoxaparin sodium|mesh-list
153367162|NCT00990236|Anticoagulants|anticoagulants|mesh-ancestor
153367163|NCT00990236|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153367196|NCT01027598|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153632328|NCT03996148|Sensory System Agents|sensory system agents|mesh-ancestor
153632329|NCT03996148|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153632330|NCT03996148|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
153632331|NCT03996148|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153632332|NCT03996148|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153632333|NCT03996148|Adrenergic Agents|adrenergic agents|mesh-ancestor
153632334|NCT03996148|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153632335|NCT03996148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153632336|NCT03996148|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153632337|NCT03996148|Anesthetics, General|anesthetics, general|mesh-ancestor
153632338|NCT03996148|Anesthetics|anesthetics|mesh-ancestor
153632389|NCT05546320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153632390|NCT05546320|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153632391|NCT05546320|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153632392|NCT05546320|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153632393|NCT05546320|Antipyretics|antipyretics|mesh-ancestor
153632394|NCT05546320|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
153632395|NCT05546320|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
153632396|NCT05546320|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
153632397|NCT05546320|Purinergic Agents|purinergic agents|mesh-ancestor
153632398|NCT05546320|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153632399|NCT05546320|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
153632400|NCT05546320|Antithrombins|antithrombins|mesh-ancestor
153632401|NCT05546320|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
153632402|NCT05546320|Protease Inhibitors|protease inhibitors|mesh-ancestor
153632403|NCT05546320|Anticoagulants|anticoagulants|mesh-ancestor
153632404|NCT05546320|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153632405|NCT05546320|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153821083|NCT00436709|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153361030|NCT02155010|Anesthetics, Local|anesthetics, local|mesh-ancestor
153632407|NCT05546320|Autonomic Agents|autonomic agents|mesh-ancestor
153632408|NCT05546320|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
153632409|NCT05546320|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
153632410|NCT05546320|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
153632411|NCT05546320|Adrenergic Agents|adrenergic agents|mesh-ancestor
153632413|NCT05535595|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
153632414|NCT05535595|Protease Inhibitors|protease inhibitors|mesh-ancestor
153632415|NCT05535595|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153632417|NCT05535595|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153421912|NCT05259527|Vitamins|vitamins|mesh-list
153367210|NCT02447250|Albuterol|albuterol|mesh-list
153367211|NCT02447250|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153367212|NCT02447250|Autonomic Agents|autonomic agents|mesh-ancestor
153367247|NCT04200066|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153367248|NCT04200066|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
153367249|NCT04200066|Hormone Antagonists|hormone antagonists|mesh-ancestor
153367250|NCT04200066|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153367277|NCT00994760|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153367278|NCT00994760|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153367279|NCT00994760|Anesthetics, General|anesthetics, general|mesh-ancestor
153367280|NCT00994760|Anesthetics|anesthetics|mesh-ancestor
153367281|NCT00995072|Metoprolol|metoprolol|mesh-list
153367282|NCT00995072|Nebivolol|nebivolol|mesh-list
153367283|NCT00995072|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153367285|NCT00995072|Sympatholytics|sympatholytics|mesh-ancestor
153632434|NCT05431543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153632435|NCT05431543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153632436|NCT05431543|Miotics|miotics|mesh-ancestor
153632437|NCT05431543|Autonomic Agents|autonomic agents|mesh-ancestor
153632438|NCT05431543|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153632439|NCT05431543|Parasympathomimetics|parasympathomimetics|mesh-ancestor
153632440|NCT05401786|Ipilimumab|ipilimumab|mesh-list
153632441|NCT05401786|Cemiplimab|cemiplimab|mesh-list
153632442|NCT05401786|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153632443|NCT05401786|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153632444|NCT05401786|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153632445|NCT05401786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153431031|NCT00000781|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153431032|NCT00000781|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153632448|NCT05285683|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
153632450|NCT05285683|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
153632451|NCT05285683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153632452|NCT05285683|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
153632453|NCT05285683|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153367290|NCT00995072|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
153367291|NCT00995072|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
153367292|NCT00995072|Adrenergic Agents|adrenergic agents|mesh-ancestor
153367293|NCT00995072|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153367395|NCT01004354|Vitamin D|vitamin d|mesh-list
153632454|NCT05285683|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153632455|NCT05285683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153632456|NCT05285683|Dopamine Agents|dopamine agents|mesh-ancestor
153632486|NCT00006441|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153632487|NCT00006441|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153632488|NCT00006441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153632489|NCT00006441|Antiviral Agents|antiviral agents|mesh-ancestor
153632490|NCT00006441|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153632491|NCT00006441|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153632492|NCT00006441|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153632493|NCT00006441|Antimetabolites|antimetabolites|mesh-ancestor
153632494|NCT00006441|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153632495|NCT00006441|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
153632496|NCT00006441|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
153632497|NCT00006441|Protease Inhibitors|protease inhibitors|mesh-ancestor
153632498|NCT05147233|Dexamethasone|dexamethasone|mesh-list
153632499|NCT05147233|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153632500|NCT05147233|Antiemetics|antiemetics|mesh-ancestor
153632501|NCT05147233|Autonomic Agents|autonomic agents|mesh-ancestor
153632546|NCT00388011|Narcotics|narcotics|mesh-ancestor
153632547|NCT00388011|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153632548|NCT00388011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153632549|NCT00388011|Analgesics|analgesics|mesh-ancestor
153632550|NCT00388011|Sensory System Agents|sensory system agents|mesh-ancestor
153632551|NCT00388011|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153632552|NCT04852978|Casirivimab and imdevimab drug combination|casirivimab and imdevimab drug combination|mesh-list
153632553|NCT04852978|Antiviral Agents|antiviral agents|mesh-ancestor
153367566|NCT01061528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153367567|NCT01061528|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
153367694|NCT03005444|Protease Inhibitors|protease inhibitors|mesh-ancestor
153367695|NCT03005444|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153891062|NCT01061710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153891063|NCT01028014|Pseudoephedrine|pseudoephedrine|mesh-list
153891064|NCT01028014|Ephedrine|ephedrine|mesh-list
153891065|NCT01028014|Cyclobenzaprine|cyclobenzaprine|mesh-list
153891066|NCT01028014|Imipramine|imipramine|mesh-list
153891067|NCT01028014|Tamsulosin|tamsulosin|mesh-list
153891068|NCT01028014|Solifenacin Succinate|solifenacin succinate|mesh-list
153891069|NCT01028014|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
153891070|NCT01028014|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
153891071|NCT01028014|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
153891072|NCT01028014|Adrenergic Agents|adrenergic agents|mesh-ancestor
153891073|NCT01028014|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153914648|NCT02709031|Natriuretic Agents|natriuretic agents|mesh-ancestor
153432087|NCT05361915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153432088|NCT05325593|Dexamethasone|dexamethasone|mesh-list
153432089|NCT05325593|Dexamethasone acetate|dexamethasone acetate|mesh-list
153432090|NCT05325593|BB 1101|bb 1101|mesh-list
153432091|NCT05325593|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153632554|NCT04852978|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153632555|NCT00388089|Bortezomib|bortezomib|mesh-list
153632556|NCT00388089|Topotecan|topotecan|mesh-list
153632562|NCT00388128|Caffeine|caffeine|mesh-list
153632611|NCT00006471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153632612|NCT00006474|Temozolomide|temozolomide|mesh-list
153632613|NCT00006474|O(6)-benzylguanine|o(6)-benzylguanine|mesh-list
153632614|NCT00006474|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153632615|NCT00006474|Alkylating Agents|alkylating agents|mesh-ancestor
153632616|NCT00006474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153632617|NCT00006474|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153632618|NCT00006474|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153632619|NCT04192435|Tranexamic Acid|tranexamic acid|mesh-list
153632620|NCT04192435|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
153632621|NCT04192435|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153632622|NCT04192435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153632623|NCT04192435|Hemostatics|hemostatics|mesh-ancestor
153632624|NCT04192435|Coagulants|coagulants|mesh-ancestor
153632625|NCT00423397|Interferons|interferons|mesh-list
153632626|NCT00423397|Interferon-alpha|interferon-alpha|mesh-list
153632627|NCT00423397|Interferon alpha-2|interferon alpha-2|mesh-list
153632667|NCT00387517|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153632668|NCT00387517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153632673|NCT02890069|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153632674|NCT02890069|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153632675|NCT02890069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153632676|NCT02890069|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153632677|NCT02890069|Immunologic Factors|immunologic factors|mesh-ancestor
153632683|NCT02425501|Aflibercept|aflibercept|mesh-list
153632728|NCT00006591|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153632729|NCT00006591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153632730|NCT00006591|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153632731|NCT00006591|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153632732|NCT00006591|Antiviral Agents|antiviral agents|mesh-ancestor
153632733|NCT00006591|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153632734|NCT00006591|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
153632735|NCT00006591|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153632736|NCT00006591|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
153367696|NCT03005444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153367697|NCT03005444|Anticoagulants|anticoagulants|mesh-ancestor
153367698|NCT03005444|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153367699|NCT03005444|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153367701|NCT01076270|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153367702|NCT01076270|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153367703|NCT01076270|Antiviral Agents|antiviral agents|mesh-ancestor
153367704|NCT01076270|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153367737|NCT01077596|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-list
153632737|NCT00006591|Antitubercular Agents|antitubercular agents|mesh-ancestor
153632738|NCT00006591|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153632739|NCT00006630|Immunoglobulins|immunoglobulins|mesh-list
153632740|NCT00006630|Antibodies|antibodies|mesh-list
153632741|NCT00006630|gamma-Globulins|gamma-globulins|mesh-list
153632742|NCT00006630|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
153632743|NCT00006630|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
153632744|NCT00006630|Immunologic Factors|immunologic factors|mesh-ancestor
153632745|NCT00006630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153632746|NCT00006669|Prednisone|prednisone|mesh-list
153632747|NCT00006669|Cyclophosphamide|cyclophosphamide|mesh-list
153632748|NCT00006669|Rituximab|rituximab|mesh-list
153632749|NCT00006669|Doxorubicin|doxorubicin|mesh-list
153632783|NCT00006708|Immunologic Factors|immunologic factors|mesh-ancestor
153632784|NCT00006708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153632785|NCT00006708|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153632786|NCT00006708|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153821086|NCT00436709|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153821087|NCT00436709|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153889985|NCT01263015|Efavirenz, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|efavirenz, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
153889986|NCT01263015|Dolutegravir|dolutegravir|mesh-list
153889987|NCT01263015|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153632789|NCT00006708|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153632790|NCT00006708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153367747|NCT01077596|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153367777|NCT03013790|Antioxidants|antioxidants|mesh-ancestor
153367778|NCT03013790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153367779|NCT03013790|Protective Agents|protective agents|mesh-ancestor
153367780|NCT03013790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153367781|NCT03013790|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153367782|NCT01078376|Azilsartan medoxomil|azilsartan medoxomil|mesh-list
153367783|NCT01078376|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
153367784|NCT01078376|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
153367785|NCT01078376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153632791|NCT00006708|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153632792|NCT00006708|Alkylating Agents|alkylating agents|mesh-ancestor
153632794|NCT00006747|Methotrexate|methotrexate|mesh-list
153632795|NCT00006747|Etoposide|etoposide|mesh-list
153632796|NCT00006747|Melphalan|melphalan|mesh-list
153632797|NCT00006747|Carmustine|carmustine|mesh-list
153632798|NCT00006747|Tacrolimus|tacrolimus|mesh-list
153632799|NCT00006747|Sargramostim|sargramostim|mesh-list
153632800|NCT00006747|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
153632801|NCT00006747|Abortifacient Agents|abortifacient agents|mesh-ancestor
153632802|NCT00006747|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153632837|NCT00006786|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153632838|NCT00006786|Antimetabolites|antimetabolites|mesh-ancestor
153632839|NCT00006786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153632840|NCT00006786|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153632841|NCT00006786|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153632842|NCT00006786|Immunologic Factors|immunologic factors|mesh-ancestor
153632843|NCT00006786|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
153632844|NCT00006786|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153632845|NCT00006786|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153632846|NCT00006786|Antidotes|antidotes|mesh-ancestor
153632847|NCT00006786|Protective Agents|protective agents|mesh-ancestor
153632848|NCT00006786|Vitamin B Complex|vitamin b complex|mesh-ancestor
153632849|NCT00006786|Vitamins|vitamins|mesh-ancestor
153632850|NCT00006786|Micronutrients|micronutrients|mesh-ancestor
153632851|NCT00006825|Doxorubicin|doxorubicin|mesh-list
153632852|NCT00006825|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
153632853|NCT00006825|Trastuzumab|trastuzumab|mesh-list
153632854|NCT00006825|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153632855|NCT00006825|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153632856|NCT00006825|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153632857|NCT00006825|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153632892|NCT00387556|Dermatologic Agents|dermatologic agents|mesh-ancestor
153632893|NCT00387556|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
153632894|NCT00387556|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153632895|NCT00387556|Serotonin Agents|serotonin agents|mesh-ancestor
153632896|NCT00387556|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153632897|NCT00387556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153632898|NCT03780790|Bupivacaine|bupivacaine|mesh-list
153632899|NCT03780790|Anesthetics, Local|anesthetics, local|mesh-ancestor
153632900|NCT03780790|Anesthetics|anesthetics|mesh-ancestor
153632901|NCT03780790|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153632902|NCT03780790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153367792|NCT02485184|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153368079|NCT00585195|Hormone Antagonists|hormone antagonists|mesh-ancestor
153368080|NCT00585195|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153368081|NCT00585195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153368082|NCT00585195|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
153891098|NCT01028014|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153891099|NCT01264770|Adalimumab|adalimumab|mesh-list
153891100|NCT01264770|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
153632903|NCT03780790|Sensory System Agents|sensory system agents|mesh-ancestor
153632904|NCT03780790|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153632905|NCT00388167|Caspofungin|caspofungin|mesh-list
153632906|NCT00388167|Antifungal Agents|antifungal agents|mesh-ancestor
153431033|NCT00000781|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
153431034|NCT00000781|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
153431035|NCT00000349|Flupenthixol|flupenthixol|mesh-list
153431036|NCT00000349|Flupenthixol decanoate|flupenthixol decanoate|mesh-list
153431037|NCT00000349|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153431038|NCT00000349|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153431039|NCT00000349|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153632952|NCT00006055|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153632953|NCT00006055|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153632954|NCT00006055|Antifungal Agents|antifungal agents|mesh-ancestor
153632955|NCT00006055|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153632956|NCT00006055|Dermatologic Agents|dermatologic agents|mesh-ancestor
153632957|NCT00006055|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
153632958|NCT00006055|Antiemetics|antiemetics|mesh-ancestor
153632959|NCT00006055|Autonomic Agents|autonomic agents|mesh-ancestor
153632960|NCT00006055|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153632961|NCT00006055|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153632962|NCT00006055|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
153632963|NCT00006055|Protective Agents|protective agents|mesh-ancestor
153632964|NCT00006070|Etanercept|etanercept|mesh-list
153632965|NCT00006070|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153632966|NCT00006070|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153632967|NCT00006070|Analgesics|analgesics|mesh-ancestor
153632968|NCT00006070|Sensory System Agents|sensory system agents|mesh-ancestor
153632969|NCT00006070|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153632970|NCT00006070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153632971|NCT00006070|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153632972|NCT00006070|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153632973|NCT00006070|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153632974|NCT00006070|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153632975|NCT00006070|Immunologic Factors|immunologic factors|mesh-ancestor
153632976|NCT00006079|Eflornithine|eflornithine|mesh-list
153632977|NCT00006079|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153632978|NCT00006079|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
153632979|NCT00006079|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153632980|NCT00006079|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153632981|NCT00006079|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153632982|NCT00006079|Ornithine Decarboxylase Inhibitors|ornithine decarboxylase inhibitors|mesh-ancestor
153632983|NCT00006079|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153632984|NCT00006079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153632985|NCT00006082|Rubitecan|rubitecan|mesh-list
153632986|NCT00006082|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153632989|NCT00006082|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153632990|NCT00006082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153632991|NCT00006088|Vinorelbine|vinorelbine|mesh-list
153632992|NCT00006088|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153632993|NCT00006088|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153368084|NCT00585195|Antitubercular Agents|antitubercular agents|mesh-ancestor
153368085|NCT00585195|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153368086|NCT00585195|Leprostatic Agents|leprostatic agents|mesh-ancestor
153368614|NCT05306990|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153632994|NCT00006088|Tubulin Modulators|tubulin modulators|mesh-ancestor
153632995|NCT00006088|Antimitotic Agents|antimitotic agents|mesh-ancestor
153632997|NCT00006088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153632998|NCT00006091|Arsenic Trioxide|arsenic trioxide|mesh-list
153632999|NCT00006091|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153633001|NCT00006094|Oxaliplatin|oxaliplatin|mesh-list
153633002|NCT00006094|Antimetabolites|antimetabolites|mesh-ancestor
153633003|NCT00006094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153633004|NCT00006094|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153633005|NCT00006094|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153633047|NCT00006106|Antimetabolites|antimetabolites|mesh-ancestor
153633048|NCT00006106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153633049|NCT00006106|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153633050|NCT00006106|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153633051|NCT00006106|Immunologic Factors|immunologic factors|mesh-ancestor
153633052|NCT00006106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153633053|NCT00006112|Leucovorin|leucovorin|mesh-list
153633054|NCT00006112|Fluorouracil|fluorouracil|mesh-list
153633055|NCT00006112|Mitomycins|mitomycins|mesh-list
153633056|NCT00006112|Mitomycin|mitomycin|mesh-list
153633057|NCT00006112|Calcium|calcium|mesh-list
153821089|NCT00436709|Growth Substances|growth substances|mesh-ancestor
153821090|NCT00436709|Growth Inhibitors|growth inhibitors|mesh-ancestor
153361035|NCT02155010|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153421921|NCT05256641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153421922|NCT05256641|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153368636|NCT04341207|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153368652|NCT02486211|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153368653|NCT02486211|Dopamine Agents|dopamine agents|mesh-ancestor
153368654|NCT02486211|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153368655|NCT02486211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153891141|NCT01263444|Brinzolamide|brinzolamide|mesh-list
153891142|NCT01263444|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
153891143|NCT01263444|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
153891144|NCT01263444|Adrenergic Agents|adrenergic agents|mesh-ancestor
153891145|NCT01263444|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153891146|NCT01263444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153891147|NCT01263444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153891157|NCT01031836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153891158|NCT01237587|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
153891159|NCT01237587|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
153889988|NCT01263015|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153889989|NCT01263015|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153889990|NCT01263015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153889991|NCT01263015|Antiviral Agents|antiviral agents|mesh-ancestor
153889992|NCT01263015|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153889993|NCT01263015|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153889994|NCT01263015|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153431040|NCT00000349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153633060|NCT00006112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153633061|NCT00006112|Antimetabolites|antimetabolites|mesh-ancestor
153633111|NCT00006124|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153633112|NCT00006124|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153633113|NCT00006124|Analgesics|analgesics|mesh-ancestor
153633114|NCT00006124|Sensory System Agents|sensory system agents|mesh-ancestor
153633115|NCT00006124|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153633116|NCT00006124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153633117|NCT00006124|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153633118|NCT00006124|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153633119|NCT00006124|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
153633120|NCT00006124|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153633121|NCT00006124|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153633122|NCT00006124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153633123|NCT00006127|Amifostine|amifostine|mesh-list
153633124|NCT00006127|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
153633125|NCT00006127|Protective Agents|protective agents|mesh-ancestor
153633126|NCT00006127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153633127|NCT00006133|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
153633128|NCT00006133|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
153633129|NCT00006133|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
153633130|NCT00006133|Ethinyl Estradiol|ethinyl estradiol|mesh-list
153633131|NCT00006133|Medroxyprogesterone|medroxyprogesterone|mesh-list
153633132|NCT00006133|Norethindrone|norethindrone|mesh-list
153633133|NCT00006133|Norethindrone Acetate|norethindrone acetate|mesh-list
153633134|NCT00006133|Estradiol|estradiol|mesh-list
153633135|NCT00006133|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
153633136|NCT00006133|Estrogens|estrogens|mesh-ancestor
153633137|NCT00006133|Hormones|hormones|mesh-ancestor
153633139|NCT00006133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153633156|NCT00006145|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153633158|NCT00006154|Indinavir|indinavir|mesh-list
153633159|NCT00006154|Aldesleukin|aldesleukin|mesh-list
153633160|NCT00006154|Abacavir|abacavir|mesh-list
153368656|NCT02486211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153368657|NCT02486211|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153368658|NCT02486211|Analgesics|analgesics|mesh-ancestor
153368659|NCT02486211|Sensory System Agents|sensory system agents|mesh-ancestor
153368660|NCT02486211|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153368661|NCT01167452|Trimethoprim|trimethoprim|mesh-list
153783546|NCT04546282|Osimertinib|osimertinib|mesh-list
153368662|NCT01167452|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
153368663|NCT01167452|Sulfamethoxazole|sulfamethoxazole|mesh-list
153368664|NCT01167452|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
153368665|NCT01167452|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153368666|NCT01167452|Antimalarials|antimalarials|mesh-ancestor
153368667|NCT01167452|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153368668|NCT01167452|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153368669|NCT01167452|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153368670|NCT01167452|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153633161|NCT00006154|Stavudine|stavudine|mesh-list
153633162|NCT00006154|Didanosine|didanosine|mesh-list
153633163|NCT00006154|Efavirenz|efavirenz|mesh-list
153633164|NCT00006154|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
153633165|NCT00006154|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
153633166|NCT00006154|Protease Inhibitors|protease inhibitors|mesh-ancestor
153633167|NCT00006154|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153633168|NCT00006154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153633169|NCT00006154|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153633170|NCT00006154|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153633171|NCT00006154|Antiviral Agents|antiviral agents|mesh-ancestor
153633172|NCT00006154|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153633173|NCT00006154|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
153633174|NCT00006154|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153633211|NCT00006190|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
153633212|NCT00006190|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
153633213|NCT00006190|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
153633214|NCT00006190|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
153633215|NCT00006190|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
153633216|NCT00006190|Protease Inhibitors|protease inhibitors|mesh-ancestor
153633217|NCT00006190|Antimetabolites|antimetabolites|mesh-ancestor
153633218|NCT00006196|Vitamin D|vitamin d|mesh-list
153633219|NCT00006196|Vitamins|vitamins|mesh-ancestor
153633220|NCT00006196|Micronutrients|micronutrients|mesh-ancestor
153633221|NCT00006196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153633222|NCT00006196|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153889995|NCT01263015|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
153633223|NCT00006199|Topotecan|topotecan|mesh-list
153633224|NCT00006199|Tipifarnib|tipifarnib|mesh-list
153368672|NCT01167452|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
153368673|NCT01167452|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
153368674|NCT01167452|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153368675|NCT01167452|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153368676|NCT02487225|Pentoxifylline|pentoxifylline|mesh-list
153368677|NCT02487225|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
153368678|NCT02487225|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153368679|NCT02487225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153368680|NCT02487225|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153368681|NCT02487225|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
153368682|NCT02487225|Protective Agents|protective agents|mesh-ancestor
153633225|NCT00006199|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
153633226|NCT00006199|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153633227|NCT00006199|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153633230|NCT00006205|Topiramate|topiramate|mesh-list
153633270|NCT00006211|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153633271|NCT00006211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153633272|NCT00006211|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153633273|NCT00006211|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153633274|NCT00006211|Antiviral Agents|antiviral agents|mesh-ancestor
153633275|NCT00006211|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153633276|NCT00006211|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153633277|NCT00006211|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153633279|NCT00006214|Androgen Antagonists|androgen antagonists|mesh-ancestor
153633280|NCT00006214|Hormone Antagonists|hormone antagonists|mesh-ancestor
153633281|NCT00006214|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153633282|NCT00006214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153633283|NCT00006214|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153633332|NCT00006232|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153633333|NCT00006232|Tubulin Modulators|tubulin modulators|mesh-ancestor
153633334|NCT00006232|Antimitotic Agents|antimitotic agents|mesh-ancestor
153633335|NCT00006232|Mitosis Modulators|mitosis modulators|mesh-ancestor
153633336|NCT00006235|Carboplatin|carboplatin|mesh-list
153633337|NCT00006235|Doxorubicin|doxorubicin|mesh-list
153633338|NCT00006235|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
153633339|NCT00006235|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153633340|NCT00006235|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153633341|NCT00006235|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153633342|NCT00006235|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153633343|NCT00006235|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153633344|NCT00006235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153633345|NCT00006241|Lenograstim|lenograstim|mesh-list
153633346|NCT00006241|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153633347|NCT00006241|Immunologic Factors|immunologic factors|mesh-ancestor
153633392|NCT00006265|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153633393|NCT00006265|Antiviral Agents|antiviral agents|mesh-ancestor
153633394|NCT00006265|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153633395|NCT00006265|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153633396|NCT00006265|Immunologic Factors|immunologic factors|mesh-ancestor
153633397|NCT00006265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153368693|NCT02384850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153368694|NCT02384850|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153368695|NCT02384850|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153368696|NCT02384850|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153368905|NCT01178528|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153368906|NCT01178528|Antioxidants|antioxidants|mesh-ancestor
153368907|NCT01178528|Protective Agents|protective agents|mesh-ancestor
153432204|NCT05118490|Leprostatic Agents|leprostatic agents|mesh-ancestor
153432205|NCT05118490|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153432206|NCT05118490|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153432207|NCT05118490|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
153432208|NCT05118490|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
153633398|NCT00006265|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153633399|NCT00006265|Immunotoxins|immunotoxins|mesh-ancestor
153633400|NCT00006265|Immunoconjugates|immunoconjugates|mesh-ancestor
153633401|NCT00007527|Buprenorphine|buprenorphine|mesh-list
153633402|NCT00007527|Naloxone|naloxone|mesh-list
153633403|NCT00007527|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153633404|NCT00007527|Narcotics|narcotics|mesh-ancestor
153361037|NCT02155010|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153361038|NCT02155010|Analgesics|analgesics|mesh-ancestor
153889997|NCT01263015|Antimetabolites|antimetabolites|mesh-ancestor
153889998|NCT04322175|Meloxicam|meloxicam|mesh-list
153633453|NCT00006292|Dermatologic Agents|dermatologic agents|mesh-ancestor
153633454|NCT00006292|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153633455|NCT00006292|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153633456|NCT03709888|Pregabalin|pregabalin|mesh-list
153633457|NCT03709888|Memantine|memantine|mesh-list
153633458|NCT03709888|Analgesics|analgesics|mesh-ancestor
153633459|NCT03709888|Sensory System Agents|sensory system agents|mesh-ancestor
153633460|NCT03709888|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153633461|NCT03709888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153633462|NCT03709888|Anticonvulsants|anticonvulsants|mesh-ancestor
153633463|NCT03709888|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153633464|NCT03709888|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153633465|NCT03709888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153633466|NCT03709888|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153633467|NCT03709888|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153633468|NCT03709888|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153633469|NCT03709888|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153633470|NCT03709888|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153633471|NCT03709888|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
153633506|NCT00006337|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
153633507|NCT00006337|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
153633508|NCT00006337|Dopamine Agents|dopamine agents|mesh-ancestor
153633509|NCT00006337|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153633510|NCT00006337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153633511|NCT00006337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153633512|NCT00006337|Adenosine A2 Receptor Antagonists|adenosine a2 receptor antagonists|mesh-ancestor
153633513|NCT00006337|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
153633514|NCT00006337|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
153368908|NCT01178528|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153368909|NCT01178528|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153368910|NCT01178528|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153368911|NCT01178528|Vasodilator Agents|vasodilator agents|mesh-ancestor
153368912|NCT01178528|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
153368913|NCT01178528|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
153368914|NCT02980250|Domperidone|domperidone|mesh-list
153368915|NCT02980250|Antiemetics|antiemetics|mesh-ancestor
153368941|NCT02492451|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153368942|NCT02492451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153368963|NCT01181258|Immunologic Factors|immunologic factors|mesh-ancestor
153368964|NCT01181258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153891200|NCT01030900|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153891216|NCT01030900|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153633515|NCT00006337|Purinergic Agents|purinergic agents|mesh-ancestor
153633516|NCT00006340|Ganciclovir|ganciclovir|mesh-list
153633517|NCT00006340|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
153633518|NCT00006340|Arginine butyrate|arginine butyrate|mesh-list
153361039|NCT02155010|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
153361040|NCT02155010|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153361041|NCT02155010|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153361042|NCT02155010|Adrenergic Agents|adrenergic agents|mesh-ancestor
153361043|NCT02155010|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153821092|NCT00436709|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153821093|NCT00436709|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153821094|NCT00436709|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153821095|NCT00436787|PENTA|penta|mesh-list
153821096|NCT00436787|Fondaparinux|fondaparinux|mesh-list
153821097|NCT00436787|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
153821098|NCT00436787|Antithrombins|antithrombins|mesh-ancestor
153821099|NCT00436787|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
153821100|NCT00436787|Protease Inhibitors|protease inhibitors|mesh-ancestor
153633569|NCT00006349|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153633570|NCT00006349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153633571|NCT00006349|Cholinergic Agents|cholinergic agents|mesh-ancestor
153633572|NCT00006349|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153633573|NCT00006349|Nootropic Agents|nootropic agents|mesh-ancestor
153633574|NCT00006349|Antioxidants|antioxidants|mesh-ancestor
153633575|NCT00006349|Protective Agents|protective agents|mesh-ancestor
153633576|NCT00006352|Antibodies|antibodies|mesh-list
153633577|NCT00006352|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
153633578|NCT00006352|BCG Vaccine|bcg vaccine|mesh-list
153633579|NCT00006352|Immunologic Factors|immunologic factors|mesh-ancestor
153633580|NCT00006352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153633581|NCT00006352|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153633582|NCT00007878|Leucovorin|leucovorin|mesh-list
153633583|NCT00007878|Fluorouracil|fluorouracil|mesh-list
153633584|NCT00007878|Bortezomib|bortezomib|mesh-list
153633585|NCT00007878|Calcium|calcium|mesh-list
153633586|NCT00007878|Levoleucovorin|levoleucovorin|mesh-list
153633587|NCT00007878|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153633588|NCT00007878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153633589|NCT00007878|Antimetabolites|antimetabolites|mesh-ancestor
153633590|NCT00007878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153633591|NCT00007878|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153368966|NCT01181258|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153368967|NCT01181258|Alkylating Agents|alkylating agents|mesh-ancestor
153368968|NCT01181258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153369183|NCT02407704|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153369184|NCT02407704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153369185|NCT02407704|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153369491|NCT01159262|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153369492|NCT01159262|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153891221|NCT01030822|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
153369493|NCT01159262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153633617|NCT00006358|Growth Inhibitors|growth inhibitors|mesh-ancestor
153633618|NCT00006361|Semaxinib|semaxinib|mesh-list
153633619|NCT00006361|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153633620|NCT00006361|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153633621|NCT00006361|Growth Substances|growth substances|mesh-ancestor
153633622|NCT00006361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153633623|NCT00006361|Growth Inhibitors|growth inhibitors|mesh-ancestor
153633624|NCT00006361|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153633625|NCT00006361|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153633626|NCT00006361|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153633627|NCT00006361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153633628|NCT00006364|Homoharringtonine|homoharringtonine|mesh-list
153890004|NCT04322175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153633629|NCT00006364|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153633631|NCT00006364|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
153633632|NCT00006364|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153633633|NCT00006364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153633634|NCT00007917|Gemcitabine|gemcitabine|mesh-list
153633635|NCT00007917|Alvocidib|alvocidib|mesh-list
153633636|NCT00007917|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153633637|NCT00007917|Antimetabolites|antimetabolites|mesh-ancestor
153633638|NCT00007917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153633639|NCT00007917|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153633666|NCT00006370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153633667|NCT00007956|Antibodies|antibodies|mesh-list
153633668|NCT00007956|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
153633669|NCT00007956|Immunologic Factors|immunologic factors|mesh-ancestor
153633670|NCT00007956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153633671|NCT00006373|Etoposide|etoposide|mesh-list
153633672|NCT00006373|Topotecan|topotecan|mesh-list
153633673|NCT00006373|Ifosfamide|ifosfamide|mesh-list
153633674|NCT00006373|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153633675|NCT00006373|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153633676|NCT00006373|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153633677|NCT00006373|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153633678|NCT00006373|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153633679|NCT00006373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153633680|NCT00006373|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
153633681|NCT00006373|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153633682|NCT00006373|Alkylating Agents|alkylating agents|mesh-ancestor
153633683|NCT00006376|Tipifarnib|tipifarnib|mesh-list
153633684|NCT00006376|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153633685|NCT00006379|Cyclophosphamide|cyclophosphamide|mesh-list
153369494|NCT01159262|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153369495|NCT01159262|Analgesics|analgesics|mesh-ancestor
153369496|NCT01159262|Sensory System Agents|sensory system agents|mesh-ancestor
153369497|NCT01159262|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153369498|NCT01159262|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
153369499|NCT01159262|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153369500|NCT01159262|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153369501|NCT01159262|Adrenergic Agents|adrenergic agents|mesh-ancestor
153369502|NCT01159262|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153432280|NCT05087914|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153633686|NCT00006379|Fludarabine|fludarabine|mesh-list
153633687|NCT00006379|Fludarabine phosphate|fludarabine phosphate|mesh-list
153633688|NCT00006379|Antilymphocyte Serum|antilymphocyte serum|mesh-list
153633689|NCT00006379|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153633690|NCT00006379|Immunologic Factors|immunologic factors|mesh-ancestor
153633691|NCT00006379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153633692|NCT00006379|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153633693|NCT00006379|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153633694|NCT00006379|Alkylating Agents|alkylating agents|mesh-ancestor
153633712|NCT00007995|Cyclophosphamide|cyclophosphamide|mesh-list
153633713|NCT00007995|Melphalan|melphalan|mesh-list
153633714|NCT00007995|Busulfan|busulfan|mesh-list
153633715|NCT00007995|Sargramostim|sargramostim|mesh-list
153361044|NCT02155010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153361045|NCT01495481|Adenosine|adenosine|mesh-list
153633718|NCT00007995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153633719|NCT00007995|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153633720|NCT00007995|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153633721|NCT00007995|Alkylating Agents|alkylating agents|mesh-ancestor
153633722|NCT00007995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153633723|NCT00007995|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153633724|NCT00007995|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153633725|NCT00007995|Antiviral Agents|antiviral agents|mesh-ancestor
153633726|NCT00007995|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153633728|NCT00006388|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
153633729|NCT00006388|Hormone Antagonists|hormone antagonists|mesh-ancestor
153633730|NCT00006388|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153633731|NCT00006388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153633732|NCT00006388|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153633733|NCT00006388|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153633734|NCT00006388|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
153633763|NCT00006394|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153633765|NCT00008073|Doxorubicin|doxorubicin|mesh-list
153633766|NCT00008073|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
153633767|NCT00008073|Octreotide|octreotide|mesh-list
153633768|NCT00008073|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153633769|NCT00008073|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153633770|NCT00008073|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153633771|NCT00008073|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153633772|NCT00008073|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153633773|NCT00008073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153633774|NCT00008073|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153633775|NCT00008073|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153633776|NCT00006397|Ritonavir|ritonavir|mesh-list
153633777|NCT00006397|Indinavir|indinavir|mesh-list
153633778|NCT00006397|Stavudine|stavudine|mesh-list
153633779|NCT00006397|Didanosine|didanosine|mesh-list
153633780|NCT00006397|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
153633781|NCT00006397|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
153633782|NCT00006397|Protease Inhibitors|protease inhibitors|mesh-ancestor
153633783|NCT00006397|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153890005|NCT04322175|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153890006|NCT04322175|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153890007|NCT04322175|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
153633784|NCT00006397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153633785|NCT00006397|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153633786|NCT00006397|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153633787|NCT00006397|Antiviral Agents|antiviral agents|mesh-ancestor
153633788|NCT00006397|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153633789|NCT00006397|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
153633790|NCT00006397|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153369543|NCT03413384|Third Generation Cephalosporins|third generation cephalosporins|mesh-ancestor
153369544|NCT03413384|Beta Lactam Antibiotics|beta lactam antibiotics|mesh-ancestor
153369545|NCT03413384|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153633791|NCT00006397|Antimetabolites|antimetabolites|mesh-ancestor
153633792|NCT00006397|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153633806|NCT00006427|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
153633807|NCT00006427|Antidepressive Agents|antidepressive agents|mesh-ancestor
153633808|NCT00006427|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153633809|NCT00006427|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153633811|NCT00006427|Sensory System Agents|sensory system agents|mesh-ancestor
153633812|NCT00006427|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153633813|NCT00006427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153633814|NCT00006427|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
153633815|NCT00006427|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153633816|NCT00006427|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153633817|NCT00006427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153633818|NCT00006427|Adrenergic Agents|adrenergic agents|mesh-ancestor
153633819|NCT00006427|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153633867|NCT00008190|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153633868|NCT00008190|Immunologic Factors|immunologic factors|mesh-ancestor
153633869|NCT00008190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153633870|NCT00008190|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153633871|NCT00008190|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153633872|NCT00008190|Alkylating Agents|alkylating agents|mesh-ancestor
153633873|NCT00008190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153633874|NCT00008190|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153633875|NCT00008190|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153633876|NCT00008190|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153633877|NCT00008190|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153633878|NCT00008190|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153633879|NCT00008190|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153633880|NCT00008190|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153633881|NCT00008190|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153633882|NCT00008190|Antiviral Agents|antiviral agents|mesh-ancestor
153633883|NCT00008190|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153633884|NCT00006451|Cyclosporine|cyclosporine|mesh-list
153633885|NCT00006451|Methylprednisolone|methylprednisolone|mesh-list
153633886|NCT00006451|Cyclophosphamide|cyclophosphamide|mesh-list
153821101|NCT00436787|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153821102|NCT00436787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153890008|NCT04322175|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153633888|NCT00006451|Cyclosporins|cyclosporins|mesh-list
153633889|NCT00006451|Antilymphocyte Serum|antilymphocyte serum|mesh-list
153633890|NCT00006451|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153633891|NCT00006451|Immunologic Factors|immunologic factors|mesh-ancestor
153633892|NCT00006451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153633916|NCT00006451|Glucocorticoids|glucocorticoids|mesh-ancestor
153369762|NCT05693675|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153369763|NCT05693675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153369764|NCT05693675|Analgesics|analgesics|mesh-ancestor
153369765|NCT05693675|Sensory System Agents|sensory system agents|mesh-ancestor
153369766|NCT05693675|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153369767|NCT05693675|Antitussive Agents|antitussive agents|mesh-ancestor
153369771|NCT05655273|Immunologic Factors|immunologic factors|mesh-ancestor
153369772|NCT05655273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153369843|NCT05467761|Psilocybin|psilocybin|mesh-list
153633917|NCT00006451|Hormones|hormones|mesh-ancestor
153633918|NCT00006451|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153633919|NCT00006451|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
153633920|NCT00006451|Protective Agents|protective agents|mesh-ancestor
153633921|NCT00006454|Paclitaxel|paclitaxel|mesh-list
153633922|NCT00006454|Carboplatin|carboplatin|mesh-list
153633923|NCT00006454|Topotecan|topotecan|mesh-list
153633924|NCT00006454|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153633925|NCT00006454|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153633926|NCT00006454|Tubulin Modulators|tubulin modulators|mesh-ancestor
153633927|NCT00006454|Antimitotic Agents|antimitotic agents|mesh-ancestor
153633928|NCT00006454|Mitosis Modulators|mitosis modulators|mesh-ancestor
153633929|NCT00006454|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153633930|NCT00006454|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
153633931|NCT00006454|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153633932|NCT00006454|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153633933|NCT00008229|Melphalan|melphalan|mesh-list
153633934|NCT00008229|Immunologic Factors|immunologic factors|mesh-ancestor
153633935|NCT00008229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153633936|NCT00008229|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153633937|NCT00008229|Alkylating Agents|alkylating agents|mesh-ancestor
153633938|NCT00008229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153633939|NCT00008229|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153633940|NCT00008229|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153633941|NCT00008229|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153633942|NCT00006457|Oltipraz|oltipraz|mesh-list
153633962|NCT00008268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153633964|NCT00008268|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153633965|NCT00008268|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153633966|NCT00006463|Trabectedin|trabectedin|mesh-list
153633967|NCT00006463|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153633968|NCT00006463|Alkylating Agents|alkylating agents|mesh-ancestor
153634030|NCT00006472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153634031|NCT00006475|Imatinib Mesylate|imatinib mesylate|mesh-list
153634032|NCT00006475|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153634033|NCT00006475|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153634034|NCT00006475|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153634035|NCT00006475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153634036|NCT00006475|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153634037|NCT00006481|Biafine|biafine|mesh-list
153634038|NCT00006481|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
153370105|NCT03505710|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153370106|NCT03505710|Immunoconjugates|immunoconjugates|mesh-ancestor
153370107|NCT03505710|Immunologic Factors|immunologic factors|mesh-ancestor
153370108|NCT03505710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153370109|NCT03435458|Misoprostol|misoprostol|mesh-list
153370342|NCT01348919|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153370344|NCT01348919|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153370345|NCT01348919|Immunologic Factors|immunologic factors|mesh-ancestor
153370346|NCT01348919|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153783547|NCT04546282|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153370347|NCT01348919|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153370348|NCT01348919|Growth Substances|growth substances|mesh-ancestor
153370349|NCT01348919|Growth Inhibitors|growth inhibitors|mesh-ancestor
153370350|NCT01348919|Proteasome Inhibitors|proteasome inhibitors|mesh-ancestor
153891396|NCT06054100|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153634039|NCT00006481|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
153634040|NCT00006481|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
153634041|NCT00008424|Irinotecan|irinotecan|mesh-list
153634042|NCT00008424|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
153634092|NCT00006760|Vinorelbine|vinorelbine|mesh-list
153634093|NCT00006760|Ifosfamide|ifosfamide|mesh-list
153634094|NCT00006760|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153634095|NCT00006760|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153634096|NCT00006760|Tubulin Modulators|tubulin modulators|mesh-ancestor
153634097|NCT00006760|Antimitotic Agents|antimitotic agents|mesh-ancestor
153634098|NCT00006760|Mitosis Modulators|mitosis modulators|mesh-ancestor
153634099|NCT00006760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153634100|NCT00006760|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153634101|NCT00006760|Alkylating Agents|alkylating agents|mesh-ancestor
153634156|NCT00007189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153634157|NCT00007189|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153634158|NCT00007189|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153634159|NCT00007189|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
153634160|NCT00007189|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153634161|NCT00007189|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153634162|NCT00007189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153634163|NCT00007189|Gout Suppressants|gout suppressants|mesh-ancestor
153634164|NCT00388219|Buprenorphine|buprenorphine|mesh-list
153634165|NCT00388219|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153634166|NCT00388219|Narcotics|narcotics|mesh-ancestor
153634169|NCT00388219|Analgesics|analgesics|mesh-ancestor
153634220|NCT00007813|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153634221|NCT00007813|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153634222|NCT00007813|Alkylating Agents|alkylating agents|mesh-ancestor
153634223|NCT00007813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153634224|NCT00007813|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153821103|NCT00436787|Anticoagulants|anticoagulants|mesh-ancestor
153361046|NCT01495481|Dexmedetomidine|dexmedetomidine|mesh-list
153361047|NCT01495481|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153361048|NCT01495481|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153890011|NCT04321785|Caffeine|caffeine|mesh-list
153431049|NCT00000805|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153634226|NCT00007813|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153634288|NCT00008047|Antimetabolites|antimetabolites|mesh-ancestor
153634289|NCT00008047|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153634290|NCT00008047|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153634291|NCT00008047|Immunologic Factors|immunologic factors|mesh-ancestor
153634292|NCT00008047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153634293|NCT00008047|Antisickling Agents|antisickling agents|mesh-ancestor
153634294|NCT00008047|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153634295|NCT00008047|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153634357|NCT00008242|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153634358|NCT00008242|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153634359|NCT00008242|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153634360|NCT00008242|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153634361|NCT00008242|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153634362|NCT00008242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153634363|NCT00008242|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153634364|NCT00008242|Immunologic Factors|immunologic factors|mesh-ancestor
153634365|NCT00008242|Leprostatic Agents|leprostatic agents|mesh-ancestor
153634366|NCT00008242|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153634367|NCT00008242|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153370354|NCT01333046|Azacitidine|azacitidine|mesh-list
153634368|NCT00008242|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153634369|NCT00008242|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153634370|NCT00008242|Growth Substances|growth substances|mesh-ancestor
153634371|NCT00008242|Growth Inhibitors|growth inhibitors|mesh-ancestor
153634373|NCT00008281|Fluorouracil|fluorouracil|mesh-list
153634374|NCT00008281|Oxaliplatin|oxaliplatin|mesh-list
153634376|NCT00008281|Levoleucovorin|levoleucovorin|mesh-list
153634377|NCT00008281|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153361049|NCT01495481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153361050|NCT01495481|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153361051|NCT01495481|Analgesics|analgesics|mesh-ancestor
153361052|NCT01495481|Sensory System Agents|sensory system agents|mesh-ancestor
153361053|NCT01495481|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153634378|NCT00008281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153634379|NCT00008281|Antimetabolites|antimetabolites|mesh-ancestor
153634410|NCT00008515|Fluocinolone Acetonide|fluocinolone acetonide|mesh-list
153634411|NCT00008515|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153634413|NCT00008515|Hormones|hormones|mesh-ancestor
153634414|NCT00008515|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153634415|NCT00008515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153634416|NCT00008554|Lamivudine|lamivudine|mesh-list
153634417|NCT00008554|Abacavir|abacavir|mesh-list
153634418|NCT00008554|Nelfinavir|nelfinavir|mesh-list
153634419|NCT00008554|Fosamprenavir|fosamprenavir|mesh-list
153634420|NCT00008554|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153634421|NCT00008554|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153634422|NCT00008554|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153634423|NCT00008554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153634424|NCT00008554|Antiviral Agents|antiviral agents|mesh-ancestor
153634425|NCT00008554|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153634426|NCT00008554|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153634427|NCT00008554|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153634428|NCT00008554|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
153634429|NCT00008554|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
153634430|NCT00008554|Protease Inhibitors|protease inhibitors|mesh-ancestor
153634431|NCT05636566|Dexmedetomidine|dexmedetomidine|mesh-list
153634432|NCT05636566|Propofol|propofol|mesh-list
153634433|NCT05636566|Sevoflurane|sevoflurane|mesh-list
153634434|NCT05636566|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153634435|NCT05636566|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153634436|NCT05636566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153370392|NCT02431806|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153370436|NCT01284296|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153634437|NCT05636566|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153634455|NCT05637073|Dienogest|dienogest|mesh-list
153634457|NCT05637073|Contraceptive Agents|contraceptive agents|mesh-ancestor
153634458|NCT05637073|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153634459|NCT05637073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153431056|NCT00000355|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153431057|NCT00000355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153431058|NCT00000355|Analgesics|analgesics|mesh-ancestor
153890013|NCT04321785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153890014|NCT04321785|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
153890015|NCT04321785|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153890016|NCT04321785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153890017|NCT04321785|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
153890018|NCT04321785|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
153890019|NCT04321785|Purinergic Agents|purinergic agents|mesh-ancestor
153890020|NCT04321785|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153890021|NCT01305408|Modafinil|modafinil|mesh-list
153431059|NCT00000355|Sensory System Agents|sensory system agents|mesh-ancestor
153634463|NCT05637073|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
153634464|NCT05637073|Hormone Antagonists|hormone antagonists|mesh-ancestor
153634465|NCT05637073|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153634466|NCT05637073|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153634467|NCT05637073|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153634469|NCT05637268|Cisplatin|cisplatin|mesh-list
153634470|NCT05637268|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153634476|NCT05638984|Decitabine|decitabine|mesh-list
153634515|NCT00000139|Antiviral Agents|antiviral agents|mesh-ancestor
153634516|NCT00000139|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153634517|NCT00388687|Fluoroazomycin arabinoside|fluoroazomycin arabinoside|mesh-list
153634518|NCT00388687|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
153634519|NCT00388687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153634520|NCT00000142|Cidofovir|cidofovir|mesh-list
153634521|NCT00000142|Antiviral Agents|antiviral agents|mesh-ancestor
153634522|NCT00000142|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153634523|NCT00000142|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153634524|NCT00000142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153634526|NCT00000145|Antioxidants|antioxidants|mesh-list
153634527|NCT00000145|Trace Elements|trace elements|mesh-ancestor
153634528|NCT00000145|Micronutrients|micronutrients|mesh-ancestor
153634529|NCT00000145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153370561|NCT00365001|Dermatologic Agents|dermatologic agents|mesh-ancestor
153370562|NCT00365001|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153370563|NCT00365001|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153370564|NCT00365001|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153370565|NCT00365001|Immunologic Factors|immunologic factors|mesh-ancestor
153370566|NCT00365001|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153370567|NCT00365001|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153370568|NCT00365001|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153370599|NCT01714739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153370600|NCT01714739|Immunologic Factors|immunologic factors|mesh-ancestor
153421931|NCT05124691|Ivermectin|ivermectin|mesh-list
153370678|NCT00003407|Antiviral Agents|antiviral agents|mesh-ancestor
153370679|NCT00003407|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153432558|NCT04560166|Alkylating Agents|alkylating agents|mesh-ancestor
153432559|NCT04538742|Paclitaxel|paclitaxel|mesh-list
153432560|NCT04538742|Trastuzumab|trastuzumab|mesh-list
153634531|NCT00000145|Protective Agents|protective agents|mesh-ancestor
153634572|NCT00000172|Autonomic Agents|autonomic agents|mesh-ancestor
153634573|NCT00000172|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153634574|NCT00000172|Nootropic Agents|nootropic agents|mesh-ancestor
153821110|NCT00481728|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153821111|NCT00481728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153821112|NCT00481728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153634639|NCT00000421|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153634640|NCT00000421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153634641|NCT00000421|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153634642|NCT00000421|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153634643|NCT00000427|Alendronate|alendronate|mesh-list
153890026|NCT01305408|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
153431062|NCT04022785|Azacitidine|azacitidine|mesh-list
153634647|NCT00000427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153634648|NCT00000427|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153634649|NCT00000427|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153634651|NCT00000457|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
153634652|NCT00000457|Antidepressive Agents|antidepressive agents|mesh-ancestor
153634653|NCT00000457|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153634654|NCT00000457|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
153634655|NCT00000457|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153634656|NCT00000457|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153634657|NCT00000457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153634658|NCT00000457|Dopamine Agents|dopamine agents|mesh-ancestor
153634659|NCT00000457|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153634682|NCT00000466|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
153634683|NCT00000466|Estrogens|estrogens|mesh-list
153634684|NCT00000466|Progestins|progestins|mesh-ancestor
153634685|NCT00000466|Hormones|hormones|mesh-ancestor
153634686|NCT00000466|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153634687|NCT00000466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153634688|NCT00000466|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
153634689|NCT00000466|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
153634690|NCT00000466|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
153634691|NCT00000466|Contraceptive Agents|contraceptive agents|mesh-ancestor
153634692|NCT00000466|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153634693|NCT00000466|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
153634694|NCT00000466|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
153634695|NCT00000466|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
153634696|NCT00000466|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153634697|NCT00000466|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153634698|NCT00000472|Heparin|heparin|mesh-list
153634699|NCT00000472|Plasminogen|plasminogen|mesh-list
153634700|NCT00000472|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
153634701|NCT00000472|Anticoagulants|anticoagulants|mesh-ancestor
153634702|NCT00000472|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153634703|NCT00000472|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153634704|NCT00000472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153634705|NCT00000478|Atenolol|atenolol|mesh-list
153634706|NCT00000478|Diltiazem|diltiazem|mesh-list
153370680|NCT00003407|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153370681|NCT00003407|Immunologic Factors|immunologic factors|mesh-ancestor
153370682|NCT00003407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153432599|NCT04180215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153432600|NCT04103034|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
153634707|NCT00000478|Nifedipine|nifedipine|mesh-list
153634708|NCT00000478|Isosorbide|isosorbide|mesh-list
153634709|NCT00000478|Isosorbide Dinitrate|isosorbide dinitrate|mesh-list
153634710|NCT00000478|Isosorbide-5-mononitrate|isosorbide-5-mononitrate|mesh-list
153634711|NCT00000478|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153634712|NCT00000478|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153634722|NCT00000478|Autonomic Agents|autonomic agents|mesh-ancestor
153361054|NCT01495481|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
153634723|NCT00000478|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153634724|NCT00000478|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
153634725|NCT00000478|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
153634726|NCT00000478|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
153634727|NCT00000478|Adrenergic Agents|adrenergic agents|mesh-ancestor
153634728|NCT00000478|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153634729|NCT00000478|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
153634730|NCT00000478|Diuretics|diuretics|mesh-ancestor
153634731|NCT00000478|Natriuretic Agents|natriuretic agents|mesh-ancestor
153634732|NCT00000478|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
153634733|NCT00388999|Lectins|lectins|mesh-list
153634734|NCT00388999|Agglutinins|agglutinins|mesh-ancestor
153634735|NCT00388999|Immunologic Factors|immunologic factors|mesh-ancestor
153634736|NCT00388999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153634737|NCT00388999|Coagulants|coagulants|mesh-ancestor
153634738|NCT00000487|Antihypertensive Agents|antihypertensive agents|mesh-list
153634739|NCT00000487|Diuretics|diuretics|mesh-list
153634740|NCT00000487|Natriuretic Agents|natriuretic agents|mesh-ancestor
153634741|NCT00000487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153634742|NCT00000493|Propranolol|propranolol|mesh-list
153634743|NCT00000493|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
153634744|NCT00000493|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
153634745|NCT00000493|Adrenergic Agents|adrenergic agents|mesh-ancestor
153634746|NCT00000493|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153634747|NCT00000493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153634772|NCT00000499|Vasodilator Agents|vasodilator agents|mesh-ancestor
153634773|NCT00000499|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153634774|NCT00000499|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153634775|NCT00000499|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153634776|NCT00000499|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153890028|NCT01261611|Botulinum Toxins|botulinum toxins|mesh-list
153634777|NCT00000499|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
153634778|NCT00000499|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153634779|NCT00000514|Atenolol|atenolol|mesh-list
153634780|NCT00000514|Chlorthalidone|chlorthalidone|mesh-list
153634781|NCT00000514|Reserpine|reserpine|mesh-list
153634782|NCT00000514|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153634783|NCT00000514|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153634784|NCT00000514|Sympatholytics|sympatholytics|mesh-ancestor
153634785|NCT00000514|Autonomic Agents|autonomic agents|mesh-ancestor
153634786|NCT00000514|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153634787|NCT00000514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153634788|NCT00000514|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
153634789|NCT00000514|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
153634790|NCT00000514|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
153634791|NCT00000514|Adrenergic Agents|adrenergic agents|mesh-ancestor
153634792|NCT00000514|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153634793|NCT00000514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153634794|NCT00000514|Diuretics|diuretics|mesh-ancestor
153634795|NCT00000514|Natriuretic Agents|natriuretic agents|mesh-ancestor
153634796|NCT00000514|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
153634797|NCT00000514|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153634798|NCT00000514|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153634799|NCT00000514|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153634800|NCT00000514|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153634801|NCT00000514|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153634802|NCT00000514|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
153634815|NCT00000520|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
153634816|NCT00000520|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153634817|NCT00000520|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153634818|NCT00000520|Analgesics|analgesics|mesh-ancestor
153634819|NCT00000520|Sensory System Agents|sensory system agents|mesh-ancestor
153634820|NCT00000520|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153634821|NCT00000520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153634822|NCT00000520|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153634823|NCT00000520|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153634824|NCT00000520|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153634825|NCT00000520|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153634826|NCT00000520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153634827|NCT00000520|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153634828|NCT00000520|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153634829|NCT00000520|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153634830|NCT00000520|Antipyretics|antipyretics|mesh-ancestor
153634831|NCT00000520|Immunologic Factors|immunologic factors|mesh-ancestor
153634873|NCT00000556|Procainamide|procainamide|mesh-list
153634874|NCT00000556|Moricizine|moricizine|mesh-list
153634875|NCT00000556|Disopyramide|disopyramide|mesh-list
153634876|NCT00000556|Diltiazem|diltiazem|mesh-list
153634877|NCT00000556|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
153634878|NCT00000556|Adrenergic Agents|adrenergic agents|mesh-list
153821115|NCT00436943|Nicotine|nicotine|mesh-list
153821116|NCT00436943|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
153361057|NCT01495481|Adrenergic Agents|adrenergic agents|mesh-ancestor
153361058|NCT01495481|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153634946|NCT00000595|Siderophores|siderophores|mesh-ancestor
153634947|NCT00000595|Iron Chelating Agents|iron chelating agents|mesh-ancestor
153634948|NCT00000595|Chelating Agents|chelating agents|mesh-ancestor
153634949|NCT00000595|Sequestering Agents|sequestering agents|mesh-ancestor
153634950|NCT00000595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153634951|NCT00000601|Hormones|hormones|mesh-list
153634952|NCT00000601|Progesterone|progesterone|mesh-list
153634953|NCT00000601|Estrogens|estrogens|mesh-list
153635005|NCT00000646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153635006|NCT00000646|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153635007|NCT00000646|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
153635008|NCT00000646|Protective Agents|protective agents|mesh-ancestor
153635009|NCT00000646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153635010|NCT00000646|Vasodilator Agents|vasodilator agents|mesh-ancestor
153635011|NCT00000646|Free Radical Scavengers|free radical scavengers|mesh-ancestor
153635012|NCT00000646|Antioxidants|antioxidants|mesh-ancestor
153635013|NCT00389038|Amitriptyline|amitriptyline|mesh-list
153635028|NCT00000652|Zidovudine|zidovudine|mesh-list
153421949|NCT05095571|Niacin|niacin|mesh-list
153635066|NCT00000679|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153635067|NCT00000682|Zidovudine|zidovudine|mesh-list
153635068|NCT00000682|Zalcitabine|zalcitabine|mesh-list
153635069|NCT00000682|Antimetabolites|antimetabolites|mesh-ancestor
153635070|NCT00000682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153635071|NCT00000682|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153635072|NCT00000682|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153890031|NCT01261611|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
153635073|NCT00000682|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153635074|NCT00000682|Antiviral Agents|antiviral agents|mesh-ancestor
153635075|NCT00000682|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153635076|NCT00000682|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153635077|NCT00000682|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153635079|NCT00000688|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
153635129|NCT00000739|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153635130|NCT00000739|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153635131|NCT00000739|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153635132|NCT00000739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153635133|NCT00000739|Leprostatic Agents|leprostatic agents|mesh-ancestor
153635134|NCT00000739|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153635136|NCT00000742|Didanosine|didanosine|mesh-list
153635137|NCT00000742|Atevirdine|atevirdine|mesh-list
153635138|NCT00000742|Antimetabolites|antimetabolites|mesh-ancestor
153635139|NCT00000742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153635140|NCT00000742|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153635141|NCT00000742|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153635190|NCT00000754|Antimetabolites|antimetabolites|mesh-ancestor
153635191|NCT00000754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153635192|NCT00000754|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153635193|NCT00000754|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153635194|NCT00000754|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153635195|NCT00000754|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153635196|NCT00000754|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153635198|NCT00000760|Didanosine|didanosine|mesh-list
153635199|NCT00000760|Antimetabolites|antimetabolites|mesh-ancestor
153635200|NCT00000760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153635201|NCT00000760|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153635202|NCT00000760|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153635203|NCT00000760|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153635204|NCT00000760|Antiviral Agents|antiviral agents|mesh-ancestor
153635206|NCT00000760|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153821117|NCT00436943|Autonomic Agents|autonomic agents|mesh-ancestor
153821118|NCT00436943|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153635259|NCT00000817|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
153635261|NCT00000817|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153635262|NCT00000817|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153635263|NCT00000817|Analgesics|analgesics|mesh-ancestor
153635264|NCT00000817|Sensory System Agents|sensory system agents|mesh-ancestor
153635265|NCT00000817|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153635266|NCT00000817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153635307|NCT00000826|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
153635308|NCT00000826|Leprostatic Agents|leprostatic agents|mesh-ancestor
153635309|NCT00000826|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
153635310|NCT00000826|Antitubercular Agents|antitubercular agents|mesh-ancestor
153635311|NCT00000859|Ritonavir|ritonavir|mesh-list
153371202|NCT02613897|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
153371203|NCT02613897|Protease Inhibitors|protease inhibitors|mesh-ancestor
153371204|NCT02613897|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153891664|NCT05592951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153891666|NCT05592951|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
153891667|NCT05592951|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153891668|NCT05592951|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153891671|NCT05579119|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153635312|NCT00000859|Nelfinavir|nelfinavir|mesh-list
153635313|NCT00000859|Indinavir|indinavir|mesh-list
153635314|NCT00000859|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
153635315|NCT00000859|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
153635316|NCT00000859|Protease Inhibitors|protease inhibitors|mesh-ancestor
153635317|NCT00000859|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153635318|NCT00000859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153635319|NCT00000859|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153635320|NCT00000859|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153635321|NCT00000859|Antiviral Agents|antiviral agents|mesh-ancestor
153635322|NCT00000859|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153821119|NCT00436943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153821120|NCT00436943|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
153821121|NCT00436943|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
153821122|NCT00436943|Cholinergic Agents|cholinergic agents|mesh-ancestor
153821123|NCT00436943|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153821124|NCT00436943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153914599|NCT02709187|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153361066|NCT01379183|Erythromycin Estolate|erythromycin estolate|mesh-list
153361067|NCT01379183|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
153361068|NCT01379183|Erythromycin stearate|erythromycin stearate|mesh-list
153361069|NCT01379183|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153361070|NCT01379183|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153635325|NCT00000877|Indinavir|indinavir|mesh-list
153635326|NCT00000877|Rifabutin|rifabutin|mesh-list
153635327|NCT00000877|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
153635360|NCT00000892|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153635362|NCT00000895|Nevirapine|nevirapine|mesh-list
153635363|NCT00000895|Nelfinavir|nelfinavir|mesh-list
153635364|NCT00000895|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153635365|NCT00000895|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153635366|NCT00000895|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153635367|NCT00000895|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153635368|NCT00000895|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153635369|NCT00000895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153635370|NCT00000895|Antiviral Agents|antiviral agents|mesh-ancestor
153635371|NCT00000895|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153635372|NCT00000895|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153635373|NCT00000895|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
153635374|NCT00000895|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
153635375|NCT00000895|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
153635376|NCT00000895|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
153635377|NCT00000895|Protease Inhibitors|protease inhibitors|mesh-ancestor
153635378|NCT00000898|Ritonavir|ritonavir|mesh-list
153635379|NCT00000898|Nelfinavir|nelfinavir|mesh-list
153635380|NCT00000898|Saquinavir|saquinavir|mesh-list
153635381|NCT00000898|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
153635382|NCT00000898|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
153635383|NCT00000898|Protease Inhibitors|protease inhibitors|mesh-ancestor
153635384|NCT00000898|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153635385|NCT00000898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153635386|NCT00000898|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153371307|NCT01246076|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153371308|NCT01246076|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153371309|NCT01246076|Growth Substances|growth substances|mesh-ancestor
153371310|NCT01246076|Growth Inhibitors|growth inhibitors|mesh-ancestor
153371311|NCT01246076|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153371312|NCT00364455|Epoetin Alfa|epoetin alfa|mesh-list
153371374|NCT04425239|Levoleucovorin|levoleucovorin|mesh-list
153635387|NCT00000898|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153635388|NCT00000898|Antiviral Agents|antiviral agents|mesh-ancestor
153635406|NCT00000904|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153635407|NCT00000904|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153635408|NCT00000904|Antiviral Agents|antiviral agents|mesh-ancestor
153635409|NCT00000904|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153635410|NCT00000904|Interferon Inducers|interferon inducers|mesh-ancestor
153361084|NCT00862784|Folic Acid|folic acid|mesh-list
153361085|NCT00862784|Oxaliplatin|oxaliplatin|mesh-list
153361086|NCT00862784|Fluorouracil|fluorouracil|mesh-list
153361087|NCT00862784|Ramucirumab|ramucirumab|mesh-list
153361088|NCT00862784|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
153361089|NCT00862784|Levoleucovorin|levoleucovorin|mesh-list
153361090|NCT00862784|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153361091|NCT00862784|Antimetabolites|antimetabolites|mesh-ancestor
153361092|NCT00862784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153361093|NCT00862784|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153635412|NCT00000904|Protective Agents|protective agents|mesh-ancestor
153635413|NCT00000919|Ritonavir|ritonavir|mesh-list
153635414|NCT00000919|Nelfinavir|nelfinavir|mesh-list
153635415|NCT00000919|Indinavir|indinavir|mesh-list
153635416|NCT00000919|Amprenavir|amprenavir|mesh-list
153635417|NCT00000919|Lamivudine|lamivudine|mesh-list
153635418|NCT00000919|Zidovudine|zidovudine|mesh-list
153635419|NCT00000919|Abacavir|abacavir|mesh-list
153635420|NCT00000919|Stavudine|stavudine|mesh-list
153635421|NCT00000919|Didanosine|didanosine|mesh-list
153635422|NCT00000919|Lamivudine, zidovudine drug combination|lamivudine, zidovudine drug combination|mesh-list
153635423|NCT00000919|Efavirenz|efavirenz|mesh-list
153635449|NCT00000922|Lamivudine|lamivudine|mesh-list
153635468|NCT00000922|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
153635469|NCT00000922|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
153635470|NCT00000922|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
153635471|NCT00000922|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
153635472|NCT00000922|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
153635473|NCT00000922|Protease Inhibitors|protease inhibitors|mesh-ancestor
153635474|NCT00000922|Antimetabolites|antimetabolites|mesh-ancestor
153635475|NCT00000940|Ritonavir|ritonavir|mesh-list
153635476|NCT00000940|Amprenavir|amprenavir|mesh-list
153635477|NCT00000940|Lamivudine|lamivudine|mesh-list
153635478|NCT00000940|Abacavir|abacavir|mesh-list
153635479|NCT00000940|Stavudine|stavudine|mesh-list
153635480|NCT00000940|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
153635481|NCT00000940|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
153635482|NCT00000940|Protease Inhibitors|protease inhibitors|mesh-ancestor
153635483|NCT00000940|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153635484|NCT00000940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153635485|NCT00000940|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153635486|NCT00000940|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153635488|NCT00000940|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153635489|NCT00000940|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
153635490|NCT00000940|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153635491|NCT00000940|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153635492|NCT00000940|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153635493|NCT00000940|Antimetabolites|antimetabolites|mesh-ancestor
153635494|NCT00000940|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
153635495|NCT00000940|Antitubercular Agents|antitubercular agents|mesh-ancestor
153635496|NCT00000940|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153635497|NCT00000943|Vaccines|vaccines|mesh-list
153635498|NCT00000943|Immunologic Factors|immunologic factors|mesh-ancestor
153891753|NCT05295589|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153891754|NCT05295589|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153891774|NCT05255913|Fluorides|fluorides|mesh-list
153635513|NCT00000952|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153635514|NCT00000952|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153635515|NCT00000952|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153635516|NCT00000952|Antimetabolites|antimetabolites|mesh-ancestor
153635517|NCT00000643|Leucovorin|leucovorin|mesh-list
153635518|NCT00000643|Pyrimethamine|pyrimethamine|mesh-list
153635519|NCT00000643|Calcium|calcium|mesh-list
153635520|NCT00000643|Levoleucovorin|levoleucovorin|mesh-list
153361094|NCT00862784|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153361095|NCT00862784|Immunologic Factors|immunologic factors|mesh-ancestor
153361096|NCT00862784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153361097|NCT00862784|Antidotes|antidotes|mesh-ancestor
153361098|NCT00862784|Protective Agents|protective agents|mesh-ancestor
153635521|NCT00000643|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153635522|NCT00000643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153635524|NCT00000643|Protective Agents|protective agents|mesh-ancestor
153635525|NCT00000643|Vitamin B Complex|vitamin b complex|mesh-ancestor
153635526|NCT00000643|Vitamins|vitamins|mesh-ancestor
153635527|NCT00000643|Micronutrients|micronutrients|mesh-ancestor
153635528|NCT00000643|Antimalarials|antimalarials|mesh-ancestor
153635529|NCT00000643|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153635575|NCT00000985|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153635576|NCT00000985|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153635577|NCT00000985|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153635578|NCT00000985|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153635579|NCT00000985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153635580|NCT00000985|Antimetabolites|antimetabolites|mesh-ancestor
153635581|NCT00001000|poly(I).poly(c12,U)|poly(i).poly(c12,u)|mesh-list
153635582|NCT00001000|Antiviral Agents|antiviral agents|mesh-ancestor
153635583|NCT00001000|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153635584|NCT00001003|Zidovudine|zidovudine|mesh-list
153635585|NCT00001003|Pentamidine|pentamidine|mesh-list
153635586|NCT00001003|Antimetabolites|antimetabolites|mesh-ancestor
153635638|NCT00001033|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153635639|NCT00001033|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
153635640|NCT00001033|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
153635641|NCT00001033|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
153635642|NCT00001033|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
153635643|NCT00001033|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
153635644|NCT00001033|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
153635645|NCT00001033|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
153635646|NCT00001033|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153635648|NCT00001033|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153635649|NCT00001033|Vitamin B Complex|vitamin b complex|mesh-ancestor
153635650|NCT00001033|Vitamins|vitamins|mesh-ancestor
153635651|NCT00001033|Micronutrients|micronutrients|mesh-ancestor
153635652|NCT00001033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153635653|NCT00001036|Zidovudine|zidovudine|mesh-list
153635654|NCT00001036|Interleukin-2|interleukin-2|mesh-list
153635655|NCT00001036|Thymalfasin|thymalfasin|mesh-list
153432849|NCT03525925|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153432850|NCT03525925|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153432851|NCT03525925|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153635656|NCT00001036|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153635657|NCT00001036|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153635658|NCT00001036|Analgesics|analgesics|mesh-ancestor
153635659|NCT00001036|Sensory System Agents|sensory system agents|mesh-ancestor
153635660|NCT00001036|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153635661|NCT00001036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153635662|NCT00001036|Antimetabolites|antimetabolites|mesh-ancestor
153635663|NCT00001036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153635664|NCT00001036|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153635673|NCT00001045|Zidovudine|zidovudine|mesh-list
153635684|NCT00001045|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153635685|NCT00001045|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
153635686|NCT00001045|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
153635687|NCT00001048|Cytarabine|cytarabine|mesh-list
153821140|NCT00481884|Dermatologic Agents|dermatologic agents|mesh-ancestor
153821141|NCT00481923|Rimonabant|rimonabant|mesh-list
153821142|NCT00481923|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
153821143|NCT00481923|Cannabinoid Receptor Antagonists|cannabinoid receptor antagonists|mesh-ancestor
153635693|NCT00001048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153635694|NCT00001048|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153635695|NCT00001048|Antiviral Agents|antiviral agents|mesh-ancestor
153635696|NCT00001048|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153635697|NCT00001048|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153635698|NCT00001048|Immunologic Factors|immunologic factors|mesh-ancestor
153635748|NCT00001084|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
153635749|NCT00001084|Protease Inhibitors|protease inhibitors|mesh-ancestor
153635751|NCT00001087|Nelfinavir|nelfinavir|mesh-list
153635752|NCT00001087|Saquinavir|saquinavir|mesh-list
153635753|NCT00001087|Lamivudine|lamivudine|mesh-list
153635754|NCT00001087|Zidovudine|zidovudine|mesh-list
153635755|NCT00001087|Stavudine|stavudine|mesh-list
153635756|NCT00001087|Didanosine|didanosine|mesh-list
153635757|NCT00001087|Zalcitabine|zalcitabine|mesh-list
153635758|NCT00001087|Efavirenz|efavirenz|mesh-list
153635759|NCT00001087|Adefovir|adefovir|mesh-list
153635760|NCT00001087|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
153635761|NCT00001087|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
153635762|NCT00001087|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
153635763|NCT00001087|Protease Inhibitors|protease inhibitors|mesh-ancestor
153635764|NCT00001087|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153635765|NCT00001087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153635766|NCT00001087|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153635809|NCT00001114|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153635810|NCT00001114|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153635811|NCT00001114|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153635812|NCT00001114|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153635813|NCT00001165|Doxorubicin|doxorubicin|mesh-list
153635814|NCT00001165|Streptozocin|streptozocin|mesh-list
153635815|NCT00001165|Fluorouracil|fluorouracil|mesh-list
153635816|NCT00001165|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153635817|NCT00001165|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153635818|NCT00001165|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153635819|NCT00001165|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153635820|NCT00001165|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153881075|NCT05212571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153891837|NCT05096195|Denosumab|denosumab|mesh-list
153891838|NCT05096195|Calcium|calcium|mesh-list
153891839|NCT05096195|Vitamins|vitamins|mesh-ancestor
153891840|NCT05096195|Micronutrients|micronutrients|mesh-ancestor
153891841|NCT05096195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153891842|NCT05096195|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153635821|NCT00001165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153635822|NCT00001165|Antimetabolites|antimetabolites|mesh-ancestor
153635823|NCT00001165|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153635824|NCT00001165|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153635825|NCT00001165|Immunologic Factors|immunologic factors|mesh-ancestor
153635826|NCT00001165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153635827|NCT00001180|Hormones|hormones|mesh-list
153635828|NCT00001180|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
153635829|NCT00001180|Corticotropin-Releasing Hormone|corticotropin-releasing hormone|mesh-list
153821144|NCT00481923|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
153821145|NCT00481923|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153821147|NCT00481923|Hormones|hormones|mesh-ancestor
153635869|NCT00001261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153635870|NCT00001267|Zidovudine|zidovudine|mesh-list
153635871|NCT00001267|Didanosine|didanosine|mesh-list
153635872|NCT00001267|Antimetabolites|antimetabolites|mesh-ancestor
153635873|NCT00001267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153635874|NCT00001267|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153635875|NCT00001267|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153635876|NCT00001267|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153635877|NCT00001267|Antiviral Agents|antiviral agents|mesh-ancestor
153635879|NCT00001267|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153635918|NCT00001378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153635920|NCT00001387|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153635921|NCT00001387|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153635922|NCT00001387|Tubulin Modulators|tubulin modulators|mesh-ancestor
153635923|NCT00001387|Antimitotic Agents|antimitotic agents|mesh-ancestor
153821155|NCT00481962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153821156|NCT00437177|Apomorphine|apomorphine|mesh-list
153821157|NCT00437177|Emetics|emetics|mesh-ancestor
153635924|NCT00001387|Mitosis Modulators|mitosis modulators|mesh-ancestor
153635925|NCT00001387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153635926|NCT00388557|Ketoconazole|ketoconazole|mesh-list
153635927|NCT00388557|Antifungal Agents|antifungal agents|mesh-ancestor
153635928|NCT00388557|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153635931|NCT00388557|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153635977|NCT00001483|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
153635978|NCT00001483|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153635979|NCT00001483|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153635980|NCT00001495|Irinotecan|irinotecan|mesh-list
153635981|NCT00001495|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
153635982|NCT00001495|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153635983|NCT00001495|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153635984|NCT00001495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153635985|NCT00001495|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153636045|NCT00001666|Dopamine Agents|dopamine agents|mesh-ancestor
153636046|NCT00001666|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153636047|NCT00001666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153636048|NCT00001666|Adrenergic Agents|adrenergic agents|mesh-ancestor
153636049|NCT00001666|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
153636050|NCT00001666|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153636051|NCT00001666|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153636052|NCT00001666|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
153636053|NCT00001669|Mecasermin|mecasermin|mesh-list
153636054|NCT00001669|Growth Substances|growth substances|mesh-ancestor
153636055|NCT00001669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153636056|NCT00001693|Celecoxib|celecoxib|mesh-list
153636057|NCT00001693|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153636058|NCT00001693|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153636059|NCT00001693|Analgesics|analgesics|mesh-ancestor
153636060|NCT00001693|Sensory System Agents|sensory system agents|mesh-ancestor
153636069|NCT00001696|Genistein|genistein|mesh-list
153636102|NCT00001723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153636103|NCT00001723|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
153636104|NCT00001723|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153636106|NCT00001729|Antimetabolites|antimetabolites|mesh-ancestor
153636107|NCT00001729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153636108|NCT00001729|Antiviral Agents|antiviral agents|mesh-ancestor
153636109|NCT00001729|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153636110|NCT00001741|Losartan|losartan|mesh-list
153636111|NCT00001741|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153636112|NCT00001741|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153636113|NCT00001741|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
153636114|NCT00001741|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
153636116|NCT00001777|Sertraline|sertraline|mesh-list
153636117|NCT00001777|Antidepressive Agents|antidepressive agents|mesh-ancestor
153636118|NCT00001777|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153636119|NCT00001777|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
153636155|NCT00000252|Analgesics|analgesics|mesh-ancestor
153636156|NCT00000252|Sensory System Agents|sensory system agents|mesh-ancestor
153636157|NCT00000252|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153636158|NCT05640817|Pentoxifylline|pentoxifylline|mesh-list
153636159|NCT05640817|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
153636160|NCT05640817|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153636161|NCT05640817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153636162|NCT05640817|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153636163|NCT05640817|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
153636164|NCT05640817|Protective Agents|protective agents|mesh-ancestor
153636165|NCT05640817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153636218|NCT05640427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153636219|NCT05640427|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153636220|NCT05640427|Analgesics|analgesics|mesh-ancestor
153636221|NCT05640427|Sensory System Agents|sensory system agents|mesh-ancestor
153636222|NCT05640427|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153636223|NCT05640427|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
153636224|NCT05640427|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153636225|NCT05640427|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153636226|NCT05640427|Adrenergic Agents|adrenergic agents|mesh-ancestor
153636227|NCT05640427|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153636228|NCT05640427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153636229|NCT00000363|Histamine Antagonists|histamine antagonists|mesh-list
153636230|NCT00000363|Histamine H1 Antagonists|histamine h1 antagonists|mesh-list
153636231|NCT00000363|Histamine Agents|histamine agents|mesh-ancestor
153636232|NCT00000363|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153636233|NCT00000363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153636234|NCT00000363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153636235|NCT00000369|Lithium Carbonate|lithium carbonate|mesh-list
153636236|NCT00000369|Antidepressive Agents|antidepressive agents|mesh-ancestor
153636237|NCT00000369|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153821172|NCT00482079|Incretins|incretins|mesh-ancestor
153821173|NCT00482079|Hormones|hormones|mesh-ancestor
153821174|NCT00482079|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153821175|NCT00482079|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
153821176|NCT00482079|Protease Inhibitors|protease inhibitors|mesh-ancestor
153821177|NCT00482079|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153821178|NCT00482079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153821179|NCT00437372|Sunitinib|sunitinib|mesh-list
153821180|NCT00437372|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153636245|NCT00000375|Antidepressive Agents|antidepressive agents|mesh-ancestor
153636246|NCT00000375|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153636247|NCT00000375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153636248|NCT00000375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153636249|NCT00000375|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
153636250|NCT00000375|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
153636252|NCT00000375|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153636254|NCT00000375|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153636255|NCT03295747|Peppermint oil|peppermint oil|mesh-list
153636256|NCT03295747|Antiemetics|antiemetics|mesh-ancestor
153636257|NCT03295747|Autonomic Agents|autonomic agents|mesh-ancestor
153636258|NCT03295747|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153636259|NCT03295747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153636260|NCT03295747|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153636261|NCT03295747|Parasympatholytics|parasympatholytics|mesh-ancestor
153636262|NCT05639959|Mometasone Furoate|mometasone furoate|mesh-list
153636263|NCT05639959|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153636264|NCT05639959|Dermatologic Agents|dermatologic agents|mesh-ancestor
153636265|NCT05639959|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
153636266|NCT03575208|Interferons|interferons|mesh-list
153636267|NCT03575208|Interferon-alpha|interferon-alpha|mesh-list
153636268|NCT03575208|Immunoglobulins|immunoglobulins|mesh-list
153636270|NCT03575208|gamma-Globulins|gamma-globulins|mesh-list
153636271|NCT03575208|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
153636272|NCT03575208|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
153636273|NCT03575208|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153636274|NCT03575208|Antiviral Agents|antiviral agents|mesh-ancestor
153636275|NCT03575208|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153636276|NCT03575208|Immunologic Factors|immunologic factors|mesh-ancestor
153636277|NCT03575208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153636278|NCT03295552|Carboplatin|carboplatin|mesh-list
153636308|NCT00000381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153636309|NCT00000381|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153636311|NCT00000381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153636312|NCT00000381|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
153821185|NCT00437372|Growth Inhibitors|growth inhibitors|mesh-ancestor
153821186|NCT00437372|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153821187|NCT00437372|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153821188|NCT00437372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153821189|NCT00437450|Epoetin Alfa|epoetin alfa|mesh-list
153821190|NCT00437450|Hematinics|hematinics|mesh-ancestor
153821191|NCT04701710|Ivermectin|ivermectin|mesh-list
153821192|NCT04701710|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153636318|NCT05631925|Propofol|propofol|mesh-list
153636319|NCT05631925|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153636320|NCT05631925|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153636321|NCT05631925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153372064|NCT01766219|Antioxidants|antioxidants|mesh-ancestor
153636322|NCT05631925|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153636323|NCT05631925|Anesthetics, General|anesthetics, general|mesh-ancestor
153636324|NCT05631925|Anesthetics|anesthetics|mesh-ancestor
153636325|NCT00389701|Dexamethasone|dexamethasone|mesh-list
153636326|NCT00389701|Bortezomib|bortezomib|mesh-list
153636327|NCT00389701|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153636328|NCT00389701|Antiemetics|antiemetics|mesh-ancestor
153636329|NCT00389701|Autonomic Agents|autonomic agents|mesh-ancestor
153636330|NCT00389701|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153636331|NCT00389701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153636332|NCT00389701|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153636333|NCT00389701|Glucocorticoids|glucocorticoids|mesh-ancestor
153636334|NCT00389701|Hormones|hormones|mesh-ancestor
153636336|NCT00389701|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153636354|NCT00000456|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
153636355|NCT00000456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153636356|NCT00000456|Sensory System Agents|sensory system agents|mesh-ancestor
153636357|NCT00000456|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153636358|NCT05519683|Escitalopram|escitalopram|mesh-list
153636359|NCT05519683|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
153636360|NCT05519683|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153636361|NCT05519683|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153636362|NCT05519683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153636363|NCT05519683|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153636364|NCT05519683|Serotonin Agents|serotonin agents|mesh-ancestor
153636365|NCT05519683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153636366|NCT05442268|Acetaminophen|acetaminophen|mesh-list
153636367|NCT05442268|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
153636368|NCT05442268|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153636369|NCT05442268|Analgesics|analgesics|mesh-ancestor
153636409|NCT02972476|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
153636410|NCT02972476|Glucocorticoids|glucocorticoids|mesh-ancestor
153636411|NCT02972476|Hormones|hormones|mesh-ancestor
153636412|NCT02972476|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153636413|NCT02972476|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
153636418|NCT02972476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153636419|NCT02972476|Anticonvulsants|anticonvulsants|mesh-ancestor
153636420|NCT02972476|Sympathomimetics|sympathomimetics|mesh-ancestor
153636421|NCT02972320|Temozolomide|temozolomide|mesh-list
153636422|NCT02972320|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153636423|NCT02972320|Alkylating Agents|alkylating agents|mesh-ancestor
153636424|NCT02972320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153636425|NCT02972320|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153636466|NCT00000492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153636467|NCT00000492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153636468|NCT00000492|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153636469|NCT00000492|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153636470|NCT00000492|Vasodilator Agents|vasodilator agents|mesh-ancestor
153636471|NCT00000498|Antihypertensive Agents|antihypertensive agents|mesh-list
153636472|NCT00000504|Flecainide|flecainide|mesh-list
153636473|NCT00000504|Moricizine|moricizine|mesh-list
153636474|NCT00000504|Encainide|encainide|mesh-list
153636475|NCT00000504|Imipramine|imipramine|mesh-list
153636476|NCT00000504|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153636477|NCT00000504|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
153636478|NCT00000504|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153821205|NCT00482313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153821206|NCT00482313|Dopamine Agents|dopamine agents|mesh-ancestor
153821207|NCT00482313|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153821208|NCT00437684|Ribavirin|ribavirin|mesh-list
153821209|NCT00437684|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
153821210|NCT00437684|Antimetabolites|antimetabolites|mesh-ancestor
153421975|NCT05061017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153421978|NCT05061017|Alkylating Agents|alkylating agents|mesh-ancestor
153821211|NCT00437684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153821212|NCT00437684|Antiviral Agents|antiviral agents|mesh-ancestor
153821213|NCT00437684|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153821214|NCT00437723|Epoetin Alfa|epoetin alfa|mesh-list
153821215|NCT00437723|Hematinics|hematinics|mesh-ancestor
153821216|NCT00437762|Botulinum Toxins|botulinum toxins|mesh-list
153821217|NCT00437762|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
153361166|NCT01382303|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
153361167|NCT01382303|Protective Agents|protective agents|mesh-ancestor
153361168|NCT01382303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153361169|NCT01382303|Vasodilator Agents|vasodilator agents|mesh-ancestor
153636480|NCT00000504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153636481|NCT00000504|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
153636482|NCT00000504|Antidepressive Agents|antidepressive agents|mesh-ancestor
153636483|NCT00000504|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153636484|NCT00000504|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
153636485|NCT00000504|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153636486|NCT00000504|Adrenergic Agents|adrenergic agents|mesh-ancestor
153636487|NCT00000504|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153636488|NCT00000504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153636489|NCT00389935|Thalidomide|thalidomide|mesh-list
153636490|NCT00389935|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153636491|NCT00389935|Immunologic Factors|immunologic factors|mesh-ancestor
153636513|NCT05116930|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
153636514|NCT05116930|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
153636515|NCT05116930|Cholinergic Agents|cholinergic agents|mesh-ancestor
153636516|NCT05116930|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153636517|NCT05116930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153636518|NCT05116930|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
153636519|NCT05116930|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153636520|NCT05116930|Parasympathomimetics|parasympathomimetics|mesh-ancestor
153636521|NCT00423475|Goserelin|goserelin|mesh-list
153636522|NCT00423475|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153636523|NCT00423475|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153636524|NCT00000516|Enalapril|enalapril|mesh-list
153636525|NCT00000516|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
153636530|NCT00000522|Acebutolol|acebutolol|mesh-list
153636574|NCT00000525|Triamterene|triamterene|mesh-list
153636575|NCT00000525|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153636576|NCT00000525|Diuretics|diuretics|mesh-ancestor
153636577|NCT00000525|Natriuretic Agents|natriuretic agents|mesh-ancestor
153636578|NCT00000525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153636579|NCT00000525|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
153636580|NCT00000525|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153361170|NCT01382303|Free Radical Scavengers|free radical scavengers|mesh-ancestor
153361171|NCT01382303|Antioxidants|antioxidants|mesh-ancestor
153361172|NCT05236634|Tadalafil|tadalafil|mesh-list
153361173|NCT05236634|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-list
153361174|NCT05236634|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-list
153881115|NCT05189223|Analgesics|analgesics|mesh-ancestor
153881116|NCT05189223|Sensory System Agents|sensory system agents|mesh-ancestor
153881117|NCT05189223|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153881118|NCT05189223|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
153881119|NCT05176418|Nicotine|nicotine|mesh-list
153881120|NCT05176418|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
153881121|NCT05176418|Autonomic Agents|autonomic agents|mesh-ancestor
153881122|NCT05176418|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153636582|NCT00000525|Epithelial Sodium Channel Blockers|epithelial sodium channel blockers|mesh-ancestor
153636583|NCT00000525|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153636584|NCT00000525|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
153636585|NCT05020483|Anti-inhibitor coagulant complex|anti-inhibitor coagulant complex|mesh-list
153636586|NCT05020483|Coagulants|coagulants|mesh-ancestor
153636587|NCT00000531|Amiodarone|amiodarone|mesh-list
153636589|NCT00000531|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153636630|NCT00000555|Micronutrients|micronutrients|mesh-ancestor
153636631|NCT00000555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153636632|NCT00000555|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153636633|NCT00000555|Progestins|progestins|mesh-ancestor
153636634|NCT00000555|Antioxidants|antioxidants|mesh-ancestor
153636635|NCT00000555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153636636|NCT00000555|Protective Agents|protective agents|mesh-ancestor
153636637|NCT00000558|Enzyme Inhibitors|enzyme inhibitors|mesh-list
153636638|NCT00000558|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
153636639|NCT00000558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153636640|NCT00000558|Protease Inhibitors|protease inhibitors|mesh-ancestor
153636691|NCT00000594|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153636692|NCT00000594|Antimetabolites|antimetabolites|mesh-ancestor
153636693|NCT00000594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153636694|NCT00000594|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153636695|NCT00390091|Abetimus|abetimus|mesh-list
153636696|NCT00390091|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153636697|NCT00390091|Immunologic Factors|immunologic factors|mesh-ancestor
153636698|NCT00390091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153636699|NCT00390130|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
153636700|NCT00390130|Immunologic Factors|immunologic factors|mesh-ancestor
153636701|NCT00390130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153636702|NCT04650880|Vitamin D|vitamin d|mesh-list
153636703|NCT04650880|Vitamins|vitamins|mesh-ancestor
153821225|NCT00437762|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
153636704|NCT04650880|Micronutrients|micronutrients|mesh-ancestor
153361175|NCT05236634|Vasodilator Agents|vasodilator agents|mesh-ancestor
153361176|NCT05236634|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
153361177|NCT05236634|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153361178|NCT05236634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153636755|NCT00000639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153636757|NCT00000639|Hormone Antagonists|hormone antagonists|mesh-ancestor
153636758|NCT00000639|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153636759|NCT00000639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153636760|NCT00000639|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
153636763|NCT00000639|Amebicides|amebicides|mesh-ancestor
153636807|NCT00390208|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
153636808|NCT00390208|Dermatologic Agents|dermatologic agents|mesh-ancestor
153636809|NCT00389025|Olopatadine Hydrochloride|olopatadine hydrochloride|mesh-list
153636810|NCT00389025|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153636811|NCT00389025|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153636813|NCT00389025|Sensory System Agents|sensory system agents|mesh-ancestor
153636814|NCT00389025|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153636815|NCT00389025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153636816|NCT00389025|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153636817|NCT00389025|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153636818|NCT00389025|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
153636819|NCT00389025|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
153636820|NCT00389025|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
153636821|NCT00389025|Histamine Antagonists|histamine antagonists|mesh-ancestor
153881131|NCT05130060|Immunologic Factors|immunologic factors|mesh-ancestor
153433112|NCT02339155|Promethazine|promethazine|mesh-list
153433113|NCT02339155|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
153636822|NCT00389025|Histamine Agents|histamine agents|mesh-ancestor
153636823|NCT00389025|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153636824|NCT00389025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153636825|NCT00390247|Thalidomide|thalidomide|mesh-list
153636838|NCT00000651|Zalcitabine|zalcitabine|mesh-list
153636862|NCT00000672|Antiviral Agents|antiviral agents|mesh-ancestor
153636863|NCT00000672|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153636864|NCT00000672|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153636865|NCT00000672|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153636866|NCT04321954|Lenvatinib|lenvatinib|mesh-list
153636867|NCT04321954|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153636868|NCT04321954|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153361201|NCT01424033|Acetylcysteine|acetylcysteine|mesh-list
153636870|NCT04321954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153636872|NCT00000675|Immunologic Factors|immunologic factors|mesh-ancestor
153636873|NCT00000675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153636874|NCT00000678|Zidovudine|zidovudine|mesh-list
153636875|NCT00000678|Zalcitabine|zalcitabine|mesh-list
153636876|NCT00000678|Antimetabolites|antimetabolites|mesh-ancestor
153636877|NCT00000678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153636878|NCT00000678|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153636879|NCT00000678|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153636880|NCT00000678|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153636914|NCT00000681|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153636915|NCT00000681|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153636916|NCT00000681|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153636917|NCT00000681|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153636918|NCT00000681|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153636919|NCT00000681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153636920|NCT00000681|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153636921|NCT00000681|Tubulin Modulators|tubulin modulators|mesh-ancestor
153636922|NCT00000681|Antimitotic Agents|antimitotic agents|mesh-ancestor
153636923|NCT00000681|Mitosis Modulators|mitosis modulators|mesh-ancestor
153636924|NCT00000681|Antimetabolites|antimetabolites|mesh-ancestor
153636925|NCT00000681|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153636926|NCT00000681|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153636927|NCT00000681|Antiviral Agents|antiviral agents|mesh-ancestor
153636928|NCT00000681|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153636929|NCT00000681|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153636930|NCT00000681|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153636931|NCT00000681|Immunologic Factors|immunologic factors|mesh-ancestor
153636932|NCT00000681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153636933|NCT00000684|Dextrans|dextrans|mesh-list
153636934|NCT00000684|Anticoagulants|anticoagulants|mesh-ancestor
153636935|NCT00000684|Plasma Substitutes|plasma substitutes|mesh-ancestor
153636936|NCT00000684|Blood Substitutes|blood substitutes|mesh-ancestor
153636937|NCT00000687|Interferons|interferons|mesh-list
153636938|NCT00000687|Interferon-alpha|interferon-alpha|mesh-list
153636939|NCT00000687|Interferon alpha-2|interferon alpha-2|mesh-list
153636940|NCT00000687|Zidovudine|zidovudine|mesh-list
153636941|NCT00000687|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153821229|NCT00482508|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153821231|NCT00437918|Acarbose|acarbose|mesh-list
153636943|NCT00000687|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153636944|NCT00000687|Immunologic Factors|immunologic factors|mesh-ancestor
153636945|NCT00000687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153636946|NCT00000687|Antimetabolites|antimetabolites|mesh-ancestor
153636947|NCT00000687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153636948|NCT00000687|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153881134|NCT05130060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153881135|NCT05130060|Antiviral Agents|antiviral agents|mesh-ancestor
153881136|NCT05130060|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153881137|NCT05114486|Pilocarpine|pilocarpine|mesh-list
153881138|NCT05114486|Miotics|miotics|mesh-ancestor
153881139|NCT05114486|Autonomic Agents|autonomic agents|mesh-ancestor
153881140|NCT05114486|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153892087|NCT03918850|Narcotics|narcotics|mesh-ancestor
153433148|NCT02246621|Letrozole|letrozole|mesh-list
153636949|NCT00000687|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153636951|NCT00000687|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153636952|NCT00000687|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153636954|NCT00000690|Anticoagulants|anticoagulants|mesh-ancestor
153636955|NCT00000690|Plasma Substitutes|plasma substitutes|mesh-ancestor
153636956|NCT00000690|Blood Substitutes|blood substitutes|mesh-ancestor
153636957|NCT00000696|Interferons|interferons|mesh-list
153636958|NCT00000696|Interferon-alpha|interferon-alpha|mesh-list
153636959|NCT00000696|Interferon alpha-2|interferon alpha-2|mesh-list
153636960|NCT00000696|Zidovudine|zidovudine|mesh-list
153636961|NCT00000696|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153637015|NCT00000711|Immunologic Factors|immunologic factors|mesh-ancestor
153637016|NCT00000711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153637017|NCT00000717|Clindamycin|clindamycin|mesh-list
153637018|NCT00000717|Clindamycin palmitate|clindamycin palmitate|mesh-list
153637019|NCT00000717|Clindamycin phosphate|clindamycin phosphate|mesh-list
153637020|NCT00000717|Primaquine|primaquine|mesh-list
153637021|NCT00000717|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153637022|NCT00000717|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153637023|NCT00000717|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
153637024|NCT00000717|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153637025|NCT00000717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153637026|NCT00000717|Antimalarials|antimalarials|mesh-ancestor
153637027|NCT00000717|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153637028|NCT00000717|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153637078|NCT00000744|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153637079|NCT00000744|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153637080|NCT00000744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153637081|NCT00000744|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153637082|NCT00000744|Hormone Antagonists|hormone antagonists|mesh-ancestor
153637083|NCT00000744|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153637084|NCT00000744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153637085|NCT00000744|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
153637086|NCT00000744|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
153637087|NCT04020172|Dobutamine|dobutamine|mesh-list
153637088|NCT04020172|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
153637089|NCT04020172|Sympathomimetics|sympathomimetics|mesh-ancestor
153637090|NCT04020172|Autonomic Agents|autonomic agents|mesh-ancestor
153637091|NCT04020172|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153637092|NCT04020172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153637093|NCT04020172|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
153637096|NCT04020172|Adrenergic Agents|adrenergic agents|mesh-ancestor
153637099|NCT04020172|Protective Agents|protective agents|mesh-ancestor
153637130|NCT03991741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153637132|NCT00000768|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
153637133|NCT00000768|Antiviral Agents|antiviral agents|mesh-ancestor
153637134|NCT00000768|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153637135|NCT00000768|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153637136|NCT00000768|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153637137|NCT00000768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153637138|NCT00000789|Zidovudine|zidovudine|mesh-list
153637139|NCT00000789|Stavudine|stavudine|mesh-list
153637140|NCT00000789|Antimetabolites|antimetabolites|mesh-ancestor
153637144|NCT00000789|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153637193|NCT00000816|Antimalarials|antimalarials|mesh-ancestor
153637194|NCT00000816|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153637195|NCT00000816|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153637196|NCT00000816|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153637197|NCT00000816|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153881141|NCT05114486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153881142|NCT05114486|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
153881143|NCT05114486|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
153372068|NCT01766219|Vitamin B Complex|vitamin b complex|mesh-ancestor
153637198|NCT00000816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153637199|NCT00000816|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
153637200|NCT00000816|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
153637201|NCT00000816|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153637202|NCT00000816|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153637256|NCT03574402|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153637258|NCT03574402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153637259|NCT03574402|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153637260|NCT03574402|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153637261|NCT03574402|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153637262|NCT03574402|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153637263|NCT03574402|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153637264|NCT03574402|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153637265|NCT00000831|Lamivudine|lamivudine|mesh-list
153637266|NCT00000831|Zidovudine|zidovudine|mesh-list
153637267|NCT00000831|Stavudine|stavudine|mesh-list
153637268|NCT00000831|Didanosine|didanosine|mesh-list
153637269|NCT00000831|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153637270|NCT00000831|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153637318|NCT00000870|Didanosine|didanosine|mesh-list
153637319|NCT00000870|Aldesleukin|aldesleukin|mesh-list
153637320|NCT00000870|Indinavir|indinavir|mesh-list
153637321|NCT00000870|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153637322|NCT00000870|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153637323|NCT00000870|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153821258|NCT00474279|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153821259|NCT00474279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153821260|NCT03270696|Propofol|propofol|mesh-list
153821261|NCT03270696|Rocuronium|rocuronium|mesh-list
153821262|NCT03270696|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153821263|NCT03270696|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153821264|NCT03270696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153821265|NCT03270696|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153361225|NCT00825266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153361226|NCT00825266|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153361227|NCT00825266|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
153361228|NCT00825266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153637325|NCT00000870|Antiviral Agents|antiviral agents|mesh-ancestor
153637326|NCT00000870|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153637387|NCT00000888|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
153637388|NCT00000888|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153637389|NCT00000888|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153637390|NCT00000888|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153637391|NCT00000888|Antimetabolites|antimetabolites|mesh-ancestor
153637392|NCT00000891|Ritonavir|ritonavir|mesh-list
153637393|NCT00000891|Saquinavir|saquinavir|mesh-list
153637394|NCT00000891|Lamivudine|lamivudine|mesh-list
153637395|NCT00000891|Zidovudine|zidovudine|mesh-list
153637396|NCT00000891|Stavudine|stavudine|mesh-list
153637397|NCT00000891|Didanosine|didanosine|mesh-list
153637398|NCT00000891|Delavirdine|delavirdine|mesh-list
153637399|NCT00000891|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
153637400|NCT00000891|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
153637401|NCT00000891|Protease Inhibitors|protease inhibitors|mesh-ancestor
153637402|NCT00000891|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153637403|NCT00000891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153637404|NCT00000891|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153637405|NCT00000891|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153637406|NCT00000891|Antiviral Agents|antiviral agents|mesh-ancestor
153637407|NCT00000891|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153637408|NCT00000891|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
153637409|NCT00000891|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153637410|NCT00000891|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153637411|NCT00000891|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153637412|NCT00000891|Antimetabolites|antimetabolites|mesh-ancestor
153637413|NCT00000903|Lamivudine|lamivudine|mesh-list
153637414|NCT00000903|Zidovudine|zidovudine|mesh-list
153637415|NCT00000903|Efavirenz|efavirenz|mesh-list
153637416|NCT00000903|Lamivudine, zidovudine drug combination|lamivudine, zidovudine drug combination|mesh-list
153637417|NCT00000903|Nelfinavir|nelfinavir|mesh-list
153637418|NCT00000903|Indinavir|indinavir|mesh-list
153637421|NCT00000903|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153637428|NCT00000903|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
153637429|NCT00000903|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153361230|NCT01385189|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153361231|NCT01385189|Immunologic Factors|immunologic factors|mesh-ancestor
153361232|NCT01385189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153361233|NCT01385189|Antacids|antacids|mesh-ancestor
153361234|NCT01385189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153361235|NCT01385189|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153361236|NCT01386983|Finasteride|finasteride|mesh-list
153361237|NCT01386983|Dutasteride|dutasteride|mesh-list
153361238|NCT01386983|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
153361239|NCT01386983|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153361240|NCT01386983|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153890099|NCT04479267|Doxorubicin|doxorubicin|mesh-list
153637430|NCT00000903|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
153637431|NCT00000903|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
153637432|NCT00000903|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
153637433|NCT00000903|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
153637434|NCT00000903|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
153637435|NCT00000903|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
153637437|NCT02939365|Abatacept|abatacept|mesh-list
153637438|NCT02939365|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153637488|NCT00000966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153637489|NCT00000966|Antidotes|antidotes|mesh-ancestor
153637490|NCT00000966|Protective Agents|protective agents|mesh-ancestor
153637491|NCT00000966|Vitamin B Complex|vitamin b complex|mesh-ancestor
153637492|NCT00000966|Vitamins|vitamins|mesh-ancestor
153637493|NCT00000966|Micronutrients|micronutrients|mesh-ancestor
153637494|NCT00000966|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153637495|NCT00000966|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153637496|NCT00000966|Antimalarials|antimalarials|mesh-ancestor
153637497|NCT00000966|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153637498|NCT00000966|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153637499|NCT00000966|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153637500|NCT00000966|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153637501|NCT00000966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153637502|NCT00000969|Didanosine|didanosine|mesh-list
153637503|NCT00000969|Zalcitabine|zalcitabine|mesh-list
153637504|NCT00000969|Antimetabolites|antimetabolites|mesh-ancestor
153637505|NCT00000969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153637506|NCT00000969|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153637507|NCT00000969|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153637508|NCT00000969|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153637509|NCT00000969|Antiviral Agents|antiviral agents|mesh-ancestor
153637510|NCT00000969|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153637511|NCT00000969|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153637512|NCT00000969|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153637513|NCT00000975|Itraconazole|itraconazole|mesh-list
153637514|NCT00000975|Antifungal Agents|antifungal agents|mesh-ancestor
153637515|NCT00000975|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153637516|NCT00000975|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
153821273|NCT00437996|Sufentanil|sufentanil|mesh-list
153821274|NCT00437996|Levobupivacaine|levobupivacaine|mesh-list
153821275|NCT00437996|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153821276|NCT00437996|Narcotics|narcotics|mesh-ancestor
153821277|NCT00437996|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153637534|NCT00000978|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153637535|NCT00000978|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153637537|NCT00000999|Antimetabolites|antimetabolites|mesh-ancestor
153637538|NCT00000999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153637539|NCT00000999|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153637540|NCT00000999|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153637541|NCT00000999|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153637542|NCT00000999|Antiviral Agents|antiviral agents|mesh-ancestor
153637543|NCT00000999|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153637544|NCT00000999|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153637545|NCT00000999|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153637546|NCT00001002|Zidovudine|zidovudine|mesh-list
153637547|NCT00001002|Foscarnet|foscarnet|mesh-list
153637548|NCT00001002|Phosphonoacetic Acid|phosphonoacetic acid|mesh-list
153637549|NCT00001002|Antimetabolites|antimetabolites|mesh-ancestor
153637550|NCT00001002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153637551|NCT00001002|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153637552|NCT00001002|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153637553|NCT00001002|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153637554|NCT00001002|Antiviral Agents|antiviral agents|mesh-ancestor
153637555|NCT00001002|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153637556|NCT00001002|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153637557|NCT00001002|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153637558|NCT00005819|Paclitaxel|paclitaxel|mesh-list
153637559|NCT00005819|Fenretinide|fenretinide|mesh-list
153637560|NCT00005819|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153637561|NCT00005819|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153372138|NCT04351724|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153372139|NCT04351724|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
153422042|NCT04908189|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153422043|NCT04908189|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153422046|NCT04908189|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153637582|NCT00391105|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153637583|NCT00391105|Narcotics|narcotics|mesh-ancestor
153637584|NCT00391105|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153637585|NCT00391105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153637586|NCT00391105|Analgesics|analgesics|mesh-ancestor
153637587|NCT00391105|Sensory System Agents|sensory system agents|mesh-ancestor
153637588|NCT00391105|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153637589|NCT00391144|Triamcinolone|triamcinolone|mesh-list
153637590|NCT00391144|Bevacizumab|bevacizumab|mesh-list
153637591|NCT00391144|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153637592|NCT00391144|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153637593|NCT00391144|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153637594|NCT00391144|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153637595|NCT00391144|Growth Substances|growth substances|mesh-ancestor
153361255|NCT01387139|Sensory System Agents|sensory system agents|mesh-ancestor
153361256|NCT01387139|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153361257|NCT01387139|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
153361258|NCT01387139|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
153361259|NCT01387139|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
153361260|NCT01387139|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153361261|NCT01387139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153361262|NCT00870896|Tiotropium Bromide|tiotropium bromide|mesh-list
153361263|NCT00870896|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153637596|NCT00391144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153637597|NCT00391144|Growth Inhibitors|growth inhibitors|mesh-ancestor
153637598|NCT00391144|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153637599|NCT00391144|Glucocorticoids|glucocorticoids|mesh-ancestor
153637601|NCT00391144|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153637602|NCT00005822|Tamoxifen|tamoxifen|mesh-list
153637603|NCT00005822|Doxorubicin|doxorubicin|mesh-list
153637604|NCT00005822|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
153637619|NCT00391261|Metformin|metformin|mesh-list
153637632|NCT00001008|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153637633|NCT00001008|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153637634|NCT00001008|Narcotics|narcotics|mesh-ancestor
153637635|NCT00001008|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153637636|NCT00001008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153637637|NCT00001008|Analgesics|analgesics|mesh-ancestor
153637638|NCT00001008|Sensory System Agents|sensory system agents|mesh-ancestor
153637639|NCT00001008|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153637640|NCT00001008|Antitussive Agents|antitussive agents|mesh-ancestor
153637641|NCT00001008|Respiratory System Agents|respiratory system agents|mesh-ancestor
153637642|NCT00005825|Vinorelbine|vinorelbine|mesh-list
153637643|NCT00005825|Mitomycins|mitomycins|mesh-list
153637644|NCT00005825|Mitomycin|mitomycin|mesh-list
153637645|NCT00005825|Tretinoin|tretinoin|mesh-list
153637646|NCT00005825|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153637647|NCT00005825|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153637648|NCT00005825|Tubulin Modulators|tubulin modulators|mesh-ancestor
153637649|NCT00005825|Antimitotic Agents|antimitotic agents|mesh-ancestor
153637650|NCT00005825|Mitosis Modulators|mitosis modulators|mesh-ancestor
153637651|NCT00005825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153637652|NCT00005825|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153637653|NCT00005825|Alkylating Agents|alkylating agents|mesh-ancestor
153637658|NCT00001011|Zidovudine|zidovudine|mesh-list
153637687|NCT00001014|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153637688|NCT00001014|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153637689|NCT00001014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153637690|NCT00001014|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
153881198|NCT04942860|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153881199|NCT04788511|Semaglutide|semaglutide|mesh-list
153881200|NCT04788511|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
153881201|NCT04788511|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153433308|NCT00000379|Fluoxetine|fluoxetine|mesh-list
153637691|NCT00001014|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
153637692|NCT00001014|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153821312|NCT00474435|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153637693|NCT00001014|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153637694|NCT00001014|Antifungal Agents|antifungal agents|mesh-ancestor
153637695|NCT00001014|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153637696|NCT00001014|Antimetabolites|antimetabolites|mesh-ancestor
153637697|NCT00001014|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153637698|NCT00005831|Paclitaxel|paclitaxel|mesh-list
153637699|NCT00005831|Carboplatin|carboplatin|mesh-list
153637700|NCT00005831|Gemcitabine|gemcitabine|mesh-list
153637701|NCT00005831|Trastuzumab|trastuzumab|mesh-list
153821313|NCT00474435|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
153821314|NCT00474435|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153637716|NCT00005834|Immunologic Factors|immunologic factors|mesh-ancestor
153637731|NCT00005834|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153637732|NCT00005834|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153637733|NCT00005834|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153637735|NCT00005834|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153637736|NCT00005834|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153637737|NCT00005834|Leprostatic Agents|leprostatic agents|mesh-ancestor
153637738|NCT00005834|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153637739|NCT00005834|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153637740|NCT00005834|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153637741|NCT00005834|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153637742|NCT00005834|Growth Substances|growth substances|mesh-ancestor
153637743|NCT00005834|Growth Inhibitors|growth inhibitors|mesh-ancestor
153637746|NCT00001029|Zalcitabine|zalcitabine|mesh-list
153637747|NCT00001029|Antimetabolites|antimetabolites|mesh-ancestor
153637748|NCT00001029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153637749|NCT00001029|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153637750|NCT00001029|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153637751|NCT00001029|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153637752|NCT00001029|Antiviral Agents|antiviral agents|mesh-ancestor
153637753|NCT00001029|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153637754|NCT00001029|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153637755|NCT00001029|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153821319|NCT04701320|Methamphetamine|methamphetamine|mesh-list
153821320|NCT04701320|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
153361283|NCT00825344|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153361284|NCT00825344|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153361285|NCT00825344|Immunologic Factors|immunologic factors|mesh-ancestor
153361286|NCT01426763|Complement C1s|complement c1s|mesh-list
153361287|NCT01426763|Complement C1 Inhibitor Protein|complement c1 inhibitor protein|mesh-list
153361288|NCT01426763|Complement C1 Inactivator Proteins|complement c1 inactivator proteins|mesh-list
153361289|NCT01426763|Immunologic Factors|immunologic factors|mesh-ancestor
153361290|NCT01426763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153361291|NCT01426763|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
153361292|NCT01426763|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153361293|NCT00825500|Loxapine|loxapine|mesh-list
153361294|NCT00825500|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153361295|NCT00825500|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153361296|NCT00825500|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153637784|NCT00005849|Bryostatin 1|bryostatin 1|mesh-list
153637785|NCT00005849|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153881202|NCT04788511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153881203|NCT04781673|Lidocaine|lidocaine|mesh-list
153881204|NCT04781673|Ketamine|ketamine|mesh-list
153637786|NCT00005849|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153637787|NCT00005849|Tubulin Modulators|tubulin modulators|mesh-ancestor
153637788|NCT00005849|Antimitotic Agents|antimitotic agents|mesh-ancestor
153637789|NCT00005849|Mitosis Modulators|mitosis modulators|mesh-ancestor
153637790|NCT00005849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153637791|NCT00005849|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153637792|NCT00005849|Immunologic Factors|immunologic factors|mesh-ancestor
153637793|NCT00005849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153637795|NCT00001047|Ethambutol|ethambutol|mesh-list
153637796|NCT00001047|Rifabutin|rifabutin|mesh-list
153637842|NCT00001071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153637843|NCT00005855|Carmustine|carmustine|mesh-list
153637844|NCT00005855|Efaproxiral|efaproxiral|mesh-list
153637845|NCT00005855|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153637846|NCT00005855|Alkylating Agents|alkylating agents|mesh-ancestor
153637847|NCT00005855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153637848|NCT00005855|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153637849|NCT00005855|Antisickling Agents|antisickling agents|mesh-ancestor
153637850|NCT00001074|Didanosine|didanosine|mesh-list
153637851|NCT00001074|Hydroxyurea|hydroxyurea|mesh-list
153637852|NCT00001074|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153637853|NCT00001074|Antisickling Agents|antisickling agents|mesh-ancestor
153637854|NCT00001074|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153637855|NCT00001074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153637856|NCT00001074|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153637857|NCT00001074|Antimetabolites|antimetabolites|mesh-ancestor
153637858|NCT00001074|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153637859|NCT00001074|Antiviral Agents|antiviral agents|mesh-ancestor
153637860|NCT00001074|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153637861|NCT00001074|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153637862|NCT00001074|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153637864|NCT00005858|Immunoconjugates|immunoconjugates|mesh-ancestor
153637865|NCT00005858|Immunologic Factors|immunologic factors|mesh-ancestor
153821332|NCT04701320|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
153821333|NCT00438113|Atenolol|atenolol|mesh-list
153821334|NCT00438113|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
153821335|NCT00438113|Terazosin|terazosin|mesh-list
153821336|NCT00438113|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153821337|NCT00438113|Diuretics|diuretics|mesh-ancestor
153821338|NCT00438113|Natriuretic Agents|natriuretic agents|mesh-ancestor
153821339|NCT00438113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153821340|NCT00438113|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
153821341|NCT00438113|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153821342|NCT00438113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153821343|NCT00438113|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153821344|NCT00438113|Sympatholytics|sympatholytics|mesh-ancestor
153821345|NCT00438113|Autonomic Agents|autonomic agents|mesh-ancestor
153821346|NCT00438113|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153361297|NCT00825500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153361307|NCT01505933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153637866|NCT00005858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153637867|NCT00005861|Doxorubicin|doxorubicin|mesh-list
153637868|NCT00005861|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
153637869|NCT00005861|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153881223|NCT04670471|Remifentanil|remifentanil|mesh-list
153881224|NCT04670471|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153881225|NCT04670471|Narcotics|narcotics|mesh-ancestor
153881226|NCT04670471|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153881227|NCT04670471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153881228|NCT04670471|Analgesics|analgesics|mesh-ancestor
153637870|NCT00005861|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153637871|NCT00005861|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153637872|NCT00005861|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153637873|NCT00005861|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153637886|NCT00001083|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153637887|NCT00001083|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153637888|NCT00001083|Antiviral Agents|antiviral agents|mesh-ancestor
153637889|NCT00001083|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153637890|NCT00001083|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
153637891|NCT00001083|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153637892|NCT00001083|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153637893|NCT00001083|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153637894|NCT00001083|Antimetabolites|antimetabolites|mesh-ancestor
153637895|NCT00001083|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
153637896|NCT00001083|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
153637897|NCT00005864|Sulfanilamides|sulfanilamides|mesh-list
153637898|NCT00005864|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153637900|NCT00001086|Abacavir|abacavir|mesh-list
153637901|NCT00001086|Indinavir|indinavir|mesh-list
153637902|NCT00001086|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153637903|NCT00001086|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153637904|NCT00001086|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153637905|NCT00001086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153637906|NCT00001086|Antiviral Agents|antiviral agents|mesh-ancestor
153637907|NCT00001086|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153637908|NCT00001086|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
153821347|NCT00438113|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
153821348|NCT00438113|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
153821349|NCT00438113|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
153821350|NCT00438113|Adrenergic Agents|adrenergic agents|mesh-ancestor
153821351|NCT00438113|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153821352|NCT00438113|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
153821353|NCT00438113|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
153821354|NCT00438113|Urological Agents|urological agents|mesh-ancestor
153821356|NCT00438152|Lopinavir|lopinavir|mesh-list
153821357|NCT00438152|Saquinavir|saquinavir|mesh-list
153821358|NCT00438152|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
153821359|NCT00438152|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
153361310|NCT01505933|Sensory System Agents|sensory system agents|mesh-ancestor
153361311|NCT01505933|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153361312|NCT01505933|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
153361313|NCT01505933|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153361314|NCT01505933|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153361315|NCT01505933|Adrenergic Agents|adrenergic agents|mesh-ancestor
153821361|NCT00438152|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153637913|NCT00001086|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
153637914|NCT00001086|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153637915|NCT00001086|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153637916|NCT00001086|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
153637917|NCT00001086|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
153637918|NCT00001086|Protease Inhibitors|protease inhibitors|mesh-ancestor
153637919|NCT00700258|Sirolimus|sirolimus|mesh-list
153637920|NCT00700258|Sunitinib|sunitinib|mesh-list
153637921|NCT00700258|Temsirolimus|temsirolimus|mesh-list
153637923|NCT00700258|MTOR Inhibitors|mtor inhibitors|mesh-list
153637924|NCT00700258|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153637925|NCT00700258|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153637926|NCT00700258|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153637927|NCT00700258|Growth Substances|growth substances|mesh-ancestor
153637928|NCT00700258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153637929|NCT00700258|Growth Inhibitors|growth inhibitors|mesh-ancestor
153637930|NCT00700258|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153637931|NCT00700258|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153637932|NCT00700258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153637933|NCT00700258|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153637934|NCT00700258|Immunologic Factors|immunologic factors|mesh-ancestor
153637935|NCT00700258|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153637936|NCT00700258|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153637937|NCT00700258|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153637938|NCT00700258|Antifungal Agents|antifungal agents|mesh-ancestor
153637939|NCT00001113|Interferons|interferons|mesh-list
153637940|NCT00001113|Interferon-alpha|interferon-alpha|mesh-list
153637941|NCT00001113|Interferon alpha-2|interferon alpha-2|mesh-list
153637942|NCT00001113|Zidovudine|zidovudine|mesh-list
153637943|NCT00001113|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153637944|NCT00001113|Antiviral Agents|antiviral agents|mesh-ancestor
153637945|NCT00001113|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153637946|NCT00001113|Immunologic Factors|immunologic factors|mesh-ancestor
153637948|NCT00001113|Antimetabolites|antimetabolites|mesh-ancestor
153637973|NCT00005867|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153637974|NCT00005867|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153637975|NCT00005867|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153637976|NCT00005867|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153637977|NCT00005867|Tubulin Modulators|tubulin modulators|mesh-ancestor
153637978|NCT00005867|Antimitotic Agents|antimitotic agents|mesh-ancestor
153637979|NCT00005867|Mitosis Modulators|mitosis modulators|mesh-ancestor
153637980|NCT00005867|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153637981|NCT00005867|Glucocorticoids|glucocorticoids|mesh-ancestor
153422095|NCT04859608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153422100|NCT04824092|Prednisone|prednisone|mesh-list
153422101|NCT04824092|Cyclophosphamide|cyclophosphamide|mesh-list
153422102|NCT04824092|Rituximab|rituximab|mesh-list
153422103|NCT04824092|Doxorubicin|doxorubicin|mesh-list
153422104|NCT04824092|Vincristine|vincristine|mesh-list
153422105|NCT04824092|Lenalidomide|lenalidomide|mesh-list
153422106|NCT04824092|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153881232|NCT04620213|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
153881233|NCT04620213|Ophthalmic Solutions|ophthalmic solutions|mesh-list
153637982|NCT00005867|Hormones|hormones|mesh-ancestor
153637983|NCT00005867|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153637984|NCT00005867|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153637985|NCT00005867|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153637986|NCT00005867|Analgesics|analgesics|mesh-ancestor
153821396|NCT00474591|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153821397|NCT00474591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153821398|NCT00474591|Anticoagulants|anticoagulants|mesh-ancestor
153821399|NCT00474591|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153821400|NCT00474591|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153821401|NCT03279809|Aspirin|aspirin|mesh-list
153821402|NCT03279809|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153821403|NCT03279809|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153821404|NCT03279809|Analgesics|analgesics|mesh-ancestor
153821405|NCT03279809|Sensory System Agents|sensory system agents|mesh-ancestor
153821406|NCT03279809|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153361355|NCT02513160|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153361356|NCT02513160|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
153361357|NCT02513160|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
153361358|NCT02513160|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153361359|NCT02513160|Adrenergic Agents|adrenergic agents|mesh-ancestor
153361360|NCT02513160|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153361361|NCT02513160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153361362|NCT02513160|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153361363|NCT02513160|Glucocorticoids|glucocorticoids|mesh-ancestor
153361364|NCT02513160|Hormones|hormones|mesh-ancestor
153361365|NCT02513160|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153637988|NCT00005870|Gemcitabine|gemcitabine|mesh-list
153637989|NCT00005870|Fluorouracil|fluorouracil|mesh-list
153637991|NCT00005870|Mitomycin|mitomycin|mesh-list
153637992|NCT00005870|Rubitecan|rubitecan|mesh-list
153637993|NCT00005870|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153372141|NCT04351724|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
153372142|NCT04351724|Antithrombins|antithrombins|mesh-ancestor
153372143|NCT04351724|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
153637994|NCT00005870|Antimetabolites|antimetabolites|mesh-ancestor
153637995|NCT00005870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153637996|NCT00005870|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153637997|NCT00005870|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153637998|NCT00005870|Immunologic Factors|immunologic factors|mesh-ancestor
153637999|NCT00005870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153638000|NCT00005870|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153638001|NCT00005870|Alkylating Agents|alkylating agents|mesh-ancestor
153638002|NCT00005870|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153638003|NCT00005870|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153638004|NCT00005870|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
153638017|NCT00008866|Antisickling Agents|antisickling agents|mesh-ancestor
153638018|NCT00008866|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153638019|NCT00008866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153821407|NCT03279809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153821408|NCT03279809|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153821409|NCT03279809|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153821410|NCT03279809|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153821411|NCT03279809|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153821412|NCT03279809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153821413|NCT03279809|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153821414|NCT03279809|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153821415|NCT03279809|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153821416|NCT03279809|Antipyretics|antipyretics|mesh-ancestor
153821417|NCT00438386|Aripiprazole|aripiprazole|mesh-list
153821418|NCT00438386|Antidepressive Agents|antidepressive agents|mesh-ancestor
153361366|NCT01507103|Cyclophosphamide|cyclophosphamide|mesh-list
153361367|NCT01507103|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153361368|NCT01507103|Immunologic Factors|immunologic factors|mesh-ancestor
153361380|NCT00876200|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153361381|NCT00876200|Vasodilator Agents|vasodilator agents|mesh-ancestor
153361382|NCT02512302|Glycopyrrolate|glycopyrrolate|mesh-list
153361383|NCT02512302|Bromides|bromides|mesh-list
153361384|NCT02512302|Charcoal|charcoal|mesh-list
153361385|NCT02512302|Anticonvulsants|anticonvulsants|mesh-ancestor
153361386|NCT02512302|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153361387|NCT02512302|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
153638020|NCT00008866|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153638021|NCT00008866|Antimetabolites|antimetabolites|mesh-ancestor
153638022|NCT00008866|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153638023|NCT00008866|Antiviral Agents|antiviral agents|mesh-ancestor
153638024|NCT00008866|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153638025|NCT00008866|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153638026|NCT00008866|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153638027|NCT00001119|Ritonavir|ritonavir|mesh-list
153638028|NCT00001119|Indinavir|indinavir|mesh-list
153638029|NCT00001119|Amprenavir|amprenavir|mesh-list
153638030|NCT00001119|Lamivudine|lamivudine|mesh-list
153638031|NCT00001119|Zidovudine|zidovudine|mesh-list
153638032|NCT00001119|Abacavir|abacavir|mesh-list
153638033|NCT00001119|Lamivudine, zidovudine drug combination|lamivudine, zidovudine drug combination|mesh-list
153638034|NCT00001119|Efavirenz|efavirenz|mesh-list
153638035|NCT00001119|Vaccines|vaccines|mesh-list
153638036|NCT00001119|Immunologic Factors|immunologic factors|mesh-ancestor
153638037|NCT00001119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153638038|NCT00001119|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
153638039|NCT00001119|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
153638040|NCT00001119|Protease Inhibitors|protease inhibitors|mesh-ancestor
153638041|NCT00001119|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153372150|NCT04351724|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
153372449|NCT01779167|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153372450|NCT01779167|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153372451|NCT01779167|Growth Substances|growth substances|mesh-ancestor
153638042|NCT00001119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153638043|NCT00001119|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153638068|NCT00009061|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153638069|NCT00009061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153638070|NCT00009061|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153361397|NCT01507181|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-list
153638071|NCT00009061|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153638072|NCT00009061|Antiviral Agents|antiviral agents|mesh-ancestor
153638073|NCT00009061|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153638074|NCT00009061|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
153361398|NCT01507181|N-Methylaspartate|n-methylaspartate|mesh-list
153361399|NCT01507181|Analgesics|analgesics|mesh-ancestor
153821435|NCT00475059|Cimetidine|cimetidine|mesh-list
153638075|NCT00009061|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153638076|NCT00009061|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153638077|NCT00009061|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153638078|NCT00005873|Rubitecan|rubitecan|mesh-list
153638079|NCT00005873|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153638080|NCT00005873|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
153638081|NCT00005873|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153638082|NCT00005873|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153638083|NCT00005873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153638085|NCT00009178|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
153638086|NCT00009178|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153638087|NCT00009178|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153638088|NCT00009178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153638089|NCT00009178|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153638090|NCT00009178|Serotonin Agents|serotonin agents|mesh-ancestor
153638091|NCT00009178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153638092|NCT00009178|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
153638093|NCT00009178|Antidepressive Agents|antidepressive agents|mesh-ancestor
153638094|NCT00009178|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153638095|NCT00009178|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
153638096|NCT00009178|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153638097|NCT00009178|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153638098|NCT00009217|Haloperidol|haloperidol|mesh-list
153638105|NCT00009217|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153638106|NCT00009217|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153638107|NCT00009217|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153638108|NCT00009217|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153638109|NCT00009217|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
153638110|NCT00009217|Dopamine Agents|dopamine agents|mesh-ancestor
153638111|NCT00009217|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153638112|NCT00009217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153638113|NCT00009217|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
153638115|NCT00005876|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153638116|NCT00005876|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
153638117|NCT00005876|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153638118|NCT00005876|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153638119|NCT00005876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153892452|NCT00856037|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153892453|NCT00856037|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153892454|NCT00856037|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153892455|NCT00856037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153892456|NCT00856037|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
153892465|NCT00602797|Paclitaxel|paclitaxel|mesh-list
153892466|NCT00602797|Vinorelbine|vinorelbine|mesh-list
153892467|NCT00602797|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
153892468|NCT00602797|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153638120|NCT00001146|Eicosapentaenoic acid ethyl ester|eicosapentaenoic acid ethyl ester|mesh-list
153638121|NCT00001146|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153361419|NCT01428245|Estradiol|estradiol|mesh-list
153638123|NCT00009646|Indomethacin|indomethacin|mesh-list
153638124|NCT00009646|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153638125|NCT00009646|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153638126|NCT00009646|Analgesics|analgesics|mesh-ancestor
153638127|NCT00009646|Sensory System Agents|sensory system agents|mesh-ancestor
153638128|NCT00009646|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153638129|NCT00009646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153638130|NCT00009646|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153638131|NCT00009646|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153638132|NCT00009646|Gout Suppressants|gout suppressants|mesh-ancestor
153638133|NCT00009646|Tocolytic Agents|tocolytic agents|mesh-ancestor
153638134|NCT00009646|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153638135|NCT00009646|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153638136|NCT00009646|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153638137|NCT00009646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153638138|NCT00009763|Cyclosporine|cyclosporine|mesh-list
153638139|NCT00009763|Paclitaxel|paclitaxel|mesh-list
153638140|NCT00009763|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
153638142|NCT00009763|Immunoglobulins|immunoglobulins|mesh-list
153638143|NCT00009763|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
153638144|NCT00009763|Cyclosporins|cyclosporins|mesh-list
153638145|NCT00009763|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153638146|NCT00009763|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153638147|NCT00009763|Tubulin Modulators|tubulin modulators|mesh-ancestor
153638148|NCT00009763|Antimitotic Agents|antimitotic agents|mesh-ancestor
153638149|NCT00009763|Mitosis Modulators|mitosis modulators|mesh-ancestor
153638150|NCT00009763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153638151|NCT00009763|Immunologic Factors|immunologic factors|mesh-ancestor
153638152|NCT00009763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153638153|NCT00009763|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153638154|NCT00009763|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153892480|NCT00471848|Thymoglobulin|thymoglobulin|mesh-list
153892481|NCT00471848|Antilymphocyte Serum|antilymphocyte serum|mesh-list
153892482|NCT00471848|Immunologic Factors|immunologic factors|mesh-ancestor
153892483|NCT00471848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153892484|NCT00471848|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153892485|NCT00006721|Prednisone|prednisone|mesh-list
153892486|NCT00006721|Cyclophosphamide|cyclophosphamide|mesh-list
153892487|NCT00006721|Rituximab|rituximab|mesh-list
153638155|NCT00009763|Antifungal Agents|antifungal agents|mesh-ancestor
153638156|NCT00009763|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153638157|NCT00009763|Dermatologic Agents|dermatologic agents|mesh-ancestor
153638158|NCT00009763|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153638159|NCT00009763|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
153638160|NCT00009802|Calcitriol|calcitriol|mesh-list
153638161|NCT00009802|Paclitaxel|paclitaxel|mesh-list
153638162|NCT00009802|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153638163|NCT00009802|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153638164|NCT00009802|Tubulin Modulators|tubulin modulators|mesh-ancestor
153638165|NCT00009802|Antimitotic Agents|antimitotic agents|mesh-ancestor
153638166|NCT00009802|Mitosis Modulators|mitosis modulators|mesh-ancestor
153638167|NCT00009802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153638168|NCT00009802|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153638169|NCT00009802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153638176|NCT00009841|Mitogens|mitogens|mesh-list
153638190|NCT00009880|Fluorouracil|fluorouracil|mesh-list
153638191|NCT00009880|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153638192|NCT00009880|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153638193|NCT00009880|Tubulin Modulators|tubulin modulators|mesh-ancestor
153638194|NCT00009880|Antimitotic Agents|antimitotic agents|mesh-ancestor
153638195|NCT00009880|Mitosis Modulators|mitosis modulators|mesh-ancestor
153638196|NCT00009880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153638197|NCT00009880|Antimetabolites|antimetabolites|mesh-ancestor
153638198|NCT00009880|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153638199|NCT00009880|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153638200|NCT00009880|Immunologic Factors|immunologic factors|mesh-ancestor
153638202|NCT00009919|Semaxinib|semaxinib|mesh-list
153638203|NCT00009919|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153638204|NCT00009919|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153638205|NCT00009919|Growth Substances|growth substances|mesh-ancestor
153638206|NCT00009919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153638207|NCT00009919|Growth Inhibitors|growth inhibitors|mesh-ancestor
153638208|NCT00009919|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153638209|NCT00009919|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153638210|NCT00009919|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153881243|NCT04608955|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153892512|NCT00006721|Mitosis Modulators|mitosis modulators|mesh-ancestor
153892513|NCT01030666|Chlorhexidine|chlorhexidine|mesh-list
153892514|NCT01030666|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
153892515|NCT01030666|Doxycycline|doxycycline|mesh-list
153892516|NCT01030666|Ibuprofen|ibuprofen|mesh-list
153892517|NCT01030666|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153892518|NCT01030666|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153638211|NCT00009919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153638212|NCT00009958|Metronidazole|metronidazole|mesh-list
153638213|NCT00009958|Vaccines|vaccines|mesh-list
153638214|NCT00009958|Sargramostim|sargramostim|mesh-list
153638215|NCT00009958|Immunologic Factors|immunologic factors|mesh-ancestor
153638216|NCT00009958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153638217|NCT00009958|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153638218|NCT00009958|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153638233|NCT00009997|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153638234|NCT00009997|Immunologic Factors|immunologic factors|mesh-ancestor
153638235|NCT00009997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153638236|NCT00009997|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153638237|NCT00009997|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153638238|NCT00009997|Alkylating Agents|alkylating agents|mesh-ancestor
153638239|NCT00009997|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153638240|NCT00009997|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153638241|NCT00009997|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153638242|NCT00009997|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153638243|NCT00009997|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153638244|NCT00009997|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153638245|NCT00009997|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
153638246|NCT00009997|Hormone Antagonists|hormone antagonists|mesh-ancestor
153821492|NCT00438737|Antidotes|antidotes|mesh-ancestor
153821493|NCT00438737|Protective Agents|protective agents|mesh-ancestor
153361458|NCT05177198|Clindamycin|clindamycin|mesh-list
153361459|NCT05177198|Clindamycin palmitate|clindamycin palmitate|mesh-list
153361460|NCT05177198|Clindamycin phosphate|clindamycin phosphate|mesh-list
153361461|NCT05177198|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153361462|NCT05177198|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153361463|NCT05177198|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
153361464|NCT05177198|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153638247|NCT00009997|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153638249|NCT00009997|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
153638250|NCT00009997|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
153638251|NCT00009997|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153638252|NCT00010036|Carboplatin|carboplatin|mesh-list
153638253|NCT00010036|Irinotecan|irinotecan|mesh-list
153638254|NCT00010036|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153638255|NCT00010036|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
153638256|NCT00010036|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153638257|NCT00010036|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153638258|NCT00010036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153638259|NCT00010075|Leucovorin|leucovorin|mesh-list
153638260|NCT00010075|Fluorouracil|fluorouracil|mesh-list
153638261|NCT00010075|Mitoxantrone|mitoxantrone|mesh-list
153638262|NCT00010075|Calcium|calcium|mesh-list
153638263|NCT00010075|Levoleucovorin|levoleucovorin|mesh-list
153638264|NCT00010075|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153638265|NCT00010075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153638266|NCT00010075|Antimetabolites|antimetabolites|mesh-ancestor
153638271|NCT00010075|Immunologic Factors|immunologic factors|mesh-ancestor
153638272|NCT00010075|Antidotes|antidotes|mesh-ancestor
153638273|NCT00010075|Protective Agents|protective agents|mesh-ancestor
153638274|NCT00010075|Vitamin B Complex|vitamin b complex|mesh-ancestor
153638275|NCT00010075|Vitamins|vitamins|mesh-ancestor
153638276|NCT00010075|Micronutrients|micronutrients|mesh-ancestor
153422125|NCT04824092|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153422126|NCT04824092|Tubulin Modulators|tubulin modulators|mesh-ancestor
153422127|NCT04824092|Antimitotic Agents|antimitotic agents|mesh-ancestor
153881251|NCT04476173|Morphine|morphine|mesh-list
153881252|NCT04476173|Methoxyflurane|methoxyflurane|mesh-list
153881253|NCT04476173|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153881254|NCT04476173|Narcotics|narcotics|mesh-ancestor
153881255|NCT04476173|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153433609|NCT00002936|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153638277|NCT00010075|Analgesics|analgesics|mesh-ancestor
153638278|NCT00010075|Sensory System Agents|sensory system agents|mesh-ancestor
153638279|NCT00010075|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153638280|NCT00010075|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153638281|NCT00010075|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153638282|NCT00010075|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153638283|NCT00010153|Fulvestrant|fulvestrant|mesh-list
153638284|NCT00010153|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153638285|NCT00010153|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153638286|NCT00010153|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
153638287|NCT00010153|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
153638288|NCT00010153|Hormone Antagonists|hormone antagonists|mesh-ancestor
153638289|NCT00010153|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153638290|NCT00010153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153821501|NCT00438776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153821502|NCT00438776|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153821503|NCT00438776|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153821504|NCT00438776|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153821505|NCT00438776|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153821506|NCT00438776|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153821507|NCT00438776|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
153821508|NCT00438776|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153821509|NCT00438776|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153821510|NCT00438776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153821511|NCT00438776|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153821512|NCT00438776|Serotonin Agents|serotonin agents|mesh-ancestor
153638327|NCT00010231|Glucocorticoids|glucocorticoids|mesh-ancestor
153638328|NCT00010231|Hormones|hormones|mesh-ancestor
153638329|NCT00010231|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153638330|NCT00010231|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153638331|NCT00010231|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153638332|NCT00010231|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153638392|NCT00011089|Tenofovir|tenofovir|mesh-list
153638393|NCT00011089|Antiviral Agents|antiviral agents|mesh-ancestor
153638394|NCT00011089|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153638395|NCT00011089|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153638396|NCT00011089|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153638397|NCT00011089|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153638398|NCT00011089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153638399|NCT00011089|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153638400|NCT00011089|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153638401|NCT00011128|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
153638402|NCT00011128|Antiviral Agents|antiviral agents|mesh-ancestor
153638403|NCT00011128|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153638404|NCT00005921|Caspofungin|caspofungin|mesh-list
153638405|NCT00005921|Antifungal Agents|antifungal agents|mesh-ancestor
153638406|NCT00005921|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153638407|NCT00005921|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153638408|NCT00005921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153638409|NCT00011362|Dexamethasone|dexamethasone|mesh-list
153638410|NCT00011362|Dexamethasone acetate|dexamethasone acetate|mesh-list
153638411|NCT00011362|BB 1101|bb 1101|mesh-list
153638412|NCT00011362|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153638413|NCT00011362|Antiemetics|antiemetics|mesh-ancestor
153638414|NCT00011362|Autonomic Agents|autonomic agents|mesh-ancestor
153638415|NCT00011362|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153638416|NCT00011362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153638417|NCT00011362|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153638418|NCT00011362|Glucocorticoids|glucocorticoids|mesh-ancestor
153638439|NCT00001212|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153638440|NCT00001212|Glucocorticoids|glucocorticoids|mesh-ancestor
153638441|NCT00001212|Hormones|hormones|mesh-ancestor
153821518|NCT00475527|Clarithromycin|clarithromycin|mesh-list
153821519|NCT00475527|Omeprazole|omeprazole|mesh-list
153821520|NCT00475527|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153821521|NCT00475527|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153821522|NCT00475527|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153821523|NCT00475527|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153821524|NCT00475527|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
153821525|NCT00475527|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153821526|NCT00475527|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
153821527|NCT00475527|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153821528|NCT00475527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153821529|NCT00475527|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
153821530|NCT00475527|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
153821532|NCT00475566|Everolimus|everolimus|mesh-list
153638442|NCT00001212|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153638443|NCT00001212|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153638444|NCT00001212|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153638445|NCT00001212|Antifungal Agents|antifungal agents|mesh-ancestor
153638446|NCT00001212|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153638447|NCT00001212|Dermatologic Agents|dermatologic agents|mesh-ancestor
153638448|NCT00001212|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
153638449|NCT00011479|Abacavir|abacavir|mesh-list
153638450|NCT00011479|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153638451|NCT00011479|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153638452|NCT00011479|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153638453|NCT00011479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153638454|NCT00011479|Antiviral Agents|antiviral agents|mesh-ancestor
153638455|NCT00011479|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153638495|NCT00001251|Immunologic Factors|immunologic factors|mesh-ancestor
153638496|NCT00001251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153638497|NCT00001251|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153638498|NCT00012142|Sirolimus|sirolimus|mesh-list
153638499|NCT00012142|Temsirolimus|temsirolimus|mesh-list
153638500|NCT00012142|MTOR Inhibitors|mtor inhibitors|mesh-list
153638501|NCT00012142|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153638502|NCT00012142|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153638503|NCT00012142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153638504|NCT00012142|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153638505|NCT00012142|Immunologic Factors|immunologic factors|mesh-ancestor
153638506|NCT00012142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153638507|NCT00012142|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153638508|NCT00012142|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153638509|NCT00012142|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153638510|NCT00012142|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153638511|NCT00012142|Antifungal Agents|antifungal agents|mesh-ancestor
153638512|NCT00012181|Alvocidib|alvocidib|mesh-list
153638513|NCT00012181|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153638514|NCT00012181|Growth Inhibitors|growth inhibitors|mesh-ancestor
153638515|NCT00012181|Growth Substances|growth substances|mesh-ancestor
153638516|NCT00012181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153638517|NCT00012181|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153638518|NCT00012181|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153638519|NCT00012181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153638521|NCT00005945|Dexamethasone|dexamethasone|mesh-list
153638522|NCT00005945|Cyclophosphamide|cyclophosphamide|mesh-list
153638523|NCT00005945|Doxorubicin|doxorubicin|mesh-list
153638542|NCT00005945|Antiemetics|antiemetics|mesh-ancestor
153638543|NCT00005945|Autonomic Agents|autonomic agents|mesh-ancestor
153638544|NCT00005945|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153638545|NCT00005945|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153881270|NCT04467723|Sensory System Agents|sensory system agents|mesh-ancestor
153372457|NCT01780337|Oxytocin|oxytocin|mesh-list
153638546|NCT00005945|Glucocorticoids|glucocorticoids|mesh-ancestor
153361492|NCT01393457|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153361493|NCT01393457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153361494|NCT01393457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153638547|NCT00005945|Hormones|hormones|mesh-ancestor
153638548|NCT00005945|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153638549|NCT00005945|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153638550|NCT00005945|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153638551|NCT00005945|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153638552|NCT00005945|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153638553|NCT00005945|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153638554|NCT00005945|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
153638555|NCT00005945|Abortifacient Agents|abortifacient agents|mesh-ancestor
153638556|NCT00005945|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153638557|NCT00005945|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153638558|NCT00005945|Antimetabolites|antimetabolites|mesh-ancestor
153638559|NCT00005945|Dermatologic Agents|dermatologic agents|mesh-ancestor
153638560|NCT00005945|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153638561|NCT00005945|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153638562|NCT00005945|Antiviral Agents|antiviral agents|mesh-ancestor
153638563|NCT00005945|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153638564|NCT00005945|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153638565|NCT00005945|Tubulin Modulators|tubulin modulators|mesh-ancestor
153638566|NCT00005945|Antimitotic Agents|antimitotic agents|mesh-ancestor
153638567|NCT00005945|Mitosis Modulators|mitosis modulators|mesh-ancestor
153638568|NCT01929811|Metformin|metformin|mesh-list
153638569|NCT01929811|Docetaxel|docetaxel|mesh-list
153638589|NCT00012220|Tubulin Modulators|tubulin modulators|mesh-ancestor
153638590|NCT00012220|Antimitotic Agents|antimitotic agents|mesh-ancestor
153638591|NCT00012220|Mitosis Modulators|mitosis modulators|mesh-ancestor
153638592|NCT00012220|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
153638593|NCT00012220|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153638594|NCT00012220|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153638595|NCT00012259|Troxacitabine|troxacitabine|mesh-list
153638596|NCT00012259|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153638597|NCT00012259|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153638598|NCT00012259|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153638599|NCT00012259|Antiviral Agents|antiviral agents|mesh-ancestor
153638600|NCT00012259|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153638601|NCT00012337|Gefitinib|gefitinib|mesh-list
153638602|NCT00012337|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153638603|NCT00012337|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153638604|NCT00012337|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153638605|NCT00012337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153638649|NCT00005951|Irinotecan|irinotecan|mesh-list
153638650|NCT00005951|Temozolomide|temozolomide|mesh-list
153638651|NCT00005951|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
153638652|NCT00005951|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153638653|NCT00005951|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153638654|NCT00005951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153638655|NCT00005951|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153638656|NCT00005951|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153638657|NCT00005951|Alkylating Agents|alkylating agents|mesh-ancestor
153638658|NCT00001287|Immunoglobulins|immunoglobulins|mesh-list
153821556|NCT00439166|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
153821557|NCT00439166|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
153821558|NCT00439166|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
153821559|NCT00439166|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
153821560|NCT00439283|Infliximab|infliximab|mesh-list
153638661|NCT00001287|gamma-Globulins|gamma-globulins|mesh-list
153638662|NCT00001287|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
153638663|NCT00001287|Immunologic Factors|immunologic factors|mesh-ancestor
153638664|NCT00001287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153638708|NCT00013624|Levodopa|levodopa|mesh-list
153638709|NCT00013624|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
153638710|NCT00013624|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
153638711|NCT00013624|Dopamine Agents|dopamine agents|mesh-ancestor
153638712|NCT00013624|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153638713|NCT00013624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153638714|NCT00013624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153638715|NCT00013663|Aldesleukin|aldesleukin|mesh-list
153638716|NCT00013663|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153638717|NCT00013663|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153638718|NCT00013663|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153638719|NCT00013663|Antiviral Agents|antiviral agents|mesh-ancestor
153638720|NCT00013663|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153638721|NCT00013702|Adefovir|adefovir|mesh-list
153638722|NCT00013702|Antiviral Agents|antiviral agents|mesh-ancestor
153638723|NCT00013702|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153638724|NCT00013702|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153638725|NCT00013702|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153638726|NCT00013702|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153638727|NCT00013702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153638728|NCT00005966|Interferons|interferons|mesh-list
153638729|NCT00005966|Interferon-alpha|interferon-alpha|mesh-list
153638730|NCT00005966|Thalidomide|thalidomide|mesh-list
153638762|NCT00014092|Temozolomide|temozolomide|mesh-list
153638763|NCT00014092|Sargramostim|sargramostim|mesh-list
153821569|NCT00439283|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153821570|NCT00439283|Dermatologic Agents|dermatologic agents|mesh-ancestor
153821571|NCT00439283|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153821572|NCT00439283|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153821573|NCT00439283|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153821574|NCT00439283|Immunologic Factors|immunologic factors|mesh-ancestor
153821575|NCT00439283|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153821576|NCT00439283|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153821577|NCT00439283|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
153821578|NCT00439283|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153821579|NCT00439283|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153821580|NCT00475800|Lumiracoxib|lumiracoxib|mesh-list
153821581|NCT00475800|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
153361533|NCT01510379|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153361535|NCT01510379|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153638767|NCT00014092|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153638768|NCT00014092|Alkylating Agents|alkylating agents|mesh-ancestor
153638769|NCT00014092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153638770|NCT00014092|Immunologic Factors|immunologic factors|mesh-ancestor
153638771|NCT00014092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153638772|NCT00014092|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153638773|NCT00014092|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153638774|NCT00005972|Gemcitabine|gemcitabine|mesh-list
153638775|NCT00005972|Irinotecan|irinotecan|mesh-list
153638776|NCT00005972|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153638777|NCT00005972|Antimetabolites|antimetabolites|mesh-ancestor
153638778|NCT00005972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153638779|NCT00005972|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153638780|NCT00005972|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
153638781|NCT00005972|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153638782|NCT00005972|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153638783|NCT00014170|Gefitinib|gefitinib|mesh-list
153638784|NCT00014170|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153638785|NCT00014170|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153638786|NCT00014170|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153638787|NCT00014170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153638788|NCT00014170|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153638789|NCT00014209|Dexamethasone|dexamethasone|mesh-list
153638790|NCT00014209|Gemcitabine|gemcitabine|mesh-list
153638791|NCT00014209|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153638792|NCT00014209|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153638793|NCT00014209|Antiemetics|antiemetics|mesh-ancestor
153638794|NCT00014209|Autonomic Agents|autonomic agents|mesh-ancestor
153638795|NCT00014209|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153638796|NCT00014209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153638797|NCT00014209|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153638798|NCT00014209|Glucocorticoids|glucocorticoids|mesh-ancestor
153638800|NCT00014209|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153638801|NCT00014209|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153638802|NCT00014209|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153638803|NCT00014209|Antimetabolites|antimetabolites|mesh-ancestor
153638804|NCT00014209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153638806|NCT00014248|Analgesics|analgesics|mesh-ancestor
153638807|NCT00014248|Sensory System Agents|sensory system agents|mesh-ancestor
153638808|NCT00014248|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153638809|NCT00014248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153638810|NCT00014248|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153638811|NCT00014248|Vasodilator Agents|vasodilator agents|mesh-ancestor
153638812|NCT00014248|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
153638813|NCT00014248|Purinergic Agonists|purinergic agonists|mesh-ancestor
153638814|NCT00014248|Purinergic Agents|purinergic agents|mesh-ancestor
153638815|NCT00014248|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153638816|NCT00014248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153638817|NCT00005975|Megestrol|megestrol|mesh-list
153638818|NCT00005975|Megestrol Acetate|megestrol acetate|mesh-list
153638819|NCT00005975|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
153638820|NCT00005975|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
153638821|NCT00005975|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
153638822|NCT00005975|Contraceptive Agents|contraceptive agents|mesh-ancestor
153638823|NCT00005975|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153638824|NCT00005975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153638825|NCT00005975|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
153638826|NCT00005975|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
153638827|NCT00005975|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153638828|NCT00005975|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153638829|NCT00005975|Appetite Stimulants|appetite stimulants|mesh-ancestor
153638830|NCT00005975|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
153638831|NCT00014287|Gemcitabine|gemcitabine|mesh-list
153638832|NCT00014287|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153638833|NCT00014287|Antimetabolites|antimetabolites|mesh-ancestor
153638836|NCT02971930|Factor VIII|factor viii|mesh-list
153638837|NCT02971930|Coagulants|coagulants|mesh-ancestor
153638838|NCT00005978|Carboplatin|carboplatin|mesh-list
153638839|NCT00005978|Etoposide|etoposide|mesh-list
153638840|NCT00005978|Melphalan|melphalan|mesh-list
153638841|NCT00005978|3-Iodobenzylguanidine|3-iodobenzylguanidine|mesh-list
153638842|NCT00005978|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153881273|NCT04467723|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153881274|NCT04467723|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153881275|NCT04467723|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153881276|NCT04467723|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153881277|NCT04464070|Aspirin|aspirin|mesh-list
153881278|NCT04464070|Niacin|niacin|mesh-list
153638843|NCT00005978|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153638844|NCT00005978|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153638845|NCT00005978|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153638846|NCT00005978|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153638847|NCT00005978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153638848|NCT00005978|Immunologic Factors|immunologic factors|mesh-ancestor
153638849|NCT00005978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153638850|NCT00005978|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153638851|NCT00005978|Alkylating Agents|alkylating agents|mesh-ancestor
153638852|NCT00005978|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153638853|NCT00005978|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153638854|NCT00005978|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
153638855|NCT00014404|Celecoxib|celecoxib|mesh-list
153638856|NCT00014404|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153361557|NCT01510457|Levomilnacipran|levomilnacipran|mesh-list
153361558|NCT01510457|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
153361559|NCT01510457|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153361565|NCT01510457|Analgesics|analgesics|mesh-ancestor
153638868|NCT00001332|Cisplatin|cisplatin|mesh-list
153638881|NCT00005981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153638882|NCT00005981|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153638883|NCT00005981|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153638885|NCT00014638|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153638886|NCT00014638|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
153638887|NCT00014638|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153638888|NCT00014638|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153638889|NCT00014638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153638890|NCT00014638|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
153821617|NCT00439400|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153821618|NCT00439400|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153361570|NCT02478372|Bupivacaine|bupivacaine|mesh-list
153361571|NCT02478372|Ropivacaine|ropivacaine|mesh-list
153361572|NCT02478372|Levobupivacaine|levobupivacaine|mesh-list
153361573|NCT02478372|Anesthetics, Local|anesthetics, local|mesh-ancestor
153361574|NCT02478372|Anesthetics|anesthetics|mesh-ancestor
153361577|NCT02478372|Sensory System Agents|sensory system agents|mesh-ancestor
153638897|NCT00001341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153638898|NCT00001341|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153638899|NCT00001341|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153638900|NCT00001341|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153638901|NCT00014677|Interleukin-4|interleukin-4|mesh-list
153638931|NCT00391651|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153638932|NCT00391651|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153638933|NCT00391690|Zoledronic Acid|zoledronic acid|mesh-list
153638934|NCT00391690|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153638935|NCT00391690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153638936|NCT00005987|Interferons|interferons|mesh-list
153638937|NCT00005987|Interferon-alpha|interferon-alpha|mesh-list
153638938|NCT00005987|Dexamethasone|dexamethasone|mesh-list
153638939|NCT00005987|Cyclophosphamide|cyclophosphamide|mesh-list
153638940|NCT00005987|Carmustine|carmustine|mesh-list
153638941|NCT00005987|Etoposide|etoposide|mesh-list
153638942|NCT00005987|Mitoxantrone|mitoxantrone|mesh-list
153638943|NCT00005987|Sargramostim|sargramostim|mesh-list
153638944|NCT00005987|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153638945|NCT00005987|Immunologic Factors|immunologic factors|mesh-ancestor
153821641|NCT00476073|Fluticasone|fluticasone|mesh-list
153821642|NCT00476073|Xhance|xhance|mesh-list
153821643|NCT00476073|Formoterol Fumarate|formoterol fumarate|mesh-list
153361595|NCT02509026|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153361596|NCT02509026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153361597|NCT02509026|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153361611|NCT03439280|Hormones|hormones|mesh-ancestor
153361617|NCT03439280|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153361618|NCT03439280|Growth Substances|growth substances|mesh-ancestor
153821661|NCT00476268|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153821662|NCT00476268|Autonomic Agents|autonomic agents|mesh-ancestor
153821663|NCT00476268|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153821664|NCT00476268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153821665|NCT00476268|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153821666|NCT00476268|Respiratory System Agents|respiratory system agents|mesh-ancestor
153361620|NCT00828074|Sorafenib|sorafenib|mesh-list
153361621|NCT00828074|Vinorelbine|vinorelbine|mesh-list
153361622|NCT00828074|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153638948|NCT00005987|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153638949|NCT00005987|Alkylating Agents|alkylating agents|mesh-ancestor
153638950|NCT00005987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153638951|NCT00005987|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153638952|NCT00005987|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153638953|NCT00005987|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153638954|NCT00005987|Antiemetics|antiemetics|mesh-ancestor
153638955|NCT00005987|Autonomic Agents|autonomic agents|mesh-ancestor
153638956|NCT00005987|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153638957|NCT00005987|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153638958|NCT00005987|Glucocorticoids|glucocorticoids|mesh-ancestor
153638980|NCT00014755|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153638981|NCT00014755|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153638982|NCT00014755|Alkylating Agents|alkylating agents|mesh-ancestor
153638983|NCT00014755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153638984|NCT00014755|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153638985|NCT00014755|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153638986|NCT00014755|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153638987|NCT00014755|Glucocorticoids|glucocorticoids|mesh-ancestor
153638989|NCT00014755|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153638990|NCT00014755|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153638991|NCT00005990|Topotecan|topotecan|mesh-list
153638992|NCT00005990|Tipifarnib|tipifarnib|mesh-list
153638993|NCT00005990|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
153638994|NCT00005990|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153638995|NCT00005990|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153638996|NCT00005990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153638997|NCT00005990|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153638998|NCT00001344|Levomethorphan|levomethorphan|mesh-list
153638999|NCT00001344|Dextromethorphan|dextromethorphan|mesh-list
153361623|NCT00828074|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153361624|NCT00828074|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153361625|NCT00828074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153361626|NCT00828074|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153361627|NCT00828074|Tubulin Modulators|tubulin modulators|mesh-ancestor
153361628|NCT00828074|Antimitotic Agents|antimitotic agents|mesh-ancestor
153361629|NCT00828074|Mitosis Modulators|mitosis modulators|mesh-ancestor
153361630|NCT03434444|Propranolol|propranolol|mesh-list
153361631|NCT03434444|Oxytocin|oxytocin|mesh-list
153361632|NCT03434444|Oxytocics|oxytocics|mesh-ancestor
153639000|NCT00001344|Antitussive Agents|antitussive agents|mesh-ancestor
153639001|NCT00001344|Respiratory System Agents|respiratory system agents|mesh-ancestor
153422155|NCT04750902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153422156|NCT04750902|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
153881290|NCT04464070|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153881291|NCT04464070|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153881292|NCT04464070|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153881293|NCT04464070|Antipyretics|antipyretics|mesh-ancestor
153881294|NCT04464070|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153881295|NCT04464070|Antimetabolites|antimetabolites|mesh-ancestor
153881296|NCT04464070|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153881297|NCT04464070|Vasodilator Agents|vasodilator agents|mesh-ancestor
153639002|NCT00001344|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
153639003|NCT00001344|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
153639004|NCT00001344|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153639005|NCT00001344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153639006|NCT00001344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153639007|NCT00001344|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153639021|NCT00014989|Anticonvulsants|anticonvulsants|mesh-ancestor
153639022|NCT00014989|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153639023|NCT00014989|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153639024|NCT00014989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153639025|NCT00014989|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153639026|NCT00014989|Tocolytic Agents|tocolytic agents|mesh-ancestor
153639027|NCT00014989|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153639029|NCT00005993|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153639030|NCT00005993|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153639031|NCT00005993|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153639032|NCT00005993|Antiviral Agents|antiviral agents|mesh-ancestor
153639033|NCT00005993|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153639034|NCT00015028|Buprenorphine|buprenorphine|mesh-list
153639035|NCT00015028|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
153639036|NCT00015028|Naloxone|naloxone|mesh-list
153639037|NCT00015028|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153639038|NCT00015028|Narcotics|narcotics|mesh-ancestor
153639039|NCT00015028|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153639040|NCT00015028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153639041|NCT00015028|Analgesics|analgesics|mesh-ancestor
153639042|NCT00015028|Sensory System Agents|sensory system agents|mesh-ancestor
153639043|NCT00015028|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153639044|NCT00015028|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
153639045|NCT00015067|Methylphenidate|methylphenidate|mesh-list
153639046|NCT00015067|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
153361642|NCT03434444|Vasodilator Agents|vasodilator agents|mesh-ancestor
153639048|NCT00015067|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
153639049|NCT00015067|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153639050|NCT00015067|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153639051|NCT00015067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153639053|NCT00015067|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153639054|NCT00015106|Lamotrigine|lamotrigine|mesh-list
153639055|NCT00015106|Anticonvulsants|anticonvulsants|mesh-ancestor
153639056|NCT00015106|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153639057|NCT00015106|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153639058|NCT00015106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153639059|NCT00015106|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153639060|NCT00015106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153639061|NCT00015106|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153639062|NCT00015106|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153821680|NCT00105989|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153821681|NCT00105989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153821682|NCT00105989|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153821683|NCT00105989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153881302|NCT04459234|Analgesics|analgesics|mesh-ancestor
153821684|NCT00105989|Analgesics|analgesics|mesh-ancestor
153821685|NCT00105989|Sensory System Agents|sensory system agents|mesh-ancestor
153821686|NCT00105989|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153821687|NCT00105989|Antidepressive Agents|antidepressive agents|mesh-ancestor
153821688|NCT00105989|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153821689|NCT00105989|Dopamine Agents|dopamine agents|mesh-ancestor
153361643|NCT04382300|Thalidomide|thalidomide|mesh-list
153361644|NCT04382300|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153361645|NCT04382300|Immunologic Factors|immunologic factors|mesh-ancestor
153361646|NCT04382300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153361647|NCT04382300|Leprostatic Agents|leprostatic agents|mesh-ancestor
153361648|NCT04382300|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153361649|NCT04382300|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153361650|NCT04382300|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153361651|NCT04382300|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153639065|NCT00015106|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153639066|NCT00005996|Gemcitabine|gemcitabine|mesh-list
153639067|NCT00005996|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153639068|NCT00005996|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153639069|NCT00005996|Antimetabolites|antimetabolites|mesh-ancestor
153639070|NCT00005996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153639071|NCT00001359|Penicillins|penicillins|mesh-list
153639072|NCT00001359|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153639073|NCT00001359|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153639074|NCT00015223|Methylphenidate|methylphenidate|mesh-list
153639075|NCT00015223|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
153639076|NCT00015223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153639077|NCT00015223|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
153639078|NCT00015223|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153639079|NCT00015223|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153639080|NCT00015223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153639081|NCT00015223|Dopamine Agents|dopamine agents|mesh-ancestor
153639082|NCT00015223|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153639083|NCT00015301|Methylphenidate|methylphenidate|mesh-list
153639084|NCT00015301|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
153639085|NCT00015301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153639086|NCT00015301|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
153639087|NCT00015301|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153639088|NCT00015301|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153639089|NCT00015301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153639090|NCT00015301|Dopamine Agents|dopamine agents|mesh-ancestor
153639091|NCT00015301|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153639092|NCT00015340|Buprenorphine|buprenorphine|mesh-list
153639093|NCT00015340|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
153639094|NCT00015340|Naloxone|naloxone|mesh-list
153639095|NCT00015340|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153639096|NCT00015340|Narcotics|narcotics|mesh-ancestor
153639097|NCT00015340|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153639098|NCT00015340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153639099|NCT00015340|Analgesics|analgesics|mesh-ancestor
153639100|NCT00015340|Sensory System Agents|sensory system agents|mesh-ancestor
153639101|NCT00015340|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153639102|NCT00015340|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
153639103|NCT00015652|Ribavirin|ribavirin|mesh-list
153639104|NCT00015652|Aldesleukin|aldesleukin|mesh-list
153639105|NCT00015652|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
153639106|NCT00015652|Antimetabolites|antimetabolites|mesh-ancestor
153361670|NCT00828542|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
153361671|NCT00828542|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153361672|NCT00828542|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153361673|NCT00828542|Progestins|progestins|mesh-ancestor
153361674|NCT00828542|Hormones|hormones|mesh-ancestor
153361675|NCT00828542|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153361676|NCT01395329|Metoprolol|metoprolol|mesh-list
153892861|NCT05525910|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153361677|NCT01395329|Nebivolol|nebivolol|mesh-list
153639156|NCT00001365|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
153639157|NCT00001365|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153639158|NCT00001365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153639159|NCT00001365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153639161|NCT00001365|Narcotics|narcotics|mesh-ancestor
153639162|NCT00001365|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153639163|NCT00001365|Analgesics|analgesics|mesh-ancestor
153639164|NCT00001365|Sensory System Agents|sensory system agents|mesh-ancestor
153639165|NCT00001365|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153639166|NCT00015925|Entinostat|entinostat|mesh-list
153639167|NCT00015925|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153639168|NCT00015925|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
153639169|NCT00015925|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153639170|NCT00015925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153639171|NCT00006005|Thalidomide|thalidomide|mesh-list
153639172|NCT00006005|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153639173|NCT00006005|Immunologic Factors|immunologic factors|mesh-ancestor
153639174|NCT00006005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153639175|NCT00006005|Leprostatic Agents|leprostatic agents|mesh-ancestor
153639176|NCT00006005|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153639177|NCT00006005|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153821717|NCT00439712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153821718|NCT00476463|Emtricitabine|emtricitabine|mesh-list
153821719|NCT00476463|Antiviral Agents|antiviral agents|mesh-ancestor
153821720|NCT00476463|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153821721|NCT00476463|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153821722|NCT00476463|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153821723|NCT00476463|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153821724|NCT00476463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153821725|NCT00476463|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153821726|NCT00476463|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153821728|NCT00439751|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153821729|NCT00439751|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153821730|NCT00438243|Bromfenac|bromfenac|mesh-list
153821731|NCT00438243|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153821732|NCT00438243|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153821733|NCT00438243|Analgesics|analgesics|mesh-ancestor
153639182|NCT00006005|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153639184|NCT00015964|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153639185|NCT00015964|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153639186|NCT00015964|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153639187|NCT00015964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153639188|NCT00015964|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153639189|NCT01630213|Vitamin D|vitamin d|mesh-list
153639190|NCT01630213|Ergocalciferols|ergocalciferols|mesh-list
153639191|NCT01630213|Cholecalciferol|cholecalciferol|mesh-list
153639192|NCT01630213|Vitamins|vitamins|mesh-list
153639193|NCT01630213|Micronutrients|micronutrients|mesh-ancestor
153639194|NCT01630213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153639195|NCT01630213|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153639196|NCT01630213|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153639197|NCT00006008|Arsenic Trioxide|arsenic trioxide|mesh-list
153639198|NCT00006008|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153639199|NCT00016042|Interferons|interferons|mesh-list
153639200|NCT00016042|Interferon-alpha|interferon-alpha|mesh-list
153639201|NCT00016042|Fluorouracil|fluorouracil|mesh-list
153639202|NCT00016042|Sargramostim|sargramostim|mesh-list
153639203|NCT00016042|Antimetabolites|antimetabolites|mesh-ancestor
153639204|NCT00016042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153639205|NCT00016042|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153881307|NCT04459234|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153881308|NCT04459234|Anesthetics, General|anesthetics, general|mesh-ancestor
153881309|NCT04459234|Anesthetics|anesthetics|mesh-ancestor
153639206|NCT00016042|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153639207|NCT00016042|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153639208|NCT00016042|Immunologic Factors|immunologic factors|mesh-ancestor
153639209|NCT00016042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153639210|NCT00016042|Antiviral Agents|antiviral agents|mesh-ancestor
153639211|NCT00016042|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153639212|NCT00016081|Ribavirin|ribavirin|mesh-list
153639213|NCT00016081|Antimetabolites|antimetabolites|mesh-ancestor
153639217|NCT00016159|Idarubicin|idarubicin|mesh-list
153639228|NCT00016159|Dermatologic Agents|dermatologic agents|mesh-ancestor
153639229|NCT00016159|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153639230|NCT00016198|Leucovorin|leucovorin|mesh-list
153639231|NCT00016198|Fluorouracil|fluorouracil|mesh-list
153639232|NCT00016198|Oxaliplatin|oxaliplatin|mesh-list
153639233|NCT00016198|Calcium|calcium|mesh-list
153639234|NCT00016198|Levoleucovorin|levoleucovorin|mesh-list
153639235|NCT00016198|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153639236|NCT00016198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153639237|NCT00016198|Antimetabolites|antimetabolites|mesh-ancestor
153639238|NCT00016198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153639239|NCT00016198|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153639240|NCT00016198|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153361690|NCT01395329|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
153361691|NCT01395329|Adrenergic Agents|adrenergic agents|mesh-ancestor
153361692|NCT01395329|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153361693|NCT01395329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153361694|NCT01395329|Vasodilator Agents|vasodilator agents|mesh-ancestor
153361695|NCT01395329|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
153361696|NCT01395329|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
153361697|NCT01395329|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153361698|NCT01395329|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
153361699|NCT01395329|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
153361700|NCT01395329|Cholinergic Agents|cholinergic agents|mesh-ancestor
153639248|NCT00016276|Tamoxifen|tamoxifen|mesh-list
153639249|NCT00016276|Paclitaxel|paclitaxel|mesh-list
153639250|NCT00016276|Razoxane|razoxane|mesh-list
153639251|NCT00016276|Cyclophosphamide|cyclophosphamide|mesh-list
153639281|NCT00016276|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
153639282|NCT00016276|Protective Agents|protective agents|mesh-ancestor
153639284|NCT00016315|Carboplatin|carboplatin|mesh-list
153639285|NCT00016315|Gemcitabine|gemcitabine|mesh-list
153639286|NCT00016315|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153639287|NCT00016315|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153639288|NCT00016315|Tubulin Modulators|tubulin modulators|mesh-ancestor
153639289|NCT00016315|Antimitotic Agents|antimitotic agents|mesh-ancestor
153639290|NCT00016315|Mitosis Modulators|mitosis modulators|mesh-ancestor
153639291|NCT00016315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153639292|NCT00016315|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153639293|NCT00016315|Antimetabolites|antimetabolites|mesh-ancestor
153639294|NCT00006014|Semaxinib|semaxinib|mesh-list
153639295|NCT00006014|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153639296|NCT00006014|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153639297|NCT00006014|Growth Substances|growth substances|mesh-ancestor
153639298|NCT00006014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153639299|NCT00006014|Growth Inhibitors|growth inhibitors|mesh-ancestor
153639300|NCT00006014|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153639301|NCT00006014|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153639302|NCT00006014|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153639303|NCT00006014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153639304|NCT00016432|Exemestane|exemestane|mesh-list
153639305|NCT00016432|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153639306|NCT00016432|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
153639307|NCT00016432|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153639308|NCT00016432|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153639309|NCT00016432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153639310|NCT00016432|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
153639311|NCT00016432|Hormone Antagonists|hormone antagonists|mesh-ancestor
153639323|NCT00016549|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153639324|NCT00016549|Growth Substances|growth substances|mesh-ancestor
153639325|NCT00016549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153639326|NCT00016549|Growth Inhibitors|growth inhibitors|mesh-ancestor
153639328|NCT00006023|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153821734|NCT00438243|Sensory System Agents|sensory system agents|mesh-ancestor
153821735|NCT00438243|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153821736|NCT00438243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153821737|NCT00438243|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153821738|NCT00438243|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153821739|NCT00439829|Cetrorelix|cetrorelix|mesh-list
153821740|NCT00439829|Fertility Agents, Female|fertility agents, female|mesh-ancestor
153821741|NCT00439829|Fertility Agents|fertility agents|mesh-ancestor
153890140|NCT04021017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153461758|NCT03708588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153639333|NCT00016588|Antiviral Agents|antiviral agents|mesh-ancestor
153639334|NCT00016588|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153639335|NCT00016588|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153639336|NCT00016588|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153639337|NCT00016588|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153639338|NCT00016588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153639379|NCT00016900|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153639380|NCT00016900|Tubulin Modulators|tubulin modulators|mesh-ancestor
153639381|NCT00016900|Antimitotic Agents|antimitotic agents|mesh-ancestor
153639382|NCT00016900|Mitosis Modulators|mitosis modulators|mesh-ancestor
153639383|NCT00016900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153639384|NCT00016939|Alvocidib|alvocidib|mesh-list
153639385|NCT00016939|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153639386|NCT00016939|Growth Inhibitors|growth inhibitors|mesh-ancestor
153639387|NCT00016939|Growth Substances|growth substances|mesh-ancestor
153639388|NCT00016939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153639389|NCT00016939|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153422185|NCT04616183|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153422186|NCT04608409|Paclitaxel|paclitaxel|mesh-list
153422187|NCT04608409|Lapatinib|lapatinib|mesh-list
153422188|NCT04608409|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153434047|NCT00380965|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153639390|NCT00016939|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153639391|NCT00016939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153639392|NCT00386672|Calcium, Dietary|calcium, dietary|mesh-list
153639443|NCT00017095|Mitosis Modulators|mitosis modulators|mesh-ancestor
153639444|NCT00017095|Antimetabolites|antimetabolites|mesh-ancestor
153639445|NCT00017095|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153430931|NCT00000313|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
153639471|NCT00371059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153639486|NCT00001482|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
153639487|NCT00001482|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
153639488|NCT00001482|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153639489|NCT00001482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153639491|NCT00001482|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153639492|NCT00001482|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153639493|NCT00001482|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153639494|NCT00001482|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153639495|NCT00001482|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153639497|NCT00017134|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153639518|NCT00006032|Etoposide|etoposide|mesh-list
153639549|NCT00017251|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153639550|NCT00017251|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153639551|NCT00017251|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153639552|NCT00017251|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153639553|NCT00017251|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153639554|NCT00017251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153639555|NCT00006038|Leucovorin|leucovorin|mesh-list
153639556|NCT00006038|Docetaxel|docetaxel|mesh-list
153639557|NCT00006038|Fluorouracil|fluorouracil|mesh-list
153639558|NCT00006038|Floxuridine|floxuridine|mesh-list
153639559|NCT00006038|Calcium|calcium|mesh-list
153639560|NCT00006038|Levoleucovorin|levoleucovorin|mesh-list
153639561|NCT00006038|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153639562|NCT00006038|Tubulin Modulators|tubulin modulators|mesh-ancestor
153639563|NCT00006038|Antimitotic Agents|antimitotic agents|mesh-ancestor
153639564|NCT00006038|Mitosis Modulators|mitosis modulators|mesh-ancestor
153639565|NCT00006038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153821753|NCT03277248|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153821754|NCT03277248|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153821755|NCT03277248|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153821756|NCT03277248|Immunologic Factors|immunologic factors|mesh-ancestor
153821758|NCT00440024|Dermatologic Agents|dermatologic agents|mesh-ancestor
153821759|NCT00440024|Keratolytic Agents|keratolytic agents|mesh-ancestor
153821760|NCT00440063|Epoetin Alfa|epoetin alfa|mesh-list
153821761|NCT00440063|Hematinics|hematinics|mesh-ancestor
153821762|NCT00440102|Ketamine|ketamine|mesh-list
153821763|NCT00440102|Etomidate|etomidate|mesh-list
153821764|NCT00440102|Analgesics|analgesics|mesh-ancestor
153821765|NCT00440102|Sensory System Agents|sensory system agents|mesh-ancestor
153821771|NCT00440102|Anesthetics|anesthetics|mesh-ancestor
153639613|NCT00017368|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
153639614|NCT00017368|Etoposide|etoposide|mesh-list
153639615|NCT00017368|Etoposide phosphate|etoposide phosphate|mesh-list
153639616|NCT00017368|Vincristine|vincristine|mesh-list
153639617|NCT00017368|Isotretinoin|isotretinoin|mesh-list
153639618|NCT00017368|Sargramostim|sargramostim|mesh-list
153639619|NCT00017368|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153372599|NCT00367185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153892995|NCT01233609|Valproic Acid|valproic acid|mesh-list
153639620|NCT00017368|Immunologic Factors|immunologic factors|mesh-ancestor
153639622|NCT00017368|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153639670|NCT00001533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153639671|NCT00001533|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153639672|NCT00001533|Immunologic Factors|immunologic factors|mesh-ancestor
153639673|NCT00001533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153639674|NCT00001533|Antifungal Agents|antifungal agents|mesh-ancestor
153639675|NCT00001533|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153639676|NCT00001533|Dermatologic Agents|dermatologic agents|mesh-ancestor
153639677|NCT00001533|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153639678|NCT00001533|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
153639679|NCT00017641|Cyclophosphamide|cyclophosphamide|mesh-list
153639680|NCT00017641|Antilymphocyte Serum|antilymphocyte serum|mesh-list
153639681|NCT00017641|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153639682|NCT00017641|Immunologic Factors|immunologic factors|mesh-ancestor
153639683|NCT00017641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153639684|NCT00017641|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153639685|NCT00017641|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153639686|NCT00017641|Alkylating Agents|alkylating agents|mesh-ancestor
153639687|NCT00017641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153639688|NCT00017641|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153361737|NCT00882206|Antiviral Agents|antiviral agents|mesh-ancestor
153361738|NCT00882206|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153361739|NCT00882206|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153914644|NCT02709031|Cicletanine|cicletanine|mesh-list
153639710|NCT00017719|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153639711|NCT00017719|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153639712|NCT00017719|Antimetabolites|antimetabolites|mesh-ancestor
153639713|NCT00017719|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
153639714|NCT00017719|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
153639715|NCT00017719|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
153639716|NCT00017719|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
153639717|NCT00017719|Protease Inhibitors|protease inhibitors|mesh-ancestor
153639718|NCT00001542|Fluconazole|fluconazole|mesh-list
153821772|NCT00440102|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153821773|NCT00440102|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
153821774|NCT00440102|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
153821775|NCT00440102|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153821777|NCT00440102|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153639828|NCT00018187|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153639829|NCT00018187|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153639830|NCT00018187|Ganglionic Blockers|ganglionic blockers|mesh-ancestor
153639831|NCT00018187|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
153372612|NCT02635035|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153372613|NCT02635035|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153372614|NCT02635035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153372615|NCT02635035|Dopamine Agents|dopamine agents|mesh-ancestor
153881319|NCT04311502|Pyridoxal|pyridoxal|mesh-list
153881320|NCT04311502|Vitamin B 6|vitamin b 6|mesh-list
153881321|NCT04311502|Rifampin|rifampin|mesh-list
153881322|NCT04311502|Rifapentine|rifapentine|mesh-list
153639832|NCT00018187|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
153639834|NCT00018343|Hormones|hormones|mesh-ancestor
153639835|NCT00018343|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153639836|NCT00018343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153639837|NCT00001566|Indinavir|indinavir|mesh-list
153639838|NCT00001566|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
153639839|NCT00001566|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
153639840|NCT00001566|Protease Inhibitors|protease inhibitors|mesh-ancestor
153639841|NCT00001566|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153639842|NCT00001566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153639843|NCT00001566|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153639844|NCT00001566|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153639845|NCT00001566|Antiviral Agents|antiviral agents|mesh-ancestor
153639846|NCT00001566|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153639847|NCT00018382|Rosiglitazone|rosiglitazone|mesh-list
153639848|NCT00018382|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153639849|NCT00018382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153639850|NCT00018460|Vitamins|vitamins|mesh-list
153639851|NCT00018460|Vitamin B Complex|vitamin b complex|mesh-list
153639852|NCT00018460|Micronutrients|micronutrients|mesh-ancestor
153890144|NCT04021017|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
153890145|NCT03764553|Leucovorin|leucovorin|mesh-list
153890146|NCT03764553|Carboplatin|carboplatin|mesh-list
153639856|NCT00386750|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
153639857|NCT00386750|Antimalarials|antimalarials|mesh-ancestor
153639858|NCT00386750|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153639859|NCT00386750|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153639860|NCT00386750|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153639870|NCT00001575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153639871|NCT00001575|Iron Chelating Agents|iron chelating agents|mesh-ancestor
153639872|NCT00001575|Anticoagulants|anticoagulants|mesh-ancestor
153639873|NCT00001575|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
153639875|NCT00001596|Analgesics|analgesics|mesh-ancestor
153639876|NCT00001596|Sensory System Agents|sensory system agents|mesh-ancestor
153639877|NCT00001596|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153639878|NCT00001596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153639879|NCT00001596|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153639880|NCT00001596|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153639881|NCT00001596|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153639882|NCT00001596|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153639883|NCT00001596|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153639884|NCT00391885|Anesthetics|anesthetics|mesh-list
153639885|NCT00391885|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153639886|NCT00391885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153639887|NCT00391924|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
153639888|NCT00391924|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153639889|NCT00391924|Immunologic Factors|immunologic factors|mesh-ancestor
153422212|NCT04521361|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
153881343|NCT04311502|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
153881344|NCT04311502|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
153881345|NCT04311502|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
153639890|NCT00391924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153639891|NCT00392002|Esomeprazole|esomeprazole|mesh-list
153639892|NCT00392002|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
153639893|NCT00392002|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153639894|NCT00392002|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
153639895|NCT00392002|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153639910|NCT00001644|Lamivudine|lamivudine|mesh-list
153639918|NCT00001644|Antiviral Agents|antiviral agents|mesh-ancestor
153639919|NCT00001644|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153639920|NCT00001644|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153639921|NCT00001644|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153639922|NCT00001644|Antimetabolites|antimetabolites|mesh-ancestor
153639923|NCT00001644|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
153639924|NCT00001644|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
153639925|NCT00001644|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
153639926|NCT00001644|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
153639927|NCT00001644|Protease Inhibitors|protease inhibitors|mesh-ancestor
153639928|NCT05573386|Lenograstim|lenograstim|mesh-list
153639929|NCT05573386|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153890147|NCT03764553|Capecitabine|capecitabine|mesh-list
153639936|NCT00001656|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153639937|NCT00001656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153639938|NCT00001656|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153639939|NCT00001656|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153639940|NCT00001656|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153639941|NCT00001656|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153639942|NCT00001656|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153639967|NCT05572996|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153639968|NCT05572723|Dexmedetomidine|dexmedetomidine|mesh-list
153639969|NCT05572723|Remifentanil|remifentanil|mesh-list
153639970|NCT05572723|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153639971|NCT05572723|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153639972|NCT05572723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153639973|NCT05572723|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153639974|NCT05572723|Analgesics|analgesics|mesh-ancestor
153639975|NCT05572723|Sensory System Agents|sensory system agents|mesh-ancestor
153639976|NCT05572723|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153639977|NCT05572723|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
153639978|NCT05572723|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153639979|NCT05572723|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153639980|NCT05572723|Adrenergic Agents|adrenergic agents|mesh-ancestor
153881352|NCT04311073|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153881353|NCT04311073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153881354|NCT04311073|Hemostatics|hemostatics|mesh-ancestor
153881355|NCT04311073|Coagulants|coagulants|mesh-ancestor
153881356|NCT04283669|Crizotinib|crizotinib|mesh-list
153422213|NCT04521361|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153434183|NCT00001339|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153434184|NCT00001339|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153434185|NCT00001339|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153639981|NCT05572723|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153639982|NCT05572723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153639983|NCT05572723|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153639984|NCT05572723|Narcotics|narcotics|mesh-ancestor
153639985|NCT05563753|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
153639986|NCT05563753|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153639987|NCT00389415|Vildagliptin|vildagliptin|mesh-list
153639988|NCT00389415|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153639989|NCT00389415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153639990|NCT00389415|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
153639991|NCT00389415|Protease Inhibitors|protease inhibitors|mesh-ancestor
153639992|NCT00389415|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153639993|NCT00389415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153821785|NCT00440141|Brimonidine Tartrate|brimonidine tartrate|mesh-list
153821786|NCT00440141|Ophthalmic Solutions|ophthalmic solutions|mesh-list
153821787|NCT00440141|Latanoprost|latanoprost|mesh-list
153821788|NCT00440141|Brinzolamide|brinzolamide|mesh-list
153821789|NCT00440141|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
153821790|NCT00440141|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153821791|NCT00440141|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
153821792|NCT00440141|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153821793|NCT00440141|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153821794|NCT00440141|Adrenergic Agents|adrenergic agents|mesh-ancestor
153361751|NCT00831272|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153361756|NCT01512251|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153640009|NCT00386828|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153640010|NCT00386828|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153640011|NCT00386828|Growth Substances|growth substances|mesh-ancestor
153640012|NCT00386828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153640013|NCT00386828|Growth Inhibitors|growth inhibitors|mesh-ancestor
153640014|NCT00001725|Levomethorphan|levomethorphan|mesh-list
153640015|NCT00001725|Dextromethorphan|dextromethorphan|mesh-list
153640016|NCT00001725|Antitussive Agents|antitussive agents|mesh-ancestor
153361768|NCT01512797|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
153361769|NCT01512797|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153361770|NCT01512797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153361771|NCT01512797|Incretins|incretins|mesh-ancestor
153361772|NCT01512797|Hormones|hormones|mesh-ancestor
153361773|NCT01512797|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153361774|NCT01512797|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
153821805|NCT00438321|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153821806|NCT00438321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153821807|NCT00438321|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153821808|NCT00438321|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153821809|NCT00438321|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
153821810|NCT00438321|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153821811|NCT00438321|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153640022|NCT00001725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153640023|NCT00001725|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153640025|NCT00001725|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153640026|NCT00001725|Analgesics|analgesics|mesh-ancestor
153640027|NCT00001725|Sensory System Agents|sensory system agents|mesh-ancestor
153640028|NCT00001725|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153640029|NCT05311618|Pembrolizumab|pembrolizumab|mesh-list
153640030|NCT05311618|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153640031|NCT05311618|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153640032|NCT05311618|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153640033|NCT05311618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153640034|NCT00001728|Alendronate|alendronate|mesh-list
153640035|NCT00001728|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153640036|NCT00001728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153640037|NCT00001731|Cyclosporine|cyclosporine|mesh-list
153640048|NCT00001731|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
153640049|NCT00392158|Anesthetics|anesthetics|mesh-list
153640050|NCT00392158|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153640051|NCT00392158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153640052|NCT00392275|Ciprofloxacin|ciprofloxacin|mesh-list
153640053|NCT00392275|Levofloxacin|levofloxacin|mesh-list
153640054|NCT00392275|Ofloxacin|ofloxacin|mesh-list
153640055|NCT00392275|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153640056|NCT00392275|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153640057|NCT00392275|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153640058|NCT00392275|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153640059|NCT00392275|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153640060|NCT00392275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153640061|NCT00392275|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153640062|NCT00392275|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
153821812|NCT00438321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153821813|NCT00438321|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
153821814|NCT00438321|Hormone Antagonists|hormone antagonists|mesh-ancestor
153821815|NCT00476619|Epoetin Alfa|epoetin alfa|mesh-list
153821816|NCT00476619|Hematinics|hematinics|mesh-ancestor
153821817|NCT03279536|Lactoferrin|lactoferrin|mesh-list
153821818|NCT03279536|Dextrans|dextrans|mesh-list
153821819|NCT03279536|Iron-Dextran Complex|iron-dextran complex|mesh-list
153361776|NCT01512797|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153361777|NCT01512797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153361778|NCT05620940|Naltrexone|naltrexone|mesh-list
153361779|NCT05620940|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
153361780|NCT05620940|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
153640064|NCT00392275|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
153640066|NCT00001749|Cyclosporins|cyclosporins|mesh-list
153640067|NCT00001749|Antilymphocyte Serum|antilymphocyte serum|mesh-list
153640068|NCT00001749|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153640069|NCT00001749|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153640070|NCT00001749|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153422223|NCT04499950|Antidepressive Agents|antidepressive agents|mesh-ancestor
153372617|NCT01267136|Acetaminophen|acetaminophen|mesh-list
153372619|NCT01267136|Codeine|codeine|mesh-list
153640071|NCT00001749|Immunologic Factors|immunologic factors|mesh-ancestor
153640072|NCT00001749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153640073|NCT00001749|Antifungal Agents|antifungal agents|mesh-ancestor
153640075|NCT00001749|Dermatologic Agents|dermatologic agents|mesh-ancestor
153640094|NCT00001758|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
153640095|NCT00001758|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
153640096|NCT00001758|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
153640097|NCT00001758|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153640098|NCT00001758|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153640099|NCT00001758|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
153821820|NCT03279536|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153821821|NCT03279536|Anticoagulants|anticoagulants|mesh-ancestor
153821822|NCT03279536|Plasma Substitutes|plasma substitutes|mesh-ancestor
153821823|NCT03279536|Blood Substitutes|blood substitutes|mesh-ancestor
153821825|NCT00440219|Prednisone|prednisone|mesh-list
153821826|NCT00440219|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153821827|NCT00440219|Glucocorticoids|glucocorticoids|mesh-ancestor
153821828|NCT00440219|Hormones|hormones|mesh-ancestor
153821829|NCT00440219|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153821830|NCT00440219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153821831|NCT00440219|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153821832|NCT00440219|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153361788|NCT05124704|Anesthetics, Local|anesthetics, local|mesh-ancestor
153361789|NCT05124704|Anesthetics|anesthetics|mesh-ancestor
153361790|NCT05124704|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153361791|NCT05124704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153361792|NCT05124704|Sensory System Agents|sensory system agents|mesh-ancestor
153361793|NCT05124704|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153361794|NCT02203019|Fentanyl|fentanyl|mesh-list
153361795|NCT02203019|Dexmedetomidine|dexmedetomidine|mesh-list
153361796|NCT02203019|Propofol|propofol|mesh-list
153361797|NCT02203019|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153361798|NCT02203019|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153361799|NCT02203019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153361801|NCT02203019|Analgesics|analgesics|mesh-ancestor
153640103|NCT00001758|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
153640104|NCT00001758|Protease Inhibitors|protease inhibitors|mesh-ancestor
153640105|NCT00001764|Mycophenolic Acid|mycophenolic acid|mesh-list
153640106|NCT00001764|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153640107|NCT00001764|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153889817|NCT01004263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153889818|NCT01265823|Adalimumab|adalimumab|mesh-list
153889819|NCT01265823|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
153430935|NCT00000313|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153640108|NCT00001764|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
153640109|NCT00001764|Antitubercular Agents|antitubercular agents|mesh-ancestor
153640110|NCT00001764|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153372744|NCT02639637|Incretins|incretins|mesh-ancestor
153372745|NCT02639637|Hormones|hormones|mesh-ancestor
153640111|NCT00001764|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153640112|NCT00001764|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153640148|NCT05641506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153640149|NCT05641506|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153640150|NCT00386867|Misoprostol|misoprostol|mesh-list
153640151|NCT00386867|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
153640152|NCT00386867|Abortifacient Agents|abortifacient agents|mesh-ancestor
153640153|NCT00386867|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153640154|NCT00386867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153821833|NCT00438477|Technetium Tc 99m Sulfur Colloid|technetium tc 99m sulfur colloid|mesh-list
153821834|NCT00438477|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
153821835|NCT00438477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153821836|NCT00440258|Cabergoline|cabergoline|mesh-list
153821837|NCT00440258|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
153821838|NCT00440258|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
153821839|NCT00440258|Dopamine Agonists|dopamine agonists|mesh-ancestor
153821840|NCT00440258|Dopamine Agents|dopamine agents|mesh-ancestor
153821841|NCT00440258|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153821844|NCT00440336|Latanoprost|latanoprost|mesh-list
153361818|NCT00886262|Hemostatics|hemostatics|mesh-ancestor
153361819|NCT00886262|Coagulants|coagulants|mesh-ancestor
153361820|NCT00886262|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
153361821|NCT00886262|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
153361822|NCT00886262|Natriuretic Agents|natriuretic agents|mesh-ancestor
153361823|NCT00886262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153361824|NCT00887510|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
153361825|NCT00887510|Trandolapril|trandolapril|mesh-list
153361826|NCT00887510|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153361827|NCT00887510|Diuretics|diuretics|mesh-ancestor
153640156|NCT00386867|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153640157|NCT00386867|Oxytocics|oxytocics|mesh-ancestor
153640159|NCT04526119|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
153640160|NCT04526119|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153640210|NCT03960151|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153640211|NCT03960151|Serotonin Agents|serotonin agents|mesh-ancestor
153640212|NCT03960151|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
153640213|NCT03960151|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153640214|NCT03960151|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
153640216|NCT04733326|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
153640217|NCT04733326|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153640218|NCT04733326|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153640219|NCT04733326|Analgesics|analgesics|mesh-ancestor
153640220|NCT04733326|Sensory System Agents|sensory system agents|mesh-ancestor
153881385|NCT04238546|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153881386|NCT04238546|Immunologic Factors|immunologic factors|mesh-ancestor
153881387|NCT04238546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153881388|NCT04212416|Leflunomide|leflunomide|mesh-list
153881389|NCT04212416|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153881391|NCT04212416|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153881411|NCT04099888|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153881412|NCT04099888|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153881413|NCT04099888|Antimetabolites|antimetabolites|mesh-ancestor
153881415|NCT04081389|Interferons|interferons|mesh-list
153640221|NCT04733326|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153640222|NCT04733326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153640223|NCT04733326|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153640224|NCT04733326|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153640225|NCT04733326|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153640226|NCT04733326|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153640227|NCT04733326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153640228|NCT00386984|Octreotide|octreotide|mesh-list
153640229|NCT00386984|Somatostatin|somatostatin|mesh-list
153640263|NCT05640726|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153640264|NCT05640726|Growth Substances|growth substances|mesh-ancestor
153640265|NCT05640726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153640266|NCT05640726|Growth Inhibitors|growth inhibitors|mesh-ancestor
153640267|NCT05640726|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153640268|NCT05640726|Antimetabolites|antimetabolites|mesh-ancestor
153640269|NCT05640726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153640270|NCT05640726|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153640271|NCT05640726|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153640272|NCT05640726|Immunologic Factors|immunologic factors|mesh-ancestor
153640273|NCT05640726|Antidotes|antidotes|mesh-ancestor
153821849|NCT00440375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153821850|NCT00440414|Pemetrexed|pemetrexed|mesh-list
153821851|NCT00440414|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
153821852|NCT00440414|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153821853|NCT00440414|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153821854|NCT00440414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153821855|NCT00440414|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153640274|NCT05640726|Protective Agents|protective agents|mesh-ancestor
153640275|NCT05640726|Vitamin B Complex|vitamin b complex|mesh-ancestor
153640276|NCT05640726|Vitamins|vitamins|mesh-ancestor
153640277|NCT05640726|Micronutrients|micronutrients|mesh-ancestor
153640278|NCT03958981|Castor Oil|castor oil|mesh-list
153640279|NCT03958981|Cathartics|cathartics|mesh-ancestor
153640280|NCT03958981|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153640281|NCT03958942|Bupivacaine|bupivacaine|mesh-list
153640282|NCT03958942|Anesthetics, Local|anesthetics, local|mesh-ancestor
153640283|NCT03958942|Anesthetics|anesthetics|mesh-ancestor
153640284|NCT03958942|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153640285|NCT03958942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153640286|NCT03958942|Sensory System Agents|sensory system agents|mesh-ancestor
153640287|NCT03958942|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153640314|NCT03958396|Narcotics|narcotics|mesh-ancestor
153640315|NCT03958396|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153640316|NCT03958396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153640317|NCT03958396|Analgesics|analgesics|mesh-ancestor
153640318|NCT03958396|Sensory System Agents|sensory system agents|mesh-ancestor
153640319|NCT03958396|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153640320|NCT03958123|Moxifloxacin|moxifloxacin|mesh-list
153361833|NCT00887510|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
153361834|NCT00887510|Protease Inhibitors|protease inhibitors|mesh-ancestor
153361835|NCT00887510|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153881425|NCT04081389|Daunorubicin|daunorubicin|mesh-list
153434322|NCT00002065|Disulfiram|disulfiram|mesh-list
153434323|NCT00002065|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
153434324|NCT00002065|Acetaldehyde Dehydrogenase Inhibitors|acetaldehyde dehydrogenase inhibitors|mesh-ancestor
153434325|NCT00002065|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153434326|NCT00002065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153434327|NCT00002071|Epoetin Alfa|epoetin alfa|mesh-list
153434328|NCT00002071|Hematinics|hematinics|mesh-ancestor
153434329|NCT00002395|Topotecan|topotecan|mesh-list
153434330|NCT00002395|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
153361836|NCT01431989|Amoxicillin|amoxicillin|mesh-list
153361837|NCT01431989|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153361838|NCT01431989|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153361840|NCT01397591|Ofatumumab|ofatumumab|mesh-list
153361841|NCT01397591|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153361842|NCT03855332|Cilostazol|cilostazol|mesh-list
153361843|NCT03855332|Sildenafil Citrate|sildenafil citrate|mesh-list
153361844|NCT03855332|Vasodilator Agents|vasodilator agents|mesh-ancestor
153821872|NCT00440609|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153821873|NCT00440648|Sevelamer|sevelamer|mesh-list
153821874|NCT00440648|Chelating Agents|chelating agents|mesh-ancestor
153821875|NCT00440648|Sequestering Agents|sequestering agents|mesh-ancestor
153821876|NCT00440648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153821877|NCT00440687|Fluticasone|fluticasone|mesh-list
153821878|NCT00440687|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153821879|NCT00440687|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153821880|NCT00440687|Autonomic Agents|autonomic agents|mesh-ancestor
153640322|NCT03958123|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153640323|NCT03958123|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153640324|NCT03958123|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153640325|NCT03958123|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153640326|NCT03958123|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153640327|NCT03958123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153640328|NCT03958123|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153640329|NCT03958123|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
153640330|NCT03958123|Contraceptive Agents|contraceptive agents|mesh-ancestor
153640331|NCT03958123|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153640332|NCT03958123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153640333|NCT03958123|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
153640334|NCT03958123|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
153640335|NCT03958123|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
153640337|NCT03933865|Hydromorphone|hydromorphone|mesh-list
153640338|NCT03933865|Analgesics|analgesics|mesh-ancestor
153640371|NCT00392899|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153640372|NCT05638893|Metformin|metformin|mesh-list
153640373|NCT05638893|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153640374|NCT05638893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153640375|NCT00392938|Docetaxel|docetaxel|mesh-list
153640376|NCT00392938|Androgen Antagonists|androgen antagonists|mesh-list
153640419|NCT03152149|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153640420|NCT03152149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153640421|NCT03151993|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
153640422|NCT03151993|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153640423|NCT03151993|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153640424|NCT03151993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153640425|NCT05633472|Vitamin D|vitamin d|mesh-list
153640426|NCT05633472|Vitamins|vitamins|mesh-ancestor
153640427|NCT05633472|Micronutrients|micronutrients|mesh-ancestor
153640428|NCT05633472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153640429|NCT05633472|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153640430|NCT03151876|Gemcitabine|gemcitabine|mesh-list
153640431|NCT03151876|Busulfan|busulfan|mesh-list
153640432|NCT03151876|Cladribine|cladribine|mesh-list
153640433|NCT03151876|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153640434|NCT03151876|Antimetabolites|antimetabolites|mesh-ancestor
153640436|NCT03151876|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153640475|NCT03151486|Purinergic Agents|purinergic agents|mesh-ancestor
153640476|NCT03151486|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153640477|NCT03151486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153640478|NCT03151486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153640479|NCT00387374|Paclitaxel|paclitaxel|mesh-list
153640480|NCT00387374|Bevacizumab|bevacizumab|mesh-list
153640481|NCT00387374|Carboplatin|carboplatin|mesh-list
153640482|NCT00387374|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
153881437|NCT04081389|Alkylating Agents|alkylating agents|mesh-ancestor
153881438|NCT04081389|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153881439|NCT04081389|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153881441|NCT04081389|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153640491|NCT00387374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153640493|NCT00387374|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153640494|NCT00387374|Growth Substances|growth substances|mesh-ancestor
153640495|NCT00387374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153640527|NCT03151213|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153640528|NCT03151174|Vitamin D|vitamin d|mesh-list
153640529|NCT03151174|Ergocalciferols|ergocalciferols|mesh-list
153640530|NCT03151174|Cholecalciferol|cholecalciferol|mesh-list
153640531|NCT03151174|Vitamins|vitamins|mesh-list
153640532|NCT03151174|Micronutrients|micronutrients|mesh-ancestor
153640533|NCT03151174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153640534|NCT03151174|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153640535|NCT03151174|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153640536|NCT03151096|Riboflavin|riboflavin|mesh-list
153640537|NCT03151096|Vitamin B Complex|vitamin b complex|mesh-ancestor
153640538|NCT03151096|Vitamins|vitamins|mesh-ancestor
153640539|NCT03151096|Micronutrients|micronutrients|mesh-ancestor
153640547|NCT03906539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153640583|NCT03150667|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
153640584|NCT03150667|Purinergic Agents|purinergic agents|mesh-ancestor
153640585|NCT03150667|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153640586|NCT03150667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153640587|NCT03150667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153640588|NCT03150316|Dexamethasone|dexamethasone|mesh-list
153640589|NCT03150316|Lenalidomide|lenalidomide|mesh-list
153640591|NCT03150316|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153640650|NCT00393289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153640651|NCT02285179|Tamoxifen|tamoxifen|mesh-list
153640652|NCT02285179|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
153640653|NCT02285179|Hormone Antagonists|hormone antagonists|mesh-ancestor
153640654|NCT02285179|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153640655|NCT02285179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153640656|NCT02285179|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153640657|NCT02285179|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153640658|NCT02285179|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
153640659|NCT02285179|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
153640660|NCT02285179|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153640661|NCT02122081|Cyclophosphamide|cyclophosphamide|mesh-list
153640662|NCT02122081|Methotrexate|methotrexate|mesh-list
153640663|NCT02122081|Tacrolimus|tacrolimus|mesh-list
153640664|NCT02122081|Thymoglobulin|thymoglobulin|mesh-list
153640665|NCT02122081|Antilymphocyte Serum|antilymphocyte serum|mesh-list
153640666|NCT02122081|Immunoglobulins|immunoglobulins|mesh-list
153640667|NCT02122081|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153640668|NCT02122081|Immunologic Factors|immunologic factors|mesh-ancestor
153640705|NCT00393328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153640706|NCT00393328|Dopamine Agonists|dopamine agonists|mesh-ancestor
153640707|NCT00393328|Dopamine Agents|dopamine agents|mesh-ancestor
153640708|NCT00393328|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153640709|NCT00393328|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
153640710|NCT00393328|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
153640711|NCT00393328|Serotonin Agents|serotonin agents|mesh-ancestor
153640712|NCT00393328|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
153640713|NCT00393328|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153640714|NCT00393328|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
153881442|NCT04081389|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153881443|NCT04081389|Antiviral Agents|antiviral agents|mesh-ancestor
153881444|NCT04081389|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153640715|NCT00393328|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
153640716|NCT05530551|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
153640717|NCT05530551|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153640718|NCT01807429|Midazolam|midazolam|mesh-list
153640719|NCT01807429|Ketamine|ketamine|mesh-list
153640720|NCT01807429|Morphine|morphine|mesh-list
153640721|NCT01807429|Analgesics|analgesics|mesh-ancestor
153640722|NCT01807429|Sensory System Agents|sensory system agents|mesh-ancestor
153640723|NCT01807429|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153640724|NCT01807429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153640725|NCT01807429|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
153640768|NCT01807000|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153640769|NCT01807000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153640770|NCT01807000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153640771|NCT01806805|Zonisamide|zonisamide|mesh-list
153640772|NCT01806805|Anticonvulsants|anticonvulsants|mesh-ancestor
153640773|NCT01806805|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153640774|NCT01806805|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153640775|NCT01806805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153640776|NCT01806805|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153640777|NCT01806805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153640778|NCT00387413|Niacinamide|niacinamide|mesh-list
153640779|NCT00387413|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
153640780|NCT00387413|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
153640781|NCT00387413|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153640782|NCT00387413|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153640783|NCT00387413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153640784|NCT00387413|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153640785|NCT00387413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153640786|NCT00387413|Analgesics|analgesics|mesh-ancestor
153640787|NCT00387413|Sensory System Agents|sensory system agents|mesh-ancestor
153640788|NCT00387413|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153640789|NCT00387413|Antidepressive Agents|antidepressive agents|mesh-ancestor
153640790|NCT00387413|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153640796|NCT01806610|Immunologic Factors|immunologic factors|mesh-ancestor
153640797|NCT01806610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153640799|NCT05517291|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153361961|NCT05946005|Lidocaine|lidocaine|mesh-list
153640801|NCT05517291|Tubulin Modulators|tubulin modulators|mesh-ancestor
153640802|NCT05517291|Antimitotic Agents|antimitotic agents|mesh-ancestor
153640803|NCT05517291|Mitosis Modulators|mitosis modulators|mesh-ancestor
153640804|NCT05517291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153640805|NCT01806454|Calcium|calcium|mesh-list
153640806|NCT01806454|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153640807|NCT01806454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153640808|NCT01806415|Imidazole|imidazole|mesh-list
153640809|NCT01806415|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153640810|NCT01806415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153640811|NCT01806376|Maleic acid|maleic acid|mesh-list
153640812|NCT01806376|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153640813|NCT01806376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153640814|NCT01806337|Alemtuzumab|alemtuzumab|mesh-list
153640849|NCT00393562|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
153640850|NCT01806103|Anti-Infective Agents|anti-infective agents|mesh-list
153640851|NCT01806103|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
153640853|NCT01805908|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153640854|NCT01805908|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153640855|NCT05437887|Fucoidan|fucoidan|mesh-list
153372749|NCT02639637|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153372750|NCT02639637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153881461|NCT04022005|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153881462|NCT04022005|Immunologic Factors|immunologic factors|mesh-ancestor
153893321|NCT01006603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153893322|NCT01006603|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153893323|NCT01006603|Immunologic Factors|immunologic factors|mesh-ancestor
153640856|NCT05437887|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
153640857|NCT05437887|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153640858|NCT05437887|Anticoagulants|anticoagulants|mesh-ancestor
153640916|NCT01466101|Sensory System Agents|sensory system agents|mesh-ancestor
153640917|NCT01466101|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153640918|NCT01466101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153640919|NCT01466101|Anticonvulsants|anticonvulsants|mesh-ancestor
153640920|NCT01466101|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153640921|NCT01466101|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153640976|NCT01465399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153640978|NCT05393505|Amoxicillin|amoxicillin|mesh-list
153640979|NCT05393505|Levofloxacin|levofloxacin|mesh-list
153640980|NCT05393505|Meropenem|meropenem|mesh-list
153640981|NCT05393505|Clavulanic Acid|clavulanic acid|mesh-list
153640982|NCT05393505|Clavulanic Acids|clavulanic acids|mesh-list
153640983|NCT05393505|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
153640984|NCT05393505|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153640985|NCT05393505|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
153640986|NCT05393505|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153640987|NCT05393505|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153640988|NCT05393505|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153640989|NCT05393505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153640990|NCT05393505|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153640991|NCT05393505|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
153640992|NCT05393505|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153640994|NCT01465009|Aspirin|aspirin|mesh-list
153641031|NCT00393679|Dapsone|dapsone|mesh-list
153641032|NCT00393679|Chlorproguanil|chlorproguanil|mesh-list
153641033|NCT00393679|Antimalarials|antimalarials|mesh-ancestor
153641034|NCT00393679|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153641035|NCT00393679|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153641040|NCT00393679|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
153641041|NCT00393679|Anthelmintics|anthelmintics|mesh-ancestor
153641042|NCT00393679|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153641043|NCT00393679|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153641044|NCT00393679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153641045|NCT00393679|Leprostatic Agents|leprostatic agents|mesh-ancestor
153641046|NCT00393679|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153641047|NCT00393835|Azithromycin|azithromycin|mesh-list
153641048|NCT00393835|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153641049|NCT00393835|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153641050|NCT01057069|Paclitaxel|paclitaxel|mesh-list
153641051|NCT01057069|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
153641052|NCT01057069|Cyclophosphamide|cyclophosphamide|mesh-list
153641053|NCT01057069|Carboplatin|carboplatin|mesh-list
153641054|NCT01057069|Doxorubicin|doxorubicin|mesh-list
153641055|NCT01057069|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
153641056|NCT01057069|Thiotepa|thiotepa|mesh-list
153641057|NCT01057069|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153641058|NCT01057069|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153881466|NCT04022005|Antimetabolites|antimetabolites|mesh-ancestor
153641059|NCT01057069|Tubulin Modulators|tubulin modulators|mesh-ancestor
153641060|NCT01057069|Antimitotic Agents|antimitotic agents|mesh-ancestor
153641061|NCT01057069|Mitosis Modulators|mitosis modulators|mesh-ancestor
153641079|NCT00847834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153641080|NCT00847834|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
153641081|NCT00847834|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153641082|NCT00847834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153641083|NCT00847834|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
153641084|NCT00847834|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
153641086|NCT00847678|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
153641087|NCT00847678|Flucytosine|flucytosine|mesh-list
153641088|NCT00847678|Efungumab|efungumab|mesh-list
153641089|NCT00847678|Amebicides|amebicides|mesh-ancestor
153641090|NCT00847678|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153641091|NCT00847678|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153641092|NCT00847678|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153641094|NCT00847678|Antifungal Agents|antifungal agents|mesh-ancestor
153641095|NCT00847678|Antimetabolites|antimetabolites|mesh-ancestor
153641096|NCT00847678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153641097|NCT00847639|Lenalidomide|lenalidomide|mesh-list
153641098|NCT00847639|Immunologic Factors|immunologic factors|mesh-ancestor
153641099|NCT00847639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153641105|NCT00847483|Bimatoprost|bimatoprost|mesh-list
153641151|NCT00847210|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153641152|NCT00847210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153641153|NCT00847171|Cyclophosphamide|cyclophosphamide|mesh-list
153641154|NCT00847171|Trastuzumab|trastuzumab|mesh-list
153641155|NCT00847171|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153641156|NCT00847171|Immunologic Factors|immunologic factors|mesh-ancestor
153641157|NCT00847171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153641159|NCT00847171|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153641160|NCT00847171|Alkylating Agents|alkylating agents|mesh-ancestor
153641161|NCT00847171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153641162|NCT00847171|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153641163|NCT00847171|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153641164|NCT00847171|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153641165|NCT00847093|Lidocaine|lidocaine|mesh-list
153641166|NCT00847093|Anesthetics, Local|anesthetics, local|mesh-ancestor
153641167|NCT00847093|Anesthetics|anesthetics|mesh-ancestor
153641168|NCT00847093|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153641169|NCT00847093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153641170|NCT00847093|Sensory System Agents|sensory system agents|mesh-ancestor
153641171|NCT00847093|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153641172|NCT00847093|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153641173|NCT00847093|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
153641174|NCT00847093|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153641175|NCT00847093|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153641176|NCT00847093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153641193|NCT00846859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153641194|NCT03885830|Imatinib Mesylate|imatinib mesylate|mesh-list
153641195|NCT03885830|Dasatinib|dasatinib|mesh-list
153641196|NCT03885830|Nilotinib|nilotinib|mesh-list
153641197|NCT03885830|Bosutinib|bosutinib|mesh-list
153641198|NCT03885830|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153641199|NCT03885830|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153641200|NCT03885830|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153361981|NCT05945979|Micronutrients|micronutrients|mesh-ancestor
153641201|NCT03885830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153641202|NCT03885830|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153372752|NCT02639637|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
153372753|NCT02639637|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
153372754|NCT02639637|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
153641203|NCT00846703|Dexamethasone|dexamethasone|mesh-list
153641204|NCT00846703|Methotrexate|methotrexate|mesh-list
153641205|NCT00846703|Vincristine|vincristine|mesh-list
153641206|NCT00846703|Mercaptopurine|mercaptopurine|mesh-list
153641207|NCT00846703|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153641208|NCT00846703|Antiemetics|antiemetics|mesh-ancestor
153641209|NCT00846703|Autonomic Agents|autonomic agents|mesh-ancestor
153641210|NCT00846703|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153641211|NCT00846703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153641212|NCT00846703|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153641213|NCT00846703|Glucocorticoids|glucocorticoids|mesh-ancestor
153641214|NCT00846703|Hormones|hormones|mesh-ancestor
153641215|NCT00846703|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153641216|NCT00846703|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153641245|NCT00846625|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153641246|NCT00846625|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153641247|NCT00846625|Glucocorticoids|glucocorticoids|mesh-ancestor
153641248|NCT00846625|Hormones|hormones|mesh-ancestor
153641249|NCT00846625|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153641250|NCT00846508|Cisplatin|cisplatin|mesh-list
153641251|NCT00846508|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153641252|NCT00846274|Antithrombins|antithrombins|mesh-list
153641253|NCT00846274|Antithrombin III|antithrombin iii|mesh-list
153641254|NCT00846274|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
153641255|NCT00846274|Protease Inhibitors|protease inhibitors|mesh-ancestor
153641256|NCT00846274|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153641257|NCT00846274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153641258|NCT00846274|Anticoagulants|anticoagulants|mesh-ancestor
153641259|NCT00846235|Glycerol|glycerol|mesh-list
153641260|NCT00846235|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
153641261|NCT00846235|Protective Agents|protective agents|mesh-ancestor
153641262|NCT00846235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153641263|NCT00846196|Risedronic Acid|risedronic acid|mesh-list
153641264|NCT00846196|Etidronic Acid|etidronic acid|mesh-list
153641265|NCT00846196|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153641266|NCT00846196|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153641267|NCT00846196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153641268|NCT00846196|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153641269|NCT00846196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153641270|NCT00846196|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153641271|NCT00846118|Pitavastatin|pitavastatin|mesh-list
153641272|NCT00846118|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
153641273|NCT00846118|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153641274|NCT00846118|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153641275|NCT00846118|Antimetabolites|antimetabolites|mesh-ancestor
153641276|NCT00846118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153641277|NCT00846118|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153641278|NCT00846118|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153641284|NCT00846079|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153641285|NCT00846079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153641286|NCT00846079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153641287|NCT00845962|Bupivacaine|bupivacaine|mesh-list
153641288|NCT00845962|Chloroprocaine|chloroprocaine|mesh-list
153641289|NCT00845962|Anesthetics, Local|anesthetics, local|mesh-ancestor
153641290|NCT00845962|Anesthetics|anesthetics|mesh-ancestor
153641291|NCT00845962|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153641292|NCT00845962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153641293|NCT00845962|Sensory System Agents|sensory system agents|mesh-ancestor
153641294|NCT00845962|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153641295|NCT03620942|Phenylephrine|phenylephrine|mesh-list
153641296|NCT03620942|Oxymetazoline|oxymetazoline|mesh-list
153641297|NCT03620942|Ephedrine|ephedrine|mesh-list
153641298|NCT03620942|Vasoconstrictor Agents|vasoconstrictor agents|mesh-list
153881479|NCT03970720|Autonomic Agents|autonomic agents|mesh-ancestor
153881480|NCT03970720|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153881481|NCT03970720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153881482|NCT03970720|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153893433|NCT01293032|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153641299|NCT03620942|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
153641300|NCT03620942|Mydriatics|mydriatics|mesh-ancestor
153641301|NCT03620942|Autonomic Agents|autonomic agents|mesh-ancestor
153641304|NCT03620942|Sympathomimetics|sympathomimetics|mesh-ancestor
153641339|NCT00276874|Aripiprazole|aripiprazole|mesh-list
153641340|NCT00276874|Antidepressive Agents|antidepressive agents|mesh-ancestor
153641341|NCT00276874|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153641342|NCT00276874|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153641343|NCT00276874|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153641344|NCT00276874|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153641345|NCT00276874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153641346|NCT00276874|Dopamine Agonists|dopamine agonists|mesh-ancestor
153641347|NCT00276874|Dopamine Agents|dopamine agents|mesh-ancestor
153641348|NCT00276874|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153641349|NCT00276874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153641350|NCT00276874|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
153641351|NCT00276874|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
153641352|NCT00276874|Serotonin Agents|serotonin agents|mesh-ancestor
153641353|NCT00276874|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
153641354|NCT00276874|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153641355|NCT00276874|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
153641356|NCT00276874|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
153641357|NCT00276835|Aldesleukin|aldesleukin|mesh-list
153641358|NCT00276835|Interleukin-2|interleukin-2|mesh-list
153641360|NCT00276835|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153641361|NCT00276835|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153641362|NCT00276835|Analgesics|analgesics|mesh-ancestor
153641363|NCT00276835|Sensory System Agents|sensory system agents|mesh-ancestor
153641364|NCT00276835|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153641366|NCT00276835|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153641386|NCT00276796|Mitosis Modulators|mitosis modulators|mesh-ancestor
153641387|NCT00276796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153641388|NCT00276796|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
153641389|NCT00276796|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153641390|NCT00276796|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153641392|NCT00276757|Prednisolone|prednisolone|mesh-list
153641393|NCT00276757|Methotrexate|methotrexate|mesh-list
153641394|NCT00276757|Vinblastine|vinblastine|mesh-list
153641395|NCT00276757|Calcium|calcium|mesh-list
153641396|NCT00276757|Levoleucovorin|levoleucovorin|mesh-list
153641397|NCT00276757|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153641398|NCT00276757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153641450|NCT00276601|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153641451|NCT00276601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153641452|NCT00276601|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153641453|NCT00276601|Antimetabolites|antimetabolites|mesh-ancestor
153641454|NCT00276601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153641455|NCT00276601|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153641456|NCT00276601|Dermatologic Agents|dermatologic agents|mesh-ancestor
153641457|NCT00276601|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153641458|NCT00276601|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153641459|NCT00276601|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153641460|NCT00276601|Immunologic Factors|immunologic factors|mesh-ancestor
153641461|NCT00276601|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153641462|NCT00276601|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153881496|NCT03912818|Doxorubicin|doxorubicin|mesh-list
153881497|NCT03912818|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
153881498|NCT03912818|Methotrexate|methotrexate|mesh-list
153881499|NCT03912818|Durvalumab|durvalumab|mesh-list
153881501|NCT03912818|Vinblastine|vinblastine|mesh-list
153893461|NCT04204603|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
153893462|NCT04204603|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153893463|NCT04204603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153893464|NCT01222533|Tiotropium Bromide|tiotropium bromide|mesh-list
153893465|NCT01222533|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153893466|NCT01222533|Autonomic Agents|autonomic agents|mesh-ancestor
153641463|NCT00276601|Antiviral Agents|antiviral agents|mesh-ancestor
153641464|NCT00276601|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153641465|NCT00276601|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153641466|NCT00276601|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153641467|NCT00276601|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153641469|NCT00276523|Interferons|interferons|mesh-list
153641505|NCT00276289|Hormone Antagonists|hormone antagonists|mesh-ancestor
153641506|NCT00276289|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153641507|NCT00276289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153641508|NCT00276289|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
153641509|NCT00276289|Diuretics|diuretics|mesh-ancestor
153641510|NCT00276289|Natriuretic Agents|natriuretic agents|mesh-ancestor
153641512|NCT00276250|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153641513|NCT00276250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153641514|NCT00276250|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153641516|NCT00276250|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153641517|NCT00276250|Immunologic Factors|immunologic factors|mesh-ancestor
153641518|NCT00276250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153641519|NCT00276250|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153641520|NCT00394186|Solabegron|solabegron|mesh-list
153641521|NCT00394186|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
153641522|NCT00394186|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
153641523|NCT00394186|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153641524|NCT00394186|Adrenergic Agents|adrenergic agents|mesh-ancestor
153641559|NCT00275938|Interferons|interferons|mesh-list
153641560|NCT00275938|Ribavirin|ribavirin|mesh-list
153641561|NCT00275938|Interferon-alpha|interferon-alpha|mesh-list
153641562|NCT00275938|Interferon alpha-2|interferon alpha-2|mesh-list
153641563|NCT00275938|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153641564|NCT00275938|Antiviral Agents|antiviral agents|mesh-ancestor
153641565|NCT00275938|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153641566|NCT00275938|Antimetabolites|antimetabolites|mesh-ancestor
153641567|NCT00275938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153641568|NCT00275938|Immunologic Factors|immunologic factors|mesh-ancestor
153641569|NCT00275938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153641570|NCT00275665|Valganciclovir|valganciclovir|mesh-list
153641571|NCT00275665|Antiviral Agents|antiviral agents|mesh-ancestor
153641572|NCT00275665|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153641573|NCT00276640|Carboplatin|carboplatin|mesh-list
153641574|NCT00276640|Etoposide|etoposide|mesh-list
153641575|NCT00276640|Vincristine|vincristine|mesh-list
153641576|NCT00276640|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153641577|NCT00276640|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153641578|NCT00276640|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153641579|NCT00276640|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153641580|NCT00276640|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153641581|NCT00276640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153641582|NCT00276640|Tubulin Modulators|tubulin modulators|mesh-ancestor
153641583|NCT00276640|Antimitotic Agents|antimitotic agents|mesh-ancestor
153641584|NCT00276640|Mitosis Modulators|mitosis modulators|mesh-ancestor
153641585|NCT00275548|Ribavirin|ribavirin|mesh-list
153641610|NCT02921555|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
153641611|NCT02921555|Prednisolone phosphate|prednisolone phosphate|mesh-list
153641612|NCT02921555|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153641613|NCT02921555|Glucocorticoids|glucocorticoids|mesh-ancestor
153641614|NCT02921555|Hormones|hormones|mesh-ancestor
153641615|NCT02921555|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153641616|NCT02921555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153641617|NCT02921555|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153641618|NCT02921555|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153641619|NCT02921555|Antiemetics|antiemetics|mesh-ancestor
153641620|NCT02921555|Autonomic Agents|autonomic agents|mesh-ancestor
153641621|NCT02921555|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153881502|NCT03912818|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153881503|NCT03912818|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153881504|NCT03912818|Antimetabolites|antimetabolites|mesh-ancestor
153881505|NCT03912818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153893500|NCT01019980|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153893501|NCT01019980|Analgesics|analgesics|mesh-ancestor
153641622|NCT02921555|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153641623|NCT02921555|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
153641624|NCT02921555|Protective Agents|protective agents|mesh-ancestor
153641625|NCT05070585|Phenethyl isothiocyanate|phenethyl isothiocyanate|mesh-list
153641626|NCT05070585|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153641627|NCT05070585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153641628|NCT05070585|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
153641629|NCT05070585|Protective Agents|protective agents|mesh-ancestor
153641630|NCT05070585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153641631|NCT05070585|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153641632|NCT00387530|Valganciclovir|valganciclovir|mesh-list
153641633|NCT00387530|4-phenylbutyric acid|4-phenylbutyric acid|mesh-list
153641634|NCT00387530|Antiviral Agents|antiviral agents|mesh-ancestor
153641635|NCT00387530|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153641636|NCT00387530|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153641637|NCT02680184|Pembrolizumab|pembrolizumab|mesh-list
153641638|NCT02680184|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153641639|NCT02680184|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153641640|NCT02680184|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153641641|NCT02680184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153641642|NCT00390000|Pemetrexed|pemetrexed|mesh-list
153641643|NCT00390000|Vatalanib|vatalanib|mesh-list
153641644|NCT00390000|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153641645|NCT00390000|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153641648|NCT00390000|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153641649|NCT00390000|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153641650|NCT02632760|Iron isomaltoside 1000|iron isomaltoside 1000|mesh-list
153641651|NCT02632760|Hematinics|hematinics|mesh-ancestor
153641652|NCT04574245|Immunomodulating Agents|immunomodulating agents|mesh-list
153641653|NCT04574245|Immunologic Factors|immunologic factors|mesh-ancestor
153641655|NCT04556617|Prednisone|prednisone|mesh-list
153641656|NCT04556617|Olaparib|olaparib|mesh-list
153641657|NCT04556617|Abiraterone Acetate|abiraterone acetate|mesh-list
153641658|NCT04556617|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153641659|NCT04556617|Glucocorticoids|glucocorticoids|mesh-ancestor
153641660|NCT04556617|Hormones|hormones|mesh-ancestor
153641661|NCT04556617|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153641662|NCT04556617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153641663|NCT04556617|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153641705|NCT04712435|Acetylcysteine|acetylcysteine|mesh-list
153641706|NCT04712435|N-monoacetylcystine|n-monoacetylcystine|mesh-list
153641707|NCT04712435|Antiviral Agents|antiviral agents|mesh-ancestor
153641708|NCT04712435|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153641709|NCT04712435|Expectorants|expectorants|mesh-ancestor
153641710|NCT04712435|Respiratory System Agents|respiratory system agents|mesh-ancestor
153641711|NCT04712435|Free Radical Scavengers|free radical scavengers|mesh-ancestor
153641712|NCT04712435|Antioxidants|antioxidants|mesh-ancestor
153641713|NCT04712435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153641714|NCT04712435|Protective Agents|protective agents|mesh-ancestor
153641715|NCT04712435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153641716|NCT04712435|Antidotes|antidotes|mesh-ancestor
153641717|NCT04729465|Propofol|propofol|mesh-list
153641718|NCT04729465|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153641719|NCT04729465|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153641768|NCT02490241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153641771|NCT02490241|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153641772|NCT02490241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153641773|NCT02395705|Paclitaxel|paclitaxel|mesh-list
153641774|NCT02395705|Cisplatin|cisplatin|mesh-list
153881527|NCT03781934|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153881528|NCT03781934|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153881529|NCT03781934|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153893528|NCT01014442|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153641775|NCT02395705|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153641835|NCT00006050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153641836|NCT00006050|Antimetabolites|antimetabolites|mesh-ancestor
153641837|NCT00006050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153641838|NCT00006050|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153641839|NCT00006050|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153641840|NCT00006050|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153641841|NCT00006050|Immunologic Factors|immunologic factors|mesh-ancestor
153641900|NCT00084214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153641901|NCT00006056|Cyclosporine|cyclosporine|mesh-list
153641902|NCT00006056|Cyclophosphamide|cyclophosphamide|mesh-list
153641903|NCT00006056|Busulfan|busulfan|mesh-list
153641904|NCT00006056|Methotrexate|methotrexate|mesh-list
153641905|NCT00006056|Etoposide|etoposide|mesh-list
153641906|NCT00006056|Cyclosporins|cyclosporins|mesh-list
153641908|NCT00006056|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153641909|NCT00006056|Immunologic Factors|immunologic factors|mesh-ancestor
153641910|NCT00006056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153641911|NCT00006056|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153641912|NCT00006056|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153641913|NCT00006056|Alkylating Agents|alkylating agents|mesh-ancestor
153641914|NCT00006056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153641915|NCT00006056|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153641916|NCT00006056|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153641957|NCT00084448|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153641958|NCT00084448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153641959|NCT00084448|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153641960|NCT00084448|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153641961|NCT00084448|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
153641962|NCT00084448|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153641963|NCT00084448|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153641964|NCT00084565|Paclitaxel|paclitaxel|mesh-list
153641965|NCT00084565|Topotecan|topotecan|mesh-list
153641966|NCT00084565|Estramustine|estramustine|mesh-list
153641967|NCT00084565|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153641968|NCT00084565|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153641969|NCT00084565|Tubulin Modulators|tubulin modulators|mesh-ancestor
153641970|NCT00084565|Antimitotic Agents|antimitotic agents|mesh-ancestor
153641971|NCT00084565|Mitosis Modulators|mitosis modulators|mesh-ancestor
153641972|NCT00084565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153641973|NCT00084565|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
153641974|NCT00084565|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153641975|NCT00084565|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153641976|NCT00084565|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153641977|NCT00084565|Alkylating Agents|alkylating agents|mesh-ancestor
153642010|NCT00084721|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153642011|NCT00084721|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153642012|NCT00084721|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153642014|NCT00084721|Sensory System Agents|sensory system agents|mesh-ancestor
153642015|NCT00084721|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153642016|NCT00084721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153642017|NCT00084721|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153642018|NCT00084721|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153642019|NCT00084721|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
153642020|NCT00084721|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153642021|NCT00084877|Irinotecan|irinotecan|mesh-list
153881530|NCT03781934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153881531|NCT03781934|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153881532|NCT03781934|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153881533|NCT03729362|Miglustat|miglustat|mesh-list
153881534|NCT03729362|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153881535|NCT03729362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153881536|NCT03729362|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153642022|NCT00084877|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
153642023|NCT00084877|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153642024|NCT00084877|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153642025|NCT00084877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153642026|NCT00084877|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153642027|NCT00084916|Sirolimus|sirolimus|mesh-list
153642028|NCT00084916|Temsirolimus|temsirolimus|mesh-list
153642029|NCT00084916|MTOR Inhibitors|mtor inhibitors|mesh-list
153642030|NCT00084916|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153642064|NCT00400075|Alkylating Agents|alkylating agents|mesh-ancestor
153642065|NCT00400075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153642066|NCT00400075|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153642067|NCT00400075|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153642068|NCT00400075|Antimetabolites|antimetabolites|mesh-ancestor
153642069|NCT00400075|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153642070|NCT00400114|Irinotecan|irinotecan|mesh-list
153642071|NCT00400114|Sunitinib|sunitinib|mesh-list
153642072|NCT00400114|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153642073|NCT00400114|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
153642074|NCT00400114|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153642075|NCT00400114|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153642076|NCT00400114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153642077|NCT00400114|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153642078|NCT00400114|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153642079|NCT00400114|Growth Substances|growth substances|mesh-ancestor
153642080|NCT00400114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153642081|NCT00400114|Growth Inhibitors|growth inhibitors|mesh-ancestor
153642082|NCT00400114|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153642083|NCT00085189|Monatide (IMS 3015)|monatide (ims 3015)|mesh-list
153642084|NCT00085189|Freund's Adjuvant|freund's adjuvant|mesh-list
153642085|NCT00085189|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153642086|NCT00085189|Immunologic Factors|immunologic factors|mesh-ancestor
153642087|NCT00085189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153642114|NCT00006077|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
153642115|NCT00085345|Ascorbic Acid|ascorbic acid|mesh-list
153642116|NCT00085345|Melphalan|melphalan|mesh-list
153642117|NCT00085345|Arsenic Trioxide|arsenic trioxide|mesh-list
153642118|NCT00085345|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153642120|NCT00085345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153642122|NCT00085345|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153642123|NCT00085345|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153642124|NCT00085345|Immunologic Factors|immunologic factors|mesh-ancestor
153642125|NCT00085345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153642126|NCT00085345|Antioxidants|antioxidants|mesh-ancestor
153642127|NCT00085345|Protective Agents|protective agents|mesh-ancestor
153642128|NCT00085345|Vitamins|vitamins|mesh-ancestor
153642129|NCT00085345|Micronutrients|micronutrients|mesh-ancestor
153642130|NCT00085384|Interferons|interferons|mesh-list
153642131|NCT00085384|Interferon-alpha|interferon-alpha|mesh-list
153642132|NCT00085384|Interferon alpha-2|interferon alpha-2|mesh-list
153642133|NCT00085384|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
153642134|NCT00085384|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153642135|NCT00085384|Antiviral Agents|antiviral agents|mesh-ancestor
153642136|NCT00085384|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153642137|NCT00085384|Immunologic Factors|immunologic factors|mesh-ancestor
153642138|NCT00085384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153642139|NCT00006080|Fenretinide|fenretinide|mesh-list
153642140|NCT00006080|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153642166|NCT00085501|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153372764|NCT01794455|Candesartan|candesartan|mesh-list
153642167|NCT00085501|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153642168|NCT00085501|Tubulin Modulators|tubulin modulators|mesh-ancestor
153642169|NCT00085501|Antimitotic Agents|antimitotic agents|mesh-ancestor
153642170|NCT00085501|Mitosis Modulators|mitosis modulators|mesh-ancestor
153642171|NCT00085501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153642172|NCT00085501|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153642173|NCT00006083|Dalteparin|dalteparin|mesh-list
153642174|NCT00006083|Anticoagulants|anticoagulants|mesh-ancestor
153642175|NCT00006083|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153642176|NCT00006083|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153642177|NCT00006083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153642178|NCT00085579|Aldesleukin|aldesleukin|mesh-list
153642179|NCT00085579|Sargramostim|sargramostim|mesh-list
153642180|NCT00085579|Immunologic Factors|immunologic factors|mesh-ancestor
153642181|NCT00085579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153642182|NCT00085579|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153642183|NCT00085579|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153642184|NCT00085579|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153642185|NCT00085579|Antiviral Agents|antiviral agents|mesh-ancestor
153642186|NCT00085579|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153642187|NCT00085696|Rituximab|rituximab|mesh-list
153642188|NCT00085696|Bortezomib|bortezomib|mesh-list
153642190|NCT00085696|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153642218|NCT00085891|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153642219|NCT00085891|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153642220|NCT00085891|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153642221|NCT00085891|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153642222|NCT00085891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153642223|NCT00085969|Exenatide|exenatide|mesh-list
153642224|NCT00085969|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
153642225|NCT00085969|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153642226|NCT00085969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153642227|NCT00085969|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
153642228|NCT00085969|Incretins|incretins|mesh-ancestor
153642229|NCT00085969|Hormones|hormones|mesh-ancestor
153362159|NCT05422664|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153642230|NCT00085969|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153642231|NCT00086086|Darbepoetin alfa|darbepoetin alfa|mesh-list
153642232|NCT00086086|Hematinics|hematinics|mesh-ancestor
153642233|NCT00006092|Arsenic Trioxide|arsenic trioxide|mesh-list
153642234|NCT00006092|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153642235|NCT00086125|Sirolimus|sirolimus|mesh-list
153642236|NCT00086125|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153642237|NCT00086125|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153642238|NCT00086125|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153642239|NCT00086125|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153642240|NCT00086125|Antifungal Agents|antifungal agents|mesh-ancestor
153642244|NCT00086203|Rituximab|rituximab|mesh-list
153642270|NCT00086320|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153642271|NCT00086320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153642272|NCT00086320|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
153642273|NCT00086320|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
153642274|NCT00086320|Dopamine Agents|dopamine agents|mesh-ancestor
153642275|NCT00086359|Ritonavir|ritonavir|mesh-list
153642276|NCT00086359|Lopinavir|lopinavir|mesh-list
153642277|NCT00086359|Lamivudine|lamivudine|mesh-list
153642278|NCT00086359|Zidovudine|zidovudine|mesh-list
153642279|NCT00086359|Abacavir|abacavir|mesh-list
153642280|NCT00086359|Lamivudine, zidovudine drug combination|lamivudine, zidovudine drug combination|mesh-list
153642281|NCT00086359|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
153642282|NCT00086359|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
153642283|NCT00086359|Protease Inhibitors|protease inhibitors|mesh-ancestor
153642284|NCT00086359|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153642285|NCT00086359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153642286|NCT00086359|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153642329|NCT00006104|Tubulin Modulators|tubulin modulators|mesh-ancestor
153642330|NCT00006104|Antimitotic Agents|antimitotic agents|mesh-ancestor
153642331|NCT00006104|Mitosis Modulators|mitosis modulators|mesh-ancestor
153642332|NCT00006104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153642333|NCT00006104|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153642334|NCT00086827|Romidepsin|romidepsin|mesh-list
153642335|NCT00086827|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153642336|NCT00086827|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153642337|NCT00086827|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
153642338|NCT00086827|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153642339|NCT00086827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153642340|NCT00086944|Rituximab|rituximab|mesh-list
153642341|NCT00086944|Carboplatin|carboplatin|mesh-list
153642342|NCT00086944|Etoposide|etoposide|mesh-list
153642343|NCT00086944|Etoposide phosphate|etoposide phosphate|mesh-list
153642344|NCT00086944|Ifosfamide|ifosfamide|mesh-list
153642345|NCT00086944|Oblimersen|oblimersen|mesh-list
153642346|NCT00086944|Lenograstim|lenograstim|mesh-list
153642348|NCT00086944|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153642387|NCT00006113|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153642388|NCT00087217|Paclitaxel|paclitaxel|mesh-list
153642389|NCT00087217|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153642390|NCT00087217|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153642391|NCT00087217|Tubulin Modulators|tubulin modulators|mesh-ancestor
153642392|NCT00087217|Antimitotic Agents|antimitotic agents|mesh-ancestor
153642393|NCT00087217|Mitosis Modulators|mitosis modulators|mesh-ancestor
153642394|NCT00087217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153642395|NCT00087256|Celecoxib|celecoxib|mesh-list
153642396|NCT00087256|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153642397|NCT00087256|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153642405|NCT00087256|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153642406|NCT00087256|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153642407|NCT00087256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153642408|NCT00006116|Gemcitabine|gemcitabine|mesh-list
153642409|NCT00006116|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153642410|NCT00006116|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153642411|NCT00006116|Antimetabolites|antimetabolites|mesh-ancestor
153642412|NCT00006116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153642413|NCT00087295|Romidepsin|romidepsin|mesh-list
153642414|NCT00087295|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153642415|NCT00087295|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153642416|NCT00087295|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
153642417|NCT00087295|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153642418|NCT00087295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153642419|NCT00087334|Capecitabine|capecitabine|mesh-list
153642425|NCT00087334|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153642426|NCT00087334|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153642427|NCT00087334|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153642428|NCT00087334|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153642429|NCT00087373|Metronidazole|metronidazole|mesh-list
153642430|NCT00087373|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153642431|NCT00087373|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153642432|NCT00087373|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153642433|NCT00087373|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153642434|NCT00006119|Hydroxyurea|hydroxyurea|mesh-list
153642435|NCT00006119|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153642436|NCT00006119|Antisickling Agents|antisickling agents|mesh-ancestor
153642437|NCT00006119|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153642438|NCT00006119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153642439|NCT00006119|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153642440|NCT00087412|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
153642441|NCT00087412|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153642442|NCT00087412|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153642443|NCT00087412|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153372780|NCT01332500|Sumatriptan|sumatriptan|mesh-list
153434801|NCT00002191|Anthelmintics|anthelmintics|mesh-ancestor
153434802|NCT00002191|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153642444|NCT00087412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153642445|NCT00087412|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153642479|NCT00087802|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153642480|NCT00087802|Tubulin Modulators|tubulin modulators|mesh-ancestor
153642481|NCT00087802|Antimitotic Agents|antimitotic agents|mesh-ancestor
153642482|NCT00087802|Mitosis Modulators|mitosis modulators|mesh-ancestor
153642483|NCT00087802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153642484|NCT00087802|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153642485|NCT00087802|Antimetabolites|antimetabolites|mesh-ancestor
153642486|NCT00006125|Doxorubicin|doxorubicin|mesh-list
153642487|NCT00006125|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
153642489|NCT00006125|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153642490|NCT00006125|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153642491|NCT00006125|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153642492|NCT00006125|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153642493|NCT00006125|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153642494|NCT00006125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153642495|NCT00006125|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
153642496|NCT00087841|Hypnotics and Sedatives|hypnotics and sedatives|mesh-list
153642497|NCT00087841|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153642499|NCT00087880|Bupropion|bupropion|mesh-list
153642532|NCT00088075|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153822246|NCT00478101|Narcotics|narcotics|mesh-ancestor
153642534|NCT00088075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153642535|NCT00088075|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153642536|NCT00088075|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153642537|NCT00088075|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153642538|NCT00088075|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153642539|NCT00088075|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
153642540|NCT00088075|Dopamine Agents|dopamine agents|mesh-ancestor
153642541|NCT00088114|Paclitaxel|paclitaxel|mesh-list
153642542|NCT00088114|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153642543|NCT00088114|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153642544|NCT00088114|Tubulin Modulators|tubulin modulators|mesh-ancestor
153642552|NCT00088231|Vatalanib|vatalanib|mesh-list
153642594|NCT00088504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153642595|NCT00006137|Enalapril|enalapril|mesh-list
153642596|NCT00006137|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
153642597|NCT00006137|Protease Inhibitors|protease inhibitors|mesh-ancestor
153642598|NCT00006137|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153642599|NCT00006137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153642600|NCT00006137|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153642601|NCT00088543|Thymoglobulin|thymoglobulin|mesh-list
153642602|NCT00088543|Antilymphocyte Serum|antilymphocyte serum|mesh-list
153642604|NCT00088543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153642605|NCT00088543|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153642606|NCT00088582|Octreotide|octreotide|mesh-list
153642607|NCT00088582|Pasireotide|pasireotide|mesh-list
153642608|NCT00088582|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153642609|NCT00088582|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153642611|NCT00088582|Hormones|hormones|mesh-ancestor
153642653|NCT00006152|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153642654|NCT00006152|Antiviral Agents|antiviral agents|mesh-ancestor
153642655|NCT00006152|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153642656|NCT00006152|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
153642657|NCT00006152|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153422446|NCT03829410|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153422447|NCT03829410|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153422448|NCT03829410|Growth Substances|growth substances|mesh-ancestor
153422449|NCT03829410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153422450|NCT03829410|Growth Inhibitors|growth inhibitors|mesh-ancestor
153422451|NCT03829410|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153642658|NCT00006152|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153642659|NCT00006152|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153642660|NCT00006152|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
153642661|NCT00006152|Antitubercular Agents|antitubercular agents|mesh-ancestor
153642662|NCT00006152|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153642663|NCT00088933|Metronidazole|metronidazole|mesh-list
153642664|NCT00088933|Docetaxel|docetaxel|mesh-list
153642665|NCT00088933|Vaccines|vaccines|mesh-list
153642666|NCT00088933|Sargramostim|sargramostim|mesh-list
153642667|NCT00088933|Immunologic Factors|immunologic factors|mesh-ancestor
153642668|NCT00088933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153642669|NCT00088933|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153642670|NCT00088933|Tubulin Modulators|tubulin modulators|mesh-ancestor
153642671|NCT00088933|Antimitotic Agents|antimitotic agents|mesh-ancestor
153642672|NCT00088933|Mitosis Modulators|mitosis modulators|mesh-ancestor
153642673|NCT00088933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153642674|NCT00088933|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153642675|NCT00088933|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153642676|NCT00088933|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153642677|NCT00088933|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153642678|NCT00089050|Cyclosporine|cyclosporine|mesh-list
153642679|NCT00089050|Gemtuzumab|gemtuzumab|mesh-list
153642680|NCT00089050|Cyclosporins|cyclosporins|mesh-list
153642681|NCT00089050|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153642682|NCT00089050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153642683|NCT00089050|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153642684|NCT00089050|Immunologic Factors|immunologic factors|mesh-ancestor
153642685|NCT00089050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153642691|NCT00089050|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153642692|NCT00089050|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153642693|NCT00089050|Immunotoxins|immunotoxins|mesh-ancestor
153642694|NCT00089050|Immunoconjugates|immunoconjugates|mesh-ancestor
153642696|NCT00006155|Semaxinib|semaxinib|mesh-list
153642697|NCT00006155|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153642698|NCT00006155|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153642699|NCT00006155|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153642700|NCT00006155|Growth Substances|growth substances|mesh-ancestor
153642701|NCT00006155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153642702|NCT00006155|Growth Inhibitors|growth inhibitors|mesh-ancestor
153642703|NCT00006155|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153642704|NCT00006155|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153642705|NCT00006155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153642706|NCT00089089|Decitabine|decitabine|mesh-list
153642707|NCT00089089|Azacitidine|azacitidine|mesh-list
153642708|NCT00089089|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153642709|NCT00089089|Antimetabolites|antimetabolites|mesh-ancestor
153642710|NCT00089089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153642711|NCT00089089|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153642712|NCT00089089|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153642713|NCT00089167|Thalidomide|thalidomide|mesh-list
153642714|NCT00089167|Dexamethasone|dexamethasone|mesh-list
153642715|NCT00089167|Melphalan|melphalan|mesh-list
153642716|NCT00089167|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153642717|NCT00089167|Antiemetics|antiemetics|mesh-ancestor
153642718|NCT00089167|Autonomic Agents|autonomic agents|mesh-ancestor
153642719|NCT00089167|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153642720|NCT00089167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153642721|NCT00089167|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153642735|NCT00089167|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153642736|NCT00089167|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153642737|NCT00089167|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153642738|NCT00089167|Growth Substances|growth substances|mesh-ancestor
153642739|NCT00089167|Growth Inhibitors|growth inhibitors|mesh-ancestor
153642740|NCT00089206|Sargramostim|sargramostim|mesh-list
153642741|NCT00089206|Freund's Adjuvant|freund's adjuvant|mesh-list
153642742|NCT00089206|Immunologic Factors|immunologic factors|mesh-ancestor
153642743|NCT00089206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153881584|NCT03340766|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153881585|NCT03340766|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153642744|NCT00089206|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153642745|NCT00400231|Metformin|metformin|mesh-list
153642746|NCT00400231|Fenofibrate|fenofibrate|mesh-list
153642747|NCT00400231|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153642748|NCT00400231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153642749|NCT00400231|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153642750|NCT00400231|Antimetabolites|antimetabolites|mesh-ancestor
153642751|NCT00400231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153642752|NCT00400231|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153642753|NCT00006158|Testosterone|testosterone|mesh-list
153642754|NCT00006158|Androgens|androgens|mesh-ancestor
153642755|NCT00006158|Hormones|hormones|mesh-ancestor
153642758|NCT00423826|Cytarabine|cytarabine|mesh-list
153642790|NCT00423865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153642791|NCT00423982|Vancomycin|vancomycin|mesh-list
153642792|NCT00423982|Rifampin|rifampin|mesh-list
153642793|NCT00423982|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
153642794|NCT00423982|Cloxacillin|cloxacillin|mesh-list
153642795|NCT00423982|Anti-Infective Agents|anti-infective agents|mesh-list
153642796|NCT00423982|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
153642797|NCT00423982|Antitubercular Agents|antitubercular agents|mesh-ancestor
153642798|NCT00423982|Leprostatic Agents|leprostatic agents|mesh-ancestor
153362254|NCT04452214|Pembrolizumab|pembrolizumab|mesh-list
153642799|NCT00423982|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153642800|NCT00423982|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153642801|NCT00423982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153642802|NCT00423982|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
153642803|NCT00423982|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
153642804|NCT00423982|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
153642805|NCT00423982|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
153642806|NCT00423982|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
153642807|NCT00423982|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
153642843|NCT00089401|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153642845|NCT00089401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153642846|NCT00089401|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153642847|NCT00089401|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153642848|NCT00089401|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153642849|NCT00089401|Immunologic Factors|immunologic factors|mesh-ancestor
153642850|NCT00089401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153642851|NCT00089440|Aripiprazole|aripiprazole|mesh-list
153642852|NCT00089440|Antidepressive Agents|antidepressive agents|mesh-ancestor
153642853|NCT00089440|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153642854|NCT00089440|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153642905|NCT00089869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153642906|NCT00089869|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153642907|NCT00089869|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153642908|NCT00089869|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153642909|NCT00089869|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153642910|NCT00089869|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153642911|NCT00089869|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
153642912|NCT00089869|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153642913|NCT00089869|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153642914|NCT00089869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153642915|NCT00089869|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153642917|NCT00089869|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
153642918|NCT00089869|Adrenergic Agents|adrenergic agents|mesh-ancestor
153642919|NCT00006167|Oxandrolone|oxandrolone|mesh-list
153642920|NCT00006167|Androgens|androgens|mesh-ancestor
153642921|NCT00006167|Hormones|hormones|mesh-ancestor
153642922|NCT00006167|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153642923|NCT00006167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153642924|NCT00006167|Anabolic Agents|anabolic agents|mesh-ancestor
153642925|NCT00089947|Thymoglobulin|thymoglobulin|mesh-list
153642926|NCT00089947|Antilymphocyte Serum|antilymphocyte serum|mesh-list
153642927|NCT00089947|Immunologic Factors|immunologic factors|mesh-ancestor
153642928|NCT00089947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153642929|NCT00089947|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153642930|NCT00090025|Leucovorin|leucovorin|mesh-list
153642931|NCT00090025|Fluorouracil|fluorouracil|mesh-list
153642932|NCT00090025|Antimetabolites|antimetabolites|mesh-ancestor
153642933|NCT00090025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153642934|NCT00090025|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153642935|NCT00090025|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153642936|NCT00090025|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153642937|NCT00090025|Immunologic Factors|immunologic factors|mesh-ancestor
153642938|NCT00090025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153642942|NCT00090025|Vitamins|vitamins|mesh-ancestor
153642944|NCT04633902|Pembrolizumab|pembrolizumab|mesh-list
153642945|NCT04633902|Olaparib|olaparib|mesh-list
153642946|NCT04633902|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153642947|NCT04633902|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153642948|NCT04633902|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153642949|NCT04633902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153642950|NCT04633902|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
153642951|NCT04633902|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153642953|NCT00090727|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153643004|NCT00091312|Fluorouracil|fluorouracil|mesh-list
153643005|NCT00091312|Irinotecan|irinotecan|mesh-list
153643006|NCT00091312|Calcium|calcium|mesh-list
153643007|NCT00091312|Levoleucovorin|levoleucovorin|mesh-list
153643008|NCT00091312|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153643009|NCT00091312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153643010|NCT00091312|Antimetabolites|antimetabolites|mesh-ancestor
153643011|NCT00091312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153362329|NCT03911414|Acetylcysteine|acetylcysteine|mesh-list
153643023|NCT00091312|Micronutrients|micronutrients|mesh-ancestor
153643024|NCT04619706|Palmidrol|palmidrol|mesh-list
153643025|NCT04619706|Analgesics|analgesics|mesh-ancestor
153643026|NCT04619706|Sensory System Agents|sensory system agents|mesh-ancestor
153643027|NCT04619706|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153643028|NCT04619706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153643029|NCT04619706|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153643048|NCT00091468|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153643049|NCT00091468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153643050|NCT00091468|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
153643051|NCT00091468|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
153643052|NCT00091468|Cholinergic Agents|cholinergic agents|mesh-ancestor
153643053|NCT00091468|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153643054|NCT00091468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153643055|NCT00006200|Thalidomide|thalidomide|mesh-list
153643056|NCT00006200|Dacarbazine|dacarbazine|mesh-list
153643057|NCT00006200|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153643058|NCT00006200|Immunologic Factors|immunologic factors|mesh-ancestor
153643059|NCT00006200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153643060|NCT00006200|Leprostatic Agents|leprostatic agents|mesh-ancestor
153822361|NCT00440622|Trastuzumab|trastuzumab|mesh-list
153822362|NCT00440622|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153822363|NCT00440622|Antimetabolites|antimetabolites|mesh-ancestor
153822364|NCT00440622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153822365|NCT00440622|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153822366|NCT00440622|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153822367|NCT00440661|Diacerein|diacerein|mesh-list
153822368|NCT00440661|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153422460|NCT03713658|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153422461|NCT03713658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153422462|NCT03713658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153422463|NCT03713658|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153372782|NCT01332500|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153783549|NCT04546282|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153822369|NCT03278444|Trimetazidine|trimetazidine|mesh-list
153822370|NCT03278444|Vasodilator Agents|vasodilator agents|mesh-ancestor
153822371|NCT00440739|Etoricoxib|etoricoxib|mesh-list
153822372|NCT00440739|Flavoxate|flavoxate|mesh-list
153643068|NCT00006200|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153643069|NCT00006200|Alkylating Agents|alkylating agents|mesh-ancestor
153822373|NCT00440739|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153822374|NCT00440739|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153822375|NCT00440739|Analgesics|analgesics|mesh-ancestor
153822376|NCT00440739|Sensory System Agents|sensory system agents|mesh-ancestor
153822377|NCT00440739|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153822378|NCT00440739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153362332|NCT03911414|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153362333|NCT03911414|Expectorants|expectorants|mesh-ancestor
153362334|NCT03911414|Respiratory System Agents|respiratory system agents|mesh-ancestor
153362336|NCT03911414|Antioxidants|antioxidants|mesh-ancestor
153362338|NCT03911414|Protective Agents|protective agents|mesh-ancestor
153643082|NCT00091624|Growth Substances|growth substances|mesh-ancestor
153643083|NCT00091624|Growth Inhibitors|growth inhibitors|mesh-ancestor
153643085|NCT00091663|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
153643086|NCT00091663|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153643087|NCT00091663|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153643088|NCT00091663|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153643089|NCT00091663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153643090|NCT00091663|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153643092|NCT00006206|Acamprosate|acamprosate|mesh-list
153643093|NCT00006206|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
153643094|NCT00006206|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
153643095|NCT00006206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153643096|NCT00006206|Sensory System Agents|sensory system agents|mesh-ancestor
153643097|NCT00006206|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153643098|NCT00091702|Vaccines|vaccines|mesh-list
153643099|NCT00091702|Immunologic Factors|immunologic factors|mesh-ancestor
153643100|NCT00091702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153643101|NCT00091741|Etanercept|etanercept|mesh-list
153643102|NCT00091741|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153643103|NCT00091741|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153643104|NCT00091741|Analgesics|analgesics|mesh-ancestor
153643105|NCT00091741|Sensory System Agents|sensory system agents|mesh-ancestor
153822379|NCT00440739|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153822380|NCT00440739|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153822381|NCT00440739|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
153822382|NCT00440739|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153822386|NCT00440739|Autonomic Agents|autonomic agents|mesh-ancestor
153890361|NCT01297920|Brinzolamide|brinzolamide|mesh-list
153643111|NCT00091741|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153643112|NCT00091741|Immunologic Factors|immunologic factors|mesh-ancestor
153643114|NCT00091858|Hematinics|hematinics|mesh-ancestor
153643115|NCT00390195|Everolimus|everolimus|mesh-list
153643124|NCT00091897|Rituximab|rituximab|mesh-list
153643131|NCT00006212|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153643132|NCT00006212|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153643133|NCT00006212|Tubulin Modulators|tubulin modulators|mesh-ancestor
153643134|NCT00006212|Antimitotic Agents|antimitotic agents|mesh-ancestor
153643135|NCT00006212|Mitosis Modulators|mitosis modulators|mesh-ancestor
153643136|NCT00006212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153643138|NCT00091936|Efavirenz|efavirenz|mesh-list
153643139|NCT00091936|Didanosine|didanosine|mesh-list
153643140|NCT00091936|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153643141|NCT00091936|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153643142|NCT00091936|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153643143|NCT00091936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153643144|NCT00091936|Antiviral Agents|antiviral agents|mesh-ancestor
153822404|NCT03278405|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153643145|NCT00091936|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153643146|NCT00091936|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153643147|NCT00091936|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153643148|NCT00091936|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
153643149|NCT00091936|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153643150|NCT00091936|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
153643151|NCT00091936|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
153643152|NCT00091936|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
153643153|NCT00091936|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
153643154|NCT00091936|Antimetabolites|antimetabolites|mesh-ancestor
153643155|NCT02972346|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
153643156|NCT02972346|Melanocyte-Stimulating Hormones|melanocyte-stimulating hormones|mesh-list
153643157|NCT02972346|beta-Endorphin|beta-endorphin|mesh-list
153643158|NCT02972346|Hormones|hormones|mesh-ancestor
153643159|NCT02972346|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153643174|NCT00006215|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153643175|NCT00006215|Tubulin Modulators|tubulin modulators|mesh-ancestor
153643176|NCT00006215|Antimitotic Agents|antimitotic agents|mesh-ancestor
153643177|NCT00006215|Mitosis Modulators|mitosis modulators|mesh-ancestor
153643178|NCT00006215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153643179|NCT00006215|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153643180|NCT00092287|Octreotide|octreotide|mesh-list
153643181|NCT00092287|Lanreotide|lanreotide|mesh-list
153643182|NCT00092287|Somatostatin|somatostatin|mesh-list
153643183|NCT00092287|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153643184|NCT00092287|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153643185|NCT00092287|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153643186|NCT00092287|Hormones|hormones|mesh-ancestor
153643187|NCT00092287|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153643188|NCT00092287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153643190|NCT00092326|Rofecoxib|rofecoxib|mesh-list
153643191|NCT00092326|Oxycodone|oxycodone|mesh-list
153643192|NCT00092326|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153643193|NCT00092326|Analgesics|analgesics|mesh-ancestor
153643194|NCT00092326|Sensory System Agents|sensory system agents|mesh-ancestor
153643195|NCT00092326|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153643196|NCT00092326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153643197|NCT00092326|Antipyretics|antipyretics|mesh-ancestor
153643198|NCT00092326|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153643199|NCT00092326|Narcotics|narcotics|mesh-ancestor
153643200|NCT00092326|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153643201|NCT00092326|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
153643202|NCT00092326|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153643203|NCT00092326|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153643204|NCT00092326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153643205|NCT00092326|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153822424|NCT00440973|Interleukin-2|interleukin-2|mesh-list
153822425|NCT00440973|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153822426|NCT00440973|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153822427|NCT00440973|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153822428|NCT00440973|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153822429|NCT00440973|Growth Substances|growth substances|mesh-ancestor
153822430|NCT00440973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153643206|NCT00092326|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153643207|NCT00092326|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153643209|NCT00092365|Rofecoxib|rofecoxib|mesh-list
153643210|NCT00092365|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153643212|NCT00092365|Analgesics|analgesics|mesh-ancestor
153643213|NCT00092365|Sensory System Agents|sensory system agents|mesh-ancestor
153643214|NCT00092365|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153643215|NCT00092365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153643216|NCT00092365|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153643217|NCT00092365|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153643218|NCT00092365|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
153643219|NCT00092365|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153643220|NCT00092365|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153643221|NCT00092365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153643222|NCT00092404|Vaccines|vaccines|mesh-list
153643223|NCT00092404|Immunologic Factors|immunologic factors|mesh-ancestor
153643224|NCT00092404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153643226|NCT04728880|Antimetabolites|antimetabolites|mesh-ancestor
153643227|NCT04728880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153643228|NCT04728880|Antiviral Agents|antiviral agents|mesh-ancestor
153643271|NCT00093301|Vasodilator Agents|vasodilator agents|mesh-ancestor
153643272|NCT00093301|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
153643273|NCT00093301|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
153643274|NCT00093301|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153643275|NCT00093301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153643276|NCT00093301|Protective Agents|protective agents|mesh-ancestor
153643277|NCT00093301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153643278|NCT00093301|Sympathomimetics|sympathomimetics|mesh-ancestor
153643279|NCT00093301|Autonomic Agents|autonomic agents|mesh-ancestor
153643280|NCT00093301|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153643281|NCT00093301|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
153643282|NCT00093301|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
153643283|NCT00093301|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153643284|NCT00093301|Adrenergic Agents|adrenergic agents|mesh-ancestor
153643285|NCT00093301|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153643286|NCT00093418|Tipifarnib|tipifarnib|mesh-list
153643287|NCT00093418|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153643288|NCT00387608|Veliparib|veliparib|mesh-list
153643289|NCT00387608|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
153643290|NCT00387608|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153643291|NCT00387608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153822432|NCT00440973|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153822433|NCT00440973|Analgesics|analgesics|mesh-ancestor
153822434|NCT00440973|Sensory System Agents|sensory system agents|mesh-ancestor
153822435|NCT00440973|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153643320|NCT00400348|Tubulin Modulators|tubulin modulators|mesh-ancestor
153643321|NCT00400348|Antimitotic Agents|antimitotic agents|mesh-ancestor
153643322|NCT00400348|Mitosis Modulators|mitosis modulators|mesh-ancestor
153643323|NCT00400348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153643325|NCT00006233|Mycophenolic Acid|mycophenolic acid|mesh-list
153643326|NCT00006233|Fludarabine|fludarabine|mesh-list
153643327|NCT00006233|Fludarabine phosphate|fludarabine phosphate|mesh-list
153643328|NCT00006233|Cyclosporins|cyclosporins|mesh-list
153643329|NCT00006233|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153643331|NCT00006233|Antimetabolites|antimetabolites|mesh-ancestor
153643386|NCT00094120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153643387|NCT00094120|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153643388|NCT00094120|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153643389|NCT00094120|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153822445|NCT00441051|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153822446|NCT00441051|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153822447|NCT00441051|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153822448|NCT00441051|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153822449|NCT00441051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153822450|NCT00443963|Esomeprazole|esomeprazole|mesh-list
153822451|NCT00443963|Ranitidine|ranitidine|mesh-list
153822452|NCT00443963|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
153822453|NCT00443963|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153822464|NCT00441207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153822465|NCT00441207|Protective Agents|protective agents|mesh-ancestor
153822466|NCT00441207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153822467|NCT00441207|Vitamins|vitamins|mesh-ancestor
153822468|NCT00441207|Micronutrients|micronutrients|mesh-ancestor
153822469|NCT00444041|Bevacizumab|bevacizumab|mesh-list
153822470|NCT00444041|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153431451|NCT06288451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153431452|NCT06288451|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
153431453|NCT06288451|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
153431454|NCT06288451|Hormone Antagonists|hormone antagonists|mesh-ancestor
153881604|NCT03208452|Tocolytic Agents|tocolytic agents|mesh-ancestor
153431455|NCT06288451|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153431457|NCT06285357|Hematinics|hematinics|mesh-ancestor
153431458|NCT06285357|Vitamin B Complex|vitamin b complex|mesh-ancestor
153643400|NCT00006245|Growth Inhibitors|growth inhibitors|mesh-ancestor
153643401|NCT00006245|Growth Substances|growth substances|mesh-ancestor
153643402|NCT00006245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153643403|NCT00006245|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153643404|NCT00006245|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153643406|NCT00094315|Anesthetics, Local|anesthetics, local|mesh-ancestor
153643408|NCT00094315|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153643409|NCT00094315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153643410|NCT00094315|Sensory System Agents|sensory system agents|mesh-ancestor
153643433|NCT00094432|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
153643435|NCT00094432|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
153643437|NCT00006248|Paclitaxel|paclitaxel|mesh-list
153643438|NCT00006248|Fluorouracil|fluorouracil|mesh-list
153643439|NCT00006248|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153643440|NCT00006248|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153643441|NCT00006248|Tubulin Modulators|tubulin modulators|mesh-ancestor
153643442|NCT00006248|Antimitotic Agents|antimitotic agents|mesh-ancestor
153643443|NCT00006248|Mitosis Modulators|mitosis modulators|mesh-ancestor
153643444|NCT00006248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153643445|NCT00006248|Antimetabolites|antimetabolites|mesh-ancestor
153643446|NCT00006248|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153643447|NCT00006248|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153643492|NCT00006251|Mycophenolic Acid|mycophenolic acid|mesh-list
153643493|NCT00006251|Fludarabine|fludarabine|mesh-list
153643494|NCT00006251|Fludarabine phosphate|fludarabine phosphate|mesh-list
153643495|NCT00006251|Cyclosporins|cyclosporins|mesh-list
153643496|NCT00006251|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153643497|NCT00006251|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153643498|NCT00006251|Antimetabolites|antimetabolites|mesh-ancestor
153643499|NCT00006251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153643500|NCT00006251|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153643501|NCT00006251|Immunologic Factors|immunologic factors|mesh-ancestor
153643502|NCT00006251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153643503|NCT00006251|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153643504|NCT00006251|Antifungal Agents|antifungal agents|mesh-ancestor
153643505|NCT00006251|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153643506|NCT00006251|Dermatologic Agents|dermatologic agents|mesh-ancestor
153643507|NCT00006251|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153643508|NCT00006251|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
153643549|NCT00006257|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153643550|NCT00006257|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153643551|NCT00095251|Dexmedetomidine|dexmedetomidine|mesh-list
153643552|NCT00095251|Lorazepam|lorazepam|mesh-list
153643553|NCT00095251|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153643554|NCT00095251|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153881609|NCT03190265|Pancrelipase|pancrelipase|mesh-list
153881610|NCT03190265|Vaccines|vaccines|mesh-list
153881611|NCT03190265|Immunologic Factors|immunologic factors|mesh-ancestor
153881612|NCT03190265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153881613|NCT03190265|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153372786|NCT01332500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153435109|NCT00381589|Bromides|bromides|mesh-list
153643555|NCT00095251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153643556|NCT00095251|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153643557|NCT00095251|Analgesics|analgesics|mesh-ancestor
153643558|NCT00095251|Sensory System Agents|sensory system agents|mesh-ancestor
153643559|NCT00095251|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153643560|NCT00095251|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
153643561|NCT00095251|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153643562|NCT00095251|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153643563|NCT00095251|Adrenergic Agents|adrenergic agents|mesh-ancestor
153643564|NCT00095251|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153643565|NCT00095251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153643566|NCT00095251|Anticonvulsants|anticonvulsants|mesh-ancestor
153643569|NCT00095251|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153643570|NCT00095251|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153643603|NCT00006263|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153643604|NCT00006263|Alkylating Agents|alkylating agents|mesh-ancestor
153643605|NCT00006263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153643606|NCT00095524|Aripiprazole|aripiprazole|mesh-list
153643607|NCT00095524|Antidepressive Agents|antidepressive agents|mesh-ancestor
153643608|NCT00095524|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153643609|NCT00095524|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153643610|NCT00095524|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153643611|NCT00095524|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153643612|NCT00095524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153643613|NCT00095524|Dopamine Agonists|dopamine agonists|mesh-ancestor
153643614|NCT00095524|Dopamine Agents|dopamine agents|mesh-ancestor
153643615|NCT00095524|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153643616|NCT00095524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153643617|NCT00095524|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
153643618|NCT00095524|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
153643619|NCT00095524|Serotonin Agents|serotonin agents|mesh-ancestor
153643620|NCT00095524|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
153643621|NCT00095524|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153643622|NCT00095524|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
153643654|NCT00095719|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
153643655|NCT00095719|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153643656|NCT00095719|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
153643657|NCT00095719|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
153643658|NCT00095758|Aripiprazole|aripiprazole|mesh-list
153643659|NCT00095758|Antidepressive Agents|antidepressive agents|mesh-list
153643660|NCT00095758|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153643661|NCT00095758|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153643662|NCT00095758|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153643663|NCT00095758|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153643664|NCT00095758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153643665|NCT00095758|Dopamine Agonists|dopamine agonists|mesh-ancestor
153643666|NCT00095758|Dopamine Agents|dopamine agents|mesh-ancestor
153643667|NCT00095758|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153643668|NCT00095758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153643670|NCT00095758|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
153643711|NCT00006275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153643714|NCT00006275|Micronutrients|micronutrients|mesh-ancestor
153643715|NCT00006275|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153643716|NCT00096148|Cytarabine|cytarabine|mesh-list
153643717|NCT00096148|Bevacizumab|bevacizumab|mesh-list
153643718|NCT00096148|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
153643719|NCT00096148|Idarubicin|idarubicin|mesh-list
153643720|NCT00096148|Antibodies|antibodies|mesh-list
153643721|NCT00096148|Immunoglobulins|immunoglobulins|mesh-list
153643722|NCT00096148|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
153643723|NCT00096148|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153643724|NCT00096148|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153643725|NCT00096148|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153643740|NCT00096187|Pemetrexed|pemetrexed|mesh-list
153643772|NCT00096616|Tocolytic Agents|tocolytic agents|mesh-ancestor
153643773|NCT00096616|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153643774|NCT00096616|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
153643775|NCT00096616|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
153643776|NCT00096616|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153643777|NCT00096616|Adrenergic Agents|adrenergic agents|mesh-ancestor
153881624|NCT02615691|BAX 855|bax 855|mesh-list
153643778|NCT00096616|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153643779|NCT00096616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153643780|NCT00096655|Infliximab|infliximab|mesh-list
153643781|NCT00096655|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
153643782|NCT00096655|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153643783|NCT00096655|Dermatologic Agents|dermatologic agents|mesh-ancestor
153643833|NCT00096850|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
153643834|NCT00096850|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
153643836|NCT00096967|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153643837|NCT00096967|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153643838|NCT00096967|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153643839|NCT00096967|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153643840|NCT00096967|Growth Substances|growth substances|mesh-ancestor
153643841|NCT00096967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153643842|NCT00096967|Growth Inhibitors|growth inhibitors|mesh-ancestor
153643847|NCT00097045|Antiviral Agents|antiviral agents|mesh-ancestor
153643848|NCT00097045|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153643849|NCT00097045|Antimetabolites|antimetabolites|mesh-ancestor
153643850|NCT00097045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153643851|NCT00097084|Insulin|insulin|mesh-list
153643852|NCT00097084|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
153643853|NCT00097084|Insulin Glargine|insulin glargine|mesh-list
153643854|NCT00097084|Insulin Aspart|insulin aspart|mesh-list
153643855|NCT00097084|Insulin Detemir|insulin detemir|mesh-list
153643856|NCT00097084|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153643857|NCT00097084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153643858|NCT04310709|Nivolumab|nivolumab|mesh-list
153643859|NCT04310709|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153643860|NCT04310709|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153643861|NCT04310709|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153643862|NCT04310709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153643863|NCT00006320|Anti-HIV Agents|anti-hiv agents|mesh-list
153643864|NCT00006320|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153643876|NCT00097279|Pioglitazone|pioglitazone|mesh-list
153643877|NCT00097279|Insulin Aspart|insulin aspart|mesh-list
153643878|NCT00097279|Biphasic Insulins|biphasic insulins|mesh-list
153643879|NCT00097279|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153643880|NCT00097279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153643882|NCT00390273|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153643883|NCT00390273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153643884|NCT00097318|Interferons|interferons|mesh-list
153643885|NCT00097318|Interferon-beta|interferon-beta|mesh-list
153643886|NCT00097318|Interferon beta-1a|interferon beta-1a|mesh-list
153643888|NCT00097318|Antiviral Agents|antiviral agents|mesh-ancestor
153643889|NCT00097318|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153643890|NCT00097318|Immunologic Factors|immunologic factors|mesh-ancestor
153643891|NCT00097318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153643892|NCT00097318|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153643894|NCT00097435|Antimetabolites|antimetabolites|mesh-ancestor
153643895|NCT00097435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153643896|NCT00097435|Antiviral Agents|antiviral agents|mesh-ancestor
153643897|NCT00097435|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153643898|NCT00006326|Ritonavir|ritonavir|mesh-list
153643899|NCT00006326|Indinavir|indinavir|mesh-list
153643900|NCT00006326|Delavirdine|delavirdine|mesh-list
153643901|NCT00006326|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
153643902|NCT00006326|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
153643903|NCT00006326|Protease Inhibitors|protease inhibitors|mesh-ancestor
153643904|NCT00006326|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153643925|NCT00400387|Vitamin B 12|vitamin b 12|mesh-list
153643927|NCT00400387|Vitamin B Complex|vitamin b complex|mesh-list
153643928|NCT00400387|Tocopherols|tocopherols|mesh-list
153643929|NCT00400387|Vitamin E|vitamin e|mesh-list
153643930|NCT00400387|Tocotrienols|tocotrienols|mesh-list
153643931|NCT00400387|alpha-Tocopherol|alpha-tocopherol|mesh-list
153643932|NCT00400387|Heparin|heparin|mesh-list
153822612|NCT02274090|Metformin|metformin|mesh-list
153643934|NCT00400387|Tinzaparin|tinzaparin|mesh-list
153643935|NCT00400387|Dalteparin|dalteparin|mesh-list
153643936|NCT00400387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153643937|NCT00400387|Anticoagulants|anticoagulants|mesh-ancestor
153643938|NCT00400387|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153643939|NCT00400387|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153643940|NCT00400387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153643942|NCT00400387|Micronutrients|micronutrients|mesh-ancestor
153643943|NCT00400387|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
153643944|NCT00400387|Dermatologic Agents|dermatologic agents|mesh-ancestor
153643945|NCT00400387|Antioxidants|antioxidants|mesh-ancestor
153643946|NCT00400387|Protective Agents|protective agents|mesh-ancestor
153643947|NCT00400387|Hematinics|hematinics|mesh-ancestor
153643948|NCT00006332|Tetrathiomolybdate|tetrathiomolybdate|mesh-list
153643949|NCT00006332|Chelating Agents|chelating agents|mesh-ancestor
153643950|NCT00006332|Sequestering Agents|sequestering agents|mesh-ancestor
153643951|NCT00006332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153643952|NCT00006332|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153643953|NCT00006332|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153643954|NCT00006332|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153643955|NCT00006332|Growth Substances|growth substances|mesh-ancestor
153643956|NCT00006332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153643957|NCT00006332|Growth Inhibitors|growth inhibitors|mesh-ancestor
153643958|NCT00006332|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153643959|NCT00390390|Lansoprazole|lansoprazole|mesh-list
153643960|NCT00390390|Dexlansoprazole|dexlansoprazole|mesh-list
153643961|NCT00390390|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
153643964|NCT00390390|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153643969|NCT00097903|Camptothecin|camptothecin|mesh-list
153643970|NCT00097903|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153643971|NCT00097903|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153643972|NCT00097903|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
153643973|NCT00097903|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153643974|NCT00097903|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153643975|NCT00097903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153643976|NCT00097942|Memantine|memantine|mesh-list
153643977|NCT00097942|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
153643978|NCT00097942|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
153644031|NCT00098800|Fenretinide|fenretinide|mesh-list
153644032|NCT00098800|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153644033|NCT00098800|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
153644034|NCT00098800|Protective Agents|protective agents|mesh-ancestor
153644035|NCT00098800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153644036|NCT00098878|Carboplatin|carboplatin|mesh-list
153644037|NCT00098878|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153644038|NCT03633305|Hypnotics and Sedatives|hypnotics and sedatives|mesh-list
153644039|NCT03633305|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153644040|NCT03633305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153644041|NCT00098917|Vaccines|vaccines|mesh-list
153644042|NCT00098917|Immunologic Factors|immunologic factors|mesh-ancestor
153644043|NCT00098917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153644044|NCT00098995|Tirapazamine|tirapazamine|mesh-list
153644089|NCT00006350|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
153644090|NCT00006350|Antitubercular Agents|antitubercular agents|mesh-ancestor
153644091|NCT00006350|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153644092|NCT00006350|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153644093|NCT00400582|Candesartan|candesartan|mesh-list
153644094|NCT00400582|Candesartan cilexetil|candesartan cilexetil|mesh-list
153362638|NCT01520207|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
153362639|NCT01520207|Diuretics|diuretics|mesh-ancestor
153822673|NCT00445055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153822674|NCT00445055|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153822675|NCT00445055|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153890543|NCT01075048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153890544|NCT01075048|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153890545|NCT01075048|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153890546|NCT01252251|Everolimus|everolimus|mesh-list
153890547|NCT01252251|Pasireotide|pasireotide|mesh-list
153890548|NCT01252251|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
153644095|NCT00400582|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153644096|NCT00400582|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
153644097|NCT00400582|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
153644098|NCT00400582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153644152|NCT00099736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153644153|NCT00099736|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153644154|NCT00099736|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
153644155|NCT00099736|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
153644156|NCT00099775|Caspofungin|caspofungin|mesh-list
153644157|NCT00099775|Antifungal Agents|antifungal agents|mesh-ancestor
153644158|NCT00099775|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153644160|NCT00099775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153644162|NCT00006362|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153644164|NCT00099892|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153644165|NCT00099892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153644166|NCT00099892|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
153644167|NCT00099892|Protease Inhibitors|protease inhibitors|mesh-ancestor
153644168|NCT00099892|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153362704|NCT02548832|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153362705|NCT03216278|Metformin|metformin|mesh-list
153362706|NCT03216278|Dapagliflozin|dapagliflozin|mesh-list
153362707|NCT03216278|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153362708|NCT03216278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153822725|NCT00479778|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
153362714|NCT05310344|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153362715|NCT05310344|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153362716|NCT05310344|Tubulin Modulators|tubulin modulators|mesh-ancestor
153362717|NCT05310344|Antimitotic Agents|antimitotic agents|mesh-ancestor
153362718|NCT05310344|Mitosis Modulators|mitosis modulators|mesh-ancestor
153362719|NCT05310344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153362720|NCT05310344|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153362721|NCT05310344|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153362722|NCT05310344|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153362723|NCT05310344|Growth Substances|growth substances|mesh-ancestor
153644169|NCT00099892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153644170|NCT00099931|Vildagliptin|vildagliptin|mesh-list
153644171|NCT00099931|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153644172|NCT00099931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153644173|NCT00099931|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
153644174|NCT00099931|Protease Inhibitors|protease inhibitors|mesh-ancestor
153644175|NCT00099931|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153644176|NCT00099931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153644200|NCT00100009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153644202|NCT00100126|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153644203|NCT00100126|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153644204|NCT00100243|Abarelix|abarelix|mesh-list
153644205|NCT00100243|Hormone Antagonists|hormone antagonists|mesh-ancestor
153644206|NCT00100243|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153644207|NCT00100243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153644208|NCT00006368|Edotreotide|edotreotide|mesh-list
153644209|NCT00006368|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
153644210|NCT00006368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153644211|NCT00100477|Etoposide|etoposide|mesh-list
153644212|NCT00100477|Mitoxantrone|mitoxantrone|mesh-list
153644213|NCT00100477|Topotecan|topotecan|mesh-list
153644214|NCT00100477|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153822779|NCT03274700|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
153822780|NCT03274700|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
153822781|NCT03274700|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
153822782|NCT03274700|Adrenergic Agents|adrenergic agents|mesh-ancestor
153822783|NCT03274700|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153822784|NCT03274700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153822785|NCT03274700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153362763|NCT03215498|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153362764|NCT03215498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153362765|NCT01441037|Danazol|danazol|mesh-list
153362766|NCT01441037|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
153362767|NCT01441037|Hormone Antagonists|hormone antagonists|mesh-ancestor
153822811|NCT00454259|Analgesics|analgesics|mesh-ancestor
153822812|NCT00454259|Sensory System Agents|sensory system agents|mesh-ancestor
153822813|NCT00454259|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153822814|NCT00454259|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153822815|NCT00454259|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153822816|NCT00454259|Anesthetics, General|anesthetics, general|mesh-ancestor
153822817|NCT00454259|Anesthetics|anesthetics|mesh-ancestor
153362768|NCT01441037|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153362769|NCT01441037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153362771|NCT00891878|Sunitinib|sunitinib|mesh-list
153362772|NCT00891878|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153422490|NCT03646357|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
153422491|NCT03646357|Adrenergic Agents|adrenergic agents|mesh-ancestor
153644215|NCT00100477|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153644216|NCT00100477|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153644217|NCT00100477|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153644218|NCT00100477|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153644219|NCT00100477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153644220|NCT00100477|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
153644221|NCT00100477|Analgesics|analgesics|mesh-ancestor
153644222|NCT00100477|Sensory System Agents|sensory system agents|mesh-ancestor
153644223|NCT00100477|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153644224|NCT00100477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153644225|NCT00100555|Zoledronic Acid|zoledronic acid|mesh-list
153644226|NCT00100555|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153644228|NCT00006371|Ketoconazole|ketoconazole|mesh-list
153644243|NCT00006371|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153644244|NCT00006371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153644245|NCT00006371|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
153644246|NCT00006371|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153644247|NCT00006371|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153644248|NCT00006371|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
153644249|NCT00006371|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
153644250|NCT00100594|Lamivudine|lamivudine|mesh-list
153644251|NCT00100594|Zidovudine|zidovudine|mesh-list
153644252|NCT00100594|Efavirenz|efavirenz|mesh-list
153644253|NCT00100594|Lamivudine, zidovudine drug combination|lamivudine, zidovudine drug combination|mesh-list
153644269|NCT00006374|Paclitaxel|paclitaxel|mesh-list
153644306|NCT01350102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153644308|NCT01350102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153644309|NCT01350102|Protective Agents|protective agents|mesh-ancestor
153644310|NCT01350102|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
153644311|NCT01350102|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153644312|NCT01350102|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153644313|NCT00424060|Sagopilone|sagopilone|mesh-list
153644314|NCT00424060|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153644315|NCT00006380|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
153644316|NCT00006380|Antibodies|antibodies|mesh-list
153644317|NCT00006380|Immunoglobulins|immunoglobulins|mesh-list
153644322|NCT00100906|Aldesleukin|aldesleukin|mesh-list
153644369|NCT00101062|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153644370|NCT00101062|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153644371|NCT00101062|Analgesics|analgesics|mesh-ancestor
153644372|NCT00101062|Sensory System Agents|sensory system agents|mesh-ancestor
153644373|NCT00101062|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153644374|NCT00101062|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153644375|NCT00101062|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153644379|NCT00006386|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153644380|NCT00006386|Alkylating Agents|alkylating agents|mesh-ancestor
153644381|NCT00006386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153644382|NCT00006386|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153644383|NCT00101140|Fludarabine|fludarabine|mesh-list
153644384|NCT00101140|Fludarabine phosphate|fludarabine phosphate|mesh-list
153644385|NCT00101140|Thiotepa|thiotepa|mesh-list
153644386|NCT00101140|Antilymphocyte Serum|antilymphocyte serum|mesh-list
153644387|NCT00101140|Immunomodulating Agents|immunomodulating agents|mesh-list
153644388|NCT00101140|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153644389|NCT00101140|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153644390|NCT00101140|Antimetabolites|antimetabolites|mesh-ancestor
153644391|NCT00101140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153644392|NCT00101140|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153644416|NCT00400777|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
153644418|NCT00400777|Diuretics|diuretics|mesh-ancestor
153644419|NCT00400777|Natriuretic Agents|natriuretic agents|mesh-ancestor
153644420|NCT00400777|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
153644421|NCT00400816|Temozolomide|temozolomide|mesh-list
153644422|NCT00400816|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153644423|NCT00400816|Alkylating Agents|alkylating agents|mesh-ancestor
153644424|NCT00400816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153644425|NCT00400816|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153644426|NCT00400855|Fluticasone|fluticasone|mesh-list
153644428|NCT00400855|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153644429|NCT00400855|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153644430|NCT00400855|Autonomic Agents|autonomic agents|mesh-ancestor
153644431|NCT00400855|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153644475|NCT00006401|Antioxidants|antioxidants|mesh-ancestor
153644476|NCT00006401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153644477|NCT00006401|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153644478|NCT00006401|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
153644479|NCT00006401|Vasodilator Agents|vasodilator agents|mesh-ancestor
153644480|NCT00006401|Gasotransmitters|gasotransmitters|mesh-ancestor
153644481|NCT00006401|Protective Agents|protective agents|mesh-ancestor
153644482|NCT00101569|Aripiprazole|aripiprazole|mesh-list
153644483|NCT00101569|Antidepressive Agents|antidepressive agents|mesh-ancestor
153822837|NCT03278808|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153822838|NCT03278808|Filaricides|filaricides|mesh-ancestor
153362787|NCT03838328|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
153362788|NCT03838328|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153362789|NCT03838328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153362790|NCT03838328|Hemostatics|hemostatics|mesh-ancestor
153362791|NCT03838328|Coagulants|coagulants|mesh-ancestor
153362792|NCT01526213|Fexofenadine|fexofenadine|mesh-list
153644538|NCT00102154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153644540|NCT00102154|GABA Agonists|gaba agonists|mesh-ancestor
153644541|NCT00102154|GABA Agents|gaba agents|mesh-ancestor
153644542|NCT00102154|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153644543|NCT00102154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153644545|NCT00102271|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153644546|NCT00102271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153644547|NCT00102310|Z 338|z 338|mesh-list
153644548|NCT00102310|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
153822842|NCT03278808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153822843|NCT03278808|Antimetabolites|antimetabolites|mesh-ancestor
153822844|NCT00480090|Cytarabine|cytarabine|mesh-list
153822845|NCT00480090|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153822846|NCT00480090|Antimetabolites|antimetabolites|mesh-ancestor
153822847|NCT00480090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153822848|NCT00480090|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153822849|NCT00480090|Antiviral Agents|antiviral agents|mesh-ancestor
153822850|NCT00480090|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153822851|NCT00480090|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153822852|NCT00480090|Immunologic Factors|immunologic factors|mesh-ancestor
153822853|NCT00480090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153822854|NCT00454883|Ziprasidone|ziprasidone|mesh-list
153822855|NCT00454883|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153822856|NCT00454883|Serotonin Agents|serotonin agents|mesh-ancestor
153362811|NCT01549223|Abortifacient Agents|abortifacient agents|mesh-ancestor
153644549|NCT00102310|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153644550|NCT00102310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153644551|NCT00102310|Cholinergic Agents|cholinergic agents|mesh-ancestor
153644552|NCT00102310|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153644553|NCT00102310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153644554|NCT00102310|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153644555|NCT00102388|Vildagliptin|vildagliptin|mesh-list
153644588|NCT00006428|Antidepressive Agents|antidepressive agents|mesh-ancestor
153644589|NCT00006428|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153644590|NCT00006428|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153644591|NCT00006428|Analgesics|analgesics|mesh-ancestor
153644592|NCT00006428|Sensory System Agents|sensory system agents|mesh-ancestor
153644593|NCT00006428|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153644594|NCT00006428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153644595|NCT00006428|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
153644596|NCT00006428|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153644597|NCT00006428|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153644598|NCT00006428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153822862|NCT00454883|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153822863|NCT00454883|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153822864|NCT00454883|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
153822865|NCT00454883|Dopamine Agents|dopamine agents|mesh-ancestor
153822867|NCT03278652|Sensory System Agents|sensory system agents|mesh-ancestor
153822868|NCT03278652|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153822869|NCT03278652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153822870|NCT00454961|Lumefantrine|lumefantrine|mesh-list
153822871|NCT00454961|Artemether|artemether|mesh-list
153881639|NCT01977417|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153822872|NCT00454961|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
153822873|NCT00454961|Antimalarials|antimalarials|mesh-ancestor
153822874|NCT00454961|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153822875|NCT00454961|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153822876|NCT00454961|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153822877|NCT00480207|Folic Acid|folic acid|mesh-list
153822878|NCT00480207|Vitamin B Complex|vitamin b complex|mesh-list
153822879|NCT00480207|Hematinics|hematinics|mesh-ancestor
153822880|NCT00480207|Vitamins|vitamins|mesh-ancestor
153362836|NCT01550471|Hormones|hormones|mesh-ancestor
153822882|NCT00480207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153822883|NCT00442455|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
153644600|NCT00006428|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153644601|NCT00102661|Alemtuzumab|alemtuzumab|mesh-list
153644602|NCT00102661|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153644603|NCT00102661|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153644604|NCT00102700|Beta-lapachone|beta-lapachone|mesh-list
153644616|NCT00102778|Lopinavir|lopinavir|mesh-list
153644644|NCT00102856|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153644645|NCT00102856|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
153644646|NCT00102856|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153644647|NCT00102856|Cholinergic Agents|cholinergic agents|mesh-ancestor
153644648|NCT00102856|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
153644649|NCT00102934|Enfuvirtide|enfuvirtide|mesh-list
153644650|NCT00102934|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
153644651|NCT00102934|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
153644652|NCT00102934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153644653|NCT00102934|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153644654|NCT00102934|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153644655|NCT00102934|Antiviral Agents|antiviral agents|mesh-ancestor
153644656|NCT00102934|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153644657|NCT00006443|Lamivudine|lamivudine|mesh-list
153644658|NCT00006443|Stavudine|stavudine|mesh-list
153644659|NCT00006443|Nelfinavir|nelfinavir|mesh-list
153644660|NCT00006443|Indinavir|indinavir|mesh-list
153644661|NCT00006443|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153644662|NCT00006443|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153644663|NCT00006443|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153890646|NCT01072396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153890647|NCT01045096|Dexlansoprazole|dexlansoprazole|mesh-list
153890648|NCT01045096|Lansoprazole|lansoprazole|mesh-list
153890649|NCT01045096|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
153890650|NCT01045096|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153890651|NCT01045096|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
153890652|NCT01045096|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153890653|NCT01045096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153890654|NCT02876146|Albendazole|albendazole|mesh-list
153890655|NCT02876146|Benzimidazole|benzimidazole|mesh-list
153890656|NCT02876146|Anthelmintics|anthelmintics|mesh-ancestor
153890657|NCT02876146|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153890658|NCT02876146|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153890659|NCT02876146|Anticestodal Agents|anticestodal agents|mesh-ancestor
153890660|NCT02876146|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
153890661|NCT02876146|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153890662|NCT02876146|Tubulin Modulators|tubulin modulators|mesh-ancestor
153890663|NCT02876146|Antimitotic Agents|antimitotic agents|mesh-ancestor
153890664|NCT02876146|Mitosis Modulators|mitosis modulators|mesh-ancestor
153890665|NCT02876146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153644667|NCT00006443|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153644668|NCT00006443|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153644669|NCT00006443|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
153644670|NCT00006443|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
153644671|NCT00006443|Protease Inhibitors|protease inhibitors|mesh-ancestor
153644672|NCT00006443|Antimetabolites|antimetabolites|mesh-ancestor
153644673|NCT00102973|Carboplatin|carboplatin|mesh-list
153644674|NCT00102973|Doxorubicin|doxorubicin|mesh-list
153644689|NCT00103051|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153644690|NCT00103051|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153644691|NCT00103168|Imatinib Mesylate|imatinib mesylate|mesh-list
153644692|NCT00103168|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153644693|NCT00103168|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153644694|NCT00103168|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153644695|NCT00103168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153644696|NCT00103168|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153644697|NCT02697474|Vaccines|vaccines|mesh-list
153644698|NCT02697474|Immunologic Factors|immunologic factors|mesh-ancestor
153435381|NCT00003146|Thiotepa|thiotepa|mesh-list
153644699|NCT02697474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153822907|NCT00455117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153822908|NCT00455117|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153822909|NCT00455117|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153822910|NCT00455117|Analgesics|analgesics|mesh-ancestor
153822911|NCT00455117|Sensory System Agents|sensory system agents|mesh-ancestor
153822912|NCT00455117|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153822913|NCT00455117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153822914|NCT00455117|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153822915|NCT00455117|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153822916|NCT00442494|Hydrocortisone|hydrocortisone|mesh-list
153822917|NCT00442494|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153822918|NCT03274427|Trimetazidine|trimetazidine|mesh-list
153822919|NCT03274427|Vasodilator Agents|vasodilator agents|mesh-ancestor
153822920|NCT00455234|Promethazine|promethazine|mesh-list
153822921|NCT00455234|Diphenhydramine|diphenhydramine|mesh-list
153822922|NCT00455234|Haloperidol|haloperidol|mesh-list
153644705|NCT00103246|Antimalarials|antimalarials|mesh-ancestor
153644706|NCT00103246|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153644707|NCT00103246|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153644708|NCT00103246|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153644709|NCT00103246|Antiviral Agents|antiviral agents|mesh-ancestor
153644710|NCT00103246|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
153644711|NCT00103246|Dermatologic Agents|dermatologic agents|mesh-ancestor
153644712|NCT00103324|Lapatinib|lapatinib|mesh-list
153644713|NCT00103324|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153644714|NCT00103324|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153644715|NCT00103324|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153644738|NCT00006449|Sensory System Agents|sensory system agents|mesh-ancestor
153644739|NCT00006449|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153644740|NCT00103753|Deferiprone|deferiprone|mesh-list
153644741|NCT00103753|Iron Chelating Agents|iron chelating agents|mesh-ancestor
153644742|NCT00103753|Chelating Agents|chelating agents|mesh-ancestor
153822928|NCT00455234|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153822929|NCT00455234|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153822930|NCT00455234|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153822931|NCT00455234|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153822932|NCT00455234|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153822933|NCT00455234|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
153822934|NCT00455234|Dopamine Agents|dopamine agents|mesh-ancestor
153822935|NCT00455234|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153822936|NCT00455234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153822937|NCT00455234|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
153822938|NCT00455234|Antipruritics|antipruritics|mesh-ancestor
153822939|NCT00455234|Dermatologic Agents|dermatologic agents|mesh-ancestor
153822940|NCT00455234|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
153822941|NCT00455234|Histamine Antagonists|histamine antagonists|mesh-ancestor
153822942|NCT00455234|Histamine Agents|histamine agents|mesh-ancestor
153822943|NCT00455234|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
153822944|NCT00455234|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
153822945|NCT00455234|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153362888|NCT01831622|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153362889|NCT04380818|Ritonavir|ritonavir|mesh-list
153362890|NCT04380818|Lopinavir|lopinavir|mesh-list
153362891|NCT04380818|Azithromycin|azithromycin|mesh-list
153362892|NCT04380818|Hydroxychloroquine|hydroxychloroquine|mesh-list
153362893|NCT04380818|Heparin|heparin|mesh-list
153362894|NCT04380818|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
153362895|NCT04380818|Tinzaparin|tinzaparin|mesh-list
153890674|NCT02874820|Idazoxan|idazoxan|mesh-list
153644750|NCT00103792|Cyclophosphamide|cyclophosphamide|mesh-list
153644751|NCT00103792|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153644752|NCT00103792|Immunologic Factors|immunologic factors|mesh-ancestor
153644753|NCT00103792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153644754|NCT00103792|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153644796|NCT03879408|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153644797|NCT03879408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153644798|NCT03879408|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153644800|NCT03879408|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153644801|NCT03879408|Antitussive Agents|antitussive agents|mesh-ancestor
153644802|NCT03879408|Respiratory System Agents|respiratory system agents|mesh-ancestor
153644803|NCT00104182|Insulin|insulin|mesh-list
153644804|NCT00104182|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
153644805|NCT00104182|Insulin Detemir|insulin detemir|mesh-list
153644806|NCT00104182|Isophane Insulin, Human|isophane insulin, human|mesh-list
153644807|NCT00104182|Insulin, Isophane|insulin, isophane|mesh-list
153644811|NCT00104260|Verapamil|verapamil|mesh-list
153644858|NCT00104767|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153644859|NCT00104767|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153644860|NCT00104767|Analgesics|analgesics|mesh-ancestor
153644861|NCT00104767|Sensory System Agents|sensory system agents|mesh-ancestor
153644862|NCT00104767|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153644863|NCT00104767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153644864|NCT00104767|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153644865|NCT00104767|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153644866|NCT00104767|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
153644867|NCT00104767|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153644868|NCT00104767|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153644869|NCT00104767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153644870|NCT02972268|Tamsulosin|tamsulosin|mesh-list
153644871|NCT02972268|Solifenacin Succinate|solifenacin succinate|mesh-list
153644872|NCT02972268|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
153644873|NCT02972268|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
153644874|NCT02972268|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
153644875|NCT02972268|Adrenergic Agents|adrenergic agents|mesh-ancestor
153644876|NCT02972268|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153644877|NCT02972268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153822946|NCT00455234|Anesthetics, Local|anesthetics, local|mesh-ancestor
153822947|NCT00455234|Anesthetics|anesthetics|mesh-ancestor
153822948|NCT00455234|Sensory System Agents|sensory system agents|mesh-ancestor
153822949|NCT00480363|Dexamethasone|dexamethasone|mesh-list
153822950|NCT00480363|Lenalidomide|lenalidomide|mesh-list
153822951|NCT00480363|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153822952|NCT00480363|Antiemetics|antiemetics|mesh-ancestor
153822960|NCT00480363|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153822961|NCT00480363|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153822962|NCT00480363|Immunologic Factors|immunologic factors|mesh-ancestor
153822963|NCT00480363|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153822964|NCT00480363|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153822965|NCT00480363|Growth Substances|growth substances|mesh-ancestor
153362909|NCT04380818|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153362910|NCT04380818|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153362911|NCT04380818|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153362912|NCT04380818|Antimalarials|antimalarials|mesh-ancestor
153362913|NCT04380818|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153362914|NCT04380818|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153362915|NCT04380818|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153362916|NCT05312294|Vaccines|vaccines|mesh-list
153431740|NCT05963217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153431741|NCT05963217|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153431742|NCT05963217|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153431743|NCT05943990|Cyclophosphamide|cyclophosphamide|mesh-list
153431744|NCT05943990|Fludarabine|fludarabine|mesh-list
153822967|NCT00455390|Psychotropic Drugs|psychotropic drugs|mesh-list
153822968|NCT00442845|Atorvastatin|atorvastatin|mesh-list
153822969|NCT00442845|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153822970|NCT00442845|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153822971|NCT00442845|Antimetabolites|antimetabolites|mesh-ancestor
153822972|NCT00442845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153362917|NCT05312294|Immunologic Factors|immunologic factors|mesh-ancestor
153362918|NCT05312294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153362919|NCT01550705|Isoniazid|isoniazid|mesh-list
153362920|NCT01550705|Antitubercular Agents|antitubercular agents|mesh-ancestor
153362921|NCT01550705|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153362922|NCT01550705|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153362923|NCT01550705|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
153362924|NCT01550705|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153362925|NCT01550705|Antimetabolites|antimetabolites|mesh-ancestor
153362926|NCT01550705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153362927|NCT01550705|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153362928|NCT01831700|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
153644909|NCT00104923|Fenretinide|fenretinide|mesh-list
153644910|NCT00104923|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153644911|NCT00104923|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
153644912|NCT00104923|Protective Agents|protective agents|mesh-ancestor
153644913|NCT00104923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153644914|NCT00104962|Lenalidomide|lenalidomide|mesh-list
153644915|NCT00104962|Immunologic Factors|immunologic factors|mesh-ancestor
153894337|NCT01208103|Bevacizumab|bevacizumab|mesh-list
153644916|NCT00104962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153644917|NCT00104962|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153644918|NCT00104962|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153644919|NCT00104962|Growth Substances|growth substances|mesh-ancestor
153644920|NCT00104962|Growth Inhibitors|growth inhibitors|mesh-ancestor
153644921|NCT00104962|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153644922|NCT00006467|Gemcitabine|gemcitabine|mesh-list
153644923|NCT00006467|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153644924|NCT00006467|Antimetabolites|antimetabolites|mesh-ancestor
153644925|NCT00006467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153644926|NCT00006467|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153644927|NCT00105040|Levetiracetam|levetiracetam|mesh-list
153644928|NCT00105040|Anticonvulsants|anticonvulsants|mesh-ancestor
153362950|NCT03214874|Diuretics|diuretics|mesh-ancestor
153362951|NCT03214874|Natriuretic Agents|natriuretic agents|mesh-ancestor
153644929|NCT00105040|Nootropic Agents|nootropic agents|mesh-ancestor
153644930|NCT00006470|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
153644932|NCT00006470|Antibodies|antibodies|mesh-list
153644933|NCT00006470|Immunoglobulins|immunoglobulins|mesh-list
153644934|NCT00006470|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
153644935|NCT00006470|Immunoglobulin Idiotypes|immunoglobulin idiotypes|mesh-list
153644950|NCT00105547|Sensory System Agents|sensory system agents|mesh-ancestor
153644951|NCT00105547|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153644952|NCT00105547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153644953|NCT00105547|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153644954|NCT00105547|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153644955|NCT00105547|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153644956|NCT00105547|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153644957|NCT00105547|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153644958|NCT00390624|Mannitol|mannitol|mesh-list
153644959|NCT00390624|Ularitide|ularitide|mesh-list
153823003|NCT00455624|Androgens|androgens|mesh-list
153645020|NCT00106054|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153645021|NCT00106054|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153645022|NCT00106054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153645023|NCT00106054|Antidotes|antidotes|mesh-ancestor
153645024|NCT00106054|Protective Agents|protective agents|mesh-ancestor
153645025|NCT00106054|Vitamin B Complex|vitamin b complex|mesh-ancestor
153645026|NCT00106054|Vitamins|vitamins|mesh-ancestor
153645027|NCT00106054|Micronutrients|micronutrients|mesh-ancestor
153645028|NCT00106132|Triamcinolone|triamcinolone|mesh-list
153645029|NCT00106132|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
153645030|NCT00106132|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
153645031|NCT00106132|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
153645032|NCT00106132|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153645033|NCT00106132|Glucocorticoids|glucocorticoids|mesh-ancestor
153645034|NCT00106132|Hormones|hormones|mesh-ancestor
153645035|NCT00106132|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153645036|NCT00106132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153645037|NCT00106132|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153645038|NCT00106132|Immunologic Factors|immunologic factors|mesh-ancestor
153645039|NCT00106132|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153645040|NCT00106132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153645041|NCT03815682|Pembrolizumab|pembrolizumab|mesh-list
153645070|NCT00106405|Dopamine Agents|dopamine agents|mesh-ancestor
153645071|NCT00106405|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153645072|NCT00106405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153645073|NCT00106405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153645074|NCT00106405|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
153645075|NCT00106405|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
153645076|NCT00006485|Irinotecan|irinotecan|mesh-list
153823066|NCT04700709|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153823067|NCT04700709|Immunologic Factors|immunologic factors|mesh-ancestor
153363051|NCT01832870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153363053|NCT01553201|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
153363054|NCT01553201|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153431789|NCT05877547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153431791|NCT05832489|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
153431792|NCT05832489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153431793|NCT05832489|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
153431794|NCT05832489|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153431795|NCT05832489|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153431796|NCT05832489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153431797|NCT05832489|Dopamine Agents|dopamine agents|mesh-ancestor
153431798|NCT05832489|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153431799|NCT05831124|Vaccines|vaccines|mesh-list
153645133|NCT00401323|Tubulin Modulators|tubulin modulators|mesh-ancestor
153645176|NCT02964949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153645177|NCT02964949|Anticoagulants|anticoagulants|mesh-ancestor
153645178|NCT00107341|Paclitaxel|paclitaxel|mesh-list
153645179|NCT00107341|Carboplatin|carboplatin|mesh-list
153645180|NCT00107341|Bortezomib|bortezomib|mesh-list
153645181|NCT00107341|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153645182|NCT00107341|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153645183|NCT00107341|Tubulin Modulators|tubulin modulators|mesh-ancestor
153645184|NCT00107341|Antimitotic Agents|antimitotic agents|mesh-ancestor
153645185|NCT00107341|Mitosis Modulators|mitosis modulators|mesh-ancestor
153645186|NCT00107341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153645187|NCT00107419|Pemetrexed|pemetrexed|mesh-list
153645188|NCT00107419|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153645189|NCT00107419|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153645196|NCT00006578|Ritonavir|ritonavir|mesh-list
153645238|NCT00006617|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153645239|NCT00006617|Antimetabolites|antimetabolites|mesh-ancestor
153645240|NCT00006617|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
153645241|NCT00006617|Antitubercular Agents|antitubercular agents|mesh-ancestor
153645242|NCT00006617|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153645243|NCT00006617|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
153645244|NCT00006617|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
153645245|NCT00006617|Protease Inhibitors|protease inhibitors|mesh-ancestor
153645246|NCT00107731|Valproic Acid|valproic acid|mesh-list
153645247|NCT00107731|Quetiapine Fumarate|quetiapine fumarate|mesh-list
153645248|NCT00107731|Antidepressive Agents|antidepressive agents|mesh-ancestor
153645249|NCT00107731|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153645250|NCT00107731|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153645251|NCT00107731|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153645252|NCT00107731|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153645253|NCT00107731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153645254|NCT00107731|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153645255|NCT00107731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153645256|NCT00107731|Antimanic Agents|antimanic agents|mesh-ancestor
153645287|NCT00006656|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153645289|NCT00006656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153645290|NCT00006656|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153645291|NCT00107848|Modafinil|modafinil|mesh-list
153645292|NCT00107848|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
153645293|NCT00107848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153645294|NCT00107848|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
153645295|NCT00107848|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
153645296|NCT00107848|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
153645350|NCT00108316|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
153645351|NCT00108316|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153645352|NCT00108316|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153645353|NCT00108394|Pamidronate|pamidronate|mesh-list
153645354|NCT00108394|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153823111|NCT00480675|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
153823112|NCT00480675|Prednisolone phosphate|prednisolone phosphate|mesh-list
153823113|NCT00480675|Anesthetics, Local|anesthetics, local|mesh-ancestor
153823114|NCT00480675|Anesthetics|anesthetics|mesh-ancestor
153823115|NCT00480675|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153823116|NCT00480675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153823117|NCT00480675|Sensory System Agents|sensory system agents|mesh-ancestor
153823118|NCT00480675|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153823119|NCT00480675|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153823120|NCT00480675|Antiemetics|antiemetics|mesh-ancestor
153823121|NCT00480675|Autonomic Agents|autonomic agents|mesh-ancestor
153823122|NCT00480675|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153823123|NCT00480675|Glucocorticoids|glucocorticoids|mesh-ancestor
153823124|NCT00480675|Hormones|hormones|mesh-ancestor
153823125|NCT00480675|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153823126|NCT00480675|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
153823127|NCT00480675|Protective Agents|protective agents|mesh-ancestor
153823128|NCT00480675|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153645478|NCT00006968|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153645479|NCT00006968|Adenosine Deaminase Inhibitors|adenosine deaminase inhibitors|mesh-ancestor
153645481|NCT00109408|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
153823129|NCT00480675|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153823130|NCT00456560|Fluvoxamine|fluvoxamine|mesh-list
153823149|NCT00456560|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
153823150|NCT00456677|Minocycline|minocycline|mesh-list
153823151|NCT00456677|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153823152|NCT00456677|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153363098|NCT01533077|Dopamine Agonists|dopamine agonists|mesh-ancestor
153363099|NCT01533077|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
153645493|NCT00109408|Immunologic Factors|immunologic factors|mesh-ancestor
153645494|NCT00109408|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153645495|NCT00109408|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153645497|NCT00109564|Nicotinic Agonists|nicotinic agonists|mesh-list
153645498|NCT00109564|Vasodilator Agents|vasodilator agents|mesh-ancestor
153363109|NCT03211988|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
153363110|NCT03211988|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153363111|NCT03211988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153363112|NCT01833728|Acetaminophen|acetaminophen|mesh-list
153363113|NCT01833728|Propacetamol|propacetamol|mesh-list
153363114|NCT01833728|Nefopam|nefopam|mesh-list
153363115|NCT01833728|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153363116|NCT01833728|Analgesics|analgesics|mesh-ancestor
153363117|NCT01833728|Sensory System Agents|sensory system agents|mesh-ancestor
153363118|NCT01833728|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153363119|NCT01833728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153363120|NCT01833728|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153363121|NCT01833728|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153823153|NCT00456716|Sorafenib|sorafenib|mesh-list
153823154|NCT00456716|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153823155|NCT00456716|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153890837|NCT01037218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153890838|NCT01038856|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
153890844|NCT01269918|Dexmedetomidine|dexmedetomidine|mesh-list
153645499|NCT00109564|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
153645500|NCT00109564|Cholinergic Agents|cholinergic agents|mesh-ancestor
153645501|NCT00109564|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153645502|NCT00109564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153645503|NCT00109564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153645505|NCT00109603|Antiviral Agents|antiviral agents|mesh-ancestor
153645506|NCT00109603|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153645507|NCT00109603|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153645508|NCT00109603|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153645509|NCT00109603|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153645510|NCT00109603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153645511|NCT00109603|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153820724|NCT03272802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153645512|NCT00109603|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153645513|NCT00109798|Temozolomide|temozolomide|mesh-list
153645514|NCT00109798|Topotecan|topotecan|mesh-list
153645515|NCT00109798|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153823156|NCT00456716|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153823157|NCT00456716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153823158|NCT04700397|Nitroglycerin|nitroglycerin|mesh-list
153823159|NCT04700397|Vasodilator Agents|vasodilator agents|mesh-ancestor
153823160|NCT00456794|Istradefylline|istradefylline|mesh-list
153823161|NCT00456794|Adenosine A2 Receptor Antagonists|adenosine a2 receptor antagonists|mesh-ancestor
153823162|NCT00456794|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
153823163|NCT00456794|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
153823164|NCT00456794|Purinergic Agents|purinergic agents|mesh-ancestor
153823165|NCT00456794|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153823169|NCT00456833|Everolimus|everolimus|mesh-list
153363134|NCT03219788|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153363136|NCT03219710|Ondansetron|ondansetron|mesh-list
153431872|NCT05677152|Zoledronic Acid|zoledronic acid|mesh-list
153431873|NCT05677152|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153431874|NCT05677152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153431875|NCT05657613|Fluconazole|fluconazole|mesh-list
153431876|NCT05657613|Bosentan|bosentan|mesh-list
153431877|NCT05657613|Antifungal Agents|antifungal agents|mesh-ancestor
153431878|NCT05657613|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153431879|NCT05657613|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
153422512|NCT03500328|Glatiramer Acetate|glatiramer acetate|mesh-list
153431880|NCT05657613|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153431881|NCT05657613|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153431882|NCT05657613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153431883|NCT05657613|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153645519|NCT00109798|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
153645520|NCT00109798|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153645521|NCT00109798|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153645522|NCT00109954|Cisplatin|cisplatin|mesh-list
153645523|NCT00109954|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153645524|NCT00109993|Methylprednisolone|methylprednisolone|mesh-list
153645525|NCT00109993|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
153645526|NCT00109993|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
153645527|NCT00109993|Prednisolone|prednisolone|mesh-list
153645528|NCT00109993|Prednisolone acetate|prednisolone acetate|mesh-list
153645529|NCT00109993|Alemtuzumab|alemtuzumab|mesh-list
153645530|NCT00109993|Tacrolimus|tacrolimus|mesh-list
153645545|NCT00109993|Hormones|hormones|mesh-ancestor
153645569|NCT00110071|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153645570|NCT00110071|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
153645571|NCT00110071|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153645573|NCT00110071|Micronutrients|micronutrients|mesh-ancestor
153645574|NCT00110188|Sirolimus|sirolimus|mesh-list
153645575|NCT00110188|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153645576|NCT00110188|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153645577|NCT00110188|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153645578|NCT00110188|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153645579|NCT00110188|Antifungal Agents|antifungal agents|mesh-ancestor
153645580|NCT00110188|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153645581|NCT00110188|Immunologic Factors|immunologic factors|mesh-ancestor
153645582|NCT00110188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153645583|NCT00007202|Atazanavir Sulfate|atazanavir sulfate|mesh-list
153823175|NCT00456833|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
153823176|NCT00456833|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153823177|NCT00456833|Immunologic Factors|immunologic factors|mesh-ancestor
153823178|NCT00456833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153823179|NCT00456872|Lidocaine|lidocaine|mesh-list
153823180|NCT00456872|Anesthetics, Local|anesthetics, local|mesh-ancestor
153823181|NCT00456872|Anesthetics|anesthetics|mesh-ancestor
153823182|NCT00456872|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153823183|NCT00456872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153823184|NCT00456872|Sensory System Agents|sensory system agents|mesh-ancestor
153823185|NCT00456872|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153823186|NCT00456872|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153823187|NCT00456872|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
153823188|NCT00456872|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153431895|NCT05651282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153431896|NCT05651282|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
153431897|NCT05651282|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
153431898|NCT05651282|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153431899|NCT05651282|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153431900|NCT05626439|Alprazolam|alprazolam|mesh-list
153431901|NCT05626439|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153431902|NCT05626439|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153431903|NCT05626439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153645630|NCT00110695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153645631|NCT00110734|Lidocaine|lidocaine|mesh-list
153645632|NCT00110734|Tetracaine|tetracaine|mesh-list
153645680|NCT00111046|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153645681|NCT00111046|Narcotics|narcotics|mesh-ancestor
153645682|NCT00111046|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153645683|NCT00388271|Alfuzosin|alfuzosin|mesh-list
153645684|NCT00388271|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
153645685|NCT00388271|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
153645686|NCT00388271|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
153645687|NCT00388271|Adrenergic Agents|adrenergic agents|mesh-ancestor
153645688|NCT00388271|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153645689|NCT00388271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153645747|NCT00111436|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153645748|NCT00111436|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153645749|NCT00111436|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153645750|NCT00111436|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153645751|NCT00111436|Immunologic Factors|immunologic factors|mesh-ancestor
153645752|NCT00111631|Metformin|metformin|mesh-list
153645753|NCT00111631|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
153645754|NCT00111631|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153645755|NCT00111631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153645756|NCT00111631|Protease Inhibitors|protease inhibitors|mesh-ancestor
153645757|NCT00111631|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153823205|NCT00480870|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153823206|NCT00480870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153823207|NCT00480870|Nootropic Agents|nootropic agents|mesh-ancestor
153823208|NCT00457106|Risperidone|risperidone|mesh-list
153823209|NCT00457106|Paroxetine|paroxetine|mesh-list
153823210|NCT00457106|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153823211|NCT00457106|Serotonin Agents|serotonin agents|mesh-ancestor
153823212|NCT00457106|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153823213|NCT00457106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153823214|NCT00457106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153823215|NCT00457106|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153823216|NCT00457106|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153363164|NCT03219710|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
153363165|NCT01532141|Opicapone|opicapone|mesh-list
153890887|NCT04301908|Interferons|interferons|mesh-list
153645810|NCT00111943|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153645811|NCT00111943|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153645812|NCT00111943|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153645813|NCT00111943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153645814|NCT00111943|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153645815|NCT00111943|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153645817|NCT00401596|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
153645818|NCT00401596|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153645819|NCT00401596|Respiratory System Agents|respiratory system agents|mesh-ancestor
153645821|NCT00401635|Doxorubicin|doxorubicin|mesh-list
153645822|NCT00401635|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
153645823|NCT00401635|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153363166|NCT01532141|Rasagiline|rasagiline|mesh-list
153363167|NCT01532141|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
153363168|NCT01532141|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153363169|NCT01532141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153363170|NCT01532141|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
153363171|NCT01532141|Protective Agents|protective agents|mesh-ancestor
153363172|NCT01532141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153363173|NCT01532141|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
153363174|NCT01532141|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
153363175|NCT01532141|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
153363176|NCT00899600|Ketamine|ketamine|mesh-list
153363177|NCT00899600|Analgesics|analgesics|mesh-ancestor
153823217|NCT00457106|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153823218|NCT00457106|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153823219|NCT00457106|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
153823220|NCT00457106|Dopamine Agents|dopamine agents|mesh-ancestor
153823221|NCT00457106|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
153431923|NCT05600426|Alkylating Agents|alkylating agents|mesh-ancestor
153431924|NCT05600426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153431925|NCT05600426|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153431926|NCT05600426|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153431927|NCT05600426|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
153431928|NCT05600426|Abortifacient Agents|abortifacient agents|mesh-ancestor
153645861|NCT00112138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153645863|NCT00112138|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153645864|NCT00112138|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153645865|NCT00112138|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153645866|NCT00112138|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153645867|NCT00112138|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
153645868|NCT00112138|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
153645869|NCT00112138|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153645870|NCT00112138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153645920|NCT00007592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153645921|NCT00007592|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153645922|NCT00007592|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
153645923|NCT00007631|Tretinoin|tretinoin|mesh-list
153645924|NCT00007631|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153645925|NCT00007631|Keratolytic Agents|keratolytic agents|mesh-ancestor
153645929|NCT00112567|Thiotepa|thiotepa|mesh-list
153645979|NCT00112684|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153645986|NCT00112879|Ascorbic Acid|ascorbic acid|mesh-list
153645987|NCT00112879|Thalidomide|thalidomide|mesh-list
153645988|NCT00112879|Dexamethasone|dexamethasone|mesh-list
153645989|NCT00112879|Arsenic Trioxide|arsenic trioxide|mesh-list
153645990|NCT00112879|Mitogens|mitogens|mesh-list
153645991|NCT00112879|Immunomodulating Agents|immunomodulating agents|mesh-list
153645992|NCT00112879|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153646042|NCT00007787|Cyclosporine|cyclosporine|mesh-list
153823268|NCT02956538|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153823270|NCT02956538|Growth Substances|growth substances|mesh-ancestor
153823276|NCT00457652|Antimetabolites|antimetabolites|mesh-ancestor
153823277|NCT00457652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153823278|NCT00457652|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153823279|NCT00457652|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
153823280|NCT00457652|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153823281|NCT00457769|Donepezil|donepezil|mesh-list
153823282|NCT00457769|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
153823283|NCT00457769|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153646045|NCT00007787|Thymoglobulin|thymoglobulin|mesh-list
153646046|NCT00007787|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153646047|NCT00007787|Immunologic Factors|immunologic factors|mesh-ancestor
153646048|NCT00007787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153646049|NCT00007787|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
153646050|NCT00007787|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153646051|NCT00007787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153646052|NCT00007787|Antifungal Agents|antifungal agents|mesh-ancestor
153646053|NCT00007787|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153646054|NCT00007787|Dermatologic Agents|dermatologic agents|mesh-ancestor
153646055|NCT00007787|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153646056|NCT00390897|Interferons|interferons|mesh-list
153646057|NCT00390897|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153823297|NCT00457808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153823298|NCT00481143|Deferasirox|deferasirox|mesh-list
153823299|NCT00481143|Iron Chelating Agents|iron chelating agents|mesh-ancestor
153823319|NCT00458081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153823321|NCT00458081|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153823322|NCT00458081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153646061|NCT00113347|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
153646062|NCT00113347|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153646098|NCT00007826|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153823335|NCT00481182|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
153823336|NCT00481182|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153823337|NCT00481182|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153823338|NCT00481182|Narcotics|narcotics|mesh-ancestor
153823339|NCT00481182|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153823340|NCT00481182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153823341|NCT00481182|Analgesics|analgesics|mesh-ancestor
153823342|NCT00481182|Sensory System Agents|sensory system agents|mesh-ancestor
153823343|NCT00481182|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153823344|NCT00481182|Antitussive Agents|antitussive agents|mesh-ancestor
153823345|NCT00481182|Respiratory System Agents|respiratory system agents|mesh-ancestor
153823346|NCT00443937|Mycophenolic Acid|mycophenolic acid|mesh-list
153823347|NCT00443937|Everolimus|everolimus|mesh-list
153823348|NCT00443937|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
153823349|NCT00443937|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153823350|NCT00443937|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153823351|NCT00443937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153823352|NCT00443937|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153823353|NCT00443937|Immunologic Factors|immunologic factors|mesh-ancestor
153363303|NCT03217838|Pyrazole|pyrazole|mesh-list
153363309|NCT01558661|Axitinib|axitinib|mesh-list
153363313|NCT01558661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153363314|NCT01835288|Arsenic Trioxide|arsenic trioxide|mesh-list
153363315|NCT01835288|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153363316|NCT02502864|Cyclophosphamide|cyclophosphamide|mesh-list
153363317|NCT02502864|Docetaxel|docetaxel|mesh-list
153363318|NCT02502864|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153363319|NCT02502864|Immunologic Factors|immunologic factors|mesh-ancestor
153363320|NCT02502864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153823354|NCT00443937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153823360|NCT00443937|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153823361|NCT00458315|Paclitaxel|paclitaxel|mesh-list
153823362|NCT00458315|Bevacizumab|bevacizumab|mesh-list
153823363|NCT00458315|Gemcitabine|gemcitabine|mesh-list
153823364|NCT00458315|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153823365|NCT00458315|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153823366|NCT00458315|Tubulin Modulators|tubulin modulators|mesh-ancestor
153823367|NCT00458315|Antimitotic Agents|antimitotic agents|mesh-ancestor
153823368|NCT00458315|Mitosis Modulators|mitosis modulators|mesh-ancestor
153363341|NCT03217448|Dabigatran|dabigatran|mesh-list
153646103|NCT00007865|Carboplatin|carboplatin|mesh-list
153646104|NCT00007865|Etoposide|etoposide|mesh-list
153646105|NCT00007865|Ifosfamide|ifosfamide|mesh-list
153646106|NCT00007865|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153646107|NCT00007865|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153646108|NCT00007865|Immunologic Factors|immunologic factors|mesh-ancestor
153646109|NCT00007865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153646110|NCT00007865|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153646111|NCT00007865|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153823401|NCT00444132|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
153823402|NCT00444132|Purinergic Agents|purinergic agents|mesh-ancestor
153823403|NCT00444132|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153823404|NCT00444132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153823405|NCT00444132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153823406|NCT00444171|Insulin|insulin|mesh-list
153823407|NCT00444171|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
153823408|NCT00444171|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153823409|NCT00444171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153823410|NCT00458900|Moxifloxacin|moxifloxacin|mesh-list
153823411|NCT00458900|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153823412|NCT00458900|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153823413|NCT00458900|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153823414|NCT00458900|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153823415|NCT00458900|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153823416|NCT00458900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153823417|NCT00458900|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153823418|NCT00488163|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
153823419|NCT00488163|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
153823433|NCT00459173|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153823434|NCT00459173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153823436|NCT00444249|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153823437|NCT00444249|Adrenergic Agents|adrenergic agents|mesh-ancestor
153823438|NCT00444249|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153823439|NCT00444249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153823440|NCT00444249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153823441|NCT00459407|Epigallocatechin gallate|epigallocatechin gallate|mesh-list
153823442|NCT00459407|Antioxidants|antioxidants|mesh-ancestor
153823443|NCT00459407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153823444|NCT00459407|Protective Agents|protective agents|mesh-ancestor
153363421|NCT01457885|Immunologic Factors|immunologic factors|mesh-ancestor
153363422|NCT01457885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153363423|NCT01457885|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153363424|NCT01457885|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153363425|NCT01457885|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153363426|NCT01457885|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153363428|NCT01460225|Lubiprostone|lubiprostone|mesh-list
153363429|NCT01460225|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
153646112|NCT00007865|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153646114|NCT00007865|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153646115|NCT00007865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153646116|NCT00007865|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153646117|NCT00007865|Alkylating Agents|alkylating agents|mesh-ancestor
153646118|NCT00113698|Enalapril|enalapril|mesh-list
153646119|NCT00113698|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
153646120|NCT00113698|Protease Inhibitors|protease inhibitors|mesh-ancestor
153646121|NCT00113698|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153646123|NCT00113698|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153823494|NCT00459719|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153823495|NCT00459719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153823496|NCT00495183|Biperiden|biperiden|mesh-list
153823497|NCT00495183|Caffeine|caffeine|mesh-list
153823498|NCT00495183|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
153823499|NCT00495183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153823500|NCT00495183|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
153823501|NCT00495183|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153823502|NCT00495183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153363455|NCT01839500|Trastuzumab|trastuzumab|mesh-list
153363456|NCT01839500|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153363457|NCT01839500|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153363458|NCT02501928|Fesoterodine|fesoterodine|mesh-list
153363459|NCT02501928|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
153363460|NCT02501928|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
153363461|NCT02501928|Cholinergic Agents|cholinergic agents|mesh-ancestor
153363462|NCT02501928|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153363463|NCT02501928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153363470|NCT01462253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153363471|NCT01462253|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153363472|NCT01462253|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153363473|NCT01462253|Alkylating Agents|alkylating agents|mesh-ancestor
153363474|NCT01462253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153363475|NCT01462253|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153363483|NCT01837394|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153363484|NCT01837394|Narcotics|narcotics|mesh-ancestor
153646154|NCT00007904|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
153646155|NCT00007904|Lenograstim|lenograstim|mesh-list
153823535|NCT00488709|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153823536|NCT00488709|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153823537|NCT00488709|Antimetabolites|antimetabolites|mesh-ancestor
153823538|NCT00488709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153823539|NCT00488709|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153823540|NCT00488709|Immunologic Factors|immunologic factors|mesh-ancestor
153823541|NCT00488709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153823542|NCT00488709|Antiviral Agents|antiviral agents|mesh-ancestor
153823543|NCT00488709|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153823544|NCT00488709|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
153823545|NCT00488709|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153823546|NCT00488709|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153823547|NCT00459992|Betahistine|betahistine|mesh-list
153823548|NCT00459992|Vasodilator Agents|vasodilator agents|mesh-ancestor
153823549|NCT00459992|Histamine Agonists|histamine agonists|mesh-ancestor
153823550|NCT00459992|Histamine Agents|histamine agents|mesh-ancestor
153823551|NCT00459992|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153363506|NCT01462565|Tezosentan|tezosentan|mesh-list
153363507|NCT01462565|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153363508|NCT01462565|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153363510|NCT01837628|Lidocaine|lidocaine|mesh-list
153363529|NCT01462877|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153363530|NCT04972656|Ambrisentan|ambrisentan|mesh-list
153363531|NCT04972656|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153363532|NCT03210506|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
153823569|NCT00460148|Dopamine Agents|dopamine agents|mesh-ancestor
153823570|NCT00460148|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153823571|NCT00460148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153823572|NCT00460148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153823573|NCT00460226|Lamotrigine|lamotrigine|mesh-list
153823574|NCT00460226|Anticonvulsants|anticonvulsants|mesh-ancestor
153646223|NCT00114205|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153646224|NCT00114205|Tubulin Modulators|tubulin modulators|mesh-ancestor
153646225|NCT00114205|Antimitotic Agents|antimitotic agents|mesh-ancestor
153646226|NCT00114205|Mitosis Modulators|mitosis modulators|mesh-ancestor
153646227|NCT00114205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153646228|NCT00114283|Lapatinib|lapatinib|mesh-list
153646234|NCT00114361|Ribavirin|ribavirin|mesh-list
153646270|NCT00114478|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153646271|NCT00114478|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153646272|NCT00114478|Respiratory System Agents|respiratory system agents|mesh-ancestor
153646273|NCT00114478|Mydriatics|mydriatics|mesh-ancestor
153646274|NCT00114478|Sympathomimetics|sympathomimetics|mesh-ancestor
153646275|NCT00114478|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
153646276|NCT00114478|Tocolytic Agents|tocolytic agents|mesh-ancestor
153646277|NCT00114478|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153646278|NCT00114478|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
153823678|NCT00495729|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153823685|NCT00460928|Antibodies|antibodies|mesh-list
153363731|NCT01566539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153363732|NCT01566539|Hemostatics|hemostatics|mesh-ancestor
153363733|NCT01566539|Coagulants|coagulants|mesh-ancestor
153363734|NCT01566539|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
153363735|NCT01566539|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
153363736|NCT01566539|Natriuretic Agents|natriuretic agents|mesh-ancestor
153363737|NCT01725776|Milrinone|milrinone|mesh-list
153363738|NCT01725776|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
153363739|NCT01725776|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153363740|NCT01725776|Vasodilator Agents|vasodilator agents|mesh-ancestor
153363747|NCT01830296|Morphine|morphine|mesh-list
153823770|NCT00591604|Vitamins|vitamins|mesh-ancestor
153823771|NCT00591604|Micronutrients|micronutrients|mesh-ancestor
153823772|NCT00591604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153823773|NCT00591604|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153823774|NCT00591643|Epinephrine|epinephrine|mesh-list
153823775|NCT00591643|Racepinephrine|racepinephrine|mesh-list
153823776|NCT00591643|Epinephryl borate|epinephryl borate|mesh-list
153823777|NCT00591643|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153823778|NCT00591643|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153823779|NCT00591643|Adrenergic Agents|adrenergic agents|mesh-ancestor
153823780|NCT00591643|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153823781|NCT00591643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153823782|NCT00591643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153823783|NCT00591643|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
153823784|NCT00591643|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153363750|NCT01830296|Narcotics|narcotics|mesh-ancestor
153363769|NCT01467947|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
153363770|NCT01467947|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153363771|NCT01467947|Immunologic Factors|immunologic factors|mesh-ancestor
153363772|NCT01467947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153363785|NCT01568255|Vitamin D|vitamin d|mesh-list
153823794|NCT00461747|Dexamethasone acetate|dexamethasone acetate|mesh-list
153823795|NCT00461747|Bortezomib|bortezomib|mesh-list
153823796|NCT00461747|BB 1101|bb 1101|mesh-list
153646340|NCT00114868|Antioxidants|antioxidants|mesh-ancestor
153646341|NCT00114868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153646342|NCT00114868|Protective Agents|protective agents|mesh-ancestor
153646343|NCT00114868|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
153646344|NCT00114868|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153646345|NCT03034200|TIC10 compound|tic10 compound|mesh-list
153646401|NCT00115102|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
153823838|NCT00461825|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153823839|NCT00461825|Antimetabolites|antimetabolites|mesh-ancestor
153823840|NCT00461825|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153823841|NCT04433026|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
153823842|NCT04433026|Natriuretic Agents|natriuretic agents|mesh-ancestor
153823843|NCT04433026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153823844|NCT00489372|Selenomethylselenocysteine|selenomethylselenocysteine|mesh-list
153823849|NCT00461903|Perindopril|perindopril|mesh-list
153431977|NCT05535764|Interferons|interferons|mesh-list
153646466|NCT00115492|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153646467|NCT00115492|Autonomic Agents|autonomic agents|mesh-ancestor
153646468|NCT00115492|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153646469|NCT00115492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153646470|NCT00115492|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153646472|NCT00115492|Dermatologic Agents|dermatologic agents|mesh-ancestor
153646530|NCT00115648|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153646531|NCT00115648|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153646532|NCT00115648|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153646533|NCT00115648|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
153646534|NCT00115648|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
153646535|NCT00008294|Leucovorin|leucovorin|mesh-list
153646536|NCT00008294|Dexamethasone|dexamethasone|mesh-list
153646537|NCT00008294|Fluorouracil|fluorouracil|mesh-list
153646538|NCT00008294|Oxaliplatin|oxaliplatin|mesh-list
153646539|NCT00008294|Floxuridine|floxuridine|mesh-list
153646540|NCT00008294|Calcium|calcium|mesh-list
153646541|NCT00008294|Levoleucovorin|levoleucovorin|mesh-list
153646542|NCT00008294|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153646543|NCT00008294|Antiemetics|antiemetics|mesh-ancestor
153646544|NCT00008294|Autonomic Agents|autonomic agents|mesh-ancestor
153646545|NCT00008294|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153646546|NCT00008294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153646589|NCT00008333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153646590|NCT00008372|Sulfanilamides|sulfanilamides|mesh-list
153646591|NCT00008372|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153646592|NCT00115921|Antimalarials|antimalarials|mesh-list
153646593|NCT00115921|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153646594|NCT00115921|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153646595|NCT00115921|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153646596|NCT00008411|Docetaxel|docetaxel|mesh-list
153646597|NCT00008411|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153646598|NCT00008411|Tubulin Modulators|tubulin modulators|mesh-ancestor
153646599|NCT00008411|Antimitotic Agents|antimitotic agents|mesh-ancestor
153646600|NCT00008411|Mitosis Modulators|mitosis modulators|mesh-ancestor
153646601|NCT00008411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153646602|NCT00008450|Cyclosporine|cyclosporine|mesh-list
153646603|NCT00008450|Mycophenolic Acid|mycophenolic acid|mesh-list
153646604|NCT00008450|Cyclosporins|cyclosporins|mesh-list
153646605|NCT00008450|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153646606|NCT00008450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153646607|NCT00008450|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153646608|NCT00008450|Immunologic Factors|immunologic factors|mesh-ancestor
153646609|NCT00008450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153646610|NCT00008450|Antifungal Agents|antifungal agents|mesh-ancestor
153646611|NCT00008450|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153646612|NCT00008450|Dermatologic Agents|dermatologic agents|mesh-ancestor
153646613|NCT00008450|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153646614|NCT00008450|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
153646615|NCT00008450|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153646616|NCT00008450|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153646617|NCT00008450|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
153646618|NCT00008450|Antitubercular Agents|antitubercular agents|mesh-ancestor
153823854|NCT00461903|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153823855|NCT00496392|Fentanyl|fentanyl|mesh-list
153823856|NCT00496392|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153823857|NCT00496392|Narcotics|narcotics|mesh-ancestor
153823858|NCT00496392|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153823859|NCT00496392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153823860|NCT00496392|Analgesics|analgesics|mesh-ancestor
153823861|NCT00496392|Sensory System Agents|sensory system agents|mesh-ancestor
153823862|NCT00496392|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153823863|NCT00496392|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153823864|NCT00496392|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153363824|NCT01726088|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
153363825|NCT01726088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153363826|NCT00911612|Colesevelam Hydrochloride|colesevelam hydrochloride|mesh-list
153363827|NCT00911612|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153363829|NCT00911612|Antimetabolites|antimetabolites|mesh-ancestor
153363830|NCT00911612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153646633|NCT00116350|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153646634|NCT00116350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153646635|NCT00116350|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
153646636|NCT00116350|Abortifacient Agents|abortifacient agents|mesh-ancestor
153646637|NCT00116350|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
153646638|NCT00116350|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153646639|NCT00116389|Gemcitabine|gemcitabine|mesh-list
153646640|NCT00116389|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153646641|NCT00116389|Antimetabolites|antimetabolites|mesh-ancestor
153823865|NCT00496392|Anesthetics, General|anesthetics, general|mesh-ancestor
153823866|NCT00496392|Anesthetics|anesthetics|mesh-ancestor
153823867|NCT02893618|Diazoxide|diazoxide|mesh-list
153823868|NCT02893618|Choline|choline|mesh-list
153823869|NCT02893618|Lipotropic Agents|lipotropic agents|mesh-ancestor
153823870|NCT02893618|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153823871|NCT02893618|Antimetabolites|antimetabolites|mesh-ancestor
153823872|NCT02893618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153823873|NCT02893618|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153823874|NCT02893618|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153823875|NCT02893618|Nootropic Agents|nootropic agents|mesh-ancestor
153823876|NCT02893618|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153823877|NCT02893618|Vasodilator Agents|vasodilator agents|mesh-ancestor
153823878|NCT00496665|Cyclophosphamide|cyclophosphamide|mesh-list
153823879|NCT00496665|Methotrexate|methotrexate|mesh-list
153823880|NCT00496665|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153363840|NCT04379492|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153363841|NCT04379492|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153363842|NCT04379492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153363843|NCT04379492|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153363844|NCT03409250|Ranibizumab|ranibizumab|mesh-list
153363845|NCT03409250|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153363846|NCT03409250|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153646648|NCT00008528|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
153646649|NCT00008528|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
153646650|NCT00008528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153646651|NCT00008528|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153823882|NCT00496665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153823883|NCT00496665|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153823884|NCT00496665|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153823885|NCT00496665|Alkylating Agents|alkylating agents|mesh-ancestor
153823886|NCT00496665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153823887|NCT00496665|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153823888|NCT00496665|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153823889|NCT00496665|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
153823890|NCT00496665|Abortifacient Agents|abortifacient agents|mesh-ancestor
153823891|NCT00496665|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153823892|NCT00496665|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153823893|NCT00496665|Antimetabolites|antimetabolites|mesh-ancestor
153823894|NCT00496665|Dermatologic Agents|dermatologic agents|mesh-ancestor
153363853|NCT01569815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153363854|NCT01469585|Doxycycline|doxycycline|mesh-list
153363855|NCT01469585|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153363856|NCT01469585|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153363857|NCT01469585|Antimalarials|antimalarials|mesh-ancestor
153363858|NCT01469585|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153363859|NCT01469585|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153363862|NCT01720940|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153363863|NCT00915590|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
153363864|NCT00915590|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153646805|NCT00117403|Thioctic Acid|thioctic acid|mesh-list
153646806|NCT00117403|Coenzyme Q10|coenzyme q10|mesh-list
153646807|NCT00117403|Ubiquinone|ubiquinone|mesh-list
153646808|NCT00117403|Micronutrients|micronutrients|mesh-ancestor
153646809|NCT00117403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153646810|NCT00117403|Antioxidants|antioxidants|mesh-ancestor
153646811|NCT00117403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153646856|NCT00117832|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153646857|NCT00117832|Respiratory System Agents|respiratory system agents|mesh-ancestor
153646858|NCT00117832|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
153646859|NCT00117832|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153646860|NCT00117832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153646861|NCT00117832|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
153646862|NCT00117832|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
153646863|NCT00117832|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
153646864|NCT00117832|Histamine Antagonists|histamine antagonists|mesh-ancestor
153646865|NCT00117832|Histamine Agents|histamine agents|mesh-ancestor
153891022|NCT01029652|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153646928|NCT00118222|Hematoporphyrin Derivative|hematoporphyrin derivative|mesh-list
153646930|NCT00118222|Trioxsalen|trioxsalen|mesh-list
153646931|NCT00118222|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153646932|NCT00118222|Dermatologic Agents|dermatologic agents|mesh-ancestor
153881653|NCT01969578|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153881654|NCT01969578|Tubulin Modulators|tubulin modulators|mesh-ancestor
153894922|NCT05661227|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153646933|NCT00118222|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
153646934|NCT00118222|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
153646935|NCT00118222|Anesthetics, General|anesthetics, general|mesh-ancestor
153646936|NCT00118222|Anesthetics|anesthetics|mesh-ancestor
153646937|NCT00118222|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153646938|NCT00118222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153646939|NCT00118261|Leucovorin|leucovorin|mesh-list
153646940|NCT00118261|Bevacizumab|bevacizumab|mesh-list
153646941|NCT00118261|Fluorouracil|fluorouracil|mesh-list
153646942|NCT00118261|Oxaliplatin|oxaliplatin|mesh-list
153646943|NCT00118261|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
153646944|NCT00118261|Calcium|calcium|mesh-list
153646945|NCT00118261|Levoleucovorin|levoleucovorin|mesh-list
153646950|NCT00118261|Growth Substances|growth substances|mesh-ancestor
153646968|NCT00118300|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153646969|NCT00118300|Antimetabolites|antimetabolites|mesh-ancestor
153646970|NCT00118300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153646971|NCT00118300|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153646972|NCT00118690|Fluticasone|fluticasone|mesh-list
153646973|NCT00118690|Xhance|xhance|mesh-list
153646974|NCT00118690|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
153646975|NCT00118690|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153646976|NCT00118690|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153646977|NCT00118690|Autonomic Agents|autonomic agents|mesh-ancestor
153646978|NCT00118690|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153646979|NCT00118690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153646980|NCT00118690|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153647031|NCT00119002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153647032|NCT00119002|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153647033|NCT00119002|Glucocorticoids|glucocorticoids|mesh-ancestor
153647034|NCT00119002|Hormones|hormones|mesh-ancestor
153647035|NCT00119002|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153647036|NCT00119002|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153647037|NCT00119002|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153647038|NCT00119119|Tocopherols|tocopherols|mesh-list
153647039|NCT00119119|Vitamin E|vitamin e|mesh-list
153647041|NCT00119119|alpha-Tocopherol|alpha-tocopherol|mesh-list
153647042|NCT00119119|Antioxidants|antioxidants|mesh-ancestor
153647043|NCT00119119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153647044|NCT00119119|Protective Agents|protective agents|mesh-ancestor
153647045|NCT00119119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153647046|NCT00119119|Vitamins|vitamins|mesh-ancestor
153647047|NCT00119119|Micronutrients|micronutrients|mesh-ancestor
153647048|NCT00119236|Irinotecan|irinotecan|mesh-list
153647049|NCT00119236|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
153647050|NCT00119236|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153647051|NCT00119236|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153647052|NCT00119236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153647053|NCT00119236|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153647054|NCT00119314|Gemcitabine|gemcitabine|mesh-list
153647055|NCT00119314|Capecitabine|capecitabine|mesh-list
153647056|NCT00119314|Docetaxel|docetaxel|mesh-list
153647057|NCT00119314|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153647083|NCT00119704|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153647084|NCT00119704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153647085|NCT00119704|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
153647088|NCT00120055|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153647143|NCT00120367|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153647144|NCT00120367|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153647146|NCT00120367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153647149|NCT00120367|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
153647150|NCT00120367|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
153647151|NCT04727320|Ursodoxicoltaurine|ursodoxicoltaurine|mesh-list
153647152|NCT04727320|Antiviral Agents|antiviral agents|mesh-ancestor
153647153|NCT04727320|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153647154|NCT04727320|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
153647155|NCT04727320|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153647157|NCT00120484|Hydroxocobalamin|hydroxocobalamin|mesh-list
153647158|NCT00120484|Vitamins|vitamins|mesh-ancestor
153647159|NCT00120484|Micronutrients|micronutrients|mesh-ancestor
153647160|NCT00120484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153647161|NCT00120484|Vitamin B Complex|vitamin b complex|mesh-ancestor
153647162|NCT00120484|Hematinics|hematinics|mesh-ancestor
153647163|NCT00391014|Amphotericin B|amphotericin b|mesh-list
153647164|NCT00391014|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
153364215|NCT01049984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153894966|NCT01187901|Analgesics|analgesics|mesh-ancestor
153364216|NCT01049984|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
153647165|NCT00391014|Amebicides|amebicides|mesh-ancestor
153647171|NCT00120601|Naltrexone|naltrexone|mesh-list
153647196|NCT00120718|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153647197|NCT00120718|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153647198|NCT00120757|Alendronate|alendronate|mesh-list
153647199|NCT00120757|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153647200|NCT00120757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153647201|NCT00120796|Lamivudine|lamivudine|mesh-list
153647202|NCT00120796|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153647203|NCT00120796|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153647204|NCT00120796|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153647205|NCT00120796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153647210|NCT00120835|Interferons|interferons|mesh-list
153647260|NCT00121303|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153647261|NCT00121303|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153647262|NCT00121303|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153647263|NCT00121303|Immunotoxins|immunotoxins|mesh-ancestor
153647264|NCT00121303|Immunoconjugates|immunoconjugates|mesh-ancestor
153647265|NCT00121381|Pimecrolimus|pimecrolimus|mesh-list
153824622|NCT00592111|Tubulin Modulators|tubulin modulators|mesh-ancestor
153647272|NCT00121381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153647274|NCT00121381|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153647321|NCT04711096|Anesthetics, Local|anesthetics, local|mesh-ancestor
153647322|NCT04711096|Anesthetics|anesthetics|mesh-ancestor
153647323|NCT04711096|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153647324|NCT04711096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153647325|NCT04711096|Sensory System Agents|sensory system agents|mesh-ancestor
153647327|NCT04705948|Magnesium Sulfate|magnesium sulfate|mesh-list
153647388|NCT02013492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153647389|NCT02013492|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153647391|NCT02013492|Vasodilator Agents|vasodilator agents|mesh-ancestor
153647392|NCT00122356|Alendronate|alendronate|mesh-list
153647393|NCT00122356|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153647394|NCT00122356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153647455|NCT00122629|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153647456|NCT00122629|Antiviral Agents|antiviral agents|mesh-ancestor
153647457|NCT00122629|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153647528|NCT00128947|Mycophenolic Acid|mycophenolic acid|mesh-list
153647529|NCT00128947|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153647561|NCT00128752|Vitamins|vitamins|mesh-ancestor
153647580|NCT00009009|Immunosuppressive Agents|immunosuppressive agents|mesh-list
153647581|NCT00009009|Complement System Proteins|complement system proteins|mesh-list
153647582|NCT00009009|Immunologic Factors|immunologic factors|mesh-ancestor
153647583|NCT00009009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153647584|NCT05638763|Ketoconazole|ketoconazole|mesh-list
153647585|NCT05638763|Dasatinib|dasatinib|mesh-list
153647586|NCT05638763|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153647587|NCT05638763|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153647588|NCT05638763|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153647589|NCT05638763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153647590|NCT05638763|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153889880|NCT01263483|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153430978|NCT00000763|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153647591|NCT05638763|Antifungal Agents|antifungal agents|mesh-ancestor
153647592|NCT05638763|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153647593|NCT05638763|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
153647594|NCT05638763|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153647595|NCT05638763|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153647596|NCT05638763|Hormone Antagonists|hormone antagonists|mesh-ancestor
153647597|NCT05638763|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153647598|NCT05638763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153647599|NCT05638763|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
153647632|NCT00009204|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153647633|NCT00009204|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153647634|NCT00009204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153647635|NCT00009204|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153647637|NCT00009204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153647638|NCT00009204|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
153647639|NCT00009204|Antidepressive Agents|antidepressive agents|mesh-ancestor
153647640|NCT00009204|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153647641|NCT00009204|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153647642|NCT00009204|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153647643|NCT00009204|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153647644|NCT00009204|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
153647646|NCT00394459|Anesthetics|anesthetics|mesh-list
153647649|NCT00394498|Lenograstim|lenograstim|mesh-list
153647688|NCT00128440|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153647689|NCT00128440|Autonomic Agents|autonomic agents|mesh-ancestor
153647690|NCT00128440|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153647691|NCT00128440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153824929|NCT01245582|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153364894|NCT04955574|Metronidazole|metronidazole|mesh-list
153647692|NCT00128440|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153647693|NCT00128440|Respiratory System Agents|respiratory system agents|mesh-ancestor
153647694|NCT00128440|Parasympatholytics|parasympatholytics|mesh-ancestor
153647695|NCT00128440|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
153647696|NCT00128440|Cholinergic Agents|cholinergic agents|mesh-ancestor
153647697|NCT00128440|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153647698|NCT00128440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153647699|NCT00128401|Cycloserine|cycloserine|mesh-list
153647700|NCT00128401|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
153647701|NCT00128401|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153647702|NCT00128401|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
153647703|NCT00128401|Antitubercular Agents|antitubercular agents|mesh-ancestor
153647704|NCT00128401|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153647705|NCT00128401|Antimetabolites|antimetabolites|mesh-ancestor
153647706|NCT00128401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153647707|NCT00128323|Nystatin|nystatin|mesh-list
153647708|NCT00128323|Gentian Violet|gentian violet|mesh-list
153647709|NCT00128323|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
153647710|NCT00128323|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153647711|NCT00128323|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153647712|NCT00128323|Antifungal Agents|antifungal agents|mesh-ancestor
153647713|NCT00128323|Ionophores|ionophores|mesh-ancestor
153647714|NCT00128323|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153647715|NCT00128323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153647716|NCT00128323|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
153647732|NCT00009672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153647734|NCT00009672|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153647735|NCT00018694|Chenodeoxycholic Acid|chenodeoxycholic acid|mesh-list
153647736|NCT00018694|Cathartics|cathartics|mesh-ancestor
153647737|NCT00018694|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153647738|NCT00018733|Paroxetine|paroxetine|mesh-list
153647739|NCT00018733|Desipramine|desipramine|mesh-list
153647744|NCT00018733|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153647789|NCT00009750|Cyclosporins|cyclosporins|mesh-list
153647790|NCT00009750|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153647791|NCT00009750|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153647792|NCT00009750|Tubulin Modulators|tubulin modulators|mesh-ancestor
153647793|NCT00009750|Antimitotic Agents|antimitotic agents|mesh-ancestor
153647794|NCT00009750|Mitosis Modulators|mitosis modulators|mesh-ancestor
153647795|NCT00009750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153647796|NCT00009750|Immunologic Factors|immunologic factors|mesh-ancestor
153647797|NCT00009750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153647798|NCT00009750|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153365498|NCT00932438|Antidotes|antidotes|mesh-ancestor
153825663|NCT00474773|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
153825664|NCT00474773|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153825667|NCT00474890|Pseudoephedrine|pseudoephedrine|mesh-list
153647799|NCT00009750|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153647852|NCT00009828|Protective Agents|protective agents|mesh-ancestor
153647853|NCT00009828|Vitamin B Complex|vitamin b complex|mesh-ancestor
153647855|NCT00009828|Micronutrients|micronutrients|mesh-ancestor
153647856|NCT00009828|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153647857|NCT00009828|Antimetabolites|antimetabolites|mesh-ancestor
153647858|NCT00019435|Immunotoxins|immunotoxins|mesh-list
153647859|NCT00019435|Immunoconjugates|immunoconjugates|mesh-ancestor
153647860|NCT00019435|Immunologic Factors|immunologic factors|mesh-ancestor
153647861|NCT00019435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153647921|NCT00019786|Melphalan|melphalan|mesh-list
153365830|NCT01607645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153365831|NCT01607645|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153365832|NCT01607645|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153365834|NCT01607645|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153647928|NCT00019786|Immunologic Factors|immunologic factors|mesh-ancestor
153647929|NCT00019786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153647930|NCT00019825|Decitabine|decitabine|mesh-list
153647931|NCT00019825|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153647932|NCT00019825|Antimetabolites|antimetabolites|mesh-ancestor
153647933|NCT00019825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153647937|NCT00019864|Doxorubicin|doxorubicin|mesh-list
153647938|NCT00019864|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
153647939|NCT00019864|Methotrexate|methotrexate|mesh-list
153647940|NCT00019864|Dexrazoxane|dexrazoxane|mesh-list
153366060|NCT01614509|Glucocorticoids|glucocorticoids|mesh-ancestor
153647941|NCT00019864|Razoxane|razoxane|mesh-list
153647942|NCT00019864|Calcium|calcium|mesh-list
153647943|NCT00019864|Levoleucovorin|levoleucovorin|mesh-list
153647944|NCT00019864|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153647945|NCT00019864|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153647946|NCT00019864|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153647947|NCT00019864|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153647948|NCT00019864|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153647949|NCT00019864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153647960|NCT00019864|Immunologic Factors|immunologic factors|mesh-ancestor
153647961|NCT00019864|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153647962|NCT00019864|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153647963|NCT00019864|Antidotes|antidotes|mesh-ancestor
153647964|NCT00019864|Protective Agents|protective agents|mesh-ancestor
153647965|NCT00019864|Vitamin B Complex|vitamin b complex|mesh-ancestor
153647966|NCT00019864|Vitamins|vitamins|mesh-ancestor
153647967|NCT00019864|Micronutrients|micronutrients|mesh-ancestor
153647968|NCT00019864|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
153647969|NCT00019864|Antimitotic Agents|antimitotic agents|mesh-ancestor
153647970|NCT00019864|Mitosis Modulators|mitosis modulators|mesh-ancestor
153647971|NCT00020176|Cyclosporine|cyclosporine|mesh-list
153647972|NCT00020176|Cyclophosphamide|cyclophosphamide|mesh-list
153647973|NCT00020176|Fludarabine|fludarabine|mesh-list
153647974|NCT00020176|Fludarabine phosphate|fludarabine phosphate|mesh-list
153647975|NCT00020176|Cyclosporins|cyclosporins|mesh-list
153647976|NCT00020176|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153647977|NCT00020176|Immunologic Factors|immunologic factors|mesh-ancestor
153647978|NCT00020176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153647979|NCT00020176|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153647980|NCT00020176|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153647981|NCT00020176|Alkylating Agents|alkylating agents|mesh-ancestor
153647982|NCT00020176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153647983|NCT00020176|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153647984|NCT00020176|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153647985|NCT00020176|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153647986|NCT00020176|Antimetabolites|antimetabolites|mesh-ancestor
153647987|NCT00020176|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153647988|NCT00020176|Antifungal Agents|antifungal agents|mesh-ancestor
153647989|NCT00020176|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153647990|NCT00020176|Dermatologic Agents|dermatologic agents|mesh-ancestor
153647991|NCT00020176|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
153647992|NCT00020254|Aldesleukin|aldesleukin|mesh-list
153647993|NCT00020254|Nilutamide|nilutamide|mesh-list
153647995|NCT00020254|Sargramostim|sargramostim|mesh-list
153648000|NCT00020254|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153648001|NCT00020254|Antiviral Agents|antiviral agents|mesh-ancestor
153648002|NCT00020254|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153648003|NCT00020254|Androgen Antagonists|androgen antagonists|mesh-ancestor
153648004|NCT00020254|Hormone Antagonists|hormone antagonists|mesh-ancestor
153648005|NCT00020254|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153648006|NCT00009984|Thalidomide|thalidomide|mesh-list
153648007|NCT00009984|Fludarabine|fludarabine|mesh-list
153648008|NCT00009984|Fludarabine phosphate|fludarabine phosphate|mesh-list
153648009|NCT00009984|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153648013|NCT00009984|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153648015|NCT00009984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153648022|NCT00009984|Growth Inhibitors|growth inhibitors|mesh-ancestor
153881656|NCT01969578|Mitosis Modulators|mitosis modulators|mesh-ancestor
153881657|NCT01969578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153881658|NCT01969578|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153881659|NCT01969578|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153881660|NCT01969578|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153648024|NCT00020332|Alvocidib|alvocidib|mesh-list
153648035|NCT00020410|Antibodies|antibodies|mesh-list
153648050|NCT00020449|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153648051|NCT00020449|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153648052|NCT00020449|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153648053|NCT00020449|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153648054|NCT00020449|Immunologic Factors|immunologic factors|mesh-ancestor
153648055|NCT00020449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153648056|NCT00020449|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153648057|NCT00020449|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153648058|NCT00020449|Growth Substances|growth substances|mesh-ancestor
153648059|NCT00020449|Growth Inhibitors|growth inhibitors|mesh-ancestor
153648060|NCT00010023|Capecitabine|capecitabine|mesh-list
153648061|NCT00010023|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153648062|NCT00010023|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153648063|NCT00010023|Antimetabolites|antimetabolites|mesh-ancestor
153648064|NCT00010023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153648066|NCT00020488|Fluorouracil|fluorouracil|mesh-list
153648067|NCT00020488|Irinotecan|irinotecan|mesh-list
153648068|NCT00020488|Calcium|calcium|mesh-list
153648069|NCT00020488|Levoleucovorin|levoleucovorin|mesh-list
153366478|NCT02022644|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153648071|NCT00020488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153648072|NCT00020488|Antimetabolites|antimetabolites|mesh-ancestor
153648104|NCT00020566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153648105|NCT00020566|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153648106|NCT00020566|Tubulin Modulators|tubulin modulators|mesh-ancestor
153648107|NCT00020566|Antimitotic Agents|antimitotic agents|mesh-ancestor
153648108|NCT00020566|Mitosis Modulators|mitosis modulators|mesh-ancestor
153648109|NCT00020566|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153366504|NCT04353362|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
153648177|NCT00010140|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
153648178|NCT00010140|Hormone Antagonists|hormone antagonists|mesh-ancestor
153648179|NCT00010140|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153648180|NCT00010140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153648181|NCT00010140|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153648182|NCT00010140|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
153648183|NCT00010140|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
153648184|NCT00010140|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153648185|NCT00020878|Celecoxib|celecoxib|mesh-list
153648186|NCT00020878|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153648187|NCT00020878|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153648188|NCT00020878|Analgesics|analgesics|mesh-ancestor
153648189|NCT00020878|Sensory System Agents|sensory system agents|mesh-ancestor
153648190|NCT00020878|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153648191|NCT00020878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153648192|NCT00020878|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153648198|NCT00020917|Leucovorin|leucovorin|mesh-list
153648207|NCT00020917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153648208|NCT00020917|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153648209|NCT00020917|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153648210|NCT00020917|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153648211|NCT00020917|Immunologic Factors|immunologic factors|mesh-ancestor
153648212|NCT00020917|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
153648213|NCT00020917|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153648214|NCT00020917|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153648216|NCT00020917|Protective Agents|protective agents|mesh-ancestor
153648273|NCT00021268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153648274|NCT00021307|Carboplatin|carboplatin|mesh-list
153648275|NCT00021307|Temozolomide|temozolomide|mesh-list
153648276|NCT00021307|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153648277|NCT00021307|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153648278|NCT00021307|Alkylating Agents|alkylating agents|mesh-ancestor
153881661|NCT01969578|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153648279|NCT00021307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153648280|NCT00021346|Carboplatin|carboplatin|mesh-list
153648281|NCT00021346|Gemcitabine|gemcitabine|mesh-list
153648282|NCT00021346|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153648283|NCT00021346|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153648284|NCT00021346|Antimetabolites|antimetabolites|mesh-ancestor
153648285|NCT00021346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153648286|NCT00021385|Squalamine|squalamine|mesh-list
153648287|NCT00021385|Carboplatin|carboplatin|mesh-list
153648288|NCT00021385|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153648289|NCT00021385|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153648290|NCT00021385|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153648291|NCT00021385|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
153648292|NCT00021385|Protective Agents|protective agents|mesh-ancestor
153648293|NCT00021385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153648294|NCT00021385|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153648326|NCT00021502|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153648327|NCT00021502|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153648328|NCT00000134|Ganciclovir|ganciclovir|mesh-list
153366544|NCT03030560|Anesthetics|anesthetics|mesh-ancestor
153826610|NCT00503490|Levofloxacin|levofloxacin|mesh-list
153366643|NCT03017066|Anesthetics|anesthetics|mesh-list
153648330|NCT00000134|Foscarnet|foscarnet|mesh-list
153648331|NCT00000134|Antiviral Agents|antiviral agents|mesh-ancestor
153648332|NCT00000134|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153648333|NCT00000134|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153648334|NCT00000134|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153648335|NCT00000134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153648336|NCT00000134|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153648337|NCT00010413|Cyclophosphamide|cyclophosphamide|mesh-list
153648338|NCT00010413|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153648339|NCT00010413|Immunologic Factors|immunologic factors|mesh-ancestor
153648340|NCT00010413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153648341|NCT00010413|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153648342|NCT00010413|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153648343|NCT00010413|Alkylating Agents|alkylating agents|mesh-ancestor
153648344|NCT00010413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153648345|NCT00010413|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153648346|NCT00010413|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153648347|NCT00010452|Picibanil|picibanil|mesh-list
153648348|NCT00010452|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153648349|NCT00394693|Interferons|interferons|mesh-list
153648376|NCT00019318|Romidepsin|romidepsin|mesh-list
153648377|NCT00019318|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153648378|NCT00019318|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153648379|NCT00019318|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
153648380|NCT00019318|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153648381|NCT00019318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153648382|NCT00022009|Gemcitabine|gemcitabine|mesh-list
153648383|NCT00022009|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153648384|NCT00022009|Antimetabolites|antimetabolites|mesh-ancestor
153648385|NCT00022009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153648386|NCT00022009|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153648387|NCT00388661|Melatonin|melatonin|mesh-list
153648388|NCT00388661|Antioxidants|antioxidants|mesh-ancestor
153648389|NCT00388661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153648390|NCT00388661|Protective Agents|protective agents|mesh-ancestor
153648391|NCT00388661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153648392|NCT00388661|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153648393|NCT00022048|Bevacizumab|bevacizumab|mesh-list
153648394|NCT00022048|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153648395|NCT00022048|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153648396|NCT00022048|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153648397|NCT00022048|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153648398|NCT00022048|Growth Substances|growth substances|mesh-ancestor
153648399|NCT00022048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153648400|NCT00022048|Growth Inhibitors|growth inhibitors|mesh-ancestor
153648401|NCT00022087|Vitamin D|vitamin d|mesh-list
153648402|NCT00022087|Cholecalciferol|cholecalciferol|mesh-list
153648403|NCT00022087|Zoledronic Acid|zoledronic acid|mesh-list
153648404|NCT00022087|Calcium|calcium|mesh-list
153648405|NCT00022087|Vitamins|vitamins|mesh-ancestor
153648406|NCT00022087|Micronutrients|micronutrients|mesh-ancestor
153648407|NCT00022087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153648408|NCT00022087|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153648409|NCT00022087|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153648410|NCT00388700|Leucovorin|leucovorin|mesh-list
153648411|NCT00388700|Bevacizumab|bevacizumab|mesh-list
153648415|NCT00388700|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153648416|NCT00388700|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153648417|NCT00388700|Growth Substances|growth substances|mesh-ancestor
153648418|NCT00388700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153648419|NCT00388700|Growth Inhibitors|growth inhibitors|mesh-ancestor
153648421|NCT00388700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153648422|NCT00388700|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153648423|NCT00388700|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153648424|NCT00388700|Immunologic Factors|immunologic factors|mesh-ancestor
153648425|NCT00388700|Antidotes|antidotes|mesh-ancestor
153648426|NCT00388700|Protective Agents|protective agents|mesh-ancestor
153648427|NCT00388700|Vitamin B Complex|vitamin b complex|mesh-ancestor
153648428|NCT00388700|Vitamins|vitamins|mesh-ancestor
153648429|NCT00388700|Micronutrients|micronutrients|mesh-ancestor
153648430|NCT00022126|Cytarabine|cytarabine|mesh-list
153648431|NCT00022126|Cyclosporine|cyclosporine|mesh-list
153648432|NCT00022126|Dexamethasone|dexamethasone|mesh-list
153648433|NCT00022126|Methylprednisolone|methylprednisolone|mesh-list
153648434|NCT00022126|Cyclophosphamide|cyclophosphamide|mesh-list
153648435|NCT00022126|Doxorubicin|doxorubicin|mesh-list
153648436|NCT00022126|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
153648437|NCT00022126|Methotrexate|methotrexate|mesh-list
153648438|NCT00022126|Vincristine|vincristine|mesh-list
153648439|NCT00022126|Daunorubicin|daunorubicin|mesh-list
153648440|NCT00022126|Asparaginase|asparaginase|mesh-list
153648441|NCT00022126|Mercaptopurine|mercaptopurine|mesh-list
153648442|NCT00022126|Pegaspargase|pegaspargase|mesh-list
153648443|NCT00022126|Thioguanine|thioguanine|mesh-list
153648444|NCT00022126|Cyclosporins|cyclosporins|mesh-list
153648445|NCT00022126|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153648446|NCT00022126|Immunologic Factors|immunologic factors|mesh-ancestor
153648455|NCT00022126|Antiemetics|antiemetics|mesh-ancestor
153648462|NCT00022126|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153648463|NCT00022126|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153648464|NCT00022126|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153648465|NCT00022126|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153648466|NCT00022126|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153648467|NCT00022126|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
153648470|NCT00022126|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153648471|NCT00022126|Antimetabolites|antimetabolites|mesh-ancestor
153648472|NCT00022126|Dermatologic Agents|dermatologic agents|mesh-ancestor
153648473|NCT00022126|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153648474|NCT00022126|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153648476|NCT00022126|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153648477|NCT00022126|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153648478|NCT00022126|Tubulin Modulators|tubulin modulators|mesh-ancestor
153648479|NCT00022126|Antimitotic Agents|antimitotic agents|mesh-ancestor
153648480|NCT00022126|Mitosis Modulators|mitosis modulators|mesh-ancestor
153648481|NCT00022126|Antifungal Agents|antifungal agents|mesh-ancestor
153648482|NCT00022126|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
153648483|NCT00022126|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
153648484|NCT00022126|Protective Agents|protective agents|mesh-ancestor
153648485|NCT00022165|Selenium|selenium|mesh-list
153648486|NCT00022165|Antioxidants|antioxidants|mesh-ancestor
153648487|NCT00022165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153648488|NCT00022165|Protective Agents|protective agents|mesh-ancestor
153648510|NCT00388739|Glucocorticoids|glucocorticoids|mesh-ancestor
153648511|NCT00388739|Hormones|hormones|mesh-ancestor
153648512|NCT00388739|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153648513|NCT00388739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153648514|NCT00388739|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153648515|NCT00388739|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153648516|NCT00388739|Autonomic Agents|autonomic agents|mesh-ancestor
153648517|NCT00388739|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153827166|NCT01248117|Growth Substances|growth substances|mesh-ancestor
153827218|NCT02891161|Durvalumab|durvalumab|mesh-list
153827286|NCT01315249|Cholinergic Agents|cholinergic agents|mesh-ancestor
153648519|NCT00388739|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153648520|NCT00388739|Respiratory System Agents|respiratory system agents|mesh-ancestor
153648521|NCT00388739|Tocolytic Agents|tocolytic agents|mesh-ancestor
153648522|NCT00388739|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153648523|NCT00388739|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
153648524|NCT00388739|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
153648525|NCT00388739|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153648526|NCT00388739|Adrenergic Agents|adrenergic agents|mesh-ancestor
153648527|NCT00388739|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153648528|NCT00388739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153648529|NCT00022321|Gemtuzumab|gemtuzumab|mesh-list
153648530|NCT00022321|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153648531|NCT00022321|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153648560|NCT00000143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153648561|NCT00022438|Aldesleukin|aldesleukin|mesh-list
153648562|NCT00022438|Freund's Adjuvant|freund's adjuvant|mesh-list
153648563|NCT00022438|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153648564|NCT00022438|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153648565|NCT00022438|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153648566|NCT00022438|Antiviral Agents|antiviral agents|mesh-ancestor
153648567|NCT00022438|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153648568|NCT00022438|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153648569|NCT00022438|Immunologic Factors|immunologic factors|mesh-ancestor
153648570|NCT00022438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153648571|NCT00010686|Phytoestrogens|phytoestrogens|mesh-list
153648572|NCT00010686|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
153648573|NCT00010686|Estrogens|estrogens|mesh-ancestor
153648574|NCT00010686|Hormones|hormones|mesh-ancestor
153648621|NCT00022711|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153648622|NCT00022711|Alkylating Agents|alkylating agents|mesh-ancestor
153648623|NCT00022711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153648624|NCT00022711|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153648625|NCT00010842|Vitamin E|vitamin e|mesh-list
153648626|NCT00010842|Thioctic Acid|thioctic acid|mesh-list
153648627|NCT00010842|Selenium|selenium|mesh-list
153648628|NCT00010842|Vitamins|vitamins|mesh-ancestor
153648629|NCT00010842|Micronutrients|micronutrients|mesh-ancestor
153648630|NCT00010842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153648631|NCT00010842|Antioxidants|antioxidants|mesh-ancestor
153648632|NCT00010842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153648633|NCT00010842|Protective Agents|protective agents|mesh-ancestor
153648634|NCT00010842|Vitamin B Complex|vitamin b complex|mesh-ancestor
153648635|NCT00010842|Trace Elements|trace elements|mesh-ancestor
153648636|NCT00000152|Aspirin|aspirin|mesh-list
153648637|NCT00000152|Beta Carotene|beta carotene|mesh-list
153648638|NCT00000152|Carotenoids|carotenoids|mesh-list
153648639|NCT00000152|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153648640|NCT00000152|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153648641|NCT00000152|Analgesics|analgesics|mesh-ancestor
153648642|NCT00000152|Sensory System Agents|sensory system agents|mesh-ancestor
153648643|NCT00000152|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153648644|NCT00000152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153648645|NCT00000152|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153648646|NCT00000152|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153648647|NCT00000152|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153648648|NCT00000152|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153648649|NCT00000152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153648650|NCT00000152|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153648651|NCT00000152|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153648652|NCT00000152|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153648653|NCT00000152|Antipyretics|antipyretics|mesh-ancestor
153648654|NCT00000152|Antioxidants|antioxidants|mesh-ancestor
153648656|NCT00000152|Provitamins|provitamins|mesh-ancestor
153648663|NCT00022906|Tositumomab I-131|tositumomab i-131|mesh-list
153648664|NCT00022906|Antibodies|antibodies|mesh-list
153648665|NCT00022906|Immunologic Factors|immunologic factors|mesh-ancestor
153648666|NCT00022906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153648667|NCT00022906|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153648668|NCT00022945|Prednisone|prednisone|mesh-list
153648669|NCT00022945|Cyclophosphamide|cyclophosphamide|mesh-list
153648670|NCT00022945|Doxorubicin|doxorubicin|mesh-list
153648671|NCT00022945|Vincristine|vincristine|mesh-list
153648672|NCT00022945|Tositumomab I-131|tositumomab i-131|mesh-list
153648673|NCT00022945|Antibodies|antibodies|mesh-list
153648674|NCT00022945|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153648675|NCT00022945|Immunologic Factors|immunologic factors|mesh-ancestor
153648676|NCT00022945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153648677|NCT00022945|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153648678|NCT00022945|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153648679|NCT00022945|Alkylating Agents|alkylating agents|mesh-ancestor
153648680|NCT00022945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153648681|NCT00022945|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153648682|NCT00022945|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153648683|NCT00022945|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153648684|NCT00022945|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153648685|NCT00022945|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153648686|NCT00022945|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153648687|NCT00022945|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153648688|NCT00022945|Glucocorticoids|glucocorticoids|mesh-ancestor
153648689|NCT00022945|Hormones|hormones|mesh-ancestor
153648690|NCT00022945|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153648691|NCT00022945|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153367827|NCT02441946|Antidiarrheals|antidiarrheals|mesh-list
153648710|NCT00023218|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153648711|NCT00023218|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153648712|NCT00023218|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
153648713|NCT00023218|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
153648714|NCT00023218|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
153648715|NCT00023218|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
153648716|NCT00023218|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
153368028|NCT01094522|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153439805|NCT00002833|Hormones|hormones|mesh-ancestor
153898736|NCT00608179|Glimepiride|glimepiride|mesh-list
153648718|NCT00394966|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
153648719|NCT00394966|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153648720|NCT00394966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153648721|NCT00394966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153648722|NCT00000170|Atropine|atropine|mesh-list
153648723|NCT00000170|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153648724|NCT00000170|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153648725|NCT00000170|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153899029|NCT04520490|Hormones|hormones|mesh-ancestor
153899109|NCT04194775|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153440431|NCT00003145|Fludarabine phosphate|fludarabine phosphate|mesh-list
153440432|NCT00003145|Cyclosporins|cyclosporins|mesh-list
153440433|NCT00003145|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153899200|NCT06268652|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153440665|NCT00004099|Micronutrients|micronutrients|mesh-ancestor
153648726|NCT00000170|Autonomic Agents|autonomic agents|mesh-ancestor
153648727|NCT00000170|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153648728|NCT00000170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153648729|NCT00000170|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153648730|NCT00000170|Respiratory System Agents|respiratory system agents|mesh-ancestor
153648731|NCT00000170|Mydriatics|mydriatics|mesh-ancestor
153648732|NCT00000170|Parasympatholytics|parasympatholytics|mesh-ancestor
153648733|NCT00000170|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
153648734|NCT00000170|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
153648735|NCT00000170|Cholinergic Agents|cholinergic agents|mesh-ancestor
153648736|NCT00000170|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153440771|NCT00003193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153648737|NCT00000170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153648738|NCT00023296|Nitric Oxide|nitric oxide|mesh-list
153648739|NCT00023296|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153648740|NCT00023296|Autonomic Agents|autonomic agents|mesh-ancestor
153648749|NCT00023296|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
153881665|NCT01969578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153648750|NCT00023296|Vasodilator Agents|vasodilator agents|mesh-ancestor
153648751|NCT00023296|Gasotransmitters|gasotransmitters|mesh-ancestor
153648752|NCT00023296|Protective Agents|protective agents|mesh-ancestor
153648753|NCT00023335|Isoniazid|isoniazid|mesh-list
153648754|NCT00023335|Rifapentine|rifapentine|mesh-list
153648755|NCT00023335|Antitubercular Agents|antitubercular agents|mesh-ancestor
153648756|NCT00023335|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153648757|NCT00023335|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153440896|NCT00003829|Fludarabine|fludarabine|mesh-list
153441196|NCT00003913|Protective Agents|protective agents|mesh-ancestor
153900132|NCT05362877|Salicylic Acid|salicylic acid|mesh-list
153900236|NCT05145283|Complement C1 Inhibitor Protein|complement c1 inhibitor protein|mesh-list
153900238|NCT05145283|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153648758|NCT00023335|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
153648759|NCT00023335|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153648760|NCT00023335|Antimetabolites|antimetabolites|mesh-ancestor
153648761|NCT00023335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153648762|NCT00023335|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153648763|NCT00023335|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
153648764|NCT00023335|Leprostatic Agents|leprostatic agents|mesh-ancestor
153648766|NCT00000173|Donepezil|donepezil|mesh-list
153648767|NCT00000173|Vitamins|vitamins|mesh-ancestor
153648768|NCT00000173|Micronutrients|micronutrients|mesh-ancestor
153648769|NCT00000173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153648770|NCT00000173|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
153648771|NCT00000173|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153648802|NCT00023413|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153648803|NCT00023413|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
153648804|NCT00023413|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153648805|NCT00023413|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
153648806|NCT00023413|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
153648807|NCT00023413|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
153648808|NCT00023413|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
153648809|NCT00023413|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153648810|NCT00023413|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
153648811|NCT00023413|Antitubercular Agents|antitubercular agents|mesh-ancestor
153648812|NCT00023530|Thalidomide|thalidomide|mesh-list
153648813|NCT00023530|Fluconazole|fluconazole|mesh-list
153648814|NCT00023530|Voriconazole|voriconazole|mesh-list
153648815|NCT00023530|Dexamethasone|dexamethasone|mesh-list
153648816|NCT00023530|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153648817|NCT00023530|Antiemetics|antiemetics|mesh-ancestor
153648818|NCT00023530|Autonomic Agents|autonomic agents|mesh-ancestor
153648819|NCT00023530|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153648820|NCT00023530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153648821|NCT00023530|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153648822|NCT00023530|Glucocorticoids|glucocorticoids|mesh-ancestor
153648823|NCT00023530|Hormones|hormones|mesh-ancestor
153648846|NCT00000176|Progesterone|progesterone|mesh-list
153648852|NCT00000179|Haloperidol|haloperidol|mesh-list
153648853|NCT00000179|Haloperidol decanoate|haloperidol decanoate|mesh-list
153648854|NCT00000179|Trazodone|trazodone|mesh-list
153648855|NCT00000179|Antiemetics|antiemetics|mesh-ancestor
153648856|NCT00000179|Autonomic Agents|autonomic agents|mesh-ancestor
153648857|NCT00000179|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153648858|NCT00000179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153648859|NCT00000179|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153648860|NCT00000179|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153648861|NCT00000179|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153648862|NCT00000179|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153648863|NCT00000179|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153648864|NCT00000179|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
153648865|NCT00000179|Dopamine Agents|dopamine agents|mesh-ancestor
153648866|NCT00000179|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153648867|NCT00000179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153648868|NCT00000179|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
153648869|NCT00000179|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153648870|NCT00000179|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
153648871|NCT00000179|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153648872|NCT00000179|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153648874|NCT00000179|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
153648875|NCT00000179|Antidepressive Agents|antidepressive agents|mesh-ancestor
153648876|NCT00023725|Semaxinib|semaxinib|mesh-list
153648877|NCT00023725|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153648878|NCT00023725|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153648879|NCT00023725|Growth Substances|growth substances|mesh-ancestor
153648880|NCT00023725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153648881|NCT00023725|Growth Inhibitors|growth inhibitors|mesh-ancestor
153648882|NCT00023725|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153648883|NCT00023725|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153648884|NCT00023725|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153648887|NCT00391404|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153820725|NCT03272802|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
153648888|NCT00391404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153648889|NCT00000191|Carbamazepine|carbamazepine|mesh-list
153648890|NCT00000191|Anticonvulsants|anticonvulsants|mesh-ancestor
153648891|NCT00000191|Antimanic Agents|antimanic agents|mesh-ancestor
153648892|NCT00000191|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153902516|NCT00931255|Sirolimus|sirolimus|mesh-list
153902580|NCT04261465|Paclitaxel|paclitaxel|mesh-list
153648893|NCT00000191|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153648894|NCT00000191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153648896|NCT00000191|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153648897|NCT00000191|Analgesics|analgesics|mesh-ancestor
153648898|NCT00000191|Sensory System Agents|sensory system agents|mesh-ancestor
153648899|NCT00000191|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153902691|NCT00927901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153902766|NCT01136733|Everolimus|everolimus|mesh-list
153648901|NCT00000191|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153648902|NCT00000191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153648903|NCT00000191|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
153648947|NCT00023920|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153648948|NCT00023920|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153648949|NCT00023920|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153648950|NCT00023920|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153648951|NCT00023920|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153648952|NCT00023959|Bevacizumab|bevacizumab|mesh-list
153648953|NCT00023959|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
153648954|NCT00023959|Fluorouracil|fluorouracil|mesh-list
153648955|NCT00023959|Hydroxyurea|hydroxyurea|mesh-list
153648956|NCT00023959|Antibodies|antibodies|mesh-list
153648957|NCT00023959|Immunoglobulins|immunoglobulins|mesh-list
153648958|NCT00023959|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
153648959|NCT00023959|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153649012|NCT00024115|Immunomodulating Agents|immunomodulating agents|mesh-list
153649013|NCT00024115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153649014|NCT00024115|Immunoconjugates|immunoconjugates|mesh-ancestor
153444566|NCT03792191|Sensory System Agents|sensory system agents|mesh-ancestor
153649015|NCT00024154|Trastuzumab|trastuzumab|mesh-list
153649016|NCT00024154|Gefitinib|gefitinib|mesh-list
153649017|NCT00024154|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153649018|NCT00024154|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153649019|NCT00024154|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153649020|NCT00024154|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153649021|NCT00024154|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153448552|NCT00003425|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
153907304|NCT02845219|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153907410|NCT00156091|Antiemetics|antiemetics|mesh-ancestor
153907483|NCT00899431|Immunologic Factors|immunologic factors|mesh-ancestor
153907508|NCT00898807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153907614|NCT02838589|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
153907643|NCT00895843|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153907669|NCT05333809|Immunoconjugates|immunoconjugates|mesh-ancestor
153909474|NCT02809573|Hormones|hormones|mesh-ancestor
153909584|NCT02854072|Gemcitabine|gemcitabine|mesh-list
153909722|NCT04302441|Tubulin Modulators|tubulin modulators|mesh-ancestor
153909871|NCT02806375|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153909943|NCT02802163|Dexamethasone|dexamethasone|mesh-list
153909983|NCT02799589|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153910039|NCT02801227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153910040|NCT02795299|Folic Acid|folic acid|mesh-list
153451784|NCT01922934|Topiramate|topiramate|mesh-list
153910155|NCT02797717|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153910156|NCT02797717|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153910243|NCT04200235|Dexmedetomidine|dexmedetomidine|mesh-list
153451978|NCT03405714|Anticonvulsants|anticonvulsants|mesh-ancestor
153452099|NCT01876446|Irinotecan|irinotecan|mesh-list
153455521|NCT05846724|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153455522|NCT05846724|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153455553|NCT05824806|Viscosupplements|viscosupplements|mesh-ancestor
153455564|NCT05786365|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153455569|NCT05773846|Ropivacaine|ropivacaine|mesh-list
153455593|NCT05757063|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153455682|NCT05194293|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
153455740|NCT05031234|Morphine|morphine|mesh-list
153914566|NCT01216163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153815103|NCT00454350|Vitamins|vitamins|mesh-ancestor
153815116|NCT00344981|Antiviral Agents|antiviral agents|mesh-ancestor
153815149|NCT00345059|Vinorelbine|vinorelbine|mesh-list
153815233|NCT00345800|Anesthetics|anesthetics|mesh-ancestor
153815312|NCT00455091|Lamivudine|lamivudine|mesh-list
153815336|NCT00346619|Protease Inhibitors|protease inhibitors|mesh-ancestor
153815387|NCT00455130|Diuretics|diuretics|mesh-ancestor
153815481|NCT00347399|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
153815712|NCT00348452|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153815730|NCT00348491|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153457125|NCT04044222|Carboplatin|carboplatin|mesh-list
153649022|NCT00024154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153649023|NCT00011076|Pirfenidone|pirfenidone|mesh-list
153649077|NCT00024271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153649078|NCT00024271|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153649079|NCT00024271|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153649080|NCT00024271|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153649081|NCT00024271|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153649082|NCT00024271|Antiviral Agents|antiviral agents|mesh-ancestor
153649083|NCT00024271|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153649084|NCT00024271|Alkylating Agents|alkylating agents|mesh-ancestor
153649085|NCT00024271|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153649086|NCT00024310|Folic Acid|folic acid|mesh-list
153649087|NCT00024310|Paclitaxel|paclitaxel|mesh-list
153816985|NCT00427388|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
153816987|NCT00427388|Prednisolone acetate|prednisolone acetate|mesh-list
153816988|NCT00427388|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
153816989|NCT00427388|Prednisolone phosphate|prednisolone phosphate|mesh-list
153458338|NCT04020588|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
153458339|NCT04020588|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153458340|NCT04020588|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153458341|NCT04020588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153458342|NCT04020588|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153458343|NCT04020588|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153458344|NCT04145856|Simethicone|simethicone|mesh-list
153458346|NCT04145856|Antifoaming Agents|antifoaming agents|mesh-ancestor
153458347|NCT04145856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153458348|NCT04145856|Emollients|emollients|mesh-ancestor
153458349|NCT04145856|Dermatologic Agents|dermatologic agents|mesh-ancestor
153458350|NCT04145856|Parasympatholytics|parasympatholytics|mesh-ancestor
153458351|NCT04145856|Autonomic Agents|autonomic agents|mesh-ancestor
153458352|NCT04145856|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153458353|NCT04145856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153458354|NCT04140786|Gentamicins|gentamicins|mesh-list
153458355|NCT04140786|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153816990|NCT00427388|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153816991|NCT00427388|Antiemetics|antiemetics|mesh-ancestor
153816992|NCT00427388|Autonomic Agents|autonomic agents|mesh-ancestor
153816993|NCT00427388|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153816994|NCT00427388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153816995|NCT00427388|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153816996|NCT00427388|Glucocorticoids|glucocorticoids|mesh-ancestor
153816997|NCT00427388|Hormones|hormones|mesh-ancestor
153817002|NCT00427388|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153817003|NCT00427427|Trastuzumab|trastuzumab|mesh-list
153817004|NCT00427427|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153817005|NCT00427427|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153817006|NCT04704947|Alendronate|alendronate|mesh-list
153458414|NCT04144218|Lacosamide|lacosamide|mesh-list
153817571|NCT06186921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153817572|NCT06186895|Fentanyl|fentanyl|mesh-list
153817573|NCT06186895|Dexmedetomidine|dexmedetomidine|mesh-list
153817574|NCT06186895|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153817575|NCT06186895|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153817576|NCT06186895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153817577|NCT06186895|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153817578|NCT06186895|Analgesics|analgesics|mesh-ancestor
153817579|NCT06186895|Sensory System Agents|sensory system agents|mesh-ancestor
153919550|NCT00028678|Tinzaparin|tinzaparin|mesh-list
153919551|NCT00028678|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
153919552|NCT00028678|Anticoagulants|anticoagulants|mesh-ancestor
153649088|NCT00024310|Lometrexol|lometrexol|mesh-list
153649089|NCT00024310|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153649090|NCT00024310|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153649091|NCT00024310|Tubulin Modulators|tubulin modulators|mesh-ancestor
153649092|NCT00024310|Antimitotic Agents|antimitotic agents|mesh-ancestor
153649093|NCT00024310|Mitosis Modulators|mitosis modulators|mesh-ancestor
153649094|NCT00024310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153649095|NCT00024310|Hematinics|hematinics|mesh-ancestor
153649096|NCT00024310|Vitamin B Complex|vitamin b complex|mesh-ancestor
153649097|NCT00024310|Vitamins|vitamins|mesh-ancestor
153649098|NCT00024310|Micronutrients|micronutrients|mesh-ancestor
153649099|NCT00024310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153458980|NCT01672476|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
153458981|NCT01672476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153458982|NCT01672554|Quetiapine Fumarate|quetiapine fumarate|mesh-list
153458983|NCT01672554|Antidepressive Agents|antidepressive agents|mesh-ancestor
153458984|NCT01672554|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153458985|NCT01672554|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153458986|NCT01672554|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153458987|NCT01672554|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153458988|NCT01672554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153458989|NCT04026984|Rifamycins|rifamycins|mesh-list
153458990|NCT04026984|Rifamycin SV|rifamycin sv|mesh-list
153458991|NCT04026984|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153817630|NCT06184282|Sensory System Agents|sensory system agents|mesh-ancestor
153817631|NCT06184282|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153817632|NCT06184282|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153817633|NCT06184282|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
153817634|NCT06184282|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153817635|NCT06184282|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153817636|NCT06184282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153817637|NCT06182267|Listerine|listerine|mesh-list
153817664|NCT06178367|Immunologic Factors|immunologic factors|mesh-ancestor
153817665|NCT06178367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153817666|NCT06178367|Viscosupplements|viscosupplements|mesh-ancestor
153817667|NCT06178367|Protective Agents|protective agents|mesh-ancestor
153649100|NCT00024310|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153649128|NCT00024388|Antimitotic Agents|antimitotic agents|mesh-ancestor
153422552|NCT03412877|Aldesleukin|aldesleukin|mesh-list
153422553|NCT03412877|Cyclophosphamide|cyclophosphamide|mesh-list
153422554|NCT03412877|Pembrolizumab|pembrolizumab|mesh-list
153422555|NCT03412877|Fludarabine|fludarabine|mesh-list
153422556|NCT03412877|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153649129|NCT00024388|Mitosis Modulators|mitosis modulators|mesh-ancestor
153649130|NCT00024388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153649131|NCT00024427|Gemcitabine|gemcitabine|mesh-list
153649132|NCT00024427|Fluorouracil|fluorouracil|mesh-list
153649133|NCT00024427|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153649134|NCT00024427|Antimetabolites|antimetabolites|mesh-ancestor
153459118|NCT01674738|Pemetrexed|pemetrexed|mesh-list
153459119|NCT01674738|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153459141|NCT03150576|Carboplatin|carboplatin|mesh-list
153459166|NCT04747080|Protease Inhibitors|protease inhibitors|mesh-ancestor
153459189|NCT01675362|Vasodilator Agents|vasodilator agents|mesh-ancestor
153459303|NCT03652974|Antimanic Agents|antimanic agents|mesh-ancestor
153459376|NCT03618654|Metformin|metformin|mesh-list
153818051|NCT05642078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153818052|NCT05641246|Diclofenac|diclofenac|mesh-list
153818053|NCT05641246|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153818065|NCT05609565|Prilocaine|prilocaine|mesh-list
153459488|NCT03825198|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153459490|NCT03825198|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
153459520|NCT06125834|Antimitotic Agents|antimitotic agents|mesh-ancestor
153459604|NCT06124560|Metformin|metformin|mesh-list
153459630|NCT06124495|Incretins|incretins|mesh-ancestor
153459827|NCT05876390|Antipyretics|antipyretics|mesh-ancestor
153459884|NCT05552001|Immunoconjugates|immunoconjugates|mesh-ancestor
153460003|NCT05160922|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153818647|NCT04038515|Nicotine|nicotine|mesh-list
153818648|NCT04038515|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
153818649|NCT04038515|Autonomic Agents|autonomic agents|mesh-ancestor
153818650|NCT04038515|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153818651|NCT04038515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153460133|NCT04535271|Trabectedin|trabectedin|mesh-list
153460240|NCT04095364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153460254|NCT03969420|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153460316|NCT03686345|Midostaurin|midostaurin|mesh-list
153460336|NCT03677141|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153460361|NCT03593915|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153460539|NCT02718066|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153460540|NCT02718066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153460541|NCT02599363|Paclitaxel|paclitaxel|mesh-list
153460542|NCT02599363|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153460543|NCT02599363|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153460544|NCT02599363|Tubulin Modulators|tubulin modulators|mesh-ancestor
153819176|NCT03011567|Antipyretics|antipyretics|mesh-ancestor
153649135|NCT00024427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153649136|NCT00024427|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153649137|NCT00024427|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153649138|NCT00024427|Immunologic Factors|immunologic factors|mesh-ancestor
153649139|NCT00024427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153649141|NCT00000257|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
153649142|NCT00000257|Anesthetics, General|anesthetics, general|mesh-ancestor
153649143|NCT00000257|Anesthetics|anesthetics|mesh-ancestor
153649144|NCT00000257|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153649145|NCT00000257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153649185|NCT00025051|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153649186|NCT00025051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153649187|NCT00025051|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153649188|NCT00025051|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153649189|NCT00025051|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
153649190|NCT00025051|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153649191|NCT00025051|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153649192|NCT00025051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153649193|NCT00025051|Mitosis Modulators|mitosis modulators|mesh-ancestor
153649194|NCT00025090|Fluorouracil|fluorouracil|mesh-list
153649195|NCT00025090|Mitomycins|mitomycins|mesh-list
153649196|NCT00025090|Mitomycin|mitomycin|mesh-list
153649197|NCT00025090|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153649198|NCT00025090|Antimetabolites|antimetabolites|mesh-ancestor
153649199|NCT00025090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153649200|NCT00025090|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153649201|NCT00025090|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153649202|NCT00025090|Immunologic Factors|immunologic factors|mesh-ancestor
153649203|NCT00025090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153649204|NCT00025090|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153649236|NCT00025207|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153649237|NCT00025246|Imatinib Mesylate|imatinib mesylate|mesh-list
153649238|NCT00025246|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153649239|NCT00025246|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153649240|NCT00025246|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153649241|NCT00025246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153649242|NCT00025246|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153649243|NCT00025285|Thalidomide|thalidomide|mesh-list
153649244|NCT00025285|Carboplatin|carboplatin|mesh-list
153649245|NCT00025285|Irinotecan|irinotecan|mesh-list
153649246|NCT00025285|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153649247|NCT00025285|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
153649248|NCT00025285|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153649249|NCT00025285|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153649299|NCT00025363|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153649300|NCT00025363|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153649301|NCT00025363|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
153649302|NCT00025363|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153649303|NCT00025363|Tubulin Modulators|tubulin modulators|mesh-ancestor
153649304|NCT00025363|Antimitotic Agents|antimitotic agents|mesh-ancestor
153649305|NCT00025363|Mitosis Modulators|mitosis modulators|mesh-ancestor
153649306|NCT00025402|Interferons|interferons|mesh-list
153649307|NCT00025402|Cytarabine|cytarabine|mesh-list
153649308|NCT00025402|Interferon-alpha|interferon-alpha|mesh-list
153649309|NCT00025402|Cyclophosphamide|cyclophosphamide|mesh-list
153649310|NCT00025402|Busulfan|busulfan|mesh-list
153649311|NCT00025402|Etoposide|etoposide|mesh-list
153649312|NCT00025402|Idarubicin|idarubicin|mesh-list
153649313|NCT00025402|Hydroxyurea|hydroxyurea|mesh-list
153649314|NCT00025402|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153649315|NCT00025402|Immunologic Factors|immunologic factors|mesh-ancestor
153649316|NCT00025402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153649317|NCT00025402|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153649318|NCT00025402|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153649319|NCT00025402|Alkylating Agents|alkylating agents|mesh-ancestor
153649320|NCT00025402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153649321|NCT00025402|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153820142|NCT00431990|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153820246|NCT02957435|Eplerenone|eplerenone|mesh-list
153820338|NCT00463359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153820371|NCT00433043|Metoprolol|metoprolol|mesh-list
153820397|NCT03273075|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
153820398|NCT03273075|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
153820494|NCT00433277|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
153649322|NCT00025402|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153649323|NCT00025402|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153649324|NCT00025402|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153649325|NCT00025402|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153649327|NCT00025402|Antiviral Agents|antiviral agents|mesh-ancestor
153649328|NCT00025402|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153649329|NCT00025402|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153649330|NCT00025402|Antimetabolites|antimetabolites|mesh-ancestor
153649331|NCT00025402|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153649332|NCT00025402|Antisickling Agents|antisickling agents|mesh-ancestor
153649333|NCT00025402|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153649334|NCT00025441|Dactinomycin|dactinomycin|mesh-list
153649335|NCT00025441|Cyclophosphamide|cyclophosphamide|mesh-list
153649336|NCT00025441|Ifosfamide|ifosfamide|mesh-list
153820726|NCT03272802|Protective Agents|protective agents|mesh-ancestor
153649337|NCT00025441|Carboplatin|carboplatin|mesh-list
153649338|NCT00025441|Doxorubicin|doxorubicin|mesh-list
153649339|NCT00025441|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
153649340|NCT00025441|Etoposide|etoposide|mesh-list
153649341|NCT00025441|Vincristine|vincristine|mesh-list
153649342|NCT00025441|Epirubicin|epirubicin|mesh-list
153649343|NCT00025441|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153649344|NCT00025441|Immunologic Factors|immunologic factors|mesh-ancestor
153649345|NCT00025441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153649346|NCT00025441|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153649347|NCT00025441|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153649348|NCT00025441|Alkylating Agents|alkylating agents|mesh-ancestor
153649349|NCT00025441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153649350|NCT00025441|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153649351|NCT00025441|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153649352|NCT00025441|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153649353|NCT00025441|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153649354|NCT00025441|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153649355|NCT00025441|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153649356|NCT00025441|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153649357|NCT00025441|Tubulin Modulators|tubulin modulators|mesh-ancestor
153649358|NCT00025441|Antimitotic Agents|antimitotic agents|mesh-ancestor
153649359|NCT00025441|Mitosis Modulators|mitosis modulators|mesh-ancestor
153649360|NCT00025441|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153649361|NCT00025441|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153649362|NCT00025441|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
153649363|NCT00025441|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153649384|NCT00000395|Vitamin B Complex|vitamin b complex|mesh-ancestor
153649386|NCT00000395|Micronutrients|micronutrients|mesh-ancestor
153649387|NCT00000395|Antidotes|antidotes|mesh-ancestor
153649388|NCT00000395|Protective Agents|protective agents|mesh-ancestor
153649389|NCT00025480|Paclitaxel|paclitaxel|mesh-list
153649390|NCT00025480|Carboplatin|carboplatin|mesh-list
153649391|NCT00025480|Tipifarnib|tipifarnib|mesh-list
153649392|NCT00025480|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153649393|NCT00025480|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153649394|NCT00025480|Tubulin Modulators|tubulin modulators|mesh-ancestor
153649395|NCT00025480|Antimitotic Agents|antimitotic agents|mesh-ancestor
153649396|NCT00025480|Mitosis Modulators|mitosis modulators|mesh-ancestor
153649397|NCT00025480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153649398|NCT00025519|Mycophenolic Acid|mycophenolic acid|mesh-list
153649399|NCT00025519|Thalidomide|thalidomide|mesh-list
153649400|NCT00025519|Fludarabine|fludarabine|mesh-list
153649401|NCT00025519|Fludarabine phosphate|fludarabine phosphate|mesh-list
153649402|NCT00025519|Tacrolimus|tacrolimus|mesh-list
153649403|NCT00025519|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153649404|NCT00025519|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153649405|NCT00025519|Antimetabolites|antimetabolites|mesh-ancestor
153649406|NCT00025519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153649407|NCT00025519|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153649408|NCT00025519|Immunologic Factors|immunologic factors|mesh-ancestor
153649410|NCT00025519|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
153649435|NCT00025597|Doxorubicin|doxorubicin|mesh-list
153649441|NCT00025597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153649442|NCT00025597|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153649443|NCT00025597|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153649444|NCT00025597|Alkylating Agents|alkylating agents|mesh-ancestor
153649445|NCT00025597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153649446|NCT00025597|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153649447|NCT00025597|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153649448|NCT00025597|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153649496|NCT00025636|Tubulin Modulators|tubulin modulators|mesh-ancestor
153649497|NCT00025636|Antimitotic Agents|antimitotic agents|mesh-ancestor
153649498|NCT00025636|Mitosis Modulators|mitosis modulators|mesh-ancestor
153649500|NCT00025675|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153649501|NCT00025675|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153422572|NCT03273023|Everolimus|everolimus|mesh-list
153649502|NCT00025675|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153649561|NCT00026182|Immunologic Factors|immunologic factors|mesh-ancestor
153649562|NCT00026182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153649563|NCT00026182|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153649564|NCT00026182|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153649565|NCT00026182|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153649566|NCT00026182|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153649567|NCT00026182|Growth Substances|growth substances|mesh-ancestor
153649568|NCT00026182|Growth Inhibitors|growth inhibitors|mesh-ancestor
153649569|NCT00026260|Semaxinib|semaxinib|mesh-list
153649570|NCT00026260|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153649571|NCT00026260|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153649572|NCT00026260|Growth Substances|growth substances|mesh-ancestor
153669007|NCT00034710|Capsaicin|capsaicin|mesh-list
153649573|NCT00026260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153649574|NCT00026260|Growth Inhibitors|growth inhibitors|mesh-ancestor
153649575|NCT00026260|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153649576|NCT00026260|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153649577|NCT00026260|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153649578|NCT00026260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153649579|NCT00026299|Oxaliplatin|oxaliplatin|mesh-list
153649580|NCT00026299|Gefitinib|gefitinib|mesh-list
153649581|NCT00026299|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153649582|NCT00026299|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153649583|NCT00026299|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153669247|NCT01805726|Narcotics|narcotics|mesh-ancestor
153669524|NCT00037011|Antibodies|antibodies|mesh-list
153649595|NCT00026377|Leuprolide|leuprolide|mesh-list
153649611|NCT00026377|Growth Substances|growth substances|mesh-ancestor
153649612|NCT00026377|Growth Inhibitors|growth inhibitors|mesh-ancestor
153649613|NCT00026377|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153649614|NCT00026377|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153649615|NCT00026377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153649616|NCT00026416|Interferons|interferons|mesh-list
153649617|NCT00026416|Interferon-alpha|interferon-alpha|mesh-list
153649618|NCT00026416|Thalidomide|thalidomide|mesh-list
153649619|NCT00026416|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153649620|NCT00026416|Antiviral Agents|antiviral agents|mesh-ancestor
153649621|NCT00026416|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153649622|NCT00026416|Immunologic Factors|immunologic factors|mesh-ancestor
153669939|NCT05116059|Amphotericin B|amphotericin b|mesh-list
153649626|NCT00026416|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153649627|NCT00026416|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153649628|NCT00026416|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153649629|NCT00026416|Growth Substances|growth substances|mesh-ancestor
153649630|NCT00026416|Growth Inhibitors|growth inhibitors|mesh-ancestor
153649631|NCT00026533|Thalidomide|thalidomide|mesh-list
153649632|NCT00026533|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153649633|NCT00026533|Immunologic Factors|immunologic factors|mesh-ancestor
153649665|NCT00027079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153649666|NCT00027079|Sensory System Agents|sensory system agents|mesh-ancestor
153649667|NCT00027079|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153649668|NCT00027079|Antiemetics|antiemetics|mesh-ancestor
153649669|NCT00027079|Autonomic Agents|autonomic agents|mesh-ancestor
153649670|NCT00027079|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153649671|NCT00027079|Antipruritics|antipruritics|mesh-ancestor
153649672|NCT00027079|Dermatologic Agents|dermatologic agents|mesh-ancestor
153649673|NCT00027079|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
153649674|NCT00027079|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153649675|NCT00027079|Serotonin Agents|serotonin agents|mesh-ancestor
153649676|NCT00027079|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153670365|NCT00275054|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153649682|NCT00000425|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-list
153649683|NCT00000425|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153649684|NCT00000425|Analgesics|analgesics|mesh-ancestor
153649685|NCT00000425|Sensory System Agents|sensory system agents|mesh-ancestor
153372870|NCT01797575|N-monoacetylcystine|n-monoacetylcystine|mesh-list
153649686|NCT00000425|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153649687|NCT00000425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153649688|NCT00000425|Antipyretics|antipyretics|mesh-ancestor
153649713|NCT00027391|Tocolytic Agents|tocolytic agents|mesh-ancestor
153649714|NCT00027391|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153649715|NCT00027391|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
153649716|NCT00027391|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
153649717|NCT00027391|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153649718|NCT00027391|Adrenergic Agents|adrenergic agents|mesh-ancestor
153649719|NCT00027391|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153649720|NCT00027391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153649721|NCT00027391|Androgens|androgens|mesh-ancestor
153649722|NCT00027391|Hormones|hormones|mesh-ancestor
153649723|NCT00027391|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153649724|NCT00027391|Anabolic Agents|anabolic agents|mesh-ancestor
153671104|NCT04573777|Protease Inhibitors|protease inhibitors|mesh-ancestor
153649728|NCT00000461|Cholestyramine Resin|cholestyramine resin|mesh-list
153649729|NCT00000461|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153649730|NCT00000461|Antimetabolites|antimetabolites|mesh-ancestor
153671561|NCT05766410|Letrozole|letrozole|mesh-list
153649732|NCT00000461|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153649733|NCT00000461|Vasodilator Agents|vasodilator agents|mesh-ancestor
153649734|NCT00000461|Vitamin B Complex|vitamin b complex|mesh-ancestor
153649735|NCT00000461|Vitamins|vitamins|mesh-ancestor
153649736|NCT00000461|Micronutrients|micronutrients|mesh-ancestor
153649737|NCT00000461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153672734|NCT02970630|Everolimus|everolimus|mesh-list
153649738|NCT00000461|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153649739|NCT00000461|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
153649743|NCT00027508|Trabectedin|trabectedin|mesh-list
153649759|NCT00027547|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153649760|NCT00027547|Antimetabolites|antimetabolites|mesh-ancestor
153649761|NCT00027547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153649762|NCT00027547|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153649763|NCT00027547|Dermatologic Agents|dermatologic agents|mesh-ancestor
153649764|NCT00027547|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153649765|NCT00027547|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153649766|NCT00027547|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153649767|NCT00027547|Immunologic Factors|immunologic factors|mesh-ancestor
153649768|NCT00027547|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153649769|NCT00027547|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153649770|NCT00027547|Antiviral Agents|antiviral agents|mesh-ancestor
153649771|NCT00027547|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153649772|NCT00027547|Antifungal Agents|antifungal agents|mesh-ancestor
153649773|NCT00027547|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
153673413|NCT00023231|Atorvastatin|atorvastatin|mesh-list
153649774|NCT00027547|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153649775|NCT00027547|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
153649776|NCT00027547|Antitubercular Agents|antitubercular agents|mesh-ancestor
153649777|NCT00027547|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153649779|NCT00011895|Zidovudine|zidovudine|mesh-list
153649780|NCT00011895|Efavirenz|efavirenz|mesh-list
153649813|NCT00000464|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153649814|NCT00000464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153649817|NCT00000464|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153649818|NCT00000464|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153649819|NCT00000464|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
153649820|NCT00000464|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
153649821|NCT00000464|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
153649822|NCT00000464|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
153649823|NCT00000464|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
153649824|NCT00000464|Adrenergic Agents|adrenergic agents|mesh-ancestor
153649825|NCT00000464|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153649826|NCT00000464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153649827|NCT00000464|Sympatholytics|sympatholytics|mesh-ancestor
153372879|NCT01797575|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153649828|NCT00000464|Autonomic Agents|autonomic agents|mesh-ancestor
153649829|NCT00000464|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153649830|NCT00000464|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
153649831|NCT00000464|Antidepressive Agents|antidepressive agents|mesh-ancestor
153649832|NCT00000464|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153649833|NCT00000464|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
153649834|NCT00000464|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153649835|NCT00000464|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
153649836|NCT00000464|Antimalarials|antimalarials|mesh-ancestor
153649837|NCT00000464|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153649838|NCT00000464|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153649839|NCT00000464|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153649840|NCT00000464|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
153673738|NCT00051831|Ritonavir|ritonavir|mesh-list
153649841|NCT00000464|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
153649842|NCT00000464|Cholinergic Agents|cholinergic agents|mesh-ancestor
153649854|NCT00027664|Interferon-alpha|interferon-alpha|mesh-list
153649856|NCT00027664|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153649857|NCT00027664|Antiviral Agents|antiviral agents|mesh-ancestor
153649858|NCT00027664|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153649859|NCT00027664|Immunologic Factors|immunologic factors|mesh-ancestor
153649860|NCT00027664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153649861|NCT00027664|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153649862|NCT00027664|Leprostatic Agents|leprostatic agents|mesh-ancestor
153649863|NCT00027664|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153649864|NCT00027664|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153649865|NCT00027664|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153649866|NCT00027664|Growth Substances|growth substances|mesh-ancestor
153649867|NCT00027664|Growth Inhibitors|growth inhibitors|mesh-ancestor
153649868|NCT00027703|Bevacizumab|bevacizumab|mesh-list
153649869|NCT00027703|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
153673969|NCT00395252|Cetuximab|cetuximab|mesh-list
153674099|NCT00025103|Melphalan|melphalan|mesh-list
153649871|NCT00027703|Antibodies|antibodies|mesh-list
153649872|NCT00027703|Immunoglobulins|immunoglobulins|mesh-list
153649873|NCT00027703|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
153649874|NCT00027703|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153649875|NCT00027703|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153649876|NCT00027703|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153649877|NCT00027703|Growth Substances|growth substances|mesh-ancestor
153649878|NCT00027703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153649879|NCT00027703|Growth Inhibitors|growth inhibitors|mesh-ancestor
153649880|NCT00027703|Immunologic Factors|immunologic factors|mesh-ancestor
153649881|NCT00027703|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153649882|NCT00027703|Antimetabolites|antimetabolites|mesh-ancestor
153649883|NCT00027703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153649884|NCT00011934|Interferons|interferons|mesh-list
153649885|NCT00011934|Interferon-alpha|interferon-alpha|mesh-list
153649886|NCT00011934|Sargramostim|sargramostim|mesh-list
153649887|NCT00011934|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153649888|NCT00011934|Antiviral Agents|antiviral agents|mesh-ancestor
153649890|NCT00011934|Immunologic Factors|immunologic factors|mesh-ancestor
153649896|NCT00027742|Antiviral Agents|antiviral agents|mesh-ancestor
153649897|NCT00027742|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153649898|NCT00027742|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153649899|NCT00027742|Alkylating Agents|alkylating agents|mesh-ancestor
153649900|NCT00027742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153649901|NCT00027742|Immunologic Factors|immunologic factors|mesh-ancestor
153674684|NCT00055302|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
153649902|NCT00027742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153649903|NCT00027820|Cyclosporine|cyclosporine|mesh-list
153649904|NCT00027820|Mycophenolic Acid|mycophenolic acid|mesh-list
153649905|NCT00027820|Fludarabine|fludarabine|mesh-list
153649906|NCT00027820|Fludarabine phosphate|fludarabine phosphate|mesh-list
153649907|NCT00027820|Cyclosporins|cyclosporins|mesh-list
153649961|NCT00027937|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153881705|NCT01810588|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153881706|NCT01810588|Immunologic Factors|immunologic factors|mesh-ancestor
153881707|NCT01810588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153649962|NCT00027937|Antiviral Agents|antiviral agents|mesh-ancestor
153649963|NCT00027937|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153649964|NCT00012051|Cytarabine|cytarabine|mesh-list
153649965|NCT00012051|Dexamethasone|dexamethasone|mesh-list
153649966|NCT00012051|Rituximab|rituximab|mesh-list
153649967|NCT00012051|Methotrexate|methotrexate|mesh-list
153649968|NCT00012051|Etoposide|etoposide|mesh-list
153649969|NCT00012051|Melphalan|melphalan|mesh-list
153649970|NCT00012051|Ifosfamide|ifosfamide|mesh-list
153649971|NCT00012051|Carmustine|carmustine|mesh-list
153674922|NCT00028028|Sirolimus|sirolimus|mesh-list
153649972|NCT00012051|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153649973|NCT00012051|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153649975|NCT00012051|Autonomic Agents|autonomic agents|mesh-ancestor
153649976|NCT00012051|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153649977|NCT00012051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153649978|NCT00012051|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153649979|NCT00012051|Glucocorticoids|glucocorticoids|mesh-ancestor
153649980|NCT00012051|Hormones|hormones|mesh-ancestor
153649981|NCT00012051|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153675847|NCT00031733|Growth Substances|growth substances|mesh-ancestor
153649982|NCT00012051|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153649983|NCT00012051|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153649984|NCT00012051|Immunologic Factors|immunologic factors|mesh-ancestor
153649985|NCT00012051|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153649986|NCT00012051|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
153675948|NCT00032084|Bupropion|bupropion|mesh-list
153649987|NCT00012051|Abortifacient Agents|abortifacient agents|mesh-ancestor
153649988|NCT00012051|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153649989|NCT00012051|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153650009|NCT00027976|Sensory System Agents|sensory system agents|mesh-ancestor
153650010|NCT00027976|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153650011|NCT00027976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153650012|NCT00027976|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153650013|NCT00027976|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153650014|NCT00027976|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
153650015|NCT00027976|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153650016|NCT00027976|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153650017|NCT00027976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153650019|NCT00000479|Vitamin E|vitamin e|mesh-list
153650020|NCT00000479|Vitamins|vitamins|mesh-ancestor
153650021|NCT00000479|Micronutrients|micronutrients|mesh-ancestor
153650024|NCT00000479|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153650069|NCT00395395|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153650070|NCT00395395|Vasodilator Agents|vasodilator agents|mesh-ancestor
153650071|NCT00395434|Bevacizumab|bevacizumab|mesh-list
153650072|NCT00395434|Combretastatin|combretastatin|mesh-list
153650073|NCT00395434|Fosbretabulin|fosbretabulin|mesh-list
153650074|NCT00395434|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153650075|NCT00395434|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153650076|NCT00395434|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153676302|NCT00033332|Growth Inhibitors|growth inhibitors|mesh-ancestor
153676304|NCT00033410|Paclitaxel|paclitaxel|mesh-list
153650077|NCT00395434|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153650078|NCT00395434|Growth Substances|growth substances|mesh-ancestor
153650079|NCT00395434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153650080|NCT00395434|Growth Inhibitors|growth inhibitors|mesh-ancestor
153650081|NCT00395434|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153650082|NCT00395434|Tubulin Modulators|tubulin modulators|mesh-ancestor
153650083|NCT00395434|Antimitotic Agents|antimitotic agents|mesh-ancestor
153650084|NCT00395434|Mitosis Modulators|mitosis modulators|mesh-ancestor
153650085|NCT00395434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153650087|NCT00395551|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153650089|NCT00395551|Growth Substances|growth substances|mesh-ancestor
153650125|NCT00028327|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153650126|NCT00028327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153650127|NCT00028327|Antiviral Agents|antiviral agents|mesh-ancestor
153650129|NCT00028327|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153650130|NCT00028327|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153650131|NCT00028327|Antimetabolites|antimetabolites|mesh-ancestor
153650132|NCT00028327|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
153650133|NCT00028327|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153650134|NCT00028327|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
153650135|NCT00028327|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
153650137|NCT00028327|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
153650138|NCT00028327|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
153650139|NCT00028327|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
153650140|NCT00028327|Protease Inhibitors|protease inhibitors|mesh-ancestor
153650141|NCT00028366|Ritonavir|ritonavir|mesh-list
153650142|NCT00028366|Lopinavir|lopinavir|mesh-list
153650143|NCT00028366|Fosamprenavir|fosamprenavir|mesh-list
153650145|NCT00028366|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
153650146|NCT00028366|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
153650147|NCT00028366|Protease Inhibitors|protease inhibitors|mesh-ancestor
153650148|NCT00028366|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153650149|NCT00028366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153650150|NCT00028366|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153650151|NCT00028366|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153650152|NCT00028366|Antiviral Agents|antiviral agents|mesh-ancestor
153650158|NCT00028405|Talaporfin|talaporfin|mesh-list
153650172|NCT00012207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153650173|NCT00012207|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153650174|NCT00012207|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153650175|NCT00012207|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153650176|NCT00012207|Glucocorticoids|glucocorticoids|mesh-ancestor
153650177|NCT00012207|Hormones|hormones|mesh-ancestor
153650179|NCT00012207|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153650180|NCT00012207|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153650181|NCT00012207|Tubulin Modulators|tubulin modulators|mesh-ancestor
153650182|NCT00012207|Antimitotic Agents|antimitotic agents|mesh-ancestor
153650183|NCT00012207|Mitosis Modulators|mitosis modulators|mesh-ancestor
153650184|NCT00012207|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153650185|NCT00012207|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153650186|NCT00012207|Antiviral Agents|antiviral agents|mesh-ancestor
153650187|NCT00012207|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153650189|NCT00028483|Doxorubicin|doxorubicin|mesh-list
153650190|NCT00028483|Immunoconjugates|immunoconjugates|mesh-list
153650191|NCT00028483|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153650192|NCT00028483|Tubulin Modulators|tubulin modulators|mesh-ancestor
153650193|NCT00028483|Antimitotic Agents|antimitotic agents|mesh-ancestor
153650194|NCT00028483|Mitosis Modulators|mitosis modulators|mesh-ancestor
153650195|NCT00028483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153650196|NCT00028483|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153650203|NCT00000485|Diuretics|diuretics|mesh-list
153650219|NCT00028600|Tacrolimus|tacrolimus|mesh-list
153650220|NCT00028600|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153650221|NCT00028600|Immunologic Factors|immunologic factors|mesh-ancestor
153650222|NCT00028600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153650223|NCT00028600|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153650224|NCT00028600|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153650225|NCT00028600|Alkylating Agents|alkylating agents|mesh-ancestor
153650226|NCT00028600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153677132|NCT00037115|Interferon beta-1a|interferon beta-1a|mesh-list
153650228|NCT00028600|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153650229|NCT00028600|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
153650230|NCT00028600|Abortifacient Agents|abortifacient agents|mesh-ancestor
153650231|NCT00028600|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153650232|NCT00028600|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153650233|NCT00028600|Antimetabolites|antimetabolites|mesh-ancestor
153650234|NCT00028600|Dermatologic Agents|dermatologic agents|mesh-ancestor
153650235|NCT00028600|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153650236|NCT00028600|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153650237|NCT00028600|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153650274|NCT00028717|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153650275|NCT00028717|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153650276|NCT00028717|Tubulin Modulators|tubulin modulators|mesh-ancestor
153650277|NCT00028717|Antimitotic Agents|antimitotic agents|mesh-ancestor
153650278|NCT00028717|Mitosis Modulators|mitosis modulators|mesh-ancestor
153650279|NCT00028756|Gemcitabine|gemcitabine|mesh-list
153650280|NCT00028756|Doxorubicin|doxorubicin|mesh-list
153650281|NCT00028756|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
153650282|NCT00028756|Methotrexate|methotrexate|mesh-list
153650283|NCT00028756|Vinblastine|vinblastine|mesh-list
153650284|NCT00028756|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153650285|NCT00028756|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153677389|NCT00398814|Sorafenib|sorafenib|mesh-list
153650306|NCT00012324|Doxorubicin|doxorubicin|mesh-list
153650336|NCT00388895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153650337|NCT00388895|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153650338|NCT00028834|Bevacizumab|bevacizumab|mesh-list
153650339|NCT00028834|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
153650340|NCT00028834|Gemcitabine|gemcitabine|mesh-list
153650341|NCT00028834|Antibodies|antibodies|mesh-list
153650342|NCT00028834|Immunoglobulins|immunoglobulins|mesh-list
153650343|NCT00028834|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
153650344|NCT00028834|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153650345|NCT00028834|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153650346|NCT00028834|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153650347|NCT00028834|Growth Substances|growth substances|mesh-ancestor
153650348|NCT00028834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153650349|NCT00028834|Growth Inhibitors|growth inhibitors|mesh-ancestor
153650397|NCT00029380|Cyclosporins|cyclosporins|mesh-list
153650398|NCT00029380|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153650399|NCT00029380|Immunologic Factors|immunologic factors|mesh-ancestor
153677494|NCT00065949|Magnesium Sulfate|magnesium sulfate|mesh-list
153650400|NCT00029380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153650402|NCT00029380|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153650403|NCT00029380|Alkylating Agents|alkylating agents|mesh-ancestor
153650404|NCT00029380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153650405|NCT00029380|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153650406|NCT00029380|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153650407|NCT00029380|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153650408|NCT00029380|Antifungal Agents|antifungal agents|mesh-ancestor
153677650|NCT00070278|Antimetabolites|antimetabolites|mesh-ancestor
153650409|NCT00029380|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153650457|NCT00000494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153650459|NCT00012519|Indinavir|indinavir|mesh-list
153650460|NCT00012519|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
153650461|NCT00012519|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
153650462|NCT00012519|Protease Inhibitors|protease inhibitors|mesh-ancestor
153650463|NCT00012519|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153677818|NCT00066768|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153677821|NCT00066846|Leucovorin|leucovorin|mesh-list
153650464|NCT00012519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153650466|NCT00012519|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153650467|NCT00012519|Antiviral Agents|antiviral agents|mesh-ancestor
153650468|NCT00012519|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153650469|NCT00012519|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
153650470|NCT00012519|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153650517|NCT00012558|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153650518|NCT00012558|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
153650519|NCT00012558|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153650522|NCT00012558|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
153650523|NCT00012558|Anticonvulsants|anticonvulsants|mesh-ancestor
153650524|NCT00012558|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153650525|NCT00012558|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153650526|NCT00012558|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153650528|NCT00012558|Vitamin B Complex|vitamin b complex|mesh-ancestor
153650529|NCT00012558|Vitamins|vitamins|mesh-ancestor
153650530|NCT00012558|Micronutrients|micronutrients|mesh-ancestor
153650531|NCT00012558|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
153650576|NCT00000503|Vasodilator Agents|vasodilator agents|mesh-ancestor
153650577|NCT00000503|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153650578|NCT00000503|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153650579|NCT00000503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153650580|NCT00030004|Midazolam|midazolam|mesh-list
153650581|NCT00030004|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153650582|NCT00030004|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153650583|NCT00030004|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153650584|NCT00030004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153650585|NCT00030004|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153650586|NCT00030004|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153650587|NCT00030004|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153650588|NCT00030004|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153650589|NCT00030004|Anesthetics, General|anesthetics, general|mesh-ancestor
153650590|NCT00030004|Anesthetics|anesthetics|mesh-ancestor
153650591|NCT00030004|GABA Modulators|gaba modulators|mesh-ancestor
153650594|NCT00030004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153650595|NCT00030082|Melphalan|melphalan|mesh-list
153650596|NCT00030082|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153650597|NCT00030082|Alkylating Agents|alkylating agents|mesh-ancestor
153895876|NCT01190007|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153650598|NCT00030082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153650599|NCT00030082|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153650604|NCT00000518|Quinidine|quinidine|mesh-list
153650625|NCT00000518|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
153650626|NCT00000518|Antimalarials|antimalarials|mesh-ancestor
153650627|NCT00000518|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153650628|NCT00000518|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153650629|NCT00000518|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153650630|NCT00000518|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153650631|NCT00000518|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
153650632|NCT00000518|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
153650633|NCT00000518|Cholinergic Agents|cholinergic agents|mesh-ancestor
153650634|NCT00000518|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
153650635|NCT00000518|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153650636|NCT00000518|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
153650637|NCT00000518|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153650639|NCT00030121|Vasodilator Agents|vasodilator agents|mesh-ancestor
153650640|NCT00030238|Calcium|calcium|mesh-list
153650641|NCT00030238|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153650642|NCT00030238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153650643|NCT00030355|Homoharringtonine|homoharringtonine|mesh-list
153650644|NCT00030355|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153650645|NCT00030355|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153650646|NCT00030355|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
153650647|NCT00030355|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153650648|NCT00030355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153650649|NCT00030394|Imatinib Mesylate|imatinib mesylate|mesh-list
153650650|NCT00030394|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153650651|NCT00030394|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153650652|NCT00030394|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153650654|NCT00030394|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153650669|NCT00030433|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153650670|NCT00030472|Doxorubicin|doxorubicin|mesh-list
153650671|NCT00030472|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
153650672|NCT00030472|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153678736|NCT00206167|Hormones|hormones|mesh-ancestor
153650673|NCT00030472|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153650674|NCT00030472|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153650675|NCT00030472|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153650737|NCT00030745|Gemcitabine|gemcitabine|mesh-list
153650738|NCT00030745|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153650739|NCT00030745|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153650740|NCT00030745|Antimetabolites|antimetabolites|mesh-ancestor
153650741|NCT00030745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153650742|NCT00030784|Doxorubicin|doxorubicin|mesh-list
153650743|NCT00030784|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
153650744|NCT00030784|Ifosfamide|ifosfamide|mesh-list
153679045|NCT00207766|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153650747|NCT00030784|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153650748|NCT00030784|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153650751|NCT00030784|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153650806|NCT00000554|Dobutamine|dobutamine|mesh-list
153650807|NCT00000554|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
153650808|NCT00000554|Sympathomimetics|sympathomimetics|mesh-ancestor
153650809|NCT00000554|Autonomic Agents|autonomic agents|mesh-ancestor
153650810|NCT00000554|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153650811|NCT00000554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153650812|NCT00000554|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
153650813|NCT00000554|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
153650814|NCT00000554|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153650815|NCT00000554|Adrenergic Agents|adrenergic agents|mesh-ancestor
153650819|NCT00012909|Hormones|hormones|mesh-list
153650858|NCT00396214|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153422613|NCT03207867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153422614|NCT03207867|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153422615|NCT03207867|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153422616|NCT03107689|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-list
153650859|NCT00396214|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153650860|NCT00396214|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153650861|NCT00396214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153650863|NCT00000563|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153650864|NCT00000563|Antiemetics|antiemetics|mesh-ancestor
153650865|NCT00000563|Autonomic Agents|autonomic agents|mesh-ancestor
153650924|NCT00031759|Interferon Inducers|interferon inducers|mesh-ancestor
153650925|NCT01791816|Phenylephrine|phenylephrine|mesh-list
153650926|NCT01791816|Oxymetazoline|oxymetazoline|mesh-list
153650927|NCT01791816|omega-N-Methylarginine|omega-n-methylarginine|mesh-list
153650928|NCT01791816|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
153650929|NCT01791816|Mydriatics|mydriatics|mesh-ancestor
153650930|NCT01791816|Autonomic Agents|autonomic agents|mesh-ancestor
153650931|NCT01791816|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153650932|NCT01791816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153650933|NCT01791816|Sympathomimetics|sympathomimetics|mesh-ancestor
153650934|NCT01791816|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
153650935|NCT01791816|Nasal Decongestants|nasal decongestants|mesh-ancestor
153650936|NCT01791816|Respiratory System Agents|respiratory system agents|mesh-ancestor
153650937|NCT01791816|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
153650938|NCT01791816|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153650939|NCT01791816|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153650940|NCT01791816|Adrenergic Agents|adrenergic agents|mesh-ancestor
153650941|NCT01791816|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153650981|NCT00031954|Paclitaxel|paclitaxel|mesh-list
153650982|NCT00031954|Carboplatin|carboplatin|mesh-list
153650983|NCT00031954|Gemcitabine|gemcitabine|mesh-list
153679646|NCT00073164|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153650987|NCT00031954|Antimitotic Agents|antimitotic agents|mesh-ancestor
153650988|NCT00031954|Mitosis Modulators|mitosis modulators|mesh-ancestor
153650989|NCT00031954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153650990|NCT00031954|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153650994|NCT00031993|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153650995|NCT00031993|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153650996|NCT00031993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153650997|NCT00031993|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153650998|NCT00000575|Nedocromil|nedocromil|mesh-list
153650999|NCT00000575|Budesonide|budesonide|mesh-list
153651000|NCT00000575|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153651001|NCT00000575|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153651002|NCT00000575|Autonomic Agents|autonomic agents|mesh-ancestor
153651004|NCT00000575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153651005|NCT00000575|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153651006|NCT00000575|Respiratory System Agents|respiratory system agents|mesh-ancestor
153651007|NCT00000575|Glucocorticoids|glucocorticoids|mesh-ancestor
153651008|NCT00000575|Hormones|hormones|mesh-ancestor
153651009|NCT00000575|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153651010|NCT00000575|Mast Cell Stabilizers|mast cell stabilizers|mesh-ancestor
153680085|NCT00214084|Antioxidants|antioxidants|mesh-ancestor
153651011|NCT00000575|Immunologic Factors|immunologic factors|mesh-ancestor
153651012|NCT00000575|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
153651024|NCT00032110|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153651025|NCT00032110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153651026|NCT00032110|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153651027|NCT00032149|Prednisolone|prednisolone|mesh-list
153651028|NCT00032149|Cyclophosphamide|cyclophosphamide|mesh-list
153651029|NCT00032149|Etoposide|etoposide|mesh-list
153651030|NCT00032149|Vincristine|vincristine|mesh-list
153651031|NCT00032149|Mitoxantrone|mitoxantrone|mesh-list
153651032|NCT00032149|Bleomycin|bleomycin|mesh-list
153651033|NCT00032149|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153651034|NCT00032149|Immunologic Factors|immunologic factors|mesh-ancestor
153651035|NCT00032149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153651036|NCT00032149|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153651037|NCT00032149|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153651038|NCT00032149|Alkylating Agents|alkylating agents|mesh-ancestor
153651039|NCT00032149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153680566|NCT00217243|Lidocaine|lidocaine|mesh-list
153422618|NCT03107689|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
153422619|NCT03091075|Oxandrolone|oxandrolone|mesh-list
153422620|NCT03091075|Androgens|androgens|mesh-ancestor
153680713|NCT00042068|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153651040|NCT00032149|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153681094|NCT00073710|Vitamins|vitamins|mesh-ancestor
153681205|NCT00042926|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
153651041|NCT00032149|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153651042|NCT00032149|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153651080|NCT00000596|Immunologic Factors|immunologic factors|mesh-ancestor
153681528|NCT00077883|Cisplatin|cisplatin|mesh-list
153651085|NCT00000596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153651086|NCT00000596|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153651087|NCT00000596|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153651088|NCT00000596|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153651089|NCT00000596|Glucocorticoids|glucocorticoids|mesh-ancestor
153682062|NCT00127387|Etanercept|etanercept|mesh-list
153546876|NCT05889624|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153682843|NCT00079365|Antimetabolites|antimetabolites|mesh-ancestor
153683010|NCT00130819|Buprenorphine|buprenorphine|mesh-list
153683165|NCT00397709|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
153683166|NCT00397709|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
153683167|NCT00397709|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
153683168|NCT00397709|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
153683169|NCT00397709|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
153683170|NCT00397709|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153683171|NCT00397709|Antimetabolites|antimetabolites|mesh-ancestor
153683172|NCT00397709|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153683173|NCT00131521|Acetylcysteine|acetylcysteine|mesh-list
153683174|NCT00131521|Antiviral Agents|antiviral agents|mesh-ancestor
153683175|NCT00131521|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153683176|NCT00131521|Expectorants|expectorants|mesh-ancestor
153683177|NCT00131521|Respiratory System Agents|respiratory system agents|mesh-ancestor
153683178|NCT00131521|Free Radical Scavengers|free radical scavengers|mesh-ancestor
153683179|NCT00131521|Antioxidants|antioxidants|mesh-ancestor
153683182|NCT00131521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153683183|NCT00080028|Motexafin gadolinium|motexafin gadolinium|mesh-list
153683184|NCT00080028|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153683185|NCT00080028|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
153683186|NCT00080028|Dermatologic Agents|dermatologic agents|mesh-ancestor
153683188|NCT00131716|Sulfadoxine|sulfadoxine|mesh-list
153683189|NCT00131716|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
153683190|NCT00131716|Antimalarials|antimalarials|mesh-ancestor
153683191|NCT00131716|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153683192|NCT00131716|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153814297|NCT00338312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153814298|NCT00451386|Ceftriaxone|ceftriaxone|mesh-list
153814299|NCT00451386|Ertapenem|ertapenem|mesh-list
153814302|NCT00451386|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153814303|NCT00451386|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153814304|NCT00338390|Lamivudine|lamivudine|mesh-list
153814305|NCT00338390|Abacavir|abacavir|mesh-list
153814306|NCT00338390|Dideoxynucleosides|dideoxynucleosides|mesh-list
153814307|NCT00338390|Didanosine|didanosine|mesh-list
153814334|NCT00338546|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
153814339|NCT00338546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153480126|NCT05995249|Anticonvulsants|anticonvulsants|mesh-ancestor
153814342|NCT00338546|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
153814343|NCT00338546|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
153814344|NCT00338546|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153814347|NCT00338624|Oxybutynin|oxybutynin|mesh-list
153814350|NCT00338624|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153651091|NCT00000596|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153651141|NCT00032890|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153651143|NCT00032890|Sensory System Agents|sensory system agents|mesh-ancestor
153651144|NCT00032890|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153651145|NCT00032890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153651146|NCT00032890|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153651147|NCT00032890|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153372950|NCT01335620|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153814353|NCT00338624|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
153814354|NCT00338624|Cholinergic Agents|cholinergic agents|mesh-ancestor
153651149|NCT00032890|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153651151|NCT00032890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153651152|NCT00032929|Selegiline|selegiline|mesh-list
153651153|NCT00032929|Antidepressive Agents|antidepressive agents|mesh-ancestor
153651154|NCT00032929|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153651155|NCT00032929|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
153651156|NCT00032929|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
153651157|NCT00032929|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
153814358|NCT00338780|Lamivudine|lamivudine|mesh-list
153815083|NCT00448149|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153651160|NCT00032929|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
153651161|NCT00032929|Protective Agents|protective agents|mesh-ancestor
153651193|NCT00033085|Antiemetics|antiemetics|mesh-ancestor
153651194|NCT00033085|Autonomic Agents|autonomic agents|mesh-ancestor
153651195|NCT00033085|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153814363|NCT00338780|Antiviral Agents|antiviral agents|mesh-ancestor
153651197|NCT00033085|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153651198|NCT00033085|Antipruritics|antipruritics|mesh-ancestor
153651199|NCT00033085|Dermatologic Agents|dermatologic agents|mesh-ancestor
153651200|NCT00033085|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
153651201|NCT00033085|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153651202|NCT00033085|Serotonin Agents|serotonin agents|mesh-ancestor
153651262|NCT00000620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153651263|NCT00000620|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153651264|NCT00000620|Vasodilator Agents|vasodilator agents|mesh-ancestor
153651265|NCT00000620|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153651266|NCT00000620|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153651267|NCT00000620|Antimetabolites|antimetabolites|mesh-ancestor
153651268|NCT00000620|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153651269|NCT00000620|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
153651270|NCT00000620|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153651271|NCT00000620|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
153651316|NCT00033319|Micronutrients|micronutrients|mesh-ancestor
153651317|NCT00033319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153651318|NCT00033319|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153651319|NCT00033319|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153651320|NCT00033319|Analgesics|analgesics|mesh-ancestor
153651321|NCT00033319|Sensory System Agents|sensory system agents|mesh-ancestor
153651322|NCT00033319|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153651323|NCT00033319|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153651324|NCT00033319|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153651325|NCT00033319|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153432343|NCT05039619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153432344|NCT05039619|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153432345|NCT05039619|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153432346|NCT05039619|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153432347|NCT05039619|Analgesics|analgesics|mesh-ancestor
153432348|NCT05039619|Sensory System Agents|sensory system agents|mesh-ancestor
153432349|NCT05039619|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153432350|NCT05039619|Antipyretics|antipyretics|mesh-ancestor
153432351|NCT05039619|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153432352|NCT05039619|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
153432353|NCT05039619|Antitubercular Agents|antitubercular agents|mesh-ancestor
153432354|NCT05039619|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153891344|NCT06054321|Mirtazapine|mirtazapine|mesh-list
153891345|NCT06054321|Citalopram|citalopram|mesh-list
153891346|NCT06054321|Antidepressive Agents|antidepressive agents|mesh-list
153891347|NCT06054321|Escitalopram|escitalopram|mesh-list
153891348|NCT06054321|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
153891349|NCT06054321|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153891350|NCT06054321|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153891351|NCT06054321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153432373|NCT05039619|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
153432374|NCT05039619|Antipruritics|antipruritics|mesh-ancestor
153432375|NCT05039619|Dermatologic Agents|dermatologic agents|mesh-ancestor
153432376|NCT05038462|Lactoferrin|lactoferrin|mesh-list
153432377|NCT05038462|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153432391|NCT04994522|Belzutifan|belzutifan|mesh-list
153432392|NCT04994522|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153432393|NCT04939935|Metformin|metformin|mesh-list
153432394|NCT04939935|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153432395|NCT04939935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153891352|NCT06054321|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153891353|NCT06054321|Serotonin Agents|serotonin agents|mesh-ancestor
153486692|NCT01843920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153651340|NCT00033358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153651341|NCT00033358|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
153651342|NCT00033358|Contraceptive Agents|contraceptive agents|mesh-ancestor
153651343|NCT00033358|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153651344|NCT00033358|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
153651345|NCT00033358|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
153651346|NCT00033358|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
153651347|NCT00033358|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
153651348|NCT00033358|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
153651351|NCT02971696|Sorafenib|sorafenib|mesh-list
153651358|NCT00033436|Nicotinic Acids|nicotinic acids|mesh-list
153651359|NCT00033436|Vitamin B Complex|vitamin b complex|mesh-ancestor
153651360|NCT00033436|Vitamins|vitamins|mesh-ancestor
153651361|NCT00033436|Micronutrients|micronutrients|mesh-ancestor
153651362|NCT00033436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153651363|NCT00033436|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153651369|NCT00000635|Polymyxins|polymyxins|mesh-list
153651370|NCT00000635|Bacitracin|bacitracin|mesh-list
153651371|NCT00000635|Polymyxin B|polymyxin b|mesh-list
153651372|NCT00000635|Antimetabolites|antimetabolites|mesh-ancestor
153651373|NCT00000635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153651374|NCT00000635|Antiviral Agents|antiviral agents|mesh-ancestor
153651375|NCT00000635|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153651376|NCT00000635|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153651377|NCT00000635|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
153651378|NCT00033553|Paclitaxel|paclitaxel|mesh-list
153651379|NCT00033553|Carboplatin|carboplatin|mesh-list
153651380|NCT00033553|Gemcitabine|gemcitabine|mesh-list
153651381|NCT00033553|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153651382|NCT00033553|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153651383|NCT00033553|Tubulin Modulators|tubulin modulators|mesh-ancestor
153651384|NCT00033553|Antimitotic Agents|antimitotic agents|mesh-ancestor
153651389|NCT00033592|Bupropion|bupropion|mesh-list
153651405|NCT00033592|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153651407|NCT00033592|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
153651408|NCT00033592|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153651409|NCT00033592|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153651410|NCT00013689|Pyrimethamine|pyrimethamine|mesh-list
153651411|NCT00013689|Sulfadoxine|sulfadoxine|mesh-list
153651412|NCT00013689|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
153651413|NCT00013689|Antimalarials|antimalarials|mesh-ancestor
153651414|NCT00013689|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153891354|NCT06054321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153891355|NCT06054321|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
153891356|NCT06054321|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
153891357|NCT06054321|Parasympatholytics|parasympatholytics|mesh-ancestor
153891358|NCT06054321|Autonomic Agents|autonomic agents|mesh-ancestor
153891359|NCT06054321|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153891360|NCT06054321|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
153891361|NCT06054321|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
153891362|NCT06054321|Cholinergic Agents|cholinergic agents|mesh-ancestor
153891364|NCT06054321|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153891365|NCT06054321|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153891366|NCT06054321|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153891369|NCT06054321|Dopamine Agents|dopamine agents|mesh-ancestor
153891379|NCT06054321|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153891380|NCT06054321|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
153891381|NCT06054321|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
153891382|NCT06054321|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
153891383|NCT06054321|Adrenergic Agents|adrenergic agents|mesh-ancestor
153891384|NCT06054321|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
153891385|NCT06054152|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
153891386|NCT06054152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153891387|NCT06054152|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153651418|NCT00013689|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153651419|NCT00013689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153651420|NCT00013689|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
153651421|NCT00033709|Thalidomide|thalidomide|mesh-list
153651422|NCT00033709|Temozolomide|temozolomide|mesh-list
153651462|NCT00000641|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153651463|NCT00000641|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
153651464|NCT00000641|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
153814371|NCT00445497|Ciprofloxacin|ciprofloxacin|mesh-list
153814372|NCT00445497|Clavulanic Acid|clavulanic acid|mesh-list
153651465|NCT00000641|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
153651466|NCT00000641|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
153651467|NCT00000641|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
153651468|NCT00000641|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
153651469|NCT00000641|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153651470|NCT00000644|Clarithromycin|clarithromycin|mesh-list
153651472|NCT00000644|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153651473|NCT00000644|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
153651474|NCT00000644|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153651522|NCT00034060|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153651523|NCT00034060|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153651524|NCT00034060|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153651525|NCT00034060|Immunologic Factors|immunologic factors|mesh-ancestor
153651526|NCT00034138|Oregovomab|oregovomab|mesh-list
153651527|NCT00034138|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153651528|NCT00034138|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153651529|NCT00034177|Paclitaxel|paclitaxel|mesh-list
153651530|NCT00034177|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
153651531|NCT00034177|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153432430|NCT04827745|Blinatumomab|blinatumomab|mesh-list
153432431|NCT04827745|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153432432|NCT04803734|Albuterol|albuterol|mesh-list
153432433|NCT04803734|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153432434|NCT04803734|Autonomic Agents|autonomic agents|mesh-ancestor
153432435|NCT04803734|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153432436|NCT04803734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153651538|NCT00389129|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153651539|NCT00389129|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153651540|NCT00389129|Analgesics|analgesics|mesh-ancestor
153651541|NCT00389129|Sensory System Agents|sensory system agents|mesh-ancestor
153651542|NCT00389129|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153651576|NCT00014001|Perphenazine|perphenazine|mesh-list
153651577|NCT00014001|Fluphenazine|fluphenazine|mesh-list
153651578|NCT00014001|Fluphenazine depot|fluphenazine depot|mesh-list
153651579|NCT00014001|Fluphenazine enanthate|fluphenazine enanthate|mesh-list
153651580|NCT00014001|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153651581|NCT00014001|Serotonin Agents|serotonin agents|mesh-ancestor
153651582|NCT00014001|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153651583|NCT00014001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153651584|NCT00014001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153651585|NCT00014001|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153651586|NCT00014001|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153651587|NCT00014001|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153651588|NCT00014001|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153651589|NCT00014001|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
153651590|NCT00014001|Dopamine Agents|dopamine agents|mesh-ancestor
153814374|NCT00445497|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
153891397|NCT06054035|Dapagliflozin|dapagliflozin|mesh-list
153891398|NCT06054035|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
153891399|NCT06054035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153891400|NCT06054035|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153891401|NCT06054035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153891402|NCT06050824|Metronidazole|metronidazole|mesh-list
153891403|NCT06050824|Clarithromycin|clarithromycin|mesh-list
153891404|NCT06050824|Pantoprazole|pantoprazole|mesh-list
153891405|NCT06050824|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153891406|NCT06050824|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153891407|NCT06050824|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153891408|NCT06050824|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153891409|NCT06050824|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
153891410|NCT06050824|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153891411|NCT06050824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153891412|NCT06050824|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
153432437|NCT04803734|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153651592|NCT00014001|Autonomic Agents|autonomic agents|mesh-ancestor
153651593|NCT00014001|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153651594|NCT00014001|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153651595|NCT00014001|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
153651596|NCT00014001|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153651597|NCT00014001|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153651598|NCT00014001|Antidepressive Agents|antidepressive agents|mesh-ancestor
153651599|NCT00014001|GABA Antagonists|gaba antagonists|mesh-ancestor
153651600|NCT00014001|GABA Agents|gaba agents|mesh-ancestor
153651601|NCT00000671|Zidovudine|zidovudine|mesh-list
153651602|NCT00000671|Didanosine|didanosine|mesh-list
153651603|NCT00000671|Antimetabolites|antimetabolites|mesh-ancestor
153651604|NCT00000671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153651605|NCT00000671|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153651606|NCT00000671|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153651607|NCT00000671|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153651608|NCT00000671|Antiviral Agents|antiviral agents|mesh-ancestor
153651609|NCT00000671|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153651610|NCT00000671|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153651612|NCT02971540|Dipyrone|dipyrone|mesh-list
153651617|NCT02971540|Anesthetics|anesthetics|mesh-ancestor
153651618|NCT02971540|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153651619|NCT02971540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153651620|NCT02971540|Sensory System Agents|sensory system agents|mesh-ancestor
153651621|NCT02971540|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153651623|NCT02971540|Narcotics|narcotics|mesh-ancestor
153651624|NCT02971540|Analgesics|analgesics|mesh-ancestor
153651625|NCT02971540|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153651626|NCT02971540|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153432451|NCT04801797|Idarubicin|idarubicin|mesh-list
153432452|NCT04801797|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153432453|NCT04801797|Antimetabolites|antimetabolites|mesh-ancestor
153432454|NCT04801797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153432455|NCT04801797|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153432456|NCT04801797|Antiviral Agents|antiviral agents|mesh-ancestor
153891413|NCT06050824|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153891414|NCT06050824|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
153891415|NCT06050824|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153891416|NCT06050824|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
153891417|NCT06024096|Atorvastatin|atorvastatin|mesh-list
153891418|NCT06024096|Vaccines|vaccines|mesh-list
153891419|NCT06024096|Immunologic Factors|immunologic factors|mesh-ancestor
153891420|NCT06024096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153891421|NCT06024096|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153891422|NCT06024096|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153891423|NCT06024096|Antimetabolites|antimetabolites|mesh-ancestor
153891425|NCT06024096|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153651684|NCT00014040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153651685|NCT00014040|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153651686|NCT00014040|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
153651687|NCT00014040|Vasodilator Agents|vasodilator agents|mesh-ancestor
153651688|NCT00014040|Gasotransmitters|gasotransmitters|mesh-ancestor
153651689|NCT00014040|Protective Agents|protective agents|mesh-ancestor
153651690|NCT00034528|Prednisone|prednisone|mesh-list
153651691|NCT00034528|Fludarabine|fludarabine|mesh-list
153651692|NCT00034528|Busulfan|busulfan|mesh-list
153651693|NCT00034528|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153651694|NCT00034528|Glucocorticoids|glucocorticoids|mesh-ancestor
153651695|NCT00034528|Hormones|hormones|mesh-ancestor
153891432|NCT05983354|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153432457|NCT04801797|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153432458|NCT04801797|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153651704|NCT00034528|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153651705|NCT00034528|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153651707|NCT00000677|Antifungal Agents|antifungal agents|mesh-ancestor
153651726|NCT00034645|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153651727|NCT00034645|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
153651728|NCT00034645|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153651729|NCT00034645|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153651730|NCT00034645|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
153651731|NCT00034645|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153651732|NCT00034645|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153651733|NCT00034645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153651734|NCT00034645|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153651735|NCT00034645|Hormone Antagonists|hormone antagonists|mesh-ancestor
153651736|NCT00034645|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153651737|NCT00034645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153651738|NCT00034762|Risperidone|risperidone|mesh-list
153430997|NCT05440591|Metformin|metformin|mesh-list
153651785|NCT00014196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153651786|NCT00034840|Valsartan|valsartan|mesh-list
153651787|NCT00034840|Telmisartan|telmisartan|mesh-list
153651788|NCT00034840|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153651789|NCT00034840|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
153651790|NCT00034840|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
153651791|NCT00034840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153651792|NCT00000689|Leucovorin|leucovorin|mesh-list
153651793|NCT00000689|Cytarabine|cytarabine|mesh-list
153651794|NCT00000689|Dexamethasone|dexamethasone|mesh-list
153651795|NCT00000689|Cyclophosphamide|cyclophosphamide|mesh-list
153651796|NCT00000689|Doxorubicin|doxorubicin|mesh-list
153651797|NCT00000689|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
153651798|NCT00000689|Methotrexate|methotrexate|mesh-list
153891434|NCT05983354|Sensory System Agents|sensory system agents|mesh-ancestor
153891435|NCT05983354|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153432492|NCT04755283|Rivaroxaban|rivaroxaban|mesh-list
153889930|NCT01003639|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153889931|NCT01003639|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153651856|NCT00014235|Cyclosporine|cyclosporine|mesh-list
153814377|NCT00445497|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153432510|NCT04749043|Analgesics|analgesics|mesh-ancestor
153432511|NCT04749043|Sensory System Agents|sensory system agents|mesh-ancestor
153432512|NCT04749043|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153432513|NCT04740918|Trastuzumab|trastuzumab|mesh-list
153432514|NCT04740918|Atezolizumab|atezolizumab|mesh-list
153432515|NCT04740918|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
153432516|NCT04740918|Maytansine|maytansine|mesh-list
153432517|NCT04740918|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153432518|NCT04740918|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153432519|NCT04740918|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153432520|NCT04740918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153891475|NCT05954962|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153891476|NCT05954962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153891477|NCT05954962|Hormone Antagonists|hormone antagonists|mesh-ancestor
153891478|NCT05943691|Dexamethasone|dexamethasone|mesh-list
153891479|NCT05943691|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153891480|NCT05943691|Antiemetics|antiemetics|mesh-ancestor
153891481|NCT05943691|Autonomic Agents|autonomic agents|mesh-ancestor
153651861|NCT00014235|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153651862|NCT00014235|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153651863|NCT00014235|Antimetabolites|antimetabolites|mesh-ancestor
153651903|NCT00014274|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153651904|NCT00014274|Antimetabolites|antimetabolites|mesh-ancestor
153651905|NCT00014274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153651906|NCT00014274|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
153651907|NCT00014274|Abortifacient Agents|abortifacient agents|mesh-ancestor
153651908|NCT00014274|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153651909|NCT00014274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153651910|NCT00014274|Dermatologic Agents|dermatologic agents|mesh-ancestor
153651911|NCT00014274|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153651912|NCT00014274|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153651913|NCT00014274|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153651914|NCT00014274|Immunologic Factors|immunologic factors|mesh-ancestor
153651915|NCT00014274|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153651916|NCT00014274|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153651917|NCT00014274|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153651918|NCT00014274|Tubulin Modulators|tubulin modulators|mesh-ancestor
153651919|NCT00014274|Antimitotic Agents|antimitotic agents|mesh-ancestor
153651920|NCT00014274|Mitosis Modulators|mitosis modulators|mesh-ancestor
153651921|NCT00035035|Gemcitabine|gemcitabine|mesh-list
153651922|NCT00035035|Pemetrexed|pemetrexed|mesh-list
153651954|NCT00035074|Antimetabolites|antimetabolites|mesh-ancestor
153651955|NCT00035074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153651956|NCT00035074|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153651957|NCT00035074|Dermatologic Agents|dermatologic agents|mesh-ancestor
153651958|NCT00035074|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153651959|NCT00035074|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153651960|NCT00035074|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153891487|NCT05943691|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153891488|NCT05943691|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153891489|NCT05943691|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153891490|NCT05931575|Quinine|quinine|mesh-list
153891491|NCT05931575|Fasudil|fasudil|mesh-list
153891492|NCT05931575|1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine|1-(5-isoquinolinesulfonyl)-2-methylpiperazine|mesh-list
153891493|NCT05931575|Antimalarials|antimalarials|mesh-ancestor
153891494|NCT05931575|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153891495|NCT05931575|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153891496|NCT05931575|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153432521|NCT04740918|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153432522|NCT04740918|Tubulin Modulators|tubulin modulators|mesh-ancestor
153432523|NCT04740918|Antimitotic Agents|antimitotic agents|mesh-ancestor
153432524|NCT04740918|Mitosis Modulators|mitosis modulators|mesh-ancestor
153432525|NCT04740918|Immunotoxins|immunotoxins|mesh-ancestor
153432526|NCT04740918|Immunoconjugates|immunoconjugates|mesh-ancestor
153651975|NCT00000722|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153651977|NCT00035152|Paclitaxel|paclitaxel|mesh-list
153652007|NCT00014352|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153652008|NCT00014352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153652009|NCT00014352|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
153652010|NCT00014352|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153652011|NCT00014352|Alkylating Agents|alkylating agents|mesh-ancestor
153652012|NCT00014352|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153652013|NCT00035191|Galantamine|galantamine|mesh-list
153652014|NCT00035191|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
153652015|NCT00035191|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153652016|NCT00035191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153652017|NCT00035191|Cholinergic Agents|cholinergic agents|mesh-ancestor
153652018|NCT00035191|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153814378|NCT00445497|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153891498|NCT05931575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153891499|NCT05931575|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
153891500|NCT05931575|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153891501|NCT05931575|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153372961|NCT01335932|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153372992|NCT01734551|Autonomic Agents|autonomic agents|mesh-ancestor
153891502|NCT05931575|Analgesics|analgesics|mesh-ancestor
153891503|NCT05931575|Sensory System Agents|sensory system agents|mesh-ancestor
153891504|NCT05931575|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153891505|NCT05931575|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153652067|NCT00035425|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153652068|NCT00035425|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153652069|NCT00035425|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
153652070|NCT00035425|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153652071|NCT00035425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153652072|NCT00000752|Cefuroxime|cefuroxime|mesh-list
153652073|NCT00000752|Cefuroxime axetil|cefuroxime axetil|mesh-list
153652075|NCT00000752|Phenylpropanolamine|phenylpropanolamine|mesh-list
153652076|NCT00000752|Pseudoephedrine|pseudoephedrine|mesh-list
153652077|NCT00000752|Ephedrine|ephedrine|mesh-list
153652078|NCT00000752|Guaifenesin|guaifenesin|mesh-list
153652079|NCT00000752|Chlorpheniramine, phenylpropanolamine drug combination|chlorpheniramine, phenylpropanolamine drug combination|mesh-list
153652080|NCT00000752|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153652081|NCT00000752|Glucocorticoids|glucocorticoids|mesh-ancestor
153652082|NCT00000752|Hormones|hormones|mesh-ancestor
153652083|NCT00000752|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153652084|NCT00000752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153652085|NCT00000752|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153652086|NCT00000752|Respiratory System Agents|respiratory system agents|mesh-ancestor
153652087|NCT00000752|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153652088|NCT00000752|Autonomic Agents|autonomic agents|mesh-ancestor
153652089|NCT00000752|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153891522|NCT05890586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153891525|NCT05890586|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153891526|NCT05890586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153891527|NCT05890586|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153891528|NCT05890586|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
153891529|NCT05890586|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153891530|NCT05890586|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153891531|NCT05890586|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153891532|NCT05890586|Serotonin Agents|serotonin agents|mesh-ancestor
153891533|NCT05890586|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
153891534|NCT05890586|Antidepressive Agents|antidepressive agents|mesh-ancestor
153891535|NCT05890586|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
153891536|NCT05890586|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153891537|NCT05890586|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
153891538|NCT05866055|Midazolam|midazolam|mesh-list
153432568|NCT04538742|Antimitotic Agents|antimitotic agents|mesh-ancestor
153432569|NCT04538742|Mitosis Modulators|mitosis modulators|mesh-ancestor
153432570|NCT04538742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153432571|NCT04538742|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153432572|NCT04538742|Immunoconjugates|immunoconjugates|mesh-ancestor
153652125|NCT00014469|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153652126|NCT00014469|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153652127|NCT00014469|Immunologic Factors|immunologic factors|mesh-ancestor
153652128|NCT00014469|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153652129|NCT00014469|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153814379|NCT00445497|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153432574|NCT04538742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153432575|NCT04538742|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153432576|NCT04538742|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153652138|NCT00000755|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153652139|NCT00000755|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153652140|NCT00000755|Antiviral Agents|antiviral agents|mesh-ancestor
153652145|NCT00035581|Poly I-C|poly i-c|mesh-list
153652167|NCT02971306|Antiviral Agents|antiviral agents|mesh-ancestor
153652168|NCT02971306|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153652169|NCT02971306|Expectorants|expectorants|mesh-ancestor
153652170|NCT02971306|Respiratory System Agents|respiratory system agents|mesh-ancestor
153652171|NCT02971306|Free Radical Scavengers|free radical scavengers|mesh-ancestor
153652173|NCT02971306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153652174|NCT02971306|Protective Agents|protective agents|mesh-ancestor
153652175|NCT02971306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153652176|NCT02971306|Antidotes|antidotes|mesh-ancestor
153652177|NCT00000761|Interferons|interferons|mesh-list
153652178|NCT00000761|Interferon-gamma|interferon-gamma|mesh-list
153652179|NCT00000761|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153896282|NCT00997438|Vitamins|vitamins|mesh-ancestor
153652180|NCT00000761|Antiviral Agents|antiviral agents|mesh-ancestor
153652181|NCT00000761|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153652182|NCT00014586|Goserelin|goserelin|mesh-list
153652183|NCT00014586|Bicalutamide|bicalutamide|mesh-list
153652184|NCT00014586|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153652185|NCT00014586|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153891539|NCT05866055|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153891540|NCT05866055|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153891541|NCT05866055|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153891542|NCT05866055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153891543|NCT05866055|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153891544|NCT05866055|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153891545|NCT05866055|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153891546|NCT05866055|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153891547|NCT05866055|Anesthetics, General|anesthetics, general|mesh-ancestor
153891548|NCT05866055|Anesthetics|anesthetics|mesh-ancestor
153891549|NCT05866055|GABA Modulators|gaba modulators|mesh-ancestor
153891550|NCT05866055|GABA Agents|gaba agents|mesh-ancestor
153891551|NCT05866055|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153891552|NCT05866055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153891553|NCT05864625|Propofol|propofol|mesh-list
153652236|NCT00014625|N-(3-chloro-7-indolyl)-1,4-benzenedisulphonamide|n-(3-chloro-7-indolyl)-1,4-benzenedisulphonamide|mesh-list
153889940|NCT01003639|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153652281|NCT00036127|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153652282|NCT00036127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153889941|NCT01003639|Antitussive Agents|antitussive agents|mesh-ancestor
153889942|NCT01003639|Respiratory System Agents|respiratory system agents|mesh-ancestor
153652283|NCT00036127|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
153652284|NCT00036127|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
153652285|NCT00036127|Serotonin Agents|serotonin agents|mesh-ancestor
153652286|NCT00036127|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
153814380|NCT00445497|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153432611|NCT04095442|Sensory System Agents|sensory system agents|mesh-ancestor
153652339|NCT00000794|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153652341|NCT00036244|Secretin|secretin|mesh-list
153652342|NCT00036244|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153652343|NCT00036244|Hormones|hormones|mesh-ancestor
153652344|NCT00036244|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153652345|NCT00036244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153652346|NCT00036283|Celecoxib|celecoxib|mesh-list
153652347|NCT00036283|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153652348|NCT00036283|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153652349|NCT00036283|Analgesics|analgesics|mesh-ancestor
153652350|NCT00036283|Sensory System Agents|sensory system agents|mesh-ancestor
153652351|NCT00036283|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153652352|NCT00036283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153652353|NCT00036283|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153652354|NCT00036283|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153652355|NCT00036283|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
153652356|NCT00036283|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153652357|NCT00036283|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153652358|NCT00036283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153652359|NCT00391638|Interferons|interferons|mesh-list
153652387|NCT00036361|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
153652388|NCT00036361|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153652389|NCT00036361|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
153652390|NCT00036361|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
153891585|NCT05852769|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
153891586|NCT05852769|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153891587|NCT05852769|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
153891588|NCT05852769|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
153891589|NCT05852769|Purinergic Agents|purinergic agents|mesh-ancestor
153891590|NCT05852769|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
153891591|NCT05852769|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153891592|NCT05852769|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
153891593|NCT05852769|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153891594|NCT05852769|Respiratory System Agents|respiratory system agents|mesh-ancestor
153652396|NCT00036439|Dermatologic Agents|dermatologic agents|mesh-ancestor
153881757|NCT00682318|Ethanol|ethanol|mesh-list
153652453|NCT00000857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153652454|NCT00000857|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153652455|NCT00000857|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153652456|NCT00000857|Growth Substances|growth substances|mesh-ancestor
153814391|NCT00451776|Anesthetics, General|anesthetics, general|mesh-ancestor
153814392|NCT00451776|Anesthetics|anesthetics|mesh-ancestor
153814393|NCT00338936|Valsartan|valsartan|mesh-list
153814394|NCT00338936|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
153814395|NCT00338936|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153814396|NCT00338936|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
153489054|NCT02413320|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153652459|NCT00036868|Cyclophosphamide|cyclophosphamide|mesh-list
153652460|NCT00036868|Fluorouracil|fluorouracil|mesh-list
153652461|NCT00036868|Methotrexate|methotrexate|mesh-list
153652462|NCT00036868|Trastuzumab|trastuzumab|mesh-list
153652463|NCT00036868|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153652464|NCT00036868|Immunologic Factors|immunologic factors|mesh-ancestor
153652465|NCT00036868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153652466|NCT00036868|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153652467|NCT00036868|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153652514|NCT00037063|Protective Agents|protective agents|mesh-ancestor
153652515|NCT00037063|Vitamin B Complex|vitamin b complex|mesh-ancestor
153652516|NCT00037063|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
153652517|NCT00037063|Dermatologic Agents|dermatologic agents|mesh-ancestor
153652518|NCT00000869|Nevirapine|nevirapine|mesh-list
153652519|NCT00000869|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153652520|NCT00000869|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153652521|NCT00000869|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153652522|NCT00000869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153652523|NCT00000869|Antiviral Agents|antiviral agents|mesh-ancestor
153814400|NCT00338936|Natriuretic Agents|natriuretic agents|mesh-ancestor
153891608|NCT05852769|Analgesics|analgesics|mesh-ancestor
153891609|NCT05852769|Sensory System Agents|sensory system agents|mesh-ancestor
153891610|NCT05852769|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153891611|NCT05852769|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153891612|NCT05852769|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153891613|NCT05852769|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153891614|NCT05852769|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153891615|NCT05852769|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153652526|NCT00000869|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153652527|NCT00000869|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
153652528|NCT00000869|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
153652530|NCT00037102|Interferon-beta|interferon-beta|mesh-list
153652531|NCT00037102|Interferon beta-1a|interferon beta-1a|mesh-list
153652532|NCT00037102|Methotrexate|methotrexate|mesh-list
153652533|NCT00037102|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
153652534|NCT00037102|Abortifacient Agents|abortifacient agents|mesh-ancestor
153652535|NCT00037102|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153652536|NCT00037102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153652537|NCT00037102|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153652538|NCT00037102|Antimetabolites|antimetabolites|mesh-ancestor
153814401|NCT00338936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153432659|NCT03829722|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153432660|NCT03829722|Tubulin Modulators|tubulin modulators|mesh-ancestor
153432661|NCT03829722|Antimitotic Agents|antimitotic agents|mesh-ancestor
153432662|NCT03829722|Mitosis Modulators|mitosis modulators|mesh-ancestor
153432663|NCT03829722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153891626|NCT05773092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153891627|NCT05773092|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153652567|NCT00037180|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
153652568|NCT00037180|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153652569|NCT00037180|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153652570|NCT00037180|Antidotes|antidotes|mesh-ancestor
153652571|NCT00037180|Protective Agents|protective agents|mesh-ancestor
153652572|NCT00037180|Vitamin B Complex|vitamin b complex|mesh-ancestor
153652573|NCT00037180|Vitamins|vitamins|mesh-ancestor
153652574|NCT00037180|Micronutrients|micronutrients|mesh-ancestor
153652575|NCT00037180|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153652576|NCT00037180|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153652577|NCT00037180|Analgesics|analgesics|mesh-ancestor
153652578|NCT00037180|Sensory System Agents|sensory system agents|mesh-ancestor
153896377|NCT02886195|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153652579|NCT00037180|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153652615|NCT00037531|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153652616|NCT00037531|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153652617|NCT00037531|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153652618|NCT00037531|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153652619|NCT00037531|Antifungal Agents|antifungal agents|mesh-ancestor
153652620|NCT00037531|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153432675|NCT03757585|Inositol|inositol|mesh-list
153889949|NCT01003249|GABA Agonists|gaba agonists|mesh-ancestor
153889950|NCT01003249|GABA Agents|gaba agents|mesh-ancestor
153814403|NCT00338936|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153652632|NCT00000899|Cyclophosphamide|cyclophosphamide|mesh-list
153652633|NCT00000899|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153652634|NCT00000899|Immunologic Factors|immunologic factors|mesh-ancestor
153652635|NCT00000899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153652636|NCT00000899|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153652668|NCT00037609|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153652669|NCT00037609|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153652670|NCT00037609|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153652671|NCT00037648|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
153652672|NCT00037648|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153652674|NCT00037804|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
153652675|NCT00037804|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153652676|NCT00037804|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153652677|NCT00037804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153432684|NCT03757585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153432685|NCT03757585|Protective Agents|protective agents|mesh-ancestor
153432686|NCT03757585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153432687|NCT03757585|Antidotes|antidotes|mesh-ancestor
153432688|NCT03757585|Vitamin B Complex|vitamin b complex|mesh-ancestor
153432689|NCT03757585|Vitamins|vitamins|mesh-ancestor
153432690|NCT03757585|Micronutrients|micronutrients|mesh-ancestor
153652685|NCT00037882|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153652686|NCT00037882|Immunologic Factors|immunologic factors|mesh-ancestor
153652687|NCT00037882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153891644|NCT05707455|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153891645|NCT05707455|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153891646|NCT05615051|Hydrogen Peroxide|hydrogen peroxide|mesh-list
153891647|NCT05615051|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
153891648|NCT05615051|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153891650|NCT05613842|Bombesin|bombesin|mesh-list
153891651|NCT05613842|Trace Elements|trace elements|mesh-ancestor
153891652|NCT05613842|Micronutrients|micronutrients|mesh-ancestor
153652699|NCT00038077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153652700|NCT00038077|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
153652701|NCT00038077|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
153652702|NCT00038077|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
153652703|NCT00038077|Adrenergic Agents|adrenergic agents|mesh-ancestor
153652707|NCT00038116|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
153652708|NCT00038116|Sympathomimetics|sympathomimetics|mesh-ancestor
153652712|NCT00038116|Dopamine Agents|dopamine agents|mesh-ancestor
153652713|NCT00038116|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153652714|NCT00038116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153652715|NCT00038116|Protective Agents|protective agents|mesh-ancestor
153652716|NCT00038194|Docetaxel|docetaxel|mesh-list
153652717|NCT00038194|Imatinib Mesylate|imatinib mesylate|mesh-list
153652718|NCT00038194|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153652719|NCT00038194|Tubulin Modulators|tubulin modulators|mesh-ancestor
153891658|NCT05592951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153891659|NCT05592951|Sympathomimetics|sympathomimetics|mesh-ancestor
153891660|NCT05592951|Autonomic Agents|autonomic agents|mesh-ancestor
153891662|NCT05592951|Dopamine Agents|dopamine agents|mesh-ancestor
153652720|NCT00038194|Antimitotic Agents|antimitotic agents|mesh-ancestor
153652721|NCT00038194|Mitosis Modulators|mitosis modulators|mesh-ancestor
153652722|NCT00038194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153881762|NCT00626990|Temozolomide|temozolomide|mesh-list
153652723|NCT00038194|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153652724|NCT00038194|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153652725|NCT00038194|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153652726|NCT00038233|Thalidomide|thalidomide|mesh-list
153652727|NCT00038233|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153652728|NCT00038233|Immunologic Factors|immunologic factors|mesh-ancestor
153652729|NCT00038233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153652731|NCT00038233|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153652732|NCT00038233|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153652733|NCT00038233|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153652734|NCT00038233|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153652735|NCT00038233|Growth Substances|growth substances|mesh-ancestor
153652736|NCT00038233|Growth Inhibitors|growth inhibitors|mesh-ancestor
153652737|NCT00038233|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153652738|NCT00000926|Nonoxynol|nonoxynol|mesh-list
153652739|NCT00000926|Spermatocidal Agents|spermatocidal agents|mesh-ancestor
153652740|NCT00000926|Antispermatogenic Agents|antispermatogenic agents|mesh-ancestor
153652748|NCT00038272|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153652749|NCT00038272|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
153652750|NCT00038272|Antitubercular Agents|antitubercular agents|mesh-ancestor
153652751|NCT00038272|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153891665|NCT05592951|Adrenergic Agents|adrenergic agents|mesh-ancestor
153652753|NCT00038272|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153652754|NCT00038272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153652755|NCT00000941|Ritonavir|ritonavir|mesh-list
153652756|NCT00000941|Nelfinavir|nelfinavir|mesh-list
153652757|NCT00000941|Saquinavir|saquinavir|mesh-list
153652758|NCT00000941|Atorvastatin|atorvastatin|mesh-list
153652759|NCT00000941|Simvastatin|simvastatin|mesh-list
153652760|NCT00000941|Pravastatin|pravastatin|mesh-list
153652761|NCT00000941|Calcium|calcium|mesh-list
153652762|NCT00000941|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153652763|NCT00000941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153652780|NCT00014937|Ritonavir|ritonavir|mesh-list
153652806|NCT00014937|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
153652807|NCT00000959|Pyridoxine|pyridoxine|mesh-list
153652808|NCT00000959|Vitamin B 6|vitamin b 6|mesh-list
153652809|NCT00000959|Isoniazid|isoniazid|mesh-list
153652810|NCT00000959|Antitubercular Agents|antitubercular agents|mesh-ancestor
153652811|NCT00000959|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153652812|NCT00000959|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153814407|NCT00445575|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153891688|NCT05518929|Anesthetics, General|anesthetics, general|mesh-ancestor
153891689|NCT05518929|Anesthetics|anesthetics|mesh-ancestor
153432726|NCT03671018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153432727|NCT03671018|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153432728|NCT03671018|Immunoconjugates|immunoconjugates|mesh-ancestor
153432729|NCT03670966|Mycophenolic Acid|mycophenolic acid|mesh-list
153432730|NCT03670966|Cyclophosphamide|cyclophosphamide|mesh-list
153432731|NCT03670966|Fludarabine|fludarabine|mesh-list
153432732|NCT03670966|Fludarabine phosphate|fludarabine phosphate|mesh-list
153432733|NCT03670966|Tacrolimus|tacrolimus|mesh-list
153432734|NCT03670966|Antibodies|antibodies|mesh-list
153432735|NCT03670966|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
153432736|NCT03670966|Lenograstim|lenograstim|mesh-list
153896459|NCT00966355|Hormones|hormones|mesh-ancestor
153432737|NCT03670966|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153432738|NCT03670966|Immunologic Factors|immunologic factors|mesh-ancestor
153652813|NCT00000959|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
153652814|NCT00000959|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153652815|NCT00000959|Antimetabolites|antimetabolites|mesh-ancestor
153652816|NCT00000959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153652817|NCT00000959|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153652818|NCT00000959|Vitamin B Complex|vitamin b complex|mesh-ancestor
153652819|NCT00000959|Vitamins|vitamins|mesh-ancestor
153652822|NCT00000962|Nevirapine|nevirapine|mesh-list
153652864|NCT00000965|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153652865|NCT00000965|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153652866|NCT00000965|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153652867|NCT00000965|Antiviral Agents|antiviral agents|mesh-ancestor
153652868|NCT00000965|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153652869|NCT00000965|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153652870|NCT00000965|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153652871|NCT00015054|Methylphenidate|methylphenidate|mesh-list
153891694|NCT05477004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153891695|NCT05477004|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
153891696|NCT05477004|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153891697|NCT05477004|Anesthetics, General|anesthetics, general|mesh-ancestor
153891699|NCT05477004|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153652879|NCT00015054|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153652880|NCT00015132|Sertraline|sertraline|mesh-list
153652881|NCT00015132|Antidepressive Agents|antidepressive agents|mesh-ancestor
153652882|NCT00015132|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153652883|NCT00015132|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
153652884|NCT00015132|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153652885|NCT00015132|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153652886|NCT00015132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153652887|NCT00015132|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153652888|NCT00015132|Serotonin Agents|serotonin agents|mesh-ancestor
153652889|NCT00015132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153652890|NCT00000971|Clarithromycin|clarithromycin|mesh-list
153652891|NCT00000971|Zidovudine|zidovudine|mesh-list
153652892|NCT00000971|Didanosine|didanosine|mesh-list
153652893|NCT00000971|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153652894|NCT00000971|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153652895|NCT00000971|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
153652903|NCT00000971|Antiviral Agents|antiviral agents|mesh-ancestor
153652904|NCT00000971|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153652905|NCT00000971|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153652906|NCT00015171|Buprenorphine|buprenorphine|mesh-list
153652907|NCT00015171|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
153652908|NCT00015171|Naloxone|naloxone|mesh-list
153652909|NCT00015171|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153652910|NCT00015171|Narcotics|narcotics|mesh-ancestor
153891704|NCT05450029|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
153652911|NCT00015171|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153652912|NCT00015171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153652913|NCT00015171|Analgesics|analgesics|mesh-ancestor
153652967|NCT00015288|Buprenorphine|buprenorphine|mesh-list
153489939|NCT02486328|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153652968|NCT00015288|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
153652969|NCT00015288|Naloxone|naloxone|mesh-list
153652970|NCT00015288|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153652971|NCT00015288|Narcotics|narcotics|mesh-ancestor
153652972|NCT00015288|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153652973|NCT00015288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153652974|NCT00015288|Analgesics|analgesics|mesh-ancestor
153652975|NCT00015288|Sensory System Agents|sensory system agents|mesh-ancestor
153652976|NCT00015288|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153652977|NCT00015288|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
153422650|NCT03089983|Leprostatic Agents|leprostatic agents|mesh-ancestor
153422651|NCT03040973|Gefitinib|gefitinib|mesh-list
153422652|NCT03040973|Osimertinib|osimertinib|mesh-list
153422653|NCT03040973|Nazartinib|nazartinib|mesh-list
153422654|NCT03040973|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153437721|NCT00004310|Serotonin Agents|serotonin agents|mesh-ancestor
153653032|NCT05076877|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153814409|NCT00445575|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153432767|NCT03642626|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153653034|NCT00001004|Interferon-gamma|interferon-gamma|mesh-list
153653035|NCT00001004|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153653036|NCT00001004|Antiviral Agents|antiviral agents|mesh-ancestor
153653037|NCT00001004|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153653038|NCT00396604|Maleic acid|maleic acid|mesh-list
153653039|NCT00396604|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153653040|NCT00396604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153653091|NCT00001010|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153653092|NCT00001010|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153653094|NCT00001010|Antiviral Agents|antiviral agents|mesh-ancestor
153653095|NCT00001010|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153653096|NCT00001010|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153891705|NCT05450029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153891706|NCT05450029|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153891707|NCT05450029|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153891708|NCT05422001|Ketamine|ketamine|mesh-list
153891709|NCT05422001|Analgesics|analgesics|mesh-ancestor
153891710|NCT05422001|Sensory System Agents|sensory system agents|mesh-ancestor
153891713|NCT05422001|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
153653159|NCT00001040|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
153653160|NCT00001040|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153814410|NCT00445575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153432771|NCT03642626|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153432772|NCT03642626|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153432773|NCT03642626|Antimetabolites|antimetabolites|mesh-ancestor
153432774|NCT03642626|Antiviral Agents|antiviral agents|mesh-ancestor
153432775|NCT03642626|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153432776|NCT03642626|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153432779|NCT03641755|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
153432780|NCT03641755|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153432781|NCT03641755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153432782|NCT03641755|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153432783|NCT03624946|Immunoglobulins|immunoglobulins|mesh-list
153432784|NCT03624946|Antibodies|antibodies|mesh-list
153653171|NCT00015873|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153653173|NCT00015873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153653174|NCT00015873|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153653175|NCT00015873|Dermatologic Agents|dermatologic agents|mesh-ancestor
153653176|NCT00015873|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153653177|NCT00015873|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153653178|NCT00015873|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153653179|NCT00015873|Immunologic Factors|immunologic factors|mesh-ancestor
153653180|NCT00015873|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153653181|NCT00015873|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153653182|NCT00015873|Antiviral Agents|antiviral agents|mesh-ancestor
153653183|NCT00015873|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153653198|NCT00015912|Antiviral Agents|antiviral agents|mesh-ancestor
153891729|NCT05363631|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153891730|NCT05363631|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153891731|NCT05363631|Antioxidants|antioxidants|mesh-ancestor
153891732|NCT05363631|Protective Agents|protective agents|mesh-ancestor
153891733|NCT05363631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153891734|NCT05363631|Trace Elements|trace elements|mesh-ancestor
153891735|NCT05363631|Micronutrients|micronutrients|mesh-ancestor
153891736|NCT05357833|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
153891737|NCT05357833|Hematinics|hematinics|mesh-ancestor
153891738|NCT05357833|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
153891739|NCT05357833|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
153891740|NCT05295589|Paclitaxel|paclitaxel|mesh-list
153881775|NCT00107198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153881776|NCT00107198|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153891741|NCT05295589|Doxorubicin|doxorubicin|mesh-list
153891742|NCT05295589|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
153891743|NCT05295589|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
153891744|NCT05295589|Topotecan|topotecan|mesh-list
153891745|NCT05295589|Olaparib|olaparib|mesh-list
153891746|NCT05295589|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
153432785|NCT03624946|gamma-Globulins|gamma-globulins|mesh-list
153653201|NCT00015912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153653202|NCT00015912|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153653203|NCT00015912|Leprostatic Agents|leprostatic agents|mesh-ancestor
153653204|NCT00015912|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153653205|NCT00015912|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153653206|NCT00015912|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153653207|NCT00015912|Growth Substances|growth substances|mesh-ancestor
153653208|NCT00015912|Growth Inhibitors|growth inhibitors|mesh-ancestor
153653210|NCT03668431|Dabrafenib|dabrafenib|mesh-list
153653211|NCT03668431|Spartalizumab|spartalizumab|mesh-list
153653212|NCT03668431|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153653213|NCT03668431|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153653214|NCT03668431|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153653215|NCT03668431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153653216|NCT03668431|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153653217|NCT03668431|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153653218|NCT00001073|Isotretinoin|isotretinoin|mesh-list
153653219|NCT00001073|Dermatologic Agents|dermatologic agents|mesh-ancestor
153889965|NCT04294537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153653253|NCT00001076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153653254|NCT00001076|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153653255|NCT00001076|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153653256|NCT00001076|Antiviral Agents|antiviral agents|mesh-ancestor
153814411|NCT00445575|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153432802|NCT03588754|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153432803|NCT03588754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153432804|NCT03588754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153432805|NCT03588754|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153432806|NCT03588754|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153432807|NCT03588754|Vasodilator Agents|vasodilator agents|mesh-ancestor
153432808|NCT03582176|Ketotifen|ketotifen|mesh-list
153432809|NCT03582176|Antipruritics|antipruritics|mesh-ancestor
153653261|NCT00015990|Thalidomide|thalidomide|mesh-list
153653262|NCT00015990|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153653263|NCT00015990|Immunologic Factors|immunologic factors|mesh-ancestor
153653317|NCT00016107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153653318|NCT00016107|Growth Inhibitors|growth inhibitors|mesh-ancestor
153653319|NCT00016107|Immunologic Factors|immunologic factors|mesh-ancestor
153653320|NCT00016107|Tubulin Modulators|tubulin modulators|mesh-ancestor
153653321|NCT00016107|Antimitotic Agents|antimitotic agents|mesh-ancestor
153653322|NCT00016107|Mitosis Modulators|mitosis modulators|mesh-ancestor
153881783|NCT00107198|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153881784|NCT00107198|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153881785|NCT00107198|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153881786|NCT00107198|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153422658|NCT03040973|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153422659|NCT02951130|Milrinone|milrinone|mesh-list
153422660|NCT02951130|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
153422661|NCT02951130|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153653323|NCT00016107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153653324|NCT00016107|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153653325|NCT00016107|Alkylating Agents|alkylating agents|mesh-ancestor
153653326|NCT00016107|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153653327|NCT00001118|Enfuvirtide|enfuvirtide|mesh-list
153653381|NCT00016302|Doxorubicin|doxorubicin|mesh-list
153653382|NCT00016302|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
153653383|NCT00016302|Methotrexate|methotrexate|mesh-list
153653384|NCT00016302|Vincristine|vincristine|mesh-list
153653385|NCT00016302|Daunorubicin|daunorubicin|mesh-list
153653386|NCT00016302|Asparaginase|asparaginase|mesh-list
153653387|NCT00016302|Mercaptopurine|mercaptopurine|mesh-list
153653388|NCT00016302|Pegaspargase|pegaspargase|mesh-list
153653389|NCT00016302|Thioguanine|thioguanine|mesh-list
153653390|NCT00016302|Levoleucovorin|levoleucovorin|mesh-list
153653391|NCT00016302|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153653392|NCT00016302|Immunologic Factors|immunologic factors|mesh-ancestor
153653393|NCT00016302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153653394|NCT00016302|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153653395|NCT00016302|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153653396|NCT00016302|Alkylating Agents|alkylating agents|mesh-ancestor
153653397|NCT00016302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153653398|NCT00016302|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153653399|NCT00016302|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153653400|NCT00016302|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153653401|NCT00016302|Antiemetics|antiemetics|mesh-ancestor
153653406|NCT00016302|Hormones|hormones|mesh-ancestor
153653438|NCT00016341|Paclitaxel|paclitaxel|mesh-list
153653439|NCT00016341|Doxorubicin|doxorubicin|mesh-list
153653440|NCT00016341|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
153653441|NCT00016341|Megestrol|megestrol|mesh-list
153653442|NCT00016341|Megestrol Acetate|megestrol acetate|mesh-list
153891755|NCT05295589|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153891756|NCT05295589|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153891758|NCT05294965|Fenoterol|fenoterol|mesh-list
153891759|NCT05294965|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153891760|NCT05294965|Autonomic Agents|autonomic agents|mesh-ancestor
153653503|NCT00001202|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
153653505|NCT00001202|Natriuretic Agents|natriuretic agents|mesh-ancestor
153653506|NCT00001202|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153653507|NCT00001202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153653508|NCT00001202|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153653509|NCT00001202|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153653511|NCT00016419|Cyclosporins|cyclosporins|mesh-list
153653512|NCT00016419|Antilymphocyte Serum|antilymphocyte serum|mesh-list
153653513|NCT00016419|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153653514|NCT00016419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153653515|NCT00016419|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153653516|NCT00016419|Immunologic Factors|immunologic factors|mesh-ancestor
153653562|NCT00016887|Interferons|interferons|mesh-list
153653563|NCT00016887|Cytarabine|cytarabine|mesh-list
153653564|NCT00016887|Interferon-alpha|interferon-alpha|mesh-list
153653565|NCT00016887|Dexamethasone|dexamethasone|mesh-list
153653566|NCT00016887|Cyclophosphamide|cyclophosphamide|mesh-list
153653567|NCT00016887|Melphalan|melphalan|mesh-list
153891779|NCT05247320|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
153891780|NCT05247320|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
153891781|NCT05247320|Adrenergic Agents|adrenergic agents|mesh-ancestor
153891782|NCT05247320|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153891783|NCT05247320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153891784|NCT05247320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153653568|NCT00016887|Carmustine|carmustine|mesh-list
153653569|NCT00016887|Etoposide|etoposide|mesh-list
153653570|NCT00016887|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153653571|NCT00016887|Immunologic Factors|immunologic factors|mesh-ancestor
153653572|NCT00016887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153653573|NCT00016887|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153653574|NCT00016887|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153653575|NCT00016887|Alkylating Agents|alkylating agents|mesh-ancestor
153653576|NCT00016887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153653580|NCT00016887|Antiemetics|antiemetics|mesh-ancestor
153653624|NCT00016926|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153653625|NCT00016926|Antimetabolites|antimetabolites|mesh-ancestor
153546877|NCT05889624|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153891785|NCT05247320|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153653633|NCT00038545|Antimitotic Agents|antimitotic agents|mesh-ancestor
153653634|NCT00038545|Mitosis Modulators|mitosis modulators|mesh-ancestor
153653635|NCT00038545|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153653636|NCT00038545|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
153653637|NCT00038545|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153653638|NCT00038545|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153653639|NCT00038584|Lonafarnib|lonafarnib|mesh-list
153653640|NCT00038584|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153653642|NCT00038623|Rituximab|rituximab|mesh-list
153653680|NCT00038974|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153653681|NCT00039013|Exenatide|exenatide|mesh-list
153653682|NCT00039013|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
153653683|NCT00039013|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153653684|NCT00039013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153653685|NCT00039013|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
153653686|NCT00039013|Incretins|incretins|mesh-ancestor
153653687|NCT00039013|Hormones|hormones|mesh-ancestor
153668023|NCT00030576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153653688|NCT00039013|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153653689|NCT00039052|Interleukin-4|interleukin-4|mesh-list
153653690|NCT00039052|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153653691|NCT00039052|Immunologic Factors|immunologic factors|mesh-ancestor
153653692|NCT00039052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153653693|NCT00039052|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153653694|NCT00039052|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153653695|NCT00017082|Oxaliplatin|oxaliplatin|mesh-list
153653696|NCT00017082|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153653697|NCT00039091|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
153653698|NCT00039091|Ipilimumab|ipilimumab|mesh-list
153653699|NCT00039091|Antibodies|antibodies|mesh-list
153653700|NCT00039091|Immunoglobulins|immunoglobulins|mesh-list
153653701|NCT00039091|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
153653702|NCT00039091|Immunologic Factors|immunologic factors|mesh-ancestor
153653703|NCT00039091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153653704|NCT00039091|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153432844|NCT03525925|Ibrutinib|ibrutinib|mesh-list
153432845|NCT03525925|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153432846|NCT03525925|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153432847|NCT03525925|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153432848|NCT03525925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153653732|NCT00039208|Antimetabolites|antimetabolites|mesh-ancestor
153653733|NCT00039208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153653734|NCT00039208|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153653735|NCT00039208|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153653736|NCT00039208|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153653737|NCT00039208|Immunologic Factors|immunologic factors|mesh-ancestor
153653738|NCT00039208|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
153653739|NCT00039208|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153653740|NCT00039208|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153653741|NCT00039208|Antidotes|antidotes|mesh-ancestor
153653742|NCT00039208|Protective Agents|protective agents|mesh-ancestor
153653743|NCT00039208|Vitamin B Complex|vitamin b complex|mesh-ancestor
153653744|NCT00039208|Vitamins|vitamins|mesh-ancestor
153653745|NCT00039208|Micronutrients|micronutrients|mesh-ancestor
153653746|NCT00017121|Sargramostim|sargramostim|mesh-list
153653793|NCT00039481|Mitosis Modulators|mitosis modulators|mesh-ancestor
153653794|NCT00001322|Leuprolide|leuprolide|mesh-list
153653795|NCT00001322|Estradiol|estradiol|mesh-list
153653796|NCT00001322|Progesterone|progesterone|mesh-list
153653797|NCT00001322|Estrogens|estrogens|mesh-ancestor
153653798|NCT00001322|Hormones|hormones|mesh-ancestor
153653799|NCT00001322|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153653800|NCT00001322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153653801|NCT00001322|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153653802|NCT00001322|Progestins|progestins|mesh-ancestor
153653803|NCT00001322|Fertility Agents, Female|fertility agents, female|mesh-ancestor
153653859|NCT00039988|Respiratory System Agents|respiratory system agents|mesh-ancestor
153653860|NCT00039988|Tocolytic Agents|tocolytic agents|mesh-ancestor
153891836|NCT05096195|Vitamin D|vitamin d|mesh-list
153653862|NCT00039988|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
153653863|NCT00039988|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
153653864|NCT00039988|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153653865|NCT00039988|Adrenergic Agents|adrenergic agents|mesh-ancestor
153653866|NCT00039988|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153653867|NCT00039988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153653868|NCT00039988|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153653869|NCT00039988|Immunologic Factors|immunologic factors|mesh-ancestor
153653870|NCT00039988|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153814413|NCT00339014|Bupropion|bupropion|mesh-list
153653876|NCT00040027|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153653877|NCT00040027|Immunologic Factors|immunologic factors|mesh-ancestor
153653878|NCT00040027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153653879|NCT00040027|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153653880|NCT00001343|Oxandrolone|oxandrolone|mesh-list
153653881|NCT00001343|Androgens|androgens|mesh-ancestor
153490846|NCT02653872|Verapamil|verapamil|mesh-list
153814414|NCT00339014|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
153814415|NCT00339014|Antidepressive Agents|antidepressive agents|mesh-ancestor
153653883|NCT00001343|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153653885|NCT00001343|Anabolic Agents|anabolic agents|mesh-ancestor
153653886|NCT00040066|Cocaine|cocaine|mesh-list
153653887|NCT00040066|Anesthetics, Local|anesthetics, local|mesh-ancestor
153653888|NCT00040066|Anesthetics|anesthetics|mesh-ancestor
153653889|NCT00040066|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153653890|NCT00040066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153653891|NCT00040066|Sensory System Agents|sensory system agents|mesh-ancestor
153653892|NCT00040066|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153653893|NCT00040066|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
153653894|NCT00040066|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
153653895|NCT00040066|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153653896|NCT00040066|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153653897|NCT00040066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153653898|NCT00040066|Dopamine Agents|dopamine agents|mesh-ancestor
153653899|NCT00040066|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153653900|NCT00040105|Imatinib Mesylate|imatinib mesylate|mesh-list
153653901|NCT00040105|Tipifarnib|tipifarnib|mesh-list
153814418|NCT00339014|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153432922|NCT03418038|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153432923|NCT03418038|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153432924|NCT03418038|Glucocorticoids|glucocorticoids|mesh-ancestor
153432925|NCT03418038|Hormones|hormones|mesh-ancestor
153653903|NCT00040105|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153653907|NCT00040144|Dexelvucitabine|dexelvucitabine|mesh-list
153653961|NCT00040495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153653962|NCT00040651|Cyclophosphamide|cyclophosphamide|mesh-list
153653963|NCT00040651|Fludarabine|fludarabine|mesh-list
153653964|NCT00040651|Thymoglobulin|thymoglobulin|mesh-list
153653965|NCT00040651|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153653966|NCT00040651|Immunologic Factors|immunologic factors|mesh-ancestor
153653967|NCT00040651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153653968|NCT00040651|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153653969|NCT00040651|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153653970|NCT00040651|Alkylating Agents|alkylating agents|mesh-ancestor
153653971|NCT00040651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153653972|NCT00040651|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153653973|NCT00040651|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153654025|NCT00040885|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153654026|NCT00040885|Tubulin Modulators|tubulin modulators|mesh-ancestor
153654027|NCT00040885|Antimitotic Agents|antimitotic agents|mesh-ancestor
153654028|NCT00040885|Mitosis Modulators|mitosis modulators|mesh-ancestor
153654029|NCT00040885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153654030|NCT00040885|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
153654031|NCT00040885|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153814421|NCT00339014|Dopamine Agents|dopamine agents|mesh-ancestor
153891855|NCT05044468|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153891856|NCT05044468|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
153891857|NCT05044468|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153654032|NCT00040885|Dermatologic Agents|dermatologic agents|mesh-ancestor
153654088|NCT00017355|Lenograstim|lenograstim|mesh-list
153654089|NCT00017355|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153881787|NCT00107198|Glucocorticoids|glucocorticoids|mesh-ancestor
153881788|NCT00107198|Hormones|hormones|mesh-ancestor
153881790|NCT00107198|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153654090|NCT00017355|Immunologic Factors|immunologic factors|mesh-ancestor
153654091|NCT00017355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153654093|NCT00397072|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153654094|NCT00017394|Bevacizumab|bevacizumab|mesh-list
153654095|NCT00017394|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
153654096|NCT00017394|Vinorelbine|vinorelbine|mesh-list
153654097|NCT00017394|Antibodies|antibodies|mesh-list
153654098|NCT00017394|Immunoglobulins|immunoglobulins|mesh-list
153654099|NCT00017394|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
153654104|NCT00017394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153654105|NCT00017394|Growth Inhibitors|growth inhibitors|mesh-ancestor
153654146|NCT00041704|Antifungal Agents|antifungal agents|mesh-ancestor
153654147|NCT00041704|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153654148|NCT00017472|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
153654149|NCT00017472|Antibodies|antibodies|mesh-list
153654150|NCT00017472|Immunoglobulins|immunoglobulins|mesh-list
153654151|NCT00017472|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
153654152|NCT00017472|Immunologic Factors|immunologic factors|mesh-ancestor
153654153|NCT00017472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153654154|NCT00017472|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153654155|NCT00041782|Dalteparin|dalteparin|mesh-list
153654156|NCT00041782|Tinzaparin|tinzaparin|mesh-list
153654157|NCT00041782|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
153654158|NCT00041782|Anticoagulants|anticoagulants|mesh-ancestor
153654159|NCT00041782|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153654160|NCT00041782|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153654161|NCT00041782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153654205|NCT00042172|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153654206|NCT00042172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153654207|NCT00042172|Cholinergic Agents|cholinergic agents|mesh-ancestor
153654208|NCT00042172|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153654209|NCT00042172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153654210|NCT00042172|Nootropic Agents|nootropic agents|mesh-ancestor
153654211|NCT00017589|Gemtuzumab|gemtuzumab|mesh-list
153654273|NCT00017628|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153654274|NCT00017628|Immunologic Factors|immunologic factors|mesh-ancestor
153654275|NCT00017628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153654276|NCT00017628|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153654277|NCT00017628|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153654278|NCT00017628|Alkylating Agents|alkylating agents|mesh-ancestor
153654279|NCT00017628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153654280|NCT00017628|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153654281|NCT00017628|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153654282|NCT00017628|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153654283|NCT00017628|Antiemetics|antiemetics|mesh-ancestor
153654284|NCT00017628|Autonomic Agents|autonomic agents|mesh-ancestor
153654333|NCT00042718|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
153654334|NCT00042718|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153654335|NCT00042718|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
153654336|NCT00042796|Decitabine|decitabine|mesh-list
153654337|NCT00042796|Azacitidine|azacitidine|mesh-list
153654338|NCT00042796|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153654339|NCT00042796|Antimetabolites|antimetabolites|mesh-ancestor
153654340|NCT00042796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153654341|NCT00042796|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153654342|NCT00042796|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153654343|NCT00042835|Paclitaxel|paclitaxel|mesh-list
153654344|NCT00042835|Etoposide|etoposide|mesh-list
153654345|NCT00042835|Docetaxel|docetaxel|mesh-list
153814423|NCT00339014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153654346|NCT00042835|Carboplatin|carboplatin|mesh-list
153654363|NCT00042874|Leucovorin|leucovorin|mesh-list
153654397|NCT00043069|Cholecalciferol|cholecalciferol|mesh-list
153654398|NCT00043069|Risedronic Acid|risedronic acid|mesh-list
153654399|NCT00043069|Calcium Carbonate|calcium carbonate|mesh-list
153654400|NCT00043069|Estrogens|estrogens|mesh-list
153654401|NCT00043069|Estrogen Antagonists|estrogen antagonists|mesh-list
153654402|NCT00043069|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-list
153654403|NCT00043069|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153654404|NCT00043069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153654405|NCT00043069|Vitamins|vitamins|mesh-ancestor
153654406|NCT00043069|Micronutrients|micronutrients|mesh-ancestor
153654407|NCT00043069|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153654408|NCT00043069|Hormones|hormones|mesh-ancestor
153654410|NCT00043069|Antacids|antacids|mesh-ancestor
153654458|NCT00043264|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
153654459|NCT00043303|Interferons|interferons|mesh-list
153654460|NCT00043303|Interferon-gamma|interferon-gamma|mesh-list
153654461|NCT00043303|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153654462|NCT00043303|Antiviral Agents|antiviral agents|mesh-ancestor
153654463|NCT00043303|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153654464|NCT00017940|Mitogens|mitogens|mesh-list
153654465|NCT00017940|Mitosis Modulators|mitosis modulators|mesh-ancestor
153654466|NCT00017940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153654467|NCT02970604|Aspirin|aspirin|mesh-list
153654468|NCT02970604|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153654469|NCT02970604|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153654470|NCT02970604|Analgesics|analgesics|mesh-ancestor
153654471|NCT02970604|Sensory System Agents|sensory system agents|mesh-ancestor
153654472|NCT02970604|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153654473|NCT02970604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153654516|NCT00043576|Docetaxel|docetaxel|mesh-list
153654517|NCT00043576|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153654518|NCT00043576|Tubulin Modulators|tubulin modulators|mesh-ancestor
153654519|NCT00043576|Antimitotic Agents|antimitotic agents|mesh-ancestor
153654520|NCT00043576|Mitosis Modulators|mitosis modulators|mesh-ancestor
153891913|NCT04964505|Azacitidine|azacitidine|mesh-list
153654521|NCT00043576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153654522|NCT00043576|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153654523|NCT00043576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153654524|NCT00043576|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
153654525|NCT00043576|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153654526|NCT00043576|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
153654527|NCT00043576|Vitamins|vitamins|mesh-ancestor
153654528|NCT00043576|Micronutrients|micronutrients|mesh-ancestor
153654529|NCT00043576|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153654530|NCT00043654|Mifepristone|mifepristone|mesh-list
153432993|NCT03271372|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153432994|NCT03271372|Immunologic Factors|immunologic factors|mesh-ancestor
153432995|NCT03271372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153432996|NCT03253289|Meclizine|meclizine|mesh-list
153432997|NCT03253289|Antiemetics|antiemetics|mesh-ancestor
153654531|NCT00043654|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
153654533|NCT00043654|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153654534|NCT00043654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153654535|NCT00043654|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
153654536|NCT00043654|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
153654537|NCT00043654|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
153654538|NCT00043654|Contraceptive Agents|contraceptive agents|mesh-ancestor
153654539|NCT00043654|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
153654540|NCT00043654|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
153654541|NCT00043654|Hormone Antagonists|hormone antagonists|mesh-ancestor
153654542|NCT00043654|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153654543|NCT00043654|Luteolytic Agents|luteolytic agents|mesh-ancestor
153654544|NCT00043654|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
153654546|NCT00043771|Tolvaptan|tolvaptan|mesh-list
153654557|NCT00043810|Antimetabolites|antimetabolites|mesh-ancestor
153654558|NCT00043810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153654559|NCT00043810|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153654560|NCT00043810|Immunologic Factors|immunologic factors|mesh-ancestor
153654561|NCT00043810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153654562|NCT00043810|Alkylating Agents|alkylating agents|mesh-ancestor
153654563|NCT00043810|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153814438|NCT00420953|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153881802|NCT01601106|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153881803|NCT01601184|Temozolomide|temozolomide|mesh-list
153891922|NCT04873895|Antimalarials|antimalarials|mesh-ancestor
153891923|NCT04873895|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153891924|NCT04873895|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153891925|NCT04873895|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153891926|NCT04873895|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153891927|NCT04873895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153891928|NCT04873895|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153891929|NCT04873895|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153891930|NCT04873895|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153891931|NCT04869436|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
153891937|NCT04615403|Travoprost|travoprost|mesh-list
153654565|NCT00043810|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153654566|NCT00043810|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
153654567|NCT00043810|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153654620|NCT00043927|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153654621|NCT00043927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153654622|NCT00043927|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
153654623|NCT00043966|Ritonavir|ritonavir|mesh-list
153654624|NCT00043966|Lopinavir|lopinavir|mesh-list
153654625|NCT00043966|Tenofovir|tenofovir|mesh-list
153654626|NCT00043966|Emtricitabine|emtricitabine|mesh-list
153654627|NCT00043966|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
153654628|NCT00043966|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
153654629|NCT00043966|Protease Inhibitors|protease inhibitors|mesh-ancestor
153654630|NCT00043966|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153654683|NCT00044473|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153654684|NCT00044473|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153654685|NCT00044473|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153654686|NCT00044473|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153654687|NCT00044473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153654688|NCT00044473|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153654689|NCT00044473|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
153654690|NCT00044473|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153654692|NCT00044551|IDN 5109|idn 5109|mesh-list
153654693|NCT00044551|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153654694|NCT00018135|Aluminum Hydroxide|aluminum hydroxide|mesh-list
153654695|NCT00018135|Calcium|calcium|mesh-list
153654696|NCT00018135|Sevelamer|sevelamer|mesh-list
153654697|NCT00018135|Calcium acetate|calcium acetate|mesh-list
153654698|NCT00018135|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153654699|NCT00018135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153654700|NCT00018135|Chelating Agents|chelating agents|mesh-ancestor
153654701|NCT00018135|Sequestering Agents|sequestering agents|mesh-ancestor
153654702|NCT00018135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153654703|NCT00018135|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153654704|NCT00018135|Immunologic Factors|immunologic factors|mesh-ancestor
153654705|NCT00018135|Antacids|antacids|mesh-ancestor
153654706|NCT00018135|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153654707|NCT00397384|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
153654708|NCT00397384|Cetuximab|cetuximab|mesh-list
153654709|NCT00397384|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
153654710|NCT00397384|Antibodies|antibodies|mesh-list
153654711|NCT00397384|Immunoglobulins|immunoglobulins|mesh-list
153654712|NCT00397384|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
153654729|NCT00397501|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
153654730|NCT00397501|Abortifacient Agents|abortifacient agents|mesh-ancestor
153891947|NCT04577014|Mitosis Modulators|mitosis modulators|mesh-ancestor
153654732|NCT00397501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153654733|NCT00397501|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153654734|NCT00397501|Antimetabolites|antimetabolites|mesh-ancestor
153654735|NCT00397501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153654736|NCT00397501|Dermatologic Agents|dermatologic agents|mesh-ancestor
153654737|NCT00397501|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153654738|NCT00397501|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153654739|NCT00397501|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153654740|NCT00397501|Immunologic Factors|immunologic factors|mesh-ancestor
153654741|NCT00397501|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153881811|NCT01643759|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153654742|NCT00397501|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153654743|NCT00397501|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153654744|NCT00397501|Antidotes|antidotes|mesh-ancestor
153654785|NCT00044707|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153814439|NCT00420953|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153654787|NCT00044746|Tazobactam|tazobactam|mesh-list
153654788|NCT00044746|Piperacillin|piperacillin|mesh-list
153654789|NCT00044746|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
153654790|NCT00044746|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153654791|NCT00044746|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153654792|NCT00044746|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
153654793|NCT00044746|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153654794|NCT00044746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153654795|NCT00044785|Leucovorin|leucovorin|mesh-list
153654796|NCT00044785|Fluorouracil|fluorouracil|mesh-list
153654797|NCT00044785|Irinotecan|irinotecan|mesh-list
153654798|NCT00044785|Antimetabolites|antimetabolites|mesh-ancestor
153654847|NCT00045136|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153654848|NCT00045136|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153654849|NCT00045136|Immunologic Factors|immunologic factors|mesh-ancestor
153654850|NCT00045136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153654851|NCT00001649|Valacyclovir|valacyclovir|mesh-list
153654852|NCT00001649|Antiviral Agents|antiviral agents|mesh-ancestor
153654853|NCT00001649|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153654855|NCT00018291|Risperidone|risperidone|mesh-list
153654856|NCT00018291|Analgesics|analgesics|mesh-ancestor
153654857|NCT00018291|Sensory System Agents|sensory system agents|mesh-ancestor
153654858|NCT00018291|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153654859|NCT00018291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153654860|NCT00018291|Anticonvulsants|anticonvulsants|mesh-ancestor
153654861|NCT00018291|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153654862|NCT00018291|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153654863|NCT00018291|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153654864|NCT00018291|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153654865|NCT00018291|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
153654866|NCT00018291|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
153654904|NCT02970682|Tamoxifen|tamoxifen|mesh-list
153654905|NCT02970682|Fulvestrant|fulvestrant|mesh-list
153654906|NCT02970682|Aromatase Inhibitors|aromatase inhibitors|mesh-list
153654907|NCT02970682|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
153654908|NCT02970682|Hormone Antagonists|hormone antagonists|mesh-ancestor
153654909|NCT02970682|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153654910|NCT02970682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153654911|NCT02970682|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153654912|NCT02970682|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153654913|NCT02970682|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
153654914|NCT02970682|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
153654915|NCT02970682|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153654916|NCT02970682|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
153654917|NCT02970682|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153654918|NCT02970682|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153654919|NCT02970682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153654920|NCT00045448|Docetaxel|docetaxel|mesh-list
153654921|NCT00045448|Alvocidib|alvocidib|mesh-list
153654959|NCT00045721|O(6)-benzylguanine|o(6)-benzylguanine|mesh-list
153654960|NCT00045721|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153654961|NCT00045721|Alkylating Agents|alkylating agents|mesh-ancestor
153654962|NCT00045721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153654963|NCT00045721|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153654964|NCT00045721|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153654965|NCT04731766|Listerine|listerine|mesh-list
153654966|NCT04731766|Fluorides|fluorides|mesh-list
153655028|NCT00045799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153655029|NCT00045799|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
153655030|NCT00045799|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153655031|NCT04394130|Ropivacaine|ropivacaine|mesh-list
153655032|NCT04394130|Anesthetics, Local|anesthetics, local|mesh-ancestor
153655033|NCT04394130|Anesthetics|anesthetics|mesh-ancestor
153655034|NCT04394130|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153655035|NCT04394130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153655037|NCT04394130|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153655038|NCT00045877|Aldesleukin|aldesleukin|mesh-list
153655039|NCT00045877|Rituximab|rituximab|mesh-list
153655040|NCT00045877|Interleukin-2|interleukin-2|mesh-list
153655041|NCT00045877|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153655042|NCT00045877|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153655043|NCT00045877|Immunologic Factors|immunologic factors|mesh-ancestor
153655044|NCT00045877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153655045|NCT00045877|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153655046|NCT00045877|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153655047|NCT00045877|Analgesics|analgesics|mesh-ancestor
153655048|NCT00045877|Sensory System Agents|sensory system agents|mesh-ancestor
153655049|NCT00045877|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153655050|NCT00045877|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153655051|NCT00045877|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153655052|NCT00045877|Antiviral Agents|antiviral agents|mesh-ancestor
153655053|NCT00045877|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153655054|NCT00045916|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
153655055|NCT00045916|Nortriptyline|nortriptyline|mesh-list
153655056|NCT00045916|Antidepressive Agents|antidepressive agents|mesh-ancestor
153655057|NCT00045916|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153655063|NCT00045916|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153655069|NCT04380207|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
153655070|NCT04380207|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153655071|NCT04380207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153655072|NCT04380207|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153655073|NCT04380207|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153655074|NCT00045955|Fexofenadine|fexofenadine|mesh-list
153655075|NCT00045955|Montelukast|montelukast|mesh-list
153655076|NCT00045955|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153655077|NCT00045955|Respiratory System Agents|respiratory system agents|mesh-ancestor
153655078|NCT00045955|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
153655079|NCT00045955|Hormone Antagonists|hormone antagonists|mesh-ancestor
153492087|NCT04677049|Niacin|niacin|mesh-list
153655129|NCT00001724|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153655130|NCT00001724|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153655131|NCT00001724|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153655132|NCT00001724|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153655133|NCT00001724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153655134|NCT00046150|Insulin glulisine|insulin glulisine|mesh-list
153655135|NCT00046150|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153655136|NCT00046150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153655137|NCT00046267|Niacin|niacin|mesh-list
153655138|NCT00046267|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153655139|NCT00046267|Antimetabolites|antimetabolites|mesh-ancestor
153655140|NCT00046267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153655141|NCT00046267|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153655142|NCT00046267|Vasodilator Agents|vasodilator agents|mesh-ancestor
153655143|NCT00046267|Vitamin B Complex|vitamin b complex|mesh-ancestor
153655144|NCT00046267|Vitamins|vitamins|mesh-ancestor
153655145|NCT00046267|Micronutrients|micronutrients|mesh-ancestor
153655146|NCT00046267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153655147|NCT00046306|Antioxidants|antioxidants|mesh-list
153655151|NCT00046345|Atazanavir Sulfate|atazanavir sulfate|mesh-list
153655187|NCT00397735|Respiratory System Agents|respiratory system agents|mesh-ancestor
153655188|NCT00397735|Free Radical Scavengers|free radical scavengers|mesh-ancestor
153655189|NCT00397735|Antioxidants|antioxidants|mesh-ancestor
153655190|NCT00397735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153655191|NCT00397735|Protective Agents|protective agents|mesh-ancestor
153655192|NCT00397735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153655193|NCT00397735|Antidotes|antidotes|mesh-ancestor
153655255|NCT00046501|Isophane Insulin, Human|isophane insulin, human|mesh-list
153655256|NCT00046501|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153655257|NCT00046501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153655258|NCT00046735|Lenalidomide|lenalidomide|mesh-list
153655259|NCT00046735|Immunologic Factors|immunologic factors|mesh-ancestor
153655260|NCT00046735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153655261|NCT00046735|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153655262|NCT00046735|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153655263|NCT00046735|Growth Substances|growth substances|mesh-ancestor
153655264|NCT00046735|Growth Inhibitors|growth inhibitors|mesh-ancestor
153655265|NCT00046735|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153655266|NCT00001784|Mexiletine|mexiletine|mesh-list
153655267|NCT00001784|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153655268|NCT00001784|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
153655269|NCT00001784|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153655270|NCT00001784|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153655272|NCT00046813|Nicotine|nicotine|mesh-list
153655314|NCT04733781|Sensory System Agents|sensory system agents|mesh-ancestor
153655315|NCT04733781|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153655316|NCT04733781|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153655317|NCT04733781|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
153655318|NCT04733781|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153655319|NCT04733781|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153814442|NCT00420953|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
153892041|NCT04191421|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153655321|NCT04733781|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153655322|NCT04733781|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153655323|NCT04733781|Adrenergic Agents|adrenergic agents|mesh-ancestor
153655324|NCT04733781|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153655325|NCT04733781|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
153655326|NCT04733781|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153655327|NCT04733781|Autonomic Agents|autonomic agents|mesh-ancestor
153655328|NCT04733781|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153655329|NCT04733781|Respiratory System Agents|respiratory system agents|mesh-ancestor
153655330|NCT04733781|Mydriatics|mydriatics|mesh-ancestor
153655331|NCT04733781|Sympathomimetics|sympathomimetics|mesh-ancestor
153655332|NCT04733781|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
153655333|NCT00047164|Ipilimumab|ipilimumab|mesh-list
153655334|NCT00047164|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153655335|NCT00047164|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153655336|NCT00047164|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153655337|NCT00047164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153655338|NCT00047203|Alvocidib|alvocidib|mesh-list
153655339|NCT00047203|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153655346|NCT04163874|Pramlintide|pramlintide|mesh-list
153655357|NCT00047242|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153655358|NCT00047242|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153655359|NCT00047281|Thalidomide|thalidomide|mesh-list
153655360|NCT00047281|Celecoxib|celecoxib|mesh-list
153655361|NCT00047281|Cyclophosphamide|cyclophosphamide|mesh-list
153655362|NCT00047281|Etoposide|etoposide|mesh-list
153655363|NCT00047281|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153655364|NCT00047281|Immunologic Factors|immunologic factors|mesh-ancestor
153655365|NCT00047281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153655366|NCT00047281|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153655367|NCT00047281|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153655368|NCT00047281|Alkylating Agents|alkylating agents|mesh-ancestor
153655378|NCT00047281|Analgesics|analgesics|mesh-ancestor
153655417|NCT00047671|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
153655418|NCT00047671|Antidepressive Agents|antidepressive agents|mesh-ancestor
153655419|NCT00047671|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153655420|NCT00047710|Bevacizumab|bevacizumab|mesh-list
153655421|NCT00047710|Capecitabine|capecitabine|mesh-list
153655422|NCT00047710|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153655423|NCT00047710|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153655424|NCT00047710|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153655425|NCT00047710|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153655426|NCT00047710|Growth Substances|growth substances|mesh-ancestor
153372998|NCT01734551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153373000|NCT01404260|Gemcitabine|gemcitabine|mesh-list
153373001|NCT01404260|Gefitinib|gefitinib|mesh-list
153655427|NCT00047710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153655428|NCT00047710|Growth Inhibitors|growth inhibitors|mesh-ancestor
153655429|NCT00047710|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153655430|NCT00047710|Antimetabolites|antimetabolites|mesh-ancestor
153655431|NCT00047710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153655433|NCT00047749|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153655434|NCT00047749|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153655435|NCT00047749|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153655436|NCT00047749|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153655437|NCT00047749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153655438|NCT00047749|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
153655439|NCT00047749|Protective Agents|protective agents|mesh-ancestor
153655441|NCT00047749|Analgesics|analgesics|mesh-ancestor
153655442|NCT00047749|Sensory System Agents|sensory system agents|mesh-ancestor
153655443|NCT00047749|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153655444|NCT00047827|Amphotericin B|amphotericin b|mesh-list
153655445|NCT00047827|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
153655446|NCT00047827|Micafungin|micafungin|mesh-list
153655461|NCT00048139|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153655463|NCT00048334|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153655464|NCT00048334|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153655465|NCT00048334|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
153655466|NCT00048334|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153655467|NCT00048334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153655468|NCT00048373|Etanercept|etanercept|mesh-list
153655469|NCT00048373|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153655470|NCT00048373|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153655471|NCT00048373|Analgesics|analgesics|mesh-ancestor
153655472|NCT00048373|Sensory System Agents|sensory system agents|mesh-ancestor
153655473|NCT00048373|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153655474|NCT00048373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153655475|NCT00048373|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153655476|NCT00048373|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153655477|NCT00048373|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153655478|NCT00048373|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153655479|NCT00048373|Immunologic Factors|immunologic factors|mesh-ancestor
153655480|NCT05641337|Insulin|insulin|mesh-list
153655481|NCT05641337|Metformin|metformin|mesh-list
153655482|NCT05641337|Insulin Aspart|insulin aspart|mesh-list
153655483|NCT05641337|Linagliptin|linagliptin|mesh-list
153655485|NCT05641337|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153655512|NCT00048607|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
153655513|NCT00048607|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153655514|NCT00048607|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153655515|NCT00048607|Antiemetics|antiemetics|mesh-ancestor
153655516|NCT00048607|Autonomic Agents|autonomic agents|mesh-ancestor
153655517|NCT00048607|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153655518|NCT00048607|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153655519|NCT00048607|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
153655521|NCT00048646|Progestins|progestins|mesh-ancestor
153655522|NCT00048646|Hormones|hormones|mesh-ancestor
153814443|NCT00425204|Panitumumab|panitumumab|mesh-list
153814444|NCT00425204|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153655523|NCT00048646|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153655524|NCT00048646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153655526|NCT00048763|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153492496|NCT02218606|Hormone Antagonists|hormone antagonists|mesh-ancestor
153655527|NCT00048763|Autonomic Agents|autonomic agents|mesh-ancestor
153655569|NCT00048802|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153655570|NCT00048802|Antidepressive Agents|antidepressive agents|mesh-ancestor
153655571|NCT00048802|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153655572|NCT00048802|Antimanic Agents|antimanic agents|mesh-ancestor
153655573|NCT00048802|Anticonvulsants|anticonvulsants|mesh-ancestor
153655574|NCT00048802|GABA Agents|gaba agents|mesh-ancestor
153655575|NCT00048841|Alendronate|alendronate|mesh-list
153655576|NCT00048841|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153655577|NCT00048841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153655578|NCT00048880|Antibodies|antibodies|mesh-list
153655579|NCT00048880|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
153655580|NCT00048880|Immunologic Factors|immunologic factors|mesh-ancestor
153655581|NCT00048880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153655582|NCT00049075|Fludarabine|fludarabine|mesh-list
153655583|NCT00049075|Fludarabine phosphate|fludarabine phosphate|mesh-list
153655584|NCT00049075|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153655585|NCT00049075|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153655592|NCT00049114|Doxorubicin|doxorubicin|mesh-list
153655626|NCT05576181|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153655627|NCT05576181|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153655628|NCT05576181|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153655629|NCT05576181|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153655630|NCT05576181|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153655631|NCT00049387|Temozolomide|temozolomide|mesh-list
153655632|NCT00049387|Tipifarnib|tipifarnib|mesh-list
153655633|NCT00049387|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153655634|NCT00049387|Alkylating Agents|alkylating agents|mesh-ancestor
153655635|NCT00049387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153655636|NCT00049387|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153655637|NCT05640791|Paclitaxel|paclitaxel|mesh-list
153655638|NCT05640791|Gemcitabine|gemcitabine|mesh-list
153892127|NCT03720717|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
153892128|NCT03720717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153892129|NCT03720717|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
153892130|NCT03720717|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153892131|NCT03720717|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
153892132|NCT03720717|GABA Agonists|gaba agonists|mesh-ancestor
153892133|NCT03720717|GABA Agents|gaba agents|mesh-ancestor
153433183|NCT02000089|Hormones|hormones|mesh-ancestor
153433184|NCT02000089|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153433185|NCT02000089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153433186|NCT01979406|Vaccines|vaccines|mesh-list
153433187|NCT01979406|Immunologic Factors|immunologic factors|mesh-ancestor
153655639|NCT05640791|Durvalumab|durvalumab|mesh-list
153655640|NCT05640791|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153655641|NCT05640791|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153655642|NCT05640791|Tubulin Modulators|tubulin modulators|mesh-ancestor
153655643|NCT05640791|Antimitotic Agents|antimitotic agents|mesh-ancestor
153655685|NCT05640713|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153655686|NCT05640713|Immunologic Factors|immunologic factors|mesh-ancestor
153655687|NCT05640713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153655688|NCT05640713|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153655689|NCT05640713|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153655690|NCT05640713|Alkylating Agents|alkylating agents|mesh-ancestor
153655691|NCT05640713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153655692|NCT05640713|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153655693|NCT05640713|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153655694|NCT00391950|Zoledronic Acid|zoledronic acid|mesh-list
153655695|NCT00391950|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153655696|NCT00391950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153655697|NCT00049777|Drotrecogin alfa activated|drotrecogin alfa activated|mesh-list
153655698|NCT00049777|Heparin|heparin|mesh-list
153655699|NCT00049777|Calcium heparin|calcium heparin|mesh-list
153655700|NCT00049777|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
153655744|NCT00050206|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153655745|NCT00050206|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153655746|NCT00050206|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
153655747|NCT00050206|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153655748|NCT00050206|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153655749|NCT00050206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153492721|NCT02801370|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153655750|NCT00050206|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153655751|NCT00050206|Serotonin Agents|serotonin agents|mesh-ancestor
153655752|NCT00050245|Rituximab|rituximab|mesh-list
153655753|NCT00050245|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153655754|NCT00050245|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153655755|NCT00050245|Immunologic Factors|immunologic factors|mesh-ancestor
153655756|NCT00050245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153655757|NCT00050245|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153655759|NCT00050362|Bupivacaine|bupivacaine|mesh-list
153655760|NCT00050362|Anesthetics, Local|anesthetics, local|mesh-ancestor
153655761|NCT00050362|Anesthetics|anesthetics|mesh-ancestor
153655762|NCT00050362|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153655763|NCT00050362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153655764|NCT00050362|Sensory System Agents|sensory system agents|mesh-ancestor
153655765|NCT00050362|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153655766|NCT00050362|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
153655767|NCT00050362|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153655768|NCT00050362|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153655769|NCT00050362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153655770|NCT00050362|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153655771|NCT00050362|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153655772|NCT00050362|Analgesics|analgesics|mesh-ancestor
153655773|NCT00050362|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153655774|NCT00050362|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153655775|NCT00050401|Vancomycin|vancomycin|mesh-list
153814445|NCT00425204|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153892134|NCT03720717|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153892135|NCT03720717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153892136|NCT03701321|Dexamethasone|dexamethasone|mesh-list
153892137|NCT03701321|Dexamethasone acetate|dexamethasone acetate|mesh-list
153892138|NCT03701321|Bortezomib|bortezomib|mesh-list
153655776|NCT00050401|Tobramycin|tobramycin|mesh-list
153655777|NCT00050401|Meropenem|meropenem|mesh-list
153820727|NCT03272802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153655778|NCT00050401|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153655779|NCT00050401|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153655780|NCT05640362|Benzydamine|benzydamine|mesh-list
153655781|NCT05640362|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153655782|NCT00050440|Dexamethasone|dexamethasone|mesh-list
153655783|NCT00050440|Trabectedin|trabectedin|mesh-list
153655784|NCT00050440|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153655785|NCT00050440|Antiemetics|antiemetics|mesh-ancestor
153655786|NCT00050440|Autonomic Agents|autonomic agents|mesh-ancestor
153655787|NCT00050440|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153655788|NCT00050440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153814448|NCT00425243|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153655790|NCT00050440|Glucocorticoids|glucocorticoids|mesh-ancestor
153655791|NCT00050440|Hormones|hormones|mesh-ancestor
153655793|NCT00050440|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153655840|NCT00050830|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153655841|NCT00050830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153655842|NCT00050830|Sensory System Agents|sensory system agents|mesh-ancestor
153422727|NCT01840189|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153881856|NCT01680146|Sequestering Agents|sequestering agents|mesh-ancestor
153881857|NCT01680146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153881858|NCT01680185|Insulin|insulin|mesh-list
153373024|NCT01404572|Antiviral Agents|antiviral agents|mesh-ancestor
153373025|NCT01404572|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153373026|NCT01381406|Tiotropium Bromide|tiotropium bromide|mesh-list
153897017|NCT00960661|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
153373027|NCT01381406|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153897019|NCT00960661|Hormones|hormones|mesh-ancestor
153655843|NCT00050830|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153655844|NCT00050830|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153655845|NCT00050830|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
153655846|NCT00050830|Protective Agents|protective agents|mesh-ancestor
153655847|NCT00050947|Oxcarbazepine|oxcarbazepine|mesh-list
153814449|NCT00425243|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153655848|NCT00050947|Anticonvulsants|anticonvulsants|mesh-ancestor
153655849|NCT00050947|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
153655850|NCT00050947|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153655851|NCT00050947|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153655852|NCT00050947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153655853|NCT00050947|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
153655854|NCT00050947|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
153655895|NCT00051298|Antiemetics|antiemetics|mesh-ancestor
153655896|NCT00051298|Autonomic Agents|autonomic agents|mesh-ancestor
153655897|NCT00051298|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153655898|NCT00051298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153655899|NCT00051298|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153655900|NCT00051298|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153655901|NCT00051298|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153655902|NCT00051298|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153655903|NCT00051298|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153655904|NCT00051298|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
153655905|NCT00051298|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153655906|NCT00051298|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153655907|NCT00051298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153655908|NCT00051298|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153655909|NCT00051298|Serotonin Agents|serotonin agents|mesh-ancestor
153655910|NCT00398008|Naltrexone|naltrexone|mesh-list
153655911|NCT00398008|Buprenorphine|buprenorphine|mesh-list
153655912|NCT00398008|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153655913|NCT00398008|Narcotics|narcotics|mesh-ancestor
153655914|NCT00398008|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153655915|NCT00398008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153655916|NCT00398008|Analgesics|analgesics|mesh-ancestor
153655917|NCT00398008|Sensory System Agents|sensory system agents|mesh-ancestor
153655918|NCT00398008|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153655919|NCT00398008|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
153655920|NCT00398008|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
153655942|NCT05573958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153655943|NCT05573958|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153655944|NCT05573958|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153655945|NCT05573958|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153655946|NCT05573958|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153655947|NCT05573958|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153655948|NCT05573958|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153655949|NCT05573958|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153655950|NCT05573958|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153655951|NCT05573958|Antipyretics|antipyretics|mesh-ancestor
153655953|NCT05573958|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
153655954|NCT05573958|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
153655955|NCT05573958|Purinergic Agents|purinergic agents|mesh-ancestor
153655956|NCT05573958|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153655957|NCT05573958|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
153655958|NCT05573958|Antithrombins|antithrombins|mesh-ancestor
153655959|NCT05573958|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
153655960|NCT05573958|Protease Inhibitors|protease inhibitors|mesh-ancestor
153655961|NCT05573958|Anticoagulants|anticoagulants|mesh-ancestor
153655962|NCT00051688|Oxaliplatin|oxaliplatin|mesh-list
153655963|NCT00051688|Tezacitabine|tezacitabine|mesh-list
153655964|NCT00051688|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153655965|NCT00051688|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153655966|NCT00051688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153655967|NCT00051844|Capravirine|capravirine|mesh-list
153655968|NCT00051844|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153655970|NCT00051844|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153655988|NCT00052039|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153655989|NCT00052039|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153655990|NCT00052039|Immunologic Factors|immunologic factors|mesh-ancestor
153655991|NCT00052039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153655992|NCT00052039|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153655993|NCT00052117|Capravirine|capravirine|mesh-list
153655994|NCT00052117|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153655995|NCT00052117|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153655996|NCT00052117|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153655997|NCT00052117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153655998|NCT00052117|Antiviral Agents|antiviral agents|mesh-ancestor
153655999|NCT00052117|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153656000|NCT00052117|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153656001|NCT00052117|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153656003|NCT00052273|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153656004|NCT00052273|Antimetabolites|antimetabolites|mesh-ancestor
153656005|NCT00052273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153656006|NCT00052273|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153656007|NCT00052312|Paclitaxel|paclitaxel|mesh-list
153656008|NCT00052312|Doxorubicin|doxorubicin|mesh-list
153656010|NCT00052312|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153656011|NCT00052312|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153656013|NCT00052312|Antimitotic Agents|antimitotic agents|mesh-ancestor
153656014|NCT00052312|Mitosis Modulators|mitosis modulators|mesh-ancestor
153656016|NCT00052312|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153656035|NCT00052351|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153656036|NCT00052351|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153656037|NCT00052351|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153656038|NCT00052351|Alkylating Agents|alkylating agents|mesh-ancestor
153656039|NCT00052351|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153656040|NCT00052351|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153656041|NCT00052351|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153656042|NCT00052351|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153656043|NCT00052351|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153656044|NCT00052351|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153656045|NCT00052351|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153656046|NCT00052351|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153656047|NCT00052351|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153656049|NCT00052390|Doxorubicin|doxorubicin|mesh-list
153656050|NCT00052390|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
153656051|NCT00052390|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153493021|NCT02938494|Tazarotene|tazarotene|mesh-list
153656052|NCT00052390|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153656053|NCT00052390|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153656063|NCT00052468|Paclitaxel|paclitaxel|mesh-list
153656091|NCT00052585|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
153656092|NCT00052585|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153656093|NCT00052585|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153656094|NCT00052585|Antidotes|antidotes|mesh-ancestor
153656095|NCT00052585|Protective Agents|protective agents|mesh-ancestor
153656096|NCT00052585|Vitamin B Complex|vitamin b complex|mesh-ancestor
153656097|NCT00052585|Vitamins|vitamins|mesh-ancestor
153656098|NCT00052585|Micronutrients|micronutrients|mesh-ancestor
153656099|NCT00052585|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153656100|NCT00052585|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153656101|NCT00052780|Temozolomide|temozolomide|mesh-list
153656102|NCT00052780|O(6)-benzylguanine|o(6)-benzylguanine|mesh-list
153656103|NCT00052780|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153656104|NCT00052780|Alkylating Agents|alkylating agents|mesh-ancestor
153656105|NCT00052780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153656106|NCT00052780|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153881876|NCT01601730|Modafinil|modafinil|mesh-list
153881877|NCT01601730|Citalopram|citalopram|mesh-list
153881878|NCT01601730|Escitalopram|escitalopram|mesh-list
153881879|NCT01601730|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
153656107|NCT00052780|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153656108|NCT00052936|Prednisone|prednisone|mesh-list
153656109|NCT00052936|Cyclophosphamide|cyclophosphamide|mesh-list
153656110|NCT00052936|Rituximab|rituximab|mesh-list
153656111|NCT00052936|Doxorubicin|doxorubicin|mesh-list
153656112|NCT00052936|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
153656113|NCT00052936|Vincristine|vincristine|mesh-list
153656114|NCT00052936|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153656115|NCT00052936|Immunologic Factors|immunologic factors|mesh-ancestor
153656116|NCT00052936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153656117|NCT00052936|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153656118|NCT00052936|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153814451|NCT00425243|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
153892216|NCT03425279|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153656145|NCT00053092|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153656146|NCT00053092|Alkylating Agents|alkylating agents|mesh-ancestor
153656147|NCT00053092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153656148|NCT00053092|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153656149|NCT00053092|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153656150|NCT00053092|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153656151|NCT00053092|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153656152|NCT00053092|Antimetabolites|antimetabolites|mesh-ancestor
153656153|NCT00053131|Cytarabine|cytarabine|mesh-list
153656196|NCT00053287|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153656197|NCT00053287|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153656198|NCT00053287|Growth Substances|growth substances|mesh-ancestor
153656199|NCT00053287|Growth Inhibitors|growth inhibitors|mesh-ancestor
153656200|NCT00053326|Fenretinide|fenretinide|mesh-list
153656201|NCT00053326|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153656202|NCT00053326|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
153656203|NCT00053326|Protective Agents|protective agents|mesh-ancestor
153656204|NCT00053326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153656205|NCT00053560|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
153656206|NCT00053560|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153656207|NCT00053560|Immunologic Factors|immunologic factors|mesh-ancestor
153656208|NCT00053560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153656209|NCT00053599|Simvastatin|simvastatin|mesh-list
153656210|NCT00053599|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153656211|NCT00053599|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153656212|NCT00053599|Antimetabolites|antimetabolites|mesh-ancestor
153656213|NCT00053599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153656214|NCT00053599|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153656215|NCT00053599|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
153656216|NCT00053599|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153656217|NCT00053638|Tenofovir|tenofovir|mesh-list
153656218|NCT00053638|Lamivudine|lamivudine|mesh-list
153656219|NCT00053638|Efavirenz|efavirenz|mesh-list
153656220|NCT00053638|Abacavir|abacavir|mesh-list
153656221|NCT00053638|Antiviral Agents|antiviral agents|mesh-ancestor
153656246|NCT00053833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153656247|NCT00053833|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153656248|NCT00053872|Vincristine|vincristine|mesh-list
153656249|NCT00053872|Lomustine|lomustine|mesh-list
153656250|NCT00053872|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153656251|NCT00053872|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153656252|NCT00053872|Tubulin Modulators|tubulin modulators|mesh-ancestor
153656253|NCT00053872|Antimitotic Agents|antimitotic agents|mesh-ancestor
153656254|NCT00053872|Mitosis Modulators|mitosis modulators|mesh-ancestor
153656255|NCT00053872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153656312|NCT00054340|Immunologic Factors|immunologic factors|mesh-ancestor
153656313|NCT00054340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153656314|NCT00054340|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153656315|NCT00054340|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153656317|NCT00054340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153656318|NCT00054340|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153656324|NCT00054340|Antimetabolites|antimetabolites|mesh-ancestor
153656379|NCT00054808|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153656381|NCT00054886|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153656382|NCT00054886|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153656383|NCT00054886|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153656384|NCT00054886|Growth Substances|growth substances|mesh-ancestor
153656385|NCT00054886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153656386|NCT00054886|Growth Inhibitors|growth inhibitors|mesh-ancestor
153656387|NCT00054886|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153656388|NCT00054886|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153656389|NCT00054886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153656390|NCT02970097|Midazolam|midazolam|mesh-list
153656391|NCT02970097|Fentanyl|fentanyl|mesh-list
153656392|NCT02970097|Ropivacaine|ropivacaine|mesh-list
153656402|NCT02970097|Anesthetics|anesthetics|mesh-ancestor
153656441|NCT00055120|Antiviral Agents|antiviral agents|mesh-ancestor
153656442|NCT00055120|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153656443|NCT00055120|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
153656444|NCT00055120|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153656445|NCT00055120|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153656446|NCT00055120|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153656447|NCT00055120|Antimetabolites|antimetabolites|mesh-ancestor
153656449|NCT00055159|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
153656450|NCT00055159|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153656451|NCT00055159|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153656452|NCT00055159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153656453|NCT00055198|Daptomycin|daptomycin|mesh-list
153656454|NCT00055198|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153656501|NCT00055549|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153656502|NCT00055549|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153656503|NCT00055549|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153656504|NCT00055549|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153656505|NCT00055549|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153656506|NCT00055549|GABA Modulators|gaba modulators|mesh-ancestor
153656508|NCT00055666|Beclomethasone|beclomethasone|mesh-list
153656509|NCT00055666|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153656510|NCT00055666|Glucocorticoids|glucocorticoids|mesh-ancestor
153656511|NCT00055666|Hormones|hormones|mesh-ancestor
153656513|NCT00055666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153656514|NCT00055666|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153656515|NCT00055666|Respiratory System Agents|respiratory system agents|mesh-ancestor
153656517|NCT00055822|Fluorouracil|fluorouracil|mesh-list
153656518|NCT00055822|Oxaliplatin|oxaliplatin|mesh-list
153656519|NCT00055822|Oblimersen|oblimersen|mesh-list
153656520|NCT00055822|Calcium|calcium|mesh-list
153656521|NCT00055822|Levoleucovorin|levoleucovorin|mesh-list
153656522|NCT00055822|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153656523|NCT00055822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153656524|NCT00055822|Antimetabolites|antimetabolites|mesh-ancestor
153656525|NCT00055822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153656526|NCT00055822|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153656527|NCT00055822|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153656528|NCT00055822|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153656529|NCT00055822|Immunologic Factors|immunologic factors|mesh-ancestor
153656530|NCT00055822|Antidotes|antidotes|mesh-ancestor
153656531|NCT00055822|Protective Agents|protective agents|mesh-ancestor
153656532|NCT00055822|Vitamin B Complex|vitamin b complex|mesh-ancestor
153656533|NCT00055822|Vitamins|vitamins|mesh-ancestor
153656548|NCT00055861|Tubulin Modulators|tubulin modulators|mesh-ancestor
153656549|NCT00055861|Antimitotic Agents|antimitotic agents|mesh-ancestor
153656550|NCT00055861|Mitosis Modulators|mitosis modulators|mesh-ancestor
153656551|NCT00055861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153656552|NCT00392106|Amiodarone|amiodarone|mesh-list
153656555|NCT00392106|Dofetilide|dofetilide|mesh-list
153656556|NCT00392106|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153656557|NCT00392106|Vasodilator Agents|vasodilator agents|mesh-ancestor
153656558|NCT00392106|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
153656559|NCT00392106|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153656560|NCT00392106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153656561|NCT00392106|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153656562|NCT00392106|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
153656563|NCT00392106|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153656564|NCT00392106|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153656565|NCT00392106|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
153656566|NCT00392106|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
153656567|NCT00392106|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
153656568|NCT00392106|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
153656569|NCT00055939|Exatecan|exatecan|mesh-list
153656570|NCT00055939|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
153656571|NCT00055939|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153656572|NCT00055939|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153656573|NCT00055939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153656574|NCT00055939|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153656575|NCT00055978|Celecoxib|celecoxib|mesh-list
153656576|NCT00055978|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153656591|NCT00056056|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
153656592|NCT00056056|Dermatologic Agents|dermatologic agents|mesh-ancestor
153656593|NCT00056095|Cyclosporine|cyclosporine|mesh-list
153656594|NCT00056095|Cyclophosphamide|cyclophosphamide|mesh-list
153656595|NCT00056095|Fludarabine|fludarabine|mesh-list
153656596|NCT00056095|Fludarabine phosphate|fludarabine phosphate|mesh-list
153656597|NCT00056095|Cyclosporins|cyclosporins|mesh-list
153656598|NCT00056095|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153814452|NCT00425243|GABA Agonists|gaba agonists|mesh-ancestor
153892306|NCT03126630|Pembrolizumab|pembrolizumab|mesh-list
153656601|NCT00056095|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153656602|NCT00056095|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153656603|NCT00056095|Alkylating Agents|alkylating agents|mesh-ancestor
153656604|NCT00056095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153656605|NCT00056095|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153656606|NCT00056095|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153656607|NCT00056095|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153656608|NCT00056095|Antimetabolites|antimetabolites|mesh-ancestor
153656609|NCT00056095|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153656610|NCT00056095|Antifungal Agents|antifungal agents|mesh-ancestor
153656611|NCT00056095|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153656612|NCT00056095|Dermatologic Agents|dermatologic agents|mesh-ancestor
153656613|NCT00056095|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
153656641|NCT00398437|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153656642|NCT00398437|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153656643|NCT05433675|Macitentan|macitentan|mesh-list
153656644|NCT05433675|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
153656645|NCT05433675|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
153656646|NCT05433675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153656647|NCT05433675|Endothelin B Receptor Antagonists|endothelin b receptor antagonists|mesh-ancestor
153656648|NCT00423709|Fludarabine|fludarabine|mesh-list
153656649|NCT00423709|Melphalan|melphalan|mesh-list
153656650|NCT00423709|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153656651|NCT00423709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153656703|NCT00057031|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
153656704|NCT00057031|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153656705|NCT00057031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153656706|NCT00057031|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
153656707|NCT00057031|Vitamins|vitamins|mesh-ancestor
153656708|NCT00057031|Micronutrients|micronutrients|mesh-ancestor
153656709|NCT00057031|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153656710|NCT00057265|Lamivudine|lamivudine|mesh-list
153656711|NCT00057265|Telbivudine|telbivudine|mesh-list
153656712|NCT00057265|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153656716|NCT00057265|Antiviral Agents|antiviral agents|mesh-ancestor
153656767|NCT00057928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153814453|NCT00425243|GABA Agents|gaba agents|mesh-ancestor
153433392|NCT00000439|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153433393|NCT00000439|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153433394|NCT00000439|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153433395|NCT00002912|Etoposide|etoposide|mesh-list
153433396|NCT00002912|Mitoxantrone|mitoxantrone|mesh-list
153433397|NCT00002912|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153433398|NCT00002912|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153656769|NCT00057928|Antimetabolites|antimetabolites|mesh-ancestor
153656771|NCT05309304|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153656772|NCT05309304|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153656773|NCT00057967|Alemtuzumab|alemtuzumab|mesh-list
153656774|NCT00057967|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153656775|NCT00057967|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153656776|NCT00058006|Celecoxib|celecoxib|mesh-list
153656779|NCT00058006|Analgesics|analgesics|mesh-ancestor
153656833|NCT00058201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153656834|NCT00058201|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153656835|NCT00058201|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153881882|NCT01601730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153881883|NCT01601730|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153881884|NCT01601730|Serotonin Agents|serotonin agents|mesh-ancestor
153881885|NCT01601730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153881886|NCT01601730|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
153656836|NCT00058201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153656837|NCT00058201|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153656838|NCT00058201|Immunologic Factors|immunologic factors|mesh-ancestor
153656839|NCT00058201|Antidotes|antidotes|mesh-ancestor
153656840|NCT00058201|Protective Agents|protective agents|mesh-ancestor
153656841|NCT00058201|Vitamin B Complex|vitamin b complex|mesh-ancestor
153656842|NCT00058201|Vitamins|vitamins|mesh-ancestor
153656843|NCT00058201|Micronutrients|micronutrients|mesh-ancestor
153656844|NCT00058279|Aldesleukin|aldesleukin|mesh-list
153656845|NCT00058279|Ipilimumab|ipilimumab|mesh-list
153656846|NCT00058279|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153656847|NCT00058279|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153656850|NCT00058279|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153656891|NCT00392262|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153656892|NCT00392262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153656893|NCT00392262|Vasodilator Agents|vasodilator agents|mesh-ancestor
153656894|NCT00392262|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
153656895|NCT00392262|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
153656896|NCT00058747|Imatinib Mesylate|imatinib mesylate|mesh-list
153656897|NCT00058747|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153656898|NCT00058747|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153656899|NCT00058747|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153814454|NCT00425243|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153892330|NCT03060473|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
153656900|NCT00058747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153656901|NCT00058747|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153656902|NCT00058903|Sertraline|sertraline|mesh-list
153656903|NCT00058903|Antidepressive Agents|antidepressive agents|mesh-ancestor
153656951|NCT02969239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153656952|NCT02969239|Sympathomimetics|sympathomimetics|mesh-ancestor
153656953|NCT02969239|Nasal Decongestants|nasal decongestants|mesh-ancestor
153656954|NCT02969239|Respiratory System Agents|respiratory system agents|mesh-ancestor
153656955|NCT02969239|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
153656956|NCT02969239|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153656957|NCT02969239|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153656958|NCT02969239|Adrenergic Agents|adrenergic agents|mesh-ancestor
153656959|NCT02969239|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153656960|NCT02969239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153656961|NCT02969239|Protective Agents|protective agents|mesh-ancestor
153656962|NCT00059761|Irinotecan|irinotecan|mesh-list
153656963|NCT00059761|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153656964|NCT00059761|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
153656965|NCT00059761|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153656966|NCT00059761|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153656967|NCT00059761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153657004|NCT00060112|Antimetabolites|antimetabolites|mesh-ancestor
153668024|NCT00030615|Decitabine|decitabine|mesh-list
153657005|NCT00060112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153657006|NCT00060112|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153657007|NCT00060307|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
153657008|NCT00060307|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153657009|NCT00060307|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153657010|NCT00060307|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153657011|NCT00060307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153657012|NCT00060307|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153657070|NCT05325164|Respiratory System Agents|respiratory system agents|mesh-ancestor
153657071|NCT00060385|Prednisone|prednisone|mesh-list
153657072|NCT00060385|Cyclophosphamide|cyclophosphamide|mesh-list
153657073|NCT00060385|Doxorubicin|doxorubicin|mesh-list
153657074|NCT00060385|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
153657075|NCT00060385|Etoposide|etoposide|mesh-list
153657076|NCT00060385|Vincristine|vincristine|mesh-list
153657077|NCT00060385|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153657078|NCT00060385|Immunologic Factors|immunologic factors|mesh-ancestor
153657079|NCT00060385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153657080|NCT00060385|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153657081|NCT00060385|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153657082|NCT00060385|Alkylating Agents|alkylating agents|mesh-ancestor
153657083|NCT00060385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153657084|NCT00060385|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153657085|NCT00060385|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153657086|NCT00060385|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153657129|NCT05312372|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153657130|NCT05312372|Tubulin Modulators|tubulin modulators|mesh-ancestor
153657131|NCT05312372|Antimitotic Agents|antimitotic agents|mesh-ancestor
153657132|NCT05312372|Mitosis Modulators|mitosis modulators|mesh-ancestor
153657133|NCT05312372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153657136|NCT05038410|Immunologic Factors|immunologic factors|mesh-ancestor
153657137|NCT05038410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153657138|NCT02968498|Methamphetamine|methamphetamine|mesh-list
153657139|NCT02968498|Lactulose|lactulose|mesh-list
153657140|NCT02968498|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153657141|NCT02968498|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
153657142|NCT02968498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153657143|NCT02968498|Sympathomimetics|sympathomimetics|mesh-ancestor
153657144|NCT02968498|Autonomic Agents|autonomic agents|mesh-ancestor
153657145|NCT02968498|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153657146|NCT02968498|Dopamine Agents|dopamine agents|mesh-ancestor
153657147|NCT02968498|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153657148|NCT02968498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153657149|NCT02968498|Adrenergic Agents|adrenergic agents|mesh-ancestor
153657150|NCT02968498|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
153657151|NCT02968498|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153657152|NCT02968498|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153657178|NCT00061087|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
153657179|NCT00061087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153657180|NCT00061087|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
153657181|NCT00061087|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153657182|NCT00061087|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153657183|NCT00061087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153657184|NCT00061087|Dopamine Agents|dopamine agents|mesh-ancestor
153657185|NCT00061087|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153657186|NCT00061087|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
153657187|NCT00061087|Antidepressive Agents|antidepressive agents|mesh-ancestor
153657188|NCT00061087|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153657189|NCT00061087|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
153657190|NCT00061087|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153657191|NCT00061087|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153657192|NCT00061243|Vaccines|vaccines|mesh-list
153657193|NCT00061243|Immunologic Factors|immunologic factors|mesh-ancestor
153657194|NCT00061243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153657195|NCT04711564|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
153657196|NCT04711564|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-list
153657197|NCT04711564|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
153657198|NCT04711564|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
153657199|NCT00061321|Nevirapine|nevirapine|mesh-list
153657200|NCT00061321|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153657201|NCT00061321|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153657202|NCT00061321|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153657203|NCT00061321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153657204|NCT00061321|Antiviral Agents|antiviral agents|mesh-ancestor
153657205|NCT00061321|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153657210|NCT00061360|Cyclosporine|cyclosporine|mesh-list
153657216|NCT00061360|Immunologic Factors|immunologic factors|mesh-ancestor
153657217|NCT00061360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153657218|NCT00061360|Antifungal Agents|antifungal agents|mesh-ancestor
153657219|NCT00061360|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153657220|NCT00061360|Dermatologic Agents|dermatologic agents|mesh-ancestor
153657221|NCT00061360|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153657222|NCT00061360|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
153657223|NCT00061360|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153657224|NCT00061360|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153657225|NCT00061360|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153657226|NCT06197763|Colesevelam Hydrochloride|colesevelam hydrochloride|mesh-list
153657227|NCT06197763|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153657228|NCT06197763|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153657229|NCT06197763|Antimetabolites|antimetabolites|mesh-ancestor
153657230|NCT06197763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153657231|NCT06197763|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153657232|NCT06197698|Technetium Tc 99m TRODAT-1|technetium tc 99m trodat-1|mesh-list
153657233|NCT06197698|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
153657234|NCT06197698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153657235|NCT06197581|Capecitabine|capecitabine|mesh-list
153657236|NCT06197581|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
153657237|NCT06197581|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153657238|NCT06197581|Antimetabolites|antimetabolites|mesh-ancestor
153657239|NCT06197581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153657240|NCT06197581|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153657241|NCT06197581|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153657243|NCT06197555|Calcium|calcium|mesh-list
153657265|NCT06197438|Tislelizumab|tislelizumab|mesh-list
153657266|NCT06197438|Levoleucovorin|levoleucovorin|mesh-list
153657267|NCT06197438|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153657268|NCT06197438|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153657269|NCT06197438|Tubulin Modulators|tubulin modulators|mesh-ancestor
153657270|NCT06197438|Antimitotic Agents|antimitotic agents|mesh-ancestor
153657271|NCT06197438|Mitosis Modulators|mitosis modulators|mesh-ancestor
153657272|NCT06197438|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153657273|NCT06197438|Antimetabolites|antimetabolites|mesh-ancestor
153657274|NCT06197438|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153657275|NCT06197438|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153657276|NCT06197438|Immunologic Factors|immunologic factors|mesh-ancestor
153814455|NCT00425243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153433474|NCT00000505|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153433475|NCT00000505|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153433476|NCT00000505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153433477|NCT00000901|Lamivudine|lamivudine|mesh-list
153433478|NCT00000901|Stavudine|stavudine|mesh-list
153433479|NCT00000901|Indinavir|indinavir|mesh-list
153657277|NCT06197438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153657278|NCT06197438|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
153657279|NCT06197438|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153657280|NCT06197438|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153657281|NCT06197438|Antidotes|antidotes|mesh-ancestor
153657282|NCT06197438|Protective Agents|protective agents|mesh-ancestor
153657283|NCT06197438|Vitamin B Complex|vitamin b complex|mesh-ancestor
153657284|NCT06197438|Vitamins|vitamins|mesh-ancestor
153657285|NCT06197438|Micronutrients|micronutrients|mesh-ancestor
153657286|NCT06197438|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153657287|NCT06197425|Trifluridine|trifluridine|mesh-list
153657288|NCT06197425|Antimetabolites|antimetabolites|mesh-ancestor
153657290|NCT06197425|Antiviral Agents|antiviral agents|mesh-ancestor
153657315|NCT06196853|Respiratory System Agents|respiratory system agents|mesh-ancestor
153657316|NCT06196853|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
153657317|NCT06196853|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
153657318|NCT06196853|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153657319|NCT06196853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153657320|NCT06196853|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
153657321|NCT06196853|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
153657322|NCT06196853|Purinergic Agents|purinergic agents|mesh-ancestor
153657323|NCT06196853|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153657324|NCT06196853|Protective Agents|protective agents|mesh-ancestor
153657325|NCT06196840|Aflibercept|aflibercept|mesh-list
153657326|NCT06196840|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153657327|NCT06196840|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153657328|NCT06196840|Growth Substances|growth substances|mesh-ancestor
153657329|NCT06196840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153657330|NCT06196840|Growth Inhibitors|growth inhibitors|mesh-ancestor
153657331|NCT06196840|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153657332|NCT06196697|Capecitabine|capecitabine|mesh-list
153657333|NCT06196697|Tegafur|tegafur|mesh-list
153657334|NCT06196697|Oxaliplatin|oxaliplatin|mesh-list
153657335|NCT06196697|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153657373|NCT06196554|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
153657374|NCT06196554|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153438620|NCT00385502|Econazole|econazole|mesh-list
153657375|NCT06196554|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153657376|NCT06196515|Calcium, Dietary|calcium, dietary|mesh-list
153657377|NCT06196515|Calcium|calcium|mesh-list
153657378|NCT06196515|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153657379|NCT06196515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153657380|NCT06196515|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153657381|NCT06196047|Cilostazol|cilostazol|mesh-list
153657382|NCT06196047|Ticagrelor|ticagrelor|mesh-list
153657383|NCT06196047|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153657384|NCT06196047|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
153814456|NCT00339131|3-Iodobenzylguanidine|3-iodobenzylguanidine|mesh-list
153892412|NCT01919086|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153892413|NCT01919086|Growth Substances|growth substances|mesh-ancestor
153892414|NCT01919086|Growth Inhibitors|growth inhibitors|mesh-ancestor
153892415|NCT01867333|Metronidazole|metronidazole|mesh-list
153892416|NCT01867333|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153892417|NCT01867333|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153892418|NCT01867333|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153892419|NCT01867333|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153892420|NCT01833715|Morphine|morphine|mesh-list
153892421|NCT01833715|Methadone|methadone|mesh-list
153892422|NCT01833715|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153892423|NCT01833715|Narcotics|narcotics|mesh-ancestor
153657385|NCT06196047|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
153657386|NCT06196047|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
153657387|NCT06196047|Purinergic Agents|purinergic agents|mesh-ancestor
153657388|NCT06196047|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153657389|NCT06196047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153657390|NCT06196047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153657391|NCT06196047|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153657427|NCT06193044|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153657428|NCT06193044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153657429|NCT06193044|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153657430|NCT06193044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153657431|NCT06193044|Vasodilator Agents|vasodilator agents|mesh-ancestor
153657432|NCT06193044|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
153657433|NCT06193044|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
153657435|NCT06192784|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153657436|NCT06192784|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153657437|NCT06192784|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153657440|NCT06192238|Racepinephrine|racepinephrine|mesh-list
153657441|NCT06192238|Epinephryl borate|epinephryl borate|mesh-list
153657442|NCT06192238|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153657443|NCT06192238|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153657444|NCT06192238|Adrenergic Agents|adrenergic agents|mesh-ancestor
153657445|NCT06192238|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153657446|NCT06192238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153657447|NCT06192238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153657448|NCT06192238|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
153657449|NCT06192238|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153657450|NCT06192238|Autonomic Agents|autonomic agents|mesh-ancestor
153657452|NCT06192238|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153657474|NCT06183437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153433510|NCT00000913|Nelfinavir|nelfinavir|mesh-list
153433511|NCT00000913|Saquinavir|saquinavir|mesh-list
153433512|NCT00000913|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
153433513|NCT00000913|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
153433514|NCT00000913|Protease Inhibitors|protease inhibitors|mesh-ancestor
153433515|NCT00000913|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153657478|NCT06170346|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153657479|NCT06158698|Colchicine|colchicine|mesh-list
153422772|NCT00445627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153422773|NCT03606889|Bupivacaine|bupivacaine|mesh-list
153422774|NCT03606889|Anesthetics, Local|anesthetics, local|mesh-ancestor
153422775|NCT03606889|Anesthetics|anesthetics|mesh-ancestor
153422776|NCT03606889|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153422779|NCT03606889|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153657480|NCT06158698|Gout Suppressants|gout suppressants|mesh-ancestor
153657481|NCT06158698|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153657482|NCT06158698|Tubulin Modulators|tubulin modulators|mesh-ancestor
153657483|NCT06158698|Antimitotic Agents|antimitotic agents|mesh-ancestor
153657484|NCT06158698|Mitosis Modulators|mitosis modulators|mesh-ancestor
153657485|NCT06158698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153657486|NCT06158698|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153657488|NCT06144242|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153657489|NCT06144242|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153657490|NCT06144242|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153657491|NCT06144242|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153657492|NCT06138132|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
153657493|NCT06138132|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153657494|NCT06138132|Alkylating Agents|alkylating agents|mesh-ancestor
153657495|NCT06138132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153657527|NCT06077422|Sensory System Agents|sensory system agents|mesh-ancestor
153657528|NCT06077422|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153657531|NCT06068543|Vitamins|vitamins|mesh-list
153657532|NCT06068543|Ascorbic Acid|ascorbic acid|mesh-list
153657533|NCT06068543|Epigallocatechin gallate|epigallocatechin gallate|mesh-list
153657534|NCT06068543|Micronutrients|micronutrients|mesh-ancestor
153657535|NCT06068543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153657536|NCT06068543|Antioxidants|antioxidants|mesh-ancestor
153657537|NCT06068543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153657538|NCT06068543|Protective Agents|protective agents|mesh-ancestor
153657539|NCT06068543|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
153657540|NCT06068543|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
153657541|NCT06068543|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153657543|NCT06053658|Nivolumab|nivolumab|mesh-list
153657587|NCT06039358|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
153657588|NCT06039358|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153657589|NCT06039358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153657590|NCT06039358|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
153657591|NCT06039358|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
153657592|NCT06039358|Purinergic Agents|purinergic agents|mesh-ancestor
153657593|NCT06039358|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153657594|NCT06036472|Anesthetics|anesthetics|mesh-list
153657595|NCT06036472|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153657596|NCT06036472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153657597|NCT05995704|Acetaminophen|acetaminophen|mesh-list
153657598|NCT05995704|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153657599|NCT05995704|Analgesics|analgesics|mesh-ancestor
153892449|NCT00856037|Topotecan|topotecan|mesh-list
153657602|NCT05995704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153657603|NCT05995704|Antipyretics|antipyretics|mesh-ancestor
153657604|NCT05925803|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
153657605|NCT05925803|Immunologic Factors|immunologic factors|mesh-ancestor
153657606|NCT05925803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153657607|NCT05892276|Cannabidiol|cannabidiol|mesh-list
153657608|NCT05892276|Anticonvulsants|anticonvulsants|mesh-ancestor
153657609|NCT05837455|Anastrozole|anastrozole|mesh-list
153657611|NCT05837455|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153657612|NCT05837455|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153657613|NCT05837455|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
153657614|NCT05837455|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153657615|NCT05837455|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153881900|NCT01601730|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
153881901|NCT01644071|Dexetimide|dexetimide|mesh-list
153881902|NCT01644071|Citalopram|citalopram|mesh-list
153881903|NCT01644071|Escitalopram|escitalopram|mesh-list
153881904|NCT01644071|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
153881905|NCT01644071|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153881906|NCT01644071|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153881907|NCT01644071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153881908|NCT01644071|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153657616|NCT05837455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153657617|NCT05837455|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
153657618|NCT05837455|Hormone Antagonists|hormone antagonists|mesh-ancestor
153657619|NCT05837455|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153657620|NCT05837455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153657626|NCT05820763|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153657627|NCT05820763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153657628|NCT05820763|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153657630|NCT05820763|Hormones|hormones|mesh-ancestor
153657631|NCT05820763|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153657632|NCT05820763|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153657633|NCT05820763|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153657634|NCT05820763|Immunologic Factors|immunologic factors|mesh-ancestor
153657635|NCT05820763|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153657636|NCT05820763|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153657637|NCT05820763|Growth Substances|growth substances|mesh-ancestor
153657638|NCT05820763|Growth Inhibitors|growth inhibitors|mesh-ancestor
153657639|NCT05786612|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
153657640|NCT05786612|Laxatives|laxatives|mesh-ancestor
153657641|NCT05786612|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153657642|NCT05783609|Rituximab|rituximab|mesh-list
153657643|NCT05783609|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153657644|NCT05783609|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153657645|NCT05783609|Immunologic Factors|immunologic factors|mesh-ancestor
153657646|NCT05783609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153657647|NCT05783609|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153657648|NCT05769530|Dexmedetomidine|dexmedetomidine|mesh-list
153657649|NCT05769530|Nalbuphine|nalbuphine|mesh-list
153657650|NCT05769530|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153657653|NCT05769530|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153657675|NCT05701059|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153657676|NCT05701059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153657677|NCT05701059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153657678|NCT05701059|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
153433554|NCT00000577|Mitosis Modulators|mitosis modulators|mesh-ancestor
153657746|NCT05606315|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153657747|NCT05606315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153657748|NCT05606315|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153657749|NCT05606315|Anesthetics, General|anesthetics, general|mesh-ancestor
153657750|NCT05606315|Anesthetics|anesthetics|mesh-ancestor
153657751|NCT05606315|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153657752|NCT05606315|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153657753|NCT05606315|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153657754|NCT05606315|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153657755|NCT05606315|GABA Modulators|gaba modulators|mesh-ancestor
153657756|NCT05606315|GABA Agents|gaba agents|mesh-ancestor
153657799|NCT05497804|Protease Inhibitors|protease inhibitors|mesh-ancestor
153657800|NCT05497804|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153657801|NCT05497804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153657802|NCT05497804|Immunologic Factors|immunologic factors|mesh-ancestor
153657803|NCT05497804|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153657804|NCT05497804|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153657805|NCT05497804|Growth Substances|growth substances|mesh-ancestor
153657806|NCT05497804|Growth Inhibitors|growth inhibitors|mesh-ancestor
153657807|NCT05497804|Dermatologic Agents|dermatologic agents|mesh-ancestor
153657808|NCT05472779|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
153657809|NCT05472779|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
153657811|NCT05472779|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
153657812|NCT05472779|Estrogens|estrogens|mesh-ancestor
153657813|NCT05472779|Hormones|hormones|mesh-ancestor
153657814|NCT05472779|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153814457|NCT00339131|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153657831|NCT05423379|Everolimus|everolimus|mesh-list
153657832|NCT05423379|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
153657833|NCT05423379|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153657836|NCT05423379|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153657837|NCT05423379|Immunologic Factors|immunologic factors|mesh-ancestor
153657838|NCT05423379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153657839|NCT05423379|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153657840|NCT05413980|Moxifloxacin|moxifloxacin|mesh-list
153657841|NCT05413980|Ophthalmic Solutions|ophthalmic solutions|mesh-list
153657842|NCT05413980|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
153657843|NCT05413980|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
153657844|NCT05413980|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153657845|NCT05413980|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153657846|NCT05413980|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153657847|NCT05413980|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153657848|NCT05413980|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153657849|NCT05413980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153657850|NCT05413980|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153657851|NCT05413980|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
153657852|NCT05413980|Contraceptive Agents|contraceptive agents|mesh-ancestor
153433578|NCT00000937|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
153433579|NCT00000937|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153433580|NCT00000613|Genistein|genistein|mesh-list
153433581|NCT00000613|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
153433582|NCT00000613|Protective Agents|protective agents|mesh-ancestor
153433583|NCT00000613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153433584|NCT00000613|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153433585|NCT00000613|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153433586|NCT00000613|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153433587|NCT00000613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153433588|NCT00000613|Phytoestrogens|phytoestrogens|mesh-ancestor
153433589|NCT00000613|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
153433590|NCT00000613|Estrogens|estrogens|mesh-ancestor
153433591|NCT00000613|Hormones|hormones|mesh-ancestor
153461763|NCT04130802|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153657854|NCT05413980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153657855|NCT05413980|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
153657856|NCT05413980|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
153657857|NCT05413980|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
153657858|NCT05388006|Durvalumab|durvalumab|mesh-list
153657859|NCT05388006|Venetoclax|venetoclax|mesh-list
153657860|NCT05388006|Acalabrutinib|acalabrutinib|mesh-list
153657861|NCT05388006|Immunoglobulins|immunoglobulins|mesh-list
153814458|NCT00339131|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153892508|NCT00006721|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153892509|NCT00006721|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153892510|NCT00006721|Tubulin Modulators|tubulin modulators|mesh-ancestor
153892511|NCT00006721|Antimitotic Agents|antimitotic agents|mesh-ancestor
153657865|NCT05388006|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153657866|NCT05388006|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153657878|NCT05381597|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153657879|NCT05381597|Immunologic Factors|immunologic factors|mesh-ancestor
153657880|NCT05381597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153657881|NCT05381597|Dermatologic Agents|dermatologic agents|mesh-ancestor
153657883|NCT05326464|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
153657884|NCT05326464|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153657885|NCT05326464|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153657886|NCT05326464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153657887|NCT05315817|Dialysis Solutions|dialysis solutions|mesh-list
153657888|NCT05315817|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
153657889|NCT05279833|Sotalol|sotalol|mesh-list
153657940|NCT05155254|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153657941|NCT05155254|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153657942|NCT05155254|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153657943|NCT05155254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153657944|NCT05090280|Nafamostat|nafamostat|mesh-list
153657945|NCT05090280|Naltrexone|naltrexone|mesh-list
153422790|NCT03187730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153461768|NCT04130802|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153461769|NCT04130802|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153461770|NCT04130802|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153461771|NCT03087162|Dexlansoprazole|dexlansoprazole|mesh-list
153461773|NCT03087162|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
153461837|NCT03286842|Olaparib|olaparib|mesh-list
153461838|NCT03286842|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
153657946|NCT05090280|Oxycodone|oxycodone|mesh-list
153657947|NCT05090280|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153657948|NCT05090280|Narcotics|narcotics|mesh-ancestor
153657949|NCT05090280|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153657950|NCT05090280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153657951|NCT05090280|Analgesics|analgesics|mesh-ancestor
153657952|NCT05090280|Sensory System Agents|sensory system agents|mesh-ancestor
153814460|NCT00339131|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
153657953|NCT05090280|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153657954|NCT05090280|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
153657955|NCT05090280|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
153657956|NCT05090280|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153657957|NCT05090280|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153657958|NCT05090280|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153657996|NCT05062356|Sympathomimetics|sympathomimetics|mesh-ancestor
153657997|NCT05062356|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
153657998|NCT05062356|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153657999|NCT05062356|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153658000|NCT05062356|Analgesics|analgesics|mesh-ancestor
153658001|NCT05062356|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153658002|NCT05062356|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153658003|NCT05062356|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153658004|NCT05062356|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153658005|NCT05056727|Valsartan|valsartan|mesh-list
153658006|NCT05056727|Lisinopril|lisinopril|mesh-list
153658007|NCT05056727|Irbesartan|irbesartan|mesh-list
153658008|NCT05056727|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153658080|NCT04883645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153658081|NCT04883645|Immunomodulating Agents|immunomodulating agents|mesh-ancestor
153658082|NCT04883645|Immunologic Factors|immunologic factors|mesh-ancestor
153658083|NCT04883645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153658084|NCT04883645|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153658085|NCT04883645|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153658086|NCT04883645|Interferon Inducers|interferon inducers|mesh-ancestor
153658087|NCT04873583|Methylprednisolone|methylprednisolone|mesh-list
153658088|NCT04873583|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
153658089|NCT04873583|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
153658090|NCT04873583|Prednisolone|prednisolone|mesh-list
153658091|NCT04873583|Prednisolone acetate|prednisolone acetate|mesh-list
153658092|NCT04873583|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
153658093|NCT04873583|Prednisolone phosphate|prednisolone phosphate|mesh-list
153658094|NCT04873583|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153658095|NCT04873583|Antiemetics|antiemetics|mesh-ancestor
153658096|NCT04873583|Autonomic Agents|autonomic agents|mesh-ancestor
153658136|NCT04825275|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153658137|NCT04825275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153658138|NCT04777851|Pembrolizumab|pembrolizumab|mesh-list
153658139|NCT04777851|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153658140|NCT04777851|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153658141|NCT04777851|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153373033|NCT01381406|Parasympatholytics|parasympatholytics|mesh-ancestor
153373034|NCT01381406|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
153658142|NCT04777851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153658144|NCT04770272|Cyclophosphamide|cyclophosphamide|mesh-list
153658145|NCT04770272|Carboplatin|carboplatin|mesh-list
153658146|NCT04770272|Atezolizumab|atezolizumab|mesh-list
153658201|NCT04508400|Fosaprepitant|fosaprepitant|mesh-list
153658202|NCT04508400|Aprepitant|aprepitant|mesh-list
153658203|NCT04508400|BB 1101|bb 1101|mesh-list
153461850|NCT05244018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153461853|NCT02398500|Ranibizumab|ranibizumab|mesh-list
153461899|NCT04396938|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153461900|NCT04396938|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153461901|NCT04396938|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153461902|NCT00639678|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
153461903|NCT00639678|Immunologic Factors|immunologic factors|mesh-ancestor
153461904|NCT00639678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153889999|NCT04322175|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153890000|NCT04322175|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153461905|NCT02914158|Tamoxifen|tamoxifen|mesh-list
153658205|NCT04508400|Antiemetics|antiemetics|mesh-ancestor
153658206|NCT04508400|Autonomic Agents|autonomic agents|mesh-ancestor
153658207|NCT04508400|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153658208|NCT04508400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153658209|NCT04508400|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153658210|NCT04508400|Glucocorticoids|glucocorticoids|mesh-ancestor
153658211|NCT04508400|Hormones|hormones|mesh-ancestor
153658212|NCT04508400|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153658213|NCT04508400|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153658214|NCT04508400|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153658259|NCT04313335|Sensory System Agents|sensory system agents|mesh-ancestor
153658260|NCT04313335|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153658261|NCT04313335|Antidepressive Agents|antidepressive agents|mesh-ancestor
153658262|NCT04313335|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153658263|NCT04313335|Dopamine Agents|dopamine agents|mesh-ancestor
153658328|NCT04198662|Ropivacaine|ropivacaine|mesh-list
153658329|NCT04198662|Anesthetics, Local|anesthetics, local|mesh-ancestor
153658330|NCT04198662|Anesthetics|anesthetics|mesh-ancestor
153658331|NCT04198662|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153658332|NCT04198662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153658333|NCT04198662|Sensory System Agents|sensory system agents|mesh-ancestor
153658334|NCT04198662|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153892558|NCT01301066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153658335|NCT04198662|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153658337|NCT04198662|Adrenergic Agents|adrenergic agents|mesh-ancestor
153658338|NCT04198662|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153658339|NCT04198662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153658340|NCT04198662|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
153658341|NCT04198662|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153658389|NCT04167033|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153658390|NCT04167033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153658391|NCT04166396|Resveratrol|resveratrol|mesh-list
153658392|NCT04166396|Antioxidants|antioxidants|mesh-ancestor
153658393|NCT04166396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153658394|NCT04166396|Protective Agents|protective agents|mesh-ancestor
153658395|NCT04166396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153881922|NCT01680536|Maraviroc|maraviroc|mesh-list
153658396|NCT04166396|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153658397|NCT04166396|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153658398|NCT04039204|Contraceptive Agents|contraceptive agents|mesh-list
153658399|NCT04039204|Contraceptives, Oral|contraceptives, oral|mesh-list
153658400|NCT04039204|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153461906|NCT02914158|Leuprolide|leuprolide|mesh-list
153461907|NCT02914158|Goserelin|goserelin|mesh-list
153461908|NCT02914158|Aromatase Inhibitors|aromatase inhibitors|mesh-list
153461909|NCT02914158|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
153658401|NCT04039204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153658402|NCT04039204|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
153814463|NCT00451971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153433665|NCT02594293|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
153892577|NCT05642624|Antifungal Agents|antifungal agents|mesh-ancestor
153892578|NCT05642624|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
153892579|NCT05642624|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153892580|NCT04324346|Paclitaxel|paclitaxel|mesh-list
153892581|NCT04324346|Docetaxel|docetaxel|mesh-list
153461910|NCT02914158|Hormone Antagonists|hormone antagonists|mesh-ancestor
153461911|NCT02914158|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153461912|NCT02914158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153890001|NCT04322175|Analgesics|analgesics|mesh-ancestor
153890002|NCT04322175|Sensory System Agents|sensory system agents|mesh-ancestor
153890003|NCT04322175|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153658404|NCT03909412|Cyclophosphamide|cyclophosphamide|mesh-list
153461919|NCT02914158|Fertility Agents|fertility agents|mesh-ancestor
153658405|NCT03909412|Lenograstim|lenograstim|mesh-list
153658406|NCT03909412|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153658407|NCT03909412|Immunologic Factors|immunologic factors|mesh-ancestor
153658444|NCT03865212|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153658445|NCT03865212|Antiviral Agents|antiviral agents|mesh-ancestor
153658446|NCT03865212|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153658447|NCT03865212|Immunologic Factors|immunologic factors|mesh-ancestor
153658514|NCT03506360|Dexamethasone acetate|dexamethasone acetate|mesh-list
153658515|NCT03506360|Pembrolizumab|pembrolizumab|mesh-list
153461960|NCT05241054|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
153658516|NCT03506360|Ixazomib|ixazomib|mesh-list
153658517|NCT03506360|Ichthammol|ichthammol|mesh-list
153658518|NCT03506360|BB 1101|bb 1101|mesh-list
153658519|NCT03506360|Glycine|glycine|mesh-list
153658520|NCT03506360|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153658521|NCT03506360|Antiemetics|antiemetics|mesh-ancestor
153658522|NCT03506360|Autonomic Agents|autonomic agents|mesh-ancestor
153658582|NCT03330821|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153658583|NCT03330821|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153658584|NCT03330821|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153658585|NCT03309475|Psychotropic Drugs|psychotropic drugs|mesh-list
153658586|NCT03270501|Golimumab|golimumab|mesh-list
153658587|NCT03270501|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
153658588|NCT03270501|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153658589|NCT03270501|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153658590|NCT03270501|Immunologic Factors|immunologic factors|mesh-ancestor
153658591|NCT03270501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153658592|NCT03258567|Nivolumab|nivolumab|mesh-list
153658593|NCT03258567|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153461961|NCT05241054|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
153461962|NCT05241054|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
153461963|NCT05241054|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
153461964|NCT05241054|Cholinergic Agents|cholinergic agents|mesh-ancestor
153461965|NCT05241054|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153461966|NCT05241054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153461968|NCT00638508|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
153461969|NCT00638508|Ropivacaine|ropivacaine|mesh-list
153461970|NCT00638508|Anesthetics, Local|anesthetics, local|mesh-ancestor
153461971|NCT00638508|Anesthetics|anesthetics|mesh-ancestor
153658594|NCT03258567|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153658595|NCT03258567|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153658596|NCT03258567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153658597|NCT03257761|Durvalumab|durvalumab|mesh-list
153658598|NCT03257761|Guadecitabine|guadecitabine|mesh-list
153658599|NCT03257761|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153658600|NCT03257761|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153658601|NCT03250273|Nivolumab|nivolumab|mesh-list
153658602|NCT03250273|Entinostat|entinostat|mesh-list
153658603|NCT03250273|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153658604|NCT03250273|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153658605|NCT03250273|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153658606|NCT03250273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153658607|NCT03250273|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
153658608|NCT03250273|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153658609|NCT03128359|Mycophenolic Acid|mycophenolic acid|mesh-list
153658610|NCT03128359|Cyclophosphamide|cyclophosphamide|mesh-list
153658611|NCT03128359|Melphalan|melphalan|mesh-list
153658612|NCT03128359|Busulfan|busulfan|mesh-list
153658613|NCT03128359|Fludarabine|fludarabine|mesh-list
153658614|NCT03128359|Fludarabine phosphate|fludarabine phosphate|mesh-list
153658615|NCT03128359|Tacrolimus|tacrolimus|mesh-list
153658616|NCT03128359|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153461976|NCT00638508|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153461977|NCT00638508|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153461978|NCT00638508|Analgesics|analgesics|mesh-ancestor
153658623|NCT03128359|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153658624|NCT03128359|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153658625|NCT03128359|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153658626|NCT03128359|Antimetabolites|antimetabolites|mesh-ancestor
153658627|NCT03128359|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
153658628|NCT03128359|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153658629|NCT03128359|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153658630|NCT03128359|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
153658631|NCT03128359|Antitubercular Agents|antitubercular agents|mesh-ancestor
153658632|NCT03128359|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153658633|NCT03128359|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153658634|NCT03122886|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
153658635|NCT03122886|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-list
153658636|NCT03122886|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
153658684|NCT02539537|Oxaliplatin|oxaliplatin|mesh-list
153658685|NCT02539537|Irinotecan|irinotecan|mesh-list
153658686|NCT02539537|Levoleucovorin|levoleucovorin|mesh-list
153461979|NCT00638508|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153461980|NCT00638508|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153461981|NCT00638508|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153461982|NCT00638508|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153461983|NCT00638508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153461984|NCT00637806|Megestrol|megestrol|mesh-list
153462008|NCT00637728|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153462009|NCT00637728|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153462010|NCT00637728|Appetite Stimulants|appetite stimulants|mesh-ancestor
153658687|NCT02539537|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153658688|NCT02539537|Antimetabolites|antimetabolites|mesh-ancestor
153658689|NCT02539537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153658690|NCT02539537|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153658691|NCT02539537|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
153658692|NCT02539537|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153658693|NCT02539537|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153658755|NCT02245230|Angiotensin I (1-7)|angiotensin i (1-7)|mesh-list
153658756|NCT02245230|Trimethaphan|trimethaphan|mesh-list
153658757|NCT02245230|Phenylephrine|phenylephrine|mesh-list
153658758|NCT02245230|Oxymetazoline|oxymetazoline|mesh-list
153658759|NCT02245230|Trimethaphan camsylate|trimethaphan camsylate|mesh-list
153658760|NCT02245230|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
153658762|NCT02245230|Autonomic Agents|autonomic agents|mesh-ancestor
153668025|NCT00030615|Azacitidine|azacitidine|mesh-list
153658763|NCT02245230|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153658764|NCT02245230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153658765|NCT02245230|Sympathomimetics|sympathomimetics|mesh-ancestor
153658766|NCT02245230|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
153658767|NCT02245230|Nasal Decongestants|nasal decongestants|mesh-ancestor
153658768|NCT02245230|Respiratory System Agents|respiratory system agents|mesh-ancestor
153658769|NCT02245230|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
153658770|NCT02245230|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153658771|NCT02245230|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153658772|NCT02245230|Adrenergic Agents|adrenergic agents|mesh-ancestor
153658816|NCT01597388|Hormone Antagonists|hormone antagonists|mesh-ancestor
153658817|NCT01597388|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153422811|NCT00375661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153892672|NCT04322760|Sensory System Agents|sensory system agents|mesh-ancestor
153892673|NCT04322760|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153433736|NCT00000991|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
153433737|NCT00000991|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153433738|NCT00000991|Leprostatic Agents|leprostatic agents|mesh-ancestor
153433739|NCT00000991|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153433740|NCT00000991|Antifungal Agents|antifungal agents|mesh-ancestor
153433741|NCT00000991|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
153433742|NCT00000673|Ganciclovir|ganciclovir|mesh-list
153433744|NCT00000673|Antiviral Agents|antiviral agents|mesh-ancestor
153433745|NCT00000673|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153433746|NCT00000673|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153433747|NCT00000673|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153433749|NCT00000685|Zidovudine|zidovudine|mesh-list
153658818|NCT01597388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153658820|NCT01394640|Immunologic Factors|immunologic factors|mesh-ancestor
153658821|NCT01394640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153658822|NCT01228331|Cytarabine|cytarabine|mesh-list
153658823|NCT01228331|Dexamethasone|dexamethasone|mesh-list
153658824|NCT01228331|Methylprednisolone|methylprednisolone|mesh-list
153658825|NCT01228331|Cyclophosphamide|cyclophosphamide|mesh-list
153658826|NCT01228331|Doxorubicin|doxorubicin|mesh-list
153658827|NCT01228331|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
153658828|NCT01228331|Methotrexate|methotrexate|mesh-list
153658829|NCT01228331|Etoposide|etoposide|mesh-list
153658830|NCT01228331|Vincristine|vincristine|mesh-list
153658831|NCT01228331|Daunorubicin|daunorubicin|mesh-list
153658832|NCT01228331|Mercaptopurine|mercaptopurine|mesh-list
153658833|NCT01228331|Clofarabine|clofarabine|mesh-list
153658834|NCT01228331|Pegaspargase|pegaspargase|mesh-list
153658835|NCT01228331|Thioguanine|thioguanine|mesh-list
153658836|NCT01228331|Etoposide phosphate|etoposide phosphate|mesh-list
153658837|NCT01228331|Amsacrine|amsacrine|mesh-list
153658838|NCT01228331|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153658839|NCT01228331|Immunologic Factors|immunologic factors|mesh-ancestor
153658840|NCT01228331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153658841|NCT01228331|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153658842|NCT01228331|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153658843|NCT01228331|Alkylating Agents|alkylating agents|mesh-ancestor
153658866|NCT01228331|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153658867|NCT01228331|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153658868|NCT01228331|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153658870|NCT01228331|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153658871|NCT01228331|Tubulin Modulators|tubulin modulators|mesh-ancestor
153658872|NCT01228331|Antimitotic Agents|antimitotic agents|mesh-ancestor
153658873|NCT01228331|Mitosis Modulators|mitosis modulators|mesh-ancestor
153814464|NCT00451971|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153658874|NCT01228331|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
153658875|NCT01228331|Protective Agents|protective agents|mesh-ancestor
153658876|NCT00957086|Nimotuzumab|nimotuzumab|mesh-list
153658877|NCT00957086|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153658878|NCT00957086|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153658879|NCT00061438|Meropenem|meropenem|mesh-list
153658880|NCT00061438|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153658881|NCT00061438|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153658882|NCT00061477|Gemcitabine|gemcitabine|mesh-list
153658883|NCT00061477|Pemetrexed|pemetrexed|mesh-list
153658884|NCT00061477|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153658885|NCT00061477|Antimetabolites|antimetabolites|mesh-ancestor
153462011|NCT00637728|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
153462012|NCT01922466|Loxoprofen|loxoprofen|mesh-list
153462013|NCT01922466|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153462014|NCT01922466|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153462015|NCT01922466|Analgesics|analgesics|mesh-ancestor
153658887|NCT00061477|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153658920|NCT00061750|Iron Chelating Agents|iron chelating agents|mesh-ancestor
153462021|NCT00637572|Megestrol|megestrol|mesh-list
153658921|NCT00061750|Chelating Agents|chelating agents|mesh-ancestor
153462066|NCT00636636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153462068|NCT05244954|Chloroquine|chloroquine|mesh-list
153462069|NCT05244954|Piperaquine|piperaquine|mesh-list
153462070|NCT05244954|Artenimol|artenimol|mesh-list
153658922|NCT00061750|Sequestering Agents|sequestering agents|mesh-ancestor
153658923|NCT00061750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153658924|NCT00061750|Siderophores|siderophores|mesh-ancestor
153658925|NCT00061789|Acetylcholine|acetylcholine|mesh-list
153658926|NCT00061789|Vasodilator Agents|vasodilator agents|mesh-ancestor
153658927|NCT00061789|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
153658928|NCT00061789|Cholinergic Agents|cholinergic agents|mesh-ancestor
153438963|NCT02211482|Lamivudine|lamivudine|mesh-list
153658929|NCT00061789|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153658930|NCT00061789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153658931|NCT00061789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153658932|NCT00061867|Doxorubicin|doxorubicin|mesh-list
153658933|NCT00061867|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
153658934|NCT00061867|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153658935|NCT00061867|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153658936|NCT00061867|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153658940|NCT00061906|Celecoxib|celecoxib|mesh-list
153658977|NCT00398554|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153658978|NCT00398554|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153658979|NCT00398554|Tubulin Modulators|tubulin modulators|mesh-ancestor
153658980|NCT00398554|Antimitotic Agents|antimitotic agents|mesh-ancestor
153658981|NCT00398554|Mitosis Modulators|mitosis modulators|mesh-ancestor
153658983|NCT04917900|Trastuzumab|trastuzumab|mesh-list
153658984|NCT04917900|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
153658986|NCT04917900|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153658987|NCT04917900|Tubulin Modulators|tubulin modulators|mesh-ancestor
153658988|NCT04917900|Antimitotic Agents|antimitotic agents|mesh-ancestor
153658989|NCT04917900|Mitosis Modulators|mitosis modulators|mesh-ancestor
153658990|NCT04917900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153658991|NCT04917900|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153658992|NCT00061984|Doxorubicin|doxorubicin|mesh-list
153658993|NCT00061984|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
153658994|NCT00061984|Ifosfamide|ifosfamide|mesh-list
153658995|NCT00061984|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153659033|NCT00062062|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153659034|NCT00062062|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153659035|NCT00062062|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153659036|NCT00392340|Doxorubicin|doxorubicin|mesh-list
153659037|NCT00392340|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
153659038|NCT00392340|Vincristine|vincristine|mesh-list
153462071|NCT05244954|Amebicides|amebicides|mesh-ancestor
153659040|NCT00392340|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153659041|NCT00392340|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153659042|NCT00392340|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153462072|NCT05244954|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153462073|NCT05244954|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153462074|NCT05244954|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153462075|NCT05244954|Antimalarials|antimalarials|mesh-ancestor
153431045|NCT00000349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153659043|NCT00392340|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153462076|NCT05244954|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153462078|NCT01929252|Levobupivacaine|levobupivacaine|mesh-list
153462079|NCT01929252|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153659044|NCT00392340|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153659045|NCT00392340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153659046|NCT00392340|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153659047|NCT00392340|Tubulin Modulators|tubulin modulators|mesh-ancestor
153659048|NCT00392340|Antimitotic Agents|antimitotic agents|mesh-ancestor
153659049|NCT00392340|Mitosis Modulators|mitosis modulators|mesh-ancestor
153659089|NCT00062179|Analgesics|analgesics|mesh-ancestor
153659090|NCT00062179|Sensory System Agents|sensory system agents|mesh-ancestor
153814466|NCT00451971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153892715|NCT01299116|Etonogestrel|etonogestrel|mesh-list
153659091|NCT00062179|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153659092|NCT00062179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153659094|NCT00062179|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153659095|NCT00062179|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
153659096|NCT00062179|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153659097|NCT00062179|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153659098|NCT00062257|Irofulven|irofulven|mesh-list
153659099|NCT00062257|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153659100|NCT00062257|Alkylating Agents|alkylating agents|mesh-ancestor
153659101|NCT00062257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153659102|NCT00062257|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153659103|NCT00062296|Rituximab|rituximab|mesh-list
153659104|NCT00062296|Epirubicin|epirubicin|mesh-list
153659105|NCT00062296|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153659106|NCT00062296|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153659115|NCT02967874|Hyaluronic Acid|hyaluronic acid|mesh-list
153659143|NCT00062842|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153659144|NCT00062842|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153659145|NCT00062842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153659146|NCT00062842|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153659147|NCT00062881|Mafosfamide|mafosfamide|mesh-list
153659148|NCT00062881|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153659149|NCT00062881|Immunologic Factors|immunologic factors|mesh-ancestor
153659150|NCT00062881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153659151|NCT00062881|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153462080|NCT01929252|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153659152|NCT00389909|Doxapram|doxapram|mesh-list
153659153|NCT00389909|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
153659154|NCT00389909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153659155|NCT00389909|Respiratory System Agents|respiratory system agents|mesh-ancestor
153659156|NCT00063076|Bexarotene|bexarotene|mesh-list
153659157|NCT00063076|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153659158|NCT00063193|Minocycline|minocycline|mesh-list
153659159|NCT00063193|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153659160|NCT00063193|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153659161|NCT00063310|Leuprolide|leuprolide|mesh-list
153462081|NCT01929252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153462082|NCT01929252|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153659162|NCT00063310|Fertility Agents, Female|fertility agents, female|mesh-ancestor
153659165|NCT00063310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153659195|NCT00064051|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153659196|NCT00064051|Antimetabolites|antimetabolites|mesh-ancestor
153659197|NCT00064051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153659198|NCT00064051|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153462083|NCT01929252|Analgesics|analgesics|mesh-ancestor
153462084|NCT01929252|Sensory System Agents|sensory system agents|mesh-ancestor
153659200|NCT00064090|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153659201|NCT00064090|Antimetabolites|antimetabolites|mesh-ancestor
153462085|NCT01929252|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153462086|NCT01929252|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
153462087|NCT01929252|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153462088|NCT01929252|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153462089|NCT01929252|Adrenergic Agents|adrenergic agents|mesh-ancestor
153659202|NCT00064090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153659203|NCT00064090|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153814470|NCT00446004|Imatinib Mesylate|imatinib mesylate|mesh-list
153814471|NCT00446004|Omeprazole|omeprazole|mesh-list
153892751|NCT01260948|Donepezil|donepezil|mesh-list
153659205|NCT00064090|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153659206|NCT00064090|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153659207|NCT00064090|Immunologic Factors|immunologic factors|mesh-ancestor
153659208|NCT00064090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153659209|NCT00064129|Ipilimumab|ipilimumab|mesh-list
153659210|NCT00064129|Sargramostim|sargramostim|mesh-list
153659211|NCT00064129|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153659212|NCT00064129|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153659213|NCT00064129|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153659214|NCT00064129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153659215|NCT00064129|Immunologic Factors|immunologic factors|mesh-ancestor
153659216|NCT00064129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153659217|NCT00064207|Gemcitabine|gemcitabine|mesh-list
153659218|NCT00064207|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153659219|NCT00064207|Antimetabolites|antimetabolites|mesh-ancestor
153659220|NCT00064207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153659221|NCT00064207|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153659222|NCT00064246|Rituximab|rituximab|mesh-list
153659223|NCT00064246|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
153462090|NCT01929252|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153462091|NCT01929252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153462092|NCT01929252|Anesthetics, Local|anesthetics, local|mesh-ancestor
153462093|NCT01929252|Anesthetics|anesthetics|mesh-ancestor
153462094|NCT04275960|Selitrectinib|selitrectinib|mesh-list
153462095|NCT04275960|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153462096|NCT04275960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153462097|NCT00634920|Cyclosporine|cyclosporine|mesh-list
153462099|NCT00634920|Prednisolone|prednisolone|mesh-list
153659224|NCT00064246|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153659225|NCT00064246|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153659236|NCT00064285|Growth Inhibitors|growth inhibitors|mesh-ancestor
153659237|NCT00064285|Growth Substances|growth substances|mesh-ancestor
153659238|NCT00064285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153659239|NCT00392418|Micronutrients|micronutrients|mesh-list
153659240|NCT00392418|Trace Elements|trace elements|mesh-list
153659241|NCT00392418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153659243|NCT00064402|Formoterol Fumarate|formoterol fumarate|mesh-list
153659244|NCT00064402|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
153659245|NCT00064402|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153659246|NCT00064402|Autonomic Agents|autonomic agents|mesh-ancestor
153659247|NCT00064402|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153659248|NCT00064402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153659249|NCT00064402|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153659250|NCT00064402|Respiratory System Agents|respiratory system agents|mesh-ancestor
153659251|NCT00064402|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
153659252|NCT00064402|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
153659253|NCT00064402|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153659254|NCT00064402|Adrenergic Agents|adrenergic agents|mesh-ancestor
153659255|NCT00064402|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153659256|NCT00064402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153659257|NCT00423748|Ambrisentan|ambrisentan|mesh-list
153659258|NCT00423748|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153659259|NCT02967211|Insulin|insulin|mesh-list
153659260|NCT02967211|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
153659261|NCT02967211|Insulin Glargine|insulin glargine|mesh-list
153659262|NCT02967211|Insulin Detemir|insulin detemir|mesh-list
153659263|NCT02967211|Insulin, Isophane|insulin, isophane|mesh-list
153659264|NCT02967211|Isophane Insulin, Human|isophane insulin, human|mesh-list
153659265|NCT02967211|Isophane insulin, beef|isophane insulin, beef|mesh-list
153659266|NCT02967211|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153659267|NCT02967211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153659280|NCT00398788|Hydromorphone|hydromorphone|mesh-list
153659281|NCT00398788|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153462113|NCT00634920|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
153462114|NCT00634920|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153462115|NCT00634920|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153462116|NCT00634920|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153462117|NCT00634920|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
153462118|NCT00634920|Antitubercular Agents|antitubercular agents|mesh-ancestor
153462119|NCT00634920|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153462120|NCT00634920|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153659282|NCT00398788|Narcotics|narcotics|mesh-ancestor
153659283|NCT00398788|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153659284|NCT00398788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153659285|NCT00398788|Analgesics|analgesics|mesh-ancestor
153659286|NCT00398788|Sensory System Agents|sensory system agents|mesh-ancestor
153659287|NCT00398788|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153462121|NCT00634920|Glucocorticoids|glucocorticoids|mesh-ancestor
153462122|NCT00634920|Hormones|hormones|mesh-ancestor
153462123|NCT00634920|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153462124|NCT00634920|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153462125|NCT01923012|Vitamin K|vitamin k|mesh-list
153462126|NCT01923012|Vitamin K 2|vitamin k 2|mesh-list
153462127|NCT01923012|Vitamins|vitamins|mesh-ancestor
153462128|NCT01923012|Micronutrients|micronutrients|mesh-ancestor
153462129|NCT01923012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153462130|NCT01923012|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
153462131|NCT01923012|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153462133|NCT01923012|Hemostatics|hemostatics|mesh-ancestor
153462167|NCT04396548|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153462168|NCT04396548|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153462169|NCT04396548|Adrenergic Agents|adrenergic agents|mesh-ancestor
153496233|NCT00002118|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153659288|NCT00398827|Dexmedetomidine|dexmedetomidine|mesh-list
153659289|NCT00398827|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153659290|NCT00398827|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153659291|NCT00398827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153659292|NCT00398827|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153659293|NCT00398827|Analgesics|analgesics|mesh-ancestor
153659294|NCT00398827|Sensory System Agents|sensory system agents|mesh-ancestor
153659302|NCT00065455|Vitamin A|vitamin a|mesh-list
153659336|NCT00066001|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153659337|NCT00066001|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153439112|NCT00002905|Zidovudine|zidovudine|mesh-list
153659338|NCT00066001|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153659339|NCT00066157|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
153659340|NCT00066157|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
153659341|NCT00066157|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
153659342|NCT00066157|Medroxyprogesterone|medroxyprogesterone|mesh-list
153659343|NCT00066157|Estradiol|estradiol|mesh-list
153659344|NCT00066157|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
153659345|NCT00066157|Estrogens|estrogens|mesh-list
153659346|NCT00066157|Progesterone|progesterone|mesh-list
153659349|NCT00066157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153659402|NCT00066391|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
153659403|NCT00066391|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153659404|NCT00066391|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153659405|NCT00066391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153659406|NCT04388475|Temozolomide|temozolomide|mesh-list
153659407|NCT04388475|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153659408|NCT04388475|Alkylating Agents|alkylating agents|mesh-ancestor
153659409|NCT04388475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153659410|NCT04388475|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153659411|NCT00389987|Tazobactam|tazobactam|mesh-list
153659412|NCT00389987|Piperacillin|piperacillin|mesh-list
153659413|NCT00389987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153659414|NCT00389987|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153659415|NCT00389987|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153431046|NCT00000805|Ganciclovir|ganciclovir|mesh-list
153659417|NCT00389987|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153659460|NCT00067015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153659461|NCT00067093|Vitamin K|vitamin k|mesh-list
153659462|NCT00067093|Heparin|heparin|mesh-list
153659463|NCT00067093|Calcium heparin|calcium heparin|mesh-list
153659464|NCT00067093|Idraparinux|idraparinux|mesh-list
153659465|NCT00067093|Vitamins|vitamins|mesh-ancestor
153659466|NCT00067093|Micronutrients|micronutrients|mesh-ancestor
153659467|NCT00067093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153659468|NCT00067093|Anticoagulants|anticoagulants|mesh-ancestor
153659469|NCT00067093|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153659470|NCT00067093|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153659471|NCT00067093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153814473|NCT00446004|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153659472|NCT00067093|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
153659473|NCT00067093|Hemostatics|hemostatics|mesh-ancestor
153659474|NCT00067093|Coagulants|coagulants|mesh-ancestor
153659475|NCT00067093|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
153659476|NCT00067093|Antithrombins|antithrombins|mesh-ancestor
153659477|NCT00067093|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
153659478|NCT00067093|Protease Inhibitors|protease inhibitors|mesh-ancestor
153659479|NCT00067093|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153659480|NCT00398905|Enoxaparin|enoxaparin|mesh-list
153659481|NCT00398905|Rivaroxaban|rivaroxaban|mesh-list
153659482|NCT00398905|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
153659483|NCT00398905|Antithrombins|antithrombins|mesh-ancestor
153659484|NCT00398905|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
153659485|NCT00398905|Protease Inhibitors|protease inhibitors|mesh-ancestor
153659486|NCT00398905|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153659487|NCT00398905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153659488|NCT00398905|Anticoagulants|anticoagulants|mesh-ancestor
153659489|NCT00398905|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153659508|NCT00399022|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
153659509|NCT00399022|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
153659510|NCT00399022|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153659511|NCT00399022|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153462170|NCT04396548|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153462171|NCT04396548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153462172|NCT01929798|Pancrelipase|pancrelipase|mesh-list
153462173|NCT01929798|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153462174|NCT00633984|Cycloserine|cycloserine|mesh-list
153462175|NCT00633984|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
153462176|NCT00633984|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153462177|NCT00633984|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
153462178|NCT00633984|Antitubercular Agents|antitubercular agents|mesh-ancestor
153462229|NCT00633360|Drospirenone|drospirenone|mesh-list
153462230|NCT00633360|Ethinyl Estradiol|ethinyl estradiol|mesh-list
153462231|NCT00633360|Drospirenone and ethinyl estradiol combination|drospirenone and ethinyl estradiol combination|mesh-list
153659512|NCT00399022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153659513|NCT00399022|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153659514|NCT00399022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153659572|NCT00067951|Metformin|metformin|mesh-list
153659573|NCT00067951|Rosiglitazone|rosiglitazone|mesh-list
153659574|NCT00067951|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153659575|NCT00067951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153659576|NCT00392457|Ketoconazole|ketoconazole|mesh-list
153814474|NCT00446004|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153659577|NCT00392457|Hormones|hormones|mesh-list
153659578|NCT00392457|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153659579|NCT00392457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153659580|NCT00392457|Antifungal Agents|antifungal agents|mesh-ancestor
153659581|NCT00392457|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153462233|NCT00633360|Estrogens|estrogens|mesh-ancestor
153659582|NCT00392457|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
153659583|NCT00392457|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153659584|NCT00392457|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153659585|NCT00392457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153659586|NCT00392457|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153462235|NCT00633360|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153462236|NCT00633360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153462237|NCT00633360|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
153462238|NCT00633360|Contraceptive Agents|contraceptive agents|mesh-ancestor
153462239|NCT00633360|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153462240|NCT00633360|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
153462241|NCT00633360|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
153462242|NCT00633360|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
153462243|NCT00633360|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
153462244|NCT00633360|Hormone Antagonists|hormone antagonists|mesh-ancestor
153462245|NCT00633360|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
153462246|NCT00633360|Diuretics|diuretics|mesh-ancestor
153462247|NCT00633360|Natriuretic Agents|natriuretic agents|mesh-ancestor
153462248|NCT00988260|Ganirelix|ganirelix|mesh-list
153462252|NCT00633126|Ceftaroline|ceftaroline|mesh-list
153462285|NCT01923948|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153462286|NCT01923948|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153462289|NCT01923948|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153659587|NCT00392457|Hormone Antagonists|hormone antagonists|mesh-ancestor
153659588|NCT00392457|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
153659590|NCT00068029|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153659591|NCT00068029|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153659593|NCT00068068|Talaporfin|talaporfin|mesh-list
153659623|NCT00068653|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153659624|NCT00068653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153659625|NCT00068653|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153659627|NCT00068653|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
153659628|NCT00068653|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153659629|NCT00068653|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153659630|NCT00068653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153659631|NCT00068653|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153659632|NCT00068653|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153659633|NCT00068653|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153659634|NCT00068731|Lycopene|lycopene|mesh-list
153659635|NCT00068731|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153659636|NCT00068731|Antioxidants|antioxidants|mesh-ancestor
153659637|NCT00068731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153659638|NCT00068731|Protective Agents|protective agents|mesh-ancestor
153659639|NCT00068731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153659640|NCT00068731|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
153659678|NCT00069550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153659679|NCT00069550|Cholinergic Agents|cholinergic agents|mesh-ancestor
153659680|NCT00069550|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153659681|NCT00069550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153659682|NCT00069550|Nootropic Agents|nootropic agents|mesh-ancestor
153659683|NCT00069550|Antitussive Agents|antitussive agents|mesh-ancestor
153659684|NCT00069550|Respiratory System Agents|respiratory system agents|mesh-ancestor
153659685|NCT00069550|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
153659686|NCT00069550|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
153659688|NCT00069550|Narcotics|narcotics|mesh-ancestor
153659689|NCT00069550|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153659690|NCT00069550|Analgesics|analgesics|mesh-ancestor
153659691|NCT00069550|Sensory System Agents|sensory system agents|mesh-ancestor
153659692|NCT00069550|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153659693|NCT02966587|Durvalumab|durvalumab|mesh-list
153659694|NCT02966587|Immunoglobulins|immunoglobulins|mesh-list
153659695|NCT02966587|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
153659696|NCT02966587|Immunoglobulin G|immunoglobulin g|mesh-list
153659697|NCT02966587|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153659698|NCT02966587|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153659699|NCT02966587|Immunologic Factors|immunologic factors|mesh-ancestor
153659700|NCT02966587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153659701|NCT04958720|Immunomodulating Agents|immunomodulating agents|mesh-list
153659702|NCT04958720|Immunologic Factors|immunologic factors|mesh-ancestor
153659728|NCT00070057|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
153659729|NCT00070057|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153659730|NCT00070057|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153659731|NCT00070057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153659732|NCT00070174|Cytarabine|cytarabine|mesh-list
153659733|NCT00070174|Cyclosporine|cyclosporine|mesh-list
153659734|NCT00070174|Cyclophosphamide|cyclophosphamide|mesh-list
153659735|NCT00070174|Busulfan|busulfan|mesh-list
153659736|NCT00070174|Methotrexate|methotrexate|mesh-list
153659737|NCT00070174|Etoposide|etoposide|mesh-list
153659797|NCT00070252|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153659798|NCT00070252|Tubulin Modulators|tubulin modulators|mesh-ancestor
153659799|NCT00070252|Antimitotic Agents|antimitotic agents|mesh-ancestor
153659800|NCT00070252|Mitosis Modulators|mitosis modulators|mesh-ancestor
153462297|NCT00631488|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153462298|NCT00631488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153462299|NCT00631488|Incretins|incretins|mesh-ancestor
153462300|NCT00631488|Hormones|hormones|mesh-ancestor
153462301|NCT00631488|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153462302|NCT00631488|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
153462303|NCT00631488|Protease Inhibitors|protease inhibitors|mesh-ancestor
153462304|NCT00631488|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153462305|NCT00631488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153462306|NCT01924104|Aspirin|aspirin|mesh-list
153462307|NCT01924104|Heparin|heparin|mesh-list
153462308|NCT01924104|Calcium heparin|calcium heparin|mesh-list
153462309|NCT01924104|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
153462310|NCT01924104|Tinzaparin|tinzaparin|mesh-list
153462311|NCT01924104|Dalteparin|dalteparin|mesh-list
153462313|NCT01924104|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153659801|NCT00070252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153659802|NCT00070252|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153659803|NCT00070252|Antimetabolites|antimetabolites|mesh-ancestor
153659804|NCT00070447|Prednisone|prednisone|mesh-list
153659805|NCT00070447|Cyclophosphamide|cyclophosphamide|mesh-list
153659806|NCT00070447|Rituximab|rituximab|mesh-list
153659807|NCT00070447|Doxorubicin|doxorubicin|mesh-list
153659808|NCT00070447|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
153659809|NCT00070447|Vincristine|vincristine|mesh-list
153659810|NCT00070447|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153659811|NCT00070447|Immunologic Factors|immunologic factors|mesh-ancestor
153659812|NCT00070447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153892895|NCT03181932|Vancomycin|vancomycin|mesh-list
153659813|NCT00070447|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153659814|NCT00070447|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153659815|NCT00070447|Alkylating Agents|alkylating agents|mesh-ancestor
153462329|NCT00987402|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
153659816|NCT00070447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153659817|NCT00070447|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153659818|NCT00070447|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153659819|NCT00070447|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153659820|NCT00070447|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153659848|NCT00070486|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153659849|NCT00070486|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153659850|NCT00070486|Analgesics|analgesics|mesh-ancestor
153659851|NCT00070486|Sensory System Agents|sensory system agents|mesh-ancestor
153659852|NCT00070486|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153659853|NCT00070486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153659854|NCT00070486|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153659855|NCT00070486|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153439258|NCT00002977|Melphalan|melphalan|mesh-list
153659856|NCT00070486|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
153659857|NCT00070486|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153462330|NCT00987402|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153462331|NCT00987402|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153462332|NCT00987402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153462335|NCT00630786|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153462399|NCT00983580|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153462400|NCT00983580|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153462401|NCT00983580|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153462402|NCT00983580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153462403|NCT00983580|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153462404|NCT00983580|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153462405|NCT00983580|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153659858|NCT00070486|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153659859|NCT00070486|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
153659860|NCT00070486|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
153659861|NCT00070486|Hormone Antagonists|hormone antagonists|mesh-ancestor
153659862|NCT00070486|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153659863|NCT00070525|Tipifarnib|tipifarnib|mesh-list
153659864|NCT00070525|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153659865|NCT00070642|Dacarbazine|dacarbazine|mesh-list
153462406|NCT00983580|Antipyretics|antipyretics|mesh-ancestor
153659866|NCT00070642|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153659868|NCT00070642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153659869|NCT00070642|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153659870|NCT00070759|Daclizumab|daclizumab|mesh-list
153659871|NCT00070759|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153659872|NCT00070759|Immunologic Factors|immunologic factors|mesh-ancestor
153659897|NCT00071227|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153659898|NCT00071227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153659899|NCT00071266|Niacin|niacin|mesh-list
153659900|NCT00071266|Lovastatin|lovastatin|mesh-list
153659901|NCT00071266|L 647318|l 647318|mesh-list
153659902|NCT00071266|Dihydromevinolin|dihydromevinolin|mesh-list
153659903|NCT00071266|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153659904|NCT00071266|Antimetabolites|antimetabolites|mesh-ancestor
153659905|NCT00071266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153659906|NCT00071266|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153659907|NCT00071266|Vasodilator Agents|vasodilator agents|mesh-ancestor
153659908|NCT00071266|Vitamin B Complex|vitamin b complex|mesh-ancestor
153659909|NCT00071266|Vitamins|vitamins|mesh-ancestor
153659915|NCT02966743|Midazolam|midazolam|mesh-list
153659959|NCT00071929|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153659960|NCT00071968|Sirolimus|sirolimus|mesh-list
153659961|NCT00071968|Temsirolimus|temsirolimus|mesh-list
153659974|NCT00390065|Nitric Oxide|nitric oxide|mesh-list
153660032|NCT03959514|Insulin Aspart|insulin aspart|mesh-list
153660033|NCT03959514|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153814475|NCT00446004|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153660035|NCT04730596|Dexmedetomidine|dexmedetomidine|mesh-list
153462411|NCT00983580|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153462412|NCT00983580|Ornithine Decarboxylase Inhibitors|ornithine decarboxylase inhibitors|mesh-ancestor
153462413|NCT00982878|Maraviroc|maraviroc|mesh-list
153462414|NCT00982878|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
153462415|NCT00982878|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
153462416|NCT00982878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153462417|NCT00982878|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153462418|NCT00982878|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153462419|NCT00982878|Antiviral Agents|antiviral agents|mesh-ancestor
153462420|NCT00982878|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153462423|NCT00982488|Dasatinib|dasatinib|mesh-list
153462449|NCT01926132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153462451|NCT01926132|Micronutrients|micronutrients|mesh-ancestor
153462452|NCT01926210|Letrozole|letrozole|mesh-list
153462453|NCT01926210|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153462454|NCT01926210|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
153462455|NCT01926210|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153462456|NCT01926210|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153462462|NCT01926288|Entecavir|entecavir|mesh-list
153462518|NCT04275414|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153660036|NCT04730596|Ketamine|ketamine|mesh-list
153660037|NCT04730596|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153660101|NCT00072163|Leprostatic Agents|leprostatic agents|mesh-ancestor
153660102|NCT00072163|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153660103|NCT00072163|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153660104|NCT00072163|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153660105|NCT00072163|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153660106|NCT00072163|Growth Substances|growth substances|mesh-ancestor
153660107|NCT00072163|Growth Inhibitors|growth inhibitors|mesh-ancestor
153660108|NCT00072319|Paclitaxel|paclitaxel|mesh-list
153660109|NCT00072319|Cyclophosphamide|cyclophosphamide|mesh-list
153660110|NCT00072319|Epirubicin|epirubicin|mesh-list
153660111|NCT00072319|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153660112|NCT00072319|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153462526|NCT04395768|Vitamins|vitamins|mesh-list
153462527|NCT04395768|Ascorbic Acid|ascorbic acid|mesh-list
153462528|NCT04395768|Vitamin B 12|vitamin b 12|mesh-list
153462587|NCT01928316|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
153462588|NCT01928316|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
153462589|NCT01928316|Histamine Antagonists|histamine antagonists|mesh-ancestor
153462590|NCT01928316|Histamine Agents|histamine agents|mesh-ancestor
153462591|NCT01928316|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153462592|NCT01928316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153462593|NCT01928316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153462595|NCT04550520|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153462596|NCT04550520|Hormones|hormones|mesh-ancestor
153462597|NCT04550520|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153462598|NCT04550520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153462599|NCT01928628|Valsartan|valsartan|mesh-list
153462600|NCT01928628|Lercanidipine|lercanidipine|mesh-list
153462601|NCT01928628|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153434041|NCT00380965|Autonomic Agents|autonomic agents|mesh-ancestor
153462602|NCT01928628|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
153660113|NCT00072319|Tubulin Modulators|tubulin modulators|mesh-ancestor
153660114|NCT00072319|Antimitotic Agents|antimitotic agents|mesh-ancestor
153660165|NCT00072553|Micronutrients|micronutrients|mesh-ancestor
153660166|NCT00072553|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153660167|NCT00072553|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153660168|NCT00072553|Analgesics|analgesics|mesh-ancestor
153660169|NCT00072553|Sensory System Agents|sensory system agents|mesh-ancestor
153660170|NCT00072553|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153660171|NCT00072553|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153660234|NCT03959124|Memantine|memantine|mesh-list
153660235|NCT03959124|Rivastigmine|rivastigmine|mesh-list
153660236|NCT03959124|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
153660237|NCT03959124|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
153660238|NCT03959124|Dopamine Agents|dopamine agents|mesh-ancestor
153660239|NCT03959124|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153660240|NCT03959124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153462603|NCT01928628|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
153462604|NCT01928628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153462605|NCT01928628|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153660241|NCT03959124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153660242|NCT03959124|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
153422821|NCT04941170|Bupivacaine|bupivacaine|mesh-list
153422822|NCT04941170|Anesthetics, Local|anesthetics, local|mesh-ancestor
153422823|NCT04941170|Anesthetics|anesthetics|mesh-ancestor
153422824|NCT04941170|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153422825|NCT04941170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153439350|NCT00002995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153439351|NCT00002995|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153660243|NCT03959124|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
153660244|NCT03959124|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
153660245|NCT03959124|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153660246|NCT03959124|Cholinergic Agents|cholinergic agents|mesh-ancestor
153660247|NCT03959124|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
153660248|NCT03959124|Protective Agents|protective agents|mesh-ancestor
153660249|NCT02966236|Tranexamic Acid|tranexamic acid|mesh-list
153660250|NCT02966236|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
153660251|NCT02966236|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153660252|NCT02966236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153660253|NCT02966236|Hemostatics|hemostatics|mesh-ancestor
153660254|NCT02966236|Coagulants|coagulants|mesh-ancestor
153660255|NCT04711291|Tacrolimus|tacrolimus|mesh-list
153660256|NCT04711291|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153660257|NCT04711291|Immunologic Factors|immunologic factors|mesh-ancestor
153660258|NCT04711291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153660259|NCT04711291|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
153660260|NCT04711291|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153660261|NCT04711291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153660262|NCT00073372|Abciximab|abciximab|mesh-list
153660263|NCT00073372|Anticoagulants|anticoagulants|mesh-ancestor
153660277|NCT00073411|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
153462606|NCT01928628|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153462638|NCT05601960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153462639|NCT05601960|Dermatologic Agents|dermatologic agents|mesh-ancestor
153462640|NCT05605002|Serotonin|serotonin|mesh-list
153462641|NCT05605002|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
153462654|NCT04124094|Xhance|xhance|mesh-list
153462655|NCT04124094|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
153462656|NCT04124094|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
153462657|NCT04124094|Charcoal|charcoal|mesh-list
153462658|NCT04124094|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153660278|NCT00073411|Analgesics|analgesics|mesh-ancestor
153660279|NCT00073411|Sensory System Agents|sensory system agents|mesh-ancestor
153660280|NCT00073411|Dopamine Agents|dopamine agents|mesh-ancestor
153462659|NCT04124094|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153660283|NCT02966041|Autonomic Agents|autonomic agents|mesh-ancestor
153660284|NCT02966041|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153660285|NCT02966041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153660286|NCT02966041|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153660287|NCT02966041|Antipruritics|antipruritics|mesh-ancestor
153660288|NCT02966041|Dermatologic Agents|dermatologic agents|mesh-ancestor
153660289|NCT02966041|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
153462660|NCT04124094|Autonomic Agents|autonomic agents|mesh-ancestor
153462661|NCT04124094|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153462662|NCT04124094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153660290|NCT02966041|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153893011|NCT01232283|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153893012|NCT01232283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153893013|NCT01232283|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153893014|NCT01232283|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153893015|NCT01232283|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
153893016|NCT01232283|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
153660291|NCT02966041|Serotonin Agents|serotonin agents|mesh-ancestor
153660292|NCT02966041|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153660293|NCT02966041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153660294|NCT00073723|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
153660295|NCT00073723|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153660296|NCT00073840|Albuterol|albuterol|mesh-list
153660297|NCT00073840|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153660298|NCT00073840|Autonomic Agents|autonomic agents|mesh-ancestor
153660299|NCT00073840|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153660328|NCT00074074|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
153660329|NCT00074074|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153660330|NCT00074074|Dermatologic Agents|dermatologic agents|mesh-ancestor
153462663|NCT04124094|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153462688|NCT04123392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153462689|NCT04123392|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153462690|NCT04123392|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153462691|NCT04123392|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153462692|NCT04123392|Antimetabolites|antimetabolites|mesh-ancestor
153462693|NCT04123392|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153462694|NCT04760262|Remifentanil|remifentanil|mesh-list
153462695|NCT04760262|Propofol|propofol|mesh-list
153462696|NCT04760262|Sevoflurane|sevoflurane|mesh-list
153462697|NCT04760262|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153462698|NCT04760262|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153462699|NCT04760262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153660331|NCT00074074|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153660332|NCT00074074|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153660333|NCT00392652|3,3'-diindolylmethane|3,3'-diindolylmethane|mesh-list
153660334|NCT00392652|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
153660335|NCT00392652|Protective Agents|protective agents|mesh-ancestor
153660336|NCT00392652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153660337|NCT00392652|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153660338|NCT00074191|Cytarabine|cytarabine|mesh-list
153660339|NCT00074191|Dexamethasone|dexamethasone|mesh-list
153660340|NCT00074191|Methotrexate|methotrexate|mesh-list
153660341|NCT00074191|Lomustine|lomustine|mesh-list
153497323|NCT00002682|Omeprazole|omeprazole|mesh-list
153660342|NCT00074191|Procarbazine|procarbazine|mesh-list
153660343|NCT00074191|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153660344|NCT00074191|Antiemetics|antiemetics|mesh-ancestor
153660345|NCT00074191|Autonomic Agents|autonomic agents|mesh-ancestor
153660346|NCT00074191|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153660347|NCT00074191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153660348|NCT00074191|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153660349|NCT00074191|Glucocorticoids|glucocorticoids|mesh-ancestor
153660350|NCT00074191|Hormones|hormones|mesh-ancestor
153660351|NCT00074191|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153660352|NCT00074191|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153660376|NCT00392691|Rituximab|rituximab|mesh-list
153660378|NCT00392691|Vinorelbine|vinorelbine|mesh-list
153660379|NCT00392691|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153660380|NCT00392691|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153660381|NCT00392691|Immunologic Factors|immunologic factors|mesh-ancestor
153660382|NCT00392691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153660383|NCT00392691|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153660384|NCT00392691|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153660385|NCT00392691|Alkylating Agents|alkylating agents|mesh-ancestor
153660387|NCT00392691|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153660444|NCT00074776|Lamotrigine|lamotrigine|mesh-list
153660445|NCT00074776|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153660446|NCT00074776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153660447|NCT00074776|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153660448|NCT00074776|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153660449|NCT00074776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153660450|NCT00074776|Anticonvulsants|anticonvulsants|mesh-ancestor
153660451|NCT00074776|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153893043|NCT01258608|Sorafenib|sorafenib|mesh-list
153660454|NCT00074776|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153660455|NCT00074776|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153660456|NCT00075010|Decitabine|decitabine|mesh-list
153660457|NCT00075010|Valproic Acid|valproic acid|mesh-list
153660458|NCT00075010|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153660459|NCT00075010|Antimetabolites|antimetabolites|mesh-ancestor
153660461|NCT00075010|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153660499|NCT00075517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153660500|NCT00075517|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153660501|NCT00075517|Tubulin Modulators|tubulin modulators|mesh-ancestor
153660502|NCT00075517|Antimitotic Agents|antimitotic agents|mesh-ancestor
153660503|NCT00075517|Mitosis Modulators|mitosis modulators|mesh-ancestor
153660504|NCT00075556|Capecitabine|capecitabine|mesh-list
153660505|NCT00075556|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153660506|NCT00075556|Antimetabolites|antimetabolites|mesh-ancestor
153660507|NCT00075556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153660508|NCT00075556|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153660509|NCT00075595|Leucovorin|leucovorin|mesh-list
153660510|NCT00075595|Fluorouracil|fluorouracil|mesh-list
153660511|NCT00075595|Irinotecan|irinotecan|mesh-list
153660512|NCT00075595|Calcium|calcium|mesh-list
153660513|NCT00075595|Levoleucovorin|levoleucovorin|mesh-list
153660514|NCT00075595|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153660515|NCT00075595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153660516|NCT00075595|Antimetabolites|antimetabolites|mesh-ancestor
153660517|NCT00075595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153462752|NCT03831126|Hormones|hormones|mesh-ancestor
153660557|NCT00075673|Sensory System Agents|sensory system agents|mesh-ancestor
153462829|NCT04120350|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
153434147|NCT00380575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153660559|NCT00075673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153660560|NCT00075673|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153660561|NCT00075673|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153660562|NCT00075673|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
153660563|NCT00075673|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153660564|NCT00075673|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153660565|NCT00075673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153660566|NCT00075673|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153660567|NCT00075673|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153660568|NCT00075673|Tubulin Modulators|tubulin modulators|mesh-ancestor
153660569|NCT00075673|Antimitotic Agents|antimitotic agents|mesh-ancestor
153660570|NCT00075673|Mitosis Modulators|mitosis modulators|mesh-ancestor
153660571|NCT00075712|Paclitaxel|paclitaxel|mesh-list
153660572|NCT00075712|Carboplatin|carboplatin|mesh-list
153660573|NCT00075712|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153660574|NCT00075712|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153660575|NCT00075712|Tubulin Modulators|tubulin modulators|mesh-ancestor
153660576|NCT00075712|Antimitotic Agents|antimitotic agents|mesh-ancestor
153660577|NCT00075712|Mitosis Modulators|mitosis modulators|mesh-ancestor
153660578|NCT00075712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153660579|NCT03958500|Methylene Blue|methylene blue|mesh-list
153814477|NCT00446004|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153814478|NCT00446004|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
153814479|NCT00446004|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153660580|NCT03958500|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153660581|NCT03958500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153660583|NCT00075751|Gemcitabine|gemcitabine|mesh-list
153660584|NCT00075751|Bortezomib|bortezomib|mesh-list
153660585|NCT00075751|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153660586|NCT00075751|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153660587|NCT00075751|Antimetabolites|antimetabolites|mesh-ancestor
153660588|NCT00075751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153660589|NCT00075868|Octreotide|octreotide|mesh-list
153462830|NCT04120350|Abortifacient Agents|abortifacient agents|mesh-ancestor
153660590|NCT00075868|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153462831|NCT04120350|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153462832|NCT04120350|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153462833|NCT04120350|Antimetabolites|antimetabolites|mesh-ancestor
153462834|NCT04120350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153462842|NCT04120350|Growth Substances|growth substances|mesh-ancestor
153462843|NCT04120350|Growth Inhibitors|growth inhibitors|mesh-ancestor
153890012|NCT04321785|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
153660591|NCT00075868|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153660596|NCT00075907|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
153660597|NCT00075907|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
153660598|NCT00075907|Protease Inhibitors|protease inhibitors|mesh-ancestor
153660599|NCT00075907|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153660600|NCT00075907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153431050|NCT00000805|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153431051|NCT00000805|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153431052|NCT00000805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153431053|NCT00000355|Buprenorphine|buprenorphine|mesh-list
153431054|NCT00000355|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153431055|NCT00000355|Narcotics|narcotics|mesh-ancestor
153462844|NCT04394598|Capecitabine|capecitabine|mesh-list
153462845|NCT04394598|Irinotecan|irinotecan|mesh-list
153660601|NCT00075907|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153660602|NCT00075907|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153660603|NCT00075907|Antiviral Agents|antiviral agents|mesh-ancestor
153660604|NCT00075907|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153660605|NCT00075907|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
153893084|NCT01052428|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153893085|NCT01052428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153893086|NCT01052428|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
153893087|NCT01052428|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
153893092|NCT01052272|Allopurinol|allopurinol|mesh-list
153660606|NCT00075907|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153660607|NCT00075907|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153660608|NCT00075907|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153660609|NCT00075907|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
153660610|NCT00075907|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
153660611|NCT00075907|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
153660612|NCT00075907|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
153660613|NCT00075907|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
153660649|NCT00399295|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
153660650|NCT00399334|Antipsychotic Agents|antipsychotic agents|mesh-list
153660651|NCT00399334|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153660652|NCT00399334|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153660653|NCT00399334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153660654|NCT00399334|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153660655|NCT00076492|Coenzyme Q10|coenzyme q10|mesh-list
153497683|NCT05360628|Allopurinol|allopurinol|mesh-list
153660718|NCT03951207|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
153660719|NCT03951207|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153660720|NCT03951207|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153660721|NCT03951207|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153660722|NCT03951207|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153660723|NCT03951207|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153660724|NCT03951207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153660725|NCT03951207|Vasodilator Agents|vasodilator agents|mesh-ancestor
153660726|NCT00077194|Romidepsin|romidepsin|mesh-list
153660727|NCT00077194|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153660728|NCT00077194|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153660779|NCT00077389|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153660780|NCT00077389|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153660781|NCT00077389|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153660782|NCT00077389|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153660783|NCT00077389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153660784|NCT00077428|Doxorubicin|doxorubicin|mesh-list
153660785|NCT00077428|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
153660786|NCT00077428|Bortezomib|bortezomib|mesh-list
153660787|NCT00077428|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153660788|NCT00077428|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153660845|NCT00078247|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153660846|NCT00078247|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153660847|NCT00078247|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153660848|NCT00078247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153660849|NCT00078247|Antiviral Agents|antiviral agents|mesh-ancestor
153814480|NCT00446082|Pasireotide|pasireotide|mesh-list
153434207|NCT00001999|Ganciclovir|ganciclovir|mesh-list
153462846|NCT04394598|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153462848|NCT04394598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153462849|NCT04394598|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153462850|NCT04394598|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
153660851|NCT00078247|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153660852|NCT00078247|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153660853|NCT00078247|Antimetabolites|antimetabolites|mesh-ancestor
153660855|NCT00078442|Interferon-alpha|interferon-alpha|mesh-list
153660856|NCT00078442|Interferon alpha-2|interferon alpha-2|mesh-list
153660857|NCT00078442|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
153660858|NCT00078442|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153660859|NCT00078442|Antiviral Agents|antiviral agents|mesh-ancestor
153462851|NCT04394598|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153660860|NCT00078442|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153660861|NCT00078442|Immunologic Factors|immunologic factors|mesh-ancestor
153660862|NCT00078442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153660864|NCT00078481|Antioxidants|antioxidants|mesh-ancestor
153660865|NCT00078481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153660866|NCT00078481|Protective Agents|protective agents|mesh-ancestor
153660867|NCT00078481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153660868|NCT00078598|Rituximab|rituximab|mesh-list
153462852|NCT04394598|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153660869|NCT00078598|Tositumomab I-131|tositumomab i-131|mesh-list
153660870|NCT00078598|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153660871|NCT00078598|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153497828|NCT00002796|Interferon-gamma|interferon-gamma|mesh-list
153660872|NCT00078598|Immunologic Factors|immunologic factors|mesh-ancestor
153660873|NCT00078598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153660874|NCT00078598|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153660889|NCT00078832|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153660890|NCT00078832|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
153660891|NCT00078832|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153660892|NCT00078832|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153660893|NCT00078832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153660894|NCT00078832|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
153660895|NCT00078832|Hormone Antagonists|hormone antagonists|mesh-ancestor
153660896|NCT00078832|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153660897|NCT00078832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153462853|NCT04127916|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
153462854|NCT04127916|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153462905|NCT04758936|Adrenergic Agents|adrenergic agents|mesh-ancestor
153462906|NCT04758936|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153462907|NCT04758936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153462908|NCT04758936|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153660898|NCT01350128|Bromides|bromides|mesh-list
153660899|NCT01350128|Ipratropium|ipratropium|mesh-list
153660900|NCT01350128|Anticonvulsants|anticonvulsants|mesh-ancestor
153660901|NCT01350128|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153660902|NCT01350128|Autonomic Agents|autonomic agents|mesh-ancestor
153660903|NCT01350128|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153660904|NCT01350128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153462909|NCT04758936|Sympatholytics|sympatholytics|mesh-ancestor
153462910|NCT04758936|Autonomic Agents|autonomic agents|mesh-ancestor
153462911|NCT04126044|Bevacizumab|bevacizumab|mesh-list
153890022|NCT01305408|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
153660905|NCT01350128|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153462912|NCT04126044|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153462913|NCT04126044|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153462914|NCT04126044|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153660906|NCT01350128|Respiratory System Agents|respiratory system agents|mesh-ancestor
153660907|NCT01350128|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
153660908|NCT01350128|Cholinergic Agents|cholinergic agents|mesh-ancestor
153660909|NCT01350128|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153660910|NCT01350128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153660911|NCT00078910|Sulindac sulfone|sulindac sulfone|mesh-list
153462971|NCT04394442|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153660912|NCT00078910|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153660913|NCT00078910|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
153660914|NCT00078910|Protective Agents|protective agents|mesh-ancestor
153660915|NCT00078910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153660916|NCT00078910|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153660917|NCT00078910|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153660918|NCT00078910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153660921|NCT00078910|Analgesics|analgesics|mesh-ancestor
153660931|NCT00078988|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153893140|NCT01020526|Pregabalin|pregabalin|mesh-list
153660932|NCT00078988|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153660933|NCT00078988|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153660934|NCT00078988|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153660935|NCT00078988|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153660936|NCT00078988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153660937|NCT00078988|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153660938|NCT00078988|Immunologic Factors|immunologic factors|mesh-ancestor
153660997|NCT00079144|Fludarabine|fludarabine|mesh-list
153660998|NCT00079144|Fludarabine phosphate|fludarabine phosphate|mesh-list
153660999|NCT00079144|Freund's Adjuvant|freund's adjuvant|mesh-list
153661000|NCT00079144|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153661001|NCT00079144|Immunologic Factors|immunologic factors|mesh-ancestor
153661002|NCT00079144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153462972|NCT04394442|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153422828|NCT05357911|Digoxin|digoxin|mesh-list
153462973|NCT04394442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153462974|NCT04394442|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153462975|NCT02972424|Teriparatide|teriparatide|mesh-list
153462976|NCT02972424|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153462977|NCT02972424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153890023|NCT01305408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153431060|NCT00000355|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153661003|NCT00079144|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153661004|NCT00079144|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153661005|NCT00079144|Alkylating Agents|alkylating agents|mesh-ancestor
153661006|NCT00079144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153661060|NCT00079300|Toll-Like Receptor Agonists|toll-like receptor agonists|mesh-ancestor
153661061|NCT00079300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153661062|NCT00079300|Immunomodulating Agents|immunomodulating agents|mesh-ancestor
153661063|NCT00079300|Immunologic Factors|immunologic factors|mesh-ancestor
153661065|NCT00079300|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153661127|NCT03526107|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153661128|NCT03526107|Respiratory System Agents|respiratory system agents|mesh-ancestor
153661129|NCT03526107|Vasodilator Agents|vasodilator agents|mesh-ancestor
153661131|NCT00079768|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153661132|NCT00079768|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153661133|NCT00079807|Thioctic Acid|thioctic acid|mesh-list
153661134|NCT00079807|Antioxidants|antioxidants|mesh-ancestor
153661135|NCT00079807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153661136|NCT00079807|Protective Agents|protective agents|mesh-ancestor
153661137|NCT00079807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153661138|NCT00079807|Vitamin B Complex|vitamin b complex|mesh-ancestor
153661139|NCT00079807|Vitamins|vitamins|mesh-ancestor
153661140|NCT00079807|Micronutrients|micronutrients|mesh-ancestor
153661141|NCT00079885|Tigecycline|tigecycline|mesh-list
153661142|NCT00079885|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153661143|NCT00079885|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153661144|NCT00079885|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
153661145|NCT00079885|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153661146|NCT00079885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153661147|NCT00079924|Teriparatide|teriparatide|mesh-list
153661148|NCT00079924|Raloxifene Hydrochloride|raloxifene hydrochloride|mesh-list
153661149|NCT00079924|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153661150|NCT00079924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153661151|NCT00079924|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153661152|NCT00079924|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
153661153|NCT00079924|Hormone Antagonists|hormone antagonists|mesh-ancestor
153661154|NCT00079924|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153434252|NCT00001381|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153661155|NCT00079924|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
153661157|NCT00079963|Vitamins|vitamins|mesh-list
153462978|NCT02972424|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153462979|NCT05608590|Ethiodized Oil|ethiodized oil|mesh-list
153462980|NCT05608590|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153463027|NCT03821454|Antimetabolites|antimetabolites|mesh-ancestor
153463028|NCT03821454|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153463029|NCT03821454|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153463030|NCT03820518|Calcitriol|calcitriol|mesh-list
153661158|NCT00079963|Vitamin E|vitamin e|mesh-list
153661159|NCT00079963|Micronutrients|micronutrients|mesh-ancestor
153661160|NCT00079963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153661167|NCT00392886|Carboplatin|carboplatin|mesh-list
153463031|NCT03820518|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153890024|NCT01305408|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
153890025|NCT01305408|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
153881933|NCT01602003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153881934|NCT01602003|Incretins|incretins|mesh-ancestor
153881935|NCT01602003|Hormones|hormones|mesh-ancestor
153431061|NCT00000355|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
153463033|NCT03820518|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
153463034|NCT03820518|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153463035|NCT03820518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153463036|NCT03820518|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
153463038|NCT03820518|Micronutrients|micronutrients|mesh-ancestor
153463039|NCT03820518|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153463040|NCT03820206|Tranexamic Acid|tranexamic acid|mesh-list
153463041|NCT03820206|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
153463042|NCT03820206|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153463043|NCT03820206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153463044|NCT03820206|Hemostatics|hemostatics|mesh-ancestor
153661168|NCT00392886|Methotrexate|methotrexate|mesh-list
153661169|NCT00392886|Etoposide|etoposide|mesh-list
153661170|NCT00392886|Vincristine|vincristine|mesh-list
153661171|NCT00392886|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153498134|NCT00003060|Methotrexate|methotrexate|mesh-list
153661172|NCT00392886|Immunologic Factors|immunologic factors|mesh-ancestor
153661173|NCT00392886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153661174|NCT00392886|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153661175|NCT00392886|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153661176|NCT00392886|Alkylating Agents|alkylating agents|mesh-ancestor
153661177|NCT00392886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153661178|NCT00392886|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153661179|NCT00392886|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153661180|NCT00392886|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
153661181|NCT00392886|Abortifacient Agents|abortifacient agents|mesh-ancestor
153661182|NCT00392886|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153661184|NCT00392886|Antimetabolites|antimetabolites|mesh-ancestor
153661185|NCT00392886|Dermatologic Agents|dermatologic agents|mesh-ancestor
153661186|NCT00392886|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153661187|NCT00392886|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153661188|NCT00392886|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153661189|NCT00392886|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153661190|NCT00392886|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153661191|NCT00392886|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153661192|NCT00392886|Tubulin Modulators|tubulin modulators|mesh-ancestor
153661215|NCT00080158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153661216|NCT00080158|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153661218|NCT00080158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153661220|NCT00080158|Antidepressive Agents|antidepressive agents|mesh-ancestor
153661221|NCT00080158|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153661222|NCT00080158|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
153661278|NCT00080314|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153463045|NCT03820206|Coagulants|coagulants|mesh-ancestor
153463046|NCT02955654|Aripiprazole|aripiprazole|mesh-list
153463047|NCT02955654|Antidepressive Agents|antidepressive agents|mesh-ancestor
153463048|NCT02955654|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153661279|NCT00080314|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
153661280|NCT00080314|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
153661281|NCT00080353|Monatide (IMS 3015)|monatide (ims 3015)|mesh-list
153661282|NCT00080353|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153661283|NCT00080353|Immunologic Factors|immunologic factors|mesh-ancestor
153661284|NCT00080353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153661285|NCT00080431|Daclizumab|daclizumab|mesh-list
153463049|NCT02955654|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153661286|NCT00080431|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153661287|NCT00080431|Immunologic Factors|immunologic factors|mesh-ancestor
153661288|NCT00080431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153661342|NCT00080743|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153661343|NCT00080743|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153661344|NCT00080743|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153661345|NCT00080743|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153661347|NCT00080782|Doxorubicin|doxorubicin|mesh-list
153881942|NCT01193920|Vaccines|vaccines|mesh-list
153881943|NCT01193920|Immunologic Factors|immunologic factors|mesh-ancestor
153898278|NCT01218516|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153898279|NCT00938431|Lacosamide|lacosamide|mesh-list
153898280|NCT00938431|Anticonvulsants|anticonvulsants|mesh-ancestor
153661348|NCT00080782|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
153661349|NCT00080782|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153661350|NCT00080782|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153661351|NCT00080782|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153661352|NCT00080782|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153661407|NCT00081133|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153661408|NCT00081133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153661409|NCT00081133|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153661410|NCT00081172|Antibodies|antibodies|mesh-list
153661411|NCT00081172|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
153661412|NCT00081172|Immunologic Factors|immunologic factors|mesh-ancestor
153661413|NCT00081172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153661414|NCT00081484|Epoetin Alfa|epoetin alfa|mesh-list
153661415|NCT00081484|Hematinics|hematinics|mesh-ancestor
153463050|NCT02955654|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153661416|NCT00390260|Acetaminophen|acetaminophen|mesh-list
153463051|NCT02955654|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153463052|NCT02955654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153661417|NCT00390260|Rofecoxib|rofecoxib|mesh-list
153661418|NCT00390260|Hydrocodone|hydrocodone|mesh-list
153661419|NCT00390260|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153661420|NCT00390260|Analgesics|analgesics|mesh-ancestor
153661421|NCT00390260|Sensory System Agents|sensory system agents|mesh-ancestor
153661422|NCT00390260|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153661423|NCT00390260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153463053|NCT02955654|Dopamine Agonists|dopamine agonists|mesh-ancestor
153661424|NCT00390260|Antipyretics|antipyretics|mesh-ancestor
153661425|NCT00390260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153661426|NCT00390260|Respiratory System Agents|respiratory system agents|mesh-ancestor
153661427|NCT00390260|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153661428|NCT00390260|Narcotics|narcotics|mesh-ancestor
153815086|NCT00448149|Immunologic Factors|immunologic factors|mesh-ancestor
153815087|NCT00448149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153661430|NCT00390260|Antitussive Agents|antitussive agents|mesh-ancestor
153463054|NCT02955654|Dopamine Agents|dopamine agents|mesh-ancestor
153463055|NCT02955654|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153463056|NCT02955654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153463057|NCT02955654|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
153463058|NCT02955654|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
153463069|NCT04392648|Immunologic Factors|immunologic factors|mesh-ancestor
153661431|NCT00390260|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
153661432|NCT00390260|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153661433|NCT00390260|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153661434|NCT00390260|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153661435|NCT00390260|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153661436|NCT00390260|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153661437|NCT00081757|Thalidomide|thalidomide|mesh-list
153661438|NCT00081757|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153661439|NCT00081757|Immunologic Factors|immunologic factors|mesh-ancestor
153661440|NCT00081757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153661441|NCT00081757|Leprostatic Agents|leprostatic agents|mesh-ancestor
153661442|NCT00081757|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153661444|NCT00081757|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153661445|NCT00081757|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153661447|NCT00081757|Growth Inhibitors|growth inhibitors|mesh-ancestor
153661448|NCT00081757|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153661449|NCT00081796|Capecitabine|capecitabine|mesh-list
153661450|NCT00081796|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153661451|NCT00081796|Antimetabolites|antimetabolites|mesh-ancestor
153661452|NCT00081796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153661453|NCT00081796|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153661454|NCT03152175|Propranolol|propranolol|mesh-list
153881945|NCT01644773|Dasatinib|dasatinib|mesh-list
153661455|NCT03152175|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
153661456|NCT03152175|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
153661457|NCT03152175|Adrenergic Agents|adrenergic agents|mesh-ancestor
153463070|NCT04392648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153434335|NCT00002401|Lamivudine|lamivudine|mesh-list
153463072|NCT04392648|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153463073|NCT04392648|Alkylating Agents|alkylating agents|mesh-ancestor
153661458|NCT03152175|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153661459|NCT03152175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153661460|NCT03152175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153661461|NCT03152175|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153661462|NCT03152175|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153661463|NCT03152175|Vasodilator Agents|vasodilator agents|mesh-ancestor
153661465|NCT00399685|Moxifloxacin|moxifloxacin|mesh-list
153661466|NCT00399685|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
153661467|NCT00399685|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153661468|NCT00399685|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153661469|NCT00399685|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153661471|NCT00399685|Antiviral Agents|antiviral agents|mesh-ancestor
153661488|NCT00399685|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
153661489|NCT00399685|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
153661490|NCT00081835|Immunoglobulins|immunoglobulins|mesh-list
153661491|NCT00081835|Antibodies|antibodies|mesh-list
153661492|NCT00081835|gamma-Globulins|gamma-globulins|mesh-list
153661493|NCT00081835|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
153661494|NCT00081835|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
153661495|NCT00081835|Immunologic Factors|immunologic factors|mesh-ancestor
153661496|NCT00081835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153463079|NCT04392648|Autonomic Agents|autonomic agents|mesh-ancestor
153463080|NCT04392648|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153463081|NCT04392648|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153661497|NCT03152097|3,3'-diindolylmethane|3,3'-diindolylmethane|mesh-list
153661498|NCT03152097|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
153661499|NCT03152097|Protective Agents|protective agents|mesh-ancestor
153661500|NCT03152097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153661501|NCT03152097|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153661502|NCT00082186|Bosentan|bosentan|mesh-list
153463082|NCT04392648|Glucocorticoids|glucocorticoids|mesh-ancestor
153463083|NCT04392648|Hormones|hormones|mesh-ancestor
153463084|NCT04392648|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153463085|NCT04392648|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153463086|NCT04392648|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153463087|NCT04392648|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153463088|NCT04392648|Growth Substances|growth substances|mesh-ancestor
153463089|NCT04392648|Growth Inhibitors|growth inhibitors|mesh-ancestor
153463090|NCT03826602|Metformin|metformin|mesh-list
153463091|NCT03826602|Tucatinib|tucatinib|mesh-list
153463092|NCT03826602|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153463093|NCT03826602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153463119|NCT02952222|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
153463181|NCT01450176|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
153463182|NCT01450176|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
153463183|NCT01450176|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
153463184|NCT01450176|Histamine Antagonists|histamine antagonists|mesh-ancestor
153463185|NCT01450176|Histamine Agents|histamine agents|mesh-ancestor
153463186|NCT01450176|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153661503|NCT00082186|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153661504|NCT00082186|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
153661505|NCT00082186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153661506|NCT00082225|Antibodies|antibodies|mesh-list
153661507|NCT00082225|Immunologic Factors|immunologic factors|mesh-ancestor
153661508|NCT00082225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153661509|NCT00082537|Caspofungin|caspofungin|mesh-list
153661510|NCT00082537|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
153661511|NCT00082537|Antifungal Agents|antifungal agents|mesh-ancestor
153661512|NCT00082537|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153661513|NCT00082537|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153661539|NCT00083005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153661541|NCT00083005|Immunologic Factors|immunologic factors|mesh-ancestor
153434367|NCT00002407|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
153661542|NCT00083005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153661544|NCT00083005|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153661545|NCT00083005|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153661546|NCT00083005|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153463188|NCT01454622|Metformin|metformin|mesh-list
153661547|NCT00083005|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153661548|NCT00083005|Growth Substances|growth substances|mesh-ancestor
153463191|NCT01454622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153463192|NCT01454622|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
153661549|NCT00083005|Growth Inhibitors|growth inhibitors|mesh-ancestor
153463193|NCT01454622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153661550|NCT00083005|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153661551|NCT00083005|Alkylating Agents|alkylating agents|mesh-ancestor
153661552|NCT00083005|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153661553|NCT00083083|Paclitaxel|paclitaxel|mesh-list
153661554|NCT00083083|Etoposide|etoposide|mesh-list
153661555|NCT00083083|Vinorelbine|vinorelbine|mesh-list
153661556|NCT00083083|Vinblastine|vinblastine|mesh-list
153661557|NCT00083083|Docetaxel|docetaxel|mesh-list
153661558|NCT00083083|Carboplatin|carboplatin|mesh-list
153661559|NCT00083083|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
153661560|NCT00083083|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153661561|NCT00083083|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153661562|NCT00083083|Tubulin Modulators|tubulin modulators|mesh-ancestor
153661563|NCT00083083|Antimitotic Agents|antimitotic agents|mesh-ancestor
153815088|NCT00448149|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153661565|NCT00083083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153661566|NCT00083083|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153661567|NCT00083083|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153661568|NCT00083083|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153661569|NCT00083083|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
153661571|NCT03151863|Analgesics, Opioid|analgesics, opioid|mesh-list
153661572|NCT03151863|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153463194|NCT01450410|Nicotinic Acids|nicotinic acids|mesh-list
153463195|NCT01450410|Niacin|niacin|mesh-list
153463196|NCT01450410|Niacinamide|niacinamide|mesh-list
153463197|NCT01450410|Vitamin B Complex|vitamin b complex|mesh-ancestor
153463198|NCT01450410|Vitamins|vitamins|mesh-ancestor
153463199|NCT01450410|Micronutrients|micronutrients|mesh-ancestor
153463200|NCT01450410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153463201|NCT01450410|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153661573|NCT03151863|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153661574|NCT03151863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153661578|NCT03151863|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153661579|NCT03151863|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
153661580|NCT03151863|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153661581|NCT03151863|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153661582|NCT03151863|Adrenergic Agents|adrenergic agents|mesh-ancestor
153661583|NCT03151863|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153661584|NCT03151863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153661585|NCT03151863|Narcotics|narcotics|mesh-ancestor
153661586|NCT00083161|Cyclophosphamide|cyclophosphamide|mesh-list
153661587|NCT00083161|Etoposide|etoposide|mesh-list
153661601|NCT00083278|Ipilimumab|ipilimumab|mesh-list
153463202|NCT01450410|Antimetabolites|antimetabolites|mesh-ancestor
153463204|NCT01450410|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153463223|NCT03043014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153463224|NCT03043014|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
153463225|NCT03043014|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153661641|NCT00083668|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
153815089|NCT00344942|Triamcinolone|triamcinolone|mesh-list
153434402|NCT00381511|Heparin|heparin|mesh-list
153661643|NCT00083668|Serotonin Agents|serotonin agents|mesh-ancestor
153661644|NCT00083668|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153661645|NCT00083668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153661708|NCT04733508|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153661709|NCT05567536|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-list
153661710|NCT00135304|Vitamin D|vitamin d|mesh-list
153661711|NCT00135304|1 alpha-hydroxyergocalciferol|1 alpha-hydroxyergocalciferol|mesh-list
153661712|NCT00135304|Cinacalcet|cinacalcet|mesh-list
153463226|NCT03043014|Oxytocics|oxytocics|mesh-ancestor
153463227|NCT03043014|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
153463228|NCT03043014|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
153463229|NCT03043014|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
153661713|NCT00135304|Vitamins|vitamins|mesh-ancestor
153661714|NCT00135304|Micronutrients|micronutrients|mesh-ancestor
153661715|NCT00135304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153661716|NCT00135304|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153661717|NCT00135304|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153661721|NCT00135499|Prednisone|prednisone|mesh-list
153661774|NCT00135811|Autonomic Agents|autonomic agents|mesh-ancestor
153661775|NCT00135811|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153661776|NCT00135811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153661777|NCT00135811|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153661778|NCT00135811|Glucocorticoids|glucocorticoids|mesh-ancestor
153661780|NCT00135811|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153661781|NCT00135811|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153661783|NCT00135811|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153661784|NCT00135811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153661785|NCT00135811|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153661786|NCT00135811|Immunologic Factors|immunologic factors|mesh-ancestor
153661787|NCT00135811|Antifungal Agents|antifungal agents|mesh-ancestor
153661788|NCT00135811|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153661789|NCT00135811|Dermatologic Agents|dermatologic agents|mesh-ancestor
153661790|NCT00135811|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153661791|NCT00135811|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
153661792|NCT00135928|Lenograstim|lenograstim|mesh-list
153661796|NCT00135967|Mycophenolic Acid|mycophenolic acid|mesh-list
153661829|NCT00136045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153661830|NCT00136045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153661831|NCT00136201|Tigecycline|tigecycline|mesh-list
153661832|NCT00136201|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153661833|NCT00136201|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153661834|NCT00136201|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
153661835|NCT00136201|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153661836|NCT00136201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153661837|NCT03151239|Niacinamide|niacinamide|mesh-list
153661838|NCT03151239|Vitamin B Complex|vitamin b complex|mesh-ancestor
153661839|NCT03151239|Vitamins|vitamins|mesh-ancestor
153661840|NCT03151239|Micronutrients|micronutrients|mesh-ancestor
153661841|NCT03151239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153661842|NCT00136396|Rituximab|rituximab|mesh-list
153814485|NCT03275376|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153814486|NCT03275376|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153661844|NCT00136396|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153661845|NCT00136396|Immunologic Factors|immunologic factors|mesh-ancestor
153661846|NCT00136396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153661847|NCT00136396|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153661848|NCT00136474|Amifostine|amifostine|mesh-list
153661849|NCT00136474|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
153661852|NCT00136552|Rituximab|rituximab|mesh-list
153661881|NCT00136747|Memantine|memantine|mesh-list
153661882|NCT00136747|Bupropion|bupropion|mesh-list
153661883|NCT00136747|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
153661884|NCT00136747|Antidepressive Agents|antidepressive agents|mesh-ancestor
153661885|NCT00136747|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153661886|NCT00136747|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
153661887|NCT00136747|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153661888|NCT00136747|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153661889|NCT00136747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153661890|NCT00136747|Dopamine Agents|dopamine agents|mesh-ancestor
153422839|NCT03374839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153422840|NCT02221674|Tapentadol|tapentadol|mesh-list
153422841|NCT02221674|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153422842|NCT02221674|Narcotics|narcotics|mesh-ancestor
153422843|NCT02221674|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153422845|NCT02221674|Analgesics|analgesics|mesh-ancestor
153898432|NCT00606775|Carvedilol|carvedilol|mesh-list
153661891|NCT00136747|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153661892|NCT00136747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153661893|NCT00136747|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
153661894|NCT00136747|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153661895|NCT00136747|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153661896|NCT00136747|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
153661897|NCT00136747|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
153661898|NCT00136747|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
153661899|NCT00136747|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
153661900|NCT00136786|Memantine|memantine|mesh-list
153661901|NCT00136786|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
153661932|NCT00393198|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
153463276|NCT03823638|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
153463277|NCT03823638|Diuretics|diuretics|mesh-ancestor
153463278|NCT03823638|Natriuretic Agents|natriuretic agents|mesh-ancestor
153463279|NCT03823638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153463284|NCT02884908|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153431063|NCT04022785|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153431064|NCT04022785|Antimetabolites|antimetabolites|mesh-ancestor
153463285|NCT02884908|Anticonvulsants|anticonvulsants|mesh-ancestor
153463286|NCT02884908|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153661933|NCT00393198|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153661934|NCT00393198|Oxytocics|oxytocics|mesh-ancestor
153661935|NCT00136942|Atorvastatin|atorvastatin|mesh-list
153661936|NCT00136942|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153661937|NCT00136942|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153661938|NCT00136942|Antimetabolites|antimetabolites|mesh-ancestor
153814487|NCT03275376|Antimetabolites|antimetabolites|mesh-ancestor
153814488|NCT03275376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153661939|NCT00136942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153661940|NCT00136942|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153661941|NCT00136942|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
153661942|NCT00136942|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153661943|NCT00136981|Atorvastatin|atorvastatin|mesh-list
153661944|NCT00136981|Torcetrapib|torcetrapib|mesh-list
153661945|NCT00136981|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153661946|NCT00136981|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153661947|NCT00136981|Antimetabolites|antimetabolites|mesh-ancestor
153661971|NCT00137098|Caffeine|caffeine|mesh-list
153661991|NCT03151044|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153661992|NCT03151044|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153661993|NCT03151044|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153661994|NCT03151044|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153661995|NCT03151044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153661997|NCT00137410|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153661998|NCT00137410|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153662057|NCT00137995|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153662058|NCT00137995|Immunologic Factors|immunologic factors|mesh-ancestor
153463287|NCT02884908|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153463288|NCT02884908|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153463289|NCT02884908|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153463290|NCT02884908|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153463333|NCT01452828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153463334|NCT01452906|Omeprazole|omeprazole|mesh-list
153463335|NCT01452906|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
153463336|NCT01452906|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153463337|NCT01452906|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
153463338|NCT01452906|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153463339|NCT01452906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153463340|NCT03823248|Folic Acid|folic acid|mesh-list
153463341|NCT03823248|Vitamin B Complex|vitamin b complex|mesh-list
153662059|NCT00137995|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153662060|NCT00137995|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153662061|NCT00137995|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153662062|NCT00137995|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153662063|NCT00137995|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153662064|NCT00137995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153662065|NCT00137995|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153662066|NCT00137995|Antimetabolites|antimetabolites|mesh-ancestor
153662067|NCT00137995|Antiviral Agents|antiviral agents|mesh-ancestor
153890029|NCT01261611|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
153890030|NCT01261611|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
153463342|NCT03823248|Hematinics|hematinics|mesh-ancestor
153463343|NCT03823248|Vitamins|vitamins|mesh-ancestor
153463344|NCT03823248|Micronutrients|micronutrients|mesh-ancestor
153463345|NCT03823248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153463346|NCT03822936|Fluorouracil|fluorouracil|mesh-list
153463347|NCT03822936|Oxaliplatin|oxaliplatin|mesh-list
153662068|NCT00137995|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153662069|NCT00137995|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153463348|NCT03822936|Irinotecan|irinotecan|mesh-list
153662070|NCT00137995|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153893376|NCT02869321|Analgesics|analgesics|mesh-ancestor
153662072|NCT00137995|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153662073|NCT03150888|Antihypertensive Agents|antihypertensive agents|mesh-list
153662075|NCT00138112|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153662076|NCT00138112|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153662077|NCT00138229|Aldesleukin|aldesleukin|mesh-list
153662078|NCT00138229|Cyclophosphamide|cyclophosphamide|mesh-list
153662079|NCT00138229|Fludarabine|fludarabine|mesh-list
153662080|NCT00138229|Fludarabine phosphate|fludarabine phosphate|mesh-list
153662081|NCT00138229|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153662082|NCT00138229|Immunologic Factors|immunologic factors|mesh-ancestor
153662083|NCT00138229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153662084|NCT00138229|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153662086|NCT00138229|Alkylating Agents|alkylating agents|mesh-ancestor
153662102|NCT00138541|Protease Inhibitors|protease inhibitors|mesh-ancestor
153662103|NCT00138541|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153662104|NCT00138541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153662105|NCT00138580|Vildagliptin|vildagliptin|mesh-list
153662106|NCT00138580|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153662107|NCT00138580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153662108|NCT00138580|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
153662109|NCT00138580|Protease Inhibitors|protease inhibitors|mesh-ancestor
153662110|NCT00138580|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153662112|NCT03150771|Aripiprazole|aripiprazole|mesh-list
153662166|NCT00138970|Antiemetics|antiemetics|mesh-ancestor
153662167|NCT00138970|Autonomic Agents|autonomic agents|mesh-ancestor
153662168|NCT00138970|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153662169|NCT00138970|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153662170|NCT00138970|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
153662171|NCT00138970|Protective Agents|protective agents|mesh-ancestor
153662172|NCT00138970|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153662173|NCT00138970|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
153662174|NCT00138970|Antitubercular Agents|antitubercular agents|mesh-ancestor
153662175|NCT00138970|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153662176|NCT00138970|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153463350|NCT03822936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153463351|NCT03822936|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153662177|NCT00138970|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153662178|NCT00138970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153662179|NCT00138970|Antifungal Agents|antifungal agents|mesh-ancestor
153662180|NCT00138970|Dermatologic Agents|dermatologic agents|mesh-ancestor
153662225|NCT00139204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153662227|NCT00139243|Fluorouracil|fluorouracil|mesh-list
153662228|NCT00139243|Docetaxel|docetaxel|mesh-list
153662229|NCT00139243|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153662230|NCT00139243|Antimetabolites|antimetabolites|mesh-ancestor
153662231|NCT00139243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153463352|NCT03822936|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153463353|NCT03822936|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153463354|NCT03822936|Immunologic Factors|immunologic factors|mesh-ancestor
153463355|NCT03822936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153662232|NCT00139243|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153662233|NCT00139243|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153662234|NCT00139243|Immunologic Factors|immunologic factors|mesh-ancestor
153662235|NCT00139243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153662236|NCT00139243|Antidotes|antidotes|mesh-ancestor
153662237|NCT00139243|Protective Agents|protective agents|mesh-ancestor
153662238|NCT00139243|Vitamin B Complex|vitamin b complex|mesh-ancestor
153662239|NCT00139243|Vitamins|vitamins|mesh-ancestor
153662240|NCT00139243|Micronutrients|micronutrients|mesh-ancestor
153662241|NCT00139243|Tubulin Modulators|tubulin modulators|mesh-ancestor
153662242|NCT00139243|Antimitotic Agents|antimitotic agents|mesh-ancestor
153662243|NCT00139243|Mitosis Modulators|mitosis modulators|mesh-ancestor
153662244|NCT00139282|Squalamine|squalamine|mesh-list
153662245|NCT00139282|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153662246|NCT00139282|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153662247|NCT00139282|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
153662248|NCT00139282|Protective Agents|protective agents|mesh-ancestor
153662249|NCT00139282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153662250|NCT00139282|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153662277|NCT00139555|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153662278|NCT00139555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153662279|NCT00139555|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153662280|NCT00139555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153662281|NCT00139555|Vasodilator Agents|vasodilator agents|mesh-ancestor
153662282|NCT00139555|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
153662283|NCT00139555|Protease Inhibitors|protease inhibitors|mesh-ancestor
153662284|NCT00139555|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153662285|NCT00139633|Carboplatin|carboplatin|mesh-list
153662286|NCT00139633|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153662287|NCT00139711|Docetaxel|docetaxel|mesh-list
153463358|NCT03822936|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153463401|NCT01890408|Sensory System Agents|sensory system agents|mesh-ancestor
153463402|NCT01890408|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153463403|NCT04849650|Amisulpride|amisulpride|mesh-list
153463404|NCT04849650|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153662288|NCT00139711|Irinotecan|irinotecan|mesh-list
153662289|NCT00139711|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153662290|NCT00139711|Tubulin Modulators|tubulin modulators|mesh-ancestor
153662291|NCT00139711|Antimitotic Agents|antimitotic agents|mesh-ancestor
153662292|NCT00139711|Mitosis Modulators|mitosis modulators|mesh-ancestor
153662335|NCT00404326|Vasodilator Agents|vasodilator agents|mesh-ancestor
153662336|NCT00139750|Varenicline|varenicline|mesh-list
153662337|NCT00139750|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
153662338|NCT00139750|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
153662341|NCT00139750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153662342|NCT00139750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153662343|NCT00139867|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
153662344|NCT00139867|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153662400|NCT00140257|Escitalopram|escitalopram|mesh-list
153662401|NCT00140257|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
153662402|NCT00140257|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153662403|NCT00140257|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153662404|NCT00140257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153662405|NCT00140257|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153662406|NCT00140257|Serotonin Agents|serotonin agents|mesh-ancestor
153662407|NCT00140257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153662408|NCT00140296|Contraceptive Agents|contraceptive agents|mesh-list
153662409|NCT00140296|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153662410|NCT00140296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153662411|NCT00140374|Immunomodulating Agents|immunomodulating agents|mesh-list
153463405|NCT04849650|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153463406|NCT04849650|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153463407|NCT04849650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153463408|NCT04849650|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153463409|NCT04849650|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
153463410|NCT04849650|Dopamine Agents|dopamine agents|mesh-ancestor
153463411|NCT04849650|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153463412|NCT04849650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153662412|NCT00140374|Immunologic Factors|immunologic factors|mesh-ancestor
153662413|NCT00140374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153662415|NCT00140452|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153662416|NCT00140452|Immunologic Factors|immunologic factors|mesh-ancestor
153814491|NCT03275376|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153814492|NCT00340184|Paclitaxel|paclitaxel|mesh-list
153814493|NCT00340184|Carboplatin|carboplatin|mesh-list
153893485|NCT01221753|Antimetabolites|antimetabolites|mesh-ancestor
153662456|NCT00140725|Interferon-alpha|interferon-alpha|mesh-list
153662457|NCT00140725|Lamivudine|lamivudine|mesh-list
153662458|NCT00140725|Interferon alpha-2|interferon alpha-2|mesh-list
153662459|NCT00140725|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153662460|NCT00140725|Antiviral Agents|antiviral agents|mesh-ancestor
153662461|NCT00140725|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153662462|NCT00140725|Immunologic Factors|immunologic factors|mesh-ancestor
153662463|NCT00140725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153662464|NCT00140725|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153662465|NCT00140725|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153463413|NCT04849650|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
153463414|NCT04849650|Antidepressive Agents|antidepressive agents|mesh-ancestor
153463416|NCT01891500|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153662520|NCT00141154|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153662521|NCT00141154|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153662522|NCT00141154|Analgesics|analgesics|mesh-ancestor
153662523|NCT00141154|Sensory System Agents|sensory system agents|mesh-ancestor
153662524|NCT00141154|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153662525|NCT00141154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153662526|NCT00141154|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153662527|NCT00141154|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153662528|NCT00141154|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
153662529|NCT00141154|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153662532|NCT00141193|Celecoxib|celecoxib|mesh-list
153662582|NCT00404404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153662583|NCT00404404|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153662584|NCT00404404|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153662585|NCT00404404|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153463417|NCT01891500|Autonomic Agents|autonomic agents|mesh-ancestor
153463418|NCT01891500|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153814496|NCT00340184|Tubulin Modulators|tubulin modulators|mesh-ancestor
153814497|NCT00340184|Antimitotic Agents|antimitotic agents|mesh-ancestor
153434592|NCT00003026|Hormone Antagonists|hormone antagonists|mesh-ancestor
153434593|NCT00003026|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153434594|NCT00003026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153434595|NCT00003026|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153434596|NCT00003026|Luteolytic Agents|luteolytic agents|mesh-ancestor
153434597|NCT00003026|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
153434598|NCT00003026|Contraceptive Agents|contraceptive agents|mesh-ancestor
153434599|NCT00003026|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153463419|NCT01891500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153463420|NCT01891500|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153463421|NCT01891500|Respiratory System Agents|respiratory system agents|mesh-ancestor
153463422|NCT01891500|Free Radical Scavengers|free radical scavengers|mesh-ancestor
153914713|NCT04908475|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153914714|NCT04908475|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153914715|NCT04908475|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
153914716|NCT04908475|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
153914717|NCT04908475|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153662586|NCT00404404|Growth Substances|growth substances|mesh-ancestor
153662587|NCT00404404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153914718|NCT04908475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153914719|NCT04611139|Pembrolizumab|pembrolizumab|mesh-list
153914720|NCT04611139|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153662588|NCT00404404|Growth Inhibitors|growth inhibitors|mesh-ancestor
153662589|NCT00404482|Cyclosporine|cyclosporine|mesh-list
153662590|NCT00404482|Cyclosporins|cyclosporins|mesh-list
153662591|NCT00404482|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153662592|NCT00404482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153662593|NCT00404482|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153662643|NCT00141700|Immunologic Factors|immunologic factors|mesh-ancestor
153662644|NCT00141700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153662645|NCT00141700|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153662646|NCT00141895|Misoprostol|misoprostol|mesh-list
153662647|NCT00141895|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
153662648|NCT00141895|Abortifacient Agents|abortifacient agents|mesh-ancestor
153914721|NCT04611139|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153914722|NCT04611139|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153914723|NCT04611139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153463423|NCT01891500|Antioxidants|antioxidants|mesh-ancestor
153914724|NCT04570501|Angiotensin I (1-7)|angiotensin i (1-7)|mesh-list
153914747|NCT00607984|Melphalan|melphalan|mesh-list
153881958|NCT01602588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153881959|NCT01602588|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153914748|NCT00607984|Thiotepa|thiotepa|mesh-list
153881960|NCT01681550|Incretins|incretins|mesh-list
153881961|NCT01681550|Hormones|hormones|mesh-ancestor
153881962|NCT01681550|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153881963|NCT01681550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153662649|NCT00141895|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153662650|NCT00141895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153662651|NCT00141895|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
153662652|NCT00141895|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153662653|NCT00141895|Oxytocics|oxytocics|mesh-ancestor
153662654|NCT00142051|Nitric Oxide|nitric oxide|mesh-list
153662655|NCT00142051|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153662656|NCT00142051|Autonomic Agents|autonomic agents|mesh-ancestor
153662657|NCT00142051|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153662658|NCT00142051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153662659|NCT00142051|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153662703|NCT00142246|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153662705|NCT00142324|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
153893489|NCT01221753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153893490|NCT01221753|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153662706|NCT00142324|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153662707|NCT00142324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153662708|NCT00142324|Cholinergic Agents|cholinergic agents|mesh-ancestor
153662709|NCT00142324|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153662710|NCT00142324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153662711|NCT00142324|Nootropic Agents|nootropic agents|mesh-ancestor
153662712|NCT00142402|Modafinil|modafinil|mesh-list
153662713|NCT00142402|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
153662714|NCT00142402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153662715|NCT00142402|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
153662716|NCT00142402|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
153662717|NCT00142402|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
153662719|NCT00142480|Bevacizumab|bevacizumab|mesh-list
153662761|NCT00142948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153662762|NCT00142948|Sensory System Agents|sensory system agents|mesh-ancestor
153662763|NCT00142948|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153662764|NCT02780427|Dexmedetomidine|dexmedetomidine|mesh-list
153662765|NCT02780427|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153662766|NCT02780427|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153662767|NCT02780427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153662768|NCT02780427|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153662769|NCT02780427|Analgesics|analgesics|mesh-ancestor
153662770|NCT02780427|Sensory System Agents|sensory system agents|mesh-ancestor
153662771|NCT02780427|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153662772|NCT02780427|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
153463445|NCT04842552|Hydralazine|hydralazine|mesh-list
153463446|NCT04842552|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153463447|NCT04842552|Vasodilator Agents|vasodilator agents|mesh-ancestor
153463448|NCT01891812|Nitrous Oxide|nitrous oxide|mesh-list
153463449|NCT01891812|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
153463450|NCT01891812|Anesthetics, General|anesthetics, general|mesh-ancestor
153463451|NCT01891812|Anesthetics|anesthetics|mesh-ancestor
153463452|NCT01891812|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153463453|NCT01891812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153463454|NCT01891812|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153463455|NCT01891812|Analgesics|analgesics|mesh-ancestor
153463456|NCT01891812|Sensory System Agents|sensory system agents|mesh-ancestor
153463457|NCT01891812|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153662773|NCT02780427|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153463458|NCT04390464|Ravulizumab|ravulizumab|mesh-list
153662774|NCT02780427|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153434628|NCT03868046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153662775|NCT02780427|Adrenergic Agents|adrenergic agents|mesh-ancestor
153662776|NCT02780427|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153662777|NCT02780427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153662778|NCT00142987|Tegaserod|tegaserod|mesh-list
153662779|NCT00142987|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
153662780|NCT00142987|Serotonin Agents|serotonin agents|mesh-ancestor
153662781|NCT00142987|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153662782|NCT00142987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153662783|NCT00142987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153662784|NCT00143026|Levodopa|levodopa|mesh-list
153662785|NCT00143026|Carbidopa|carbidopa|mesh-list
153662804|NCT02756247|Ibrutinib|ibrutinib|mesh-list
153662805|NCT02756247|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153662806|NCT02756247|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153463459|NCT04390464|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
153463460|NCT04390464|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153662807|NCT02756247|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153662808|NCT02756247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153662809|NCT00143065|Rituximab|rituximab|mesh-list
153662810|NCT00143065|Alemtuzumab|alemtuzumab|mesh-list
153662811|NCT00143065|Fludarabine|fludarabine|mesh-list
153662812|NCT00143065|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153662813|NCT00143065|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153662814|NCT00143065|Immunologic Factors|immunologic factors|mesh-ancestor
153662815|NCT00143065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153662816|NCT00143065|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153662817|NCT00143104|Insulin|insulin|mesh-list
153662818|NCT00143104|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153662819|NCT00143104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153662820|NCT00143143|Pregabalin|pregabalin|mesh-list
153662821|NCT00143143|Analgesics|analgesics|mesh-ancestor
153662822|NCT00143143|Sensory System Agents|sensory system agents|mesh-ancestor
153662823|NCT00143143|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153662824|NCT00143143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153662825|NCT00143143|Anticonvulsants|anticonvulsants|mesh-ancestor
153662826|NCT00143143|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153662827|NCT00143143|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153662828|NCT00143143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153662829|NCT00143143|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153662830|NCT00143143|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153662831|NCT00143143|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153662832|NCT00143143|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153662833|NCT00143143|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153893533|NCT01014442|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153662835|NCT00143221|Vasodilator Agents|vasodilator agents|mesh-ancestor
153662836|NCT00143221|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
153662842|NCT00143260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153662843|NCT00143260|Vasodilator Agents|vasodilator agents|mesh-ancestor
153662844|NCT00143260|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
153662845|NCT00143260|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
153662846|NCT00143260|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153662847|NCT00143260|Urological Agents|urological agents|mesh-ancestor
153662848|NCT00143299|Varenicline|varenicline|mesh-list
153662849|NCT00143299|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
153662850|NCT00143299|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
153662851|NCT00143299|Cholinergic Agents|cholinergic agents|mesh-ancestor
153662852|NCT00143299|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153662853|NCT00143299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153662855|NCT00143338|Insulin|insulin|mesh-list
153662902|NCT00393315|Tubulin Modulators|tubulin modulators|mesh-ancestor
153662903|NCT00393315|Antimitotic Agents|antimitotic agents|mesh-ancestor
153662904|NCT00393315|Mitosis Modulators|mitosis modulators|mesh-ancestor
153662905|NCT00393315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153881964|NCT01645085|Mannitol|mannitol|mesh-list
153881965|NCT01645085|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
153881966|NCT01645085|Diuretics|diuretics|mesh-ancestor
153881967|NCT01645085|Natriuretic Agents|natriuretic agents|mesh-ancestor
153662906|NCT00143689|Ritonavir|ritonavir|mesh-list
153662907|NCT00143689|Lopinavir|lopinavir|mesh-list
153662908|NCT00143689|Lamivudine|lamivudine|mesh-list
153662909|NCT00143689|Zidovudine|zidovudine|mesh-list
153662910|NCT00143689|Nevirapine|nevirapine|mesh-list
153662913|NCT00143689|Protease Inhibitors|protease inhibitors|mesh-ancestor
153914772|NCT00613249|Dapivirine|dapivirine|mesh-list
153662969|NCT00144118|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153463474|NCT01893060|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
153662971|NCT00144118|Anesthetics, General|anesthetics, general|mesh-ancestor
153662972|NCT00144118|Anesthetics|anesthetics|mesh-ancestor
153662973|NCT00144118|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153662974|NCT00144118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153662975|NCT00144157|Zidovudine|zidovudine|mesh-list
153662976|NCT00144157|Nevirapine|nevirapine|mesh-list
153662977|NCT00144157|Antimetabolites|antimetabolites|mesh-ancestor
153662978|NCT00144157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153814502|NCT00446316|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153814503|NCT00446316|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153662979|NCT00144157|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153662980|NCT00144157|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153662981|NCT00144157|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153662982|NCT00144157|Antiviral Agents|antiviral agents|mesh-ancestor
153662983|NCT00144157|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153663029|NCT00404794|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
153663030|NCT00404794|Methylprednisolone|methylprednisolone|mesh-list
153663031|NCT00404794|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
153663032|NCT00404794|Prednisolone acetate|prednisolone acetate|mesh-list
153663033|NCT00404794|Tacrolimus|tacrolimus|mesh-list
153663034|NCT00404794|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
153663035|NCT00404794|Prednisolone phosphate|prednisolone phosphate|mesh-list
153663036|NCT00404794|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153663037|NCT00404794|Immunologic Factors|immunologic factors|mesh-ancestor
153663038|NCT00404794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153663039|NCT00404794|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
153663040|NCT00404794|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153663092|NCT05595109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153663093|NCT05595109|Protective Agents|protective agents|mesh-ancestor
153663094|NCT05595109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153663095|NCT01807494|Cimetidine|cimetidine|mesh-list
153663096|NCT01807494|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
153663097|NCT01807494|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153663098|NCT01807494|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
153663099|NCT01807494|Histamine Antagonists|histamine antagonists|mesh-ancestor
153663100|NCT01807494|Histamine Agents|histamine agents|mesh-ancestor
153663154|NCT02972255|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153663155|NCT05468671|Remifentanil|remifentanil|mesh-list
153663156|NCT05468671|Oxycodone|oxycodone|mesh-list
153663157|NCT05468671|Propofol|propofol|mesh-list
153663158|NCT05468671|Rocuronium|rocuronium|mesh-list
153663159|NCT05468671|Flumazenil|flumazenil|mesh-list
153663160|NCT05468671|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153663161|NCT05468671|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153663162|NCT05468671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153663163|NCT05468671|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153663164|NCT05468671|Anesthetics, General|anesthetics, general|mesh-ancestor
153663165|NCT05468671|Anesthetics|anesthetics|mesh-ancestor
153663166|NCT05468671|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153663167|NCT05468671|Narcotics|narcotics|mesh-ancestor
153663168|NCT05468671|Analgesics|analgesics|mesh-ancestor
153663169|NCT05468671|Sensory System Agents|sensory system agents|mesh-ancestor
153663170|NCT05468671|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153663171|NCT05468671|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
153663172|NCT05468671|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
153663173|NCT05468671|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
153663174|NCT05468671|Antidotes|antidotes|mesh-ancestor
153663175|NCT05468671|Protective Agents|protective agents|mesh-ancestor
153663211|NCT00390923|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
153663212|NCT00390923|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153663213|NCT00390923|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
153663214|NCT00390923|Protective Agents|protective agents|mesh-ancestor
153663215|NCT00425425|Fluorouracil|fluorouracil|mesh-list
153663216|NCT00425425|Oxaliplatin|oxaliplatin|mesh-list
153663217|NCT00425425|Cetuximab|cetuximab|mesh-list
153663218|NCT00425425|Antimetabolites|antimetabolites|mesh-ancestor
153663219|NCT00425425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153663220|NCT00425425|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153663275|NCT01806753|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153663276|NCT01806753|GABA Modulators|gaba modulators|mesh-ancestor
153893594|NCT00993265|Acetylcysteine|acetylcysteine|mesh-list
153663277|NCT01806753|GABA Agents|gaba agents|mesh-ancestor
153663278|NCT01806753|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153914792|NCT01009983|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153668026|NCT00030615|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153663279|NCT01806753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153663280|NCT01806675|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
153663281|NCT01806675|Glycine|glycine|mesh-list
153663282|NCT01806675|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
153663283|NCT01806675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153663284|NCT01806675|Glycine Agents|glycine agents|mesh-ancestor
153663285|NCT01806675|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153663338|NCT00405262|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153663339|NCT00405262|Analgesics|analgesics|mesh-ancestor
153663340|NCT00405262|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153663341|NCT00405262|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153663342|NCT00405262|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153663343|NCT00405262|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153663344|NCT00405262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153663345|NCT00405301|Rifampin|rifampin|mesh-list
153663346|NCT00405301|Pyrazinamide|pyrazinamide|mesh-list
153663347|NCT00405301|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
153663348|NCT00405301|Antitubercular Agents|antitubercular agents|mesh-ancestor
153663349|NCT00405301|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153663350|NCT00405301|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153663351|NCT00405301|Leprostatic Agents|leprostatic agents|mesh-ancestor
153663352|NCT00405301|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153663353|NCT00405301|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153893614|NCT00993031|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153663354|NCT00405301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153663355|NCT00405301|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
153663356|NCT00405301|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
153663357|NCT00405301|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
153663361|NCT00405340|Rituximab|rituximab|mesh-list
153663389|NCT01806090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153914806|NCT04297215|Chelating Agents|chelating agents|mesh-ancestor
153663391|NCT04341181|Trastuzumab|trastuzumab|mesh-list
153663392|NCT04341181|Atezolizumab|atezolizumab|mesh-list
153663393|NCT04341181|Pertuzumab|pertuzumab|mesh-list
153663394|NCT04341181|Avelumab|avelumab|mesh-list
153663395|NCT04341181|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
153663396|NCT04341181|Niraparib|niraparib|mesh-list
153663397|NCT04341181|Axitinib|axitinib|mesh-list
153663398|NCT04341181|Vemurafenib|vemurafenib|mesh-list
153663399|NCT04341181|Maytansine|maytansine|mesh-list
153663400|NCT04341181|Alectinib|alectinib|mesh-list
153663401|NCT04341181|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153663402|NCT04341181|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153663403|NCT04341181|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153663404|NCT04341181|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153663405|NCT04341181|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153663406|NCT04341181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153663407|NCT04341181|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153663408|NCT04341181|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
153663409|NCT04341181|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153663410|NCT04341181|Tubulin Modulators|tubulin modulators|mesh-ancestor
153663411|NCT04341181|Antimitotic Agents|antimitotic agents|mesh-ancestor
153663412|NCT04341181|Mitosis Modulators|mitosis modulators|mesh-ancestor
153663413|NCT04341181|Immunotoxins|immunotoxins|mesh-ancestor
153663414|NCT04341181|Immunoconjugates|immunoconjugates|mesh-ancestor
153663415|NCT04341181|Immunologic Factors|immunologic factors|mesh-ancestor
153663416|NCT04341181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153663417|NCT01806324|Losartan|losartan|mesh-list
153663418|NCT01806324|Atorvastatin|atorvastatin|mesh-list
153814505|NCT00446316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153893638|NCT01010776|Serotonin Agents|serotonin agents|mesh-ancestor
153893639|NCT01010776|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153893640|NCT01010776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153893641|NCT01010776|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
153893642|NCT01010776|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
153434745|NCT00003050|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153434746|NCT00003050|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
153434747|NCT00003050|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
153373046|NCT01799213|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153434748|NCT00003050|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153434749|NCT00002179|Lamivudine|lamivudine|mesh-list
153434750|NCT00002179|Zidovudine|zidovudine|mesh-list
153434751|NCT00002179|Indinavir|indinavir|mesh-list
153434752|NCT00002179|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153663421|NCT01806324|Antimetabolites|antimetabolites|mesh-ancestor
153663422|NCT01806324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153663423|NCT01806324|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153663424|NCT01806324|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
153663425|NCT01806324|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153663427|NCT01806324|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153668027|NCT00030615|Antimetabolites|antimetabolites|mesh-ancestor
153663428|NCT01806324|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
153663429|NCT01806324|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
153663430|NCT02423876|Hydromorphone|hydromorphone|mesh-list
153663431|NCT02423876|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153663432|NCT02423876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153663433|NCT02423876|Sensory System Agents|sensory system agents|mesh-ancestor
153663434|NCT02423876|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153663435|NCT02423876|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153663436|NCT02423876|Narcotics|narcotics|mesh-ancestor
153663437|NCT02423876|Analgesics|analgesics|mesh-ancestor
153663439|NCT01805895|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153663440|NCT01805895|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153663441|NCT01805856|Cefazolin|cefazolin|mesh-list
153663442|NCT01805856|Piperacillin|piperacillin|mesh-list
153663443|NCT01805856|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153663444|NCT01805856|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153663445|NCT01805817|Copper|copper|mesh-list
153663446|NCT01805817|Drospirenone|drospirenone|mesh-list
153663447|NCT01805817|Levonorgestrel|levonorgestrel|mesh-list
153663448|NCT01805817|Ethinyl Estradiol|ethinyl estradiol|mesh-list
153663450|NCT01805817|Estradiol|estradiol|mesh-list
153663482|NCT02157077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153663483|NCT02157077|Growth Inhibitors|growth inhibitors|mesh-ancestor
153663484|NCT02157077|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153663485|NCT01805700|Caffeine|caffeine|mesh-list
153663486|NCT01805700|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
153663487|NCT01805700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153663488|NCT01805700|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
153663489|NCT01805700|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153663490|NCT01805700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153663492|NCT01805700|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
153663493|NCT01805700|Purinergic Agents|purinergic agents|mesh-ancestor
153663494|NCT01805700|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153663495|NCT04033276|Rituximab|rituximab|mesh-list
153663496|NCT04033276|Immunoglobulins|immunoglobulins|mesh-list
153663497|NCT04033276|Antibodies|antibodies|mesh-list
153663498|NCT04033276|gamma-Globulins|gamma-globulins|mesh-list
153663499|NCT04033276|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
153663500|NCT04033276|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
153663501|NCT04033276|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153663502|NCT04033276|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153373047|NCT01799213|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
153373048|NCT01799213|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153373051|NCT01383200|Lidocaine|lidocaine|mesh-list
153663503|NCT04033276|Immunologic Factors|immunologic factors|mesh-ancestor
153663504|NCT04033276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153663506|NCT00391157|Dexamethasone|dexamethasone|mesh-list
153663533|NCT01805544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153663534|NCT01805544|Anticoagulants|anticoagulants|mesh-ancestor
153663535|NCT01903421|Fentanyl|fentanyl|mesh-list
153663536|NCT01903421|Bupivacaine|bupivacaine|mesh-list
153663537|NCT01903421|Anesthetics|anesthetics|mesh-list
153663538|NCT01903421|Propofol|propofol|mesh-list
153663539|NCT01903421|Sevoflurane|sevoflurane|mesh-list
153663540|NCT01903421|Isoflurane|isoflurane|mesh-list
153663541|NCT01903421|Anesthetics, Local|anesthetics, local|mesh-ancestor
153663542|NCT01903421|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153663543|NCT01903421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153663544|NCT01903421|Sensory System Agents|sensory system agents|mesh-ancestor
153663545|NCT01903421|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153663546|NCT01903421|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153663547|NCT01903421|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153663548|NCT01903421|Anesthetics, General|anesthetics, general|mesh-ancestor
153663549|NCT01903421|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153663550|NCT01903421|Narcotics|narcotics|mesh-ancestor
153893643|NCT01010776|Dopamine Agents|dopamine agents|mesh-ancestor
153893644|NCT04291729|Interferons|interferons|mesh-list
153893645|NCT04291729|Ritonavir|ritonavir|mesh-list
153893646|NCT04291729|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153663552|NCT01903421|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153663553|NCT01903421|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153663554|NCT01903421|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
153663555|NCT01723839|Cyclophosphamide|cyclophosphamide|mesh-list
153663556|NCT01723839|Rituximab|rituximab|mesh-list
153663557|NCT01723839|Fludarabine|fludarabine|mesh-list
153663558|NCT01723839|Lenalidomide|lenalidomide|mesh-list
153663559|NCT01723839|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153663560|NCT01723839|Immunologic Factors|immunologic factors|mesh-ancestor
153663561|NCT01723839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153663562|NCT01723839|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153663563|NCT01723839|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153663564|NCT01723839|Alkylating Agents|alkylating agents|mesh-ancestor
153663565|NCT01723839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153663566|NCT01723839|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153663577|NCT03421483|Micronutrients|micronutrients|mesh-ancestor
153663578|NCT03421483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153663579|NCT03205696|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
153663580|NCT03205696|Antiviral Agents|antiviral agents|mesh-ancestor
153663581|NCT03205696|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153663582|NCT00405496|Difluprednate|difluprednate|mesh-list
153663583|NCT00405496|Glucocorticoids|glucocorticoids|mesh-ancestor
153663584|NCT00405496|Hormones|hormones|mesh-ancestor
153663585|NCT00405496|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153663586|NCT00405496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153663587|NCT00405535|Glycine|glycine|mesh-list
153663588|NCT00405535|Glycine Agents|glycine agents|mesh-ancestor
153663589|NCT00405535|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153663590|NCT00405535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153663591|NCT00405535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153663592|NCT00405574|Tetrathiomolybdate|tetrathiomolybdate|mesh-list
153663593|NCT00405574|Chelating Agents|chelating agents|mesh-ancestor
153663594|NCT00405574|Sequestering Agents|sequestering agents|mesh-ancestor
153663595|NCT00405574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153663596|NCT00405574|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153663597|NCT00405574|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153663598|NCT00405574|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153663599|NCT00405574|Growth Substances|growth substances|mesh-ancestor
153663600|NCT00405574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153881982|NCT01602861|Natriuretic Agents|natriuretic agents|mesh-ancestor
153663601|NCT00405574|Growth Inhibitors|growth inhibitors|mesh-ancestor
153663602|NCT00405574|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153663603|NCT02825641|Oxytocin|oxytocin|mesh-list
153881983|NCT01681667|Ibuprofen|ibuprofen|mesh-list
153663604|NCT02825641|Dinoprostone|dinoprostone|mesh-list
153663605|NCT02825641|Oxytocics|oxytocics|mesh-ancestor
153814506|NCT00446316|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153663607|NCT02825641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153663608|NCT01646034|Paclitaxel|paclitaxel|mesh-list
153663609|NCT01646034|Docetaxel|docetaxel|mesh-list
153663610|NCT01646034|Cyclophosphamide|cyclophosphamide|mesh-list
153663611|NCT01646034|Carboplatin|carboplatin|mesh-list
153663612|NCT01646034|Gemcitabine|gemcitabine|mesh-list
153663613|NCT01646034|Doxorubicin|doxorubicin|mesh-list
153663614|NCT01646034|Thiotepa|thiotepa|mesh-list
153663615|NCT01646034|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153663616|NCT01646034|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153663617|NCT01646034|Tubulin Modulators|tubulin modulators|mesh-ancestor
153663618|NCT01646034|Antimitotic Agents|antimitotic agents|mesh-ancestor
153814507|NCT00446316|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153814508|NCT00446433|Lenalidomide|lenalidomide|mesh-list
153814509|NCT00446433|Immunologic Factors|immunologic factors|mesh-ancestor
153663619|NCT01646034|Mitosis Modulators|mitosis modulators|mesh-ancestor
153663620|NCT01646034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153663621|NCT01646034|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153663622|NCT01646034|Immunologic Factors|immunologic factors|mesh-ancestor
153663623|NCT01646034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153663624|NCT01646034|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153663683|NCT01466361|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
153663684|NCT01466361|Autonomic Agents|autonomic agents|mesh-ancestor
153663685|NCT01466361|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153663686|NCT01466361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153663687|NCT01466361|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
153663688|NCT01466361|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
153663689|NCT01466361|Cholinergic Agents|cholinergic agents|mesh-ancestor
153663690|NCT01466361|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153663691|NCT01466361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153663692|NCT00001832|Cyclophosphamide|cyclophosphamide|mesh-list
153663693|NCT00001832|Fludarabine|fludarabine|mesh-list
153663694|NCT00001832|Interleukin-2|interleukin-2|mesh-list
153663695|NCT00001832|Monatide (IMS 3015)|monatide (ims 3015)|mesh-list
153663696|NCT00001832|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153663697|NCT00001832|Immunologic Factors|immunologic factors|mesh-ancestor
153663698|NCT00001832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153663699|NCT00001832|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153663700|NCT00001832|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153663701|NCT00001832|Alkylating Agents|alkylating agents|mesh-ancestor
153663702|NCT00001832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153663735|NCT01466088|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153663736|NCT01466088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153663737|NCT01466088|Cholinergic Agents|cholinergic agents|mesh-ancestor
153663738|NCT01466088|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153663739|NCT01466088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153663740|NCT01466088|Nootropic Agents|nootropic agents|mesh-ancestor
153663741|NCT00009230|Celecoxib|celecoxib|mesh-list
153663742|NCT00009230|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153663743|NCT00009230|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153663744|NCT00009230|Analgesics|analgesics|mesh-ancestor
153663745|NCT00009230|Sensory System Agents|sensory system agents|mesh-ancestor
153663746|NCT00009230|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153663747|NCT00009230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153663794|NCT01465893|Ergocalciferols|ergocalciferols|mesh-list
153663795|NCT01465893|Cholecalciferol|cholecalciferol|mesh-list
153663796|NCT01465893|Vitamins|vitamins|mesh-list
153663797|NCT01465893|Micronutrients|micronutrients|mesh-ancestor
153663798|NCT01465893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153663799|NCT01465893|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153663800|NCT01465893|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153663801|NCT00009776|Cyclosporine|cyclosporine|mesh-list
153663802|NCT00009776|Paclitaxel|paclitaxel|mesh-list
153663803|NCT00009776|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
153663804|NCT00009776|Antibodies|antibodies|mesh-list
153663805|NCT00009776|Immunoglobulins|immunoglobulins|mesh-list
153663806|NCT00009776|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
153663807|NCT00009776|Cyclosporins|cyclosporins|mesh-list
153663810|NCT00009776|Tubulin Modulators|tubulin modulators|mesh-ancestor
153663857|NCT00009854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153663858|NCT00009854|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153663859|NCT00009893|Leucovorin|leucovorin|mesh-list
153663860|NCT00009893|Gemcitabine|gemcitabine|mesh-list
153663861|NCT00009893|Fluorouracil|fluorouracil|mesh-list
153663862|NCT00009893|Calcium|calcium|mesh-list
153663863|NCT00009893|Levoleucovorin|levoleucovorin|mesh-list
153663864|NCT00009893|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153663865|NCT00009893|Antimetabolites|antimetabolites|mesh-ancestor
153663866|NCT00009893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153663867|NCT00009893|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153663924|NCT01465503|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153663925|NCT01465503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153663926|NCT01465503|Antithrombins|antithrombins|mesh-ancestor
153663927|NCT01465503|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
153663928|NCT01465503|Protease Inhibitors|protease inhibitors|mesh-ancestor
153663929|NCT01465503|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153663930|NCT00010166|Gemcitabine|gemcitabine|mesh-list
153663931|NCT00010166|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153663932|NCT00010166|Antimetabolites|antimetabolites|mesh-ancestor
153663933|NCT00010166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153663934|NCT00010166|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153663936|NCT01465152|Repaglinide|repaglinide|mesh-list
153663937|NCT01465152|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153663938|NCT01465152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153663939|NCT01465113|Vitamin D|vitamin d|mesh-list
153663940|NCT01465113|Ergocalciferols|ergocalciferols|mesh-list
153663941|NCT01465113|Cholecalciferol|cholecalciferol|mesh-list
153663942|NCT01465113|Vitamins|vitamins|mesh-list
153663943|NCT01465113|Metformin|metformin|mesh-list
153663944|NCT01465113|Omeprazole|omeprazole|mesh-list
153663945|NCT01465113|Micronutrients|micronutrients|mesh-ancestor
153663946|NCT01465113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153663947|NCT01465113|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153663948|NCT01465113|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153663949|NCT01465113|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153500935|NCT00367302|Methadone|methadone|mesh-list
153663950|NCT01465113|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
153663951|NCT01465113|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153663952|NCT01465113|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
153663955|NCT01465074|Nicotine|nicotine|mesh-list
153663969|NCT00010283|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153663970|NCT00010283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153893726|NCT00986245|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
153663971|NCT00010283|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153663972|NCT00010283|Respiratory System Agents|respiratory system agents|mesh-ancestor
153663974|NCT00010322|Atamestane|atamestane|mesh-list
153663975|NCT00010322|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153663976|NCT00010322|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153663977|NCT00010322|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
153663978|NCT00010322|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
153663979|NCT00010322|Hormone Antagonists|hormone antagonists|mesh-ancestor
153663980|NCT00010322|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153663981|NCT00010322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153663982|NCT00010322|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153663983|NCT00010322|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153663984|NCT00010322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153663985|NCT00010361|Cyclosporine|cyclosporine|mesh-list
153663986|NCT00010361|Mycophenolic Acid|mycophenolic acid|mesh-list
153914899|NCT04205097|Autonomic Agents|autonomic agents|mesh-ancestor
153663987|NCT00010361|Fludarabine|fludarabine|mesh-list
153663988|NCT00010361|Cyclosporins|cyclosporins|mesh-list
153663989|NCT00010361|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153663990|NCT00010361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153663991|NCT00010361|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153663992|NCT00010361|Immunologic Factors|immunologic factors|mesh-ancestor
153422869|NCT02221284|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
153422870|NCT02221284|Protease Inhibitors|protease inhibitors|mesh-ancestor
153422871|NCT02221284|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153422872|NCT02221284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153663993|NCT00010361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153663994|NCT00010361|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153663995|NCT00010361|Antifungal Agents|antifungal agents|mesh-ancestor
153663996|NCT00010361|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153663997|NCT00010361|Dermatologic Agents|dermatologic agents|mesh-ancestor
153663998|NCT00010361|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153663999|NCT00010361|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
153664000|NCT00010361|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153664001|NCT00010361|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
153664002|NCT00010361|Antitubercular Agents|antitubercular agents|mesh-ancestor
153664003|NCT00010361|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153360713|NCT01404923|Parasympatholytics|parasympatholytics|mesh-list
153664004|NCT00010400|Cyclophosphamide|cyclophosphamide|mesh-list
153664005|NCT00010400|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153664006|NCT00010400|Immunologic Factors|immunologic factors|mesh-ancestor
153664007|NCT00010400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153664008|NCT00010400|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153664009|NCT00010400|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153664010|NCT00010400|Alkylating Agents|alkylating agents|mesh-ancestor
153664011|NCT00010400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153664012|NCT00010400|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153664013|NCT00010400|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153664014|NCT01464840|Azithromycin|azithromycin|mesh-list
153664015|NCT01464840|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153664016|NCT01464840|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153664017|NCT01464801|Resveratrol|resveratrol|mesh-list
153664018|NCT01464801|Antioxidants|antioxidants|mesh-ancestor
153664019|NCT01464801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153664020|NCT01464801|Protective Agents|protective agents|mesh-ancestor
153664021|NCT01464801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153664022|NCT01464801|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153664023|NCT01464801|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153664024|NCT01464762|Bedaquiline|bedaquiline|mesh-list
153664025|NCT01464762|Antitubercular Agents|antitubercular agents|mesh-ancestor
153664026|NCT01464762|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153501021|NCT00369096|Bemiparin|bemiparin|mesh-list
153664027|NCT01464762|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153664028|NCT02035358|Immunomodulating Agents|immunomodulating agents|mesh-list
153664029|NCT02035358|Immunologic Factors|immunologic factors|mesh-ancestor
153664030|NCT02035358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153664031|NCT01464723|Ranibizumab|ranibizumab|mesh-list
153463603|NCT01459146|Tubulin Modulators|tubulin modulators|mesh-ancestor
153664032|NCT01464723|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153664033|NCT01464723|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153463613|NCT05026398|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153664047|NCT01464606|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153664048|NCT01464606|Alkylating Agents|alkylating agents|mesh-ancestor
153664049|NCT01464606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153664050|NCT01464606|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153664051|NCT01464606|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153664052|NCT01464606|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153664053|NCT01464606|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153664054|NCT01464606|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153664055|NCT01464606|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153664056|NCT01464606|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153664057|NCT01464606|Tubulin Modulators|tubulin modulators|mesh-ancestor
153664058|NCT01464606|Antimitotic Agents|antimitotic agents|mesh-ancestor
153664059|NCT01464606|Mitosis Modulators|mitosis modulators|mesh-ancestor
153664060|NCT01464606|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153664061|NCT01464606|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153664062|NCT01464606|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
153664063|NCT01464606|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153664064|NCT01464528|Hyaluronic Acid|hyaluronic acid|mesh-list
153664065|NCT01464528|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153664066|NCT01464528|Immunologic Factors|immunologic factors|mesh-ancestor
153664067|NCT01464528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153881987|NCT01681667|Sensory System Agents|sensory system agents|mesh-ancestor
153881988|NCT01681667|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153664068|NCT01464528|Viscosupplements|viscosupplements|mesh-ancestor
153664069|NCT01464528|Protective Agents|protective agents|mesh-ancestor
153664070|NCT00393744|Amoxicillin|amoxicillin|mesh-list
153664071|NCT00393744|Pristinamycin|pristinamycin|mesh-list
153664072|NCT00393744|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153664073|NCT00393744|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153664074|NCT00011297|Gabapentin|gabapentin|mesh-list
153664075|NCT00011297|Lorazepam|lorazepam|mesh-list
153664076|NCT00011297|Analgesics|analgesics|mesh-ancestor
153664077|NCT00011297|Sensory System Agents|sensory system agents|mesh-ancestor
153664078|NCT00011297|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153664079|NCT00011297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153434934|NCT00003092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153434935|NCT00381199|Amitriptyline|amitriptyline|mesh-list
153434936|NCT00381199|Nabilone|nabilone|mesh-list
153434937|NCT00381199|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
153893801|NCT01013740|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153893802|NCT01013740|Tubulin Modulators|tubulin modulators|mesh-ancestor
153893803|NCT01013740|Antimitotic Agents|antimitotic agents|mesh-ancestor
153893804|NCT01013740|Mitosis Modulators|mitosis modulators|mesh-ancestor
153893805|NCT01013740|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153893806|NCT01013740|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153814513|NCT00446433|Growth Substances|growth substances|mesh-ancestor
153814514|NCT00446433|Growth Inhibitors|growth inhibitors|mesh-ancestor
153360714|NCT01404923|Autonomic Agents|autonomic agents|mesh-ancestor
153664086|NCT00011297|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
153664087|NCT00011297|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153664088|NCT00011297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153664089|NCT00011297|Antimanic Agents|antimanic agents|mesh-ancestor
153664090|NCT00011297|Antiemetics|antiemetics|mesh-ancestor
153664091|NCT00011297|Autonomic Agents|autonomic agents|mesh-ancestor
153664092|NCT00011297|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153664093|NCT00011297|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153664095|NCT00011297|GABA Agents|gaba agents|mesh-ancestor
153664096|NCT00011375|Rolipram|rolipram|mesh-list
153664097|NCT00011375|Antidepressive Agents|antidepressive agents|mesh-ancestor
153664098|NCT00011375|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153893824|NCT01215435|Insulin|insulin|mesh-list
153664100|NCT00011375|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
153501114|NCT00370968|Zinc Sulfate|zinc sulfate|mesh-list
153664101|NCT00011375|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153664102|NCT00011375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153664103|NCT00847938|Neostigmine|neostigmine|mesh-list
153664104|NCT00847938|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
153664105|NCT00847938|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153664106|NCT00847938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153664107|NCT00847938|Cholinergic Agents|cholinergic agents|mesh-ancestor
153664108|NCT00847938|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153814516|NCT00340574|Aluminum Hydroxide|aluminum hydroxide|mesh-list
153814517|NCT00340574|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153664110|NCT00847938|Parasympathomimetics|parasympathomimetics|mesh-ancestor
153664111|NCT00847938|Autonomic Agents|autonomic agents|mesh-ancestor
153664112|NCT00847938|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153664113|NCT00847899|1-(1-acetyl-piperidine-4-yl)-3-adamantan-1-yl-urea|1-(1-acetyl-piperidine-4-yl)-3-adamantan-1-yl-urea|mesh-list
153664114|NCT00847899|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153664115|NCT00847899|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153664116|NCT00847899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153664117|NCT00847860|Aspirin|aspirin|mesh-list
153664118|NCT00847860|Cilostazol|cilostazol|mesh-list
153664119|NCT00847860|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153664120|NCT00847860|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153664122|NCT00847860|Sensory System Agents|sensory system agents|mesh-ancestor
153664123|NCT00847860|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153664124|NCT00847860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153664125|NCT00847860|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153664127|NCT00847860|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153664128|NCT00847860|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153664129|NCT00847860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153664130|NCT00847860|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153664131|NCT00847860|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153664132|NCT00847860|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153664133|NCT00847860|Antipyretics|antipyretics|mesh-ancestor
153664134|NCT00847860|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153664135|NCT00847860|Autonomic Agents|autonomic agents|mesh-ancestor
153664136|NCT00847860|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153664137|NCT00847860|Respiratory System Agents|respiratory system agents|mesh-ancestor
153664138|NCT00847860|Vasodilator Agents|vasodilator agents|mesh-ancestor
153664139|NCT00847860|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
153664140|NCT00847860|Protective Agents|protective agents|mesh-ancestor
153664141|NCT00847860|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
153664142|NCT00847860|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
153664143|NCT00847821|Raloxifene Hydrochloride|raloxifene hydrochloride|mesh-list
153664144|NCT00847821|Bazedoxifene|bazedoxifene|mesh-list
153664145|NCT00847821|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
153664171|NCT00847587|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
153664172|NCT00847587|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
153664173|NCT00847587|Progestins|progestins|mesh-ancestor
153664174|NCT00847587|Hormones|hormones|mesh-ancestor
153664175|NCT00847587|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153664176|NCT00011765|Fluoxetine|fluoxetine|mesh-list
153664177|NCT00011765|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
153664178|NCT00011765|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153664179|NCT00011765|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153434961|NCT00002509|Immunologic Factors|immunologic factors|mesh-ancestor
153434962|NCT00002509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153434963|NCT00002509|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153434964|NCT00002509|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153434965|NCT00002509|Alkylating Agents|alkylating agents|mesh-ancestor
153434966|NCT00002509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153664180|NCT00011765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153664182|NCT00011765|Serotonin Agents|serotonin agents|mesh-ancestor
153664183|NCT00011765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153664184|NCT00011765|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
153664185|NCT00011765|Antidepressive Agents|antidepressive agents|mesh-ancestor
153664186|NCT00011765|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153664187|NCT00011765|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
153664188|NCT00011765|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153664189|NCT00011765|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153664190|NCT00011804|Topiramate|topiramate|mesh-list
153664191|NCT00011804|Anticonvulsants|anticonvulsants|mesh-ancestor
153664192|NCT00011804|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153664193|NCT00011804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153664194|NCT00011921|Paclitaxel|paclitaxel|mesh-list
153664195|NCT00011921|Etoposide|etoposide|mesh-list
153664196|NCT00011921|Carboplatin|carboplatin|mesh-list
153664197|NCT00011921|Etoposide phosphate|etoposide phosphate|mesh-list
153664198|NCT00011921|Epirubicin|epirubicin|mesh-list
153664199|NCT00011921|Ifosfamide|ifosfamide|mesh-list
153664217|NCT00011960|Antimitotic Agents|antimitotic agents|mesh-ancestor
153664218|NCT00011960|Mitosis Modulators|mitosis modulators|mesh-ancestor
153664219|NCT00011960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153664221|NCT00847314|Testosterone|testosterone|mesh-list
153664222|NCT00847314|Testosterone undecanoate|testosterone undecanoate|mesh-list
153664223|NCT00847314|Testosterone enanthate|testosterone enanthate|mesh-list
153664224|NCT00847314|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
153664225|NCT00847314|Androgens|androgens|mesh-ancestor
153664226|NCT00847314|Hormones|hormones|mesh-ancestor
153664227|NCT00847314|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153664228|NCT00847314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153664229|NCT00847314|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153664230|NCT00847314|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153664231|NCT00847314|Anabolic Agents|anabolic agents|mesh-ancestor
153664232|NCT00011999|Paclitaxel|paclitaxel|mesh-list
153664233|NCT00011999|Cisplatin|cisplatin|mesh-list
153664234|NCT00011999|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153664235|NCT00011999|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153664236|NCT00011999|Tubulin Modulators|tubulin modulators|mesh-ancestor
153664237|NCT00011999|Antimitotic Agents|antimitotic agents|mesh-ancestor
153664238|NCT00011999|Mitosis Modulators|mitosis modulators|mesh-ancestor
153664239|NCT00011999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153664240|NCT00012038|Irofulven|irofulven|mesh-list
153664241|NCT00012038|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153664242|NCT00012038|Alkylating Agents|alkylating agents|mesh-ancestor
153664264|NCT00847080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153814519|NCT00340574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153664266|NCT00847080|Hormones|hormones|mesh-ancestor
153664267|NCT00847080|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153664268|NCT00847080|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
153664269|NCT00847080|Protease Inhibitors|protease inhibitors|mesh-ancestor
153664270|NCT00847080|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153664271|NCT00847080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153664272|NCT00012194|7-hydroxystaurosporine|7-hydroxystaurosporine|mesh-list
153664273|NCT00012194|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153664274|NCT00012194|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153664275|NCT00012194|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153664276|NCT00012194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153664277|NCT01818323|Immunomodulating Agents|immunomodulating agents|mesh-list
153664278|NCT01818323|Immunologic Factors|immunologic factors|mesh-ancestor
153664279|NCT01818323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153434998|NCT00002521|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153434999|NCT00002521|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153893865|NCT00627952|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153893866|NCT01009840|Bortezomib|bortezomib|mesh-list
153893867|NCT01009840|Busulfan|busulfan|mesh-list
153893868|NCT01009840|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153893869|NCT01009840|Alkylating Agents|alkylating agents|mesh-ancestor
153893870|NCT01009840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153893871|NCT01009840|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153893872|NCT01009840|Immunologic Factors|immunologic factors|mesh-ancestor
153664280|NCT00012311|Cyclophosphamide|cyclophosphamide|mesh-list
153664281|NCT00012311|Ifosfamide|ifosfamide|mesh-list
153664320|NCT00846963|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
153664321|NCT00846963|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
153664322|NCT00846963|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153664324|NCT00012389|Irinotecan|irinotecan|mesh-list
153501314|NCT00377910|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
153664325|NCT00012389|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153664326|NCT00012389|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
153664328|NCT00012389|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153664329|NCT00012389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153664330|NCT00846885|Sumatriptan|sumatriptan|mesh-list
153664331|NCT00846885|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
153664332|NCT00846885|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
153914959|NCT05345119|Sirolimus|sirolimus|mesh-list
153664333|NCT00846885|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
153664334|NCT00846885|Serotonin Agents|serotonin agents|mesh-ancestor
153814521|NCT00340574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153814522|NCT00340574|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153814524|NCT00340613|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153664335|NCT00846885|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153664336|NCT00846885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153664337|NCT00846885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153664338|NCT00012467|Interferons|interferons|mesh-list
153664339|NCT00012467|Interferon-gamma|interferon-gamma|mesh-list
153664340|NCT00012467|Itraconazole|itraconazole|mesh-list
153664371|NCT00012506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153664372|NCT00012506|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153664373|NCT00012506|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153664374|NCT00012506|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153664375|NCT00012506|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153664376|NCT00012506|Immunologic Factors|immunologic factors|mesh-ancestor
153664378|NCT00012584|Methylphenidate|methylphenidate|mesh-list
153664379|NCT00012584|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
153664380|NCT00012584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153664381|NCT00012584|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
153664382|NCT00012584|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153664383|NCT00012584|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153664384|NCT00012584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153664385|NCT00012584|Dopamine Agents|dopamine agents|mesh-ancestor
153664386|NCT00012584|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153664387|NCT00012584|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153664388|NCT00012584|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153664389|NCT00012584|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153664390|NCT00012584|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153664391|NCT00012584|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
153664392|NCT00012584|Serotonin Agents|serotonin agents|mesh-ancestor
153664393|NCT00012584|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
153664394|NCT00012584|Antidepressive Agents|antidepressive agents|mesh-ancestor
153664420|NCT00846690|Respiratory System Agents|respiratory system agents|mesh-ancestor
153664421|NCT00846690|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
153664422|NCT00846690|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153664423|NCT00846690|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153664424|NCT00846690|Adrenergic Agents|adrenergic agents|mesh-ancestor
153914986|NCT03529123|Insulin|insulin|mesh-list
153664425|NCT00846690|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153664426|NCT00846690|Protective Agents|protective agents|mesh-ancestor
153664427|NCT00846651|Phenylephrine|phenylephrine|mesh-list
153664428|NCT00846651|Oxymetazoline|oxymetazoline|mesh-list
153664429|NCT00846651|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
153664430|NCT00846651|Mydriatics|mydriatics|mesh-ancestor
153664431|NCT00846651|Autonomic Agents|autonomic agents|mesh-ancestor
153664432|NCT00846651|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153664433|NCT00846651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153664434|NCT00846651|Sympathomimetics|sympathomimetics|mesh-ancestor
153664435|NCT00846651|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
153664436|NCT00846651|Nasal Decongestants|nasal decongestants|mesh-ancestor
153664437|NCT00846651|Respiratory System Agents|respiratory system agents|mesh-ancestor
153664438|NCT00846651|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
153664439|NCT00846651|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153664440|NCT00846651|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153664441|NCT00846651|Adrenergic Agents|adrenergic agents|mesh-ancestor
153664442|NCT00846651|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153664443|NCT00846651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153664444|NCT00846651|Protective Agents|protective agents|mesh-ancestor
153664445|NCT00846612|Bevacizumab|bevacizumab|mesh-list
153664446|NCT00846612|Doxorubicin|doxorubicin|mesh-list
153664447|NCT00846612|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153664448|NCT00846612|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153664449|NCT00846612|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153664450|NCT00846612|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153664451|NCT00846612|Growth Substances|growth substances|mesh-ancestor
153664452|NCT00846612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153664461|NCT00012857|Analgesics|analgesics|mesh-ancestor
153664462|NCT00012857|Sensory System Agents|sensory system agents|mesh-ancestor
153664463|NCT00012857|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153664464|NCT00012857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153664465|NCT00012857|Antipyretics|antipyretics|mesh-ancestor
153915004|NCT04074187|Immunologic Factors|immunologic factors|mesh-ancestor
153664467|NCT00394056|Vestipitant|vestipitant|mesh-list
153915005|NCT04074187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153664468|NCT00394056|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
153664469|NCT00394056|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153664470|NCT00394056|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153664471|NCT00394056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153501459|NCT00381264|Nabilone|nabilone|mesh-list
153664472|NCT00394056|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153664473|NCT00394056|Serotonin Agents|serotonin agents|mesh-ancestor
153664474|NCT00394056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153664475|NCT00394056|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
153664496|NCT00846144|Copper|copper|mesh-list
153664517|NCT00845988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153664518|NCT00845988|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
153664519|NCT00845988|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
153664520|NCT00845988|Serotonin Agents|serotonin agents|mesh-ancestor
153664521|NCT00845988|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
153664522|NCT00845988|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153664523|NCT00845988|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
153664524|NCT00845988|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
153664525|NCT00845910|Bevacizumab|bevacizumab|mesh-list
153664526|NCT00845910|Docetaxel|docetaxel|mesh-list
153664527|NCT00845910|Capecitabine|capecitabine|mesh-list
153882000|NCT01600365|Antiviral Agents|antiviral agents|mesh-ancestor
153882001|NCT01600365|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153882002|NCT01600365|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153664528|NCT00845910|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153664529|NCT00845910|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153664530|NCT00845910|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153664531|NCT00845910|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153664532|NCT00845910|Growth Substances|growth substances|mesh-ancestor
153664533|NCT00845910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153664534|NCT00845910|Growth Inhibitors|growth inhibitors|mesh-ancestor
153664535|NCT00845910|Tubulin Modulators|tubulin modulators|mesh-ancestor
153664536|NCT00845910|Antimitotic Agents|antimitotic agents|mesh-ancestor
153664537|NCT00845910|Mitosis Modulators|mitosis modulators|mesh-ancestor
153664538|NCT00845910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153664539|NCT00845910|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153664540|NCT00845910|Antimetabolites|antimetabolites|mesh-ancestor
153664542|NCT00680628|Tenecteplase|tenecteplase|mesh-list
153664543|NCT00680628|Enoxaparin sodium|enoxaparin sodium|mesh-list
153664544|NCT00680628|Anticoagulants|anticoagulants|mesh-ancestor
153664545|NCT00680628|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153501532|NCT00383682|Mexiletine|mexiletine|mesh-list
153664546|NCT00680628|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153664547|NCT00680628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153664548|NCT00013520|Lamivudine|lamivudine|mesh-list
153664549|NCT00013520|Zidovudine|zidovudine|mesh-list
153664551|NCT00013520|Nevirapine|nevirapine|mesh-list
153664552|NCT00013520|Abacavir|abacavir|mesh-list
153664553|NCT00013520|Dideoxynucleosides|dideoxynucleosides|mesh-list
153664556|NCT00013520|Lamivudine, zidovudine drug combination|lamivudine, zidovudine drug combination|mesh-list
153664557|NCT00013520|Atazanavir Sulfate|atazanavir sulfate|mesh-list
153664558|NCT00013520|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153664559|NCT00013520|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153664560|NCT00013520|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153664561|NCT00013520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153664562|NCT00013520|Antiviral Agents|antiviral agents|mesh-ancestor
153664563|NCT00013520|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153664564|NCT00013520|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153664565|NCT00013520|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153664566|NCT00013520|Antimetabolites|antimetabolites|mesh-ancestor
153664567|NCT00013520|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
153915016|NCT04074187|Protective Agents|protective agents|mesh-ancestor
153664568|NCT00013520|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153664569|NCT00013520|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
153664570|NCT00013520|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
153664571|NCT00013520|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
153664572|NCT00013520|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
153664573|NCT00013520|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
153664574|NCT00013520|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
153664575|NCT00013520|Protease Inhibitors|protease inhibitors|mesh-ancestor
153664576|NCT00013598|Pioglitazone|pioglitazone|mesh-list
153664577|NCT00013598|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153664578|NCT00013598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153664579|NCT00277017|Interferons|interferons|mesh-list
153664580|NCT00277017|Thalidomide|thalidomide|mesh-list
153664581|NCT00277017|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153664582|NCT00277017|Antiviral Agents|antiviral agents|mesh-ancestor
153664602|NCT00276978|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153664603|NCT00276978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153664604|NCT00276978|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
153664605|NCT00276978|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
153664606|NCT00276978|Serotonin Agents|serotonin agents|mesh-ancestor
153664607|NCT00276978|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
153664608|NCT00276978|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153664609|NCT00276978|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
153664610|NCT00276978|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
153664611|NCT00276900|Sertraline|sertraline|mesh-list
153664612|NCT00276900|Antidepressive Agents|antidepressive agents|mesh-ancestor
153664613|NCT00276900|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153664614|NCT00276900|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
153664615|NCT00276900|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153664616|NCT00276900|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153664617|NCT00276900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153664618|NCT00276900|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153664619|NCT00276900|Serotonin Agents|serotonin agents|mesh-ancestor
153501605|NCT00384618|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153664620|NCT00276900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153664621|NCT00276861|Gemcitabine|gemcitabine|mesh-list
153664622|NCT00276861|Oxaliplatin|oxaliplatin|mesh-list
153664623|NCT00276861|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153664624|NCT00276861|Antimetabolites|antimetabolites|mesh-ancestor
153664625|NCT00276861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153664626|NCT00276861|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153664628|NCT00013871|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
153664629|NCT00013871|Immunologic Factors|immunologic factors|mesh-ancestor
153664645|NCT00276705|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153664646|NCT00276705|Alkylating Agents|alkylating agents|mesh-ancestor
153664647|NCT00276705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153664648|NCT00276705|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153664649|NCT00276705|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153664650|NCT00276705|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153664651|NCT00276705|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153664652|NCT00276705|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153664653|NCT00276705|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153664654|NCT00276705|Leprostatic Agents|leprostatic agents|mesh-ancestor
153664655|NCT00276705|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153664656|NCT00276705|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153664657|NCT00276705|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153664658|NCT00276705|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153664659|NCT00276705|Growth Substances|growth substances|mesh-ancestor
153664660|NCT00276705|Growth Inhibitors|growth inhibitors|mesh-ancestor
153664661|NCT00276666|Vincristine|vincristine|mesh-list
153664662|NCT00276666|Lomustine|lomustine|mesh-list
153664663|NCT00276666|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153664664|NCT00276666|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153664665|NCT00276666|Tubulin Modulators|tubulin modulators|mesh-ancestor
153664666|NCT00276666|Antimitotic Agents|antimitotic agents|mesh-ancestor
153664667|NCT00276666|Mitosis Modulators|mitosis modulators|mesh-ancestor
153664668|NCT00276666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153664669|NCT00276666|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153664670|NCT00276666|Alkylating Agents|alkylating agents|mesh-ancestor
153664671|NCT00014066|Hematoporphyrin Derivative|hematoporphyrin derivative|mesh-list
153664672|NCT00014066|Hematoporphyrins|hematoporphyrins|mesh-list
153664673|NCT00014066|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
153814526|NCT00340691|Doxycycline|doxycycline|mesh-list
153893967|NCT04297462|Oseltamivir|oseltamivir|mesh-list
153893968|NCT04297462|Antiviral Agents|antiviral agents|mesh-ancestor
153893969|NCT04297462|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153893970|NCT04297462|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153893971|NCT04297462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153664674|NCT00014066|Dermatologic Agents|dermatologic agents|mesh-ancestor
153664675|NCT00014066|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153664676|NCT00014105|Carboplatin|carboplatin|mesh-list
153664677|NCT00014105|Temozolomide|temozolomide|mesh-list
153664678|NCT00014105|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153664679|NCT00014105|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153664680|NCT00014105|Alkylating Agents|alkylating agents|mesh-ancestor
153664682|NCT00014144|Gefitinib|gefitinib|mesh-list
153664683|NCT00014144|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153664684|NCT00014144|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153664685|NCT00014144|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153664686|NCT00014144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153664687|NCT00014144|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153664688|NCT00276588|Paclitaxel|paclitaxel|mesh-list
153664689|NCT00276588|Carboplatin|carboplatin|mesh-list
153664690|NCT00276588|Gemcitabine|gemcitabine|mesh-list
153664691|NCT00276588|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153664692|NCT00276588|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153664693|NCT00276588|Tubulin Modulators|tubulin modulators|mesh-ancestor
153501683|NCT00422526|Progesterone|progesterone|mesh-list
153664695|NCT00276588|Mitosis Modulators|mitosis modulators|mesh-ancestor
153664696|NCT00276588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153664697|NCT00276588|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153664698|NCT00276588|Antimetabolites|antimetabolites|mesh-ancestor
153664699|NCT00276549|Gemcitabine|gemcitabine|mesh-list
153664700|NCT00276549|Docetaxel|docetaxel|mesh-list
153664701|NCT00276549|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153664702|NCT00276549|Antimetabolites|antimetabolites|mesh-ancestor
153664703|NCT00276549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153664704|NCT00276549|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153664705|NCT00276549|Tubulin Modulators|tubulin modulators|mesh-ancestor
153664706|NCT00276549|Antimitotic Agents|antimitotic agents|mesh-ancestor
153893976|NCT00981409|Anticoagulants|anticoagulants|mesh-ancestor
153893977|NCT00981409|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153893978|NCT00981409|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153893979|NCT00981409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153893980|NCT00981409|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
153893981|NCT00981409|Antithrombins|antithrombins|mesh-ancestor
153664707|NCT00276549|Mitosis Modulators|mitosis modulators|mesh-ancestor
153664709|NCT00014183|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153664710|NCT00014183|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153664711|NCT00014183|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153664727|NCT00014339|Prednisone|prednisone|mesh-list
153664728|NCT00014339|Melphalan|melphalan|mesh-list
153664729|NCT00014339|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153664730|NCT00014339|Glucocorticoids|glucocorticoids|mesh-ancestor
153664731|NCT00014339|Hormones|hormones|mesh-ancestor
153664732|NCT00014339|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153664733|NCT00014339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153664734|NCT00014339|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153664735|NCT00014339|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153664736|NCT00014339|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153664737|NCT00014339|Alkylating Agents|alkylating agents|mesh-ancestor
153664738|NCT00014339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153664739|NCT00014339|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153664740|NCT00014339|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153664741|NCT00014339|Immunologic Factors|immunologic factors|mesh-ancestor
153664742|NCT00014456|Gemcitabine|gemcitabine|mesh-list
153664743|NCT00014456|Docetaxel|docetaxel|mesh-list
153664744|NCT00014456|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153664745|NCT00014456|Antimetabolites|antimetabolites|mesh-ancestor
153664746|NCT00014456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153664747|NCT00014456|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153664748|NCT00014456|Tubulin Modulators|tubulin modulators|mesh-ancestor
153664749|NCT00014456|Antimitotic Agents|antimitotic agents|mesh-ancestor
153664750|NCT00014456|Mitosis Modulators|mitosis modulators|mesh-ancestor
153664751|NCT00276393|Insulin|insulin|mesh-list
153664752|NCT00276393|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153664753|NCT00276393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153664754|NCT00014534|Gemcitabine|gemcitabine|mesh-list
153664755|NCT00014534|Doxorubicin|doxorubicin|mesh-list
153664756|NCT00014534|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
153664757|NCT00014534|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153664758|NCT00014534|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153664759|NCT00014534|Antimetabolites|antimetabolites|mesh-ancestor
153664761|NCT00014534|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153664769|NCT00014573|Sargramostim|sargramostim|mesh-list
153664770|NCT00014573|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153664771|NCT00014573|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153664772|NCT00014573|Tubulin Modulators|tubulin modulators|mesh-ancestor
153435122|NCT00002239|Ritonavir|ritonavir|mesh-list
153664773|NCT00014573|Antimitotic Agents|antimitotic agents|mesh-ancestor
153664774|NCT00014573|Mitosis Modulators|mitosis modulators|mesh-ancestor
153664775|NCT00014573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153664776|NCT00014573|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153664777|NCT00014573|Immunologic Factors|immunologic factors|mesh-ancestor
153664778|NCT00014573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153664779|NCT00014573|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153664780|NCT00014573|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153664781|NCT00014573|Alkylating Agents|alkylating agents|mesh-ancestor
153664782|NCT00014573|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153664784|NCT00014573|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153664785|NCT00014573|Antiviral Agents|antiviral agents|mesh-ancestor
153664786|NCT00014573|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153664787|NCT00276315|Botulinum Toxins|botulinum toxins|mesh-list
153664788|NCT00276315|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
153664789|NCT00276315|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
153664790|NCT00276315|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
153664791|NCT00276315|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153664792|NCT00276315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153664793|NCT00276315|Cholinergic Agents|cholinergic agents|mesh-ancestor
153664794|NCT00276315|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153664795|NCT00276315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153664796|NCT00276315|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
153664797|NCT00276315|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153664798|NCT00276276|Topotecan|topotecan|mesh-list
153664804|NCT00014651|Vapreotide|vapreotide|mesh-list
153664812|NCT00014690|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153664813|NCT00014690|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153664814|NCT00014690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153664815|NCT00014690|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153664816|NCT00014729|Isotretinoin|isotretinoin|mesh-list
153664817|NCT00014729|Dermatologic Agents|dermatologic agents|mesh-ancestor
153664819|NCT00276198|Vitamin A|vitamin a|mesh-list
153664820|NCT00276198|Vitamins|vitamins|mesh-ancestor
153664821|NCT00276198|Micronutrients|micronutrients|mesh-ancestor
153664822|NCT00276198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153664823|NCT00276198|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153664824|NCT00276081|Gabapentin|gabapentin|mesh-list
153664825|NCT00276081|Estrogens|estrogens|mesh-list
153664826|NCT00276081|Analgesics|analgesics|mesh-ancestor
153664827|NCT00276081|Sensory System Agents|sensory system agents|mesh-ancestor
153664828|NCT00276081|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153664829|NCT00276081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153664830|NCT00276081|Anticonvulsants|anticonvulsants|mesh-ancestor
153664831|NCT00276081|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153664832|NCT00276081|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153664833|NCT00276081|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153664834|NCT00276081|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153664835|NCT00276081|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
153664836|NCT00276081|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
153664837|NCT00276081|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153664838|NCT00276081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153664839|NCT00276081|Antimanic Agents|antimanic agents|mesh-ancestor
153664840|NCT00276081|Hormones|hormones|mesh-ancestor
153664841|NCT00276081|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153664842|NCT00276003|Gemcitabine|gemcitabine|mesh-list
153664843|NCT00276003|Irinotecan|irinotecan|mesh-list
153664844|NCT00276003|Allopurinol|allopurinol|mesh-list
153664845|NCT00276003|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153664847|NCT00276003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153664848|NCT00276003|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153894028|NCT00978757|Ketamine|ketamine|mesh-list
153664850|NCT00276003|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153664851|NCT00276003|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153664852|NCT00276003|Gout Suppressants|gout suppressants|mesh-ancestor
153664853|NCT00276003|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153664854|NCT00276003|Free Radical Scavengers|free radical scavengers|mesh-ancestor
153664855|NCT00276003|Antioxidants|antioxidants|mesh-ancestor
153664856|NCT00276003|Protective Agents|protective agents|mesh-ancestor
153664857|NCT00276003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153664858|NCT00275925|Oxcarbazepine|oxcarbazepine|mesh-list
153664859|NCT00275925|Anticonvulsants|anticonvulsants|mesh-ancestor
153664860|NCT00275925|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
153664861|NCT00275925|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153664862|NCT00275925|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153664863|NCT00275925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153882006|NCT01602900|Antidepressive Agents|antidepressive agents|mesh-ancestor
153882007|NCT01602900|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153664864|NCT00275925|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
153664865|NCT00275925|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
153882008|NCT01602900|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
153882009|NCT01602900|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
153882010|NCT01602900|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153664866|NCT00015041|Buprenorphine|buprenorphine|mesh-list
153664867|NCT00015041|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153664868|NCT00015041|Narcotics|narcotics|mesh-ancestor
153664869|NCT00015041|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153664870|NCT00015041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153664871|NCT00015041|Analgesics|analgesics|mesh-ancestor
153664872|NCT00015041|Sensory System Agents|sensory system agents|mesh-ancestor
153664873|NCT00015041|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153664874|NCT00015041|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
153664875|NCT00015080|Naltrexone|naltrexone|mesh-list
153664876|NCT00015080|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
153664877|NCT00015080|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
153664878|NCT00015080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153664879|NCT00015080|Sensory System Agents|sensory system agents|mesh-ancestor
153664880|NCT00015080|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153664881|NCT00015236|Amantadine|amantadine|mesh-list
153664882|NCT00015236|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
153664883|NCT00015236|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
153664884|NCT00015236|Antiviral Agents|antiviral agents|mesh-ancestor
153664889|NCT00015236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153664890|NCT00015236|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153664892|NCT00015236|Sensory System Agents|sensory system agents|mesh-ancestor
153664893|NCT00015236|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153664894|NCT00015275|Cocaine|cocaine|mesh-list
153664895|NCT00015275|Anesthetics, Local|anesthetics, local|mesh-ancestor
153664896|NCT00015275|Anesthetics|anesthetics|mesh-ancestor
153664897|NCT00015275|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153664898|NCT00015275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153664899|NCT00015275|Sensory System Agents|sensory system agents|mesh-ancestor
153664900|NCT00015275|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153664901|NCT00015275|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
153664902|NCT00015275|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
153664903|NCT00015275|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153664904|NCT00015275|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153664905|NCT00015275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153664906|NCT00015275|Dopamine Agents|dopamine agents|mesh-ancestor
153664907|NCT00015275|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153664908|NCT00275730|Indomethacin|indomethacin|mesh-list
153664909|NCT00275730|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153664910|NCT00275730|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153664911|NCT00275730|Analgesics|analgesics|mesh-ancestor
153894054|NCT02866903|Oxaliplatin|oxaliplatin|mesh-list
153664914|NCT00275730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153664915|NCT00275730|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153664916|NCT00275730|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153664917|NCT00275730|Gout Suppressants|gout suppressants|mesh-ancestor
153664918|NCT00275730|Tocolytic Agents|tocolytic agents|mesh-ancestor
153501906|NCT02992704|Antiviral Agents|antiviral agents|mesh-ancestor
153664919|NCT00275730|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153664928|NCT00275652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153664929|NCT00275652|Antiviral Agents|antiviral agents|mesh-ancestor
153664930|NCT00275652|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153664931|NCT00275652|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153664932|NCT00275652|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153387538|NCT00355277|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153814527|NCT00340691|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153814528|NCT00340691|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153664934|NCT00275613|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153664935|NCT00275613|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153664936|NCT00275613|Immunologic Factors|immunologic factors|mesh-ancestor
153664937|NCT00275613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153664938|NCT00275613|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153664939|NCT00015548|Olanzapine|olanzapine|mesh-list
153664940|NCT00015548|Risperidone|risperidone|mesh-list
153664941|NCT00015548|Quetiapine Fumarate|quetiapine fumarate|mesh-list
153882016|NCT01602939|Cladribine|cladribine|mesh-list
153664942|NCT00015548|Citalopram|citalopram|mesh-list
153664943|NCT00015548|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153664944|NCT00015548|Serotonin Agents|serotonin agents|mesh-ancestor
153664945|NCT00015548|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153664946|NCT00015548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153664947|NCT00015548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153664948|NCT00015548|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153664949|NCT00015548|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153664950|NCT00015548|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153664951|NCT00015548|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153664952|NCT00015548|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
153664953|NCT00015548|Dopamine Agents|dopamine agents|mesh-ancestor
153664954|NCT00015548|Antiemetics|antiemetics|mesh-ancestor
153664955|NCT00015548|Autonomic Agents|autonomic agents|mesh-ancestor
153664956|NCT00015548|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153664957|NCT00015548|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153664958|NCT00015548|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
153664959|NCT00015548|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153664960|NCT00015548|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153664961|NCT00015548|Antidepressive Agents|antidepressive agents|mesh-ancestor
153664962|NCT00015548|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
153664963|NCT00275535|Mycophenolic Acid|mycophenolic acid|mesh-list
153664964|NCT00275535|Sirolimus|sirolimus|mesh-list
153664966|NCT00275535|Tacrolimus|tacrolimus|mesh-list
153664967|NCT00275535|Thymoglobulin|thymoglobulin|mesh-list
153664968|NCT00275535|Antilymphocyte Serum|antilymphocyte serum|mesh-list
153664969|NCT00275535|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153664970|NCT00275535|Glucocorticoids|glucocorticoids|mesh-ancestor
153664971|NCT00275535|Hormones|hormones|mesh-ancestor
153664972|NCT00275535|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153664973|NCT00275535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153664974|NCT00275535|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153664975|NCT00275535|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153664976|NCT00275535|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153664977|NCT00275535|Immunologic Factors|immunologic factors|mesh-ancestor
153664978|NCT00275535|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
153664979|NCT00275535|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153664980|NCT00275535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153664981|NCT00275535|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153664982|NCT00275535|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
153664983|NCT00275535|Antitubercular Agents|antitubercular agents|mesh-ancestor
153664984|NCT00275535|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153664985|NCT00275535|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153664986|NCT00275535|Antifungal Agents|antifungal agents|mesh-ancestor
153664987|NCT00015626|Metformin|metformin|mesh-list
153664988|NCT00015626|Pioglitazone|pioglitazone|mesh-list
153664989|NCT00015626|Rosiglitazone|rosiglitazone|mesh-list
153664990|NCT00015626|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153664991|NCT00015626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153664992|NCT00015665|Voriconazole|voriconazole|mesh-list
153664993|NCT00015665|Antifungal Agents|antifungal agents|mesh-ancestor
153664994|NCT00015665|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153664995|NCT00015665|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
153664996|NCT00015665|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153664997|NCT00015665|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153664998|NCT00015665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153665000|NCT00015665|Hormone Antagonists|hormone antagonists|mesh-ancestor
153665007|NCT00275457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153665008|NCT00275457|Protective Agents|protective agents|mesh-ancestor
153665009|NCT00275457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153665010|NCT00275457|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
153665011|NCT00275457|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
153665012|NCT00275457|Dopamine Agonists|dopamine agonists|mesh-ancestor
153665013|NCT00275457|Dopamine Agents|dopamine agents|mesh-ancestor
153665014|NCT00275457|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153665015|NCT00015704|Aldesleukin|aldesleukin|mesh-list
153665016|NCT00015704|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153665017|NCT00015704|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153665018|NCT00015704|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153665019|NCT00015704|Antiviral Agents|antiviral agents|mesh-ancestor
153665020|NCT00015704|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153665021|NCT00275418|Beta Carotene|beta carotene|mesh-list
153665022|NCT00275418|Carotenoids|carotenoids|mesh-list
153665023|NCT00275418|Antioxidants|antioxidants|mesh-ancestor
153665024|NCT00275418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153665025|NCT00275418|Protective Agents|protective agents|mesh-ancestor
153665026|NCT00275418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153665027|NCT00275418|Provitamins|provitamins|mesh-ancestor
153665029|NCT00275418|Micronutrients|micronutrients|mesh-ancestor
153665030|NCT00015821|Thalidomide|thalidomide|mesh-list
153665031|NCT00015821|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153665032|NCT00015821|Immunologic Factors|immunologic factors|mesh-ancestor
153665033|NCT00015821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153665034|NCT00015821|Leprostatic Agents|leprostatic agents|mesh-ancestor
153665035|NCT00015821|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153665036|NCT00015821|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153665037|NCT00015821|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153665042|NCT00275184|Metoclopramide|metoclopramide|mesh-list
153665052|NCT00275184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153665054|NCT00015860|Vincristine|vincristine|mesh-list
153665055|NCT00015860|Imatinib Mesylate|imatinib mesylate|mesh-list
153665056|NCT00015860|Daunorubicin|daunorubicin|mesh-list
153665057|NCT00015860|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153665058|NCT00015860|Glucocorticoids|glucocorticoids|mesh-ancestor
153665059|NCT00015860|Hormones|hormones|mesh-ancestor
153665060|NCT00015860|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153665061|NCT00015860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153665062|NCT00015860|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153894131|NCT01011868|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153665063|NCT00015860|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153665064|NCT00015860|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153665065|NCT00015860|Tubulin Modulators|tubulin modulators|mesh-ancestor
153665066|NCT00015860|Antimitotic Agents|antimitotic agents|mesh-ancestor
153665067|NCT00015860|Mitosis Modulators|mitosis modulators|mesh-ancestor
153502057|NCT01271166|Growth Inhibitors|growth inhibitors|mesh-ancestor
153665068|NCT00015860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153665069|NCT00015860|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153665070|NCT00015860|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153665071|NCT00015860|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153814530|NCT00340691|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153814531|NCT00340691|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153665107|NCT00275106|Hormones|hormones|mesh-ancestor
153665108|NCT00275106|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153665109|NCT00275106|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153665110|NCT00275106|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153665111|NCT00275106|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153665112|NCT00275106|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153665113|NCT00275106|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153665114|NCT00275106|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
153665115|NCT00275106|Abortifacient Agents|abortifacient agents|mesh-ancestor
153665116|NCT00275106|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153665117|NCT00275106|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153665118|NCT00275106|Antimetabolites|antimetabolites|mesh-ancestor
153665119|NCT00275106|Dermatologic Agents|dermatologic agents|mesh-ancestor
153665120|NCT00275106|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153665121|NCT00275106|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153665122|NCT00275106|Antiviral Agents|antiviral agents|mesh-ancestor
153665123|NCT00275106|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153665124|NCT00275106|Antidotes|antidotes|mesh-ancestor
153665125|NCT00275106|Protective Agents|protective agents|mesh-ancestor
153665126|NCT00275106|Vitamin B Complex|vitamin b complex|mesh-ancestor
153665159|NCT00015977|Immunologic Factors|immunologic factors|mesh-ancestor
153665160|NCT00015977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153665161|NCT00015977|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153665162|NCT00015977|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153665163|NCT00015977|Growth Substances|growth substances|mesh-ancestor
153665164|NCT00015977|Growth Inhibitors|growth inhibitors|mesh-ancestor
153882023|NCT01600404|Cholinergic Agents|cholinergic agents|mesh-ancestor
153882024|NCT01600404|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153665165|NCT00015977|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153665166|NCT01678586|Diphenhydramine|diphenhydramine|mesh-list
153665167|NCT01678586|Gabapentin|gabapentin|mesh-list
153665168|NCT01678586|Analgesics|analgesics|mesh-ancestor
153665169|NCT01678586|Sensory System Agents|sensory system agents|mesh-ancestor
153665170|NCT01678586|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153665171|NCT01678586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153665172|NCT01678586|Anticonvulsants|anticonvulsants|mesh-ancestor
153665173|NCT01678586|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153665174|NCT01678586|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153665175|NCT01678586|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153665176|NCT01678586|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153665177|NCT01678586|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
153665178|NCT01678586|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
153665179|NCT01678586|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153665180|NCT01678586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153665181|NCT01678586|Antimanic Agents|antimanic agents|mesh-ancestor
153665182|NCT01678586|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
153665183|NCT01678586|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153665184|NCT01678586|Anesthetics, Local|anesthetics, local|mesh-ancestor
153665185|NCT01678586|Anesthetics|anesthetics|mesh-ancestor
153665186|NCT01678586|Antiemetics|antiemetics|mesh-ancestor
153665187|NCT01678586|Autonomic Agents|autonomic agents|mesh-ancestor
153665206|NCT00274950|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153915088|NCT02118727|Memantine|memantine|mesh-list
153665207|NCT00274950|Tubulin Modulators|tubulin modulators|mesh-ancestor
153665208|NCT00274950|Antimitotic Agents|antimitotic agents|mesh-ancestor
153665209|NCT00274950|Mitosis Modulators|mitosis modulators|mesh-ancestor
153665210|NCT00016016|Cytarabine|cytarabine|mesh-list
153665211|NCT00016016|Mitoxantrone|mitoxantrone|mesh-list
153665212|NCT00016016|Alvocidib|alvocidib|mesh-list
153665213|NCT00016016|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153665214|NCT00016016|Antimetabolites|antimetabolites|mesh-ancestor
153665215|NCT00016016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153665216|NCT00016016|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153665217|NCT00016016|Antiviral Agents|antiviral agents|mesh-ancestor
153665218|NCT00016016|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153665219|NCT00016016|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153665220|NCT00016016|Immunologic Factors|immunologic factors|mesh-ancestor
153894142|NCT04290013|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
153665221|NCT00016016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153665222|NCT00016016|Analgesics|analgesics|mesh-ancestor
153665223|NCT00016016|Sensory System Agents|sensory system agents|mesh-ancestor
153665224|NCT00016016|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153665225|NCT00016016|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153665226|NCT00016016|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153665227|NCT00016016|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153665228|NCT00016016|Growth Inhibitors|growth inhibitors|mesh-ancestor
153665229|NCT00016016|Growth Substances|growth substances|mesh-ancestor
153665230|NCT00016016|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153665231|NCT00130455|Escitalopram|escitalopram|mesh-list
153665232|NCT00130455|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
153665233|NCT00130455|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153665234|NCT00130455|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153665235|NCT00130455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153665236|NCT00130455|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153665237|NCT00130455|Serotonin Agents|serotonin agents|mesh-ancestor
153665247|NCT00016094|Immunoglobulins|immunoglobulins|mesh-list
153665248|NCT00016094|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
153665249|NCT00016094|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153665250|NCT00016094|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153665251|NCT00016094|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153665252|NCT00016094|Growth Substances|growth substances|mesh-ancestor
153665253|NCT00016094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153665254|NCT00016094|Growth Inhibitors|growth inhibitors|mesh-ancestor
153665255|NCT00016094|Immunologic Factors|immunologic factors|mesh-ancestor
153665256|NCT00130338|Rivastigmine|rivastigmine|mesh-list
153665257|NCT00130338|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
153665258|NCT00130338|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153665259|NCT00130338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153665260|NCT00130338|Cholinergic Agents|cholinergic agents|mesh-ancestor
153665261|NCT00130338|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153665262|NCT00130338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153665263|NCT00130338|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
153665264|NCT00130338|Protective Agents|protective agents|mesh-ancestor
153665265|NCT00016133|Leucovorin|leucovorin|mesh-list
153665266|NCT00016133|Fluorouracil|fluorouracil|mesh-list
153665267|NCT00016133|Vaccines|vaccines|mesh-list
153665268|NCT00016133|BCG Vaccine|bcg vaccine|mesh-list
153665269|NCT00016133|Calcium|calcium|mesh-list
153665270|NCT00016133|Levoleucovorin|levoleucovorin|mesh-list
153665271|NCT00016133|Immunologic Factors|immunologic factors|mesh-ancestor
153665272|NCT00016133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153665273|NCT00016133|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153665274|NCT00016133|Antimetabolites|antimetabolites|mesh-ancestor
153915098|NCT05343637|Vasodilator Agents|vasodilator agents|mesh-ancestor
153665275|NCT00016133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153665276|NCT00016133|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153665277|NCT00016133|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153665292|NCT00016172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153665293|NCT01470716|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
153665294|NCT01470716|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153665295|NCT01470716|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153502283|NCT01279590|Atorvastatin|atorvastatin|mesh-list
153665296|NCT01470716|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153665297|NCT01470716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153665298|NCT01470716|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153665299|NCT00394368|Fluticasone|fluticasone|mesh-list
153665300|NCT00394368|Xhance|xhance|mesh-list
153665301|NCT00394368|Beclomethasone|beclomethasone|mesh-list
153665302|NCT00394368|Formoterol Fumarate|formoterol fumarate|mesh-list
153665303|NCT00394368|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
153665304|NCT00394368|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153665305|NCT00394368|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153665306|NCT00394368|Autonomic Agents|autonomic agents|mesh-ancestor
153665307|NCT00394368|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153665308|NCT00394368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153665309|NCT00394368|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153665310|NCT00394368|Respiratory System Agents|respiratory system agents|mesh-ancestor
153665311|NCT00394368|Dermatologic Agents|dermatologic agents|mesh-ancestor
153665312|NCT00394368|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
153665313|NCT00394368|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
153665314|NCT00394368|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
153665315|NCT00394368|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153665316|NCT00394368|Adrenergic Agents|adrenergic agents|mesh-ancestor
153665339|NCT00016289|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153665340|NCT00016289|Immunologic Factors|immunologic factors|mesh-ancestor
153665341|NCT00016289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153665342|NCT00016289|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153665343|NCT00016289|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153665344|NCT00016289|Growth Substances|growth substances|mesh-ancestor
153665345|NCT00016289|Growth Inhibitors|growth inhibitors|mesh-ancestor
153665346|NCT00016289|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153665347|NCT00130065|Folic Acid|folic acid|mesh-list
153665348|NCT00130065|Pyrimethamine|pyrimethamine|mesh-list
153665349|NCT00130065|Sulfadoxine|sulfadoxine|mesh-list
153665350|NCT00130065|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
153665351|NCT00130065|Hematinics|hematinics|mesh-ancestor
153665352|NCT00130065|Vitamin B Complex|vitamin b complex|mesh-ancestor
153665353|NCT00130065|Vitamins|vitamins|mesh-ancestor
153665354|NCT00130065|Micronutrients|micronutrients|mesh-ancestor
153665355|NCT00130065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153665356|NCT00130065|Antimalarials|antimalarials|mesh-ancestor
153665357|NCT00130065|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153665358|NCT00130065|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153665359|NCT00130065|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153665360|NCT00130065|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153665361|NCT00130065|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153665362|NCT00130065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153665363|NCT00130065|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
153665364|NCT00016328|Sirolimus|sirolimus|mesh-list
153665365|NCT00016328|Temsirolimus|temsirolimus|mesh-list
153665366|NCT00016328|MTOR Inhibitors|mtor inhibitors|mesh-list
153665367|NCT00016328|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153882028|NCT01603134|Antimetabolites|antimetabolites|mesh-ancestor
153882029|NCT01603134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153882030|NCT01603134|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153882031|NCT01603134|Gout Suppressants|gout suppressants|mesh-ancestor
153665368|NCT00016328|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153665369|NCT00016328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153665370|NCT00016328|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153665378|NCT00130026|Caffeine|caffeine|mesh-list
153665383|NCT00130026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153665384|NCT00130026|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
153665385|NCT00130026|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
153665386|NCT00130026|Purinergic Agents|purinergic agents|mesh-ancestor
153665387|NCT00130026|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153665388|NCT00016367|Cisplatin|cisplatin|mesh-list
153665389|NCT00016367|Gemcitabine|gemcitabine|mesh-list
153665390|NCT00016367|Trastuzumab|trastuzumab|mesh-list
153435351|NCT00003392|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153435352|NCT00003392|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153435353|NCT00003392|Alkylating Agents|alkylating agents|mesh-ancestor
153665391|NCT00016367|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153665392|NCT00016367|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153665393|NCT00016367|Antimetabolites|antimetabolites|mesh-ancestor
153665394|NCT00016367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153665395|NCT00016367|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153665396|NCT00129948|Troxacitabine|troxacitabine|mesh-list
153665397|NCT00129948|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153665398|NCT00129948|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153665399|NCT00129948|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153665400|NCT00129948|Antiviral Agents|antiviral agents|mesh-ancestor
153665401|NCT00129948|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153665403|NCT00016406|Cyclophosphamide|cyclophosphamide|mesh-list
153665404|NCT00016406|Doxorubicin|doxorubicin|mesh-list
153665405|NCT00016406|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153665407|NCT00016406|Tubulin Modulators|tubulin modulators|mesh-ancestor
153665429|NCT00129753|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153665430|NCT00016523|Nitric Oxide|nitric oxide|mesh-list
153665431|NCT00016523|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153665432|NCT00016523|Autonomic Agents|autonomic agents|mesh-ancestor
153665433|NCT00016523|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153665434|NCT00016523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153665435|NCT00016523|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153665436|NCT00016523|Respiratory System Agents|respiratory system agents|mesh-ancestor
153665437|NCT00016523|Free Radical Scavengers|free radical scavengers|mesh-ancestor
153665438|NCT00016523|Antioxidants|antioxidants|mesh-ancestor
153665439|NCT00016523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153665440|NCT00016523|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153665441|NCT00016523|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
153665442|NCT00016523|Vasodilator Agents|vasodilator agents|mesh-ancestor
153665443|NCT00016523|Gasotransmitters|gasotransmitters|mesh-ancestor
153665444|NCT00016523|Protective Agents|protective agents|mesh-ancestor
153665445|NCT00129597|Ketamine|ketamine|mesh-list
153665446|NCT00129597|Analgesics|analgesics|mesh-ancestor
153665447|NCT00129597|Sensory System Agents|sensory system agents|mesh-ancestor
153665448|NCT00129597|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153665449|NCT00129597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153665450|NCT00129597|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
153665451|NCT00129597|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153665452|NCT00129597|Anesthetics, General|anesthetics, general|mesh-ancestor
153665478|NCT00016601|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153665479|NCT00016601|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
153665480|NCT00016601|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
153665481|NCT00016601|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
153665482|NCT00016601|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
153665483|NCT00016601|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
153665484|NCT00016601|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
153665485|NCT00016601|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
153665486|NCT00016601|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
153665487|NCT00016601|Contraceptive Agents|contraceptive agents|mesh-ancestor
153882034|NCT01603134|Antioxidants|antioxidants|mesh-ancestor
153665488|NCT00016601|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153882035|NCT01603134|Protective Agents|protective agents|mesh-ancestor
153665489|NCT00016601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153435369|NCT00002551|Protective Agents|protective agents|mesh-ancestor
153665490|NCT00016601|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
153665491|NCT00016601|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
153665492|NCT00016601|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
153665493|NCT00016601|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153665494|NCT00016601|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153665496|NCT00129519|Toll-Like Receptor Agonists|toll-like receptor agonists|mesh-ancestor
153665497|NCT00129519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153665498|NCT00129519|Immunomodulating Agents|immunomodulating agents|mesh-ancestor
153665499|NCT00129519|Immunologic Factors|immunologic factors|mesh-ancestor
153665511|NCT00016874|Paclitaxel|paclitaxel|mesh-list
153665528|NCT00016952|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153665529|NCT00016952|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153665530|NCT00016952|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153665532|NCT00016952|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
153665533|NCT00016952|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153665534|NCT00016952|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153665535|NCT00016952|Antidotes|antidotes|mesh-ancestor
153665536|NCT00016952|Protective Agents|protective agents|mesh-ancestor
153665537|NCT00016952|Vitamin B Complex|vitamin b complex|mesh-ancestor
153665538|NCT00016952|Vitamins|vitamins|mesh-ancestor
153665539|NCT00016952|Micronutrients|micronutrients|mesh-ancestor
153665540|NCT00129363|Carvedilol|carvedilol|mesh-list
153665541|NCT00129363|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
153665542|NCT00129363|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
153665543|NCT00129363|Adrenergic Agents|adrenergic agents|mesh-ancestor
153665544|NCT00129363|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153665545|NCT00129363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153665546|NCT00129363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153665547|NCT00129363|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153665548|NCT00129363|Antioxidants|antioxidants|mesh-ancestor
153665549|NCT00129363|Protective Agents|protective agents|mesh-ancestor
153665550|NCT00129363|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153665551|NCT00129363|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153665552|NCT00129363|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153665553|NCT00129363|Vasodilator Agents|vasodilator agents|mesh-ancestor
153665554|NCT00129363|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
153665555|NCT00129363|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
153665556|NCT00016991|Gefitinib|gefitinib|mesh-list
153665557|NCT00016991|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153665558|NCT00016991|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153665571|NCT00017069|Autonomic Agents|autonomic agents|mesh-ancestor
153665572|NCT00017069|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153665573|NCT00017069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153665574|NCT00017069|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153665575|NCT00017069|Glucocorticoids|glucocorticoids|mesh-ancestor
153894274|NCT04287361|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153894275|NCT04287361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153894276|NCT04287361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153894277|NCT00624429|Budesonide|budesonide|mesh-list
153894278|NCT00624429|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153894279|NCT00624429|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153894280|NCT00624429|Autonomic Agents|autonomic agents|mesh-ancestor
153894281|NCT00624429|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153894282|NCT00624429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153894283|NCT00624429|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153894284|NCT00624429|Respiratory System Agents|respiratory system agents|mesh-ancestor
153894285|NCT00624429|Glucocorticoids|glucocorticoids|mesh-ancestor
153894286|NCT00624429|Hormones|hormones|mesh-ancestor
153665577|NCT00017069|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153665578|NCT00017069|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153665579|NCT00017069|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153665580|NCT00129285|Modafinil|modafinil|mesh-list
153665581|NCT00129285|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
153665582|NCT00129285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153665583|NCT00129285|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
153665584|NCT00129285|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
153665585|NCT00129285|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
153665586|NCT00129285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153665587|NCT00017108|Cyclophosphamide|cyclophosphamide|mesh-list
153665588|NCT00017108|Chlorambucil|chlorambucil|mesh-list
153665589|NCT00017108|Fludarabine|fludarabine|mesh-list
153665590|NCT00017108|Fludarabine phosphate|fludarabine phosphate|mesh-list
153665591|NCT00017108|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153665592|NCT00017108|Immunologic Factors|immunologic factors|mesh-ancestor
153665593|NCT00017108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153665594|NCT00017108|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153665595|NCT00017108|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153665596|NCT00017108|Alkylating Agents|alkylating agents|mesh-ancestor
153665597|NCT00017108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153665598|NCT00017108|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153665599|NCT00017108|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153665600|NCT00017108|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153665601|NCT00017108|Antimetabolites|antimetabolites|mesh-ancestor
153665602|NCT00129246|Naltrexone|naltrexone|mesh-list
153915138|NCT02699281|Antiviral Agents|antiviral agents|mesh-ancestor
153665604|NCT00129246|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
153665605|NCT00129246|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
153665607|NCT00129246|Sensory System Agents|sensory system agents|mesh-ancestor
153665608|NCT00129246|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153665609|NCT00129246|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
153665610|NCT00129246|Antidepressive Agents|antidepressive agents|mesh-ancestor
153665611|NCT00129246|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153665612|NCT00129246|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
153665613|NCT00129246|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153665614|NCT00129246|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153665615|NCT00129246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153665616|NCT00129246|Dopamine Agents|dopamine agents|mesh-ancestor
153665617|NCT00129246|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153665618|NCT00129246|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
153665619|NCT00129246|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153665620|NCT00129246|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153665621|NCT00017147|Carmustine|carmustine|mesh-list
153665622|NCT00017147|O(6)-benzylguanine|o(6)-benzylguanine|mesh-list
153665623|NCT00017147|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153665624|NCT00017147|Alkylating Agents|alkylating agents|mesh-ancestor
153665625|NCT00017147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153665626|NCT00017147|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153665627|NCT00017147|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153894294|NCT01001572|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153894295|NCT01001572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153894296|NCT01001572|Vasodilator Agents|vasodilator agents|mesh-ancestor
153894297|NCT01001572|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
153894298|NCT01001572|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
153665628|NCT00129207|Bortezomib|bortezomib|mesh-list
153665629|NCT00129207|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153665630|NCT00129168|Cytarabine|cytarabine|mesh-list
153665631|NCT00129168|Daunorubicin|daunorubicin|mesh-list
153665632|NCT00129168|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153665633|NCT00129168|Antimetabolites|antimetabolites|mesh-ancestor
153665636|NCT00129168|Antiviral Agents|antiviral agents|mesh-ancestor
153665653|NCT00017186|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153665654|NCT00017186|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153665655|NCT00017225|Cyclophosphamide|cyclophosphamide|mesh-list
153665656|NCT00017225|Melphalan|melphalan|mesh-list
153665657|NCT00017225|Ifosfamide|ifosfamide|mesh-list
153665658|NCT00017225|Dacarbazine|dacarbazine|mesh-list
153665659|NCT00017225|Carboplatin|carboplatin|mesh-list
153665660|NCT00017225|Doxorubicin|doxorubicin|mesh-list
153665661|NCT00017225|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
153665662|NCT00017225|Etoposide|etoposide|mesh-list
153665663|NCT00017225|Vincristine|vincristine|mesh-list
153665664|NCT00017225|Tretinoin|tretinoin|mesh-list
153665665|NCT00017225|Vindesine|vindesine|mesh-list
153665666|NCT00017225|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153665667|NCT00017225|Immunologic Factors|immunologic factors|mesh-ancestor
153665668|NCT00017225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153665669|NCT00017225|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153502662|NCT03216564|Vitamin D|vitamin d|mesh-list
153665670|NCT00017225|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153665671|NCT00017225|Alkylating Agents|alkylating agents|mesh-ancestor
153665672|NCT00017225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153665673|NCT00017225|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153665674|NCT00017225|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153665675|NCT00017225|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153665676|NCT00017225|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153665677|NCT00017225|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153665678|NCT00017225|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153665679|NCT00017225|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153665680|NCT00017225|Tubulin Modulators|tubulin modulators|mesh-ancestor
153665681|NCT00017225|Antimitotic Agents|antimitotic agents|mesh-ancestor
153665682|NCT00017225|Mitosis Modulators|mitosis modulators|mesh-ancestor
153665683|NCT00017225|Keratolytic Agents|keratolytic agents|mesh-ancestor
153665684|NCT00017225|Dermatologic Agents|dermatologic agents|mesh-ancestor
153665685|NCT00128934|Levonorgestrel|levonorgestrel|mesh-list
153665686|NCT00128934|Ethinyl Estradiol|ethinyl estradiol|mesh-list
153665688|NCT00128934|Estrogens|estrogens|mesh-ancestor
153665689|NCT00128934|Hormones|hormones|mesh-ancestor
153665690|NCT00128934|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153665694|NCT00128934|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153665695|NCT00128934|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
153665696|NCT00128934|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
153665697|NCT00128934|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
153665698|NCT00128934|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
153665699|NCT00017264|Atrasentan|atrasentan|mesh-list
153665700|NCT00017264|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153665701|NCT00017264|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
153665702|NCT00017264|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
153665703|NCT00017264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153665705|NCT00128895|Antimetabolites|antimetabolites|mesh-ancestor
153665706|NCT00128895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153665707|NCT00128895|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153665708|NCT00128895|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153665709|NCT00128895|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153665710|NCT00128895|Immunologic Factors|immunologic factors|mesh-ancestor
153665711|NCT00128895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153665712|NCT00128895|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153665713|NCT00017303|Paclitaxel|paclitaxel|mesh-list
153665714|NCT00017303|Carboplatin|carboplatin|mesh-list
153665721|NCT00017342|Cytarabine|cytarabine|mesh-list
153665747|NCT00017381|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153665748|NCT00017381|Immunologic Factors|immunologic factors|mesh-ancestor
153665749|NCT00017381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153665751|NCT00017381|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153665752|NCT00017381|Alkylating Agents|alkylating agents|mesh-ancestor
153665753|NCT00017381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153665754|NCT00017381|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153665755|NCT00017381|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153814532|NCT00452244|Gefitinib|gefitinib|mesh-list
153360206|NCT00802100|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
153894359|NCT01206777|Immunologic Factors|immunologic factors|mesh-ancestor
153665756|NCT00017381|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153665758|NCT00128700|Vatalanib|vatalanib|mesh-list
153665759|NCT00128700|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153665760|NCT00128700|Alkylating Agents|alkylating agents|mesh-ancestor
153665761|NCT00128700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153665762|NCT00128700|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153665763|NCT00128700|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153665764|NCT00128700|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153665765|NCT00017459|Vinorelbine|vinorelbine|mesh-list
153665766|NCT00017459|Tirapazamine|tirapazamine|mesh-list
153665767|NCT00017459|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153665768|NCT00017459|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153665769|NCT00017459|Tubulin Modulators|tubulin modulators|mesh-ancestor
153665770|NCT00017459|Antimitotic Agents|antimitotic agents|mesh-ancestor
153665771|NCT00017459|Mitosis Modulators|mitosis modulators|mesh-ancestor
153665772|NCT00017459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153665773|NCT00128622|Denileukin diftitox|denileukin diftitox|mesh-list
153665774|NCT00128622|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153665775|NCT00017498|Gemcitabine|gemcitabine|mesh-list
153665776|NCT00017498|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153665777|NCT00017498|Antimetabolites|antimetabolites|mesh-ancestor
153665778|NCT00017498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153665779|NCT00017498|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153665780|NCT00128544|Telbivudine|telbivudine|mesh-list
153665785|NCT00128544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153665786|NCT00128505|Mifepristone|mifepristone|mesh-list
153665787|NCT00128505|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
153665788|NCT00128505|Abortifacient Agents|abortifacient agents|mesh-ancestor
153665789|NCT00128505|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153665790|NCT00128505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153665791|NCT00128505|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
153665792|NCT00128505|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
153665793|NCT00128505|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
153665794|NCT00128505|Contraceptive Agents|contraceptive agents|mesh-ancestor
153665795|NCT00128505|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
153665796|NCT00128505|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
153814533|NCT00452244|Simvastatin|simvastatin|mesh-list
153814534|NCT00452244|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153360207|NCT00802100|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153665797|NCT00128505|Hormone Antagonists|hormone antagonists|mesh-ancestor
153665798|NCT00128505|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153665799|NCT00128505|Luteolytic Agents|luteolytic agents|mesh-ancestor
153665800|NCT00128505|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
153665801|NCT00128505|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
153665803|NCT00017576|Carboplatin|carboplatin|mesh-list
153665804|NCT00017576|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153665805|NCT00017576|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153665806|NCT00017576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153665807|NCT00017576|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
153665808|NCT00017576|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153665809|NCT00017576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153665810|NCT00017576|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
153665811|NCT00017576|Vitamins|vitamins|mesh-ancestor
153665812|NCT00017576|Micronutrients|micronutrients|mesh-ancestor
153665813|NCT00017576|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153665814|NCT00017654|Cyclosporine|cyclosporine|mesh-list
153665815|NCT00017654|Methylprednisolone|methylprednisolone|mesh-list
153665825|NCT00017654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153665826|NCT00017654|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153665827|NCT00017654|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153665828|NCT00017654|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153665829|NCT00017654|Antifungal Agents|antifungal agents|mesh-ancestor
153665830|NCT00017654|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153665831|NCT00017654|Dermatologic Agents|dermatologic agents|mesh-ancestor
153665832|NCT00017654|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
153665833|NCT00017654|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153665835|NCT00017654|Autonomic Agents|autonomic agents|mesh-ancestor
153665836|NCT00017654|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153665837|NCT00017654|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153665838|NCT00017654|Glucocorticoids|glucocorticoids|mesh-ancestor
153665839|NCT00017654|Hormones|hormones|mesh-ancestor
153665840|NCT00017654|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153665841|NCT00017654|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
153665842|NCT00017654|Protective Agents|protective agents|mesh-ancestor
153665843|NCT00394485|Tiotropium Bromide|tiotropium bromide|mesh-list
153665844|NCT00394485|Procaterol|procaterol|mesh-list
153665845|NCT00394485|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153665846|NCT00394485|Autonomic Agents|autonomic agents|mesh-ancestor
153665847|NCT00394485|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153665848|NCT00394485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153665849|NCT00394485|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153665850|NCT00394485|Respiratory System Agents|respiratory system agents|mesh-ancestor
153665851|NCT00394485|Parasympatholytics|parasympatholytics|mesh-ancestor
153665852|NCT00394485|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
153665853|NCT00394485|Cholinergic Agents|cholinergic agents|mesh-ancestor
153665854|NCT00394485|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153463948|NCT04390152|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153665855|NCT00394485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153665857|NCT00394485|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
153665868|NCT00128466|Streptomycin|streptomycin|mesh-list
153665869|NCT00128466|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153665870|NCT00128466|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153665871|NCT00128466|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
153665872|NCT00128466|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153665873|NCT00128466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153665874|NCT00128427|Colchicine|colchicine|mesh-list
153665875|NCT00128427|Gout Suppressants|gout suppressants|mesh-ancestor
153814535|NCT00452244|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153814536|NCT00452244|Antimetabolites|antimetabolites|mesh-ancestor
153665876|NCT00128427|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153665877|NCT00128427|Tubulin Modulators|tubulin modulators|mesh-ancestor
153665878|NCT00128427|Antimitotic Agents|antimitotic agents|mesh-ancestor
153665879|NCT00128427|Mitosis Modulators|mitosis modulators|mesh-ancestor
153665880|NCT00128427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153665881|NCT00128427|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153665882|NCT00018603|Guanfacine|guanfacine|mesh-list
153665883|NCT00018603|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153665884|NCT00018603|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
153665885|NCT00018603|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153665886|NCT00018603|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153665887|NCT00018603|Adrenergic Agents|adrenergic agents|mesh-ancestor
153665888|NCT00018603|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153665889|NCT00018603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153665890|NCT00018603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153665891|NCT00018642|Haloperidol|haloperidol|mesh-list
153665918|NCT00018083|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
153665919|NCT00018083|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153665920|NCT00018083|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
153665921|NCT00018083|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
153665922|NCT00018083|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
153665923|NCT00018083|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
153665924|NCT00018083|Antitubercular Agents|antitubercular agents|mesh-ancestor
153665925|NCT00018083|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153665926|NCT00018083|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
153665927|NCT00018083|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153665928|NCT00018083|Antimetabolites|antimetabolites|mesh-ancestor
153665929|NCT00018083|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153665930|NCT00018083|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
153665931|NCT00018200|Benztropine|benztropine|mesh-list
153665932|NCT00018200|Fluoxetine|fluoxetine|mesh-list
153665933|NCT00018200|Desipramine|desipramine|mesh-list
153665935|NCT00018200|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
153665936|NCT00018200|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153665937|NCT00018200|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153665938|NCT00018200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153665939|NCT00018200|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153665941|NCT00018200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153665942|NCT00018200|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
153665943|NCT00018200|Antidepressive Agents|antidepressive agents|mesh-ancestor
153665944|NCT00018200|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153665945|NCT00018200|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
153665959|NCT00018200|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
153665960|NCT00018200|Dopamine Agents|dopamine agents|mesh-ancestor
153665961|NCT00018759|Paroxetine|paroxetine|mesh-list
153665962|NCT00018759|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
153665963|NCT00018759|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153665964|NCT00018759|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153665965|NCT00018759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153665966|NCT00018759|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153665967|NCT00018759|Serotonin Agents|serotonin agents|mesh-ancestor
153665968|NCT00018759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153665969|NCT00018759|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
153373980|NCT01421186|Felzartamab|felzartamab|mesh-list
153665970|NCT00018759|Antidepressive Agents|antidepressive agents|mesh-ancestor
153665971|NCT00018759|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153665972|NCT00018759|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
153665973|NCT00018759|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153665974|NCT00018759|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153665975|NCT04734353|Ticagrelor|ticagrelor|mesh-list
153665976|NCT04734353|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
153665977|NCT04734353|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153814537|NCT00452244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153814538|NCT00452244|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153435608|NCT00002557|Doxorubicin|doxorubicin|mesh-list
153665979|NCT04734353|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
153665980|NCT04734353|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
153666010|NCT00018954|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153666012|NCT00018954|Hormones|hormones|mesh-ancestor
153666013|NCT00018954|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153666014|NCT00018954|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153666015|NCT00018954|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
153666016|NCT00018954|Abortifacient Agents|abortifacient agents|mesh-ancestor
153666017|NCT00018954|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153666018|NCT00018954|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153666019|NCT00018954|Antimetabolites|antimetabolites|mesh-ancestor
153666020|NCT00018954|Dermatologic Agents|dermatologic agents|mesh-ancestor
153666021|NCT00018954|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153666022|NCT00018954|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153666023|NCT00018954|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153666024|NCT00018954|Antiviral Agents|antiviral agents|mesh-ancestor
153666025|NCT00018954|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153666026|NCT00018954|Tubulin Modulators|tubulin modulators|mesh-ancestor
153666027|NCT00018954|Antimitotic Agents|antimitotic agents|mesh-ancestor
153666028|NCT00018954|Mitosis Modulators|mitosis modulators|mesh-ancestor
153666029|NCT00018278|Donepezil|donepezil|mesh-list
153666030|NCT00018278|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
153666031|NCT00018278|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153666032|NCT00018278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153666033|NCT00018278|Cholinergic Agents|cholinergic agents|mesh-ancestor
153666034|NCT00018278|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153666036|NCT00018278|Nootropic Agents|nootropic agents|mesh-ancestor
153666058|NCT00019227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153666059|NCT00019227|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153666060|NCT00019227|Immunologic Factors|immunologic factors|mesh-ancestor
153666062|NCT00019227|Protective Agents|protective agents|mesh-ancestor
153666063|NCT00019227|Chelating Agents|chelating agents|mesh-ancestor
153666064|NCT00019227|Sequestering Agents|sequestering agents|mesh-ancestor
153666065|NCT00019227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153666066|NCT00019227|Iron Chelating Agents|iron chelating agents|mesh-ancestor
153666067|NCT04734041|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
153666068|NCT00019344|Alvocidib|alvocidib|mesh-list
153666069|NCT00019344|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153666070|NCT00019344|Growth Inhibitors|growth inhibitors|mesh-ancestor
153815091|NCT00344942|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
153894455|NCT01201785|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153894456|NCT01201785|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153894457|NCT01201785|Analgesics|analgesics|mesh-ancestor
153894458|NCT01201785|Sensory System Agents|sensory system agents|mesh-ancestor
153894459|NCT01201785|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153894460|NCT01201785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153894461|NCT01201785|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153894462|NCT01201785|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153894463|NCT01201785|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153894470|NCT01200069|Ibuprofen|ibuprofen|mesh-list
153666071|NCT00019344|Growth Substances|growth substances|mesh-ancestor
153666072|NCT00019344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153666073|NCT00019344|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153666074|NCT00019344|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153373988|NCT01421186|Hormones|hormones|mesh-ancestor
153666075|NCT00019344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153666076|NCT00019383|Aldesleukin|aldesleukin|mesh-list
153666077|NCT00019383|Sargramostim|sargramostim|mesh-list
153666078|NCT00019383|Freund's Adjuvant|freund's adjuvant|mesh-list
153666079|NCT00019383|Immunologic Factors|immunologic factors|mesh-ancestor
153666081|NCT00019383|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153666110|NCT00019734|Aldesleukin|aldesleukin|mesh-list
153666111|NCT00019734|Vaccines|vaccines|mesh-list
153666112|NCT00019734|Immunologic Factors|immunologic factors|mesh-ancestor
153666113|NCT00019734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153666114|NCT00019734|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153666115|NCT00019734|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153915264|NCT00405613|Aspirin|aspirin|mesh-list
153666116|NCT00019734|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153666117|NCT00019734|Antiviral Agents|antiviral agents|mesh-ancestor
153666118|NCT00019734|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153666119|NCT00019773|Capecitabine|capecitabine|mesh-list
153666120|NCT00019773|Oxaliplatin|oxaliplatin|mesh-list
153666121|NCT00019773|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153666122|NCT00019773|Antimetabolites|antimetabolites|mesh-ancestor
153666123|NCT00019773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153666124|NCT00019773|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153666125|NCT00019812|Paclitaxel|paclitaxel|mesh-list
153666126|NCT00019812|Trastuzumab|trastuzumab|mesh-list
153666127|NCT00019812|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153666128|NCT00019812|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153666129|NCT00019812|Tubulin Modulators|tubulin modulators|mesh-ancestor
153666130|NCT00019812|Antimitotic Agents|antimitotic agents|mesh-ancestor
153666131|NCT00019812|Mitosis Modulators|mitosis modulators|mesh-ancestor
153666132|NCT00019812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153666133|NCT00019812|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153666134|NCT00020007|Paclitaxel|paclitaxel|mesh-list
153666135|NCT00020007|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153666136|NCT00020007|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153666137|NCT00020007|Tubulin Modulators|tubulin modulators|mesh-ancestor
153666138|NCT00020007|Antimitotic Agents|antimitotic agents|mesh-ancestor
153666139|NCT00020007|Mitosis Modulators|mitosis modulators|mesh-ancestor
153666141|NCT00142454|Imiquimod|imiquimod|mesh-list
153666154|NCT00020124|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153666155|NCT00020124|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153666156|NCT00020124|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153666157|NCT00020124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153666158|NCT05576675|Sufentanil|sufentanil|mesh-list
153666159|NCT05576675|Dsuvia|dsuvia|mesh-list
153666160|NCT05576675|Hydromorphone|hydromorphone|mesh-list
153666161|NCT05576675|Nalbuphine|nalbuphine|mesh-list
153666162|NCT05576675|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153666163|NCT05576675|Narcotics|narcotics|mesh-ancestor
153666164|NCT05576675|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153894484|NCT01199055|Paclitaxel|paclitaxel|mesh-list
153666165|NCT05576675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153666166|NCT05576675|Analgesics|analgesics|mesh-ancestor
153666167|NCT05576675|Sensory System Agents|sensory system agents|mesh-ancestor
153666168|NCT05576675|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153666169|NCT05576675|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153666170|NCT05576675|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153666171|NCT05576675|Anesthetics, General|anesthetics, general|mesh-ancestor
153666172|NCT05576675|Anesthetics|anesthetics|mesh-ancestor
153666173|NCT00020358|Aldesleukin|aldesleukin|mesh-list
153666174|NCT00020358|Freund's Adjuvant|freund's adjuvant|mesh-list
153666175|NCT00020358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153666178|NCT00020358|Antiviral Agents|antiviral agents|mesh-ancestor
153666208|NCT05576324|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153666209|NCT05576324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153666211|NCT00020709|Etoposide|etoposide|mesh-list
153666212|NCT00020709|Etoposide phosphate|etoposide phosphate|mesh-list
153374199|NCT00555425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153374200|NCT00555425|Analgesics|analgesics|mesh-ancestor
153882048|NCT01603212|Interleukin-2|interleukin-2|mesh-list
153666213|NCT00020709|Gefitinib|gefitinib|mesh-list
153666214|NCT00020709|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153666215|NCT00020709|Tubulin Modulators|tubulin modulators|mesh-ancestor
153666216|NCT00020709|Antimitotic Agents|antimitotic agents|mesh-ancestor
153666217|NCT00020709|Mitosis Modulators|mitosis modulators|mesh-ancestor
153666218|NCT00020709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153666219|NCT00020709|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153666220|NCT00020709|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153666221|NCT00020709|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153666222|NCT00020709|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153666223|NCT00020709|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153666224|NCT00020709|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153666225|NCT00020748|Irinotecan|irinotecan|mesh-list
153666226|NCT00020748|Epirubicin|epirubicin|mesh-list
153666227|NCT00020748|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
153666228|NCT00020748|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153666229|NCT00020748|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153666230|NCT00020748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153666231|NCT00020748|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153666232|NCT00020748|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153666233|NCT00020748|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153666234|NCT00020787|Cisplatin|cisplatin|mesh-list
153666235|NCT00020787|Fluorouracil|fluorouracil|mesh-list
153666236|NCT00020787|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153666237|NCT00020787|Antimetabolites|antimetabolites|mesh-ancestor
153666238|NCT00020787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153666239|NCT00020787|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153666240|NCT00020787|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153666241|NCT00020787|Immunologic Factors|immunologic factors|mesh-ancestor
153666242|NCT00020787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153666246|NCT00020865|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153666248|NCT00020865|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153666249|NCT00020865|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153666250|NCT00020865|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153666251|NCT00020865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153666252|NCT00020865|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153666253|NCT00020865|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
153666254|NCT00020865|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153666256|NCT00020943|Cytarabine|cytarabine|mesh-list
153666257|NCT00020943|Prednisone|prednisone|mesh-list
153666258|NCT00020943|Cyclophosphamide|cyclophosphamide|mesh-list
153666259|NCT00020943|Carmustine|carmustine|mesh-list
153666260|NCT00020943|Rituximab|rituximab|mesh-list
153666261|NCT00020943|Doxorubicin|doxorubicin|mesh-list
153666262|NCT00020943|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
153666263|NCT00020943|Methotrexate|methotrexate|mesh-list
153666264|NCT00020943|Etoposide|etoposide|mesh-list
153666265|NCT00020943|Vincristine|vincristine|mesh-list
153666266|NCT00020943|Levoleucovorin|levoleucovorin|mesh-list
153666267|NCT00020943|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153666268|NCT00020943|Immunologic Factors|immunologic factors|mesh-ancestor
153666269|NCT00020943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153666270|NCT00020943|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153666271|NCT00020943|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153666272|NCT00020943|Alkylating Agents|alkylating agents|mesh-ancestor
153666273|NCT00020943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153666274|NCT00020943|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153666275|NCT00020943|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153666276|NCT00020943|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153666277|NCT00020943|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153666278|NCT00020943|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153666280|NCT00020943|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153666288|NCT00020943|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153666289|NCT00020943|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153666290|NCT00020943|Antimetabolites|antimetabolites|mesh-ancestor
153666291|NCT00020943|Dermatologic Agents|dermatologic agents|mesh-ancestor
153666292|NCT00020943|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153666293|NCT00020943|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153814539|NCT00452244|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
153894573|NCT00977197|Pregabalin|pregabalin|mesh-list
153666295|NCT00020943|Antiviral Agents|antiviral agents|mesh-ancestor
153666296|NCT00020943|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153666297|NCT00020943|Antidotes|antidotes|mesh-ancestor
153666298|NCT00020943|Protective Agents|protective agents|mesh-ancestor
153666299|NCT00020943|Vitamin B Complex|vitamin b complex|mesh-ancestor
153666300|NCT00020943|Vitamins|vitamins|mesh-ancestor
153666301|NCT00020943|Micronutrients|micronutrients|mesh-ancestor
153666302|NCT00020943|Tubulin Modulators|tubulin modulators|mesh-ancestor
153666303|NCT00020943|Antimitotic Agents|antimitotic agents|mesh-ancestor
153666304|NCT00020943|Mitosis Modulators|mitosis modulators|mesh-ancestor
153666305|NCT00021060|Paclitaxel|paclitaxel|mesh-list
153666306|NCT00021060|Bevacizumab|bevacizumab|mesh-list
153666307|NCT00021060|Carboplatin|carboplatin|mesh-list
153666308|NCT00021060|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
153666309|NCT00021060|Antibodies|antibodies|mesh-list
153666310|NCT00021060|Immunoglobulins|immunoglobulins|mesh-list
153666311|NCT00021060|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
153666312|NCT00021060|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153666313|NCT00021060|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153666314|NCT00021060|Tubulin Modulators|tubulin modulators|mesh-ancestor
153666315|NCT00021060|Antimitotic Agents|antimitotic agents|mesh-ancestor
153666316|NCT00021060|Mitosis Modulators|mitosis modulators|mesh-ancestor
153666324|NCT00021099|Epothilones|epothilones|mesh-list
153666336|NCT05574257|Anesthetics, General|anesthetics, general|mesh-ancestor
153666337|NCT05574257|Anesthetics|anesthetics|mesh-ancestor
153666339|NCT05574218|Glycine Agents|glycine agents|mesh-ancestor
153666340|NCT05574218|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153666341|NCT05574218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153666342|NCT05574218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153666343|NCT00021138|Nicotine|nicotine|mesh-list
153666344|NCT00021138|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
153666345|NCT00021138|Autonomic Agents|autonomic agents|mesh-ancestor
153666346|NCT00021138|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153666347|NCT00021138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153666348|NCT00021138|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
153666349|NCT00021138|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
153666350|NCT00021138|Cholinergic Agents|cholinergic agents|mesh-ancestor
153666351|NCT00021138|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153666352|NCT00021138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153666353|NCT00020670|Vaccines|vaccines|mesh-list
153666354|NCT00020670|Immunologic Factors|immunologic factors|mesh-ancestor
153666355|NCT00020670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153666356|NCT05574179|Midazolam|midazolam|mesh-list
153666357|NCT05574179|Dexmedetomidine|dexmedetomidine|mesh-list
153666358|NCT05574179|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153666359|NCT05574179|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153666360|NCT05574179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153666361|NCT05574179|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153666362|NCT05574179|Analgesics|analgesics|mesh-ancestor
153666377|NCT05574179|Anesthetics|anesthetics|mesh-ancestor
153666384|NCT00021294|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153666385|NCT00021294|Glucocorticoids|glucocorticoids|mesh-ancestor
153666386|NCT00021294|Hormones|hormones|mesh-ancestor
153666387|NCT00021294|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153666388|NCT00021294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153666389|NCT00021294|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153666390|NCT00021294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153814540|NCT00452244|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153814541|NCT00452244|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153666392|NCT00021294|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
153666393|NCT00021294|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153666394|NCT00021294|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153666395|NCT00021294|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153666396|NCT00021294|Ornithine Decarboxylase Inhibitors|ornithine decarboxylase inhibitors|mesh-ancestor
153666397|NCT00021333|Paclitaxel|paclitaxel|mesh-list
153666398|NCT00021333|Cisplatin|cisplatin|mesh-list
153666399|NCT00021333|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153666400|NCT00021333|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153666401|NCT00021333|Tubulin Modulators|tubulin modulators|mesh-ancestor
153666402|NCT00021333|Antimitotic Agents|antimitotic agents|mesh-ancestor
153666403|NCT00021333|Mitosis Modulators|mitosis modulators|mesh-ancestor
153666404|NCT00021333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153666405|NCT00021372|Paclitaxel|paclitaxel|mesh-list
153666406|NCT00021372|Estramustine|estramustine|mesh-list
153666407|NCT00021372|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153666408|NCT00021372|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153666409|NCT00021372|Tubulin Modulators|tubulin modulators|mesh-ancestor
153666410|NCT00021372|Antimitotic Agents|antimitotic agents|mesh-ancestor
153666411|NCT00021372|Mitosis Modulators|mitosis modulators|mesh-ancestor
153666412|NCT00021372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153882057|NCT01603212|Sensory System Agents|sensory system agents|mesh-ancestor
153666428|NCT00018161|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
153666429|NCT00018161|Cholinergic Agents|cholinergic agents|mesh-ancestor
153666430|NCT00018161|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153666431|NCT00018161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153666432|NCT00018161|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153666433|NCT00018161|Ganglionic Blockers|ganglionic blockers|mesh-ancestor
153666434|NCT00018161|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
153666435|NCT00018161|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
153666436|NCT00021450|Goserelin|goserelin|mesh-list
153666437|NCT00021450|Bicalutamide|bicalutamide|mesh-list
153666438|NCT00021450|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153894650|NCT05366049|Antipyretics|antipyretics|mesh-ancestor
153666441|NCT00021450|Hormone Antagonists|hormone antagonists|mesh-ancestor
153666442|NCT00021450|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153666443|NCT00021450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153666444|NCT00021489|Mycophenolic Acid|mycophenolic acid|mesh-list
153666484|NCT00021528|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
153666485|NCT00021528|Adrenergic Agents|adrenergic agents|mesh-ancestor
153666486|NCT00021528|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
153666487|NCT00021528|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153666488|NCT00021528|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
153666489|NCT00021528|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
153666490|NCT00021528|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
153666491|NCT00021528|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
153666492|NCT00021528|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
153666493|NCT00021567|Interferons|interferons|mesh-list
153666494|NCT00021567|Interferon-gamma|interferon-gamma|mesh-list
153666495|NCT00021567|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153666496|NCT00021567|Antiviral Agents|antiviral agents|mesh-ancestor
153666497|NCT00021567|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153666498|NCT00021645|Vitamin E|vitamin e|mesh-list
153666499|NCT00021645|Vitamins|vitamins|mesh-ancestor
153666500|NCT00021645|Micronutrients|micronutrients|mesh-ancestor
153666501|NCT00021645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153666502|NCT00021645|Antioxidants|antioxidants|mesh-ancestor
153666503|NCT00021645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153666504|NCT00021645|Protective Agents|protective agents|mesh-ancestor
153666505|NCT00021996|Valdecoxib|valdecoxib|mesh-list
153666506|NCT00021996|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
153666507|NCT00021996|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153666508|NCT00021996|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153666509|NCT00021996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153666510|NCT00021996|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153666511|NCT00021996|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153666512|NCT00021996|Analgesics|analgesics|mesh-ancestor
153666527|NCT00022074|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153666528|NCT00022074|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
153666529|NCT00022074|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
153666530|NCT00022074|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153666531|NCT00022074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153666532|NCT00022074|Antimanic Agents|antimanic agents|mesh-ancestor
153666533|NCT00022152|Vinorelbine|vinorelbine|mesh-list
153666534|NCT00022152|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153666535|NCT00022152|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153666536|NCT00022152|Tubulin Modulators|tubulin modulators|mesh-ancestor
153666537|NCT00022152|Antimitotic Agents|antimitotic agents|mesh-ancestor
153666538|NCT00022152|Mitosis Modulators|mitosis modulators|mesh-ancestor
153666539|NCT00022152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153666540|NCT00022191|Paclitaxel|paclitaxel|mesh-list
153666542|NCT00022191|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153666544|NCT00022191|Tubulin Modulators|tubulin modulators|mesh-ancestor
153882058|NCT01603212|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153666545|NCT00022191|Antimitotic Agents|antimitotic agents|mesh-ancestor
153666546|NCT00022191|Mitosis Modulators|mitosis modulators|mesh-ancestor
153666547|NCT00022191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153666548|NCT00022191|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153666549|NCT00022191|Antimetabolites|antimetabolites|mesh-ancestor
153666550|NCT00022230|Aldesleukin|aldesleukin|mesh-list
153666551|NCT00022230|Paclitaxel|paclitaxel|mesh-list
153666552|NCT00022230|Cyclophosphamide|cyclophosphamide|mesh-list
153666553|NCT00022230|Doxorubicin|doxorubicin|mesh-list
153666555|NCT00022230|Sargramostim|sargramostim|mesh-list
153666574|NCT00022230|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153666575|NCT00022230|Antiviral Agents|antiviral agents|mesh-ancestor
153503548|NCT03400254|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153666576|NCT00022230|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153666578|NCT00022308|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153814542|NCT00452244|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153814543|NCT00452244|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153894719|NCT01192815|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153666580|NCT00022308|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153666581|NCT00022308|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153666582|NCT00022308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153666583|NCT00022386|Epoetin Alfa|epoetin alfa|mesh-list
153666584|NCT00022386|Hematinics|hematinics|mesh-ancestor
153666585|NCT00022425|Perillyl alcohol|perillyl alcohol|mesh-list
153666586|NCT00022425|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153666587|NCT00022425|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153666588|NCT00022425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153666590|NCT00022464|Temsirolimus|temsirolimus|mesh-list
153666591|NCT00022464|MTOR Inhibitors|mtor inhibitors|mesh-list
153666592|NCT00022464|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153666593|NCT00022464|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153666594|NCT00022464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153666628|NCT05551871|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
153666629|NCT05551871|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153666631|NCT00022620|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153666632|NCT00022620|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153666633|NCT00022620|Tubulin Modulators|tubulin modulators|mesh-ancestor
153666634|NCT00022620|Antimitotic Agents|antimitotic agents|mesh-ancestor
153666635|NCT00022620|Mitosis Modulators|mitosis modulators|mesh-ancestor
153666636|NCT00022620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153666637|NCT00022737|Leucovorin|leucovorin|mesh-list
153666638|NCT00022737|Cytarabine|cytarabine|mesh-list
153666639|NCT00022737|Cyclosporine|cyclosporine|mesh-list
153666640|NCT00022737|Dexamethasone|dexamethasone|mesh-list
153666641|NCT00022737|Cyclophosphamide|cyclophosphamide|mesh-list
153666642|NCT00022737|Ifosfamide|ifosfamide|mesh-list
153666643|NCT00022737|Methotrexate|methotrexate|mesh-list
153666644|NCT00022737|Etoposide|etoposide|mesh-list
153666645|NCT00022737|Vincristine|vincristine|mesh-list
153666646|NCT00022737|Etoposide phosphate|etoposide phosphate|mesh-list
153666647|NCT00022737|Imatinib Mesylate|imatinib mesylate|mesh-list
153666648|NCT00022737|Daunorubicin|daunorubicin|mesh-list
153666649|NCT00022737|Asparaginase|asparaginase|mesh-list
153666650|NCT00022737|Mercaptopurine|mercaptopurine|mesh-list
153503624|NCT02242656|Opium|opium|mesh-list
153666651|NCT00022737|Pegaspargase|pegaspargase|mesh-list
153666652|NCT00022737|Cyclosporins|cyclosporins|mesh-list
153666653|NCT00022737|Levoleucovorin|levoleucovorin|mesh-list
153666654|NCT00022737|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153666655|NCT00022737|Immunologic Factors|immunologic factors|mesh-ancestor
153666656|NCT00022737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153666657|NCT00022737|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153422948|NCT00716755|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153422949|NCT00716755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153666658|NCT00022737|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153666659|NCT00022737|Alkylating Agents|alkylating agents|mesh-ancestor
153666660|NCT00022737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153666661|NCT00022737|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153666662|NCT00022737|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153666663|NCT00022737|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153666664|NCT00022737|Antiemetics|antiemetics|mesh-ancestor
153666665|NCT00022737|Autonomic Agents|autonomic agents|mesh-ancestor
153666666|NCT00022737|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153666667|NCT00022737|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153666668|NCT00022737|Glucocorticoids|glucocorticoids|mesh-ancestor
153666670|NCT00022737|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153666671|NCT00022737|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153666672|NCT00022737|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
153666673|NCT00022737|Abortifacient Agents|abortifacient agents|mesh-ancestor
153666675|NCT00022737|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153666676|NCT00022737|Antimetabolites|antimetabolites|mesh-ancestor
153666677|NCT00022737|Dermatologic Agents|dermatologic agents|mesh-ancestor
153666678|NCT00022737|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153666679|NCT00022737|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153666680|NCT00022737|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153666681|NCT00022737|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153666682|NCT00022737|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153666683|NCT00022737|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153666684|NCT00022737|Antiviral Agents|antiviral agents|mesh-ancestor
153666685|NCT00022737|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153666686|NCT00022737|Antidotes|antidotes|mesh-ancestor
153666687|NCT00022737|Protective Agents|protective agents|mesh-ancestor
153666688|NCT00022737|Vitamin B Complex|vitamin b complex|mesh-ancestor
153666689|NCT00022737|Vitamins|vitamins|mesh-ancestor
153666690|NCT00022737|Micronutrients|micronutrients|mesh-ancestor
153666721|NCT02971878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153814546|NCT00446472|Angiogenesis Inducing Agents|angiogenesis inducing agents|mesh-ancestor
153894781|NCT00624663|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153666723|NCT02971878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153666724|NCT02971878|Vitamin B Complex|vitamin b complex|mesh-ancestor
153666726|NCT02971878|Micronutrients|micronutrients|mesh-ancestor
153666727|NCT02971878|Nootropic Agents|nootropic agents|mesh-ancestor
153666728|NCT02971878|Antiviral Agents|antiviral agents|mesh-ancestor
153666729|NCT02971878|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153666730|NCT02971878|Expectorants|expectorants|mesh-ancestor
153666731|NCT02971878|Respiratory System Agents|respiratory system agents|mesh-ancestor
153666732|NCT02971878|Free Radical Scavengers|free radical scavengers|mesh-ancestor
153666734|NCT00023166|Paclitaxel|paclitaxel|mesh-list
153666735|NCT00023166|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153666736|NCT00023166|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153666737|NCT00023166|Tubulin Modulators|tubulin modulators|mesh-ancestor
153666738|NCT00023166|Antimitotic Agents|antimitotic agents|mesh-ancestor
153666739|NCT00023166|Mitosis Modulators|mitosis modulators|mesh-ancestor
153666740|NCT00023166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153666741|NCT00394992|Bevacizumab|bevacizumab|mesh-list
153666742|NCT00394992|Capecitabine|capecitabine|mesh-list
153666743|NCT00394992|Oxaliplatin|oxaliplatin|mesh-list
153666744|NCT00394992|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153666745|NCT00394992|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153666746|NCT00394992|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153666747|NCT00394992|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153666748|NCT00394992|Growth Substances|growth substances|mesh-ancestor
153666749|NCT00394992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153666750|NCT00394992|Growth Inhibitors|growth inhibitors|mesh-ancestor
153666751|NCT00394992|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153666752|NCT00394992|Antimetabolites|antimetabolites|mesh-ancestor
153666753|NCT00394992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153666754|NCT00395031|Ziprasidone|ziprasidone|mesh-list
153666756|NCT00395031|Serotonin Agents|serotonin agents|mesh-ancestor
153666763|NCT00395031|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153422950|NCT00716755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153422951|NCT00716755|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153422952|NCT00716755|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153666764|NCT00395031|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
153666765|NCT00395031|Dopamine Agents|dopamine agents|mesh-ancestor
153666766|NCT00395070|Temozolomide|temozolomide|mesh-list
153666767|NCT00395070|Dacarbazine|dacarbazine|mesh-list
153666768|NCT00395070|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153666769|NCT00395070|Alkylating Agents|alkylating agents|mesh-ancestor
153666770|NCT00395070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153666771|NCT00395070|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153666772|NCT00023244|Cyclosporine|cyclosporine|mesh-list
153666773|NCT00023244|Sirolimus|sirolimus|mesh-list
153666774|NCT00023244|Trimethoprim|trimethoprim|mesh-list
153666775|NCT00023244|Sulfamethoxazole|sulfamethoxazole|mesh-list
153814547|NCT00446472|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153894808|NCT02887443|Antioxidants|antioxidants|mesh-ancestor
153666778|NCT00023244|Methylprednisolone|methylprednisolone|mesh-list
153666779|NCT00023244|Tacrolimus|tacrolimus|mesh-list
153666780|NCT00023244|Cyclosporins|cyclosporins|mesh-list
153666781|NCT00023244|Basiliximab|basiliximab|mesh-list
153666782|NCT00023244|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153666783|NCT00023244|Glucocorticoids|glucocorticoids|mesh-ancestor
153666784|NCT00023244|Hormones|hormones|mesh-ancestor
153666785|NCT00023244|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153666786|NCT00023244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153666787|NCT00023244|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153666814|NCT00023283|Buprenorphine|buprenorphine|mesh-list
153666815|NCT00023283|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153666816|NCT00023283|Narcotics|narcotics|mesh-ancestor
153666817|NCT00023283|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153666818|NCT00023283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153666819|NCT00023283|Analgesics|analgesics|mesh-ancestor
153666820|NCT00023283|Sensory System Agents|sensory system agents|mesh-ancestor
153666821|NCT00023283|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153666822|NCT00023283|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
153666823|NCT00023361|Rifabutin|rifabutin|mesh-list
153666824|NCT00023361|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153666825|NCT00023361|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153666826|NCT00023361|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
153666827|NCT00023361|Antitubercular Agents|antitubercular agents|mesh-ancestor
153666828|NCT00023400|Nelfinavir|nelfinavir|mesh-list
153666829|NCT00023400|Rifabutin|rifabutin|mesh-list
153666830|NCT00023400|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
153666831|NCT00023400|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
153666832|NCT00023400|Protease Inhibitors|protease inhibitors|mesh-ancestor
153666874|NCT00023790|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153666875|NCT00023790|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153666876|NCT00023790|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153666877|NCT00023790|Antiviral Agents|antiviral agents|mesh-ancestor
153666878|NCT00023790|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
153666879|NCT00023790|Dermatologic Agents|dermatologic agents|mesh-ancestor
153666880|NCT02971982|Dexamethasone|dexamethasone|mesh-list
153666881|NCT02971982|Dexamethasone acetate|dexamethasone acetate|mesh-list
153666882|NCT02971982|Cyclophosphamide|cyclophosphamide|mesh-list
153666883|NCT02971982|Rituximab|rituximab|mesh-list
153666884|NCT02971982|Bortezomib|bortezomib|mesh-list
153666885|NCT02971982|BB 1101|bb 1101|mesh-list
153666886|NCT02971982|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153666887|NCT02971982|Immunologic Factors|immunologic factors|mesh-ancestor
153666888|NCT02971982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153882061|NCT01603212|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153882062|NCT01603212|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153666889|NCT02971982|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153666890|NCT02971982|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153666891|NCT02971982|Alkylating Agents|alkylating agents|mesh-ancestor
153666892|NCT02971982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153666893|NCT02971982|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153666894|NCT02971982|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153666895|NCT02971982|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153666896|NCT02971982|Antiemetics|antiemetics|mesh-ancestor
153666897|NCT02971982|Autonomic Agents|autonomic agents|mesh-ancestor
153666898|NCT02971982|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153666899|NCT02971982|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153666900|NCT02971982|Glucocorticoids|glucocorticoids|mesh-ancestor
153666901|NCT02971982|Hormones|hormones|mesh-ancestor
153666902|NCT02971982|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153666903|NCT02971982|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153666908|NCT00023829|Flutamide|flutamide|mesh-list
153666922|NCT00023868|Mitomycin|mitomycin|mesh-list
153666923|NCT00023868|Levoleucovorin|levoleucovorin|mesh-list
153666924|NCT00023868|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153666925|NCT00023868|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153666926|NCT00023868|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153666927|NCT00023868|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153666928|NCT00023868|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153666929|NCT00023868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153666930|NCT00023868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153666931|NCT00023868|Antimetabolites|antimetabolites|mesh-ancestor
153666932|NCT00023868|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153666933|NCT00023868|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153666934|NCT00023868|Immunologic Factors|immunologic factors|mesh-ancestor
153666935|NCT00023868|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
153666936|NCT00023868|Antidotes|antidotes|mesh-ancestor
153666937|NCT00023868|Protective Agents|protective agents|mesh-ancestor
153666938|NCT00023868|Vitamin B Complex|vitamin b complex|mesh-ancestor
153666939|NCT00023868|Vitamins|vitamins|mesh-ancestor
153666940|NCT00023868|Micronutrients|micronutrients|mesh-ancestor
153666941|NCT00023868|Alkylating Agents|alkylating agents|mesh-ancestor
153666942|NCT00023868|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153666943|NCT00023907|Paclitaxel|paclitaxel|mesh-list
153666944|NCT00023907|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153666973|NCT00024141|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
153666974|NCT00024141|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153666975|NCT00024141|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153666976|NCT05239286|Anesthetics|anesthetics|mesh-list
153666977|NCT05239286|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153666978|NCT05239286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153666979|NCT00024180|Romidepsin|romidepsin|mesh-list
153666980|NCT00024180|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153666981|NCT00024180|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153666982|NCT00024180|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
153666983|NCT00024180|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153666984|NCT00024180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153666985|NCT00024297|Warfarin|warfarin|mesh-list
153666986|NCT00024297|Anticoagulants|anticoagulants|mesh-ancestor
153666987|NCT00024336|Tamoxifen|tamoxifen|mesh-list
153666988|NCT00024336|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
153666989|NCT00024336|Hormone Antagonists|hormone antagonists|mesh-ancestor
153666990|NCT00024336|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153666991|NCT00024336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153666992|NCT00024336|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153667026|NCT00024531|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153667027|NCT00024531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153667028|NCT00024531|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153667029|NCT00024531|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153667030|NCT00024531|Antimetabolites|antimetabolites|mesh-ancestor
153667031|NCT00024531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153667032|NCT00024531|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153667033|NCT00024531|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
153667034|NCT00024531|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153503992|NCT00558636|Tubulin Modulators|tubulin modulators|mesh-ancestor
153667036|NCT05080049|Hematinics|hematinics|mesh-ancestor
153667037|NCT00024687|Immunotoxins|immunotoxins|mesh-list
153667038|NCT00024687|Immunoconjugates|immunoconjugates|mesh-ancestor
153667039|NCT00024687|Immunologic Factors|immunologic factors|mesh-ancestor
153667040|NCT00024687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153667041|NCT05072444|QPX7728|qpx7728|mesh-list
153667042|NCT05072444|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
153667043|NCT05072444|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153667044|NCT05072444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153667045|NCT05072444|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153667046|NCT05072444|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153667047|NCT00025038|Cytarabine|cytarabine|mesh-list
153667048|NCT00025038|Cyclophosphamide|cyclophosphamide|mesh-list
153667049|NCT00025038|Fludarabine|fludarabine|mesh-list
153667050|NCT00025038|Fludarabine phosphate|fludarabine phosphate|mesh-list
153667051|NCT00025038|Tipifarnib|tipifarnib|mesh-list
153667052|NCT00025038|Isotretinoin|isotretinoin|mesh-list
153667053|NCT00025038|Thymoglobulin|thymoglobulin|mesh-list
153667054|NCT00025038|Antilymphocyte Serum|antilymphocyte serum|mesh-list
153667055|NCT00025038|Immunoglobulins|immunoglobulins|mesh-list
153667056|NCT00025038|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153667057|NCT00025038|Immunologic Factors|immunologic factors|mesh-ancestor
153667058|NCT00025038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153667059|NCT00025038|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153667060|NCT00025038|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153814548|NCT00446472|Growth Substances|growth substances|mesh-ancestor
153436043|NCT00003212|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153436044|NCT00003212|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153436045|NCT00003212|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153436046|NCT00003212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153436047|NCT00003212|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153436048|NCT00003212|Alkylating Agents|alkylating agents|mesh-ancestor
153436049|NCT00002611|Dactinomycin|dactinomycin|mesh-list
153436050|NCT00002611|Cyclophosphamide|cyclophosphamide|mesh-list
153436051|NCT00002611|Doxorubicin|doxorubicin|mesh-list
153436052|NCT00002611|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
153436053|NCT00002611|Etoposide|etoposide|mesh-list
153436054|NCT00002611|Vincristine|vincristine|mesh-list
153436055|NCT00002611|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153436056|NCT00002611|Immunologic Factors|immunologic factors|mesh-ancestor
153436057|NCT00002611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153436058|NCT00002611|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153436059|NCT00002611|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153436060|NCT00002611|Alkylating Agents|alkylating agents|mesh-ancestor
153667066|NCT00025038|Antimetabolites|antimetabolites|mesh-ancestor
153667067|NCT00025038|Antiviral Agents|antiviral agents|mesh-ancestor
153667068|NCT00025038|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153667069|NCT00025038|Dermatologic Agents|dermatologic agents|mesh-ancestor
153667070|NCT00025077|Cyclophosphamide|cyclophosphamide|mesh-list
153667071|NCT00025077|Thiotepa|thiotepa|mesh-list
153667072|NCT00025077|Carboplatin|carboplatin|mesh-list
153464099|NCT02063022|Busulfan|busulfan|mesh-list
153667073|NCT00025077|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153667074|NCT00025077|Immunologic Factors|immunologic factors|mesh-ancestor
153667075|NCT00025077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153667076|NCT00025077|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153667077|NCT00025077|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153667078|NCT00025077|Alkylating Agents|alkylating agents|mesh-ancestor
153667079|NCT00025077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153667080|NCT00025077|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153667081|NCT00025077|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153667082|NCT05051891|Prednisone|prednisone|mesh-list
153667083|NCT05051891|Cyclophosphamide|cyclophosphamide|mesh-list
153667084|NCT05051891|Vincristine|vincristine|mesh-list
153667085|NCT05051891|Rituximab|rituximab|mesh-list
153667086|NCT05051891|Doxorubicin|doxorubicin|mesh-list
153667087|NCT05051891|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153667088|NCT05051891|Immunologic Factors|immunologic factors|mesh-ancestor
153667089|NCT05051891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153667090|NCT05051891|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153667118|NCT00025272|Topotecan|topotecan|mesh-list
153667119|NCT00025272|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153667120|NCT00025272|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153667121|NCT00025272|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153667122|NCT00025272|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153667123|NCT00025272|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153667124|NCT00025272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153667125|NCT00025272|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
153667126|NCT00025311|Topotecan|topotecan|mesh-list
153667127|NCT00025311|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
153667128|NCT00025311|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153667129|NCT00025311|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153667130|NCT00025311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153667131|NCT00025311|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153667132|NCT00025116|Gefitinib|gefitinib|mesh-list
153667133|NCT00025116|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153667134|NCT00025116|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153667135|NCT00025116|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153667136|NCT00025116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153667137|NCT00025116|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153667138|NCT00025350|Gefitinib|gefitinib|mesh-list
153667139|NCT00025350|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153667140|NCT00025350|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153667141|NCT00025350|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153667142|NCT00025350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153667144|NCT00025389|Paclitaxel|paclitaxel|mesh-list
153667166|NCT00025428|Immunologic Factors|immunologic factors|mesh-ancestor
153667167|NCT00025428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153667168|NCT00025428|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153915385|NCT01007253|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153667170|NCT00025428|Alkylating Agents|alkylating agents|mesh-ancestor
153667171|NCT00025428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153667172|NCT00025428|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153667173|NCT00025428|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153667174|NCT00025428|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153667175|NCT00025428|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153667176|NCT00025428|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153667177|NCT00025428|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153667178|NCT00025428|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153667179|NCT00025428|Tubulin Modulators|tubulin modulators|mesh-ancestor
153667180|NCT00025428|Antimitotic Agents|antimitotic agents|mesh-ancestor
153667181|NCT00025428|Mitosis Modulators|mitosis modulators|mesh-ancestor
153667182|NCT00025467|Thalidomide|thalidomide|mesh-list
153667183|NCT00025467|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153667184|NCT00025467|Immunologic Factors|immunologic factors|mesh-ancestor
153667185|NCT00025467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153667186|NCT00025467|Leprostatic Agents|leprostatic agents|mesh-ancestor
153667187|NCT00025467|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153667188|NCT00025467|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153667189|NCT00025467|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153667190|NCT00025467|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153667191|NCT00025467|Growth Substances|growth substances|mesh-ancestor
153667192|NCT00025467|Growth Inhibitors|growth inhibitors|mesh-ancestor
153667193|NCT00025467|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153667211|NCT00025545|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153667212|NCT00025545|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153667213|NCT00025545|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153667215|NCT00025584|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153667216|NCT00025623|Cyclophosphamide|cyclophosphamide|mesh-list
153667217|NCT00025623|Carboplatin|carboplatin|mesh-list
153667218|NCT00025623|Doxorubicin|doxorubicin|mesh-list
153667219|NCT00025623|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
153667220|NCT00025623|Etoposide|etoposide|mesh-list
153667221|NCT00025623|Vincristine|vincristine|mesh-list
153915393|NCT01007253|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153667222|NCT00025623|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153667223|NCT00025623|Immunologic Factors|immunologic factors|mesh-ancestor
153667224|NCT00025623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153667225|NCT00025623|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153667226|NCT00025623|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153667227|NCT00025623|Alkylating Agents|alkylating agents|mesh-ancestor
153667228|NCT00025623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153667229|NCT00025623|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153667230|NCT00025623|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153667231|NCT00025623|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153667232|NCT00025623|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153667233|NCT00025623|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153667234|NCT00025623|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153667235|NCT00025623|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153667236|NCT00025623|Tubulin Modulators|tubulin modulators|mesh-ancestor
153667237|NCT00025623|Antimitotic Agents|antimitotic agents|mesh-ancestor
153667238|NCT00025623|Mitosis Modulators|mitosis modulators|mesh-ancestor
153667239|NCT00025740|Clonazepam|clonazepam|mesh-list
153667240|NCT00025740|Paroxetine|paroxetine|mesh-list
153667256|NCT00025740|GABA Agents|gaba agents|mesh-ancestor
153667257|NCT00025779|Guanfacine|guanfacine|mesh-list
153667258|NCT00025779|Methylphenidate|methylphenidate|mesh-list
153667259|NCT00025779|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
153667260|NCT00025779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153667261|NCT00025779|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
153667262|NCT00025779|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153667263|NCT00025779|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153667264|NCT00025779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153667265|NCT00025779|Dopamine Agents|dopamine agents|mesh-ancestor
153667266|NCT00025779|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153667267|NCT00025779|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153667268|NCT00025779|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
153667269|NCT00025779|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153667270|NCT00025779|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153667271|NCT00025779|Adrenergic Agents|adrenergic agents|mesh-ancestor
153667272|NCT00026052|Riluzole|riluzole|mesh-list
153667273|NCT00026052|Anticonvulsants|anticonvulsants|mesh-ancestor
153667275|NCT00026052|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
153667312|NCT00026364|Antimetabolites|antimetabolites|mesh-ancestor
153667313|NCT00026364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153667314|NCT00026364|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153667315|NCT00026364|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153667316|NCT00026364|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153667317|NCT00026364|Immunologic Factors|immunologic factors|mesh-ancestor
153667318|NCT00026364|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
153667319|NCT00026364|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153667320|NCT00026364|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153436112|NCT00003464|Temozolomide|temozolomide|mesh-list
153667329|NCT00026403|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153667330|NCT00026403|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153667333|NCT00026442|Capecitabine|capecitabine|mesh-list
153667368|NCT00027066|Sensory System Agents|sensory system agents|mesh-ancestor
153667369|NCT00027066|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153667370|NCT00027066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153667371|NCT00027066|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153667372|NCT00027066|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153667373|NCT00027066|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153667374|NCT00027066|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153667375|NCT00027066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153667376|NCT00027066|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153894977|NCT05927922|Ibuprofen|ibuprofen|mesh-list
153667377|NCT00027066|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153667378|NCT00027066|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153667379|NCT00027066|Antipyretics|antipyretics|mesh-ancestor
153667380|NCT00027066|Anticoagulants|anticoagulants|mesh-ancestor
153667381|NCT04473950|Naloxone|naloxone|mesh-list
153667382|NCT04473950|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
153667383|NCT04473950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153667384|NCT04473950|Sensory System Agents|sensory system agents|mesh-ancestor
153667385|NCT04473950|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153667386|NCT00027300|Natalizumab|natalizumab|mesh-list
153667387|NCT00027300|Immunologic Factors|immunologic factors|mesh-ancestor
153667388|NCT00027300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153667389|NCT00395382|Alendronate|alendronate|mesh-list
153667390|NCT00395382|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153667391|NCT00395382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153667392|NCT00027339|Ritonavir|ritonavir|mesh-list
153667393|NCT00027339|Lopinavir|lopinavir|mesh-list
153667394|NCT00027339|Indinavir|indinavir|mesh-list
153667395|NCT00027339|Fosamprenavir|fosamprenavir|mesh-list
153667396|NCT00027339|Tenofovir|tenofovir|mesh-list
153667397|NCT00027339|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
153667398|NCT00027339|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
153667399|NCT00027339|Protease Inhibitors|protease inhibitors|mesh-ancestor
153667411|NCT04206488|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153667412|NCT04206488|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
153667413|NCT04206488|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153667414|NCT04206488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153667415|NCT04206488|Protective Agents|protective agents|mesh-ancestor
153667416|NCT04206488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153667417|NCT00027495|Curcumin|curcumin|mesh-list
153667418|NCT00027495|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153667419|NCT00027495|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153667420|NCT00027495|Analgesics|analgesics|mesh-ancestor
153667421|NCT00027495|Sensory System Agents|sensory system agents|mesh-ancestor
153667422|NCT00027495|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153667423|NCT00027495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153667424|NCT00027495|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153667425|NCT00027495|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153667426|NCT00027495|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153667427|NCT00027495|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153667428|NCT00027495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153667429|NCT00027534|Metronidazole|metronidazole|mesh-list
153667430|NCT00027534|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153464121|NCT02063022|Tubulin Modulators|tubulin modulators|mesh-ancestor
153667431|NCT00027534|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153667432|NCT00027534|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153667433|NCT00027534|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153667434|NCT00027573|Cyclophosphamide|cyclophosphamide|mesh-list
153667435|NCT00027573|Methotrexate|methotrexate|mesh-list
153667436|NCT00027573|Fludarabine|fludarabine|mesh-list
153667437|NCT00027573|Fludarabine phosphate|fludarabine phosphate|mesh-list
153667438|NCT00027573|Tacrolimus|tacrolimus|mesh-list
153667439|NCT00027573|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153667440|NCT00027573|Immunologic Factors|immunologic factors|mesh-ancestor
153667441|NCT00027573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153667452|NCT00027573|Antimetabolites|antimetabolites|mesh-ancestor
153667454|NCT00027573|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153667455|NCT00027573|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153667456|NCT00027573|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153894993|NCT05927857|Growth Substances|growth substances|mesh-ancestor
153667457|NCT00027573|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
153667458|NCT00027612|Irinotecan|irinotecan|mesh-list
153667459|NCT00027612|Carmustine|carmustine|mesh-list
153667460|NCT00027612|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
153667461|NCT00027612|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153667462|NCT00027612|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153667463|NCT00027612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153667464|NCT00027612|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153667465|NCT00027612|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153667466|NCT00027612|Alkylating Agents|alkylating agents|mesh-ancestor
153667467|NCT00027690|Gefitinib|gefitinib|mesh-list
153667468|NCT00027690|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153667469|NCT00027690|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153667470|NCT00027690|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153667471|NCT00027690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153667472|NCT00027690|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153667473|NCT00027768|Ethiodized Oil|ethiodized oil|mesh-list
153667474|NCT00027768|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153464131|NCT01895010|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153667475|NCT00027807|Aldesleukin|aldesleukin|mesh-list
153667476|NCT00027807|Molgramostim|molgramostim|mesh-list
153667477|NCT00027807|Sargramostim|sargramostim|mesh-list
153667478|NCT00027807|Immunologic Factors|immunologic factors|mesh-ancestor
153667479|NCT00027807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153667480|NCT00027807|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153667481|NCT00027807|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153667503|NCT00027885|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153667504|NCT00027885|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153667505|NCT00027885|Alkylating Agents|alkylating agents|mesh-ancestor
153814552|NCT00446589|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153814553|NCT00446589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153814554|NCT00446589|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153814555|NCT00452322|Methyltestosterone|methyltestosterone|mesh-list
153814556|NCT00452322|Testosterone|testosterone|mesh-list
153360208|NCT00802100|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153667506|NCT00027885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153667507|NCT00027885|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153667508|NCT00027885|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153667509|NCT00027885|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153667510|NCT00027885|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153667511|NCT00027885|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153667512|NCT00027885|Growth Substances|growth substances|mesh-ancestor
153667513|NCT00027885|Growth Inhibitors|growth inhibitors|mesh-ancestor
153667514|NCT00027885|Tubulin Modulators|tubulin modulators|mesh-ancestor
153667515|NCT00027885|Antimitotic Agents|antimitotic agents|mesh-ancestor
153667516|NCT00027885|Mitosis Modulators|mitosis modulators|mesh-ancestor
153667517|NCT00027885|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153667521|NCT00027924|Cyclosporine|cyclosporine|mesh-list
153667562|NCT00027963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153667563|NCT00027963|Anticonvulsants|anticonvulsants|mesh-ancestor
153667564|NCT00027963|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153667565|NCT00027963|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153667566|NCT00027963|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153667567|NCT00027963|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153667568|NCT00027963|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
153667569|NCT00027963|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
153667570|NCT00027963|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153667571|NCT00027963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153667572|NCT00027963|Antimanic Agents|antimanic agents|mesh-ancestor
153667573|NCT00395421|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
153667574|NCT00395421|Antiviral Agents|antiviral agents|mesh-ancestor
153915421|NCT01006707|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
153667575|NCT00395421|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153667576|NCT00395499|Risperidone|risperidone|mesh-list
153667577|NCT00395499|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153667578|NCT00395499|Serotonin Agents|serotonin agents|mesh-ancestor
153667579|NCT00395499|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153667580|NCT00395499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153667581|NCT00395499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153667582|NCT00395499|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153667583|NCT00395499|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153667584|NCT00395499|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153667585|NCT00395499|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153667610|NCT00395655|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153667611|NCT00395655|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153667612|NCT00395655|Vasodilator Agents|vasodilator agents|mesh-ancestor
153667613|NCT00392561|Vitamin E|vitamin e|mesh-list
153667614|NCT00392561|Selenium|selenium|mesh-list
153667615|NCT00392561|Vitamins|vitamins|mesh-ancestor
153667616|NCT00392561|Micronutrients|micronutrients|mesh-ancestor
153667617|NCT00392561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153667618|NCT00392561|Antioxidants|antioxidants|mesh-ancestor
153667619|NCT00392561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153667620|NCT00392561|Protective Agents|protective agents|mesh-ancestor
153667621|NCT00392561|Trace Elements|trace elements|mesh-ancestor
153667622|NCT00028275|Interferons|interferons|mesh-list
153436212|NCT00003248|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153436213|NCT00003248|Antimetabolites|antimetabolites|mesh-ancestor
153436214|NCT00003248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153436216|NCT00002641|Doxorubicin|doxorubicin|mesh-list
153667623|NCT00028275|Interferon-gamma|interferon-gamma|mesh-list
153667624|NCT00028275|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153667625|NCT00028275|Antiviral Agents|antiviral agents|mesh-ancestor
153667626|NCT00028275|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153667627|NCT03959969|Ibuprofen|ibuprofen|mesh-list
153667628|NCT03959969|Oxycodone|oxycodone|mesh-list
153667629|NCT03959969|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153667630|NCT03959969|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153667631|NCT03959969|Analgesics|analgesics|mesh-ancestor
153667632|NCT03959969|Sensory System Agents|sensory system agents|mesh-ancestor
153667633|NCT03959969|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153915430|NCT04214977|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153667634|NCT03959969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153667635|NCT03959969|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153504597|NCT05217342|Diuretics|diuretics|mesh-list
153667636|NCT03959969|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153667637|NCT03959969|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153667638|NCT03959969|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153667639|NCT03959969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153667640|NCT03959969|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153667641|NCT03959969|Narcotics|narcotics|mesh-ancestor
153667642|NCT03959969|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153667643|NCT00028314|Ritonavir|ritonavir|mesh-list
153667644|NCT00028314|Lopinavir|lopinavir|mesh-list
153667652|NCT00028314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153667653|NCT00028314|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153667654|NCT00028314|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153667655|NCT00028314|Antiviral Agents|antiviral agents|mesh-ancestor
153667656|NCT00028314|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153667657|NCT00028314|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
153667658|NCT00028314|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153667659|NCT00028314|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153667660|NCT00028314|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153667661|NCT00028314|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
153667662|NCT00028314|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
153667663|NCT00028353|Toremifene|toremifene|mesh-list
153667664|NCT00028353|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153882074|NCT02484924|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
153667665|NCT00028353|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153667666|NCT00028353|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
153667667|NCT00028353|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
153667668|NCT00028353|Hormone Antagonists|hormone antagonists|mesh-ancestor
153895076|NCT05926882|Analgesics|analgesics|mesh-ancestor
153667672|NCT03959852|Fentanyl|fentanyl|mesh-list
153667702|NCT00028587|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153667703|NCT00028587|Tubulin Modulators|tubulin modulators|mesh-ancestor
153667704|NCT00028587|Antimitotic Agents|antimitotic agents|mesh-ancestor
153667705|NCT00028587|Mitosis Modulators|mitosis modulators|mesh-ancestor
153667706|NCT00028587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153667707|NCT04733196|Chlorhexidine|chlorhexidine|mesh-list
153667708|NCT04733196|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
153667709|NCT04733196|Hydrogen Peroxide|hydrogen peroxide|mesh-list
153667710|NCT04733196|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
153667711|NCT04733196|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153667712|NCT04733196|Disinfectants|disinfectants|mesh-ancestor
153667713|NCT04733196|Dermatologic Agents|dermatologic agents|mesh-ancestor
153667714|NCT00028665|Cyclophosphamide|cyclophosphamide|mesh-list
153667716|NCT00028665|Rituximab|rituximab|mesh-list
153667717|NCT00028665|Etoposide|etoposide|mesh-list
153667718|NCT00028665|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153464163|NCT01490502|Vitamins|vitamins|mesh-ancestor
153464168|NCT01428024|Hyaluronic Acid|hyaluronic acid|mesh-list
153667719|NCT00028665|Immunologic Factors|immunologic factors|mesh-ancestor
153667720|NCT00028665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153814559|NCT00452322|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
153814560|NCT00452322|Androgens|androgens|mesh-ancestor
153814561|NCT00452322|Hormones|hormones|mesh-ancestor
153667721|NCT00028665|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153667722|NCT00028665|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153667723|NCT00028665|Alkylating Agents|alkylating agents|mesh-ancestor
153667724|NCT00028665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153667725|NCT00028665|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153667726|NCT00028665|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153667727|NCT00028665|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153667728|NCT00028665|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153667729|NCT00028665|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153667730|NCT00028665|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153667731|NCT00028665|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153667732|NCT03959540|Levodopa|levodopa|mesh-list
153667733|NCT03959540|Opicapone|opicapone|mesh-list
153667734|NCT03959540|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
153667742|NCT00028743|Paclitaxel|paclitaxel|mesh-list
153667745|NCT00028743|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153814562|NCT00452322|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153895125|NCT05690984|Antiemetics|antiemetics|mesh-ancestor
153667746|NCT00028743|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153667747|NCT00028743|Tubulin Modulators|tubulin modulators|mesh-ancestor
153667748|NCT00028743|Antimitotic Agents|antimitotic agents|mesh-ancestor
153667749|NCT00028743|Mitosis Modulators|mitosis modulators|mesh-ancestor
153667750|NCT00028743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153667751|NCT00028743|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
153667752|NCT00028743|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153667753|NCT00028743|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153667754|NCT03959501|Dapagliflozin|dapagliflozin|mesh-list
153667755|NCT03959501|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
153667756|NCT03959501|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
153667757|NCT03959501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153667758|NCT03959501|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153667759|NCT03959501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153667760|NCT03959501|Incretins|incretins|mesh-ancestor
153667762|NCT03959501|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153667763|NCT03959501|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
153667764|NCT03959501|Protease Inhibitors|protease inhibitors|mesh-ancestor
153667765|NCT03959501|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153667766|NCT00028782|Etanidazole|etanidazole|mesh-list
153667767|NCT00028782|Imidazole|imidazole|mesh-list
153667768|NCT00028782|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153667769|NCT00028782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153667770|NCT00028782|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153667771|NCT00028821|2-Methoxyestradiol|2-methoxyestradiol|mesh-list
153667772|NCT00028821|Estradiol|estradiol|mesh-list
153667773|NCT00028821|Estrogens|estrogens|mesh-ancestor
153667774|NCT00028821|Hormones|hormones|mesh-ancestor
153667776|NCT00028821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153667788|NCT00028860|Ifosfamide|ifosfamide|mesh-list
153667789|NCT00028860|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153667790|NCT00028860|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153667791|NCT00028860|Tubulin Modulators|tubulin modulators|mesh-ancestor
153667792|NCT00028860|Antimitotic Agents|antimitotic agents|mesh-ancestor
153667794|NCT00028860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153667797|NCT00028860|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153667798|NCT00028860|Alkylating Agents|alkylating agents|mesh-ancestor
153667799|NCT00028899|Cytarabine|cytarabine|mesh-list
153667800|NCT00028899|Asparaginase|asparaginase|mesh-list
153667801|NCT00028899|Mitoxantrone|mitoxantrone|mesh-list
153667802|NCT00028899|Gemtuzumab|gemtuzumab|mesh-list
153667803|NCT00028899|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153667804|NCT00028899|Antimetabolites|antimetabolites|mesh-ancestor
153667805|NCT00028899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153667806|NCT00028899|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153667807|NCT00028899|Antiviral Agents|antiviral agents|mesh-ancestor
153667808|NCT00028899|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153667809|NCT00028899|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153667810|NCT00028899|Immunologic Factors|immunologic factors|mesh-ancestor
153667811|NCT00028899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153667812|NCT00028899|Analgesics|analgesics|mesh-ancestor
153667813|NCT00028899|Sensory System Agents|sensory system agents|mesh-ancestor
153667814|NCT00028899|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153667815|NCT00028899|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153667816|NCT00028899|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153667817|NCT00028899|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153667818|NCT00028899|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153667819|NCT00028899|Immunotoxins|immunotoxins|mesh-ancestor
153667820|NCT00028899|Immunoconjugates|immunoconjugates|mesh-ancestor
153667832|NCT00028938|Hematinics|hematinics|mesh-ancestor
153667833|NCT00029250|Allicin|allicin|mesh-list
153667834|NCT00029250|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153667835|NCT00029250|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153667836|NCT00029250|Antimetabolites|antimetabolites|mesh-ancestor
153667837|NCT00029250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153667838|NCT00029250|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153667839|NCT00029250|Antioxidants|antioxidants|mesh-ancestor
153667840|NCT00029250|Protective Agents|protective agents|mesh-ancestor
153667841|NCT00029250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153667842|NCT00029250|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153667843|NCT00029250|Free Radical Scavengers|free radical scavengers|mesh-ancestor
153667844|NCT03959150|Capecitabine|capecitabine|mesh-list
153667845|NCT03959150|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153667846|NCT03959150|Antimetabolites|antimetabolites|mesh-ancestor
153667847|NCT03959150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153667848|NCT03959150|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153667849|NCT00029328|Etanercept|etanercept|mesh-list
153667850|NCT00029328|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153667851|NCT00029328|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153667852|NCT00029328|Analgesics|analgesics|mesh-ancestor
153667853|NCT00029328|Sensory System Agents|sensory system agents|mesh-ancestor
153667854|NCT00029328|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153667855|NCT00029328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153667856|NCT00029328|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153667857|NCT00029328|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153667858|NCT00029328|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153667859|NCT00029328|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153667860|NCT00029328|Immunologic Factors|immunologic factors|mesh-ancestor
153667861|NCT00029523|Cytarabine|cytarabine|mesh-list
153667862|NCT00029523|Methotrexate|methotrexate|mesh-list
153667863|NCT00029523|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
153667864|NCT00029523|Abortifacient Agents|abortifacient agents|mesh-ancestor
153814564|NCT00452322|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153895176|NCT04983966|Desflurane|desflurane|mesh-list
153667865|NCT00029523|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153667866|NCT00029523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153667871|NCT00029523|Dermatologic Agents|dermatologic agents|mesh-ancestor
153667872|NCT00029523|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153667873|NCT00029523|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153667874|NCT00029523|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153667875|NCT00029523|Immunologic Factors|immunologic factors|mesh-ancestor
153667876|NCT00029523|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153667877|NCT00029523|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153667878|NCT00029523|Antiviral Agents|antiviral agents|mesh-ancestor
153667879|NCT00029523|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153667881|NCT00392717|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153667882|NCT00392717|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153667883|NCT00392717|Antimetabolites|antimetabolites|mesh-ancestor
153667884|NCT00392717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153667887|NCT00392717|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153667933|NCT00030069|Dexamethasone|dexamethasone|mesh-list
153667934|NCT00030069|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153667935|NCT00030069|Antiemetics|antiemetics|mesh-ancestor
153667936|NCT00030069|Autonomic Agents|autonomic agents|mesh-ancestor
153667937|NCT00030069|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153667938|NCT00030069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153667939|NCT00030069|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153667940|NCT00030069|Glucocorticoids|glucocorticoids|mesh-ancestor
153504897|NCT03426904|Vitamins|vitamins|mesh-ancestor
153667941|NCT00030069|Hormones|hormones|mesh-ancestor
153915463|NCT02549209|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153667942|NCT00030069|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153667943|NCT00030069|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153667997|NCT00030459|Antimitotic Agents|antimitotic agents|mesh-ancestor
153667998|NCT00030459|Mitosis Modulators|mitosis modulators|mesh-ancestor
153667999|NCT00030459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153668000|NCT00030459|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153668001|NCT00030459|Alkylating Agents|alkylating agents|mesh-ancestor
153668002|NCT00030459|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153668003|NCT00030459|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153668004|NCT00030498|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
153668005|NCT00030498|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153668006|NCT00030498|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153668007|NCT00030498|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153668008|NCT00030498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153915470|NCT02698267|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153814590|NCT00452595|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
153814591|NCT00452595|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
153814592|NCT00452595|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153814606|NCT00341432|Cholinergic Agents|cholinergic agents|mesh-ancestor
153814607|NCT00341432|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153814614|NCT00452634|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153814625|NCT03277599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153814626|NCT03277599|Analgesics|analgesics|mesh-ancestor
153360737|NCT00815360|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153360738|NCT00815360|Growth Substances|growth substances|mesh-ancestor
153360739|NCT00815360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153360740|NCT00815360|Growth Inhibitors|growth inhibitors|mesh-ancestor
153360741|NCT00815360|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153360742|NCT00815360|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153360743|NCT00815360|Glucocorticoids|glucocorticoids|mesh-ancestor
153820745|NCT00464880|Protease Inhibitors|protease inhibitors|mesh-ancestor
153820746|NCT00464880|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153820747|NCT00464880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153820748|NCT00464919|Sorafenib|sorafenib|mesh-list
153820749|NCT00464919|Tegafur|tegafur|mesh-list
153820750|NCT00464919|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153820751|NCT00464919|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153820752|NCT00464919|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153820753|NCT00464919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153820754|NCT00464919|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153820770|NCT00464958|Sensory System Agents|sensory system agents|mesh-ancestor
153820771|NCT00464958|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153820772|NCT00464958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153820773|NCT00464958|Anticonvulsants|anticonvulsants|mesh-ancestor
153820774|NCT00464958|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
153820775|NCT00464958|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
153820776|NCT00464958|Parasympatholytics|parasympatholytics|mesh-ancestor
153820777|NCT00464958|Autonomic Agents|autonomic agents|mesh-ancestor
153820778|NCT00464958|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
153820779|NCT00464958|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153820780|NCT00464958|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153820781|NCT00464958|Adrenergic Agents|adrenergic agents|mesh-ancestor
153820782|NCT00464958|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153360769|NCT01368653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153360770|NCT01407107|Nitroglycerin|nitroglycerin|mesh-list
153360771|NCT01407107|Vasodilator Agents|vasodilator agents|mesh-ancestor
153820792|NCT01055444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153820793|NCT01055444|Sensory System Agents|sensory system agents|mesh-ancestor
153820794|NCT01055444|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153820795|NCT01055444|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153820796|NCT01055444|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
153820797|NCT01055444|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153360786|NCT01369745|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
153360787|NCT01369745|Methylprednisolone|methylprednisolone|mesh-list
153360788|NCT01369745|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
153360789|NCT01369745|Prednisolone acetate|prednisolone acetate|mesh-list
153360790|NCT01369745|Dipyridamole|dipyridamole|mesh-list
153360791|NCT01369745|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
153360792|NCT01369745|Prednisolone phosphate|prednisolone phosphate|mesh-list
153820807|NCT01055015|Sensory System Agents|sensory system agents|mesh-ancestor
153820808|NCT01055015|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153820810|NCT00472875|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153820811|NCT00472875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153820812|NCT00434291|Nemonoxacin|nemonoxacin|mesh-list
153820813|NCT00434291|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153820814|NCT00434291|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153360803|NCT01369745|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153360804|NCT01369745|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
153360805|NCT01369745|Protective Agents|protective agents|mesh-ancestor
153360806|NCT01369745|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
153360807|NCT01369745|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153360808|NCT01369745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153360809|NCT01369745|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153360810|NCT01369745|Vasodilator Agents|vasodilator agents|mesh-ancestor
153360811|NCT01475513|Moxifloxacin|moxifloxacin|mesh-list
153360812|NCT01475513|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
153360819|NCT01475513|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153360820|NCT01475513|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
153360821|NCT01475513|Contraceptive Agents|contraceptive agents|mesh-ancestor
153360822|NCT01475513|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153360823|NCT01475513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153360824|NCT01475513|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
153360825|NCT01475513|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
153820830|NCT02957630|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
153820831|NCT02957630|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
153820833|NCT02957630|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
153820834|NCT02957630|Hormone Antagonists|hormone antagonists|mesh-ancestor
153820835|NCT02957630|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153820836|NCT02957630|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
153820837|NCT02957630|Diuretics|diuretics|mesh-ancestor
153820838|NCT02957630|Natriuretic Agents|natriuretic agents|mesh-ancestor
153814643|NCT00452907|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153814644|NCT00452907|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153811373|NCT00325286|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153811374|NCT00325286|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153811375|NCT00325286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153811376|NCT00325286|Anticonvulsants|anticonvulsants|mesh-ancestor
153811377|NCT00325286|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153811378|NCT00325286|Analgesics|analgesics|mesh-ancestor
153811379|NCT00325286|Sensory System Agents|sensory system agents|mesh-ancestor
153811380|NCT00325286|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153811381|NCT00325286|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153811382|NCT00325286|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153811383|NCT00325286|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
153811384|NCT00325286|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
153811385|NCT00325325|Everolimus|everolimus|mesh-list
153811386|NCT00325325|Tacrolimus|tacrolimus|mesh-list
153811387|NCT00325325|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153811388|NCT00325325|Immunologic Factors|immunologic factors|mesh-ancestor
153882075|NCT02484924|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
153882076|NCT02484924|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
153882077|NCT02484924|Purinergic Agents|purinergic agents|mesh-ancestor
153422956|NCT00716755|Dopamine Agents|dopamine agents|mesh-ancestor
153422957|NCT00716755|Antiemetics|antiemetics|mesh-ancestor
153811389|NCT00325325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153811390|NCT00325325|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
153811427|NCT04714593|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153811429|NCT00426582|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153811459|NCT00325715|Esomeprazole|esomeprazole|mesh-list
153811460|NCT00325715|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
153811461|NCT00325715|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153811462|NCT00325715|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
153811463|NCT00325715|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153811464|NCT00325715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153811465|NCT00354237|Hypoglycemic Agents|hypoglycemic agents|mesh-list
153811466|NCT00354237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153811467|NCT00325793|Nicardipine|nicardipine|mesh-list
153811468|NCT00325793|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153811469|NCT00325793|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153811470|NCT00325793|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153811471|NCT00325793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153811491|NCT04714242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153811493|NCT04714242|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153811494|NCT00354276|Cytarabine|cytarabine|mesh-list
153811495|NCT00354276|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153811496|NCT00354276|Antimetabolites|antimetabolites|mesh-ancestor
153811497|NCT00354276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153811498|NCT00354276|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153811499|NCT00354276|Antiviral Agents|antiviral agents|mesh-ancestor
153811500|NCT00354276|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153811501|NCT00354276|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153811502|NCT00354276|Immunologic Factors|immunologic factors|mesh-ancestor
153811503|NCT00354276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153811504|NCT00325910|Metformin|metformin|mesh-list
153811505|NCT00325910|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153811506|NCT00325910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153811507|NCT00325949|Acetaminophen|acetaminophen|mesh-list
153811524|NCT00325949|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153811525|NCT00326027|Pantoprazole|pantoprazole|mesh-list
153811537|NCT01059318|Immunologic Factors|immunologic factors|mesh-ancestor
153811538|NCT01059318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153811539|NCT01059318|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153811540|NCT04714515|Hydroxychloroquine|hydroxychloroquine|mesh-list
153811542|NCT04714515|Montelukast|montelukast|mesh-list
153811543|NCT04714515|Antimalarials|antimalarials|mesh-ancestor
153811544|NCT04714515|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153811545|NCT04714515|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153811546|NCT04714515|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153811547|NCT04714515|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153811548|NCT04714515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153811549|NCT04714515|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153811550|NCT04714515|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153811551|NCT04714515|Respiratory System Agents|respiratory system agents|mesh-ancestor
153811552|NCT04714515|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
153811553|NCT04714515|Hormone Antagonists|hormone antagonists|mesh-ancestor
153811554|NCT04714515|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153811555|NCT04714515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153811556|NCT04714515|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
153811557|NCT04714515|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
153811558|NCT00326105|Quetiapine Fumarate|quetiapine fumarate|mesh-list
153811559|NCT00326105|Antidepressive Agents|antidepressive agents|mesh-ancestor
153811560|NCT00326105|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153358047|NCT01303835|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153811581|NCT00326144|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153811582|NCT00326144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153811583|NCT01058655|Everolimus|everolimus|mesh-list
153811584|NCT01058655|Tivozanib|tivozanib|mesh-list
153811585|NCT01058655|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
153811586|NCT01058655|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153811587|NCT01058655|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153811602|NCT00426777|Risedronic Acid|risedronic acid|mesh-list
153811603|NCT00426777|Etidronic Acid|etidronic acid|mesh-list
153811604|NCT00426777|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153811612|NCT00419549|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153811613|NCT00419549|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153811614|NCT00419549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153811615|NCT00419549|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153811616|NCT00419549|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153811617|NCT00419549|Analgesics|analgesics|mesh-ancestor
153811618|NCT00419549|Sensory System Agents|sensory system agents|mesh-ancestor
153811619|NCT00419549|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153811620|NCT00419549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153811621|NCT00419549|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153811622|NCT00419549|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153811623|NCT00326378|Docetaxel|docetaxel|mesh-list
153811624|NCT00326378|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153811625|NCT00326378|Tubulin Modulators|tubulin modulators|mesh-ancestor
153811626|NCT00326378|Antimitotic Agents|antimitotic agents|mesh-ancestor
153811627|NCT00326378|Mitosis Modulators|mitosis modulators|mesh-ancestor
153811628|NCT00326378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153811630|NCT00326768|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
153811631|NCT00326768|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153811632|NCT00326768|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
153811633|NCT00326768|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
153811634|NCT00326768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153811635|NCT00326768|Diuretics|diuretics|mesh-ancestor
153811636|NCT00326768|Natriuretic Agents|natriuretic agents|mesh-ancestor
153811637|NCT00326768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153811638|NCT00326768|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
153811639|NCT00326768|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153811640|NCT00326807|Naltrexone|naltrexone|mesh-list
153811641|NCT00326807|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
153811642|NCT00326807|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
153811643|NCT00326807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153811660|NCT00354549|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153811661|NCT00354549|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153811663|NCT01057251|Nebivolol|nebivolol|mesh-list
153448057|NCT00002903|Docetaxel|docetaxel|mesh-list
153811664|NCT01057251|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153811665|NCT01057251|Vasodilator Agents|vasodilator agents|mesh-ancestor
153811666|NCT01057251|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
153811667|NCT01057251|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
153811668|NCT01057251|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153811669|NCT01057251|Adrenergic Agents|adrenergic agents|mesh-ancestor
153811670|NCT01057251|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153811671|NCT01057251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153374323|NCT01868633|Antiemetics|antiemetics|mesh-ancestor
153374324|NCT01868633|Autonomic Agents|autonomic agents|mesh-ancestor
153811672|NCT01057251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153811674|NCT04708353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153811675|NCT04708353|Analgesics|analgesics|mesh-ancestor
153811676|NCT04708353|Sensory System Agents|sensory system agents|mesh-ancestor
153811677|NCT04708353|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153811678|NCT04708353|Anticonvulsants|anticonvulsants|mesh-ancestor
153811679|NCT04708353|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153811680|NCT04708353|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153811681|NCT04708353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153811682|NCT04708353|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153811683|NCT04708353|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153811684|NCT04708353|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153811685|NCT04708353|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153811686|NCT04708353|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153811687|NCT00425646|Bevacizumab|bevacizumab|mesh-list
153811688|NCT00425646|Imatinib Mesylate|imatinib mesylate|mesh-list
153811689|NCT00425646|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153811690|NCT00425646|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153811691|NCT00425646|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153811692|NCT00425646|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153811693|NCT00425646|Growth Substances|growth substances|mesh-ancestor
153811694|NCT00425646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153811695|NCT00425646|Growth Inhibitors|growth inhibitors|mesh-ancestor
153811696|NCT00425646|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153811697|NCT00425646|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153811698|NCT00425646|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153918808|NCT02675023|Adalimumab|adalimumab|mesh-list
153811699|NCT00425646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153811718|NCT00327197|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153811720|NCT00327197|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153811721|NCT00327197|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153811722|NCT00425724|Cyclosporine|cyclosporine|mesh-list
153811723|NCT00425724|Prednisone|prednisone|mesh-list
153358122|NCT01306175|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
153811724|NCT00425724|Methylprednisolone|methylprednisolone|mesh-list
153811725|NCT00425724|Cyclosporins|cyclosporins|mesh-list
153811726|NCT00425724|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153811727|NCT00425724|Glucocorticoids|glucocorticoids|mesh-ancestor
153811728|NCT00425724|Hormones|hormones|mesh-ancestor
153811729|NCT00425724|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153811730|NCT00425724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153811731|NCT00425724|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153811732|NCT00425724|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153811733|NCT00425724|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153811734|NCT00425724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153811736|NCT00425724|Immunologic Factors|immunologic factors|mesh-ancestor
153811737|NCT00425724|Antifungal Agents|antifungal agents|mesh-ancestor
153811738|NCT00425724|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153811739|NCT00425724|Dermatologic Agents|dermatologic agents|mesh-ancestor
153811740|NCT00425724|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153811741|NCT00425724|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
153811742|NCT00425724|Antiemetics|antiemetics|mesh-ancestor
153811743|NCT00425724|Autonomic Agents|autonomic agents|mesh-ancestor
153811744|NCT00425724|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153811745|NCT00425724|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153811746|NCT00425724|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
153811747|NCT00425724|Protective Agents|protective agents|mesh-ancestor
153811748|NCT00426972|Estradiol|estradiol|mesh-list
153811749|NCT00426972|Estrogens|estrogens|mesh-ancestor
153811750|NCT00426972|Hormones|hormones|mesh-ancestor
153811751|NCT00426972|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153811752|NCT00426972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153448080|NCT00383045|Naltrexone|naltrexone|mesh-list
153811753|NCT00327353|Formoterol Fumarate|formoterol fumarate|mesh-list
153882100|NCT01603251|Ivermectin|ivermectin|mesh-list
153811754|NCT00327353|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
153811755|NCT00327353|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153811756|NCT00327353|Autonomic Agents|autonomic agents|mesh-ancestor
153811772|NCT00425841|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153811773|NCT00427089|Ascorbic Acid|ascorbic acid|mesh-list
153811774|NCT00427089|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
153811775|NCT00427089|Antioxidants|antioxidants|mesh-ancestor
153811776|NCT00427089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153811777|NCT00427089|Protective Agents|protective agents|mesh-ancestor
153811778|NCT00427089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153811779|NCT00427089|Vitamins|vitamins|mesh-ancestor
153811780|NCT00427089|Micronutrients|micronutrients|mesh-ancestor
153811781|NCT00427089|Laxatives|laxatives|mesh-ancestor
153811782|NCT00427089|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153811783|NCT00427128|Fluoxetine|fluoxetine|mesh-list
153811784|NCT00427128|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
153811785|NCT00427128|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153811786|NCT00427128|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153811787|NCT00427128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153811788|NCT00427128|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153811789|NCT00427128|Serotonin Agents|serotonin agents|mesh-ancestor
153811790|NCT00427128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153811791|NCT00427128|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
153811792|NCT00427128|Antidepressive Agents|antidepressive agents|mesh-ancestor
153811793|NCT00427128|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153811794|NCT00427128|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
153811795|NCT00427128|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153811796|NCT00427128|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153358200|NCT00783614|Antipyretics|antipyretics|mesh-ancestor
153811797|NCT00427167|Aluminum Hydroxide|aluminum hydroxide|mesh-list
153811805|NCT00427206|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153811806|NCT00427206|Analgesics|analgesics|mesh-ancestor
153811807|NCT00427206|Sensory System Agents|sensory system agents|mesh-ancestor
153811840|NCT05458076|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
153811841|NCT05458076|Protease Inhibitors|protease inhibitors|mesh-ancestor
153811842|NCT05458076|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153811843|NCT05458076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153811844|NCT05458076|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153811845|NCT05458076|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153814747|NCT00446940|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
153814748|NCT00446940|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153360219|NCT00802100|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
153897772|NCT01149369|Antiemetics|antiemetics|mesh-ancestor
153811847|NCT05458076|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153811848|NCT05458076|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
153811849|NCT05458076|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153811851|NCT00427362|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
153811852|NCT00427362|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153811853|NCT00427362|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153811854|NCT00426192|Mannitol|mannitol|mesh-list
153811855|NCT00426192|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
153811856|NCT00426192|Diuretics|diuretics|mesh-ancestor
153811857|NCT00426192|Natriuretic Agents|natriuretic agents|mesh-ancestor
153811858|NCT00426192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153811859|NCT05457530|Emtricitabine tenofovir alafenamide|emtricitabine tenofovir alafenamide|mesh-list
153811860|NCT05457530|Antiviral Agents|antiviral agents|mesh-ancestor
153811861|NCT05457530|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153811862|NCT05457530|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153811863|NCT05457530|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153811864|NCT05457530|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153811865|NCT05457530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153811866|NCT05457530|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153811868|NCT00432393|Levodopa|levodopa|mesh-list
153811869|NCT00432393|Carbidopa|carbidopa|mesh-list
153811870|NCT00432393|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
153811871|NCT00432393|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
153811872|NCT00432393|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
153811873|NCT00432393|Dopamine Agents|dopamine agents|mesh-ancestor
153811886|NCT05453045|Anticestodal Agents|anticestodal agents|mesh-ancestor
153811887|NCT05453045|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
153811888|NCT05453045|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153811889|NCT05453045|Tubulin Modulators|tubulin modulators|mesh-ancestor
153811890|NCT05453045|Antimitotic Agents|antimitotic agents|mesh-ancestor
153811891|NCT05453045|Mitosis Modulators|mitosis modulators|mesh-ancestor
153811892|NCT05453045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153811893|NCT05453045|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153811894|NCT00432432|Infliximab|infliximab|mesh-list
153811895|NCT00432432|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
153811896|NCT00432432|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153811897|NCT00432432|Dermatologic Agents|dermatologic agents|mesh-ancestor
153811898|NCT00432432|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153811899|NCT00432432|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153811900|NCT02957448|Rifampin|rifampin|mesh-list
153811901|NCT02957448|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
153811902|NCT02957448|Antitubercular Agents|antitubercular agents|mesh-ancestor
153811903|NCT02957448|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153918851|NCT05908513|Acetylcysteine|acetylcysteine|mesh-list
153811904|NCT02957448|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153811905|NCT02957448|Leprostatic Agents|leprostatic agents|mesh-ancestor
153811909|NCT02957448|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
153811910|NCT02957448|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
153811911|NCT02957448|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
153811912|NCT02957448|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
153811913|NCT02957448|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
153811914|NCT02957448|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
153811915|NCT00427596|Solabegron|solabegron|mesh-list
153811916|NCT00427596|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
153811917|NCT00427596|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
153811918|NCT00427596|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153811919|NCT00427596|Adrenergic Agents|adrenergic agents|mesh-ancestor
153811920|NCT00427596|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153811921|NCT00427596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153811922|NCT00427596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153811924|NCT00432510|Complement C1 Inhibitor Protein|complement c1 inhibitor protein|mesh-list
153811925|NCT00432510|Complement C1 Inactivator Proteins|complement c1 inactivator proteins|mesh-list
153811926|NCT00432510|Immunologic Factors|immunologic factors|mesh-ancestor
153811927|NCT00432510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153811928|NCT00432510|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
153811929|NCT00432510|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153811930|NCT05354258|Pyrimethamine|pyrimethamine|mesh-list
153811931|NCT05354258|Sulfadoxine|sulfadoxine|mesh-list
153811932|NCT05354258|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
153811933|NCT05354258|Amodiaquine|amodiaquine|mesh-list
153811934|NCT05354258|Albendazole|albendazole|mesh-list
153811946|NCT05354258|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
153811947|NCT05354258|Tubulin Modulators|tubulin modulators|mesh-ancestor
153811948|NCT05354258|Antimitotic Agents|antimitotic agents|mesh-ancestor
153811966|NCT02273466|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153811980|NCT02273505|Antifungal Agents|antifungal agents|mesh-ancestor
153811981|NCT02273505|Keratolytic Agents|keratolytic agents|mesh-ancestor
153811982|NCT02273505|Dermatologic Agents|dermatologic agents|mesh-ancestor
153811983|NCT02273505|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153811984|NCT02273505|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153811985|NCT02273505|Analgesics|analgesics|mesh-ancestor
153811986|NCT02273505|Sensory System Agents|sensory system agents|mesh-ancestor
153811987|NCT02273505|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153811989|NCT02273505|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153811990|NCT02273505|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153811991|NCT02273505|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153811992|NCT02273505|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153811993|NCT02273505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153811994|NCT02273505|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153811995|NCT02273505|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153422990|NCT03202550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153422991|NCT04088786|Irinotecan|irinotecan|mesh-list
153422992|NCT04088786|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
153422993|NCT04088786|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153812013|NCT00427947|Anesthetics, Local|anesthetics, local|mesh-ancestor
153812014|NCT00427947|Anesthetics|anesthetics|mesh-ancestor
153812015|NCT00427947|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153812016|NCT00427947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153812017|NCT00427947|Sensory System Agents|sensory system agents|mesh-ancestor
153812018|NCT00427947|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153812019|NCT00432588|Misoprostol|misoprostol|mesh-list
153812020|NCT00432588|Dinoprostone|dinoprostone|mesh-list
153812021|NCT00432588|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
153812022|NCT00432588|Abortifacient Agents|abortifacient agents|mesh-ancestor
153812023|NCT00432588|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153812024|NCT00432588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153812025|NCT00432588|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
153812026|NCT00432588|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153812027|NCT00432588|Oxytocics|oxytocics|mesh-ancestor
153812029|NCT00428025|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153812030|NCT00428025|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153812031|NCT00428025|Analgesics|analgesics|mesh-ancestor
153812032|NCT00428025|Sensory System Agents|sensory system agents|mesh-ancestor
153812034|NCT00428025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153812035|NCT00428025|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153812036|NCT00428025|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153812037|NCT00428025|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153812038|NCT00428025|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153812039|NCT00428025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153812040|NCT00428064|Cyclosporine|cyclosporine|mesh-list
153812041|NCT00428064|Sirolimus|sirolimus|mesh-list
153812042|NCT00428064|Cyclosporins|cyclosporins|mesh-list
153812043|NCT00428064|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153812044|NCT00428064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153812045|NCT00428064|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153812046|NCT00428064|Immunologic Factors|immunologic factors|mesh-ancestor
153812047|NCT00428064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153812048|NCT00428064|Antifungal Agents|antifungal agents|mesh-ancestor
153812049|NCT00428064|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153812051|NCT00428064|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153812052|NCT00428064|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
153812053|NCT00428064|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153812054|NCT00428064|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153812055|NCT00428064|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153812062|NCT00419783|Ketoconazole|ketoconazole|mesh-list
153812063|NCT00419783|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153812064|NCT00419783|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153812065|NCT00419783|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153812066|NCT00419783|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153812067|NCT00419783|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153812068|NCT00419783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153812070|NCT00419783|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153812071|NCT00419783|Antifungal Agents|antifungal agents|mesh-ancestor
153812072|NCT00419783|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
153812073|NCT00419783|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153812074|NCT00419783|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153812075|NCT00419783|Hormone Antagonists|hormone antagonists|mesh-ancestor
153812076|NCT00419783|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153812077|NCT00419783|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
153812080|NCT00428181|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153812081|NCT00428181|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153812082|NCT00428181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153812083|NCT00432861|Pancrelipase|pancrelipase|mesh-list
153812084|NCT00432861|Pancreatin|pancreatin|mesh-list
153812085|NCT00432861|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153812086|NCT04575233|Ropivacaine|ropivacaine|mesh-list
153812087|NCT04575233|Anesthetics, Local|anesthetics, local|mesh-ancestor
153812088|NCT04575233|Anesthetics|anesthetics|mesh-ancestor
153812089|NCT04575233|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153812090|NCT04575233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153812091|NCT04575233|Sensory System Agents|sensory system agents|mesh-ancestor
153812093|NCT00428454|Sirolimus|sirolimus|mesh-list
153812094|NCT00428454|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153812095|NCT00428454|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153812096|NCT00428454|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153812097|NCT00428454|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153812098|NCT00428454|Antifungal Agents|antifungal agents|mesh-ancestor
153812099|NCT00428454|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153812100|NCT00428454|Immunologic Factors|immunologic factors|mesh-ancestor
153812101|NCT00428454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153812102|NCT00432978|Bosentan|bosentan|mesh-list
153812103|NCT00432978|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153812104|NCT00432978|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
153812105|NCT00432978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153812107|NCT01051791|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
153812108|NCT01051791|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153812109|NCT01051791|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153812110|NCT01051791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153812111|NCT01051791|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153812112|NCT01051791|Immunologic Factors|immunologic factors|mesh-ancestor
153812113|NCT01051791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153812114|NCT01051791|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153812115|NCT01056510|Rituximab|rituximab|mesh-list
153812116|NCT01056510|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
153812117|NCT01056510|Chlorambucil|chlorambucil|mesh-list
153812118|NCT01056510|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153812119|NCT01056510|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153812120|NCT01056510|Immunologic Factors|immunologic factors|mesh-ancestor
153812121|NCT01056510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153812122|NCT01056510|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153812123|NCT01056510|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153812124|NCT01056510|Alkylating Agents|alkylating agents|mesh-ancestor
153812140|NCT01056276|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153812142|NCT01056276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153812143|NCT01055886|Nicotine|nicotine|mesh-list
153812144|NCT01055886|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
153812145|NCT01055886|Autonomic Agents|autonomic agents|mesh-ancestor
153812146|NCT01055886|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153812147|NCT01055886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153812148|NCT01055886|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
153812149|NCT01055886|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
153812150|NCT01055886|Cholinergic Agents|cholinergic agents|mesh-ancestor
153812151|NCT01055886|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153812152|NCT01055886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153812153|NCT00433095|Trastuzumab|trastuzumab|mesh-list
153812154|NCT00433095|Vinorelbine|vinorelbine|mesh-list
153812155|NCT00433095|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153812156|NCT00433095|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153812157|NCT00433095|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153919005|NCT05760807|Oxytocin|oxytocin|mesh-list
153812158|NCT00433095|Tubulin Modulators|tubulin modulators|mesh-ancestor
153812159|NCT00433095|Antimitotic Agents|antimitotic agents|mesh-ancestor
153812160|NCT00433095|Mitosis Modulators|mitosis modulators|mesh-ancestor
153812161|NCT00433095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153812162|NCT01055613|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
153812163|NCT01055457|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
153812164|NCT00428649|Selenium|selenium|mesh-list
153812165|NCT00428649|Antioxidants|antioxidants|mesh-ancestor
153812166|NCT00428649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153358569|NCT02199041|Prednisolone phosphate|prednisolone phosphate|mesh-list
153358592|NCT02199041|Hormones|hormones|mesh-ancestor
153812167|NCT00428649|Protective Agents|protective agents|mesh-ancestor
153812168|NCT00428649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153812169|NCT00428649|Trace Elements|trace elements|mesh-ancestor
153812170|NCT00428649|Micronutrients|micronutrients|mesh-ancestor
153812171|NCT00433173|Anastrozole|anastrozole|mesh-list
153812172|NCT00433173|Goserelin|goserelin|mesh-list
153812173|NCT00433173|Testosterone|testosterone|mesh-list
153812174|NCT00433173|Androgens|androgens|mesh-ancestor
153812175|NCT00433173|Hormones|hormones|mesh-ancestor
153812176|NCT00433173|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153812177|NCT00433173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153812178|NCT00433173|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153812179|NCT00433173|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153812180|NCT00433173|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
153812181|NCT00433173|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153812182|NCT00433173|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153812198|NCT01055028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153812199|NCT01055028|Growth Inhibitors|growth inhibitors|mesh-ancestor
153812200|NCT00428727|Nitric Oxide|nitric oxide|mesh-list
153812201|NCT00428727|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153812202|NCT00428727|Autonomic Agents|autonomic agents|mesh-ancestor
153812203|NCT00428727|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153812204|NCT00428727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153812205|NCT00428727|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153812206|NCT00428727|Respiratory System Agents|respiratory system agents|mesh-ancestor
153812207|NCT00428727|Free Radical Scavengers|free radical scavengers|mesh-ancestor
153812208|NCT00428727|Antioxidants|antioxidants|mesh-ancestor
153812209|NCT00428727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153812210|NCT00428727|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153812211|NCT00428727|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
153812212|NCT00428727|Vasodilator Agents|vasodilator agents|mesh-ancestor
153812213|NCT00428727|Gasotransmitters|gasotransmitters|mesh-ancestor
153812214|NCT00428727|Protective Agents|protective agents|mesh-ancestor
153812215|NCT00433368|N-Methylaspartate|n-methylaspartate|mesh-list
153812216|NCT00433368|Excitatory Amino Acid Agonists|excitatory amino acid agonists|mesh-ancestor
153812218|NCT00433368|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153919038|NCT05687500|Glyburide|glyburide|mesh-list
153812219|NCT00433368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153812220|NCT00433368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153812221|NCT00428766|Farletuzumab|farletuzumab|mesh-list
153812222|NCT00428766|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153812223|NCT04716569|Ivermectin|ivermectin|mesh-list
153812224|NCT04716569|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153812225|NCT04716569|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153812226|NCT04703127|Lidocaine|lidocaine|mesh-list
153812227|NCT04703127|Tadalafil|tadalafil|mesh-list
153812228|NCT04703127|Anesthetics, Local|anesthetics, local|mesh-ancestor
153812229|NCT04703127|Anesthetics|anesthetics|mesh-ancestor
153812230|NCT04703127|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153812231|NCT04703127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153812232|NCT04703127|Sensory System Agents|sensory system agents|mesh-ancestor
153812233|NCT04703127|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153812234|NCT04703127|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153812235|NCT04703127|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
153812236|NCT04703127|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153812237|NCT04703127|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153812238|NCT04703127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153812239|NCT04703127|Vasodilator Agents|vasodilator agents|mesh-ancestor
153812254|NCT00428883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153812256|NCT04702971|Flunarizine|flunarizine|mesh-list
153812257|NCT04702971|Anticonvulsants|anticonvulsants|mesh-ancestor
153812258|NCT04702971|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153812259|NCT04702971|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153812260|NCT04702971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153812261|NCT04702971|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153812262|NCT04702971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153812264|NCT04702971|Histamine Antagonists|histamine antagonists|mesh-ancestor
153812265|NCT04702971|Histamine Agents|histamine agents|mesh-ancestor
153812266|NCT04702971|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153812267|NCT04702971|Vasodilator Agents|vasodilator agents|mesh-ancestor
153812268|NCT00433407|Trastuzumab|trastuzumab|mesh-list
153812269|NCT00433407|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153812270|NCT00433407|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153812271|NCT00433485|Sirolimus|sirolimus|mesh-list
153812272|NCT00433485|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153812273|NCT00433485|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153812274|NCT00433485|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153812275|NCT00433485|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153812276|NCT00433485|Antifungal Agents|antifungal agents|mesh-ancestor
153812277|NCT00433485|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153812278|NCT00433485|Immunologic Factors|immunologic factors|mesh-ancestor
153812279|NCT00433485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153812280|NCT02676791|Povidone-Iodine|povidone-iodine|mesh-list
153882105|NCT01603251|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153812281|NCT02676791|Povidone|povidone|mesh-list
153812282|NCT02676791|Plasma Substitutes|plasma substitutes|mesh-ancestor
153882106|NCT01603251|Antimalarials|antimalarials|mesh-ancestor
153882107|NCT01603251|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153882108|NCT01646294|Mirabegron|mirabegron|mesh-list
153812283|NCT02676791|Blood Substitutes|blood substitutes|mesh-ancestor
153812284|NCT02676791|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
153812285|NCT02676791|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153812286|NCT01600079|Vaccines|vaccines|mesh-list
153812287|NCT01600079|Immunologic Factors|immunologic factors|mesh-ancestor
153812288|NCT01600079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153812289|NCT01370486|Melatonin|melatonin|mesh-list
153812290|NCT01370486|Antioxidants|antioxidants|mesh-ancestor
153812291|NCT01370486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153812292|NCT01370486|Protective Agents|protective agents|mesh-ancestor
153812293|NCT01370486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153812294|NCT01370486|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153812295|NCT00327587|Amlodipine|amlodipine|mesh-list
153812296|NCT00327587|Valsartan|valsartan|mesh-list
153812297|NCT00327587|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
153812298|NCT00327587|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153812299|NCT00327587|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153812300|NCT00327587|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153812301|NCT00327587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153812316|NCT00433641|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153812317|NCT00433641|Appetite Depressants|appetite depressants|mesh-ancestor
153812318|NCT00433641|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
153812321|NCT00429234|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153812322|NCT00429234|Antimetabolites|antimetabolites|mesh-ancestor
153812323|NCT00429234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153812324|NCT00429234|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153812325|NCT00429234|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153467845|NCT00549042|Analgesics|analgesics|mesh-ancestor
153812326|NCT00429234|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153812327|NCT00429234|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153812328|NCT00433719|Efavirenz|efavirenz|mesh-list
153812329|NCT00433719|Lamivudine, zidovudine drug combination|lamivudine, zidovudine drug combination|mesh-list
153812330|NCT00433719|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153812331|NCT00433719|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153812332|NCT00433719|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153812333|NCT00433719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153812334|NCT00433719|Antiviral Agents|antiviral agents|mesh-ancestor
153812335|NCT00433719|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153812336|NCT00433719|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
153812337|NCT00433719|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153812338|NCT00433719|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
153812339|NCT00433719|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
153812340|NCT00433719|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
153812341|NCT00433719|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
153812342|NCT00433719|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153812343|NCT00433719|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153812344|NCT04704297|Acetaminophen|acetaminophen|mesh-list
153812345|NCT04704297|Ibuprofen|ibuprofen|mesh-list
153812346|NCT04704297|Ketorolac|ketorolac|mesh-list
153812347|NCT04704297|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
153812348|NCT04704297|Amitriptyline|amitriptyline|mesh-list
153812349|NCT04704297|Bupivacaine|bupivacaine|mesh-list
153812350|NCT04704297|Cyclobenzaprine|cyclobenzaprine|mesh-list
153812351|NCT04704297|Anesthetics, Local|anesthetics, local|mesh-ancestor
153812352|NCT04704297|Anesthetics|anesthetics|mesh-ancestor
153812353|NCT04704297|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153812354|NCT04704297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153812355|NCT04704297|Sensory System Agents|sensory system agents|mesh-ancestor
153812356|NCT04704297|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153812357|NCT04704297|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153812358|NCT04704297|Analgesics|analgesics|mesh-ancestor
153812359|NCT04704297|Antipyretics|antipyretics|mesh-ancestor
153812384|NCT00328367|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153812386|NCT00328367|Dopamine Agonists|dopamine agonists|mesh-ancestor
153812387|NCT00328367|Dopamine Agents|dopamine agents|mesh-ancestor
153812388|NCT00328367|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153812389|NCT00328367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153812390|NCT00328367|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
153812391|NCT00328367|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
153812392|NCT00328367|Serotonin Agents|serotonin agents|mesh-ancestor
153812393|NCT00328367|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
153812394|NCT00328367|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153812395|NCT00328367|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
153812396|NCT00328367|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
153812397|NCT04703088|Ondansetron|ondansetron|mesh-list
153812398|NCT04703088|Antiemetics|antiemetics|mesh-ancestor
153812399|NCT04703088|Autonomic Agents|autonomic agents|mesh-ancestor
153812400|NCT04703088|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153812401|NCT04703088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153812402|NCT04703088|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153812403|NCT04703088|Antipruritics|antipruritics|mesh-ancestor
153812404|NCT04703088|Dermatologic Agents|dermatologic agents|mesh-ancestor
153812405|NCT04703088|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
153812407|NCT04703088|Serotonin Agents|serotonin agents|mesh-ancestor
153812408|NCT04703088|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153812431|NCT00328718|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153812433|NCT00328718|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
153812435|NCT00328796|Anesthetics, Local|anesthetics, local|mesh-ancestor
153812436|NCT00328796|Anesthetics|anesthetics|mesh-ancestor
153812437|NCT00328796|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153812438|NCT00328796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153812439|NCT00328796|Sensory System Agents|sensory system agents|mesh-ancestor
153812440|NCT00328796|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153812441|NCT00328796|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153812442|NCT00328796|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
153812443|NCT00328796|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153812444|NCT00328796|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153812445|NCT00328796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153812447|NCT00429468|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
153812448|NCT00429468|Hydrocodone|hydrocodone|mesh-list
153812449|NCT00429468|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153812450|NCT00429468|Analgesics|analgesics|mesh-ancestor
153812451|NCT00429468|Sensory System Agents|sensory system agents|mesh-ancestor
153812452|NCT00429468|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153812453|NCT00429468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153812454|NCT00429468|Antipyretics|antipyretics|mesh-ancestor
153812455|NCT00429468|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153812456|NCT00429468|Narcotics|narcotics|mesh-ancestor
153812457|NCT00429468|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153812458|NCT00429468|Antitussive Agents|antitussive agents|mesh-ancestor
153812470|NCT00328874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153812471|NCT00328874|Vitamins|vitamins|mesh-ancestor
153812472|NCT00328913|5-Hydroxytryptophan|5-hydroxytryptophan|mesh-list
153812474|NCT00328913|Antidepressive Agents|antidepressive agents|mesh-ancestor
153812475|NCT00328913|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153812476|NCT00433953|Mycophenolic Acid|mycophenolic acid|mesh-list
153812477|NCT00433953|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153812478|NCT00433953|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153812479|NCT00433953|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
153812480|NCT00433953|Antitubercular Agents|antitubercular agents|mesh-ancestor
153812481|NCT00433953|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153812483|NCT00433953|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153812484|NCT00433953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153812486|NCT02957643|Trace Elements|trace elements|mesh-ancestor
153812488|NCT02957643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153812489|NCT02957604|Evolocumab|evolocumab|mesh-list
153812490|NCT02957604|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
153812491|NCT02957604|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153812493|NCT02957604|Antimetabolites|antimetabolites|mesh-ancestor
153812495|NCT02957604|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
153812496|NCT02957604|Protease Inhibitors|protease inhibitors|mesh-ancestor
153812497|NCT02957604|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153812498|NCT02957604|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153812499|NCT00329069|Atorvastatin|atorvastatin|mesh-list
153812500|NCT00329069|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153812501|NCT00329069|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153812502|NCT00329069|Antimetabolites|antimetabolites|mesh-ancestor
153812503|NCT00329069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153812505|NCT00329069|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
153812506|NCT00329069|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153812507|NCT00429624|Acetaminophen|acetaminophen|mesh-list
153812517|NCT00329147|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
153812519|NCT00329147|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153812520|NCT00329147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153812521|NCT00329147|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153812523|NCT00329147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153812524|NCT00329147|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
153812554|NCT00434031|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153812556|NCT00434031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153812557|NCT00434031|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153812558|NCT00434031|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153812559|NCT00434031|Tubulin Modulators|tubulin modulators|mesh-ancestor
153812560|NCT00434031|Antimitotic Agents|antimitotic agents|mesh-ancestor
153812561|NCT00434031|Mitosis Modulators|mitosis modulators|mesh-ancestor
153812562|NCT00434031|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153812563|NCT00434031|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153812565|NCT00434031|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153812592|NCT00329381|Immunologic Factors|immunologic factors|mesh-ancestor
153812593|NCT00329381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153812595|NCT00429780|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153359024|NCT06212648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153359025|NCT06212648|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153359026|NCT06212648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153359029|NCT06212648|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
153812597|NCT00429780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153812599|NCT00329459|Sumatriptan|sumatriptan|mesh-list
153812600|NCT00329459|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153812624|NCT00329537|Sargramostim|sargramostim|mesh-list
153812625|NCT00329537|Immunologic Factors|immunologic factors|mesh-ancestor
153812626|NCT00329537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153812627|NCT00429897|Bendroflumethiazide|bendroflumethiazide|mesh-list
153812628|NCT00429897|Amiloride|amiloride|mesh-list
153812629|NCT00429897|Spironolactone|spironolactone|mesh-list
153812630|NCT00429897|Furosemide|furosemide|mesh-list
153812631|NCT00429897|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
153812632|NCT00429897|Hormone Antagonists|hormone antagonists|mesh-ancestor
153812633|NCT00429897|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153812635|NCT00429897|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
153812636|NCT00429897|Diuretics|diuretics|mesh-ancestor
153812637|NCT00429897|Natriuretic Agents|natriuretic agents|mesh-ancestor
153812638|NCT00429897|Acid Sensing Ion Channel Blockers|acid sensing ion channel blockers|mesh-ancestor
153812639|NCT00429897|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153812641|NCT00429897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153812643|NCT00429897|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
153812644|NCT00429897|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153812645|NCT00429897|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
153812647|NCT00429936|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153812648|NCT00429936|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
153812649|NCT00429936|Protective Agents|protective agents|mesh-ancestor
153812650|NCT00429936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153812652|NCT00429975|Ceftriaxone|ceftriaxone|mesh-list
153812670|NCT01056393|Ibalizumab|ibalizumab|mesh-list
153812672|NCT01056393|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153812673|NCT01056393|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153812674|NCT01056393|Antiviral Agents|antiviral agents|mesh-ancestor
153812675|NCT01056393|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153812676|NCT01056393|Immunologic Factors|immunologic factors|mesh-ancestor
153812677|NCT01056393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153812678|NCT01055106|Metronidazole|metronidazole|mesh-list
153812679|NCT01055106|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153812680|NCT01055106|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153812681|NCT01055106|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153812682|NCT01055106|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153812684|NCT00329693|Dopamine Agonists|dopamine agonists|mesh-ancestor
153812685|NCT00329693|Dopamine Agents|dopamine agents|mesh-ancestor
153812687|NCT00329693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153812688|NCT00329693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153812690|NCT00329810|Antidepressive Agents|antidepressive agents|mesh-ancestor
153812691|NCT00329810|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153812692|NCT00329810|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153812694|NCT00329810|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153812695|NCT00329810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153812696|NCT00329810|Dopamine Agonists|dopamine agonists|mesh-ancestor
153812697|NCT00329810|Dopamine Agents|dopamine agents|mesh-ancestor
153812699|NCT00329810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153812700|NCT00329810|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
153812701|NCT00329810|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
153812703|NCT00329810|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
153812704|NCT00329810|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153812705|NCT00329810|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
153812706|NCT00329810|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
153812727|NCT00430365|Growth Substances|growth substances|mesh-ancestor
153812730|NCT00330239|Paroxetine|paroxetine|mesh-list
153812731|NCT00330239|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
153812732|NCT00330239|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153812733|NCT00330239|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153812734|NCT00330239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153812735|NCT00330239|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153812736|NCT00330239|Serotonin Agents|serotonin agents|mesh-ancestor
153812737|NCT00330239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153812738|NCT00330239|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
153812739|NCT00330239|Antidepressive Agents|antidepressive agents|mesh-ancestor
153812740|NCT00330239|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153812744|NCT01051557|Sirolimus|sirolimus|mesh-list
153812745|NCT01051557|Temsirolimus|temsirolimus|mesh-list
153812746|NCT01051557|MTOR Inhibitors|mtor inhibitors|mesh-list
153812747|NCT01051557|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153812748|NCT01051557|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153812749|NCT01051557|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153812750|NCT01051557|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153812751|NCT01051557|Antifungal Agents|antifungal agents|mesh-ancestor
153812752|NCT01051557|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153812753|NCT01051557|Immunologic Factors|immunologic factors|mesh-ancestor
153812754|NCT01051557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153812755|NCT01051557|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153812756|NCT01051557|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153812757|NCT01051557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153812758|NCT00330278|Cefazolin|cefazolin|mesh-list
153812759|NCT00330278|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153812788|NCT00434382|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153812789|NCT00434382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153812790|NCT00434382|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153812792|NCT00434382|Anesthetics|anesthetics|mesh-ancestor
153812793|NCT00434382|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153812794|NCT00434382|Narcotics|narcotics|mesh-ancestor
153812795|NCT00434382|Analgesics|analgesics|mesh-ancestor
153812796|NCT00434382|Sensory System Agents|sensory system agents|mesh-ancestor
153812797|NCT00434382|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153812798|NCT00434382|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153812799|NCT00434382|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153812800|NCT00434382|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
153812801|NCT00330707|Interferons|interferons|mesh-list
153812802|NCT00330707|Interferon-alpha|interferon-alpha|mesh-list
153812803|NCT00330707|BCG Vaccine|bcg vaccine|mesh-list
153812804|NCT00330707|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153812805|NCT00330707|Antiviral Agents|antiviral agents|mesh-ancestor
153812806|NCT00330707|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153812807|NCT00330707|Immunologic Factors|immunologic factors|mesh-ancestor
153812808|NCT00330707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153812809|NCT00330707|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153812842|NCT00330824|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153812844|NCT00330824|Autonomic Agents|autonomic agents|mesh-ancestor
153812845|NCT00330824|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153812846|NCT00330824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153812847|NCT00330824|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153812848|NCT00330824|Glucocorticoids|glucocorticoids|mesh-ancestor
153812879|NCT00330902|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153812880|NCT00330902|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153812881|NCT00330902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153812882|NCT00330902|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
153882109|NCT01646294|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
153812883|NCT00430794|Spironolactone|spironolactone|mesh-list
153812884|NCT00430794|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
153812885|NCT00430794|Hormone Antagonists|hormone antagonists|mesh-ancestor
153812886|NCT00430794|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153812887|NCT00430794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153812888|NCT00430794|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
153812890|NCT00430794|Natriuretic Agents|natriuretic agents|mesh-ancestor
153812891|NCT00330980|Simvastatin|simvastatin|mesh-list
153812892|NCT00330980|Pravastatin|pravastatin|mesh-list
153812918|NCT00331097|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153812920|NCT00331097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153812921|NCT00331097|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153812922|NCT00331097|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153812923|NCT00331097|Alkylating Agents|alkylating agents|mesh-ancestor
153812924|NCT00331097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153812925|NCT00331097|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153812926|NCT00331097|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153812927|NCT00331097|Tubulin Modulators|tubulin modulators|mesh-ancestor
153812928|NCT00331097|Antimitotic Agents|antimitotic agents|mesh-ancestor
153812929|NCT00331097|Mitosis Modulators|mitosis modulators|mesh-ancestor
153812930|NCT00331097|Antimetabolites|antimetabolites|mesh-ancestor
153812931|NCT00331097|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153812933|NCT00331097|Abortifacient Agents|abortifacient agents|mesh-ancestor
153812934|NCT00331097|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153919366|NCT03087903|Antioxidants|antioxidants|mesh-ancestor
153812935|NCT00331097|Dermatologic Agents|dermatologic agents|mesh-ancestor
153812936|NCT00331097|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153812937|NCT00331097|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153812971|NCT00431106|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153812972|NCT00431106|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153812974|NCT00431106|Antimitotic Agents|antimitotic agents|mesh-ancestor
153812975|NCT00431106|Mitosis Modulators|mitosis modulators|mesh-ancestor
153813002|NCT00431262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153813005|NCT00331604|Insulin Aspart|insulin aspart|mesh-list
153813006|NCT00331604|Insulin, Long-Acting|insulin, long-acting|mesh-list
153813007|NCT00331604|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
153813008|NCT00331604|Insulin Detemir|insulin detemir|mesh-list
153813009|NCT00331604|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153813010|NCT00331604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153813012|NCT00331643|Epothilone B|epothilone b|mesh-list
153813014|NCT00331643|Antimitotic Agents|antimitotic agents|mesh-ancestor
153813015|NCT00331643|Mitosis Modulators|mitosis modulators|mesh-ancestor
153813016|NCT00331643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153813017|NCT00331643|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153813018|NCT00431340|Belinostat|belinostat|mesh-list
153813019|NCT00431340|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153813020|NCT00431340|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
153813021|NCT00431340|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153813022|NCT00431340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153813024|NCT00431379|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153813025|NCT00431379|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153813026|NCT00431379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153813027|NCT00331838|Enoxaparin|enoxaparin|mesh-list
153359540|NCT05004350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153359541|NCT05004350|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153359543|NCT05004350|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153359544|NCT05004350|Immunologic Factors|immunologic factors|mesh-ancestor
153359545|NCT05004350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153359546|NCT05004350|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
153359547|NCT05004350|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153359548|NCT05004350|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153359549|NCT05004350|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153359551|NCT04899765|BCG Vaccine|bcg vaccine|mesh-list
153359552|NCT04899765|Immunologic Factors|immunologic factors|mesh-ancestor
153359554|NCT04899765|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153359555|NCT04891991|Infliximab|infliximab|mesh-list
153359556|NCT04891991|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
153359557|NCT04891991|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153359558|NCT04891991|Dermatologic Agents|dermatologic agents|mesh-ancestor
153359559|NCT04891991|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153813114|NCT00332306|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153813115|NCT00332306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153813116|NCT00332306|Antiviral Agents|antiviral agents|mesh-ancestor
153813117|NCT00332306|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153813118|NCT00332306|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153813119|NCT00332306|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153813151|NCT00332384|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153813152|NCT00332384|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153813153|NCT00435435|Disulfiram|disulfiram|mesh-list
153813154|NCT00435435|Acamprosate|acamprosate|mesh-list
153813155|NCT00435435|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
153813156|NCT00435435|Acetaldehyde Dehydrogenase Inhibitors|acetaldehyde dehydrogenase inhibitors|mesh-ancestor
153813157|NCT00435435|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153813158|NCT00435435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153359669|NCT04430426|Keratolytic Agents|keratolytic agents|mesh-ancestor
153359670|NCT04430426|Dermatologic Agents|dermatologic agents|mesh-ancestor
153359671|NCT04412096|Timolol|timolol|mesh-list
153359672|NCT04412096|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
153359673|NCT04412096|Latanoprost|latanoprost|mesh-list
153359675|NCT04412096|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
153359676|NCT04412096|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
153359677|NCT04412096|Adrenergic Agents|adrenergic agents|mesh-ancestor
153359678|NCT04412096|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153877832|NCT05316168|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153877833|NCT05316168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153877834|NCT05316168|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153877836|NCT05316168|Hormones|hormones|mesh-ancestor
153877837|NCT05316168|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153877838|NCT05316168|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153877839|NCT05316168|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153877840|NCT05316168|Anesthetics, Local|anesthetics, local|mesh-ancestor
153418615|NCT02823080|Fertility Agents, Female|fertility agents, female|mesh-ancestor
153418616|NCT02823080|Fertility Agents|fertility agents|mesh-ancestor
153418617|NCT02823080|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153418618|NCT02823080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153418625|NCT03031795|Ketorolac|ketorolac|mesh-list
153418626|NCT03031795|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153418627|NCT03031795|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153418628|NCT03031795|Analgesics|analgesics|mesh-ancestor
153418629|NCT03031795|Sensory System Agents|sensory system agents|mesh-ancestor
153418630|NCT03031795|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153418631|NCT03031795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153877841|NCT05316168|Anesthetics|anesthetics|mesh-ancestor
153877842|NCT05316168|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153877843|NCT05316168|Sensory System Agents|sensory system agents|mesh-ancestor
153877844|NCT05300191|Dialysis Solutions|dialysis solutions|mesh-list
153877845|NCT05300191|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
153877846|NCT05293509|Cyclosporine|cyclosporine|mesh-list
153877847|NCT05293509|Mycophenolic Acid|mycophenolic acid|mesh-list
153877848|NCT05293509|Dexamethasone|dexamethasone|mesh-list
153877849|NCT05293509|Cyclophosphamide|cyclophosphamide|mesh-list
153877850|NCT05293509|Busulfan|busulfan|mesh-list
153877851|NCT05293509|Rituximab|rituximab|mesh-list
153877852|NCT05293509|Fludarabine|fludarabine|mesh-list
153877853|NCT05293509|Bortezomib|bortezomib|mesh-list
153877854|NCT05293509|Tacrolimus|tacrolimus|mesh-list
153877855|NCT05293509|Cyclosporins|cyclosporins|mesh-list
153877856|NCT05293509|Thymoglobulin|thymoglobulin|mesh-list
153877857|NCT05293509|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153877858|NCT05293509|Immunologic Factors|immunologic factors|mesh-ancestor
153877859|NCT05293509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153418632|NCT03031795|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153418633|NCT03031795|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153418636|NCT03031795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153418638|NCT02942654|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153418639|NCT02942654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153423002|NCT00392821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153423003|NCT00392821|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153423004|NCT00392821|Immunologic Factors|immunologic factors|mesh-ancestor
153418640|NCT02909959|Sulforaphane|sulforaphane|mesh-list
153418641|NCT02909959|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
153418642|NCT02909959|Protective Agents|protective agents|mesh-ancestor
153418643|NCT02909959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153418644|NCT02909959|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153418645|NCT00373802|Phenylephrine|phenylephrine|mesh-list
153418646|NCT00373802|Oxymetazoline|oxymetazoline|mesh-list
153418647|NCT00373802|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
153418648|NCT00373802|Mydriatics|mydriatics|mesh-ancestor
153418649|NCT00373802|Autonomic Agents|autonomic agents|mesh-ancestor
153418650|NCT00373802|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153877861|NCT05293509|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153877862|NCT05293509|Alkylating Agents|alkylating agents|mesh-ancestor
153877863|NCT05293509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153877864|NCT05293509|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153877865|NCT05293509|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153877866|NCT05293509|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153877867|NCT05293509|Antiemetics|antiemetics|mesh-ancestor
153877869|NCT05293509|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153877877|NCT05293509|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153418651|NCT00373802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153418653|NCT00373802|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
153418654|NCT00373802|Nasal Decongestants|nasal decongestants|mesh-ancestor
153418655|NCT00373802|Respiratory System Agents|respiratory system agents|mesh-ancestor
153418656|NCT00373802|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
153418657|NCT00373802|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153418658|NCT00373802|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153418659|NCT00373802|Adrenergic Agents|adrenergic agents|mesh-ancestor
153418660|NCT00373802|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153418661|NCT00373802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153418664|NCT02945150|Antiviral Agents|antiviral agents|mesh-ancestor
153418665|NCT02945150|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153418667|NCT03032965|Isoproterenol|isoproterenol|mesh-list
153418668|NCT03032965|Analgesics|analgesics|mesh-ancestor
153418669|NCT03032965|Sensory System Agents|sensory system agents|mesh-ancestor
153877880|NCT05293509|Dermatologic Agents|dermatologic agents|mesh-ancestor
153877881|NCT05293509|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153877882|NCT05293509|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
153877883|NCT05293509|Antitubercular Agents|antitubercular agents|mesh-ancestor
153877886|NCT05284643|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153877887|NCT05284643|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153877888|NCT05284643|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153877898|NCT05227937|Amikacin|amikacin|mesh-list
153877899|NCT05227937|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153877900|NCT05227937|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153877901|NCT05208879|Carotenoids|carotenoids|mesh-list
153877902|NCT05208879|Antioxidants|antioxidants|mesh-ancestor
153877903|NCT05208879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153877904|NCT05208879|Protective Agents|protective agents|mesh-ancestor
153877905|NCT05208879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153877906|NCT05201313|Lidocaine|lidocaine|mesh-list
153877907|NCT05201313|Mepivacaine|mepivacaine|mesh-list
153877908|NCT05201313|Anesthetics, Local|anesthetics, local|mesh-ancestor
153418682|NCT03032965|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153882118|NCT01603758|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153882119|NCT01603758|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153882120|NCT01603758|Antimetabolites|antimetabolites|mesh-ancestor
153882121|NCT01603758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153882122|NCT01603758|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153882123|NCT01177228|Vedolizumab|vedolizumab|mesh-list
153882124|NCT01177228|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153882125|NCT02279342|Febuxostat|febuxostat|mesh-list
153882126|NCT02279342|Gout Suppressants|gout suppressants|mesh-ancestor
153882127|NCT02279342|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153418683|NCT03032965|Autonomic Agents|autonomic agents|mesh-ancestor
153418684|NCT03032965|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153418685|NCT03032965|Respiratory System Agents|respiratory system agents|mesh-ancestor
153418686|NCT03032965|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
153418687|NCT03032965|Sympathomimetics|sympathomimetics|mesh-ancestor
153418688|NCT03032965|Protective Agents|protective agents|mesh-ancestor
153418689|NCT03030638|Olodaterol|olodaterol|mesh-list
153418690|NCT03030638|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153418691|NCT03030638|Autonomic Agents|autonomic agents|mesh-ancestor
153418692|NCT03030638|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153418693|NCT03030638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153418696|NCT02949674|Bupivacaine|bupivacaine|mesh-list
153418697|NCT02949674|Ropivacaine|ropivacaine|mesh-list
153418698|NCT02949674|Anesthetics, Local|anesthetics, local|mesh-ancestor
153418699|NCT02949674|Anesthetics|anesthetics|mesh-ancestor
153877909|NCT05201313|Anesthetics|anesthetics|mesh-ancestor
153877910|NCT05201313|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153877911|NCT05201313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153877912|NCT05201313|Sensory System Agents|sensory system agents|mesh-ancestor
153877913|NCT05201313|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153877914|NCT05201313|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153877915|NCT05201313|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
153877916|NCT05201313|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153877917|NCT05201313|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153877918|NCT05201313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153418701|NCT02949674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153418702|NCT02949674|Sensory System Agents|sensory system agents|mesh-ancestor
153418703|NCT02949674|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153418704|NCT03033511|Dexamethasone|dexamethasone|mesh-list
153418705|NCT03033511|Dexamethasone acetate|dexamethasone acetate|mesh-list
153418706|NCT03033511|BB 1101|bb 1101|mesh-list
153418707|NCT03033511|Rovalpituzumab tesirine|rovalpituzumab tesirine|mesh-list
153418708|NCT03033511|Immunoconjugates|immunoconjugates|mesh-list
153418709|NCT03033511|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153418710|NCT03033511|Antiemetics|antiemetics|mesh-ancestor
153418711|NCT03033511|Autonomic Agents|autonomic agents|mesh-ancestor
153418712|NCT03033511|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153418713|NCT03033511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153418714|NCT03033511|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153418715|NCT03033511|Glucocorticoids|glucocorticoids|mesh-ancestor
153877927|NCT05183412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153877928|NCT05183412|Sympathomimetics|sympathomimetics|mesh-ancestor
153877929|NCT05183412|Autonomic Agents|autonomic agents|mesh-ancestor
153877930|NCT05183412|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153877931|NCT05183412|Dopamine Agents|dopamine agents|mesh-ancestor
153418847|NCT02956616|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153418848|NCT02956616|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153418849|NCT02956616|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153418850|NCT02956616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153418851|NCT02958956|Pioglitazone|pioglitazone|mesh-list
153418852|NCT02958956|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153418853|NCT02958956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153418854|NCT05829551|Ritonavir|ritonavir|mesh-list
153418855|NCT05829551|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
153418856|NCT05829551|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
153418857|NCT05829551|Protease Inhibitors|protease inhibitors|mesh-ancestor
153545952|NCT06278779|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153545953|NCT06278779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153546034|NCT06263153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153546035|NCT06262932|Amiodarone|amiodarone|mesh-list
153546036|NCT06262932|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153546037|NCT06262932|Vasodilator Agents|vasodilator agents|mesh-ancestor
153546104|NCT06239389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153546106|NCT06233071|Drospirenone|drospirenone|mesh-list
153546175|NCT06207331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153546177|NCT06205381|Itraconazole|itraconazole|mesh-list
153546248|NCT06172296|Etoposide|etoposide|mesh-list
153423018|NCT02076217|Copper|copper|mesh-list
153546249|NCT06172296|Vincristine|vincristine|mesh-list
153546323|NCT06158620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153546396|NCT06108297|Lithium Carbonate|lithium carbonate|mesh-list
153546397|NCT06108297|Antidepressive Agents|antidepressive agents|mesh-ancestor
153546405|NCT06108063|Losartan|losartan|mesh-list
153546540|NCT06065735|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153546541|NCT06065735|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153546610|NCT06015477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153546611|NCT06015477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153546612|NCT06013319|Esmolol|esmolol|mesh-list
153546613|NCT06013319|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
153546614|NCT06013319|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
153546615|NCT06013319|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
153546616|NCT06013319|Adrenergic Agents|adrenergic agents|mesh-ancestor
153546617|NCT06013319|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153546618|NCT06013319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153546619|NCT06013319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153546620|NCT06012435|Docetaxel|docetaxel|mesh-list
153546621|NCT06012435|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153546622|NCT06012435|Tubulin Modulators|tubulin modulators|mesh-ancestor
153418958|NCT05827497|Immunologic Factors|immunologic factors|mesh-ancestor
153418959|NCT05827497|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153418960|NCT05827497|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153418961|NCT05827263|Salicylic Acid|salicylic acid|mesh-list
153418962|NCT05827263|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153418963|NCT05827263|Antifungal Agents|antifungal agents|mesh-ancestor
153878186|NCT04798755|Methotrexate|methotrexate|mesh-list
153878187|NCT04798755|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
153878188|NCT04798755|Abortifacient Agents|abortifacient agents|mesh-ancestor
153878189|NCT04798755|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153878190|NCT04798755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153418973|NCT05825443|Tubulin Modulators|tubulin modulators|mesh-ancestor
153878196|NCT04798755|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153878197|NCT04798755|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153878198|NCT04798755|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153878199|NCT04798755|Immunologic Factors|immunologic factors|mesh-ancestor
153878200|NCT04798755|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153878201|NCT04798755|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153878202|NCT04798755|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
153878203|NCT04798755|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153419009|NCT05774236|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153419010|NCT05774236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153475845|NCT00835224|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153419014|NCT05748587|Micronutrients|micronutrients|mesh-ancestor
153419015|NCT05748587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153419092|NCT05615311|Ergocalciferols|ergocalciferols|mesh-list
153419093|NCT05615311|Cholecalciferol|cholecalciferol|mesh-list
153878343|NCT04516447|Gemcitabine|gemcitabine|mesh-list
153878344|NCT04516447|Doxorubicin|doxorubicin|mesh-list
153878345|NCT04516447|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
153878346|NCT04516447|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153878347|NCT04516447|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153547173|NCT05726383|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153419523|NCT03469284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153419524|NCT03425331|Nivolumab|nivolumab|mesh-list
153419525|NCT03425331|Ipilimumab|ipilimumab|mesh-list
153547199|NCT05719883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153547200|NCT05718297|Durvalumab|durvalumab|mesh-list
153547201|NCT05718297|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153547202|NCT05718297|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153547203|NCT05706701|Nicotine|nicotine|mesh-list
153547204|NCT05706701|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
153878723|NCT03646175|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153878724|NCT03646175|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153878725|NCT03646175|Nootropic Agents|nootropic agents|mesh-ancestor
153419569|NCT03035890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153419570|NCT03004261|Ganciclovir|ganciclovir|mesh-list
153419571|NCT03004261|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
153419573|NCT03004261|Antiviral Agents|antiviral agents|mesh-ancestor
153878745|NCT03616886|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153878746|NCT03616886|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153419591|NCT02785952|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153419592|NCT02785952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153878773|NCT03562507|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153878774|NCT03562507|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153878775|NCT03562507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153547205|NCT05706701|Autonomic Agents|autonomic agents|mesh-ancestor
153547206|NCT05706701|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153547207|NCT05706701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153547208|NCT05706701|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
153547209|NCT05706701|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
153547210|NCT05706701|Cholinergic Agents|cholinergic agents|mesh-ancestor
153547211|NCT05706701|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153878783|NCT03534713|Carboplatin|carboplatin|mesh-list
153878784|NCT03534713|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153878785|NCT03534713|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153878786|NCT03534713|Tubulin Modulators|tubulin modulators|mesh-ancestor
153878787|NCT03534713|Antimitotic Agents|antimitotic agents|mesh-ancestor
153878788|NCT03534713|Mitosis Modulators|mitosis modulators|mesh-ancestor
153878789|NCT03534713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153878790|NCT03518203|Eculizumab|eculizumab|mesh-list
153878791|NCT03518203|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
153419593|NCT02443727|Oxytocin|oxytocin|mesh-list
153419594|NCT02443727|Oxytocics|oxytocics|mesh-ancestor
153419595|NCT02443727|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153419596|NCT02443727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153419597|NCT02429700|Paclitaxel|paclitaxel|mesh-list
153419601|NCT02429700|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153419602|NCT02429700|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153419603|NCT02429700|Tubulin Modulators|tubulin modulators|mesh-ancestor
153878798|NCT03493932|Nivolumab|nivolumab|mesh-list
153878799|NCT03493932|Relatlimab|relatlimab|mesh-list
153878800|NCT03493932|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153878801|NCT03493932|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153878802|NCT03493932|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153878803|NCT03493932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153878804|NCT03487809|Budesonide|budesonide|mesh-list
153419607|NCT02429700|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153419608|NCT02429700|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153419609|NCT02429700|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153419610|NCT02429700|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153419612|NCT02429687|Etoposide|etoposide|mesh-list
153419613|NCT02429687|Carboplatin|carboplatin|mesh-list
153419614|NCT02429687|Bleomycin|bleomycin|mesh-list
153419615|NCT02429687|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153419616|NCT02429687|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153419617|NCT02429687|Tubulin Modulators|tubulin modulators|mesh-ancestor
153419618|NCT02429687|Antimitotic Agents|antimitotic agents|mesh-ancestor
153419619|NCT02429687|Mitosis Modulators|mitosis modulators|mesh-ancestor
153461751|NCT03708588|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153878805|NCT03487809|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153878806|NCT03487809|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153878807|NCT03487809|Autonomic Agents|autonomic agents|mesh-ancestor
153878808|NCT03487809|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153882131|NCT02279381|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153878809|NCT03487809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153878810|NCT03487809|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153878811|NCT03487809|Respiratory System Agents|respiratory system agents|mesh-ancestor
153882132|NCT02279381|Disinfectants|disinfectants|mesh-ancestor
153878812|NCT03487809|Glucocorticoids|glucocorticoids|mesh-ancestor
153878813|NCT03487809|Hormones|hormones|mesh-ancestor
153878814|NCT03487809|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153878815|NCT03470922|Nivolumab|nivolumab|mesh-list
153878816|NCT03470922|Relatlimab|relatlimab|mesh-list
153878817|NCT03470922|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153419620|NCT02429687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153419621|NCT02429687|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153419622|NCT02429687|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153419623|NCT02429687|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153419624|NCT02429687|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153419625|NCT02194829|Paclitaxel|paclitaxel|mesh-list
153419626|NCT02194829|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
153419627|NCT02194829|Gemcitabine|gemcitabine|mesh-list
153419628|NCT02194829|Adavosertib|adavosertib|mesh-list
153419629|NCT02194829|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153419630|NCT02194829|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153878828|NCT03427814|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
153878830|NCT03427814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153419634|NCT02194829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153419636|NCT02194829|Antimetabolites|antimetabolites|mesh-ancestor
153419637|NCT02194829|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153419638|NCT01370460|Tranexamic Acid|tranexamic acid|mesh-list
153419639|NCT01370460|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
153419640|NCT01370460|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153419641|NCT01370460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153419642|NCT01370460|Hemostatics|hemostatics|mesh-ancestor
153419643|NCT01370460|Coagulants|coagulants|mesh-ancestor
153419644|NCT00621192|Meropenem|meropenem|mesh-list
153419645|NCT00621192|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153419646|NCT00621192|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153419647|NCT00255346|Dasatinib|dasatinib|mesh-list
153419648|NCT00255346|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153419649|NCT00255346|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153419650|NCT00255346|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153878831|NCT03427814|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153878832|NCT03380559|Botulinum Toxins|botulinum toxins|mesh-list
153878833|NCT03380559|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
153878834|NCT03380559|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153878835|NCT03380559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153878836|NCT03380559|Cholinergic Agents|cholinergic agents|mesh-ancestor
153878837|NCT03380559|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153878838|NCT03380559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153878839|NCT03379909|Metformin|metformin|mesh-list
153878840|NCT03379909|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153878841|NCT03379909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153878842|NCT03368664|Interferons|interferons|mesh-list
153878843|NCT03368664|Acyclovir|acyclovir|mesh-list
153878844|NCT03368664|Interferon-beta|interferon-beta|mesh-list
153878845|NCT03368664|Methylprednisolone|methylprednisolone|mesh-list
153878846|NCT03368664|Prednisolone|prednisolone|mesh-list
153878847|NCT03368664|Alemtuzumab|alemtuzumab|mesh-list
153878848|NCT03368664|Glatiramer Acetate|glatiramer acetate|mesh-list
153878849|NCT03368664|Ranitidine|ranitidine|mesh-list
153878850|NCT03368664|(T,G)-A-L|(t,g)-a-l|mesh-list
153419653|NCT02834624|Poractant alfa|poractant alfa|mesh-list
153419654|NCT02834624|Calfactant|calfactant|mesh-list
153419655|NCT02834624|Pulmonary Surfactants|pulmonary surfactants|mesh-ancestor
153419656|NCT02834624|Respiratory System Agents|respiratory system agents|mesh-ancestor
153419657|NCT02837744|Hemostatics|hemostatics|mesh-list
153419658|NCT02837744|Coagulants|coagulants|mesh-ancestor
153419659|NCT02918617|Fluorides|fluorides|mesh-list
153419660|NCT02918617|Cariostatic Agents|cariostatic agents|mesh-ancestor
153419661|NCT02918617|Protective Agents|protective agents|mesh-ancestor
153419662|NCT02918617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153419663|NCT02839772|Glycerol|glycerol|mesh-list
153878864|NCT03368664|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
153878865|NCT03368664|Protective Agents|protective agents|mesh-ancestor
153878866|NCT03368664|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153419671|NCT03043105|Thalidomide|thalidomide|mesh-list
153419672|NCT03043105|Prednisone|prednisone|mesh-list
153419673|NCT03043105|Cyclophosphamide|cyclophosphamide|mesh-list
153547213|NCT05687058|Empagliflozin|empagliflozin|mesh-list
153547214|NCT05687058|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
153547215|NCT05687058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153878867|NCT03368664|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153878868|NCT03368664|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153878869|NCT03368664|Immunologic Factors|immunologic factors|mesh-ancestor
153878870|NCT03368664|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153878871|NCT03368664|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153878872|NCT03368664|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
153878873|NCT03368664|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
153878874|NCT03368664|Histamine Antagonists|histamine antagonists|mesh-ancestor
153878875|NCT03368664|Histamine Agents|histamine agents|mesh-ancestor
153878876|NCT03368664|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153878877|NCT03368664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153878878|NCT03368664|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
153878880|NCT03343054|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
153878881|NCT03343054|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153878882|NCT03343054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153878883|NCT03343054|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153878884|NCT03339596|Epoetin Alfa|epoetin alfa|mesh-list
153878885|NCT03339596|Hematinics|hematinics|mesh-ancestor
153878886|NCT03322358|Diphenhydramine|diphenhydramine|mesh-list
153878887|NCT03322358|Promethazine|promethazine|mesh-list
153878888|NCT03322358|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
153878889|NCT03322358|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153419695|NCT00374647|Mycophenolic Acid|mycophenolic acid|mesh-list
153419697|NCT00374647|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153419698|NCT00374647|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153419699|NCT00374647|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
153419700|NCT00374647|Antitubercular Agents|antitubercular agents|mesh-ancestor
153878897|NCT03322358|Autonomic Agents|autonomic agents|mesh-ancestor
153878898|NCT03322358|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153878899|NCT03322358|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
153878900|NCT03322358|Histamine Antagonists|histamine antagonists|mesh-ancestor
153878901|NCT03322358|Histamine Agents|histamine agents|mesh-ancestor
153878902|NCT03322358|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153419708|NCT00374647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153419709|NCT02964416|Tramadol|tramadol|mesh-list
153419710|NCT02964416|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153419711|NCT02964416|Narcotics|narcotics|mesh-ancestor
153419712|NCT02964416|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153419713|NCT02964416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153419714|NCT02964416|Analgesics|analgesics|mesh-ancestor
153419715|NCT02964416|Sensory System Agents|sensory system agents|mesh-ancestor
153419716|NCT02964416|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153419717|NCT02812771|Efinaconazole|efinaconazole|mesh-list
153419718|NCT02812771|Antifungal Agents|antifungal agents|mesh-ancestor
153419719|NCT02812771|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153419720|NCT02969876|Vortioxetine|vortioxetine|mesh-list
153419721|NCT02969876|Antidepressive Agents|antidepressive agents|mesh-ancestor
153419722|NCT02969876|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153419723|NCT02969876|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153419724|NCT02969876|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153878903|NCT03322358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153878904|NCT03322358|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
153878905|NCT03322358|Antipruritics|antipruritics|mesh-ancestor
153878906|NCT03322358|Dermatologic Agents|dermatologic agents|mesh-ancestor
153878907|NCT03309878|Pembrolizumab|pembrolizumab|mesh-list
153878908|NCT03309878|Mogamulizumab|mogamulizumab|mesh-list
153878909|NCT03309878|Immunoglobulins|immunoglobulins|mesh-list
153878910|NCT03309878|Immunoglobulin G|immunoglobulin g|mesh-list
153878911|NCT03309878|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153878912|NCT03309878|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153878913|NCT03309878|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153878914|NCT03309878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153878915|NCT03309878|Immunologic Factors|immunologic factors|mesh-ancestor
153878916|NCT03309878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153878917|NCT03298295|Insulin|insulin|mesh-list
153878918|NCT03298295|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153419725|NCT02969876|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153419726|NCT02969876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153419774|NCT03054103|Analgesics|analgesics|mesh-ancestor
153419775|NCT03054103|Sensory System Agents|sensory system agents|mesh-ancestor
153419776|NCT03054103|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153419777|NCT03054103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153419778|NCT03054103|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
153419779|NCT03054103|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153419780|NCT03054103|Anesthetics, General|anesthetics, general|mesh-ancestor
153547225|NCT05671757|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153419795|NCT03043274|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153419796|NCT03043274|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
153419797|NCT03043274|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
153419798|NCT03043274|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
153419799|NCT03043274|Purinergic Agents|purinergic agents|mesh-ancestor
153419800|NCT03043274|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153419801|NCT03043274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153419803|NCT03054805|Magnesium Oxide|magnesium oxide|mesh-list
153419805|NCT03054805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153419806|NCT03054805|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153419807|NCT00374101|Omeprazole|omeprazole|mesh-list
153419808|NCT00374101|Pantoprazole|pantoprazole|mesh-list
153419809|NCT00374101|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
153419810|NCT00374101|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153419811|NCT00374101|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
153419812|NCT00374101|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153461752|NCT03708588|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
153419813|NCT00374101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153419814|NCT00373789|Botulinum Toxins|botulinum toxins|mesh-list
153547231|NCT05661201|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153547233|NCT05661201|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153547234|NCT05661201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153547235|NCT05658003|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
153879045|NCT06080854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153879046|NCT06080854|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153879047|NCT06080854|Antimetabolites|antimetabolites|mesh-ancestor
153879048|NCT06080841|Curcumin|curcumin|mesh-list
153879049|NCT06080841|Piperine|piperine|mesh-list
153879050|NCT06080841|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153879051|NCT06080841|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153879052|NCT06080841|Analgesics|analgesics|mesh-ancestor
153879053|NCT06080841|Sensory System Agents|sensory system agents|mesh-ancestor
153879054|NCT06080841|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153879055|NCT06080841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153879056|NCT06080841|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153879057|NCT06080841|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153879058|NCT06080841|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153879059|NCT06080841|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153879060|NCT06080841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153879061|NCT06080841|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153879062|NCT06080802|Metformin|metformin|mesh-list
153879063|NCT06080802|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153879066|NCT06080724|Bleomycin|bleomycin|mesh-list
153879067|NCT06080724|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153879068|NCT06080724|Antiemetics|antiemetics|mesh-ancestor
153879069|NCT06080724|Autonomic Agents|autonomic agents|mesh-ancestor
153879070|NCT06080724|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153879071|NCT06080724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153879072|NCT06080724|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153879073|NCT06080724|Glucocorticoids|glucocorticoids|mesh-ancestor
153879074|NCT06080724|Hormones|hormones|mesh-ancestor
153879075|NCT06080724|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153879076|NCT06080724|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153879077|NCT06080724|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153879078|NCT06080724|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153879079|NCT06080490|Tacrolimus|tacrolimus|mesh-list
153879080|NCT06080490|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153879081|NCT06080490|Immunologic Factors|immunologic factors|mesh-ancestor
153879082|NCT06080490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153879083|NCT06080490|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
153879084|NCT06080490|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153879085|NCT06080490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153879086|NCT06080438|Botulinum Toxins|botulinum toxins|mesh-list
153879087|NCT06080438|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
153879088|NCT06080438|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153419892|NCT02988986|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153419893|NCT02988986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153419894|NCT02988986|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153419895|NCT02988986|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153879089|NCT06080438|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153879090|NCT06080438|Cholinergic Agents|cholinergic agents|mesh-ancestor
153879091|NCT06080438|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153879092|NCT06080438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153879093|NCT06080256|Atorvastatin|atorvastatin|mesh-list
153879095|NCT06080256|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153879096|NCT06080256|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153879097|NCT06080256|Antimetabolites|antimetabolites|mesh-ancestor
153879098|NCT06080256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153879099|NCT06080256|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153879100|NCT06080256|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
153879101|NCT06080256|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153879102|NCT06080256|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
153879103|NCT06080256|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
153419907|NCT02832115|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153419908|NCT02832115|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
153419909|NCT02832115|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153419910|NCT02832115|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153419911|NCT02832115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153419912|NCT02832115|Vasodilator Agents|vasodilator agents|mesh-ancestor
153419913|NCT03054506|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
153419914|NCT03054506|Laxatives|laxatives|mesh-ancestor
153419915|NCT03054506|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153419916|NCT02935699|Diphenhydramine|diphenhydramine|mesh-list
153419917|NCT02935699|Promethazine|promethazine|mesh-list
153419918|NCT02935699|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
153419919|NCT02935699|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153879104|NCT06080256|Protease Inhibitors|protease inhibitors|mesh-ancestor
153879105|NCT06079996|Caffeine|caffeine|mesh-list
153879106|NCT06079996|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
153879107|NCT06079996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153879108|NCT06079996|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
153879109|NCT06079996|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153879110|NCT06079996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153879111|NCT06079996|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
153879112|NCT06079996|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
153879113|NCT06079996|Purinergic Agents|purinergic agents|mesh-ancestor
153879114|NCT06079996|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153879116|NCT06079983|Vinorelbine|vinorelbine|mesh-list
153879117|NCT06079983|Docetaxel|docetaxel|mesh-list
153419920|NCT02935699|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153419921|NCT02935699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153419923|NCT02935699|Anesthetics|anesthetics|mesh-ancestor
153419924|NCT02935699|Sensory System Agents|sensory system agents|mesh-ancestor
153879130|NCT06079788|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153879131|NCT06079788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153879132|NCT06079606|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
153419974|NCT00374881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153419975|NCT00374881|Protective Agents|protective agents|mesh-ancestor
153419976|NCT00374881|Cathartics|cathartics|mesh-ancestor
153419977|NCT00374881|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153419978|NCT00374959|Ceftriaxone|ceftriaxone|mesh-list
153879139|NCT06079333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153879140|NCT06078995|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
153879141|NCT06078995|Tenecteplase|tenecteplase|mesh-list
153879174|NCT06078787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153879175|NCT06078787|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153879176|NCT06078696|Sirolimus|sirolimus|mesh-list
153879177|NCT06078696|Cyclophosphamide|cyclophosphamide|mesh-list
153879178|NCT06078696|Rituximab|rituximab|mesh-list
153879179|NCT06078696|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153879180|NCT06078696|Immunologic Factors|immunologic factors|mesh-ancestor
153879181|NCT06078696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153879182|NCT06078696|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153879183|NCT06078696|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153423025|NCT02076217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153423026|NCT02076217|Trace Elements|trace elements|mesh-ancestor
153423027|NCT02076217|Micronutrients|micronutrients|mesh-ancestor
153879184|NCT06078696|Alkylating Agents|alkylating agents|mesh-ancestor
153420075|NCT03057704|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
153420076|NCT03057704|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153420077|NCT03057704|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153420078|NCT03057704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153420080|NCT02874092|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153420081|NCT02874092|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
153879284|NCT05943821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153420092|NCT02876900|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153420093|NCT02876900|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153420094|NCT02876900|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153420095|NCT02876900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153420096|NCT02876900|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153420097|NCT02878382|Calcipotriene|calcipotriene|mesh-list
153420098|NCT02878382|Dermatologic Agents|dermatologic agents|mesh-ancestor
153420099|NCT03117140|Dexamethasone|dexamethasone|mesh-list
153420100|NCT03117140|Clonidine|clonidine|mesh-list
153420101|NCT03117140|Buprenorphine|buprenorphine|mesh-list
153420102|NCT03117140|Ropivacaine|ropivacaine|mesh-list
153420103|NCT03117140|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153420104|NCT03117140|Antiemetics|antiemetics|mesh-ancestor
153420105|NCT03117140|Autonomic Agents|autonomic agents|mesh-ancestor
153420106|NCT03117140|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153420107|NCT03117140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153420108|NCT03117140|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153420109|NCT03117140|Glucocorticoids|glucocorticoids|mesh-ancestor
153420110|NCT03117140|Hormones|hormones|mesh-ancestor
153420111|NCT03117140|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153879285|NCT05878951|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
153879286|NCT05878951|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
153879287|NCT05878951|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
153879288|NCT05878951|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153547240|NCT05655754|Anesthetics, General|anesthetics, general|mesh-ancestor
153547242|NCT05655754|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153782504|NCT00267813|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153547243|NCT05655754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153547244|NCT05655182|Vaccines|vaccines|mesh-list
153547245|NCT05655182|Immunologic Factors|immunologic factors|mesh-ancestor
153879296|NCT05837806|Disitamab vedotin|disitamab vedotin|mesh-list
153879297|NCT05837806|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153879298|NCT05837806|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153879299|NCT05837806|Immunoconjugates|immunoconjugates|mesh-ancestor
153879300|NCT05837806|Immunologic Factors|immunologic factors|mesh-ancestor
153879301|NCT05837806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153879302|NCT05827874|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
153420112|NCT03117140|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153420113|NCT03117140|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153420114|NCT03117140|Anesthetics, Local|anesthetics, local|mesh-ancestor
153420115|NCT03117140|Anesthetics|anesthetics|mesh-ancestor
153420116|NCT03117140|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153420117|NCT03117140|Sensory System Agents|sensory system agents|mesh-ancestor
153420118|NCT03117140|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153420119|NCT03117140|Narcotics|narcotics|mesh-ancestor
153420120|NCT03117140|Analgesics|analgesics|mesh-ancestor
153420121|NCT03117140|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
153420122|NCT03117140|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153420123|NCT03117140|Sympatholytics|sympatholytics|mesh-ancestor
153420124|NCT03117140|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
153420125|NCT03117140|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153420126|NCT03117140|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153420127|NCT03117140|Adrenergic Agents|adrenergic agents|mesh-ancestor
153420128|NCT03117140|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153879303|NCT05827874|Immunologic Factors|immunologic factors|mesh-ancestor
153879304|NCT05827874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153879305|NCT05824728|Levetiracetam|levetiracetam|mesh-list
153879306|NCT05824728|Anticonvulsants|anticonvulsants|mesh-ancestor
153420129|NCT03117140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153420130|NCT03118466|Cytarabine|cytarabine|mesh-list
153420131|NCT03118466|Etoposide|etoposide|mesh-list
153420132|NCT03118466|Mitoxantrone|mitoxantrone|mesh-list
153420133|NCT03118466|Lenalidomide|lenalidomide|mesh-list
153420134|NCT03118466|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153420135|NCT03118466|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153420136|NCT03118466|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153420137|NCT03118466|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153420138|NCT03118466|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153420139|NCT03118466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153420140|NCT03118466|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153420141|NCT03118466|Antimetabolites|antimetabolites|mesh-ancestor
153420142|NCT03118466|Antiviral Agents|antiviral agents|mesh-ancestor
153420143|NCT03118466|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153420205|NCT03123614|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153420206|NCT03123614|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153420207|NCT03123614|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
153420208|NCT03123614|Protective Agents|protective agents|mesh-ancestor
153420209|NCT03123614|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
153879378|NCT05509257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153879379|NCT05509257|Sensory System Agents|sensory system agents|mesh-ancestor
153879380|NCT05509257|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153879381|NCT05507541|Pembrolizumab|pembrolizumab|mesh-list
153879382|NCT05507541|Immunoglobulin G|immunoglobulin g|mesh-list
153879383|NCT05507541|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153879384|NCT05507541|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153879385|NCT05507541|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153879386|NCT05507541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153879387|NCT05507541|Immunologic Factors|immunologic factors|mesh-ancestor
153879388|NCT05507541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153879389|NCT05463965|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
153879390|NCT05463965|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
153879391|NCT05463965|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
153879392|NCT05463965|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153879393|NCT05463965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153420210|NCT03123848|Darunavir|darunavir|mesh-list
153420211|NCT03123848|Cobicistat|cobicistat|mesh-list
153420212|NCT03123848|Cobicistat mixture with darunavir|cobicistat mixture with darunavir|mesh-list
153420213|NCT03123848|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
153547249|NCT05652400|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153547250|NCT05636592|Immunomodulating Agents|immunomodulating agents|mesh-list
153879394|NCT05463965|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
153879395|NCT05463965|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153879396|NCT05463965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153879397|NCT05463965|Cholinergic Agents|cholinergic agents|mesh-ancestor
153879398|NCT05463965|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153879400|NCT05395091|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153879401|NCT05395091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153879402|NCT05387759|Moxifloxacin|moxifloxacin|mesh-list
153879403|NCT05387759|Aticaprant|aticaprant|mesh-list
153879404|NCT05387759|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153879405|NCT05387759|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153879406|NCT05387759|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153879407|NCT05387759|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153879408|NCT05387759|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153420226|NCT02946073|Narcotics|narcotics|mesh-ancestor
153420227|NCT02946073|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153420228|NCT02946073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153420229|NCT02946073|Analgesics|analgesics|mesh-ancestor
153420230|NCT02946073|Sensory System Agents|sensory system agents|mesh-ancestor
153420231|NCT02946073|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153420232|NCT02946073|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
153420233|NCT03071744|Fentanyl|fentanyl|mesh-list
153420234|NCT03071744|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153420235|NCT03071744|Narcotics|narcotics|mesh-ancestor
153547252|NCT05636592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153547253|NCT05636111|Paclitaxel|paclitaxel|mesh-list
153547254|NCT05636111|Bevacizumab|bevacizumab|mesh-list
153547255|NCT05636111|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153547256|NCT05636111|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153547257|NCT05636111|Tubulin Modulators|tubulin modulators|mesh-ancestor
153547258|NCT05636111|Antimitotic Agents|antimitotic agents|mesh-ancestor
153547259|NCT05636111|Mitosis Modulators|mitosis modulators|mesh-ancestor
153547260|NCT05636111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153547261|NCT05636111|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153547262|NCT05636111|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153547263|NCT05636111|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153547264|NCT05636111|Growth Substances|growth substances|mesh-ancestor
153879409|NCT05387759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153879410|NCT05387759|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153879412|NCT05387759|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
153879413|NCT05387759|Sensory System Agents|sensory system agents|mesh-ancestor
153879414|NCT05387759|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153879416|NCT05373186|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153420236|NCT03071744|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153420237|NCT03071744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153420238|NCT03071744|Analgesics|analgesics|mesh-ancestor
153420239|NCT03071744|Sensory System Agents|sensory system agents|mesh-ancestor
153420240|NCT03071744|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153420241|NCT03071744|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153420242|NCT03071744|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153420243|NCT03071744|Anesthetics, General|anesthetics, general|mesh-ancestor
153420244|NCT03071744|Anesthetics|anesthetics|mesh-ancestor
153420245|NCT03074630|Dapagliflozin|dapagliflozin|mesh-list
153420246|NCT03074630|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
153420247|NCT03074630|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153420248|NCT03074630|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153879423|NCT05314933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153879424|NCT05314933|Antiviral Agents|antiviral agents|mesh-ancestor
153879425|NCT05314933|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153879427|NCT05309187|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153879428|NCT05309187|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153879429|NCT05309187|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153879430|NCT05309187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153879433|NCT05223010|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
153879434|NCT05223010|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153879435|NCT05223010|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
153420256|NCT03074630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153420257|NCT05404334|Androgens|androgens|mesh-list
153420258|NCT05404334|Hormones|hormones|mesh-ancestor
153420259|NCT05404334|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153420260|NCT05404334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153420261|NCT00374894|Succimer|succimer|mesh-list
153420262|NCT00374894|Antidotes|antidotes|mesh-ancestor
153420263|NCT00374894|Protective Agents|protective agents|mesh-ancestor
153420264|NCT00374894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153420265|NCT00374894|Chelating Agents|chelating agents|mesh-ancestor
153420266|NCT00374894|Sequestering Agents|sequestering agents|mesh-ancestor
153420267|NCT00374894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153420268|NCT03088267|Amphetamine|amphetamine|mesh-list
153420269|NCT03088267|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
153420270|NCT03088267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153420271|NCT03088267|Sympathomimetics|sympathomimetics|mesh-ancestor
153420272|NCT03088267|Autonomic Agents|autonomic agents|mesh-ancestor
153420273|NCT03088267|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153420274|NCT03088267|Dopamine Agents|dopamine agents|mesh-ancestor
153420275|NCT03088267|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153420276|NCT03088267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153420277|NCT03088267|Adrenergic Agents|adrenergic agents|mesh-ancestor
153420278|NCT03088267|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
153420279|NCT03088267|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153879436|NCT05223010|Anesthetics, General|anesthetics, general|mesh-ancestor
153879437|NCT05223010|Anesthetics|anesthetics|mesh-ancestor
153879438|NCT05223010|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153879439|NCT05223010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153547266|NCT05636111|Growth Inhibitors|growth inhibitors|mesh-ancestor
153547268|NCT05634057|Heparin|heparin|mesh-list
153547269|NCT05634057|Anticoagulants|anticoagulants|mesh-ancestor
153547270|NCT05634057|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153547271|NCT05634057|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153411126|NCT00004941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153547272|NCT05634057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153547273|NCT05634057|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153374327|NCT01868633|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153374328|NCT01868633|Glucocorticoids|glucocorticoids|mesh-ancestor
153374329|NCT01868633|Hormones|hormones|mesh-ancestor
153547274|NCT05634057|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153547275|NCT05634057|Adrenergic Agents|adrenergic agents|mesh-ancestor
153547276|NCT05634057|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153547277|NCT05634057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153879457|NCT05169554|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153879458|NCT05169554|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
153879459|NCT05169554|Antitubercular Agents|antitubercular agents|mesh-ancestor
153879460|NCT05169554|Leprostatic Agents|leprostatic agents|mesh-ancestor
153420280|NCT03088267|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153420281|NCT03088267|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
153420282|NCT03088345|Vasopressins|vasopressins|mesh-list
153420283|NCT03088345|Arginine Vasopressin|arginine vasopressin|mesh-list
153420284|NCT03088345|Hemostatics|hemostatics|mesh-ancestor
153420285|NCT03088345|Coagulants|coagulants|mesh-ancestor
153420286|NCT03088345|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
153420287|NCT03088345|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
153420288|NCT03088345|Natriuretic Agents|natriuretic agents|mesh-ancestor
153420289|NCT03088345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153420290|NCT03127514|4-phenylbutyric acid|4-phenylbutyric acid|mesh-list
153420291|NCT03127514|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153420292|NCT02858713|Betamethasone|betamethasone|mesh-list
153879461|NCT05169554|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153879462|NCT05169554|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
153879463|NCT05169554|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
153879464|NCT05169554|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
153879465|NCT05169554|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
153879466|NCT05169554|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
153879467|NCT05169554|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
153879468|NCT05169554|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
153879469|NCT05154994|Durvalumab|durvalumab|mesh-list
153879470|NCT05154994|Belinostat|belinostat|mesh-list
153879471|NCT05154994|Immunoglobulins|immunoglobulins|mesh-list
153420293|NCT02858713|Betamethasone Valerate|betamethasone valerate|mesh-list
153420294|NCT02858713|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
153420295|NCT02858713|Betamethasone benzoate|betamethasone benzoate|mesh-list
153420296|NCT02858713|Calcipotriene|calcipotriene|mesh-list
153420297|NCT02858713|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
153420298|NCT02858713|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153420299|NCT02858713|Glucocorticoids|glucocorticoids|mesh-ancestor
153420300|NCT02858713|Hormones|hormones|mesh-ancestor
153420301|NCT02858713|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153879478|NCT05154994|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
153879480|NCT05154994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153420302|NCT02858713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153420303|NCT02858713|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153420304|NCT02858713|Respiratory System Agents|respiratory system agents|mesh-ancestor
153420305|NCT02858713|Dermatologic Agents|dermatologic agents|mesh-ancestor
153420307|NCT00375050|Anticonvulsants|anticonvulsants|mesh-ancestor
153420308|NCT00375050|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
153420309|NCT00375050|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
153420310|NCT00375050|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153420311|NCT00375050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153420312|NCT00375050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153547278|NCT05634057|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153547279|NCT05634057|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153547280|NCT05634057|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153547282|NCT05634057|Sensory System Agents|sensory system agents|mesh-ancestor
153547283|NCT05634057|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153547284|NCT05634057|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153547285|NCT05634057|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153879482|NCT05112952|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153879483|NCT05112952|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153879484|NCT05112952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153879485|NCT05101356|Pembrolizumab|pembrolizumab|mesh-list
153879486|NCT05101356|Antineoplastic Agents|antineoplastic agents|mesh-list
153879487|NCT05101356|Vaccines|vaccines|mesh-list
153879508|NCT04867798|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153879509|NCT04867798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153879510|NCT04867798|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153879511|NCT04867798|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153879512|NCT04852224|Leuprolide|leuprolide|mesh-list
153879513|NCT04852224|Goserelin|goserelin|mesh-list
153420352|NCT02953561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153420353|NCT02953561|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153420354|NCT02953561|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153420355|NCT02953561|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153420356|NCT02953561|Immunologic Factors|immunologic factors|mesh-ancestor
153420357|NCT02953561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153420359|NCT03090620|Physostigmine|physostigmine|mesh-list
153420360|NCT03090620|Anticonvulsants|anticonvulsants|mesh-ancestor
153420361|NCT03090620|Antiemetics|antiemetics|mesh-ancestor
153420362|NCT03090620|Autonomic Agents|autonomic agents|mesh-ancestor
153420363|NCT03090620|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153420364|NCT03090620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153879526|NCT04833114|Ifosfamide|ifosfamide|mesh-list
153879527|NCT04833114|Polatuzumab vedotin|polatuzumab vedotin|mesh-list
153879528|NCT04833114|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153879529|NCT04833114|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153879530|NCT04833114|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153879531|NCT04833114|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153879532|NCT04833114|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153879533|NCT04833114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153879534|NCT04833114|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153879535|NCT04833114|Immunologic Factors|immunologic factors|mesh-ancestor
153879536|NCT04833114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153879537|NCT04833114|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153879539|NCT04833114|Alkylating Agents|alkylating agents|mesh-ancestor
153879540|NCT04833114|Immunoconjugates|immunoconjugates|mesh-ancestor
153879541|NCT04812535|Pembrolizumab|pembrolizumab|mesh-list
153879542|NCT04812535|Vilobelimab|vilobelimab|mesh-list
153420365|NCT03090620|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153420366|NCT03090620|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153420367|NCT03090620|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153420368|NCT03090620|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153879635|NCT04640779|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153879636|NCT04640779|Analgesics|analgesics|mesh-ancestor
153879637|NCT04640779|Sensory System Agents|sensory system agents|mesh-ancestor
153879638|NCT04640779|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153879639|NCT04640779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153420467|NCT02957305|Misoprostol|misoprostol|mesh-list
153547303|NCT05614089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153420468|NCT02957305|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
153420469|NCT02957305|Abortifacient Agents|abortifacient agents|mesh-ancestor
153420470|NCT02957305|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153420471|NCT02957305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153420472|NCT02957305|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
153420473|NCT02957305|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153420474|NCT02957305|Oxytocics|oxytocics|mesh-ancestor
153420475|NCT03104725|Acetylcysteine|acetylcysteine|mesh-list
153882170|NCT01607580|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
153882171|NCT01607580|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
153420476|NCT03104725|N-monoacetylcystine|n-monoacetylcystine|mesh-list
153420477|NCT03104725|Antiviral Agents|antiviral agents|mesh-ancestor
153420478|NCT03104725|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153420479|NCT03104725|Expectorants|expectorants|mesh-ancestor
153420480|NCT03104725|Respiratory System Agents|respiratory system agents|mesh-ancestor
153420481|NCT03104725|Free Radical Scavengers|free radical scavengers|mesh-ancestor
153420482|NCT03104725|Antioxidants|antioxidants|mesh-ancestor
153420483|NCT03104725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153420484|NCT03104725|Protective Agents|protective agents|mesh-ancestor
153420485|NCT03104725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153879640|NCT04640779|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153879641|NCT04640779|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153879642|NCT04640779|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153879643|NCT04640779|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153879644|NCT04598321|Talazoparib|talazoparib|mesh-list
153879645|NCT04598321|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
153879646|NCT04598321|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153879656|NCT04471233|Analgesics|analgesics|mesh-ancestor
153879657|NCT04471233|Sensory System Agents|sensory system agents|mesh-ancestor
153879658|NCT04471233|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153420486|NCT03104725|Antidotes|antidotes|mesh-ancestor
153420487|NCT03154658|Ropivacaine|ropivacaine|mesh-list
153420488|NCT03154658|Anesthetics, Local|anesthetics, local|mesh-ancestor
153420489|NCT03154658|Anesthetics|anesthetics|mesh-ancestor
153420490|NCT03154658|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153420491|NCT03154658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153420492|NCT03154658|Sensory System Agents|sensory system agents|mesh-ancestor
153420493|NCT03154658|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153420494|NCT03098420|Dexamethasone|dexamethasone|mesh-list
153420495|NCT03098420|Dexamethasone acetate|dexamethasone acetate|mesh-list
153420496|NCT03098420|Morphine|morphine|mesh-list
153879659|NCT04471233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153879660|NCT04471233|Anticonvulsants|anticonvulsants|mesh-ancestor
153879661|NCT04471233|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153879662|NCT04471233|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153879663|NCT04471233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153879664|NCT04471233|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153879665|NCT04471233|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153879666|NCT04471233|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153420499|NCT03098420|BB 1101|bb 1101|mesh-list
153420500|NCT03098420|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153420501|NCT03098420|Antiemetics|antiemetics|mesh-ancestor
153420502|NCT03098420|Autonomic Agents|autonomic agents|mesh-ancestor
153420503|NCT03098420|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153420504|NCT03098420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153420514|NCT03098420|Anesthetics, Local|anesthetics, local|mesh-ancestor
153879667|NCT04471233|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153879668|NCT04471233|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153879669|NCT04445571|Pulmonary Surfactants|pulmonary surfactants|mesh-list
153879670|NCT04445571|Respiratory System Agents|respiratory system agents|mesh-ancestor
153879671|NCT04401267|Antihypertensive Agents|antihypertensive agents|mesh-list
153879672|NCT04370509|Pembrolizumab|pembrolizumab|mesh-list
153879674|NCT04370509|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153879675|NCT04370509|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153879676|NCT04370509|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153879677|NCT04370509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153879678|NCT04370509|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153879679|NCT04370509|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153879680|NCT04312659|Infliximab|infliximab|mesh-list
153879681|NCT04312659|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
153879682|NCT04312659|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153879684|NCT04312659|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153420516|NCT03098420|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153420517|NCT03098420|Sensory System Agents|sensory system agents|mesh-ancestor
153420518|NCT03098420|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153420520|NCT03098420|Analgesics|analgesics|mesh-ancestor
153420521|NCT02878057|Apatinib|apatinib|mesh-list
153420522|NCT02878057|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153420523|NCT02878057|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153420524|NCT02878057|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153420525|NCT02878057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153420526|NCT00422617|Alefacept|alefacept|mesh-list
153420527|NCT00422617|Dermatologic Agents|dermatologic agents|mesh-ancestor
153547315|NCT05604222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153547316|NCT05604222|Urological Agents|urological agents|mesh-ancestor
153547317|NCT05602207|Abrocitinib|abrocitinib|mesh-list
153547318|NCT05602207|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153782505|NCT00234026|Gemcitabine|gemcitabine|mesh-list
153547319|NCT05602207|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153547320|NCT05602207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153547321|NCT05601973|Amivantamab-vmjw|amivantamab-vmjw|mesh-list
153547322|NCT05601973|Lazertinib|lazertinib|mesh-list
153879685|NCT04312659|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153879686|NCT04245397|Decitabine|decitabine|mesh-list
153879687|NCT04245397|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153879688|NCT04245397|Antimetabolites|antimetabolites|mesh-ancestor
153879689|NCT04245397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153879690|NCT04245397|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153879691|NCT04245397|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153879692|NCT04151342|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-list
153879700|NCT04116112|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
153879701|NCT04116112|Adrenergic Agents|adrenergic agents|mesh-ancestor
153547323|NCT05601973|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153547324|NCT05601973|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153547325|NCT05601973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153547326|NCT05601973|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153547327|NCT05601973|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153547328|NCT05598567|Anesthetics|anesthetics|mesh-list
153547329|NCT05598567|Sevoflurane|sevoflurane|mesh-list
153547330|NCT05598567|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153547331|NCT05598567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153879702|NCT04116112|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153879703|NCT04116112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153879704|NCT04116112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153879705|NCT04116112|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153879706|NCT04116112|Sympathomimetics|sympathomimetics|mesh-ancestor
153879707|NCT04116112|Autonomic Agents|autonomic agents|mesh-ancestor
153879708|NCT04116112|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153879709|NCT04116112|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
153879710|NCT04116112|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
153879711|NCT04116112|Vasodilator Agents|vasodilator agents|mesh-ancestor
153879712|NCT04116112|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153879713|NCT04116112|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153879714|NCT04116112|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153879715|NCT04077684|Interleukin-2|interleukin-2|mesh-list
153879716|NCT04077684|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153879717|NCT04077684|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153879718|NCT04077684|Analgesics|analgesics|mesh-ancestor
153879719|NCT04077684|Sensory System Agents|sensory system agents|mesh-ancestor
153420554|NCT04468568|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153420577|NCT03109015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153420578|NCT03109015|Growth Inhibitors|growth inhibitors|mesh-ancestor
153420579|NCT03109015|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153420580|NCT03109015|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153879751|NCT03927690|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153879753|NCT03833921|Abiraterone Acetate|abiraterone acetate|mesh-list
153879754|NCT03833921|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153879755|NCT03833921|Glucocorticoids|glucocorticoids|mesh-ancestor
153879756|NCT03833921|Hormones|hormones|mesh-ancestor
153879757|NCT03833921|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153879758|NCT03833921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153879759|NCT03833921|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153879760|NCT03833921|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153879761|NCT03833921|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153879762|NCT03833921|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153879763|NCT03833921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153879764|NCT03833921|Hormone Antagonists|hormone antagonists|mesh-ancestor
153879765|NCT03833921|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153879766|NCT03821246|Atezolizumab|atezolizumab|mesh-list
153879767|NCT03821246|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
153879768|NCT03821246|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153879769|NCT03821246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153420667|NCT02222922|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153420669|NCT02222922|Antifungal Agents|antifungal agents|mesh-ancestor
153420670|NCT02222922|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153420671|NCT02222922|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
153420672|NCT02222922|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153420673|NCT02222922|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153420674|NCT02222922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153420675|NCT02222922|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153420676|NCT02222922|Hormone Antagonists|hormone antagonists|mesh-ancestor
153420677|NCT02222922|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153547358|NCT05574400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153547359|NCT05574400|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
153547360|NCT05574400|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153547361|NCT05574400|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
153547362|NCT05574400|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
153547363|NCT05574400|Purinergic Agents|purinergic agents|mesh-ancestor
153547364|NCT05574400|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153547365|NCT05548660|Analgesics|analgesics|mesh-list
153879823|NCT03709992|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153879824|NCT03709992|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
153879825|NCT03709992|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
153879826|NCT03709992|Cholinergic Agents|cholinergic agents|mesh-ancestor
153879827|NCT03606499|Ustekinumab|ustekinumab|mesh-list
153879828|NCT03606499|Dermatologic Agents|dermatologic agents|mesh-ancestor
153879829|NCT03570632|Metformin|metformin|mesh-list
153879830|NCT03570632|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153879832|NCT03538691|Antidepressive Agents|antidepressive agents|mesh-list
153879833|NCT03538691|Brexpiprazole|brexpiprazole|mesh-list
153879834|NCT03538691|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153879835|NCT03538691|Serotonin Agents|serotonin agents|mesh-ancestor
153879836|NCT03538691|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153879837|NCT03538691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153879838|NCT03538691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153879839|NCT03538691|Dopamine Agonists|dopamine agonists|mesh-ancestor
153879840|NCT03538691|Dopamine Agents|dopamine agents|mesh-ancestor
153879841|NCT03490760|Durvalumab|durvalumab|mesh-list
153879842|NCT03490760|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153420678|NCT02222922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153420679|NCT02222922|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
153420680|NCT02222922|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
153420681|NCT02222922|Immunoconjugates|immunoconjugates|mesh-ancestor
153420682|NCT02222922|Immunologic Factors|immunologic factors|mesh-ancestor
153420683|NCT03503942|Metformin|metformin|mesh-list
153420684|NCT03503942|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153420685|NCT03503942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153420686|NCT03122587|Dihydrotachysterol|dihydrotachysterol|mesh-list
153420713|NCT03123055|Pembrolizumab|pembrolizumab|mesh-list
153420714|NCT03123055|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153420715|NCT03123055|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153420716|NCT03123055|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153420717|NCT03123055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153420718|NCT02969317|Tiotropium Bromide|tiotropium bromide|mesh-list
153411128|NCT00004941|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153547537|NCT05419050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153547539|NCT05412576|Anesthetics, Local|anesthetics, local|mesh-ancestor
153547540|NCT05412576|Anesthetics|anesthetics|mesh-ancestor
153547541|NCT05412576|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153547542|NCT05412576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153547606|NCT05383170|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153547607|NCT05383170|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153547608|NCT05383170|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153547690|NCT05319730|Hormones|hormones|mesh-ancestor
153547691|NCT05319730|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153547692|NCT05319730|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153879914|NCT03089905|Narcotics|narcotics|mesh-ancestor
153547693|NCT05319730|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153547696|NCT05319730|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153547757|NCT05296798|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153547758|NCT05296798|Tubulin Modulators|tubulin modulators|mesh-ancestor
153547759|NCT05296798|Antimitotic Agents|antimitotic agents|mesh-ancestor
153547760|NCT05296798|Mitosis Modulators|mitosis modulators|mesh-ancestor
153547761|NCT05296798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153547762|NCT05296798|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153547763|NCT05287906|Cardiac Glycosides|cardiac glycosides|mesh-list
153547764|NCT05287906|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153547765|NCT05287906|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
153547826|NCT05281471|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153547828|NCT05281471|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153547829|NCT05281471|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153547830|NCT05281471|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153547897|NCT05232032|Analgesics|analgesics|mesh-ancestor
153547898|NCT05232032|Sensory System Agents|sensory system agents|mesh-ancestor
153547899|NCT05232032|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153547969|NCT05153239|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153547970|NCT05153239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153547971|NCT05153239|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153547972|NCT05150015|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
153547973|NCT05150015|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153547974|NCT05148195|Leucovorin|leucovorin|mesh-list
153547975|NCT05148195|Docetaxel|docetaxel|mesh-list
153547976|NCT05148195|Irinotecan|irinotecan|mesh-list
153548038|NCT05092360|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
153548039|NCT05092360|Gemcitabine|gemcitabine|mesh-list
153548040|NCT05092360|Doxorubicin|doxorubicin|mesh-list
153548041|NCT05092360|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
153548042|NCT05092360|Pembrolizumab|pembrolizumab|mesh-list
153548043|NCT05092360|Topotecan|topotecan|mesh-list
153548044|NCT05092360|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153548045|NCT05092360|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153548046|NCT05092360|Tubulin Modulators|tubulin modulators|mesh-ancestor
153548047|NCT05092360|Antimitotic Agents|antimitotic agents|mesh-ancestor
153548048|NCT05092360|Mitosis Modulators|mitosis modulators|mesh-ancestor
153548049|NCT05092360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153548050|NCT05092360|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153548051|NCT05092360|Antimetabolites|antimetabolites|mesh-ancestor
153548052|NCT05092360|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153548055|NCT05092360|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153548094|NCT05073718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153548095|NCT05073718|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153548096|NCT05073718|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153548097|NCT05073718|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153548099|NCT05046860|Dalbavancin|dalbavancin|mesh-list
153548100|NCT05046860|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153548101|NCT05046860|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153548102|NCT05041309|Axicabtagene ciloleucel|axicabtagene ciloleucel|mesh-list
153548103|NCT05041309|Brexucabtagene autoleucel|brexucabtagene autoleucel|mesh-list
153548168|NCT05001880|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
153548169|NCT05001880|Atezolizumab|atezolizumab|mesh-list
153548170|NCT05001880|Carboplatin|carboplatin|mesh-list
153548171|NCT05001880|Pemetrexed|pemetrexed|mesh-list
153548172|NCT05001880|Endothelial Growth Factors|endothelial growth factors|mesh-list
153882180|NCT01607580|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153548173|NCT05001880|Antibodies|antibodies|mesh-list
153548174|NCT05001880|Immunoglobulins|immunoglobulins|mesh-list
153548175|NCT05001880|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
153548176|NCT05001880|Immunoglobulin G|immunoglobulin g|mesh-list
153548240|NCT04931615|Coagulants|coagulants|mesh-ancestor
153882181|NCT01607580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153882182|NCT01607580|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153882183|NCT01607580|Hormones|hormones|mesh-ancestor
153882184|NCT01607580|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153548241|NCT04927312|Metronidazole|metronidazole|mesh-list
153548242|NCT04927312|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153548243|NCT04927312|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153548246|NCT04918186|Durvalumab|durvalumab|mesh-list
153548314|NCT04875702|Protective Agents|protective agents|mesh-ancestor
153548315|NCT04874038|Lidocaine|lidocaine|mesh-list
153548316|NCT04874038|Anesthetics, Local|anesthetics, local|mesh-ancestor
153548317|NCT04874038|Anesthetics|anesthetics|mesh-ancestor
153548318|NCT04874038|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153548319|NCT04874038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153548320|NCT04874038|Sensory System Agents|sensory system agents|mesh-ancestor
153548321|NCT04874038|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153548322|NCT04874038|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153548323|NCT04874038|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
153548324|NCT04874038|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153548325|NCT04874038|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153548326|NCT04874038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153548327|NCT04854499|Carboplatin|carboplatin|mesh-list
153548328|NCT04854499|Docetaxel|docetaxel|mesh-list
153548329|NCT04854499|Pembrolizumab|pembrolizumab|mesh-list
153548330|NCT04854499|Magrolimab|magrolimab|mesh-list
153548388|NCT04821284|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153548389|NCT04821284|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153548390|NCT04821284|Antidotes|antidotes|mesh-ancestor
153548391|NCT04821284|Protective Agents|protective agents|mesh-ancestor
153548392|NCT04821284|Vitamin B Complex|vitamin b complex|mesh-ancestor
153548393|NCT04821284|Vitamins|vitamins|mesh-ancestor
153548457|NCT04772300|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153548458|NCT04772300|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153548459|NCT04772300|Antifungal Agents|antifungal agents|mesh-ancestor
153548460|NCT04772300|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153548461|NCT04772300|Immunologic Factors|immunologic factors|mesh-ancestor
153548462|NCT04772300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153548463|NCT04761601|Paclitaxel|paclitaxel|mesh-list
153548464|NCT04761601|Gemcitabine|gemcitabine|mesh-list
153548465|NCT04761601|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153548466|NCT04761601|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153548467|NCT04761601|Tubulin Modulators|tubulin modulators|mesh-ancestor
153548468|NCT04761601|Antimitotic Agents|antimitotic agents|mesh-ancestor
153548469|NCT04761601|Mitosis Modulators|mitosis modulators|mesh-ancestor
153548471|NCT04761601|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153548516|NCT04746235|Decitabine and cedazuridine drug combination|decitabine and cedazuridine drug combination|mesh-list
153548517|NCT04746235|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153548518|NCT04746235|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153548519|NCT04746235|Antimetabolites|antimetabolites|mesh-ancestor
153548520|NCT04746235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153548521|NCT04746235|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153548522|NCT04744831|Camptothecin|camptothecin|mesh-list
153548523|NCT04744831|Trastuzumab deruxtecan|trastuzumab deruxtecan|mesh-list
153548524|NCT04744831|Immunoconjugates|immunoconjugates|mesh-list
153548549|NCT04719273|Estrogens|estrogens|mesh-list
153548582|NCT04717193|Autonomic Agents|autonomic agents|mesh-ancestor
153548583|NCT04717193|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153548584|NCT04717193|Respiratory System Agents|respiratory system agents|mesh-ancestor
153548585|NCT04717193|Mydriatics|mydriatics|mesh-ancestor
153548586|NCT04717193|Sympathomimetics|sympathomimetics|mesh-ancestor
153548657|NCT04663347|Antimetabolites|antimetabolites|mesh-ancestor
153548658|NCT04663347|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153548659|NCT04663347|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153548660|NCT04663347|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153548661|NCT04663347|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153411129|NCT00004941|Dermatologic Agents|dermatologic agents|mesh-ancestor
153548662|NCT04663347|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153548725|NCT04626791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153548726|NCT04626791|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153548727|NCT04626791|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153548728|NCT04626791|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153548729|NCT04626791|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153548730|NCT04626791|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153548731|NCT04626791|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153548732|NCT04626791|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153548733|NCT04626791|Glucocorticoids|glucocorticoids|mesh-ancestor
153548734|NCT04626791|Hormones|hormones|mesh-ancestor
153548735|NCT04626791|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153548787|NCT04602221|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153548788|NCT04602221|Nootropic Agents|nootropic agents|mesh-ancestor
153548789|NCT04589845|Trastuzumab|trastuzumab|mesh-list
153548790|NCT04589845|Atezolizumab|atezolizumab|mesh-list
153548791|NCT04589845|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
153548792|NCT04589845|Maytansine|maytansine|mesh-list
153548793|NCT04589845|Ipatasertib|ipatasertib|mesh-list
153548794|NCT04589845|Pralsetinib|pralsetinib|mesh-list
153548795|NCT04589845|Alectinib|alectinib|mesh-list
153548796|NCT04589845|Entrectinib|entrectinib|mesh-list
153548797|NCT04589845|Inavolisib|inavolisib|mesh-list
153548798|NCT04589845|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153548799|NCT04589845|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153548800|NCT04589845|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153548801|NCT04589845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153548850|NCT04551131|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153548851|NCT04551131|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153548852|NCT04551131|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153548853|NCT04551131|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153548854|NCT04551131|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153548855|NCT04551131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153548856|NCT04550260|Cisplatin|cisplatin|mesh-list
153548857|NCT04550260|Capecitabine|capecitabine|mesh-list
153548858|NCT04550260|Fluorouracil|fluorouracil|mesh-list
153548859|NCT04550260|Durvalumab|durvalumab|mesh-list
153548860|NCT04550260|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153548861|NCT04550260|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153548862|NCT04550260|Antimetabolites|antimetabolites|mesh-ancestor
153548863|NCT04550260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153548864|NCT04550260|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153548918|NCT04530565|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
153548920|NCT04530565|Antibodies|antibodies|mesh-list
153548921|NCT04530565|Immunoglobulins|immunoglobulins|mesh-list
153548922|NCT04530565|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
153548923|NCT04530565|Antibodies, Bispecific|antibodies, bispecific|mesh-list
153548924|NCT04530565|BB 1101|bb 1101|mesh-list
153548926|NCT04530565|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153548927|NCT04530565|Immunologic Factors|immunologic factors|mesh-ancestor
153548928|NCT04530565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153548929|NCT04530565|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153548984|NCT04524871|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153548985|NCT04524871|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153548986|NCT04524871|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153548987|NCT04524871|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153548988|NCT04524871|Growth Substances|growth substances|mesh-ancestor
153548989|NCT04524871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153548990|NCT04524871|Growth Inhibitors|growth inhibitors|mesh-ancestor
153548991|NCT04524871|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153548992|NCT04524871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153548993|NCT04504812|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
153549048|NCT04442919|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153549049|NCT04442919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153549050|NCT04442919|Analgesics|analgesics|mesh-ancestor
153549051|NCT04442919|Sensory System Agents|sensory system agents|mesh-ancestor
153549052|NCT04442919|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153549056|NCT04442919|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
153549113|NCT04396860|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153549114|NCT04396860|Alkylating Agents|alkylating agents|mesh-ancestor
153549115|NCT04374630|Paclitaxel|paclitaxel|mesh-list
153549116|NCT04374630|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153549117|NCT04374630|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153549118|NCT04374630|Tubulin Modulators|tubulin modulators|mesh-ancestor
153549119|NCT04374630|Antimitotic Agents|antimitotic agents|mesh-ancestor
153549120|NCT04374630|Mitosis Modulators|mitosis modulators|mesh-ancestor
153549178|NCT04314193|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153549179|NCT04314193|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153549180|NCT04314193|Immunologic Factors|immunologic factors|mesh-ancestor
153549181|NCT04314193|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153549182|NCT04314193|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153549183|NCT04314193|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153549184|NCT04314193|Glucocorticoids|glucocorticoids|mesh-ancestor
153549185|NCT04314193|Hormones|hormones|mesh-ancestor
153549188|NCT04293562|Cytarabine|cytarabine|mesh-list
153549246|NCT04287049|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153549247|NCT04287049|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153549248|NCT04278768|Venetoclax|venetoclax|mesh-list
153549311|NCT04199026|Isophosphamide mustard|isophosphamide mustard|mesh-list
153549312|NCT04199026|MTOR Inhibitors|mtor inhibitors|mesh-list
153882197|NCT01604187|Sensory System Agents|sensory system agents|mesh-ancestor
153549313|NCT04199026|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
153549314|NCT04199026|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153549315|NCT04199026|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153549316|NCT04199026|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153549317|NCT04199026|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153549318|NCT04199026|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153549319|NCT04199026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153549320|NCT04199026|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
153549321|NCT04199026|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153549322|NCT04199026|Tubulin Modulators|tubulin modulators|mesh-ancestor
153549372|NCT04177433|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153549373|NCT04177433|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
153549374|NCT04177433|Protective Agents|protective agents|mesh-ancestor
153549375|NCT04177433|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153549376|NCT04177433|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153549378|NCT04172597|Antidiarrheals|antidiarrheals|mesh-list
153549442|NCT04127578|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153549443|NCT04127578|Antiemetics|antiemetics|mesh-ancestor
153549444|NCT04127578|Autonomic Agents|autonomic agents|mesh-ancestor
153549445|NCT04127578|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153549446|NCT04127578|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153549447|NCT04127578|Glucocorticoids|glucocorticoids|mesh-ancestor
153549448|NCT04127578|Hormones|hormones|mesh-ancestor
153549449|NCT04127578|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153549472|NCT04094961|Ixazomib|ixazomib|mesh-list
153549584|NCT04014634|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
153549585|NCT04014634|Prednisolone phosphate|prednisolone phosphate|mesh-list
153549586|NCT04014634|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153549587|NCT04014634|Antiemetics|antiemetics|mesh-ancestor
153549588|NCT04014634|Autonomic Agents|autonomic agents|mesh-ancestor
153549589|NCT04014634|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153549590|NCT04014634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153549591|NCT04014634|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153549592|NCT04014634|Glucocorticoids|glucocorticoids|mesh-ancestor
153549593|NCT04014634|Hormones|hormones|mesh-ancestor
153549594|NCT04014634|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153549595|NCT04014634|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
153549596|NCT04014634|Protective Agents|protective agents|mesh-ancestor
153549597|NCT04014634|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153549598|NCT04014634|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153549599|NCT04014361|Itraconazole|itraconazole|mesh-list
153549632|NCT03972527|Analgesics|analgesics|mesh-list
153549640|NCT03969901|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153549641|NCT03969901|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153549642|NCT03939897|Fulvestrant|fulvestrant|mesh-list
153549643|NCT03939897|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153549644|NCT03939897|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153549645|NCT03939897|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
153549646|NCT03939897|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
153549647|NCT03939897|Hormone Antagonists|hormone antagonists|mesh-ancestor
153549648|NCT03939897|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153549650|NCT03934203|Moxifloxacin|moxifloxacin|mesh-list
153549651|NCT03934203|BI 409306|bi 409306|mesh-list
153549652|NCT03934203|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153549653|NCT03934203|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153549654|NCT03934203|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153549655|NCT03934203|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153549656|NCT03934203|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153549657|NCT03934203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153549658|NCT03934203|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153549659|NCT03934203|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
153549660|NCT03933306|Dexmedetomidine|dexmedetomidine|mesh-list
153549661|NCT03933306|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153549692|NCT03918278|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153549693|NCT03918278|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153882198|NCT01604187|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153882201|NCT01604187|Anesthetics, General|anesthetics, general|mesh-ancestor
153549694|NCT03918278|Tubulin Modulators|tubulin modulators|mesh-ancestor
153549695|NCT03918278|Antimitotic Agents|antimitotic agents|mesh-ancestor
153549696|NCT03918278|Mitosis Modulators|mitosis modulators|mesh-ancestor
153549697|NCT03918278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153549698|NCT03918278|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153549699|NCT03918278|Antimetabolites|antimetabolites|mesh-ancestor
153549700|NCT03918278|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153549701|NCT03918278|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153549702|NCT03918278|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153549703|NCT03918278|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153549704|NCT03918278|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153549705|NCT03916185|Vaccines|vaccines|mesh-list
153549706|NCT03916185|Immunologic Factors|immunologic factors|mesh-ancestor
153549707|NCT03916185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153549708|NCT03914625|Calcium, Dietary|calcium, dietary|mesh-list
153549709|NCT03914625|Leucovorin|leucovorin|mesh-list
153549711|NCT03914625|Cytarabine|cytarabine|mesh-list
153549712|NCT03914625|Dexamethasone|dexamethasone|mesh-list
153549751|NCT03914625|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153549752|NCT03914625|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153549753|NCT03914625|Alkylating Agents|alkylating agents|mesh-ancestor
153549754|NCT03914625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153549755|NCT03914625|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153549756|NCT03914625|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153549757|NCT03914625|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153549758|NCT03914625|Antiemetics|antiemetics|mesh-ancestor
153549759|NCT03914625|Autonomic Agents|autonomic agents|mesh-ancestor
153549760|NCT03914625|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153549761|NCT03914625|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153549762|NCT03914625|Glucocorticoids|glucocorticoids|mesh-ancestor
153549763|NCT03914625|Hormones|hormones|mesh-ancestor
153549764|NCT03914625|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153549765|NCT03914625|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153549766|NCT03914625|Protease Inhibitors|protease inhibitors|mesh-ancestor
153549767|NCT03914625|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153549777|NCT03914625|Antimetabolites|antimetabolites|mesh-ancestor
153549808|NCT03902782|Autonomic Agents|autonomic agents|mesh-ancestor
153549809|NCT03902782|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153549810|NCT03902782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153549811|NCT03902782|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153549812|NCT03902782|Glucocorticoids|glucocorticoids|mesh-ancestor
153549813|NCT03902782|Hormones|hormones|mesh-ancestor
153549814|NCT03902782|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153549815|NCT03902782|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153549816|NCT03902782|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153549872|NCT03851627|Androgens|androgens|mesh-ancestor
153549873|NCT03851627|Hormones|hormones|mesh-ancestor
153549874|NCT03851627|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153549875|NCT03851627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153549876|NCT03851627|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153420773|NCT03132571|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
153420774|NCT03132571|Antidepressive Agents|antidepressive agents|mesh-ancestor
153549877|NCT03851627|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153549878|NCT03851627|Anabolic Agents|anabolic agents|mesh-ancestor
153549879|NCT03841747|Paclitaxel|paclitaxel|mesh-list
153549880|NCT03841747|Pembrolizumab|pembrolizumab|mesh-list
153549881|NCT03841747|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153549882|NCT03841747|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153549883|NCT03841747|Tubulin Modulators|tubulin modulators|mesh-ancestor
153549884|NCT03841747|Antimitotic Agents|antimitotic agents|mesh-ancestor
153549885|NCT03841747|Mitosis Modulators|mitosis modulators|mesh-ancestor
153549886|NCT03841747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153882211|NCT01604382|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153882212|NCT01604382|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153882213|NCT01604382|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153882214|NCT01604382|Anesthetics, General|anesthetics, general|mesh-ancestor
153882215|NCT01604382|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153882216|NCT01604382|Narcotics|narcotics|mesh-ancestor
153549887|NCT03841747|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153549888|NCT03841747|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153549889|NCT03836261|Venetoclax|venetoclax|mesh-list
153549890|NCT03836261|Obinutuzumab|obinutuzumab|mesh-list
153549891|NCT03836261|Acalabrutinib|acalabrutinib|mesh-list
153549932|NCT03728361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153549933|NCT03728361|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153549934|NCT03728361|Alkylating Agents|alkylating agents|mesh-ancestor
153549935|NCT03712605|Pembrolizumab|pembrolizumab|mesh-list
153549936|NCT03712605|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153549937|NCT03712605|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153549938|NCT03712605|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153549939|NCT03712605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153549940|NCT03691376|Aldesleukin|aldesleukin|mesh-list
153549941|NCT03691376|Melphalan|melphalan|mesh-list
153549944|NCT03691376|Interleukin-2|interleukin-2|mesh-list
153549996|NCT03660930|Sirolimus|sirolimus|mesh-list
153549997|NCT03660930|Temsirolimus|temsirolimus|mesh-list
153549998|NCT03660930|MTOR Inhibitors|mtor inhibitors|mesh-list
153549999|NCT03660930|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153550000|NCT03660930|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153550001|NCT03660930|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153550002|NCT03660930|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153550003|NCT03660930|Antifungal Agents|antifungal agents|mesh-ancestor
153550004|NCT03660930|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153550005|NCT03660930|Immunologic Factors|immunologic factors|mesh-ancestor
153550006|NCT03660930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153550016|NCT03615105|Melphalan|melphalan|mesh-list
153550062|NCT03574571|Docetaxel|docetaxel|mesh-list
153550063|NCT03574571|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153550064|NCT03574571|Tubulin Modulators|tubulin modulators|mesh-ancestor
153550065|NCT03574571|Antimitotic Agents|antimitotic agents|mesh-ancestor
153550066|NCT03574571|Mitosis Modulators|mitosis modulators|mesh-ancestor
153550067|NCT03574571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153550068|NCT03565783|Cemiplimab|cemiplimab|mesh-list
153550129|NCT03519295|Fluorouracil|fluorouracil|mesh-list
153550130|NCT03519295|Atezolizumab|atezolizumab|mesh-list
153550131|NCT03519295|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153550132|NCT03519295|Tubulin Modulators|tubulin modulators|mesh-ancestor
153550133|NCT03519295|Antimitotic Agents|antimitotic agents|mesh-ancestor
153550134|NCT03519295|Mitosis Modulators|mitosis modulators|mesh-ancestor
153550135|NCT03519295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153550136|NCT03519295|Antimetabolites|antimetabolites|mesh-ancestor
153550195|NCT03472573|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153550196|NCT03472573|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153550197|NCT03472573|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153550198|NCT03472573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153550200|NCT03471143|Sequestering Agents|sequestering agents|mesh-ancestor
153550201|NCT03471143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153550202|NCT03452137|Atezolizumab|atezolizumab|mesh-list
153550203|NCT03452137|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153550204|NCT03452137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153550207|NCT03436745|Zolpidem|zolpidem|mesh-list
153550258|NCT03424005|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153550259|NCT03424005|Phosphoinositide-3 Kinase Inhibitors|phosphoinositide-3 kinase inhibitors|mesh-ancestor
153882217|NCT01604382|Analgesics|analgesics|mesh-ancestor
153882218|NCT01682408|Mannitol|mannitol|mesh-list
153882219|NCT01682408|Ranitidine|ranitidine|mesh-list
153882220|NCT01682408|Ranitidine bismuth citrate|ranitidine bismuth citrate|mesh-list
153882221|NCT01682408|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
153882222|NCT01682408|Diuretics|diuretics|mesh-ancestor
153882223|NCT01682408|Natriuretic Agents|natriuretic agents|mesh-ancestor
153882224|NCT01682408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153550262|NCT03386578|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
153550264|NCT03386578|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153550265|NCT03386578|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153550266|NCT03386578|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153550267|NCT03386578|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153550268|NCT03386578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153550269|NCT03386578|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153550322|NCT03337698|Antimetabolites|antimetabolites|mesh-ancestor
153550323|NCT03337698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153550324|NCT03337698|Tubulin Modulators|tubulin modulators|mesh-ancestor
153550325|NCT03337698|Antimitotic Agents|antimitotic agents|mesh-ancestor
153550326|NCT03337698|Mitosis Modulators|mitosis modulators|mesh-ancestor
153550327|NCT03337698|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153550328|NCT03337698|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153550329|NCT03337698|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153550330|NCT03337698|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153550331|NCT03337698|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153550332|NCT03337698|Incretins|incretins|mesh-ancestor
153550334|NCT03337698|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153550335|NCT03337698|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
153550336|NCT03337698|Protease Inhibitors|protease inhibitors|mesh-ancestor
153550337|NCT03337698|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
153550338|NCT03337698|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153550339|NCT03337698|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153550340|NCT03337698|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
153550341|NCT03337698|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153550342|NCT03337698|Immunoconjugates|immunoconjugates|mesh-ancestor
153550343|NCT03337698|Immunologic Factors|immunologic factors|mesh-ancestor
153550344|NCT03337698|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153550374|NCT03280563|Immunologic Factors|immunologic factors|mesh-ancestor
153550375|NCT03280563|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153550376|NCT03280563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153550377|NCT03280563|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
153550378|NCT03280563|Hormone Antagonists|hormone antagonists|mesh-ancestor
153550379|NCT03280563|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153550380|NCT03280563|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153550381|NCT03280563|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
153550382|NCT03280563|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
153550383|NCT03280563|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153550434|NCT03151057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153550435|NCT03124407|Capsaicin|capsaicin|mesh-list
153550436|NCT03124407|Antipruritics|antipruritics|mesh-ancestor
153550437|NCT03124407|Dermatologic Agents|dermatologic agents|mesh-ancestor
153550438|NCT03124407|Sensory System Agents|sensory system agents|mesh-ancestor
153550439|NCT03124407|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153550440|NCT03124407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153550441|NCT03111485|Levodopa|levodopa|mesh-list
153550443|NCT03111485|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
153550501|NCT02960022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153550502|NCT02960022|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153550503|NCT02960022|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153550504|NCT02960022|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153550505|NCT02960022|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153550506|NCT02960022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153550507|NCT02960022|Hormone Antagonists|hormone antagonists|mesh-ancestor
153550508|NCT02960022|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153882240|NCT01608009|Antimitotic Agents|antimitotic agents|mesh-ancestor
153882241|NCT01608009|Mitosis Modulators|mitosis modulators|mesh-ancestor
153550509|NCT02923739|Paclitaxel|paclitaxel|mesh-list
153550510|NCT02923739|Bevacizumab|bevacizumab|mesh-list
153550511|NCT02923739|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
153550512|NCT02923739|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
153550513|NCT02923739|Endothelial Growth Factors|endothelial growth factors|mesh-list
153550514|NCT02923739|Antibodies|antibodies|mesh-list
153550515|NCT02923739|Immunoglobulins|immunoglobulins|mesh-list
153550516|NCT02923739|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
153550517|NCT02923739|Immunoglobulin G|immunoglobulin g|mesh-list
153550518|NCT02923739|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153550519|NCT02923739|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153550520|NCT02923739|Tubulin Modulators|tubulin modulators|mesh-ancestor
153550521|NCT02923739|Antimitotic Agents|antimitotic agents|mesh-ancestor
153550600|NCT02720094|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153550601|NCT02720094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153550603|NCT02720094|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153550604|NCT02720094|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153782554|NCT04556110|Protease Inhibitors|protease inhibitors|mesh-ancestor
153782555|NCT04556110|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153550606|NCT02720094|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
153550607|NCT02720094|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
153550642|NCT02645266|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153550643|NCT02645266|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153550644|NCT02645266|Growth Substances|growth substances|mesh-ancestor
153550645|NCT02645266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153550646|NCT02645266|Growth Inhibitors|growth inhibitors|mesh-ancestor
153550647|NCT02645266|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153550648|NCT02636322|Prednisone|prednisone|mesh-list
153550649|NCT02636322|Cortisone|cortisone|mesh-list
153550650|NCT02636322|Cyclophosphamide|cyclophosphamide|mesh-list
153550651|NCT02636322|Rituximab|rituximab|mesh-list
153550652|NCT02636322|Doxorubicin|doxorubicin|mesh-list
153550653|NCT02636322|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
153550654|NCT02636322|Etoposide|etoposide|mesh-list
153550706|NCT02574910|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153550707|NCT02574910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153550708|NCT02574910|Hormone Antagonists|hormone antagonists|mesh-ancestor
153550709|NCT02574910|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153550710|NCT02574910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153550711|NCT02574910|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153550713|NCT02543983|Analgesics|analgesics|mesh-ancestor
153550714|NCT02543983|Sensory System Agents|sensory system agents|mesh-ancestor
153550715|NCT02543983|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153550716|NCT02543983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153550717|NCT02543983|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
153550718|NCT02543983|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153550719|NCT02543983|Anesthetics, General|anesthetics, general|mesh-ancestor
153550720|NCT02543983|Anesthetics|anesthetics|mesh-ancestor
153550721|NCT02543983|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153550722|NCT02543983|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
153550723|NCT02543983|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
153550724|NCT02543983|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153550725|NCT02543983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153550726|NCT02499328|Durvalumab|durvalumab|mesh-list
153550727|NCT02499328|Tremelimumab|tremelimumab|mesh-list
153550728|NCT02499328|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153550729|NCT02499328|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153550730|NCT02465060|Nivolumab|nivolumab|mesh-list
153550733|NCT02465060|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
153550753|NCT02465060|Immunoconjugates|immunoconjugates|mesh-list
153550754|NCT02465060|Immunologic Factors|immunologic factors|mesh-ancestor
153550755|NCT02465060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153550756|NCT02465060|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153550757|NCT02465060|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153550758|NCT02465060|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153550759|NCT02465060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153550760|NCT02465060|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153550761|NCT02465060|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153550762|NCT02465060|Growth Substances|growth substances|mesh-ancestor
153550764|NCT02465060|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153550765|NCT02465060|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153550766|NCT02465060|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153550768|NCT02465060|Antimitotic Agents|antimitotic agents|mesh-ancestor
153550769|NCT02465060|Mitosis Modulators|mitosis modulators|mesh-ancestor
153550771|NCT02451943|Doxorubicin|doxorubicin|mesh-list
153550772|NCT02451943|Olaratumab|olaratumab|mesh-list
153550773|NCT02451943|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153550774|NCT02451943|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153550808|NCT02436707|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153550809|NCT02436707|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153550810|NCT02436707|Glucocorticoids|glucocorticoids|mesh-ancestor
153550811|NCT02436707|Hormones|hormones|mesh-ancestor
153550812|NCT02436707|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153550813|NCT02436707|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153550814|NCT02436707|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153550815|NCT02436707|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153919569|NCT00003764|Immunologic Factors|immunologic factors|mesh-ancestor
153550817|NCT02436707|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153550818|NCT02436707|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153550819|NCT02436707|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153550820|NCT02436707|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153550821|NCT02436707|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153550822|NCT02436707|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153550823|NCT02389374|Chloroquine|chloroquine|mesh-list
153550824|NCT02389374|Lumefantrine|lumefantrine|mesh-list
153550825|NCT02389374|Artemether|artemether|mesh-list
153550826|NCT02389374|Primaquine|primaquine|mesh-list
153550827|NCT02389374|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
153550828|NCT02389374|Amebicides|amebicides|mesh-ancestor
153550829|NCT02389374|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153550830|NCT02389374|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153550861|NCT02230930|Dopamine Agents|dopamine agents|mesh-ancestor
153550862|NCT02230930|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153550863|NCT02230930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153550864|NCT02159404|Immunomodulating Agents|immunomodulating agents|mesh-list
153550865|NCT02159404|Immunologic Factors|immunologic factors|mesh-ancestor
153550866|NCT02159404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153550867|NCT02155647|Avelumab|avelumab|mesh-list
153550868|NCT02155647|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153550869|NCT02155647|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153550870|NCT02136134|Dexamethasone|dexamethasone|mesh-list
153550871|NCT02136134|Bortezomib|bortezomib|mesh-list
153550872|NCT02136134|Daratumumab|daratumumab|mesh-list
153550873|NCT02136134|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153550874|NCT02136134|Antiemetics|antiemetics|mesh-ancestor
153550875|NCT02136134|Autonomic Agents|autonomic agents|mesh-ancestor
153550876|NCT02136134|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153550877|NCT02136134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153550878|NCT02136134|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153550879|NCT02136134|Glucocorticoids|glucocorticoids|mesh-ancestor
153550880|NCT02136134|Hormones|hormones|mesh-ancestor
153550881|NCT02136134|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153550882|NCT02136134|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153550883|NCT02136134|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153550884|NCT02107703|Fulvestrant|fulvestrant|mesh-list
153550885|NCT02107703|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153550886|NCT02107703|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153550887|NCT02107703|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
153550908|NCT02096588|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153782557|NCT04556110|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153550909|NCT02096588|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153550910|NCT02096588|Antimetabolites|antimetabolites|mesh-ancestor
153550911|NCT02096588|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153550912|NCT02096588|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
153550914|NCT02079740|Navitoclax|navitoclax|mesh-list
153550915|NCT02079740|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153550916|NCT02079740|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153550917|NCT02079740|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153411130|NCT00004941|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153550918|NCT02079740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153550920|NCT02008721|Protective Agents|protective agents|mesh-ancestor
153550921|NCT02008721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153550922|NCT01910610|Bevacizumab|bevacizumab|mesh-list
153550924|NCT01910610|Panitumumab|panitumumab|mesh-list
153550925|NCT01910610|Irinotecan|irinotecan|mesh-list
153550926|NCT01910610|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153550927|NCT01910610|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153550928|NCT01910610|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153550929|NCT01910610|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153550930|NCT01910610|Growth Substances|growth substances|mesh-ancestor
153550931|NCT01910610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153550932|NCT01910610|Growth Inhibitors|growth inhibitors|mesh-ancestor
153550933|NCT01910610|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
153550934|NCT01910610|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153550935|NCT01910610|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153550936|NCT01910610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153550951|NCT01892722|Antiviral Agents|antiviral agents|mesh-ancestor
153550952|NCT01892722|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153550953|NCT01892722|Immunologic Factors|immunologic factors|mesh-ancestor
153550954|NCT01892722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153550956|NCT01892722|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
153550957|NCT01892722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153550958|NCT01892722|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153550959|NCT01885949|Tivozanib|tivozanib|mesh-list
153550960|NCT01885949|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153550961|NCT01885949|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153550962|NCT01885949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153550963|NCT01869114|Sirolimus|sirolimus|mesh-list
153550964|NCT01869114|Azacitidine|azacitidine|mesh-list
153550965|NCT01869114|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153550966|NCT01869114|Antimetabolites|antimetabolites|mesh-ancestor
153550967|NCT01869114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153411131|NCT00004941|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153550969|NCT01869114|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153550970|NCT01869114|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153550971|NCT01869114|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153550972|NCT01869114|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153550973|NCT01869114|Antifungal Agents|antifungal agents|mesh-ancestor
153550974|NCT01869114|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153550975|NCT01869114|Immunologic Factors|immunologic factors|mesh-ancestor
153551002|NCT01798004|Immunologic Factors|immunologic factors|mesh-ancestor
153551003|NCT01798004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153551004|NCT01798004|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153551005|NCT01798004|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153551006|NCT01798004|Alkylating Agents|alkylating agents|mesh-ancestor
153919579|NCT00003601|Tretinoin|tretinoin|mesh-list
153551007|NCT01798004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153551008|NCT01798004|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153551009|NCT01798004|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153551010|NCT01798004|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153551011|NCT01798004|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153551012|NCT01798004|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153551013|NCT01798004|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153551014|NCT01798004|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153551015|NCT01798004|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153551016|NCT01798004|Tubulin Modulators|tubulin modulators|mesh-ancestor
153551017|NCT01798004|Antimitotic Agents|antimitotic agents|mesh-ancestor
153551018|NCT01798004|Mitosis Modulators|mitosis modulators|mesh-ancestor
153551019|NCT01798004|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
153551020|NCT01798004|Protective Agents|protective agents|mesh-ancestor
153551021|NCT01798004|Keratolytic Agents|keratolytic agents|mesh-ancestor
153551022|NCT01798004|Dermatologic Agents|dermatologic agents|mesh-ancestor
153551023|NCT01660971|Gemcitabine|gemcitabine|mesh-list
153551025|NCT01660971|Dasatinib|dasatinib|mesh-list
153551054|NCT01375829|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153551055|NCT01375829|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153551056|NCT01375829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153551057|NCT01375829|Tubulin Modulators|tubulin modulators|mesh-ancestor
153551058|NCT01375829|Antimitotic Agents|antimitotic agents|mesh-ancestor
153551059|NCT01375829|Mitosis Modulators|mitosis modulators|mesh-ancestor
153551061|NCT01374984|gamma-Globulins|gamma-globulins|mesh-list
153551063|NCT01374984|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
153551064|NCT01374984|Immunologic Factors|immunologic factors|mesh-ancestor
153551065|NCT01374984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153551067|NCT01364051|Maleic acid|maleic acid|mesh-list
153551068|NCT01364051|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153551069|NCT01364051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153551070|NCT01364051|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153551071|NCT01364051|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153551073|NCT01352962|Gemcitabine|gemcitabine|mesh-list
153551074|NCT01352962|Lenalidomide|lenalidomide|mesh-list
153551086|NCT01351909|Veliparib|veliparib|mesh-list
153551110|NCT01013649|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153551111|NCT01013649|Immunologic Factors|immunologic factors|mesh-ancestor
153551112|NCT01013649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153551113|NCT01013649|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153551114|NCT01013649|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153551115|NCT01013649|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153551117|NCT00878163|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
153551118|NCT00878163|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153551119|NCT00878163|Antimetabolites|antimetabolites|mesh-ancestor
153551120|NCT00878163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153551121|NCT00878163|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153551122|NCT00878163|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153551123|NCT00878163|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153551124|NCT00878163|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153551125|NCT00588991|Carboplatin|carboplatin|mesh-list
153551126|NCT00588991|Topotecan|topotecan|mesh-list
153551127|NCT00588991|Veliparib|veliparib|mesh-list
153551128|NCT00588991|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153551129|NCT00588991|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
153551130|NCT00588991|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153551131|NCT00588991|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153551132|NCT00588991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153551160|NCT00025935|Lithium Carbonate|lithium carbonate|mesh-list
153551161|NCT00025935|Antidepressive Agents|antidepressive agents|mesh-ancestor
153551162|NCT00025935|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153551163|NCT00025935|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153551164|NCT00025935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153551165|NCT00025935|Antimanic Agents|antimanic agents|mesh-ancestor
153551166|NCT00025935|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153551167|NCT00025935|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153411132|NCT00003657|Carboplatin|carboplatin|mesh-list
153551168|NCT00025935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153551174|NCT00001230|Diethylcarbamazine|diethylcarbamazine|mesh-list
153551175|NCT00001230|Filaricides|filaricides|mesh-ancestor
153551176|NCT00001230|Antinematodal Agents|antinematodal agents|mesh-ancestor
153551177|NCT00001230|Anthelmintics|anthelmintics|mesh-ancestor
153551178|NCT00001230|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153551179|NCT00001230|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153551180|NCT00001230|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
153551181|NCT00001230|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153551220|NCT01570569|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153551221|NCT01570569|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
153551222|NCT01570569|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
153551223|NCT01570569|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
153551224|NCT01570569|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
153551225|NCT01570569|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153551226|NCT01570569|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
153551227|NCT01570569|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
153551228|NCT01570569|Purinergic Agents|purinergic agents|mesh-ancestor
153551229|NCT01570569|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
153551230|NCT01570569|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153551231|NCT01570569|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
153551232|NCT01570569|Antitussive Agents|antitussive agents|mesh-ancestor
153551233|NCT01570569|Respiratory System Agents|respiratory system agents|mesh-ancestor
153551234|NCT01570569|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
153551235|NCT01570569|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
153551236|NCT01570569|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153551238|NCT01570569|Analgesics|analgesics|mesh-ancestor
153551239|NCT01570569|Sensory System Agents|sensory system agents|mesh-ancestor
153551240|NCT01570569|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153551241|NCT01570582|Paclitaxel|paclitaxel|mesh-list
153551242|NCT01570582|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
153551243|NCT01570582|Carboplatin|carboplatin|mesh-list
153551244|NCT01570582|Gemcitabine|gemcitabine|mesh-list
153551245|NCT01570582|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153551246|NCT01570582|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153551247|NCT01570582|Tubulin Modulators|tubulin modulators|mesh-ancestor
153551248|NCT01570582|Antimitotic Agents|antimitotic agents|mesh-ancestor
153551249|NCT01570582|Mitosis Modulators|mitosis modulators|mesh-ancestor
153551250|NCT01570582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153551252|NCT01570582|Antimetabolites|antimetabolites|mesh-ancestor
153551263|NCT01570660|Pioglitazone|pioglitazone|mesh-list
153551264|NCT01570660|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153551266|NCT01570764|Cyclophosphamide|cyclophosphamide|mesh-list
153551267|NCT01570764|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153551268|NCT01570764|Immunologic Factors|immunologic factors|mesh-ancestor
153551269|NCT01570764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153551270|NCT01570764|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153551271|NCT01570764|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153551272|NCT01570764|Alkylating Agents|alkylating agents|mesh-ancestor
153551273|NCT01570764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153551274|NCT01570764|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153551275|NCT01570764|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153551277|NCT01570790|Combretastatin|combretastatin|mesh-list
153551278|NCT01570790|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153551279|NCT01570790|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153551280|NCT01570790|Tubulin Modulators|tubulin modulators|mesh-ancestor
153551281|NCT01570790|Antimitotic Agents|antimitotic agents|mesh-ancestor
153551282|NCT01570790|Mitosis Modulators|mitosis modulators|mesh-ancestor
153551283|NCT01570790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153551284|NCT01570894|Quetiapine Fumarate|quetiapine fumarate|mesh-list
153551285|NCT01570894|Antidepressive Agents|antidepressive agents|mesh-ancestor
153551311|NCT01570985|Hormones|hormones|mesh-ancestor
153551312|NCT01570985|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153551313|NCT01570985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153551315|NCT01570985|Immunologic Factors|immunologic factors|mesh-ancestor
153551316|NCT01570985|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153551317|NCT01570985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153551318|NCT01571024|Leucovorin|leucovorin|mesh-list
153551319|NCT01571024|Fluorouracil|fluorouracil|mesh-list
153551320|NCT01571024|Oxaliplatin|oxaliplatin|mesh-list
153551322|NCT01571024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153551323|NCT01571024|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153551324|NCT01571024|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153551325|NCT01571024|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153551326|NCT01571024|Immunologic Factors|immunologic factors|mesh-ancestor
153551327|NCT01571024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153551329|NCT01571024|Protective Agents|protective agents|mesh-ancestor
153551330|NCT01571024|Vitamin B Complex|vitamin b complex|mesh-ancestor
153551331|NCT01571024|Vitamins|vitamins|mesh-ancestor
153551359|NCT01571219|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153551360|NCT01571219|Dermatologic Agents|dermatologic agents|mesh-ancestor
153551361|NCT01571219|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153551362|NCT01571219|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153551365|NCT01571323|Oxytocics|oxytocics|mesh-ancestor
153551366|NCT01571323|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153551367|NCT01571323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153551368|NCT01571323|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
153551370|NCT01571323|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
153551371|NCT01571323|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153551373|NCT01571388|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153551374|NCT01571388|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153551375|NCT01571388|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153551376|NCT01571388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153551377|NCT01571414|Ritonavir|ritonavir|mesh-list
153551378|NCT01571414|Lopinavir|lopinavir|mesh-list
153551379|NCT01571414|Efavirenz|efavirenz|mesh-list
153551380|NCT01571414|Rifampin|rifampin|mesh-list
153551381|NCT01571414|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
153551382|NCT01571414|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
153551383|NCT01571414|Protease Inhibitors|protease inhibitors|mesh-ancestor
153551384|NCT01571414|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153551409|NCT01571570|Protease Inhibitors|protease inhibitors|mesh-ancestor
153551410|NCT01571570|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153551411|NCT01571570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153551413|NCT01571583|Ribavirin|ribavirin|mesh-list
153882253|NCT01604031|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153551414|NCT01571583|Interferon-alpha|interferon-alpha|mesh-list
153551415|NCT01571583|Interferon alpha-2|interferon alpha-2|mesh-list
153551416|NCT01571583|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
153551417|NCT01571583|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153551418|NCT01571583|Antiviral Agents|antiviral agents|mesh-ancestor
153551419|NCT01571583|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153551420|NCT01571583|Antimetabolites|antimetabolites|mesh-ancestor
153551421|NCT01571583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153411133|NCT00003657|Etoposide|etoposide|mesh-list
153782559|NCT00234299|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153782560|NCT00234299|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153782561|NCT00234299|Analgesics|analgesics|mesh-ancestor
153782562|NCT00234299|Sensory System Agents|sensory system agents|mesh-ancestor
153782563|NCT00234299|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153782564|NCT00234299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153782565|NCT00234299|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153782566|NCT00234299|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153782567|NCT00234299|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153782568|NCT00234299|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153551422|NCT01571583|Immunologic Factors|immunologic factors|mesh-ancestor
153551423|NCT01571583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153551424|NCT01571609|Insulin|insulin|mesh-list
153551425|NCT01571609|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153551440|NCT01571791|Anesthetics|anesthetics|mesh-ancestor
153411134|NCT00003657|Ifosfamide|ifosfamide|mesh-list
153551441|NCT01571791|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153551442|NCT01571791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153551443|NCT01571791|Sensory System Agents|sensory system agents|mesh-ancestor
153551444|NCT01571791|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153551445|NCT01571791|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153551446|NCT01571791|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
153551447|NCT01571791|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153551448|NCT01571791|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153551449|NCT01571791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153551450|NCT01571791|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153551451|NCT01571791|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153551452|NCT01571791|Analgesics|analgesics|mesh-ancestor
153551453|NCT01571791|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153551454|NCT01571791|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153551455|NCT01571791|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153551456|NCT01571791|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153551457|NCT01571804|Pregabalin|pregabalin|mesh-list
153551458|NCT01571804|Analgesics|analgesics|mesh-ancestor
153551459|NCT01571804|Sensory System Agents|sensory system agents|mesh-ancestor
153551460|NCT01571804|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153551461|NCT01571804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153551462|NCT01571804|Anticonvulsants|anticonvulsants|mesh-ancestor
153551463|NCT01571804|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153551464|NCT01571804|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153551465|NCT01571804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153551466|NCT01571804|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153551467|NCT01571804|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153551468|NCT01571804|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153551469|NCT01571804|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153551470|NCT01571804|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153551471|NCT01571856|Zinc Sulfate|zinc sulfate|mesh-list
153551472|NCT01571856|Astringents|astringents|mesh-ancestor
153551476|NCT01571882|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153551477|NCT01571882|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153551478|NCT01571882|Antimetabolites|antimetabolites|mesh-ancestor
153551479|NCT01571882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153551480|NCT01571882|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153551481|NCT01571882|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153551482|NCT01571921|Tocotrienols|tocotrienols|mesh-list
153551483|NCT01571921|Vitamin E|vitamin e|mesh-list
153551484|NCT01571921|Tocopherols|tocopherols|mesh-list
153551485|NCT01571921|Antioxidants|antioxidants|mesh-ancestor
153551486|NCT01571921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153551487|NCT01571921|Protective Agents|protective agents|mesh-ancestor
153551488|NCT01571921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153551489|NCT01571921|Vitamins|vitamins|mesh-ancestor
153551490|NCT01571921|Micronutrients|micronutrients|mesh-ancestor
153551491|NCT01571960|Vaccines|vaccines|mesh-list
153782577|NCT04556032|Protective Agents|protective agents|mesh-ancestor
153551493|NCT01571960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153551495|NCT01572012|Antiemetics|antiemetics|mesh-ancestor
153551496|NCT01572012|Autonomic Agents|autonomic agents|mesh-ancestor
153551500|NCT01572012|Antipruritics|antipruritics|mesh-ancestor
153551533|NCT01572116|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
153551534|NCT01572116|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153551535|NCT01572116|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153551536|NCT01572116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153551537|NCT01572116|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153551538|NCT01572116|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153551539|NCT01572116|Adrenergic Agents|adrenergic agents|mesh-ancestor
153551540|NCT01572116|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153551541|NCT01572116|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
153551542|NCT01572116|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153551543|NCT01572116|Autonomic Agents|autonomic agents|mesh-ancestor
153551544|NCT01572116|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153551545|NCT01572116|Respiratory System Agents|respiratory system agents|mesh-ancestor
153551546|NCT01572116|Mydriatics|mydriatics|mesh-ancestor
153551547|NCT01572116|Sympathomimetics|sympathomimetics|mesh-ancestor
153551549|NCT01572116|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153551550|NCT01572116|Narcotics|narcotics|mesh-ancestor
153551551|NCT01572116|Analgesics|analgesics|mesh-ancestor
153551552|NCT01572116|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153551553|NCT01572116|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153551555|NCT01572129|Clopidogrel|clopidogrel|mesh-list
153551556|NCT01572129|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153551557|NCT01572129|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
153551558|NCT01572129|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
153551581|NCT01572285|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153551582|NCT01572285|Antiemetics|antiemetics|mesh-ancestor
153551583|NCT01572285|Autonomic Agents|autonomic agents|mesh-ancestor
153551584|NCT01572285|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153551585|NCT01572285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153551586|NCT01572285|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153551587|NCT01572285|Glucocorticoids|glucocorticoids|mesh-ancestor
153551588|NCT01572285|Hormones|hormones|mesh-ancestor
153551589|NCT01572285|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153551590|NCT01572285|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153551591|NCT01572285|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153551592|NCT01572285|Protease Inhibitors|protease inhibitors|mesh-ancestor
153551600|NCT01572324|Antimetabolites|antimetabolites|mesh-ancestor
153551601|NCT01572324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153551602|NCT01572324|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153551603|NCT01572324|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153551604|NCT01572324|Immunologic Factors|immunologic factors|mesh-ancestor
153551605|NCT01572324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153551630|NCT01572350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153551631|NCT01572363|Sildenafil Citrate|sildenafil citrate|mesh-list
153551632|NCT01572363|Vasodilator Agents|vasodilator agents|mesh-ancestor
153551633|NCT01572363|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
153882259|NCT01608360|Lidocaine|lidocaine|mesh-list
153551634|NCT01572363|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
153551635|NCT01572363|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153551636|NCT01572363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153551637|NCT01572363|Urological Agents|urological agents|mesh-ancestor
153551638|NCT01572454|Dexmedetomidine|dexmedetomidine|mesh-list
153551639|NCT01572454|Remifentanil|remifentanil|mesh-list
153782578|NCT04556032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153551640|NCT01572454|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153782580|NCT04556071|Niraparib|niraparib|mesh-list
153551641|NCT01572454|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153551642|NCT01572454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153551656|NCT01572545|Denosumab|denosumab|mesh-list
153551685|NCT01572597|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153551686|NCT01572597|Antiviral Agents|antiviral agents|mesh-ancestor
153551687|NCT01572597|Expectorants|expectorants|mesh-ancestor
153551688|NCT01572597|Respiratory System Agents|respiratory system agents|mesh-ancestor
153551690|NCT01572597|Antioxidants|antioxidants|mesh-ancestor
153551691|NCT01572597|Protective Agents|protective agents|mesh-ancestor
153551692|NCT01572597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153551693|NCT01572623|Clopidogrel|clopidogrel|mesh-list
153551694|NCT01572623|Atorvastatin|atorvastatin|mesh-list
153551695|NCT01572623|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153551696|NCT01572623|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153551697|NCT01572623|Antimetabolites|antimetabolites|mesh-ancestor
153551698|NCT01572623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153551699|NCT01572623|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153551700|NCT01572623|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
153551701|NCT01572623|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153551702|NCT01572623|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153551740|NCT01572961|Analgesics|analgesics|mesh-ancestor
153551741|NCT01572961|Sensory System Agents|sensory system agents|mesh-ancestor
153551742|NCT01572961|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153551743|NCT01572961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153551744|NCT01572961|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153551745|NCT01572961|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153551746|NCT01572961|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153551747|NCT01572961|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153551748|NCT01572961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153551752|NCT01572961|Antipyretics|antipyretics|mesh-ancestor
153551754|NCT01573013|Trace Elements|trace elements|mesh-ancestor
153551755|NCT01573013|Micronutrients|micronutrients|mesh-ancestor
153551756|NCT01573013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153551757|NCT01573143|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
153551761|NCT01573143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153551765|NCT01573286|Glucagon|glucagon|mesh-list
153551792|NCT01573377|Estrogens|estrogens|mesh-ancestor
153551793|NCT01573377|Hormones|hormones|mesh-ancestor
153879929|NCT02921256|Antimetabolites|antimetabolites|mesh-ancestor
153879930|NCT02921256|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153551796|NCT01573377|Hormone Antagonists|hormone antagonists|mesh-ancestor
153551797|NCT01573377|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153551798|NCT01573377|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
153551799|NCT01573468|Capecitabine|capecitabine|mesh-list
153551800|NCT01573468|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153551801|NCT01573468|Antimetabolites|antimetabolites|mesh-ancestor
153551802|NCT01573468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153551803|NCT01573468|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153411135|NCT00003657|Amifostine|amifostine|mesh-list
153551807|NCT01573598|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
153551808|NCT01573598|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153423169|NCT03219866|Tiotropium Bromide|tiotropium bromide|mesh-list
153551809|NCT01573598|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153551810|NCT01573598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153551811|NCT01573598|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153551812|NCT01573598|Serotonin Agents|serotonin agents|mesh-ancestor
153551813|NCT01573598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153551814|NCT01573598|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
153551816|NCT01573637|Raloxifene Hydrochloride|raloxifene hydrochloride|mesh-list
153551817|NCT01573637|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
153551818|NCT01573637|Hormone Antagonists|hormone antagonists|mesh-ancestor
153551819|NCT01573637|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153551820|NCT01573637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153551821|NCT01573637|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
153551825|NCT01573663|Ambroxol|ambroxol|mesh-list
153551831|NCT01573715|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
153551832|NCT01573715|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
153551833|NCT01573715|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153551834|NCT01573715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153551835|NCT01573715|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
153551837|NCT01573715|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
153551838|NCT01573715|Cholinergic Agents|cholinergic agents|mesh-ancestor
153551839|NCT01573715|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153551840|NCT01573715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153551841|NCT01573741|Ketamine|ketamine|mesh-list
153551842|NCT01573741|Analgesics|analgesics|mesh-ancestor
153551843|NCT01573741|Sensory System Agents|sensory system agents|mesh-ancestor
153551844|NCT01573741|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153551846|NCT01573741|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
153551847|NCT01573741|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153551848|NCT01573741|Anesthetics, General|anesthetics, general|mesh-ancestor
153551849|NCT01573741|Anesthetics|anesthetics|mesh-ancestor
153551850|NCT01573741|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153551851|NCT01573741|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
153551852|NCT01573741|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
153551853|NCT01573741|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153551855|NCT01573806|Exenatide|exenatide|mesh-list
153551879|NCT01574027|Vitamins|vitamins|mesh-ancestor
153551880|NCT01574027|Micronutrients|micronutrients|mesh-ancestor
153551881|NCT01574027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153551882|NCT01574027|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153551883|NCT01574027|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153551886|NCT01574092|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
153551887|NCT01574092|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153551888|NCT01574092|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153551889|NCT01574092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153551890|NCT01574131|Fenofibrate|fenofibrate|mesh-list
153551891|NCT01574131|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153551892|NCT01574131|Antimetabolites|antimetabolites|mesh-ancestor
153551893|NCT01574131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153551894|NCT01574131|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153551895|NCT01574261|Inositol|inositol|mesh-list
153551897|NCT01574261|Vitamins|vitamins|mesh-ancestor
153551898|NCT01574261|Micronutrients|micronutrients|mesh-ancestor
153551899|NCT01574261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153551900|NCT01574313|Tocopherols|tocopherols|mesh-list
153551901|NCT01574313|Vitamin E|vitamin e|mesh-list
153551902|NCT01574313|Tocotrienols|tocotrienols|mesh-list
153551903|NCT01574313|alpha-Tocopherol|alpha-tocopherol|mesh-list
153551904|NCT01574313|Niacin|niacin|mesh-list
153551905|NCT01574313|Diphenidol|diphenidol|mesh-list
153551906|NCT01574313|Antioxidants|antioxidants|mesh-ancestor
153551931|NCT01574742|Minocycline|minocycline|mesh-list
153551932|NCT01574742|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153551933|NCT01574742|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153551934|NCT01574820|Rosiglitazone|rosiglitazone|mesh-list
153551935|NCT01574820|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153423182|NCT03219866|Parasympatholytics|parasympatholytics|mesh-ancestor
153551936|NCT01574820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153551937|NCT01575158|Citalopram|citalopram|mesh-list
153551938|NCT01575158|Clomipramine|clomipramine|mesh-list
153551939|NCT01575158|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
153551940|NCT01575158|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153551943|NCT01575158|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153551944|NCT01575158|Serotonin Agents|serotonin agents|mesh-ancestor
153551945|NCT01575158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153551946|NCT01575158|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
153551947|NCT01575158|Antidepressive Agents|antidepressive agents|mesh-ancestor
153551948|NCT01575158|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153551949|NCT01575158|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
153551984|NCT01575418|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153551985|NCT01575418|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153551986|NCT01575418|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
153551987|NCT01575418|Protective Agents|protective agents|mesh-ancestor
153551988|NCT01575418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153551989|NCT01575483|Saxagliptin|saxagliptin|mesh-list
153551990|NCT01575483|Incretins|incretins|mesh-ancestor
153551991|NCT01575483|Hormones|hormones|mesh-ancestor
153551992|NCT01575483|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153551993|NCT01575483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153919580|NCT00003601|Fenretinide|fenretinide|mesh-list
153919581|NCT00003601|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153551995|NCT01575483|Protease Inhibitors|protease inhibitors|mesh-ancestor
153551996|NCT01575483|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153551997|NCT01575483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153551998|NCT01575483|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153551999|NCT01575509|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
153552000|NCT01575613|Lumefantrine|lumefantrine|mesh-list
153552001|NCT01575613|Artemether|artemether|mesh-list
153552002|NCT01575613|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
153552003|NCT01575613|Antimalarials|antimalarials|mesh-ancestor
153552004|NCT01575613|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153552005|NCT01575613|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153552006|NCT01575613|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153552035|NCT01575678|Protective Agents|protective agents|mesh-ancestor
153552036|NCT01575678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153552037|NCT01575678|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153552038|NCT01575717|Vitamin D|vitamin d|mesh-list
153552039|NCT01575717|Ergocalciferols|ergocalciferols|mesh-list
153552040|NCT01575717|Cholecalciferol|cholecalciferol|mesh-list
153552041|NCT01575717|Vitamins|vitamins|mesh-list
153552047|NCT01575782|Amebicides|amebicides|mesh-ancestor
153552048|NCT01575782|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153552049|NCT01575782|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153552050|NCT01575782|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153552054|NCT01575795|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153552055|NCT01575795|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
153552056|NCT01575795|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
153552057|NCT01575795|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
153411136|NCT00003657|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153552089|NCT01576263|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153552090|NCT01576263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153552091|NCT01576263|Sensory System Agents|sensory system agents|mesh-ancestor
153552092|NCT01576263|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153552093|NCT01576354|4-Aminopyridine|4-aminopyridine|mesh-list
153552094|NCT01576354|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
153552095|NCT01576354|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153552096|NCT01576354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153552097|NCT01576419|Celecoxib|celecoxib|mesh-list
153552098|NCT01576419|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153552099|NCT01576419|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153552100|NCT01576419|Analgesics|analgesics|mesh-ancestor
153552109|NCT01576419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153552110|NCT01576458|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
153552111|NCT01576458|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
153552112|NCT01576458|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153552113|NCT01576627|Zinc|zinc|mesh-list
153552129|NCT01576640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153552130|NCT01576640|Dopamine Agents|dopamine agents|mesh-ancestor
153552131|NCT01576640|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153552132|NCT01576640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153552133|NCT01576640|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
153552134|NCT01576640|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153552135|NCT01576640|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153552136|NCT01576679|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
153552137|NCT01576679|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153552138|NCT01576679|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153552139|NCT01576679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153552141|NCT01576692|Antibodies|antibodies|mesh-list
153552142|NCT01576692|Immunoglobulins|immunoglobulins|mesh-list
153552143|NCT01576692|Sargramostim|sargramostim|mesh-list
153552147|NCT01576692|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153552148|NCT01576692|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153552149|NCT01576692|Antiviral Agents|antiviral agents|mesh-ancestor
153552153|NCT01576731|Lopinavir|lopinavir|mesh-list
153552154|NCT01576731|Raltegravir Potassium|raltegravir potassium|mesh-list
153552155|NCT01576731|Antiviral Agents|antiviral agents|mesh-ancestor
153552156|NCT01576731|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153552161|NCT01576731|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153552173|NCT01576770|Anesthetics, Local|anesthetics, local|mesh-ancestor
153552174|NCT01576770|Anesthetics|anesthetics|mesh-ancestor
153552175|NCT01576770|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153552176|NCT01576770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153552179|NCT01576770|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153552180|NCT01576770|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
153552181|NCT01576770|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153552182|NCT01576770|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153552184|NCT01576848|Caseins|caseins|mesh-list
153552188|NCT01577017|Letrozole|letrozole|mesh-list
153552232|NCT01577199|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
153552233|NCT01577199|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
153552236|NCT01577342|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153552237|NCT01577342|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153552238|NCT01577342|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153552239|NCT01577342|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153552240|NCT01577342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153552241|NCT01577342|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153552242|NCT01577368|Tazobactam|tazobactam|mesh-list
153552243|NCT01577368|Piperacillin|piperacillin|mesh-list
153552244|NCT01577368|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
153552245|NCT01577368|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153552246|NCT01577368|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153552248|NCT01577368|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153552249|NCT01577368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153552250|NCT01577407|Nefopam|nefopam|mesh-list
153552251|NCT01577407|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153552252|NCT01577407|Analgesics|analgesics|mesh-ancestor
153552253|NCT01577407|Sensory System Agents|sensory system agents|mesh-ancestor
153552254|NCT01577407|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153552255|NCT01577407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153552256|NCT01577459|Tedizolid phosphate|tedizolid phosphate|mesh-list
153552258|NCT01577459|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153552260|NCT01577524|Povidone-Iodine|povidone-iodine|mesh-list
153552279|NCT01577693|Hormone Antagonists|hormone antagonists|mesh-ancestor
153552280|NCT01577693|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153552282|NCT01577771|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
153552283|NCT01577771|Immunologic Factors|immunologic factors|mesh-ancestor
153552284|NCT01577771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153552286|NCT01577849|Cholecalciferol|cholecalciferol|mesh-list
153552288|NCT01577849|Micronutrients|micronutrients|mesh-ancestor
153552289|NCT01577849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153552290|NCT01577849|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153552291|NCT01577849|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153552292|NCT01577862|Rifampin|rifampin|mesh-list
153552293|NCT01577862|Colistin|colistin|mesh-list
153552294|NCT01577862|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
153552295|NCT01577862|Antitubercular Agents|antitubercular agents|mesh-ancestor
153552296|NCT01577862|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153552297|NCT01577862|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153552298|NCT01577862|Leprostatic Agents|leprostatic agents|mesh-ancestor
153552299|NCT01577862|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153552328|NCT01577940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153552329|NCT01577940|Sensory System Agents|sensory system agents|mesh-ancestor
153552330|NCT01577940|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153552332|NCT01577992|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
153552333|NCT01577992|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
153552334|NCT01577992|Dopamine Agents|dopamine agents|mesh-ancestor
153552335|NCT01577992|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153552336|NCT01577992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153552337|NCT01577992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153552339|NCT01578057|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
153552340|NCT01578057|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153552341|NCT01578057|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153552342|NCT01578057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153552343|NCT01578070|Salicylic Acid|salicylic acid|mesh-list
153552344|NCT01578070|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153552345|NCT01578070|Antifungal Agents|antifungal agents|mesh-ancestor
153552346|NCT01578070|Keratolytic Agents|keratolytic agents|mesh-ancestor
153552347|NCT01578070|Dermatologic Agents|dermatologic agents|mesh-ancestor
153552353|NCT01578161|Dexmedetomidine|dexmedetomidine|mesh-list
153552354|NCT01578161|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153552355|NCT01578161|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153552356|NCT01578161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153552357|NCT01578161|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153552358|NCT01578161|Analgesics|analgesics|mesh-ancestor
153552359|NCT01578161|Sensory System Agents|sensory system agents|mesh-ancestor
153552360|NCT01578161|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153552378|NCT01578174|Adrenergic Agents|adrenergic agents|mesh-ancestor
153552380|NCT01578174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153552381|NCT01578200|Calcium Carbonate|calcium carbonate|mesh-list
153552382|NCT01578200|Calcium|calcium|mesh-list
153552383|NCT01578200|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153552384|NCT01578200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153552385|NCT01578200|Antacids|antacids|mesh-ancestor
153552386|NCT01578200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153552387|NCT01578200|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153552388|NCT01578213|Imatinib Mesylate|imatinib mesylate|mesh-list
153552389|NCT01578213|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153552390|NCT01578213|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153552391|NCT01578213|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153552392|NCT01578213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153552393|NCT01578213|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153552394|NCT01578252|Ondansetron|ondansetron|mesh-list
153552395|NCT01578252|Antiemetics|antiemetics|mesh-ancestor
153552396|NCT01578252|Autonomic Agents|autonomic agents|mesh-ancestor
153552397|NCT01578252|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153552398|NCT01578252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153552399|NCT01578252|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153552429|NCT01578343|Dexamethasone acetate|dexamethasone acetate|mesh-list
153552430|NCT01578343|Fludarabine|fludarabine|mesh-list
153552431|NCT01578343|Fludarabine phosphate|fludarabine phosphate|mesh-list
153552432|NCT01578343|Mitoxantrone|mitoxantrone|mesh-list
153552433|NCT01578343|Vorinostat|vorinostat|mesh-list
153552434|NCT01578343|BB 1101|bb 1101|mesh-list
153552435|NCT01578343|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153552436|NCT01578343|Antiemetics|antiemetics|mesh-ancestor
153552438|NCT01578343|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153552439|NCT01578343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153552440|NCT01578343|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153552441|NCT01578343|Glucocorticoids|glucocorticoids|mesh-ancestor
153552442|NCT01578343|Hormones|hormones|mesh-ancestor
153552443|NCT01578343|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153552444|NCT01578343|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153423187|NCT03219866|Sympathomimetics|sympathomimetics|mesh-ancestor
153423188|NCT03300674|Lidocaine|lidocaine|mesh-list
153552445|NCT01578343|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153552446|NCT01578343|Protease Inhibitors|protease inhibitors|mesh-ancestor
153552447|NCT01578343|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153552448|NCT01578343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153552449|NCT01578343|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153552450|NCT01578343|Antimetabolites|antimetabolites|mesh-ancestor
153552451|NCT01578343|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153782585|NCT04556071|Growth Substances|growth substances|mesh-ancestor
153552452|NCT01578343|Immunologic Factors|immunologic factors|mesh-ancestor
153552453|NCT01578343|Analgesics|analgesics|mesh-ancestor
153552454|NCT01578343|Sensory System Agents|sensory system agents|mesh-ancestor
153552455|NCT01578343|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153552456|NCT01578343|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153552457|NCT01578343|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
153552458|NCT01578434|Calcium, Dietary|calcium, dietary|mesh-list
153552460|NCT01578434|Ergocalciferols|ergocalciferols|mesh-list
153552461|NCT01578434|Cholecalciferol|cholecalciferol|mesh-list
153552470|NCT01578434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153552471|NCT01578434|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153552472|NCT01578447|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
153552473|NCT01578447|Medroxyprogesterone|medroxyprogesterone|mesh-list
153552474|NCT01578447|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
153552475|NCT01578447|Contraceptive Agents|contraceptive agents|mesh-ancestor
153552476|NCT01578447|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153552477|NCT01578447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153552478|NCT01578447|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
153870535|NCT01084161|Analgesics|analgesics|mesh-ancestor
153552479|NCT01578447|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
153552480|NCT01578447|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153552481|NCT01578447|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153552482|NCT01578447|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
153552483|NCT01578447|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
153552484|NCT01578447|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
153552485|NCT01578473|Vitamin D|vitamin d|mesh-list
153552486|NCT01578473|Ergocalciferols|ergocalciferols|mesh-list
153552487|NCT01578473|Vitamins|vitamins|mesh-list
153552488|NCT01578473|Vitamin E|vitamin e|mesh-list
153552489|NCT01578473|Methyltestosterone|methyltestosterone|mesh-list
153552520|NCT01578603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153552523|NCT01578629|Tocopherols|tocopherols|mesh-list
153552524|NCT01578629|Tocotrienols|tocotrienols|mesh-list
153552525|NCT01578629|Vitamins|vitamins|mesh-ancestor
153552526|NCT01578629|Micronutrients|micronutrients|mesh-ancestor
153782586|NCT04556071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153552527|NCT01578629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153552528|NCT01578629|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153552529|NCT01578629|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153552530|NCT01578629|Analgesics|analgesics|mesh-ancestor
153552531|NCT01578629|Sensory System Agents|sensory system agents|mesh-ancestor
153552532|NCT01578629|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153552533|NCT01578629|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153552534|NCT01578629|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153552541|NCT01578629|Antipyretics|antipyretics|mesh-ancestor
153552578|NCT01578928|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153552579|NCT01578928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153552581|NCT01579019|Ribavirin|ribavirin|mesh-list
153552582|NCT01579019|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
153552583|NCT01579019|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
153552584|NCT01579019|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
153552585|NCT01579019|Protease Inhibitors|protease inhibitors|mesh-ancestor
153552586|NCT01579019|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153552587|NCT01579019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153552588|NCT01579019|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153552589|NCT01579019|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153552590|NCT01579019|Antiviral Agents|antiviral agents|mesh-ancestor
153552591|NCT01579019|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153423197|NCT03300674|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
153552592|NCT01579019|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
153552593|NCT01579019|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153552595|NCT01579058|Bisoprolol|bisoprolol|mesh-list
153552596|NCT01579058|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153552597|NCT01579058|Sympatholytics|sympatholytics|mesh-ancestor
153552598|NCT01579058|Autonomic Agents|autonomic agents|mesh-ancestor
153552599|NCT01579058|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153552600|NCT01579058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153552602|NCT01579058|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
153552627|NCT01579149|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153552628|NCT01579201|Carbetocin|carbetocin|mesh-list
153552629|NCT01579201|Oxytocics|oxytocics|mesh-ancestor
153552630|NCT01579201|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153552631|NCT01579201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153552632|NCT01579227|Tamoxifen|tamoxifen|mesh-list
153552633|NCT01579227|Tocotrienols|tocotrienols|mesh-list
153552634|NCT01579227|Vitamin E|vitamin e|mesh-list
153552635|NCT01579227|Tocopherols|tocopherols|mesh-list
153552638|NCT01579227|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153552639|NCT01579227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153552640|NCT01579227|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153552641|NCT01579227|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153552685|NCT01579500|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
153552686|NCT01579500|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
153552687|NCT01579500|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153552688|NCT01579500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153552690|NCT01579500|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153552691|NCT01579500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153552692|NCT01579500|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
153552693|NCT01579500|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153552694|NCT01579539|Methylprednisolone|methylprednisolone|mesh-list
153552697|NCT01579539|Prednisolone|prednisolone|mesh-list
153552749|NCT01579838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153552750|NCT01579864|Rocuronium|rocuronium|mesh-list
153552751|NCT01579864|Succinylcholine|succinylcholine|mesh-list
153552752|NCT01579864|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
153552753|NCT01579864|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
153552754|NCT01579864|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
153552755|NCT01579864|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153552756|NCT01579864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153552757|NCT01579864|Neuromuscular Depolarizing Agents|neuromuscular depolarizing agents|mesh-ancestor
153552758|NCT01579890|Diclofenac|diclofenac|mesh-list
153552760|NCT01579890|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153552761|NCT01579890|Analgesics|analgesics|mesh-ancestor
153552762|NCT01579890|Sensory System Agents|sensory system agents|mesh-ancestor
153552763|NCT01579890|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153552764|NCT01579890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153552765|NCT01579890|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153552766|NCT01579890|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153552767|NCT01579890|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153552768|NCT01579890|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153552769|NCT01579890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153552770|NCT01579903|Factor VIII|factor viii|mesh-list
153552771|NCT01579903|Coagulants|coagulants|mesh-ancestor
153552772|NCT01579929|Etoposide|etoposide|mesh-list
153552773|NCT01579929|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153552774|NCT01579929|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153552775|NCT01579929|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153552776|NCT01579929|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153552777|NCT01579929|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153552788|NCT01581333|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
153552789|NCT01581359|Triptorelin Pamoate|triptorelin pamoate|mesh-list
153552790|NCT01581359|Luteolytic Agents|luteolytic agents|mesh-ancestor
153882293|NCT01683032|Dopamine Agents|dopamine agents|mesh-ancestor
153552791|NCT01581359|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
153552792|NCT01581359|Contraceptive Agents|contraceptive agents|mesh-ancestor
153552793|NCT01581359|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153552794|NCT01581359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153552795|NCT01581359|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
153552796|NCT01581359|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153552799|NCT01581476|Atorvastatin|atorvastatin|mesh-list
153552800|NCT01581476|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
153552801|NCT01581476|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153552802|NCT01581476|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153552803|NCT01581476|Antimetabolites|antimetabolites|mesh-ancestor
153552804|NCT01581476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153552805|NCT01581476|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153552843|NCT01583062|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153552844|NCT01583062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153552845|NCT01583062|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
153552846|NCT01583426|Paclitaxel|paclitaxel|mesh-list
153552847|NCT01583426|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
153552848|NCT01583426|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153552849|NCT01583426|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153552850|NCT01583426|Tubulin Modulators|tubulin modulators|mesh-ancestor
153552851|NCT01583426|Antimitotic Agents|antimitotic agents|mesh-ancestor
153552852|NCT01583426|Mitosis Modulators|mitosis modulators|mesh-ancestor
153552853|NCT01583426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153879949|NCT02757885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153879950|NCT02757885|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153552855|NCT01583972|Retinol palmitate|retinol palmitate|mesh-list
153552856|NCT01583972|Vitamins|vitamins|mesh-ancestor
153552857|NCT01583972|Micronutrients|micronutrients|mesh-ancestor
153552858|NCT01583972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153782596|NCT00234377|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153782597|NCT00234377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153782598|NCT02211118|Dexmedetomidine|dexmedetomidine|mesh-list
153782599|NCT02211118|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153782600|NCT02211118|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153782601|NCT02211118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153782602|NCT02211118|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153552897|NCT01587339|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153552898|NCT01587339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153552899|NCT01587339|Anticonvulsants|anticonvulsants|mesh-ancestor
153552901|NCT01587339|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153552902|NCT01587339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153552903|NCT01587339|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153552904|NCT01587339|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153552905|NCT01587339|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153552906|NCT01587339|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153552907|NCT01587339|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153552945|NCT01588873|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
153552947|NCT01588873|Hormones|hormones|mesh-ancestor
153552948|NCT01588873|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153553010|NCT01590199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153553011|NCT01590199|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153553012|NCT01590199|Hormones|hormones|mesh-ancestor
153553013|NCT01590199|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153553014|NCT01590225|Ribavirin|ribavirin|mesh-list
153553015|NCT01590225|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
153553016|NCT01590225|Interferon-alpha|interferon-alpha|mesh-list
153553017|NCT01590225|Antimetabolites|antimetabolites|mesh-ancestor
153553018|NCT01590225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153553019|NCT01590225|Antiviral Agents|antiviral agents|mesh-ancestor
153553020|NCT01590225|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153553021|NCT01590225|Immunologic Factors|immunologic factors|mesh-ancestor
153553022|NCT01590225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153553023|NCT01590342|Diclofenac|diclofenac|mesh-list
153553070|NCT01590732|Romidepsin|romidepsin|mesh-list
153553071|NCT01590732|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153553072|NCT01590732|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153553073|NCT01590732|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153553074|NCT01590732|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153553075|NCT01590732|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153553076|NCT01590732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153553077|NCT01590732|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153553078|NCT01590732|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153553079|NCT01590732|Alkylating Agents|alkylating agents|mesh-ancestor
153553080|NCT01590732|Keratolytic Agents|keratolytic agents|mesh-ancestor
153553081|NCT01590732|Dermatologic Agents|dermatologic agents|mesh-ancestor
153553082|NCT01590732|Tubulin Modulators|tubulin modulators|mesh-ancestor
153553130|NCT01591031|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
153553131|NCT01591031|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
153553133|NCT01591031|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153553135|NCT01591070|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153553136|NCT01591070|Immunologic Factors|immunologic factors|mesh-ancestor
153553137|NCT01591070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153553138|NCT01591070|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
153553139|NCT01591070|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153553140|NCT01591070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153553141|NCT01591083|Esomeprazole|esomeprazole|mesh-list
153553142|NCT01591083|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
153553143|NCT01591083|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153553144|NCT01591083|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
153553145|NCT01591083|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153553146|NCT01591083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153553184|NCT01591226|Sodium Citrate|sodium citrate|mesh-list
153553192|NCT01591226|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
153553195|NCT01591226|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
153553197|NCT01591226|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153553198|NCT01591226|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
153553199|NCT01591226|Diuretics|diuretics|mesh-ancestor
153553200|NCT01591226|Natriuretic Agents|natriuretic agents|mesh-ancestor
153553201|NCT01591434|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
153553202|NCT01591434|Laxatives|laxatives|mesh-ancestor
153553203|NCT01591434|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153553204|NCT01591551|Natalizumab|natalizumab|mesh-list
153553238|NCT01591850|Antifungal Agents|antifungal agents|mesh-ancestor
153553239|NCT01591850|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
153553240|NCT01591850|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153553241|NCT01591850|Hormone Antagonists|hormone antagonists|mesh-ancestor
153553242|NCT01591850|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153553243|NCT01591850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153553245|NCT01591889|Alkylating Agents|alkylating agents|mesh-ancestor
153553246|NCT01591889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153553247|NCT01591889|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153553248|NCT01591889|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153553249|NCT01591889|Antitrichomonal Agents|antitrichomonal agents|mesh-ancestor
153553250|NCT01591889|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153553251|NCT01591889|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153553252|NCT01591902|Tesamorelin|tesamorelin|mesh-list
153919582|NCT00003601|Keratolytic Agents|keratolytic agents|mesh-ancestor
153553253|NCT01591902|Growth Substances|growth substances|mesh-ancestor
153553254|NCT01591902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153553255|NCT01591980|Pregabalin|pregabalin|mesh-list
153553294|NCT01592032|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153553295|NCT01592032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153553296|NCT01592032|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
153553297|NCT01592032|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153553299|NCT01592136|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153553300|NCT01592136|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153553301|NCT01592136|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153553302|NCT01592136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153553303|NCT01592136|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153553304|NCT01592162|Remifentanil|remifentanil|mesh-list
153553305|NCT01592162|Propofol|propofol|mesh-list
153553306|NCT01592162|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153553307|NCT01592162|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153553310|NCT01592162|Anesthetics, General|anesthetics, general|mesh-ancestor
153553354|NCT01592227|Sensory System Agents|sensory system agents|mesh-ancestor
153882305|NCT01604928|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
153882308|NCT01683149|Sorafenib|sorafenib|mesh-list
153553355|NCT01592227|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153553356|NCT01592227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153553357|NCT01592227|Antipyretics|antipyretics|mesh-ancestor
153553358|NCT01592253|Sirolimus|sirolimus|mesh-list
153553359|NCT01592253|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153553360|NCT01592253|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153553362|NCT01592253|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153420801|NCT01306994|Sensory System Agents|sensory system agents|mesh-ancestor
153420802|NCT01306994|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153553364|NCT01592253|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153553365|NCT01592253|Immunologic Factors|immunologic factors|mesh-ancestor
153553366|NCT01592253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153553367|NCT01592279|Liraglutide|liraglutide|mesh-list
153553368|NCT01592279|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153553369|NCT01592279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153553370|NCT01592279|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
153553372|NCT01592279|Hormones|hormones|mesh-ancestor
153553373|NCT01592279|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153553374|NCT01592305|Ritonavir|ritonavir|mesh-list
153553375|NCT01592305|Atazanavir Sulfate|atazanavir sulfate|mesh-list
153553376|NCT01592305|Tenofovir|tenofovir|mesh-list
153553377|NCT01592305|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
153553378|NCT01592305|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
153553404|NCT01592526|Nicotine|nicotine|mesh-list
153553405|NCT01592526|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
153553406|NCT01592526|Autonomic Agents|autonomic agents|mesh-ancestor
153553407|NCT01592526|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153553408|NCT01592526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153553411|NCT01592526|Cholinergic Agents|cholinergic agents|mesh-ancestor
153553412|NCT01592526|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153553413|NCT01592526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153553415|NCT01592630|Anesthetics, Local|anesthetics, local|mesh-ancestor
153553416|NCT01592630|Anesthetics|anesthetics|mesh-ancestor
153553417|NCT01592630|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153553418|NCT01592630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153553419|NCT01592630|Sensory System Agents|sensory system agents|mesh-ancestor
153553420|NCT01592630|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153553421|NCT01592981|Cyclophosphamide|cyclophosphamide|mesh-list
153553423|NCT01592981|Fludarabine|fludarabine|mesh-list
153553424|NCT01592981|Bortezomib|bortezomib|mesh-list
153553460|NCT01593124|Spermatocidal Agents|spermatocidal agents|mesh-ancestor
153553462|NCT01593124|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
153553463|NCT01593124|Contraceptive Agents|contraceptive agents|mesh-ancestor
153553464|NCT01593124|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153553465|NCT01593124|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
153553467|NCT01593137|Liraglutide|liraglutide|mesh-list
153553468|NCT01593137|Glimepiride|glimepiride|mesh-list
153553469|NCT01593137|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153553470|NCT01593137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153553473|NCT01593137|Hormones|hormones|mesh-ancestor
153553474|NCT01593137|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153553475|NCT01593137|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153553519|NCT01593319|Ropivacaine|ropivacaine|mesh-list
153553520|NCT01593319|Anesthetics, Local|anesthetics, local|mesh-ancestor
153553521|NCT01593319|Anesthetics|anesthetics|mesh-ancestor
153553522|NCT01593319|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153553523|NCT01593319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153553524|NCT01593319|Sensory System Agents|sensory system agents|mesh-ancestor
153553525|NCT01593319|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153553527|NCT01593332|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153553528|NCT01593332|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153553531|NCT01593332|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153553533|NCT01593371|Pioglitazone|pioglitazone|mesh-list
153553534|NCT01593371|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153553535|NCT01593371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153553536|NCT01593397|Fentanyl|fentanyl|mesh-list
153553537|NCT01593397|Propofol|propofol|mesh-list
153553579|NCT01593514|Cathartics|cathartics|mesh-ancestor
153553580|NCT01593514|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153553583|NCT01593566|Anesthetics|anesthetics|mesh-ancestor
153553584|NCT01593566|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153553585|NCT01593566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153553586|NCT01593566|Sensory System Agents|sensory system agents|mesh-ancestor
153553587|NCT01593566|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153553588|NCT01593605|Resveratrol|resveratrol|mesh-list
153553589|NCT01593605|Antioxidants|antioxidants|mesh-ancestor
153553590|NCT01593605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153553591|NCT01593605|Protective Agents|protective agents|mesh-ancestor
153553593|NCT01593605|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153553594|NCT01593605|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153553636|NCT01593826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153553637|NCT01593826|Antidotes|antidotes|mesh-ancestor
153553638|NCT01593826|Protective Agents|protective agents|mesh-ancestor
153553639|NCT01593930|Lidocaine|lidocaine|mesh-list
153553640|NCT01593930|Carticaine|carticaine|mesh-list
153553641|NCT01593930|Anesthetics, Local|anesthetics, local|mesh-ancestor
153553642|NCT01593930|Anesthetics|anesthetics|mesh-ancestor
153553643|NCT01593930|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153553644|NCT01593930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153553645|NCT01593930|Sensory System Agents|sensory system agents|mesh-ancestor
153553646|NCT01593930|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153553647|NCT01593930|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153553648|NCT01593930|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
153553649|NCT01593930|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153553650|NCT01593930|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153553651|NCT01593930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153553652|NCT01593995|Mitogens|mitogens|mesh-list
153553653|NCT01593995|Mitosis Modulators|mitosis modulators|mesh-ancestor
153553654|NCT01593995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153553655|NCT01594060|Insulin|insulin|mesh-list
153553656|NCT01594060|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
153553688|NCT01594177|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153553689|NCT01594177|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153553690|NCT01594177|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153553691|NCT01594177|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153553692|NCT01594177|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153553693|NCT01594177|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153553694|NCT01594229|Rituximab|rituximab|mesh-list
153553695|NCT01594229|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
153553696|NCT01594229|Venetoclax|venetoclax|mesh-list
153553697|NCT01594229|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153553698|NCT01594229|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153553699|NCT01594229|Immunologic Factors|immunologic factors|mesh-ancestor
153553700|NCT01594229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153553701|NCT01594229|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153553702|NCT01594229|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153553704|NCT01594229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153553705|NCT01594242|Bortezomib|bortezomib|mesh-list
153553706|NCT01594242|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153553707|NCT01594255|Moxifloxacin|moxifloxacin|mesh-list
153553708|NCT01594255|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153553709|NCT01594255|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153553710|NCT01594255|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153553711|NCT01594255|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153553712|NCT01594255|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153553713|NCT01594255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153553738|NCT01594489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153553742|NCT01594489|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
153553743|NCT01594489|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153553744|NCT01594489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153553745|NCT01594489|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
153553746|NCT01594489|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
153553747|NCT01594489|Purinergic Agents|purinergic agents|mesh-ancestor
153553748|NCT01594489|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153553749|NCT01594489|Protective Agents|protective agents|mesh-ancestor
153553751|NCT01594502|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
153553753|NCT01594502|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153553794|NCT01594866|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
153553795|NCT01594866|Parasympatholytics|parasympatholytics|mesh-ancestor
153553797|NCT01594866|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153553798|NCT01594866|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
153553799|NCT01594866|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
153553801|NCT01594866|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
153553802|NCT01594866|Antidepressive Agents|antidepressive agents|mesh-ancestor
153553803|NCT01594866|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153553805|NCT01594879|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
153553806|NCT01594879|Contraceptive Agents|contraceptive agents|mesh-ancestor
153553807|NCT01594879|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153553809|NCT01594879|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
153553810|NCT01594879|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
153553811|NCT01594879|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
153553812|NCT01594905|Tenofovir|tenofovir|mesh-list
153553813|NCT01594905|Entecavir|entecavir|mesh-list
153553814|NCT01594905|Antiviral Agents|antiviral agents|mesh-ancestor
153553815|NCT01594905|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153553816|NCT01594905|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153553817|NCT01594905|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153553818|NCT01594905|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153553819|NCT01594905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153553820|NCT01594905|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153879960|NCT02757885|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153879961|NCT02703623|Prednisone|prednisone|mesh-list
153879962|NCT02703623|Cortisone|cortisone|mesh-list
153879963|NCT02703623|Carboplatin|carboplatin|mesh-list
153879965|NCT02703623|Abiraterone Acetate|abiraterone acetate|mesh-list
153879966|NCT02703623|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153879967|NCT02703623|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153879968|NCT02703623|Glucocorticoids|glucocorticoids|mesh-ancestor
153879969|NCT02703623|Hormones|hormones|mesh-ancestor
153879970|NCT02703623|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153879971|NCT02703623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153879972|NCT02703623|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153553840|NCT01595009|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153553841|NCT01595009|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153553842|NCT01595009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153553843|NCT01595009|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153553844|NCT01595009|Immunologic Factors|immunologic factors|mesh-ancestor
153553845|NCT01595009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153553846|NCT01595009|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153553847|NCT01595022|Contraceptive Agents|contraceptive agents|mesh-list
153553848|NCT01595022|Levonorgestrel|levonorgestrel|mesh-list
153553849|NCT01595022|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153553850|NCT01595022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153914736|NCT01010061|Rituximab|rituximab|mesh-list
153553851|NCT01595022|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
153553852|NCT01595022|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
153553853|NCT01595022|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
153553854|NCT01595022|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
153553855|NCT01595152|Solifenacin Succinate|solifenacin succinate|mesh-list
153553857|NCT01595152|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
153553858|NCT01595152|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
153553859|NCT01595152|Cholinergic Agents|cholinergic agents|mesh-ancestor
153553871|NCT01595399|Atropine|atropine|mesh-list
153553892|NCT01595425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153553893|NCT01595594|Doxycycline|doxycycline|mesh-list
153553894|NCT01595594|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153553895|NCT01595594|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153553896|NCT01595594|Antimalarials|antimalarials|mesh-ancestor
153553897|NCT01595594|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153553898|NCT01595594|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153553899|NCT01595633|Tenofovir|tenofovir|mesh-list
153553900|NCT01595633|Adefovir|adefovir|mesh-list
153553901|NCT01595633|Antiviral Agents|antiviral agents|mesh-ancestor
153553902|NCT01595633|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153553903|NCT01595633|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153553904|NCT01595633|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153553905|NCT01595633|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153553906|NCT01595633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153553907|NCT01595633|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153553908|NCT01595633|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153553910|NCT01595685|Telbivudine|telbivudine|mesh-list
153553911|NCT01595685|Antiviral Agents|antiviral agents|mesh-ancestor
153553912|NCT01595685|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153553913|NCT01595685|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153914858|NCT01009203|Temsirolimus|temsirolimus|mesh-list
153553914|NCT01595685|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153423200|NCT03300674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153553915|NCT01595685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153879974|NCT02703623|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153420804|NCT01306994|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153420805|NCT01306994|Vasodilator Agents|vasodilator agents|mesh-ancestor
153420806|NCT01306994|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
153420807|NCT01306994|Purinergic Agonists|purinergic agonists|mesh-ancestor
153420808|NCT01306994|Purinergic Agents|purinergic agents|mesh-ancestor
153463893|NCT02549898|Respiratory System Agents|respiratory system agents|mesh-ancestor
153420809|NCT01306994|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153420810|NCT01306994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153420811|NCT02979301|Tamoxifen|tamoxifen|mesh-list
153420812|NCT02979301|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
153420813|NCT02979301|Hormone Antagonists|hormone antagonists|mesh-ancestor
153553916|NCT01595724|Dienogest|dienogest|mesh-list
153553917|NCT01595724|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
153553918|NCT01595724|Contraceptive Agents|contraceptive agents|mesh-ancestor
153553919|NCT01595724|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153553920|NCT01595724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153553921|NCT01595724|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
153782608|NCT02211118|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153553923|NCT01595724|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
153553925|NCT01595724|Hormone Antagonists|hormone antagonists|mesh-ancestor
153553930|NCT01595737|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
153553931|NCT01595737|Vasodilator Agents|vasodilator agents|mesh-ancestor
153553932|NCT01595737|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
153553933|NCT01595737|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
153553934|NCT01595737|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153553935|NCT01595737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153553936|NCT01595737|Protective Agents|protective agents|mesh-ancestor
153553937|NCT01595737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153553938|NCT01595763|Fibrin fragment D|fibrin fragment d|mesh-list
153553939|NCT01595763|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
153553940|NCT01595763|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153466846|NCT00458952|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
153553941|NCT01595763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153553942|NCT01595763|Hemostatics|hemostatics|mesh-ancestor
153553943|NCT01595763|Coagulants|coagulants|mesh-ancestor
153553944|NCT01595789|Liraglutide|liraglutide|mesh-list
153553945|NCT01595789|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
153553946|NCT01595789|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153553947|NCT01595789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153553948|NCT01595789|Incretins|incretins|mesh-ancestor
153553949|NCT01595789|Hormones|hormones|mesh-ancestor
153553950|NCT01595789|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153553951|NCT01595815|Calcium|calcium|mesh-list
153553952|NCT01595815|Ionophores|ionophores|mesh-list
153553980|NCT01595893|Vitamin D|vitamin d|mesh-list
153553981|NCT01595893|Cholecalciferol|cholecalciferol|mesh-list
153553982|NCT01595893|Vitamins|vitamins|mesh-ancestor
153553983|NCT01595893|Micronutrients|micronutrients|mesh-ancestor
153553984|NCT01595893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153553985|NCT01595893|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153553986|NCT01595893|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153553987|NCT01595958|Cyclosporine|cyclosporine|mesh-list
153553988|NCT01595958|Cyclosporins|cyclosporins|mesh-list
153553989|NCT01595958|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153553990|NCT01595958|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153553991|NCT01595958|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153553992|NCT01595958|Immunologic Factors|immunologic factors|mesh-ancestor
153553993|NCT01595958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153553994|NCT01595958|Antifungal Agents|antifungal agents|mesh-ancestor
153554037|NCT01596114|Cariostatic Agents|cariostatic agents|mesh-ancestor
153554038|NCT01596114|Protective Agents|protective agents|mesh-ancestor
153423208|NCT02158806|Sensory System Agents|sensory system agents|mesh-ancestor
153374868|NCT02214290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153554039|NCT01596114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153554040|NCT01596140|Sirolimus|sirolimus|mesh-list
153554041|NCT01596140|Everolimus|everolimus|mesh-list
153554042|NCT01596140|Temsirolimus|temsirolimus|mesh-list
153554043|NCT01596140|MTOR Inhibitors|mtor inhibitors|mesh-list
153554044|NCT01596140|Vemurafenib|vemurafenib|mesh-list
153920455|NCT06331520|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153920456|NCT06331494|3-n-butylphthalide|3-n-butylphthalide|mesh-list
153920457|NCT06331494|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153920458|NCT06331494|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
153920459|NCT06331494|Protective Agents|protective agents|mesh-ancestor
153920460|NCT06331494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153469284|NCT05298423|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153554045|NCT01596140|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153554046|NCT01596140|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153554047|NCT01596140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153554048|NCT01596140|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153554049|NCT01596140|Immunologic Factors|immunologic factors|mesh-ancestor
153554050|NCT01596140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153554051|NCT01596140|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153469638|NCT04671667|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153554097|NCT01596400|Autonomic Agents|autonomic agents|mesh-ancestor
153554098|NCT01596400|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153554099|NCT01596400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153554100|NCT01596400|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153554101|NCT01596400|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
153554102|NCT01596400|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153554103|NCT01596400|Serotonin Agents|serotonin agents|mesh-ancestor
153554104|NCT01596400|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153554105|NCT01596400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153554107|NCT01596413|Antiemetics|antiemetics|mesh-ancestor
153554108|NCT01596413|Autonomic Agents|autonomic agents|mesh-ancestor
153554109|NCT01596413|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153554159|NCT01596647|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153554160|NCT01596647|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153554161|NCT01596647|Anesthetics, General|anesthetics, general|mesh-ancestor
153554162|NCT01596647|Anesthetics|anesthetics|mesh-ancestor
153554163|NCT01596647|GABA Modulators|gaba modulators|mesh-ancestor
153554164|NCT01596647|GABA Agents|gaba agents|mesh-ancestor
153554165|NCT01596647|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153554166|NCT01596647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153554167|NCT01596647|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
153554168|NCT01596647|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
153554169|NCT01596647|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153554170|NCT01596647|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
153554171|NCT01596647|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
153554172|NCT01596647|Purinergic Agents|purinergic agents|mesh-ancestor
153554173|NCT01596647|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
153554174|NCT01596647|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153554175|NCT01596647|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
153554176|NCT01596647|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153554177|NCT01596647|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153554179|NCT01596647|Sensory System Agents|sensory system agents|mesh-ancestor
153554180|NCT01596647|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153554181|NCT01596647|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153554182|NCT01596647|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153554183|NCT01596647|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153554184|NCT01596660|Bupivacaine|bupivacaine|mesh-list
153554207|NCT01596738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153554208|NCT01596738|Hemostatics|hemostatics|mesh-ancestor
153554209|NCT01596738|Coagulants|coagulants|mesh-ancestor
153554210|NCT01596764|Sulfasalazine|sulfasalazine|mesh-list
153554211|NCT01596764|Naloxone|naloxone|mesh-list
153374869|NCT02214290|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
153374871|NCT02214290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153374872|NCT02214290|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
153554212|NCT01596764|Methylnaltrexone|methylnaltrexone|mesh-list
153554213|NCT01596764|Loperamide|loperamide|mesh-list
153554214|NCT01596764|Antidiarrheals|antidiarrheals|mesh-list
153554215|NCT01596764|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
153554216|NCT01596764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153554217|NCT01596764|Sensory System Agents|sensory system agents|mesh-ancestor
153919794|NCT00934648|Antimetabolites|antimetabolites|mesh-ancestor
153554278|NCT01596907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153554279|NCT01596907|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
153554280|NCT01596907|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
153554281|NCT01596907|Purinergic Agents|purinergic agents|mesh-ancestor
153554282|NCT01596907|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153554283|NCT01596907|Sympathomimetics|sympathomimetics|mesh-ancestor
153554284|NCT01596907|Autonomic Agents|autonomic agents|mesh-ancestor
153554285|NCT01596907|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153554286|NCT01596907|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
153554287|NCT01596907|Adrenergic Agents|adrenergic agents|mesh-ancestor
153554288|NCT01596907|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153554289|NCT01596907|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153554341|NCT01597232|Sensory System Agents|sensory system agents|mesh-ancestor
153554342|NCT01597232|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153554343|NCT01597232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153554344|NCT01597232|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153554345|NCT01597232|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153554346|NCT01597297|4-Aminopyridine|4-aminopyridine|mesh-list
153554347|NCT01597297|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
153554348|NCT01597297|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153554349|NCT01597297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153554350|NCT01597310|Pramipexole|pramipexole|mesh-list
153554399|NCT01597531|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153919903|NCT04287387|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153554400|NCT01597531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153554401|NCT01597531|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
153554402|NCT01597531|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153554403|NCT01597609|Sibutramine|sibutramine|mesh-list
153554404|NCT01597609|Antidepressive Agents|antidepressive agents|mesh-ancestor
153554405|NCT01597609|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153554406|NCT01597609|Appetite Depressants|appetite depressants|mesh-ancestor
153554407|NCT01597609|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
153554408|NCT01597648|Maraviroc|maraviroc|mesh-list
153554409|NCT01597648|Lamivudine, zidovudine drug combination|lamivudine, zidovudine drug combination|mesh-list
153919957|NCT04176367|Adrenergic Agents|adrenergic agents|mesh-ancestor
153919958|NCT04176367|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153919959|NCT04176367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153919960|NCT04176367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153919961|NCT04176367|Vasodilator Agents|vasodilator agents|mesh-ancestor
153919962|NCT04176367|Nootropic Agents|nootropic agents|mesh-ancestor
153554410|NCT01597648|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
153554411|NCT01597648|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
153554412|NCT01597648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153554414|NCT01597648|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153554415|NCT01597648|Antiviral Agents|antiviral agents|mesh-ancestor
153554416|NCT01597648|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153554417|NCT01597648|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
153554418|NCT01597648|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153554419|NCT01597648|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153554421|NCT01597661|Bupropion|bupropion|mesh-list
153554422|NCT01597661|Antidepressive Agents|antidepressive agents|mesh-list
153554443|NCT01597713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153554445|NCT01597726|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
153554446|NCT01597726|Abortifacient Agents|abortifacient agents|mesh-ancestor
153554447|NCT01597726|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153554448|NCT01597726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153554449|NCT01597726|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
153554450|NCT01597726|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153554451|NCT01597726|Oxytocics|oxytocics|mesh-ancestor
153554452|NCT01597765|Vitamins|vitamins|mesh-list
153554453|NCT01597765|Vitamin E|vitamin e|mesh-list
153554454|NCT01597765|Tocopherols|tocopherols|mesh-list
153554455|NCT01597765|Tocotrienols|tocotrienols|mesh-list
153554456|NCT01597765|alpha-Tocopherol|alpha-tocopherol|mesh-list
153554457|NCT01597765|Acetylcysteine|acetylcysteine|mesh-list
153554458|NCT01597765|N-monoacetylcystine|n-monoacetylcystine|mesh-list
153554459|NCT01597765|Deferiprone|deferiprone|mesh-list
153554460|NCT01597765|Micronutrients|micronutrients|mesh-ancestor
153920075|NCT03695445|Adrenergic Agents|adrenergic agents|mesh-ancestor
153554474|NCT01597817|Chitosan|chitosan|mesh-list
153554505|NCT01597934|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153554506|NCT01597934|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153554507|NCT01597986|Isavuconazole|isavuconazole|mesh-list
153554508|NCT01597986|Ethinyl Estradiol|ethinyl estradiol|mesh-list
153554509|NCT01597986|Norethindrone|norethindrone|mesh-list
153554510|NCT01597986|Norethindrone Acetate|norethindrone acetate|mesh-list
153554511|NCT01597986|Norinyl|norinyl|mesh-list
153554512|NCT01597986|Contraceptive Agents|contraceptive agents|mesh-list
153554513|NCT01597986|Contraceptives, Oral|contraceptives, oral|mesh-list
153554514|NCT01597986|Estradiol|estradiol|mesh-list
153782618|NCT00234416|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153554515|NCT01597986|Estrogens|estrogens|mesh-ancestor
153554516|NCT01597986|Hormones|hormones|mesh-ancestor
153554517|NCT01597986|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153554518|NCT01597986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153920136|NCT04033471|Sensory System Agents|sensory system agents|mesh-ancestor
153554519|NCT01597986|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
153554520|NCT01597986|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153782619|NCT00234416|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153554521|NCT01597986|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
153554522|NCT01597986|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
153554523|NCT01597986|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
153554525|NCT01597986|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153554526|NCT01597986|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
153554527|NCT01598012|Mefenamic Acid|mefenamic acid|mesh-list
153554528|NCT01598012|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153554529|NCT01598012|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153554530|NCT01598012|Analgesics|analgesics|mesh-ancestor
153554531|NCT01598012|Sensory System Agents|sensory system agents|mesh-ancestor
153554532|NCT01598012|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153554533|NCT01598012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153554539|NCT01598051|Rivaroxaban|rivaroxaban|mesh-list
153554546|NCT01598051|Anticoagulants|anticoagulants|mesh-ancestor
153554547|NCT01598168|Rivaroxaban|rivaroxaban|mesh-list
153554548|NCT01598168|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
153554549|NCT01598168|Antithrombins|antithrombins|mesh-ancestor
153554550|NCT01598168|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
153554551|NCT01598168|Protease Inhibitors|protease inhibitors|mesh-ancestor
153554552|NCT01598168|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153554553|NCT01598168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153554554|NCT01598168|Anticoagulants|anticoagulants|mesh-ancestor
153554556|NCT01598259|Antioxidants|antioxidants|mesh-ancestor
153554557|NCT01598259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153554558|NCT01598259|Protective Agents|protective agents|mesh-ancestor
153554559|NCT01598259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153554560|NCT01598259|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153554561|NCT01598337|Aspirin|aspirin|mesh-list
153554562|NCT01598337|Tirofiban|tirofiban|mesh-list
153554563|NCT01598337|Clopidogrel|clopidogrel|mesh-list
153554564|NCT01598337|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
153554565|NCT01598337|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153920217|NCT00644761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153375516|NCT01562678|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153882311|NCT01683149|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153882312|NCT01683149|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153882313|NCT01683149|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153882314|NCT01683149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153920218|NCT00645073|Levofloxacin|levofloxacin|mesh-list
153920219|NCT00645073|Cefdinir|cefdinir|mesh-list
153920220|NCT00645073|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
153920221|NCT00645073|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153920222|NCT00645073|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153920223|NCT00645073|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153920224|NCT00645073|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153554567|NCT01598337|Analgesics|analgesics|mesh-ancestor
153554569|NCT01598337|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153554570|NCT01598337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153554571|NCT01598337|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153554572|NCT01598337|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153554594|NCT01598441|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153554595|NCT01598441|Vasodilator Agents|vasodilator agents|mesh-ancestor
153554596|NCT01598480|Anti-Infective Agents|anti-infective agents|mesh-list
153554597|NCT01598480|Silver Sulfadiazine|silver sulfadiazine|mesh-list
153554598|NCT01598480|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
153554599|NCT01598480|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
153554600|NCT01598493|Anti-Infective Agents|anti-infective agents|mesh-list
153554601|NCT01598493|Silver Sulfadiazine|silver sulfadiazine|mesh-list
153554602|NCT01598493|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
153554603|NCT01598493|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
153554604|NCT01598558|Rituximab|rituximab|mesh-list
153554605|NCT01598558|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153554606|NCT01598558|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153469143|NCT05504083|Benzbromarone|benzbromarone|mesh-list
153554607|NCT01598558|Immunologic Factors|immunologic factors|mesh-ancestor
153554608|NCT01598558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153554609|NCT01598558|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153554610|NCT01598584|Gemcitabine|gemcitabine|mesh-list
153554611|NCT01598584|Mirtazapine|mirtazapine|mesh-list
153554612|NCT01598584|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153554613|NCT01598584|Antimetabolites|antimetabolites|mesh-ancestor
153554614|NCT01598584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153920417|NCT06331559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153920418|NCT06331559|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153922237|NCT05116462|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153920430|NCT06331520|Dexamethasone|dexamethasone|mesh-list
153920431|NCT06331520|Olanzapine|olanzapine|mesh-list
153920432|NCT06331520|Palonosetron|palonosetron|mesh-list
153920433|NCT06331520|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153920434|NCT06331520|Antiemetics|antiemetics|mesh-ancestor
153920435|NCT06331520|Autonomic Agents|autonomic agents|mesh-ancestor
153920436|NCT06331520|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153920437|NCT06331520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153920439|NCT06331520|Glucocorticoids|glucocorticoids|mesh-ancestor
153554615|NCT01598584|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153554616|NCT01598584|Antidepressive Agents|antidepressive agents|mesh-ancestor
153554617|NCT01598584|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153554618|NCT01598584|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
153554619|NCT01598584|Histamine Antagonists|histamine antagonists|mesh-ancestor
153554620|NCT01598584|Histamine Agents|histamine agents|mesh-ancestor
153554621|NCT01598584|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153554622|NCT01598584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153554642|NCT01598649|Natriuretic Agents|natriuretic agents|mesh-ancestor
153554643|NCT01598649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153554645|NCT01598649|Sequestering Agents|sequestering agents|mesh-ancestor
153879975|NCT02703623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153554646|NCT01598649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153554647|NCT01598675|Methamphetamine|methamphetamine|mesh-list
153554648|NCT01598675|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
153554649|NCT01598675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153554650|NCT01598675|Sympathomimetics|sympathomimetics|mesh-ancestor
153554651|NCT01598675|Autonomic Agents|autonomic agents|mesh-ancestor
153554652|NCT01598675|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153554653|NCT01598675|Dopamine Agents|dopamine agents|mesh-ancestor
153554654|NCT01598675|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153554655|NCT01598675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153554656|NCT01598675|Adrenergic Agents|adrenergic agents|mesh-ancestor
153554657|NCT01598675|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
153554658|NCT01598675|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153554659|NCT01598675|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153554660|NCT01598675|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
153554661|NCT01598883|Heparin|heparin|mesh-list
153554662|NCT01598883|Calcium heparin|calcium heparin|mesh-list
153554663|NCT01598883|Antithrombins|antithrombins|mesh-list
153554664|NCT01598883|Anticoagulants|anticoagulants|mesh-ancestor
153554665|NCT01598883|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153554666|NCT01598883|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153554686|NCT01599013|Vinblastine|vinblastine|mesh-list
153922774|NCT04384484|Gemcitabine|gemcitabine|mesh-list
153922775|NCT04384484|Oxaliplatin|oxaliplatin|mesh-list
153922776|NCT04384484|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153922777|NCT04384484|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153922778|NCT04384484|Immunologic Factors|immunologic factors|mesh-ancestor
153922779|NCT04384484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153920860|NCT06308653|Hallucinogens|hallucinogens|mesh-ancestor
153920861|NCT06308653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153920862|NCT06308653|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153554687|NCT01599013|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153554688|NCT01599013|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153554690|NCT01599013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153554691|NCT01599013|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153554692|NCT01599013|Tubulin Modulators|tubulin modulators|mesh-ancestor
153554693|NCT01599013|Antimitotic Agents|antimitotic agents|mesh-ancestor
153554694|NCT01599013|Mitosis Modulators|mitosis modulators|mesh-ancestor
153554695|NCT01599078|Paclitaxel|paclitaxel|mesh-list
153554696|NCT01599078|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153922924|NCT04177498|ON 01910|on 01910|mesh-list
153922925|NCT04177498|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153922926|NCT04177498|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153922927|NCT04177498|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153922928|NCT04177498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153471698|NCT03439033|Sequestering Agents|sequestering agents|mesh-ancestor
153471699|NCT03439033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153471700|NCT03439033|Anticoagulants|anticoagulants|mesh-ancestor
153471701|NCT03439033|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
153554697|NCT01599078|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153554698|NCT01599078|Tubulin Modulators|tubulin modulators|mesh-ancestor
153554699|NCT01599078|Antimitotic Agents|antimitotic agents|mesh-ancestor
153554700|NCT01599078|Mitosis Modulators|mitosis modulators|mesh-ancestor
153554701|NCT01599078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153554703|NCT01599117|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
153554704|NCT01599117|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
153554705|NCT01599117|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153469887|NCT04088890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153554706|NCT01599117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153554707|NCT01599130|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
153554709|NCT01599130|Antiviral Agents|antiviral agents|mesh-ancestor
153554710|NCT01599130|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153554711|NCT01599273|Triamcinolone|triamcinolone|mesh-list
153554714|NCT01599273|Hormones|hormones|mesh-ancestor
153554734|NCT01599364|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153554735|NCT01599364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153554736|NCT01599364|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153554737|NCT01599364|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153554739|NCT01599364|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153554740|NCT01599364|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
153554741|NCT01599364|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153554742|NCT01599364|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153921203|NCT06093893|Nicardipine|nicardipine|mesh-list
153882319|NCT01647893|Bivalirudin|bivalirudin|mesh-list
153882320|NCT01647893|Antithrombins|antithrombins|mesh-ancestor
153882321|NCT01647893|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
153554743|NCT01599364|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153554744|NCT01599377|Tofacitinib|tofacitinib|mesh-list
153554745|NCT01599377|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
153554746|NCT01599377|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153554747|NCT01599377|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153554748|NCT01599377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153554749|NCT05691088|Acetaminophen|acetaminophen|mesh-list
153554750|NCT05691088|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153554751|NCT05691088|Analgesics|analgesics|mesh-ancestor
153554752|NCT05691088|Sensory System Agents|sensory system agents|mesh-ancestor
153554753|NCT05691088|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153554755|NCT05691088|Antipyretics|antipyretics|mesh-ancestor
153554756|NCT05690802|Palonosetron|palonosetron|mesh-list
153554779|NCT05690191|Rituximab|rituximab|mesh-list
153554784|NCT05690191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153554785|NCT05690191|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153554786|NCT05690191|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153554787|NCT05690191|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153554788|NCT05690191|Growth Substances|growth substances|mesh-ancestor
153554789|NCT05690191|Growth Inhibitors|growth inhibitors|mesh-ancestor
153554790|NCT05689996|Ophthalmic Solutions|ophthalmic solutions|mesh-list
153554791|NCT05689996|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
153554792|NCT05689983|Budesonide|budesonide|mesh-list
153554793|NCT05689983|Formoterol Fumarate|formoterol fumarate|mesh-list
153554794|NCT05689983|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153554795|NCT05689983|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153554796|NCT05689983|Autonomic Agents|autonomic agents|mesh-ancestor
153554797|NCT05689983|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153554798|NCT05689983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153554799|NCT05689983|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153554800|NCT05689983|Respiratory System Agents|respiratory system agents|mesh-ancestor
153554801|NCT05689983|Glucocorticoids|glucocorticoids|mesh-ancestor
153554802|NCT05689983|Hormones|hormones|mesh-ancestor
153554803|NCT05689983|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153554804|NCT05689983|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
153554805|NCT05689983|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
153554806|NCT05689983|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153554807|NCT05689983|Adrenergic Agents|adrenergic agents|mesh-ancestor
153554808|NCT05689983|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153554809|NCT05689983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153554810|NCT05689957|Rocuronium|rocuronium|mesh-list
153554811|NCT05689957|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
153554812|NCT05689957|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
153554826|NCT05689242|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153554827|NCT05689242|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153554828|NCT05689242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153921401|NCT05997238|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153921402|NCT05997238|Immunologic Factors|immunologic factors|mesh-ancestor
153921403|NCT05997238|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153921404|NCT05997238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153921405|NCT05995769|Psilocybin|psilocybin|mesh-list
153921406|NCT05995769|Hallucinogens|hallucinogens|mesh-ancestor
153921407|NCT05995769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153554829|NCT05689242|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153554830|NCT05689242|Analgesics|analgesics|mesh-ancestor
153554831|NCT05689242|Sensory System Agents|sensory system agents|mesh-ancestor
153554832|NCT05689242|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153554833|NCT05689242|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
153554834|NCT05689242|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153554835|NCT05689242|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153554836|NCT05689242|Adrenergic Agents|adrenergic agents|mesh-ancestor
153554837|NCT05689242|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153472161|NCT04372836|Hemostatics|hemostatics|mesh-ancestor
153472162|NCT04372836|Coagulants|coagulants|mesh-ancestor
153470282|NCT03151499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153470283|NCT03151499|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
153470284|NCT03151499|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
153470293|NCT02963077|Antimetabolites|antimetabolites|mesh-ancestor
153921519|NCT05857384|Acetazolamide|acetazolamide|mesh-list
153921520|NCT05857384|Dronabinol|dronabinol|mesh-list
153921521|NCT05857384|Anticonvulsants|anticonvulsants|mesh-ancestor
153554838|NCT05689242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153554839|NCT05689242|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153554840|NCT05689242|Narcotics|narcotics|mesh-ancestor
153554841|NCT05689229|Colistin|colistin|mesh-list
153554842|NCT05689229|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153554843|NCT05689229|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153554844|NCT05688046|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
153554880|NCT05473195|Antitubercular Agents|antitubercular agents|mesh-ancestor
153554881|NCT05473195|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153554882|NCT05473195|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153554883|NCT05473195|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
153554885|NCT05473195|Antimetabolites|antimetabolites|mesh-ancestor
153554886|NCT05473195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153554887|NCT05473195|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153554888|NCT05422053|Insulin|insulin|mesh-list
153554889|NCT05422053|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153554890|NCT05422053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153554891|NCT05344911|Remifentanil|remifentanil|mesh-list
153554892|NCT05344911|Alfentanil|alfentanil|mesh-list
153554893|NCT05344911|Propofol|propofol|mesh-list
153554894|NCT05344911|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153554895|NCT05344911|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153554896|NCT05344911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153554897|NCT05344911|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153554898|NCT05344911|Anesthetics, General|anesthetics, general|mesh-ancestor
153554899|NCT05344911|Anesthetics|anesthetics|mesh-ancestor
153554900|NCT05344911|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153554935|NCT04812457|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
153554936|NCT04812457|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153554937|NCT04789616|Maraviroc|maraviroc|mesh-list
153554938|NCT04789616|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
153554939|NCT04789616|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
153554940|NCT04789616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153554941|NCT04789616|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153554942|NCT04789616|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153554943|NCT04789616|Antiviral Agents|antiviral agents|mesh-ancestor
153554944|NCT04789616|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153554945|NCT04789616|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
153554946|NCT04753216|Bevacizumab|bevacizumab|mesh-list
153554947|NCT04753216|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
153554949|NCT04753216|Endothelial Growth Factors|endothelial growth factors|mesh-list
153554951|NCT04753216|Immunoglobulins|immunoglobulins|mesh-list
153554952|NCT04753216|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
153554953|NCT04753216|Immunoglobulin G|immunoglobulin g|mesh-list
153554990|NCT04563494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153554991|NCT04563494|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153554992|NCT04563494|Glucocorticoids|glucocorticoids|mesh-ancestor
153554994|NCT04563494|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153554995|NCT04563494|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153554996|NCT04563494|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153554997|NCT04530747|Metformin|metformin|mesh-list
153554998|NCT04530747|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153554999|NCT04530747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153555000|NCT04456296|Methyltestosterone|methyltestosterone|mesh-list
153555001|NCT04456296|Testosterone|testosterone|mesh-list
153555002|NCT04456296|Testosterone undecanoate|testosterone undecanoate|mesh-list
153420825|NCT00375440|Hemostatics|hemostatics|mesh-ancestor
153420826|NCT00375440|Coagulants|coagulants|mesh-ancestor
153420827|NCT05113004|Mycophenolic Acid|mycophenolic acid|mesh-list
153420828|NCT05113004|Hydroxychloroquine|hydroxychloroquine|mesh-list
153420829|NCT05113004|Leflunomide|leflunomide|mesh-list
153420830|NCT05113004|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153420831|NCT05113004|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153420832|NCT05113004|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
153555003|NCT04456296|Testosterone enanthate|testosterone enanthate|mesh-list
153555004|NCT04456296|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
153555005|NCT04456296|Androgens|androgens|mesh-ancestor
153555006|NCT04456296|Hormones|hormones|mesh-ancestor
153555007|NCT04456296|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153423209|NCT02158806|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153555008|NCT04456296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153555009|NCT04456296|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153555010|NCT04456296|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153555011|NCT04456296|Anabolic Agents|anabolic agents|mesh-ancestor
153555012|NCT04403321|Tacrolimus|tacrolimus|mesh-list
153555013|NCT04403321|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153555014|NCT04403321|Immunologic Factors|immunologic factors|mesh-ancestor
153555015|NCT04403321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153555016|NCT04403321|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
153555017|NCT04403321|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153555019|NCT04265755|Erenumab|erenumab|mesh-list
153555035|NCT04123444|Iloprost|iloprost|mesh-list
153555036|NCT04123444|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153555037|NCT04123444|Vasodilator Agents|vasodilator agents|mesh-ancestor
153555038|NCT03987503|Sofosbuvir-velpatasvir drug combination|sofosbuvir-velpatasvir drug combination|mesh-list
153555039|NCT03987503|Antiviral Agents|antiviral agents|mesh-ancestor
153555040|NCT03987503|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153555041|NCT03967197|Lidocaine|lidocaine|mesh-list
153555042|NCT03967197|Anesthetics, Local|anesthetics, local|mesh-ancestor
153555043|NCT03967197|Anesthetics|anesthetics|mesh-ancestor
153555044|NCT03967197|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153555045|NCT03967197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153782622|NCT00234455|Temsirolimus|temsirolimus|mesh-list
153782623|NCT00234455|MTOR Inhibitors|mtor inhibitors|mesh-list
153555046|NCT03967197|Sensory System Agents|sensory system agents|mesh-ancestor
153555047|NCT03967197|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153555048|NCT03967197|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153555049|NCT03967197|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
153555050|NCT03967197|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153555051|NCT03967197|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153555052|NCT03967197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153555053|NCT03935646|Adderall|adderall|mesh-list
153555054|NCT03935646|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
153555055|NCT03935646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153555056|NCT03547999|Nivolumab|nivolumab|mesh-list
153555057|NCT03547999|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153555082|NCT03462251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153555083|NCT03462251|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153921813|NCT05667662|Itraconazole|itraconazole|mesh-list
153555084|NCT03462251|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153555085|NCT03462251|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153555087|NCT03462251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153555088|NCT03462251|Growth Inhibitors|growth inhibitors|mesh-ancestor
153555089|NCT03462251|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153555090|NCT03462251|Antimetabolites|antimetabolites|mesh-ancestor
153555091|NCT03462251|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153555092|NCT03462251|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
153555093|NCT03462251|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
153555094|NCT03462251|Hormone Antagonists|hormone antagonists|mesh-ancestor
153555095|NCT03462251|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153555096|NCT03462251|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153555097|NCT03462251|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153555098|NCT03272685|Nicotine|nicotine|mesh-list
153555135|NCT05705336|Coagulants|coagulants|mesh-ancestor
153555136|NCT05705037|6-chloro-2-(1-piperazinyl)pyrazine|6-chloro-2-(1-piperazinyl)pyrazine|mesh-list
153555137|NCT05705037|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
153555138|NCT05705037|Serotonin Agents|serotonin agents|mesh-ancestor
153555139|NCT05705037|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153555140|NCT05705037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153555141|NCT05705037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153555142|NCT05704959|Povidone-Iodine|povidone-iodine|mesh-list
153555143|NCT05704959|Povidone|povidone|mesh-list
153555145|NCT05704959|Blood Substitutes|blood substitutes|mesh-ancestor
153555146|NCT05704959|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
153555147|NCT05704959|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153555148|NCT05704894|Epoetin Alfa|epoetin alfa|mesh-list
153555149|NCT05704894|Hematinics|hematinics|mesh-ancestor
153555150|NCT05704816|Anesthetics|anesthetics|mesh-list
153555151|NCT05704816|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153555152|NCT05704816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153555153|NCT05704114|Tazarotene|tazarotene|mesh-list
153555154|NCT05704114|Dermatologic Agents|dermatologic agents|mesh-ancestor
153555155|NCT05704114|Keratolytic Agents|keratolytic agents|mesh-ancestor
153782626|NCT00234455|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153555190|NCT05584709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153782627|NCT00234455|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153922034|NCT05421065|Ketamine|ketamine|mesh-list
153555191|NCT05504486|Brexpiprazole|brexpiprazole|mesh-list
153555192|NCT05504486|Serotonin Agents|serotonin agents|mesh-ancestor
153555193|NCT05504486|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153555194|NCT05504486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153555195|NCT05504486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153555196|NCT05504486|Dopamine Agonists|dopamine agonists|mesh-ancestor
153555197|NCT05504486|Dopamine Agents|dopamine agents|mesh-ancestor
153555198|NCT05458232|Tadalafil|tadalafil|mesh-list
153555199|NCT05458232|Vasodilator Agents|vasodilator agents|mesh-ancestor
153555200|NCT05458232|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
153555201|NCT05458232|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
153555202|NCT05458232|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153555203|NCT05458232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153555204|NCT05458232|Urological Agents|urological agents|mesh-ancestor
153555205|NCT05271799|Gepotidacin|gepotidacin|mesh-list
153471005|NCT00614484|Carboplatin|carboplatin|mesh-list
153555206|NCT05271799|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153555207|NCT05271799|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153555208|NCT05271799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153555209|NCT05271799|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153555210|NCT05253417|Cannabidiol|cannabidiol|mesh-list
153555211|NCT05253417|Anticonvulsants|anticonvulsants|mesh-ancestor
153555212|NCT05030506|Pembrolizumab|pembrolizumab|mesh-list
153555213|NCT05030506|Lenvatinib|lenvatinib|mesh-list
153555214|NCT05030506|Belzutifan|belzutifan|mesh-list
153555221|NCT04911621|Temozolomide|temozolomide|mesh-list
153555234|NCT04764643|Free Radical Scavengers|free radical scavengers|mesh-ancestor
153555235|NCT04764643|Antioxidants|antioxidants|mesh-ancestor
153555236|NCT04764643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153555237|NCT04764643|Protective Agents|protective agents|mesh-ancestor
153555238|NCT04764643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153555239|NCT04764643|Antidotes|antidotes|mesh-ancestor
153555240|NCT04764643|Antitubercular Agents|antitubercular agents|mesh-ancestor
153555241|NCT04764643|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153555242|NCT04764643|Chelating Agents|chelating agents|mesh-ancestor
153555243|NCT04764643|Sequestering Agents|sequestering agents|mesh-ancestor
153555244|NCT04558892|Enoxaparin|enoxaparin|mesh-list
153555245|NCT04558892|Anticoagulants|anticoagulants|mesh-ancestor
153471067|NCT00616122|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153555246|NCT04558892|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153555247|NCT04558892|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153555249|NCT04077515|Sirolimus|sirolimus|mesh-list
153555296|NCT03802630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153555297|NCT03802630|Growth Inhibitors|growth inhibitors|mesh-ancestor
153555298|NCT03802630|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153555299|NCT03785691|Ondansetron|ondansetron|mesh-list
153555300|NCT03785691|Mirtazapine|mirtazapine|mesh-list
153555301|NCT03785691|Antiemetics|antiemetics|mesh-ancestor
153555302|NCT03785691|Autonomic Agents|autonomic agents|mesh-ancestor
153555303|NCT03785691|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153922327|NCT04975919|Venetoclax|venetoclax|mesh-list
153922328|NCT04975919|Decitabine|decitabine|mesh-list
153555304|NCT03785691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153555305|NCT03785691|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153555306|NCT03785691|Antipruritics|antipruritics|mesh-ancestor
153555307|NCT03785691|Dermatologic Agents|dermatologic agents|mesh-ancestor
153555308|NCT03785691|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
153555309|NCT03785691|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153555310|NCT03785691|Serotonin Agents|serotonin agents|mesh-ancestor
153882326|NCT01648010|Mitomycins|mitomycins|mesh-list
153555311|NCT03785691|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153555312|NCT03785691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153555313|NCT03785691|Antidepressive Agents|antidepressive agents|mesh-ancestor
153555326|NCT03710564|Aflibercept|aflibercept|mesh-list
153555351|NCT03499899|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153922437|NCT04799275|Prednisone|prednisone|mesh-list
153555352|NCT03499899|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153555353|NCT03499899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153555355|NCT03481634|Aflibercept|aflibercept|mesh-list
153555356|NCT03481634|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153555357|NCT03481634|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153555358|NCT03481634|Growth Substances|growth substances|mesh-ancestor
153555359|NCT03481634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153555360|NCT03481634|Growth Inhibitors|growth inhibitors|mesh-ancestor
153555361|NCT03481634|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153555362|NCT03430700|Pembrolizumab|pembrolizumab|mesh-list
153555363|NCT03430700|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153555364|NCT03430700|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153555367|NCT03106454|Ferrous fumarate|ferrous fumarate|mesh-list
153555409|NCT02811263|Hematinics|hematinics|mesh-ancestor
153555411|NCT02188121|Simvastatin|simvastatin|mesh-list
153555412|NCT02188121|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153555413|NCT02188121|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153555414|NCT02188121|Antimetabolites|antimetabolites|mesh-ancestor
153555415|NCT02188121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153555416|NCT02188121|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153555417|NCT02188121|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
153555418|NCT02188121|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153555419|NCT02188121|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153555420|NCT02188121|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153555421|NCT02188121|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
153555422|NCT02188121|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
153555424|NCT02039063|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
153555425|NCT02039063|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153555426|NCT02039063|Immunologic Factors|immunologic factors|mesh-ancestor
153555439|NCT01746173|Plerixafor|plerixafor|mesh-list
153555467|NCT01746173|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153555468|NCT01746173|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153555469|NCT01746173|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153555470|NCT01746173|Tubulin Modulators|tubulin modulators|mesh-ancestor
153555471|NCT01746173|Antimitotic Agents|antimitotic agents|mesh-ancestor
153555472|NCT01746173|Mitosis Modulators|mitosis modulators|mesh-ancestor
153555473|NCT01746173|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153555474|NCT01746173|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153555475|NCT01746173|Antiviral Agents|antiviral agents|mesh-ancestor
153555476|NCT01746173|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153555477|NCT01694004|Benzocaine|benzocaine|mesh-list
153555478|NCT01694004|Anesthetics, Local|anesthetics, local|mesh-ancestor
153555479|NCT01694004|Anesthetics|anesthetics|mesh-ancestor
153555480|NCT01694004|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153922874|NCT04198571|Beta Lactam Antibiotics|beta lactam antibiotics|mesh-ancestor
153922875|NCT04198571|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153922876|NCT04198571|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153922877|NCT04194645|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
153922878|NCT04188548|Trastuzumab|trastuzumab|mesh-list
153555481|NCT01694004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153879991|NCT02654119|Antimitotic Agents|antimitotic agents|mesh-ancestor
153555482|NCT01694004|Sensory System Agents|sensory system agents|mesh-ancestor
153555484|NCT01545843|Fluoxetine|fluoxetine|mesh-list
153555520|NCT03136731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153555521|NCT02956382|Venetoclax|venetoclax|mesh-list
153555522|NCT02956382|Ibrutinib|ibrutinib|mesh-list
153555523|NCT02956382|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153882331|NCT01648010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153882332|NCT01648010|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153415624|NCT02028806|Irinotecan|irinotecan|mesh-list
153555524|NCT02956382|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153555525|NCT02956382|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153555526|NCT02956382|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153555527|NCT02956382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153555528|NCT02855229|Methylphenidate|methylphenidate|mesh-list
153555529|NCT02855229|Modafinil|modafinil|mesh-list
153555530|NCT02855229|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
153555531|NCT02855229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153922997|NCT04058756|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153555532|NCT02855229|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
153555533|NCT02855229|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153555534|NCT02855229|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153555535|NCT02855229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153555537|NCT02855229|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153555538|NCT02855229|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
153555575|NCT02702492|Micronutrients|micronutrients|mesh-ancestor
153555576|NCT02702492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153555577|NCT02652455|Aldesleukin|aldesleukin|mesh-list
153555578|NCT02652455|Cyclophosphamide|cyclophosphamide|mesh-list
153555579|NCT02652455|Nivolumab|nivolumab|mesh-list
153555581|NCT02652455|Interleukin-2|interleukin-2|mesh-list
153555582|NCT02652455|Antibodies|antibodies|mesh-list
153555583|NCT02652455|Immunoglobulins|immunoglobulins|mesh-list
153555584|NCT02652455|Antibodies, Blocking|antibodies, blocking|mesh-list
153555585|NCT02652455|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153555586|NCT02652455|Immunologic Factors|immunologic factors|mesh-ancestor
153555587|NCT02652455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153555588|NCT02652455|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153555636|NCT02466243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153555637|NCT02321098|Amorolfine|amorolfine|mesh-list
153782631|NCT00234455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153555638|NCT02321098|Antifungal Agents|antifungal agents|mesh-ancestor
153555639|NCT02321098|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153555640|NCT02185417|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
153555641|NCT02185417|Chlorthalidone|chlorthalidone|mesh-list
153555642|NCT02185417|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153555643|NCT02185417|Diuretics|diuretics|mesh-ancestor
153555645|NCT02185417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153555646|NCT02185417|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
153555647|NCT02185417|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153555648|NCT02185417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153555650|NCT02158234|Alkylating Agents|alkylating agents|mesh-list
153555651|NCT02158234|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153555652|NCT02158234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153555653|NCT01859026|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
153555654|NCT01859026|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-list
153555656|NCT01859026|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153555689|NCT01599819|BAX 855|bax 855|mesh-list
153555690|NCT01599819|Coagulants|coagulants|mesh-ancestor
153555691|NCT01599858|Omeprazole|omeprazole|mesh-list
153555692|NCT01599858|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
153555693|NCT01599858|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153555694|NCT01599858|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
153555695|NCT01599858|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153555696|NCT01599858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153555697|NCT01599871|Theophylline|theophylline|mesh-list
153923214|NCT03539952|Antidotes|antidotes|mesh-ancestor
153882333|NCT01648010|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153882334|NCT01608711|Gemcitabine|gemcitabine|mesh-list
153882335|NCT01608711|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153882336|NCT01608711|Antimetabolites|antimetabolites|mesh-ancestor
153882337|NCT01608711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153555698|NCT01599871|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153555699|NCT01599871|Autonomic Agents|autonomic agents|mesh-ancestor
153555700|NCT01599871|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153555701|NCT01599871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153555702|NCT01599871|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153555703|NCT01599871|Respiratory System Agents|respiratory system agents|mesh-ancestor
153555704|NCT01599871|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
153555705|NCT01599871|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153555706|NCT01599871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153555707|NCT01599871|Vasodilator Agents|vasodilator agents|mesh-ancestor
153555708|NCT01599871|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
153555709|NCT01599871|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
153555710|NCT01599871|Purinergic Agents|purinergic agents|mesh-ancestor
153555711|NCT01599871|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153555712|NCT01599884|Acetylcysteine|acetylcysteine|mesh-list
153555713|NCT01599884|N-monoacetylcystine|n-monoacetylcystine|mesh-list
153555714|NCT01599884|Antiviral Agents|antiviral agents|mesh-ancestor
153555715|NCT01599884|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153555716|NCT01599884|Expectorants|expectorants|mesh-ancestor
153555717|NCT01599884|Respiratory System Agents|respiratory system agents|mesh-ancestor
153555734|NCT01599949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153555735|NCT01599962|Cinacalcet|cinacalcet|mesh-list
153555736|NCT01599962|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153555737|NCT01599962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153555738|NCT01599962|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
153555739|NCT01599962|Hormone Antagonists|hormone antagonists|mesh-ancestor
153555740|NCT01599962|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153555741|NCT01599975|Methylphenidate|methylphenidate|mesh-list
153555742|NCT01599975|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
153555743|NCT01599975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153555744|NCT01599975|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
153923268|NCT03412409|Cytarabine|cytarabine|mesh-list
153555745|NCT01599975|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153555746|NCT01599975|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153555747|NCT01599975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153555748|NCT01599975|Dopamine Agents|dopamine agents|mesh-ancestor
153555749|NCT01599975|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153555751|NCT01599988|Chelating Agents|chelating agents|mesh-ancestor
153555752|NCT01599988|Sequestering Agents|sequestering agents|mesh-ancestor
153555754|NCT01600430|Vitamin D|vitamin d|mesh-list
153782632|NCT00234455|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153782633|NCT00234455|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153555785|NCT01602029|Antiemetics|antiemetics|mesh-ancestor
153555786|NCT01602029|Autonomic Agents|autonomic agents|mesh-ancestor
153555787|NCT01602029|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153555788|NCT01602029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153555789|NCT01602029|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153555790|NCT01602029|Antipruritics|antipruritics|mesh-ancestor
153555791|NCT01602029|Dermatologic Agents|dermatologic agents|mesh-ancestor
153555792|NCT01602029|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
153555793|NCT01602029|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153555794|NCT01602029|Serotonin Agents|serotonin agents|mesh-ancestor
153555795|NCT01602029|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153555796|NCT01602874|Metronidazole|metronidazole|mesh-list
153555797|NCT01602874|Clarithromycin|clarithromycin|mesh-list
153555798|NCT01602874|Ceftriaxone|ceftriaxone|mesh-list
153555799|NCT01602874|Tigecycline|tigecycline|mesh-list
153555800|NCT01602874|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153555801|NCT01602874|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153555802|NCT01602874|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153880000|NCT02654119|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153555804|NCT01602874|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
153555805|NCT01602874|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153555806|NCT01602874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153555807|NCT01602874|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
153555808|NCT01602874|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153555809|NCT01602874|Third Generation Cephalosporins|third generation cephalosporins|mesh-ancestor
153555810|NCT01602874|Beta Lactam Antibiotics|beta lactam antibiotics|mesh-ancestor
153555830|NCT01604213|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
153555831|NCT01604213|Protease Inhibitors|protease inhibitors|mesh-ancestor
153555833|NCT01604213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153555834|NCT01605240|Acetaminophen|acetaminophen|mesh-list
153555835|NCT01605240|Ibuprofen|ibuprofen|mesh-list
153555836|NCT01605240|Codeine|codeine|mesh-list
153555837|NCT01605240|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153555838|NCT01605240|Analgesics|analgesics|mesh-ancestor
153555839|NCT01605240|Sensory System Agents|sensory system agents|mesh-ancestor
153555840|NCT01605240|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153555841|NCT01605240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153555842|NCT01605240|Antipyretics|antipyretics|mesh-ancestor
153555843|NCT01605240|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153555844|NCT01605240|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153555845|NCT01605240|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153555846|NCT01605240|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153923459|NCT02465268|Molgramostim|molgramostim|mesh-list
153555847|NCT01605240|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153555848|NCT01605240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153555849|NCT01605240|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153555850|NCT01605240|Narcotics|narcotics|mesh-ancestor
153555851|NCT01605240|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153555884|NCT01606722|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
153555885|NCT01606722|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153555886|NCT01607983|Nitric Oxide|nitric oxide|mesh-list
153555887|NCT01607983|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153555888|NCT01607983|Autonomic Agents|autonomic agents|mesh-ancestor
153555889|NCT01607983|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153923553|NCT01578109|Sorafenib|sorafenib|mesh-list
153555890|NCT01607983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153555891|NCT01607983|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153555892|NCT01607983|Respiratory System Agents|respiratory system agents|mesh-ancestor
153923613|NCT00889733|Cisplatin|cisplatin|mesh-list
153555893|NCT01607983|Free Radical Scavengers|free radical scavengers|mesh-ancestor
153555894|NCT01607983|Antioxidants|antioxidants|mesh-ancestor
153555895|NCT01607983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153555896|NCT01607983|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153555897|NCT01607983|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
153555898|NCT01607983|Vasodilator Agents|vasodilator agents|mesh-ancestor
153555899|NCT01607983|Gasotransmitters|gasotransmitters|mesh-ancestor
153555900|NCT01607983|Protective Agents|protective agents|mesh-ancestor
153555901|NCT01608217|Acetaminophen|acetaminophen|mesh-list
153555902|NCT01608217|Dronabinol|dronabinol|mesh-list
153555937|NCT01609153|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153555938|NCT01609153|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153555939|NCT01609153|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153555940|NCT01609153|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153555941|NCT01609153|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
153555942|NCT01609153|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153555943|NCT01609153|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153555944|NCT01609153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153555945|NCT01609153|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153555946|NCT01609153|Serotonin Agents|serotonin agents|mesh-ancestor
153555947|NCT01609153|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
153555948|NCT01609153|Dopamine Agents|dopamine agents|mesh-ancestor
153555949|NCT01609153|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
153555950|NCT01609153|Antidepressive Agents|antidepressive agents|mesh-ancestor
153555951|NCT01610141|Warfarin|warfarin|mesh-list
153555952|NCT01610141|Anticoagulants|anticoagulants|mesh-ancestor
153555953|NCT01610310|Interferon-beta|interferon-beta|mesh-list
153555954|NCT01610310|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153555955|NCT01610310|Antiviral Agents|antiviral agents|mesh-ancestor
153555956|NCT01610310|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153555957|NCT01610310|Immunologic Factors|immunologic factors|mesh-ancestor
153555958|NCT01610310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153555959|NCT01610362|Immunoglobulins|immunoglobulins|mesh-list
153555960|NCT01610362|Antibodies|antibodies|mesh-list
153555961|NCT01610362|gamma-Globulins|gamma-globulins|mesh-list
153555962|NCT01610362|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
153923671|NCT00381680|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153882338|NCT01608711|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153882339|NCT01605357|Mannitol|mannitol|mesh-list
153555963|NCT01610362|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
153882340|NCT01605357|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
153555964|NCT01610362|Immunoglobulin G|immunoglobulin g|mesh-list
153555985|NCT01610869|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153555986|NCT01610869|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153555987|NCT01610869|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153555988|NCT01610869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153555990|NCT01610921|Analgesics|analgesics|mesh-ancestor
153555991|NCT01610921|Sensory System Agents|sensory system agents|mesh-ancestor
153555992|NCT01610921|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153555993|NCT01610921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153555994|NCT01610921|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153555995|NCT01610921|Vasodilator Agents|vasodilator agents|mesh-ancestor
153556001|NCT01610934|Liraglutide|liraglutide|mesh-list
153556049|NCT01611077|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153556050|NCT01611077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153556051|NCT01611077|Vasodilator Agents|vasodilator agents|mesh-ancestor
153556052|NCT01611077|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
153556053|NCT01611077|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
153556054|NCT01611142|Mogamulizumab|mogamulizumab|mesh-list
153556055|NCT01611142|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153556056|NCT01611324|Epinephrine|epinephrine|mesh-list
153556058|NCT01611324|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153556059|NCT01611324|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153556060|NCT01611324|Adrenergic Agents|adrenergic agents|mesh-ancestor
153556061|NCT01611324|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153556108|NCT01611506|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153556109|NCT01611506|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153556110|NCT01611506|Antimetabolites|antimetabolites|mesh-ancestor
153556111|NCT01611506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153556112|NCT01611506|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153556113|NCT01611675|Vemurafenib|vemurafenib|mesh-list
153556114|NCT01611675|Leflunomide|leflunomide|mesh-list
153556115|NCT01611675|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153556116|NCT01611675|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153556117|NCT01611675|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153556118|NCT01611675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153556119|NCT01611675|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153556121|NCT01611675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153556168|NCT01612247|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
153556169|NCT01612247|Abortifacient Agents|abortifacient agents|mesh-ancestor
153556170|NCT01612247|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153556171|NCT01612247|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153556172|NCT01612247|Antimetabolites|antimetabolites|mesh-ancestor
153556173|NCT01612247|Dermatologic Agents|dermatologic agents|mesh-ancestor
153556174|NCT01612247|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153556175|NCT01612247|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153556176|NCT01612247|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153556177|NCT01612247|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153556178|NCT01612247|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153556179|NCT01612247|Analgesics|analgesics|mesh-ancestor
153556180|NCT01612247|Sensory System Agents|sensory system agents|mesh-ancestor
153556181|NCT01612247|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153556182|NCT01612247|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153556183|NCT01612247|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153423235|NCT03220958|Diphenhydramine|diphenhydramine|mesh-list
153423236|NCT03220958|Promethazine|promethazine|mesh-list
153423238|NCT03220958|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
153423240|NCT03220958|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153423241|NCT03220958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153423242|NCT03220958|Anesthetics, Local|anesthetics, local|mesh-ancestor
153423243|NCT03220958|Anesthetics|anesthetics|mesh-ancestor
153423246|NCT03220958|Antiemetics|antiemetics|mesh-ancestor
153556184|NCT01612247|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153556185|NCT01612247|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153556186|NCT01612247|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153556187|NCT01612247|Antipyretics|antipyretics|mesh-ancestor
153556188|NCT01612273|Aspirin|aspirin|mesh-list
153556190|NCT01612273|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153556218|NCT01612299|Immunologic Factors|immunologic factors|mesh-ancestor
153556219|NCT01612299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153556220|NCT01612299|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153556222|NCT01612377|Prednisolone|prednisolone|mesh-list
153556223|NCT01612377|Dipyridamole|dipyridamole|mesh-list
153556224|NCT01612377|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153556225|NCT01612377|Glucocorticoids|glucocorticoids|mesh-ancestor
153556226|NCT01612377|Hormones|hormones|mesh-ancestor
153556227|NCT01612377|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153556228|NCT01612377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153556229|NCT01612377|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153556230|NCT01612377|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153556231|NCT01612377|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
153556232|NCT01612377|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153556233|NCT01612377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153556234|NCT01612377|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153556235|NCT01612377|Vasodilator Agents|vasodilator agents|mesh-ancestor
153556236|NCT01612403|Zinc Sulfate|zinc sulfate|mesh-list
153556237|NCT01612403|Astringents|astringents|mesh-ancestor
153556238|NCT01612403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153556239|NCT01612403|Dermatologic Agents|dermatologic agents|mesh-ancestor
153556240|NCT01612468|Liraglutide|liraglutide|mesh-list
153556241|NCT01612468|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
153556242|NCT01612468|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153556245|NCT01612468|Hormones|hormones|mesh-ancestor
153556267|NCT01612832|Analgesics|analgesics|mesh-ancestor
153556268|NCT01612832|Sensory System Agents|sensory system agents|mesh-ancestor
153556269|NCT01612832|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153556270|NCT01612832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153556271|NCT01612832|Anticonvulsants|anticonvulsants|mesh-ancestor
153556272|NCT01612832|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153556273|NCT01612832|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153474312|NCT00661674|Autonomic Agents|autonomic agents|mesh-ancestor
153474455|NCT00678834|Vitamin E|vitamin e|mesh-list
153556274|NCT01612832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153556275|NCT01612832|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153556277|NCT01612832|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153556278|NCT01612832|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153556279|NCT01612832|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153556280|NCT01612871|Tamoxifen|tamoxifen|mesh-list
153556281|NCT01612871|Letrozole|letrozole|mesh-list
153556282|NCT01612871|Anastrozole|anastrozole|mesh-list
153556322|NCT01613040|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153556323|NCT01613040|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153556324|NCT01613040|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153556325|NCT01613040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153556326|NCT01613040|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153556327|NCT01613040|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
153556328|NCT01613040|Contraceptive Agents|contraceptive agents|mesh-ancestor
153556329|NCT01613040|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153556330|NCT01613040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153556331|NCT01613040|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
153556332|NCT01613040|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
153556333|NCT01613040|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
153556334|NCT01613053|Imatinib Mesylate|imatinib mesylate|mesh-list
153474679|NCT00715884|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153556336|NCT01613053|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153556337|NCT01613053|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153556338|NCT01613053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153556339|NCT01613053|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153556340|NCT01613079|Methotrexate|methotrexate|mesh-list
153556341|NCT01613079|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
153556342|NCT01613079|Abortifacient Agents|abortifacient agents|mesh-ancestor
153474767|NCT00724464|Immunologic Factors|immunologic factors|mesh-ancestor
153474904|NCT00741156|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153474905|NCT00741468|Tolbutamide|tolbutamide|mesh-list
153556343|NCT01613079|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153556344|NCT01613079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153556345|NCT01613079|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153556346|NCT01613079|Antimetabolites|antimetabolites|mesh-ancestor
153556347|NCT01613079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153556348|NCT01613079|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153556349|NCT01613079|Dermatologic Agents|dermatologic agents|mesh-ancestor
153556365|NCT01613092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153556366|NCT01613092|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
153556368|NCT01613105|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
153556369|NCT01613105|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153556370|NCT01613105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153556371|NCT01613105|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153556372|NCT01613105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153556373|NCT01613170|Estrogens|estrogens|mesh-list
153556374|NCT01613170|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
153556375|NCT01613170|Hormones|hormones|mesh-ancestor
153870536|NCT01084161|Sensory System Agents|sensory system agents|mesh-ancestor
153556376|NCT01613170|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153556377|NCT01613170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153556385|NCT01613209|Olmesartan|olmesartan|mesh-list
153556427|NCT01613690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153556428|NCT01613755|Metformin|metformin|mesh-list
153556429|NCT01613755|Dipyridamole|dipyridamole|mesh-list
153556430|NCT01613755|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153556431|NCT01613755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153475183|NCT00770874|Cisplatin|cisplatin|mesh-list
153556432|NCT01613755|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
153556433|NCT01613755|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153556434|NCT01613755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153556435|NCT01613755|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153556440|NCT01613794|Antimetabolites|antimetabolites|mesh-ancestor
153556495|NCT01613963|Immunologic Factors|immunologic factors|mesh-ancestor
153556496|NCT01613963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153556497|NCT01613963|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153475277|NCT00788892|Cytarabine|cytarabine|mesh-list
153556498|NCT01613963|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
153556499|NCT01613963|Abortifacient Agents|abortifacient agents|mesh-ancestor
153556500|NCT01613963|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153556501|NCT01613963|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153556502|NCT01613963|Antimetabolites|antimetabolites|mesh-ancestor
153556503|NCT01613963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153556504|NCT01613963|Dermatologic Agents|dermatologic agents|mesh-ancestor
153556505|NCT01613963|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153556506|NCT01613963|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153556507|NCT01613963|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153556508|NCT01613963|Antifungal Agents|antifungal agents|mesh-ancestor
153556509|NCT01613963|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153556511|NCT01613963|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153375517|NCT01562678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153375519|NCT01562678|Hormones|hormones|mesh-ancestor
153375520|NCT01562678|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153375521|NCT02767869|Magnesium Oxide|magnesium oxide|mesh-list
153375522|NCT02767869|Antacids|antacids|mesh-ancestor
153375523|NCT02767869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153556512|NCT01613963|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
153556513|NCT01613963|Antitubercular Agents|antitubercular agents|mesh-ancestor
153556514|NCT01613963|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153556515|NCT01613963|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153556516|NCT01613963|Glucocorticoids|glucocorticoids|mesh-ancestor
153556518|NCT01613963|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153556519|NCT01613963|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153556520|NCT01613963|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153556521|NCT01613963|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153556522|NCT01613963|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
153556523|NCT01613963|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153556524|NCT01613963|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153556525|NCT01613963|Analgesics|analgesics|mesh-ancestor
153556526|NCT01613963|Sensory System Agents|sensory system agents|mesh-ancestor
153556527|NCT01613976|Panobinostat|panobinostat|mesh-list
153556528|NCT01613976|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153556533|NCT01614041|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153556534|NCT01614041|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153556535|NCT01614041|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153556536|NCT01614041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153556537|NCT01614041|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153556538|NCT01614041|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
153556539|NCT01614041|Serotonin Agents|serotonin agents|mesh-ancestor
153556540|NCT01614041|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153556541|NCT01614041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153556542|NCT01614132|Cisplatin|cisplatin|mesh-list
153556543|NCT01614132|Vincristine|vincristine|mesh-list
153556544|NCT01614132|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153475641|NCT03763656|Hydroxyurea|hydroxyurea|mesh-list
153556545|NCT01614132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153556546|NCT01614132|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153556547|NCT01614132|Tubulin Modulators|tubulin modulators|mesh-ancestor
153556548|NCT01614132|Antimitotic Agents|antimitotic agents|mesh-ancestor
153556549|NCT01614132|Mitosis Modulators|mitosis modulators|mesh-ancestor
153556550|NCT01614223|Betamethasone|betamethasone|mesh-list
153556551|NCT01614223|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153556552|NCT01614223|Glucocorticoids|glucocorticoids|mesh-ancestor
153556553|NCT01614223|Hormones|hormones|mesh-ancestor
153556554|NCT01614223|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153556555|NCT01614223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153556556|NCT01614223|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153556557|NCT01614223|Respiratory System Agents|respiratory system agents|mesh-ancestor
153556558|NCT01614236|Pregabalin|pregabalin|mesh-list
153556559|NCT01614236|Analgesics|analgesics|mesh-ancestor
153556560|NCT01614236|Sensory System Agents|sensory system agents|mesh-ancestor
153556561|NCT01614236|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153556562|NCT01614236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153556577|NCT01614301|Dacarbazine|dacarbazine|mesh-list
153556578|NCT01614301|Trofosfamide|trofosfamide|mesh-list
153556579|NCT01614301|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153556580|NCT01614301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153556581|NCT01614301|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153556582|NCT01614301|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153556583|NCT01614301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153556584|NCT01614301|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153556585|NCT01614301|Immunologic Factors|immunologic factors|mesh-ancestor
153556586|NCT01614301|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153556587|NCT01614301|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153556588|NCT01614301|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153556589|NCT01614301|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153556590|NCT01614301|Antifungal Agents|antifungal agents|mesh-ancestor
153556591|NCT01614301|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153556592|NCT01614301|Alkylating Agents|alkylating agents|mesh-ancestor
153556593|NCT01614301|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153556594|NCT01614301|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153556595|NCT01614301|Analgesics|analgesics|mesh-ancestor
153556596|NCT01614301|Sensory System Agents|sensory system agents|mesh-ancestor
153556597|NCT01614301|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153556598|NCT01614301|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153556599|NCT01614301|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153556600|NCT01614301|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
153556601|NCT01614301|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153556602|NCT01614366|Amlodipine|amlodipine|mesh-list
153556603|NCT01614366|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153556604|NCT01614366|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153556605|NCT01614366|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153415280|NCT02207088|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153556620|NCT01614405|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153556621|NCT01614405|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153556622|NCT01614405|Antiviral Agents|antiviral agents|mesh-ancestor
153556623|NCT01614405|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153556624|NCT01614405|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
153556625|NCT01614405|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153556626|NCT01614405|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153556627|NCT01614405|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153556628|NCT01614431|Acetylcysteine|acetylcysteine|mesh-list
153556629|NCT01614431|N-monoacetylcystine|n-monoacetylcystine|mesh-list
153556630|NCT01614431|Antiviral Agents|antiviral agents|mesh-ancestor
153556631|NCT01614431|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153556632|NCT01614431|Expectorants|expectorants|mesh-ancestor
153556633|NCT01614431|Respiratory System Agents|respiratory system agents|mesh-ancestor
153556634|NCT01614431|Free Radical Scavengers|free radical scavengers|mesh-ancestor
153556635|NCT01614431|Antioxidants|antioxidants|mesh-ancestor
153556636|NCT01614431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153556637|NCT01614431|Protective Agents|protective agents|mesh-ancestor
153556638|NCT01614431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153556639|NCT01614431|Antidotes|antidotes|mesh-ancestor
153556641|NCT01614496|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153556642|NCT01614496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153556643|NCT01614535|Remifentanil|remifentanil|mesh-list
153556673|NCT01613729|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
153556674|NCT01613729|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153556675|NCT01615016|Pulmonary Surfactants|pulmonary surfactants|mesh-list
153556676|NCT01615016|Respiratory System Agents|respiratory system agents|mesh-ancestor
153556677|NCT01615042|Lenalidomide|lenalidomide|mesh-list
153556678|NCT01615042|Immunologic Factors|immunologic factors|mesh-ancestor
153556679|NCT01615042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153556680|NCT01615042|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153556681|NCT01615042|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153556682|NCT01615042|Growth Substances|growth substances|mesh-ancestor
153556683|NCT01615042|Growth Inhibitors|growth inhibitors|mesh-ancestor
153556684|NCT01615042|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153556686|NCT01615055|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
153556687|NCT01615055|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153556688|NCT01615055|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153556689|NCT01615055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153556690|NCT01615055|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153556727|NCT01615211|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153556728|NCT01615211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153556729|NCT01615211|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
153556730|NCT01615211|Abortifacient Agents|abortifacient agents|mesh-ancestor
153556731|NCT01615211|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153556733|NCT01615224|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
153556735|NCT01615224|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153556736|NCT01615224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153556737|NCT01615224|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
153556738|NCT01615224|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153556739|NCT01615224|Oxytocics|oxytocics|mesh-ancestor
153556740|NCT01615289|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
153556741|NCT01615354|Ethinyl estradiol, levonorgestrel drug combination|ethinyl estradiol, levonorgestrel drug combination|mesh-list
153556742|NCT01615354|Ethinyl Estradiol-Norgestrel Combination|ethinyl estradiol-norgestrel combination|mesh-list
153556743|NCT01615354|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
153556755|NCT01615393|Ribavirin|ribavirin|mesh-list
153556778|NCT01615601|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153556779|NCT01615601|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
153556780|NCT01615601|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153556781|NCT01615601|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153556782|NCT01615601|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153556783|NCT01615614|Rilpivirine|rilpivirine|mesh-list
153556784|NCT01615614|Rifabutin|rifabutin|mesh-list
153556785|NCT01615614|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153556786|NCT01615614|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153556787|NCT01615614|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153556788|NCT01615614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153556789|NCT01615614|Antiviral Agents|antiviral agents|mesh-ancestor
153556790|NCT01615614|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153556791|NCT01615614|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153556792|NCT01615614|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153556793|NCT01615614|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153556794|NCT01615614|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
153556795|NCT01615614|Antitubercular Agents|antitubercular agents|mesh-ancestor
153556796|NCT01615627|Treprostinil|treprostinil|mesh-list
153556797|NCT01615627|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
153556798|NCT01615627|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153556800|NCT01615757|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153556801|NCT01615757|Antimetabolites|antimetabolites|mesh-ancestor
153415568|NCT00367562|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
153415569|NCT00367562|Protease Inhibitors|protease inhibitors|mesh-ancestor
153556802|NCT01615757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153556803|NCT01615757|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153782634|NCT00234455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153556824|NCT01615913|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153874873|NCT04546256|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153556825|NCT01615913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153556826|NCT01615913|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
153556827|NCT01615978|Liraglutide|liraglutide|mesh-list
153556828|NCT01615978|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
153556829|NCT01615978|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153556830|NCT01615978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153874940|NCT01646229|Polymyxins|polymyxins|mesh-list
153556832|NCT01615978|Hormones|hormones|mesh-ancestor
153556833|NCT01615978|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153556834|NCT01616004|Nitrous Oxide|nitrous oxide|mesh-list
153556835|NCT01616004|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
153556836|NCT01616004|Anesthetics, General|anesthetics, general|mesh-ancestor
153556837|NCT01616004|Anesthetics|anesthetics|mesh-ancestor
153556838|NCT01616004|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153556839|NCT01616004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153556840|NCT01616004|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153556841|NCT01616004|Analgesics|analgesics|mesh-ancestor
153556842|NCT01616004|Sensory System Agents|sensory system agents|mesh-ancestor
153556843|NCT01616004|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153556844|NCT01616069|Simendan|simendan|mesh-list
153556845|NCT01616069|Epinephrine|epinephrine|mesh-list
153556846|NCT01616069|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153556847|NCT01616069|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153556848|NCT01616069|Adrenergic Agents|adrenergic agents|mesh-ancestor
153556867|NCT01616108|Bupivacaine|bupivacaine|mesh-list
153556868|NCT01616108|Anesthetics, Local|anesthetics, local|mesh-ancestor
153556869|NCT01616108|Anesthetics|anesthetics|mesh-ancestor
153556870|NCT01616108|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153556871|NCT01616108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153556872|NCT01616108|Sensory System Agents|sensory system agents|mesh-ancestor
153556873|NCT01616108|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153556874|NCT01616186|Everolimus|everolimus|mesh-list
153556875|NCT01616186|Sorafenib|sorafenib|mesh-list
153556876|NCT01616186|Sunitinib|sunitinib|mesh-list
153556877|NCT01616186|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
153556878|NCT01616186|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153556879|NCT01616186|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153556880|NCT01616186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153556881|NCT01616186|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153556882|NCT01616186|Immunologic Factors|immunologic factors|mesh-ancestor
153556883|NCT01616186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153556884|NCT01616186|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153556885|NCT01616186|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153556886|NCT01616186|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153556887|NCT01616186|Growth Substances|growth substances|mesh-ancestor
153556888|NCT01616186|Growth Inhibitors|growth inhibitors|mesh-ancestor
153556889|NCT01616225|Hormones|hormones|mesh-list
153556890|NCT01616225|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153556891|NCT01616225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153556892|NCT01616355|Sodium Hypochlorite|sodium hypochlorite|mesh-list
153556894|NCT01616355|Disinfectants|disinfectants|mesh-ancestor
153782635|NCT00234572|Lanreotide|lanreotide|mesh-list
153782636|NCT00234572|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153556895|NCT01616355|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153556909|NCT01616407|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153556910|NCT01616407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153556911|NCT01616407|Dopamine Agents|dopamine agents|mesh-ancestor
153556912|NCT01616407|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153556913|NCT01616407|Hallucinogens|hallucinogens|mesh-ancestor
153877148|NCT06042816|Narcotics|narcotics|mesh-ancestor
153415785|NCT02666846|Analgesics|analgesics|mesh-ancestor
153556914|NCT01616407|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153556915|NCT01616407|Serotonin Agents|serotonin agents|mesh-ancestor
153556916|NCT01616407|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
153556917|NCT01616407|Adrenergic Agents|adrenergic agents|mesh-ancestor
153556918|NCT01616485|Sildenafil Citrate|sildenafil citrate|mesh-list
153556919|NCT01616485|Nitroglycerin|nitroglycerin|mesh-list
153556920|NCT01616485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153556921|NCT01616485|Vasodilator Agents|vasodilator agents|mesh-ancestor
153875067|NCT01646775|Anesthetics, General|anesthetics, general|mesh-ancestor
153556922|NCT01616485|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
153556923|NCT01616485|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
153556924|NCT01616485|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153556925|NCT01616485|Urological Agents|urological agents|mesh-ancestor
153556926|NCT01616615|Aspirin|aspirin|mesh-list
153556927|NCT01616615|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153556928|NCT01616615|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153556929|NCT01616615|Analgesics|analgesics|mesh-ancestor
153556930|NCT01616615|Sensory System Agents|sensory system agents|mesh-ancestor
153415828|NCT02645617|Cholinergic Agents|cholinergic agents|mesh-ancestor
153556931|NCT01616615|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153556961|NCT01616784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153556963|NCT01616849|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153556964|NCT01616849|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153556965|NCT01616875|Cisplatin|cisplatin|mesh-list
153556966|NCT01616875|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153556967|NCT01616888|Paclitaxel|paclitaxel|mesh-list
153556968|NCT01616888|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153556969|NCT01616888|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153556970|NCT01616888|Tubulin Modulators|tubulin modulators|mesh-ancestor
153556971|NCT01616888|Antimitotic Agents|antimitotic agents|mesh-ancestor
153556972|NCT01616888|Mitosis Modulators|mitosis modulators|mesh-ancestor
153556973|NCT01616888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153556974|NCT01616927|Lanreotide|lanreotide|mesh-list
153556975|NCT01616927|Somatostatin|somatostatin|mesh-list
153556976|NCT01616927|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153556977|NCT01616927|Hormones|hormones|mesh-ancestor
153556978|NCT01616927|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153556979|NCT01616927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153375526|NCT01449266|Chelating Agents|chelating agents|mesh-ancestor
153375527|NCT01449266|Sequestering Agents|sequestering agents|mesh-ancestor
153556980|NCT01616966|Remifentanil|remifentanil|mesh-list
153556981|NCT01616966|Propofol|propofol|mesh-list
153556982|NCT01616966|Sevoflurane|sevoflurane|mesh-list
153556983|NCT01616966|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153556984|NCT01616966|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153556987|NCT01616966|Anesthetics, General|anesthetics, general|mesh-ancestor
153557012|NCT01617135|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153557013|NCT01617135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153557014|NCT01617135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153557015|NCT01617135|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
153557016|NCT01617135|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153557017|NCT01617135|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153557018|NCT01617135|Immunologic Factors|immunologic factors|mesh-ancestor
153557019|NCT01617135|Dopamine Agonists|dopamine agonists|mesh-ancestor
153557020|NCT01617200|Olanzapine|olanzapine|mesh-list
153557021|NCT01617200|Asenapine|asenapine|mesh-list
153557022|NCT01617200|Antiemetics|antiemetics|mesh-ancestor
153557023|NCT01617200|Autonomic Agents|autonomic agents|mesh-ancestor
153557024|NCT01617200|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153557025|NCT01617200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153557026|NCT01617200|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153557027|NCT01617200|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153880005|NCT02635867|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153880006|NCT02426658|Pemetrexed|pemetrexed|mesh-list
153880007|NCT02426658|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153880008|NCT02426658|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153557028|NCT01617200|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153415956|NCT05470465|Serotonin Agents|serotonin agents|mesh-ancestor
153557029|NCT01617200|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153557030|NCT01617200|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153557031|NCT01617200|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
153557032|NCT01617200|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153557033|NCT01617200|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153557034|NCT01617200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153557035|NCT01617200|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153415995|NCT02710981|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
153415996|NCT02710981|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
153415997|NCT02710981|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153875247|NCT01682343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153557036|NCT01617200|Serotonin Agents|serotonin agents|mesh-ancestor
153557037|NCT01617213|Lenalidomide|lenalidomide|mesh-list
153557038|NCT01617213|Melphalan|melphalan|mesh-list
153557055|NCT01617226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153557056|NCT01617226|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153557057|NCT01617226|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153557058|NCT01617226|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
153557059|NCT01617317|Immunoglobulins|immunoglobulins|mesh-list
153557060|NCT01617317|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
153557061|NCT01617317|Antibodies|antibodies|mesh-list
153557062|NCT01617317|gamma-Globulins|gamma-globulins|mesh-list
153423282|NCT03435614|Analgesics|analgesics|mesh-list
153423283|NCT03435614|Narcotics|narcotics|mesh-list
153882364|NCT04528277|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153882365|NCT04528277|Antimetabolites|antimetabolites|mesh-ancestor
153882366|NCT04528277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153882367|NCT04528277|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153882368|NCT04528277|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
153882370|NCT01683656|Niacin|niacin|mesh-list
153375594|NCT01450826|Autonomic Agents|autonomic agents|mesh-ancestor
153557063|NCT01617317|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
153557064|NCT01617317|Immunologic Factors|immunologic factors|mesh-ancestor
153557065|NCT01617317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153557066|NCT01617356|Lidocaine|lidocaine|mesh-list
153875343|NCT01648881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153875344|NCT01202227|Pregabalin|pregabalin|mesh-list
153875345|NCT01202227|Analgesics|analgesics|mesh-ancestor
153557067|NCT01617356|Anesthetics, Local|anesthetics, local|mesh-ancestor
153557068|NCT01617356|Anesthetics|anesthetics|mesh-ancestor
153875349|NCT01202227|Anticonvulsants|anticonvulsants|mesh-ancestor
153557069|NCT01617356|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153557070|NCT01617356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153557071|NCT01617356|Sensory System Agents|sensory system agents|mesh-ancestor
153557110|NCT01617590|Immunologic Factors|immunologic factors|mesh-ancestor
153557111|NCT01617590|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153557112|NCT01617590|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153557114|NCT01617694|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153782640|NCT00260793|Dopamine Agonists|dopamine agonists|mesh-ancestor
153782641|NCT00260793|Dopamine Agents|dopamine agents|mesh-ancestor
153557115|NCT01617694|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153557116|NCT01617694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153875382|NCT01649037|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153557117|NCT01617694|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153557118|NCT01617694|Analgesics|analgesics|mesh-ancestor
153557119|NCT01617694|Sensory System Agents|sensory system agents|mesh-ancestor
153557120|NCT01617694|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153557121|NCT01617694|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
153557122|NCT01617694|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153557123|NCT01617694|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153557124|NCT01617694|Adrenergic Agents|adrenergic agents|mesh-ancestor
153557125|NCT01617694|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153557126|NCT01617694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153557163|NCT01617798|Natriuretic Agents|natriuretic agents|mesh-ancestor
153557164|NCT01617798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153557165|NCT01617798|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
153557166|NCT01617798|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153557167|NCT01617798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153557168|NCT01617798|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153557169|NCT01617798|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
153557171|NCT01617811|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153557172|NCT01617811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153875435|NCT01683006|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
153557173|NCT01617824|Linagliptin|linagliptin|mesh-list
153557174|NCT01617824|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153557176|NCT01617824|Incretins|incretins|mesh-ancestor
153557222|NCT01618396|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153557224|NCT01618396|Anesthetics|anesthetics|mesh-ancestor
153557225|NCT01618396|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153557226|NCT01618396|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153557227|NCT01618396|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153557228|NCT01618396|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153557229|NCT01618396|GABA Modulators|gaba modulators|mesh-ancestor
153557230|NCT01618396|GABA Agents|gaba agents|mesh-ancestor
153557231|NCT01618396|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153557232|NCT01618396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153557233|NCT01618188|Insulin|insulin|mesh-list
153557234|NCT01618188|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
153557235|NCT01618188|Insulin Aspart|insulin aspart|mesh-list
153557236|NCT01618188|Insulin, Long-Acting|insulin, long-acting|mesh-list
153557237|NCT01618188|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
153557238|NCT01618188|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153557239|NCT01618188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153557240|NCT01618448|Tolvaptan|tolvaptan|mesh-list
153557279|NCT01618591|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153875489|NCT01201798|Antiemetics|antiemetics|mesh-ancestor
153557280|NCT01618591|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153557281|NCT01618643|Acetic Acid|acetic acid|mesh-list
153557282|NCT01618643|Retinol acetate|retinol acetate|mesh-list
153557283|NCT01618643|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153557284|NCT01618643|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153557285|NCT01618643|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153557286|NCT01618643|Immunologic Factors|immunologic factors|mesh-ancestor
153557287|NCT01618643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153557288|NCT01618643|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
153557289|NCT01618643|Protective Agents|protective agents|mesh-ancestor
153557290|NCT01618643|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153557291|NCT01618760|Risperidone|risperidone|mesh-list
153557292|NCT01618760|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153557293|NCT01618760|Serotonin Agents|serotonin agents|mesh-ancestor
153557294|NCT01618760|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153557295|NCT01618760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153557296|NCT01618760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153557297|NCT01618760|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153557298|NCT01618760|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153557299|NCT01618760|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153557300|NCT01618760|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153557331|NCT01618825|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153557332|NCT01618825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153557333|NCT01618825|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153557334|NCT01618825|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153557335|NCT01618825|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153557336|NCT01618825|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153557337|NCT01618825|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153557340|NCT01618877|Nootropic Agents|nootropic agents|mesh-ancestor
153557341|NCT01618890|Propranolol|propranolol|mesh-list
153557342|NCT01618890|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
153557343|NCT01618890|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
153557344|NCT01618890|Adrenergic Agents|adrenergic agents|mesh-ancestor
153557345|NCT01618890|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153557346|NCT01618890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153557347|NCT01618890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153557348|NCT01618890|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153557349|NCT01618890|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153557350|NCT01618890|Vasodilator Agents|vasodilator agents|mesh-ancestor
153557351|NCT01618903|Levetiracetam|levetiracetam|mesh-list
153557352|NCT01618903|Anticonvulsants|anticonvulsants|mesh-ancestor
153557353|NCT01618903|Nootropic Agents|nootropic agents|mesh-ancestor
153557354|NCT01618929|Montelukast|montelukast|mesh-list
153557355|NCT01618929|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153557385|NCT01619137|Blood Substitutes|blood substitutes|mesh-ancestor
153557386|NCT01619137|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
153557387|NCT01619137|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153557388|NCT01619150|Etoricoxib|etoricoxib|mesh-list
153557389|NCT01619150|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153557390|NCT01619150|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153557391|NCT01619150|Analgesics|analgesics|mesh-ancestor
153557392|NCT01619150|Sensory System Agents|sensory system agents|mesh-ancestor
153557393|NCT01619150|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153557394|NCT01619150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153557395|NCT01619150|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153557396|NCT01619150|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153557397|NCT01619150|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
153557398|NCT01619150|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153557399|NCT01619150|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153557400|NCT01619150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153557402|NCT01619163|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153557403|NCT01619163|Glucocorticoids|glucocorticoids|mesh-ancestor
153557405|NCT01619163|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153557406|NCT01619163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153557407|NCT01619163|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153557408|NCT01619163|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153557409|NCT01619280|Nitroprusside|nitroprusside|mesh-list
153557410|NCT01619280|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153557411|NCT01619280|Vasodilator Agents|vasodilator agents|mesh-ancestor
153557412|NCT01619280|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
153782643|NCT00260793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153870537|NCT01084161|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153557413|NCT01619280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153557415|NCT01619345|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
153557416|NCT01619345|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153557424|NCT01619436|Sympatholytics|sympatholytics|mesh-ancestor
153557425|NCT01619436|Autonomic Agents|autonomic agents|mesh-ancestor
153557426|NCT01619436|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
153557427|NCT01619436|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153557428|NCT01619436|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153557429|NCT01619436|Adrenergic Agents|adrenergic agents|mesh-ancestor
153557430|NCT01619436|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153557431|NCT01619436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153557432|NCT01619462|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
153557433|NCT01619462|Immunologic Factors|immunologic factors|mesh-ancestor
153416347|NCT05442931|Magnesium Sulfate|magnesium sulfate|mesh-list
153557434|NCT01619462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153557435|NCT01619527|Darunavir|darunavir|mesh-list
153557436|NCT01619527|Cobicistat|cobicistat|mesh-list
153557437|NCT01619527|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
153557438|NCT01619527|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
153557439|NCT01619527|Protease Inhibitors|protease inhibitors|mesh-ancestor
153557440|NCT01619527|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153557441|NCT01619527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153557442|NCT01619527|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153557443|NCT01619527|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153557444|NCT01619527|Antiviral Agents|antiviral agents|mesh-ancestor
153557445|NCT01619527|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153557446|NCT01619527|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
153557448|NCT01619566|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
153557473|NCT01619683|Clomiphene|clomiphene|mesh-list
153557474|NCT01619683|Zuclomiphene|zuclomiphene|mesh-list
153557475|NCT01619683|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
153557476|NCT01619683|Hormone Antagonists|hormone antagonists|mesh-ancestor
153557477|NCT01619683|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153557478|NCT01619683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153557479|NCT01619683|Fertility Agents, Female|fertility agents, female|mesh-ancestor
153557480|NCT01619683|Fertility Agents|fertility agents|mesh-ancestor
153557481|NCT01619683|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153875656|NCT01649895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153557482|NCT01619683|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
153875657|NCT01649505|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
153557486|NCT01619761|Melphalan|melphalan|mesh-list
153557487|NCT01619761|Mechlorethamine|mechlorethamine|mesh-list
153557488|NCT01619761|Nitrogen Mustard Compounds|nitrogen mustard compounds|mesh-list
153557489|NCT01619761|Rituximab|rituximab|mesh-list
153557490|NCT01619761|Fludarabine|fludarabine|mesh-list
153557491|NCT01619761|Fludarabine phosphate|fludarabine phosphate|mesh-list
153557492|NCT01619761|Lenalidomide|lenalidomide|mesh-list
153557493|NCT01619761|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
153420853|NCT00375583|Antimitotic Agents|antimitotic agents|mesh-ancestor
153420854|NCT00375583|Mitosis Modulators|mitosis modulators|mesh-ancestor
153420855|NCT00375583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153420856|NCT00375583|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153557494|NCT01619761|Tacrolimus|tacrolimus|mesh-list
153557495|NCT01619761|Antibodies|antibodies|mesh-list
153557496|NCT01619761|Immunoglobulins|immunoglobulins|mesh-list
153557497|NCT01619761|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
153557528|NCT01620112|Anesthetics|anesthetics|mesh-ancestor
153557529|NCT01620112|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153557530|NCT01620112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153557531|NCT01620112|Sensory System Agents|sensory system agents|mesh-ancestor
153557532|NCT01620112|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153557533|NCT01620112|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153557534|NCT01620112|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
153375595|NCT01450826|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153557535|NCT01620112|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153557536|NCT01620112|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153557537|NCT01620112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153557539|NCT01620112|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153557540|NCT01620112|Sympatholytics|sympatholytics|mesh-ancestor
153557541|NCT01620112|Autonomic Agents|autonomic agents|mesh-ancestor
153557542|NCT01620112|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
153557544|NCT01620112|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153557588|NCT01620333|Insulin, Long-Acting|insulin, long-acting|mesh-list
153557589|NCT01620333|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
153557590|NCT01620333|Biphasic Insulins|biphasic insulins|mesh-list
153875689|NCT01684059|Dermatologic Agents|dermatologic agents|mesh-ancestor
153875691|NCT04531748|Melatonin|melatonin|mesh-list
153557591|NCT01620333|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153557592|NCT01620333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153557593|NCT01620424|Insulin|insulin|mesh-list
153557594|NCT01620424|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
153557595|NCT01620424|Insulin Aspart|insulin aspart|mesh-list
153557596|NCT01620424|Insulin, Long-Acting|insulin, long-acting|mesh-list
153557597|NCT01620424|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
153557598|NCT01620424|Biphasic Insulins|biphasic insulins|mesh-list
153557648|NCT01620840|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
153557649|NCT01620840|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153557650|NCT01620840|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153557651|NCT01620840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153557653|NCT01621022|Nicotine|nicotine|mesh-list
153557654|NCT01621022|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
153557655|NCT01621022|Autonomic Agents|autonomic agents|mesh-ancestor
153557656|NCT01621022|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153557657|NCT01621022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153557658|NCT01621022|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
153557659|NCT01621022|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
153557660|NCT01621022|Cholinergic Agents|cholinergic agents|mesh-ancestor
153557661|NCT01621022|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153557662|NCT01621022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153557706|NCT01621217|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153557708|NCT01621217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153557709|NCT01621217|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153557710|NCT01621217|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153557711|NCT01621217|Antimetabolites|antimetabolites|mesh-ancestor
153557712|NCT01621217|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153557713|NCT01621217|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153416531|NCT04338373|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153416532|NCT04338373|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153557714|NCT01621217|Immunologic Factors|immunologic factors|mesh-ancestor
153557715|NCT01621217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153557717|NCT01621256|Anticoagulants|anticoagulants|mesh-ancestor
153557718|NCT01621256|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153557719|NCT01621256|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153557720|NCT01621256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153557721|NCT01621269|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
153557722|NCT01621269|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
153557723|NCT01621269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153557724|NCT01621269|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153557725|NCT01621269|Immunologic Factors|immunologic factors|mesh-ancestor
153557726|NCT01621269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153557728|NCT01621308|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153557729|NCT01621308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153557730|NCT01621321|Voriconazole|voriconazole|mesh-list
153557731|NCT01621321|Prednisolone|prednisolone|mesh-list
153557732|NCT01621321|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153557753|NCT01621373|Anesthetics, General|anesthetics, general|mesh-ancestor
153375596|NCT01450826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153557754|NCT01621373|Anesthetics|anesthetics|mesh-ancestor
153557756|NCT01621386|Montelukast|montelukast|mesh-list
153557757|NCT01621386|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153557758|NCT01621386|Glucocorticoids|glucocorticoids|mesh-ancestor
153557759|NCT01621386|Hormones|hormones|mesh-ancestor
153557760|NCT01621386|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153416565|NCT04338919|Aspirin|aspirin|mesh-list
153557761|NCT01621386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153557762|NCT01621386|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153557763|NCT01621386|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153557764|NCT01621386|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153557765|NCT01621386|Respiratory System Agents|respiratory system agents|mesh-ancestor
153557766|NCT01621386|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
153557768|NCT01621386|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
153557769|NCT01621386|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
153557770|NCT01621386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153557771|NCT01621451|Aspirin|aspirin|mesh-list
153557772|NCT01621451|Clopidogrel|clopidogrel|mesh-list
153557773|NCT01621451|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153557774|NCT01621451|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153557803|NCT01621620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153557804|NCT01621620|Urological Agents|urological agents|mesh-ancestor
153557805|NCT01621698|Fentanyl|fentanyl|mesh-list
153557807|NCT01621698|Propofol|propofol|mesh-list
153557808|NCT01621698|Atracurium|atracurium|mesh-list
153557809|NCT01621698|Anesthetics, Local|anesthetics, local|mesh-ancestor
153557810|NCT01621698|Anesthetics|anesthetics|mesh-ancestor
153557811|NCT01621698|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153557812|NCT01621698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153557813|NCT01621698|Sensory System Agents|sensory system agents|mesh-ancestor
153557814|NCT01621698|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153557815|NCT01621698|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153557816|NCT01621698|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153557817|NCT01621698|Anesthetics, General|anesthetics, general|mesh-ancestor
153557818|NCT01621698|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153557819|NCT01621698|Narcotics|narcotics|mesh-ancestor
153557820|NCT01621698|Analgesics|analgesics|mesh-ancestor
153557821|NCT01621698|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153557823|NCT01621698|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
153557824|NCT01621698|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
153557825|NCT01621698|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
153557854|NCT01621893|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153782646|NCT00415935|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
153557856|NCT01621971|Milrinone|milrinone|mesh-list
153557857|NCT01621971|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
153557858|NCT01621971|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153557859|NCT01621971|Vasodilator Agents|vasodilator agents|mesh-ancestor
153557860|NCT01621971|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
153557861|NCT01621971|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
153557862|NCT01621971|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153557863|NCT01621971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153557864|NCT01621971|Protective Agents|protective agents|mesh-ancestor
153557865|NCT01621971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153557866|NCT01622075|Paclitaxel|paclitaxel|mesh-list
153557867|NCT01622075|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
153557868|NCT01622075|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153557869|NCT01622075|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153557870|NCT01622075|Tubulin Modulators|tubulin modulators|mesh-ancestor
153557871|NCT01622075|Antimitotic Agents|antimitotic agents|mesh-ancestor
153557872|NCT01622075|Mitosis Modulators|mitosis modulators|mesh-ancestor
153870538|NCT01083615|Prednisone|prednisone|mesh-list
153416634|NCT05441150|Sensory System Agents|sensory system agents|mesh-ancestor
153557873|NCT01622075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153557874|NCT01622283|Cetirizine|cetirizine|mesh-list
153557875|NCT01622283|Levocetirizine|levocetirizine|mesh-list
153557876|NCT01622283|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
153557877|NCT01622283|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
153557878|NCT01622283|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
153557879|NCT01622283|Histamine Antagonists|histamine antagonists|mesh-ancestor
153557880|NCT01622283|Histamine Agents|histamine agents|mesh-ancestor
153557881|NCT01622283|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153557882|NCT01622283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153557883|NCT01622283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153557884|NCT01622361|Tamoxifen|tamoxifen|mesh-list
153557885|NCT01622361|Cyclophosphamide|cyclophosphamide|mesh-list
153557886|NCT01622361|Docetaxel|docetaxel|mesh-list
153557893|NCT01622361|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153557894|NCT01622361|Alkylating Agents|alkylating agents|mesh-ancestor
153557895|NCT01622361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153557896|NCT01622361|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153557897|NCT01622361|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153557898|NCT01622361|Tubulin Modulators|tubulin modulators|mesh-ancestor
153557899|NCT01622361|Antimitotic Agents|antimitotic agents|mesh-ancestor
153557900|NCT01622361|Mitosis Modulators|mitosis modulators|mesh-ancestor
153557901|NCT01622361|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153557902|NCT01622361|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153557903|NCT01622361|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153557904|NCT01622361|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153557905|NCT01622361|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
153557906|NCT01622361|Hormone Antagonists|hormone antagonists|mesh-ancestor
153557907|NCT01622361|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153557908|NCT01622361|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153557909|NCT01622361|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
153557910|NCT01622361|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
153557911|NCT01622361|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153557913|NCT01622439|Cyclophosphamide|cyclophosphamide|mesh-list
153557914|NCT01622439|Rituximab|rituximab|mesh-list
153557915|NCT01622439|Doxorubicin|doxorubicin|mesh-list
153557916|NCT01622439|Vincristine|vincristine|mesh-list
153557917|NCT01622439|Valproic Acid|valproic acid|mesh-list
153557918|NCT01622439|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153557919|NCT01622439|Immunologic Factors|immunologic factors|mesh-ancestor
153557920|NCT01622439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153557921|NCT01622439|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153557922|NCT01622439|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153557923|NCT01622439|Alkylating Agents|alkylating agents|mesh-ancestor
153870539|NCT01083615|Docetaxel|docetaxel|mesh-list
153557925|NCT01622439|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153557926|NCT01622439|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153557929|NCT01622439|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153557930|NCT01622439|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153557931|NCT01622439|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153557932|NCT01622439|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153557933|NCT01622439|Glucocorticoids|glucocorticoids|mesh-ancestor
153557934|NCT01622439|Hormones|hormones|mesh-ancestor
153557935|NCT01622439|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153557936|NCT01622439|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153557937|NCT01622439|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153557938|NCT01622439|Tubulin Modulators|tubulin modulators|mesh-ancestor
153557939|NCT01622439|Antimitotic Agents|antimitotic agents|mesh-ancestor
153418980|NCT05822934|Carboplatin|carboplatin|mesh-list
153557941|NCT01622439|Anticonvulsants|anticonvulsants|mesh-ancestor
153557942|NCT01622439|GABA Agents|gaba agents|mesh-ancestor
153557943|NCT01622439|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153557944|NCT01622439|Antimanic Agents|antimanic agents|mesh-ancestor
153557945|NCT01622439|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153557946|NCT01622439|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153557947|NCT01622439|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153557948|NCT01622504|Naloxone|naloxone|mesh-list
153557949|NCT01622504|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
153557950|NCT01622504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153557951|NCT01622504|Sensory System Agents|sensory system agents|mesh-ancestor
153557952|NCT01622504|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153557953|NCT01622556|Fludarabine|fludarabine|mesh-list
153557954|NCT01622556|Busulfan|busulfan|mesh-list
153557955|NCT01622556|Thymoglobulin|thymoglobulin|mesh-list
153876029|NCT02217956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153557956|NCT01622556|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153557957|NCT01622556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153557958|NCT01622556|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153557959|NCT01622556|Immunologic Factors|immunologic factors|mesh-ancestor
153557960|NCT01622556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153557961|NCT01622556|Alkylating Agents|alkylating agents|mesh-ancestor
153557962|NCT01622556|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153557963|NCT01622556|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153557968|NCT01622777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153557969|NCT01622777|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153557970|NCT01622777|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
153557971|NCT01622777|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153557972|NCT01622790|Lamivudine|lamivudine|mesh-list
153557973|NCT01622790|Abacavir|abacavir|mesh-list
153557974|NCT01622790|Dideoxynucleosides|dideoxynucleosides|mesh-list
153557975|NCT01622790|Dolutegravir|dolutegravir|mesh-list
153557976|NCT01622790|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153557977|NCT01622790|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153557978|NCT01622790|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153557979|NCT01622790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153557980|NCT01622790|Antiviral Agents|antiviral agents|mesh-ancestor
153557981|NCT01622790|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153557982|NCT01622790|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153557983|NCT01622790|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153557984|NCT01622790|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
153557985|NCT01622790|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
153557987|NCT01622881|Nefopam|nefopam|mesh-list
153558024|NCT01623102|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153558025|NCT01623102|Antimetabolites|antimetabolites|mesh-ancestor
153558026|NCT01623102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153558027|NCT01623206|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
153558028|NCT01623206|Hemostatics|hemostatics|mesh-ancestor
153558029|NCT01623206|Coagulants|coagulants|mesh-ancestor
153558030|NCT01623206|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
153416845|NCT02618720|Amebicides|amebicides|mesh-ancestor
153558032|NCT01623206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153558033|NCT01623284|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
153558034|NCT01623284|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
153558035|NCT01623284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153558036|NCT01623336|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
153558037|NCT01623336|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
153558038|NCT01623336|Interferon-alpha|interferon-alpha|mesh-list
153558039|NCT01623336|Antiviral Agents|antiviral agents|mesh-ancestor
153558040|NCT01623336|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153558041|NCT01623336|Immunologic Factors|immunologic factors|mesh-ancestor
153558042|NCT01623336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153558043|NCT01623349|Olaparib|olaparib|mesh-list
153558081|NCT01623570|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153558082|NCT01623570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153558083|NCT01623609|Naloxegol|naloxegol|mesh-list
153558084|NCT01623609|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
153558085|NCT01623609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153558086|NCT01623609|Sensory System Agents|sensory system agents|mesh-ancestor
153558087|NCT01623609|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153558088|NCT01623635|Ropivacaine|ropivacaine|mesh-list
153558089|NCT01623635|Anesthetics, Local|anesthetics, local|mesh-ancestor
153558090|NCT01623635|Anesthetics|anesthetics|mesh-ancestor
153558091|NCT01623635|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153558092|NCT01623635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153558094|NCT01623635|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153558095|NCT01623713|Risperidone|risperidone|mesh-list
153558096|NCT01623713|Iloperidone|iloperidone|mesh-list
153558097|NCT01623713|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153558098|NCT01623713|Serotonin Agents|serotonin agents|mesh-ancestor
153558099|NCT01623713|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153558100|NCT01623713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153558101|NCT01623713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153558102|NCT01623713|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153558103|NCT01623713|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153558104|NCT01623713|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153558105|NCT01623713|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153558106|NCT01623713|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
153558107|NCT01623713|Dopamine Agents|dopamine agents|mesh-ancestor
153558108|NCT01623778|Interferons|interferons|mesh-list
153558109|NCT01623778|Interferon-alpha|interferon-alpha|mesh-list
153558110|NCT01623778|Interferon alpha-2|interferon alpha-2|mesh-list
153558125|NCT01623921|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153558126|NCT01623921|Antimetabolites|antimetabolites|mesh-ancestor
153558127|NCT01623921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153558128|NCT01623921|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153558129|NCT01623921|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
153558130|NCT01623921|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153558131|NCT01623921|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153558132|NCT01623921|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153558134|NCT01623921|Sensory System Agents|sensory system agents|mesh-ancestor
153558135|NCT01623921|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153558136|NCT01623921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153558137|NCT01623921|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153558138|NCT01623921|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153558139|NCT01623921|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
153558140|NCT01623921|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153558141|NCT01624025|Docetaxel|docetaxel|mesh-list
153558142|NCT01624025|Epirubicin|epirubicin|mesh-list
153558143|NCT01624025|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153558179|NCT01624103|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153558180|NCT01624103|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
153558181|NCT01624103|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153558182|NCT01624103|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153558183|NCT01624103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153558184|NCT01624116|Metformin|metformin|mesh-list
153558185|NCT01624116|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
153558186|NCT01624116|Acarbose|acarbose|mesh-list
153558187|NCT01624116|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153558188|NCT01624116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153558189|NCT01624116|Incretins|incretins|mesh-ancestor
153558190|NCT01624116|Hormones|hormones|mesh-ancestor
153558191|NCT01624116|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153558192|NCT01624116|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
153558193|NCT01624116|Protease Inhibitors|protease inhibitors|mesh-ancestor
153558194|NCT01624116|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153558195|NCT01624116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153558231|NCT01624428|Cholinergic Agents|cholinergic agents|mesh-ancestor
153558232|NCT01624428|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153558233|NCT01624428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153876195|NCT02216513|Iron Chelating Agents|iron chelating agents|mesh-ancestor
153558234|NCT01624428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153558236|NCT01624441|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153558237|NCT01624441|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153558238|NCT01624441|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153558239|NCT01624441|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153558240|NCT01624441|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153558241|NCT01624441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153416993|NCT05454085|Bisphenol A|bisphenol a|mesh-list
153558244|NCT01624493|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153558245|NCT01624493|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153558246|NCT01624493|Antimetabolites|antimetabolites|mesh-ancestor
153558247|NCT01624493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153558248|NCT01624649|Methylphenidate|methylphenidate|mesh-list
153558249|NCT01624649|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
153558250|NCT01624649|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
153558251|NCT01624649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153558252|NCT01624649|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
153558253|NCT01624649|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153558280|NCT01624766|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153558281|NCT01624766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153558282|NCT01624766|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153558283|NCT01624766|Immunologic Factors|immunologic factors|mesh-ancestor
153558284|NCT01624766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153558285|NCT01624766|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153558286|NCT01624766|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153558287|NCT01624766|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153558288|NCT01624857|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
153558290|NCT01624857|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153558291|NCT01624857|Antimetabolites|antimetabolites|mesh-ancestor
153558292|NCT01624857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153558293|NCT01624857|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153558294|NCT01624857|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
153558295|NCT01624857|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153558296|NCT01625026|Chenodeoxycholic Acid|chenodeoxycholic acid|mesh-list
153558297|NCT01625026|Cathartics|cathartics|mesh-ancestor
153558298|NCT01625026|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153558299|NCT01625260|Gemcitabine|gemcitabine|mesh-list
153558300|NCT01625260|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153558301|NCT01625260|Antimetabolites|antimetabolites|mesh-ancestor
153558304|NCT01625351|Sirolimus|sirolimus|mesh-list
153558332|NCT01625494|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153558333|NCT01625494|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153558334|NCT01625494|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153558335|NCT01625494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153558336|NCT01625494|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153558337|NCT01625494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153558338|NCT01625494|Vasodilator Agents|vasodilator agents|mesh-ancestor
153558339|NCT01625494|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
153558340|NCT01625494|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
153558341|NCT01625520|Everolimus|everolimus|mesh-list
153558342|NCT01625520|Pasireotide|pasireotide|mesh-list
153558343|NCT01625520|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
153558344|NCT01625520|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153558345|NCT01625520|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153558346|NCT01625520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153558347|NCT01625520|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153558348|NCT01625520|Immunologic Factors|immunologic factors|mesh-ancestor
153558349|NCT01625520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153558350|NCT01625520|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153558352|NCT01625520|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153558353|NCT01625572|Morphine|morphine|mesh-list
153558383|NCT01625793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153558384|NCT01625806|Ketoconazole|ketoconazole|mesh-list
153558385|NCT01625806|Antifungal Agents|antifungal agents|mesh-ancestor
153558386|NCT01625806|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153558387|NCT01625806|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
153558388|NCT01625806|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153558389|NCT01625806|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153876356|NCT04534452|Phenylephrine|phenylephrine|mesh-list
153558390|NCT01625806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153558391|NCT01625806|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153558392|NCT01625806|Hormone Antagonists|hormone antagonists|mesh-ancestor
153558393|NCT01625806|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153558394|NCT01625806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153558395|NCT01625806|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
153558396|NCT01625871|Lumefantrine|lumefantrine|mesh-list
153558397|NCT01625871|Artemether|artemether|mesh-list
153558398|NCT01625871|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
153558399|NCT01625871|Antimalarials|antimalarials|mesh-ancestor
153558439|NCT01626222|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153558440|NCT01626339|Bevacizumab|bevacizumab|mesh-list
153558441|NCT01626339|Ranibizumab|ranibizumab|mesh-list
153558443|NCT01626339|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153558444|NCT01626339|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153558445|NCT01626339|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153558446|NCT01626339|Growth Substances|growth substances|mesh-ancestor
153558447|NCT01626339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153558448|NCT01626339|Growth Inhibitors|growth inhibitors|mesh-ancestor
153558450|NCT01626443|Vitamin B Complex|vitamin b complex|mesh-list
153558452|NCT01626443|Hematinics|hematinics|mesh-ancestor
153558453|NCT01626443|Vitamins|vitamins|mesh-ancestor
153558454|NCT01626443|Micronutrients|micronutrients|mesh-ancestor
153558455|NCT01626443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153558457|NCT01626469|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
153558458|NCT01626469|Protease Inhibitors|protease inhibitors|mesh-ancestor
153558459|NCT01626469|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153558460|NCT01626469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153558493|NCT01626911|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
153558494|NCT01626911|Tinzaparin|tinzaparin|mesh-list
153558495|NCT01626911|Dalteparin|dalteparin|mesh-list
153558496|NCT01626911|Anticoagulants|anticoagulants|mesh-ancestor
153558497|NCT01626911|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153558498|NCT01626911|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153558499|NCT01626911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153558500|NCT01627041|Cytarabine|cytarabine|mesh-list
153558501|NCT01627041|Decitabine|decitabine|mesh-list
153558502|NCT01627041|Daunorubicin|daunorubicin|mesh-list
153558503|NCT01627041|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153558504|NCT01627041|Antimetabolites|antimetabolites|mesh-ancestor
153558505|NCT01627041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153558506|NCT01627041|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153558507|NCT01627041|Antiviral Agents|antiviral agents|mesh-ancestor
153558508|NCT01627041|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153558509|NCT01627041|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153558510|NCT01627041|Immunologic Factors|immunologic factors|mesh-ancestor
153558511|NCT01627041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153558512|NCT01627041|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153558513|NCT01627041|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153558514|NCT01627041|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153558515|NCT01627041|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153558542|NCT01627145|Urological Agents|urological agents|mesh-ancestor
153558543|NCT01627158|Budesonide|budesonide|mesh-list
153558544|NCT01627158|Formoterol Fumarate|formoterol fumarate|mesh-list
153558545|NCT01627158|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
153558546|NCT01627158|Charcoal|charcoal|mesh-list
153558547|NCT01627158|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153558548|NCT01627158|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153558549|NCT01627158|Autonomic Agents|autonomic agents|mesh-ancestor
153558550|NCT01627158|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153558551|NCT01627158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153558552|NCT01627158|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153558553|NCT01627158|Respiratory System Agents|respiratory system agents|mesh-ancestor
153558554|NCT01627158|Glucocorticoids|glucocorticoids|mesh-ancestor
153558555|NCT01627158|Hormones|hormones|mesh-ancestor
153870540|NCT01083615|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153417253|NCT02162862|Dopamine Agents|dopamine agents|mesh-ancestor
153558556|NCT01627158|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153558563|NCT01627158|Antidotes|antidotes|mesh-ancestor
153558604|NCT01627262|Sensory System Agents|sensory system agents|mesh-ancestor
153558605|NCT01627262|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153558606|NCT01627262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153558607|NCT01627262|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153558608|NCT01627262|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153558609|NCT01627353|Dexamethasone|dexamethasone|mesh-list
153558610|NCT01627353|Lidocaine|lidocaine|mesh-list
153558611|NCT01627353|Magnesium Sulfate|magnesium sulfate|mesh-list
153558612|NCT01627353|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153558613|NCT01627353|Antiemetics|antiemetics|mesh-ancestor
153558614|NCT01627353|Autonomic Agents|autonomic agents|mesh-ancestor
153558615|NCT01627353|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153558616|NCT01627353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153558617|NCT01627353|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153558618|NCT01627353|Glucocorticoids|glucocorticoids|mesh-ancestor
153558619|NCT01627353|Hormones|hormones|mesh-ancestor
153558620|NCT01627353|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153558621|NCT01627353|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153558660|NCT01627431|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
153558661|NCT01627431|Purinergic Agents|purinergic agents|mesh-ancestor
153558662|NCT01627431|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153375718|NCT00372177|Immunoglobulin Fab Fragments|immunoglobulin fab fragments|mesh-list
153558663|NCT01627587|Ketoconazole|ketoconazole|mesh-list
153375719|NCT00372177|Immunologic Factors|immunologic factors|mesh-ancestor
153423301|NCT03437564|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
153423302|NCT03437564|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
153558664|NCT01627587|Antifungal Agents|antifungal agents|mesh-ancestor
153558665|NCT01627587|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153870541|NCT01083615|Tubulin Modulators|tubulin modulators|mesh-ancestor
153558666|NCT01627587|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
153558667|NCT01627587|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153558668|NCT01627587|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153558669|NCT01627587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153558670|NCT01627587|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153558671|NCT01627587|Hormone Antagonists|hormone antagonists|mesh-ancestor
153782652|NCT00415935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153782653|NCT00415935|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153782654|NCT00415935|Dermatologic Agents|dermatologic agents|mesh-ancestor
153782655|NCT00415935|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153782656|NCT00415935|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153782657|NCT00415935|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153558672|NCT01627587|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153558673|NCT01627587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153558705|NCT01627717|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
153558706|NCT01627717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153558707|NCT01627717|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153558708|NCT01627717|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153558709|NCT01627717|Antiviral Agents|antiviral agents|mesh-ancestor
153558710|NCT01627717|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153876607|NCT01194154|Epoetin Alfa|epoetin alfa|mesh-list
153558711|NCT01627717|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
153558712|NCT01627834|Ropinirole|ropinirole|mesh-list
153558713|NCT01627834|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
153558714|NCT01627834|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
153558715|NCT01627834|Dopamine Agonists|dopamine agonists|mesh-ancestor
153558716|NCT01627834|Dopamine Agents|dopamine agents|mesh-ancestor
153558717|NCT01627834|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153558718|NCT01627834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153876644|NCT01640639|Thalidomide|thalidomide|mesh-list
153558719|NCT01627834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153558720|NCT01627847|Ropinirole|ropinirole|mesh-list
153558721|NCT01627847|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
153558722|NCT01627847|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
153558723|NCT01627847|Dopamine Agonists|dopamine agonists|mesh-ancestor
153558724|NCT01627847|Dopamine Agents|dopamine agents|mesh-ancestor
153558725|NCT01627847|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153876685|NCT01642862|Simvastatin|simvastatin|mesh-list
153558726|NCT01627847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153558727|NCT01627847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153558728|NCT01627873|Fentanyl|fentanyl|mesh-list
153558729|NCT01627873|Remifentanil|remifentanil|mesh-list
153558730|NCT01627873|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153558731|NCT01627873|Narcotics|narcotics|mesh-ancestor
153558732|NCT01627873|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153558733|NCT01627873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153558750|NCT01627938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153558751|NCT01627938|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153558752|NCT01627938|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153558753|NCT01627938|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153558754|NCT01627938|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153558755|NCT01627938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153558756|NCT01627938|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
153558757|NCT01627938|Protective Agents|protective agents|mesh-ancestor
153558758|NCT01627938|Antimitotic Agents|antimitotic agents|mesh-ancestor
153558759|NCT01627938|Mitosis Modulators|mitosis modulators|mesh-ancestor
153558760|NCT01628055|Immunoglobulins|immunoglobulins|mesh-list
153417581|NCT04337918|Nitric Oxide|nitric oxide|mesh-list
153558763|NCT01628055|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
153558813|NCT01628562|Adrenergic Agents|adrenergic agents|mesh-ancestor
153558814|NCT01628562|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153558815|NCT01628562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153376033|NCT06194214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153558816|NCT01628666|Vancomycin|vancomycin|mesh-list
153558817|NCT01628666|Cefazolin|cefazolin|mesh-list
153558818|NCT01628666|Cephalexin|cephalexin|mesh-list
153558819|NCT01628666|Bacitracin|bacitracin|mesh-list
153558820|NCT01628666|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153558821|NCT01628666|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153558822|NCT01628666|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
153558823|NCT01628731|Furosemide|furosemide|mesh-list
153558824|NCT01628731|Ethacrynic Acid|ethacrynic acid|mesh-list
153558825|NCT01628731|Diuretics|diuretics|mesh-ancestor
153558826|NCT01628731|Natriuretic Agents|natriuretic agents|mesh-ancestor
153558827|NCT01628731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153558833|NCT01628770|Hematinics|hematinics|mesh-ancestor
153558875|NCT01629212|Anticonvulsants|anticonvulsants|mesh-ancestor
153558876|NCT01629212|Parasympatholytics|parasympatholytics|mesh-ancestor
153558877|NCT01629212|Autonomic Agents|autonomic agents|mesh-ancestor
153558878|NCT01629212|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153558879|NCT01629212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153558880|NCT01629212|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153558881|NCT01629212|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153558882|NCT01629212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153558883|NCT01629212|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153558884|NCT01629212|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153558885|NCT01629212|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
153558886|NCT01629212|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
153558887|NCT01629212|Cholinergic Agents|cholinergic agents|mesh-ancestor
153782660|NCT00415935|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153558888|NCT01629212|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153558890|NCT01629225|Candesartan cilexetil|candesartan cilexetil|mesh-list
153876960|NCT06045975|Durvalumab|durvalumab|mesh-list
153558892|NCT01629225|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
153558893|NCT01629225|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
153558894|NCT01629225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153558895|NCT01629251|Insulin|insulin|mesh-list
153558896|NCT01629251|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153558897|NCT01629251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153558898|NCT01629277|Insulin|insulin|mesh-list
153558899|NCT01629277|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153558900|NCT01629277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153558901|NCT01629368|Carbamazepine|carbamazepine|mesh-list
153558902|NCT01629368|Anticonvulsants|anticonvulsants|mesh-ancestor
153558903|NCT01629368|Antimanic Agents|antimanic agents|mesh-ancestor
153558904|NCT01629368|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153558905|NCT01629368|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153558906|NCT01629368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153558907|NCT01629368|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153558911|NCT01629368|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153558912|NCT01629368|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153558913|NCT01629368|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153558914|NCT01629368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153558915|NCT01629368|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
153558916|NCT01629368|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
153558918|NCT01629394|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
153417779|NCT00372476|Antimitotic Agents|antimitotic agents|mesh-ancestor
153558919|NCT01629394|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153417781|NCT04737967|Memantine|memantine|mesh-list
153558920|NCT01629394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153558922|NCT01629394|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153558923|NCT01629394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153558924|NCT01629394|Parasympathomimetics|parasympathomimetics|mesh-ancestor
153558969|NCT01629628|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
153558970|NCT01629628|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153558971|NCT01629628|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153558972|NCT01629628|Antimetabolites|antimetabolites|mesh-ancestor
153558973|NCT01629628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153558974|NCT01629628|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153558975|NCT01629628|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153558976|NCT01629628|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153558978|NCT01629628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153558979|NCT01629628|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153558980|NCT01629628|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153558981|NCT01629680|Moxaverine|moxaverine|mesh-list
153558982|NCT01629680|Parasympatholytics|parasympatholytics|mesh-ancestor
153558983|NCT01629680|Autonomic Agents|autonomic agents|mesh-ancestor
153558984|NCT01629680|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153558985|NCT01629680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153558986|NCT01629732|Ribavirin|ribavirin|mesh-list
153558987|NCT01629732|Antimetabolites|antimetabolites|mesh-ancestor
153558988|NCT01629732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153558989|NCT01629732|Antiviral Agents|antiviral agents|mesh-ancestor
153558990|NCT01629732|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153558991|NCT01629758|Nivolumab|nivolumab|mesh-list
153558992|NCT01629758|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153877071|NCT06043908|Cyclosporine|cyclosporine|mesh-list
153558993|NCT01629758|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153558994|NCT01629758|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153558995|NCT01629758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153558996|NCT01629875|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
153558997|NCT01629875|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
153558998|NCT01629875|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
153558999|NCT01629875|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153559000|NCT01629875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153559001|NCT01629875|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
153559004|NCT01629875|Cholinergic Agents|cholinergic agents|mesh-ancestor
153559009|NCT01630018|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153559010|NCT01630018|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153559011|NCT01630018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153559012|NCT01630018|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153559013|NCT01630057|Zonisamide|zonisamide|mesh-list
153559014|NCT01630057|Anticonvulsants|anticonvulsants|mesh-ancestor
153559015|NCT01630057|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153559016|NCT01630057|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153559017|NCT01630057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153559018|NCT01630057|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153559020|NCT01630070|Paclitaxel|paclitaxel|mesh-list
153559021|NCT01630070|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153559022|NCT01630070|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153559023|NCT01630070|Tubulin Modulators|tubulin modulators|mesh-ancestor
153559067|NCT01630343|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153559068|NCT01630343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153559069|NCT01630343|Antipyretics|antipyretics|mesh-ancestor
153559070|NCT01630343|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153559071|NCT01630343|Narcotics|narcotics|mesh-ancestor
153559072|NCT01630343|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153559073|NCT01630369|Insulin|insulin|mesh-list
153559074|NCT01630369|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
153559075|NCT01630369|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153559076|NCT01630369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153559077|NCT01630538|Cyclophosphamide|cyclophosphamide|mesh-list
153559078|NCT01630538|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153559079|NCT01630538|Immunologic Factors|immunologic factors|mesh-ancestor
153559080|NCT01630538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153559081|NCT01630538|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153559083|NCT01630538|Alkylating Agents|alkylating agents|mesh-ancestor
153559084|NCT01630538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153559085|NCT01630538|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153559086|NCT01630538|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153559120|NCT01630720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153559121|NCT01630720|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153559123|NCT01630733|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153559124|NCT01630733|Tubulin Modulators|tubulin modulators|mesh-ancestor
153559125|NCT01630733|Antimitotic Agents|antimitotic agents|mesh-ancestor
153559126|NCT01630733|Mitosis Modulators|mitosis modulators|mesh-ancestor
153559127|NCT01630733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153559128|NCT01630902|Felodipine|felodipine|mesh-list
153559129|NCT01630902|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153559184|NCT01631201|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153559185|NCT01631201|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
153559186|NCT01631201|Antitubercular Agents|antitubercular agents|mesh-ancestor
153559187|NCT01631201|Leprostatic Agents|leprostatic agents|mesh-ancestor
153559188|NCT01631305|Magnesium Oxide|magnesium oxide|mesh-list
153559189|NCT01631305|Calcium|calcium|mesh-list
153559190|NCT01631305|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153559191|NCT01631305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153559192|NCT01631305|Antacids|antacids|mesh-ancestor
153559193|NCT01631305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153559194|NCT01631305|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153559195|NCT01631357|Cisplatin|cisplatin|mesh-list
153559196|NCT01631357|Gemcitabine|gemcitabine|mesh-list
153559197|NCT01631357|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153870542|NCT01083615|Antimitotic Agents|antimitotic agents|mesh-ancestor
153877239|NCT06010810|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
153559198|NCT01631357|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153559199|NCT01631357|Antimetabolites|antimetabolites|mesh-ancestor
153559200|NCT01631357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153559201|NCT01631383|Tetrahydropalmatine|tetrahydropalmatine|mesh-list
153559218|NCT01631383|Analgesics|analgesics|mesh-ancestor
153559239|NCT01631409|Nitroglycerin|nitroglycerin|mesh-list
153559240|NCT01631409|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153559241|NCT01631409|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153559242|NCT01631409|Analgesics|analgesics|mesh-ancestor
153559243|NCT01631409|Sensory System Agents|sensory system agents|mesh-ancestor
153559244|NCT01631409|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153559245|NCT01631409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153559246|NCT01631409|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153559247|NCT01631409|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153559248|NCT01631409|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153559249|NCT01631409|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153559250|NCT01631409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153559251|NCT01631409|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153559252|NCT01631409|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153559253|NCT01631409|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153559254|NCT01631409|Antipyretics|antipyretics|mesh-ancestor
153559255|NCT01631409|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
153559294|NCT01631526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153559295|NCT01631526|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153559296|NCT01631539|Irinotecan|irinotecan|mesh-list
153559297|NCT01631539|Cetuximab|cetuximab|mesh-list
153559298|NCT01631539|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
153559299|NCT01631539|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153559300|NCT01631539|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153559301|NCT01631539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153559302|NCT01631539|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153559303|NCT01631539|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153559304|NCT01631604|Botulinum Toxins|botulinum toxins|mesh-list
153559305|NCT01631604|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
153559306|NCT01631604|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153559307|NCT01631604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153559308|NCT01631604|Cholinergic Agents|cholinergic agents|mesh-ancestor
153877328|NCT05895838|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153559309|NCT01631604|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153559310|NCT01631604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153559351|NCT01631994|Dopamine Agents|dopamine agents|mesh-ancestor
153559352|NCT01631994|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153559353|NCT01631994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153559354|NCT01632046|Dialysis Solutions|dialysis solutions|mesh-list
153559355|NCT01632046|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
153559356|NCT01632189|Varenicline|varenicline|mesh-list
153559357|NCT01632189|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
153559358|NCT01632189|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
153559359|NCT01632189|Cholinergic Agents|cholinergic agents|mesh-ancestor
153559360|NCT01632189|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153559361|NCT01632189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153418191|NCT02790788|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
153559365|NCT01632371|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153559366|NCT01632371|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153559367|NCT01632371|Tubulin Modulators|tubulin modulators|mesh-ancestor
153559368|NCT01632371|Antimitotic Agents|antimitotic agents|mesh-ancestor
153559369|NCT01632371|Mitosis Modulators|mitosis modulators|mesh-ancestor
153559370|NCT01632371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153880015|NCT02400242|Immunomodulating Agents|immunomodulating agents|mesh-list
153880016|NCT02400242|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153880017|NCT02400242|Antiemetics|antiemetics|mesh-ancestor
153880018|NCT02400242|Autonomic Agents|autonomic agents|mesh-ancestor
153880019|NCT02400242|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153559371|NCT01632514|Cholecalciferol|cholecalciferol|mesh-list
153559404|NCT01632722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153559405|NCT01632722|Growth Inhibitors|growth inhibitors|mesh-ancestor
153559406|NCT01632761|Vitamin D|vitamin d|mesh-list
153559407|NCT01632761|Ergocalciferols|ergocalciferols|mesh-list
153559408|NCT01632761|Cholecalciferol|cholecalciferol|mesh-list
153559409|NCT01632761|Vitamins|vitamins|mesh-list
153559410|NCT01632761|Micronutrients|micronutrients|mesh-ancestor
153559411|NCT01632761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153559412|NCT01632761|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153559413|NCT01632761|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153559414|NCT01632826|Pomalidomide|pomalidomide|mesh-list
153559415|NCT01632826|Immunologic Factors|immunologic factors|mesh-ancestor
153559416|NCT01632826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153559417|NCT01632826|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153559418|NCT01632826|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153559419|NCT01632826|Growth Substances|growth substances|mesh-ancestor
153559420|NCT01632826|Growth Inhibitors|growth inhibitors|mesh-ancestor
153559421|NCT01632826|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153559422|NCT01633086|Nitric Oxide|nitric oxide|mesh-list
153559423|NCT01633086|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153559424|NCT01633086|Autonomic Agents|autonomic agents|mesh-ancestor
153559425|NCT01633086|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153559454|NCT01633294|Ampicillin|ampicillin|mesh-list
153559455|NCT01633294|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153559456|NCT01633294|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153559457|NCT01633294|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
153559458|NCT01633294|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153559459|NCT01633294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153559460|NCT01633359|Atorvastatin|atorvastatin|mesh-list
153559461|NCT01633359|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-list
153559462|NCT01633359|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153559463|NCT01633359|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153559464|NCT01633359|Antimetabolites|antimetabolites|mesh-ancestor
153559465|NCT01633359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153559466|NCT01633359|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153559467|NCT01633359|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153559468|NCT01633450|Zinc|zinc|mesh-list
153559469|NCT01633450|Trace Elements|trace elements|mesh-ancestor
153559470|NCT01633450|Micronutrients|micronutrients|mesh-ancestor
153559471|NCT01633450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153559472|NCT01633476|Valacyclovir|valacyclovir|mesh-list
153559473|NCT01633476|Antiviral Agents|antiviral agents|mesh-ancestor
153559474|NCT01633476|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153559475|NCT01633593|Donepezil|donepezil|mesh-list
153559508|NCT01633957|Anticoagulants|anticoagulants|mesh-ancestor
153559509|NCT01633970|Leucovorin|leucovorin|mesh-list
153559510|NCT01633970|Paclitaxel|paclitaxel|mesh-list
153559511|NCT01633970|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
153559512|NCT01633970|Bevacizumab|bevacizumab|mesh-list
153559513|NCT01633970|Carboplatin|carboplatin|mesh-list
153559515|NCT01633970|Pemetrexed|pemetrexed|mesh-list
153559516|NCT01633970|Atezolizumab|atezolizumab|mesh-list
153559517|NCT01633970|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153559518|NCT01633970|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153559519|NCT01633970|Tubulin Modulators|tubulin modulators|mesh-ancestor
153559520|NCT01633970|Antimitotic Agents|antimitotic agents|mesh-ancestor
153559572|NCT01634295|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153559573|NCT01634295|Vitamin B Complex|vitamin b complex|mesh-ancestor
153559574|NCT01634295|Vitamins|vitamins|mesh-ancestor
153559575|NCT01634295|Micronutrients|micronutrients|mesh-ancestor
153559576|NCT01634321|Leuprolide|leuprolide|mesh-list
153559577|NCT01634321|Fertility Agents, Female|fertility agents, female|mesh-ancestor
153559579|NCT01634321|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153559580|NCT01634321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153559581|NCT01634321|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153559582|NCT01634321|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153559583|NCT01634347|Propranolol|propranolol|mesh-list
153559584|NCT01634347|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
153559585|NCT01634347|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
153418347|NCT03007225|Hormones|hormones|mesh-ancestor
153559586|NCT01634347|Adrenergic Agents|adrenergic agents|mesh-ancestor
153559587|NCT01634347|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153559588|NCT01634347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153559589|NCT01634347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153559590|NCT01634347|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153559591|NCT01634347|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153559592|NCT01634347|Vasodilator Agents|vasodilator agents|mesh-ancestor
153559593|NCT01634373|Quetiapine Fumarate|quetiapine fumarate|mesh-list
153559594|NCT01634373|Antidepressive Agents|antidepressive agents|mesh-ancestor
153559595|NCT01634373|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153559596|NCT01634373|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153559597|NCT01634373|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153559598|NCT01634373|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153559600|NCT01634386|Quetiapine Fumarate|quetiapine fumarate|mesh-list
153559621|NCT01634412|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
153559622|NCT01634412|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153559623|NCT01634412|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153559624|NCT01634412|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153559625|NCT01634412|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153559626|NCT01634412|Analgesics|analgesics|mesh-ancestor
153559627|NCT01634412|Sensory System Agents|sensory system agents|mesh-ancestor
153559628|NCT01634412|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
153559629|NCT01634412|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153559630|NCT01634412|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153559685|NCT01634763|Ceritinib|ceritinib|mesh-list
153559686|NCT01634763|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153559687|NCT01634763|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153559688|NCT01634763|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153559689|NCT01634763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153559690|NCT01634763|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153559691|NCT01634789|Bazedoxifene|bazedoxifene|mesh-list
153559692|NCT01634789|Estrogens|estrogens|mesh-list
153559693|NCT01634789|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
153559694|NCT01634789|Hormones|hormones|mesh-ancestor
153559695|NCT01634789|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153559696|NCT01634789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153559697|NCT01634789|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
153559698|NCT01634789|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
153559699|NCT01634789|Hormone Antagonists|hormone antagonists|mesh-ancestor
153559700|NCT01634789|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153559701|NCT01634880|Panitumumab|panitumumab|mesh-list
153559702|NCT01634880|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153559703|NCT01634880|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153559704|NCT01634893|Hydroxychloroquine|hydroxychloroquine|mesh-list
153559705|NCT01634893|Sorafenib|sorafenib|mesh-list
153559706|NCT01634893|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153877686|NCT05500170|Antimetabolites|antimetabolites|mesh-ancestor
153559738|NCT01634958|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153559739|NCT01634958|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153559740|NCT01635088|Mometasone Furoate|mometasone furoate|mesh-list
153559741|NCT01635088|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153559742|NCT01635088|Dermatologic Agents|dermatologic agents|mesh-ancestor
153559743|NCT01635088|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
153559744|NCT01635114|Resveratrol|resveratrol|mesh-list
153559745|NCT01635114|Antioxidants|antioxidants|mesh-ancestor
153559746|NCT01635114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153559747|NCT01635114|Protective Agents|protective agents|mesh-ancestor
153559748|NCT01635114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153559749|NCT01635114|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153559750|NCT01635114|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153559751|NCT01635205|Anesthetics|anesthetics|mesh-list
153559799|NCT01635608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153559800|NCT01635608|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153559801|NCT01635608|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153559803|NCT01635686|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153559804|NCT01635686|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153418510|NCT03020095|Ritonavir|ritonavir|mesh-list
153559805|NCT01635686|Analgesics|analgesics|mesh-ancestor
153559806|NCT01635686|Sensory System Agents|sensory system agents|mesh-ancestor
153559807|NCT01635686|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153559808|NCT01635686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153559809|NCT01635686|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153559810|NCT01635686|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153559811|NCT01635686|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153559863|NCT01635829|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153559864|NCT01635829|Analgesics|analgesics|mesh-ancestor
153559865|NCT01635829|Sensory System Agents|sensory system agents|mesh-ancestor
153559866|NCT01635829|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153559867|NCT01635829|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153559868|NCT01635829|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153559930|NCT01636128|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153418587|NCT03022526|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153418588|NCT03022526|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153418589|NCT03022526|Narcotics|narcotics|mesh-ancestor
153418590|NCT03022526|Analgesics|analgesics|mesh-ancestor
153418591|NCT03022526|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153418592|NCT03022526|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153418593|NCT03022526|Anesthetics, General|anesthetics, general|mesh-ancestor
153418594|NCT02794441|Dexamethasone|dexamethasone|mesh-list
153418595|NCT02794441|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153418596|NCT02794441|Antiemetics|antiemetics|mesh-ancestor
153418597|NCT02794441|Autonomic Agents|autonomic agents|mesh-ancestor
153418598|NCT02794441|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153418599|NCT02794441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153418600|NCT02794441|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153877826|NCT05358704|Micronutrients|micronutrients|mesh-ancestor
153877827|NCT05316168|Dexamethasone|dexamethasone|mesh-list
153877828|NCT05316168|Bupivacaine|bupivacaine|mesh-list
153877829|NCT05316168|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153877830|NCT05316168|Antiemetics|antiemetics|mesh-ancestor
153559996|NCT01636505|Hormone Antagonists|hormone antagonists|mesh-ancestor
153559997|NCT01636505|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153559998|NCT01636531|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
153559999|NCT01636531|Immunologic Factors|immunologic factors|mesh-ancestor
153560000|NCT01636531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153560007|NCT01636557|Micronutrients|micronutrients|mesh-ancestor
153560008|NCT01636557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153560009|NCT01636557|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153560010|NCT01636557|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153560011|NCT01636557|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153560012|NCT01636557|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153560013|NCT01636557|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153560014|NCT01636557|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153560015|NCT01636557|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153560033|NCT01636557|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153560034|NCT01636557|Hemostatics|hemostatics|mesh-ancestor
153560036|NCT01636570|Vitamin D|vitamin d|mesh-list
153560037|NCT01636570|Cholecalciferol|cholecalciferol|mesh-list
153560038|NCT01636570|Vitamins|vitamins|mesh-ancestor
153560039|NCT01636570|Micronutrients|micronutrients|mesh-ancestor
153421150|NCT06280274|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153560047|NCT01636609|Azacitidine|azacitidine|mesh-list
153560083|NCT01635426|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153560084|NCT01635426|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153560085|NCT01635426|Analgesics|analgesics|mesh-ancestor
153560086|NCT01635426|Sensory System Agents|sensory system agents|mesh-ancestor
153560087|NCT01635426|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153560088|NCT01635426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153560089|NCT01635426|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153560090|NCT01635426|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153560091|NCT01635426|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153560092|NCT01635426|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153560093|NCT01635426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153560094|NCT01635426|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153560095|NCT01635426|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153560096|NCT01635426|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153560097|NCT01635426|Antipyretics|antipyretics|mesh-ancestor
153560098|NCT01635426|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
153560140|NCT01636908|Growth Inhibitors|growth inhibitors|mesh-ancestor
153560142|NCT01636999|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
153560143|NCT01636999|Anesthetics, General|anesthetics, general|mesh-ancestor
153560144|NCT01636999|Anesthetics|anesthetics|mesh-ancestor
153560145|NCT01636999|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153560146|NCT01636999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153560147|NCT01636999|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153560148|NCT01636999|Analgesics|analgesics|mesh-ancestor
153560149|NCT01636999|Sensory System Agents|sensory system agents|mesh-ancestor
153880320|NCT02276274|Alogliptin|alogliptin|mesh-list
153560219|NCT01637259|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
153560221|NCT01637259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153560222|NCT01637259|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153560223|NCT01637259|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153560224|NCT01637259|Antiviral Agents|antiviral agents|mesh-ancestor
153560225|NCT01637259|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153560226|NCT01637259|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
153870543|NCT01083615|Mitosis Modulators|mitosis modulators|mesh-ancestor
153560257|NCT01637532|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153560258|NCT01637532|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153560259|NCT01637532|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153560260|NCT01637532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153560261|NCT01637532|Antiviral Agents|antiviral agents|mesh-ancestor
153560262|NCT01637532|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153560263|NCT01637532|Immunologic Factors|immunologic factors|mesh-ancestor
153560264|NCT01637532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153560265|NCT01637545|Ramosetron|ramosetron|mesh-list
153560266|NCT01637545|Antiemetics|antiemetics|mesh-ancestor
153560267|NCT01637545|Autonomic Agents|autonomic agents|mesh-ancestor
153560268|NCT01637545|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153560269|NCT01637545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153782671|NCT00234689|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
153560310|NCT01637636|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
153560315|NCT01637636|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
153560316|NCT01637636|Antifungal Agents|antifungal agents|mesh-ancestor
153560317|NCT01637636|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
153560318|NCT01637636|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153560319|NCT01637636|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153421228|NCT06130423|Nicotine|nicotine|mesh-list
153560366|NCT01637818|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
153560367|NCT01637818|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-list
153560368|NCT01637818|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153560369|NCT01637818|Analgesics|analgesics|mesh-ancestor
153560370|NCT01637818|Sensory System Agents|sensory system agents|mesh-ancestor
153560371|NCT01637818|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153560372|NCT01637818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153560373|NCT01637818|Antipyretics|antipyretics|mesh-ancestor
153560375|NCT01637844|Telbivudine|telbivudine|mesh-list
153560424|NCT01638247|Tamoxifen|tamoxifen|mesh-list
153560425|NCT01638247|Goserelin|goserelin|mesh-list
153560426|NCT01638247|Exemestane|exemestane|mesh-list
153560427|NCT01638247|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
153560428|NCT01638247|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
153560429|NCT01638247|Hormone Antagonists|hormone antagonists|mesh-ancestor
153560430|NCT01638247|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153376035|NCT06194214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153560481|NCT01638377|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153560483|NCT01638403|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
153560484|NCT01638403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153560485|NCT01638403|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
153560486|NCT01638403|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
153880426|NCT02046460|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
153880427|NCT02046460|Hemostatics|hemostatics|mesh-ancestor
153560556|NCT01638780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153560557|NCT01638780|Protective Agents|protective agents|mesh-ancestor
153560561|NCT01638858|Ranibizumab|ranibizumab|mesh-list
153560562|NCT01638858|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153560563|NCT01638858|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153560564|NCT01638858|Growth Substances|growth substances|mesh-ancestor
153560565|NCT01638858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153560566|NCT01638858|Growth Inhibitors|growth inhibitors|mesh-ancestor
153560593|NCT01638962|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153560594|NCT01638962|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153560595|NCT01638962|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153560596|NCT01638962|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153560597|NCT01638962|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153560598|NCT01638962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153560600|NCT01638962|Gout Suppressants|gout suppressants|mesh-ancestor
153421302|NCT06048809|Fluorides|fluorides|mesh-list
153421303|NCT06048809|Tin Fluorides|tin fluorides|mesh-list
153421324|NCT06012916|Antidepressive Agents|antidepressive agents|mesh-ancestor
153560656|NCT01639326|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153560657|NCT01639326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153560658|NCT01639326|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153560659|NCT01639456|Aldesleukin|aldesleukin|mesh-list
153560660|NCT01639456|Cyclophosphamide|cyclophosphamide|mesh-list
153560661|NCT01639456|Fludarabine|fludarabine|mesh-list
153560662|NCT01639456|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153880495|NCT01659658|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153880496|NCT01659658|Protease Inhibitors|protease inhibitors|mesh-ancestor
153560664|NCT01639456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153560665|NCT01639456|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153560666|NCT01639456|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153560667|NCT01639456|Alkylating Agents|alkylating agents|mesh-ancestor
153560668|NCT01639456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153560669|NCT01639456|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153880520|NCT01523977|Antimitotic Agents|antimitotic agents|mesh-ancestor
153880522|NCT01523977|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
153560673|NCT01639456|Antiviral Agents|antiviral agents|mesh-ancestor
153560674|NCT01639456|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153560675|NCT01639521|Gemcitabine|gemcitabine|mesh-list
153560676|NCT01639521|Doxorubicin|doxorubicin|mesh-list
153560677|NCT01639521|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
153560708|NCT01639794|Solifenacin Succinate|solifenacin succinate|mesh-list
153560709|NCT01639794|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
153560711|NCT01639794|Cholinergic Agents|cholinergic agents|mesh-ancestor
153560712|NCT01639794|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153560713|NCT01639794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153560714|NCT01639794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153560715|NCT01639794|Urological Agents|urological agents|mesh-ancestor
153560717|NCT01639807|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
153560718|NCT01639807|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
153560719|NCT01639885|Interferons|interferons|mesh-list
153560720|NCT01639885|Interferon-alpha|interferon-alpha|mesh-list
153560721|NCT01639885|Interferon alpha-2|interferon alpha-2|mesh-list
153560731|NCT01639898|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153560732|NCT01639898|Antiemetics|antiemetics|mesh-ancestor
153560733|NCT01639898|Autonomic Agents|autonomic agents|mesh-ancestor
153560734|NCT01639898|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153560735|NCT01639898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153560736|NCT01639898|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153560737|NCT01639898|Glucocorticoids|glucocorticoids|mesh-ancestor
153560738|NCT01639898|Hormones|hormones|mesh-ancestor
153560739|NCT01639898|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153418605|NCT02794441|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153560818|NCT01642979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153560820|NCT01642979|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153560821|NCT01642979|Dermatologic Agents|dermatologic agents|mesh-ancestor
153560822|NCT01642979|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153560823|NCT01642979|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
153560824|NCT01642979|Hormones|hormones|mesh-ancestor
153880612|NCT01190930|Glucocorticoids|glucocorticoids|mesh-ancestor
153560874|NCT01645839|Antimetabolites|antimetabolites|mesh-ancestor
153560875|NCT01645839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153560876|NCT01645839|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153560877|NCT01645839|Antiviral Agents|antiviral agents|mesh-ancestor
153560878|NCT01645839|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153560879|NCT01645839|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153560880|NCT01645839|Immunologic Factors|immunologic factors|mesh-ancestor
153560881|NCT01645839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153560882|NCT01646437|Aspirin|aspirin|mesh-list
153560883|NCT01646437|Vitamin D|vitamin d|mesh-list
153560884|NCT01646437|Cholecalciferol|cholecalciferol|mesh-list
153560885|NCT01646437|Vitamins|vitamins|mesh-ancestor
153421490|NCT05850520|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153421491|NCT05850520|Growth Substances|growth substances|mesh-ancestor
153421495|NCT05839652|Midodrine|midodrine|mesh-list
153560931|NCT01648218|Insulin, Isophane|insulin, isophane|mesh-list
153560932|NCT01648218|Isophane Insulin, Human|isophane insulin, human|mesh-list
153560933|NCT01648218|Protamines|protamines|mesh-list
153560934|NCT01648218|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153560935|NCT01648218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153560936|NCT01648218|Heparin Antagonists|heparin antagonists|mesh-ancestor
153560937|NCT01648218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153560938|NCT01648218|Coagulants|coagulants|mesh-ancestor
153560939|NCT01648465|Everolimus|everolimus|mesh-list
153560940|NCT01648465|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
153560941|NCT01648465|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153560942|NCT01648465|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153560972|NCT01650012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153560973|NCT01650012|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
153560974|NCT01650012|Diuretics|diuretics|mesh-ancestor
153560975|NCT01650012|Natriuretic Agents|natriuretic agents|mesh-ancestor
153560976|NCT01650012|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153782676|NCT04561960|Fluorides|fluorides|mesh-list
153560977|NCT01650090|Cisplatin|cisplatin|mesh-list
153782677|NCT04561960|Cariostatic Agents|cariostatic agents|mesh-ancestor
153560978|NCT01650090|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153560979|NCT01650129|Insulin|insulin|mesh-list
153880028|NCT02400242|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153880029|NCT02400242|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153880030|NCT02400242|Growth Substances|growth substances|mesh-ancestor
153880031|NCT02400242|Growth Inhibitors|growth inhibitors|mesh-ancestor
153560980|NCT01650129|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
153560981|NCT01650129|Insulin Aspart|insulin aspart|mesh-list
153561032|NCT01650428|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153561033|NCT01650428|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153561034|NCT01650428|Immunologic Factors|immunologic factors|mesh-ancestor
153561035|NCT01650428|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
153561036|NCT01650428|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153561037|NCT01650428|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153561039|NCT01650441|Formoterol Fumarate|formoterol fumarate|mesh-list
153561041|NCT01650441|Autonomic Agents|autonomic agents|mesh-ancestor
153561093|NCT01650662|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153561094|NCT01650662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153561095|NCT01650662|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153561096|NCT01650662|Immunologic Factors|immunologic factors|mesh-ancestor
153561097|NCT01650662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153561098|NCT01650662|Antifungal Agents|antifungal agents|mesh-ancestor
153561158|NCT01651169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153561160|NCT01651169|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153561161|NCT01651182|Tranexamic Acid|tranexamic acid|mesh-list
153561162|NCT01651182|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
153561163|NCT01651182|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153561164|NCT01651182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153561167|NCT01651312|Mirabegron|mirabegron|mesh-list
153561214|NCT01651390|Paclitaxel|paclitaxel|mesh-list
153561215|NCT01651390|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153561216|NCT01651390|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153561217|NCT01651390|Tubulin Modulators|tubulin modulators|mesh-ancestor
153561218|NCT01651390|Antimitotic Agents|antimitotic agents|mesh-ancestor
153880720|NCT00003838|Antifungal Agents|antifungal agents|mesh-ancestor
153880724|NCT06031376|Trifluridine|trifluridine|mesh-list
153561232|NCT01651416|Sulfadoxine|sulfadoxine|mesh-list
153561233|NCT01651416|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
153561234|NCT01651416|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
153561235|NCT01651416|Amodiaquine|amodiaquine|mesh-list
153561236|NCT01651416|Artenimol|artenimol|mesh-list
153561237|NCT01651416|Antimalarials|antimalarials|mesh-ancestor
153561238|NCT01651416|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153561239|NCT01651416|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153561240|NCT01651416|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153561241|NCT01651416|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153561242|NCT01651416|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153561243|NCT01651416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153561244|NCT01651416|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
153561246|NCT01651481|Levocetirizine|levocetirizine|mesh-list
153561247|NCT01651481|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153561269|NCT01651572|Rocuronium|rocuronium|mesh-list
153561270|NCT01651572|Cisatracurium|cisatracurium|mesh-list
153561271|NCT01651572|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
153561272|NCT01651572|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
153561273|NCT01651572|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
153561274|NCT01651572|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153421612|NCT05689047|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153561275|NCT01651572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153561276|NCT01651585|Valacyclovir|valacyclovir|mesh-list
153561277|NCT01651585|Antiviral Agents|antiviral agents|mesh-ancestor
153561278|NCT01651585|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153561279|NCT01651637|Pulmonary Surfactants|pulmonary surfactants|mesh-list
153561280|NCT01651637|Respiratory System Agents|respiratory system agents|mesh-ancestor
153561282|NCT01651715|Immunologic Factors|immunologic factors|mesh-ancestor
153561283|NCT01651715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153561284|NCT01651728|Simvastatin|simvastatin|mesh-list
153561285|NCT01651728|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153561286|NCT01651728|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153561287|NCT01651728|Antimetabolites|antimetabolites|mesh-ancestor
153561292|NCT01651923|Heparin|heparin|mesh-list
153421645|NCT05607420|Alemtuzumab|alemtuzumab|mesh-list
153421647|NCT05607420|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153561306|NCT01651962|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153561307|NCT01651962|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153561308|NCT01651962|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153561309|NCT01651962|Anesthetics, General|anesthetics, general|mesh-ancestor
153561310|NCT01651962|Anesthetics|anesthetics|mesh-ancestor
153561311|NCT01651962|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153561312|NCT01651962|Autonomic Agents|autonomic agents|mesh-ancestor
153561313|NCT01651962|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153561314|NCT01651962|Respiratory System Agents|respiratory system agents|mesh-ancestor
153561315|NCT01651962|Sympathomimetics|sympathomimetics|mesh-ancestor
153561316|NCT01651962|Tocolytic Agents|tocolytic agents|mesh-ancestor
153561317|NCT01651962|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153561318|NCT01651962|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
153561319|NCT01651962|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
153561320|NCT01651962|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153561324|NCT01651988|Propofol|propofol|mesh-list
153561351|NCT01652014|Antitubercular Agents|antitubercular agents|mesh-ancestor
153880812|NCT06030492|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
153561360|NCT01652118|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
153561361|NCT01652118|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153561362|NCT01652157|Pancrelipase|pancrelipase|mesh-list
153561363|NCT01652157|Pancreatin|pancreatin|mesh-list
153561364|NCT01652157|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153561366|NCT01652183|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153561367|NCT01652183|Analgesics|analgesics|mesh-ancestor
153561368|NCT01652183|Sensory System Agents|sensory system agents|mesh-ancestor
153561369|NCT01652183|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153561407|NCT01652326|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153561408|NCT01652326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153561409|NCT01652326|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153561410|NCT01652326|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153561411|NCT01652326|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153561412|NCT01652326|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
153561413|NCT01652326|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
153561414|NCT01652326|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153561415|NCT01652326|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153421676|NCT05603104|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153561424|NCT01652339|Amlodipine|amlodipine|mesh-list
153561425|NCT01652339|Valsartan|valsartan|mesh-list
153561426|NCT01652339|Amlodipine, Valsartan Drug Combination|amlodipine, valsartan drug combination|mesh-list
153561459|NCT01652417|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
153561460|NCT01652417|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
153561461|NCT01652417|Prednisolone|prednisolone|mesh-list
153561462|NCT01652417|Prednisolone acetate|prednisolone acetate|mesh-list
153561463|NCT01652417|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
153376045|NCT06194058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153561464|NCT01652417|Prednisolone phosphate|prednisolone phosphate|mesh-list
153561465|NCT01652417|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153561466|NCT01652417|Antiemetics|antiemetics|mesh-ancestor
153561467|NCT01652417|Autonomic Agents|autonomic agents|mesh-ancestor
153561468|NCT01652417|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153561469|NCT01652417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153561470|NCT01652417|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153561471|NCT01652417|Glucocorticoids|glucocorticoids|mesh-ancestor
153561472|NCT01652417|Hormones|hormones|mesh-ancestor
153561473|NCT01652417|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153880830|NCT06030479|Sympathomimetics|sympathomimetics|mesh-ancestor
153880831|NCT06030479|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
153880832|NCT06027567|Semaglutide|semaglutide|mesh-list
153880833|NCT06027567|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
153880834|NCT06027567|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153421704|NCT05554406|Cytarabine|cytarabine|mesh-list
153561517|NCT01652586|Adrenergic Agents|adrenergic agents|mesh-ancestor
153561518|NCT01652586|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153561519|NCT01652586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153561520|NCT01652586|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153561521|NCT01652586|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153561522|NCT01652586|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153561523|NCT01652586|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153561524|NCT01652586|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153561525|NCT01652586|Anesthetics, General|anesthetics, general|mesh-ancestor
153561526|NCT01652586|Anesthetics|anesthetics|mesh-ancestor
153561527|NCT01652586|GABA Modulators|gaba modulators|mesh-ancestor
153561528|NCT01652586|GABA Agents|gaba agents|mesh-ancestor
153561529|NCT01652586|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153561530|NCT01652586|Narcotics|narcotics|mesh-ancestor
153561531|NCT01652599|Dexamethasone|dexamethasone|mesh-list
153561532|NCT01652599|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153561533|NCT01652599|Antiemetics|antiemetics|mesh-ancestor
153561534|NCT01652599|Autonomic Agents|autonomic agents|mesh-ancestor
153561535|NCT01652599|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153421705|NCT05554406|Azacitidine|azacitidine|mesh-list
153421721|NCT05537740|Pembrolizumab|pembrolizumab|mesh-list
153561580|NCT01652898|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
153782683|NCT04561921|Analgesics|analgesics|mesh-ancestor
153561581|NCT01652898|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
153561582|NCT01652898|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
153561583|NCT01652898|Adrenergic Agents|adrenergic agents|mesh-ancestor
153561584|NCT01652898|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153561585|NCT01652898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153561586|NCT01652898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153561590|NCT01653015|Vaccines|vaccines|mesh-list
153561617|NCT01653067|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153561618|NCT01653067|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153561619|NCT01653067|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153561620|NCT01653067|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153561621|NCT01653067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153561622|NCT01653067|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153561623|NCT01653067|Immunologic Factors|immunologic factors|mesh-ancestor
153561624|NCT01653067|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153561625|NCT01653067|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153561626|NCT01653067|Antimetabolites|antimetabolites|mesh-ancestor
153561627|NCT01653067|Antiviral Agents|antiviral agents|mesh-ancestor
153561628|NCT01653067|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153561629|NCT01653067|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153561630|NCT01653067|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153561631|NCT01653067|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153561632|NCT01653067|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153561633|NCT01653067|Antifungal Agents|antifungal agents|mesh-ancestor
153561634|NCT01653119|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
153561635|NCT01653119|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153561636|NCT01653119|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153561671|NCT01653457|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
153561672|NCT01653457|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
153561673|NCT01653457|Dopamine Agents|dopamine agents|mesh-ancestor
153561674|NCT01653457|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153561682|NCT01653470|Carboplatin|carboplatin|mesh-list
153561683|NCT01653470|Fluorouracil|fluorouracil|mesh-list
153561684|NCT01653470|Irinotecan|irinotecan|mesh-list
153561685|NCT01653470|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153561686|NCT01653470|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153561687|NCT01653470|Tubulin Modulators|tubulin modulators|mesh-ancestor
153561688|NCT01653470|Antimitotic Agents|antimitotic agents|mesh-ancestor
153561689|NCT01653470|Mitosis Modulators|mitosis modulators|mesh-ancestor
153561690|NCT01653470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153561691|NCT01653470|Antimetabolites|antimetabolites|mesh-ancestor
153561692|NCT01653470|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153561693|NCT01653470|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153561694|NCT01653470|Immunologic Factors|immunologic factors|mesh-ancestor
153561695|NCT01653470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153561696|NCT01653470|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
153561720|NCT01653717|Cyclophosphamide|cyclophosphamide|mesh-list
153561721|NCT01653717|Fludarabine|fludarabine|mesh-list
153561722|NCT01653717|Fludarabine phosphate|fludarabine phosphate|mesh-list
153561723|NCT01653717|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153561724|NCT01653717|Immunologic Factors|immunologic factors|mesh-ancestor
153561725|NCT01653717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153421783|NCT05479747|Analgesics|analgesics|mesh-list
153421784|NCT05479747|Sensory System Agents|sensory system agents|mesh-ancestor
153561735|NCT01653990|Moxifloxacin|moxifloxacin|mesh-list
153561736|NCT01653990|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
153561737|NCT01653990|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153561738|NCT01653990|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153561739|NCT01653990|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153561740|NCT01653990|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153561741|NCT01653990|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153561773|NCT01654146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153561776|NCT01654185|Aromatase Inhibitors|aromatase inhibitors|mesh-list
153561777|NCT01654185|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153561778|NCT01654185|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153561779|NCT01654185|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153561780|NCT01654185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153561781|NCT01654185|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
153561782|NCT01654185|Hormone Antagonists|hormone antagonists|mesh-ancestor
153561783|NCT01654185|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153561784|NCT01654185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153561785|NCT01654211|Ritonavir|ritonavir|mesh-list
153561786|NCT01654211|Lactams|lactams|mesh-list
153561787|NCT01654211|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
153880933|NCT05842759|Norepinephrine|norepinephrine|mesh-list
153561796|NCT01654211|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
153561797|NCT01654211|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153561798|NCT01654211|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153561800|NCT01654367|Aromatase Inhibitors|aromatase inhibitors|mesh-list
153561801|NCT01654367|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153561802|NCT01654367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153561803|NCT01654367|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153421818|NCT05434689|Hormones|hormones|mesh-ancestor
153782685|NCT04561921|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153561810|NCT01654497|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153561811|NCT01654497|Antiemetics|antiemetics|mesh-ancestor
153561812|NCT01654497|Autonomic Agents|autonomic agents|mesh-ancestor
153561813|NCT01654497|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153561814|NCT01654497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153561815|NCT01654497|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153561816|NCT01654497|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
153561822|NCT01654562|Simvastatin|simvastatin|mesh-list
153561868|NCT01654809|Immunologic Factors|immunologic factors|mesh-ancestor
153561869|NCT01654809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153561870|NCT01654913|Chrysarobin|chrysarobin|mesh-list
153561871|NCT01654913|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153561872|NCT01654913|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153376047|NCT06193993|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153376048|NCT06193993|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153376049|NCT06193993|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153376050|NCT06193993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153376051|NCT06193993|Hormone Antagonists|hormone antagonists|mesh-ancestor
153561873|NCT01654913|Analgesics|analgesics|mesh-ancestor
153561881|NCT01654939|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153561882|NCT01654939|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153561884|NCT01654965|Lenograstim|lenograstim|mesh-list
153561885|NCT01654965|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153561886|NCT01654965|Immunologic Factors|immunologic factors|mesh-ancestor
153561921|NCT01655095|Prucalopride|prucalopride|mesh-list
153561922|NCT01655095|Bisacodyl|bisacodyl|mesh-list
153561923|NCT01655095|Laxatives|laxatives|mesh-ancestor
153561924|NCT01655095|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153561925|NCT01655095|Serotonin 5-HT4 Receptor Agonists|serotonin 5-ht4 receptor agonists|mesh-ancestor
153418606|NCT02941640|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
153561985|NCT01655303|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153561986|NCT01655303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153561987|NCT01655303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153561988|NCT01655303|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153561989|NCT01655303|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153561990|NCT01655303|Vasodilator Agents|vasodilator agents|mesh-ancestor
153561991|NCT01655303|Sympatholytics|sympatholytics|mesh-ancestor
153561992|NCT01655303|Autonomic Agents|autonomic agents|mesh-ancestor
153561993|NCT01655303|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153561994|NCT01655303|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
153561995|NCT01655303|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153561996|NCT01655303|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153561997|NCT01655303|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153561999|NCT01655316|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153562000|NCT01655316|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153562050|NCT01655706|Dopamine Agents|dopamine agents|mesh-ancestor
153562051|NCT01655706|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
153562052|NCT01655706|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
153562053|NCT01655706|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
153562060|NCT01655758|Timolol|timolol|mesh-list
153562087|NCT01655810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153562088|NCT01655810|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153562090|NCT01655862|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
153562091|NCT01655862|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
153562092|NCT01655862|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
153562093|NCT01655862|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153421976|NCT05061017|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153421977|NCT05061017|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153562101|NCT01655875|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153562102|NCT01655875|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153562103|NCT01655875|Antiviral Agents|antiviral agents|mesh-ancestor
153562104|NCT01655875|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153562105|NCT01655888|Tremelimumab|tremelimumab|mesh-list
153562106|NCT01655888|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153562108|NCT01655914|Antidotes|antidotes|mesh-ancestor
153562109|NCT01655914|Protective Agents|protective agents|mesh-ancestor
153562110|NCT01655914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153562111|NCT01655914|GABA Modulators|gaba modulators|mesh-ancestor
153562112|NCT01655914|GABA Agents|gaba agents|mesh-ancestor
153562113|NCT01655914|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153562129|NCT01655966|Antiviral Agents|antiviral agents|mesh-ancestor
153562130|NCT01655966|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153562131|NCT01655966|Antimetabolites|antimetabolites|mesh-ancestor
153422012|NCT05006794|Immunoconjugates|immunoconjugates|mesh-ancestor
153562169|NCT01656005|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
153562170|NCT01656005|Sympatholytics|sympatholytics|mesh-ancestor
153376054|NCT06193993|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153376055|NCT06191640|Ivacaftor|ivacaftor|mesh-list
153376056|NCT06191640|Elexacaftor|elexacaftor|mesh-list
153376057|NCT06191640|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
153882397|NCT01608984|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153882398|NCT01608984|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153882399|NCT01608984|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153882400|NCT01608984|Anesthetics, General|anesthetics, general|mesh-ancestor
153562171|NCT01656005|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
153562172|NCT01656005|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153562173|NCT01656005|Glucocorticoids|glucocorticoids|mesh-ancestor
153562174|NCT01656005|Hormones|hormones|mesh-ancestor
153562175|NCT01656005|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153562176|NCT01656018|Rilpivirine|rilpivirine|mesh-list
153562177|NCT01656018|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153562184|NCT01656018|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153562186|NCT01656057|Metformin|metformin|mesh-list
153562187|NCT01656057|Cholecystokinin|cholecystokinin|mesh-list
153562188|NCT01656057|Colesevelam Hydrochloride|colesevelam hydrochloride|mesh-list
153562189|NCT01656057|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153422066|NCT04873596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153562199|NCT01656057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153562214|NCT01656109|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153562215|NCT01656109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153562216|NCT01656109|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153562217|NCT01656109|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153880041|NCT02158091|Immunologic Factors|immunologic factors|mesh-ancestor
153880042|NCT02158091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153880043|NCT02158091|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153881214|NCT04781673|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153881215|NCT04781673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153881216|NCT04781673|Analgesics|analgesics|mesh-ancestor
153881217|NCT04781673|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
153422108|NCT04824092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153422122|NCT04824092|Hormones|hormones|mesh-ancestor
153562326|NCT01657058|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153562327|NCT01657058|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
153562328|NCT01657058|Histamine Antagonists|histamine antagonists|mesh-ancestor
153562329|NCT01657058|Histamine Agents|histamine agents|mesh-ancestor
153562330|NCT01657058|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153562331|NCT01657058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153562332|NCT01657071|Aspirin|aspirin|mesh-list
153562333|NCT01657071|Clopidogrel|clopidogrel|mesh-list
153562334|NCT01657071|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153562335|NCT01657071|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153562336|NCT01657071|Analgesics|analgesics|mesh-ancestor
153562337|NCT01657071|Sensory System Agents|sensory system agents|mesh-ancestor
153562338|NCT01657071|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153562383|NCT01657240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153562384|NCT01657240|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153562385|NCT01657240|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153562386|NCT01657240|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
153411158|NCT00004089|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153562403|NCT01657331|Immunoconjugates|immunoconjugates|mesh-ancestor
153562404|NCT01657331|Immunologic Factors|immunologic factors|mesh-ancestor
153562405|NCT01657331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153562406|NCT01657409|Botulinum Toxins|botulinum toxins|mesh-list
153562407|NCT01657409|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
153562409|NCT01657409|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
153562410|NCT01657409|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
153562411|NCT01657409|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153562412|NCT01657409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153562440|NCT01657487|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
153562441|NCT01657487|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
153562442|NCT01657487|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153562443|NCT01657487|Adrenergic Agents|adrenergic agents|mesh-ancestor
153562444|NCT01657487|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153562445|NCT01657487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153562446|NCT01657487|Glucocorticoids|glucocorticoids|mesh-ancestor
153562447|NCT01657487|Hormones|hormones|mesh-ancestor
153562448|NCT01657487|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153562449|NCT01657487|Sympathomimetics|sympathomimetics|mesh-ancestor
153562450|NCT01657578|Omeprazole|omeprazole|mesh-list
153562451|NCT01657578|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
153562452|NCT01657578|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153562486|NCT01657812|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
153562487|NCT01657812|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153562489|NCT01657812|Adrenergic Agents|adrenergic agents|mesh-ancestor
153562490|NCT01657812|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153562528|NCT01657864|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153562529|NCT01657864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153562530|NCT01657864|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153562531|NCT01657864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153562532|NCT01657864|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153562533|NCT01657864|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153562534|NCT01657864|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153562535|NCT01657864|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153562536|NCT01657864|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153562537|NCT01657890|Isavuconazole|isavuconazole|mesh-list
153422161|NCT04747301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153562558|NCT01657513|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153562559|NCT01657513|Dermatologic Agents|dermatologic agents|mesh-ancestor
153562560|NCT01657513|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153562561|NCT01657513|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153562562|NCT01657513|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153562564|NCT01657513|Sensory System Agents|sensory system agents|mesh-ancestor
153562565|NCT01657513|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153562566|NCT01657513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153562567|NCT01657513|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153422178|NCT04616183|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
153562577|NCT01658007|Sirolimus|sirolimus|mesh-list
153562578|NCT01658007|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153562579|NCT01658007|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153562580|NCT01658007|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153562581|NCT01658007|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153562582|NCT01658007|Antifungal Agents|antifungal agents|mesh-ancestor
153562583|NCT01658007|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153562584|NCT01658007|Immunologic Factors|immunologic factors|mesh-ancestor
153562585|NCT01658007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153562586|NCT01658033|Leucovorin|leucovorin|mesh-list
153562587|NCT01658033|Oxaliplatin|oxaliplatin|mesh-list
153562588|NCT01658033|Bevacizumab|bevacizumab|mesh-list
153562589|NCT01658033|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153562590|NCT01658033|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153562591|NCT01658033|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153562594|NCT01658033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153562595|NCT01658033|Growth Inhibitors|growth inhibitors|mesh-ancestor
153562596|NCT01658033|Antidotes|antidotes|mesh-ancestor
153562597|NCT01658033|Protective Agents|protective agents|mesh-ancestor
153562598|NCT01658033|Vitamin B Complex|vitamin b complex|mesh-ancestor
153562599|NCT01658033|Vitamins|vitamins|mesh-ancestor
153562600|NCT01658033|Micronutrients|micronutrients|mesh-ancestor
153562601|NCT01658124|Tranexamic Acid|tranexamic acid|mesh-list
153562602|NCT01658124|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
153562603|NCT01658124|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153562615|NCT01658176|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153562646|NCT01658319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153562647|NCT01658319|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153562648|NCT01658319|Immunologic Factors|immunologic factors|mesh-ancestor
153562649|NCT01658319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153562651|NCT01658358|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
153562652|NCT01658358|Lapatinib|lapatinib|mesh-list
153562653|NCT01658358|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153562654|NCT01658358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153562655|NCT01658358|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153562656|NCT01658358|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153562657|NCT01658358|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153562658|NCT01658358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153562659|NCT01658358|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153562672|NCT01658462|Nintedanib|nintedanib|mesh-list
153562673|NCT01658462|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153562674|NCT01658462|Tubulin Modulators|tubulin modulators|mesh-ancestor
153562675|NCT01658462|Antimitotic Agents|antimitotic agents|mesh-ancestor
153562676|NCT01658462|Mitosis Modulators|mitosis modulators|mesh-ancestor
153562677|NCT01658462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153562678|NCT01658462|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153562679|NCT01658462|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153562684|NCT01658527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153562685|NCT01658527|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153562686|NCT01658553|Trametinib|trametinib|mesh-list
153562687|NCT01658553|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153782691|NCT04561921|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153562688|NCT01658553|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153782692|NCT04561921|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153562689|NCT01658553|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153562702|NCT01658774|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153562703|NCT01658852|Metronidazole|metronidazole|mesh-list
153562704|NCT01658852|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153562705|NCT01658852|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153562706|NCT01658852|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153562707|NCT01658852|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153562708|NCT01658891|Beclomethasone|beclomethasone|mesh-list
153562709|NCT01658891|Formoterol Fumarate|formoterol fumarate|mesh-list
153562710|NCT01658891|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153562711|NCT01658891|Autonomic Agents|autonomic agents|mesh-ancestor
153562712|NCT01658891|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153562713|NCT01658891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153562714|NCT01658891|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153562733|NCT01659047|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153562734|NCT01659047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153562750|NCT01659099|Alkylating Agents|alkylating agents|mesh-ancestor
153562770|NCT01659190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153562771|NCT01659190|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153562774|NCT01659242|Leflunomide|leflunomide|mesh-list
153562775|NCT01659242|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
153562776|NCT01659242|Abortifacient Agents|abortifacient agents|mesh-ancestor
153562777|NCT01659242|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153562778|NCT01659242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153562779|NCT01659242|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153562780|NCT01659242|Antimetabolites|antimetabolites|mesh-ancestor
153562781|NCT01659242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153562782|NCT01659242|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153562783|NCT01659242|Dermatologic Agents|dermatologic agents|mesh-ancestor
153562784|NCT01659242|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153562803|NCT01659281|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153562804|NCT01659281|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153562809|NCT01659346|Carvedilol|carvedilol|mesh-list
153562810|NCT01659346|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
153562811|NCT01659346|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
153562812|NCT01659346|Adrenergic Agents|adrenergic agents|mesh-ancestor
153562813|NCT01659346|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153562814|NCT01659346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153562815|NCT01659346|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153562816|NCT01659346|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153562817|NCT01659346|Antioxidants|antioxidants|mesh-ancestor
153881407|NCT04187105|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
153562829|NCT01659359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153562831|NCT01659359|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153562832|NCT01659359|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153562833|NCT01659359|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
153562834|NCT01659359|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153782694|NCT04561921|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153562835|NCT01659359|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153562836|NCT01659359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153562837|NCT01659372|Naproxen|naproxen|mesh-list
153562838|NCT01659372|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153562839|NCT01659372|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153562840|NCT01659372|Analgesics|analgesics|mesh-ancestor
153562845|NCT01659372|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153562846|NCT01659372|Gout Suppressants|gout suppressants|mesh-ancestor
153562847|NCT01659372|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153562848|NCT01659372|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153422297|NCT04128956|Sensory System Agents|sensory system agents|mesh-ancestor
153562861|NCT01659476|Autonomic Agents|autonomic agents|mesh-ancestor
153562862|NCT01659476|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153562863|NCT01659476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153562864|NCT01659476|Parasympathomimetics|parasympathomimetics|mesh-ancestor
153881440|NCT04081389|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153562874|NCT01659515|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153562875|NCT01659619|Erythromycin|erythromycin|mesh-list
153562876|NCT01659619|Erythromycin Estolate|erythromycin estolate|mesh-list
153562877|NCT01659619|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
153562885|NCT01659684|Immunoglobulins|immunoglobulins|mesh-list
153562886|NCT01659684|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
153562888|NCT01659684|gamma-Globulins|gamma-globulins|mesh-list
153562889|NCT01659684|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
153562890|NCT01659684|Immunologic Factors|immunologic factors|mesh-ancestor
153562891|NCT01659684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153562893|NCT01659788|Coenzyme Q10|coenzyme q10|mesh-list
153562894|NCT01659788|Micronutrients|micronutrients|mesh-ancestor
153562895|NCT01659788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153562896|NCT01659788|Vitamins|vitamins|mesh-ancestor
153562897|NCT01659827|Bupivacaine|bupivacaine|mesh-list
153562898|NCT01659827|Anesthetics, Local|anesthetics, local|mesh-ancestor
153562899|NCT01659827|Anesthetics|anesthetics|mesh-ancestor
153881458|NCT04022005|Gemcitabine|gemcitabine|mesh-list
153881459|NCT04022005|Oxaliplatin|oxaliplatin|mesh-list
153881460|NCT04022005|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153562912|NCT01659892|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
153562913|NCT01659892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153562914|NCT01659905|Montelukast|montelukast|mesh-list
153562923|NCT01659905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153562925|NCT01659918|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153562926|NCT01659918|Respiratory System Agents|respiratory system agents|mesh-ancestor
153562927|NCT01659918|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
153562928|NCT01659918|Hormone Antagonists|hormone antagonists|mesh-ancestor
153562929|NCT01659918|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153562930|NCT01659918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153562931|NCT01659918|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
153562932|NCT01659918|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
153562933|NCT01659918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153562934|NCT01659931|Montelukast|montelukast|mesh-list
153562935|NCT01659931|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153562936|NCT01659931|Respiratory System Agents|respiratory system agents|mesh-ancestor
153562937|NCT01659931|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
153562938|NCT01659931|Hormone Antagonists|hormone antagonists|mesh-ancestor
153562939|NCT01659931|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153562940|NCT01659931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153562941|NCT01659931|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
153562942|NCT01659931|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
153881500|NCT03912818|Daunorubicin|daunorubicin|mesh-list
153562951|NCT01659944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153562958|NCT01659944|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153562959|NCT01659775|Ondansetron|ondansetron|mesh-list
153562960|NCT01659775|Antiemetics|antiemetics|mesh-ancestor
153562961|NCT01659775|Autonomic Agents|autonomic agents|mesh-ancestor
153562962|NCT01659775|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153562963|NCT01659775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153562964|NCT01659775|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153562965|NCT01659775|Antipruritics|antipruritics|mesh-ancestor
153562966|NCT01659775|Dermatologic Agents|dermatologic agents|mesh-ancestor
153562967|NCT01659775|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
153562968|NCT01659775|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153562969|NCT01659775|Serotonin Agents|serotonin agents|mesh-ancestor
153562970|NCT01659775|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153562971|NCT01659775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153562972|NCT01660295|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
153562973|NCT01660295|Dihydroergotamine|dihydroergotamine|mesh-list
153562974|NCT01660295|Certoparin|certoparin|mesh-list
153562975|NCT01660295|Anticoagulants|anticoagulants|mesh-ancestor
153562976|NCT01660295|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153562977|NCT01660295|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153562980|NCT01660295|Dopamine Agonists|dopamine agonists|mesh-ancestor
153782697|NCT04561921|Anesthetics, Local|anesthetics, local|mesh-ancestor
153562981|NCT01660295|Dopamine Agents|dopamine agents|mesh-ancestor
153562982|NCT01660295|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153562983|NCT01660295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153563005|NCT01660386|Incretins|incretins|mesh-ancestor
153563006|NCT01660386|Hormones|hormones|mesh-ancestor
153563007|NCT01660386|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153563008|NCT01660386|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
153563009|NCT01660386|Protease Inhibitors|protease inhibitors|mesh-ancestor
153563010|NCT01660386|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153563011|NCT01660386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153563012|NCT01660386|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153563013|NCT01660386|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153563014|NCT01660386|Immunologic Factors|immunologic factors|mesh-ancestor
153563015|NCT01660399|Docetaxel|docetaxel|mesh-list
153422439|NCT03844061|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153563024|NCT01660477|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
153563025|NCT01660477|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
153563026|NCT01660477|Protease Inhibitors|protease inhibitors|mesh-ancestor
153563027|NCT01660477|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153563043|NCT01660594|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153563044|NCT01660594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153563046|NCT01660620|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153563047|NCT01660620|Sympatholytics|sympatholytics|mesh-ancestor
153563048|NCT01660620|Autonomic Agents|autonomic agents|mesh-ancestor
153563049|NCT01660620|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153563050|NCT01660620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153420925|NCT02995915|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153420926|NCT03163303|Nicotine|nicotine|mesh-list
153563051|NCT01660620|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
153563052|NCT01660620|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
153782698|NCT04561921|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
153782699|NCT04561687|Azelastine|azelastine|mesh-list
153563053|NCT01660620|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
153563054|NCT01660620|Adrenergic Agents|adrenergic agents|mesh-ancestor
153563055|NCT01660620|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153563056|NCT01660620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153563057|NCT01660750|Dexamethasone|dexamethasone|mesh-list
153563058|NCT01660750|Cyclophosphamide|cyclophosphamide|mesh-list
153563059|NCT01660750|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153563071|NCT01660750|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153563079|NCT01660854|Antimalarials|antimalarials|mesh-ancestor
153563080|NCT01660854|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153563081|NCT01660854|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153563082|NCT01660854|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153563083|NCT01660854|Antimetabolites|antimetabolites|mesh-ancestor
153881633|NCT02429570|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153563096|NCT01660867|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153563097|NCT01660919|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
153563098|NCT01660919|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153563099|NCT01660919|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153563100|NCT01660919|Antimetabolites|antimetabolites|mesh-ancestor
153563101|NCT01660919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153563102|NCT01660919|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153563103|NCT01660919|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
153563117|NCT01660997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153563118|NCT01660997|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153563119|NCT01660997|Glucocorticoids|glucocorticoids|mesh-ancestor
153376059|NCT06191640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153563121|NCT01660997|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153563122|NCT01660997|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153563123|NCT01660997|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153563124|NCT01660997|Protease Inhibitors|protease inhibitors|mesh-ancestor
153563130|NCT01661101|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153563131|NCT01661101|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
153563132|NCT01661101|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153563133|NCT01661101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153563134|NCT01661101|Antithrombins|antithrombins|mesh-ancestor
153563135|NCT01661101|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
153563136|NCT01661101|Protease Inhibitors|protease inhibitors|mesh-ancestor
153563137|NCT01661101|Anticoagulants|anticoagulants|mesh-ancestor
153563138|NCT01661192|Alpha 1-Antitrypsin|alpha 1-antitrypsin|mesh-list
153563139|NCT01661192|Protein C Inhibitor|protein c inhibitor|mesh-list
153563140|NCT01661192|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
153563141|NCT01661192|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
153563142|NCT01661192|Protease Inhibitors|protease inhibitors|mesh-ancestor
153563143|NCT01661192|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153563144|NCT01661192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153563145|NCT01661257|Infliximab|infliximab|mesh-list
153563169|NCT01661322|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153563170|NCT01661322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153563171|NCT01661322|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153563172|NCT01661322|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153563173|NCT01661322|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153563174|NCT01661322|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153563175|NCT01661322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153563176|NCT01661322|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153563177|NCT01661322|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153563178|NCT01661322|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153563179|NCT01661322|Antipyretics|antipyretics|mesh-ancestor
153563180|NCT01661322|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
153563184|NCT01661322|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153563186|NCT01661335|Dexamethasone acetate|dexamethasone acetate|mesh-list
153563187|NCT01661335|Ondansetron|ondansetron|mesh-list
153563188|NCT01661335|Aprepitant|aprepitant|mesh-list
153563189|NCT01661335|Fosaprepitant|fosaprepitant|mesh-list
153563190|NCT01661335|BB 1101|bb 1101|mesh-list
153881709|NCT01810588|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153881710|NCT01810588|Antimetabolites|antimetabolites|mesh-ancestor
153881711|NCT01810588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153881712|NCT01810588|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153881713|NCT01810588|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153881714|NCT01810588|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
153881715|NCT01810588|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153881716|NCT01810588|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153422582|NCT03273023|Micronutrients|micronutrients|mesh-ancestor
153422583|NCT03237741|Rabeprazole|rabeprazole|mesh-list
153422584|NCT03237741|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
153422585|NCT03237741|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153422586|NCT03237741|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
153563203|NCT01661335|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153563204|NCT01661335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153422611|NCT03207867|Spartalizumab|spartalizumab|mesh-list
153422612|NCT03207867|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153563209|NCT01661335|Serotonin Agents|serotonin agents|mesh-ancestor
153563210|NCT01661335|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153563211|NCT01661335|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
153563212|NCT01661439|Heparin|heparin|mesh-list
153563213|NCT01661439|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
153563214|NCT01661439|Tinzaparin|tinzaparin|mesh-list
153563215|NCT01661439|Dalteparin|dalteparin|mesh-list
153563216|NCT01661439|Anticoagulants|anticoagulants|mesh-ancestor
153563217|NCT01661439|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153563218|NCT01661439|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153411160|NCT00004089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153563219|NCT01661439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153563222|NCT01661530|Micronutrients|micronutrients|mesh-ancestor
153563223|NCT01661530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153563224|NCT01661530|Antioxidants|antioxidants|mesh-ancestor
153563234|NCT01661556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153377190|NCT05168202|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153563235|NCT01661556|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153563237|NCT01661556|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153563238|NCT01661556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153563239|NCT01661556|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
153563240|NCT01661556|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
153563241|NCT01661556|Antioxidants|antioxidants|mesh-ancestor
153563242|NCT01661556|Protective Agents|protective agents|mesh-ancestor
153563243|NCT01661556|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
153563244|NCT01661751|Vaccines|vaccines|mesh-list
153563245|NCT01661751|Immunologic Factors|immunologic factors|mesh-ancestor
153563246|NCT01661751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153563247|NCT01661777|Diuretics|diuretics|mesh-list
153563248|NCT01661777|Histamine Antagonists|histamine antagonists|mesh-list
153563249|NCT01661777|Histamine H1 Antagonists|histamine h1 antagonists|mesh-list
153563250|NCT01661777|Natriuretic Agents|natriuretic agents|mesh-ancestor
153563251|NCT01661777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153563252|NCT01661777|Histamine Agents|histamine agents|mesh-ancestor
153563253|NCT01661777|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153563254|NCT01661777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153563255|NCT01661855|Riluzole|riluzole|mesh-list
153563256|NCT01661855|Anticonvulsants|anticonvulsants|mesh-ancestor
153563257|NCT01661855|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
153563258|NCT01661855|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
153563259|NCT01661855|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153563260|NCT01661855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153563261|NCT01661855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153563262|NCT01661855|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
153563264|NCT01661868|Olaparib|olaparib|mesh-list
153563273|NCT01662089|Zinc|zinc|mesh-list
153563274|NCT01662089|Trace Elements|trace elements|mesh-ancestor
153563275|NCT01662089|Micronutrients|micronutrients|mesh-ancestor
153881836|NCT04528628|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153881837|NCT04528628|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153881838|NCT04528628|Serotonin Agents|serotonin agents|mesh-ancestor
153881839|NCT04528628|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
153881840|NCT01641341|Nitazoxanide|nitazoxanide|mesh-list
153563276|NCT01662089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153563277|NCT01662128|Capecitabine|capecitabine|mesh-list
153563278|NCT01662128|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153563279|NCT01662128|Antimetabolites|antimetabolites|mesh-ancestor
153563280|NCT01662128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153563281|NCT01662128|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153563282|NCT01662180|Hormones|hormones|mesh-list
153881865|NCT01680185|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153881866|NCT01680185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153422777|NCT03606889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153422778|NCT03606889|Sensory System Agents|sensory system agents|mesh-ancestor
153563283|NCT01662180|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
153563284|NCT01662180|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153563285|NCT01662180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153563286|NCT01662193|Calcium, Dietary|calcium, dietary|mesh-list
153563287|NCT01662193|Vitamin D|vitamin d|mesh-list
153563288|NCT01662193|Ergocalciferols|ergocalciferols|mesh-list
153563289|NCT01662193|Cholecalciferol|cholecalciferol|mesh-list
153563290|NCT01662193|Vitamins|vitamins|mesh-list
153422844|NCT02221674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153563292|NCT01662193|Calcium|calcium|mesh-list
153563293|NCT01662193|Micronutrients|micronutrients|mesh-ancestor
153563294|NCT01662193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153563295|NCT01662193|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153563296|NCT01662193|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153563297|NCT01662193|Antacids|antacids|mesh-ancestor
153563298|NCT01662193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153563299|NCT01662193|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153563300|NCT01662349|Anti-Infective Agents|anti-infective agents|mesh-list
153563301|NCT01662349|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
153563302|NCT01662401|Bupivacaine|bupivacaine|mesh-list
153563303|NCT01662401|Anesthetics, Local|anesthetics, local|mesh-ancestor
153563304|NCT01662401|Anesthetics|anesthetics|mesh-ancestor
153563305|NCT01662401|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153563306|NCT01662401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153563307|NCT01662401|Sensory System Agents|sensory system agents|mesh-ancestor
153563314|NCT01662466|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
153563315|NCT01662466|Androgens|androgens|mesh-ancestor
153563316|NCT01662466|Hormones|hormones|mesh-ancestor
153563317|NCT01662466|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153563318|NCT01662466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153563319|NCT01662466|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153563320|NCT01662466|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153563321|NCT01662466|Anabolic Agents|anabolic agents|mesh-ancestor
153563322|NCT01662466|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153563323|NCT01662466|Immunologic Factors|immunologic factors|mesh-ancestor
153563324|NCT01662518|Dexamethasone|dexamethasone|mesh-list
153563325|NCT01662518|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153563326|NCT01662518|Antiemetics|antiemetics|mesh-ancestor
153563327|NCT01662518|Autonomic Agents|autonomic agents|mesh-ancestor
153563328|NCT01662518|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153563329|NCT01662518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153563330|NCT01662518|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153563331|NCT01662518|Glucocorticoids|glucocorticoids|mesh-ancestor
153563332|NCT01662518|Hormones|hormones|mesh-ancestor
153563333|NCT01662518|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153563334|NCT01662518|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153563335|NCT01662518|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153563336|NCT01662622|Sevoflurane|sevoflurane|mesh-list
153563337|NCT01662622|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153422888|NCT02971033|Ezetimibe|ezetimibe|mesh-list
153563339|NCT01662622|Anesthetics, General|anesthetics, general|mesh-ancestor
153563340|NCT01662622|Anesthetics|anesthetics|mesh-ancestor
153563341|NCT01662622|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153563342|NCT01662622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153563343|NCT01662674|Metformin|metformin|mesh-list
153563344|NCT01662674|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153563346|NCT01662687|Granisetron|granisetron|mesh-list
153563359|NCT01662700|Antimalarials|antimalarials|mesh-ancestor
153563360|NCT01662700|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153563361|NCT01662700|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153563362|NCT01662700|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153563363|NCT01662700|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153563364|NCT01662700|Antiviral Agents|antiviral agents|mesh-ancestor
153563365|NCT01662700|Schistosomicides|schistosomicides|mesh-ancestor
153563366|NCT01662700|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
153563367|NCT01662700|Anthelmintics|anthelmintics|mesh-ancestor
153563368|NCT01662700|Amebicides|amebicides|mesh-ancestor
153563369|NCT01662700|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153563370|NCT01662804|Interleukin-2|interleukin-2|mesh-list
153563371|NCT01662804|Antibodies|antibodies|mesh-list
153563372|NCT01662804|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
153563373|NCT01662804|Immunologic Factors|immunologic factors|mesh-ancestor
153882005|NCT01602900|Rolipram|rolipram|mesh-list
153563374|NCT01662804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153563375|NCT01662804|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153563376|NCT01662804|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153563377|NCT01662804|Analgesics|analgesics|mesh-ancestor
153563378|NCT01662804|Sensory System Agents|sensory system agents|mesh-ancestor
153880065|NCT01460654|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153880066|NCT01460654|Anabolic Agents|anabolic agents|mesh-ancestor
153880067|NCT01460654|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153880068|NCT01093326|Ponesimod|ponesimod|mesh-list
153563379|NCT01662804|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153563380|NCT01662869|Leucovorin|leucovorin|mesh-list
153563381|NCT01662869|Folic Acid|folic acid|mesh-list
153563382|NCT01662869|Oxaliplatin|oxaliplatin|mesh-list
153563383|NCT01662869|Fluorouracil|fluorouracil|mesh-list
153563384|NCT01662869|Levoleucovorin|levoleucovorin|mesh-list
153563385|NCT01662869|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153563386|NCT01662869|Antidotes|antidotes|mesh-ancestor
153563387|NCT01662869|Protective Agents|protective agents|mesh-ancestor
153563388|NCT01662869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153563389|NCT01662869|Vitamin B Complex|vitamin b complex|mesh-ancestor
153563390|NCT01662869|Vitamins|vitamins|mesh-ancestor
153563391|NCT01662869|Micronutrients|micronutrients|mesh-ancestor
153563392|NCT01662869|Hematinics|hematinics|mesh-ancestor
153563393|NCT01662869|Antimetabolites|antimetabolites|mesh-ancestor
153563394|NCT01662869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153563395|NCT01662869|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153563396|NCT01662869|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153563397|NCT01662869|Immunologic Factors|immunologic factors|mesh-ancestor
153563398|NCT01662921|Insulin|insulin|mesh-list
153563399|NCT01662921|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
153563400|NCT01662921|Insulin Lispro|insulin lispro|mesh-list
153563401|NCT01662921|Insulin glulisine|insulin glulisine|mesh-list
153563402|NCT01662921|Isophane Insulin, Human|isophane insulin, human|mesh-list
153563403|NCT01662921|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153563404|NCT01662921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153422999|NCT00392821|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
153563405|NCT01663038|Aspirin|aspirin|mesh-list
153563406|NCT01663038|Clopidogrel|clopidogrel|mesh-list
153563407|NCT01663038|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153563408|NCT01663038|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153563409|NCT01663038|Analgesics|analgesics|mesh-ancestor
153563410|NCT01663038|Sensory System Agents|sensory system agents|mesh-ancestor
153563411|NCT01663038|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153563412|NCT01663038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153563413|NCT01663038|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153563414|NCT01663038|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153563415|NCT01663038|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153563416|NCT01663038|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153563417|NCT01663038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153563418|NCT01663038|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153563419|NCT01663038|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153563420|NCT01663038|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153563421|NCT01663038|Antipyretics|antipyretics|mesh-ancestor
153563422|NCT01663038|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
153411161|NCT00004089|Antisickling Agents|antisickling agents|mesh-ancestor
153563423|NCT01663038|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
153563424|NCT01663038|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
153782705|NCT04561687|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153563425|NCT01663038|Purinergic Agents|purinergic agents|mesh-ancestor
153563426|NCT01663038|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153563442|NCT01663090|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
153563443|NCT01663168|Rifabutin|rifabutin|mesh-list
153563444|NCT01663168|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153563445|NCT01663168|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153563446|NCT01663168|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
153563447|NCT01663168|Antitubercular Agents|antitubercular agents|mesh-ancestor
153563448|NCT01663441|Oprelvekin|oprelvekin|mesh-list
153563449|NCT01663441|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153563450|NCT01661985|Azithromycin|azithromycin|mesh-list
153563451|NCT01661985|Doxycycline|doxycycline|mesh-list
153563452|NCT01661985|Lymecycline|lymecycline|mesh-list
153563453|NCT01661985|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153563454|NCT01661985|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153563455|NCT01661985|Antimalarials|antimalarials|mesh-ancestor
153563456|NCT01661985|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153563457|NCT01661985|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153563459|NCT01663558|Toll-Like Receptor Agonists|toll-like receptor agonists|mesh-ancestor
153882157|NCT01681979|Dermatologic Agents|dermatologic agents|mesh-ancestor
153418607|NCT02941640|Melanocyte-Stimulating Hormones|melanocyte-stimulating hormones|mesh-list
153563460|NCT01663558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153563461|NCT01663558|Immunomodulating Agents|immunomodulating agents|mesh-ancestor
153563462|NCT01663558|Immunologic Factors|immunologic factors|mesh-ancestor
153563463|NCT01663558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153563495|NCT01663961|Adrenergic Agents|adrenergic agents|mesh-ancestor
153563496|NCT01663961|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153563497|NCT01663961|Urological Agents|urological agents|mesh-ancestor
153563498|NCT01664013|Botulinum Toxins|botulinum toxins|mesh-list
153563499|NCT01664013|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
153782706|NCT04561687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153882233|NCT01607970|Oxytocics|oxytocics|mesh-ancestor
153882236|NCT01608009|Paclitaxel|paclitaxel|mesh-list
153563501|NCT01664013|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
153563502|NCT01664013|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153563503|NCT01664013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153563505|NCT01664013|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153563506|NCT01664013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153563507|NCT01664013|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
153563508|NCT01664013|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153563509|NCT01664065|Ceftaroline|ceftaroline|mesh-list
153563510|NCT01664065|Cephalosporins|cephalosporins|mesh-list
153563511|NCT01664065|Beta Lactam Antibiotics|beta lactam antibiotics|mesh-ancestor
153411162|NCT00004089|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153411163|NCT00004089|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153870561|NCT00591188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153870562|NCT00591383|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
153870563|NCT00591383|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153870564|NCT00591383|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153870565|NCT00591383|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153870566|NCT00591383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153423190|NCT03300674|Anesthetics, Local|anesthetics, local|mesh-ancestor
153423191|NCT03300674|Anesthetics|anesthetics|mesh-ancestor
153882296|NCT01604928|Tolterodine Tartrate|tolterodine tartrate|mesh-list
153563513|NCT01664065|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153563514|NCT01664195|Epoetin Alfa|epoetin alfa|mesh-list
153563515|NCT01664195|Hematinics|hematinics|mesh-ancestor
153563516|NCT01664221|Epoetin Alfa|epoetin alfa|mesh-list
153563517|NCT01664221|Hematinics|hematinics|mesh-ancestor
153563518|NCT01664260|Acetylcysteine|acetylcysteine|mesh-list
153563519|NCT01664260|N-monoacetylcystine|n-monoacetylcystine|mesh-list
153563520|NCT01664260|Antiviral Agents|antiviral agents|mesh-ancestor
153418609|NCT02941640|Hormones|hormones|mesh-ancestor
153423237|NCT03220958|Metoclopramide|metoclopramide|mesh-list
153423239|NCT03220958|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153563522|NCT01664260|Expectorants|expectorants|mesh-ancestor
153563543|NCT01664520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153563544|NCT01664650|Genistein|genistein|mesh-list
153563545|NCT01664650|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
153563546|NCT01664650|Protective Agents|protective agents|mesh-ancestor
153563547|NCT01664650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153563548|NCT01664650|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153563549|NCT01664650|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153563550|NCT01664650|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153563551|NCT01664650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153563552|NCT01664650|Phytoestrogens|phytoestrogens|mesh-ancestor
153563553|NCT01664650|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
153563554|NCT01664650|Estrogens|estrogens|mesh-ancestor
153563555|NCT01664650|Hormones|hormones|mesh-ancestor
153563556|NCT01664650|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153423259|NCT03220958|Dopamine Agents|dopamine agents|mesh-ancestor
153563558|NCT01664676|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
153563559|NCT01664676|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153563560|NCT01664676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153563561|NCT01664676|Incretins|incretins|mesh-ancestor
153563563|NCT01664676|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153563564|NCT01664728|Abiraterone Acetate|abiraterone acetate|mesh-list
153563565|NCT01664728|Glucocorticoids|glucocorticoids|mesh-list
153563566|NCT01664728|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153563567|NCT01664728|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153882384|NCT01608945|Hydrocortisone|hydrocortisone|mesh-list
153423312|NCT03315104|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
153423364|NCT03236168|Permethrin|permethrin|mesh-list
153563568|NCT01664728|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153563569|NCT01664728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153563570|NCT01664728|Hormone Antagonists|hormone antagonists|mesh-ancestor
153563571|NCT01664728|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153563572|NCT01664728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153563573|NCT01664728|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153882495|NCT01688700|Paclitaxel|paclitaxel|mesh-list
153563578|NCT01664754|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153563580|NCT01664754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153563581|NCT01664754|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153563582|NCT01664754|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153563583|NCT01664754|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
153563584|NCT01664754|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153563585|NCT01664754|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
153563586|NCT01664754|Hormone Antagonists|hormone antagonists|mesh-ancestor
153423445|NCT03321097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153563600|NCT01664845|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153563627|NCT01665196|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
153563628|NCT01665196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153563629|NCT01665196|Antimetabolites|antimetabolites|mesh-ancestor
153563630|NCT01665196|Antiviral Agents|antiviral agents|mesh-ancestor
153563631|NCT01665196|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153563633|NCT01665209|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153563634|NCT01665209|Narcotics|narcotics|mesh-ancestor
153563635|NCT01665209|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153563636|NCT01665209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153563637|NCT01665209|Analgesics|analgesics|mesh-ancestor
153563638|NCT01665209|Sensory System Agents|sensory system agents|mesh-ancestor
153423489|NCT03468920|Analgesics|analgesics|mesh-ancestor
153563639|NCT01665209|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153563640|NCT01665222|Morphine|morphine|mesh-list
153563641|NCT01665222|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153563642|NCT01665222|Narcotics|narcotics|mesh-ancestor
153563643|NCT01665222|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153563644|NCT01665222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153563645|NCT01665222|Analgesics|analgesics|mesh-ancestor
153782707|NCT04561687|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153563646|NCT01665222|Sensory System Agents|sensory system agents|mesh-ancestor
153563647|NCT01665222|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153563648|NCT01665235|Aspirin|aspirin|mesh-list
153563649|NCT01665235|Amlodipine|amlodipine|mesh-list
153563665|NCT01665235|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153563666|NCT01665235|Antipyretics|antipyretics|mesh-ancestor
153563667|NCT01665235|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153563668|NCT01665235|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153563669|NCT01665235|Antimetabolites|antimetabolites|mesh-ancestor
153563670|NCT01665235|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153563671|NCT01665235|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
153563672|NCT01665235|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
153563673|NCT01665235|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
153563674|NCT01665235|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
153563675|NCT01665235|Purinergic Agents|purinergic agents|mesh-ancestor
153563676|NCT01665235|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153563677|NCT01665235|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153563678|NCT01665235|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153563679|NCT01665235|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153563680|NCT01665235|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153563681|NCT01665235|Vasodilator Agents|vasodilator agents|mesh-ancestor
153563683|NCT01665248|Fluorides|fluorides|mesh-list
153563684|NCT01665248|Sodium Fluoride|sodium fluoride|mesh-list
153563685|NCT01665248|Cariostatic Agents|cariostatic agents|mesh-ancestor
153563686|NCT01665248|Protective Agents|protective agents|mesh-ancestor
153563687|NCT01665248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153563688|NCT01665248|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
153563689|NCT01665248|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153563690|NCT01665378|Folic Acid|folic acid|mesh-list
153563691|NCT01665378|Vitamin B Complex|vitamin b complex|mesh-list
153563692|NCT01665378|Micronutrients|micronutrients|mesh-list
153563693|NCT01665378|Trace Elements|trace elements|mesh-list
153563694|NCT01665378|Hematinics|hematinics|mesh-ancestor
153563695|NCT01665378|Vitamins|vitamins|mesh-ancestor
153563696|NCT01665378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153563697|NCT01665404|Fluvoxamine|fluvoxamine|mesh-list
153563698|NCT01665404|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153423545|NCT03355820|Antibodies|antibodies|mesh-list
153563706|NCT01665404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153563707|NCT01665404|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153563709|NCT01665404|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
153563710|NCT01665404|Antidepressive Agents|antidepressive agents|mesh-ancestor
153563711|NCT01665404|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
153563712|NCT01665404|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153563713|NCT01665404|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153563714|NCT01665404|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
153563716|NCT01665417|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153563717|NCT01665417|Tubulin Modulators|tubulin modulators|mesh-ancestor
153563718|NCT01665417|Antimitotic Agents|antimitotic agents|mesh-ancestor
153563719|NCT01665417|Mitosis Modulators|mitosis modulators|mesh-ancestor
153882673|NCT01609491|Sympathomimetics|sympathomimetics|mesh-ancestor
153563729|NCT01665469|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153563730|NCT01664507|Epinephrine|epinephrine|mesh-list
153882686|NCT01684865|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153563756|NCT01665586|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
153563757|NCT01665586|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153563758|NCT01665586|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153563759|NCT01665586|Adrenergic Agents|adrenergic agents|mesh-ancestor
153563760|NCT01665586|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153563761|NCT01665586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153563762|NCT01665638|Canagliflozin|canagliflozin|mesh-list
153563763|NCT01665638|Somatostatin|somatostatin|mesh-list
153563764|NCT01665638|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
153563765|NCT01665638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153563766|NCT01665638|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153563767|NCT01665638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153563768|NCT01665638|Hormones|hormones|mesh-ancestor
153563769|NCT01665638|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153563770|NCT01665703|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
153563771|NCT01665703|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
153563772|NCT01665703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153563773|NCT01665742|Tocopherols|tocopherols|mesh-list
153423599|NCT02181504|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153423600|NCT02181504|Growth Substances|growth substances|mesh-ancestor
153563799|NCT01666067|Ezetimibe, Simvastatin Drug Combination|ezetimibe, simvastatin drug combination|mesh-list
153563800|NCT01666067|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153563801|NCT01666067|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153563802|NCT01666067|Antimetabolites|antimetabolites|mesh-ancestor
153563803|NCT01666067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153563804|NCT01666067|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153563805|NCT01666067|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
153563806|NCT01666067|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153563807|NCT01666171|Metformin|metformin|mesh-list
153563808|NCT01666171|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153563809|NCT01666171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153563810|NCT01666223|Chenodeoxycholic Acid|chenodeoxycholic acid|mesh-list
153563811|NCT01666223|Colesevelam Hydrochloride|colesevelam hydrochloride|mesh-list
153563812|NCT01666223|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153563813|NCT01666223|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153563814|NCT01666223|Antimetabolites|antimetabolites|mesh-ancestor
153563815|NCT01666223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153563816|NCT01666223|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153563817|NCT01666223|Cathartics|cathartics|mesh-ancestor
153563843|NCT01666301|Hematinics|hematinics|mesh-ancestor
153563844|NCT01666353|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
153563845|NCT01666353|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
153563846|NCT01666353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153563847|NCT01666379|Fentanyl|fentanyl|mesh-list
153563848|NCT01666379|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153563849|NCT01666379|Narcotics|narcotics|mesh-ancestor
153563850|NCT01666379|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153423628|NCT02177838|Cetuximab|cetuximab|mesh-list
153563895|NCT01666587|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153563897|NCT01666600|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153563898|NCT01666600|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153563899|NCT01666600|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153563900|NCT01666600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153563902|NCT01666665|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153563903|NCT01666665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153563904|NCT01666678|Diphenhydramine|diphenhydramine|mesh-list
153563905|NCT01666678|Promethazine|promethazine|mesh-list
153563906|NCT01666678|Naproxen|naproxen|mesh-list
153563907|NCT01666678|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153563908|NCT01666678|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153563909|NCT01666678|Analgesics|analgesics|mesh-ancestor
153563910|NCT01666678|Sensory System Agents|sensory system agents|mesh-ancestor
153563911|NCT01666678|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153563912|NCT01666678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153563913|NCT01666678|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153563915|NCT01666678|Gout Suppressants|gout suppressants|mesh-ancestor
153563916|NCT01666678|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153563917|NCT01666678|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153563918|NCT01666678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153563919|NCT01666678|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
153563920|NCT01666678|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153563921|NCT01666678|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153882760|NCT01649999|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153563922|NCT01666678|Anesthetics, Local|anesthetics, local|mesh-ancestor
153563932|NCT01666678|Antipruritics|antipruritics|mesh-ancestor
153563933|NCT01666678|Dermatologic Agents|dermatologic agents|mesh-ancestor
153563935|NCT01666691|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153563936|NCT01666691|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153563937|NCT01666691|Growth Substances|growth substances|mesh-ancestor
153563938|NCT01666691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153563939|NCT01666691|Growth Inhibitors|growth inhibitors|mesh-ancestor
153563940|NCT01666691|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153563941|NCT01666743|Ceftaroline|ceftaroline|mesh-list
153563942|NCT01666743|Beta Lactam Antibiotics|beta lactam antibiotics|mesh-ancestor
153563943|NCT01666743|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153782710|NCT04561687|Hormones|hormones|mesh-ancestor
153563944|NCT01666743|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153563945|NCT01666756|Sorafenib|sorafenib|mesh-list
153563949|NCT01666756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153563951|NCT01666769|Antifungal Agents|antifungal agents|mesh-ancestor
153563952|NCT01666769|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153563953|NCT01667094|Meropenem|meropenem|mesh-list
153563954|NCT01667094|Tazobactam|tazobactam|mesh-list
153563955|NCT01667094|Piperacillin|piperacillin|mesh-list
153563956|NCT01667094|Clavulanic Acid|clavulanic acid|mesh-list
153563957|NCT01667094|Clavulanic Acids|clavulanic acids|mesh-list
153563958|NCT01667094|Ceftazidime|ceftazidime|mesh-list
153423731|NCT02176356|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
153563978|NCT01667211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153563979|NCT01667263|Tretinoin|tretinoin|mesh-list
153563980|NCT01667263|Danazol|danazol|mesh-list
153563981|NCT01667263|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153563982|NCT01667263|Keratolytic Agents|keratolytic agents|mesh-ancestor
153563983|NCT01667263|Dermatologic Agents|dermatologic agents|mesh-ancestor
153563984|NCT01667263|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
153563985|NCT01667263|Hormone Antagonists|hormone antagonists|mesh-ancestor
153563986|NCT01667263|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153423802|NCT03404648|Antimetabolites|antimetabolites|mesh-ancestor
153563987|NCT01667263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153563988|NCT01667315|Bupivacaine|bupivacaine|mesh-list
153563989|NCT01667315|Anesthetics, Local|anesthetics, local|mesh-ancestor
153563990|NCT01667315|Anesthetics|anesthetics|mesh-ancestor
153563991|NCT01667315|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153563992|NCT01667315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153563993|NCT01667315|Sensory System Agents|sensory system agents|mesh-ancestor
153563994|NCT01667315|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153563995|NCT01667445|Morphine|morphine|mesh-list
153563996|NCT01667445|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153563997|NCT01667445|Narcotics|narcotics|mesh-ancestor
153564020|NCT01667523|Protective Agents|protective agents|mesh-ancestor
153564021|NCT01667575|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
153564022|NCT01667575|Amoxicillin|amoxicillin|mesh-list
153564023|NCT01667575|Clarithromycin|clarithromycin|mesh-list
153564024|NCT01667575|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
153564025|NCT01667575|Potassium Citrate|potassium citrate|mesh-list
153564026|NCT01667575|Esomeprazole|esomeprazole|mesh-list
153564027|NCT01667575|Bismuth|bismuth|mesh-list
153564028|NCT01667575|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
153564029|NCT01667575|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153564030|NCT01667575|Antitubercular Agents|antitubercular agents|mesh-ancestor
153564031|NCT01667575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153564032|NCT01667575|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
153564033|NCT01667575|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153564034|NCT01667575|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153564035|NCT01667575|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
153564036|NCT01667575|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
153564037|NCT01667575|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153564079|NCT01667874|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153377191|NCT05139420|Topiramate|topiramate|mesh-list
153377192|NCT05139420|Phentermine|phentermine|mesh-list
153377193|NCT05139420|Anticonvulsants|anticonvulsants|mesh-ancestor
153377194|NCT05139420|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153564080|NCT01667874|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153564081|NCT01667874|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
153564082|NCT01667874|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153882919|NCT01688648|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
153423836|NCT03525548|Ivacaftor|ivacaftor|mesh-list
153882928|NCT01688648|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153564083|NCT01667874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153564086|NCT01668043|Immunologic Factors|immunologic factors|mesh-ancestor
153564087|NCT01668043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153564088|NCT01668043|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153564089|NCT01668043|Antiviral Agents|antiviral agents|mesh-ancestor
153564090|NCT01668043|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153564091|NCT01668056|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
153564092|NCT01668056|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153782712|NCT04561687|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
153782713|NCT04561687|Hormone Antagonists|hormone antagonists|mesh-ancestor
153782714|NCT04561687|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
153782715|NCT04561687|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
153423869|NCT02133924|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153883003|NCT02271399|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153564093|NCT01668056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153564094|NCT01668069|Ondansetron|ondansetron|mesh-list
153564096|NCT01668069|Autonomic Agents|autonomic agents|mesh-ancestor
153564097|NCT01668069|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153564098|NCT01668069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153564099|NCT01668069|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153564100|NCT01668069|Antipruritics|antipruritics|mesh-ancestor
153564101|NCT01668069|Dermatologic Agents|dermatologic agents|mesh-ancestor
153564102|NCT01668069|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
153564124|NCT01668121|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153564125|NCT01668121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153564126|NCT01668433|Primaquine|primaquine|mesh-list
153564127|NCT01668433|Methylene Blue|methylene blue|mesh-list
153564128|NCT01668433|Antimalarials|antimalarials|mesh-ancestor
153564129|NCT01668433|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153564130|NCT01668433|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153564131|NCT01668433|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153564132|NCT01668433|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153564133|NCT01668433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153564134|NCT01668446|Sildenafil Citrate|sildenafil citrate|mesh-list
153564136|NCT01668446|Estrogens|estrogens|mesh-ancestor
153564137|NCT01668446|Hormones|hormones|mesh-ancestor
153564138|NCT01668446|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153564139|NCT01668446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153564140|NCT01668446|Vasodilator Agents|vasodilator agents|mesh-ancestor
153564141|NCT01668446|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
153564142|NCT01668446|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
153564143|NCT01668446|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153564144|NCT01668446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153564145|NCT01668446|Urological Agents|urological agents|mesh-ancestor
153564146|NCT01668485|Hypoglycemic Agents|hypoglycemic agents|mesh-list
153564147|NCT01668485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153564148|NCT01668498|Doxycycline|doxycycline|mesh-list
153564149|NCT01668498|Erythromycin|erythromycin|mesh-list
153564150|NCT01668498|Erythromycin Estolate|erythromycin estolate|mesh-list
153564151|NCT01668498|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
153564152|NCT01668498|Erythromycin stearate|erythromycin stearate|mesh-list
153564153|NCT01668498|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153564154|NCT01668498|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153564155|NCT01668498|Antimalarials|antimalarials|mesh-ancestor
153883034|NCT02271555|Remifentanil|remifentanil|mesh-list
153564172|NCT01668680|Methotrexate|methotrexate|mesh-list
153564173|NCT01668680|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153564174|NCT01668680|Antimetabolites|antimetabolites|mesh-ancestor
153564175|NCT01668680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153564176|NCT01668680|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153883094|NCT01689311|Ergonovine|ergonovine|mesh-list
153883095|NCT01689311|Dinoprost|dinoprost|mesh-list
153564224|NCT01668927|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153564225|NCT01668927|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153564226|NCT01668927|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153564227|NCT01668927|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
153564228|NCT01668927|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153564229|NCT01668927|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153564230|NCT01668927|Antacids|antacids|mesh-ancestor
153564231|NCT01668927|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
153377196|NCT05139420|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
153564232|NCT01668927|Diuretics|diuretics|mesh-ancestor
153564233|NCT01668927|Natriuretic Agents|natriuretic agents|mesh-ancestor
153564234|NCT01668927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153564235|NCT01668927|Expectorants|expectorants|mesh-ancestor
153564236|NCT01668927|Respiratory System Agents|respiratory system agents|mesh-ancestor
153564237|NCT01668927|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
153564238|NCT01668927|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
153564239|NCT01668927|Antitrichomonal Agents|antitrichomonal agents|mesh-ancestor
153564240|NCT01668927|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
153883117|NCT01588782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153564271|NCT01669213|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153564272|NCT01669213|Antipruritics|antipruritics|mesh-ancestor
153564273|NCT01669213|Dermatologic Agents|dermatologic agents|mesh-ancestor
153564274|NCT01669213|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
153564275|NCT01669213|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153564276|NCT01669213|Serotonin Agents|serotonin agents|mesh-ancestor
153564277|NCT01669213|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153424067|NCT04342130|Morphine|morphine|mesh-list
153564278|NCT01669213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153564280|NCT01669226|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153564281|NCT01669239|Doxorubicin|doxorubicin|mesh-list
153564282|NCT01669239|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
153564283|NCT01669239|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153564284|NCT01669239|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153564285|NCT01669239|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153564286|NCT01669239|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153564287|NCT01669239|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153564288|NCT01669239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153564289|NCT01669291|Leuprolide|leuprolide|mesh-list
153564290|NCT01669291|Cetrorelix|cetrorelix|mesh-list
153564291|NCT01669291|Menotropins|menotropins|mesh-list
153564292|NCT01669291|Ganirelix|ganirelix|mesh-list
153564293|NCT01669291|Fertility Agents, Female|fertility agents, female|mesh-ancestor
153564294|NCT01669291|Fertility Agents|fertility agents|mesh-ancestor
153564295|NCT01669291|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153564296|NCT01669291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153564322|NCT01669369|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153564323|NCT01669369|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153564324|NCT01669369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153564325|NCT01669447|Ranibizumab|ranibizumab|mesh-list
153564326|NCT01669447|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153564327|NCT01669447|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153564328|NCT01669447|Growth Substances|growth substances|mesh-ancestor
153564329|NCT01669447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153564330|NCT01669447|Growth Inhibitors|growth inhibitors|mesh-ancestor
153564331|NCT01669447|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153564332|NCT01669499|Dexamethasone|dexamethasone|mesh-list
153564333|NCT01669499|Dexamethasone acetate|dexamethasone acetate|mesh-list
153564334|NCT01669499|BB 1101|bb 1101|mesh-list
153564335|NCT01669499|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153564336|NCT01669499|Antiemetics|antiemetics|mesh-ancestor
153564337|NCT01669499|Autonomic Agents|autonomic agents|mesh-ancestor
153564338|NCT01669499|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153564339|NCT01669499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153564340|NCT01669499|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153564341|NCT01669499|Glucocorticoids|glucocorticoids|mesh-ancestor
153564342|NCT01669499|Hormones|hormones|mesh-ancestor
153424092|NCT03964220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153564343|NCT01669499|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153564344|NCT01669499|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153564376|NCT01669967|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153564377|NCT01669967|Antiemetics|antiemetics|mesh-ancestor
153564379|NCT01669967|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153564380|NCT01669967|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
153420945|NCT03168295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153564381|NCT01669967|Histamine Antagonists|histamine antagonists|mesh-ancestor
153564382|NCT01669967|Histamine Agents|histamine agents|mesh-ancestor
153564383|NCT01669967|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153564384|NCT01669967|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
153564385|NCT01669967|Antipruritics|antipruritics|mesh-ancestor
153564386|NCT01669967|Dermatologic Agents|dermatologic agents|mesh-ancestor
153564388|NCT01670149|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153564389|NCT01670149|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153564390|NCT01670149|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153564391|NCT01670370|Gemcitabine|gemcitabine|mesh-list
153564392|NCT01670370|Oxaliplatin|oxaliplatin|mesh-list
153564393|NCT01670370|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153564394|NCT01670370|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153564398|NCT01670552|Nimesulide|nimesulide|mesh-list
153564411|NCT01670552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153564412|NCT01670552|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153564413|NCT01670552|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153564414|NCT01670552|Gout Suppressants|gout suppressants|mesh-ancestor
153564415|NCT01670552|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153564416|NCT01670578|Hyaluronic Acid|hyaluronic acid|mesh-list
153424130|NCT03329911|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153564428|NCT01670812|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153564429|NCT01670812|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153564430|NCT01670812|Antiemetics|antiemetics|mesh-ancestor
153564431|NCT01670812|Autonomic Agents|autonomic agents|mesh-ancestor
153564432|NCT01670812|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153564433|NCT01670812|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153564434|NCT01670812|Glucocorticoids|glucocorticoids|mesh-ancestor
153564435|NCT01670812|Hormones|hormones|mesh-ancestor
153564436|NCT01670812|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153564437|NCT01670812|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
153564438|NCT01670812|Protective Agents|protective agents|mesh-ancestor
153564439|NCT01671449|Oxaliplatin|oxaliplatin|mesh-list
153564440|NCT01671449|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153564441|NCT01671800|rimabotulinumtoxinB|rimabotulinumtoxinb|mesh-list
153564442|NCT01671800|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
153564443|NCT01671800|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
153564449|NCT01672359|Choline|choline|mesh-list
153564453|NCT01672359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153564454|NCT01672359|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153564455|NCT01672359|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153564456|NCT01672359|Nootropic Agents|nootropic agents|mesh-ancestor
153564468|NCT01673737|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153883220|NCT01316133|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153564469|NCT01673737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153564472|NCT01674556|Antimetabolites|antimetabolites|mesh-ancestor
153564503|NCT01676649|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153564504|NCT01676649|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153564506|NCT01676987|Formoterol Fumarate|formoterol fumarate|mesh-list
153564507|NCT01676987|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153564508|NCT01676987|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153883239|NCT05654064|Narcotics|narcotics|mesh-ancestor
153564509|NCT01676987|Autonomic Agents|autonomic agents|mesh-ancestor
153564510|NCT01676987|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153564511|NCT01676987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153564512|NCT01676987|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153564513|NCT01676987|Respiratory System Agents|respiratory system agents|mesh-ancestor
153564514|NCT01676987|Glucocorticoids|glucocorticoids|mesh-ancestor
153564515|NCT01676987|Hormones|hormones|mesh-ancestor
153564516|NCT01676987|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153564517|NCT01676987|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
153564518|NCT01676987|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
153564519|NCT01676987|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153564520|NCT01676987|Adrenergic Agents|adrenergic agents|mesh-ancestor
153564521|NCT01676987|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153564522|NCT01676987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153564523|NCT01677039|Ethanol|ethanol|mesh-list
153424194|NCT03670160|Autonomic Agents|autonomic agents|mesh-ancestor
153424195|NCT03670160|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
153564525|NCT01677039|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153564526|NCT01677039|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153564527|NCT01677039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153782722|NCT04561687|Histamine Antagonists|histamine antagonists|mesh-ancestor
153782723|NCT04561687|Histamine Agents|histamine agents|mesh-ancestor
153564549|NCT01677650|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153564550|NCT01677650|Narcotics|narcotics|mesh-ancestor
153564551|NCT01677650|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153564552|NCT01677650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153564553|NCT01677650|Analgesics|analgesics|mesh-ancestor
153564554|NCT01677650|Sensory System Agents|sensory system agents|mesh-ancestor
153564555|NCT01677650|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153564556|NCT01677650|Antitussive Agents|antitussive agents|mesh-ancestor
153564557|NCT01677650|Respiratory System Agents|respiratory system agents|mesh-ancestor
153564558|NCT01678053|Omeprazole|omeprazole|mesh-list
153883289|NCT03558854|Sensory System Agents|sensory system agents|mesh-ancestor
153564570|NCT01678053|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153564571|NCT01678053|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153564588|NCT01678937|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153564589|NCT01678937|Dermatologic Agents|dermatologic agents|mesh-ancestor
153564590|NCT01678937|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153564591|NCT01678937|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153564592|NCT01678937|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153564593|NCT01678937|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
153564594|NCT01678937|Antitubercular Agents|antitubercular agents|mesh-ancestor
153564595|NCT01678937|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153564596|NCT01678937|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153564597|NCT01679041|Cyclophosphamide|cyclophosphamide|mesh-list
153564598|NCT01679041|Fludarabine|fludarabine|mesh-list
153564599|NCT01679041|Alemtuzumab|alemtuzumab|mesh-list
153564600|NCT01679041|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153564601|NCT01679041|Immunologic Factors|immunologic factors|mesh-ancestor
153564608|NCT01679041|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153564609|NCT01679041|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153564611|NCT01679093|Droperidol|droperidol|mesh-list
153564612|NCT01679093|Ondansetron|ondansetron|mesh-list
153782724|NCT04561687|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153782725|NCT04561219|Nitazoxanide|nitazoxanide|mesh-list
153782726|NCT04561219|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153782727|NCT04561219|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153782728|NCT00234845|Adalimumab|adalimumab|mesh-list
153564631|NCT01679093|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153564632|NCT01679093|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153564633|NCT01679093|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153564634|NCT01679093|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153564635|NCT01679093|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153564636|NCT01679093|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
153564637|NCT01679093|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
153564638|NCT01679093|Dopamine Agents|dopamine agents|mesh-ancestor
153564639|NCT01679743|Trastuzumab|trastuzumab|mesh-list
153564640|NCT01679743|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153564642|NCT01680094|Panobinostat|panobinostat|mesh-list
153782734|NCT00234845|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153564678|NCT05596669|Ketamine|ketamine|mesh-list
153564679|NCT05596669|Morphine|morphine|mesh-list
153564680|NCT05596669|Analgesics|analgesics|mesh-ancestor
153564681|NCT05596669|Sensory System Agents|sensory system agents|mesh-ancestor
153564684|NCT05596669|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
153564685|NCT05596669|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153564686|NCT05596669|Anesthetics, General|anesthetics, general|mesh-ancestor
153564687|NCT05596669|Anesthetics|anesthetics|mesh-ancestor
153564688|NCT05596669|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153564689|NCT05596669|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
153564690|NCT05596669|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
153564691|NCT05596669|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153564692|NCT05596669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153564695|NCT05596617|Melatonin|melatonin|mesh-list
153564696|NCT05596617|Antioxidants|antioxidants|mesh-ancestor
153564697|NCT05596617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153564698|NCT05596617|Protective Agents|protective agents|mesh-ancestor
153564699|NCT05596617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153564700|NCT05596617|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153564701|NCT05596552|Fentanyl|fentanyl|mesh-list
153564702|NCT05596552|Dexmedetomidine|dexmedetomidine|mesh-list
153564703|NCT05596552|Bupivacaine|bupivacaine|mesh-list
153564704|NCT05596552|Anesthetics, Local|anesthetics, local|mesh-ancestor
153564705|NCT05596552|Anesthetics|anesthetics|mesh-ancestor
153564706|NCT05596552|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153564707|NCT05596552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153564708|NCT05596552|Sensory System Agents|sensory system agents|mesh-ancestor
153377264|NCT05032820|Immunologic Factors|immunologic factors|mesh-ancestor
153564709|NCT05596552|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153564710|NCT05596552|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153564711|NCT05596552|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153564712|NCT05596552|Analgesics|analgesics|mesh-ancestor
153564713|NCT05596552|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
153564714|NCT05596552|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153564715|NCT05596552|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153564716|NCT05596552|Adrenergic Agents|adrenergic agents|mesh-ancestor
153564723|NCT05596552|Anesthetics, General|anesthetics, general|mesh-ancestor
153564724|NCT05596227|Fentanyl|fentanyl|mesh-list
153564765|NCT05596071|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153564766|NCT05596071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153564767|NCT05596071|Sensory System Agents|sensory system agents|mesh-ancestor
153564768|NCT05596071|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153564769|NCT05596071|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153564770|NCT05596071|Narcotics|narcotics|mesh-ancestor
153564771|NCT05596071|Analgesics|analgesics|mesh-ancestor
153564772|NCT05596071|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153564773|NCT05596071|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153564774|NCT05596071|Anesthetics, General|anesthetics, general|mesh-ancestor
153564775|NCT05595824|Molnupiravir|molnupiravir|mesh-list
153564776|NCT05595824|Antiviral Agents|antiviral agents|mesh-ancestor
153564777|NCT05595824|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153564778|NCT05595590|Tislelizumab|tislelizumab|mesh-list
153564779|NCT05595590|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153564780|NCT05595590|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153564781|NCT05595408|Immunomodulating Agents|immunomodulating agents|mesh-list
153564782|NCT05595408|Immunologic Factors|immunologic factors|mesh-ancestor
153564783|NCT05595408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153564784|NCT05567822|Esmolol|esmolol|mesh-list
153564785|NCT05567822|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
153564786|NCT05567822|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
153564787|NCT05567822|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
153564788|NCT05567822|Adrenergic Agents|adrenergic agents|mesh-ancestor
153564789|NCT05567822|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153564790|NCT05567822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153564791|NCT05567822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153564815|NCT05539924|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153564817|NCT05539924|Vitamin B Complex|vitamin b complex|mesh-ancestor
153564818|NCT05514782|Sunscreening Agents|sunscreening agents|mesh-list
153564819|NCT05514782|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
153564820|NCT05514782|Protective Agents|protective agents|mesh-ancestor
153564821|NCT05514782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153564833|NCT05433402|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153564834|NCT05433402|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153564849|NCT05209165|Semaglutide|semaglutide|mesh-list
153564850|NCT05209165|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
153564851|NCT05209165|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153564852|NCT05209165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153564853|NCT05057949|Itraconazole|itraconazole|mesh-list
153564854|NCT05057949|Hydroxyitraconazole|hydroxyitraconazole|mesh-list
153564856|NCT05057949|Antifungal Agents|antifungal agents|mesh-ancestor
153564857|NCT05057949|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153564858|NCT05057949|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
153564859|NCT05057949|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153564860|NCT05057949|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153564861|NCT05057949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153564862|NCT05057949|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153564863|NCT05057949|Hormone Antagonists|hormone antagonists|mesh-ancestor
153564864|NCT05057949|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153564865|NCT05057949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153564866|NCT05057949|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
153564867|NCT05057949|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
153782770|NCT00234923|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153377270|NCT05032820|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153377271|NCT04961619|Trametinib|trametinib|mesh-list
153377272|NCT04961619|Dabrafenib|dabrafenib|mesh-list
153782771|NCT00234923|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153782772|NCT00234923|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153782773|NCT00234923|Antimetabolites|antimetabolites|mesh-ancestor
153564874|NCT05057949|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
153564875|NCT05057949|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
153564876|NCT05057949|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
153564877|NCT05057949|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
153564878|NCT04901312|Analgesics, Opioid|analgesics, opioid|mesh-list
153564879|NCT04901312|Narcotics|narcotics|mesh-ancestor
153564880|NCT04901312|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153564881|NCT04901312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153564882|NCT04901312|Analgesics|analgesics|mesh-ancestor
153564883|NCT04901312|Sensory System Agents|sensory system agents|mesh-ancestor
153883452|NCT01332318|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153883453|NCT01332318|Anesthetics, Local|anesthetics, local|mesh-ancestor
153883454|NCT01332318|Anesthetics|anesthetics|mesh-ancestor
153883455|NCT01332318|Antiemetics|antiemetics|mesh-ancestor
153564896|NCT04810793|Furazolidone|furazolidone|mesh-list
153564897|NCT04810793|Esomeprazole|esomeprazole|mesh-list
153564898|NCT04810793|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153564899|NCT04810793|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153564900|NCT04810793|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
153564908|NCT04810793|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153564909|NCT04810793|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
153564910|NCT04810793|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153564911|NCT04810793|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
153564912|NCT04810793|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
153564913|NCT04810793|Antitrichomonal Agents|antitrichomonal agents|mesh-ancestor
153564914|NCT04810793|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153424426|NCT04114058|Anesthetics, Local|anesthetics, local|mesh-ancestor
153424427|NCT04114058|Anesthetics|anesthetics|mesh-ancestor
153424428|NCT04114058|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153564926|NCT04684511|Analgesics|analgesics|mesh-ancestor
153564927|NCT04684511|Sensory System Agents|sensory system agents|mesh-ancestor
153564928|NCT04684511|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153564929|NCT04684511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153564930|NCT04684511|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153564931|NCT04684511|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153564932|NCT04565171|Yimitasvir|yimitasvir|mesh-list
153564933|NCT04565171|Antiviral Agents|antiviral agents|mesh-ancestor
153564934|NCT04565171|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153564935|NCT04450407|Insulin|insulin|mesh-list
153564936|NCT04450407|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153564937|NCT04450407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153564944|NCT04231838|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
153564945|NCT04231838|Cholinergic Agents|cholinergic agents|mesh-ancestor
153564946|NCT04231838|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153424437|NCT03862040|Chelating Agents|chelating agents|mesh-ancestor
153564948|NCT04218266|Apixaban|apixaban|mesh-list
153564949|NCT04218266|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
153564950|NCT04218266|Antithrombins|antithrombins|mesh-ancestor
153564951|NCT04218266|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
153377417|NCT04640545|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153377418|NCT04620603|Immunomodulating Agents|immunomodulating agents|mesh-list
153564952|NCT04218266|Protease Inhibitors|protease inhibitors|mesh-ancestor
153564953|NCT04218266|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153564954|NCT04218266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153564955|NCT04218266|Anticoagulants|anticoagulants|mesh-ancestor
153564956|NCT04172363|Octenidine|octenidine|mesh-list
153564957|NCT04172363|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153564958|NCT04172363|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
153564959|NCT04074603|Insulin|insulin|mesh-list
153564960|NCT04074603|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153564961|NCT04074603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153564962|NCT04068246|Metformin|metformin|mesh-list
153564963|NCT04068246|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153424463|NCT00376831|GABA Agents|gaba agents|mesh-ancestor
153424466|NCT03857750|Rocuronium|rocuronium|mesh-list
153564970|NCT04002258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153564971|NCT04002258|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153564972|NCT03907800|Paclitaxel|paclitaxel|mesh-list
153564973|NCT03907800|Carboplatin|carboplatin|mesh-list
153564974|NCT03907800|Trastuzumab|trastuzumab|mesh-list
153564975|NCT03907800|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153564976|NCT03907800|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153564977|NCT03907800|Tubulin Modulators|tubulin modulators|mesh-ancestor
153564978|NCT03907800|Antimitotic Agents|antimitotic agents|mesh-ancestor
153564979|NCT03907800|Mitosis Modulators|mitosis modulators|mesh-ancestor
153564980|NCT03907800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153564982|NCT03894904|Heparin|heparin|mesh-list
153564983|NCT03894904|Papaverine|papaverine|mesh-list
153564984|NCT03894904|Anticoagulants|anticoagulants|mesh-ancestor
153564985|NCT03894904|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153564986|NCT03894904|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153564987|NCT03894904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153564988|NCT03894904|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
153564989|NCT03894904|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153564990|NCT03894904|Vasodilator Agents|vasodilator agents|mesh-ancestor
153564991|NCT03894904|Urological Agents|urological agents|mesh-ancestor
153564992|NCT03797833|Anesthetics|anesthetics|mesh-list
153564993|NCT03797833|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153564994|NCT03797833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153564995|NCT03749174|Anesthetics|anesthetics|mesh-list
153883567|NCT01342887|Antimetabolites|antimetabolites|mesh-ancestor
153782797|NCT04551703|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153565008|NCT03578198|Immunologic Factors|immunologic factors|mesh-ancestor
153565009|NCT03578198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153565010|NCT03578198|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153565012|NCT03554200|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
153565013|NCT03554200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153565014|NCT03554200|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153565015|NCT03554200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153565017|NCT03517176|Gemcitabine|gemcitabine|mesh-list
153565018|NCT03517176|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153565038|NCT03512964|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
153565039|NCT03512964|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
153565045|NCT03463499|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153565046|NCT03463499|Immunologic Factors|immunologic factors|mesh-ancestor
153565047|NCT03463499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153565048|NCT03463499|Viscosupplements|viscosupplements|mesh-ancestor
153565049|NCT03463499|Protective Agents|protective agents|mesh-ancestor
153565050|NCT03366974|Clarithromycin|clarithromycin|mesh-list
153565051|NCT03366974|Midazolam|midazolam|mesh-list
153565052|NCT03366974|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153565053|NCT03366974|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153565054|NCT03366974|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153565055|NCT03366974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153565066|NCT03366974|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153565067|NCT03366974|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153377426|NCT04551144|Estradiol|estradiol|mesh-list
153565069|NCT03366974|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153565070|NCT03366974|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
153565075|NCT03128398|Domperidone|domperidone|mesh-list
153565076|NCT03128398|Antiemetics|antiemetics|mesh-ancestor
153565077|NCT03128398|Autonomic Agents|autonomic agents|mesh-ancestor
153565078|NCT03128398|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153565079|NCT03128398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153565080|NCT03128398|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153565081|NCT03128398|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
153565082|NCT03128398|Dopamine Agents|dopamine agents|mesh-ancestor
153565083|NCT03128398|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153565084|NCT03128398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153424550|NCT03806270|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153424551|NCT03806270|Anesthetics, General|anesthetics, general|mesh-ancestor
153565100|NCT03119038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153565101|NCT03119038|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
153565102|NCT03119038|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153565103|NCT03119038|Autonomic Agents|autonomic agents|mesh-ancestor
153565104|NCT03119038|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153565105|NCT03119038|Respiratory System Agents|respiratory system agents|mesh-ancestor
153565106|NCT03119038|Mydriatics|mydriatics|mesh-ancestor
153565107|NCT03119038|Sympathomimetics|sympathomimetics|mesh-ancestor
153565108|NCT03119038|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
153565109|NCT03119038|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153565116|NCT03119038|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153565117|NCT03119038|Sympatholytics|sympatholytics|mesh-ancestor
153565118|NCT03119038|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
153565119|NCT03099265|Leucovorin|leucovorin|mesh-list
153565120|NCT03099265|Fluorouracil|fluorouracil|mesh-list
153565125|NCT03099265|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153565126|NCT03099265|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153565127|NCT03099265|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153782816|NCT00235001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153565128|NCT03099265|Immunologic Factors|immunologic factors|mesh-ancestor
153565129|NCT03099265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153565130|NCT03099265|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
153565131|NCT03099265|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153565132|NCT03099265|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153565134|NCT03099265|Protective Agents|protective agents|mesh-ancestor
153565135|NCT03099265|Vitamin B Complex|vitamin b complex|mesh-ancestor
153565136|NCT03099265|Vitamins|vitamins|mesh-ancestor
153565137|NCT03099265|Micronutrients|micronutrients|mesh-ancestor
153565139|NCT02975037|Itraconazole|itraconazole|mesh-list
153565151|NCT02975037|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153883668|NCT05138978|Cariostatic Agents|cariostatic agents|mesh-ancestor
153424609|NCT04028960|Insulin|insulin|mesh-list
153565153|NCT02975037|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
153565154|NCT02975037|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153565155|NCT02975037|Hormone Antagonists|hormone antagonists|mesh-ancestor
153565156|NCT02975037|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153565157|NCT02975037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153565158|NCT02931890|Paclitaxel|paclitaxel|mesh-list
153565159|NCT02931890|Docetaxel|docetaxel|mesh-list
153565160|NCT02931890|Carboplatin|carboplatin|mesh-list
153565161|NCT02931890|Capecitabine|capecitabine|mesh-list
153565162|NCT02931890|Oxaliplatin|oxaliplatin|mesh-list
153565163|NCT02931890|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153565164|NCT02931890|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153565165|NCT02931890|Tubulin Modulators|tubulin modulators|mesh-ancestor
153565169|NCT02931890|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153565170|NCT02931890|Antimetabolites|antimetabolites|mesh-ancestor
153565171|NCT02812862|Tiotropium Bromide|tiotropium bromide|mesh-list
153565172|NCT02812862|Olodaterol|olodaterol|mesh-list
153565173|NCT02812862|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153565174|NCT02812862|Autonomic Agents|autonomic agents|mesh-ancestor
153565175|NCT02812862|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153565176|NCT02812862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153565177|NCT02812862|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153565178|NCT02812862|Respiratory System Agents|respiratory system agents|mesh-ancestor
153565179|NCT02812862|Parasympatholytics|parasympatholytics|mesh-ancestor
153377428|NCT04551144|Testosterone|testosterone|mesh-list
153377429|NCT04551144|Testosterone undecanoate|testosterone undecanoate|mesh-list
153565180|NCT02812862|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
153565181|NCT02812862|Cholinergic Agents|cholinergic agents|mesh-ancestor
153565182|NCT02812862|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153565183|NCT02812862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153565184|NCT02587312|Nicotine|nicotine|mesh-list
153565185|NCT02587312|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
153782819|NCT00235001|Vasodilator Agents|vasodilator agents|mesh-ancestor
153782820|NCT00235001|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
153782821|NCT00235001|Protease Inhibitors|protease inhibitors|mesh-ancestor
153782827|NCT04551781|Hormones|hormones|mesh-ancestor
153782828|NCT04551781|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153565186|NCT02587312|Autonomic Agents|autonomic agents|mesh-ancestor
153565187|NCT02587312|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153565188|NCT02587312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153565190|NCT02587312|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
153565191|NCT02587312|Cholinergic Agents|cholinergic agents|mesh-ancestor
153565192|NCT02587312|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153565193|NCT02587312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153565194|NCT02549677|Cyclophosphamide|cyclophosphamide|mesh-list
153565195|NCT02549677|Docetaxel|docetaxel|mesh-list
153565223|NCT02257970|Analgesics|analgesics|mesh-ancestor
153565224|NCT02257970|Sensory System Agents|sensory system agents|mesh-ancestor
153883764|NCT02893488|Antiviral Agents|antiviral agents|mesh-ancestor
153565240|NCT05838066|Trastuzumab|trastuzumab|mesh-list
153565241|NCT05838066|Pertuzumab|pertuzumab|mesh-list
153565242|NCT05838066|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153565243|NCT05838066|Tubulin Modulators|tubulin modulators|mesh-ancestor
153565244|NCT05838066|Antimitotic Agents|antimitotic agents|mesh-ancestor
153565245|NCT05838066|Mitosis Modulators|mitosis modulators|mesh-ancestor
153565246|NCT05838066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153565247|NCT05838066|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153565248|NCT05838001|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
153565259|NCT05837286|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153565262|NCT05836831|Tranexamic Acid|tranexamic acid|mesh-list
153565263|NCT05836831|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
153565278|NCT05836545|Anesthetics|anesthetics|mesh-ancestor
153565279|NCT05836545|GABA Modulators|gaba modulators|mesh-ancestor
153565280|NCT05836545|GABA Agents|gaba agents|mesh-ancestor
153424771|NCT04018664|Analgesics|analgesics|mesh-ancestor
153565286|NCT05836441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153565287|NCT05836441|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
153565288|NCT05836441|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153565289|NCT05836441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153565290|NCT05836233|Vasodilator Agents|vasodilator agents|mesh-list
153565291|NCT05835726|Daratumumab|daratumumab|mesh-list
153880116|NCT02831933|Antiviral Agents|antiviral agents|mesh-ancestor
153880117|NCT02831933|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153880118|NCT02760407|Adalimumab|adalimumab|mesh-list
153565303|NCT05814744|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153565304|NCT05814744|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153565305|NCT05814744|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153565306|NCT05814744|Analgesics|analgesics|mesh-ancestor
153565307|NCT05814744|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
153565308|NCT05814744|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153565309|NCT05814744|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153565310|NCT05814744|Adrenergic Agents|adrenergic agents|mesh-ancestor
153565311|NCT05814744|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153565312|NCT05814744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153565314|NCT05797558|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-list
153565315|NCT05797558|Mineralocorticoids|mineralocorticoids|mesh-list
153883867|NCT00592332|GABA Modulators|gaba modulators|mesh-ancestor
153565317|NCT05797558|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153565319|NCT05797558|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
153565320|NCT05797558|Diuretics|diuretics|mesh-ancestor
153565321|NCT05797558|Natriuretic Agents|natriuretic agents|mesh-ancestor
153565322|NCT05797558|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153565323|NCT05797558|Hormones|hormones|mesh-ancestor
153565324|NCT05786820|Pycnogenols|pycnogenols|mesh-list
153565325|NCT05786820|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153565326|NCT05786820|Immunologic Factors|immunologic factors|mesh-ancestor
153565327|NCT05786820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153565328|NCT05786820|Antioxidants|antioxidants|mesh-ancestor
153565329|NCT05786820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153565330|NCT05786820|Protective Agents|protective agents|mesh-ancestor
153883906|NCT04374123|Antibodies|antibodies|mesh-list
153565335|NCT05781308|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153565338|NCT05781308|Antimitotic Agents|antimitotic agents|mesh-ancestor
153565339|NCT05781308|Mitosis Modulators|mitosis modulators|mesh-ancestor
153565340|NCT05781308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153565341|NCT05781308|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153565342|NCT05781308|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153565343|NCT05781308|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153565344|NCT05781308|Growth Substances|growth substances|mesh-ancestor
153565345|NCT05781308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153565350|NCT05772156|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153565351|NCT05772156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153782855|NCT00260988|Dalteparin|dalteparin|mesh-list
153782856|NCT00260988|Tinzaparin|tinzaparin|mesh-list
153884032|NCT01175668|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153782858|NCT00260988|Anticoagulants|anticoagulants|mesh-ancestor
153782859|NCT00260988|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153782860|NCT00260988|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153782861|NCT00260988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153782862|NCT00235157|Sirolimus|sirolimus|mesh-list
153782863|NCT00235157|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153782864|NCT00235157|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153782865|NCT00235157|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153782866|NCT00235157|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153782867|NCT00235157|Antifungal Agents|antifungal agents|mesh-ancestor
153565352|NCT05769868|Esmolol|esmolol|mesh-list
153565353|NCT05769868|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
153565354|NCT05769868|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
153565355|NCT05769868|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
153565356|NCT05769868|Adrenergic Agents|adrenergic agents|mesh-ancestor
153565357|NCT05769868|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153565358|NCT05769868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153565359|NCT05769868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153565360|NCT05727579|Ertugliflozin|ertugliflozin|mesh-list
153565361|NCT05727579|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
153565362|NCT05727579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153565363|NCT05727579|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153565364|NCT05727579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153565365|NCT05652764|Immunomodulating Agents|immunomodulating agents|mesh-list
153565366|NCT05652764|Immunologic Factors|immunologic factors|mesh-ancestor
153565367|NCT05652764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153565368|NCT05597254|Niacin|niacin|mesh-list
153565369|NCT05597254|Niacinamide|niacinamide|mesh-list
153565370|NCT05597254|Nicotinic Acids|nicotinic acids|mesh-list
153565371|NCT05597254|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153565375|NCT05597254|Vasodilator Agents|vasodilator agents|mesh-ancestor
153565376|NCT05597254|Vitamin B Complex|vitamin b complex|mesh-ancestor
153884061|NCT01607762|Olanzapine|olanzapine|mesh-list
153565390|NCT05324761|Sensory System Agents|sensory system agents|mesh-ancestor
153565391|NCT05324761|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153565392|NCT05324761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153565393|NCT05324761|Anticonvulsants|anticonvulsants|mesh-ancestor
153565394|NCT05324761|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153782868|NCT00235157|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153782869|NCT00235157|Immunologic Factors|immunologic factors|mesh-ancestor
153782870|NCT00235157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153782871|NCT04550338|Tranexamic Acid|tranexamic acid|mesh-list
153782872|NCT04550338|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
153565408|NCT05317403|Venetoclax|venetoclax|mesh-list
153565409|NCT05317403|Vorinostat|vorinostat|mesh-list
153565410|NCT05317403|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153565411|NCT05317403|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153565412|NCT05317403|Antimetabolites|antimetabolites|mesh-ancestor
153565413|NCT05317403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153565414|NCT05317403|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153565415|NCT05317403|Immunologic Factors|immunologic factors|mesh-ancestor
153565416|NCT05317403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153565417|NCT05317403|Antiviral Agents|antiviral agents|mesh-ancestor
153565418|NCT05317403|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153565419|NCT05317403|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
153565420|NCT05317403|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153565421|NCT05312242|Folic Acid|folic acid|mesh-list
153565422|NCT05312242|Micronutrients|micronutrients|mesh-list
153565423|NCT05312242|Trace Elements|trace elements|mesh-list
153565424|NCT05312242|Hematinics|hematinics|mesh-ancestor
153565425|NCT05312242|Vitamin B Complex|vitamin b complex|mesh-ancestor
153565426|NCT05312242|Vitamins|vitamins|mesh-ancestor
153565427|NCT05312242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153565428|NCT05288829|Ravulizumab|ravulizumab|mesh-list
153884113|NCT01607996|Anesthetics|anesthetics|mesh-list
153884116|NCT01601561|Insulin|insulin|mesh-list
153565429|NCT05288829|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
153565430|NCT05288829|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153565432|NCT05288829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153565433|NCT05233566|Ketamine|ketamine|mesh-list
153565434|NCT05233566|Analgesics|analgesics|mesh-ancestor
153565435|NCT05233566|Sensory System Agents|sensory system agents|mesh-ancestor
153565436|NCT05233566|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153565437|NCT05233566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153565438|NCT05233566|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
153565439|NCT05233566|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153565440|NCT05233566|Anesthetics, General|anesthetics, general|mesh-ancestor
153565441|NCT05233566|Anesthetics|anesthetics|mesh-ancestor
153565442|NCT05233566|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153565443|NCT05233566|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
153565444|NCT05233566|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
153565445|NCT05233566|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153565446|NCT05233566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153565448|NCT05210517|Benzbromarone|benzbromarone|mesh-list
153565449|NCT05210517|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
153565450|NCT05210517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153565451|NCT05210517|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153565452|NCT05210517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153565479|NCT05032118|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153565480|NCT05032118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153565481|NCT05032118|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153565483|NCT05032118|Anesthetics|anesthetics|mesh-ancestor
153565484|NCT05032118|Analgesics|analgesics|mesh-ancestor
153565485|NCT05032118|Sensory System Agents|sensory system agents|mesh-ancestor
153565486|NCT05032118|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153565487|NCT05032118|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
153565488|NCT05032118|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
153565489|NCT05032118|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
153565490|NCT05032118|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153565491|NCT05032118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153565492|NCT04874597|Ocrelizumab|ocrelizumab|mesh-list
153565493|NCT04874597|Immunologic Factors|immunologic factors|mesh-ancestor
153565535|NCT04257448|Paclitaxel|paclitaxel|mesh-list
153565536|NCT04257448|Gemcitabine|gemcitabine|mesh-list
153565537|NCT04257448|Lenalidomide|lenalidomide|mesh-list
153565538|NCT04257448|Azacitidine|azacitidine|mesh-list
153565539|NCT04257448|Durvalumab|durvalumab|mesh-list
153565540|NCT04257448|Romidepsin|romidepsin|mesh-list
153565541|NCT04257448|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153565542|NCT04257448|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153565543|NCT04257448|Tubulin Modulators|tubulin modulators|mesh-ancestor
153565544|NCT04257448|Antimitotic Agents|antimitotic agents|mesh-ancestor
153565545|NCT04257448|Mitosis Modulators|mitosis modulators|mesh-ancestor
153565556|NCT04257448|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153565562|NCT03959566|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153565563|NCT03959566|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153565564|NCT03959566|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153565565|NCT03959566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153565598|NCT03875755|Vitamin B Complex|vitamin b complex|mesh-ancestor
153565599|NCT03875755|Vitamins|vitamins|mesh-ancestor
153565600|NCT03875755|Micronutrients|micronutrients|mesh-ancestor
153565601|NCT03875755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153565602|NCT03380546|Insulin|insulin|mesh-list
153565603|NCT03380546|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
153565604|NCT03380546|Acarbose|acarbose|mesh-list
153565605|NCT03380546|Insulin, Short-Acting|insulin, short-acting|mesh-list
153565606|NCT03380546|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153565607|NCT03380546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153565608|NCT03380546|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
153565609|NCT03380546|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153565610|NCT03380546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153565659|NCT02141542|Tremelimumab|tremelimumab|mesh-list
153565660|NCT02141542|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153565661|NCT01930955|Amoxicillin|amoxicillin|mesh-list
153565662|NCT01930955|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153565663|NCT01930955|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153565664|NCT01333514|Insulin Aspart|insulin aspart|mesh-list
153565665|NCT01333514|Insulin, Long-Acting|insulin, long-acting|mesh-list
153425128|NCT03490916|Natriuretic Agents|natriuretic agents|mesh-ancestor
153425129|NCT03490916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153425131|NCT03333746|Lenalidomide|lenalidomide|mesh-list
153565677|NCT02066636|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153565678|NCT02066636|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153565679|NCT02066636|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153565680|NCT02066636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153565681|NCT02036086|Vemurafenib|vemurafenib|mesh-list
153565682|NCT02036086|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153565683|NCT02036086|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153565684|NCT02036086|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153565685|NCT02036086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153565701|NCT01681446|Interferon-alpha|interferon-alpha|mesh-list
153782945|NCT00268398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153782946|NCT00268398|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153782947|NCT00268398|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153782948|NCT00268398|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153782949|NCT00268398|Immunologic Factors|immunologic factors|mesh-ancestor
153782950|NCT00268398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153782951|NCT00268398|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
153782952|NCT00268398|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153782953|NCT00268398|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153782954|NCT00268398|Antidotes|antidotes|mesh-ancestor
153565702|NCT01681446|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153565744|NCT06225258|Growth Substances|growth substances|mesh-ancestor
153565745|NCT06225258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153565746|NCT06225258|Growth Inhibitors|growth inhibitors|mesh-ancestor
153565747|NCT06225232|Psilocybin|psilocybin|mesh-list
153565748|NCT06225232|Hallucinogens|hallucinogens|mesh-ancestor
153565749|NCT06225232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153565750|NCT06225232|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153565751|NCT06225011|Fluoxetine|fluoxetine|mesh-list
153565752|NCT06225011|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
153565753|NCT06225011|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153565754|NCT06225011|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153565755|NCT06225011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153565756|NCT06225011|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153565757|NCT06225011|Serotonin Agents|serotonin agents|mesh-ancestor
153565758|NCT06225011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153565759|NCT06225011|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
153565800|NCT06224790|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153565801|NCT06224790|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153565802|NCT06224790|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153565803|NCT06224777|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
153425188|NCT02389712|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153565804|NCT06224530|Levetiracetam|levetiracetam|mesh-list
153565805|NCT06224530|Anticonvulsants|anticonvulsants|mesh-ancestor
153565806|NCT06224530|Nootropic Agents|nootropic agents|mesh-ancestor
153565807|NCT06224439|Anesthetics|anesthetics|mesh-list
153565808|NCT06224439|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153565809|NCT06224439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153565810|NCT06223932|Molnupiravir|molnupiravir|mesh-list
153565811|NCT06223932|Antiviral Agents|antiviral agents|mesh-ancestor
153565812|NCT06223932|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153565814|NCT06223880|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
153565815|NCT06223880|Antidepressive Agents|antidepressive agents|mesh-ancestor
153565816|NCT06223880|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153565817|NCT06223880|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
153565818|NCT06223880|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153565819|NCT06223880|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153565820|NCT06223880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153565821|NCT06223880|Dopamine Agents|dopamine agents|mesh-ancestor
153565822|NCT06223880|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153565823|NCT06223880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153565824|NCT06223880|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
153565827|NCT06223711|Durvalumab|durvalumab|mesh-list
153565847|NCT06223659|Lidocaine|lidocaine|mesh-list
153565848|NCT06223659|Anesthetics, Local|anesthetics, local|mesh-list
153565849|NCT06223659|Prilocaine|prilocaine|mesh-list
153565850|NCT06223659|Lidocaine, Prilocaine Drug Combination|lidocaine, prilocaine drug combination|mesh-list
153565851|NCT06223659|Anesthetics|anesthetics|mesh-list
153565852|NCT06223659|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153565853|NCT06223659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153565854|NCT06223659|Sensory System Agents|sensory system agents|mesh-ancestor
153565855|NCT06223659|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153425207|NCT02367170|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153565857|NCT06223659|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
153565858|NCT06223659|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153565859|NCT06223659|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153565860|NCT06223659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153565861|NCT06223659|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
153565863|NCT06223477|Cholecalciferol|cholecalciferol|mesh-list
153565865|NCT06223477|Micronutrients|micronutrients|mesh-ancestor
153565866|NCT06223477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153565867|NCT06223477|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153565868|NCT06223477|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153565869|NCT06223243|Chlorhexidine|chlorhexidine|mesh-list
153565870|NCT06223243|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
153565871|NCT06223243|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153565872|NCT06223243|Disinfectants|disinfectants|mesh-ancestor
153565873|NCT06223074|Methylprednisolone|methylprednisolone|mesh-list
153565874|NCT06223074|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
153565875|NCT06223074|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
153565876|NCT06223074|Prednisolone|prednisolone|mesh-list
153565877|NCT06223074|Prednisolone acetate|prednisolone acetate|mesh-list
153565878|NCT06223074|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
153425230|NCT00376051|Citalopram|citalopram|mesh-list
153565881|NCT06223074|Antiemetics|antiemetics|mesh-ancestor
153565888|NCT06223074|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153565889|NCT06223074|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
153565890|NCT06223074|Protective Agents|protective agents|mesh-ancestor
153565891|NCT06223074|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153565892|NCT06223074|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153565893|NCT06222944|Paclitaxel|paclitaxel|mesh-list
153565894|NCT06222944|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
153565895|NCT06222944|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153565896|NCT06222944|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153565897|NCT06222944|Tubulin Modulators|tubulin modulators|mesh-ancestor
153565898|NCT06222944|Antimitotic Agents|antimitotic agents|mesh-ancestor
153565899|NCT06222944|Mitosis Modulators|mitosis modulators|mesh-ancestor
153565900|NCT06222944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153565901|NCT06222801|Interferons|interferons|mesh-list
153565902|NCT06222801|Interferon-gamma|interferon-gamma|mesh-list
153565903|NCT06222801|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153565907|NCT06222723|Dexamethasone|dexamethasone|mesh-list
153565908|NCT06222723|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153565909|NCT06222723|Antiemetics|antiemetics|mesh-ancestor
153565910|NCT06222723|Autonomic Agents|autonomic agents|mesh-ancestor
153565939|NCT06217120|Antimitotic Agents|antimitotic agents|mesh-ancestor
153565940|NCT06217120|Mitosis Modulators|mitosis modulators|mesh-ancestor
153565941|NCT06217120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153565942|NCT06217120|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153565944|NCT06212388|Pembrolizumab|pembrolizumab|mesh-list
153565945|NCT06212388|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153565946|NCT06212388|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153565947|NCT06212388|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153565948|NCT06212388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153565949|NCT06212388|Antiviral Agents|antiviral agents|mesh-ancestor
153565950|NCT06212388|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153565951|NCT06212284|Citalopram|citalopram|mesh-list
153565952|NCT06212284|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
153565953|NCT06212284|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153565954|NCT06212284|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153565955|NCT06212284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153565956|NCT06212284|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153565957|NCT06212284|Serotonin Agents|serotonin agents|mesh-ancestor
153565958|NCT06212284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153782956|NCT00268398|Vitamin B Complex|vitamin b complex|mesh-ancestor
153782957|NCT00268398|Vitamins|vitamins|mesh-ancestor
153565991|NCT06192160|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
153565992|NCT06192160|Antitubercular Agents|antitubercular agents|mesh-ancestor
153565993|NCT06192160|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153565994|NCT06192160|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153565995|NCT06192160|Leprostatic Agents|leprostatic agents|mesh-ancestor
153425262|NCT00376129|Alefacept|alefacept|mesh-list
153566007|NCT06192160|Antimetabolites|antimetabolites|mesh-ancestor
153566008|NCT06192160|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153566009|NCT06192160|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
153566010|NCT06144944|Paclitaxel|paclitaxel|mesh-list
153566011|NCT06144944|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
153566012|NCT06144944|Cyclophosphamide|cyclophosphamide|mesh-list
153566013|NCT06144944|Doxorubicin|doxorubicin|mesh-list
153566014|NCT06144944|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
153566015|NCT06144944|Epirubicin|epirubicin|mesh-list
153566016|NCT06144944|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153566017|NCT06144944|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153566018|NCT06144944|Tubulin Modulators|tubulin modulators|mesh-ancestor
153566019|NCT06144944|Antimitotic Agents|antimitotic agents|mesh-ancestor
153566020|NCT06144944|Mitosis Modulators|mitosis modulators|mesh-ancestor
153566022|NCT06144944|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153566030|NCT06144944|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153566032|NCT06144944|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153566033|NCT06131801|Venetoclax|venetoclax|mesh-list
153566034|NCT06131801|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153566039|NCT06101394|Cetuximab|cetuximab|mesh-list
153566040|NCT06101394|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153566041|NCT06101394|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153566042|NCT06084338|Testosterone|testosterone|mesh-list
153566043|NCT06084338|Androgens|androgens|mesh-ancestor
153566044|NCT06084338|Hormones|hormones|mesh-ancestor
153566045|NCT06084338|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153566046|NCT06084338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153566050|NCT06056596|Lamivudine|lamivudine|mesh-list
153566051|NCT06056596|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153566052|NCT06056596|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153566053|NCT06056596|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153566054|NCT06056596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153566055|NCT06056596|Antiviral Agents|antiviral agents|mesh-ancestor
153566056|NCT06056596|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153566057|NCT06056596|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153566058|NCT06056596|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153566059|NCT06023641|Dactinomycin|dactinomycin|mesh-list
153566060|NCT06023641|Cyclophosphamide|cyclophosphamide|mesh-list
153566070|NCT06023641|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153566072|NCT06023641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153566073|NCT06023641|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153566074|NCT06023641|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153566075|NCT06023641|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
153566076|NCT06023641|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153566077|NCT06023641|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153566078|NCT06023641|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153566079|NCT06023641|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153566080|NCT06023641|Tubulin Modulators|tubulin modulators|mesh-ancestor
153566081|NCT06023641|Antimitotic Agents|antimitotic agents|mesh-ancestor
153566082|NCT06023641|Mitosis Modulators|mitosis modulators|mesh-ancestor
153566083|NCT06023641|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153566084|NCT06023641|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153566085|NCT06023641|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153566086|NCT06023641|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
153566087|NCT06023641|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153566088|NCT06009055|Propofol|propofol|mesh-list
153566089|NCT06009055|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153566090|NCT06009055|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153566091|NCT06009055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153566092|NCT06009055|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153566093|NCT06009055|Anesthetics, General|anesthetics, general|mesh-ancestor
153566099|NCT05995535|Clonidine|clonidine|mesh-list
153566100|NCT05995535|Pregabalin|pregabalin|mesh-list
153566101|NCT05995535|Analgesics|analgesics|mesh-ancestor
153566102|NCT05995535|Sensory System Agents|sensory system agents|mesh-ancestor
153566103|NCT05995535|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153566104|NCT05995535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153566105|NCT05995535|Anticonvulsants|anticonvulsants|mesh-ancestor
153566108|NCT05995535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153566109|NCT05995535|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153566110|NCT05995535|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153566111|NCT05995535|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153566112|NCT05995535|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153566113|NCT05995535|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153566114|NCT05995535|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153566115|NCT05995535|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
153566116|NCT05995535|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
153566117|NCT05995535|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153566118|NCT05995535|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153566181|NCT05991401|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
153566182|NCT05991401|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
153566183|NCT05991401|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
153566184|NCT05991401|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
153566185|NCT05991401|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
153566187|NCT05991401|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
153566197|NCT05899127|Sufentanil|sufentanil|mesh-list
153782964|NCT00235313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153782965|NCT00235313|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
153782966|NCT00235313|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
153566216|NCT05899127|Anesthetics, General|anesthetics, general|mesh-ancestor
153566240|NCT05870800|Micronutrients|micronutrients|mesh-ancestor
153566241|NCT05870800|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153566242|NCT05870800|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153566243|NCT05854784|Afamelanotide|afamelanotide|mesh-list
153566244|NCT05854784|Dermatologic Agents|dermatologic agents|mesh-ancestor
153566245|NCT05814666|Pembrolizumab|pembrolizumab|mesh-list
153566246|NCT05814666|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153566247|NCT05814666|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153566248|NCT05814666|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153566249|NCT05814666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153566250|NCT05753956|N,N-Dimethyltryptamine|n,n-dimethyltryptamine|mesh-list
153566251|NCT05753956|Hallucinogens|hallucinogens|mesh-ancestor
153566252|NCT05753956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153566253|NCT05753956|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153782977|NCT04549012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153782978|NCT04549012|Hemostatics|hemostatics|mesh-ancestor
153782979|NCT04549012|Coagulants|coagulants|mesh-ancestor
153782980|NCT00261105|Telithromycin|telithromycin|mesh-list
153782981|NCT00261105|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153782982|NCT00261105|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153566264|NCT05745480|Sensory System Agents|sensory system agents|mesh-ancestor
153566265|NCT05745480|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153566273|NCT05706870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153566274|NCT05694364|Cyclophosphamide|cyclophosphamide|mesh-list
153566275|NCT05694364|Fludarabine|fludarabine|mesh-list
153566276|NCT05694364|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153566277|NCT05694364|Immunologic Factors|immunologic factors|mesh-ancestor
153566278|NCT05694364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153566279|NCT05694364|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153566280|NCT05694364|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153566281|NCT05694364|Alkylating Agents|alkylating agents|mesh-ancestor
153566282|NCT05694364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153566283|NCT05694364|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153566284|NCT05694364|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153566285|NCT05655689|Moxifloxacin|moxifloxacin|mesh-list
153884440|NCT00592917|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153566310|NCT05655689|Beta Lactam Antibiotics|beta lactam antibiotics|mesh-ancestor
153566311|NCT05655689|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
153566312|NCT05626257|Omalizumab|omalizumab|mesh-list
153566313|NCT05626257|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
153566314|NCT05626257|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153566315|NCT05626257|Respiratory System Agents|respiratory system agents|mesh-ancestor
153566321|NCT05539053|Acetylcysteine|acetylcysteine|mesh-list
153566322|NCT05539053|N-monoacetylcystine|n-monoacetylcystine|mesh-list
153782995|NCT00268515|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153782998|NCT00268515|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153782999|NCT00268515|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153783000|NCT00268515|Immunologic Factors|immunologic factors|mesh-ancestor
153566332|NCT05539053|Antidotes|antidotes|mesh-ancestor
153566333|NCT05536011|Sodium Oxybate|sodium oxybate|mesh-list
153566334|NCT05536011|Methylphenidate|methylphenidate|mesh-list
153566335|NCT05536011|Modafinil|modafinil|mesh-list
153566336|NCT05536011|Amphetamine|amphetamine|mesh-list
153566337|NCT05536011|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
153566338|NCT05536011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153884490|NCT00593502|Antiviral Agents|antiviral agents|mesh-ancestor
153884491|NCT00593502|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153566386|NCT05466279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153566387|NCT05457257|Prednisone|prednisone|mesh-list
153566390|NCT05457257|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153566391|NCT05457257|Glucocorticoids|glucocorticoids|mesh-ancestor
153566392|NCT05457257|Hormones|hormones|mesh-ancestor
153566393|NCT05457257|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153566394|NCT05457257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153566395|NCT05457257|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153566396|NCT05457257|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153566397|NCT05457257|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
153566398|NCT05457257|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153783001|NCT00268515|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
153566399|NCT05457257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153566400|NCT05457257|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153566401|NCT05457257|Hormone Antagonists|hormone antagonists|mesh-ancestor
153566402|NCT05457257|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153566404|NCT05456256|Pemetrexed|pemetrexed|mesh-list
153566405|NCT05456256|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153880154|NCT02703610|Oxycodone|oxycodone|mesh-list
153420986|NCT06289205|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153566406|NCT05456256|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153566407|NCT05456256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153566408|NCT05456256|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153566409|NCT05456256|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153566410|NCT05438602|Ritonavir|ritonavir|mesh-list
153566411|NCT05438602|Nirmatrelvir|nirmatrelvir|mesh-list
153566412|NCT05438602|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
153566413|NCT05438602|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
153566414|NCT05438602|Protease Inhibitors|protease inhibitors|mesh-ancestor
153566415|NCT05438602|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153566416|NCT05438602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153566419|NCT05438602|Antiviral Agents|antiviral agents|mesh-ancestor
153566420|NCT05438602|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153884525|NCT00593619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153566422|NCT05438602|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153566423|NCT05436093|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
153566424|NCT05436093|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
153783002|NCT00268515|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153783003|NCT00268515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153783004|NCT00268515|Antifungal Agents|antifungal agents|mesh-ancestor
153783005|NCT00268515|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153783006|NCT00268515|Dermatologic Agents|dermatologic agents|mesh-ancestor
153783007|NCT00268515|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153783008|NCT00268515|Antimetabolites|antimetabolites|mesh-ancestor
153783009|NCT00268515|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153783010|NCT02214433|Pantoprazole|pantoprazole|mesh-list
153783011|NCT02214433|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
153783012|NCT02214433|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
153783013|NCT02214433|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153783014|NCT02214433|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
153783015|NCT02214433|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153783016|NCT02214433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153783017|NCT02212561|Cytarabine|cytarabine|mesh-list
153783018|NCT02212561|Hydrocortisone|hydrocortisone|mesh-list
153783019|NCT02212561|Methotrexate|methotrexate|mesh-list
153783020|NCT02212561|Fludarabine phosphate|fludarabine phosphate|mesh-list
153783021|NCT02212561|Fludarabine|fludarabine|mesh-list
153566445|NCT05363111|Immunologic Factors|immunologic factors|mesh-ancestor
153566446|NCT05363111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153783025|NCT02212561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153783026|NCT02212561|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153783027|NCT02212561|Antimetabolites|antimetabolites|mesh-ancestor
153566448|NCT05363111|Sequestering Agents|sequestering agents|mesh-ancestor
153566449|NCT05363111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153566450|NCT06235424|Cardioplegic Solutions|cardioplegic solutions|mesh-list
153566460|NCT06235294|Vitamin B Complex|vitamin b complex|mesh-ancestor
153566461|NCT06235294|Vitamins|vitamins|mesh-ancestor
153566462|NCT06235294|Micronutrients|micronutrients|mesh-ancestor
153566463|NCT06235294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153566464|NCT06235294|Antioxidants|antioxidants|mesh-ancestor
153870567|NCT00591383|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153425490|NCT00379028|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153566497|NCT06235086|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
153566498|NCT06235086|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153566499|NCT06235086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153566500|NCT06235021|Chlorhexidine|chlorhexidine|mesh-list
153566501|NCT06235021|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
153566502|NCT06235021|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153566503|NCT06235021|Disinfectants|disinfectants|mesh-ancestor
153566504|NCT06234995|Levodopa|levodopa|mesh-list
153566505|NCT06234995|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
153566506|NCT06234995|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
153566507|NCT06234995|Dopamine Agents|dopamine agents|mesh-ancestor
153566508|NCT06234995|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153566509|NCT06234995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153566510|NCT06234995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153566511|NCT06234852|Glucocorticoids|glucocorticoids|mesh-list
153566512|NCT06234852|Hormones|hormones|mesh-ancestor
153566513|NCT06234852|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153566514|NCT06234852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153566515|NCT06234813|Clotrimazole|clotrimazole|mesh-list
153566516|NCT06234813|Miconazole|miconazole|mesh-list
153566546|NCT06234722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153566549|NCT06234592|Vasopressins|vasopressins|mesh-list
153566550|NCT06234592|Arginine Vasopressin|arginine vasopressin|mesh-list
153566551|NCT06234592|Norepinephrine|norepinephrine|mesh-list
153566552|NCT06234592|Angiotensin II|angiotensin ii|mesh-list
153566553|NCT06234592|Giapreza|giapreza|mesh-list
153566554|NCT06234592|Angiotensinogen|angiotensinogen|mesh-list
153566555|NCT06234592|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153566556|NCT06234592|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153566557|NCT06234592|Adrenergic Agents|adrenergic agents|mesh-ancestor
153566573|NCT06234579|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153566574|NCT06234579|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153566576|NCT06234579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153566577|NCT06234514|Ranibizumab|ranibizumab|mesh-list
153566578|NCT06234514|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153566579|NCT06234514|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153566580|NCT06234514|Growth Substances|growth substances|mesh-ancestor
153566581|NCT06234514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153566582|NCT06234514|Growth Inhibitors|growth inhibitors|mesh-ancestor
153566583|NCT06234514|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153566584|NCT06234501|Vitamin B 6|vitamin b 6|mesh-list
153566585|NCT06234501|Pyridoxal|pyridoxal|mesh-list
153783041|NCT00268554|Caffeine|caffeine|mesh-list
153566586|NCT06234501|Pyridoxal Phosphate|pyridoxal phosphate|mesh-list
153783042|NCT00268554|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
153783043|NCT00268554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153783044|NCT00268554|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
153783045|NCT00268554|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153783046|NCT00268554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153783047|NCT00268554|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
153783048|NCT00268554|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
153783049|NCT00268554|Purinergic Agents|purinergic agents|mesh-ancestor
153783050|NCT00268554|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153783051|NCT00268554|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153783052|NCT00268554|Vasodilator Agents|vasodilator agents|mesh-ancestor
153783053|NCT00268593|Prednisone|prednisone|mesh-list
153783054|NCT00268593|Docetaxel|docetaxel|mesh-list
153566587|NCT06234501|Vitamins|vitamins|mesh-ancestor
153566588|NCT06234501|Micronutrients|micronutrients|mesh-ancestor
153566589|NCT06234501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153566590|NCT06234501|Vitamin B Complex|vitamin b complex|mesh-ancestor
153566591|NCT06234462|Amantadine|amantadine|mesh-list
153566601|NCT06234462|Analgesics|analgesics|mesh-ancestor
153566602|NCT06234462|Sensory System Agents|sensory system agents|mesh-ancestor
153566603|NCT06234462|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153566604|NCT06234345|Fluticasone|fluticasone|mesh-list
153566605|NCT06234345|Xhance|xhance|mesh-list
153566607|NCT06234345|Glycopyrrolate|glycopyrrolate|mesh-list
153566608|NCT06234345|Bromides|bromides|mesh-list
153566609|NCT06234345|Formoterol Fumarate|formoterol fumarate|mesh-list
153566610|NCT06234345|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153566611|NCT06234345|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153566612|NCT06234345|Autonomic Agents|autonomic agents|mesh-ancestor
153566613|NCT06234345|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153566614|NCT06234345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153566615|NCT06234345|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153566616|NCT06234345|Respiratory System Agents|respiratory system agents|mesh-ancestor
153566617|NCT06234345|Dermatologic Agents|dermatologic agents|mesh-ancestor
153566618|NCT06234345|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
153566619|NCT06234345|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
153566620|NCT06234345|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
153566621|NCT06234345|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153566655|NCT06233994|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153566656|NCT06233994|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153566657|NCT06233994|Growth Substances|growth substances|mesh-ancestor
153566658|NCT06233994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153566659|NCT06233994|Growth Inhibitors|growth inhibitors|mesh-ancestor
153566660|NCT06233981|Tislelizumab|tislelizumab|mesh-list
153566661|NCT06233981|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153566662|NCT06233981|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153566663|NCT06233799|Naltrexone|naltrexone|mesh-list
153566664|NCT06233799|Bupropion|bupropion|mesh-list
153566665|NCT06233799|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
153566719|NCT06233604|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153566720|NCT06233604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153566721|NCT06233604|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153783055|NCT00268593|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153566722|NCT06233604|Glucocorticoids|glucocorticoids|mesh-ancestor
153566723|NCT06233604|Hormones|hormones|mesh-ancestor
153566724|NCT06233604|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153566725|NCT06233604|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153566726|NCT06233604|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153566727|NCT06233604|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153566728|NCT06233604|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153566729|NCT06233604|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153566730|NCT06233604|Analgesics|analgesics|mesh-ancestor
153566731|NCT06233604|Sensory System Agents|sensory system agents|mesh-ancestor
153566732|NCT06233604|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
153566733|NCT06233604|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153566734|NCT06233604|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153566735|NCT06233604|Adrenergic Agents|adrenergic agents|mesh-ancestor
153566736|NCT06233604|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153566737|NCT06233604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153566738|NCT06233591|Tacrolimus|tacrolimus|mesh-list
153566739|NCT06233591|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153566740|NCT06233591|Immunologic Factors|immunologic factors|mesh-ancestor
153566741|NCT06233591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153566742|NCT06233591|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
153566743|NCT06233591|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153566744|NCT06233591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153566745|NCT06233565|Dexamethasone|dexamethasone|mesh-list
153566746|NCT06233565|Dexmedetomidine|dexmedetomidine|mesh-list
153566747|NCT06233565|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153566748|NCT06233565|Antiemetics|antiemetics|mesh-ancestor
153566749|NCT06233565|Autonomic Agents|autonomic agents|mesh-ancestor
153566750|NCT06233565|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153566751|NCT06233565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153566756|NCT06233565|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153566757|NCT06233565|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153566758|NCT06233565|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153566759|NCT06233565|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153566760|NCT06233565|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153566761|NCT06233565|Analgesics|analgesics|mesh-ancestor
153566762|NCT06233565|Sensory System Agents|sensory system agents|mesh-ancestor
153566763|NCT06233565|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
153332025|NCT03960658|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153332026|NCT03960658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153783158|NCT02212795|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153332027|NCT03960658|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
153332028|NCT03960658|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153332029|NCT03960658|Anesthetics, General|anesthetics, general|mesh-ancestor
153332030|NCT03960658|Anesthetics|anesthetics|mesh-ancestor
153332031|NCT03960658|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153332032|NCT03960658|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
153332033|NCT03960658|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
153332034|NCT03960658|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153332035|NCT03960658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153332036|NCT01005407|Vaccines|vaccines|mesh-list
153332042|NCT03633448|Expectorants|expectorants|mesh-ancestor
153332043|NCT03633448|Respiratory System Agents|respiratory system agents|mesh-ancestor
153332044|NCT03633448|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153332045|NCT03633448|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153332046|NCT03633448|Adrenergic Agents|adrenergic agents|mesh-ancestor
153332047|NCT03633448|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153332048|NCT03633448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153332049|NCT03633448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153332050|NCT03633448|Appetite Depressants|appetite depressants|mesh-ancestor
153332051|NCT03633448|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
153332052|NCT03633448|Sympathomimetics|sympathomimetics|mesh-ancestor
153332053|NCT03633448|Autonomic Agents|autonomic agents|mesh-ancestor
153332054|NCT03633448|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153332055|NCT03633448|Nasal Decongestants|nasal decongestants|mesh-ancestor
153332056|NCT03633448|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
153332057|NCT05313958|Cytarabine|cytarabine|mesh-list
153332059|NCT05313958|Mitoxantrone|mitoxantrone|mesh-list
153332060|NCT05313958|Idarubicin|idarubicin|mesh-list
153332061|NCT05313958|Cladribine|cladribine|mesh-list
153332062|NCT05313958|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153332063|NCT05313958|Antimetabolites|antimetabolites|mesh-ancestor
153332064|NCT05313958|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153332065|NCT05313958|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153332066|NCT05313958|Antiviral Agents|antiviral agents|mesh-ancestor
153332067|NCT05313958|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153332068|NCT05313958|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153332069|NCT05313958|Immunologic Factors|immunologic factors|mesh-ancestor
153332070|NCT05313958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153332071|NCT05313958|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153332072|NCT05313958|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153332073|NCT05313958|Analgesics|analgesics|mesh-ancestor
153332074|NCT05313958|Sensory System Agents|sensory system agents|mesh-ancestor
153332075|NCT05313958|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153332076|NCT05313958|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153332082|NCT01006655|Hormones|hormones|mesh-ancestor
153332084|NCT01006655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153332085|NCT01006655|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153332086|NCT01006655|Respiratory System Agents|respiratory system agents|mesh-ancestor
153332087|NCT03633526|Ivacaftor|ivacaftor|mesh-list
153332089|NCT03633526|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
153332090|NCT03633526|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153332091|NCT03633526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153332092|NCT01007591|Hydrocortisone|hydrocortisone|mesh-list
153332093|NCT01007591|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153332094|NCT03019523|Caffeine|caffeine|mesh-list
153332095|NCT03019523|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
153332096|NCT03019523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153332097|NCT03019523|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
153332098|NCT03019523|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153332099|NCT03019523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153332100|NCT03019523|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
153332101|NCT03019523|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
153783160|NCT00261261|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153783161|NCT00261261|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153332102|NCT03019523|Purinergic Agents|purinergic agents|mesh-ancestor
153332103|NCT03019523|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153332104|NCT01008059|Alfentanil|alfentanil|mesh-list
153377431|NCT04551144|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
153377432|NCT04551144|Estrogens|estrogens|mesh-ancestor
153377433|NCT04551144|Hormones|hormones|mesh-ancestor
153332105|NCT01008059|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153332106|NCT01008059|Narcotics|narcotics|mesh-ancestor
153332107|NCT01008059|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153332108|NCT01008059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153332109|NCT01008059|Analgesics|analgesics|mesh-ancestor
153332128|NCT04467424|Anesthetics, Local|anesthetics, local|mesh-ancestor
153880213|NCT02627846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153880214|NCT02627846|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153880216|NCT02627846|Adrenergic Agents|adrenergic agents|mesh-ancestor
153880217|NCT02627846|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153332130|NCT04467424|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153332131|NCT04467424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153332132|NCT04467424|Sensory System Agents|sensory system agents|mesh-ancestor
153332133|NCT04467424|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153332134|NCT04467424|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153332135|NCT04467424|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
153332136|NCT04467424|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153332137|NCT04467424|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153332138|NCT04467424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153332139|NCT04467424|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153332140|NCT04467424|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153332142|NCT04467424|Analgesics|analgesics|mesh-ancestor
153332143|NCT04467424|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
153332144|NCT04467424|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
153332145|NCT04467424|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
153332146|NCT04467424|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153332147|NCT03016715|Sirolimus|sirolimus|mesh-list
153332148|NCT03016715|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153332149|NCT03016715|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153332150|NCT03016715|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153332151|NCT03016715|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153332152|NCT03016715|Antifungal Agents|antifungal agents|mesh-ancestor
153332154|NCT03016715|Immunologic Factors|immunologic factors|mesh-ancestor
153332155|NCT03016715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153332156|NCT00377104|Alvocidib|alvocidib|mesh-list
153332157|NCT00377104|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153332174|NCT01010399|Protease Inhibitors|protease inhibitors|mesh-ancestor
153332175|NCT01010399|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153332176|NCT01010399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153332177|NCT01010399|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153332178|NCT01010399|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153783162|NCT00261261|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153332179|NCT01010399|Antiviral Agents|antiviral agents|mesh-ancestor
153377434|NCT04551144|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153377435|NCT04551144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153377436|NCT04551144|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
153377437|NCT04551144|Contraceptive Agents|contraceptive agents|mesh-ancestor
153377438|NCT04551144|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153332180|NCT01010399|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153332181|NCT01010399|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
153332182|NCT01010399|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153332183|NCT03638908|Fluoxetine|fluoxetine|mesh-list
153332184|NCT03638908|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
153332185|NCT03638908|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153332186|NCT03638908|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153332187|NCT03638908|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153332188|NCT03638908|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153332189|NCT03638908|Serotonin Agents|serotonin agents|mesh-ancestor
153332190|NCT03638908|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153332191|NCT03638908|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
153332192|NCT03638908|Antidepressive Agents|antidepressive agents|mesh-ancestor
153332193|NCT03638908|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153332194|NCT03638908|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
153880218|NCT02627846|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
153332195|NCT03638908|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153332196|NCT03638908|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153332197|NCT01041781|Celecoxib|celecoxib|mesh-list
153332198|NCT01041781|Carboplatin|carboplatin|mesh-list
153332199|NCT01041781|Gemcitabine|gemcitabine|mesh-list
153332200|NCT01041781|Pemetrexed|pemetrexed|mesh-list
153332201|NCT01041781|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153332202|NCT01041781|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153332203|NCT01041781|Antimetabolites|antimetabolites|mesh-ancestor
153332204|NCT01041781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153332205|NCT01041781|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153332206|NCT01041781|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153332209|NCT01041781|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153332210|NCT01041781|Analgesics|analgesics|mesh-ancestor
153332211|NCT01041781|Sensory System Agents|sensory system agents|mesh-ancestor
153332212|NCT01041781|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153332213|NCT01041781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153332214|NCT01041781|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153332215|NCT01041781|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153332216|NCT01041781|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
153332217|NCT01041781|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153332218|NCT01010477|Nicotine|nicotine|mesh-list
153332219|NCT01010477|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
153332220|NCT01010477|Autonomic Agents|autonomic agents|mesh-ancestor
153332221|NCT01010477|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153332222|NCT01010477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153332223|NCT01010477|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
153332224|NCT01010477|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
153332225|NCT01010477|Cholinergic Agents|cholinergic agents|mesh-ancestor
153332266|NCT03639766|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153332268|NCT01042795|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153332269|NCT01042795|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153332270|NCT01042795|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153332271|NCT01042795|Growth Substances|growth substances|mesh-ancestor
153332272|NCT01042795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153332273|NCT01042795|Growth Inhibitors|growth inhibitors|mesh-ancestor
153332274|NCT01042795|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153332275|NCT01042795|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153377439|NCT04551144|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
153377440|NCT04551144|Androgens|androgens|mesh-ancestor
153377441|NCT04551144|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153332276|NCT01042795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153332277|NCT03644212|Vitamin D|vitamin d|mesh-list
153332278|NCT03644212|Cholecalciferol|cholecalciferol|mesh-list
153332279|NCT03644212|Vitamins|vitamins|mesh-list
153332280|NCT03644212|Micronutrients|micronutrients|mesh-ancestor
153332281|NCT03644212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153332282|NCT03644212|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153377442|NCT04551144|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153332283|NCT03644212|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153332284|NCT03906448|Temozolomide|temozolomide|mesh-list
153332285|NCT03906448|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153332286|NCT03906448|Alkylating Agents|alkylating agents|mesh-ancestor
153332287|NCT03906448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153332288|NCT03906448|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153332314|NCT01104025|Dexamethasone|dexamethasone|mesh-list
153332315|NCT01104025|Hydrocortisone|hydrocortisone|mesh-list
153332316|NCT01104025|Methotrexate|methotrexate|mesh-list
153332317|NCT01104025|Etoposide|etoposide|mesh-list
153332318|NCT01104025|Thymoglobulin|thymoglobulin|mesh-list
153332319|NCT01104025|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153332320|NCT01104025|Antiemetics|antiemetics|mesh-ancestor
153332321|NCT01104025|Autonomic Agents|autonomic agents|mesh-ancestor
153332322|NCT01104025|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153332323|NCT01104025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153332324|NCT01104025|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153332325|NCT01104025|Glucocorticoids|glucocorticoids|mesh-ancestor
153332326|NCT01104025|Hormones|hormones|mesh-ancestor
153332327|NCT01104025|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153332328|NCT01104025|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153332329|NCT01104025|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153332330|NCT01104025|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
153332375|NCT03885154|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153332376|NCT01106833|Sirolimus|sirolimus|mesh-list
153332377|NCT01106833|Prednisone|prednisone|mesh-list
153332378|NCT01106833|Temsirolimus|temsirolimus|mesh-list
153332379|NCT01106833|MTOR Inhibitors|mtor inhibitors|mesh-list
153332380|NCT01106833|Calcineurin Inhibitors|calcineurin inhibitors|mesh-list
153426322|NCT00000800|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153426323|NCT00000800|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153426324|NCT00000800|Antiviral Agents|antiviral agents|mesh-ancestor
153426325|NCT00000800|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153332386|NCT01106833|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153332387|NCT01106833|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153332388|NCT01106833|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153332389|NCT01106833|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153332390|NCT01106833|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153332391|NCT01106833|Antifungal Agents|antifungal agents|mesh-ancestor
153332392|NCT01106833|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153332393|NCT01106833|Immunologic Factors|immunologic factors|mesh-ancestor
153332394|NCT01106833|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153332430|NCT04322968|Analgesics|analgesics|mesh-ancestor
153332431|NCT04322968|Sensory System Agents|sensory system agents|mesh-ancestor
153332432|NCT04322968|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153332433|NCT04322968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153332434|NCT04322968|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
153332435|NCT04322968|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153332436|NCT04322968|Anesthetics, General|anesthetics, general|mesh-ancestor
153332437|NCT04322968|Anesthetics|anesthetics|mesh-ancestor
153332439|NCT04322968|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
153332440|NCT04322968|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
153332441|NCT04322968|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153332442|NCT04322968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153332443|NCT04322968|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153332444|NCT04322968|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153332445|NCT04322968|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153332446|NCT04322968|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153332447|NCT04322968|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153332448|NCT04322968|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153332449|NCT03018899|Anesthetics|anesthetics|mesh-list
153332450|NCT03018899|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153332451|NCT03018899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153332454|NCT00958919|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
153332455|NCT00958919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153332456|NCT00958919|Sensory System Agents|sensory system agents|mesh-ancestor
153332457|NCT00958919|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153332458|NCT00958919|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153332459|NCT00958919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153332461|NCT04323592|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
153332463|NCT04323592|Prednisolone|prednisolone|mesh-list
153332472|NCT04323592|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153332473|NCT04323592|Glucocorticoids|glucocorticoids|mesh-ancestor
153332474|NCT04323592|Hormones|hormones|mesh-ancestor
153332475|NCT04323592|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153332476|NCT04323592|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
153332477|NCT04323592|Protective Agents|protective agents|mesh-ancestor
153783163|NCT00261261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153332478|NCT04323592|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153332479|NCT04323592|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153332480|NCT01047241|Sufentanil|sufentanil|mesh-list
153332481|NCT01047241|Ketamine|ketamine|mesh-list
153332482|NCT01047241|Analgesics|analgesics|mesh-ancestor
153377644|NCT04224636|Growth Substances|growth substances|mesh-ancestor
153377645|NCT04224636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153332483|NCT01047241|Sensory System Agents|sensory system agents|mesh-ancestor
153332484|NCT01047241|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153332485|NCT01047241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153332486|NCT01047241|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
153332487|NCT01047241|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153332490|NCT01047241|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153332491|NCT01047241|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
153332492|NCT01047241|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
153332493|NCT01047241|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153332494|NCT01047241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153332496|NCT01047241|Narcotics|narcotics|mesh-ancestor
153332497|NCT01047241|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153332498|NCT01012661|Lidocaine|lidocaine|mesh-list
153332499|NCT01012661|Anesthetics, Local|anesthetics, local|mesh-ancestor
153332500|NCT01012661|Anesthetics|anesthetics|mesh-ancestor
153332501|NCT01012661|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153332502|NCT01012661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153332503|NCT01012661|Sensory System Agents|sensory system agents|mesh-ancestor
153332508|NCT01012661|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153332509|NCT01012661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153332511|NCT03655444|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153332512|NCT03655444|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153332513|NCT03655444|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153332514|NCT03655444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153332515|NCT03018977|Hypnotics and Sedatives|hypnotics and sedatives|mesh-list
153377646|NCT04224636|Growth Inhibitors|growth inhibitors|mesh-ancestor
153377647|NCT04224636|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153377648|NCT04224636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153377650|NCT04126278|Cortisone|cortisone|mesh-list
153377651|NCT04126278|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153377652|NCT04126278|Antiemetics|antiemetics|mesh-ancestor
153332516|NCT03018977|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153332517|NCT03018977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153332520|NCT03018821|Antiviral Agents|antiviral agents|mesh-ancestor
153332521|NCT03018821|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153332522|NCT03018821|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153332523|NCT03018821|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153332524|NCT03018821|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153332525|NCT03018821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153332527|NCT03018821|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153332528|NCT03866434|Anagrelide|anagrelide|mesh-list
153332529|NCT03866434|Omeprazole|omeprazole|mesh-list
153332530|NCT03866434|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
153332532|NCT03866434|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
153332533|NCT03866434|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153332534|NCT03866434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153332552|NCT03375385|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153332553|NCT03375385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153332554|NCT03375385|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153332556|NCT03375385|Sensory System Agents|sensory system agents|mesh-ancestor
153332557|NCT03375385|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153332558|NCT03375385|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
153332559|NCT03375385|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153332560|NCT03375385|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153332561|NCT03375385|Adrenergic Agents|adrenergic agents|mesh-ancestor
153332562|NCT03375385|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153332563|NCT03375385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153332564|NCT03375385|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153332565|NCT03375385|Anesthetics, General|anesthetics, general|mesh-ancestor
153332566|NCT03375385|Anesthetics|anesthetics|mesh-ancestor
153332568|NCT03018665|Exenatide|exenatide|mesh-list
153332569|NCT03018665|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153332572|NCT03018665|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
153332609|NCT03012607|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153332610|NCT01048879|Oseltamivir|oseltamivir|mesh-list
153332611|NCT01048879|Dialysis Solutions|dialysis solutions|mesh-list
153332612|NCT01048879|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
153332613|NCT01048879|Antiviral Agents|antiviral agents|mesh-ancestor
153332614|NCT01048879|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153332615|NCT01048879|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153332616|NCT01048879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153332618|NCT04290676|Dexamethasone acetate|dexamethasone acetate|mesh-list
153332619|NCT04290676|BB 1101|bb 1101|mesh-list
153332620|NCT04290676|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153332621|NCT04290676|Antiemetics|antiemetics|mesh-ancestor
153332622|NCT04290676|Autonomic Agents|autonomic agents|mesh-ancestor
153332623|NCT04290676|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153332624|NCT04290676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153332625|NCT04290676|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153332626|NCT04290676|Glucocorticoids|glucocorticoids|mesh-ancestor
153332627|NCT04290676|Hormones|hormones|mesh-ancestor
153332628|NCT04290676|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153332629|NCT04290676|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153332630|NCT04290676|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153332631|NCT04290676|Protease Inhibitors|protease inhibitors|mesh-ancestor
153332632|NCT04290676|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153332633|NCT04290676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153332634|NCT03112993|Neostigmine|neostigmine|mesh-list
153332635|NCT03112993|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
153332636|NCT03112993|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153332637|NCT03112993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153332655|NCT03859960|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153332656|NCT03859960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153332657|NCT03857230|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
153332658|NCT03857230|Hormones|hormones|mesh-ancestor
153332659|NCT03857230|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153332660|NCT03857230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153882439|NCT01648595|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153882440|NCT01648595|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153377655|NCT04126278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153332661|NCT02181127|Glucagon|glucagon|mesh-list
153332662|NCT02181127|Pancrelipase|pancrelipase|mesh-list
153332663|NCT02181127|Pancreatin|pancreatin|mesh-list
153332664|NCT02181127|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153332665|NCT02181127|Hormones|hormones|mesh-ancestor
153332666|NCT02181127|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153332667|NCT02181127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153332668|NCT04332094|Azithromycin|azithromycin|mesh-list
153332669|NCT04332094|Hydroxychloroquine|hydroxychloroquine|mesh-list
153332670|NCT04332094|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153332671|NCT04332094|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153332674|NCT04332094|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153332675|NCT04332094|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153332676|NCT04332094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153332677|NCT04332094|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153332679|NCT05314270|Trace Elements|trace elements|mesh-ancestor
153332680|NCT05314270|Micronutrients|micronutrients|mesh-ancestor
153332681|NCT05314270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153332682|NCT01167829|Testosterone|testosterone|mesh-list
153332683|NCT01167829|Acyline|acyline|mesh-list
153332684|NCT01167829|Androgens|androgens|mesh-ancestor
153332685|NCT01167829|Hormones|hormones|mesh-ancestor
153332686|NCT01167829|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153332689|NCT02066623|Everolimus|everolimus|mesh-list
153332700|NCT04974151|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153332701|NCT04974151|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153332702|NCT04974151|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153332703|NCT04974151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153332704|NCT04974151|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153332705|NCT04974151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153332706|NCT04974151|Vasodilator Agents|vasodilator agents|mesh-ancestor
153332707|NCT04974151|Hematinics|hematinics|mesh-ancestor
153332708|NCT04974151|Vitamin B Complex|vitamin b complex|mesh-ancestor
153332709|NCT04974151|Vitamins|vitamins|mesh-ancestor
153332710|NCT04974151|Micronutrients|micronutrients|mesh-ancestor
153332711|NCT01924819|Leucovorin|leucovorin|mesh-list
153332712|NCT01924819|Formyltetrahydrofolates|formyltetrahydrofolates|mesh-list
153332713|NCT01924819|Cisplatin|cisplatin|mesh-list
153332714|NCT01924819|Docetaxel|docetaxel|mesh-list
153332715|NCT01924819|Capecitabine|capecitabine|mesh-list
153332716|NCT01924819|Fluorouracil|fluorouracil|mesh-list
153332717|NCT01924819|Oxaliplatin|oxaliplatin|mesh-list
153332718|NCT01924819|Epirubicin|epirubicin|mesh-list
153332719|NCT01924819|Levoleucovorin|levoleucovorin|mesh-list
153332720|NCT01924819|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153332721|NCT01924819|Tubulin Modulators|tubulin modulators|mesh-ancestor
153332722|NCT01924819|Antimitotic Agents|antimitotic agents|mesh-ancestor
153332723|NCT01924819|Mitosis Modulators|mitosis modulators|mesh-ancestor
153332724|NCT01924819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153332725|NCT01924819|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153332726|NCT01924819|Antimetabolites|antimetabolites|mesh-ancestor
153332727|NCT01924819|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153332728|NCT01924819|Immunologic Factors|immunologic factors|mesh-ancestor
153332729|NCT01924819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153332730|NCT01924819|Antidotes|antidotes|mesh-ancestor
153332731|NCT01924819|Protective Agents|protective agents|mesh-ancestor
153332732|NCT01924819|Vitamin B Complex|vitamin b complex|mesh-ancestor
153332733|NCT01924819|Vitamins|vitamins|mesh-ancestor
153332734|NCT01924819|Micronutrients|micronutrients|mesh-ancestor
153332743|NCT03685396|Coagulants|coagulants|mesh-ancestor
153332745|NCT01126255|Progesterone|progesterone|mesh-list
153332748|NCT01126255|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153332749|NCT01126255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153332750|NCT01126255|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153332753|NCT04198948|Omeprazole|omeprazole|mesh-list
153332754|NCT04198948|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
153332755|NCT04198948|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153332756|NCT04198948|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
153332757|NCT04198948|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153332758|NCT04198948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153332759|NCT04198948|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153332760|NCT04198948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153332761|NCT01169467|Dexmedetomidine|dexmedetomidine|mesh-list
153332762|NCT01169467|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153880227|NCT02603887|Pembrolizumab|pembrolizumab|mesh-list
153880228|NCT02603887|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153880229|NCT02603887|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153880230|NCT02603887|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153880231|NCT02603887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153421085|NCT06287944|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
153421087|NCT06287944|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153421088|NCT06287944|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153421089|NCT06287944|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153332763|NCT01169467|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153332764|NCT01169467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153332765|NCT01169467|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153332767|NCT01169467|Sensory System Agents|sensory system agents|mesh-ancestor
153332768|NCT01169467|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153332769|NCT01169467|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
153332770|NCT01169467|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153332771|NCT01169467|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153332772|NCT01169467|Adrenergic Agents|adrenergic agents|mesh-ancestor
153332773|NCT01169467|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153332774|NCT01169467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153332775|NCT04822363|Aspirin|aspirin|mesh-list
153332787|NCT04822363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153332788|NCT04822363|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153332789|NCT04822363|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153332790|NCT04822363|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153332791|NCT04822363|Antipyretics|antipyretics|mesh-ancestor
153332792|NCT04822363|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
153332793|NCT04822363|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
153332794|NCT04822363|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
153332795|NCT04822363|Purinergic Agents|purinergic agents|mesh-ancestor
153332796|NCT04822363|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153332798|NCT01170247|Analgesics|analgesics|mesh-ancestor
153332799|NCT01170247|Sensory System Agents|sensory system agents|mesh-ancestor
153332800|NCT01170247|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153332801|NCT01170247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153332802|NCT01170247|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
153885477|NCT00591617|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
153332803|NCT01170247|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153332804|NCT01170247|Anesthetics, General|anesthetics, general|mesh-ancestor
153332805|NCT01170247|Anesthetics|anesthetics|mesh-ancestor
153332806|NCT01170247|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153332807|NCT01170247|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
153332808|NCT01170247|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
153332809|NCT01170247|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153332810|NCT01170247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153332811|NCT01126099|Prazosin|prazosin|mesh-list
153332812|NCT01126099|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153332813|NCT01126099|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
153332814|NCT01126099|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
153332815|NCT01126099|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
153332816|NCT01126099|Adrenergic Agents|adrenergic agents|mesh-ancestor
153332817|NCT01126099|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153377665|NCT04106557|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153377748|NCT04007289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153377750|NCT03984578|Pembrolizumab|pembrolizumab|mesh-list
153332818|NCT01126099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153332819|NCT01126099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153332824|NCT01170715|Sensory System Agents|sensory system agents|mesh-ancestor
153332825|NCT01170715|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153332826|NCT01170715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153332827|NCT01170715|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153332828|NCT01170715|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153332829|NCT01170715|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153332830|NCT01170715|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153332831|NCT01170715|Immunologic Factors|immunologic factors|mesh-ancestor
153332832|NCT03809182|Fentanyl|fentanyl|mesh-list
153885478|NCT00591617|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153426447|NCT00089414|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153426448|NCT00089414|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
153332834|NCT03809182|Morphine|morphine|mesh-list
153332835|NCT03809182|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153332836|NCT03809182|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153332837|NCT03809182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153332838|NCT03809182|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153332839|NCT03809182|Analgesics|analgesics|mesh-ancestor
153332840|NCT03809182|Sensory System Agents|sensory system agents|mesh-ancestor
153332841|NCT03809182|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153332842|NCT03809182|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
153332843|NCT03809182|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153332844|NCT03809182|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153332845|NCT03809182|Adrenergic Agents|adrenergic agents|mesh-ancestor
153332878|NCT03797872|Prednisolone acetate|prednisolone acetate|mesh-list
153332879|NCT03797872|Triamcinolone|triamcinolone|mesh-list
153332880|NCT03797872|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
153332881|NCT03797872|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
153332882|NCT03797872|Methotrexate|methotrexate|mesh-list
153332883|NCT03797872|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
153332885|NCT03797872|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
153332886|NCT03797872|Prednisolone phosphate|prednisolone phosphate|mesh-list
153332887|NCT03797872|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
153332888|NCT03797872|Abortifacient Agents|abortifacient agents|mesh-ancestor
153332889|NCT03797872|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153332890|NCT03797872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153332891|NCT03797872|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153332892|NCT03797872|Antimetabolites|antimetabolites|mesh-ancestor
153332893|NCT03797872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153332894|NCT03797872|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153332895|NCT03797872|Dermatologic Agents|dermatologic agents|mesh-ancestor
153332896|NCT03797872|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153332897|NCT03797872|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153332898|NCT03797872|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153332900|NCT03797872|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153332901|NCT03797872|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153332902|NCT03797872|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153332903|NCT03797872|Antiemetics|antiemetics|mesh-ancestor
153332904|NCT03797872|Autonomic Agents|autonomic agents|mesh-ancestor
153332924|NCT00377728|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
153332925|NCT00377728|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153885498|NCT01357655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153426468|NCT03704467|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153332926|NCT00377728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153332928|NCT04498351|Dexmedetomidine|dexmedetomidine|mesh-list
153332929|NCT04498351|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153332930|NCT04498351|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153332931|NCT04498351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153332932|NCT04498351|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153332933|NCT04498351|Analgesics|analgesics|mesh-ancestor
153332934|NCT04498351|Sensory System Agents|sensory system agents|mesh-ancestor
153332935|NCT04498351|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153882443|NCT01648595|Anesthetics|anesthetics|mesh-ancestor
153882444|NCT01648634|Nebivolol|nebivolol|mesh-list
153882445|NCT01648634|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153882446|NCT01648634|Vasodilator Agents|vasodilator agents|mesh-ancestor
153332936|NCT04498351|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
153332937|NCT04498351|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153332938|NCT04498351|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153332939|NCT04498351|Adrenergic Agents|adrenergic agents|mesh-ancestor
153332940|NCT04498351|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153332941|NCT04498351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153332942|NCT04498351|Anesthetics|anesthetics|mesh-ancestor
153332943|NCT04498351|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153332944|NCT04498351|Anticonvulsants|anticonvulsants|mesh-ancestor
153332975|NCT04138498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153332976|NCT04138498|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
153332977|NCT04138498|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153332978|NCT04138498|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153332979|NCT04138498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153332980|NCT04138498|Dopamine Agents|dopamine agents|mesh-ancestor
153332981|NCT04138498|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153332984|NCT03746002|Diuretics|diuretics|mesh-ancestor
153332985|NCT03746002|Natriuretic Agents|natriuretic agents|mesh-ancestor
153332986|NCT03746002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153332987|NCT03746002|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
153332988|NCT03746002|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153332989|NCT03746002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153332990|NCT03746002|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153332991|NCT03746002|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
153332992|NCT04089982|Varenicline|varenicline|mesh-list
153332993|NCT04089982|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
153332995|NCT04089982|Cholinergic Agents|cholinergic agents|mesh-ancestor
153332996|NCT04089982|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153333026|NCT01926236|Fluorouracil|fluorouracil|mesh-list
153333027|NCT01926236|Oxaliplatin|oxaliplatin|mesh-list
153333028|NCT01926236|Levoleucovorin|levoleucovorin|mesh-list
153333029|NCT01926236|Antimetabolites|antimetabolites|mesh-ancestor
153333030|NCT01926236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153333031|NCT01926236|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153333032|NCT01926236|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153333033|NCT01926236|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153333034|NCT01926236|Immunologic Factors|immunologic factors|mesh-ancestor
153333035|NCT01926236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153333036|NCT01926236|Antidotes|antidotes|mesh-ancestor
153333037|NCT01926236|Protective Agents|protective agents|mesh-ancestor
153333038|NCT01926236|Vitamin B Complex|vitamin b complex|mesh-ancestor
153333040|NCT01926236|Micronutrients|micronutrients|mesh-ancestor
153333041|NCT01926236|Hematinics|hematinics|mesh-ancestor
153333042|NCT00983528|Alemtuzumab|alemtuzumab|mesh-list
153333043|NCT00983528|Clofarabine|clofarabine|mesh-list
153333044|NCT00983528|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153333045|NCT00983528|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153333046|NCT00983528|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153333047|NCT00983528|Antimetabolites|antimetabolites|mesh-ancestor
153333048|NCT00983528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153333049|NCT00983372|Colchicine|colchicine|mesh-list
153333050|NCT00983372|Diltiazem|diltiazem|mesh-list
153333051|NCT00983372|Gout Suppressants|gout suppressants|mesh-ancestor
153333052|NCT00983372|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153333053|NCT00983372|Tubulin Modulators|tubulin modulators|mesh-ancestor
153333054|NCT00983372|Antimitotic Agents|antimitotic agents|mesh-ancestor
153333055|NCT00983372|Mitosis Modulators|mitosis modulators|mesh-ancestor
153333056|NCT00983372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153333071|NCT00983294|Gout Suppressants|gout suppressants|mesh-ancestor
153333072|NCT00983294|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153333073|NCT00983294|Tubulin Modulators|tubulin modulators|mesh-ancestor
153333074|NCT00983294|Antimitotic Agents|antimitotic agents|mesh-ancestor
153333075|NCT00983294|Mitosis Modulators|mitosis modulators|mesh-ancestor
153783168|NCT00261261|Anesthetics, General|anesthetics, general|mesh-ancestor
153333076|NCT00983294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153333077|NCT00983294|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153783169|NCT00261261|Anesthetics|anesthetics|mesh-ancestor
153333078|NCT01926392|Sulfadiazine|sulfadiazine|mesh-list
153333079|NCT01926392|Silver Sulfadiazine|silver sulfadiazine|mesh-list
153783170|NCT00261261|GABA Modulators|gaba modulators|mesh-ancestor
153333080|NCT01926392|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153333081|NCT01926392|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153426518|NCT04298918|Maytansine|maytansine|mesh-list
153333082|NCT01926392|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153333083|NCT01926392|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153333084|NCT01926392|Coccidiostats|coccidiostats|mesh-ancestor
153333085|NCT01926392|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
153333087|NCT05601830|Cyclophosphamide|cyclophosphamide|mesh-list
153333088|NCT05601830|Fludarabine|fludarabine|mesh-list
153333089|NCT05601830|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153333090|NCT05601830|Immunologic Factors|immunologic factors|mesh-ancestor
153333091|NCT05601830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153333092|NCT05601830|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153333093|NCT05601830|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153333094|NCT05601830|Alkylating Agents|alkylating agents|mesh-ancestor
153333095|NCT05601830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153880240|NCT02554279|Menotropins|menotropins|mesh-list
153880241|NCT02554279|Fertility Agents, Female|fertility agents, female|mesh-ancestor
153880242|NCT02554279|Fertility Agents|fertility agents|mesh-ancestor
153880243|NCT02554279|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153880244|NCT02554279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153880245|NCT02535988|Thymalfasin|thymalfasin|mesh-list
153333099|NCT05601830|Antimetabolites|antimetabolites|mesh-ancestor
153333117|NCT01175395|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
153333118|NCT01175395|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
153333120|NCT01175395|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
153333121|NCT01175395|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153333124|NCT01175395|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153333125|NCT01175395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153333126|NCT01175395|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153333127|NCT01175395|Immunologic Factors|immunologic factors|mesh-ancestor
153333128|NCT01175395|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153333129|NCT01175395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153333130|NCT01175395|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153333131|NCT01175395|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153333132|NCT01175395|Growth Substances|growth substances|mesh-ancestor
153333133|NCT01175395|Growth Inhibitors|growth inhibitors|mesh-ancestor
153333134|NCT01175395|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153333136|NCT03011905|Dexamethasone|dexamethasone|mesh-list
153333137|NCT03011905|Etoricoxib|etoricoxib|mesh-list
153333138|NCT03011905|Oxycodone|oxycodone|mesh-list
153333139|NCT03011905|Ropivacaine|ropivacaine|mesh-list
153333140|NCT03011905|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153333141|NCT03011905|Antiemetics|antiemetics|mesh-ancestor
153333143|NCT03011905|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153333144|NCT03011905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153333145|NCT03011905|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153333146|NCT03011905|Glucocorticoids|glucocorticoids|mesh-ancestor
153333147|NCT03011905|Hormones|hormones|mesh-ancestor
153333148|NCT03011905|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153333149|NCT03011905|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153333150|NCT03011905|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153333151|NCT03011905|Anesthetics, Local|anesthetics, local|mesh-ancestor
153333152|NCT03011905|Anesthetics|anesthetics|mesh-ancestor
153333153|NCT03011905|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153333154|NCT03011905|Sensory System Agents|sensory system agents|mesh-ancestor
153333155|NCT03011905|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153333157|NCT03011905|Antipyretics|antipyretics|mesh-ancestor
153333158|NCT03011905|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153333159|NCT03011905|Narcotics|narcotics|mesh-ancestor
153333160|NCT03011905|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153333161|NCT03011905|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153333162|NCT03011905|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
153333163|NCT03011905|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153333164|NCT03011905|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153333165|NCT03011905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153333166|NCT01926548|Imatinib Mesylate|imatinib mesylate|mesh-list
153333167|NCT01926548|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153333168|NCT01926548|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153333169|NCT01926548|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153333170|NCT01926548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153333171|NCT01926548|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153333172|NCT01176955|Benzoyl Peroxide|benzoyl peroxide|mesh-list
153333173|NCT01176955|Dermatologic Agents|dermatologic agents|mesh-ancestor
153333174|NCT00980798|Hydromorphone|hydromorphone|mesh-list
153333175|NCT00980798|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153333176|NCT00980798|Narcotics|narcotics|mesh-ancestor
153333177|NCT00980798|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153333178|NCT00980798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153333179|NCT00980798|Analgesics|analgesics|mesh-ancestor
153333180|NCT00980798|Sensory System Agents|sensory system agents|mesh-ancestor
153333208|NCT01178281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153333209|NCT01178281|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153333210|NCT01178281|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153333211|NCT01178281|Growth Substances|growth substances|mesh-ancestor
153333212|NCT01178281|Growth Inhibitors|growth inhibitors|mesh-ancestor
153333213|NCT01178281|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153333214|NCT01178281|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153333215|NCT01178281|Leprostatic Agents|leprostatic agents|mesh-ancestor
153333216|NCT01178281|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153333217|NCT01178281|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153333220|NCT01178827|Trospium chloride|trospium chloride|mesh-list
153333221|NCT01178827|Parasympatholytics|parasympatholytics|mesh-ancestor
153333222|NCT01178827|Autonomic Agents|autonomic agents|mesh-ancestor
153333223|NCT01178827|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153333224|NCT01178827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153333225|NCT01178827|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
153333226|NCT01178827|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
153333227|NCT01178827|Cholinergic Agents|cholinergic agents|mesh-ancestor
153333235|NCT01135537|Immunologic Factors|immunologic factors|mesh-ancestor
153333236|NCT01135537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153333237|NCT01135537|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153333238|NCT02181517|Ranibizumab|ranibizumab|mesh-list
153333239|NCT02181517|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153333240|NCT02181517|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153333248|NCT03010267|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153333249|NCT03010267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153333250|NCT03010267|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
153333251|NCT03010267|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
153333252|NCT03010267|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153333253|NCT01181323|Vaccines|vaccines|mesh-list
153333254|NCT01181323|Immunologic Factors|immunologic factors|mesh-ancestor
153333255|NCT01181323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153333256|NCT02246881|Factor VIII|factor viii|mesh-list
153333257|NCT02246881|Coagulants|coagulants|mesh-ancestor
153333258|NCT00980330|Ribavirin|ribavirin|mesh-list
153333259|NCT00980330|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
153426596|NCT04204057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153333260|NCT00980330|Interferon alpha-2|interferon alpha-2|mesh-list
153333261|NCT00980330|Simeprevir|simeprevir|mesh-list
153333262|NCT00980330|Antimetabolites|antimetabolites|mesh-ancestor
153333263|NCT00980330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153333264|NCT00980330|Antiviral Agents|antiviral agents|mesh-ancestor
153333265|NCT00980330|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153333266|NCT00980330|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153333267|NCT00980330|Protease Inhibitors|protease inhibitors|mesh-ancestor
153426598|NCT00001736|Cystine Depleting Agents|cystine depleting agents|mesh-ancestor
153426599|NCT00001736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153426600|NCT00000884|polysaccharide-K|polysaccharide-k|mesh-list
153426601|NCT00000884|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153426602|NCT00000884|Immunologic Factors|immunologic factors|mesh-ancestor
153426606|NCT00000884|Antiviral Agents|antiviral agents|mesh-ancestor
153333270|NCT01138735|Adapalene, Benzoyl Peroxide Drug Combination|adapalene, benzoyl peroxide drug combination|mesh-list
153333273|NCT01138735|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153333274|NCT01138735|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153333275|NCT01138735|Analgesics|analgesics|mesh-ancestor
153333276|NCT01138735|Sensory System Agents|sensory system agents|mesh-ancestor
153333277|NCT01138735|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153333278|NCT01138735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153333279|NCT01138735|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153333280|NCT01138735|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153333291|NCT01139515|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
153333292|NCT01139515|Serotonin Agents|serotonin agents|mesh-ancestor
153333293|NCT01139515|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153333294|NCT01139515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153333295|NCT01139515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153333296|NCT00980018|Nilotinib|nilotinib|mesh-list
153333297|NCT00980018|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153333298|NCT00980018|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153333299|NCT00980018|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153333300|NCT00980018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153333301|NCT00987272|Olopatadine Hydrochloride|olopatadine hydrochloride|mesh-list
153333302|NCT00987272|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
153783172|NCT00261261|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153333306|NCT00987272|Analgesics|analgesics|mesh-ancestor
153333307|NCT00987272|Sensory System Agents|sensory system agents|mesh-ancestor
153333308|NCT00987272|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153333309|NCT00987272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153333310|NCT00987272|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153333311|NCT00987272|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153333312|NCT00987272|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
153333313|NCT00987272|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
153333314|NCT00987272|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
153333315|NCT00987272|Histamine Antagonists|histamine antagonists|mesh-ancestor
153333316|NCT00987272|Histamine Agents|histamine agents|mesh-ancestor
153333317|NCT00987272|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153333318|NCT00987272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153333319|NCT00986882|Ibuprofen|ibuprofen|mesh-list
153333320|NCT00986882|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153333322|NCT00986882|Analgesics|analgesics|mesh-ancestor
153333331|NCT04395170|Immunoglobulins|immunoglobulins|mesh-list
153333332|NCT04395170|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
153333334|NCT04395170|Immunologic Factors|immunologic factors|mesh-ancestor
153333335|NCT04395170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153333336|NCT01927328|Iron isomaltoside 1000|iron isomaltoside 1000|mesh-list
153333337|NCT01927328|Hematinics|hematinics|mesh-ancestor
153333338|NCT04552808|Yimitasvir|yimitasvir|mesh-list
153333339|NCT04552808|Antiviral Agents|antiviral agents|mesh-ancestor
153333342|NCT01927406|Bimatoprost|bimatoprost|mesh-list
153333343|NCT01927406|Travoprost|travoprost|mesh-list
153333344|NCT01927406|Latanoprost|latanoprost|mesh-list
153333345|NCT01927406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153333347|NCT01927406|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
153333349|NCT01927406|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153333350|NCT01927406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153333351|NCT01927406|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153333352|NCT01927406|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153333353|NCT01927406|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
153333354|NCT01927406|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
153333355|NCT01182493|Insulin|insulin|mesh-list
153333356|NCT01182493|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153333357|NCT01182493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153333358|NCT01927484|Methotrexate|methotrexate|mesh-list
153333359|NCT01927484|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
153333360|NCT01927484|Abortifacient Agents|abortifacient agents|mesh-ancestor
153333361|NCT01927484|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153333362|NCT01927484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153885638|NCT04207632|Cholinergic Agents|cholinergic agents|mesh-ancestor
153333363|NCT01927484|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153333365|NCT01927484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153333366|NCT01927484|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153333367|NCT01927484|Dermatologic Agents|dermatologic agents|mesh-ancestor
153333368|NCT01927484|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153333369|NCT01927484|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153333372|NCT01927484|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153333373|NCT01927484|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153333374|NCT05607446|Montelukast|montelukast|mesh-list
153333375|NCT05607446|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153333376|NCT05607446|Respiratory System Agents|respiratory system agents|mesh-ancestor
153333377|NCT05607446|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
153333378|NCT05607446|Hormone Antagonists|hormone antagonists|mesh-ancestor
153333379|NCT05607446|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153882458|NCT01606059|Sensory System Agents|sensory system agents|mesh-ancestor
153882459|NCT01606059|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153882460|NCT01606059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153333380|NCT05607446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153333381|NCT05607446|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
153333382|NCT05607446|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
153333383|NCT05607446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153333385|NCT02185339|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
153333386|NCT02185339|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
153333387|NCT02185339|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
153333388|NCT02185339|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153333389|NCT02185339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153333390|NCT01928498|Paclitaxel|paclitaxel|mesh-list
153333391|NCT01928498|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153333392|NCT01928498|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153333393|NCT01928498|Tubulin Modulators|tubulin modulators|mesh-ancestor
153333420|NCT01219777|Bevacizumab|bevacizumab|mesh-list
153333421|NCT01219777|Carboplatin|carboplatin|mesh-list
153333423|NCT01219777|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153333424|NCT01219777|Tubulin Modulators|tubulin modulators|mesh-ancestor
153333425|NCT01219777|Antimitotic Agents|antimitotic agents|mesh-ancestor
153333426|NCT01219777|Mitosis Modulators|mitosis modulators|mesh-ancestor
153333427|NCT01219777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153333428|NCT01219777|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153333429|NCT01219777|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153333430|NCT01219777|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153333431|NCT01219777|Growth Substances|growth substances|mesh-ancestor
153333432|NCT01219777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153333433|NCT01219777|Growth Inhibitors|growth inhibitors|mesh-ancestor
153333434|NCT05603156|Inotuzumab Ozogamicin|inotuzumab ozogamicin|mesh-list
153333435|NCT05603156|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153333436|NCT05603156|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153333437|NCT05603156|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153333438|NCT05603156|Immunotoxins|immunotoxins|mesh-ancestor
153333439|NCT05603156|Immunoconjugates|immunoconjugates|mesh-ancestor
153333440|NCT05603156|Immunologic Factors|immunologic factors|mesh-ancestor
153333441|NCT05603156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153333442|NCT04759742|Ropivacaine|ropivacaine|mesh-list
153333443|NCT04759742|Anesthetics, Local|anesthetics, local|mesh-ancestor
153333444|NCT04759742|Anesthetics|anesthetics|mesh-ancestor
153333445|NCT04759742|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153333446|NCT04759742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153333447|NCT04759742|Sensory System Agents|sensory system agents|mesh-ancestor
153421119|NCT06287307|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
153880259|NCT02484248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153880260|NCT02484248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153333449|NCT01928888|Famotidine|famotidine|mesh-list
153333450|NCT01928888|Hydrotalcite|hydrotalcite|mesh-list
153333459|NCT01928888|Antacids|antacids|mesh-ancestor
153333468|NCT02569710|Protease Inhibitors|protease inhibitors|mesh-ancestor
153333469|NCT02569710|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153333470|NCT02569710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153333471|NCT04550624|Pembrolizumab|pembrolizumab|mesh-list
153333472|NCT04550624|Lenvatinib|lenvatinib|mesh-list
153333473|NCT04550624|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153333474|NCT04550624|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153333475|NCT04550624|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153333476|NCT04550624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153333477|NCT04550624|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153333478|NCT04550624|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153333479|NCT04550546|Nystatin|nystatin|mesh-list
153333480|NCT04550546|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153333481|NCT04550546|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153333482|NCT04550546|Antifungal Agents|antifungal agents|mesh-ancestor
153333483|NCT04550546|Ionophores|ionophores|mesh-ancestor
153333484|NCT04550546|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153333485|NCT04550546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153333486|NCT02984072|Menthol|menthol|mesh-list
153333487|NCT02984072|Antipruritics|antipruritics|mesh-ancestor
153333488|NCT02984072|Dermatologic Agents|dermatologic agents|mesh-ancestor
153333491|NCT05506410|Rituximab|rituximab|mesh-list
153333492|NCT05506410|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
153333493|NCT05506410|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153333494|NCT05506410|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153333495|NCT05506410|Immunologic Factors|immunologic factors|mesh-ancestor
153333496|NCT05506410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153333497|NCT05506410|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153333498|NCT05506410|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153333499|NCT05506410|Glucocorticoids|glucocorticoids|mesh-ancestor
153333500|NCT05506410|Hormones|hormones|mesh-ancestor
153333501|NCT05506410|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153333502|NCT05506410|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153333504|NCT05506410|Antimetabolites|antimetabolites|mesh-ancestor
153333505|NCT05506410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153333506|NCT05506410|Antiviral Agents|antiviral agents|mesh-ancestor
153333507|NCT05506410|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153333508|NCT05506410|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153333509|NCT05506410|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153333510|NCT05506410|Alkylating Agents|alkylating agents|mesh-ancestor
153333511|NCT05506332|Venetoclax|venetoclax|mesh-list
153333512|NCT05506332|Mercaptopurine|mercaptopurine|mesh-list
153333513|NCT05506332|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153333514|NCT05506332|Antimetabolites|antimetabolites|mesh-ancestor
153333516|NCT05506332|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153333517|NCT05506332|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153333518|NCT05506332|Immunologic Factors|immunologic factors|mesh-ancestor
153333521|NCT05506332|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153333562|NCT02569476|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153333563|NCT02569476|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153333564|NCT02569476|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153333565|NCT02569476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153333566|NCT00955253|Guanfacine|guanfacine|mesh-list
153333567|NCT00955253|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153333568|NCT00955253|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
153333569|NCT00955253|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153333570|NCT00955253|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153333571|NCT00955253|Adrenergic Agents|adrenergic agents|mesh-ancestor
153333572|NCT00955253|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153333573|NCT00955253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153333574|NCT00955253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153333576|NCT04394390|Ergocalciferols|ergocalciferols|mesh-list
153333577|NCT04394390|Cholecalciferol|cholecalciferol|mesh-list
153333578|NCT04394390|Vitamins|vitamins|mesh-list
153333579|NCT04394390|Micronutrients|micronutrients|mesh-ancestor
153333580|NCT04394390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153333581|NCT04394390|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153333582|NCT04394390|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153333585|NCT04120454|Ramucirumab|ramucirumab|mesh-list
153333587|NCT04120454|Immunoglobulins|immunoglobulins|mesh-list
153333588|NCT04120454|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
153333589|NCT04120454|Lexatumumab|lexatumumab|mesh-list
153333590|NCT04120454|Immunologic Factors|immunologic factors|mesh-ancestor
153333591|NCT04120454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153333592|NCT04120454|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153333593|NCT04120454|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153333594|NCT04120454|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153333603|NCT01017653|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153333604|NCT01017653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153333606|NCT01017653|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153333607|NCT00966641|Naproxen|naproxen|mesh-list
153333608|NCT00966641|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153333609|NCT00966641|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153333610|NCT00966641|Analgesics|analgesics|mesh-ancestor
153333611|NCT00966641|Sensory System Agents|sensory system agents|mesh-ancestor
153333612|NCT00966641|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153333614|NCT00966641|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153333615|NCT00966641|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153333616|NCT00966641|Gout Suppressants|gout suppressants|mesh-ancestor
153333617|NCT00966641|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153333618|NCT00966641|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153333619|NCT00966641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153333620|NCT00970073|Mycophenolic Acid|mycophenolic acid|mesh-list
153333621|NCT00970073|Tacrolimus|tacrolimus|mesh-list
153333622|NCT00970073|Thymoglobulin|thymoglobulin|mesh-list
153333623|NCT00970073|Antilymphocyte Serum|antilymphocyte serum|mesh-list
153333624|NCT00970073|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153333625|NCT00970073|Immunologic Factors|immunologic factors|mesh-ancestor
153333626|NCT00970073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153333627|NCT00970073|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
153333628|NCT00970073|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153333629|NCT00970073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153333630|NCT00970073|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153333631|NCT00970073|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153333632|NCT00970073|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
153333633|NCT00970073|Antitubercular Agents|antitubercular agents|mesh-ancestor
153333634|NCT00970073|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153333635|NCT00970073|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153333637|NCT00971633|Antiemetics|antiemetics|mesh-ancestor
153333641|NCT00971633|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153333642|NCT00971633|Antipruritics|antipruritics|mesh-ancestor
153333643|NCT00971633|Dermatologic Agents|dermatologic agents|mesh-ancestor
153333644|NCT00971633|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
153333646|NCT00971633|Serotonin Agents|serotonin agents|mesh-ancestor
153333647|NCT00971633|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153333648|NCT00971633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153333650|NCT00971789|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
153333653|NCT00971789|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153333654|NCT00971789|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153333655|NCT00971789|Antifungal Agents|antifungal agents|mesh-ancestor
153333656|NCT00971789|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153333657|NCT00971789|Immunologic Factors|immunologic factors|mesh-ancestor
153333658|NCT00971789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153333659|NCT00971789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153333660|NCT00971789|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
153333662|NCT05510778|Antidotes|antidotes|mesh-ancestor
153333663|NCT05510778|Protective Agents|protective agents|mesh-ancestor
153333664|NCT05510778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153333665|NCT00972335|Bevacizumab|bevacizumab|mesh-list
153333666|NCT00972335|Everolimus|everolimus|mesh-list
153333667|NCT00972335|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153333668|NCT00972335|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153333669|NCT00972335|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153333670|NCT00972335|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153333680|NCT03341156|Thrombin|thrombin|mesh-list
153333690|NCT04122560|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153333691|NCT04122560|Hormone Antagonists|hormone antagonists|mesh-ancestor
153333693|NCT04122560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153333694|NCT04122560|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
153333695|NCT04122560|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
153333696|NCT02569242|Paclitaxel|paclitaxel|mesh-list
153333697|NCT02569242|Docetaxel|docetaxel|mesh-list
153333698|NCT02569242|Nivolumab|nivolumab|mesh-list
153333699|NCT02569242|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153333700|NCT02569242|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153333701|NCT02569242|Tubulin Modulators|tubulin modulators|mesh-ancestor
153333702|NCT02569242|Antimitotic Agents|antimitotic agents|mesh-ancestor
153333703|NCT02569242|Mitosis Modulators|mitosis modulators|mesh-ancestor
153333704|NCT02569242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153333705|NCT02569242|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153333706|NCT02569242|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153333708|NCT05501340|Sargramostim|sargramostim|mesh-list
153333709|NCT05501340|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153333710|NCT05501340|Immunologic Factors|immunologic factors|mesh-ancestor
153333711|NCT05501340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153333712|NCT00972725|Chloroquine|chloroquine|mesh-list
153333713|NCT00972725|Amebicides|amebicides|mesh-ancestor
153333714|NCT00972725|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153333715|NCT00972725|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153333716|NCT00972725|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153333717|NCT00972725|Antimalarials|antimalarials|mesh-ancestor
153333718|NCT00972725|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153333719|NCT05600660|Rituximab|rituximab|mesh-list
153333720|NCT05600660|Methotrexate|methotrexate|mesh-list
153333721|NCT05600660|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153333722|NCT05600660|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153333726|NCT05600660|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
153333727|NCT05600660|Abortifacient Agents|abortifacient agents|mesh-ancestor
153333728|NCT05600660|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153333729|NCT05600660|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153333730|NCT05600660|Antimetabolites|antimetabolites|mesh-ancestor
153333731|NCT05600660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153333732|NCT05600660|Dermatologic Agents|dermatologic agents|mesh-ancestor
153333733|NCT05600660|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153333734|NCT05600660|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153333735|NCT05600660|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153333736|NCT05600660|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153333737|NCT00972959|Zoledronic Acid|zoledronic acid|mesh-list
153333738|NCT00972959|Dexamethasone|dexamethasone|mesh-list
153333739|NCT00972959|Bortezomib|bortezomib|mesh-list
153333740|NCT00972959|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153333741|NCT00972959|Antiemetics|antiemetics|mesh-ancestor
153333742|NCT00972959|Autonomic Agents|autonomic agents|mesh-ancestor
153333743|NCT00972959|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153333744|NCT00972959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153333745|NCT00972959|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153333746|NCT00972959|Glucocorticoids|glucocorticoids|mesh-ancestor
153333747|NCT00972959|Hormones|hormones|mesh-ancestor
153333748|NCT00972959|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153333749|NCT00972959|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153333750|NCT00972959|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153333751|NCT00972959|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153333752|NCT00973739|Lapatinib|lapatinib|mesh-list
153783174|NCT00235820|Adalimumab|adalimumab|mesh-list
153783175|NCT00235820|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
153333769|NCT00974051|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153333770|NCT00974051|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153333771|NCT00974051|Respiratory System Agents|respiratory system agents|mesh-ancestor
153333772|NCT00974051|Sympathomimetics|sympathomimetics|mesh-ancestor
153333773|NCT00974051|Tocolytic Agents|tocolytic agents|mesh-ancestor
153333774|NCT00974051|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153333775|NCT00974051|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
153333776|NCT00974051|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
153333777|NCT03017963|Sodium thiosulfate|sodium thiosulfate|mesh-list
153333778|NCT03017963|Antidotes|antidotes|mesh-ancestor
153333779|NCT03017963|Protective Agents|protective agents|mesh-ancestor
153333780|NCT03017963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153333781|NCT03017963|Antioxidants|antioxidants|mesh-ancestor
153333782|NCT03017963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153333783|NCT03017963|Antitubercular Agents|antitubercular agents|mesh-ancestor
153333831|NCT00979121|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
153333832|NCT00979121|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153333833|NCT00979121|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153333834|NCT00979121|Antimetabolites|antimetabolites|mesh-ancestor
153333835|NCT00979121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153333836|NCT00979121|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153333837|NCT00979121|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
153333838|NCT00979121|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153333840|NCT03828032|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
153421148|NCT06280313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153421149|NCT06280274|Metformin|metformin|mesh-list
153333841|NCT03828032|Diuretics|diuretics|mesh-ancestor
153333842|NCT03828032|Natriuretic Agents|natriuretic agents|mesh-ancestor
153333843|NCT03828032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153333844|NCT03827876|Calcitriol|calcitriol|mesh-list
153333845|NCT03827876|Betamethasone|betamethasone|mesh-list
153333846|NCT03827876|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
153333847|NCT03827876|Calcipotriene|calcipotriene|mesh-list
153333848|NCT03827876|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153333849|NCT03827876|Glucocorticoids|glucocorticoids|mesh-ancestor
153333850|NCT03827876|Hormones|hormones|mesh-ancestor
153333851|NCT03827876|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153333852|NCT03827876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153333853|NCT03827876|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153333854|NCT03827876|Respiratory System Agents|respiratory system agents|mesh-ancestor
153333855|NCT03827876|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153333856|NCT03827876|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
153333859|NCT03827876|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
153333880|NCT04129112|Anesthetics, General|anesthetics, general|mesh-ancestor
153333881|NCT01608893|Metoprolol|metoprolol|mesh-list
153333882|NCT01608893|Carvedilol|carvedilol|mesh-list
153333883|NCT01608893|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153333884|NCT01608893|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153333885|NCT01608893|Sympatholytics|sympatholytics|mesh-ancestor
153333886|NCT01608893|Autonomic Agents|autonomic agents|mesh-ancestor
153333887|NCT01608893|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153333888|NCT01608893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153333889|NCT01608893|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
153333890|NCT01608893|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
153333891|NCT01608893|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
153333892|NCT01608893|Adrenergic Agents|adrenergic agents|mesh-ancestor
153333893|NCT01608893|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153333894|NCT01608893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153333895|NCT01608893|Antioxidants|antioxidants|mesh-ancestor
153333896|NCT01608893|Protective Agents|protective agents|mesh-ancestor
153333897|NCT01608893|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153333898|NCT01608893|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153333899|NCT01608893|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153333900|NCT01608893|Vasodilator Agents|vasodilator agents|mesh-ancestor
153333901|NCT01608893|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
153333902|NCT01608893|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
153333903|NCT04128878|Sotalol|sotalol|mesh-list
153333904|NCT04128878|Dofetilide|dofetilide|mesh-list
153333905|NCT04128878|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
153333906|NCT04128878|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
153333907|NCT04128878|Adrenergic Agents|adrenergic agents|mesh-ancestor
153333908|NCT04128878|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153333909|NCT04128878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153333913|NCT04128878|Autonomic Agents|autonomic agents|mesh-ancestor
153333920|NCT00042341|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153333921|NCT00042341|Antimetabolites|antimetabolites|mesh-ancestor
153333922|NCT00042341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153333923|NCT00042341|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153880288|NCT02439450|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153880289|NCT02439450|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153880290|NCT02439450|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153880291|NCT02437136|Pembrolizumab|pembrolizumab|mesh-list
153880292|NCT02437136|Entinostat|entinostat|mesh-list
153333924|NCT00980681|Gadolinium 1,4,7,10-tetraazacyclododecane-N,N',N'',N'''-tetraacetate|gadolinium 1,4,7,10-tetraazacyclododecane-n,n',n'',n'''-tetraacetate|mesh-list
153333925|NCT00980681|Chelating Agents|chelating agents|mesh-ancestor
153333926|NCT00980681|Sequestering Agents|sequestering agents|mesh-ancestor
153333927|NCT00980681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153333928|NCT04759196|Topiramate|topiramate|mesh-list
153333929|NCT04759196|Levetiracetam|levetiracetam|mesh-list
153333930|NCT04759196|Anticonvulsants|anticonvulsants|mesh-ancestor
153333931|NCT04759196|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153333932|NCT04759196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153333933|NCT04759196|Nootropic Agents|nootropic agents|mesh-ancestor
153333934|NCT04128254|Apixaban|apixaban|mesh-list
153333935|NCT04128254|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
153333936|NCT04128254|Antithrombins|antithrombins|mesh-ancestor
153333937|NCT04128254|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
153333938|NCT04128254|Protease Inhibitors|protease inhibitors|mesh-ancestor
153333939|NCT04128254|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153333940|NCT04128254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153377759|NCT03936218|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153333941|NCT04128254|Anticoagulants|anticoagulants|mesh-ancestor
153333942|NCT04128020|Nivolumab|nivolumab|mesh-list
153882461|NCT01606059|Antipyretics|antipyretics|mesh-ancestor
153333943|NCT04128020|Azacitidine|azacitidine|mesh-list
153333944|NCT04128020|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153333948|NCT04128020|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153333949|NCT04128020|Antimetabolites|antimetabolites|mesh-ancestor
153333950|NCT04128020|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153333951|NCT03827642|Naloxone|naloxone|mesh-list
153333952|NCT03827642|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
153333953|NCT03827642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153333954|NCT03827642|Sensory System Agents|sensory system agents|mesh-ancestor
153333955|NCT03827642|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153333956|NCT05510310|Oxytocin|oxytocin|mesh-list
153333957|NCT05510310|Oxytocics|oxytocics|mesh-ancestor
153333958|NCT05510310|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153333959|NCT05510310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153333960|NCT00981227|Eslicarbazepine acetate|eslicarbazepine acetate|mesh-list
153333961|NCT00981227|Anticonvulsants|anticonvulsants|mesh-ancestor
153333962|NCT00981227|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
153426884|NCT00000974|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153426885|NCT00000974|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153426886|NCT00000974|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
153426888|NCT00000242|Anticonvulsants|anticonvulsants|mesh-ancestor
153333966|NCT01022567|Ertapenem|ertapenem|mesh-list
153333967|NCT01022567|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153333968|NCT01022567|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153333969|NCT04411524|Capecitabine|capecitabine|mesh-list
153333970|NCT04411524|Irinotecan|irinotecan|mesh-list
153333971|NCT04411524|Antibodies|antibodies|mesh-list
153333972|NCT04411524|Immunologic Factors|immunologic factors|mesh-ancestor
153333973|NCT04411524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153333974|NCT04411524|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153333975|NCT04411524|Antimetabolites|antimetabolites|mesh-ancestor
153333976|NCT04411524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153333977|NCT04411524|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153333978|NCT04411524|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
153333979|NCT04411524|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153333980|NCT04411524|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153333981|NCT04127396|Sorafenib|sorafenib|mesh-list
153333982|NCT04127396|Lenvatinib|lenvatinib|mesh-list
153333983|NCT04127396|Chlorotrianisene|chlorotrianisene|mesh-list
153333984|NCT04127396|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153333985|NCT04127396|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153333986|NCT04127396|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153333987|NCT04127396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153333988|NCT04127396|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
153333999|NCT04120064|Micronutrients|micronutrients|mesh-ancestor
153334000|NCT04120064|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153334001|NCT00982007|Ferric Compounds|ferric compounds|mesh-list
153334002|NCT00982007|Hematinics|hematinics|mesh-ancestor
153334003|NCT04814940|Menotropins|menotropins|mesh-list
153334004|NCT04814940|Fertility Agents, Female|fertility agents, female|mesh-ancestor
153334005|NCT04814940|Fertility Agents|fertility agents|mesh-ancestor
153334006|NCT04814940|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153334007|NCT04814940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153334008|NCT05042934|Irinotecan|irinotecan|mesh-list
153334009|NCT05042934|Camptothecin|camptothecin|mesh-list
153334010|NCT05042934|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
153334011|NCT05042934|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153334012|NCT05042934|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153334013|NCT05042934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153334014|NCT05042934|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153334015|NCT05042934|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153334016|NCT05505006|Folic Acid|folic acid|mesh-list
153334017|NCT05505006|Vitamin B 12|vitamin b 12|mesh-list
153334018|NCT05505006|Hematinics|hematinics|mesh-ancestor
153334019|NCT05505006|Vitamin B Complex|vitamin b complex|mesh-ancestor
153334020|NCT05505006|Vitamins|vitamins|mesh-ancestor
153334021|NCT05505006|Micronutrients|micronutrients|mesh-ancestor
153334023|NCT03826706|Pyrithione zinc|pyrithione zinc|mesh-list
153334024|NCT03826706|Keratolytic Agents|keratolytic agents|mesh-ancestor
153334025|NCT03826706|Dermatologic Agents|dermatologic agents|mesh-ancestor
153334027|NCT02979548|Aprepitant|aprepitant|mesh-list
153334028|NCT02979548|Metoclopramide|metoclopramide|mesh-list
153334029|NCT02979548|Antiemetics|antiemetics|mesh-ancestor
153334030|NCT02979548|Autonomic Agents|autonomic agents|mesh-ancestor
153334031|NCT02979548|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153334048|NCT03826316|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153334049|NCT03826316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153334050|NCT03826316|Analgesics|analgesics|mesh-ancestor
153334051|NCT03826316|Sensory System Agents|sensory system agents|mesh-ancestor
153334052|NCT03826316|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153334053|NCT04393610|Lidocaine|lidocaine|mesh-list
153334054|NCT04393610|Magnesium Sulfate|magnesium sulfate|mesh-list
153783176|NCT00235820|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153334055|NCT04393610|Fentanyl|fentanyl|mesh-list
153334056|NCT04393610|Anesthetics, Local|anesthetics, local|mesh-ancestor
153334058|NCT04393610|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153334059|NCT04393610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153334060|NCT04393610|Sensory System Agents|sensory system agents|mesh-ancestor
153334061|NCT04393610|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153334062|NCT04393610|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153334063|NCT04393610|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
153334064|NCT04393610|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153334065|NCT04393610|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153334066|NCT04393610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153334067|NCT04393610|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153334069|NCT04393610|Analgesics|analgesics|mesh-ancestor
153334070|NCT04393610|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153334071|NCT04393610|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153334072|NCT04393610|Anesthetics, General|anesthetics, general|mesh-ancestor
153334073|NCT04393610|Anticonvulsants|anticonvulsants|mesh-ancestor
153334074|NCT04393610|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153334075|NCT04393610|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153334076|NCT04393610|Tocolytic Agents|tocolytic agents|mesh-ancestor
153334077|NCT04393610|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153334078|NCT03820466|Aspirin|aspirin|mesh-list
153334079|NCT03820466|Atorvastatin|atorvastatin|mesh-list
153334080|NCT03820466|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153334081|NCT03820466|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153334082|NCT03820466|Analgesics|analgesics|mesh-ancestor
153334083|NCT03820466|Sensory System Agents|sensory system agents|mesh-ancestor
153334084|NCT03820466|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153334085|NCT03820466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153334086|NCT03820466|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153334087|NCT03820466|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153334088|NCT03820466|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153334089|NCT03820466|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153334090|NCT03820466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153427032|NCT03907033|Anesthetics|anesthetics|mesh-ancestor
153427033|NCT03907033|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153427034|NCT03907033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153427035|NCT03907033|Sensory System Agents|sensory system agents|mesh-ancestor
153427036|NCT03907033|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153427037|NCT00001034|Ganciclovir|ganciclovir|mesh-list
153427038|NCT00001034|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
153334104|NCT03826004|Histamine Antagonists|histamine antagonists|mesh-ancestor
153334105|NCT03826004|Histamine Agents|histamine agents|mesh-ancestor
153334106|NCT03826004|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153334107|NCT03826004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153334108|NCT03826004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153334109|NCT03826004|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
153334110|NCT02338076|Petrolatum|petrolatum|mesh-list
153334111|NCT02338076|Emollients|emollients|mesh-ancestor
153334112|NCT02338076|Dermatologic Agents|dermatologic agents|mesh-ancestor
153334113|NCT02978534|Quetiapine Fumarate|quetiapine fumarate|mesh-list
153334128|NCT01222195|Immunologic Factors|immunologic factors|mesh-ancestor
153334129|NCT01222195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153334130|NCT01222195|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153334131|NCT01222195|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153334132|NCT01222195|Growth Substances|growth substances|mesh-ancestor
153334134|NCT01222195|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153334135|NCT01222195|Hematinics|hematinics|mesh-ancestor
153334137|NCT01222273|Cholecalciferol|cholecalciferol|mesh-list
153334138|NCT01222273|Vitamins|vitamins|mesh-ancestor
153334139|NCT01222273|Micronutrients|micronutrients|mesh-ancestor
153334140|NCT01222273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153334141|NCT01222273|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153334142|NCT01222273|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153334143|NCT03161912|Aflibercept|aflibercept|mesh-list
153334144|NCT03161912|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153334145|NCT03161912|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153334146|NCT03161912|Growth Substances|growth substances|mesh-ancestor
153334147|NCT03161912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153421155|NCT06275035|Dopamine Agents|dopamine agents|mesh-ancestor
153421156|NCT06275035|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153421157|NCT06275035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153421158|NCT06275035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153421159|NCT06275035|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
153421160|NCT06275035|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
153334148|NCT03161912|Growth Inhibitors|growth inhibitors|mesh-ancestor
153334149|NCT03161912|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153334150|NCT01222585|Metronidazole|metronidazole|mesh-list
153334151|NCT01222585|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153334177|NCT01142947|Respiratory System Agents|respiratory system agents|mesh-ancestor
153334179|NCT02972294|Tranexamic Acid|tranexamic acid|mesh-list
153334180|NCT02972294|Iron isomaltoside 1000|iron isomaltoside 1000|mesh-list
153334181|NCT02972294|Ferric Compounds|ferric compounds|mesh-list
153334182|NCT02972294|Trace Elements|trace elements|mesh-ancestor
153334183|NCT02972294|Micronutrients|micronutrients|mesh-ancestor
153334184|NCT02972294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153334185|NCT02972294|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
153334186|NCT02972294|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153334187|NCT02972294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153334188|NCT02972294|Hemostatics|hemostatics|mesh-ancestor
153334189|NCT02972294|Coagulants|coagulants|mesh-ancestor
153334190|NCT02972294|Hematinics|hematinics|mesh-ancestor
153334191|NCT02983214|Cilostazol|cilostazol|mesh-list
153334192|NCT02983214|Clopidogrel|clopidogrel|mesh-list
153334193|NCT02983214|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153334194|NCT02983214|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
153334195|NCT02983214|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
153334196|NCT02983214|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
153334197|NCT02983214|Purinergic Agents|purinergic agents|mesh-ancestor
153334198|NCT02983214|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153334199|NCT02983214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153334200|NCT02983214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153334201|NCT02983214|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153334202|NCT02983214|Autonomic Agents|autonomic agents|mesh-ancestor
153334203|NCT02983214|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153334204|NCT02983214|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153334205|NCT02983214|Respiratory System Agents|respiratory system agents|mesh-ancestor
153334206|NCT02983214|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153334221|NCT03824834|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153334222|NCT03824834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153334223|NCT03824834|Analgesics|analgesics|mesh-ancestor
153334224|NCT03824834|Sensory System Agents|sensory system agents|mesh-ancestor
153334225|NCT03824834|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153334226|NCT03829124|Ketamine|ketamine|mesh-list
153334227|NCT03829124|Propofol|propofol|mesh-list
153334228|NCT03829124|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153334229|NCT03829124|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153334230|NCT03829124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153334231|NCT03829124|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153334232|NCT03829124|Anesthetics, General|anesthetics, general|mesh-ancestor
153334233|NCT03829124|Anesthetics|anesthetics|mesh-ancestor
153334234|NCT03829124|Analgesics|analgesics|mesh-ancestor
153334235|NCT03829124|Sensory System Agents|sensory system agents|mesh-ancestor
153334236|NCT03829124|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153334237|NCT03829124|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
153334238|NCT03829124|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
153334239|NCT03829124|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
153334240|NCT03829124|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153334241|NCT03829124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153334242|NCT02965976|Botulinum Toxins|botulinum toxins|mesh-list
153334243|NCT02965976|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
153334245|NCT02965976|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
153334246|NCT02965976|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
153334247|NCT02965976|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153334248|NCT02965976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153334249|NCT02965976|Cholinergic Agents|cholinergic agents|mesh-ancestor
153334250|NCT02965976|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153334251|NCT02965976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153334252|NCT02965976|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
153334253|NCT02965976|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153334254|NCT04393220|Bevacizumab|bevacizumab|mesh-list
153334256|NCT04393220|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153334257|NCT04393220|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153334259|NCT04393220|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153334260|NCT04393220|Growth Substances|growth substances|mesh-ancestor
153334261|NCT04393220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153334262|NCT04393220|Growth Inhibitors|growth inhibitors|mesh-ancestor
153334263|NCT04393220|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153334264|NCT04393220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153334265|NCT01025453|Sirolimus|sirolimus|mesh-list
153334266|NCT01025453|Sorafenib|sorafenib|mesh-list
153334267|NCT01025453|Temsirolimus|temsirolimus|mesh-list
153334268|NCT01025453|MTOR Inhibitors|mtor inhibitors|mesh-list
153334269|NCT01025453|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153334270|NCT01025453|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153334271|NCT01025453|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153334272|NCT01025453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153334273|NCT01025453|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153334274|NCT01025453|Immunologic Factors|immunologic factors|mesh-ancestor
153334275|NCT01025453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153334276|NCT01025453|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153334277|NCT01025453|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153334278|NCT01025453|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153334279|NCT01025453|Antifungal Agents|antifungal agents|mesh-ancestor
153334280|NCT05394233|Bevacizumab|bevacizumab|mesh-list
153334281|NCT05394233|Tislelizumab|tislelizumab|mesh-list
153334282|NCT05394233|Pemetrexed|pemetrexed|mesh-list
153334283|NCT05394233|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153334284|NCT05394233|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153334285|NCT05394233|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153334286|NCT05394233|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153334287|NCT05394233|Growth Substances|growth substances|mesh-ancestor
153334288|NCT05394233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153334289|NCT05394233|Growth Inhibitors|growth inhibitors|mesh-ancestor
153334290|NCT05394233|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153334292|NCT05394233|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153334300|NCT00982553|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153334301|NCT00982553|Antiviral Agents|antiviral agents|mesh-ancestor
153334302|NCT00982553|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153334303|NCT00982553|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153334304|NCT00982553|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153377760|NCT03936218|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153377762|NCT03935451|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
153377763|NCT03935451|Antithrombins|antithrombins|mesh-ancestor
153377768|NCT03935451|Anticoagulants|anticoagulants|mesh-ancestor
153334305|NCT00982553|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
153334306|NCT00982553|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
153334307|NCT00982553|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153334308|NCT02939300|Nivolumab|nivolumab|mesh-list
153334309|NCT02939300|Ipilimumab|ipilimumab|mesh-list
153334310|NCT02939300|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153334311|NCT02939300|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153334312|NCT02939300|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153334313|NCT02939300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153334314|NCT04392128|Azithromycin|azithromycin|mesh-list
153334315|NCT04392128|Hydroxychloroquine|hydroxychloroquine|mesh-list
153334316|NCT04392128|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153334317|NCT04392128|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153334318|NCT04392128|Antimalarials|antimalarials|mesh-ancestor
153334319|NCT04392128|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153334320|NCT04392128|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153334321|NCT04392128|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153334322|NCT04392128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153334324|NCT02565186|Lasmiditan|lasmiditan|mesh-list
153334325|NCT02565186|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
153334326|NCT02565186|Serotonin Agents|serotonin agents|mesh-ancestor
153334327|NCT02565186|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153334328|NCT02565186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153334329|NCT02565186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153334330|NCT04274816|Tremelimumab|tremelimumab|mesh-list
153334331|NCT04274816|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153334342|NCT05509374|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153334343|NCT05509374|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153334344|NCT05509374|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153334345|NCT05509374|Immunologic Factors|immunologic factors|mesh-ancestor
153334346|NCT05509374|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153334347|NCT05509374|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153334348|NCT05509374|Growth Substances|growth substances|mesh-ancestor
153334349|NCT05509374|Growth Inhibitors|growth inhibitors|mesh-ancestor
153334350|NCT04124822|Prednisolone|prednisolone|mesh-list
153334351|NCT04124822|Piroxicam|piroxicam|mesh-list
153334352|NCT04124822|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153334353|NCT04124822|Glucocorticoids|glucocorticoids|mesh-ancestor
153334354|NCT04124822|Hormones|hormones|mesh-ancestor
153334355|NCT04124822|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153334358|NCT04124822|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153334359|NCT04124822|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153334360|NCT04124822|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153334361|NCT04124822|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153334362|NCT04124822|Analgesics|analgesics|mesh-ancestor
153334363|NCT04124822|Sensory System Agents|sensory system agents|mesh-ancestor
153334364|NCT04124822|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153334365|NCT04124822|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153334366|NCT04124822|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153334367|NCT04124822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153334368|NCT05504694|Ofatumumab|ofatumumab|mesh-list
153334369|NCT05504694|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153334370|NCT02854670|Capsaicin|capsaicin|mesh-list
153334384|NCT02565108|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
153334385|NCT02565108|GABA Agonists|gaba agonists|mesh-ancestor
153334386|NCT02565108|GABA Agents|gaba agents|mesh-ancestor
153334387|NCT02565108|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153334388|NCT02565108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153334389|NCT03821168|Bevacizumab|bevacizumab|mesh-list
153334390|NCT03821168|Epoetin Alfa|epoetin alfa|mesh-list
153334391|NCT03821168|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153334392|NCT03821168|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153334393|NCT03821168|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153334394|NCT03821168|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153334395|NCT03821168|Growth Substances|growth substances|mesh-ancestor
153334396|NCT03821168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153334398|NCT03821168|Hematinics|hematinics|mesh-ancestor
153334399|NCT01454180|Leucovorin|leucovorin|mesh-list
153334400|NCT01454180|Gemcitabine|gemcitabine|mesh-list
153334401|NCT01454180|Capecitabine|capecitabine|mesh-list
153334403|NCT01454180|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
153334404|NCT01454180|Oxaliplatin|oxaliplatin|mesh-list
153334405|NCT01454180|Folfirinox|folfirinox|mesh-list
153334406|NCT01454180|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153334407|NCT01454180|Antimetabolites|antimetabolites|mesh-ancestor
153334408|NCT01454180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153334409|NCT01454180|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153334410|NCT01454180|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153334411|NCT01454180|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153334412|NCT01454180|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153334413|NCT01454180|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153334414|NCT01454180|Immunologic Factors|immunologic factors|mesh-ancestor
153334415|NCT01454180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153334416|NCT01454180|Antidotes|antidotes|mesh-ancestor
153334417|NCT01454180|Protective Agents|protective agents|mesh-ancestor
153334418|NCT01454180|Vitamin B Complex|vitamin b complex|mesh-ancestor
153334419|NCT01454180|Vitamins|vitamins|mesh-ancestor
153334420|NCT01454180|Micronutrients|micronutrients|mesh-ancestor
153334430|NCT02564952|GABA Agonists|gaba agonists|mesh-ancestor
153334431|NCT02564952|GABA Agents|gaba agents|mesh-ancestor
153334432|NCT02564952|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153783181|NCT00268710|Antimitotic Agents|antimitotic agents|mesh-ancestor
153334433|NCT02564952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153334434|NCT05564286|Dexamethasone|dexamethasone|mesh-list
153334435|NCT05564286|Fosaprepitant|fosaprepitant|mesh-list
153334436|NCT05564286|Aprepitant|aprepitant|mesh-list
153334437|NCT05564286|Tropisetron|tropisetron|mesh-list
153334438|NCT05564286|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153334439|NCT05564286|Antiemetics|antiemetics|mesh-ancestor
153334440|NCT05564286|Autonomic Agents|autonomic agents|mesh-ancestor
153334441|NCT05564286|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153334442|NCT05564286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153334443|NCT05564286|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153334444|NCT05564286|Glucocorticoids|glucocorticoids|mesh-ancestor
153334445|NCT05564286|Hormones|hormones|mesh-ancestor
153334446|NCT05564286|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153334447|NCT05564286|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153334448|NCT05564286|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153334449|NCT05564286|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
153334450|NCT05564286|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153334451|NCT05564286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153334452|NCT05564286|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
153334453|NCT05564286|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153334454|NCT05564286|Serotonin Agents|serotonin agents|mesh-ancestor
153334455|NCT01454804|Trastuzumab|trastuzumab|mesh-list
153334456|NCT01454804|Lapatinib|lapatinib|mesh-list
153334458|NCT01454804|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153334459|NCT01454804|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153334460|NCT01454804|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153334461|NCT01454804|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153334466|NCT03820622|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153334467|NCT03820622|Tubulin Modulators|tubulin modulators|mesh-ancestor
153334468|NCT03820622|Antimitotic Agents|antimitotic agents|mesh-ancestor
153334469|NCT03820622|Mitosis Modulators|mitosis modulators|mesh-ancestor
153334470|NCT03820622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153334472|NCT05504382|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153334475|NCT05504382|Sensory System Agents|sensory system agents|mesh-ancestor
153334476|NCT05504382|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153334477|NCT05504382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153334478|NCT05504382|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153334480|NCT05504382|Gout Suppressants|gout suppressants|mesh-ancestor
153334481|NCT05504382|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153334482|NCT05504382|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153334483|NCT05504382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153334484|NCT03823040|Oxiconazole|oxiconazole|mesh-list
153334485|NCT03823040|Antifungal Agents|antifungal agents|mesh-ancestor
153334486|NCT03823040|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153334487|NCT02566902|Albuterol|albuterol|mesh-list
153880316|NCT02312258|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153880317|NCT02312258|Protease Inhibitors|protease inhibitors|mesh-ancestor
153880318|NCT02312258|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153880319|NCT02312258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153880321|NCT02276274|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153334488|NCT02566902|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153334489|NCT02566902|Autonomic Agents|autonomic agents|mesh-ancestor
153334490|NCT02566902|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153334491|NCT02566902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153334492|NCT02566902|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153334493|NCT02566902|Respiratory System Agents|respiratory system agents|mesh-ancestor
153334494|NCT02566902|Tocolytic Agents|tocolytic agents|mesh-ancestor
153334495|NCT02566902|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153334511|NCT05508516|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153334512|NCT05508516|Antidepressive Agents|antidepressive agents|mesh-ancestor
153783182|NCT00268710|Mitosis Modulators|mitosis modulators|mesh-ancestor
153334513|NCT05508516|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153334514|NCT05508516|Dopamine Agents|dopamine agents|mesh-ancestor
153334515|NCT01455506|Fludarabine|fludarabine|mesh-list
153334516|NCT01455506|Busulfan|busulfan|mesh-list
153334517|NCT01455506|Decitabine|decitabine|mesh-list
153334518|NCT01455506|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153334519|NCT01455506|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153334520|NCT01455506|Antimetabolites|antimetabolites|mesh-ancestor
153334521|NCT01455506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153334522|NCT01455506|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153334523|NCT01455506|Immunologic Factors|immunologic factors|mesh-ancestor
153334524|NCT01455506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153334525|NCT01455506|Alkylating Agents|alkylating agents|mesh-ancestor
153334526|NCT01455506|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153334527|NCT01455506|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153334528|NCT01455506|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153334529|NCT02564796|Iron|iron|mesh-list
153334530|NCT02564796|Epoetin Alfa|epoetin alfa|mesh-list
153334531|NCT02564796|Trace Elements|trace elements|mesh-ancestor
153334532|NCT02564796|Micronutrients|micronutrients|mesh-ancestor
153334533|NCT02564796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153334534|NCT02564796|Hematinics|hematinics|mesh-ancestor
153334539|NCT05563350|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153334540|NCT05563350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153334541|NCT05563350|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153334542|NCT05563350|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153334543|NCT05563350|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153334544|NCT05563350|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153334545|NCT05563350|Anesthetics, General|anesthetics, general|mesh-ancestor
153334546|NCT05563350|Anesthetics|anesthetics|mesh-ancestor
153334552|NCT05563350|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153334553|NCT05563350|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
153334554|NCT05563350|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153334555|NCT04273100|Lenvatinib|lenvatinib|mesh-list
153334556|NCT04273100|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153334557|NCT04273100|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153334558|NCT04273100|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153334559|NCT04273100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153334560|NCT02564718|Rivaroxaban|rivaroxaban|mesh-list
153334561|NCT02564718|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
153334562|NCT02564718|Antithrombins|antithrombins|mesh-ancestor
153334563|NCT02564718|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
153334594|NCT05560542|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153334595|NCT05560542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153334596|NCT05560542|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153334598|NCT05560542|Hormones|hormones|mesh-ancestor
153334600|NCT05560542|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153334601|NCT05560542|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153334602|NCT05560542|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153334603|NCT05560542|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153334604|NCT05560542|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153334605|NCT05560542|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153334606|NCT05560542|Respiratory System Agents|respiratory system agents|mesh-ancestor
153334607|NCT05560542|Mydriatics|mydriatics|mesh-ancestor
153334608|NCT05560542|Parasympatholytics|parasympatholytics|mesh-ancestor
153334609|NCT05560542|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
153334610|NCT05560542|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
153334614|NCT01455974|Dialysis Solutions|dialysis solutions|mesh-list
153334654|NCT03780010|Paclitaxel|paclitaxel|mesh-list
153334655|NCT03780010|Carboplatin|carboplatin|mesh-list
153334656|NCT03780010|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153334657|NCT03780010|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153334658|NCT03780010|Tubulin Modulators|tubulin modulators|mesh-ancestor
153334659|NCT03780010|Antimitotic Agents|antimitotic agents|mesh-ancestor
153334660|NCT03780010|Mitosis Modulators|mitosis modulators|mesh-ancestor
153334663|NCT03826550|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153334664|NCT03826550|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153334665|NCT03826550|Analgesics|analgesics|mesh-ancestor
153334666|NCT03826550|Sensory System Agents|sensory system agents|mesh-ancestor
153334667|NCT03826550|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153334668|NCT03826550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153334669|NCT03826550|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153334671|NCT03826550|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153334672|NCT03826550|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153427244|NCT00380276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153427245|NCT00380354|6-((3-((dimethylamino)carbonyl)phenyl)sulfonyl)-8-methyl-4-((3-methyloxyphenyl)amino)-3-quinolinecarboxamide|6-((3-((dimethylamino)carbonyl)phenyl)sulfonyl)-8-methyl-4-((3-methyloxyphenyl)amino)-3-quinolinecarboxamide|mesh-list
153334674|NCT05325762|Dexmedetomidine|dexmedetomidine|mesh-list
153334675|NCT05325762|Propofol|propofol|mesh-list
153334676|NCT05325762|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153334677|NCT05325762|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153334678|NCT05325762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153334679|NCT05325762|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153334680|NCT05325762|Analgesics|analgesics|mesh-ancestor
153334681|NCT05325762|Sensory System Agents|sensory system agents|mesh-ancestor
153334682|NCT05325762|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153334683|NCT05325762|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
153334684|NCT05325762|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153334685|NCT05325762|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153334686|NCT05325762|Adrenergic Agents|adrenergic agents|mesh-ancestor
153334687|NCT05325762|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153334696|NCT04391582|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153334699|NCT04391582|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
153334700|NCT05498064|Ensartinib|ensartinib|mesh-list
153334701|NCT05498064|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153880332|NCT02199184|Cyclophosphamide|cyclophosphamide|mesh-list
153880333|NCT02199184|Rituximab|rituximab|mesh-list
153880334|NCT02199184|Doxorubicin|doxorubicin|mesh-list
153880335|NCT02199184|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
153421180|NCT06263491|Pirtobrutinib|pirtobrutinib|mesh-list
153421181|NCT06263491|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153421182|NCT06263491|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153421183|NCT06263491|Immunologic Factors|immunologic factors|mesh-ancestor
153334702|NCT05498064|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153334703|NCT05498064|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153334704|NCT05498064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153334706|NCT03767062|Anticonvulsants|anticonvulsants|mesh-ancestor
153334707|NCT03767062|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153334708|NCT03767062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153334709|NCT01456364|Ticagrelor|ticagrelor|mesh-list
153334710|NCT01456364|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
153334711|NCT01456364|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153334712|NCT01456364|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
153334713|NCT01456364|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
153334714|NCT01456364|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
153334715|NCT01456364|Purinergic Agents|purinergic agents|mesh-ancestor
153334716|NCT01456364|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153334717|NCT01456364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153334718|NCT01456364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153334720|NCT04281420|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153334721|NCT04281420|Antimetabolites|antimetabolites|mesh-ancestor
153334722|NCT04281420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153334723|NCT04281420|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153334724|NCT04281420|Vasodilator Agents|vasodilator agents|mesh-ancestor
153334725|NCT04281420|Vitamin B Complex|vitamin b complex|mesh-ancestor
153334726|NCT04281420|Vitamins|vitamins|mesh-ancestor
153334727|NCT04281420|Micronutrients|micronutrients|mesh-ancestor
153334728|NCT04281420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153334729|NCT03765502|Glucagon|glucagon|mesh-list
153334730|NCT03765502|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
153334731|NCT03765502|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153334732|NCT03765502|Hormones|hormones|mesh-ancestor
153334734|NCT03765502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153334735|NCT03765502|Incretins|incretins|mesh-ancestor
153334736|NCT05285124|Melatonin|melatonin|mesh-list
153334737|NCT05285124|Antioxidants|antioxidants|mesh-ancestor
153334738|NCT05285124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153334739|NCT05285124|Protective Agents|protective agents|mesh-ancestor
153334740|NCT05285124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153334741|NCT05285124|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153334742|NCT01450046|Vitamin E|vitamin e|mesh-list
153334743|NCT01450046|Tocopherols|tocopherols|mesh-list
153334744|NCT01450046|Tocotrienols|tocotrienols|mesh-list
153334745|NCT01450046|Vitamins|vitamins|mesh-ancestor
153334746|NCT01450046|Micronutrients|micronutrients|mesh-ancestor
153334747|NCT01450046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153334748|NCT01450046|Antioxidants|antioxidants|mesh-ancestor
153334749|NCT01450046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153334750|NCT01450046|Protective Agents|protective agents|mesh-ancestor
153334751|NCT01450124|Boswellic acid|boswellic acid|mesh-list
153334752|NCT01450124|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153334753|NCT01450124|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153334754|NCT01450124|Analgesics|analgesics|mesh-ancestor
153334755|NCT01450124|Sensory System Agents|sensory system agents|mesh-ancestor
153334756|NCT01450124|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153334761|NCT03751124|Norethindrone Acetate|norethindrone acetate|mesh-list
153334762|NCT03751124|Estradiol|estradiol|mesh-list
153334763|NCT03751124|Relugolix|relugolix|mesh-list
153334764|NCT03751124|Estrogens|estrogens|mesh-ancestor
153334765|NCT03751124|Hormones|hormones|mesh-ancestor
153334766|NCT03751124|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153334767|NCT03751124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153334768|NCT03751124|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
153334769|NCT03751124|Contraceptive Agents|contraceptive agents|mesh-ancestor
153334770|NCT03751124|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153334771|NCT03751124|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
153334772|NCT03751124|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
153334774|NCT03751124|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
153334775|NCT03751124|Androgen Antagonists|androgen antagonists|mesh-ancestor
153334776|NCT03751124|Hormone Antagonists|hormone antagonists|mesh-ancestor
153334778|NCT02563548|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153334779|NCT02563548|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153334780|NCT02563548|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153334781|NCT02563548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153334783|NCT01450358|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153334784|NCT04081324|Lasmiditan|lasmiditan|mesh-list
153334785|NCT04081324|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
153334786|NCT04081324|Serotonin Agents|serotonin agents|mesh-ancestor
153334787|NCT04081324|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153334788|NCT04081324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153334789|NCT04081324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153334790|NCT01456676|Nilotinib|nilotinib|mesh-list
153334791|NCT01456676|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153334792|NCT01456676|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153334793|NCT01456676|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153334794|NCT01456676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153334795|NCT04042324|Heparin|heparin|mesh-list
153334796|NCT04042324|Calcium heparin|calcium heparin|mesh-list
153334823|NCT04066426|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153334825|NCT04066426|Autonomic Agents|autonomic agents|mesh-ancestor
153334826|NCT04066426|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153334827|NCT04066426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153334828|NCT04066426|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153334829|NCT04066426|Glucocorticoids|glucocorticoids|mesh-ancestor
153334830|NCT04066426|Hormones|hormones|mesh-ancestor
153334831|NCT04066426|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153334832|NCT04066426|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153334833|NCT04066426|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153334834|NCT04066426|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153334835|NCT04066426|Analgesics|analgesics|mesh-ancestor
153334836|NCT04066426|Sensory System Agents|sensory system agents|mesh-ancestor
153334837|NCT04066426|Antipyretics|antipyretics|mesh-ancestor
153334838|NCT04066426|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153334839|NCT04066426|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153334840|NCT04066426|Gout Suppressants|gout suppressants|mesh-ancestor
153334842|NCT04066426|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153334843|NCT04066426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153334844|NCT04066426|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153334845|NCT04066426|Narcotics|narcotics|mesh-ancestor
153334846|NCT04066426|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153334848|NCT04066426|Respiratory System Agents|respiratory system agents|mesh-ancestor
153334872|NCT04758728|Mydriatics|mydriatics|mesh-ancestor
153334873|NCT04758728|Sympathomimetics|sympathomimetics|mesh-ancestor
153334874|NCT04758728|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
153334875|NCT02559570|Linaclotide|linaclotide|mesh-list
153334876|NCT02559570|Guanylyl Cyclase C Agonists|guanylyl cyclase c agonists|mesh-ancestor
153334877|NCT02559570|Enzyme Activators|enzyme activators|mesh-ancestor
153334878|NCT02559570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153334879|NCT02559570|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153334880|NCT04051684|Ropivacaine|ropivacaine|mesh-list
153334881|NCT04051684|Anesthetics, Local|anesthetics, local|mesh-ancestor
153334882|NCT04051684|Anesthetics|anesthetics|mesh-ancestor
153334883|NCT04051684|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153334884|NCT04051684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153334885|NCT04051684|Sensory System Agents|sensory system agents|mesh-ancestor
153334888|NCT04840238|Vitamin D|vitamin d|mesh-list
153334889|NCT04840238|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153334890|NCT04840238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153334891|NCT04840238|Vitamins|vitamins|mesh-ancestor
153334892|NCT04840238|Micronutrients|micronutrients|mesh-ancestor
153334893|NCT04840238|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153334894|NCT05015010|Alectinib|alectinib|mesh-list
153334895|NCT05015010|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153334896|NCT05015010|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153334897|NCT05015010|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153334898|NCT05015010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153334899|NCT03829618|Lidocaine|lidocaine|mesh-list
153334900|NCT03829618|Anesthetics, Local|anesthetics, local|mesh-ancestor
153334901|NCT03829618|Anesthetics|anesthetics|mesh-ancestor
153334902|NCT03829618|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153334903|NCT03829618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153334904|NCT03829618|Sensory System Agents|sensory system agents|mesh-ancestor
153334905|NCT03829618|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153334906|NCT03829618|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153334907|NCT03829618|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
153334910|NCT03829618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153334911|NCT04272788|Infliximab|infliximab|mesh-list
153334912|NCT04272788|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
153334913|NCT04272788|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153334914|NCT04272788|Dermatologic Agents|dermatologic agents|mesh-ancestor
153334915|NCT04272788|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153334916|NCT04272788|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153334918|NCT01457690|Vitamin E|vitamin e|mesh-list
153334919|NCT01457690|Tocotrienols|tocotrienols|mesh-list
153334949|NCT01451294|Autonomic Agents|autonomic agents|mesh-ancestor
153334950|NCT01451294|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153334951|NCT01451294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153334952|NCT01451294|Sympathomimetics|sympathomimetics|mesh-ancestor
153334953|NCT01451294|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
153334954|NCT01451294|Nasal Decongestants|nasal decongestants|mesh-ancestor
153334955|NCT01451294|Respiratory System Agents|respiratory system agents|mesh-ancestor
153334956|NCT01451294|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
153334957|NCT01451294|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153334958|NCT01451294|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153334959|NCT01451294|Adrenergic Agents|adrenergic agents|mesh-ancestor
153334960|NCT01451294|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153334961|NCT01451294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153334962|NCT01451294|Protective Agents|protective agents|mesh-ancestor
153334963|NCT01451294|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
153334964|NCT01187017|Cyclophosphamide|cyclophosphamide|mesh-list
153334966|NCT01187017|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153334967|NCT01187017|Immunologic Factors|immunologic factors|mesh-ancestor
153334968|NCT01187017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153334970|NCT01187017|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153334971|NCT01187017|Alkylating Agents|alkylating agents|mesh-ancestor
153334972|NCT01187017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153334973|NCT01187017|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153334979|NCT00378118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153334980|NCT01224145|Bupivacaine|bupivacaine|mesh-list
153334981|NCT01224145|Anesthetics, Local|anesthetics, local|mesh-ancestor
153334982|NCT01224145|Anesthetics|anesthetics|mesh-ancestor
153334983|NCT01224145|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153334984|NCT01224145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153334985|NCT01224145|Sensory System Agents|sensory system agents|mesh-ancestor
153334986|NCT01224145|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153334987|NCT01451840|Lidocaine|lidocaine|mesh-list
153334988|NCT01451840|Remifentanil|remifentanil|mesh-list
153334989|NCT01451840|Anesthetics, Local|anesthetics, local|mesh-ancestor
153334990|NCT01451840|Anesthetics|anesthetics|mesh-ancestor
153334991|NCT01451840|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153334992|NCT01451840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153334993|NCT01451840|Sensory System Agents|sensory system agents|mesh-ancestor
153334994|NCT01451840|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153334995|NCT01451840|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153334996|NCT01451840|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
153334997|NCT01451840|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153334998|NCT01451840|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153334999|NCT01451840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153335000|NCT01451840|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153335001|NCT01451840|Narcotics|narcotics|mesh-ancestor
153335003|NCT01451918|Resveratrol|resveratrol|mesh-list
153335004|NCT01451918|Antioxidants|antioxidants|mesh-ancestor
153335005|NCT01451918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153335006|NCT01451918|Protective Agents|protective agents|mesh-ancestor
153335008|NCT01451918|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153335009|NCT01451918|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153335010|NCT00378196|Ranibizumab|ranibizumab|mesh-list
153335011|NCT00378196|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153335012|NCT00378196|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153335013|NCT00378196|Growth Substances|growth substances|mesh-ancestor
153335014|NCT00378196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153335018|NCT01188109|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153335019|NCT01188109|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153335021|NCT01188109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153335023|NCT01458236|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153335024|NCT01458236|Vasodilator Agents|vasodilator agents|mesh-ancestor
153335025|NCT01146457|Morphine|morphine|mesh-list
153335026|NCT01146457|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
153335027|NCT01146457|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153335028|NCT01146457|Narcotics|narcotics|mesh-ancestor
153335029|NCT01146457|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153335030|NCT01146457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153335031|NCT01146457|Analgesics|analgesics|mesh-ancestor
153335032|NCT01146457|Sensory System Agents|sensory system agents|mesh-ancestor
153335033|NCT01146457|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153335034|NCT05495958|Vitamin D|vitamin d|mesh-list
153335035|NCT05495958|Ophthalmic Solutions|ophthalmic solutions|mesh-list
153335037|NCT05495958|Micronutrients|micronutrients|mesh-ancestor
153335038|NCT05495958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153335039|NCT05495958|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153335040|NCT05495958|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
153335041|NCT04011592|Ketamine|ketamine|mesh-list
153335042|NCT04011592|Analgesics|analgesics|mesh-ancestor
153335043|NCT04011592|Sensory System Agents|sensory system agents|mesh-ancestor
153880338|NCT02199184|Etoposide phosphate|etoposide phosphate|mesh-list
153880340|NCT02199184|Podophyllotoxin|podophyllotoxin|mesh-list
153880341|NCT02199184|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
153335044|NCT04011592|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153335045|NCT04011592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153335046|NCT04011592|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
153335047|NCT04011592|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153335048|NCT04011592|Anesthetics, General|anesthetics, general|mesh-ancestor
153335050|NCT04011592|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153335051|NCT04011592|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
153335052|NCT04011592|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
153335053|NCT04011592|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153335054|NCT04011592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153335055|NCT01458470|Memantine|memantine|mesh-list
153335057|NCT01458470|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
153335058|NCT01458470|Dopamine Agents|dopamine agents|mesh-ancestor
153335059|NCT01458470|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153335060|NCT01458470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153335061|NCT01458470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153335062|NCT01458470|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
153335064|NCT01452542|Eliglustat|eliglustat|mesh-list
153335065|NCT01452542|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153335066|NCT01452542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153335067|NCT01458548|Rituximab|rituximab|mesh-list
153335068|NCT01458548|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153335069|NCT01458548|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153335070|NCT01458548|Immunologic Factors|immunologic factors|mesh-ancestor
153335071|NCT01458548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153335072|NCT01458548|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153335073|NCT05027204|Docetaxel|docetaxel|mesh-list
153335074|NCT05027204|Nivolumab|nivolumab|mesh-list
153335075|NCT05027204|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153335076|NCT05027204|Tubulin Modulators|tubulin modulators|mesh-ancestor
153335077|NCT05027204|Antimitotic Agents|antimitotic agents|mesh-ancestor
153335078|NCT05027204|Mitosis Modulators|mitosis modulators|mesh-ancestor
153335079|NCT05027204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153335081|NCT05027204|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153335082|NCT01458626|Mirtazapine|mirtazapine|mesh-list
153335083|NCT01458626|Paroxetine|paroxetine|mesh-list
153335084|NCT01458626|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
153335085|NCT01458626|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153335086|NCT01458626|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153335087|NCT01458626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153335088|NCT01458626|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153335089|NCT01458626|Serotonin Agents|serotonin agents|mesh-ancestor
153335090|NCT01458626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153335091|NCT01458626|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
153335092|NCT01458626|Antidepressive Agents|antidepressive agents|mesh-ancestor
153335095|NCT01458626|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153427502|NCT00000446|Serotonin Agents|serotonin agents|mesh-ancestor
153335097|NCT01458626|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
153335098|NCT01458626|Histamine Antagonists|histamine antagonists|mesh-ancestor
153335099|NCT01458626|Histamine Agents|histamine agents|mesh-ancestor
153335100|NCT01458626|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153335101|NCT01458626|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153335102|NCT01458626|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153335103|NCT01458626|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
153335104|NCT01458626|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
153335105|NCT01458626|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
153335106|NCT01458626|Adrenergic Agents|adrenergic agents|mesh-ancestor
153335107|NCT01458626|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
153335108|NCT01458626|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153335109|NCT01458626|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
153335110|NCT00377806|Diclofenac|diclofenac|mesh-list
153421191|NCT06205485|Capecitabine|capecitabine|mesh-list
153335111|NCT00377806|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153335112|NCT00377806|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153335113|NCT00377806|Analgesics|analgesics|mesh-ancestor
153335114|NCT00377806|Sensory System Agents|sensory system agents|mesh-ancestor
153335115|NCT00377806|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153335116|NCT00377806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153335118|NCT00377806|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153335119|NCT00377806|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153335120|NCT00377806|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153335121|NCT00377806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153335122|NCT05495724|Tislelizumab|tislelizumab|mesh-list
153335123|NCT05495724|Disitamab vedotin|disitamab vedotin|mesh-list
153335124|NCT05495724|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153335125|NCT05495724|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153335137|NCT02559414|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153335138|NCT02559414|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153335139|NCT02559414|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153335140|NCT02559414|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153335141|NCT02559414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153335142|NCT02559414|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153335143|NCT02559414|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153335144|NCT02559414|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153335145|NCT02559414|Antipyretics|antipyretics|mesh-ancestor
153335146|NCT02559414|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
153335147|NCT02559414|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
153335148|NCT02559414|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
153335149|NCT02559414|Purinergic Agents|purinergic agents|mesh-ancestor
153335150|NCT02559414|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153335152|NCT03527264|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153783183|NCT00268710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153335153|NCT03527264|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153335154|NCT03527264|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153335155|NCT03527264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153335156|NCT04713904|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
153335158|NCT04713904|Ethinyl Estradiol|ethinyl estradiol|mesh-list
153335159|NCT04713904|Estradiol|estradiol|mesh-list
153335160|NCT04713904|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
153335161|NCT04713904|Estrogens|estrogens|mesh-ancestor
153335162|NCT04713904|Hormones|hormones|mesh-ancestor
153335163|NCT04713904|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153335164|NCT04713904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153335165|NCT04713904|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
153335166|NCT04713904|Contraceptive Agents|contraceptive agents|mesh-ancestor
153335167|NCT04713904|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153335168|NCT04713904|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
153335175|NCT03995680|Antinematodal Agents|antinematodal agents|mesh-ancestor
153335176|NCT03995680|Anthelmintics|anthelmintics|mesh-ancestor
153335177|NCT03995680|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153335178|NCT03995680|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153335179|NCT03995680|Tubulin Modulators|tubulin modulators|mesh-ancestor
153335180|NCT03995680|Antimitotic Agents|antimitotic agents|mesh-ancestor
153335181|NCT03995680|Mitosis Modulators|mitosis modulators|mesh-ancestor
153335182|NCT03995680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153335183|NCT03995680|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153335184|NCT03995680|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153335185|NCT01452698|Lansoprazole|lansoprazole|mesh-list
153335186|NCT01452698|Dexlansoprazole|dexlansoprazole|mesh-list
153335187|NCT01452698|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
153335188|NCT01452698|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153335189|NCT01452698|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
153335190|NCT01452698|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153335191|NCT01452698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153335193|NCT05029856|Immunologic Factors|immunologic factors|mesh-ancestor
153335194|NCT05029856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153335195|NCT05490342|Antibodies|antibodies|mesh-list
153335196|NCT05490342|Myeloma Proteins|myeloma proteins|mesh-list
153335197|NCT05490342|Paraproteins|paraproteins|mesh-list
153335198|NCT05490342|Immunologic Factors|immunologic factors|mesh-ancestor
153335199|NCT05490342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153335200|NCT05495100|Azacitidine|azacitidine|mesh-list
153335202|NCT05495100|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153335203|NCT05495100|Antimetabolites|antimetabolites|mesh-ancestor
153335204|NCT05495100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153335205|NCT05495100|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153335220|NCT03325114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153335222|NCT01453400|Acetaminophen|acetaminophen|mesh-list
153335223|NCT01453400|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153335224|NCT01453400|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153335226|NCT01453400|Sensory System Agents|sensory system agents|mesh-ancestor
153335227|NCT01453400|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153335228|NCT01453400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153335229|NCT01453400|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153335230|NCT01453400|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153335231|NCT01453400|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153335232|NCT01453400|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153335233|NCT01453400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153335234|NCT01453400|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153335235|NCT01453400|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153335236|NCT01453400|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153335238|NCT05025644|Dobutamine|dobutamine|mesh-list
153335239|NCT05025644|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
153335240|NCT05025644|Sympathomimetics|sympathomimetics|mesh-ancestor
153335241|NCT05025644|Autonomic Agents|autonomic agents|mesh-ancestor
153427600|NCT00002102|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153427602|NCT00002108|Lamivudine|lamivudine|mesh-list
153335244|NCT05025644|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
153335245|NCT05025644|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
153335246|NCT05025644|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153335268|NCT00377494|Immunologic Factors|immunologic factors|mesh-ancestor
153335269|NCT00377494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153335270|NCT01459250|Agomelatine|agomelatine|mesh-list
153335271|NCT01459250|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153335272|NCT01459250|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153335273|NCT01459250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153335274|NCT04303156|Islatravir|islatravir|mesh-list
153335275|NCT04303156|Antiviral Agents|antiviral agents|mesh-ancestor
153335276|NCT04303156|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153335277|NCT04303156|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153335278|NCT04303156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153335279|NCT04303156|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153335280|NCT04303156|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153335281|NCT04303156|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153335282|NCT04390334|Efavirenz|efavirenz|mesh-list
153335283|NCT04390334|Famotidine|famotidine|mesh-list
153335284|NCT04390334|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153335285|NCT04390334|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153335286|NCT04390334|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153335287|NCT04390334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153335288|NCT04390334|Antiviral Agents|antiviral agents|mesh-ancestor
153335289|NCT04390334|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153335290|NCT04390334|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
153421193|NCT06205485|Oxaliplatin|oxaliplatin|mesh-list
153421194|NCT06205485|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153421195|NCT06205485|Antimetabolites|antimetabolites|mesh-ancestor
153421196|NCT06205485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153421197|NCT06205485|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153421198|NCT06205485|Antidotes|antidotes|mesh-ancestor
153421199|NCT06205485|Protective Agents|protective agents|mesh-ancestor
153335291|NCT04390334|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153335292|NCT04390334|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
153335293|NCT04390334|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
153335294|NCT04390334|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
153335295|NCT04390334|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
153335296|NCT04390334|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
153427636|NCT00000506|Adrenergic Agents|adrenergic agents|mesh-ancestor
153335297|NCT04390334|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153335298|NCT04390334|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
153783184|NCT00261300|Pantoprazole|pantoprazole|mesh-list
153335299|NCT04390334|Histamine Antagonists|histamine antagonists|mesh-ancestor
153335300|NCT04390334|Histamine Agents|histamine agents|mesh-ancestor
153335305|NCT02880020|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153335306|NCT02880020|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153335307|NCT02880020|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153335308|NCT02880020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153335309|NCT03150160|Brimonidine Tartrate|brimonidine tartrate|mesh-list
153335310|NCT03150160|Travoprost|travoprost|mesh-list
153335311|NCT03150160|Ophthalmic Solutions|ophthalmic solutions|mesh-list
153335312|NCT03150160|Brinzolamide|brinzolamide|mesh-list
153335313|NCT03150160|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
153335314|NCT03150160|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153335315|NCT03150160|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
153335316|NCT03150160|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153335366|NCT03984838|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153335367|NCT03984838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153335368|NCT03984838|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153335369|NCT03984838|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153335370|NCT03984838|Antiviral Agents|antiviral agents|mesh-ancestor
153335371|NCT03984838|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153335372|NCT03984838|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153335373|NCT03984838|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153783186|NCT00261300|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153335374|NCT01890902|Ketoprofen|ketoprofen|mesh-list
153335375|NCT01890902|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153335376|NCT01890902|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153335378|NCT01890902|Sensory System Agents|sensory system agents|mesh-ancestor
153335379|NCT01890902|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153335380|NCT01890902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153335382|NCT01890902|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153335383|NCT01890902|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153335384|NCT01890902|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153335385|NCT01890902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153335386|NCT04423926|Prednisolone|prednisolone|mesh-list
153335387|NCT04423926|Cyclophosphamide|cyclophosphamide|mesh-list
153335388|NCT04423926|Doxorubicin|doxorubicin|mesh-list
153335389|NCT04423926|Vincristine|vincristine|mesh-list
153335390|NCT04423926|Lenalidomide|lenalidomide|mesh-list
153335391|NCT04423926|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153335392|NCT04423926|Immunologic Factors|immunologic factors|mesh-ancestor
153335393|NCT04423926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153335394|NCT04423926|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153335395|NCT04423926|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153335396|NCT04423926|Alkylating Agents|alkylating agents|mesh-ancestor
153335397|NCT04423926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153335398|NCT04423926|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153335399|NCT04423926|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153335400|NCT04423926|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153335401|NCT04423926|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153335402|NCT04423926|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153335403|NCT04423926|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153335404|NCT04423926|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153335405|NCT04423926|Tubulin Modulators|tubulin modulators|mesh-ancestor
153335406|NCT04423926|Antimitotic Agents|antimitotic agents|mesh-ancestor
153427704|NCT00002120|Levoleucovorin|levoleucovorin|mesh-list
153335408|NCT04423926|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153335409|NCT04423926|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153335410|NCT04423926|Growth Substances|growth substances|mesh-ancestor
153335411|NCT04423926|Growth Inhibitors|growth inhibitors|mesh-ancestor
153335412|NCT04423926|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153335413|NCT04423926|Glucocorticoids|glucocorticoids|mesh-ancestor
153335414|NCT04423926|Hormones|hormones|mesh-ancestor
153335415|NCT04423926|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153335416|NCT04423926|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153335417|NCT03979066|Atezolizumab|atezolizumab|mesh-list
153335418|NCT03979066|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153335419|NCT03979066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153335420|NCT03979066|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153335421|NCT03979066|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153335422|NCT03968848|Acalabrutinib|acalabrutinib|mesh-list
153335423|NCT03968848|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153335424|NCT03968848|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153335425|NCT03968848|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153335426|NCT03968848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153335427|NCT03968848|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153335428|NCT01479010|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
153783195|NCT02212990|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153335441|NCT04758260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153335443|NCT04758260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153335444|NCT01446250|Ribavirin|ribavirin|mesh-list
153335445|NCT01446250|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
153335446|NCT01446250|Antimetabolites|antimetabolites|mesh-ancestor
153335447|NCT01446250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153335448|NCT01446250|Antiviral Agents|antiviral agents|mesh-ancestor
153335449|NCT01446250|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153335450|NCT05493618|Dexamethasone|dexamethasone|mesh-list
153335451|NCT05493618|Pembrolizumab|pembrolizumab|mesh-list
153335452|NCT05493618|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153335453|NCT05493618|Antiemetics|antiemetics|mesh-ancestor
153335454|NCT05493618|Autonomic Agents|autonomic agents|mesh-ancestor
153335455|NCT05493618|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153335456|NCT05493618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153335457|NCT05493618|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153335458|NCT05493618|Glucocorticoids|glucocorticoids|mesh-ancestor
153335459|NCT05493618|Hormones|hormones|mesh-ancestor
153335460|NCT05493618|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153335461|NCT05493618|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153335462|NCT05493618|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153335488|NCT01406860|Promethazine|promethazine|mesh-list
153335489|NCT01406860|Droperidol|droperidol|mesh-list
153335490|NCT01406860|Metoclopramide|metoclopramide|mesh-list
153335491|NCT01406860|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
153335492|NCT01406860|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153335493|NCT01406860|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153335494|NCT01406860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153335495|NCT01406860|Anesthetics, Local|anesthetics, local|mesh-ancestor
153335496|NCT01406860|Anesthetics|anesthetics|mesh-ancestor
153335497|NCT01406860|Sensory System Agents|sensory system agents|mesh-ancestor
153335498|NCT01406860|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153335499|NCT01406860|Antiemetics|antiemetics|mesh-ancestor
153335500|NCT01406860|Autonomic Agents|autonomic agents|mesh-ancestor
153335501|NCT01406860|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153335502|NCT01406860|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
153335504|NCT01406860|Histamine Agents|histamine agents|mesh-ancestor
153335505|NCT01406860|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153335506|NCT01406860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153335509|NCT01406860|Dermatologic Agents|dermatologic agents|mesh-ancestor
153335510|NCT01406860|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
153335511|NCT01406860|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
153335512|NCT01406860|Dopamine Agents|dopamine agents|mesh-ancestor
153335518|NCT04138212|Cisplatin|cisplatin|mesh-list
153335540|NCT05021978|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153335541|NCT05021978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153335542|NCT05021978|Sensory System Agents|sensory system agents|mesh-ancestor
153335543|NCT05021978|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153335545|NCT04280406|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153335546|NCT04280406|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153335547|NCT05599828|Sotorasib|sotorasib|mesh-list
153335548|NCT05599828|Omeprazole|omeprazole|mesh-list
153335549|NCT05599828|Famotidine|famotidine|mesh-list
153335550|NCT05599828|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
153335551|NCT05599828|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153335552|NCT05599828|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
153335553|NCT05599828|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153335555|NCT05599828|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
153335599|NCT02758132|Glucocorticoids|glucocorticoids|mesh-ancestor
153335600|NCT02758132|Hormones|hormones|mesh-ancestor
153335601|NCT02758132|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153335602|NCT02758132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153335603|NCT02758132|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153335604|NCT02758132|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153335605|NCT02758132|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153335607|NCT01891916|Chelating Agents|chelating agents|mesh-ancestor
153335608|NCT01891916|Sequestering Agents|sequestering agents|mesh-ancestor
153335609|NCT01891916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153335610|NCT01313416|Gemcitabine|gemcitabine|mesh-list
153335611|NCT01313416|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153335612|NCT01313416|Antimetabolites|antimetabolites|mesh-ancestor
153335613|NCT01313416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153335615|NCT05599360|Gemtuzumab|gemtuzumab|mesh-list
153335616|NCT05599360|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153335617|NCT05599360|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153335618|NCT05599360|Immunotoxins|immunotoxins|mesh-ancestor
153335619|NCT05599360|Immunoconjugates|immunoconjugates|mesh-ancestor
153335620|NCT05599360|Immunologic Factors|immunologic factors|mesh-ancestor
153335621|NCT05599360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153335622|NCT05499234|Acetaminophen|acetaminophen|mesh-list
153335623|NCT05499234|Meperidine|meperidine|mesh-list
153335624|NCT05499234|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153335625|NCT05499234|Analgesics|analgesics|mesh-ancestor
153335626|NCT05499234|Sensory System Agents|sensory system agents|mesh-ancestor
153335627|NCT05499234|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153335628|NCT05499234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153335629|NCT05499234|Antipyretics|antipyretics|mesh-ancestor
153335630|NCT05499234|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153335632|NCT05499234|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153335633|NCT05499234|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153335634|NCT01269034|Insulin|insulin|mesh-list
153335636|NCT01269034|Exenatide|exenatide|mesh-list
153335640|NCT01269034|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153335641|NCT01269034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153335642|NCT01269034|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
153335643|NCT01269034|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
153335644|NCT01269034|Incretins|incretins|mesh-ancestor
153335645|NCT01269034|Hormones|hormones|mesh-ancestor
153335646|NCT01269034|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153335647|NCT05599126|Lorazepam|lorazepam|mesh-list
153335648|NCT05599126|Mianserin|mianserin|mesh-list
153335649|NCT05599126|Anticonvulsants|anticonvulsants|mesh-ancestor
153335650|NCT05599126|Antiemetics|antiemetics|mesh-ancestor
153335651|NCT05599126|Autonomic Agents|autonomic agents|mesh-ancestor
153335652|NCT05599126|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153335653|NCT05599126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153335654|NCT05599126|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153335655|NCT05599126|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153335656|NCT05599126|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153335658|NCT05599126|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153335659|NCT05599126|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153335661|NCT05599126|GABA Agents|gaba agents|mesh-ancestor
153335662|NCT05599126|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153335663|NCT05599126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153335664|NCT05599126|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
153335665|NCT05599126|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
153335667|NCT05599126|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
153335668|NCT05599126|Histamine Antagonists|histamine antagonists|mesh-ancestor
153335669|NCT05599126|Histamine Agents|histamine agents|mesh-ancestor
153335687|NCT01253668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153335688|NCT01890200|Ribavirin|ribavirin|mesh-list
153335689|NCT01890200|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
153335690|NCT01890200|Antimetabolites|antimetabolites|mesh-ancestor
153335691|NCT01890200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153335693|NCT01890200|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153335694|NCT01662648|Paliperidone Palmitate|paliperidone palmitate|mesh-list
153335697|NCT01662648|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153335698|NCT01662648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153335699|NCT01662648|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153335700|NCT01662648|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
153335701|NCT01662648|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153335702|NCT01662648|Serotonin Agents|serotonin agents|mesh-ancestor
153335703|NCT01662648|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153335704|NCT01662648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153335705|NCT01662648|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
153335706|NCT01662648|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
153335707|NCT01662648|Dopamine Agents|dopamine agents|mesh-ancestor
153335708|NCT05586620|Mitomycins|mitomycins|mesh-list
153335709|NCT05586620|Mitomycin|mitomycin|mesh-list
153335710|NCT05586620|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153335711|NCT05586620|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153335736|NCT05488860|Triamcinolone|triamcinolone|mesh-list
153335737|NCT05488860|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
153335738|NCT05488860|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
153335739|NCT05488860|Aminolevulinic Acid|aminolevulinic acid|mesh-list
153335740|NCT05488860|Photosensitizing Agents|photosensitizing agents|mesh-list
153335741|NCT05488860|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
153335742|NCT05488860|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153335743|NCT05488860|Glucocorticoids|glucocorticoids|mesh-ancestor
153335745|NCT05488860|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153335746|NCT05488860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153335747|NCT05488860|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153335752|NCT02549716|Acetaminophen|acetaminophen|mesh-list
153335798|NCT01202110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153335799|NCT01202110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153335800|NCT01202110|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153335801|NCT01202110|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153335802|NCT01202110|Vasodilator Agents|vasodilator agents|mesh-ancestor
153335803|NCT02556918|Insulin|insulin|mesh-list
153335804|NCT02556918|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
153880353|NCT02199184|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153880354|NCT02199184|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153880355|NCT02199184|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153880356|NCT02199184|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153880357|NCT02199184|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153880358|NCT02199184|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153880359|NCT02199184|Glucocorticoids|glucocorticoids|mesh-ancestor
153880360|NCT02199184|Hormones|hormones|mesh-ancestor
153880361|NCT02199184|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153335805|NCT02556918|Insulin Glargine|insulin glargine|mesh-list
153335806|NCT02556918|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
153335807|NCT02556918|Insulin Aspart|insulin aspart|mesh-list
153335808|NCT02556918|Insulin Lispro|insulin lispro|mesh-list
153335809|NCT02556918|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153335810|NCT02556918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153335811|NCT02556918|Incretins|incretins|mesh-ancestor
153335812|NCT02556918|Hormones|hormones|mesh-ancestor
153335813|NCT02556918|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153783199|NCT02212990|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153335814|NCT02556918|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
153335815|NCT02556918|Protease Inhibitors|protease inhibitors|mesh-ancestor
153335816|NCT02556918|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153335817|NCT02556918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153335825|NCT02518750|Cytarabine|cytarabine|mesh-list
153335852|NCT02518750|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153335853|NCT02518750|Glucocorticoids|glucocorticoids|mesh-ancestor
153335855|NCT02518750|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153335856|NCT02518750|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153335857|NCT02518750|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
153335858|NCT02518750|Abortifacient Agents|abortifacient agents|mesh-ancestor
153335859|NCT02518750|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153335860|NCT02518750|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153335861|NCT02518750|Antimetabolites|antimetabolites|mesh-ancestor
153335862|NCT02518750|Dermatologic Agents|dermatologic agents|mesh-ancestor
153335863|NCT02518750|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153335864|NCT02518750|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153335865|NCT02518750|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153335866|NCT02518750|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153335867|NCT02518750|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153335868|NCT02518750|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153335869|NCT02518750|Antiviral Agents|antiviral agents|mesh-ancestor
153335870|NCT02518750|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153335871|NCT02518750|Tubulin Modulators|tubulin modulators|mesh-ancestor
153335903|NCT01182610|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153335904|NCT01182610|Tubulin Modulators|tubulin modulators|mesh-ancestor
153335905|NCT01182610|Antimitotic Agents|antimitotic agents|mesh-ancestor
153335906|NCT01182610|Mitosis Modulators|mitosis modulators|mesh-ancestor
153335907|NCT01182610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153335909|NCT01182610|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153335910|NCT01182610|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153335911|NCT01182610|Immunologic Factors|immunologic factors|mesh-ancestor
153335912|NCT01182610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153335913|NCT01182610|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153335915|NCT05491902|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
153335916|NCT05491902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153335917|NCT05485896|Pembrolizumab|pembrolizumab|mesh-list
153335918|NCT05485896|Lenvatinib|lenvatinib|mesh-list
153335919|NCT05485896|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153335920|NCT05485896|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153335921|NCT05485896|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153335922|NCT05485896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153335958|NCT01108666|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153335959|NCT01108666|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153335960|NCT01108666|Antiviral Agents|antiviral agents|mesh-ancestor
153335961|NCT01108666|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153335962|NCT02317276|Triamcinolone|triamcinolone|mesh-list
153783202|NCT02212990|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153335963|NCT02317276|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
153335965|NCT02317276|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
153335966|NCT02317276|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153335967|NCT02317276|Glucocorticoids|glucocorticoids|mesh-ancestor
153335969|NCT02317276|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153335970|NCT02317276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153335971|NCT02317276|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153335972|NCT02317276|Immunologic Factors|immunologic factors|mesh-ancestor
153335973|NCT02317276|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153335974|NCT02317276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153335975|NCT01662492|Botulinum Toxins|botulinum toxins|mesh-list
153335976|NCT01662492|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
153335977|NCT01662492|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
153335978|NCT01662492|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
153335979|NCT01662492|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153335980|NCT01662492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153336004|NCT02282332|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
153336005|NCT02282332|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
153336006|NCT02282332|Purinergic Agents|purinergic agents|mesh-ancestor
153336007|NCT02282332|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153336008|NCT02282332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153336009|NCT02282332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153336011|NCT02287636|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
153336012|NCT02287636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153336013|NCT05486988|Antineoplastic Agents|antineoplastic agents|mesh-list
153336014|NCT02253394|Ambrisentan|ambrisentan|mesh-list
153336015|NCT02253394|Spironolactone|spironolactone|mesh-list
153336016|NCT02253394|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
153336017|NCT02253394|Hormone Antagonists|hormone antagonists|mesh-ancestor
153336018|NCT02253394|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153336019|NCT02253394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153336020|NCT02253394|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
153336021|NCT02253394|Diuretics|diuretics|mesh-ancestor
153336022|NCT02253394|Natriuretic Agents|natriuretic agents|mesh-ancestor
153336023|NCT02253394|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153336024|NCT02236546|Deoxyglucose|deoxyglucose|mesh-list
153336025|NCT02236546|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
153336026|NCT02236546|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
153336027|NCT02236546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153336028|NCT02236546|Antimetabolites|antimetabolites|mesh-ancestor
153336029|NCT02236546|Antiviral Agents|antiviral agents|mesh-ancestor
153336030|NCT02236546|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153336031|NCT05484648|Dexamethasone|dexamethasone|mesh-list
153336032|NCT05484648|Dexmedetomidine|dexmedetomidine|mesh-list
153336033|NCT05484648|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153336034|NCT05484648|Antiemetics|antiemetics|mesh-ancestor
153783203|NCT02212990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153336035|NCT05484648|Autonomic Agents|autonomic agents|mesh-ancestor
153336036|NCT05484648|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153336040|NCT05484648|Hormones|hormones|mesh-ancestor
153336041|NCT05484648|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153336042|NCT05484648|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153336043|NCT05484648|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153336044|NCT05484648|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153336045|NCT05484648|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153336046|NCT05484648|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153336048|NCT05484648|Sensory System Agents|sensory system agents|mesh-ancestor
153336049|NCT05484648|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
153336051|NCT05484648|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153336052|NCT05484648|Adrenergic Agents|adrenergic agents|mesh-ancestor
153336053|NCT05484648|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153336054|NCT05484648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153336055|NCT02137096|Carboplatin|carboplatin|mesh-list
153336056|NCT02137096|Etoposide|etoposide|mesh-list
153336057|NCT02137096|Ifosfamide|ifosfamide|mesh-list
153336058|NCT02137096|Etoposide phosphate|etoposide phosphate|mesh-list
153336059|NCT02137096|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153336060|NCT02137096|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153336061|NCT02137096|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153336062|NCT02137096|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153336063|NCT02137096|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153336064|NCT02137096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153336065|NCT02137096|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153336067|NCT02130622|Promethazine|promethazine|mesh-list
153336068|NCT02130622|Diphenhydramine|diphenhydramine|mesh-list
153336069|NCT02130622|Antipruritics|antipruritics|mesh-ancestor
153336070|NCT02130622|Dermatologic Agents|dermatologic agents|mesh-ancestor
153336071|NCT02130622|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
153336072|NCT02130622|Histamine Antagonists|histamine antagonists|mesh-ancestor
153336081|NCT02130622|Anesthetics, Local|anesthetics, local|mesh-ancestor
153336082|NCT02130622|Anesthetics|anesthetics|mesh-ancestor
153336083|NCT02130622|Sensory System Agents|sensory system agents|mesh-ancestor
153336084|NCT02130622|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153336085|NCT02130622|Antiemetics|antiemetics|mesh-ancestor
153336086|NCT02130622|Autonomic Agents|autonomic agents|mesh-ancestor
153336087|NCT02130622|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153336088|NCT02134912|Pemetrexed|pemetrexed|mesh-list
153336089|NCT02134912|Crizotinib|crizotinib|mesh-list
153336090|NCT02134912|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-list
153336091|NCT02134912|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153336092|NCT02134912|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153336093|NCT02134912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153336094|NCT02134912|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153336095|NCT02134912|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153336096|NCT02134912|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153336097|NCT02094352|Ketamine|ketamine|mesh-list
153336098|NCT02094352|Analgesics|analgesics|mesh-ancestor
153336099|NCT02094352|Sensory System Agents|sensory system agents|mesh-ancestor
153336100|NCT02094352|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153336101|NCT02094352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153336102|NCT02094352|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
153336103|NCT02094352|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153336104|NCT02094352|Anesthetics, General|anesthetics, general|mesh-ancestor
153336131|NCT01188421|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153336132|NCT01188421|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153336133|NCT01188421|Adrenergic Agents|adrenergic agents|mesh-ancestor
153336134|NCT01188421|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153336135|NCT01188421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153336137|NCT01006018|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
153336138|NCT01006018|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153336139|NCT01006018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153336142|NCT01006018|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153336143|NCT01006018|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
153336144|NCT01006018|Protease Inhibitors|protease inhibitors|mesh-ancestor
153336145|NCT01006018|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153336146|NCT01006018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153336147|NCT00996502|Prednisone|prednisone|mesh-list
153336148|NCT00996502|Bevacizumab|bevacizumab|mesh-list
153336149|NCT00996502|Docetaxel|docetaxel|mesh-list
153336150|NCT00996502|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
153336151|NCT00996502|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153336152|NCT00996502|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153336153|NCT00996502|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153336183|NCT02027272|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153336184|NCT02027272|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153336185|NCT02027272|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153336186|NCT05475444|Ciprofloxacin|ciprofloxacin|mesh-list
153336187|NCT05475444|Chitosan|chitosan|mesh-list
153336188|NCT05475444|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153336189|NCT05475444|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153336190|NCT05475444|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153336191|NCT05475444|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153336192|NCT05475444|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153336193|NCT05475444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153336194|NCT05475444|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153336195|NCT05475444|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
153336196|NCT05475444|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153336197|NCT05475444|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153336200|NCT05475444|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153336201|NCT05475444|Chelating Agents|chelating agents|mesh-ancestor
153336202|NCT05475444|Sequestering Agents|sequestering agents|mesh-ancestor
153336203|NCT05475444|Hemostatics|hemostatics|mesh-ancestor
153336204|NCT05475444|Coagulants|coagulants|mesh-ancestor
153336212|NCT05478330|Flutamide|flutamide|mesh-list
153336235|NCT00970606|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153336236|NCT00970606|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
153336237|NCT00970606|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153336239|NCT01973062|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
153336240|NCT01973062|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153336241|NCT01973062|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153336242|NCT01973062|Immunologic Factors|immunologic factors|mesh-ancestor
153882464|NCT01606059|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153336243|NCT01973062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153336244|NCT01973062|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153336245|NCT00981370|Deferasirox|deferasirox|mesh-list
153336246|NCT00981370|Iron Chelating Agents|iron chelating agents|mesh-ancestor
153336247|NCT00981370|Chelating Agents|chelating agents|mesh-ancestor
153336248|NCT00981370|Sequestering Agents|sequestering agents|mesh-ancestor
153336249|NCT00981370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153336250|NCT00979810|Alovudine|alovudine|mesh-list
153336251|NCT00979810|Antiviral Agents|antiviral agents|mesh-ancestor
153336252|NCT00979810|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153336253|NCT00947284|Nalbuphine|nalbuphine|mesh-list
153336254|NCT00947284|Naloxone|naloxone|mesh-list
153336255|NCT00947284|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
153336256|NCT00947284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153336257|NCT00947284|Sensory System Agents|sensory system agents|mesh-ancestor
153336258|NCT00947284|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153336260|NCT00947284|Narcotics|narcotics|mesh-ancestor
153336261|NCT00947284|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153336262|NCT00947284|Analgesics|analgesics|mesh-ancestor
153336263|NCT00932152|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
153336264|NCT00932152|Bevacizumab|bevacizumab|mesh-list
153336265|NCT00932152|Fulvestrant|fulvestrant|mesh-list
153336282|NCT00932152|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
153336294|NCT01916590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153336296|NCT01916590|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153336297|NCT01890694|Tolvaptan|tolvaptan|mesh-list
153336344|NCT01844206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153336345|NCT01844206|Analgesics|analgesics|mesh-ancestor
153336346|NCT01844206|Sensory System Agents|sensory system agents|mesh-ancestor
153336347|NCT01844206|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153336349|NCT03626454|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
153336350|NCT03626454|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153336351|NCT03626454|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153336352|NCT03626454|Adrenergic Agents|adrenergic agents|mesh-ancestor
153336353|NCT03626454|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153336355|NCT03626454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153336357|NCT03626454|Autonomic Agents|autonomic agents|mesh-ancestor
153336358|NCT03626454|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153336360|NCT01830790|Sildenafil Citrate|sildenafil citrate|mesh-list
153336361|NCT01830790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153336362|NCT01830790|Vasodilator Agents|vasodilator agents|mesh-ancestor
153336363|NCT01830790|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
153336364|NCT01830790|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
153336365|NCT01830790|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153336366|NCT01830790|Urological Agents|urological agents|mesh-ancestor
153336367|NCT01662102|Rituximab|rituximab|mesh-list
153336368|NCT01662102|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153336369|NCT01662102|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153336370|NCT01662102|Immunologic Factors|immunologic factors|mesh-ancestor
153336371|NCT01662102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153336372|NCT01662102|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153336373|NCT05292976|Albuterol|albuterol|mesh-list
153336374|NCT05292976|Methacholine Chloride|methacholine chloride|mesh-list
153336375|NCT05292976|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153336376|NCT05292976|Autonomic Agents|autonomic agents|mesh-ancestor
153336377|NCT05292976|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153336381|NCT05292976|Tocolytic Agents|tocolytic agents|mesh-ancestor
153336386|NCT05292976|Adrenergic Agents|adrenergic agents|mesh-ancestor
153336387|NCT05292976|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153336388|NCT05292976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153336389|NCT05292976|Miotics|miotics|mesh-ancestor
153336390|NCT05292976|Parasympathomimetics|parasympathomimetics|mesh-ancestor
153336391|NCT05292976|Bronchoconstrictor Agents|bronchoconstrictor agents|mesh-ancestor
153336392|NCT05292976|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
153336393|NCT05292976|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
153336394|NCT05292976|Cholinergic Agents|cholinergic agents|mesh-ancestor
153336395|NCT01808950|Resiquimod|resiquimod|mesh-list
153336396|NCT01808950|Toll-Like Receptor Agonists|toll-like receptor agonists|mesh-ancestor
153336397|NCT01808950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153336398|NCT01808950|Immunomodulating Agents|immunomodulating agents|mesh-ancestor
153336399|NCT01808950|Immunologic Factors|immunologic factors|mesh-ancestor
153336400|NCT01808950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153336401|NCT00850720|Hydrocortisone|hydrocortisone|mesh-list
153336402|NCT00850720|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
153336403|NCT00850720|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
153336404|NCT00850720|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
153336405|NCT00850720|Vasopressins|vasopressins|mesh-list
153336406|NCT00850720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153336407|NCT00850720|Hemostatics|hemostatics|mesh-ancestor
153336408|NCT00850720|Coagulants|coagulants|mesh-ancestor
153336409|NCT00850720|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
153336438|NCT00809458|Tocopherols|tocopherols|mesh-list
153336439|NCT00809458|Tocotrienols|tocotrienols|mesh-list
153336440|NCT00809458|alpha-Tocopherol|alpha-tocopherol|mesh-list
153336441|NCT00809458|Vitamins|vitamins|mesh-ancestor
153336442|NCT00809458|Micronutrients|micronutrients|mesh-ancestor
153336443|NCT00809458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153336444|NCT00809458|Antioxidants|antioxidants|mesh-ancestor
153336445|NCT00809458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153336446|NCT00809458|Protective Agents|protective agents|mesh-ancestor
153336447|NCT01701622|Febuxostat|febuxostat|mesh-list
153336448|NCT01701622|Gout Suppressants|gout suppressants|mesh-ancestor
153336449|NCT01701622|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153336450|NCT01675960|Gabapentin|gabapentin|mesh-list
153336451|NCT01675960|Analgesics|analgesics|mesh-ancestor
153336452|NCT01675960|Sensory System Agents|sensory system agents|mesh-ancestor
153336453|NCT01675960|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153336454|NCT01675960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153336455|NCT01675960|Anticonvulsants|anticonvulsants|mesh-ancestor
153336456|NCT01675960|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153336457|NCT01675960|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153336458|NCT01675960|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153336459|NCT01675960|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153336460|NCT01675960|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
153336461|NCT01675960|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
153336462|NCT01675960|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153336463|NCT01675960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153336464|NCT01675960|Antimanic Agents|antimanic agents|mesh-ancestor
153336465|NCT01607320|Raloxifene Hydrochloride|raloxifene hydrochloride|mesh-list
153336467|NCT01607320|Clomiphene|clomiphene|mesh-list
153783208|NCT00235859|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153336484|NCT01607320|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
153336485|NCT01607320|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
153336486|NCT01607320|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
153336487|NCT01607320|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153336488|NCT01606150|Lidocaine|lidocaine|mesh-list
153336489|NCT01606150|Anesthetics, Local|anesthetics, local|mesh-ancestor
153336490|NCT01606150|Anesthetics|anesthetics|mesh-ancestor
153336491|NCT01606150|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153336492|NCT01606150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153336494|NCT01606150|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153336495|NCT01606150|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153336496|NCT01606150|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
153336497|NCT01606150|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153336498|NCT01606150|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153336499|NCT01606150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153336500|NCT01602016|Leucovorin|leucovorin|mesh-list
153336501|NCT01602016|Folic Acid|folic acid|mesh-list
153336502|NCT01602016|Levoleucovorin|levoleucovorin|mesh-list
153336503|NCT01602016|Antidotes|antidotes|mesh-ancestor
153336504|NCT01602016|Protective Agents|protective agents|mesh-ancestor
153336505|NCT01602016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153336506|NCT01602016|Vitamin B Complex|vitamin b complex|mesh-ancestor
153336507|NCT01602016|Vitamins|vitamins|mesh-ancestor
153336509|NCT01602016|Hematinics|hematinics|mesh-ancestor
153336510|NCT00731770|Fluticasone|fluticasone|mesh-list
153882472|NCT01688544|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153882473|NCT01688544|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153882474|NCT01688583|Fentanyl|fentanyl|mesh-list
153882475|NCT01688583|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153882476|NCT01688583|Narcotics|narcotics|mesh-ancestor
153882477|NCT01688583|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153377777|NCT03856658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153377779|NCT03850418|Azacitidine|azacitidine|mesh-list
153377951|NCT03502577|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153336512|NCT00731770|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
153336513|NCT00731770|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
153336530|NCT00731770|Hormones|hormones|mesh-ancestor
153336531|NCT00731770|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153336532|NCT00731770|Sympathomimetics|sympathomimetics|mesh-ancestor
153336533|NCT00719914|Eptifibatide|eptifibatide|mesh-list
153336534|NCT00719914|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153336535|NCT01566370|Zonisamide|zonisamide|mesh-list
153336536|NCT01566370|Anticonvulsants|anticonvulsants|mesh-ancestor
153336537|NCT01566370|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153336538|NCT01566370|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153336539|NCT01566370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153336540|NCT01566370|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153336541|NCT01566370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153336542|NCT01558492|Paclitaxel|paclitaxel|mesh-list
153336543|NCT01558492|Carboplatin|carboplatin|mesh-list
153336544|NCT01558492|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153336545|NCT01558492|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153336546|NCT01558492|Tubulin Modulators|tubulin modulators|mesh-ancestor
153336547|NCT01558492|Antimitotic Agents|antimitotic agents|mesh-ancestor
153336548|NCT01558492|Mitosis Modulators|mitosis modulators|mesh-ancestor
153336549|NCT01558492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153336550|NCT03579472|Halichondrin B|halichondrin b|mesh-list
153336551|NCT03579472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153336552|NCT03579472|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153336553|NCT03579472|Tubulin Modulators|tubulin modulators|mesh-ancestor
153336554|NCT03579472|Antimitotic Agents|antimitotic agents|mesh-ancestor
153336555|NCT03579472|Mitosis Modulators|mitosis modulators|mesh-ancestor
153336556|NCT05286190|Bupivacaine|bupivacaine|mesh-list
153336558|NCT05286190|Anesthetics|anesthetics|mesh-ancestor
153336577|NCT01530880|Sensory System Agents|sensory system agents|mesh-ancestor
153336578|NCT01530880|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153336579|NCT01530880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153336580|NCT01530880|Antipyretics|antipyretics|mesh-ancestor
153336581|NCT01530880|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153336582|NCT01530880|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153336584|NCT01530880|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153336585|NCT01530880|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153336586|NCT01530880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153336588|NCT05482074|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
153336589|NCT05482074|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153336590|NCT05482074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153336591|NCT05482074|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153336592|NCT00678574|Fluoxetine|fluoxetine|mesh-list
153336593|NCT00678574|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
153336594|NCT00678574|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153336595|NCT00678574|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153336596|NCT00678574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153336597|NCT00678574|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153336598|NCT00678574|Serotonin Agents|serotonin agents|mesh-ancestor
153336599|NCT00678574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153336600|NCT00678574|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
153336601|NCT00678574|Antidepressive Agents|antidepressive agents|mesh-ancestor
153336603|NCT00678574|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
153336604|NCT00678574|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153336605|NCT00678574|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153336606|NCT02551692|Nicotine|nicotine|mesh-list
153336607|NCT02551692|Varenicline|varenicline|mesh-list
153336618|NCT00542542|Fentanyl|fentanyl|mesh-list
153336619|NCT00542542|Propofol|propofol|mesh-list
153336620|NCT00542542|Ropivacaine|ropivacaine|mesh-list
153336621|NCT00542542|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153336622|NCT00542542|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153336623|NCT00542542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153336624|NCT00542542|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153336625|NCT00542542|Anesthetics, General|anesthetics, general|mesh-ancestor
153336626|NCT00542542|Anesthetics|anesthetics|mesh-ancestor
153336627|NCT00542542|Anesthetics, Local|anesthetics, local|mesh-ancestor
153336628|NCT00542542|Sensory System Agents|sensory system agents|mesh-ancestor
153336629|NCT00542542|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153336630|NCT00542542|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153783209|NCT00235859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153783210|NCT00235859|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153336634|NCT00542542|GABA Modulators|gaba modulators|mesh-ancestor
153336635|NCT00542542|GABA Agents|gaba agents|mesh-ancestor
153336636|NCT00542542|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153336637|NCT00542542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153336638|NCT00542542|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153336639|NCT00542542|Narcotics|narcotics|mesh-ancestor
153336640|NCT00542542|Analgesics|analgesics|mesh-ancestor
153336641|NCT03333486|Cyclophosphamide|cyclophosphamide|mesh-list
153336642|NCT03333486|Fludarabine|fludarabine|mesh-list
153336643|NCT03333486|Fludarabine phosphate|fludarabine phosphate|mesh-list
153336644|NCT03333486|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153336645|NCT03333486|Immunologic Factors|immunologic factors|mesh-ancestor
153880369|NCT02165007|Sirolimus|sirolimus|mesh-list
153880370|NCT02165007|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153880371|NCT02165007|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153336646|NCT03333486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153336647|NCT03333486|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153336648|NCT03333486|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153336649|NCT03333486|Alkylating Agents|alkylating agents|mesh-ancestor
153336651|NCT03333486|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153336656|NCT02598778|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
153336658|NCT02598778|Fluorides|fluorides|mesh-list
153336659|NCT02598778|Sodium Fluoride|sodium fluoride|mesh-list
153336660|NCT02598778|Cariostatic Agents|cariostatic agents|mesh-ancestor
153336661|NCT02598778|Protective Agents|protective agents|mesh-ancestor
153336662|NCT02598778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153336663|NCT02598778|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
153336664|NCT02598778|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153336665|NCT02598778|Disinfectants|disinfectants|mesh-ancestor
153336666|NCT02598778|Dermatologic Agents|dermatologic agents|mesh-ancestor
153336667|NCT00642382|Hyaluronic Acid|hyaluronic acid|mesh-list
153336668|NCT00642382|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153336669|NCT00642382|Immunologic Factors|immunologic factors|mesh-ancestor
153336670|NCT00642382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153336671|NCT00642382|Viscosupplements|viscosupplements|mesh-ancestor
153336672|NCT00642382|Protective Agents|protective agents|mesh-ancestor
153336673|NCT05476380|Paclitaxel|paclitaxel|mesh-list
153336674|NCT05476380|Cisplatin|cisplatin|mesh-list
153336675|NCT05476380|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153336676|NCT05476380|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153336677|NCT05476380|Tubulin Modulators|tubulin modulators|mesh-ancestor
153336678|NCT05476380|Antimitotic Agents|antimitotic agents|mesh-ancestor
153336679|NCT05476380|Mitosis Modulators|mitosis modulators|mesh-ancestor
153336680|NCT05476380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153336681|NCT00634972|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
153336682|NCT00634972|Ketorolac|ketorolac|mesh-list
153336683|NCT00634972|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153336684|NCT00634972|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153336685|NCT00634972|Analgesics|analgesics|mesh-ancestor
153336686|NCT00634972|Sensory System Agents|sensory system agents|mesh-ancestor
153336687|NCT00634972|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153336688|NCT00634972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153336694|NCT00529282|Vancomycin|vancomycin|mesh-list
153336701|NCT00623974|Calcitriol|calcitriol|mesh-list
153336702|NCT00623974|Calcium|calcium|mesh-list
153336703|NCT00623974|Parathyroid Hormone|parathyroid hormone|mesh-list
153336705|NCT00623974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153336706|NCT00623974|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153336707|NCT00623974|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
153336708|NCT00623974|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153783211|NCT00235859|Antimetabolites|antimetabolites|mesh-ancestor
153336709|NCT00623974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153336710|NCT00623974|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
153336711|NCT00623974|Vitamins|vitamins|mesh-ancestor
153336760|NCT00000736|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153336762|NCT00000736|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153336763|NCT00379522|Vasopressins|vasopressins|mesh-list
153336764|NCT00379522|Arginine Vasopressin|arginine vasopressin|mesh-list
153336765|NCT00379522|Hemostatics|hemostatics|mesh-ancestor
153336766|NCT00379522|Coagulants|coagulants|mesh-ancestor
153880374|NCT02165007|Antifungal Agents|antifungal agents|mesh-ancestor
153336768|NCT00379522|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
153336769|NCT00379522|Natriuretic Agents|natriuretic agents|mesh-ancestor
153336770|NCT00379522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153336771|NCT00421954|Ziprasidone|ziprasidone|mesh-list
153336772|NCT00421954|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153336773|NCT00421954|Serotonin Agents|serotonin agents|mesh-ancestor
153336774|NCT00421954|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153336775|NCT00421954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153336776|NCT00421954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153336777|NCT00421954|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153336778|NCT00421954|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153336779|NCT00421954|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153336780|NCT00421954|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153336782|NCT00421954|Dopamine Agents|dopamine agents|mesh-ancestor
153783212|NCT00235859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153336783|NCT01662336|Ritonavir|ritonavir|mesh-list
153336784|NCT01662336|Lopinavir|lopinavir|mesh-list
153783213|NCT00235859|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153336785|NCT01662336|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
153336786|NCT01662336|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
153336787|NCT01662336|Protease Inhibitors|protease inhibitors|mesh-ancestor
153336788|NCT01662336|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153336789|NCT01662336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153336802|NCT00000766|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153336803|NCT00000766|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153336804|NCT00000766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153336805|NCT00000766|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153336808|NCT00000772|Antimetabolites|antimetabolites|mesh-ancestor
153336809|NCT00000772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153336812|NCT00000772|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153336813|NCT00000772|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153336815|NCT00000772|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153336816|NCT00000772|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153336817|NCT00572260|Daptomycin|daptomycin|mesh-list
153336818|NCT00572260|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153336819|NCT00572260|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153336820|NCT00000778|Pyridoxine|pyridoxine|mesh-list
153336821|NCT00000778|Vitamin B 6|vitamin b 6|mesh-list
153336822|NCT00000778|Levofloxacin|levofloxacin|mesh-list
153336823|NCT00000778|Isoniazid|isoniazid|mesh-list
153336824|NCT00000778|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
153336825|NCT00000778|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153336826|NCT00000778|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153336827|NCT00000778|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153336837|NCT00000778|Antimetabolites|antimetabolites|mesh-ancestor
153336855|NCT00000796|Ethionamide|ethionamide|mesh-list
153336856|NCT00000796|Capreomycin|capreomycin|mesh-list
153336857|NCT00000796|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
153783214|NCT00235859|Dermatologic Agents|dermatologic agents|mesh-ancestor
153336858|NCT00000796|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153336859|NCT00000796|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153336860|NCT00000796|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153336862|NCT00000796|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153336863|NCT00000796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153336864|NCT00000796|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153336865|NCT00000796|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
153336866|NCT00000796|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153336867|NCT00000796|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
153336868|NCT00000796|Antitubercular Agents|antitubercular agents|mesh-ancestor
153336869|NCT00000796|Leprostatic Agents|leprostatic agents|mesh-ancestor
153421222|NCT06140784|Fluorides|fluorides|mesh-list
153336870|NCT00000796|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153336871|NCT00000796|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
153336872|NCT00000796|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
153336873|NCT00000796|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
153336874|NCT00000796|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
153336875|NCT00000796|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
153336876|NCT00000796|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
153336877|NCT00000796|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
153336879|NCT00000796|Antimetabolites|antimetabolites|mesh-ancestor
153336880|NCT00000796|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153336881|NCT00000796|Vitamin B Complex|vitamin b complex|mesh-ancestor
153336882|NCT00000796|Vitamins|vitamins|mesh-ancestor
153336883|NCT00000796|Micronutrients|micronutrients|mesh-ancestor
153336884|NCT00000796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153336888|NCT00000802|Atovaquone|atovaquone|mesh-list
153336897|NCT00000802|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153336898|NCT02389946|Sirolimus|sirolimus|mesh-list
153336899|NCT02389946|Everolimus|everolimus|mesh-list
153336900|NCT02389946|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
153336901|NCT02389946|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153336902|NCT02389946|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153336903|NCT02389946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153336904|NCT02389946|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153336905|NCT02389946|Immunologic Factors|immunologic factors|mesh-ancestor
153336906|NCT02389946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153336907|NCT02389946|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153336908|NCT02389946|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153336909|NCT02389946|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153336910|NCT02389946|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153336911|NCT02389946|Antifungal Agents|antifungal agents|mesh-ancestor
153336912|NCT00245128|Imatinib Mesylate|imatinib mesylate|mesh-list
153336913|NCT00245128|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153336914|NCT00245128|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153336915|NCT00245128|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153336916|NCT00245128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153336917|NCT00245128|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153336919|NCT00268450|Bevacizumab|bevacizumab|mesh-list
153336920|NCT00268450|Gemcitabine|gemcitabine|mesh-list
153336921|NCT00268450|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153336922|NCT00268450|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153336923|NCT00268450|Tubulin Modulators|tubulin modulators|mesh-ancestor
153336924|NCT00268450|Antimitotic Agents|antimitotic agents|mesh-ancestor
153336925|NCT00268450|Mitosis Modulators|mitosis modulators|mesh-ancestor
153336928|NCT00268450|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153336939|NCT00000808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153336940|NCT00000808|Antiviral Agents|antiviral agents|mesh-ancestor
153336941|NCT00000808|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153336942|NCT00000808|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153336943|NCT00000808|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153336944|NCT00000808|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
153336945|NCT00000808|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
153336946|NCT00000814|Zidovudine|zidovudine|mesh-list
153336947|NCT00000814|Nevirapine|nevirapine|mesh-list
153336948|NCT00000814|Didanosine|didanosine|mesh-list
153336949|NCT00000814|Antimetabolites|antimetabolites|mesh-ancestor
153336950|NCT00000814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153336951|NCT00000814|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153336952|NCT00000814|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153336953|NCT00000814|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153336954|NCT00000814|Antiviral Agents|antiviral agents|mesh-ancestor
153336955|NCT00000814|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153336956|NCT00000814|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153336957|NCT00000814|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153336958|NCT00000814|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
153336961|NCT02661932|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153336962|NCT02661932|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
153336963|NCT02661932|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153336964|NCT02661932|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153421232|NCT06130423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153336965|NCT02661932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153336966|NCT02661932|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
153336967|NCT02661932|Hormone Antagonists|hormone antagonists|mesh-ancestor
153336986|NCT00088972|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153336987|NCT00088972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153336988|NCT00088972|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153336990|NCT00088972|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
153336991|NCT00088972|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153336992|NCT00088972|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153336993|NCT00088972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153336994|NCT00089128|Gemcitabine|gemcitabine|mesh-list
153336995|NCT00089128|Irinotecan|irinotecan|mesh-list
153336996|NCT00089128|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153336997|NCT00089128|Antimetabolites|antimetabolites|mesh-ancestor
153336998|NCT00089128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153336999|NCT00089128|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153337000|NCT00089128|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
153337001|NCT00089128|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153337002|NCT00089128|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153337003|NCT00000838|Lamivudine|lamivudine|mesh-list
153337004|NCT00000838|Zidovudine|zidovudine|mesh-list
153337008|NCT00000838|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153337009|NCT00000838|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153337010|NCT00000838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153337011|NCT00000838|Antiviral Agents|antiviral agents|mesh-ancestor
153337012|NCT00000838|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153337013|NCT00000838|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153337014|NCT00000838|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153337015|NCT00000838|Antimetabolites|antimetabolites|mesh-ancestor
153337016|NCT00001768|Immunoglobulins|immunoglobulins|mesh-list
153337017|NCT00001768|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
153337018|NCT00001768|Antibodies|antibodies|mesh-list
153337029|NCT00000844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153337030|NCT00014560|Antibodies|antibodies|mesh-list
153337031|NCT00014560|Sargramostim|sargramostim|mesh-list
153337032|NCT00014560|Antibodies, Bispecific|antibodies, bispecific|mesh-list
153337033|NCT00014560|Immunologic Factors|immunologic factors|mesh-ancestor
153337035|NCT00020722|Cyclophosphamide|cyclophosphamide|mesh-list
153337036|NCT00020722|Ifosfamide|ifosfamide|mesh-list
153337038|NCT00020722|Carboplatin|carboplatin|mesh-list
153337039|NCT00020722|Etoposide|etoposide|mesh-list
153337040|NCT00020722|Etoposide phosphate|etoposide phosphate|mesh-list
153337041|NCT00020722|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153337042|NCT00020722|Immunologic Factors|immunologic factors|mesh-ancestor
153337043|NCT00020722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153337044|NCT00020722|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153337045|NCT00020722|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153337046|NCT00020722|Alkylating Agents|alkylating agents|mesh-ancestor
153337047|NCT00020722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153337048|NCT00020722|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153337049|NCT00020722|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153337050|NCT00020722|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153337051|NCT00020722|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153337052|NCT00020722|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153337053|NCT00020722|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153337054|NCT04051996|Decitabine|decitabine|mesh-list
153337055|NCT04051996|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153337056|NCT04051996|Antimetabolites|antimetabolites|mesh-ancestor
153337057|NCT04051996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153337058|NCT04051996|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153337059|NCT04051996|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153337063|NCT02126878|Hormones|hormones|mesh-ancestor
153337075|NCT02634008|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153337076|NCT02634008|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153337077|NCT02634008|Antiviral Agents|antiviral agents|mesh-ancestor
153337078|NCT02634008|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153337079|NCT02634008|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
153337080|NCT02634008|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153337081|NCT02634008|Antimetabolites|antimetabolites|mesh-ancestor
153337082|NCT00000850|Indinavir|indinavir|mesh-list
153337083|NCT00000850|Sargramostim|sargramostim|mesh-list
153337084|NCT00000850|Immunologic Factors|immunologic factors|mesh-ancestor
153337085|NCT00000850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153337086|NCT00000850|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
153337087|NCT00000850|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
153337088|NCT00000850|Protease Inhibitors|protease inhibitors|mesh-ancestor
153337089|NCT00000850|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153337090|NCT00000850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153337091|NCT00000850|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153783217|NCT00235859|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153337092|NCT00000850|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153337094|NCT00000850|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153337127|NCT02344472|Paclitaxel|paclitaxel|mesh-list
153337128|NCT02344472|Vinorelbine|vinorelbine|mesh-list
153337129|NCT02344472|Docetaxel|docetaxel|mesh-list
153337130|NCT02344472|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
153337131|NCT02344472|Capecitabine|capecitabine|mesh-list
153337132|NCT02344472|Trastuzumab|trastuzumab|mesh-list
153337133|NCT02344472|Letrozole|letrozole|mesh-list
153337134|NCT02344472|Fulvestrant|fulvestrant|mesh-list
153337136|NCT02344472|Anastrozole|anastrozole|mesh-list
153337137|NCT02344472|Exemestane|exemestane|mesh-list
153337138|NCT02344472|Goserelin|goserelin|mesh-list
153337139|NCT02344472|Leuprolide|leuprolide|mesh-list
153337140|NCT02344472|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153337141|NCT02344472|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153337142|NCT02344472|Tubulin Modulators|tubulin modulators|mesh-ancestor
153337143|NCT02344472|Antimitotic Agents|antimitotic agents|mesh-ancestor
153337144|NCT02344472|Mitosis Modulators|mitosis modulators|mesh-ancestor
153337145|NCT02344472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153337146|NCT02344472|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153337147|NCT02344472|Antimetabolites|antimetabolites|mesh-ancestor
153337148|NCT02344472|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153337149|NCT02344472|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
153337150|NCT02344472|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153337151|NCT02344472|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153337152|NCT02344472|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
153337153|NCT02344472|Hormone Antagonists|hormone antagonists|mesh-ancestor
153337154|NCT02344472|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153337155|NCT02344472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153337156|NCT02344472|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153337157|NCT02344472|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
153337158|NCT02344472|Fertility Agents, Female|fertility agents, female|mesh-ancestor
153337159|NCT02344472|Fertility Agents|fertility agents|mesh-ancestor
153337160|NCT02344472|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153337161|NCT02338232|Telmisartan|telmisartan|mesh-list
153337169|NCT01780636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153337170|NCT01780636|Cholinergic Agents|cholinergic agents|mesh-ancestor
153337171|NCT01780636|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153337172|NCT01780636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153337173|NCT00000868|Aluminum Hydroxide|aluminum hydroxide|mesh-list
153337176|NCT00000868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153337177|NCT00000868|Antacids|antacids|mesh-ancestor
153337178|NCT00000868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153337179|NCT00000868|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153337181|NCT05586464|Antacids|antacids|mesh-ancestor
153337182|NCT05586464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153337183|NCT05586464|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153421236|NCT06130423|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153421237|NCT06130423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153421238|NCT06116578|Pembrolizumab|pembrolizumab|mesh-list
153337184|NCT01561378|Insulin Aspart|insulin aspart|mesh-list
153337185|NCT01561378|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153337186|NCT01561378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153337187|NCT00000880|Cyclosporine|cyclosporine|mesh-list
153337188|NCT00000880|Cyclosporins|cyclosporins|mesh-list
153337189|NCT00000880|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153337190|NCT00000880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153337191|NCT00000880|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153337192|NCT00000880|Immunologic Factors|immunologic factors|mesh-ancestor
153337193|NCT00000880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153337194|NCT00000880|Antifungal Agents|antifungal agents|mesh-ancestor
153337195|NCT00000880|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153337196|NCT00000880|Dermatologic Agents|dermatologic agents|mesh-ancestor
153337197|NCT00000880|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153337198|NCT00000880|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
153337199|NCT02279654|Lenalidomide|lenalidomide|mesh-list
153337200|NCT02279654|Immunologic Factors|immunologic factors|mesh-ancestor
153337201|NCT02279654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153337202|NCT02279654|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153337203|NCT02279654|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153337204|NCT02279654|Growth Substances|growth substances|mesh-ancestor
153337205|NCT02279654|Growth Inhibitors|growth inhibitors|mesh-ancestor
153337206|NCT02279654|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153337207|NCT02268656|Propofol|propofol|mesh-list
153337208|NCT02268656|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153337209|NCT02268656|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153337210|NCT02268656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153337211|NCT02268656|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153337212|NCT02268656|Anesthetics, General|anesthetics, general|mesh-ancestor
153337213|NCT02268656|Anesthetics|anesthetics|mesh-ancestor
153337214|NCT02554890|Valsartan|valsartan|mesh-list
153337215|NCT02554890|Enalapril|enalapril|mesh-list
153337216|NCT02554890|Enalaprilat|enalaprilat|mesh-list
153337217|NCT02554890|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
153337218|NCT02554890|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153337219|NCT02554890|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
153337220|NCT02554890|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
153337221|NCT02554890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153337222|NCT02554890|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
153337223|NCT02554890|Protease Inhibitors|protease inhibitors|mesh-ancestor
153337224|NCT02554890|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153337226|NCT00001864|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153337227|NCT00001864|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153337228|NCT00001864|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153337254|NCT03252600|BB 1101|bb 1101|mesh-list
153337255|NCT03252600|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153337256|NCT03252600|Immunologic Factors|immunologic factors|mesh-ancestor
153337257|NCT03252600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153337258|NCT03252600|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153337259|NCT03252600|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153337260|NCT03252600|Alkylating Agents|alkylating agents|mesh-ancestor
153337261|NCT03252600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153337262|NCT03252600|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153337263|NCT03252600|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153337264|NCT03252600|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153337265|NCT03252600|Antiemetics|antiemetics|mesh-ancestor
153337266|NCT03252600|Autonomic Agents|autonomic agents|mesh-ancestor
153337267|NCT03252600|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153337268|NCT03252600|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153337269|NCT03252600|Glucocorticoids|glucocorticoids|mesh-ancestor
153337271|NCT03252600|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153337272|NCT03252600|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153337273|NCT03252600|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153337274|NCT03252600|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153337275|NCT03252600|Growth Substances|growth substances|mesh-ancestor
153337276|NCT03252600|Growth Inhibitors|growth inhibitors|mesh-ancestor
153337277|NCT03252600|Protease Inhibitors|protease inhibitors|mesh-ancestor
153337278|NCT03252600|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153337279|NCT03252600|Dermatologic Agents|dermatologic agents|mesh-ancestor
153337280|NCT02749526|Tegafur|tegafur|mesh-list
153337281|NCT02749526|Endostar protein|endostar protein|mesh-list
153337282|NCT02749526|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153337283|NCT02749526|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153337284|NCT02749526|Antimetabolites|antimetabolites|mesh-ancestor
153337300|NCT00000916|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153337301|NCT00000916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153337302|NCT00000916|Antiviral Agents|antiviral agents|mesh-ancestor
153337303|NCT00000916|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153337304|NCT00000916|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153337305|NCT00000916|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153337306|NCT00000916|Antimetabolites|antimetabolites|mesh-ancestor
153337307|NCT00000916|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153337308|NCT00000916|Antisickling Agents|antisickling agents|mesh-ancestor
153337309|NCT00000916|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
153337310|NCT00000916|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
153337311|NCT00000916|Protease Inhibitors|protease inhibitors|mesh-ancestor
153337312|NCT00000130|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
153337313|NCT00000130|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153783219|NCT00235859|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153337315|NCT00000160|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
153337316|NCT00000160|Anesthetics, General|anesthetics, general|mesh-ancestor
153337317|NCT00000160|Anesthetics|anesthetics|mesh-ancestor
153337318|NCT00000160|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153337319|NCT00000160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153337321|NCT00000178|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153337322|NCT00000178|Glucocorticoids|glucocorticoids|mesh-ancestor
153337324|NCT00000178|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153337325|NCT00000178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153337326|NCT00000178|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153337327|NCT00000178|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153337328|NCT05480280|Leucovorin|leucovorin|mesh-list
153337329|NCT05480280|Fluorouracil|fluorouracil|mesh-list
153337330|NCT05480280|Oxaliplatin|oxaliplatin|mesh-list
153337331|NCT05480280|Calcium|calcium|mesh-list
153337345|NCT05480280|Micronutrients|micronutrients|mesh-ancestor
153337347|NCT00001906|Aluminum Hydroxide|aluminum hydroxide|mesh-list
153337348|NCT00001906|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153337349|NCT00001906|Immunologic Factors|immunologic factors|mesh-ancestor
153337350|NCT00001906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153337351|NCT00001906|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153337352|NCT00001906|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153337353|NCT00001906|Growth Substances|growth substances|mesh-ancestor
153337354|NCT00001906|Growth Inhibitors|growth inhibitors|mesh-ancestor
153337355|NCT00001906|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153337356|NCT00001906|Antacids|antacids|mesh-ancestor
153337357|NCT00001906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153337358|NCT00001906|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153337359|NCT00000196|Naltrexone|naltrexone|mesh-list
153337362|NCT00000196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153337363|NCT00000196|Sensory System Agents|sensory system agents|mesh-ancestor
153337364|NCT00000196|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153337365|NCT00000946|polysaccharide-K|polysaccharide-k|mesh-list
153337366|NCT00000946|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153337367|NCT00000946|Immunologic Factors|immunologic factors|mesh-ancestor
153337368|NCT00000946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153337369|NCT00000946|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153337370|NCT00000946|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153337395|NCT00000202|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153337396|NCT00000202|Narcotics|narcotics|mesh-ancestor
153337397|NCT00000202|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153337398|NCT00000202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153337399|NCT00000202|Analgesics|analgesics|mesh-ancestor
153337400|NCT00000202|Sensory System Agents|sensory system agents|mesh-ancestor
153337401|NCT00000202|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153337402|NCT00000202|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
153337403|NCT00000208|Buprenorphine|buprenorphine|mesh-list
153337404|NCT00000208|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153337406|NCT00000208|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153337407|NCT00000208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153337408|NCT00000208|Analgesics|analgesics|mesh-ancestor
153337409|NCT00000208|Sensory System Agents|sensory system agents|mesh-ancestor
153337410|NCT00000208|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153337411|NCT00000208|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
153337413|NCT00001930|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
153337414|NCT00001930|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
153337415|NCT00001930|Antiviral Agents|antiviral agents|mesh-ancestor
153337416|NCT00001930|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153337417|NCT00001930|Dopamine Agents|dopamine agents|mesh-ancestor
153337418|NCT00001930|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153337419|NCT00001930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153337420|NCT00001930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153337421|NCT00001930|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153337422|NCT00001930|Analgesics|analgesics|mesh-ancestor
153337423|NCT00001930|Sensory System Agents|sensory system agents|mesh-ancestor
153337424|NCT00001930|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153337426|NCT00000964|Phosphonoacetic Acid|phosphonoacetic acid|mesh-list
153337427|NCT00000964|Ranitidine|ranitidine|mesh-list
153337428|NCT00000964|Ranitidine bismuth citrate|ranitidine bismuth citrate|mesh-list
153337429|NCT00000964|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
153337430|NCT00000964|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153337438|NCT00000964|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153337439|NCT00000964|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153337440|NCT00000964|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153337441|NCT00000964|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153337443|NCT00000976|CD4 Immunoadhesins|cd4 immunoadhesins|mesh-list
153337444|NCT00000976|Antimetabolites|antimetabolites|mesh-ancestor
153337445|NCT00000976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153337446|NCT00000976|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153337447|NCT00000976|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153337448|NCT00000976|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153337449|NCT00000976|Antiviral Agents|antiviral agents|mesh-ancestor
153337450|NCT00000976|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153337451|NCT00000976|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153337452|NCT00000976|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153337453|NCT00000976|Immunologic Factors|immunologic factors|mesh-ancestor
153337454|NCT00000976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153337456|NCT00000226|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153337457|NCT00000226|Narcotics|narcotics|mesh-ancestor
153337458|NCT00000226|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153337460|NCT00000226|Analgesics|analgesics|mesh-ancestor
153337461|NCT00000226|Sensory System Agents|sensory system agents|mesh-ancestor
153337462|NCT00000226|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153337463|NCT00000226|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
153337464|NCT00000982|Zidovudine|zidovudine|mesh-list
153337465|NCT00000982|Didanosine|didanosine|mesh-list
153337466|NCT00000982|Antimetabolites|antimetabolites|mesh-ancestor
153337467|NCT00000982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153337468|NCT00000982|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153337469|NCT00000982|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153783220|NCT00235859|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153337470|NCT00000982|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153337471|NCT00000982|Antiviral Agents|antiviral agents|mesh-ancestor
153337473|NCT00000982|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153337474|NCT00000982|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153337475|NCT02549196|Donepezil|donepezil|mesh-list
153337476|NCT02549196|Solifenacin Succinate|solifenacin succinate|mesh-list
153337478|NCT02549196|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153337479|NCT02549196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153337480|NCT02549196|Cholinergic Agents|cholinergic agents|mesh-ancestor
153337481|NCT02549196|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153337482|NCT02549196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153337483|NCT02549196|Nootropic Agents|nootropic agents|mesh-ancestor
153337485|NCT02549196|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
153337486|NCT02549196|Urological Agents|urological agents|mesh-ancestor
153337488|NCT00000988|Antimetabolites|antimetabolites|mesh-ancestor
153337489|NCT00000988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153337490|NCT00000988|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153337491|NCT00000988|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153337492|NCT00000988|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153337493|NCT00000988|Antiviral Agents|antiviral agents|mesh-ancestor
153337494|NCT00000988|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153337495|NCT00000988|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153337496|NCT00000988|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153337497|NCT00000232|Buprenorphine|buprenorphine|mesh-list
153337498|NCT00000232|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153337499|NCT00000232|Narcotics|narcotics|mesh-ancestor
153337500|NCT00000232|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153337501|NCT00000232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153337502|NCT00000232|Analgesics|analgesics|mesh-ancestor
153337503|NCT00000232|Sensory System Agents|sensory system agents|mesh-ancestor
153337504|NCT00000232|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153337505|NCT00000232|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
153337506|NCT00000238|Buprenorphine|buprenorphine|mesh-list
153337507|NCT00000238|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153337512|NCT00000238|Sensory System Agents|sensory system agents|mesh-ancestor
153337513|NCT00000238|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153337515|NCT00000244|Dynorphins|dynorphins|mesh-list
153337516|NCT00000244|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153337517|NCT00000244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153337518|NCT00000244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153337519|NCT00000994|Zidovudine|zidovudine|mesh-list
153337520|NCT00000994|Antimetabolites|antimetabolites|mesh-ancestor
153337521|NCT00000994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153337522|NCT00000994|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153337523|NCT00000994|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153337524|NCT00000994|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153337525|NCT00000994|Antiviral Agents|antiviral agents|mesh-ancestor
153337526|NCT00000994|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153337528|NCT00000994|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153337529|NCT00001006|Ammonium trichloro(dioxoethylene-O,O'-)tellurate|ammonium trichloro(dioxoethylene-o,o'-)tellurate|mesh-list
153337530|NCT00001006|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153337531|NCT00001006|Immunologic Factors|immunologic factors|mesh-ancestor
153337532|NCT00001006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153337533|NCT00001006|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153337534|NCT00001006|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
153337535|NCT00001006|Protective Agents|protective agents|mesh-ancestor
153337536|NCT00001006|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153337537|NCT00001006|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153337538|NCT00001006|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153337539|NCT00001006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153337540|NCT00001006|Antiviral Agents|antiviral agents|mesh-ancestor
153337541|NCT00001006|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153337542|NCT00001954|Etanercept|etanercept|mesh-list
153337543|NCT00001954|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153880390|NCT02110069|Tubulin Modulators|tubulin modulators|mesh-ancestor
153880391|NCT02110069|Antimitotic Agents|antimitotic agents|mesh-ancestor
153337552|NCT00001954|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153337553|NCT00001954|Immunologic Factors|immunologic factors|mesh-ancestor
153337555|NCT02904954|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
153337557|NCT02904954|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153337559|NCT02904954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153337560|NCT00000250|Nitrous Oxide|nitrous oxide|mesh-list
153337561|NCT00000250|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
153337562|NCT00000250|Anesthetics, General|anesthetics, general|mesh-ancestor
153337563|NCT00000250|Anesthetics|anesthetics|mesh-ancestor
153337564|NCT00000250|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153337565|NCT00000250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153337566|NCT00000250|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153337567|NCT00000250|Analgesics|analgesics|mesh-ancestor
153337568|NCT00000250|Sensory System Agents|sensory system agents|mesh-ancestor
153337569|NCT00000250|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153337571|NCT03244020|Enoxaparin|enoxaparin|mesh-list
153337572|NCT03244020|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153337573|NCT03244020|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153337574|NCT03244020|Analgesics|analgesics|mesh-ancestor
153337575|NCT03244020|Sensory System Agents|sensory system agents|mesh-ancestor
153337576|NCT03244020|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153337577|NCT03244020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153337578|NCT03244020|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153337579|NCT03244020|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153337580|NCT03244020|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153337581|NCT03244020|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153337582|NCT03244020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153337583|NCT03244020|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153337584|NCT03244020|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153337585|NCT03244020|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153337586|NCT03244020|Antipyretics|antipyretics|mesh-ancestor
153337592|NCT00000262|Anesthetics, General|anesthetics, general|mesh-ancestor
153337593|NCT00000262|Anesthetics|anesthetics|mesh-ancestor
153337594|NCT00000262|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153337595|NCT00000262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153337596|NCT00000262|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153337597|NCT00000262|Analgesics|analgesics|mesh-ancestor
153337598|NCT00000262|Sensory System Agents|sensory system agents|mesh-ancestor
153337599|NCT00000262|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153337600|NCT00001024|Zidovudine|zidovudine|mesh-list
153337601|NCT00001024|Didanosine|didanosine|mesh-list
153337602|NCT00001024|Antimetabolites|antimetabolites|mesh-ancestor
153337603|NCT00001024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153337604|NCT00001024|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153337605|NCT00001024|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153337606|NCT00001024|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153337607|NCT00001024|Antiviral Agents|antiviral agents|mesh-ancestor
153337610|NCT00001024|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153337611|NCT00000268|Bupropion|bupropion|mesh-list
153337612|NCT00000268|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
153337613|NCT00000268|Antidepressive Agents|antidepressive agents|mesh-ancestor
153337614|NCT00000268|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153337615|NCT00000268|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
153337616|NCT00000268|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153337617|NCT00000268|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153337618|NCT00000268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153337619|NCT00000268|Dopamine Agents|dopamine agents|mesh-ancestor
153337620|NCT00000268|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153337621|NCT00000268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153337624|NCT00000268|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153337630|NCT00001042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153337631|NCT00001042|Antacids|antacids|mesh-ancestor
153337633|NCT00001042|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153337634|NCT00982865|Niacinamide|niacinamide|mesh-list
153337635|NCT00982865|Vitamin B Complex|vitamin b complex|mesh-ancestor
153337637|NCT00982865|Micronutrients|micronutrients|mesh-ancestor
153337638|NCT00982865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153337639|NCT00001054|Valacyclovir|valacyclovir|mesh-list
153337640|NCT00001054|Antiviral Agents|antiviral agents|mesh-ancestor
153337641|NCT00001054|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153337642|NCT01226719|Leucovorin|leucovorin|mesh-list
153337643|NCT01226719|Fluorouracil|fluorouracil|mesh-list
153337644|NCT01226719|Oxaliplatin|oxaliplatin|mesh-list
153337645|NCT01226719|Irinotecan|irinotecan|mesh-list
153337646|NCT01226719|Panitumumab|panitumumab|mesh-list
153337647|NCT01226719|Antimetabolites|antimetabolites|mesh-ancestor
153337648|NCT01226719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153337649|NCT01226719|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153337650|NCT01226719|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153337651|NCT01226719|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153337652|NCT01226719|Immunologic Factors|immunologic factors|mesh-ancestor
153337653|NCT01226719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153337654|NCT01226719|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
153337655|NCT01226719|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153337656|NCT01226719|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153337657|NCT01226719|Antidotes|antidotes|mesh-ancestor
153337658|NCT01226719|Protective Agents|protective agents|mesh-ancestor
153337659|NCT01226719|Vitamin B Complex|vitamin b complex|mesh-ancestor
153337660|NCT01226719|Vitamins|vitamins|mesh-ancestor
153337661|NCT01226719|Micronutrients|micronutrients|mesh-ancestor
153337662|NCT01226719|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153337663|NCT00001072|polysaccharide-K|polysaccharide-k|mesh-list
153337664|NCT00001072|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153337665|NCT00001072|Immunologic Factors|immunologic factors|mesh-ancestor
153337672|NCT00001072|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
153337673|NCT00001072|Protective Agents|protective agents|mesh-ancestor
153337674|NCT04331470|Ritonavir|ritonavir|mesh-list
153337675|NCT04331470|Lopinavir|lopinavir|mesh-list
153337676|NCT04331470|Chloroquine|chloroquine|mesh-list
153337677|NCT04331470|Levamisole|levamisole|mesh-list
153337678|NCT04331470|Hydroxychloroquine|hydroxychloroquine|mesh-list
153337679|NCT04331470|Budesonide|budesonide|mesh-list
153337680|NCT04331470|Formoterol Fumarate|formoterol fumarate|mesh-list
153337681|NCT04331470|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
153337682|NCT04331470|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
153337683|NCT04331470|Protease Inhibitors|protease inhibitors|mesh-ancestor
153337684|NCT04331470|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153337685|NCT04331470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153337686|NCT04331470|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153337687|NCT04331470|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153337738|NCT02548962|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153337740|NCT02548962|Autonomic Agents|autonomic agents|mesh-ancestor
153337741|NCT02548962|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153337742|NCT02548962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153337743|NCT02548962|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153337744|NCT02548962|Glucocorticoids|glucocorticoids|mesh-ancestor
153337745|NCT02548962|Hormones|hormones|mesh-ancestor
153337746|NCT02548962|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153337747|NCT02548962|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153337748|NCT02548962|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153337749|NCT02548962|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153337750|NCT02548962|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153337751|NCT02548962|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153337752|NCT02548962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153337753|NCT02548962|Immunologic Factors|immunologic factors|mesh-ancestor
153337754|NCT02548962|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153337755|NCT02548962|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153337756|NCT02548962|Growth Substances|growth substances|mesh-ancestor
153337757|NCT02548962|Growth Inhibitors|growth inhibitors|mesh-ancestor
153337759|NCT00000274|Flupenthixol decanoate|flupenthixol decanoate|mesh-list
153337760|NCT00000274|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153337761|NCT00000274|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153337762|NCT00000274|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153337763|NCT00000274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153337764|NCT00000274|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153337765|NCT00000274|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
153337769|NCT02743598|Liraglutide|liraglutide|mesh-list
153337780|NCT00000280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153337781|NCT00000280|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153337782|NCT00000280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153337783|NCT00000280|Vasodilator Agents|vasodilator agents|mesh-ancestor
153337784|NCT00000286|Nefazodone|nefazodone|mesh-list
153337785|NCT00000286|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
153337786|NCT00000286|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153337787|NCT00000286|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153337788|NCT00000286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153337789|NCT00000286|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153337790|NCT00000286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153337791|NCT00000286|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
153337792|NCT00000286|Antidepressive Agents|antidepressive agents|mesh-ancestor
153337793|NCT00000286|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153337794|NCT00000286|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
153337795|NCT00000286|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153337797|NCT01188577|Epinephrine|epinephrine|mesh-list
153337798|NCT01188577|Racepinephrine|racepinephrine|mesh-list
153337799|NCT01188577|Epinephryl borate|epinephryl borate|mesh-list
153337800|NCT01188577|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153337801|NCT01188577|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153337802|NCT01188577|Adrenergic Agents|adrenergic agents|mesh-ancestor
153337803|NCT01188577|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153337804|NCT01188577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153337805|NCT01188577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153337806|NCT01188577|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
153337807|NCT01188577|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153337809|NCT01188577|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153337810|NCT01188577|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153337811|NCT01188577|Respiratory System Agents|respiratory system agents|mesh-ancestor
153337812|NCT01188577|Mydriatics|mydriatics|mesh-ancestor
153337813|NCT01188577|Sympathomimetics|sympathomimetics|mesh-ancestor
153337814|NCT01188577|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
153337815|NCT02507336|Thalidomide|thalidomide|mesh-list
153337816|NCT02507336|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153337817|NCT02507336|Immunologic Factors|immunologic factors|mesh-ancestor
153337818|NCT02507336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153337819|NCT02507336|Leprostatic Agents|leprostatic agents|mesh-ancestor
153337820|NCT02507336|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153337821|NCT02507336|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153337822|NCT02507336|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153337823|NCT02507336|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153337824|NCT02507336|Growth Substances|growth substances|mesh-ancestor
153337825|NCT02507336|Growth Inhibitors|growth inhibitors|mesh-ancestor
153337826|NCT02507336|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153337827|NCT00000292|Cocaine|cocaine|mesh-list
153337828|NCT00000292|Anesthetics, Local|anesthetics, local|mesh-ancestor
153337829|NCT00000292|Anesthetics|anesthetics|mesh-ancestor
153337830|NCT00000292|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153337831|NCT00000292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153337832|NCT00000292|Sensory System Agents|sensory system agents|mesh-ancestor
153337834|NCT00000292|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
153337835|NCT00000292|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
153337836|NCT00000292|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153337837|NCT00000292|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153337838|NCT00000292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153337839|NCT00000292|Dopamine Agents|dopamine agents|mesh-ancestor
153337840|NCT00000292|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153337841|NCT00000298|Buprenorphine|buprenorphine|mesh-list
153880401|NCT02049515|Ofatumumab|ofatumumab|mesh-list
153880402|NCT02049515|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153880403|NCT02046460|Aspirin|aspirin|mesh-list
153880404|NCT02046460|Vitamin K|vitamin k|mesh-list
153880405|NCT02046460|Warfarin|warfarin|mesh-list
153421240|NCT06116578|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153421241|NCT06116578|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153421242|NCT06116578|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153337842|NCT00000298|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
153337843|NCT00000298|Naloxone|naloxone|mesh-list
153337861|NCT00000304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153337862|NCT00000304|Adrenergic Agents|adrenergic agents|mesh-ancestor
153337863|NCT00000304|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
153337864|NCT00000304|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153337865|NCT00000304|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153337866|NCT00000304|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
153337869|NCT02548650|Vorapaxar|vorapaxar|mesh-list
153337870|NCT02548650|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153337871|NCT02548650|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153337872|NCT02548650|Analgesics|analgesics|mesh-ancestor
153337873|NCT02548650|Sensory System Agents|sensory system agents|mesh-ancestor
153337874|NCT02548650|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153337875|NCT02548650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153337876|NCT02548650|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153337877|NCT02548650|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153337878|NCT02548650|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153337879|NCT02548650|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153337880|NCT02548650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153337881|NCT02548650|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153337883|NCT02548650|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153337884|NCT02548650|Antipyretics|antipyretics|mesh-ancestor
153337912|NCT01227655|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
153337913|NCT01227655|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153337914|NCT01227655|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
153337916|NCT00000316|Anesthetics, Local|anesthetics, local|mesh-ancestor
153337917|NCT00000316|Anesthetics|anesthetics|mesh-ancestor
153337918|NCT00000316|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153337919|NCT00000316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153337920|NCT00000316|Sensory System Agents|sensory system agents|mesh-ancestor
153337921|NCT00000316|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153337922|NCT00000316|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
153337923|NCT00000316|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
153337924|NCT00000316|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153337926|NCT00000316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153337928|NCT00000316|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153337929|NCT05459532|Molnupiravir|molnupiravir|mesh-list
153337930|NCT05459532|Antiviral Agents|antiviral agents|mesh-ancestor
153337931|NCT05459532|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153337932|NCT00001990|Atovaquone|atovaquone|mesh-list
153337933|NCT00001990|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153337935|NCT00001990|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153337936|NCT00001990|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153337937|NCT00001990|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153337938|NCT00001990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153337939|NCT01026623|Sirolimus|sirolimus|mesh-list
153337941|NCT01026623|MTOR Inhibitors|mtor inhibitors|mesh-list
153337942|NCT01026623|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
153337943|NCT01026623|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153337944|NCT01026623|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153337945|NCT01026623|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153337946|NCT01026623|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153337955|NCT00001996|Pentamidine|pentamidine|mesh-list
153337956|NCT00001996|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153337957|NCT00001996|Antimalarials|antimalarials|mesh-ancestor
153337958|NCT00001996|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153337959|NCT00001996|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153337960|NCT00001996|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153337961|NCT00001996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153337962|NCT00001996|Antifungal Agents|antifungal agents|mesh-ancestor
153337963|NCT00001996|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
153337964|NCT02725424|Docetaxel|docetaxel|mesh-list
153337965|NCT02725424|Oxaliplatin|oxaliplatin|mesh-list
153337966|NCT02725424|Trastuzumab|trastuzumab|mesh-list
153337967|NCT02725424|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153337968|NCT02725424|Tubulin Modulators|tubulin modulators|mesh-ancestor
153337969|NCT02725424|Antimitotic Agents|antimitotic agents|mesh-ancestor
153337970|NCT02725424|Mitosis Modulators|mitosis modulators|mesh-ancestor
153337971|NCT02725424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153337972|NCT02725424|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153337974|NCT01189279|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153337976|NCT00001108|Nelfinavir|nelfinavir|mesh-list
153337977|NCT00001108|Saquinavir|saquinavir|mesh-list
153337978|NCT00001108|Lamivudine|lamivudine|mesh-list
153337979|NCT00001108|Nevirapine|nevirapine|mesh-list
153337980|NCT00001108|Didanosine|didanosine|mesh-list
153337981|NCT00001108|Stavudine|stavudine|mesh-list
153337982|NCT00001108|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
153337983|NCT00001108|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
153337984|NCT00001108|Protease Inhibitors|protease inhibitors|mesh-ancestor
153337985|NCT00001108|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153337986|NCT00001108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153337988|NCT00001108|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153337989|NCT00001108|Antiviral Agents|antiviral agents|mesh-ancestor
153337990|NCT00001108|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153337991|NCT00001108|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
153337994|NCT00001108|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153337995|NCT00001108|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
153337996|NCT00001108|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
153337997|NCT00001108|Antimetabolites|antimetabolites|mesh-ancestor
153337998|NCT00000328|Analgesics, Opioid|analgesics, opioid|mesh-list
153337999|NCT00000328|Narcotics|narcotics|mesh-ancestor
153783225|NCT02213029|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153338000|NCT00000328|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153338001|NCT00000328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153338002|NCT00000328|Analgesics|analgesics|mesh-ancestor
153338003|NCT00000328|Sensory System Agents|sensory system agents|mesh-ancestor
153338004|NCT00000328|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153338005|NCT00380224|Olanzapine|olanzapine|mesh-list
153338006|NCT00380224|Antiemetics|antiemetics|mesh-ancestor
153338007|NCT00380224|Autonomic Agents|autonomic agents|mesh-ancestor
153338008|NCT00380224|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153338009|NCT00380224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153338010|NCT00380224|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153338011|NCT00380224|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153338012|NCT00380224|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153338015|NCT00380224|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
153338016|NCT00380224|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153338017|NCT00380224|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153338018|NCT00380224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153338019|NCT00380224|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153338020|NCT00380224|Serotonin Agents|serotonin agents|mesh-ancestor
153338021|NCT00002002|Leucovorin|leucovorin|mesh-list
153338022|NCT00002002|Trimethoprim|trimethoprim|mesh-list
153338024|NCT00002002|Calcium|calcium|mesh-list
153338036|NCT00002002|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153338037|NCT00002002|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153338038|NCT00002002|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153338039|NCT00002002|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153338040|NCT00002002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153338041|NCT00002002|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
153338042|NCT00002002|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
153338043|NCT00002002|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153338044|NCT02535000|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
153338045|NCT02535000|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
153338046|NCT02535000|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153338047|NCT02535000|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153338048|NCT02535000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153338050|NCT02535000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153338051|NCT02535000|Analgesics|analgesics|mesh-ancestor
153338052|NCT02535000|Sensory System Agents|sensory system agents|mesh-ancestor
153338053|NCT02535000|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153338054|NCT02535000|Antidepressive Agents|antidepressive agents|mesh-ancestor
153338055|NCT02535000|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153338056|NCT02535000|Dopamine Agents|dopamine agents|mesh-ancestor
153338057|NCT00380380|Vildagliptin|vildagliptin|mesh-list
153338058|NCT00380380|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153338059|NCT00380380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153338060|NCT00380380|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
153338062|NCT00380380|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153338063|NCT00380380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153338064|NCT01228903|Allopurinol|allopurinol|mesh-list
153338065|NCT01228903|Antimetabolites|antimetabolites|mesh-ancestor
153338066|NCT01228903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153338067|NCT01228903|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153338068|NCT01228903|Gout Suppressants|gout suppressants|mesh-ancestor
153338069|NCT01228903|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153338072|NCT01228903|Protective Agents|protective agents|mesh-ancestor
153338073|NCT01228903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153783226|NCT02213029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153783229|NCT02213146|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
153338074|NCT01189747|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
153338075|NCT01189747|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
153338076|NCT01189747|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
153338077|NCT01189747|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153338078|NCT01189747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153338079|NCT01189747|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
153338080|NCT01189747|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153338081|NCT01189747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153338082|NCT01189747|Cholinergic Agents|cholinergic agents|mesh-ancestor
153338083|NCT01189747|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153338084|NCT00001126|Cidofovir|cidofovir|mesh-list
153338085|NCT00001126|Antiviral Agents|antiviral agents|mesh-ancestor
153338086|NCT00001126|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153338087|NCT00001126|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153338088|NCT00001126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153338089|NCT00002008|Sargramostim|sargramostim|mesh-list
153338090|NCT00002008|Immunologic Factors|immunologic factors|mesh-ancestor
153338091|NCT00002008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153338092|NCT00001132|Abacavir|abacavir|mesh-list
153338093|NCT00001132|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153338094|NCT00001132|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153338095|NCT00001132|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153338096|NCT00001132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153338098|NCT00001132|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153338099|NCT00001132|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153338100|NCT00001132|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153338101|NCT01149733|Tamsulosin|tamsulosin|mesh-list
153338104|NCT01149733|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
153338108|NCT01149733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153338109|NCT01149733|Urological Agents|urological agents|mesh-ancestor
153338110|NCT00002014|Zidovudine|zidovudine|mesh-list
153338111|NCT00002014|Didanosine|didanosine|mesh-list
153338112|NCT00002014|Antimetabolites|antimetabolites|mesh-ancestor
153338113|NCT00002014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153880406|NCT02046460|Acenocoumarol|acenocoumarol|mesh-list
153880407|NCT02046460|Phenprocoumon|phenprocoumon|mesh-list
153338114|NCT00002014|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153338115|NCT00002014|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153338116|NCT00002014|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153338117|NCT00002014|Antiviral Agents|antiviral agents|mesh-ancestor
153338118|NCT00002014|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153338119|NCT00002014|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153338120|NCT00002014|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153338121|NCT00000334|Buprenorphine|buprenorphine|mesh-list
153338122|NCT00000334|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153338123|NCT00000334|Narcotics|narcotics|mesh-ancestor
153338124|NCT00000334|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153338125|NCT00000334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153338126|NCT00000334|Analgesics|analgesics|mesh-ancestor
153338127|NCT00000334|Sensory System Agents|sensory system agents|mesh-ancestor
153338128|NCT00000334|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153338129|NCT00000334|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
153338131|NCT00000340|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
153338132|NCT00000340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153338134|NCT00002020|Antimetabolites|antimetabolites|mesh-ancestor
153338135|NCT00002020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153338136|NCT00002020|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153338137|NCT00002020|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153338138|NCT00002020|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153338139|NCT00002020|Antiviral Agents|antiviral agents|mesh-ancestor
153338140|NCT00002020|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153338141|NCT00002020|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153338142|NCT00002020|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153338143|NCT00002026|Acyclovir|acyclovir|mesh-list
153338144|NCT00002026|Antiviral Agents|antiviral agents|mesh-ancestor
153338147|NCT00000352|Dextromethorphan|dextromethorphan|mesh-list
153338148|NCT00000352|Antitussive Agents|antitussive agents|mesh-ancestor
153338149|NCT00000352|Respiratory System Agents|respiratory system agents|mesh-ancestor
153338150|NCT00000352|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
153338151|NCT00000352|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
153338152|NCT00000352|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153338153|NCT00000352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153338154|NCT00000352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153338155|NCT00000352|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153338156|NCT00000352|Narcotics|narcotics|mesh-ancestor
153338157|NCT00000352|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153338158|NCT00000352|Analgesics|analgesics|mesh-ancestor
153338159|NCT00000352|Sensory System Agents|sensory system agents|mesh-ancestor
153338160|NCT00000352|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153338162|NCT00002032|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153338163|NCT00002032|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153338164|NCT00002032|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
153338165|NCT00002032|Antitubercular Agents|antitubercular agents|mesh-ancestor
153338166|NCT01229527|Meperidine|meperidine|mesh-list
153338167|NCT01229527|Remifentanil|remifentanil|mesh-list
153338168|NCT01229527|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153338169|NCT01229527|Narcotics|narcotics|mesh-ancestor
153338170|NCT01229527|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153338171|NCT01229527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153880408|NCT02046460|Vitamins|vitamins|mesh-ancestor
153338173|NCT01229527|Sensory System Agents|sensory system agents|mesh-ancestor
153338174|NCT01229527|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153338175|NCT01229527|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153338176|NCT02723162|Acetylcysteine|acetylcysteine|mesh-list
153338177|NCT02723162|Varenicline|varenicline|mesh-list
153338178|NCT02723162|N-monoacetylcystine|n-monoacetylcystine|mesh-list
153338179|NCT02723162|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
153338180|NCT02723162|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
153338181|NCT02723162|Cholinergic Agents|cholinergic agents|mesh-ancestor
153338182|NCT02723162|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153338183|NCT02723162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153338184|NCT02723162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153338185|NCT02723162|Antiviral Agents|antiviral agents|mesh-ancestor
153338186|NCT02723162|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153338188|NCT02723162|Respiratory System Agents|respiratory system agents|mesh-ancestor
153338189|NCT02723162|Free Radical Scavengers|free radical scavengers|mesh-ancestor
153338190|NCT02723162|Antioxidants|antioxidants|mesh-ancestor
153338191|NCT02723162|Protective Agents|protective agents|mesh-ancestor
153338192|NCT02723162|Antidotes|antidotes|mesh-ancestor
153338193|NCT00000358|Lofexidine|lofexidine|mesh-list
153338194|NCT00000358|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153338195|NCT00000358|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
153338196|NCT00000358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153338197|NCT00000358|Sensory System Agents|sensory system agents|mesh-ancestor
153338198|NCT00000358|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153338200|NCT00000358|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153338201|NCT00000358|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153338202|NCT00000358|Adrenergic Agents|adrenergic agents|mesh-ancestor
153338203|NCT00000358|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153338204|NCT00000358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153338205|NCT00000376|Desipramine|desipramine|mesh-list
153338206|NCT00000376|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
153338209|NCT00000376|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153338210|NCT00000376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153338211|NCT00000376|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
153338212|NCT00000376|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153338213|NCT00000376|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153338214|NCT00000376|Adrenergic Agents|adrenergic agents|mesh-ancestor
153338215|NCT00000376|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153338216|NCT00000376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153338220|NCT02143388|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153338222|NCT02143388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153338223|NCT00001228|Interferons|interferons|mesh-list
153338224|NCT00001228|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153338226|NCT00001228|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153338227|NCT00002038|Fluconazole|fluconazole|mesh-list
153338228|NCT00002038|Antifungal Agents|antifungal agents|mesh-ancestor
153338229|NCT00002038|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153338230|NCT00002038|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
153338231|NCT00002038|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153338232|NCT00002038|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153338233|NCT00002038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153338234|NCT00002038|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153338236|NCT00002038|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153338237|NCT00002038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153338238|NCT00002038|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
153338239|NCT00002038|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
153338241|NCT01894334|Tranexamic Acid|tranexamic acid|mesh-list
153338242|NCT01894334|Urinastatin|urinastatin|mesh-list
153338243|NCT01894334|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
153338244|NCT01894334|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153338245|NCT01894334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153338246|NCT01894334|Hemostatics|hemostatics|mesh-ancestor
153338247|NCT01894334|Coagulants|coagulants|mesh-ancestor
153338248|NCT01894334|Free Radical Scavengers|free radical scavengers|mesh-ancestor
153338249|NCT01894334|Antioxidants|antioxidants|mesh-ancestor
153338250|NCT01894334|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
153338251|NCT01894334|Protective Agents|protective agents|mesh-ancestor
153338252|NCT01894334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153338263|NCT00002044|Antiviral Agents|antiviral agents|mesh-ancestor
153338264|NCT00002044|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153338265|NCT00002044|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153338266|NCT00002044|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153338267|NCT00001282|Zidovudine|zidovudine|mesh-list
153338268|NCT00001282|Interleukin-2|interleukin-2|mesh-list
153338269|NCT00001282|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153338270|NCT00001282|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153338271|NCT00001282|Analgesics|analgesics|mesh-ancestor
153338272|NCT00001282|Sensory System Agents|sensory system agents|mesh-ancestor
153338273|NCT00001282|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153338274|NCT00001282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153338275|NCT00001282|Antimetabolites|antimetabolites|mesh-ancestor
153338276|NCT00001282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153338277|NCT00001282|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153338278|NCT00001282|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153338279|NCT00001282|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153338283|NCT00001282|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153338284|NCT01150981|Rosiglitazone|rosiglitazone|mesh-list
153338285|NCT01150981|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153338286|NCT01150981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153338287|NCT00001300|Doxorubicin|doxorubicin|mesh-list
153338288|NCT00001300|Ifosfamide|ifosfamide|mesh-list
153338289|NCT00001300|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153338290|NCT00001300|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153338291|NCT00001300|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153783232|NCT00268749|Glycine|glycine|mesh-list
153783233|NCT00268749|Glycine Agents|glycine agents|mesh-ancestor
153338292|NCT00001300|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153783234|NCT00268749|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153783235|NCT00268749|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153783236|NCT00268749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153783240|NCT00235898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153783241|NCT00235898|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153783242|NCT00235898|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153783243|NCT00235898|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153783244|NCT00235898|Immunologic Factors|immunologic factors|mesh-ancestor
153338293|NCT00001300|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153338294|NCT00001300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153338295|NCT00001300|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153338296|NCT00001300|Alkylating Agents|alkylating agents|mesh-ancestor
153338297|NCT00000400|Alendronate|alendronate|mesh-list
153338298|NCT00000400|Teriparatide|teriparatide|mesh-list
153338299|NCT00000400|Hormones|hormones|mesh-list
153338300|NCT00000400|Parathyroid Hormone|parathyroid hormone|mesh-list
153338301|NCT00000400|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153338302|NCT00000400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153338303|NCT00000400|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153338304|NCT00000400|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153338306|NCT01195597|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
153338307|NCT01195597|Autonomic Agents|autonomic agents|mesh-ancestor
153338308|NCT01195597|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153338311|NCT01195597|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
153338312|NCT01195597|Cholinergic Agents|cholinergic agents|mesh-ancestor
153338313|NCT01195597|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153338314|NCT01195597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153338315|NCT00002050|Thymopentin|thymopentin|mesh-list
153338316|NCT00002050|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153338317|NCT00002050|Immunologic Factors|immunologic factors|mesh-ancestor
153338318|NCT00002050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153338332|NCT00002056|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153338333|NCT00002056|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153338334|NCT00002056|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153338335|NCT00002056|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
153338337|NCT03110562|Bortezomib|bortezomib|mesh-list
153338338|NCT03110562|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153338339|NCT03110562|Antiemetics|antiemetics|mesh-ancestor
153338340|NCT03110562|Autonomic Agents|autonomic agents|mesh-ancestor
153338341|NCT03110562|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153338342|NCT03110562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153338343|NCT03110562|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153338344|NCT03110562|Glucocorticoids|glucocorticoids|mesh-ancestor
153338345|NCT03110562|Hormones|hormones|mesh-ancestor
153338346|NCT03110562|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153338347|NCT03110562|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153338348|NCT03110562|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153338349|NCT00380614|Lamivudine|lamivudine|mesh-list
153338350|NCT00380614|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153338351|NCT00380614|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153338352|NCT00380614|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153338353|NCT00380614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153338354|NCT00380614|Antiviral Agents|antiviral agents|mesh-ancestor
153338355|NCT00380614|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153338356|NCT00380614|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153338357|NCT00380614|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153338358|NCT00000430|Alendronate|alendronate|mesh-list
153338381|NCT01231399|Everolimus|everolimus|mesh-list
153338382|NCT01231399|Calcium|calcium|mesh-list
153338383|NCT01231399|Levoleucovorin|levoleucovorin|mesh-list
153338386|NCT01231399|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153338387|NCT01231399|Antimetabolites|antimetabolites|mesh-ancestor
153338388|NCT01231399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153338389|NCT01231399|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153338390|NCT01231399|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153338391|NCT01231399|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153338392|NCT01231399|Immunologic Factors|immunologic factors|mesh-ancestor
153338393|NCT01231399|Antidotes|antidotes|mesh-ancestor
153338394|NCT01231399|Protective Agents|protective agents|mesh-ancestor
153338395|NCT01231399|Vitamin B Complex|vitamin b complex|mesh-ancestor
153338396|NCT01231399|Vitamins|vitamins|mesh-ancestor
153338397|NCT01231399|Micronutrients|micronutrients|mesh-ancestor
153338398|NCT01231399|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
153338399|NCT01231399|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153338400|NCT01231399|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153338401|NCT00002062|Spiramycin|spiramycin|mesh-list
153338402|NCT00002062|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153338403|NCT00002062|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153338404|NCT00002062|Coccidiostats|coccidiostats|mesh-ancestor
153338405|NCT00002062|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153338407|NCT01231633|Dexamethasone|dexamethasone|mesh-list
153338408|NCT01231633|Bevacizumab|bevacizumab|mesh-list
153338409|NCT01231633|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153338410|NCT01231633|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153338411|NCT01231633|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153338412|NCT01231633|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153338413|NCT01231633|Growth Substances|growth substances|mesh-ancestor
153338414|NCT01231633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153338415|NCT01231633|Growth Inhibitors|growth inhibitors|mesh-ancestor
153338416|NCT01231633|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153338417|NCT01231633|Antiemetics|antiemetics|mesh-ancestor
153338422|NCT01231633|Hormones|hormones|mesh-ancestor
153338426|NCT00000442|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
153338427|NCT00000442|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
153338428|NCT00000442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153338429|NCT00000442|Sensory System Agents|sensory system agents|mesh-ancestor
153338430|NCT00000442|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153338431|NCT00002068|Fluconazole|fluconazole|mesh-list
153338432|NCT00002068|Amphotericin B|amphotericin b|mesh-list
153338433|NCT00002068|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
153338434|NCT00002068|Antifungal Agents|antifungal agents|mesh-ancestor
153783245|NCT00235898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153338436|NCT00002068|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
153338437|NCT00002068|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153338438|NCT00002068|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153338439|NCT00002068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153338440|NCT00002068|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153338441|NCT00002068|Hormone Antagonists|hormone antagonists|mesh-ancestor
153338442|NCT00002068|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153338443|NCT00002068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153338444|NCT00002068|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
153338445|NCT00002068|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
153338446|NCT00002068|Amebicides|amebicides|mesh-ancestor
153338447|NCT00002068|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153338448|NCT00002068|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153338449|NCT00002068|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153338450|NCT00000448|Naltrexone|naltrexone|mesh-list
153338451|NCT00000448|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
153338472|NCT00002074|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153338473|NCT00002074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153338474|NCT00002074|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
153338475|NCT00002074|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
153338477|NCT00002074|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153338478|NCT00002074|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153338479|NCT00002074|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153338480|NCT00001354|Zidovudine|zidovudine|mesh-list
153338481|NCT00001354|Interleukin-2|interleukin-2|mesh-list
153338482|NCT00001354|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153338483|NCT00001354|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153338484|NCT00001354|Analgesics|analgesics|mesh-ancestor
153338485|NCT00001354|Sensory System Agents|sensory system agents|mesh-ancestor
153338486|NCT00001354|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153338487|NCT00001354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153338488|NCT00001354|Antimetabolites|antimetabolites|mesh-ancestor
153338489|NCT00001354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153338491|NCT00001354|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153338492|NCT00001354|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153338493|NCT00001354|Antiviral Agents|antiviral agents|mesh-ancestor
153338494|NCT00001354|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153338495|NCT00001354|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153338496|NCT00001354|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153338497|NCT00000454|Nicotine|nicotine|mesh-list
153338498|NCT00000454|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
153338499|NCT00000454|Autonomic Agents|autonomic agents|mesh-ancestor
153338500|NCT00000454|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153338516|NCT00000484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153338517|NCT00000484|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
153338518|NCT00000484|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153338519|NCT00000484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153338521|NCT00000496|Dipyridamole|dipyridamole|mesh-list
153338522|NCT00000496|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153338523|NCT00000496|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153338524|NCT00000496|Analgesics|analgesics|mesh-ancestor
153338525|NCT00000496|Sensory System Agents|sensory system agents|mesh-ancestor
153338526|NCT00000496|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153338528|NCT00000496|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153338529|NCT00000496|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153338530|NCT00000496|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153338531|NCT00000496|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153338532|NCT00000496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153338533|NCT00000496|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153338534|NCT00000496|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153338535|NCT00000496|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153338536|NCT00000496|Antipyretics|antipyretics|mesh-ancestor
153338537|NCT00000496|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
153338538|NCT00000496|Vasodilator Agents|vasodilator agents|mesh-ancestor
153338539|NCT00002086|Interferons|interferons|mesh-list
153338540|NCT00002086|Interferon-alpha|interferon-alpha|mesh-list
153338542|NCT00002086|Zalcitabine|zalcitabine|mesh-list
153338543|NCT00002086|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153338544|NCT00002086|Antiviral Agents|antiviral agents|mesh-ancestor
153338545|NCT00002086|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153338546|NCT00002086|Immunologic Factors|immunologic factors|mesh-ancestor
153338547|NCT00002086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153338548|NCT00002086|Antimetabolites|antimetabolites|mesh-ancestor
153338549|NCT00002086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153338550|NCT00002086|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153338552|NCT00002086|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153338553|NCT00002086|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153423376|NCT03306589|Cantharidin|cantharidin|mesh-list
153423377|NCT03306589|Immunologic Factors|immunologic factors|mesh-ancestor
153423378|NCT03306589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153423379|NCT03306589|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153338555|NCT01151449|2,2-dimethyl-N-(6-oxo-6,7-dihydro-5H-dibenzo(b,d)azepin-7-yl)-N'-(2,2,3,3,3-pentafluoropropyl)malonamide|2,2-dimethyl-n-(6-oxo-6,7-dihydro-5h-dibenzo(b,d)azepin-7-yl)-n'-(2,2,3,3,3-pentafluoropropyl)malonamide|mesh-list
153338556|NCT01151449|Gamma Secretase Inhibitors and Modulators|gamma secretase inhibitors and modulators|mesh-ancestor
153338557|NCT01151449|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153338558|NCT01151449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153338559|NCT00001384|Paclitaxel|paclitaxel|mesh-list
153338560|NCT00001384|Cyclophosphamide|cyclophosphamide|mesh-list
153338561|NCT00001384|Doxorubicin|doxorubicin|mesh-list
153338562|NCT00001384|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
153338563|NCT00001384|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153338564|NCT00001384|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153338565|NCT00001384|Tubulin Modulators|tubulin modulators|mesh-ancestor
153338566|NCT00001384|Antimitotic Agents|antimitotic agents|mesh-ancestor
153338567|NCT00001384|Mitosis Modulators|mitosis modulators|mesh-ancestor
153338568|NCT00001384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153338569|NCT00001384|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153880428|NCT02046460|Coagulants|coagulants|mesh-ancestor
153880429|NCT02004522|Ofatumumab|ofatumumab|mesh-list
153338570|NCT00001384|Immunologic Factors|immunologic factors|mesh-ancestor
153338571|NCT00001384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153338572|NCT00001384|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153338573|NCT00001384|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153338574|NCT00001384|Alkylating Agents|alkylating agents|mesh-ancestor
153338575|NCT00001384|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153338577|NCT00001384|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153338578|NCT00001384|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153338579|NCT00001384|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153338581|NCT01151761|Carboplatin|carboplatin|mesh-list
153338582|NCT01151761|Gemcitabine|gemcitabine|mesh-list
153338583|NCT01151761|Capecitabine|capecitabine|mesh-list
153338584|NCT01151761|Fluorouracil|fluorouracil|mesh-list
153338585|NCT01151761|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153338586|NCT01151761|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153338587|NCT01151761|Antimetabolites|antimetabolites|mesh-ancestor
153338590|NCT01151761|Immunologic Factors|immunologic factors|mesh-ancestor
153338591|NCT01151761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153338593|NCT00002092|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
153338594|NCT00002092|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153338595|NCT00002092|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
153338596|NCT00002092|Histamine Antagonists|histamine antagonists|mesh-ancestor
153338597|NCT00002092|Histamine Agents|histamine agents|mesh-ancestor
153338598|NCT00002092|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153338599|NCT00002092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153338600|NCT00002092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153338601|NCT00002092|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
153338602|NCT00002092|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153338603|NCT00002092|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153338605|NCT00002098|Lentinan|lentinan|mesh-list
153338606|NCT00002098|Antimetabolites|antimetabolites|mesh-ancestor
153338607|NCT00002098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153338608|NCT00002098|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153338609|NCT00002098|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153338611|NCT00002098|Antiviral Agents|antiviral agents|mesh-ancestor
153338612|NCT00002098|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153338614|NCT00002098|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153338615|NCT00002098|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153338616|NCT00002098|Immunologic Factors|immunologic factors|mesh-ancestor
153338619|NCT01196377|Albuterol|albuterol|mesh-list
153338638|NCT00001426|Tubulin Modulators|tubulin modulators|mesh-ancestor
153338639|NCT00001426|Antimitotic Agents|antimitotic agents|mesh-ancestor
153338640|NCT00001426|Mitosis Modulators|mitosis modulators|mesh-ancestor
153338641|NCT00001426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153338642|NCT00001426|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153338643|NCT00001426|Immunologic Factors|immunologic factors|mesh-ancestor
153338644|NCT00001426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153338645|NCT00001426|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153338646|NCT00001426|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153338647|NCT00001426|Alkylating Agents|alkylating agents|mesh-ancestor
153338648|NCT00001426|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153338649|NCT00002104|Thalidomide|thalidomide|mesh-list
153338650|NCT00002104|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153338651|NCT00002104|Immunologic Factors|immunologic factors|mesh-ancestor
153338652|NCT00002104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153338653|NCT00002104|Leprostatic Agents|leprostatic agents|mesh-ancestor
153338654|NCT00002104|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153338655|NCT00002104|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153338656|NCT00002104|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153338658|NCT00002104|Growth Substances|growth substances|mesh-ancestor
153338659|NCT00002104|Growth Inhibitors|growth inhibitors|mesh-ancestor
153783247|NCT00235898|Protective Agents|protective agents|mesh-ancestor
153338660|NCT00002104|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153338661|NCT00001438|Interferon alpha-2|interferon alpha-2|mesh-list
153338662|NCT00001438|Tretinoin|tretinoin|mesh-list
153338685|NCT00002110|Zidovudine|zidovudine|mesh-list
153338686|NCT00002110|Cysteamine|cysteamine|mesh-list
153338687|NCT00002110|Antimetabolites|antimetabolites|mesh-ancestor
153338688|NCT00002110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153338689|NCT00002110|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153338690|NCT00002110|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153338691|NCT00002110|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153338692|NCT00002110|Antiviral Agents|antiviral agents|mesh-ancestor
153338693|NCT00002110|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153338694|NCT00002110|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153338695|NCT00002110|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153338696|NCT00002110|Cystine Depleting Agents|cystine depleting agents|mesh-ancestor
153338697|NCT00001450|Paclitaxel|paclitaxel|mesh-list
153338698|NCT00001450|Cisplatin|cisplatin|mesh-list
153338699|NCT00001450|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153338700|NCT00001450|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153338701|NCT00001450|Tubulin Modulators|tubulin modulators|mesh-ancestor
153338702|NCT00001450|Antimitotic Agents|antimitotic agents|mesh-ancestor
153338703|NCT00001450|Mitosis Modulators|mitosis modulators|mesh-ancestor
153338704|NCT00001450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153338705|NCT00000580|Immunoglobulins|immunoglobulins|mesh-list
153338706|NCT00000580|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
153338707|NCT00000580|Antibodies|antibodies|mesh-list
153338708|NCT00000580|gamma-Globulins|gamma-globulins|mesh-list
153338709|NCT00000580|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
153338712|NCT00002116|Cidofovir|cidofovir|mesh-list
153338713|NCT00002116|Antiviral Agents|antiviral agents|mesh-ancestor
153338714|NCT00002116|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153338715|NCT00002116|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153338716|NCT00002116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153338717|NCT00001498|Leucovorin|leucovorin|mesh-list
153338718|NCT00001498|Paclitaxel|paclitaxel|mesh-list
153338719|NCT00001498|Cyclophosphamide|cyclophosphamide|mesh-list
153338720|NCT00001498|Doxorubicin|doxorubicin|mesh-list
153338721|NCT00001498|Fluorouracil|fluorouracil|mesh-list
153338728|NCT00001498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153338729|NCT00001498|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153338730|NCT00001498|Immunologic Factors|immunologic factors|mesh-ancestor
153338731|NCT00001498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153338732|NCT00001498|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153338733|NCT00001498|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153338734|NCT00001498|Alkylating Agents|alkylating agents|mesh-ancestor
153783248|NCT00235898|Vitamin B Complex|vitamin b complex|mesh-ancestor
153783249|NCT00235898|Vitamins|vitamins|mesh-ancestor
153783250|NCT00235898|Micronutrients|micronutrients|mesh-ancestor
153421283|NCT06091865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153421284|NCT06091865|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153421285|NCT06091865|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153338735|NCT00001498|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153338736|NCT00001498|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153338737|NCT00001498|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153338739|NCT00001498|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153338740|NCT00001498|Antimetabolites|antimetabolites|mesh-ancestor
153338741|NCT00001498|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153338742|NCT00001498|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
153338743|NCT00001498|Abortifacient Agents|abortifacient agents|mesh-ancestor
153338744|NCT00001498|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153338745|NCT00001498|Dermatologic Agents|dermatologic agents|mesh-ancestor
153338748|NCT00001498|Antidotes|antidotes|mesh-ancestor
153338776|NCT02688140|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153338777|NCT02688140|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153338778|NCT02688140|Immunologic Factors|immunologic factors|mesh-ancestor
153338779|NCT02688140|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153338780|NCT02688140|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153338781|NCT02688140|Antiviral Agents|antiviral agents|mesh-ancestor
153338782|NCT02688140|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153338783|NCT02688140|Analgesics|analgesics|mesh-ancestor
153338784|NCT02688140|Sensory System Agents|sensory system agents|mesh-ancestor
153338785|NCT02688140|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153338786|NCT02688140|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153338787|NCT02688140|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153338788|NCT02688140|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153338789|NCT02688140|Keratolytic Agents|keratolytic agents|mesh-ancestor
153338791|NCT00002122|Rifabutin|rifabutin|mesh-list
153338792|NCT00002122|Fluconazole|fluconazole|mesh-list
153338793|NCT00002122|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153338794|NCT00002122|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153338795|NCT00002122|Antifungal Agents|antifungal agents|mesh-ancestor
153338796|NCT00002122|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
153338797|NCT00002122|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153338798|NCT00002122|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153338799|NCT00002122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153338800|NCT00002122|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153338801|NCT00002122|Hormone Antagonists|hormone antagonists|mesh-ancestor
153338802|NCT00002122|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153338803|NCT00002122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153783253|NCT02213224|Perindopril|perindopril|mesh-list
153338816|NCT01027559|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153338817|NCT01027559|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
153880438|NCT01752049|Maleic acid|maleic acid|mesh-list
153880439|NCT01752049|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153880440|NCT01752049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153880441|NCT01752049|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
153880442|NCT01752049|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
153880443|NCT01752049|Adrenergic Agents|adrenergic agents|mesh-ancestor
153880444|NCT01752049|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153338819|NCT01027559|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153338820|NCT01027559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153338821|NCT01027559|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153338822|NCT01027559|Serotonin Agents|serotonin agents|mesh-ancestor
153338823|NCT01027559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153338825|NCT00002128|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
153338826|NCT00002128|Antiviral Agents|antiviral agents|mesh-ancestor
153338827|NCT00002128|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153338828|NCT00002128|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153338829|NCT00002128|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153338830|NCT00002128|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153338831|NCT00002128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153338833|NCT00001570|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153338834|NCT00001570|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153338835|NCT00001570|Tubulin Modulators|tubulin modulators|mesh-ancestor
153338836|NCT00001570|Antimitotic Agents|antimitotic agents|mesh-ancestor
153338837|NCT00001570|Mitosis Modulators|mitosis modulators|mesh-ancestor
153338838|NCT00001570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153338839|NCT00000628|Zidovudine|zidovudine|mesh-list
153338840|NCT00000628|L-697661|l-697661|mesh-list
153338841|NCT00000628|Antimetabolites|antimetabolites|mesh-ancestor
153338843|NCT00000628|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153338844|NCT00000628|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153338845|NCT00000628|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153338846|NCT00000628|Antiviral Agents|antiviral agents|mesh-ancestor
153338847|NCT00000628|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153338848|NCT00000628|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153338849|NCT00000628|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153338851|NCT00000634|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153338852|NCT00000634|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153338853|NCT00000634|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153882482|NCT01688583|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153882483|NCT01688583|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153882484|NCT01688583|Anesthetics, General|anesthetics, general|mesh-ancestor
153882485|NCT01688583|Anesthetics|anesthetics|mesh-ancestor
153882486|NCT01648829|Atorvastatin|atorvastatin|mesh-list
153882487|NCT01648829|Pitavastatin|pitavastatin|mesh-list
153338854|NCT00000634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153338855|NCT00000634|Antiviral Agents|antiviral agents|mesh-ancestor
153338856|NCT00000634|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153338857|NCT00000634|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153338858|NCT00000634|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153338859|NCT00000634|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
153338860|NCT00000634|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
153338862|NCT01661790|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153338863|NCT01661790|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153338864|NCT01661790|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153338865|NCT01661790|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153338866|NCT01661790|Growth Substances|growth substances|mesh-ancestor
153338870|NCT00002134|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
153338876|NCT00985907|Bortezomib|bortezomib|mesh-list
153338902|NCT00000658|Cyclophosphamide|cyclophosphamide|mesh-list
153338904|NCT00000658|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
153338905|NCT00000658|Methotrexate|methotrexate|mesh-list
153338906|NCT00000658|Vincristine|vincristine|mesh-list
153338907|NCT00000658|Bleomycin|bleomycin|mesh-list
153338908|NCT00000658|Allopurinol|allopurinol|mesh-list
153338909|NCT00000658|Sargramostim|sargramostim|mesh-list
153338910|NCT00000658|Levoleucovorin|levoleucovorin|mesh-list
153338911|NCT00000658|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153338912|NCT00000658|Immunologic Factors|immunologic factors|mesh-ancestor
153338913|NCT00000658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153338914|NCT00000658|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153338915|NCT00000658|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153338916|NCT00000658|Alkylating Agents|alkylating agents|mesh-ancestor
153338917|NCT00000658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153338918|NCT00000658|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153338919|NCT00000658|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153338920|NCT00000658|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153338922|NCT00000658|Autonomic Agents|autonomic agents|mesh-ancestor
153338923|NCT00000658|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153338924|NCT00000658|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153338925|NCT00000658|Glucocorticoids|glucocorticoids|mesh-ancestor
153338926|NCT00000658|Hormones|hormones|mesh-ancestor
153338953|NCT00000658|Free Radical Scavengers|free radical scavengers|mesh-ancestor
153338954|NCT00000658|Antioxidants|antioxidants|mesh-ancestor
153338955|NCT01027793|Tretinoin|tretinoin|mesh-list
153338956|NCT01027793|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153338957|NCT01027793|Keratolytic Agents|keratolytic agents|mesh-ancestor
153338958|NCT01027793|Dermatologic Agents|dermatologic agents|mesh-ancestor
153338959|NCT00002146|Foscarnet|foscarnet|mesh-list
153338960|NCT00002146|Phosphonoacetic Acid|phosphonoacetic acid|mesh-list
153338961|NCT00002146|Magnesium Sulfate|magnesium sulfate|mesh-list
153338962|NCT00002146|Analgesics|analgesics|mesh-ancestor
153338963|NCT00002146|Sensory System Agents|sensory system agents|mesh-ancestor
153338964|NCT00002146|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153338965|NCT00002146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153338966|NCT00002146|Anesthetics|anesthetics|mesh-ancestor
153338967|NCT00002146|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153338968|NCT00002146|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153338969|NCT00002146|Anticonvulsants|anticonvulsants|mesh-ancestor
153338970|NCT00002146|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153338971|NCT00002146|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153338972|NCT00002146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153338973|NCT00002146|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153338974|NCT00002146|Tocolytic Agents|tocolytic agents|mesh-ancestor
153338975|NCT00002146|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153338976|NCT00002146|Antiviral Agents|antiviral agents|mesh-ancestor
153339005|NCT00000664|Antiviral Agents|antiviral agents|mesh-ancestor
153339006|NCT00000664|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153339007|NCT00000664|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153339008|NCT00000664|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153421306|NCT06048809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153339012|NCT00000670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153339013|NCT00000670|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153339014|NCT00000670|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153339015|NCT00000670|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153339016|NCT00000670|Antiviral Agents|antiviral agents|mesh-ancestor
153339017|NCT00000670|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153339018|NCT00000670|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153339019|NCT00000670|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153339020|NCT00000670|Uricosuric Agents|uricosuric agents|mesh-ancestor
153339021|NCT00000670|Gout Suppressants|gout suppressants|mesh-ancestor
153339022|NCT00000670|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153339023|NCT00002158|Nitazoxanide|nitazoxanide|mesh-list
153339024|NCT00002158|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153339025|NCT00002158|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153339026|NCT00000694|Interferons|interferons|mesh-list
153339027|NCT00000694|Interferon-alpha|interferon-alpha|mesh-list
153339028|NCT00000694|Interferon alpha-2|interferon alpha-2|mesh-list
153339030|NCT00000694|Sargramostim|sargramostim|mesh-list
153339031|NCT00000694|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153339033|NCT00000694|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153339034|NCT00000694|Immunologic Factors|immunologic factors|mesh-ancestor
153339035|NCT00000694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153339036|NCT00000694|Antimetabolites|antimetabolites|mesh-ancestor
153339053|NCT01894412|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153339054|NCT01894412|Immunologic Factors|immunologic factors|mesh-ancestor
153339055|NCT00000700|Zidovudine|zidovudine|mesh-list
153339056|NCT00000700|Antimetabolites|antimetabolites|mesh-ancestor
153339057|NCT00000700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153339058|NCT00000700|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153339059|NCT00000700|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153339060|NCT00000700|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153339061|NCT00000700|Antiviral Agents|antiviral agents|mesh-ancestor
153339062|NCT00000700|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153339063|NCT00000700|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153339064|NCT00000700|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153339065|NCT00002164|Nelfinavir|nelfinavir|mesh-list
153339066|NCT00002164|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
153339068|NCT00002164|Protease Inhibitors|protease inhibitors|mesh-ancestor
153339069|NCT00002164|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153339070|NCT00002164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153339071|NCT00002164|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153339072|NCT00002164|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153339073|NCT00002164|Antiviral Agents|antiviral agents|mesh-ancestor
153880454|NCT01747447|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153880455|NCT01747447|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153880456|NCT01724346|Chlorambucil|chlorambucil|mesh-list
153880457|NCT01724346|Ibrutinib|ibrutinib|mesh-list
153880458|NCT01724346|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153880459|NCT01724346|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153880460|NCT01724346|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153880461|NCT01724346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153880462|NCT01724346|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153880463|NCT01724346|Alkylating Agents|alkylating agents|mesh-ancestor
153880464|NCT01724346|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153880465|NCT01659658|Thalidomide|thalidomide|mesh-list
153339074|NCT00002164|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153339075|NCT00000706|Zidovudine|zidovudine|mesh-list
153339076|NCT00000706|Quinine|quinine|mesh-list
153339077|NCT00000706|Probenecid|probenecid|mesh-list
153339079|NCT00000706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153339080|NCT00000706|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153339081|NCT00000706|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153339082|NCT00000706|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153423393|NCT03315559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153423394|NCT03239522|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
153423395|NCT03239522|Glycine|glycine|mesh-list
153423396|NCT03239522|Glycine Agents|glycine agents|mesh-ancestor
153423397|NCT03239522|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153339083|NCT00000706|Antiviral Agents|antiviral agents|mesh-ancestor
153339084|NCT00000706|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153339085|NCT00000706|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153339094|NCT00000706|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153339095|NCT00000706|Analgesics|analgesics|mesh-ancestor
153339096|NCT00000706|Sensory System Agents|sensory system agents|mesh-ancestor
153339097|NCT00000706|Uricosuric Agents|uricosuric agents|mesh-ancestor
153339098|NCT00000706|Gout Suppressants|gout suppressants|mesh-ancestor
153339099|NCT00000706|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153339100|NCT00988325|Oseltamivir|oseltamivir|mesh-list
153339101|NCT00988325|Antiviral Agents|antiviral agents|mesh-ancestor
153339102|NCT00988325|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153339103|NCT00988325|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153339104|NCT00988325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153339105|NCT00002296|Inosine Pranobex|inosine pranobex|mesh-list
153339106|NCT00002296|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153339107|NCT00002296|Immunologic Factors|immunologic factors|mesh-ancestor
153339108|NCT00002296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153339109|NCT00002296|Antiviral Agents|antiviral agents|mesh-ancestor
153339110|NCT00002296|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153339111|NCT00002302|Epoetin Alfa|epoetin alfa|mesh-list
153339112|NCT00002302|Hematinics|hematinics|mesh-ancestor
153339113|NCT00002170|Nelfinavir|nelfinavir|mesh-list
153339114|NCT00002170|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
153339115|NCT00002170|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
153339118|NCT00002170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153339119|NCT00002170|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153339120|NCT00002170|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153339121|NCT00002170|Antiviral Agents|antiviral agents|mesh-ancestor
153339122|NCT00002170|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153339123|NCT00002308|Stavudine|stavudine|mesh-list
153339124|NCT00002308|Antimetabolites|antimetabolites|mesh-ancestor
153339126|NCT00002308|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153339140|NCT00000724|Protective Agents|protective agents|mesh-ancestor
153339141|NCT00000724|Vitamin B Complex|vitamin b complex|mesh-ancestor
153339143|NCT00000724|Micronutrients|micronutrients|mesh-ancestor
153339144|NCT00000724|Antifungal Agents|antifungal agents|mesh-ancestor
153339145|NCT00000724|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153339146|NCT00000724|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153339147|NCT00000724|Antimetabolites|antimetabolites|mesh-ancestor
153339148|NCT00000724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153339149|NCT00000724|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153339150|NCT00000724|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153339151|NCT00000724|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153339152|NCT00000730|Leucovorin|leucovorin|mesh-list
153339153|NCT00000730|Trimethoprim|trimethoprim|mesh-list
153339154|NCT00000730|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
153339156|NCT00000730|Pentamidine|pentamidine|mesh-list
153339157|NCT00000730|Trimetrexate|trimetrexate|mesh-list
153339158|NCT00000730|Methylprednisolone|methylprednisolone|mesh-list
153339159|NCT00000730|Levoleucovorin|levoleucovorin|mesh-list
153339160|NCT00000730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153339161|NCT00000730|Antidotes|antidotes|mesh-ancestor
153339162|NCT00000730|Protective Agents|protective agents|mesh-ancestor
153339163|NCT00000730|Vitamin B Complex|vitamin b complex|mesh-ancestor
153339164|NCT00000730|Vitamins|vitamins|mesh-ancestor
153339165|NCT00000730|Micronutrients|micronutrients|mesh-ancestor
153339166|NCT00000730|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153339167|NCT00000730|Antiemetics|antiemetics|mesh-ancestor
153339172|NCT00000730|Hormones|hormones|mesh-ancestor
153339189|NCT00000730|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153339190|NCT00000730|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153339191|NCT00000730|Antimetabolites|antimetabolites|mesh-ancestor
153339193|NCT00002176|Didanosine|didanosine|mesh-list
153339194|NCT00002176|Stavudine|stavudine|mesh-list
153339195|NCT00002176|Hydroxyurea|hydroxyurea|mesh-list
153339196|NCT00002176|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153339197|NCT00002176|Antisickling Agents|antisickling agents|mesh-ancestor
153339198|NCT00002176|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153339199|NCT00002176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153339202|NCT00002176|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
153339203|NCT00002176|Protease Inhibitors|protease inhibitors|mesh-ancestor
153339205|NCT00002176|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153339206|NCT00002176|Antiviral Agents|antiviral agents|mesh-ancestor
153339207|NCT00002176|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153339208|NCT00002176|Antimetabolites|antimetabolites|mesh-ancestor
153339209|NCT00002176|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153339210|NCT00381316|Technetium tc-99m tetrofosmin|technetium tc-99m tetrofosmin|mesh-list
153339211|NCT00381316|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
153339212|NCT00381316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153339214|NCT00002182|Megestrol Acetate|megestrol acetate|mesh-list
153339215|NCT00002182|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
153339216|NCT00002182|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
153339217|NCT00002182|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
153339218|NCT00002182|Contraceptive Agents|contraceptive agents|mesh-ancestor
153339219|NCT00002182|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153339220|NCT00002182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153339231|NCT00002320|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153339232|NCT00002320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153339233|NCT00002320|Antiviral Agents|antiviral agents|mesh-ancestor
153339234|NCT00002320|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153339235|NCT00002320|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153339236|NCT00002320|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153339237|NCT00002320|Antimetabolites|antimetabolites|mesh-ancestor
153339238|NCT01236391|Ibrutinib|ibrutinib|mesh-list
153339239|NCT01236391|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153339240|NCT01236391|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153339241|NCT01236391|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153339242|NCT01236391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153339243|NCT02167217|Prednisolone|prednisolone|mesh-list
153339244|NCT02167217|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
153339245|NCT02167217|Methylprednisolone|methylprednisolone|mesh-list
153339246|NCT02167217|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
153339247|NCT02167217|Prednisolone acetate|prednisolone acetate|mesh-list
153339248|NCT02167217|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
153339249|NCT02167217|Prednisolone phosphate|prednisolone phosphate|mesh-list
153339250|NCT02167217|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153339251|NCT02167217|Glucocorticoids|glucocorticoids|mesh-ancestor
153339252|NCT02167217|Hormones|hormones|mesh-ancestor
153339253|NCT02167217|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153339254|NCT02167217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153339255|NCT02167217|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153339256|NCT02167217|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153339257|NCT02167217|Antiemetics|antiemetics|mesh-ancestor
153339258|NCT02167217|Autonomic Agents|autonomic agents|mesh-ancestor
153339259|NCT02167217|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153339277|NCT01152697|Autonomic Agents|autonomic agents|mesh-ancestor
153339278|NCT01152697|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153339279|NCT01152697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153339280|NCT01152697|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153339281|NCT01152697|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153339282|NCT01152697|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153339283|NCT01152697|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153339284|NCT01152697|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153339285|NCT01152697|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
153339286|NCT01152697|Dopamine Agents|dopamine agents|mesh-ancestor
153339287|NCT01152697|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153339303|NCT00002194|Erythromycin|erythromycin|mesh-list
153339304|NCT00002194|Erythromycin Estolate|erythromycin estolate|mesh-list
153339305|NCT00002194|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
153339306|NCT00002194|Erythromycin stearate|erythromycin stearate|mesh-list
153339308|NCT00002194|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153339309|NCT00002194|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153339310|NCT00002194|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
153339311|NCT00002194|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153339312|NCT00002194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153339316|NCT00002194|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153339317|NCT00002194|Antiviral Agents|antiviral agents|mesh-ancestor
153339318|NCT00002194|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153339319|NCT00002194|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153889874|NCT01263483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153889875|NCT01263483|Incretins|incretins|mesh-ancestor
153430973|NCT03521102|Antipyretics|antipyretics|mesh-ancestor
153430974|NCT03521102|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153430975|NCT03521102|Narcotics|narcotics|mesh-ancestor
153339324|NCT04756622|N-monoacetylcystine|n-monoacetylcystine|mesh-list
153339325|NCT04756622|Antiviral Agents|antiviral agents|mesh-ancestor
153339326|NCT04756622|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153339328|NCT04756622|Respiratory System Agents|respiratory system agents|mesh-ancestor
153339329|NCT04756622|Free Radical Scavengers|free radical scavengers|mesh-ancestor
153339330|NCT04756622|Antioxidants|antioxidants|mesh-ancestor
153339331|NCT04756622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153339332|NCT04756622|Protective Agents|protective agents|mesh-ancestor
153339333|NCT04756622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153339334|NCT04756622|Antidotes|antidotes|mesh-ancestor
153339335|NCT00002344|Azithromycin|azithromycin|mesh-list
153339336|NCT00002344|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153339337|NCT00002344|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153339339|NCT01198327|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153339340|NCT01198327|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153339341|NCT01198327|Growth Substances|growth substances|mesh-ancestor
153339342|NCT01198327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153339366|NCT00002206|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153339367|NCT00002206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153339369|NCT02403986|Anesthetics, Local|anesthetics, local|mesh-ancestor
153339371|NCT02403986|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153339372|NCT02403986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153339373|NCT02403986|Sensory System Agents|sensory system agents|mesh-ancestor
153430976|NCT03521102|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153430977|NCT00000763|O-(Chloroacetylcarbamoyl)fumagillol|o-(chloroacetylcarbamoyl)fumagillol|mesh-list
153339375|NCT02403986|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153339376|NCT02403986|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
153339377|NCT02403986|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153339378|NCT02403986|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153339379|NCT02403986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153339381|NCT00002212|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153339382|NCT00002362|Emtricitabine|emtricitabine|mesh-list
153339383|NCT00002362|Efavirenz|efavirenz|mesh-list
153339384|NCT00002362|Abacavir|abacavir|mesh-list
153339385|NCT00002362|Stavudine|stavudine|mesh-list
153339386|NCT00002362|Antiviral Agents|antiviral agents|mesh-ancestor
153339387|NCT00002362|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153339388|NCT00002362|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153339389|NCT00002362|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153339390|NCT00002362|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153339391|NCT00002362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153339392|NCT00002362|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153339394|NCT00002362|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
153339395|NCT00002362|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153339396|NCT00002362|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
153339398|NCT00002362|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
153339399|NCT00002362|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
153339405|NCT02168309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153339406|NCT02168309|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153339407|NCT02168309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153339408|NCT02168309|Vasodilator Agents|vasodilator agents|mesh-ancestor
153339410|NCT02168309|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153339411|NCT02168309|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
153339412|NCT02168309|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
153339413|NCT02168309|Adrenergic Agents|adrenergic agents|mesh-ancestor
153339414|NCT02168309|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153339415|NCT02168309|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153339416|NCT02168309|Sympathomimetics|sympathomimetics|mesh-ancestor
153339417|NCT02168309|Autonomic Agents|autonomic agents|mesh-ancestor
153339418|NCT02168309|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153339419|NCT02168309|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
153339420|NCT02168309|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
153339421|NCT00002368|Lamivudine|lamivudine|mesh-list
153339422|NCT00002368|Nevirapine|nevirapine|mesh-list
153421334|NCT06008795|Glucocorticoids|glucocorticoids|mesh-ancestor
153421335|NCT06008795|Hormones|hormones|mesh-ancestor
153880475|NCT01659658|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153880476|NCT01659658|Alkylating Agents|alkylating agents|mesh-ancestor
153880477|NCT01659658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153880478|NCT01659658|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153880479|NCT01659658|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153880480|NCT01659658|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153339423|NCT00002368|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153339424|NCT00002368|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153339425|NCT00002368|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153339426|NCT00002368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153339427|NCT00002368|Antiviral Agents|antiviral agents|mesh-ancestor
153339428|NCT00002368|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153339429|NCT00002368|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153339441|NCT01199965|Analgesics|analgesics|mesh-ancestor
153339452|NCT00995501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153339453|NCT00995501|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153339454|NCT00995501|Antiemetics|antiemetics|mesh-ancestor
153339455|NCT00995501|Autonomic Agents|autonomic agents|mesh-ancestor
153339456|NCT00995501|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153339457|NCT00995501|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153339458|NCT00995501|Glucocorticoids|glucocorticoids|mesh-ancestor
153339459|NCT00995501|Hormones|hormones|mesh-ancestor
153339460|NCT00995501|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153339461|NCT00995501|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153339462|NCT00995501|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153339463|NCT00995501|Protease Inhibitors|protease inhibitors|mesh-ancestor
153339464|NCT00995501|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153339465|NCT00995501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153339466|NCT00995501|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153339467|NCT00995501|Cathartics|cathartics|mesh-ancestor
153339468|NCT00002374|Ritonavir|ritonavir|mesh-list
153339469|NCT00002374|Nelfinavir|nelfinavir|mesh-list
153339470|NCT00002374|Saquinavir|saquinavir|mesh-list
153339471|NCT00002374|Stavudine|stavudine|mesh-list
153339472|NCT00002374|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
153339477|NCT00002374|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153339508|NCT00002386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153339509|NCT00002386|Antiviral Agents|antiviral agents|mesh-ancestor
153339510|NCT00002386|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153339511|NCT00002386|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153339512|NCT00002386|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153339513|NCT00002386|Antimetabolites|antimetabolites|mesh-ancestor
153339514|NCT00002386|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
153339515|NCT00002386|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
153339516|NCT00002386|Protease Inhibitors|protease inhibitors|mesh-ancestor
153339518|NCT01942694|Cholecalciferol|cholecalciferol|mesh-list
153339519|NCT01942694|Vitamins|vitamins|mesh-ancestor
153339520|NCT01942694|Micronutrients|micronutrients|mesh-ancestor
153339523|NCT01942694|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153339524|NCT01153711|Ketoconazole|ketoconazole|mesh-list
153339525|NCT01153711|Antifungal Agents|antifungal agents|mesh-ancestor
153339526|NCT01153711|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153339527|NCT01153711|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
153339528|NCT01153711|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153339529|NCT01153711|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153339530|NCT01153711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153339531|NCT01153711|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153339532|NCT01153711|Hormone Antagonists|hormone antagonists|mesh-ancestor
153339534|NCT01153711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153339558|NCT05751850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153339559|NCT05751850|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153339560|NCT05751850|Antimetabolites|antimetabolites|mesh-ancestor
153339561|NCT05751850|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153339562|NCT05751850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153783257|NCT02213224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153339563|NCT05751850|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153339564|NCT05751850|Immunologic Factors|immunologic factors|mesh-ancestor
153339565|NCT05751850|Antidotes|antidotes|mesh-ancestor
153339566|NCT05751850|Protective Agents|protective agents|mesh-ancestor
153339567|NCT05751850|Vitamin B Complex|vitamin b complex|mesh-ancestor
153339570|NCT00002230|Efavirenz|efavirenz|mesh-list
153339571|NCT00002230|Didanosine|didanosine|mesh-list
153339572|NCT00002230|Stavudine|stavudine|mesh-list
153339573|NCT00002230|Hydroxyurea|hydroxyurea|mesh-list
153339574|NCT00002230|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153339575|NCT00002230|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153339576|NCT00002230|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153339577|NCT00002230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153339578|NCT00002230|Antiviral Agents|antiviral agents|mesh-ancestor
153339579|NCT00002230|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153378123|NCT03087136|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153339580|NCT00002230|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
153339581|NCT00002230|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153339582|NCT00002230|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
153339583|NCT00002230|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
153339584|NCT00002230|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
153339602|NCT03009877|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153339603|NCT03009877|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153339604|NCT03009877|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153339605|NCT03009877|GABA Modulators|gaba modulators|mesh-ancestor
153339606|NCT03009877|GABA Agents|gaba agents|mesh-ancestor
153339607|NCT03009877|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153339608|NCT03009877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153339609|NCT03009877|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153339615|NCT03009877|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
153339616|NCT03009877|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
153339617|NCT00002392|Thalidomide|thalidomide|mesh-list
153339618|NCT00002392|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153339619|NCT00002392|Immunologic Factors|immunologic factors|mesh-ancestor
153339620|NCT00002392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153339621|NCT00002392|Leprostatic Agents|leprostatic agents|mesh-ancestor
153339622|NCT00002392|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153339623|NCT00002392|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153339624|NCT00002392|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153339625|NCT00002392|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153339626|NCT00002392|Growth Substances|growth substances|mesh-ancestor
153339627|NCT00002392|Growth Inhibitors|growth inhibitors|mesh-ancestor
153339628|NCT00002392|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153339629|NCT00002398|Adefovir|adefovir|mesh-list
153339630|NCT00002398|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
153339631|NCT00002398|Antiviral Agents|antiviral agents|mesh-ancestor
153421338|NCT06008795|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153339649|NCT00002236|Delavirdine|delavirdine|mesh-list
153339650|NCT00002236|Indinavir|indinavir|mesh-list
153339651|NCT00002236|Antimetabolites|antimetabolites|mesh-ancestor
153339652|NCT00002236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153339653|NCT00002236|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153339654|NCT00002236|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153339655|NCT00002236|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153339656|NCT00002236|Antiviral Agents|antiviral agents|mesh-ancestor
153339657|NCT00002236|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153339658|NCT00002236|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153339659|NCT00002236|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153339660|NCT00002236|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
153339661|NCT00002236|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
153339663|NCT01241539|Dabigatran|dabigatran|mesh-list
153339664|NCT01241539|Antithrombins|antithrombins|mesh-ancestor
153339665|NCT01241539|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
153339666|NCT01241539|Protease Inhibitors|protease inhibitors|mesh-ancestor
153339667|NCT01241539|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153339698|NCT01200433|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153339699|NCT01200433|Adrenergic Agents|adrenergic agents|mesh-ancestor
153339700|NCT01200433|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153339701|NCT01200433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153339702|NCT01200433|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153339703|NCT01200433|Anesthetics, General|anesthetics, general|mesh-ancestor
153339704|NCT01200433|Anesthetics|anesthetics|mesh-ancestor
153339705|NCT00002410|Lamivudine|lamivudine|mesh-list
153339706|NCT00002410|Zidovudine|zidovudine|mesh-list
153339707|NCT00002410|Indinavir|indinavir|mesh-list
153339708|NCT00002410|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153339709|NCT00002410|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153339710|NCT00002410|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153339711|NCT00002410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153339712|NCT00002410|Antiviral Agents|antiviral agents|mesh-ancestor
153783258|NCT02213224|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153339713|NCT00002410|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153339714|NCT00002410|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153339715|NCT00002410|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153339716|NCT00002410|Antimetabolites|antimetabolites|mesh-ancestor
153339717|NCT00002410|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
153339718|NCT00002410|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
153339720|NCT01243333|Deoxyglucose|deoxyglucose|mesh-list
153339721|NCT01243333|Alovudine|alovudine|mesh-list
153339722|NCT01243333|Dideoxynucleosides|dideoxynucleosides|mesh-list
153339723|NCT01243333|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
153339724|NCT01243333|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
153339725|NCT01243333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153339726|NCT01243333|Antimetabolites|antimetabolites|mesh-ancestor
153339727|NCT01243333|Antiviral Agents|antiviral agents|mesh-ancestor
153339728|NCT01243333|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153339729|NCT01243333|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153339730|NCT01243333|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153339738|NCT01924052|Vasodilator Agents|vasodilator agents|mesh-ancestor
153339739|NCT00002416|Lamivudine|lamivudine|mesh-list
153339740|NCT00002416|Emtricitabine|emtricitabine|mesh-list
153339741|NCT00002416|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153339742|NCT00002416|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153339743|NCT00002416|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153339744|NCT00002416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153339746|NCT00002416|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153339747|NCT00002416|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153339748|NCT00002416|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153339749|NCT00002254|Alovudine|alovudine|mesh-list
153339750|NCT00002254|Antiviral Agents|antiviral agents|mesh-ancestor
153339751|NCT00002254|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153339754|NCT01243567|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
153339755|NCT01243567|Latanoprost|latanoprost|mesh-list
153339756|NCT01243567|Ophthalmic Solutions|ophthalmic solutions|mesh-list
153339757|NCT01243567|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
153339758|NCT01243567|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
153339759|NCT01243567|Adrenergic Agents|adrenergic agents|mesh-ancestor
153339760|NCT01243567|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153339761|NCT01243567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153339762|NCT01243567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153339763|NCT01243567|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153339764|NCT01243567|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153339765|NCT01001195|Bimatoprost|bimatoprost|mesh-list
153339787|NCT00002260|Antiviral Agents|antiviral agents|mesh-ancestor
153339788|NCT00002260|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153783259|NCT02213224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153783260|NCT02213224|Vasodilator Agents|vasodilator agents|mesh-ancestor
153339789|NCT01444040|Travoprost|travoprost|mesh-list
153339791|NCT00002266|Ammonium trichloro(dioxoethylene-O,O'-)tellurate|ammonium trichloro(dioxoethylene-o,o'-)tellurate|mesh-list
153339792|NCT00002266|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153339793|NCT00002266|Immunologic Factors|immunologic factors|mesh-ancestor
153339794|NCT00002266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153339795|NCT00002266|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153339796|NCT00002266|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
153339797|NCT00002266|Protective Agents|protective agents|mesh-ancestor
153339798|NCT00002266|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153339799|NCT00002266|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153339800|NCT00002266|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153339802|NCT00002266|Antiviral Agents|antiviral agents|mesh-ancestor
153339803|NCT00002266|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153339804|NCT05751304|Dexmedetomidine|dexmedetomidine|mesh-list
153339805|NCT05751304|Ketamine|ketamine|mesh-list
153339806|NCT05751304|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153339807|NCT05751304|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153339809|NCT05751304|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153339836|NCT01422746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153339837|NCT00002272|Foscarnet|foscarnet|mesh-list
153339838|NCT00002272|Phosphonoacetic Acid|phosphonoacetic acid|mesh-list
153339839|NCT00002272|Antiviral Agents|antiviral agents|mesh-ancestor
153339840|NCT00002272|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153339842|NCT00002272|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153339843|NCT00002272|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153339844|NCT00002272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153339845|NCT01002755|Lenalidomide|lenalidomide|mesh-list
153339846|NCT01002755|Ofatumumab|ofatumumab|mesh-list
153339904|NCT00002440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153339905|NCT00002440|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153339906|NCT00002440|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153339907|NCT00002440|Antiviral Agents|antiviral agents|mesh-ancestor
153339908|NCT00002440|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153339909|NCT00002440|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
153339910|NCT00002440|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153339911|NCT00002440|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153339912|NCT00002440|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153339913|NCT00002440|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
153339914|NCT00002440|Antitubercular Agents|antitubercular agents|mesh-ancestor
153339915|NCT00002440|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153339916|NCT01421810|Dexamethasone|dexamethasone|mesh-list
153339917|NCT01421810|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153339918|NCT01421810|Antiemetics|antiemetics|mesh-ancestor
153339919|NCT01421810|Autonomic Agents|autonomic agents|mesh-ancestor
153339920|NCT01421810|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153339921|NCT01421810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153339923|NCT01421810|Glucocorticoids|glucocorticoids|mesh-ancestor
153339924|NCT01421810|Hormones|hormones|mesh-ancestor
153339925|NCT01421810|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153339926|NCT01421810|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153339927|NCT01421810|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153339928|NCT00002284|Zidovudine|zidovudine|mesh-list
153421346|NCT05994820|Vaccines|vaccines|mesh-list
153421347|NCT05994820|Immunologic Factors|immunologic factors|mesh-ancestor
153421348|NCT05994820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153421349|NCT05993182|Ephedrine|ephedrine|mesh-list
153339929|NCT00002284|Antimetabolites|antimetabolites|mesh-ancestor
153339930|NCT00002284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153339931|NCT00002284|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153339932|NCT00002284|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153339933|NCT00002284|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153339934|NCT00002284|Antiviral Agents|antiviral agents|mesh-ancestor
153339935|NCT00002284|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153339936|NCT00002284|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153339942|NCT01243957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153339944|NCT01243957|Serotonin Agents|serotonin agents|mesh-ancestor
153339945|NCT01243957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153339946|NCT01243957|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
153339947|NCT01243957|Antidepressive Agents|antidepressive agents|mesh-ancestor
153339948|NCT01243957|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153339949|NCT01243957|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
153339950|NCT01243957|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153339951|NCT01243957|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153339952|NCT00002446|Fluconazole|fluconazole|mesh-list
153339953|NCT00002446|Posaconazole|posaconazole|mesh-list
153339954|NCT00002446|Antifungal Agents|antifungal agents|mesh-ancestor
153339955|NCT00002446|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153339956|NCT00002446|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
153339957|NCT00002446|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153339958|NCT00002446|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153339959|NCT00002446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153339960|NCT00002446|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153339961|NCT00002446|Hormone Antagonists|hormone antagonists|mesh-ancestor
153339964|NCT00002446|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
153339994|NCT01003769|Immunologic Factors|immunologic factors|mesh-ancestor
153339995|NCT01003769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153339996|NCT01003769|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153339997|NCT01003769|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153339998|NCT01003769|Growth Substances|growth substances|mesh-ancestor
153339999|NCT01003769|Growth Inhibitors|growth inhibitors|mesh-ancestor
153340000|NCT01003769|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153340001|NCT01003769|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153340003|NCT01003769|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153340004|NCT01003769|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
153340005|NCT01003769|Protective Agents|protective agents|mesh-ancestor
153340006|NCT01003769|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
153340007|NCT01003769|Contraceptive Agents|contraceptive agents|mesh-ancestor
153340008|NCT01003769|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153340009|NCT01003769|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153340010|NCT01003769|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
153340011|NCT01003769|Spermatocidal Agents|spermatocidal agents|mesh-ancestor
153340012|NCT01003769|Antispermatogenic Agents|antispermatogenic agents|mesh-ancestor
153890027|NCT01305408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153463230|NCT03043014|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
153463231|NCT03043014|Contraceptive Agents|contraceptive agents|mesh-ancestor
153463232|NCT03043014|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
153463233|NCT03043014|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
153463234|NCT03043014|Hormone Antagonists|hormone antagonists|mesh-ancestor
153463235|NCT03043014|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153463236|NCT03043014|Luteolytic Agents|luteolytic agents|mesh-ancestor
153463237|NCT03043014|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
153463238|NCT03043014|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
153463239|NCT02983344|Fentanyl|fentanyl|mesh-list
153463240|NCT02983344|Ropivacaine|ropivacaine|mesh-list
153463241|NCT02983344|Anesthetics, Local|anesthetics, local|mesh-ancestor
153463242|NCT02983344|Anesthetics|anesthetics|mesh-ancestor
153463243|NCT02983344|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153340013|NCT00002452|Indinavir|indinavir|mesh-list
153340014|NCT00002452|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
153340015|NCT00002452|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
153340016|NCT00002452|Protease Inhibitors|protease inhibitors|mesh-ancestor
153340017|NCT00002452|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153340018|NCT00002452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153340019|NCT00002452|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153340020|NCT00002452|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153340041|NCT00002470|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153340042|NCT00002470|Immunologic Factors|immunologic factors|mesh-ancestor
153340043|NCT00002470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153340045|NCT00002470|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153340046|NCT00002476|Leucovorin|leucovorin|mesh-list
153340047|NCT00002476|Cobalt|cobalt|mesh-list
153340048|NCT00002476|Fluorouracil|fluorouracil|mesh-list
153340049|NCT00002476|Methotrexate|methotrexate|mesh-list
153340050|NCT00002476|Vincristine|vincristine|mesh-list
153340051|NCT00002476|Bleomycin|bleomycin|mesh-list
153340052|NCT00002476|Calcium|calcium|mesh-list
153340053|NCT00002476|Levoleucovorin|levoleucovorin|mesh-list
153340054|NCT00002476|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153340055|NCT00002476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153340056|NCT00002476|Antimetabolites|antimetabolites|mesh-ancestor
153340057|NCT00002476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153340058|NCT00002476|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153340062|NCT00002476|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
153340063|NCT00002476|Abortifacient Agents|abortifacient agents|mesh-ancestor
153340064|NCT00002476|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153914746|NCT01010061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153914749|NCT00607984|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153914750|NCT00607984|Alkylating Agents|alkylating agents|mesh-ancestor
153914751|NCT00607984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153914752|NCT00607984|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153463434|NCT02859402|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153340066|NCT00002476|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153340067|NCT00002476|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153340068|NCT00002476|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153340069|NCT00002476|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153340070|NCT00002476|Antidotes|antidotes|mesh-ancestor
153340071|NCT00002476|Protective Agents|protective agents|mesh-ancestor
153340072|NCT00002476|Vitamin B Complex|vitamin b complex|mesh-ancestor
153340073|NCT00002476|Vitamins|vitamins|mesh-ancestor
153340074|NCT00002476|Micronutrients|micronutrients|mesh-ancestor
153340075|NCT00002476|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153340076|NCT00002476|Tubulin Modulators|tubulin modulators|mesh-ancestor
153340085|NCT01876628|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153340086|NCT01876628|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153340087|NCT01876628|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
153340088|NCT01876628|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153340089|NCT01876628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153340091|NCT01004705|Ramipril|ramipril|mesh-list
153340092|NCT01004705|Simvastatin|simvastatin|mesh-list
153340093|NCT01004705|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153340094|NCT01004705|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153340095|NCT01004705|Antimetabolites|antimetabolites|mesh-ancestor
153340096|NCT01004705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153340098|NCT01004705|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
153340099|NCT01004705|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153340100|NCT01004705|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153340101|NCT01004705|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153340102|NCT01004705|Analgesics|analgesics|mesh-ancestor
153463484|NCT01457820|Gout Suppressants|gout suppressants|mesh-ancestor
153463485|NCT01457820|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153463486|NCT01457820|Free Radical Scavengers|free radical scavengers|mesh-ancestor
153463487|NCT01457820|Antioxidants|antioxidants|mesh-ancestor
153463488|NCT01457820|Protective Agents|protective agents|mesh-ancestor
153914789|NCT01009983|Carboplatin|carboplatin|mesh-list
153914790|NCT01009983|Panitumumab|panitumumab|mesh-list
153914791|NCT01009983|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153890032|NCT01261611|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153914793|NCT01009983|Tubulin Modulators|tubulin modulators|mesh-ancestor
153914794|NCT01009983|Antimitotic Agents|antimitotic agents|mesh-ancestor
153914795|NCT01009983|Mitosis Modulators|mitosis modulators|mesh-ancestor
153914796|NCT01009983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153914797|NCT01009983|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153914798|NCT04297215|Anti-Infective Agents|anti-infective agents|mesh-list
153914799|NCT04297215|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
153914800|NCT04297215|Chitosan|chitosan|mesh-list
153914801|NCT04297215|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153914802|NCT04297215|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153914803|NCT04297215|Antimetabolites|antimetabolites|mesh-ancestor
153914804|NCT04297215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153914805|NCT04297215|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153340105|NCT01004705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153340106|NCT01004705|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153340107|NCT01004705|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153340108|NCT01004705|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153340109|NCT01004705|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153340110|NCT01004705|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153340111|NCT01004705|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153340112|NCT01004705|Antipyretics|antipyretics|mesh-ancestor
153340113|NCT01004705|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
153340115|NCT01004705|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153340117|NCT00002482|Muromonab-CD3|muromonab-cd3|mesh-list
153340118|NCT00002482|Antibodies|antibodies|mesh-list
153340119|NCT00002482|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153340120|NCT00002482|Immunologic Factors|immunologic factors|mesh-ancestor
153340121|NCT00002482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153340122|NCT00002482|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153340126|NCT00002482|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153340127|NCT00002482|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153340129|NCT01004939|Fondaparinux|fondaparinux|mesh-list
153340130|NCT01004939|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
153340131|NCT01004939|Antithrombins|antithrombins|mesh-ancestor
153340132|NCT01004939|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
153914807|NCT04297215|Sequestering Agents|sequestering agents|mesh-ancestor
153914808|NCT04297215|Hemostatics|hemostatics|mesh-ancestor
153914809|NCT04297215|Coagulants|coagulants|mesh-ancestor
153914810|NCT02873091|Sufentanil|sufentanil|mesh-list
153914811|NCT02873091|Ropivacaine|ropivacaine|mesh-list
153914812|NCT02873091|Anesthetics, Local|anesthetics, local|mesh-ancestor
153914813|NCT02873091|Anesthetics|anesthetics|mesh-ancestor
153914814|NCT02873091|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153914815|NCT02873091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153914816|NCT02873091|Sensory System Agents|sensory system agents|mesh-ancestor
153463502|NCT01893294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153463503|NCT01458054|Ritonavir|ritonavir|mesh-list
153463504|NCT01458054|Omeprazole|omeprazole|mesh-list
153463505|NCT01458054|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
153463506|NCT01458054|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
153463507|NCT01458054|Protease Inhibitors|protease inhibitors|mesh-ancestor
153463508|NCT01458054|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153914836|NCT01215227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153914837|NCT01215227|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
153914838|NCT01215227|Protective Agents|protective agents|mesh-ancestor
153890033|NCT01261611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153340135|NCT01004939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153340137|NCT01004939|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153340138|NCT01004939|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153340139|NCT00002488|Cyclophosphamide|cyclophosphamide|mesh-list
153340140|NCT00002488|Etoposide|etoposide|mesh-list
153340141|NCT00002488|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153340142|NCT00002488|Immunologic Factors|immunologic factors|mesh-ancestor
153340143|NCT00002488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153340144|NCT00002488|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153340145|NCT00002488|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153340146|NCT00002488|Alkylating Agents|alkylating agents|mesh-ancestor
153340147|NCT00002488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153340148|NCT00002488|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153340149|NCT00002488|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153340170|NCT01864772|Cetuximab|cetuximab|mesh-list
153340175|NCT00002494|Cytarabine|cytarabine|mesh-list
153340176|NCT00002494|Dexamethasone|dexamethasone|mesh-list
153340177|NCT00002494|Prednisone|prednisone|mesh-list
153340178|NCT00002494|Hydrocortisone|hydrocortisone|mesh-list
153890034|NCT01261611|Cholinergic Agents|cholinergic agents|mesh-ancestor
153890035|NCT01261611|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153890036|NCT01261611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153890037|NCT01261611|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
153890038|NCT01261611|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153890039|NCT04207125|Psychotropic Drugs|psychotropic drugs|mesh-list
153890040|NCT04320693|Sacituzumab govitecan|sacituzumab govitecan|mesh-list
153890041|NCT04320693|Immunoconjugates|immunoconjugates|mesh-ancestor
153890042|NCT04320693|Immunologic Factors|immunologic factors|mesh-ancestor
153890043|NCT04320693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153890044|NCT00624039|Pilocarpine|pilocarpine|mesh-list
153890045|NCT00624039|Miotics|miotics|mesh-ancestor
153914840|NCT01009515|Paclitaxel|paclitaxel|mesh-list
153340181|NCT00002494|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
153340182|NCT00002494|Cyclophosphamide|cyclophosphamide|mesh-list
153340183|NCT00002494|Ifosfamide|ifosfamide|mesh-list
153340184|NCT00002494|Doxorubicin|doxorubicin|mesh-list
153340185|NCT00002494|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
153340186|NCT00002494|Methotrexate|methotrexate|mesh-list
153340187|NCT00002494|Etoposide|etoposide|mesh-list
153340188|NCT00002494|Vincristine|vincristine|mesh-list
153340189|NCT00002494|Levoleucovorin|levoleucovorin|mesh-list
153340190|NCT00002494|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153340191|NCT00002494|Immunologic Factors|immunologic factors|mesh-ancestor
153340192|NCT00002494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153340193|NCT00002494|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153340194|NCT00002494|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153340195|NCT00002494|Alkylating Agents|alkylating agents|mesh-ancestor
153340196|NCT00002494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153340197|NCT00002494|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153340198|NCT00002494|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153340200|NCT00002494|Antiemetics|antiemetics|mesh-ancestor
153340228|NCT00002494|Tubulin Modulators|tubulin modulators|mesh-ancestor
153340229|NCT00002494|Antimitotic Agents|antimitotic agents|mesh-ancestor
153340230|NCT00002494|Mitosis Modulators|mitosis modulators|mesh-ancestor
153340231|NCT00002494|Trace Elements|trace elements|mesh-ancestor
153340232|NCT00002506|Interferons|interferons|mesh-list
153340233|NCT00002506|Interferon-alpha|interferon-alpha|mesh-list
153340234|NCT00002506|Isotretinoin|isotretinoin|mesh-list
153463564|NCT01458600|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
153463565|NCT01458600|Adrenergic Agents|adrenergic agents|mesh-ancestor
153463566|NCT01458600|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153463567|NCT01458600|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153463568|NCT01458600|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153463569|NCT01458600|Vasodilator Agents|vasodilator agents|mesh-ancestor
153463570|NCT01458600|Sympatholytics|sympatholytics|mesh-ancestor
153463571|NCT01458600|Autonomic Agents|autonomic agents|mesh-ancestor
153463572|NCT01458600|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
153463573|NCT01458600|Antithyroid Agents|antithyroid agents|mesh-ancestor
153463574|NCT01458600|Hormone Antagonists|hormone antagonists|mesh-ancestor
153463575|NCT01458600|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153463576|NCT02832570|Sildenafil Citrate|sildenafil citrate|mesh-list
153463577|NCT02832570|Vasodilator Agents|vasodilator agents|mesh-ancestor
153463578|NCT02832570|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
153463579|NCT02832570|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
153463580|NCT02832570|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153890047|NCT00624039|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153340235|NCT00002506|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153340237|NCT00002506|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153340238|NCT00002506|Immunologic Factors|immunologic factors|mesh-ancestor
153340239|NCT00002506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153340240|NCT00002506|Dermatologic Agents|dermatologic agents|mesh-ancestor
153340241|NCT01895894|Mycophenolic Acid|mycophenolic acid|mesh-list
153340242|NCT01895894|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153783261|NCT02213224|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
153340243|NCT01895894|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153340244|NCT01895894|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
153340245|NCT01895894|Antitubercular Agents|antitubercular agents|mesh-ancestor
153340246|NCT01895894|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153340247|NCT01895894|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153340248|NCT01895894|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153340249|NCT01895894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153340250|NCT02165111|Botulinum Toxins|botulinum toxins|mesh-list
153340251|NCT02165111|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
153340252|NCT02165111|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
153463581|NCT02832570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153463582|NCT02832570|Urological Agents|urological agents|mesh-ancestor
153463583|NCT02742324|Interferon-alpha|interferon-alpha|mesh-list
153914872|NCT01009047|Aripiprazole|aripiprazole|mesh-list
153914873|NCT01009047|Paliperidone Palmitate|paliperidone palmitate|mesh-list
153914874|NCT01009047|Antidepressive Agents|antidepressive agents|mesh-ancestor
153914875|NCT01009047|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153914876|NCT01009047|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153914877|NCT01009047|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153914878|NCT01009047|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153914879|NCT01009047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153914880|NCT01009047|Dopamine Agonists|dopamine agonists|mesh-ancestor
153914881|NCT01009047|Dopamine Agents|dopamine agents|mesh-ancestor
153914882|NCT01009047|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153914883|NCT01009047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153914884|NCT01009047|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
153914885|NCT01009047|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
153914886|NCT01009047|Serotonin Agents|serotonin agents|mesh-ancestor
153914887|NCT01009047|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
153914888|NCT01009047|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153914889|NCT01009047|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
153914890|NCT01009047|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
153914891|NCT04205097|Neostigmine|neostigmine|mesh-list
153914892|NCT04205097|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
153914893|NCT04205097|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153914895|NCT04205097|Cholinergic Agents|cholinergic agents|mesh-ancestor
153340253|NCT02165111|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
153340271|NCT03845621|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153340272|NCT03845621|Antifungal Agents|antifungal agents|mesh-ancestor
153340273|NCT03845621|Keratolytic Agents|keratolytic agents|mesh-ancestor
153340274|NCT03845621|Dermatologic Agents|dermatologic agents|mesh-ancestor
153340275|NCT01840046|Interleukin-2|interleukin-2|mesh-list
153340276|NCT01840046|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153340277|NCT01840046|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153340278|NCT01840046|Analgesics|analgesics|mesh-ancestor
153340279|NCT01840046|Sensory System Agents|sensory system agents|mesh-ancestor
153340280|NCT01840046|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153340281|NCT01840046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153340282|NCT00437216|Clobetasol|clobetasol|mesh-list
153340283|NCT00437216|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153340284|NCT00437216|Glucocorticoids|glucocorticoids|mesh-ancestor
153340285|NCT00437216|Hormones|hormones|mesh-ancestor
153340286|NCT00437216|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153340287|NCT00437216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153340288|NCT00002524|Leucovorin|leucovorin|mesh-list
153340289|NCT00002524|Cytarabine|cytarabine|mesh-list
153340290|NCT00002524|Zidovudine|zidovudine|mesh-list
153340291|NCT00002524|Trimethoprim|trimethoprim|mesh-list
153340292|NCT00002524|Sulfamethoxazole|sulfamethoxazole|mesh-list
153340293|NCT00002524|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
153340294|NCT00002524|Pentamidine|pentamidine|mesh-list
153340295|NCT00002524|Prednisone|prednisone|mesh-list
153340296|NCT00002524|Methylprednisolone|methylprednisolone|mesh-list
153340297|NCT00002524|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
153914896|NCT04205097|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153914897|NCT04205097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153914898|NCT04205097|Parasympathomimetics|parasympathomimetics|mesh-ancestor
153914900|NCT04205097|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153914901|NCT01025193|Belimumab|belimumab|mesh-list
153914902|NCT01025193|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153914903|NCT01025193|Immunologic Factors|immunologic factors|mesh-ancestor
153914904|NCT01025193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153463593|NCT01459146|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
153463594|NCT01459146|Albendazole|albendazole|mesh-list
153463595|NCT01459146|Praziquantel|praziquantel|mesh-list
153463596|NCT01459146|Antimalarials|antimalarials|mesh-ancestor
153463597|NCT01459146|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153463598|NCT01459146|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153463599|NCT01459146|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153463600|NCT01459146|Anthelmintics|anthelmintics|mesh-ancestor
153463601|NCT01459146|Anticestodal Agents|anticestodal agents|mesh-ancestor
153463602|NCT01459146|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
153890050|NCT00624039|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
153890051|NCT00624039|Cholinergic Agents|cholinergic agents|mesh-ancestor
153463604|NCT01459146|Antimitotic Agents|antimitotic agents|mesh-ancestor
153463605|NCT01459146|Mitosis Modulators|mitosis modulators|mesh-ancestor
153463606|NCT01459146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153463607|NCT01459146|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153340319|NCT00002524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153340320|NCT00002524|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153340321|NCT00002524|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153340322|NCT00002524|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153340323|NCT00002524|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153340324|NCT00002524|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153340325|NCT00002524|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153783262|NCT02213224|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
153340326|NCT00002524|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153340327|NCT00002524|Glucocorticoids|glucocorticoids|mesh-ancestor
153340328|NCT00002524|Hormones|hormones|mesh-ancestor
153880503|NCT01523977|Asparaginase|asparaginase|mesh-list
153880504|NCT01523977|Pegaspargase|pegaspargase|mesh-list
153880505|NCT01523977|Razoxane|razoxane|mesh-list
153880506|NCT01523977|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153880507|NCT01523977|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153880508|NCT01523977|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153340329|NCT00002524|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153340330|NCT00002524|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153340331|NCT00002524|Antimetabolites|antimetabolites|mesh-ancestor
153340332|NCT00002524|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153340333|NCT00002524|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
153340334|NCT00002524|Abortifacient Agents|abortifacient agents|mesh-ancestor
153340335|NCT00002524|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153340336|NCT00002524|Dermatologic Agents|dermatologic agents|mesh-ancestor
153340337|NCT00002524|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153340340|NCT00002524|Antiviral Agents|antiviral agents|mesh-ancestor
153340370|NCT00002536|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153340371|NCT00002536|Tubulin Modulators|tubulin modulators|mesh-ancestor
153340372|NCT00002536|Antimitotic Agents|antimitotic agents|mesh-ancestor
153340373|NCT00002536|Mitosis Modulators|mitosis modulators|mesh-ancestor
153463609|NCT05026398|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
153463610|NCT05026398|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153463611|NCT05026398|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153463612|NCT05026398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153463614|NCT05026398|Serotonin Agents|serotonin agents|mesh-ancestor
153463615|NCT05026398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153463616|NCT05586750|Atorvastatin|atorvastatin|mesh-list
153914909|NCT01008423|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153914910|NCT01008423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153914911|NCT01008423|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153914912|NCT01008423|Respiratory System Agents|respiratory system agents|mesh-ancestor
153914913|NCT01008423|Glucocorticoids|glucocorticoids|mesh-ancestor
153914914|NCT01008423|Hormones|hormones|mesh-ancestor
153340376|NCT01203319|Immunologic Factors|immunologic factors|mesh-ancestor
153340377|NCT01203319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153340378|NCT01204255|Diphenhydramine|diphenhydramine|mesh-list
153340379|NCT01204255|Promethazine|promethazine|mesh-list
153340380|NCT01204255|Lorazepam|lorazepam|mesh-list
153340381|NCT01204255|Haloperidol|haloperidol|mesh-list
153340382|NCT01204255|Haloperidol decanoate|haloperidol decanoate|mesh-list
153340383|NCT01204255|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
153340384|NCT01204255|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153340385|NCT01204255|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153340386|NCT01204255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153340387|NCT01204255|Anesthetics, Local|anesthetics, local|mesh-ancestor
153340388|NCT01204255|Anesthetics|anesthetics|mesh-ancestor
153340389|NCT01204255|Sensory System Agents|sensory system agents|mesh-ancestor
153340390|NCT01204255|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153340391|NCT01204255|Antiemetics|antiemetics|mesh-ancestor
153340392|NCT01204255|Autonomic Agents|autonomic agents|mesh-ancestor
153340393|NCT01204255|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153340394|NCT01204255|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
153340395|NCT01204255|Histamine Antagonists|histamine antagonists|mesh-ancestor
153914915|NCT01008423|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153914916|NCT04735861|Bevacizumab|bevacizumab|mesh-list
153914917|NCT04735861|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153914918|NCT04735861|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153914919|NCT04735861|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153914920|NCT04735861|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153914921|NCT04735861|Growth Substances|growth substances|mesh-ancestor
153914922|NCT04735861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153914923|NCT04735861|Growth Inhibitors|growth inhibitors|mesh-ancestor
153914924|NCT03685747|Vancomycin|vancomycin|mesh-list
153914925|NCT03685747|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153914926|NCT03685747|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153914927|NCT03586687|Triamcinolone|triamcinolone|mesh-list
153914928|NCT03586687|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153914929|NCT03586687|Glucocorticoids|glucocorticoids|mesh-ancestor
153914930|NCT03586687|Hormones|hormones|mesh-ancestor
153914931|NCT03586687|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153431070|NCT00000361|Abortifacient Agents|abortifacient agents|mesh-ancestor
153340396|NCT01204255|Histamine Agents|histamine agents|mesh-ancestor
153340397|NCT01204255|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153340398|NCT01204255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153340399|NCT01204255|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
153340400|NCT01204255|Antipruritics|antipruritics|mesh-ancestor
153340401|NCT01204255|Dermatologic Agents|dermatologic agents|mesh-ancestor
153340402|NCT01204255|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153340403|NCT01204255|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153340404|NCT01204255|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153340405|NCT01204255|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
153340406|NCT01204255|Dopamine Agents|dopamine agents|mesh-ancestor
153340407|NCT01204255|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
153340408|NCT01204255|Anticonvulsants|anticonvulsants|mesh-ancestor
153340409|NCT01204255|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153914949|NCT00613717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153914950|NCT00613717|Protective Agents|protective agents|mesh-ancestor
153914951|NCT00613717|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
153914952|NCT00613717|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153463639|NCT02716974|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153463640|NCT01459380|Bevacizumab|bevacizumab|mesh-list
153463641|NCT01459380|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
153340410|NCT01204255|GABA Modulators|gaba modulators|mesh-ancestor
153340411|NCT01204255|GABA Agents|gaba agents|mesh-ancestor
153340412|NCT00002542|Tamoxifen|tamoxifen|mesh-list
153340413|NCT00002542|Cyclophosphamide|cyclophosphamide|mesh-list
153340414|NCT00002542|Doxorubicin|doxorubicin|mesh-list
153340415|NCT00002542|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
153340416|NCT00002542|Fluorouracil|fluorouracil|mesh-list
153340417|NCT00002542|Methotrexate|methotrexate|mesh-list
153340418|NCT00002542|Epirubicin|epirubicin|mesh-list
153340419|NCT00002542|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153340420|NCT00002542|Immunologic Factors|immunologic factors|mesh-ancestor
153340421|NCT00002542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153340423|NCT00002542|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153340424|NCT00002542|Alkylating Agents|alkylating agents|mesh-ancestor
153340425|NCT00002542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153340426|NCT00002542|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153340427|NCT00002542|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153340428|NCT00002542|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153340429|NCT00002542|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153340430|NCT00002542|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153340431|NCT00002542|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153340432|NCT00002542|Antimetabolites|antimetabolites|mesh-ancestor
153340433|NCT00002542|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153340434|NCT00002542|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
153340435|NCT00002542|Abortifacient Agents|abortifacient agents|mesh-ancestor
153340436|NCT00002542|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153340456|NCT03011125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153340457|NCT05749900|Gemcitabine|gemcitabine|mesh-list
153340459|NCT05749900|Trastuzumab|trastuzumab|mesh-list
153340460|NCT05749900|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153340461|NCT05749900|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153915003|NCT04074187|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153890053|NCT00624039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153890054|NCT01304706|Fluocinolone Acetonide|fluocinolone acetonide|mesh-list
153431073|NCT00000361|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153431074|NCT00000361|Antimetabolites|antimetabolites|mesh-ancestor
153431076|NCT00000361|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153915006|NCT04074187|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153915007|NCT04074187|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153915008|NCT04074187|Antiemetics|antiemetics|mesh-ancestor
153915009|NCT04074187|Autonomic Agents|autonomic agents|mesh-ancestor
153915010|NCT04074187|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153915011|NCT04074187|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153915012|NCT04074187|Glucocorticoids|glucocorticoids|mesh-ancestor
153915013|NCT04074187|Hormones|hormones|mesh-ancestor
153915014|NCT04074187|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153915015|NCT04074187|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
153890055|NCT01304706|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153890056|NCT01304706|Glucocorticoids|glucocorticoids|mesh-ancestor
153890057|NCT01304706|Hormones|hormones|mesh-ancestor
153890058|NCT01304706|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153890059|NCT01304706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153890060|NCT05661240|Docetaxel|docetaxel|mesh-list
153340469|NCT05749666|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
153340471|NCT05749666|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
153340472|NCT05749666|Prednisolone phosphate|prednisolone phosphate|mesh-list
153340473|NCT05749666|Tofacitinib|tofacitinib|mesh-list
153340474|NCT05749666|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153340475|NCT05749666|Glucocorticoids|glucocorticoids|mesh-ancestor
153340476|NCT05749666|Hormones|hormones|mesh-ancestor
153783263|NCT02213224|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
153340477|NCT05749666|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153783264|NCT02213224|Protease Inhibitors|protease inhibitors|mesh-ancestor
153340478|NCT05749666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153340479|NCT05749666|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153340503|NCT02940509|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153340504|NCT02940509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153340505|NCT02940509|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
153915017|NCT04074187|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153463702|NCT02703948|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153340515|NCT02940509|Anticonvulsants|anticonvulsants|mesh-ancestor
153340516|NCT02940509|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153340517|NCT02940509|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153340518|NCT02940509|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153340519|NCT02940509|Tocolytic Agents|tocolytic agents|mesh-ancestor
153340520|NCT02940509|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153340521|NCT02170649|Eslicarbazepine acetate|eslicarbazepine acetate|mesh-list
153340522|NCT02170649|Anticonvulsants|anticonvulsants|mesh-ancestor
153340523|NCT02170649|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
153340524|NCT02170649|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153340525|NCT02170649|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153880509|NCT01523977|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153340526|NCT02170649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153340527|NCT04094207|Pentoxifylline|pentoxifylline|mesh-list
153340528|NCT04094207|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
153340529|NCT04094207|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153463725|NCT02666742|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153463726|NCT02666742|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153463727|NCT02666742|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153463728|NCT02666742|Antipyretics|antipyretics|mesh-ancestor
153463729|NCT02666742|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
153463730|NCT02666742|Antithrombins|antithrombins|mesh-ancestor
153463731|NCT02666742|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
153463732|NCT02666742|Protease Inhibitors|protease inhibitors|mesh-ancestor
153463733|NCT02684292|Pembrolizumab|pembrolizumab|mesh-list
153463734|NCT02684292|Brentuximab Vedotin|brentuximab vedotin|mesh-list
153463735|NCT02684292|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153463736|NCT02684292|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153915018|NCT03128905|Prednisone|prednisone|mesh-list
153915019|NCT03128905|Colchicine|colchicine|mesh-list
153915020|NCT03128905|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153915021|NCT03128905|Glucocorticoids|glucocorticoids|mesh-ancestor
153340530|NCT04094207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153340532|NCT04094207|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
153340533|NCT04094207|Protective Agents|protective agents|mesh-ancestor
153340534|NCT04094207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153340535|NCT04094207|Vasodilator Agents|vasodilator agents|mesh-ancestor
153340538|NCT02144831|Aspirin|aspirin|mesh-list
153340539|NCT02144831|Clopidogrel|clopidogrel|mesh-list
153340540|NCT02144831|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153340541|NCT02144831|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153340542|NCT02144831|Analgesics|analgesics|mesh-ancestor
153340543|NCT02144831|Sensory System Agents|sensory system agents|mesh-ancestor
153340544|NCT02144831|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153340545|NCT02144831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153340546|NCT02144831|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153340547|NCT02144831|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153340548|NCT02144831|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153340549|NCT02144831|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153783265|NCT02213224|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153340550|NCT02144831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153340551|NCT02144831|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153340552|NCT02144831|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153340553|NCT02144831|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153340554|NCT02144831|Antipyretics|antipyretics|mesh-ancestor
153340555|NCT02144831|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
153340556|NCT02144831|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
153340557|NCT02144831|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
153340558|NCT02144831|Purinergic Agents|purinergic agents|mesh-ancestor
153340559|NCT02144831|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153340560|NCT05232461|Ciprofloxacin|ciprofloxacin|mesh-list
153340561|NCT05232461|Celecoxib|celecoxib|mesh-list
153340562|NCT05232461|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153340563|NCT05232461|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153340564|NCT05232461|Analgesics|analgesics|mesh-ancestor
153915022|NCT03128905|Hormones|hormones|mesh-ancestor
153915023|NCT03128905|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153915024|NCT03128905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153915025|NCT03128905|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153915026|NCT03128905|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153915027|NCT03128905|Gout Suppressants|gout suppressants|mesh-ancestor
153915028|NCT03128905|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153915029|NCT03128905|Tubulin Modulators|tubulin modulators|mesh-ancestor
153915030|NCT03128905|Antimitotic Agents|antimitotic agents|mesh-ancestor
153915031|NCT03128905|Mitosis Modulators|mitosis modulators|mesh-ancestor
153915032|NCT03128905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153915033|NCT02430181|Interferons|interferons|mesh-list
153915034|NCT02430181|Ritonavir|ritonavir|mesh-list
153915035|NCT02430181|Interferon-alpha|interferon-alpha|mesh-list
153915036|NCT02430181|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
153915037|NCT02430181|Lonafarnib|lonafarnib|mesh-list
153915038|NCT02430181|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153915039|NCT02430181|Antiviral Agents|antiviral agents|mesh-ancestor
153915040|NCT02430181|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153340565|NCT05232461|Sensory System Agents|sensory system agents|mesh-ancestor
153340566|NCT05232461|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153340567|NCT05232461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153340568|NCT05232461|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153340569|NCT05232461|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153340575|NCT05232461|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153340576|NCT05232461|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153340577|NCT05232461|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153340578|NCT05232461|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153340579|NCT05232461|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
153915042|NCT02430181|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
153915043|NCT02430181|Protease Inhibitors|protease inhibitors|mesh-ancestor
153915044|NCT02430181|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153915045|NCT02430181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153915046|NCT02430181|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153915047|NCT02430181|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153915048|NCT02430181|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
153915049|NCT02430181|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153915050|NCT02430181|Immunologic Factors|immunologic factors|mesh-ancestor
153915051|NCT02430181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153915052|NCT00614653|Bevacizumab|bevacizumab|mesh-list
153463737|NCT02684292|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153463738|NCT02684292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153463739|NCT02684292|Immunotoxins|immunotoxins|mesh-ancestor
153463740|NCT02684292|Immunoconjugates|immunoconjugates|mesh-ancestor
153463741|NCT02684292|Immunologic Factors|immunologic factors|mesh-ancestor
153463742|NCT02684292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153431080|NCT00000361|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153431081|NCT00000361|Immunologic Factors|immunologic factors|mesh-ancestor
153463743|NCT04390854|Clotrimazole|clotrimazole|mesh-list
153463744|NCT04390854|Miconazole|miconazole|mesh-list
153463745|NCT04390854|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
153463746|NCT04390854|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153463747|NCT04390854|Antifungal Agents|antifungal agents|mesh-ancestor
153463748|NCT04390854|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
153463749|NCT04390854|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153463750|NCT04390854|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153463760|NCT02624544|Desonide|desonide|mesh-list
153463761|NCT02624544|Esomeprazole|esomeprazole|mesh-list
153340580|NCT05232461|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153340582|NCT01804790|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153340583|NCT01804790|Antimetabolites|antimetabolites|mesh-ancestor
153340584|NCT01804790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153340585|NCT01804790|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153340586|NCT01313702|Atenolol|atenolol|mesh-list
153340587|NCT01313702|Lisinopril|lisinopril|mesh-list
153340588|NCT01313702|Simvastatin|simvastatin|mesh-list
153340589|NCT01313702|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153340590|NCT01313702|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153340591|NCT01313702|Antimetabolites|antimetabolites|mesh-ancestor
153340592|NCT01313702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153340593|NCT01313702|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153340594|NCT01313702|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
153340595|NCT01313702|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153340596|NCT01313702|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
153340597|NCT01313702|Protease Inhibitors|protease inhibitors|mesh-ancestor
153421363|NCT05993182|Nasal Decongestants|nasal decongestants|mesh-ancestor
153340599|NCT01313702|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
153340600|NCT01313702|Protective Agents|protective agents|mesh-ancestor
153340623|NCT04868708|Growth Substances|growth substances|mesh-ancestor
153463767|NCT02624544|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153463768|NCT02603328|Atorvastatin|atorvastatin|mesh-list
153463769|NCT02603328|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153463770|NCT02603328|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153463771|NCT02603328|Antimetabolites|antimetabolites|mesh-ancestor
153463772|NCT02603328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153915053|NCT00614653|Capecitabine|capecitabine|mesh-list
153915054|NCT00614653|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
153915055|NCT00614653|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153915056|NCT00614653|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153915057|NCT00614653|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153890066|NCT02889003|Pioglitazone|pioglitazone|mesh-list
153431083|NCT00000361|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153431084|NCT06316830|Buprenorphine|buprenorphine|mesh-list
153915058|NCT00614653|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153915059|NCT00614653|Growth Substances|growth substances|mesh-ancestor
153915060|NCT00614653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153915061|NCT00614653|Growth Inhibitors|growth inhibitors|mesh-ancestor
153915062|NCT00614653|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153915063|NCT00614653|Antimetabolites|antimetabolites|mesh-ancestor
153340625|NCT04868708|Growth Inhibitors|growth inhibitors|mesh-ancestor
153340627|NCT00382330|Antifungal Agents|antifungal agents|mesh-ancestor
153340628|NCT00382330|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153340629|NCT05520892|Immunoglobulins|immunoglobulins|mesh-list
153340630|NCT05520892|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
153340631|NCT05520892|Antibodies|antibodies|mesh-list
153340632|NCT05520892|gamma-Globulins|gamma-globulins|mesh-list
153340633|NCT05520892|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
153340634|NCT05520892|Immunologic Factors|immunologic factors|mesh-ancestor
153340635|NCT05520892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153340636|NCT00002548|Interferons|interferons|mesh-list
153340637|NCT00002548|Interferon-alpha|interferon-alpha|mesh-list
153340638|NCT00002548|Dexamethasone|dexamethasone|mesh-list
153340639|NCT00002548|Prednisone|prednisone|mesh-list
153340640|NCT00002548|Cyclophosphamide|cyclophosphamide|mesh-list
153340641|NCT00002548|Melphalan|melphalan|mesh-list
153340642|NCT00002548|Carmustine|carmustine|mesh-list
153340643|NCT00002548|Doxorubicin|doxorubicin|mesh-list
153340644|NCT00002548|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
153340645|NCT00002548|Vincristine|vincristine|mesh-list
153340646|NCT00002548|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153340647|NCT00002548|Immunologic Factors|immunologic factors|mesh-ancestor
153340648|NCT00002548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153340649|NCT00002548|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153340650|NCT00002548|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153340651|NCT00002548|Alkylating Agents|alkylating agents|mesh-ancestor
153340652|NCT00002548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153340653|NCT00002548|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153915071|NCT03909451|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153915072|NCT03909451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153915073|NCT03463135|Immunomodulating Agents|immunomodulating agents|mesh-list
153915074|NCT03463135|Immunologic Factors|immunologic factors|mesh-ancestor
153915075|NCT03463135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153915076|NCT03596125|Acetylcysteine|acetylcysteine|mesh-list
153915077|NCT03596125|N-monoacetylcystine|n-monoacetylcystine|mesh-list
153915078|NCT03596125|Antiviral Agents|antiviral agents|mesh-ancestor
153915079|NCT03596125|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153915080|NCT03596125|Expectorants|expectorants|mesh-ancestor
153915081|NCT03596125|Respiratory System Agents|respiratory system agents|mesh-ancestor
153915082|NCT03596125|Free Radical Scavengers|free radical scavengers|mesh-ancestor
153915083|NCT03596125|Antioxidants|antioxidants|mesh-ancestor
153915084|NCT03596125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153915085|NCT03596125|Protective Agents|protective agents|mesh-ancestor
153915086|NCT03596125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153463773|NCT02603328|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153463774|NCT02603328|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
153463775|NCT02603328|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153463776|NCT01451736|Risperidone|risperidone|mesh-list
153463777|NCT01451736|Paliperidone Palmitate|paliperidone palmitate|mesh-list
153463785|NCT01451736|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153340655|NCT00002548|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153340656|NCT00002548|Antiemetics|antiemetics|mesh-ancestor
153340657|NCT00002548|Autonomic Agents|autonomic agents|mesh-ancestor
153340658|NCT00002548|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153340659|NCT00002548|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153340660|NCT00002548|Glucocorticoids|glucocorticoids|mesh-ancestor
153340661|NCT00002548|Hormones|hormones|mesh-ancestor
153340662|NCT00002548|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153340663|NCT00002548|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153340664|NCT00002548|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153340665|NCT00002548|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153340666|NCT00002548|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153340667|NCT00002548|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153340668|NCT00002548|Antiviral Agents|antiviral agents|mesh-ancestor
153340669|NCT00002548|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153340670|NCT00002548|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153340671|NCT00002548|Tubulin Modulators|tubulin modulators|mesh-ancestor
153340672|NCT00002548|Antimitotic Agents|antimitotic agents|mesh-ancestor
153340673|NCT00002548|Mitosis Modulators|mitosis modulators|mesh-ancestor
153340674|NCT02087306|Brincidofovir|brincidofovir|mesh-list
153340675|NCT02087306|Antiviral Agents|antiviral agents|mesh-ancestor
153340676|NCT02087306|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153340677|NCT00002554|Cyclophosphamide|cyclophosphamide|mesh-list
153340678|NCT00002554|Busulfan|busulfan|mesh-list
153340679|NCT00002554|Methotrexate|methotrexate|mesh-list
153340680|NCT00002554|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153340681|NCT00002554|Immunologic Factors|immunologic factors|mesh-ancestor
153340682|NCT00002554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153340683|NCT00002554|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153463787|NCT01451736|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
153463788|NCT01451736|Dopamine Agents|dopamine agents|mesh-ancestor
153463789|NCT01451736|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
153890067|NCT02889003|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153890068|NCT02889003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153431085|NCT06316830|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153431086|NCT06316830|Narcotics|narcotics|mesh-ancestor
153463790|NCT01451736|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
153463791|NCT01450956|Sevoflurane|sevoflurane|mesh-list
153463792|NCT01450956|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153463793|NCT01450956|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
153915087|NCT03596125|Antidotes|antidotes|mesh-ancestor
153915089|NCT02118727|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
153915090|NCT02118727|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
153915091|NCT02118727|Dopamine Agents|dopamine agents|mesh-ancestor
153915092|NCT02118727|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153915093|NCT02118727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153915094|NCT02118727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153915095|NCT02118727|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
153340684|NCT00002554|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153340685|NCT00002554|Alkylating Agents|alkylating agents|mesh-ancestor
153340686|NCT00002554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153340688|NCT00002554|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153340689|NCT00002554|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
153340690|NCT00002554|Abortifacient Agents|abortifacient agents|mesh-ancestor
153340691|NCT00002554|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153340692|NCT00002554|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153340693|NCT00002554|Antimetabolites|antimetabolites|mesh-ancestor
153340694|NCT00002554|Dermatologic Agents|dermatologic agents|mesh-ancestor
153340701|NCT00002560|Immunologic Factors|immunologic factors|mesh-ancestor
153340702|NCT00002560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153340703|NCT00002566|Cyclophosphamide|cyclophosphamide|mesh-list
153340706|NCT00002566|Etoposide|etoposide|mesh-list
153340707|NCT00002566|Vinblastine|vinblastine|mesh-list
153340708|NCT00002566|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153340709|NCT00002566|Immunologic Factors|immunologic factors|mesh-ancestor
153340710|NCT00002566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153340711|NCT00002566|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153340712|NCT00002566|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153340713|NCT00002566|Alkylating Agents|alkylating agents|mesh-ancestor
153340714|NCT00002566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153340715|NCT00002566|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153340716|NCT00002566|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153340717|NCT00002566|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153915096|NCT02118727|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
153915097|NCT05343637|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
153340720|NCT00002566|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153340721|NCT00002566|Tubulin Modulators|tubulin modulators|mesh-ancestor
153340722|NCT00002566|Antimitotic Agents|antimitotic agents|mesh-ancestor
153340723|NCT00002566|Mitosis Modulators|mitosis modulators|mesh-ancestor
153340725|NCT00002572|Muromonab-CD3|muromonab-cd3|mesh-list
153340726|NCT00002572|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153340727|NCT00002572|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153340728|NCT00002572|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153340729|NCT00002572|Antiviral Agents|antiviral agents|mesh-ancestor
153340730|NCT00002572|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153340731|NCT00002572|Immunologic Factors|immunologic factors|mesh-ancestor
153340732|NCT00002572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153340733|NCT00002572|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153340734|NCT00002578|Leucovorin|leucovorin|mesh-list
153340747|NCT00002578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153340748|NCT00002578|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153340749|NCT00002578|Dermatologic Agents|dermatologic agents|mesh-ancestor
153340750|NCT00002578|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153340751|NCT00002578|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153340752|NCT00002578|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153340753|NCT00002578|Immunologic Factors|immunologic factors|mesh-ancestor
153340754|NCT00002578|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153340755|NCT00002578|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153340756|NCT00002578|Antiviral Agents|antiviral agents|mesh-ancestor
153340757|NCT00002578|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153340758|NCT00002578|Antidotes|antidotes|mesh-ancestor
153340759|NCT00002578|Protective Agents|protective agents|mesh-ancestor
153340760|NCT00002578|Vitamin B Complex|vitamin b complex|mesh-ancestor
153463826|NCT02983422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153463827|NCT02983422|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
153463830|NCT02983422|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153463831|NCT02983422|Protective Agents|protective agents|mesh-ancestor
153463832|NCT02983422|Diuretics|diuretics|mesh-ancestor
153463833|NCT02983422|Natriuretic Agents|natriuretic agents|mesh-ancestor
153463834|NCT02983422|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
153463835|NCT02983422|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153463836|NCT05585814|Bevacizumab|bevacizumab|mesh-list
153463837|NCT05585814|Pembrolizumab|pembrolizumab|mesh-list
153463838|NCT05585814|Capecitabine|capecitabine|mesh-list
153463839|NCT05585814|Oxaliplatin|oxaliplatin|mesh-list
153463840|NCT05585814|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153463841|NCT05585814|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153915135|NCT02699281|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153915136|NCT02699281|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153340762|NCT00002578|Micronutrients|micronutrients|mesh-ancestor
153340763|NCT00002596|Cyclophosphamide|cyclophosphamide|mesh-list
153340764|NCT00002596|Carboplatin|carboplatin|mesh-list
153340765|NCT00002596|Etoposide|etoposide|mesh-list
153340766|NCT00002596|Bleomycin|bleomycin|mesh-list
153340767|NCT00002596|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153340768|NCT00002596|Immunologic Factors|immunologic factors|mesh-ancestor
153340769|NCT00002596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153340770|NCT00002596|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153340771|NCT00002596|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153340772|NCT00002596|Alkylating Agents|alkylating agents|mesh-ancestor
153340773|NCT00002596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153340774|NCT00002596|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153340775|NCT00002596|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153340776|NCT00002596|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153340777|NCT00002596|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153340778|NCT00002596|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153340779|NCT00002596|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153340780|NCT00002596|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153340781|NCT00199082|Cytarabine|cytarabine|mesh-list
153340791|NCT00199082|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153340792|NCT00199082|Immunologic Factors|immunologic factors|mesh-ancestor
153340793|NCT00199082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153340794|NCT00199082|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153340795|NCT00199082|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153340796|NCT00199082|Alkylating Agents|alkylating agents|mesh-ancestor
153340798|NCT00199082|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153340799|NCT00199082|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153340800|NCT00199082|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153340801|NCT00199082|Antiemetics|antiemetics|mesh-ancestor
153340802|NCT00199082|Autonomic Agents|autonomic agents|mesh-ancestor
153340803|NCT00199082|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153915146|NCT02704507|Triamcinolone|triamcinolone|mesh-list
153915147|NCT02704507|Tretinoin|tretinoin|mesh-list
153915148|NCT02704507|Emollients|emollients|mesh-list
153915149|NCT02704507|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153915150|NCT02704507|Glucocorticoids|glucocorticoids|mesh-ancestor
153915151|NCT02704507|Hormones|hormones|mesh-ancestor
153890105|NCT04479267|Prednisolone phosphate|prednisolone phosphate|mesh-list
153890106|NCT04479267|Immunoconjugates|immunoconjugates|mesh-list
153915152|NCT02704507|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153915153|NCT02704507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153915154|NCT02704507|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153915155|NCT02704507|Keratolytic Agents|keratolytic agents|mesh-ancestor
153915156|NCT02704507|Dermatologic Agents|dermatologic agents|mesh-ancestor
153915157|NCT01210001|Empagliflozin|empagliflozin|mesh-list
153915158|NCT01210001|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
153915159|NCT01210001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153915160|NCT01210001|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153915161|NCT01210001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153340804|NCT00199082|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153340805|NCT00199082|Glucocorticoids|glucocorticoids|mesh-ancestor
153340806|NCT00199082|Hormones|hormones|mesh-ancestor
153340807|NCT00199082|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153340808|NCT00199082|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153340809|NCT00199082|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153340810|NCT00199082|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
153340811|NCT00199082|Abortifacient Agents|abortifacient agents|mesh-ancestor
153340812|NCT00199082|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153340813|NCT00199082|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153340814|NCT00199082|Antimetabolites|antimetabolites|mesh-ancestor
153340815|NCT00199082|Dermatologic Agents|dermatologic agents|mesh-ancestor
153340816|NCT00199082|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153340817|NCT00199082|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153340818|NCT00199082|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153340819|NCT00199082|Antiviral Agents|antiviral agents|mesh-ancestor
153340828|NCT00194090|Celecoxib|celecoxib|mesh-list
153340833|NCT00194090|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153340834|NCT00194090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153340835|NCT00194090|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153340836|NCT00194090|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153340837|NCT00194090|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
153340838|NCT00194090|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153340839|NCT00194090|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153340840|NCT00194090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153915169|NCT00624455|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153915170|NCT00624455|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153915171|NCT00624455|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153915172|NCT00624455|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
153915173|NCT00624455|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
153463843|NCT05585814|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153915174|NCT00624455|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153915175|NCT00624455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153915176|NCT00624455|Antimanic Agents|antimanic agents|mesh-ancestor
153915177|NCT01127659|Testosterone|testosterone|mesh-list
153915178|NCT01127659|Androgens|androgens|mesh-ancestor
153915179|NCT01127659|Hormones|hormones|mesh-ancestor
153915180|NCT01127659|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153915181|NCT01127659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153915182|NCT02698969|Atropine|atropine|mesh-list
153915183|NCT02698969|Fentanyl|fentanyl|mesh-list
153915184|NCT02698969|Propofol|propofol|mesh-list
153915185|NCT02698969|Sevoflurane|sevoflurane|mesh-list
153915186|NCT02698969|Rocuronium|rocuronium|mesh-list
153915187|NCT02698969|Neostigmine|neostigmine|mesh-list
153915188|NCT02698969|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153915189|NCT02698969|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153915190|NCT02698969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153463897|NCT02549898|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153340841|NCT00002608|Tamoxifen|tamoxifen|mesh-list
153340842|NCT00002608|Doxorubicin|doxorubicin|mesh-list
153340843|NCT00002608|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
153340844|NCT00002608|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153340845|NCT00002608|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153340846|NCT00002608|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153340847|NCT00002608|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153340848|NCT00002608|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153340849|NCT00002608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153340850|NCT00002608|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
153340851|NCT00002608|Hormone Antagonists|hormone antagonists|mesh-ancestor
153340852|NCT00002608|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153340853|NCT00002608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153340854|NCT00002608|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153340855|NCT00002608|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
153340857|NCT00002608|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153340858|NCT00002620|Cobalt|cobalt|mesh-list
153340859|NCT00002620|Carmustine|carmustine|mesh-list
153340880|NCT00002638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153340881|NCT00002638|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153340882|NCT00002638|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153340883|NCT00002638|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153340884|NCT00002638|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153340885|NCT00002638|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153340886|NCT00002638|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153340887|NCT00002638|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153340888|NCT00002638|Antimetabolites|antimetabolites|mesh-ancestor
153340889|NCT00002638|Antiviral Agents|antiviral agents|mesh-ancestor
153463899|NCT02549898|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
153463900|NCT02549898|Protective Agents|protective agents|mesh-ancestor
153463901|NCT02549898|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
153463902|NCT02549898|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
153463903|NCT02549898|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153463904|NCT02549898|Hematinics|hematinics|mesh-ancestor
153463905|NCT02549898|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
153463906|NCT02549898|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
153340890|NCT00002638|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153340891|NCT05120362|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-list
153340892|NCT05120362|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153340893|NCT05120362|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153340894|NCT05120362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153340896|NCT01896440|Antiemetics|antiemetics|mesh-ancestor
153340897|NCT01896440|Autonomic Agents|autonomic agents|mesh-ancestor
153340898|NCT01896440|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153340899|NCT01896440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153340900|NCT01896440|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153340901|NCT01896440|Antipruritics|antipruritics|mesh-ancestor
153340902|NCT01896440|Dermatologic Agents|dermatologic agents|mesh-ancestor
153340903|NCT01896440|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
153340904|NCT01896440|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153340905|NCT01896440|Serotonin Agents|serotonin agents|mesh-ancestor
153340906|NCT01896440|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153340907|NCT01896440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153340908|NCT00002656|NSC 366140|nsc 366140|mesh-list
153340909|NCT00002656|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153340924|NCT00002674|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153340925|NCT00002674|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153340926|NCT00002674|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153340927|NCT00002674|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153340928|NCT00002674|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153340929|NCT00002674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153783268|NCT00268788|Antibodies|antibodies|mesh-list
153783269|NCT00268788|gamma-Globulins|gamma-globulins|mesh-list
153783270|NCT00268788|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
153340930|NCT00002674|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153340931|NCT00002674|Antimetabolites|antimetabolites|mesh-ancestor
153340932|NCT00002674|Antiviral Agents|antiviral agents|mesh-ancestor
153340933|NCT00002674|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153340934|NCT00002674|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153340935|NCT00002674|Immunologic Factors|immunologic factors|mesh-ancestor
153915214|NCT02698969|Cholinergic Agents|cholinergic agents|mesh-ancestor
153915215|NCT02698969|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153915216|NCT02698969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153915217|NCT02698969|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
153915218|NCT02698969|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153915219|NCT02698969|Parasympathomimetics|parasympathomimetics|mesh-ancestor
153915220|NCT00848731|Nitric Oxide|nitric oxide|mesh-list
153915221|NCT00848731|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153463936|NCT02369484|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153463937|NCT02369484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153463938|NCT02369484|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153463941|NCT04390152|Azithromycin|azithromycin|mesh-list
153463942|NCT04390152|Hydroxychloroquine|hydroxychloroquine|mesh-list
153463943|NCT04390152|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
153463944|NCT04390152|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
153463945|NCT04390152|Protease Inhibitors|protease inhibitors|mesh-ancestor
153463946|NCT04390152|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153463949|NCT04390152|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153340936|NCT00002674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153340937|NCT00002674|Analgesics|analgesics|mesh-ancestor
153340938|NCT00002674|Sensory System Agents|sensory system agents|mesh-ancestor
153340939|NCT00002674|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153340940|NCT00002674|Antisickling Agents|antisickling agents|mesh-ancestor
153340941|NCT00002674|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153340942|NCT01743872|Dextrans|dextrans|mesh-list
153340943|NCT01743872|Anticoagulants|anticoagulants|mesh-ancestor
153340945|NCT01743872|Blood Substitutes|blood substitutes|mesh-ancestor
153340946|NCT00002680|Tamoxifen|tamoxifen|mesh-list
153340947|NCT00002680|Cyclophosphamide|cyclophosphamide|mesh-list
153340948|NCT00002680|Melphalan|melphalan|mesh-list
153340949|NCT00002680|Thiotepa|thiotepa|mesh-list
153340950|NCT00002680|Megestrol|megestrol|mesh-list
153340951|NCT00002680|Megestrol Acetate|megestrol acetate|mesh-list
153340952|NCT00002680|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153340953|NCT00002680|Immunologic Factors|immunologic factors|mesh-ancestor
153340966|NCT00002680|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
153340967|NCT00002680|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153340968|NCT00002680|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
153340969|NCT00002680|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
153340970|NCT00002680|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
153340971|NCT00002680|Contraceptive Agents|contraceptive agents|mesh-ancestor
153340972|NCT00002680|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153463952|NCT04390152|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
153463953|NCT04390152|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153463954|NCT04390152|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153915234|NCT00848731|Protective Agents|protective agents|mesh-ancestor
153915235|NCT01209143|Rosiglitazone|rosiglitazone|mesh-list
153915236|NCT01209143|Ethinyl Estradiol|ethinyl estradiol|mesh-list
153915237|NCT01209143|Norethindrone|norethindrone|mesh-list
153915238|NCT01209143|Norethindrone Acetate|norethindrone acetate|mesh-list
153915239|NCT01209143|Estradiol|estradiol|mesh-list
153915240|NCT01209143|Estrogens|estrogens|mesh-ancestor
153915241|NCT01209143|Hormones|hormones|mesh-ancestor
153915242|NCT01209143|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153915243|NCT01209143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153915244|NCT01209143|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
153915245|NCT01209143|Contraceptive Agents|contraceptive agents|mesh-ancestor
153915246|NCT01209143|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153915247|NCT01209143|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
153915253|NCT00454285|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153915254|NCT00454285|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153915255|NCT00614965|Irinotecan|irinotecan|mesh-list
153915256|NCT00614965|Pemetrexed|pemetrexed|mesh-list
153340973|NCT00002680|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
153340974|NCT00002680|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
153340975|NCT00002680|Appetite Stimulants|appetite stimulants|mesh-ancestor
153340976|NCT00002680|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
153340978|NCT00002692|Fluorouracil|fluorouracil|mesh-list
153340979|NCT00002692|Calcium|calcium|mesh-list
153340980|NCT00002692|Levoleucovorin|levoleucovorin|mesh-list
153340981|NCT00002692|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153340982|NCT00002692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153340983|NCT00002692|Antimetabolites|antimetabolites|mesh-ancestor
153340984|NCT00002692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153340985|NCT00002692|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153340986|NCT00002692|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153340987|NCT00002692|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153340988|NCT00002692|Immunologic Factors|immunologic factors|mesh-ancestor
153340989|NCT00002692|Antidotes|antidotes|mesh-ancestor
153340990|NCT00002692|Protective Agents|protective agents|mesh-ancestor
153340991|NCT00002692|Vitamin B Complex|vitamin b complex|mesh-ancestor
153340992|NCT00002692|Vitamins|vitamins|mesh-ancestor
153340993|NCT00002692|Micronutrients|micronutrients|mesh-ancestor
153340994|NCT05293210|Dexamethasone|dexamethasone|mesh-list
153340995|NCT05293210|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153340996|NCT05293210|Antiemetics|antiemetics|mesh-ancestor
153340997|NCT05293210|Autonomic Agents|autonomic agents|mesh-ancestor
153340998|NCT05293210|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153341009|NCT01895348|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153341010|NCT01895348|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153341011|NCT01895348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153341012|NCT01895348|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153915257|NCT00614965|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153915258|NCT00614965|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
153915259|NCT00614965|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153915260|NCT00614965|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153463955|NCT04390152|Antimalarials|antimalarials|mesh-ancestor
153463956|NCT04390152|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153463957|NCT04390152|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153463958|NCT04390152|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153463959|NCT02496780|Insulin|insulin|mesh-list
153463960|NCT02496780|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
153463961|NCT02496780|Insulin Aspart|insulin aspart|mesh-list
153463962|NCT02496780|Insulin Detemir|insulin detemir|mesh-list
153463963|NCT02496780|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153463964|NCT02496780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153463965|NCT01953588|Fulvestrant|fulvestrant|mesh-list
153341014|NCT01895348|Sensory System Agents|sensory system agents|mesh-ancestor
153341015|NCT01895348|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153341016|NCT01895348|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
153341017|NCT01895348|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153341018|NCT01895348|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153341019|NCT01895348|Adrenergic Agents|adrenergic agents|mesh-ancestor
153341020|NCT01895348|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153341021|NCT01895348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153341022|NCT01895348|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153341023|NCT01895348|Anesthetics, General|anesthetics, general|mesh-ancestor
153341024|NCT01895348|Anesthetics|anesthetics|mesh-ancestor
153341025|NCT01895348|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153341026|NCT01895348|Narcotics|narcotics|mesh-ancestor
153341027|NCT04784000|Carbamazepine|carbamazepine|mesh-list
153341028|NCT04784000|Anticonvulsants|anticonvulsants|mesh-ancestor
153341029|NCT04784000|Antimanic Agents|antimanic agents|mesh-ancestor
153341060|NCT01113476|Antimetabolites|antimetabolites|mesh-ancestor
153341061|NCT01107236|Naproxen|naproxen|mesh-list
153341062|NCT01107236|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153341063|NCT01107236|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153341064|NCT01107236|Analgesics|analgesics|mesh-ancestor
153341065|NCT01107236|Sensory System Agents|sensory system agents|mesh-ancestor
153915271|NCT00405613|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153915272|NCT00405613|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153915273|NCT00405613|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153915274|NCT00405613|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153915275|NCT00405613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153915276|NCT00405613|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153915277|NCT00405613|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153915278|NCT00405613|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153915279|NCT00405613|Antipyretics|antipyretics|mesh-ancestor
153915280|NCT02703961|Cisplatin|cisplatin|mesh-list
153915281|NCT02703961|Docetaxel|docetaxel|mesh-list
153915282|NCT02703961|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153915283|NCT02703961|Tubulin Modulators|tubulin modulators|mesh-ancestor
153915284|NCT02703961|Antimitotic Agents|antimitotic agents|mesh-ancestor
153915285|NCT02703961|Mitosis Modulators|mitosis modulators|mesh-ancestor
153915286|NCT02703961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153915287|NCT02703649|Letrozole|letrozole|mesh-list
153915288|NCT02703649|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153915289|NCT02703649|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
153915290|NCT02703649|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153341069|NCT01107236|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153341070|NCT01107236|Gout Suppressants|gout suppressants|mesh-ancestor
153341071|NCT01107236|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153341072|NCT01107236|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153341073|NCT01107236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153341074|NCT00002704|Leucovorin|leucovorin|mesh-list
153341075|NCT00002704|Cytarabine|cytarabine|mesh-list
153341076|NCT00002704|Dexamethasone|dexamethasone|mesh-list
153341077|NCT00002704|Hydrocortisone|hydrocortisone|mesh-list
153341078|NCT00002704|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
153341079|NCT00002704|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
153783272|NCT00268788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153341080|NCT00002704|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
153341081|NCT00002704|Cyclophosphamide|cyclophosphamide|mesh-list
153341082|NCT00002704|Thiotepa|thiotepa|mesh-list
153915308|NCT02703415|Sensory System Agents|sensory system agents|mesh-ancestor
153915309|NCT02703415|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153915310|NCT02703415|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153915311|NCT02703415|Narcotics|narcotics|mesh-ancestor
153915312|NCT02703415|Analgesics|analgesics|mesh-ancestor
153915313|NCT02703181|Diketopiperazines|diketopiperazines|mesh-list
153915314|NCT02703181|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153915315|NCT02703181|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153464011|NCT05586126|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153890113|NCT04479267|Alkylating Agents|alkylating agents|mesh-ancestor
153890114|NCT04479267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153464012|NCT05586126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153464013|NCT01893996|Adalimumab|adalimumab|mesh-list
153464014|NCT01893996|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
153464015|NCT01893996|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153464016|NCT01893996|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153464017|NCT02442180|Methylprednisolone|methylprednisolone|mesh-list
153915317|NCT04215835|Misoprostol|misoprostol|mesh-list
153915318|NCT04215835|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153915319|NCT04215835|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
153915320|NCT04215835|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153915321|NCT04215835|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153341083|NCT00002704|Methotrexate|methotrexate|mesh-list
153341084|NCT00002704|Etoposide|etoposide|mesh-list
153341085|NCT00002704|Vincristine|vincristine|mesh-list
153341086|NCT00002704|Daunorubicin|daunorubicin|mesh-list
153341087|NCT00002704|Asparaginase|asparaginase|mesh-list
153341088|NCT00002704|Mercaptopurine|mercaptopurine|mesh-list
153341108|NCT00002704|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
153341109|NCT00002704|Abortifacient Agents|abortifacient agents|mesh-ancestor
153341110|NCT00002704|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153341111|NCT00002704|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153341112|NCT00002704|Antimetabolites|antimetabolites|mesh-ancestor
153341113|NCT00002704|Dermatologic Agents|dermatologic agents|mesh-ancestor
153341114|NCT00002704|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153341115|NCT00002704|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153341116|NCT00002704|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153341117|NCT00002704|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153341118|NCT00002704|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153341119|NCT00002704|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153341120|NCT00002704|Antiviral Agents|antiviral agents|mesh-ancestor
153341121|NCT00002704|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153341122|NCT00002704|Antidotes|antidotes|mesh-ancestor
153341123|NCT00002704|Protective Agents|protective agents|mesh-ancestor
153341124|NCT00002704|Vitamin B Complex|vitamin b complex|mesh-ancestor
153341125|NCT00002704|Vitamins|vitamins|mesh-ancestor
153341126|NCT00002704|Micronutrients|micronutrients|mesh-ancestor
153341127|NCT00002704|Tubulin Modulators|tubulin modulators|mesh-ancestor
153341128|NCT00002704|Antimitotic Agents|antimitotic agents|mesh-ancestor
153378180|NCT02696993|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153378181|NCT02696993|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153378182|NCT02696993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153341129|NCT00002704|Mitosis Modulators|mitosis modulators|mesh-ancestor
153341130|NCT00002704|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153341160|NCT02533674|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153341161|NCT02533674|Antimetabolites|antimetabolites|mesh-ancestor
153341162|NCT02533674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153341163|NCT02533674|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153341164|NCT00002722|Leucovorin|leucovorin|mesh-list
153341165|NCT00002722|Fluorouracil|fluorouracil|mesh-list
153915327|NCT04215835|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
153915328|NCT04215835|Abortifacient Agents|abortifacient agents|mesh-ancestor
153915329|NCT04215835|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153915330|NCT04215835|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
153915331|NCT04215835|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153915332|NCT04215835|Oxytocics|oxytocics|mesh-ancestor
153915333|NCT01208207|Naproxen|naproxen|mesh-list
153915334|NCT01208207|Etoricoxib|etoricoxib|mesh-list
153915335|NCT01208207|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153915336|NCT01208207|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153915337|NCT01208207|Analgesics|analgesics|mesh-ancestor
153915338|NCT01208207|Sensory System Agents|sensory system agents|mesh-ancestor
153341166|NCT00002722|Calcium|calcium|mesh-list
153341167|NCT00002722|Levoleucovorin|levoleucovorin|mesh-list
153341168|NCT00002722|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153341169|NCT00002722|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153341170|NCT00002722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153341171|NCT00002722|Antimetabolites|antimetabolites|mesh-ancestor
153341172|NCT00002722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153341173|NCT00002722|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153341174|NCT00002722|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153341175|NCT00002722|Immunologic Factors|immunologic factors|mesh-ancestor
153341177|NCT00002722|Protective Agents|protective agents|mesh-ancestor
153341178|NCT00002722|Vitamin B Complex|vitamin b complex|mesh-ancestor
153341179|NCT00002722|Vitamins|vitamins|mesh-ancestor
153341180|NCT00002722|Micronutrients|micronutrients|mesh-ancestor
153341181|NCT00002734|Interferons|interferons|mesh-list
153341182|NCT00002734|Interferon-alpha|interferon-alpha|mesh-list
153341183|NCT00002734|Paclitaxel|paclitaxel|mesh-list
153341184|NCT00002734|Topotecan|topotecan|mesh-list
153341185|NCT00002734|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
153341186|NCT00002734|Antibodies|antibodies|mesh-list
153341187|NCT00002734|Immunoglobulins|immunoglobulins|mesh-list
153341188|NCT00002734|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
153341189|NCT00002734|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153341190|NCT00002734|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153341191|NCT00002734|Tubulin Modulators|tubulin modulators|mesh-ancestor
153341192|NCT00002734|Antimitotic Agents|antimitotic agents|mesh-ancestor
153880521|NCT01523977|Mitosis Modulators|mitosis modulators|mesh-ancestor
153880523|NCT01523977|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153880524|NCT01523977|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153880525|NCT01523977|Immunologic Factors|immunologic factors|mesh-ancestor
153915358|NCT01012713|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153915359|NCT01012713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153915372|NCT02698813|Viscosupplements|viscosupplements|mesh-ancestor
153915373|NCT02698813|Protective Agents|protective agents|mesh-ancestor
153915374|NCT02702323|Apatinib|apatinib|mesh-list
153915375|NCT02702323|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153915376|NCT02702323|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153915377|NCT02702323|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153464018|NCT02442180|Prednisolone|prednisolone|mesh-list
153915378|NCT02702323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153915379|NCT01007253|Fluticasone|fluticasone|mesh-list
153915380|NCT01007253|Xhance|xhance|mesh-list
153915381|NCT01007253|Olopatadine Hydrochloride|olopatadine hydrochloride|mesh-list
153464079|NCT04757532|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
153464080|NCT04757532|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153464081|NCT04757532|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153464082|NCT04757532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153464083|NCT04757532|Dopamine Agents|dopamine agents|mesh-ancestor
153341195|NCT00002734|Immunologic Factors|immunologic factors|mesh-ancestor
153341196|NCT00002734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153341197|NCT00002734|Antiviral Agents|antiviral agents|mesh-ancestor
153341198|NCT00002734|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153341199|NCT00002734|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
153341200|NCT00002734|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153341201|NCT00002734|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153341202|NCT04783610|Ethanol|ethanol|mesh-list
153341203|NCT04783610|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
153341204|NCT04783610|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153341205|NCT04783610|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153341206|NCT04783610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153341207|NCT00002740|Cobalt|cobalt|mesh-list
153341208|NCT00002740|Cyclophosphamide|cyclophosphamide|mesh-list
153341209|NCT00002740|Carboplatin|carboplatin|mesh-list
153341210|NCT00002740|Doxorubicin|doxorubicin|mesh-list
153341211|NCT00002740|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
153341212|NCT00002740|Etoposide|etoposide|mesh-list
153341213|NCT00002740|Vincristine|vincristine|mesh-list
153341214|NCT00002740|Lenograstim|lenograstim|mesh-list
153341215|NCT00002740|Mesna|mesna|mesh-list
153341216|NCT00002740|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153341217|NCT00002740|Immunologic Factors|immunologic factors|mesh-ancestor
153464092|NCT04757532|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153464093|NCT04757532|Diuretics|diuretics|mesh-ancestor
153464094|NCT04757532|Natriuretic Agents|natriuretic agents|mesh-ancestor
153464095|NCT04757532|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
153464096|NCT02063022|Dactinomycin|dactinomycin|mesh-list
153464097|NCT02063022|Cyclophosphamide|cyclophosphamide|mesh-list
153464098|NCT02063022|Melphalan|melphalan|mesh-list
153464100|NCT02063022|Ifosfamide|ifosfamide|mesh-list
153464101|NCT02063022|Isophosphamide mustard|isophosphamide mustard|mesh-list
153464102|NCT02063022|Doxorubicin|doxorubicin|mesh-list
153464103|NCT02063022|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
153464104|NCT02063022|Etoposide|etoposide|mesh-list
153915382|NCT01007253|Ophthalmic Solutions|ophthalmic solutions|mesh-list
153915383|NCT01007253|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
153915384|NCT01007253|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153915386|NCT01007253|Autonomic Agents|autonomic agents|mesh-ancestor
153915387|NCT01007253|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153915388|NCT01007253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153915389|NCT01007253|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153915390|NCT01007253|Respiratory System Agents|respiratory system agents|mesh-ancestor
153915391|NCT01007253|Dermatologic Agents|dermatologic agents|mesh-ancestor
153915392|NCT01007253|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
153341220|NCT00002740|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153341221|NCT00002740|Alkylating Agents|alkylating agents|mesh-ancestor
153341222|NCT00002740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153341223|NCT00002740|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153341224|NCT00002740|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153341225|NCT00002740|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153341226|NCT00002740|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153341227|NCT00002740|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153341237|NCT00002746|Aldesleukin|aldesleukin|mesh-list
153341249|NCT01049945|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153341252|NCT01049945|Glucocorticoids|glucocorticoids|mesh-ancestor
153341253|NCT01049945|Hormones|hormones|mesh-ancestor
153341254|NCT01049945|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153341255|NCT01049945|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153341256|NCT01049945|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153341257|NCT01049945|Immunologic Factors|immunologic factors|mesh-ancestor
153341258|NCT01049945|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153341259|NCT01049945|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153341260|NCT01049945|Growth Substances|growth substances|mesh-ancestor
153341261|NCT01049945|Growth Inhibitors|growth inhibitors|mesh-ancestor
153341262|NCT01049945|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153341263|NCT01049945|Alkylating Agents|alkylating agents|mesh-ancestor
153915394|NCT01007253|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153915395|NCT01007253|Analgesics|analgesics|mesh-ancestor
153915396|NCT01007253|Sensory System Agents|sensory system agents|mesh-ancestor
153915397|NCT01007253|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153915398|NCT01007253|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
153915399|NCT01007253|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
153915400|NCT01007253|Histamine Antagonists|histamine antagonists|mesh-ancestor
153915401|NCT01007253|Histamine Agents|histamine agents|mesh-ancestor
153915402|NCT01007253|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153915403|NCT01007253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153890121|NCT04479267|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153890122|NCT04479267|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153890123|NCT04479267|Glucocorticoids|glucocorticoids|mesh-ancestor
153464105|NCT02063022|Etoposide phosphate|etoposide phosphate|mesh-list
153464106|NCT02063022|Vincristine|vincristine|mesh-list
153464107|NCT02063022|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153464108|NCT02063022|Immunologic Factors|immunologic factors|mesh-ancestor
153341264|NCT01049945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153341266|NCT00002752|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
153341267|NCT00002752|Immunologic Factors|immunologic factors|mesh-ancestor
153341268|NCT00002752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153341269|NCT01050647|Castor Oil|castor oil|mesh-list
153341270|NCT01050647|17 alpha-Hydroxyprogesterone Caproate|17 alpha-hydroxyprogesterone caproate|mesh-list
153341271|NCT01050647|11-hydroxyprogesterone|11-hydroxyprogesterone|mesh-list
153341272|NCT01050647|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
153341273|NCT01050647|Hormone Antagonists|hormone antagonists|mesh-ancestor
153341274|NCT01050647|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153341275|NCT01050647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153421373|NCT05973851|Anesthetics, General|anesthetics, general|mesh-ancestor
153421374|NCT05973851|Anesthetics|anesthetics|mesh-ancestor
153421375|NCT05973851|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153421376|NCT05973851|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
153341277|NCT01050647|Hormones|hormones|mesh-ancestor
153341278|NCT01050647|Cathartics|cathartics|mesh-ancestor
153341279|NCT01050647|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153341280|NCT00002764|Doxorubicin|doxorubicin|mesh-list
153341293|NCT05167175|Abiraterone Acetate|abiraterone acetate|mesh-list
153464109|NCT02063022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153464110|NCT02063022|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153464111|NCT02063022|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153464112|NCT02063022|Alkylating Agents|alkylating agents|mesh-ancestor
153464113|NCT02063022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153464114|NCT02063022|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153464115|NCT02063022|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153464116|NCT02063022|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153464117|NCT02063022|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153464118|NCT02063022|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153464119|NCT02063022|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153464120|NCT02063022|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153890124|NCT04479267|Hormones|hormones|mesh-ancestor
153341294|NCT05167175|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153341296|NCT05167175|Hormones|hormones|mesh-ancestor
153341297|NCT05167175|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153341298|NCT05167175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153341299|NCT05167175|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153341300|NCT05167175|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153341301|NCT05167175|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
153341302|NCT05167175|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153341303|NCT05167175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153341304|NCT05167175|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153341305|NCT05167175|Hormone Antagonists|hormone antagonists|mesh-ancestor
153341306|NCT05167175|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153341307|NCT00002590|Leucovorin|leucovorin|mesh-list
153341308|NCT00002590|Cytarabine|cytarabine|mesh-list
153783275|NCT00235937|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153341309|NCT00002590|Prednisone|prednisone|mesh-list
153341310|NCT00002590|Cyclophosphamide|cyclophosphamide|mesh-list
153341311|NCT00002590|Doxorubicin|doxorubicin|mesh-list
153341312|NCT00002590|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
153341313|NCT00002590|Methotrexate|methotrexate|mesh-list
153341314|NCT00002590|Etoposide|etoposide|mesh-list
153464132|NCT01895010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153915422|NCT01006707|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153915423|NCT01006707|Serotonin Agents|serotonin agents|mesh-ancestor
153915424|NCT01006707|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153915425|NCT01006707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153915426|NCT01006629|Palivizumab|palivizumab|mesh-list
153915427|NCT01006629|Antiviral Agents|antiviral agents|mesh-ancestor
153915428|NCT01006629|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153915429|NCT04214977|Anesthetics|anesthetics|mesh-list
153890126|NCT04479267|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153890127|NCT04479267|Antiemetics|antiemetics|mesh-ancestor
153341353|NCT00002590|Vitamins|vitamins|mesh-ancestor
153341354|NCT00002590|Micronutrients|micronutrients|mesh-ancestor
153341355|NCT00002590|Tubulin Modulators|tubulin modulators|mesh-ancestor
153341356|NCT00002590|Antimitotic Agents|antimitotic agents|mesh-ancestor
153341357|NCT00002590|Mitosis Modulators|mitosis modulators|mesh-ancestor
153341358|NCT00002788|Dexamethasone|dexamethasone|mesh-list
153341359|NCT00002788|Cyclophosphamide|cyclophosphamide|mesh-list
153341360|NCT00002788|Etoposide|etoposide|mesh-list
153915431|NCT04214977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153915432|NCT02701933|Ketamine|ketamine|mesh-list
153915433|NCT02701933|Analgesics|analgesics|mesh-ancestor
153915434|NCT02701933|Sensory System Agents|sensory system agents|mesh-ancestor
153915435|NCT02701933|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153915436|NCT02701933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153915437|NCT02701933|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
153915438|NCT02701933|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153915439|NCT02701933|Anesthetics, General|anesthetics, general|mesh-ancestor
153890128|NCT04479267|Autonomic Agents|autonomic agents|mesh-ancestor
153890129|NCT04479267|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153890130|NCT04479267|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153890131|NCT04479267|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
153341363|NCT00002788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153341364|NCT00002788|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153341365|NCT00002788|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153341366|NCT00002788|Alkylating Agents|alkylating agents|mesh-ancestor
153341367|NCT00002788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153341368|NCT00002788|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153341369|NCT00002788|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153341370|NCT00002788|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153341371|NCT00002788|Antiemetics|antiemetics|mesh-ancestor
153783276|NCT00235937|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153783277|NCT00235937|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
153341386|NCT04352933|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153341388|NCT04352933|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153341389|NCT04352933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153341390|NCT04352933|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153341391|NCT04783792|Ascorbic Acid|ascorbic acid|mesh-list
153341392|NCT04783792|Antioxidants|antioxidants|mesh-ancestor
153915440|NCT02701933|Anesthetics|anesthetics|mesh-ancestor
153915441|NCT02701933|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153915442|NCT02701933|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
153915443|NCT02701933|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
153915444|NCT02701933|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153915445|NCT02701933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153915447|NCT04295967|Disinfectants|disinfectants|mesh-ancestor
153915448|NCT04295967|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153915449|NCT01012323|Immunoglobulins|immunoglobulins|mesh-list
153464151|NCT02087748|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153915452|NCT02871765|Warfarin|warfarin|mesh-list
153341393|NCT04783792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153341394|NCT04783792|Protective Agents|protective agents|mesh-ancestor
153341395|NCT04783792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153341397|NCT04783792|Micronutrients|micronutrients|mesh-ancestor
153341398|NCT01676402|Vaccines|vaccines|mesh-list
153341399|NCT01676402|Immunologic Factors|immunologic factors|mesh-ancestor
153341400|NCT01676402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153341401|NCT01052831|Naltrexone|naltrexone|mesh-list
153341402|NCT01052831|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
153341403|NCT01052831|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
153341404|NCT01052831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153341405|NCT01052831|Sensory System Agents|sensory system agents|mesh-ancestor
153341406|NCT01052831|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153341407|NCT04330300|Losartan|losartan|mesh-list
153341408|NCT04330300|Verapamil|verapamil|mesh-list
153341409|NCT04330300|Felodipine|felodipine|mesh-list
153341410|NCT04330300|Amlodipine|amlodipine|mesh-list
153341411|NCT04330300|Valsartan|valsartan|mesh-list
153341412|NCT04330300|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
153341413|NCT04330300|Telmisartan|telmisartan|mesh-list
153341414|NCT04330300|Candesartan|candesartan|mesh-list
153341415|NCT04330300|Ramipril|ramipril|mesh-list
153341416|NCT04330300|Olmesartan|olmesartan|mesh-list
153341417|NCT04330300|Enalapril|enalapril|mesh-list
153341418|NCT04330300|Lisinopril|lisinopril|mesh-list
153341419|NCT04330300|Irbesartan|irbesartan|mesh-list
153341420|NCT04330300|Chlorthalidone|chlorthalidone|mesh-list
153341421|NCT04330300|Perindopril|perindopril|mesh-list
153341422|NCT04330300|Diltiazem|diltiazem|mesh-list
153915462|NCT02549209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153915464|NCT02549209|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153915465|NCT02698267|Itraconazole|itraconazole|mesh-list
153915466|NCT02698267|Antifungal Agents|antifungal agents|mesh-ancestor
153915467|NCT02698267|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153915468|NCT02698267|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
153915469|NCT02698267|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153341444|NCT04330300|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153341445|NCT04330300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153341446|NCT04330300|Vasodilator Agents|vasodilator agents|mesh-ancestor
153341447|NCT04330300|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
153341448|NCT04330300|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153341449|NCT04330300|Natriuretic Agents|natriuretic agents|mesh-ancestor
153341450|NCT04330300|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
153341451|NCT04330300|Protease Inhibitors|protease inhibitors|mesh-ancestor
153341452|NCT04330300|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153341454|NCT04330300|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153341455|NCT04330300|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
153915471|NCT02698267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153915472|NCT02698267|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153915473|NCT02698267|Hormone Antagonists|hormone antagonists|mesh-ancestor
153915474|NCT02698267|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153915475|NCT02698267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153890134|NCT04021017|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
153890135|NCT04021017|Estradiol|estradiol|mesh-list
153890136|NCT04021017|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
153890137|NCT04021017|Estrogens|estrogens|mesh-ancestor
153890138|NCT04021017|Hormones|hormones|mesh-ancestor
153341456|NCT04330300|Protective Agents|protective agents|mesh-ancestor
153341479|NCT00995150|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
153341480|NCT00995150|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
153341482|NCT00382642|Ondansetron|ondansetron|mesh-list
153341483|NCT00382642|Antiemetics|antiemetics|mesh-ancestor
153341484|NCT00382642|Autonomic Agents|autonomic agents|mesh-ancestor
153341485|NCT00382642|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153341486|NCT00382642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153341487|NCT00382642|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153341488|NCT00382642|Antipruritics|antipruritics|mesh-ancestor
153341489|NCT00382642|Dermatologic Agents|dermatologic agents|mesh-ancestor
153341490|NCT00382642|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
153341491|NCT00382642|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153341492|NCT00382642|Serotonin Agents|serotonin agents|mesh-ancestor
153341493|NCT00382642|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153915478|NCT01011465|Oxytocics|oxytocics|mesh-ancestor
153915479|NCT01011465|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153915480|NCT01011465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153915481|NCT02494141|Curcumin|curcumin|mesh-list
153915482|NCT02494141|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153915483|NCT02494141|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153915484|NCT02494141|Analgesics|analgesics|mesh-ancestor
153915485|NCT02494141|Sensory System Agents|sensory system agents|mesh-ancestor
153915486|NCT02494141|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153915487|NCT02494141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153915489|NCT02494141|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153915490|NCT02494141|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153915491|NCT02494141|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153915492|NCT02494141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153914643|NCT00609388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153915498|NCT01011309|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
153915499|NCT01011309|Anthelmintics|anthelmintics|mesh-ancestor
153915500|NCT04214821|Moxifloxacin|moxifloxacin|mesh-list
153915503|NCT04214821|Ophthalmic Solutions|ophthalmic solutions|mesh-list
153464208|NCT01253070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153464209|NCT01253070|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153464210|NCT01253070|Antiviral Agents|antiviral agents|mesh-ancestor
153464211|NCT01253070|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153341494|NCT00382642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153341495|NCT01054079|Cinacalcet|cinacalcet|mesh-list
153341496|NCT01054079|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153341497|NCT01054079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153341498|NCT01054079|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
153341499|NCT01054079|Hormone Antagonists|hormone antagonists|mesh-ancestor
153341500|NCT01054079|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153341532|NCT02171195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153341533|NCT01620788|Losartan|losartan|mesh-list
153341534|NCT01620788|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
153341535|NCT01620788|Indapamide|indapamide|mesh-list
153341536|NCT01620788|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153341537|NCT01620788|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153341538|NCT01620788|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
153341539|NCT01620788|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
153341540|NCT01620788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153341541|NCT01620788|Diuretics|diuretics|mesh-ancestor
153341542|NCT01620788|Natriuretic Agents|natriuretic agents|mesh-ancestor
153341543|NCT01620788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153341544|NCT01620788|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
153341545|NCT01620788|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153341546|NCT03014843|Bromides|bromides|mesh-list
153341547|NCT03014843|Naloxone|naloxone|mesh-list
153341548|NCT03014843|Methylnaltrexone|methylnaltrexone|mesh-list
153341549|NCT03014843|Anticonvulsants|anticonvulsants|mesh-ancestor
153341550|NCT03014843|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
153341551|NCT03014843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153341552|NCT03014843|Sensory System Agents|sensory system agents|mesh-ancestor
153341553|NCT03014843|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153341554|NCT05081375|Enoxaparin|enoxaparin|mesh-list
153341556|NCT05081375|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153341557|NCT05081375|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153341558|NCT05081375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153341559|NCT04755062|Micronutrients|micronutrients|mesh-list
153341560|NCT04755062|Trace Elements|trace elements|mesh-list
153341561|NCT04755062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153341563|NCT03852797|Propofol|propofol|mesh-list
153341564|NCT03852797|Etomidate|etomidate|mesh-list
153341565|NCT03852797|Oxytocin|oxytocin|mesh-list
153341566|NCT03852797|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153341567|NCT03852797|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153341574|NCT03852797|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153341575|NCT03852797|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
153341576|NCT03852797|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
153341577|NCT03852797|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
153341579|NCT03852797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153341581|NCT03852797|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153341582|NCT01055171|Propranolol|propranolol|mesh-list
153341583|NCT01055171|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
153341584|NCT01055171|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
153341585|NCT01055171|Adrenergic Agents|adrenergic agents|mesh-ancestor
153341586|NCT01055171|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153341587|NCT01055171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153341588|NCT01055171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153341589|NCT01055171|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153341590|NCT01055171|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153341591|NCT01055171|Vasodilator Agents|vasodilator agents|mesh-ancestor
153341592|NCT01057277|Everolimus|everolimus|mesh-list
153341593|NCT01057277|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
153341594|NCT01057277|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153341595|NCT01057277|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153341596|NCT01057277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153341597|NCT01057277|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153341598|NCT01057277|Immunologic Factors|immunologic factors|mesh-ancestor
153341599|NCT01057277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153341600|NCT01057277|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153341601|NCT00866840|Riluzole|riluzole|mesh-list
153341602|NCT00866840|Anticonvulsants|anticonvulsants|mesh-ancestor
153341609|NCT00866840|Protective Agents|protective agents|mesh-ancestor
153341616|NCT04349722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153341617|NCT04349722|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153341618|NCT04349722|Mydriatics|mydriatics|mesh-ancestor
153341619|NCT04349722|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
153341621|NCT04349722|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153341622|NCT04349722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153341623|NCT04349722|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
153341624|NCT04349722|Parasympatholytics|parasympatholytics|mesh-ancestor
153341625|NCT01058993|Plerixafor|plerixafor|mesh-list
153341626|NCT01058993|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153341627|NCT01058993|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153915612|NCT02870673|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
153915616|NCT02870673|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153341628|NCT01058993|Antiviral Agents|antiviral agents|mesh-ancestor
153341629|NCT01058993|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153341630|NCT01059305|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
153341631|NCT01059305|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153341632|NCT01059305|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153341633|NCT01059305|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153341634|NCT01059305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153341635|NCT01059305|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153341636|NCT04650490|Immunomodulating Agents|immunomodulating agents|mesh-list
153341637|NCT04650490|Immunologic Factors|immunologic factors|mesh-ancestor
153341638|NCT04650490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153341639|NCT03014687|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
153341640|NCT03014687|Cefdinir|cefdinir|mesh-list
153341641|NCT03014687|Cephalosporins|cephalosporins|mesh-list
153341642|NCT03014687|Trimethoprim|trimethoprim|mesh-list
153341643|NCT03014687|Sulfamethoxazole|sulfamethoxazole|mesh-list
153341644|NCT03014687|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153341645|NCT03014687|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
153341646|NCT03014687|Antimalarials|antimalarials|mesh-ancestor
153341647|NCT03014687|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153341648|NCT03014687|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153341660|NCT04199572|Analgesics|analgesics|mesh-ancestor
153341661|NCT04199572|Sensory System Agents|sensory system agents|mesh-ancestor
153341662|NCT04199572|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153880533|NCT01517243|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153880534|NCT01517243|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153341663|NCT04199572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153341664|NCT04199572|Antipyretics|antipyretics|mesh-ancestor
153341665|NCT04199572|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153341666|NCT04199572|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153341667|NCT04199572|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153341668|NCT04199572|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153915710|NCT02700217|Sensory System Agents|sensory system agents|mesh-ancestor
153915711|NCT02700217|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153915712|NCT02700217|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153915713|NCT02700217|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153341669|NCT04199572|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153341670|NCT04199572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153341671|NCT02169479|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
153915714|NCT02700217|Anesthetics, General|anesthetics, general|mesh-ancestor
153915715|NCT02700217|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153341672|NCT02169479|Opicapone|opicapone|mesh-list
153341673|NCT02169479|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153341674|NCT02169479|Immunologic Factors|immunologic factors|mesh-ancestor
153341675|NCT02169479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153341676|NCT02169479|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
153341677|NCT02169479|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
153341678|NCT02169479|Dopamine Agonists|dopamine agonists|mesh-ancestor
153341679|NCT02169479|Dopamine Agents|dopamine agents|mesh-ancestor
153341680|NCT02169479|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153341681|NCT02169479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153341682|NCT02169479|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
153341683|NCT02169479|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153341684|NCT01059851|Suvorexant|suvorexant|mesh-list
153341692|NCT02169869|Levonorgestrel|levonorgestrel|mesh-list
153341707|NCT01059929|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153341709|NCT01059929|Sensory System Agents|sensory system agents|mesh-ancestor
153341710|NCT01059929|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153464474|NCT02744430|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
153464475|NCT02744430|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153464477|NCT02744430|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153341711|NCT01059929|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
153464478|NCT02744430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153464479|NCT02744430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153464480|NCT02744430|Urological Agents|urological agents|mesh-ancestor
153464481|NCT00054756|Hormones|hormones|mesh-list
153464482|NCT00054756|Thyrotropin-Releasing Hormone|thyrotropin-releasing hormone|mesh-list
153464483|NCT00054756|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153464484|NCT00054756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153464485|NCT01896960|Fentanyl|fentanyl|mesh-list
153464489|NCT01896960|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153464490|NCT01896960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153464491|NCT01896960|Sensory System Agents|sensory system agents|mesh-ancestor
153915758|NCT01208051|Immunologic Factors|immunologic factors|mesh-ancestor
153341712|NCT01059929|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153341713|NCT01059929|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153341714|NCT01059929|Adrenergic Agents|adrenergic agents|mesh-ancestor
153341715|NCT01059929|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153341716|NCT01059929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153341717|NCT01059929|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153341718|NCT01059929|Anesthetics, General|anesthetics, general|mesh-ancestor
153341719|NCT01059929|Anesthetics|anesthetics|mesh-ancestor
153341720|NCT01059929|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153341721|NCT01059929|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153341722|NCT01059929|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153341724|NCT01059929|GABA Modulators|gaba modulators|mesh-ancestor
153341725|NCT01059929|GABA Agents|gaba agents|mesh-ancestor
153341726|NCT01059929|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153341727|NCT01059929|Narcotics|narcotics|mesh-ancestor
153341728|NCT04162522|Escitalopram|escitalopram|mesh-list
153341729|NCT04162522|Brexpiprazole|brexpiprazole|mesh-list
153341730|NCT04162522|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
153341731|NCT04162522|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153341732|NCT04162522|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153341733|NCT04162522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153341735|NCT04162522|Serotonin Agents|serotonin agents|mesh-ancestor
153341752|NCT04896658|Autonomic Agents|autonomic agents|mesh-ancestor
153341753|NCT04896658|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153341754|NCT04896658|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153341755|NCT04896658|Glucocorticoids|glucocorticoids|mesh-ancestor
153341756|NCT04896658|Hormones|hormones|mesh-ancestor
153341757|NCT04896658|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153341758|NCT04896658|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153341759|NCT01062269|Cholestyramine Resin|cholestyramine resin|mesh-list
153341760|NCT01062269|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153341761|NCT01062269|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153341762|NCT01062269|Antimetabolites|antimetabolites|mesh-ancestor
153341763|NCT01062269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153341764|NCT01062269|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153915775|NCT00616915|Antidepressive Agents|antidepressive agents|mesh-ancestor
153915776|NCT00616915|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153915777|NCT00616915|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
153431255|NCT06315478|Omeprazole|omeprazole|mesh-list
153341765|NCT04156828|Dexamethasone|dexamethasone|mesh-list
153783279|NCT00235937|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153341767|NCT04156828|Rituximab|rituximab|mesh-list
153341768|NCT04156828|Carboplatin|carboplatin|mesh-list
153341769|NCT04156828|Gemcitabine|gemcitabine|mesh-list
153341770|NCT04156828|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
153341771|NCT04156828|Antibodies|antibodies|mesh-list
153341772|NCT04156828|Immunoglobulins|immunoglobulins|mesh-list
153341773|NCT04156828|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
153341774|NCT04156828|Lenograstim|lenograstim|mesh-list
153341775|NCT04156828|Immunologic Factors|immunologic factors|mesh-ancestor
153341776|NCT04156828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153341777|NCT04156828|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153341779|NCT04156828|Autonomic Agents|autonomic agents|mesh-ancestor
153341780|NCT04156828|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153341781|NCT04156828|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153341782|NCT04156828|Glucocorticoids|glucocorticoids|mesh-ancestor
153341784|NCT04156828|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153341785|NCT04156828|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153341786|NCT04156828|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153341787|NCT04156828|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153464531|NCT00056472|Antidepressive Agents|antidepressive agents|mesh-ancestor
153464532|NCT00056550|Antithrombins|antithrombins|mesh-list
153341792|NCT01063049|Bisacodyl|bisacodyl|mesh-list
153341793|NCT01063049|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
153341795|NCT01063049|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153341796|NCT01063049|Laxatives|laxatives|mesh-ancestor
153341797|NCT04104178|Clindamycin|clindamycin|mesh-list
153341798|NCT04104178|Clindamycin palmitate|clindamycin palmitate|mesh-list
153341799|NCT04104178|Clindamycin phosphate|clindamycin phosphate|mesh-list
153341800|NCT04104178|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153341801|NCT04104178|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153341802|NCT04104178|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
153341803|NCT04104178|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153341804|NCT04104178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153341805|NCT03661138|Upadacitinib|upadacitinib|mesh-list
153341806|NCT03661138|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
153341807|NCT03661138|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153341808|NCT03661138|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153341809|NCT03661138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153341810|NCT03661138|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153341811|NCT04081792|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
153341812|NCT04081792|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153341813|NCT04038970|Methotrexate|methotrexate|mesh-list
153341814|NCT04038970|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
153341842|NCT01246063|Doxorubicin|doxorubicin|mesh-list
153341843|NCT01246063|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
153341844|NCT01246063|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153341845|NCT01246063|Antiemetics|antiemetics|mesh-ancestor
153341846|NCT01246063|Autonomic Agents|autonomic agents|mesh-ancestor
153341847|NCT01246063|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153341848|NCT01246063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153431478|NCT06273397|Furosemide|furosemide|mesh-list
153915859|NCT02844907|Autonomic Agents|autonomic agents|mesh-ancestor
153915860|NCT02844907|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153915861|NCT02844907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153915874|NCT00628719|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153341849|NCT01246063|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153341850|NCT01246063|Glucocorticoids|glucocorticoids|mesh-ancestor
153341851|NCT01246063|Hormones|hormones|mesh-ancestor
153341852|NCT01246063|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153341853|NCT01246063|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153341854|NCT01246063|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153341855|NCT01246063|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153341856|NCT01246063|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153341857|NCT01246063|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153341858|NCT01246063|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153915875|NCT00628719|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153915876|NCT00628719|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153915877|NCT00628719|Antifungal Agents|antifungal agents|mesh-ancestor
153915878|NCT00628719|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
153915879|NCT00628719|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153915880|NCT00616993|Difluprednate|difluprednate|mesh-list
153915881|NCT00616993|Glucocorticoids|glucocorticoids|mesh-ancestor
153915882|NCT00616993|Hormones|hormones|mesh-ancestor
153341859|NCT01246063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153341860|NCT03836014|Dexamethasone|dexamethasone|mesh-list
153341863|NCT03836014|Daratumumab|daratumumab|mesh-list
153341865|NCT03836014|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
153341866|NCT03836014|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153341867|NCT03836014|Antiemetics|antiemetics|mesh-ancestor
153341868|NCT03836014|Autonomic Agents|autonomic agents|mesh-ancestor
153341869|NCT03836014|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153341870|NCT03836014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153341871|NCT03836014|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153341872|NCT03836014|Glucocorticoids|glucocorticoids|mesh-ancestor
153341873|NCT03836014|Hormones|hormones|mesh-ancestor
153341874|NCT03836014|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153341885|NCT01205503|Cyclophosphamide|cyclophosphamide|mesh-list
153341886|NCT01205503|Doxorubicin|doxorubicin|mesh-list
153341887|NCT01205503|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153341888|NCT01205503|Immunologic Factors|immunologic factors|mesh-ancestor
153341889|NCT01205503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153341890|NCT01205503|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153341891|NCT01205503|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153341892|NCT01205503|Alkylating Agents|alkylating agents|mesh-ancestor
153341893|NCT01205503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153341894|NCT01205503|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153341895|NCT01205503|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153341896|NCT01205503|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153341897|NCT01205503|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153341898|NCT01205503|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153341899|NCT01205503|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153341900|NCT03187834|Amoxicillin|amoxicillin|mesh-list
153341901|NCT03187834|Azithromycin|azithromycin|mesh-list
153341902|NCT03187834|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
153341903|NCT03187834|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153915918|NCT01203917|Gefitinib|gefitinib|mesh-list
153341905|NCT03187834|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
153341906|NCT03187834|Antimalarials|antimalarials|mesh-ancestor
153341936|NCT01158703|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
153341937|NCT01158703|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
153341938|NCT01158703|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
153341939|NCT01158703|Purinergic Agents|purinergic agents|mesh-ancestor
153341940|NCT01158703|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153341941|NCT03009643|Nitric Oxide|nitric oxide|mesh-list
153341942|NCT03009643|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153341943|NCT03009643|Autonomic Agents|autonomic agents|mesh-ancestor
153341944|NCT03009643|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153341945|NCT03009643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153341946|NCT03009643|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153341947|NCT03009643|Respiratory System Agents|respiratory system agents|mesh-ancestor
153341948|NCT03009643|Free Radical Scavengers|free radical scavengers|mesh-ancestor
153341949|NCT03009643|Antioxidants|antioxidants|mesh-ancestor
153341950|NCT03009643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153341951|NCT03009643|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153341952|NCT03009643|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
153341954|NCT03009643|Gasotransmitters|gasotransmitters|mesh-ancestor
153341955|NCT03009643|Protective Agents|protective agents|mesh-ancestor
153915959|NCT00620269|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
153341956|NCT01207765|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
153915965|NCT04212403|Levofloxacin|levofloxacin|mesh-list
153341957|NCT01207765|Immunologic Factors|immunologic factors|mesh-ancestor
153341958|NCT01207765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153341960|NCT00002890|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153341961|NCT00002890|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153341962|NCT00002896|Leucovorin|leucovorin|mesh-list
153341964|NCT00002896|Fluorouracil|fluorouracil|mesh-list
153341965|NCT00002896|Calcium|calcium|mesh-list
153341966|NCT00002896|Levoleucovorin|levoleucovorin|mesh-list
153421405|NCT05973747|Calcium|calcium|mesh-list
153341967|NCT00002896|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153341968|NCT00002896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153341979|NCT00002896|Micronutrients|micronutrients|mesh-ancestor
153341980|NCT00002896|Trace Elements|trace elements|mesh-ancestor
153341981|NCT01249027|Everolimus|everolimus|mesh-list
153341982|NCT01249027|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
153341983|NCT01249027|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153341984|NCT01249027|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153341985|NCT01249027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153341986|NCT01249027|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153341987|NCT01249027|Immunologic Factors|immunologic factors|mesh-ancestor
153341988|NCT01249027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153915975|NCT04212403|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153890935|NCT01033942|Tenofovir|tenofovir|mesh-list
153341989|NCT01249027|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153341990|NCT00002902|Irinotecan|irinotecan|mesh-list
153341991|NCT00002902|Raltitrexed|raltitrexed|mesh-list
153341992|NCT00002902|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
153783282|NCT00235937|Hormone Antagonists|hormone antagonists|mesh-ancestor
153341994|NCT00002902|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153341995|NCT00002902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153341996|NCT00002902|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153341997|NCT00002902|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153341998|NCT00002902|Antimetabolites|antimetabolites|mesh-ancestor
153341999|NCT00002902|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153342000|NCT02992756|Mitogens|mitogens|mesh-list
153342001|NCT02992756|Mitosis Modulators|mitosis modulators|mesh-ancestor
153342002|NCT02992756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153342003|NCT01250899|Vitamin D|vitamin d|mesh-list
153342004|NCT01250899|Vitamins|vitamins|mesh-ancestor
153342005|NCT01250899|Micronutrients|micronutrients|mesh-ancestor
153342006|NCT01250899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153342007|NCT01250899|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153342008|NCT01212445|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
153342009|NCT01212445|Laxatives|laxatives|mesh-list
153342010|NCT01212445|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153342011|NCT00002908|Vincristine|vincristine|mesh-list
153342012|NCT00002908|Bryostatin 1|bryostatin 1|mesh-list
153342013|NCT00002908|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153342014|NCT00002908|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153342019|NCT00002908|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153342020|NCT00002908|Immunologic Factors|immunologic factors|mesh-ancestor
153342021|NCT00002908|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153342022|NCT00002920|Tamoxifen|tamoxifen|mesh-list
153342023|NCT00002920|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
153342024|NCT00002920|Medroxyprogesterone|medroxyprogesterone|mesh-list
153342026|NCT00002920|Hormone Antagonists|hormone antagonists|mesh-ancestor
153342027|NCT00002920|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153342028|NCT00002920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153342029|NCT00002920|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153342030|NCT00002920|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153342031|NCT00002920|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
153342032|NCT00002920|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
153342033|NCT00002920|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153342034|NCT00002920|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
153342035|NCT00002920|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
153342036|NCT00002920|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
153342037|NCT00002920|Contraceptive Agents|contraceptive agents|mesh-ancestor
153342038|NCT00002920|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153342039|NCT00002920|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
153342040|NCT00002920|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
153342041|NCT00002920|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
153342043|NCT01250977|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
153342044|NCT01250977|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153342045|NCT01250977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153342046|NCT01250977|Cholinergic Agents|cholinergic agents|mesh-ancestor
153342047|NCT01250977|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153342048|NCT01250977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153916063|NCT04924621|Anesthetics, Local|anesthetics, local|mesh-ancestor
153464737|NCT00036738|Antimetabolites|antimetabolites|mesh-ancestor
153464739|NCT00036738|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153916064|NCT00618163|Meloxicam|meloxicam|mesh-list
153916065|NCT00618163|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153916066|NCT00618163|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153916067|NCT00618163|Analgesics|analgesics|mesh-ancestor
153916068|NCT00618163|Sensory System Agents|sensory system agents|mesh-ancestor
153916069|NCT00618163|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153916070|NCT00618163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153916071|NCT00618163|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153342061|NCT01161121|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153342062|NCT01161121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153342063|NCT01161121|Adenosine A2 Receptor Agonists|adenosine a2 receptor agonists|mesh-ancestor
153916072|NCT00618163|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153342064|NCT03010579|Epoetin Alfa|epoetin alfa|mesh-list
153342066|NCT03010579|Hematinics|hematinics|mesh-list
153342067|NCT01214083|Acetylcysteine|acetylcysteine|mesh-list
153342068|NCT01214083|Naltrexone|naltrexone|mesh-list
153342069|NCT01214083|N-monoacetylcystine|n-monoacetylcystine|mesh-list
153342070|NCT01214083|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
153342071|NCT01214083|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
153342072|NCT01214083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153342073|NCT01214083|Sensory System Agents|sensory system agents|mesh-ancestor
153342074|NCT01214083|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153342075|NCT01214083|Antiviral Agents|antiviral agents|mesh-ancestor
153342076|NCT01214083|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153342078|NCT01214083|Respiratory System Agents|respiratory system agents|mesh-ancestor
153342079|NCT01214083|Free Radical Scavengers|free radical scavengers|mesh-ancestor
153342080|NCT01214083|Antioxidants|antioxidants|mesh-ancestor
153342121|NCT01214161|Anesthetics, Local|anesthetics, local|mesh-ancestor
153916079|NCT00618241|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153916080|NCT00618241|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153342122|NCT01214161|Anesthetics|anesthetics|mesh-ancestor
153916081|NCT00618241|Antiviral Agents|antiviral agents|mesh-ancestor
153916082|NCT00618241|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153342123|NCT01214161|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153916083|NCT00618241|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
153342124|NCT01214161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153342125|NCT01214161|Sensory System Agents|sensory system agents|mesh-ancestor
153916084|NCT00618241|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
153916085|NCT00618241|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153916086|NCT00618241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153916087|NCT00618241|Anticonvulsants|anticonvulsants|mesh-ancestor
153916088|NCT00618241|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153342126|NCT01214161|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153432191|NCT05122767|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153916089|NCT00618241|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153916090|NCT00618241|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153916091|NCT00618241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153916092|NCT00618241|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153916093|NCT00618241|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153342127|NCT01214161|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153342128|NCT01214161|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
153342129|NCT01214161|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153342130|NCT01214161|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153342131|NCT01214161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153342132|NCT00383656|Hormones|hormones|mesh-list
153342133|NCT00383656|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153342134|NCT00383656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153342136|NCT01214317|Analgesics|analgesics|mesh-ancestor
153342137|NCT01214317|Sensory System Agents|sensory system agents|mesh-ancestor
153342140|NCT01214317|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153342174|NCT01281007|Antiviral Agents|antiviral agents|mesh-ancestor
153342175|NCT01281007|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153342176|NCT01281007|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153342177|NCT01281007|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153342178|NCT01281007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153342179|NCT02898610|Colchicine|colchicine|mesh-list
153916108|NCT00618397|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
153916109|NCT00618397|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153916110|NCT00618397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153916112|NCT04211545|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
153916113|NCT04211545|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153916114|NCT04211545|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
153916115|NCT04211545|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153916116|NCT04211545|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153916117|NCT00620581|Paroxetine|paroxetine|mesh-list
153916118|NCT00620581|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
153916119|NCT00620581|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153464812|NCT00079326|Epothilones|epothilones|mesh-list
153916120|NCT00620581|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153916121|NCT00620581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153464815|NCT00079326|Tubulin Modulators|tubulin modulators|mesh-ancestor
153916122|NCT00620581|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153916123|NCT00620581|Serotonin Agents|serotonin agents|mesh-ancestor
153916124|NCT00620581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153916126|NCT00620581|Antidepressive Agents|antidepressive agents|mesh-ancestor
153342180|NCT02898610|Gout Suppressants|gout suppressants|mesh-ancestor
153342181|NCT02898610|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153342182|NCT02898610|Tubulin Modulators|tubulin modulators|mesh-ancestor
153342183|NCT02898610|Antimitotic Agents|antimitotic agents|mesh-ancestor
153342184|NCT02898610|Mitosis Modulators|mitosis modulators|mesh-ancestor
153342185|NCT02898610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153342186|NCT02898610|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153342187|NCT01281475|Levodopa|levodopa|mesh-list
153342188|NCT01281475|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
153342189|NCT01281475|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
153342190|NCT01281475|Dopamine Agents|dopamine agents|mesh-ancestor
153342191|NCT01281475|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153342192|NCT01281475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153342193|NCT01281475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153342194|NCT00002932|Cisplatin|cisplatin|mesh-list
153342195|NCT00002932|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153342196|NCT01572662|Methotrexate|methotrexate|mesh-list
153342197|NCT01572662|Fludarabine phosphate|fludarabine phosphate|mesh-list
153464858|NCT00168324|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153464859|NCT00168324|Antiemetics|antiemetics|mesh-ancestor
153464860|NCT00168324|Autonomic Agents|autonomic agents|mesh-ancestor
153464861|NCT00168324|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153464862|NCT00168324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153464863|NCT00168324|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153464864|NCT00168324|Glucocorticoids|glucocorticoids|mesh-ancestor
153464865|NCT00168324|Hormones|hormones|mesh-ancestor
153464866|NCT00168324|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153464867|NCT00168324|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153342199|NCT01572662|Busulfan|busulfan|mesh-list
153464868|NCT00168324|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153464869|NCT00168324|Protease Inhibitors|protease inhibitors|mesh-ancestor
153464870|NCT00168324|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153464871|NCT00168324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153464872|NCT02091882|Aripiprazole|aripiprazole|mesh-list
153464873|NCT02091882|Antidepressive Agents|antidepressive agents|mesh-ancestor
153464874|NCT02091882|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153464875|NCT02091882|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153464876|NCT02091882|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153342200|NCT01572662|Tacrolimus|tacrolimus|mesh-list
153342201|NCT01572662|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
153342202|NCT01572662|Abortifacient Agents|abortifacient agents|mesh-ancestor
153342203|NCT01572662|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153342204|NCT01572662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153342205|NCT01572662|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153342206|NCT01572662|Antimetabolites|antimetabolites|mesh-ancestor
153342215|NCT01572662|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153342216|NCT01572662|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
153342217|NCT01572662|Alkylating Agents|alkylating agents|mesh-ancestor
153342218|NCT01572662|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153342219|NCT01572662|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153342220|NCT01258153|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
153342222|NCT01258153|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153342223|NCT01258153|Autonomic Agents|autonomic agents|mesh-ancestor
153342224|NCT01258153|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153464877|NCT02091882|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153916132|NCT01000311|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
153916133|NCT01000311|Immunologic Factors|immunologic factors|mesh-ancestor
153342225|NCT01258153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153342226|NCT01258153|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153342227|NCT01258153|Respiratory System Agents|respiratory system agents|mesh-ancestor
153342229|NCT01555268|Trebananib|trebananib|mesh-list
153342230|NCT01555268|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153916136|NCT04209439|Bupivacaine|bupivacaine|mesh-list
153342231|NCT01555268|Antimetabolites|antimetabolites|mesh-ancestor
153342233|NCT01555268|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153342274|NCT00003400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153342275|NCT00003400|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153342276|NCT00003400|Alkylating Agents|alkylating agents|mesh-ancestor
153342277|NCT00003400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153342278|NCT00003400|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153342279|NCT00003400|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153342280|NCT00003400|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153342281|NCT00003400|Tubulin Modulators|tubulin modulators|mesh-ancestor
153342282|NCT00003400|Antimitotic Agents|antimitotic agents|mesh-ancestor
153342283|NCT00003400|Mitosis Modulators|mitosis modulators|mesh-ancestor
153342284|NCT04348370|Vaccines|vaccines|mesh-list
153342285|NCT04348370|BCG Vaccine|bcg vaccine|mesh-list
153342286|NCT04348370|Immunologic Factors|immunologic factors|mesh-ancestor
153342287|NCT04348370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153342288|NCT04348370|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153342289|NCT00002944|Carboplatin|carboplatin|mesh-list
153342290|NCT00002944|Vincristine|vincristine|mesh-list
153342291|NCT00002944|Thioguanine|thioguanine|mesh-list
153342292|NCT00002944|Lomustine|lomustine|mesh-list
153342293|NCT00002944|Procarbazine|procarbazine|mesh-list
153916140|NCT04209439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153916141|NCT04209439|Sensory System Agents|sensory system agents|mesh-ancestor
153916142|NCT04209439|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153916147|NCT04209439|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153916148|NCT05228041|Benralizumab|benralizumab|mesh-list
153916149|NCT05228041|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153916150|NCT05228041|Respiratory System Agents|respiratory system agents|mesh-ancestor
153916151|NCT01003899|Afatinib|afatinib|mesh-list
153916152|NCT01003899|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153916153|NCT01003899|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153916154|NCT01003899|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153916155|NCT01003899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153916156|NCT01003899|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153916157|NCT04160377|Fluvoxamine|fluvoxamine|mesh-list
153342294|NCT00002944|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153342295|NCT00002944|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153342296|NCT00002944|Tubulin Modulators|tubulin modulators|mesh-ancestor
153342297|NCT00002944|Antimitotic Agents|antimitotic agents|mesh-ancestor
153342298|NCT00002944|Mitosis Modulators|mitosis modulators|mesh-ancestor
153342299|NCT00002944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153342300|NCT00002944|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153342301|NCT00002944|Antimetabolites|antimetabolites|mesh-ancestor
153342302|NCT00002944|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153342304|NCT04778072|Iron|iron|mesh-list
153916158|NCT04160377|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153342305|NCT04778072|Trace Elements|trace elements|mesh-ancestor
153342306|NCT04778072|Micronutrients|micronutrients|mesh-ancestor
153342319|NCT00777140|Iron Chelating Agents|iron chelating agents|mesh-ancestor
153342320|NCT00777140|Chelating Agents|chelating agents|mesh-ancestor
153342321|NCT00777140|Sequestering Agents|sequestering agents|mesh-ancestor
153342322|NCT00777140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153342324|NCT00003406|Docetaxel|docetaxel|mesh-list
153342389|NCT00002980|Antimetabolites|antimetabolites|mesh-ancestor
153342390|NCT00002980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153342391|NCT00002980|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153880544|NCT01517243|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153342392|NCT00002980|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153342393|NCT00002986|Topotecan|topotecan|mesh-list
153342394|NCT00002986|Carmustine|carmustine|mesh-list
153342395|NCT00002986|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
153342396|NCT00002986|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153342397|NCT00002986|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153342398|NCT00002986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153342399|NCT00002986|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153342400|NCT00002986|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153342401|NCT00002986|Alkylating Agents|alkylating agents|mesh-ancestor
153342402|NCT00003418|Tamoxifen|tamoxifen|mesh-list
153342403|NCT00003418|Exemestane|exemestane|mesh-list
153916170|NCT04160377|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
153916171|NCT04160377|Antidepressive Agents|antidepressive agents|mesh-ancestor
153916172|NCT04160377|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
153891363|NCT06054321|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
153916173|NCT04160377|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153916174|NCT04160377|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
153916175|NCT01000155|Vorinostat|vorinostat|mesh-list
153916176|NCT01000155|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153916177|NCT01000155|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
153916178|NCT01000155|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153916180|NCT00999921|Tamoxifen|tamoxifen|mesh-list
153342404|NCT00003418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153342405|NCT00003418|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
153342406|NCT00003418|Hormone Antagonists|hormone antagonists|mesh-ancestor
153342407|NCT00003418|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153342408|NCT00003418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153342409|NCT00003418|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153342410|NCT00003418|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153342411|NCT00003418|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
153342412|NCT00003418|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
153342413|NCT00003418|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153342414|NCT00003418|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
153342415|NCT00003418|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153342416|NCT00003418|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153342417|NCT04777838|Amitriptyline|amitriptyline|mesh-list
153342419|NCT04777838|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
153342429|NCT04777838|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153342430|NCT04777838|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
153342431|NCT04777838|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153342432|NCT04777838|Analgesics|analgesics|mesh-ancestor
153342433|NCT04777838|Sensory System Agents|sensory system agents|mesh-ancestor
153342434|NCT04777838|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
153464923|NCT00254592|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153464924|NCT00254592|Immunologic Factors|immunologic factors|mesh-ancestor
153464925|NCT00254592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153464926|NCT00254592|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153464927|NCT00254592|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153342435|NCT04777838|Adrenergic Agents|adrenergic agents|mesh-ancestor
153464928|NCT00254592|Alkylating Agents|alkylating agents|mesh-ancestor
153916232|NCT04293549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153916233|NCT04293549|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
153464963|NCT00255684|Antitubercular Agents|antitubercular agents|mesh-ancestor
153464964|NCT00255684|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153891523|NCT05890586|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153891524|NCT05890586|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153464966|NCT00256776|Dexamethasone|dexamethasone|mesh-list
153464967|NCT00256776|Bortezomib|bortezomib|mesh-list
153342437|NCT00003424|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
153342438|NCT00003424|Hormone Antagonists|hormone antagonists|mesh-ancestor
153342439|NCT00003424|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153342440|NCT00003424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153342441|NCT00003424|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153342442|NCT00003424|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153783286|NCT00261339|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
153342443|NCT00003424|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
153464968|NCT00256776|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153464969|NCT00256776|Antiemetics|antiemetics|mesh-ancestor
153342444|NCT00003424|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
153342445|NCT00003424|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153342446|NCT00002998|Gemcitabine|gemcitabine|mesh-list
153342484|NCT00003436|Amsacrine|amsacrine|mesh-list
153464970|NCT00256776|Autonomic Agents|autonomic agents|mesh-ancestor
153464971|NCT00256776|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153464972|NCT00256776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153342485|NCT00003436|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
153342487|NCT00003436|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153342488|NCT00003436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153342489|NCT00003436|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153342490|NCT00003436|Antimetabolites|antimetabolites|mesh-ancestor
153342491|NCT00003436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153916261|NCT01349101|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153916262|NCT01349101|Alkylating Agents|alkylating agents|mesh-ancestor
153916263|NCT01349101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153916264|NCT01349101|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153342492|NCT00003436|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153342493|NCT00003436|Dermatologic Agents|dermatologic agents|mesh-ancestor
153342494|NCT00003436|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153342495|NCT00003436|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153342496|NCT00003436|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153342497|NCT00003436|Immunologic Factors|immunologic factors|mesh-ancestor
153342498|NCT00003436|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153916265|NCT01349101|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153916266|NCT01349101|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153916267|NCT01349101|Antimetabolites|antimetabolites|mesh-ancestor
153916268|NCT01349101|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153916269|NCT01349101|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
153464983|NCT00256776|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153916270|NCT01349101|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153916275|NCT00620971|Bevacizumab|bevacizumab|mesh-list
153342499|NCT00003436|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153342500|NCT00003436|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153342501|NCT00003436|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153342502|NCT00003436|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153916296|NCT04223661|Daratumumab|daratumumab|mesh-list
153916297|NCT04223661|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153342503|NCT00003436|Antiviral Agents|antiviral agents|mesh-ancestor
153342504|NCT00003436|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153342505|NCT00003436|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153916298|NCT04223661|Antiemetics|antiemetics|mesh-ancestor
153916299|NCT04223661|Autonomic Agents|autonomic agents|mesh-ancestor
153916300|NCT04223661|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153916301|NCT04223661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153916302|NCT04223661|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153916303|NCT04223661|Glucocorticoids|glucocorticoids|mesh-ancestor
153916304|NCT04223661|Hormones|hormones|mesh-ancestor
153916305|NCT04223661|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153916306|NCT04223661|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153916307|NCT04223661|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153916308|NCT04223661|Immunologic Factors|immunologic factors|mesh-ancestor
153916310|NCT04223661|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153916311|NCT04223661|Growth Substances|growth substances|mesh-ancestor
153891670|NCT05579119|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
153891673|NCT05579119|Incretins|incretins|mesh-ancestor
153342506|NCT00003436|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153342507|NCT00003436|Analgesics|analgesics|mesh-ancestor
153342508|NCT00003436|Sensory System Agents|sensory system agents|mesh-ancestor
153342509|NCT00003436|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153342510|NCT02432378|Celecoxib|celecoxib|mesh-list
153342511|NCT02432378|Cisplatin|cisplatin|mesh-list
153342512|NCT02432378|Vaccines|vaccines|mesh-list
153342513|NCT02432378|Immunologic Factors|immunologic factors|mesh-ancestor
153342514|NCT02432378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153342518|NCT02432378|Analgesics|analgesics|mesh-ancestor
153342524|NCT02432378|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153342525|NCT02432378|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153916314|NCT00622141|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
153342526|NCT02432378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153916315|NCT00622141|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
153916316|NCT00622141|Protease Inhibitors|protease inhibitors|mesh-ancestor
153342529|NCT00003466|Alkylating Agents|alkylating agents|mesh-ancestor
153342530|NCT00003466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153916317|NCT00622141|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153342531|NCT00003466|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153916319|NCT00622141|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153342532|NCT00003478|Antibodies|antibodies|mesh-list
153342533|NCT00003478|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
153342534|NCT00003478|Immunologic Factors|immunologic factors|mesh-ancestor
153342535|NCT00003478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153342536|NCT00003016|Tamoxifen|tamoxifen|mesh-list
153342537|NCT00003016|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
153342538|NCT00003016|Hormone Antagonists|hormone antagonists|mesh-ancestor
153342539|NCT00003016|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153342540|NCT00003016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153342541|NCT00003016|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153342542|NCT00003016|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153342543|NCT00003016|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
153342544|NCT00003016|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
153342545|NCT00003016|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153342546|NCT00003022|Antibodies|antibodies|mesh-list
153916327|NCT04210765|Zuclomiphene|zuclomiphene|mesh-list
153916328|NCT04210765|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
153916329|NCT04210765|Hormone Antagonists|hormone antagonists|mesh-ancestor
153916330|NCT04210765|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153916331|NCT04210765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153916332|NCT04210765|Fertility Agents, Female|fertility agents, female|mesh-ancestor
153916333|NCT04210765|Fertility Agents|fertility agents|mesh-ancestor
153916334|NCT04210765|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153916335|NCT04210765|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
153432750|NCT03670966|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153916337|NCT00621283|Secretin|secretin|mesh-list
153916338|NCT00621283|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153916339|NCT00621283|Hormones|hormones|mesh-ancestor
153916340|NCT00621283|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153916341|NCT00621283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153916342|NCT00995709|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
153916343|NCT00995709|Immunologic Factors|immunologic factors|mesh-ancestor
153342547|NCT00003022|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
153342548|NCT00003022|Immunologic Factors|immunologic factors|mesh-ancestor
153342549|NCT00003022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153342550|NCT01258387|Mitogens|mitogens|mesh-list
153342551|NCT01258387|Mitosis Modulators|mitosis modulators|mesh-ancestor
153342552|NCT01258387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153342572|NCT00003490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153342573|NCT00003490|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153342574|NCT00003490|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153342575|NCT00003490|Alkylating Agents|alkylating agents|mesh-ancestor
153342576|NCT00003490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153342577|NCT00003490|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153342578|NCT00003490|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153342579|NCT00003490|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153342580|NCT00003490|Glucocorticoids|glucocorticoids|mesh-ancestor
153342581|NCT00003490|Hormones|hormones|mesh-ancestor
153342582|NCT00003490|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153916345|NCT00629031|Paromomycin|paromomycin|mesh-list
153342583|NCT00003490|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153342584|NCT00003490|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153342585|NCT00003490|Tubulin Modulators|tubulin modulators|mesh-ancestor
153342586|NCT00003490|Antimitotic Agents|antimitotic agents|mesh-ancestor
153342587|NCT00003490|Mitosis Modulators|mitosis modulators|mesh-ancestor
153342589|NCT00003034|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
153342590|NCT00003034|Ranpirnase|ranpirnase|mesh-list
153342591|NCT00003034|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153342592|NCT00003034|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153342603|NCT00383890|Analgesics|analgesics|mesh-ancestor
153342625|NCT00003052|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153342626|NCT00003052|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153342627|NCT00003052|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153342628|NCT00003052|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153342629|NCT00003052|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153342630|NCT00003052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153342631|NCT00003052|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153342632|NCT00003052|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153342633|NCT00003052|Alkylating Agents|alkylating agents|mesh-ancestor
153342634|NCT00003058|Troglitazone|troglitazone|mesh-list
153916350|NCT00621361|Etoposide|etoposide|mesh-list
153916351|NCT00621361|Cediranib|cediranib|mesh-list
153916352|NCT00621361|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153465084|NCT00088218|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153465086|NCT00088218|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153465087|NCT00088218|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153465088|NCT00088218|Immunologic Factors|immunologic factors|mesh-ancestor
153465089|NCT00088218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153342635|NCT00003058|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153916353|NCT00621361|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153916354|NCT00621361|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153342636|NCT00003058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153342637|NCT04775732|Infliximab|infliximab|mesh-list
153342638|NCT04775732|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
153342639|NCT04775732|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153342640|NCT04775732|Dermatologic Agents|dermatologic agents|mesh-ancestor
153342641|NCT04775732|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153342642|NCT04775732|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153342643|NCT04754750|Paliperidone Palmitate|paliperidone palmitate|mesh-list
153342644|NCT04754750|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153342645|NCT04754750|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153916355|NCT00621361|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153342646|NCT04754750|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153342647|NCT04754750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153342648|NCT04754750|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153342649|NCT04754750|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
153342650|NCT04754750|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153342672|NCT00003064|Immunologic Factors|immunologic factors|mesh-ancestor
153342673|NCT00003064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153342674|NCT00003064|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
153342675|NCT00003064|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153342676|NCT00003064|Alkylating Agents|alkylating agents|mesh-ancestor
153342677|NCT00003064|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153342678|NCT00003064|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153342679|NCT00003544|Irinotecan|irinotecan|mesh-list
153342680|NCT00003544|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
153342681|NCT00003544|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153342682|NCT00003544|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153342683|NCT00003544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153342684|NCT00003544|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153342685|NCT03475394|Chlorhexidine|chlorhexidine|mesh-list
153342686|NCT03475394|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
153342687|NCT03475394|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153342688|NCT03475394|Disinfectants|disinfectants|mesh-ancestor
153342689|NCT01269424|Temozolomide|temozolomide|mesh-list
153342690|NCT01269424|O(6)-benzylguanine|o(6)-benzylguanine|mesh-list
153342691|NCT01269424|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153342692|NCT01269424|Alkylating Agents|alkylating agents|mesh-ancestor
153418613|NCT02941640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153891757|NCT05295589|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
153916378|NCT04208581|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153916379|NCT04208581|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
153916381|NCT04208581|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153916382|NCT04208581|Adrenergic Agents|adrenergic agents|mesh-ancestor
153916383|NCT04208581|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153342693|NCT01269424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153342694|NCT01269424|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153342695|NCT01269424|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153342696|NCT03395912|Anesthetics|anesthetics|mesh-list
153342697|NCT03395912|Anesthetics, Local|anesthetics, local|mesh-list
153342698|NCT03395912|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153342699|NCT03395912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153342700|NCT03395912|Sensory System Agents|sensory system agents|mesh-ancestor
153342701|NCT03395912|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153342702|NCT00384436|Escitalopram|escitalopram|mesh-list
153342715|NCT00003562|Mitosis Modulators|mitosis modulators|mesh-ancestor
153342716|NCT00003562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153342717|NCT04775576|Anesthetics|anesthetics|mesh-list
153342718|NCT04775576|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153342719|NCT04775576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153342720|NCT00003568|Aldesleukin|aldesleukin|mesh-list
153342721|NCT00003568|Freund's Adjuvant|freund's adjuvant|mesh-list
153342722|NCT00003568|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153342723|NCT00003568|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153342724|NCT00003568|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153342725|NCT00003568|Antiviral Agents|antiviral agents|mesh-ancestor
153342726|NCT00003568|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153916416|NCT02641873|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153465090|NCT00189228|Omalizumab|omalizumab|mesh-list
153916417|NCT02641873|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153916418|NCT02641873|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153916419|NCT02641873|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153916420|NCT02641873|Growth Substances|growth substances|mesh-ancestor
153916421|NCT02641873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153432863|NCT03490864|Melatonin|melatonin|mesh-list
153342727|NCT00003568|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153342728|NCT00003568|Immunologic Factors|immunologic factors|mesh-ancestor
153342729|NCT00003568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153342730|NCT00003070|Enalapril|enalapril|mesh-list
153342731|NCT00003070|Enalaprilat|enalaprilat|mesh-list
153342732|NCT00003070|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153465155|NCT00194532|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153342733|NCT00003070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153916446|NCT05240391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153916448|NCT00628953|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
153916449|NCT00628953|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153342734|NCT00003070|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
153342735|NCT00003070|Protease Inhibitors|protease inhibitors|mesh-ancestor
153342736|NCT00003070|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153342737|NCT00003076|Eflornithine|eflornithine|mesh-list
153342738|NCT00003076|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153342739|NCT00003076|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
153342740|NCT00003076|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153916450|NCT00628953|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
153916451|NCT00628953|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153916452|NCT00628953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153916453|NCT04294953|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
153916454|NCT04294953|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
153916455|NCT04294953|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153916456|NCT04294953|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153916457|NCT04294953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153916458|NCT04294953|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153916459|NCT04294953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153916460|NCT04294953|Analgesics|analgesics|mesh-ancestor
153916461|NCT04294953|Sensory System Agents|sensory system agents|mesh-ancestor
153916462|NCT04294953|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153342741|NCT00003076|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153342743|NCT00003076|Ornithine Decarboxylase Inhibitors|ornithine decarboxylase inhibitors|mesh-ancestor
153342744|NCT00003076|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153342745|NCT00003076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153342746|NCT01896518|Nicotine|nicotine|mesh-list
153342747|NCT01896518|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
153342748|NCT01896518|Autonomic Agents|autonomic agents|mesh-ancestor
153342755|NCT01896518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153342756|NCT00003082|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
153342758|NCT00003082|Immunoglobulins|immunoglobulins|mesh-list
153342759|NCT00003082|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
153342760|NCT00003082|Immunologic Factors|immunologic factors|mesh-ancestor
153342761|NCT00003082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153342762|NCT00003082|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153342763|NCT00003088|Paclitaxel|paclitaxel|mesh-list
153342764|NCT00003088|Cyclophosphamide|cyclophosphamide|mesh-list
153342765|NCT00003088|Doxorubicin|doxorubicin|mesh-list
153342766|NCT00003088|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
153342767|NCT00003088|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153342768|NCT00003088|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153342769|NCT00003088|Tubulin Modulators|tubulin modulators|mesh-ancestor
153342770|NCT00003088|Antimitotic Agents|antimitotic agents|mesh-ancestor
153342772|NCT00003088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153916471|NCT04293081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153916473|NCT02868801|Analgesics|analgesics|mesh-ancestor
153916474|NCT02868801|Sensory System Agents|sensory system agents|mesh-ancestor
153916475|NCT02868801|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153916476|NCT02868801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153342773|NCT00003088|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153342774|NCT00003088|Immunologic Factors|immunologic factors|mesh-ancestor
153342775|NCT00003088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153342776|NCT00003088|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153342777|NCT00003088|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153342805|NCT00003118|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153342806|NCT00003118|Antimetabolites|antimetabolites|mesh-ancestor
153882503|NCT01688700|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153882504|NCT01684085|Lorazepam|lorazepam|mesh-list
153916477|NCT02868801|Anticonvulsants|anticonvulsants|mesh-ancestor
153916479|NCT02868801|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153916480|NCT02868801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153916481|NCT02868801|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153916482|NCT02868801|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153916483|NCT02868801|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153465220|NCT00195624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153465222|NCT00195624|Immunologic Factors|immunologic factors|mesh-ancestor
153342807|NCT00003118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153342808|NCT00003118|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153342809|NCT00003118|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153342810|NCT00003118|Immunologic Factors|immunologic factors|mesh-ancestor
153342811|NCT00003118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153342812|NCT00003124|Leuprolide|leuprolide|mesh-list
153342813|NCT00003124|Flutamide|flutamide|mesh-list
153342814|NCT00003124|Fertility Agents, Female|fertility agents, female|mesh-ancestor
153342815|NCT00003124|Fertility Agents|fertility agents|mesh-ancestor
153465223|NCT00195624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153916487|NCT01002339|Cyclosporine|cyclosporine|mesh-list
153342817|NCT00003124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153342818|NCT00003124|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153342819|NCT00003124|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153342820|NCT00003124|Androgen Antagonists|androgen antagonists|mesh-ancestor
153342821|NCT00003124|Hormone Antagonists|hormone antagonists|mesh-ancestor
153342823|NCT00003580|Amifostine|amifostine|mesh-list
153342864|NCT00058370|Mitosis Modulators|mitosis modulators|mesh-ancestor
153342865|NCT00058370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153342866|NCT00058370|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153342867|NCT00058370|Alkylating Agents|alkylating agents|mesh-ancestor
153342868|NCT00059228|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
153916503|NCT01002339|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153342869|NCT00059228|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
153342870|NCT00059228|Estradiol|estradiol|mesh-list
153342871|NCT00059228|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
153342872|NCT00059228|Estrogens|estrogens|mesh-ancestor
153342873|NCT00059228|Hormones|hormones|mesh-ancestor
153342874|NCT00059228|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153342875|NCT00059228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153342876|NCT00059228|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
153342877|NCT00059228|Contraceptive Agents|contraceptive agents|mesh-ancestor
153916504|NCT01002339|Glucocorticoids|glucocorticoids|mesh-ancestor
153916505|NCT01002339|Hormones|hormones|mesh-ancestor
153916506|NCT01002339|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153916507|NCT01002339|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153916508|NCT01002339|Antifungal Agents|antifungal agents|mesh-ancestor
153916509|NCT01002339|Dermatologic Agents|dermatologic agents|mesh-ancestor
153916510|NCT01002339|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153916511|NCT01002105|Baclofen|baclofen|mesh-list
153916512|NCT01002105|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
153916513|NCT01002105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153916514|NCT01002105|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
153342878|NCT00059228|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153342879|NCT00059228|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
153916549|NCT02471911|Autonomic Agents|autonomic agents|mesh-ancestor
153916550|NCT02471911|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153342880|NCT00060008|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
153342881|NCT00060008|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
153342882|NCT00060008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153342883|NCT00062738|Paroxetine|paroxetine|mesh-list
153342884|NCT00062738|Nortriptyline|nortriptyline|mesh-list
153342885|NCT00062738|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
153342886|NCT00062738|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153342887|NCT00062738|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153342888|NCT00062738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153783290|NCT00261339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153342889|NCT00062738|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153916551|NCT02471911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153916552|NCT02471911|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153916553|NCT02471911|Glucocorticoids|glucocorticoids|mesh-ancestor
153916554|NCT02471911|Hormones|hormones|mesh-ancestor
153465288|NCT00103194|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153465289|NCT00103194|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153465290|NCT00103194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153465292|NCT00208026|Pimecrolimus|pimecrolimus|mesh-list
153465293|NCT00208026|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153465294|NCT00208026|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153465295|NCT00208026|Analgesics|analgesics|mesh-ancestor
153342890|NCT00062738|Serotonin Agents|serotonin agents|mesh-ancestor
153342906|NCT00063362|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153342907|NCT00063362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153342908|NCT00063362|Antimanic Agents|antimanic agents|mesh-ancestor
153342909|NCT00063362|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153342910|NCT00063362|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153342911|NCT00063362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153342912|NCT00063362|Anticonvulsants|anticonvulsants|mesh-ancestor
153342913|NCT00063362|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153342914|NCT00063362|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153465296|NCT00208026|Sensory System Agents|sensory system agents|mesh-ancestor
153465297|NCT00208026|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153916555|NCT02471911|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153916556|NCT02471911|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153342916|NCT00063362|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153916570|NCT00622375|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153916571|NCT00622375|Analgesics|analgesics|mesh-ancestor
153916572|NCT00622375|Sensory System Agents|sensory system agents|mesh-ancestor
153916573|NCT00622375|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153916574|NCT00622375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153916575|NCT00622375|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153916576|NCT00622375|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153916577|NCT02691325|Charcoal|charcoal|mesh-list
153916578|NCT02691325|Nemiralisib|nemiralisib|mesh-list
153916579|NCT02691325|Antidotes|antidotes|mesh-ancestor
153916580|NCT02691325|Protective Agents|protective agents|mesh-ancestor
153916581|NCT02691325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153916582|NCT02691325|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153916583|NCT02691325|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153916584|NCT02691325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153916585|NCT02697331|Progesterone|progesterone|mesh-list
153916586|NCT02697331|Progestins|progestins|mesh-ancestor
153916587|NCT02697331|Hormones|hormones|mesh-ancestor
153916588|NCT02697331|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153892172|NCT03661684|Glucocorticoids|glucocorticoids|mesh-ancestor
153916589|NCT02697331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153916590|NCT04278625|Acetaminophen|acetaminophen|mesh-list
153916591|NCT04278625|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153916592|NCT04278625|Analgesics|analgesics|mesh-ancestor
153342917|NCT00063362|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153342918|NCT00063362|GABA Agents|gaba agents|mesh-ancestor
153342919|NCT00063362|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153342920|NCT00064844|Nicotine|nicotine|mesh-list
153342921|NCT00064844|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
153342922|NCT00064844|Autonomic Agents|autonomic agents|mesh-ancestor
153342923|NCT00064844|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153342924|NCT00064844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153342925|NCT00064844|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
153342926|NCT00064844|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
153342958|NCT00493870|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153342959|NCT00493870|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153342960|NCT00493870|Alkylating Agents|alkylating agents|mesh-ancestor
153342961|NCT00493870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153783291|NCT04553380|Insulin|insulin|mesh-list
153342962|NCT00493870|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153342963|NCT00493870|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153342964|NCT00493870|Tubulin Modulators|tubulin modulators|mesh-ancestor
153342965|NCT00493870|Antimitotic Agents|antimitotic agents|mesh-ancestor
153342966|NCT00493870|Mitosis Modulators|mitosis modulators|mesh-ancestor
153342967|NCT00493870|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153342968|NCT00493870|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153342969|NCT00493870|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153342970|NCT00493870|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153342971|NCT03287336|Tranexamic Acid|tranexamic acid|mesh-list
153342973|NCT03287336|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153342974|NCT03287336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153342975|NCT03287336|Hemostatics|hemostatics|mesh-ancestor
153342976|NCT03287336|Coagulants|coagulants|mesh-ancestor
153342977|NCT00003136|Cyclophosphamide|cyclophosphamide|mesh-list
153342978|NCT00003136|Carboplatin|carboplatin|mesh-list
153342979|NCT00003136|Amifostine|amifostine|mesh-list
153342980|NCT00003136|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153342981|NCT00003136|Immunologic Factors|immunologic factors|mesh-ancestor
153342982|NCT00003136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153342983|NCT00003136|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153343006|NCT00002794|Antimitotic Agents|antimitotic agents|mesh-ancestor
153343007|NCT00002794|Mitosis Modulators|mitosis modulators|mesh-ancestor
153343008|NCT00002794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153343009|NCT00003610|Capsaicin|capsaicin|mesh-list
153916594|NCT04278625|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153916595|NCT04278625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153916596|NCT04278625|Antipyretics|antipyretics|mesh-ancestor
153916597|NCT02689141|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
153916598|NCT02689141|Ofatumumab|ofatumumab|mesh-list
153916599|NCT02689141|Ibrutinib|ibrutinib|mesh-list
153916600|NCT02689141|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153916601|NCT02689141|Alkylating Agents|alkylating agents|mesh-ancestor
153916602|NCT02689141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153916603|NCT02689141|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153916604|NCT02689141|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153916605|NCT02689141|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153916606|NCT02689141|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153916607|NCT00622687|Iloprost|iloprost|mesh-list
153465299|NCT00208026|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153916608|NCT00622687|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153916609|NCT00622687|Vasodilator Agents|vasodilator agents|mesh-ancestor
153916610|NCT02691403|Bupivacaine|bupivacaine|mesh-list
153916611|NCT02691403|Levobupivacaine|levobupivacaine|mesh-list
153916612|NCT02691403|Anesthetics, Local|anesthetics, local|mesh-ancestor
153916613|NCT02691403|Anesthetics|anesthetics|mesh-ancestor
153343010|NCT00003610|Antipruritics|antipruritics|mesh-ancestor
153343011|NCT00003610|Dermatologic Agents|dermatologic agents|mesh-ancestor
153343012|NCT00003610|Sensory System Agents|sensory system agents|mesh-ancestor
153343013|NCT00003610|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153343014|NCT00003610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153343015|NCT00003616|Irinotecan|irinotecan|mesh-list
153343016|NCT00003616|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
153343017|NCT00003616|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153343018|NCT00003616|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153343019|NCT00003616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153343020|NCT00003616|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153343021|NCT01063829|Letermovir|letermovir|mesh-list
153343022|NCT01063829|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
153343023|NCT01063829|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153916614|NCT02691403|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153343025|NCT01063829|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153343026|NCT01063829|Antiviral Agents|antiviral agents|mesh-ancestor
153343027|NCT01063829|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153343028|NCT00072566|Cyclophosphamide|cyclophosphamide|mesh-list
153343029|NCT00072566|Bevacizumab|bevacizumab|mesh-list
153343030|NCT00072566|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
153343031|NCT00072566|Antibodies|antibodies|mesh-list
153343032|NCT00072566|Immunoglobulins|immunoglobulins|mesh-list
153343033|NCT00072566|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
153343034|NCT00072566|Immunoglobulin G|immunoglobulin g|mesh-list
153343035|NCT00072566|Endothelial Growth Factors|endothelial growth factors|mesh-list
153343036|NCT00072566|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153343037|NCT00072566|Immunologic Factors|immunologic factors|mesh-ancestor
153783292|NCT04553380|Insulin Glargine|insulin glargine|mesh-list
153343044|NCT00072566|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153343045|NCT00072566|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153343046|NCT00072566|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153343048|NCT00072566|Growth Inhibitors|growth inhibitors|mesh-ancestor
153343049|NCT00003622|Paclitaxel|paclitaxel|mesh-list
153343050|NCT00003622|Vinorelbine|vinorelbine|mesh-list
153343051|NCT00003622|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153343052|NCT00003622|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153343053|NCT00003622|Tubulin Modulators|tubulin modulators|mesh-ancestor
153343054|NCT00003622|Antimitotic Agents|antimitotic agents|mesh-ancestor
153343055|NCT00003622|Mitosis Modulators|mitosis modulators|mesh-ancestor
153916616|NCT02691403|Sensory System Agents|sensory system agents|mesh-ancestor
153916617|NCT02691403|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153343056|NCT00003622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153343057|NCT00003148|Aldesleukin|aldesleukin|mesh-list
153343058|NCT00003148|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153465352|NCT00216060|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153465353|NCT00216060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153465354|NCT00216060|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153465355|NCT00216060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153465357|NCT00282282|Sirolimus|sirolimus|mesh-list
153343059|NCT00003148|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153343060|NCT00003148|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153343061|NCT00003148|Antiviral Agents|antiviral agents|mesh-ancestor
153343062|NCT00003148|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153343063|NCT00384046|Testosterone|testosterone|mesh-list
153343064|NCT00384046|Androgens|androgens|mesh-ancestor
153343065|NCT00384046|Hormones|hormones|mesh-ancestor
153343066|NCT00384046|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153343067|NCT00384046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153343068|NCT00002800|Cytarabine|cytarabine|mesh-list
153343069|NCT00002800|Etoposide|etoposide|mesh-list
153343070|NCT00002800|Idarubicin|idarubicin|mesh-list
153343071|NCT00002800|Lintuzumab|lintuzumab|mesh-list
153343073|NCT00002800|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153343094|NCT00002806|Mitosis Modulators|mitosis modulators|mesh-ancestor
153343095|NCT00002806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153343096|NCT00002806|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153343097|NCT00002806|Alkylating Agents|alkylating agents|mesh-ancestor
153343098|NCT00003160|Paclitaxel|paclitaxel|mesh-list
153343099|NCT00003160|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153343100|NCT00003160|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153343101|NCT00003160|Tubulin Modulators|tubulin modulators|mesh-ancestor
153343102|NCT00003160|Antimitotic Agents|antimitotic agents|mesh-ancestor
153343103|NCT00003160|Mitosis Modulators|mitosis modulators|mesh-ancestor
153343104|NCT00003160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153916630|NCT00639925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153421421|NCT05941247|Hemay005|hemay005|mesh-list
153916631|NCT00639925|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153916633|NCT00994461|Loxoprofen|loxoprofen|mesh-list
153916634|NCT00994461|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153892379|NCT02652195|Oxytocics|oxytocics|mesh-ancestor
153916639|NCT00994461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153916640|NCT00994461|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153916641|NCT00994461|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153421422|NCT05941247|Dermatologic Agents|dermatologic agents|mesh-ancestor
153421423|NCT05941247|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
153421424|NCT05941247|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
153421425|NCT05941247|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153461754|NCT03708588|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
153343105|NCT00002812|Cytarabine|cytarabine|mesh-list
153343106|NCT00002812|Dexamethasone|dexamethasone|mesh-list
153343107|NCT00002812|Prednisone|prednisone|mesh-list
153343109|NCT00002812|Doxorubicin|doxorubicin|mesh-list
153343110|NCT00002812|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
153343111|NCT00002812|Methotrexate|methotrexate|mesh-list
153433537|NCT00000577|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153465402|NCT00223236|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153465403|NCT00223236|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153465405|NCT00223704|Icatibant|icatibant|mesh-list
153465406|NCT00223704|Aminocaproic Acid|aminocaproic acid|mesh-list
153465407|NCT00223704|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
153465408|NCT00223704|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153465409|NCT00223704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153465410|NCT00223704|Hemostatics|hemostatics|mesh-ancestor
153465411|NCT00223704|Coagulants|coagulants|mesh-ancestor
153465412|NCT00223704|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153465413|NCT00223704|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153465414|NCT00223704|Analgesics|analgesics|mesh-ancestor
153465415|NCT00223704|Sensory System Agents|sensory system agents|mesh-ancestor
153916667|NCT01202279|Phenylpropanolamine|phenylpropanolamine|mesh-list
153916668|NCT01202279|Pseudoephedrine|pseudoephedrine|mesh-list
153343112|NCT00002812|Vincristine|vincristine|mesh-list
153343113|NCT00002812|Daunorubicin|daunorubicin|mesh-list
153343114|NCT00002812|Asparaginase|asparaginase|mesh-list
153343115|NCT00002812|Mercaptopurine|mercaptopurine|mesh-list
153343150|NCT00002812|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153343151|NCT00002812|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153343153|NCT00002812|Antimitotic Agents|antimitotic agents|mesh-ancestor
153343154|NCT00002812|Mitosis Modulators|mitosis modulators|mesh-ancestor
153343156|NCT01258855|Aflibercept|aflibercept|mesh-list
153343157|NCT01258855|Interleukin-2|interleukin-2|mesh-list
153916669|NCT01202279|Guaifenesin|guaifenesin|mesh-list
153343158|NCT01258855|Endothelial Growth Factors|endothelial growth factors|mesh-list
153343159|NCT01258855|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153343160|NCT01258855|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153343161|NCT01258855|Growth Substances|growth substances|mesh-ancestor
153343162|NCT01258855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153343163|NCT01258855|Growth Inhibitors|growth inhibitors|mesh-ancestor
153916670|NCT01202279|Chlorpheniramine, phenylpropanolamine drug combination|chlorpheniramine, phenylpropanolamine drug combination|mesh-list
153343164|NCT01258855|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153343165|NCT01258855|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153343166|NCT01258855|Analgesics|analgesics|mesh-ancestor
153343167|NCT01258855|Sensory System Agents|sensory system agents|mesh-ancestor
153343168|NCT01258855|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153343169|NCT01258855|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153343170|NCT01258855|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153343207|NCT00003172|Antisickling Agents|antisickling agents|mesh-ancestor
153343208|NCT00003172|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153343210|NCT00003634|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153343211|NCT00003634|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153343212|NCT02191033|Nicotine|nicotine|mesh-list
153343213|NCT02191033|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
153343214|NCT02191033|Autonomic Agents|autonomic agents|mesh-ancestor
153343215|NCT02191033|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153916685|NCT01202279|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153916686|NCT01202279|Appetite Depressants|appetite depressants|mesh-ancestor
153916687|NCT01202279|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
153916688|NCT03877315|Cimetidine|cimetidine|mesh-list
153916689|NCT03877315|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
153916690|NCT03877315|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153916691|NCT03877315|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
153916692|NCT03877315|Histamine Antagonists|histamine antagonists|mesh-ancestor
153916693|NCT03877315|Histamine Agents|histamine agents|mesh-ancestor
153916694|NCT03877315|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153916695|NCT03877315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153916696|NCT03877315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153916697|NCT03877315|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
153916698|NCT03877315|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153916699|NCT03877315|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153916700|NCT02687347|Morphine|morphine|mesh-list
153343216|NCT02191033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153343217|NCT02191033|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
153343218|NCT02191033|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
153343219|NCT02191033|Cholinergic Agents|cholinergic agents|mesh-ancestor
153343220|NCT02191033|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153343221|NCT02191033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153343222|NCT00002818|Cytarabine|cytarabine|mesh-list
153916701|NCT02687347|Methadone|methadone|mesh-list
153916702|NCT02687347|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153916703|NCT02687347|Narcotics|narcotics|mesh-ancestor
153343224|NCT00002818|Antimetabolites|antimetabolites|mesh-ancestor
153343225|NCT00002818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153343226|NCT00002818|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153343227|NCT00002818|Antiviral Agents|antiviral agents|mesh-ancestor
153343228|NCT00002818|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153343229|NCT00002818|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153343230|NCT00002818|Immunologic Factors|immunologic factors|mesh-ancestor
153343231|NCT00002818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153343232|NCT00003640|Doxorubicin|doxorubicin|mesh-list
153343233|NCT00003640|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
153343234|NCT00003640|Methotrexate|methotrexate|mesh-list
153343235|NCT00003640|Vinblastine|vinblastine|mesh-list
153343236|NCT00003640|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153343237|NCT00003640|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153343238|NCT00003640|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153916721|NCT02687269|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153916722|NCT02687269|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153916723|NCT02687269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153916724|NCT02689297|Chlorine dioxide|chlorine dioxide|mesh-list
153916725|NCT02689297|Dental Disinfectants|dental disinfectants|mesh-ancestor
153433743|NCT00000673|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
153465463|NCT00225498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153465464|NCT00225498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153465465|NCT00225498|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153465466|NCT00225498|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153465467|NCT00225498|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153465468|NCT00225498|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153465469|NCT00225498|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
153343239|NCT00003640|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153343240|NCT00003640|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153343242|NCT00003640|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
153343246|NCT00003640|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153343248|NCT00003640|Dermatologic Agents|dermatologic agents|mesh-ancestor
153343249|NCT00003640|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153343250|NCT00003640|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153343251|NCT00003640|Immunologic Factors|immunologic factors|mesh-ancestor
153343252|NCT00003640|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153343253|NCT00003640|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153465470|NCT00225498|Dopamine Agents|dopamine agents|mesh-ancestor
153916749|NCT05392127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153916750|NCT05392127|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153916751|NCT05392127|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153343254|NCT00003640|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153343255|NCT00003640|Tubulin Modulators|tubulin modulators|mesh-ancestor
153343256|NCT00003640|Antimitotic Agents|antimitotic agents|mesh-ancestor
153343257|NCT00003640|Mitosis Modulators|mitosis modulators|mesh-ancestor
153343258|NCT00002824|Ganciclovir|ganciclovir|mesh-list
153343259|NCT00002824|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
153343260|NCT00002824|Antiviral Agents|antiviral agents|mesh-ancestor
153343261|NCT00002824|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153343262|NCT00002824|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153343263|NCT00002824|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153916752|NCT05392127|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153916753|NCT05392127|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153916754|NCT05392127|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153916755|NCT05392127|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153916756|NCT05392127|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153916757|NCT05392127|Anesthetics, General|anesthetics, general|mesh-ancestor
153916759|NCT05392127|GABA Modulators|gaba modulators|mesh-ancestor
153916760|NCT05392127|GABA Agents|gaba agents|mesh-ancestor
153916761|NCT05392127|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153916762|NCT05392127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153916763|NCT05392127|Anticoagulants|anticoagulants|mesh-ancestor
153916764|NCT05392127|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
153916765|NCT05392127|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153916766|NCT05392127|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
153916767|NCT05392127|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153916768|NCT05392127|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
153343264|NCT00002824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153343265|NCT00003178|Idarubicin|idarubicin|mesh-list
153343266|NCT00003178|Cladribine|cladribine|mesh-list
153343267|NCT00003178|Lenograstim|lenograstim|mesh-list
153783294|NCT04553380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153343268|NCT00003178|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153343297|NCT01260883|Sensory System Agents|sensory system agents|mesh-ancestor
153343298|NCT01260883|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153343299|NCT01260883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153343300|NCT01260883|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153343301|NCT01260883|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153343302|NCT01260883|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153343303|NCT01260883|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153343304|NCT01260883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153343305|NCT00076622|Antidepressive Agents|antidepressive agents|mesh-list
153343306|NCT00076622|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153343307|NCT00423202|Ambrisentan|ambrisentan|mesh-list
153343308|NCT00423202|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153343309|NCT00003184|Vaccines|vaccines|mesh-list
153343310|NCT00003184|Sargramostim|sargramostim|mesh-list
153343311|NCT00003184|BCG Vaccine|bcg vaccine|mesh-list
153343312|NCT00003184|Immunologic Factors|immunologic factors|mesh-ancestor
153343313|NCT00003184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153343314|NCT00003184|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153343315|NCT00003190|Cytarabine|cytarabine|mesh-list
153343316|NCT00003190|Etoposide|etoposide|mesh-list
153343352|NCT04773236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153343353|NCT00003658|Cyclophosphamide|cyclophosphamide|mesh-list
153343354|NCT00003658|Rituximab|rituximab|mesh-list
153343355|NCT00003658|Pentostatin|pentostatin|mesh-list
153343356|NCT00003658|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153343357|NCT00003658|Immunologic Factors|immunologic factors|mesh-ancestor
153343358|NCT00003658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153343359|NCT00003658|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153343360|NCT00003658|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153343361|NCT00003658|Alkylating Agents|alkylating agents|mesh-ancestor
153343362|NCT00003658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153465478|NCT00225732|Ibuprofen|ibuprofen|mesh-list
153916780|NCT00640003|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
153916781|NCT00640003|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153916782|NCT00640003|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
153916783|NCT00640003|GABA Agonists|gaba agonists|mesh-ancestor
153916784|NCT00640003|GABA Agents|gaba agents|mesh-ancestor
153916785|NCT00640003|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153916786|NCT00640003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153916787|NCT01201343|Interferons|interferons|mesh-list
153343363|NCT00003658|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153343364|NCT00003658|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153465528|NCT00227994|Donepezil|donepezil|mesh-list
153343365|NCT00003658|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153343366|NCT00003658|Adenosine Deaminase Inhibitors|adenosine deaminase inhibitors|mesh-ancestor
153343367|NCT00003658|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153343368|NCT00002836|Cyclophosphamide|cyclophosphamide|mesh-list
153343369|NCT00002836|Thiotepa|thiotepa|mesh-list
153343370|NCT00002836|Carmustine|carmustine|mesh-list
153343371|NCT00002836|Cisplatin|cisplatin|mesh-list
153343372|NCT00002836|Etoposide|etoposide|mesh-list
153343373|NCT00002836|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153343374|NCT00002836|Immunologic Factors|immunologic factors|mesh-ancestor
153343375|NCT00002836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153343376|NCT00002836|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153343377|NCT00002836|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153343378|NCT00002836|Alkylating Agents|alkylating agents|mesh-ancestor
153343379|NCT00002836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153343380|NCT00002836|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153343381|NCT00002836|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153343382|NCT00002836|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153343383|NCT00002836|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153916804|NCT04185649|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153916805|NCT01201265|Bevacizumab|bevacizumab|mesh-list
153916806|NCT01201265|Carboplatin|carboplatin|mesh-list
153916807|NCT01201265|Gemcitabine|gemcitabine|mesh-list
153916808|NCT01201265|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153916809|NCT01201265|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153916810|NCT01201265|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153916811|NCT01201265|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153916823|NCT04246801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153343384|NCT00002836|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153343385|NCT00002836|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153343393|NCT00003664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153343394|NCT00003664|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153343395|NCT00003664|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153916824|NCT00638677|Sorbitol|sorbitol|mesh-list
153916825|NCT00638677|Cathartics|cathartics|mesh-ancestor
153916842|NCT02686645|Vancomycin|vancomycin|mesh-list
153343396|NCT00003664|Immunologic Factors|immunologic factors|mesh-ancestor
153343397|NCT00003664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153343398|NCT00003664|Antiviral Agents|antiviral agents|mesh-ancestor
153343399|NCT00003664|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153343400|NCT00003664|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153343401|NCT00003664|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153343402|NCT00003196|Cyclosporine|cyclosporine|mesh-list
153343403|NCT00003196|Mycophenolic Acid|mycophenolic acid|mesh-list
153343404|NCT00003196|Cyclosporins|cyclosporins|mesh-list
153343405|NCT00003196|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153343406|NCT00003196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153343407|NCT00003196|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153343408|NCT00003196|Immunologic Factors|immunologic factors|mesh-ancestor
153343409|NCT00003196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153343410|NCT00003196|Antifungal Agents|antifungal agents|mesh-ancestor
153343411|NCT00003196|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153343412|NCT00003196|Dermatologic Agents|dermatologic agents|mesh-ancestor
153343413|NCT00003196|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153343414|NCT00003196|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
153343415|NCT00003196|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153343416|NCT00003196|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153343417|NCT00003196|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
153783296|NCT00236015|Anticonvulsants|anticonvulsants|mesh-ancestor
153343418|NCT00003196|Antitubercular Agents|antitubercular agents|mesh-ancestor
153343419|NCT00003196|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153343421|NCT00003202|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153343422|NCT00003202|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153343425|NCT00002854|Paclitaxel|paclitaxel|mesh-list
153343436|NCT00002854|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153343437|NCT00002854|Immunologic Factors|immunologic factors|mesh-ancestor
153343438|NCT00002854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153465591|NCT00290472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153465592|NCT00290472|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153465593|NCT00290472|Immunologic Factors|immunologic factors|mesh-ancestor
153465594|NCT00290472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153465595|NCT00290472|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153343439|NCT00002854|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153343440|NCT00002854|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153343441|NCT00002854|Alkylating Agents|alkylating agents|mesh-ancestor
153465596|NCT00290472|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153343442|NCT00002854|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153343443|NCT00002854|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153343444|NCT00002854|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153343445|NCT00002854|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153343446|NCT02308202|Perindopril|perindopril|mesh-list
153343447|NCT02308202|Doxazosin|doxazosin|mesh-list
153916875|NCT02685085|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153916876|NCT02685085|Oxytocics|oxytocics|mesh-ancestor
153916877|NCT02688595|Anesthetics|anesthetics|mesh-list
153916878|NCT02688595|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153916879|NCT02688595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153916880|NCT01200329|Gemcitabine|gemcitabine|mesh-list
153916881|NCT01200329|Melphalan|melphalan|mesh-list
153916882|NCT01200329|Busulfan|busulfan|mesh-list
153916883|NCT01200329|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153916884|NCT01200329|Antimetabolites|antimetabolites|mesh-ancestor
153343448|NCT02308202|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
153343449|NCT02308202|Protease Inhibitors|protease inhibitors|mesh-ancestor
153343450|NCT02308202|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153916885|NCT01200329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153916886|NCT01200329|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153916887|NCT01200329|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153916888|NCT01200329|Alkylating Agents|alkylating agents|mesh-ancestor
153916889|NCT01200329|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153916890|NCT01200329|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153343451|NCT02308202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153916891|NCT01200329|Immunologic Factors|immunologic factors|mesh-ancestor
153916892|NCT01200329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153916893|NCT01199939|Ritonavir|ritonavir|mesh-list
153343452|NCT02308202|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153343453|NCT02308202|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
153343454|NCT02308202|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
153343456|NCT02308202|Adrenergic Agents|adrenergic agents|mesh-ancestor
153343457|NCT02308202|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153343458|NCT02308202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153343459|NCT00003214|Paclitaxel|paclitaxel|mesh-list
153343460|NCT00003214|Cyclophosphamide|cyclophosphamide|mesh-list
153343461|NCT00003214|Carboplatin|carboplatin|mesh-list
153343462|NCT00003214|Doxorubicin|doxorubicin|mesh-list
153343463|NCT00003214|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
153343464|NCT00003214|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153343465|NCT00003214|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153343466|NCT00003214|Tubulin Modulators|tubulin modulators|mesh-ancestor
153343467|NCT00003214|Antimitotic Agents|antimitotic agents|mesh-ancestor
153916894|NCT01199939|Darunavir|darunavir|mesh-list
153916895|NCT01199939|Etravirine|etravirine|mesh-list
153343468|NCT00003214|Mitosis Modulators|mitosis modulators|mesh-ancestor
153916896|NCT01199939|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
153343469|NCT00003214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153343478|NCT00003214|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153343479|NCT00003214|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153343480|NCT00003214|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153343482|NCT00384592|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
153916905|NCT01199939|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
153916906|NCT01199939|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153465640|NCT00118404|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153465641|NCT00118404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153465642|NCT00118404|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153343483|NCT00384592|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153343484|NCT00384592|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
153343485|NCT00384592|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153343486|NCT00384592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153343487|NCT00003220|Bryostatin 1|bryostatin 1|mesh-list
153343488|NCT00003220|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153343489|NCT00003220|Immunologic Factors|immunologic factors|mesh-ancestor
153343490|NCT00003220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153343491|NCT00003220|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153343492|NCT00002866|Docetaxel|docetaxel|mesh-list
153783297|NCT00236015|GABA Uptake Inhibitors|gaba uptake inhibitors|mesh-ancestor
153465643|NCT00118404|Serotonin Agents|serotonin agents|mesh-ancestor
153465644|NCT00118404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153465645|NCT00118404|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
153465646|NCT00118404|Antidepressive Agents|antidepressive agents|mesh-ancestor
153343493|NCT00002866|Epirubicin|epirubicin|mesh-list
153343494|NCT00002866|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153343495|NCT00002866|Tubulin Modulators|tubulin modulators|mesh-ancestor
153343496|NCT00002866|Antimitotic Agents|antimitotic agents|mesh-ancestor
153343497|NCT00002866|Mitosis Modulators|mitosis modulators|mesh-ancestor
153343498|NCT00002866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153465647|NCT00118404|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153465651|NCT00121836|Bevacizumab|bevacizumab|mesh-list
153343500|NCT00002866|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153343501|NCT00002866|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153343502|NCT00002866|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153343504|NCT00003232|Prednisone|prednisone|mesh-list
153343505|NCT00003232|Mitoxantrone|mitoxantrone|mesh-list
153343506|NCT00003232|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153343507|NCT00003232|Glucocorticoids|glucocorticoids|mesh-ancestor
153343508|NCT00003232|Hormones|hormones|mesh-ancestor
153343509|NCT00003232|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153916915|NCT02688361|Respiratory System Agents|respiratory system agents|mesh-ancestor
153916916|NCT02688361|Free Radical Scavengers|free radical scavengers|mesh-ancestor
153916917|NCT02688361|Antioxidants|antioxidants|mesh-ancestor
153916918|NCT02688361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153916919|NCT02688361|Protective Agents|protective agents|mesh-ancestor
153916920|NCT02688361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153916921|NCT02688361|Antidotes|antidotes|mesh-ancestor
153916922|NCT01199861|Vaccines|vaccines|mesh-list
153916923|NCT01199861|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
153916924|NCT01199861|Immunologic Factors|immunologic factors|mesh-ancestor
153916925|NCT01199861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153916926|NCT01199861|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
153916927|NCT01199861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153916928|NCT01199861|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153916929|NCT03196219|Anti-Infective Agents|anti-infective agents|mesh-list
153916930|NCT03196219|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
153916931|NCT00640081|Leucovorin|leucovorin|mesh-list
153916932|NCT00640081|Capecitabine|capecitabine|mesh-list
153916933|NCT00640081|Fluorouracil|fluorouracil|mesh-list
153916934|NCT00640081|Oxaliplatin|oxaliplatin|mesh-list
153916935|NCT00640081|Cetuximab|cetuximab|mesh-list
153343519|NCT00003232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153343520|NCT00003232|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153343521|NCT00003238|Perillyl alcohol|perillyl alcohol|mesh-list
153343522|NCT00003238|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153343523|NCT00003238|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153916936|NCT00640081|Calcium|calcium|mesh-list
153343524|NCT00003238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153343525|NCT00002884|Fluorouracil|fluorouracil|mesh-list
153343526|NCT00002884|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153343527|NCT00002884|Antimetabolites|antimetabolites|mesh-ancestor
153343528|NCT00002884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153343529|NCT00002884|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153343530|NCT00002884|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153343531|NCT00002884|Immunologic Factors|immunologic factors|mesh-ancestor
153916937|NCT00640081|Levoleucovorin|levoleucovorin|mesh-list
153916938|NCT00640081|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153916939|NCT00640081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153343532|NCT00002884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153343533|NCT00003682|Methylprednisolone|methylprednisolone|mesh-list
153343534|NCT00003682|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
153343535|NCT00003682|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
153343537|NCT00003682|Prednisolone acetate|prednisolone acetate|mesh-list
153343538|NCT00003682|Doxorubicin|doxorubicin|mesh-list
153343539|NCT00003682|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
153343540|NCT00003682|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
153343541|NCT00003682|Prednisolone phosphate|prednisolone phosphate|mesh-list
153343542|NCT00003682|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153343543|NCT00003682|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153343544|NCT00003682|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153343545|NCT00003682|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153343546|NCT00003682|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153343547|NCT00003682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153343548|NCT00003682|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153916942|NCT00640081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153916943|NCT00640081|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153916944|NCT00640081|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153916945|NCT00640081|Immunologic Factors|immunologic factors|mesh-ancestor
153916946|NCT00640081|Antidotes|antidotes|mesh-ancestor
153916947|NCT00640081|Protective Agents|protective agents|mesh-ancestor
153916948|NCT00640081|Vitamin B Complex|vitamin b complex|mesh-ancestor
153916949|NCT00640081|Vitamins|vitamins|mesh-ancestor
153916950|NCT00640081|Micronutrients|micronutrients|mesh-ancestor
153916951|NCT00640081|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153916952|NCT01199705|Immunoglobulins|immunoglobulins|mesh-list
153916953|NCT01199705|Antibodies|antibodies|mesh-list
153465686|NCT00296322|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153465687|NCT00296322|Immunologic Factors|immunologic factors|mesh-ancestor
153343549|NCT00003682|Antiemetics|antiemetics|mesh-ancestor
153343560|NCT00003688|Dactinomycin|dactinomycin|mesh-list
153343561|NCT00003688|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153343562|NCT00003688|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153343563|NCT00003688|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153343564|NCT00003688|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153343565|NCT00003688|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
153343566|NCT00003688|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153343567|NCT00003688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153343568|NCT00003688|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153343569|NCT00003934|Cytarabine|cytarabine|mesh-list
153343570|NCT00003934|Methotrexate|methotrexate|mesh-list
153343571|NCT00003934|Mercaptopurine|mercaptopurine|mesh-list
153343572|NCT00003934|Daunorubicin|daunorubicin|mesh-list
153343575|NCT00003934|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
153465688|NCT00296322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153465689|NCT00296322|Appetite Stimulants|appetite stimulants|mesh-ancestor
153343624|NCT00003946|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
153343625|NCT00003946|Hormone Antagonists|hormone antagonists|mesh-ancestor
153343626|NCT00003946|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153343627|NCT00003946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153343628|NCT04679480|Cemiplimab|cemiplimab|mesh-list
153343629|NCT04679480|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153343630|NCT04679480|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153343631|NCT00003262|Prednisone|prednisone|mesh-list
153916959|NCT02688127|Tranexamic Acid|tranexamic acid|mesh-list
153916960|NCT02688127|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
153916961|NCT02688127|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153916962|NCT02688127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153916964|NCT02688127|Coagulants|coagulants|mesh-ancestor
153916965|NCT04184947|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
153916966|NCT04184947|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-list
153916967|NCT04184947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153916968|NCT04184947|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153916969|NCT04184947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153916970|NCT00638833|Memantine|memantine|mesh-list
153916986|NCT01198145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153916987|NCT01198145|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153916988|NCT01198145|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153916989|NCT01198145|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153916990|NCT01179048|Liraglutide|liraglutide|mesh-list
153916991|NCT01179048|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
153916992|NCT01179048|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153916993|NCT01179048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153916994|NCT01179048|Incretins|incretins|mesh-ancestor
153343632|NCT00003262|Doxorubicin|doxorubicin|mesh-list
153343633|NCT00003262|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
153343634|NCT00003262|Epirubicin|epirubicin|mesh-list
153343635|NCT00003262|Bleomycin|bleomycin|mesh-list
153343636|NCT00003262|Etoposide|etoposide|mesh-list
153343637|NCT00003262|Vincristine|vincristine|mesh-list
153916995|NCT01179048|Hormones|hormones|mesh-ancestor
153343638|NCT00003262|Vinblastine|vinblastine|mesh-list
153343639|NCT00003262|Mechlorethamine|mechlorethamine|mesh-list
153343640|NCT00003262|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153343641|NCT00003262|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153343642|NCT00003262|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153343643|NCT00003262|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153343644|NCT00003262|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153343645|NCT00003262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153343646|NCT00003262|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153343647|NCT00003262|Glucocorticoids|glucocorticoids|mesh-ancestor
153916997|NCT00603265|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
153343649|NCT00003262|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153343650|NCT00003262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153343676|NCT00003700|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153917000|NCT00603265|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153343677|NCT00003700|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153917001|NCT00603265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153917002|NCT00603265|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153917003|NCT00603265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153917004|NCT00603265|Analgesics|analgesics|mesh-ancestor
153917005|NCT00603265|Sensory System Agents|sensory system agents|mesh-ancestor
153917006|NCT00603265|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153917007|NCT00603265|Antidepressive Agents|antidepressive agents|mesh-ancestor
153917008|NCT00603265|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153917009|NCT00603265|Dopamine Agents|dopamine agents|mesh-ancestor
153917010|NCT02686177|Metformin|metformin|mesh-list
153917011|NCT02686177|Liraglutide|liraglutide|mesh-list
153917012|NCT02686177|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153917013|NCT02686177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153465748|NCT00300456|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153465749|NCT00300456|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
153465750|NCT00300456|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153465751|NCT00125034|Oxaliplatin|oxaliplatin|mesh-list
153343678|NCT00003700|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153343679|NCT00003700|Glucocorticoids|glucocorticoids|mesh-ancestor
153343680|NCT00003700|Hormones|hormones|mesh-ancestor
153343681|NCT00003700|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153343682|NCT00003700|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153343683|NCT00003700|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
153343684|NCT00003700|Abortifacient Agents|abortifacient agents|mesh-ancestor
153343685|NCT00003700|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153343686|NCT00003700|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153343688|NCT00003700|Dermatologic Agents|dermatologic agents|mesh-ancestor
153343689|NCT00003700|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153343690|NCT00003700|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153343691|NCT00003700|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153343692|NCT00003700|Antiviral Agents|antiviral agents|mesh-ancestor
153343693|NCT00003700|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153343694|NCT00003700|Antidotes|antidotes|mesh-ancestor
153465752|NCT00125034|Cetuximab|cetuximab|mesh-list
153343696|NCT00003700|Vitamin B Complex|vitamin b complex|mesh-ancestor
153343697|NCT00003700|Vitamins|vitamins|mesh-ancestor
153343730|NCT00003958|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153343731|NCT00003958|Tubulin Modulators|tubulin modulators|mesh-ancestor
153343732|NCT00003958|Antimitotic Agents|antimitotic agents|mesh-ancestor
153343733|NCT00003958|Mitosis Modulators|mitosis modulators|mesh-ancestor
153343734|NCT00003958|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
153343735|NCT00003958|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153343736|NCT00003958|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153465773|NCT00241176|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153465774|NCT00241176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153465775|NCT00241176|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
153465776|NCT00241176|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
153465778|NCT00241176|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
153917014|NCT02686177|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
153917016|NCT02686177|Hormones|hormones|mesh-ancestor
153917017|NCT02686177|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153917018|NCT02686021|Dipyrone|dipyrone|mesh-list
153917019|NCT02686021|Ibuprofen|ibuprofen|mesh-list
153917020|NCT02686021|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153917021|NCT02686021|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153917022|NCT02686021|Analgesics|analgesics|mesh-ancestor
153917023|NCT02686021|Sensory System Agents|sensory system agents|mesh-ancestor
153917024|NCT02686021|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153917025|NCT02686021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153893510|NCT01019980|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153343737|NCT00003958|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153343738|NCT00003958|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153343739|NCT00003958|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153343740|NCT00003958|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
153343741|NCT00003958|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153343742|NCT00003712|Sirolimus|sirolimus|mesh-list
153917026|NCT02686021|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153465779|NCT00241176|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153917027|NCT02686021|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153343743|NCT00003712|Temsirolimus|temsirolimus|mesh-list
153343744|NCT00003712|MTOR Inhibitors|mtor inhibitors|mesh-list
153343745|NCT00003712|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153343746|NCT00003712|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153343747|NCT00003712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153917032|NCT01158534|Interferons|interferons|mesh-list
153343748|NCT00003712|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153343749|NCT00003712|Immunologic Factors|immunologic factors|mesh-ancestor
153343750|NCT00003712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153343751|NCT00003712|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153343753|NCT00003712|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153343754|NCT00003712|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153343757|NCT00003268|Idarubicin|idarubicin|mesh-list
153343758|NCT00003268|Amifostine|amifostine|mesh-list
153343759|NCT00003268|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153343760|NCT00003268|Antimetabolites|antimetabolites|mesh-ancestor
153343774|NCT00083720|Cetuximab|cetuximab|mesh-list
153343775|NCT00083720|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153343776|NCT00083720|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153343777|NCT00003274|Sargramostim|sargramostim|mesh-list
153343778|NCT00003274|Freund's Adjuvant|freund's adjuvant|mesh-list
153343779|NCT00003274|Immunologic Factors|immunologic factors|mesh-ancestor
153343780|NCT00003274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153343781|NCT00003274|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153343782|NCT00003280|Rituximab|rituximab|mesh-list
153343783|NCT00003280|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153343784|NCT00003280|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153343785|NCT00003280|Immunologic Factors|immunologic factors|mesh-ancestor
153343786|NCT00003280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153343787|NCT00003280|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153917036|NCT01158534|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153917037|NCT01158534|Antiviral Agents|antiviral agents|mesh-ancestor
153917038|NCT01158534|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153917039|NCT01158534|Immunologic Factors|immunologic factors|mesh-ancestor
153917040|NCT01158534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153917041|NCT01158534|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153917042|NCT01158534|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153917043|NCT01158534|Analgesics|analgesics|mesh-ancestor
153917044|NCT01158534|Sensory System Agents|sensory system agents|mesh-ancestor
153343788|NCT00384124|Imiquimod|imiquimod|mesh-list
153917046|NCT01158534|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153343790|NCT00384124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153343791|NCT00384124|Immunomodulating Agents|immunomodulating agents|mesh-ancestor
153343792|NCT00384124|Immunologic Factors|immunologic factors|mesh-ancestor
153917070|NCT02683213|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153917071|NCT02683213|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153917072|NCT04185103|Valsartan|valsartan|mesh-list
153917073|NCT04185103|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
153917075|NCT04185103|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
153917076|NCT04185103|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
153917077|NCT04185103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153917078|NCT04033939|Propofol|propofol|mesh-list
153917079|NCT04033939|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153917080|NCT04033939|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153917081|NCT04033939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153917082|NCT04033939|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153343793|NCT00384124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153343794|NCT00384124|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153343795|NCT00384124|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153343796|NCT00384124|Interferon Inducers|interferon inducers|mesh-ancestor
153343797|NCT00003718|Temozolomide|temozolomide|mesh-list
153343798|NCT00003718|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153343799|NCT00003718|Alkylating Agents|alkylating agents|mesh-ancestor
153917083|NCT04033939|Anesthetics, General|anesthetics, general|mesh-ancestor
153343800|NCT00003718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153343803|NCT00003970|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
153343804|NCT00003970|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153343822|NCT00384202|Immunologic Factors|immunologic factors|mesh-ancestor
153343823|NCT00384202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153343824|NCT00384202|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
153343825|NCT00384202|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153917084|NCT04033939|Anesthetics|anesthetics|mesh-ancestor
153917085|NCT00639691|Omalizumab|omalizumab|mesh-list
153917086|NCT00639691|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
153917087|NCT00639691|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153917088|NCT00639691|Respiratory System Agents|respiratory system agents|mesh-ancestor
153343826|NCT00384202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153343828|NCT00086138|Antidepressive Agents|antidepressive agents|mesh-ancestor
153343829|NCT00086138|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153343830|NCT00086138|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
153917106|NCT02684071|Dermatologic Agents|dermatologic agents|mesh-ancestor
153917107|NCT02684071|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153917108|NCT02684071|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153917109|NCT02684071|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153917110|NCT02684071|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
153917111|NCT02684071|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153917112|NCT00640861|Vaccines|vaccines|mesh-list
153917113|NCT00640861|Sargramostim|sargramostim|mesh-list
153465836|NCT00127218|Niacin|niacin|mesh-list
153917114|NCT00640861|Freund's Adjuvant|freund's adjuvant|mesh-list
153343831|NCT00086138|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153343832|NCT00086138|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153343833|NCT00086138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153343834|NCT00086138|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153343835|NCT00086138|Serotonin Agents|serotonin agents|mesh-ancestor
153343836|NCT00086138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153343837|NCT04329130|Lenalidomide|lenalidomide|mesh-list
153343838|NCT04329130|Immunologic Factors|immunologic factors|mesh-ancestor
153343839|NCT04329130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153917115|NCT00640861|Immunologic Factors|immunologic factors|mesh-ancestor
153917116|NCT00640861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153917117|NCT00640861|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153917118|NCT01158222|Sunitinib|sunitinib|mesh-list
153917119|NCT01158222|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153917120|NCT01158222|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153465858|NCT00250926|Dexamethasone acetate|dexamethasone acetate|mesh-list
153465859|NCT00250926|Rituximab|rituximab|mesh-list
153343840|NCT04329130|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153343841|NCT04329130|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153343842|NCT04329130|Growth Substances|growth substances|mesh-ancestor
153343843|NCT04329130|Growth Inhibitors|growth inhibitors|mesh-ancestor
153343870|NCT00003730|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153343871|NCT00003730|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153343872|NCT00003730|Immunologic Factors|immunologic factors|mesh-ancestor
153465860|NCT00250926|Bortezomib|bortezomib|mesh-list
153465861|NCT00250926|BB 1101|bb 1101|mesh-list
153465862|NCT00250926|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153465863|NCT00250926|Antiemetics|antiemetics|mesh-ancestor
153343874|NCT00003730|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153343875|NCT00003730|Tubulin Modulators|tubulin modulators|mesh-ancestor
153343876|NCT00003730|Antimitotic Agents|antimitotic agents|mesh-ancestor
153343877|NCT00003730|Mitosis Modulators|mitosis modulators|mesh-ancestor
153343878|NCT01881308|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-list
153343879|NCT01881308|Antirheumatic Agents|antirheumatic agents|mesh-list
153343880|NCT01881308|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153343882|NCT00003292|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153343883|NCT00003292|Alkylating Agents|alkylating agents|mesh-ancestor
153343884|NCT00003292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153343885|NCT00003292|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153343886|NCT00088634|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
153343887|NCT00088634|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153343888|NCT00088634|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153343889|NCT00088634|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153343890|NCT00088634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153343891|NCT00088634|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153343892|NCT00088634|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
153343893|NCT00088634|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
153343894|NCT00088634|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
153343895|NCT00088634|Adrenergic Agents|adrenergic agents|mesh-ancestor
153343896|NCT00088634|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153343897|NCT00088634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153917127|NCT01158222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153917129|NCT02684305|Oxytocics|oxytocics|mesh-ancestor
153917130|NCT02684305|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153917131|NCT02684305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153917132|NCT02940769|Methamphetamine|methamphetamine|mesh-list
153917133|NCT02940769|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
153917135|NCT02940769|Sympathomimetics|sympathomimetics|mesh-ancestor
153343898|NCT00088634|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
153343915|NCT00003994|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153343916|NCT00003994|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153343917|NCT00003994|Immunologic Factors|immunologic factors|mesh-ancestor
153343918|NCT00003994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153343919|NCT00003994|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153343920|NCT00003994|Tubulin Modulators|tubulin modulators|mesh-ancestor
153343921|NCT00003994|Antimitotic Agents|antimitotic agents|mesh-ancestor
153343922|NCT00003994|Mitosis Modulators|mitosis modulators|mesh-ancestor
153343923|NCT00003994|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
153343925|NCT00003742|Paclitaxel|paclitaxel|mesh-list
153343926|NCT00003742|Irinotecan|irinotecan|mesh-list
153343927|NCT00003742|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153343928|NCT00003742|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153343929|NCT00003742|Tubulin Modulators|tubulin modulators|mesh-ancestor
153343930|NCT00003742|Antimitotic Agents|antimitotic agents|mesh-ancestor
153343931|NCT00003742|Mitosis Modulators|mitosis modulators|mesh-ancestor
153917170|NCT02683291|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153917171|NCT02683291|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153917172|NCT02683291|Immunologic Factors|immunologic factors|mesh-ancestor
153917173|NCT02683291|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
153917174|NCT02683291|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153917175|NCT02683291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153917176|NCT02683291|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153917177|NCT02683291|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
153917178|NCT02683291|Antitubercular Agents|antitubercular agents|mesh-ancestor
153465939|NCT01790022|Hormones|hormones|mesh-ancestor
153343932|NCT00003742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153343933|NCT00003742|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
153343934|NCT00003742|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153343935|NCT00003742|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153343936|NCT00003304|Temozolomide|temozolomide|mesh-list
153343937|NCT00003304|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153343938|NCT00003304|Alkylating Agents|alkylating agents|mesh-ancestor
153343939|NCT00003304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153343940|NCT00003304|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153343941|NCT00004006|Cyclophosphamide|cyclophosphamide|mesh-list
153343942|NCT00004006|Carboplatin|carboplatin|mesh-list
153343943|NCT00004006|Doxorubicin|doxorubicin|mesh-list
153343944|NCT00004006|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
153343945|NCT00004006|Etoposide|etoposide|mesh-list
153343946|NCT00004006|Topotecan|topotecan|mesh-list
153917197|NCT02683837|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153343947|NCT00004006|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153343948|NCT00004006|Immunologic Factors|immunologic factors|mesh-ancestor
153917198|NCT02683837|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
153917199|NCT02683837|Anesthetics, General|anesthetics, general|mesh-ancestor
153917200|NCT02683837|Anesthetics|anesthetics|mesh-ancestor
153343949|NCT00004006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153343950|NCT00004006|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153917204|NCT02683837|Narcotics|narcotics|mesh-ancestor
153343954|NCT00004006|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153343955|NCT00004006|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153343956|NCT00004006|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153343957|NCT00004006|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153343958|NCT00004006|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153343959|NCT00004006|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153343960|NCT00004006|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153343961|NCT00004006|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
153343962|NCT00003316|Gemcitabine|gemcitabine|mesh-list
153343963|NCT00003316|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153343964|NCT00003316|Antimetabolites|antimetabolites|mesh-ancestor
153343965|NCT00003316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153343966|NCT00003316|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153465986|NCT00142506|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
153917237|NCT02680717|Glucocorticoids|glucocorticoids|mesh-ancestor
153917238|NCT02680717|Hormones|hormones|mesh-ancestor
153917239|NCT02680717|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153917240|NCT02680717|Dermatologic Agents|dermatologic agents|mesh-ancestor
153917241|NCT02680795|Belinostat|belinostat|mesh-list
153917242|NCT02680795|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153343967|NCT00003322|Paclitaxel|paclitaxel|mesh-list
153917243|NCT02680795|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
153917244|NCT02680795|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153343968|NCT00003322|Cisplatin|cisplatin|mesh-list
153343969|NCT00003322|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153343970|NCT00003322|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153343971|NCT00003322|Tubulin Modulators|tubulin modulators|mesh-ancestor
153343972|NCT00003322|Antimitotic Agents|antimitotic agents|mesh-ancestor
153343973|NCT00003322|Mitosis Modulators|mitosis modulators|mesh-ancestor
153343974|NCT00003322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153343975|NCT00519818|Hydrocortisone|hydrocortisone|mesh-list
153343976|NCT00519818|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
153343977|NCT00519818|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
153343978|NCT00519818|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
153343979|NCT00519818|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153343981|NCT00003748|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
153343982|NCT00003748|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153343983|NCT00003748|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153343984|NCT00003748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153343985|NCT00003748|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153343986|NCT00089102|Gemcitabine|gemcitabine|mesh-list
153343995|NCT00004012|Capecitabine|capecitabine|mesh-list
153343996|NCT00004012|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153343997|NCT00004012|Antimetabolites|antimetabolites|mesh-ancestor
153343998|NCT00004012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153343999|NCT00004012|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153344000|NCT00003754|Thalidomide|thalidomide|mesh-list
153344001|NCT00003754|Cyclophosphamide|cyclophosphamide|mesh-list
153344002|NCT00003754|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153466024|NCT05266716|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153344003|NCT00003754|Immunologic Factors|immunologic factors|mesh-ancestor
153344005|NCT00003754|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153344006|NCT00003754|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153344007|NCT00003754|Alkylating Agents|alkylating agents|mesh-ancestor
153344008|NCT00003754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153344009|NCT00003754|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153344010|NCT00003754|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153344011|NCT00003754|Leprostatic Agents|leprostatic agents|mesh-ancestor
153344012|NCT00003754|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153344013|NCT00003754|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153344014|NCT00003754|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153344015|NCT00003754|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153344016|NCT00003754|Growth Substances|growth substances|mesh-ancestor
153344017|NCT00003754|Growth Inhibitors|growth inhibitors|mesh-ancestor
153344019|NCT00003328|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153344020|NCT00003328|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153344021|NCT00004024|Aldesleukin|aldesleukin|mesh-list
153344023|NCT00004024|Muromonab-CD3|muromonab-cd3|mesh-list
153344042|NCT00003334|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153344043|NCT00003334|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153344044|NCT00003334|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153344045|NCT00093782|Sirolimus|sirolimus|mesh-list
153344046|NCT00093782|Temsirolimus|temsirolimus|mesh-list
153344047|NCT00093782|MTOR Inhibitors|mtor inhibitors|mesh-list
153344048|NCT00093782|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153344049|NCT00093782|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153344050|NCT00093782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153344051|NCT00093782|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153344052|NCT00093782|Immunologic Factors|immunologic factors|mesh-ancestor
153344053|NCT00093782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153344054|NCT00093782|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153344055|NCT00093782|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153344056|NCT00093782|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153344057|NCT00093782|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153344058|NCT00093782|Antifungal Agents|antifungal agents|mesh-ancestor
153344059|NCT00003760|Irofulven|irofulven|mesh-list
153344060|NCT00003760|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153344061|NCT00003760|Alkylating Agents|alkylating agents|mesh-ancestor
153344062|NCT00003760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153344063|NCT00003760|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153344064|NCT00003766|O(6)-benzylguanine|o(6)-benzylguanine|mesh-list
153344065|NCT00003766|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153344066|NCT00003766|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153344067|NCT00003766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153344068|NCT00004030|Doxorubicin|doxorubicin|mesh-list
153344069|NCT00004030|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
153344070|NCT00004030|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153344086|NCT00003340|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153344087|NCT00003340|Immunologic Factors|immunologic factors|mesh-ancestor
153344088|NCT00003340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153344089|NCT00003340|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153344090|NCT00003340|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153344091|NCT00003340|Alkylating Agents|alkylating agents|mesh-ancestor
153344092|NCT00003340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153344093|NCT00003340|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153344094|NCT00003340|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153344095|NCT00003340|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
153344097|NCT00003340|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153344099|NCT00004036|Carboplatin|carboplatin|mesh-list
153344100|NCT00004036|Sargramostim|sargramostim|mesh-list
153783299|NCT00236015|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153344101|NCT00004036|Amifostine|amifostine|mesh-list
153344102|NCT00004036|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153344103|NCT00004036|Immunologic Factors|immunologic factors|mesh-ancestor
153344104|NCT00004036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153344105|NCT00004036|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153344106|NCT00004036|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153344107|NCT00004036|Alkylating Agents|alkylating agents|mesh-ancestor
153344109|NCT00004036|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153344139|NCT00096122|Antimetabolites|antimetabolites|mesh-ancestor
153466151|NCT00343044|Bevacizumab|bevacizumab|mesh-list
153466153|NCT00343044|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153466154|NCT00343044|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153466155|NCT00343044|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153917408|NCT00983385|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153917409|NCT00983385|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153917410|NCT00983385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153917411|NCT00983385|Adrenergic Agents|adrenergic agents|mesh-ancestor
153917412|NCT00983385|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153917413|NCT00992511|Vaccines|vaccines|mesh-list
153917414|NCT00992511|Immunologic Factors|immunologic factors|mesh-ancestor
153917415|NCT00992511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153917416|NCT02869035|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
153917417|NCT02869035|Escitalopram|escitalopram|mesh-list
153917418|NCT02869035|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
153917419|NCT02869035|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153917420|NCT02869035|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153917421|NCT02869035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153344140|NCT00096122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153344141|NCT00096122|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153344142|NCT00096122|Antiviral Agents|antiviral agents|mesh-ancestor
153344143|NCT00096122|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153344144|NCT00096122|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153344145|NCT00096122|Immunologic Factors|immunologic factors|mesh-ancestor
153344146|NCT00096122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153344147|NCT00096122|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153344148|NCT00096122|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153344149|NCT00096122|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153344150|NCT00096122|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153344152|NCT00003778|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153344153|NCT00003778|Tubulin Modulators|tubulin modulators|mesh-ancestor
153344154|NCT00003778|Antimitotic Agents|antimitotic agents|mesh-ancestor
153344155|NCT00003778|Mitosis Modulators|mitosis modulators|mesh-ancestor
153344156|NCT00003778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153344157|NCT00004042|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
153344158|NCT00004042|Antibodies|antibodies|mesh-list
153344159|NCT00004042|Immunoglobulins|immunoglobulins|mesh-list
153344160|NCT00004042|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
153344162|NCT00004042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153344163|NCT00004042|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153344164|NCT00003784|Prednisone|prednisone|mesh-list
153344188|NCT00003784|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153344189|NCT00003784|Tubulin Modulators|tubulin modulators|mesh-ancestor
153344190|NCT00003784|Antimitotic Agents|antimitotic agents|mesh-ancestor
153344191|NCT00003784|Mitosis Modulators|mitosis modulators|mesh-ancestor
153917422|NCT02869035|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153917423|NCT02869035|Serotonin Agents|serotonin agents|mesh-ancestor
153917424|NCT02869035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153917425|NCT02869035|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153917426|NCT02869035|Antidepressive Agents|antidepressive agents|mesh-ancestor
153917427|NCT02869035|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153917428|NCT02869035|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
153917429|NCT02869035|Analgesics|analgesics|mesh-ancestor
153917430|NCT02869035|Sensory System Agents|sensory system agents|mesh-ancestor
153917431|NCT02869035|Dopamine Agents|dopamine agents|mesh-ancestor
153917433|NCT04290819|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
153917434|NCT04290819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153917435|NCT04290819|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
153917436|NCT04290819|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153917437|NCT04290819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153344192|NCT00003352|Cyclophosphamide|cyclophosphamide|mesh-list
153344193|NCT00003352|Docetaxel|docetaxel|mesh-list
153344194|NCT00003352|Doxorubicin|doxorubicin|mesh-list
153344195|NCT00003352|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
153344196|NCT00003352|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153344197|NCT00003352|Immunologic Factors|immunologic factors|mesh-ancestor
153344198|NCT00003352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153344199|NCT00003352|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153344200|NCT00003352|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153344201|NCT00003352|Alkylating Agents|alkylating agents|mesh-ancestor
153344202|NCT00003352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153344203|NCT00003352|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153344204|NCT00003352|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153344244|NCT00384826|Mitosis Modulators|mitosis modulators|mesh-ancestor
153917438|NCT04290819|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
153344245|NCT00384826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153344248|NCT00384826|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153344249|NCT00003364|Cyclophosphamide|cyclophosphamide|mesh-list
153344250|NCT00003364|Doxorubicin|doxorubicin|mesh-list
153344251|NCT00003364|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
153917458|NCT01196429|Antifungal Agents|antifungal agents|mesh-ancestor
153917459|NCT01196429|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153917460|NCT01196429|Immunologic Factors|immunologic factors|mesh-ancestor
153917461|NCT01196429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153917462|NCT01196429|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153917463|NCT01196429|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153466164|NCT00344370|Atorvastatin|atorvastatin|mesh-list
153917464|NCT01157364|Bimatoprost|bimatoprost|mesh-list
153917465|NCT01157364|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153917466|NCT01195415|Gemcitabine|gemcitabine|mesh-list
153917467|NCT01195415|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153917468|NCT01195415|Antimetabolites|antimetabolites|mesh-ancestor
153917469|NCT01195415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153917470|NCT01195415|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153917471|NCT01195103|Midazolam|midazolam|mesh-list
153917472|NCT01195103|Fentanyl|fentanyl|mesh-list
153917473|NCT01195103|Fospropofol|fospropofol|mesh-list
153344252|NCT00003364|Etoposide|etoposide|mesh-list
153344253|NCT00003364|Vincristine|vincristine|mesh-list
153344254|NCT00003364|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153783300|NCT00236015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153344255|NCT00003364|Immunologic Factors|immunologic factors|mesh-ancestor
153344256|NCT00003364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153344257|NCT00003364|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153344258|NCT00003364|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153344259|NCT00003364|Alkylating Agents|alkylating agents|mesh-ancestor
153344260|NCT00003364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153466211|NCT01791192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153466213|NCT00350142|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153466214|NCT00350142|Antimetabolites|antimetabolites|mesh-ancestor
153344261|NCT00003364|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153344262|NCT00003364|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153344263|NCT00003364|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153344264|NCT00003364|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153344265|NCT00003364|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153466215|NCT00350142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153344266|NCT00003364|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153466217|NCT00350532|Clonidine|clonidine|mesh-list
153466218|NCT00350532|Analgesics|analgesics|mesh-ancestor
153344268|NCT00003364|Tubulin Modulators|tubulin modulators|mesh-ancestor
153344269|NCT00003364|Antimitotic Agents|antimitotic agents|mesh-ancestor
153344270|NCT00003364|Mitosis Modulators|mitosis modulators|mesh-ancestor
153344271|NCT00004066|Gemcitabine|gemcitabine|mesh-list
153466226|NCT00350532|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153466227|NCT00350532|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153466228|NCT00350532|Adrenergic Agents|adrenergic agents|mesh-ancestor
153466229|NCT00350532|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153466230|NCT00350532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153344272|NCT00004066|Docetaxel|docetaxel|mesh-list
153344289|NCT00003382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153344290|NCT00003382|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153344291|NCT00003382|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
153344292|NCT00003382|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153466231|NCT00351000|Ziprasidone|ziprasidone|mesh-list
153466232|NCT00351000|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153466233|NCT00351000|Serotonin Agents|serotonin agents|mesh-ancestor
153466234|NCT00351000|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153466235|NCT00351000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153466237|NCT00351000|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153917474|NCT01195103|Propofol|propofol|mesh-list
153917475|NCT01195103|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153344293|NCT00003382|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153344294|NCT00004834|Imipramine|imipramine|mesh-list
153344295|NCT00004834|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
153344296|NCT00004834|Antidepressive Agents|antidepressive agents|mesh-ancestor
153344297|NCT00004834|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153344298|NCT00004834|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
153917476|NCT01195103|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153917477|NCT01195103|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153917478|NCT01195103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153917479|NCT01195103|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153917480|NCT01195103|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153917481|NCT01195103|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153917484|NCT01195103|Anesthetics|anesthetics|mesh-ancestor
153344299|NCT00004834|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153344300|NCT00004834|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153344301|NCT00004834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153344302|NCT00004834|Adrenergic Agents|adrenergic agents|mesh-ancestor
153344303|NCT00004834|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153344304|NCT00004834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153344309|NCT00004852|Lamivudine|lamivudine|mesh-list
153344344|NCT00004864|Tubulin Modulators|tubulin modulators|mesh-ancestor
153344345|NCT00004864|Antimitotic Agents|antimitotic agents|mesh-ancestor
153344346|NCT00004864|Mitosis Modulators|mitosis modulators|mesh-ancestor
153344347|NCT00004864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153344348|NCT00003796|Irofulven|irofulven|mesh-list
153344349|NCT00003796|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153344350|NCT00003796|Alkylating Agents|alkylating agents|mesh-ancestor
153344351|NCT00003796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153344352|NCT00003796|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153344353|NCT00003802|NSC 366140|nsc 366140|mesh-list
153344354|NCT00003802|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153344355|NCT02972866|Budesonide|budesonide|mesh-list
153344356|NCT02972866|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153378183|NCT02635061|Nivolumab|nivolumab|mesh-list
153378184|NCT02635061|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153378185|NCT02635061|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153378186|NCT02635061|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153344357|NCT02972866|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153344358|NCT02972866|Autonomic Agents|autonomic agents|mesh-ancestor
153344359|NCT02972866|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153344360|NCT02972866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153917497|NCT01194869|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153917498|NCT01194869|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153917499|NCT01194869|Tubulin Modulators|tubulin modulators|mesh-ancestor
153917500|NCT01194869|Antimitotic Agents|antimitotic agents|mesh-ancestor
153917501|NCT01194869|Mitosis Modulators|mitosis modulators|mesh-ancestor
153917502|NCT01194869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153917503|NCT01194869|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153917504|NCT01194869|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153917505|NCT01177800|Infliximab|infliximab|mesh-list
153344361|NCT02972866|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153917506|NCT01177800|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
153917507|NCT01177800|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153344362|NCT02972866|Respiratory System Agents|respiratory system agents|mesh-ancestor
153917508|NCT01177800|Dermatologic Agents|dermatologic agents|mesh-ancestor
153344363|NCT02972866|Glucocorticoids|glucocorticoids|mesh-ancestor
153344364|NCT02972866|Hormones|hormones|mesh-ancestor
153344365|NCT02972866|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153344366|NCT00003814|Eflornithine|eflornithine|mesh-list
153344367|NCT00003814|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153466274|NCT00352794|Growth Inhibitors|growth inhibitors|mesh-ancestor
153917523|NCT02884986|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
153917524|NCT02884986|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153895034|NCT05927259|Expectorants|expectorants|mesh-ancestor
153917525|NCT02884986|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153917526|NCT02884986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153917528|NCT04124562|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
153917529|NCT04124562|Anesthetics, General|anesthetics, general|mesh-ancestor
153917530|NCT04124562|Anesthetics|anesthetics|mesh-ancestor
153917531|NCT04124562|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153917532|NCT04124562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153917533|NCT04124562|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153917534|NCT04124562|Analgesics|analgesics|mesh-ancestor
153917535|NCT04124562|Sensory System Agents|sensory system agents|mesh-ancestor
153344396|NCT00004072|O(6)-benzylguanine|o(6)-benzylguanine|mesh-list
153344397|NCT00004072|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153917536|NCT04124562|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153344398|NCT00004072|Alkylating Agents|alkylating agents|mesh-ancestor
153344399|NCT00004072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153344400|NCT00004072|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153344401|NCT00004072|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153344402|NCT00004078|Irinotecan|irinotecan|mesh-list
153344403|NCT00004078|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
153344404|NCT00004078|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153783301|NCT00236015|GABA Agents|gaba agents|mesh-ancestor
153783302|NCT00236015|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153783303|NCT00236015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153783304|NCT00261378|Doxorubicin|doxorubicin|mesh-list
153783305|NCT00261378|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
153783306|NCT00261378|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153783307|NCT00261378|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153783308|NCT00261378|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153783309|NCT00261378|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153783310|NCT00261378|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153344441|NCT00004870|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
153344442|NCT00004870|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153344443|NCT00004870|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153917537|NCT01177410|Mesalamine|mesalamine|mesh-list
153917539|NCT01177410|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153344444|NCT00004870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153344445|NCT00004870|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153344446|NCT00004084|Epratuzumab|epratuzumab|mesh-list
153344447|NCT00004084|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153344448|NCT00004084|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153344449|NCT00004876|Thalidomide|thalidomide|mesh-list
153344450|NCT00004876|Carboplatin|carboplatin|mesh-list
153344451|NCT00004876|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153344452|NCT00004876|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153344453|NCT00004876|Immunologic Factors|immunologic factors|mesh-ancestor
153344454|NCT00004876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153344455|NCT00004876|Leprostatic Agents|leprostatic agents|mesh-ancestor
153344456|NCT00004876|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153344457|NCT00004876|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153344498|NCT00003868|Abortifacient Agents|abortifacient agents|mesh-ancestor
153344499|NCT00003868|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153344500|NCT00003868|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153344502|NCT00003868|Dermatologic Agents|dermatologic agents|mesh-ancestor
153344504|NCT00003868|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153917552|NCT02884596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153917553|NCT02884596|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153917554|NCT02884596|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153917555|NCT04205916|Moxifloxacin|moxifloxacin|mesh-list
153917556|NCT04205916|Dexamethasone|dexamethasone|mesh-list
153917557|NCT04205916|Ketorolac|ketorolac|mesh-list
153917558|NCT04205916|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153917559|NCT04205916|Antiemetics|antiemetics|mesh-ancestor
153917560|NCT04205916|Autonomic Agents|autonomic agents|mesh-ancestor
153917561|NCT04205916|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153917562|NCT04205916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153917563|NCT04205916|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153917564|NCT04205916|Glucocorticoids|glucocorticoids|mesh-ancestor
153917565|NCT04205916|Hormones|hormones|mesh-ancestor
153917566|NCT04205916|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153917567|NCT04205916|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153917568|NCT04205916|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153344505|NCT00003868|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153344506|NCT00003874|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
153344507|NCT00003874|Antibodies|antibodies|mesh-list
153344508|NCT00003874|Immunoglobulins|immunoglobulins|mesh-list
153344509|NCT00003874|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
153344510|NCT00003874|Immunologic Factors|immunologic factors|mesh-ancestor
153344511|NCT00003874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153344512|NCT00003874|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153344513|NCT00004090|Gemcitabine|gemcitabine|mesh-list
153344514|NCT00004090|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153344515|NCT00004090|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153344516|NCT00004090|Antimetabolites|antimetabolites|mesh-ancestor
153344517|NCT00004090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153917580|NCT04205916|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153917581|NCT01176240|Mannitol|mannitol|mesh-list
153917582|NCT01176240|Droxidopa|droxidopa|mesh-list
153917583|NCT01176240|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
153344518|NCT00004102|Leucovorin|leucovorin|mesh-list
153917584|NCT01176240|Diuretics|diuretics|mesh-ancestor
153917585|NCT01176240|Natriuretic Agents|natriuretic agents|mesh-ancestor
153917586|NCT01176240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153917587|NCT01176240|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
153917588|NCT01176240|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
153917589|NCT01149096|Lenograstim|lenograstim|mesh-list
153895194|NCT04917406|Antiemetics|antiemetics|mesh-ancestor
153917590|NCT01149096|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153917591|NCT01149096|Immunologic Factors|immunologic factors|mesh-ancestor
153917592|NCT01149096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153917593|NCT02867397|Oxaliplatin|oxaliplatin|mesh-list
153917594|NCT02867397|Epirubicin|epirubicin|mesh-list
153917595|NCT02867397|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153344519|NCT00004102|Fluorouracil|fluorouracil|mesh-list
153344520|NCT00004102|Oxaliplatin|oxaliplatin|mesh-list
153344521|NCT00004102|Calcium|calcium|mesh-list
153344522|NCT00004102|Levoleucovorin|levoleucovorin|mesh-list
153344523|NCT00004102|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153344524|NCT00004102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153344525|NCT00004102|Antimetabolites|antimetabolites|mesh-ancestor
153344526|NCT00004102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153917596|NCT02867397|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153344527|NCT00004102|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153917597|NCT02867397|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153917598|NCT02867397|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153344528|NCT00004102|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153344529|NCT00004102|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153344530|NCT00004102|Immunologic Factors|immunologic factors|mesh-ancestor
153344541|NCT00003880|Antimitotic Agents|antimitotic agents|mesh-ancestor
153344542|NCT00003880|Mitosis Modulators|mitosis modulators|mesh-ancestor
153344543|NCT00003880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153344544|NCT00004108|Exatecan|exatecan|mesh-list
153344545|NCT00004108|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
153344546|NCT00004108|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153344547|NCT00004108|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153344548|NCT00004108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153344549|NCT00004108|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153344550|NCT00004900|Cyclophosphamide|cyclophosphamide|mesh-list
153344552|NCT00004900|Carboplatin|carboplatin|mesh-list
153344553|NCT00004900|Etoposide|etoposide|mesh-list
153344554|NCT00004900|Anastrozole|anastrozole|mesh-list
153344555|NCT00004900|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153344556|NCT00004900|Immunologic Factors|immunologic factors|mesh-ancestor
153344557|NCT00004900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153344558|NCT00004900|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153917613|NCT01175382|Cholinergic Agents|cholinergic agents|mesh-ancestor
153917614|NCT01194245|Insulin|insulin|mesh-list
153917615|NCT01194245|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
153917616|NCT01194245|Insulin Glargine|insulin glargine|mesh-list
153917617|NCT01194245|Insulin Aspart|insulin aspart|mesh-list
153917618|NCT01194245|Insulin Lispro|insulin lispro|mesh-list
153917619|NCT01194245|Insulin glulisine|insulin glulisine|mesh-list
153344559|NCT00004900|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153344560|NCT00004900|Alkylating Agents|alkylating agents|mesh-ancestor
153344561|NCT00004900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153344562|NCT00004900|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153344563|NCT00004900|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153344564|NCT00004900|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153917620|NCT01194245|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153917621|NCT01194245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153344565|NCT00004900|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153917622|NCT00979407|Vaccines|vaccines|mesh-list
153917625|NCT00975975|Basiliximab|basiliximab|mesh-list
153344568|NCT00004900|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153344569|NCT00004900|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
153344570|NCT00004900|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153344571|NCT00004900|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
153344572|NCT00004900|Hormone Antagonists|hormone antagonists|mesh-ancestor
153344573|NCT00004900|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153344574|NCT00004114|Cytarabine|cytarabine|mesh-list
153344575|NCT00004114|Cyclophosphamide|cyclophosphamide|mesh-list
153344576|NCT00004114|Fludarabine|fludarabine|mesh-list
153344577|NCT00004114|Fludarabine phosphate|fludarabine phosphate|mesh-list
153344578|NCT00004114|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153344579|NCT00004114|Immunologic Factors|immunologic factors|mesh-ancestor
153344580|NCT00004114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153344581|NCT00004114|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153344582|NCT00004114|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153344583|NCT00004114|Alkylating Agents|alkylating agents|mesh-ancestor
153344584|NCT00004114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153344585|NCT00004114|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153344586|NCT00004114|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153344587|NCT00004114|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153344588|NCT00004114|Antimetabolites|antimetabolites|mesh-ancestor
153344589|NCT00004114|Antiviral Agents|antiviral agents|mesh-ancestor
153344590|NCT00004114|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153344591|NCT00004906|Pamidronate|pamidronate|mesh-list
153344592|NCT00004906|Cyclophosphamide|cyclophosphamide|mesh-list
153466389|NCT00359736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153344593|NCT00004906|Thiotepa|thiotepa|mesh-list
153344594|NCT00004906|Carboplatin|carboplatin|mesh-list
153344595|NCT00004906|Docetaxel|docetaxel|mesh-list
153344596|NCT00004906|Doxorubicin|doxorubicin|mesh-list
153344597|NCT00004906|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
153344598|NCT00004906|Etoposide|etoposide|mesh-list
153344599|NCT00004906|Anastrozole|anastrozole|mesh-list
153344600|NCT00004906|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153344601|NCT00004906|Immunologic Factors|immunologic factors|mesh-ancestor
153344602|NCT00004906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153344603|NCT00004906|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153344628|NCT00004918|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153344629|NCT00003892|ISIS 5132|isis 5132|mesh-list
153344630|NCT00003892|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153344631|NCT00003892|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153344632|NCT00003892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153344633|NCT00004132|Cyclophosphamide|cyclophosphamide|mesh-list
153344634|NCT00004132|Ifosfamide|ifosfamide|mesh-list
153344635|NCT00004132|Etoposide|etoposide|mesh-list
153344636|NCT00004132|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153344637|NCT00004132|Immunologic Factors|immunologic factors|mesh-ancestor
153344638|NCT00004132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153344639|NCT00004132|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153344640|NCT00004132|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153917665|NCT01154166|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
153917666|NCT01154166|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
153917667|NCT01154166|Dopamine Agonists|dopamine agonists|mesh-ancestor
153917668|NCT01154166|Dopamine Agents|dopamine agents|mesh-ancestor
153917669|NCT01154166|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153344641|NCT00004132|Alkylating Agents|alkylating agents|mesh-ancestor
153436699|NCT00004070|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153344642|NCT00004132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153344643|NCT00004132|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153344644|NCT00004132|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153344645|NCT00004132|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153344646|NCT00004132|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153344647|NCT00004132|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153344648|NCT00004132|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153344649|NCT00004138|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
153344650|NCT00004138|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
153344652|NCT05776940|Dexamethasone|dexamethasone|mesh-list
153344679|NCT05776407|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153344680|NCT05776407|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153344681|NCT05776407|Alkylating Agents|alkylating agents|mesh-ancestor
153344682|NCT05776407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153344683|NCT05776407|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153344684|NCT05776407|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153344685|NCT05776407|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153880574|NCT01276704|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
153880575|NCT01276704|Estrogens|estrogens|mesh-ancestor
153880576|NCT01276704|Hormones|hormones|mesh-ancestor
153880577|NCT01276704|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153880578|NCT01276704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153880579|NCT01190930|Calcium, Dietary|calcium, dietary|mesh-list
153344686|NCT05776407|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153344687|NCT05776407|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153344688|NCT05776407|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153344690|NCT05776212|Cariostatic Agents|cariostatic agents|mesh-ancestor
153917699|NCT05656079|Antimitotic Agents|antimitotic agents|mesh-ancestor
153917702|NCT05656079|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153344692|NCT05776212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153344693|NCT05776186|Bupivacaine|bupivacaine|mesh-list
153344694|NCT05776186|Anesthetics, Local|anesthetics, local|mesh-ancestor
153344695|NCT05776186|Anesthetics|anesthetics|mesh-ancestor
153344696|NCT05776186|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153783316|NCT04553458|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153344697|NCT05776186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153344699|NCT05776186|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153344700|NCT05776043|Dapagliflozin|dapagliflozin|mesh-list
153344701|NCT05776043|Empagliflozin|empagliflozin|mesh-list
153344702|NCT05776043|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
153466484|NCT00361140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153466486|NCT00361140|Immunologic Factors|immunologic factors|mesh-ancestor
153466487|NCT00361140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153466488|NCT00361140|Alkylating Agents|alkylating agents|mesh-ancestor
153466489|NCT00361140|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153466490|NCT00361140|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153466491|NCT00362466|Imatinib Mesylate|imatinib mesylate|mesh-list
153466493|NCT00362466|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153466494|NCT00362466|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153436864|NCT00003338|Epratuzumab|epratuzumab|mesh-list
153466495|NCT00362466|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153466496|NCT00362466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153466497|NCT00362466|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153466498|NCT00305682|Mycophenolic Acid|mycophenolic acid|mesh-list
153466499|NCT00305682|Sirolimus|sirolimus|mesh-list
153466500|NCT00305682|Cyclophosphamide|cyclophosphamide|mesh-list
153917747|NCT04264078|Melphalan|melphalan|mesh-list
153917748|NCT04264078|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153917749|NCT04264078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153344703|NCT05776043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153344704|NCT05776043|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153344705|NCT05776043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153344706|NCT05775965|Aspirin|aspirin|mesh-list
153344707|NCT05775965|Rivaroxaban|rivaroxaban|mesh-list
153917750|NCT04264078|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153344709|NCT05775965|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153344722|NCT05775965|Antipyretics|antipyretics|mesh-ancestor
153344723|NCT05775965|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
153344724|NCT05775965|Antithrombins|antithrombins|mesh-ancestor
153344725|NCT05775965|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
153344726|NCT05775965|Protease Inhibitors|protease inhibitors|mesh-ancestor
153344727|NCT05775965|Anticoagulants|anticoagulants|mesh-ancestor
153344728|NCT05775874|Tislelizumab|tislelizumab|mesh-list
153344729|NCT05775874|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
153344730|NCT05775874|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153344731|NCT05775874|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153344732|NCT05775874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153344734|NCT05775770|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153344735|NCT05775770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153344736|NCT05775705|Antibodies|antibodies|mesh-list
153917758|NCT00608218|Glucocorticoids|glucocorticoids|mesh-ancestor
153917759|NCT00608218|Hormones|hormones|mesh-ancestor
153917760|NCT00608218|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153917761|NCT00608218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153917762|NCT00608218|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
153917763|NCT02884050|Topiramate|topiramate|mesh-list
153917764|NCT02884050|Anticonvulsants|anticonvulsants|mesh-ancestor
153917765|NCT02884050|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153917766|NCT02884050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153344737|NCT05775705|Immunologic Factors|immunologic factors|mesh-ancestor
153344738|NCT05775705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153344739|NCT05775692|Fluconazole|fluconazole|mesh-list
153344740|NCT05775692|Antifungal Agents|antifungal agents|mesh-ancestor
153344741|NCT05775692|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153344742|NCT05775692|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
153344743|NCT05775692|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153344744|NCT05775692|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153344745|NCT05775692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153344773|NCT00004126|Antimitotic Agents|antimitotic agents|mesh-ancestor
153344774|NCT00004126|Mitosis Modulators|mitosis modulators|mesh-ancestor
153344775|NCT00004126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153344777|NCT05774964|Vitamin A|vitamin a|mesh-list
153344778|NCT05774964|Metronidazole|metronidazole|mesh-list
153344779|NCT05774964|Oxaliplatin|oxaliplatin|mesh-list
153917767|NCT00609934|Sorafenib|sorafenib|mesh-list
153917768|NCT00609934|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153917769|NCT00609934|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153917770|NCT00609934|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153917771|NCT00609934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153917772|NCT01147926|Prucalopride|prucalopride|mesh-list
153917773|NCT01147926|Laxatives|laxatives|mesh-ancestor
153917774|NCT01147926|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153917775|NCT01147926|Serotonin 5-HT4 Receptor Agonists|serotonin 5-ht4 receptor agonists|mesh-ancestor
153344780|NCT05774964|Cetuximab|cetuximab|mesh-list
153344781|NCT05774964|Tegafur|tegafur|mesh-list
153344782|NCT05774964|Vitamins|vitamins|mesh-ancestor
153344783|NCT05774964|Micronutrients|micronutrients|mesh-ancestor
153344784|NCT05774964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153917776|NCT01147926|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
153917777|NCT01147926|Serotonin Agents|serotonin agents|mesh-ancestor
153466501|NCT00305682|Fludarabine|fludarabine|mesh-list
153344785|NCT05774964|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153344786|NCT05774964|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153344787|NCT05774964|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153344788|NCT05774964|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153344789|NCT05774964|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153344790|NCT05774964|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153344791|NCT05774964|Hematinics|hematinics|mesh-ancestor
153344792|NCT05774964|Vitamin B Complex|vitamin b complex|mesh-ancestor
153344793|NCT05774964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153344794|NCT05774964|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153344795|NCT05774964|Antimetabolites|antimetabolites|mesh-ancestor
153344796|NCT05773222|Apixaban|apixaban|mesh-list
153344827|NCT05493475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153344829|NCT05493475|Sensory System Agents|sensory system agents|mesh-ancestor
153344830|NCT05493475|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153344831|NCT05493475|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153344832|NCT05493475|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153344833|NCT05493475|Anesthetics, General|anesthetics, general|mesh-ancestor
153344834|NCT05493475|Anesthetics|anesthetics|mesh-ancestor
153344835|NCT05463341|Fentanyl|fentanyl|mesh-list
153344836|NCT05463341|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153917784|NCT05115136|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
153917785|NCT05115136|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153917786|NCT05115136|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153917787|NCT05115136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153917788|NCT05115136|Anesthetics, Local|anesthetics, local|mesh-ancestor
153917789|NCT05115136|Anesthetics|anesthetics|mesh-ancestor
153917790|NCT05115136|Sensory System Agents|sensory system agents|mesh-ancestor
153917791|NCT05115136|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153917792|NCT05115136|Antiemetics|antiemetics|mesh-ancestor
153917793|NCT05115136|Autonomic Agents|autonomic agents|mesh-ancestor
153917794|NCT05115136|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153917795|NCT05115136|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
153344837|NCT05463341|Narcotics|narcotics|mesh-ancestor
153917796|NCT05115136|Histamine Antagonists|histamine antagonists|mesh-ancestor
153344838|NCT05463341|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153344839|NCT05463341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153344840|NCT05463341|Analgesics|analgesics|mesh-ancestor
153344841|NCT05463341|Sensory System Agents|sensory system agents|mesh-ancestor
153344842|NCT05463341|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153344843|NCT05463341|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153344844|NCT05463341|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153344845|NCT05463341|Anesthetics, General|anesthetics, general|mesh-ancestor
153344846|NCT05463341|Anesthetics|anesthetics|mesh-ancestor
153344847|NCT05376904|Ropivacaine|ropivacaine|mesh-list
153344848|NCT05376904|Anesthetics, Local|anesthetics, local|mesh-ancestor
153344849|NCT05376904|Anesthetics|anesthetics|mesh-ancestor
153344851|NCT05376904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153917807|NCT00608374|Fludarabine phosphate|fludarabine phosphate|mesh-list
153917808|NCT00608374|Chlorambucil|chlorambucil|mesh-list
153917810|NCT00608374|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153917811|NCT00608374|Antimetabolites|antimetabolites|mesh-ancestor
153917812|NCT00608374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153917813|NCT00608374|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153344852|NCT05376904|Sensory System Agents|sensory system agents|mesh-ancestor
153344853|NCT05376904|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153344854|NCT05298670|Metformin|metformin|mesh-list
153344855|NCT05298670|Interferons|interferons|mesh-list
153344856|NCT05298670|Interferon-beta|interferon-beta|mesh-list
153917814|NCT00608374|Immunologic Factors|immunologic factors|mesh-ancestor
153344857|NCT05298670|Interferon beta-1a|interferon beta-1a|mesh-list
153344858|NCT05298670|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153917817|NCT00608374|Alkylating Agents|alkylating agents|mesh-ancestor
153344859|NCT05298670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153344860|NCT05298670|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153344861|NCT05298670|Antiviral Agents|antiviral agents|mesh-ancestor
153344862|NCT05298670|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153344873|NCT05297851|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153466593|NCT00311376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153466594|NCT00311376|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
153466595|NCT00311376|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153466596|NCT02104830|Lenograstim|lenograstim|mesh-list
153466597|NCT02104830|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153466598|NCT02104830|Immunologic Factors|immunologic factors|mesh-ancestor
153917854|NCT04261270|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
153917855|NCT04261270|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
153917856|NCT04261270|Protease Inhibitors|protease inhibitors|mesh-ancestor
153917857|NCT04261270|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153917858|NCT04261270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153917859|NCT04261270|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153917860|NCT04261270|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153917861|NCT04261270|Antiviral Agents|antiviral agents|mesh-ancestor
153917862|NCT04261270|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153917863|NCT04261270|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
153344874|NCT05297851|Antimetabolites|antimetabolites|mesh-ancestor
153344875|NCT05297851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153344876|NCT05297851|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153344877|NCT05297851|Vasodilator Agents|vasodilator agents|mesh-ancestor
153344878|NCT05297851|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
153344879|NCT05297851|Dermatologic Agents|dermatologic agents|mesh-ancestor
153344881|NCT05252598|Hallucinogens|hallucinogens|mesh-ancestor
153344882|NCT05252598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153344883|NCT05252598|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153344884|NCT05180006|Bevacizumab|bevacizumab|mesh-list
153344885|NCT05180006|Trastuzumab|trastuzumab|mesh-list
153344886|NCT05180006|Atezolizumab|atezolizumab|mesh-list
153344887|NCT05180006|Pertuzumab|pertuzumab|mesh-list
153917864|NCT04261270|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153917865|NCT01152996|Vortioxetine|vortioxetine|mesh-list
153344888|NCT05180006|Ipatasertib|ipatasertib|mesh-list
153344889|NCT05180006|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153344890|NCT05180006|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153344891|NCT05180006|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153917867|NCT01152996|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153344892|NCT05180006|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153344893|NCT05180006|Growth Substances|growth substances|mesh-ancestor
153344894|NCT05180006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153344895|NCT05180006|Growth Inhibitors|growth inhibitors|mesh-ancestor
153344896|NCT05180006|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153344897|NCT05180006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153344898|NCT05180006|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153344899|NCT05180006|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153344901|NCT05148884|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
153344902|NCT05148884|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
153344903|NCT05148884|Serotonin Agents|serotonin agents|mesh-ancestor
153344904|NCT05148884|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153344905|NCT05148884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153344906|NCT05148884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153344907|NCT05042817|Sufentanil|sufentanil|mesh-list
153344908|NCT05042817|Morphine|morphine|mesh-list
153344909|NCT05042817|Prilocaine|prilocaine|mesh-list
153344910|NCT05042817|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153344911|NCT05042817|Narcotics|narcotics|mesh-ancestor
153344912|NCT05042817|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153344913|NCT05042817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153344915|NCT05042817|Sensory System Agents|sensory system agents|mesh-ancestor
153344916|NCT05042817|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153344917|NCT05042817|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153344918|NCT05042817|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153917882|NCT00624936|Azacitidine|azacitidine|mesh-list
153344919|NCT05042817|Anesthetics, General|anesthetics, general|mesh-ancestor
153344920|NCT05042817|Anesthetics|anesthetics|mesh-ancestor
153344921|NCT05042817|Anesthetics, Local|anesthetics, local|mesh-ancestor
153344922|NCT04895566|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
153344923|NCT04895566|Antibodies|antibodies|mesh-list
153344924|NCT04895566|Immunoglobulins|immunoglobulins|mesh-list
153344925|NCT04895566|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
153344927|NCT04895566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153344928|NCT04895566|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153344930|NCT04779320|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153344931|NCT04762199|Osimertinib|osimertinib|mesh-list
153344932|NCT04762199|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153344969|NCT04304755|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153344970|NCT04304755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153344972|NCT04273165|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153344973|NCT04273165|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153344974|NCT04273165|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153344975|NCT04273165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153344976|NCT04273165|Antiviral Agents|antiviral agents|mesh-ancestor
153344977|NCT04273165|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153344978|NCT04179968|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
153344979|NCT04179968|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
153344980|NCT04179968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153344981|NCT04041128|Olaparib|olaparib|mesh-list
153344982|NCT04041128|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
153344983|NCT04041128|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153466663|NCT00390234|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153466664|NCT00390234|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153466665|NCT00390234|Growth Substances|growth substances|mesh-ancestor
153917917|NCT01152450|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153917918|NCT01152450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153917919|NCT00610246|Sorafenib|sorafenib|mesh-list
153917920|NCT00610246|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153917921|NCT00610246|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153917922|NCT00610246|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153917923|NCT00610246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153344985|NCT04041128|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153344986|NCT04030962|Lifitegrast|lifitegrast|mesh-list
153344987|NCT04030962|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
153344988|NCT04030962|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
153344989|NCT03951753|Semaglutide|semaglutide|mesh-list
153344990|NCT03951753|Tirzepatide|tirzepatide|mesh-list
153344991|NCT03951753|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
153344992|NCT03951753|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153344994|NCT03951753|Incretins|incretins|mesh-ancestor
153917952|NCT00977379|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153917953|NCT00977379|Antimetabolites|antimetabolites|mesh-ancestor
153917954|NCT00977379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153917955|NCT00977379|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153917956|NCT04263844|Midazolam|midazolam|mesh-list
153917957|NCT04263844|Dexmedetomidine|dexmedetomidine|mesh-list
153917958|NCT04263844|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153917959|NCT04263844|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153917960|NCT04263844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153917961|NCT04263844|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153345022|NCT03603184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153345023|NCT03603184|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153345024|NCT03603184|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153345025|NCT03507452|BAY 2287411|bay 2287411|mesh-list
153345026|NCT03507452|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
153345027|NCT03507452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153345028|NCT03493490|Diclofenac|diclofenac|mesh-list
153345029|NCT03493490|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153345030|NCT03493490|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153917962|NCT04263844|Analgesics|analgesics|mesh-ancestor
153345031|NCT03493490|Analgesics|analgesics|mesh-ancestor
153345032|NCT03493490|Sensory System Agents|sensory system agents|mesh-ancestor
153917963|NCT04263844|Sensory System Agents|sensory system agents|mesh-ancestor
153917964|NCT04263844|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153917965|NCT04263844|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
153917966|NCT04263844|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153917967|NCT04263844|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153917968|NCT04263844|Adrenergic Agents|adrenergic agents|mesh-ancestor
153917969|NCT04263844|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153917970|NCT04263844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153345034|NCT03493490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153345035|NCT03493490|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153345037|NCT03493490|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153345041|NCT03377491|Gemcitabine|gemcitabine|mesh-list
153345079|NCT02840539|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153345080|NCT02840539|Antiemetics|antiemetics|mesh-ancestor
153345081|NCT02840539|Autonomic Agents|autonomic agents|mesh-ancestor
153345082|NCT02840539|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153466719|NCT00396006|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153917995|NCT02884128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153917996|NCT02884128|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
153917997|NCT02884128|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153917998|NCT02884128|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153917999|NCT02884128|Antidotes|antidotes|mesh-ancestor
153918000|NCT02884128|Protective Agents|protective agents|mesh-ancestor
153918001|NCT02884128|Vitamin B Complex|vitamin b complex|mesh-ancestor
153918002|NCT02884128|Vitamins|vitamins|mesh-ancestor
153918003|NCT02884128|Micronutrients|micronutrients|mesh-ancestor
153345083|NCT02840539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153345084|NCT02840539|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153345085|NCT02840539|Glucocorticoids|glucocorticoids|mesh-ancestor
153345087|NCT02840539|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153345088|NCT02840539|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153345089|NCT02840539|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153345090|NCT02840539|Protease Inhibitors|protease inhibitors|mesh-ancestor
153345091|NCT02840539|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153345092|NCT02840539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153345093|NCT02840539|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153345094|NCT02840539|Antimetabolites|antimetabolites|mesh-ancestor
153345095|NCT02840539|Antiviral Agents|antiviral agents|mesh-ancestor
153345096|NCT02840539|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153345097|NCT02840539|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153918004|NCT00629343|Azacitidine|azacitidine|mesh-list
153918005|NCT00629343|Temozolomide|temozolomide|mesh-list
153918006|NCT00629343|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153918007|NCT00629343|Antimetabolites|antimetabolites|mesh-ancestor
153918008|NCT00629343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153918009|NCT00629343|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153918010|NCT00629343|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153918011|NCT00629343|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153345098|NCT02840539|Immunologic Factors|immunologic factors|mesh-ancestor
153345099|NCT02291055|Durvalumab|durvalumab|mesh-list
153345100|NCT02291055|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153345101|NCT02291055|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153345102|NCT02112864|Dexamethasone|dexamethasone|mesh-list
153345103|NCT02112864|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153345104|NCT02112864|Antiemetics|antiemetics|mesh-ancestor
153345105|NCT02112864|Autonomic Agents|autonomic agents|mesh-ancestor
153345106|NCT02112864|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153345107|NCT02112864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153345108|NCT02112864|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153345109|NCT02112864|Glucocorticoids|glucocorticoids|mesh-ancestor
153345123|NCT00723697|Sensory System Agents|sensory system agents|mesh-ancestor
153345124|NCT00723697|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153345125|NCT00723697|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
153345126|NCT00684073|Buprenorphine|buprenorphine|mesh-list
153345127|NCT00684073|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
153345128|NCT00684073|Naloxone|naloxone|mesh-list
153345129|NCT00684073|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153345130|NCT00684073|Narcotics|narcotics|mesh-ancestor
153345131|NCT00684073|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153345132|NCT00684073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153345133|NCT00684073|Analgesics|analgesics|mesh-ancestor
153345134|NCT00684073|Sensory System Agents|sensory system agents|mesh-ancestor
153345135|NCT00684073|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153918026|NCT01180049|Antifungal Agents|antifungal agents|mesh-ancestor
153918027|NCT01147458|Naproxen|naproxen|mesh-list
153918028|NCT01147458|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153918029|NCT01147458|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153918030|NCT01147458|Analgesics|analgesics|mesh-ancestor
153918031|NCT01147458|Sensory System Agents|sensory system agents|mesh-ancestor
153918032|NCT01147458|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153918033|NCT01147458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153918034|NCT01147458|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153918035|NCT01147458|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153918036|NCT01147458|Gout Suppressants|gout suppressants|mesh-ancestor
153918037|NCT01147458|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153345136|NCT00684073|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
153345137|NCT00603109|Rimonabant|rimonabant|mesh-list
153466720|NCT00396006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153918047|NCT01172808|Respiratory System Agents|respiratory system agents|mesh-ancestor
153918048|NCT01172808|Parasympatholytics|parasympatholytics|mesh-ancestor
153918049|NCT01172808|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
153918050|NCT01172808|Cholinergic Agents|cholinergic agents|mesh-ancestor
153918051|NCT01172808|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153918052|NCT01172808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153918053|NCT01172808|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
153918054|NCT01172808|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
153918055|NCT01172808|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153918056|NCT01172808|Adrenergic Agents|adrenergic agents|mesh-ancestor
153918057|NCT04315194|Clarithromycin|clarithromycin|mesh-list
153918058|NCT04315194|Oseltamivir|oseltamivir|mesh-list
153345138|NCT00603109|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
153345139|NCT00603109|Cannabinoid Receptor Antagonists|cannabinoid receptor antagonists|mesh-ancestor
153345140|NCT00603109|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
153345141|NCT00603109|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153345142|NCT00603109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153345143|NCT00603109|Hormones|hormones|mesh-ancestor
153345144|NCT00603109|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153345145|NCT00603109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153345146|NCT00199095|Cytarabine|cytarabine|mesh-list
153378195|NCT02625480|Brexucabtagene autoleucel|brexucabtagene autoleucel|mesh-list
153378196|NCT02625480|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153378197|NCT02625480|Immunologic Factors|immunologic factors|mesh-ancestor
153378198|NCT02625480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153345147|NCT00199095|Dexamethasone|dexamethasone|mesh-list
153345148|NCT00199095|Cyclophosphamide|cyclophosphamide|mesh-list
153345149|NCT00199095|Ifosfamide|ifosfamide|mesh-list
153345150|NCT00199095|Methotrexate|methotrexate|mesh-list
153345151|NCT00199095|Vincristine|vincristine|mesh-list
153345152|NCT00199095|Doxorubicin|doxorubicin|mesh-list
153345153|NCT00199095|Mercaptopurine|mercaptopurine|mesh-list
153345155|NCT00199095|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153345156|NCT00199095|Immunologic Factors|immunologic factors|mesh-ancestor
153345167|NCT00199095|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153345168|NCT00199095|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153345169|NCT00199095|Glucocorticoids|glucocorticoids|mesh-ancestor
153345171|NCT00199095|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153345172|NCT00199095|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153345173|NCT00199095|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
153918059|NCT04315194|Naproxen|naproxen|mesh-list
153918060|NCT04315194|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153918061|NCT04315194|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153345174|NCT00199095|Abortifacient Agents|abortifacient agents|mesh-ancestor
153345175|NCT00199095|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153918069|NCT04315194|Analgesics|analgesics|mesh-ancestor
153345176|NCT00199095|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153345177|NCT00199095|Antimetabolites|antimetabolites|mesh-ancestor
153345178|NCT00199095|Dermatologic Agents|dermatologic agents|mesh-ancestor
153345179|NCT00199095|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153345182|NCT00199095|Antiviral Agents|antiviral agents|mesh-ancestor
153345231|NCT00199056|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153345232|NCT00199056|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153345233|NCT00199056|Antiviral Agents|antiviral agents|mesh-ancestor
153345235|NCT00199056|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153345237|NCT00199056|Antimitotic Agents|antimitotic agents|mesh-ancestor
153345238|NCT00199056|Mitosis Modulators|mitosis modulators|mesh-ancestor
153345239|NCT00199056|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153345240|NCT00199056|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153345241|NCT00199056|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153345242|NCT00199030|Alemtuzumab|alemtuzumab|mesh-list
153345243|NCT00199030|Cladribine|cladribine|mesh-list
153345244|NCT00199030|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153345245|NCT00199030|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153345246|NCT00199030|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153345247|NCT00199030|Immunologic Factors|immunologic factors|mesh-ancestor
153345248|NCT00199030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153345249|NCT00198978|Cytarabine|cytarabine|mesh-list
153345250|NCT00198978|Dexamethasone|dexamethasone|mesh-list
153918080|NCT01149486|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153918081|NCT01149486|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153918082|NCT01149486|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
153918083|NCT01149486|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
153918084|NCT01149486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153918085|NCT01149486|Diuretics|diuretics|mesh-ancestor
153918086|NCT01149486|Natriuretic Agents|natriuretic agents|mesh-ancestor
153918087|NCT01149486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153918088|NCT01149486|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
153466797|NCT00405288|Pramoxine|pramoxine|mesh-list
153345251|NCT00198978|Prednisolone|prednisolone|mesh-list
153345252|NCT00198978|Cyclophosphamide|cyclophosphamide|mesh-list
153345253|NCT00198978|Rituximab|rituximab|mesh-list
153345254|NCT00198978|Methotrexate|methotrexate|mesh-list
153345255|NCT00198978|Vincristine|vincristine|mesh-list
153345256|NCT00198978|Asparaginase|asparaginase|mesh-list
153345257|NCT00198978|Mercaptopurine|mercaptopurine|mesh-list
153345258|NCT00198978|Idarubicin|idarubicin|mesh-list
153345270|NCT00198978|Antiemetics|antiemetics|mesh-ancestor
153345282|NCT00198978|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153345283|NCT00198978|Antimetabolites|antimetabolites|mesh-ancestor
153345284|NCT00198978|Dermatologic Agents|dermatologic agents|mesh-ancestor
153345285|NCT00198978|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153345286|NCT00198978|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153345287|NCT00198978|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153345288|NCT00198978|Antiviral Agents|antiviral agents|mesh-ancestor
153345289|NCT00198978|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153918109|NCT00641173|Paroxetine|paroxetine|mesh-list
153918110|NCT00641173|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
153918111|NCT00641173|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153918112|NCT00641173|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153918113|NCT00641173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153918114|NCT00641173|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153918115|NCT00641173|Serotonin Agents|serotonin agents|mesh-ancestor
153918116|NCT00641173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153918117|NCT00641173|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
153918118|NCT00641173|Antidepressive Agents|antidepressive agents|mesh-ancestor
153918119|NCT00641173|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153918120|NCT00641173|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
153345290|NCT00198978|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153345291|NCT00198978|Tubulin Modulators|tubulin modulators|mesh-ancestor
153345292|NCT00198978|Antimitotic Agents|antimitotic agents|mesh-ancestor
153345293|NCT00198978|Mitosis Modulators|mitosis modulators|mesh-ancestor
153345294|NCT00198978|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153345295|NCT00198978|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153345296|NCT00198978|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153345297|NCT00198978|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153918121|NCT00641173|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153345299|NCT00109395|Lorazepam|lorazepam|mesh-list
153345350|NCT00004150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153345351|NCT00004150|Antimetabolites|antimetabolites|mesh-ancestor
153345352|NCT00004150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153345353|NCT00004150|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153345354|NCT00004150|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153345355|NCT00004150|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153345356|NCT00004150|Immunologic Factors|immunologic factors|mesh-ancestor
153345357|NCT00004150|Antidotes|antidotes|mesh-ancestor
153345358|NCT00004150|Protective Agents|protective agents|mesh-ancestor
153345359|NCT00004150|Vitamin B Complex|vitamin b complex|mesh-ancestor
153345360|NCT00004150|Vitamins|vitamins|mesh-ancestor
153345361|NCT00004150|Micronutrients|micronutrients|mesh-ancestor
153345362|NCT00004930|Doxorubicin|doxorubicin|mesh-list
153345363|NCT00004930|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
153345364|NCT00004930|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153345365|NCT00004930|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153345366|NCT00004930|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153345367|NCT00004930|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153345368|NCT00004930|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153345369|NCT00004930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153345370|NCT00003928|Gemcitabine|gemcitabine|mesh-list
153345371|NCT00003928|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153345372|NCT00003928|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153345373|NCT00003928|Antimetabolites|antimetabolites|mesh-ancestor
153345374|NCT00003928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153345375|NCT00004162|Doxorubicin|doxorubicin|mesh-list
153918148|NCT00640549|Atorvastatin|atorvastatin|mesh-list
153918149|NCT00640549|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153918150|NCT00640549|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153918151|NCT00640549|Antimetabolites|antimetabolites|mesh-ancestor
153918152|NCT00640549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153918153|NCT00640549|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153918154|NCT00640549|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
153918155|NCT00640549|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153918156|NCT02683369|Iron|iron|mesh-list
153918157|NCT02683369|Trace Elements|trace elements|mesh-ancestor
153918158|NCT02683369|Micronutrients|micronutrients|mesh-ancestor
153918160|NCT01147068|Hemagglutinins|hemagglutinins|mesh-list
153345377|NCT00004162|Methotrexate|methotrexate|mesh-list
153345378|NCT00004162|Vincristine|vincristine|mesh-list
153345379|NCT00004162|Sargramostim|sargramostim|mesh-list
153345380|NCT00004162|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153345381|NCT00004162|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153345382|NCT00004162|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153345383|NCT00004162|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153345384|NCT00004162|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153345385|NCT00004162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153918181|NCT02681887|Protective Agents|protective agents|mesh-ancestor
153918182|NCT02681887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153918183|NCT02681887|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153918185|NCT01134042|Xhance|xhance|mesh-list
153918186|NCT01134042|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153345386|NCT00004162|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
153345388|NCT00004162|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153345389|NCT00004162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153918187|NCT01134042|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153918188|NCT01134042|Autonomic Agents|autonomic agents|mesh-ancestor
153438129|NCT00004448|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153918190|NCT01134042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153918191|NCT01134042|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153918192|NCT01134042|Respiratory System Agents|respiratory system agents|mesh-ancestor
153918193|NCT01134042|Dermatologic Agents|dermatologic agents|mesh-ancestor
153918194|NCT01134042|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
153918195|NCT01179347|Tiotropium Bromide|tiotropium bromide|mesh-list
153918196|NCT01179347|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153918197|NCT01179347|Autonomic Agents|autonomic agents|mesh-ancestor
153918198|NCT01179347|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153918199|NCT01179347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153345390|NCT00004162|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153918201|NCT01179347|Respiratory System Agents|respiratory system agents|mesh-ancestor
153918202|NCT01179347|Parasympatholytics|parasympatholytics|mesh-ancestor
153918203|NCT01179347|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
153918204|NCT01179347|Cholinergic Agents|cholinergic agents|mesh-ancestor
153345392|NCT00004162|Dermatologic Agents|dermatologic agents|mesh-ancestor
153345394|NCT00004162|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153345395|NCT00004162|Immunologic Factors|immunologic factors|mesh-ancestor
153345396|NCT00004162|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153345397|NCT00004162|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153345398|NCT00004162|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153345399|NCT00004162|Tubulin Modulators|tubulin modulators|mesh-ancestor
153345400|NCT00004162|Antimitotic Agents|antimitotic agents|mesh-ancestor
153345401|NCT00004162|Mitosis Modulators|mitosis modulators|mesh-ancestor
153345402|NCT00004984|Insulin|insulin|mesh-list
153345403|NCT00004984|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
153918205|NCT01179347|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153345405|NCT00004984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153345407|NCT00004174|Cyclophosphamide|cyclophosphamide|mesh-list
153345408|NCT00004174|Thiotepa|thiotepa|mesh-list
153345409|NCT00004174|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153345410|NCT00004174|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153345411|NCT00004174|Tubulin Modulators|tubulin modulators|mesh-ancestor
153345412|NCT00004174|Antimitotic Agents|antimitotic agents|mesh-ancestor
153345413|NCT00004174|Mitosis Modulators|mitosis modulators|mesh-ancestor
153345414|NCT00004174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153345415|NCT00004174|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153345416|NCT00004174|Immunologic Factors|immunologic factors|mesh-ancestor
153345417|NCT00004174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153345428|NCT01284517|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
153918210|NCT01146288|Natriuretic Agents|natriuretic agents|mesh-ancestor
153918211|NCT01146288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153918212|NCT01146288|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
153918213|NCT01146288|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153918215|NCT01146288|Anticonvulsants|anticonvulsants|mesh-ancestor
153345429|NCT01284517|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
153345430|NCT01284517|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
153345431|NCT01284517|Adrenergic Agents|adrenergic agents|mesh-ancestor
153345432|NCT01284517|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153345433|NCT01284517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153345434|NCT01284517|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
153345435|NCT01284517|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153918242|NCT01145898|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153918243|NCT01145898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153918244|NCT01145898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153918245|NCT01145898|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153918246|NCT01145898|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153918247|NCT01145898|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
153918248|NCT01145898|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153897047|NCT00957853|Cetuximab|cetuximab|mesh-list
153345437|NCT01284517|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
153345438|NCT01284517|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
153345439|NCT01284517|Dopamine Agents|dopamine agents|mesh-ancestor
153345440|NCT00004990|Dexamethasone|dexamethasone|mesh-list
153345441|NCT00004990|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153345442|NCT00004990|Antiemetics|antiemetics|mesh-ancestor
153345443|NCT00004990|Autonomic Agents|autonomic agents|mesh-ancestor
153345444|NCT00004990|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153345445|NCT00004990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153345446|NCT00004990|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153345448|NCT00004990|Hormones|hormones|mesh-ancestor
153345449|NCT00004990|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153345450|NCT00004990|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153345483|NCT00005002|Antiviral Agents|antiviral agents|mesh-ancestor
153345484|NCT00005002|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153345485|NCT00005002|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153345486|NCT00005002|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153345487|NCT00005002|Antimetabolites|antimetabolites|mesh-ancestor
153345488|NCT00005002|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
153345489|NCT00005002|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
153345490|NCT00005002|Protease Inhibitors|protease inhibitors|mesh-ancestor
153345491|NCT01264705|Sorafenib|sorafenib|mesh-list
153345492|NCT01264705|Bavituximab|bavituximab|mesh-list
153345493|NCT01264705|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
153345494|NCT01264705|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153345495|NCT01264705|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153345496|NCT01264705|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153345497|NCT01264705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153345498|NCT01264705|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153345499|NCT01264705|Immunologic Factors|immunologic factors|mesh-ancestor
153345500|NCT01264705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153345501|NCT00004204|Temozolomide|temozolomide|mesh-list
153345502|NCT00004204|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153345503|NCT00004204|Alkylating Agents|alkylating agents|mesh-ancestor
153345504|NCT00004204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153345505|NCT00004204|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153345506|NCT01217515|Diltiazem|diltiazem|mesh-list
153345507|NCT01217515|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153345508|NCT01217515|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153467038|NCT00385788|Antilymphocyte Serum|antilymphocyte serum|mesh-list
153467039|NCT00385788|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153467040|NCT00385788|Antimetabolites|antimetabolites|mesh-ancestor
153467041|NCT00385788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153467042|NCT00385788|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153467043|NCT00385788|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
153467044|NCT00385788|Abortifacient Agents|abortifacient agents|mesh-ancestor
153467045|NCT00385788|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153345509|NCT01217515|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153345510|NCT01217515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153345511|NCT01217515|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153345512|NCT01217515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153345526|NCT03009799|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
153345527|NCT03009799|Laxatives|laxatives|mesh-ancestor
153345528|NCT03009799|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153345529|NCT00005026|Paclitaxel|paclitaxel|mesh-list
153345530|NCT00005026|Carboplatin|carboplatin|mesh-list
153345531|NCT00005026|Topotecan|topotecan|mesh-list
153345532|NCT00005026|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153345533|NCT00005026|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153345534|NCT00005026|Tubulin Modulators|tubulin modulators|mesh-ancestor
153345535|NCT00005026|Antimitotic Agents|antimitotic agents|mesh-ancestor
153345536|NCT00005026|Mitosis Modulators|mitosis modulators|mesh-ancestor
153918313|NCT00931918|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153345537|NCT00005026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153345538|NCT00005026|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
153345539|NCT00005026|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153345540|NCT00005026|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153345541|NCT00016718|Emtricitabine|emtricitabine|mesh-list
153345542|NCT00016718|Efavirenz|efavirenz|mesh-list
153345544|NCT00016718|Antiviral Agents|antiviral agents|mesh-ancestor
153345545|NCT00016718|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153345546|NCT00016718|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153345547|NCT00016718|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153345548|NCT00016718|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153345549|NCT00016718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153345550|NCT00016718|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153345551|NCT00016718|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153345552|NCT00016718|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
153345553|NCT00016718|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153345554|NCT00016718|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
153345555|NCT00016718|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
153345556|NCT00016718|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
153345557|NCT00016718|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
153345559|NCT00004216|Ciprofloxacin|ciprofloxacin|mesh-list
153345567|NCT00004216|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153918343|NCT02678221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153918344|NCT02678221|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153918345|NCT02678221|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153918346|NCT02678221|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153345568|NCT00004216|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153918347|NCT02678221|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153467113|NCT00413166|Immunotoxins|immunotoxins|mesh-ancestor
153345570|NCT00004216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153345571|NCT00004216|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153345572|NCT00004216|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
153345573|NCT00004216|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153345574|NCT00004216|Third Generation Cephalosporins|third generation cephalosporins|mesh-ancestor
153345575|NCT00004216|Beta Lactam Antibiotics|beta lactam antibiotics|mesh-ancestor
153345576|NCT00004216|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
153345577|NCT00004216|Antimalarials|antimalarials|mesh-ancestor
153345578|NCT00004216|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153345579|NCT00004216|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153345580|NCT00004216|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153345581|NCT00004216|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
153345582|NCT00004216|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
153345584|NCT00005032|Oblimersen|oblimersen|mesh-list
153345585|NCT00005032|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153345586|NCT00005032|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153345587|NCT00005032|Tubulin Modulators|tubulin modulators|mesh-ancestor
153345588|NCT00005032|Antimitotic Agents|antimitotic agents|mesh-ancestor
153345589|NCT00005032|Mitosis Modulators|mitosis modulators|mesh-ancestor
153345590|NCT00005032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153345591|NCT00005038|Aldesleukin|aldesleukin|mesh-list
153345592|NCT00005038|Histamine|histamine|mesh-list
153345593|NCT00005038|Histamine phosphate|histamine phosphate|mesh-list
153345594|NCT00005038|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153345596|NCT00005038|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153345597|NCT00005038|Antiviral Agents|antiviral agents|mesh-ancestor
153345598|NCT00005038|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153345599|NCT00005038|Histamine Agonists|histamine agonists|mesh-ancestor
153467141|NCT00387036|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153467142|NCT00387036|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153467143|NCT00387036|Autonomic Agents|autonomic agents|mesh-ancestor
153467144|NCT00387036|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153467145|NCT00387036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153467146|NCT00387036|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153467148|NCT00387036|Dermatologic Agents|dermatologic agents|mesh-ancestor
153345600|NCT00005038|Histamine Agents|histamine agents|mesh-ancestor
153345601|NCT00005038|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153345602|NCT00005038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153345603|NCT00005038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153345604|NCT00019682|Aldesleukin|aldesleukin|mesh-list
153345606|NCT00019682|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153345607|NCT00019682|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153345608|NCT00019682|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153345609|NCT00019682|Antiviral Agents|antiviral agents|mesh-ancestor
153345610|NCT00019682|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153345611|NCT00019682|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153345612|NCT00019682|Immunologic Factors|immunologic factors|mesh-ancestor
153345613|NCT00019682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153345614|NCT00005050|Fluorouracil|fluorouracil|mesh-list
153345615|NCT00005050|Oxaliplatin|oxaliplatin|mesh-list
153345616|NCT00005050|Eniluracil|eniluracil|mesh-list
153345617|NCT00005050|Antimetabolites|antimetabolites|mesh-ancestor
153345618|NCT00005050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153345619|NCT00005050|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153345620|NCT00005050|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153345621|NCT00005050|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153345623|NCT00005050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153345624|NCT00005050|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153345625|NCT00005578|Prednisone|prednisone|mesh-list
153345626|NCT00005578|Cyclophosphamide|cyclophosphamide|mesh-list
153345627|NCT00005578|Doxorubicin|doxorubicin|mesh-list
153345628|NCT00005578|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
153345629|NCT00005578|Etoposide|etoposide|mesh-list
153345630|NCT00005578|Vincristine|vincristine|mesh-list
153345631|NCT00005578|Bleomycin|bleomycin|mesh-list
153345661|NCT00022490|Imatinib Mesylate|imatinib mesylate|mesh-list
153918410|NCT02678767|Hematinics|hematinics|mesh-ancestor
153918411|NCT02678767|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
153918412|NCT02678767|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
153345662|NCT00022490|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153918413|NCT00931762|Panobinostat|panobinostat|mesh-list
153345663|NCT00022490|Antimetabolites|antimetabolites|mesh-ancestor
153345664|NCT00022490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153918414|NCT00931762|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153345665|NCT00022490|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153345666|NCT00022490|Antiviral Agents|antiviral agents|mesh-ancestor
153345667|NCT00022490|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153345668|NCT00022490|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153345669|NCT00022490|Immunologic Factors|immunologic factors|mesh-ancestor
153345670|NCT00022490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153345675|NCT00386230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153345676|NCT00386230|Antimetabolites|antimetabolites|mesh-ancestor
153345677|NCT00386230|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153345678|NCT00386230|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153345679|NCT00386230|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153345680|NCT00386230|Antiviral Agents|antiviral agents|mesh-ancestor
153345681|NCT00386230|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153345682|NCT00386230|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153345683|NCT00386230|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153918434|NCT02677519|Methylphenidate|methylphenidate|mesh-list
153918435|NCT02677519|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
153918439|NCT02677519|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153918440|NCT02677519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153918441|NCT02677519|Dopamine Agents|dopamine agents|mesh-ancestor
153918442|NCT02677519|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153918443|NCT01145508|Metronidazole|metronidazole|mesh-list
153918444|NCT01145508|Prednisone|prednisone|mesh-list
153918445|NCT01145508|Cortisone|cortisone|mesh-list
153918446|NCT01145508|Docetaxel|docetaxel|mesh-list
153345685|NCT00097448|Methylprednisolone|methylprednisolone|mesh-list
153345686|NCT00097448|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
153345687|NCT00097448|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
153345688|NCT00097448|Prednisolone|prednisolone|mesh-list
153345689|NCT00097448|Prednisolone acetate|prednisolone acetate|mesh-list
153345690|NCT00097448|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
153345691|NCT00097448|Prednisolone phosphate|prednisolone phosphate|mesh-list
153345692|NCT00097448|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153345693|NCT00097448|Glucocorticoids|glucocorticoids|mesh-ancestor
153345694|NCT00097448|Hormones|hormones|mesh-ancestor
153918447|NCT01145508|Vaccines|vaccines|mesh-list
153345698|NCT00097448|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153918448|NCT01145508|Immunologic Factors|immunologic factors|mesh-ancestor
153345710|NCT00004246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153345711|NCT00004246|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153345712|NCT00004246|Immunologic Factors|immunologic factors|mesh-ancestor
153345713|NCT00004246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153345714|NCT00028262|Cysteamine|cysteamine|mesh-list
153345715|NCT00028262|Cystine Depleting Agents|cystine depleting agents|mesh-ancestor
153345716|NCT00028262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153345717|NCT00005056|Bryostatin 1|bryostatin 1|mesh-list
153345718|NCT00005056|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153345720|NCT00005056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153345721|NCT00005056|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153345723|NCT00004252|Fluorouracil|fluorouracil|mesh-list
153345724|NCT00004252|Calcium|calcium|mesh-list
153345725|NCT00004252|Levoleucovorin|levoleucovorin|mesh-list
153345726|NCT00004252|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153345727|NCT00004252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153345728|NCT00004252|Antimetabolites|antimetabolites|mesh-ancestor
153345729|NCT00004252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153345730|NCT00004252|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153345731|NCT00004252|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153345732|NCT00004252|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153345733|NCT00004252|Immunologic Factors|immunologic factors|mesh-ancestor
153345734|NCT00004252|Antidotes|antidotes|mesh-ancestor
153345735|NCT00004252|Protective Agents|protective agents|mesh-ancestor
153345736|NCT00004252|Vitamin B Complex|vitamin b complex|mesh-ancestor
153345737|NCT00004252|Vitamins|vitamins|mesh-ancestor
153345738|NCT00004252|Micronutrients|micronutrients|mesh-ancestor
153345739|NCT00005590|Levofloxacin|levofloxacin|mesh-list
153345740|NCT00005590|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
153345751|NCT00005596|Cytarabine|cytarabine|mesh-list
153345753|NCT00005596|Cyclophosphamide|cyclophosphamide|mesh-list
153345754|NCT00005596|Methotrexate|methotrexate|mesh-list
153345755|NCT00005596|Vincristine|vincristine|mesh-list
153345756|NCT00005596|Daunorubicin|daunorubicin|mesh-list
153918533|NCT01145352|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153918534|NCT01145352|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153918535|NCT01145352|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153918536|NCT01145352|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153918537|NCT01145352|Immunologic Factors|immunologic factors|mesh-ancestor
153918538|NCT01178099|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
153467289|NCT00425802|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153467290|NCT00425802|Antifungal Agents|antifungal agents|mesh-ancestor
153467291|NCT00425802|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153467292|NCT00425802|Dermatologic Agents|dermatologic agents|mesh-ancestor
153467293|NCT00425802|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
153345757|NCT00005596|Mercaptopurine|mercaptopurine|mesh-list
153345758|NCT00005596|Pegaspargase|pegaspargase|mesh-list
153345759|NCT00005596|Thioguanine|thioguanine|mesh-list
153897658|NCT01228734|Leucovorin|leucovorin|mesh-list
153467294|NCT00425802|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153345760|NCT00005596|Levoleucovorin|levoleucovorin|mesh-list
153345761|NCT00005596|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153345762|NCT00005596|Immunologic Factors|immunologic factors|mesh-ancestor
153345763|NCT00005596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153345764|NCT00005596|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153345765|NCT00005596|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153345766|NCT00005596|Alkylating Agents|alkylating agents|mesh-ancestor
153345767|NCT00005596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153345768|NCT00005596|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153345769|NCT00005596|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153345770|NCT00005596|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153345771|NCT00005596|Antiemetics|antiemetics|mesh-ancestor
153345772|NCT00005596|Autonomic Agents|autonomic agents|mesh-ancestor
153345773|NCT00005596|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153345774|NCT00005596|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153345775|NCT00005596|Glucocorticoids|glucocorticoids|mesh-ancestor
153345777|NCT00005596|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153345778|NCT00005596|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153345779|NCT00005596|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
153345780|NCT00005596|Abortifacient Agents|abortifacient agents|mesh-ancestor
153345781|NCT00005596|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153345782|NCT00005596|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153345783|NCT00005596|Antimetabolites|antimetabolites|mesh-ancestor
153345784|NCT00005596|Dermatologic Agents|dermatologic agents|mesh-ancestor
153345785|NCT00005596|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153345786|NCT00005596|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153345787|NCT00005596|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153345795|NCT00005596|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153345796|NCT00005596|Tubulin Modulators|tubulin modulators|mesh-ancestor
153345797|NCT00005596|Antimitotic Agents|antimitotic agents|mesh-ancestor
153345798|NCT00005596|Mitosis Modulators|mitosis modulators|mesh-ancestor
153345799|NCT00005596|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153345800|NCT00005596|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153345801|NCT00005596|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153345802|NCT00005068|Leucovorin|leucovorin|mesh-list
153345803|NCT00005068|Fluorouracil|fluorouracil|mesh-list
153345804|NCT00005068|Oxaliplatin|oxaliplatin|mesh-list
153345805|NCT00005068|Irinotecan|irinotecan|mesh-list
153345806|NCT00005068|Calcium|calcium|mesh-list
153345807|NCT00005068|Levoleucovorin|levoleucovorin|mesh-list
153345808|NCT00005068|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153345809|NCT00005068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153345810|NCT00005068|Antimetabolites|antimetabolites|mesh-ancestor
153345811|NCT00005068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153345812|NCT00005068|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153345813|NCT00005068|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153345814|NCT00005068|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153345815|NCT00005068|Immunologic Factors|immunologic factors|mesh-ancestor
153345816|NCT00005068|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
153345817|NCT00005068|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153345818|NCT00005068|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153345820|NCT00005068|Protective Agents|protective agents|mesh-ancestor
153345821|NCT00005068|Vitamin B Complex|vitamin b complex|mesh-ancestor
153345824|NCT00004264|Docetaxel|docetaxel|mesh-list
153345825|NCT00004264|Amifostine|amifostine|mesh-list
153345826|NCT00004264|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153345827|NCT00004264|Tubulin Modulators|tubulin modulators|mesh-ancestor
153345843|NCT00005602|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153345844|NCT00004276|Thalidomide|thalidomide|mesh-list
153345845|NCT00004276|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153345846|NCT00004276|Immunologic Factors|immunologic factors|mesh-ancestor
153345847|NCT00004276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153345848|NCT00004276|Leprostatic Agents|leprostatic agents|mesh-ancestor
153345849|NCT00004276|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153467363|NCT00533442|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153918640|NCT01168596|Protective Agents|protective agents|mesh-ancestor
153918641|NCT01168596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153918642|NCT02675647|Heparin|heparin|mesh-list
153918643|NCT02675647|Protamines|protamines|mesh-list
153918644|NCT02675647|Anticoagulants|anticoagulants|mesh-ancestor
153918645|NCT02675647|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153918646|NCT02675647|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153345850|NCT00004276|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153345851|NCT00004276|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153345852|NCT00004276|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153345853|NCT00004276|Growth Substances|growth substances|mesh-ancestor
153345854|NCT00004276|Growth Inhibitors|growth inhibitors|mesh-ancestor
153345855|NCT00004276|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153918647|NCT02675647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153918648|NCT02675647|Heparin Antagonists|heparin antagonists|mesh-ancestor
153345857|NCT00004288|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153345858|NCT00004288|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153345859|NCT00004288|Analgesics|analgesics|mesh-ancestor
153345860|NCT00004288|Sensory System Agents|sensory system agents|mesh-ancestor
153345861|NCT00004288|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153345862|NCT00004288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153345863|NCT00004288|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153345896|NCT00101036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153345897|NCT00101036|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153345899|NCT00004300|Sertraline|sertraline|mesh-list
153345900|NCT00004300|Antidepressive Agents|antidepressive agents|mesh-ancestor
153345901|NCT00004300|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153345902|NCT00004300|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
153345903|NCT00004300|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153345904|NCT00004300|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153345905|NCT00004300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153345906|NCT00004300|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153345907|NCT00004300|Serotonin Agents|serotonin agents|mesh-ancestor
153345908|NCT00004300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153345909|NCT00004300|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
153918669|NCT00610948|Antidotes|antidotes|mesh-ancestor
153918670|NCT00610948|Protective Agents|protective agents|mesh-ancestor
153918671|NCT00610948|Vitamin B Complex|vitamin b complex|mesh-ancestor
153918672|NCT00610948|Vitamins|vitamins|mesh-ancestor
153918673|NCT00610948|Micronutrients|micronutrients|mesh-ancestor
153345910|NCT00004300|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
153345911|NCT00004300|Hormone Antagonists|hormone antagonists|mesh-ancestor
153918679|NCT02675413|Dermatologic Agents|dermatologic agents|mesh-ancestor
153918680|NCT02675413|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153345912|NCT00004300|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153345915|NCT00005626|Irinotecan|irinotecan|mesh-list
153345953|NCT00005104|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153345954|NCT00005104|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
153345955|NCT00005104|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
153345957|NCT00005110|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
153345958|NCT00005110|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153345959|NCT00005110|Autonomic Agents|autonomic agents|mesh-ancestor
153345960|NCT00005110|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153345961|NCT00005110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153345962|NCT00005110|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153345963|NCT00005110|Respiratory System Agents|respiratory system agents|mesh-ancestor
153345964|NCT00005110|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
153345965|NCT00005110|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
153345967|NCT00005110|Adrenergic Agents|adrenergic agents|mesh-ancestor
153345968|NCT00005110|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153423409|NCT03242408|Hormones|hormones|mesh-ancestor
153345969|NCT00005110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153345970|NCT00005110|Tocolytic Agents|tocolytic agents|mesh-ancestor
153346008|NCT00030992|Antipruritics|antipruritics|mesh-ancestor
153346009|NCT00030992|Dermatologic Agents|dermatologic agents|mesh-ancestor
153346010|NCT00030992|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
153346011|NCT00030992|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
153346012|NCT00004360|Chlorothiazide|chlorothiazide|mesh-list
153346013|NCT00004360|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153467472|NCT00431184|Analgesics|analgesics|mesh-ancestor
153467473|NCT00431184|Sensory System Agents|sensory system agents|mesh-ancestor
153467474|NCT00431184|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153467475|NCT00431184|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
153467476|NCT00535938|Botulinum Toxins|botulinum toxins|mesh-list
153467477|NCT00535938|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
153346014|NCT00004360|Diuretics|diuretics|mesh-ancestor
153346015|NCT00004360|Natriuretic Agents|natriuretic agents|mesh-ancestor
153346016|NCT00004360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153346017|NCT00004360|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
153346018|NCT00004360|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153897861|NCT02853253|SMOFlipid|smoflipid|mesh-list
153467487|NCT01795794|Omeprazole|omeprazole|mesh-list
153346019|NCT00004360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153346022|NCT00385450|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
153346023|NCT00385450|Protease Inhibitors|protease inhibitors|mesh-ancestor
153346024|NCT00385450|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153346025|NCT00385450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153346026|NCT00385450|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153346027|NCT00385450|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153346028|NCT00385450|Antiviral Agents|antiviral agents|mesh-ancestor
153346029|NCT00385450|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153346030|NCT00004390|Morphine|morphine|mesh-list
153346031|NCT00004390|Methadone|methadone|mesh-list
153346032|NCT00004390|Nortriptyline|nortriptyline|mesh-list
153346033|NCT00004390|Desipramine|desipramine|mesh-list
153346034|NCT00004390|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153346035|NCT00004390|Narcotics|narcotics|mesh-ancestor
153346036|NCT00004390|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153346037|NCT00004390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153346038|NCT00004390|Analgesics|analgesics|mesh-ancestor
153346039|NCT00004390|Sensory System Agents|sensory system agents|mesh-ancestor
153346040|NCT00004390|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153346041|NCT00004390|Antitussive Agents|antitussive agents|mesh-ancestor
153346042|NCT00004390|Respiratory System Agents|respiratory system agents|mesh-ancestor
153346043|NCT00004390|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
153346044|NCT00004390|Antidepressive Agents|antidepressive agents|mesh-ancestor
153346045|NCT00004390|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153346046|NCT00004390|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
153346047|NCT00004390|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153346048|NCT00004390|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153346049|NCT00004390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153346050|NCT00004390|Adrenergic Agents|adrenergic agents|mesh-ancestor
153346051|NCT00004390|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153467489|NCT01795794|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153346052|NCT00004390|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153346053|NCT00004396|Tin mesoporphyrin|tin mesoporphyrin|mesh-list
153423418|NCT03211117|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
153423419|NCT03211117|Pembrolizumab|pembrolizumab|mesh-list
153882519|NCT01684085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153882520|NCT01684241|Vaccines|vaccines|mesh-list
153346054|NCT00004396|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153346055|NCT00004396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153346056|NCT00004402|Calcitriol|calcitriol|mesh-list
153346057|NCT00004402|Interferons|interferons|mesh-list
153346058|NCT00004402|Interferon-gamma|interferon-gamma|mesh-list
153346059|NCT00004402|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153346060|NCT00004402|Antiviral Agents|antiviral agents|mesh-ancestor
153346061|NCT00004402|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153346062|NCT00004402|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153346063|NCT00004402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153346064|NCT00004402|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
153346065|NCT00004402|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153346066|NCT00004402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153346067|NCT00004402|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
153346068|NCT00004402|Vitamins|vitamins|mesh-ancestor
153346069|NCT00004402|Micronutrients|micronutrients|mesh-ancestor
153346070|NCT00004402|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153346071|NCT00004420|Evening primrose oil|evening primrose oil|mesh-list
153346092|NCT00004426|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153346093|NCT00004426|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153346094|NCT00004438|Leuprolide|leuprolide|mesh-list
153346095|NCT00004438|Fertility Agents, Female|fertility agents, female|mesh-ancestor
153346097|NCT00004438|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153346098|NCT00004438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153346099|NCT00004438|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153346100|NCT00004438|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153346102|NCT01217749|Ibrutinib|ibrutinib|mesh-list
153346103|NCT01217749|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153346104|NCT01217749|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153346105|NCT01217749|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153346106|NCT01217749|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153346107|NCT01217749|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153346108|NCT02197273|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
153346109|NCT02197273|Epinephrine|epinephrine|mesh-list
153346110|NCT02197273|Fentanyl|fentanyl|mesh-list
153346111|NCT02197273|Morphine|morphine|mesh-list
153346112|NCT02197273|Bupivacaine|bupivacaine|mesh-list
153346113|NCT02197273|Ropivacaine|ropivacaine|mesh-list
153346114|NCT02197273|Anesthetics, Local|anesthetics, local|mesh-ancestor
153346116|NCT02197273|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153346117|NCT02197273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153346146|NCT02197273|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153346147|NCT00004444|Paromomycin|paromomycin|mesh-list
153346148|NCT00004444|Streptomycin|streptomycin|mesh-list
153346149|NCT00004444|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153918830|NCT05911126|Analgesics|analgesics|mesh-ancestor
153783317|NCT04553458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153918831|NCT05911126|Sensory System Agents|sensory system agents|mesh-ancestor
153346150|NCT00004444|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153783318|NCT04553458|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
153346153|NCT00004444|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
153346154|NCT00004444|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153346155|NCT00004444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153346156|NCT00004450|Interferons|interferons|mesh-list
153346157|NCT00004450|Interferon-beta|interferon-beta|mesh-list
153346158|NCT00004450|Thalidomide|thalidomide|mesh-list
153346159|NCT00004450|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153346160|NCT00004450|Antiviral Agents|antiviral agents|mesh-ancestor
153346161|NCT00004450|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153346162|NCT00004450|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153346163|NCT00004450|Immunologic Factors|immunologic factors|mesh-ancestor
153346199|NCT00005764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153346200|NCT00005764|Antiviral Agents|antiviral agents|mesh-ancestor
153346201|NCT00005764|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153346202|NCT00005764|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153346203|NCT00005764|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153346204|NCT00005764|Antimetabolites|antimetabolites|mesh-ancestor
153918907|NCT05907902|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153918908|NCT05907902|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153346206|NCT01289275|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
153346207|NCT01289275|Autonomic Agents|autonomic agents|mesh-ancestor
153346208|NCT01289275|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153346209|NCT01289275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153346210|NCT01289275|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
153346211|NCT01289275|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
153346212|NCT01289275|Cholinergic Agents|cholinergic agents|mesh-ancestor
153346213|NCT01289275|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153346214|NCT01289275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153346215|NCT00004474|Cyclophosphamide|cyclophosphamide|mesh-list
153346216|NCT00004474|Antilymphocyte Serum|antilymphocyte serum|mesh-list
153346226|NCT00004480|Botulinum Toxins|botulinum toxins|mesh-list
153346251|NCT00004492|Clotrimazole|clotrimazole|mesh-list
153918971|NCT05906524|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153918972|NCT05906524|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153918973|NCT05906524|Growth Substances|growth substances|mesh-ancestor
153918974|NCT05906524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153918975|NCT05906524|Growth Inhibitors|growth inhibitors|mesh-ancestor
153918976|NCT05906498|Vitamin E|vitamin e|mesh-list
153918977|NCT05906498|Acetylcysteine|acetylcysteine|mesh-list
153918978|NCT05906498|N-monoacetylcystine|n-monoacetylcystine|mesh-list
153918979|NCT05906498|Vitamins|vitamins|mesh-ancestor
153918980|NCT05906498|Micronutrients|micronutrients|mesh-ancestor
153918981|NCT05906498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153918982|NCT05906498|Antioxidants|antioxidants|mesh-ancestor
153346252|NCT00004492|Miconazole|miconazole|mesh-list
153346253|NCT00004492|Hydroxyurea|hydroxyurea|mesh-list
153346254|NCT00004492|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153346255|NCT00004492|Antisickling Agents|antisickling agents|mesh-ancestor
153346256|NCT00004492|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153346257|NCT00004492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153346258|NCT00004492|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153346259|NCT00004492|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
153346260|NCT00004492|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153346261|NCT00004492|Antifungal Agents|antifungal agents|mesh-ancestor
153346262|NCT00004492|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
153346263|NCT00004492|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153346264|NCT00004492|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153918983|NCT05906498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153346265|NCT00004492|Hormone Antagonists|hormone antagonists|mesh-ancestor
153346266|NCT00004492|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153346308|NCT00005800|Tubulin Modulators|tubulin modulators|mesh-ancestor
153346309|NCT00005800|Antimitotic Agents|antimitotic agents|mesh-ancestor
153346310|NCT00005800|Mitosis Modulators|mitosis modulators|mesh-ancestor
153346311|NCT00005800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153346312|NCT00005800|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153346313|NCT00005800|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153346314|NCT00005800|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153346315|NCT00005800|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153346316|NCT00004564|Clopidogrel|clopidogrel|mesh-list
153346317|NCT00004564|Atorvastatin|atorvastatin|mesh-list
153346319|NCT00004564|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153346368|NCT00004582|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
153346370|NCT00004582|Protease Inhibitors|protease inhibitors|mesh-ancestor
153346371|NCT00004582|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153346372|NCT00004582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153346373|NCT00004582|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153346374|NCT00004582|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153346375|NCT00004582|Antiviral Agents|antiviral agents|mesh-ancestor
153346376|NCT00004582|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153346377|NCT00004582|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
153346378|NCT00004582|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153346379|NCT00004582|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153346380|NCT00004582|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153346381|NCT00004582|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
153919016|NCT05746442|Cholinergic Agents|cholinergic agents|mesh-ancestor
153919017|NCT05746442|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153919018|NCT05746442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153919019|NCT05736874|Fluticasone|fluticasone|mesh-list
153919020|NCT05736874|Xhance|xhance|mesh-list
153919021|NCT05736874|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153346382|NCT00004582|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
153346383|NCT00004582|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
153346384|NCT00004582|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
153346385|NCT00004582|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
153346386|NCT00004690|Monolaurin|monolaurin|mesh-list
153346387|NCT00004690|Cariostatic Agents|cariostatic agents|mesh-ancestor
153346388|NCT00004690|Protective Agents|protective agents|mesh-ancestor
153346389|NCT00004690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153346391|NCT00004696|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153346392|NCT00004696|Narcotics|narcotics|mesh-ancestor
153346393|NCT00004696|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153346394|NCT00004696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153346395|NCT00004696|Analgesics|analgesics|mesh-ancestor
153346396|NCT00004696|Sensory System Agents|sensory system agents|mesh-ancestor
153346397|NCT00004696|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153346398|NCT00004744|Immunoglobulins|immunoglobulins|mesh-list
153919061|NCT05564611|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
153919062|NCT05564611|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153919063|NCT05564611|Respiratory System Agents|respiratory system agents|mesh-ancestor
153346399|NCT00004744|Antibodies|antibodies|mesh-list
153346400|NCT00004744|gamma-Globulins|gamma-globulins|mesh-list
153346408|NCT01292005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153346409|NCT01292005|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153346410|NCT01292005|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
153346411|NCT01292005|Protective Agents|protective agents|mesh-ancestor
153346412|NCT01292005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153346413|NCT01292005|Vasodilator Agents|vasodilator agents|mesh-ancestor
153346414|NCT01292005|Free Radical Scavengers|free radical scavengers|mesh-ancestor
153346415|NCT01292005|Antioxidants|antioxidants|mesh-ancestor
153346417|NCT00004762|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153346418|NCT00004762|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153346419|NCT00004762|Immunologic Factors|immunologic factors|mesh-ancestor
153346420|NCT00004762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153346421|NCT00004786|Iloprost|iloprost|mesh-list
153346422|NCT00004786|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153346423|NCT00004786|Vasodilator Agents|vasodilator agents|mesh-ancestor
153346424|NCT01272583|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
153467896|NCT00552786|Antidotes|antidotes|mesh-ancestor
153467897|NCT00517530|Obinutuzumab|obinutuzumab|mesh-list
153467898|NCT00517530|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153467899|NCT00517530|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153467900|NCT00518154|Pyridostigmine Bromide|pyridostigmine bromide|mesh-list
153467901|NCT00518154|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
153467902|NCT00518154|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153919120|NCT05332444|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153919121|NCT05332444|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153919122|NCT05332444|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153919123|NCT05332444|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
153919124|NCT05332444|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
153919125|NCT05332444|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153467903|NCT00518154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153346425|NCT01272583|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153346426|NCT01272583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153346427|NCT01272583|Incretins|incretins|mesh-ancestor
153346428|NCT01272583|Hormones|hormones|mesh-ancestor
153346429|NCT01272583|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153346430|NCT01272583|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
153346431|NCT01272583|Protease Inhibitors|protease inhibitors|mesh-ancestor
153346432|NCT01272583|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153346456|NCT01341301|Tacrolimus|tacrolimus|mesh-list
153346457|NCT01341301|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153346458|NCT01341301|Immunologic Factors|immunologic factors|mesh-ancestor
153346459|NCT01341301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153346460|NCT01341301|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153346461|NCT01341301|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153467904|NCT00518154|Cholinergic Agents|cholinergic agents|mesh-ancestor
153346463|NCT01341301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153346464|NCT01341301|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153346465|NCT01341301|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153346466|NCT01341301|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
153346467|NCT01341301|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153346468|NCT01341301|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153346469|NCT01341301|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
153346470|NCT01341301|Antitubercular Agents|antitubercular agents|mesh-ancestor
153346471|NCT01341301|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153346472|NCT01341301|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153346473|NCT01273207|Cyclosporine|cyclosporine|mesh-list
153346474|NCT01273207|Cyclosporins|cyclosporins|mesh-list
153346475|NCT01273207|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153346476|NCT01273207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153346510|NCT01277341|Bepotastine besilate|bepotastine besilate|mesh-list
153919154|NCT05006417|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153919155|NCT05006417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153919156|NCT05006417|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
153919157|NCT05006417|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153919158|NCT05006417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153467911|NCT00553098|Fludarabine|fludarabine|mesh-list
153467912|NCT00553098|Fludarabine phosphate|fludarabine phosphate|mesh-list
153467913|NCT00553098|Antibodies|antibodies|mesh-list
153467914|NCT00553098|Immunoglobulins|immunoglobulins|mesh-list
153467915|NCT00553098|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
153467916|NCT00553098|Cyclosporins|cyclosporins|mesh-list
153467917|NCT00553098|Immunologic Factors|immunologic factors|mesh-ancestor
153467918|NCT00553098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153467919|NCT00553098|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153346511|NCT01277341|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
153346513|NCT00101816|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153346514|NCT00101816|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153346515|NCT00101816|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153346516|NCT00101816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153346517|NCT00101816|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153346519|NCT00102518|Antidepressive Agents|antidepressive agents|mesh-ancestor
153346520|NCT00102518|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153346521|NCT00102518|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153346522|NCT00102518|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153346523|NCT00102518|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153346524|NCT00102518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153346525|NCT00102518|Dopamine Agonists|dopamine agonists|mesh-ancestor
153346526|NCT00102518|Dopamine Agents|dopamine agents|mesh-ancestor
153346527|NCT00102518|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153346528|NCT00102518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153346529|NCT00102518|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
153346530|NCT00102518|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
153346532|NCT00102518|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
153346561|NCT01296763|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153346562|NCT01296763|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
153346563|NCT01296763|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153346564|NCT01296763|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153346565|NCT01296763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153346566|NCT01296763|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
153346567|NCT01296763|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153346568|NCT01296763|Alkylating Agents|alkylating agents|mesh-ancestor
153346569|NCT01296763|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153346570|NCT01349491|Ranolazine|ranolazine|mesh-list
153346571|NCT01349491|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153346572|NCT01349491|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153346573|NCT01349491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153346574|NCT01280695|Pioglitazone|pioglitazone|mesh-list
153346575|NCT01280695|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153346577|NCT00103844|Imatinib Mesylate|imatinib mesylate|mesh-list
153346621|NCT00104858|Cyclosporins|cyclosporins|mesh-list
153346622|NCT00104858|Immunologic Factors|immunologic factors|mesh-ancestor
153346623|NCT00104858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153346624|NCT00104858|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153346625|NCT00104858|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153346626|NCT00104858|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153346627|NCT00104858|Antimetabolites|antimetabolites|mesh-ancestor
153346628|NCT00104858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153346629|NCT00104858|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153346630|NCT00104858|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153467932|NCT00553098|Antitubercular Agents|antitubercular agents|mesh-ancestor
153467935|NCT00553410|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153467936|NCT00553410|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
153467937|NCT00553410|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153467938|NCT00553410|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153467940|NCT00553410|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
153346631|NCT00104858|Antifungal Agents|antifungal agents|mesh-ancestor
153346632|NCT00104858|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153346633|NCT00104858|Dermatologic Agents|dermatologic agents|mesh-ancestor
153346634|NCT00104858|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
153346635|NCT00104858|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153346636|NCT00104858|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
153346638|NCT00104858|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153346640|NCT01407523|Anticonvulsants|anticonvulsants|mesh-ancestor
153346641|NCT01407523|Nootropic Agents|nootropic agents|mesh-ancestor
153346642|NCT01304407|Calcium|calcium|mesh-list
153346643|NCT01304407|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153919187|NCT04794569|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
153346644|NCT01304407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153346645|NCT00106106|Acamprosate|acamprosate|mesh-list
153346646|NCT00106106|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
153346647|NCT01304641|Atorvastatin|atorvastatin|mesh-list
153346648|NCT01304641|Simvastatin|simvastatin|mesh-list
153346649|NCT01304641|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153346650|NCT01304641|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153919227|NCT04524910|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153919229|NCT04410653|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153919230|NCT04410653|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153346651|NCT01304641|Antimetabolites|antimetabolites|mesh-ancestor
153346652|NCT01304641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153346653|NCT01304641|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153346654|NCT01304641|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
153919231|NCT04410653|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153467979|NCT00555048|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153919234|NCT04377087|Olaparib|olaparib|mesh-list
153346655|NCT01304641|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153346657|NCT04753112|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
153346658|NCT04753112|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153346660|NCT04753112|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
153346661|NCT04753112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153346662|NCT01409239|Insulin|insulin|mesh-list
153346663|NCT01409239|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
153346664|NCT01409239|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153346665|NCT01409239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153346667|NCT00108524|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153346668|NCT00108524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153346669|NCT00108524|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
153346670|NCT00108524|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153346671|NCT00052442|10-deazaaminopterin|10-deazaaminopterin|mesh-list
153346672|NCT00052442|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153346673|NCT00052442|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153346674|NCT00052442|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153346675|NCT00052442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153346676|NCT01410409|Acetaminophen|acetaminophen|mesh-list
153346720|NCT01310179|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153346721|NCT01310179|Antimetabolites|antimetabolites|mesh-ancestor
153346722|NCT01310179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153346723|NCT01310179|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153346724|NCT01310179|Immunologic Factors|immunologic factors|mesh-ancestor
153346725|NCT01310179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153346726|NCT01412281|Vaccines|vaccines|mesh-list
153346727|NCT01412281|Immunologic Factors|immunologic factors|mesh-ancestor
153346728|NCT01412281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153346729|NCT01359007|Leucovorin|leucovorin|mesh-list
153346730|NCT01359007|Oxaliplatin|oxaliplatin|mesh-list
153919263|NCT04205838|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153919264|NCT04205838|Antimetabolites|antimetabolites|mesh-ancestor
153919265|NCT04205838|Antiviral Agents|antiviral agents|mesh-ancestor
153919266|NCT04205838|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153919267|NCT04205838|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153919268|NCT04170543|Dapagliflozin|dapagliflozin|mesh-list
153919269|NCT04170543|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
153346731|NCT01359007|Irinotecan|irinotecan|mesh-list
153346732|NCT01359007|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153346733|NCT01359007|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
153346734|NCT01359007|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153346735|NCT01359007|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153346736|NCT01359007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153346737|NCT01359007|Antidotes|antidotes|mesh-ancestor
153346738|NCT01359007|Protective Agents|protective agents|mesh-ancestor
153346739|NCT01359007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153346740|NCT01359007|Vitamin B Complex|vitamin b complex|mesh-ancestor
153783325|NCT00236054|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153346741|NCT01359007|Vitamins|vitamins|mesh-ancestor
153346742|NCT01359007|Micronutrients|micronutrients|mesh-ancestor
153346771|NCT01362205|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153346772|NCT01362205|Analgesics|analgesics|mesh-ancestor
153346773|NCT01362205|Sensory System Agents|sensory system agents|mesh-ancestor
153346774|NCT01362205|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153346775|NCT01362205|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
153346776|NCT01362205|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153346777|NCT01362205|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153346778|NCT01362205|Adrenergic Agents|adrenergic agents|mesh-ancestor
153346779|NCT01362205|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153346780|NCT01362205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153346781|NCT00052910|Leucovorin|leucovorin|mesh-list
153346782|NCT00052910|Fluorouracil|fluorouracil|mesh-list
153346783|NCT00052910|Epirubicin|epirubicin|mesh-list
153346784|NCT00052910|Calcium|calcium|mesh-list
153346785|NCT00052910|Levoleucovorin|levoleucovorin|mesh-list
153346786|NCT00052910|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153346787|NCT00052910|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153346788|NCT00052910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153346790|NCT00052910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153346791|NCT00052910|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153346792|NCT00052910|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153346793|NCT00052910|Immunologic Factors|immunologic factors|mesh-ancestor
153346794|NCT00052910|Antidotes|antidotes|mesh-ancestor
153919299|NCT03991819|Pembrolizumab|pembrolizumab|mesh-list
153346795|NCT00052910|Protective Agents|protective agents|mesh-ancestor
153346796|NCT00052910|Vitamin B Complex|vitamin b complex|mesh-ancestor
153346798|NCT00052910|Micronutrients|micronutrients|mesh-ancestor
153346799|NCT00052910|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153346800|NCT00052910|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153346801|NCT00052910|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153346802|NCT00052910|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153346803|NCT01363843|Leucovorin|leucovorin|mesh-list
153346804|NCT01363843|Oxaliplatin|oxaliplatin|mesh-list
153346805|NCT01363843|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153346816|NCT02092298|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153346817|NCT02092298|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153346818|NCT02092298|Alkylating Agents|alkylating agents|mesh-ancestor
153346819|NCT02092298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153346820|NCT02092298|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153346821|NCT02092298|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153346822|NCT02092298|Antidotes|antidotes|mesh-ancestor
153346823|NCT02092298|Protective Agents|protective agents|mesh-ancestor
153346824|NCT02092298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153346825|NCT02092298|Antioxidants|antioxidants|mesh-ancestor
153346826|NCT02092298|Antitubercular Agents|antitubercular agents|mesh-ancestor
153346827|NCT02092298|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153346828|NCT02092298|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153346829|NCT02092298|Chelating Agents|chelating agents|mesh-ancestor
153346830|NCT02092298|Sequestering Agents|sequestering agents|mesh-ancestor
153346832|NCT00151814|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
153346833|NCT00151814|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153346834|NCT00151814|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
153346835|NCT00151814|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
153346836|NCT00151814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153346837|NCT00153842|Bexarotene|bexarotene|mesh-list
153919332|NCT03641456|Protease Inhibitors|protease inhibitors|mesh-ancestor
153346838|NCT00153842|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153346839|NCT01314001|Nicotine|nicotine|mesh-list
153346841|NCT01314001|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
153346842|NCT01314001|Autonomic Agents|autonomic agents|mesh-ancestor
153346843|NCT01314001|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153346844|NCT01314001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153346845|NCT01314001|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
153346846|NCT01314001|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
153346847|NCT01314001|Cholinergic Agents|cholinergic agents|mesh-ancestor
153346848|NCT01314001|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153346856|NCT01363999|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153346857|NCT01363999|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
153346858|NCT01363999|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153346859|NCT00257894|Baclofen|baclofen|mesh-list
153346860|NCT00257894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153346861|NCT00257894|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
153346862|NCT00257894|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
153346863|NCT00257894|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153346865|NCT00257894|GABA Agonists|gaba agonists|mesh-ancestor
153346866|NCT00257894|GABA Agents|gaba agents|mesh-ancestor
153346867|NCT00257894|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153346868|NCT00257894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153346869|NCT00258128|Salicylsalicylic acid|salicylsalicylic acid|mesh-list
153346870|NCT00258128|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153346871|NCT00258128|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153346872|NCT00258128|Analgesics|analgesics|mesh-ancestor
153346873|NCT00258128|Sensory System Agents|sensory system agents|mesh-ancestor
153468131|NCT00561834|Ranibizumab|ranibizumab|mesh-list
153346874|NCT00258128|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153346875|NCT00258128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153346876|NCT00258128|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153346877|NCT00258128|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153346878|NCT01364623|Methyltestosterone|methyltestosterone|mesh-list
153346879|NCT01364623|Testosterone|testosterone|mesh-list
153346880|NCT01364623|Testosterone undecanoate|testosterone undecanoate|mesh-list
153346883|NCT01364623|Androgens|androgens|mesh-ancestor
153346906|NCT03015857|Phenylephrine|phenylephrine|mesh-list
153346907|NCT03015857|Oxymetazoline|oxymetazoline|mesh-list
153346908|NCT03015857|Norepinephrine|norepinephrine|mesh-list
153346909|NCT03015857|Fentanyl|fentanyl|mesh-list
153346910|NCT03015857|Bupivacaine|bupivacaine|mesh-list
153346911|NCT03015857|Anesthetics, Local|anesthetics, local|mesh-ancestor
153346912|NCT03015857|Anesthetics|anesthetics|mesh-ancestor
153346913|NCT03015857|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153461755|NCT03708588|Purinergic Agents|purinergic agents|mesh-ancestor
153346915|NCT03015857|Sensory System Agents|sensory system agents|mesh-ancestor
153346916|NCT03015857|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153346917|NCT03015857|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153346919|NCT03015857|Analgesics|analgesics|mesh-ancestor
153346920|NCT03015857|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153346921|NCT03015857|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153346922|NCT03015857|Anesthetics, General|anesthetics, general|mesh-ancestor
153346923|NCT03015857|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
153346924|NCT03015857|Mydriatics|mydriatics|mesh-ancestor
153346925|NCT03015857|Autonomic Agents|autonomic agents|mesh-ancestor
153346926|NCT03015857|Sympathomimetics|sympathomimetics|mesh-ancestor
153346927|NCT03015857|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
153346928|NCT03015857|Nasal Decongestants|nasal decongestants|mesh-ancestor
153346929|NCT03015857|Respiratory System Agents|respiratory system agents|mesh-ancestor
153346930|NCT03015857|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
153346931|NCT03015857|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153346932|NCT03015857|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153346933|NCT03015857|Adrenergic Agents|adrenergic agents|mesh-ancestor
153346934|NCT03015857|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153919415|NCT02705508|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153346935|NCT03015857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153346936|NCT03015857|Protective Agents|protective agents|mesh-ancestor
153346937|NCT03295487|Estrogens|estrogens|mesh-list
153346938|NCT03295487|Hormones|hormones|mesh-ancestor
153346939|NCT03295487|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153346949|NCT03015701|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153346950|NCT03015701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153346951|NCT03015701|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
153346952|NCT03015701|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
153346953|NCT03015701|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
153346954|NCT03015701|Contraceptive Agents|contraceptive agents|mesh-ancestor
153346955|NCT03015701|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
153346956|NCT03015701|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
153346957|NCT03015701|Hormone Antagonists|hormone antagonists|mesh-ancestor
153346958|NCT03015701|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153346959|NCT03015701|Luteolytic Agents|luteolytic agents|mesh-ancestor
153346960|NCT03015701|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
153346961|NCT03015701|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
153346962|NCT04780061|Vitamin D|vitamin d|mesh-list
153346963|NCT04780061|Cholecalciferol|cholecalciferol|mesh-list
153346964|NCT04780061|Vitamins|vitamins|mesh-list
153346965|NCT04780061|Vitamin K|vitamin k|mesh-list
153919450|NCT02396043|Doxorubicin|doxorubicin|mesh-list
153439763|NCT00003049|Vitamins|vitamins|mesh-ancestor
153346967|NCT04780061|Micronutrients|micronutrients|mesh-ancestor
153346968|NCT04780061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153346969|NCT04780061|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153783327|NCT00236054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153783328|NCT00236054|GABA Agents|gaba agents|mesh-ancestor
153783329|NCT00236054|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153783330|NCT00236054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153783331|NCT04552951|Vitamin D|vitamin d|mesh-list
153783332|NCT04552951|Cholecalciferol|cholecalciferol|mesh-list
153346970|NCT04780061|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153346971|NCT04780061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153346972|NCT04780061|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
153346973|NCT04780061|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153346974|NCT04780061|Hemostatics|hemostatics|mesh-ancestor
153346975|NCT04780061|Coagulants|coagulants|mesh-ancestor
153346976|NCT02172755|Eslicarbazepine acetate|eslicarbazepine acetate|mesh-list
153346977|NCT02172755|Anticonvulsants|anticonvulsants|mesh-ancestor
153346981|NCT02172755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153877893|NCT05256472|Axitinib|axitinib|mesh-list
153346983|NCT02973737|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153346984|NCT02973737|Antimetabolites|antimetabolites|mesh-ancestor
153346985|NCT02973737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153346986|NCT02973737|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153346987|NCT02762669|Oxytocin|oxytocin|mesh-list
153346988|NCT02762669|Oxytocics|oxytocics|mesh-ancestor
153346989|NCT02762669|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153346990|NCT02762669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153346991|NCT01072643|Dexmedetomidine|dexmedetomidine|mesh-list
153346992|NCT01072643|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153346993|NCT01072643|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153346994|NCT01072643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153346995|NCT01072643|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153346997|NCT01072643|Sensory System Agents|sensory system agents|mesh-ancestor
153346998|NCT01072643|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153346999|NCT01072643|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
153347000|NCT01072643|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153347001|NCT01072643|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153347002|NCT01072643|Adrenergic Agents|adrenergic agents|mesh-ancestor
153347003|NCT01072643|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153347005|NCT01076231|Etoposide|etoposide|mesh-list
153347032|NCT01109069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153347033|NCT00118274|Cyclophosphamide|cyclophosphamide|mesh-list
153347034|NCT00118274|Vaccines|vaccines|mesh-list
153347035|NCT00118274|Freund's Adjuvant|freund's adjuvant|mesh-list
153347036|NCT00118274|Immunologic Factors|immunologic factors|mesh-ancestor
153783333|NCT04552951|Vitamins|vitamins|mesh-ancestor
153347037|NCT00118274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153347038|NCT00118274|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153347039|NCT00118274|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153877951|NCT05118854|Cisplatin|cisplatin|mesh-list
153347040|NCT00118274|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153347041|NCT00118274|Alkylating Agents|alkylating agents|mesh-ancestor
153347042|NCT00118274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153347043|NCT00118274|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153347044|NCT00118274|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153347045|NCT00118274|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153347046|NCT01898000|Chlorhexidine|chlorhexidine|mesh-list
153347047|NCT01898000|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
153347048|NCT01898000|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153347049|NCT01898000|Disinfectants|disinfectants|mesh-ancestor
153347050|NCT00166166|Fluconazole|fluconazole|mesh-list
153347051|NCT00166166|Nitroprusside|nitroprusside|mesh-list
153347052|NCT00166166|Tetraethylammonium|tetraethylammonium|mesh-list
153877964|NCT05116007|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153347053|NCT00166166|Acetylcholine|acetylcholine|mesh-list
153347054|NCT00166166|Bradykinin|bradykinin|mesh-list
153877965|NCT05116007|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153877966|NCT05116007|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153877967|NCT05116007|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153877968|NCT05116007|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153877969|NCT05116007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153877970|NCT05095376|Temozolomide|temozolomide|mesh-list
153877971|NCT05095376|Lomustine|lomustine|mesh-list
153877972|NCT05095376|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153877973|NCT05095376|Alkylating Agents|alkylating agents|mesh-ancestor
153877974|NCT05095376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153877975|NCT05095376|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153877976|NCT05083312|Fluticasone|fluticasone|mesh-list
153347055|NCT00166166|omega-N-Methylarginine|omega-n-methylarginine|mesh-list
153347056|NCT00166166|Kininogens|kininogens|mesh-list
153347057|NCT00166166|Antifungal Agents|antifungal agents|mesh-ancestor
153347058|NCT00166166|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153877977|NCT05083312|Xhance|xhance|mesh-list
153877978|NCT05083312|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153347059|NCT00166166|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
153347060|NCT00166166|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153347061|NCT00166166|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153347063|NCT00166166|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153347074|NCT00166166|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153347075|NCT00166166|Cysteine Proteinase Inhibitors|cysteine proteinase inhibitors|mesh-ancestor
153347076|NCT00166166|Protease Inhibitors|protease inhibitors|mesh-ancestor
153347077|NCT00166166|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
153877979|NCT05083312|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153347078|NCT00166166|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153418774|NCT03035708|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153418775|NCT03035708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153418776|NCT03035708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153418777|NCT00374426|Sertraline|sertraline|mesh-list
153418778|NCT00374426|Antidepressive Agents|antidepressive agents|mesh-ancestor
153347080|NCT00118352|Mycophenolic Acid|mycophenolic acid|mesh-list
153347081|NCT00118352|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
153347082|NCT00118352|Alemtuzumab|alemtuzumab|mesh-list
153347083|NCT00118352|Fludarabine|fludarabine|mesh-list
153347084|NCT00118352|Fludarabine phosphate|fludarabine phosphate|mesh-list
153347085|NCT00118352|Antibodies|antibodies|mesh-list
153347086|NCT00118352|Immunoglobulins|immunoglobulins|mesh-list
153347087|NCT00118352|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
153347088|NCT00118352|Cyclosporins|cyclosporins|mesh-list
153347089|NCT00118352|Immunologic Factors|immunologic factors|mesh-ancestor
153347090|NCT00118352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153347091|NCT00118352|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153418779|NCT00374426|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153418780|NCT00374426|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
153418781|NCT00374426|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153418782|NCT00374426|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153878008|NCT05062902|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
153878009|NCT05062902|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153418789|NCT02916745|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153347092|NCT00118352|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153347093|NCT00118352|Antimetabolites|antimetabolites|mesh-ancestor
153347094|NCT00118352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153347095|NCT00118352|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153347096|NCT00118352|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153347097|NCT00118352|Antifungal Agents|antifungal agents|mesh-ancestor
153347098|NCT00118352|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153347099|NCT00118352|Dermatologic Agents|dermatologic agents|mesh-ancestor
153347100|NCT00118352|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153347101|NCT00118352|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
153347102|NCT00118352|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153347120|NCT01859819|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153347122|NCT01859819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153347123|NCT01859819|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153347124|NCT01859819|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153347125|NCT01859819|Antimetabolites|antimetabolites|mesh-ancestor
153347126|NCT01859819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153347127|NCT01859819|Antiviral Agents|antiviral agents|mesh-ancestor
153347128|NCT01859819|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153347129|NCT01859819|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153347130|NCT02176031|Methylprednisolone|methylprednisolone|mesh-list
153347131|NCT02176031|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
153347132|NCT02176031|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
153347134|NCT02176031|Prednisolone acetate|prednisolone acetate|mesh-list
153347135|NCT02176031|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
153347136|NCT02176031|Prednisolone phosphate|prednisolone phosphate|mesh-list
153418826|NCT02956070|Antiemetics|antiemetics|mesh-ancestor
153418827|NCT02956070|Autonomic Agents|autonomic agents|mesh-ancestor
153418828|NCT02956070|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153418829|NCT02956070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153418830|NCT02956070|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153418831|NCT02956070|Glucocorticoids|glucocorticoids|mesh-ancestor
153418833|NCT02956070|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153418834|NCT02956070|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153347137|NCT02176031|Natalizumab|natalizumab|mesh-list
153347138|NCT02176031|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153347139|NCT02176031|Antiemetics|antiemetics|mesh-ancestor
153347140|NCT02176031|Autonomic Agents|autonomic agents|mesh-ancestor
153347141|NCT02176031|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153347142|NCT02176031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153347143|NCT02176031|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153347144|NCT02176031|Glucocorticoids|glucocorticoids|mesh-ancestor
153347145|NCT02176031|Hormones|hormones|mesh-ancestor
153418835|NCT02956070|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153347147|NCT02176031|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
153347148|NCT02176031|Protective Agents|protective agents|mesh-ancestor
153347149|NCT02176031|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153347150|NCT02176031|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153347151|NCT02176031|Immunologic Factors|immunologic factors|mesh-ancestor
153347152|NCT03013361|Bupivacaine|bupivacaine|mesh-list
153347161|NCT01077401|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153347162|NCT01077401|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153347163|NCT01077401|Growth Substances|growth substances|mesh-ancestor
153347164|NCT01077401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153418865|NCT05829551|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153418867|NCT05829148|Dexmedetomidine|dexmedetomidine|mesh-list
153418868|NCT05829148|Melatonin|melatonin|mesh-list
153418869|NCT05829148|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153418870|NCT05829148|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153418871|NCT05829148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153418872|NCT05829148|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153418873|NCT05829148|Analgesics|analgesics|mesh-ancestor
153418874|NCT05829148|Sensory System Agents|sensory system agents|mesh-ancestor
153418875|NCT05829148|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153418876|NCT05829148|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
153878077|NCT04971577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153347165|NCT01077401|Growth Inhibitors|growth inhibitors|mesh-ancestor
153347166|NCT01077401|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153347167|NCT01316341|Empagliflozin|empagliflozin|mesh-list
153347168|NCT01316341|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
153347169|NCT01316341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153347170|NCT01316341|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153347171|NCT01316341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153347172|NCT01112735|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
153347173|NCT01112735|Hemostatics|hemostatics|mesh-ancestor
153347174|NCT01112735|Coagulants|coagulants|mesh-ancestor
153347176|NCT03014297|Fosbretabulin|fosbretabulin|mesh-list
153878078|NCT04971577|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153347179|NCT03014297|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153347180|NCT03014297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153347182|NCT03014297|Immunologic Factors|immunologic factors|mesh-ancestor
153347213|NCT01114997|Adrenergic Agents|adrenergic agents|mesh-ancestor
153347214|NCT01114997|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153347215|NCT00118742|Cyclosporine|cyclosporine|mesh-list
153347216|NCT00118742|Sirolimus|sirolimus|mesh-list
153347217|NCT00118742|Mycophenolic Acid|mycophenolic acid|mesh-list
153347218|NCT00118742|Tacrolimus|tacrolimus|mesh-list
153347219|NCT00118742|Cyclosporins|cyclosporins|mesh-list
153347220|NCT00118742|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153347221|NCT00118742|Immunologic Factors|immunologic factors|mesh-ancestor
153347222|NCT00118742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153347223|NCT00118742|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
153347224|NCT00118742|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153347225|NCT00118742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153347226|NCT00118742|Antifungal Agents|antifungal agents|mesh-ancestor
153347227|NCT00118742|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153347228|NCT00118742|Dermatologic Agents|dermatologic agents|mesh-ancestor
153878101|NCT04947631|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
153878102|NCT04947631|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153878103|NCT04947631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153878104|NCT04947631|Urological Agents|urological agents|mesh-ancestor
153878105|NCT04947631|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
153878106|NCT04947631|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153878107|NCT04947631|Hormone Antagonists|hormone antagonists|mesh-ancestor
153878108|NCT04947631|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153347229|NCT00118742|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153347230|NCT00118742|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153347231|NCT00118742|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153347232|NCT00118742|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
153347233|NCT00118742|Antitubercular Agents|antitubercular agents|mesh-ancestor
153347234|NCT00118742|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153347235|NCT01317667|Vaccines|vaccines|mesh-list
153347236|NCT01317667|Immunologic Factors|immunologic factors|mesh-ancestor
153878110|NCT04914910|Insulin|insulin|mesh-list
153347238|NCT00167180|Cyclophosphamide|cyclophosphamide|mesh-list
153347239|NCT00167180|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153347240|NCT00167180|Immunologic Factors|immunologic factors|mesh-ancestor
153347241|NCT00167180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153347242|NCT00167180|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153347243|NCT00167180|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153347244|NCT00167180|Alkylating Agents|alkylating agents|mesh-ancestor
153347245|NCT00167180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153347254|NCT01317901|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153347255|NCT01317901|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153347256|NCT01317901|Alkylating Agents|alkylating agents|mesh-ancestor
153418917|NCT05828199|Adrenergic Agents|adrenergic agents|mesh-ancestor
153418918|NCT05828199|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153418919|NCT05828199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153418920|NCT05828199|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
153418921|NCT05828199|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153418922|NCT05828199|Anesthetics, General|anesthetics, general|mesh-ancestor
153418923|NCT05828199|Anesthetics|anesthetics|mesh-ancestor
153418924|NCT05828199|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
153418925|NCT05828199|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
153418926|NCT05827991|Minoxidil|minoxidil|mesh-list
153418927|NCT05827991|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153418928|NCT05827991|Vasodilator Agents|vasodilator agents|mesh-ancestor
153418929|NCT05827796|Paclitaxel|paclitaxel|mesh-list
153418930|NCT05827796|Gemcitabine|gemcitabine|mesh-list
153418937|NCT05827796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153418938|NCT05827796|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153347257|NCT01317901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153347258|NCT03008551|Metformin|metformin|mesh-list
153347259|NCT03008551|Empagliflozin|empagliflozin|mesh-list
153347260|NCT03008551|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153783337|NCT04552951|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153347261|NCT03008551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153347262|NCT03008551|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
153347263|NCT03008551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153347264|NCT01366885|Vitamin D|vitamin d|mesh-list
153347265|NCT01366885|Cholecalciferol|cholecalciferol|mesh-list
153347266|NCT01366885|Vitamins|vitamins|mesh-ancestor
153347267|NCT01366885|Micronutrients|micronutrients|mesh-ancestor
153347268|NCT01366885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153347269|NCT01366885|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153347270|NCT01366885|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153347271|NCT01899170|Carfentanil|carfentanil|mesh-list
153418939|NCT05827796|Antimetabolites|antimetabolites|mesh-ancestor
153418940|NCT05827770|Temozolomide|temozolomide|mesh-list
153347310|NCT00123110|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153347311|NCT00123110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153347312|NCT00123110|Fertility Agents, Female|fertility agents, female|mesh-ancestor
153347313|NCT00123110|Fertility Agents|fertility agents|mesh-ancestor
153347314|NCT00123110|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153347315|NCT00123110|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153347316|NCT00123110|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153347317|NCT01425853|Celecoxib|celecoxib|mesh-list
153347318|NCT01425853|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153347319|NCT01425853|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153347320|NCT01425853|Analgesics|analgesics|mesh-ancestor
153347321|NCT01425853|Sensory System Agents|sensory system agents|mesh-ancestor
153347322|NCT01425853|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153347323|NCT01425853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153347324|NCT01425853|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153347325|NCT01425853|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153347326|NCT01425853|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
153347327|NCT01425853|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153347328|NCT01425853|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153347329|NCT01425853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153347330|NCT01426867|Brimonidine Tartrate|brimonidine tartrate|mesh-list
153347331|NCT01426867|Ophthalmic Solutions|ophthalmic solutions|mesh-list
153347332|NCT01426867|Brinzolamide|brinzolamide|mesh-list
153347333|NCT01426867|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
153347334|NCT01426867|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153347335|NCT01426867|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
153418949|NCT05827497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153418950|NCT05827497|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153347336|NCT01426867|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153347337|NCT01426867|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153347338|NCT01426867|Adrenergic Agents|adrenergic agents|mesh-ancestor
153347339|NCT01426867|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153347340|NCT01426867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153347341|NCT01426867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153347348|NCT00168428|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153347349|NCT00168428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153347350|NCT00168428|Cholinergic Agents|cholinergic agents|mesh-ancestor
153347351|NCT00168428|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153347352|NCT00168428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153347353|NCT00168428|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
153347354|NCT00168428|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153347355|NCT01427881|Cyclosporine|cyclosporine|mesh-list
153347356|NCT01427881|Cyclophosphamide|cyclophosphamide|mesh-list
153347358|NCT01427881|Fludarabine|fludarabine|mesh-list
153347359|NCT01427881|Fludarabine phosphate|fludarabine phosphate|mesh-list
153347360|NCT01427881|Cyclosporins|cyclosporins|mesh-list
153347361|NCT01427881|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153878216|NCT04775550|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153347362|NCT01427881|Immunologic Factors|immunologic factors|mesh-ancestor
153347363|NCT01427881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153347364|NCT01427881|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153347365|NCT01427881|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153347366|NCT01427881|Alkylating Agents|alkylating agents|mesh-ancestor
153347367|NCT01427881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153347368|NCT01427881|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153347369|NCT01427881|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153347370|NCT01427881|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153347371|NCT01427881|Antimetabolites|antimetabolites|mesh-ancestor
153347372|NCT01427881|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153347373|NCT01427881|Antifungal Agents|antifungal agents|mesh-ancestor
153347374|NCT01427881|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153347377|NCT01319773|Cyclosporine|cyclosporine|mesh-list
153347397|NCT04351867|Tubulin Modulators|tubulin modulators|mesh-ancestor
153347398|NCT04351867|Antimitotic Agents|antimitotic agents|mesh-ancestor
153347399|NCT04351867|Mitosis Modulators|mitosis modulators|mesh-ancestor
153347400|NCT04351867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153347401|NCT04351867|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153347402|NCT04351867|Antimetabolites|antimetabolites|mesh-ancestor
153347403|NCT00262730|Temozolomide|temozolomide|mesh-list
153347405|NCT00262730|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153347406|NCT00262730|Alkylating Agents|alkylating agents|mesh-ancestor
153347407|NCT00262730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153347408|NCT00262730|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153347409|NCT00262730|Interferon Inducers|interferon inducers|mesh-ancestor
153347410|NCT00262730|Immunologic Factors|immunologic factors|mesh-ancestor
153347411|NCT00262730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153783338|NCT02213419|Ethanol|ethanol|mesh-list
153783339|NCT02213419|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
153878248|NCT04721132|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
153878249|NCT04721132|Atezolizumab|atezolizumab|mesh-list
153347412|NCT04262934|Vitamin D|vitamin d|mesh-list
153347413|NCT04262934|Cholecalciferol|cholecalciferol|mesh-list
153878250|NCT04721132|Endothelial Growth Factors|endothelial growth factors|mesh-list
153347416|NCT04262934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153347417|NCT04262934|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153347418|NCT04262934|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153347419|NCT00262964|Niacin|niacin|mesh-list
153347420|NCT00262964|Fenofibrate|fenofibrate|mesh-list
153347421|NCT00262964|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153347445|NCT01899248|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153347446|NCT01899248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153347447|NCT01322815|Leucovorin|leucovorin|mesh-list
153347448|NCT01322815|Fluorouracil|fluorouracil|mesh-list
153347449|NCT01322815|Oxaliplatin|oxaliplatin|mesh-list
153347450|NCT01322815|Irinotecan|irinotecan|mesh-list
153419072|NCT05675319|Immunologic Factors|immunologic factors|mesh-ancestor
153419073|NCT05675319|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153419074|NCT05675319|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153419075|NCT05675319|Growth Substances|growth substances|mesh-ancestor
153419076|NCT05675319|Growth Inhibitors|growth inhibitors|mesh-ancestor
153419077|NCT05641376|Dexmedetomidine|dexmedetomidine|mesh-list
153419078|NCT05641376|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153419079|NCT05641376|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153347451|NCT01322815|Bevacizumab|bevacizumab|mesh-list
153347452|NCT01322815|Levoleucovorin|levoleucovorin|mesh-list
153347453|NCT01322815|Antimetabolites|antimetabolites|mesh-ancestor
153347454|NCT01322815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153347455|NCT01322815|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153347456|NCT01322815|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153419080|NCT05641376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153419081|NCT05641376|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153419082|NCT05641376|Analgesics|analgesics|mesh-ancestor
153419094|NCT05615311|Vitamins|vitamins|mesh-list
153419095|NCT05615311|Micronutrients|micronutrients|mesh-ancestor
153878278|NCT04620746|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153878279|NCT04620746|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153878280|NCT04614909|Temozolomide|temozolomide|mesh-list
153878281|NCT04614909|Olaparib|olaparib|mesh-list
153878282|NCT04614909|Pamiparib|pamiparib|mesh-list
153878283|NCT04614909|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153347457|NCT01322815|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153347458|NCT01322815|Immunologic Factors|immunologic factors|mesh-ancestor
153347459|NCT01322815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153347460|NCT01322815|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
153347461|NCT01322815|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153347462|NCT01322815|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153347463|NCT01322815|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153347464|NCT01322815|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153347465|NCT01322815|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153878284|NCT04614909|Alkylating Agents|alkylating agents|mesh-ancestor
153347466|NCT01322815|Growth Substances|growth substances|mesh-ancestor
153347467|NCT01322815|Growth Inhibitors|growth inhibitors|mesh-ancestor
153347468|NCT01322815|Antidotes|antidotes|mesh-ancestor
153347469|NCT01322815|Protective Agents|protective agents|mesh-ancestor
153347470|NCT01322815|Vitamin B Complex|vitamin b complex|mesh-ancestor
153347471|NCT01322815|Vitamins|vitamins|mesh-ancestor
153347472|NCT01322815|Micronutrients|micronutrients|mesh-ancestor
153347473|NCT00176228|Lamotrigine|lamotrigine|mesh-list
153347474|NCT00176228|Anticonvulsants|anticonvulsants|mesh-ancestor
153878290|NCT04614636|Fludarabine|fludarabine|mesh-list
153878291|NCT04614636|Daratumumab|daratumumab|mesh-list
153878292|NCT04614636|Elotuzumab|elotuzumab|mesh-list
153878293|NCT04614636|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153878294|NCT04614636|Immunologic Factors|immunologic factors|mesh-ancestor
153878295|NCT04614636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153878296|NCT04614636|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153347475|NCT00176228|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153347476|NCT00176228|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153347480|NCT00176228|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153347487|NCT00176306|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153347488|NCT00176306|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153347489|NCT00176306|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153347490|NCT00176306|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153347491|NCT00176306|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153347492|NCT00176306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153878297|NCT04614636|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153347493|NCT00176306|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153347494|NCT00176306|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
153878298|NCT04614636|Alkylating Agents|alkylating agents|mesh-ancestor
153878299|NCT04614636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153878300|NCT04614636|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153878301|NCT04614636|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153878302|NCT04588246|Memantine|memantine|mesh-list
153878303|NCT04588246|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
153878304|NCT04588246|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
153347495|NCT00176306|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153878305|NCT04588246|Dopamine Agents|dopamine agents|mesh-ancestor
153347496|NCT01429987|Plecanatide|plecanatide|mesh-list
153347497|NCT01429987|Guanylyl Cyclase C Agonists|guanylyl cyclase c agonists|mesh-ancestor
153347498|NCT01429987|Enzyme Activators|enzyme activators|mesh-ancestor
153347551|NCT01323517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153347552|NCT01323517|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153347553|NCT01323517|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153347554|NCT01323517|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153347555|NCT01323517|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
153347556|NCT01323517|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153347557|NCT01323517|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153347559|NCT01323595|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153783340|NCT02213419|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153347560|NCT01323595|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153347561|NCT01323595|Analgesics|analgesics|mesh-ancestor
153419112|NCT05593939|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153419113|NCT05593939|Vasodilator Agents|vasodilator agents|mesh-ancestor
153347562|NCT01323595|Sensory System Agents|sensory system agents|mesh-ancestor
153783341|NCT02213419|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153783342|NCT02213419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153347604|NCT01325311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153347606|NCT01325311|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
153347607|NCT01325311|Estrogens|estrogens|mesh-ancestor
153347609|NCT01325311|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153347610|NCT01432015|Aprepitant|aprepitant|mesh-list
153347611|NCT01432015|Fosaprepitant|fosaprepitant|mesh-list
153347612|NCT01432015|Antiemetics|antiemetics|mesh-ancestor
153347613|NCT01432015|Autonomic Agents|autonomic agents|mesh-ancestor
153347614|NCT01432015|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153347615|NCT01432015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153347616|NCT01432015|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153347618|NCT01432015|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153347659|NCT03008317|Trace Elements|trace elements|mesh-ancestor
153347660|NCT03008317|Micronutrients|micronutrients|mesh-ancestor
153347661|NCT03008317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153347662|NCT01433107|Terbinafine|terbinafine|mesh-list
153347663|NCT01433107|Antifungal Agents|antifungal agents|mesh-ancestor
153347664|NCT01433107|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153347665|NCT01433107|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153347666|NCT01433107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153347667|NCT01082939|Cyclophosphamide|cyclophosphamide|mesh-list
153347668|NCT01082939|Rituximab|rituximab|mesh-list
153347669|NCT01082939|Fludarabine|fludarabine|mesh-list
153347670|NCT01082939|Fludarabine phosphate|fludarabine phosphate|mesh-list
153347671|NCT01082939|Alemtuzumab|alemtuzumab|mesh-list
153347672|NCT01082939|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153347673|NCT01082939|Immunologic Factors|immunologic factors|mesh-ancestor
153347674|NCT01082939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153347675|NCT01082939|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153347717|NCT05448378|Micronutrients|micronutrients|mesh-ancestor
153347718|NCT05448378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153347719|NCT01434121|Ascorbic Acid|ascorbic acid|mesh-list
153347720|NCT01434121|Vitamins|vitamins|mesh-ancestor
153419161|NCT05414331|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
153419166|NCT05398367|Galactogogues|galactogogues|mesh-list
153347721|NCT01434121|Micronutrients|micronutrients|mesh-ancestor
153347722|NCT01434121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153347723|NCT01434121|Antioxidants|antioxidants|mesh-ancestor
153347724|NCT01434121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153347725|NCT01434121|Protective Agents|protective agents|mesh-ancestor
153347726|NCT01381861|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
153347727|NCT01381861|Immunologic Factors|immunologic factors|mesh-ancestor
153347728|NCT01381861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153347729|NCT01040819|Pioglitazone|pioglitazone|mesh-list
153347730|NCT01040819|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153347731|NCT01040819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153347732|NCT01041209|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
153347733|NCT01041209|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153347735|NCT01084265|Hormones|hormones|mesh-list
153347736|NCT01084265|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
153347737|NCT01084265|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153347738|NCT01084265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153347739|NCT01084265|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153347740|NCT01084499|Letrozole|letrozole|mesh-list
153347741|NCT01084499|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153347742|NCT01084499|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
153419196|NCT05330377|Sensory System Agents|sensory system agents|mesh-ancestor
153347743|NCT01084499|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153347745|NCT01084499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153347747|NCT01084499|Hormone Antagonists|hormone antagonists|mesh-ancestor
153347748|NCT01084499|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153347749|NCT01084499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153347750|NCT01118273|Diphenhydramine|diphenhydramine|mesh-list
153347751|NCT01118273|Promethazine|promethazine|mesh-list
153347752|NCT01118273|Ibuprofen|ibuprofen|mesh-list
153347754|NCT01118273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153347755|NCT01118273|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153347757|NCT01118273|Analgesics|analgesics|mesh-ancestor
153347758|NCT01118273|Sensory System Agents|sensory system agents|mesh-ancestor
153347759|NCT01118273|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153347760|NCT01118273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153347761|NCT01118273|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153347762|NCT01118273|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153347764|NCT01118273|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153347765|NCT01118273|Gout Suppressants|gout suppressants|mesh-ancestor
153347766|NCT01118273|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
153347767|NCT01118273|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153347768|NCT01118273|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153347769|NCT01118273|Anesthetics, Local|anesthetics, local|mesh-ancestor
153347814|NCT01332253|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153878425|NCT04356729|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153419215|NCT05322252|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
153419216|NCT05322252|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
153347815|NCT01332253|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153347816|NCT01332253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153419218|NCT05322252|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
153347818|NCT01332721|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153347819|NCT01332721|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153347820|NCT01332721|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153347821|NCT01332721|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153347822|NCT01332721|Growth Substances|growth substances|mesh-ancestor
153347823|NCT01332721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153347824|NCT01332721|Growth Inhibitors|growth inhibitors|mesh-ancestor
153347825|NCT01384591|Acetylcysteine|acetylcysteine|mesh-list
153347826|NCT01384591|Losartan|losartan|mesh-list
153347827|NCT01384591|N-monoacetylcystine|n-monoacetylcystine|mesh-list
153347828|NCT01384591|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153347829|NCT01384591|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153347831|NCT01384591|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
153347875|NCT00265850|Micronutrients|micronutrients|mesh-ancestor
153347876|NCT00265850|Hematinics|hematinics|mesh-ancestor
153347877|NCT00125372|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
153347878|NCT00125372|Bexarotene|bexarotene|mesh-list
153880598|NCT01190930|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153880599|NCT01190930|Immunologic Factors|immunologic factors|mesh-ancestor
153880600|NCT01190930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153880601|NCT01190930|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153880602|NCT01190930|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153347879|NCT00125372|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153419248|NCT05079828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153419249|NCT05042700|Melatonin|melatonin|mesh-list
153419250|NCT05042700|Antioxidants|antioxidants|mesh-ancestor
153419251|NCT05042700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153419252|NCT05042700|Protective Agents|protective agents|mesh-ancestor
153419253|NCT05042700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153419254|NCT05042700|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153419255|NCT05010954|Lansoprazole|lansoprazole|mesh-list
153878474|NCT04251910|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153878475|NCT04251910|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153878476|NCT04251910|Adrenergic Agents|adrenergic agents|mesh-ancestor
153347880|NCT00125372|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153347881|NCT00125372|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153347882|NCT00125372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153347883|NCT00125372|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153878477|NCT04251910|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153878478|NCT04251910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153878479|NCT04246151|Vancomycin|vancomycin|mesh-list
153347884|NCT00125528|Cycloserine|cycloserine|mesh-list
153347885|NCT00125528|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
153347886|NCT00125528|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153419292|NCT04987892|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153347887|NCT00125528|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
153347888|NCT00125528|Antitubercular Agents|antitubercular agents|mesh-ancestor
153347889|NCT00125528|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153347890|NCT00125528|Antimetabolites|antimetabolites|mesh-ancestor
153347891|NCT00125528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153347892|NCT01390909|Oxcarbazepine|oxcarbazepine|mesh-list
153347893|NCT01390909|Anticonvulsants|anticonvulsants|mesh-list
153347894|NCT01390909|Lactitol|lactitol|mesh-list
153347895|NCT01390909|Cathartics|cathartics|mesh-ancestor
153347896|NCT01390909|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153347928|NCT01087931|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153347929|NCT03009409|Ketamine|ketamine|mesh-list
153347930|NCT03009409|Analgesics|analgesics|mesh-ancestor
153783351|NCT00236093|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153347931|NCT03009409|Sensory System Agents|sensory system agents|mesh-ancestor
153419302|NCT05019222|Anesthetics, General|anesthetics, general|mesh-ancestor
153419303|NCT04966663|Carboplatin|carboplatin|mesh-list
153419304|NCT04966663|Gemcitabine|gemcitabine|mesh-list
153419306|NCT04966663|Pemetrexed|pemetrexed|mesh-list
153419307|NCT04966663|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153419308|NCT04966663|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153419309|NCT04966663|Antimetabolites|antimetabolites|mesh-ancestor
153783352|NCT00236093|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153347932|NCT03009409|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153347933|NCT03009409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153347934|NCT03009409|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
153347935|NCT03009409|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153347936|NCT03009409|Anesthetics, General|anesthetics, general|mesh-ancestor
153347937|NCT03009409|Anesthetics|anesthetics|mesh-ancestor
153347938|NCT03009409|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153419310|NCT04966663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153347939|NCT03009409|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
153347940|NCT03009409|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
153347941|NCT03009409|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153347942|NCT03009409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153347943|NCT00176930|Cyclophosphamide|cyclophosphamide|mesh-list
153419329|NCT04922593|Dopamine Agents|dopamine agents|mesh-ancestor
153419330|NCT04902950|Tranexamic Acid|tranexamic acid|mesh-list
153419331|NCT04902950|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
153419332|NCT04902950|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153419333|NCT04902950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153419335|NCT04902950|Coagulants|coagulants|mesh-ancestor
153419336|NCT04889118|Pembrolizumab|pembrolizumab|mesh-list
153419337|NCT04889118|Lenvatinib|lenvatinib|mesh-list
153419338|NCT04889118|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153419339|NCT04889118|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153347945|NCT00176930|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153419340|NCT04889118|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153347946|NCT00176930|Immunologic Factors|immunologic factors|mesh-ancestor
153347947|NCT00176930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153347948|NCT00176930|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153347949|NCT00176930|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153347950|NCT00176930|Alkylating Agents|alkylating agents|mesh-ancestor
153347954|NCT01473745|Daminozide|daminozide|mesh-list
153347975|NCT01441843|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153347976|NCT01441843|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153347977|NCT01441843|GABA Modulators|gaba modulators|mesh-ancestor
153419341|NCT04889118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153419342|NCT04889118|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153347979|NCT01441843|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153347980|NCT01441843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153347982|NCT00178646|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
153347983|NCT00178646|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
153347984|NCT00178646|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
153347985|NCT00178646|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153347986|NCT00178646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153347987|NCT00178646|Cholinergic Agents|cholinergic agents|mesh-ancestor
153347988|NCT00178646|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153347989|NCT00178646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153347990|NCT00178646|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
153347991|NCT00178646|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153347992|NCT01089569|Insulin Glargine|insulin glargine|mesh-list
153347993|NCT01089569|Exenatide|exenatide|mesh-list
153347994|NCT01089569|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153347995|NCT01089569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153347996|NCT01089569|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
153347997|NCT01089569|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
153347998|NCT01089569|Incretins|incretins|mesh-ancestor
153347999|NCT01089569|Hormones|hormones|mesh-ancestor
153348000|NCT01089569|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153348001|NCT00128180|Methylprednisolone|methylprednisolone|mesh-list
153348002|NCT00128180|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
153348003|NCT00128180|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
153348004|NCT00128180|Prednisolone|prednisolone|mesh-list
153878562|NCT04067115|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
153878563|NCT04067115|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153348006|NCT00128180|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
153348016|NCT00128180|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153348017|NCT00128180|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
153348018|NCT00128180|Protective Agents|protective agents|mesh-ancestor
153348019|NCT00128180|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153348020|NCT00128180|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153348021|NCT01121939|Bevacizumab|bevacizumab|mesh-list
153348022|NCT01121939|Pertuzumab|pertuzumab|mesh-list
153348023|NCT01121939|Octreotide|octreotide|mesh-list
153348024|NCT01121939|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153348025|NCT01121939|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153348026|NCT01121939|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153348027|NCT01121939|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153348028|NCT01121939|Growth Substances|growth substances|mesh-ancestor
153348029|NCT01121939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153348030|NCT01121939|Growth Inhibitors|growth inhibitors|mesh-ancestor
153348031|NCT01121939|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153348032|NCT01121939|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153348033|NCT03013751|Udenafil|udenafil|mesh-list
153348034|NCT03013751|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
153348035|NCT03013751|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
153348036|NCT03013751|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153348037|NCT03013751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153348038|NCT01897844|Somatostatin|somatostatin|mesh-list
153348039|NCT01897844|Hormones|hormones|mesh-ancestor
153348040|NCT01897844|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153348041|NCT01897844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153348042|NCT00131378|Hormones|hormones|mesh-list
153348043|NCT00131378|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153348044|NCT00131378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153348045|NCT01445821|Methylprednisolone|methylprednisolone|mesh-list
153419397|NCT04516850|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153878586|NCT04017442|Narcotics|narcotics|mesh-ancestor
153348046|NCT01445821|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
153348047|NCT01445821|Cyclophosphamide|cyclophosphamide|mesh-list
153348055|NCT01445821|Alkylating Agents|alkylating agents|mesh-ancestor
153419408|NCT04503460|Respiratory System Agents|respiratory system agents|mesh-ancestor
153419409|NCT04503460|Dermatologic Agents|dermatologic agents|mesh-ancestor
153348056|NCT01445821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153348057|NCT01445821|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153348058|NCT01445821|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153348059|NCT01445821|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153348060|NCT01445821|Antiemetics|antiemetics|mesh-ancestor
153348061|NCT01445821|Autonomic Agents|autonomic agents|mesh-ancestor
153348062|NCT01445821|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153348064|NCT01445821|Glucocorticoids|glucocorticoids|mesh-ancestor
153348066|NCT01445821|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153348067|NCT01445821|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
153348068|NCT01445821|Protective Agents|protective agents|mesh-ancestor
153348069|NCT01445821|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153348070|NCT00182000|Cycloserine|cycloserine|mesh-list
153348071|NCT00182000|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
153348072|NCT00182000|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153348073|NCT00182000|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
153348074|NCT00182000|Antitubercular Agents|antitubercular agents|mesh-ancestor
153348075|NCT00182000|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153348076|NCT00182000|Antimetabolites|antimetabolites|mesh-ancestor
153348077|NCT00182000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153348078|NCT01092923|Sevoflurane|sevoflurane|mesh-list
153348079|NCT01092923|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153783353|NCT00236093|Anesthetics, General|anesthetics, general|mesh-ancestor
153348082|NCT01092923|Anesthetics|anesthetics|mesh-ancestor
153348105|NCT02543658|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153348106|NCT02543658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153348107|NCT02543658|Cholinergic Agents|cholinergic agents|mesh-ancestor
153348108|NCT02543658|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153348109|NCT02543658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153348110|NCT02543658|Parasympathomimetics|parasympathomimetics|mesh-ancestor
153348111|NCT02543658|Autonomic Agents|autonomic agents|mesh-ancestor
153348112|NCT02543658|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153348114|NCT00183092|Anticestodal Agents|anticestodal agents|mesh-ancestor
153348115|NCT00183092|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
153348116|NCT00183092|Anthelmintics|anthelmintics|mesh-ancestor
153348117|NCT00183092|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153348118|NCT00183092|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153419449|NCT04150042|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153419450|NCT04150042|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153419451|NCT04150042|Immunologic Factors|immunologic factors|mesh-ancestor
153419452|NCT04150042|Antioxidants|antioxidants|mesh-ancestor
153878647|NCT03848676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153878648|NCT03843294|Nivolumab|nivolumab|mesh-list
153878649|NCT03843294|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153878650|NCT03843294|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153878653|NCT03765541|Cytarabine|cytarabine|mesh-list
153348119|NCT00183092|Antimalarials|antimalarials|mesh-ancestor
153348120|NCT00183092|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153348121|NCT00183092|Antinematodal Agents|antinematodal agents|mesh-ancestor
153348122|NCT00183092|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153348123|NCT00183092|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153348124|NCT00183092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153348125|NCT00132002|Vorinostat|vorinostat|mesh-list
153348126|NCT00132002|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153348127|NCT00132002|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
153348128|NCT00132002|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153348129|NCT00132002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153348155|NCT00270296|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153783354|NCT00236093|Anesthetics|anesthetics|mesh-ancestor
153348156|NCT00270296|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153348157|NCT00270296|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153348158|NCT00270296|Antimetabolites|antimetabolites|mesh-ancestor
153348159|NCT00270296|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
153348160|NCT00270296|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
153348162|NCT01047527|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
153348163|NCT01047527|Autonomic Agents|autonomic agents|mesh-ancestor
153348164|NCT01047527|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153348165|NCT01047527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153348166|NCT01047527|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
153348167|NCT01047527|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
153348168|NCT01047527|Cholinergic Agents|cholinergic agents|mesh-ancestor
153348212|NCT01094717|Dermatologic Agents|dermatologic agents|mesh-ancestor
153348213|NCT01094717|Keratolytic Agents|keratolytic agents|mesh-ancestor
153348214|NCT01095497|Complement C1 Inhibitor Protein|complement c1 inhibitor protein|mesh-list
153348215|NCT01095497|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
153419482|NCT03827070|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153348216|NCT01095497|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153348217|NCT01095497|Immunologic Factors|immunologic factors|mesh-ancestor
153348218|NCT01095497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153348219|NCT01095887|Eculizumab|eculizumab|mesh-list
153348220|NCT01095887|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
153348221|NCT01095887|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153348222|NCT01095887|Immunologic Factors|immunologic factors|mesh-ancestor
153348223|NCT01095887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153348224|NCT03110315|Suvorexant|suvorexant|mesh-list
153348225|NCT03110315|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
153348226|NCT03110315|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153348227|NCT03110315|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153348228|NCT03110315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153348229|NCT03110315|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
153348233|NCT05307341|Dsuvia|dsuvia|mesh-list
153348269|NCT01100723|Micronutrients|micronutrients|mesh-ancestor
153348270|NCT01100723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153348271|NCT01100723|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153348272|NCT01100723|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153348273|NCT01100723|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
153348274|NCT01100723|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153419509|NCT03657602|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
153419510|NCT03657602|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
153419511|NCT03657602|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
153419512|NCT03632369|Xenon|xenon|mesh-list
153419513|NCT03632369|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
153419514|NCT03632369|Anesthetics, General|anesthetics, general|mesh-ancestor
153419515|NCT03632369|Anesthetics|anesthetics|mesh-ancestor
153419516|NCT03632369|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153419517|NCT03632369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153419518|NCT03625687|Antiviral Agents|antiviral agents|mesh-list
153419521|NCT03469284|Methylene Blue|methylene blue|mesh-list
153348275|NCT01100723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153348276|NCT01100723|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
153348277|NCT01100723|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
153348278|NCT01100723|Hormone Antagonists|hormone antagonists|mesh-ancestor
153348279|NCT01100723|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153348281|NCT05306405|Estradiol|estradiol|mesh-list
153348282|NCT05306405|Estrogens|estrogens|mesh-ancestor
153348283|NCT05306405|Hormones|hormones|mesh-ancestor
153348284|NCT05306405|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153348285|NCT05306405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153348287|NCT05306405|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
153348288|NCT05306405|Abortifacient Agents|abortifacient agents|mesh-ancestor
153348289|NCT05306405|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
153419567|NCT03035890|Immunomodulating Agents|immunomodulating agents|mesh-list
153419568|NCT03035890|Immunologic Factors|immunologic factors|mesh-ancestor
153878756|NCT03609840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153878757|NCT03609840|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153878758|NCT03609840|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153878759|NCT03609840|Immunologic Factors|immunologic factors|mesh-ancestor
153878760|NCT03609840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153348290|NCT05306405|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153348291|NCT05306405|Oxytocics|oxytocics|mesh-ancestor
153348292|NCT04352621|Ketamine|ketamine|mesh-list
153348293|NCT04352621|Analgesics|analgesics|mesh-ancestor
153878762|NCT03601897|Rebastinib|rebastinib|mesh-list
153878763|NCT03601897|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153878764|NCT03601897|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153878765|NCT03601897|Tubulin Modulators|tubulin modulators|mesh-ancestor
153348294|NCT04352621|Sensory System Agents|sensory system agents|mesh-ancestor
153348295|NCT04352621|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153348296|NCT04352621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153348297|NCT04352621|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
153348298|NCT04352621|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153348299|NCT04352621|Anesthetics, General|anesthetics, general|mesh-ancestor
153878766|NCT03601897|Antimitotic Agents|antimitotic agents|mesh-ancestor
153348312|NCT05272397|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
153348313|NCT05272397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153348314|NCT05272397|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
153348315|NCT05272397|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153348316|NCT05272397|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153348317|NCT05272397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153348318|NCT05272397|Dopamine Agents|dopamine agents|mesh-ancestor
153348319|NCT05272397|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153348320|NCT00185900|Magnesium Sulfate|magnesium sulfate|mesh-list
153348321|NCT00185900|Nifedipine|nifedipine|mesh-list
153348322|NCT00185900|Analgesics|analgesics|mesh-ancestor
153348323|NCT00185900|Sensory System Agents|sensory system agents|mesh-ancestor
153348324|NCT00185900|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153348325|NCT00185900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153348326|NCT00185900|Anesthetics|anesthetics|mesh-ancestor
153348327|NCT00185900|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153348328|NCT00185900|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153348329|NCT00185900|Anticonvulsants|anticonvulsants|mesh-ancestor
153348330|NCT00185900|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153419670|NCT03041636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153348331|NCT00185900|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153348332|NCT00185900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153348333|NCT00185900|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153348334|NCT00185900|Tocolytic Agents|tocolytic agents|mesh-ancestor
153419674|NCT03043105|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153419675|NCT03043105|Immunologic Factors|immunologic factors|mesh-ancestor
153419676|NCT03043105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153419677|NCT03043105|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153348335|NCT00185900|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153348336|NCT00185900|Vasodilator Agents|vasodilator agents|mesh-ancestor
153348337|NCT00186056|Mifepristone|mifepristone|mesh-list
153421473|NCT05889741|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153348338|NCT00186056|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
153348339|NCT00186056|Abortifacient Agents|abortifacient agents|mesh-ancestor
153348340|NCT00186056|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153348341|NCT00186056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153348342|NCT00186056|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
153348343|NCT00186056|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
153348349|NCT00186056|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153348350|NCT00186056|Luteolytic Agents|luteolytic agents|mesh-ancestor
153348351|NCT00186056|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
153348352|NCT00186056|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
153348354|NCT00186446|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
153348355|NCT00186446|Antidepressive Agents|antidepressive agents|mesh-ancestor
153348356|NCT00186446|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153348357|NCT00186446|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
153348359|NCT00186446|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153419742|NCT02970032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153419743|NCT02813551|Torsemide|torsemide|mesh-list
153419745|NCT02813551|Diuretics|diuretics|mesh-ancestor
153348360|NCT00186446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153348363|NCT00186446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153348364|NCT00186446|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
153348365|NCT00186446|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153348366|NCT00186446|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153348367|NCT00136760|Bupropion|bupropion|mesh-list
153348368|NCT00136760|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
153348369|NCT00136760|Antidepressive Agents|antidepressive agents|mesh-ancestor
153348370|NCT00136760|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153348371|NCT00136760|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
153348372|NCT00136760|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153348373|NCT00136760|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153348374|NCT00136760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153348375|NCT00136760|Dopamine Agents|dopamine agents|mesh-ancestor
153348376|NCT00136760|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153348377|NCT00136760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153348378|NCT00136760|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
153348379|NCT00136760|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153348390|NCT00189098|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153348391|NCT00189098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153348392|NCT00189098|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
153348393|NCT00189098|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
153419819|NCT00373789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153419820|NCT00373789|Cholinergic Agents|cholinergic agents|mesh-ancestor
153419821|NCT00373789|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153419822|NCT00373789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153419823|NCT00373789|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
153419824|NCT00373789|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153419825|NCT03062605|Povidone-Iodine|povidone-iodine|mesh-list
153348394|NCT00189098|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153348395|NCT00189098|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153348396|NCT00145418|Docetaxel|docetaxel|mesh-list
153348397|NCT00145418|Oxaliplatin|oxaliplatin|mesh-list
153419826|NCT03062605|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
153419827|NCT03062605|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153419828|NCT03050294|Desoximetasone|desoximetasone|mesh-list
153419831|NCT03050294|Hormones|hormones|mesh-ancestor
153419834|NCT02831569|Loxoprofen|loxoprofen|mesh-list
153348398|NCT00145418|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153348399|NCT00145418|Tubulin Modulators|tubulin modulators|mesh-ancestor
153348400|NCT00145418|Antimitotic Agents|antimitotic agents|mesh-ancestor
153348401|NCT00145418|Mitosis Modulators|mitosis modulators|mesh-ancestor
153348402|NCT00145418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153348450|NCT00277394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153783357|NCT04552483|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153348451|NCT01450189|Tenofovir|tenofovir|mesh-list
153348452|NCT01450189|Emtricitabine|emtricitabine|mesh-list
153378493|NCT05045937|Vitamin D|vitamin d|mesh-list
153378494|NCT05045937|Vitamins|vitamins|mesh-list
153378495|NCT05045937|Ivermectin|ivermectin|mesh-list
153348453|NCT01450189|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
153348454|NCT01450189|Raltegravir Potassium|raltegravir potassium|mesh-list
153348455|NCT01450189|Antiviral Agents|antiviral agents|mesh-ancestor
153348456|NCT01450189|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153348457|NCT01450189|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153348458|NCT01450189|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153348459|NCT01450189|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153348460|NCT01450189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153348461|NCT01450189|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153348462|NCT01450189|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153348463|NCT01450189|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
153348464|NCT01450189|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
153348465|NCT00278876|Imatinib Mesylate|imatinib mesylate|mesh-list
153348466|NCT00278876|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153348467|NCT00278876|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153348469|NCT00278876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153348470|NCT00278876|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153348498|NCT01474915|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153348499|NCT01474915|Antiemetics|antiemetics|mesh-ancestor
153419849|NCT03065179|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153419850|NCT03065179|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153419851|NCT03065179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153419852|NCT02988050|Lidocaine|lidocaine|mesh-list
153348501|NCT01474915|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153419853|NCT02988050|Epinephrine|epinephrine|mesh-list
153348502|NCT01474915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153348503|NCT01474915|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153348504|NCT01474915|Glucocorticoids|glucocorticoids|mesh-ancestor
153348505|NCT01474915|Hormones|hormones|mesh-ancestor
153348506|NCT01474915|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153348507|NCT01474915|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153348508|NCT01474915|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153348509|NCT01474915|Antipruritics|antipruritics|mesh-ancestor
153348510|NCT01474915|Dermatologic Agents|dermatologic agents|mesh-ancestor
153348511|NCT01474915|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
153348512|NCT01474915|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153348513|NCT01474915|Serotonin Agents|serotonin agents|mesh-ancestor
153348514|NCT01474915|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153348515|NCT01474915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153348516|NCT01474915|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
153348525|NCT01474915|Anesthetics|anesthetics|mesh-ancestor
153348549|NCT01391299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153348551|NCT01391299|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153348552|NCT02099084|Teduglutide|teduglutide|mesh-list
153348553|NCT02099084|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153348554|NCT02099084|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
153348555|NCT02099084|Protective Agents|protective agents|mesh-ancestor
153348556|NCT02099084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153348557|NCT00281918|Cyclophosphamide|cyclophosphamide|mesh-list
153348558|NCT00281918|Rituximab|rituximab|mesh-list
153348559|NCT00281918|Fludarabine|fludarabine|mesh-list
153348560|NCT00281918|Fludarabine phosphate|fludarabine phosphate|mesh-list
153348561|NCT00281918|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153348562|NCT00281918|Immunologic Factors|immunologic factors|mesh-ancestor
153348563|NCT00281918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153348612|NCT00210470|Analgesics|analgesics|mesh-ancestor
153348613|NCT00210470|Sensory System Agents|sensory system agents|mesh-ancestor
153348614|NCT00210470|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153348615|NCT00210470|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153348616|NCT00210470|Gout Suppressants|gout suppressants|mesh-ancestor
153419958|NCT00374881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153419959|NCT00374881|Analgesics|analgesics|mesh-ancestor
153419960|NCT00374881|Sensory System Agents|sensory system agents|mesh-ancestor
153419961|NCT00374881|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153419962|NCT00374881|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
153419963|NCT00374881|Mydriatics|mydriatics|mesh-ancestor
153419964|NCT00374881|Autonomic Agents|autonomic agents|mesh-ancestor
153419965|NCT00374881|Sympathomimetics|sympathomimetics|mesh-ancestor
153419966|NCT00374881|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
153419967|NCT00374881|Nasal Decongestants|nasal decongestants|mesh-ancestor
153419968|NCT00374881|Respiratory System Agents|respiratory system agents|mesh-ancestor
153348617|NCT00210470|Tocolytic Agents|tocolytic agents|mesh-ancestor
153348618|NCT00210470|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153348619|NCT00210470|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153348620|NCT01108445|Everolimus|everolimus|mesh-list
153348621|NCT01108445|Sunitinib|sunitinib|mesh-list
153348622|NCT01108445|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
153348623|NCT01108445|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153348624|NCT01108445|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153348625|NCT01108445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153348626|NCT01108445|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153348627|NCT01108445|Immunologic Factors|immunologic factors|mesh-ancestor
153419969|NCT00374881|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
153348628|NCT01108445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153348629|NCT01108445|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153348630|NCT01108445|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153348631|NCT01108445|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153348669|NCT01131065|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
153348670|NCT01131065|Immunologic Factors|immunologic factors|mesh-ancestor
153348671|NCT01131065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153348672|NCT01165541|Quetiapine Fumarate|quetiapine fumarate|mesh-list
153348673|NCT01165541|Mirtazapine|mirtazapine|mesh-list
153348674|NCT01165541|Antidepressive Agents|antidepressive agents|mesh-ancestor
153880619|NCT01190930|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153880620|NCT01190930|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153880621|NCT01190930|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153783360|NCT02213614|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153348675|NCT01165541|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153783361|NCT02213614|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153783362|NCT02213614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153783363|NCT02213614|Antimanic Agents|antimanic agents|mesh-ancestor
153783364|NCT02213614|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153783365|NCT02213614|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153348676|NCT01165541|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153348677|NCT01165541|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153879167|NCT06078839|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
153879169|NCT06078839|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153348678|NCT01165541|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153348679|NCT01165541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153348680|NCT01165541|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
153348681|NCT01165541|Histamine Antagonists|histamine antagonists|mesh-ancestor
153348683|NCT01165541|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153879207|NCT06078605|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153348684|NCT01165541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153348685|NCT01165541|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153348689|NCT01165541|Adrenergic Agents|adrenergic agents|mesh-ancestor
153879208|NCT06078605|Antimetabolites|antimetabolites|mesh-ancestor
153879209|NCT06078605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153879210|NCT06078605|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153348713|NCT00287222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153348714|NCT00287222|Growth Inhibitors|growth inhibitors|mesh-ancestor
153348715|NCT00287222|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153348716|NCT00287222|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153348717|NCT00287222|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153348718|NCT00287222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153348719|NCT00218426|Naltrexone|naltrexone|mesh-list
153348720|NCT00218426|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
153348721|NCT00218426|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
153348722|NCT00218426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153348723|NCT00218426|Sensory System Agents|sensory system agents|mesh-ancestor
153348724|NCT00218426|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153348726|NCT01790672|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
153348727|NCT01790672|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153348728|NCT01790672|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153348729|NCT01790672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153348730|NCT00223262|Lamotrigine|lamotrigine|mesh-list
153348731|NCT00223262|Anticonvulsants|anticonvulsants|mesh-ancestor
153348732|NCT00223262|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153348733|NCT00223262|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153348734|NCT00223262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153348735|NCT00223262|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153348736|NCT00223262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153348737|NCT00223262|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153348738|NCT00223262|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153348739|NCT00223262|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153348740|NCT00223262|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153348741|NCT00223262|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153348742|NCT00290654|Tamoxifen|tamoxifen|mesh-list
153420074|NCT03057704|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153879231|NCT06076980|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153879232|NCT06076980|Analgesics|analgesics|mesh-ancestor
153879236|NCT06076980|Antipyretics|antipyretics|mesh-ancestor
153348743|NCT00290654|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
153783366|NCT02213614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153348744|NCT00290654|Hormone Antagonists|hormone antagonists|mesh-ancestor
153348745|NCT00290654|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153348746|NCT00290654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153348747|NCT00290654|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153348748|NCT00290654|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153348749|NCT00290654|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
153348750|NCT00290654|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
153348751|NCT00290654|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153348753|NCT00290810|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
153348754|NCT00290810|Antibodies|antibodies|mesh-list
153348755|NCT00290810|Immunoglobulins|immunoglobulins|mesh-list
153348756|NCT00290810|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
153348757|NCT00290810|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153348758|NCT00290810|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153348759|NCT00290810|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153348760|NCT00290810|Growth Substances|growth substances|mesh-ancestor
153348761|NCT00290810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153348762|NCT00290810|Growth Inhibitors|growth inhibitors|mesh-ancestor
153348763|NCT00290810|Immunologic Factors|immunologic factors|mesh-ancestor
153348764|NCT04042142|Glucagon|glucagon|mesh-list
153348765|NCT04042142|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153348766|NCT04042142|Hormones|hormones|mesh-ancestor
153348767|NCT04042142|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153420089|NCT02876900|Maleic acid|maleic acid|mesh-list
153420090|NCT02876900|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153420091|NCT02876900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153879267|NCT05975450|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153879268|NCT05975450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153879269|NCT05975450|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153879270|NCT05975450|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153348768|NCT04042142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153348769|NCT01138475|Cholecalciferol|cholecalciferol|mesh-list
153348770|NCT01138475|Vitamin D|vitamin d|mesh-list
153348771|NCT01138475|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153879275|NCT05943821|Allopurinol|allopurinol|mesh-list
153348772|NCT01138475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153348791|NCT03012113|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153348792|NCT03012113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153348793|NCT03012113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153348794|NCT03012113|Urological Agents|urological agents|mesh-ancestor
153348795|NCT01139801|Misoprostol|misoprostol|mesh-list
153348796|NCT01139801|Oxytocin|oxytocin|mesh-list
153348797|NCT01139801|Oxytocics|oxytocics|mesh-ancestor
153348799|NCT01139801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153348800|NCT01139801|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
153348801|NCT01139801|Abortifacient Agents|abortifacient agents|mesh-ancestor
153348802|NCT01139801|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
153348803|NCT01139801|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153348804|NCT00294632|Rituximab|rituximab|mesh-list
153348805|NCT00294632|Lenalidomide|lenalidomide|mesh-list
153348806|NCT00294632|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153348807|NCT00294632|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153348808|NCT00294632|Immunologic Factors|immunologic factors|mesh-ancestor
153348809|NCT00294632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153348810|NCT00294632|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153348848|NCT01141595|Verapamil|verapamil|mesh-list
153348849|NCT01141595|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153348850|NCT01141595|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153348851|NCT01141595|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153348852|NCT01141595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153348853|NCT01141595|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153348854|NCT01141595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153348855|NCT01141595|Vasodilator Agents|vasodilator agents|mesh-ancestor
153348856|NCT01167569|Ascorbic Acid|ascorbic acid|mesh-list
153348857|NCT01167569|Vitamins|vitamins|mesh-ancestor
153348858|NCT01167569|Micronutrients|micronutrients|mesh-ancestor
153879328|NCT05721755|Immunologic Factors|immunologic factors|mesh-ancestor
153879329|NCT05721755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153348859|NCT01167569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153348860|NCT01167569|Antioxidants|antioxidants|mesh-ancestor
153879331|NCT05717166|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153879333|NCT05689099|Semaglutide|semaglutide|mesh-list
153348861|NCT01167569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153880642|NCT01190930|Hematinics|hematinics|mesh-ancestor
153348862|NCT01167569|Protective Agents|protective agents|mesh-ancestor
153348864|NCT00296192|Dopamine Agonists|dopamine agonists|mesh-ancestor
153348865|NCT00296192|Dopamine Agents|dopamine agents|mesh-ancestor
153348866|NCT00296192|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153348867|NCT00296192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153348868|NCT00296192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153348869|NCT04312139|Lincomycin|lincomycin|mesh-list
153420176|NCT03070730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153420177|NCT03070730|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
153420178|NCT03070730|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
153420179|NCT03121820|Memantine|memantine|mesh-list
153420180|NCT03121820|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
153420181|NCT03121820|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
153420182|NCT03121820|Dopamine Agents|dopamine agents|mesh-ancestor
153879339|NCT05656443|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
153879340|NCT05656443|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
153879341|NCT05656443|Protease Inhibitors|protease inhibitors|mesh-ancestor
153879342|NCT05656443|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153879343|NCT05656443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153879344|NCT05656443|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153348870|NCT04312139|Calcium|calcium|mesh-list
153348871|NCT04312139|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153348872|NCT04312139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153348873|NCT04312139|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153348874|NCT04312139|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153348876|NCT04312139|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153783368|NCT02213653|Trace Elements|trace elements|mesh-ancestor
153348894|NCT00298610|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153348895|NCT00298610|Antiviral Agents|antiviral agents|mesh-ancestor
153348896|NCT00298610|Schistosomicides|schistosomicides|mesh-ancestor
153348897|NCT00298610|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
153348898|NCT00298610|Anthelmintics|anthelmintics|mesh-ancestor
153348899|NCT00298610|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153348900|NCT00298610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153348901|NCT00298610|Antimetabolites|antimetabolites|mesh-ancestor
153879345|NCT05656443|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153348902|NCT00298610|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
153348903|NCT00298610|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
153348905|NCT00298610|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153348906|NCT00298610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153348907|NCT00298610|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153348908|NCT00298610|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
153348909|NCT00298610|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
153348910|NCT00298610|Cholinergic Agents|cholinergic agents|mesh-ancestor
153348911|NCT00298610|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
153348912|NCT00298610|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153420216|NCT03123848|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153420217|NCT03123848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153420218|NCT03123848|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153420219|NCT03123848|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153420220|NCT03123848|Antiviral Agents|antiviral agents|mesh-ancestor
153420221|NCT03123848|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153420222|NCT03123848|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
153420223|NCT03123848|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153420224|NCT02946073|Buprenorphine|buprenorphine|mesh-list
153420225|NCT02946073|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153879440|NCT05223010|Antioxidants|antioxidants|mesh-ancestor
153378503|NCT05045937|Micronutrients|micronutrients|mesh-ancestor
153879441|NCT05223010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153879442|NCT05223010|Protective Agents|protective agents|mesh-ancestor
153879443|NCT05181592|Luspatercept|luspatercept|mesh-list
153879444|NCT05181592|Hematinics|hematinics|mesh-ancestor
153879445|NCT05169554|Amoxicillin|amoxicillin|mesh-list
153348913|NCT00298610|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153348914|NCT00298610|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
153348915|NCT00298610|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153348916|NCT01144949|Silodosin|silodosin|mesh-list
153348917|NCT01144949|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
153348918|NCT01144949|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
153348919|NCT01144949|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
153348920|NCT01144949|Adrenergic Agents|adrenergic agents|mesh-ancestor
153348921|NCT01144949|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153348922|NCT01144949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153348923|NCT01144949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153348924|NCT01144949|Urological Agents|urological agents|mesh-ancestor
153348925|NCT00215930|Carboplatin|carboplatin|mesh-list
153348926|NCT00215930|Gemcitabine|gemcitabine|mesh-list
153348927|NCT00215930|Docetaxel|docetaxel|mesh-list
153348931|NCT00215930|Antimetabolites|antimetabolites|mesh-ancestor
153348932|NCT00215930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153420314|NCT00375050|Protective Agents|protective agents|mesh-ancestor
153348934|NCT00215930|Antimitotic Agents|antimitotic agents|mesh-ancestor
153348935|NCT00215930|Mitosis Modulators|mitosis modulators|mesh-ancestor
153348936|NCT00215930|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153348937|NCT01145183|Doxazosin|doxazosin|mesh-list
153348938|NCT01145183|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153348939|NCT01145183|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
153348940|NCT01145183|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
153348941|NCT01145183|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
153348942|NCT01145183|Adrenergic Agents|adrenergic agents|mesh-ancestor
153348943|NCT01145183|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153348944|NCT01145183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153421493|NCT05850520|Growth Inhibitors|growth inhibitors|mesh-ancestor
153421494|NCT05850520|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153421496|NCT05839652|Droxidopa|droxidopa|mesh-list
153420315|NCT02860507|Glycopyrrolate|glycopyrrolate|mesh-list
153420316|NCT02860507|Neostigmine|neostigmine|mesh-list
153421497|NCT05839652|Sympathomimetics|sympathomimetics|mesh-ancestor
153421498|NCT05839652|Autonomic Agents|autonomic agents|mesh-ancestor
153348948|NCT00230126|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153348986|NCT03011645|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153348987|NCT03011645|Serotonin Agents|serotonin agents|mesh-ancestor
153348988|NCT03011645|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153348989|NCT03011645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153348990|NCT03011645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153348991|NCT03011645|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153348992|NCT03011645|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153348993|NCT03011645|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153420317|NCT02860507|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
153420318|NCT02860507|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153420319|NCT02860507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153420320|NCT02860507|Cholinergic Agents|cholinergic agents|mesh-ancestor
153420321|NCT02860507|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153420322|NCT02860507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153420323|NCT02860507|Parasympathomimetics|parasympathomimetics|mesh-ancestor
153348994|NCT03011645|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153348995|NCT03011645|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
153420324|NCT02860507|Autonomic Agents|autonomic agents|mesh-ancestor
153879505|NCT04867798|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153348996|NCT03011645|Dopamine Agents|dopamine agents|mesh-ancestor
153348997|NCT01149785|Ketoconazole|ketoconazole|mesh-list
153348999|NCT01149785|Antifungal Agents|antifungal agents|mesh-ancestor
153349000|NCT01149785|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153349001|NCT01149785|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
153349002|NCT01149785|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153349003|NCT01149785|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153349004|NCT01149785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153879506|NCT04867798|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153879507|NCT04867798|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153349005|NCT01149785|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153420329|NCT03082196|Fluorides|fluorides|mesh-list
153420330|NCT03082196|Sodium Fluoride|sodium fluoride|mesh-list
153420331|NCT03082196|Fluorides, Topical|fluorides, topical|mesh-list
153420332|NCT03082196|Cariostatic Agents|cariostatic agents|mesh-ancestor
153420333|NCT03082196|Protective Agents|protective agents|mesh-ancestor
153349006|NCT01149785|Hormone Antagonists|hormone antagonists|mesh-ancestor
153349007|NCT01149785|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153349008|NCT01149785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153349009|NCT01149785|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
153349011|NCT01149785|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153349012|NCT01149785|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153349013|NCT02182115|Anti-Infective Agents, Local|anti-infective agents, local|mesh-list
153349014|NCT02182115|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153349015|NCT01173029|Antihypertensive Agents|antihypertensive agents|mesh-list
153349016|NCT01173029|Calcium Channel Blockers|calcium channel blockers|mesh-list
153349018|NCT01173029|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
153420407|NCT03091478|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153879553|NCT04730947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153879554|NCT04730947|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153879555|NCT04730947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153879556|NCT04725331|Pembrolizumab|pembrolizumab|mesh-list
153879557|NCT04725331|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153879558|NCT04725331|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153879559|NCT04725331|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153879560|NCT04725331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153879561|NCT04716725|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
153879562|NCT04716725|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
153349019|NCT01173029|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-list
153349020|NCT01173029|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-list
153349021|NCT01173029|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-list
153349022|NCT01173029|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153349023|NCT01173029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153349024|NCT01173029|Natriuretic Agents|natriuretic agents|mesh-ancestor
153349025|NCT01173029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153349026|NCT01173029|Protease Inhibitors|protease inhibitors|mesh-ancestor
153420408|NCT03091478|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153349028|NCT01173029|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153349029|NCT01173029|Hormone Antagonists|hormone antagonists|mesh-ancestor
153349080|NCT03465527|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153349082|NCT03465527|Hormones|hormones|mesh-ancestor
153349083|NCT03465527|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153349084|NCT03465527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153349085|NCT03465527|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153349086|NCT03465527|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153349087|NCT03418805|Ibuprofen|ibuprofen|mesh-list
153349088|NCT03418805|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153349089|NCT03418805|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153420422|NCT00375596|Histamine Antagonists|histamine antagonists|mesh-ancestor
153420423|NCT00375596|Histamine Agents|histamine agents|mesh-ancestor
153420424|NCT00375596|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153420425|NCT00375596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153420426|NCT00375596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153420428|NCT03093272|Prednisone|prednisone|mesh-list
153349091|NCT03418805|Sensory System Agents|sensory system agents|mesh-ancestor
153349092|NCT03418805|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153349093|NCT03418805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153349094|NCT03418805|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153349095|NCT03418805|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153349096|NCT03418805|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153420429|NCT03093272|Docetaxel|docetaxel|mesh-list
153349097|NCT03418805|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153420430|NCT03093272|Leuprolide|leuprolide|mesh-list
153420437|NCT03093272|Glucocorticoids|glucocorticoids|mesh-ancestor
153349098|NCT03418805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153349101|NCT01156571|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153349102|NCT01156571|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
153349103|NCT01156571|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
153349104|NCT01156571|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
153349105|NCT01156571|Purinergic Agents|purinergic agents|mesh-ancestor
153349106|NCT01156571|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153349107|NCT01156571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153349108|NCT01156571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153349109|NCT01220687|Nitric Oxide|nitric oxide|mesh-list
153349110|NCT01220687|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153349111|NCT01220687|Autonomic Agents|autonomic agents|mesh-ancestor
153349112|NCT01220687|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153349117|NCT01220687|Antioxidants|antioxidants|mesh-ancestor
153349118|NCT01220687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153349119|NCT01220687|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153349120|NCT01220687|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
153349121|NCT01220687|Vasodilator Agents|vasodilator agents|mesh-ancestor
153349122|NCT01220687|Gasotransmitters|gasotransmitters|mesh-ancestor
153349123|NCT01220687|Protective Agents|protective agents|mesh-ancestor
153349124|NCT03010865|Butyric Acid|butyric acid|mesh-list
153349125|NCT03010865|Histamine Antagonists|histamine antagonists|mesh-ancestor
153349126|NCT03010865|Histamine Agents|histamine agents|mesh-ancestor
153349127|NCT03010865|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153349128|NCT03010865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153349129|NCT03010865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153349130|NCT01157429|Cycloserine|cycloserine|mesh-list
153349131|NCT01157429|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
153420451|NCT03100123|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153420452|NCT03100123|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153349132|NCT01157429|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153420454|NCT03100123|Sensory System Agents|sensory system agents|mesh-ancestor
153420455|NCT03100123|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153349133|NCT01157429|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
153349134|NCT01157429|Antitubercular Agents|antitubercular agents|mesh-ancestor
153349135|NCT01157429|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153349136|NCT01157429|Antimetabolites|antimetabolites|mesh-ancestor
153349137|NCT01157429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153349138|NCT00234884|Adalimumab|adalimumab|mesh-list
153349139|NCT00234884|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
153349140|NCT00234884|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153349141|NCT00234884|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153349167|NCT00301418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153349168|NCT00301418|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153349170|NCT05414214|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153349171|NCT05414214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153349172|NCT05014230|Analgesics, Opioid|analgesics, opioid|mesh-list
153349173|NCT05014230|Narcotics|narcotics|mesh-ancestor
153349174|NCT05014230|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153349175|NCT05014230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153349176|NCT05014230|Analgesics|analgesics|mesh-ancestor
153349177|NCT05014230|Sensory System Agents|sensory system agents|mesh-ancestor
153420555|NCT04468568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153420556|NCT04468568|Hormone Antagonists|hormone antagonists|mesh-ancestor
153349178|NCT05014230|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153349179|NCT01896284|Aflibercept|aflibercept|mesh-list
153349180|NCT01896284|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153349181|NCT01896284|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153349182|NCT01896284|Growth Substances|growth substances|mesh-ancestor
153349183|NCT01896284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153783372|NCT04552444|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153783373|NCT00236171|Methylprednisolone aceponate|methylprednisolone aceponate|mesh-list
153349184|NCT01896284|Growth Inhibitors|growth inhibitors|mesh-ancestor
153349185|NCT01896284|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153349186|NCT05438160|Coal Tar|coal tar|mesh-list
153349187|NCT05438160|Keratolytic Agents|keratolytic agents|mesh-ancestor
153349190|NCT01478581|Ibrutinib|ibrutinib|mesh-list
153349216|NCT00241904|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-list
153349217|NCT00241904|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
153349218|NCT00241904|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
153349219|NCT00241904|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
153349220|NCT00241904|Adrenergic Agents|adrenergic agents|mesh-ancestor
153349221|NCT00241904|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153349222|NCT00241904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153420587|NCT03115177|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153420588|NCT03115177|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153420589|NCT03174158|Nicotine|nicotine|mesh-list
153420590|NCT03174158|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
153420591|NCT03174158|Autonomic Agents|autonomic agents|mesh-ancestor
153420592|NCT03174158|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153420593|NCT03174158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153420594|NCT03174158|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
153420595|NCT03174158|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
153420596|NCT03174158|Cholinergic Agents|cholinergic agents|mesh-ancestor
153420597|NCT03174158|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153420598|NCT03174158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153349223|NCT00241904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153349224|NCT00241904|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153349225|NCT00241904|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153349226|NCT00241904|Vasodilator Agents|vasodilator agents|mesh-ancestor
153349227|NCT00241904|Sympatholytics|sympatholytics|mesh-ancestor
153349228|NCT00241904|Autonomic Agents|autonomic agents|mesh-ancestor
153349229|NCT00241904|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153349230|NCT00241904|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
153420599|NCT03115801|Pembrolizumab|pembrolizumab|mesh-list
153420600|NCT03115801|Nivolumab|nivolumab|mesh-list
153420601|NCT03115801|Atezolizumab|atezolizumab|mesh-list
153420619|NCT00375284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153420620|NCT00375284|Protective Agents|protective agents|mesh-ancestor
153420621|NCT00375284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153349231|NCT00241904|Protease Inhibitors|protease inhibitors|mesh-ancestor
153349232|NCT00241904|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153349233|NCT00241904|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
153349234|NCT00241904|Protective Agents|protective agents|mesh-ancestor
153349235|NCT01791296|Dexmedetomidine|dexmedetomidine|mesh-list
153349236|NCT01791296|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153349237|NCT01791296|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153349238|NCT01791296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153349239|NCT01791296|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153349240|NCT01791296|Analgesics|analgesics|mesh-ancestor
153349241|NCT01791296|Sensory System Agents|sensory system agents|mesh-ancestor
153349242|NCT01791296|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153349243|NCT01791296|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
153349244|NCT01791296|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153349245|NCT01791296|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153420622|NCT00375284|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
153420623|NCT00375284|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
153420624|NCT00375284|Dopamine Agonists|dopamine agonists|mesh-ancestor
153349246|NCT01791296|Adrenergic Agents|adrenergic agents|mesh-ancestor
153349247|NCT01791296|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153349249|NCT01479127|Silicon|silicon|mesh-list
153349255|NCT01479127|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153349256|NCT01479127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153349257|NCT01479127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153420625|NCT00375284|Dopamine Agents|dopamine agents|mesh-ancestor
153420627|NCT02966275|Glucagon|glucagon|mesh-list
153349258|NCT01479127|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
153349259|NCT01479127|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153349260|NCT01479127|Trace Elements|trace elements|mesh-ancestor
153349261|NCT01479127|Micronutrients|micronutrients|mesh-ancestor
153349262|NCT03917966|Docetaxel|docetaxel|mesh-list
153349263|NCT03917966|Apatinib|apatinib|mesh-list
153349264|NCT03917966|Nedaplatin|nedaplatin|mesh-list
153349265|NCT03917966|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153349266|NCT03917966|Tubulin Modulators|tubulin modulators|mesh-ancestor
153349267|NCT03917966|Antimitotic Agents|antimitotic agents|mesh-ancestor
153349268|NCT03917966|Mitosis Modulators|mitosis modulators|mesh-ancestor
153349269|NCT03917966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153349270|NCT03917966|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153349271|NCT03917966|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153349272|NCT00243152|Lamotrigine|lamotrigine|mesh-list
153349273|NCT00243152|Anticonvulsants|anticonvulsants|mesh-list
153349274|NCT00243152|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153349275|NCT00243152|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153349276|NCT00243152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153349277|NCT00243152|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153879794|NCT03721653|Growth Substances|growth substances|mesh-ancestor
153879795|NCT03721653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153879796|NCT03721653|Growth Inhibitors|growth inhibitors|mesh-ancestor
153879797|NCT03721653|Antimetabolites|antimetabolites|mesh-ancestor
153879798|NCT03721653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153879799|NCT03721653|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153879800|NCT03721653|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153879801|NCT03721653|Immunologic Factors|immunologic factors|mesh-ancestor
153879802|NCT03721653|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
153879803|NCT03721653|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153879804|NCT03721653|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153879805|NCT03721653|Antidotes|antidotes|mesh-ancestor
153879806|NCT03721653|Protective Agents|protective agents|mesh-ancestor
153879807|NCT03721653|Vitamin B Complex|vitamin b complex|mesh-ancestor
153879808|NCT03721653|Vitamins|vitamins|mesh-ancestor
153879809|NCT03721653|Micronutrients|micronutrients|mesh-ancestor
153349278|NCT00243152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153349279|NCT00243152|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153349280|NCT00243152|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153349281|NCT00243152|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153349282|NCT00243152|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153349283|NCT00243152|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153349284|NCT01453075|Valacyclovir|valacyclovir|mesh-list
153349285|NCT01453075|Antiviral Agents|antiviral agents|mesh-ancestor
153880647|NCT01047007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153349287|NCT01791374|Rilotumumab|rilotumumab|mesh-list
153349288|NCT01791374|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
153349296|NCT03783416|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153349297|NCT03783416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153349298|NCT00248534|Methylprednisolone|methylprednisolone|mesh-list
153879810|NCT03721653|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153879811|NCT03709992|Tamsulosin|tamsulosin|mesh-list
153349299|NCT00248534|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
153420692|NCT02161146|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153420698|NCT02161146|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153420699|NCT02161146|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153420700|NCT02161146|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
153420701|NCT02161146|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
153420702|NCT02161146|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
153420703|NCT02161146|Histamine Antagonists|histamine antagonists|mesh-ancestor
153420704|NCT02161146|Histamine Agents|histamine agents|mesh-ancestor
153420705|NCT02161146|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153420706|NCT02161146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153349300|NCT00248534|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
153349301|NCT00248534|Prednisolone|prednisolone|mesh-list
153349302|NCT00248534|Prednisolone acetate|prednisolone acetate|mesh-list
153349303|NCT00248534|Rituximab|rituximab|mesh-list
153349304|NCT00248534|Temozolomide|temozolomide|mesh-list
153349305|NCT00248534|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
153349306|NCT00248534|Prednisolone phosphate|prednisolone phosphate|mesh-list
153349307|NCT00248534|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153349308|NCT00248534|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153349309|NCT00248534|Immunologic Factors|immunologic factors|mesh-ancestor
153420708|NCT03447782|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
153349310|NCT00248534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153349311|NCT00248534|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153349312|NCT00248534|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153349313|NCT00248534|Alkylating Agents|alkylating agents|mesh-ancestor
153349314|NCT00248534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153349315|NCT00248534|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153349316|NCT00248534|Antiemetics|antiemetics|mesh-ancestor
153349317|NCT00248534|Autonomic Agents|autonomic agents|mesh-ancestor
153349318|NCT00248534|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153349319|NCT00248534|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153349320|NCT00248534|Glucocorticoids|glucocorticoids|mesh-ancestor
153349322|NCT00248534|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153349323|NCT00248534|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
153349324|NCT00248534|Protective Agents|protective agents|mesh-ancestor
153349325|NCT00248534|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153349326|NCT00248612|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
153349327|NCT00248612|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
153349328|NCT00248612|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153349331|NCT00248612|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153783375|NCT04552405|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
153349332|NCT00248612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153349333|NCT00248612|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
153879884|NCT03266991|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153879885|NCT03266991|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
153879886|NCT03266991|Leprostatic Agents|leprostatic agents|mesh-ancestor
153879887|NCT03104855|Hydroxycholecalciferols|hydroxycholecalciferols|mesh-list
153879888|NCT03104855|Calcifediol|calcifediol|mesh-list
153879889|NCT03104855|Vitamins|vitamins|mesh-ancestor
153420722|NCT02969317|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153420723|NCT02969317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153420724|NCT02969317|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153420725|NCT02969317|Respiratory System Agents|respiratory system agents|mesh-ancestor
153420726|NCT02969317|Parasympatholytics|parasympatholytics|mesh-ancestor
153420727|NCT02969317|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
153420728|NCT02969317|Cholinergic Agents|cholinergic agents|mesh-ancestor
153349334|NCT00248612|Antidepressive Agents|antidepressive agents|mesh-ancestor
153349335|NCT00248612|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153349337|NCT05266820|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153349338|NCT05266820|Immunologic Factors|immunologic factors|mesh-ancestor
153349339|NCT05266820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153349340|NCT05266820|Leprostatic Agents|leprostatic agents|mesh-ancestor
153349341|NCT05266820|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153349342|NCT05266820|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153349343|NCT05266820|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153349344|NCT05266820|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153349345|NCT05266820|Growth Substances|growth substances|mesh-ancestor
153349346|NCT05266820|Growth Inhibitors|growth inhibitors|mesh-ancestor
153349347|NCT05266820|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153349348|NCT03549650|Pentosan Sulfuric Polyester|pentosan sulfuric polyester|mesh-list
153420729|NCT02969317|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153420730|NCT02969317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153420731|NCT00375362|Nitroglycerin|nitroglycerin|mesh-list
153420732|NCT00375362|Vasodilator Agents|vasodilator agents|mesh-ancestor
153349350|NCT01454791|Diclofenac|diclofenac|mesh-list
153349351|NCT01454791|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153349352|NCT01454791|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153349353|NCT01454791|Analgesics|analgesics|mesh-ancestor
153349354|NCT01454791|Sensory System Agents|sensory system agents|mesh-ancestor
153349357|NCT01454791|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153349379|NCT02099006|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
153349381|NCT02099006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153349382|NCT02099006|Anticonvulsants|anticonvulsants|mesh-ancestor
153880648|NCT01007578|Paclitaxel|paclitaxel|mesh-list
153349384|NCT02099006|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153349385|NCT02099006|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153349386|NCT02099006|Antimanic Agents|antimanic agents|mesh-ancestor
153349387|NCT02099006|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
153349388|NCT02099006|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
153349389|NCT02099006|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
153349390|NCT02099006|GABA Agonists|gaba agonists|mesh-ancestor
153349391|NCT02099006|GABA Agents|gaba agents|mesh-ancestor
153349392|NCT02099006|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
153349393|NCT02099006|Antidepressive Agents|antidepressive agents|mesh-ancestor
153349394|NCT02099006|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153349395|NCT02099006|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
153349396|NCT02099006|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153349397|NCT02099006|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153349398|NCT02099006|Adrenergic Agents|adrenergic agents|mesh-ancestor
153349399|NCT02099006|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153349400|NCT02099006|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153349401|NCT02099006|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153349402|NCT02099006|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153349403|NCT02099006|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153349404|NCT02099006|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153349405|NCT05266274|Azacitidine|azacitidine|mesh-list
153349407|NCT05266274|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
153420767|NCT03132571|Bupropion|bupropion|mesh-list
153349424|NCT00324896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153349425|NCT01479517|Tetracaine|tetracaine|mesh-list
153349426|NCT01479517|Anesthetics, Local|anesthetics, local|mesh-ancestor
153349427|NCT01479517|Anesthetics|anesthetics|mesh-ancestor
153349428|NCT01479517|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153349429|NCT01479517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153349430|NCT01479517|Sensory System Agents|sensory system agents|mesh-ancestor
153349431|NCT01479517|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153349432|NCT01480219|Voriconazole|voriconazole|mesh-list
153349433|NCT01480219|Antifungal Agents|antifungal agents|mesh-ancestor
153349434|NCT01480219|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153349435|NCT01480219|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
153378512|NCT05045937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153349436|NCT01480219|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153349437|NCT01480219|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153349438|NCT01480219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153349439|NCT01480219|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153349440|NCT01480219|Hormone Antagonists|hormone antagonists|mesh-ancestor
153349441|NCT01480219|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153349442|NCT01480219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153349443|NCT01480219|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
153349444|NCT01480297|Salicylsalicylic acid|salicylsalicylic acid|mesh-list
153349445|NCT01480297|Sodium Salicylate|sodium salicylate|mesh-list
153349446|NCT01480297|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153349447|NCT01480297|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153349472|NCT01392859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153349473|NCT01392859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153349474|NCT01457521|Ibuprofen|ibuprofen|mesh-list
153349475|NCT01457521|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153349476|NCT01457521|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153349477|NCT01457521|Analgesics|analgesics|mesh-ancestor
153349478|NCT01457521|Sensory System Agents|sensory system agents|mesh-ancestor
153349479|NCT01457521|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153349480|NCT01457521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153349482|NCT01457521|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153349483|NCT01457521|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153349484|NCT01457521|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153349485|NCT01457521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153349486|NCT00325442|Treprostinil|treprostinil|mesh-list
153349487|NCT00325442|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153349488|NCT01393717|Brentuximab Vedotin|brentuximab vedotin|mesh-list
153349489|NCT01393717|Antibodies|antibodies|mesh-list
153349490|NCT01393717|Immunoglobulins|immunoglobulins|mesh-list
153349491|NCT01393717|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
153349492|NCT01393717|Immunoconjugates|immunoconjugates|mesh-list
153349497|NCT01393717|Immunotoxins|immunotoxins|mesh-ancestor
153349526|NCT01481545|Antidotes|antidotes|mesh-ancestor
153349527|NCT01481545|Protective Agents|protective agents|mesh-ancestor
153349528|NCT01481545|Vitamin B Complex|vitamin b complex|mesh-ancestor
153349529|NCT01481545|Vitamins|vitamins|mesh-ancestor
153349530|NCT01481545|Micronutrients|micronutrients|mesh-ancestor
153349531|NCT01482091|Fentanyl|fentanyl|mesh-list
153879989|NCT02654119|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153879990|NCT02654119|Tubulin Modulators|tubulin modulators|mesh-ancestor
153420819|NCT02979301|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
153420820|NCT02979301|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153420821|NCT00375440|Tranexamic Acid|tranexamic acid|mesh-list
153420822|NCT00375440|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
153420823|NCT00375440|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153349532|NCT01482091|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153349533|NCT01482091|Narcotics|narcotics|mesh-ancestor
153349534|NCT01482091|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153349535|NCT01482091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153349536|NCT01482091|Analgesics|analgesics|mesh-ancestor
153349537|NCT01482091|Sensory System Agents|sensory system agents|mesh-ancestor
153349538|NCT01482091|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153349542|NCT01482091|Anesthetics|anesthetics|mesh-ancestor
153349543|NCT00327392|Fospropofol|fospropofol|mesh-list
153349544|NCT00327392|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153349545|NCT00327392|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153349546|NCT00327392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153349548|NCT01791608|Zinc Sulfate|zinc sulfate|mesh-list
153349549|NCT01791608|Trace Elements|trace elements|mesh-ancestor
153349550|NCT01791608|Micronutrients|micronutrients|mesh-ancestor
153349551|NCT01791608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153349552|NCT01791608|Astringents|astringents|mesh-ancestor
153349553|NCT01791608|Dermatologic Agents|dermatologic agents|mesh-ancestor
153349554|NCT04346030|Triamcinolone|triamcinolone|mesh-list
153880011|NCT02426658|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153880012|NCT02400242|Dexamethasone|dexamethasone|mesh-list
153880013|NCT02400242|Pomalidomide|pomalidomide|mesh-list
153880014|NCT02400242|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-list
153420844|NCT05113004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153420845|NCT00375583|Albendazole|albendazole|mesh-list
153420846|NCT00375583|Anthelmintics|anthelmintics|mesh-ancestor
153420847|NCT00375583|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153420848|NCT00375583|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153420849|NCT00375583|Anticestodal Agents|anticestodal agents|mesh-ancestor
153420850|NCT00375583|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
153420851|NCT00375583|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153420852|NCT00375583|Tubulin Modulators|tubulin modulators|mesh-ancestor
153783378|NCT02213848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153349555|NCT04346030|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
153349556|NCT04346030|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
153349570|NCT04346030|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153349571|NCT04346030|Glucocorticoids|glucocorticoids|mesh-ancestor
153349572|NCT04346030|Hormones|hormones|mesh-ancestor
153349573|NCT04346030|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153349574|NCT04346030|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153349575|NCT04346030|Immunologic Factors|immunologic factors|mesh-ancestor
153349576|NCT04346030|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153349577|NCT05075330|Analgesics, Opioid|analgesics, opioid|mesh-list
153349578|NCT05075330|Narcotics|narcotics|mesh-ancestor
153349579|NCT05075330|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153349580|NCT05075330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153349581|NCT05075330|Analgesics|analgesics|mesh-ancestor
153349583|NCT05075330|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153349585|NCT02108288|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
153349586|NCT02108288|Latanoprost|latanoprost|mesh-list
153349587|NCT02108288|Ophthalmic Solutions|ophthalmic solutions|mesh-list
153349588|NCT02108288|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
153349589|NCT02108288|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
153349590|NCT02108288|Adrenergic Agents|adrenergic agents|mesh-ancestor
153349626|NCT00335504|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153349627|NCT00335504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153349628|NCT00335504|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153349629|NCT00335504|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153349630|NCT00335504|Antimetabolites|antimetabolites|mesh-ancestor
153349631|NCT00335504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153783379|NCT00261573|Galantamine|galantamine|mesh-list
153349632|NCT00335504|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153349633|NCT00335504|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
153349634|NCT00335504|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153349635|NCT00335504|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153349636|NCT00335504|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153420861|NCT03143569|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153420862|NCT03143569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153420863|NCT03149887|Bupivacaine|bupivacaine|mesh-list
153420864|NCT03149887|Anesthetics, Local|anesthetics, local|mesh-ancestor
153420865|NCT03149887|Anesthetics|anesthetics|mesh-ancestor
153420866|NCT03149887|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153420867|NCT03149887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153349637|NCT00335504|Analgesics|analgesics|mesh-ancestor
153349638|NCT00335504|Sensory System Agents|sensory system agents|mesh-ancestor
153880032|NCT02400242|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153880034|NCT02338687|Calcium|calcium|mesh-list
153349639|NCT00335504|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153349640|NCT00335504|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153349641|NCT00335504|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153349642|NCT00335504|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153349643|NCT00335504|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153349645|NCT01183169|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
153349646|NCT01183169|Antimetabolites|antimetabolites|mesh-ancestor
153349647|NCT01183169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153349648|NCT01183169|Antiviral Agents|antiviral agents|mesh-ancestor
153349649|NCT01183169|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153349651|NCT01183481|Granisetron|granisetron|mesh-list
153349673|NCT01183559|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153349674|NCT01183559|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153349675|NCT01183559|Immunologic Factors|immunologic factors|mesh-ancestor
153349676|NCT01183559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153349677|NCT01184417|Phenobarbital|phenobarbital|mesh-list
153349679|NCT01184417|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153349680|NCT01184417|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153349681|NCT01184417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153349682|NCT01184417|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
153349683|NCT01184417|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
153349684|NCT01184417|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153349685|NCT01184417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153349686|NCT01184417|GABA Modulators|gaba modulators|mesh-ancestor
153349687|NCT01184417|GABA Agents|gaba agents|mesh-ancestor
153349688|NCT01184417|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
153349689|NCT01184417|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
153349690|NCT01184417|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
153349691|NCT01159067|Deferasirox|deferasirox|mesh-list
153349692|NCT01159067|Iron Chelating Agents|iron chelating agents|mesh-ancestor
153880050|NCT02054429|Insulin|insulin|mesh-list
153349694|NCT01159067|Sequestering Agents|sequestering agents|mesh-ancestor
153349695|NCT01159067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153349696|NCT01222091|Propranolol|propranolol|mesh-list
153349697|NCT01222091|Remifentanil|remifentanil|mesh-list
153349721|NCT01336140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153349722|NCT01336140|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153349723|NCT01336140|Respiratory System Agents|respiratory system agents|mesh-ancestor
153420921|NCT02995915|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153420923|NCT02995915|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
153420924|NCT02995915|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153349724|NCT01336140|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
153349725|NCT01336140|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
153349726|NCT01336140|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153349727|NCT01336140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153349728|NCT01336140|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
153349729|NCT01336140|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
153349730|NCT01336140|Purinergic Agents|purinergic agents|mesh-ancestor
153349731|NCT01336140|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153349732|NCT01336140|Protective Agents|protective agents|mesh-ancestor
153349734|NCT01184885|Cyclophosphamide|cyclophosphamide|mesh-list
153349735|NCT01184885|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153349736|NCT01184885|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153349737|NCT01184885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153880108|NCT02872259|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153880109|NCT02872259|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153880110|NCT02831933|Valacyclovir|valacyclovir|mesh-list
153880111|NCT02831933|Nivolumab|nivolumab|mesh-list
153880112|NCT02831933|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153880113|NCT02831933|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153880114|NCT02831933|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153880115|NCT02831933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153420946|NCT03168841|Efinaconazole|efinaconazole|mesh-list
153349738|NCT01184885|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153349739|NCT01184885|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153349740|NCT01184885|Antifungal Agents|antifungal agents|mesh-ancestor
153349741|NCT01184885|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153349742|NCT01184885|Immunologic Factors|immunologic factors|mesh-ancestor
153349743|NCT01184885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153349745|NCT01184885|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153349746|NCT01184885|Alkylating Agents|alkylating agents|mesh-ancestor
153349747|NCT01184885|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153349748|NCT01187381|Trastuzumab|trastuzumab|mesh-list
153349766|NCT01161563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153349767|NCT01161563|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153349768|NCT01161563|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153349769|NCT01161563|Luteolytic Agents|luteolytic agents|mesh-ancestor
153349770|NCT01161563|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
153349771|NCT01161563|Contraceptive Agents|contraceptive agents|mesh-ancestor
153349772|NCT01161563|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
153349773|NCT01189409|Sennosides|sennosides|mesh-list
153349774|NCT01189409|Laxatives|laxatives|mesh-ancestor
153349775|NCT01189409|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153349776|NCT03010475|Semaglutide|semaglutide|mesh-list
153349777|NCT03010475|Furosemide|furosemide|mesh-list
153349778|NCT03010475|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
153349779|NCT03010475|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153349780|NCT03010475|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153349781|NCT03010475|Antimetabolites|antimetabolites|mesh-ancestor
153349782|NCT03010475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153420971|NCT06289283|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153420972|NCT06289257|Vitamin D|vitamin d|mesh-list
153420973|NCT06289257|Ergocalciferols|ergocalciferols|mesh-list
153420981|NCT06289205|Antimetabolites|antimetabolites|mesh-list
153349784|NCT03010475|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
153349785|NCT03010475|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153349786|NCT03010475|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
153349787|NCT03010475|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153349788|NCT03010475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153349789|NCT03010475|Diuretics|diuretics|mesh-ancestor
153349815|NCT01191749|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153349816|NCT01191749|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153349817|NCT04934696|Contraceptive Agents|contraceptive agents|mesh-list
153349818|NCT04934696|Contraceptives, Oral|contraceptives, oral|mesh-list
153349819|NCT04934696|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153349820|NCT04934696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153349821|NCT04934696|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
153349822|NCT01192139|Metformin|metformin|mesh-list
153349823|NCT01192139|Saxagliptin|saxagliptin|mesh-list
153349824|NCT01192139|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153349825|NCT01192139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153349826|NCT01192139|Incretins|incretins|mesh-ancestor
153349827|NCT01192139|Hormones|hormones|mesh-ancestor
153349828|NCT01192139|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153349829|NCT01192139|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
153349830|NCT01192139|Protease Inhibitors|protease inhibitors|mesh-ancestor
153349831|NCT01192139|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153349869|NCT00349388|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153349870|NCT00349388|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153349871|NCT00349388|Analgesics|analgesics|mesh-ancestor
153349872|NCT00349388|Sensory System Agents|sensory system agents|mesh-ancestor
153880166|NCT02703610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153880167|NCT02703610|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153349873|NCT00349388|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153349874|NCT00349388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153349875|NCT00349388|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153349876|NCT00349388|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153349877|NCT00349778|Cyclophosphamide|cyclophosphamide|mesh-list
153349878|NCT00349778|Melphalan|melphalan|mesh-list
153349879|NCT00349778|Carmustine|carmustine|mesh-list
153349880|NCT00349778|Etoposide|etoposide|mesh-list
153349881|NCT00349778|Etoposide phosphate|etoposide phosphate|mesh-list
153349882|NCT00349778|Lenograstim|lenograstim|mesh-list
153349883|NCT00349778|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153349884|NCT00349778|Immunologic Factors|immunologic factors|mesh-ancestor
153349885|NCT00349778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153349886|NCT00349778|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153349887|NCT00349778|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153421032|NCT06288373|Paclitaxel|paclitaxel|mesh-list
153421033|NCT06288373|Cisplatin|cisplatin|mesh-list
153421034|NCT06288373|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153421035|NCT06288373|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153421036|NCT06288373|Tubulin Modulators|tubulin modulators|mesh-ancestor
153421037|NCT06288373|Antimitotic Agents|antimitotic agents|mesh-ancestor
153421038|NCT06288373|Mitosis Modulators|mitosis modulators|mesh-ancestor
153880201|NCT02627846|Sodium Tetradecyl Sulfate|sodium tetradecyl sulfate|mesh-list
153880203|NCT02627846|Anesthetics, Local|anesthetics, local|mesh-ancestor
153880204|NCT02627846|Anesthetics|anesthetics|mesh-ancestor
153880205|NCT02627846|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153880206|NCT02627846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153880207|NCT02627846|Sensory System Agents|sensory system agents|mesh-ancestor
153880208|NCT02627846|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153880209|NCT02627846|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153880210|NCT02627846|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
153880211|NCT02627846|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153349888|NCT00349778|Alkylating Agents|alkylating agents|mesh-ancestor
153349889|NCT00349778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153349890|NCT00349778|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153349891|NCT00349778|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153349892|NCT00349778|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153349893|NCT00349778|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153349894|NCT00349778|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153349918|NCT00351416|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153349919|NCT00351416|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153349920|NCT00351416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153349921|NCT00351416|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
153349922|NCT00351416|Hormone Antagonists|hormone antagonists|mesh-ancestor
153349923|NCT00351416|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153349924|NCT00351416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153349925|NCT00305942|Carboplatin|carboplatin|mesh-list
153349926|NCT00305942|Topotecan|topotecan|mesh-list
153349927|NCT00305942|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153349928|NCT00305942|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
153349929|NCT00305942|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153349931|NCT00305942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153349932|NCT00352976|Mycophenolic Acid|mycophenolic acid|mesh-list
153349933|NCT00352976|Sirolimus|sirolimus|mesh-list
153349934|NCT00352976|Cyclophosphamide|cyclophosphamide|mesh-list
153349935|NCT00352976|Fludarabine|fludarabine|mesh-list
153349974|NCT00343460|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153349975|NCT00343460|Glucocorticoids|glucocorticoids|mesh-ancestor
153349976|NCT00343460|Hormones|hormones|mesh-ancestor
153349977|NCT00343460|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153349978|NCT00343460|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153349980|NCT00343460|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
153349981|NCT00343460|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153349982|NCT00343460|Serotonin Agents|serotonin agents|mesh-ancestor
153349983|NCT00343460|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153349984|NCT00343460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153349985|NCT00353522|Dalcetrapib|dalcetrapib|mesh-list
153349986|NCT00353522|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153349987|NCT00353522|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153349988|NCT00353522|Antimetabolites|antimetabolites|mesh-ancestor
153349989|NCT00353522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153349990|NCT00353522|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153349991|NCT00310076|Thalidomide|thalidomide|mesh-list
153349992|NCT00310076|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153880212|NCT02627846|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153421045|NCT06288360|Tubulin Modulators|tubulin modulators|mesh-ancestor
153349993|NCT00310076|Immunologic Factors|immunologic factors|mesh-ancestor
153349994|NCT00310076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153349995|NCT00310076|Leprostatic Agents|leprostatic agents|mesh-ancestor
153421046|NCT06288360|Antimitotic Agents|antimitotic agents|mesh-ancestor
153421047|NCT06288360|Mitosis Modulators|mitosis modulators|mesh-ancestor
153349996|NCT00310076|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153350026|NCT00354224|Capecitabine|capecitabine|mesh-list
153350027|NCT00354224|Oxaliplatin|oxaliplatin|mesh-list
153350028|NCT00354224|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153350029|NCT00354224|Antimetabolites|antimetabolites|mesh-ancestor
153350030|NCT00354224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153350031|NCT00354224|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153350032|NCT01792388|Vitamin D|vitamin d|mesh-list
153378514|NCT05045937|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153378515|NCT05045937|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153378516|NCT05045937|Autonomic Agents|autonomic agents|mesh-ancestor
153378517|NCT05045937|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153378518|NCT05045937|Respiratory System Agents|respiratory system agents|mesh-ancestor
153378521|NCT05045937|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153378522|NCT05045937|Antioxidants|antioxidants|mesh-ancestor
153378523|NCT05045937|Protective Agents|protective agents|mesh-ancestor
153350033|NCT01792388|Vitamins|vitamins|mesh-ancestor
153350034|NCT01792388|Micronutrients|micronutrients|mesh-ancestor
153350035|NCT01792388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153350036|NCT01792388|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153350037|NCT01793870|Carvedilol|carvedilol|mesh-list
153350038|NCT01793870|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
153350039|NCT01793870|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
153350040|NCT01793870|Adrenergic Agents|adrenergic agents|mesh-ancestor
153350041|NCT01793870|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153350042|NCT01793870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153350043|NCT01793870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153350044|NCT01793870|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153350045|NCT01793870|Antioxidants|antioxidants|mesh-ancestor
153350046|NCT01793870|Protective Agents|protective agents|mesh-ancestor
153880258|NCT02484248|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153421090|NCT06287944|Antifungal Agents|antifungal agents|mesh-ancestor
153421091|NCT06287944|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153421092|NCT06287944|Alkylating Agents|alkylating agents|mesh-ancestor
153421093|NCT06287944|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153421094|NCT06287944|Chelating Agents|chelating agents|mesh-ancestor
153421095|NCT06287944|Sequestering Agents|sequestering agents|mesh-ancestor
153421096|NCT06287905|Prazosin|prazosin|mesh-list
153421097|NCT06287905|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153475857|NCT00837252|Hormone Antagonists|hormone antagonists|mesh-ancestor
153421098|NCT06287905|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
153421099|NCT06287905|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
153350047|NCT01793870|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153350048|NCT01793870|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153350049|NCT01793870|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153350050|NCT01793870|Vasodilator Agents|vasodilator agents|mesh-ancestor
153350051|NCT01793870|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
153350052|NCT01793870|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
153350054|NCT01793948|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153350068|NCT00355394|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153350069|NCT00355394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153421100|NCT06287905|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
153421101|NCT06287905|Adrenergic Agents|adrenergic agents|mesh-ancestor
153350071|NCT00311246|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
153350072|NCT00311246|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153421115|NCT06287320|Immunomodulating Agents|immunomodulating agents|mesh-list
153421117|NCT06287320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153421118|NCT06287307|Semaglutide|semaglutide|mesh-list
153880261|NCT02484248|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
153880262|NCT02478788|Amphetamine|amphetamine|mesh-list
153880263|NCT02478788|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
153880264|NCT02478788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153880265|NCT02478788|Sympathomimetics|sympathomimetics|mesh-ancestor
153880266|NCT02478788|Autonomic Agents|autonomic agents|mesh-ancestor
153880267|NCT02478788|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153880268|NCT02478788|Dopamine Agents|dopamine agents|mesh-ancestor
153880269|NCT02478788|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153880270|NCT02478788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153880271|NCT02478788|Adrenergic Agents|adrenergic agents|mesh-ancestor
153350073|NCT00311246|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153350074|NCT02105324|Pancrelipase|pancrelipase|mesh-list
153350075|NCT02105324|Pancreatin|pancreatin|mesh-list
153880272|NCT02478788|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
153880273|NCT02478788|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153880274|NCT02478788|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153880275|NCT02478788|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
153350076|NCT02105324|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153783385|NCT00261573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153350077|NCT02105558|Anesthetics|anesthetics|mesh-list
153350078|NCT02105558|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153350079|NCT02105558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153350080|NCT02106962|Bacitracin|bacitracin|mesh-list
153350081|NCT02106962|Tranexamic Acid|tranexamic acid|mesh-list
153350082|NCT02106962|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
153350083|NCT02106962|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153350084|NCT02106962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153350085|NCT02106962|Hemostatics|hemostatics|mesh-ancestor
153350086|NCT02106962|Coagulants|coagulants|mesh-ancestor
153350087|NCT02106962|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
153350088|NCT02106962|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153350089|NCT02106962|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153350090|NCT00315146|Pioglitazone|pioglitazone|mesh-list
153880276|NCT02456194|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
153350092|NCT00315146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153350093|NCT01792700|Amoxicillin|amoxicillin|mesh-list
153350094|NCT01792700|Moxifloxacin|moxifloxacin|mesh-list
153350095|NCT01792700|Metronidazole|metronidazole|mesh-list
153350114|NCT00315302|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153350115|NCT00315302|Autonomic Agents|autonomic agents|mesh-ancestor
153350116|NCT00315302|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153350117|NCT00315302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153350118|NCT00315302|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153350119|NCT00315302|Respiratory System Agents|respiratory system agents|mesh-ancestor
153350120|NCT00315302|Mydriatics|mydriatics|mesh-ancestor
153350121|NCT00315302|Parasympatholytics|parasympatholytics|mesh-ancestor
153350122|NCT00315302|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
153350123|NCT00315302|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
153350124|NCT00315302|Cholinergic Agents|cholinergic agents|mesh-ancestor
153350125|NCT00315302|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153421121|NCT06287307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153421122|NCT06287229|Blinatumomab|blinatumomab|mesh-list
153421123|NCT06287229|Inotuzumab Ozogamicin|inotuzumab ozogamicin|mesh-list
153421124|NCT06287229|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153421125|NCT06287229|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153421126|NCT06287229|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153421127|NCT06287229|Immunotoxins|immunotoxins|mesh-ancestor
153350126|NCT00315302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153350128|NCT00316862|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153350130|NCT00316862|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153350131|NCT00316862|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153350132|NCT00316862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153350133|NCT00357032|Belinostat|belinostat|mesh-list
153350134|NCT00357032|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153421128|NCT06287229|Immunoconjugates|immunoconjugates|mesh-ancestor
153350135|NCT00357032|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
153421129|NCT06287229|Immunologic Factors|immunologic factors|mesh-ancestor
153350136|NCT00357032|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153350137|NCT00357032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153350138|NCT00357734|Gefitinib|gefitinib|mesh-list
153350139|NCT00357734|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153350140|NCT00357734|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153350159|NCT00365144|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153350160|NCT00365144|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153350161|NCT00365144|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153350162|NCT00365144|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153350163|NCT00365144|Growth Substances|growth substances|mesh-ancestor
153350164|NCT00365144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153421523|NCT05839054|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
153421524|NCT05811403|Sodium Hypochlorite|sodium hypochlorite|mesh-list
153421525|NCT05811403|Eusol|eusol|mesh-list
153350166|NCT00365144|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153350167|NCT00365144|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153350168|NCT00365144|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153350169|NCT00365144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153350171|NCT00366626|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
153350172|NCT00366626|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
153880304|NCT02403778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153880305|NCT02403778|Keratolytic Agents|keratolytic agents|mesh-ancestor
153880306|NCT02403778|Dermatologic Agents|dermatologic agents|mesh-ancestor
153880307|NCT02386826|Bevacizumab|bevacizumab|mesh-list
153880308|NCT02386826|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153880309|NCT02386826|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153880310|NCT02386826|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153880311|NCT02386826|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153880312|NCT02386826|Growth Substances|growth substances|mesh-ancestor
153880313|NCT02386826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153880314|NCT02386826|Growth Inhibitors|growth inhibitors|mesh-ancestor
153880315|NCT02312258|Ixazomib|ixazomib|mesh-list
153350173|NCT00366626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153350174|NCT00366626|Sensory System Agents|sensory system agents|mesh-ancestor
153350175|NCT00366626|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153350176|NCT00367016|Omalizumab|omalizumab|mesh-list
153350177|NCT00367016|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
153350178|NCT00367016|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153350179|NCT00367016|Respiratory System Agents|respiratory system agents|mesh-ancestor
153350180|NCT04422678|Imatinib Mesylate|imatinib mesylate|mesh-list
153350181|NCT04422678|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153350182|NCT04422678|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153421151|NCT06280274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153421152|NCT06275035|Memantine|memantine|mesh-list
153880323|NCT02276274|Incretins|incretins|mesh-ancestor
153350183|NCT04422678|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153350184|NCT04422678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153350185|NCT04422678|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153350186|NCT00573378|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
153350187|NCT00573378|Antiviral Agents|antiviral agents|mesh-ancestor
153350188|NCT00573378|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153350189|NCT05334654|Enoxaparin|enoxaparin|mesh-list
153350190|NCT05334654|Enoxaparin sodium|enoxaparin sodium|mesh-list
153350191|NCT05334654|Bivalirudin|bivalirudin|mesh-list
153350192|NCT05334654|Anticoagulants|anticoagulants|mesh-ancestor
153350198|NCT05334654|Protease Inhibitors|protease inhibitors|mesh-ancestor
153350199|NCT05334654|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153350200|NCT03561584|Sulfasalazine|sulfasalazine|mesh-list
153350201|NCT03561584|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153350202|NCT03561584|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153350203|NCT03561584|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153350205|NCT03561584|Sensory System Agents|sensory system agents|mesh-ancestor
153350206|NCT03561584|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153350207|NCT03561584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153350208|NCT03561584|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153350209|NCT03561584|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153350210|NCT03561584|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153350211|NCT00369512|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
153350212|NCT00369512|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153350218|NCT00324272|Hemostatics|hemostatics|mesh-ancestor
153350257|NCT05610774|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153350258|NCT05610774|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
153350259|NCT05610774|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153350260|NCT05610774|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153350261|NCT05610774|Adrenergic Agents|adrenergic agents|mesh-ancestor
153350262|NCT05610774|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153350263|NCT05610774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153350264|NCT00369746|Citalopram|citalopram|mesh-list
153350265|NCT00369746|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
153880346|NCT02199184|Immunologic Factors|immunologic factors|mesh-ancestor
153421192|NCT06205485|Fluorouracil|fluorouracil|mesh-list
153350267|NCT00369746|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153350268|NCT00369746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153350269|NCT00369746|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153350270|NCT00369746|Serotonin Agents|serotonin agents|mesh-ancestor
153350271|NCT00369746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153350272|NCT00369746|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
153350273|NCT00369746|Antidepressive Agents|antidepressive agents|mesh-ancestor
153350274|NCT00369746|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153350275|NCT00392054|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-list
153350277|NCT02525874|Dermatologic Agents|dermatologic agents|mesh-ancestor
153350278|NCT02525874|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153350279|NCT02525874|Immunologic Factors|immunologic factors|mesh-ancestor
153421214|NCT06175403|Micronutrients|micronutrients|mesh-ancestor
153421215|NCT06175403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153421216|NCT06156059|Melatonin|melatonin|mesh-list
153421217|NCT06156059|Antioxidants|antioxidants|mesh-ancestor
153421218|NCT06156059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153421219|NCT06156059|Protective Agents|protective agents|mesh-ancestor
153421220|NCT06156059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153421221|NCT06156059|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153880372|NCT02165007|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153880373|NCT02165007|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153880375|NCT02165007|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153880376|NCT02165007|Immunologic Factors|immunologic factors|mesh-ancestor
153880377|NCT02165007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153880378|NCT02164734|Remifentanil|remifentanil|mesh-list
153880379|NCT02164734|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153350283|NCT01794572|Alkylating Agents|alkylating agents|mesh-ancestor
153350284|NCT01794572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153350285|NCT01794572|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153350286|NCT01794572|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153350287|NCT01794572|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153350288|NCT01794572|Immunologic Factors|immunologic factors|mesh-ancestor
153350289|NCT01794572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153350291|NCT00392444|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153350292|NCT00392444|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153350293|NCT00392444|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153350294|NCT00392444|Growth Substances|growth substances|mesh-ancestor
153350295|NCT00392444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153350296|NCT00392444|Growth Inhibitors|growth inhibitors|mesh-ancestor
153350297|NCT00392444|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153880380|NCT02164734|Narcotics|narcotics|mesh-ancestor
153880386|NCT02110069|Sirolimus|sirolimus|mesh-list
153350298|NCT00392444|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153350299|NCT00392444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153350301|NCT02528214|Prednisolone|prednisolone|mesh-list
153350302|NCT02528214|Albuterol|albuterol|mesh-list
153350303|NCT02528214|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153350304|NCT02528214|Glucocorticoids|glucocorticoids|mesh-ancestor
153350305|NCT02528214|Hormones|hormones|mesh-ancestor
153350306|NCT02528214|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153350307|NCT02528214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153350308|NCT02528214|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153350309|NCT02528214|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153350310|NCT02528214|Autonomic Agents|autonomic agents|mesh-ancestor
153350311|NCT02528214|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153350312|NCT02528214|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153350313|NCT02528214|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153350314|NCT02528214|Respiratory System Agents|respiratory system agents|mesh-ancestor
153350315|NCT02528214|Tocolytic Agents|tocolytic agents|mesh-ancestor
153350316|NCT02528214|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153350317|NCT02528214|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
153350318|NCT02528214|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
153350319|NCT02528214|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153350324|NCT00392678|Sodium Salicylate|sodium salicylate|mesh-list
153350336|NCT05902299|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
153350337|NCT05902299|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153350338|NCT05902260|Immunomodulating Agents|immunomodulating agents|mesh-list
153350339|NCT05902260|Immunologic Factors|immunologic factors|mesh-ancestor
153421226|NCT06140784|Protective Agents|protective agents|mesh-ancestor
153421227|NCT06140784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153421229|NCT06130423|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
153421230|NCT06130423|Autonomic Agents|autonomic agents|mesh-ancestor
153421231|NCT06130423|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153421233|NCT06130423|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
153350340|NCT05902260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153350342|NCT05902221|Moxifloxacin|moxifloxacin|mesh-list
153350343|NCT05902221|Rifampin|rifampin|mesh-list
153350344|NCT05902221|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
153350345|NCT05902221|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153350346|NCT05902221|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153350347|NCT05902221|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153350348|NCT05902221|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153350349|NCT05902221|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153880669|NCT00648648|Carboplatin|carboplatin|mesh-list
153350350|NCT05902221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153350351|NCT05902221|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153350352|NCT05902221|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
153350353|NCT05902221|Contraceptive Agents|contraceptive agents|mesh-ancestor
153880434|NCT01932697|Antimitotic Agents|antimitotic agents|mesh-ancestor
153880435|NCT01932697|Mitosis Modulators|mitosis modulators|mesh-ancestor
153880436|NCT01932697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153421270|NCT06100237|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153421271|NCT06091865|Prednisone|prednisone|mesh-list
153421272|NCT06091865|Prednisolone|prednisolone|mesh-list
153421273|NCT06091865|Cyclophosphamide|cyclophosphamide|mesh-list
153421274|NCT06091865|Rituximab|rituximab|mesh-list
153421275|NCT06091865|Doxorubicin|doxorubicin|mesh-list
153421276|NCT06091865|Vincristine|vincristine|mesh-list
153421277|NCT06091865|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153421278|NCT06091865|Immunologic Factors|immunologic factors|mesh-ancestor
153421279|NCT06091865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153421280|NCT06091865|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153421281|NCT06091865|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153350354|NCT05902221|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153350355|NCT05902221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153350356|NCT05902221|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
153350357|NCT05902221|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
153350358|NCT05902221|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
153350359|NCT05902221|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
153350360|NCT05902221|Antitubercular Agents|antitubercular agents|mesh-ancestor
153350361|NCT05902221|Leprostatic Agents|leprostatic agents|mesh-ancestor
153350362|NCT05902221|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153350363|NCT05902221|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
153350364|NCT05902221|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
153350365|NCT05902221|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
153421282|NCT06091865|Alkylating Agents|alkylating agents|mesh-ancestor
153880445|NCT01752049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153350366|NCT05902221|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
153350367|NCT05902221|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
153350368|NCT05902221|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
153387677|NCT03360903|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
153350371|NCT05902078|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153350372|NCT05902078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153783389|NCT00261573|Nootropic Agents|nootropic agents|mesh-ancestor
153783390|NCT04548271|Apatinib|apatinib|mesh-list
153350373|NCT05902078|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
153350374|NCT05902078|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153350375|NCT05902078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153350376|NCT05902078|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
153350377|NCT05902078|Vitamins|vitamins|mesh-ancestor
153421294|NCT06091865|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153421295|NCT06091865|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153421296|NCT06091865|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153421297|NCT06091865|Tubulin Modulators|tubulin modulators|mesh-ancestor
153421298|NCT06091865|Antimitotic Agents|antimitotic agents|mesh-ancestor
153421299|NCT06091865|Mitosis Modulators|mitosis modulators|mesh-ancestor
153421300|NCT06085729|Carboplatin|carboplatin|mesh-list
153421301|NCT06085729|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153421304|NCT06048809|Cariostatic Agents|cariostatic agents|mesh-ancestor
153421305|NCT06048809|Protective Agents|protective agents|mesh-ancestor
153880466|NCT01659658|Dexamethasone|dexamethasone|mesh-list
153880467|NCT01659658|Cyclophosphamide|cyclophosphamide|mesh-list
153880468|NCT01659658|Melphalan|melphalan|mesh-list
153880469|NCT01659658|Lenalidomide|lenalidomide|mesh-list
153880470|NCT01659658|Ixazomib|ixazomib|mesh-list
153350378|NCT05902078|Micronutrients|micronutrients|mesh-ancestor
153350379|NCT05902078|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153350380|NCT05901935|Capecitabine|capecitabine|mesh-list
153350381|NCT05901935|Trastuzumab|trastuzumab|mesh-list
153350382|NCT05901935|Vinorelbine|vinorelbine|mesh-list
153350383|NCT05901935|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153350384|NCT05901935|Antimetabolites|antimetabolites|mesh-ancestor
153350385|NCT05901935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153350386|NCT05901935|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153350387|NCT05901935|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153350388|NCT05901935|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153350389|NCT05901935|Tubulin Modulators|tubulin modulators|mesh-ancestor
153350390|NCT05901935|Antimitotic Agents|antimitotic agents|mesh-ancestor
153350391|NCT05901935|Mitosis Modulators|mitosis modulators|mesh-ancestor
153350392|NCT05901766|Micronutrients|micronutrients|mesh-list
153880471|NCT01659658|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153350394|NCT05901766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153350396|NCT05901701|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153350416|NCT05901571|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
153350417|NCT05901571|Cholinergic Agents|cholinergic agents|mesh-ancestor
153350418|NCT05901571|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
153350419|NCT05901571|Antidepressive Agents|antidepressive agents|mesh-ancestor
153350421|NCT05901454|Vaccines|vaccines|mesh-list
153350422|NCT05901454|Immunologic Factors|immunologic factors|mesh-ancestor
153350423|NCT05901454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153350424|NCT05901441|Sufentanil|sufentanil|mesh-list
153350425|NCT05901441|Hydromorphone|hydromorphone|mesh-list
153350427|NCT05901441|Anesthetics, Local|anesthetics, local|mesh-ancestor
153350428|NCT05901441|Anesthetics|anesthetics|mesh-ancestor
153350429|NCT05901441|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153350430|NCT05901441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153350431|NCT05901441|Sensory System Agents|sensory system agents|mesh-ancestor
153421319|NCT06038682|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
153421320|NCT06038682|Protease Inhibitors|protease inhibitors|mesh-ancestor
153421321|NCT06038682|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153421322|NCT06038682|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153421323|NCT06012916|Esketamine|esketamine|mesh-list
153421325|NCT06012916|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153421326|NCT06008795|Dexamethasone|dexamethasone|mesh-list
153421327|NCT06008795|Ropivacaine|ropivacaine|mesh-list
153421328|NCT06008795|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153421329|NCT06008795|Antiemetics|antiemetics|mesh-ancestor
153421330|NCT06008795|Autonomic Agents|autonomic agents|mesh-ancestor
153421331|NCT06008795|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153350432|NCT05901441|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153350433|NCT05901441|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153350434|NCT05901441|Narcotics|narcotics|mesh-ancestor
153350435|NCT05901441|Analgesics|analgesics|mesh-ancestor
153350436|NCT05901441|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153350437|NCT05901441|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153350438|NCT05901441|Anesthetics, General|anesthetics, general|mesh-ancestor
153350439|NCT05901389|Lidocaine|lidocaine|mesh-list
153421332|NCT06008795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153350440|NCT05901389|Anesthetics, Local|anesthetics, local|mesh-ancestor
153350441|NCT05901389|Anesthetics|anesthetics|mesh-ancestor
153350442|NCT05901389|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153421333|NCT06008795|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153880481|NCT01659658|Antiemetics|antiemetics|mesh-ancestor
153880482|NCT01659658|Autonomic Agents|autonomic agents|mesh-ancestor
153350443|NCT05901389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153350445|NCT05901389|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153350446|NCT05901389|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153350447|NCT05901389|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
153350448|NCT05901389|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153350449|NCT05901389|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153350450|NCT05901389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153350456|NCT05901012|N,N-Dimethyltryptamine|n,n-dimethyltryptamine|mesh-list
153350457|NCT05901012|Hallucinogens|hallucinogens|mesh-ancestor
153350458|NCT05901012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153350459|NCT05901012|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153350460|NCT05901012|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153350461|NCT05901012|Serotonin Agents|serotonin agents|mesh-ancestor
153350462|NCT05901012|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153350463|NCT05901012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153350464|NCT05901012|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
153350465|NCT05900921|Paclitaxel|paclitaxel|mesh-list
153350466|NCT05900921|Carboplatin|carboplatin|mesh-list
153350467|NCT05900921|Tislelizumab|tislelizumab|mesh-list
153350468|NCT05900921|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153350469|NCT05900921|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153350470|NCT05900921|Tubulin Modulators|tubulin modulators|mesh-ancestor
153350471|NCT05900921|Antimitotic Agents|antimitotic agents|mesh-ancestor
153350472|NCT05900921|Mitosis Modulators|mitosis modulators|mesh-ancestor
153350473|NCT05900921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153421336|NCT06008795|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153421337|NCT06008795|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153421339|NCT06008795|Anesthetics, Local|anesthetics, local|mesh-ancestor
153421340|NCT06008795|Anesthetics|anesthetics|mesh-ancestor
153421341|NCT06008795|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153421342|NCT06008795|Sensory System Agents|sensory system agents|mesh-ancestor
153421350|NCT05993182|Pseudoephedrine|pseudoephedrine|mesh-list
153350474|NCT05900921|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153350475|NCT05899699|Adapalene|adapalene|mesh-list
153350476|NCT05899699|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153350477|NCT05899699|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153350478|NCT05899699|Analgesics|analgesics|mesh-ancestor
153350479|NCT05899699|Sensory System Agents|sensory system agents|mesh-ancestor
153421351|NCT05993182|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
153421352|NCT05993182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153880510|NCT01523977|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153880511|NCT01523977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153880512|NCT01523977|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153880513|NCT01523977|Glucocorticoids|glucocorticoids|mesh-ancestor
153880514|NCT01523977|Hormones|hormones|mesh-ancestor
153350480|NCT05899699|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153350481|NCT05899699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153350482|NCT05899699|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153350502|NCT05895162|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153350503|NCT05895162|Hormone Antagonists|hormone antagonists|mesh-ancestor
153350504|NCT05895162|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153350505|NCT05895162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153350506|NCT05895162|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
153350507|NCT05895162|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
153350509|NCT05877326|Propofol|propofol|mesh-list
153350510|NCT05877326|Sevoflurane|sevoflurane|mesh-list
153421359|NCT05993182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153421360|NCT05993182|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153421361|NCT05993182|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153421362|NCT05993182|Respiratory System Agents|respiratory system agents|mesh-ancestor
153880526|NCT01523977|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
153880527|NCT01523977|Protective Agents|protective agents|mesh-ancestor
153880528|NCT01517243|Sirolimus|sirolimus|mesh-list
153880529|NCT01517243|Sunitinib|sunitinib|mesh-list
153880530|NCT01517243|Temsirolimus|temsirolimus|mesh-list
153880531|NCT01517243|MTOR Inhibitors|mtor inhibitors|mesh-list
153880532|NCT01517243|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153421365|NCT05973851|Esketamine|esketamine|mesh-list
153421366|NCT05973851|Antidepressive Agents|antidepressive agents|mesh-list
153421367|NCT05973851|Analgesics|analgesics|mesh-ancestor
153421368|NCT05973851|Sensory System Agents|sensory system agents|mesh-ancestor
153421369|NCT05973851|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153421370|NCT05973851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153350511|NCT05877326|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153350512|NCT05877326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153350513|NCT05877326|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153350514|NCT05877326|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153350515|NCT05877326|Anesthetics, General|anesthetics, general|mesh-ancestor
153350516|NCT05877326|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153350517|NCT05877326|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
153350518|NCT05837000|Magnesium Sulfate|magnesium sulfate|mesh-list
153350519|NCT05837000|Dexmedetomidine|dexmedetomidine|mesh-list
153350520|NCT05837000|Ketamine|ketamine|mesh-list
153350521|NCT05837000|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153350522|NCT05837000|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153350523|NCT05837000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153421371|NCT05973851|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
153421372|NCT05973851|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153880535|NCT01517243|Growth Substances|growth substances|mesh-ancestor
153350525|NCT05837000|Analgesics|analgesics|mesh-ancestor
153350526|NCT05837000|Sensory System Agents|sensory system agents|mesh-ancestor
153350551|NCT05833139|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153350552|NCT05833139|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153350553|NCT05833139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153350554|NCT05833139|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153350555|NCT05833139|Hormone Antagonists|hormone antagonists|mesh-ancestor
153350556|NCT05833139|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153880684|NCT00608725|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153350558|NCT05833139|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
153421379|NCT05973851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153421380|NCT05973851|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153421382|NCT05973786|Quetiapine Fumarate|quetiapine fumarate|mesh-list
153421383|NCT05973786|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
153421384|NCT05973786|Sertraline|sertraline|mesh-list
153421385|NCT05973786|Escitalopram|escitalopram|mesh-list
153421386|NCT05973786|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
153421387|NCT05973786|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153421388|NCT05973786|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153421389|NCT05973786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153421390|NCT05973786|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153421391|NCT05973786|Serotonin Agents|serotonin agents|mesh-ancestor
153421392|NCT05973786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153421393|NCT05973786|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
153421394|NCT05973786|Antidepressive Agents|antidepressive agents|mesh-ancestor
153421395|NCT05973786|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153421396|NCT05973786|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153421397|NCT05973786|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153350559|NCT05821296|Methamphetamine|methamphetamine|mesh-list
153350560|NCT05821296|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
153350561|NCT05821296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153350562|NCT05821296|Sympathomimetics|sympathomimetics|mesh-ancestor
153350563|NCT05821296|Autonomic Agents|autonomic agents|mesh-ancestor
153350564|NCT05821296|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153350565|NCT05821296|Dopamine Agents|dopamine agents|mesh-ancestor
153350566|NCT05821296|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153350567|NCT05821296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153350568|NCT05821296|Adrenergic Agents|adrenergic agents|mesh-ancestor
153350571|NCT05821296|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153350572|NCT05821296|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
153350574|NCT05736861|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153350575|NCT05736861|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153350576|NCT05707273|Cyclophosphamide|cyclophosphamide|mesh-list
153783391|NCT04548271|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153350598|NCT05672173|Alkylating Agents|alkylating agents|mesh-ancestor
153350599|NCT05672173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153350600|NCT05672173|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153350601|NCT05672173|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153350602|NCT05672173|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153350603|NCT05672173|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153350604|NCT05672173|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153350605|NCT05672173|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153350607|NCT05659056|Paclitaxel|paclitaxel|mesh-list
153350608|NCT05659056|Trastuzumab|trastuzumab|mesh-list
153350609|NCT05659056|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153350610|NCT05659056|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153350611|NCT05659056|Tubulin Modulators|tubulin modulators|mesh-ancestor
153350612|NCT05659056|Antimitotic Agents|antimitotic agents|mesh-ancestor
153350613|NCT05659056|Mitosis Modulators|mitosis modulators|mesh-ancestor
153350614|NCT05659056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153350615|NCT05659056|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153350616|NCT05654649|Dexamethasone|dexamethasone|mesh-list
153350617|NCT05654649|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153350618|NCT05654649|Antiemetics|antiemetics|mesh-ancestor
153350619|NCT05654649|Autonomic Agents|autonomic agents|mesh-ancestor
153350620|NCT05654649|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153350621|NCT05654649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153421398|NCT05973786|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153421399|NCT05973786|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153421400|NCT05973786|Antimanic Agents|antimanic agents|mesh-ancestor
153421401|NCT05973786|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
153421402|NCT05973786|Anticonvulsants|anticonvulsants|mesh-ancestor
153421403|NCT05973786|GABA Agents|gaba agents|mesh-ancestor
153421404|NCT05973747|Calcium, Dietary|calcium, dietary|mesh-list
153880545|NCT01517243|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153350622|NCT05654649|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153880546|NCT01517243|Antifungal Agents|antifungal agents|mesh-ancestor
153880547|NCT01357161|Paclitaxel|paclitaxel|mesh-list
153350623|NCT05654649|Glucocorticoids|glucocorticoids|mesh-ancestor
153350641|NCT05519111|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153350644|NCT05427474|Analgesics|analgesics|mesh-ancestor
153880548|NCT01357161|Carboplatin|carboplatin|mesh-list
153880549|NCT01357161|Adavosertib|adavosertib|mesh-list
153880550|NCT01357161|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153350645|NCT05427474|Sensory System Agents|sensory system agents|mesh-ancestor
153350646|NCT05427474|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153350647|NCT05427474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153350648|NCT05427474|Anticonvulsants|anticonvulsants|mesh-ancestor
153350649|NCT05427474|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153350650|NCT05427474|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153350651|NCT05427474|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153350652|NCT05427474|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153880551|NCT01357161|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153880552|NCT01357161|Tubulin Modulators|tubulin modulators|mesh-ancestor
153350653|NCT05427474|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
153350654|NCT05427474|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
153350655|NCT05427474|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153350656|NCT05427474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153880565|NCT01308203|Vitamin B Complex|vitamin b complex|mesh-ancestor
153880566|NCT01308203|Vitamins|vitamins|mesh-ancestor
153880567|NCT01308203|Micronutrients|micronutrients|mesh-ancestor
153880568|NCT01308203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153880569|NCT01289171|Glycolic acid|glycolic acid|mesh-list
153880570|NCT01289171|Keratolytic Agents|keratolytic agents|mesh-ancestor
153880571|NCT01289171|Dermatologic Agents|dermatologic agents|mesh-ancestor
153880572|NCT01276704|Secoisolariciresinol|secoisolariciresinol|mesh-list
153880573|NCT01276704|Phytoestrogens|phytoestrogens|mesh-ancestor
153421406|NCT05973747|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153421407|NCT05973747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153421408|NCT05973747|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153421409|NCT05958875|Antipsychotic Agents|antipsychotic agents|mesh-list
153421410|NCT05958875|Clozapine|clozapine|mesh-list
153421411|NCT05958875|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153421412|NCT05958875|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153421413|NCT05958875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153421414|NCT05958875|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153421415|NCT05958875|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153421416|NCT05958875|Serotonin Agents|serotonin agents|mesh-ancestor
153421417|NCT05958875|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153421418|NCT05958875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153350658|NCT05427474|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
153350659|NCT05427474|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
153350660|NCT05427474|Adrenergic Agents|adrenergic agents|mesh-ancestor
153350661|NCT05427474|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153350662|NCT05427474|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153350663|NCT05427474|Vasodilator Agents|vasodilator agents|mesh-ancestor
153350664|NCT05418647|Dialysis Solutions|dialysis solutions|mesh-list
153350665|NCT05418647|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
153350666|NCT05340673|Petrolatum|petrolatum|mesh-list
153350667|NCT05340673|Mineral Oil|mineral oil|mesh-list
153350668|NCT05340673|Emollients|emollients|mesh-ancestor
153350669|NCT05340673|Dermatologic Agents|dermatologic agents|mesh-ancestor
153350670|NCT05320406|Leuprolide|leuprolide|mesh-list
153350671|NCT05320406|Relugolix|relugolix|mesh-list
153350672|NCT05320406|Fertility Agents, Female|fertility agents, female|mesh-ancestor
153350673|NCT05320406|Fertility Agents|fertility agents|mesh-ancestor
153350674|NCT05320406|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153350675|NCT05320406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153350676|NCT05320406|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153350677|NCT05320406|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153350678|NCT05320406|Androgen Antagonists|androgen antagonists|mesh-ancestor
153350682|NCT05312151|Hallucinogens|hallucinogens|mesh-ancestor
153350683|NCT05312151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153350684|NCT05312151|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153421419|NCT05958875|GABA Antagonists|gaba antagonists|mesh-ancestor
153350686|NCT05299073|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153350687|NCT05299073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153350688|NCT05221398|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
153350689|NCT05221398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153350690|NCT05221398|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153350691|NCT05221398|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153350692|NCT05213221|Lenvatinib|lenvatinib|mesh-list
153350693|NCT05213221|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153350694|NCT05213221|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153350695|NCT05213221|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153350696|NCT05213221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153350697|NCT05123040|Prednisone|prednisone|mesh-list
153350698|NCT05123040|Methylprednisolone|methylprednisolone|mesh-list
153350699|NCT05123040|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153350700|NCT05123040|Glucocorticoids|glucocorticoids|mesh-ancestor
153350701|NCT05123040|Hormones|hormones|mesh-ancestor
153350702|NCT05123040|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153350705|NCT05123040|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153350735|NCT05013424|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
153350736|NCT05013424|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153350737|NCT05013424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153350738|NCT05013424|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
153350739|NCT05013424|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153350740|NCT05013424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153350741|NCT05013424|Cholinergic Agents|cholinergic agents|mesh-ancestor
153350742|NCT05013424|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153350743|NCT04999215|Choline|choline|mesh-list
153783392|NCT04548271|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153350744|NCT04999215|Lipotropic Agents|lipotropic agents|mesh-ancestor
153350745|NCT04999215|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153783393|NCT04548271|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153350747|NCT04999215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153350748|NCT04999215|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153421420|NCT05958875|GABA Agents|gaba agents|mesh-ancestor
153880580|NCT01190930|Leucovorin|leucovorin|mesh-list
153880581|NCT01190930|Folic Acid|folic acid|mesh-list
153880582|NCT01190930|Cytarabine|cytarabine|mesh-list
153880583|NCT01190930|Dexamethasone|dexamethasone|mesh-list
153880584|NCT01190930|Dexamethasone acetate|dexamethasone acetate|mesh-list
153880585|NCT01190930|Cyclophosphamide|cyclophosphamide|mesh-list
153880586|NCT01190930|Doxorubicin|doxorubicin|mesh-list
153880587|NCT01190930|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
153880588|NCT01190930|Methotrexate|methotrexate|mesh-list
153880589|NCT01190930|Vincristine|vincristine|mesh-list
153880590|NCT01190930|Asparaginase|asparaginase|mesh-list
153880591|NCT01190930|Mercaptopurine|mercaptopurine|mesh-list
153350749|NCT04999215|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153350750|NCT04999215|Nootropic Agents|nootropic agents|mesh-ancestor
153350751|NCT04991025|Certolizumab Pegol|certolizumab pegol|mesh-list
153350752|NCT04991025|Carboplatin|carboplatin|mesh-list
153350753|NCT04991025|Gemcitabine|gemcitabine|mesh-list
153350754|NCT04991025|Nivolumab|nivolumab|mesh-list
153350755|NCT04991025|Pemetrexed|pemetrexed|mesh-list
153350756|NCT04991025|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153350757|NCT04991025|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153350758|NCT04991025|Antimetabolites|antimetabolites|mesh-ancestor
153421442|NCT05896228|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153421443|NCT05896228|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153421444|NCT05896228|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153421445|NCT05896228|Analgesics|analgesics|mesh-ancestor
153421446|NCT05896228|Sensory System Agents|sensory system agents|mesh-ancestor
153421447|NCT05896228|Antipyretics|antipyretics|mesh-ancestor
153421448|NCT05896228|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153880603|NCT01190930|Alkylating Agents|alkylating agents|mesh-ancestor
153880604|NCT01190930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153880605|NCT01190930|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153880606|NCT01190930|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153880607|NCT01190930|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153880608|NCT01190930|Antiemetics|antiemetics|mesh-ancestor
153880609|NCT01190930|Autonomic Agents|autonomic agents|mesh-ancestor
153880610|NCT01190930|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153880611|NCT01190930|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153350759|NCT04991025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153350760|NCT04991025|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153350761|NCT04991025|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153350762|NCT04991025|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153350763|NCT04991025|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153350764|NCT04991025|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153350765|NCT04991025|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
153350766|NCT04991025|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153350767|NCT04991025|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153350768|NCT04991025|Immunologic Factors|immunologic factors|mesh-ancestor
153350769|NCT04991025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153350770|NCT04991025|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153350771|NCT04979130|Semaglutide|semaglutide|mesh-list
153350772|NCT04979130|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
153350773|NCT04979130|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153350774|NCT04979130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153880613|NCT01190930|Hormones|hormones|mesh-ancestor
153880614|NCT01190930|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153880615|NCT01190930|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153880616|NCT01190930|Protease Inhibitors|protease inhibitors|mesh-ancestor
153880617|NCT01190930|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153880618|NCT01190930|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153421454|NCT05896228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153421455|NCT05896228|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
153421456|NCT05896228|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153350775|NCT04935658|Hypnotics and Sedatives|hypnotics and sedatives|mesh-list
153421457|NCT05896228|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153421458|NCT05896228|Anesthetics, Local|anesthetics, local|mesh-ancestor
153421459|NCT05896228|Anesthetics|anesthetics|mesh-ancestor
153421460|NCT05896228|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
153421461|NCT05896228|Histamine Antagonists|histamine antagonists|mesh-ancestor
153378665|NCT01576952|Sensory System Agents|sensory system agents|mesh-ancestor
153378666|NCT01576952|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153421462|NCT05896228|Histamine Agents|histamine agents|mesh-ancestor
153421463|NCT05896228|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153350776|NCT04935658|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153350777|NCT04935658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153350778|NCT04930315|Apatinib|apatinib|mesh-list
153350779|NCT04930315|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153350780|NCT04930315|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153350781|NCT04930315|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153350782|NCT04930315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153350783|NCT04855266|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
153350784|NCT04855266|Hematinics|hematinics|mesh-ancestor
153350785|NCT04772209|Heparin|heparin|mesh-list
153350786|NCT04772209|Anticoagulants|anticoagulants|mesh-ancestor
153350787|NCT04772209|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153350788|NCT04772209|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153421464|NCT05896228|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
153421465|NCT05896228|Antipruritics|antipruritics|mesh-ancestor
153421466|NCT05896228|Dermatologic Agents|dermatologic agents|mesh-ancestor
153350789|NCT04772209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153350790|NCT04757662|Tadalafil|tadalafil|mesh-list
153350792|NCT04757662|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
153350793|NCT04757662|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
153350794|NCT04757662|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153350795|NCT04757662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153350796|NCT04757662|Urological Agents|urological agents|mesh-ancestor
153350797|NCT04756050|Epinephrine|epinephrine|mesh-list
153350798|NCT04756050|Racepinephrine|racepinephrine|mesh-list
153350799|NCT04756050|Bupivacaine|bupivacaine|mesh-list
153350800|NCT04756050|Prilocaine|prilocaine|mesh-list
153350801|NCT04756050|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
153421467|NCT05889741|Ropivacaine|ropivacaine|mesh-list
153350802|NCT04756050|Epinephryl borate|epinephryl borate|mesh-list
153350803|NCT04756050|Anesthetics, Local|anesthetics, local|mesh-ancestor
153350809|NCT04756050|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153350810|NCT04756050|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153350811|NCT04756050|Adrenergic Agents|adrenergic agents|mesh-ancestor
153350812|NCT04756050|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153350813|NCT04756050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153350814|NCT04756050|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
153350815|NCT04756050|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153350816|NCT04756050|Autonomic Agents|autonomic agents|mesh-ancestor
153350817|NCT04756050|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153350818|NCT04756050|Respiratory System Agents|respiratory system agents|mesh-ancestor
153350819|NCT04756050|Mydriatics|mydriatics|mesh-ancestor
153350820|NCT04756050|Sympathomimetics|sympathomimetics|mesh-ancestor
153350821|NCT04756050|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
153350822|NCT04731103|Lamivudine|lamivudine|mesh-list
153350823|NCT04731103|Zidovudine|zidovudine|mesh-list
153350824|NCT04731103|Abacavir|abacavir|mesh-list
153880635|NCT01190930|Vitamin B Complex|vitamin b complex|mesh-ancestor
153880636|NCT01190930|Vitamins|vitamins|mesh-ancestor
153880637|NCT01190930|Micronutrients|micronutrients|mesh-ancestor
153880638|NCT01190930|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153880639|NCT01190930|Tubulin Modulators|tubulin modulators|mesh-ancestor
153880640|NCT01190930|Antimitotic Agents|antimitotic agents|mesh-ancestor
153880641|NCT01190930|Mitosis Modulators|mitosis modulators|mesh-ancestor
153880643|NCT01047007|Cisplatin|cisplatin|mesh-list
153880644|NCT01047007|Adavosertib|adavosertib|mesh-list
153350825|NCT04731103|Dideoxynucleosides|dideoxynucleosides|mesh-list
153880645|NCT01047007|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153880646|NCT01047007|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153421482|NCT05861986|Risdiplam|risdiplam|mesh-list
153421483|NCT05861986|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
153421484|NCT05861986|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153350826|NCT04731103|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153350827|NCT04731103|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153350828|NCT04731103|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153350829|NCT04731103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153350830|NCT04731103|Antiviral Agents|antiviral agents|mesh-ancestor
153350831|NCT04731103|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153350832|NCT04731103|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153350833|NCT04731103|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153350834|NCT04731103|Antimetabolites|antimetabolites|mesh-ancestor
153350835|NCT04716712|Azithromycin|azithromycin|mesh-list
153350836|NCT04716712|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153350837|NCT04716712|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153350838|NCT04683640|gamma-Aminobutyric Acid|gamma-aminobutyric acid|mesh-list
153350839|NCT04683640|GABA Agents|gaba agents|mesh-ancestor
153350840|NCT04683640|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153421485|NCT05861986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153421486|NCT05855967|Ixekizumab|ixekizumab|mesh-list
153421487|NCT05855967|Dermatologic Agents|dermatologic agents|mesh-ancestor
153421488|NCT05850520|Aflibercept|aflibercept|mesh-list
153421489|NCT05850520|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153350841|NCT04683640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153350852|NCT04644796|Anesthetics|anesthetics|mesh-ancestor
153421528|NCT05811403|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153350853|NCT04644796|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153350854|NCT04644796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153350855|NCT04644796|Sensory System Agents|sensory system agents|mesh-ancestor
153350856|NCT04644796|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153350858|NCT04621929|Phentermine|phentermine|mesh-list
153350859|NCT04621929|Allopurinol|allopurinol|mesh-list
153350860|NCT04621929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153350861|NCT04621929|Anticonvulsants|anticonvulsants|mesh-ancestor
153350862|NCT04621929|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153350863|NCT04621929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153350864|NCT04621929|Antimetabolites|antimetabolites|mesh-ancestor
153350865|NCT04621929|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153350866|NCT04621929|Gout Suppressants|gout suppressants|mesh-ancestor
153350867|NCT04621929|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153350868|NCT04621929|Free Radical Scavengers|free radical scavengers|mesh-ancestor
153350869|NCT04621929|Antioxidants|antioxidants|mesh-ancestor
153350870|NCT04621929|Protective Agents|protective agents|mesh-ancestor
153350871|NCT04621929|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
153350872|NCT04621929|Appetite Depressants|appetite depressants|mesh-ancestor
153350873|NCT04621929|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
153350874|NCT04621929|Sympathomimetics|sympathomimetics|mesh-ancestor
153350875|NCT04621929|Autonomic Agents|autonomic agents|mesh-ancestor
153350876|NCT04621929|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153350877|NCT04621929|Adrenergic Agents|adrenergic agents|mesh-ancestor
153350878|NCT04621929|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153350879|NCT04572763|Venetoclax|venetoclax|mesh-list
153350880|NCT04572763|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153350898|NCT04527887|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153421499|NCT05839652|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153421500|NCT05839652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153421501|NCT05839652|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
153421502|NCT05839652|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
153421503|NCT05839652|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153421504|NCT05839652|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153421505|NCT05839652|Adrenergic Agents|adrenergic agents|mesh-ancestor
153421506|NCT05839652|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153421507|NCT05839652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153421508|NCT05839652|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
153421509|NCT05839652|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
153421511|NCT05839054|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
153880670|NCT00648648|Gemcitabine|gemcitabine|mesh-list
153350899|NCT04527887|Antiemetics|antiemetics|mesh-ancestor
153350900|NCT04527887|Autonomic Agents|autonomic agents|mesh-ancestor
153350901|NCT04527887|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153350902|NCT04527887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153350903|NCT04527887|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153350904|NCT04527887|Glucocorticoids|glucocorticoids|mesh-ancestor
153350906|NCT04527887|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153350907|NCT04527887|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153350908|NCT04527887|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153880676|NCT00648648|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153880677|NCT00608725|Propranolol|propranolol|mesh-list
153880678|NCT00608725|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
153880679|NCT00608725|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
153880680|NCT00608725|Adrenergic Agents|adrenergic agents|mesh-ancestor
153880681|NCT00608725|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153880682|NCT00608725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153880683|NCT00608725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153880685|NCT00608725|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153880686|NCT00608725|Vasodilator Agents|vasodilator agents|mesh-ancestor
153880687|NCT00546351|Lacosamide|lacosamide|mesh-list
153880688|NCT00546351|Anticonvulsants|anticonvulsants|mesh-ancestor
153880689|NCT00546351|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
153880690|NCT00546351|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153880691|NCT00546351|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153880692|NCT00546351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153880693|NCT00536172|Escitalopram|escitalopram|mesh-list
153421526|NCT05811403|Epigallocatechin gallate|epigallocatechin gallate|mesh-list
153421527|NCT05811403|Disinfectants|disinfectants|mesh-ancestor
153421529|NCT05811403|Antioxidants|antioxidants|mesh-ancestor
153421530|NCT05811403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153350909|NCT04436926|Analgesics, Opioid|analgesics, opioid|mesh-list
153350910|NCT04436926|Narcotics|narcotics|mesh-ancestor
153350911|NCT04436926|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153350912|NCT04436926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153350913|NCT04436926|Analgesics|analgesics|mesh-ancestor
153350914|NCT04436926|Sensory System Agents|sensory system agents|mesh-ancestor
153350915|NCT04436926|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153350916|NCT04423055|Contraceptive Agents|contraceptive agents|mesh-list
153350917|NCT04423055|Etonogestrel|etonogestrel|mesh-list
153350918|NCT04423055|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153350919|NCT04423055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153350920|NCT04423055|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
153350921|NCT04423055|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
153350922|NCT04418401|Antibodies|antibodies|mesh-list
153350923|NCT04418401|Immunologic Factors|immunologic factors|mesh-ancestor
153350924|NCT04418401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153350925|NCT04385602|Dexmedetomidine|dexmedetomidine|mesh-list
153350926|NCT04385602|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153350927|NCT04385602|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153421531|NCT05811403|Protective Agents|protective agents|mesh-ancestor
153350929|NCT04385602|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153350942|NCT04379713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153350943|NCT04218773|Phenylephrine|phenylephrine|mesh-list
153421533|NCT05811403|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
153421534|NCT05811403|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
153350944|NCT04218773|Oxymetazoline|oxymetazoline|mesh-list
153350945|NCT04218773|Norepinephrine|norepinephrine|mesh-list
153350947|NCT04218773|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
153350948|NCT04218773|Mydriatics|mydriatics|mesh-ancestor
153350949|NCT04218773|Autonomic Agents|autonomic agents|mesh-ancestor
153421535|NCT05811403|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153421536|NCT05811403|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
153421537|NCT05788393|Lidocaine|lidocaine|mesh-list
153421538|NCT05788393|Dexmedetomidine|dexmedetomidine|mesh-list
153421539|NCT05788393|Anesthetics, Local|anesthetics, local|mesh-ancestor
153421540|NCT05788393|Anesthetics|anesthetics|mesh-ancestor
153421541|NCT05788393|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153421542|NCT05788393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153421543|NCT05788393|Sensory System Agents|sensory system agents|mesh-ancestor
153421544|NCT05788393|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153421547|NCT05788393|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153421548|NCT05788393|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153880696|NCT00536172|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153880697|NCT00536172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153880698|NCT00536172|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153350950|NCT04218773|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153350951|NCT04218773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153350953|NCT04218773|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
153350954|NCT04218773|Nasal Decongestants|nasal decongestants|mesh-ancestor
153350955|NCT04218773|Respiratory System Agents|respiratory system agents|mesh-ancestor
153350956|NCT04218773|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
153350957|NCT04218773|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153350958|NCT04218773|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153350959|NCT04218773|Adrenergic Agents|adrenergic agents|mesh-ancestor
153350960|NCT04218773|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153350961|NCT04218773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153350962|NCT04218773|Protective Agents|protective agents|mesh-ancestor
153350974|NCT04100824|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153350975|NCT04100824|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153350976|NCT04100824|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153350977|NCT04100824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153350978|NCT04100824|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153350979|NCT04100824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153880699|NCT00536172|Serotonin Agents|serotonin agents|mesh-ancestor
153880700|NCT00536172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153880701|NCT00003838|Cyclosporine|cyclosporine|mesh-list
153350980|NCT04100824|Vasodilator Agents|vasodilator agents|mesh-ancestor
153350981|NCT04088851|Metformin|metformin|mesh-list
153350982|NCT04088851|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153350983|NCT04088851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153350984|NCT04074265|Ketorolac|ketorolac|mesh-list
153350985|NCT04074265|Epinephrine|epinephrine|mesh-list
153350986|NCT04074265|Ropivacaine|ropivacaine|mesh-list
153350993|NCT04074265|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153350994|NCT04074265|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153350995|NCT04074265|Adrenergic Agents|adrenergic agents|mesh-ancestor
153350996|NCT04074265|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153350997|NCT04074265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153350998|NCT04074265|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
153350999|NCT04074265|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153351000|NCT04074265|Autonomic Agents|autonomic agents|mesh-ancestor
153351001|NCT04074265|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153351002|NCT04074265|Respiratory System Agents|respiratory system agents|mesh-ancestor
153351003|NCT04074265|Mydriatics|mydriatics|mesh-ancestor
153351004|NCT04074265|Sympathomimetics|sympathomimetics|mesh-ancestor
153351005|NCT04074265|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
153351006|NCT04074265|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153351007|NCT04074265|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153880709|NCT00003838|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153880710|NCT00003838|Antimetabolites|antimetabolites|mesh-ancestor
153880711|NCT00003838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153880712|NCT00003838|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153880713|NCT00003838|Dermatologic Agents|dermatologic agents|mesh-ancestor
153880714|NCT00003838|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153880715|NCT00003838|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153421549|NCT05788393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153421550|NCT05788393|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153351008|NCT04074265|Analgesics|analgesics|mesh-ancestor
153351009|NCT04074265|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153351010|NCT04074265|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153351011|NCT04074265|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153351012|NCT04074265|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153351048|NCT03693560|Vildagliptin|vildagliptin|mesh-list
153351049|NCT03693560|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153351050|NCT03693560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153351051|NCT03693560|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153351052|NCT03693560|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153351053|NCT03693560|Immunologic Factors|immunologic factors|mesh-ancestor
153351054|NCT03693560|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
153351055|NCT03693560|Protease Inhibitors|protease inhibitors|mesh-ancestor
153351056|NCT03693560|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153351057|NCT03693560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153351059|NCT03675893|Letrozole|letrozole|mesh-list
153351060|NCT03675893|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153351061|NCT03675893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153351062|NCT03675893|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153351063|NCT03675893|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
153351064|NCT03675893|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153351065|NCT03675893|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153351066|NCT03675893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153351067|NCT03675893|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
153351068|NCT03675893|Hormone Antagonists|hormone antagonists|mesh-ancestor
153351069|NCT03675893|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153351070|NCT03574090|Amoxicillin|amoxicillin|mesh-list
153351071|NCT03574090|Clavulanic Acid|clavulanic acid|mesh-list
153351081|NCT03417544|Pertuzumab|pertuzumab|mesh-list
153421545|NCT05788393|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153421546|NCT05788393|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
153351096|NCT03113851|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153421570|NCT05754684|Interleukin-2|interleukin-2|mesh-list
153421571|NCT05754684|Molgramostim|molgramostim|mesh-list
153421572|NCT05754684|Dinutuximab|dinutuximab|mesh-list
153421573|NCT05754684|Spironolactone|spironolactone|mesh-list
153421574|NCT05754684|Sargramostim|sargramostim|mesh-list
153421575|NCT05754684|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153421576|NCT05754684|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153421577|NCT05754684|Analgesics|analgesics|mesh-ancestor
153421578|NCT05754684|Sensory System Agents|sensory system agents|mesh-ancestor
153421579|NCT05754684|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153421580|NCT05754684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153421581|NCT05754684|Immunologic Factors|immunologic factors|mesh-ancestor
153421582|NCT05754684|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153421583|NCT05754684|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153421584|NCT05754684|Antiviral Agents|antiviral agents|mesh-ancestor
153351097|NCT02903381|Dexamethasone|dexamethasone|mesh-list
153351099|NCT02903381|Lenalidomide|lenalidomide|mesh-list
153351100|NCT02903381|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153351101|NCT02903381|Antiemetics|antiemetics|mesh-ancestor
153351102|NCT02903381|Autonomic Agents|autonomic agents|mesh-ancestor
153351103|NCT02903381|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153351104|NCT02903381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153351105|NCT02903381|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153351106|NCT02903381|Glucocorticoids|glucocorticoids|mesh-ancestor
153351107|NCT02903381|Hormones|hormones|mesh-ancestor
153351108|NCT02903381|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153351109|NCT02903381|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153351110|NCT02903381|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153351111|NCT02903381|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153880733|NCT06031376|Growth Inhibitors|growth inhibitors|mesh-ancestor
153880734|NCT06031376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153880735|NCT06031376|Antimetabolites|antimetabolites|mesh-ancestor
153880736|NCT06031376|Antiviral Agents|antiviral agents|mesh-ancestor
153880740|NCT06031285|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153880741|NCT06031285|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153880742|NCT06031285|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153880743|NCT06031285|Growth Substances|growth substances|mesh-ancestor
153880744|NCT06031285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153880745|NCT06031285|Growth Inhibitors|growth inhibitors|mesh-ancestor
153880746|NCT06031168|Metformin|metformin|mesh-list
153880747|NCT06031168|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153880748|NCT06031168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153421585|NCT05754684|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153421586|NCT05754684|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
153421587|NCT05754684|Hormone Antagonists|hormone antagonists|mesh-ancestor
153421588|NCT05754684|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153421589|NCT05754684|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
153421591|NCT05754684|Natriuretic Agents|natriuretic agents|mesh-ancestor
153421593|NCT05709652|Selamectin|selamectin|mesh-list
153421594|NCT05709652|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153421595|NCT05709652|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153351112|NCT02903381|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153351113|NCT02903381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153351114|NCT02903381|Immunologic Factors|immunologic factors|mesh-ancestor
153351115|NCT02903381|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153351116|NCT02903381|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153351117|NCT02903381|Growth Substances|growth substances|mesh-ancestor
153351118|NCT02903381|Growth Inhibitors|growth inhibitors|mesh-ancestor
153351119|NCT02744391|Levodopa|levodopa|mesh-list
153351120|NCT02744391|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
153783396|NCT04541719|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153783397|NCT04541719|Narcotics|narcotics|mesh-ancestor
153351121|NCT02744391|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
153351122|NCT02744391|Dopamine Agents|dopamine agents|mesh-ancestor
153351126|NCT02462837|Mirabegron|mirabegron|mesh-list
153351141|NCT02346201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153351142|NCT02346201|Dopamine Agents|dopamine agents|mesh-ancestor
153351143|NCT02346201|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153351144|NCT02042378|Rucaparib|rucaparib|mesh-list
153351145|NCT02042378|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
153351146|NCT02042378|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153351147|NCT02042378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153351148|NCT02042378|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153351149|NCT01866930|Interferons|interferons|mesh-list
153351150|NCT01866930|Ribavirin|ribavirin|mesh-list
153351151|NCT01866930|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153421596|NCT05708235|Inavolisib|inavolisib|mesh-list
153421597|NCT05708235|Phosphoinositide-3 Kinase Inhibitors|phosphoinositide-3 kinase inhibitors|mesh-ancestor
153351152|NCT01866930|Antiviral Agents|antiviral agents|mesh-ancestor
153421598|NCT05708235|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153421599|NCT05708235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153880757|NCT06031129|Antitussive Agents|antitussive agents|mesh-ancestor
153351153|NCT01866930|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153351154|NCT01866930|Antimetabolites|antimetabolites|mesh-ancestor
153880761|NCT06031090|Granisetron|granisetron|mesh-list
153880762|NCT06031090|Analgesics|analgesics|mesh-ancestor
153421606|NCT05689047|Pyronaridine|pyronaridine|mesh-list
153421607|NCT05689047|Pyronaridine tetraphosphate, artesunate drug combination|pyronaridine tetraphosphate, artesunate drug combination|mesh-list
153351155|NCT01866930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153351156|NCT01682187|Lomustine|lomustine|mesh-list
153351157|NCT01682187|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153351158|NCT01682187|Alkylating Agents|alkylating agents|mesh-ancestor
153351159|NCT01682187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153421608|NCT05689047|Antimalarials|antimalarials|mesh-ancestor
153421609|NCT05689047|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153421610|NCT05689047|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153421611|NCT05689047|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153421613|NCT05689047|Antiviral Agents|antiviral agents|mesh-ancestor
153421616|NCT05689047|Anthelmintics|anthelmintics|mesh-ancestor
153421618|NCT05676749|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153421619|NCT05676749|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153421620|NCT05676749|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153880766|NCT06031090|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153880767|NCT06031090|Sympatholytics|sympatholytics|mesh-ancestor
153880768|NCT06031090|Autonomic Agents|autonomic agents|mesh-ancestor
153421622|NCT05668585|Trametinib|trametinib|mesh-list
153351160|NCT01682187|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153351161|NCT01621568|Sunitinib|sunitinib|mesh-list
153351162|NCT01621568|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153351163|NCT01621568|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153351164|NCT01621568|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153351165|NCT01621568|Growth Substances|growth substances|mesh-ancestor
153351166|NCT01621568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153351167|NCT01621568|Growth Inhibitors|growth inhibitors|mesh-ancestor
153351168|NCT01621568|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153351169|NCT01621568|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153351170|NCT01621568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153351171|NCT01366612|Vidarabine|vidarabine|mesh-list
153351179|NCT01366612|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153351180|NCT01366612|Immunologic Factors|immunologic factors|mesh-ancestor
153351181|NCT01366612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153351182|NCT01366612|Antiviral Agents|antiviral agents|mesh-ancestor
153351183|NCT01366612|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153351184|NCT01366612|Alkylating Agents|alkylating agents|mesh-ancestor
153351185|NCT01366612|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153351186|NCT01366612|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153351187|NCT00813293|Sorafenib|sorafenib|mesh-list
153351188|NCT00813293|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153351189|NCT00813293|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153351190|NCT00813293|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153351191|NCT00813293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153351192|NCT00481091|Navitoclax|navitoclax|mesh-list
153351193|NCT00481091|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153351194|NCT00003641|Interferons|interferons|mesh-list
153351195|NCT00003641|Interferon-alpha|interferon-alpha|mesh-list
153351196|NCT00003641|Interferon alpha-2|interferon alpha-2|mesh-list
153351197|NCT00003641|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153351198|NCT00003641|Antiviral Agents|antiviral agents|mesh-ancestor
153351199|NCT00003641|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153351200|NCT00003641|Immunologic Factors|immunologic factors|mesh-ancestor
153421642|NCT05617508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153421655|NCT05603104|Esketamine|esketamine|mesh-list
153351201|NCT00003641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153351203|NCT00392834|Cytarabine|cytarabine|mesh-list
153351204|NCT00392834|Hydrocortisone|hydrocortisone|mesh-list
153351205|NCT00392834|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
153351206|NCT00392834|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
153351207|NCT00392834|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
153351208|NCT00392834|Cyclophosphamide|cyclophosphamide|mesh-list
153351209|NCT00392834|Ifosfamide|ifosfamide|mesh-list
153351210|NCT00392834|Rituximab|rituximab|mesh-list
153351211|NCT00392834|Doxorubicin|doxorubicin|mesh-list
153351212|NCT00392834|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
153351213|NCT00392834|Methotrexate|methotrexate|mesh-list
153351214|NCT00392834|Etoposide|etoposide|mesh-list
153351223|NCT00392834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153351224|NCT00392834|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153351225|NCT00392834|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153351226|NCT00392834|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153351227|NCT00392834|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153351228|NCT00392834|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153351229|NCT00392834|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153351230|NCT00392834|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153351231|NCT00392834|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
153351232|NCT00392834|Abortifacient Agents|abortifacient agents|mesh-ancestor
153351233|NCT00392834|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153351234|NCT00392834|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153351235|NCT00392834|Antimetabolites|antimetabolites|mesh-ancestor
153351236|NCT00392834|Dermatologic Agents|dermatologic agents|mesh-ancestor
153351237|NCT00392834|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153351238|NCT00392834|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153351239|NCT00392834|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153351240|NCT00392834|Antiviral Agents|antiviral agents|mesh-ancestor
153351241|NCT00392834|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153351242|NCT00392834|Antidotes|antidotes|mesh-ancestor
153351243|NCT00392834|Protective Agents|protective agents|mesh-ancestor
153351244|NCT00392834|Vitamin B Complex|vitamin b complex|mesh-ancestor
153351245|NCT00392834|Vitamins|vitamins|mesh-ancestor
153351246|NCT00392834|Micronutrients|micronutrients|mesh-ancestor
153421664|NCT05603104|Anesthetics, General|anesthetics, general|mesh-ancestor
153421665|NCT05603104|Anesthetics|anesthetics|mesh-ancestor
153421666|NCT05603104|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153421667|NCT05603104|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
153880816|NCT06030479|Epinephryl borate|epinephryl borate|mesh-list
153351247|NCT00392834|Tubulin Modulators|tubulin modulators|mesh-ancestor
153351248|NCT00392834|Antimitotic Agents|antimitotic agents|mesh-ancestor
153351268|NCT05361642|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
153351269|NCT05361642|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153351270|NCT05361642|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153351271|NCT05361642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153351272|NCT05361642|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153351273|NCT05361642|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153351274|NCT05361642|Analgesics|analgesics|mesh-ancestor
153351275|NCT05361642|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
153351276|NCT05361642|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153351277|NCT05361642|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153351278|NCT05361642|Adrenergic Agents|adrenergic agents|mesh-ancestor
153351279|NCT05361642|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153351332|NCT05610384|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153351334|NCT05610384|Analgesics|analgesics|mesh-ancestor
153351335|NCT05610384|Sensory System Agents|sensory system agents|mesh-ancestor
153351336|NCT05610384|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153351337|NCT05610384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153351338|NCT05610384|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153351339|NCT05610384|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153351340|NCT05610384|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153351341|NCT05610384|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153351342|NCT05610384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153351343|NCT00397904|Irinotecan|irinotecan|mesh-list
153351344|NCT00397904|Cetuximab|cetuximab|mesh-list
153351345|NCT00397904|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153351346|NCT00397904|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
153351348|NCT00397904|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153351349|NCT00397904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153351350|NCT00397904|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153351351|NCT00398918|Zonisamide|zonisamide|mesh-list
153351352|NCT00398918|Anticonvulsants|anticonvulsants|mesh-ancestor
153421702|NCT05556512|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153421703|NCT05556512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153880850|NCT06027099|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153351353|NCT00398918|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153351354|NCT00398918|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153351355|NCT00398918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153351356|NCT00398918|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153351357|NCT00398918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153351358|NCT05380752|Tecovirimat|tecovirimat|mesh-list
153351359|NCT05380752|Antiviral Agents|antiviral agents|mesh-ancestor
153351360|NCT05380752|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153351377|NCT00370838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153351378|NCT00370838|Anticonvulsants|anticonvulsants|mesh-ancestor
153351379|NCT00370838|Nootropic Agents|nootropic agents|mesh-ancestor
153351380|NCT01795430|Etoposide|etoposide|mesh-list
153351381|NCT01795430|Etoposide phosphate|etoposide phosphate|mesh-list
153351382|NCT01795430|Melphalan|melphalan|mesh-list
153351383|NCT01795430|Busulfan|busulfan|mesh-list
153351384|NCT01795430|Topotecan|topotecan|mesh-list
153351385|NCT01795430|Ifosfamide|ifosfamide|mesh-list
153351386|NCT01795430|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153351387|NCT01795430|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153351388|NCT01795430|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153351389|NCT01795430|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153351390|NCT01795430|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153351391|NCT01795430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153351392|NCT01795430|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153351393|NCT01795430|Alkylating Agents|alkylating agents|mesh-ancestor
153351394|NCT01795430|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153351395|NCT01795430|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153351396|NCT01795430|Immunologic Factors|immunologic factors|mesh-ancestor
153351397|NCT01795430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153351398|NCT01795430|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
153351400|NCT04750382|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153351401|NCT04750382|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153351402|NCT04750382|Antimetabolites|antimetabolites|mesh-ancestor
153351403|NCT04750382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153351404|NCT00401882|Metoprolol|metoprolol|mesh-list
153351405|NCT00401882|Epinephrine|epinephrine|mesh-list
153351406|NCT00401882|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153351407|NCT00401882|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153351408|NCT00401882|Adrenergic Agents|adrenergic agents|mesh-ancestor
153880870|NCT06014073|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153351422|NCT00401882|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153351424|NCT00401882|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
153351425|NCT00401882|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
153351426|NCT00401882|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
153351427|NCT00373334|Nizatidine|nizatidine|mesh-list
153351428|NCT00373334|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
153351429|NCT00373334|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153351430|NCT00373334|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
153351431|NCT00373334|Histamine Antagonists|histamine antagonists|mesh-ancestor
153351432|NCT00373334|Histamine Agents|histamine agents|mesh-ancestor
153351433|NCT00373334|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153351434|NCT00373334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153351435|NCT00373334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153351436|NCT00402194|Losartan|losartan|mesh-list
153351437|NCT00402194|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153351438|NCT00402194|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153351439|NCT00402194|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
153351440|NCT00402194|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
153351441|NCT00402194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153351442|NCT05305404|Dexamethasone|dexamethasone|mesh-list
153351443|NCT05305404|Dexamethasone acetate|dexamethasone acetate|mesh-list
153351444|NCT05305404|BB 1101|bb 1101|mesh-list
153351445|NCT05305404|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153351446|NCT05305404|Antiemetics|antiemetics|mesh-ancestor
153351447|NCT05305404|Autonomic Agents|autonomic agents|mesh-ancestor
153351448|NCT05305404|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153351449|NCT05305404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153351450|NCT05305404|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153351451|NCT05305404|Glucocorticoids|glucocorticoids|mesh-ancestor
153351452|NCT05305404|Hormones|hormones|mesh-ancestor
153351453|NCT05305404|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153351454|NCT05305404|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153351455|NCT05305404|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153351456|NCT05305404|Protease Inhibitors|protease inhibitors|mesh-ancestor
153351457|NCT05305404|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153351461|NCT00402896|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-list
153351462|NCT00402896|Mitosis Modulators|mitosis modulators|mesh-ancestor
153351463|NCT00402896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153351464|NCT00402896|Growth Substances|growth substances|mesh-ancestor
153351465|NCT00402896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153351466|NCT00402896|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153351467|NCT00402896|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153421747|NCT05514054|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153421749|NCT05514054|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
153351470|NCT00405704|Sulfamethoxazole|sulfamethoxazole|mesh-list
153351471|NCT00405704|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
153351472|NCT00405704|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153351473|NCT00405704|Antimalarials|antimalarials|mesh-ancestor
153351474|NCT00405704|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153351475|NCT00405704|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153351476|NCT00405704|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153351477|NCT00405704|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153351478|NCT00405704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153351479|NCT00405704|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
153351480|NCT00405704|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
153351481|NCT00405704|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153351482|NCT00405704|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153351483|NCT01657266|Nepafenac|nepafenac|mesh-list
153351484|NCT01657266|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153351485|NCT01657266|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153351486|NCT01657266|Analgesics|analgesics|mesh-ancestor
153351487|NCT01657266|Sensory System Agents|sensory system agents|mesh-ancestor
153351488|NCT01657266|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153351489|NCT01657266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153351490|NCT01657266|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153351507|NCT05286008|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153351508|NCT05286008|Sensory System Agents|sensory system agents|mesh-ancestor
153351509|NCT05302284|Carboplatin|carboplatin|mesh-list
153351510|NCT05302284|Gemcitabine|gemcitabine|mesh-list
153351511|NCT05302284|Disitamab vedotin|disitamab vedotin|mesh-list
153351512|NCT05302284|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153351513|NCT05302284|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153351514|NCT05302284|Antimetabolites|antimetabolites|mesh-ancestor
153351515|NCT05302284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153351516|NCT05302284|Immunoconjugates|immunoconjugates|mesh-ancestor
153351517|NCT05302284|Immunologic Factors|immunologic factors|mesh-ancestor
153351518|NCT05302284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153351519|NCT05300802|Dexmedetomidine|dexmedetomidine|mesh-list
153351520|NCT05300802|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153351521|NCT05300802|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153351522|NCT05300802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153351523|NCT05300802|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153351524|NCT05300802|Analgesics|analgesics|mesh-ancestor
153880904|NCT05897554|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153880694|NCT00536172|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
153880695|NCT00536172|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153351526|NCT05300802|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153351527|NCT05300802|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
153351528|NCT05300802|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153351529|NCT05300802|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153351530|NCT05300802|Adrenergic Agents|adrenergic agents|mesh-ancestor
153351531|NCT05300802|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153351532|NCT05300802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153351534|NCT05299476|Tislelizumab|tislelizumab|mesh-list
153351535|NCT05299476|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153351552|NCT00405938|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153351553|NCT00405938|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
153351554|NCT00405938|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
153351555|NCT00405938|Hormone Antagonists|hormone antagonists|mesh-ancestor
153351556|NCT00405938|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153351557|NCT00405938|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
153351558|NCT00405938|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153351559|NCT00405938|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153351560|NCT00405938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153351562|NCT05299398|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153351563|NCT05299398|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153351564|NCT05299398|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153351565|NCT05299398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153351566|NCT05299398|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153351567|NCT05299398|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
153351568|NCT05299398|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153351569|NCT05299398|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153351570|NCT05299398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153783399|NCT04541719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153783400|NCT04541719|Analgesics|analgesics|mesh-ancestor
153351571|NCT05299398|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153351575|NCT01793480|Methadone|methadone|mesh-list
153351599|NCT05256264|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
153351600|NCT05256264|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153351601|NCT05256264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153351603|NCT00379574|Cyclophosphamide|cyclophosphamide|mesh-list
153351604|NCT00379574|Doxorubicin|doxorubicin|mesh-list
153351605|NCT00379574|Vincristine|vincristine|mesh-list
153351606|NCT00379574|Bortezomib|bortezomib|mesh-list
153351607|NCT00379574|Lenograstim|lenograstim|mesh-list
153351608|NCT00379574|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153351609|NCT00379574|Immunologic Factors|immunologic factors|mesh-ancestor
153351610|NCT00379574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153421785|NCT05479747|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153421786|NCT05479747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153421788|NCT05476939|TIC10 compound|tic10 compound|mesh-list
153880926|NCT05846399|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153351611|NCT00379574|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153351612|NCT00379574|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153351613|NCT00379574|Alkylating Agents|alkylating agents|mesh-ancestor
153351614|NCT00379574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153351615|NCT00379574|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153351616|NCT00379574|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153351617|NCT00379574|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153351618|NCT00379574|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153351619|NCT00379574|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153351620|NCT00379574|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153351621|NCT00379574|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153351622|NCT00379574|Tubulin Modulators|tubulin modulators|mesh-ancestor
153351623|NCT00379574|Antimitotic Agents|antimitotic agents|mesh-ancestor
153351624|NCT00379574|Mitosis Modulators|mitosis modulators|mesh-ancestor
153351625|NCT00379574|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153351626|NCT00379574|Glucocorticoids|glucocorticoids|mesh-ancestor
153351627|NCT00379574|Hormones|hormones|mesh-ancestor
153351628|NCT00379574|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153351629|NCT00379574|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153351630|NCT00379574|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153351631|NCT05256108|Oxycodone|oxycodone|mesh-list
153351632|NCT05256108|Tramadol|tramadol|mesh-list
153351633|NCT05256108|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153351639|NCT05256108|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153351640|NCT05484492|Calcium|calcium|mesh-list
153351641|NCT05484492|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153351642|NCT05484492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153351643|NCT00407888|Paclitaxel|paclitaxel|mesh-list
153351644|NCT00407888|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
153351645|NCT00407888|Cyclophosphamide|cyclophosphamide|mesh-list
153351646|NCT00407888|Doxorubicin|doxorubicin|mesh-list
153351647|NCT00407888|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
153351649|NCT00407888|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153351650|NCT00407888|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153351651|NCT00407888|Tubulin Modulators|tubulin modulators|mesh-ancestor
153351652|NCT00407888|Antimitotic Agents|antimitotic agents|mesh-ancestor
153421789|NCT05476939|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
153421790|NCT05476939|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153351653|NCT00407888|Mitosis Modulators|mitosis modulators|mesh-ancestor
153351654|NCT00407888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153351655|NCT00407888|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153351656|NCT00407888|Immunologic Factors|immunologic factors|mesh-ancestor
153351657|NCT00407888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153351658|NCT00407888|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153351659|NCT00407888|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153351660|NCT00407888|Alkylating Agents|alkylating agents|mesh-ancestor
153351661|NCT00407888|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153351662|NCT00407888|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153351663|NCT00407888|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153351664|NCT00407888|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153351665|NCT00407888|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153423432|NCT00376285|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153423433|NCT00376285|Antimetabolites|antimetabolites|mesh-ancestor
153423434|NCT00376285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153351666|NCT00407888|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153351668|NCT00407966|Mitoxantrone|mitoxantrone|mesh-list
153351669|NCT00407966|Alvocidib|alvocidib|mesh-list
153351670|NCT00407966|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153351671|NCT00407966|Antimetabolites|antimetabolites|mesh-ancestor
153351672|NCT00407966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153351673|NCT00407966|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153351674|NCT00407966|Antiviral Agents|antiviral agents|mesh-ancestor
153351675|NCT00407966|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153351676|NCT00407966|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153351677|NCT00407966|Immunologic Factors|immunologic factors|mesh-ancestor
153351678|NCT00407966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153351679|NCT00407966|Analgesics|analgesics|mesh-ancestor
153351680|NCT00407966|Sensory System Agents|sensory system agents|mesh-ancestor
153351681|NCT00407966|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153351682|NCT00407966|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153351683|NCT00407966|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153351684|NCT00407966|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153351685|NCT00407966|Growth Inhibitors|growth inhibitors|mesh-ancestor
153351686|NCT00407966|Growth Substances|growth substances|mesh-ancestor
153421825|NCT05431595|Haloperidol decanoate|haloperidol decanoate|mesh-list
153421826|NCT05431595|Antiemetics|antiemetics|mesh-ancestor
153880962|NCT05779007|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153880963|NCT05779007|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153351687|NCT00407966|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153351688|NCT00408200|Flecainide|flecainide|mesh-list
153351690|NCT00408200|Propafenone|propafenone|mesh-list
153351691|NCT00408200|Dofetilide|dofetilide|mesh-list
153351692|NCT00408200|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153351693|NCT00408200|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
153351694|NCT00408200|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153351695|NCT00408200|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153351696|NCT00408200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153351697|NCT00408200|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
153351698|NCT00408200|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
153351730|NCT05250050|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
153880965|NCT05731323|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
153880966|NCT05731323|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153880967|NCT05731323|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
153880968|NCT05731323|Antitubercular Agents|antitubercular agents|mesh-ancestor
153880969|NCT05731323|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153351731|NCT05250050|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153351732|NCT05250050|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153351733|NCT05250050|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153351734|NCT05250050|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
153351735|NCT05250050|Antacids|antacids|mesh-ancestor
153351736|NCT05250050|Diuretics|diuretics|mesh-ancestor
153351737|NCT05250050|Natriuretic Agents|natriuretic agents|mesh-ancestor
153351738|NCT05250050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153351739|NCT05250050|Expectorants|expectorants|mesh-ancestor
153351740|NCT05250050|Respiratory System Agents|respiratory system agents|mesh-ancestor
153351741|NCT05294328|Brimonidine Tartrate|brimonidine tartrate|mesh-list
153351742|NCT05294328|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
153351743|NCT05294328|Ophthalmic Solutions|ophthalmic solutions|mesh-list
153351744|NCT05294328|Aceclidine|aceclidine|mesh-list
153351745|NCT05294328|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153421831|NCT05431595|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153421832|NCT05431595|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153421833|NCT05431595|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153421834|NCT05431595|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153421835|NCT05431595|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
153421836|NCT05431595|Dopamine Agents|dopamine agents|mesh-ancestor
153421842|NCT05431595|GABA Agents|gaba agents|mesh-ancestor
153881013|NCT05609240|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153881014|NCT05609240|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153881015|NCT05511623|Tislelizumab|tislelizumab|mesh-list
153881016|NCT05511623|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153881017|NCT05511623|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153351747|NCT05294328|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153351748|NCT05294328|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153351749|NCT05294328|Adrenergic Agents|adrenergic agents|mesh-ancestor
153351750|NCT05294328|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153351751|NCT05294328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153351752|NCT05294328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153351753|NCT05294328|Miotics|miotics|mesh-ancestor
153351754|NCT05294328|Autonomic Agents|autonomic agents|mesh-ancestor
153351755|NCT05294328|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153351756|NCT05294328|Parasympathomimetics|parasympathomimetics|mesh-ancestor
153351777|NCT05292066|Anticonvulsants|anticonvulsants|mesh-ancestor
153351778|NCT05292066|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153351779|NCT05292066|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153351780|NCT05292066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153351781|NCT05292066|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153351782|NCT05292066|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153351783|NCT05292066|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153881018|NCT05465317|Empagliflozin|empagliflozin|mesh-list
153881019|NCT05465317|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
153881020|NCT05465317|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-list
153881021|NCT05465317|Glucagon|glucagon|mesh-list
153881022|NCT05465317|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
153351784|NCT05292066|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153351785|NCT05292066|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153351786|NCT05292066|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
153351787|NCT05292066|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153351788|NCT05292066|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153351789|NCT05292066|Antidepressive Agents|antidepressive agents|mesh-ancestor
153351790|NCT05292066|Dopamine Agents|dopamine agents|mesh-ancestor
153351792|NCT04270994|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
153351793|NCT04270994|Abortifacient Agents|abortifacient agents|mesh-ancestor
153351794|NCT04270994|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153351795|NCT04270994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153351796|NCT04270994|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
153351797|NCT04270994|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153351798|NCT04270994|Oxytocics|oxytocics|mesh-ancestor
153351800|NCT02111798|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
153351801|NCT02111798|Antidepressive Agents|antidepressive agents|mesh-ancestor
153351802|NCT02111798|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153351803|NCT02111798|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
153351804|NCT02111798|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153881023|NCT05465317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153881024|NCT05465317|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153881025|NCT05465317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153421880|NCT05328908|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153421881|NCT05328908|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153421882|NCT05328908|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153421883|NCT05328908|Antimetabolites|antimetabolites|mesh-ancestor
153351805|NCT02111798|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153351806|NCT02111798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153351807|NCT02111798|Dopamine Agents|dopamine agents|mesh-ancestor
153351808|NCT02111798|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153351809|NCT02111798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153351813|NCT05290662|Cyclophosphamide|cyclophosphamide|mesh-list
153351814|NCT05290662|Fludarabine|fludarabine|mesh-list
153351815|NCT05290662|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153351816|NCT05290662|Immunologic Factors|immunologic factors|mesh-ancestor
153351817|NCT05290662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153351818|NCT05290662|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153351819|NCT05290662|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153351820|NCT05290662|Alkylating Agents|alkylating agents|mesh-ancestor
153351821|NCT05290662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153351822|NCT05290662|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153351823|NCT05290662|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153351824|NCT05143502|Fluticasone|fluticasone|mesh-list
153421884|NCT05328908|Antiviral Agents|antiviral agents|mesh-ancestor
153421885|NCT05328908|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153421887|NCT05327127|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
153421889|NCT05327127|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153351825|NCT05143502|Xhance|xhance|mesh-list
153351826|NCT05143502|Prednisolone|prednisolone|mesh-list
153351827|NCT05143502|Montelukast|montelukast|mesh-list
153351828|NCT05143502|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153351829|NCT05143502|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153351830|NCT05143502|Autonomic Agents|autonomic agents|mesh-ancestor
153351832|NCT05143502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153351833|NCT05143502|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153351834|NCT05143502|Respiratory System Agents|respiratory system agents|mesh-ancestor
153351835|NCT05143502|Dermatologic Agents|dermatologic agents|mesh-ancestor
153351836|NCT05143502|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
153351837|NCT05143502|Glucocorticoids|glucocorticoids|mesh-ancestor
153351838|NCT05143502|Hormones|hormones|mesh-ancestor
153351839|NCT05143502|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153351841|NCT05143502|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153351842|NCT05143502|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
153351843|NCT05143502|Hormone Antagonists|hormone antagonists|mesh-ancestor
153351844|NCT05143502|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
153351845|NCT05143502|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
153351856|NCT00409292|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153351857|NCT00409292|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153351858|NCT00409292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153421898|NCT05273554|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153421899|NCT05273554|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153421900|NCT05273554|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153421901|NCT05273554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153881029|NCT05465317|Incretins|incretins|mesh-ancestor
153881030|NCT05405270|Imiquimod|imiquimod|mesh-list
153881031|NCT05405270|Toll-Like Receptor Agonists|toll-like receptor agonists|mesh-ancestor
153351859|NCT00409292|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153351860|NCT00409292|Immunologic Factors|immunologic factors|mesh-ancestor
153351861|NCT00409292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153351862|NCT00409292|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153351863|NCT05246046|Bromides|bromides|mesh-list
153351864|NCT05246046|Tiotropium Bromide|tiotropium bromide|mesh-list
153351865|NCT05246046|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153351866|NCT05246046|Autonomic Agents|autonomic agents|mesh-ancestor
153351867|NCT05246046|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153351868|NCT05246046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153351870|NCT05246046|Respiratory System Agents|respiratory system agents|mesh-ancestor
153351871|NCT05246046|Parasympatholytics|parasympatholytics|mesh-ancestor
153881032|NCT05405270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153881033|NCT05405270|Immunomodulating Agents|immunomodulating agents|mesh-ancestor
153881034|NCT05405270|Immunologic Factors|immunologic factors|mesh-ancestor
153881035|NCT05405270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153881037|NCT05405270|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153881038|NCT05405270|Interferon Inducers|interferon inducers|mesh-ancestor
153881039|NCT05338190|Rituximab|rituximab|mesh-list
153881040|NCT05338190|Belimumab|belimumab|mesh-list
153881041|NCT05338190|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153351872|NCT05246046|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
153351873|NCT05246046|Cholinergic Agents|cholinergic agents|mesh-ancestor
153351874|NCT05246046|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153351875|NCT05246046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153351877|NCT00383942|Misoprostol|misoprostol|mesh-list
153351908|NCT05474040|Narcotics|narcotics|mesh-ancestor
153351909|NCT05474040|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153351910|NCT05474040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153351911|NCT05474040|Analgesics|analgesics|mesh-ancestor
153351912|NCT05474040|Sensory System Agents|sensory system agents|mesh-ancestor
153351913|NCT05474040|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153351915|NCT00410150|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153351916|NCT00410150|Autonomic Agents|autonomic agents|mesh-ancestor
153351917|NCT00410150|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153351918|NCT00410150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153351919|NCT00410150|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153351920|NCT00410150|Respiratory System Agents|respiratory system agents|mesh-ancestor
153351921|NCT00410150|Tocolytic Agents|tocolytic agents|mesh-ancestor
153351922|NCT00410150|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153351923|NCT00410150|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
153351924|NCT00410150|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
153351925|NCT00410150|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153351926|NCT00410150|Adrenergic Agents|adrenergic agents|mesh-ancestor
153351927|NCT00410150|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153351928|NCT00410150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153351929|NCT00385268|Acamprosate|acamprosate|mesh-list
153351930|NCT00385268|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
153351931|NCT01657500|Gentamicins|gentamicins|mesh-list
153351932|NCT01657500|Dextrans|dextrans|mesh-list
153351933|NCT01657500|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
153421558|NCT05769946|Hemay005|hemay005|mesh-list
153351934|NCT01657500|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153351935|NCT01657500|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153351936|NCT01657500|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
153351937|NCT01657500|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153351938|NCT01657500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153351939|NCT01657500|Anticoagulants|anticoagulants|mesh-ancestor
153351940|NCT01657500|Plasma Substitutes|plasma substitutes|mesh-ancestor
153351941|NCT01657500|Blood Substitutes|blood substitutes|mesh-ancestor
153351942|NCT00411086|Rituximab|rituximab|mesh-list
153351952|NCT01658904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153351953|NCT01658904|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153351954|NCT01658904|Alkylating Agents|alkylating agents|mesh-ancestor
153351955|NCT01658904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153351956|NCT01658904|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153351957|NCT01658904|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153881042|NCT05338190|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153881043|NCT05338190|Immunologic Factors|immunologic factors|mesh-ancestor
153881044|NCT05338190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153881045|NCT05338190|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153881046|NCT05338190|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153351958|NCT01658904|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153351960|NCT05238948|CKD-506|ckd-506|mesh-list
153351961|NCT05238948|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153351962|NCT05238948|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153351963|NCT05238948|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153351964|NCT05238948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153351965|NCT05238948|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153351966|NCT05238948|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153351967|NCT05238948|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153351968|NCT05238948|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153351969|NCT05238948|Anesthetics, General|anesthetics, general|mesh-ancestor
153351970|NCT05238948|Anesthetics|anesthetics|mesh-ancestor
153351971|NCT05238948|GABA Modulators|gaba modulators|mesh-ancestor
153351972|NCT05238948|GABA Agents|gaba agents|mesh-ancestor
153351973|NCT05238948|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153351974|NCT05238948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153351975|NCT05238948|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
153421919|NCT05256641|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153421920|NCT05256641|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153421923|NCT05252533|Ustekinumab|ustekinumab|mesh-list
153421924|NCT05252533|Dermatologic Agents|dermatologic agents|mesh-ancestor
153421925|NCT05203510|Treprostinil|treprostinil|mesh-list
153881057|NCT05263908|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153881058|NCT05263908|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153881059|NCT05263908|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153881060|NCT05263908|Antiviral Agents|antiviral agents|mesh-ancestor
153881061|NCT05263908|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153881062|NCT05263908|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
153881063|NCT05263908|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153881064|NCT05227001|Camphor|camphor|mesh-list
153881065|NCT05227001|Menthol|menthol|mesh-list
153351976|NCT05238948|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153351977|NCT00385580|Dasatinib|dasatinib|mesh-list
153351978|NCT00385580|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153351979|NCT00385580|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153351983|NCT05236530|Metformin|metformin|mesh-list
153351997|NCT05236530|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153351998|NCT05236530|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153351999|NCT05236530|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153352000|NCT05236530|Anesthetics, General|anesthetics, general|mesh-ancestor
153352001|NCT05236530|Anesthetics|anesthetics|mesh-ancestor
153352002|NCT05236530|GABA Modulators|gaba modulators|mesh-ancestor
153352003|NCT05236530|GABA Agents|gaba agents|mesh-ancestor
153352004|NCT05236530|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153352005|NCT05236530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153352006|NCT05236530|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153352007|NCT05236530|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153352008|NCT05236530|Antimetabolites|antimetabolites|mesh-ancestor
153881066|NCT05227001|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
153881067|NCT05227001|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153881068|NCT05227001|Antipruritics|antipruritics|mesh-ancestor
153881069|NCT05227001|Dermatologic Agents|dermatologic agents|mesh-ancestor
153352009|NCT05236530|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153352010|NCT05236530|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
153352011|NCT05236530|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153352012|NCT05236530|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
153352013|NCT05236530|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
153352014|NCT05236530|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153352015|NCT05236530|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153352016|NCT05236530|Antiviral Agents|antiviral agents|mesh-ancestor
153352017|NCT05236530|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153352018|NCT05236530|Antimalarials|antimalarials|mesh-ancestor
153352019|NCT05236530|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153352020|NCT05236530|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153421561|NCT05769946|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
153421562|NCT05769946|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153352023|NCT05236530|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
153352024|NCT05236530|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
153352025|NCT05236530|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153421928|NCT05196191|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
153421929|NCT05196191|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153421930|NCT05196191|Dermatologic Agents|dermatologic agents|mesh-ancestor
153421932|NCT05124691|Albendazole|albendazole|mesh-list
153421933|NCT05124691|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153421934|NCT05124691|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153421935|NCT05124691|Anthelmintics|anthelmintics|mesh-ancestor
153421936|NCT05124691|Anticestodal Agents|anticestodal agents|mesh-ancestor
153421937|NCT05124691|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
153421938|NCT05124691|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153421939|NCT05124691|Tubulin Modulators|tubulin modulators|mesh-ancestor
153352026|NCT05236530|Narcotics|narcotics|mesh-ancestor
153352042|NCT00456014|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153352043|NCT00456014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153352045|NCT00456014|Serotonin Agents|serotonin agents|mesh-ancestor
153352046|NCT00456014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153352047|NCT00456014|Antidepressive Agents|antidepressive agents|mesh-ancestor
153352048|NCT00456014|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153352049|NCT00456014|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
153352050|NCT00456014|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153352051|NCT00456014|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
153352052|NCT00456014|Adrenergic Agents|adrenergic agents|mesh-ancestor
153352053|NCT05235516|Cisplatin|cisplatin|mesh-list
153352054|NCT05235516|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153352055|NCT00411398|Memantine|memantine|mesh-list
153352056|NCT00411398|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
153352057|NCT00411398|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
153352058|NCT00411398|Dopamine Agents|dopamine agents|mesh-ancestor
153352059|NCT00411398|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153421943|NCT05124691|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153421944|NCT05098470|Metformin|metformin|mesh-list
153421945|NCT05098470|Insulin Glargine|insulin glargine|mesh-list
153421946|NCT05098470|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153421947|NCT05098470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153421948|NCT05095571|Niacinamide|niacinamide|mesh-list
153352060|NCT00411398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153352062|NCT00411398|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
153352063|NCT00411398|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
153352067|NCT00457730|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
153352093|NCT00389168|Atenolol|atenolol|mesh-list
153352094|NCT00389168|Irbesartan|irbesartan|mesh-list
153352095|NCT00389168|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153352096|NCT00389168|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
153352097|NCT00389168|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
153352098|NCT00389168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153352099|NCT00389168|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153352100|NCT00389168|Sympatholytics|sympatholytics|mesh-ancestor
153352101|NCT00389168|Autonomic Agents|autonomic agents|mesh-ancestor
153352102|NCT00389168|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153352103|NCT00389168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153352104|NCT00389168|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
153352105|NCT00389168|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
153352106|NCT00389168|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
153352107|NCT00389168|Adrenergic Agents|adrenergic agents|mesh-ancestor
153352108|NCT00389168|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153352109|NCT00462020|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
153352110|NCT00462020|Metronidazole|metronidazole|mesh-list
153352111|NCT00462020|Ceftriaxone|ceftriaxone|mesh-list
153352112|NCT00462020|Clavulanic Acids|clavulanic acids|mesh-list
153352113|NCT00462020|Clavulanic Acid|clavulanic acid|mesh-list
153352116|NCT00462020|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153352117|NCT00462020|Antitubercular Agents|antitubercular agents|mesh-ancestor
153352118|NCT00462020|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153352119|NCT00462020|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153421987|NCT05041153|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153421988|NCT05041153|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153421989|NCT05041153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153421990|NCT05041153|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153352120|NCT00462020|Third Generation Cephalosporins|third generation cephalosporins|mesh-ancestor
153352140|NCT04241640|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153352141|NCT04241640|Analgesics|analgesics|mesh-ancestor
153421991|NCT05041153|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153422005|NCT05006794|Docetaxel|docetaxel|mesh-list
153352142|NCT04241640|Sensory System Agents|sensory system agents|mesh-ancestor
153352143|NCT04241640|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153352144|NCT04241640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153352145|NCT00462332|Vidarabine|vidarabine|mesh-list
153352146|NCT00462332|Fludarabine|fludarabine|mesh-list
153352147|NCT00462332|Fludarabine phosphate|fludarabine phosphate|mesh-list
153352148|NCT00462332|Alemtuzumab|alemtuzumab|mesh-list
153352149|NCT00462332|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153352150|NCT00462332|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153352151|NCT00462332|Antimetabolites|antimetabolites|mesh-ancestor
153352152|NCT00462332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153352153|NCT00462332|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153352154|NCT00462332|Immunologic Factors|immunologic factors|mesh-ancestor
153352155|NCT00462332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153352156|NCT00462332|Antiviral Agents|antiviral agents|mesh-ancestor
153352157|NCT00462332|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153422009|NCT05006794|Antimitotic Agents|antimitotic agents|mesh-ancestor
153422010|NCT05006794|Mitosis Modulators|mitosis modulators|mesh-ancestor
153422011|NCT05006794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153422013|NCT05006794|Immunologic Factors|immunologic factors|mesh-ancestor
153422014|NCT05006794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153422015|NCT04996004|Doxorubicin|doxorubicin|mesh-list
153422016|NCT04996004|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153422017|NCT04996004|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153422018|NCT04996004|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153422019|NCT04996004|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153422020|NCT04996004|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153352193|NCT00462722|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153352194|NCT00462722|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153352195|NCT00462722|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153352196|NCT00462722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153352197|NCT00528398|Cytarabine|cytarabine|mesh-list
153352198|NCT00528398|Idarubicin|idarubicin|mesh-list
153352199|NCT00528398|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153352200|NCT00528398|Antimetabolites|antimetabolites|mesh-ancestor
153352201|NCT00528398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153352202|NCT00528398|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153352203|NCT00528398|Antiviral Agents|antiviral agents|mesh-ancestor
153352204|NCT00528398|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153352205|NCT00528398|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153352206|NCT00528398|Immunologic Factors|immunologic factors|mesh-ancestor
153422021|NCT04996004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153422022|NCT04922333|Risedronic Acid|risedronic acid|mesh-list
153352207|NCT00528398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153352208|NCT00528398|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153352209|NCT00528398|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153352210|NCT00528398|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153352211|NCT00528398|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153352212|NCT00528788|1 alpha-hydroxyergocalciferol|1 alpha-hydroxyergocalciferol|mesh-list
153352213|NCT00528788|Vitamins|vitamins|mesh-ancestor
153352214|NCT00528788|Micronutrients|micronutrients|mesh-ancestor
153352215|NCT00528788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153352216|NCT00528788|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153352217|NCT00414518|Ritonavir|ritonavir|mesh-list
153352218|NCT00414518|Lopinavir|lopinavir|mesh-list
153352219|NCT00414518|Tenofovir|tenofovir|mesh-list
153352220|NCT00414518|Emtricitabine|emtricitabine|mesh-list
153352221|NCT00414518|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
153352222|NCT00414518|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
153352223|NCT00414518|Protease Inhibitors|protease inhibitors|mesh-ancestor
153352224|NCT00414518|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153352237|NCT01795664|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
153352238|NCT01795664|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153352239|NCT01795664|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153352240|NCT01795664|Autonomic Agents|autonomic agents|mesh-ancestor
153352241|NCT01795664|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153352242|NCT01795664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153881177|NCT04943848|Immunologic Factors|immunologic factors|mesh-ancestor
153881178|NCT04943848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153881179|NCT04943848|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
153352243|NCT01795664|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153352244|NCT01795664|Respiratory System Agents|respiratory system agents|mesh-ancestor
153881180|NCT04943848|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153881181|NCT04943848|Trace Elements|trace elements|mesh-ancestor
153881182|NCT04943848|Micronutrients|micronutrients|mesh-ancestor
153881183|NCT04942860|Methotrexate|methotrexate|mesh-list
153881184|NCT04942860|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
153881185|NCT04942860|Abortifacient Agents|abortifacient agents|mesh-ancestor
153783405|NCT00414089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153352245|NCT01795664|Dermatologic Agents|dermatologic agents|mesh-ancestor
153352246|NCT01795664|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
153352247|NCT01795664|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
153352248|NCT01795664|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
153352249|NCT01795664|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153352250|NCT01795664|Adrenergic Agents|adrenergic agents|mesh-ancestor
153352251|NCT01795664|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153352252|NCT01795664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153352253|NCT01795664|Glucocorticoids|glucocorticoids|mesh-ancestor
153352254|NCT01795664|Hormones|hormones|mesh-ancestor
153352255|NCT01795664|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153352256|NCT01795664|Sympathomimetics|sympathomimetics|mesh-ancestor
153352257|NCT05271084|Pentoxifylline|pentoxifylline|mesh-list
153352258|NCT05271084|Dexetimide|dexetimide|mesh-list
153352259|NCT05271084|Citalopram|citalopram|mesh-list
153352260|NCT05271084|Escitalopram|escitalopram|mesh-list
153352261|NCT05271084|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
153352262|NCT05271084|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153352263|NCT05271084|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153352264|NCT05271084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153352279|NCT05271084|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
153881211|NCT04781673|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153881212|NCT04781673|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
153881213|NCT04781673|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153881218|NCT04781673|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153881219|NCT04781673|Anesthetics, General|anesthetics, general|mesh-ancestor
153352280|NCT05271084|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153352281|NCT05271084|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153352282|NCT05271084|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
153352283|NCT05271084|Protective Agents|protective agents|mesh-ancestor
153352284|NCT05271084|Vasodilator Agents|vasodilator agents|mesh-ancestor
153352285|NCT05271084|Free Radical Scavengers|free radical scavengers|mesh-ancestor
153352286|NCT05271084|Antioxidants|antioxidants|mesh-ancestor
153352287|NCT00531518|Lamotrigine|lamotrigine|mesh-list
153352289|NCT00531518|Bupropion|bupropion|mesh-list
153352290|NCT00531518|Fluoxetine|fluoxetine|mesh-list
153352291|NCT00531518|Sertraline|sertraline|mesh-list
153352292|NCT00531518|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
153352293|NCT00531518|Antidepressive Agents|antidepressive agents|mesh-ancestor
153352294|NCT00531518|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153352295|NCT00531518|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
153352296|NCT00531518|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153352297|NCT00531518|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153352298|NCT00531518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153352299|NCT00531518|Dopamine Agents|dopamine agents|mesh-ancestor
153352300|NCT00531518|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153352301|NCT00531518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153352302|NCT00531518|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
153352303|NCT00531518|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153352304|NCT00531518|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153352305|NCT00531518|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153352306|NCT00531518|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153422192|NCT04608409|Mitosis Modulators|mitosis modulators|mesh-ancestor
153352307|NCT00531518|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153422193|NCT04608409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153422194|NCT04608409|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153422197|NCT04521803|Rifampin|rifampin|mesh-list
153352308|NCT00531518|Dopamine Agonists|dopamine agonists|mesh-ancestor
153352309|NCT00531518|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
153352310|NCT00531518|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
153352321|NCT00533546|Drotrecogin alfa activated|drotrecogin alfa activated|mesh-list
153352324|NCT00533546|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153352325|NCT00533546|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153352326|NCT00533546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153352327|NCT00533546|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153352328|NCT00534794|Olopatadine Hydrochloride|olopatadine hydrochloride|mesh-list
153352329|NCT00534794|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153352330|NCT00534794|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153352331|NCT00534794|Analgesics|analgesics|mesh-ancestor
153352332|NCT00534794|Sensory System Agents|sensory system agents|mesh-ancestor
153352333|NCT00534794|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153352334|NCT00534794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153352335|NCT00534794|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153352336|NCT00534794|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153352337|NCT00534794|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
153352338|NCT00534794|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
153352339|NCT00534794|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
153352340|NCT00534794|Histamine Antagonists|histamine antagonists|mesh-ancestor
153352341|NCT00534794|Histamine Agents|histamine agents|mesh-ancestor
153352342|NCT00534794|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153352343|NCT00534794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153352344|NCT01658436|Dactolisib|dactolisib|mesh-list
153352345|NCT01658436|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153352346|NCT05168280|Dexmedetomidine|dexmedetomidine|mesh-list
153352347|NCT05168280|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153352348|NCT05168280|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153352366|NCT00464438|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153352367|NCT00464438|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153352368|NCT00464438|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153352369|NCT00464438|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153352370|NCT00464438|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153352371|NCT00464438|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153352372|NCT00464438|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153352373|NCT00464438|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
153352374|NCT00465530|Gentamicins|gentamicins|mesh-list
153352375|NCT00465530|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153352376|NCT00465530|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153352377|NCT00465530|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
153352378|NCT00465530|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153352379|NCT00465530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153352380|NCT00466310|Risperidone|risperidone|mesh-list
153352381|NCT00466310|Aripiprazole|aripiprazole|mesh-list
153352382|NCT00466310|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153352383|NCT00466310|Serotonin Agents|serotonin agents|mesh-ancestor
153352384|NCT00466310|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153352385|NCT00466310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153352386|NCT00466310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153352387|NCT00466310|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153352388|NCT00466310|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153422229|NCT04499950|Dopamine Agents|dopamine agents|mesh-ancestor
153352389|NCT00466310|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153352390|NCT00466310|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153783407|NCT00261612|Rituximab|rituximab|mesh-list
153352391|NCT00466310|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
153352392|NCT00466310|Dopamine Agents|dopamine agents|mesh-ancestor
153352393|NCT00466310|Antidepressive Agents|antidepressive agents|mesh-ancestor
153352394|NCT00466310|Dopamine Agonists|dopamine agonists|mesh-ancestor
153352395|NCT00466310|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
153352399|NCT00535652|Ertapenem|ertapenem|mesh-list
153352406|NCT00418028|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153352408|NCT00537290|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153352409|NCT00537290|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153352410|NCT00537290|Immunologic Factors|immunologic factors|mesh-ancestor
153352411|NCT00537290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153352412|NCT00537290|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153352413|NCT00538304|Bimatoprost|bimatoprost|mesh-list
153352414|NCT00538304|Ophthalmic Solutions|ophthalmic solutions|mesh-list
153352415|NCT00538304|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
153352416|NCT00538304|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153352417|NCT00538616|Dexmedetomidine|dexmedetomidine|mesh-list
153352418|NCT00538616|Propofol|propofol|mesh-list
153352419|NCT00538616|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153352420|NCT00538616|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153352421|NCT00538616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153352422|NCT00538616|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153352423|NCT00538616|Analgesics|analgesics|mesh-ancestor
153352424|NCT00538616|Sensory System Agents|sensory system agents|mesh-ancestor
153352425|NCT00538616|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153352426|NCT00538616|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
153352427|NCT00538616|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153352428|NCT00538616|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153881361|NCT04283669|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153881362|NCT04276883|Dexmedetomidine|dexmedetomidine|mesh-list
153881363|NCT04276883|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153881364|NCT04276883|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153881365|NCT04276883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153881366|NCT04276883|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153881367|NCT04276883|Analgesics|analgesics|mesh-ancestor
153881368|NCT04276883|Sensory System Agents|sensory system agents|mesh-ancestor
153352429|NCT00538616|Adrenergic Agents|adrenergic agents|mesh-ancestor
153352430|NCT00538616|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153352431|NCT00538616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153352432|NCT00538616|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153352434|NCT00538616|Anesthetics|anesthetics|mesh-ancestor
153352435|NCT00469274|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
153352452|NCT00470600|Analgesics|analgesics|mesh-ancestor
153352453|NCT00470600|Sensory System Agents|sensory system agents|mesh-ancestor
153352454|NCT00470600|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153352455|NCT00470600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153352456|NCT00470600|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153352457|NCT00470600|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153352458|NCT00470600|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153352459|NCT00470600|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153352460|NCT00470600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153352461|NCT00471068|Timolol|timolol|mesh-list
153352462|NCT00471068|Travoprost|travoprost|mesh-list
153352463|NCT00471068|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
153783408|NCT00261612|Bortezomib|bortezomib|mesh-list
153783409|NCT00261612|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153352464|NCT00471068|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
153352465|NCT00471068|Adrenergic Agents|adrenergic agents|mesh-ancestor
153352506|NCT00418574|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153352507|NCT00418574|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153352509|NCT00473642|Verteporfin|verteporfin|mesh-list
153352510|NCT00473642|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153352511|NCT00473642|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153352512|NCT00473642|Growth Substances|growth substances|mesh-ancestor
153352513|NCT00473642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153881403|NCT04187105|Alkylating Agents|alkylating agents|mesh-ancestor
153422258|NCT04295486|Sensory System Agents|sensory system agents|mesh-ancestor
153352514|NCT00473642|Growth Inhibitors|growth inhibitors|mesh-ancestor
153352515|NCT00473642|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153352516|NCT00473642|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
153352517|NCT00473642|Dermatologic Agents|dermatologic agents|mesh-ancestor
153352519|NCT00539942|Fondaparinux|fondaparinux|mesh-list
153352520|NCT00539942|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
153352521|NCT00539942|Antithrombins|antithrombins|mesh-ancestor
153352522|NCT00539942|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
153352523|NCT00539942|Protease Inhibitors|protease inhibitors|mesh-ancestor
153352524|NCT00539942|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153352525|NCT00539942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153352526|NCT00539942|Anticoagulants|anticoagulants|mesh-ancestor
153352527|NCT00539942|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153352528|NCT00539942|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153352561|NCT00542750|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153352562|NCT00542750|Expectorants|expectorants|mesh-ancestor
153352563|NCT00542750|Respiratory System Agents|respiratory system agents|mesh-ancestor
153352564|NCT00542750|Free Radical Scavengers|free radical scavengers|mesh-ancestor
153352565|NCT00542750|Antioxidants|antioxidants|mesh-ancestor
153352566|NCT00542750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153352567|NCT00542750|Protective Agents|protective agents|mesh-ancestor
153352568|NCT00542750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153352569|NCT00542750|Antidotes|antidotes|mesh-ancestor
153352570|NCT00475904|Gabapentin|gabapentin|mesh-list
153352571|NCT00475904|Analgesics|analgesics|mesh-ancestor
153352572|NCT00475904|Sensory System Agents|sensory system agents|mesh-ancestor
153352573|NCT00475904|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153880725|NCT06031376|Bevacizumab|bevacizumab|mesh-list
153880726|NCT06031376|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
153352575|NCT00475904|Anticonvulsants|anticonvulsants|mesh-ancestor
153352576|NCT00475904|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153352577|NCT00475904|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153352578|NCT00475904|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153352579|NCT00475904|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153352580|NCT00475904|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
153352615|NCT00423878|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
153783412|NCT00261612|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153352616|NCT00423878|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153352617|NCT00423878|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153352619|NCT00423878|Dopamine Agonists|dopamine agonists|mesh-ancestor
153352620|NCT00423878|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
153881428|NCT04081389|Tubulin Modulators|tubulin modulators|mesh-ancestor
153352621|NCT00423878|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
153352622|NCT00423878|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
153352623|NCT00423878|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
153352624|NCT00480740|Dexmedetomidine|dexmedetomidine|mesh-list
153352625|NCT00480740|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153352626|NCT00480740|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153352627|NCT00480740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153352628|NCT00480740|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153352630|NCT00480740|Sensory System Agents|sensory system agents|mesh-ancestor
153352631|NCT00480740|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153352632|NCT00480740|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
153352633|NCT00480740|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153352634|NCT00480740|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153352635|NCT00480740|Adrenergic Agents|adrenergic agents|mesh-ancestor
153352636|NCT00480740|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153352638|NCT00424502|Rituximab|rituximab|mesh-list
153352662|NCT00425672|Sensory System Agents|sensory system agents|mesh-ancestor
153352663|NCT00425672|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153352664|NCT00425672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153352665|NCT00425672|Immunoconjugates|immunoconjugates|mesh-ancestor
153352666|NCT00425672|Immunologic Factors|immunologic factors|mesh-ancestor
153352667|NCT00544076|Sildenafil Citrate|sildenafil citrate|mesh-list
153352668|NCT00544076|Alprostadil|alprostadil|mesh-list
153352669|NCT00544076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153352670|NCT00544076|Vasodilator Agents|vasodilator agents|mesh-ancestor
153352671|NCT00544076|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
153352672|NCT00544076|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
153352673|NCT00544076|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153352674|NCT00544076|Urological Agents|urological agents|mesh-ancestor
153352675|NCT00544076|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153352676|NCT00544778|Doxorubicin|doxorubicin|mesh-list
153422313|NCT04117087|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153352677|NCT00544778|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
153352679|NCT00544778|Irinotecan|irinotecan|mesh-list
153352680|NCT00544778|Ifosfamide|ifosfamide|mesh-list
153352681|NCT00544778|Razoxane|razoxane|mesh-list
153352682|NCT00544778|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153352683|NCT00544778|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153352684|NCT00544778|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153352685|NCT00544778|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153352686|NCT00544778|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153783413|NCT00261612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153352687|NCT00544778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153352708|NCT00486824|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153352709|NCT00486824|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153352710|NCT00486824|Analgesics|analgesics|mesh-ancestor
153352711|NCT00486824|Sensory System Agents|sensory system agents|mesh-ancestor
153352712|NCT00486824|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153422364|NCT04008030|Nivolumab|nivolumab|mesh-list
153352713|NCT00486824|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153352714|NCT00486824|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153352715|NCT00486824|Gout Suppressants|gout suppressants|mesh-ancestor
153352716|NCT00486824|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153352717|NCT00486824|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153352719|NCT00489086|Dermatologic Agents|dermatologic agents|mesh-ancestor
153352720|NCT00489086|Keratolytic Agents|keratolytic agents|mesh-ancestor
153352722|NCT00489866|Antidepressive Agents|antidepressive agents|mesh-ancestor
153352723|NCT00489866|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153352724|NCT00489866|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153352725|NCT00489866|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153352726|NCT00489866|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153422399|NCT03954067|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153352727|NCT00489866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153352728|NCT00489866|Dopamine Agonists|dopamine agonists|mesh-ancestor
153352729|NCT00489866|Dopamine Agents|dopamine agents|mesh-ancestor
153352730|NCT00489866|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153352731|NCT00489866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153352733|NCT00489866|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
153352734|NCT00489866|Serotonin Agents|serotonin agents|mesh-ancestor
153352735|NCT00489866|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
153352736|NCT00489866|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153352737|NCT00489866|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
153352738|NCT00489866|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
153352739|NCT00546104|Dasatinib|dasatinib|mesh-list
153352740|NCT00546104|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153352741|NCT00546104|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153352742|NCT00546104|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153352743|NCT00546104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153352748|NCT00546728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153352749|NCT00546728|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
153352750|NCT00546728|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
153352751|NCT00546728|Incretins|incretins|mesh-ancestor
153352753|NCT00546728|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153352754|NCT00547586|Bromides|bromides|mesh-list
153352755|NCT00547586|Methylnaltrexone|methylnaltrexone|mesh-list
153352756|NCT00547586|Anticonvulsants|anticonvulsants|mesh-ancestor
153352757|NCT00547586|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
153352758|NCT00547586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153352759|NCT00547586|Sensory System Agents|sensory system agents|mesh-ancestor
153352760|NCT00547586|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153352761|NCT00548132|Chlorhexidine|chlorhexidine|mesh-list
153352763|NCT00548132|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153352764|NCT00548132|Disinfectants|disinfectants|mesh-ancestor
153352765|NCT00490100|Mecasermin|mecasermin|mesh-list
153881563|NCT03587961|Ivacaftor|ivacaftor|mesh-list
153352766|NCT00490100|Growth Substances|growth substances|mesh-ancestor
153352767|NCT00490100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153352768|NCT00490802|Oxytocin|oxytocin|mesh-list
153352769|NCT00490802|Oxytocics|oxytocics|mesh-ancestor
153352770|NCT00490802|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153352772|NCT00550394|Topiramate|topiramate|mesh-list
153352804|NCT00493064|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
153352805|NCT00493064|Prednisolone phosphate|prednisolone phosphate|mesh-list
153352806|NCT00493064|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153352807|NCT00493064|Glucocorticoids|glucocorticoids|mesh-ancestor
153352808|NCT00493064|Hormones|hormones|mesh-ancestor
153352810|NCT00493064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153352811|NCT00493064|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153352812|NCT00493064|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153352813|NCT00493064|Antiemetics|antiemetics|mesh-ancestor
153352814|NCT00493064|Autonomic Agents|autonomic agents|mesh-ancestor
153352815|NCT00493064|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153352816|NCT00493064|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153352817|NCT00493064|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
153352818|NCT00493064|Protective Agents|protective agents|mesh-ancestor
153352819|NCT00493064|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153352820|NCT00493064|Antimetabolites|antimetabolites|mesh-ancestor
153352821|NCT00493064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153352822|NCT00493064|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153352823|NCT00493064|Vasodilator Agents|vasodilator agents|mesh-ancestor
153352824|NCT00493064|Vitamin B Complex|vitamin b complex|mesh-ancestor
153352825|NCT00493064|Vitamins|vitamins|mesh-ancestor
153352826|NCT00493064|Micronutrients|micronutrients|mesh-ancestor
153352829|NCT00552422|Autonomic Agents|autonomic agents|mesh-ancestor
153352858|NCT00433550|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
153352859|NCT00433550|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153352860|NCT00433550|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153881627|NCT02429570|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153352861|NCT02208037|Mycophenolic Acid|mycophenolic acid|mesh-list
153352863|NCT02208037|Cyclophosphamide|cyclophosphamide|mesh-list
153352864|NCT02208037|Methotrexate|methotrexate|mesh-list
153352866|NCT02208037|Tacrolimus|tacrolimus|mesh-list
153352867|NCT02208037|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153352868|NCT02208037|Immunologic Factors|immunologic factors|mesh-ancestor
153352869|NCT02208037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153352870|NCT02208037|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153352871|NCT02208037|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153352872|NCT02208037|Alkylating Agents|alkylating agents|mesh-ancestor
153423435|NCT00376285|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153423436|NCT03460652|Serdexmethylphenidate and dexmethylphenidate|serdexmethylphenidate and dexmethylphenidate|mesh-list
153423437|NCT03460652|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
153352873|NCT02208037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153352874|NCT02208037|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153352875|NCT02208037|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153352876|NCT02208037|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
153352880|NCT02208037|Antimetabolites|antimetabolites|mesh-ancestor
153352916|NCT05150496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153352918|NCT00496340|Busulfan|busulfan|mesh-list
153352919|NCT00496340|Pentostatin|pentostatin|mesh-list
153352920|NCT00496340|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153352921|NCT00496340|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153352922|NCT00496340|Immunologic Factors|immunologic factors|mesh-ancestor
153352923|NCT00496340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153352924|NCT00496340|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153352925|NCT00496340|Alkylating Agents|alkylating agents|mesh-ancestor
153352926|NCT00496340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153352927|NCT00496340|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153352928|NCT00496340|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153352929|NCT00496340|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153352930|NCT00496340|Adenosine Deaminase Inhibitors|adenosine deaminase inhibitors|mesh-ancestor
153352931|NCT00496340|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153352932|NCT00496808|Trastuzumab|trastuzumab|mesh-list
153352933|NCT00496808|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153352934|NCT00496808|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153352935|NCT01795820|Ticagrelor|ticagrelor|mesh-list
153352936|NCT01795820|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153352937|NCT01795820|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
153352938|NCT01795820|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
153352939|NCT01795820|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
153352940|NCT01795820|Purinergic Agents|purinergic agents|mesh-ancestor
153352941|NCT01795820|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153352942|NCT01795820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153352943|NCT01795820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153881722|NCT01810588|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153881724|NCT01499888|Alemtuzumab|alemtuzumab|mesh-list
153352944|NCT01484041|Aromatase Inhibitors|aromatase inhibitors|mesh-list
153352957|NCT00555152|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153352959|NCT01461499|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-list
153352960|NCT01461499|Renin Inhibitors|renin inhibitors|mesh-ancestor
153352961|NCT01461499|Protease Inhibitors|protease inhibitors|mesh-ancestor
153352962|NCT01461499|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153352963|NCT01461499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153352965|NCT00555464|Prednisolone|prednisolone|mesh-list
153352966|NCT00555464|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
153352967|NCT00555464|Methylprednisolone|methylprednisolone|mesh-list
153352968|NCT00555464|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
153352969|NCT00555464|Prednisolone acetate|prednisolone acetate|mesh-list
153352970|NCT00555464|Vincristine|vincristine|mesh-list
153352971|NCT00555464|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
153352972|NCT00555464|Prednisolone phosphate|prednisolone phosphate|mesh-list
153352973|NCT00555464|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153352974|NCT00555464|Glucocorticoids|glucocorticoids|mesh-ancestor
153352975|NCT00555464|Hormones|hormones|mesh-ancestor
153352976|NCT00555464|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153352977|NCT00555464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153352978|NCT00555464|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153352979|NCT00555464|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153352980|NCT00555464|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153422677|NCT02693808|Viscosupplements|viscosupplements|mesh-ancestor
153422678|NCT02693808|Protective Agents|protective agents|mesh-ancestor
153422679|NCT02470780|Rifaximin|rifaximin|mesh-list
153881808|NCT01643759|Buprenorphine|buprenorphine|mesh-list
153352981|NCT00555464|Tubulin Modulators|tubulin modulators|mesh-ancestor
153352982|NCT00555464|Antimitotic Agents|antimitotic agents|mesh-ancestor
153352983|NCT00555464|Mitosis Modulators|mitosis modulators|mesh-ancestor
153352984|NCT00555464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153352985|NCT00555464|Antiemetics|antiemetics|mesh-ancestor
153353005|NCT01795976|Sensory System Agents|sensory system agents|mesh-ancestor
153353006|NCT01795976|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153353007|NCT01461733|Amiodarone|amiodarone|mesh-list
153353008|NCT01461733|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153353009|NCT01461733|Vasodilator Agents|vasodilator agents|mesh-ancestor
153353010|NCT01461733|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
153353011|NCT01461733|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153353012|NCT01461733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153353013|NCT01461733|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153353014|NCT01461733|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
153353015|NCT01461733|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153353016|NCT01461733|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153353017|NCT01461733|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
153353018|NCT01461733|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
153353019|NCT01461733|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
153353020|NCT01462279|Thiamine|thiamine|mesh-list
153353021|NCT01462279|Vitamin B Complex|vitamin b complex|mesh-ancestor
153353022|NCT01462279|Vitamins|vitamins|mesh-ancestor
153353023|NCT01462279|Micronutrients|micronutrients|mesh-ancestor
153353024|NCT01462279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153353026|NCT00435812|Immunologic Factors|immunologic factors|mesh-ancestor
153353027|NCT00435812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153353028|NCT05081466|Vitamin D|vitamin d|mesh-list
153353029|NCT05081466|Calcium|calcium|mesh-list
153353030|NCT05081466|Vitamins|vitamins|mesh-ancestor
153353032|NCT05081466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153353033|NCT05081466|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153353034|NCT05081466|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153353035|NCT01464229|Iloperidone|iloperidone|mesh-list
153353036|NCT01464229|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153353037|NCT01464229|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153353038|NCT01464229|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153353039|NCT01464229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153353046|NCT00556478|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153353047|NCT00556478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153353048|NCT00556478|Sensory System Agents|sensory system agents|mesh-ancestor
153353049|NCT00556478|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153353050|NCT00556478|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153353051|NCT00556478|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
153353052|NCT00556478|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153353053|NCT00556478|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153353054|NCT00556478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153353055|NCT00556478|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
153353056|NCT00500240|Insulin|insulin|mesh-list
153353057|NCT00500240|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
153353058|NCT00500240|Insulin Glargine|insulin glargine|mesh-list
153353059|NCT00500240|Insulin Aspart|insulin aspart|mesh-list
153353060|NCT00500240|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153353061|NCT00500240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153353062|NCT01469767|Fluocinonide|fluocinonide|mesh-list
153353063|NCT01469767|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153881953|NCT01602588|Antimalarials|antimalarials|mesh-ancestor
153353067|NCT01469767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153353068|NCT01469767|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
153353070|NCT03246620|Haloperidol|haloperidol|mesh-list
153353071|NCT03246620|Olanzapine|olanzapine|mesh-list
153353072|NCT03246620|Haloperidol decanoate|haloperidol decanoate|mesh-list
153353073|NCT03246620|Antiemetics|antiemetics|mesh-ancestor
153353074|NCT03246620|Autonomic Agents|autonomic agents|mesh-ancestor
153353088|NCT03246620|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
153353089|NCT03246620|Dopamine Agents|dopamine agents|mesh-ancestor
153353090|NCT03246620|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
153353091|NCT03246620|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153353092|NCT03246620|Anticonvulsants|anticonvulsants|mesh-ancestor
153353093|NCT03246620|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153353094|NCT03246620|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
153353095|NCT03246620|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
153353096|NCT03246620|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153353097|NCT03246620|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153353098|NCT03246620|Anesthetics, General|anesthetics, general|mesh-ancestor
153353100|NCT03246620|GABA Modulators|gaba modulators|mesh-ancestor
153353101|NCT03246620|GABA Agents|gaba agents|mesh-ancestor
153379005|NCT02904915|Sensory System Agents|sensory system agents|mesh-ancestor
153379006|NCT02904915|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153379007|NCT02904915|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153379008|NCT02904915|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
153379009|NCT02904915|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153353102|NCT01470859|Levodopa|levodopa|mesh-list
153353103|NCT01470859|Carbidopa|carbidopa|mesh-list
153353104|NCT01470859|Pramipexole|pramipexole|mesh-list
153353105|NCT01470859|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
153353106|NCT01470859|Dexpramipexole|dexpramipexole|mesh-list
153353107|NCT01470859|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
153353108|NCT01470859|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
153353109|NCT01470859|Dopamine Agents|dopamine agents|mesh-ancestor
153353110|NCT01470859|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153353111|NCT01470859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153882027|NCT01603134|Allopurinol|allopurinol|mesh-list
153422908|NCT03198884|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
153353112|NCT01470859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153353113|NCT01470859|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
153353114|NCT01470859|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153353116|NCT01470859|Protective Agents|protective agents|mesh-ancestor
153353117|NCT01470859|Dopamine Agonists|dopamine agonists|mesh-ancestor
153353118|NCT01470859|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153353119|NCT01470859|Immunologic Factors|immunologic factors|mesh-ancestor
153353120|NCT00436046|Interferons|interferons|mesh-list
153353121|NCT00436046|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153353133|NCT01471639|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153353134|NCT01471639|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153353135|NCT01471639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153353136|NCT05622656|Dexmedetomidine|dexmedetomidine|mesh-list
153353137|NCT05622656|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153353138|NCT05622656|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153783414|NCT00261612|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153353139|NCT05622656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153353140|NCT05622656|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153353142|NCT05622656|Sensory System Agents|sensory system agents|mesh-ancestor
153353143|NCT05622656|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153353144|NCT05622656|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
153353145|NCT05622656|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153353146|NCT05622656|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153353147|NCT05622656|Adrenergic Agents|adrenergic agents|mesh-ancestor
153353148|NCT05622656|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153353149|NCT05622656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153353150|NCT05079126|Trans-sodium crocetinate|trans-sodium crocetinate|mesh-list
153353151|NCT05079126|Antioxidants|antioxidants|mesh-ancestor
153353152|NCT05079126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153353153|NCT05079126|Protective Agents|protective agents|mesh-ancestor
153353154|NCT05079126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153353155|NCT05079126|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
153353156|NCT05079126|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153353157|NCT00436904|Rituximab|rituximab|mesh-list
153353158|NCT00436904|Alemtuzumab|alemtuzumab|mesh-list
153353159|NCT00436904|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153353160|NCT00436904|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153353161|NCT00436904|Immunologic Factors|immunologic factors|mesh-ancestor
153353162|NCT00436904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153353172|NCT01485055|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
153353173|NCT01485055|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153353174|NCT01485055|Dermatologic Agents|dermatologic agents|mesh-ancestor
153353175|NCT01485055|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153353176|NCT01485055|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153353177|NCT01485055|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153353178|NCT01485055|Immunologic Factors|immunologic factors|mesh-ancestor
153353179|NCT01485055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153353180|NCT05028348|Dexamethasone|dexamethasone|mesh-list
153353181|NCT05028348|Pomalidomide|pomalidomide|mesh-list
153379045|NCT01536938|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153379046|NCT01536938|Respiratory System Agents|respiratory system agents|mesh-ancestor
153353183|NCT05028348|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153353184|NCT05028348|Antiemetics|antiemetics|mesh-ancestor
153353185|NCT05028348|Autonomic Agents|autonomic agents|mesh-ancestor
153353186|NCT05028348|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153353187|NCT05028348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153353188|NCT05028348|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153353189|NCT05028348|Glucocorticoids|glucocorticoids|mesh-ancestor
153353190|NCT05028348|Hormones|hormones|mesh-ancestor
153353191|NCT05028348|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153353192|NCT05028348|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153353193|NCT05028348|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153353227|NCT00508118|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153353228|NCT00508118|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153353229|NCT00508118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153353230|NCT00508118|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153353231|NCT00508118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153353232|NCT00508118|Vasodilator Agents|vasodilator agents|mesh-ancestor
153353234|NCT05139030|Anesthetics, Local|anesthetics, local|mesh-ancestor
153353235|NCT05139030|Anesthetics|anesthetics|mesh-ancestor
153353236|NCT05139030|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153353237|NCT05139030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153353238|NCT05139030|Sensory System Agents|sensory system agents|mesh-ancestor
153353239|NCT05139030|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153353240|NCT00440180|Anastrozole|anastrozole|mesh-list
153353241|NCT00440180|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153353242|NCT00440180|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153353243|NCT00440180|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
153353244|NCT00440180|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153353245|NCT00440180|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153353246|NCT00440180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153353247|NCT00440180|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
153353248|NCT00440180|Hormone Antagonists|hormone antagonists|mesh-ancestor
153353249|NCT00440180|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153353250|NCT00440180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153353251|NCT05021094|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
153353252|NCT05021094|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
153353253|NCT05021094|Estradiol|estradiol|mesh-list
153353254|NCT05021094|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
153353255|NCT05021094|Dydrogesterone|dydrogesterone|mesh-list
153353256|NCT05021094|Estrogens|estrogens|mesh-ancestor
153423058|NCT03296072|Listerine|listerine|mesh-list
153353258|NCT05021094|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153353261|NCT05021094|Contraceptive Agents|contraceptive agents|mesh-ancestor
153353262|NCT05021094|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153353266|NCT01364298|Gabapentin|gabapentin|mesh-list
153353267|NCT01364298|Analgesics|analgesics|mesh-ancestor
153353268|NCT01364298|Sensory System Agents|sensory system agents|mesh-ancestor
153353269|NCT01364298|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153353270|NCT01364298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153353271|NCT01364298|Anticonvulsants|anticonvulsants|mesh-ancestor
153353272|NCT01364298|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153353273|NCT01364298|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153353274|NCT01364298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153353275|NCT01364298|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153353276|NCT01364298|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153353277|NCT01364298|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153353278|NCT01364298|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153353279|NCT01364298|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153353280|NCT01364298|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
153353281|NCT01364298|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
153353282|NCT01364298|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153353283|NCT01364298|Antimanic Agents|antimanic agents|mesh-ancestor
153353284|NCT04421742|Beclomethasone|beclomethasone|mesh-list
153353285|NCT04421742|Formoterol Fumarate|formoterol fumarate|mesh-list
153353287|NCT04421742|Autonomic Agents|autonomic agents|mesh-ancestor
153353317|NCT01488409|Antimetabolites|antimetabolites|mesh-ancestor
153882186|NCT01607580|Protective Agents|protective agents|mesh-ancestor
153353318|NCT01488409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153353319|NCT01488409|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153353320|NCT01488877|Spironolactone|spironolactone|mesh-list
153353321|NCT01488877|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
153353322|NCT01488877|Hormone Antagonists|hormone antagonists|mesh-ancestor
153353323|NCT01488877|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153353324|NCT01488877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153353325|NCT01488877|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
153353326|NCT01488877|Diuretics|diuretics|mesh-ancestor
153353327|NCT01488877|Natriuretic Agents|natriuretic agents|mesh-ancestor
153353328|NCT01364922|Acetaminophen|acetaminophen|mesh-list
153353329|NCT01364922|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
153353330|NCT01364922|Hydrocodone|hydrocodone|mesh-list
153353331|NCT01364922|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153353332|NCT01364922|Analgesics|analgesics|mesh-ancestor
153353333|NCT01364922|Sensory System Agents|sensory system agents|mesh-ancestor
153353334|NCT01364922|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153353335|NCT01364922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153353336|NCT01364922|Antipyretics|antipyretics|mesh-ancestor
153353337|NCT01364922|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153353368|NCT00442364|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
153353369|NCT00442364|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
153353370|NCT00510224|Octreotide|octreotide|mesh-list
153353371|NCT00510224|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153353372|NCT00510224|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153353373|NCT00510224|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153353374|NCT00511706|Dexamethasone|dexamethasone|mesh-list
153353375|NCT00511706|Ranibizumab|ranibizumab|mesh-list
153353376|NCT00511706|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153353377|NCT00511706|Antiemetics|antiemetics|mesh-ancestor
153353378|NCT00511706|Autonomic Agents|autonomic agents|mesh-ancestor
153353379|NCT00511706|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153353380|NCT00511706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153353381|NCT00511706|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153353382|NCT00511706|Glucocorticoids|glucocorticoids|mesh-ancestor
153353383|NCT00511706|Hormones|hormones|mesh-ancestor
153353384|NCT00511706|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153353385|NCT00511706|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153353386|NCT00511706|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153353387|NCT00511706|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153423106|NCT03190213|Pembrolizumab|pembrolizumab|mesh-list
153423108|NCT03190213|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153353424|NCT00446264|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153353426|NCT01495819|Nicotine|nicotine|mesh-list
153353427|NCT01495819|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
153353428|NCT01495819|Autonomic Agents|autonomic agents|mesh-ancestor
153353429|NCT01495819|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153353430|NCT01495819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153353431|NCT01495819|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
153353432|NCT01495819|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
153353433|NCT01495819|Cholinergic Agents|cholinergic agents|mesh-ancestor
153353434|NCT01495819|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153353435|NCT01495819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153353436|NCT04214886|Cyclophosphamide|cyclophosphamide|mesh-list
153882535|NCT01688934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153882536|NCT01684319|Caseins|caseins|mesh-list
153882537|NCT01684319|Chelating Agents|chelating agents|mesh-ancestor
153882538|NCT01684319|Sequestering Agents|sequestering agents|mesh-ancestor
153882540|NCT02279576|Paclitaxel|paclitaxel|mesh-list
153353437|NCT04214886|Fludarabine|fludarabine|mesh-list
153353438|NCT04214886|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153353439|NCT04214886|Immunologic Factors|immunologic factors|mesh-ancestor
153353440|NCT04214886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153353441|NCT04214886|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153353442|NCT04214886|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153353443|NCT04214886|Alkylating Agents|alkylating agents|mesh-ancestor
153353480|NCT01496131|Immunologic Factors|immunologic factors|mesh-ancestor
153880729|NCT06031376|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153880730|NCT06031376|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153880731|NCT06031376|Growth Substances|growth substances|mesh-ancestor
153880732|NCT06031376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153353481|NCT01496131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153353482|NCT01496131|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153353483|NCT01496131|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153353484|NCT01496131|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153353485|NCT01496131|Alkylating Agents|alkylating agents|mesh-ancestor
153353486|NCT01496131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153353487|NCT01496131|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153353488|NCT01496131|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153353489|NCT01496131|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153353491|NCT02520726|Antidepressive Agents|antidepressive agents|mesh-ancestor
153353492|NCT02520726|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153353493|NCT02520726|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
153353494|NCT02520726|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153353495|NCT02520726|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153353496|NCT02520726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153353497|NCT02520726|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153353498|NCT02520726|Serotonin Agents|serotonin agents|mesh-ancestor
153353499|NCT02520726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153353500|NCT00450242|Lidocaine|lidocaine|mesh-list
153353501|NCT00450242|Anesthetics, Local|anesthetics, local|mesh-ancestor
153353502|NCT00450242|Anesthetics|anesthetics|mesh-ancestor
153353503|NCT00450242|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153423129|NCT01632150|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153353504|NCT00450242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153353505|NCT00450242|Sensory System Agents|sensory system agents|mesh-ancestor
153353506|NCT00450242|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153353522|NCT00517556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153353523|NCT00517556|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
153353525|NCT00519584|Ropivacaine|ropivacaine|mesh-list
153353526|NCT00519584|Anesthetics, Local|anesthetics, local|mesh-ancestor
153353527|NCT00519584|Anesthetics|anesthetics|mesh-ancestor
153353528|NCT00519584|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153353529|NCT00519584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153353530|NCT00519584|Sensory System Agents|sensory system agents|mesh-ancestor
153353531|NCT00519584|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153353532|NCT05122884|Milrinone|milrinone|mesh-list
153353533|NCT05122884|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
153353534|NCT05122884|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153353535|NCT05122884|Vasodilator Agents|vasodilator agents|mesh-ancestor
153353536|NCT05122884|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
153353537|NCT05122884|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
153353538|NCT05122884|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153353542|NCT00520286|Modafinil|modafinil|mesh-list
153353579|NCT00521456|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153353580|NCT00521456|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153353581|NCT00521456|Analgesics|analgesics|mesh-ancestor
153353582|NCT00521456|Sensory System Agents|sensory system agents|mesh-ancestor
153353583|NCT00521456|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153353584|NCT00521456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153353585|NCT00521456|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153783417|NCT00261612|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153353587|NCT00521456|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153353588|NCT00521456|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153353589|NCT00521456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153353590|NCT01796366|Insulin|insulin|mesh-list
153353591|NCT01796366|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
153353592|NCT01796366|Insulin Glargine|insulin glargine|mesh-list
153353593|NCT01796366|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153353594|NCT01796366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153353595|NCT03326180|Bupivacaine|bupivacaine|mesh-list
153353596|NCT03326180|Anesthetics, Local|anesthetics, local|mesh-ancestor
153423154|NCT03297944|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
153353598|NCT03326180|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153353599|NCT03326180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153353600|NCT03326180|Sensory System Agents|sensory system agents|mesh-ancestor
153353601|NCT03326180|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153353602|NCT01498549|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
153353603|NCT01498549|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
153353607|NCT01498549|Adrenergic Agents|adrenergic agents|mesh-ancestor
153353623|NCT00524264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153353625|NCT00524264|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153353626|NCT00524264|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153353627|NCT00524264|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153353628|NCT00524264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153353629|NCT00452426|Analgesics, Opioid|analgesics, opioid|mesh-list
153353630|NCT00452426|Narcotics|narcotics|mesh-ancestor
153353631|NCT00452426|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153353632|NCT00452426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153353633|NCT00452426|Analgesics|analgesics|mesh-ancestor
153353634|NCT00452426|Sensory System Agents|sensory system agents|mesh-ancestor
153353635|NCT00452426|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153353636|NCT05117814|Zanubrutinib|zanubrutinib|mesh-list
153353637|NCT05117814|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153353638|NCT05117814|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153353639|NCT05117814|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153353641|NCT05117814|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153353678|NCT02124044|Asunaprevir|asunaprevir|mesh-list
153353679|NCT02124044|Protease Inhibitors|protease inhibitors|mesh-ancestor
153353680|NCT02124044|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153353681|NCT02124044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153353682|NCT01502761|Magnesium Sulfate|magnesium sulfate|mesh-list
153353683|NCT01502761|Analgesics|analgesics|mesh-ancestor
153353684|NCT01502761|Sensory System Agents|sensory system agents|mesh-ancestor
153353685|NCT01502761|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153353686|NCT01502761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153353687|NCT01502761|Anesthetics|anesthetics|mesh-ancestor
153353688|NCT01502761|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153353689|NCT01502761|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153353690|NCT01502761|Anticonvulsants|anticonvulsants|mesh-ancestor
153353691|NCT01502761|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153353692|NCT01502761|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153353694|NCT01502761|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153353695|NCT01502761|Tocolytic Agents|tocolytic agents|mesh-ancestor
153353696|NCT01502761|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153353697|NCT01504477|Bortezomib|bortezomib|mesh-list
153353698|NCT01504477|Panitumumab|panitumumab|mesh-list
153353699|NCT01504477|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153353700|NCT01504477|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153353702|NCT02124512|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153353703|NCT02124512|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153353704|NCT02124512|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153353705|NCT01504711|Fosaprepitant|fosaprepitant|mesh-list
153353706|NCT01504711|Aprepitant|aprepitant|mesh-list
153353707|NCT01504711|Antiemetics|antiemetics|mesh-ancestor
153353708|NCT01504711|Autonomic Agents|autonomic agents|mesh-ancestor
153353709|NCT01504711|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153353710|NCT01504711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153353711|NCT01504711|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153353712|NCT01504711|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
153353715|NCT02209519|Metronidazole|metronidazole|mesh-list
153353717|NCT02209519|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153353718|NCT02209519|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153353719|NCT02209519|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153353720|NCT02129660|Glycopyrrolate|glycopyrrolate|mesh-list
153353721|NCT02129660|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153353722|NCT02129660|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
153353723|NCT02129660|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
153353724|NCT02129660|Cholinergic Agents|cholinergic agents|mesh-ancestor
153353725|NCT02129660|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153353726|NCT02129660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153353727|NCT02129660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153353729|NCT01505179|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153783418|NCT00261612|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153423272|NCT03303794|Bupivacaine|bupivacaine|mesh-list
153783420|NCT00261612|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153353730|NCT01505179|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153353731|NCT01505179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153353733|NCT01797848|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
153353734|NCT01797848|Antimetabolites|antimetabolites|mesh-ancestor
153353735|NCT01797848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153353736|NCT01797848|Antiviral Agents|antiviral agents|mesh-ancestor
153353737|NCT01797848|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153353738|NCT01398943|Antioxidants|antioxidants|mesh-list
153353739|NCT01398943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153353740|NCT01398943|Protective Agents|protective agents|mesh-ancestor
153353741|NCT01398943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153353742|NCT01550341|Buprenorphine|buprenorphine|mesh-list
153353743|NCT01550341|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
153353744|NCT01550341|Naloxone|naloxone|mesh-list
153353745|NCT01550341|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153353746|NCT01550341|Narcotics|narcotics|mesh-ancestor
153353754|NCT02125292|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153353755|NCT02125292|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153353756|NCT02125292|Analgesics|analgesics|mesh-ancestor
153353757|NCT02125292|Sensory System Agents|sensory system agents|mesh-ancestor
153353758|NCT02125292|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153353759|NCT02125292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153353760|NCT02125292|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153353761|NCT02125292|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153353762|NCT01653912|Paclitaxel|paclitaxel|mesh-list
153353763|NCT01653912|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
153353764|NCT01653912|Carboplatin|carboplatin|mesh-list
153353765|NCT01653912|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153353766|NCT01653912|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153353768|NCT01653912|Antimitotic Agents|antimitotic agents|mesh-ancestor
153353769|NCT01653912|Mitosis Modulators|mitosis modulators|mesh-ancestor
153353770|NCT01653912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153353771|NCT04132388|Adalimumab|adalimumab|mesh-list
153353772|NCT04132388|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
153353773|NCT04132388|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153353774|NCT04132388|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153353775|NCT02514174|Afatinib|afatinib|mesh-list
153353776|NCT02514174|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153353777|NCT02514174|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153353780|NCT02514174|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153353781|NCT02132468|Fosbretabulin|fosbretabulin|mesh-list
153353782|NCT02132468|Combretastatin|combretastatin|mesh-list
153353783|NCT02132468|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153353784|NCT02132468|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153353785|NCT02132468|Tubulin Modulators|tubulin modulators|mesh-ancestor
153353786|NCT02132468|Antimitotic Agents|antimitotic agents|mesh-ancestor
153353795|NCT01508455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153353796|NCT01508455|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153353797|NCT01508455|Analgesics|analgesics|mesh-ancestor
153353798|NCT01508455|Sensory System Agents|sensory system agents|mesh-ancestor
153353799|NCT01508455|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153353800|NCT01508455|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
153353801|NCT01508455|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153353802|NCT01508455|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153353803|NCT01508455|Adrenergic Agents|adrenergic agents|mesh-ancestor
153783421|NCT00261612|Immunologic Factors|immunologic factors|mesh-ancestor
153353804|NCT01508455|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153353805|NCT01508455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153353806|NCT01508455|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153353807|NCT01508455|Narcotics|narcotics|mesh-ancestor
153353808|NCT01508455|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153353809|NCT01508455|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153353810|NCT01508455|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153353811|NCT01508455|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153353812|NCT01508455|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153353813|NCT01508455|Anesthetics, General|anesthetics, general|mesh-ancestor
153379242|NCT01595282|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153379309|NCT03006380|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153353814|NCT01508455|Anesthetics|anesthetics|mesh-ancestor
153353815|NCT01508455|GABA Modulators|gaba modulators|mesh-ancestor
153353816|NCT01508455|GABA Agents|gaba agents|mesh-ancestor
153353817|NCT01509625|Fulvestrant|fulvestrant|mesh-list
153353818|NCT01509625|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153353819|NCT01509625|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153353820|NCT01509625|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
153353821|NCT01509625|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
153353825|NCT02482428|Imiquimod|imiquimod|mesh-list
153353841|NCT01510327|Sensory System Agents|sensory system agents|mesh-ancestor
153353843|NCT01510327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153353844|NCT01510327|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153353845|NCT01510327|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153353846|NCT01510327|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153353847|NCT01510327|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153353848|NCT01510327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153353849|NCT01510327|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153353850|NCT01510327|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153423336|NCT03228914|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
153423337|NCT03228914|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
153423338|NCT03228914|Protective Agents|protective agents|mesh-ancestor
153423339|NCT03316976|Dexlansoprazole|dexlansoprazole|mesh-list
153423340|NCT03316976|Lansoprazole|lansoprazole|mesh-list
153423341|NCT03316976|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
153423342|NCT03316976|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153423343|NCT03316976|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
153423344|NCT03316976|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153423345|NCT03316976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153423346|NCT03234374|Bupivacaine|bupivacaine|mesh-list
153353851|NCT01510327|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153353854|NCT01510327|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153353855|NCT01510327|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153353856|NCT01510327|Immunologic Factors|immunologic factors|mesh-ancestor
153353857|NCT01510327|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153353858|NCT01510327|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
153353859|NCT01510327|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
153353860|NCT01510327|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
153353861|NCT01510327|Purinergic Agents|purinergic agents|mesh-ancestor
153353862|NCT01510327|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153353863|NCT01510327|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
153353864|NCT01510327|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153353865|NCT01401595|Dexetimide|dexetimide|mesh-list
153353866|NCT01401595|Citalopram|citalopram|mesh-list
153353867|NCT01401595|Escitalopram|escitalopram|mesh-list
153353868|NCT01401595|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
153353888|NCT02480712|Velpatasvir|velpatasvir|mesh-list
153353889|NCT02480712|Antiviral Agents|antiviral agents|mesh-ancestor
153353890|NCT02480712|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153353891|NCT03916094|Trastuzumab|trastuzumab|mesh-list
153353892|NCT03916094|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153353893|NCT03916094|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153353894|NCT00115700|Prednisolone|prednisolone|mesh-list
153353895|NCT00115700|Cyclophosphamide|cyclophosphamide|mesh-list
153353897|NCT00115700|Vincristine|vincristine|mesh-list
153423413|NCT03459794|Ivermectin|ivermectin|mesh-list
153353899|NCT00115700|Immunologic Factors|immunologic factors|mesh-ancestor
153353900|NCT00115700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153353901|NCT00115700|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153353902|NCT00115700|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153353903|NCT00115700|Alkylating Agents|alkylating agents|mesh-ancestor
153353904|NCT00115700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153379310|NCT03006380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153379312|NCT02981030|Mifepristone|mifepristone|mesh-list
153379314|NCT02981030|Abortifacient Agents|abortifacient agents|mesh-ancestor
153353905|NCT00115700|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153353906|NCT00115700|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153353907|NCT00115700|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153353908|NCT00115700|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153353909|NCT00115700|Tubulin Modulators|tubulin modulators|mesh-ancestor
153353910|NCT00115700|Antimitotic Agents|antimitotic agents|mesh-ancestor
153353911|NCT00115700|Mitosis Modulators|mitosis modulators|mesh-ancestor
153353912|NCT00115700|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153353913|NCT00115700|Glucocorticoids|glucocorticoids|mesh-ancestor
153353914|NCT00115700|Hormones|hormones|mesh-ancestor
153353915|NCT00115700|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153353916|NCT00115700|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153353935|NCT00560612|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153353936|NCT00560612|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153353937|NCT00560612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153353938|NCT00560612|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153353939|NCT00560612|Serotonin Agents|serotonin agents|mesh-ancestor
153353940|NCT00560612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153353941|NCT00560612|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
153353942|NCT00560612|Antidepressive Agents|antidepressive agents|mesh-ancestor
153353943|NCT00560612|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153353944|NCT00560612|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
153353945|NCT00560612|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153353946|NCT00560612|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153353947|NCT01556347|Rituximab|rituximab|mesh-list
153353948|NCT01556347|Bortezomib|bortezomib|mesh-list
153353949|NCT01556347|Thymoglobulin|thymoglobulin|mesh-list
153353950|NCT01556347|Antilymphocyte Serum|antilymphocyte serum|mesh-list
153353951|NCT01556347|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
153353952|NCT01556347|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153353953|NCT01556347|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153353954|NCT01556347|Immunologic Factors|immunologic factors|mesh-ancestor
153783423|NCT04547764|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
153423443|NCT03321097|Cholinergic Agents|cholinergic agents|mesh-ancestor
153353955|NCT01556347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153353956|NCT01556347|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153353957|NCT01556347|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153353959|NCT00561002|Immunologic Factors|immunologic factors|mesh-ancestor
153353961|NCT03236792|Dexamethasone|dexamethasone|mesh-list
153353981|NCT03236792|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153353982|NCT03236792|Protease Inhibitors|protease inhibitors|mesh-ancestor
153353983|NCT03236792|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153353984|NCT03725384|Ascorbic Acid|ascorbic acid|mesh-list
153353985|NCT03725384|Iron|iron|mesh-list
153353986|NCT03725384|Vitamins|vitamins|mesh-ancestor
153353987|NCT03725384|Micronutrients|micronutrients|mesh-ancestor
153353988|NCT03725384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153353989|NCT03725384|Trace Elements|trace elements|mesh-ancestor
153353990|NCT03725384|Antioxidants|antioxidants|mesh-ancestor
153353991|NCT03725384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153353992|NCT03725384|Protective Agents|protective agents|mesh-ancestor
153353993|NCT01556425|Naltrexone|naltrexone|mesh-list
153353994|NCT01556425|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
153353995|NCT01556425|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
153353996|NCT01556425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153353997|NCT01556425|Sensory System Agents|sensory system agents|mesh-ancestor
153353998|NCT01556425|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153353999|NCT01798628|Abiraterone Acetate|abiraterone acetate|mesh-list
153354000|NCT01798628|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153354001|NCT01798628|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153354002|NCT01798628|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153354004|NCT01798628|Hormone Antagonists|hormone antagonists|mesh-ancestor
153354033|NCT01558063|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153354034|NCT01558063|Anesthetics, General|anesthetics, general|mesh-ancestor
153354036|NCT01558063|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153354037|NCT01558063|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
153354038|NCT01558063|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
153354039|NCT01558063|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153354040|NCT01558063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153354041|NCT03641846|Tadalafil|tadalafil|mesh-list
153354042|NCT03641846|Vasodilator Agents|vasodilator agents|mesh-ancestor
153354043|NCT03641846|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
153354044|NCT03641846|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
153354045|NCT03641846|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153354046|NCT03641846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153354047|NCT03641846|Urological Agents|urological agents|mesh-ancestor
153354048|NCT01516957|Brodalumab|brodalumab|mesh-list
153354049|NCT01516957|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
153354050|NCT01516957|Dermatologic Agents|dermatologic agents|mesh-ancestor
153354051|NCT01516957|Immunologic Factors|immunologic factors|mesh-ancestor
153354052|NCT01516957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153423604|NCT02213094|Vitamins|vitamins|mesh-list
153354055|NCT01519063|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
153354056|NCT01519063|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
153354058|NCT01519063|Sensory System Agents|sensory system agents|mesh-ancestor
153354059|NCT01519063|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153354060|NCT01519063|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
153354061|NCT01519063|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
153354062|NCT01519063|Dopamine Agents|dopamine agents|mesh-ancestor
153354063|NCT01519063|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153354064|NCT01519063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153354065|NCT01519063|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
153354066|NCT01519063|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
153354067|NCT01559857|Pioglitazone|pioglitazone|mesh-list
153354068|NCT01559857|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153354072|NCT01562041|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153354073|NCT01562041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153354074|NCT00634166|Anti-Infective Agents|anti-infective agents|mesh-list
153354075|NCT00634166|Amphotericin B|amphotericin b|mesh-list
153354076|NCT00634166|Clotrimazole|clotrimazole|mesh-list
153354078|NCT00634166|Bacitracin|bacitracin|mesh-list
153354079|NCT00634166|Mafenide|mafenide|mesh-list
153354080|NCT00634166|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
153354081|NCT00634166|Antifungal Agents|antifungal agents|mesh-list
153354082|NCT00634166|Amebicides|amebicides|mesh-ancestor
153354083|NCT00634166|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153354084|NCT00634166|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153354085|NCT00634166|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
153354086|NCT00634166|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
153354087|NCT00634166|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153354088|NCT00634166|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153354089|NCT00634166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153354090|NCT00634166|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153354091|NCT00634166|Hormone Antagonists|hormone antagonists|mesh-ancestor
153354092|NCT00634166|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153354093|NCT00634166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153354094|NCT00634166|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
153354095|NCT00634166|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
153354096|NCT00634166|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
153354097|NCT00565370|Capecitabine|capecitabine|mesh-list
153354098|NCT00565370|Sorafenib|sorafenib|mesh-list
153354099|NCT00565370|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153354115|NCT03303950|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153354116|NCT03303950|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153354117|NCT01563055|Ofatumumab|ofatumumab|mesh-list
153354118|NCT01563055|Chlorambucil|chlorambucil|mesh-list
153354119|NCT01563055|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153354120|NCT01563055|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153354121|NCT01563055|Alkylating Agents|alkylating agents|mesh-ancestor
153354122|NCT01563055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153354123|NCT00565916|Estradiol|estradiol|mesh-list
153354124|NCT00565916|Estrogens|estrogens|mesh-list
153354125|NCT00565916|Progesterone|progesterone|mesh-list
153354126|NCT00565916|Hormones|hormones|mesh-ancestor
153354127|NCT00565916|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153354128|NCT00565916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153354129|NCT00565916|Progestins|progestins|mesh-ancestor
153354130|NCT03258320|Docetaxel|docetaxel|mesh-list
153354131|NCT03258320|Mitoxantrone|mitoxantrone|mesh-list
153354132|NCT03258320|Satraplatin|satraplatin|mesh-list
153354133|NCT03258320|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153354134|NCT03258320|Tubulin Modulators|tubulin modulators|mesh-ancestor
153354135|NCT03258320|Antimitotic Agents|antimitotic agents|mesh-ancestor
153354136|NCT03258320|Mitosis Modulators|mitosis modulators|mesh-ancestor
153354137|NCT03258320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153354138|NCT03258320|Analgesics|analgesics|mesh-ancestor
153354170|NCT00566150|Anticonvulsants|anticonvulsants|mesh-ancestor
153354171|NCT00566150|Nootropic Agents|nootropic agents|mesh-ancestor
153354172|NCT00566540|Paclitaxel|paclitaxel|mesh-list
153354173|NCT00566540|Cisplatin|cisplatin|mesh-list
153354174|NCT00566540|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153354175|NCT00566540|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153354176|NCT00566540|Tubulin Modulators|tubulin modulators|mesh-ancestor
153354177|NCT00566540|Antimitotic Agents|antimitotic agents|mesh-ancestor
153354178|NCT00566540|Mitosis Modulators|mitosis modulators|mesh-ancestor
153783425|NCT04547764|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153354179|NCT00566540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153354180|NCT00567008|Varenicline|varenicline|mesh-list
153354182|NCT00567008|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
153354183|NCT00567008|Cholinergic Agents|cholinergic agents|mesh-ancestor
153354184|NCT00567008|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153354185|NCT00567008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153354186|NCT00567008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153354187|NCT00567320|Varenicline|varenicline|mesh-list
153354188|NCT00567320|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
153354189|NCT00567320|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
153354190|NCT00567320|Cholinergic Agents|cholinergic agents|mesh-ancestor
153354191|NCT00567320|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153354192|NCT00567320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153354193|NCT00567320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153354194|NCT01522417|Tirofiban|tirofiban|mesh-list
153354195|NCT01522417|Eptifibatide|eptifibatide|mesh-list
153354196|NCT01522417|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153354197|NCT01522417|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153354198|NCT01522417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153354199|NCT01522417|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153354200|NCT00568022|Capecitabine|capecitabine|mesh-list
153354201|NCT00568022|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153354212|NCT01522963|Cholinergic Agents|cholinergic agents|mesh-ancestor
153354213|NCT01522963|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153354214|NCT01522963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153354216|NCT03094286|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153354217|NCT03094286|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153354218|NCT03071666|Vitamin B 12|vitamin b 12|mesh-list
153354220|NCT03071666|Micronutrients|micronutrients|mesh-ancestor
153354221|NCT03071666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153354222|NCT03071666|Vitamin B Complex|vitamin b complex|mesh-ancestor
153354223|NCT05533580|Sufentanil|sufentanil|mesh-list
153354224|NCT05533580|Dsuvia|dsuvia|mesh-list
153354225|NCT05533580|Propofol|propofol|mesh-list
153354226|NCT05533580|Cisatracurium|cisatracurium|mesh-list
153882839|NCT02270424|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153882840|NCT02270424|Autonomic Agents|autonomic agents|mesh-ancestor
153882841|NCT02270424|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153882842|NCT02270424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153882843|NCT02270424|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153354227|NCT05533580|Atracurium|atracurium|mesh-list
153354228|NCT05533580|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153354229|NCT05533580|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153354230|NCT05533580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153354273|NCT02129426|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
153354274|NCT02129426|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153882844|NCT02270424|Respiratory System Agents|respiratory system agents|mesh-ancestor
153354275|NCT02129426|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153354276|NCT02129426|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153354277|NCT02129426|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153354278|NCT02129426|GABA Modulators|gaba modulators|mesh-ancestor
153354279|NCT02129426|GABA Agents|gaba agents|mesh-ancestor
153354280|NCT01523821|Protease Inhibitors|protease inhibitors|mesh-list
153354281|NCT01523821|Alpha 1-Antitrypsin|alpha 1-antitrypsin|mesh-list
153354282|NCT01523821|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153354283|NCT01523821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153354284|NCT01523821|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
153354285|NCT01523821|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
153354286|NCT05409716|Hemostatics|hemostatics|mesh-list
153354287|NCT05409716|Coagulants|coagulants|mesh-ancestor
153354288|NCT05395910|Paclitaxel|paclitaxel|mesh-list
153354289|NCT05395910|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153354290|NCT05395910|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153354292|NCT05395910|Antimitotic Agents|antimitotic agents|mesh-ancestor
153354293|NCT05395910|Mitosis Modulators|mitosis modulators|mesh-ancestor
153354294|NCT05395910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153354295|NCT01566409|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
153354296|NCT01566409|Laxatives|laxatives|mesh-ancestor
153354297|NCT01566409|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153354298|NCT02184416|Everolimus|everolimus|mesh-list
153354299|NCT02184416|Temsirolimus|temsirolimus|mesh-list
153354301|NCT02184416|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
153354302|NCT02184416|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153354303|NCT02184416|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153354304|NCT02184416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153354305|NCT02184416|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153354306|NCT02184416|Immunologic Factors|immunologic factors|mesh-ancestor
153354318|NCT01568905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153354319|NCT01569451|Rituximab|rituximab|mesh-list
153354321|NCT01569451|(T,G)-A-L|(t,g)-a-l|mesh-list
153354322|NCT01569451|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153354323|NCT01569451|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153354324|NCT01569451|Immunologic Factors|immunologic factors|mesh-ancestor
153354325|NCT01569451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153354326|NCT01569451|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153354327|NCT01569451|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153354328|NCT01569451|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153354329|NCT02132936|Calcipotriene|calcipotriene|mesh-list
153354330|NCT02132936|Dermatologic Agents|dermatologic agents|mesh-ancestor
153354380|NCT01529827|Antitubercular Agents|antitubercular agents|mesh-ancestor
153354381|NCT01529827|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153354382|NCT01529827|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153354383|NCT01529827|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153354384|NCT01529827|Alkylating Agents|alkylating agents|mesh-ancestor
153354385|NCT01529827|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153354386|NCT01571557|Dexamethasone|dexamethasone|mesh-list
153354387|NCT01571557|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153354388|NCT01571557|Antiemetics|antiemetics|mesh-ancestor
153354389|NCT01571557|Autonomic Agents|autonomic agents|mesh-ancestor
153354390|NCT01571557|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153354391|NCT01571557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153354392|NCT01571557|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153354393|NCT01571557|Glucocorticoids|glucocorticoids|mesh-ancestor
153354394|NCT01571557|Hormones|hormones|mesh-ancestor
153354436|NCT05041946|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153354438|NCT00574340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153354439|NCT05004896|Midazolam|midazolam|mesh-list
153354440|NCT05004896|Ketamine|ketamine|mesh-list
153354441|NCT05004896|Analgesics|analgesics|mesh-ancestor
153354442|NCT05004896|Sensory System Agents|sensory system agents|mesh-ancestor
153354443|NCT05004896|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153354444|NCT05004896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153354445|NCT05004896|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
153354446|NCT05004896|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153354447|NCT05004896|Anesthetics, General|anesthetics, general|mesh-ancestor
153354448|NCT05004896|Anesthetics|anesthetics|mesh-ancestor
153354449|NCT05004896|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153354450|NCT05004896|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
153354451|NCT05004896|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
153354452|NCT05004896|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153354453|NCT05004896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153354454|NCT05004896|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153354455|NCT05004896|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153354456|NCT05004896|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153354457|NCT05004896|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153354458|NCT05004896|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153354459|NCT05004896|GABA Modulators|gaba modulators|mesh-ancestor
153354460|NCT05004896|GABA Agents|gaba agents|mesh-ancestor
153354462|NCT00576680|Everolimus|everolimus|mesh-list
153354463|NCT00576680|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153354464|NCT00576680|Alkylating Agents|alkylating agents|mesh-ancestor
153354465|NCT00576680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153354466|NCT00576680|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153354467|NCT00576680|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
153354468|NCT00576680|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153354469|NCT00576680|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153354470|NCT00576680|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153354471|NCT00576680|Immunologic Factors|immunologic factors|mesh-ancestor
153354473|NCT04866602|Atovaquone|atovaquone|mesh-list
153354478|NCT04866602|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153354479|NCT04866602|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153354480|NCT04866602|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153354481|NCT04866602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153354482|NCT04866602|Antimetabolites|antimetabolites|mesh-ancestor
153783428|NCT04547608|Propofol|propofol|mesh-list
153354485|NCT04730648|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153423870|NCT02133924|Glucocorticoids|glucocorticoids|mesh-ancestor
153354486|NCT04730648|Antimetabolites|antimetabolites|mesh-ancestor
153354487|NCT04730648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153354488|NCT04730648|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
153354489|NCT04730648|Protease Inhibitors|protease inhibitors|mesh-ancestor
153354490|NCT04730648|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153354491|NCT04730648|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153354492|NCT00578552|Gabapentin|gabapentin|mesh-list
153354493|NCT00578552|Analgesics|analgesics|mesh-ancestor
153354494|NCT00578552|Sensory System Agents|sensory system agents|mesh-ancestor
153354535|NCT05246072|Tubulin Modulators|tubulin modulators|mesh-ancestor
153354536|NCT05246072|Antimitotic Agents|antimitotic agents|mesh-ancestor
153354537|NCT05246072|Mitosis Modulators|mitosis modulators|mesh-ancestor
153354538|NCT05246072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153354539|NCT05246072|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153354540|NCT05246072|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153354541|NCT05246072|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153354542|NCT02135432|Ivacaftor|ivacaftor|mesh-list
153354543|NCT02135432|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
153354544|NCT02135432|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153354545|NCT02135432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153354546|NCT05245994|Carboplatin|carboplatin|mesh-list
153354547|NCT05245994|Etoposide|etoposide|mesh-list
153354548|NCT05245994|Durvalumab|durvalumab|mesh-list
153354549|NCT05245994|Olaparib|olaparib|mesh-list
153354550|NCT05245994|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153354551|NCT05245994|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153354552|NCT05245994|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153354553|NCT05245994|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153354554|NCT05245994|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153354555|NCT05245994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153354556|NCT05245994|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153783429|NCT04547608|Rocuronium|rocuronium|mesh-list
153783430|NCT04547608|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153354557|NCT05245994|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
153354559|NCT05245604|Ophthalmic Solutions|ophthalmic solutions|mesh-list
153354560|NCT05245604|Cyclosporins|cyclosporins|mesh-list
153354561|NCT05245604|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153379350|NCT03006471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153379351|NCT03006471|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153379353|NCT03005678|Denosumab|denosumab|mesh-list
153354563|NCT05245604|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153354577|NCT05245448|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153354578|NCT05245448|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153354579|NCT05245448|Antiviral Agents|antiviral agents|mesh-ancestor
153354580|NCT05245448|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153354581|NCT05245448|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153354582|NCT05245448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153354583|NCT05245448|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153354584|NCT05245448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153354585|NCT05245448|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153354587|NCT00581048|Vitamin E|vitamin e|mesh-list
153354588|NCT00581048|Tocopherols|tocopherols|mesh-list
153354589|NCT00581048|alpha-Tocopherol|alpha-tocopherol|mesh-list
153354590|NCT00581048|Vitamins|vitamins|mesh-ancestor
153354591|NCT00581048|Micronutrients|micronutrients|mesh-ancestor
153354592|NCT00581048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153354593|NCT00581048|Antioxidants|antioxidants|mesh-ancestor
153354594|NCT00581048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153354595|NCT00581048|Protective Agents|protective agents|mesh-ancestor
153354634|NCT05121350|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153354635|NCT05121350|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153354636|NCT05121350|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153354637|NCT05121350|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153354638|NCT05121350|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153354639|NCT05121350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153354640|NCT00583622|Bevacizumab|bevacizumab|mesh-list
153354641|NCT00583622|Carboplatin|carboplatin|mesh-list
153354642|NCT00583622|Gemcitabine|gemcitabine|mesh-list
153354643|NCT00583622|Docetaxel|docetaxel|mesh-list
153354644|NCT00583622|Melphalan|melphalan|mesh-list
153354645|NCT00583622|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153354646|NCT00583622|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153354647|NCT00583622|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153354648|NCT00583622|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153354649|NCT00583622|Growth Substances|growth substances|mesh-ancestor
153354650|NCT00583622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153354651|NCT00583622|Growth Inhibitors|growth inhibitors|mesh-ancestor
153354652|NCT00583622|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153354653|NCT00583622|Antimetabolites|antimetabolites|mesh-ancestor
153354654|NCT00583622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153354655|NCT00583622|Tubulin Modulators|tubulin modulators|mesh-ancestor
153354656|NCT00583622|Antimitotic Agents|antimitotic agents|mesh-ancestor
153354657|NCT00583622|Mitosis Modulators|mitosis modulators|mesh-ancestor
153354658|NCT00583622|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153354659|NCT00583622|Alkylating Agents|alkylating agents|mesh-ancestor
153354660|NCT00583622|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153354663|NCT00583700|Vitamin E|vitamin e|mesh-list
153354664|NCT00583700|Pentoxifylline|pentoxifylline|mesh-list
153354665|NCT00583700|Vitamins|vitamins|mesh-ancestor
153354666|NCT00583700|Micronutrients|micronutrients|mesh-ancestor
153354667|NCT00583700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153354668|NCT00583700|Antioxidants|antioxidants|mesh-ancestor
153354669|NCT00583700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153354678|NCT05540743|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
153354679|NCT05540743|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153354680|NCT05540743|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153354681|NCT01537315|Hydroxychloroquine|hydroxychloroquine|mesh-list
153354682|NCT01537315|Antimalarials|antimalarials|mesh-ancestor
153354683|NCT01537315|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153354684|NCT01537315|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153883010|NCT02271399|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
153883011|NCT02271399|Antithrombins|antithrombins|mesh-ancestor
153883012|NCT02271399|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
153883013|NCT02271399|Protease Inhibitors|protease inhibitors|mesh-ancestor
153883014|NCT02271399|Anticoagulants|anticoagulants|mesh-ancestor
153883015|NCT02271438|Moxifloxacin|moxifloxacin|mesh-list
153883016|NCT02271438|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
153883017|NCT02271438|Ibrutinib|ibrutinib|mesh-list
153379359|NCT03008889|Antiviral Agents|antiviral agents|mesh-ancestor
153379361|NCT03008889|Expectorants|expectorants|mesh-ancestor
153883018|NCT02271438|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153883019|NCT02271438|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153883020|NCT02271438|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153883021|NCT02271438|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153883022|NCT02271438|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153883023|NCT02271438|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153354685|NCT01537315|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153883024|NCT02271438|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153883026|NCT02271438|Contraceptive Agents|contraceptive agents|mesh-ancestor
153354687|NCT01537315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153354688|NCT01537315|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153354689|NCT04257188|Anesthetics|anesthetics|mesh-list
153354690|NCT04257188|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153354691|NCT04257188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153354692|NCT04224428|Fexofenadine|fexofenadine|mesh-list
153354693|NCT04224428|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
153354694|NCT04224428|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
153354695|NCT04224428|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
153354696|NCT04224428|Histamine Antagonists|histamine antagonists|mesh-ancestor
153354697|NCT04224428|Histamine Agents|histamine agents|mesh-ancestor
153354698|NCT04224428|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153354699|NCT04224428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153354700|NCT04224428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153354702|NCT04224194|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
153354703|NCT04224194|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153783431|NCT04547608|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153354704|NCT04224194|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153354705|NCT00584948|Memantine|memantine|mesh-list
153354706|NCT00584948|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
153354707|NCT00584948|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
153423958|NCT04495712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153883047|NCT01687205|Tenofovir|tenofovir|mesh-list
153354711|NCT00584948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153354712|NCT00584948|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
153354714|NCT00605072|Metoprolol|metoprolol|mesh-list
153354715|NCT00605072|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
153354716|NCT00605072|Candesartan|candesartan|mesh-list
153354729|NCT00605072|Autonomic Agents|autonomic agents|mesh-ancestor
153354730|NCT00605072|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153354731|NCT00605072|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
153354732|NCT00605072|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
153354733|NCT00605072|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
153354734|NCT00605072|Adrenergic Agents|adrenergic agents|mesh-ancestor
153424154|NCT03225313|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
153354743|NCT00605072|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
153424230|NCT03338803|Protease Inhibitors|protease inhibitors|mesh-ancestor
153354755|NCT00585104|Protective Agents|protective agents|mesh-ancestor
153354756|NCT00585104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153354758|NCT00585182|Anticoagulants|anticoagulants|mesh-ancestor
153354759|NCT00585182|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153354760|NCT00585182|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153354761|NCT00585182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153354763|NCT04856228|Anesthetics, Local|anesthetics, local|mesh-ancestor
153354764|NCT04856228|Anesthetics|anesthetics|mesh-ancestor
153880749|NCT06031129|Butorphanol|butorphanol|mesh-list
153880750|NCT06031129|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153880751|NCT06031129|Narcotics|narcotics|mesh-ancestor
153880752|NCT06031129|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153880753|NCT06031129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153880754|NCT06031129|Analgesics|analgesics|mesh-ancestor
153880755|NCT06031129|Sensory System Agents|sensory system agents|mesh-ancestor
153880756|NCT06031129|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153354766|NCT04856228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153354767|NCT04856228|Sensory System Agents|sensory system agents|mesh-ancestor
153354768|NCT04856228|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153354769|NCT04856228|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153354770|NCT04856228|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
153354771|NCT04856228|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153354772|NCT04856228|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153354773|NCT04856228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153354775|NCT00605384|Lamivudine|lamivudine|mesh-list
153354776|NCT00605384|Entecavir|entecavir|mesh-list
153354777|NCT00605384|Adefovir|adefovir|mesh-list
153354778|NCT00605384|Antiviral Agents|antiviral agents|mesh-ancestor
153354779|NCT00605384|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153354780|NCT00605384|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153354781|NCT00605384|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153354783|NCT00605384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153354784|NCT00605384|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153354785|NCT00605384|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153354786|NCT00586196|Donepezil|donepezil|mesh-list
153883397|NCT01365507|Insulin|insulin|mesh-list
153354809|NCT00587678|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
153883451|NCT01332318|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
153883464|NCT01331109|Milnacipran|milnacipran|mesh-list
153354810|NCT00587678|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153354812|NCT02138006|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
153354813|NCT02138006|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153354814|NCT02138006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153424429|NCT04114058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153354816|NCT04545008|Famotidine|famotidine|mesh-list
153354817|NCT04545008|N-monoacetylcystine|n-monoacetylcystine|mesh-list
153354818|NCT04545008|Antiviral Agents|antiviral agents|mesh-ancestor
153354819|NCT04545008|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153354821|NCT04545008|Respiratory System Agents|respiratory system agents|mesh-ancestor
153354822|NCT04545008|Free Radical Scavengers|free radical scavengers|mesh-ancestor
153354823|NCT04545008|Antioxidants|antioxidants|mesh-ancestor
153354824|NCT04545008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153354825|NCT04545008|Protective Agents|protective agents|mesh-ancestor
153354826|NCT04545008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153354827|NCT04545008|Antidotes|antidotes|mesh-ancestor
153354828|NCT04545008|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
153354829|NCT04545008|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153354830|NCT04545008|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
153354831|NCT04545008|Histamine Antagonists|histamine antagonists|mesh-ancestor
153883588|NCT01340625|Norethindrone Acetate|norethindrone acetate|mesh-list
153883589|NCT01340625|Estradiol|estradiol|mesh-list
153883590|NCT01340625|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
153883591|NCT01340625|Estrogens|estrogens|mesh-ancestor
153883592|NCT01340625|Hormones|hormones|mesh-ancestor
153883593|NCT01340625|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153880763|NCT06031090|Sensory System Agents|sensory system agents|mesh-ancestor
153354853|NCT04527770|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153354854|NCT04527770|Anesthetics, General|anesthetics, general|mesh-ancestor
153354856|NCT04527770|GABA Modulators|gaba modulators|mesh-ancestor
153354857|NCT04527770|GABA Agents|gaba agents|mesh-ancestor
153354858|NCT04527770|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153783434|NCT04547608|Anesthetics, General|anesthetics, general|mesh-ancestor
153783435|NCT04547608|Anesthetics|anesthetics|mesh-ancestor
153354859|NCT04527770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153424523|NCT03831854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153354865|NCT00609128|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153354866|NCT00609128|Analgesics|analgesics|mesh-ancestor
153354867|NCT00609128|Sensory System Agents|sensory system agents|mesh-ancestor
153354868|NCT00609128|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153354869|NCT00609128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153354870|NCT00609128|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153354871|NCT00609128|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153354872|NCT00609128|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
153421614|NCT05689047|Schistosomicides|schistosomicides|mesh-ancestor
153421615|NCT05689047|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
153421617|NCT05676749|Pembrolizumab|pembrolizumab|mesh-list
153354873|NCT00609128|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
153354894|NCT00610688|Cholecalciferol|cholecalciferol|mesh-list
153354895|NCT00610688|Vitamins|vitamins|mesh-list
153354896|NCT00610688|Micronutrients|micronutrients|mesh-ancestor
153354897|NCT00610688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153354898|NCT00610688|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153354899|NCT00610688|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153354900|NCT00669578|Pomalidomide|pomalidomide|mesh-list
153354901|NCT00669578|Immunologic Factors|immunologic factors|mesh-ancestor
153354902|NCT00669578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153354903|NCT00669578|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153354904|NCT00669578|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153354905|NCT00669578|Growth Substances|growth substances|mesh-ancestor
153354906|NCT00669578|Growth Inhibitors|growth inhibitors|mesh-ancestor
153354907|NCT00669578|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153354908|NCT02137382|Pancrelipase|pancrelipase|mesh-list
153354909|NCT02137382|Pancreatin|pancreatin|mesh-list
153354910|NCT02137382|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153354911|NCT00611468|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
153354912|NCT00611468|Topotecan|topotecan|mesh-list
153354913|NCT00611468|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153354914|NCT00611468|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153883595|NCT01340625|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
153354923|NCT00670202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153354924|NCT00670202|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153354926|NCT00670202|Vasodilator Agents|vasodilator agents|mesh-ancestor
153354927|NCT00670202|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153354928|NCT00670202|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153354929|NCT00670982|Bevacizumab|bevacizumab|mesh-list
153354930|NCT00670982|Trastuzumab|trastuzumab|mesh-list
153354931|NCT00670982|Vinorelbine|vinorelbine|mesh-list
153354932|NCT00670982|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153354933|NCT00670982|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153354934|NCT00670982|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153354935|NCT00670982|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153354936|NCT00670982|Growth Substances|growth substances|mesh-ancestor
153354937|NCT00670982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153354938|NCT00670982|Growth Inhibitors|growth inhibitors|mesh-ancestor
153354940|NCT00670982|Tubulin Modulators|tubulin modulators|mesh-ancestor
153354941|NCT00670982|Antimitotic Agents|antimitotic agents|mesh-ancestor
153354942|NCT00670982|Mitosis Modulators|mitosis modulators|mesh-ancestor
153354943|NCT00670982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153354945|NCT00612560|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153354946|NCT00612560|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153354947|NCT00612560|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
153354948|NCT00612560|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153354949|NCT00612560|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153354950|NCT00612560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153354951|NCT00612560|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
153354952|NCT00612560|Hormone Antagonists|hormone antagonists|mesh-ancestor
153354953|NCT00612560|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153354954|NCT00612560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153354955|NCT00612716|Cyclophosphamide|cyclophosphamide|mesh-list
153354956|NCT00612716|Busulfan|busulfan|mesh-list
153883645|NCT01327599|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
153354957|NCT00612716|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153354958|NCT00612716|Immunologic Factors|immunologic factors|mesh-ancestor
153354961|NCT00612716|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153354962|NCT00612716|Alkylating Agents|alkylating agents|mesh-ancestor
153354963|NCT00612716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153354964|NCT00612716|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153354965|NCT00612716|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153354966|NCT00613028|Bevacizumab|bevacizumab|mesh-list
153354967|NCT00613028|Etoposide|etoposide|mesh-list
153354968|NCT00613028|Temozolomide|temozolomide|mesh-list
153354969|NCT00613028|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153354970|NCT00613028|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153354971|NCT00613028|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153354972|NCT00613028|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153354973|NCT00613028|Growth Substances|growth substances|mesh-ancestor
153354974|NCT00613028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153354975|NCT00613028|Growth Inhibitors|growth inhibitors|mesh-ancestor
153354976|NCT00613028|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153354977|NCT00613028|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153354978|NCT00613028|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153354979|NCT00613028|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153354980|NCT00613028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153354981|NCT00613028|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153424616|NCT03502915|Anesthetics|anesthetics|mesh-ancestor
153354982|NCT00613028|Alkylating Agents|alkylating agents|mesh-ancestor
153354983|NCT01799798|Denosumab|denosumab|mesh-list
153354992|NCT00616772|Fenofibric acid|fenofibric acid|mesh-list
153354993|NCT00616772|Fenofibrate|fenofibrate|mesh-list
153354994|NCT00616772|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153354995|NCT00616772|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153354996|NCT00616772|Antimetabolites|antimetabolites|mesh-ancestor
153354997|NCT00616772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153354998|NCT00616772|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153354999|NCT00616772|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
153355000|NCT00616772|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153355001|NCT00616772|Lipotropic Agents|lipotropic agents|mesh-ancestor
153355002|NCT00616772|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153355003|NCT00616772|Nootropic Agents|nootropic agents|mesh-ancestor
153355004|NCT00672854|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
153355005|NCT00672854|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
153355006|NCT00672854|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
153355007|NCT00672854|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
153355008|NCT00672932|Raltegravir Potassium|raltegravir potassium|mesh-list
153355010|NCT00672932|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153883700|NCT04329000|Esomeprazole|esomeprazole|mesh-list
153355011|NCT00672932|Antiviral Agents|antiviral agents|mesh-ancestor
153355012|NCT00672932|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153883706|NCT01192399|Eculizumab|eculizumab|mesh-list
153355025|NCT00673712|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153355027|NCT04062032|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153355028|NCT04062032|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153355029|NCT04062032|Analgesics|analgesics|mesh-ancestor
153355030|NCT04062032|Sensory System Agents|sensory system agents|mesh-ancestor
153355031|NCT04062032|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153355033|NCT04062032|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153355034|NCT04062032|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153355035|NCT04062032|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153355036|NCT04062032|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153355037|NCT04062032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153355038|NCT04062032|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153355039|NCT04062032|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153355040|NCT04062032|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153355041|NCT04062032|Antipyretics|antipyretics|mesh-ancestor
153355042|NCT00617396|Quetiapine Fumarate|quetiapine fumarate|mesh-list
153355043|NCT00617396|Antidepressive Agents|antidepressive agents|mesh-ancestor
153355044|NCT00617396|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153355046|NCT00617396|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153355047|NCT00617396|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153355048|NCT00617396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153355049|NCT03722966|Nicotine|nicotine|mesh-list
153355050|NCT03722966|Varenicline|varenicline|mesh-list
153355051|NCT03722966|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
153355052|NCT03722966|Autonomic Agents|autonomic agents|mesh-ancestor
153355053|NCT03722966|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153355054|NCT03722966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153355055|NCT03722966|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
153355056|NCT03722966|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
153355057|NCT03722966|Cholinergic Agents|cholinergic agents|mesh-ancestor
153355058|NCT03722966|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153355059|NCT03722966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153355060|NCT01581541|9H-purine-9-propanamine, 6-amino-8-((6-iodo-1,3-benzodioxol-5-yl)thio)-N-(1-methylethyl)-|9h-purine-9-propanamine, 6-amino-8-((6-iodo-1,3-benzodioxol-5-yl)thio)-n-(1-methylethyl)-|mesh-list
153355061|NCT01581541|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153355063|NCT01582477|Anesthetics, Local|anesthetics, local|mesh-ancestor
153355064|NCT01582477|Anesthetics|anesthetics|mesh-ancestor
153355065|NCT01582477|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153355066|NCT01582477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153355067|NCT01582477|Sensory System Agents|sensory system agents|mesh-ancestor
153355068|NCT01582477|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153355069|NCT03001687|Vitamin D|vitamin d|mesh-list
153355070|NCT03001687|Vitamins|vitamins|mesh-ancestor
153355071|NCT03001687|Micronutrients|micronutrients|mesh-ancestor
153355072|NCT03001687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153355073|NCT03001687|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153355074|NCT03001609|Abivertinib|abivertinib|mesh-list
153355075|NCT03001609|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153355076|NCT03001609|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153355077|NCT03001609|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153355078|NCT03001609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153355080|NCT03007381|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
153355081|NCT03007381|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153355082|NCT03007381|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153355083|NCT03007381|Analgesics|analgesics|mesh-ancestor
153355084|NCT03007381|Sensory System Agents|sensory system agents|mesh-ancestor
153783436|NCT04547608|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
153355085|NCT03007381|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153355086|NCT03007381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153355087|NCT03007381|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153355088|NCT03007381|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153355089|NCT03007381|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153355090|NCT03007381|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153355091|NCT03007381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153355092|NCT01585129|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
153355093|NCT01585129|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
153355094|NCT01585129|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153355095|NCT01585129|Antitubercular Agents|antitubercular agents|mesh-ancestor
153355097|NCT01585207|Anticonvulsants|anticonvulsants|mesh-ancestor
153355098|NCT01585207|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153355099|NCT01585207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153355100|NCT01585207|GABA Agents|gaba agents|mesh-ancestor
153355101|NCT01585207|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153355104|NCT03007303|Risperidone|risperidone|mesh-list
153355105|NCT03007303|Quetiapine Fumarate|quetiapine fumarate|mesh-list
153355107|NCT03007303|Antipsychotic Agents|antipsychotic agents|mesh-list
153883840|NCT00592215|Mifepristone|mifepristone|mesh-list
153355118|NCT03007303|Antiemetics|antiemetics|mesh-ancestor
153355119|NCT03007303|Autonomic Agents|autonomic agents|mesh-ancestor
153355120|NCT03007303|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153355121|NCT03007303|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153355122|NCT03007303|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
153355123|NCT03007303|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153355124|NCT03007303|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153355125|NCT03007303|Antidepressive Agents|antidepressive agents|mesh-ancestor
153355126|NCT01585441|Finasteride|finasteride|mesh-list
153355127|NCT01585441|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
153355128|NCT01585441|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153355129|NCT01585441|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153355130|NCT01585441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153355131|NCT01585441|Hormone Antagonists|hormone antagonists|mesh-ancestor
153355132|NCT01585441|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153355133|NCT01585441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153355136|NCT00617942|Carboplatin|carboplatin|mesh-list
153355137|NCT00617942|Trastuzumab|trastuzumab|mesh-list
153355138|NCT00617942|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153355139|NCT00617942|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153355140|NCT00617942|Tubulin Modulators|tubulin modulators|mesh-ancestor
153355141|NCT00617942|Antimitotic Agents|antimitotic agents|mesh-ancestor
153355142|NCT00617942|Mitosis Modulators|mitosis modulators|mesh-ancestor
153387706|NCT00000765|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153355148|NCT00618332|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
153355149|NCT01588561|Nicotine|nicotine|mesh-list
153355150|NCT01588561|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
153355151|NCT01588561|Autonomic Agents|autonomic agents|mesh-ancestor
153355152|NCT01588561|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153355153|NCT01588561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153355154|NCT01588561|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
153355155|NCT01588561|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
153355156|NCT01588561|Cholinergic Agents|cholinergic agents|mesh-ancestor
153355157|NCT01588561|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153783437|NCT04547608|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
153355158|NCT01588561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153355160|NCT00619190|Antidepressive Agents|antidepressive agents|mesh-ancestor
153355161|NCT00619190|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153355162|NCT00619190|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153355163|NCT00619190|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153355164|NCT00619190|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153355165|NCT00619190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153355166|NCT00619190|Dopamine Agonists|dopamine agonists|mesh-ancestor
153355167|NCT00619190|Dopamine Agents|dopamine agents|mesh-ancestor
153355168|NCT00619190|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153355169|NCT00619190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153387708|NCT00000765|Antiviral Agents|antiviral agents|mesh-ancestor
153883894|NCT01600274|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153883896|NCT01600274|Androgens|androgens|mesh-ancestor
153355178|NCT01589263|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
153355179|NCT01589263|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
153355180|NCT01589263|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
153355181|NCT01589263|Adrenergic Agents|adrenergic agents|mesh-ancestor
153355182|NCT01589263|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153355183|NCT01589263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153355184|NCT01589263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153355185|NCT01589263|Urological Agents|urological agents|mesh-ancestor
153355187|NCT01590979|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153355188|NCT01590979|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153355189|NCT01590979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153355191|NCT00619970|Lactulose|lactulose|mesh-list
153355192|NCT00619970|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153355193|NCT00619970|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153355194|NCT00619970|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153355195|NCT01591837|Vaccines|vaccines|mesh-list
153355196|NCT01591837|Immunologic Factors|immunologic factors|mesh-ancestor
153355197|NCT01591837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153355198|NCT01592851|Fluorides|fluorides|mesh-list
153355199|NCT01592851|Tin Fluorides|tin fluorides|mesh-list
153355200|NCT01592851|Fluorophosphate|fluorophosphate|mesh-list
153355201|NCT01592851|Cariostatic Agents|cariostatic agents|mesh-ancestor
153355204|NCT00675584|Budesonide|budesonide|mesh-list
153355214|NCT00675584|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153355215|NCT00676364|Lidocaine|lidocaine|mesh-list
153355216|NCT00676364|Anesthetics, Local|anesthetics, local|mesh-list
153355217|NCT00676364|Anesthetics|anesthetics|mesh-list
153355218|NCT00676364|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153355219|NCT00676364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153355220|NCT00676364|Sensory System Agents|sensory system agents|mesh-ancestor
153355221|NCT00676364|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153880764|NCT06031090|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153880765|NCT06031090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153355222|NCT00676364|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153355223|NCT00676364|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
153355224|NCT00676364|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153379404|NCT02918097|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
153355225|NCT00676364|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153355226|NCT00676364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153883971|NCT01607333|Lamotrigine|lamotrigine|mesh-list
153355227|NCT00676676|Testosterone|testosterone|mesh-list
153355228|NCT00676676|Androgens|androgens|mesh-ancestor
153355229|NCT00676676|Hormones|hormones|mesh-ancestor
153783438|NCT04547608|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
153355230|NCT00676676|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153355231|NCT00676676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153355233|NCT00621530|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
153355234|NCT00621530|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153355235|NCT00621530|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153355236|NCT00621530|Analgesics|analgesics|mesh-ancestor
153355237|NCT00621530|Sensory System Agents|sensory system agents|mesh-ancestor
153355238|NCT00621530|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153355239|NCT00621530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153355240|NCT00621530|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153355241|NCT00621530|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153355242|NCT00621530|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153355243|NCT00621530|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153355244|NCT00621530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153355245|NCT02513472|Pembrolizumab|pembrolizumab|mesh-list
153355246|NCT02513472|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153355252|NCT00621686|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153355254|NCT00621686|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153355255|NCT00621686|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153355256|NCT00621686|Growth Substances|growth substances|mesh-ancestor
153355257|NCT00621686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153355258|NCT00621686|Growth Inhibitors|growth inhibitors|mesh-ancestor
153355259|NCT00621686|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153355260|NCT00621686|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153355261|NCT00621686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153355262|NCT02924714|Imatinib Mesylate|imatinib mesylate|mesh-list
153355263|NCT02924714|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153355264|NCT02924714|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153355265|NCT02924714|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153355266|NCT02924714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153884005|NCT01175824|Coagulants|coagulants|mesh-ancestor
153355269|NCT00678470|Dermatologic Agents|dermatologic agents|mesh-ancestor
153355270|NCT00678470|Immunologic Factors|immunologic factors|mesh-ancestor
153355271|NCT00678470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153355272|NCT00623012|Sirolimus|sirolimus|mesh-list
153355273|NCT00623012|Tacrolimus|tacrolimus|mesh-list
153355274|NCT00623012|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153355275|NCT00623012|Immunologic Factors|immunologic factors|mesh-ancestor
153355276|NCT00623012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153355277|NCT00623012|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
153355278|NCT00623012|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153355279|NCT00623012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153355280|NCT00623012|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153355281|NCT00623012|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153355282|NCT00623012|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153355283|NCT00623012|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153355285|NCT01799954|Vaccines|vaccines|mesh-list
153355286|NCT01799954|Immunologic Factors|immunologic factors|mesh-ancestor
153355287|NCT01799954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153355288|NCT00623714|Fluticasone|fluticasone|mesh-list
153355289|NCT00623714|Xhance|xhance|mesh-list
153355290|NCT00623714|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153355291|NCT00623714|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153355292|NCT00623714|Autonomic Agents|autonomic agents|mesh-ancestor
153355293|NCT00623714|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153884044|NCT01601327|Testosterone undecanoate|testosterone undecanoate|mesh-list
153884045|NCT01601327|Testosterone enanthate|testosterone enanthate|mesh-list
153424983|NCT00378092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153355294|NCT00623714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153355295|NCT00623714|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153355296|NCT00623714|Respiratory System Agents|respiratory system agents|mesh-ancestor
153424984|NCT00378092|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153424990|NCT01347632|Metronidazole|metronidazole|mesh-list
153355320|NCT00624416|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
153355321|NCT00624416|Methylprednisolone|methylprednisolone|mesh-list
153880775|NCT06031090|Antiemetics|antiemetics|mesh-ancestor
153355322|NCT00624416|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
153355323|NCT00624416|Prednisolone acetate|prednisolone acetate|mesh-list
153884065|NCT01607762|Paliperidone Palmitate|paliperidone palmitate|mesh-list
153425054|NCT03565328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153355368|NCT00653276|Dermatologic Agents|dermatologic agents|mesh-ancestor
153355369|NCT00653276|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153355370|NCT00653276|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
153355371|NCT00653276|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153355372|NCT00653276|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153355373|NCT00653276|Antimetabolites|antimetabolites|mesh-ancestor
153355374|NCT00653276|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153355375|NCT00683852|Aripiprazole|aripiprazole|mesh-list
153355376|NCT00683852|Antidepressive Agents|antidepressive agents|mesh-ancestor
153355377|NCT00683852|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153355378|NCT00683852|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153355379|NCT00683852|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153355380|NCT00683852|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153355381|NCT00683852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153355382|NCT00683852|Dopamine Agonists|dopamine agonists|mesh-ancestor
153355383|NCT00683852|Dopamine Agents|dopamine agents|mesh-ancestor
153355384|NCT00683852|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153355385|NCT00683852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153355386|NCT00683852|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
153355387|NCT00683852|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
153355388|NCT00683852|Serotonin Agents|serotonin agents|mesh-ancestor
153355389|NCT00683852|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
153425143|NCT01139996|Analgesics|analgesics|mesh-ancestor
153425144|NCT01139996|Sensory System Agents|sensory system agents|mesh-ancestor
153884191|NCT01111552|Serotonin Agents|serotonin agents|mesh-ancestor
153884192|NCT01111552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153884194|NCT01111552|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153421646|NCT05607420|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153421649|NCT05603104|Valproic Acid|valproic acid|mesh-list
153421650|NCT05603104|Quetiapine Fumarate|quetiapine fumarate|mesh-list
153421651|NCT05603104|Clozapine|clozapine|mesh-list
153421652|NCT05603104|Antipsychotic Agents|antipsychotic agents|mesh-list
153421653|NCT05603104|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
153421654|NCT05603104|Sertraline|sertraline|mesh-list
153355398|NCT03006835|Purinergic Agents|purinergic agents|mesh-ancestor
153355399|NCT03006835|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153355401|NCT03006835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153425173|NCT02389712|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
153355403|NCT03006757|Sunscreening Agents|sunscreening agents|mesh-ancestor
153355404|NCT03006757|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
153355405|NCT03006757|Protective Agents|protective agents|mesh-ancestor
153355406|NCT03006757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153425174|NCT02389712|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153425175|NCT02389712|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153884227|NCT01602302|Golimumab|golimumab|mesh-list
153355408|NCT03006757|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
153355409|NCT05566405|Anesthetics|anesthetics|mesh-list
153355410|NCT05566405|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153355411|NCT05566405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153355412|NCT03000127|Testosterone|testosterone|mesh-list
153355413|NCT03000127|Androgens|androgens|mesh-ancestor
153355415|NCT03000127|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153355416|NCT03000127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153355417|NCT02999815|Immunoglobulins|immunoglobulins|mesh-list
153355418|NCT02999815|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
153355419|NCT02999815|Antibodies|antibodies|mesh-list
153355420|NCT02999815|Antitoxins|antitoxins|mesh-list
153355421|NCT02999815|Immunologic Factors|immunologic factors|mesh-ancestor
153355422|NCT02999815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153355423|NCT03006679|Meropenem|meropenem|mesh-list
153355424|NCT03006679|Tazobactam|tazobactam|mesh-list
153355425|NCT03006679|Piperacillin|piperacillin|mesh-list
153355426|NCT03006679|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
153355427|NCT03006679|Vaborbactam|vaborbactam|mesh-list
153355428|NCT03006679|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153355429|NCT03006679|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153355430|NCT03006679|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
153355431|NCT03006679|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153355432|NCT03006679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153355434|NCT03006445|Uricosuric Agents|uricosuric agents|mesh-ancestor
153355435|NCT03006445|Gout Suppressants|gout suppressants|mesh-ancestor
153355442|NCT03006211|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153355443|NCT03006211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153425236|NCT00376051|Serotonin Agents|serotonin agents|mesh-ancestor
153355451|NCT03006211|Respiratory System Agents|respiratory system agents|mesh-ancestor
153355452|NCT03006211|Free Radical Scavengers|free radical scavengers|mesh-ancestor
153355454|NCT03006211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153355455|NCT03006211|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153355456|NCT03006211|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
153355457|NCT03006211|Vasodilator Agents|vasodilator agents|mesh-ancestor
153355458|NCT03006211|Gasotransmitters|gasotransmitters|mesh-ancestor
153355459|NCT03006211|Protective Agents|protective agents|mesh-ancestor
153355460|NCT02248051|CXA-10|cxa-10|mesh-list
153355461|NCT02248051|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153355462|NCT02247505|Tadalafil|tadalafil|mesh-list
153355467|NCT02247505|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153355468|NCT02247505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153355469|NCT02247505|Urological Agents|urological agents|mesh-ancestor
153355470|NCT02247505|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
153355471|NCT02247505|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
153355472|NCT02247505|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
153355473|NCT02247505|Adrenergic Agents|adrenergic agents|mesh-ancestor
153355474|NCT02247505|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153355475|NCT02247505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153355478|NCT02248129|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153355480|NCT02248129|Natriuretic Agents|natriuretic agents|mesh-ancestor
153884307|NCT01608698|Estrogens|estrogens|mesh-ancestor
153355481|NCT02248129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153355482|NCT02248129|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
153355483|NCT02248129|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153355484|NCT02248129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153355485|NCT02248129|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
153355486|NCT02248129|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
153355487|NCT02248207|Pramipexole|pramipexole|mesh-list
153355488|NCT02248207|Dexpramipexole|dexpramipexole|mesh-list
153355489|NCT02248207|Antioxidants|antioxidants|mesh-ancestor
153355490|NCT02248207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153355491|NCT02248207|Protective Agents|protective agents|mesh-ancestor
153355492|NCT02248207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153355493|NCT02248207|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
153355494|NCT02248207|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
153355495|NCT02248207|Dopamine Agonists|dopamine agonists|mesh-ancestor
153355496|NCT02248207|Dopamine Agents|dopamine agents|mesh-ancestor
153355516|NCT00651560|Ezetimibe|ezetimibe|mesh-list
153355517|NCT00651560|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153355518|NCT00651560|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153355519|NCT00651560|Antimetabolites|antimetabolites|mesh-ancestor
153355520|NCT00651560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153355521|NCT00651560|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153355522|NCT00651560|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
153355523|NCT00651560|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153355524|NCT00684554|Buprenorphine|buprenorphine|mesh-list
153355525|NCT00684554|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153355526|NCT00684554|Narcotics|narcotics|mesh-ancestor
153355527|NCT00684554|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153355528|NCT00684554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153355529|NCT00684554|Analgesics|analgesics|mesh-ancestor
153355530|NCT00684554|Sensory System Agents|sensory system agents|mesh-ancestor
153355531|NCT00684554|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153355532|NCT00684554|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
153783439|NCT04547608|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153355533|NCT00551876|Simvastatin|simvastatin|mesh-list
153355534|NCT00551876|Ezetimibe|ezetimibe|mesh-list
153355535|NCT00551876|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153355536|NCT00551876|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153355537|NCT00551876|Antimetabolites|antimetabolites|mesh-ancestor
153355538|NCT00551876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153355539|NCT00551876|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153355540|NCT00551876|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
153355541|NCT00551876|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153355542|NCT00628394|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
153355543|NCT00628394|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
153355544|NCT00628394|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153355545|NCT00628394|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153387711|NCT00000765|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153355547|NCT00628394|Adrenergic Agents|adrenergic agents|mesh-ancestor
153355548|NCT00628394|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153355549|NCT00628394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153355550|NCT00251576|Heparin|heparin|mesh-list
153355551|NCT00251576|Calcium heparin|calcium heparin|mesh-list
153355552|NCT00251576|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
153355553|NCT00251576|Tinzaparin|tinzaparin|mesh-list
153355554|NCT00251576|Dalteparin|dalteparin|mesh-list
153355555|NCT00251576|Tirofiban|tirofiban|mesh-list
153355556|NCT00251576|Simvastatin|simvastatin|mesh-list
153355557|NCT00251576|Anticoagulants|anticoagulants|mesh-ancestor
153355558|NCT00251576|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153355559|NCT00251576|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153355560|NCT00251576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153355561|NCT00251576|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153355562|NCT00251576|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153355563|NCT00251576|Antimetabolites|antimetabolites|mesh-ancestor
153355564|NCT00251576|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153355565|NCT00251576|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
153355566|NCT00251576|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153355567|NCT00251576|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153355568|NCT04387604|Ranibizumab|ranibizumab|mesh-list
153355569|NCT04387604|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153355570|NCT04387604|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153355571|NCT04387604|Growth Substances|growth substances|mesh-ancestor
153355572|NCT04387604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153355573|NCT04387604|Growth Inhibitors|growth inhibitors|mesh-ancestor
153355574|NCT04387604|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153355575|NCT03005665|Acetazolamide|acetazolamide|mesh-list
153355576|NCT03005665|Anticonvulsants|anticonvulsants|mesh-ancestor
153884364|NCT01604057|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153884365|NCT00592566|Dexamethasone|dexamethasone|mesh-list
153884366|NCT00592566|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
153884367|NCT00592566|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153355580|NCT03005665|Diuretics|diuretics|mesh-ancestor
153355581|NCT03005665|Natriuretic Agents|natriuretic agents|mesh-ancestor
153355582|NCT03005665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153355583|NCT00628628|Rasburicase|rasburicase|mesh-list
153355584|NCT00628628|Gout Suppressants|gout suppressants|mesh-ancestor
153355585|NCT00628628|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153355587|NCT00630734|Darunavir|darunavir|mesh-list
153355588|NCT00630734|Pravastatin|pravastatin|mesh-list
153355589|NCT00630734|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
153355590|NCT00630734|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
153884399|NCT01173679|Fludarabine|fludarabine|mesh-list
153884400|NCT01173679|Dasatinib|dasatinib|mesh-list
153425341|NCT04327843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153425342|NCT04327843|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
153425344|NCT02147834|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153355591|NCT00630734|Protease Inhibitors|protease inhibitors|mesh-ancestor
153355592|NCT00630734|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153355593|NCT00630734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153355594|NCT00630734|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153355595|NCT00630734|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153425345|NCT02147834|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153425346|NCT02147834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153425347|NCT00979550|Imiquimod|imiquimod|mesh-list
153425348|NCT00979550|Toll-Like Receptor Agonists|toll-like receptor agonists|mesh-ancestor
153425350|NCT00979550|Immunomodulating Agents|immunomodulating agents|mesh-ancestor
153355599|NCT00630734|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153355601|NCT00630734|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153355602|NCT00630734|Antimetabolites|antimetabolites|mesh-ancestor
153355603|NCT00630734|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153355604|NCT00630734|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
153355605|NCT05644249|Doxorubicin|doxorubicin|mesh-list
153355606|NCT05644249|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153355607|NCT05644249|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153783441|NCT00236249|Anesthetics, Local|anesthetics, local|mesh-ancestor
153355608|NCT05644249|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153355609|NCT05644249|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153355610|NCT05644249|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153884427|NCT01110382|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153425368|NCT02074904|Anticonvulsants|anticonvulsants|mesh-ancestor
153425369|NCT02074904|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153425370|NCT02074904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153425371|NCT02043860|Melphalan|melphalan|mesh-list
153425385|NCT00869414|Insulin|insulin|mesh-list
153783443|NCT00236249|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153783444|NCT00236249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153355614|NCT00686582|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153355615|NCT00631358|Dexamethasone|dexamethasone|mesh-list
153355616|NCT00631358|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153355617|NCT00631358|Antiemetics|antiemetics|mesh-ancestor
153355618|NCT00631358|Autonomic Agents|autonomic agents|mesh-ancestor
153355619|NCT00631358|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153355620|NCT00631358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153355621|NCT00631358|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153355622|NCT00631358|Glucocorticoids|glucocorticoids|mesh-ancestor
153355624|NCT00631358|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153355625|NCT00631358|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153355626|NCT00631358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153355628|NCT02248753|Digoxin|digoxin|mesh-list
153355629|NCT02248753|Amiodarone|amiodarone|mesh-list
153355630|NCT02248753|Verapamil|verapamil|mesh-list
153355631|NCT02248753|Flecainide|flecainide|mesh-list
153355632|NCT02248753|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153355633|NCT02248753|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153355634|NCT02248753|Sympatholytics|sympatholytics|mesh-ancestor
153355635|NCT02248753|Autonomic Agents|autonomic agents|mesh-ancestor
153355636|NCT02248753|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153355637|NCT02248753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153355638|NCT02248753|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
153355639|NCT02248753|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
153355640|NCT02248753|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
153355641|NCT02248753|Adrenergic Agents|adrenergic agents|mesh-ancestor
153387712|NCT00000243|Buprenorphine|buprenorphine|mesh-list
153884466|NCT01609673|Everolimus|everolimus|mesh-list
153884467|NCT01609673|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
153884468|NCT01609673|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153355649|NCT02248753|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153355650|NCT02248753|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153355651|NCT02248753|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
153355652|NCT02248753|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153355653|NCT02248753|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
153355654|NCT02248753|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
153355655|NCT02248753|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
153355656|NCT02248753|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153355657|NCT02248753|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153355658|NCT02248753|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
153880815|NCT06030479|Racepinephrine|racepinephrine|mesh-list
153355670|NCT00687674|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153355671|NCT00687674|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153355683|NCT00687908|Dermatologic Agents|dermatologic agents|mesh-ancestor
153355684|NCT00687908|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153425444|NCT00832520|Serotonin Agents|serotonin agents|mesh-ancestor
153425446|NCT03545893|Ibuprofen|ibuprofen|mesh-list
153355689|NCT00687908|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153355691|NCT00687908|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153355692|NCT00689078|Loteprednol Etabonate|loteprednol etabonate|mesh-list
153355693|NCT00689078|Prednisolone|prednisolone|mesh-list
153355694|NCT00689078|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
153355695|NCT00689078|Methylprednisolone|methylprednisolone|mesh-list
153355696|NCT00689078|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
153355697|NCT00689078|Prednisolone acetate|prednisolone acetate|mesh-list
153355698|NCT00689078|Lubricant Eye Drops|lubricant eye drops|mesh-list
153355699|NCT00689078|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
153355700|NCT00689078|Prednisolone phosphate|prednisolone phosphate|mesh-list
153355701|NCT00689078|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153355702|NCT00689078|Glucocorticoids|glucocorticoids|mesh-ancestor
153355703|NCT00689078|Hormones|hormones|mesh-ancestor
153355704|NCT00689078|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153355705|NCT00689078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153355706|NCT00689078|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153355707|NCT00689078|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153355708|NCT00689078|Antiemetics|antiemetics|mesh-ancestor
153425469|NCT00376987|Protective Agents|protective agents|mesh-ancestor
153884513|NCT00593580|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153355709|NCT00689078|Autonomic Agents|autonomic agents|mesh-ancestor
153355710|NCT00689078|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153355711|NCT00689078|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153355712|NCT00689078|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
153355713|NCT00689078|Protective Agents|protective agents|mesh-ancestor
153355714|NCT00689078|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
153355715|NCT00689078|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
153355716|NCT00689078|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
153355718|NCT05568979|Immunologic Factors|immunologic factors|mesh-ancestor
153355719|NCT05568979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153355720|NCT03005353|Clotrimazole|clotrimazole|mesh-list
153355721|NCT03005353|Miconazole|miconazole|mesh-list
153355722|NCT03005353|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
153355723|NCT03005353|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153355724|NCT03005353|Antifungal Agents|antifungal agents|mesh-ancestor
153355725|NCT03005353|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
153355726|NCT03005353|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153355727|NCT03005353|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153355728|NCT03005353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153355729|NCT03005353|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153355730|NCT03005353|Hormone Antagonists|hormone antagonists|mesh-ancestor
153355731|NCT03005353|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153355732|NCT03005353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153355733|NCT03005353|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
153355734|NCT03005353|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
153355736|NCT00588536|Methotrexate|methotrexate|mesh-list
153355737|NCT00588536|Thioguanine|thioguanine|mesh-list
153355738|NCT00588536|Calcium|calcium|mesh-list
153355739|NCT00588536|Levoleucovorin|levoleucovorin|mesh-list
153355744|NCT00588536|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153355745|NCT00588536|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153355746|NCT00588536|Antimetabolites|antimetabolites|mesh-ancestor
153355747|NCT00588536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153355748|NCT00588536|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153355749|NCT00588536|Dermatologic Agents|dermatologic agents|mesh-ancestor
153355750|NCT00588536|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153355751|NCT00588536|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153355752|NCT00588536|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153355753|NCT00588536|Immunologic Factors|immunologic factors|mesh-ancestor
153355754|NCT00588536|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153355755|NCT00588536|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153355756|NCT00588536|Antidotes|antidotes|mesh-ancestor
153355757|NCT00588536|Protective Agents|protective agents|mesh-ancestor
153355758|NCT00588536|Vitamin B Complex|vitamin b complex|mesh-ancestor
153355759|NCT00588536|Vitamins|vitamins|mesh-ancestor
153355760|NCT00588536|Micronutrients|micronutrients|mesh-ancestor
153355761|NCT03977233|Leucovorin|leucovorin|mesh-list
153355762|NCT03977233|Oxaliplatin|oxaliplatin|mesh-list
153355764|NCT03977233|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153355765|NCT03977233|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
153355766|NCT03977233|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153355767|NCT03977233|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153355768|NCT03977233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153355769|NCT03977233|Antidotes|antidotes|mesh-ancestor
153355770|NCT03977233|Protective Agents|protective agents|mesh-ancestor
153355771|NCT03977233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153355772|NCT03977233|Vitamin B Complex|vitamin b complex|mesh-ancestor
153355773|NCT03977233|Vitamins|vitamins|mesh-ancestor
153355775|NCT00590018|Hydrocortisone|hydrocortisone|mesh-list
153355776|NCT00590018|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153355778|NCT02219503|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
153355779|NCT02219503|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
153355780|NCT02219503|Protease Inhibitors|protease inhibitors|mesh-ancestor
153355788|NCT02219503|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153355790|NCT00592124|Antiviral Agents|antiviral agents|mesh-ancestor
153355791|NCT00592124|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153355792|NCT00592124|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153355793|NCT00592124|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153355794|NCT00592124|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153355795|NCT00592124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153355796|NCT00592124|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153355797|NCT00592124|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153355798|NCT02221219|Indomethacin|indomethacin|mesh-list
153355799|NCT02221219|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153355800|NCT02221219|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153355802|NCT02221219|Sensory System Agents|sensory system agents|mesh-ancestor
153355803|NCT02221219|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153355804|NCT02221219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153355805|NCT02221219|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153355806|NCT02221219|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153355807|NCT02221219|Gout Suppressants|gout suppressants|mesh-ancestor
153355808|NCT02221219|Tocolytic Agents|tocolytic agents|mesh-ancestor
153355809|NCT02221219|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153355810|NCT02221219|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153355811|NCT02221219|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153355812|NCT02221219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153355813|NCT00593450|Bevacizumab|bevacizumab|mesh-list
153355814|NCT00593450|Ranibizumab|ranibizumab|mesh-list
153355815|NCT00593450|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153425553|NCT00790478|Protective Agents|protective agents|mesh-ancestor
153355827|NCT00631748|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153355828|NCT00631748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153355829|NCT00594230|Panobinostat|panobinostat|mesh-list
153355830|NCT00594230|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153355831|NCT00594230|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
153355832|NCT00594230|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153355833|NCT00594230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153355835|NCT00594308|Mycophenolic Acid|mycophenolic acid|mesh-list
153882562|NCT01689051|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
153355836|NCT00594308|Cyclophosphamide|cyclophosphamide|mesh-list
153355837|NCT00594308|Fludarabine|fludarabine|mesh-list
153355838|NCT00594308|Cyclosporins|cyclosporins|mesh-list
153355839|NCT00594308|Basiliximab|basiliximab|mesh-list
153882563|NCT01689051|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153882564|NCT01689051|Hormones|hormones|mesh-ancestor
153882567|NCT01689051|Incretins|incretins|mesh-ancestor
153355840|NCT00594308|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153355841|NCT00594308|Immunologic Factors|immunologic factors|mesh-ancestor
153355842|NCT00594308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153355869|NCT02137538|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153355871|NCT00595556|Anticonvulsants|anticonvulsants|mesh-ancestor
153355872|NCT00595556|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153355873|NCT00595556|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153355874|NCT00595556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153355875|NCT00595556|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153355876|NCT00595556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153355878|NCT00595790|Immunologic Factors|immunologic factors|mesh-ancestor
153355879|NCT00595790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153355880|NCT00595946|Lubiprostone|lubiprostone|mesh-list
153355881|NCT00595946|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
153355882|NCT00595946|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153884624|NCT00593463|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153355895|NCT00597428|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153355896|NCT00597428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153355897|NCT00597818|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
153355898|NCT00597818|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-list
153355899|NCT00597818|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153355901|NCT00597818|Sensory System Agents|sensory system agents|mesh-ancestor
153884650|NCT00592410|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153884651|NCT00592410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153884652|NCT04328064|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
153884653|NCT04328064|Calcium|calcium|mesh-list
153884663|NCT01605734|Sorafenib|sorafenib|mesh-list
153355923|NCT03843541|Acetylcysteine|acetylcysteine|mesh-list
153425616|NCT00732680|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153425617|NCT00732680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153355924|NCT03843541|Ambroxol|ambroxol|mesh-list
153355925|NCT03843541|N-monoacetylcystine|n-monoacetylcystine|mesh-list
153355926|NCT03843541|Antiviral Agents|antiviral agents|mesh-ancestor
153355927|NCT03843541|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153355928|NCT03843541|Expectorants|expectorants|mesh-ancestor
153355929|NCT03843541|Respiratory System Agents|respiratory system agents|mesh-ancestor
153355930|NCT03843541|Free Radical Scavengers|free radical scavengers|mesh-ancestor
153355931|NCT03843541|Antioxidants|antioxidants|mesh-ancestor
153355932|NCT03843541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153355933|NCT03843541|Protective Agents|protective agents|mesh-ancestor
153355934|NCT03843541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153355935|NCT03843541|Antidotes|antidotes|mesh-ancestor
153355936|NCT00639158|Choline|choline|mesh-list
153355937|NCT00639158|Atorvastatin|atorvastatin|mesh-list
153884708|NCT02270606|Fluorouracil|fluorouracil|mesh-list
153884709|NCT02270606|Oxaliplatin|oxaliplatin|mesh-list
153884710|NCT02270606|Calcium|calcium|mesh-list
153884711|NCT02270606|Levoleucovorin|levoleucovorin|mesh-list
153355982|NCT00601718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153355983|NCT00601718|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153355984|NCT00601718|Alkylating Agents|alkylating agents|mesh-ancestor
153355985|NCT00601718|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
153355986|NCT00601796|Cyclophosphamide|cyclophosphamide|mesh-list
153355987|NCT00601796|Tretinoin|tretinoin|mesh-list
153355988|NCT00601796|Vaccines|vaccines|mesh-list
153355989|NCT00601796|Immunologic Factors|immunologic factors|mesh-ancestor
153355990|NCT00601796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153355991|NCT00601796|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153355992|NCT00601796|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153355993|NCT00601796|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153355994|NCT00601796|Alkylating Agents|alkylating agents|mesh-ancestor
153355995|NCT00601796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153355996|NCT00601796|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153355997|NCT00601796|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153355998|NCT00601796|Keratolytic Agents|keratolytic agents|mesh-ancestor
153356000|NCT00693992|Sunitinib|sunitinib|mesh-list
153356001|NCT00693992|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153356002|NCT00693992|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153356003|NCT00693992|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153356004|NCT00693992|Growth Substances|growth substances|mesh-ancestor
153356005|NCT00693992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153884800|NCT00595140|Sympathomimetics|sympathomimetics|mesh-ancestor
153884801|NCT00595140|Autonomic Agents|autonomic agents|mesh-ancestor
153356006|NCT00693992|Growth Inhibitors|growth inhibitors|mesh-ancestor
153356007|NCT00693992|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153356008|NCT00693992|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153356009|NCT00693992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153356010|NCT00645710|Gemcitabine|gemcitabine|mesh-list
153356011|NCT00645710|Floxuridine|floxuridine|mesh-list
153356012|NCT00645710|Antibodies|antibodies|mesh-list
153356013|NCT00645710|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
153356014|NCT00645710|Immunologic Factors|immunologic factors|mesh-ancestor
153356015|NCT00645710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153356016|NCT00645710|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153356017|NCT00645710|Antimetabolites|antimetabolites|mesh-ancestor
153425783|NCT01705106|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153884841|NCT00595374|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153884842|NCT00595374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153884844|NCT00595569|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153425787|NCT01705106|Sensory System Agents|sensory system agents|mesh-ancestor
153356018|NCT00645710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153356019|NCT00645710|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153356020|NCT00603044|Fluticasone|fluticasone|mesh-list
153356022|NCT00603044|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153356023|NCT00603044|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153356024|NCT00603044|Autonomic Agents|autonomic agents|mesh-ancestor
153425788|NCT01705106|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153425789|NCT01705106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153425800|NCT00624650|Epinephrine|epinephrine|mesh-list
153356025|NCT00603044|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153356026|NCT00603044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153356027|NCT00603044|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153356028|NCT00603044|Respiratory System Agents|respiratory system agents|mesh-ancestor
153356029|NCT00603044|Dermatologic Agents|dermatologic agents|mesh-ancestor
153356030|NCT00603044|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
153356033|NCT00646646|Propofol|propofol|mesh-list
153356034|NCT00646646|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153356039|NCT00646646|Sensory System Agents|sensory system agents|mesh-ancestor
153356040|NCT00646646|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153356041|NCT00646646|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
153356042|NCT00646646|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153356043|NCT00646646|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153356044|NCT00646646|Adrenergic Agents|adrenergic agents|mesh-ancestor
153356045|NCT00646646|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153356046|NCT00646646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153356047|NCT00646646|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153356048|NCT00646646|Anesthetics, General|anesthetics, general|mesh-ancestor
153356049|NCT00646646|Anesthetics|anesthetics|mesh-ancestor
153356050|NCT00646646|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153356051|NCT00646646|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153356052|NCT00646646|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153356053|NCT00646646|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153356054|NCT00646646|GABA Modulators|gaba modulators|mesh-ancestor
153356055|NCT00646646|GABA Agents|gaba agents|mesh-ancestor
153356056|NCT02998424|Propofol|propofol|mesh-list
153356057|NCT02998424|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153783446|NCT00236249|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153356058|NCT02998424|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153356059|NCT02998424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153356060|NCT02998424|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153356061|NCT02998424|Anesthetics, General|anesthetics, general|mesh-ancestor
153356062|NCT02998424|Anesthetics|anesthetics|mesh-ancestor
153356063|NCT00696488|Fluorouracil|fluorouracil|mesh-list
153356064|NCT00696488|Antimetabolites|antimetabolites|mesh-ancestor
153421680|NCT05603104|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
153421681|NCT05603104|Anticonvulsants|anticonvulsants|mesh-ancestor
153421682|NCT05603104|GABA Agents|gaba agents|mesh-ancestor
153425840|NCT00377065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153884868|NCT01172938|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153884869|NCT01172938|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153356080|NCT00650078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153356081|NCT00650078|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153356082|NCT00650078|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153356083|NCT01799486|Adefovir|adefovir|mesh-list
153356084|NCT01799486|Telbivudine|telbivudine|mesh-list
153356085|NCT01799486|Antiviral Agents|antiviral agents|mesh-ancestor
153356086|NCT01799486|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153356087|NCT01799486|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153425859|NCT03642457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153425862|NCT00379418|Abciximab|abciximab|mesh-list
153356098|NCT00650546|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153356099|NCT00650858|Plasminogen|plasminogen|mesh-list
153356100|NCT00650858|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
153356101|NCT00650858|Fibrinolytic Agents|fibrinolytic agents|mesh-list
153356102|NCT00650858|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153884935|NCT01109524|Antimitotic Agents|antimitotic agents|mesh-ancestor
153884936|NCT01109524|Mitosis Modulators|mitosis modulators|mesh-ancestor
153884937|NCT01109524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153884938|NCT01109173|Nepafenac|nepafenac|mesh-list
153884941|NCT01109173|Analgesics|analgesics|mesh-ancestor
153356103|NCT00650858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153356104|NCT00651482|Bevacizumab|bevacizumab|mesh-list
153356105|NCT00651482|Everolimus|everolimus|mesh-list
153356106|NCT00651482|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153356107|NCT00651482|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153356108|NCT00651482|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153356109|NCT00651482|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153356110|NCT00651482|Growth Substances|growth substances|mesh-ancestor
153356111|NCT00651482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153356112|NCT00651482|Growth Inhibitors|growth inhibitors|mesh-ancestor
153356113|NCT00651482|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
153356114|NCT00651482|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153356115|NCT00651482|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153356116|NCT00651482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153356117|NCT00651482|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153356118|NCT00651482|Immunologic Factors|immunologic factors|mesh-ancestor
153356119|NCT00654836|Bevacizumab|bevacizumab|mesh-list
153356120|NCT00654836|Carboplatin|carboplatin|mesh-list
153356121|NCT00654836|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
153356147|NCT02997800|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153356148|NCT02997800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153356150|NCT02997800|Sympathomimetics|sympathomimetics|mesh-ancestor
153356151|NCT02997800|Autonomic Agents|autonomic agents|mesh-ancestor
153356152|NCT02997800|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
153356153|NCT02997800|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
153356154|NCT00701636|Daptomycin|daptomycin|mesh-list
153356155|NCT00701636|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153356156|NCT00701636|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153356157|NCT00701714|Epoetin Alfa|epoetin alfa|mesh-list
153356158|NCT00701714|Hematinics|hematinics|mesh-ancestor
153356159|NCT00655538|Dalcetrapib|dalcetrapib|mesh-list
153356160|NCT00655538|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153356161|NCT00655538|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153356162|NCT00655538|Antimetabolites|antimetabolites|mesh-ancestor
153356163|NCT00655538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153884952|NCT02271971|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153884953|NCT02271971|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153356164|NCT00655538|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153356165|NCT00656630|Naltrexone|naltrexone|mesh-list
153356166|NCT00656630|Acamprosate|acamprosate|mesh-list
153356167|NCT00656630|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
153356168|NCT00656630|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
153356169|NCT00656630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153356170|NCT00656630|Sensory System Agents|sensory system agents|mesh-ancestor
153356171|NCT00656630|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153356172|NCT01362998|Fentanyl|fentanyl|mesh-list
153356173|NCT01362998|Morphine|morphine|mesh-list
153356174|NCT01362998|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153356175|NCT01362998|Narcotics|narcotics|mesh-ancestor
153356176|NCT01362998|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153356177|NCT01362998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153356178|NCT01362998|Analgesics|analgesics|mesh-ancestor
153356179|NCT01362998|Sensory System Agents|sensory system agents|mesh-ancestor
153356184|NCT01362998|Anesthetics|anesthetics|mesh-ancestor
153356194|NCT02997332|Tubulin Modulators|tubulin modulators|mesh-ancestor
153356195|NCT02997332|Antimitotic Agents|antimitotic agents|mesh-ancestor
153356196|NCT02997332|Mitosis Modulators|mitosis modulators|mesh-ancestor
153356197|NCT02997332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153356198|NCT02997332|Antimetabolites|antimetabolites|mesh-ancestor
153356199|NCT02997332|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153356200|NCT02997332|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153356201|NCT02997332|Immunologic Factors|immunologic factors|mesh-ancestor
153425941|NCT00589550|Interferons|interferons|mesh-list
153884993|NCT02273102|Tretinoin|tretinoin|mesh-list
153356202|NCT02997332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153356203|NCT02997332|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153356205|NCT04345094|Antioxidants|antioxidants|mesh-ancestor
153356206|NCT04345094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153356207|NCT04345094|Protective Agents|protective agents|mesh-ancestor
153356208|NCT04345094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153356209|NCT04345094|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
153356210|NCT00702884|Sunitinib|sunitinib|mesh-list
153356211|NCT00702884|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153356212|NCT00702884|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153356213|NCT00702884|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153356214|NCT00702884|Growth Substances|growth substances|mesh-ancestor
153356215|NCT00702884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153356216|NCT00702884|Growth Inhibitors|growth inhibitors|mesh-ancestor
153356217|NCT00702884|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153356218|NCT00702884|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153356219|NCT00702884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153356220|NCT00703508|Metformin|metformin|mesh-list
153356221|NCT00703508|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153356222|NCT00703508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153356223|NCT01284335|Gemcitabine|gemcitabine|mesh-list
153356224|NCT01284335|Docetaxel|docetaxel|mesh-list
153356226|NCT01284335|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
153356227|NCT01284335|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153356228|NCT01284335|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153356229|NCT01284335|Antimetabolites|antimetabolites|mesh-ancestor
153356233|NCT01284335|Mitosis Modulators|mitosis modulators|mesh-ancestor
153356234|NCT01284335|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153356235|NCT01284335|Alkylating Agents|alkylating agents|mesh-ancestor
153356236|NCT01284335|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153356237|NCT01284335|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153356238|NCT01284335|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153356239|NCT01194479|Formoterol Fumarate|formoterol fumarate|mesh-list
153356240|NCT01194479|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153356241|NCT01194479|Autonomic Agents|autonomic agents|mesh-ancestor
153356242|NCT01194479|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153426055|NCT01550510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153426056|NCT01550510|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153885088|NCT01108510|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
153885089|NCT01108510|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
153885090|NCT01108510|Protease Inhibitors|protease inhibitors|mesh-ancestor
153356243|NCT01194479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153356244|NCT01194479|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153356245|NCT01194479|Respiratory System Agents|respiratory system agents|mesh-ancestor
153356246|NCT01194479|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
153356247|NCT01194479|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
153356248|NCT01194479|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153356249|NCT01194479|Adrenergic Agents|adrenergic agents|mesh-ancestor
153356261|NCT01230593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153885118|NCT01340027|Solifenacin Succinate|solifenacin succinate|mesh-list
153885119|NCT01340027|Mirabegron|mirabegron|mesh-list
153885120|NCT01340027|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
153356262|NCT01230593|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153356263|NCT01230593|Glucocorticoids|glucocorticoids|mesh-ancestor
153356265|NCT01230593|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153356266|NCT01230593|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153356267|NCT01230593|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153356268|NCT01230593|Protease Inhibitors|protease inhibitors|mesh-ancestor
153356269|NCT01230593|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153356270|NCT01230593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153356271|NCT01230593|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153356272|NCT01230593|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153356273|NCT01230593|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
153356274|NCT01230593|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
153356275|NCT01195025|Chrysarobin|chrysarobin|mesh-list
153356276|NCT01195025|Hydroxyethyl Starch Derivatives|hydroxyethyl starch derivatives|mesh-list
153885177|NCT00107315|Bevacizumab|bevacizumab|mesh-list
153885178|NCT00107315|Capecitabine|capecitabine|mesh-list
153885179|NCT00107315|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153885183|NCT00107315|Growth Substances|growth substances|mesh-ancestor
153356284|NCT01195025|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153356285|NCT01195025|Plasma Substitutes|plasma substitutes|mesh-ancestor
153356286|NCT01195025|Blood Substitutes|blood substitutes|mesh-ancestor
153356288|NCT00703664|Vorinostat|vorinostat|mesh-list
153426176|NCT00000764|Interferon alpha-2|interferon alpha-2|mesh-list
153426177|NCT00000764|Isotretinoin|isotretinoin|mesh-list
153426178|NCT00000764|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153426179|NCT00000764|Antiviral Agents|antiviral agents|mesh-ancestor
153426180|NCT00000764|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153426181|NCT00000764|Immunologic Factors|immunologic factors|mesh-ancestor
153356289|NCT00703664|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153356290|NCT00703664|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
153356291|NCT00703664|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153356292|NCT00703664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153356293|NCT00658736|Triamcinolone|triamcinolone|mesh-list
153356294|NCT00658736|Bupivacaine|bupivacaine|mesh-list
153356295|NCT00658736|Anesthetics, Local|anesthetics, local|mesh-ancestor
153356296|NCT00658736|Anesthetics|anesthetics|mesh-ancestor
153356297|NCT00658736|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153356298|NCT00658736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153356299|NCT00658736|Sensory System Agents|sensory system agents|mesh-ancestor
153356300|NCT00658736|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153356301|NCT00658736|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153356303|NCT00658736|Hormones|hormones|mesh-ancestor
153426200|NCT00484718|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153426201|NCT00484718|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153426202|NCT00484718|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
153426203|NCT00484718|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153356305|NCT00659360|Saracatinib|saracatinib|mesh-list
153356306|NCT00659360|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153356307|NCT00659360|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153356309|NCT01197833|Polidocanol|polidocanol|mesh-list
153356334|NCT02990078|Urological Agents|urological agents|mesh-ancestor
153356335|NCT01288859|Curcumin|curcumin|mesh-list
153356336|NCT01288859|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153356337|NCT01288859|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153356338|NCT01288859|Analgesics|analgesics|mesh-ancestor
153356339|NCT01288859|Sensory System Agents|sensory system agents|mesh-ancestor
153356340|NCT01288859|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153356341|NCT01288859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153356342|NCT01288859|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153356343|NCT01288859|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153356344|NCT01288859|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153356345|NCT01288859|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153356346|NCT01288859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153356347|NCT01235195|Sertraline|sertraline|mesh-list
153356348|NCT01235195|Antidepressive Agents|antidepressive agents|mesh-ancestor
153356349|NCT01235195|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153356350|NCT01235195|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
153356351|NCT01235195|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153356352|NCT01235195|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153356353|NCT01235195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153783449|NCT00236249|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153783450|NCT00236249|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153356354|NCT01235195|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153356355|NCT01235195|Serotonin Agents|serotonin agents|mesh-ancestor
153356356|NCT01235195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153356358|NCT02996942|Coagulants|coagulants|mesh-ancestor
153356359|NCT01199237|Glycopyrrolate|glycopyrrolate|mesh-list
153356360|NCT01199237|Sevoflurane|sevoflurane|mesh-list
153356361|NCT01199237|Desflurane|desflurane|mesh-list
153356362|NCT01199237|Rocuronium|rocuronium|mesh-list
153356363|NCT01199237|Neostigmine|neostigmine|mesh-list
153356364|NCT01199237|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153356365|NCT01199237|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
153356366|NCT01199237|Anesthetics, General|anesthetics, general|mesh-ancestor
153356367|NCT01199237|Anesthetics|anesthetics|mesh-ancestor
153356368|NCT01199237|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153356369|NCT01199237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153356370|NCT01199237|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
153356371|NCT01199237|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
153426234|NCT00380120|Anticoagulants|anticoagulants|mesh-ancestor
153356372|NCT01199237|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
153356373|NCT01199237|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153356374|NCT01199237|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
153356375|NCT01199237|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153356376|NCT01199237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153356377|NCT01199237|Cholinergic Agents|cholinergic agents|mesh-ancestor
153356378|NCT01199237|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153356379|NCT01199237|Parasympathomimetics|parasympathomimetics|mesh-ancestor
153356380|NCT01199237|Autonomic Agents|autonomic agents|mesh-ancestor
153356381|NCT01199237|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153356382|NCT01199237|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
153356383|NCT01199237|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
153356386|NCT01235897|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153356387|NCT01235897|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153356388|NCT01235897|Tubulin Modulators|tubulin modulators|mesh-ancestor
153356389|NCT01235897|Antimitotic Agents|antimitotic agents|mesh-ancestor
153356390|NCT01235897|Mitosis Modulators|mitosis modulators|mesh-ancestor
153356391|NCT01235897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153356392|NCT01235897|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153356393|NCT01236053|Gabapentin|gabapentin|mesh-list
153356394|NCT01236053|Analgesics|analgesics|mesh-ancestor
153356395|NCT01236053|Sensory System Agents|sensory system agents|mesh-ancestor
153356396|NCT01236053|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153356397|NCT01236053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153356398|NCT01236053|Anticonvulsants|anticonvulsants|mesh-ancestor
153356399|NCT01236053|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153356400|NCT01236053|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153356401|NCT01236053|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153356402|NCT01236053|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153356404|NCT01236053|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
153356405|NCT01236053|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153426247|NCT00000770|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
153426259|NCT00368654|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153426260|NCT00368654|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153356406|NCT01236053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153356408|NCT00703976|Bevacizumab|bevacizumab|mesh-list
153356409|NCT00703976|Cetuximab|cetuximab|mesh-list
153356410|NCT00703976|Pemetrexed|pemetrexed|mesh-list
153356411|NCT00703976|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153356412|NCT00703976|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153356413|NCT00703976|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153426261|NCT00368654|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153356414|NCT00703976|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153356415|NCT00703976|Growth Substances|growth substances|mesh-ancestor
153356468|NCT00664430|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153356469|NCT01292135|Ibrutinib|ibrutinib|mesh-list
153356470|NCT01292135|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153356471|NCT01292135|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153356472|NCT01292135|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153356473|NCT01292135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153356474|NCT01292447|Lidocaine|lidocaine|mesh-list
153356475|NCT01292447|Anesthetics, Local|anesthetics, local|mesh-ancestor
153356476|NCT01292447|Anesthetics|anesthetics|mesh-ancestor
153356477|NCT01292447|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153356478|NCT01292447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153356479|NCT01292447|Sensory System Agents|sensory system agents|mesh-ancestor
153356480|NCT01292447|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153356481|NCT01292447|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153356482|NCT01292447|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
153356483|NCT01292447|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153356484|NCT01292447|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153426279|NCT00000776|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153426280|NCT00000776|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153426281|NCT00000776|Antifungal Agents|antifungal agents|mesh-ancestor
153426282|NCT00000776|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153885320|NCT00599235|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
153885321|NCT00599235|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153885322|NCT00599235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153885323|NCT00599235|Urological Agents|urological agents|mesh-ancestor
153885324|NCT00599235|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153885326|NCT00599274|Interferon-beta|interferon-beta|mesh-list
153885327|NCT00599274|Interferon beta-1a|interferon beta-1a|mesh-list
153356485|NCT01292447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153356486|NCT00704912|Orlistat|orlistat|mesh-list
153356487|NCT00704912|Contraceptive Agents|contraceptive agents|mesh-list
153356488|NCT00704912|Norethindrone acetate, ethinyl estradiol, ferrous fumarate drug combination|norethindrone acetate, ethinyl estradiol, ferrous fumarate drug combination|mesh-list
153356489|NCT00704912|Contraceptives, Oral|contraceptives, oral|mesh-list
153356490|NCT00704912|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153356510|NCT02189213|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
153356511|NCT02189213|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153356512|NCT02189213|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153356513|NCT02189213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153356514|NCT02189213|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153356515|NCT02189213|Serotonin Agents|serotonin agents|mesh-ancestor
153356516|NCT02189213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153356517|NCT01241903|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
153356519|NCT01241903|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153356520|NCT01241903|Antimetabolites|antimetabolites|mesh-ancestor
153356521|NCT01241903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153885328|NCT00599274|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153356522|NCT01241903|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153356523|NCT01241903|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
153356524|NCT01241903|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153356525|NCT00666848|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
153356527|NCT00666848|Enalaprilat|enalaprilat|mesh-list
153356528|NCT00666848|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153356529|NCT00666848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153356530|NCT00666848|Incretins|incretins|mesh-ancestor
153356531|NCT00666848|Hormones|hormones|mesh-ancestor
153356532|NCT00666848|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153356533|NCT00666848|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
153356534|NCT00666848|Protease Inhibitors|protease inhibitors|mesh-ancestor
153356535|NCT00666848|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153356536|NCT00666848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153356537|NCT00666848|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
153356538|NCT00666848|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153356554|NCT01511042|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153356555|NCT01511042|Adrenergic Agents|adrenergic agents|mesh-ancestor
153356556|NCT01511042|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153356557|NCT01511042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153356558|NCT01511042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153356559|NCT01511042|Sympathomimetics|sympathomimetics|mesh-ancestor
153356560|NCT01511042|Autonomic Agents|autonomic agents|mesh-ancestor
153356561|NCT01511042|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153356562|NCT01511042|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
153356563|NCT01511042|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
153356564|NCT01511042|Protease Inhibitors|protease inhibitors|mesh-ancestor
153356565|NCT01511042|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153356566|NCT00667004|Ecabet|ecabet|mesh-list
153356567|NCT00667004|Ophthalmic Solutions|ophthalmic solutions|mesh-list
153356568|NCT00667004|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
153356569|NCT00667004|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153356570|NCT00667004|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
153356571|NCT00667004|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153426304|NCT00329732|Anesthetics|anesthetics|mesh-ancestor
153426305|NCT00329732|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153356581|NCT01204853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153426380|NCT00218036|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
153426387|NCT00233090|Modafinil|modafinil|mesh-list
153356592|NCT04386122|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153356593|NCT04386122|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153356594|NCT03009461|Sorafenib|sorafenib|mesh-list
153356595|NCT03009461|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153356596|NCT03009461|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153356597|NCT03009461|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153356598|NCT03009461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153356599|NCT02990702|Bupivacaine|bupivacaine|mesh-list
153356600|NCT02990702|Anesthetics, Local|anesthetics, local|mesh-ancestor
153356601|NCT02990702|Anesthetics|anesthetics|mesh-ancestor
153356602|NCT02990702|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153356603|NCT02990702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153426425|NCT00177866|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153356615|NCT02995304|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153356616|NCT02995304|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153356617|NCT02995304|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153356618|NCT02995304|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153356619|NCT02995304|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153356620|NCT02995304|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153356621|NCT02995304|Anesthetics, General|anesthetics, general|mesh-ancestor
153356622|NCT02995304|Anesthetics|anesthetics|mesh-ancestor
153356623|NCT02995304|GABA Modulators|gaba modulators|mesh-ancestor
153356624|NCT02995304|GABA Agents|gaba agents|mesh-ancestor
153356625|NCT02995304|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153356626|NCT02995304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153356628|NCT02990858|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
153356629|NCT02990858|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
153356630|NCT02990858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153356631|NCT02990858|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153356632|NCT02990858|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153356633|NCT02990858|Antiviral Agents|antiviral agents|mesh-ancestor
153356634|NCT02990858|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153356635|NCT00725504|Lidocaine|lidocaine|mesh-list
153426584|NCT00000878|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153426585|NCT00000878|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153356636|NCT00725504|Anesthetics, Local|anesthetics, local|mesh-ancestor
153356637|NCT00725504|Anesthetics|anesthetics|mesh-ancestor
153356638|NCT00725504|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153426586|NCT00000878|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153426588|NCT00000878|Antiviral Agents|antiviral agents|mesh-ancestor
153356640|NCT00725504|Sensory System Agents|sensory system agents|mesh-ancestor
153356641|NCT00725504|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153356642|NCT00725504|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153356643|NCT00725504|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
153356644|NCT00725504|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153356645|NCT00725504|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153356646|NCT00725504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153356648|NCT03830684|Antioxidants|antioxidants|mesh-ancestor
153356649|NCT03830684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153356650|NCT03830684|Protective Agents|protective agents|mesh-ancestor
153783452|NCT00269061|Pioglitazone|pioglitazone|mesh-list
153356651|NCT03830684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153356652|NCT03830684|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153356653|NCT03830684|Prostaglandin Antagonists|prostaglandin antagonists|mesh-ancestor
153356654|NCT03830684|Hormone Antagonists|hormone antagonists|mesh-ancestor
153387715|NCT00000243|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153356655|NCT03830684|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153356657|NCT00727064|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
153356658|NCT00727064|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
153356659|NCT00727064|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153356660|NCT00727064|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153356661|NCT00727064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153356662|NCT00727064|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153356663|NCT00727064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153885655|NCT00598572|Chelating Agents|chelating agents|mesh-ancestor
153885656|NCT00598572|Sequestering Agents|sequestering agents|mesh-ancestor
153426639|NCT00000896|Growth Substances|growth substances|mesh-ancestor
153426640|NCT00000896|Growth Inhibitors|growth inhibitors|mesh-ancestor
153356664|NCT00727064|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
153356665|NCT00727064|Antidepressive Agents|antidepressive agents|mesh-ancestor
153356667|NCT01294163|Propofol|propofol|mesh-list
153356668|NCT01294163|Sevoflurane|sevoflurane|mesh-list
153356669|NCT01294163|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153356670|NCT01294163|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153356671|NCT01294163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153423457|NCT03322657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153423458|NCT03322657|Parasympathomimetics|parasympathomimetics|mesh-ancestor
153423459|NCT03322657|Autonomic Agents|autonomic agents|mesh-ancestor
153423460|NCT03322657|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153356711|NCT01294319|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
153356712|NCT01294319|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
153356713|NCT00727298|Infliximab|infliximab|mesh-list
153356714|NCT00727298|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
153356715|NCT00727298|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153356716|NCT00727298|Dermatologic Agents|dermatologic agents|mesh-ancestor
153356717|NCT00727298|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153356718|NCT00727298|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153356719|NCT02990312|Sirolimus|sirolimus|mesh-list
153356720|NCT02990312|Maraviroc|maraviroc|mesh-list
153356721|NCT02990312|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153356722|NCT02990312|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153356723|NCT02990312|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153783453|NCT00269061|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153783454|NCT00269061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153356724|NCT02990312|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153356725|NCT02990312|Antifungal Agents|antifungal agents|mesh-ancestor
153356726|NCT02990312|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153356727|NCT02990312|Immunologic Factors|immunologic factors|mesh-ancestor
153356728|NCT02990312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153356729|NCT02990312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153356730|NCT02990312|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
153356731|NCT02990312|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
153356732|NCT02990312|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153356733|NCT02990312|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153356734|NCT02990312|Antiviral Agents|antiviral agents|mesh-ancestor
153356735|NCT02990312|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
153356737|NCT01295879|Ergocalciferols|ergocalciferols|mesh-list
153356738|NCT01295879|Vitamins|vitamins|mesh-ancestor
153356739|NCT01295879|Micronutrients|micronutrients|mesh-ancestor
153356740|NCT01295879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153356754|NCT01296191|Besifloxacin|besifloxacin|mesh-list
153356755|NCT01296191|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153356756|NCT01296191|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153356757|NCT01296191|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153885668|NCT00599898|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153356772|NCT01210079|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153356773|NCT01210079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153356774|NCT01210079|Anticonvulsants|anticonvulsants|mesh-ancestor
153356775|NCT01210079|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153356776|NCT01210079|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153356777|NCT01210079|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153356778|NCT01210079|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153356779|NCT01210079|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
153356780|NCT01210079|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
153356781|NCT01210079|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153356782|NCT01210079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153356783|NCT01210079|Antimanic Agents|antimanic agents|mesh-ancestor
153356785|NCT01245647|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
153426691|NCT00000188|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
153426692|NCT00000188|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153356792|NCT00708110|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
153356793|NCT00708110|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153356794|NCT00708110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153356795|NCT00708110|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153356796|NCT00708110|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153356797|NCT00708110|Antiviral Agents|antiviral agents|mesh-ancestor
153783455|NCT04547452|Antibodies|antibodies|mesh-list
153356798|NCT00708110|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153356799|NCT01296815|Bevacizumab|bevacizumab|mesh-list
153356800|NCT01296815|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153356801|NCT01296815|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153356802|NCT01296815|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153421714|NCT05554406|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153421715|NCT05554406|Immunologic Factors|immunologic factors|mesh-ancestor
153421717|NCT05554406|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153356803|NCT01296815|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153356804|NCT01296815|Growth Substances|growth substances|mesh-ancestor
153356805|NCT01296815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153356806|NCT01296815|Growth Inhibitors|growth inhibitors|mesh-ancestor
153356807|NCT01276262|Contraceptive Agents|contraceptive agents|mesh-list
153356808|NCT01276262|Ethinyl estradiol, levonorgestrel drug combination|ethinyl estradiol, levonorgestrel drug combination|mesh-list
153356809|NCT01276262|Ethinyl Estradiol-Norgestrel Combination|ethinyl estradiol-norgestrel combination|mesh-list
153356810|NCT01276262|Contraceptives, Oral|contraceptives, oral|mesh-list
153356811|NCT01276262|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153356812|NCT01276262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153356813|NCT01276262|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
153356814|NCT01276262|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
153356815|NCT01276262|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
153356816|NCT01276262|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
153885699|NCT01326546|Entecavir|entecavir|mesh-list
153885700|NCT01326546|Antiviral Agents|antiviral agents|mesh-ancestor
153885701|NCT01326546|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153356817|NCT01276262|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
153356818|NCT01276262|Contraceptives, Postcoital, Hormonal|contraceptives, postcoital, hormonal|mesh-ancestor
153356819|NCT01276262|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
153356820|NCT01276262|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
153426723|NCT00000920|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
153426724|NCT00000920|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
153426725|NCT00000920|Protease Inhibitors|protease inhibitors|mesh-ancestor
153426726|NCT00000920|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153426727|NCT00000920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153426728|NCT00000920|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153426729|NCT00000920|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153426730|NCT00000920|Antiviral Agents|antiviral agents|mesh-ancestor
153426731|NCT00000920|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153426732|NCT00000920|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
153356822|NCT01276496|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
153356823|NCT01276496|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153356824|NCT01276496|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153356825|NCT01276496|Tubulin Modulators|tubulin modulators|mesh-ancestor
153356826|NCT01276496|Antimitotic Agents|antimitotic agents|mesh-ancestor
153356827|NCT01276496|Mitosis Modulators|mitosis modulators|mesh-ancestor
153356828|NCT01276496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153356830|NCT01297595|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153356831|NCT01297595|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153356832|NCT01297595|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153426733|NCT00000920|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153426734|NCT00000920|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153426735|NCT00000920|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153426736|NCT00000920|Antimetabolites|antimetabolites|mesh-ancestor
153426737|NCT00000938|Doxycycline|doxycycline|mesh-list
153426738|NCT00000938|Ceftriaxone|ceftriaxone|mesh-list
153426739|NCT00000938|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153426746|NCT00001862|Etanercept|etanercept|mesh-list
153356835|NCT02992418|Vaccines|vaccines|mesh-list
153356836|NCT02992418|Immunologic Factors|immunologic factors|mesh-ancestor
153356837|NCT02992418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153356838|NCT01276730|Interferons|interferons|mesh-list
153356839|NCT01276730|Tretinoin|tretinoin|mesh-list
153885741|NCT00601302|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153885742|NCT00601302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153356868|NCT02322242|BB 1101|bb 1101|mesh-list
153356869|NCT02322242|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153356870|NCT02322242|Antiemetics|antiemetics|mesh-ancestor
153356871|NCT02322242|Autonomic Agents|autonomic agents|mesh-ancestor
153356872|NCT02322242|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153356873|NCT02322242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153356876|NCT02322242|Hormones|hormones|mesh-ancestor
153882571|NCT01689090|omega-N-Methylarginine|omega-n-methylarginine|mesh-list
153882572|NCT01689090|Anticoagulants|anticoagulants|mesh-ancestor
153882573|NCT01689090|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
153882574|NCT01689090|Chelating Agents|chelating agents|mesh-ancestor
153882575|NCT01689090|Sequestering Agents|sequestering agents|mesh-ancestor
153356877|NCT02322242|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153356878|NCT02322242|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153356879|NCT02322242|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153356880|NCT02322242|Protease Inhibitors|protease inhibitors|mesh-ancestor
153356881|NCT02322242|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153356882|NCT02322242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153356883|NCT01211873|Gadolinium 1,4,7,10-tetraazacyclododecane-N,N',N'',N'''-tetraacetate|gadolinium 1,4,7,10-tetraazacyclododecane-n,n',n'',n'''-tetraacetate|mesh-list
153356884|NCT01211873|Chelating Agents|chelating agents|mesh-ancestor
153356885|NCT01211873|Sequestering Agents|sequestering agents|mesh-ancestor
153356886|NCT01211873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153356887|NCT02993588|Melatonin|melatonin|mesh-list
153356888|NCT02993588|Antioxidants|antioxidants|mesh-ancestor
153426867|NCT00000230|Sensory System Agents|sensory system agents|mesh-ancestor
153356894|NCT01270178|Antiviral Agents|antiviral agents|mesh-ancestor
153356895|NCT01270178|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153356897|NCT01270412|Hyaluronic Acid|hyaluronic acid|mesh-list
153356898|NCT01270412|Mitosis Modulators|mitosis modulators|mesh-ancestor
153356899|NCT01270412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153356900|NCT01270412|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153356901|NCT01270412|Immunologic Factors|immunologic factors|mesh-ancestor
153356902|NCT01270412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153356903|NCT01270412|Viscosupplements|viscosupplements|mesh-ancestor
153356904|NCT01270412|Protective Agents|protective agents|mesh-ancestor
153356905|NCT02992496|Midazolam|midazolam|mesh-list
153356906|NCT02992496|Ketamine|ketamine|mesh-list
153356907|NCT02992496|Analgesics|analgesics|mesh-ancestor
153356908|NCT02992496|Sensory System Agents|sensory system agents|mesh-ancestor
153356909|NCT02992496|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153356910|NCT02992496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153356911|NCT02992496|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
153356912|NCT02992496|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153356913|NCT02992496|Anesthetics, General|anesthetics, general|mesh-ancestor
153356914|NCT02992496|Anesthetics|anesthetics|mesh-ancestor
153356915|NCT02992496|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153356916|NCT02992496|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
153356917|NCT02992496|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
153356918|NCT02992496|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153356919|NCT02992496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153356920|NCT02992496|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153885901|NCT01099579|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
153885902|NCT01099579|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
153885903|NCT01099579|Protease Inhibitors|protease inhibitors|mesh-ancestor
153356931|NCT00729482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153356932|NCT00729482|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153356933|NCT00729482|Immunologic Factors|immunologic factors|mesh-ancestor
153356934|NCT00729482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153356935|NCT00729482|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153356936|NCT01270490|Interferons|interferons|mesh-list
153356937|NCT01270490|Interferon-gamma|interferon-gamma|mesh-list
153356938|NCT01270490|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153356939|NCT01270490|Antiviral Agents|antiviral agents|mesh-ancestor
153356940|NCT01270490|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153426939|NCT00000260|Analgesics|analgesics|mesh-ancestor
153356948|NCT02992652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153356949|NCT02992652|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153356950|NCT02992652|Gout Suppressants|gout suppressants|mesh-ancestor
153356951|NCT02992652|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153356952|NCT02992652|Free Radical Scavengers|free radical scavengers|mesh-ancestor
153356953|NCT02992652|Antioxidants|antioxidants|mesh-ancestor
153356954|NCT02992652|Protective Agents|protective agents|mesh-ancestor
153356955|NCT02992652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153356956|NCT01270724|Paclitaxel|paclitaxel|mesh-list
153885969|NCT02880085|Sensory System Agents|sensory system agents|mesh-ancestor
153885970|NCT02880085|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153885971|NCT02880085|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153885972|NCT02880085|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
153356957|NCT01270724|Gemcitabine|gemcitabine|mesh-list
153356958|NCT01270724|Oxaliplatin|oxaliplatin|mesh-list
153356959|NCT01270724|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153356960|NCT01270724|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153356961|NCT01270724|Tubulin Modulators|tubulin modulators|mesh-ancestor
153885973|NCT02880085|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153426972|NCT03811951|Insulin|insulin|mesh-list
153426973|NCT03811951|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153426980|NCT00001022|Zidovudine|zidovudine|mesh-list
153356962|NCT01270724|Antimitotic Agents|antimitotic agents|mesh-ancestor
153356963|NCT01270724|Mitosis Modulators|mitosis modulators|mesh-ancestor
153356965|NCT01270724|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153356967|NCT00709826|Gemcitabine|gemcitabine|mesh-list
153356968|NCT00709826|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
153356969|NCT00709826|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153356970|NCT00709826|Antimetabolites|antimetabolites|mesh-ancestor
153356971|NCT00709826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153356972|NCT00709826|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153356973|NCT00709826|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153356974|NCT00709826|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153356975|NCT00709826|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153356976|NCT01271114|Terlipressin|terlipressin|mesh-list
153356977|NCT01271114|Norepinephrine|norepinephrine|mesh-list
153356978|NCT01271114|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153356979|NCT01271114|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153356980|NCT01271114|Adrenergic Agents|adrenergic agents|mesh-ancestor
153356981|NCT01271114|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153356982|NCT01271114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153356983|NCT01271114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153356984|NCT01271114|Sympathomimetics|sympathomimetics|mesh-ancestor
153356985|NCT01271114|Autonomic Agents|autonomic agents|mesh-ancestor
153356986|NCT01271114|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153356987|NCT01271114|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
153356988|NCT01271114|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153356989|NCT02992340|Gemcitabine|gemcitabine|mesh-list
153356990|NCT02992340|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153356991|NCT02992340|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153356992|NCT02992340|Antimetabolites|antimetabolites|mesh-ancestor
153885996|NCT04328636|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153885997|NCT04328636|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153885998|NCT04328636|Anticonvulsants|anticonvulsants|mesh-ancestor
153427067|NCT00001964|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153880868|NCT06014073|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153783458|NCT04547335|Voriconazole|voriconazole|mesh-list
153357021|NCT02339558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153357022|NCT00731198|Drotaverin|drotaverin|mesh-list
153357023|NCT00731198|Scopolamine|scopolamine|mesh-list
153357024|NCT00731198|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
153357025|NCT00731198|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153357026|NCT00731198|Antiemetics|antiemetics|mesh-ancestor
153357027|NCT00731198|Autonomic Agents|autonomic agents|mesh-ancestor
153357028|NCT00731198|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153357029|NCT00731198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153357030|NCT00731198|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153427117|NCT00001052|Antacids|antacids|mesh-ancestor
153427183|NCT03978403|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153357031|NCT00731198|Mydriatics|mydriatics|mesh-ancestor
153357032|NCT00731198|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
153357033|NCT00731198|Cholinergic Agents|cholinergic agents|mesh-ancestor
153357034|NCT00731198|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153357035|NCT00731198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153357037|NCT00731198|Parasympatholytics|parasympatholytics|mesh-ancestor
153357038|NCT00731198|Analgesics|analgesics|mesh-ancestor
153357039|NCT00731198|Sensory System Agents|sensory system agents|mesh-ancestor
153427263|NCT03799783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153357040|NCT00731198|Vasodilator Agents|vasodilator agents|mesh-ancestor
153357041|NCT01278602|Rituximab|rituximab|mesh-list
153427264|NCT00001088|Bupivacaine|bupivacaine|mesh-list
153357043|NCT01278602|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153357044|NCT01278602|Immunologic Factors|immunologic factors|mesh-ancestor
153357045|NCT01278602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153357046|NCT01278602|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153357047|NCT00712244|Hyaluronic Acid|hyaluronic acid|mesh-list
153357048|NCT00712244|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153357049|NCT00712244|Immunologic Factors|immunologic factors|mesh-ancestor
153886323|NCT04308031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153886324|NCT01096849|Levofloxacin|levofloxacin|mesh-list
153357052|NCT00712244|Protective Agents|protective agents|mesh-ancestor
153357054|NCT02991950|Anticoagulants|anticoagulants|mesh-ancestor
153357055|NCT02991950|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153357056|NCT02991950|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153357057|NCT02991950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153357058|NCT01271582|Leucovorin|leucovorin|mesh-list
153357059|NCT01271582|Irinotecan|irinotecan|mesh-list
153357060|NCT01271582|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
153357061|NCT01271582|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153357062|NCT01271582|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153357063|NCT01271582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153357064|NCT01271582|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153427455|NCT00002054|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
153427456|NCT00002060|Inosine Pranobex|inosine pranobex|mesh-list
153427457|NCT00002060|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153427458|NCT00002060|Immunologic Factors|immunologic factors|mesh-ancestor
153427459|NCT00002060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153427460|NCT00002060|Antiviral Agents|antiviral agents|mesh-ancestor
153427461|NCT00002060|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153427462|NCT00002066|Thymopentin|thymopentin|mesh-list
153427463|NCT00002066|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153427464|NCT00002066|Immunologic Factors|immunologic factors|mesh-ancestor
153427465|NCT00002066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153427466|NCT00002072|Epoetin Alfa|epoetin alfa|mesh-list
153427468|NCT00002078|Interferons|interferons|mesh-list
153427469|NCT00002078|Interferon-alpha|interferon-alpha|mesh-list
153427470|NCT00002078|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153886421|NCT01324232|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
153427471|NCT00002078|Antiviral Agents|antiviral agents|mesh-ancestor
153886422|NCT01324232|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
153886423|NCT01324232|Cholinergic Agents|cholinergic agents|mesh-ancestor
153886424|NCT01324232|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
153886425|NCT01324232|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153886426|NCT01324232|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153886427|NCT01324232|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
153886428|NCT01324232|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153886429|NCT02878291|Vaccines|vaccines|mesh-list
153886430|NCT02878291|Immunologic Factors|immunologic factors|mesh-ancestor
153886431|NCT02878291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153886432|NCT05350891|Immunomodulating Agents|immunomodulating agents|mesh-list
153886433|NCT05350891|Immunologic Factors|immunologic factors|mesh-ancestor
153886434|NCT05350891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153886435|NCT01323920|Methotrexate|methotrexate|mesh-list
153357065|NCT01271582|Antidotes|antidotes|mesh-ancestor
153357066|NCT01271582|Protective Agents|protective agents|mesh-ancestor
153357067|NCT01271582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153357068|NCT01271582|Vitamin B Complex|vitamin b complex|mesh-ancestor
153357069|NCT01271582|Vitamins|vitamins|mesh-ancestor
153357070|NCT01271582|Micronutrients|micronutrients|mesh-ancestor
153357071|NCT02991638|Ibrutinib|ibrutinib|mesh-list
153357072|NCT02991638|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153357073|NCT02991638|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153357074|NCT02991638|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153357075|NCT02991638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153357076|NCT01271660|Pregabalin|pregabalin|mesh-list
153357077|NCT01271660|Analgesics|analgesics|mesh-ancestor
153357078|NCT01271660|Sensory System Agents|sensory system agents|mesh-ancestor
153357079|NCT01271660|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153357080|NCT01271660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153357081|NCT01271660|Anticonvulsants|anticonvulsants|mesh-ancestor
153357082|NCT01271660|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153886436|NCT01323920|Bortezomib|bortezomib|mesh-list
153886437|NCT01323920|Tacrolimus|tacrolimus|mesh-list
153886438|NCT01323920|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
153886439|NCT01323920|Abortifacient Agents|abortifacient agents|mesh-ancestor
153886440|NCT01323920|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153886441|NCT01323920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153886442|NCT01323920|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153886443|NCT01323920|Antimetabolites|antimetabolites|mesh-ancestor
153886444|NCT01323920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153886445|NCT01323920|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153886446|NCT01323920|Dermatologic Agents|dermatologic agents|mesh-ancestor
153886447|NCT01323920|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153427477|NCT00000440|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
153427479|NCT00000440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153427480|NCT00000440|Sensory System Agents|sensory system agents|mesh-ancestor
153427481|NCT00000440|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153427482|NCT00000440|Antidepressive Agents|antidepressive agents|mesh-ancestor
153427483|NCT00000440|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153427484|NCT00000440|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
153427485|NCT00000440|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153427486|NCT00000440|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153427487|NCT00000440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153427489|NCT00000440|Serotonin Agents|serotonin agents|mesh-ancestor
153357084|NCT01271660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153357085|NCT01271660|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153357086|NCT01271660|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153357087|NCT01271660|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153357088|NCT01271660|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153357089|NCT01271660|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153357091|NCT00731588|Vitamin B Complex|vitamin b complex|mesh-ancestor
153357092|NCT00731588|Vitamins|vitamins|mesh-ancestor
153357093|NCT00731588|Micronutrients|micronutrients|mesh-ancestor
153357094|NCT00731588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153357095|NCT01271894|Efavirenz|efavirenz|mesh-list
153357096|NCT01271894|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153783459|NCT04547335|Antifungal Agents|antifungal agents|mesh-ancestor
153357097|NCT01271894|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153357099|NCT01271894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153357100|NCT01271894|Antiviral Agents|antiviral agents|mesh-ancestor
153357101|NCT01271894|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153357102|NCT01271894|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
153427497|NCT00000446|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
153427498|NCT00000446|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153886489|NCT00598533|Antioxidants|antioxidants|mesh-ancestor
153886490|NCT00598533|Protective Agents|protective agents|mesh-ancestor
153886491|NCT00599937|Tretinoin|tretinoin|mesh-list
153427507|NCT04131517|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
153427508|NCT04131517|Contraceptive Agents|contraceptive agents|mesh-ancestor
153427509|NCT04131517|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153427510|NCT04131517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153427511|NCT04131517|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
153427512|NCT04131517|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
153427513|NCT04131517|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
153427514|NCT04131517|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
153427515|NCT04131517|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
153427516|NCT04131517|Contraceptives, Postcoital, Hormonal|contraceptives, postcoital, hormonal|mesh-ancestor
153427517|NCT04131517|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
153427518|NCT04131517|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
153427519|NCT04131517|Anticonvulsants|anticonvulsants|mesh-ancestor
153427520|NCT00001256|Prednisone|prednisone|mesh-list
153427521|NCT00001256|Methotrexate|methotrexate|mesh-list
153427522|NCT00001256|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153357103|NCT01271894|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153357104|NCT01271894|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
153357105|NCT01271894|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
153357106|NCT01271894|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
153357107|NCT01271894|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
153357108|NCT01278758|Vadimezan|vadimezan|mesh-list
153357109|NCT01278758|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153421755|NCT05514054|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
153357110|NCT00717626|Factor VIII|factor viii|mesh-list
153357124|NCT00719186|Zuclomiphene|zuclomiphene|mesh-list
153357125|NCT00719186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153357126|NCT00719186|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153427523|NCT00001256|Glucocorticoids|glucocorticoids|mesh-ancestor
153427524|NCT00001256|Hormones|hormones|mesh-ancestor
153427525|NCT00001256|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153427526|NCT00001256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153427527|NCT00001256|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153427528|NCT00001256|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153427529|NCT00001256|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
153427530|NCT00001256|Abortifacient Agents|abortifacient agents|mesh-ancestor
153886494|NCT00599937|Dermatologic Agents|dermatologic agents|mesh-ancestor
153886496|NCT00600093|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
153886497|NCT00600093|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
153886498|NCT00600093|Antiviral Agents|antiviral agents|mesh-ancestor
153886499|NCT00600093|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153886500|NCT00600093|Dopamine Agents|dopamine agents|mesh-ancestor
153886501|NCT00600093|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153886502|NCT00600093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153379487|NCT02998970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153886503|NCT00600093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153886504|NCT00600093|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153886505|NCT00600093|Analgesics|analgesics|mesh-ancestor
153886506|NCT00600093|Sensory System Agents|sensory system agents|mesh-ancestor
153886507|NCT00600093|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153886508|NCT00600249|Docetaxel|docetaxel|mesh-list
153886509|NCT00600249|Cetuximab|cetuximab|mesh-list
153886511|NCT00600249|Tubulin Modulators|tubulin modulators|mesh-ancestor
153357127|NCT00719186|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
153357128|NCT00719186|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153357129|NCT00719186|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153357130|NCT00719186|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
153357131|NCT00719186|Hormone Antagonists|hormone antagonists|mesh-ancestor
153357132|NCT00719186|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153357137|NCT00719186|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
153357138|NCT00719186|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
153357139|NCT00721136|Heparin|heparin|mesh-list
153357140|NCT00721136|Warfarin|warfarin|mesh-list
153357141|NCT00721136|Anticoagulants|anticoagulants|mesh-ancestor
153357142|NCT00721136|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153357143|NCT00721136|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153357144|NCT00721136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153357145|NCT00737204|Modafinil|modafinil|mesh-list
153357146|NCT00737204|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
153357147|NCT00737204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153357148|NCT00737204|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
153357149|NCT00737204|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
153357150|NCT00737204|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
153357151|NCT00737204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153357153|NCT00722072|Fulvestrant|fulvestrant|mesh-list
153357154|NCT00722072|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153357155|NCT00722072|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153427538|NCT00001256|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153427539|NCT00001256|Immunologic Factors|immunologic factors|mesh-ancestor
153427540|NCT00001256|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153427553|NCT00000458|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153427554|NCT00000458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153427555|NCT00000458|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153427556|NCT00000458|Serotonin Agents|serotonin agents|mesh-ancestor
153427557|NCT00000458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153427559|NCT03782233|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
153427560|NCT03782233|Rocuronium|rocuronium|mesh-list
153427561|NCT03782233|Anticonvulsants|anticonvulsants|mesh-ancestor
153427562|NCT03782233|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
153427563|NCT03782233|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
153886589|NCT00598611|Cholinergic Agents|cholinergic agents|mesh-ancestor
153427604|NCT00002108|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153427605|NCT00002108|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153427606|NCT00002108|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153427607|NCT00002108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153427610|NCT00002108|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153427611|NCT00002108|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153427612|NCT00002108|Antimetabolites|antimetabolites|mesh-ancestor
153427613|NCT00381134|Losartan|losartan|mesh-list
153427614|NCT00381134|Spironolactone|spironolactone|mesh-list
153427615|NCT00381134|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153427616|NCT00381134|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153427617|NCT00381134|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
153427618|NCT00381134|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
153427619|NCT00381134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153886632|NCT01325493|Anesthetics, General|anesthetics, general|mesh-ancestor
153886633|NCT01325493|Anesthetics|anesthetics|mesh-ancestor
153886634|NCT01325493|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153886635|NCT01325493|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
153886636|NCT01325493|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
153886637|NCT01325493|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153886638|NCT01325493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153357162|NCT00722072|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153357163|NCT00722072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153357164|NCT01275170|Imipenem|imipenem|mesh-list
153357165|NCT01275170|Relebactam|relebactam|mesh-list
153379488|NCT05406752|Acetaminophen|acetaminophen|mesh-list
153880886|NCT05898672|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
153880887|NCT05898672|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
153357166|NCT01275170|Cilastatin, Imipenem Drug Combination|cilastatin, imipenem drug combination|mesh-list
153357168|NCT01275170|Caffeine|caffeine|mesh-list
153357169|NCT01275170|Omeprazole|omeprazole|mesh-list
153357170|NCT01275170|Cilastatin|cilastatin|mesh-list
153357171|NCT01275170|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153357172|NCT01275170|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153357173|NCT01275170|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153886648|NCT01324947|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153886649|NCT01324947|Growth Substances|growth substances|mesh-ancestor
153886650|NCT01324947|Growth Inhibitors|growth inhibitors|mesh-ancestor
153886651|NCT01324947|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153886652|NCT01101841|Paroxetine|paroxetine|mesh-list
153427669|NCT00000542|Lisinopril|lisinopril|mesh-list
153427670|NCT00000542|Chlorthalidone|chlorthalidone|mesh-list
153427671|NCT00000542|Doxazosin|doxazosin|mesh-list
153427690|NCT00000542|Diuretics|diuretics|mesh-ancestor
153427691|NCT00000542|Natriuretic Agents|natriuretic agents|mesh-ancestor
153427692|NCT00000542|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
153427693|NCT00000542|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
153427694|NCT00000542|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
153427695|NCT00000542|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
153886663|NCT01101841|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
153886664|NCT01101841|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153886665|NCT01101841|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153886666|NCT02877511|Sunscreening Agents|sunscreening agents|mesh-list
153886667|NCT02877511|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
153886668|NCT02877511|Protective Agents|protective agents|mesh-ancestor
153886671|NCT01324323|Rifampin|rifampin|mesh-list
153357174|NCT01275170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153357175|NCT01275170|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153357823|NCT01213199|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153357824|NCT01213199|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153357825|NCT01213199|Analgesics|analgesics|mesh-ancestor
153357826|NCT01213199|Sensory System Agents|sensory system agents|mesh-ancestor
153357827|NCT01213199|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153357828|NCT01213199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153357829|NCT01213199|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153783460|NCT04547335|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153783461|NCT04547335|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
153357830|NCT01213199|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153357831|NCT01213199|Dermatologic Agents|dermatologic agents|mesh-ancestor
153357832|NCT03809702|Pregabalin|pregabalin|mesh-list
153886688|NCT01324323|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153886689|NCT01324323|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
153886690|NCT05344963|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
153886691|NCT05344963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153886692|NCT05344963|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153886693|NCT05344963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153886694|NCT02879227|Cisplatin|cisplatin|mesh-list
153886695|NCT02879227|Oxaliplatin|oxaliplatin|mesh-list
153886696|NCT02879227|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153886697|NCT01323582|Azithromycin|azithromycin|mesh-list
153886698|NCT01323582|Erythromycin|erythromycin|mesh-list
153886699|NCT01323582|Erythromycin Estolate|erythromycin estolate|mesh-list
153427719|NCT00002120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153427730|NCT00002126|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153427731|NCT00002126|Immunologic Factors|immunologic factors|mesh-ancestor
153427732|NCT00002126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153427733|NCT03231397|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
153427734|NCT03231397|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
153427735|NCT03231397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153427736|NCT03189433|Dantrolene|dantrolene|mesh-list
153427737|NCT03189433|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
153357833|NCT03809702|Analgesics|analgesics|mesh-ancestor
153357834|NCT03809702|Sensory System Agents|sensory system agents|mesh-ancestor
153357835|NCT03809702|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153357836|NCT03809702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153357837|NCT03809702|Anticonvulsants|anticonvulsants|mesh-ancestor
153357838|NCT03809702|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153357843|NCT03809702|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153357844|NCT03809702|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153357845|NCT03809702|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153357847|NCT03806036|Clomiphene|clomiphene|mesh-list
153427738|NCT03189433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153427739|NCT03189433|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
153427740|NCT03189433|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153427741|NCT00002132|Itraconazole|itraconazole|mesh-list
153427742|NCT00002132|Fluconazole|fluconazole|mesh-list
153427750|NCT00002132|Hormone Antagonists|hormone antagonists|mesh-ancestor
153427751|NCT00002132|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153427752|NCT00002132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153427753|NCT00002132|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
153427754|NCT00002132|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
153427755|NCT00002132|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
153427756|NCT00002144|Foscarnet|foscarnet|mesh-list
153427757|NCT00002144|Phosphonoacetic Acid|phosphonoacetic acid|mesh-list
153427758|NCT00002144|Antiviral Agents|antiviral agents|mesh-ancestor
153886719|NCT01323621|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153886720|NCT01323621|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153886721|NCT01323621|Autonomic Agents|autonomic agents|mesh-ancestor
153886722|NCT01323621|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153357848|NCT03806036|Enclomiphene|enclomiphene|mesh-list
153357849|NCT03806036|Zuclomiphene|zuclomiphene|mesh-list
153357850|NCT03806036|Vitamins|vitamins|mesh-ancestor
153357851|NCT03806036|Micronutrients|micronutrients|mesh-ancestor
153357852|NCT03806036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153357853|NCT03806036|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153357854|NCT03806036|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
153357855|NCT03806036|Hormone Antagonists|hormone antagonists|mesh-ancestor
153357856|NCT03806036|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153357857|NCT03806036|Fertility Agents, Female|fertility agents, female|mesh-ancestor
153357858|NCT03806036|Fertility Agents|fertility agents|mesh-ancestor
153357859|NCT03806036|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153357860|NCT03806036|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
153427772|NCT00000578|Respiratory System Agents|respiratory system agents|mesh-ancestor
153427786|NCT03774745|Progestins|progestins|mesh-ancestor
153427787|NCT03774745|Hormones|hormones|mesh-ancestor
153886742|NCT01320033|Antimalarials|antimalarials|mesh-ancestor
153886743|NCT01320033|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153886744|NCT01320033|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153886745|NCT05644743|Gemcitabine|gemcitabine|mesh-list
153886746|NCT05644743|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153886747|NCT05644743|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153886748|NCT05644743|Antimetabolites|antimetabolites|mesh-ancestor
153886749|NCT05644743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153886750|NCT01317615|Paclitaxel|paclitaxel|mesh-list
153886751|NCT01317615|Carboplatin|carboplatin|mesh-list
153886752|NCT01317615|Everolimus|everolimus|mesh-list
153886753|NCT01317615|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153886754|NCT01317615|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153886755|NCT01317615|Tubulin Modulators|tubulin modulators|mesh-ancestor
153886756|NCT01317615|Antimitotic Agents|antimitotic agents|mesh-ancestor
153886757|NCT01317615|Mitosis Modulators|mitosis modulators|mesh-ancestor
153886758|NCT01317615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153886759|NCT01317615|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
153886760|NCT01317615|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153886761|NCT01317615|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153886762|NCT01317615|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153886763|NCT01317615|Immunologic Factors|immunologic factors|mesh-ancestor
153886764|NCT01317615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153357863|NCT00780026|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153357864|NCT00780026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153357865|NCT01214057|Remifentanil|remifentanil|mesh-list
153357866|NCT01214057|Propofol|propofol|mesh-list
153357867|NCT01214057|Sevoflurane|sevoflurane|mesh-list
153357868|NCT01214057|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153880888|NCT05898672|Protease Inhibitors|protease inhibitors|mesh-ancestor
153357877|NCT01214057|Narcotics|narcotics|mesh-ancestor
153357878|NCT01214057|Analgesics|analgesics|mesh-ancestor
153357879|NCT01214057|Sensory System Agents|sensory system agents|mesh-ancestor
153357880|NCT01214057|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153357881|NCT03809546|Dronabinol|dronabinol|mesh-list
153357882|NCT03809546|Hallucinogens|hallucinogens|mesh-ancestor
153357883|NCT03809546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153357884|NCT03809546|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153357885|NCT03809546|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153357886|NCT03809546|Analgesics|analgesics|mesh-ancestor
153357887|NCT03809546|Sensory System Agents|sensory system agents|mesh-ancestor
153357888|NCT03809546|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153357889|NCT03809546|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
153357890|NCT03809546|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
153357891|NCT03809546|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153357892|NCT03809546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153357893|NCT03809546|Hormones|hormones|mesh-ancestor
153357894|NCT03809546|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153357895|NCT03809312|Amoxicillin|amoxicillin|mesh-list
153357896|NCT03809312|Clavulanic Acids|clavulanic acids|mesh-list
153357897|NCT03809312|Clavulanic Acid|clavulanic acid|mesh-list
153886765|NCT01078675|Calcium, Dietary|calcium, dietary|mesh-list
153886766|NCT01078675|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
153886767|NCT01078675|Calcium|calcium|mesh-list
153886768|NCT01078675|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153886769|NCT01078675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153427788|NCT03774745|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153427789|NCT03774745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153427790|NCT03774745|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
153427791|NCT03774745|Abortifacient Agents|abortifacient agents|mesh-ancestor
153427792|NCT03774745|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153427793|NCT03774745|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
153427794|NCT03774745|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
153427795|NCT03774745|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
153886785|NCT01100437|Sensory System Agents|sensory system agents|mesh-ancestor
153886787|NCT01100437|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
153886799|NCT01314261|Ribavirin|ribavirin|mesh-list
153886800|NCT01314261|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153886801|NCT01314261|Antiviral Agents|antiviral agents|mesh-ancestor
153886802|NCT01314261|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153886803|NCT01314261|Antimetabolites|antimetabolites|mesh-ancestor
153886804|NCT01314261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153427824|NCT00000626|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
153427825|NCT00000626|Bleomycin|bleomycin|mesh-list
153427826|NCT00000626|Dacarbazine|dacarbazine|mesh-list
153427827|NCT00000626|Vinblastine|vinblastine|mesh-list
153427828|NCT00000626|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153427829|NCT00000626|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153427830|NCT00000626|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153427831|NCT00000626|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153427832|NCT00000626|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153427833|NCT00000626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153427843|NCT04713254|Metoprolol|metoprolol|mesh-list
153357905|NCT01247363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153357906|NCT00780494|Bevacizumab|bevacizumab|mesh-list
153357907|NCT00780494|Carboplatin|carboplatin|mesh-list
153357908|NCT00780494|Capecitabine|capecitabine|mesh-list
153357909|NCT00780494|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153357910|NCT00780494|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153357911|NCT00780494|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153357912|NCT00780494|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153886832|NCT01321008|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153886833|NCT01321008|Glucocorticoids|glucocorticoids|mesh-ancestor
153886835|NCT01321008|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153886836|NCT01321008|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153886837|NCT01321008|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153886838|NCT01321008|Tubulin Modulators|tubulin modulators|mesh-ancestor
153886839|NCT01321008|Antimitotic Agents|antimitotic agents|mesh-ancestor
153886840|NCT01321008|Mitosis Modulators|mitosis modulators|mesh-ancestor
153886841|NCT01323530|Capecitabine|capecitabine|mesh-list
153886842|NCT01323530|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153886843|NCT01323530|Antimetabolites|antimetabolites|mesh-ancestor
153886844|NCT01323530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153886845|NCT01323530|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153427882|NCT00002156|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153427883|NCT00002156|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153427884|NCT00002156|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153886862|NCT01320722|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153886863|NCT01320722|Free Radical Scavengers|free radical scavengers|mesh-ancestor
153357913|NCT00780494|Growth Substances|growth substances|mesh-ancestor
153357914|NCT00780494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153357915|NCT00780494|Growth Inhibitors|growth inhibitors|mesh-ancestor
153357916|NCT00780494|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153357917|NCT00780494|Antimetabolites|antimetabolites|mesh-ancestor
153379561|NCT02921061|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153357918|NCT00780494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153357919|NCT00763412|Repaglinide|repaglinide|mesh-list
153357920|NCT00763412|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153357921|NCT00763412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153357922|NCT01302743|Metformin|metformin|mesh-list
153357923|NCT01302743|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153886864|NCT01320722|Antioxidants|antioxidants|mesh-ancestor
153886865|NCT01320722|Protective Agents|protective agents|mesh-ancestor
153886866|NCT01320722|Uricosuric Agents|uricosuric agents|mesh-ancestor
153886867|NCT01313559|Everolimus|everolimus|mesh-list
153886868|NCT01313559|Pasireotide|pasireotide|mesh-list
153886869|NCT01313559|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
153886870|NCT01313559|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153886871|NCT01313559|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153427893|NCT00002162|Saquinavir|saquinavir|mesh-list
153427894|NCT00002162|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153427895|NCT00002162|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153427896|NCT00002162|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153427897|NCT00002162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153427899|NCT00002162|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153427900|NCT00002162|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153427901|NCT00002162|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153427902|NCT00002162|Antimetabolites|antimetabolites|mesh-ancestor
153427903|NCT00002162|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
153427904|NCT00002162|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
153427905|NCT00002162|Protease Inhibitors|protease inhibitors|mesh-ancestor
153427919|NCT00000638|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153427920|NCT00000638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153427921|NCT00000638|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
153427922|NCT00000638|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
153886874|NCT01313559|Immunologic Factors|immunologic factors|mesh-ancestor
153886875|NCT01313559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153886876|NCT01313559|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153886877|NCT01313559|Hormones|hormones|mesh-ancestor
153886879|NCT02890875|Ethanol|ethanol|mesh-list
153357924|NCT01302743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153357925|NCT00763490|Mycophenolic Acid|mycophenolic acid|mesh-list
153357926|NCT00763490|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153357927|NCT00763490|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153357928|NCT00763490|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
153357929|NCT00763490|Antitubercular Agents|antitubercular agents|mesh-ancestor
153357930|NCT00763490|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153357931|NCT00763490|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153357932|NCT00763490|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153357933|NCT00763490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153357934|NCT01214759|Tenofovir|tenofovir|mesh-list
153357937|NCT01214759|Raltegravir Potassium|raltegravir potassium|mesh-list
153357938|NCT01214759|Antiviral Agents|antiviral agents|mesh-ancestor
153357939|NCT01214759|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153357940|NCT01214759|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153357941|NCT01214759|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153357942|NCT01214759|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153357943|NCT01214759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153886884|NCT02890875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153886885|NCT02890875|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
153886886|NCT02890875|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153886887|NCT02890875|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153886888|NCT02890875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153886889|NCT01312467|Metformin|metformin|mesh-list
153886890|NCT01312467|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153886891|NCT01312467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153886892|NCT01310127|Nepafenac|nepafenac|mesh-list
153886893|NCT01310127|Bromfenac|bromfenac|mesh-list
153886894|NCT01310127|Ophthalmic Solutions|ophthalmic solutions|mesh-list
153886895|NCT01310127|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
153357944|NCT01214759|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153357945|NCT01214759|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153357946|NCT01214759|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
153357947|NCT01214759|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
153357948|NCT00780962|Acetylcysteine|acetylcysteine|mesh-list
153357949|NCT00780962|N-monoacetylcystine|n-monoacetylcystine|mesh-list
153357950|NCT00780962|Antiviral Agents|antiviral agents|mesh-ancestor
153880916|NCT05846399|Clindamycin|clindamycin|mesh-list
153357951|NCT00780962|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153357952|NCT00780962|Expectorants|expectorants|mesh-ancestor
153357953|NCT00780962|Respiratory System Agents|respiratory system agents|mesh-ancestor
153357954|NCT00780962|Free Radical Scavengers|free radical scavengers|mesh-ancestor
153357955|NCT00780962|Antioxidants|antioxidants|mesh-ancestor
153357956|NCT00780962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153427949|NCT00000656|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153427950|NCT00000656|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153427951|NCT00000656|Antiviral Agents|antiviral agents|mesh-ancestor
153427952|NCT00000656|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153427953|NCT00000656|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153427954|NCT00000656|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153427955|NCT00000662|Zidovudine|zidovudine|mesh-list
153427956|NCT00000662|Antimetabolites|antimetabolites|mesh-ancestor
153886901|NCT01310127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153886902|NCT01310127|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153886903|NCT01310127|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153886904|NCT01318902|Dexamethasone|dexamethasone|mesh-list
153886905|NCT01318902|Ixazomib|ixazomib|mesh-list
153886906|NCT01318902|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153886907|NCT01318902|Antiemetics|antiemetics|mesh-ancestor
153886908|NCT01318902|Autonomic Agents|autonomic agents|mesh-ancestor
153886909|NCT01318902|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153886910|NCT01318902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153886911|NCT01318902|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153886912|NCT01318902|Glucocorticoids|glucocorticoids|mesh-ancestor
153886913|NCT01318902|Hormones|hormones|mesh-ancestor
153886914|NCT01318902|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153886915|NCT01318902|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153886920|NCT01313858|Golimumab|golimumab|mesh-list
153357958|NCT00780962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153357959|NCT00780962|Antidotes|antidotes|mesh-ancestor
153357960|NCT00764738|Ranibizumab|ranibizumab|mesh-list
153357961|NCT00764738|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153357962|NCT00764738|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153357963|NCT00764738|Growth Substances|growth substances|mesh-ancestor
153357964|NCT00764738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153357965|NCT00764738|Growth Inhibitors|growth inhibitors|mesh-ancestor
153357966|NCT00764738|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153357967|NCT00781508|Sildenafil Citrate|sildenafil citrate|mesh-list
153357968|NCT00781508|Vasodilator Agents|vasodilator agents|mesh-ancestor
153357969|NCT00781508|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
153357979|NCT03805568|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153357980|NCT03805568|Analgesics|analgesics|mesh-ancestor
153357981|NCT03805568|Sensory System Agents|sensory system agents|mesh-ancestor
153357982|NCT03805568|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153357983|NCT03805568|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
153357984|NCT03805568|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153357985|NCT03805568|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153357986|NCT03805568|Adrenergic Agents|adrenergic agents|mesh-ancestor
153357987|NCT03805568|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153357988|NCT03805568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153357989|NCT03805568|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153357990|NCT03805568|Narcotics|narcotics|mesh-ancestor
153357991|NCT00781898|Naltrexone|naltrexone|mesh-list
153357992|NCT00781898|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
153357993|NCT00781898|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
153357994|NCT00781898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153357995|NCT00781898|Sensory System Agents|sensory system agents|mesh-ancestor
153886932|NCT01313858|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153886933|NCT01313858|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153886934|NCT01313858|Immunologic Factors|immunologic factors|mesh-ancestor
153886935|NCT01313858|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153886936|NCT01313858|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153886937|NCT01313858|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
153886938|NCT01313858|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153886940|NCT01313780|Naloxone|naloxone|mesh-list
153427964|NCT00000662|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153427966|NCT00002168|Zidovudine|zidovudine|mesh-list
153427967|NCT00002168|Didanosine|didanosine|mesh-list
153427968|NCT00002168|Stavudine|stavudine|mesh-list
153427969|NCT00002168|Indinavir|indinavir|mesh-list
153427970|NCT00002168|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153427971|NCT00002168|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153427972|NCT00002168|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153427973|NCT00002168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153357996|NCT00781898|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153357997|NCT00765128|Ketorolac|ketorolac|mesh-list
153357998|NCT00765128|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153357999|NCT00765128|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153358000|NCT00765128|Analgesics|analgesics|mesh-ancestor
153358001|NCT00765128|Sensory System Agents|sensory system agents|mesh-ancestor
153358002|NCT00765128|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153358003|NCT00765128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153358004|NCT00765128|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153358005|NCT00765128|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153358006|NCT00765128|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153358007|NCT00765128|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153358008|NCT00765128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153358009|NCT00765206|Omeprazole|omeprazole|mesh-list
153358010|NCT00765206|Omeprazole, sodium bicarbonate drug combination|omeprazole, sodium bicarbonate drug combination|mesh-list
153358011|NCT00765206|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
153358012|NCT00765206|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153358018|NCT03809156|Enzyme Activators|enzyme activators|mesh-ancestor
153358019|NCT03809156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153427974|NCT00002168|Antiviral Agents|antiviral agents|mesh-ancestor
153358020|NCT03809156|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153358021|NCT03808844|Propofol|propofol|mesh-list
153427975|NCT00002168|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153427976|NCT00002168|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153427977|NCT00002168|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153427978|NCT00002168|Antimetabolites|antimetabolites|mesh-ancestor
153427979|NCT00002168|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
153427980|NCT00002168|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
153427981|NCT00002168|Protease Inhibitors|protease inhibitors|mesh-ancestor
153427988|NCT00001442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153427989|NCT00002174|Thalidomide|thalidomide|mesh-list
153427990|NCT00002174|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153427991|NCT00002174|Immunologic Factors|immunologic factors|mesh-ancestor
153427992|NCT00002174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153427993|NCT00002174|Leprostatic Agents|leprostatic agents|mesh-ancestor
153427994|NCT00002174|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153427995|NCT00002174|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153427996|NCT00002174|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153427997|NCT00002174|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153427998|NCT00002174|Growth Substances|growth substances|mesh-ancestor
153427999|NCT00002174|Growth Inhibitors|growth inhibitors|mesh-ancestor
153886941|NCT01313780|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153886942|NCT01313780|Narcotics|narcotics|mesh-ancestor
153886943|NCT01313780|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153886944|NCT01313780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153886945|NCT01313780|Analgesics|analgesics|mesh-ancestor
153358022|NCT03808844|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153358023|NCT03808844|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153358024|NCT03808844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153358025|NCT03808844|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153358026|NCT03808844|Anesthetics, General|anesthetics, general|mesh-ancestor
153358027|NCT03808844|Anesthetics|anesthetics|mesh-ancestor
153358028|NCT05316428|Ethanol|ethanol|mesh-list
153358029|NCT05316428|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
153358030|NCT05316428|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153358031|NCT05316428|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153358032|NCT05316428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153358033|NCT03805178|Abatacept|abatacept|mesh-list
153358034|NCT03805178|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153358035|NCT03805178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153886947|NCT01313780|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153886948|NCT01313780|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
153886949|NCT01090453|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
153886950|NCT01090453|Immunologic Factors|immunologic factors|mesh-ancestor
153886951|NCT01090453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153886952|NCT01170364|Sibutramine|sibutramine|mesh-list
153886953|NCT01170364|Antidepressive Agents|antidepressive agents|mesh-ancestor
153886954|NCT01170364|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153886956|NCT01170364|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
153886957|NCT01170208|Insulin|insulin|mesh-list
153886958|NCT01170208|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153886959|NCT01170208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153886960|NCT02891018|Paclitaxel|paclitaxel|mesh-list
153886961|NCT02891018|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
153886962|NCT02891018|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153886963|NCT02891018|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153379562|NCT02921061|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153886964|NCT02891018|Tubulin Modulators|tubulin modulators|mesh-ancestor
153886965|NCT02891018|Antimitotic Agents|antimitotic agents|mesh-ancestor
153886966|NCT02891018|Mitosis Modulators|mitosis modulators|mesh-ancestor
153886967|NCT02891018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153886968|NCT01169350|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
153886969|NCT01169350|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
153886970|NCT01169350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153886971|NCT01169038|Azithromycin|azithromycin|mesh-list
153886972|NCT01169038|Rifampin|rifampin|mesh-list
153886973|NCT01169038|Ethambutol|ethambutol|mesh-list
153886974|NCT01169038|Levofloxacin|levofloxacin|mesh-list
153428000|NCT00002174|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153428001|NCT00000668|Ganciclovir|ganciclovir|mesh-list
153428002|NCT00000668|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
153358036|NCT03805178|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153421787|NCT05476939|Everolimus|everolimus|mesh-list
153358039|NCT03805178|Immunologic Factors|immunologic factors|mesh-ancestor
153358040|NCT03805178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153358041|NCT03805178|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153358042|NCT01303835|Naltrexone|naltrexone|mesh-list
153358043|NCT01303835|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
153358044|NCT01303835|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
153358045|NCT01303835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153358046|NCT01303835|Sensory System Agents|sensory system agents|mesh-ancestor
153358048|NCT01250717|Dexamethasone|dexamethasone|mesh-list
153358049|NCT01250717|Goserelin|goserelin|mesh-list
153358050|NCT01250717|Estramustine|estramustine|mesh-list
153428003|NCT00000668|Antiviral Agents|antiviral agents|mesh-ancestor
153428004|NCT00000668|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153428005|NCT00000668|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153428006|NCT00000668|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153428007|NCT00000668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153428008|NCT00000680|Zidovudine|zidovudine|mesh-list
153428009|NCT00000680|Aldesleukin|aldesleukin|mesh-list
153428010|NCT00000680|Antimetabolites|antimetabolites|mesh-ancestor
153428011|NCT00000680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153428012|NCT00000680|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153428013|NCT00000680|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153428014|NCT00000680|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153428015|NCT00000680|Antiviral Agents|antiviral agents|mesh-ancestor
153428016|NCT00000680|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153428017|NCT00000680|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153428018|NCT00000680|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153428019|NCT00000680|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153428020|NCT00000692|Miglustat|miglustat|mesh-list
153428021|NCT00000692|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153428022|NCT00000692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153428023|NCT00000692|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153428024|NCT00000692|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153428025|NCT00000692|Antiviral Agents|antiviral agents|mesh-ancestor
153428026|NCT00000692|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153428027|NCT00000692|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
153886982|NCT01169038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153886983|NCT01169038|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
153886984|NCT01169038|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
153886985|NCT01169038|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
153886986|NCT01169038|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
153886987|NCT01169038|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
153886988|NCT01169038|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
153886989|NCT01169038|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
153886990|NCT01169038|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153886991|NCT01169038|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153886992|NCT01169038|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153886993|NCT01169038|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
153886994|NCT01169038|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153886996|NCT00624754|Formoterol Fumarate|formoterol fumarate|mesh-list
153886997|NCT00624754|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153886998|NCT00624754|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153358063|NCT01250717|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153358064|NCT01250717|Tubulin Modulators|tubulin modulators|mesh-ancestor
153358065|NCT01250717|Antimitotic Agents|antimitotic agents|mesh-ancestor
153358066|NCT01250717|Mitosis Modulators|mitosis modulators|mesh-ancestor
153358067|NCT01250717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153358068|NCT01250717|Androgen Antagonists|androgen antagonists|mesh-ancestor
153358069|NCT01250717|Hormone Antagonists|hormone antagonists|mesh-ancestor
153358070|NCT01250717|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153358071|NCT01250717|Alkylating Agents|alkylating agents|mesh-ancestor
153358072|NCT03804866|Doxorubicin|doxorubicin|mesh-list
153358073|NCT03804866|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
153358074|NCT03804866|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153358075|NCT03804866|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153358076|NCT03804866|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153358077|NCT03804866|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153358078|NCT03804866|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153387716|NCT00000243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153887007|NCT00624754|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
153887008|NCT00624754|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
153887009|NCT00624754|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153887010|NCT00624754|Adrenergic Agents|adrenergic agents|mesh-ancestor
153887011|NCT00624754|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153887012|NCT00624754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153887013|NCT01114828|Tolvaptan|tolvaptan|mesh-list
153887014|NCT01114828|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
153887015|NCT01114828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153428045|NCT00002180|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153428046|NCT00002180|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153428047|NCT00002180|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153428048|NCT00002180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153428049|NCT00002180|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153428050|NCT00002180|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153428052|NCT00002186|Antiviral Agents|antiviral agents|mesh-ancestor
153428053|NCT00002186|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153428054|NCT00001502|Carboplatin|carboplatin|mesh-list
153887019|NCT01313312|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
153358110|NCT00782756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153358111|NCT00782756|Growth Inhibitors|growth inhibitors|mesh-ancestor
153358112|NCT00782756|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153358113|NCT00782756|Alkylating Agents|alkylating agents|mesh-ancestor
153358114|NCT00782756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153358115|NCT03808142|Interferon beta-1b|interferon beta-1b|mesh-list
153358116|NCT03808142|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153358117|NCT03808142|Immunologic Factors|immunologic factors|mesh-ancestor
153358118|NCT03808142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153358119|NCT01306175|Empagliflozin|empagliflozin|mesh-list
153428092|NCT00000728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153428093|NCT00000728|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153428095|NCT00000728|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153428096|NCT00000728|Antiviral Agents|antiviral agents|mesh-ancestor
153887046|NCT01114516|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153887047|NCT01114516|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153887048|NCT01114516|Analgesics|analgesics|mesh-ancestor
153887049|NCT01114516|Sensory System Agents|sensory system agents|mesh-ancestor
153887050|NCT01114516|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153887051|NCT01114516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153887052|NCT01114516|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153887053|NCT01114516|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153887054|NCT01114516|Gout Suppressants|gout suppressants|mesh-ancestor
153887055|NCT01114516|Tocolytic Agents|tocolytic agents|mesh-ancestor
153887056|NCT01114516|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153887057|NCT01114516|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153887058|NCT01313078|Asparaginase|asparaginase|mesh-list
153887059|NCT01313078|Pegaspargase|pegaspargase|mesh-list
153887060|NCT01313078|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153887061|NCT01114360|Melatonin|melatonin|mesh-list
153887062|NCT01114360|Antioxidants|antioxidants|mesh-ancestor
153887063|NCT01114360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153887064|NCT01114360|Protective Agents|protective agents|mesh-ancestor
153887065|NCT01114360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153887066|NCT01114360|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153428097|NCT00000728|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153428099|NCT00000728|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153428100|NCT00000728|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153358123|NCT01306175|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153358124|NCT01306175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153358125|NCT01306175|Protective Agents|protective agents|mesh-ancestor
153379564|NCT03004118|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
153358126|NCT01306175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153358127|NCT01306175|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
153358128|NCT01306175|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153358129|NCT01215929|Dextroamphetamine|dextroamphetamine|mesh-list
153358130|NCT01215929|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
153358131|NCT01215929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153428107|NCT00001520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153428108|NCT00001520|Parasympathomimetics|parasympathomimetics|mesh-ancestor
153428109|NCT00001520|Autonomic Agents|autonomic agents|mesh-ancestor
153428110|NCT00001520|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153428111|NCT00001526|Daclizumab|daclizumab|mesh-list
153428112|NCT00001526|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153428113|NCT00001526|Immunologic Factors|immunologic factors|mesh-ancestor
153428114|NCT00001526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153428115|NCT00002294|Fluconazole|fluconazole|mesh-list
153428116|NCT00002294|Antifungal Agents|antifungal agents|mesh-ancestor
153428117|NCT00002294|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153428118|NCT00002294|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
153428119|NCT00002294|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153428120|NCT00002294|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153428121|NCT00002294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153428122|NCT00002294|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153428123|NCT00002294|Hormone Antagonists|hormone antagonists|mesh-ancestor
153428124|NCT00002294|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153428126|NCT00002294|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
153428127|NCT00002294|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
153428129|NCT03758365|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
153887068|NCT01310036|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153887069|NCT01310036|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153887074|NCT01075321|Everolimus|everolimus|mesh-list
153358133|NCT01215929|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153358134|NCT01215929|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153358135|NCT01215929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153358137|NCT01215929|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153358138|NCT00767624|Antidepressive Agents|antidepressive agents|mesh-list
153358139|NCT00767624|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153887085|NCT01075321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153887086|NCT01075321|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153358140|NCT01216241|Daptomycin|daptomycin|mesh-list
153887088|NCT01114204|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
153887089|NCT01114204|Hematinics|hematinics|mesh-ancestor
153887090|NCT01114204|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
153887091|NCT01114204|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
153887092|NCT01075243|Acetaminophen|acetaminophen|mesh-list
153887093|NCT01075243|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153887094|NCT01075243|Analgesics|analgesics|mesh-ancestor
153887095|NCT01075243|Sensory System Agents|sensory system agents|mesh-ancestor
153887096|NCT01075243|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153887097|NCT01075243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153887099|NCT01078441|Dexamethasone|dexamethasone|mesh-list
153887100|NCT01078441|Cyclophosphamide|cyclophosphamide|mesh-list
153887101|NCT01078441|Doxorubicin|doxorubicin|mesh-list
153887102|NCT01078441|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
153887103|NCT01078441|Bortezomib|bortezomib|mesh-list
153887104|NCT01078441|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153887105|NCT01078441|Immunologic Factors|immunologic factors|mesh-ancestor
153887106|NCT01078441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153887107|NCT01078441|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153887108|NCT01078441|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153428139|NCT03758365|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
153428140|NCT03758365|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
153428141|NCT03758365|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153428142|NCT03758365|Glucocorticoids|glucocorticoids|mesh-ancestor
153428143|NCT03758365|Hormones|hormones|mesh-ancestor
153358141|NCT01216241|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153358142|NCT01216241|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153358144|NCT01216397|Linagliptin|linagliptin|mesh-list
153358145|NCT01216397|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153358146|NCT01216397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153358147|NCT01216397|Incretins|incretins|mesh-ancestor
153358148|NCT01216397|Hormones|hormones|mesh-ancestor
153428144|NCT03758365|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153428145|NCT03758365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153428146|NCT03758365|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153428147|NCT03758365|Immunologic Factors|immunologic factors|mesh-ancestor
153428148|NCT03758365|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153428149|NCT03758365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153428150|NCT03758365|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153428151|NCT03758365|Respiratory System Agents|respiratory system agents|mesh-ancestor
153428152|NCT03758365|Dermatologic Agents|dermatologic agents|mesh-ancestor
153428153|NCT00002300|Megestrol|megestrol|mesh-list
153428154|NCT00002300|Megestrol Acetate|megestrol acetate|mesh-list
153428155|NCT00002300|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
153428156|NCT00002300|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
153428157|NCT00002300|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
153428158|NCT00002300|Contraceptive Agents|contraceptive agents|mesh-ancestor
153428159|NCT00002300|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153428160|NCT00002300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153428161|NCT00002300|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
153428167|NCT00002306|Fluconazole|fluconazole|mesh-list
153887129|NCT00626665|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
153887130|NCT00626665|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153887131|NCT00626665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153887132|NCT00626665|Urological Agents|urological agents|mesh-ancestor
153887133|NCT01090063|Ustekinumab|ustekinumab|mesh-list
153887134|NCT01090063|Dermatologic Agents|dermatologic agents|mesh-ancestor
153887135|NCT01306214|Empagliflozin|empagliflozin|mesh-list
153887136|NCT01306214|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
153887137|NCT01306214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153887138|NCT01306214|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153887139|NCT01306214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153887140|NCT00623402|Interferons|interferons|mesh-list
153887141|NCT00623402|Sorafenib|sorafenib|mesh-list
153887142|NCT00623402|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153887143|NCT00623402|Antiviral Agents|antiviral agents|mesh-ancestor
153887144|NCT00623402|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153887145|NCT00623402|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153887148|NCT01077739|Leucovorin|leucovorin|mesh-list
153358150|NCT01216397|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
153358151|NCT01216397|Protease Inhibitors|protease inhibitors|mesh-ancestor
153358152|NCT01216397|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153880919|NCT05846399|Clavulanic Acid|clavulanic acid|mesh-list
153880920|NCT05846399|Clavulanic Acids|clavulanic acids|mesh-list
153880921|NCT05846399|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
153358154|NCT04345406|Chloroquine|chloroquine|mesh-list
153428186|NCT00002210|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153428187|NCT00002210|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153428188|NCT00002210|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153428189|NCT00002216|Lamivudine|lamivudine|mesh-list
153428190|NCT00002216|Zidovudine|zidovudine|mesh-list
153428191|NCT00002216|Abacavir|abacavir|mesh-list
153428192|NCT00002216|Lamivudine, zidovudine drug combination|lamivudine, zidovudine drug combination|mesh-list
153428193|NCT00002216|Nelfinavir|nelfinavir|mesh-list
153428194|NCT00002216|Amprenavir|amprenavir|mesh-list
153428195|NCT00002216|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153428196|NCT00002216|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153428197|NCT00002216|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153428198|NCT00002216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153428199|NCT00002216|Antiviral Agents|antiviral agents|mesh-ancestor
153428200|NCT00002216|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153428201|NCT00002216|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153428202|NCT00002216|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153428203|NCT00002216|Antimetabolites|antimetabolites|mesh-ancestor
153428204|NCT00002216|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
153428205|NCT00002216|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
153428206|NCT00002216|Protease Inhibitors|protease inhibitors|mesh-ancestor
153428207|NCT00002216|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
153428208|NCT00002216|Antitubercular Agents|antitubercular agents|mesh-ancestor
153428209|NCT00002216|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153428211|NCT00002222|Antiviral Agents|antiviral agents|mesh-ancestor
153428212|NCT00002222|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153887150|NCT01077739|Capecitabine|capecitabine|mesh-list
153887151|NCT01077739|Fluorouracil|fluorouracil|mesh-list
153887153|NCT01077739|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153887164|NCT01077739|Immunologic Factors|immunologic factors|mesh-ancestor
153887166|NCT01077739|Protective Agents|protective agents|mesh-ancestor
153887167|NCT01077739|Vitamin B Complex|vitamin b complex|mesh-ancestor
153887168|NCT01077739|Vitamins|vitamins|mesh-ancestor
153887169|NCT01077739|Micronutrients|micronutrients|mesh-ancestor
153887170|NCT01306058|Sorafenib|sorafenib|mesh-list
153887171|NCT01306058|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153887172|NCT01306058|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153887173|NCT01306058|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153887174|NCT01306058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153887175|NCT00626509|Sunitinib|sunitinib|mesh-list
153887176|NCT00626509|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153887177|NCT00626509|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153887178|NCT00626509|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153887179|NCT00626509|Growth Substances|growth substances|mesh-ancestor
153887180|NCT00626509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153358160|NCT04345406|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153358161|NCT04345406|Antimalarials|antimalarials|mesh-ancestor
153358162|NCT04345406|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153358163|NCT04345406|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
153358164|NCT04345406|Protease Inhibitors|protease inhibitors|mesh-ancestor
153358165|NCT04345406|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153358166|NCT04345406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153358167|NCT04345406|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153358168|NCT01216943|Timolol|timolol|mesh-list
153358169|NCT01216943|Brimonidine Tartrate|brimonidine tartrate|mesh-list
153358170|NCT01216943|Bimatoprost|bimatoprost|mesh-list
153358171|NCT01216943|Ophthalmic Solutions|ophthalmic solutions|mesh-list
153358172|NCT01216943|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
153358173|NCT01216943|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
153428240|NCT00002228|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
153428241|NCT00002228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153428242|NCT00002228|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153428243|NCT00002228|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153428244|NCT00002228|Antiviral Agents|antiviral agents|mesh-ancestor
153428245|NCT00002228|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153428246|NCT04714177|Edaravone|edaravone|mesh-list
153428247|NCT04714177|Free Radical Scavengers|free radical scavengers|mesh-ancestor
153428248|NCT04714177|Antioxidants|antioxidants|mesh-ancestor
153428249|NCT04714177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153428250|NCT04714177|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
153428251|NCT04714177|Protective Agents|protective agents|mesh-ancestor
153428252|NCT04714177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153428253|NCT00001628|Angiotensin II|angiotensin ii|mesh-list
153428254|NCT00001628|Giapreza|giapreza|mesh-list
153887191|NCT02877901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153887192|NCT02877901|Urological Agents|urological agents|mesh-ancestor
153887193|NCT04306159|Anesthetics|anesthetics|mesh-list
153887194|NCT04306159|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153887195|NCT04306159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153428255|NCT00001628|Angiotensinogen|angiotensinogen|mesh-list
153428256|NCT00001628|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-list
153887196|NCT01305200|Calcium|calcium|mesh-list
153887197|NCT01305200|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153887199|NCT01304498|Vaccines|vaccines|mesh-list
153358174|NCT01216943|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
153358175|NCT01216943|Adrenergic Agents|adrenergic agents|mesh-ancestor
153358176|NCT01216943|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153358177|NCT01216943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153358178|NCT01216943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153358179|NCT01216943|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153358180|NCT01216943|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153358181|NCT01216943|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
153358182|NCT01216943|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153358183|NCT01216943|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153358184|NCT00783614|Aspirin|aspirin|mesh-list
153358185|NCT00783614|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
153387717|NCT00000243|Analgesics|analgesics|mesh-ancestor
153887209|NCT01074931|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153887210|NCT01074931|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153887211|NCT01074931|Antiviral Agents|antiviral agents|mesh-ancestor
153887212|NCT01074931|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153887213|NCT01074931|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
153887214|NCT01074931|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153887216|NCT04774159|Gout Suppressants|gout suppressants|mesh-ancestor
153887217|NCT04774159|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153887218|NCT04774159|Tubulin Modulators|tubulin modulators|mesh-ancestor
153887219|NCT04774159|Antimitotic Agents|antimitotic agents|mesh-ancestor
153887220|NCT04774159|Mitosis Modulators|mitosis modulators|mesh-ancestor
153887221|NCT04774159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153887222|NCT04774159|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153887223|NCT01303172|Gemcitabine|gemcitabine|mesh-list
153887224|NCT01303172|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153887225|NCT01303172|Antimetabolites|antimetabolites|mesh-ancestor
153887226|NCT01303172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153887227|NCT01303172|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153887228|NCT01302938|Tolterodine Tartrate|tolterodine tartrate|mesh-list
153887229|NCT01302938|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
153887230|NCT01302938|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
153428263|NCT00002234|Lamivudine|lamivudine|mesh-list
153887233|NCT01302938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153887234|NCT01302938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153887235|NCT01302938|Urological Agents|urological agents|mesh-ancestor
153887236|NCT01076647|Insulin|insulin|mesh-list
153887237|NCT01076647|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
153887238|NCT01076647|Insulin Glargine|insulin glargine|mesh-list
153887239|NCT01076647|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153887240|NCT01076647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153887241|NCT04306081|Evolocumab|evolocumab|mesh-list
153887242|NCT04306081|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
153887243|NCT04306081|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153887244|NCT04306081|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153887245|NCT04306081|Antimetabolites|antimetabolites|mesh-ancestor
153887246|NCT04306081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153887247|NCT04306081|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
153887248|NCT04306081|Protease Inhibitors|protease inhibitors|mesh-ancestor
153887249|NCT04306081|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153887250|NCT04306081|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153887251|NCT01074307|Bisoprolol|bisoprolol|mesh-list
153887252|NCT01074307|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153887253|NCT01074307|Sympatholytics|sympatholytics|mesh-ancestor
153887254|NCT01074307|Autonomic Agents|autonomic agents|mesh-ancestor
153887259|NCT01074307|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
153358192|NCT00783614|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153358193|NCT00783614|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153358194|NCT00783614|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153358210|NCT01252745|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153358211|NCT01252745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153358212|NCT01252745|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153887267|NCT01076335|Tubulin Modulators|tubulin modulators|mesh-ancestor
153887268|NCT01076335|Antimitotic Agents|antimitotic agents|mesh-ancestor
153887269|NCT01076335|Mitosis Modulators|mitosis modulators|mesh-ancestor
153887270|NCT01076335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153887271|NCT01076335|Fertility Agents, Female|fertility agents, female|mesh-ancestor
153887272|NCT01076335|Fertility Agents|fertility agents|mesh-ancestor
153887273|NCT01076335|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153887274|NCT01076335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153887275|NCT01076335|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153887276|NCT01309737|Tofacitinib|tofacitinib|mesh-list
153887277|NCT01309737|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
153887278|NCT01309737|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153887279|NCT01309737|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153887280|NCT01309737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153887281|NCT01074229|Ropivacaine|ropivacaine|mesh-list
153887282|NCT01074229|Anesthetics, Local|anesthetics, local|mesh-ancestor
153887283|NCT01074229|Anesthetics|anesthetics|mesh-ancestor
153358216|NCT04278872|Hormone Antagonists|hormone antagonists|mesh-ancestor
153358217|NCT04278872|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153358218|NCT04278872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153358219|NCT03807596|Hyaluronic Acid|hyaluronic acid|mesh-list
153358220|NCT03807596|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153358221|NCT03807596|Immunologic Factors|immunologic factors|mesh-ancestor
153358222|NCT03807596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153428317|NCT03740659|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153428318|NCT03740659|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153428319|NCT03740659|Protease Inhibitors|protease inhibitors|mesh-ancestor
153428320|NCT03740659|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153428321|NCT03740659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153428322|NCT03740659|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
153428323|NCT03740659|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153428324|NCT03740659|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153428325|NCT03740659|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153428326|NCT03740659|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153428327|NCT03740659|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
153428328|NCT03740659|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153428329|NCT00002336|Clarithromycin|clarithromycin|mesh-list
153428330|NCT00002336|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153428332|NCT00002336|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
153428333|NCT00002336|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153428334|NCT00002336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153428335|NCT00002336|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
153428336|NCT00002336|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153428338|NCT00001646|Amphotericin B|amphotericin b|mesh-list
153428339|NCT00001646|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
153428340|NCT00001646|Antifungal Agents|antifungal agents|mesh-ancestor
153428341|NCT00001646|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153358225|NCT01217411|2,2-dimethyl-N-(6-oxo-6,7-dihydro-5H-dibenzo(b,d)azepin-7-yl)-N'-(2,2,3,3,3-pentafluoropropyl)malonamide|2,2-dimethyl-n-(6-oxo-6,7-dihydro-5h-dibenzo(b,d)azepin-7-yl)-n'-(2,2,3,3,3-pentafluoropropyl)malonamide|mesh-list
153358226|NCT01217411|Gamma Secretase Inhibitors and Modulators|gamma secretase inhibitors and modulators|mesh-ancestor
153358227|NCT01217411|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153358228|NCT01217411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153428342|NCT00001646|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
153428343|NCT00001646|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153428345|NCT00001646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153428346|NCT00001646|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153428347|NCT00001646|Hormone Antagonists|hormone antagonists|mesh-ancestor
153428348|NCT00001646|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153428349|NCT00001646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153428350|NCT00001646|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
153428351|NCT00001646|Amebicides|amebicides|mesh-ancestor
153887284|NCT01074229|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153887285|NCT01074229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153887286|NCT01074229|Sensory System Agents|sensory system agents|mesh-ancestor
153887287|NCT01074229|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153887289|NCT01106014|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153887290|NCT01105936|Acetaminophen|acetaminophen|mesh-list
153887291|NCT01105936|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153887292|NCT01105936|Analgesics|analgesics|mesh-ancestor
153887293|NCT01105936|Sensory System Agents|sensory system agents|mesh-ancestor
153887294|NCT01105936|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153887295|NCT01105936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153887296|NCT01105936|Antipyretics|antipyretics|mesh-ancestor
153887297|NCT01309659|Iron|iron|mesh-list
153887298|NCT01309659|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
153887300|NCT01309659|Micronutrients|micronutrients|mesh-ancestor
153887301|NCT01309659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153887302|NCT01309659|Hematinics|hematinics|mesh-ancestor
153887303|NCT04989166|Curcumin|curcumin|mesh-list
153887304|NCT04989166|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153887305|NCT04989166|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153887306|NCT04989166|Analgesics|analgesics|mesh-ancestor
153887307|NCT04989166|Sensory System Agents|sensory system agents|mesh-ancestor
153887308|NCT04989166|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153428367|NCT02721277|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
153428368|NCT02721277|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
153428370|NCT00002270|Interferons|interferons|mesh-list
153428371|NCT00002270|Interferon-alpha|interferon-alpha|mesh-list
153428372|NCT00002270|Interferon alpha-2|interferon alpha-2|mesh-list
153428373|NCT00002270|Zidovudine|zidovudine|mesh-list
153428374|NCT00002270|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153428375|NCT00002270|Antiviral Agents|antiviral agents|mesh-ancestor
153428376|NCT00002270|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153428381|NCT00002270|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153428382|NCT00002270|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153428384|NCT00002270|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153428385|NCT00002270|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153428386|NCT00002354|Stavudine|stavudine|mesh-list
153428387|NCT00002354|Indinavir|indinavir|mesh-list
153358238|NCT01253525|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153358239|NCT01253525|Growth Substances|growth substances|mesh-ancestor
153358240|NCT01253525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153358241|NCT01253525|Growth Inhibitors|growth inhibitors|mesh-ancestor
153358242|NCT05310968|Aspirin|aspirin|mesh-list
153358243|NCT05310968|Tirofiban|tirofiban|mesh-list
153358244|NCT05310968|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153358245|NCT05310968|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153358246|NCT05310968|Analgesics|analgesics|mesh-ancestor
153358247|NCT05310968|Sensory System Agents|sensory system agents|mesh-ancestor
153887338|NCT01104766|Dopamine Agents|dopamine agents|mesh-ancestor
153887339|NCT01104766|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153887340|NCT01104766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153358262|NCT00768716|Sensory System Agents|sensory system agents|mesh-ancestor
153358263|NCT00768716|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153358264|NCT00768716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153358266|NCT05743634|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
153358267|NCT05743634|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
153358268|NCT05743634|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
153358269|NCT05743634|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153358270|NCT05743634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153358271|NCT05743634|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
153358272|NCT05743634|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153358273|NCT05743634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153887341|NCT01104766|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
153887342|NCT01104766|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
153887343|NCT01104766|Serotonin Agents|serotonin agents|mesh-ancestor
153887344|NCT01104766|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
153887345|NCT01104766|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153887346|NCT01104766|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
153887347|NCT01104766|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
153887348|NCT02880280|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
153887350|NCT02880280|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153887353|NCT02880280|Fertility Agents|fertility agents|mesh-ancestor
153428388|NCT00002354|Antimetabolites|antimetabolites|mesh-ancestor
153428389|NCT00002354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153428390|NCT00002354|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153428391|NCT00002354|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153428392|NCT00002354|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153428393|NCT00002354|Antiviral Agents|antiviral agents|mesh-ancestor
153428394|NCT00002354|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153358274|NCT05743634|Cholinergic Agents|cholinergic agents|mesh-ancestor
153358275|NCT05743634|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153783463|NCT04547335|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153783464|NCT04547335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153783465|NCT04547335|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153783466|NCT04547335|Hormone Antagonists|hormone antagonists|mesh-ancestor
153783467|NCT04547335|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153783468|NCT04547335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153887356|NCT01104376|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153887357|NCT01104376|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153887358|NCT01104376|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153887359|NCT01104376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153887360|NCT01104376|Antiviral Agents|antiviral agents|mesh-ancestor
153887361|NCT01104376|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153887362|NCT01104376|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
153887363|NCT01104376|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153887364|NCT01104376|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
153887365|NCT01104376|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
153887366|NCT01104376|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
153887367|NCT01104376|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
153887368|NCT01104376|Antifungal Agents|antifungal agents|mesh-ancestor
153887369|NCT01104376|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
153887370|NCT01104376|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153887371|NCT01104376|Hormone Antagonists|hormone antagonists|mesh-ancestor
153428407|NCT00002360|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153428408|NCT00002360|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153428409|NCT00002360|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153428410|NCT00002276|Zidovudine|zidovudine|mesh-list
153428411|NCT00002276|Ibuprofen|ibuprofen|mesh-list
153428412|NCT00002276|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153428413|NCT00002276|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153379685|NCT03003416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153428414|NCT00002276|Analgesics|analgesics|mesh-ancestor
153428415|NCT00002276|Sensory System Agents|sensory system agents|mesh-ancestor
153428416|NCT00002276|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153428417|NCT00002276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153428418|NCT00002276|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153783472|NCT00236288|Antidepressive Agents|antidepressive agents|mesh-ancestor
153428419|NCT00002276|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153428420|NCT00002276|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153428421|NCT00002276|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153428422|NCT00002276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153428423|NCT00002276|Antimetabolites|antimetabolites|mesh-ancestor
153428424|NCT00002276|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153428425|NCT00002276|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153428426|NCT00002276|Antiviral Agents|antiviral agents|mesh-ancestor
153428427|NCT00002276|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153428428|NCT00002276|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153428429|NCT00002276|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153428430|NCT00378547|Acetaminophen|acetaminophen|mesh-list
153428431|NCT00378547|Dexamethasone|dexamethasone|mesh-list
153428432|NCT00378547|Dexamethasone acetate|dexamethasone acetate|mesh-list
153428433|NCT00378547|Pregabalin|pregabalin|mesh-list
153428434|NCT00378547|BB 1101|bb 1101|mesh-list
153428435|NCT00378547|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153428436|NCT00378547|Antiemetics|antiemetics|mesh-ancestor
153428437|NCT00378547|Autonomic Agents|autonomic agents|mesh-ancestor
153428438|NCT00378547|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153428439|NCT00378547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153428440|NCT00378547|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153428442|NCT00378547|Hormones|hormones|mesh-ancestor
153887372|NCT01104376|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153887373|NCT01104376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153428443|NCT00378547|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153887374|NCT01104376|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
153887375|NCT02875873|Methamphetamine|methamphetamine|mesh-list
153783477|NCT00236288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153783478|NCT00236288|Dopamine Agents|dopamine agents|mesh-ancestor
153783479|NCT00236288|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153887387|NCT02875873|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153887388|NCT02875873|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153887389|NCT02875873|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
153887390|NCT02875873|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
153887391|NCT02875873|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
153887392|NCT01072357|Bevacizumab|bevacizumab|mesh-list
153887393|NCT01072357|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
153887394|NCT01072357|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153887395|NCT01072357|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153887396|NCT01072357|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153887397|NCT01072357|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153887399|NCT01072357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153887400|NCT01072357|Growth Inhibitors|growth inhibitors|mesh-ancestor
153887401|NCT01072357|Laxatives|laxatives|mesh-ancestor
153887402|NCT01072357|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153887403|NCT01072201|Triclosan|triclosan|mesh-list
153887404|NCT01072201|Fluorides|fluorides|mesh-list
153887405|NCT01072201|Cariostatic Agents|cariostatic agents|mesh-ancestor
153887406|NCT01072201|Protective Agents|protective agents|mesh-ancestor
153887407|NCT01072201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153428446|NCT00378547|Protease Inhibitors|protease inhibitors|mesh-ancestor
153428447|NCT00378547|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153428449|NCT00378547|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153358277|NCT01218971|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
153358278|NCT01218971|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
153358279|NCT01218971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153358280|NCT01218971|Sensory System Agents|sensory system agents|mesh-ancestor
153358281|NCT01218971|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153358283|NCT01337687|Oxytocics|oxytocics|mesh-ancestor
153358284|NCT01337687|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153358285|NCT01337687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153358286|NCT04351919|Azithromycin|azithromycin|mesh-list
153358287|NCT04351919|Hydroxychloroquine|hydroxychloroquine|mesh-list
153358288|NCT04351919|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153358289|NCT04351919|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153428468|NCT00002282|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153428470|NCT00002282|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153887408|NCT01072201|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
153887409|NCT01072201|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153887410|NCT01072201|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
153887411|NCT01072201|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153887412|NCT01072201|Antimetabolites|antimetabolites|mesh-ancestor
153887413|NCT01072201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153887414|NCT01072201|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153887415|NCT02893709|Omeprazole|omeprazole|mesh-list
153887416|NCT02893709|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
153887417|NCT02893709|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153887418|NCT02893709|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
153887419|NCT02893709|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153887420|NCT02893709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153887422|NCT04972396|Digoxin|digoxin|mesh-list
153887424|NCT04972396|Atorvastatin|atorvastatin|mesh-list
153887457|NCT01089361|Anesthetics, General|anesthetics, general|mesh-ancestor
153887458|NCT01089361|Anesthetics|anesthetics|mesh-ancestor
153428495|NCT00002366|Protease Inhibitors|protease inhibitors|mesh-ancestor
153428496|NCT00002366|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153428497|NCT00002366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153428498|NCT00002366|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153428499|NCT00002366|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153428500|NCT00002366|Antiviral Agents|antiviral agents|mesh-ancestor
153428501|NCT00002366|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153428502|NCT00002366|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
153428503|NCT00002366|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153428505|NCT00378313|Gemcitabine|gemcitabine|mesh-list
153428506|NCT00378313|Epirubicin|epirubicin|mesh-list
153428507|NCT00378313|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153428508|NCT00378313|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153428509|NCT00378313|Tubulin Modulators|tubulin modulators|mesh-ancestor
153428510|NCT00378313|Antimitotic Agents|antimitotic agents|mesh-ancestor
153428511|NCT00378313|Mitosis Modulators|mitosis modulators|mesh-ancestor
153428512|NCT00378313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153428513|NCT00378313|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153428514|NCT00378313|Antimetabolites|antimetabolites|mesh-ancestor
153428515|NCT00378313|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153428516|NCT00378313|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153428517|NCT00378313|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153428518|NCT00378313|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153428520|NCT00002372|Indinavir|indinavir|mesh-list
153428521|NCT00002372|Saquinavir|saquinavir|mesh-list
153887474|NCT01102972|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
153887476|NCT01102972|Protease Inhibitors|protease inhibitors|mesh-ancestor
153428551|NCT00002378|Antiviral Agents|antiviral agents|mesh-ancestor
153428552|NCT00002378|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153428553|NCT00002378|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
153428554|NCT00002378|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153428555|NCT00002378|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153428569|NCT02589145|Autonomic Agents|autonomic agents|mesh-ancestor
153428570|NCT02589145|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153428571|NCT02589145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153428574|NCT02589145|Hormones|hormones|mesh-ancestor
153428575|NCT02589145|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153882579|NCT01689090|Analgesics|analgesics|mesh-ancestor
153428577|NCT02589145|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153887515|NCT04306471|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153887516|NCT04306471|Antimetabolites|antimetabolites|mesh-ancestor
153887517|NCT04306471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153887518|NCT04306471|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
153887519|NCT04306471|Protease Inhibitors|protease inhibitors|mesh-ancestor
153887520|NCT04306471|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153887521|NCT04306471|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153887522|NCT04296253|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
153887523|NCT04296253|Mitogens|mitogens|mesh-list
153887524|NCT04296253|Mitosis Modulators|mitosis modulators|mesh-ancestor
153887525|NCT04296253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153887526|NCT01082965|Donepezil|donepezil|mesh-list
153887527|NCT01082965|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
153887528|NCT01082965|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153887529|NCT01082965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153887530|NCT01082965|Cholinergic Agents|cholinergic agents|mesh-ancestor
153887531|NCT01082965|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153887532|NCT01082965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153887533|NCT01082965|Nootropic Agents|nootropic agents|mesh-ancestor
153887534|NCT01102426|Dexamethasone|dexamethasone|mesh-list
153887535|NCT01102426|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153428595|NCT02589145|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
153887536|NCT01102426|Antiemetics|antiemetics|mesh-ancestor
153887537|NCT01102426|Autonomic Agents|autonomic agents|mesh-ancestor
153358336|NCT01309451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153358339|NCT01309451|Antiemetics|antiemetics|mesh-ancestor
153358340|NCT01309451|Autonomic Agents|autonomic agents|mesh-ancestor
153358341|NCT01309451|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153358342|NCT01309451|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153358344|NCT01309451|Hormones|hormones|mesh-ancestor
153358345|NCT01309451|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153358346|NCT01309451|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153887538|NCT01102426|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153887539|NCT01102426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153887540|NCT01102426|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153887541|NCT01102426|Glucocorticoids|glucocorticoids|mesh-ancestor
153887542|NCT01102426|Hormones|hormones|mesh-ancestor
153887543|NCT01102426|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153887544|NCT01102426|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153887545|NCT01102426|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153887546|NCT04308850|Vitamin D|vitamin d|mesh-list
153887547|NCT04308850|Vitamins|vitamins|mesh-ancestor
153887548|NCT04308850|Micronutrients|micronutrients|mesh-ancestor
153887549|NCT04308850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153887550|NCT04308850|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153887552|NCT01101334|Efatutazone|efatutazone|mesh-list
153887553|NCT01101334|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153887554|NCT01101334|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153887555|NCT01101334|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153887556|NCT01101334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153887596|NCT04325061|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153428644|NCT00002420|Stavudine|stavudine|mesh-list
153428645|NCT00002420|Delavirdine|delavirdine|mesh-list
153428646|NCT00002420|Emivirine|emivirine|mesh-list
153428647|NCT00002420|Hydroxyurea|hydroxyurea|mesh-list
153428648|NCT00002420|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153358368|NCT00795002|Sensory System Agents|sensory system agents|mesh-ancestor
153358369|NCT00795002|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153358370|NCT00795002|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153358371|NCT00795002|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153358372|NCT00795002|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153358373|NCT00795002|Growth Inhibitors|growth inhibitors|mesh-ancestor
153358374|NCT00795002|Growth Substances|growth substances|mesh-ancestor
153358375|NCT00795002|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153358376|NCT03802838|Amisulpride|amisulpride|mesh-list
153358377|NCT03802838|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153358378|NCT03802838|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153428650|NCT00002420|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153358390|NCT00772304|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153358392|NCT00772304|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153358393|NCT00772304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153358394|NCT00772304|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153358395|NCT00772304|Respiratory System Agents|respiratory system agents|mesh-ancestor
153358396|NCT00772304|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
153783491|NCT00236327|Sensory System Agents|sensory system agents|mesh-ancestor
153358397|NCT00772304|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153358398|NCT00772304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153358399|NCT00772304|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
153358400|NCT00772304|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
153358401|NCT00772304|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
153358402|NCT00772304|Histamine Antagonists|histamine antagonists|mesh-ancestor
153358403|NCT00772304|Histamine Agents|histamine agents|mesh-ancestor
153358404|NCT00772304|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153358405|NCT00772304|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153428651|NCT00002420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153428652|NCT00002420|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153428653|NCT00002420|Antimetabolites|antimetabolites|mesh-ancestor
153428654|NCT00002420|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153428655|NCT00002420|Antiviral Agents|antiviral agents|mesh-ancestor
153428656|NCT00002420|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153428657|NCT00002420|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153428658|NCT00002420|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153428659|NCT00381368|Ibandronic Acid|ibandronic acid|mesh-list
153428660|NCT00381368|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153428661|NCT00381368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153428662|NCT04024501|Verinurad|verinurad|mesh-list
153428663|NCT04024501|Gout Suppressants|gout suppressants|mesh-ancestor
153428665|NCT05709626|Aspirin|aspirin|mesh-list
153358408|NCT00772304|Sensory System Agents|sensory system agents|mesh-ancestor
153358409|NCT00772304|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153358410|NCT00772304|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153358411|NCT01310231|Metformin|metformin|mesh-list
153358412|NCT01310231|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153358413|NCT01310231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153358414|NCT00789074|Varenicline|varenicline|mesh-list
153358415|NCT00789074|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
153358416|NCT00789074|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
153358417|NCT00789074|Cholinergic Agents|cholinergic agents|mesh-ancestor
153358418|NCT00789074|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153358419|NCT00789074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153358420|NCT00789074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153358422|NCT01338857|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153358423|NCT01338857|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153358424|NCT01338857|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153887604|NCT04325061|Protease Inhibitors|protease inhibitors|mesh-ancestor
153887605|NCT04325061|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153887606|NCT04325061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153887607|NCT01307319|Beclomethasone|beclomethasone|mesh-list
153887608|NCT01307319|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153887609|NCT01307319|Glucocorticoids|glucocorticoids|mesh-ancestor
153887610|NCT01307319|Hormones|hormones|mesh-ancestor
153887611|NCT01307319|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153887612|NCT01307319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153887613|NCT01307319|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153887614|NCT01307319|Respiratory System Agents|respiratory system agents|mesh-ancestor
153887616|NCT04365725|Antimetabolites|antimetabolites|mesh-ancestor
153887617|NCT04365725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153887618|NCT04365725|Antiviral Agents|antiviral agents|mesh-ancestor
153887619|NCT04365725|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153887620|NCT01080391|Dexamethasone|dexamethasone|mesh-list
153887621|NCT01080391|Lenalidomide|lenalidomide|mesh-list
153887622|NCT01080391|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153428666|NCT05709626|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153428667|NCT05709626|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153358430|NCT01339091|Linezolid|linezolid|mesh-list
153358431|NCT01339091|Dalbavancin|dalbavancin|mesh-list
153358441|NCT01339247|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153358442|NCT01339247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153358443|NCT01339247|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153358444|NCT01339247|Serotonin Agents|serotonin agents|mesh-ancestor
153358445|NCT01339247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153358446|NCT01339247|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
153358447|NCT01339247|Antidepressive Agents|antidepressive agents|mesh-ancestor
153358448|NCT01339247|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153358449|NCT01339247|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
153358450|NCT01339247|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153358451|NCT01339247|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153358452|NCT01339247|Antimalarials|antimalarials|mesh-ancestor
153358453|NCT01339247|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153358454|NCT01339247|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153358455|NCT01339247|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153358457|NCT00772772|Ergocalciferols|ergocalciferols|mesh-list
153358458|NCT00772772|Cholecalciferol|cholecalciferol|mesh-list
153358459|NCT00772772|Vitamins|vitamins|mesh-list
153358460|NCT00772772|Micronutrients|micronutrients|mesh-ancestor
153358461|NCT00772772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153358462|NCT00772772|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153358463|NCT00772772|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153358464|NCT00773474|Lonafarnib|lonafarnib|mesh-list
153358465|NCT00773474|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153358466|NCT00773474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153358467|NCT01310855|Gefitinib|gefitinib|mesh-list
153358468|NCT01310855|Cediranib|cediranib|mesh-list
153358469|NCT01310855|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153887625|NCT01080391|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153887626|NCT01080391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153887627|NCT01080391|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153887628|NCT01080391|Glucocorticoids|glucocorticoids|mesh-ancestor
153887629|NCT01080391|Hormones|hormones|mesh-ancestor
153887630|NCT01080391|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153887631|NCT01080391|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153887632|NCT01080391|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153887633|NCT01080391|Immunologic Factors|immunologic factors|mesh-ancestor
153887634|NCT01080391|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153887635|NCT01080391|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153887645|NCT01070329|Analgesics|analgesics|mesh-ancestor
153428695|NCT03538015|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
153428696|NCT03538015|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
153428697|NCT03342157|Bismuth subsalicylate|bismuth subsalicylate|mesh-list
153428699|NCT03342157|Antidiarrheals|antidiarrheals|mesh-ancestor
153428700|NCT03342157|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153428701|NCT03342157|Laxatives|laxatives|mesh-ancestor
153428702|NCT04331210|Diclofenac|diclofenac|mesh-list
153428703|NCT04331210|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153358470|NCT01310855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153358471|NCT01310855|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153358472|NCT01310855|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153358473|NCT01310855|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153358474|NCT00773786|Formoterol Fumarate|formoterol fumarate|mesh-list
153358475|NCT00773786|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153358477|NCT00773786|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153358478|NCT00773786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153428704|NCT04331210|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153428706|NCT04331210|Sensory System Agents|sensory system agents|mesh-ancestor
153428707|NCT04331210|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153428708|NCT04331210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153428709|NCT04331210|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153428710|NCT04331210|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153428711|NCT04331210|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153428712|NCT04331210|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153428713|NCT04331210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153428714|NCT00002426|Adefovir|adefovir|mesh-list
153428715|NCT00002426|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
153428716|NCT00002426|Antiviral Agents|antiviral agents|mesh-ancestor
153428717|NCT00002426|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153428718|NCT00002426|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153428719|NCT00002426|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153428720|NCT00002426|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153428721|NCT00002426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153428722|NCT00002432|Foscarnet|foscarnet|mesh-list
153428724|NCT00002432|Antiviral Agents|antiviral agents|mesh-ancestor
153887646|NCT01070329|Sensory System Agents|sensory system agents|mesh-ancestor
153887647|NCT01070329|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153887648|NCT01070329|Antidepressive Agents|antidepressive agents|mesh-ancestor
153887649|NCT01070329|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153887650|NCT01070329|Dopamine Agents|dopamine agents|mesh-ancestor
153887651|NCT04327427|Aspirin|aspirin|mesh-list
153887652|NCT04327427|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153887653|NCT04327427|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153887654|NCT04327427|Analgesics|analgesics|mesh-ancestor
153887655|NCT04327427|Sensory System Agents|sensory system agents|mesh-ancestor
153887657|NCT04327427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153887661|NCT04327427|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153428725|NCT00002432|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153887662|NCT04327427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153887663|NCT04327427|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153887664|NCT04327427|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153887665|NCT04327427|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153887666|NCT04327427|Antipyretics|antipyretics|mesh-ancestor
153887667|NCT02875717|Aspirin|aspirin|mesh-list
153358504|NCT03801746|Probenecid|probenecid|mesh-list
153358505|NCT03801746|Cyclosporins|cyclosporins|mesh-list
153358506|NCT03801746|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153358507|NCT03801746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153358508|NCT03801746|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153358509|NCT03801746|Immunologic Factors|immunologic factors|mesh-ancestor
153358510|NCT03801746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153358511|NCT03801746|Antifungal Agents|antifungal agents|mesh-ancestor
153358512|NCT03801746|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153358513|NCT03801746|Dermatologic Agents|dermatologic agents|mesh-ancestor
153358514|NCT03801746|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153358515|NCT03801746|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
153358516|NCT03801746|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
153358517|NCT03801746|Antitubercular Agents|antitubercular agents|mesh-ancestor
153358518|NCT03801746|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153358519|NCT03801746|Leprostatic Agents|leprostatic agents|mesh-ancestor
153358520|NCT03801746|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153358521|NCT03801746|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
153358522|NCT03801746|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
153358523|NCT03801746|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
153358524|NCT03801746|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
153887687|NCT02875717|Antipyretics|antipyretics|mesh-ancestor
153887689|NCT04334837|Trace Elements|trace elements|mesh-ancestor
153887690|NCT04334837|Micronutrients|micronutrients|mesh-ancestor
153428741|NCT05701436|Antimetabolites|antimetabolites|mesh-ancestor
153428742|NCT05701436|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153428743|NCT05701436|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153428744|NCT05701436|Immunologic Factors|immunologic factors|mesh-ancestor
153428745|NCT05701436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153428746|NCT05701436|Antidotes|antidotes|mesh-ancestor
153428747|NCT05701436|Protective Agents|protective agents|mesh-ancestor
153428748|NCT05701436|Vitamin B Complex|vitamin b complex|mesh-ancestor
153428750|NCT05701436|Micronutrients|micronutrients|mesh-ancestor
153428751|NCT05701436|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153428752|NCT02487277|Paclitaxel|paclitaxel|mesh-list
153428753|NCT02487277|Gemcitabine|gemcitabine|mesh-list
153428754|NCT02487277|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153428761|NCT02487277|Antimetabolites|antimetabolites|mesh-ancestor
153428762|NCT00002438|Itraconazole|itraconazole|mesh-list
153428763|NCT00002438|Antifungal Agents|antifungal agents|mesh-ancestor
153428764|NCT00002438|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153428765|NCT00002438|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
153428766|NCT00002438|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153428767|NCT00002438|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153428768|NCT00002438|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153428769|NCT00002438|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153428770|NCT00002438|Hormone Antagonists|hormone antagonists|mesh-ancestor
153887691|NCT04334837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153887693|NCT00593099|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
153887694|NCT00593099|Antidepressive Agents|antidepressive agents|mesh-ancestor
153887695|NCT00593099|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153887696|NCT00593099|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
153887697|NCT00593099|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153887698|NCT00593099|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153887699|NCT00593099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153887700|NCT00593099|Dopamine Agents|dopamine agents|mesh-ancestor
153358528|NCT03801746|Gout Suppressants|gout suppressants|mesh-ancestor
153358529|NCT03801668|Paclitaxel|paclitaxel|mesh-list
153358530|NCT03801668|Oxaliplatin|oxaliplatin|mesh-list
153358531|NCT03801668|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
153358532|NCT03801668|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153358533|NCT03801668|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153358534|NCT03801668|Tubulin Modulators|tubulin modulators|mesh-ancestor
153358535|NCT03801668|Antimitotic Agents|antimitotic agents|mesh-ancestor
153358536|NCT03801668|Mitosis Modulators|mitosis modulators|mesh-ancestor
153358537|NCT03801668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153358538|NCT05414006|Ketamine|ketamine|mesh-list
153358539|NCT05414006|Esketamine|esketamine|mesh-list
153358540|NCT05414006|Analgesics|analgesics|mesh-ancestor
153358541|NCT05414006|Sensory System Agents|sensory system agents|mesh-ancestor
153358542|NCT05414006|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153358543|NCT05414006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153358544|NCT05414006|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
153887706|NCT00593177|Parathyroid Hormone|parathyroid hormone|mesh-list
153887707|NCT00593177|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153887708|NCT00593177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153887709|NCT00593255|Insulin|insulin|mesh-list
153887710|NCT00593255|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
153887711|NCT00593255|Insulin Aspart|insulin aspart|mesh-list
153887712|NCT00593255|Isophane Insulin, Human|isophane insulin, human|mesh-list
153887713|NCT00593255|Insulin, Isophane|insulin, isophane|mesh-list
153887714|NCT00593255|Isophane insulin, beef|isophane insulin, beef|mesh-list
153887715|NCT00593255|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153887716|NCT00593255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153887717|NCT00593801|Epoetin Alfa|epoetin alfa|mesh-list
153887718|NCT00593801|Hematinics|hematinics|mesh-ancestor
153887719|NCT00593879|Mecamylamine|mecamylamine|mesh-list
153887720|NCT00593879|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153887721|NCT00593879|Ganglionic Blockers|ganglionic blockers|mesh-ancestor
153887722|NCT00593879|Autonomic Agents|autonomic agents|mesh-ancestor
153887723|NCT00593879|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153887724|NCT00593879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153887725|NCT00593879|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
153887726|NCT00593879|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
153887727|NCT00593879|Cholinergic Agents|cholinergic agents|mesh-ancestor
153887728|NCT00593879|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153887729|NCT00593879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153887730|NCT00594191|Simvastatin|simvastatin|mesh-list
153887731|NCT00594191|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153428784|NCT02436265|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153428785|NCT02436265|Glucocorticoids|glucocorticoids|mesh-ancestor
153428786|NCT02436265|Hormones|hormones|mesh-ancestor
153783492|NCT00236327|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153358545|NCT05414006|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153358546|NCT05414006|Anesthetics, General|anesthetics, general|mesh-ancestor
153358547|NCT05414006|Anesthetics|anesthetics|mesh-ancestor
153358548|NCT05414006|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153358549|NCT05414006|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
153358550|NCT05414006|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
153358551|NCT05414006|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153358552|NCT05414006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153358553|NCT05414006|Antidepressive Agents|antidepressive agents|mesh-ancestor
153358554|NCT05414006|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153358555|NCT02199041|Mycophenolic Acid|mycophenolic acid|mesh-list
153428787|NCT02436265|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153428788|NCT02436265|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153428789|NCT02436265|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153428790|NCT02436265|Anesthetics, Local|anesthetics, local|mesh-ancestor
153428791|NCT02436265|Anesthetics|anesthetics|mesh-ancestor
153428792|NCT02436265|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153428793|NCT02436265|Sensory System Agents|sensory system agents|mesh-ancestor
153428794|NCT05751746|Magnesium Sulfate|magnesium sulfate|mesh-list
153428795|NCT05751746|Analgesics|analgesics|mesh-ancestor
153428796|NCT05751746|Sensory System Agents|sensory system agents|mesh-ancestor
153428797|NCT05751746|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153428798|NCT05751746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153428799|NCT05751746|Anesthetics|anesthetics|mesh-ancestor
153428800|NCT05751746|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153428801|NCT05751746|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153428802|NCT05751746|Anticonvulsants|anticonvulsants|mesh-ancestor
153428803|NCT05751746|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153887740|NCT00594269|Sertraline|sertraline|mesh-list
153358560|NCT02199041|Prednisolone acetate|prednisolone acetate|mesh-list
153358561|NCT02199041|Cyclophosphamide|cyclophosphamide|mesh-list
153358562|NCT02199041|Melphalan|melphalan|mesh-list
153358563|NCT02199041|Mechlorethamine|mechlorethamine|mesh-list
153358564|NCT02199041|Thiotepa|thiotepa|mesh-list
153358565|NCT02199041|Fludarabine|fludarabine|mesh-list
153880944|NCT05842759|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153880945|NCT05842759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153880946|NCT05842759|Sympathomimetics|sympathomimetics|mesh-ancestor
153880947|NCT05842759|Autonomic Agents|autonomic agents|mesh-ancestor
153880948|NCT05842759|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153358566|NCT02199041|Tacrolimus|tacrolimus|mesh-list
153887761|NCT00594269|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153887762|NCT00594347|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
153887763|NCT00594347|Immunologic Factors|immunologic factors|mesh-ancestor
153887764|NCT00594347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153887765|NCT04326959|Triamcinolone|triamcinolone|mesh-list
153358568|NCT02199041|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
153358570|NCT02199041|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153358571|NCT02199041|Immunologic Factors|immunologic factors|mesh-ancestor
153358572|NCT02199041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153358573|NCT02199041|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153358574|NCT02199041|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153358575|NCT02199041|Alkylating Agents|alkylating agents|mesh-ancestor
153358576|NCT02199041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153358577|NCT02199041|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153358578|NCT02199041|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153428869|NCT00002492|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
153428870|NCT00002492|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153887789|NCT00595049|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
153887790|NCT00595049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153887792|NCT00595985|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153887793|NCT00595985|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153887794|NCT00595985|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153887795|NCT00595985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153887796|NCT00596063|Insulin|insulin|mesh-list
153887797|NCT00596063|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153887798|NCT00596063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153887799|NCT00596219|Celecoxib|celecoxib|mesh-list
153887800|NCT00596219|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153887801|NCT00596219|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153887802|NCT00596219|Analgesics|analgesics|mesh-ancestor
153887803|NCT00596219|Sensory System Agents|sensory system agents|mesh-ancestor
153887804|NCT00596219|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153887805|NCT00596219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153887806|NCT00596219|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153887807|NCT00596219|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153887808|NCT00596219|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
153887809|NCT00596219|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153887810|NCT00596219|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153887811|NCT00596219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153887812|NCT00596297|Bevacizumab|bevacizumab|mesh-list
153887813|NCT00596297|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153887814|NCT00596297|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153428872|NCT00002492|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153428873|NCT00002492|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153428874|NCT00002492|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153428875|NCT00002492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153428876|NCT05751512|Methotrexate|methotrexate|mesh-list
153428877|NCT05751512|Cetuximab|cetuximab|mesh-list
153428878|NCT05751512|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
153428879|NCT05751512|Abortifacient Agents|abortifacient agents|mesh-ancestor
153428880|NCT05751512|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153428881|NCT05751512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153428882|NCT05751512|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153428883|NCT05751512|Antimetabolites|antimetabolites|mesh-ancestor
153428884|NCT05751512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153428885|NCT05751512|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153428886|NCT05751512|Dermatologic Agents|dermatologic agents|mesh-ancestor
153428887|NCT05751512|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153428888|NCT05751512|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153428889|NCT05751512|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153428890|NCT05751512|Immunologic Factors|immunologic factors|mesh-ancestor
153428891|NCT05751512|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153428892|NCT05751512|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153887849|NCT00597233|Insulin, Isophane|insulin, isophane|mesh-list
153887850|NCT00597233|Isophane insulin, beef|isophane insulin, beef|mesh-list
153887851|NCT00597233|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153887852|NCT00597233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153887853|NCT01064401|Interferons|interferons|mesh-list
153358579|NCT02199041|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
153358580|NCT02199041|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153358581|NCT02199041|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153358582|NCT02199041|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
153358583|NCT02199041|Antitubercular Agents|antitubercular agents|mesh-ancestor
153358584|NCT02199041|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153358585|NCT02199041|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153358586|NCT02199041|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153358587|NCT02199041|Antiemetics|antiemetics|mesh-ancestor
153358588|NCT02199041|Autonomic Agents|autonomic agents|mesh-ancestor
153358603|NCT00789776|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153358604|NCT00789776|Immunologic Factors|immunologic factors|mesh-ancestor
153358605|NCT00789776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153358606|NCT00789776|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153880950|NCT05779007|Pirfenidone|pirfenidone|mesh-list
153429054|NCT00002534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153358625|NCT03801590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153358627|NCT03801590|Dermatologic Agents|dermatologic agents|mesh-ancestor
153429145|NCT00378781|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153429149|NCT00377923|Progesterone|progesterone|mesh-list
153429168|NCT00002570|Vitamin B Complex|vitamin b complex|mesh-ancestor
153429169|NCT00002570|Vitamins|vitamins|mesh-ancestor
153429170|NCT00002570|Micronutrients|micronutrients|mesh-ancestor
153429171|NCT00002576|Prednisolone|prednisolone|mesh-list
153429172|NCT00002576|Cyclophosphamide|cyclophosphamide|mesh-list
153429173|NCT00002576|Doxorubicin|doxorubicin|mesh-list
153429174|NCT00002576|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
153429175|NCT00002576|Vincristine|vincristine|mesh-list
153429176|NCT00002576|Mitoxantrone|mitoxantrone|mesh-list
153429177|NCT00002576|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153429178|NCT00002576|Immunologic Factors|immunologic factors|mesh-ancestor
153888120|NCT00623207|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153888121|NCT00623207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153888122|NCT00623207|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153888123|NCT00623207|Respiratory System Agents|respiratory system agents|mesh-ancestor
153888124|NCT00623207|Mydriatics|mydriatics|mesh-ancestor
153888125|NCT00623207|Parasympatholytics|parasympatholytics|mesh-ancestor
153358643|NCT00775658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153358644|NCT02199197|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
153358645|NCT02199197|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153358647|NCT00799604|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153358648|NCT00799604|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153888126|NCT00623207|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
153888127|NCT00623207|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
153888128|NCT00623207|Cholinergic Agents|cholinergic agents|mesh-ancestor
153888129|NCT00623207|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153888130|NCT00623207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153888132|NCT00600977|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
153888133|NCT00600977|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153429194|NCT00002576|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153429197|NCT00002576|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153429198|NCT00002576|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153358649|NCT00799604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153358650|NCT00799604|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153358651|NCT00799604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153358652|NCT01259063|Gemcitabine|gemcitabine|mesh-list
153358654|NCT01259063|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153358655|NCT01259063|Antimetabolites|antimetabolites|mesh-ancestor
153358656|NCT01259063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153358657|NCT01259063|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153358658|NCT01259063|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
153358659|NCT01259063|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153358660|NCT01259063|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153358661|NCT01259063|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153358662|NCT01259063|Immunologic Factors|immunologic factors|mesh-ancestor
153358663|NCT01259063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153358664|NCT04383548|Immunoglobulins|immunoglobulins|mesh-list
153358665|NCT04383548|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
153358667|NCT04383548|Immunologic Factors|immunologic factors|mesh-ancestor
153358668|NCT04383548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153358669|NCT01313897|Bortezomib|bortezomib|mesh-list
153429199|NCT00002576|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153429200|NCT00002576|Analgesics|analgesics|mesh-ancestor
153429212|NCT00002582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153429213|NCT00002582|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153429214|NCT00002582|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153429215|NCT00002582|Alkylating Agents|alkylating agents|mesh-ancestor
153429216|NCT00002582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153429217|NCT00002582|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153429218|NCT00002582|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153429223|NCT00002582|Antimetabolites|antimetabolites|mesh-ancestor
153421821|NCT05434689|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153421822|NCT05431595|Valproic Acid|valproic acid|mesh-list
153421823|NCT05431595|Haloperidol|haloperidol|mesh-list
153421824|NCT05431595|Chlorpromazine|chlorpromazine|mesh-list
153358684|NCT04351763|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
153358685|NCT04351763|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
153358687|NCT04351763|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153358688|NCT04351763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153888154|NCT00601913|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
153888155|NCT00601913|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153888158|NCT00601913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153888161|NCT00601991|Endothelial Growth Factors|endothelial growth factors|mesh-list
153888162|NCT00601991|Growth Substances|growth substances|mesh-ancestor
153888163|NCT00601991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153888164|NCT00601991|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153888165|NCT00601991|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153888166|NCT00601991|Growth Inhibitors|growth inhibitors|mesh-ancestor
153888167|NCT00601991|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153429232|NCT00002582|Hormone Antagonists|hormone antagonists|mesh-ancestor
153888179|NCT04325633|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153358689|NCT00801398|Oxymorphone|oxymorphone|mesh-list
153358690|NCT00801398|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153358691|NCT00801398|Narcotics|narcotics|mesh-ancestor
153358692|NCT00801398|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153358693|NCT00801398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153358694|NCT00801398|Analgesics|analgesics|mesh-ancestor
153358695|NCT00801398|Sensory System Agents|sensory system agents|mesh-ancestor
153783493|NCT00236327|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153358696|NCT00801398|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153358697|NCT00801398|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153358699|NCT01342523|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
153358700|NCT01342523|Autonomic Agents|autonomic agents|mesh-ancestor
153358714|NCT01342757|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
153358715|NCT01342757|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153358717|NCT02199743|Haloperidol decanoate|haloperidol decanoate|mesh-list
153358718|NCT02199743|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
153358719|NCT02199743|Perphenazine|perphenazine|mesh-list
153358720|NCT02199743|Antiemetics|antiemetics|mesh-ancestor
153358721|NCT02199743|Autonomic Agents|autonomic agents|mesh-ancestor
153358722|NCT02199743|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153358723|NCT02199743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153358724|NCT02199743|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153358725|NCT02199743|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153358726|NCT02199743|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153358727|NCT02199743|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153358728|NCT02199743|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153888180|NCT04325633|Gout Suppressants|gout suppressants|mesh-ancestor
153429262|NCT02239627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153429263|NCT05750576|Chlorhexidine|chlorhexidine|mesh-list
153429264|NCT05750576|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
153429265|NCT05750576|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153429266|NCT05750576|Disinfectants|disinfectants|mesh-ancestor
153429267|NCT00002594|Cyclophosphamide|cyclophosphamide|mesh-list
153429268|NCT00002594|Melphalan|melphalan|mesh-list
153429269|NCT00002594|Molgramostim|molgramostim|mesh-list
153358729|NCT02199743|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
153358730|NCT02199743|Dopamine Agents|dopamine agents|mesh-ancestor
153358731|NCT02199743|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153429270|NCT00002594|Sargramostim|sargramostim|mesh-list
153429271|NCT00002594|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153358732|NCT02199743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153358733|NCT02199743|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
153358734|NCT02199743|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
153358735|NCT02199743|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
153358736|NCT02199743|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
153358737|NCT02199743|Adrenergic Agents|adrenergic agents|mesh-ancestor
153358738|NCT02199743|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
153358739|NCT02199743|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153783495|NCT00236327|Anesthetics, General|anesthetics, general|mesh-ancestor
153429290|NCT02234011|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
153429291|NCT02234011|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
153429292|NCT02234011|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153429293|NCT02234011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153429294|NCT00002600|Cyclophosphamide|cyclophosphamide|mesh-list
153429295|NCT00002600|Carboplatin|carboplatin|mesh-list
153429296|NCT00002600|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153429297|NCT00002600|Immunologic Factors|immunologic factors|mesh-ancestor
153429298|NCT00002600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153429299|NCT00002600|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153429300|NCT00002600|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153429313|NCT02144155|Oxytocics|oxytocics|mesh-ancestor
153429314|NCT02144155|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153888220|NCT00626977|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153888221|NCT00626977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153888223|NCT04303819|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
153888224|NCT04303819|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153888225|NCT04303819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153888226|NCT04303819|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
153888227|NCT04303819|Incretins|incretins|mesh-ancestor
153888248|NCT05271721|Antiemetics|antiemetics|mesh-ancestor
153429316|NCT00002618|Leucovorin|leucovorin|mesh-list
153880961|NCT05779007|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153880964|NCT05731323|Cycloserine|cycloserine|mesh-list
153783506|NCT00236366|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153783507|NCT00236366|Anesthetics, General|anesthetics, general|mesh-ancestor
153358758|NCT00777062|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
153358759|NCT00777062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153358760|NCT00777062|Sensory System Agents|sensory system agents|mesh-ancestor
153358761|NCT00777062|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153358762|NCT01318577|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
153429479|NCT00002678|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153429480|NCT00002678|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153358764|NCT01318967|Diuretics|diuretics|mesh-ancestor
153429481|NCT00002678|Alkylating Agents|alkylating agents|mesh-ancestor
153429482|NCT00002678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153888386|NCT04309240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153888387|NCT04309240|Anticoagulants|anticoagulants|mesh-ancestor
153888388|NCT01035229|Everolimus|everolimus|mesh-list
153888409|NCT01106092|Vaccines|vaccines|mesh-list
153358768|NCT01318967|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153358769|NCT01318967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153358770|NCT01319045|Iloprost|iloprost|mesh-list
153358771|NCT01319045|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153358772|NCT01319045|Vasodilator Agents|vasodilator agents|mesh-ancestor
153358773|NCT01348607|Methylphenidate|methylphenidate|mesh-list
153888437|NCT01095094|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
153888438|NCT01095094|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
153888439|NCT01095094|Protease Inhibitors|protease inhibitors|mesh-ancestor
153888440|NCT01095094|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153429539|NCT00002696|Abortifacient Agents|abortifacient agents|mesh-ancestor
153429540|NCT00002696|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153429541|NCT00002696|Dermatologic Agents|dermatologic agents|mesh-ancestor
153429569|NCT01303003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153429570|NCT01303003|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153429571|NCT01303003|Glucocorticoids|glucocorticoids|mesh-ancestor
153429572|NCT01303003|Hormones|hormones|mesh-ancestor
153358778|NCT01348607|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153358779|NCT01348607|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153358780|NCT01348607|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153358782|NCT01348607|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153358783|NCT01348607|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
153429605|NCT00002720|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153429606|NCT00002720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153358792|NCT06214572|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153358793|NCT06214572|Tubulin Modulators|tubulin modulators|mesh-ancestor
153358794|NCT06214572|Antimitotic Agents|antimitotic agents|mesh-ancestor
153358795|NCT06214572|Mitosis Modulators|mitosis modulators|mesh-ancestor
153423484|NCT03249272|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153358796|NCT06214572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153358797|NCT06214572|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153358799|NCT06214572|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153358800|NCT06214533|Ropivacaine|ropivacaine|mesh-list
153358801|NCT06214533|Anesthetics, Local|anesthetics, local|mesh-ancestor
153358802|NCT06214533|Anesthetics|anesthetics|mesh-ancestor
153358803|NCT06214533|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153358804|NCT06214533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153358805|NCT06214533|Sensory System Agents|sensory system agents|mesh-ancestor
153358806|NCT06214533|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153358807|NCT06214468|Acetaminophen|acetaminophen|mesh-list
153358808|NCT06214468|Niacinamide|niacinamide|mesh-list
153358810|NCT06214468|Nicotinic Acids|nicotinic acids|mesh-list
153358811|NCT06214468|Vitamins|vitamins|mesh-ancestor
153358812|NCT06214468|Micronutrients|micronutrients|mesh-ancestor
153358813|NCT06214468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153358814|NCT06214468|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153358815|NCT06214468|Analgesics|analgesics|mesh-ancestor
153358816|NCT06214468|Sensory System Agents|sensory system agents|mesh-ancestor
153429607|NCT00002720|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153429608|NCT00002720|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153429609|NCT00002720|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
153429610|NCT00002720|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
153429611|NCT00002720|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153429613|NCT01821859|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
153429614|NCT01821859|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153429615|NCT01821859|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153888513|NCT01318811|Heparin|heparin|mesh-list
153888514|NCT01318811|Calcium heparin|calcium heparin|mesh-list
153888515|NCT01318811|Anticoagulants|anticoagulants|mesh-ancestor
153888516|NCT01318811|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153888535|NCT01093534|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
153888536|NCT01093534|Cholinergic Agents|cholinergic agents|mesh-ancestor
153888537|NCT01093534|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153888538|NCT01093534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153888539|NCT01093534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153888540|NCT01093534|Urological Agents|urological agents|mesh-ancestor
153888541|NCT01314911|Oseltamivir|oseltamivir|mesh-list
153888542|NCT01314911|Antiviral Agents|antiviral agents|mesh-ancestor
153888543|NCT01314911|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153888544|NCT01314911|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153888545|NCT01314911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153888546|NCT01093222|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
153888547|NCT01093222|Sorafenib|sorafenib|mesh-list
153888548|NCT01093222|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153429619|NCT01821859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153429620|NCT01821859|Growth Inhibitors|growth inhibitors|mesh-ancestor
153429621|NCT05600023|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
153429622|NCT05600023|Nitrofurantoin|nitrofurantoin|mesh-list
153429625|NCT01194427|Tamoxifen|tamoxifen|mesh-list
153429626|NCT01194427|Vorinostat|vorinostat|mesh-list
153429627|NCT01194427|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
153429628|NCT01194427|Hormone Antagonists|hormone antagonists|mesh-ancestor
153429629|NCT01194427|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153429630|NCT01194427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153358823|NCT06214468|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153358824|NCT06214468|Vasodilator Agents|vasodilator agents|mesh-ancestor
153358826|NCT06214377|Dopamine Agonists|dopamine agonists|mesh-list
153358827|NCT06214377|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
153358828|NCT06214377|Sympathomimetics|sympathomimetics|mesh-ancestor
153358829|NCT06214377|Autonomic Agents|autonomic agents|mesh-ancestor
153358830|NCT06214377|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153358831|NCT06214377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153783509|NCT04547179|Erenumab|erenumab|mesh-list
153783510|NCT04547179|Calcitonin Gene-Related Peptide Receptor Antagonists|calcitonin gene-related peptide receptor antagonists|mesh-ancestor
153358832|NCT06214377|Dopamine Agents|dopamine agents|mesh-ancestor
153358833|NCT06214377|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153358834|NCT06214377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153358835|NCT06214377|Protective Agents|protective agents|mesh-ancestor
153358836|NCT06214169|Lidocaine|lidocaine|mesh-list
153358837|NCT06214169|Cisatracurium|cisatracurium|mesh-list
153888553|NCT02878018|Hormones|hormones|mesh-list
153888554|NCT02878018|Adrenergic Agents|adrenergic agents|mesh-list
153888555|NCT02878018|Immunosuppressive Agents|immunosuppressive agents|mesh-list
153888556|NCT02878018|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
153888557|NCT02878018|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153888558|NCT02878018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153888559|NCT02878018|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153429634|NCT01194427|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
153429635|NCT01194427|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153429636|NCT01194427|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
153429637|NCT01194427|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153429638|NCT01194427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153429640|NCT05599555|Immunologic Factors|immunologic factors|mesh-ancestor
153429641|NCT05599555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153358840|NCT06214169|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153358841|NCT06214169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153358842|NCT06214169|Sensory System Agents|sensory system agents|mesh-ancestor
153358843|NCT06214169|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153358844|NCT06214169|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153358845|NCT06214169|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
153358846|NCT06214169|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153358848|NCT06214169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153358849|NCT06214169|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
153358850|NCT06214169|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
153358851|NCT06214117|Anesthetics|anesthetics|mesh-list
153358852|NCT06214117|Sevoflurane|sevoflurane|mesh-list
153358853|NCT06214117|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153358854|NCT06214117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153358855|NCT06214117|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153358856|NCT06214117|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
153358857|NCT06214117|Anesthetics, General|anesthetics, general|mesh-ancestor
153358858|NCT06214078|Niacinamide|niacinamide|mesh-list
153358860|NCT06214078|Nicotinic Acids|nicotinic acids|mesh-list
153358861|NCT06214078|Vitamin B Complex|vitamin b complex|mesh-ancestor
153358862|NCT06214078|Vitamins|vitamins|mesh-ancestor
153358863|NCT06214078|Micronutrients|micronutrients|mesh-ancestor
153358864|NCT06214078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153358865|NCT06214078|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153358866|NCT06214078|Antimetabolites|antimetabolites|mesh-ancestor
153358867|NCT06214078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153358868|NCT06214078|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153888563|NCT02878018|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153888564|NCT01313663|Pemetrexed|pemetrexed|mesh-list
153888565|NCT01313663|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153888566|NCT01313663|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153888567|NCT01313663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153888568|NCT01313663|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153888569|NCT01313663|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153888570|NCT01092832|Voriconazole|voriconazole|mesh-list
153429660|NCT00002738|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153429661|NCT04706455|Hyaluronic Acid|hyaluronic acid|mesh-list
153429662|NCT04706455|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153429663|NCT04706455|Immunologic Factors|immunologic factors|mesh-ancestor
153888576|NCT01092832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153358881|NCT06213948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153358882|NCT06213948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153358883|NCT06213948|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153358884|NCT06213948|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153358885|NCT06213948|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153358886|NCT06213948|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
153358887|NCT06213948|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
153358888|NCT06213948|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
153358889|NCT06213948|Adrenergic Agents|adrenergic agents|mesh-ancestor
153358890|NCT06213948|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
153358891|NCT06213948|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153358892|NCT06213948|Serotonin Agents|serotonin agents|mesh-ancestor
153358893|NCT06213948|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
153888585|NCT02878564|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153888587|NCT04308070|Coagulants|coagulants|mesh-ancestor
153888588|NCT01313273|Ascorbic Acid|ascorbic acid|mesh-list
153888589|NCT01313273|Methyltestosterone|methyltestosterone|mesh-list
153888590|NCT01313273|Lanreotide|lanreotide|mesh-list
153429672|NCT00002744|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
153429673|NCT00002744|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
153358894|NCT06213935|Norepinephrine|norepinephrine|mesh-list
153358895|NCT06213935|Midodrine|midodrine|mesh-list
153358896|NCT06213935|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153358897|NCT06213935|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153358898|NCT06213935|Adrenergic Agents|adrenergic agents|mesh-ancestor
153358899|NCT06213935|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153358900|NCT06213935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153358901|NCT06213935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153429717|NCT00002744|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153429719|NCT00002744|Antimitotic Agents|antimitotic agents|mesh-ancestor
153429720|NCT00002744|Mitosis Modulators|mitosis modulators|mesh-ancestor
153429721|NCT00002744|Trace Elements|trace elements|mesh-ancestor
153888634|NCT01312961|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
153888635|NCT01312961|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
153888636|NCT01312961|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153888637|NCT01312961|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153888638|NCT01312961|Autonomic Agents|autonomic agents|mesh-ancestor
153888639|NCT01312961|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153888640|NCT01312961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153888647|NCT01312961|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153888648|NCT01312961|Adrenergic Agents|adrenergic agents|mesh-ancestor
153429733|NCT01788475|Hormones|hormones|mesh-ancestor
153429734|NCT01788475|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153429735|NCT01788475|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153429736|NCT01788475|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153429740|NCT01183897|Immunomodulating Agents|immunomodulating agents|mesh-list
153429741|NCT01183897|Immunologic Factors|immunologic factors|mesh-ancestor
153429742|NCT01183897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153429744|NCT00381914|Ergocalciferols|ergocalciferols|mesh-list
153429745|NCT00381914|Cholecalciferol|cholecalciferol|mesh-list
153429747|NCT00381914|Micronutrients|micronutrients|mesh-ancestor
153429748|NCT00381914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153429749|NCT00381914|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153429750|NCT00381914|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153429751|NCT00423007|Bromfenac|bromfenac|mesh-list
153429752|NCT00423007|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153429754|NCT00423007|Analgesics|analgesics|mesh-ancestor
153429755|NCT00423007|Sensory System Agents|sensory system agents|mesh-ancestor
153358917|NCT06213662|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
153358918|NCT06213662|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153358932|NCT06213519|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153358934|NCT06213506|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
153358935|NCT06213506|Immunologic Factors|immunologic factors|mesh-ancestor
153358936|NCT06213506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153358937|NCT06213311|Obinutuzumab|obinutuzumab|mesh-list
153358938|NCT06213311|Axicabtagene ciloleucel|axicabtagene ciloleucel|mesh-list
153358939|NCT06213311|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153358940|NCT06213311|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153888774|NCT01034137|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153888775|NCT01034137|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153358941|NCT06213116|Lidocaine|lidocaine|mesh-list
153888776|NCT01034137|Immunologic Factors|immunologic factors|mesh-ancestor
153429898|NCT00002780|Thiotepa|thiotepa|mesh-list
153358949|NCT06213116|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
153358950|NCT06213116|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153358951|NCT06213116|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153387718|NCT00000243|Sensory System Agents|sensory system agents|mesh-ancestor
153358952|NCT06213116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153358954|NCT06213077|Tadalafil|tadalafil|mesh-list
153358955|NCT06213077|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153358956|NCT06213077|Autonomic Agents|autonomic agents|mesh-ancestor
153358957|NCT06213077|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153358958|NCT06213077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153358959|NCT06213077|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153358960|NCT06213077|Respiratory System Agents|respiratory system agents|mesh-ancestor
153358961|NCT06213077|Free Radical Scavengers|free radical scavengers|mesh-ancestor
153358962|NCT06213077|Antioxidants|antioxidants|mesh-ancestor
153358963|NCT06213077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153358964|NCT06213077|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153888805|NCT01033825|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153888806|NCT01033825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153888807|NCT01033825|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153888808|NCT01033825|Glucocorticoids|glucocorticoids|mesh-ancestor
153888809|NCT01033825|Hormones|hormones|mesh-ancestor
153888810|NCT01033825|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153888812|NCT01033825|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153429915|NCT01692691|Carmustine|carmustine|mesh-list
153358965|NCT06213077|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
153358966|NCT06213077|Vasodilator Agents|vasodilator agents|mesh-ancestor
153358967|NCT06213077|Gasotransmitters|gasotransmitters|mesh-ancestor
153358968|NCT06213077|Protective Agents|protective agents|mesh-ancestor
153358969|NCT06213077|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
153358970|NCT06213077|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
153358971|NCT06213077|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153358972|NCT06213077|Urological Agents|urological agents|mesh-ancestor
153358973|NCT06212973|Azelastine|azelastine|mesh-list
153358974|NCT06212973|Epinastine|epinastine|mesh-list
153358975|NCT06212973|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153421837|NCT05431595|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153421838|NCT05431595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153429932|NCT01122511|Hormones|hormones|mesh-ancestor
153421839|NCT05431595|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
153421840|NCT05431595|Anticonvulsants|anticonvulsants|mesh-ancestor
153421841|NCT05431595|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153358985|NCT06212973|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
153358986|NCT06212973|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
153358987|NCT06212973|Histamine Antagonists|histamine antagonists|mesh-ancestor
153358988|NCT06212973|Histamine Agents|histamine agents|mesh-ancestor
153358989|NCT06212973|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153358990|NCT06212934|Estazolam|estazolam|mesh-list
153358991|NCT06212934|Anticonvulsants|anticonvulsants|mesh-ancestor
153358992|NCT06212934|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153358993|NCT06212934|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153358994|NCT06212934|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153358995|NCT06212934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153358996|NCT06212934|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153358997|NCT06212934|GABA Modulators|gaba modulators|mesh-ancestor
153429933|NCT01122511|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153429934|NCT01122511|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153429935|NCT01122511|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153429936|NCT01122511|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153429937|NCT01122511|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153429939|NCT01122511|Growth Inhibitors|growth inhibitors|mesh-ancestor
153429940|NCT05535218|Pembrolizumab|pembrolizumab|mesh-list
153429941|NCT05535218|Sacituzumab govitecan|sacituzumab govitecan|mesh-list
153429942|NCT05535218|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153429943|NCT05535218|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153429944|NCT05535218|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153429945|NCT05535218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153429946|NCT05535218|Immunoconjugates|immunoconjugates|mesh-ancestor
153429947|NCT05535218|Immunologic Factors|immunologic factors|mesh-ancestor
153358998|NCT06212934|GABA Agents|gaba agents|mesh-ancestor
153888843|NCT01096342|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153359039|NCT06212596|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153359040|NCT06212596|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153359041|NCT06212596|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153359042|NCT06212596|Glucocorticoids|glucocorticoids|mesh-ancestor
153359043|NCT06212596|Hormones|hormones|mesh-ancestor
153888901|NCT01095796|Efavirenz, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|efavirenz, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
153888903|NCT01095796|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153888911|NCT01023061|Prednisone|prednisone|mesh-list
153359044|NCT06212596|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153359045|NCT06212596|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153359059|NCT06210126|Anesthetics|anesthetics|mesh-list
153359060|NCT06210126|Anesthetics, Local|anesthetics, local|mesh-list
153359061|NCT06210126|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153359062|NCT06210126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153359063|NCT06210126|Sensory System Agents|sensory system agents|mesh-ancestor
153430029|NCT05513612|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153359064|NCT06210126|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153359065|NCT06209606|Methylprednisolone|methylprednisolone|mesh-list
153359066|NCT06209606|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
153359067|NCT06209606|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
153359068|NCT06209606|Prednisolone|prednisolone|mesh-list
153359069|NCT06209606|Prednisolone acetate|prednisolone acetate|mesh-list
153359070|NCT06209606|Lenalidomide|lenalidomide|mesh-list
153359071|NCT06209606|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
153359072|NCT06209606|Prednisolone phosphate|prednisolone phosphate|mesh-list
153359073|NCT06209606|Immunologic Factors|immunologic factors|mesh-ancestor
153888964|NCT01294449|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153888965|NCT01294449|Immunologic Factors|immunologic factors|mesh-ancestor
153888966|NCT01294449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153888967|NCT01294449|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153888968|NCT01294449|Antiemetics|antiemetics|mesh-ancestor
153430069|NCT00379717|Cisplatin|cisplatin|mesh-list
153430070|NCT00379717|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153430071|NCT00379717|Tubulin Modulators|tubulin modulators|mesh-ancestor
153430072|NCT00379717|Antimitotic Agents|antimitotic agents|mesh-ancestor
153430073|NCT00379717|Mitosis Modulators|mitosis modulators|mesh-ancestor
153430074|NCT00379717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153430075|NCT04706377|Vitamin B 12|vitamin b 12|mesh-list
153430076|NCT04706377|Vitamins|vitamins|mesh-ancestor
153430077|NCT04706377|Micronutrients|micronutrients|mesh-ancestor
153430079|NCT04706377|Vitamin B Complex|vitamin b complex|mesh-ancestor
153430117|NCT01555489|Antioxidants|antioxidants|mesh-ancestor
153430118|NCT01555489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153430119|NCT01555489|Protective Agents|protective agents|mesh-ancestor
153430120|NCT01035073|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
153430121|NCT01035073|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
153430122|NCT01035073|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153430123|NCT01035073|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153430124|NCT01035073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153430125|NCT01035073|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153430126|NCT01035073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153430127|NCT01035073|Analgesics|analgesics|mesh-ancestor
153430128|NCT01035073|Sensory System Agents|sensory system agents|mesh-ancestor
153430129|NCT01035073|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153889016|NCT01026493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153359087|NCT06209606|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153889044|NCT01289847|Immunologic Factors|immunologic factors|mesh-ancestor
153889045|NCT01289847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153430149|NCT05296759|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153430150|NCT05296759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153430151|NCT05296759|Cholinergic Agents|cholinergic agents|mesh-ancestor
153430152|NCT05296759|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153430153|NCT05296759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153430154|NCT05296759|Analgesics|analgesics|mesh-ancestor
153430155|NCT05296759|Sensory System Agents|sensory system agents|mesh-ancestor
153430160|NCT05296759|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153430162|NCT05296759|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
153359088|NCT06209606|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
153359089|NCT06209606|Protective Agents|protective agents|mesh-ancestor
153359090|NCT06209606|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153359092|NCT06202014|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153359093|NCT06202014|Antimetabolites|antimetabolites|mesh-ancestor
153359094|NCT06202014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153359095|NCT06202014|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153359096|NCT06200194|Atropine|atropine|mesh-list
153889063|NCT01021423|Growth Inhibitors|growth inhibitors|mesh-ancestor
153889064|NCT01021423|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153889065|NCT01020877|Metronidazole|metronidazole|mesh-list
153889066|NCT01020877|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153889067|NCT01020877|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153430172|NCT05546047|Immunologic Factors|immunologic factors|mesh-ancestor
153430173|NCT05546047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153430182|NCT01532635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153430183|NCT01532635|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153889092|NCT02872597|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153379689|NCT03003416|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153379690|NCT03003416|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153889093|NCT02872597|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153359097|NCT06200194|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153889094|NCT02872597|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153889095|NCT02872597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153889096|NCT02872597|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
153359098|NCT06200194|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153359099|NCT06200194|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153889097|NCT02872597|Protective Agents|protective agents|mesh-ancestor
153889098|NCT02872597|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153889099|NCT02872597|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153359100|NCT06200194|Autonomic Agents|autonomic agents|mesh-ancestor
153359101|NCT06200194|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153359102|NCT06200194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153359103|NCT06200194|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153359104|NCT06200194|Respiratory System Agents|respiratory system agents|mesh-ancestor
153359105|NCT06200194|Mydriatics|mydriatics|mesh-ancestor
153359106|NCT06200194|Parasympatholytics|parasympatholytics|mesh-ancestor
153359107|NCT06200194|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
153359108|NCT06200194|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
153359109|NCT06200194|Cholinergic Agents|cholinergic agents|mesh-ancestor
153359120|NCT06174688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153359121|NCT06174688|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
153359122|NCT06174688|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153359123|NCT06164951|Infigratinib|infigratinib|mesh-list
153359124|NCT06164951|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153359126|NCT06108830|Esketamine|esketamine|mesh-list
153359127|NCT06108830|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153359128|NCT06108830|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153359129|NCT06108830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153359135|NCT06089577|Cangrelor|cangrelor|mesh-list
153359136|NCT06089577|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153359137|NCT06089577|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
153359138|NCT06089577|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
153359140|NCT06089577|Purinergic Agents|purinergic agents|mesh-ancestor
153359141|NCT06089577|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153359142|NCT06089577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153359143|NCT06089577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153359144|NCT06089395|Ubiquinone|ubiquinone|mesh-list
153359145|NCT06089395|Coenzyme Q10|coenzyme q10|mesh-list
153359146|NCT06089395|Micronutrients|micronutrients|mesh-ancestor
153359147|NCT06089395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153889101|NCT02872597|Tocolytic Agents|tocolytic agents|mesh-ancestor
153889102|NCT02872597|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153889103|NCT02872597|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
153889104|NCT02872597|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
153430210|NCT00539617|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153430211|NCT00539617|Immunologic Factors|immunologic factors|mesh-ancestor
153430212|NCT00539617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153430213|NCT00539617|Antidotes|antidotes|mesh-ancestor
153430214|NCT00539617|Protective Agents|protective agents|mesh-ancestor
153430215|NCT00539617|Vitamin B Complex|vitamin b complex|mesh-ancestor
153430217|NCT00539617|Micronutrients|micronutrients|mesh-ancestor
153430218|NCT00539617|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153359154|NCT06077721|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153783513|NCT04547179|Sensory System Agents|sensory system agents|mesh-ancestor
153783514|NCT04547179|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153783515|NCT04547179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153783517|NCT00236405|Hematinics|hematinics|mesh-ancestor
153430232|NCT00976339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153430233|NCT00976339|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153430234|NCT00976339|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153430236|NCT04579640|Vitamins|vitamins|mesh-ancestor
153430237|NCT04579640|Micronutrients|micronutrients|mesh-ancestor
153430238|NCT04579640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153430239|NCT04579640|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153430240|NCT00523939|Cytarabine|cytarabine|mesh-list
153430241|NCT00523939|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153889105|NCT02872597|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153889106|NCT02872597|Adrenergic Agents|adrenergic agents|mesh-ancestor
153889107|NCT02872597|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153889108|NCT02872597|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
153889122|NCT02873065|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153889123|NCT02873065|Diuretics|diuretics|mesh-ancestor
153889124|NCT02873065|Natriuretic Agents|natriuretic agents|mesh-ancestor
153889125|NCT02873065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153889126|NCT02873065|Expectorants|expectorants|mesh-ancestor
153889127|NCT02873065|Respiratory System Agents|respiratory system agents|mesh-ancestor
153889128|NCT00628225|Bupropion|bupropion|mesh-list
153889129|NCT00628225|Nicotine|nicotine|mesh-list
153889130|NCT00628225|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
153889131|NCT00628225|Autonomic Agents|autonomic agents|mesh-ancestor
153889132|NCT00628225|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153889133|NCT00628225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153889134|NCT00628225|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
153889135|NCT00628225|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
153359161|NCT06077721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153359162|NCT06068673|Clindamycin|clindamycin|mesh-list
153359163|NCT06068673|Clindamycin palmitate|clindamycin palmitate|mesh-list
153359164|NCT06068673|Clindamycin phosphate|clindamycin phosphate|mesh-list
153359165|NCT06068673|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153359166|NCT06068673|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153359167|NCT06068673|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
153359168|NCT06068673|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153359169|NCT06068673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153359170|NCT06065280|Dapagliflozin|dapagliflozin|mesh-list
153359171|NCT06065280|Empagliflozin|empagliflozin|mesh-list
153359172|NCT06065280|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
153359173|NCT06065280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153359174|NCT06065280|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153359175|NCT06065280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153359176|NCT05942300|Carboplatin|carboplatin|mesh-list
153359177|NCT05942300|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153359178|NCT05927142|poly(I).poly(c12,U)|poly(i).poly(c12,u)|mesh-list
153359179|NCT05927142|Durvalumab|durvalumab|mesh-list
153359180|NCT05927142|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153359181|NCT05927142|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153359182|NCT05927142|Antiviral Agents|antiviral agents|mesh-ancestor
153359183|NCT05927142|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153359184|NCT05916690|Bleomycin|bleomycin|mesh-list
153359185|NCT05916690|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153359186|NCT05916690|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153359187|NCT05899465|Tranexamic Acid|tranexamic acid|mesh-list
153359188|NCT05899465|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
153359189|NCT05899465|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153359190|NCT05899465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153880979|NCT05629260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153880980|NCT05629260|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153880981|NCT05629260|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153359196|NCT05885074|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153889151|NCT01014013|Third Generation Cephalosporins|third generation cephalosporins|mesh-ancestor
153889152|NCT01014013|Beta Lactam Antibiotics|beta lactam antibiotics|mesh-ancestor
153889153|NCT01014013|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153889154|NCT01014013|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153889156|NCT01013701|Xhance|xhance|mesh-list
153889157|NCT01013701|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153889158|NCT01013701|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153430264|NCT00382538|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
153430265|NCT00382538|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
153430266|NCT00954187|Pregabalin|pregabalin|mesh-list
153430267|NCT00954187|Gabapentin|gabapentin|mesh-list
153430268|NCT00954187|Analgesics|analgesics|mesh-ancestor
153430269|NCT00954187|Sensory System Agents|sensory system agents|mesh-ancestor
153430270|NCT00954187|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153430271|NCT00954187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153430272|NCT00954187|Anticonvulsants|anticonvulsants|mesh-ancestor
153430273|NCT00954187|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153430274|NCT00954187|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153430275|NCT00954187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153359197|NCT05885074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153359199|NCT05869591|Edoxaban|edoxaban|mesh-list
153359200|NCT05869591|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
153359201|NCT05869591|Antithrombins|antithrombins|mesh-ancestor
153359202|NCT05869591|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
153359203|NCT05869591|Protease Inhibitors|protease inhibitors|mesh-ancestor
153359204|NCT05869591|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153359205|NCT05869591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153889159|NCT01013701|Autonomic Agents|autonomic agents|mesh-ancestor
153889160|NCT01013701|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153889161|NCT01013701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153889162|NCT01013701|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153889163|NCT01013701|Respiratory System Agents|respiratory system agents|mesh-ancestor
153889164|NCT01013701|Dermatologic Agents|dermatologic agents|mesh-ancestor
153889165|NCT01013701|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
153889166|NCT01020019|Lofexidine|lofexidine|mesh-list
153889167|NCT01020019|Dronabinol|dronabinol|mesh-list
153889168|NCT01020019|Hallucinogens|hallucinogens|mesh-ancestor
153889180|NCT01020019|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153889181|NCT01020019|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153889182|NCT01020019|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
153889183|NCT01020019|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
153889184|NCT01020019|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153889185|NCT01020019|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153889186|NCT01020019|Adrenergic Agents|adrenergic agents|mesh-ancestor
153889188|NCT00627835|Sorafenib|sorafenib|mesh-list
153889189|NCT00627835|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153889190|NCT00627835|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153889191|NCT00627835|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153359208|NCT05834738|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153359209|NCT05834738|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
153359210|NCT05834738|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
153359211|NCT05834738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153359212|NCT05782608|Ibuprofen|ibuprofen|mesh-list
153359213|NCT05782608|Ketorolac|ketorolac|mesh-list
153889198|NCT01019317|Antimetabolites|antimetabolites|mesh-ancestor
153889199|NCT01019317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153889200|NCT01019317|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153889201|NCT01019317|Immunologic Factors|immunologic factors|mesh-ancestor
153889202|NCT01019317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153889203|NCT01019317|Antiviral Agents|antiviral agents|mesh-ancestor
153889204|NCT01019317|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153889205|NCT02877238|Sevoflurane|sevoflurane|mesh-list
153889206|NCT02877238|Anesthetics|anesthetics|mesh-ancestor
153889207|NCT02877238|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153889208|NCT02877238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153889209|NCT02877238|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153889210|NCT02877238|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
153430317|NCT00379015|Trastuzumab|trastuzumab|mesh-list
153430318|NCT00379015|Epirubicin|epirubicin|mesh-list
153430319|NCT00379015|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153430320|NCT00379015|Immunologic Factors|immunologic factors|mesh-ancestor
153430321|NCT00379015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153430331|NCT00379015|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153430332|NCT00379015|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153430344|NCT04713410|Glucocorticoids|glucocorticoids|mesh-ancestor
153889232|NCT01288443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153889233|NCT01288209|Ribavirin|ribavirin|mesh-list
153889234|NCT01288209|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
153889235|NCT01288209|Simeprevir|simeprevir|mesh-list
153889236|NCT01288209|Antimetabolites|antimetabolites|mesh-ancestor
153889237|NCT01288209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153889238|NCT01288209|Antiviral Agents|antiviral agents|mesh-ancestor
153889239|NCT01288209|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153889240|NCT01288209|Protease Inhibitors|protease inhibitors|mesh-ancestor
153889241|NCT01288209|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153889242|NCT01287195|Omeprazole|omeprazole|mesh-list
153889243|NCT01287195|Muromonab-CD3|muromonab-cd3|mesh-list
153889244|NCT01287195|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
153889245|NCT01287195|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153889246|NCT01287195|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
153889247|NCT01287195|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153889248|NCT01287195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153889249|NCT01287195|Immunologic Factors|immunologic factors|mesh-ancestor
153889250|NCT01287195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153889251|NCT01287195|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153889252|NCT01287117|Omalizumab|omalizumab|mesh-list
153889253|NCT01287117|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
153889254|NCT01287117|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153430388|NCT00459121|Mitosis Modulators|mitosis modulators|mesh-ancestor
153430389|NCT00459121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153430390|NCT00904423|Vitamin D|vitamin d|mesh-list
153430391|NCT00904423|Vitamins|vitamins|mesh-ancestor
153430392|NCT00904423|Micronutrients|micronutrients|mesh-ancestor
153430393|NCT00904423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153430394|NCT00904423|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153430395|NCT05328895|Betahistine|betahistine|mesh-list
153430396|NCT05328895|Vasodilator Agents|vasodilator agents|mesh-ancestor
153430397|NCT05328895|Histamine Agonists|histamine agonists|mesh-ancestor
153430398|NCT05328895|Histamine Agents|histamine agents|mesh-ancestor
153430399|NCT05328895|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153430400|NCT05328895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153430402|NCT00879619|Prednisone|prednisone|mesh-list
153430403|NCT00879619|Cortisone|cortisone|mesh-list
153430404|NCT00879619|Docetaxel|docetaxel|mesh-list
153430405|NCT00879619|Sunitinib|sunitinib|mesh-list
153889285|NCT01283139|Sifalimumab|sifalimumab|mesh-list
153889286|NCT01283139|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
153889287|NCT01283139|Immunologic Factors|immunologic factors|mesh-ancestor
153889288|NCT01283139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153889289|NCT01281969|Immunoglobulins|immunoglobulins|mesh-list
153889290|NCT01281969|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
153889291|NCT01281969|Antibodies|antibodies|mesh-list
153359220|NCT05782608|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153359221|NCT05782608|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153359222|NCT05782608|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153359223|NCT05782608|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153783519|NCT00236444|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153783520|NCT00236444|Serotonin Agents|serotonin agents|mesh-ancestor
153783521|NCT00236444|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153783522|NCT00236444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153889292|NCT01281969|gamma-Globulins|gamma-globulins|mesh-list
153889293|NCT01281969|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
153889294|NCT01281969|Immunologic Factors|immunologic factors|mesh-ancestor
153889295|NCT01281969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153889296|NCT01281813|Ritonavir|ritonavir|mesh-list
153889297|NCT01281813|Darunavir|darunavir|mesh-list
153430407|NCT00879619|Tubulin Modulators|tubulin modulators|mesh-ancestor
153430408|NCT00879619|Antimitotic Agents|antimitotic agents|mesh-ancestor
153430409|NCT00879619|Mitosis Modulators|mitosis modulators|mesh-ancestor
153430410|NCT00879619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153430411|NCT00879619|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153430412|NCT00879619|Glucocorticoids|glucocorticoids|mesh-ancestor
153430416|NCT00879619|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153430417|NCT00879619|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153430418|NCT00879619|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153430419|NCT00879619|Growth Substances|growth substances|mesh-ancestor
153430420|NCT00879619|Growth Inhibitors|growth inhibitors|mesh-ancestor
153430421|NCT00879619|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153430422|NCT00879619|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153359224|NCT05782608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153359226|NCT05776524|Gemcitabine|gemcitabine|mesh-list
153359227|NCT05776524|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153359228|NCT05776524|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153359229|NCT05776524|Tubulin Modulators|tubulin modulators|mesh-ancestor
153359230|NCT05776524|Antimitotic Agents|antimitotic agents|mesh-ancestor
153359231|NCT05776524|Mitosis Modulators|mitosis modulators|mesh-ancestor
153359232|NCT05776524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153359233|NCT05776524|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153421848|NCT05430152|Sensory System Agents|sensory system agents|mesh-ancestor
153421849|NCT05430152|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153889302|NCT01281813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153889304|NCT01281813|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153889305|NCT01281813|Antiviral Agents|antiviral agents|mesh-ancestor
153889306|NCT01281813|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153889307|NCT01281813|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
153889308|NCT01281813|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153889310|NCT01090414|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153889311|NCT01090414|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153889312|NCT01090414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153889313|NCT01090102|Aminosalicylic Acid|aminosalicylic acid|mesh-list
153889314|NCT01090102|Mesalamine|mesalamine|mesh-list
153430423|NCT00822679|Eszopiclone|eszopiclone|mesh-list
153430424|NCT00822679|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153430425|NCT00822679|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153359259|NCT05737693|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153359260|NCT05737693|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153359261|NCT05737693|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153359263|NCT05737693|GABA Agents|gaba agents|mesh-ancestor
153359264|NCT05723601|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
153359265|NCT05723601|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
153359266|NCT05723601|Estradiol|estradiol|mesh-list
153359267|NCT05723601|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
153359268|NCT05723601|Estrogens|estrogens|mesh-ancestor
153430426|NCT00822679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153430427|NCT00323635|Tolterodine Tartrate|tolterodine tartrate|mesh-list
153430428|NCT00323635|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
153359269|NCT05723601|Hormones|hormones|mesh-ancestor
153430429|NCT00323635|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
153430430|NCT00323635|Cholinergic Agents|cholinergic agents|mesh-ancestor
153430431|NCT00323635|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153430432|NCT00323635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153430433|NCT00323635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153430434|NCT00323635|Urological Agents|urological agents|mesh-ancestor
153430435|NCT00314353|Bevacizumab|bevacizumab|mesh-list
153430436|NCT00314353|Capecitabine|capecitabine|mesh-list
153889325|NCT01090102|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153889326|NCT01281189|Pramipexole|pramipexole|mesh-list
153889327|NCT01281189|Dexpramipexole|dexpramipexole|mesh-list
153889328|NCT01281189|Antioxidants|antioxidants|mesh-ancestor
153889329|NCT01281189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153889330|NCT01281189|Protective Agents|protective agents|mesh-ancestor
153889331|NCT01281189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153889332|NCT01281189|Dopamine Agents|dopamine agents|mesh-ancestor
153430442|NCT00314353|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153359272|NCT05723601|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
153359273|NCT05723601|Contraceptive Agents|contraceptive agents|mesh-ancestor
153359274|NCT05723601|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153430449|NCT00314353|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
153430450|NCT00314353|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153430451|NCT00314353|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153430452|NCT00279409|Aripiprazole|aripiprazole|mesh-list
153430453|NCT00279409|Antidepressive Agents|antidepressive agents|mesh-ancestor
153889338|NCT04306666|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153889339|NCT04306666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153889340|NCT01280955|Plerixafor|plerixafor|mesh-list
153889341|NCT01280955|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153889342|NCT01280955|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153889343|NCT01280955|Antiviral Agents|antiviral agents|mesh-ancestor
153889344|NCT01280955|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153889345|NCT01280721|Tolvaptan|tolvaptan|mesh-list
153430454|NCT00279409|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153430455|NCT00279409|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153430456|NCT00279409|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153430457|NCT00279409|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153430458|NCT00279409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153430459|NCT00279409|Dopamine Agonists|dopamine agonists|mesh-ancestor
153430460|NCT00279409|Dopamine Agents|dopamine agents|mesh-ancestor
153430461|NCT00279409|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153430462|NCT00279409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153889356|NCT01087762|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153889357|NCT04306354|Oxytocin|oxytocin|mesh-list
153889362|NCT04306276|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
153889363|NCT04306276|Contraceptive Agents|contraceptive agents|mesh-ancestor
153889364|NCT04306276|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153889365|NCT04306276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153889366|NCT04306276|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
153889367|NCT04306276|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
153359288|NCT05671510|Tubulin Modulators|tubulin modulators|mesh-ancestor
153430515|NCT00019747|Leprostatic Agents|leprostatic agents|mesh-ancestor
153430516|NCT00019747|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153430517|NCT00019747|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153430518|NCT00019747|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153430519|NCT00019747|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153430520|NCT00019747|Growth Substances|growth substances|mesh-ancestor
153430521|NCT00019747|Growth Inhibitors|growth inhibitors|mesh-ancestor
153430522|NCT00019747|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153889384|NCT01086358|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153889404|NCT01277523|Tiotropium Bromide|tiotropium bromide|mesh-list
153889405|NCT01277523|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153889406|NCT01277523|Autonomic Agents|autonomic agents|mesh-ancestor
153889407|NCT01277523|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153889408|NCT01277523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153889412|NCT01277523|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
153889413|NCT01277523|Cholinergic Agents|cholinergic agents|mesh-ancestor
153430523|NCT00759577|Solifenacin Succinate|solifenacin succinate|mesh-list
153430524|NCT00759577|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
153430542|NCT00746239|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
153430543|NCT00746239|Parasympatholytics|parasympatholytics|mesh-ancestor
153430544|NCT00746239|Autonomic Agents|autonomic agents|mesh-ancestor
153430548|NCT00746239|Cholinergic Agents|cholinergic agents|mesh-ancestor
153430549|NCT00746239|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
153430550|NCT00746239|Antidepressive Agents|antidepressive agents|mesh-ancestor
153430551|NCT00746239|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153430553|NCT04977674|Ketamine|ketamine|mesh-list
153430554|NCT04977674|Analgesics|analgesics|mesh-ancestor
153430555|NCT04977674|Sensory System Agents|sensory system agents|mesh-ancestor
153430556|NCT04977674|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153889443|NCT01274637|Tinzaparin|tinzaparin|mesh-list
153889444|NCT01274637|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
153889445|NCT01274637|Anticoagulants|anticoagulants|mesh-ancestor
153430557|NCT04977674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153430558|NCT04977674|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
153430559|NCT04977674|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153430560|NCT04977674|Anesthetics, General|anesthetics, general|mesh-ancestor
153359295|NCT05670236|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153359296|NCT05670236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153359297|NCT05670236|Sensory System Agents|sensory system agents|mesh-ancestor
153359298|NCT05670236|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153359299|NCT05670236|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153359300|NCT05670236|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
153359301|NCT05670236|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153889447|NCT01274637|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153889448|NCT01274637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153889449|NCT01079806|Entecavir|entecavir|mesh-list
153889450|NCT01079806|Antiviral Agents|antiviral agents|mesh-ancestor
153889451|NCT01079806|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153889452|NCT02876770|Melatonin|melatonin|mesh-list
153889453|NCT02876770|Antioxidants|antioxidants|mesh-ancestor
153889466|NCT01313676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153889467|NCT01313676|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153889468|NCT01313676|Respiratory System Agents|respiratory system agents|mesh-ancestor
153889469|NCT01313676|Dermatologic Agents|dermatologic agents|mesh-ancestor
153889470|NCT01313676|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
153889472|NCT00623376|Nabilone|nabilone|mesh-list
153889473|NCT00623376|Antiemetics|antiemetics|mesh-ancestor
153889474|NCT00623376|Autonomic Agents|autonomic agents|mesh-ancestor
153889475|NCT00623376|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153889476|NCT00623376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153889477|NCT00623376|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153889485|NCT00623376|Sensory System Agents|sensory system agents|mesh-ancestor
153430611|NCT00728845|Hydroxychloroquine|hydroxychloroquine|mesh-list
153430612|NCT00728845|Paclitaxel|paclitaxel|mesh-list
153430613|NCT00728845|Bevacizumab|bevacizumab|mesh-list
153430645|NCT00703885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153430647|NCT00703339|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153430648|NCT04330586|Ciclesonide|ciclesonide|mesh-list
153430649|NCT04330586|Glucocorticoids|glucocorticoids|mesh-ancestor
153430650|NCT04330586|Hormones|hormones|mesh-ancestor
153430651|NCT04330586|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153430652|NCT04330586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153359302|NCT05670236|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153359303|NCT05670236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153359304|NCT05643651|Aspirin|aspirin|mesh-list
153359305|NCT05643651|Vitamin K|vitamin k|mesh-list
153359306|NCT05643651|Warfarin|warfarin|mesh-list
153359307|NCT05643651|Rivaroxaban|rivaroxaban|mesh-list
153359308|NCT05643651|Clopidogrel|clopidogrel|mesh-list
153359309|NCT05643651|Vitamins|vitamins|mesh-ancestor
153889528|NCT01077544|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153889529|NCT01077544|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153889530|NCT01077544|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153889531|NCT01077544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153889532|NCT01012999|Sufentanil|sufentanil|mesh-list
153889533|NCT01012999|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153889534|NCT01012999|Narcotics|narcotics|mesh-ancestor
153889535|NCT01012999|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153889536|NCT01012999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153889537|NCT01012999|Analgesics|analgesics|mesh-ancestor
153430673|NCT04828057|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153430674|NCT04828057|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
153430675|NCT04828057|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
153430677|NCT02973451|Anesthetics, Local|anesthetics, local|mesh-ancestor
153430678|NCT02973451|Anesthetics|anesthetics|mesh-ancestor
153430679|NCT02973451|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153430680|NCT02973451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153430681|NCT02973451|Sensory System Agents|sensory system agents|mesh-ancestor
153430682|NCT02973451|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153430683|NCT00000199|Piracetam|piracetam|mesh-list
153430684|NCT00000199|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
153430685|NCT00000199|Protective Agents|protective agents|mesh-ancestor
153889558|NCT01016977|Benzoyl Peroxide|benzoyl peroxide|mesh-list
153889559|NCT01016977|Tazarotene|tazarotene|mesh-list
153889560|NCT01016977|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153889561|NCT01016977|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153889562|NCT01016977|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
153889563|NCT01016977|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153889564|NCT01016977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153359320|NCT05643651|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153359321|NCT05643651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153359322|NCT05643651|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153359323|NCT05643651|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153359324|NCT05643651|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153359325|NCT05643651|Antipyretics|antipyretics|mesh-ancestor
153359326|NCT05643651|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
153359327|NCT05643651|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
153359328|NCT05643651|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
153359329|NCT05643651|Purinergic Agents|purinergic agents|mesh-ancestor
153430691|NCT00668785|Growth Substances|growth substances|mesh-ancestor
153430692|NCT00668785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153430693|NCT00668785|Growth Inhibitors|growth inhibitors|mesh-ancestor
153430694|NCT00668785|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153430696|NCT00655057|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
153430697|NCT00655057|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153430698|NCT00655057|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153889578|NCT02871661|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153889579|NCT02871661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153889581|NCT02871661|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153889582|NCT02871661|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153889583|NCT02871661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153430701|NCT00655057|Serotonin Agents|serotonin agents|mesh-ancestor
153430702|NCT00655057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153430703|NCT00655057|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
153430704|NCT00655057|Antidepressive Agents|antidepressive agents|mesh-ancestor
153430705|NCT00655057|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153430706|NCT00000211|Buprenorphine|buprenorphine|mesh-list
153430707|NCT00000211|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153430708|NCT00000211|Narcotics|narcotics|mesh-ancestor
153430709|NCT00000211|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153430710|NCT00000211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153430711|NCT00000211|Analgesics|analgesics|mesh-ancestor
153430712|NCT00000211|Sensory System Agents|sensory system agents|mesh-ancestor
153430713|NCT00000211|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153430714|NCT00000211|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
153430715|NCT04358432|Ezetimibe|ezetimibe|mesh-list
153430743|NCT00000223|Sensory System Agents|sensory system agents|mesh-ancestor
153430744|NCT00000223|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153430745|NCT00000223|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
153430747|NCT00000229|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153430748|NCT00000229|Narcotics|narcotics|mesh-ancestor
153430750|NCT00000229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153430751|NCT00000229|Analgesics|analgesics|mesh-ancestor
153430752|NCT00000229|Sensory System Agents|sensory system agents|mesh-ancestor
153430753|NCT00000229|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153430754|NCT00000229|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
153430755|NCT00000235|Buprenorphine|buprenorphine|mesh-list
153430756|NCT00000235|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153430757|NCT00000235|Narcotics|narcotics|mesh-ancestor
153430758|NCT00000235|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153430759|NCT00000235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153889645|NCT01012219|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153889646|NCT01012219|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153889647|NCT01012219|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153889648|NCT01012219|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153889649|NCT01012219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153889650|NCT01012219|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153889651|NCT01012219|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153889652|NCT01012219|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153889653|NCT01012219|Antipyretics|antipyretics|mesh-ancestor
153430788|NCT00000259|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
153430789|NCT00000259|Anesthetics, General|anesthetics, general|mesh-ancestor
153430790|NCT00000259|Anesthetics|anesthetics|mesh-ancestor
153430791|NCT00000259|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153430792|NCT00000259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153889669|NCT01011907|Cholinergic Agents|cholinergic agents|mesh-ancestor
153889670|NCT01011907|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153889671|NCT01011907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153889672|NCT01011907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153889673|NCT01011673|Ketorolac|ketorolac|mesh-list
153889674|NCT01011673|Metoclopramide|metoclopramide|mesh-list
153889675|NCT01011673|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153889676|NCT01011673|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153889677|NCT01011673|Analgesics|analgesics|mesh-ancestor
153889678|NCT01011673|Sensory System Agents|sensory system agents|mesh-ancestor
153430836|NCT00000277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153430839|NCT00000277|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153430840|NCT00000277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153430841|NCT00000277|Adrenergic Agents|adrenergic agents|mesh-ancestor
153430843|NCT00000277|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
153430844|NCT00000277|Dopamine Agents|dopamine agents|mesh-ancestor
153430845|NCT00599131|Docetaxel|docetaxel|mesh-list
153430846|NCT00599131|Fluorouracil|fluorouracil|mesh-list
153430847|NCT00599131|Cetuximab|cetuximab|mesh-list
153430848|NCT00599131|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153430849|NCT00599131|Tubulin Modulators|tubulin modulators|mesh-ancestor
153430858|NCT00599131|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153430860|NCT04302350|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
153430861|NCT04302350|Anesthetics, General|anesthetics, general|mesh-ancestor
153430862|NCT04302350|Anesthetics|anesthetics|mesh-ancestor
153430863|NCT04302350|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153430864|NCT04302350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153430865|NCT04302350|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153430866|NCT04302350|Analgesics|analgesics|mesh-ancestor
153430867|NCT04302350|Sensory System Agents|sensory system agents|mesh-ancestor
153430868|NCT04302350|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153889751|NCT02889549|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
153889752|NCT02889549|Purinergic Agents|purinergic agents|mesh-ancestor
153430878|NCT00000289|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153430879|NCT00000289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153430880|NCT00000289|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153430881|NCT00000289|Antipruritics|antipruritics|mesh-ancestor
153430882|NCT00000289|Dermatologic Agents|dermatologic agents|mesh-ancestor
153430883|NCT00000289|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
153430884|NCT00000289|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153430885|NCT00000289|Serotonin Agents|serotonin agents|mesh-ancestor
153430886|NCT00000289|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153430887|NCT00000289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153430888|NCT00000295|Progesterone|progesterone|mesh-list
153430889|NCT00000295|Progestins|progestins|mesh-ancestor
153430890|NCT00000295|Hormones|hormones|mesh-ancestor
153430903|NCT04246723|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153430904|NCT04246723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153430905|NCT04246723|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153430906|NCT04246723|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153430907|NCT04246723|Antiviral Agents|antiviral agents|mesh-ancestor
153889762|NCT01309386|Analgesics|analgesics|mesh-ancestor
153889763|NCT01309386|Sensory System Agents|sensory system agents|mesh-ancestor
153359344|NCT05623319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153359345|NCT05623319|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
153359346|NCT05623319|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153359347|NCT05548075|Psilocybin|psilocybin|mesh-list
153359348|NCT05548075|N,N-Dimethyltryptamine|n,n-dimethyltryptamine|mesh-list
153359349|NCT05548075|Hallucinogens|hallucinogens|mesh-ancestor
153359350|NCT05548075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153359351|NCT05548075|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153359352|NCT05548075|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153359353|NCT05548075|Serotonin Agents|serotonin agents|mesh-ancestor
153359354|NCT05548075|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153359355|NCT05548075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153359356|NCT05548075|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
153359357|NCT05534243|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-list
153359358|NCT05534243|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
153359391|NCT05444699|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153359393|NCT05444699|Autonomic Agents|autonomic agents|mesh-ancestor
153359394|NCT05444699|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153359395|NCT05444699|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153359396|NCT05444699|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
153359397|NCT05444699|Protective Agents|protective agents|mesh-ancestor
153359399|NCT05400369|Sitafloxacin|sitafloxacin|mesh-list
153431066|NCT04022785|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153431067|NCT04022785|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153359437|NCT05354778|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153359438|NCT05309616|Ixekizumab|ixekizumab|mesh-list
153359439|NCT05309616|Dermatologic Agents|dermatologic agents|mesh-ancestor
153359440|NCT05308979|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
153359441|NCT05308979|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
153359442|NCT05308979|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
153359443|NCT05308979|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153359444|NCT05308979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153359445|NCT05308979|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
153359446|NCT05308979|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153359447|NCT05308979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153359448|NCT05308979|Cholinergic Agents|cholinergic agents|mesh-ancestor
153359449|NCT05308979|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153359451|NCT05249556|Neurosteroids|neurosteroids|mesh-ancestor
153359452|NCT05249556|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153359453|NCT05249556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153359454|NCT05249556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153359455|NCT05249556|GABA Modulators|gaba modulators|mesh-ancestor
153359456|NCT05249556|GABA Agents|gaba agents|mesh-ancestor
153359457|NCT05191472|Pembrolizumab|pembrolizumab|mesh-list
153359458|NCT05191472|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153359459|NCT05191472|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153359460|NCT05191472|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153359461|NCT05191472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153359462|NCT05176223|Edetic Acid|edetic acid|mesh-list
153359463|NCT05176223|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
153359464|NCT05176223|Chelating Agents|chelating agents|mesh-ancestor
153359465|NCT05176223|Sequestering Agents|sequestering agents|mesh-ancestor
153359466|NCT05176223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153359467|NCT05176223|Anticoagulants|anticoagulants|mesh-ancestor
153359468|NCT05176223|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
153359469|NCT05176223|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
153359470|NCT05171075|Dalteparin|dalteparin|mesh-list
153359471|NCT05171075|Tinzaparin|tinzaparin|mesh-list
153359472|NCT05171075|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
153359473|NCT05171075|Anticoagulants|anticoagulants|mesh-ancestor
153359474|NCT05171075|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153359475|NCT05171075|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153359476|NCT05171075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153359477|NCT05171049|Apixaban|apixaban|mesh-list
153359478|NCT05171049|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
153359479|NCT05171049|Antithrombins|antithrombins|mesh-ancestor
153359480|NCT05171049|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
153359481|NCT05171049|Protease Inhibitors|protease inhibitors|mesh-ancestor
153359482|NCT05171049|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153359483|NCT05171049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153359484|NCT05171049|Anticoagulants|anticoagulants|mesh-ancestor
153359485|NCT05164549|Buprenorphine|buprenorphine|mesh-list
153359486|NCT05164549|Methadone|methadone|mesh-list
153359487|NCT05164549|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153359488|NCT05164549|Narcotics|narcotics|mesh-ancestor
153359489|NCT05164549|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153359490|NCT05164549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153359491|NCT05164549|Analgesics|analgesics|mesh-ancestor
153359492|NCT05164549|Sensory System Agents|sensory system agents|mesh-ancestor
153359616|NCT04665843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153359617|NCT04665843|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153359619|NCT04657302|Obinutuzumab|obinutuzumab|mesh-list
153359620|NCT04657302|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153359621|NCT04657302|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153359622|NCT04583501|Omalizumab|omalizumab|mesh-list
153359623|NCT04583501|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
153359624|NCT04583501|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153783526|NCT00236444|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153359646|NCT04493060|Dostarlimab|dostarlimab|mesh-list
153359647|NCT04493060|Immunoglobulins|immunoglobulins|mesh-list
153359648|NCT04493060|Immunoglobulin G|immunoglobulin g|mesh-list
153359649|NCT04493060|Immunologic Factors|immunologic factors|mesh-ancestor
153359650|NCT04493060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153359651|NCT04493060|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
153359652|NCT04493060|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153359653|NCT04493060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153359654|NCT04493060|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153362513|NCT01515995|Magnesium Sulfate|magnesium sulfate|mesh-list
153362514|NCT01515995|Analgesics|analgesics|mesh-ancestor
153362515|NCT01515995|Sensory System Agents|sensory system agents|mesh-ancestor
153362516|NCT01515995|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153362517|NCT01515995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153362518|NCT01515995|Anesthetics|anesthetics|mesh-ancestor
153362519|NCT01515995|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153362520|NCT01515995|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153362521|NCT01515995|Anticonvulsants|anticonvulsants|mesh-ancestor
153362522|NCT01515995|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153783540|NCT00269217|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153362523|NCT01515995|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153431583|NCT06067828|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153431587|NCT06067828|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153362530|NCT01436045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153362562|NCT02210195|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
153362563|NCT02210195|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153362564|NCT02210195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153362566|NCT00836888|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153362567|NCT00836888|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153362568|NCT00836888|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153362569|NCT00836888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153362570|NCT02262026|Saracatinib|saracatinib|mesh-list
153362594|NCT00837512|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
153362595|NCT00837512|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153362596|NCT00837512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153890592|NCT01074502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153362603|NCT00837590|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153362604|NCT00837590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153362605|NCT00837590|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153362606|NCT00837590|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153362607|NCT00837590|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153362608|NCT00837590|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153362609|NCT00837590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153362610|NCT00891176|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
153362612|NCT00891176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153362613|NCT00839540|Caspofungin|caspofungin|mesh-list
153362614|NCT00839540|Micafungin|micafungin|mesh-list
153362615|NCT00839540|Antifungal Agents|antifungal agents|mesh-ancestor
153362616|NCT00839540|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153362617|NCT00839540|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153362618|NCT00839540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153362619|NCT02966912|Magnesium Oxide|magnesium oxide|mesh-list
153362621|NCT02966912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153363000|NCT01832558|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
153363001|NCT01832558|Hormone Antagonists|hormone antagonists|mesh-ancestor
153363002|NCT01832558|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153431646|NCT06041646|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153363003|NCT01832558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153363004|NCT01832558|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
153363005|NCT01832558|Diuretics|diuretics|mesh-ancestor
153363006|NCT01832558|Natriuretic Agents|natriuretic agents|mesh-ancestor
153363007|NCT01832558|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153363009|NCT02476422|Diclofenac|diclofenac|mesh-list
153363010|NCT02476422|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153363235|NCT01535573|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
153363236|NCT01535573|Parasympatholytics|parasympatholytics|mesh-ancestor
153363237|NCT01535573|Autonomic Agents|autonomic agents|mesh-ancestor
153363238|NCT01535573|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153363239|NCT01535573|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
153363240|NCT01535573|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
153363241|NCT01535573|Cholinergic Agents|cholinergic agents|mesh-ancestor
153363242|NCT01834508|Entecavir|entecavir|mesh-list
153363243|NCT01834508|Adefovir|adefovir|mesh-list
153363377|NCT01836224|Sympathomimetics|sympathomimetics|mesh-ancestor
153363378|NCT01836224|Autonomic Agents|autonomic agents|mesh-ancestor
153363379|NCT01836224|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153363380|NCT01836536|Bevacizumab|bevacizumab|mesh-list
153363631|NCT02498652|Gout Suppressants|gout suppressants|mesh-ancestor
153431653|NCT06041646|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153431654|NCT06041646|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153431655|NCT06041646|Adrenergic Agents|adrenergic agents|mesh-ancestor
153431656|NCT06041646|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153431657|NCT06041646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153431658|NCT06031441|Atezolizumab|atezolizumab|mesh-list
153431659|NCT06031441|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153431660|NCT06031441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153431661|NCT06031441|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153431662|NCT06031441|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153431663|NCT06029179|Polystyrene sulfonic acid|polystyrene sulfonic acid|mesh-list
153431664|NCT06029179|Chelating Agents|chelating agents|mesh-ancestor
153431665|NCT06029179|Sequestering Agents|sequestering agents|mesh-ancestor
153431667|NCT06023368|Lidocaine, Prilocaine Drug Combination|lidocaine, prilocaine drug combination|mesh-list
153363667|NCT02472366|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153363668|NCT02472366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153363670|NCT01724606|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153363776|NCT00910520|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
153363777|NCT00910520|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153363778|NCT00910520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153363780|NCT00910520|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153363781|NCT00910520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153363782|NCT00910520|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
153363783|NCT00910520|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153363784|NCT01568255|Ergocalciferols|ergocalciferols|mesh-list
153363786|NCT01568255|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153363787|NCT01568255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153363788|NCT01568255|Vitamins|vitamins|mesh-ancestor
153363789|NCT01568255|Micronutrients|micronutrients|mesh-ancestor
153363790|NCT01568255|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153363791|NCT01720628|Angiogenin|angiogenin|mesh-list
153363792|NCT01720628|Angiogenesis Inducing Agents|angiogenesis inducing agents|mesh-ancestor
153363793|NCT01720628|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153363794|NCT01720628|Growth Substances|growth substances|mesh-ancestor
153363795|NCT01720628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153363916|NCT01574183|Vilazodone Hydrochloride|vilazodone hydrochloride|mesh-list
153363917|NCT01574183|Antidepressive Agents|antidepressive agents|mesh-ancestor
153363919|NCT01574183|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
153363981|NCT03407300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153363983|NCT01722968|Bevacizumab|bevacizumab|mesh-list
153363984|NCT01722968|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153363985|NCT01722968|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153363986|NCT01722968|Tubulin Modulators|tubulin modulators|mesh-ancestor
153363987|NCT01722968|Antimitotic Agents|antimitotic agents|mesh-ancestor
153431699|NCT06004336|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153363990|NCT01722968|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153363991|NCT01722968|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153363992|NCT01722968|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153363993|NCT01722968|Growth Substances|growth substances|mesh-ancestor
153363994|NCT01722968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153363995|NCT01722968|Growth Inhibitors|growth inhibitors|mesh-ancestor
153363997|NCT04379180|Sildenafil Citrate|sildenafil citrate|mesh-list
153363998|NCT04379180|Tadalafil|tadalafil|mesh-list
153364129|NCT01722656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153364130|NCT01722656|Growth Inhibitors|growth inhibitors|mesh-ancestor
153364131|NCT01722656|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153364132|NCT03405584|Amoxicillin|amoxicillin|mesh-list
153364133|NCT03405584|Potassium Citrate|potassium citrate|mesh-list
153364134|NCT03405584|Esomeprazole|esomeprazole|mesh-list
153364135|NCT03405584|Bismuth|bismuth|mesh-list
153364136|NCT03405584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153890705|NCT04304794|Hormone Antagonists|hormone antagonists|mesh-ancestor
153890706|NCT04304794|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153364705|NCT02248181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153364706|NCT02248181|Protective Agents|protective agents|mesh-ancestor
153364707|NCT02248181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153364708|NCT02248181|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
153364709|NCT02248181|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
153364710|NCT02248181|Dopamine Agonists|dopamine agonists|mesh-ancestor
153364712|NCT02248181|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153364713|NCT03003143|Vigabatrin|vigabatrin|mesh-list
153364714|NCT03003143|Anticonvulsants|anticonvulsants|mesh-ancestor
153364715|NCT03003143|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153364716|NCT03003143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153364717|NCT03003143|GABA Agents|gaba agents|mesh-ancestor
153364718|NCT03003143|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153364719|NCT03003143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153365149|NCT04371146|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153890758|NCT01250379|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153365317|NCT02244632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153365319|NCT02244632|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153365320|NCT02244632|Immunologic Factors|immunologic factors|mesh-ancestor
153365321|NCT02244632|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
153365322|NCT02244632|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153365323|NCT02244632|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153365324|NCT03060083|Nicotine|nicotine|mesh-list
153365325|NCT03060083|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
153365326|NCT03060083|Autonomic Agents|autonomic agents|mesh-ancestor
153365327|NCT03060083|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153365328|NCT03060083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153365329|NCT03060083|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
153365330|NCT03060083|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
153365331|NCT03060083|Cholinergic Agents|cholinergic agents|mesh-ancestor
153365332|NCT03060083|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153365333|NCT03060083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153365334|NCT02244710|Clopidogrel|clopidogrel|mesh-list
153365457|NCT02459964|Anesthetics, General|anesthetics, general|mesh-ancestor
153431807|NCT05818150|Autonomic Agents|autonomic agents|mesh-ancestor
153365458|NCT02459964|Anesthetics|anesthetics|mesh-ancestor
153431811|NCT05818150|Glucocorticoids|glucocorticoids|mesh-ancestor
153365459|NCT01635101|Acetaminophen|acetaminophen|mesh-list
153365460|NCT01635101|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153365461|NCT01635101|Analgesics|analgesics|mesh-ancestor
153365462|NCT01635101|Sensory System Agents|sensory system agents|mesh-ancestor
153365463|NCT01635101|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153365464|NCT01635101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153365465|NCT01635101|Antipyretics|antipyretics|mesh-ancestor
153365466|NCT02087111|Interferons|interferons|mesh-list
153365629|NCT01640171|Anesthetics|anesthetics|mesh-list
153365630|NCT01640171|Anesthetics, Local|anesthetics, local|mesh-ancestor
153365631|NCT01640171|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153365632|NCT01640171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153365633|NCT01640171|Sensory System Agents|sensory system agents|mesh-ancestor
153365634|NCT01640171|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153365635|NCT01640171|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153365636|NCT01640171|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
153365637|NCT01640171|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153365638|NCT01640171|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153365639|NCT01640171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153365640|NCT01640171|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153365641|NCT01640171|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153365642|NCT01640171|Analgesics|analgesics|mesh-ancestor
153365643|NCT01640171|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153365644|NCT01640171|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153365645|NCT01640171|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153783541|NCT00269217|Vasodilator Agents|vasodilator agents|mesh-ancestor
153783542|NCT00269217|Vitamin B Complex|vitamin b complex|mesh-ancestor
153365700|NCT02487108|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153365702|NCT02487030|Sofosbuvir|sofosbuvir|mesh-list
153365703|NCT02487030|Ledipasvir, sofosbuvir drug combination|ledipasvir, sofosbuvir drug combination|mesh-list
153365705|NCT02487030|Antiviral Agents|antiviral agents|mesh-ancestor
153365706|NCT02487030|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153365707|NCT02486952|Prednisone|prednisone|mesh-list
153890817|NCT04640896|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153890944|NCT01033942|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153890945|NCT01062256|Phenylpropanolamine|phenylpropanolamine|mesh-list
153890946|NCT01062256|Guaifenesin|guaifenesin|mesh-list
153890947|NCT01062256|Chlorpheniramine, phenylpropanolamine drug combination|chlorpheniramine, phenylpropanolamine drug combination|mesh-list
153890948|NCT01062256|Expectorants|expectorants|mesh-ancestor
153365781|NCT02450526|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
153365782|NCT02450526|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153365878|NCT02449902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153365879|NCT02449902|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
153365880|NCT02449902|Contraceptive Agents|contraceptive agents|mesh-ancestor
153365881|NCT02449902|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153365882|NCT02449902|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
153365883|NCT02449044|Tolvaptan|tolvaptan|mesh-list
153783543|NCT00269217|Vitamins|vitamins|mesh-ancestor
153365990|NCT01652495|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153365991|NCT01652495|Antiemetics|antiemetics|mesh-ancestor
153431980|NCT05535764|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
153431981|NCT05535764|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153431982|NCT05535764|Antiviral Agents|antiviral agents|mesh-ancestor
153431983|NCT05535764|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153431984|NCT05535764|Immunologic Factors|immunologic factors|mesh-ancestor
153431985|NCT05535764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153431986|NCT05534984|Tecovirimat|tecovirimat|mesh-list
153431987|NCT05534984|Antiviral Agents|antiviral agents|mesh-ancestor
153431988|NCT05534984|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153431989|NCT05509777|Mirikizumab|mirikizumab|mesh-list
153365992|NCT01652495|Autonomic Agents|autonomic agents|mesh-ancestor
153365993|NCT01652495|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153365994|NCT01652495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153365995|NCT01652495|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153365996|NCT01652495|Glucocorticoids|glucocorticoids|mesh-ancestor
153366033|NCT01699607|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153366070|NCT01614743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153366141|NCT01617083|Azithromycin|azithromycin|mesh-list
153366349|NCT03031808|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
153366351|NCT01662791|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153366352|NCT01662791|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153366353|NCT01662791|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153366354|NCT03035084|Vitamin D|vitamin d|mesh-list
153366355|NCT03035084|Ergocalciferols|ergocalciferols|mesh-list
153366650|NCT03016832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153366652|NCT00955916|Imatinib Mesylate|imatinib mesylate|mesh-list
153366653|NCT00955916|Cladribine|cladribine|mesh-list
153366654|NCT00955916|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153366656|NCT00955916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153366657|NCT00955916|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153366658|NCT00955916|Antiviral Agents|antiviral agents|mesh-ancestor
153366659|NCT00955916|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153366660|NCT00955916|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153366661|NCT00955916|Immunologic Factors|immunologic factors|mesh-ancestor
153366662|NCT00955916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153366663|NCT00955916|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153366664|NCT00955916|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153366665|NCT00955916|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153366666|NCT01668017|Niacinamide|niacinamide|mesh-list
153366667|NCT01668017|Vitamin B Complex|vitamin b complex|mesh-ancestor
153366668|NCT01668017|Vitamins|vitamins|mesh-ancestor
153366669|NCT01668017|Micronutrients|micronutrients|mesh-ancestor
153366670|NCT01668017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153366671|NCT01010984|Doxorubicin|doxorubicin|mesh-list
153366672|NCT01010984|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153366760|NCT01016678|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153366761|NCT01016678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153366762|NCT02457546|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
153366763|NCT02457546|Hemostatics|hemostatics|mesh-ancestor
153890991|NCT01266876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153890992|NCT01266876|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
153890993|NCT01266876|Protease Inhibitors|protease inhibitors|mesh-ancestor
153890994|NCT01266876|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153890995|NCT01266876|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153890996|NCT01033240|Sorafenib|sorafenib|mesh-list
153890997|NCT01033240|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153890998|NCT01033240|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153891000|NCT01033240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153891001|NCT01032382|Gentamicins|gentamicins|mesh-list
153891002|NCT01032382|Paromomycin|paromomycin|mesh-list
153891003|NCT01032382|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153891004|NCT01032382|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153366778|NCT04923594|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153366779|NCT04923594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153366780|NCT04923594|Adrenergic Agents|adrenergic agents|mesh-ancestor
153366781|NCT04923594|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153891005|NCT01032382|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
153432012|NCT05487235|Omeprazole|omeprazole|mesh-list
153891006|NCT01032382|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153891007|NCT01032382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153891008|NCT01032382|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153891009|NCT01032382|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153891010|NCT01029652|Triamcinolone|triamcinolone|mesh-list
153891011|NCT01029652|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
153891012|NCT01029652|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
153891013|NCT01029652|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
153891014|NCT01029652|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
153891015|NCT01029652|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153891016|NCT01029652|Glucocorticoids|glucocorticoids|mesh-ancestor
153891017|NCT01029652|Hormones|hormones|mesh-ancestor
153891018|NCT01029652|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153891019|NCT01029652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153891020|NCT01029652|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153367164|NCT00990236|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153367165|NCT00990236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153367193|NCT01027598|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
153367194|NCT01027598|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153367195|NCT01027598|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153367197|NCT01027598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153367198|NCT01027598|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153367200|NCT01654224|Immunologic Factors|immunologic factors|mesh-ancestor
153367201|NCT01654224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153367202|NCT02447328|Fulvestrant|fulvestrant|mesh-list
153367203|NCT02447328|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153367204|NCT02447328|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153367205|NCT02447328|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
153367206|NCT02447328|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
153367207|NCT02447328|Hormone Antagonists|hormone antagonists|mesh-ancestor
153367208|NCT02447328|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153891031|NCT01265550|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153891032|NCT01265550|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
153891033|NCT01265550|GABA Agonists|gaba agonists|mesh-ancestor
153891034|NCT01265550|GABA Agents|gaba agents|mesh-ancestor
153891035|NCT01265550|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153891036|NCT01265550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153891037|NCT01265550|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
153891038|NCT01265550|Antidepressive Agents|antidepressive agents|mesh-ancestor
153891039|NCT01265550|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153891040|NCT01265550|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153432052|NCT05469204|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153432053|NCT05469204|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153432054|NCT05469204|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153432055|NCT05469204|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153367284|NCT00995072|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153367286|NCT00995072|Autonomic Agents|autonomic agents|mesh-ancestor
153367287|NCT00995072|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153367288|NCT00995072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153367289|NCT00995072|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
153367294|NCT00995072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153367389|NCT01004042|Cholinergic Agents|cholinergic agents|mesh-ancestor
153367390|NCT01004042|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153367391|NCT01004042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153367392|NCT01004042|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
153367393|NCT01004042|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153367394|NCT01004354|Ergocalciferols|ergocalciferols|mesh-list
153367396|NCT01004354|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153367398|NCT01004354|Vitamins|vitamins|mesh-ancestor
153367399|NCT01004354|Micronutrients|micronutrients|mesh-ancestor
153367400|NCT01004354|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153367401|NCT02417064|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
153367402|NCT02417064|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
153367403|NCT02417064|Sertraline|sertraline|mesh-list
153367404|NCT02417064|Esketamine|esketamine|mesh-list
153367405|NCT02417064|Antidepressive Agents|antidepressive agents|mesh-list
153367406|NCT02417064|Escitalopram|escitalopram|mesh-list
153367407|NCT02417064|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
153367408|NCT02417064|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153367409|NCT02417064|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153367410|NCT02417064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153367411|NCT02417064|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153367412|NCT02417064|Serotonin Agents|serotonin agents|mesh-ancestor
153367448|NCT01051778|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153367563|NCT01061528|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
153367564|NCT01061528|Autonomic Agents|autonomic agents|mesh-ancestor
153367565|NCT01061528|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153891052|NCT01029262|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153432065|NCT05469204|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153432066|NCT05469204|Antipyretics|antipyretics|mesh-ancestor
153432067|NCT05469204|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153432068|NCT05469204|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
153432069|NCT05469204|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153432070|NCT05469204|Protective Agents|protective agents|mesh-ancestor
153432071|NCT05421741|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
153432072|NCT05421741|Vancomycin|vancomycin|mesh-list
153432073|NCT05421741|Gentamicins|gentamicins|mesh-list
153432074|NCT05421741|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153432075|NCT05421741|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
153432076|NCT05421741|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153432077|NCT05421741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153432078|NCT05377255|Naloxone|naloxone|mesh-list
153432079|NCT05377255|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
153432080|NCT05377255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153432081|NCT05377255|Sensory System Agents|sensory system agents|mesh-ancestor
153432092|NCT05325593|Antiemetics|antiemetics|mesh-ancestor
153432093|NCT05325593|Autonomic Agents|autonomic agents|mesh-ancestor
153432094|NCT05325593|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153432095|NCT05325593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153432097|NCT05325593|Glucocorticoids|glucocorticoids|mesh-ancestor
153367739|NCT01077596|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-list
153367740|NCT01077596|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
153367741|NCT01077596|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153367742|NCT01077596|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
153367743|NCT01077596|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153367744|NCT01077596|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153783545|NCT00269217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153367745|NCT01077596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153891084|NCT01028014|Respiratory System Agents|respiratory system agents|mesh-ancestor
153891086|NCT01028014|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
153891087|NCT01028014|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
153891088|NCT01028014|Sympathomimetics|sympathomimetics|mesh-ancestor
153891089|NCT01028014|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
153891090|NCT01028014|Antidepressive Agents|antidepressive agents|mesh-ancestor
153891091|NCT01028014|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153891092|NCT01028014|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
153891093|NCT01028014|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
153367788|NCT02485184|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
153367789|NCT02485184|Anticoagulants|anticoagulants|mesh-ancestor
153367790|NCT02485184|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
153367791|NCT02485184|Adrenergic Agents|adrenergic agents|mesh-ancestor
153891094|NCT01028014|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153432108|NCT05300087|Albuterol|albuterol|mesh-list
153432109|NCT05300087|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153432110|NCT05300087|Autonomic Agents|autonomic agents|mesh-ancestor
153432111|NCT05300087|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153432112|NCT05300087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153432113|NCT05300087|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153432114|NCT05300087|Respiratory System Agents|respiratory system agents|mesh-ancestor
153432115|NCT05300087|Tocolytic Agents|tocolytic agents|mesh-ancestor
153432116|NCT05300087|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153432117|NCT05300087|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
153432118|NCT05300087|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
153432119|NCT05300087|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153432120|NCT05300087|Adrenergic Agents|adrenergic agents|mesh-ancestor
153432121|NCT05300087|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153432122|NCT05300087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153432124|NCT05280314|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153432125|NCT05280314|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153432126|NCT05280314|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153432127|NCT05280314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153432128|NCT05263206|Loratadine|loratadine|mesh-list
153432129|NCT05263206|Fexofenadine|fexofenadine|mesh-list
153432130|NCT05263206|Antipruritics|antipruritics|mesh-ancestor
153368087|NCT00585195|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153368088|NCT00585195|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
153368089|NCT00585195|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
153368090|NCT00585195|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
153368091|NCT00585195|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
153368092|NCT00585195|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
153368093|NCT00585195|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
153368094|NCT00585195|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153368613|NCT05306990|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
153368615|NCT02557035|Dexamethasone|dexamethasone|mesh-list
153368616|NCT02557035|Palonosetron|palonosetron|mesh-list
153368617|NCT02557035|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153368618|NCT02557035|Antiemetics|antiemetics|mesh-ancestor
153368619|NCT02557035|Autonomic Agents|autonomic agents|mesh-ancestor
153368620|NCT02557035|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153891101|NCT01264770|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153891160|NCT01237587|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153891161|NCT01237587|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153891162|NCT01237587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153891163|NCT01237587|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153891164|NCT01237587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153891165|NCT01237587|Analgesics|analgesics|mesh-ancestor
153891166|NCT01237587|Sensory System Agents|sensory system agents|mesh-ancestor
153891167|NCT01237587|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153891168|NCT01237587|Antidepressive Agents|antidepressive agents|mesh-ancestor
153891169|NCT01237587|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153891170|NCT01237587|Dopamine Agents|dopamine agents|mesh-ancestor
153891171|NCT01031680|Dapagliflozin|dapagliflozin|mesh-list
153368683|NCT02487225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153368684|NCT02487225|Vasodilator Agents|vasodilator agents|mesh-ancestor
153368685|NCT02487225|Free Radical Scavengers|free radical scavengers|mesh-ancestor
153368686|NCT02487225|Antioxidants|antioxidants|mesh-ancestor
153368689|NCT02384850|Fluorouracil|fluorouracil|mesh-list
153368690|NCT02384850|Oxaliplatin|oxaliplatin|mesh-list
153368691|NCT02384850|Levoleucovorin|levoleucovorin|mesh-list
153368692|NCT02384850|Antimetabolites|antimetabolites|mesh-ancestor
153891172|NCT01031680|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
153432187|NCT05122767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153432189|NCT05122767|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153432190|NCT05122767|Antiviral Agents|antiviral agents|mesh-ancestor
153432193|NCT05118490|Rifapentine|rifapentine|mesh-list
153432194|NCT05118490|Rifampin|rifampin|mesh-list
153432195|NCT05118490|Antitubercular Agents|antitubercular agents|mesh-ancestor
153432196|NCT05118490|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153432197|NCT05118490|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153432198|NCT05118490|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
153432199|NCT05118490|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153432200|NCT05118490|Antimetabolites|antimetabolites|mesh-ancestor
153432201|NCT05118490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153432202|NCT05118490|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153432203|NCT05118490|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
153369546|NCT03413384|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153369547|NCT02976441|Temozolomide|temozolomide|mesh-list
153369548|NCT02976441|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153369759|NCT05693675|Methadone|methadone|mesh-list
153369760|NCT05693675|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153369761|NCT05693675|Narcotics|narcotics|mesh-ancestor
153891303|NCT06055166|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
153477005|NCT01018056|Riluzole|riluzole|mesh-list
153369773|NCT05655273|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
153369842|NCT05528458|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153369844|NCT05467761|Hallucinogens|hallucinogens|mesh-ancestor
153369845|NCT05467761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153369846|NCT05467761|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153369847|NCT05418361|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
153891333|NCT06054919|Cholecalciferol|cholecalciferol|mesh-list
153369848|NCT05418361|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-list
153369849|NCT05418361|Protease Inhibitors|protease inhibitors|mesh-ancestor
153891334|NCT06054919|Vitamins|vitamins|mesh-ancestor
153369850|NCT05418361|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153891335|NCT06054919|Micronutrients|micronutrients|mesh-ancestor
153370351|NCT01348919|Protease Inhibitors|protease inhibitors|mesh-ancestor
153370352|NCT01348919|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153370353|NCT01348919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153370355|NCT01333046|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153370384|NCT02431806|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153370385|NCT02431806|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
153370386|NCT02431806|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153370387|NCT02431806|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153370388|NCT02431806|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
153370389|NCT02431806|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153370390|NCT02431806|Analgesics|analgesics|mesh-ancestor
153370391|NCT02431806|Sensory System Agents|sensory system agents|mesh-ancestor
153432476|NCT04785300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153432477|NCT04785300|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153891449|NCT05960708|Omalizumab|omalizumab|mesh-list
153370683|NCT00003407|Analgesics|analgesics|mesh-ancestor
153370684|NCT00003407|Sensory System Agents|sensory system agents|mesh-ancestor
153370685|NCT00003407|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153370686|NCT00003407|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153370687|NCT00003407|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153370688|NCT00003407|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153371053|NCT02597907|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153371054|NCT02597907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153371055|NCT02597907|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
153371056|NCT02597907|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153371057|NCT02597907|Serotonin Agents|serotonin agents|mesh-ancestor
153371059|NCT02600325|Elbasvir-grazoprevir drug combination|elbasvir-grazoprevir drug combination|mesh-list
153371060|NCT02600325|Antiviral Agents|antiviral agents|mesh-ancestor
153371061|NCT02600325|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153371062|NCT02600715|Morphine|morphine|mesh-list
153891602|NCT05852769|Protective Agents|protective agents|mesh-ancestor
153891603|NCT05852769|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153371063|NCT02600715|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
153371064|NCT02600715|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
153891604|NCT05852769|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153432644|NCT03927105|Nivolumab|nivolumab|mesh-list
153371065|NCT02600715|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153371066|NCT02600715|Narcotics|narcotics|mesh-ancestor
153421940|NCT05124691|Antimitotic Agents|antimitotic agents|mesh-ancestor
153421941|NCT05124691|Mitosis Modulators|mitosis modulators|mesh-ancestor
153421942|NCT05124691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153371194|NCT02613897|Saxagliptin|saxagliptin|mesh-list
153371195|NCT02613897|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
153371196|NCT02613897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153371197|NCT02613897|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153371198|NCT02613897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153371199|NCT02613897|Incretins|incretins|mesh-ancestor
153371201|NCT02613897|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153891638|NCT05707455|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153891639|NCT05707455|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153891640|NCT05707455|Analgesics|analgesics|mesh-ancestor
153891641|NCT05707455|Sensory System Agents|sensory system agents|mesh-ancestor
153891642|NCT05707455|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153891643|NCT05707455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153432676|NCT03757585|Acetylcysteine|acetylcysteine|mesh-list
153432677|NCT03757585|N-monoacetylcystine|n-monoacetylcystine|mesh-list
153432692|NCT03732677|Durvalumab|durvalumab|mesh-list
153371375|NCT04425239|Antimetabolites|antimetabolites|mesh-ancestor
153371376|NCT04425239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153371377|NCT04425239|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153371378|NCT04425239|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153371379|NCT04425239|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153371380|NCT04425239|Immunologic Factors|immunologic factors|mesh-ancestor
153371381|NCT04425239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153891712|NCT05422001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153891714|NCT05422001|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153891715|NCT05422001|Anesthetics, General|anesthetics, general|mesh-ancestor
153881076|NCT05212571|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
153881077|NCT05212571|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153881078|NCT05212571|Anesthetics, General|anesthetics, general|mesh-ancestor
153881079|NCT05212571|Anesthetics|anesthetics|mesh-ancestor
153881080|NCT05212571|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153881081|NCT05212571|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
153881082|NCT05212571|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
153881086|NCT05212571|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153371430|NCT03009422|Antimony Sodium Gluconate|antimony sodium gluconate|mesh-list
153371431|NCT03009422|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153371432|NCT03009422|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153371433|NCT03009422|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153371434|NCT03009422|Schistosomicides|schistosomicides|mesh-ancestor
153881087|NCT05201001|Carboplatin|carboplatin|mesh-list
153881088|NCT05201001|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153881089|NCT05198050|Letrozole|letrozole|mesh-list
153881090|NCT05198050|Alprostadil|alprostadil|mesh-list
153891873|NCT04989283|Antimitotic Agents|antimitotic agents|mesh-ancestor
153891874|NCT04989283|Mitosis Modulators|mitosis modulators|mesh-ancestor
153891887|NCT04988841|Nivolumab|nivolumab|mesh-list
153881091|NCT05198050|Misoprostol|misoprostol|mesh-list
153881092|NCT05198050|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153881093|NCT05198050|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
153881094|NCT05198050|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153881095|NCT05198050|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153881096|NCT05198050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153881097|NCT05198050|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
153881098|NCT05198050|Hormone Antagonists|hormone antagonists|mesh-ancestor
153881099|NCT05198050|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153421954|NCT05095571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153421955|NCT05095571|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153421956|NCT05095571|Antimetabolites|antimetabolites|mesh-ancestor
153891898|NCT04977778|Cariostatic Agents|cariostatic agents|mesh-ancestor
153421957|NCT05095571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153421958|NCT05095571|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153421959|NCT05095571|Vasodilator Agents|vasodilator agents|mesh-ancestor
153372065|NCT01766219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153372066|NCT01766219|Protective Agents|protective agents|mesh-ancestor
153881100|NCT05198050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153881101|NCT05198050|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
153881102|NCT05198050|Abortifacient Agents|abortifacient agents|mesh-ancestor
153881103|NCT05198050|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153881104|NCT05198050|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
153881105|NCT05198050|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153881106|NCT05198050|Oxytocics|oxytocics|mesh-ancestor
153881107|NCT05198050|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153881108|NCT05198050|Vasodilator Agents|vasodilator agents|mesh-ancestor
153881109|NCT05198050|Urological Agents|urological agents|mesh-ancestor
153881110|NCT05189223|Buprenorphine|buprenorphine|mesh-list
153881111|NCT05189223|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153881112|NCT05189223|Narcotics|narcotics|mesh-ancestor
153881113|NCT05189223|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153881114|NCT05189223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153421971|NCT05061017|Cyclophosphamide|cyclophosphamide|mesh-list
153421972|NCT05061017|Nivolumab|nivolumab|mesh-list
153421973|NCT05061017|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153421974|NCT05061017|Immunologic Factors|immunologic factors|mesh-ancestor
153421979|NCT05061017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153421980|NCT05061017|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153421981|NCT05061017|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153421982|NCT05061017|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153421983|NCT05061017|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153421984|NCT05041153|Pembrolizumab|pembrolizumab|mesh-list
153421985|NCT05041153|Lenvatinib|lenvatinib|mesh-list
153421986|NCT05041153|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153891968|NCT04477304|Analgesics|analgesics|mesh-ancestor
153881123|NCT05176418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153881124|NCT05176418|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
153881125|NCT05176418|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
153881126|NCT05176418|Cholinergic Agents|cholinergic agents|mesh-ancestor
153881127|NCT05176418|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153881128|NCT05176418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153881129|NCT05130060|Trifluridine|trifluridine|mesh-list
153881130|NCT05130060|Vaccines|vaccines|mesh-list
153892005|NCT04300049|Incretins|incretins|mesh-ancestor
153892006|NCT04278729|Apixaban|apixaban|mesh-list
153892007|NCT04278729|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
153892008|NCT04278729|Antithrombins|antithrombins|mesh-ancestor
153372069|NCT01766219|Vitamins|vitamins|mesh-ancestor
153372070|NCT01766219|Micronutrients|micronutrients|mesh-ancestor
153372071|NCT01767155|Doxorubicin|doxorubicin|mesh-list
153372123|NCT04351724|Hydroxychloroquine|hydroxychloroquine|mesh-list
153372125|NCT04351724|Remdesivir|remdesivir|mesh-list
153372126|NCT04351724|Candesartan|candesartan|mesh-list
153372127|NCT04351724|Candesartan cilexetil|candesartan cilexetil|mesh-list
153372128|NCT04351724|Antihypertensive Agents|antihypertensive agents|mesh-list
153372129|NCT04351724|Rivaroxaban|rivaroxaban|mesh-list
153372130|NCT04351724|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
153892118|NCT03877549|Hormones|hormones|mesh-ancestor
153881156|NCT05041647|Hallucinogens|hallucinogens|mesh-ancestor
153881157|NCT05041647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153881158|NCT05041647|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153881159|NCT05041647|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153881160|NCT05041647|Analgesics|analgesics|mesh-ancestor
153881161|NCT05041647|Sensory System Agents|sensory system agents|mesh-ancestor
153881162|NCT05041647|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153881163|NCT05041647|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
153881164|NCT05041647|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
153881165|NCT05041647|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153881166|NCT05041647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153881167|NCT05041647|Hormones|hormones|mesh-ancestor
153881168|NCT05041647|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153881169|NCT05014815|Tislelizumab|tislelizumab|mesh-list
153881170|NCT05014815|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153881171|NCT05014815|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153881172|NCT05002465|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
153881173|NCT05002465|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
153881174|NCT05002465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153881175|NCT04943848|Iodine|iodine|mesh-list
153881176|NCT04943848|Vaccines|vaccines|mesh-list
153422029|NCT04920383|Pembrolizumab|pembrolizumab|mesh-list
153422030|NCT04920383|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153433213|NCT01500551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153422031|NCT04920383|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153422032|NCT04920383|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153422033|NCT04920383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153372132|NCT04351724|Protease Inhibitors|protease inhibitors|mesh-ancestor
153372133|NCT04351724|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153372134|NCT04351724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153372136|NCT04351724|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153372137|NCT04351724|Antiviral Agents|antiviral agents|mesh-ancestor
153892188|NCT03469271|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153892189|NCT03469271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153892194|NCT03469271|Vitamins|vitamins|mesh-ancestor
153422044|NCT04908189|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
153422045|NCT04908189|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
153422047|NCT04908189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153422048|NCT04908189|Dermatologic Agents|dermatologic agents|mesh-ancestor
153422049|NCT04908189|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153422050|NCT04905693|Treprostinil|treprostinil|mesh-list
153422051|NCT04905693|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153422052|NCT04885894|Ozanimod|ozanimod|mesh-list
153422053|NCT04885894|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
153422055|NCT04885894|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153892214|NCT03425279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153892215|NCT03425279|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153892217|NCT03376672|Dexamethasone|dexamethasone|mesh-list
153892218|NCT03376672|Lenalidomide|lenalidomide|mesh-list
153892219|NCT03376672|Ixazomib|ixazomib|mesh-list
153892220|NCT03376672|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153892221|NCT03376672|Antiemetics|antiemetics|mesh-ancestor
153892222|NCT03376672|Autonomic Agents|autonomic agents|mesh-ancestor
153892223|NCT03376672|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153892224|NCT03376672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153892225|NCT03376672|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153892226|NCT03376672|Glucocorticoids|glucocorticoids|mesh-ancestor
153892227|NCT03376672|Hormones|hormones|mesh-ancestor
153892228|NCT03376672|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153892239|NCT03302234|Pembrolizumab|pembrolizumab|mesh-list
153433306|NCT00000823|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153433307|NCT00000823|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153433309|NCT00000379|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
153433310|NCT00000379|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153433311|NCT00000379|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153433313|NCT00000379|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153881205|NCT04781673|Anesthetics, Local|anesthetics, local|mesh-ancestor
153881206|NCT04781673|Anesthetics|anesthetics|mesh-ancestor
153422062|NCT04873596|Midazolam|midazolam|mesh-list
153422063|NCT04873596|Dexmedetomidine|dexmedetomidine|mesh-list
153422064|NCT04873596|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153422065|NCT04873596|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153422067|NCT04873596|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153422068|NCT04873596|Analgesics|analgesics|mesh-ancestor
153422069|NCT04873596|Sensory System Agents|sensory system agents|mesh-ancestor
153422070|NCT04873596|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153892281|NCT03218137|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
153892282|NCT03218137|Purinergic Agonists|purinergic agonists|mesh-ancestor
153892283|NCT03218137|Purinergic Agents|purinergic agents|mesh-ancestor
153892284|NCT03218137|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153914651|NCT00612547|Amodiaquine|amodiaquine|mesh-list
153881229|NCT04670471|Sensory System Agents|sensory system agents|mesh-ancestor
153881230|NCT04670471|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153881231|NCT04620213|Phentolamine|phentolamine|mesh-list
153892301|NCT03155100|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153892302|NCT03155100|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153892303|NCT03155100|Protease Inhibitors|protease inhibitors|mesh-ancestor
153892304|NCT03155100|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153892305|NCT03155100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153892307|NCT03126630|Maytansine|maytansine|mesh-list
153892308|NCT03126630|Anetumab ravtansine|anetumab ravtansine|mesh-list
153422086|NCT04872543|Decitabine and cedazuridine drug combination|decitabine and cedazuridine drug combination|mesh-list
153422087|NCT04872543|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153422088|NCT04872543|Antimetabolites|antimetabolites|mesh-ancestor
153422089|NCT04872543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153422090|NCT04872543|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153422091|NCT04859608|Eculizumab|eculizumab|mesh-list
153422092|NCT04859608|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
153422093|NCT04859608|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153422094|NCT04859608|Immunologic Factors|immunologic factors|mesh-ancestor
153892331|NCT03060473|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153892332|NCT03060473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153892333|NCT02949284|Prednisone|prednisone|mesh-list
153892334|NCT02949284|Cortisone|cortisone|mesh-list
153892335|NCT02949284|Abiraterone Acetate|abiraterone acetate|mesh-list
153892337|NCT02949284|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
153892338|NCT02949284|Androgens|androgens|mesh-list
153892339|NCT02949284|Androgen Receptor Antagonists|androgen receptor antagonists|mesh-list
153892340|NCT02949284|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153892341|NCT02949284|Glucocorticoids|glucocorticoids|mesh-ancestor
153892342|NCT02949284|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153892343|NCT02949284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153892344|NCT02949284|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153892345|NCT02949284|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153892346|NCT02949284|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153892347|NCT02949284|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153892348|NCT02949284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153892349|NCT02949284|Hormone Antagonists|hormone antagonists|mesh-ancestor
153892350|NCT02949284|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153892351|NCT02949284|Androgen Antagonists|androgen antagonists|mesh-ancestor
153892352|NCT02891954|Canagliflozin|canagliflozin|mesh-list
153892353|NCT02891954|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
153892355|NCT02891954|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153881234|NCT04620213|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
153881235|NCT04620213|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
153433425|NCT00000451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153433426|NCT00000451|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153433428|NCT00000865|Lamivudine|lamivudine|mesh-list
153892356|NCT02891954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153892357|NCT02754596|Timolol|timolol|mesh-list
153892358|NCT02754596|Travoprost|travoprost|mesh-list
153892359|NCT02754596|Ophthalmic Solutions|ophthalmic solutions|mesh-list
153892360|NCT02754596|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
153892362|NCT02754596|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
153372144|NCT04351724|Anticoagulants|anticoagulants|mesh-ancestor
153372145|NCT04351724|Antimalarials|antimalarials|mesh-ancestor
153372146|NCT04351724|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153372147|NCT04351724|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153372148|NCT04351724|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153372149|NCT04351724|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
153892401|NCT01919086|Autonomic Agents|autonomic agents|mesh-ancestor
153892402|NCT01919086|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153892403|NCT01919086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153892404|NCT01919086|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153892405|NCT01919086|Glucocorticoids|glucocorticoids|mesh-ancestor
153892406|NCT01919086|Hormones|hormones|mesh-ancestor
153892407|NCT01919086|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153892408|NCT01919086|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153892409|NCT01919086|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153892410|NCT01919086|Immunologic Factors|immunologic factors|mesh-ancestor
153892411|NCT01919086|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153914652|NCT00612547|Antimalarials|antimalarials|mesh-ancestor
153433467|NCT00000889|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153433468|NCT00000889|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153433469|NCT00000889|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153433470|NCT00000889|Antiviral Agents|antiviral agents|mesh-ancestor
153433471|NCT00000889|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153433473|NCT00000505|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
153433480|NCT00000901|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153433481|NCT00000901|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153433482|NCT00000901|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153433483|NCT00000901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153433484|NCT00000901|Antiviral Agents|antiviral agents|mesh-ancestor
153433485|NCT00000901|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153433486|NCT00000901|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153433487|NCT00000901|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153433488|NCT00000901|Antimetabolites|antimetabolites|mesh-ancestor
153433489|NCT00000901|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
153433490|NCT00000901|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
153433491|NCT00000901|Protease Inhibitors|protease inhibitors|mesh-ancestor
153372452|NCT01779167|Growth Inhibitors|growth inhibitors|mesh-ancestor
153892424|NCT01833715|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153892425|NCT01833715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153892426|NCT01833715|Analgesics|analgesics|mesh-ancestor
153892427|NCT01833715|Sensory System Agents|sensory system agents|mesh-ancestor
153892428|NCT01833715|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153892429|NCT01833715|Antitussive Agents|antitussive agents|mesh-ancestor
153892430|NCT01833715|Respiratory System Agents|respiratory system agents|mesh-ancestor
153892431|NCT01534494|Psilocybin|psilocybin|mesh-list
153892432|NCT01534494|Hallucinogens|hallucinogens|mesh-ancestor
153892469|NCT00602797|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153892470|NCT00602797|Tubulin Modulators|tubulin modulators|mesh-ancestor
153892471|NCT00602797|Antimitotic Agents|antimitotic agents|mesh-ancestor
153892488|NCT00006721|Doxorubicin|doxorubicin|mesh-list
153892489|NCT00006721|Vincristine|vincristine|mesh-list
153892490|NCT00006721|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153892491|NCT00006721|Immunologic Factors|immunologic factors|mesh-ancestor
153892492|NCT00006721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153892493|NCT00006721|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153892494|NCT00006721|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153892495|NCT00006721|Alkylating Agents|alkylating agents|mesh-ancestor
153892496|NCT00006721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153892497|NCT00006721|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153892498|NCT00006721|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153892499|NCT00006721|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153892501|NCT00006721|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153892502|NCT00006721|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153892503|NCT00006721|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153892504|NCT00006721|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153892505|NCT00006721|Glucocorticoids|glucocorticoids|mesh-ancestor
153892507|NCT00006721|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153433568|NCT03015896|Growth Substances|growth substances|mesh-ancestor
153433569|NCT03015896|Growth Inhibitors|growth inhibitors|mesh-ancestor
153433571|NCT02994836|Infliximab|infliximab|mesh-list
153433572|NCT02994836|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
153433573|NCT02994836|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
153433574|NCT02994836|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153433575|NCT02994836|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153892519|NCT01030666|Analgesics|analgesics|mesh-ancestor
153892520|NCT01030666|Sensory System Agents|sensory system agents|mesh-ancestor
153892521|NCT01030666|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153892522|NCT01030666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153892523|NCT01030666|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153892524|NCT01030666|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153892525|NCT01030666|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153892526|NCT01030666|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153892527|NCT01030666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153892528|NCT01030666|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
153892529|NCT01030666|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153892530|NCT01030666|Disinfectants|disinfectants|mesh-ancestor
153433592|NCT00000613|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153433593|NCT02909348|Pembrolizumab|pembrolizumab|mesh-list
153433594|NCT02909348|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153433595|NCT02909348|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153433596|NCT02909348|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153433597|NCT02909348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153433598|NCT00000949|Aldesleukin|aldesleukin|mesh-list
153433599|NCT00000949|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153433600|NCT00000949|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153433601|NCT00000949|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153881256|NCT04476173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153881257|NCT04476173|Analgesics|analgesics|mesh-ancestor
153881258|NCT04476173|Sensory System Agents|sensory system agents|mesh-ancestor
153881259|NCT04476173|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153881260|NCT04476173|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
153881261|NCT04476173|Anesthetics, General|anesthetics, general|mesh-ancestor
153881262|NCT04476173|Anesthetics|anesthetics|mesh-ancestor
153881263|NCT04467723|Pirfenidone|pirfenidone|mesh-list
153881264|NCT04467723|Atezolizumab|atezolizumab|mesh-list
153881265|NCT04467723|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153881266|NCT04467723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153881267|NCT04467723|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153881268|NCT04467723|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153881269|NCT04467723|Analgesics|analgesics|mesh-ancestor
153892576|NCT05642624|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153433635|NCT00000961|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153433636|NCT00000961|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153881271|NCT04467723|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153881272|NCT04467723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153422128|NCT04824092|Mitosis Modulators|mitosis modulators|mesh-ancestor
153422129|NCT04824092|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153372455|NCT01779167|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153372456|NCT01779167|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153892615|NCT02890238|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153892618|NCT00627796|Lanreotide|lanreotide|mesh-list
153372458|NCT01780337|Oxytocics|oxytocics|mesh-ancestor
153372459|NCT01780337|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153372460|NCT01780337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153372541|NCT03362775|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153372542|NCT03362775|Anesthetics, General|anesthetics, general|mesh-ancestor
153372543|NCT03362775|Anesthetics|anesthetics|mesh-ancestor
153372544|NCT01786967|Fesoterodine|fesoterodine|mesh-list
153422134|NCT04813926|Enzyme Activators|enzyme activators|mesh-ancestor
153422135|NCT04813926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153422136|NCT04810078|Nivolumab|nivolumab|mesh-list
153892659|NCT01236573|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153882587|NCT01689129|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
153422137|NCT04810078|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153422138|NCT04810078|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153422139|NCT04810078|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153422140|NCT04810078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153422141|NCT04786067|Abatacept|abatacept|mesh-list
153422142|NCT04786067|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153422143|NCT04786067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153422144|NCT04786067|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153433771|NCT00000691|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153433772|NCT00000691|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153433773|NCT00000691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153433774|NCT00002984|Paclitaxel|paclitaxel|mesh-list
153433775|NCT00002984|Fluorouracil|fluorouracil|mesh-list
153881279|NCT04464070|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153881280|NCT04464070|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153881281|NCT04464070|Analgesics|analgesics|mesh-ancestor
153881282|NCT04464070|Sensory System Agents|sensory system agents|mesh-ancestor
153881283|NCT04464070|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153881284|NCT04464070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153881285|NCT04464070|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153372546|NCT01786967|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
153372595|NCT02327741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153372596|NCT00367185|Thalidomide|thalidomide|mesh-list
153881286|NCT04464070|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153881287|NCT04464070|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153881288|NCT04464070|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153881289|NCT04464070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153422145|NCT04786067|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153422146|NCT04786067|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153422148|NCT04786067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153422149|NCT04786067|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153422150|NCT04750902|Listerine|listerine|mesh-list
153422151|NCT04750902|Fluorides|fluorides|mesh-list
153422152|NCT04750902|Sodium Fluoride|sodium fluoride|mesh-list
153422153|NCT04750902|Cariostatic Agents|cariostatic agents|mesh-ancestor
153422154|NCT04750902|Protective Agents|protective agents|mesh-ancestor
153892753|NCT01260948|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153892754|NCT01260948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153881298|NCT04464070|Vitamin B Complex|vitamin b complex|mesh-ancestor
153881299|NCT04464070|Vitamins|vitamins|mesh-ancestor
153881300|NCT04464070|Micronutrients|micronutrients|mesh-ancestor
153881301|NCT04459234|Ketamine|ketamine|mesh-list
153892790|NCT01298570|Antimetabolites|antimetabolites|mesh-ancestor
153892792|NCT01298570|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153422157|NCT04750902|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153422158|NCT04747301|Dinoprostone|dinoprostone|mesh-list
153422159|NCT04747301|Oxytocics|oxytocics|mesh-ancestor
153422160|NCT04747301|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153422162|NCT04670432|Troxerutin|troxerutin|mesh-list
153422163|NCT04670432|Anticoagulants|anticoagulants|mesh-ancestor
153422164|NCT04651088|Potassium Citrate|potassium citrate|mesh-list
153422165|NCT04651088|Diuretics|diuretics|mesh-ancestor
153422166|NCT04651088|Natriuretic Agents|natriuretic agents|mesh-ancestor
153422167|NCT04651088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153422168|NCT04651088|Expectorants|expectorants|mesh-ancestor
153422169|NCT04651088|Respiratory System Agents|respiratory system agents|mesh-ancestor
153422170|NCT04625530|Tranexamic Acid|tranexamic acid|mesh-list
153422171|NCT04625530|Ferric Compounds|ferric compounds|mesh-list
153422172|NCT04625530|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
153422173|NCT04625530|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153422174|NCT04625530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153881303|NCT04459234|Sensory System Agents|sensory system agents|mesh-ancestor
153881304|NCT04459234|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153881305|NCT04459234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153433913|NCT00000727|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
153881310|NCT04459234|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153881311|NCT04459234|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
153881312|NCT04459234|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
153892894|NCT03377478|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153892896|NCT03181932|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153892897|NCT03181932|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153892898|NCT02888730|Tobramycin|tobramycin|mesh-list
153892899|NCT02888730|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153882589|NCT01689129|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153881313|NCT04459234|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153881314|NCT04459234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153881315|NCT04441138|Durvalumab|durvalumab|mesh-list
153881316|NCT04441138|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153881317|NCT04441138|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153881318|NCT04311502|Pyridoxine|pyridoxine|mesh-list
153422175|NCT04625530|Hemostatics|hemostatics|mesh-ancestor
153422176|NCT04625530|Coagulants|coagulants|mesh-ancestor
153422177|NCT04625530|Hematinics|hematinics|mesh-ancestor
153422179|NCT04616183|Cetuximab|cetuximab|mesh-list
153422180|NCT04616183|Antibodies|antibodies|mesh-list
153422181|NCT04616183|Immunoglobulins|immunoglobulins|mesh-list
153422182|NCT04616183|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
153422183|NCT04616183|Immunologic Factors|immunologic factors|mesh-ancestor
153422184|NCT04616183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153892929|NCT01235949|Sensory System Agents|sensory system agents|mesh-ancestor
153892930|NCT01235949|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153434017|NCT00002317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153892931|NCT01235949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153892932|NCT01235949|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153892933|NCT01235949|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153892934|NCT01235949|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153892935|NCT01235949|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153892936|NCT01235949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153892937|NCT01235949|Antipyretics|antipyretics|mesh-ancestor
153892938|NCT00691158|Pramlintide|pramlintide|mesh-list
153892939|NCT00691158|Islet Amyloid Polypeptide|islet amyloid polypeptide|mesh-list
153892940|NCT00691158|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153892941|NCT00691158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153892942|NCT00691158|Appetite Depressants|appetite depressants|mesh-ancestor
153892943|NCT00691158|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
153892944|NCT00691158|Amylin Receptor Agonists|amylin receptor agonists|mesh-ancestor
153892945|NCT00691158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153892946|NCT01235793|Temozolomide|temozolomide|mesh-list
153892947|NCT01235793|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153783548|NCT04546282|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153372600|NCT00367185|Leprostatic Agents|leprostatic agents|mesh-ancestor
153372601|NCT00367185|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153372602|NCT00367185|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153372603|NCT00367185|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153372604|NCT00367185|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153372605|NCT00367185|Growth Substances|growth substances|mesh-ancestor
153372606|NCT00367185|Growth Inhibitors|growth inhibitors|mesh-ancestor
153372607|NCT00367185|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153372608|NCT02635035|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
153372609|NCT02635035|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
153372610|NCT02635035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153372611|NCT02635035|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
153892994|NCT01233687|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153892996|NCT01233609|Anticonvulsants|anticonvulsants|mesh-ancestor
153892997|NCT01233609|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153892999|NCT01233609|GABA Agents|gaba agents|mesh-ancestor
153881323|NCT04311502|Clofazimine|clofazimine|mesh-list
153893026|NCT01232127|Protease Inhibitors|protease inhibitors|mesh-ancestor
153893027|NCT01232127|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153893028|NCT01232127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153893029|NCT01232127|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153893030|NCT01232127|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153893031|NCT01232127|Antiviral Agents|antiviral agents|mesh-ancestor
153893032|NCT01232127|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153893033|NCT01232127|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
153893034|NCT01232127|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153893035|NCT01232127|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153893036|NCT01232127|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
153893037|NCT01232127|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153893038|NCT01232127|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
153893039|NCT01232127|Histamine Antagonists|histamine antagonists|mesh-ancestor
153881346|NCT04311502|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153881347|NCT04311502|Antimetabolites|antimetabolites|mesh-ancestor
153881348|NCT04311502|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153881349|NCT04311502|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153881350|NCT04311073|Tranexamic Acid|tranexamic acid|mesh-list
153881351|NCT04311073|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
153893049|NCT01231659|Everolimus|everolimus|mesh-list
153893050|NCT01231659|Letrozole|letrozole|mesh-list
153893051|NCT01231659|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
153893052|NCT01231659|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153893053|NCT01231659|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153893054|NCT01231659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153893055|NCT01231659|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153893056|NCT01231659|Immunologic Factors|immunologic factors|mesh-ancestor
153893057|NCT01231659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153893058|NCT01231659|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153893059|NCT01231659|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
153893060|NCT01231659|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153893061|NCT01231659|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
153893062|NCT01231659|Hormone Antagonists|hormone antagonists|mesh-ancestor
153434186|NCT00001339|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153434187|NCT00001339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153434188|NCT00001339|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153434189|NCT00001339|Tubulin Modulators|tubulin modulators|mesh-ancestor
153434190|NCT00001339|Antimitotic Agents|antimitotic agents|mesh-ancestor
153434191|NCT00001339|Mitosis Modulators|mitosis modulators|mesh-ancestor
153434192|NCT00001339|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153434193|NCT00001993|Miglustat|miglustat|mesh-list
153434194|NCT00001993|Zidovudine|zidovudine|mesh-list
153434195|NCT00001993|Antimetabolites|antimetabolites|mesh-ancestor
153434196|NCT00001993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153434197|NCT00001993|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153434198|NCT00001993|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153434199|NCT00001993|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153434200|NCT00001993|Antiviral Agents|antiviral agents|mesh-ancestor
153434201|NCT00001993|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153422214|NCT04499950|Bupropion hydrochloride, naltrexone hydrochoride drug combination|bupropion hydrochloride, naltrexone hydrochoride drug combination|mesh-list
153422215|NCT04499950|Naltrexone|naltrexone|mesh-list
153422216|NCT04499950|Bupropion|bupropion|mesh-list
153422217|NCT04499950|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
153422218|NCT04499950|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
153422219|NCT04499950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153422220|NCT04499950|Sensory System Agents|sensory system agents|mesh-ancestor
153422221|NCT04499950|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153434218|NCT00002383|Saquinavir|saquinavir|mesh-list
153893111|NCT01257204|Ribavirin|ribavirin|mesh-list
153893112|NCT01257204|Interferon-alpha|interferon-alpha|mesh-list
153893113|NCT01257204|Interferon alpha-2|interferon alpha-2|mesh-list
153893114|NCT01257204|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
153893115|NCT01257204|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153893116|NCT01257204|Antiviral Agents|antiviral agents|mesh-ancestor
153893117|NCT01257204|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153893118|NCT01257204|Antimetabolites|antimetabolites|mesh-ancestor
153893119|NCT01257204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153893120|NCT01257204|Immunologic Factors|immunologic factors|mesh-ancestor
153893121|NCT01257204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153893122|NCT01231581|Gemcitabine|gemcitabine|mesh-list
153893123|NCT01231581|Trametinib|trametinib|mesh-list
153893124|NCT01231581|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153893125|NCT01231581|Antimetabolites|antimetabolites|mesh-ancestor
153893126|NCT01231581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153893127|NCT01231581|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153893128|NCT01231581|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153372723|NCT01373450|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153372724|NCT01793285|Etanercept|etanercept|mesh-list
153372725|NCT01793285|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153372726|NCT01793285|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153372727|NCT01793285|Analgesics|analgesics|mesh-ancestor
153372728|NCT01793285|Sensory System Agents|sensory system agents|mesh-ancestor
153372729|NCT01793285|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153372730|NCT01793285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153372731|NCT01793285|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153372732|NCT01793285|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153434244|NCT00001357|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153434245|NCT00001357|Analgesics|analgesics|mesh-ancestor
153434246|NCT00001357|Sensory System Agents|sensory system agents|mesh-ancestor
153434247|NCT00001357|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153434248|NCT00001357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153434249|NCT00001381|Suramin|suramin|mesh-list
153434250|NCT00001381|Antinematodal Agents|antinematodal agents|mesh-ancestor
153434251|NCT00001381|Anthelmintics|anthelmintics|mesh-ancestor
153434253|NCT00001381|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153434254|NCT00001381|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153434255|NCT00001381|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
153372746|NCT02639637|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153422240|NCT04420975|Nivolumab|nivolumab|mesh-list
153422241|NCT04420975|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153422242|NCT04420975|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153422243|NCT04420975|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153422244|NCT04420975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153422245|NCT04396236|Lasmiditan|lasmiditan|mesh-list
153422246|NCT04396236|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
153422247|NCT04396236|Serotonin Agents|serotonin agents|mesh-ancestor
153422248|NCT04396236|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153422249|NCT04396236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153422250|NCT04396236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153422251|NCT04370093|Pioglitazone|pioglitazone|mesh-list
153422252|NCT04370093|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153422253|NCT04370093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153422254|NCT04295486|Aspirin|aspirin|mesh-list
153422255|NCT04295486|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153422256|NCT04295486|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153422257|NCT04295486|Analgesics|analgesics|mesh-ancestor
153893173|NCT01256658|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153893174|NCT01256190|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
153893175|NCT01256190|Fibrin Foam|fibrin foam|mesh-list
153893176|NCT01256190|Hemostatics|hemostatics|mesh-ancestor
153893177|NCT01256190|Coagulants|coagulants|mesh-ancestor
153893179|NCT02888574|Oxytocics|oxytocics|mesh-ancestor
153881414|NCT04099888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153881416|NCT04081389|Interferon-alpha|interferon-alpha|mesh-list
153881417|NCT04081389|Interferon alpha-2|interferon alpha-2|mesh-list
153881418|NCT04081389|poly(I).poly(c12,U)|poly(i).poly(c12,u)|mesh-list
153881419|NCT04081389|Celecoxib|celecoxib|mesh-list
153881420|NCT04081389|Paclitaxel|paclitaxel|mesh-list
153881421|NCT04081389|Cyclophosphamide|cyclophosphamide|mesh-list
153881422|NCT04081389|Doxorubicin|doxorubicin|mesh-list
153893191|NCT04319289|Ergocalciferols|ergocalciferols|mesh-list
153893192|NCT04319289|Cholecalciferol|cholecalciferol|mesh-list
153893193|NCT04319289|Vitamins|vitamins|mesh-list
153893194|NCT04319289|Micronutrients|micronutrients|mesh-ancestor
153893195|NCT04319289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153893196|NCT04319289|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153893198|NCT01008475|Irinotecan|irinotecan|mesh-list
153434331|NCT00002395|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153434332|NCT00002395|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153434333|NCT00002395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153434334|NCT00002395|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153434336|NCT00002401|Zidovudine|zidovudine|mesh-list
153881445|NCT04081389|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153881446|NCT04081389|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153881447|NCT04081389|Analgesics|analgesics|mesh-ancestor
153881448|NCT04081389|Sensory System Agents|sensory system agents|mesh-ancestor
153881449|NCT04081389|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153881450|NCT04081389|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153881451|NCT04081389|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
153881452|NCT04081389|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153881453|NCT04032080|Prexasertib|prexasertib|mesh-list
153881454|NCT04032080|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153881455|NCT04032080|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153893286|NCT04295161|Hormone Antagonists|hormone antagonists|mesh-ancestor
153893287|NCT04295161|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153893290|NCT01007149|Omalizumab|omalizumab|mesh-list
153881463|NCT04022005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153881464|NCT04022005|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153881465|NCT04022005|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153881467|NCT04022005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153881468|NCT04016142|Paclitaxel|paclitaxel|mesh-list
153881469|NCT04016142|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
153881470|NCT04016142|Carboplatin|carboplatin|mesh-list
153881471|NCT04016142|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153881472|NCT04016142|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153881473|NCT04016142|Tubulin Modulators|tubulin modulators|mesh-ancestor
153881474|NCT04016142|Antimitotic Agents|antimitotic agents|mesh-ancestor
153881475|NCT04016142|Mitosis Modulators|mitosis modulators|mesh-ancestor
153422333|NCT04062669|Vaccines|vaccines|mesh-list
153422334|NCT04062669|Immunologic Factors|immunologic factors|mesh-ancestor
153422335|NCT04062669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153422336|NCT04047862|Paclitaxel|paclitaxel|mesh-list
153422337|NCT04047862|Etoposide|etoposide|mesh-list
153882590|NCT01689129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153882591|NCT01689285|Valacyclovir|valacyclovir|mesh-list
153882592|NCT01689285|Antiviral Agents|antiviral agents|mesh-ancestor
153882593|NCT01689285|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153379728|NCT03028467|Vitamins|vitamins|mesh-ancestor
153379729|NCT03028467|Micronutrients|micronutrients|mesh-ancestor
153379730|NCT02222870|Vaccines|vaccines|mesh-list
153783551|NCT04546282|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153379731|NCT02222870|Immunologic Factors|immunologic factors|mesh-ancestor
153379732|NCT02222870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153422338|NCT04047862|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
153422339|NCT04047862|Carboplatin|carboplatin|mesh-list
153422340|NCT04047862|Capecitabine|capecitabine|mesh-list
153422341|NCT04047862|Fluorouracil|fluorouracil|mesh-list
153422342|NCT04047862|Oxaliplatin|oxaliplatin|mesh-list
153422343|NCT04047862|Pemetrexed|pemetrexed|mesh-list
153422344|NCT04047862|Tislelizumab|tislelizumab|mesh-list
153422345|NCT04047862|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153434473|NCT00002107|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153372751|NCT02639637|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153372755|NCT01332188|Cetirizine|cetirizine|mesh-list
153372756|NCT01332188|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
153372757|NCT01332188|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
153881476|NCT04016142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153893399|NCT01293968|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153881477|NCT03970720|Metoclopramide|metoclopramide|mesh-list
153881478|NCT03970720|Antiemetics|antiemetics|mesh-ancestor
153372759|NCT01332188|Histamine Antagonists|histamine antagonists|mesh-ancestor
153372760|NCT01332188|Histamine Agents|histamine agents|mesh-ancestor
153893567|NCT01014208|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153372761|NCT01332188|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153372762|NCT01332188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153372763|NCT01332188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153372765|NCT01794455|Candesartan cilexetil|candesartan cilexetil|mesh-list
153372766|NCT01794455|Sertraline|sertraline|mesh-list
153372767|NCT01794455|Antidepressive Agents|antidepressive agents|mesh-ancestor
153372768|NCT01794455|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153372769|NCT01794455|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
153372770|NCT01794455|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153372771|NCT01794455|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153372772|NCT01794455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153434727|NCT00003050|Tubulin Modulators|tubulin modulators|mesh-ancestor
153434728|NCT00003050|Antimitotic Agents|antimitotic agents|mesh-ancestor
153434729|NCT00003050|Mitosis Modulators|mitosis modulators|mesh-ancestor
153434731|NCT00003050|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153372773|NCT01794455|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153372774|NCT01794455|Serotonin Agents|serotonin agents|mesh-ancestor
153422433|NCT03844061|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153422434|NCT03844061|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153422435|NCT03844061|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
153881546|NCT03630211|Alemtuzumab|alemtuzumab|mesh-list
153372775|NCT01794455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153372776|NCT01794455|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153372777|NCT01794455|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
153372778|NCT01794455|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
153372779|NCT01332500|Naproxen|naproxen|mesh-list
153379733|NCT02223260|Dabigatran|dabigatran|mesh-list
153379734|NCT02223260|Antithrombins|antithrombins|mesh-ancestor
153379735|NCT02223260|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
153434763|NCT00002179|Protease Inhibitors|protease inhibitors|mesh-ancestor
153434764|NCT00003056|Cyclosporine|cyclosporine|mesh-list
153422452|NCT03829410|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153379736|NCT02223260|Protease Inhibitors|protease inhibitors|mesh-ancestor
153881580|NCT03387423|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153881581|NCT03387423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153881582|NCT03340766|Pembrolizumab|pembrolizumab|mesh-list
153881583|NCT03340766|Blinatumomab|blinatumomab|mesh-list
153434838|NCT00003068|Immunologic Factors|immunologic factors|mesh-ancestor
153434840|NCT00003068|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153881586|NCT03340766|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153881587|NCT03340766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153881588|NCT03267589|Durvalumab|durvalumab|mesh-list
153881589|NCT03267589|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153434864|NCT00003080|Immunologic Factors|immunologic factors|mesh-ancestor
153881590|NCT03267589|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153422453|NCT03829410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153422454|NCT03781986|Carboplatin|carboplatin|mesh-list
153422455|NCT03781986|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153422456|NCT03713658|Risperidone|risperidone|mesh-list
153422457|NCT03713658|Paliperidone Palmitate|paliperidone palmitate|mesh-list
153422458|NCT03713658|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153422459|NCT03713658|Serotonin Agents|serotonin agents|mesh-ancestor
153893796|NCT01013740|Lapatinib|lapatinib|mesh-list
153893797|NCT01013740|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153434906|NCT00003086|Ifosfamide|ifosfamide|mesh-list
153372783|NCT01332500|Analgesics|analgesics|mesh-ancestor
153372784|NCT01332500|Sensory System Agents|sensory system agents|mesh-ancestor
153434946|NCT00381199|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153372785|NCT01332500|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153881591|NCT03208452|Magnesium Sulfate|magnesium sulfate|mesh-list
153881592|NCT03208452|Analgesics|analgesics|mesh-ancestor
153881593|NCT03208452|Sensory System Agents|sensory system agents|mesh-ancestor
153881594|NCT03208452|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153881595|NCT03208452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153881596|NCT03208452|Anesthetics|anesthetics|mesh-ancestor
153881597|NCT03208452|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153881598|NCT03208452|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153881599|NCT03208452|Anticonvulsants|anticonvulsants|mesh-ancestor
153881600|NCT03208452|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153881601|NCT03208452|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153434980|NCT00002515|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153434981|NCT00002515|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153422465|NCT03713658|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153422466|NCT03713658|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153422467|NCT03713658|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
153422468|NCT03713658|Dopamine Agents|dopamine agents|mesh-ancestor
153893907|NCT01005316|Prednisone|prednisone|mesh-list
153422469|NCT03713658|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
153422470|NCT03713658|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
153881602|NCT03208452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153881603|NCT03208452|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153881605|NCT03208452|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153881606|NCT03190265|Cyclophosphamide|cyclophosphamide|mesh-list
153881607|NCT03190265|Nivolumab|nivolumab|mesh-list
153881608|NCT03190265|Ipilimumab|ipilimumab|mesh-list
153435062|NCT00002233|Antiviral Agents|antiviral agents|mesh-ancestor
153372787|NCT01332500|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153372788|NCT01332500|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153372789|NCT01332500|Gout Suppressants|gout suppressants|mesh-ancestor
153372790|NCT01332500|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153372791|NCT01332500|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153372792|NCT01332500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153881616|NCT03190265|Alkylating Agents|alkylating agents|mesh-ancestor
153881617|NCT03190265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153881618|NCT03190265|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153881619|NCT03190265|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153881620|NCT03190265|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153881621|NCT03190265|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153435099|NCT00002533|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
153881622|NCT03190265|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153881623|NCT02615691|Factor VIII|factor viii|mesh-list
153422489|NCT03646357|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
153435172|NCT00003128|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153435180|NCT04331197|Letrozole|letrozole|mesh-list
153435214|NCT00002798|Dexamethasone|dexamethasone|mesh-list
153379770|NCT01887587|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153435215|NCT00002798|Hydrocortisone|hydrocortisone|mesh-list
153422492|NCT03646357|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153422493|NCT03646357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153422494|NCT03646357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153422495|NCT03594747|Paclitaxel|paclitaxel|mesh-list
153435382|NCT00003146|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153881640|NCT01977417|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153881641|NCT01977417|Analgesics|analgesics|mesh-ancestor
153881642|NCT01977417|Sensory System Agents|sensory system agents|mesh-ancestor
153894300|NCT04287205|Progestins|progestins|mesh-ancestor
153894338|NCT01208103|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
153894339|NCT01208103|Capecitabine|capecitabine|mesh-list
153881643|NCT01977417|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153881644|NCT01977417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153881645|NCT01977417|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153881646|NCT01977417|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153881647|NCT01969578|Paclitaxel|paclitaxel|mesh-list
153422513|NCT03500328|Ocrelizumab|ocrelizumab|mesh-list
153422514|NCT03500328|Natalizumab|natalizumab|mesh-list
153422515|NCT03500328|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
153422517|NCT03500328|Ozanimod|ozanimod|mesh-list
153422518|NCT03500328|Ponesimod|ponesimod|mesh-list
153422519|NCT03500328|Siponimod|siponimod|mesh-list
153894552|NCT02864095|Epinephrine|epinephrine|mesh-list
153894601|NCT00974233|Immunologic Factors|immunologic factors|mesh-ancestor
153422520|NCT03500328|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153422521|NCT03500328|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153422522|NCT03500328|Immunologic Factors|immunologic factors|mesh-ancestor
153422523|NCT03500328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153422524|NCT03500328|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153422525|NCT03500328|Antiviral Agents|antiviral agents|mesh-ancestor
153894674|NCT02863705|Timolol|timolol|mesh-list
153422526|NCT03500328|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153422527|NCT03500328|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153435940|NCT00002888|Tubulin Modulators|tubulin modulators|mesh-ancestor
153435941|NCT00002888|Antimitotic Agents|antimitotic agents|mesh-ancestor
153422528|NCT03500328|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
153422529|NCT03500328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153422530|NCT03500328|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153881648|NCT01969578|Carboplatin|carboplatin|mesh-list
153881649|NCT01969578|Doxorubicin|doxorubicin|mesh-list
153881650|NCT01969578|Bicalutamide|bicalutamide|mesh-list
153881651|NCT01969578|Triptorelin Pamoate|triptorelin pamoate|mesh-list
153881652|NCT01969578|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153894831|NCT05658549|Acetylcysteine|acetylcysteine|mesh-list
153894832|NCT05658549|N-monoacetylcystine|n-monoacetylcystine|mesh-list
153894833|NCT05658549|Antiviral Agents|antiviral agents|mesh-ancestor
153894835|NCT05658549|Expectorants|expectorants|mesh-ancestor
153436042|NCT00003212|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153436061|NCT00002611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153895011|NCT05927818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153895055|NCT05926895|Betamethasone Valerate|betamethasone valerate|mesh-list
153881662|NCT01969578|Androgen Antagonists|androgen antagonists|mesh-ancestor
153881663|NCT01969578|Hormone Antagonists|hormone antagonists|mesh-ancestor
153881664|NCT01969578|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153422531|NCT03500328|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153422532|NCT03500328|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153422533|NCT03500328|Analgesics|analgesics|mesh-ancestor
153422534|NCT03500328|Sensory System Agents|sensory system agents|mesh-ancestor
153895162|NCT05354453|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153895164|NCT05354453|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
153422535|NCT03500328|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153422536|NCT03500328|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153422537|NCT03498612|Pembrolizumab|pembrolizumab|mesh-list
153422538|NCT03498612|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153422539|NCT03498612|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153422540|NCT03498612|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153422541|NCT03498612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153422542|NCT03473756|Atezolizumab|atezolizumab|mesh-list
153436453|NCT00004022|Immunologic Factors|immunologic factors|mesh-ancestor
153881666|NCT01969578|Luteolytic Agents|luteolytic agents|mesh-ancestor
153881667|NCT01969578|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
153881668|NCT01969578|Contraceptive Agents|contraceptive agents|mesh-ancestor
153881669|NCT01969578|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153881670|NCT01969578|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
153881671|NCT01969578|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153436536|NCT00003560|Docetaxel|docetaxel|mesh-list
153436577|NCT00002689|Antimetabolites|antimetabolites|mesh-ancestor
153881672|NCT01951885|Mycophenolic Acid|mycophenolic acid|mesh-list
153881673|NCT01951885|Methotrexate|methotrexate|mesh-list
153881674|NCT01951885|Tacrolimus|tacrolimus|mesh-list
153881675|NCT01951885|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
153881676|NCT01951885|Abortifacient Agents|abortifacient agents|mesh-ancestor
153881677|NCT01951885|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153422543|NCT03473756|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153422544|NCT03473756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153436625|NCT00003578|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153436626|NCT00003578|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153422545|NCT03473756|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153422546|NCT03473756|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153422547|NCT03444376|Pembrolizumab|pembrolizumab|mesh-list
153422548|NCT03444376|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153422549|NCT03444376|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153422550|NCT03444376|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153422551|NCT03444376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153436684|NCT00002701|Dermatologic Agents|dermatologic agents|mesh-ancestor
153436685|NCT00002701|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153372793|NCT01332500|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
153372794|NCT01332500|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
153372795|NCT01332500|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
153372829|NCT01332578|Adrenergic Agents|adrenergic agents|mesh-ancestor
153372830|NCT01332578|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153881678|NCT01951885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153881679|NCT01951885|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153881680|NCT01951885|Antimetabolites|antimetabolites|mesh-ancestor
153881681|NCT01951885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153881682|NCT01951885|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153881683|NCT01951885|Dermatologic Agents|dermatologic agents|mesh-ancestor
153436721|NCT00002707|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153881684|NCT01951885|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153881685|NCT01951885|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153881686|NCT01951885|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153881687|NCT01951885|Immunologic Factors|immunologic factors|mesh-ancestor
153881688|NCT01951885|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153881689|NCT01951885|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153881690|NCT01951885|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
153881691|NCT01951885|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153895569|NCT02004782|Prednisolone|prednisolone|mesh-list
153881692|NCT01951885|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
153881693|NCT01951885|Antitubercular Agents|antitubercular agents|mesh-ancestor
153881694|NCT01951885|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153881695|NCT01951885|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153881696|NCT01810588|Mycophenolic Acid|mycophenolic acid|mesh-list
153881697|NCT01810588|Rituximab|rituximab|mesh-list
153881698|NCT01810588|Fludarabine|fludarabine|mesh-list
153422563|NCT03412877|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153422564|NCT03412877|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153436785|NCT00003326|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153436786|NCT00003326|Tubulin Modulators|tubulin modulators|mesh-ancestor
153422565|NCT03412877|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153372831|NCT01333592|Mitiglinide|mitiglinide|mesh-list
153372832|NCT01333592|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153372833|NCT01333592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153372834|NCT01375946|Contraceptive Agents|contraceptive agents|mesh-list
153372835|NCT01375946|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153372836|NCT01375946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153372838|NCT01267292|Methylphenidate|methylphenidate|mesh-list
153372839|NCT01267292|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
153372840|NCT01267292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153372869|NCT01797575|Acetylcysteine|acetylcysteine|mesh-list
153895643|NCT01745588|Glucocorticoids|glucocorticoids|mesh-ancestor
153372871|NCT01797575|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153372872|NCT01797575|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153372873|NCT01797575|Analgesics|analgesics|mesh-ancestor
153372874|NCT01797575|Sensory System Agents|sensory system agents|mesh-ancestor
153372875|NCT01797575|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153372876|NCT01797575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153372877|NCT01797575|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153372878|NCT01797575|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153436858|NCT00002737|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153436859|NCT00002737|Antiviral Agents|antiviral agents|mesh-ancestor
153372880|NCT01797575|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153881699|NCT01810588|Fludarabine phosphate|fludarabine phosphate|mesh-list
153881700|NCT01810588|Melphalan|melphalan|mesh-list
153881701|NCT01810588|Tacrolimus|tacrolimus|mesh-list
153881702|NCT01810588|Antilymphocyte Serum|antilymphocyte serum|mesh-list
153881703|NCT01810588|Thymoglobulin|thymoglobulin|mesh-list
153881704|NCT01810588|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153895711|NCT00673309|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
153895713|NCT00673309|Adrenergic Agents|adrenergic agents|mesh-ancestor
153881708|NCT01810588|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153881723|NCT01499888|Sirolimus|sirolimus|mesh-list
153372882|NCT01797575|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153372883|NCT01797575|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153372884|NCT01797575|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153436952|NCT00004142|Fluorouracil|fluorouracil|mesh-list
153895794|NCT00101283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153895795|NCT00101283|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153895833|NCT04207385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153895834|NCT04207385|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153422617|NCT03107689|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
153895924|NCT01183143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153895925|NCT01183065|Folic Acid|folic acid|mesh-list
153422621|NCT03091075|Hormones|hormones|mesh-ancestor
153422622|NCT03091075|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153422623|NCT03091075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153437181|NCT00003380|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153372951|NCT01335620|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153372952|NCT01335620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153372954|NCT01335620|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153372955|NCT01335620|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
153881746|NCT00745316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153896006|NCT01181271|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153896007|NCT01181271|Immunologic Factors|immunologic factors|mesh-ancestor
153881747|NCT00745316|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
153881748|NCT00745316|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
153881749|NCT00709865|1,3-dipropyl-8-(2-(5,6-epoxy)norbornyl)xanthine|1,3-dipropyl-8-(2-(5,6-epoxy)norbornyl)xanthine|mesh-list
153881750|NCT00709865|Adenosine A1 Receptor Antagonists|adenosine a1 receptor antagonists|mesh-ancestor
153881751|NCT00709865|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
153881752|NCT00709865|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
153437266|NCT00002785|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153437267|NCT00002785|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
153437315|NCT00003386|Antimitotic Agents|antimitotic agents|mesh-ancestor
153437316|NCT00003386|Mitosis Modulators|mitosis modulators|mesh-ancestor
153437317|NCT00003386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153437324|NCT00384566|Metoprolol|metoprolol|mesh-list
153881753|NCT00709865|Purinergic Agents|purinergic agents|mesh-ancestor
153881754|NCT00709865|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153881755|NCT00709865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153422624|NCT03091075|Anabolic Agents|anabolic agents|mesh-ancestor
153422625|NCT03089983|Isoniazid|isoniazid|mesh-list
153422626|NCT03089983|Rifapentine|rifapentine|mesh-list
153422627|NCT03089983|Buprenorphine|buprenorphine|mesh-list
153422628|NCT03089983|Methadone|methadone|mesh-list
153422629|NCT03089983|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
153422630|NCT03089983|Naloxone|naloxone|mesh-list
153422631|NCT03089983|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153437362|NCT00002791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153422633|NCT03089983|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153422634|NCT03089983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153422635|NCT03089983|Analgesics|analgesics|mesh-ancestor
153422636|NCT03089983|Sensory System Agents|sensory system agents|mesh-ancestor
153422637|NCT03089983|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153422638|NCT03089983|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
153422639|NCT03089983|Antitussive Agents|antitussive agents|mesh-ancestor
153422640|NCT03089983|Respiratory System Agents|respiratory system agents|mesh-ancestor
153422641|NCT03089983|Antitubercular Agents|antitubercular agents|mesh-ancestor
153422642|NCT03089983|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153422643|NCT03089983|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153422644|NCT03089983|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
153372958|NCT01335932|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
153372959|NCT01335932|Antiviral Agents|antiviral agents|mesh-ancestor
153372960|NCT01335932|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153896235|NCT01299389|Serotonin Agents|serotonin agents|mesh-ancestor
153372993|NCT01734551|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
153372994|NCT01734551|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153372995|NCT01734551|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153372996|NCT01734551|Adrenergic Agents|adrenergic agents|mesh-ancestor
153372997|NCT01734551|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153881756|NCT00709865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153896257|NCT01298765|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153896258|NCT01298765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153896280|NCT00997438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153881758|NCT00682318|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
153881759|NCT00682318|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153881760|NCT00682318|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153896328|NCT02862691|Antipyretics|antipyretics|mesh-ancestor
153437578|NCT00003728|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
153896378|NCT02862769|Lidocaine|lidocaine|mesh-list
153437630|NCT00004892|Carmustine|carmustine|mesh-list
153881761|NCT00682318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153881763|NCT00626990|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153881764|NCT00626990|Alkylating Agents|alkylating agents|mesh-ancestor
153881765|NCT00626990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153881766|NCT00626990|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153881767|NCT00107198|Prednisone|prednisone|mesh-list
153881768|NCT00107198|Cortisone|cortisone|mesh-list
153881769|NCT00107198|Cyclophosphamide|cyclophosphamide|mesh-list
153881770|NCT00107198|Doxorubicin|doxorubicin|mesh-list
153896424|NCT02862145|Hormones|hormones|mesh-ancestor
153881771|NCT00107198|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
153881772|NCT00107198|Vincristine|vincristine|mesh-list
153881773|NCT00107198|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153881774|NCT00107198|Immunologic Factors|immunologic factors|mesh-ancestor
153422645|NCT03089983|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153422646|NCT03089983|Antimetabolites|antimetabolites|mesh-ancestor
153422647|NCT03089983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153422648|NCT03089983|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153422649|NCT03089983|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
153896460|NCT00966355|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153896461|NCT00966355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153896462|NCT01172535|Ritonavir|ritonavir|mesh-list
153896463|NCT01172535|Lopinavir|lopinavir|mesh-list
153896464|NCT01172535|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
153896465|NCT01172535|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
153896466|NCT01172535|Protease Inhibitors|protease inhibitors|mesh-ancestor
153896467|NCT01172535|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153896468|NCT01172535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153896469|NCT01172535|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153896470|NCT01172535|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153896471|NCT01172535|Antiviral Agents|antiviral agents|mesh-ancestor
153896472|NCT01172535|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153896475|NCT05160493|Pregabalin|pregabalin|mesh-list
153881777|NCT00107198|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153881778|NCT00107198|Alkylating Agents|alkylating agents|mesh-ancestor
153881779|NCT00107198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153881780|NCT00107198|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153881781|NCT00107198|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153881782|NCT00107198|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153437752|NCT00004328|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153437755|NCT00004934|Paclitaxel|paclitaxel|mesh-list
153422662|NCT02951130|Vasodilator Agents|vasodilator agents|mesh-ancestor
153422663|NCT02951130|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
153422664|NCT02951130|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
153422665|NCT02951130|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153422666|NCT02951130|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153422667|NCT02951130|Protective Agents|protective agents|mesh-ancestor
153422668|NCT02951130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153422669|NCT02818660|Cosyntropin|cosyntropin|mesh-list
153422670|NCT02818660|Hormones|hormones|mesh-ancestor
153422672|NCT02818660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153437797|NCT00003776|Vitamin B Complex|vitamin b complex|mesh-ancestor
153379774|NCT01887587|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153437799|NCT00003776|Micronutrients|micronutrients|mesh-ancestor
153896602|NCT00630175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153896603|NCT00630175|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
153896639|NCT01170663|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153896643|NCT04315155|Nivolumab|nivolumab|mesh-list
153881789|NCT00107198|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153881791|NCT00107198|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153881792|NCT00107198|Tubulin Modulators|tubulin modulators|mesh-ancestor
153881793|NCT00107198|Antimitotic Agents|antimitotic agents|mesh-ancestor
153896690|NCT02889692|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153881794|NCT00107198|Mitosis Modulators|mitosis modulators|mesh-ancestor
153881795|NCT01601106|Prednisolone|prednisolone|mesh-list
153881796|NCT01601106|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153881797|NCT01601106|Glucocorticoids|glucocorticoids|mesh-ancestor
153881798|NCT01601106|Hormones|hormones|mesh-ancestor
153881799|NCT01601106|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153881800|NCT01601106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153881801|NCT01601106|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153896720|NCT01285310|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153896721|NCT01285310|Analgesics|analgesics|mesh-ancestor
153896825|NCT01290263|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153881812|NCT01643759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153881813|NCT01643759|Analgesics|analgesics|mesh-ancestor
153881814|NCT01643759|Sensory System Agents|sensory system agents|mesh-ancestor
153881815|NCT01643759|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153881816|NCT01643759|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
153881817|NCT04488237|Vitamin D|vitamin d|mesh-list
153881818|NCT04488237|Vitamins|vitamins|mesh-ancestor
153881819|NCT04488237|Micronutrients|micronutrients|mesh-ancestor
153881820|NCT04488237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153881821|NCT04488237|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153881822|NCT04528628|Norepinephrine|norepinephrine|mesh-list
153881823|NCT04528628|Serotonin|serotonin|mesh-list
153881824|NCT04528628|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-list
153881825|NCT04528628|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-list
153881826|NCT04528628|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153438131|NCT00003860|Etoposide|etoposide|mesh-list
153438132|NCT00003860|Ifosfamide|ifosfamide|mesh-list
153373002|NCT01404260|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153373003|NCT01404260|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153373004|NCT01404260|Antimetabolites|antimetabolites|mesh-ancestor
153373005|NCT01404260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153373022|NCT01404572|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153438157|NCT00004466|Atorvastatin|atorvastatin|mesh-list
153438158|NCT00004466|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153373023|NCT01404572|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153881831|NCT04528628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153881832|NCT04528628|Sympathomimetics|sympathomimetics|mesh-ancestor
153881833|NCT04528628|Autonomic Agents|autonomic agents|mesh-ancestor
153881834|NCT04528628|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153881835|NCT04528628|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
153881841|NCT01641341|Pancrelipase|pancrelipase|mesh-list
153881842|NCT01641341|Pancreatin|pancreatin|mesh-list
153881843|NCT01641341|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153438179|NCT00005060|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153881844|NCT01641341|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153881845|NCT01641341|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153881846|NCT01680107|Cycloserine|cycloserine|mesh-list
153881847|NCT01680107|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
153881848|NCT01680107|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153881849|NCT01680107|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
153881850|NCT01680107|Antitubercular Agents|antitubercular agents|mesh-ancestor
153881851|NCT01680107|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153881852|NCT01680107|Antimetabolites|antimetabolites|mesh-ancestor
153881853|NCT01680107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153881854|NCT01680146|Caseins|caseins|mesh-list
153881855|NCT01680146|Chelating Agents|chelating agents|mesh-ancestor
153373028|NCT01381406|Autonomic Agents|autonomic agents|mesh-ancestor
153373029|NCT01381406|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153373030|NCT01381406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153373031|NCT01381406|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153897018|NCT00960661|Incretins|incretins|mesh-ancestor
153897021|NCT00960193|Colchicine|colchicine|mesh-list
153881859|NCT01680185|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
153881860|NCT01680185|Insulin Lispro|insulin lispro|mesh-list
153881861|NCT01680185|Isophane Insulin, Human|isophane insulin, human|mesh-list
153881862|NCT01680185|Insulin, Isophane|insulin, isophane|mesh-list
153881863|NCT01680185|Isophane insulin, beef|isophane insulin, beef|mesh-list
153881864|NCT01680185|Insulin, Short-Acting|insulin, short-acting|mesh-list
153881867|NCT01680263|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
153881868|NCT01680263|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-list
153881869|NCT01680263|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153881870|NCT01680263|Analgesics|analgesics|mesh-ancestor
153881871|NCT01680263|Sensory System Agents|sensory system agents|mesh-ancestor
153881872|NCT01680263|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153881873|NCT01680263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153881874|NCT01680263|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153897039|NCT00959647|Bevacizumab|bevacizumab|mesh-list
153881880|NCT01601730|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153897089|NCT04282291|Morphine|morphine|mesh-list
153881887|NCT01601730|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
153881888|NCT01601730|Parasympatholytics|parasympatholytics|mesh-ancestor
153881889|NCT01601730|Autonomic Agents|autonomic agents|mesh-ancestor
153881890|NCT01601730|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153881891|NCT01601730|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
153881892|NCT01601730|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
153881893|NCT01601730|Cholinergic Agents|cholinergic agents|mesh-ancestor
153881894|NCT01601730|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
153881895|NCT01601730|Antidepressive Agents|antidepressive agents|mesh-ancestor
153881896|NCT01601730|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153881897|NCT01601730|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
153881898|NCT01601730|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
153881899|NCT01601730|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
153438618|NCT00005624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153438619|NCT00005624|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153422780|NCT05363917|Folic Acid|folic acid|mesh-list
153438674|NCT00005684|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153422781|NCT05363917|Vitamin B Complex|vitamin b complex|mesh-list
153422782|NCT05363917|Hematinics|hematinics|mesh-ancestor
153422783|NCT05363917|Vitamins|vitamins|mesh-ancestor
153422784|NCT05363917|Micronutrients|micronutrients|mesh-ancestor
153422785|NCT05363917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153422786|NCT03187730|Nicotine|nicotine|mesh-list
153422787|NCT03187730|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
153422788|NCT03187730|Autonomic Agents|autonomic agents|mesh-ancestor
153422789|NCT03187730|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153897483|NCT01232790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153422791|NCT03187730|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
153422792|NCT03187730|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
153422793|NCT03187730|Cholinergic Agents|cholinergic agents|mesh-ancestor
153422794|NCT03187730|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153422795|NCT03187730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153422796|NCT03261193|Bupivacaine|bupivacaine|mesh-list
153422797|NCT03261193|Anesthetics, Local|anesthetics, local|mesh-ancestor
153422798|NCT03261193|Anesthetics|anesthetics|mesh-ancestor
153422799|NCT03261193|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153897516|NCT01160289|Urological Agents|urological agents|mesh-ancestor
153373035|NCT01381406|Cholinergic Agents|cholinergic agents|mesh-ancestor
153373036|NCT01381406|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153373037|NCT01381406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153881909|NCT01644071|Serotonin Agents|serotonin agents|mesh-ancestor
153881910|NCT01644071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153881911|NCT01644071|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
153881912|NCT01644071|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
153881913|NCT01644071|Parasympatholytics|parasympatholytics|mesh-ancestor
153881914|NCT01644071|Autonomic Agents|autonomic agents|mesh-ancestor
153881915|NCT01644071|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153881916|NCT01644071|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
153881917|NCT01644071|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
153881918|NCT01644071|Cholinergic Agents|cholinergic agents|mesh-ancestor
153881919|NCT01644071|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
153881920|NCT01644071|Antidepressive Agents|antidepressive agents|mesh-ancestor
153881921|NCT01644071|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153881923|NCT01680536|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
153881924|NCT01680536|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
153881925|NCT01680536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153881926|NCT01680536|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153881927|NCT01680536|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153422802|NCT03261193|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153422803|NCT00375661|Interferons|interferons|mesh-list
153422804|NCT00375661|Ribavirin|ribavirin|mesh-list
153422805|NCT00375661|Interferon-alpha|interferon-alpha|mesh-list
153422806|NCT00375661|Interferon alpha-2|interferon alpha-2|mesh-list
153422807|NCT00375661|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153422808|NCT00375661|Antiviral Agents|antiviral agents|mesh-ancestor
153422809|NCT00375661|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153438855|NCT04568876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153438856|NCT04568876|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153438857|NCT04568876|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153438858|NCT04568876|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153422810|NCT00375661|Antimetabolites|antimetabolites|mesh-ancestor
153438884|NCT02210702|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
153373039|NCT01799213|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153373040|NCT01799213|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153373041|NCT01799213|Analgesics|analgesics|mesh-ancestor
153373042|NCT01799213|Sensory System Agents|sensory system agents|mesh-ancestor
153373043|NCT01799213|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153438923|NCT04564430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153439018|NCT04561856|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153439060|NCT03472495|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153439061|NCT03472495|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153439107|NCT03818581|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153439108|NCT03818581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153439109|NCT03818581|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
153439110|NCT03818581|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153439111|NCT03818581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153439113|NCT00002905|Didanosine|didanosine|mesh-list
153439198|NCT00002941|Cyclophosphamide|cyclophosphamide|mesh-list
153439259|NCT00002977|Thiotepa|thiotepa|mesh-list
153439260|NCT00002977|Immunologic Factors|immunologic factors|mesh-ancestor
153439261|NCT00002977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153439262|NCT00002977|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153439263|NCT00002977|Alkylating Agents|alkylating agents|mesh-ancestor
153439264|NCT00002977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153439352|NCT00002995|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153439353|NCT00002995|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153439354|NCT00002995|Tubulin Modulators|tubulin modulators|mesh-ancestor
153439355|NCT00002995|Antimitotic Agents|antimitotic agents|mesh-ancestor
153439356|NCT00002995|Mitosis Modulators|mitosis modulators|mesh-ancestor
153439357|NCT00002995|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153439358|NCT00002995|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153439359|NCT00002995|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153439360|NCT00002995|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
153439394|NCT00003421|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153439395|NCT00003421|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153439398|NCT00003421|Tubulin Modulators|tubulin modulators|mesh-ancestor
153439446|NCT00003007|Hormones|hormones|mesh-ancestor
153439470|NCT00003013|Mitosis Modulators|mitosis modulators|mesh-ancestor
153439471|NCT00003013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153422826|NCT04941170|Sensory System Agents|sensory system agents|mesh-ancestor
153439496|NCT00003013|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
153422827|NCT04941170|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153881928|NCT01680536|Antiviral Agents|antiviral agents|mesh-ancestor
153881929|NCT01680536|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153881930|NCT01680536|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
153881931|NCT01602003|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
153881932|NCT01602003|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153881936|NCT01602003|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153881937|NCT01602003|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
153881938|NCT01602003|Protease Inhibitors|protease inhibitors|mesh-ancestor
153881939|NCT01602003|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153881940|NCT01602003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153881941|NCT01193920|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
153881944|NCT01193920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153881946|NCT01644773|Crizotinib|crizotinib|mesh-list
153881947|NCT01644773|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153881948|NCT01644773|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153881949|NCT01644773|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153881950|NCT01644773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153881951|NCT01644773|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153881952|NCT01602588|Hydroxychloroquine|hydroxychloroquine|mesh-list
153422829|NCT05357911|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153422830|NCT05357911|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
153422831|NCT05357911|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153898313|NCT04312347|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
153422832|NCT05357911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153422833|NCT05357911|Protective Agents|protective agents|mesh-ancestor
153422834|NCT05357911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153422836|NCT03374839|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153422837|NCT03374839|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153422838|NCT03374839|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153898343|NCT00604591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153898344|NCT02691156|Carbon Monoxide|carbon monoxide|mesh-list
153898346|NCT02691156|Antimetabolites|antimetabolites|mesh-ancestor
153898433|NCT00606775|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
153439783|NCT00002833|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
153881968|NCT01645085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153881969|NCT01645124|Hydroxyurea|hydroxyurea|mesh-list
153881970|NCT01645124|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153881971|NCT01645124|Antisickling Agents|antisickling agents|mesh-ancestor
153881972|NCT01645124|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153881973|NCT01645124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153881974|NCT01645124|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153881975|NCT01602861|Spironolactone|spironolactone|mesh-list
153422851|NCT02221674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153422852|NCT02221674|Adrenergic Agents|adrenergic agents|mesh-ancestor
153422853|NCT02221674|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153422854|NCT04736719|Warfarin|warfarin|mesh-list
153422856|NCT04736719|Anticoagulants|anticoagulants|mesh-ancestor
153422857|NCT04736719|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
153422858|NCT04736719|Antithrombins|antithrombins|mesh-ancestor
153422859|NCT04736719|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
153422860|NCT04736719|Protease Inhibitors|protease inhibitors|mesh-ancestor
153422861|NCT04736719|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153422862|NCT04736719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153422863|NCT02221284|Alogliptin|alogliptin|mesh-list
153373045|NCT01799213|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153373049|NCT01799213|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153373050|NCT01799213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153373052|NCT01383200|Tetracaine|tetracaine|mesh-list
153373053|NCT01383200|Anesthetics, Local|anesthetics, local|mesh-ancestor
153373054|NCT01383200|Anesthetics|anesthetics|mesh-ancestor
153373055|NCT01383200|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153373056|NCT01383200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153373057|NCT01383200|Sensory System Agents|sensory system agents|mesh-ancestor
153373058|NCT01383200|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153373059|NCT01383200|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153373060|NCT01383200|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
153881976|NCT01602861|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
153881977|NCT01602861|Hormone Antagonists|hormone antagonists|mesh-ancestor
153881978|NCT01602861|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153881979|NCT01602861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153881980|NCT01602861|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
153881981|NCT01602861|Diuretics|diuretics|mesh-ancestor
153881984|NCT01681667|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153881985|NCT01681667|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153881986|NCT01681667|Analgesics|analgesics|mesh-ancestor
153422864|NCT02221284|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153422865|NCT02221284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153422867|NCT02221284|Hormones|hormones|mesh-ancestor
153422868|NCT02221284|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153881989|NCT01681667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153881990|NCT01681667|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153881991|NCT01681667|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153881992|NCT01681667|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153881993|NCT01681667|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153881994|NCT01681667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153881995|NCT01600365|Ganciclovir|ganciclovir|mesh-list
153881996|NCT01600365|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
153881997|NCT01600365|Lubricant Eye Drops|lubricant eye drops|mesh-list
153881998|NCT01600365|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
153881999|NCT01600365|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
153882003|NCT01600365|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153882004|NCT01600365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153422883|NCT04736108|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153422884|NCT04736108|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153422894|NCT05406674|Cisplatin|cisplatin|mesh-list
153882011|NCT01602900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153882012|NCT01645241|Ganirelix|ganirelix|mesh-list
153882013|NCT01645241|Hormone Antagonists|hormone antagonists|mesh-ancestor
153882014|NCT01645241|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153882015|NCT01645241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153882017|NCT01602939|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153882018|NCT01602939|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153882019|NCT01602939|Immunologic Factors|immunologic factors|mesh-ancestor
153882020|NCT01602939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153882021|NCT01600404|Muscarinic Antagonists|muscarinic antagonists|mesh-list
153882022|NCT01600404|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
153882032|NCT01603134|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153882033|NCT01603134|Free Radical Scavengers|free radical scavengers|mesh-ancestor
153882036|NCT01603134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153882037|NCT01603173|Quetiapine Fumarate|quetiapine fumarate|mesh-list
153882038|NCT01603173|Antidepressive Agents|antidepressive agents|mesh-ancestor
153882039|NCT01603173|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153882040|NCT01603173|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153882041|NCT01603173|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153882042|NCT01603173|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153882043|NCT01603173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153882044|NCT01603212|Interferons|interferons|mesh-list
153882045|NCT01603212|Interferon-alpha|interferon-alpha|mesh-list
153882046|NCT01603212|Interferon alpha-2|interferon alpha-2|mesh-list
153882047|NCT01603212|Aldesleukin|aldesleukin|mesh-list
153422927|NCT01801189|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153422928|NCT01801189|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153422930|NCT01801189|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153422931|NCT01801189|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153422933|NCT04275362|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
153422934|NCT04275362|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153422935|NCT04275362|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
153422936|NCT04275362|Histamine Antagonists|histamine antagonists|mesh-ancestor
153422937|NCT04275362|Histamine Agents|histamine agents|mesh-ancestor
153373981|NCT01421186|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153373982|NCT01421186|Antiemetics|antiemetics|mesh-ancestor
153373983|NCT01421186|Autonomic Agents|autonomic agents|mesh-ancestor
153373984|NCT01421186|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153373985|NCT01421186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153373986|NCT01421186|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153373987|NCT01421186|Glucocorticoids|glucocorticoids|mesh-ancestor
153373989|NCT01421186|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153373990|NCT01421186|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153373991|NCT01421186|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153373992|NCT01421186|Immunologic Factors|immunologic factors|mesh-ancestor
153374196|NCT00555425|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153374197|NCT00555425|Narcotics|narcotics|mesh-ancestor
153374198|NCT00555425|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153882049|NCT01603212|Vemurafenib|vemurafenib|mesh-list
153882050|NCT01603212|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153882051|NCT01603212|Antiviral Agents|antiviral agents|mesh-ancestor
153882052|NCT01603212|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153882053|NCT01603212|Immunologic Factors|immunologic factors|mesh-ancestor
153882054|NCT01603212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153882055|NCT01603212|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153882056|NCT01603212|Analgesics|analgesics|mesh-ancestor
153882059|NCT01603212|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153882060|NCT01603212|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153422939|NCT04275362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153422940|NCT04275362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153422941|NCT04275362|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
153422942|NCT04275362|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153422943|NCT04275362|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153422944|NCT00716755|Olanzapine|olanzapine|mesh-list
153422945|NCT00716755|Risperidone|risperidone|mesh-list
153422946|NCT00716755|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153422947|NCT00716755|Serotonin Agents|serotonin agents|mesh-ancestor
153422953|NCT00716755|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153422954|NCT00716755|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153422955|NCT00716755|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
153882063|NCT01603212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153882064|NCT01645748|Cisplatin|cisplatin|mesh-list
153882065|NCT01645748|Docetaxel|docetaxel|mesh-list
153882066|NCT01645748|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153882067|NCT01645748|Tubulin Modulators|tubulin modulators|mesh-ancestor
153882068|NCT01645748|Antimitotic Agents|antimitotic agents|mesh-ancestor
153882069|NCT01645748|Mitosis Modulators|mitosis modulators|mesh-ancestor
153882070|NCT01645748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153882071|NCT02484924|Clopidogrel|clopidogrel|mesh-list
153882072|NCT02484924|Ticagrelor|ticagrelor|mesh-list
153882073|NCT02484924|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153422958|NCT00716755|Autonomic Agents|autonomic agents|mesh-ancestor
153422959|NCT00716755|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153422960|NCT00716755|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153422961|NCT00716755|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
153422962|NCT00716755|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153422963|NCT00716755|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153422964|NCT05406050|Eldecalcitol|eldecalcitol|mesh-list
153422966|NCT05406050|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153422967|NCT05406050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153422968|NCT05406050|Vitamins|vitamins|mesh-ancestor
153422969|NCT05406050|Micronutrients|micronutrients|mesh-ancestor
153422970|NCT03202550|Oxycodone|oxycodone|mesh-list
153422971|NCT03202550|Lorazepam|lorazepam|mesh-list
153422972|NCT03202550|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153374201|NCT00555425|Sensory System Agents|sensory system agents|mesh-ancestor
153374202|NCT00555425|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153374203|NCT00555425|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
153374204|NCT05444673|Cisplatin|cisplatin|mesh-list
153374205|NCT05444673|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153374313|NCT00553319|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
153374314|NCT00553319|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153374315|NCT00553319|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153374316|NCT00553319|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
153374317|NCT00369291|Keyhole-limpet hemocyanin|keyhole-limpet hemocyanin|mesh-list
153374318|NCT00369291|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153374319|NCT00369291|Immunologic Factors|immunologic factors|mesh-ancestor
153374320|NCT00369291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153374322|NCT01868633|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153374325|NCT01868633|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153882093|NCT01607034|Protective Agents|protective agents|mesh-ancestor
153882094|NCT01607034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153882095|NCT01607034|Dopamine Agents|dopamine agents|mesh-ancestor
153882096|NCT01607034|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153882097|NCT01607034|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
153882098|NCT01607034|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
153882099|NCT01607034|Dopamine Agonists|dopamine agonists|mesh-ancestor
153422982|NCT03202550|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153422983|NCT03202550|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153422984|NCT03202550|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153422985|NCT03202550|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153422986|NCT03202550|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153422987|NCT03202550|GABA Modulators|gaba modulators|mesh-ancestor
153422988|NCT03202550|GABA Agents|gaba agents|mesh-ancestor
153422989|NCT03202550|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153422994|NCT04088786|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153422995|NCT04088786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153422996|NCT04088786|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153422997|NCT00392821|Everolimus|everolimus|mesh-list
153422998|NCT00392821|Sorafenib|sorafenib|mesh-list
153882101|NCT01603251|Lumefantrine|lumefantrine|mesh-list
153882102|NCT01603251|Artemether|artemether|mesh-list
153882110|NCT01646294|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
153882111|NCT01646294|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153882112|NCT01646294|Adrenergic Agents|adrenergic agents|mesh-ancestor
153882113|NCT01646294|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153882114|NCT01646294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153882115|NCT01646294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153882116|NCT01646294|Urological Agents|urological agents|mesh-ancestor
153423000|NCT00392821|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153423001|NCT00392821|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153423005|NCT00392821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153423006|NCT00392821|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153423007|NCT04708171|Anesthetics|anesthetics|mesh-list
153423008|NCT04708171|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153423009|NCT04708171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153423011|NCT03290378|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153882117|NCT01603758|Ezetimibe|ezetimibe|mesh-list
153882128|NCT01607307|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
153882129|NCT02279381|Chlorhexidine|chlorhexidine|mesh-list
153882130|NCT02279381|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
153423012|NCT03290378|Narcotics|narcotics|mesh-ancestor
153423013|NCT03290378|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153423014|NCT03290378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153423015|NCT03290378|Analgesics|analgesics|mesh-ancestor
153423016|NCT03290378|Sensory System Agents|sensory system agents|mesh-ancestor
153423017|NCT03290378|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153423019|NCT02076217|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
153423020|NCT02076217|Contraceptive Agents|contraceptive agents|mesh-list
153882133|NCT01646567|Betamethasone|betamethasone|mesh-list
153882134|NCT01646567|Betamethasone Valerate|betamethasone valerate|mesh-list
153882135|NCT01646567|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
153882136|NCT01646567|Betamethasone benzoate|betamethasone benzoate|mesh-list
153882137|NCT01646567|Calcipotriene|calcipotriene|mesh-list
153882138|NCT01646567|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
153882139|NCT01646567|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153423021|NCT02076217|Medroxyprogesterone|medroxyprogesterone|mesh-list
153423022|NCT02076217|Etonogestrel|etonogestrel|mesh-list
153423023|NCT02076217|Desogestrel|desogestrel|mesh-list
153423024|NCT02076217|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153423028|NCT02076217|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
153423029|NCT02076217|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
153423030|NCT02076217|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
153423031|NCT02076217|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
153423032|NCT02076217|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
153423033|NCT02076217|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
153423034|NCT02076217|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153374330|NCT01868633|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153374331|NCT01868633|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153882140|NCT01646567|Glucocorticoids|glucocorticoids|mesh-ancestor
153882141|NCT01646567|Hormones|hormones|mesh-ancestor
153882142|NCT01646567|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153882143|NCT01646567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153882144|NCT01646567|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153882145|NCT01646567|Respiratory System Agents|respiratory system agents|mesh-ancestor
153882146|NCT01646567|Dermatologic Agents|dermatologic agents|mesh-ancestor
153882147|NCT01681979|Fluticasone|fluticasone|mesh-list
153374332|NCT01868633|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153374334|NCT04738773|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
153374335|NCT04738773|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
153374336|NCT04738773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153374337|NCT04738773|Sensory System Agents|sensory system agents|mesh-ancestor
153374338|NCT04738773|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153374339|NCT03833063|Botulinum Toxins|botulinum toxins|mesh-list
153882165|NCT01646684|Pasireotide|pasireotide|mesh-list
153882166|NCT01646684|Hormones|hormones|mesh-ancestor
153882167|NCT01646684|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153882168|NCT01646684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153882169|NCT01607580|Methylprednisolone|methylprednisolone|mesh-list
153882172|NCT01607580|Prednisolone|prednisolone|mesh-list
153882173|NCT01607580|Prednisolone acetate|prednisolone acetate|mesh-list
153882174|NCT01607580|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
153882175|NCT01607580|Prednisolone phosphate|prednisolone phosphate|mesh-list
153882176|NCT01607580|Glucocorticoids|glucocorticoids|mesh-list
153882177|NCT01607580|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153882178|NCT01607580|Antiemetics|antiemetics|mesh-ancestor
153882179|NCT01607580|Autonomic Agents|autonomic agents|mesh-ancestor
153374341|NCT03833063|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
153374342|NCT03833063|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
153374343|NCT03833063|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153374344|NCT03833063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153374345|NCT03833063|Cholinergic Agents|cholinergic agents|mesh-ancestor
153374346|NCT03833063|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153374347|NCT03833063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153374348|NCT03833063|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
153882188|NCT01607580|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153882189|NCT01647152|Ustekinumab|ustekinumab|mesh-list
153882190|NCT01647152|Dermatologic Agents|dermatologic agents|mesh-ancestor
153882191|NCT01604187|Fentanyl|fentanyl|mesh-list
153882192|NCT01604187|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153882193|NCT01604187|Narcotics|narcotics|mesh-ancestor
153882194|NCT01604187|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153882195|NCT01604187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153882196|NCT01604187|Analgesics|analgesics|mesh-ancestor
153882225|NCT01682408|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
153882226|NCT01682408|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153374350|NCT02676375|Bupropion|bupropion|mesh-list
153374351|NCT02676375|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
153374352|NCT02676375|Antidepressive Agents|antidepressive agents|mesh-ancestor
153882238|NCT01608009|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153882239|NCT01608009|Tubulin Modulators|tubulin modulators|mesh-ancestor
153882242|NCT01608009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153882243|NCT01647347|Povidone-Iodine|povidone-iodine|mesh-list
153882244|NCT01647347|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
153882245|NCT01647347|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153882246|NCT01604031|Lenalidomide|lenalidomide|mesh-list
153882247|NCT01604031|Immunologic Factors|immunologic factors|mesh-ancestor
153882248|NCT01604031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153882249|NCT01604031|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153882250|NCT01604031|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153882251|NCT01604031|Growth Substances|growth substances|mesh-ancestor
153882252|NCT01604031|Growth Inhibitors|growth inhibitors|mesh-ancestor
153882254|NCT01682564|Candesartan cilexetil|candesartan cilexetil|mesh-list
153882255|NCT01682564|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153882256|NCT01682564|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
153882257|NCT01682564|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
153423143|NCT01632150|Growth Inhibitors|growth inhibitors|mesh-ancestor
153374353|NCT02676375|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153374690|NCT05430867|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
153374691|NCT05448885|Cisplatin|cisplatin|mesh-list
153374692|NCT05448885|Gemcitabine|gemcitabine|mesh-list
153374850|NCT02213900|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
153374851|NCT02213900|Dopamine Agents|dopamine agents|mesh-ancestor
153374852|NCT02213900|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153374853|NCT02213900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153374854|NCT02213900|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
153374855|NCT02370888|Lenalidomide|lenalidomide|mesh-list
153374856|NCT02370888|Immunologic Factors|immunologic factors|mesh-ancestor
153882260|NCT01608360|Anesthetics, Local|anesthetics, local|mesh-ancestor
153882261|NCT01608360|Anesthetics|anesthetics|mesh-ancestor
153882262|NCT01608360|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153882263|NCT01608360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153882264|NCT01608360|Sensory System Agents|sensory system agents|mesh-ancestor
153882265|NCT01608360|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153882266|NCT01608360|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153882267|NCT01608360|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
153882268|NCT01608360|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153882269|NCT01608360|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153882270|NCT01608360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153882271|NCT01647659|Trametinib|trametinib|mesh-list
153882272|NCT01647659|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153882273|NCT01647659|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153882274|NCT01647659|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153882275|NCT01647659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153882276|NCT01604811|Saw palmetto extract|saw palmetto extract|mesh-list
153882277|NCT01604811|Tamsulosin|tamsulosin|mesh-list
153882278|NCT01604811|Urological Agents|urological agents|mesh-ancestor
153882279|NCT01604811|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
153423166|NCT04333004|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153423167|NCT04333004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153423168|NCT03219866|Budesonide|budesonide|mesh-list
153374857|NCT02370888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153374858|NCT02370888|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153374859|NCT02370888|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153374860|NCT02370888|Growth Substances|growth substances|mesh-ancestor
153423501|NCT02181816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153423502|NCT02181816|Vasodilator Agents|vasodilator agents|mesh-ancestor
153423503|NCT02181816|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
153423504|NCT02181816|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
153882602|NCT01606527|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153882603|NCT01606527|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153882604|NCT01606527|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153374861|NCT02370888|Growth Inhibitors|growth inhibitors|mesh-ancestor
153374862|NCT02370888|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153374863|NCT05358873|Antibodies|antibodies|mesh-list
153374864|NCT05358873|Immunologic Factors|immunologic factors|mesh-ancestor
153374865|NCT05358873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153374866|NCT02214290|Caffeine|caffeine|mesh-list
153374867|NCT02214290|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
153882280|NCT01604811|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
153882281|NCT01604811|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
153882282|NCT01604811|Adrenergic Agents|adrenergic agents|mesh-ancestor
153882283|NCT01604811|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153882284|NCT01604811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153882285|NCT01604811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153882286|NCT01683032|Methylphenidate|methylphenidate|mesh-list
153882287|NCT01683032|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
153882288|NCT01683032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153882289|NCT01683032|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
153882290|NCT01683032|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153882291|NCT01683032|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153882292|NCT01683032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153423181|NCT03219866|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153423183|NCT03219866|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
153423184|NCT03219866|Cholinergic Agents|cholinergic agents|mesh-ancestor
153423185|NCT03219866|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153423186|NCT03219866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153423189|NCT03300674|Hydromorphone|hydromorphone|mesh-list
153423192|NCT03300674|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153423193|NCT03300674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153423194|NCT03300674|Sensory System Agents|sensory system agents|mesh-ancestor
153423195|NCT03300674|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153423196|NCT03300674|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153882294|NCT01683032|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153882295|NCT01604928|Mirabegron|mirabegron|mesh-list
153882297|NCT01604928|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
153882298|NCT01604928|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
153882299|NCT01604928|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153882300|NCT01604928|Adrenergic Agents|adrenergic agents|mesh-ancestor
153882301|NCT01604928|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153882302|NCT01604928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153882303|NCT01604928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153882304|NCT01604928|Urological Agents|urological agents|mesh-ancestor
153882306|NCT01604928|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
153882307|NCT01604928|Cholinergic Agents|cholinergic agents|mesh-ancestor
153882309|NCT01683149|Topotecan|topotecan|mesh-list
153882310|NCT01683149|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-list
153423198|NCT03300674|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153423199|NCT03300674|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153423201|NCT03300674|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153423202|NCT03300674|Narcotics|narcotics|mesh-ancestor
153423203|NCT03300674|Analgesics|analgesics|mesh-ancestor
153423204|NCT02158806|Aspirin|aspirin|mesh-list
153423205|NCT02158806|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153423206|NCT02158806|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153423207|NCT02158806|Analgesics|analgesics|mesh-ancestor
153375506|NCT01448486|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153375507|NCT01448486|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153375508|NCT01448486|Antiviral Agents|antiviral agents|mesh-ancestor
153375509|NCT01448486|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153375510|NCT01448486|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
153375511|NCT01448486|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
153375512|NCT01448486|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153375513|NCT01448486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153375514|NCT01562678|Liraglutide|liraglutide|mesh-list
153375515|NCT01562678|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
153882315|NCT01683149|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153882316|NCT01608555|Tobramycin|tobramycin|mesh-list
153882317|NCT01608555|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153882318|NCT01608555|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153423210|NCT02158806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153423211|NCT02158806|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153423212|NCT02158806|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153423213|NCT02158806|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153423214|NCT02158806|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153423215|NCT02158806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153423216|NCT02158806|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153423217|NCT02158806|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153423218|NCT02158806|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153423219|NCT02158806|Antipyretics|antipyretics|mesh-ancestor
153423220|NCT03197389|Pembrolizumab|pembrolizumab|mesh-list
153423221|NCT03197389|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153423222|NCT03197389|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153423223|NCT03197389|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153423224|NCT03197389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153423225|NCT03198871|Acetaminophen|acetaminophen|mesh-list
153423226|NCT03198871|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153423227|NCT03198871|Analgesics|analgesics|mesh-ancestor
153882341|NCT01605357|Diuretics|diuretics|mesh-ancestor
153882342|NCT01605357|Natriuretic Agents|natriuretic agents|mesh-ancestor
153882343|NCT01605357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153882344|NCT01648127|Ceftaroline|ceftaroline|mesh-list
153882345|NCT01648127|Beta Lactam Antibiotics|beta lactam antibiotics|mesh-ancestor
153882346|NCT01648127|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153375524|NCT02767869|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153882347|NCT01648127|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153882348|NCT01608750|Folic Acid|folic acid|mesh-list
153882349|NCT01608750|Hematinics|hematinics|mesh-ancestor
153882350|NCT01608750|Vitamin B Complex|vitamin b complex|mesh-ancestor
153882351|NCT01608750|Vitamins|vitamins|mesh-ancestor
153882352|NCT01608750|Micronutrients|micronutrients|mesh-ancestor
153882353|NCT01608750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153882354|NCT01605513|Interferons|interferons|mesh-list
153882355|NCT01605513|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153882356|NCT01605513|Antiviral Agents|antiviral agents|mesh-ancestor
153882357|NCT01605513|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153882358|NCT04528277|Isoniazid|isoniazid|mesh-list
153882359|NCT04528277|Rifapentine|rifapentine|mesh-list
153882360|NCT04528277|Antitubercular Agents|antitubercular agents|mesh-ancestor
153882361|NCT04528277|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153882362|NCT04528277|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153882363|NCT04528277|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
153423252|NCT03220958|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153423254|NCT03220958|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
153375525|NCT01449266|Gadolinium 1,4,7,10-tetraazacyclododecane-N,N',N'',N'''-tetraacetate|gadolinium 1,4,7,10-tetraazacyclododecane-n,n',n'',n'''-tetraacetate|mesh-list
153375528|NCT01449266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153375529|NCT02767947|Luliconazole|luliconazole|mesh-list
153375530|NCT02767947|Antifungal Agents|antifungal agents|mesh-ancestor
153375531|NCT02767947|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153375532|NCT02770365|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
153375533|NCT02770365|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
153375534|NCT02770365|Estradiol|estradiol|mesh-list
153375535|NCT02770365|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
153375536|NCT02770365|Estrogens|estrogens|mesh-ancestor
153375537|NCT02770365|Hormones|hormones|mesh-ancestor
153423280|NCT03305822|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153423281|NCT03305822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153375597|NCT01450826|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153375598|NCT01450826|Antipruritics|antipruritics|mesh-ancestor
153375599|NCT01450826|Dermatologic Agents|dermatologic agents|mesh-ancestor
153375600|NCT01450826|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
153375601|NCT01450826|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153375602|NCT01450826|Serotonin Agents|serotonin agents|mesh-ancestor
153375603|NCT01450826|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153375604|NCT01450826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153375605|NCT01450826|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
153375606|NCT05349903|Epigallocatechin gallate|epigallocatechin gallate|mesh-list
153375607|NCT05349903|Antioxidants|antioxidants|mesh-ancestor
153375608|NCT05349903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153375609|NCT05349903|Protective Agents|protective agents|mesh-ancestor
153375610|NCT05349903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153375611|NCT05349903|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
153375612|NCT05349903|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
153375613|NCT05349903|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153375614|NCT05349903|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
153375615|NCT05349825|Losartan|losartan|mesh-list
153375714|NCT05013255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153375715|NCT01461668|Retapamulin|retapamulin|mesh-list
153375716|NCT01461668|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153375717|NCT01461668|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153376036|NCT06194214|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153376037|NCT06194214|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153376039|NCT06194201|Antifungal Agents|antifungal agents|mesh-ancestor
153376040|NCT06194201|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153376041|NCT06194201|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153376042|NCT06194201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153376043|NCT06194058|Anesthetics|anesthetics|mesh-list
153376044|NCT06194058|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153376046|NCT06193993|Abiraterone Acetate|abiraterone acetate|mesh-list
153376052|NCT06193993|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153376053|NCT06193993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153376061|NCT06191497|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
153376062|NCT06191497|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153376063|NCT06191497|Disinfectants|disinfectants|mesh-ancestor
153376309|NCT06145373|Protease Inhibitors|protease inhibitors|mesh-ancestor
153376310|NCT06145373|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153376311|NCT06145373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153376312|NCT06145373|Anticoagulants|anticoagulants|mesh-ancestor
153376313|NCT06136507|Factor VIII|factor viii|mesh-list
153376314|NCT06136507|Coagulants|coagulants|mesh-ancestor
153376315|NCT06132685|Dexamethasone|dexamethasone|mesh-list
153376316|NCT06132685|Dexamethasone acetate|dexamethasone acetate|mesh-list
153376317|NCT06132685|Ichthammol|ichthammol|mesh-list
153376318|NCT06132685|BB 1101|bb 1101|mesh-list
153376869|NCT05570409|Glucocorticoids|glucocorticoids|mesh-ancestor
153376870|NCT05570409|Hormones|hormones|mesh-ancestor
153377185|NCT05168202|Venetoclax|venetoclax|mesh-list
153377186|NCT05168202|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153377187|NCT05168202|Antimetabolites|antimetabolites|mesh-ancestor
153377188|NCT05168202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153377189|NCT05168202|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153377195|NCT05139420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153377197|NCT05139420|Appetite Depressants|appetite depressants|mesh-ancestor
153377198|NCT05139420|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
153377199|NCT05139420|Sympathomimetics|sympathomimetics|mesh-ancestor
153377200|NCT05139420|Autonomic Agents|autonomic agents|mesh-ancestor
153377201|NCT05139420|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153377262|NCT05036408|Dermatologic Agents|dermatologic agents|mesh-ancestor
153377263|NCT05032820|Lenalidomide|lenalidomide|mesh-list
153377265|NCT05032820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153377266|NCT05032820|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153377267|NCT05032820|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153377268|NCT05032820|Growth Substances|growth substances|mesh-ancestor
153377269|NCT05032820|Growth Inhibitors|growth inhibitors|mesh-ancestor
153377273|NCT04961619|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153377274|NCT04961619|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153377275|NCT04961619|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153377276|NCT04961619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153377419|NCT04620603|Immunologic Factors|immunologic factors|mesh-ancestor
153377420|NCT04620603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153377423|NCT04551144|Methyltestosterone|methyltestosterone|mesh-list
153377424|NCT04551144|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
153377425|NCT04551144|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
153377427|NCT04551144|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
153377443|NCT04551144|Anabolic Agents|anabolic agents|mesh-ancestor
153377444|NCT04546425|Vaccines|vaccines|mesh-list
153377445|NCT04546425|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
153377446|NCT04546425|Immunologic Factors|immunologic factors|mesh-ancestor
153377447|NCT04546425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153377448|NCT04523922|Oxytocin|oxytocin|mesh-list
153377643|NCT04224636|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153882441|NCT01648595|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153882442|NCT01648595|Anesthetics, General|anesthetics, general|mesh-ancestor
153423329|NCT03228914|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153423330|NCT03228914|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153377654|NCT04126278|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153377656|NCT04126278|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153377657|NCT04126278|Glucocorticoids|glucocorticoids|mesh-ancestor
153377658|NCT04126278|Hormones|hormones|mesh-ancestor
153377659|NCT04126278|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153377660|NCT04126278|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153377661|NCT04126278|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153377662|NCT04106557|Gaboxadol|gaboxadol|mesh-list
153377663|NCT04106557|Analgesics|analgesics|mesh-ancestor
153377664|NCT04106557|Sensory System Agents|sensory system agents|mesh-ancestor
153377751|NCT03984578|Capecitabine|capecitabine|mesh-list
153377752|NCT03984578|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153377753|NCT03984578|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153377754|NCT03984578|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153377755|NCT03984578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153377756|NCT03984578|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153882447|NCT01648634|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
153882448|NCT01648634|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
153882449|NCT01648634|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153882450|NCT01648634|Adrenergic Agents|adrenergic agents|mesh-ancestor
153882451|NCT01648634|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153882452|NCT01648634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153882453|NCT01648634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153882454|NCT01606059|Acetaminophen|acetaminophen|mesh-list
153882455|NCT01606059|Tramadol|tramadol|mesh-list
153882456|NCT01606059|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153882457|NCT01606059|Analgesics|analgesics|mesh-ancestor
153882462|NCT01606059|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153882463|NCT01606059|Narcotics|narcotics|mesh-ancestor
153423350|NCT03234374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153423351|NCT03234374|Sensory System Agents|sensory system agents|mesh-ancestor
153423352|NCT03234374|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153423353|NCT04332536|Codeine|codeine|mesh-list
153423354|NCT04332536|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153423355|NCT04332536|Narcotics|narcotics|mesh-ancestor
153423356|NCT04332536|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153423357|NCT04332536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153423358|NCT04332536|Analgesics|analgesics|mesh-ancestor
153423359|NCT04332536|Sensory System Agents|sensory system agents|mesh-ancestor
153423360|NCT04332536|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153423361|NCT04332536|Antitussive Agents|antitussive agents|mesh-ancestor
153423362|NCT04332536|Respiratory System Agents|respiratory system agents|mesh-ancestor
153423363|NCT03236168|Ivermectin|ivermectin|mesh-list
153423365|NCT03236168|Malathion|malathion|mesh-list
153423366|NCT03236168|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153423367|NCT03236168|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153377764|NCT03935451|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
153377765|NCT03935451|Protease Inhibitors|protease inhibitors|mesh-ancestor
153377766|NCT03935451|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153377767|NCT03935451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153377769|NCT03884998|Nivolumab|nivolumab|mesh-list
153377770|NCT03884998|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153377771|NCT03884998|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153377772|NCT03884998|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153377773|NCT03884998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153377774|NCT03856658|Floxuridine|floxuridine|mesh-list
153783550|NCT04546282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153377775|NCT03856658|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153882465|NCT01648712|Heparin|heparin|mesh-list
153882466|NCT01648712|Anticoagulants|anticoagulants|mesh-ancestor
153882467|NCT01648712|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153882468|NCT01648712|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153882469|NCT01648712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153882470|NCT01688544|Benzimidazole|benzimidazole|mesh-list
153882471|NCT01688544|Anthelmintics|anthelmintics|mesh-ancestor
153377952|NCT03502577|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153377953|NCT03502577|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153377954|NCT03491540|Gentamicins|gentamicins|mesh-list
153377955|NCT03491540|Ornidazole|ornidazole|mesh-list
153377956|NCT03491540|Sennosides|sennosides|mesh-list
153377957|NCT03491540|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153377958|NCT03491540|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153377959|NCT03491540|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
153377960|NCT03491540|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153377961|NCT03491540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153377962|NCT03491540|Laxatives|laxatives|mesh-ancestor
153377963|NCT03491540|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153377964|NCT03491540|Amebicides|amebicides|mesh-ancestor
153377965|NCT03491540|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153377966|NCT03491540|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153377967|NCT03491540|Antitrichomonal Agents|antitrichomonal agents|mesh-ancestor
153377968|NCT03479268|Ibrutinib|ibrutinib|mesh-list
153377969|NCT03479268|Enzyme Inhibitors|enzyme inhibitors|mesh-list
153377970|NCT03479268|Pevonedistat|pevonedistat|mesh-list
153377971|NCT03479268|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153377972|NCT03479268|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153882478|NCT01688583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153882479|NCT01688583|Analgesics|analgesics|mesh-ancestor
153882480|NCT01688583|Sensory System Agents|sensory system agents|mesh-ancestor
153882481|NCT01688583|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153423369|NCT03236168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153423370|NCT03236168|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
153423371|NCT03236168|Cholinergic Agents|cholinergic agents|mesh-ancestor
153423372|NCT03236168|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153423373|NCT03236168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153423374|NCT03306589|Molgramostim|molgramostim|mesh-list
153423375|NCT03306589|Sargramostim|sargramostim|mesh-list
153423380|NCT03306589|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153882605|NCT01606527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153882606|NCT01609335|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
153882607|NCT01609335|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
153882608|NCT01609335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153379779|NCT01887587|Mitosis Modulators|mitosis modulators|mesh-ancestor
153379817|NCT03029715|Dexmedetomidine|dexmedetomidine|mesh-list
153379818|NCT03029715|Remifentanil|remifentanil|mesh-list
153379853|NCT03830060|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153378120|NCT03087136|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153882488|NCT01648829|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153882489|NCT01648829|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153882490|NCT01648829|Antimetabolites|antimetabolites|mesh-ancestor
153882491|NCT01648829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153882492|NCT01648829|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153882493|NCT01648829|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
153882494|NCT01648829|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153882496|NCT01688700|Nimotuzumab|nimotuzumab|mesh-list
153882497|NCT01688700|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153882498|NCT01688700|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153882499|NCT01688700|Tubulin Modulators|tubulin modulators|mesh-ancestor
153882500|NCT01688700|Antimitotic Agents|antimitotic agents|mesh-ancestor
153882501|NCT01688700|Mitosis Modulators|mitosis modulators|mesh-ancestor
153882502|NCT01688700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153423389|NCT03312517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153423390|NCT03315559|Nemiralisib|nemiralisib|mesh-list
153423391|NCT03315559|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153423392|NCT03315559|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153378124|NCT03087136|Interferon Inducers|interferon inducers|mesh-ancestor
153378125|NCT03087136|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
153378126|NCT03087136|Protective Agents|protective agents|mesh-ancestor
153378127|NCT03055221|Treprostinil|treprostinil|mesh-list
153378169|NCT02719613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153378170|NCT02719613|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153378171|NCT02719613|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153378172|NCT02719613|Immunologic Factors|immunologic factors|mesh-ancestor
153378173|NCT02719613|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153378174|NCT02719613|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153378175|NCT02719613|Growth Substances|growth substances|mesh-ancestor
153378176|NCT02719613|Growth Inhibitors|growth inhibitors|mesh-ancestor
153378177|NCT02696993|Nivolumab|nivolumab|mesh-list
153378178|NCT02696993|Ipilimumab|ipilimumab|mesh-list
153378179|NCT02696993|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153378187|NCT02635061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153378188|NCT02632409|Nivolumab|nivolumab|mesh-list
153378189|NCT02632409|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153378190|NCT02632409|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153378191|NCT02632409|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153378192|NCT02632409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153378193|NCT02625480|Cyclophosphamide|cyclophosphamide|mesh-list
153378194|NCT02625480|Fludarabine|fludarabine|mesh-list
153378492|NCT00295893|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153882521|NCT01684241|Immunologic Factors|immunologic factors|mesh-ancestor
153882522|NCT01684241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153882523|NCT01688934|Naproxen|naproxen|mesh-list
153882524|NCT01688934|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153882525|NCT01688934|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153882526|NCT01688934|Analgesics|analgesics|mesh-ancestor
153882527|NCT01688934|Sensory System Agents|sensory system agents|mesh-ancestor
153882528|NCT01688934|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153882529|NCT01688934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153882530|NCT01688934|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153882531|NCT01688934|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153882532|NCT01688934|Gout Suppressants|gout suppressants|mesh-ancestor
153882533|NCT01688934|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153378496|NCT05045937|Remdesivir|remdesivir|mesh-list
153378497|NCT05045937|Ibuprofen|ibuprofen|mesh-list
153378498|NCT05045937|Budesonide|budesonide|mesh-list
153378499|NCT05045937|Melatonin|melatonin|mesh-list
153378500|NCT05045937|Albuterol|albuterol|mesh-list
153378501|NCT05045937|Quercetin|quercetin|mesh-list
153378502|NCT05045937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153379856|NCT02927223|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153379857|NCT02927223|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153379858|NCT02927223|Autonomic Agents|autonomic agents|mesh-ancestor
153379859|NCT02927223|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153379924|NCT03022097|Anticonvulsants|anticonvulsants|mesh-ancestor
153378504|NCT05045937|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153378505|NCT05045937|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153378506|NCT05045937|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153378508|NCT05045937|Sensory System Agents|sensory system agents|mesh-ancestor
153378509|NCT05045937|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153378510|NCT05045937|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153378511|NCT05045937|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153378524|NCT05045937|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153378525|NCT05045937|Tocolytic Agents|tocolytic agents|mesh-ancestor
153378526|NCT05045937|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153378660|NCT01576874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153378662|NCT01576952|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153378663|NCT01576952|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153378664|NCT01576952|Analgesics|analgesics|mesh-ancestor
153378667|NCT01576952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153378668|NCT01576952|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153378670|NCT01577966|Sulfasalazine|sulfasalazine|mesh-list
153423438|NCT03460652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153379010|NCT02904915|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153379227|NCT01593722|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153379228|NCT01593722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153379229|NCT01594424|Immunoglobulins|immunoglobulins|mesh-list
153379230|NCT01594424|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
153379232|NCT01594424|gamma-Globulins|gamma-globulins|mesh-list
153379233|NCT01594424|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
153379234|NCT01594424|Immunologic Factors|immunologic factors|mesh-ancestor
153379235|NCT01594424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153379236|NCT01595282|Ibuprofen|ibuprofen|mesh-list
153379237|NCT01595282|Ketorolac|ketorolac|mesh-list
153882539|NCT01684319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153882541|NCT02279576|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
153379313|NCT02981030|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
153379315|NCT02981030|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153379316|NCT02981030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153379317|NCT02981030|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
153379318|NCT02981030|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153379345|NCT00551213|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153379346|NCT00551213|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153379347|NCT00551213|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153379348|NCT03006471|Dapagliflozin|dapagliflozin|mesh-list
153379352|NCT03006471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153379354|NCT03005678|Alendronate|alendronate|mesh-list
153379355|NCT03005678|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153379356|NCT03005678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153379357|NCT03008889|Acetylcysteine|acetylcysteine|mesh-list
153379358|NCT03008889|N-monoacetylcystine|n-monoacetylcystine|mesh-list
153379360|NCT03008889|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153379362|NCT03008889|Respiratory System Agents|respiratory system agents|mesh-ancestor
153379363|NCT03008889|Free Radical Scavengers|free radical scavengers|mesh-ancestor
153379364|NCT03008889|Antioxidants|antioxidants|mesh-ancestor
153379365|NCT03008889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153379466|NCT03019887|Antiemetics|antiemetics|mesh-ancestor
153379467|NCT03019887|Autonomic Agents|autonomic agents|mesh-ancestor
153379468|NCT03019887|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153379469|NCT03019887|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153379470|NCT03019887|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
153379471|NCT03019887|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153379931|NCT03039543|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
153379472|NCT03019887|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153379473|NCT03019887|Antidepressive Agents|antidepressive agents|mesh-ancestor
153379474|NCT03019887|Dopamine Agonists|dopamine agonists|mesh-ancestor
153379475|NCT03019887|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
153379476|NCT03019887|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
153379477|NCT03019887|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
153379478|NCT03019887|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
153379479|NCT03019887|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
153379480|NCT03019887|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153379481|NCT03019887|Analgesics|analgesics|mesh-ancestor
153379482|NCT03019887|Sensory System Agents|sensory system agents|mesh-ancestor
153379483|NCT02998970|Empagliflozin|empagliflozin|mesh-list
153379484|NCT02998970|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
153379485|NCT02998970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153882555|NCT02279615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153882556|NCT02279615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153882557|NCT02279615|Urological Agents|urological agents|mesh-ancestor
153882558|NCT02279615|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
153882559|NCT02279615|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
153882560|NCT02279615|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153882561|NCT01689051|Glucagon|glucagon|mesh-list
153882565|NCT01689051|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153882566|NCT01689051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153423453|NCT03322657|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153423454|NCT03322657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153423461|NCT03322657|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153423462|NCT03322657|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
153423463|NCT03322657|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
153423464|NCT03324451|Insulin|insulin|mesh-list
153423465|NCT03324451|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153423466|NCT03324451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153423467|NCT03247790|Lasmiditan|lasmiditan|mesh-list
153882568|NCT01689090|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-list
153882569|NCT01689090|Citric Acid|citric acid|mesh-list
153882570|NCT01689090|Sodium Citrate|sodium citrate|mesh-list
153379563|NCT03004118|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
153379565|NCT03004118|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153379566|NCT03004196|Chlorhexidine|chlorhexidine|mesh-list
153379567|NCT03004196|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
153379568|NCT03004196|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153379683|NCT03003416|Autonomic Agents|autonomic agents|mesh-ancestor
153379684|NCT03003416|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153379686|NCT03003416|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153882576|NCT01689090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153882577|NCT01689090|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153882578|NCT01689090|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153882580|NCT01689090|Sensory System Agents|sensory system agents|mesh-ancestor
153882581|NCT01689090|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153882582|NCT01689090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153882583|NCT01689090|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153423468|NCT03247790|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
153423469|NCT03247790|Serotonin Agents|serotonin agents|mesh-ancestor
153423470|NCT03247790|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153423471|NCT03247790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153423472|NCT03247790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153423473|NCT03249272|Adenosine|adenosine|mesh-list
153423474|NCT03249272|Regadenoson|regadenoson|mesh-list
153423475|NCT03249272|Analgesics|analgesics|mesh-ancestor
153423476|NCT03249272|Sensory System Agents|sensory system agents|mesh-ancestor
153423477|NCT03249272|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153423478|NCT03249272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153379985|NCT02870283|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
153379986|NCT02931045|Clopidogrel|clopidogrel|mesh-list
153423479|NCT03249272|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153423480|NCT03249272|Vasodilator Agents|vasodilator agents|mesh-ancestor
153423481|NCT03249272|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
153423482|NCT03249272|Purinergic Agonists|purinergic agonists|mesh-ancestor
153423483|NCT03249272|Purinergic Agents|purinergic agents|mesh-ancestor
153379687|NCT03003416|Glucocorticoids|glucocorticoids|mesh-ancestor
153379692|NCT02988869|Formoterol Fumarate|formoterol fumarate|mesh-list
153379693|NCT02988869|Tiotropium Bromide|tiotropium bromide|mesh-list
153379694|NCT02988869|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153882584|NCT01689090|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153882585|NCT01689090|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153882586|NCT01689129|Insulin|insulin|mesh-list
153882588|NCT01689129|Insulin Glargine|insulin glargine|mesh-list
153379737|NCT02223260|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153379769|NCT01887587|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153379771|NCT01887587|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153379772|NCT01887587|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153379773|NCT01887587|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153379775|NCT01887587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153379776|NCT01887587|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153379777|NCT01887587|Tubulin Modulators|tubulin modulators|mesh-ancestor
153423492|NCT03468920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153423493|NCT03468920|Antipyretics|antipyretics|mesh-ancestor
153423494|NCT02181816|Amlodipine|amlodipine|mesh-list
153423495|NCT02181816|Azilsartan medoxomil|azilsartan medoxomil|mesh-list
153423496|NCT02181816|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153423497|NCT02181816|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153423498|NCT02181816|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153423499|NCT02181816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153423500|NCT02181816|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153379860|NCT02927223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153379925|NCT03002636|Anesthetics|anesthetics|mesh-list
153379926|NCT03002636|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153379927|NCT03002636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153379929|NCT03039543|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
153379930|NCT03039543|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
153379975|NCT02870283|Anticonvulsants|anticonvulsants|mesh-ancestor
153379976|NCT02870283|GABA Agents|gaba agents|mesh-ancestor
153379977|NCT02870283|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153379978|NCT02870283|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153379979|NCT02870283|Analgesics|analgesics|mesh-ancestor
153379980|NCT02870283|Sensory System Agents|sensory system agents|mesh-ancestor
153379981|NCT02870283|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153379982|NCT02870283|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153379983|NCT02870283|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153379984|NCT02870283|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
153882925|NCT01688648|Analgesics|analgesics|mesh-ancestor
153382552|NCT01997411|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153382553|NCT01997411|Hormones|hormones|mesh-ancestor
153486915|NCT03776760|Sofosbuvir|sofosbuvir|mesh-list
153387453|NCT00000201|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
153387481|NCT01807611|Immunologic Factors|immunologic factors|mesh-ancestor
153387482|NCT01807611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153387483|NCT01807611|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153387484|NCT01807611|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153387485|NCT01807611|Alkylating Agents|alkylating agents|mesh-ancestor
153387486|NCT01807611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153387487|NCT01807611|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153387488|NCT01807611|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153387489|NCT01807611|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153387490|NCT01807611|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
153387491|NCT01807611|Antitubercular Agents|antitubercular agents|mesh-ancestor
153387492|NCT01807611|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153387493|NCT01807611|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153387494|NCT01807611|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153387495|NCT01807611|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153883371|NCT01332630|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153883372|NCT01332630|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153883377|NCT01332630|Anesthetics|anesthetics|mesh-ancestor
153469181|NCT05450718|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
153469182|NCT05450718|Naloxone|naloxone|mesh-list
153469183|NCT05450718|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153469184|NCT05450718|Narcotics|narcotics|mesh-ancestor
153469185|NCT05450718|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153469186|NCT05450718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153379990|NCT02931045|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
153379991|NCT02931045|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
153379992|NCT02931045|Purinergic Agents|purinergic agents|mesh-ancestor
153469187|NCT05450718|Analgesics|analgesics|mesh-ancestor
153469188|NCT05450718|Sensory System Agents|sensory system agents|mesh-ancestor
153469189|NCT05450718|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153469190|NCT05450718|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
153469191|NCT05422885|Dasatinib|dasatinib|mesh-list
153469192|NCT05422885|Quercetin|quercetin|mesh-list
153469193|NCT05422885|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153469194|NCT05422885|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153469195|NCT05422885|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153469196|NCT05422885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153469197|NCT05422885|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153469198|NCT05422885|Antioxidants|antioxidants|mesh-ancestor
153469199|NCT05422885|Protective Agents|protective agents|mesh-ancestor
153469200|NCT05422885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153469201|NCT05421819|Calcium, Dietary|calcium, dietary|mesh-list
153813756|NCT00437229|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153360163|NCT02196857|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153469203|NCT05421819|Ergocalciferols|ergocalciferols|mesh-list
153469204|NCT05421819|Cholecalciferol|cholecalciferol|mesh-list
153469205|NCT05421819|Vitamins|vitamins|mesh-list
153469206|NCT05421819|Calcium|calcium|mesh-list
153469207|NCT05421819|Micronutrients|micronutrients|mesh-ancestor
153469208|NCT05421819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153469215|NCT05418088|Immunologic Factors|immunologic factors|mesh-ancestor
153469216|NCT05418088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153469217|NCT05418088|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153469218|NCT05418088|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153469219|NCT05418088|Alkylating Agents|alkylating agents|mesh-ancestor
153469220|NCT05418088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153469221|NCT05418088|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153424319|NCT03861338|Analgesics|analgesics|mesh-ancestor
153424320|NCT03861338|Sensory System Agents|sensory system agents|mesh-ancestor
153469266|NCT05305924|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
153469267|NCT05305924|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
153469268|NCT05305924|Hormone Antagonists|hormone antagonists|mesh-ancestor
153469269|NCT05305924|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153469270|NCT05305924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153469271|NCT05298423|Paclitaxel|paclitaxel|mesh-list
153469272|NCT05298423|Etoposide|etoposide|mesh-list
153469273|NCT05298423|Carboplatin|carboplatin|mesh-list
153469274|NCT05298423|Pembrolizumab|pembrolizumab|mesh-list
153469275|NCT05298423|Pemetrexed|pemetrexed|mesh-list
153469276|NCT05298423|Durvalumab|durvalumab|mesh-list
153469277|NCT05298423|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153469302|NCT05285358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153469304|NCT05285358|Antimetabolites|antimetabolites|mesh-ancestor
153469305|NCT05225961|Aspirin|aspirin|mesh-list
153469306|NCT05225961|Tirofiban|tirofiban|mesh-list
153813757|NCT00437229|Glucocorticoids|glucocorticoids|mesh-ancestor
153469307|NCT05225961|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153469308|NCT05225961|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153469309|NCT05225961|Analgesics|analgesics|mesh-ancestor
153469310|NCT05225961|Sensory System Agents|sensory system agents|mesh-ancestor
153469311|NCT05225961|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153469312|NCT05225961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153469313|NCT05225961|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153469314|NCT05225961|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153469315|NCT05225961|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153469316|NCT05225961|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153379993|NCT02931045|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153379994|NCT02931045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153379995|NCT02931045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153379996|NCT03040011|Dexamethasone|dexamethasone|mesh-list
153379997|NCT03040011|Bupivacaine|bupivacaine|mesh-list
153379998|NCT03040011|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153379999|NCT03040011|Antiemetics|antiemetics|mesh-ancestor
153380000|NCT03040011|Autonomic Agents|autonomic agents|mesh-ancestor
153380001|NCT03040011|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153469317|NCT05225961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153469320|NCT05225961|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153469322|NCT05223816|Nivolumab|nivolumab|mesh-list
153469323|NCT05223816|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153469324|NCT05223816|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153469325|NCT05223816|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153469326|NCT05223816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153469327|NCT05203913|Paclitaxel|paclitaxel|mesh-list
153469336|NCT05203913|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153469337|NCT05176470|Cyclophosphamide|cyclophosphamide|mesh-list
153469338|NCT05176470|Pembrolizumab|pembrolizumab|mesh-list
153469353|NCT05118477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153469355|NCT05118477|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153469356|NCT05118477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153469357|NCT05118477|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
153469358|NCT05118477|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
153469359|NCT05118477|Purinergic Agents|purinergic agents|mesh-ancestor
153469360|NCT05118477|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153469362|NCT05112601|Ipilimumab|ipilimumab|mesh-list
153469363|NCT05112601|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153469364|NCT05112601|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153469365|NCT05112601|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153883386|NCT01332630|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
153883387|NCT01366209|Pirfenidone|pirfenidone|mesh-list
153883388|NCT01366209|Analgesics|analgesics|mesh-ancestor
153883389|NCT01366209|Sensory System Agents|sensory system agents|mesh-ancestor
153883390|NCT01366209|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153883391|NCT01366209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153883392|NCT01366209|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153883395|NCT01366209|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153469366|NCT05112601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153469368|NCT05111860|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153469369|NCT05111860|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153469383|NCT05102591|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153469384|NCT05102591|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153469385|NCT05102591|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153469386|NCT05102591|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153813758|NCT00437229|Hormones|hormones|mesh-ancestor
153469387|NCT05102591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153469388|NCT05102591|Antiemetics|antiemetics|mesh-ancestor
153469389|NCT05102591|Autonomic Agents|autonomic agents|mesh-ancestor
153469390|NCT05102591|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153469391|NCT05102591|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
153469392|NCT05102591|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
153469393|NCT05102591|Dopamine Agents|dopamine agents|mesh-ancestor
153469410|NCT05080790|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153469411|NCT05059522|Pemetrexed|pemetrexed|mesh-list
153469412|NCT05059522|Avelumab|avelumab|mesh-list
153469413|NCT05059522|Axitinib|axitinib|mesh-list
153469414|NCT05059522|Talazoparib|talazoparib|mesh-list
153469415|NCT05059522|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153469416|NCT05059522|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153424338|NCT00376519|Mycophenolic Acid|mycophenolic acid|mesh-list
153424339|NCT00376519|Cyclophosphamide|cyclophosphamide|mesh-list
153424340|NCT00376519|Fludarabine|fludarabine|mesh-list
153424341|NCT00376519|Fludarabine phosphate|fludarabine phosphate|mesh-list
153424342|NCT00376519|Cyclosporins|cyclosporins|mesh-list
153424343|NCT00376519|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153380002|NCT03040011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153380003|NCT03040011|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153380067|NCT02994602|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
153380069|NCT03297710|Antimetabolites|antimetabolites|mesh-ancestor
153424344|NCT00376519|Immunologic Factors|immunologic factors|mesh-ancestor
153424345|NCT00376519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153424346|NCT00376519|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153424347|NCT00376519|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153424348|NCT00376519|Alkylating Agents|alkylating agents|mesh-ancestor
153469417|NCT05059522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153469418|NCT05059522|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153469419|NCT05059522|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153469420|NCT05059522|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153469421|NCT05059522|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153469422|NCT05059522|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
153469423|NCT05053503|Lofexidine|lofexidine|mesh-list
153469424|NCT05053503|Naltrexone|naltrexone|mesh-list
153469425|NCT05053503|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
153469426|NCT05053503|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
153469427|NCT05053503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153469428|NCT05053503|Sensory System Agents|sensory system agents|mesh-ancestor
153469429|NCT05053503|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153469430|NCT05053503|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153469431|NCT05053503|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
153469432|NCT05053503|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153469433|NCT05053503|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153883404|NCT02995694|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153883405|NCT02995694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153883413|NCT01365468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153883414|NCT01365468|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153469434|NCT05053503|Adrenergic Agents|adrenergic agents|mesh-ancestor
153469435|NCT05053503|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153469436|NCT05053503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153469438|NCT05051449|Analgesics|analgesics|mesh-ancestor
153469439|NCT05051449|Sensory System Agents|sensory system agents|mesh-ancestor
153469440|NCT05051449|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153469441|NCT05051449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153469442|NCT05051449|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
153469443|NCT05051449|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153469444|NCT05051449|Anesthetics, General|anesthetics, general|mesh-ancestor
153469445|NCT05051449|Anesthetics|anesthetics|mesh-ancestor
153469446|NCT05051449|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153423515|NCT03256136|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153423516|NCT03344510|Anesthetics|anesthetics|mesh-list
153423517|NCT03344510|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153423518|NCT03344510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153469447|NCT05051449|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
153469448|NCT05051449|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
153469449|NCT05051449|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153469450|NCT05051449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153469451|NCT05034562|Edetic Acid|edetic acid|mesh-list
153469473|NCT04952753|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153469474|NCT04952753|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153469475|NCT04952753|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153469476|NCT04952753|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153469477|NCT04952753|Growth Substances|growth substances|mesh-ancestor
153469478|NCT04952753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153469479|NCT04952753|Growth Inhibitors|growth inhibitors|mesh-ancestor
153469480|NCT04952753|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
153469481|NCT04952753|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153469482|NCT04952753|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153469483|NCT04952753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153469484|NCT04952753|Antidotes|antidotes|mesh-ancestor
153469485|NCT04952753|Protective Agents|protective agents|mesh-ancestor
153469522|NCT04900766|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153469523|NCT04900766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153469524|NCT04900766|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153469525|NCT04900766|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153469526|NCT04900766|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153469527|NCT04900766|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153469528|NCT04900766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153469529|NCT04898894|Cytarabine|cytarabine|mesh-list
153469530|NCT04898894|Hydrocortisone|hydrocortisone|mesh-list
153469531|NCT04898894|Methotrexate|methotrexate|mesh-list
153469532|NCT04898894|Fludarabine phosphate|fludarabine phosphate|mesh-list
153469533|NCT04898894|Fludarabine|fludarabine|mesh-list
153469534|NCT04898894|Venetoclax|venetoclax|mesh-list
153469535|NCT04898894|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
153469536|NCT04898894|Abortifacient Agents|abortifacient agents|mesh-ancestor
153469537|NCT04898894|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153469538|NCT04898894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153469539|NCT04898894|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153469540|NCT04898894|Antimetabolites|antimetabolites|mesh-ancestor
153387496|NCT02977949|Raloxifene Hydrochloride|raloxifene hydrochloride|mesh-list
153469559|NCT04847557|Incretins|incretins|mesh-ancestor
153469561|NCT04847557|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153469562|NCT04847557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153469563|NCT04817969|Cimetidine|cimetidine|mesh-list
153469564|NCT04817969|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
153469565|NCT04817969|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153469566|NCT04817969|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
153469567|NCT04817969|Histamine Antagonists|histamine antagonists|mesh-ancestor
153469568|NCT04817969|Histamine Agents|histamine agents|mesh-ancestor
153469569|NCT04817969|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153469570|NCT04817969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153469571|NCT04817969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153469585|NCT04777357|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153469586|NCT04777201|Faricimab|faricimab|mesh-list
153469587|NCT04777201|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153469593|NCT04752813|Vitamin K|vitamin k|mesh-list
153469594|NCT04752813|Vitamin K 1|vitamin k 1|mesh-list
153469595|NCT04752813|Temozolomide|temozolomide|mesh-list
153469596|NCT04752813|Vitamins|vitamins|mesh-ancestor
153360165|NCT02196857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153380070|NCT03297710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153380071|NCT03297710|Antiviral Agents|antiviral agents|mesh-ancestor
153380072|NCT03297710|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153380109|NCT03045861|Cobicistat|cobicistat|mesh-list
153380110|NCT03045861|GSK-2838232|gsk-2838232|mesh-list
153380111|NCT03045861|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153380112|NCT03045861|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153380113|NCT03045861|Antiviral Agents|antiviral agents|mesh-ancestor
153783552|NCT00236483|Acetaminophen|acetaminophen|mesh-list
153380135|NCT01907321|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153380136|NCT01907321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153380138|NCT02219516|Gout Suppressants|gout suppressants|mesh-ancestor
153380139|NCT02219516|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153380140|NCT04976777|Dexamethasone|dexamethasone|mesh-list
153380141|NCT04976777|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153469597|NCT04752813|Micronutrients|micronutrients|mesh-ancestor
153469598|NCT04752813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153469599|NCT04752813|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153469600|NCT04752813|Alkylating Agents|alkylating agents|mesh-ancestor
153469601|NCT04752813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153469602|NCT04752813|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153469603|NCT04752813|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
153469604|NCT04752813|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153469605|NCT04752813|Hemostatics|hemostatics|mesh-ancestor
153469606|NCT04752813|Coagulants|coagulants|mesh-ancestor
153469607|NCT04718402|Mitoxantrone|mitoxantrone|mesh-list
153469608|NCT04718402|Analgesics|analgesics|mesh-ancestor
153469609|NCT04718402|Sensory System Agents|sensory system agents|mesh-ancestor
153424407|NCT04121078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153424408|NCT04121078|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
153424409|NCT04121078|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
153469610|NCT04718402|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153469611|NCT04718402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153469612|NCT04718402|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153469613|NCT04718402|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153469614|NCT04718402|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153469615|NCT04718402|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153469616|NCT04718402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153469617|NCT04718376|Mitoxantrone|mitoxantrone|mesh-list
153469618|NCT04718376|Analgesics|analgesics|mesh-ancestor
153469619|NCT04718376|Sensory System Agents|sensory system agents|mesh-ancestor
153469620|NCT04718376|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153469648|NCT04632992|Maytansine|maytansine|mesh-list
153469649|NCT04632992|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
153469650|NCT04632992|Trastuzumab|trastuzumab|mesh-list
153469651|NCT04632992|Atezolizumab|atezolizumab|mesh-list
153469652|NCT04632992|Pertuzumab|pertuzumab|mesh-list
153469653|NCT04632992|Tucatinib|tucatinib|mesh-list
153469654|NCT04632992|Ipatasertib|ipatasertib|mesh-list
153469655|NCT04632992|Pralsetinib|pralsetinib|mesh-list
153469656|NCT04632992|Alectinib|alectinib|mesh-list
153469657|NCT04632992|Entrectinib|entrectinib|mesh-list
153469658|NCT04632992|Inavolisib|inavolisib|mesh-list
153469659|NCT04632992|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153469665|NCT04632992|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153469666|NCT04632992|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153469667|NCT04632992|Immunotoxins|immunotoxins|mesh-ancestor
153469668|NCT04632992|Immunoconjugates|immunoconjugates|mesh-ancestor
153469669|NCT04632992|Immunologic Factors|immunologic factors|mesh-ancestor
153469670|NCT04632992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153469671|NCT04632992|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153380142|NCT04976777|Antiemetics|antiemetics|mesh-ancestor
153380143|NCT04976777|Autonomic Agents|autonomic agents|mesh-ancestor
153380144|NCT04976777|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153380145|NCT04976777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153380146|NCT04976777|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153380147|NCT04976777|Glucocorticoids|glucocorticoids|mesh-ancestor
153380148|NCT04976777|Hormones|hormones|mesh-ancestor
153469672|NCT04632992|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153469673|NCT04632992|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153469674|NCT04632992|Phosphoinositide-3 Kinase Inhibitors|phosphoinositide-3 kinase inhibitors|mesh-ancestor
153469675|NCT04595617|Antibodies|antibodies|mesh-list
153469676|NCT04595617|Immunologic Factors|immunologic factors|mesh-ancestor
153469677|NCT04595617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153883468|NCT01331109|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153883469|NCT01331109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153883470|NCT01331109|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153883471|NCT01331109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153883472|NCT01331109|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153883473|NCT01331109|Analgesics|analgesics|mesh-ancestor
153883474|NCT01331109|Sensory System Agents|sensory system agents|mesh-ancestor
153883475|NCT01331109|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153883476|NCT01331109|Antidepressive Agents|antidepressive agents|mesh-ancestor
153883477|NCT01331109|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153883478|NCT01351350|Paclitaxel|paclitaxel|mesh-list
153883479|NCT01351350|Trastuzumab|trastuzumab|mesh-list
153883480|NCT01351350|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153883481|NCT01351350|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153883482|NCT01351350|Tubulin Modulators|tubulin modulators|mesh-ancestor
153883483|NCT01351350|Antimitotic Agents|antimitotic agents|mesh-ancestor
153469678|NCT04585958|Trastuzumab|trastuzumab|mesh-list
153469679|NCT04585958|Olaparib|olaparib|mesh-list
153469680|NCT04585958|Camptothecin|camptothecin|mesh-list
153813760|NCT00437229|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153360166|NCT02196857|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153360167|NCT02196857|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153360168|NCT02196857|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153360169|NCT01272245|Cytarabine|cytarabine|mesh-list
153469681|NCT04585958|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
153469682|NCT04585958|Trastuzumab deruxtecan|trastuzumab deruxtecan|mesh-list
153469683|NCT04585958|Immunoconjugates|immunoconjugates|mesh-list
153469684|NCT04585958|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153469685|NCT04585958|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153469686|NCT04585958|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153469687|NCT04585958|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153469688|NCT04585958|Immunologic Factors|immunologic factors|mesh-ancestor
153469689|NCT04585958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153469690|NCT04585958|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153469691|NCT04585958|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
153469692|NCT04585958|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153469706|NCT04548700|Cyclophosphamide|cyclophosphamide|mesh-list
153469707|NCT04548700|Vincristine|vincristine|mesh-list
153469708|NCT04548700|Mitoxantrone|mitoxantrone|mesh-list
153469709|NCT04548700|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153469710|NCT04548700|Immunologic Factors|immunologic factors|mesh-ancestor
153469711|NCT04548700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153469712|NCT04548700|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153469713|NCT04548700|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153469714|NCT04548700|Alkylating Agents|alkylating agents|mesh-ancestor
153469715|NCT04548700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153469716|NCT04548700|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153469717|NCT04548700|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153469718|NCT04548700|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153469719|NCT04548700|Glucocorticoids|glucocorticoids|mesh-ancestor
153469721|NCT04548700|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153469731|NCT04548700|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153469732|NCT04548700|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153469733|NCT04509466|Mitoxantrone|mitoxantrone|mesh-list
153469734|NCT04509466|Pegaspargase|pegaspargase|mesh-list
153469735|NCT04509466|Asparaginase|asparaginase|mesh-list
153469736|NCT04509466|Analgesics|analgesics|mesh-ancestor
153469737|NCT04509466|Sensory System Agents|sensory system agents|mesh-ancestor
153469738|NCT04509466|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153469739|NCT04509466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153469740|NCT04509466|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153469741|NCT04509466|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153469742|NCT04509466|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153469743|NCT04509466|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153469744|NCT04509466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153469745|NCT04473911|Mycophenolic Acid|mycophenolic acid|mesh-list
153469746|NCT04473911|Sirolimus|sirolimus|mesh-list
153469747|NCT04473911|Cyclophosphamide|cyclophosphamide|mesh-list
153469748|NCT04473911|Melphalan|melphalan|mesh-list
153469749|NCT04473911|Fludarabine|fludarabine|mesh-list
153469750|NCT04473911|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153469751|NCT04473911|Immunologic Factors|immunologic factors|mesh-ancestor
153469752|NCT04473911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153469753|NCT04473911|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153813761|NCT00437229|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153813762|NCT00437229|Protease Inhibitors|protease inhibitors|mesh-ancestor
153469757|NCT04473911|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153469758|NCT04473911|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153469759|NCT04473911|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153469760|NCT04473911|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
153469761|NCT04473911|Antitubercular Agents|antitubercular agents|mesh-ancestor
153469784|NCT04431388|Anesthetics, Local|anesthetics, local|mesh-ancestor
153469785|NCT04431388|Anesthetics|anesthetics|mesh-ancestor
153469786|NCT04431388|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153469787|NCT04431388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153469788|NCT04431388|Sensory System Agents|sensory system agents|mesh-ancestor
153469789|NCT04431388|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153469790|NCT04410874|Smallpox and monkeypox vaccine modified vaccinia ankara-bavarian nordic|smallpox and monkeypox vaccine modified vaccinia ankara-bavarian nordic|mesh-list
153469791|NCT04410874|Vaccines|vaccines|mesh-list
153469792|NCT04410874|Immunologic Factors|immunologic factors|mesh-ancestor
153469793|NCT04410874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153469794|NCT04410874|Antiviral Agents|antiviral agents|mesh-ancestor
153469795|NCT04410874|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153469796|NCT04380311|Tacrolimus|tacrolimus|mesh-list
153469797|NCT04380311|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153469798|NCT04380311|Immunologic Factors|immunologic factors|mesh-ancestor
153469799|NCT04380311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153469831|NCT04234113|Pembrolizumab|pembrolizumab|mesh-list
153469832|NCT04234113|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153469833|NCT04234113|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153469834|NCT04234113|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153469835|NCT04234113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153469842|NCT04234048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153469843|NCT04234048|Keratolytic Agents|keratolytic agents|mesh-ancestor
153469844|NCT04234048|Dermatologic Agents|dermatologic agents|mesh-ancestor
153469845|NCT04214288|Fulvestrant|fulvestrant|mesh-list
153469846|NCT04214288|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153469847|NCT04214288|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153469848|NCT04214288|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
153469849|NCT04214288|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
153469850|NCT04214288|Hormone Antagonists|hormone antagonists|mesh-ancestor
153469851|NCT04214288|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153469852|NCT04214288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153469853|NCT04181359|Nitric Oxide|nitric oxide|mesh-list
153813766|NCT00437229|Dermatologic Agents|dermatologic agents|mesh-ancestor
153360172|NCT01272245|Antimetabolites|antimetabolites|mesh-ancestor
153469854|NCT04181359|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153469855|NCT04181359|Autonomic Agents|autonomic agents|mesh-ancestor
153469856|NCT04181359|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153469857|NCT04181359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153469858|NCT04181359|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153469859|NCT04181359|Respiratory System Agents|respiratory system agents|mesh-ancestor
153883492|NCT02271503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153883493|NCT02271503|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
153883494|NCT02271503|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
153883495|NCT02271503|Dopamine Agonists|dopamine agonists|mesh-ancestor
153883496|NCT02271503|Dopamine Agents|dopamine agents|mesh-ancestor
153883497|NCT02271503|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153883500|NCT02271503|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153882621|NCT02279966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153882622|NCT02279966|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
153882623|NCT02279966|Antidepressive Agents|antidepressive agents|mesh-ancestor
153882624|NCT02279966|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153882625|NCT02279966|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
153882626|NCT02279966|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153882627|NCT02279966|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153469867|NCT04181359|Protective Agents|protective agents|mesh-ancestor
153469868|NCT04150913|Axicabtagene ciloleucel|axicabtagene ciloleucel|mesh-list
153469869|NCT04150913|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
153469870|NCT04150913|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153469871|NCT04150913|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153469872|NCT04150913|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153469874|NCT04108026|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153469875|NCT04108026|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153469877|NCT04107038|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153469878|NCT04107038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153469879|NCT04088890|Cyclophosphamide|cyclophosphamide|mesh-list
153469880|NCT04088890|Fludarabine|fludarabine|mesh-list
153469900|NCT04053478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153469901|NCT04053478|Sympathomimetics|sympathomimetics|mesh-ancestor
153469902|NCT04053478|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
153469903|NCT04053478|Nasal Decongestants|nasal decongestants|mesh-ancestor
153469904|NCT04053478|Respiratory System Agents|respiratory system agents|mesh-ancestor
153469905|NCT04053478|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
153469906|NCT04053478|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153469907|NCT04053478|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153469908|NCT04053478|Adrenergic Agents|adrenergic agents|mesh-ancestor
153469909|NCT04053478|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153469910|NCT04053478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153469911|NCT04053478|Protective Agents|protective agents|mesh-ancestor
153469914|NCT04053478|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
153469915|NCT04053478|Natriuretic Agents|natriuretic agents|mesh-ancestor
153469916|NCT04053478|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
153469917|NCT04024254|Folic Acid|folic acid|mesh-list
153469918|NCT04024254|Hematinics|hematinics|mesh-ancestor
153469919|NCT04024254|Vitamin B Complex|vitamin b complex|mesh-ancestor
153469920|NCT04024254|Vitamins|vitamins|mesh-ancestor
153469921|NCT04024254|Micronutrients|micronutrients|mesh-ancestor
153469922|NCT04024254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153469923|NCT03991988|Montelukast|montelukast|mesh-list
153469924|NCT03991988|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153469925|NCT03991988|Respiratory System Agents|respiratory system agents|mesh-ancestor
153469926|NCT03991988|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
153469927|NCT03991988|Hormone Antagonists|hormone antagonists|mesh-ancestor
153469928|NCT03991988|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153469929|NCT03991988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153469930|NCT03991988|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
153469931|NCT03991988|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
153469932|NCT03991988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153469965|NCT03973333|Atezolizumab|atezolizumab|mesh-list
153469966|NCT03973333|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153469967|NCT03973333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153469968|NCT03973333|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153883504|NCT01350804|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153883505|NCT01350804|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153883506|NCT01350804|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153882628|NCT02279966|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153469976|NCT03945591|Immunologic Factors|immunologic factors|mesh-ancestor
153469977|NCT03945591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153469978|NCT03945591|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153469979|NCT03945591|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153469980|NCT03945591|Alkylating Agents|alkylating agents|mesh-ancestor
153469981|NCT03945591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153469982|NCT03945591|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153469983|NCT03945591|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153469984|NCT03943589|Immunoglobulins|immunoglobulins|mesh-list
153469985|NCT03943589|Immunoglobulin G|immunoglobulin g|mesh-list
153469986|NCT03943589|Immunologic Factors|immunologic factors|mesh-ancestor
153469987|NCT03943589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153469988|NCT03913104|Mifepristone|mifepristone|mesh-list
153469989|NCT03913104|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
153470009|NCT03850301|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153470010|NCT03816397|Adalimumab|adalimumab|mesh-list
153470011|NCT03816397|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
153470012|NCT03816397|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153470013|NCT03816397|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153470014|NCT03801902|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
153470015|NCT03801902|Durvalumab|durvalumab|mesh-list
153470016|NCT03801902|Antibodies|antibodies|mesh-list
153470017|NCT03801902|Immunoglobulins|immunoglobulins|mesh-list
153470018|NCT03801902|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
153470019|NCT03801902|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
153470020|NCT03801902|Immunoglobulin G|immunoglobulin g|mesh-list
153470021|NCT03801902|Immunologic Factors|immunologic factors|mesh-ancestor
153470022|NCT03801902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153470023|NCT03801902|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153470024|NCT03793179|Carboplatin|carboplatin|mesh-list
153470025|NCT03793179|Pembrolizumab|pembrolizumab|mesh-list
153470026|NCT03793179|Pemetrexed|pemetrexed|mesh-list
153470027|NCT03793179|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153470028|NCT03793179|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153470029|NCT03793179|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153470030|NCT03793179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153470031|NCT03793179|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153470032|NCT03793179|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153470033|NCT03793179|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153470106|NCT03601455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153470107|NCT03594110|Empagliflozin|empagliflozin|mesh-list
153470108|NCT03594110|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
153470109|NCT03594110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153470110|NCT03594110|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153470111|NCT03594110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153470112|NCT03591731|Nivolumab|nivolumab|mesh-list
153470113|NCT03591731|Ipilimumab|ipilimumab|mesh-list
153470114|NCT03591731|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153470115|NCT03591731|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153470116|NCT03591731|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153470117|NCT03591731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153470118|NCT03576417|Nivolumab|nivolumab|mesh-list
153470119|NCT03576417|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153470120|NCT03576417|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153470121|NCT03576417|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153470122|NCT03576417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153470123|NCT03469960|Nivolumab|nivolumab|mesh-list
153470124|NCT03469960|Ipilimumab|ipilimumab|mesh-list
153360173|NCT01272245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153470125|NCT03469960|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153470126|NCT03469960|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153470127|NCT03469960|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153424454|NCT00376831|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
153424455|NCT00376831|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153424456|NCT00376831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153424457|NCT00376831|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153424458|NCT00376831|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153424459|NCT00376831|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153470151|NCT03396926|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153470152|NCT03396926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153470153|NCT03396926|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153470155|NCT03391466|Cyclophosphamide|cyclophosphamide|mesh-list
153470156|NCT03391466|Fludarabine|fludarabine|mesh-list
153470157|NCT03391466|Axicabtagene ciloleucel|axicabtagene ciloleucel|mesh-list
153470158|NCT03391466|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153470159|NCT03391466|Immunologic Factors|immunologic factors|mesh-ancestor
153470160|NCT03391466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153470185|NCT03340896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153470187|NCT03338621|Rifampin|rifampin|mesh-list
153470188|NCT03338621|Isoniazid|isoniazid|mesh-list
153470189|NCT03338621|Pyrazinamide|pyrazinamide|mesh-list
153470190|NCT03338621|Ethambutol|ethambutol|mesh-list
153470191|NCT03338621|Bedaquiline|bedaquiline|mesh-list
153470192|NCT03338621|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153470193|NCT03338621|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153470194|NCT03338621|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153470225|NCT03321981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153470227|NCT03321981|Hormone Antagonists|hormone antagonists|mesh-ancestor
153470228|NCT03321981|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153470229|NCT03321981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153813768|NCT00437229|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153813769|NCT00437229|Serotonin Agents|serotonin agents|mesh-ancestor
153470230|NCT03321981|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153470231|NCT03321981|Tubulin Modulators|tubulin modulators|mesh-ancestor
153470232|NCT03321981|Antimitotic Agents|antimitotic agents|mesh-ancestor
153470233|NCT03321981|Mitosis Modulators|mitosis modulators|mesh-ancestor
153470234|NCT03321981|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153470235|NCT03321981|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
153470236|NCT03249831|Mycophenolic Acid|mycophenolic acid|mesh-list
153470237|NCT03249831|Cyclophosphamide|cyclophosphamide|mesh-list
153470238|NCT03249831|Pentostatin|pentostatin|mesh-list
153470239|NCT03249831|Tacrolimus|tacrolimus|mesh-list
153470240|NCT03249831|Thymoglobulin|thymoglobulin|mesh-list
153470241|NCT03249831|Antilymphocyte Serum|antilymphocyte serum|mesh-list
153470242|NCT03249831|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153470249|NCT03249831|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153470250|NCT03249831|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153470251|NCT03249831|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
153470252|NCT03249831|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153470253|NCT03249831|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153470254|NCT03249831|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
153470255|NCT03249831|Antitubercular Agents|antitubercular agents|mesh-ancestor
153470256|NCT03249831|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153470257|NCT03249831|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153470258|NCT03249831|Adenosine Deaminase Inhibitors|adenosine deaminase inhibitors|mesh-ancestor
153470259|NCT03201458|Atezolizumab|atezolizumab|mesh-list
153470260|NCT03201458|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
153470261|NCT03201458|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153470262|NCT03201458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153470263|NCT03201458|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153470264|NCT03201458|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153470265|NCT03201458|Immunologic Factors|immunologic factors|mesh-ancestor
153470266|NCT03201458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153470267|NCT03179605|Clobetasol|clobetasol|mesh-list
153470268|NCT03179605|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153470269|NCT03179605|Glucocorticoids|glucocorticoids|mesh-ancestor
153470270|NCT03179605|Hormones|hormones|mesh-ancestor
153470271|NCT03179605|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153470272|NCT03179605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153470273|NCT03151499|Rifampin|rifampin|mesh-list
153883515|NCT02270957|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153470294|NCT02963077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153470295|NCT02963077|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153470296|NCT02858310|Aldesleukin|aldesleukin|mesh-list
153470297|NCT02858310|Cyclophosphamide|cyclophosphamide|mesh-list
153470298|NCT02858310|Fludarabine|fludarabine|mesh-list
153470299|NCT02858310|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153470300|NCT02858310|Immunologic Factors|immunologic factors|mesh-ancestor
153470301|NCT02858310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153470302|NCT02858310|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153470303|NCT02858310|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153470304|NCT02858310|Alkylating Agents|alkylating agents|mesh-ancestor
153470305|NCT02858310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153470306|NCT02858310|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153470307|NCT02858310|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153470308|NCT02858310|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153470309|NCT02858310|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153470310|NCT02858310|Antiviral Agents|antiviral agents|mesh-ancestor
153470311|NCT02858310|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153470312|NCT02853331|Pembrolizumab|pembrolizumab|mesh-list
153470313|NCT02853331|Sunitinib|sunitinib|mesh-list
153470314|NCT02853331|Axitinib|axitinib|mesh-list
153470315|NCT02853331|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153470316|NCT02853331|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153470317|NCT02853331|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153470318|NCT02853331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153470319|NCT02853331|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153470320|NCT02853331|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153470321|NCT02853331|Growth Substances|growth substances|mesh-ancestor
153470322|NCT02853331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153470323|NCT02853331|Growth Inhibitors|growth inhibitors|mesh-ancestor
153470334|NCT02749799|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
153470335|NCT02749799|Betamethasone benzoate|betamethasone benzoate|mesh-list
153470336|NCT02749799|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
153470337|NCT02749799|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153470338|NCT02749799|Glucocorticoids|glucocorticoids|mesh-ancestor
153470339|NCT02749799|Hormones|hormones|mesh-ancestor
153424461|NCT00376831|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153424462|NCT00376831|GABA Modulators|gaba modulators|mesh-ancestor
153424464|NCT00376831|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153424465|NCT00376831|Narcotics|narcotics|mesh-ancestor
153424467|NCT03857750|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
153470340|NCT02749799|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153470341|NCT02749799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153470342|NCT02749799|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153470385|NCT02498977|Azathioprine|azathioprine|mesh-list
153470386|NCT02498977|Tacrolimus|tacrolimus|mesh-list
153470387|NCT02498977|Cyclosporins|cyclosporins|mesh-list
153470388|NCT02498977|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153470389|NCT02498977|Immunologic Factors|immunologic factors|mesh-ancestor
153470407|NCT02379377|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
153883531|NCT01348542|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
153883532|NCT01348542|Antidepressive Agents|antidepressive agents|mesh-ancestor
153883533|NCT01346592|Vaccines|vaccines|mesh-list
153883534|NCT01346592|Immunologic Factors|immunologic factors|mesh-ancestor
153883535|NCT01346592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153883536|NCT01193335|Vaccines|vaccines|mesh-list
153883537|NCT01193335|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
153883538|NCT01193335|Immunologic Factors|immunologic factors|mesh-ancestor
153883539|NCT01193335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153883540|NCT02893995|Treprostinil|treprostinil|mesh-list
153883541|NCT02893995|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153883542|NCT01342887|Cyclosporine|cyclosporine|mesh-list
153883543|NCT01342887|Etoposide|etoposide|mesh-list
153883544|NCT01342887|Mitoxantrone|mitoxantrone|mesh-list
153470410|NCT02379377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153470411|NCT02379377|Cariostatic Agents|cariostatic agents|mesh-ancestor
153470412|NCT02379377|Protective Agents|protective agents|mesh-ancestor
153470413|NCT02379377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153470414|NCT02332668|Pembrolizumab|pembrolizumab|mesh-list
153470415|NCT02332668|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153470416|NCT02332668|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153470417|NCT02332668|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153470418|NCT02332668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153470419|NCT02222168|BI 409306|bi 409306|mesh-list
153470420|NCT02222168|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
153470421|NCT02222168|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153470422|NCT02222168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153470423|NCT01983241|Alpha 1-Antitrypsin|alpha 1-antitrypsin|mesh-list
153470477|NCT01822314|Tubulin Modulators|tubulin modulators|mesh-ancestor
153470478|NCT01822314|Antimitotic Agents|antimitotic agents|mesh-ancestor
153883545|NCT01342887|Etoposide phosphate|etoposide phosphate|mesh-list
153883546|NCT01342887|Pravastatin|pravastatin|mesh-list
153883547|NCT01342887|Cyclosporins|cyclosporins|mesh-list
153883548|NCT01342887|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153883549|NCT01342887|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153883550|NCT01342887|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153424484|NCT04081610|Viscosupplements|viscosupplements|mesh-ancestor
153470480|NCT01822314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153470482|NCT01711554|Lenalidomide|lenalidomide|mesh-list
153470483|NCT01711554|Tretinoin|tretinoin|mesh-list
153470484|NCT01711554|Dinutuximab|dinutuximab|mesh-list
153470485|NCT01711554|Isotretinoin|isotretinoin|mesh-list
153470486|NCT01711554|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
153470487|NCT01711554|Vitamins|vitamins|mesh-ancestor
153470488|NCT01711554|Micronutrients|micronutrients|mesh-ancestor
153470489|NCT01711554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153470490|NCT01711554|Immunologic Factors|immunologic factors|mesh-ancestor
153470491|NCT01711554|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153470520|NCT01475123|Vitamin B Complex|vitamin b complex|mesh-ancestor
153470522|NCT01475123|Micronutrients|micronutrients|mesh-ancestor
153470523|NCT01475123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153470524|NCT01366144|Paclitaxel|paclitaxel|mesh-list
153470525|NCT01366144|Carboplatin|carboplatin|mesh-list
153470526|NCT01366144|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
153470527|NCT01366144|Veliparib|veliparib|mesh-list
153470528|NCT01366144|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153470529|NCT01366144|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153470530|NCT01366144|Tubulin Modulators|tubulin modulators|mesh-ancestor
153470531|NCT01366144|Antimitotic Agents|antimitotic agents|mesh-ancestor
153470532|NCT01366144|Mitosis Modulators|mitosis modulators|mesh-ancestor
153470533|NCT01366144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153470534|NCT01366144|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
153470535|NCT01366144|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153470536|NCT01258933|Ofatumumab|ofatumumab|mesh-list
153470537|NCT01258933|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153470538|NCT01169259|Vitamin D|vitamin d|mesh-list
153470539|NCT01169259|Ergocalciferols|ergocalciferols|mesh-list
153470540|NCT01169259|Cholecalciferol|cholecalciferol|mesh-list
153470541|NCT01169259|Vitamins|vitamins|mesh-list
153470542|NCT01169259|Micronutrients|micronutrients|mesh-ancestor
153470543|NCT01169259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153470544|NCT01169259|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153470545|NCT01169259|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153470547|NCT00114101|Melphalan|melphalan|mesh-list
153470548|NCT00114101|Mechlorethamine|mechlorethamine|mesh-list
153470549|NCT00114101|Nitrogen Mustard Compounds|nitrogen mustard compounds|mesh-list
153470550|NCT00114101|Immunologic Factors|immunologic factors|mesh-ancestor
153470551|NCT00114101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153470552|NCT00114101|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153883554|NCT01342887|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153883555|NCT01342887|Immunologic Factors|immunologic factors|mesh-ancestor
153883556|NCT01342887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153470553|NCT00114101|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153470554|NCT00114101|Growth Substances|growth substances|mesh-ancestor
153470555|NCT00114101|Growth Inhibitors|growth inhibitors|mesh-ancestor
153470556|NCT00114101|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153470557|NCT00114101|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153470558|NCT00114101|Alkylating Agents|alkylating agents|mesh-ancestor
153470559|NCT00114101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153470560|NCT00114101|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153470584|NCT00565266|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153470585|NCT00565266|Adrenergic Agents|adrenergic agents|mesh-ancestor
153470586|NCT00565266|Anticonvulsants|anticonvulsants|mesh-ancestor
153470587|NCT00565266|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153470588|NCT00565266|Glucocorticoids|glucocorticoids|mesh-ancestor
153470590|NCT00565266|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153470591|NCT00568386|Ophthalmic Solutions|ophthalmic solutions|mesh-list
153470592|NCT00568386|Lubricant Eye Drops|lubricant eye drops|mesh-list
153387498|NCT02977949|Hormone Antagonists|hormone antagonists|mesh-ancestor
153470593|NCT00568386|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
153470594|NCT01797978|Methylene Blue|methylene blue|mesh-list
153470595|NCT01797978|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153470596|NCT01797978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153470597|NCT05363202|Fluticasone|fluticasone|mesh-list
153470599|NCT05363202|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153470600|NCT05363202|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153470601|NCT05363202|Autonomic Agents|autonomic agents|mesh-ancestor
153470602|NCT05363202|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153470603|NCT05363202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153470604|NCT05363202|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153470605|NCT05363202|Respiratory System Agents|respiratory system agents|mesh-ancestor
153470606|NCT05363202|Dermatologic Agents|dermatologic agents|mesh-ancestor
153470607|NCT05363202|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
153470608|NCT02129478|Olanzapine|olanzapine|mesh-list
153470609|NCT02129478|Antiemetics|antiemetics|mesh-ancestor
153470610|NCT02129478|Autonomic Agents|autonomic agents|mesh-ancestor
153470611|NCT02129478|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153470612|NCT02129478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153470613|NCT02129478|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153470615|NCT02129478|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153470616|NCT02129478|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153470617|NCT02129478|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153470618|NCT02129478|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
153470619|NCT02129478|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153470620|NCT02129478|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153470621|NCT02129478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153470622|NCT02129478|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153470639|NCT05362500|Antidepressive Agents|antidepressive agents|mesh-ancestor
153470641|NCT05362500|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
153470642|NCT05362500|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153470643|NCT05362500|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153470644|NCT05362500|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153470646|NCT05362500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153470647|NCT05161806|Aflibercept|aflibercept|mesh-list
153470648|NCT05161806|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153470649|NCT05161806|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153470650|NCT05161806|Growth Substances|growth substances|mesh-ancestor
153470651|NCT05161806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153470661|NCT05362188|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153470662|NCT05362188|Antimetabolites|antimetabolites|mesh-ancestor
153470663|NCT05362188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153883565|NCT01342887|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153883566|NCT01342887|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153883568|NCT01342887|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153883569|NCT01342887|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
153883570|NCT04445415|Antibodies|antibodies|mesh-list
153470665|NCT05362188|Vasodilator Agents|vasodilator agents|mesh-ancestor
153470666|NCT05353374|Fusidic Acid|fusidic acid|mesh-list
153470667|NCT05353374|Petrolatum|petrolatum|mesh-list
153470668|NCT05353374|Emollients|emollients|mesh-ancestor
153470669|NCT05353374|Dermatologic Agents|dermatologic agents|mesh-ancestor
153470670|NCT05353374|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153470671|NCT05353374|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153470672|NCT05353374|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
153470673|NCT05353374|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153470674|NCT05353374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153470675|NCT05214222|Paclitaxel|paclitaxel|mesh-list
153470676|NCT05214222|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
153470677|NCT05214222|Cisplatin|cisplatin|mesh-list
153470678|NCT05214222|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153470679|NCT05214222|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153470680|NCT05214222|Tubulin Modulators|tubulin modulators|mesh-ancestor
153470681|NCT05214222|Antimitotic Agents|antimitotic agents|mesh-ancestor
153470682|NCT05214222|Mitosis Modulators|mitosis modulators|mesh-ancestor
153470707|NCT05017194|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153470708|NCT05017194|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153470709|NCT04501380|Rifamycins|rifamycins|mesh-list
153470710|NCT04501380|Rifamycin SV|rifamycin sv|mesh-list
153470711|NCT04501380|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153470712|NCT04501380|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153470713|NCT04501380|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153470714|NCT04465734|Sorafenib|sorafenib|mesh-list
153470715|NCT04465734|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153470716|NCT04465734|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153470717|NCT04465734|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153470718|NCT04465734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153470727|NCT01798602|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
153470728|NCT01798602|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153470729|NCT01798602|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153470730|NCT01798602|Antimetabolites|antimetabolites|mesh-ancestor
153470731|NCT01798602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153470732|NCT01798602|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153470733|NCT01798602|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
153470734|NCT01798602|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153470735|NCT02783430|Ketamine|ketamine|mesh-list
153470736|NCT02783430|Milnacipran|milnacipran|mesh-list
153470737|NCT02783430|Levomilnacipran|levomilnacipran|mesh-list
153470738|NCT02783430|Analgesics|analgesics|mesh-ancestor
153470739|NCT02783430|Sensory System Agents|sensory system agents|mesh-ancestor
153470740|NCT02783430|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153813771|NCT00437229|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
153360174|NCT01272245|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153470741|NCT02783430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153470742|NCT02783430|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
153470743|NCT02783430|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153470744|NCT02783430|Anesthetics, General|anesthetics, general|mesh-ancestor
153470759|NCT03642366|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
153470760|NCT03642366|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
153470771|NCT00604968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153470772|NCT00605202|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
153470786|NCT00605904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153470787|NCT00605904|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
153470788|NCT00605904|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
153470789|NCT00605904|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
153470790|NCT00605904|Adrenergic Agents|adrenergic agents|mesh-ancestor
153470791|NCT00605904|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153470792|NCT00605904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153470793|NCT00605904|Urological Agents|urological agents|mesh-ancestor
153470795|NCT01798914|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153470796|NCT01798914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153470797|NCT05175768|Niacinamide|niacinamide|mesh-list
153470798|NCT05175768|Niacin|niacin|mesh-list
153470799|NCT05175768|Nicotinic Acids|nicotinic acids|mesh-list
153470800|NCT05175768|Vitamin B Complex|vitamin b complex|mesh-ancestor
153470801|NCT05175768|Vitamins|vitamins|mesh-ancestor
153470802|NCT05175768|Micronutrients|micronutrients|mesh-ancestor
153470816|NCT05097846|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
153470817|NCT05097846|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153470818|NCT05097846|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
153470819|NCT05097846|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153470820|NCT05097846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153470821|NCT05097846|Antimalarials|antimalarials|mesh-ancestor
153470822|NCT05097846|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153470823|NCT05097846|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153424517|NCT04039412|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153424518|NCT03831854|Lamotrigine|lamotrigine|mesh-list
153424519|NCT03831854|Ketamine|ketamine|mesh-list
153424520|NCT03831854|Analgesics|analgesics|mesh-ancestor
153424521|NCT03831854|Sensory System Agents|sensory system agents|mesh-ancestor
153424522|NCT03831854|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153470825|NCT05097846|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
153470826|NCT05097846|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
153470827|NCT05097846|Antitrichomonal Agents|antitrichomonal agents|mesh-ancestor
153470828|NCT05097846|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
153470829|NCT00608634|Perillyl alcohol|perillyl alcohol|mesh-list
153883579|NCT01340664|Canagliflozin|canagliflozin|mesh-list
153883580|NCT01340664|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153883581|NCT01340664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153883582|NCT01340664|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
153883583|NCT01340664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153883584|NCT01340625|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
153883585|NCT01340625|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
153883586|NCT01340625|Ethinyl Estradiol|ethinyl estradiol|mesh-list
153360175|NCT01272245|Antiviral Agents|antiviral agents|mesh-ancestor
153470842|NCT02897700|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153470843|NCT02897700|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153470844|NCT02897700|Alkylating Agents|alkylating agents|mesh-ancestor
153470845|NCT02897700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153470846|NCT02897700|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153470847|NCT02897700|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153470848|NCT02897700|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153470849|NCT02897700|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153470850|NCT02897700|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153470851|NCT02897700|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153470852|NCT02897700|Antimetabolites|antimetabolites|mesh-ancestor
153470853|NCT02897700|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153470865|NCT02889666|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153470866|NCT02889666|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153470882|NCT00610428|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153470883|NCT00610428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153470884|NCT00610428|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153470885|NCT00610428|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153470886|NCT00610428|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153470887|NCT00610428|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153470888|NCT00610428|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153470889|NCT00610428|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
153470890|NCT00610428|Dopamine Agents|dopamine agents|mesh-ancestor
153470891|NCT00610428|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153470892|NCT00610428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153470894|NCT00610740|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153470895|NCT00610740|Antimetabolites|antimetabolites|mesh-ancestor
153470896|NCT00610740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153470897|NCT00610740|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153470898|NCT00611442|Lubiprostone|lubiprostone|mesh-list
153470899|NCT00611442|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
153470900|NCT00611442|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153470901|NCT00611442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153470902|NCT02136420|Promethazine|promethazine|mesh-list
153470903|NCT02136420|Diphenhydramine|diphenhydramine|mesh-list
153470904|NCT02136420|Antipruritics|antipruritics|mesh-ancestor
153424541|NCT03806270|Midazolam|midazolam|mesh-list
153424542|NCT03806270|Hydroxyzine|hydroxyzine|mesh-list
153424543|NCT03806270|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153424544|NCT03806270|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153424545|NCT03806270|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153424546|NCT03806270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153424547|NCT03806270|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153424548|NCT03806270|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153470905|NCT02136420|Dermatologic Agents|dermatologic agents|mesh-ancestor
153470906|NCT02136420|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
153470907|NCT02136420|Histamine Antagonists|histamine antagonists|mesh-ancestor
153470908|NCT02136420|Histamine Agents|histamine agents|mesh-ancestor
153470909|NCT02136420|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153470910|NCT02136420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153470912|NCT02136420|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
153470933|NCT00612222|Fludarabine phosphate|fludarabine phosphate|mesh-list
153470935|NCT00612222|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153470936|NCT00612222|Immunologic Factors|immunologic factors|mesh-ancestor
153470937|NCT00612222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153470938|NCT00612222|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153470939|NCT00612222|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153470940|NCT00612222|Alkylating Agents|alkylating agents|mesh-ancestor
153470941|NCT00612222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153470942|NCT00612222|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153470943|NCT00612222|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153470944|NCT00612222|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153470945|NCT00612222|Antimetabolites|antimetabolites|mesh-ancestor
153470946|NCT00612222|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153470947|NCT00612222|Analgesics|analgesics|mesh-ancestor
153470948|NCT00612222|Sensory System Agents|sensory system agents|mesh-ancestor
153470949|NCT00612222|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153470950|NCT00612222|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153470951|NCT00612222|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153470952|NCT00612222|Antiviral Agents|antiviral agents|mesh-ancestor
153470953|NCT00612222|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153470954|NCT01711242|Capecitabine|capecitabine|mesh-list
153470955|NCT01711242|Oxaliplatin|oxaliplatin|mesh-list
153470956|NCT01711242|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153470957|NCT01711242|Antimetabolites|antimetabolites|mesh-ancestor
153470958|NCT01711242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153470959|NCT01711242|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153470960|NCT04405908|Aluminum Hydroxide|aluminum hydroxide|mesh-list
153470961|NCT04405908|Aluminum sulfate|aluminum sulfate|mesh-list
153470962|NCT04405908|1018 oligonucleotide|1018 oligonucleotide|mesh-list
153470963|NCT04405908|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153470964|NCT04405908|Immunologic Factors|immunologic factors|mesh-ancestor
153380149|NCT04976777|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153470965|NCT04405908|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153470966|NCT04405908|Antacids|antacids|mesh-ancestor
153470967|NCT04405908|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153470970|NCT04304274|Morphine|morphine|mesh-list
153470971|NCT04304274|Ropivacaine|ropivacaine|mesh-list
153470972|NCT04304274|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153470973|NCT04304274|Narcotics|narcotics|mesh-ancestor
153470974|NCT04304274|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153470975|NCT04304274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153470976|NCT04304274|Analgesics|analgesics|mesh-ancestor
153470977|NCT04304274|Sensory System Agents|sensory system agents|mesh-ancestor
153883602|NCT04823468|Cisplatin|cisplatin|mesh-list
153470978|NCT04304274|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153470979|NCT04304274|Anesthetics, Local|anesthetics, local|mesh-ancestor
153470981|NCT02132832|Buspirone|buspirone|mesh-list
153470982|NCT02132832|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153470983|NCT02132832|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153470984|NCT02132832|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153470985|NCT02132832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153470986|NCT02132832|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153470987|NCT02132832|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
153470988|NCT02132832|Serotonin Agents|serotonin agents|mesh-ancestor
153470989|NCT02132832|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153470990|NCT02132832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153470991|NCT00614406|Celecoxib|celecoxib|mesh-list
153470992|NCT00614406|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153470993|NCT00614406|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153470994|NCT00614406|Analgesics|analgesics|mesh-ancestor
153470995|NCT00614406|Sensory System Agents|sensory system agents|mesh-ancestor
153470996|NCT00614406|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153470997|NCT00614406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153470998|NCT00614406|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153470999|NCT00614406|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153471009|NCT00614484|Antimitotic Agents|antimitotic agents|mesh-ancestor
153471010|NCT00614484|Mitosis Modulators|mitosis modulators|mesh-ancestor
153471011|NCT00614484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153813777|NCT00335192|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153471012|NCT04159974|Durvalumab|durvalumab|mesh-list
153471013|NCT04159974|Tremelimumab|tremelimumab|mesh-list
153471014|NCT04159974|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153471015|NCT04159974|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153471017|NCT04142502|Propofol|propofol|mesh-list
153471018|NCT04142502|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153471019|NCT04142502|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153471020|NCT04142502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153471021|NCT04142502|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153471022|NCT04142502|Anesthetics, General|anesthetics, general|mesh-ancestor
153471023|NCT04142502|Anesthetics|anesthetics|mesh-ancestor
153471024|NCT04142502|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153471025|NCT04142502|Analgesics|analgesics|mesh-ancestor
153471026|NCT04142502|Sensory System Agents|sensory system agents|mesh-ancestor
153471027|NCT04142502|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153471029|NCT04142502|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153471030|NCT04142502|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153471031|NCT04142502|Adrenergic Agents|adrenergic agents|mesh-ancestor
153424549|NCT03806270|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153424554|NCT03806270|GABA Agents|gaba agents|mesh-ancestor
153424555|NCT03806270|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153424556|NCT03806270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153424557|NCT03806270|Antipruritics|antipruritics|mesh-ancestor
153424558|NCT03806270|Dermatologic Agents|dermatologic agents|mesh-ancestor
153424559|NCT03806270|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
153424560|NCT03806270|Histamine Antagonists|histamine antagonists|mesh-ancestor
153424561|NCT03806270|Histamine Agents|histamine agents|mesh-ancestor
153424562|NCT03497845|Vaccines|vaccines|mesh-list
153424563|NCT03497845|Immunologic Factors|immunologic factors|mesh-ancestor
153424564|NCT03497845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153424565|NCT04036292|Varenicline|varenicline|mesh-list
153471033|NCT04142502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153471034|NCT00569010|Cytarabine|cytarabine|mesh-list
153471035|NCT00569010|Azacitidine|azacitidine|mesh-list
153471036|NCT00569010|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153471037|NCT00569010|Antimetabolites|antimetabolites|mesh-ancestor
153471038|NCT00569010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153471039|NCT00569010|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153471040|NCT00569010|Antiviral Agents|antiviral agents|mesh-ancestor
153471041|NCT00569010|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153471042|NCT00569010|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153471043|NCT00569010|Immunologic Factors|immunologic factors|mesh-ancestor
153471044|NCT00569010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153471045|NCT00569010|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153471046|NCT00616122|Cyclophosphamide|cyclophosphamide|mesh-list
153471047|NCT00616122|Methotrexate|methotrexate|mesh-list
153471048|NCT00616122|Sunitinib|sunitinib|mesh-list
153471049|NCT00616122|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153471050|NCT00616122|Immunologic Factors|immunologic factors|mesh-ancestor
153471051|NCT00616122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153471052|NCT00616122|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153471053|NCT00616122|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153471054|NCT00616122|Alkylating Agents|alkylating agents|mesh-ancestor
153471055|NCT00616122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153471056|NCT00616122|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153471057|NCT00616122|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153471058|NCT00616122|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
153471059|NCT00616122|Abortifacient Agents|abortifacient agents|mesh-ancestor
153471060|NCT00616122|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153471061|NCT00616122|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153471062|NCT00616122|Antimetabolites|antimetabolites|mesh-ancestor
153471063|NCT00616122|Dermatologic Agents|dermatologic agents|mesh-ancestor
153471064|NCT00616122|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153471065|NCT00616122|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153471081|NCT00618540|Antimetabolites|antimetabolites|mesh-ancestor
153471082|NCT00618540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153471083|NCT00618540|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153471084|NCT00618540|Immunologic Factors|immunologic factors|mesh-ancestor
153471085|NCT00618540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153471086|NCT00618540|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153883619|NCT02893332|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153883620|NCT04328493|Chloroquine|chloroquine|mesh-list
153883621|NCT04328493|Chloroquine diphosphate|chloroquine diphosphate|mesh-list
153883622|NCT04328493|Amebicides|amebicides|mesh-ancestor
153883623|NCT04328493|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153883624|NCT04328493|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153883625|NCT04328493|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153883626|NCT04328493|Antimalarials|antimalarials|mesh-ancestor
153883627|NCT04328493|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153883628|NCT04328493|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153471088|NCT00618540|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153471089|NCT00618540|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153471091|NCT00570960|Anticoagulants|anticoagulants|mesh-ancestor
153471092|NCT00570960|Plasma Substitutes|plasma substitutes|mesh-ancestor
153471093|NCT00570960|Blood Substitutes|blood substitutes|mesh-ancestor
153471094|NCT00571428|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
153471095|NCT00571428|Formoterol Fumarate|formoterol fumarate|mesh-list
153471116|NCT00574236|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153471117|NCT00574236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153471118|NCT00574548|Vaccines|vaccines|mesh-list
153471119|NCT00574548|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
153471120|NCT00574548|Immunologic Factors|immunologic factors|mesh-ancestor
153471121|NCT00574548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153471122|NCT01168219|Methotrexate|methotrexate|mesh-list
153471123|NCT01168219|Fludarabine phosphate|fludarabine phosphate|mesh-list
153471124|NCT01168219|Azacitidine|azacitidine|mesh-list
153471125|NCT01168219|Fludarabine|fludarabine|mesh-list
153471126|NCT01168219|Busulfan|busulfan|mesh-list
153471127|NCT01168219|Tacrolimus|tacrolimus|mesh-list
153471128|NCT01168219|Antilymphocyte Serum|antilymphocyte serum|mesh-list
153471145|NCT01168219|Alkylating Agents|alkylating agents|mesh-ancestor
153380151|NCT04976777|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153380152|NCT02247596|Resveratrol|resveratrol|mesh-list
153380153|NCT02247596|Antioxidants|antioxidants|mesh-ancestor
153882629|NCT02279966|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153882630|NCT02279966|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153882631|NCT02279966|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
153882632|NCT02279966|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
153423519|NCT03478982|Alprazolam|alprazolam|mesh-list
153471146|NCT01168219|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153471148|NCT01115803|Everolimus|everolimus|mesh-list
153471149|NCT01115803|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
153471150|NCT01115803|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
153471151|NCT01115803|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153471152|NCT01115803|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153471153|NCT01115803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153471154|NCT01115803|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153471155|NCT01115803|Immunologic Factors|immunologic factors|mesh-ancestor
153471156|NCT01115803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153471157|NCT01115803|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153471158|NCT01115803|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153471159|NCT01115569|Hydrocodone|hydrocodone|mesh-list
153471160|NCT01115569|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153471161|NCT01115569|Narcotics|narcotics|mesh-ancestor
153471162|NCT01115569|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153471163|NCT01115569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153471164|NCT01115569|Analgesics|analgesics|mesh-ancestor
153471165|NCT01115569|Sensory System Agents|sensory system agents|mesh-ancestor
153471166|NCT01115569|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153471167|NCT01115569|Antitussive Agents|antitussive agents|mesh-ancestor
153471168|NCT01115569|Respiratory System Agents|respiratory system agents|mesh-ancestor
153471169|NCT01107886|Saxagliptin|saxagliptin|mesh-list
153471170|NCT01107886|Incretins|incretins|mesh-ancestor
153471172|NCT01107886|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153471186|NCT05766605|Leucovorin|leucovorin|mesh-list
153471194|NCT05766605|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153471195|NCT05766605|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153471196|NCT05766605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153471198|NCT05766605|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153471199|NCT05766605|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153471200|NCT05766605|Immunologic Factors|immunologic factors|mesh-ancestor
153471201|NCT05766605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153813778|NCT00335192|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153471202|NCT05766605|Antidotes|antidotes|mesh-ancestor
153471203|NCT05766605|Protective Agents|protective agents|mesh-ancestor
153471204|NCT05766605|Vitamin B Complex|vitamin b complex|mesh-ancestor
153471205|NCT05766605|Vitamins|vitamins|mesh-ancestor
153471206|NCT05766605|Micronutrients|micronutrients|mesh-ancestor
153471207|NCT05766605|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153471208|NCT05766436|Dexmedetomidine|dexmedetomidine|mesh-list
153471209|NCT05766436|Melatonin|melatonin|mesh-list
153471210|NCT05766436|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153471211|NCT05766436|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153471212|NCT05766436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153471213|NCT05766436|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153471214|NCT05766436|Analgesics|analgesics|mesh-ancestor
153471215|NCT05766436|Sensory System Agents|sensory system agents|mesh-ancestor
153471216|NCT05766436|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153471217|NCT05766436|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
153471218|NCT05766436|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153471220|NCT05766436|Adrenergic Agents|adrenergic agents|mesh-ancestor
153471236|NCT05766085|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153471238|NCT05766085|Autonomic Agents|autonomic agents|mesh-ancestor
153471239|NCT05766085|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153471240|NCT05766085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153471241|NCT05766085|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153471242|NCT05766085|Glucocorticoids|glucocorticoids|mesh-ancestor
153471243|NCT05766085|Hormones|hormones|mesh-ancestor
153423520|NCT03478982|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153423521|NCT03478982|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153423522|NCT03478982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153423523|NCT03478982|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153423524|NCT03478982|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153423525|NCT03478982|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153423526|NCT03478982|GABA Modulators|gaba modulators|mesh-ancestor
153423527|NCT03478982|GABA Agents|gaba agents|mesh-ancestor
153423528|NCT03478982|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153423529|NCT03478982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153423530|NCT03270332|Albuterol|albuterol|mesh-list
153423531|NCT03270332|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153423532|NCT03270332|Autonomic Agents|autonomic agents|mesh-ancestor
153380154|NCT02247596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153380155|NCT02247596|Protective Agents|protective agents|mesh-ancestor
153380156|NCT02247596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153380157|NCT02247596|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153471244|NCT05766085|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153471245|NCT05766085|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153471246|NCT05766085|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153471247|NCT05765825|Carboplatin|carboplatin|mesh-list
153471248|NCT05765825|Etoposide|etoposide|mesh-list
153471249|NCT05765825|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153471250|NCT05765825|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153471251|NCT05765825|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153471252|NCT05765825|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153471253|NCT05765825|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153471254|NCT05765825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153424645|NCT00377468|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153424646|NCT03799484|Lidocaine|lidocaine|mesh-list
153424647|NCT03799484|Prilocaine|prilocaine|mesh-list
153424648|NCT03799484|Petrolatum|petrolatum|mesh-list
153424649|NCT03799484|Botulinum Toxins|botulinum toxins|mesh-list
153424650|NCT03799484|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
153424651|NCT03799484|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
153424652|NCT03799484|Anesthetics, Local|anesthetics, local|mesh-ancestor
153424653|NCT03799484|Anesthetics|anesthetics|mesh-ancestor
153424654|NCT03799484|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153424655|NCT03799484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153424656|NCT03799484|Sensory System Agents|sensory system agents|mesh-ancestor
153424657|NCT03799484|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153424658|NCT03799484|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153424659|NCT03799484|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
153424660|NCT03799484|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153424661|NCT03799484|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153424662|NCT03799484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153424663|NCT03799484|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
153424664|NCT03799484|Cholinergic Agents|cholinergic agents|mesh-ancestor
153471278|NCT05765357|Trastuzumab|trastuzumab|mesh-list
153471279|NCT05765357|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153471280|NCT05765357|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153471281|NCT05765240|Hyaluronic Acid|hyaluronic acid|mesh-list
153471282|NCT05765240|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153471283|NCT05765240|Immunologic Factors|immunologic factors|mesh-ancestor
153471284|NCT05765240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153380158|NCT02247596|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153380159|NCT03686657|Metformin|metformin|mesh-list
153380160|NCT03686657|Celecoxib|celecoxib|mesh-list
153380161|NCT03686657|Valsartan|valsartan|mesh-list
153380162|NCT03686657|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153380163|NCT03686657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153380164|NCT03686657|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153882633|NCT02279966|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
153882634|NCT02279966|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153882635|NCT01684787|Ribavirin|ribavirin|mesh-list
153882636|NCT01684787|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
153882637|NCT01684787|Interferon-alpha|interferon-alpha|mesh-list
153882638|NCT01684787|Antimetabolites|antimetabolites|mesh-ancestor
153882639|NCT01684787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153882640|NCT01684787|Antiviral Agents|antiviral agents|mesh-ancestor
153882641|NCT01684787|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153882642|NCT01684787|Immunologic Factors|immunologic factors|mesh-ancestor
153882643|NCT01684787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153882644|NCT01649258|Granisetron|granisetron|mesh-list
153471285|NCT05765240|Viscosupplements|viscosupplements|mesh-ancestor
153471286|NCT05765240|Protective Agents|protective agents|mesh-ancestor
153471299|NCT05764811|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
153471300|NCT05764811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153471301|NCT05764811|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153471302|NCT05764811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153471303|NCT05764798|Zolpidem|zolpidem|mesh-list
153471304|NCT05764798|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
153471305|NCT05764798|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153471306|NCT05764798|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153471307|NCT05764798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153471308|NCT05764798|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
153471309|NCT05764798|GABA Agonists|gaba agonists|mesh-ancestor
153471310|NCT05764798|GABA Agents|gaba agents|mesh-ancestor
153471311|NCT05764798|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153471312|NCT05764798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153471313|NCT05764746|Artesunate|artesunate|mesh-list
153471314|NCT05764746|Lumefantrine|lumefantrine|mesh-list
153471315|NCT05764746|Artemether|artemether|mesh-list
153471316|NCT05764746|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
153471317|NCT05764746|Amodiaquine|amodiaquine|mesh-list
153471318|NCT05764746|Antimalarials|antimalarials|mesh-ancestor
153471319|NCT05764746|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153471325|NCT05764746|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
153471326|NCT05764746|Anthelmintics|anthelmintics|mesh-ancestor
153471327|NCT05763602|Povidone-Iodine|povidone-iodine|mesh-list
153471328|NCT05763602|Povidone|povidone|mesh-list
153471329|NCT05763602|Plasma Substitutes|plasma substitutes|mesh-ancestor
153471330|NCT05763602|Blood Substitutes|blood substitutes|mesh-ancestor
153471331|NCT05763602|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
153471332|NCT05763602|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153471333|NCT05757622|Remifentanil|remifentanil|mesh-list
153471334|NCT05757622|Propofol|propofol|mesh-list
153471335|NCT05757622|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153471336|NCT05757622|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153471337|NCT05757622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153471338|NCT05757622|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153471339|NCT05757622|Anesthetics, General|anesthetics, general|mesh-ancestor
153471340|NCT05757622|Anesthetics|anesthetics|mesh-ancestor
153471341|NCT05757622|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153882645|NCT01649258|Fosaprepitant|fosaprepitant|mesh-list
153882646|NCT01649258|Aprepitant|aprepitant|mesh-list
153882647|NCT01649258|Antiemetics|antiemetics|mesh-ancestor
153423533|NCT03270332|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153423534|NCT03270332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153423535|NCT03270332|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153423536|NCT03270332|Respiratory System Agents|respiratory system agents|mesh-ancestor
153423538|NCT03270332|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153423539|NCT03270332|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
153423540|NCT03270332|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
153423541|NCT03270332|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153471342|NCT05757622|Narcotics|narcotics|mesh-ancestor
153471356|NCT05731726|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153471358|NCT05731726|Analgesics|analgesics|mesh-ancestor
153424680|NCT00377546|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153424681|NCT00377546|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153424682|NCT00377546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153424683|NCT04290494|Plasminogen|plasminogen|mesh-list
153424684|NCT04290494|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153424685|NCT04290494|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153424686|NCT04290494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153424687|NCT04005404|Ropivacaine|ropivacaine|mesh-list
153471359|NCT05731726|Sensory System Agents|sensory system agents|mesh-ancestor
153471360|NCT05731726|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153471361|NCT05731726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153471362|NCT05731726|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153471363|NCT05731726|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153471364|NCT05731726|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
153471365|NCT05731726|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153471366|NCT05731726|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153471368|NCT05715931|Docetaxel|docetaxel|mesh-list
153813779|NCT00335192|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153360178|NCT01272245|Immunologic Factors|immunologic factors|mesh-ancestor
153471369|NCT05715931|Oxaliplatin|oxaliplatin|mesh-list
153471370|NCT05715931|Trastuzumab|trastuzumab|mesh-list
153471371|NCT05715931|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153471372|NCT05715931|Tubulin Modulators|tubulin modulators|mesh-ancestor
153471373|NCT05715931|Antimitotic Agents|antimitotic agents|mesh-ancestor
153471374|NCT05715931|Mitosis Modulators|mitosis modulators|mesh-ancestor
153471375|NCT05715931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153471385|NCT05708183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153471386|NCT05594823|Furosemide|furosemide|mesh-list
153471387|NCT05594823|Diuretics|diuretics|mesh-list
153471388|NCT05594823|Natriuretic Agents|natriuretic agents|mesh-ancestor
153471389|NCT05594823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153471390|NCT05594823|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
153471391|NCT05594823|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153471399|NCT05510544|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153471400|NCT05510544|Antiviral Agents|antiviral agents|mesh-ancestor
153471401|NCT05510544|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153471402|NCT05509699|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
153471403|NCT05509699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153471404|NCT05509699|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153471405|NCT05509699|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153471406|NCT05177588|Metformin|metformin|mesh-list
153471407|NCT05177588|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153471408|NCT05177588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153471409|NCT05171660|Bevacizumab|bevacizumab|mesh-list
153471410|NCT05171660|Capecitabine|capecitabine|mesh-list
153471411|NCT05171660|Oxaliplatin|oxaliplatin|mesh-list
153471412|NCT05171660|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153471413|NCT05171660|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153471414|NCT05171660|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153471415|NCT05171660|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153423542|NCT03270332|Adrenergic Agents|adrenergic agents|mesh-ancestor
153423543|NCT03270332|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153423546|NCT03355820|Immunologic Factors|immunologic factors|mesh-ancestor
153380165|NCT03686657|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153380198|NCT02476058|Dermatologic Agents|dermatologic agents|mesh-ancestor
153380199|NCT03050619|Empagliflozin|empagliflozin|mesh-list
153380200|NCT03050619|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
153380201|NCT03050619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153380202|NCT03050619|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153471416|NCT05171660|Growth Substances|growth substances|mesh-ancestor
153471423|NCT05133258|Dexamethasone|dexamethasone|mesh-list
153471424|NCT05133258|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153471425|NCT05133258|Antiemetics|antiemetics|mesh-ancestor
153471426|NCT05133258|Autonomic Agents|autonomic agents|mesh-ancestor
153471427|NCT05133258|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153471428|NCT05133258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153471429|NCT05133258|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153471430|NCT05133258|Glucocorticoids|glucocorticoids|mesh-ancestor
153471431|NCT05133258|Hormones|hormones|mesh-ancestor
153471432|NCT05133258|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153471433|NCT05133258|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153471435|NCT05133258|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153471445|NCT05059873|Glucocorticoids|glucocorticoids|mesh-ancestor
153471446|NCT05059873|Hormones|hormones|mesh-ancestor
153471447|NCT05059873|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153471448|NCT05059873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153471449|NCT05059873|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153471450|NCT05059873|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153883785|NCT04328883|Antipyretics|antipyretics|mesh-ancestor
153471452|NCT05055024|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
153471453|NCT05055024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153471454|NCT05055024|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
153471455|NCT05055024|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153471456|NCT05055024|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153471457|NCT05055024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153471458|NCT05055024|Adrenergic Agents|adrenergic agents|mesh-ancestor
153471470|NCT05012631|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
153471471|NCT05012631|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
153471472|NCT05012631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153471474|NCT04954196|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153471475|NCT04954196|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153471476|NCT04954196|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153471477|NCT04954196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153471478|NCT04954196|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153471479|NCT04954196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153471480|NCT04954196|Vasodilator Agents|vasodilator agents|mesh-ancestor
153471481|NCT04944290|Brimonidine Tartrate|brimonidine tartrate|mesh-list
153471482|NCT04944290|Brinzolamide|brinzolamide|mesh-list
153471483|NCT04944290|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153471484|NCT04944290|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
153471485|NCT04944290|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153471486|NCT04944290|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153471487|NCT04944290|Adrenergic Agents|adrenergic agents|mesh-ancestor
153471488|NCT04944290|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153471505|NCT04908176|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153471506|NCT04908176|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153471507|NCT04908176|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153471508|NCT04908176|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153471509|NCT04908176|Anesthetics, General|anesthetics, general|mesh-ancestor
153471510|NCT04908176|Anesthetics|anesthetics|mesh-ancestor
153471511|NCT04908176|GABA Modulators|gaba modulators|mesh-ancestor
153471512|NCT04908176|GABA Agents|gaba agents|mesh-ancestor
153380203|NCT03050619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153380205|NCT02071394|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
153380206|NCT02071394|Anesthetics, General|anesthetics, general|mesh-ancestor
153380207|NCT02071394|Anesthetics|anesthetics|mesh-ancestor
153380302|NCT05376722|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
153471513|NCT04908176|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153471514|NCT04908176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153471515|NCT04882540|Brivaracetam|brivaracetam|mesh-list
153471516|NCT04882540|Anticonvulsants|anticonvulsants|mesh-ancestor
153471517|NCT04859829|Immunoglobulins|immunoglobulins|mesh-list
153471518|NCT04859829|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
153471520|NCT04859829|gamma-Globulins|gamma-globulins|mesh-list
153471521|NCT04859829|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
153471522|NCT04859829|Immunologic Factors|immunologic factors|mesh-ancestor
153471539|NCT04778267|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153471540|NCT04778267|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153471541|NCT04778267|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153471543|NCT04778267|Anesthetics|anesthetics|mesh-ancestor
153471544|NCT04778267|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153471545|NCT04778267|Sensory System Agents|sensory system agents|mesh-ancestor
153471546|NCT04735471|Cyclophosphamide|cyclophosphamide|mesh-list
153471547|NCT04735471|Fludarabine|fludarabine|mesh-list
153471548|NCT04735471|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153360179|NCT01272245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153471549|NCT04735471|Immunologic Factors|immunologic factors|mesh-ancestor
153471550|NCT04735471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153471551|NCT04735471|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153471552|NCT04735471|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153471553|NCT04735471|Alkylating Agents|alkylating agents|mesh-ancestor
153471554|NCT04735471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153471555|NCT04735471|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153471556|NCT04735471|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153471557|NCT04718181|Omeprazole|omeprazole|mesh-list
153471558|NCT04718181|Risdiplam|risdiplam|mesh-list
153471559|NCT04718181|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
153471560|NCT04718181|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153471561|NCT04718181|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
153471562|NCT04718181|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153471581|NCT04521335|Copper|copper|mesh-list
153471582|NCT04521335|Disulfiram|disulfiram|mesh-list
153471608|NCT04247126|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
153471609|NCT04247126|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
153471610|NCT04247126|Hormone Antagonists|hormone antagonists|mesh-ancestor
153471611|NCT04247126|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153471612|NCT04247126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153471613|NCT04151706|Cyclophosphamide|cyclophosphamide|mesh-list
153471615|NCT04151706|Thiotepa|thiotepa|mesh-list
153471616|NCT04151706|Fludarabine|fludarabine|mesh-list
153471617|NCT04151706|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153471618|NCT04151706|Immunologic Factors|immunologic factors|mesh-ancestor
153471619|NCT04151706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153471620|NCT04151706|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153471621|NCT04151706|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153471622|NCT04151706|Alkylating Agents|alkylating agents|mesh-ancestor
153471623|NCT04151706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153471624|NCT04151706|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153883834|NCT04135092|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153471625|NCT04151706|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153471626|NCT04119453|Apatinib|apatinib|mesh-list
153471660|NCT03783026|Apremilast|apremilast|mesh-list
153471661|NCT03783026|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153471670|NCT03783026|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
153471671|NCT03783026|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153471672|NCT03783026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153471673|NCT03775460|Prednisolone|prednisolone|mesh-list
153471674|NCT03775460|Methotrexate|methotrexate|mesh-list
153471675|NCT03775460|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
153471676|NCT03775460|Abortifacient Agents|abortifacient agents|mesh-ancestor
153471677|NCT03775460|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153471678|NCT03775460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153471679|NCT03775460|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153471680|NCT03775460|Antimetabolites|antimetabolites|mesh-ancestor
153471681|NCT03775460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153471682|NCT03775460|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153471683|NCT03775460|Dermatologic Agents|dermatologic agents|mesh-ancestor
153471684|NCT03775460|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153471685|NCT03775460|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153471686|NCT03775460|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153471687|NCT03775460|Immunologic Factors|immunologic factors|mesh-ancestor
153471688|NCT03775460|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153471691|NCT03775460|Glucocorticoids|glucocorticoids|mesh-ancestor
153471743|NCT02894398|Palbociclib|palbociclib|mesh-list
153471744|NCT02894398|Anastrozole|anastrozole|mesh-list
153471745|NCT02894398|Exemestane|exemestane|mesh-list
153471746|NCT02894398|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153471747|NCT02894398|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
153471748|NCT02894398|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153471749|NCT02894398|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153471750|NCT02894398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153471751|NCT02894398|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
153883871|NCT04477382|Tretinoin|tretinoin|mesh-list
153471752|NCT02894398|Hormone Antagonists|hormone antagonists|mesh-ancestor
153471753|NCT02894398|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153471754|NCT02894398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153471755|NCT02894398|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153471756|NCT02894398|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
153471757|NCT02894398|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153471758|NCT02678052|Vedolizumab|vedolizumab|mesh-list
153471759|NCT02678052|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153471760|NCT02564263|Paclitaxel|paclitaxel|mesh-list
153471761|NCT02564263|Docetaxel|docetaxel|mesh-list
153471762|NCT02564263|Pembrolizumab|pembrolizumab|mesh-list
153471763|NCT02564263|Irinotecan|irinotecan|mesh-list
153471764|NCT02564263|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153471765|NCT02564263|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153471766|NCT02564263|Tubulin Modulators|tubulin modulators|mesh-ancestor
153471767|NCT02564263|Antimitotic Agents|antimitotic agents|mesh-ancestor
153471768|NCT02564263|Mitosis Modulators|mitosis modulators|mesh-ancestor
153471769|NCT02564263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153471770|NCT02564263|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153471771|NCT02564263|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153813781|NCT00335192|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153471772|NCT02564263|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
153471773|NCT02564263|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153471774|NCT02564263|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153471775|NCT02540018|Paclitaxel|paclitaxel|mesh-list
153471776|NCT02540018|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153471787|NCT02368886|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153471788|NCT02368886|Glucocorticoids|glucocorticoids|mesh-ancestor
153471789|NCT02368886|Hormones|hormones|mesh-ancestor
153471816|NCT02099188|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153471817|NCT02099188|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153471818|NCT02099188|Immunologic Factors|immunologic factors|mesh-ancestor
153471819|NCT02099188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153471820|NCT02099188|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153471822|NCT02099188|Protective Agents|protective agents|mesh-ancestor
153471823|NCT02099188|Vitamin B Complex|vitamin b complex|mesh-ancestor
153471824|NCT02099188|Vitamins|vitamins|mesh-ancestor
153471825|NCT02099188|Micronutrients|micronutrients|mesh-ancestor
153471826|NCT02099188|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153471827|NCT02099188|Alkylating Agents|alkylating agents|mesh-ancestor
153471828|NCT02099175|Leucovorin|leucovorin|mesh-list
153471829|NCT02099175|Docetaxel|docetaxel|mesh-list
153471830|NCT02099175|Doxorubicin|doxorubicin|mesh-list
153471831|NCT02099175|Fluorouracil|fluorouracil|mesh-list
153471832|NCT02099175|Etoposide|etoposide|mesh-list
153471833|NCT02099175|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
153471834|NCT02099175|Ifosfamide|ifosfamide|mesh-list
153471835|NCT02099175|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153471836|NCT02099175|Tubulin Modulators|tubulin modulators|mesh-ancestor
153471837|NCT02099175|Antimitotic Agents|antimitotic agents|mesh-ancestor
153471838|NCT02099175|Mitosis Modulators|mitosis modulators|mesh-ancestor
153471839|NCT02099175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153471840|NCT02099175|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153471841|NCT02099175|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153471842|NCT02099175|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153471852|NCT02099175|Vitamin B Complex|vitamin b complex|mesh-ancestor
153471853|NCT02099175|Vitamins|vitamins|mesh-ancestor
153471854|NCT02099175|Micronutrients|micronutrients|mesh-ancestor
153471855|NCT02099175|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153471856|NCT02099175|Alkylating Agents|alkylating agents|mesh-ancestor
153471857|NCT01715285|Prednisone|prednisone|mesh-list
153471858|NCT01715285|Abiraterone Acetate|abiraterone acetate|mesh-list
153471859|NCT01715285|Androgens|androgens|mesh-list
153471860|NCT01715285|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153471861|NCT01715285|Glucocorticoids|glucocorticoids|mesh-ancestor
153471862|NCT01715285|Hormones|hormones|mesh-ancestor
153471863|NCT01715285|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153471864|NCT01715285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153471865|NCT01715285|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153471867|NCT01715285|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153471879|NCT01705184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153471880|NCT01705184|Growth Inhibitors|growth inhibitors|mesh-ancestor
153471881|NCT01705184|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153360180|NCT01272245|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153471882|NCT01705184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153471883|NCT01705184|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153471884|NCT01705184|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153471886|NCT01285817|Cyclophosphamide|cyclophosphamide|mesh-list
153471887|NCT01285817|Methotrexate|methotrexate|mesh-list
153471888|NCT01285817|Vinblastine|vinblastine|mesh-list
153471889|NCT01285817|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153471890|NCT01285817|Immunologic Factors|immunologic factors|mesh-ancestor
153471891|NCT01285817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153471892|NCT01285817|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153471893|NCT01285817|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153471894|NCT01285817|Alkylating Agents|alkylating agents|mesh-ancestor
153471895|NCT01285817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153471896|NCT01285817|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153471897|NCT01285817|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153471898|NCT01285817|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
153471899|NCT01285817|Abortifacient Agents|abortifacient agents|mesh-ancestor
153471900|NCT01285817|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153471901|NCT01285817|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153471902|NCT01285817|Antimetabolites|antimetabolites|mesh-ancestor
153471903|NCT01285817|Dermatologic Agents|dermatologic agents|mesh-ancestor
153471912|NCT01285817|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153471913|NCT01285817|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
153471914|NCT01285817|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153471915|NCT01285817|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153471916|NCT01285817|Tubulin Modulators|tubulin modulators|mesh-ancestor
153471962|NCT00280202|Sequestering Agents|sequestering agents|mesh-ancestor
153471963|NCT00280202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153471965|NCT00079417|Cadexomer iodine|cadexomer iodine|mesh-list
153471966|NCT00079417|Carboplatin|carboplatin|mesh-list
153471967|NCT00079417|Vincristine|vincristine|mesh-list
153471968|NCT00079417|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153472011|NCT04384380|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153472012|NCT04384380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153472013|NCT04384380|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153472014|NCT04384458|Hydroxychloroquine|hydroxychloroquine|mesh-list
153472015|NCT04384458|Ivermectin|ivermectin|mesh-list
153472016|NCT04384458|Antimalarials|antimalarials|mesh-ancestor
153472017|NCT04384458|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153472018|NCT04384458|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153472019|NCT04384458|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153472020|NCT04384458|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153472021|NCT04384458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153380306|NCT04737057|Cariostatic Agents|cariostatic agents|mesh-ancestor
153380307|NCT04737057|Protective Agents|protective agents|mesh-ancestor
153380308|NCT04737057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153380309|NCT03111381|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
153380310|NCT03111381|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153380338|NCT03112863|Vitamin A|vitamin a|mesh-list
153380339|NCT03112863|Retinol palmitate|retinol palmitate|mesh-list
153380340|NCT03112863|Vitamins|vitamins|mesh-ancestor
153380341|NCT03112863|Micronutrients|micronutrients|mesh-ancestor
153380342|NCT03112863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153380343|NCT03112863|Antioxidants|antioxidants|mesh-ancestor
153882648|NCT01649258|Autonomic Agents|autonomic agents|mesh-ancestor
153882649|NCT01649258|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153472022|NCT04384458|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153472023|NCT04383990|Insulin|insulin|mesh-list
153472024|NCT04383990|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153472025|NCT04383990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153472026|NCT04381884|Ivermectin|ivermectin|mesh-list
153472027|NCT04381884|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153472028|NCT04381884|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153472029|NCT04381962|Azithromycin|azithromycin|mesh-list
153472030|NCT04381962|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153472031|NCT04381962|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153472032|NCT04381104|Acetaminophen|acetaminophen|mesh-list
153472033|NCT04381104|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153472034|NCT04381104|Analgesics|analgesics|mesh-ancestor
153472060|NCT04378608|Antimetabolites|antimetabolites|mesh-ancestor
153472061|NCT04378608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153472062|NCT04378608|Antiviral Agents|antiviral agents|mesh-ancestor
153472063|NCT04378608|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153472064|NCT04376970|Fluorometholone|fluorometholone|mesh-list
153472065|NCT04376970|Cyclosporine|cyclosporine|mesh-list
153472066|NCT04376970|Ophthalmic Solutions|ophthalmic solutions|mesh-list
153472067|NCT04376970|Cyclosporins|cyclosporins|mesh-list
153472068|NCT04376970|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153472069|NCT04376970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153472070|NCT04376970|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153472071|NCT04376970|Immunologic Factors|immunologic factors|mesh-ancestor
153472072|NCT04376970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153472073|NCT04376970|Antifungal Agents|antifungal agents|mesh-ancestor
153472074|NCT04376970|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153472075|NCT04376970|Dermatologic Agents|dermatologic agents|mesh-ancestor
153472076|NCT04376970|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153472077|NCT04376970|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
153472078|NCT04376970|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
153472079|NCT04376970|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153472080|NCT04376970|Glucocorticoids|glucocorticoids|mesh-ancestor
153472081|NCT04376970|Hormones|hormones|mesh-ancestor
153472107|NCT04376814|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153472108|NCT04376814|Antimalarials|antimalarials|mesh-ancestor
153472109|NCT04376814|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153472110|NCT04376814|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153472111|NCT04376814|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153472112|NCT04374942|Hydroxychloroquine|hydroxychloroquine|mesh-list
153472113|NCT04374942|Antimalarials|antimalarials|mesh-ancestor
153472114|NCT04374942|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153472115|NCT04374942|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153472117|NCT04374942|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153472118|NCT04374942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153472119|NCT04374942|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153472120|NCT04374318|Dexmedetomidine|dexmedetomidine|mesh-list
153472121|NCT04374318|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153472122|NCT04374318|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153472123|NCT04374318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153472124|NCT04374318|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153472125|NCT04374318|Analgesics|analgesics|mesh-ancestor
153472126|NCT04374318|Sensory System Agents|sensory system agents|mesh-ancestor
153472127|NCT04374318|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153472128|NCT04374318|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
153472129|NCT04374318|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153472130|NCT04374318|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153472131|NCT04374318|Adrenergic Agents|adrenergic agents|mesh-ancestor
153472132|NCT04374318|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153472133|NCT04374318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153472134|NCT04374552|Azithromycin|azithromycin|mesh-list
153472135|NCT04374552|Hydroxychloroquine|hydroxychloroquine|mesh-list
153472136|NCT04374552|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153472137|NCT04374552|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153472138|NCT04374552|Antimalarials|antimalarials|mesh-ancestor
153472139|NCT04374552|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153472140|NCT04374552|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153472141|NCT04374552|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153472142|NCT04374552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153472154|NCT04374006|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
153472155|NCT04374006|Hormone Antagonists|hormone antagonists|mesh-ancestor
153472156|NCT04374006|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153472157|NCT04374006|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153472164|NCT04372836|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
153472165|NCT04372836|Natriuretic Agents|natriuretic agents|mesh-ancestor
153472166|NCT04372836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153472167|NCT04371978|Linagliptin|linagliptin|mesh-list
153472168|NCT04371978|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153472169|NCT04371978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153472170|NCT04371978|Incretins|incretins|mesh-ancestor
153472172|NCT04371978|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153472173|NCT04371978|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
153472174|NCT04371978|Protease Inhibitors|protease inhibitors|mesh-ancestor
153472175|NCT04371978|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153472176|NCT04371978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153472177|NCT04371822|Protoporphyrin IX|protoporphyrin ix|mesh-list
153472178|NCT04371822|Tin protoporphyrin IX|tin protoporphyrin ix|mesh-list
153472179|NCT04371822|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
153472180|NCT04371822|Dermatologic Agents|dermatologic agents|mesh-ancestor
153472181|NCT04371822|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153472182|NCT04371822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153472185|NCT04370262|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153472186|NCT04370262|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
153472187|NCT04370262|Histamine Antagonists|histamine antagonists|mesh-ancestor
153472188|NCT04370262|Histamine Agents|histamine agents|mesh-ancestor
153472189|NCT04370262|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153472190|NCT04370262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153472191|NCT04370262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153472192|NCT04368546|Sunitinib|sunitinib|mesh-list
153472193|NCT04368546|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153472194|NCT04368546|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153472195|NCT04368546|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153472196|NCT04368546|Growth Substances|growth substances|mesh-ancestor
153472197|NCT04368546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153472198|NCT04368546|Growth Inhibitors|growth inhibitors|mesh-ancestor
153472199|NCT04368546|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153472200|NCT04368546|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153472201|NCT04368546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153472257|NCT04365426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153472258|NCT04365426|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
153472259|NCT04365036|Gemcitabine|gemcitabine|mesh-list
153472260|NCT04365036|Oxaliplatin|oxaliplatin|mesh-list
153472261|NCT04365036|Pegaspargase|pegaspargase|mesh-list
153472262|NCT04365036|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153472263|NCT04365036|Antimetabolites|antimetabolites|mesh-ancestor
153472264|NCT04365036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153472265|NCT04365036|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153472267|NCT04364022|Lopinavir|lopinavir|mesh-list
153472268|NCT04364022|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
153472269|NCT04364022|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
153472270|NCT04364022|Protease Inhibitors|protease inhibitors|mesh-ancestor
153472271|NCT04364022|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153472272|NCT04364022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153472273|NCT04364022|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153472274|NCT04364022|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153472275|NCT04364022|Antiviral Agents|antiviral agents|mesh-ancestor
153472276|NCT04364022|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153472277|NCT04364022|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
153472293|NCT04362384|Glucocorticoids|glucocorticoids|mesh-ancestor
153472294|NCT04362384|Hormones|hormones|mesh-ancestor
153472295|NCT04362384|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153472296|NCT04362384|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153472297|NCT04362384|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153472298|NCT04362384|Protective Agents|protective agents|mesh-ancestor
153472299|NCT04362384|Antioxidants|antioxidants|mesh-ancestor
153472300|NCT04362384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153472301|NCT04361370|Bevacizumab|bevacizumab|mesh-list
153472302|NCT04361370|Pembrolizumab|pembrolizumab|mesh-list
153472303|NCT04361370|Olaparib|olaparib|mesh-list
153472304|NCT04361370|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153472305|NCT04361370|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153472306|NCT04361370|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153472307|NCT04361370|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153472308|NCT04361370|Growth Substances|growth substances|mesh-ancestor
153472309|NCT04361370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153472310|NCT04361370|Growth Inhibitors|growth inhibitors|mesh-ancestor
153472311|NCT04361370|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153472312|NCT04361370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153472313|NCT04361370|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
153472314|NCT04361370|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153472315|NCT04359966|Amoxicillin|amoxicillin|mesh-list
153472316|NCT04359966|Metronidazole|metronidazole|mesh-list
153472317|NCT04359966|Clarithromycin|clarithromycin|mesh-list
153472318|NCT04359966|Levofloxacin|levofloxacin|mesh-list
153472319|NCT04359966|Bismuth tripotassium dicitrate|bismuth tripotassium dicitrate|mesh-list
153472320|NCT04359966|Esomeprazole|esomeprazole|mesh-list
153472321|NCT04359966|Bismuth|bismuth|mesh-list
153472322|NCT04359966|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153813788|NCT00437307|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153472331|NCT04359966|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
153472332|NCT04359966|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
153472333|NCT04359966|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153472334|NCT04359966|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
153472335|NCT04359966|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153472336|NCT04359966|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153472337|NCT04359966|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153472338|NCT04359966|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
153472339|NCT04359966|Antacids|antacids|mesh-ancestor
153472340|NCT04360122|Levamisole|levamisole|mesh-list
153472341|NCT04360122|Inosine Pranobex|inosine pranobex|mesh-list
153472342|NCT04360122|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153472343|NCT04360122|Immunologic Factors|immunologic factors|mesh-ancestor
153472344|NCT04360122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153472345|NCT04360122|Antinematodal Agents|antinematodal agents|mesh-ancestor
153472346|NCT04360122|Anthelmintics|anthelmintics|mesh-ancestor
153472347|NCT04360122|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153472348|NCT04360122|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153472350|NCT04360122|Antiviral Agents|antiviral agents|mesh-ancestor
153472351|NCT04360356|Ivermectin|ivermectin|mesh-list
153472352|NCT04360356|Nitazoxanide|nitazoxanide|mesh-list
153472359|NCT04358718|Anesthetics|anesthetics|mesh-list
153472386|NCT04357002|Dinoprostone|dinoprostone|mesh-list
153472387|NCT04357002|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
153472388|NCT04357002|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153472389|NCT04357002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153472390|NCT04357002|Hemostatics|hemostatics|mesh-ancestor
153472391|NCT04357002|Coagulants|coagulants|mesh-ancestor
153472392|NCT04357002|Oxytocics|oxytocics|mesh-ancestor
153472393|NCT04357002|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153472394|NCT04357002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153472395|NCT04356222|Methotrexate|methotrexate|mesh-list
153472396|NCT04356222|Durvalumab|durvalumab|mesh-list
153472397|NCT04356222|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
153472398|NCT04356222|Abortifacient Agents|abortifacient agents|mesh-ancestor
153472399|NCT04356222|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153472400|NCT04356222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153882650|NCT01649258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153882651|NCT01649258|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153882652|NCT01649258|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
153882653|NCT01649258|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153882654|NCT01649258|Serotonin Agents|serotonin agents|mesh-ancestor
153882655|NCT01649258|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153882656|NCT01649258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153882657|NCT01649258|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
153882658|NCT01649336|Paclitaxel|paclitaxel|mesh-list
153882659|NCT01649336|Antimitotic Agents|antimitotic agents|mesh-list
153882660|NCT01649336|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153882661|NCT01649336|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153882662|NCT01649336|Tubulin Modulators|tubulin modulators|mesh-ancestor
153882663|NCT01649336|Mitosis Modulators|mitosis modulators|mesh-ancestor
153882665|NCT01609491|Phenylephrine|phenylephrine|mesh-list
153472401|NCT04356222|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153472402|NCT04356222|Antimetabolites|antimetabolites|mesh-ancestor
153472403|NCT04356222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153472404|NCT04356222|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153472405|NCT04356222|Dermatologic Agents|dermatologic agents|mesh-ancestor
153472406|NCT04356222|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153472407|NCT04356222|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153472408|NCT04356222|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153472409|NCT04356222|Immunologic Factors|immunologic factors|mesh-ancestor
153472410|NCT04356222|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153813789|NCT00335231|Gatifloxacin|gatifloxacin|mesh-list
153472411|NCT04356222|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153472412|NCT04356222|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153425039|NCT03591458|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
153425040|NCT03591458|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153425041|NCT03591458|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153425042|NCT03591458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153425043|NCT03591458|Adrenergic Agents|adrenergic agents|mesh-ancestor
153425044|NCT03591458|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153425045|NCT03565328|Niacinamide|niacinamide|mesh-list
153425047|NCT03565328|Nicotinic Acids|nicotinic acids|mesh-list
153425048|NCT03565328|Vitamin B Complex|vitamin b complex|mesh-ancestor
153425049|NCT03565328|Vitamins|vitamins|mesh-ancestor
153425050|NCT03565328|Micronutrients|micronutrients|mesh-ancestor
153472418|NCT04355598|Prilocaine|prilocaine|mesh-list
153472419|NCT04355598|Lidocaine, Prilocaine Drug Combination|lidocaine, prilocaine drug combination|mesh-list
153472432|NCT04355598|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
153472433|NCT04355520|Fulvestrant|fulvestrant|mesh-list
153472434|NCT04355520|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153472435|NCT04355520|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153472436|NCT04355520|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
153472437|NCT04355520|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
153472438|NCT04355520|Hormone Antagonists|hormone antagonists|mesh-ancestor
153472439|NCT04355520|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153472440|NCT04355520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153472441|NCT04355052|Azithromycin|azithromycin|mesh-list
153472442|NCT04355052|Hydroxychloroquine|hydroxychloroquine|mesh-list
153472443|NCT04355052|Camostat|camostat|mesh-list
153472444|NCT04355052|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153472445|NCT04355052|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153472446|NCT04355052|Antimalarials|antimalarials|mesh-ancestor
153472447|NCT04355052|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153472448|NCT04355052|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153472449|NCT04355052|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153380344|NCT03112863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153380345|NCT03112863|Protective Agents|protective agents|mesh-ancestor
153380346|NCT03112863|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
153380347|NCT03112863|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153380348|NCT02950467|Psilocybin|psilocybin|mesh-list
153380349|NCT02950467|N,N-Dimethyltryptamine|n,n-dimethyltryptamine|mesh-list
153380350|NCT02950467|Hallucinogens|hallucinogens|mesh-ancestor
153380351|NCT02950467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153380352|NCT02950467|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153380353|NCT02950467|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153380354|NCT02950467|Serotonin Agents|serotonin agents|mesh-ancestor
153380355|NCT02950467|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153380356|NCT02950467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153380357|NCT02950467|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
153472450|NCT04355052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153472451|NCT04355052|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153472452|NCT04355052|Protease Inhibitors|protease inhibitors|mesh-ancestor
153472453|NCT04355052|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
153472454|NCT04355052|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
153472455|NCT04354662|Leucovorin|leucovorin|mesh-list
153472456|NCT04354662|Docetaxel|docetaxel|mesh-list
153472484|NCT04353336|Chloroquine|chloroquine|mesh-list
153472485|NCT04353336|Chloroquine diphosphate|chloroquine diphosphate|mesh-list
153472486|NCT04353336|Antimalarials|antimalarials|mesh-ancestor
153472487|NCT04353336|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153472488|NCT04353336|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153472489|NCT04353336|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153472490|NCT04353336|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153472491|NCT04353336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153472492|NCT04353336|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153360182|NCT01272245|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153360183|NCT00802100|Metformin|metformin|mesh-list
153360184|NCT00802100|Benztropine|benztropine|mesh-list
153884097|NCT01607918|Metronidazole|metronidazole|mesh-list
153884098|NCT01607918|Clarithromycin|clarithromycin|mesh-list
153884099|NCT01607918|Lansoprazole|lansoprazole|mesh-list
153884100|NCT01607918|Dexlansoprazole|dexlansoprazole|mesh-list
153884101|NCT01607918|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153884102|NCT01607918|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153884103|NCT01607918|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153884104|NCT01607918|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153884105|NCT01607918|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
153884106|NCT01607918|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153884107|NCT01607918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153884108|NCT01607918|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
153472503|NCT04353336|Anthelmintics|anthelmintics|mesh-ancestor
153472505|NCT04353180|Isotretinoin|isotretinoin|mesh-list
153472506|NCT04353180|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153472507|NCT04353180|Keratolytic Agents|keratolytic agents|mesh-ancestor
153472508|NCT04353180|Dermatologic Agents|dermatologic agents|mesh-ancestor
153472509|NCT04352946|Hydroxychloroquine|hydroxychloroquine|mesh-list
153472510|NCT04352946|Antimalarials|antimalarials|mesh-ancestor
153472517|NCT04351308|Apatinib|apatinib|mesh-list
153472548|NCT04350684|Hydroxychloroquine|hydroxychloroquine|mesh-list
153472549|NCT04350684|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153472550|NCT04350684|Antiviral Agents|antiviral agents|mesh-ancestor
153472551|NCT04350684|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153472552|NCT04350684|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
153472553|NCT04350684|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
153472554|NCT04350684|Protease Inhibitors|protease inhibitors|mesh-ancestor
153472555|NCT04350684|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153472556|NCT04350684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153472557|NCT04350684|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153472558|NCT04350684|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153472559|NCT04350684|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
153472583|NCT04349592|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153472584|NCT04349592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153472585|NCT04349592|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153472586|NCT04347252|Glucagon|glucagon|mesh-list
153472596|NCT04346862|Nootropic Agents|nootropic agents|mesh-ancestor
153472597|NCT04345848|Heparin|heparin|mesh-list
153472598|NCT04345848|Enoxaparin|enoxaparin|mesh-list
153472599|NCT04345848|Calcium heparin|calcium heparin|mesh-list
153813790|NCT00335231|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153813791|NCT00335231|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153472614|NCT04345458|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153472626|NCT04344756|Tinzaparin|tinzaparin|mesh-list
153472627|NCT04344756|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
153472628|NCT04344756|Dalteparin|dalteparin|mesh-list
153884109|NCT01607918|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153884110|NCT01607918|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
153884111|NCT01607918|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153884112|NCT01607918|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
153472631|NCT04344756|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153472632|NCT04344756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153472633|NCT04344288|Prednisone|prednisone|mesh-list
153472634|NCT04344288|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153472635|NCT04344288|Glucocorticoids|glucocorticoids|mesh-ancestor
153472636|NCT04344288|Hormones|hormones|mesh-ancestor
153472637|NCT04344288|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153472638|NCT04344288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153472639|NCT04344288|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153472640|NCT04344288|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153472641|NCT04343742|Chlorine dioxide|chlorine dioxide|mesh-list
153472642|NCT04343742|Dental Disinfectants|dental disinfectants|mesh-ancestor
153472643|NCT04343742|Disinfectants|disinfectants|mesh-ancestor
153472644|NCT04343742|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153472645|NCT04342728|Vitamins|vitamins|mesh-list
153472646|NCT04342728|Ascorbic Acid|ascorbic acid|mesh-list
153472648|NCT04342728|Micronutrients|micronutrients|mesh-ancestor
153472649|NCT04342728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153472650|NCT04342728|Trace Elements|trace elements|mesh-ancestor
153472651|NCT04342728|Antioxidants|antioxidants|mesh-ancestor
153472652|NCT04342728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153472653|NCT04342728|Protective Agents|protective agents|mesh-ancestor
153472654|NCT04342650|Chloroquine|chloroquine|mesh-list
153472655|NCT04342650|Chloroquine diphosphate|chloroquine diphosphate|mesh-list
153472656|NCT04342650|Amebicides|amebicides|mesh-ancestor
153472669|NCT04342650|Filaricides|filaricides|mesh-ancestor
153472674|NCT04341402|Miconazole|miconazole|mesh-list
153472675|NCT04341402|Diclofenac|diclofenac|mesh-list
153472676|NCT04341402|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153472677|NCT04341402|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153472678|NCT04341402|Analgesics|analgesics|mesh-ancestor
153472679|NCT04341402|Sensory System Agents|sensory system agents|mesh-ancestor
153472680|NCT04341402|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153472681|NCT04341402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153472682|NCT04341402|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153472693|NCT04341402|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153472694|NCT04341402|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
153472695|NCT04341402|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
153472696|NCT04340544|Hydroxychloroquine|hydroxychloroquine|mesh-list
153472697|NCT04340544|Antimalarials|antimalarials|mesh-ancestor
153472698|NCT04340544|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153472699|NCT04340544|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153884117|NCT01601561|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
153884118|NCT01601561|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153884119|NCT01601561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153882667|NCT01609491|Norepinephrine|norepinephrine|mesh-list
153882668|NCT01609491|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
153882669|NCT01609491|Mydriatics|mydriatics|mesh-ancestor
153882670|NCT01609491|Autonomic Agents|autonomic agents|mesh-ancestor
153882671|NCT01609491|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153423558|NCT03357614|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153423559|NCT03357614|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153423560|NCT03357614|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153423561|NCT03357614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153423562|NCT03357614|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153423563|NCT03357614|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
153423564|NCT03357614|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153423565|NCT03357614|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
153423566|NCT03357614|Uricosuric Agents|uricosuric agents|mesh-ancestor
153423567|NCT03357614|Gout Suppressants|gout suppressants|mesh-ancestor
153423568|NCT03357614|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153472702|NCT04340544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153472704|NCT04340778|Lidocaine|lidocaine|mesh-list
153472705|NCT04340778|Prilocaine|prilocaine|mesh-list
153472733|NCT04340388|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153472735|NCT04340388|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153472736|NCT04340388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153472737|NCT04340388|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153472738|NCT04340388|Antimetabolites|antimetabolites|mesh-ancestor
153472739|NCT04340388|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
153472740|NCT04340388|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
153472741|NCT04340388|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
153472742|NCT04340388|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
153472743|NCT04340388|Protease Inhibitors|protease inhibitors|mesh-ancestor
153472744|NCT04340388|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
153472745|NCT04340388|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153472746|NCT04338906|Hydroxychloroquine|hydroxychloroquine|mesh-list
153472747|NCT04338906|Camostat|camostat|mesh-list
153472748|NCT04338906|Antimalarials|antimalarials|mesh-ancestor
153472754|NCT04338906|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153472755|NCT04338906|Protease Inhibitors|protease inhibitors|mesh-ancestor
153472756|NCT04338906|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
153472757|NCT04338906|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
153472758|NCT04338438|Apatinib|apatinib|mesh-list
153472759|NCT04338438|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153472760|NCT04338438|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153472761|NCT04338438|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153472762|NCT04338438|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153472763|NCT04338126|Tranexamic Acid|tranexamic acid|mesh-list
153472764|NCT04338126|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
153472765|NCT04338126|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153472772|NCT04337658|Pertuzumab|pertuzumab|mesh-list
153472783|NCT04337658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153472784|NCT04337268|Glucagon|glucagon|mesh-list
153472785|NCT04337268|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
153472786|NCT04337268|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153472787|NCT04337268|Hormones|hormones|mesh-ancestor
153472788|NCT04337268|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153472789|NCT04337268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153472790|NCT04337268|Incretins|incretins|mesh-ancestor
153472791|NCT04336566|Melatonin|melatonin|mesh-list
153472792|NCT04336566|Antioxidants|antioxidants|mesh-ancestor
153472793|NCT04336566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153423569|NCT03275870|Hydroxychloroquine|hydroxychloroquine|mesh-list
153380392|NCT01915823|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153380393|NCT01915823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153380394|NCT01915823|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153380395|NCT01915823|Respiratory System Agents|respiratory system agents|mesh-ancestor
153783554|NCT00236483|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153380396|NCT01915823|Dermatologic Agents|dermatologic agents|mesh-ancestor
153380397|NCT01915823|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
153472794|NCT04336566|Protective Agents|protective agents|mesh-ancestor
153472795|NCT04336566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153472796|NCT04336566|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153472797|NCT04336488|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
153472798|NCT04336488|Matrix Metalloproteinase Inhibitors|matrix metalloproteinase inhibitors|mesh-list
153472799|NCT04336488|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153472800|NCT04336488|Glucocorticoids|glucocorticoids|mesh-ancestor
153472801|NCT04336488|Hormones|hormones|mesh-ancestor
153472850|NCT04333992|Anesthetics|anesthetics|mesh-ancestor
153472851|NCT04333992|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153472852|NCT04333992|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
153472853|NCT04333992|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153472854|NCT04333992|Narcotics|narcotics|mesh-ancestor
153472855|NCT04333992|Analgesics|analgesics|mesh-ancestor
153472856|NCT04333992|Sensory System Agents|sensory system agents|mesh-ancestor
153472857|NCT04333992|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153472859|NCT04332978|Xhance|xhance|mesh-list
153472860|NCT04332978|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153472861|NCT04332978|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153472862|NCT04332978|Autonomic Agents|autonomic agents|mesh-ancestor
153472863|NCT04332978|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153472864|NCT04332978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153813794|NCT00335231|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153472865|NCT04332978|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153472866|NCT04332978|Respiratory System Agents|respiratory system agents|mesh-ancestor
153472867|NCT04332978|Dermatologic Agents|dermatologic agents|mesh-ancestor
153472868|NCT04332978|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
153472869|NCT04332666|Angiotensin I (1-7)|angiotensin i (1-7)|mesh-list
153472870|NCT04332666|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153472871|NCT04332666|Vasodilator Agents|vasodilator agents|mesh-ancestor
153472872|NCT04332276|Dopamine|dopamine|mesh-list
153472913|NCT04330326|Sorbitol|sorbitol|mesh-list
153472923|NCT04329858|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153472924|NCT04329858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153472925|NCT04329858|Adrenergic Agents|adrenergic agents|mesh-ancestor
153472926|NCT04329858|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
153472927|NCT04329858|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153472928|NCT04329858|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153472929|NCT04329858|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
153472930|NCT00704106|Entecavir|entecavir|mesh-list
153472931|NCT00704106|Antiviral Agents|antiviral agents|mesh-ancestor
153472932|NCT00704106|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153472933|NCT05614752|Fexuprazan|fexuprazan|mesh-list
153472934|NCT05614752|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153472935|NCT05278884|Anesthetics|anesthetics|mesh-list
153472936|NCT05278884|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153472951|NCT03063450|Nivolumab|nivolumab|mesh-list
153472952|NCT03063450|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153472953|NCT03063450|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153472954|NCT03063450|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153472955|NCT03063450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153472956|NCT01326000|Cetuximab|cetuximab|mesh-list
153425082|NCT01200602|Appetite Stimulants|appetite stimulants|mesh-ancestor
153425083|NCT01200602|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
153425084|NCT01194908|Tamoxifen|tamoxifen|mesh-list
153425085|NCT01194908|Decitabine|decitabine|mesh-list
153425086|NCT01194908|Panobinostat|panobinostat|mesh-list
153425087|NCT01194908|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153425088|NCT01194908|Antimetabolites|antimetabolites|mesh-ancestor
153425089|NCT01194908|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153472957|NCT01326000|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153472958|NCT01326000|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153472987|NCT03033732|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153472988|NCT03033732|Narcotics|narcotics|mesh-ancestor
153472989|NCT03033732|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153472990|NCT03033732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153472991|NCT03033732|Analgesics|analgesics|mesh-ancestor
153472992|NCT03033732|Sensory System Agents|sensory system agents|mesh-ancestor
153472993|NCT03033732|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153472994|NCT03033732|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
153472995|NCT03033732|Antitussive Agents|antitussive agents|mesh-ancestor
153472996|NCT03033732|Respiratory System Agents|respiratory system agents|mesh-ancestor
153472997|NCT03033264|Dinoprostone|dinoprostone|mesh-list
153472998|NCT03033264|Oxytocics|oxytocics|mesh-ancestor
153473004|NCT03030768|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153473005|NCT03030768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153473008|NCT03030768|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153473053|NCT03019848|Sensory System Agents|sensory system agents|mesh-ancestor
153473054|NCT03019848|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153813795|NCT00335231|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153473055|NCT03019848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153473056|NCT03019848|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153473057|NCT03019848|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153473058|NCT03019848|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153473059|NCT03019848|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153473060|NCT03019848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153473061|NCT03019614|Hydrocortisone|hydrocortisone|mesh-list
153473062|NCT03019614|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153473063|NCT03019224|Hydrogen Peroxide|hydrogen peroxide|mesh-list
153473064|NCT03019224|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
153473119|NCT03017430|Autonomic Agents|autonomic agents|mesh-ancestor
153473120|NCT03017430|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
153884140|NCT01601912|Antidepressive Agents|antidepressive agents|mesh-ancestor
153884141|NCT01601912|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153884145|NCT01601912|Autonomic Agents|autonomic agents|mesh-ancestor
153473121|NCT03017430|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153473122|NCT03017430|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153473123|NCT03017430|Adrenergic Agents|adrenergic agents|mesh-ancestor
153473124|NCT03017430|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153473125|NCT03017430|Antiemetics|antiemetics|mesh-ancestor
153473126|NCT03017430|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153473127|NCT03017430|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
153473128|NCT03017430|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
153473129|NCT03017430|Dopamine Agents|dopamine agents|mesh-ancestor
153473130|NCT03017430|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153473131|NCT03017430|Immunologic Factors|immunologic factors|mesh-ancestor
153473143|NCT03016884|Immunologic Factors|immunologic factors|mesh-ancestor
153473144|NCT03016884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153473145|NCT03016806|Cyclophosphamide|cyclophosphamide|mesh-list
153473148|NCT03016806|Fludarabine|fludarabine|mesh-list
153473149|NCT03016806|Mesna|mesna|mesh-list
153473150|NCT03016806|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153473151|NCT03016806|Immunologic Factors|immunologic factors|mesh-ancestor
153473152|NCT03016806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153813796|NCT00335231|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153473175|NCT03016260|Infliximab|infliximab|mesh-list
153473176|NCT03016260|Golimumab|golimumab|mesh-list
153473177|NCT03016260|Certolizumab Pegol|certolizumab pegol|mesh-list
153473178|NCT03016260|Etanercept|etanercept|mesh-list
153473179|NCT03016260|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
153473180|NCT03016260|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153473181|NCT03016260|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153473182|NCT03016260|Dermatologic Agents|dermatologic agents|mesh-ancestor
153473183|NCT03016260|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153473184|NCT03016260|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153473185|NCT03016260|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153473186|NCT03016260|Analgesics|analgesics|mesh-ancestor
153473187|NCT03016260|Sensory System Agents|sensory system agents|mesh-ancestor
153473188|NCT03016260|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153473189|NCT03016260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153473190|NCT03016260|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153473191|NCT03016260|Immunologic Factors|immunologic factors|mesh-ancestor
153473192|NCT03015246|Morphine|morphine|mesh-list
153380433|NCT01934231|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153380434|NCT01934231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153380435|NCT01935791|Glucagon|glucagon|mesh-list
153380436|NCT01935791|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
153380437|NCT01935791|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153380438|NCT01935791|Hormones|hormones|mesh-ancestor
153380439|NCT01935791|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153380440|NCT01935791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153380470|NCT03119181|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153380471|NCT03119181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153473193|NCT03015246|Buprenorphine|buprenorphine|mesh-list
153473194|NCT03015246|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
153473195|NCT03015246|Naloxone|naloxone|mesh-list
153473196|NCT03015246|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153473197|NCT03015246|Narcotics|narcotics|mesh-ancestor
153473236|NCT03010098|Anesthetics|anesthetics|mesh-ancestor
153473237|NCT03010098|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153473238|NCT03010098|Narcotics|narcotics|mesh-ancestor
153473239|NCT03010098|Analgesics|analgesics|mesh-ancestor
153473240|NCT03010098|Sensory System Agents|sensory system agents|mesh-ancestor
153473241|NCT03010098|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153473242|NCT03009474|Amlodipine, Valsartan Drug Combination|amlodipine, valsartan drug combination|mesh-list
153473243|NCT03009474|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
153473244|NCT03009474|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153473245|NCT03009474|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153884167|NCT01111825|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153884168|NCT01175590|Besifloxacin|besifloxacin|mesh-list
153884169|NCT01175590|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153884170|NCT01175590|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153473248|NCT03009474|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153473249|NCT03009474|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
153473250|NCT03009474|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153473251|NCT03009474|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153473252|NCT03009006|Calcium, Dietary|calcium, dietary|mesh-list
153473253|NCT03009006|Chlorhexidine|chlorhexidine|mesh-list
153473254|NCT03009006|Calcium|calcium|mesh-list
153473255|NCT03009006|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153473306|NCT03005496|BB 1101|bb 1101|mesh-list
153473307|NCT03005496|Carotenoids|carotenoids|mesh-list
153473308|NCT03005496|Picolinic acid|picolinic acid|mesh-list
153473309|NCT03005496|Vitamins|vitamins|mesh-ancestor
153473310|NCT03005496|Micronutrients|micronutrients|mesh-ancestor
153473311|NCT03005496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153473312|NCT03005496|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153473313|NCT03005496|Antiemetics|antiemetics|mesh-ancestor
153473314|NCT03005496|Autonomic Agents|autonomic agents|mesh-ancestor
153473315|NCT03005496|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153473316|NCT03005496|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153473317|NCT03005496|Glucocorticoids|glucocorticoids|mesh-ancestor
153473318|NCT03005496|Hormones|hormones|mesh-ancestor
153473319|NCT03005496|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153473320|NCT03005496|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153473321|NCT03005496|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153473322|NCT03005496|Protease Inhibitors|protease inhibitors|mesh-ancestor
153473323|NCT03005496|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153813797|NCT00335231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153360190|NCT00802100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153473324|NCT03005496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153473325|NCT03005496|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153473326|NCT03005496|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153473327|NCT03005496|Trace Elements|trace elements|mesh-ancestor
153473350|NCT03005340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153473352|NCT03005340|Micronutrients|micronutrients|mesh-ancestor
153473353|NCT03005340|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153473372|NCT03005184|Sensory System Agents|sensory system agents|mesh-ancestor
153473373|NCT03005184|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153473374|NCT03005184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153473375|NCT03005184|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153473376|NCT03005184|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153473377|NCT03005184|Bradykinin B2 Receptor Antagonists|bradykinin b2 receptor antagonists|mesh-ancestor
153473378|NCT03005184|Bradykinin Receptor Antagonists|bradykinin receptor antagonists|mesh-ancestor
153884172|NCT01175590|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153884173|NCT01175590|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153884174|NCT01175590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153884175|NCT01175590|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153884176|NCT01175473|Metformin|metformin|mesh-list
153884177|NCT01175473|Liraglutide|liraglutide|mesh-list
153473389|NCT03002844|Carboplatin|carboplatin|mesh-list
153473390|NCT03002844|Gemcitabine|gemcitabine|mesh-list
153473392|NCT03002844|Gefitinib|gefitinib|mesh-list
153473393|NCT03002844|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-list
153473394|NCT03002844|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153473395|NCT03002844|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153473396|NCT03002844|Antimetabolites|antimetabolites|mesh-ancestor
153473397|NCT03002844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153473398|NCT03002844|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153473399|NCT03002844|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153473400|NCT03002844|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153473401|NCT03002844|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153473402|NCT03002376|Cemiplimab|cemiplimab|mesh-list
153473403|NCT03002376|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153473404|NCT03002376|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153473405|NCT03002064|Docetaxel|docetaxel|mesh-list
153473406|NCT03002064|Fluorouracil|fluorouracil|mesh-list
153473407|NCT03002064|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153473408|NCT03002064|Tubulin Modulators|tubulin modulators|mesh-ancestor
153473410|NCT03002064|Mitosis Modulators|mitosis modulators|mesh-ancestor
153813798|NCT00335231|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153360191|NCT00802100|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153473428|NCT03000660|Glucocorticoids|glucocorticoids|mesh-ancestor
153473430|NCT03000660|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153473431|NCT03000660|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153473432|NCT03000660|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153473433|NCT03000036|Doxorubicin|doxorubicin|mesh-list
153473434|NCT03000036|Gadolinium 1,4,7,10-tetraazacyclododecane-N,N',N'',N'''-tetraacetate|gadolinium 1,4,7,10-tetraazacyclododecane-n,n',n'',n'''-tetraacetate|mesh-list
153473533|NCT02981784|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153473534|NCT02981784|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153473535|NCT02981784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153473536|NCT02981784|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153473538|NCT02980926|Mepivacaine|mepivacaine|mesh-list
153473539|NCT02980926|Anesthetics, Local|anesthetics, local|mesh-ancestor
153473540|NCT02980926|Anesthetics|anesthetics|mesh-ancestor
153473541|NCT02980926|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153473542|NCT02980926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153884178|NCT01175473|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153884179|NCT01175473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153884180|NCT01175473|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
153884181|NCT01175473|Incretins|incretins|mesh-ancestor
153884182|NCT01175473|Hormones|hormones|mesh-ancestor
153884183|NCT01175473|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153884184|NCT01111552|Aripiprazole|aripiprazole|mesh-list
153884185|NCT01111552|Escitalopram|escitalopram|mesh-list
153884186|NCT01111552|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
153473544|NCT02980926|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153473545|NCT02980458|Deferiprone|deferiprone|mesh-list
153473546|NCT02980458|Iron Chelating Agents|iron chelating agents|mesh-ancestor
153473547|NCT02980458|Chelating Agents|chelating agents|mesh-ancestor
153473548|NCT02980458|Sequestering Agents|sequestering agents|mesh-ancestor
153473557|NCT02978976|Respiratory System Agents|respiratory system agents|mesh-ancestor
153473558|NCT02979132|Iron|iron|mesh-list
153473559|NCT02979132|Trace Elements|trace elements|mesh-ancestor
153473560|NCT02979132|Micronutrients|micronutrients|mesh-ancestor
153473561|NCT02979132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153473562|NCT02978040|Tirofiban|tirofiban|mesh-list
153473563|NCT02978040|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
153473564|NCT02978040|Cangrelor|cangrelor|mesh-list
153473565|NCT02978040|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153473566|NCT02978040|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153473567|NCT02978040|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153473569|NCT02978040|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
153473586|NCT02976012|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153473587|NCT02976012|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153473588|NCT02976012|Growth Substances|growth substances|mesh-ancestor
153473589|NCT02976012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153473590|NCT02976012|Growth Inhibitors|growth inhibitors|mesh-ancestor
153473591|NCT02976012|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153473592|NCT02975076|Aspirin|aspirin|mesh-list
153473593|NCT02975076|Clopidogrel|clopidogrel|mesh-list
153473594|NCT02975076|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153473595|NCT02975076|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153473596|NCT02975076|Analgesics|analgesics|mesh-ancestor
153473597|NCT02975076|Sensory System Agents|sensory system agents|mesh-ancestor
153473598|NCT02975076|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153473697|NCT02641314|Propranolol|propranolol|mesh-list
153473698|NCT02641314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153473699|NCT02641314|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153473700|NCT02641314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153473701|NCT02641314|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153473702|NCT02641314|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153473703|NCT02641314|Analgesics|analgesics|mesh-ancestor
153473704|NCT02641314|Sensory System Agents|sensory system agents|mesh-ancestor
153473705|NCT02641314|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153473706|NCT02641314|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153473707|NCT02641314|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
153473708|NCT02641314|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153473709|NCT02641314|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153473710|NCT02641314|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
153473712|NCT02641314|Adrenergic Agents|adrenergic agents|mesh-ancestor
153473713|NCT02641314|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153473717|NCT04769778|Valsartan|valsartan|mesh-list
153473761|NCT04745286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153473762|NCT04745286|Antidepressive Agents|antidepressive agents|mesh-ancestor
153473763|NCT04745286|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153473764|NCT04745442|Antithrombins|antithrombins|mesh-list
153473765|NCT04745442|Antithrombin III|antithrombin iii|mesh-list
153473766|NCT04745442|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
153473767|NCT04745442|Protease Inhibitors|protease inhibitors|mesh-ancestor
153473768|NCT04745442|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153473769|NCT04745442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153473770|NCT04745442|Anticoagulants|anticoagulants|mesh-ancestor
153473772|NCT04743180|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153473773|NCT04743180|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153473774|NCT04743180|Tubulin Modulators|tubulin modulators|mesh-ancestor
153473775|NCT04743180|Antimitotic Agents|antimitotic agents|mesh-ancestor
153473776|NCT04743180|Mitosis Modulators|mitosis modulators|mesh-ancestor
153473777|NCT04743180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153473778|NCT04740840|Amlodipine|amlodipine|mesh-list
153473779|NCT04740840|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153473780|NCT04740840|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153473798|NCT04739202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153473799|NCT04739202|Immunologic Factors|immunologic factors|mesh-ancestor
153473800|NCT04739202|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153473801|NCT04739202|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153473802|NCT04738188|Epirubicin|epirubicin|mesh-list
153473803|NCT04738188|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153473804|NCT04738188|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153473805|NCT04738188|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153473806|NCT04738188|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153473807|NCT04738188|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153473808|NCT04738188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153473809|NCT04737408|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
153473810|NCT04737408|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153473811|NCT04737408|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153473814|NCT04737408|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153473815|NCT04737408|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
153473816|NCT04737408|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153473818|NCT05314140|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153473819|NCT05314140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153473820|NCT05313906|Cisplatin|cisplatin|mesh-list
153473821|NCT05313906|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153473822|NCT05313828|Fluorometholone|fluorometholone|mesh-list
153473823|NCT05313828|Tobramycin|tobramycin|mesh-list
153473824|NCT05313828|Acyclovir|acyclovir|mesh-list
153473825|NCT05313828|Hyaluronic Acid|hyaluronic acid|mesh-list
153473826|NCT05313828|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153473827|NCT05313828|Immunologic Factors|immunologic factors|mesh-ancestor
153473828|NCT05313828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153473829|NCT05313828|Viscosupplements|viscosupplements|mesh-ancestor
153473830|NCT05313828|Protective Agents|protective agents|mesh-ancestor
153473831|NCT05313828|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153473832|NCT05313828|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153473920|NCT00582894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153884187|NCT01111552|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153884188|NCT01111552|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153884189|NCT01111552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153884190|NCT01111552|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153473921|NCT00582894|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153473922|NCT00582894|Immunologic Factors|immunologic factors|mesh-ancestor
153473923|NCT00582894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153473924|NCT00582894|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153473925|NCT00582894|Alkylating Agents|alkylating agents|mesh-ancestor
153473926|NCT00582894|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153473927|NCT00582894|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153473929|NCT00585780|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153473930|NCT00585780|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
153473931|NCT00585780|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
153473932|NCT00585780|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
153473933|NCT00585780|Adrenergic Agents|adrenergic agents|mesh-ancestor
153473984|NCT01327638|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153473985|NCT01327638|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153473986|NCT01327638|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153473987|NCT01327638|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153473988|NCT01327638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153473989|NCT00393354|Etoricoxib|etoricoxib|mesh-list
153473990|NCT00393354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153473991|NCT00393354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153473992|NCT00393354|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153473993|NCT00393354|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153473994|NCT00393354|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153473995|NCT00393354|Analgesics|analgesics|mesh-ancestor
153473996|NCT00393354|Sensory System Agents|sensory system agents|mesh-ancestor
153473997|NCT00393354|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153473998|NCT00393354|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153474010|NCT00166530|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
153474011|NCT00166530|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153474013|NCT00588900|Cediranib|cediranib|mesh-list
153474014|NCT00588900|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
153474015|NCT00588900|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153474016|NCT00588900|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153884203|NCT01111552|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153425145|NCT01139996|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153425146|NCT01139996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153425147|NCT01139996|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153425148|NCT01139996|Sympatholytics|sympatholytics|mesh-ancestor
153425149|NCT01139996|Autonomic Agents|autonomic agents|mesh-ancestor
153425150|NCT01139996|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
153425151|NCT01139996|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153425152|NCT01139996|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153425153|NCT01139996|Adrenergic Agents|adrenergic agents|mesh-ancestor
153425154|NCT01139996|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153425156|NCT02417870|Aldesleukin|aldesleukin|mesh-list
153474017|NCT00588900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153474018|NCT00588900|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153474019|NCT00588900|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153474020|NCT00589056|Nelfinavir|nelfinavir|mesh-list
153474021|NCT00589056|Etoposide|etoposide|mesh-list
153474022|NCT00589056|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153474023|NCT00589056|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153474024|NCT00589056|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153474025|NCT00589056|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153474030|NCT00589056|Protease Inhibitors|protease inhibitors|mesh-ancestor
153474031|NCT00589056|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153474032|NCT00589056|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153474033|NCT00589056|Antiviral Agents|antiviral agents|mesh-ancestor
153474034|NCT00589056|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153474035|NCT00590226|Insulin|insulin|mesh-list
153474036|NCT00590226|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
153474037|NCT00590226|Insulin Aspart|insulin aspart|mesh-list
153474038|NCT00590226|Insulin, Isophane|insulin, isophane|mesh-list
153474039|NCT00590226|Isophane Insulin, Human|isophane insulin, human|mesh-list
153474040|NCT00590226|Isophane insulin, beef|isophane insulin, beef|mesh-list
153474041|NCT00590226|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153474110|NCT00598806|Apaziquone|apaziquone|mesh-list
153474111|NCT00598806|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153474112|NCT00601926|Bevacizumab|bevacizumab|mesh-list
153474113|NCT00601926|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153474114|NCT00601926|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153884204|NCT01111552|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
153474115|NCT00601926|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153474116|NCT00601926|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153474117|NCT00601926|Growth Substances|growth substances|mesh-ancestor
153474118|NCT00601926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153474119|NCT00601926|Growth Inhibitors|growth inhibitors|mesh-ancestor
153474121|NCT00603018|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
153474122|NCT00603018|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153474123|NCT00603018|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153474124|NCT00603018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153474154|NCT00603720|Protective Agents|protective agents|mesh-ancestor
153474155|NCT00603720|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153474156|NCT00625404|Tenofovir|tenofovir|mesh-list
153474157|NCT00625404|Emtricitabine|emtricitabine|mesh-list
153474158|NCT00625404|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
153474159|NCT00625404|Antiviral Agents|antiviral agents|mesh-ancestor
153474160|NCT00625404|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153474161|NCT00625404|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153474162|NCT00625404|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153474163|NCT00625404|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153474164|NCT00625404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153474165|NCT00625404|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153474166|NCT00625404|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153474167|NCT00626340|Fluoxetine|fluoxetine|mesh-list
153474168|NCT00626340|Estrogens|estrogens|mesh-list
153474169|NCT00626340|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
153474170|NCT00626340|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153474222|NCT00635232|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
153474223|NCT00635232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153474224|NCT00637494|Mifepristone|mifepristone|mesh-list
153474225|NCT00637494|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
153474226|NCT00637494|Abortifacient Agents|abortifacient agents|mesh-ancestor
153474227|NCT00637494|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153380476|NCT03119181|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
153380477|NCT03119181|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153380478|NCT03119181|Autonomic Agents|autonomic agents|mesh-ancestor
153474228|NCT00637494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153474229|NCT00637494|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
153474230|NCT00637494|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
153474231|NCT00637494|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
153474232|NCT00637494|Contraceptive Agents|contraceptive agents|mesh-ancestor
153474233|NCT00637494|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
153474234|NCT00637494|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
153474235|NCT00637494|Hormone Antagonists|hormone antagonists|mesh-ancestor
153474236|NCT00637494|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153474237|NCT00637494|Luteolytic Agents|luteolytic agents|mesh-ancestor
153474291|NCT00647400|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153474292|NCT00647400|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153474293|NCT00652314|Thrombin|thrombin|mesh-list
153474294|NCT00652314|Hemostatics|hemostatics|mesh-ancestor
153474295|NCT00652314|Coagulants|coagulants|mesh-ancestor
153474296|NCT00654030|Vaccines|vaccines|mesh-list
153474297|NCT00654030|Immunologic Factors|immunologic factors|mesh-ancestor
153474298|NCT00654030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153474299|NCT00656448|Epoetin Alfa|epoetin alfa|mesh-list
153474300|NCT00656448|Hematinics|hematinics|mesh-ancestor
153474301|NCT00660504|Etoposide|etoposide|mesh-list
153474302|NCT00660504|Amrubicin|amrubicin|mesh-list
153474303|NCT00660504|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153474304|NCT00660504|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153474305|NCT00660504|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153474306|NCT00660504|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153474307|NCT00660504|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153474358|NCT00666978|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153474359|NCT00666978|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153474360|NCT00666978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153474361|NCT00666978|Dopamine Agents|dopamine agents|mesh-ancestor
153474362|NCT00666978|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153474363|NCT00666978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153474364|NCT00666978|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
153474365|NCT00666978|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153474366|NCT00666978|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153474367|NCT00670956|Betamethasone|betamethasone|mesh-list
153474368|NCT00670956|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153474369|NCT00670956|Glucocorticoids|glucocorticoids|mesh-ancestor
153474370|NCT00670956|Hormones|hormones|mesh-ancestor
153474371|NCT00670956|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153474372|NCT00670956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153474373|NCT00670956|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153474374|NCT00670956|Respiratory System Agents|respiratory system agents|mesh-ancestor
153474375|NCT00671502|Carisoprodol|carisoprodol|mesh-list
153474418|NCT00672594|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153474419|NCT00672594|Growth Substances|growth substances|mesh-ancestor
153474420|NCT00672594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153425178|NCT02389712|Serotonin Agents|serotonin agents|mesh-ancestor
153425179|NCT02389712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153425180|NCT02389712|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
153425181|NCT02389712|Antidepressive Agents|antidepressive agents|mesh-ancestor
153425182|NCT02389712|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153425183|NCT02389712|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
153425184|NCT02389712|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153425185|NCT02389712|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153884218|NCT01602185|Respiratory System Agents|respiratory system agents|mesh-ancestor
153884219|NCT01602185|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153884220|NCT01602185|Narcotics|narcotics|mesh-ancestor
153884221|NCT01602185|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153884222|NCT01602185|Analgesics|analgesics|mesh-ancestor
153380479|NCT03119181|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153380480|NCT03119181|Respiratory System Agents|respiratory system agents|mesh-ancestor
153380481|NCT03119181|Mydriatics|mydriatics|mesh-ancestor
153380482|NCT03119181|Sympathomimetics|sympathomimetics|mesh-ancestor
153380483|NCT03119181|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
153380484|NCT01691534|Pyrazinamide|pyrazinamide|mesh-list
153380485|NCT01691534|Clofazimine|clofazimine|mesh-list
153380486|NCT01691534|Antitubercular Agents|antitubercular agents|mesh-ancestor
153380487|NCT01691534|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153380515|NCT01691690|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153380516|NCT01691690|Narcotics|narcotics|mesh-ancestor
153882672|NCT01609491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153882674|NCT01609491|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
153884223|NCT01602185|Sensory System Agents|sensory system agents|mesh-ancestor
153884224|NCT01602185|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153884225|NCT01602302|Adalimumab|adalimumab|mesh-list
153813805|NCT00335270|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153474421|NCT00672594|Growth Inhibitors|growth inhibitors|mesh-ancestor
153474422|NCT00672594|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153474423|NCT00672594|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153474424|NCT00672594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153474425|NCT00673764|Ophthalmic Solutions|ophthalmic solutions|mesh-list
153474426|NCT00673764|Lubricant Eye Drops|lubricant eye drops|mesh-list
153474427|NCT00673764|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
153474428|NCT00675792|Bromides|bromides|mesh-list
153474429|NCT00675792|Rocuronium|rocuronium|mesh-list
153474430|NCT00675792|Neostigmine|neostigmine|mesh-list
153474431|NCT00675792|Anticonvulsants|anticonvulsants|mesh-ancestor
153474432|NCT00675792|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
153474433|NCT00675792|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
153474518|NCT00687102|Raloxifene Hydrochloride|raloxifene hydrochloride|mesh-list
153474520|NCT00687102|Hormone Antagonists|hormone antagonists|mesh-ancestor
153474521|NCT00687102|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153474522|NCT00687102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153474523|NCT00687102|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153474524|NCT00687102|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153474525|NCT00687102|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
153474526|NCT00687102|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
153474527|NCT00687102|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153474528|NCT00690924|Calcitriol|calcitriol|mesh-list
153474529|NCT00690924|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153474530|NCT00690924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153474531|NCT00690924|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
153474532|NCT00690924|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153474533|NCT00690924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153474535|NCT00690924|Vitamins|vitamins|mesh-ancestor
153474587|NCT00704028|Anticoagulants|anticoagulants|mesh-ancestor
153474588|NCT00704028|Plasma Substitutes|plasma substitutes|mesh-ancestor
153474589|NCT00704028|Blood Substitutes|blood substitutes|mesh-ancestor
153474590|NCT00704028|Hematinics|hematinics|mesh-ancestor
153474591|NCT00704262|Hydrocortisone|hydrocortisone|mesh-list
153474592|NCT00704262|Calcipotriene|calcipotriene|mesh-list
153474593|NCT00704262|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153474594|NCT00704262|Dermatologic Agents|dermatologic agents|mesh-ancestor
153474595|NCT00706446|Fluticasone|fluticasone|mesh-list
153474597|NCT00706446|Budesonide|budesonide|mesh-list
153474598|NCT00706446|Bromides|bromides|mesh-list
153474599|NCT00706446|Formoterol Fumarate|formoterol fumarate|mesh-list
153882675|NCT01609491|Nasal Decongestants|nasal decongestants|mesh-ancestor
153882676|NCT01609491|Respiratory System Agents|respiratory system agents|mesh-ancestor
153882677|NCT01609491|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
153882678|NCT01609491|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153882679|NCT01609491|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153882680|NCT01609491|Adrenergic Agents|adrenergic agents|mesh-ancestor
153882681|NCT01609491|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153882682|NCT01609491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153882683|NCT01609491|Protective Agents|protective agents|mesh-ancestor
153882684|NCT01684865|Rituximab|rituximab|mesh-list
153423570|NCT03275870|Antimalarials|antimalarials|mesh-ancestor
153423571|NCT03275870|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153474600|NCT00706446|Tiotropium Bromide|tiotropium bromide|mesh-list
153884226|NCT01602302|Infliximab|infliximab|mesh-list
153474601|NCT00706446|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
153474602|NCT00706446|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153474603|NCT00706446|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153474604|NCT00706446|Autonomic Agents|autonomic agents|mesh-ancestor
153474605|NCT00706446|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153474606|NCT00706446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153474607|NCT00706446|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153474608|NCT00706446|Respiratory System Agents|respiratory system agents|mesh-ancestor
153474609|NCT00706446|Dermatologic Agents|dermatologic agents|mesh-ancestor
153474610|NCT00706446|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
153474611|NCT00706446|Glucocorticoids|glucocorticoids|mesh-ancestor
153474612|NCT00706446|Hormones|hormones|mesh-ancestor
153474613|NCT00706446|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153474630|NCT00706836|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153474631|NCT00706836|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153474632|NCT00706836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153474633|NCT00706836|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153474634|NCT00706836|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153474635|NCT00706836|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153474636|NCT00706836|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153474637|NCT00706836|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153474646|NCT00711828|Immunologic Factors|immunologic factors|mesh-ancestor
153474647|NCT00711828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153474648|NCT00711828|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153474649|NCT00711828|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153474650|NCT00711828|Alkylating Agents|alkylating agents|mesh-ancestor
153474651|NCT00711828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153474652|NCT00711828|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153474653|NCT00711828|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153474654|NCT00711828|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153474655|NCT00711828|Antiemetics|antiemetics|mesh-ancestor
153474656|NCT00711828|Autonomic Agents|autonomic agents|mesh-ancestor
153474657|NCT00711828|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153474658|NCT00711828|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153474659|NCT00711828|Glucocorticoids|glucocorticoids|mesh-ancestor
153474660|NCT00711828|Hormones|hormones|mesh-ancestor
153474661|NCT00711828|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153474662|NCT00711828|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153474664|NCT00712530|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
153474665|NCT00712530|Antiviral Agents|antiviral agents|mesh-ancestor
153474666|NCT00712530|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153474667|NCT00715884|Sirolimus|sirolimus|mesh-list
153474668|NCT00715884|Temsirolimus|temsirolimus|mesh-list
153474777|NCT00726414|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153474778|NCT00726414|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153474779|NCT00726414|Analgesics|analgesics|mesh-ancestor
153474780|NCT00726414|Sensory System Agents|sensory system agents|mesh-ancestor
153474781|NCT00727740|Indomethacin|indomethacin|mesh-list
153423572|NCT03275870|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153423573|NCT03275870|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153423574|NCT03275870|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153423575|NCT03275870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153423576|NCT03275870|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153423577|NCT02216214|Mirabegron|mirabegron|mesh-list
153423578|NCT02216214|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
153423579|NCT02216214|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
153423580|NCT02216214|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153474782|NCT00727740|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153474783|NCT00727740|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153474784|NCT00727740|Analgesics|analgesics|mesh-ancestor
153425201|NCT02369744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153474785|NCT00727740|Sensory System Agents|sensory system agents|mesh-ancestor
153474786|NCT00727740|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153474787|NCT00727740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153474788|NCT00727740|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153474789|NCT00727740|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153474790|NCT00727740|Gout Suppressants|gout suppressants|mesh-ancestor
153474791|NCT00727740|Tocolytic Agents|tocolytic agents|mesh-ancestor
153474792|NCT00727740|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153474793|NCT00727740|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153474794|NCT00727740|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153474795|NCT00727740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153474796|NCT00728910|Niacin|niacin|mesh-list
153474797|NCT00728910|Atorvastatin|atorvastatin|mesh-list
153474798|NCT00728910|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153474799|NCT00728910|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153474800|NCT00728910|Antimetabolites|antimetabolites|mesh-ancestor
153813807|NCT00335270|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
153474801|NCT00728910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153474802|NCT00728910|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153474803|NCT00728910|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
153474804|NCT00728910|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153474805|NCT00728910|Vasodilator Agents|vasodilator agents|mesh-ancestor
153474806|NCT00728910|Vitamin B Complex|vitamin b complex|mesh-ancestor
153474816|NCT00729846|Growth Substances|growth substances|mesh-ancestor
153474817|NCT00729846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153474818|NCT00729846|Growth Inhibitors|growth inhibitors|mesh-ancestor
153474819|NCT00729846|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
153474841|NCT00732654|Chelating Agents|chelating agents|mesh-ancestor
153474842|NCT00732654|Sequestering Agents|sequestering agents|mesh-ancestor
153474843|NCT00732654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153474845|NCT00733278|Contraceptive Agents|contraceptive agents|mesh-list
153474846|NCT00733278|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153474847|NCT00733278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153474848|NCT00733278|Trace Elements|trace elements|mesh-ancestor
153474849|NCT00733278|Micronutrients|micronutrients|mesh-ancestor
153474850|NCT00733356|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
153884245|NCT01602302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153884246|NCT01602302|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153884247|NCT01602302|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153884248|NCT02893722|Oxytocin|oxytocin|mesh-list
153884249|NCT02893722|Atosiban|atosiban|mesh-list
153884250|NCT02893722|Oxytocics|oxytocics|mesh-ancestor
153884251|NCT02893722|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153884252|NCT02893722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153884253|NCT02893722|Hormone Antagonists|hormone antagonists|mesh-ancestor
153884254|NCT02893722|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153884255|NCT02893722|Tocolytic Agents|tocolytic agents|mesh-ancestor
153884256|NCT01608269|Lamivudine|lamivudine|mesh-list
153884257|NCT01608269|Abacavir|abacavir|mesh-list
153884258|NCT01608269|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153884259|NCT01608269|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153884260|NCT01608269|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153423581|NCT02216214|Adrenergic Agents|adrenergic agents|mesh-ancestor
153423582|NCT02216214|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153423583|NCT02216214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153423584|NCT02216214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153423585|NCT02216214|Urological Agents|urological agents|mesh-ancestor
153425203|NCT03577171|Entecavir|entecavir|mesh-list
153474852|NCT00733356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153474853|NCT00733356|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
153474854|NCT00733356|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153474855|NCT00733356|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153474856|NCT00733356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153474866|NCT00735306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153474867|NCT00735306|Growth Inhibitors|growth inhibitors|mesh-ancestor
153474868|NCT00735306|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153474869|NCT00735306|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153474870|NCT00735306|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153474925|NCT00741468|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
153474926|NCT00741468|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153474927|NCT00741468|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
153474928|NCT00741468|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
153474929|NCT00741468|Purinergic Agents|purinergic agents|mesh-ancestor
153474930|NCT00741468|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
153474931|NCT00741468|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153474932|NCT00741468|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
153474933|NCT00741468|Antitussive Agents|antitussive agents|mesh-ancestor
153474934|NCT00741468|Respiratory System Agents|respiratory system agents|mesh-ancestor
153474935|NCT00741468|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
153474936|NCT00741468|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
153474937|NCT00741468|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153474938|NCT00741858|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
153474939|NCT00741858|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
153474940|NCT00741858|Estradiol|estradiol|mesh-list
153474941|NCT00741858|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
153474942|NCT00741858|Estrogens|estrogens|mesh-ancestor
153474943|NCT00741858|Hormones|hormones|mesh-ancestor
153425205|NCT03577171|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153425206|NCT02367170|Midazolam|midazolam|mesh-list
153425208|NCT02367170|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153425209|NCT02367170|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153425210|NCT02367170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153425211|NCT02367170|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153425212|NCT02367170|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153425213|NCT02367170|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153425214|NCT02367170|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153425215|NCT02367170|Anesthetics, General|anesthetics, general|mesh-ancestor
153425216|NCT02367170|Anesthetics|anesthetics|mesh-ancestor
153425217|NCT02367170|GABA Modulators|gaba modulators|mesh-ancestor
153425218|NCT02367170|GABA Agents|gaba agents|mesh-ancestor
153425219|NCT02367170|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153813808|NCT00335270|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
153813809|NCT00335270|Protease Inhibitors|protease inhibitors|mesh-ancestor
153474947|NCT00741858|Contraceptive Agents|contraceptive agents|mesh-ancestor
153475024|NCT00755040|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153475025|NCT00755040|Dermatologic Agents|dermatologic agents|mesh-ancestor
153882685|NCT01684865|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153882687|NCT01684865|Immunologic Factors|immunologic factors|mesh-ancestor
153882688|NCT01684865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153882689|NCT01684865|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153475026|NCT00755040|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153475027|NCT00755040|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
153475028|NCT00755274|Vaccines|vaccines|mesh-list
153475029|NCT00755274|Immunologic Factors|immunologic factors|mesh-ancestor
153475030|NCT00755274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153475031|NCT00756600|Anesthetics|anesthetics|mesh-list
153475032|NCT00756600|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153475033|NCT00756600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153475034|NCT00756678|Ophthalmic Solutions|ophthalmic solutions|mesh-list
153475035|NCT00756678|Lubricant Eye Drops|lubricant eye drops|mesh-list
153475036|NCT00756678|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
153475037|NCT00758784|Bromfenac|bromfenac|mesh-list
153475042|NCT00758784|Analgesics|analgesics|mesh-ancestor
153475107|NCT00761592|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153475108|NCT00762450|Triclosan|triclosan|mesh-list
153475109|NCT00762450|Fluorides|fluorides|mesh-list
153475110|NCT00762450|Cariostatic Agents|cariostatic agents|mesh-ancestor
153475111|NCT00762450|Protective Agents|protective agents|mesh-ancestor
153475112|NCT00762450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153475113|NCT00762450|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
153475114|NCT00762450|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153475136|NCT00765648|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
153475137|NCT00765648|Adrenergic Agents|adrenergic agents|mesh-ancestor
153475138|NCT00765648|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153475139|NCT00765648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153475140|NCT00765648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153475141|NCT00765648|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153475142|NCT00765648|Sympathomimetics|sympathomimetics|mesh-ancestor
153475143|NCT00765648|Autonomic Agents|autonomic agents|mesh-ancestor
153475146|NCT00765648|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
153360197|NCT00802100|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153360198|NCT00802100|Antiemetics|antiemetics|mesh-ancestor
153360199|NCT00802100|Autonomic Agents|autonomic agents|mesh-ancestor
153475207|NCT00784524|Aldesleukin|aldesleukin|mesh-list
153475208|NCT00784524|Interleukin-2|interleukin-2|mesh-list
153475209|NCT00784524|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153475210|NCT00784524|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153475211|NCT00784524|Analgesics|analgesics|mesh-ancestor
153475212|NCT00784524|Sensory System Agents|sensory system agents|mesh-ancestor
153884261|NCT01608269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153884262|NCT01608269|Antiviral Agents|antiviral agents|mesh-ancestor
153884263|NCT01608269|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153884264|NCT01608269|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153884265|NCT01608269|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153884267|NCT01608347|Vitamin B Complex|vitamin b complex|mesh-list
153884268|NCT01608347|Hematinics|hematinics|mesh-ancestor
153884269|NCT01608347|Vitamins|vitamins|mesh-ancestor
153884270|NCT01608347|Micronutrients|micronutrients|mesh-ancestor
153884271|NCT01608347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153884272|NCT04405284|Disinfectants|disinfectants|mesh-list
153884273|NCT04405284|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153475213|NCT00784524|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153475214|NCT00784524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153475215|NCT00784524|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153475216|NCT00784524|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153475217|NCT00784524|Antiviral Agents|antiviral agents|mesh-ancestor
153475218|NCT00784524|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153475220|NCT00785772|Analgesics|analgesics|mesh-ancestor
153475221|NCT00785772|Sensory System Agents|sensory system agents|mesh-ancestor
153475281|NCT00788892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153475282|NCT00788892|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153475283|NCT00788892|Antiviral Agents|antiviral agents|mesh-ancestor
153475284|NCT00788892|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153475285|NCT00788892|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153475286|NCT00788892|Immunologic Factors|immunologic factors|mesh-ancestor
153882691|NCT01580163|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153882692|NCT01580163|Narcotics|narcotics|mesh-ancestor
153882693|NCT01580163|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153882694|NCT01580163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153882695|NCT01580163|Analgesics|analgesics|mesh-ancestor
153882696|NCT01580163|Sensory System Agents|sensory system agents|mesh-ancestor
153882697|NCT01580163|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153882698|NCT01580163|Antitussive Agents|antitussive agents|mesh-ancestor
153882699|NCT01580163|Respiratory System Agents|respiratory system agents|mesh-ancestor
153882700|NCT01609647|Clopidogrel|clopidogrel|mesh-list
153475287|NCT00788892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153475288|NCT00788892|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153475289|NCT00788892|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153475290|NCT00788892|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153475291|NCT00788892|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153475292|NCT00789672|Levodopa|levodopa|mesh-list
153475405|NCT00798018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153475406|NCT00798720|Bortezomib|bortezomib|mesh-list
153475407|NCT00798720|Vorinostat|vorinostat|mesh-list
153475408|NCT00798720|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153475409|NCT00798720|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
153475410|NCT00798720|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153475411|NCT00798720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153475412|NCT00799578|Cysteamine|cysteamine|mesh-list
153475413|NCT00799578|Cystine Depleting Agents|cystine depleting agents|mesh-ancestor
153475414|NCT00799578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153475415|NCT00799812|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
153475416|NCT00799812|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
153475417|NCT00799812|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153475418|NCT00799812|Dermatologic Agents|dermatologic agents|mesh-ancestor
153475419|NCT00801138|Dexamethasone|dexamethasone|mesh-list
153475420|NCT00801138|Bupivacaine|bupivacaine|mesh-list
153475421|NCT00801138|Ropivacaine|ropivacaine|mesh-list
153475422|NCT00801138|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153884274|NCT01608464|Cisplatin|cisplatin|mesh-list
153884275|NCT01608464|Docetaxel|docetaxel|mesh-list
153884276|NCT01608464|Fluorouracil|fluorouracil|mesh-list
153884277|NCT01608464|Irinotecan|irinotecan|mesh-list
153425225|NCT01078844|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153425226|NCT01078844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153475474|NCT00803010|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153475475|NCT00803010|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153475476|NCT00803010|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
153475477|NCT00803010|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153475478|NCT00803010|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153475479|NCT00803010|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153475480|NCT00803010|Antifungal Agents|antifungal agents|mesh-ancestor
153475482|NCT00803400|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153475483|NCT00803400|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153475505|NCT00806598|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
153475506|NCT00806598|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
153475508|NCT00806598|Prednisolone acetate|prednisolone acetate|mesh-list
153475509|NCT00806598|Cyclosporins|cyclosporins|mesh-list
153475510|NCT00806598|Thymoglobulin|thymoglobulin|mesh-list
153475511|NCT00806598|Antilymphocyte Serum|antilymphocyte serum|mesh-list
153475512|NCT00806598|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
153475513|NCT00806598|Prednisolone phosphate|prednisolone phosphate|mesh-list
153475514|NCT00806598|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153475515|NCT00806598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153475516|NCT00806598|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153475517|NCT00806598|Immunologic Factors|immunologic factors|mesh-ancestor
153475518|NCT00806598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153475519|NCT00806598|Antifungal Agents|antifungal agents|mesh-ancestor
153475520|NCT00806598|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153475521|NCT00806598|Dermatologic Agents|dermatologic agents|mesh-ancestor
153475522|NCT00806598|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153423587|NCT00376376|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
153423588|NCT00376376|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153423589|NCT00376376|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153423590|NCT00376376|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153423591|NCT00376376|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153423592|NCT00376376|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153423593|NCT00376376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153423594|NCT00376376|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153423595|NCT00376376|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
153423596|NCT00376376|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153475523|NCT00806598|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
153475524|NCT00806598|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153475526|NCT00806598|Autonomic Agents|autonomic agents|mesh-ancestor
153475527|NCT00806598|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153475528|NCT00806598|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153475529|NCT00806598|Glucocorticoids|glucocorticoids|mesh-ancestor
153475538|NCT00807768|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
153475539|NCT00807768|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153475540|NCT00807768|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153475573|NCT00812838|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153813815|NCT00335270|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153813816|NCT00335270|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
153475574|NCT00812838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153475575|NCT00812838|Cholinergic Agents|cholinergic agents|mesh-ancestor
153475576|NCT00812838|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153475577|NCT00812838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153475578|NCT00812838|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
153475579|NCT00812838|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153475581|NCT00814788|Bicalutamide|bicalutamide|mesh-list
153475582|NCT00814788|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
153475583|NCT00814788|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153884280|NCT01608464|Antimitotic Agents|antimitotic agents|mesh-ancestor
153884281|NCT01608464|Mitosis Modulators|mitosis modulators|mesh-ancestor
153475585|NCT00814788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153475586|NCT00814788|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153475611|NCT00821184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153475612|NCT00821184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153475613|NCT00821184|Urological Agents|urological agents|mesh-ancestor
153475614|NCT05206812|Durvalumab|durvalumab|mesh-list
153475615|NCT05206812|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153884282|NCT01608464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153475625|NCT05131152|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153475626|NCT05131152|Dermatologic Agents|dermatologic agents|mesh-ancestor
153475627|NCT05131152|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153475628|NCT05131152|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
153475630|NCT04900116|Anesthetics, Local|anesthetics, local|mesh-ancestor
153475631|NCT04900116|Anesthetics|anesthetics|mesh-ancestor
153475632|NCT04900116|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153475633|NCT04900116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153475634|NCT04900116|Sensory System Agents|sensory system agents|mesh-ancestor
153475635|NCT04900116|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153475637|NCT04603248|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153475666|NCT00821886|Carboplatin|carboplatin|mesh-list
153475667|NCT00821886|Trastuzumab|trastuzumab|mesh-list
153475668|NCT00821886|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153475669|NCT00821886|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153475670|NCT00821964|Paclitaxel|paclitaxel|mesh-list
153475671|NCT00821964|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
153475672|NCT00821964|Imiquimod|imiquimod|mesh-list
153380517|NCT01691690|Analgesics|analgesics|mesh-ancestor
153380518|NCT01691690|Sensory System Agents|sensory system agents|mesh-ancestor
153475673|NCT00821964|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153475674|NCT00821964|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153475676|NCT00821964|Antimitotic Agents|antimitotic agents|mesh-ancestor
153475677|NCT00821964|Mitosis Modulators|mitosis modulators|mesh-ancestor
153475678|NCT00821964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153475679|NCT00821964|Toll-Like Receptor Agonists|toll-like receptor agonists|mesh-ancestor
153475680|NCT00821964|Immunomodulating Agents|immunomodulating agents|mesh-ancestor
153475681|NCT00821964|Immunologic Factors|immunologic factors|mesh-ancestor
153475682|NCT00821964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153475683|NCT00821964|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153475717|NCT00824460|Chelating Agents|chelating agents|mesh-ancestor
153475718|NCT00824460|Sequestering Agents|sequestering agents|mesh-ancestor
153475761|NCT00830388|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153475763|NCT00830388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153475764|NCT00830388|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153475766|NCT00830388|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153475795|NCT00832338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153475796|NCT00832338|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153475797|NCT00832338|Immunologic Factors|immunologic factors|mesh-ancestor
153475798|NCT00832338|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153475803|NCT00834210|Dapsone|dapsone|mesh-list
153475809|NCT00834210|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153475810|NCT00834210|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153475811|NCT00834210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153475812|NCT00834210|Leprostatic Agents|leprostatic agents|mesh-ancestor
153475847|NCT00835224|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153884299|NCT01608698|Diuretics|diuretics|mesh-ancestor
153884300|NCT01608698|Natriuretic Agents|natriuretic agents|mesh-ancestor
153884301|NCT01608698|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
153884302|NCT01608698|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
153884303|NCT01608698|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
153884304|NCT01608698|Contraceptive Agents|contraceptive agents|mesh-ancestor
153475850|NCT00835926|Immunologic Factors|immunologic factors|mesh-ancestor
153475851|NCT00835926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153475852|NCT00837252|Finasteride|finasteride|mesh-list
153475853|NCT00837252|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
153476005|NCT00875550|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153476006|NCT00875550|Analgesics|analgesics|mesh-ancestor
153476007|NCT00875550|Sensory System Agents|sensory system agents|mesh-ancestor
153476008|NCT00875550|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153476009|NCT00875550|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
153476010|NCT00875550|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153476011|NCT00875550|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153476012|NCT00875550|Adrenergic Agents|adrenergic agents|mesh-ancestor
153425270|NCT01035944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153425271|NCT01035944|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153425272|NCT01035944|Chelating Agents|chelating agents|mesh-ancestor
153425273|NCT01035944|Sequestering Agents|sequestering agents|mesh-ancestor
153425274|NCT01035944|Hemostatics|hemostatics|mesh-ancestor
153425275|NCT01035944|Coagulants|coagulants|mesh-ancestor
153425276|NCT00378638|Bevacizumab|bevacizumab|mesh-list
153476039|NCT00878826|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153476040|NCT00878826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153476042|NCT00879060|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
153476043|NCT00879060|Hormone Antagonists|hormone antagonists|mesh-ancestor
153476044|NCT00879060|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153476045|NCT00879060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153476046|NCT00879060|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
153476047|NCT00879060|Diuretics|diuretics|mesh-ancestor
153476048|NCT00879060|Natriuretic Agents|natriuretic agents|mesh-ancestor
153476049|NCT00882102|Decitabine|decitabine|mesh-list
153476050|NCT00882102|Gemtuzumab|gemtuzumab|mesh-list
153476051|NCT00882102|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153476052|NCT00882102|Antimetabolites|antimetabolites|mesh-ancestor
153476053|NCT00882102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153476054|NCT00882102|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153476055|NCT00882102|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153476056|NCT00882102|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153476057|NCT00882102|Immunotoxins|immunotoxins|mesh-ancestor
153476058|NCT00882102|Immunoconjugates|immunoconjugates|mesh-ancestor
153884316|NCT04310254|Chelating Agents|chelating agents|mesh-ancestor
153884317|NCT04310254|Sequestering Agents|sequestering agents|mesh-ancestor
153884318|NCT04310254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153884319|NCT04310254|Antidotes|antidotes|mesh-ancestor
153884320|NCT04310254|Protective Agents|protective agents|mesh-ancestor
153476061|NCT00884052|Levetiracetam|levetiracetam|mesh-list
153476062|NCT00884052|Anticonvulsants|anticonvulsants|mesh-ancestor
153476067|NCT00886236|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153476068|NCT00886236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153476069|NCT00886236|Anticonvulsants|anticonvulsants|mesh-ancestor
153476070|NCT00886236|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153476071|NCT00886236|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153476072|NCT00886236|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153476073|NCT00886236|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153476074|NCT00886236|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
153476075|NCT00886236|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
153476076|NCT00886236|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153476077|NCT00886236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153476078|NCT00886236|Antimanic Agents|antimanic agents|mesh-ancestor
153476117|NCT00887640|Antiemetics|antiemetics|mesh-ancestor
153476118|NCT00887640|Autonomic Agents|autonomic agents|mesh-ancestor
153476139|NCT00892710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153476140|NCT00892710|Growth Inhibitors|growth inhibitors|mesh-ancestor
153476141|NCT00892710|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153476142|NCT00892710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153476143|NCT00892710|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153476144|NCT00892710|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153476145|NCT00894504|Carboplatin|carboplatin|mesh-list
153476146|NCT00894504|Gemcitabine|gemcitabine|mesh-list
153476147|NCT00894504|Panitumumab|panitumumab|mesh-list
153425298|NCT04331834|Antimalarials|antimalarials|mesh-ancestor
153425299|NCT04331834|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153425300|NCT04331834|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153425301|NCT04331834|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153476149|NCT00894504|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153476150|NCT00894504|Antimetabolites|antimetabolites|mesh-ancestor
153476151|NCT00894504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153476152|NCT00894504|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153476153|NCT00895752|Riluzole|riluzole|mesh-list
153476154|NCT00895752|Anticonvulsants|anticonvulsants|mesh-ancestor
153476155|NCT00895752|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
153476156|NCT00895752|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
153476157|NCT00895752|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153476158|NCT00895752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153476159|NCT00895752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153476160|NCT00895752|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
153476161|NCT00895752|Protective Agents|protective agents|mesh-ancestor
153476162|NCT00896064|Vaccines|vaccines|mesh-list
153476163|NCT00896064|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
153476164|NCT00896064|Immunologic Factors|immunologic factors|mesh-ancestor
153476165|NCT00896064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153476166|NCT00898560|Eslicarbazepine acetate|eslicarbazepine acetate|mesh-list
153476167|NCT00898560|Anticonvulsants|anticonvulsants|mesh-ancestor
153476168|NCT00898560|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
153476169|NCT00898560|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153476170|NCT00898560|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153884337|NCT01609049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153884338|NCT01609049|Antiviral Agents|antiviral agents|mesh-ancestor
153884340|NCT01609088|Erythritol|erythritol|mesh-list
153476194|NCT00902226|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153476195|NCT00902226|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153476196|NCT00902226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153425311|NCT03595579|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153425312|NCT03595579|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
153425313|NCT03595579|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153425314|NCT03595579|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153425315|NCT03595579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153425316|NCT03595579|Dopamine Agents|dopamine agents|mesh-ancestor
153425317|NCT03595579|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153425318|NCT03595579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153425319|NCT03595579|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
153425320|NCT03595579|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153425321|NCT03595579|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153425323|NCT02200328|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153425324|NCT02200328|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153884361|NCT01604057|Teriparatide|teriparatide|mesh-list
153476197|NCT00902226|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153476198|NCT00902226|Serotonin Agents|serotonin agents|mesh-ancestor
153476199|NCT00902226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153476200|NCT00903162|Zoledronic Acid|zoledronic acid|mesh-list
153476201|NCT00903162|Letrozole|letrozole|mesh-list
153476202|NCT00903162|Leuprolide|leuprolide|mesh-list
153476203|NCT00903162|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153476204|NCT00903162|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
153476205|NCT00903162|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153476206|NCT00903162|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153813817|NCT00335270|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153476207|NCT00903162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153476208|NCT00903162|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
153476209|NCT00903162|Hormone Antagonists|hormone antagonists|mesh-ancestor
153476210|NCT00903162|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153476211|NCT00903162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153476212|NCT00903162|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153476213|NCT00903162|Fertility Agents, Female|fertility agents, female|mesh-ancestor
153476214|NCT00903162|Fertility Agents|fertility agents|mesh-ancestor
153476215|NCT00903162|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153476229|NCT00905580|Analgesics|analgesics|mesh-ancestor
153476230|NCT00905580|Sensory System Agents|sensory system agents|mesh-ancestor
153476231|NCT00905580|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153476232|NCT00905580|Anticonvulsants|anticonvulsants|mesh-ancestor
153476237|NCT00905580|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153476238|NCT00905580|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153884362|NCT01604057|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153884363|NCT01604057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153476239|NCT00905580|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153476241|NCT00908466|Sirolimus|sirolimus|mesh-list
153476242|NCT00908466|Temsirolimus|temsirolimus|mesh-list
153476243|NCT00908466|MTOR Inhibitors|mtor inhibitors|mesh-list
153476244|NCT00908466|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153476245|NCT00908466|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153476246|NCT00908466|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153476247|NCT00908466|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153476248|NCT00908466|Antifungal Agents|antifungal agents|mesh-ancestor
153476249|NCT00908466|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153476250|NCT00908466|Immunologic Factors|immunologic factors|mesh-ancestor
153476251|NCT00908466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153476252|NCT00908466|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153476254|NCT00908466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153476255|NCT00911586|Methyltestosterone|methyltestosterone|mesh-list
153476256|NCT00911586|Testosterone|testosterone|mesh-list
153476257|NCT00911586|Testosterone undecanoate|testosterone undecanoate|mesh-list
153476258|NCT00911586|Testosterone enanthate|testosterone enanthate|mesh-list
153476259|NCT00911586|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
153476260|NCT00911586|Androgens|androgens|mesh-ancestor
153476261|NCT00911586|Hormones|hormones|mesh-ancestor
153476262|NCT00911586|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153476263|NCT00911586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153476264|NCT00911586|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153476265|NCT00911586|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153476266|NCT00911586|Anabolic Agents|anabolic agents|mesh-ancestor
153884388|NCT01604330|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153425330|NCT04327843|Autonomic Agents|autonomic agents|mesh-ancestor
153425331|NCT04327843|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153425332|NCT04327843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153425333|NCT04327843|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153425334|NCT04327843|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153425335|NCT04327843|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153425336|NCT04327843|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153425337|NCT04327843|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153425338|NCT04327843|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
153425339|NCT04327843|Dopamine Agents|dopamine agents|mesh-ancestor
153425340|NCT04327843|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153476267|NCT00911742|Tramadol|tramadol|mesh-list
153476268|NCT00911742|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153476281|NCT00913068|Ropivacaine|ropivacaine|mesh-list
153476282|NCT00913068|Anesthetics, Local|anesthetics, local|mesh-ancestor
153476283|NCT00913068|Anesthetics|anesthetics|mesh-ancestor
153813818|NCT00335270|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153476284|NCT00913068|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153476285|NCT00913068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153476286|NCT00913068|Sensory System Agents|sensory system agents|mesh-ancestor
153476287|NCT00913068|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153476288|NCT00913068|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153476289|NCT00913068|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
153476290|NCT00913068|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153476291|NCT00913068|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153476292|NCT00913068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153476294|NCT00916032|Coagulants|coagulants|mesh-ancestor
153476295|NCT00922194|Metformin|metformin|mesh-list
153476296|NCT00922194|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153476297|NCT00922194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153476298|NCT00923910|Acetaminophen|acetaminophen|mesh-list
153476299|NCT00923910|Diphenhydramine|diphenhydramine|mesh-list
153476300|NCT00923910|Promethazine|promethazine|mesh-list
153476301|NCT00923910|Interleukin-4|interleukin-4|mesh-list
153476338|NCT00924612|Testosterone enanthate|testosterone enanthate|mesh-list
153476339|NCT00924612|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
153476341|NCT00924612|Hormones|hormones|mesh-ancestor
153476342|NCT00924612|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153476343|NCT00924612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153476352|NCT00925782|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153476353|NCT00925782|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153476354|NCT00925782|Immunologic Factors|immunologic factors|mesh-ancestor
153476355|NCT00925782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153476356|NCT00925938|Misoprostol|misoprostol|mesh-list
153476357|NCT00925938|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
153476358|NCT00925938|Abortifacient Agents|abortifacient agents|mesh-ancestor
153476359|NCT00925938|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153476360|NCT00925938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153476361|NCT00925938|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
153476399|NCT00928200|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153476400|NCT00928200|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153476401|NCT00928200|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153476402|NCT00928200|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
153476415|NCT00928200|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153476417|NCT00928200|Antimitotic Agents|antimitotic agents|mesh-ancestor
153476418|NCT00928200|Mitosis Modulators|mitosis modulators|mesh-ancestor
153476419|NCT00928200|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
153476420|NCT00928200|Protective Agents|protective agents|mesh-ancestor
153476421|NCT00931164|Sodium Oxybate|sodium oxybate|mesh-list
153476422|NCT00931164|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153476423|NCT00931164|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153476424|NCT00931164|Anesthetics, General|anesthetics, general|mesh-ancestor
153476425|NCT00931164|Anesthetics|anesthetics|mesh-ancestor
153884389|NCT01604330|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
153884390|NCT01604330|GABA Agonists|gaba agonists|mesh-ancestor
153884391|NCT01604330|GABA Agents|gaba agents|mesh-ancestor
153884392|NCT01604330|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153884393|NCT01604330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153884394|NCT00622830|Darapladib|darapladib|mesh-list
153884395|NCT00622830|Phospholipase A2 Inhibitors|phospholipase a2 inhibitors|mesh-ancestor
153884396|NCT00622830|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153884397|NCT00622830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153884398|NCT01173679|Rituximab|rituximab|mesh-list
153476430|NCT00931242|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153476431|NCT00931242|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153476432|NCT00931242|Analgesics|analgesics|mesh-ancestor
153476433|NCT00931242|Sensory System Agents|sensory system agents|mesh-ancestor
153476434|NCT00931242|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153476435|NCT00931242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153476436|NCT00931242|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153380519|NCT01691690|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153380520|NCT01691690|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153380521|NCT01691690|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153380522|NCT01691690|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153380523|NCT01691690|GABA Modulators|gaba modulators|mesh-ancestor
153380524|NCT01691690|GABA Agents|gaba agents|mesh-ancestor
153380525|NCT01691690|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153380526|NCT01691690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153380527|NCT01691690|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153380528|NCT01691690|Antipyretics|antipyretics|mesh-ancestor
153380529|NCT01691690|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153380530|NCT01691690|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
153380531|NCT01691690|Antipruritics|antipruritics|mesh-ancestor
153380532|NCT01691690|Dermatologic Agents|dermatologic agents|mesh-ancestor
153380533|NCT01691690|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
153380534|NCT01691690|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153380535|NCT01691690|Serotonin Agents|serotonin agents|mesh-ancestor
153380536|NCT01694108|BCG Vaccine|bcg vaccine|mesh-list
153380537|NCT01694108|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153380538|NCT01694108|Immunologic Factors|immunologic factors|mesh-ancestor
153380539|NCT01694108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153380568|NCT01626092|Antitubercular Agents|antitubercular agents|mesh-ancestor
153476437|NCT00931242|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153476438|NCT00931242|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
153476439|NCT00931242|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
153476440|NCT00931242|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153476441|NCT00931242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153476442|NCT00931242|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153476443|NCT00931242|Immunologic Factors|immunologic factors|mesh-ancestor
153476444|NCT00931242|Leprostatic Agents|leprostatic agents|mesh-ancestor
153476445|NCT00931242|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153476446|NCT00931242|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153476447|NCT00931242|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153476448|NCT00931242|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153476449|NCT00931242|Growth Substances|growth substances|mesh-ancestor
153476450|NCT00931242|Growth Inhibitors|growth inhibitors|mesh-ancestor
153476465|NCT00935064|Protease Inhibitors|protease inhibitors|mesh-ancestor
153476466|NCT00935064|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153476492|NCT00943098|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153476493|NCT00943098|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153476494|NCT00943098|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153476495|NCT00943098|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153476496|NCT00943098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153476497|NCT00943800|Vidarabine|vidarabine|mesh-list
153476498|NCT00943800|Fludarabine|fludarabine|mesh-list
153476499|NCT00943800|Fludarabine phosphate|fludarabine phosphate|mesh-list
153476500|NCT00943800|Melphalan|melphalan|mesh-list
153476501|NCT00943800|Busulfan|busulfan|mesh-list
153476502|NCT00943800|Thiotepa|thiotepa|mesh-list
153476503|NCT00943800|Antilymphocyte Serum|antilymphocyte serum|mesh-list
153476504|NCT00943800|Thymoglobulin|thymoglobulin|mesh-list
153476505|NCT00943800|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153476506|NCT00943800|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153476507|NCT00943800|Antimetabolites|antimetabolites|mesh-ancestor
153380569|NCT01626092|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153380570|NCT01626092|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153380571|NCT01626092|Alkylating Agents|alkylating agents|mesh-ancestor
153380572|NCT01626092|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153380573|NCT01626092|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153380574|NCT01626092|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153380575|NCT01626092|Antimetabolites|antimetabolites|mesh-ancestor
153476508|NCT00943800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153476511|NCT00943800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153884401|NCT01173679|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153884402|NCT01173679|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153884403|NCT01173679|Immunologic Factors|immunologic factors|mesh-ancestor
153476513|NCT00943800|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153476514|NCT00943800|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153476538|NCT00945750|Histamine Agents|histamine agents|mesh-ancestor
153476539|NCT00945750|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153476540|NCT00945750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153476541|NCT00945750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153476542|NCT00948090|Cyclophosphamide|cyclophosphamide|mesh-list
153476543|NCT00948090|Busulfan|busulfan|mesh-list
153476544|NCT00948090|Etoposide|etoposide|mesh-list
153476545|NCT00948090|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153476546|NCT00948090|Immunologic Factors|immunologic factors|mesh-ancestor
153813819|NCT00335270|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153813820|NCT00335270|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
153476547|NCT00948090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153476548|NCT00948090|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153476549|NCT00948090|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153476550|NCT00948090|Alkylating Agents|alkylating agents|mesh-ancestor
153476551|NCT00948090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153476552|NCT00948090|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153476553|NCT00948090|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153476554|NCT00948090|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153476555|NCT00948090|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153476556|NCT00948090|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153476557|NCT00948090|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153476558|NCT00950352|Choline|choline|mesh-list
153476559|NCT00950352|Cytidine Diphosphate Choline|cytidine diphosphate choline|mesh-list
153476560|NCT00950352|Lipotropic Agents|lipotropic agents|mesh-ancestor
153476561|NCT00950352|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153476562|NCT00950352|Antimetabolites|antimetabolites|mesh-ancestor
153476563|NCT00950352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153476564|NCT00950352|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153476565|NCT00950352|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153476566|NCT00950352|Nootropic Agents|nootropic agents|mesh-ancestor
153476577|NCT00955266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153476578|NCT00957684|Eslicarbazepine acetate|eslicarbazepine acetate|mesh-list
153476579|NCT00957684|Anticonvulsants|anticonvulsants|mesh-ancestor
153884404|NCT01173679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153884405|NCT01173679|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153884406|NCT01173679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153884407|NCT01173679|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153884408|NCT01173679|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153884409|NCT01173679|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153884410|NCT02881528|Metformin|metformin|mesh-list
153884411|NCT02881528|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153425354|NCT00979550|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153425355|NCT00979550|Interferon Inducers|interferon inducers|mesh-ancestor
153425356|NCT00966992|Zoledronic Acid|zoledronic acid|mesh-list
153425359|NCT00379730|Prednisolone|prednisolone|mesh-list
153476580|NCT00957684|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
153476582|NCT00957684|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153476583|NCT00957684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153476584|NCT00961662|Tagatose|tagatose|mesh-list
153476585|NCT00961662|Iron Chelating Agents|iron chelating agents|mesh-ancestor
153380576|NCT01694966|Methylene Blue|methylene blue|mesh-list
153380577|NCT01694966|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153380578|NCT01694966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153380579|NCT01937975|Grazoprevir|grazoprevir|mesh-list
153380580|NCT01937975|Antiviral Agents|antiviral agents|mesh-ancestor
153380581|NCT01937975|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153380582|NCT01628588|Bimatoprost|bimatoprost|mesh-list
153380656|NCT01924169|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153380657|NCT01924169|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153380658|NCT01924169|Growth Substances|growth substances|mesh-ancestor
153380659|NCT01924169|Growth Inhibitors|growth inhibitors|mesh-ancestor
153380660|NCT01924169|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153380661|NCT02958969|Apixaban|apixaban|mesh-list
153380662|NCT02958969|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
153380663|NCT02958969|Antithrombins|antithrombins|mesh-ancestor
153380664|NCT02958969|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
153380665|NCT02958969|Protease Inhibitors|protease inhibitors|mesh-ancestor
153380733|NCT03078075|Sensory System Agents|sensory system agents|mesh-ancestor
153476586|NCT00961662|Chelating Agents|chelating agents|mesh-ancestor
153476587|NCT00961662|Sequestering Agents|sequestering agents|mesh-ancestor
153476588|NCT00961662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153476589|NCT00964548|Dantrolene|dantrolene|mesh-list
153476590|NCT00964548|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
153476591|NCT00964548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153476592|NCT00964548|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
153476593|NCT00964548|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153476594|NCT00905268|Idebenone|idebenone|mesh-list
153476595|NCT00905268|Antioxidants|antioxidants|mesh-ancestor
153476596|NCT00905268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153476597|NCT00905268|Protective Agents|protective agents|mesh-ancestor
153476598|NCT00905268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153476614|NCT00973752|Vincristine|vincristine|mesh-list
153476615|NCT00973752|Asparaginase|asparaginase|mesh-list
153476616|NCT00973752|Mercaptopurine|mercaptopurine|mesh-list
153476617|NCT00973752|Clofarabine|clofarabine|mesh-list
153476618|NCT00973752|Pegaspargase|pegaspargase|mesh-list
153476619|NCT00973752|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153476620|NCT00973752|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153476621|NCT00973752|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153476622|NCT00973752|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153476623|NCT00973752|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153476624|NCT00973752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153476625|NCT00973752|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153476626|NCT00973752|Glucocorticoids|glucocorticoids|mesh-ancestor
153476627|NCT00973752|Hormones|hormones|mesh-ancestor
153476628|NCT00973752|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153813821|NCT00335270|Antitubercular Agents|antitubercular agents|mesh-ancestor
153476629|NCT00973752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153476630|NCT00973752|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153476634|NCT00973752|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153476635|NCT00973752|Antimetabolites|antimetabolites|mesh-ancestor
153476636|NCT00973752|Dermatologic Agents|dermatologic agents|mesh-ancestor
153476637|NCT00973752|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153476638|NCT00973752|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153476639|NCT00973752|Immunologic Factors|immunologic factors|mesh-ancestor
153476640|NCT00973752|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153476641|NCT00973752|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153380734|NCT03078075|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153380735|NCT03078075|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
153476643|NCT00973752|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153476644|NCT00973752|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153476645|NCT00973752|Tubulin Modulators|tubulin modulators|mesh-ancestor
153476646|NCT00973752|Antimitotic Agents|antimitotic agents|mesh-ancestor
153476647|NCT00973752|Mitosis Modulators|mitosis modulators|mesh-ancestor
153476648|NCT00974142|Cyclosporine|cyclosporine|mesh-list
153476649|NCT00974142|Cyclosporins|cyclosporins|mesh-list
153476650|NCT00974142|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153476651|NCT00974142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153476652|NCT00974142|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153476653|NCT00974142|Immunologic Factors|immunologic factors|mesh-ancestor
153476654|NCT00974142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153476655|NCT00974142|Antifungal Agents|antifungal agents|mesh-ancestor
153476656|NCT00974142|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153884412|NCT02881528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153884413|NCT01609439|Vitamin D|vitamin d|mesh-list
153476668|NCT00974376|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153476669|NCT00974376|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153476670|NCT00974376|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
153476671|NCT00974376|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
153476672|NCT00974376|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153476673|NCT00974376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153476674|NCT00974376|Antimanic Agents|antimanic agents|mesh-ancestor
153476678|NCT00976248|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153476679|NCT00976248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153476680|NCT00976248|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153476681|NCT00976248|Immunologic Factors|immunologic factors|mesh-ancestor
153476682|NCT00976248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153476683|NCT00976248|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153476684|NCT00976404|Raltegravir Potassium|raltegravir potassium|mesh-list
153476685|NCT00976404|Maraviroc|maraviroc|mesh-list
153476686|NCT00976404|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153476687|NCT00976404|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153476688|NCT00976404|Antiviral Agents|antiviral agents|mesh-ancestor
153476689|NCT00976404|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153476690|NCT00976404|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
153476691|NCT00976404|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
153476692|NCT00976404|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153476693|NCT00976404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153476694|NCT00976404|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
153476695|NCT00976404|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
153476696|NCT00976404|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
153476697|NCT00983346|Bortezomib|bortezomib|mesh-list
153476698|NCT00983346|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153476699|NCT00986856|Fusidic Acid|fusidic acid|mesh-list
153476700|NCT00986856|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153476701|NCT00986856|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153425374|NCT02043860|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153425375|NCT02043860|Alkylating Agents|alkylating agents|mesh-ancestor
153425376|NCT02043860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153425377|NCT02043860|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153425378|NCT02043860|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153425379|NCT02043860|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153425380|NCT01974284|Ethanol|ethanol|mesh-list
153425381|NCT01974284|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
153425382|NCT01974284|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153425383|NCT01974284|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153425384|NCT01974284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153476720|NCT00987480|Antifungal Agents|antifungal agents|mesh-ancestor
153476721|NCT00987480|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153476722|NCT00987480|Dermatologic Agents|dermatologic agents|mesh-ancestor
153476723|NCT00987480|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
153476724|NCT00987558|Eslicarbazepine acetate|eslicarbazepine acetate|mesh-list
153476725|NCT00987558|Simvastatin|simvastatin|mesh-list
153476726|NCT00987558|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153476727|NCT00987558|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153476728|NCT00987558|Antimetabolites|antimetabolites|mesh-ancestor
153476729|NCT00987558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153476730|NCT00987558|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153476731|NCT00987558|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
153476732|NCT00987558|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153476733|NCT00987558|Anticonvulsants|anticonvulsants|mesh-ancestor
153476734|NCT00987558|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
153476735|NCT00987558|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153884428|NCT01110382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153884429|NCT00592917|Cholecalciferol|cholecalciferol|mesh-list
153884430|NCT00592917|Vitamin D|vitamin d|mesh-list
153884431|NCT00592917|Calcium Carbonate|calcium carbonate|mesh-list
153884432|NCT00592917|Calcium|calcium|mesh-list
153884433|NCT00592917|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153884434|NCT00592917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153884435|NCT00592917|Vitamins|vitamins|mesh-ancestor
153884436|NCT00592917|Micronutrients|micronutrients|mesh-ancestor
153884437|NCT00592917|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153884438|NCT00592917|Antacids|antacids|mesh-ancestor
153884439|NCT00592917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153476737|NCT00987948|Maraviroc|maraviroc|mesh-list
153476738|NCT00987948|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
153476739|NCT00987948|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
153476740|NCT00987948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153476741|NCT00987948|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153476742|NCT00987948|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153476743|NCT00987948|Antiviral Agents|antiviral agents|mesh-ancestor
153476744|NCT00987948|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153476745|NCT00987948|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
153476746|NCT00989586|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
153476747|NCT00989586|Veltuzumab|veltuzumab|mesh-list
153476748|NCT00989586|Antibodies|antibodies|mesh-list
153476749|NCT00989586|Immunoglobulins|immunoglobulins|mesh-list
153476750|NCT00989586|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
153476751|NCT00989586|Immunologic Factors|immunologic factors|mesh-ancestor
153476752|NCT00989586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153476753|NCT00989586|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153476754|NCT00990288|Thrombin|thrombin|mesh-list
153476768|NCT00991458|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153476769|NCT00991458|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
153476788|NCT00997620|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
153476789|NCT00997932|Contraceptive Agents|contraceptive agents|mesh-list
153476791|NCT00997932|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153476792|NCT00997932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153476795|NCT00997932|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
153476796|NCT00997932|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
153476797|NCT00998010|Temozolomide|temozolomide|mesh-list
153476798|NCT00998010|Bortezomib|bortezomib|mesh-list
153476799|NCT00998010|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153476800|NCT00998010|Alkylating Agents|alkylating agents|mesh-ancestor
153476801|NCT00998010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153476802|NCT00998010|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153476803|NCT00999102|Metoprolol|metoprolol|mesh-list
153476804|NCT00999102|Nebivolol|nebivolol|mesh-list
153476805|NCT00999102|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153476806|NCT00999102|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153476807|NCT00999102|Sympatholytics|sympatholytics|mesh-ancestor
153476808|NCT00999102|Autonomic Agents|autonomic agents|mesh-ancestor
153476809|NCT00999102|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153476810|NCT00999102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153813823|NCT00437385|Lithium Carbonate|lithium carbonate|mesh-list
153476811|NCT00999102|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
153476812|NCT00999102|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
153476813|NCT00999102|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
153476814|NCT00999102|Adrenergic Agents|adrenergic agents|mesh-ancestor
153476815|NCT00999102|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153476816|NCT00999102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153476817|NCT00999102|Vasodilator Agents|vasodilator agents|mesh-ancestor
153476818|NCT00999102|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
153476819|NCT00999102|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
153476820|NCT00999102|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153476821|NCT01000818|Raltegravir Potassium|raltegravir potassium|mesh-list
153476822|NCT01000818|Omeprazole|omeprazole|mesh-list
153476823|NCT01000818|Famotidine|famotidine|mesh-list
153476824|NCT01000818|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
153476825|NCT01000818|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153476826|NCT01000818|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
153476827|NCT01000818|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153476847|NCT01001052|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153476848|NCT01001442|Indatuximab ravtansine|indatuximab ravtansine|mesh-list
153476849|NCT01001442|Immunoconjugates|immunoconjugates|mesh-ancestor
153476850|NCT01001442|Immunologic Factors|immunologic factors|mesh-ancestor
153476851|NCT01001442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153476852|NCT01003080|Hemostatics|hemostatics|mesh-list
153476853|NCT01003080|Coagulants|coagulants|mesh-ancestor
153476854|NCT01003938|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
153476860|NCT01003938|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153476861|NCT01003938|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
153476862|NCT01003938|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153476864|NCT01004718|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
153476865|NCT01004718|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
153476866|NCT01004718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153476867|NCT01004718|Antimetabolites|antimetabolites|mesh-ancestor
153476868|NCT01004718|Antiviral Agents|antiviral agents|mesh-ancestor
153476869|NCT01004718|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153476870|NCT01005576|Fludarabine|fludarabine|mesh-list
153476871|NCT01005576|Melphalan|melphalan|mesh-list
153476872|NCT01005576|Alemtuzumab|alemtuzumab|mesh-list
153425412|NCT03608839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153425413|NCT00845702|Gadolinium 1,4,7,10-tetraazacyclododecane-N,N',N'',N'''-tetraacetate|gadolinium 1,4,7,10-tetraazacyclododecane-n,n',n'',n'''-tetraacetate|mesh-list
153425415|NCT00845702|Sequestering Agents|sequestering agents|mesh-ancestor
153425416|NCT00845702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153425417|NCT03610399|Primaquine|primaquine|mesh-list
153425418|NCT03610399|Antimalarials|antimalarials|mesh-ancestor
153425419|NCT03610399|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153425420|NCT03610399|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153425421|NCT03610399|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153425422|NCT03610633|Oxytocin|oxytocin|mesh-list
153425423|NCT03610633|Oxytocics|oxytocics|mesh-ancestor
153476879|NCT01005576|Alkylating Agents|alkylating agents|mesh-ancestor
153476880|NCT01005576|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153476881|NCT01005576|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153476882|NCT01005810|Acetylcysteine|acetylcysteine|mesh-list
153476884|NCT01005810|Antiviral Agents|antiviral agents|mesh-ancestor
153476885|NCT01005810|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153476886|NCT01005810|Expectorants|expectorants|mesh-ancestor
153476887|NCT01005810|Respiratory System Agents|respiratory system agents|mesh-ancestor
153476888|NCT01005810|Free Radical Scavengers|free radical scavengers|mesh-ancestor
153476889|NCT01005810|Antioxidants|antioxidants|mesh-ancestor
153476890|NCT01005810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153476891|NCT01005810|Protective Agents|protective agents|mesh-ancestor
153476918|NCT01007994|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153476920|NCT01008462|Mycophenolic Acid|mycophenolic acid|mesh-list
153476921|NCT01008462|Cyclophosphamide|cyclophosphamide|mesh-list
153476922|NCT01008462|Melphalan|melphalan|mesh-list
153476923|NCT01008462|Mechlorethamine|mechlorethamine|mesh-list
153476924|NCT01008462|Carmustine|carmustine|mesh-list
153476925|NCT01008462|Nitrogen Mustard Compounds|nitrogen mustard compounds|mesh-list
153476926|NCT01008462|Fludarabine|fludarabine|mesh-list
153476927|NCT01008462|Fludarabine phosphate|fludarabine phosphate|mesh-list
153476928|NCT01008462|Etoposide|etoposide|mesh-list
153476929|NCT01008462|Etoposide phosphate|etoposide phosphate|mesh-list
153476930|NCT01008462|Podophyllotoxin|podophyllotoxin|mesh-list
153476931|NCT01008462|Tacrolimus|tacrolimus|mesh-list
153476932|NCT01008462|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153476933|NCT01008462|Immunologic Factors|immunologic factors|mesh-ancestor
153476934|NCT01008462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153884470|NCT01609673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153476938|NCT01008462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153476940|NCT01008462|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153476958|NCT01008462|Mitosis Modulators|mitosis modulators|mesh-ancestor
153476959|NCT01010568|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
153476961|NCT01010568|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
153476962|NCT01010568|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153476963|NCT01010568|Alkylating Agents|alkylating agents|mesh-ancestor
153476964|NCT01010568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153476965|NCT01010568|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153476966|NCT01010568|Immunologic Factors|immunologic factors|mesh-ancestor
153476967|NCT01010568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153476968|NCT01011816|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
153476969|NCT01011816|Hemostatics|hemostatics|mesh-ancestor
153476970|NCT01011816|Coagulants|coagulants|mesh-ancestor
153476971|NCT01011894|Lenalidomide|lenalidomide|mesh-list
153476972|NCT01011894|Immunologic Factors|immunologic factors|mesh-ancestor
153476973|NCT01011894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153476974|NCT01011894|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153476975|NCT01011894|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153476976|NCT01011894|Growth Substances|growth substances|mesh-ancestor
153476977|NCT01011894|Growth Inhibitors|growth inhibitors|mesh-ancestor
153476978|NCT01011894|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153476979|NCT01012674|Gadolinium 1,4,7,10-tetraazacyclododecane-N,N',N'',N'''-tetraacetate|gadolinium 1,4,7,10-tetraazacyclododecane-n,n',n'',n'''-tetraacetate|mesh-list
153476980|NCT01012674|Chelating Agents|chelating agents|mesh-ancestor
153476981|NCT01012674|Sequestering Agents|sequestering agents|mesh-ancestor
153476982|NCT01012674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153476984|NCT01015170|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
153476985|NCT01015170|Antidepressive Agents|antidepressive agents|mesh-ancestor
153476986|NCT01015170|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153476988|NCT01015170|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153476989|NCT01015170|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153476990|NCT01015170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153476991|NCT01015170|Dopamine Agents|dopamine agents|mesh-ancestor
153477021|NCT01020006|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153477023|NCT01020006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153477024|NCT01020006|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153477026|NCT05395962|Bleomycin|bleomycin|mesh-list
153477027|NCT05395962|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153477028|NCT05395962|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153477029|NCT05394480|Hydrocortisone|hydrocortisone|mesh-list
153477030|NCT05394480|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153477031|NCT05017584|Bupivacaine|bupivacaine|mesh-list
153477032|NCT05017584|Anesthetics, Local|anesthetics, local|mesh-ancestor
153477033|NCT05017584|Anesthetics|anesthetics|mesh-ancestor
153477034|NCT05017584|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153477035|NCT05017584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153477036|NCT05017584|Sensory System Agents|sensory system agents|mesh-ancestor
153477037|NCT05017584|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153425436|NCT00832520|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153477040|NCT04147416|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153477041|NCT04147416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153477042|NCT04147416|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153477043|NCT04147416|Anesthetics, General|anesthetics, general|mesh-ancestor
153477044|NCT04147416|Anesthetics|anesthetics|mesh-ancestor
153477045|NCT02406222|Dexamethasone|dexamethasone|mesh-list
153477046|NCT02406222|Cyclophosphamide|cyclophosphamide|mesh-list
153477047|NCT02406222|Pomalidomide|pomalidomide|mesh-list
153477048|NCT02406222|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153477105|NCT01029054|Autonomic Agents|autonomic agents|mesh-ancestor
153477106|NCT01029054|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153477107|NCT01029054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153477108|NCT01029054|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153477109|NCT01029054|Glucocorticoids|glucocorticoids|mesh-ancestor
153477111|NCT01029054|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153477112|NCT01029054|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153884494|NCT01609907|Valsartan|valsartan|mesh-list
153477113|NCT01029054|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153477114|NCT01029054|Protease Inhibitors|protease inhibitors|mesh-ancestor
153477115|NCT01029054|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153477116|NCT01029054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153477117|NCT01029054|Immunologic Factors|immunologic factors|mesh-ancestor
153477124|NCT01032954|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153477125|NCT01032954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153477126|NCT01032954|Cholinergic Agents|cholinergic agents|mesh-ancestor
153477127|NCT01032954|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153477128|NCT01032954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153477129|NCT05402826|Vitamin E|vitamin e|mesh-list
153477130|NCT05402826|Vitamins|vitamins|mesh-ancestor
153477131|NCT05402826|Micronutrients|micronutrients|mesh-ancestor
153477132|NCT05402826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153477133|NCT05402826|Antioxidants|antioxidants|mesh-ancestor
153477134|NCT05402826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153477135|NCT05402826|Protective Agents|protective agents|mesh-ancestor
153477136|NCT05179668|Dapagliflozin|dapagliflozin|mesh-list
153477137|NCT05179668|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
153477138|NCT05179668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153477139|NCT05179668|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153477140|NCT05179668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153477141|NCT04460430|Neratinib|neratinib|mesh-list
153477142|NCT04460430|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153813824|NCT00437385|Antidepressive Agents|antidepressive agents|mesh-ancestor
153813825|NCT00437385|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153477143|NCT04460430|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153477144|NCT04460430|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153477145|NCT04460430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153477146|NCT04316910|Anesthetics|anesthetics|mesh-list
153477147|NCT04316910|Anesthetics, General|anesthetics, general|mesh-list
153477148|NCT04316910|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153477149|NCT04316910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153477150|NCT01842672|Mitoxantrone|mitoxantrone|mesh-list
153477151|NCT01842672|Clofarabine|clofarabine|mesh-list
153477152|NCT01842672|Analgesics|analgesics|mesh-ancestor
153477153|NCT01842672|Sensory System Agents|sensory system agents|mesh-ancestor
153477160|NCT01842672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153477161|NCT01842672|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153477162|NCT01842672|Antimetabolites|antimetabolites|mesh-ancestor
153477163|NCT01034592|Lenalidomide|lenalidomide|mesh-list
153477164|NCT01034592|Immunologic Factors|immunologic factors|mesh-ancestor
153477165|NCT01034592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153477166|NCT01034592|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153477167|NCT01034592|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153477168|NCT01034592|Growth Substances|growth substances|mesh-ancestor
153477169|NCT01034592|Growth Inhibitors|growth inhibitors|mesh-ancestor
153477170|NCT01034592|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153477171|NCT01037790|Palbociclib|palbociclib|mesh-list
153477172|NCT01037790|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153477173|NCT01037790|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153477174|NCT01037790|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153477175|NCT01037790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153477176|NCT01043094|Pitavastatin|pitavastatin|mesh-list
153477177|NCT01043094|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
153477196|NCT01043640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153477198|NCT01043640|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153477199|NCT01043640|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153477200|NCT01043640|Antifungal Agents|antifungal agents|mesh-ancestor
153477201|NCT01043640|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153477202|NCT01043640|Dermatologic Agents|dermatologic agents|mesh-ancestor
153477203|NCT01043640|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
153477204|NCT01043640|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153477205|NCT01043640|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
153477206|NCT01043640|Antitubercular Agents|antitubercular agents|mesh-ancestor
153477207|NCT01043640|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153477208|NCT01043640|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153477209|NCT01044966|Temozolomide|temozolomide|mesh-list
153477244|NCT01050660|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
153884510|NCT00593580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153884512|NCT00593580|Micronutrients|micronutrients|mesh-ancestor
153884514|NCT04327011|Flucytosine|flucytosine|mesh-list
153477245|NCT01050660|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-list
153477246|NCT01050660|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
153477247|NCT01050660|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
153477248|NCT01051440|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
153477249|NCT01051440|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
153477250|NCT01051440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153477251|NCT01051440|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
153477252|NCT01051440|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153477253|NCT01051440|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153477254|NCT01051440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153477255|NCT01051440|Dopamine Agents|dopamine agents|mesh-ancestor
153477256|NCT01051440|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153477257|NCT01051596|Temozolomide|temozolomide|mesh-list
153477258|NCT01051596|Veliparib|veliparib|mesh-list
153477259|NCT01051596|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153477260|NCT01051596|Alkylating Agents|alkylating agents|mesh-ancestor
153477261|NCT01051596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153477262|NCT01051596|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153477263|NCT01051596|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
153477264|NCT01051596|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153477265|NCT01053000|Tazarotene|tazarotene|mesh-list
153477266|NCT01053000|Dermatologic Agents|dermatologic agents|mesh-ancestor
153477267|NCT01053000|Keratolytic Agents|keratolytic agents|mesh-ancestor
153477268|NCT05822453|Gemcitabine|gemcitabine|mesh-list
153884519|NCT00593619|Iron|iron|mesh-list
153884520|NCT00593619|Dextrans|dextrans|mesh-list
153884521|NCT00593619|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
153884522|NCT00593619|Iron-Dextran Complex|iron-dextran complex|mesh-list
153884523|NCT00593619|Trace Elements|trace elements|mesh-ancestor
153884524|NCT00593619|Micronutrients|micronutrients|mesh-ancestor
153884526|NCT00593619|Hematinics|hematinics|mesh-ancestor
153425470|NCT00376987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153425471|NCT01889420|Everolimus|everolimus|mesh-list
153425472|NCT01889420|Pomalidomide|pomalidomide|mesh-list
153425473|NCT01889420|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
153425474|NCT01889420|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153477280|NCT01028820|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153477281|NCT01028820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153477282|NCT01028820|Dopamine Agonists|dopamine agonists|mesh-ancestor
153477283|NCT01028820|Dopamine Agents|dopamine agents|mesh-ancestor
153477284|NCT01028820|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153477285|NCT01028820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153477286|NCT01028820|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
153477287|NCT01028820|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
153477288|NCT01028820|Serotonin Agents|serotonin agents|mesh-ancestor
153477289|NCT01028820|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
153477290|NCT01028820|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153477291|NCT01028820|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
153884527|NCT00593619|Anticoagulants|anticoagulants|mesh-ancestor
153884528|NCT00593619|Plasma Substitutes|plasma substitutes|mesh-ancestor
153884529|NCT00593619|Blood Substitutes|blood substitutes|mesh-ancestor
153884530|NCT00593658|Pentoxifylline|pentoxifylline|mesh-list
153884531|NCT00593658|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
153884532|NCT00593658|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153477299|NCT05822323|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153477300|NCT05822323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153477301|NCT05822323|Cholinergic Agents|cholinergic agents|mesh-ancestor
153884533|NCT00593658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153884534|NCT00593658|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153884535|NCT00593658|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
153884536|NCT00593658|Protective Agents|protective agents|mesh-ancestor
153884537|NCT00593658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153884538|NCT00593658|Vasodilator Agents|vasodilator agents|mesh-ancestor
153884539|NCT00593658|Free Radical Scavengers|free radical scavengers|mesh-ancestor
153884541|NCT00593697|Docetaxel|docetaxel|mesh-list
153884542|NCT00593697|Trastuzumab|trastuzumab|mesh-list
153425486|NCT00379028|Budesonide|budesonide|mesh-list
153425487|NCT00379028|Formoterol Fumarate|formoterol fumarate|mesh-list
153425488|NCT00379028|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
153425499|NCT00379028|Hormones|hormones|mesh-ancestor
153477303|NCT05821751|Pembrolizumab|pembrolizumab|mesh-list
153477304|NCT05821751|Nivolumab|nivolumab|mesh-list
153477305|NCT05821751|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153477306|NCT05821751|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153477307|NCT05821751|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153477308|NCT05821751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153477309|NCT05821712|Listerine|listerine|mesh-list
153477310|NCT05821712|Fluorides|fluorides|mesh-list
153477311|NCT05821712|Sodium Fluoride|sodium fluoride|mesh-list
153477312|NCT05821712|Cariostatic Agents|cariostatic agents|mesh-ancestor
153813826|NCT00437385|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153477313|NCT05821712|Protective Agents|protective agents|mesh-ancestor
153477314|NCT05821712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153477315|NCT05821712|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
153477316|NCT05821712|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153477317|NCT05821452|Paclitaxel|paclitaxel|mesh-list
153477318|NCT05821452|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
153477319|NCT05821452|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153477320|NCT05821452|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153477321|NCT05821452|Tubulin Modulators|tubulin modulators|mesh-ancestor
153477324|NCT05821452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153477325|NCT05821361|Bevacizumab|bevacizumab|mesh-list
153477326|NCT05821361|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153477327|NCT05821361|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153477328|NCT05821361|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153477329|NCT05821361|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153477330|NCT05821361|Growth Substances|growth substances|mesh-ancestor
153477331|NCT05821361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153477332|NCT05821361|Growth Inhibitors|growth inhibitors|mesh-ancestor
153477333|NCT05821192|Dexamethasone|dexamethasone|mesh-list
153477334|NCT05821192|Rituximab|rituximab|mesh-list
153884543|NCT00593697|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153884544|NCT00593697|Tubulin Modulators|tubulin modulators|mesh-ancestor
153477335|NCT05821192|Gemcitabine|gemcitabine|mesh-list
153477336|NCT05821192|Antibodies|antibodies|mesh-list
153477337|NCT05821192|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
153477338|NCT05821192|Immunologic Factors|immunologic factors|mesh-ancestor
153477354|NCT05821192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153477356|NCT05821153|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153477357|NCT05821153|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153477358|NCT05821153|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153477359|NCT05821153|Antiviral Agents|antiviral agents|mesh-ancestor
153884545|NCT00593697|Antimitotic Agents|antimitotic agents|mesh-ancestor
153884546|NCT00593697|Mitosis Modulators|mitosis modulators|mesh-ancestor
153884549|NCT01601522|Ranitidine|ranitidine|mesh-list
153477362|NCT05821062|Clopidogrel|clopidogrel|mesh-list
153477363|NCT05821062|Ticagrelor|ticagrelor|mesh-list
153477364|NCT05821062|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
153477365|NCT05821062|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153477366|NCT05821062|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153477367|NCT05821062|Analgesics|analgesics|mesh-ancestor
153477368|NCT05821062|Sensory System Agents|sensory system agents|mesh-ancestor
153477369|NCT05821062|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153477370|NCT05821062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153477371|NCT05821062|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153477372|NCT05821062|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153477373|NCT05821062|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153477374|NCT05821062|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153477375|NCT05821062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153477376|NCT05821062|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153477388|NCT05817162|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153477389|NCT05817162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153477390|NCT05817162|Sensory System Agents|sensory system agents|mesh-ancestor
153477391|NCT05817162|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153477392|NCT05809180|Rituximab|rituximab|mesh-list
153477393|NCT05809180|Pomalidomide|pomalidomide|mesh-list
153477394|NCT05809180|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153477395|NCT05809180|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153477396|NCT05809180|Immunologic Factors|immunologic factors|mesh-ancestor
153477397|NCT05809180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153477398|NCT05809180|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153477399|NCT05809180|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153477400|NCT05809180|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153477401|NCT05809180|Growth Substances|growth substances|mesh-ancestor
153477402|NCT05809180|Growth Inhibitors|growth inhibitors|mesh-ancestor
153477403|NCT05802238|Tranexamic Acid|tranexamic acid|mesh-list
153477404|NCT05802238|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
153477405|NCT05802238|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153477406|NCT05802238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153477407|NCT05802238|Hemostatics|hemostatics|mesh-ancestor
153477408|NCT05802238|Coagulants|coagulants|mesh-ancestor
153477409|NCT05796570|Decitabine|decitabine|mesh-list
153477410|NCT05796570|Lenograstim|lenograstim|mesh-list
153477411|NCT05796570|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153477412|NCT05796570|Immunologic Factors|immunologic factors|mesh-ancestor
153884557|NCT01601522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153884558|NCT01601522|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
153884559|NCT01601522|Histamine Agents|histamine agents|mesh-ancestor
153884560|NCT01601522|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
153884561|NCT01601522|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153884562|NCT01601522|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
153884563|NCT00593853|Methylphenidate|methylphenidate|mesh-list
153884564|NCT00593853|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
153884565|NCT00593853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153884566|NCT00593853|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
153425510|NCT00379262|Antimetabolites|antimetabolites|mesh-ancestor
153477431|NCT06024005|Solifenacin Succinate|solifenacin succinate|mesh-list
153477432|NCT06024005|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
153477433|NCT06024005|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
153477434|NCT06024005|Cholinergic Agents|cholinergic agents|mesh-ancestor
153477435|NCT06024005|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153477436|NCT06024005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153477437|NCT06024005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153477438|NCT06024005|Urological Agents|urological agents|mesh-ancestor
153477439|NCT06023875|Docetaxel|docetaxel|mesh-list
153477440|NCT06023875|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153477441|NCT06023875|Tubulin Modulators|tubulin modulators|mesh-ancestor
153477442|NCT06023875|Antimitotic Agents|antimitotic agents|mesh-ancestor
153477443|NCT06023875|Mitosis Modulators|mitosis modulators|mesh-ancestor
153477444|NCT06023875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153477445|NCT05814042|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
153477447|NCT05557877|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153477448|NCT05557877|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153425514|NCT00379262|Immunologic Factors|immunologic factors|mesh-ancestor
153425515|NCT00379262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153425516|NCT00793520|Milnacipran|milnacipran|mesh-list
153425517|NCT00793520|Levomilnacipran|levomilnacipran|mesh-list
153425518|NCT00793520|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
153425519|NCT00793520|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153425520|NCT00793520|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153425521|NCT00793520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153425522|NCT00793520|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153425523|NCT00793520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153425524|NCT00793520|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153425525|NCT00793520|Analgesics|analgesics|mesh-ancestor
153425526|NCT00793520|Sensory System Agents|sensory system agents|mesh-ancestor
153477451|NCT05557877|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153477452|NCT05557877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153477453|NCT05557877|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153477454|NCT05557877|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153477455|NCT05557877|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153477456|NCT05557877|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153477457|NCT05557877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153477458|NCT05557877|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153477459|NCT05557877|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153477460|NCT05557877|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153477461|NCT05557877|Antipyretics|antipyretics|mesh-ancestor
153477462|NCT05297396|Analgesics, Opioid|analgesics, opioid|mesh-list
153477463|NCT05297396|Narcotics|narcotics|mesh-ancestor
153477464|NCT05297396|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153477465|NCT05297396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153477466|NCT05297396|Analgesics|analgesics|mesh-ancestor
153477467|NCT05297396|Sensory System Agents|sensory system agents|mesh-ancestor
153477468|NCT05297396|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153477469|NCT03695471|Pembrolizumab|pembrolizumab|mesh-list
153477470|NCT03695471|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153477471|NCT03695471|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153477561|NCT05398484|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153477562|NCT05398484|Vasodilator Agents|vasodilator agents|mesh-ancestor
153477563|NCT05398484|Vitamin B Complex|vitamin b complex|mesh-ancestor
153477564|NCT05398484|Vitamins|vitamins|mesh-ancestor
153477565|NCT05398484|Micronutrients|micronutrients|mesh-ancestor
153477566|NCT05398484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153477567|NCT05398484|Hallucinogens|hallucinogens|mesh-ancestor
153477568|NCT05398484|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153477569|NCT05292755|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
153477570|NCT05292755|Lubricant Eye Drops|lubricant eye drops|mesh-list
153477571|NCT05292755|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
153477572|NCT05292755|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
153477573|NCT05292755|Laxatives|laxatives|mesh-ancestor
153477574|NCT05292755|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153477575|NCT05283395|Ophthalmic Solutions|ophthalmic solutions|mesh-list
153477576|NCT05283395|Latanoprost|latanoprost|mesh-list
153477577|NCT05283395|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
153477578|NCT05270863|Brimonidine Tartrate|brimonidine tartrate|mesh-list
153477579|NCT05270863|Carbachol|carbachol|mesh-list
153477580|NCT05270863|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153477581|NCT05270863|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
153884567|NCT00593853|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153884568|NCT00593853|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153884569|NCT00593853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153884570|NCT00593853|Dopamine Agents|dopamine agents|mesh-ancestor
153884571|NCT00593853|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153884572|NCT01607294|8-hydroxy-2,2,14,14-tetramethylpentadecanedioic acid|8-hydroxy-2,2,14,14-tetramethylpentadecanedioic acid|mesh-list
153477582|NCT05270863|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153477583|NCT05270863|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153477584|NCT05270863|Adrenergic Agents|adrenergic agents|mesh-ancestor
153477585|NCT05270863|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153477586|NCT05270863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153477587|NCT05270863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153477588|NCT05270863|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
153477589|NCT05270863|Miotics|miotics|mesh-ancestor
153477590|NCT05270863|Autonomic Agents|autonomic agents|mesh-ancestor
153477591|NCT05270863|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153477592|NCT05270863|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
153477595|NCT05270863|Analgesics|analgesics|mesh-ancestor
153477605|NCT05232409|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153477606|NCT05232409|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153477607|NCT05232409|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153477608|NCT05232409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153477609|NCT05014087|Digoxin|digoxin|mesh-list
153477610|NCT05014087|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153477645|NCT04908371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153477647|NCT04908371|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153477648|NCT04908371|Adrenergic Agents|adrenergic agents|mesh-ancestor
153477649|NCT04908371|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153477650|NCT04908371|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
153477651|NCT04908371|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153477660|NCT04838379|Bupivacaine|bupivacaine|mesh-list
153477661|NCT04838379|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153477662|NCT04838379|Antiemetics|antiemetics|mesh-ancestor
153477663|NCT04838379|Autonomic Agents|autonomic agents|mesh-ancestor
153477664|NCT04838379|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153477665|NCT04838379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153477666|NCT04838379|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153477667|NCT04838379|Glucocorticoids|glucocorticoids|mesh-ancestor
153477668|NCT04838379|Hormones|hormones|mesh-ancestor
153477669|NCT04838379|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153477670|NCT04838379|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153477671|NCT04838379|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153477672|NCT04838379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153884577|NCT01607294|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153884578|NCT01607294|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153884579|NCT01607294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153884581|NCT00594087|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153884582|NCT00594087|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153477677|NCT04838379|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153477678|NCT04838379|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153477679|NCT04838379|Analgesics|analgesics|mesh-ancestor
153477680|NCT04838379|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
153477681|NCT04838379|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153477682|NCT04838379|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153477683|NCT04838379|Adrenergic Agents|adrenergic agents|mesh-ancestor
153477684|NCT04838379|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153477685|NCT04830878|Methotrexate|methotrexate|mesh-list
153477686|NCT04830878|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
153477687|NCT04830878|Abortifacient Agents|abortifacient agents|mesh-ancestor
153477688|NCT04830878|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153477689|NCT04830878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153477690|NCT04830878|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153477691|NCT04830878|Antimetabolites|antimetabolites|mesh-ancestor
153477692|NCT04830878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153477693|NCT04830878|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153477694|NCT04830878|Dermatologic Agents|dermatologic agents|mesh-ancestor
153477695|NCT04830878|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153477696|NCT04830878|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153477697|NCT04830878|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153477698|NCT04830878|Immunologic Factors|immunologic factors|mesh-ancestor
153477699|NCT04830878|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153477700|NCT04830878|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153477701|NCT04800107|Curcumin|curcumin|mesh-list
153477702|NCT04800107|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153477703|NCT04800107|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153477704|NCT04800107|Analgesics|analgesics|mesh-ancestor
153477705|NCT04800107|Sensory System Agents|sensory system agents|mesh-ancestor
153477706|NCT04800107|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153477707|NCT04800107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153884583|NCT00594087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153477708|NCT04800107|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153477709|NCT04800107|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153477710|NCT04800107|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153477717|NCT04786574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153477736|NCT04716296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153477737|NCT04716296|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
153477738|NCT04716296|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153477739|NCT04716296|Anesthetics, General|anesthetics, general|mesh-ancestor
153477741|NCT04716296|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153477742|NCT04716296|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
153884584|NCT00594126|Imetelstat|imetelstat|mesh-list
153884585|NCT00594126|Motesanib diphosphate|motesanib diphosphate|mesh-list
153884586|NCT00594126|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153884587|NCT00594126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153884588|NCT00594126|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153884589|NCT01605344|Leucovorin|leucovorin|mesh-list
153884590|NCT01605344|Fluorouracil|fluorouracil|mesh-list
153884591|NCT01605344|Irinotecan|irinotecan|mesh-list
153884592|NCT01605344|Atorvastatin|atorvastatin|mesh-list
153884593|NCT01605344|Antimetabolites|antimetabolites|mesh-ancestor
153884594|NCT01605344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153477745|NCT04716296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153477746|NCT04704141|Hormones|hormones|mesh-list
153477747|NCT04704141|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153477749|NCT04682041|Immunoglobulins|immunoglobulins|mesh-list
153477772|NCT04652661|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153477783|NCT04590781|Pembrolizumab|pembrolizumab|mesh-list
153477784|NCT04590781|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153477785|NCT04590781|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153477786|NCT04590781|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153477787|NCT04590781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153477788|NCT04573751|Verapamil|verapamil|mesh-list
153477789|NCT04573751|Epinephrine|epinephrine|mesh-list
153477790|NCT04573751|Racepinephrine|racepinephrine|mesh-list
153477791|NCT04573751|Epinephryl borate|epinephryl borate|mesh-list
153477792|NCT04573751|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153477793|NCT04573751|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153477794|NCT04573751|Adrenergic Agents|adrenergic agents|mesh-ancestor
153477795|NCT04573751|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153477796|NCT04573751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153477797|NCT04573751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153477798|NCT04573751|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
153477799|NCT04573751|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153477800|NCT04573751|Autonomic Agents|autonomic agents|mesh-ancestor
153477801|NCT04573751|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153477802|NCT04573751|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153477803|NCT04573751|Respiratory System Agents|respiratory system agents|mesh-ancestor
153477804|NCT04573751|Mydriatics|mydriatics|mesh-ancestor
153477805|NCT04573751|Sympathomimetics|sympathomimetics|mesh-ancestor
153477806|NCT04573751|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
153477807|NCT04573751|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153477808|NCT04573751|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153477809|NCT04573751|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153477810|NCT04573751|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153477811|NCT04573751|Vasodilator Agents|vasodilator agents|mesh-ancestor
153477812|NCT04522622|Teriparatide|teriparatide|mesh-list
153477813|NCT04522622|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153477814|NCT04522622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153477815|NCT04522622|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153477816|NCT04432207|Atezolizumab|atezolizumab|mesh-list
153477817|NCT04432207|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153477828|NCT04148105|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153477829|NCT04148105|Autonomic Agents|autonomic agents|mesh-ancestor
153477830|NCT04148105|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153477831|NCT04148105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153477832|NCT04148105|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153477833|NCT04148105|Respiratory System Agents|respiratory system agents|mesh-ancestor
153477834|NCT04148105|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153477835|NCT04148105|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153477836|NCT04148105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153477849|NCT04033419|Dopamine Agents|dopamine agents|mesh-ancestor
153477850|NCT04033419|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153477851|NCT04033419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153884597|NCT01605344|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153884598|NCT01605344|Immunologic Factors|immunologic factors|mesh-ancestor
153884599|NCT01605344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153884600|NCT01605344|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
153884601|NCT01605344|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153884602|NCT01605344|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153884603|NCT01605344|Antidotes|antidotes|mesh-ancestor
153884606|NCT01605344|Vitamins|vitamins|mesh-ancestor
153477852|NCT04033419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153477853|NCT04033419|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
153477854|NCT04033419|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
153477855|NCT04014283|Selenium|selenium|mesh-list
153477856|NCT04014283|Antioxidants|antioxidants|mesh-ancestor
153477857|NCT04014283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153477858|NCT04014283|Protective Agents|protective agents|mesh-ancestor
153477859|NCT04014283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153477860|NCT04014283|Trace Elements|trace elements|mesh-ancestor
153477861|NCT04014283|Micronutrients|micronutrients|mesh-ancestor
153477862|NCT03912233|Ivacaftor|ivacaftor|mesh-list
153477863|NCT03912233|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
153477864|NCT03912233|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153477865|NCT03912233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153477866|NCT03842865|Immunomodulating Agents|immunomodulating agents|mesh-list
153477867|NCT03842865|Immunologic Factors|immunologic factors|mesh-ancestor
153477868|NCT03842865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153477869|NCT03781817|Ketamine|ketamine|mesh-list
153477870|NCT03781817|Analgesics|analgesics|mesh-ancestor
153477871|NCT03781817|Sensory System Agents|sensory system agents|mesh-ancestor
153477872|NCT03781817|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153477873|NCT03781817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153477874|NCT03781817|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
153477875|NCT03781817|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153477926|NCT02621489|Metformin|metformin|mesh-list
153477927|NCT02621489|Insulin Aspart|insulin aspart|mesh-list
153477928|NCT02621489|Exenatide|exenatide|mesh-list
153477929|NCT02621489|Biguanides|biguanides|mesh-list
153477930|NCT02621489|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153477931|NCT02621489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153477932|NCT02621489|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
153477933|NCT02621489|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
153477934|NCT02621489|Incretins|incretins|mesh-ancestor
153477935|NCT02621489|Hormones|hormones|mesh-ancestor
153477936|NCT02621489|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153477937|NCT02596880|Ribavirin|ribavirin|mesh-list
153477938|NCT02596880|Sofosbuvir|sofosbuvir|mesh-list
153477939|NCT02596880|Antimetabolites|antimetabolites|mesh-ancestor
153477940|NCT02596880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153477941|NCT02596880|Antiviral Agents|antiviral agents|mesh-ancestor
153477942|NCT02596880|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153477979|NCT01591291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153477980|NCT01093300|Paclitaxel|paclitaxel|mesh-list
153477981|NCT01093300|Everolimus|everolimus|mesh-list
153477982|NCT01093300|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153477983|NCT01093300|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153477984|NCT01093300|Tubulin Modulators|tubulin modulators|mesh-ancestor
153477985|NCT01093300|Antimitotic Agents|antimitotic agents|mesh-ancestor
153477986|NCT01093300|Mitosis Modulators|mitosis modulators|mesh-ancestor
153477987|NCT01093300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153477988|NCT01093300|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
153477989|NCT01093300|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153477990|NCT01093300|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153477991|NCT01093300|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153477992|NCT01093300|Immunologic Factors|immunologic factors|mesh-ancestor
153477993|NCT01093300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153477995|NCT01053078|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
153477996|NCT01053078|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
153477997|NCT01053078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153477998|NCT01053078|Sensory System Agents|sensory system agents|mesh-ancestor
153477999|NCT01053078|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153478000|NCT01053156|Minocycline|minocycline|mesh-list
153478001|NCT01053156|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153478002|NCT01053156|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153478003|NCT01053312|Flutemetamol|flutemetamol|mesh-list
153478004|NCT01053312|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
153478005|NCT01053312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153478006|NCT01054404|Furosemide|furosemide|mesh-list
153478007|NCT01054404|Diuretics|diuretics|mesh-ancestor
153478008|NCT01054404|Natriuretic Agents|natriuretic agents|mesh-ancestor
153478009|NCT01054404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153884637|NCT00593463|Vasodilator Agents|vasodilator agents|mesh-ancestor
153478012|NCT01054404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153884667|NCT01605734|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153884668|NCT01605734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153884671|NCT01605734|Hormones|hormones|mesh-ancestor
153478038|NCT01061034|Omeprazole|omeprazole|mesh-list
153478039|NCT01061034|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153478040|NCT01061034|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153478041|NCT01061034|Analgesics|analgesics|mesh-ancestor
153478042|NCT01061034|Sensory System Agents|sensory system agents|mesh-ancestor
153478043|NCT01061034|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153478044|NCT01061034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153813828|NCT00437385|Antimanic Agents|antimanic agents|mesh-ancestor
153478045|NCT01061034|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153478046|NCT01061034|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153478047|NCT01061034|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153478048|NCT01061034|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153478049|NCT01061034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153478050|NCT01061034|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153478051|NCT01061034|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153884674|NCT01605734|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153884675|NCT01605773|Glyburide|glyburide|mesh-list
153884676|NCT01605773|Repaglinide|repaglinide|mesh-list
153884677|NCT01605773|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153884678|NCT01605773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153884679|NCT00592527|Insulin Detemir|insulin detemir|mesh-list
153884680|NCT00592527|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153884681|NCT00592527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153884682|NCT00594555|Cytarabine|cytarabine|mesh-list
153478059|NCT01065558|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153478060|NCT01065558|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153478061|NCT01065558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153478062|NCT01065558|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153478063|NCT01065558|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
153478065|NCT01065558|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153478066|NCT01065558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153478067|NCT01066026|Hyaluronic Acid|hyaluronic acid|mesh-list
153478068|NCT01066026|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153478069|NCT01066026|Immunologic Factors|immunologic factors|mesh-ancestor
153478070|NCT01066026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153478071|NCT01066026|Viscosupplements|viscosupplements|mesh-ancestor
153478072|NCT01066026|Protective Agents|protective agents|mesh-ancestor
153478073|NCT01072188|Calcium Carbonate|calcium carbonate|mesh-list
153478074|NCT01072188|Calcium|calcium|mesh-list
153478075|NCT01072188|Fluorides|fluorides|mesh-list
153478076|NCT01072188|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153478077|NCT01072188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153478078|NCT01072188|Cariostatic Agents|cariostatic agents|mesh-ancestor
153478079|NCT01072188|Protective Agents|protective agents|mesh-ancestor
153478080|NCT01072188|Antacids|antacids|mesh-ancestor
153478081|NCT01072188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153478082|NCT01072188|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153478083|NCT01083732|Dabigatran|dabigatran|mesh-list
153478090|NCT01084278|Colchicine|colchicine|mesh-list
153478091|NCT01084278|Gout Suppressants|gout suppressants|mesh-ancestor
153478092|NCT01084278|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153478093|NCT01084278|Tubulin Modulators|tubulin modulators|mesh-ancestor
153478094|NCT01084278|Antimitotic Agents|antimitotic agents|mesh-ancestor
153478095|NCT01084278|Mitosis Modulators|mitosis modulators|mesh-ancestor
153478096|NCT01084278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153478097|NCT01084278|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153478098|NCT01085760|Metronidazole|metronidazole|mesh-list
153478099|NCT01085760|Vancomycin|vancomycin|mesh-list
153478100|NCT01085760|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153478101|NCT01085760|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153478102|NCT01085760|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153478103|NCT01085760|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153478104|NCT01090752|Metformin|metformin|mesh-list
153478105|NCT01090752|Pioglitazone|pioglitazone|mesh-list
153478106|NCT01090752|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153478107|NCT01090752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153478108|NCT01093794|Metformin|metformin|mesh-list
153478109|NCT01093794|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
153478110|NCT01093794|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153478120|NCT01094106|Anesthetics, Local|anesthetics, local|mesh-ancestor
153478121|NCT01094106|Anesthetics|anesthetics|mesh-ancestor
153478122|NCT01094106|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153478123|NCT01094106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153478124|NCT01094106|Sensory System Agents|sensory system agents|mesh-ancestor
153478125|NCT01094106|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153813829|NCT00437385|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153478126|NCT01094574|Propranolol|propranolol|mesh-list
153478127|NCT01094574|Alfentanil|alfentanil|mesh-list
153478128|NCT01094574|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
153478129|NCT01094574|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
153478130|NCT01094574|Adrenergic Agents|adrenergic agents|mesh-ancestor
153478131|NCT01094574|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153478132|NCT01094574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153478133|NCT01094574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153478134|NCT01094574|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153478135|NCT01094574|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153425639|NCT00691652|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153425640|NCT00691652|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153425641|NCT00691652|Immunologic Factors|immunologic factors|mesh-ancestor
153425642|NCT00691652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153425643|NCT00691652|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153425644|NCT00691652|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153425645|NCT00691652|Antimetabolites|antimetabolites|mesh-ancestor
153425646|NCT00691652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153425648|NCT00691574|Antioxidants|antioxidants|mesh-ancestor
153425649|NCT00691574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153425650|NCT00691574|Protective Agents|protective agents|mesh-ancestor
153425651|NCT00691574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153425653|NCT00685880|Betamethasone|betamethasone|mesh-list
153478136|NCT01094574|Vasodilator Agents|vasodilator agents|mesh-ancestor
153478137|NCT01094574|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153478138|NCT01094574|Narcotics|narcotics|mesh-ancestor
153478139|NCT01094574|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153478140|NCT01094574|Analgesics|analgesics|mesh-ancestor
153478141|NCT01094574|Sensory System Agents|sensory system agents|mesh-ancestor
153478142|NCT01094574|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153478143|NCT01094574|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153478144|NCT01094574|Anesthetics, General|anesthetics, general|mesh-ancestor
153478145|NCT01094574|Anesthetics|anesthetics|mesh-ancestor
153478146|NCT01095510|Complement C1 Inhibitor Protein|complement c1 inhibitor protein|mesh-list
153478147|NCT01095510|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
153478162|NCT01096680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153478164|NCT01096680|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153478165|NCT01096680|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
153478166|NCT01096680|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
153478167|NCT01096680|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
153478169|NCT01096992|Fludarabine|fludarabine|mesh-list
153478170|NCT01096992|Fludarabine phosphate|fludarabine phosphate|mesh-list
153478171|NCT01096992|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
153884697|NCT01605929|Mepivacaine|mepivacaine|mesh-list
153884698|NCT01605929|Anesthetics, Local|anesthetics, local|mesh-ancestor
153884699|NCT01605929|Anesthetics|anesthetics|mesh-ancestor
153884700|NCT01605929|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153884701|NCT01605929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153884702|NCT01605929|Sensory System Agents|sensory system agents|mesh-ancestor
153884703|NCT01605929|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153884704|NCT02270606|Calcium, Dietary|calcium, dietary|mesh-list
153884705|NCT02270606|Leucovorin|leucovorin|mesh-list
153884706|NCT02270606|Tetrahydrofolates|tetrahydrofolates|mesh-list
153478172|NCT01096992|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153478173|NCT01096992|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153478174|NCT01096992|Immunologic Factors|immunologic factors|mesh-ancestor
153478175|NCT01096992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153478176|NCT01096992|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153478177|NCT01096992|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153478178|NCT01096992|Antimetabolites|antimetabolites|mesh-ancestor
153478179|NCT01096992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153478180|NCT01096992|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153478181|NCT01096992|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153478182|NCT01096992|Alkylating Agents|alkylating agents|mesh-ancestor
153478183|NCT01097304|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
153478184|NCT01097304|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
153478185|NCT01097304|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153478186|NCT01097460|Trastuzumab|trastuzumab|mesh-list
153478187|NCT01097460|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153478188|NCT01097460|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153478189|NCT01098318|Sertraline|sertraline|mesh-list
153478190|NCT01098318|Antidepressive Agents|antidepressive agents|mesh-ancestor
153478236|NCT01103934|Cholecalciferol|cholecalciferol|mesh-list
153478239|NCT01103934|Vitamins|vitamins|mesh-ancestor
153478240|NCT01103934|Micronutrients|micronutrients|mesh-ancestor
153478241|NCT01103934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153478242|NCT01103934|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153478243|NCT01103934|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153478250|NCT01103934|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
153478251|NCT01103934|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153478253|NCT01105650|Methylprednisolone|methylprednisolone|mesh-list
153478254|NCT01105650|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
153478255|NCT01105650|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
153478256|NCT01105650|Prednisolone|prednisolone|mesh-list
153478257|NCT01105650|Prednisolone acetate|prednisolone acetate|mesh-list
153884707|NCT02270606|Formyltetrahydrofolates|formyltetrahydrofolates|mesh-list
153478259|NCT01105650|Fludarabine|fludarabine|mesh-list
153478260|NCT01105650|Interleukin-2|interleukin-2|mesh-list
153478261|NCT01105650|Cyclosporins|cyclosporins|mesh-list
153478262|NCT01105650|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
153478263|NCT01105650|Prednisolone phosphate|prednisolone phosphate|mesh-list
153478264|NCT01105650|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153478265|NCT01105650|Immunologic Factors|immunologic factors|mesh-ancestor
153478266|NCT01105650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153478267|NCT01105650|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153478268|NCT01105650|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153478269|NCT01105650|Alkylating Agents|alkylating agents|mesh-ancestor
153478270|NCT01105650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153478271|NCT01105650|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153478272|NCT01105650|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153478273|NCT01105650|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153478274|NCT01105650|Antifungal Agents|antifungal agents|mesh-ancestor
153478275|NCT01105650|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153478276|NCT01105650|Dermatologic Agents|dermatologic agents|mesh-ancestor
153478277|NCT01105650|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
153478278|NCT01105650|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153478279|NCT01105650|Antiemetics|antiemetics|mesh-ancestor
153478280|NCT01105650|Autonomic Agents|autonomic agents|mesh-ancestor
153478297|NCT01110876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153478298|NCT01110876|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153478299|NCT01110876|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153478300|NCT01110876|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153478301|NCT01110876|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153478302|NCT01110876|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
153478303|NCT01112358|Cetrorelix|cetrorelix|mesh-list
153478304|NCT01112358|Progesterone|progesterone|mesh-list
153478305|NCT01112358|Progestins|progestins|mesh-ancestor
153478306|NCT01112358|Hormones|hormones|mesh-ancestor
153813832|NCT00335309|Amoxicillin|amoxicillin|mesh-list
153813833|NCT00335309|Clavulanic Acid|clavulanic acid|mesh-list
153813834|NCT00335309|Clavulanic Acids|clavulanic acids|mesh-list
153478307|NCT01112358|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153478308|NCT01112358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153478309|NCT01112358|Fertility Agents, Female|fertility agents, female|mesh-ancestor
153478310|NCT01112358|Fertility Agents|fertility agents|mesh-ancestor
153478311|NCT01112358|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153478312|NCT01112358|Hormone Antagonists|hormone antagonists|mesh-ancestor
153478313|NCT01112670|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
153478314|NCT01112670|Atorvastatin|atorvastatin|mesh-list
153478329|NCT01115556|Ranibizumab|ranibizumab|mesh-list
153478330|NCT01115556|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153478331|NCT01115556|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153478332|NCT01115556|Growth Substances|growth substances|mesh-ancestor
153478333|NCT01115556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153478334|NCT01115556|Growth Inhibitors|growth inhibitors|mesh-ancestor
153478335|NCT01115556|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153478336|NCT01116102|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
153478337|NCT01119222|Diphenhydramine|diphenhydramine|mesh-list
153478338|NCT01119222|Promethazine|promethazine|mesh-list
153478339|NCT01119222|Morphine|morphine|mesh-list
153478340|NCT01119222|Gabapentin|gabapentin|mesh-list
153478347|NCT01119222|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153884725|NCT02270606|Micronutrients|micronutrients|mesh-ancestor
153884727|NCT00594633|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
153884728|NCT00594633|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153884729|NCT00594633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153884733|NCT00594633|Nootropic Agents|nootropic agents|mesh-ancestor
153478355|NCT01119222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153478356|NCT01119222|Antimanic Agents|antimanic agents|mesh-ancestor
153478357|NCT01119222|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
153478358|NCT01119222|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153478359|NCT01119222|Anesthetics, Local|anesthetics, local|mesh-ancestor
153478361|NCT01119222|Antiemetics|antiemetics|mesh-ancestor
153478362|NCT01119222|Autonomic Agents|autonomic agents|mesh-ancestor
153478363|NCT01119222|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153478364|NCT01119222|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
153478365|NCT01119222|Histamine Antagonists|histamine antagonists|mesh-ancestor
153478366|NCT01119222|Histamine Agents|histamine agents|mesh-ancestor
153478367|NCT01119222|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
153478368|NCT01119222|Antipruritics|antipruritics|mesh-ancestor
153478369|NCT01119222|Dermatologic Agents|dermatologic agents|mesh-ancestor
153478371|NCT01120236|Goserelin|goserelin|mesh-list
153478372|NCT01120236|Bicalutamide|bicalutamide|mesh-list
153478373|NCT01120236|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
153478374|NCT01120236|Fertility Agents, Female|fertility agents, female|mesh-ancestor
153478375|NCT01120236|Fertility Agents|fertility agents|mesh-ancestor
153478376|NCT01120236|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153478377|NCT01120236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153478378|NCT01120236|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153478379|NCT01120236|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153478380|NCT01120236|Androgen Antagonists|androgen antagonists|mesh-ancestor
153478381|NCT01120236|Hormone Antagonists|hormone antagonists|mesh-ancestor
153425693|NCT01756586|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153478386|NCT01120704|Autonomic Agents|autonomic agents|mesh-ancestor
153478387|NCT01120704|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153478388|NCT01120704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153813835|NCT00335309|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153478389|NCT01120704|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
153478390|NCT01120704|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
153478391|NCT01120704|Cholinergic Agents|cholinergic agents|mesh-ancestor
153478392|NCT01120704|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153478393|NCT01120704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153478394|NCT01122108|Colesevelam Hydrochloride|colesevelam hydrochloride|mesh-list
153478395|NCT01122108|Cholestyramine Resin|cholestyramine resin|mesh-list
153478396|NCT01122108|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153478397|NCT01122108|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153478398|NCT01122108|Antimetabolites|antimetabolites|mesh-ancestor
153478399|NCT01122108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153478400|NCT01122108|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153478401|NCT05307042|Vasopressins|vasopressins|mesh-list
153478402|NCT05307042|Arginine Vasopressin|arginine vasopressin|mesh-list
153478403|NCT05307042|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
153478404|NCT05307042|Hemostatics|hemostatics|mesh-ancestor
153478405|NCT05307042|Coagulants|coagulants|mesh-ancestor
153478406|NCT05307042|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
153478407|NCT05307042|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
153478408|NCT05307042|Natriuretic Agents|natriuretic agents|mesh-ancestor
153884739|NCT01606046|Lidocaine, Prilocaine Drug Combination|lidocaine, prilocaine drug combination|mesh-list
153884740|NCT01606046|Anesthetics, Local|anesthetics, local|mesh-list
153884741|NCT01606046|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153478440|NCT03697356|Lenalidomide|lenalidomide|mesh-list
153478441|NCT03697356|Bortezomib|bortezomib|mesh-list
153478442|NCT03697356|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153478443|NCT03697356|Antiemetics|antiemetics|mesh-ancestor
153478444|NCT03697356|Autonomic Agents|autonomic agents|mesh-ancestor
153478445|NCT03697356|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153478446|NCT03697356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153478447|NCT03697356|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153478448|NCT03697356|Glucocorticoids|glucocorticoids|mesh-ancestor
153478449|NCT03697356|Hormones|hormones|mesh-ancestor
153478450|NCT03697356|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153478451|NCT03697356|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153478452|NCT03697356|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153478453|NCT03697356|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153478454|NCT03697356|Immunologic Factors|immunologic factors|mesh-ancestor
153478455|NCT03697356|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153478456|NCT03697356|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153478457|NCT03697356|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153478458|NCT03697356|Growth Substances|growth substances|mesh-ancestor
153478459|NCT03697356|Growth Inhibitors|growth inhibitors|mesh-ancestor
153478461|NCT03616782|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153478462|NCT03616782|Protease Inhibitors|protease inhibitors|mesh-ancestor
153478463|NCT03616782|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153478464|NCT03616782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153478482|NCT00255138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153478484|NCT01128192|Hormones|hormones|mesh-ancestor
153478490|NCT01128270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153478492|NCT01128972|Fluorides|fluorides|mesh-list
153478493|NCT01128972|Sodium Fluoride|sodium fluoride|mesh-list
153478494|NCT01128972|Cariostatic Agents|cariostatic agents|mesh-ancestor
153478495|NCT01128972|Protective Agents|protective agents|mesh-ancestor
153478496|NCT01128972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153478497|NCT01128972|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
153478498|NCT01128972|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153478499|NCT01129206|Deoxyglucose|deoxyglucose|mesh-list
153478500|NCT01129206|Docetaxel|docetaxel|mesh-list
153813836|NCT00335309|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153478501|NCT01129206|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
153478502|NCT01129206|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153478503|NCT01129206|Tubulin Modulators|tubulin modulators|mesh-ancestor
153478504|NCT01129206|Antimitotic Agents|antimitotic agents|mesh-ancestor
153478505|NCT01129206|Mitosis Modulators|mitosis modulators|mesh-ancestor
153478506|NCT01129206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153478507|NCT01129206|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
153478508|NCT01129206|Antimetabolites|antimetabolites|mesh-ancestor
153478509|NCT01129206|Antiviral Agents|antiviral agents|mesh-ancestor
153478511|NCT01129440|Fluorides|fluorides|mesh-list
153478512|NCT01129440|Fluorides, Topical|fluorides, topical|mesh-list
153478513|NCT01129440|Cariostatic Agents|cariostatic agents|mesh-ancestor
153478514|NCT01129440|Protective Agents|protective agents|mesh-ancestor
153478515|NCT01129440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153478516|NCT01130844|Mesalamine|mesalamine|mesh-list
153478517|NCT01130844|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153478518|NCT01130844|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153478519|NCT01130844|Analgesics|analgesics|mesh-ancestor
153884751|NCT02892942|Hormone Antagonists|hormone antagonists|mesh-ancestor
153425694|NCT01756586|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153425695|NCT01756586|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153425696|NCT01756586|Anesthetics, Local|anesthetics, local|mesh-ancestor
153425697|NCT01756586|Anesthetics|anesthetics|mesh-ancestor
153425698|NCT01756586|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153425699|NCT01756586|Sensory System Agents|sensory system agents|mesh-ancestor
153425700|NCT03636061|Varenicline|varenicline|mesh-list
153425701|NCT03636061|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
153425702|NCT03636061|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
153425703|NCT03636061|Cholinergic Agents|cholinergic agents|mesh-ancestor
153478521|NCT01130844|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153478522|NCT01130844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153478523|NCT01130844|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153478542|NCT01135368|Dexlansoprazole|dexlansoprazole|mesh-list
153478543|NCT01135368|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
153478544|NCT01135368|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153478545|NCT01135368|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
153478546|NCT01135368|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153478547|NCT01135368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153478548|NCT01136226|Leuprolide|leuprolide|mesh-list
153478549|NCT01136226|Fertility Agents, Female|fertility agents, female|mesh-ancestor
153478550|NCT01136226|Fertility Agents|fertility agents|mesh-ancestor
153478551|NCT01136226|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153478552|NCT01136226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153478553|NCT01136226|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153478554|NCT01136226|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153478555|NCT01137396|Modafinil|modafinil|mesh-list
153478556|NCT01137396|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
153478557|NCT01137396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153478558|NCT01137396|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
153478559|NCT01137396|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
153478560|NCT01137396|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
153478562|NCT01139190|Naproxen|naproxen|mesh-list
153478565|NCT01139190|Analgesics|analgesics|mesh-ancestor
153478588|NCT01142310|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153478589|NCT01142310|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153478590|NCT01142310|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153478591|NCT01142310|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153478592|NCT01142310|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153478593|NCT01144338|Exenatide|exenatide|mesh-list
153478594|NCT01144338|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
153478595|NCT01144338|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153478596|NCT01144338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153478597|NCT01144338|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
153478598|NCT01144338|Incretins|incretins|mesh-ancestor
153478599|NCT01144338|Hormones|hormones|mesh-ancestor
153478600|NCT01144338|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153478602|NCT01146600|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153478603|NCT01146600|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153478604|NCT01146600|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
153478605|NCT01146600|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153478606|NCT01146600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153478607|NCT01146600|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
153478608|NCT01146600|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153478609|NCT01146834|Plerixafor|plerixafor|mesh-list
153478610|NCT01146834|Cyclophosphamide|cyclophosphamide|mesh-list
153478611|NCT01146834|Bortezomib|bortezomib|mesh-list
153478612|NCT01146834|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153478613|NCT01146834|Immunologic Factors|immunologic factors|mesh-ancestor
153478614|NCT01146834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153478615|NCT01146834|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153478616|NCT01146834|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153478617|NCT01146834|Alkylating Agents|alkylating agents|mesh-ancestor
153478618|NCT01146834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153884752|NCT02892942|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153884753|NCT00594867|Aspirin|aspirin|mesh-list
153884754|NCT00594867|Acetaminophen|acetaminophen|mesh-list
153884755|NCT00594867|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153884756|NCT00594867|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153884757|NCT00594867|Analgesics|analgesics|mesh-ancestor
153884758|NCT00594867|Sensory System Agents|sensory system agents|mesh-ancestor
153425707|NCT00661466|Bupivacaine|bupivacaine|mesh-list
153478621|NCT01146834|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153478622|NCT01146834|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153478623|NCT01146834|Antiviral Agents|antiviral agents|mesh-ancestor
153478624|NCT01146834|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153478625|NCT01147302|Complement C1s|complement c1s|mesh-list
153478626|NCT01147302|Complement C1 Inhibitor Protein|complement c1 inhibitor protein|mesh-list
153478635|NCT01149876|Dermatologic Agents|dermatologic agents|mesh-ancestor
153478637|NCT01150500|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153478638|NCT01150500|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153478639|NCT01150500|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153478640|NCT01150500|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153478641|NCT01150500|Antifungal Agents|antifungal agents|mesh-ancestor
153478642|NCT01150500|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153478652|NCT01151046|Hormone Antagonists|hormone antagonists|mesh-ancestor
153478653|NCT01151046|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153478654|NCT01151046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153478655|NCT01151436|Hyaluronic Acid|hyaluronic acid|mesh-list
153478656|NCT01151436|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153478657|NCT01151436|Immunologic Factors|immunologic factors|mesh-ancestor
153478658|NCT01151436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153478659|NCT01151436|Viscosupplements|viscosupplements|mesh-ancestor
153478660|NCT01151436|Protective Agents|protective agents|mesh-ancestor
153478662|NCT01153620|Disinfectants|disinfectants|mesh-ancestor
153478663|NCT01153620|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153478664|NCT01163214|Ropivacaine|ropivacaine|mesh-list
153478665|NCT01163214|Anesthetics, Local|anesthetics, local|mesh-ancestor
153478666|NCT01163214|Anesthetics|anesthetics|mesh-ancestor
153478667|NCT01163214|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153478668|NCT01163214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153425721|NCT01718444|Medroxyprogesterone|medroxyprogesterone|mesh-list
153425722|NCT01718444|Progestins|progestins|mesh-list
153425723|NCT01718444|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
153425724|NCT01718444|Hormone Antagonists|hormone antagonists|mesh-ancestor
153478670|NCT01163214|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153478671|NCT01163604|Argatroban|argatroban|mesh-list
153478672|NCT01163604|Clopidogrel|clopidogrel|mesh-list
153478673|NCT01163604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153478674|NCT01163604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153478675|NCT01163604|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153478676|NCT01163604|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153478677|NCT01163604|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
153387724|NCT00000771|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153478678|NCT01163604|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
153478679|NCT01163604|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
153478680|NCT01163604|Purinergic Agents|purinergic agents|mesh-ancestor
153478681|NCT01163604|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153478682|NCT01163604|Antithrombins|antithrombins|mesh-ancestor
153813837|NCT00335309|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
153478683|NCT01163604|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
153478684|NCT01163604|Protease Inhibitors|protease inhibitors|mesh-ancestor
153478685|NCT01163604|Anticoagulants|anticoagulants|mesh-ancestor
153478686|NCT01168674|Ziprasidone|ziprasidone|mesh-list
153478687|NCT01168674|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153478688|NCT01168674|Serotonin Agents|serotonin agents|mesh-ancestor
153478689|NCT01168674|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153478690|NCT01168674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153478691|NCT01168674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153478692|NCT01168674|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153478693|NCT01168674|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153478694|NCT01168674|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153478703|NCT01168908|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153478704|NCT01168908|Urological Agents|urological agents|mesh-ancestor
153425729|NCT01718444|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153425730|NCT01718444|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
153425731|NCT01718444|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
153425732|NCT01718444|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
153425733|NCT01718444|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
153425734|NCT01718444|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
153478706|NCT01170390|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
153478707|NCT01170390|Levonorgestrel|levonorgestrel|mesh-list
153478708|NCT01170390|Ethinyl Estradiol|ethinyl estradiol|mesh-list
153478716|NCT01170390|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
153478717|NCT01170390|Contraceptive Agents|contraceptive agents|mesh-ancestor
153478718|NCT01170390|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153478719|NCT01170390|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
153478720|NCT01170390|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
153478721|NCT01170390|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
153478722|NCT01170390|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
153478723|NCT01170390|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
153884788|NCT02270918|Anticoagulants|anticoagulants|mesh-ancestor
153478726|NCT01134510|Complement C1 Inactivator Proteins|complement c1 inactivator proteins|mesh-list
153478727|NCT01134510|Immunologic Factors|immunologic factors|mesh-ancestor
153478728|NCT01134510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153478729|NCT01134510|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
153478730|NCT01134510|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153478731|NCT01171794|Ibuprofen|ibuprofen|mesh-list
153478732|NCT01171794|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153478733|NCT01171794|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153478734|NCT01171794|Analgesics|analgesics|mesh-ancestor
153478735|NCT01171794|Sensory System Agents|sensory system agents|mesh-ancestor
153478736|NCT01171794|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153478737|NCT01171794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153478738|NCT01171794|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153478739|NCT01171794|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153478740|NCT01171794|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153478741|NCT01171794|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153478742|NCT01171794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153478743|NCT01175148|Atorvastatin|atorvastatin|mesh-list
153478744|NCT01175148|Calcium|calcium|mesh-list
153478745|NCT01175148|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153478746|NCT01175148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153478747|NCT01175148|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153478748|NCT01175148|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153478749|NCT01175148|Antimetabolites|antimetabolites|mesh-ancestor
153478750|NCT01175148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153478751|NCT01175148|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153478752|NCT01175148|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
153478758|NCT01177098|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
153478759|NCT01177098|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
153380767|NCT01928693|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153380768|NCT01928693|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
153380769|NCT01928693|Contraceptive Agents|contraceptive agents|mesh-ancestor
153380770|NCT01928693|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153380771|NCT01928693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153380772|NCT01928693|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
153882701|NCT01609647|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
153882702|NCT01609647|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153478760|NCT01177098|Adrenergic Agents|adrenergic agents|mesh-ancestor
153478761|NCT01177098|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153478762|NCT01177098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153478763|NCT01177098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153478764|NCT01177098|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153478765|NCT01177098|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153478766|NCT01177956|Fluorouracil|fluorouracil|mesh-list
153478767|NCT01177956|Cetuximab|cetuximab|mesh-list
153478768|NCT01177956|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153478769|NCT01177956|Antimetabolites|antimetabolites|mesh-ancestor
153478770|NCT01177956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153478771|NCT01177956|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153478772|NCT01177956|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153478773|NCT01177956|Immunologic Factors|immunologic factors|mesh-ancestor
153478774|NCT01177956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153478793|NCT01184898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153478795|NCT01184898|Antimetabolites|antimetabolites|mesh-ancestor
153478796|NCT01184898|Antiviral Agents|antiviral agents|mesh-ancestor
153478797|NCT01184898|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153478798|NCT01184898|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153478799|NCT01184898|Immunologic Factors|immunologic factors|mesh-ancestor
153478800|NCT01184898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153478801|NCT01184898|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153478802|NCT01184898|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153478803|NCT01184898|Antifungal Agents|antifungal agents|mesh-ancestor
153478804|NCT01184898|Analgesics|analgesics|mesh-ancestor
153478805|NCT01184898|Sensory System Agents|sensory system agents|mesh-ancestor
153478806|NCT01184898|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153478807|NCT01188876|Folic Acid|folic acid|mesh-list
153478808|NCT01188876|Vitamin B 12|vitamin b 12|mesh-list
153478809|NCT01188876|Hydroxocobalamin|hydroxocobalamin|mesh-list
153478810|NCT01188876|Carboplatin|carboplatin|mesh-list
153478811|NCT01188876|Vitamins|vitamins|mesh-ancestor
153425760|NCT00634322|Protective Agents|protective agents|mesh-ancestor
153425761|NCT00634322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153425762|NCT00634322|Vitamin B Complex|vitamin b complex|mesh-ancestor
153425763|NCT00634322|Vitamins|vitamins|mesh-ancestor
153425764|NCT00634322|Micronutrients|micronutrients|mesh-ancestor
153425765|NCT00379886|Thiopental|thiopental|mesh-list
153425766|NCT00379886|Propofol|propofol|mesh-list
153425767|NCT00379886|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153425768|NCT00379886|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153478812|NCT01188876|Micronutrients|micronutrients|mesh-ancestor
153478813|NCT01188876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153478814|NCT01188876|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153478816|NCT01188876|Vitamin B Complex|vitamin b complex|mesh-ancestor
153478817|NCT01193868|2,2-dimethyl-N-(6-oxo-6,7-dihydro-5H-dibenzo(b,d)azepin-7-yl)-N'-(2,2,3,3,3-pentafluoropropyl)malonamide|2,2-dimethyl-n-(6-oxo-6,7-dihydro-5h-dibenzo(b,d)azepin-7-yl)-n'-(2,2,3,3,3-pentafluoropropyl)malonamide|mesh-list
153478818|NCT01193868|Gamma Secretase Inhibitors and Modulators|gamma secretase inhibitors and modulators|mesh-ancestor
153478819|NCT01193868|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153478820|NCT01193868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153478821|NCT01195116|Dexmedetomidine|dexmedetomidine|mesh-list
153478822|NCT01195116|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153478823|NCT01195116|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153478824|NCT01195116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153478825|NCT01195116|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153478826|NCT01195116|Analgesics|analgesics|mesh-ancestor
153478827|NCT01195116|Sensory System Agents|sensory system agents|mesh-ancestor
153478828|NCT01195116|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153478829|NCT01195116|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
153478830|NCT01195116|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153478845|NCT01197612|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153478847|NCT01198158|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
153478863|NCT01198158|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153478864|NCT01198158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153813838|NCT00335309|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153813839|NCT00335309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153478865|NCT01198158|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153478866|NCT01203774|Insulin Glargine|insulin glargine|mesh-list
153478867|NCT01203774|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153478868|NCT01203774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153478869|NCT01205646|Zoledronic Acid|zoledronic acid|mesh-list
153478870|NCT01205646|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153478871|NCT01205646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153478872|NCT01206660|Desoximetasone|desoximetasone|mesh-list
153478873|NCT01206660|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153478874|NCT01206660|Glucocorticoids|glucocorticoids|mesh-ancestor
153478875|NCT01206660|Hormones|hormones|mesh-ancestor
153478891|NCT01208922|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153478902|NCT01210560|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
153478903|NCT01210560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153478905|NCT01210560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153478906|NCT01211730|Insulin|insulin|mesh-list
153478907|NCT01211730|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
153478908|NCT01211730|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153478909|NCT01211730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153478910|NCT01212900|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-list
153478911|NCT01212900|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153478912|NCT01212900|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153478913|NCT01212900|Antimetabolites|antimetabolites|mesh-ancestor
153478914|NCT01212900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153478915|NCT01212900|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153478916|NCT01212900|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153478917|NCT01215318|Silicon|silicon|mesh-list
153478918|NCT01215318|Trace Elements|trace elements|mesh-ancestor
153478919|NCT01215318|Micronutrients|micronutrients|mesh-ancestor
153478920|NCT01215318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153478921|NCT01215786|Timolol|timolol|mesh-list
153478922|NCT01215786|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
153478937|NCT01216410|Autonomic Agents|autonomic agents|mesh-ancestor
153478938|NCT01216410|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153478939|NCT01216410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153478940|NCT01216410|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153884827|NCT02271191|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153884828|NCT02271191|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153884829|NCT02271191|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153884830|NCT02271191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153884831|NCT02271191|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153884832|NCT02271191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153884833|NCT02271191|Vasodilator Agents|vasodilator agents|mesh-ancestor
153884834|NCT00595374|Insulin|insulin|mesh-list
153884835|NCT00595374|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
153884836|NCT00595374|Insulin Aspart|insulin aspart|mesh-list
153884837|NCT00595374|Insulin Detemir|insulin detemir|mesh-list
153884838|NCT00595374|Isophane Insulin, Human|isophane insulin, human|mesh-list
153884839|NCT00595374|Insulin, Isophane|insulin, isophane|mesh-list
153884840|NCT00595374|Isophane insulin, beef|isophane insulin, beef|mesh-list
153884843|NCT00595569|Insulin|insulin|mesh-list
153478941|NCT01216410|Antipruritics|antipruritics|mesh-ancestor
153478942|NCT01216410|Dermatologic Agents|dermatologic agents|mesh-ancestor
153478943|NCT01216410|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
153478944|NCT01216410|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153478945|NCT01216410|Serotonin Agents|serotonin agents|mesh-ancestor
153478946|NCT01216410|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153478947|NCT01216410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153478992|NCT01222260|Alkylating Agents|alkylating agents|mesh-ancestor
153425790|NCT01705106|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153425791|NCT01705106|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153425792|NCT01705106|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
153425793|NCT01705106|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153425794|NCT01705106|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153425795|NCT00624650|Phenylephrine|phenylephrine|mesh-list
153425796|NCT00624650|Dobutamine|dobutamine|mesh-list
153425797|NCT00624650|Furosemide|furosemide|mesh-list
153425798|NCT00624650|Vasopressins|vasopressins|mesh-list
153425799|NCT00624650|Arginine Vasopressin|arginine vasopressin|mesh-list
153478993|NCT01222260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153478994|NCT01222572|Etoposide|etoposide|mesh-list
153478995|NCT01222572|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153478996|NCT01222572|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153478997|NCT01222572|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153478998|NCT01222572|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153478999|NCT01222572|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153479000|NCT01222572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153479014|NCT01225068|Milnacipran|milnacipran|mesh-list
153479015|NCT01225068|Levomilnacipran|levomilnacipran|mesh-list
153479016|NCT01225068|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
153479017|NCT01225068|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153479018|NCT01225068|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153479019|NCT01225068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153479020|NCT01225068|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153479021|NCT01225068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153479022|NCT01225068|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153479023|NCT01225068|Analgesics|analgesics|mesh-ancestor
153479024|NCT01225068|Sensory System Agents|sensory system agents|mesh-ancestor
153479025|NCT01225068|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153479027|NCT01225068|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153479028|NCT01226706|Botulinum Toxins|botulinum toxins|mesh-list
153479029|NCT01226706|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
153479030|NCT01226706|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
153479031|NCT01226706|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
153479032|NCT01226706|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153479033|NCT01226706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153884848|NCT02271347|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153884849|NCT01172938|Thalidomide|thalidomide|mesh-list
153884850|NCT01172938|Apremilast|apremilast|mesh-list
153884851|NCT01172938|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153884852|NCT01172938|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153884853|NCT01172938|Analgesics|analgesics|mesh-ancestor
153884854|NCT01172938|Sensory System Agents|sensory system agents|mesh-ancestor
153884855|NCT01172938|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153884856|NCT01172938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153884857|NCT01172938|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153884858|NCT01172938|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153884859|NCT01172938|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
153884860|NCT01172938|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
153884861|NCT01172938|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153479038|NCT01226706|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153479041|NCT01231230|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
153479042|NCT01231230|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
153479043|NCT01231230|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153479044|NCT01231230|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153479045|NCT01231230|Autonomic Agents|autonomic agents|mesh-ancestor
153479046|NCT01231230|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153479047|NCT01231230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153479048|NCT01231230|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153479049|NCT01231230|Respiratory System Agents|respiratory system agents|mesh-ancestor
153479050|NCT01231230|Dermatologic Agents|dermatologic agents|mesh-ancestor
153479051|NCT01231230|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
153479052|NCT01231230|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
153479053|NCT01231230|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
153479054|NCT01231230|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153479055|NCT01231230|Adrenergic Agents|adrenergic agents|mesh-ancestor
153479056|NCT01231230|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153479057|NCT01231230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153479058|NCT01231230|Glucocorticoids|glucocorticoids|mesh-ancestor
153479059|NCT01231230|Hormones|hormones|mesh-ancestor
153479061|NCT01231230|Sympathomimetics|sympathomimetics|mesh-ancestor
153479077|NCT01235910|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153479078|NCT01235910|Immunologic Factors|immunologic factors|mesh-ancestor
153479079|NCT01235910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153813841|NCT00335348|Bortezomib|bortezomib|mesh-list
153479080|NCT01235910|Antifungal Agents|antifungal agents|mesh-ancestor
153479081|NCT01235910|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153479082|NCT01235910|Dermatologic Agents|dermatologic agents|mesh-ancestor
153479083|NCT01235910|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153479084|NCT01235910|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
153479085|NCT01235910|Renin Inhibitors|renin inhibitors|mesh-ancestor
153479086|NCT01235910|Protease Inhibitors|protease inhibitors|mesh-ancestor
153479087|NCT01236378|Sirolimus|sirolimus|mesh-list
153479088|NCT01236378|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153479089|NCT01236378|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153479090|NCT01236378|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153479091|NCT01236378|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153479092|NCT01236378|Antifungal Agents|antifungal agents|mesh-ancestor
153479093|NCT01236378|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153884864|NCT01172938|Immunologic Factors|immunologic factors|mesh-ancestor
153479095|NCT01236378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153479096|NCT01236768|Contraceptive Agents|contraceptive agents|mesh-list
153479097|NCT01236768|Contraceptives, Oral|contraceptives, oral|mesh-list
153479098|NCT01236768|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-list
153479099|NCT01236768|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153479100|NCT01236768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153479101|NCT01236768|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
153479102|NCT01236768|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
153479119|NCT01247220|Growth Inhibitors|growth inhibitors|mesh-ancestor
153479120|NCT01247220|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153479121|NCT01249872|Morphine|morphine|mesh-list
153479122|NCT01249872|Levobupivacaine|levobupivacaine|mesh-list
153479123|NCT01249872|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153479124|NCT01249872|Narcotics|narcotics|mesh-ancestor
153479125|NCT01249872|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153479126|NCT01249872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153479127|NCT01249872|Analgesics|analgesics|mesh-ancestor
153479128|NCT01249872|Sensory System Agents|sensory system agents|mesh-ancestor
153479129|NCT01249872|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153479142|NCT01250184|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153479143|NCT01250184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153479145|NCT01250730|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153387725|NCT00000771|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153479146|NCT01250730|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153479147|NCT01250730|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153479148|NCT01250730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153479149|NCT01250730|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153479150|NCT01251978|Ranibizumab|ranibizumab|mesh-list
153479151|NCT01251978|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153479152|NCT01251978|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153479153|NCT01251978|Growth Substances|growth substances|mesh-ancestor
153479154|NCT01251978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153479155|NCT01251978|Growth Inhibitors|growth inhibitors|mesh-ancestor
153479156|NCT01251978|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153479157|NCT01253460|Cyclophosphamide|cyclophosphamide|mesh-list
153479158|NCT01253460|Rituximab|rituximab|mesh-list
153479159|NCT01253460|Sapacitabine|sapacitabine|mesh-list
153479160|NCT01253460|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153479161|NCT01253460|Immunologic Factors|immunologic factors|mesh-ancestor
153479162|NCT01253460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153479163|NCT01253460|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153479164|NCT01253460|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153813842|NCT00335348|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153479181|NCT01244724|Escitalopram|escitalopram|mesh-list
153479182|NCT01244724|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
153479183|NCT01244724|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153479184|NCT01244724|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153479185|NCT01244724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153479186|NCT01244724|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153479187|NCT01244724|Serotonin Agents|serotonin agents|mesh-ancestor
153479188|NCT01244724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153479189|NCT01258374|Raltegravir Potassium|raltegravir potassium|mesh-list
153479205|NCT01262118|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153479206|NCT01262118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153479207|NCT01263132|Thiamine|thiamine|mesh-list
153479208|NCT01263132|Vitamin B 12|vitamin b 12|mesh-list
153479209|NCT01263132|Gabapentin|gabapentin|mesh-list
153479210|NCT01263132|Analgesics|analgesics|mesh-ancestor
153479211|NCT01263132|Sensory System Agents|sensory system agents|mesh-ancestor
153479212|NCT01263132|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153479213|NCT01263132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153479214|NCT01263132|Anticonvulsants|anticonvulsants|mesh-ancestor
153479215|NCT01263132|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153479216|NCT01263132|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153479217|NCT01263132|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153479218|NCT01263132|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153479219|NCT01263132|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
153479220|NCT01263132|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
153884867|NCT01172938|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153479221|NCT01263132|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153479222|NCT01263132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153479225|NCT01263132|Vitamins|vitamins|mesh-ancestor
153479226|NCT01263132|Micronutrients|micronutrients|mesh-ancestor
153479227|NCT01267656|Ophthalmic Solutions|ophthalmic solutions|mesh-list
153479228|NCT01267656|Lubricant Eye Drops|lubricant eye drops|mesh-list
153479229|NCT01267656|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
153479230|NCT01270542|Bevacizumab|bevacizumab|mesh-list
153479231|NCT01270542|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153479232|NCT01270542|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153479233|NCT01270542|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153479234|NCT01270542|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153479235|NCT01270542|Growth Substances|growth substances|mesh-ancestor
153479236|NCT01270542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153479237|NCT01270542|Growth Inhibitors|growth inhibitors|mesh-ancestor
153479238|NCT01271244|Escitalopram|escitalopram|mesh-list
153360201|NCT00802100|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153479262|NCT01275300|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153479263|NCT01275300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153479264|NCT01275300|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153884892|NCT04326894|Methotrexate|methotrexate|mesh-list
153884893|NCT04326894|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
153884894|NCT04326894|Abortifacient Agents|abortifacient agents|mesh-ancestor
153425841|NCT00377143|Warfarin|warfarin|mesh-list
153425842|NCT00377143|Anticoagulants|anticoagulants|mesh-ancestor
153425843|NCT00610532|Probenecid|probenecid|mesh-list
153425844|NCT00610532|Phenytoin|phenytoin|mesh-list
153479267|NCT01275300|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153479268|NCT01275300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153479269|NCT01275300|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153479270|NCT01275300|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153479271|NCT01275300|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153479272|NCT01275300|Antipyretics|antipyretics|mesh-ancestor
153479273|NCT01275300|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153479274|NCT01275300|Antimetabolites|antimetabolites|mesh-ancestor
153479275|NCT01275300|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153479276|NCT01275300|Vasodilator Agents|vasodilator agents|mesh-ancestor
153479277|NCT01275300|Vitamin B Complex|vitamin b complex|mesh-ancestor
153479278|NCT01275300|Vitamins|vitamins|mesh-ancestor
153884895|NCT04326894|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153884896|NCT04326894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153884897|NCT04326894|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153884898|NCT04326894|Antimetabolites|antimetabolites|mesh-ancestor
153884899|NCT04326894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153884900|NCT04326894|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153884901|NCT04326894|Dermatologic Agents|dermatologic agents|mesh-ancestor
153479279|NCT01275300|Micronutrients|micronutrients|mesh-ancestor
153479280|NCT01276314|Prednisolone|prednisolone|mesh-list
153479281|NCT01276314|Etanercept|etanercept|mesh-list
153479282|NCT01276314|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153479283|NCT01276314|Glucocorticoids|glucocorticoids|mesh-ancestor
153479284|NCT01276314|Hormones|hormones|mesh-ancestor
153479294|NCT01276314|Sensory System Agents|sensory system agents|mesh-ancestor
153479296|NCT01276314|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153479297|NCT01276314|Immunologic Factors|immunologic factors|mesh-ancestor
153479298|NCT01280058|Paclitaxel|paclitaxel|mesh-list
153479299|NCT01280058|Carboplatin|carboplatin|mesh-list
153479300|NCT01280058|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
153479301|NCT01280058|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153479302|NCT01280058|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153479303|NCT01280058|Tubulin Modulators|tubulin modulators|mesh-ancestor
153479304|NCT01280058|Antimitotic Agents|antimitotic agents|mesh-ancestor
153479305|NCT01280058|Mitosis Modulators|mitosis modulators|mesh-ancestor
153479306|NCT01280058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153479307|NCT01280604|Fenofibrate|fenofibrate|mesh-list
153479308|NCT01280604|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153479320|NCT01285050|Antiviral Agents|antiviral agents|mesh-ancestor
153479321|NCT01285050|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153479322|NCT01285050|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153479323|NCT01285050|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153479324|NCT01285050|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153479325|NCT01285050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153479326|NCT01285050|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153479327|NCT01285050|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
153479328|NCT01285050|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
153479329|NCT01286454|Fesoterodine|fesoterodine|mesh-list
153479330|NCT01286454|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
153479332|NCT01286454|Cholinergic Agents|cholinergic agents|mesh-ancestor
153479333|NCT01286454|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153479334|NCT01286454|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153479335|NCT01286454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153479336|NCT01286454|Urological Agents|urological agents|mesh-ancestor
153479337|NCT01287078|Cyclosporine|cyclosporine|mesh-list
153479338|NCT01287078|Cyclosporins|cyclosporins|mesh-list
153813845|NCT00335348|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153884906|NCT04326894|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153884907|NCT04326894|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153884908|NCT02271542|Propofol|propofol|mesh-list
153884909|NCT02271542|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153884910|NCT02271542|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153884911|NCT02271542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153884912|NCT02271542|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153884913|NCT02271542|Anesthetics, General|anesthetics, general|mesh-ancestor
153884914|NCT02271542|Anesthetics|anesthetics|mesh-ancestor
153884915|NCT01109992|Regadenoson|regadenoson|mesh-list
153884916|NCT01109992|Adenosine A2 Receptor Agonists|adenosine a2 receptor agonists|mesh-ancestor
153479340|NCT01287078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153479341|NCT01287078|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153479342|NCT01287078|Immunologic Factors|immunologic factors|mesh-ancestor
153479343|NCT01287078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153479344|NCT01287078|Antifungal Agents|antifungal agents|mesh-ancestor
153479345|NCT01287078|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153479362|NCT01292304|Natriuretic Agents|natriuretic agents|mesh-ancestor
153479363|NCT01292304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153479364|NCT01293396|Insulin|insulin|mesh-list
153479365|NCT01293396|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
153479366|NCT01293396|Insulin Aspart|insulin aspart|mesh-list
153479367|NCT01293396|Insulin, Long-Acting|insulin, long-acting|mesh-list
153387797|NCT00000807|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153425878|NCT00378716|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153425879|NCT00378716|Immunologic Factors|immunologic factors|mesh-ancestor
153425880|NCT00378716|Antidotes|antidotes|mesh-ancestor
153425881|NCT00378716|Protective Agents|protective agents|mesh-ancestor
153425882|NCT00378716|Vitamin B Complex|vitamin b complex|mesh-ancestor
153479369|NCT01293396|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
153479371|NCT01293396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153479372|NCT01294098|Bupivacaine|bupivacaine|mesh-list
153479373|NCT01294098|Anesthetics, Local|anesthetics, local|mesh-ancestor
153479374|NCT01294098|Anesthetics|anesthetics|mesh-ancestor
153479375|NCT01294098|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153479376|NCT01294098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153479377|NCT01294098|Sensory System Agents|sensory system agents|mesh-ancestor
153479378|NCT01294098|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153479379|NCT01295112|Dexamethasone|dexamethasone|mesh-list
153479380|NCT01295112|Dexamethasone acetate|dexamethasone acetate|mesh-list
153479381|NCT01295112|Bevacizumab|bevacizumab|mesh-list
153479382|NCT01295112|BB 1101|bb 1101|mesh-list
153479383|NCT01295112|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153479384|NCT01295112|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153479394|NCT01295112|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153479395|NCT01295112|Glucocorticoids|glucocorticoids|mesh-ancestor
153479396|NCT01295112|Hormones|hormones|mesh-ancestor
153479397|NCT01295112|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153479398|NCT01295112|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153479399|NCT01295112|Protease Inhibitors|protease inhibitors|mesh-ancestor
153479400|NCT01295112|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153479407|NCT01301742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153479409|NCT01301742|Antimetabolites|antimetabolites|mesh-ancestor
153479410|NCT01301742|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153479411|NCT01301742|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
153479412|NCT01301742|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153479413|NCT01301742|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153479414|NCT01304082|Lidocaine|lidocaine|mesh-list
153479415|NCT01304082|Anesthetics, Local|anesthetics, local|mesh-ancestor
153479416|NCT01304082|Anesthetics|anesthetics|mesh-ancestor
153479417|NCT01304082|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153813846|NCT00335348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153479419|NCT01304082|Sensory System Agents|sensory system agents|mesh-ancestor
153479420|NCT01304082|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153479421|NCT01304082|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153479422|NCT01304082|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
153479423|NCT01304082|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153479424|NCT01304082|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153479434|NCT01304238|Protease Inhibitors|protease inhibitors|mesh-ancestor
153479435|NCT01304238|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153479436|NCT01304238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153479437|NCT01304238|Anticoagulants|anticoagulants|mesh-ancestor
153425895|NCT03644095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153425896|NCT03644095|Appetite Depressants|appetite depressants|mesh-ancestor
153425897|NCT03644095|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
153425898|NCT03644095|Sympathomimetics|sympathomimetics|mesh-ancestor
153425899|NCT03644095|Autonomic Agents|autonomic agents|mesh-ancestor
153479439|NCT01304238|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153479440|NCT01304238|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153479441|NCT01305252|Treprostinil|treprostinil|mesh-list
153479442|NCT01305252|Tadalafil|tadalafil|mesh-list
153479443|NCT01305252|Vasodilator Agents|vasodilator agents|mesh-ancestor
153479444|NCT01305252|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
153479445|NCT01305252|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
153479446|NCT01305252|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153479447|NCT01305252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153479448|NCT01305252|Urological Agents|urological agents|mesh-ancestor
153479449|NCT01305252|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153479450|NCT01308060|Botulinum Toxins|botulinum toxins|mesh-list
153479471|NCT01308840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153479479|NCT01311102|Sensory System Agents|sensory system agents|mesh-ancestor
153479480|NCT01311102|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153479481|NCT01311102|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153479482|NCT01311102|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
153479483|NCT01311102|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153479484|NCT01311102|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153479485|NCT01311102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153479486|NCT01312038|Simethicone|simethicone|mesh-list
153479487|NCT01312038|Antifoaming Agents|antifoaming agents|mesh-ancestor
153479488|NCT01312038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153479489|NCT01312038|Emollients|emollients|mesh-ancestor
153479490|NCT01312038|Dermatologic Agents|dermatologic agents|mesh-ancestor
153479491|NCT01312272|Oxytocin|oxytocin|mesh-list
153479492|NCT01312272|Oxytocics|oxytocics|mesh-ancestor
153479493|NCT01312272|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153479494|NCT01312272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153479495|NCT01312818|Dexamethasone|dexamethasone|mesh-list
153479496|NCT01312818|Methotrexate|methotrexate|mesh-list
153479497|NCT01312818|Bortezomib|bortezomib|mesh-list
153479498|NCT01312818|Imatinib Mesylate|imatinib mesylate|mesh-list
153479499|NCT01312818|Vorinostat|vorinostat|mesh-list
153479500|NCT01312818|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153479501|NCT01312818|Antiemetics|antiemetics|mesh-ancestor
153479502|NCT01312818|Autonomic Agents|autonomic agents|mesh-ancestor
153479503|NCT01312818|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153884934|NCT01109524|Tubulin Modulators|tubulin modulators|mesh-ancestor
153479504|NCT01312818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153479528|NCT01313520|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
153479529|NCT01313520|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153479530|NCT01313520|Dermatologic Agents|dermatologic agents|mesh-ancestor
153479531|NCT01313520|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153479532|NCT01313520|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153479534|NCT01315002|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
153479535|NCT01315002|Autonomic Agents|autonomic agents|mesh-ancestor
153479536|NCT01315002|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153479537|NCT01315002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153479538|NCT01315002|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
153479539|NCT01315002|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
153479540|NCT01315002|Cholinergic Agents|cholinergic agents|mesh-ancestor
153479541|NCT01315002|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153479542|NCT01315002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153479543|NCT01315158|Midazolam|midazolam|mesh-list
153479544|NCT01315158|Fentanyl|fentanyl|mesh-list
153479545|NCT01315158|Analgesics, Opioid|analgesics, opioid|mesh-list
153425914|NCT04714099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153425915|NCT04714099|Antifungal Agents|antifungal agents|mesh-ancestor
153425916|NCT04714099|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153425917|NCT04714099|Dermatologic Agents|dermatologic agents|mesh-ancestor
153425918|NCT04714099|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153479546|NCT01315158|Propofol|propofol|mesh-list
153479547|NCT01315158|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153479548|NCT01315158|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153479549|NCT01315158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153479550|NCT01315158|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153479551|NCT01315158|Anesthetics, General|anesthetics, general|mesh-ancestor
153479552|NCT01315158|Anesthetics|anesthetics|mesh-ancestor
153479553|NCT01315158|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153479554|NCT01315158|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153479555|NCT01315158|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153479556|NCT01315158|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153479557|NCT01315158|GABA Modulators|gaba modulators|mesh-ancestor
153479559|NCT01315158|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153479560|NCT01315158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153479561|NCT01315158|Narcotics|narcotics|mesh-ancestor
153479562|NCT01315158|Analgesics|analgesics|mesh-ancestor
153479563|NCT01315158|Sensory System Agents|sensory system agents|mesh-ancestor
153479564|NCT01315158|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153479566|NCT01318278|Vasopressins|vasopressins|mesh-list
153479567|NCT01318278|Arginine Vasopressin|arginine vasopressin|mesh-list
153479568|NCT01318278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153479591|NCT01318356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153479594|NCT01324128|Trace Elements|trace elements|mesh-ancestor
153479595|NCT01324128|Micronutrients|micronutrients|mesh-ancestor
153479596|NCT01324128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153479597|NCT01324128|Chelating Agents|chelating agents|mesh-ancestor
153479598|NCT01324128|Sequestering Agents|sequestering agents|mesh-ancestor
153479599|NCT01324128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153425942|NCT00589550|Interferon-alpha|interferon-alpha|mesh-list
153425943|NCT00589550|Interferon alpha-2|interferon alpha-2|mesh-list
153425944|NCT00589550|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
153425945|NCT00589550|Sorafenib|sorafenib|mesh-list
153425946|NCT00589550|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153479611|NCT01328184|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
153479612|NCT01328184|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
153479613|NCT01328184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153479614|NCT01328184|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153479615|NCT01328184|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
153479616|NCT01328184|Estrogens|estrogens|mesh-ancestor
153479618|NCT01328184|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153479620|NCT01328184|Contraceptives, Postcoital, Hormonal|contraceptives, postcoital, hormonal|mesh-ancestor
153479621|NCT01328184|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
153479622|NCT01328184|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
153479623|NCT01328964|Fluticasone|fluticasone|mesh-list
153479624|NCT01328964|Xhance|xhance|mesh-list
153479625|NCT01328964|Budesonide|budesonide|mesh-list
153479626|NCT01328964|Montelukast|montelukast|mesh-list
153479627|NCT01328964|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153479628|NCT01328964|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153479629|NCT01328964|Autonomic Agents|autonomic agents|mesh-ancestor
153479630|NCT01328964|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153479631|NCT01328964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153479632|NCT01328964|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153479633|NCT01328964|Respiratory System Agents|respiratory system agents|mesh-ancestor
153479658|NCT01330290|Dopamine Agents|dopamine agents|mesh-ancestor
153479659|NCT01330290|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153479660|NCT01330290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153479661|NCT01330290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153885051|NCT00596115|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
153479662|NCT01331304|Quetiapine Fumarate|quetiapine fumarate|mesh-list
153479663|NCT01331304|Antidepressive Agents|antidepressive agents|mesh-ancestor
153479664|NCT01331304|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153479674|NCT01331694|Ipratropium|ipratropium|mesh-list
153479675|NCT01331694|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
153479676|NCT01331694|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153479677|NCT01331694|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153479678|NCT01331694|Autonomic Agents|autonomic agents|mesh-ancestor
153479679|NCT01331694|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153479680|NCT01331694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153479681|NCT01331694|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153479682|NCT01331694|Respiratory System Agents|respiratory system agents|mesh-ancestor
153479683|NCT01331694|Dermatologic Agents|dermatologic agents|mesh-ancestor
153479684|NCT01331694|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
153479685|NCT01331694|Parasympatholytics|parasympatholytics|mesh-ancestor
153479728|NCT01333488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153479729|NCT01333488|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153479731|NCT01333488|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153479732|NCT01335204|Bavituximab|bavituximab|mesh-list
153479733|NCT01335204|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153479734|NCT01335204|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153479735|NCT06244979|Deferoxamine|deferoxamine|mesh-list
153479736|NCT06244979|Radiopharmaceuticals|radiopharmaceuticals|mesh-list
153479737|NCT06244979|Siderophores|siderophores|mesh-ancestor
153479738|NCT06244979|Iron Chelating Agents|iron chelating agents|mesh-ancestor
153479739|NCT06244979|Chelating Agents|chelating agents|mesh-ancestor
153479740|NCT06244979|Sequestering Agents|sequestering agents|mesh-ancestor
153479741|NCT06244979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153479742|NCT06244706|Analgesics, Opioid|analgesics, opioid|mesh-list
153479743|NCT06244706|Narcotics|narcotics|mesh-ancestor
153479744|NCT06244706|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153479745|NCT06244706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153479746|NCT06244706|Analgesics|analgesics|mesh-ancestor
153479785|NCT06244290|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153479787|NCT06244277|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
153479788|NCT06244277|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153479789|NCT06244277|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153479790|NCT06244277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153479791|NCT06244277|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
153479793|NCT06244277|GABA Agents|gaba agents|mesh-ancestor
153479794|NCT06244277|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153479795|NCT06244277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153479796|NCT06244212|Triamcinolone|triamcinolone|mesh-list
153479797|NCT06244212|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153479798|NCT06244212|Glucocorticoids|glucocorticoids|mesh-ancestor
153479799|NCT06244212|Hormones|hormones|mesh-ancestor
153479846|NCT06243614|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153479847|NCT06243614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153479848|NCT06243614|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153479849|NCT06243614|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
153479850|NCT06243614|Serotonin Agents|serotonin agents|mesh-ancestor
153479851|NCT06243614|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153479852|NCT06243614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153479854|NCT06243536|Pioglitazone|pioglitazone|mesh-list
153479855|NCT06243536|Semaglutide|semaglutide|mesh-list
153479856|NCT06243536|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
153479857|NCT06243536|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153479858|NCT06243536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153479859|NCT06243536|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
153479860|NCT06243536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153479861|NCT06243510|Enoxaparin|enoxaparin|mesh-list
153479862|NCT06243510|Apixaban|apixaban|mesh-list
153479863|NCT06243510|Anticoagulants|anticoagulants|mesh-ancestor
153479864|NCT06243510|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153479878|NCT06243185|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
153479879|NCT06243185|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153479880|NCT06243185|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153479881|NCT06243185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153479882|NCT06243185|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
153479883|NCT06243185|Hormone Antagonists|hormone antagonists|mesh-ancestor
153479900|NCT06243133|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153479901|NCT06243133|Analgesics|analgesics|mesh-ancestor
153479902|NCT06243133|Sensory System Agents|sensory system agents|mesh-ancestor
153479903|NCT06243133|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153479904|NCT06243133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153479905|NCT06243133|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153479906|NCT06243133|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153479918|NCT06243133|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153479919|NCT06243120|Lidocaine|lidocaine|mesh-list
153479920|NCT06243120|Anesthetics, Local|anesthetics, local|mesh-ancestor
153479921|NCT06243120|Anesthetics|anesthetics|mesh-ancestor
153479922|NCT06243120|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153479923|NCT06243120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153479924|NCT06243120|Sensory System Agents|sensory system agents|mesh-ancestor
153479925|NCT06243120|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153479937|NCT06238778|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153479938|NCT06238778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153479939|NCT06235606|Dexmedetomidine|dexmedetomidine|mesh-list
153479941|NCT06235606|Anesthetics, Local|anesthetics, local|mesh-ancestor
153479951|NCT06235606|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153479952|NCT06235606|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153479953|NCT06235606|Adrenergic Agents|adrenergic agents|mesh-ancestor
153479954|NCT06235606|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153479955|NCT06235606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153479956|NCT06209879|Ophthalmic Solutions|ophthalmic solutions|mesh-list
153479957|NCT06209879|Lubricant Eye Drops|lubricant eye drops|mesh-list
153479958|NCT06209879|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
153479959|NCT06203041|Vitamin D|vitamin d|mesh-list
153479960|NCT06203041|Cholecalciferol|cholecalciferol|mesh-list
153479961|NCT06203041|Vitamins|vitamins|mesh-ancestor
153479962|NCT06203041|Micronutrients|micronutrients|mesh-ancestor
153479963|NCT06203041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153479964|NCT06203041|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153479974|NCT06192979|Bortezomib|bortezomib|mesh-list
153479975|NCT06192979|Venetoclax|venetoclax|mesh-list
153479976|NCT06192979|Daratumumab|daratumumab|mesh-list
153479977|NCT06192979|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153479978|NCT06192979|Antiemetics|antiemetics|mesh-ancestor
153479979|NCT06192979|Autonomic Agents|autonomic agents|mesh-ancestor
153479980|NCT06192979|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153479981|NCT06192979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153479982|NCT06192979|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153479983|NCT06192979|Glucocorticoids|glucocorticoids|mesh-ancestor
153479984|NCT06192979|Hormones|hormones|mesh-ancestor
153479985|NCT06192979|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153479986|NCT06192979|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153479987|NCT06192979|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153479988|NCT06189742|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
153480003|NCT06133075|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
153480004|NCT06133075|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153480005|NCT06133075|Adrenergic Agents|adrenergic agents|mesh-ancestor
153480006|NCT06133075|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153426233|NCT00380120|Warfarin|warfarin|mesh-list
153480022|NCT06076213|Schistosomicides|schistosomicides|mesh-ancestor
153480023|NCT06076213|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
153480024|NCT06076213|Anthelmintics|anthelmintics|mesh-ancestor
153480025|NCT06073821|Venetoclax|venetoclax|mesh-list
153480026|NCT06073821|Obinutuzumab|obinutuzumab|mesh-list
153480027|NCT06073821|Zanubrutinib|zanubrutinib|mesh-list
153480028|NCT06073821|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153426238|NCT00000770|Antimetabolites|antimetabolites|mesh-ancestor
153426265|NCT00000776|Fluconazole|fluconazole|mesh-list
153480029|NCT06073821|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153480030|NCT06073821|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153480031|NCT06073821|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153480032|NCT06073821|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153480033|NCT06073821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153480035|NCT06070701|Anesthetics|anesthetics|mesh-list
153480036|NCT06070701|Anesthetics, General|anesthetics, general|mesh-list
153480037|NCT06070701|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153480038|NCT06070701|Narcotics|narcotics|mesh-ancestor
153480039|NCT06070701|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153480040|NCT06070701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153480041|NCT06070701|Analgesics|analgesics|mesh-ancestor
153480042|NCT06070701|Sensory System Agents|sensory system agents|mesh-ancestor
153480043|NCT06070701|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153480044|NCT06066554|Methotrexate|methotrexate|mesh-list
153480045|NCT06066554|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
153480046|NCT06066554|Abortifacient Agents|abortifacient agents|mesh-ancestor
153480047|NCT06066554|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153480048|NCT06066554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153480049|NCT06066554|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153480057|NCT06066554|Immunologic Factors|immunologic factors|mesh-ancestor
153480058|NCT06066554|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153480059|NCT06066554|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153480061|NCT06022003|Gilteritinib|gilteritinib|mesh-list
153480062|NCT06022003|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153480063|NCT06022003|Antimetabolites|antimetabolites|mesh-ancestor
153480064|NCT06022003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153480087|NCT05999240|Pimavanserin|pimavanserin|mesh-list
153480088|NCT05999240|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
153480089|NCT05999240|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
153480090|NCT05999240|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153480091|NCT05999240|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153480092|NCT05999240|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153480093|NCT05999240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153480094|NCT05999240|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153480095|NCT05999240|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
153480096|NCT05999240|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153480097|NCT05999240|Serotonin Agents|serotonin agents|mesh-ancestor
153480098|NCT05999240|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153480099|NCT05999240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153480100|NCT05997277|Deucravacitinib|deucravacitinib|mesh-list
153480101|NCT05997277|Dermatologic Agents|dermatologic agents|mesh-ancestor
153480102|NCT05997277|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153480103|NCT05997277|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153480104|NCT05997277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153480106|NCT05995249|Erythromycin|erythromycin|mesh-list
153480107|NCT05995249|Erythromycin Estolate|erythromycin estolate|mesh-list
153480108|NCT05995249|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
153480109|NCT05995249|Erythromycin stearate|erythromycin stearate|mesh-list
153480166|NCT05962034|Analgesics|analgesics|mesh-ancestor
153480167|NCT05962034|Sensory System Agents|sensory system agents|mesh-ancestor
153480168|NCT05962034|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153480169|NCT05962034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153480170|NCT05962034|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153480171|NCT05962034|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153480172|NCT05962034|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153480173|NCT05962034|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153480174|NCT05962034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153480175|NCT05962034|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153480176|NCT05962034|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153480177|NCT05962034|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153480178|NCT05962034|Antipyretics|antipyretics|mesh-ancestor
153480179|NCT05949125|Cyclophosphamide|cyclophosphamide|mesh-list
153480180|NCT05949125|Fludarabine|fludarabine|mesh-list
153480181|NCT05949125|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153480182|NCT05949125|Immunologic Factors|immunologic factors|mesh-ancestor
153480183|NCT05949125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153480184|NCT05949125|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153480185|NCT05949125|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153480186|NCT05949125|Alkylating Agents|alkylating agents|mesh-ancestor
153480203|NCT05932472|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153480204|NCT05932472|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153480205|NCT05932472|Antipyretics|antipyretics|mesh-ancestor
153480206|NCT05925140|Ritonavir|ritonavir|mesh-list
153480207|NCT05925140|Lopinavir|lopinavir|mesh-list
153480209|NCT05925140|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
153480210|NCT05925140|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
153426396|NCT02921906|Analgesics|analgesics|mesh-ancestor
153480212|NCT05925140|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153480213|NCT05925140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153480214|NCT05925140|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153480215|NCT05925140|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153480216|NCT05925140|Antiviral Agents|antiviral agents|mesh-ancestor
153480217|NCT05925140|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153480218|NCT05925140|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
153480249|NCT05839756|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153480251|NCT05832255|Hallucinogens|hallucinogens|mesh-ancestor
153480252|NCT05832255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153480253|NCT05832255|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153480254|NCT05813847|Anesthetics|anesthetics|mesh-list
153480255|NCT05813847|Anesthetics, Local|anesthetics, local|mesh-list
153480256|NCT05813847|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153480257|NCT05813847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153480258|NCT05813847|Sensory System Agents|sensory system agents|mesh-ancestor
153480259|NCT05813847|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153480260|NCT05803083|Hyaluronic Acid|hyaluronic acid|mesh-list
153480261|NCT05803083|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153480262|NCT05803083|Immunologic Factors|immunologic factors|mesh-ancestor
153480263|NCT05803083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153480264|NCT05803083|Viscosupplements|viscosupplements|mesh-ancestor
153480265|NCT05803083|Protective Agents|protective agents|mesh-ancestor
153480266|NCT05800275|Capecitabine|capecitabine|mesh-list
153480267|NCT05800275|Trastuzumab|trastuzumab|mesh-list
153480269|NCT05800275|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153480270|NCT05800275|Antimetabolites|antimetabolites|mesh-ancestor
153480271|NCT05800275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153480272|NCT05800275|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153480273|NCT05800275|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153480274|NCT05800275|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153480275|NCT05800275|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153480276|NCT05785377|Bupivacaine|bupivacaine|mesh-list
153480277|NCT05785377|Neostigmine|neostigmine|mesh-list
153480278|NCT05785377|Anesthetics, Local|anesthetics, local|mesh-ancestor
153480279|NCT05785377|Anesthetics|anesthetics|mesh-ancestor
153480280|NCT05785377|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153480289|NCT05785377|Parasympathomimetics|parasympathomimetics|mesh-ancestor
153480290|NCT05785377|Autonomic Agents|autonomic agents|mesh-ancestor
153480291|NCT05769153|Aflibercept|aflibercept|mesh-list
153480292|NCT05769153|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153480293|NCT05769153|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153480294|NCT05769153|Growth Substances|growth substances|mesh-ancestor
153480295|NCT05769153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153480296|NCT05769153|Growth Inhibitors|growth inhibitors|mesh-ancestor
153480297|NCT05769153|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153480298|NCT05766124|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
153480314|NCT05759572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153480316|NCT05759572|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
153480317|NCT05759572|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
153480318|NCT05759572|Hormone Antagonists|hormone antagonists|mesh-ancestor
153480319|NCT05759572|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153480320|NCT05759572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153480321|NCT05759546|Fulvestrant|fulvestrant|mesh-list
153480322|NCT05759546|Fluzoparib|fluzoparib|mesh-list
153480323|NCT05759546|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153480324|NCT05759546|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153480325|NCT05759546|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
153480326|NCT05759546|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
153480327|NCT05759546|Hormone Antagonists|hormone antagonists|mesh-ancestor
153480328|NCT05759546|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153480329|NCT05759546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153480330|NCT05759546|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
153480335|NCT05750992|Bupivacaine|bupivacaine|mesh-list
153480336|NCT05750992|Anesthetics, Local|anesthetics, local|mesh-ancestor
153480337|NCT05750992|Anesthetics|anesthetics|mesh-ancestor
153480338|NCT05750992|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153480339|NCT05750992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153480340|NCT05750992|Sensory System Agents|sensory system agents|mesh-ancestor
153480341|NCT05750992|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153480342|NCT05750992|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153480343|NCT05750992|Narcotics|narcotics|mesh-ancestor
153480344|NCT05750992|Analgesics|analgesics|mesh-ancestor
153480345|NCT05750992|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153480367|NCT05709990|Cholecalciferol|cholecalciferol|mesh-list
153480368|NCT05709990|Solifenacin Succinate|solifenacin succinate|mesh-list
153480369|NCT05709990|Vitamins|vitamins|mesh-ancestor
153480370|NCT05709990|Micronutrients|micronutrients|mesh-ancestor
153480371|NCT05709990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153480372|NCT05709990|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153480373|NCT05709990|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153480374|NCT05709990|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
153480375|NCT05709990|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
153480376|NCT05709990|Cholinergic Agents|cholinergic agents|mesh-ancestor
153480377|NCT05709990|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153480378|NCT05709990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153480379|NCT05709990|Urological Agents|urological agents|mesh-ancestor
153480380|NCT05687266|Paclitaxel|paclitaxel|mesh-list
153480381|NCT05687266|Carboplatin|carboplatin|mesh-list
153480382|NCT05687266|Pembrolizumab|pembrolizumab|mesh-list
153480383|NCT05687266|Pemetrexed|pemetrexed|mesh-list
153480384|NCT05687266|Durvalumab|durvalumab|mesh-list
153480385|NCT05687266|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153480386|NCT05687266|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153480387|NCT05687266|Tubulin Modulators|tubulin modulators|mesh-ancestor
153480388|NCT05687266|Antimitotic Agents|antimitotic agents|mesh-ancestor
153480389|NCT05687266|Mitosis Modulators|mitosis modulators|mesh-ancestor
153480390|NCT05687266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153480391|NCT05687266|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153480392|NCT05687266|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153480393|NCT05687266|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153480394|NCT05687266|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153480395|NCT05687266|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153480396|NCT05658874|Methenamine|methenamine|mesh-list
153480397|NCT05658874|Methenamine hippurate|methenamine hippurate|mesh-list
153480398|NCT05658874|Methenamine mandelate|methenamine mandelate|mesh-list
153480399|NCT05658874|Gabapentin|gabapentin|mesh-list
153480400|NCT05658874|Amitriptyline|amitriptyline|mesh-list
153480401|NCT05658874|Mirabegron|mirabegron|mesh-list
153480402|NCT05658874|Oxybutynin|oxybutynin|mesh-list
153480442|NCT05631899|Paclitaxel|paclitaxel|mesh-list
153480450|NCT05631899|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153480451|NCT05631899|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153480452|NCT05631899|Alkylating Agents|alkylating agents|mesh-ancestor
153480453|NCT05631899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153480454|NCT05631899|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153480455|NCT05631899|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153480460|NCT05631899|Antimitotic Agents|antimitotic agents|mesh-ancestor
153480461|NCT05631899|Mitosis Modulators|mitosis modulators|mesh-ancestor
153480463|NCT05602636|Bupivacaine|bupivacaine|mesh-list
153480464|NCT05602636|Anesthetics, Local|anesthetics, local|mesh-ancestor
153480465|NCT05602636|Anesthetics|anesthetics|mesh-ancestor
153480466|NCT05602636|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153480467|NCT05602636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153480468|NCT05602636|Sensory System Agents|sensory system agents|mesh-ancestor
153480469|NCT05602636|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153480470|NCT05602636|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153480471|NCT05602636|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153480472|NCT05602636|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153480473|NCT05602636|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153480474|NCT05602636|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153480475|NCT05602636|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153480476|NCT05602636|Anesthetics, General|anesthetics, general|mesh-ancestor
153480488|NCT05594095|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153480489|NCT05594095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153480490|NCT05594095|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153480491|NCT05594095|Immunologic Factors|immunologic factors|mesh-ancestor
153480492|NCT05594095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153480493|NCT05594095|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153480494|NCT05594095|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153480495|NCT05594095|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
153480496|NCT05594095|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
153480497|NCT05594095|Hormone Antagonists|hormone antagonists|mesh-ancestor
153480498|NCT05594095|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153480499|NCT05594095|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153480500|NCT05594095|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
153480502|NCT05583552|Motesanib diphosphate|motesanib diphosphate|mesh-list
153480503|NCT05583552|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153480504|NCT05583552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153480505|NCT05583552|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153480506|NCT05545020|Chromium|chromium|mesh-list
153480507|NCT05545020|Trace Elements|trace elements|mesh-ancestor
153480508|NCT05545020|Micronutrients|micronutrients|mesh-ancestor
153480509|NCT05545020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153480510|NCT05543785|Ketorolac|ketorolac|mesh-list
153480511|NCT05543785|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153480512|NCT05543785|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153480513|NCT05543785|Analgesics|analgesics|mesh-ancestor
153480514|NCT05543785|Sensory System Agents|sensory system agents|mesh-ancestor
153480515|NCT05543785|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153480516|NCT05543785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153480517|NCT05543785|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153480518|NCT05543785|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153480519|NCT05543785|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153480521|NCT05543785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153480522|NCT05536856|Fluorouracil|fluorouracil|mesh-list
153480523|NCT05536856|Antimetabolites|antimetabolites|mesh-ancestor
153480524|NCT05536856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153480525|NCT05536856|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153480537|NCT05525013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153480538|NCT05525013|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153480539|NCT05525013|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
153480540|NCT05525013|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153480541|NCT05512754|Ibuprofen|ibuprofen|mesh-list
153480542|NCT05512754|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153480543|NCT05512754|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153480544|NCT05512754|Analgesics|analgesics|mesh-ancestor
153480545|NCT05512754|Sensory System Agents|sensory system agents|mesh-ancestor
153480546|NCT05512754|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153480560|NCT05501600|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153480561|NCT05501600|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
153480562|NCT05501600|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153480563|NCT05501600|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153480564|NCT05501600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153480565|NCT05498103|Methazolamide|methazolamide|mesh-list
153480566|NCT05498103|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
153480567|NCT05498103|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153480568|NCT05498103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153480569|NCT05498103|Diuretics|diuretics|mesh-ancestor
153480570|NCT05498103|Natriuretic Agents|natriuretic agents|mesh-ancestor
153480571|NCT05498103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153480572|NCT05491317|Pembrolizumab|pembrolizumab|mesh-list
153480573|NCT05491317|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153480574|NCT05491317|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153480575|NCT05491317|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153480576|NCT05491317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153480577|NCT05473910|Trans-sodium crocetinate|trans-sodium crocetinate|mesh-list
153480578|NCT05473910|Antioxidants|antioxidants|mesh-ancestor
153480579|NCT05473910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153480580|NCT05473910|Protective Agents|protective agents|mesh-ancestor
153480581|NCT05473910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153480582|NCT05473910|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
153480583|NCT05473910|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153480584|NCT05470491|Maraviroc|maraviroc|mesh-list
153480585|NCT05470491|Plerixafor|plerixafor|mesh-list
153480586|NCT05470491|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
153480595|NCT05465330|Desflurane|desflurane|mesh-list
153480596|NCT05465330|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153480597|NCT05465330|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153480598|NCT05465330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153480599|NCT05465330|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153480600|NCT05465330|Anesthetics, General|anesthetics, general|mesh-ancestor
153480602|NCT05465330|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
153480621|NCT05451771|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153480622|NCT05451771|Protease Inhibitors|protease inhibitors|mesh-ancestor
153480623|NCT05451771|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153480624|NCT05451771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153480625|NCT05451771|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153480626|NCT05451771|Alkylating Agents|alkylating agents|mesh-ancestor
153480627|NCT05451771|Immunologic Factors|immunologic factors|mesh-ancestor
153480628|NCT05451771|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153480629|NCT05451771|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153480630|NCT05451771|Growth Substances|growth substances|mesh-ancestor
153480631|NCT05451771|Growth Inhibitors|growth inhibitors|mesh-ancestor
153480632|NCT05400265|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
153480634|NCT05400265|Immunoglobulins|immunoglobulins|mesh-list
153480635|NCT05400265|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
153480636|NCT05400265|Immunologic Factors|immunologic factors|mesh-ancestor
153480637|NCT05400265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153480638|NCT05400265|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153480639|NCT05387525|Diclofenac|diclofenac|mesh-list
153480640|NCT05387525|Tirbanibulin|tirbanibulin|mesh-list
153480641|NCT05387525|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153480642|NCT05387525|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153480643|NCT05387525|Analgesics|analgesics|mesh-ancestor
153480644|NCT05387525|Sensory System Agents|sensory system agents|mesh-ancestor
153480645|NCT05387525|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153480646|NCT05387525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153480647|NCT05387525|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153480648|NCT05387525|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153480649|NCT05387525|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153480650|NCT05387525|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153480651|NCT05387525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153480652|NCT05386472|Ritonavir|ritonavir|mesh-list
153480653|NCT05386472|Nirmatrelvir|nirmatrelvir|mesh-list
153480654|NCT05386472|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
153480690|NCT05347212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153480692|NCT05327530|Sacituzumab govitecan|sacituzumab govitecan|mesh-list
153480693|NCT05327530|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153480694|NCT05327530|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153480695|NCT05327530|Immunoconjugates|immunoconjugates|mesh-ancestor
153480696|NCT05327530|Immunologic Factors|immunologic factors|mesh-ancestor
153480697|NCT05327530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153480698|NCT05310110|Lidocaine|lidocaine|mesh-list
153480699|NCT05310110|Propofol|propofol|mesh-list
153480700|NCT05310110|Cisatracurium|cisatracurium|mesh-list
153480701|NCT05310110|Atracurium|atracurium|mesh-list
153480704|NCT05310110|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153885678|NCT00600054|Nimotuzumab|nimotuzumab|mesh-list
153885679|NCT00600054|Antibodies|antibodies|mesh-list
153480705|NCT05310110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153480706|NCT05310110|Sensory System Agents|sensory system agents|mesh-ancestor
153480707|NCT05310110|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153480708|NCT05310110|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153480709|NCT05310110|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
153480710|NCT05310110|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153480711|NCT05310110|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153480712|NCT05310110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153480713|NCT05310110|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153480714|NCT05310110|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153480726|NCT05289063|Antimetabolites|antimetabolites|mesh-ancestor
153480727|NCT05289063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153480728|NCT05289063|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153480729|NCT05289063|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
153480746|NCT05195918|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153480747|NCT05195918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153480748|NCT05195918|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153480749|NCT05195918|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153480750|NCT05195918|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153480751|NCT05195918|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153480752|NCT05195918|Antioxidants|antioxidants|mesh-ancestor
153480753|NCT05195918|Protective Agents|protective agents|mesh-ancestor
153480754|NCT05195918|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
153480755|NCT05195918|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
153480756|NCT05195918|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
153480757|NCT05189028|Gemcitabine|gemcitabine|mesh-list
153480758|NCT05189028|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153480759|NCT05189028|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153480760|NCT05189028|Antimetabolites|antimetabolites|mesh-ancestor
153480761|NCT05189028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153480762|NCT05188508|Pembrolizumab|pembrolizumab|mesh-list
153480763|NCT05188508|Temozolomide|temozolomide|mesh-list
153480764|NCT05188508|Olaparib|olaparib|mesh-list
153480774|NCT05096481|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153480775|NCT05096481|Alkylating Agents|alkylating agents|mesh-ancestor
153480776|NCT05096481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153480777|NCT05096481|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153480797|NCT05028751|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153480798|NCT05028751|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153480799|NCT05028751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153480800|NCT04995497|Lidocaine|lidocaine|mesh-list
153480801|NCT04995497|Anesthetics, Local|anesthetics, local|mesh-ancestor
153480802|NCT04995497|Anesthetics|anesthetics|mesh-ancestor
153480803|NCT04995497|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153480804|NCT04995497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153480817|NCT04973605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153480818|NCT04973605|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153480819|NCT04973605|Glucocorticoids|glucocorticoids|mesh-ancestor
153480820|NCT04973605|Hormones|hormones|mesh-ancestor
153480821|NCT04973605|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153480822|NCT04973605|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153480823|NCT04973605|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153480824|NCT04939428|Molnupiravir|molnupiravir|mesh-list
153480825|NCT04939428|Antiviral Agents|antiviral agents|mesh-ancestor
153480826|NCT04939428|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153480827|NCT04907370|Cisplatin|cisplatin|mesh-list
153480828|NCT04907370|Gemcitabine|gemcitabine|mesh-list
153480829|NCT04907370|Antibodies|antibodies|mesh-list
153480830|NCT04907370|Antibodies, Blocking|antibodies, blocking|mesh-list
153480831|NCT04907370|Immunologic Factors|immunologic factors|mesh-ancestor
153480832|NCT04907370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153480850|NCT04893109|Maytansine|maytansine|mesh-list
153480851|NCT04893109|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
153480852|NCT04893109|Trastuzumab|trastuzumab|mesh-list
153480853|NCT04893109|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153480854|NCT04893109|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153480855|NCT04893109|Tubulin Modulators|tubulin modulators|mesh-ancestor
153480911|NCT04778527|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
153480912|NCT04778527|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153480913|NCT04778527|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153480914|NCT04778527|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153480915|NCT04778527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153480916|NCT04778527|Antiviral Agents|antiviral agents|mesh-ancestor
153480917|NCT04778527|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153480918|NCT04778527|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153480919|NCT04778527|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153480921|NCT04764188|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153480922|NCT04764188|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153480923|NCT04764188|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153885712|NCT00623064|Antimetabolites|antimetabolites|mesh-ancestor
153480936|NCT04725032|Anesthetics, General|anesthetics, general|mesh-ancestor
153480937|NCT04725032|Anesthetics|anesthetics|mesh-ancestor
153480938|NCT04725032|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153480939|NCT04725032|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
153480940|NCT04720157|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
153480941|NCT04720157|Pluvicto|pluvicto|mesh-list
153480942|NCT04720157|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
153480943|NCT04720157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153480944|NCT04712539|Oseltamivir|oseltamivir|mesh-list
153480945|NCT04712539|Baloxavir|baloxavir|mesh-list
153480946|NCT04712539|Antiviral Agents|antiviral agents|mesh-ancestor
153480947|NCT04712539|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153480948|NCT04712539|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153815062|NCT00344825|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153480989|NCT04625283|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153480990|NCT04625283|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
153480991|NCT04625283|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
153480992|NCT04625283|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153480993|NCT04625283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153480995|NCT04606316|Ipilimumab|ipilimumab|mesh-list
153480996|NCT04606316|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153480997|NCT04606316|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153480998|NCT04606316|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153480999|NCT04606316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153481001|NCT04548349|Dermatologic Agents|dermatologic agents|mesh-ancestor
153481002|NCT04546230|Anesthetics|anesthetics|mesh-list
153481003|NCT04546230|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153481015|NCT04486716|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153481016|NCT04482309|Trastuzumab|trastuzumab|mesh-list
153481017|NCT04482309|Trastuzumab deruxtecan|trastuzumab deruxtecan|mesh-list
153481018|NCT04482309|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153481041|NCT04357795|Ophthalmic Solutions|ophthalmic solutions|mesh-list
153481042|NCT04357795|Cyclosporins|cyclosporins|mesh-list
153481043|NCT04357795|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153481044|NCT04357795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153481045|NCT04357795|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153481046|NCT04357795|Immunologic Factors|immunologic factors|mesh-ancestor
153481047|NCT04357795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153481049|NCT04357795|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153481050|NCT04357795|Dermatologic Agents|dermatologic agents|mesh-ancestor
153481066|NCT04323436|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153481067|NCT04323436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153481098|NCT04227184|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
153481099|NCT04227184|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
153813850|NCT00335348|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153481100|NCT04227184|Cholinergic Agents|cholinergic agents|mesh-ancestor
153481101|NCT04227184|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153481102|NCT04227184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153481103|NCT04227184|Urological Agents|urological agents|mesh-ancestor
153481105|NCT04221529|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153481106|NCT04221529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153481107|NCT04221529|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153481108|NCT04221529|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153481109|NCT04167514|Protease Inhibitors|protease inhibitors|mesh-list
153481110|NCT04167514|Alpha 1-Antitrypsin|alpha 1-antitrypsin|mesh-list
153481127|NCT04141696|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
153481128|NCT04141696|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
153481129|NCT04141696|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153481130|NCT04141696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153481131|NCT04141696|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153481132|NCT04141696|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153481133|NCT04141696|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153481134|NCT04141696|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153481135|NCT04141696|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153481136|NCT04141696|GABA Modulators|gaba modulators|mesh-ancestor
153481138|NCT04098068|Pembrolizumab|pembrolizumab|mesh-list
153481139|NCT04098068|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153481140|NCT04098068|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153481141|NCT04098068|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153481142|NCT04098068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153481143|NCT04084314|Erenumab|erenumab|mesh-list
153481152|NCT04059484|Fulvestrant|fulvestrant|mesh-list
153481153|NCT04059484|Anastrozole|anastrozole|mesh-list
153481154|NCT04059484|Exemestane|exemestane|mesh-list
153481155|NCT04059484|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153481156|NCT04059484|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
153481157|NCT04059484|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153481158|NCT04059484|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153481159|NCT04059484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153481160|NCT04059484|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
153481161|NCT04059484|Hormone Antagonists|hormone antagonists|mesh-ancestor
153481162|NCT04059484|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153481163|NCT04059484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153481164|NCT04059484|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153481165|NCT04059484|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
153481166|NCT04059484|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
153426787|NCT00000944|Indinavir|indinavir|mesh-list
153481167|NCT04059484|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153481168|NCT04059484|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
153481169|NCT04051203|Methylprednisolone|methylprednisolone|mesh-list
153481196|NCT04051203|Protective Agents|protective agents|mesh-ancestor
153481197|NCT04051203|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153481198|NCT04051203|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153481199|NCT04046614|Nivolumab|nivolumab|mesh-list
153481200|NCT04046614|Nintedanib|nintedanib|mesh-list
153481201|NCT04046614|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153481202|NCT04046614|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153481203|NCT04046614|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153481204|NCT04046614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153481205|NCT04046614|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153481206|NCT04046614|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153481207|NCT04040452|Ketorolac|ketorolac|mesh-list
153481208|NCT04040452|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153481209|NCT04040452|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153481210|NCT04040452|Analgesics|analgesics|mesh-ancestor
153481211|NCT04040452|Sensory System Agents|sensory system agents|mesh-ancestor
153481257|NCT03913845|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153481258|NCT03913845|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153481259|NCT03913845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153481260|NCT03913845|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153481261|NCT03913845|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153481262|NCT03913845|Adrenergic Agents|adrenergic agents|mesh-ancestor
153481263|NCT03913845|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153481264|NCT03913845|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
153481265|NCT03913845|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153481266|NCT03913845|Autonomic Agents|autonomic agents|mesh-ancestor
153481267|NCT03913845|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153481268|NCT03913845|Respiratory System Agents|respiratory system agents|mesh-ancestor
153481270|NCT03913845|Sympathomimetics|sympathomimetics|mesh-ancestor
153481271|NCT03913845|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
153481272|NCT03907969|AZD7648|azd7648|mesh-list
153481273|NCT03907969|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153481286|NCT03900793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153481287|NCT03900793|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153481288|NCT03900793|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153481289|NCT03900793|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
153481303|NCT03875638|Anticonvulsants|anticonvulsants|mesh-ancestor
153481304|NCT03875638|Nootropic Agents|nootropic agents|mesh-ancestor
153481306|NCT03866837|Trace Elements|trace elements|mesh-list
153481307|NCT03866837|Lactoferrin|lactoferrin|mesh-list
153481308|NCT03866837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153481309|NCT03866837|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153481310|NCT03809000|Leuprolide|leuprolide|mesh-list
153481311|NCT03809000|Goserelin|goserelin|mesh-list
153481312|NCT03809000|Bicalutamide|bicalutamide|mesh-list
153481313|NCT03809000|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153481314|NCT03809000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153813851|NCT00335348|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153815063|NCT00344825|Immunologic Factors|immunologic factors|mesh-ancestor
153481315|NCT03809000|Fertility Agents, Female|fertility agents, female|mesh-ancestor
153481316|NCT03809000|Fertility Agents|fertility agents|mesh-ancestor
153481317|NCT03809000|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153481318|NCT03809000|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153481319|NCT03809000|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153481320|NCT03809000|Androgen Antagonists|androgen antagonists|mesh-ancestor
153481321|NCT03809000|Hormone Antagonists|hormone antagonists|mesh-ancestor
153481322|NCT03778944|Dopamine|dopamine|mesh-list
153481323|NCT03778944|Mannitol|mannitol|mesh-list
153481324|NCT03778944|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
153481325|NCT03778944|Diuretics|diuretics|mesh-ancestor
153481326|NCT03778944|Natriuretic Agents|natriuretic agents|mesh-ancestor
153481327|NCT03778944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153481328|NCT03778944|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
153481329|NCT03778944|Sympathomimetics|sympathomimetics|mesh-ancestor
153481330|NCT03778944|Autonomic Agents|autonomic agents|mesh-ancestor
153481331|NCT03778944|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153481332|NCT03778944|Dopamine Agents|dopamine agents|mesh-ancestor
153481333|NCT03778944|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153481334|NCT03778944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153481335|NCT03778944|Protective Agents|protective agents|mesh-ancestor
153481336|NCT03764293|Sorafenib|sorafenib|mesh-list
153481337|NCT03764293|Apatinib|apatinib|mesh-list
153481338|NCT03764293|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153481341|NCT03764293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153481343|NCT03752307|Methylprednisolone|methylprednisolone|mesh-list
153481344|NCT03752307|Isoxsuprine|isoxsuprine|mesh-list
153481345|NCT03752307|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153481346|NCT03752307|Glucocorticoids|glucocorticoids|mesh-ancestor
153481348|NCT03752307|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153481349|NCT03752307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153481350|NCT03752307|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153481351|NCT03752307|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153481352|NCT03752307|Antiemetics|antiemetics|mesh-ancestor
153481353|NCT03752307|Autonomic Agents|autonomic agents|mesh-ancestor
153481354|NCT03752307|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153481383|NCT03628209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153481384|NCT03628209|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153481385|NCT03628209|Antimetabolites|antimetabolites|mesh-ancestor
153481386|NCT03628209|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153481387|NCT03617328|Monatide (IMS 3015)|monatide (ims 3015)|mesh-list
153481388|NCT03617328|Poly ICLC|poly iclc|mesh-list
153481389|NCT03617328|Immunologic Factors|immunologic factors|mesh-ancestor
153481390|NCT03617328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153481391|NCT03617328|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153481392|NCT03617328|Interferon Inducers|interferon inducers|mesh-ancestor
153481393|NCT03554473|Temozolomide|temozolomide|mesh-list
153481402|NCT03484507|Chlorhexidine|chlorhexidine|mesh-list
153481403|NCT03484507|Povidone-Iodine|povidone-iodine|mesh-list
153481436|NCT03457142|Glycine|glycine|mesh-list
153481437|NCT03457142|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153481438|NCT03457142|Antiemetics|antiemetics|mesh-ancestor
153481439|NCT03457142|Autonomic Agents|autonomic agents|mesh-ancestor
153481488|NCT03338205|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
153481489|NCT03338205|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153481490|NCT03338205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153481492|NCT03333616|Ipilimumab|ipilimumab|mesh-list
153481493|NCT03333616|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153481494|NCT03333616|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153481496|NCT03333616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153481497|NCT03283761|Leucovorin|leucovorin|mesh-list
153481498|NCT03283761|Paclitaxel|paclitaxel|mesh-list
153481499|NCT03283761|Fluorouracil|fluorouracil|mesh-list
153481500|NCT03283761|Oxaliplatin|oxaliplatin|mesh-list
153481501|NCT03283761|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153481502|NCT03283761|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153481503|NCT03283761|Tubulin Modulators|tubulin modulators|mesh-ancestor
153481504|NCT03283761|Antimitotic Agents|antimitotic agents|mesh-ancestor
153481505|NCT03283761|Mitosis Modulators|mitosis modulators|mesh-ancestor
153481506|NCT03283761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153481507|NCT03283761|Antimetabolites|antimetabolites|mesh-ancestor
153885912|NCT01103713|Azithromycin|azithromycin|mesh-list
153481565|NCT02965690|Histamine Agents|histamine agents|mesh-ancestor
153481566|NCT02965690|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153481567|NCT02965690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153481568|NCT02965690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153481569|NCT02965690|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
153481570|NCT02965690|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153481571|NCT02965690|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153481572|NCT02859337|Ulipristal acetate|ulipristal acetate|mesh-list
153481573|NCT02859337|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
153481574|NCT02859337|Contraceptive Agents|contraceptive agents|mesh-ancestor
153481579|NCT02817659|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153481603|NCT02765256|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
153481604|NCT02765256|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153481606|NCT02765256|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
153481607|NCT02765256|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153481608|NCT02765256|Hormone Antagonists|hormone antagonists|mesh-ancestor
153481609|NCT02765256|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153481610|NCT02765256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153481611|NCT02765256|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
153481612|NCT02765256|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
153481613|NCT02765256|Antipruritics|antipruritics|mesh-ancestor
153481614|NCT02765256|Dermatologic Agents|dermatologic agents|mesh-ancestor
153481625|NCT02765256|Sensory System Agents|sensory system agents|mesh-ancestor
153481638|NCT02467270|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153481639|NCT02467270|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153481640|NCT02467270|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153481641|NCT02467270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153481642|NCT02467270|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153481643|NCT02202772|Cisplatin|cisplatin|mesh-list
153481644|NCT02202772|Gemcitabine|gemcitabine|mesh-list
153481645|NCT02202772|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153481646|NCT02202772|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153481647|NCT02202772|Antimetabolites|antimetabolites|mesh-ancestor
153815064|NCT00344825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153481648|NCT02202772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153481649|NCT01981551|Nirogacestat|nirogacestat|mesh-list
153481650|NCT01981551|Gamma Secretase Inhibitors and Modulators|gamma secretase inhibitors and modulators|mesh-ancestor
153481651|NCT01981551|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153481652|NCT01981551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153481653|NCT01796197|Paclitaxel|paclitaxel|mesh-list
153481654|NCT01796197|Cyclophosphamide|cyclophosphamide|mesh-list
153481655|NCT01796197|Doxorubicin|doxorubicin|mesh-list
153481695|NCT01659606|Cyclosporins|cyclosporins|mesh-list
153481696|NCT01659606|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153481697|NCT01659606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153481698|NCT01659606|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153481699|NCT01659606|Immunologic Factors|immunologic factors|mesh-ancestor
153481700|NCT01659606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153481701|NCT01659606|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
153481702|NCT01659606|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153481703|NCT01659606|Antifungal Agents|antifungal agents|mesh-ancestor
153481704|NCT01659606|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153481718|NCT01525082|Bevacizumab|bevacizumab|mesh-list
153481719|NCT01525082|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
153481720|NCT01525082|Capecitabine|capecitabine|mesh-list
153481721|NCT01525082|Temozolomide|temozolomide|mesh-list
153481722|NCT01525082|Antibodies|antibodies|mesh-list
153481723|NCT01525082|Immunoglobulins|immunoglobulins|mesh-list
153481724|NCT01525082|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
153481725|NCT01525082|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153481726|NCT01525082|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153481727|NCT01525082|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153481728|NCT01525082|Growth Substances|growth substances|mesh-ancestor
153481729|NCT01525082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153481730|NCT01525082|Growth Inhibitors|growth inhibitors|mesh-ancestor
153481731|NCT01525082|Immunologic Factors|immunologic factors|mesh-ancestor
153481744|NCT00936936|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153481745|NCT00936936|Antimetabolites|antimetabolites|mesh-ancestor
153481746|NCT00936936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153481761|NCT00770809|Trastuzumab|trastuzumab|mesh-list
153481762|NCT00770809|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
153481763|NCT00770809|Lapatinib|lapatinib|mesh-list
153481764|NCT00770809|Trastuzumab biosimilar HLX02|trastuzumab biosimilar hlx02|mesh-list
153481765|NCT00770809|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153481766|NCT00770809|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153481767|NCT00770809|Tubulin Modulators|tubulin modulators|mesh-ancestor
153481768|NCT00770809|Antimitotic Agents|antimitotic agents|mesh-ancestor
153481771|NCT00770809|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153481772|NCT00770809|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153481773|NCT00770809|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153481774|NCT00770809|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153481775|NCT00392353|Azacitidine|azacitidine|mesh-list
153481776|NCT00392353|Vorinostat|vorinostat|mesh-list
153481777|NCT00392353|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153481778|NCT00392353|Antimetabolites|antimetabolites|mesh-ancestor
153481779|NCT00392353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153481780|NCT00392353|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153481781|NCT00392353|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153481782|NCT00392353|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
153481783|NCT00390325|Sorafenib|sorafenib|mesh-list
153481784|NCT00390325|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153481785|NCT00390325|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153481786|NCT00390325|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153481798|NCT00104676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153481799|NCT00104676|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153481800|NCT00104676|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153481801|NCT00104676|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153481802|NCT00104676|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153481803|NCT00104676|Alkylating Agents|alkylating agents|mesh-ancestor
153481804|NCT00104676|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153481805|NCT01335750|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
153481806|NCT01336296|Mycophenolic Acid|mycophenolic acid|mesh-list
153481807|NCT01336296|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153481808|NCT01336296|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153481839|NCT01339260|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153481840|NCT01339260|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153481841|NCT01339260|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153481842|NCT01339260|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
153481843|NCT01339260|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153481844|NCT01339260|Serotonin Agents|serotonin agents|mesh-ancestor
153481845|NCT01339260|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153481846|NCT01339260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153481848|NCT01340586|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
153481849|NCT01340586|Antithrombins|antithrombins|mesh-ancestor
153481850|NCT01340586|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
153481851|NCT01340586|Protease Inhibitors|protease inhibitors|mesh-ancestor
153481852|NCT01340586|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153481862|NCT01343004|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153481863|NCT01347060|Fluticasone|fluticasone|mesh-list
153481865|NCT01347060|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
153481866|NCT01347060|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153481867|NCT01347060|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153481868|NCT01347060|Autonomic Agents|autonomic agents|mesh-ancestor
153481886|NCT01351740|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153481887|NCT01351740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153481888|NCT01351740|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153481889|NCT01351740|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153481890|NCT01351740|Antiviral Agents|antiviral agents|mesh-ancestor
153481891|NCT01351740|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153481892|NCT01351740|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
153481893|NCT01351740|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153481894|NCT01353144|Aspirin|aspirin|mesh-list
153481895|NCT01353144|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153481896|NCT01353144|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153481897|NCT01353144|Analgesics|analgesics|mesh-ancestor
153481898|NCT01353144|Sensory System Agents|sensory system agents|mesh-ancestor
153481899|NCT01353144|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153481900|NCT01353144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153481901|NCT01353144|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153481902|NCT01353144|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153481903|NCT01353144|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153481904|NCT01353144|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153481905|NCT01353144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153481906|NCT01353144|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153481907|NCT01353144|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153481908|NCT01353144|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153481909|NCT01353144|Antipyretics|antipyretics|mesh-ancestor
153481910|NCT01362192|Chlorhexidine|chlorhexidine|mesh-list
153481911|NCT01362192|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
153481912|NCT01362192|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
153481913|NCT01362192|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153481914|NCT01362192|Disinfectants|disinfectants|mesh-ancestor
153481915|NCT01362192|Dermatologic Agents|dermatologic agents|mesh-ancestor
153481916|NCT01363050|Ketorolac|ketorolac|mesh-list
153481917|NCT01363050|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
153481929|NCT01363128|Cytarabine|cytarabine|mesh-list
153481930|NCT01363128|Dexamethasone|dexamethasone|mesh-list
153481931|NCT01363128|Dexamethasone acetate|dexamethasone acetate|mesh-list
153481958|NCT01363128|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153481959|NCT01363128|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153481961|NCT01363128|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153481962|NCT01363128|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
153481963|NCT01363128|Abortifacient Agents|abortifacient agents|mesh-ancestor
153481964|NCT01363128|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153481965|NCT01363128|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153481966|NCT01363128|Antimetabolites|antimetabolites|mesh-ancestor
153481967|NCT01363128|Dermatologic Agents|dermatologic agents|mesh-ancestor
153481968|NCT01363128|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153482008|NCT01377636|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153482009|NCT01377636|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153482010|NCT01377636|Respiratory System Agents|respiratory system agents|mesh-ancestor
153482011|NCT01377636|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
153482013|NCT01377636|Protective Agents|protective agents|mesh-ancestor
153482014|NCT01378416|Decitabine|decitabine|mesh-list
153482015|NCT01378416|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153482016|NCT01378416|Antimetabolites|antimetabolites|mesh-ancestor
153482017|NCT01378416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153482018|NCT01378416|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153482032|NCT01387464|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153482033|NCT01387464|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153482034|NCT01387464|Analgesics|analgesics|mesh-ancestor
153482058|NCT01390818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153482059|NCT01390818|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153482060|NCT01390818|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153482061|NCT01390818|Immunologic Factors|immunologic factors|mesh-ancestor
153482062|NCT01390818|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153482063|NCT01390818|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153482064|NCT01390818|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153482110|NCT01399866|Antimetabolites|antimetabolites|mesh-ancestor
153482111|NCT01399866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153482112|NCT01402050|Dinoprostone|dinoprostone|mesh-list
153482113|NCT01402050|Oxytocics|oxytocics|mesh-ancestor
153482114|NCT01402050|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153482115|NCT01402050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153482116|NCT01403376|Interferons|interferons|mesh-list
153482117|NCT01403376|Interferon-beta|interferon-beta|mesh-list
153482118|NCT01403376|Teriflunomide|teriflunomide|mesh-list
153482119|NCT01403376|Interferon beta-1b|interferon beta-1b|mesh-list
153482120|NCT01403376|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153482121|NCT01403376|Antiviral Agents|antiviral agents|mesh-ancestor
153482122|NCT01403376|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153482123|NCT01403376|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153482124|NCT01403376|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153482226|NCT01429350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153482227|NCT01432236|Pregabalin|pregabalin|mesh-list
153482228|NCT01432236|Analgesics|analgesics|mesh-ancestor
153482229|NCT01432236|Sensory System Agents|sensory system agents|mesh-ancestor
153482284|NCT01443546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153482285|NCT01443546|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153482286|NCT01443546|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153482287|NCT01444716|Ofatumumab|ofatumumab|mesh-list
153482288|NCT01444716|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
153482289|NCT01444716|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153482290|NCT01444716|Immunologic Factors|immunologic factors|mesh-ancestor
153482291|NCT01444716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153482292|NCT01445028|Isotretinoin|isotretinoin|mesh-list
153482293|NCT01445028|Dermatologic Agents|dermatologic agents|mesh-ancestor
153482294|NCT01452126|Ropivacaine|ropivacaine|mesh-list
153482295|NCT01452126|Anesthetics, Local|anesthetics, local|mesh-ancestor
153482296|NCT01452126|Anesthetics|anesthetics|mesh-ancestor
153482297|NCT01452126|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153482298|NCT01452126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153482299|NCT01452126|Sensory System Agents|sensory system agents|mesh-ancestor
153482300|NCT01452126|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153482301|NCT01457430|Icatibant|icatibant|mesh-list
153482302|NCT01457430|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153482303|NCT01457430|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153427222|NCT00002006|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153482305|NCT01457430|Sensory System Agents|sensory system agents|mesh-ancestor
153482306|NCT01457430|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153482307|NCT01457430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153482308|NCT01457430|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153482309|NCT01457430|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153482310|NCT01457430|Bradykinin B2 Receptor Antagonists|bradykinin b2 receptor antagonists|mesh-ancestor
153482311|NCT01457430|Bradykinin Receptor Antagonists|bradykinin receptor antagonists|mesh-ancestor
153482312|NCT01457430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153482313|NCT01457430|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
153482314|NCT01457430|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153482315|NCT01457430|Immunologic Factors|immunologic factors|mesh-ancestor
153482316|NCT01458990|Omeprazole|omeprazole|mesh-list
153482317|NCT01458990|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
153482318|NCT01458990|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153482319|NCT01458990|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
153482320|NCT01458990|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153482321|NCT01458990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153482322|NCT01460940|Lenalidomide|lenalidomide|mesh-list
153482323|NCT01460940|Panobinostat|panobinostat|mesh-list
153482324|NCT01460940|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-list
153482325|NCT01460940|Immunologic Factors|immunologic factors|mesh-ancestor
153482326|NCT01460940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153482327|NCT01460940|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153482399|NCT01478256|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
153482400|NCT01478256|Erythromycin stearate|erythromycin stearate|mesh-list
153482402|NCT01478256|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153482403|NCT01478256|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153482404|NCT01478256|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153482405|NCT01478256|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
153482406|NCT01478256|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153482407|NCT01478256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153482408|NCT01478256|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153482409|NCT01478256|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153482410|NCT01478256|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153482412|NCT01479270|Ropivacaine|ropivacaine|mesh-list
153482413|NCT01479270|Anesthetics, Local|anesthetics, local|mesh-ancestor
153482414|NCT01479270|Anesthetics|anesthetics|mesh-ancestor
153482415|NCT01479270|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153482416|NCT01479270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153482417|NCT01479270|Sensory System Agents|sensory system agents|mesh-ancestor
153482418|NCT01479270|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153482419|NCT01479270|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153482426|NCT01479270|Autonomic Agents|autonomic agents|mesh-ancestor
153482427|NCT01479270|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153482428|NCT01479270|Respiratory System Agents|respiratory system agents|mesh-ancestor
153482429|NCT01479270|Mydriatics|mydriatics|mesh-ancestor
153482458|NCT01488318|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153482459|NCT01488318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153482460|NCT01495572|Aldesleukin|aldesleukin|mesh-list
153482461|NCT01495572|Cyclophosphamide|cyclophosphamide|mesh-list
153482462|NCT01495572|Fludarabine|fludarabine|mesh-list
153482463|NCT01495572|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153482464|NCT01495572|Immunologic Factors|immunologic factors|mesh-ancestor
153482465|NCT01495572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153482466|NCT01495572|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153482467|NCT01495572|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153482468|NCT01495572|Alkylating Agents|alkylating agents|mesh-ancestor
153482469|NCT01495572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153482470|NCT01495572|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153482471|NCT01495572|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153482472|NCT01495572|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153482473|NCT01495572|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153482474|NCT01495572|Antiviral Agents|antiviral agents|mesh-ancestor
153482517|NCT01513122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153482519|NCT01513122|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153482541|NCT01515540|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153482542|NCT01515540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153482544|NCT01519284|Carbidopa|carbidopa|mesh-list
153482545|NCT01519284|Opicapone|opicapone|mesh-list
153482546|NCT01519284|Entacapone|entacapone|mesh-list
153482547|NCT01519284|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
153482548|NCT01519284|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
153482549|NCT01519284|Dopamine Agents|dopamine agents|mesh-ancestor
153482550|NCT01519284|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153482551|NCT01519284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153482552|NCT01519284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153482553|NCT01519284|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
153482554|NCT01519284|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153482555|NCT01519284|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
153482556|NCT01520454|Heparin|heparin|mesh-list
153482557|NCT01520454|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
153482558|NCT01520454|Anticoagulants|anticoagulants|mesh-ancestor
153482559|NCT01520454|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153482560|NCT01520454|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153482561|NCT01520454|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153482566|NCT01520688|Xhance|xhance|mesh-list
153482567|NCT01520688|Budesonide|budesonide|mesh-list
153482568|NCT01520688|Beclomethasone|beclomethasone|mesh-list
153482569|NCT01520688|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153482570|NCT01520688|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153482571|NCT01520688|Autonomic Agents|autonomic agents|mesh-ancestor
153482580|NCT01520688|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153482581|NCT01521546|Eplerenone|eplerenone|mesh-list
153482582|NCT01521546|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
153482583|NCT01521546|Hormone Antagonists|hormone antagonists|mesh-ancestor
153482584|NCT01521546|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153482585|NCT01521546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153482586|NCT01521546|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
153482587|NCT01521546|Diuretics|diuretics|mesh-ancestor
153427340|NCT00001106|Zidovudine|zidovudine|mesh-list
153482588|NCT01521546|Natriuretic Agents|natriuretic agents|mesh-ancestor
153482589|NCT01521546|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153482591|NCT01523496|Ergocalciferols|ergocalciferols|mesh-list
153482592|NCT01523496|Cholecalciferol|cholecalciferol|mesh-list
153482593|NCT01523496|Calcifediol|calcifediol|mesh-list
153482594|NCT01523496|Vitamins|vitamins|mesh-list
153482595|NCT01523496|Micronutrients|micronutrients|mesh-ancestor
153482596|NCT01523496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153482597|NCT01523496|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153482598|NCT01523496|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153482599|NCT01526538|Cycloserine|cycloserine|mesh-list
153482600|NCT01526538|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
153482601|NCT01526538|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153482602|NCT01526538|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
153482603|NCT01526538|Antitubercular Agents|antitubercular agents|mesh-ancestor
153482604|NCT01526538|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153482605|NCT01526538|Antimetabolites|antimetabolites|mesh-ancestor
153813857|NCT00437463|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153813858|NCT00437463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153482612|NCT01529502|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153482613|NCT01529502|Respiratory System Agents|respiratory system agents|mesh-ancestor
153482614|NCT01529502|Free Radical Scavengers|free radical scavengers|mesh-ancestor
153482615|NCT01529502|Antioxidants|antioxidants|mesh-ancestor
153482616|NCT01529502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153482617|NCT01529502|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153482618|NCT01529502|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
153482619|NCT01529502|Vasodilator Agents|vasodilator agents|mesh-ancestor
153482620|NCT01529502|Gasotransmitters|gasotransmitters|mesh-ancestor
153482621|NCT01529502|Protective Agents|protective agents|mesh-ancestor
153482622|NCT01532700|Ofatumumab|ofatumumab|mesh-list
153482623|NCT01532700|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153482624|NCT01533948|Axitinib|axitinib|mesh-list
153482626|NCT01533948|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153482627|NCT01533948|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153482628|NCT01533948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153482629|NCT01534416|Bupivacaine|bupivacaine|mesh-list
153482630|NCT01534416|Anesthetics, Local|anesthetics, local|mesh-ancestor
153482631|NCT01534416|Anesthetics|anesthetics|mesh-ancestor
153482632|NCT01534416|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153482633|NCT01534416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153482634|NCT01534416|Sensory System Agents|sensory system agents|mesh-ancestor
153482684|NCT06114979|Adrenergic Agents|adrenergic agents|mesh-ancestor
153482685|NCT06114979|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153482686|NCT06114979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153482687|NCT06114979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153482688|NCT06114979|Urological Agents|urological agents|mesh-ancestor
153482690|NCT06114953|Mizoribine|mizoribine|mesh-list
153482691|NCT06114953|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153482692|NCT06114953|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153482693|NCT06114953|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
153482694|NCT06114953|Antitubercular Agents|antitubercular agents|mesh-ancestor
153482695|NCT06114953|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153482696|NCT06114953|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153482697|NCT06114953|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153482698|NCT06114953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153482699|NCT06114953|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153482700|NCT06114953|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153482701|NCT06114953|Analgesics|analgesics|mesh-ancestor
153482702|NCT06114953|Sensory System Agents|sensory system agents|mesh-ancestor
153482703|NCT06114953|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153482704|NCT06114953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153482705|NCT06114953|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153482706|NCT06114953|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153482707|NCT06114953|Antimalarials|antimalarials|mesh-ancestor
153482708|NCT06114953|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153482709|NCT06114953|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153482710|NCT06114953|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153482711|NCT06114953|Immunologic Factors|immunologic factors|mesh-ancestor
153482712|NCT06114940|Sunitinib|sunitinib|mesh-list
153482713|NCT06114940|Lenvatinib|lenvatinib|mesh-list
153482714|NCT06114940|Axitinib|axitinib|mesh-list
153482715|NCT06114940|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153482716|NCT06114940|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153482717|NCT06114940|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153482718|NCT06114940|Growth Substances|growth substances|mesh-ancestor
153482719|NCT06114940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153482720|NCT06114940|Growth Inhibitors|growth inhibitors|mesh-ancestor
153482721|NCT06114940|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153482722|NCT06114940|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153482729|NCT06114758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153482730|NCT06114758|Hemostatics|hemostatics|mesh-ancestor
153482731|NCT06114758|Coagulants|coagulants|mesh-ancestor
153482732|NCT06114758|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
153482768|NCT06114381|Cholecalciferol|cholecalciferol|mesh-list
153482770|NCT06114381|Micronutrients|micronutrients|mesh-ancestor
153482771|NCT06114381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153482772|NCT06114381|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153482773|NCT06114381|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153482806|NCT06114082|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153482807|NCT06114082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153482808|NCT06114082|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153482809|NCT06114030|Lithium Carbonate|lithium carbonate|mesh-list
153482810|NCT06114030|Antidepressive Agents|antidepressive agents|mesh-ancestor
153482811|NCT06114030|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153482812|NCT06114030|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153482813|NCT06114030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153482814|NCT06114030|Antimanic Agents|antimanic agents|mesh-ancestor
153482815|NCT06114030|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153482816|NCT06114030|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153482817|NCT06114030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153482819|NCT06114004|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153482820|NCT06114004|Antimetabolites|antimetabolites|mesh-ancestor
153482841|NCT06110130|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153482842|NCT06110130|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153482843|NCT06110130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153482844|NCT06108895|Morphine|morphine|mesh-list
153482845|NCT06108895|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153482846|NCT06108895|Narcotics|narcotics|mesh-ancestor
153482847|NCT06108895|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153482848|NCT06108895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153482849|NCT06108895|Analgesics|analgesics|mesh-ancestor
153482850|NCT06108895|Sensory System Agents|sensory system agents|mesh-ancestor
153482851|NCT06108895|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153482852|NCT06090266|Cemiplimab|cemiplimab|mesh-list
153482853|NCT06090266|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153482854|NCT06090266|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153482855|NCT06087419|Venetoclax|venetoclax|mesh-list
153813861|NCT00437502|Immunologic Factors|immunologic factors|mesh-ancestor
153813862|NCT00437502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153813863|NCT00420797|Phenylephrine|phenylephrine|mesh-list
153813864|NCT00420797|Oxymetazoline|oxymetazoline|mesh-list
153813865|NCT00420797|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
153813866|NCT00420797|Mydriatics|mydriatics|mesh-ancestor
153813867|NCT00420797|Autonomic Agents|autonomic agents|mesh-ancestor
153813868|NCT00420797|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153813869|NCT00420797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153813870|NCT00420797|Sympathomimetics|sympathomimetics|mesh-ancestor
153813871|NCT00420797|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
153813872|NCT00420797|Nasal Decongestants|nasal decongestants|mesh-ancestor
153813873|NCT00420797|Respiratory System Agents|respiratory system agents|mesh-ancestor
153813874|NCT00420797|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
153482858|NCT06087419|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153482859|NCT06087419|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153482860|NCT06087419|Immunotoxins|immunotoxins|mesh-ancestor
153482861|NCT06087419|Immunoconjugates|immunoconjugates|mesh-ancestor
153482862|NCT06087419|Immunologic Factors|immunologic factors|mesh-ancestor
153482863|NCT06087419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153482864|NCT06048107|Teniposide|teniposide|mesh-list
153482865|NCT06048107|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153482866|NCT06048107|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153482867|NCT06048107|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153482868|NCT06048107|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153482869|NCT06048107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153482870|NCT06038617|Vaccines|vaccines|mesh-list
153482871|NCT06038617|Immunologic Factors|immunologic factors|mesh-ancestor
153482872|NCT06038617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153482889|NCT05997732|Mydriatics|mydriatics|mesh-ancestor
153482899|NCT05997732|Protective Agents|protective agents|mesh-ancestor
153482900|NCT05997732|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
153482901|NCT05997732|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
153482902|NCT05997732|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153482903|NCT05997732|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153482904|NCT05941858|Nicotine|nicotine|mesh-list
153482905|NCT05941858|Carbon Monoxide|carbon monoxide|mesh-list
153482906|NCT05941858|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
153427379|NCT00001112|Interferons|interferons|mesh-list
153482907|NCT05941858|Autonomic Agents|autonomic agents|mesh-ancestor
153482908|NCT05941858|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153482909|NCT05941858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153482910|NCT05941858|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
153482911|NCT05941858|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
153482912|NCT05941858|Cholinergic Agents|cholinergic agents|mesh-ancestor
153482913|NCT05941858|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153482914|NCT05941858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153482915|NCT05941858|Antimetabolites|antimetabolites|mesh-ancestor
153482916|NCT05941858|Gasotransmitters|gasotransmitters|mesh-ancestor
153482917|NCT05935917|Brincidofovir|brincidofovir|mesh-list
153482918|NCT05935917|Antiviral Agents|antiviral agents|mesh-ancestor
153482919|NCT05935917|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153482920|NCT05918302|Everolimus|everolimus|mesh-list
153482984|NCT05723588|Cholinergic Agents|cholinergic agents|mesh-ancestor
153482985|NCT05723588|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153482986|NCT05723588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153482988|NCT05705492|Antiemetics|antiemetics|mesh-ancestor
153482989|NCT05705492|Autonomic Agents|autonomic agents|mesh-ancestor
153483018|NCT05557578|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153483019|NCT05557578|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153483020|NCT05500586|Glucagon|glucagon|mesh-list
153483021|NCT05500586|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153483022|NCT05500586|Hormones|hormones|mesh-ancestor
153483023|NCT05500586|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153483024|NCT05500586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153483025|NCT05482516|Bevacizumab|bevacizumab|mesh-list
153483026|NCT05482516|Atezolizumab|atezolizumab|mesh-list
153483027|NCT05482516|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153483028|NCT05482516|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153483029|NCT05482516|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153483030|NCT05482516|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153483031|NCT05482516|Growth Substances|growth substances|mesh-ancestor
153483032|NCT05482516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153483053|NCT05470595|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153483055|NCT05412875|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
153483056|NCT05412875|Autonomic Agents|autonomic agents|mesh-ancestor
153483057|NCT05412875|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153483058|NCT05412875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153483059|NCT05412875|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
153483060|NCT05412875|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
153483061|NCT05412875|Cholinergic Agents|cholinergic agents|mesh-ancestor
153483062|NCT05412875|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153483063|NCT05412875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153483064|NCT05318469|Ivermectin|ivermectin|mesh-list
153483065|NCT05318469|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153813875|NCT00420797|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153483077|NCT05186363|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153483078|NCT05186363|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153483079|NCT05186363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153483080|NCT05186363|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
153483081|NCT05136703|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
153483082|NCT05136703|Antiviral Agents|antiviral agents|mesh-ancestor
153483083|NCT05136703|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153483084|NCT05094804|Docetaxel|docetaxel|mesh-list
153483085|NCT05094804|Cemiplimab|cemiplimab|mesh-list
153483086|NCT05094804|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153483087|NCT05094804|Tubulin Modulators|tubulin modulators|mesh-ancestor
153483088|NCT05094804|Antimitotic Agents|antimitotic agents|mesh-ancestor
153483089|NCT05094804|Mitosis Modulators|mitosis modulators|mesh-ancestor
153483090|NCT05094804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153483099|NCT05021562|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
153483100|NCT05021562|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153483101|NCT05021562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153483102|NCT05021562|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153483122|NCT04966585|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153483123|NCT04966585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153483124|NCT04919369|Vitamins|vitamins|mesh-list
153483125|NCT04919369|Vitamin A|vitamin a|mesh-list
153483126|NCT04919369|Atezolizumab|atezolizumab|mesh-list
153483127|NCT04919369|Tretinoin|tretinoin|mesh-list
153483153|NCT04812379|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153483155|NCT04812379|Dopamine Agonists|dopamine agonists|mesh-ancestor
153483156|NCT04812379|Dopamine Agents|dopamine agents|mesh-ancestor
153483187|NCT04597099|Estradiol|estradiol|mesh-list
153483188|NCT04597099|Progesterone|progesterone|mesh-list
153483189|NCT04597099|Estrogens|estrogens|mesh-ancestor
153483190|NCT04597099|Hormones|hormones|mesh-ancestor
153483191|NCT04597099|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153483192|NCT04597099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153483193|NCT04597099|Progestins|progestins|mesh-ancestor
153483194|NCT04597099|Androgen Antagonists|androgen antagonists|mesh-ancestor
153483195|NCT04597099|Hormone Antagonists|hormone antagonists|mesh-ancestor
153483196|NCT04597099|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153813876|NCT00420797|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153813877|NCT00420797|Adrenergic Agents|adrenergic agents|mesh-ancestor
153815066|NCT00448110|Diclofenac|diclofenac|mesh-list
153483197|NCT04597099|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153483198|NCT04582383|Doxycycline|doxycycline|mesh-list
153483199|NCT04582383|Spironolactone|spironolactone|mesh-list
153483200|NCT04582383|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153483201|NCT04582383|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153483202|NCT04582383|Antimalarials|antimalarials|mesh-ancestor
153483221|NCT04546672|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153483222|NCT04738292|Fulvestrant|fulvestrant|mesh-list
153483223|NCT04738292|Onapristone|onapristone|mesh-list
153483224|NCT04738292|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153483225|NCT04738292|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153483226|NCT04738292|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
153483227|NCT04738292|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
153483228|NCT04738292|Hormone Antagonists|hormone antagonists|mesh-ancestor
153483229|NCT04738292|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153483230|NCT04738292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153483231|NCT04738292|Fertility Agents, Female|fertility agents, female|mesh-ancestor
153483233|NCT04738292|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153483234|NCT04537923|Insulin Lispro|insulin lispro|mesh-list
153483235|NCT04537923|Tirzepatide|tirzepatide|mesh-list
153483236|NCT04537923|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153483237|NCT04537923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153483238|NCT04537923|Incretins|incretins|mesh-ancestor
153483239|NCT04537923|Hormones|hormones|mesh-ancestor
153483241|NCT04484623|Dexamethasone|dexamethasone|mesh-list
153483295|NCT04306510|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
153483297|NCT04306510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153483298|NCT04082442|Evolocumab|evolocumab|mesh-list
153483299|NCT04082442|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
153483300|NCT04082442|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153483301|NCT04082442|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153483302|NCT04082442|Antimetabolites|antimetabolites|mesh-ancestor
153483303|NCT04082442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153483304|NCT04082442|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
153483305|NCT04082442|Protease Inhibitors|protease inhibitors|mesh-ancestor
153483323|NCT04003285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153483324|NCT03924856|Gemcitabine|gemcitabine|mesh-list
153483325|NCT03924856|Pembrolizumab|pembrolizumab|mesh-list
153483326|NCT03924856|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153483327|NCT03924856|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153483328|NCT03924856|Antimetabolites|antimetabolites|mesh-ancestor
153483329|NCT03924856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153483330|NCT03924856|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153483331|NCT03924856|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153483333|NCT03834766|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
153483334|NCT03834766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153483335|NCT03834766|Sympathomimetics|sympathomimetics|mesh-ancestor
153427467|NCT00002072|Hematinics|hematinics|mesh-ancestor
153427478|NCT00000440|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
153813878|NCT00420797|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153483336|NCT03834766|Autonomic Agents|autonomic agents|mesh-ancestor
153483337|NCT03834766|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153483338|NCT03834766|Dopamine Agents|dopamine agents|mesh-ancestor
153483339|NCT03834766|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153483340|NCT03834766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153483341|NCT03834766|Adrenergic Agents|adrenergic agents|mesh-ancestor
153483342|NCT03834766|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
153483343|NCT03834766|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153483344|NCT03834766|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153483345|NCT03834766|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
153483346|NCT03761056|Cyclophosphamide|cyclophosphamide|mesh-list
153483347|NCT03761056|Fludarabine|fludarabine|mesh-list
153483348|NCT03761056|Axicabtagene ciloleucel|axicabtagene ciloleucel|mesh-list
153483349|NCT03761056|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153483350|NCT03761056|Immunologic Factors|immunologic factors|mesh-ancestor
153483402|NCT03546686|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153483403|NCT03546686|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153483404|NCT03546686|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153483405|NCT03546686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153483406|NCT03508921|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
153483407|NCT03508921|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
153483408|NCT03508921|Trimethoprim|trimethoprim|mesh-list
153483409|NCT03508921|Sulfamethoxazole|sulfamethoxazole|mesh-list
153483410|NCT03508921|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
153483411|NCT03508921|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
153483412|NCT03508921|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153483413|NCT03508921|Antitubercular Agents|antitubercular agents|mesh-ancestor
153483414|NCT03508921|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
153483415|NCT03508921|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153483416|NCT03508921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153483417|NCT03508921|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
153813879|NCT00420797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153813880|NCT00420797|Protective Agents|protective agents|mesh-ancestor
153483443|NCT03349450|Alkylating Agents|alkylating agents|mesh-ancestor
153483444|NCT03349450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153483445|NCT03349450|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153483446|NCT03349450|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153483447|NCT03349450|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153483448|NCT03349450|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153483449|NCT03315026|Siltuximab|siltuximab|mesh-list
153483450|NCT03315026|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153483451|NCT03307616|Nivolumab|nivolumab|mesh-list
153483452|NCT03307616|Ipilimumab|ipilimumab|mesh-list
153483453|NCT03307616|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153483454|NCT03307616|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153483455|NCT03307616|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153483456|NCT03307616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153483457|NCT03280147|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
153483458|NCT03280147|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
153483459|NCT03280147|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153483460|NCT03280147|Antitubercular Agents|antitubercular agents|mesh-ancestor
153483473|NCT03200236|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
153483474|NCT03200236|Cholinergic Agents|cholinergic agents|mesh-ancestor
153483475|NCT03200236|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153483476|NCT03200236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153483477|NCT03125642|Cytarabine|cytarabine|mesh-list
153483478|NCT03125642|Cyclophosphamide|cyclophosphamide|mesh-list
153483479|NCT03125642|Melphalan|melphalan|mesh-list
153483480|NCT03125642|Carmustine|carmustine|mesh-list
153483481|NCT03125642|Etoposide|etoposide|mesh-list
153483482|NCT03125642|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153483483|NCT03125642|Immunologic Factors|immunologic factors|mesh-ancestor
153483484|NCT03125642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153483493|NCT03125642|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153483494|NCT03125642|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153483495|NCT03125642|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153483496|NCT03125642|Antimetabolites|antimetabolites|mesh-ancestor
153427608|NCT00002108|Antiviral Agents|antiviral agents|mesh-ancestor
153483507|NCT03105843|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153483508|NCT03105843|Parasympathomimetics|parasympathomimetics|mesh-ancestor
153483509|NCT03105843|Bronchoconstrictor Agents|bronchoconstrictor agents|mesh-ancestor
153483510|NCT03105843|Respiratory System Agents|respiratory system agents|mesh-ancestor
153483511|NCT03105843|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
153483512|NCT03105843|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
153483513|NCT03105843|Cholinergic Agents|cholinergic agents|mesh-ancestor
153483514|NCT03105843|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153483515|NCT03105843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153483516|NCT03068910|Spironolactone|spironolactone|mesh-list
153483517|NCT03068910|Progesterone|progesterone|mesh-list
153483518|NCT03068910|Progestins|progestins|mesh-ancestor
153483519|NCT03068910|Hormones|hormones|mesh-ancestor
153483520|NCT03068910|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153483521|NCT03068910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153483522|NCT03068910|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
153427609|NCT00002108|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153483537|NCT02520362|Diphosphonates|diphosphonates|mesh-list
153483538|NCT02520362|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153483539|NCT02520362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153483540|NCT02346747|Immunomodulating Agents|immunomodulating agents|mesh-list
153483541|NCT02346747|Immunologic Factors|immunologic factors|mesh-ancestor
153483542|NCT02346747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153483543|NCT02324387|Technetium Tc 99m Sestamibi|technetium tc 99m sestamibi|mesh-list
153483544|NCT02324387|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
153483545|NCT02324387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153483546|NCT02267252|Antibodies|antibodies|mesh-list
153483547|NCT02267252|Immunologic Factors|immunologic factors|mesh-ancestor
153483548|NCT02267252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153483549|NCT02266329|Prazosin|prazosin|mesh-list
153483550|NCT02266329|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153483551|NCT02266329|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
153483567|NCT01873131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153483568|NCT01873131|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153483569|NCT01873131|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153483571|NCT01508949|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
153483572|NCT01508949|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153483573|NCT01508949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153483574|NCT01508949|Incretins|incretins|mesh-ancestor
153483575|NCT01508949|Hormones|hormones|mesh-ancestor
153483576|NCT01508949|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153483577|NCT01507285|Liraglutide|liraglutide|mesh-list
153483578|NCT01507285|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
153483579|NCT01507285|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153483580|NCT01507285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153483581|NCT01507285|Incretins|incretins|mesh-ancestor
153483582|NCT01507285|Hormones|hormones|mesh-ancestor
153483583|NCT01507285|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153483584|NCT01486862|Insulin Aspart|insulin aspart|mesh-list
153483585|NCT01486862|Biphasic Insulins|biphasic insulins|mesh-list
153483586|NCT01486862|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
153427668|NCT00000542|Amlodipine|amlodipine|mesh-list
153483595|NCT01425541|Estradiol|estradiol|mesh-list
153483596|NCT01425541|Estrogens|estrogens|mesh-list
153483597|NCT01425541|Progestins|progestins|mesh-ancestor
153483598|NCT01425541|Hormones|hormones|mesh-ancestor
153483599|NCT01425541|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153483600|NCT01425541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153483602|NCT00930228|Androgen Antagonists|androgen antagonists|mesh-ancestor
153483613|NCT00745433|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153483614|NCT00745433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153483615|NCT00712478|Insulin|insulin|mesh-list
153483616|NCT00712478|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153483617|NCT00712478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153483618|NCT00701155|Insulin Detemir|insulin detemir|mesh-list
153483627|NCT00653068|Calcium, Dietary|calcium, dietary|mesh-list
153483628|NCT00653068|Leucovorin|leucovorin|mesh-list
153483629|NCT00653068|Folic Acid|folic acid|mesh-list
153483630|NCT00653068|Cyclophosphamide|cyclophosphamide|mesh-list
153483631|NCT00653068|Thiotepa|thiotepa|mesh-list
153483632|NCT00653068|Cisplatin|cisplatin|mesh-list
153483633|NCT00653068|Carboplatin|carboplatin|mesh-list
153483634|NCT00653068|Methotrexate|methotrexate|mesh-list
153483635|NCT00653068|Etoposide|etoposide|mesh-list
153483636|NCT00653068|Vincristine|vincristine|mesh-list
153483637|NCT00653068|Etoposide phosphate|etoposide phosphate|mesh-list
153483638|NCT00653068|Podophyllotoxin|podophyllotoxin|mesh-list
153483639|NCT00653068|Lenograstim|lenograstim|mesh-list
153483640|NCT00653068|Calcium|calcium|mesh-list
153483641|NCT00653068|Levoleucovorin|levoleucovorin|mesh-list
153483642|NCT00653068|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153483643|NCT00653068|Immunologic Factors|immunologic factors|mesh-ancestor
153483644|NCT00653068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153483645|NCT00653068|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153483646|NCT00653068|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153483647|NCT00653068|Alkylating Agents|alkylating agents|mesh-ancestor
153483648|NCT00653068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153483649|NCT00653068|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153483650|NCT00653068|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153483651|NCT00653068|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153483652|NCT00653068|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153483653|NCT00653068|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
153483654|NCT00653068|Abortifacient Agents|abortifacient agents|mesh-ancestor
153483655|NCT00653068|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153483656|NCT00653068|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153483657|NCT00653068|Antimetabolites|antimetabolites|mesh-ancestor
153483658|NCT00653068|Dermatologic Agents|dermatologic agents|mesh-ancestor
153483659|NCT00653068|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153483678|NCT00521690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153483679|NCT00504673|Insulin|insulin|mesh-list
153483680|NCT00504673|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
153483681|NCT00504673|Insulin Aspart|insulin aspart|mesh-list
153483682|NCT00504673|Insulin Detemir|insulin detemir|mesh-list
153483683|NCT00504673|Isophane Insulin, Human|isophane insulin, human|mesh-list
153483684|NCT00504673|Insulin, Isophane|insulin, isophane|mesh-list
153483685|NCT00504673|Isophane insulin, beef|isophane insulin, beef|mesh-list
153483686|NCT00504673|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153483687|NCT00504673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153483688|NCT00476437|Insulin|insulin|mesh-list
153483689|NCT00476437|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
153483690|NCT00476437|Insulin Aspart|insulin aspart|mesh-list
153483710|NCT00313742|Insulin, Isophane|insulin, isophane|mesh-list
153483711|NCT00313742|Isophane insulin, beef|isophane insulin, beef|mesh-list
153483712|NCT00313742|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153483713|NCT00313742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153427721|NCT00002120|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
153483735|NCT00077285|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153483736|NCT00077285|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153483737|NCT00077285|Alkylating Agents|alkylating agents|mesh-ancestor
153483738|NCT00077285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153483739|NCT00077285|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153483740|NCT00077285|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153483741|NCT00077285|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153483742|NCT00077285|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153483743|NCT00077285|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153483744|NCT00077285|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153483745|NCT00077285|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
153483746|NCT00077285|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153483747|NCT00077285|Tubulin Modulators|tubulin modulators|mesh-ancestor
153886714|NCT05367765|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153483748|NCT00077285|Antimitotic Agents|antimitotic agents|mesh-ancestor
153483777|NCT01542372|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153483778|NCT01542372|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
153483779|NCT01542372|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
153483780|NCT01542372|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
153427773|NCT00000578|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153427775|NCT00000578|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153483798|NCT01543074|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153483799|NCT01543074|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153483801|NCT01545336|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153483815|NCT01548690|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153483816|NCT01551888|Formoterol Fumarate|formoterol fumarate|mesh-list
153483817|NCT01551888|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153483818|NCT01551888|Autonomic Agents|autonomic agents|mesh-ancestor
153483822|NCT01551888|Respiratory System Agents|respiratory system agents|mesh-ancestor
153483823|NCT01551888|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
153483825|NCT01551888|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153483826|NCT01551888|Adrenergic Agents|adrenergic agents|mesh-ancestor
153427783|NCT00000578|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153427785|NCT03774745|Progesterone|progesterone|mesh-list
153483846|NCT01558128|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153483847|NCT01558128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153483848|NCT01558128|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153483849|NCT01558128|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
153483850|NCT01558128|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153483851|NCT01558128|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153483852|NCT01558128|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
153483853|NCT01558128|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
153483854|NCT01558128|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
153483855|NCT01559064|Lidocaine|lidocaine|mesh-list
153483856|NCT01559064|Hyaluronic Acid|hyaluronic acid|mesh-list
153483857|NCT01559064|Anesthetics, Local|anesthetics, local|mesh-ancestor
153483858|NCT01559064|Anesthetics|anesthetics|mesh-ancestor
153483859|NCT01559064|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153483860|NCT01559064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153483861|NCT01559064|Sensory System Agents|sensory system agents|mesh-ancestor
153483862|NCT01559064|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153483863|NCT01559064|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153483864|NCT01559064|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
153483865|NCT01559064|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153483866|NCT01559064|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153483867|NCT01559064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153483868|NCT01559064|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153813885|NCT00420836|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153813886|NCT00437697|Dalteparin|dalteparin|mesh-list
153483877|NCT01560624|Treprostinil|treprostinil|mesh-list
153483878|NCT01560624|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153483879|NCT01562886|Rilpivirine|rilpivirine|mesh-list
153483880|NCT01562886|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153483881|NCT01562886|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153483882|NCT01562886|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153483887|NCT01562886|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153483906|NCT01565538|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153483907|NCT01565538|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153483908|NCT01565616|Fludarabine|fludarabine|mesh-list
153483909|NCT01565616|Busulfan|busulfan|mesh-list
153483910|NCT01565616|Thymoglobulin|thymoglobulin|mesh-list
153483911|NCT01565616|Antilymphocyte Serum|antilymphocyte serum|mesh-list
153483912|NCT01565616|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153483913|NCT01565616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153483914|NCT01565616|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153483915|NCT01565616|Immunologic Factors|immunologic factors|mesh-ancestor
153483916|NCT01565616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153886770|NCT01078675|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153886771|NCT01078675|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153886772|NCT01078675|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153886773|NCT01078675|Antimetabolites|antimetabolites|mesh-ancestor
153886774|NCT01078675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153886775|NCT01078675|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153483925|NCT01566162|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153483926|NCT01566162|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
153483927|NCT01566162|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
153886783|NCT01100437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153886784|NCT01100437|Analgesics|analgesics|mesh-ancestor
153483950|NCT01569126|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153483951|NCT01569126|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153483952|NCT01569828|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
153483953|NCT01569828|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
153483959|NCT01577706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153483960|NCT01577706|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153483961|NCT01577706|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153483962|NCT01577706|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153483963|NCT01577706|GABA Modulators|gaba modulators|mesh-ancestor
153483965|NCT01577706|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153483966|NCT01577706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153483967|NCT01577706|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
153483968|NCT01577706|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
153483969|NCT01577706|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153483970|NCT01577706|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153483971|NCT01577706|Dopamine Agents|dopamine agents|mesh-ancestor
153483972|NCT01580592|Omalizumab|omalizumab|mesh-list
153483973|NCT01580592|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
153483974|NCT01580592|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
153483975|NCT01580592|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153483994|NCT01588158|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153483995|NCT01588158|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153886788|NCT01100437|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
153886789|NCT01322490|Molgramostim|molgramostim|mesh-list
153886790|NCT01322490|Sargramostim|sargramostim|mesh-list
153886791|NCT01322490|Immunologic Factors|immunologic factors|mesh-ancestor
153886792|NCT01322490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153886793|NCT01322490|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153886794|NCT02877355|Semaglutide|semaglutide|mesh-list
153886795|NCT02877355|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
153886796|NCT02877355|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153483996|NCT01588470|Pioglitazone|pioglitazone|mesh-list
153483997|NCT01588470|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153483998|NCT01588470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153483999|NCT01591746|Botulinum Toxins|botulinum toxins|mesh-list
153484000|NCT01591746|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
153484001|NCT01591746|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
153484002|NCT01591746|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
153484003|NCT01591746|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153484004|NCT01591746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153484005|NCT01591746|Cholinergic Agents|cholinergic agents|mesh-ancestor
153484006|NCT01591746|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153484007|NCT01591746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153484008|NCT01591746|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
153484009|NCT01591746|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153484030|NCT05564442|Sensory System Agents|sensory system agents|mesh-ancestor
153484031|NCT05564442|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153484033|NCT05493540|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153484034|NCT05493540|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153484035|NCT05493540|Analgesics|analgesics|mesh-ancestor
153484036|NCT05493540|Sensory System Agents|sensory system agents|mesh-ancestor
153484037|NCT05493540|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153484038|NCT05493540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153484039|NCT05493540|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153484040|NCT05493540|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153484041|NCT05493540|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153484042|NCT05493540|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153484043|NCT05493540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153484044|NCT05672472|Sivelestat|sivelestat|mesh-list
153484045|NCT05672472|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
153886798|NCT01314261|Interferons|interferons|mesh-list
153484046|NCT05672472|Protease Inhibitors|protease inhibitors|mesh-ancestor
153484047|NCT05672472|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153484048|NCT05672472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153484050|NCT05672394|Epinephrine|epinephrine|mesh-list
153813891|NCT00437697|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153484051|NCT05672394|Bupivacaine|bupivacaine|mesh-list
153484052|NCT05672394|Anesthetics, Local|anesthetics, local|mesh-ancestor
153484053|NCT05672394|Anesthetics|anesthetics|mesh-ancestor
153484054|NCT05672394|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153484055|NCT05672394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153484056|NCT05672394|Sensory System Agents|sensory system agents|mesh-ancestor
153484057|NCT05672394|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153484058|NCT05672394|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153484059|NCT05672394|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
153484060|NCT05672394|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153484061|NCT05672394|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153484062|NCT05672394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153484063|NCT05672394|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153484064|NCT05672394|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153484065|NCT05672394|Adrenergic Agents|adrenergic agents|mesh-ancestor
153484094|NCT03355170|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153484095|NCT03355170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153484096|NCT03355170|Antiemetics|antiemetics|mesh-ancestor
153484097|NCT03355170|Autonomic Agents|autonomic agents|mesh-ancestor
153484154|NCT03624270|Arsenic Trioxide|arsenic trioxide|mesh-list
153484155|NCT03624270|Antioxidants|antioxidants|mesh-ancestor
153484156|NCT03624270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153484168|NCT03455088|Serotonin Agents|serotonin agents|mesh-ancestor
153484169|NCT03455088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153484170|NCT03455088|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
153484171|NCT03455088|Antidepressive Agents|antidepressive agents|mesh-ancestor
153484172|NCT03455088|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153484173|NCT03455088|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
153484174|NCT03455088|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153484175|NCT03455088|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153484176|NCT01600170|Atorvastatin|atorvastatin|mesh-list
153484177|NCT01600170|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153484178|NCT01600170|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153484179|NCT01600170|Antimetabolites|antimetabolites|mesh-ancestor
153484180|NCT01600170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153484181|NCT01600170|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153484182|NCT01600170|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
153484183|NCT01600170|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153484184|NCT01600950|Insulin Glargine|insulin glargine|mesh-list
153484185|NCT01600950|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153886846|NCT01313637|Bromides|bromides|mesh-list
153484202|NCT01608672|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
153484203|NCT01608672|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153484204|NCT01608672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153484205|NCT01608672|Cholinergic Agents|cholinergic agents|mesh-ancestor
153484206|NCT01608672|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153484207|NCT01608672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153484208|NCT01608672|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
153484209|NCT01608672|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153484210|NCT01610154|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
153484211|NCT01610154|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153484232|NCT01612884|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
153484233|NCT01612884|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
153484234|NCT01612884|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
153484235|NCT01612884|Purinergic Agents|purinergic agents|mesh-ancestor
153484236|NCT01612884|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153484237|NCT01612884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153484238|NCT01612884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153484240|NCT01614210|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
153484241|NCT01614210|Hormone Antagonists|hormone antagonists|mesh-ancestor
153484242|NCT01614210|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153484243|NCT01614210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153484244|NCT01614210|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153484245|NCT01614210|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153484246|NCT01614210|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
153484247|NCT01614210|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
153484248|NCT01614210|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153484249|NCT01616082|Phentermine|phentermine|mesh-list
153484250|NCT01616082|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
153484251|NCT01616082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153484252|NCT01616082|Appetite Depressants|appetite depressants|mesh-ancestor
153484253|NCT01616082|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
153484255|NCT01616082|Autonomic Agents|autonomic agents|mesh-ancestor
153484256|NCT01616082|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153484257|NCT01616082|Adrenergic Agents|adrenergic agents|mesh-ancestor
153484258|NCT01616082|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153484259|NCT01616082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153484260|NCT01616160|Mometasone Furoate|mometasone furoate|mesh-list
153484261|NCT01616160|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153484262|NCT01616160|Dermatologic Agents|dermatologic agents|mesh-ancestor
153484263|NCT01616160|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
153484265|NCT01619982|Cefazolin|cefazolin|mesh-list
153886852|NCT01320722|Allopurinol|allopurinol|mesh-list
153886853|NCT01320722|Probenecid|probenecid|mesh-list
153886854|NCT01320722|Micronutrients|micronutrients|mesh-ancestor
153886855|NCT01320722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153886856|NCT01320722|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153886857|NCT01320722|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153886858|NCT01320722|Antimetabolites|antimetabolites|mesh-ancestor
153886859|NCT01320722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153484280|NCT01620216|Growth Substances|growth substances|mesh-ancestor
153815067|NCT00448110|Ketorolac|ketorolac|mesh-list
153484318|NCT01631682|Vasodilator Agents|vasodilator agents|mesh-ancestor
153484319|NCT01631682|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
153484320|NCT01631682|Abortifacient Agents|abortifacient agents|mesh-ancestor
153484321|NCT01631682|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
153484322|NCT01631682|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
153484357|NCT01639872|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
153484358|NCT01639872|Dopamine Agents|dopamine agents|mesh-ancestor
153484359|NCT01639872|GABA Antagonists|gaba antagonists|mesh-ancestor
153484360|NCT01639872|GABA Agents|gaba agents|mesh-ancestor
153484383|NCT01640340|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
153484384|NCT01641120|Interferons|interferons|mesh-list
153484385|NCT01641120|Interferon-beta|interferon-beta|mesh-list
153484386|NCT01641120|Interferon beta-1a|interferon beta-1a|mesh-list
153484387|NCT01641120|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153484388|NCT01641120|Antiviral Agents|antiviral agents|mesh-ancestor
153484389|NCT01641120|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153484390|NCT01641120|Immunologic Factors|immunologic factors|mesh-ancestor
153484391|NCT01641120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153484392|NCT01641120|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153484393|NCT01643382|Insulin|insulin|mesh-list
153484394|NCT01643382|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
153484395|NCT01643382|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153484396|NCT01643382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153484398|NCT01643616|Ropivacaine|ropivacaine|mesh-list
153484399|NCT01643616|Prilocaine|prilocaine|mesh-list
153484400|NCT01643616|Anesthetics, Local|anesthetics, local|mesh-ancestor
153484401|NCT01643616|Anesthetics|anesthetics|mesh-ancestor
153484402|NCT01643616|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153484403|NCT01643616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153484404|NCT01643616|Sensory System Agents|sensory system agents|mesh-ancestor
153484405|NCT01643616|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153484406|NCT01643616|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153484407|NCT01643616|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153484408|NCT01643616|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153484409|NCT01643616|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153484410|NCT01643616|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153484411|NCT01643616|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153484416|NCT01643616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153484418|NCT01644396|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
153484446|NCT01651806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153484448|NCT01651806|Coagulants|coagulants|mesh-ancestor
153484449|NCT01652040|Methyltestosterone|methyltestosterone|mesh-list
153427906|NCT00002162|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
153427907|NCT00002162|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153427908|NCT00000638|Pyridoxine|pyridoxine|mesh-list
153427909|NCT00000638|Vitamin B 6|vitamin b 6|mesh-list
153427910|NCT00000638|Rifampin|rifampin|mesh-list
153427911|NCT00000638|Isoniazid|isoniazid|mesh-list
153427912|NCT00000638|Pyrazinamide|pyrazinamide|mesh-list
153427913|NCT00000638|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
153427914|NCT00000638|Antitubercular Agents|antitubercular agents|mesh-ancestor
153427915|NCT00000638|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153427916|NCT00000638|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153427917|NCT00000638|Leprostatic Agents|leprostatic agents|mesh-ancestor
153427918|NCT00000638|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153484451|NCT01652040|Testosterone undecanoate|testosterone undecanoate|mesh-list
153484452|NCT01652040|Testosterone enanthate|testosterone enanthate|mesh-list
153484453|NCT01652040|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
153484454|NCT01652040|Androgens|androgens|mesh-ancestor
153484455|NCT01652040|Hormones|hormones|mesh-ancestor
153484456|NCT01652040|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153484457|NCT01652040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153484458|NCT01652040|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153484459|NCT01652040|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153484460|NCT01652040|Anabolic Agents|anabolic agents|mesh-ancestor
153484461|NCT01652976|Leucovorin|leucovorin|mesh-list
153484462|NCT01652976|Fluorouracil|fluorouracil|mesh-list
153484463|NCT01652976|Oxaliplatin|oxaliplatin|mesh-list
153484464|NCT01652976|Dasatinib|dasatinib|mesh-list
153484465|NCT01652976|Antimetabolites|antimetabolites|mesh-ancestor
153484500|NCT01661946|Growth Inhibitors|growth inhibitors|mesh-ancestor
153484501|NCT01663272|Gemcitabine|gemcitabine|mesh-list
153484502|NCT01663272|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153484503|NCT01663272|Antimetabolites|antimetabolites|mesh-ancestor
153484504|NCT01663272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153484505|NCT01663272|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153484528|NCT01669434|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
153484529|NCT01669434|Protease Inhibitors|protease inhibitors|mesh-ancestor
153484530|NCT01669434|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153484531|NCT01669434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153484532|NCT01669434|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153484533|NCT01669434|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
153484534|NCT01669434|Protective Agents|protective agents|mesh-ancestor
153484535|NCT01669434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153484536|NCT01678794|Candesartan|candesartan|mesh-list
153484537|NCT01678794|Candesartan cilexetil|candesartan cilexetil|mesh-list
153484538|NCT01678794|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153484539|NCT01678794|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
153484540|NCT01678794|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
153484541|NCT01678794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153484542|NCT01680900|Vilazodone Hydrochloride|vilazodone hydrochloride|mesh-list
153484543|NCT01680900|Antidepressive Agents|antidepressive agents|mesh-ancestor
153484544|NCT01680900|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153484545|NCT01680900|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
153484546|NCT01680900|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153484547|NCT01680900|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153484548|NCT01680900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153484549|NCT01680900|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153484550|NCT01680900|Serotonin Agents|serotonin agents|mesh-ancestor
153484551|NCT01680900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153886872|NCT01313559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153886873|NCT01313559|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153484566|NCT01684410|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
153484568|NCT01689324|Immunologic Factors|immunologic factors|mesh-ancestor
153484569|NCT01689324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153484570|NCT01692756|Triamcinolone|triamcinolone|mesh-list
153484571|NCT01692756|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
153484572|NCT01692756|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
153484579|NCT01692756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153484580|NCT01692756|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153484581|NCT01692756|Immunologic Factors|immunologic factors|mesh-ancestor
153484582|NCT01692756|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153484583|NCT01692756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153484585|NCT01695330|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153484586|NCT01701102|Fentanyl|fentanyl|mesh-list
153484587|NCT01701102|Mepivacaine|mepivacaine|mesh-list
153484588|NCT01701102|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153484589|NCT01701102|Narcotics|narcotics|mesh-ancestor
153484590|NCT01701102|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153484591|NCT01701102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153484592|NCT01701102|Analgesics|analgesics|mesh-ancestor
153484593|NCT01701102|Sensory System Agents|sensory system agents|mesh-ancestor
153484594|NCT01701102|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153484595|NCT01701102|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153484596|NCT01701102|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153484597|NCT01701102|Anesthetics, General|anesthetics, general|mesh-ancestor
153484598|NCT01701102|Anesthetics|anesthetics|mesh-ancestor
153484599|NCT01701102|Anesthetics, Local|anesthetics, local|mesh-ancestor
153484600|NCT01701414|Bupivacaine|bupivacaine|mesh-list
153813893|NCT00335465|Insulin Glargine|insulin glargine|mesh-list
153484601|NCT01701414|Anesthetics, Local|anesthetics, local|mesh-ancestor
153484602|NCT01701414|Anesthetics|anesthetics|mesh-ancestor
153484603|NCT01701414|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153484615|NCT01706952|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153484616|NCT01706952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153484617|NCT01706952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153484618|NCT01706952|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
153484619|NCT01706952|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153484620|NCT01706952|Autonomic Agents|autonomic agents|mesh-ancestor
153484621|NCT01706952|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153484622|NCT01706952|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153484623|NCT01706952|Respiratory System Agents|respiratory system agents|mesh-ancestor
153484624|NCT01706952|Mydriatics|mydriatics|mesh-ancestor
153484625|NCT01706952|Sympathomimetics|sympathomimetics|mesh-ancestor
153484626|NCT01706952|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
153484627|NCT01706952|Anesthetics, Local|anesthetics, local|mesh-ancestor
153484628|NCT01706952|Anesthetics|anesthetics|mesh-ancestor
153484629|NCT01706952|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153484630|NCT01706952|Sensory System Agents|sensory system agents|mesh-ancestor
153484631|NCT01706952|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
153484632|NCT01706952|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153484633|NCT01706952|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153484634|NCT01706952|Dopamine Agents|dopamine agents|mesh-ancestor
153484636|NCT01707420|Analgesics|analgesics|mesh-ancestor
153484637|NCT01707420|Sensory System Agents|sensory system agents|mesh-ancestor
153484638|NCT01707420|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153484639|NCT01707420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153484640|NCT01707420|Anticonvulsants|anticonvulsants|mesh-ancestor
153484641|NCT01707420|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153484642|NCT01707420|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153484643|NCT01707420|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153484653|NCT01708122|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153484654|NCT01708122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153484672|NCT01708590|Brodalumab|brodalumab|mesh-list
153484673|NCT01708590|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
153484674|NCT01708590|Dermatologic Agents|dermatologic agents|mesh-ancestor
153484675|NCT01708590|Immunologic Factors|immunologic factors|mesh-ancestor
153484676|NCT01708590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153484677|NCT05710146|Tranexamic Acid|tranexamic acid|mesh-list
153484678|NCT05710146|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
153484679|NCT05710146|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153484680|NCT05710146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153484681|NCT05710146|Hemostatics|hemostatics|mesh-ancestor
153484682|NCT05710146|Coagulants|coagulants|mesh-ancestor
153484683|NCT05683548|Interferons|interferons|mesh-list
153484684|NCT05683548|Tenofovir|tenofovir|mesh-list
153484685|NCT05683548|Interferon-alpha|interferon-alpha|mesh-list
153813894|NCT00335465|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153484686|NCT05683548|Interferon alpha-2|interferon alpha-2|mesh-list
153484687|NCT05683548|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
153484689|NCT05683548|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153484690|NCT05683548|Antiviral Agents|antiviral agents|mesh-ancestor
153484691|NCT05683548|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153484692|NCT05683548|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153484693|NCT05683548|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153484694|NCT05683548|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153484695|NCT05683548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153484696|NCT05683548|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153484697|NCT05683548|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153484698|NCT05683548|Immunologic Factors|immunologic factors|mesh-ancestor
153484699|NCT05683548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153886939|NCT01313780|Oxycodone|oxycodone|mesh-list
153484701|NCT05661942|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153484702|NCT05661942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153484703|NCT05636436|Vaccines|vaccines|mesh-list
153484704|NCT05636436|Immunologic Factors|immunologic factors|mesh-ancestor
153484705|NCT05636436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153484706|NCT05463354|Vaccines|vaccines|mesh-list
153484707|NCT05463354|Immunologic Factors|immunologic factors|mesh-ancestor
153484708|NCT05463354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153484709|NCT05293548|Vaccines|vaccines|mesh-list
153484710|NCT05293548|Immunologic Factors|immunologic factors|mesh-ancestor
153484711|NCT05293548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153484727|NCT04676802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153484728|NCT04676802|Analgesics|analgesics|mesh-ancestor
153484729|NCT04676802|Sensory System Agents|sensory system agents|mesh-ancestor
153484730|NCT04676802|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153484731|NCT01309074|Pregabalin|pregabalin|mesh-list
153484765|NCT00951132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153484766|NCT00951132|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153484767|NCT00951132|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
153484768|NCT00951132|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153484769|NCT01717872|Pyrithione zinc|pyrithione zinc|mesh-list
153484770|NCT01717872|Keratolytic Agents|keratolytic agents|mesh-ancestor
153484771|NCT01717872|Dermatologic Agents|dermatologic agents|mesh-ancestor
153484772|NCT01721226|Opiate Alkaloids|opiate alkaloids|mesh-list
153484773|NCT01721226|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153484774|NCT01721226|Narcotics|narcotics|mesh-ancestor
153484775|NCT01721226|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153484776|NCT01721226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153484777|NCT01721226|Analgesics|analgesics|mesh-ancestor
153484778|NCT01721226|Sensory System Agents|sensory system agents|mesh-ancestor
153484805|NCT01723722|Sensory System Agents|sensory system agents|mesh-ancestor
153484806|NCT01723722|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153484808|NCT01723722|Respiratory System Agents|respiratory system agents|mesh-ancestor
153427982|NCT00001442|Paclitaxel|paclitaxel|mesh-list
153427983|NCT00001442|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153427984|NCT00001442|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153427985|NCT00001442|Tubulin Modulators|tubulin modulators|mesh-ancestor
153427986|NCT00001442|Antimitotic Agents|antimitotic agents|mesh-ancestor
153427987|NCT00001442|Mitosis Modulators|mitosis modulators|mesh-ancestor
153484809|NCT01728636|Tranexamic Acid|tranexamic acid|mesh-list
153484810|NCT01728636|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
153484811|NCT01728636|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153484812|NCT01728636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153484813|NCT01728636|Hemostatics|hemostatics|mesh-ancestor
153484814|NCT01728636|Coagulants|coagulants|mesh-ancestor
153484841|NCT01729494|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153484842|NCT01729494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153484843|NCT01729494|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153886946|NCT01313780|Sensory System Agents|sensory system agents|mesh-ancestor
153484844|NCT01729494|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153484845|NCT01729494|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153484846|NCT01729494|Immunologic Factors|immunologic factors|mesh-ancestor
153484847|NCT01729494|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
153484848|NCT01729494|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153484849|NCT01729494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153484850|NCT01729494|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153484851|NCT01729494|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
153484868|NCT05316246|Immunoconjugates|immunoconjugates|mesh-ancestor
153484869|NCT05316246|Immunologic Factors|immunologic factors|mesh-ancestor
153484870|NCT05316246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153484871|NCT05315388|Vitamins|vitamins|mesh-list
153484872|NCT05315388|Micronutrients|micronutrients|mesh-ancestor
153484873|NCT05315388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153484874|NCT04894188|Goserelin|goserelin|mesh-list
153484875|NCT04894188|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153484876|NCT04894188|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153484877|NCT04724772|Tranexamic Acid|tranexamic acid|mesh-list
153484878|NCT04724772|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
153484879|NCT04724772|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153484880|NCT04724772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153484881|NCT04724772|Hemostatics|hemostatics|mesh-ancestor
153484882|NCT04724772|Coagulants|coagulants|mesh-ancestor
153484883|NCT03878472|Oxaliplatin|oxaliplatin|mesh-list
153484884|NCT03878472|Apatinib|apatinib|mesh-list
153484885|NCT03878472|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153484886|NCT03878472|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153484887|NCT03878472|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153484888|NCT03878472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153484889|NCT03162510|Paclitaxel|paclitaxel|mesh-list
153484911|NCT02394132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153484912|NCT02394132|Immunomodulating Agents|immunomodulating agents|mesh-ancestor
153484913|NCT02394132|Immunologic Factors|immunologic factors|mesh-ancestor
153484914|NCT02394132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153484915|NCT02394132|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153484916|NCT02394132|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153484917|NCT02394132|Interferon Inducers|interferon inducers|mesh-ancestor
153886999|NCT00624754|Autonomic Agents|autonomic agents|mesh-ancestor
153484919|NCT00700596|Hallucinogens|hallucinogens|mesh-ancestor
153484920|NCT00700596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153484921|NCT00700596|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153484922|NCT01733472|Remifentanil|remifentanil|mesh-list
153484923|NCT01733472|Propofol|propofol|mesh-list
153484924|NCT01733472|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153484925|NCT01733472|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153484926|NCT01733472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153484927|NCT01733472|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153484928|NCT01733472|Anesthetics, General|anesthetics, general|mesh-ancestor
153484929|NCT01733472|Anesthetics|anesthetics|mesh-ancestor
153484946|NCT01736358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153484947|NCT01740258|Bevacizumab|bevacizumab|mesh-list
153484948|NCT01740258|Temozolomide|temozolomide|mesh-list
153484949|NCT01740258|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153484950|NCT01740258|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153484951|NCT01740258|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153484952|NCT01740258|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153484954|NCT01740258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153484955|NCT01740258|Growth Inhibitors|growth inhibitors|mesh-ancestor
153484957|NCT01740258|Alkylating Agents|alkylating agents|mesh-ancestor
153484958|NCT01740258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153484960|NCT01740414|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153484984|NCT01740726|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153813895|NCT00335465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153813896|NCT00335543|Gemcitabine|gemcitabine|mesh-list
153484985|NCT01742208|(2S,3R,4R,5S,6R)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2H-pyran-3,4,5-triol|(2s,3r,4r,5s,6r)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2h-pyran-3,4,5-triol|mesh-list
153484986|NCT01742208|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
153484987|NCT01742208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153484988|NCT01742208|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153484989|NCT01742208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153484990|NCT01746264|Vitamin D|vitamin d|mesh-list
153484991|NCT01746264|Cholecalciferol|cholecalciferol|mesh-list
153484992|NCT01746264|Vitamins|vitamins|mesh-ancestor
153484993|NCT01746264|Micronutrients|micronutrients|mesh-ancestor
153484994|NCT01746264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153484995|NCT01746264|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153484996|NCT01746264|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153484997|NCT01746420|Becaplermin|becaplermin|mesh-list
153485002|NCT01746420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153485003|NCT01749930|Timolol|timolol|mesh-list
153485004|NCT01749930|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
153485005|NCT01749930|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
153485006|NCT01749930|Adrenergic Agents|adrenergic agents|mesh-ancestor
153485007|NCT01749930|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153485039|NCT01752426|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153485040|NCT01752426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153485041|NCT01752426|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153485042|NCT01752426|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
153485043|NCT01752426|Protective Agents|protective agents|mesh-ancestor
153485044|NCT01752426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153485045|NCT01753362|Liraglutide|liraglutide|mesh-list
153485046|NCT01753362|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
153485047|NCT01753362|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153485048|NCT01753362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153485049|NCT01753362|Incretins|incretins|mesh-ancestor
153485050|NCT01753362|Hormones|hormones|mesh-ancestor
153485064|NCT01759602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153428056|NCT00002192|Azithromycin|azithromycin|mesh-list
153428057|NCT00002192|Clarithromycin|clarithromycin|mesh-list
153428058|NCT00002192|Ethambutol|ethambutol|mesh-list
153428059|NCT00002192|Rifapentine|rifapentine|mesh-list
153428060|NCT00002192|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153428061|NCT00002192|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153428062|NCT00002192|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
153428063|NCT00002192|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153428064|NCT00002192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153428065|NCT00002192|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
153428066|NCT00002192|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153428067|NCT00002192|Antitubercular Agents|antitubercular agents|mesh-ancestor
153485083|NCT01760304|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153485084|NCT01760304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153485086|NCT01763346|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153485087|NCT01763346|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153485088|NCT01766466|Ticagrelor|ticagrelor|mesh-list
153485089|NCT01766466|Cangrelor|cangrelor|mesh-list
153485090|NCT01766466|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153485091|NCT01766466|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
153485092|NCT01766466|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
153485093|NCT01766466|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
153485094|NCT01766466|Purinergic Agents|purinergic agents|mesh-ancestor
153485095|NCT01766466|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153485096|NCT01766466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153485097|NCT01766466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153485098|NCT01769586|Diphenhydramine|diphenhydramine|mesh-list
153887016|NCT01114828|Natriuretic Agents|natriuretic agents|mesh-ancestor
153485099|NCT01769586|Promethazine|promethazine|mesh-list
153485100|NCT01769586|Midazolam|midazolam|mesh-list
153485101|NCT01769586|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153485138|NCT01783236|Acetaminophen|acetaminophen|mesh-list
153485139|NCT01783236|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153485140|NCT01783236|Analgesics|analgesics|mesh-ancestor
153485141|NCT01783236|Sensory System Agents|sensory system agents|mesh-ancestor
153485142|NCT01783236|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153485143|NCT01783236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153485144|NCT01783236|Antipyretics|antipyretics|mesh-ancestor
153485145|NCT01783470|Mirabegron|mirabegron|mesh-list
153485146|NCT01783470|Adrenergic Agents|adrenergic agents|mesh-list
153485147|NCT01783470|Adrenergic Agonists|adrenergic agonists|mesh-list
153485148|NCT01783470|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
153485149|NCT01783470|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
153485150|NCT01783470|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153485151|NCT01783470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153485152|NCT01783470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153485153|NCT01783470|Urological Agents|urological agents|mesh-ancestor
153485154|NCT01783860|Azithromycin|azithromycin|mesh-list
153485155|NCT01783860|Doxycycline|doxycycline|mesh-list
153485156|NCT01783860|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153485157|NCT01783860|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153485158|NCT01783860|Antimalarials|antimalarials|mesh-ancestor
153485159|NCT01783860|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153485160|NCT01783860|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153485161|NCT01785186|Pyridoxine|pyridoxine|mesh-list
153485162|NCT01785186|Moxifloxacin|moxifloxacin|mesh-list
153485163|NCT01785186|Rifampin|rifampin|mesh-list
153485164|NCT01785186|Isoniazid|isoniazid|mesh-list
153485166|NCT01785186|Ethambutol|ethambutol|mesh-list
153485186|NCT01785186|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153485187|NCT01785186|Antimetabolites|antimetabolites|mesh-ancestor
153485188|NCT01785186|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153485189|NCT01785186|Vitamin B Complex|vitamin b complex|mesh-ancestor
153485190|NCT01785186|Vitamins|vitamins|mesh-ancestor
153485191|NCT01785186|Micronutrients|micronutrients|mesh-ancestor
153485192|NCT01785810|Maraviroc|maraviroc|mesh-list
153485193|NCT01785810|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
153485194|NCT01785810|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
153485195|NCT01785810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153485196|NCT01785810|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153485197|NCT01785810|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153485198|NCT01785810|Antiviral Agents|antiviral agents|mesh-ancestor
153485199|NCT01785810|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153485200|NCT01785810|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
153485211|NCT01790490|Ketamine|ketamine|mesh-list
153485212|NCT01790490|Lorazepam|lorazepam|mesh-list
153485213|NCT01790490|Analgesics|analgesics|mesh-ancestor
153485214|NCT01790490|Sensory System Agents|sensory system agents|mesh-ancestor
153428079|NCT00000704|Zalcitabine|zalcitabine|mesh-list
153428080|NCT00000704|Antimetabolites|antimetabolites|mesh-ancestor
153428081|NCT00000704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153428082|NCT00000704|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153428083|NCT00000704|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153428084|NCT00000704|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153428085|NCT00000704|Antiviral Agents|antiviral agents|mesh-ancestor
153428086|NCT00000704|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153428087|NCT00000704|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153485215|NCT01790490|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153485216|NCT01790490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153485217|NCT01790490|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
153485218|NCT01790490|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153485219|NCT01790490|Anesthetics, General|anesthetics, general|mesh-ancestor
153485260|NCT01794702|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153485262|NCT01794702|Immunologic Factors|immunologic factors|mesh-ancestor
153485263|NCT01794702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153882703|NCT01609647|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
153882704|NCT01609647|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
153882705|NCT01609647|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
153380774|NCT01928693|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
153380776|NCT01928849|Anticonvulsants|anticonvulsants|mesh-ancestor
153380777|NCT01928849|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153380778|NCT01928849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153380902|NCT03093207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153485264|NCT01794702|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153485265|NCT01794702|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153485266|NCT01794702|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153485267|NCT01794702|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153485268|NCT01795716|Imatinib Mesylate|imatinib mesylate|mesh-list
153485269|NCT01795716|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153485270|NCT01795716|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153485271|NCT01795716|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153485272|NCT01795716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153485273|NCT01795716|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153485274|NCT01769352|Prednisolone acetate|prednisolone acetate|mesh-list
153485275|NCT01769352|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153485276|NCT01810692|Tiotropium Bromide|tiotropium bromide|mesh-list
153485277|NCT01810692|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153485278|NCT01810692|Autonomic Agents|autonomic agents|mesh-ancestor
153485279|NCT01810692|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153485280|NCT01810692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153485281|NCT01810692|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153485282|NCT01810692|Respiratory System Agents|respiratory system agents|mesh-ancestor
153485283|NCT01810692|Parasympatholytics|parasympatholytics|mesh-ancestor
153485284|NCT01810692|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
153485285|NCT01810692|Cholinergic Agents|cholinergic agents|mesh-ancestor
153485286|NCT01810692|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153485287|NCT01810692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153485288|NCT01811940|Topiramate|topiramate|mesh-list
153485289|NCT01811940|Adderall|adderall|mesh-list
153485290|NCT01811940|Anticonvulsants|anticonvulsants|mesh-ancestor
153485291|NCT01811940|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153485292|NCT01811940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153485293|NCT01811940|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
153485294|NCT01813734|Ponatinib|ponatinib|mesh-list
153485295|NCT01813734|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153485324|NCT06020456|Natriuretic Agents|natriuretic agents|mesh-ancestor
153485334|NCT06020352|Axitinib|axitinib|mesh-list
153485335|NCT06020352|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153485336|NCT06020352|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153485337|NCT06020352|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153485338|NCT06020352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153485339|NCT06020313|Resveratrol|resveratrol|mesh-list
153485340|NCT06020313|Antioxidants|antioxidants|mesh-ancestor
153485341|NCT06020313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153485342|NCT06020313|Protective Agents|protective agents|mesh-ancestor
153485343|NCT06020313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153485344|NCT06020313|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153485345|NCT06020313|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153485346|NCT06020300|Pyridoxine|pyridoxine|mesh-list
153485347|NCT06020300|Pyridoxal|pyridoxal|mesh-list
153485348|NCT06020300|Vitamin B 6|vitamin b 6|mesh-list
153485349|NCT06020300|Colchicine|colchicine|mesh-list
153485350|NCT06020300|Gout Suppressants|gout suppressants|mesh-ancestor
153485351|NCT06020300|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153485352|NCT06020300|Tubulin Modulators|tubulin modulators|mesh-ancestor
153485353|NCT06020300|Antimitotic Agents|antimitotic agents|mesh-ancestor
153485354|NCT06020300|Mitosis Modulators|mitosis modulators|mesh-ancestor
153485355|NCT06020300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153485356|NCT06020300|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153485357|NCT06020300|Vitamin B Complex|vitamin b complex|mesh-ancestor
153485358|NCT06020300|Vitamins|vitamins|mesh-ancestor
153485359|NCT06020300|Micronutrients|micronutrients|mesh-ancestor
153485360|NCT06020300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153485361|NCT06020196|Anesthetics|anesthetics|mesh-list
153485362|NCT06020196|Anesthetics, Local|anesthetics, local|mesh-list
153485363|NCT06020196|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153485364|NCT06020196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153485365|NCT06020196|Sensory System Agents|sensory system agents|mesh-ancestor
153485366|NCT06020196|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153485367|NCT06020066|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-list
153485368|NCT06020066|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153485369|NCT06020066|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153485370|NCT06020066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153485371|NCT06019858|Vitamins|vitamins|mesh-list
153485372|NCT06019858|Micronutrients|micronutrients|mesh-ancestor
153485373|NCT06019858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153485374|NCT06019520|Acetylcysteine|acetylcysteine|mesh-list
153485375|NCT06019520|N-monoacetylcystine|n-monoacetylcystine|mesh-list
153485376|NCT06019520|Antiviral Agents|antiviral agents|mesh-ancestor
153485377|NCT06019520|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153485378|NCT06019520|Expectorants|expectorants|mesh-ancestor
153485379|NCT06019520|Respiratory System Agents|respiratory system agents|mesh-ancestor
153485380|NCT06019520|Free Radical Scavengers|free radical scavengers|mesh-ancestor
153485381|NCT06019520|Antioxidants|antioxidants|mesh-ancestor
153485382|NCT06019520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153485429|NCT06018675|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153887087|NCT01114204|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
153485430|NCT06018675|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
153485431|NCT06018675|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153485432|NCT06018675|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153485433|NCT06018675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153485443|NCT06014359|Analgesics|analgesics|mesh-ancestor
153485444|NCT06014359|Sensory System Agents|sensory system agents|mesh-ancestor
153485445|NCT06014359|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153485454|NCT06011746|Analgesics|analgesics|mesh-ancestor
153485455|NCT06011746|Sensory System Agents|sensory system agents|mesh-ancestor
153485457|NCT06011746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153485458|NCT06011746|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
153485459|NCT06011746|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153485460|NCT06011746|Anesthetics, General|anesthetics, general|mesh-ancestor
153485461|NCT06011746|Anesthetics|anesthetics|mesh-ancestor
153485462|NCT06011746|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153485463|NCT06011746|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
153485464|NCT06011746|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
153485465|NCT06011746|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153485466|NCT06011746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153485467|NCT06011746|Anesthetics, Local|anesthetics, local|mesh-ancestor
153485468|NCT05997134|Ketamine|ketamine|mesh-list
153485469|NCT05997134|Analgesics|analgesics|mesh-ancestor
153485470|NCT05997134|Sensory System Agents|sensory system agents|mesh-ancestor
153485471|NCT05997134|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153485472|NCT05997134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153485473|NCT05997134|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
153485474|NCT05997134|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153485475|NCT05997134|Anesthetics, General|anesthetics, general|mesh-ancestor
153485477|NCT05997134|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153485478|NCT05997134|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
153485479|NCT05997134|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
153485480|NCT05997134|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153887098|NCT01075243|Antipyretics|antipyretics|mesh-ancestor
153485481|NCT05997134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153485482|NCT05982990|Fluticasone|fluticasone|mesh-list
153485483|NCT05982990|Xhance|xhance|mesh-list
153485484|NCT05982990|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
153485485|NCT05982990|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
153485486|NCT05982990|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153485487|NCT05982990|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153485496|NCT05982990|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
153485497|NCT05982990|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153485498|NCT05982990|Adrenergic Agents|adrenergic agents|mesh-ancestor
153485499|NCT05982990|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153485505|NCT05979740|Disitamab vedotin|disitamab vedotin|mesh-list
153485506|NCT05979740|Immunoconjugates|immunoconjugates|mesh-ancestor
153485507|NCT05979740|Immunologic Factors|immunologic factors|mesh-ancestor
153485508|NCT05979740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153380903|NCT03093207|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153380904|NCT03093207|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153380906|NCT03093207|Antipyretics|antipyretics|mesh-ancestor
153380907|NCT05482451|Nivolumab|nivolumab|mesh-list
153380908|NCT05482451|Tretinoin|tretinoin|mesh-list
153485509|NCT05972655|Capecitabine|capecitabine|mesh-list
153485510|NCT05972655|Oxaliplatin|oxaliplatin|mesh-list
153485512|NCT05972655|Immunologic Factors|immunologic factors|mesh-ancestor
153485513|NCT05972655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153485514|NCT05972655|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153485515|NCT05972655|Antimetabolites|antimetabolites|mesh-ancestor
153485523|NCT05962502|Cetuximab|cetuximab|mesh-list
153485524|NCT05962502|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
153485525|NCT05962502|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153485526|NCT05962502|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153485527|NCT05962502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153485528|NCT05962502|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153485529|NCT05962502|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153485530|NCT05957757|Tislelizumab|tislelizumab|mesh-list
153485531|NCT05957757|Disitamab vedotin|disitamab vedotin|mesh-list
153485532|NCT05957757|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153485533|NCT05957757|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153485534|NCT05957757|Immunoconjugates|immunoconjugates|mesh-ancestor
153485535|NCT05957757|Immunologic Factors|immunologic factors|mesh-ancestor
153485536|NCT05957757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153485537|NCT05934227|Amoxicillin|amoxicillin|mesh-list
153485538|NCT05934227|Metronidazole|metronidazole|mesh-list
153485539|NCT05934227|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153485540|NCT05934227|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153485541|NCT05934227|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153485542|NCT05934227|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153485543|NCT05880706|Osimertinib|osimertinib|mesh-list
153485544|NCT05880706|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153485545|NCT05880706|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153485546|NCT05880706|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153485547|NCT05880706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153485548|NCT05880706|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153485568|NCT05875077|Adrenergic Agents|adrenergic agents|mesh-ancestor
153485569|NCT05875077|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153485576|NCT05852158|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153485578|NCT05833529|Anesthetics, Local|anesthetics, local|mesh-ancestor
153485579|NCT05833529|Anesthetics|anesthetics|mesh-ancestor
153485580|NCT05833529|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153485581|NCT05833529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153485582|NCT05833529|Sensory System Agents|sensory system agents|mesh-ancestor
153485583|NCT05833529|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153485584|NCT05833529|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
153485585|NCT05833529|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
153887114|NCT01078441|Antiemetics|antiemetics|mesh-ancestor
153485587|NCT05833529|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153485588|NCT05833529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153485589|NCT05833529|Dopamine Agents|dopamine agents|mesh-ancestor
153485590|NCT05833529|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153485591|NCT05727397|Aflibercept|aflibercept|mesh-list
153485592|NCT05727397|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153485603|NCT05677490|Fluorouracil|fluorouracil|mesh-list
153485604|NCT05677490|Oxaliplatin|oxaliplatin|mesh-list
153485605|NCT05677490|Irinotecan|irinotecan|mesh-list
153485606|NCT05677490|Calcium|calcium|mesh-list
153485607|NCT05677490|Levoleucovorin|levoleucovorin|mesh-list
153485608|NCT05677490|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153485621|NCT05677490|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153485622|NCT05677490|Antidotes|antidotes|mesh-ancestor
153485623|NCT05677490|Protective Agents|protective agents|mesh-ancestor
153485624|NCT05677490|Vitamin B Complex|vitamin b complex|mesh-ancestor
153485625|NCT05677490|Vitamins|vitamins|mesh-ancestor
153485626|NCT05677490|Micronutrients|micronutrients|mesh-ancestor
153485627|NCT05656664|Folic Acid|folic acid|mesh-list
153485628|NCT05656664|Hematinics|hematinics|mesh-ancestor
153485629|NCT05656664|Vitamin B Complex|vitamin b complex|mesh-ancestor
153485630|NCT05656664|Vitamins|vitamins|mesh-ancestor
153485631|NCT05656664|Micronutrients|micronutrients|mesh-ancestor
153485632|NCT05656664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153485633|NCT05644223|Edaravone|edaravone|mesh-list
153485634|NCT05644223|Free Radical Scavengers|free radical scavengers|mesh-ancestor
153485636|NCT05644223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153485637|NCT05644223|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
153485638|NCT05644223|Protective Agents|protective agents|mesh-ancestor
153485639|NCT05644223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153485666|NCT05622318|Immunologic Factors|immunologic factors|mesh-ancestor
153485667|NCT05622318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153485668|NCT05622318|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153485669|NCT05622318|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153485690|NCT05528848|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153485691|NCT05528848|Analgesics|analgesics|mesh-ancestor
153485692|NCT05528848|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153485693|NCT05528848|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153485694|NCT05528848|Anesthetics, General|anesthetics, general|mesh-ancestor
153485695|NCT05528848|Anesthetics|anesthetics|mesh-ancestor
153485696|NCT05525065|Glucocorticoids|glucocorticoids|mesh-list
153485697|NCT05525065|Hormones|hormones|mesh-ancestor
153485698|NCT05525065|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153485699|NCT05525065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153485700|NCT05420948|Paclitaxel|paclitaxel|mesh-list
153485701|NCT05420948|Carboplatin|carboplatin|mesh-list
153485702|NCT05420948|Pembrolizumab|pembrolizumab|mesh-list
153485703|NCT05420948|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153485704|NCT05420948|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153485705|NCT05420948|Tubulin Modulators|tubulin modulators|mesh-ancestor
153485706|NCT05420948|Antimitotic Agents|antimitotic agents|mesh-ancestor
153485707|NCT05420948|Mitosis Modulators|mitosis modulators|mesh-ancestor
153485723|NCT05377606|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153485724|NCT05377606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153485725|NCT05377606|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153485726|NCT05377606|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153485727|NCT05377606|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153485728|NCT05377606|GABA Modulators|gaba modulators|mesh-ancestor
153485729|NCT05377606|GABA Agents|gaba agents|mesh-ancestor
153485730|NCT05377606|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153485731|NCT05377606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153485740|NCT05372367|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153887152|NCT01077739|Oxaliplatin|oxaliplatin|mesh-list
153485741|NCT05372367|Hormone Antagonists|hormone antagonists|mesh-ancestor
153485742|NCT05372367|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153485743|NCT05372367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153485744|NCT05372367|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
153485745|NCT05372367|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
153485746|NCT05372367|Antitubercular Agents|antitubercular agents|mesh-ancestor
153485747|NCT05372367|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153485748|NCT05372367|Leprostatic Agents|leprostatic agents|mesh-ancestor
153485749|NCT05372367|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153485750|NCT05372367|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
153485751|NCT05372367|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
153485752|NCT05372367|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
153485753|NCT05372367|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
153485754|NCT05372367|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
153485755|NCT05372367|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
153485756|NCT05350371|Pirfenidone|pirfenidone|mesh-list
153485757|NCT05350371|Analgesics|analgesics|mesh-ancestor
153485758|NCT05350371|Sensory System Agents|sensory system agents|mesh-ancestor
153485759|NCT05350371|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153485760|NCT05350371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153485761|NCT05350371|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153485762|NCT05350371|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153485768|NCT05348200|Halobetasol|halobetasol|mesh-list
153485769|NCT05348200|Anesthetics, Local|anesthetics, local|mesh-ancestor
153485770|NCT05348200|Anesthetics|anesthetics|mesh-ancestor
153485771|NCT05348200|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153485772|NCT05348200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153485773|NCT05348200|Sensory System Agents|sensory system agents|mesh-ancestor
153485774|NCT05348200|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153485775|NCT05348200|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153485776|NCT05348200|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
153485777|NCT05348200|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153485778|NCT05348200|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153485779|NCT05348200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153485780|NCT05348200|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
153485781|NCT05348200|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153485782|NCT05348200|Glucocorticoids|glucocorticoids|mesh-ancestor
153485783|NCT05348200|Hormones|hormones|mesh-ancestor
153485784|NCT05348200|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153485785|NCT05325502|Mannitol|mannitol|mesh-list
153485786|NCT05325502|Caffeine|caffeine|mesh-list
153485787|NCT05325502|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
153485788|NCT05325502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153485789|NCT05325502|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
153485799|NCT05285384|Myeloma Proteins|myeloma proteins|mesh-list
153485800|NCT05285384|Paraproteins|paraproteins|mesh-list
153485801|NCT05285384|Immunologic Factors|immunologic factors|mesh-ancestor
153485803|NCT05235737|Pembrolizumab|pembrolizumab|mesh-list
153485878|NCT04811573|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153485879|NCT04811573|Analgesics|analgesics|mesh-ancestor
153485964|NCT04605081|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153486049|NCT04329325|Dasatinib|dasatinib|mesh-list
153486159|NCT03777813|Levoleucovorin|levoleucovorin|mesh-list
153486161|NCT03777813|Antidotes|antidotes|mesh-ancestor
153486369|NCT01740557|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153813901|NCT00437814|Ketamine|ketamine|mesh-list
153813902|NCT00437814|Analgesics|analgesics|mesh-ancestor
153486371|NCT01740557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153486372|NCT01740557|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153486373|NCT01740557|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153486374|NCT01740557|Alkylating Agents|alkylating agents|mesh-ancestor
153486375|NCT01740557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153486445|NCT00788164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153486446|NCT00788164|Immunomodulating Agents|immunomodulating agents|mesh-ancestor
153486447|NCT00788164|Immunologic Factors|immunologic factors|mesh-ancestor
153486448|NCT00788164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153486588|NCT01835262|Sensory System Agents|sensory system agents|mesh-ancestor
153486589|NCT01835262|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153486590|NCT01835262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153486668|NCT01842594|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153486669|NCT01842594|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153486670|NCT01842594|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153486671|NCT01842594|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153486672|NCT01842594|Antifungal Agents|antifungal agents|mesh-ancestor
153486673|NCT01842594|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153486697|NCT01843920|Adrenergic Agents|adrenergic agents|mesh-ancestor
153486698|NCT01843920|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153486803|NCT01856712|Sensory System Agents|sensory system agents|mesh-ancestor
153486804|NCT01856712|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153486882|NCT01879332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153486883|NCT05327088|Dexmedetomidine|dexmedetomidine|mesh-list
153486986|NCT04470804|Cyclosporine|cyclosporine|mesh-list
153486987|NCT04470804|Sirolimus|sirolimus|mesh-list
153486988|NCT04470804|Temsirolimus|temsirolimus|mesh-list
153487080|NCT01881828|Metformin|metformin|mesh-list
153487081|NCT01881828|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153487082|NCT01881828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153487083|NCT01887132|Donepezil|donepezil|mesh-list
153487084|NCT01887132|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
153487085|NCT01887132|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153487086|NCT01887132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153487087|NCT01887132|Cholinergic Agents|cholinergic agents|mesh-ancestor
153487088|NCT01887132|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153487099|NCT01887990|Anesthetics|anesthetics|mesh-ancestor
153487100|NCT01887990|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153487101|NCT01887990|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
153487102|NCT01887990|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
153487103|NCT01887990|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153487104|NCT01887990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153487105|NCT01890642|Lidocaine|lidocaine|mesh-list
153887215|NCT04774159|Colchicine|colchicine|mesh-list
153487106|NCT01890642|Anesthetics, Local|anesthetics, local|mesh-ancestor
153487107|NCT01890642|Anesthetics|anesthetics|mesh-ancestor
153813908|NCT00437814|Anesthetics, General|anesthetics, general|mesh-ancestor
153813909|NCT00437814|Anesthetics|anesthetics|mesh-ancestor
153487108|NCT01890642|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153487109|NCT01890642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153487110|NCT01890642|Sensory System Agents|sensory system agents|mesh-ancestor
153487111|NCT01890642|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153487112|NCT01890642|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153487113|NCT01890642|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
153487114|NCT01890642|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153428279|NCT00002234|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
153487116|NCT01890642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153487117|NCT01891968|Bortezomib|bortezomib|mesh-list
153487118|NCT01891968|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153487119|NCT01901250|Fluorides|fluorides|mesh-list
153487120|NCT01901250|Fluorides, Topical|fluorides, topical|mesh-list
153487121|NCT01901250|Cariostatic Agents|cariostatic agents|mesh-ancestor
153487122|NCT01901250|Protective Agents|protective agents|mesh-ancestor
153487123|NCT01901250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153487124|NCT01904526|Guanfacine|guanfacine|mesh-list
153487125|NCT01904526|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153487126|NCT01904526|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
153487127|NCT01904526|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153487128|NCT01904526|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153487129|NCT01904526|Adrenergic Agents|adrenergic agents|mesh-ancestor
153487130|NCT01904526|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153487131|NCT01904526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153487143|NCT01907334|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
153487144|NCT01907334|Methacholine Chloride|methacholine chloride|mesh-list
153487164|NCT01907334|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153487165|NCT01907334|Sympathomimetics|sympathomimetics|mesh-ancestor
153487166|NCT01907334|Miotics|miotics|mesh-ancestor
153487167|NCT01907334|Parasympathomimetics|parasympathomimetics|mesh-ancestor
153487168|NCT01907334|Bronchoconstrictor Agents|bronchoconstrictor agents|mesh-ancestor
153487169|NCT01907334|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
153428280|NCT00002234|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
153428281|NCT00002234|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
153428282|NCT00002234|Antimetabolites|antimetabolites|mesh-ancestor
153428283|NCT00002324|Zidovudine|zidovudine|mesh-list
153428284|NCT00002324|Nevirapine|nevirapine|mesh-list
153428285|NCT00002324|Antimetabolites|antimetabolites|mesh-ancestor
153487173|NCT01907490|Anesthetics, Local|anesthetics, local|mesh-ancestor
153487174|NCT01907490|Anesthetics|anesthetics|mesh-ancestor
153487175|NCT01907490|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153487176|NCT01907490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153487177|NCT01907490|Sensory System Agents|sensory system agents|mesh-ancestor
153487178|NCT01907490|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153487179|NCT01908972|Prednisolone|prednisolone|mesh-list
153487180|NCT01908972|Propranolol|propranolol|mesh-list
153487181|NCT01908972|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153487182|NCT01908972|Glucocorticoids|glucocorticoids|mesh-ancestor
153487184|NCT01908972|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153487185|NCT01908972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153487186|NCT01908972|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153487187|NCT01908972|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153487188|NCT01908972|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
153487189|NCT01908972|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
153487190|NCT01908972|Adrenergic Agents|adrenergic agents|mesh-ancestor
153487191|NCT01908972|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153487192|NCT01908972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153487193|NCT01908972|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153487194|NCT01908972|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153487203|NCT01910064|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153487204|NCT01910064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153487205|NCT01910064|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153487206|NCT01910064|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153487207|NCT01912716|Indomethacin|indomethacin|mesh-list
153487208|NCT01912716|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153487209|NCT01912716|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153487210|NCT01912716|Analgesics|analgesics|mesh-ancestor
153487211|NCT01912716|Sensory System Agents|sensory system agents|mesh-ancestor
153487212|NCT01912716|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153487213|NCT01912716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153487214|NCT01912716|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153487215|NCT01912716|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153487216|NCT01912716|Gout Suppressants|gout suppressants|mesh-ancestor
153487217|NCT01912716|Tocolytic Agents|tocolytic agents|mesh-ancestor
153487218|NCT01912716|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153487220|NCT01912716|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153487247|NCT01929642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153487248|NCT01929642|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153487249|NCT01929642|Immunologic Factors|immunologic factors|mesh-ancestor
153487250|NCT01929642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153487251|NCT01929642|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153487265|NCT01933464|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153487277|NCT01936896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153487278|NCT01937598|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
153487280|NCT01937598|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153487281|NCT01937598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153487282|NCT01937598|Incretins|incretins|mesh-ancestor
153487283|NCT01937598|Hormones|hormones|mesh-ancestor
153487284|NCT01937598|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153487285|NCT01937598|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
153487286|NCT01937598|Protease Inhibitors|protease inhibitors|mesh-ancestor
153487287|NCT01937598|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153487288|NCT01937598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153487289|NCT01937598|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
153487290|NCT01942668|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
153487291|NCT01942668|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
153487292|NCT01942668|Estradiol|estradiol|mesh-list
153487293|NCT01942668|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
153487294|NCT01942668|Progesterone|progesterone|mesh-list
153487295|NCT01942668|Estrogens|estrogens|mesh-ancestor
153487296|NCT01942668|Hormones|hormones|mesh-ancestor
153487297|NCT01942668|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153487298|NCT01942668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153487299|NCT01942668|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
153487300|NCT01942668|Contraceptive Agents|contraceptive agents|mesh-ancestor
153487301|NCT01942668|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153487302|NCT01942668|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
153487303|NCT01942668|Progestins|progestins|mesh-ancestor
153487304|NCT01948518|Sildenafil Citrate|sildenafil citrate|mesh-list
153487305|NCT01948518|Vasodilator Agents|vasodilator agents|mesh-ancestor
153487306|NCT01948518|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
153487307|NCT01948518|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
153428304|NCT03740659|Ofloxacin|ofloxacin|mesh-list
153487308|NCT01948518|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153487309|NCT01948518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153487310|NCT01948518|Urological Agents|urological agents|mesh-ancestor
153487311|NCT01948986|Ertugliflozin|ertugliflozin|mesh-list
153487312|NCT01948986|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
153487313|NCT01948986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153487314|NCT01948986|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153487315|NCT01948986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153487316|NCT01949844|Regadenoson|regadenoson|mesh-list
153487317|NCT01949844|Adenosine A2 Receptor Agonists|adenosine a2 receptor agonists|mesh-ancestor
153487319|NCT01949844|Purinergic Agonists|purinergic agonists|mesh-ancestor
153487365|NCT01957410|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153487366|NCT01957410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153487367|NCT01957410|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
153487368|NCT01957410|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153487369|NCT01957410|Anesthetics, General|anesthetics, general|mesh-ancestor
153487370|NCT01957410|Anesthetics|anesthetics|mesh-ancestor
153487371|NCT01957410|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153487372|NCT01957410|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
153487373|NCT01957410|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
153813910|NCT00437814|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153487374|NCT01957410|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153487375|NCT01957410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153487376|NCT01958112|Trametinib|trametinib|mesh-list
153487377|NCT01958112|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153487378|NCT01958112|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153487379|NCT01958112|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153487381|NCT05739786|Vitamin D|vitamin d|mesh-list
153487416|NCT05738616|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153487417|NCT05738616|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153428310|NCT03740659|Autonomic Agents|autonomic agents|mesh-ancestor
153428311|NCT03740659|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153428312|NCT03740659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153428313|NCT03740659|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153428314|NCT03740659|Glucocorticoids|glucocorticoids|mesh-ancestor
153428315|NCT03740659|Hormones|hormones|mesh-ancestor
153428316|NCT03740659|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153487431|NCT05737680|Colchicine|colchicine|mesh-list
153487432|NCT05737680|Antimalarials|antimalarials|mesh-ancestor
153487433|NCT05737680|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153487434|NCT05737680|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153487435|NCT05737680|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153887265|NCT01076335|Goserelin|goserelin|mesh-list
153487464|NCT05725200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153487465|NCT05725200|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153487466|NCT05725200|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153487467|NCT05725200|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153487468|NCT05725200|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
153487469|NCT05725200|Abortifacient Agents|abortifacient agents|mesh-ancestor
153487470|NCT05725200|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153487471|NCT05725200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153487472|NCT05725200|Dermatologic Agents|dermatologic agents|mesh-ancestor
153487473|NCT05725200|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153487474|NCT05725200|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153487475|NCT05725200|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153487476|NCT05725200|Immunologic Factors|immunologic factors|mesh-ancestor
153487477|NCT05725200|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153487478|NCT05725200|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153813911|NCT00437814|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
153487486|NCT05574894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153487487|NCT05530278|Midazolam|midazolam|mesh-list
153487488|NCT05530278|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153487489|NCT05530278|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153487490|NCT05530278|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153487491|NCT05530278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153487492|NCT05530278|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153487493|NCT05530278|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153487494|NCT05530278|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153487495|NCT05530278|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153487496|NCT05530278|Anesthetics, General|anesthetics, general|mesh-ancestor
153487497|NCT05530278|Anesthetics|anesthetics|mesh-ancestor
153487498|NCT05530278|GABA Modulators|gaba modulators|mesh-ancestor
153487499|NCT05530278|GABA Agents|gaba agents|mesh-ancestor
153487500|NCT05530278|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153487501|NCT05530278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153428331|NCT00002336|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153487502|NCT05436288|Hyaluronic Acid|hyaluronic acid|mesh-list
153428337|NCT00001646|Voriconazole|voriconazole|mesh-list
153487503|NCT05436288|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153487504|NCT05436288|Immunologic Factors|immunologic factors|mesh-ancestor
153487505|NCT05436288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153487506|NCT05436288|Viscosupplements|viscosupplements|mesh-ancestor
153487544|NCT05087940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153487546|NCT04922658|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153487547|NCT04922658|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153487548|NCT04922658|Tubulin Modulators|tubulin modulators|mesh-ancestor
153487549|NCT04922658|Antimitotic Agents|antimitotic agents|mesh-ancestor
153487550|NCT04922658|Mitosis Modulators|mitosis modulators|mesh-ancestor
153487551|NCT04922658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153487552|NCT04438902|Osimertinib|osimertinib|mesh-list
153487553|NCT04438902|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153487554|NCT04438902|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153487555|NCT04438902|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153487556|NCT04438902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153487557|NCT04438902|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153428344|NCT00001646|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153813912|NCT00437814|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
153813913|NCT00437814|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153487558|NCT04329390|Anticoagulants|anticoagulants|mesh-list
153487559|NCT04177602|Trifluridine|trifluridine|mesh-list
153487560|NCT04177602|Capecitabine|capecitabine|mesh-list
153487561|NCT04177602|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153487562|NCT04177602|Antimetabolites|antimetabolites|mesh-ancestor
153487563|NCT04177602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153487564|NCT04177602|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153487565|NCT04177602|Antiviral Agents|antiviral agents|mesh-ancestor
153487566|NCT04177602|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153487567|NCT03816618|Fusidic Acid|fusidic acid|mesh-list
153487568|NCT03816618|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153487569|NCT03816618|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153487570|NCT03816618|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
153487571|NCT03816618|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153487599|NCT02065596|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153487600|NCT02065596|Antimetabolites|antimetabolites|mesh-ancestor
153487601|NCT02065596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153487602|NCT02065596|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153487603|NCT02065596|Immunologic Factors|immunologic factors|mesh-ancestor
153487604|NCT02065596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153487605|NCT01239030|Methylphenidate|methylphenidate|mesh-list
153487606|NCT01239030|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
153487607|NCT01239030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153487608|NCT01239030|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
153487609|NCT01239030|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153487610|NCT01239030|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153487611|NCT01239030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153487612|NCT01239030|Dopamine Agents|dopamine agents|mesh-ancestor
153487613|NCT01239030|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153487614|NCT01086540|Acetaminophen|acetaminophen|mesh-list
153887288|NCT01106014|Selexipag|selexipag|mesh-list
153487615|NCT01086540|Diphenhydramine|diphenhydramine|mesh-list
153487621|NCT01086540|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153487622|NCT01086540|Immunologic Factors|immunologic factors|mesh-ancestor
153487623|NCT01086540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153487624|NCT01086540|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153487625|NCT01086540|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153487626|NCT01086540|Glucocorticoids|glucocorticoids|mesh-ancestor
153487627|NCT01086540|Hormones|hormones|mesh-ancestor
153487628|NCT01086540|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153487629|NCT01086540|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153487630|NCT01086540|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153487631|NCT01086540|Analgesics|analgesics|mesh-ancestor
153487632|NCT01086540|Sensory System Agents|sensory system agents|mesh-ancestor
153487633|NCT01086540|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153487634|NCT01086540|Antipyretics|antipyretics|mesh-ancestor
153487635|NCT01086540|Antiemetics|antiemetics|mesh-ancestor
153813914|NCT00437814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153813915|NCT00335582|Clonidine|clonidine|mesh-list
153813916|NCT00335582|Analgesics|analgesics|mesh-ancestor
153813917|NCT00335582|Sensory System Agents|sensory system agents|mesh-ancestor
153487636|NCT01086540|Autonomic Agents|autonomic agents|mesh-ancestor
153487637|NCT01086540|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153487638|NCT01086540|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
153487639|NCT01086540|Protective Agents|protective agents|mesh-ancestor
153487640|NCT01086540|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
153487641|NCT01086540|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153487663|NCT01965366|Antiemetics|antiemetics|mesh-ancestor
153487664|NCT01965366|Autonomic Agents|autonomic agents|mesh-ancestor
153487665|NCT01965366|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153887299|NCT01309659|Trace Elements|trace elements|mesh-ancestor
153487667|NCT01965366|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153487668|NCT01965366|Glucocorticoids|glucocorticoids|mesh-ancestor
153487669|NCT01965366|Hormones|hormones|mesh-ancestor
153487670|NCT01965366|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153487671|NCT01965366|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153487672|NCT01965366|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153487673|NCT01965756|Metformin|metformin|mesh-list
153487674|NCT01965756|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153487675|NCT01965756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153487676|NCT01967862|Listerine|listerine|mesh-list
153487677|NCT01967862|Fluorides|fluorides|mesh-list
153487691|NCT01980654|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153487693|NCT01980654|Immunologic Factors|immunologic factors|mesh-ancestor
153487694|NCT01980654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153487695|NCT01980654|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153487696|NCT01980654|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153487709|NCT01984398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153487711|NCT01984398|Hormone Antagonists|hormone antagonists|mesh-ancestor
153487713|NCT01984398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153487734|NCT01987752|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153487735|NCT01988922|Ketamine|ketamine|mesh-list
153487736|NCT01988922|Analgesics|analgesics|mesh-ancestor
153487737|NCT01988922|Sensory System Agents|sensory system agents|mesh-ancestor
153487738|NCT01988922|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153487739|NCT01988922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153813918|NCT00335582|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153487740|NCT01988922|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
153487741|NCT01988922|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153487742|NCT01988922|Anesthetics, General|anesthetics, general|mesh-ancestor
153487743|NCT01988922|Anesthetics|anesthetics|mesh-ancestor
153487744|NCT01988922|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153487745|NCT01988922|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
153487746|NCT01988922|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
153487747|NCT01988922|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153487748|NCT01988922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153487749|NCT01994538|Oxymetazoline|oxymetazoline|mesh-list
153428360|NCT00002252|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153428361|NCT00002252|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153428362|NCT00002348|Mitoguazone|mitoguazone|mesh-list
153428363|NCT00002348|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153428364|NCT00002348|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153487803|NCT02002650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153487804|NCT02004132|Testosterone|testosterone|mesh-list
153487805|NCT02004132|Androgens|androgens|mesh-ancestor
153487806|NCT02004132|Hormones|hormones|mesh-ancestor
153487807|NCT02004132|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153487808|NCT02004132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153487809|NCT02004366|Insulin Glargine|insulin glargine|mesh-list
153487810|NCT02004366|Linagliptin|linagliptin|mesh-list
153487811|NCT02004366|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153487813|NCT02004366|Incretins|incretins|mesh-ancestor
153487815|NCT02004366|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153487816|NCT02004366|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
153487817|NCT02004366|Protease Inhibitors|protease inhibitors|mesh-ancestor
153487818|NCT02004366|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153813919|NCT00335582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153487855|NCT02024646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153487856|NCT02024724|Dexamethasone|dexamethasone|mesh-list
153487857|NCT02024724|Triamcinolone|triamcinolone|mesh-list
153487858|NCT02024724|Bupivacaine|bupivacaine|mesh-list
153487859|NCT02024724|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153487860|NCT02024724|Antiemetics|antiemetics|mesh-ancestor
153487861|NCT02024724|Autonomic Agents|autonomic agents|mesh-ancestor
153487862|NCT02024724|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153487882|NCT02025426|Sympathomimetics|sympathomimetics|mesh-ancestor
153487883|NCT02025426|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
153487884|NCT02025426|Nasal Decongestants|nasal decongestants|mesh-ancestor
153487887|NCT02025426|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153487888|NCT02025426|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153487889|NCT02025426|Adrenergic Agents|adrenergic agents|mesh-ancestor
153487890|NCT02025426|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153487891|NCT02025426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153487892|NCT02025426|Protective Agents|protective agents|mesh-ancestor
153487893|NCT02025426|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
153487894|NCT02028780|Dabigatran|dabigatran|mesh-list
153487895|NCT02028780|Antithrombins|antithrombins|mesh-ancestor
153487896|NCT02028780|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
153487897|NCT02028780|Protease Inhibitors|protease inhibitors|mesh-ancestor
153487898|NCT02028780|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153487899|NCT02028780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153487900|NCT02028780|Anticoagulants|anticoagulants|mesh-ancestor
153487901|NCT02029872|Chlorhexidine|chlorhexidine|mesh-list
153487902|NCT02029872|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
153487903|NCT02029872|Mupirocin|mupirocin|mesh-list
153487904|NCT02029872|Calcium|calcium|mesh-list
153487905|NCT02029872|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153487906|NCT02029872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153487907|NCT02029872|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
153487908|NCT02029872|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153487909|NCT02029872|Disinfectants|disinfectants|mesh-ancestor
153487910|NCT02029872|Dermatologic Agents|dermatologic agents|mesh-ancestor
153487914|NCT02029872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153487915|NCT02030574|Gemcitabine|gemcitabine|mesh-list
153487916|NCT02030574|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153487917|NCT02030574|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153487918|NCT02030574|Antimetabolites|antimetabolites|mesh-ancestor
153487919|NCT02030574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153487920|NCT02032212|Nicotine|nicotine|mesh-list
153487921|NCT02032212|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
153487922|NCT02032212|Autonomic Agents|autonomic agents|mesh-ancestor
153487923|NCT02032212|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153487924|NCT02032212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153487925|NCT02032212|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
153487926|NCT02032212|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
153487927|NCT02032212|Cholinergic Agents|cholinergic agents|mesh-ancestor
153487928|NCT02032212|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153813921|NCT00335582|Sympatholytics|sympatholytics|mesh-ancestor
153487929|NCT02032212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153487930|NCT02032758|Propranolol|propranolol|mesh-list
153813922|NCT00335582|Autonomic Agents|autonomic agents|mesh-ancestor
153487931|NCT02032758|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
153487944|NCT02036424|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153487945|NCT02036424|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153487946|NCT02036424|Growth Substances|growth substances|mesh-ancestor
153487947|NCT02036424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153487950|NCT02036424|Antiemetics|antiemetics|mesh-ancestor
153487971|NCT02047032|Urological Agents|urological agents|mesh-ancestor
153487972|NCT02047500|Paclitaxel|paclitaxel|mesh-list
153487982|NCT02054754|HU 211|hu 211|mesh-list
153487983|NCT02054754|Dronabinol|dronabinol|mesh-list
153487984|NCT02054754|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153487985|NCT02054754|Antiemetics|antiemetics|mesh-ancestor
153487986|NCT02054754|Autonomic Agents|autonomic agents|mesh-ancestor
153487987|NCT02054754|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153487988|NCT02054754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153487989|NCT02054754|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153487990|NCT02054754|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
153487991|NCT02054754|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
153487992|NCT02054754|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153488009|NCT02057640|Antiemetics|antiemetics|mesh-ancestor
153488010|NCT02057640|Autonomic Agents|autonomic agents|mesh-ancestor
153488011|NCT02057640|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153488012|NCT02057640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153488013|NCT02057640|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153488014|NCT02057640|Glucocorticoids|glucocorticoids|mesh-ancestor
153488015|NCT02057640|Hormones|hormones|mesh-ancestor
153488016|NCT02057640|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153488029|NCT02059902|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153488030|NCT02059902|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153488031|NCT02059902|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
153488032|NCT02059902|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153488033|NCT02059902|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153488053|NCT02061774|Analgesics|analgesics|mesh-ancestor
153488054|NCT02061774|Sensory System Agents|sensory system agents|mesh-ancestor
153488097|NCT02062710|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153488099|NCT02062710|Analgesics|analgesics|mesh-ancestor
153488100|NCT02064582|Leuprolide|leuprolide|mesh-list
153488101|NCT02064582|Fertility Agents, Female|fertility agents, female|mesh-ancestor
153488102|NCT02064582|Fertility Agents|fertility agents|mesh-ancestor
153813924|NCT00335582|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153488103|NCT02064582|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153488104|NCT02064582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153488105|NCT02064582|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153488106|NCT02064582|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153488107|NCT02069184|Acetaminophen|acetaminophen|mesh-list
153488108|NCT02069184|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153488109|NCT02069184|Analgesics|analgesics|mesh-ancestor
153488110|NCT02069184|Sensory System Agents|sensory system agents|mesh-ancestor
153488111|NCT02069184|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153488121|NCT02135016|Lidocaine|lidocaine|mesh-list
153488122|NCT02135016|Anesthetics, Local|anesthetics, local|mesh-ancestor
153488123|NCT02135016|Anesthetics|anesthetics|mesh-ancestor
153488192|NCT02156154|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153488193|NCT02156154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153488194|NCT02156154|Antipyretics|antipyretics|mesh-ancestor
153488195|NCT02158572|Contraceptive Agents|contraceptive agents|mesh-list
153488196|NCT02158572|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153488215|NCT02159976|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
153488216|NCT02159976|Antacids|antacids|mesh-ancestor
153488217|NCT02160288|Botulinum Toxins|botulinum toxins|mesh-list
153488218|NCT02160288|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
153488219|NCT02160288|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
153488220|NCT02160288|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
153488221|NCT02160288|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153488222|NCT02160288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153488223|NCT02160288|Cholinergic Agents|cholinergic agents|mesh-ancestor
153488224|NCT02160288|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153488225|NCT02160288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153488226|NCT02160288|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
153428377|NCT00002270|Immunologic Factors|immunologic factors|mesh-ancestor
153428378|NCT00002270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153428379|NCT00002270|Antimetabolites|antimetabolites|mesh-ancestor
153428380|NCT00002270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153428383|NCT00002270|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153488228|NCT02160990|Exenatide|exenatide|mesh-list
153488229|NCT02160990|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
153488230|NCT02160990|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153488231|NCT02160990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153488232|NCT02160990|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
153488234|NCT02160990|Hormones|hormones|mesh-ancestor
153488235|NCT02160990|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153488236|NCT02164422|Guanfacine|guanfacine|mesh-list
153488237|NCT02164422|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153488238|NCT02164422|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
153488239|NCT02164422|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153488240|NCT02164422|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153488241|NCT02164422|Adrenergic Agents|adrenergic agents|mesh-ancestor
153488243|NCT02164422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153488244|NCT02164422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153488245|NCT02170662|Bimatoprost|bimatoprost|mesh-list
153488246|NCT02170662|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153488247|NCT02173392|Brodalumab|brodalumab|mesh-list
153488248|NCT02173392|Dermatologic Agents|dermatologic agents|mesh-ancestor
153488249|NCT02178540|Tobramycin|tobramycin|mesh-list
153488250|NCT02178540|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153488251|NCT02178540|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153488252|NCT02178696|Antidepressive Agents|antidepressive agents|mesh-list
153488253|NCT02178696|Citalopram|citalopram|mesh-list
153488254|NCT02178696|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153488270|NCT02180100|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
153488271|NCT02180100|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153488272|NCT02180100|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153488273|NCT02180100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153488274|NCT02180100|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153488275|NCT02180100|Hormone Antagonists|hormone antagonists|mesh-ancestor
153488277|NCT02180100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153488289|NCT02181426|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153488290|NCT02181426|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153488291|NCT02181426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153488293|NCT02192814|Anticonvulsants|anticonvulsants|mesh-ancestor
153488294|NCT02192814|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
153488295|NCT02192814|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153488296|NCT02192814|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153488297|NCT02192814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153488298|NCT02195232|Quercetin|quercetin|mesh-list
153488299|NCT02195232|Antioxidants|antioxidants|mesh-ancestor
153488300|NCT02195232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153488301|NCT02195232|Protective Agents|protective agents|mesh-ancestor
153488302|NCT02195232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153488303|NCT02196168|Cisplatin|cisplatin|mesh-list
153488304|NCT02196168|Adavosertib|adavosertib|mesh-list
153488305|NCT02196168|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153488306|NCT02196168|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153488307|NCT02196168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153488308|NCT02201394|Aspirin|aspirin|mesh-list
153488309|NCT02201394|Ticagrelor|ticagrelor|mesh-list
153488310|NCT02201394|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153488320|NCT02201394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153488353|NCT02206776|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153488354|NCT02206776|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153488355|NCT02206776|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153488356|NCT02206776|GABA Modulators|gaba modulators|mesh-ancestor
153488357|NCT02206776|GABA Agents|gaba agents|mesh-ancestor
153488358|NCT02209272|Lidocaine|lidocaine|mesh-list
153488359|NCT02209272|Benzyl Alcohol|benzyl alcohol|mesh-list
153488360|NCT02209272|Anesthetics, Local|anesthetics, local|mesh-ancestor
153488361|NCT02209272|Anesthetics|anesthetics|mesh-ancestor
153488362|NCT02209272|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153488363|NCT02209272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153488364|NCT02209272|Sensory System Agents|sensory system agents|mesh-ancestor
153488365|NCT02209272|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153488366|NCT02209272|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153813927|NCT00335582|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153488367|NCT02209272|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
153488368|NCT02209272|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153488369|NCT02209272|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153488371|NCT02214420|Ribavirin|ribavirin|mesh-list
153488413|NCT02223702|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153488414|NCT02223702|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153488415|NCT02223702|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153488416|NCT02225106|Methylphenidate|methylphenidate|mesh-list
153488417|NCT02225106|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
153488418|NCT02225106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153488419|NCT02225106|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
153488420|NCT02225106|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153488421|NCT02225106|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153488422|NCT02225106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153488423|NCT02225106|Dopamine Agents|dopamine agents|mesh-ancestor
153488424|NCT02225106|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153488443|NCT02237898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153488444|NCT02239380|Lorazepam|lorazepam|mesh-list
153488456|NCT02239380|GABA Modulators|gaba modulators|mesh-ancestor
153488457|NCT02239380|GABA Agents|gaba agents|mesh-ancestor
153488458|NCT02239380|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153813928|NCT00335582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153488459|NCT02239380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153488461|NCT02239770|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
153488462|NCT02239770|Autonomic Agents|autonomic agents|mesh-ancestor
153488463|NCT02239770|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153488464|NCT02239770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153488465|NCT02239770|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
153488466|NCT02239770|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
153488467|NCT02239770|Cholinergic Agents|cholinergic agents|mesh-ancestor
153488468|NCT02239770|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153488469|NCT02239770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153488470|NCT02241486|Fentanyl|fentanyl|mesh-list
153488471|NCT02241486|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153488472|NCT02241486|Narcotics|narcotics|mesh-ancestor
153488473|NCT02241486|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153488474|NCT02241486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153488475|NCT02241486|Analgesics|analgesics|mesh-ancestor
153488476|NCT02241486|Sensory System Agents|sensory system agents|mesh-ancestor
153488477|NCT02241486|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153488478|NCT02241486|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153488479|NCT02241486|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153488480|NCT02241486|Anesthetics, General|anesthetics, general|mesh-ancestor
153488481|NCT02241486|Anesthetics|anesthetics|mesh-ancestor
153488482|NCT02244918|Nicotine|nicotine|mesh-list
153488483|NCT02244918|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
153488484|NCT02244918|Autonomic Agents|autonomic agents|mesh-ancestor
153488485|NCT02244918|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153488486|NCT02244918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153488487|NCT02244918|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
153488488|NCT02244918|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
153488489|NCT02244918|Cholinergic Agents|cholinergic agents|mesh-ancestor
153488490|NCT02244918|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153488491|NCT02244918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153488492|NCT02250612|Timolol|timolol|mesh-list
153488493|NCT02250612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153488494|NCT02250612|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
153488495|NCT02250612|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
153488496|NCT02250612|Adrenergic Agents|adrenergic agents|mesh-ancestor
153488497|NCT02250612|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153488498|NCT02250612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153488499|NCT02250612|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153488500|NCT02250612|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153488502|NCT02251236|Emtricitabine|emtricitabine|mesh-list
153488503|NCT02251236|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
153488504|NCT02251236|Cobicistat|cobicistat|mesh-list
153488505|NCT02251236|Emtricitabine tenofovir alafenamide|emtricitabine tenofovir alafenamide|mesh-list
153870569|NCT01081782|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
153488527|NCT02251938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153488529|NCT02258412|Anti-Infective Agents, Local|anti-infective agents, local|mesh-list
153488530|NCT02258412|Hand Sanitizers|hand sanitizers|mesh-list
153488531|NCT02258412|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153488532|NCT02258412|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153488533|NCT02258412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153488534|NCT02258412|Disinfectants|disinfectants|mesh-ancestor
153488535|NCT02260440|Pembrolizumab|pembrolizumab|mesh-list
153488536|NCT02260440|Azacitidine|azacitidine|mesh-list
153488537|NCT02260440|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153488538|NCT02260440|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153813929|NCT00437853|Anastrozole|anastrozole|mesh-list
153488539|NCT02260440|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153488540|NCT02260440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153488541|NCT02260440|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153488542|NCT02260440|Antimetabolites|antimetabolites|mesh-ancestor
153488543|NCT02260440|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153488544|NCT02267538|Dexmedetomidine|dexmedetomidine|mesh-list
153488545|NCT02267538|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153488546|NCT02267538|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153488547|NCT02267538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153488548|NCT02267538|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153488549|NCT02267538|Analgesics|analgesics|mesh-ancestor
153488550|NCT02267538|Sensory System Agents|sensory system agents|mesh-ancestor
153488561|NCT02267772|Narcotics|narcotics|mesh-ancestor
153488562|NCT02267772|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153488563|NCT02267772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153488564|NCT02267772|Analgesics|analgesics|mesh-ancestor
153488565|NCT02267772|Sensory System Agents|sensory system agents|mesh-ancestor
153488566|NCT02267772|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153488567|NCT02267772|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153488568|NCT02267772|Antipyretics|antipyretics|mesh-ancestor
153488569|NCT02271906|Afatinib|afatinib|mesh-list
153488570|NCT02271906|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153488571|NCT02271906|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153488594|NCT02282514|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
153488595|NCT02282514|Cyclophosphamide|cyclophosphamide|mesh-list
153488596|NCT02282514|Rituximab|rituximab|mesh-list
153488597|NCT02282514|Thymoglobulin|thymoglobulin|mesh-list
153488598|NCT02282514|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153488599|NCT02282514|Immunologic Factors|immunologic factors|mesh-ancestor
153488600|NCT02282514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153488601|NCT02282514|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153488602|NCT02282514|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153488603|NCT02282514|Alkylating Agents|alkylating agents|mesh-ancestor
153488611|NCT02282514|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153488613|NCT02282514|Glucocorticoids|glucocorticoids|mesh-ancestor
153488615|NCT02282514|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153488616|NCT02282514|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
153488617|NCT02282514|Protective Agents|protective agents|mesh-ancestor
153488619|NCT02282904|Sirolimus|sirolimus|mesh-list
153488623|NCT02282904|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153488639|NCT02283840|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153488640|NCT02283840|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153488641|NCT02283840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153488643|NCT02284386|Anesthetics, Local|anesthetics, local|mesh-ancestor
153813930|NCT00437853|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153488645|NCT02284386|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153488646|NCT02284386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153488647|NCT02284386|Sensory System Agents|sensory system agents|mesh-ancestor
153488648|NCT02284386|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153813931|NCT00437853|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153488649|NCT02284464|Prednisone|prednisone|mesh-list
153488650|NCT02284464|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153488651|NCT02284464|Glucocorticoids|glucocorticoids|mesh-ancestor
153488702|NCT02285634|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
153488703|NCT02285634|Nasal Decongestants|nasal decongestants|mesh-ancestor
153488704|NCT02285634|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
153488705|NCT02285634|Protective Agents|protective agents|mesh-ancestor
153887333|NCT01104766|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153488706|NCT02287350|Diclofenac|diclofenac|mesh-list
153488707|NCT02287350|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153488708|NCT02287350|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153488709|NCT02287350|Analgesics|analgesics|mesh-ancestor
153488710|NCT02287350|Sensory System Agents|sensory system agents|mesh-ancestor
153488711|NCT02287350|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153488712|NCT02287350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153488713|NCT02287350|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153488714|NCT02287350|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153488715|NCT02287350|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153488716|NCT02287350|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153488717|NCT02287350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153488718|NCT02288364|Lidocaine|lidocaine|mesh-list
153488719|NCT02288364|Anesthetics, Local|anesthetics, local|mesh-ancestor
153488720|NCT02288364|Anesthetics|anesthetics|mesh-ancestor
153488721|NCT02288364|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153488722|NCT02288364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153488723|NCT02288364|Sensory System Agents|sensory system agents|mesh-ancestor
153488724|NCT02288364|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153488725|NCT02288364|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153488726|NCT02288364|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
153488727|NCT02288364|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153488755|NCT02291016|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153488756|NCT02291016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153488757|NCT02291016|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153488758|NCT02291016|Respiratory System Agents|respiratory system agents|mesh-ancestor
153488759|NCT02291016|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
153488760|NCT02291016|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
153488761|NCT02291016|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153488762|NCT02291016|Adrenergic Agents|adrenergic agents|mesh-ancestor
153488763|NCT02291016|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153488764|NCT02291016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153488765|NCT02296164|Mechlorethamine|mechlorethamine|mesh-list
153488766|NCT02296164|Alkylating Agents|alkylating agents|mesh-ancestor
153488767|NCT02296164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153488768|NCT02296164|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153488769|NCT02296164|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153488770|NCT02297100|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
153488771|NCT02297100|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
153488772|NCT02297100|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
153488773|NCT02297100|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153488774|NCT02297100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153488775|NCT02297100|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
153488776|NCT02297100|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153488777|NCT02297100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153488778|NCT02297100|Cholinergic Agents|cholinergic agents|mesh-ancestor
153488779|NCT02297100|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153488780|NCT02299050|Bromocriptine|bromocriptine|mesh-list
153488781|NCT02299050|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
153488782|NCT02299050|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
153488783|NCT02299050|Hormone Antagonists|hormone antagonists|mesh-ancestor
153488784|NCT02299050|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153488785|NCT02299050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153488794|NCT02303184|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153488795|NCT02303184|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153488797|NCT02303184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153488801|NCT02304432|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
153488803|NCT02304432|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
153488804|NCT02304432|Antitubercular Agents|antitubercular agents|mesh-ancestor
153488814|NCT02314104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153488815|NCT02314104|Sensory System Agents|sensory system agents|mesh-ancestor
153488816|NCT02314104|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153488817|NCT02321748|Montelukast|montelukast|mesh-list
153488818|NCT02321748|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153813933|NCT00437853|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153488819|NCT02321748|Respiratory System Agents|respiratory system agents|mesh-ancestor
153488820|NCT02321748|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
153488821|NCT02321748|Hormone Antagonists|hormone antagonists|mesh-ancestor
153488822|NCT02321748|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153488823|NCT02321748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153488824|NCT02321748|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
153488825|NCT02321748|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
153488826|NCT02321748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153488827|NCT02322528|Loteprednol Etabonate|loteprednol etabonate|mesh-list
153488828|NCT02322528|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
153488829|NCT02330094|Gabapentin|gabapentin|mesh-list
153488830|NCT02330094|Analgesics|analgesics|mesh-ancestor
153488831|NCT02330094|Sensory System Agents|sensory system agents|mesh-ancestor
153488832|NCT02330094|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153488833|NCT02330094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153488835|NCT02330094|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153488836|NCT02330094|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153488837|NCT02330094|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153488838|NCT02330094|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153488839|NCT02330094|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
153488840|NCT02330094|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
153488841|NCT02330094|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153488842|NCT02330094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153488843|NCT02330094|Antimanic Agents|antimanic agents|mesh-ancestor
153488844|NCT02330172|Neostigmine|neostigmine|mesh-list
153488845|NCT02330172|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
153488846|NCT02330172|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153488847|NCT02330172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153488848|NCT02330172|Cholinergic Agents|cholinergic agents|mesh-ancestor
153488849|NCT02330172|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153488850|NCT02330172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153488851|NCT02330172|Parasympathomimetics|parasympathomimetics|mesh-ancestor
153488852|NCT02330172|Autonomic Agents|autonomic agents|mesh-ancestor
153488853|NCT02330172|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153488912|NCT02357706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153488914|NCT02359110|Gabapentin|gabapentin|mesh-list
153488915|NCT02359110|Analgesics|analgesics|mesh-ancestor
153488916|NCT02359110|Sensory System Agents|sensory system agents|mesh-ancestor
153488917|NCT02359110|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153488918|NCT02359110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153488919|NCT02359110|Anticonvulsants|anticonvulsants|mesh-ancestor
153488920|NCT02359110|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153488921|NCT02359110|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153488922|NCT02359110|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153488923|NCT02359110|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153488924|NCT02359110|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
153488925|NCT02359110|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
153488926|NCT02359110|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153488927|NCT02359110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153488928|NCT02359110|Antimanic Agents|antimanic agents|mesh-ancestor
153488929|NCT02360124|Fluorides|fluorides|mesh-list
153488956|NCT02377752|Doxorubicin|doxorubicin|mesh-list
153488957|NCT02377752|Olaratumab|olaratumab|mesh-list
153488958|NCT02377752|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153488959|NCT02377752|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153488960|NCT02377752|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153488961|NCT02377752|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153488972|NCT02384070|Sensory System Agents|sensory system agents|mesh-ancestor
153488973|NCT02384070|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153488974|NCT02384070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153489005|NCT02391714|Povidone|povidone|mesh-list
153489006|NCT02391714|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
153489007|NCT02391714|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153489008|NCT02391714|Disinfectants|disinfectants|mesh-ancestor
153489009|NCT02391714|Plasma Substitutes|plasma substitutes|mesh-ancestor
153489010|NCT02391714|Blood Substitutes|blood substitutes|mesh-ancestor
153489011|NCT02391714|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
153489012|NCT02391714|Anesthetics, General|anesthetics, general|mesh-ancestor
153489013|NCT02391714|Anesthetics|anesthetics|mesh-ancestor
153489014|NCT02391714|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153489015|NCT02391714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153489016|NCT02391714|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153489017|NCT02391714|Analgesics|analgesics|mesh-ancestor
153489018|NCT02391714|Sensory System Agents|sensory system agents|mesh-ancestor
153489019|NCT02391714|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153489020|NCT02395692|Temozolomide|temozolomide|mesh-list
153489080|NCT05717790|Gemcitabine|gemcitabine|mesh-list
153489081|NCT05717790|Nimotuzumab|nimotuzumab|mesh-list
153489082|NCT05717790|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153489083|NCT05717790|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153489084|NCT05717790|Antimetabolites|antimetabolites|mesh-ancestor
153489085|NCT05717790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153489086|NCT05717790|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153489087|NCT05602272|Anesthetics|anesthetics|mesh-list
153489088|NCT05602272|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153489089|NCT05602272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153489090|NCT05543694|Bupivacaine|bupivacaine|mesh-list
153489091|NCT05543694|Anesthetics, Local|anesthetics, local|mesh-ancestor
153489092|NCT05543694|Anesthetics|anesthetics|mesh-ancestor
153489093|NCT05543694|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153489094|NCT05543694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153489095|NCT05543694|Sensory System Agents|sensory system agents|mesh-ancestor
153489096|NCT05543694|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153814196|NCT00444834|Vasodilator Agents|vasodilator agents|mesh-ancestor
153814197|NCT00444834|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
153814198|NCT00444834|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
153814199|NCT00337766|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
153814200|NCT00337766|Hemostatics|hemostatics|mesh-ancestor
153814201|NCT00337766|Coagulants|coagulants|mesh-ancestor
153814202|NCT00337766|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
153814203|NCT00337766|Natriuretic Agents|natriuretic agents|mesh-ancestor
153814204|NCT00337766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153814206|NCT00444873|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153429117|NCT00002552|Alkylating Agents|alkylating agents|mesh-ancestor
153814236|NCT00451230|Hydrocortisone|hydrocortisone|mesh-list
153814237|NCT00451230|Cocaine|cocaine|mesh-list
153814238|NCT00451230|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153814239|NCT00451230|Anesthetics, Local|anesthetics, local|mesh-ancestor
153814240|NCT00451230|Anesthetics|anesthetics|mesh-ancestor
153814241|NCT00451230|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153814242|NCT00451230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153814243|NCT00451230|Sensory System Agents|sensory system agents|mesh-ancestor
153814244|NCT00451230|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153814245|NCT00451230|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
153814246|NCT00451230|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
153814247|NCT00451230|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153368064|NCT02174510|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153368066|NCT02174510|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
153368067|NCT02174510|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
153368068|NCT02174510|Dopamine Agents|dopamine agents|mesh-ancestor
153368069|NCT00585195|Itraconazole|itraconazole|mesh-list
153368070|NCT00585195|Rifampin|rifampin|mesh-list
153368071|NCT00585195|Crizotinib|crizotinib|mesh-list
153828046|NCT00483158|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
153828047|NCT00483158|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153828048|NCT00483158|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153828049|NCT00483158|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153828050|NCT00483158|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153828052|NCT00483158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153828053|NCT00483158|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153828055|NCT01308580|Prednisolone|prednisolone|mesh-list
153828056|NCT01308580|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153828057|NCT01308580|Glucocorticoids|glucocorticoids|mesh-ancestor
153828058|NCT01308580|Hormones|hormones|mesh-ancestor
153828059|NCT01308580|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153828065|NCT00483275|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153828066|NCT00483275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153828067|NCT00483275|Vitamins|vitamins|mesh-ancestor
153828068|NCT00483275|Micronutrients|micronutrients|mesh-ancestor
153828069|NCT00483314|Acetylcysteine|acetylcysteine|mesh-list
153828070|NCT00483314|N-monoacetylcystine|n-monoacetylcystine|mesh-list
153828071|NCT00483314|Antiviral Agents|antiviral agents|mesh-ancestor
153828072|NCT00483314|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153828073|NCT00483314|Expectorants|expectorants|mesh-ancestor
153828074|NCT00483314|Respiratory System Agents|respiratory system agents|mesh-ancestor
153828075|NCT00483314|Free Radical Scavengers|free radical scavengers|mesh-ancestor
153828076|NCT00483314|Antioxidants|antioxidants|mesh-ancestor
153828077|NCT00483314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153828078|NCT00483314|Protective Agents|protective agents|mesh-ancestor
153828079|NCT00483314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153828080|NCT00483314|Antidotes|antidotes|mesh-ancestor
153828081|NCT00483392|Metformin|metformin|mesh-list
153828082|NCT00483392|Rosiglitazone|rosiglitazone|mesh-list
153828083|NCT00483392|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153828084|NCT00483392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153828085|NCT00483431|Menaquinone 7|menaquinone 7|mesh-list
153828086|NCT00483431|Hemostatics|hemostatics|mesh-ancestor
153828087|NCT00483431|Coagulants|coagulants|mesh-ancestor
153828088|NCT00483600|PENTA|penta|mesh-list
153828089|NCT00483600|Fondaparinux|fondaparinux|mesh-list
153828091|NCT00483600|Antithrombins|antithrombins|mesh-ancestor
153828092|NCT00483600|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
153368104|NCT01113398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153368105|NCT01113398|Growth Inhibitors|growth inhibitors|mesh-ancestor
153368106|NCT03013556|Tenofovir|tenofovir|mesh-list
153368107|NCT03013556|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
153368108|NCT03013556|Interferon-alpha|interferon-alpha|mesh-list
153368109|NCT03013556|Antiviral Agents|antiviral agents|mesh-ancestor
153368110|NCT03013556|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153368111|NCT03013556|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153368112|NCT03013556|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153368113|NCT03013556|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153368114|NCT03013556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153368115|NCT03013556|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153368116|NCT03013556|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153368117|NCT03013556|Immunologic Factors|immunologic factors|mesh-ancestor
153368118|NCT03013556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153368119|NCT01113632|Ofatumumab|ofatumumab|mesh-list
153368120|NCT01113632|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153368121|NCT00458835|Ciclesonide|ciclesonide|mesh-list
153828095|NCT00483600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153828096|NCT00483600|Anticoagulants|anticoagulants|mesh-ancestor
153828097|NCT00483600|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153828098|NCT00483600|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153828099|NCT00488189|Tazobactam|tazobactam|mesh-list
153828100|NCT00488189|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
153828101|NCT00488189|Piperacillin|piperacillin|mesh-list
153828102|NCT00488189|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153828103|NCT00488189|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153828104|NCT00488189|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
153828105|NCT00488189|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153828106|NCT00488189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153828107|NCT02956421|Vaccines|vaccines|mesh-list
153828108|NCT02956421|Immunologic Factors|immunologic factors|mesh-ancestor
153828109|NCT02956421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153828110|NCT00483470|Vaccines|vaccines|mesh-list
153828111|NCT00483470|Immunologic Factors|immunologic factors|mesh-ancestor
153828112|NCT00483470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153828113|NCT00488306|Tigecycline|tigecycline|mesh-list
153828114|NCT00488306|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153828115|NCT00488306|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153828116|NCT00488306|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
153828117|NCT00488306|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153828118|NCT00488306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153368135|NCT03013400|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153368136|NCT03013400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153368137|NCT03013400|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153368156|NCT01048658|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
153368157|NCT01048658|Anesthetics, General|anesthetics, general|mesh-ancestor
153368158|NCT01048658|Anesthetics|anesthetics|mesh-ancestor
153368159|NCT01048658|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153368160|NCT01048658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153368161|NCT04341675|Sirolimus|sirolimus|mesh-list
153368162|NCT04341675|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153368163|NCT04341675|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153368164|NCT04341675|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153368165|NCT04341675|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153828154|NCT05644210|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153828155|NCT05644210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153828156|NCT05644210|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153828157|NCT05644210|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153828158|NCT05644210|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153828159|NCT05644210|Antipyretics|antipyretics|mesh-ancestor
153828160|NCT05644210|Anticoagulants|anticoagulants|mesh-ancestor
153828161|NCT05644210|Antimalarials|antimalarials|mesh-ancestor
153828162|NCT05644210|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153368178|NCT00362973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153368179|NCT01116986|Nicotine|nicotine|mesh-list
153368180|NCT01116986|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
153828168|NCT00483834|Bevacizumab|bevacizumab|mesh-list
153828169|NCT00483834|Capecitabine|capecitabine|mesh-list
153828170|NCT00483834|Irinotecan|irinotecan|mesh-list
153828171|NCT00483834|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153828172|NCT00483834|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153828173|NCT00483834|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153828174|NCT00483834|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153828175|NCT00483834|Growth Substances|growth substances|mesh-ancestor
153828176|NCT00483834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153828177|NCT00483834|Growth Inhibitors|growth inhibitors|mesh-ancestor
153828178|NCT00483834|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153828179|NCT00483834|Antimetabolites|antimetabolites|mesh-ancestor
153828180|NCT00483834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153828181|NCT00483834|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
153828184|NCT01307449|Vaccines|vaccines|mesh-list
153368193|NCT01099202|Epoetin Alfa|epoetin alfa|mesh-list
153368194|NCT01099202|Hematinics|hematinics|mesh-ancestor
153368195|NCT02448303|Pembrolizumab|pembrolizumab|mesh-list
153368196|NCT02448303|Acalabrutinib|acalabrutinib|mesh-list
153368197|NCT02448303|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153368198|NCT02448303|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153368199|NCT02448303|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153368200|NCT02448303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153368201|NCT02448303|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153368202|NCT02448303|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153368203|NCT02448303|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153368204|NCT02415855|Dabigatran|dabigatran|mesh-list
153368205|NCT02415855|Antithrombins|antithrombins|mesh-ancestor
153368206|NCT02415855|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
153368223|NCT02424357|Povidone|povidone|mesh-list
153368224|NCT02424357|Ophthalmic Solutions|ophthalmic solutions|mesh-list
153368225|NCT02424357|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
153368226|NCT02424357|Plasma Substitutes|plasma substitutes|mesh-ancestor
153368227|NCT02424357|Blood Substitutes|blood substitutes|mesh-ancestor
153368228|NCT02424357|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
153368229|NCT02424357|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153368230|NCT02425449|Succinylcholine|succinylcholine|mesh-list
153368231|NCT02425449|Neuromuscular Depolarizing Agents|neuromuscular depolarizing agents|mesh-ancestor
153368232|NCT02425449|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
153368233|NCT02425449|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
153368234|NCT02425449|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153368235|NCT02425449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153368236|NCT02455167|Ribavirin|ribavirin|mesh-list
153368237|NCT02455167|Sofosbuvir|sofosbuvir|mesh-list
153368238|NCT02455167|Antimetabolites|antimetabolites|mesh-ancestor
153368239|NCT02455167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153828226|NCT00483782|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153828228|NCT00483782|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153828229|NCT00483782|Growth Substances|growth substances|mesh-ancestor
153828230|NCT00483782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153828231|NCT00483782|Growth Inhibitors|growth inhibitors|mesh-ancestor
153828232|NCT02890771|Turmeric extract|turmeric extract|mesh-list
153828233|NCT02890771|Antioxidants|antioxidants|mesh-ancestor
153828234|NCT02890771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153828235|NCT02890771|Protective Agents|protective agents|mesh-ancestor
153828236|NCT02890771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153368249|NCT02434497|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153368250|NCT02435901|Cyclosporine|cyclosporine|mesh-list
153368251|NCT02435901|Mycophenolic Acid|mycophenolic acid|mesh-list
153368259|NCT02435901|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153368260|NCT02435901|Immunologic Factors|immunologic factors|mesh-ancestor
153368261|NCT02435901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153368262|NCT02435901|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
153368263|NCT02435901|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153368264|NCT02435901|Antifungal Agents|antifungal agents|mesh-ancestor
153368265|NCT02435901|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153368266|NCT02435901|Dermatologic Agents|dermatologic agents|mesh-ancestor
153368267|NCT02435901|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153429185|NCT00002576|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153368288|NCT02385708|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
153368289|NCT02385708|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153429186|NCT00002576|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153429187|NCT00002576|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153429188|NCT00002576|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153429189|NCT00002576|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153429190|NCT00002576|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153429191|NCT00002576|Tubulin Modulators|tubulin modulators|mesh-ancestor
153429192|NCT00002576|Antimitotic Agents|antimitotic agents|mesh-ancestor
153429193|NCT00002576|Mitosis Modulators|mitosis modulators|mesh-ancestor
153828268|NCT00483990|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153828269|NCT00483990|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
153828270|NCT01304329|Empagliflozin|empagliflozin|mesh-list
153828271|NCT01304329|Simvastatin|simvastatin|mesh-list
153828272|NCT01304329|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153828273|NCT01304329|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153828274|NCT01304329|Antimetabolites|antimetabolites|mesh-ancestor
153828275|NCT01304329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153828276|NCT01304329|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153828277|NCT01304329|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
153828278|NCT01304329|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153828279|NCT01304329|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
153828280|NCT01304329|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153828282|NCT04515420|Norepinephrine|norepinephrine|mesh-list
153828288|NCT04515420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153368291|NCT02385708|Dermatologic Agents|dermatologic agents|mesh-ancestor
153368292|NCT01099358|Fluorouracil|fluorouracil|mesh-list
153368294|NCT01099358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153368295|NCT01099358|Antimetabolites|antimetabolites|mesh-ancestor
153368296|NCT01099358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153368297|NCT01099358|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153368298|NCT01099358|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153368299|NCT01099358|Immunologic Factors|immunologic factors|mesh-ancestor
153368300|NCT01099358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153368301|NCT01099358|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153368302|NCT01118624|Vitamins|vitamins|mesh-list
153368303|NCT01118624|Folic Acid|folic acid|mesh-list
153368304|NCT01118624|Vitamin B 12|vitamin b 12|mesh-list
153828299|NCT00488540|Antipyretics|antipyretics|mesh-ancestor
153828300|NCT00484068|Enalapril|enalapril|mesh-list
153828301|NCT00484068|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
153828302|NCT00484068|Protease Inhibitors|protease inhibitors|mesh-ancestor
153828303|NCT00484068|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153828304|NCT00484068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153828305|NCT00484068|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153828306|NCT00483860|Topotecan|topotecan|mesh-list
153828307|NCT00483860|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
153828308|NCT00483860|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153828309|NCT00483860|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153828310|NCT00483860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153828311|NCT00483860|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153828312|NCT01241097|Simvastatin|simvastatin|mesh-list
153828313|NCT01241097|Ezetimibe|ezetimibe|mesh-list
153368316|NCT02439879|Antioxidants|antioxidants|mesh-ancestor
153368317|NCT02439879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153368318|NCT02439879|Protective Agents|protective agents|mesh-ancestor
153368319|NCT02439879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153368320|NCT02439879|Vitamin B Complex|vitamin b complex|mesh-ancestor
153368321|NCT02439879|Vitamins|vitamins|mesh-ancestor
153368322|NCT02439879|Micronutrients|micronutrients|mesh-ancestor
153828318|NCT01241097|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153828319|NCT01241097|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
153828321|NCT01303861|Bupropion|bupropion|mesh-list
153828322|NCT01303861|Nicotine|nicotine|mesh-list
153828323|NCT01303861|Varenicline|varenicline|mesh-list
153828324|NCT01303861|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
153828325|NCT01303861|Autonomic Agents|autonomic agents|mesh-ancestor
153828326|NCT01303861|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153828327|NCT01303861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153828328|NCT01303861|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
153828329|NCT01303861|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
153368333|NCT03013010|Antimetabolites|antimetabolites|mesh-ancestor
153368334|NCT03013010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153368336|NCT02518191|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153368337|NCT02518191|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153368338|NCT01119794|Bortezomib|bortezomib|mesh-list
153368339|NCT01119794|Ofatumumab|ofatumumab|mesh-list
153368340|NCT01119794|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153368341|NCT01103414|Pioglitazone|pioglitazone|mesh-list
153368342|NCT01103414|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153368343|NCT01103414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153368344|NCT02180828|Fluconazole|fluconazole|mesh-list
153828344|NCT01303627|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153828345|NCT01303627|Narcotics|narcotics|mesh-ancestor
153828346|NCT01303627|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153828347|NCT01303627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153828350|NCT01303627|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153828351|NCT01241175|Magnesium Sulfate|magnesium sulfate|mesh-list
153828352|NCT01241175|Analgesics|analgesics|mesh-ancestor
153828353|NCT01241175|Sensory System Agents|sensory system agents|mesh-ancestor
153828354|NCT01241175|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153828355|NCT01241175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153828356|NCT01241175|Anesthetics|anesthetics|mesh-ancestor
153828357|NCT01241175|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153368363|NCT02525523|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153368364|NCT02525523|Immunologic Factors|immunologic factors|mesh-ancestor
153368365|NCT02525523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153368366|NCT02528409|Vortioxetine|vortioxetine|mesh-list
153368367|NCT02528409|Antidepressive Agents|antidepressive agents|mesh-ancestor
153368368|NCT02528409|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153368369|NCT02528409|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153368370|NCT02528409|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153368371|NCT02528409|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153368372|NCT02528409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153368373|NCT02528409|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
153368374|NCT02528409|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153368375|NCT02528409|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153368376|NCT02528409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153368377|NCT02528409|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153368378|NCT02528409|Serotonin Agents|serotonin agents|mesh-ancestor
153368379|NCT02528409|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
153368380|NCT02528409|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
153368381|NCT02528409|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
153368382|NCT02528409|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153368383|NCT02530281|Glycopyrrolate|glycopyrrolate|mesh-list
153368384|NCT02530281|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153828358|NCT01241175|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153828359|NCT01241175|Anticonvulsants|anticonvulsants|mesh-ancestor
153828360|NCT01241175|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153828361|NCT01241175|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153828362|NCT01241175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153828363|NCT01241175|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153828364|NCT01241175|Tocolytic Agents|tocolytic agents|mesh-ancestor
153828365|NCT01241175|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153828366|NCT00484107|Estrogens|estrogens|mesh-list
153828367|NCT00484107|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
153828368|NCT00484107|Hormones|hormones|mesh-ancestor
153828369|NCT00484107|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153828370|NCT00484107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153828371|NCT01302964|Mirtazapine|mirtazapine|mesh-list
153828372|NCT01302964|Antidepressive Agents|antidepressive agents|mesh-ancestor
153368400|NCT03013634|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153368401|NCT03013634|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153368402|NCT03013634|Adrenergic Agents|adrenergic agents|mesh-ancestor
153368403|NCT03013634|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153368404|NCT03013634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153368411|NCT02980094|Antioxidants|antioxidants|mesh-list
153368412|NCT02980094|Micronutrients|micronutrients|mesh-ancestor
153368413|NCT02980094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153828383|NCT01302964|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
153828384|NCT01302964|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
153828389|NCT01302964|Serotonin Agents|serotonin agents|mesh-ancestor
153828393|NCT00484055|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153828394|NCT00484055|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
153828395|NCT00484055|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153828396|NCT00484055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153828397|NCT01302691|Losartan|losartan|mesh-list
153828398|NCT01302691|Amlodipine|amlodipine|mesh-list
153828399|NCT01302691|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
153828400|NCT01302691|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153828401|NCT01302691|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153828402|NCT01302691|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153828403|NCT01302691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153828404|NCT01302691|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153828408|NCT01302691|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
153828409|NCT01302691|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
153828411|NCT01302691|Natriuretic Agents|natriuretic agents|mesh-ancestor
153828412|NCT01302691|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
153828413|NCT01241084|Leukotriene Antagonists|leukotriene antagonists|mesh-list
153828414|NCT01241084|Hormone Antagonists|hormone antagonists|mesh-ancestor
153828415|NCT01241084|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153828416|NCT01241084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153828417|NCT01241084|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153828418|NCT01241084|Respiratory System Agents|respiratory system agents|mesh-ancestor
153828419|NCT05643820|Ivermectin|ivermectin|mesh-list
153828420|NCT05643820|Permethrin|permethrin|mesh-list
153828449|NCT00484133|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153828450|NCT00484133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153828451|NCT00484133|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
153368457|NCT04743687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153368458|NCT04743687|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153368460|NCT02542761|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
153368461|NCT02542761|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153368462|NCT02475837|Vorapaxar|vorapaxar|mesh-list
153368463|NCT02475837|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153828476|NCT04514835|Capecitabine|capecitabine|mesh-list
153828477|NCT04514835|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153828478|NCT04514835|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153828479|NCT04514835|Antimetabolites|antimetabolites|mesh-ancestor
153828480|NCT04514835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153828481|NCT00488813|Cephalosporins|cephalosporins|mesh-list
153828482|NCT00488813|Third Generation Cephalosporins|third generation cephalosporins|mesh-list
153828483|NCT00488813|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153828484|NCT00488813|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153828485|NCT00488813|Beta Lactam Antibiotics|beta lactam antibiotics|mesh-ancestor
153828486|NCT00484250|Metronidazole|metronidazole|mesh-list
153828487|NCT00484250|Doxycycline|doxycycline|mesh-list
153828488|NCT00484250|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153828489|NCT00484250|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153828490|NCT00484250|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153828491|NCT00484250|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153828492|NCT00484250|Antimalarials|antimalarials|mesh-ancestor
153828493|NCT00488891|Paliperidone Palmitate|paliperidone palmitate|mesh-list
153828494|NCT00488891|Antipsychotic Agents|antipsychotic agents|mesh-list
153828495|NCT00488891|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153828496|NCT00488891|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153828498|NCT00488891|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153828499|NCT00488891|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
153828500|NCT00488891|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153828501|NCT00488891|Serotonin Agents|serotonin agents|mesh-ancestor
153828502|NCT00488891|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153828503|NCT00488891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153828504|NCT00488891|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
153828505|NCT00488891|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
153828506|NCT00488891|Dopamine Agents|dopamine agents|mesh-ancestor
153828507|NCT00484328|Ribavirin|ribavirin|mesh-list
153828508|NCT00484328|Antimetabolites|antimetabolites|mesh-ancestor
153828509|NCT00484328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153828510|NCT00484328|Antiviral Agents|antiviral agents|mesh-ancestor
153828521|NCT00484575|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
153368527|NCT02481219|Antiemetics|antiemetics|mesh-ancestor
153368528|NCT02481219|Autonomic Agents|autonomic agents|mesh-ancestor
153368529|NCT02481219|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153368530|NCT02481219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153828540|NCT00484692|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153828541|NCT00484692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153828542|NCT00484692|Dopamine Agents|dopamine agents|mesh-ancestor
153828543|NCT00484692|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153828544|NCT00484692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153828545|NCT00484692|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
153828548|NCT00484731|Bupivacaine|bupivacaine|mesh-list
153368582|NCT02556333|Tenofovir|tenofovir|mesh-list
153368583|NCT02556333|Emtricitabine|emtricitabine|mesh-list
153368584|NCT02556333|Antiviral Agents|antiviral agents|mesh-ancestor
153368585|NCT02556333|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153368586|NCT02556333|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153368587|NCT02556333|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153828556|NCT00484484|Analgesics|analgesics|mesh-ancestor
153828557|NCT00484484|Sensory System Agents|sensory system agents|mesh-ancestor
153828558|NCT00484484|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153828559|NCT00484484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153828560|NCT00484484|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
153828561|NCT00484484|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153828562|NCT00484484|Anesthetics, General|anesthetics, general|mesh-ancestor
153828563|NCT00484484|Anesthetics|anesthetics|mesh-ancestor
153828564|NCT00484484|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153828565|NCT00484484|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
153828566|NCT00484484|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
153828567|NCT00484484|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153828568|NCT00484484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153828569|NCT00484601|Doxorubicin|doxorubicin|mesh-list
153828571|NCT00484601|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153828572|NCT00484601|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153828573|NCT00484601|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153828574|NCT00484601|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153828575|NCT00484601|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153828576|NCT00484601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153368589|NCT02556333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153368590|NCT02556333|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153368591|NCT02556333|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153368593|NCT01166126|Temsirolimus|temsirolimus|mesh-list
153368594|NCT01166126|MTOR Inhibitors|mtor inhibitors|mesh-list
153368595|NCT01166126|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153368596|NCT01166126|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153368600|NCT01166126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153368601|NCT01166126|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153368602|NCT01166126|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153368603|NCT01166126|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153368604|NCT01166126|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153368605|NCT01166126|Antifungal Agents|antifungal agents|mesh-ancestor
153368606|NCT05306990|Atorvastatin|atorvastatin|mesh-list
153368607|NCT05306990|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
153368608|NCT05306990|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153368609|NCT05306990|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153368610|NCT05306990|Antimetabolites|antimetabolites|mesh-ancestor
153368611|NCT05306990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153368612|NCT05306990|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153828581|NCT00489164|Sirolimus|sirolimus|mesh-list
153828582|NCT00489164|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153828583|NCT00489164|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153828584|NCT00489164|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153828585|NCT00489164|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153828586|NCT00489164|Antifungal Agents|antifungal agents|mesh-ancestor
153828597|NCT00484809|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153828598|NCT00484809|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153828599|NCT00484809|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153828600|NCT00484809|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153828601|NCT00484809|Immunologic Factors|immunologic factors|mesh-ancestor
153828602|NCT04514094|Fluorides|fluorides|mesh-list
153828603|NCT04514094|Cariostatic Agents|cariostatic agents|mesh-ancestor
153828604|NCT04514094|Protective Agents|protective agents|mesh-ancestor
153828605|NCT04514094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153828606|NCT04514289|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
153828608|NCT00484926|Clopidogrel|clopidogrel|mesh-list
153828609|NCT00484926|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153828610|NCT00484926|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153828611|NCT00484926|Analgesics|analgesics|mesh-ancestor
153828612|NCT00484926|Sensory System Agents|sensory system agents|mesh-ancestor
153828613|NCT00484926|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153828614|NCT00484926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153828615|NCT00484926|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153828616|NCT00484926|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153828617|NCT00484926|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153828618|NCT00484926|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153828619|NCT00484926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153828620|NCT00484926|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153828621|NCT00484926|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153828622|NCT00484926|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153828623|NCT00484926|Antipyretics|antipyretics|mesh-ancestor
153828624|NCT00484926|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
153828625|NCT00484926|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
153828626|NCT00484926|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
153828627|NCT00484926|Purinergic Agents|purinergic agents|mesh-ancestor
153828628|NCT00484926|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153828629|NCT02275806|Irinotecan|irinotecan|mesh-list
153828630|NCT02275806|Camptothecin|camptothecin|mesh-list
153368637|NCT04341207|Antimalarials|antimalarials|mesh-ancestor
153368638|NCT04341207|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153368639|NCT04341207|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153368640|NCT04341207|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153368641|NCT04341207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153368642|NCT04341207|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153368643|NCT02411292|Enoxaparin|enoxaparin|mesh-list
153368644|NCT02411292|Anticoagulants|anticoagulants|mesh-ancestor
153368645|NCT02411292|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153368646|NCT02411292|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153368647|NCT02411292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153368648|NCT02486211|Amantadine|amantadine|mesh-list
153368649|NCT02486211|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
153368650|NCT02486211|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
153368651|NCT02486211|Antiviral Agents|antiviral agents|mesh-ancestor
153368687|NCT02384850|Leucovorin|leucovorin|mesh-list
153828631|NCT02275806|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153828632|NCT02275806|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
153828641|NCT01241409|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153828642|NCT01241409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153828643|NCT02275845|Metformin|metformin|mesh-list
153828644|NCT02275845|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153828645|NCT02275845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153828646|NCT00489398|Olopatadine Hydrochloride|olopatadine hydrochloride|mesh-list
153828647|NCT00489398|Epinastine|epinastine|mesh-list
153828648|NCT00489398|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153828649|NCT00489398|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153828650|NCT00489398|Analgesics|analgesics|mesh-ancestor
153828651|NCT00489398|Sensory System Agents|sensory system agents|mesh-ancestor
153828652|NCT00489398|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153828653|NCT00489398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153828654|NCT00489398|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153828655|NCT00489398|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153828656|NCT00489398|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
153828657|NCT00489398|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
153828658|NCT00489398|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
153828659|NCT00489398|Histamine Antagonists|histamine antagonists|mesh-ancestor
153828660|NCT00489398|Histamine Agents|histamine agents|mesh-ancestor
153828661|NCT00489398|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153828662|NCT00489398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153828664|NCT00485004|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153828665|NCT00485004|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153828666|NCT00485004|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153828667|NCT00485004|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153828668|NCT00485004|Antifungal Agents|antifungal agents|mesh-ancestor
153828669|NCT00485004|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153828670|NCT00485004|Immunologic Factors|immunologic factors|mesh-ancestor
153828671|NCT00485004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153828672|NCT00484991|Verapamil|verapamil|mesh-list
153828676|NCT00484991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153828677|NCT00484991|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153828678|NCT00484991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153828679|NCT00484991|Vasodilator Agents|vasodilator agents|mesh-ancestor
153828680|NCT00485121|Ezetimibe|ezetimibe|mesh-list
153828681|NCT00485121|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153828682|NCT00485121|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153828683|NCT00485121|Antimetabolites|antimetabolites|mesh-ancestor
153828684|NCT00485121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153828685|NCT00485121|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153828686|NCT00489437|Heparin|heparin|mesh-list
153828687|NCT00489437|Antibodies|antibodies|mesh-list
153828688|NCT00489437|Immunologic Factors|immunologic factors|mesh-ancestor
153828689|NCT00489437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153368697|NCT02384850|Immunologic Factors|immunologic factors|mesh-ancestor
153368698|NCT02384850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153368700|NCT02384850|Protective Agents|protective agents|mesh-ancestor
153368701|NCT02384850|Vitamin B Complex|vitamin b complex|mesh-ancestor
153368702|NCT02384850|Vitamins|vitamins|mesh-ancestor
153368703|NCT02384850|Micronutrients|micronutrients|mesh-ancestor
153368704|NCT02384850|Hematinics|hematinics|mesh-ancestor
153368705|NCT02558829|Insulin|insulin|mesh-list
153368706|NCT02558829|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
153368707|NCT02558829|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153380910|NCT05482451|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153368708|NCT02558829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153368709|NCT02487303|Acetaminophen|acetaminophen|mesh-list
153368710|NCT02487303|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153368711|NCT02487303|Analgesics|analgesics|mesh-ancestor
153368712|NCT02487303|Sensory System Agents|sensory system agents|mesh-ancestor
153368713|NCT02487303|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153828709|NCT00485160|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153828710|NCT00485030|Sirolimus|sirolimus|mesh-list
153828711|NCT00485030|Everolimus|everolimus|mesh-list
153828712|NCT00485030|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
153828713|NCT00485030|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153828714|NCT00485030|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153828715|NCT00485030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153828716|NCT00485030|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153828717|NCT00485030|Immunologic Factors|immunologic factors|mesh-ancestor
153368728|NCT01170884|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
153368729|NCT01170884|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
153368730|NCT01170884|Adrenergic Agents|adrenergic agents|mesh-ancestor
153368731|NCT01170884|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153368732|NCT01170884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153368733|NCT01170884|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153368734|NCT01170884|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153368735|NCT01170884|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
153368737|NCT01170884|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153368738|NCT01171118|Physostigmine|physostigmine|mesh-list
153368739|NCT01171118|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
153368740|NCT01171118|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153368741|NCT01171118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153368742|NCT01171118|Cholinergic Agents|cholinergic agents|mesh-ancestor
153368743|NCT01171118|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153368744|NCT01171118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153368745|NCT01171118|Miotics|miotics|mesh-ancestor
153368746|NCT01171118|Autonomic Agents|autonomic agents|mesh-ancestor
153368747|NCT01171118|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153368748|NCT03011918|Vitamin D|vitamin d|mesh-list
153368749|NCT03011918|Vitamins|vitamins|mesh-ancestor
153368750|NCT03011918|Micronutrients|micronutrients|mesh-ancestor
153368751|NCT03011918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153368752|NCT03011918|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153368753|NCT05296460|Dapsone|dapsone|mesh-list
153368754|NCT05296460|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153368755|NCT05296460|Antimalarials|antimalarials|mesh-ancestor
153368756|NCT05296460|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153368757|NCT05296460|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153368758|NCT05296460|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153368759|NCT05296460|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153828722|NCT00485030|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153828723|NCT00485030|Antifungal Agents|antifungal agents|mesh-ancestor
153828724|NCT04513821|Minocycline|minocycline|mesh-list
153828725|NCT04513821|Ethanol|ethanol|mesh-list
153828726|NCT04513821|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153828727|NCT04513821|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153828728|NCT04513821|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
153828729|NCT04513821|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153828730|NCT04513821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153828731|NCT00485108|Prednisolone|prednisolone|mesh-list
153828732|NCT00485108|Ketorolac|ketorolac|mesh-list
153828733|NCT00485108|Lubricant Eye Drops|lubricant eye drops|mesh-list
153828734|NCT00485108|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153828735|NCT00485108|Glucocorticoids|glucocorticoids|mesh-ancestor
153828736|NCT00485108|Hormones|hormones|mesh-ancestor
153828737|NCT00485108|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153828738|NCT00485108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153828739|NCT00485108|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153828740|NCT00485108|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153828741|NCT00485108|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153828742|NCT00485108|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153828743|NCT00485108|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153828744|NCT00485108|Analgesics|analgesics|mesh-ancestor
153368770|NCT01136798|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153368771|NCT01172522|Fexofenadine|fexofenadine|mesh-list
153368772|NCT01172522|Terfenadine|terfenadine|mesh-list
153368773|NCT01172522|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
153368774|NCT01172522|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
153368775|NCT01172522|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
153368776|NCT01172522|Histamine Antagonists|histamine antagonists|mesh-ancestor
153368777|NCT01172522|Histamine Agents|histamine agents|mesh-ancestor
153368778|NCT01172522|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153368779|NCT01172522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153368780|NCT01172522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153368781|NCT01172600|Nitrous Oxide|nitrous oxide|mesh-list
153368782|NCT01172600|Entonox|entonox|mesh-list
153368783|NCT01172600|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
153368784|NCT01172600|Anesthetics, General|anesthetics, general|mesh-ancestor
153368785|NCT01172600|Anesthetics|anesthetics|mesh-ancestor
153368786|NCT01172600|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153368787|NCT01172600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153368788|NCT01172600|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153368789|NCT01172600|Analgesics|analgesics|mesh-ancestor
153368790|NCT01172600|Sensory System Agents|sensory system agents|mesh-ancestor
153368791|NCT01172600|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153368792|NCT01172600|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
153368794|NCT02246816|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153368795|NCT02246816|Narcotics|narcotics|mesh-ancestor
153828748|NCT00485108|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153828749|NCT00485108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153828750|NCT00485108|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
153828751|NCT00485108|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
153828753|NCT04513704|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
153828754|NCT04513704|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153828755|NCT04513704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153828756|NCT00485238|Acetazolamide|acetazolamide|mesh-list
153828757|NCT00485238|Anticonvulsants|anticonvulsants|mesh-ancestor
153828758|NCT00485238|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
153828759|NCT00485238|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153828760|NCT00485238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153828761|NCT00485238|Diuretics|diuretics|mesh-ancestor
153828762|NCT00485238|Natriuretic Agents|natriuretic agents|mesh-ancestor
153828763|NCT00485238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153828764|NCT00485277|Smallpox and monkeypox vaccine modified vaccinia ankara-bavarian nordic|smallpox and monkeypox vaccine modified vaccinia ankara-bavarian nordic|mesh-list
153828765|NCT00485277|Antiviral Agents|antiviral agents|mesh-ancestor
153828766|NCT00485277|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153368799|NCT02246816|Sensory System Agents|sensory system agents|mesh-ancestor
153888108|NCT00600587|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153888109|NCT01045447|Insulin|insulin|mesh-list
153888110|NCT01045447|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
153368800|NCT02246816|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153368801|NCT02246816|Antidiarrheals|antidiarrheals|mesh-ancestor
153888111|NCT01045447|Insulin Glargine|insulin glargine|mesh-list
153368802|NCT02246816|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153368803|NCT02246816|Antitussive Agents|antitussive agents|mesh-ancestor
153368804|NCT02246816|Respiratory System Agents|respiratory system agents|mesh-ancestor
153368805|NCT01137890|Zonisamide|zonisamide|mesh-list
153368806|NCT01137890|Cocaine|cocaine|mesh-list
153368807|NCT01137890|Anticonvulsants|anticonvulsants|mesh-ancestor
153368808|NCT01137890|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153368809|NCT01137890|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153368810|NCT01137890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153368811|NCT01137890|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153368812|NCT01137890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153368813|NCT01137890|Anesthetics, Local|anesthetics, local|mesh-ancestor
153888112|NCT01045447|Insulin Aspart|insulin aspart|mesh-list
153888113|NCT01045447|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153888114|NCT01045447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153888115|NCT00623207|Atropine|atropine|mesh-list
153888116|NCT00623207|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153888117|NCT00623207|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153888118|NCT00623207|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153828794|NCT04513509|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153828795|NCT04513509|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153828796|NCT04513509|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153828797|NCT00485342|Interferons|interferons|mesh-list
153828798|NCT00485342|Ribavirin|ribavirin|mesh-list
153828799|NCT00485342|Interferon-alpha|interferon-alpha|mesh-list
153828800|NCT00485342|Interferon alpha-2|interferon alpha-2|mesh-list
153828801|NCT00485342|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
153368829|NCT01138124|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153368830|NCT01138124|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153368831|NCT01138124|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153368832|NCT01138124|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153368833|NCT01138124|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
153368834|NCT01138124|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
153368835|NCT01138124|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153368836|NCT01138124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153368837|NCT01138124|Antimanic Agents|antimanic agents|mesh-ancestor
153368838|NCT02560779|Sorafenib|sorafenib|mesh-list
153368839|NCT02560779|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153888119|NCT00623207|Autonomic Agents|autonomic agents|mesh-ancestor
153828816|NCT00489593|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153828817|NCT00489593|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153828818|NCT00489593|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153828819|NCT00489593|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153828820|NCT00489593|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
153828821|NCT00489593|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153828822|NCT00489593|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153368868|NCT01174082|Immunologic Factors|immunologic factors|mesh-ancestor
153368869|NCT01174082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153368870|NCT01175798|Vitamin D|vitamin d|mesh-list
153368871|NCT01175798|Cholecalciferol|cholecalciferol|mesh-list
153368872|NCT01175798|Vitamins|vitamins|mesh-ancestor
153368873|NCT01175798|Micronutrients|micronutrients|mesh-ancestor
153828834|NCT01241487|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153828835|NCT01241487|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153828836|NCT01241487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153828837|NCT01241487|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153828838|NCT01241487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153828839|NCT01241487|Vasodilator Agents|vasodilator agents|mesh-ancestor
153828840|NCT01241487|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
153828841|NCT01241487|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
153828842|NCT00505791|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
153828843|NCT00505791|Natriuretic Agents|natriuretic agents|mesh-ancestor
153828844|NCT00505791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153828845|NCT00485459|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
153828846|NCT00485459|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
153828847|NCT00485459|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153828857|NCT04697511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153368874|NCT01175798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153368875|NCT01175798|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153368876|NCT01175798|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153368878|NCT02246894|Coagulants|coagulants|mesh-ancestor
153368879|NCT03011996|Amoxicillin|amoxicillin|mesh-list
153368880|NCT03011996|Clarithromycin|clarithromycin|mesh-list
153368881|NCT03011996|Pantoprazole|pantoprazole|mesh-list
153368885|NCT03011996|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153368886|NCT03011996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153368887|NCT03011996|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
153368888|NCT03011996|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153368889|NCT03011996|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
153368890|NCT03011996|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153368891|NCT03011996|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
153368892|NCT01178216|Rituximab|rituximab|mesh-list
153368893|NCT01178216|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153368894|NCT01178216|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153368895|NCT01178216|Immunologic Factors|immunologic factors|mesh-ancestor
153368896|NCT01178216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153368897|NCT01178216|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153368898|NCT01178528|Carvedilol|carvedilol|mesh-list
153368899|NCT01178528|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
153368900|NCT01178528|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
153368901|NCT01178528|Adrenergic Agents|adrenergic agents|mesh-ancestor
153368902|NCT01178528|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153368903|NCT01178528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153368904|NCT01178528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153828858|NCT04697511|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153828859|NCT04697511|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153828860|NCT04697511|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153828871|NCT00485511|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153828872|NCT00485511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153828873|NCT00485511|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153828874|NCT00485498|Olanzapine|olanzapine|mesh-list
153828875|NCT00485498|Risperidone|risperidone|mesh-list
153828876|NCT00485498|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153828877|NCT00485498|Serotonin Agents|serotonin agents|mesh-ancestor
153828878|NCT00485498|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153828879|NCT00485498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153828880|NCT00485498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153828881|NCT00485498|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153828882|NCT00485498|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153828883|NCT00485498|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153828884|NCT00485498|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153828885|NCT00485498|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
153828886|NCT00485498|Dopamine Agents|dopamine agents|mesh-ancestor
153828887|NCT00485498|Antiemetics|antiemetics|mesh-ancestor
153828888|NCT00485498|Autonomic Agents|autonomic agents|mesh-ancestor
153828889|NCT00485498|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153828890|NCT00485498|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153828891|NCT00485498|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
153828892|NCT00485498|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153828893|NCT00485498|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153828895|NCT01302067|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
153828896|NCT01302067|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
153828897|NCT01302067|Cholinergic Agents|cholinergic agents|mesh-ancestor
153828898|NCT01302067|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153828899|NCT01302067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153368916|NCT02980250|Autonomic Agents|autonomic agents|mesh-ancestor
153368917|NCT02980250|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153368918|NCT02980250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153368919|NCT02980250|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153368920|NCT02980250|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
153368921|NCT02980250|Dopamine Agents|dopamine agents|mesh-ancestor
153368922|NCT02980250|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153368923|NCT02980250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153368924|NCT02491437|Progesterone|progesterone|mesh-list
153368925|NCT02491437|Dydrogesterone|dydrogesterone|mesh-list
153368926|NCT02491437|Progestins|progestins|mesh-ancestor
153368928|NCT02491437|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153368929|NCT02491437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153368931|NCT02383758|Glycerol|glycerol|mesh-list
153368932|NCT02383758|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
153368933|NCT02383758|Protective Agents|protective agents|mesh-ancestor
153368934|NCT02383758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153828915|NCT00485628|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
153828916|NCT00485628|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153828917|NCT00485628|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153828918|NCT00485628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153828920|NCT00485628|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153828921|NCT00485628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153828923|NCT00485576|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
153828924|NCT00485576|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153828925|NCT00485576|Immunologic Factors|immunologic factors|mesh-ancestor
153828926|NCT00485576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153828927|NCT00485667|Moxifloxacin|moxifloxacin|mesh-list
153828928|NCT00485667|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153828929|NCT00485667|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153828930|NCT00485667|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153828931|NCT00485667|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153828932|NCT00485667|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153828933|NCT00485667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153828934|NCT00485667|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153828935|NCT00489905|Zoledronic Acid|zoledronic acid|mesh-list
153828936|NCT00489905|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153828937|NCT00489905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153828938|NCT00489944|Tamoxifen|tamoxifen|mesh-list
153828939|NCT00489944|Sunitinib|sunitinib|mesh-list
153828940|NCT00489944|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153828941|NCT00489944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153828942|NCT00489944|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153828943|NCT00489944|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153828944|NCT00489944|Growth Substances|growth substances|mesh-ancestor
153368977|NCT01181258|Glucocorticoids|glucocorticoids|mesh-ancestor
153368979|NCT01181258|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153368980|NCT01181258|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
153368981|NCT01181258|Protective Agents|protective agents|mesh-ancestor
153368982|NCT01181258|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153368983|NCT01181258|Analgesics|analgesics|mesh-ancestor
153368984|NCT01181258|Sensory System Agents|sensory system agents|mesh-ancestor
153368985|NCT02570139|Protective Agents|protective agents|mesh-list
153368987|NCT02410200|Dimethyl Fumarate|dimethyl fumarate|mesh-list
153368993|NCT02409732|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
153368994|NCT02409732|Dermatologic Agents|dermatologic agents|mesh-ancestor
153368997|NCT02494713|Doxorubicin|doxorubicin|mesh-list
153368998|NCT02494713|Estramustine|estramustine|mesh-list
153368999|NCT02494713|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153369000|NCT02494713|Tubulin Modulators|tubulin modulators|mesh-ancestor
153369001|NCT02494713|Antimitotic Agents|antimitotic agents|mesh-ancestor
153369002|NCT02494713|Mitosis Modulators|mitosis modulators|mesh-ancestor
153369003|NCT02494713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153369004|NCT02494713|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153369005|NCT02494713|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153369006|NCT02494713|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153828949|NCT00489944|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
153828950|NCT00489944|Hormone Antagonists|hormone antagonists|mesh-ancestor
153828951|NCT00489944|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153828952|NCT00489944|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153828953|NCT00489944|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
153828954|NCT00489944|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
153828955|NCT00489944|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153828956|NCT00485706|Dialysis Solutions|dialysis solutions|mesh-list
153828957|NCT00485706|Calcium|calcium|mesh-list
153828958|NCT00485706|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153828959|NCT00485706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153828960|NCT00485706|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
153828962|NCT00505947|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
153828963|NCT00505947|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153828964|NCT00505947|Dermatologic Agents|dermatologic agents|mesh-ancestor
153828965|NCT00505947|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153828966|NCT00505947|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153828967|NCT00489983|Gemcitabine|gemcitabine|mesh-list
153828980|NCT01241682|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153828981|NCT01241682|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153828982|NCT01241682|Alkylating Agents|alkylating agents|mesh-ancestor
153828983|NCT01241682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153369008|NCT02494713|Antifungal Agents|antifungal agents|mesh-ancestor
153369009|NCT02494713|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153369010|NCT02494713|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
153369011|NCT02494713|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153369018|NCT02494713|Alkylating Agents|alkylating agents|mesh-ancestor
153369019|NCT02494713|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153369020|NCT02495103|Metformin|metformin|mesh-list
153369021|NCT02495103|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153369022|NCT02495103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153369023|NCT02382276|Nalmefene|nalmefene|mesh-list
153369024|NCT02382276|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
153369025|NCT02382276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153369026|NCT02382276|Sensory System Agents|sensory system agents|mesh-ancestor
153369027|NCT02382276|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153369028|NCT02571153|Ketamine|ketamine|mesh-list
153369029|NCT02571153|Analgesics|analgesics|mesh-ancestor
153369030|NCT02571153|Sensory System Agents|sensory system agents|mesh-ancestor
153369031|NCT02571153|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153369032|NCT02571153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153369033|NCT02571153|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
153369034|NCT02571153|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153369035|NCT02571153|Anesthetics, General|anesthetics, general|mesh-ancestor
153369036|NCT02571153|Anesthetics|anesthetics|mesh-ancestor
153828989|NCT00490178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153828990|NCT00490178|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153828991|NCT00490178|Antimetabolites|antimetabolites|mesh-ancestor
153828995|NCT00485771|Olanzapine|olanzapine|mesh-list
153828996|NCT00485771|Fluoxetine|fluoxetine|mesh-list
153380911|NCT05482451|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153380912|NCT05482451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153380914|NCT05482451|Dermatologic Agents|dermatologic agents|mesh-ancestor
153380915|NCT02228408|Hydralazine|hydralazine|mesh-list
153380916|NCT02228408|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153380917|NCT02228408|Vasodilator Agents|vasodilator agents|mesh-ancestor
153380918|NCT01951391|Benzalkonium Compounds|benzalkonium compounds|mesh-list
153380919|NCT01951391|Triclocarban|triclocarban|mesh-list
153380920|NCT01951391|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
153423608|NCT02213094|Vitamin B Complex|vitamin b complex|mesh-list
153423609|NCT02213094|Micronutrients|micronutrients|mesh-ancestor
153423610|NCT02213094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153423611|NCT02213094|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153423612|NCT02213094|Antimetabolites|antimetabolites|mesh-ancestor
153423613|NCT02213094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153829007|NCT00485771|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153829008|NCT00485771|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153829009|NCT00485771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153829010|NCT00485771|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153829012|NCT00485771|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
153829013|NCT00485771|Antidepressive Agents|antidepressive agents|mesh-ancestor
153369037|NCT02571153|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153369038|NCT02571153|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
153369039|NCT02571153|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
153369040|NCT02571153|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153369041|NCT02571153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153369042|NCT04573322|Trans-sodium crocetinate|trans-sodium crocetinate|mesh-list
153369044|NCT04573322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153369045|NCT04573322|Protective Agents|protective agents|mesh-ancestor
153369046|NCT04573322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153369047|NCT04573322|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
153369048|NCT04573322|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153369049|NCT01143818|Methyltestosterone|methyltestosterone|mesh-list
153369050|NCT01143818|Testosterone|testosterone|mesh-list
153369051|NCT01143818|Testosterone undecanoate|testosterone undecanoate|mesh-list
153369052|NCT01143818|Testosterone enanthate|testosterone enanthate|mesh-list
153369053|NCT01143818|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
153369054|NCT01143818|Androgens|androgens|mesh-ancestor
153369055|NCT01143818|Hormones|hormones|mesh-ancestor
153369056|NCT01143818|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153369057|NCT01143818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153369058|NCT01143818|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153829018|NCT00485771|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153829019|NCT00485771|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153829020|NCT00485771|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153829034|NCT00485810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153369060|NCT01143818|Anabolic Agents|anabolic agents|mesh-ancestor
153369061|NCT02573181|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
153369062|NCT02573181|Immunologic Factors|immunologic factors|mesh-ancestor
153369063|NCT02573181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153369064|NCT02498769|Botulinum Toxins|botulinum toxins|mesh-list
153369065|NCT02498769|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
153369066|NCT02498769|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
153369067|NCT02498769|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
153369068|NCT02498769|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153369069|NCT02498769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153369070|NCT02498769|Cholinergic Agents|cholinergic agents|mesh-ancestor
153369071|NCT02498769|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153369072|NCT02498769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153369076|NCT01650558|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
153369077|NCT01650558|Amebicides|amebicides|mesh-ancestor
153369078|NCT01650558|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153369079|NCT01650558|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153369080|NCT01650558|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153369081|NCT01650558|Antimalarials|antimalarials|mesh-ancestor
153369082|NCT01650558|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153369083|NCT01650558|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
153369084|NCT01650558|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153369085|NCT02579343|Dexetimide|dexetimide|mesh-list
153369086|NCT02579343|Citalopram|citalopram|mesh-list
153369087|NCT02579343|Escitalopram|escitalopram|mesh-list
153829035|NCT00485810|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153829036|NCT00485810|Serotonin Agents|serotonin agents|mesh-ancestor
153829037|NCT00490373|Pemetrexed|pemetrexed|mesh-list
153829038|NCT00490373|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153829039|NCT00490373|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153829059|NCT00485849|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
153829060|NCT00485849|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
153829061|NCT00485849|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153829062|NCT00485849|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153829063|NCT00485849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153829064|NCT00485849|Adrenergic Agents|adrenergic agents|mesh-ancestor
153829065|NCT00485849|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153829066|NCT00485849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153369091|NCT02579343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153369092|NCT02579343|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153369093|NCT02579343|Serotonin Agents|serotonin agents|mesh-ancestor
153369094|NCT02579343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153369095|NCT02579343|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
153369096|NCT02579343|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
153369097|NCT02579343|Parasympatholytics|parasympatholytics|mesh-ancestor
153369098|NCT02579343|Autonomic Agents|autonomic agents|mesh-ancestor
153369099|NCT02579343|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153369100|NCT02579343|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
153369101|NCT02579343|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
153369102|NCT02579343|Cholinergic Agents|cholinergic agents|mesh-ancestor
153369103|NCT02579343|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
153369104|NCT02579343|Antidepressive Agents|antidepressive agents|mesh-ancestor
153369105|NCT02579343|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153369106|NCT01144442|Paclitaxel|paclitaxel|mesh-list
153369107|NCT01144442|Carboplatin|carboplatin|mesh-list
153369108|NCT01144442|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153369109|NCT01144442|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153369113|NCT01144442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153369114|NCT02499081|Ixazomib|ixazomib|mesh-list
153369115|NCT02499081|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153369116|NCT02499081|Protease Inhibitors|protease inhibitors|mesh-ancestor
153369117|NCT02499081|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153369118|NCT02499081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153369119|NCT02380248|Ophthalmic Solutions|ophthalmic solutions|mesh-list
153369120|NCT02380248|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
153369121|NCT02501265|Nicotine|nicotine|mesh-list
153369122|NCT02501265|Varenicline|varenicline|mesh-list
153369123|NCT02501265|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
153829067|NCT00485888|Escitalopram|escitalopram|mesh-list
153829068|NCT00485888|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
153888131|NCT00600977|Doxorubicin|doxorubicin|mesh-list
153829069|NCT00485888|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153829070|NCT00485888|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153829071|NCT00485888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153829072|NCT00485888|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153829073|NCT00485888|Serotonin Agents|serotonin agents|mesh-ancestor
153829074|NCT00485888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153829075|NCT00485862|Sertraline|sertraline|mesh-list
153829076|NCT00485862|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
153829077|NCT00485862|Antidepressive Agents|antidepressive agents|mesh-ancestor
153829078|NCT00485862|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153829079|NCT00485862|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
153829080|NCT00485862|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153380925|NCT02342886|Pyrazinamide|pyrazinamide|mesh-list
153380926|NCT02342886|Ethambutol|ethambutol|mesh-list
153829092|NCT00485901|Autonomic Agents|autonomic agents|mesh-ancestor
153829093|NCT00485901|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153829094|NCT00485901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153829095|NCT00485901|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153829096|NCT00485901|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153829097|NCT00485901|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153369124|NCT02501265|Autonomic Agents|autonomic agents|mesh-ancestor
153369125|NCT02501265|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153369126|NCT02501265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153369127|NCT02501265|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
153369128|NCT02501265|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
153369129|NCT02501265|Cholinergic Agents|cholinergic agents|mesh-ancestor
153369130|NCT02501265|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153369131|NCT02501265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153369132|NCT02408016|Aldesleukin|aldesleukin|mesh-list
153369133|NCT02408016|Cyclophosphamide|cyclophosphamide|mesh-list
153369134|NCT02408016|Interleukin-2|interleukin-2|mesh-list
153369135|NCT02408016|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153369136|NCT02408016|Immunologic Factors|immunologic factors|mesh-ancestor
153369137|NCT02408016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153369138|NCT02408016|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153369141|NCT02408016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153369142|NCT02408016|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153369143|NCT02408016|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153369144|NCT02408016|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153369145|NCT02408016|Analgesics|analgesics|mesh-ancestor
153369146|NCT02408016|Sensory System Agents|sensory system agents|mesh-ancestor
153369147|NCT02408016|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153369148|NCT02408016|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153829110|NCT00490412|Vitamins|vitamins|mesh-ancestor
153829111|NCT00490412|Micronutrients|micronutrients|mesh-ancestor
153829112|NCT00490412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153829113|NCT00490412|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153829114|NCT00485940|Prucalopride|prucalopride|mesh-list
153829115|NCT00485940|Laxatives|laxatives|mesh-ancestor
153829116|NCT00485940|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153829117|NCT00485940|Serotonin 5-HT4 Receptor Agonists|serotonin 5-ht4 receptor agonists|mesh-ancestor
153829118|NCT00485940|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
153829119|NCT00485940|Serotonin Agents|serotonin agents|mesh-ancestor
153829120|NCT00485940|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153829121|NCT00485940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153829122|NCT00485940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153369149|NCT02408016|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153369150|NCT02408016|Antiviral Agents|antiviral agents|mesh-ancestor
153369151|NCT02408016|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153369152|NCT02579421|Progesterone|progesterone|mesh-list
153369153|NCT02579421|Progestins|progestins|mesh-ancestor
153369154|NCT02579421|Hormones|hormones|mesh-ancestor
153369155|NCT02579421|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153369156|NCT02579421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153369157|NCT00422175|Siponimod|siponimod|mesh-list
153369158|NCT00422175|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
153369172|NCT01186406|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153369173|NCT01186406|Growth Substances|growth substances|mesh-ancestor
153369174|NCT01186406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153369175|NCT01186406|Growth Inhibitors|growth inhibitors|mesh-ancestor
153369176|NCT01186406|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153369177|NCT01186406|Alkylating Agents|alkylating agents|mesh-ancestor
153369178|NCT01186406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153369179|NCT02407704|Lorazepam|lorazepam|mesh-list
153369180|NCT02407704|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
153369181|NCT02407704|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
153369182|NCT02407704|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153829123|NCT00486005|Olanzapine|olanzapine|mesh-list
153829124|NCT00486005|Nizatidine|nizatidine|mesh-list
153829125|NCT00486005|Antiemetics|antiemetics|mesh-ancestor
153829126|NCT00486005|Autonomic Agents|autonomic agents|mesh-ancestor
153829127|NCT00486005|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153829128|NCT00486005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153829129|NCT00486005|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153829130|NCT00486005|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153829131|NCT00486005|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153829132|NCT00486005|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153829133|NCT00486005|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153829137|NCT00486005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153829138|NCT00486005|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153829140|NCT00486005|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
153829141|NCT00486005|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
153829142|NCT00486005|Histamine Antagonists|histamine antagonists|mesh-ancestor
153829143|NCT00486005|Histamine Agents|histamine agents|mesh-ancestor
153829144|NCT00485979|Docetaxel|docetaxel|mesh-list
153829145|NCT00485979|Trastuzumab|trastuzumab|mesh-list
153829146|NCT00485979|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153829147|NCT00485979|Tubulin Modulators|tubulin modulators|mesh-ancestor
153829148|NCT00485979|Antimitotic Agents|antimitotic agents|mesh-ancestor
153829149|NCT00485979|Mitosis Modulators|mitosis modulators|mesh-ancestor
153829150|NCT00485979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153829151|NCT00485979|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153829152|NCT00486083|Methylphenidate|methylphenidate|mesh-list
153829153|NCT00486083|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
153829154|NCT00486083|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
153829155|NCT00486083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153369213|NCT02581839|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153369214|NCT02581839|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153369215|NCT02581839|Protease Inhibitors|protease inhibitors|mesh-ancestor
153369216|NCT02581839|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153369222|NCT02504775|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153369234|NCT02504931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153369235|NCT02584725|Tranexamic Acid|tranexamic acid|mesh-list
153369236|NCT02584725|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
153369237|NCT02584725|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153369238|NCT02584725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153369239|NCT02584725|Hemostatics|hemostatics|mesh-ancestor
153369240|NCT02584725|Coagulants|coagulants|mesh-ancestor
153369242|NCT04423029|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153369243|NCT04423029|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153829209|NCT00486213|Vitamins|vitamins|mesh-ancestor
153829210|NCT00486213|Micronutrients|micronutrients|mesh-ancestor
153829211|NCT00486213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153829212|NCT00486369|Calcitonin|calcitonin|mesh-list
153829213|NCT00486369|Salmon calcitonin|salmon calcitonin|mesh-list
153829214|NCT00486369|Calcitonin Gene-Related Peptide|calcitonin gene-related peptide|mesh-list
153829215|NCT00486369|Katacalcin|katacalcin|mesh-list
153829216|NCT00486369|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153829217|NCT00486369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153829218|NCT00486369|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153829219|NCT00486369|Vasodilator Agents|vasodilator agents|mesh-ancestor
153829220|NCT00490997|Ketamine|ketamine|mesh-list
153829221|NCT00490997|Propofol|propofol|mesh-list
153829222|NCT00490997|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153829223|NCT00490997|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153829224|NCT00490997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153829225|NCT00490997|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153829226|NCT00490997|Anesthetics, General|anesthetics, general|mesh-ancestor
153829227|NCT00490997|Anesthetics|anesthetics|mesh-ancestor
153369254|NCT01186562|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153369255|NCT01186562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153369256|NCT01187498|Oxybutynin|oxybutynin|mesh-list
153369257|NCT01187498|Parasympatholytics|parasympatholytics|mesh-ancestor
153369258|NCT01187498|Autonomic Agents|autonomic agents|mesh-ancestor
153369259|NCT01187498|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153369260|NCT01187498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153369261|NCT01187498|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
153369262|NCT01187498|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
153369263|NCT01187498|Cholinergic Agents|cholinergic agents|mesh-ancestor
153369264|NCT01187498|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153369265|NCT01187498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153829233|NCT00490997|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
153829234|NCT00490997|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153829235|NCT00490997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153829236|NCT04511637|Rivaroxaban|rivaroxaban|mesh-list
153829237|NCT04511637|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
153829238|NCT04511637|Antithrombins|antithrombins|mesh-ancestor
153829239|NCT04511637|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
153829240|NCT04511637|Protease Inhibitors|protease inhibitors|mesh-ancestor
153829241|NCT04511637|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153829242|NCT04511637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153829243|NCT04511637|Anticoagulants|anticoagulants|mesh-ancestor
153829244|NCT00486486|Timolol|timolol|mesh-list
153829245|NCT00486486|Bimatoprost|bimatoprost|mesh-list
153829246|NCT00486486|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
153829247|NCT00486486|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
153829248|NCT00486486|Adrenergic Agents|adrenergic agents|mesh-ancestor
153829249|NCT00486486|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153829250|NCT00486486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153829251|NCT00486486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153829252|NCT00486486|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153829253|NCT00486486|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153829254|NCT00491114|Gemcitabine|gemcitabine|mesh-list
153829255|NCT00491114|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153829256|NCT00491114|Antimetabolites|antimetabolites|mesh-ancestor
153369283|NCT01149434|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153369294|NCT01150838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153369295|NCT01150838|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153369296|NCT01150838|Anesthetics, General|anesthetics, general|mesh-ancestor
153369297|NCT01150838|Anesthetics|anesthetics|mesh-ancestor
153369298|NCT01189292|Dexamethasone|dexamethasone|mesh-list
153369299|NCT01189292|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153369300|NCT01189292|Antiemetics|antiemetics|mesh-ancestor
153369301|NCT01189292|Autonomic Agents|autonomic agents|mesh-ancestor
153369302|NCT01189292|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153829265|NCT00486668|Cyclophosphamide|cyclophosphamide|mesh-list
153829267|NCT00486668|Trastuzumab|trastuzumab|mesh-list
153829268|NCT00486668|Lapatinib|lapatinib|mesh-list
153829269|NCT00486668|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153829270|NCT00486668|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153369310|NCT01189370|Sorafenib|sorafenib|mesh-list
153369311|NCT01189370|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153369329|NCT03010202|Autonomic Agents|autonomic agents|mesh-ancestor
153369330|NCT03010202|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153369331|NCT03010202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153829285|NCT00486668|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153829286|NCT00486668|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153829287|NCT00486668|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153829288|NCT00486668|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153829289|NCT04510935|Anesthetics|anesthetics|mesh-list
153829290|NCT04510935|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153829291|NCT04510935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153829292|NCT00491192|Diclofenac|diclofenac|mesh-list
153829293|NCT00491192|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153829294|NCT00491192|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153829295|NCT00491192|Analgesics|analgesics|mesh-ancestor
153829296|NCT00491192|Sensory System Agents|sensory system agents|mesh-ancestor
153829297|NCT00491192|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153829298|NCT00491192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153829299|NCT00491192|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153829300|NCT00491192|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153829301|NCT00491192|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153829302|NCT00491192|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153829303|NCT00491192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153829304|NCT00486798|Quetiapine Fumarate|quetiapine fumarate|mesh-list
153369332|NCT03010202|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153369333|NCT03010202|Glucocorticoids|glucocorticoids|mesh-ancestor
153369349|NCT01191320|Fertility Agents|fertility agents|mesh-ancestor
153369350|NCT01191320|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153369351|NCT01191320|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
153369352|NCT01191320|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
153369353|NCT01151852|Imatinib Mesylate|imatinib mesylate|mesh-list
153369354|NCT01151852|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153369355|NCT01151852|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153429230|NCT00002582|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153829318|NCT00486785|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
153829319|NCT00486785|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
153829320|NCT00486785|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
153829321|NCT00486785|Adrenergic Agents|adrenergic agents|mesh-ancestor
153829322|NCT00486785|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153829323|NCT00486785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153829324|NCT00486785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153829325|NCT00486785|Urological Agents|urological agents|mesh-ancestor
153829326|NCT04324411|Sirolimus|sirolimus|mesh-list
153829327|NCT04324411|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153829328|NCT04324411|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153369356|NCT01151852|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153369357|NCT01151852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153369358|NCT01151852|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153369359|NCT01191398|Atropine|atropine|mesh-list
153369360|NCT01191398|Glycopyrrolate|glycopyrrolate|mesh-list
153888139|NCT00601211|Pilocarpine|pilocarpine|mesh-list
153369361|NCT01191398|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153369362|NCT01191398|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153369363|NCT01191398|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153369374|NCT01191398|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153369375|NCT01191398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153369376|NCT01191476|Propofol|propofol|mesh-list
153369377|NCT01191476|Sevoflurane|sevoflurane|mesh-list
153369378|NCT01191476|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153369379|NCT01191476|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153369380|NCT01191476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153829332|NCT04324411|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153829333|NCT04324411|Immunologic Factors|immunologic factors|mesh-ancestor
153829334|NCT04324411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153829336|NCT00486876|Antidepressive Agents|antidepressive agents|mesh-ancestor
153829337|NCT00486876|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153829338|NCT05643586|Ticagrelor|ticagrelor|mesh-list
153829339|NCT05643586|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
153829340|NCT05643586|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153888153|NCT00601289|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153829346|NCT05643586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153829347|NCT05643586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153829348|NCT01242072|Isophosphamide mustard|isophosphamide mustard|mesh-list
153829349|NCT01242072|Ifosfamide|ifosfamide|mesh-list
153829350|NCT01242072|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153829351|NCT01242072|Alkylating Agents|alkylating agents|mesh-ancestor
153829352|NCT01242072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153829353|NCT01242072|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153829354|NCT00491348|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
153829355|NCT00491348|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
153369393|NCT01194674|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153369394|NCT01194674|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153369395|NCT01194674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153369396|NCT02509767|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
153369397|NCT02509767|Medroxyprogesterone|medroxyprogesterone|mesh-list
153369398|NCT02509767|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
153369399|NCT02509767|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
153369400|NCT02509767|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
153369407|NCT02509767|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153369408|NCT02509767|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153369410|NCT01154192|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
153888157|NCT00601913|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153369411|NCT01154192|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153369412|NCT01154192|Antiemetics|antiemetics|mesh-ancestor
153369413|NCT01154192|Autonomic Agents|autonomic agents|mesh-ancestor
153369414|NCT01154192|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153369415|NCT01154192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153888159|NCT00601913|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153829378|NCT01242098|Dermatologic Agents|dermatologic agents|mesh-ancestor
153829379|NCT01242098|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
153829380|NCT01242098|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
153829381|NCT01242098|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
153829382|NCT01242098|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153829383|NCT01242098|Adrenergic Agents|adrenergic agents|mesh-ancestor
153829384|NCT01242098|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153829385|NCT01242098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153829386|NCT01242098|Glucocorticoids|glucocorticoids|mesh-ancestor
153369423|NCT02511561|Ciprofloxacin|ciprofloxacin|mesh-list
153369424|NCT02511561|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153369425|NCT02511561|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153369438|NCT01195922|Antifungal Agents|antifungal agents|mesh-ancestor
153369439|NCT01195922|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153369440|NCT01195922|Immunologic Factors|immunologic factors|mesh-ancestor
153369441|NCT01195922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153369442|NCT02512575|Prednisolone|prednisolone|mesh-list
153369443|NCT02512575|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153829388|NCT01242098|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153829389|NCT01301092|Dulaglutide|dulaglutide|mesh-list
153829390|NCT01301092|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
153829391|NCT01301092|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153829395|NCT04510623|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153829396|NCT04510623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153829397|NCT04510818|Capecitabine|capecitabine|mesh-list
153829398|NCT04510818|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153829399|NCT04510818|Antimetabolites|antimetabolites|mesh-ancestor
153829400|NCT04510818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153829403|NCT05642689|Trace Elements|trace elements|mesh-ancestor
153829404|NCT05642689|Micronutrients|micronutrients|mesh-ancestor
153829405|NCT05642689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153829407|NCT01300819|Dopamine Agonists|dopamine agonists|mesh-ancestor
153829408|NCT01300819|Dopamine Agents|dopamine agents|mesh-ancestor
153829409|NCT01300819|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153829410|NCT01300819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153829411|NCT01300819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153829412|NCT00486980|Peramivir|peramivir|mesh-list
153829413|NCT00486980|Antiviral Agents|antiviral agents|mesh-ancestor
153829414|NCT00486980|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153829415|NCT00486980|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153369444|NCT02512575|Glucocorticoids|glucocorticoids|mesh-ancestor
153369452|NCT01199744|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153369453|NCT01199744|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153369454|NCT01199744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153369455|NCT03702374|Antioxidants|antioxidants|mesh-list
153369456|NCT03702374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153369457|NCT03702374|Protective Agents|protective agents|mesh-ancestor
153369458|NCT03702374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153829429|NCT02275962|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
153829430|NCT02275962|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
153369459|NCT02512809|Dexmedetomidine|dexmedetomidine|mesh-list
153369460|NCT02512809|Isoflurane|isoflurane|mesh-list
153369461|NCT02512809|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153369462|NCT02512809|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153369463|NCT02512809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153369464|NCT02512809|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153369465|NCT02512809|Analgesics|analgesics|mesh-ancestor
153369466|NCT02512809|Sensory System Agents|sensory system agents|mesh-ancestor
153369467|NCT02512809|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153369468|NCT02512809|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
153369469|NCT02512809|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153369470|NCT02512809|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153369471|NCT02512809|Adrenergic Agents|adrenergic agents|mesh-ancestor
153369472|NCT02512809|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153369473|NCT02512809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153369474|NCT02512809|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
153369475|NCT02512809|Anesthetics, General|anesthetics, general|mesh-ancestor
153369476|NCT02512809|Anesthetics|anesthetics|mesh-ancestor
153369477|NCT01201772|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
153369478|NCT01201772|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153369479|NCT01202162|Sevoflurane|sevoflurane|mesh-list
153369480|NCT01202162|Desflurane|desflurane|mesh-list
153369481|NCT01202162|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153369482|NCT01202162|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
153369483|NCT01202162|Anesthetics, General|anesthetics, general|mesh-ancestor
153369484|NCT01202162|Anesthetics|anesthetics|mesh-ancestor
153369485|NCT01202162|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153369486|NCT01202162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153369487|NCT01159262|Midazolam|midazolam|mesh-list
153369488|NCT01159262|Fentanyl|fentanyl|mesh-list
153829431|NCT02275962|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
153829432|NCT02275962|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
153369489|NCT01159262|Dexmedetomidine|dexmedetomidine|mesh-list
153829441|NCT00487032|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153829442|NCT00487032|Autonomic Agents|autonomic agents|mesh-ancestor
153829443|NCT00487032|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153829444|NCT00487032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153829445|NCT00487032|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153829446|NCT00487032|Respiratory System Agents|respiratory system agents|mesh-ancestor
153829447|NCT00487032|Dermatologic Agents|dermatologic agents|mesh-ancestor
153829448|NCT00487032|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
153829449|NCT00487032|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153829450|NCT00487032|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153829451|NCT00487032|Adrenergic Agents|adrenergic agents|mesh-ancestor
153829452|NCT00487032|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153829453|NCT00487032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153829454|NCT00487032|Sympathomimetics|sympathomimetics|mesh-ancestor
153829455|NCT00487032|Nasal Decongestants|nasal decongestants|mesh-ancestor
153829456|NCT00487032|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
153829457|NCT00487032|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
153829458|NCT00487032|Mydriatics|mydriatics|mesh-ancestor
153369508|NCT01159262|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153369509|NCT01159262|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153369510|NCT01159262|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153369511|NCT01159262|Anesthetics, General|anesthetics, general|mesh-ancestor
153369512|NCT01159262|Anesthetics|anesthetics|mesh-ancestor
153369514|NCT01159262|GABA Agents|gaba agents|mesh-ancestor
153369515|NCT03011060|Capecitabine|capecitabine|mesh-list
153369516|NCT03011060|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153369517|NCT03011060|Antimetabolites|antimetabolites|mesh-ancestor
153369518|NCT03011060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153369519|NCT03011060|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153369520|NCT03010670|Oxytocin|oxytocin|mesh-list
153369521|NCT03010670|Oxytocics|oxytocics|mesh-ancestor
153369522|NCT03010670|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153369523|NCT03010670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153369524|NCT04377711|Ciclesonide|ciclesonide|mesh-list
153369525|NCT04377711|Glucocorticoids|glucocorticoids|mesh-ancestor
153369526|NCT04377711|Hormones|hormones|mesh-ancestor
153369527|NCT04377711|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153369528|NCT04377711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153369529|NCT04377711|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
153369530|NCT04366713|Capecitabine|capecitabine|mesh-list
153369531|NCT04366713|Loperamide|loperamide|mesh-list
153369532|NCT04366713|Antidiarrheals|antidiarrheals|mesh-list
153369533|NCT04366713|Neratinib|neratinib|mesh-list
153369542|NCT03413384|Ceftriaxone|ceftriaxone|mesh-list
153829476|NCT00491426|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153829477|NCT00491426|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153829478|NCT00491426|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153829479|NCT00491426|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
153829480|NCT00491426|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153829481|NCT00491426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153829482|NCT00491426|Amebicides|amebicides|mesh-ancestor
153829483|NCT00491426|Antifungal Agents|antifungal agents|mesh-ancestor
153829484|NCT00491426|Antiviral Agents|antiviral agents|mesh-ancestor
153829485|NCT01300546|Naproxen|naproxen|mesh-list
153829486|NCT01300546|Sumatriptan|sumatriptan|mesh-list
153829487|NCT01300546|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153829488|NCT01300546|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153829489|NCT01300546|Analgesics|analgesics|mesh-ancestor
153829490|NCT01300546|Sensory System Agents|sensory system agents|mesh-ancestor
153829491|NCT01300546|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153829492|NCT01300546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153829508|NCT00487110|Sensory System Agents|sensory system agents|mesh-ancestor
153829509|NCT00487110|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153829510|NCT00487110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153829511|NCT00487110|Antipyretics|antipyretics|mesh-ancestor
153829512|NCT00487110|Antiemetics|antiemetics|mesh-ancestor
153829513|NCT00487110|Autonomic Agents|autonomic agents|mesh-ancestor
153829514|NCT00487110|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153829521|NCT00487136|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
153829522|NCT00487136|Fenofibric acid|fenofibric acid|mesh-list
153829523|NCT00487136|Fenofibrate|fenofibrate|mesh-list
153829524|NCT00487136|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153829525|NCT00487136|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153829526|NCT00487136|Antimetabolites|antimetabolites|mesh-ancestor
153829527|NCT00487136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153829528|NCT00487136|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153829529|NCT00487136|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
153829530|NCT00487136|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153829531|NCT00487136|Anticoagulants|anticoagulants|mesh-ancestor
153829532|NCT02276001|Cyclosporine|cyclosporine|mesh-list
153829533|NCT02276001|Cyclosporins|cyclosporins|mesh-list
153829534|NCT02276001|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153829535|NCT02276001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153829536|NCT02276001|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153829537|NCT02276001|Immunologic Factors|immunologic factors|mesh-ancestor
153829538|NCT02276001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153829539|NCT02276001|Antifungal Agents|antifungal agents|mesh-ancestor
153829540|NCT02276001|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153829541|NCT02276001|Dermatologic Agents|dermatologic agents|mesh-ancestor
153829542|NCT02276001|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153369570|NCT00363753|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
153369571|NCT00363753|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
153369572|NCT00363753|Purinergic Agents|purinergic agents|mesh-ancestor
153369573|NCT00363753|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153369574|NCT02434770|Vaccines|vaccines|mesh-list
153369575|NCT02434770|Immunologic Factors|immunologic factors|mesh-ancestor
153369576|NCT02434770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153369577|NCT01203644|Bupivacaine|bupivacaine|mesh-list
153369578|NCT01203644|Anesthetics, Local|anesthetics, local|mesh-ancestor
153369579|NCT01203644|Anesthetics|anesthetics|mesh-ancestor
153369580|NCT01203644|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153369581|NCT01203644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153369594|NCT02433834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153369595|NCT02433834|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153369596|NCT02433834|Autonomic Agents|autonomic agents|mesh-ancestor
153369597|NCT02433834|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153369598|NCT02433834|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153369599|NCT02433834|Respiratory System Agents|respiratory system agents|mesh-ancestor
153369600|NCT02433834|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
153369601|NCT02433834|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
153369602|NCT02433834|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153369603|NCT02433834|Adrenergic Agents|adrenergic agents|mesh-ancestor
153369605|NCT02433678|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
153829543|NCT02276001|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
153829544|NCT00491582|Hormones|hormones|mesh-list
153829545|NCT00491582|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153829546|NCT00491582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153829547|NCT00487175|Tramadol|tramadol|mesh-list
153829548|NCT00487175|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153829549|NCT00487175|Narcotics|narcotics|mesh-ancestor
153829550|NCT00487175|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153829551|NCT00487175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153829552|NCT00487175|Analgesics|analgesics|mesh-ancestor
153829553|NCT00487175|Sensory System Agents|sensory system agents|mesh-ancestor
153829554|NCT00487175|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153829555|NCT00487227|Caffeine|caffeine|mesh-list
153829556|NCT00487227|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
153829557|NCT00487227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153829558|NCT00487227|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
153829559|NCT00487227|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153829572|NCT01300351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153829573|NCT00487253|Miltefosine|miltefosine|mesh-list
153829574|NCT00487253|Meglumine Antimoniate|meglumine antimoniate|mesh-list
153829575|NCT00487253|Antifungal Agents|antifungal agents|mesh-ancestor
153829576|NCT00487253|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153369606|NCT02433678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153369607|NCT02433678|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153369608|NCT02433678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153369609|NCT00363909|Dexetimide|dexetimide|mesh-list
153369610|NCT00363909|Citalopram|citalopram|mesh-list
153369611|NCT00363909|Escitalopram|escitalopram|mesh-list
153369612|NCT00363909|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
153369613|NCT00363909|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153369614|NCT00363909|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153369615|NCT00363909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153369616|NCT00363909|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153369617|NCT00363909|Serotonin Agents|serotonin agents|mesh-ancestor
153369618|NCT00363909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153369619|NCT00363909|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
153369620|NCT00363909|Antidepressive Agents|antidepressive agents|mesh-ancestor
153369621|NCT00363909|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153369622|NCT00363909|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
153369623|NCT00363909|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
153369624|NCT00363909|Parasympatholytics|parasympatholytics|mesh-ancestor
153369625|NCT00363909|Autonomic Agents|autonomic agents|mesh-ancestor
153369626|NCT00363909|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153369627|NCT00363909|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
153369628|NCT00363909|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
153369629|NCT00363909|Cholinergic Agents|cholinergic agents|mesh-ancestor
153369630|NCT01205828|Temozolomide|temozolomide|mesh-list
153369631|NCT01205828|Veliparib|veliparib|mesh-list
153369632|NCT01205828|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153369633|NCT01205828|Alkylating Agents|alkylating agents|mesh-ancestor
153369634|NCT01205828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153829580|NCT04510233|Ivermectin|ivermectin|mesh-list
153829581|NCT04510233|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153829582|NCT04510233|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153829583|NCT05641909|Fentanyl|fentanyl|mesh-list
153829584|NCT05641909|Remifentanil|remifentanil|mesh-list
153829585|NCT05641909|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153829586|NCT05641909|Narcotics|narcotics|mesh-ancestor
153829587|NCT05641909|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153829588|NCT05641909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153829589|NCT05641909|Analgesics|analgesics|mesh-ancestor
153829590|NCT05641909|Sensory System Agents|sensory system agents|mesh-ancestor
153829591|NCT05641909|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153829592|NCT05641909|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153829593|NCT05641909|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153829594|NCT05641909|Anesthetics, General|anesthetics, general|mesh-ancestor
153829595|NCT05641909|Anesthetics|anesthetics|mesh-ancestor
153829596|NCT02276196|Insulin glulisine|insulin glulisine|mesh-list
153829597|NCT02276196|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153369644|NCT02515305|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
153369646|NCT02515305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153369647|NCT02515305|Dermatologic Agents|dermatologic agents|mesh-ancestor
153369648|NCT01206452|Prednisone|prednisone|mesh-list
153369649|NCT01206452|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153369650|NCT01206452|Glucocorticoids|glucocorticoids|mesh-ancestor
153369651|NCT01206452|Hormones|hormones|mesh-ancestor
153369652|NCT01206452|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153829623|NCT00491816|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
153829624|NCT00491816|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153829625|NCT00491816|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153829626|NCT00491816|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153369653|NCT01206452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153369654|NCT01206452|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153369655|NCT01206452|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153369656|NCT01206608|Bupivacaine|bupivacaine|mesh-list
153369657|NCT01206608|Anesthetics, Local|anesthetics, local|mesh-ancestor
153369658|NCT01206608|Anesthetics|anesthetics|mesh-ancestor
153369659|NCT01206608|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153369660|NCT01206608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153369661|NCT01206608|Sensory System Agents|sensory system agents|mesh-ancestor
153369662|NCT01206608|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153829627|NCT00491816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153829628|NCT00491816|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153829629|NCT00491855|Paclitaxel|paclitaxel|mesh-list
153829630|NCT00491855|Bevacizumab|bevacizumab|mesh-list
153829631|NCT00491855|Oxaliplatin|oxaliplatin|mesh-list
153829632|NCT00491855|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153829633|NCT00491855|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153829634|NCT00491855|Tubulin Modulators|tubulin modulators|mesh-ancestor
153829635|NCT00491855|Antimitotic Agents|antimitotic agents|mesh-ancestor
153829636|NCT00491855|Mitosis Modulators|mitosis modulators|mesh-ancestor
153829637|NCT00491855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153829638|NCT00491855|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153829649|NCT00487448|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153829650|NCT00487448|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153369681|NCT02517021|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153369682|NCT02517021|Glucocorticoids|glucocorticoids|mesh-ancestor
153369683|NCT02517021|Hormones|hormones|mesh-ancestor
153369684|NCT02517021|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153369685|NCT02517021|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153369686|NCT02517021|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153369687|NCT02517021|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
153369688|NCT02517021|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153369689|NCT02517021|Serotonin Agents|serotonin agents|mesh-ancestor
153369690|NCT02517021|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153369691|NCT02517021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153369692|NCT05859217|Atezolizumab|atezolizumab|mesh-list
153369693|NCT05859217|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153369694|NCT05859217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153369695|NCT05859217|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153369701|NCT05858645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153369703|NCT05858177|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153369704|NCT05858177|Alkylating Agents|alkylating agents|mesh-ancestor
153369705|NCT05858177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153369706|NCT05858177|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153369707|NCT05857982|Dexamethasone|dexamethasone|mesh-list
153369708|NCT05857982|Daratumumab|daratumumab|mesh-list
153369709|NCT05857982|Mitoxantrone|mitoxantrone|mesh-list
153369710|NCT05857982|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153369712|NCT05857982|Autonomic Agents|autonomic agents|mesh-ancestor
153369713|NCT05857982|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153369714|NCT05857982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153369715|NCT05857982|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153369722|NCT05857982|Sensory System Agents|sensory system agents|mesh-ancestor
153369723|NCT05857982|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153369724|NCT05857982|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153369725|NCT05857982|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153369726|NCT05857982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153369727|NCT05857891|Epoetin Alfa|epoetin alfa|mesh-list
153369728|NCT05857891|Hematinics|hematinics|mesh-ancestor
153829671|NCT00506298|Antimetabolites|antimetabolites|mesh-ancestor
153829672|NCT00506298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153829673|NCT00506298|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153829674|NCT00506298|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153369732|NCT05836025|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153369733|NCT05836025|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153369734|NCT05836025|Antifungal Agents|antifungal agents|mesh-ancestor
153369735|NCT05836025|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153369736|NCT05836025|Immunologic Factors|immunologic factors|mesh-ancestor
153369737|NCT05836025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153369738|NCT05794971|Irinotecan|irinotecan|mesh-list
153369739|NCT05794971|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
153369740|NCT05794971|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153369741|NCT05794971|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153369742|NCT05794971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153369743|NCT05794971|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153369744|NCT05785195|Nitric Oxide|nitric oxide|mesh-list
153369752|NCT05785195|Antioxidants|antioxidants|mesh-ancestor
153369753|NCT05785195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153369754|NCT05785195|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153369755|NCT05785195|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
153369756|NCT05785195|Vasodilator Agents|vasodilator agents|mesh-ancestor
153369757|NCT05785195|Gasotransmitters|gasotransmitters|mesh-ancestor
153369758|NCT05785195|Protective Agents|protective agents|mesh-ancestor
153829704|NCT01242228|Hormones|hormones|mesh-ancestor
153829705|NCT01242228|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153829706|NCT01242228|Protease Inhibitors|protease inhibitors|mesh-ancestor
153829707|NCT01242228|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153829708|NCT01242228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153829709|NCT01242228|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
153829710|NCT01242306|Acetylcholine|acetylcholine|mesh-list
153829711|NCT01242306|Vasodilator Agents|vasodilator agents|mesh-ancestor
153829712|NCT01242306|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
153829713|NCT01242306|Cholinergic Agents|cholinergic agents|mesh-ancestor
153829714|NCT01242306|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153829715|NCT01242306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153829716|NCT01242306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153829717|NCT00492128|Losartan|losartan|mesh-list
153829718|NCT00492128|Amlodipine|amlodipine|mesh-list
153829719|NCT00492128|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
153829720|NCT00492128|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153829721|NCT00492128|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153829722|NCT00492128|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153829723|NCT00492128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153829724|NCT00492128|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153829725|NCT00492128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153829726|NCT00492128|Vasodilator Agents|vasodilator agents|mesh-ancestor
153829727|NCT00492128|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153829738|NCT00487734|Androgens|androgens|mesh-ancestor
153829739|NCT00487734|Hormones|hormones|mesh-ancestor
153829740|NCT00487734|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153829741|NCT00487734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153829742|NCT00487734|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153829743|NCT00487734|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153829744|NCT00487734|Anabolic Agents|anabolic agents|mesh-ancestor
153829745|NCT01300234|Tenofovir|tenofovir|mesh-list
153829746|NCT01300234|Adefovir|adefovir|mesh-list
153829747|NCT01300234|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
153369774|NCT05655273|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153369776|NCT05624151|Magnesium Sulfate|magnesium sulfate|mesh-list
153369780|NCT05624151|Anesthetics|anesthetics|mesh-ancestor
153369781|NCT05624151|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153369782|NCT05624151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153369783|NCT05624151|Sensory System Agents|sensory system agents|mesh-ancestor
153369784|NCT05624151|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153369785|NCT05624151|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153369786|NCT05624151|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153369787|NCT05624151|Analgesics|analgesics|mesh-ancestor
153369788|NCT05624151|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
153369789|NCT05624151|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153369790|NCT05624151|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153369791|NCT05624151|Adrenergic Agents|adrenergic agents|mesh-ancestor
153369792|NCT05624151|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153369793|NCT05624151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153369794|NCT05624151|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153369795|NCT05624151|Anticonvulsants|anticonvulsants|mesh-ancestor
153369796|NCT05624151|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153369797|NCT05624151|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153369798|NCT05624151|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153369799|NCT05624151|Tocolytic Agents|tocolytic agents|mesh-ancestor
153369800|NCT05624151|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153369801|NCT05584007|Floxacillin|floxacillin|mesh-list
153369802|NCT05584007|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153369803|NCT05584007|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153369804|NCT05570292|Folic Acid|folic acid|mesh-list
153369805|NCT05570292|Domperidone|domperidone|mesh-list
153369806|NCT05570292|Hematinics|hematinics|mesh-ancestor
153369807|NCT05570292|Vitamin B Complex|vitamin b complex|mesh-ancestor
153369808|NCT05570292|Vitamins|vitamins|mesh-ancestor
153369809|NCT05570292|Micronutrients|micronutrients|mesh-ancestor
153829758|NCT01242332|Sensory System Agents|sensory system agents|mesh-ancestor
153829759|NCT01242332|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153829760|NCT01242332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153829761|NCT01242332|Anticonvulsants|anticonvulsants|mesh-ancestor
153829762|NCT01242332|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153829763|NCT01242332|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153829764|NCT01242332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153829765|NCT01242332|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153829766|NCT01242332|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153829767|NCT01242332|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153829768|NCT01242332|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153829769|NCT01242332|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153829770|NCT00487773|Cholecalciferol|cholecalciferol|mesh-list
153829771|NCT00487773|Budesonide|budesonide|mesh-list
153829772|NCT00487773|Albuterol|albuterol|mesh-list
153829773|NCT00487773|Montelukast|montelukast|mesh-list
153829774|NCT00487773|Vitamins|vitamins|mesh-ancestor
153829775|NCT00487773|Micronutrients|micronutrients|mesh-ancestor
153829776|NCT00487773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153829777|NCT00487773|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153829778|NCT00487773|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153829779|NCT00487773|Autonomic Agents|autonomic agents|mesh-ancestor
153829780|NCT00487773|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153829781|NCT00487773|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153829782|NCT00487773|Respiratory System Agents|respiratory system agents|mesh-ancestor
153829783|NCT00487773|Glucocorticoids|glucocorticoids|mesh-ancestor
153369812|NCT05570292|Autonomic Agents|autonomic agents|mesh-ancestor
153369813|NCT05570292|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153369814|NCT05570292|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153369815|NCT05570292|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
153369816|NCT05570292|Dopamine Agents|dopamine agents|mesh-ancestor
153369817|NCT05570292|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153369818|NCT05570292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153369822|NCT05545891|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153369823|NCT05545891|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153429260|NCT02239627|Adrenergic Agents|adrenergic agents|mesh-ancestor
153369824|NCT05545891|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153369825|NCT05545891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153369826|NCT05545891|Dopamine Agonists|dopamine agonists|mesh-ancestor
153369827|NCT05545891|Dopamine Agents|dopamine agents|mesh-ancestor
153369828|NCT05545891|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153369829|NCT05545891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153369830|NCT05545891|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
153369831|NCT05545891|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
153369832|NCT05545891|Serotonin Agents|serotonin agents|mesh-ancestor
153369833|NCT05545891|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
153369834|NCT05545891|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153369835|NCT05545891|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
153369836|NCT05545891|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
153369837|NCT05528458|Osimertinib|osimertinib|mesh-list
153369838|NCT05528458|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153369839|NCT05528458|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153369840|NCT05528458|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153369841|NCT05528458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153829784|NCT00487773|Hormones|hormones|mesh-ancestor
153829785|NCT00487773|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153829786|NCT00487773|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
153829787|NCT00487773|Hormone Antagonists|hormone antagonists|mesh-ancestor
153829788|NCT00487773|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
153829789|NCT00487773|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
153829790|NCT00487773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153829791|NCT00487773|Tocolytic Agents|tocolytic agents|mesh-ancestor
153829792|NCT00487773|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153829793|NCT00487773|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
153829794|NCT00487773|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
153829795|NCT00487773|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153829812|NCT00492245|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153829813|NCT00492245|Alkylating Agents|alkylating agents|mesh-ancestor
153829814|NCT00492245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153829815|NCT00492245|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153829816|NCT00492245|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153829817|NCT00487812|Dobutamine|dobutamine|mesh-list
153829818|NCT00487812|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
153829819|NCT00487812|Sympathomimetics|sympathomimetics|mesh-ancestor
153829820|NCT00487812|Autonomic Agents|autonomic agents|mesh-ancestor
153829821|NCT00487812|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153829822|NCT00487812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153829823|NCT00487812|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
153369852|NCT05379530|Anesthetics|anesthetics|mesh-list
153369853|NCT05379530|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153369854|NCT05379530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153369855|NCT05272605|Vaccines|vaccines|mesh-list
153369856|NCT05272605|Immunologic Factors|immunologic factors|mesh-ancestor
153369867|NCT05233202|Protective Agents|protective agents|mesh-ancestor
153369868|NCT05233202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153369871|NCT05229055|Ketamine|ketamine|mesh-list
153369872|NCT05229055|Analgesics|analgesics|mesh-ancestor
153369873|NCT05229055|Sensory System Agents|sensory system agents|mesh-ancestor
153369874|NCT05229055|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153369875|NCT05229055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153369876|NCT05229055|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
153369877|NCT05229055|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153369878|NCT05229055|Anesthetics, General|anesthetics, general|mesh-ancestor
153369879|NCT05229055|Anesthetics|anesthetics|mesh-ancestor
153829824|NCT00487812|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
153829825|NCT00487812|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153829826|NCT00487812|Adrenergic Agents|adrenergic agents|mesh-ancestor
153829827|NCT00487812|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153829828|NCT00487812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153829829|NCT00487812|Protective Agents|protective agents|mesh-ancestor
153829830|NCT01299805|Vortioxetine|vortioxetine|mesh-list
153829831|NCT01299805|Antidepressive Agents|antidepressive agents|mesh-ancestor
153829832|NCT01299805|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153829833|NCT01299805|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153829834|NCT01299805|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153829835|NCT01299805|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153829836|NCT01299805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153829837|NCT01299805|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
153369880|NCT05229055|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153369881|NCT05229055|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
153369883|NCT05229055|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153369884|NCT05229055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153369885|NCT04986072|Nitroprusside|nitroprusside|mesh-list
153369886|NCT04986072|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153369887|NCT04986072|Vasodilator Agents|vasodilator agents|mesh-ancestor
153369888|NCT04986072|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
153369889|NCT04986072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153369890|NCT04964869|Epinephrine|epinephrine|mesh-list
153369891|NCT04964869|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153369892|NCT04964869|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153369893|NCT04964869|Adrenergic Agents|adrenergic agents|mesh-ancestor
153369894|NCT04964869|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153369895|NCT04964869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153369896|NCT04964869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153369897|NCT04964869|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
153369898|NCT04964869|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153369904|NCT04964869|Sympathomimetics|sympathomimetics|mesh-ancestor
153369905|NCT04964869|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
153369906|NCT04936841|Pembrolizumab|pembrolizumab|mesh-list
153369907|NCT04936841|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153369909|NCT04936841|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153369910|NCT04936841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153369911|NCT04930536|Acalabrutinib|acalabrutinib|mesh-list
153829857|NCT04512261|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153829858|NCT04512261|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153829859|NCT00487799|Ularitide|ularitide|mesh-list
153829860|NCT00487799|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153829862|NCT00487799|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153829863|NCT00487799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153829864|NCT00487799|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153829865|NCT00487799|Respiratory System Agents|respiratory system agents|mesh-ancestor
153829866|NCT00487799|Diuretics|diuretics|mesh-ancestor
153829867|NCT00487799|Natriuretic Agents|natriuretic agents|mesh-ancestor
153829868|NCT05149170|Antibodies|antibodies|mesh-list
153829869|NCT05149170|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
153829870|NCT05149170|Immunologic Factors|immunologic factors|mesh-ancestor
153829871|NCT05149170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153829872|NCT04518501|Arsenic Trioxide|arsenic trioxide|mesh-list
153829873|NCT04518501|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153829874|NCT00495287|Cytarabine|cytarabine|mesh-list
153829875|NCT00495287|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153829876|NCT00495287|Antimetabolites|antimetabolites|mesh-ancestor
153829877|NCT00495287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153829878|NCT00495287|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153829879|NCT00495287|Antiviral Agents|antiviral agents|mesh-ancestor
153829880|NCT00495287|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153829881|NCT00495287|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153829882|NCT00495287|Immunologic Factors|immunologic factors|mesh-ancestor
153829883|NCT00495287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153829884|NCT00495326|Efavirenz|efavirenz|mesh-list
153829885|NCT00495326|Nevirapine|nevirapine|mesh-list
153829886|NCT00495326|Rifampin|rifampin|mesh-list
153369913|NCT04930536|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153369914|NCT04930536|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153369915|NCT04930536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153369916|NCT04930536|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153369917|NCT04893291|Sirolimus|sirolimus|mesh-list
153369918|NCT04893291|Everolimus|everolimus|mesh-list
153369919|NCT04893291|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
153369924|NCT04893291|Immunologic Factors|immunologic factors|mesh-ancestor
153369925|NCT04893291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153369926|NCT04893291|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153369927|NCT04893291|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153369928|NCT04893291|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153369929|NCT04893291|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153369941|NCT04803422|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153369942|NCT04803422|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
153369943|NCT04803422|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153369944|NCT04803422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153369945|NCT04770532|Insulin|insulin|mesh-list
153369946|NCT04770532|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
153369947|NCT04770532|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153369948|NCT04770532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153829887|NCT00495326|Isoniazid|isoniazid|mesh-list
153829888|NCT00495326|Ethambutol|ethambutol|mesh-list
153829889|NCT00495326|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153829890|NCT00495326|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153829891|NCT00495326|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153829892|NCT00495326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153829893|NCT00495326|Antiviral Agents|antiviral agents|mesh-ancestor
153829894|NCT00495326|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153829895|NCT00495326|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
153829896|NCT00495326|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153829897|NCT00495326|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
153829898|NCT00495326|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
153829899|NCT00495326|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
153829900|NCT00495326|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
153829901|NCT00495326|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
153829902|NCT00495326|Antitubercular Agents|antitubercular agents|mesh-ancestor
153829903|NCT00495326|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153829904|NCT00495326|Leprostatic Agents|leprostatic agents|mesh-ancestor
153829905|NCT00495326|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
153829906|NCT00495326|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
153829907|NCT00495326|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
153829908|NCT00495326|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
153829909|NCT00495326|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153829910|NCT00495326|Antimetabolites|antimetabolites|mesh-ancestor
153829911|NCT00495326|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153369952|NCT04715568|Antihypertensive Agents|antihypertensive agents|mesh-list
153369953|NCT04715568|Angiotensin II|angiotensin ii|mesh-list
153369954|NCT04715568|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-list
153369955|NCT04715568|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153369956|NCT04715568|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
153369957|NCT04715568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153369958|NCT04715568|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
153369960|NCT04658849|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153369961|NCT04658849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153369962|NCT04616313|Xenon|xenon|mesh-list
153369963|NCT04616313|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
153369964|NCT04616313|Anesthetics, General|anesthetics, general|mesh-ancestor
153369965|NCT04616313|Anesthetics|anesthetics|mesh-ancestor
153369966|NCT04616313|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153369967|NCT04616313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153369968|NCT04577404|Edaravone|edaravone|mesh-list
153369969|NCT04577404|Free Radical Scavengers|free radical scavengers|mesh-ancestor
153369979|NCT04421339|Melatonin|melatonin|mesh-list
153369980|NCT04421339|Antioxidants|antioxidants|mesh-ancestor
153369981|NCT04421339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153369982|NCT04421339|Protective Agents|protective agents|mesh-ancestor
153829921|NCT00492518|Theophylline|theophylline|mesh-list
153829922|NCT00492518|N-monoacetylcystine|n-monoacetylcystine|mesh-list
153829923|NCT00492518|Antiviral Agents|antiviral agents|mesh-ancestor
153829924|NCT00492518|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153829925|NCT00492518|Expectorants|expectorants|mesh-ancestor
153829926|NCT00492518|Respiratory System Agents|respiratory system agents|mesh-ancestor
153829937|NCT00492518|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
153829938|NCT00492518|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153829939|NCT00492518|Vasodilator Agents|vasodilator agents|mesh-ancestor
153829940|NCT00492518|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
153829941|NCT00492518|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
153829942|NCT00492518|Purinergic Agents|purinergic agents|mesh-ancestor
153829943|NCT00492518|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153829945|NCT04513860|Anticonvulsants|anticonvulsants|mesh-ancestor
153829946|NCT00495560|Misoprostol|misoprostol|mesh-list
153829947|NCT00495560|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
153829948|NCT00495560|Abortifacient Agents|abortifacient agents|mesh-ancestor
153829949|NCT00495560|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153888169|NCT01301391|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153888170|NCT01301391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153888171|NCT04325633|Naproxen|naproxen|mesh-list
153369988|NCT04342572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153369990|NCT04342572|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153369991|NCT04342572|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153369992|NCT04342572|Immunologic Factors|immunologic factors|mesh-ancestor
153369993|NCT04342572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153369994|NCT04250051|Vidarabine|vidarabine|mesh-list
153369995|NCT04250051|Cytarabine|cytarabine|mesh-list
153369996|NCT04250051|Fludarabine|fludarabine|mesh-list
153369997|NCT04250051|Fludarabine phosphate|fludarabine phosphate|mesh-list
153369998|NCT04250051|Ivosidenib|ivosidenib|mesh-list
153369999|NCT04250051|Lenograstim|lenograstim|mesh-list
153370000|NCT04250051|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153829966|NCT00506961|Simvastatin|simvastatin|mesh-list
153829967|NCT00506961|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153829968|NCT00506961|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153829969|NCT00506961|Antimetabolites|antimetabolites|mesh-ancestor
153829970|NCT00506961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153829971|NCT00506961|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153370001|NCT04250051|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153370006|NCT04250051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153370007|NCT04250051|Antiviral Agents|antiviral agents|mesh-ancestor
153370008|NCT04250051|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153370009|NCT04250051|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153370010|NCT04250051|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153370012|NCT04165824|Free Radical Scavengers|free radical scavengers|mesh-ancestor
153370016|NCT04165824|Protective Agents|protective agents|mesh-ancestor
153370017|NCT04165824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153370018|NCT04108039|Cetrorelix|cetrorelix|mesh-list
153370019|NCT04108039|Progesterone|progesterone|mesh-list
153370020|NCT04108039|Ganirelix|ganirelix|mesh-list
153370021|NCT04108039|Progestins|progestins|mesh-ancestor
153370022|NCT04108039|Hormones|hormones|mesh-ancestor
153370023|NCT04108039|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153370024|NCT04108039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153370025|NCT04108039|Hormone Antagonists|hormone antagonists|mesh-ancestor
153370026|NCT04108039|Fertility Agents, Female|fertility agents, female|mesh-ancestor
153370027|NCT04108039|Fertility Agents|fertility agents|mesh-ancestor
153370028|NCT04108039|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153370029|NCT04069169|Lidocaine|lidocaine|mesh-list
153370030|NCT04069169|Anesthetics, Local|anesthetics, local|mesh-ancestor
153370031|NCT04069169|Anesthetics|anesthetics|mesh-ancestor
153370032|NCT04069169|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153370033|NCT04069169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153370034|NCT04069169|Sensory System Agents|sensory system agents|mesh-ancestor
153829972|NCT00506961|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
153829973|NCT00506961|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153829974|NCT00492635|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
153829975|NCT00492635|Vasodilator Agents|vasodilator agents|mesh-ancestor
153829986|NCT00507000|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153829987|NCT00507000|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153829988|NCT00495872|Lenalidomide|lenalidomide|mesh-list
153829989|NCT00495872|Sunitinib|sunitinib|mesh-list
153829990|NCT00495872|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
153829991|NCT00495872|Sorafenib|sorafenib|mesh-list
153829992|NCT00495872|Dasatinib|dasatinib|mesh-list
153829993|NCT00495872|Lapatinib|lapatinib|mesh-list
153829994|NCT00495872|Valproic Acid|valproic acid|mesh-list
153829995|NCT00495872|Immunologic Factors|immunologic factors|mesh-ancestor
153829996|NCT00495872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153829997|NCT00495872|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153829998|NCT00495872|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153829999|NCT00495872|Growth Substances|growth substances|mesh-ancestor
153830000|NCT00495872|Growth Inhibitors|growth inhibitors|mesh-ancestor
153830001|NCT00495872|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153888181|NCT04325633|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153888182|NCT04325633|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153888183|NCT04325633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153888184|NCT01061359|Epirubicin|epirubicin|mesh-list
153888185|NCT01061359|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153888186|NCT01061359|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153888187|NCT01061359|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153888188|NCT01061359|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153888189|NCT01061359|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153888190|NCT01061359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153888191|NCT05643417|Bevacizumab|bevacizumab|mesh-list
153370035|NCT04069169|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153370036|NCT04069169|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153370037|NCT04069169|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
153370038|NCT04069169|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153370039|NCT04069169|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153370040|NCT04069169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153888196|NCT05643417|Growth Substances|growth substances|mesh-ancestor
153429261|NCT02239627|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153370044|NCT04002674|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153370045|NCT04002674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153370046|NCT03997097|Sildenafil Citrate|sildenafil citrate|mesh-list
153370047|NCT03997097|Vasodilator Agents|vasodilator agents|mesh-ancestor
153370048|NCT03997097|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
153370049|NCT03997097|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
153370050|NCT03997097|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153370051|NCT03997097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153370052|NCT03997097|Urological Agents|urological agents|mesh-ancestor
153370054|NCT03988036|Trastuzumab|trastuzumab|mesh-list
153370055|NCT03988036|Pertuzumab|pertuzumab|mesh-list
153370056|NCT03988036|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153370057|NCT03988036|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153370058|NCT03988036|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153370059|NCT03988036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153370060|NCT03850028|Atezolizumab|atezolizumab|mesh-list
153370061|NCT03850028|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153370062|NCT03850028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153370063|NCT03850028|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153830014|NCT00507117|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153830015|NCT00507117|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153830016|NCT00507117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153830017|NCT00492830|Antibodies|antibodies|mesh-list
153830018|NCT00492830|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
153830019|NCT00492830|Immunologic Factors|immunologic factors|mesh-ancestor
153830020|NCT00492830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153830021|NCT01299571|Dutasteride|dutasteride|mesh-list
153830022|NCT01299571|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
153830023|NCT01299571|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153830024|NCT01299571|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153830025|NCT01299571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153830026|NCT01299571|Hormone Antagonists|hormone antagonists|mesh-ancestor
153830027|NCT01299571|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153830028|NCT01299571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153830029|NCT01243736|Metoclopramide|metoclopramide|mesh-list
153830030|NCT01243736|Simethicone|simethicone|mesh-list
153830031|NCT01243736|Antiemetics|antiemetics|mesh-ancestor
153830032|NCT01243736|Autonomic Agents|autonomic agents|mesh-ancestor
153830033|NCT01243736|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153830034|NCT01243736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153830035|NCT01243736|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153830036|NCT01243736|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
153830037|NCT01243736|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
153830038|NCT01243736|Dopamine Agents|dopamine agents|mesh-ancestor
153830039|NCT01243736|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153370069|NCT03554044|Gemcitabine|gemcitabine|mesh-list
153370070|NCT03554044|Letrozole|letrozole|mesh-list
153370071|NCT03554044|Fulvestrant|fulvestrant|mesh-list
153370072|NCT03554044|Anastrozole|anastrozole|mesh-list
153370073|NCT03554044|Exemestane|exemestane|mesh-list
153370074|NCT03554044|Talimogene laherparepvec|talimogene laherparepvec|mesh-list
153370075|NCT03554044|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153370076|NCT03554044|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153370077|NCT03554044|Tubulin Modulators|tubulin modulators|mesh-ancestor
153370078|NCT03554044|Antimitotic Agents|antimitotic agents|mesh-ancestor
153370079|NCT03554044|Mitosis Modulators|mitosis modulators|mesh-ancestor
153370080|NCT03554044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153370081|NCT03554044|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153370082|NCT03554044|Antimetabolites|antimetabolites|mesh-ancestor
153370090|NCT03554044|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153370094|NCT03554044|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
153370095|NCT03554044|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153370097|NCT03524937|Antioxidants|antioxidants|mesh-ancestor
153370098|NCT03524937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153830040|NCT01243736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153830041|NCT01243736|Antifoaming Agents|antifoaming agents|mesh-ancestor
153830042|NCT01243736|Emollients|emollients|mesh-ancestor
153830043|NCT01243736|Dermatologic Agents|dermatologic agents|mesh-ancestor
153830044|NCT00492986|Sorafenib|sorafenib|mesh-list
153830045|NCT00492986|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153830046|NCT00492986|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153830047|NCT00492986|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153830048|NCT00492986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153830049|NCT01243970|Phenylephrine|phenylephrine|mesh-list
153830050|NCT01243970|Oxymetazoline|oxymetazoline|mesh-list
153830051|NCT01243970|Ephedrine|ephedrine|mesh-list
153830052|NCT01243970|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
153830053|NCT01243970|Mydriatics|mydriatics|mesh-ancestor
153830054|NCT01243970|Autonomic Agents|autonomic agents|mesh-ancestor
153830055|NCT01243970|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153830056|NCT01243970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153830057|NCT01243970|Sympathomimetics|sympathomimetics|mesh-ancestor
153830058|NCT01243970|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
153830059|NCT01243970|Nasal Decongestants|nasal decongestants|mesh-ancestor
153830060|NCT01243970|Respiratory System Agents|respiratory system agents|mesh-ancestor
153830061|NCT01243970|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
153830062|NCT01243970|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153830063|NCT01243970|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153830064|NCT01243970|Adrenergic Agents|adrenergic agents|mesh-ancestor
153830065|NCT01243970|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153830066|NCT01243970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153830067|NCT01243970|Protective Agents|protective agents|mesh-ancestor
153830068|NCT01243970|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
153830069|NCT04515576|Dulaglutide|dulaglutide|mesh-list
153830070|NCT04515576|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
153830071|NCT04515576|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153830072|NCT04515576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153830073|NCT01298362|Aromatase Inhibitors|aromatase inhibitors|mesh-list
153830074|NCT01298362|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153830075|NCT01298362|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153830076|NCT01298362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153830077|NCT01298362|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
153830078|NCT01298362|Hormone Antagonists|hormone antagonists|mesh-ancestor
153830079|NCT01298362|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153370121|NCT03184194|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153370122|NCT03184194|Immunologic Factors|immunologic factors|mesh-ancestor
153370123|NCT03184194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153370124|NCT03184194|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153370125|NCT03184194|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153370126|NCT03184194|Alkylating Agents|alkylating agents|mesh-ancestor
153370127|NCT03184194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153370128|NCT03184194|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153370129|NCT03184194|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153370130|NCT03184194|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153370131|NCT03184194|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153370133|NCT03096041|Sensory System Agents|sensory system agents|mesh-ancestor
153370134|NCT03096041|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153830087|NCT01244009|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153830089|NCT04511832|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153830090|NCT04511832|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153830091|NCT04511832|Analgesics|analgesics|mesh-ancestor
153882712|NCT01580202|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153882713|NCT01580202|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153882714|NCT01580202|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153882715|NCT01580202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153882716|NCT01580202|Antiviral Agents|antiviral agents|mesh-ancestor
153882717|NCT01580202|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153380928|NCT02342886|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153381052|NCT01705496|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153381053|NCT01705496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153381085|NCT01602068|Autonomic Agents|autonomic agents|mesh-ancestor
153381086|NCT01602068|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153381087|NCT01602068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153381088|NCT01602068|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153381089|NCT01602068|Glucocorticoids|glucocorticoids|mesh-ancestor
153381090|NCT01602068|Hormones|hormones|mesh-ancestor
153381091|NCT01602068|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153381092|NCT01602068|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153381093|NCT01602068|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153381094|NCT01602068|Anticoagulants|anticoagulants|mesh-ancestor
153381095|NCT01602068|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
153381096|NCT01602068|Chelating Agents|chelating agents|mesh-ancestor
153830092|NCT04511832|Sensory System Agents|sensory system agents|mesh-ancestor
153830093|NCT04511832|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153830094|NCT04511832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153830095|NCT04511832|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153830096|NCT04511832|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153830097|NCT04511832|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153830098|NCT04511832|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153830099|NCT04511832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153830100|NCT01244204|Vitamin D|vitamin d|mesh-list
153830101|NCT01244204|Vitamins|vitamins|mesh-ancestor
153830102|NCT01244204|Micronutrients|micronutrients|mesh-ancestor
153830103|NCT01244204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153830104|NCT01244204|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153830105|NCT00496028|Paclitaxel|paclitaxel|mesh-list
153830106|NCT00496028|Carboplatin|carboplatin|mesh-list
153830107|NCT00496028|Saracatinib|saracatinib|mesh-list
153830108|NCT00496028|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153830109|NCT00496028|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153830110|NCT00496028|Tubulin Modulators|tubulin modulators|mesh-ancestor
153830111|NCT00496028|Antimitotic Agents|antimitotic agents|mesh-ancestor
153830112|NCT00496028|Mitosis Modulators|mitosis modulators|mesh-ancestor
153370149|NCT02889159|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153370150|NCT02841280|Chlorthalidone|chlorthalidone|mesh-list
153370151|NCT02841280|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153370152|NCT02841280|Diuretics|diuretics|mesh-ancestor
153370153|NCT02841280|Natriuretic Agents|natriuretic agents|mesh-ancestor
153370154|NCT02841280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153370155|NCT02841280|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
153370156|NCT02841280|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153370157|NCT02841280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153370159|NCT02813356|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
153370160|NCT02813356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153370161|NCT02813356|Sensory System Agents|sensory system agents|mesh-ancestor
153370162|NCT02813356|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153370163|NCT02760329|Nitric Oxide|nitric oxide|mesh-list
153370164|NCT02760329|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153370165|NCT02760329|Autonomic Agents|autonomic agents|mesh-ancestor
153370166|NCT02760329|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153370167|NCT02760329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153370168|NCT02760329|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153370169|NCT02760329|Respiratory System Agents|respiratory system agents|mesh-ancestor
153370170|NCT02760329|Free Radical Scavengers|free radical scavengers|mesh-ancestor
153370171|NCT02760329|Antioxidants|antioxidants|mesh-ancestor
153370172|NCT02760329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153370173|NCT02760329|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153370174|NCT02760329|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
153830120|NCT04516278|Growth Substances|growth substances|mesh-ancestor
153830121|NCT04516278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153830122|NCT04516278|Growth Inhibitors|growth inhibitors|mesh-ancestor
153830123|NCT00493532|Ibandronic Acid|ibandronic acid|mesh-list
153830124|NCT00493532|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153830125|NCT00493532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153830126|NCT01297465|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
153830127|NCT01297465|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
153830129|NCT01297465|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153830130|NCT01297465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153830131|NCT01297465|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153429278|NCT00002594|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153429279|NCT00002594|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153429280|NCT02234011|Ketamine|ketamine|mesh-list
153429281|NCT02234011|Analgesics|analgesics|mesh-ancestor
153429282|NCT02234011|Sensory System Agents|sensory system agents|mesh-ancestor
153429283|NCT02234011|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153370177|NCT02760329|Protective Agents|protective agents|mesh-ancestor
153370179|NCT02723500|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
153370180|NCT02723500|Anesthetics, General|anesthetics, general|mesh-ancestor
153370181|NCT02723500|Anesthetics|anesthetics|mesh-ancestor
153370182|NCT02723500|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153370183|NCT02723500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153370184|NCT02678182|Capecitabine|capecitabine|mesh-list
153370188|NCT02678182|Rucaparib|rucaparib|mesh-list
153370189|NCT02678182|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153370190|NCT02678182|Antimetabolites|antimetabolites|mesh-ancestor
153370191|NCT02678182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153370192|NCT02678182|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153370193|NCT02678182|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153370194|NCT02678182|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153370195|NCT02678182|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153370196|NCT02678182|Growth Substances|growth substances|mesh-ancestor
153370197|NCT02678182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153370198|NCT02678182|Growth Inhibitors|growth inhibitors|mesh-ancestor
153370199|NCT02678182|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
153370200|NCT02678182|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153370201|NCT02620865|Calcium, Dietary|calcium, dietary|mesh-list
153370202|NCT02620865|Leucovorin|leucovorin|mesh-list
153370203|NCT02620865|Folic Acid|folic acid|mesh-list
153370204|NCT02620865|Aldesleukin|aldesleukin|mesh-list
153370205|NCT02620865|Paclitaxel|paclitaxel|mesh-list
153370206|NCT02620865|Camptothecin|camptothecin|mesh-list
153370207|NCT02620865|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
153370208|NCT02620865|Gemcitabine|gemcitabine|mesh-list
153370209|NCT02620865|Fluorouracil|fluorouracil|mesh-list
153370210|NCT02620865|Oxaliplatin|oxaliplatin|mesh-list
153370211|NCT02620865|Irinotecan|irinotecan|mesh-list
153830159|NCT00493610|Antidotes|antidotes|mesh-ancestor
153830160|NCT02274506|Cyclophosphamide|cyclophosphamide|mesh-list
153830161|NCT02274506|Fludarabine|fludarabine|mesh-list
153830162|NCT02274506|Fludarabine phosphate|fludarabine phosphate|mesh-list
153830163|NCT02274506|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153830164|NCT02274506|Immunologic Factors|immunologic factors|mesh-ancestor
153830165|NCT02274506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153830166|NCT02274506|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153830167|NCT02274506|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153830168|NCT02274506|Alkylating Agents|alkylating agents|mesh-ancestor
153830169|NCT02274506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153830170|NCT02274506|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153830171|NCT02274506|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153830172|NCT02274506|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153830173|NCT02274506|Antimetabolites|antimetabolites|mesh-ancestor
153830175|NCT00496223|Dacarbazine|dacarbazine|mesh-list
153830176|NCT00496223|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153830177|NCT00496223|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153370220|NCT02620865|Tubulin Modulators|tubulin modulators|mesh-ancestor
153370221|NCT02620865|Antimitotic Agents|antimitotic agents|mesh-ancestor
153370222|NCT02620865|Mitosis Modulators|mitosis modulators|mesh-ancestor
153370223|NCT02620865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153370224|NCT02620865|Immunologic Factors|immunologic factors|mesh-ancestor
153370225|NCT02620865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153370226|NCT02620865|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153370227|NCT02620865|Antimetabolites|antimetabolites|mesh-ancestor
153370228|NCT02620865|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153370229|NCT02620865|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153370230|NCT02620865|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153370231|NCT02620865|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
153370232|NCT02620865|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153370233|NCT02620865|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153370234|NCT02620865|Antidotes|antidotes|mesh-ancestor
153370235|NCT02620865|Protective Agents|protective agents|mesh-ancestor
153370236|NCT02620865|Vitamin B Complex|vitamin b complex|mesh-ancestor
153370238|NCT02620865|Micronutrients|micronutrients|mesh-ancestor
153370239|NCT02620865|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153830191|NCT00496301|Antimetabolites|antimetabolites|mesh-ancestor
153830192|NCT00496301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153830193|NCT00496301|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153830194|NCT00496301|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153830195|NCT00496301|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153830196|NCT05141838|Vitamin D|vitamin d|mesh-list
153830197|NCT05141838|Vitamins|vitamins|mesh-ancestor
153830198|NCT05141838|Micronutrients|micronutrients|mesh-ancestor
153830199|NCT05141838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153830200|NCT05141838|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153830204|NCT00493727|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153830206|NCT00493727|Respiratory System Agents|respiratory system agents|mesh-ancestor
153830207|NCT00493727|Free Radical Scavengers|free radical scavengers|mesh-ancestor
153830208|NCT00493727|Antioxidants|antioxidants|mesh-ancestor
153370242|NCT02620865|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153370243|NCT02620865|Hematinics|hematinics|mesh-ancestor
153370244|NCT02620865|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153370245|NCT02620865|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153370246|NCT02620865|Antiviral Agents|antiviral agents|mesh-ancestor
153370247|NCT02620865|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153370248|NCT02505477|Acetylcysteine|acetylcysteine|mesh-list
153370249|NCT02505477|N-monoacetylcystine|n-monoacetylcystine|mesh-list
153370250|NCT02505477|Antiviral Agents|antiviral agents|mesh-ancestor
153370251|NCT02505477|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153370252|NCT02505477|Expectorants|expectorants|mesh-ancestor
153370253|NCT02505477|Respiratory System Agents|respiratory system agents|mesh-ancestor
153370254|NCT02505477|Free Radical Scavengers|free radical scavengers|mesh-ancestor
153370255|NCT02505477|Antioxidants|antioxidants|mesh-ancestor
153370256|NCT02505477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153370257|NCT02505477|Protective Agents|protective agents|mesh-ancestor
153370258|NCT02505477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153370259|NCT02505477|Antidotes|antidotes|mesh-ancestor
153370261|NCT02484885|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
153370262|NCT02484885|Anesthetics, General|anesthetics, general|mesh-ancestor
153370263|NCT02484885|Anesthetics|anesthetics|mesh-ancestor
153370264|NCT02484885|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153370265|NCT02484885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153370266|NCT02418572|Testosterone|testosterone|mesh-list
153370267|NCT02418572|Androgens|androgens|mesh-ancestor
153370268|NCT02418572|Hormones|hormones|mesh-ancestor
153370269|NCT02418572|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153370270|NCT02418572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153370271|NCT02345330|Interleukin-12|interleukin-12|mesh-list
153370272|NCT02345330|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153370273|NCT02345330|Immunologic Factors|immunologic factors|mesh-ancestor
153370274|NCT02345330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153370275|NCT02345330|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153370276|NCT02345330|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153370277|NCT02345330|Growth Substances|growth substances|mesh-ancestor
153370278|NCT02345330|Growth Inhibitors|growth inhibitors|mesh-ancestor
153370279|NCT02345330|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153888207|NCT00626977|Anesthetics|anesthetics|mesh-ancestor
153830223|NCT05145621|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
153830224|NCT05145621|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
153830225|NCT05145621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153830226|NCT05145621|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153830227|NCT05145621|Immunologic Factors|immunologic factors|mesh-ancestor
153830228|NCT05145621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153830229|NCT01296568|Gemcitabine|gemcitabine|mesh-list
153830230|NCT01296568|Pemetrexed|pemetrexed|mesh-list
153830231|NCT01296568|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153830232|NCT01296568|Antimetabolites|antimetabolites|mesh-ancestor
153830233|NCT01296568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153830234|NCT01296568|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153830235|NCT01296568|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153830236|NCT01296568|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153830237|NCT01296568|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153830238|NCT02598999|Lactoferrin|lactoferrin|mesh-list
153830239|NCT02598999|Hypothiocyanite ion|hypothiocyanite ion|mesh-list
153830240|NCT02598999|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153830241|NCT01296412|Metformin|metformin|mesh-list
153830242|NCT01296412|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
153830243|NCT01296412|Liraglutide|liraglutide|mesh-list
153830244|NCT01296412|Glimepiride|glimepiride|mesh-list
153370280|NCT01665677|Atorvastatin|atorvastatin|mesh-list
153370288|NCT01665677|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153370289|NCT01665677|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
153370290|NCT01665677|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153370292|NCT01530373|Solifenacin Succinate|solifenacin succinate|mesh-list
153370293|NCT01530373|Analgesics|analgesics|mesh-ancestor
153370294|NCT01530373|Sensory System Agents|sensory system agents|mesh-ancestor
153370295|NCT01530373|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153370296|NCT01530373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153370297|NCT01530373|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153370298|NCT01530373|Sympatholytics|sympatholytics|mesh-ancestor
153370299|NCT01530373|Autonomic Agents|autonomic agents|mesh-ancestor
153370300|NCT01530373|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
153370301|NCT01530373|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153370302|NCT01530373|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153370303|NCT01530373|Adrenergic Agents|adrenergic agents|mesh-ancestor
153830251|NCT01296412|Protease Inhibitors|protease inhibitors|mesh-ancestor
153830252|NCT01296412|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153830253|NCT01296412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153830254|NCT01296412|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
153830255|NCT01296412|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153830256|NCT01296412|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153830257|NCT01296412|Immunologic Factors|immunologic factors|mesh-ancestor
153830258|NCT00496652|Zalutumumab|zalutumumab|mesh-list
153830259|NCT00496652|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153830260|NCT00496652|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153830261|NCT02597634|Ibuprofen|ibuprofen|mesh-list
153830262|NCT02597634|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153830263|NCT02597634|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153830264|NCT02597634|Analgesics|analgesics|mesh-ancestor
153830265|NCT02597634|Sensory System Agents|sensory system agents|mesh-ancestor
153830266|NCT02597634|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153830267|NCT02597634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153830268|NCT02597634|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153830269|NCT02597634|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153830270|NCT02597634|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153830271|NCT02597634|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153830272|NCT02597634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153830273|NCT02591199|Lidocaine|lidocaine|mesh-list
153830274|NCT02591199|Heparin|heparin|mesh-list
153370312|NCT01499953|Fondaparinux|fondaparinux|mesh-list
153370313|NCT01499953|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
153370314|NCT01499953|Antithrombins|antithrombins|mesh-ancestor
153370330|NCT01440816|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153370331|NCT01348919|Dexamethasone|dexamethasone|mesh-list
153370332|NCT01348919|Lenalidomide|lenalidomide|mesh-list
153370333|NCT01348919|Delanzomib|delanzomib|mesh-list
153370334|NCT01348919|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153370335|NCT01348919|Antiemetics|antiemetics|mesh-ancestor
153370336|NCT01348919|Autonomic Agents|autonomic agents|mesh-ancestor
153370337|NCT01348919|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153370338|NCT01348919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153370339|NCT01348919|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153370340|NCT01348919|Glucocorticoids|glucocorticoids|mesh-ancestor
153370341|NCT01348919|Hormones|hormones|mesh-ancestor
153370343|NCT01348919|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153830275|NCT02591199|Anesthetics, Local|anesthetics, local|mesh-ancestor
153830276|NCT02591199|Anesthetics|anesthetics|mesh-ancestor
153830277|NCT02591199|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153830278|NCT02591199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153830279|NCT02591199|Sensory System Agents|sensory system agents|mesh-ancestor
153830280|NCT02591199|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153830281|NCT02591199|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153830291|NCT00494078|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
153830293|NCT00494078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153830294|NCT02596035|Nivolumab|nivolumab|mesh-list
153830295|NCT02596035|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153830296|NCT02596035|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153830297|NCT02596035|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153830298|NCT02596035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153830299|NCT00494156|Aspirin|aspirin|mesh-list
153429301|NCT00002600|Alkylating Agents|alkylating agents|mesh-ancestor
153830300|NCT00494156|Heparin|heparin|mesh-list
153830316|NCT00494156|Antipyretics|antipyretics|mesh-ancestor
153370356|NCT01333046|Antimetabolites|antimetabolites|mesh-ancestor
153370357|NCT01333046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153370358|NCT01333046|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153370359|NCT01333046|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153370361|NCT01217970|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153370362|NCT01217970|Autonomic Agents|autonomic agents|mesh-ancestor
153370363|NCT01217970|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153370364|NCT01217970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153370365|NCT01217970|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153370366|NCT01217970|Respiratory System Agents|respiratory system agents|mesh-ancestor
153370367|NCT01217970|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
153370368|NCT01217970|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153370369|NCT01217970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153370370|NCT01217970|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153429303|NCT00002600|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153429304|NCT00002600|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153429305|NCT02177773|Octreotide|octreotide|mesh-list
153429306|NCT02177773|Edotreotide|edotreotide|mesh-list
153429307|NCT02177773|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153429308|NCT02177773|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153429309|NCT02177773|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153429310|NCT02177773|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
153429311|NCT02177773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153429312|NCT02144155|Oxytocin|oxytocin|mesh-list
153370371|NCT01217970|Vasodilator Agents|vasodilator agents|mesh-ancestor
153370372|NCT02431806|Milnacipran|milnacipran|mesh-list
153370373|NCT02431806|Fluoxetine|fluoxetine|mesh-list
153370374|NCT02431806|Levomilnacipran|levomilnacipran|mesh-list
153370375|NCT02431806|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
153370376|NCT02431806|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153830317|NCT00494156|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
153830318|NCT00494156|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
153830320|NCT00494156|Purinergic Agents|purinergic agents|mesh-ancestor
153830321|NCT00494156|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153830322|NCT00494156|Anticoagulants|anticoagulants|mesh-ancestor
153830323|NCT02595489|Vitamin D|vitamin d|mesh-list
153830324|NCT02595489|Ergocalciferols|ergocalciferols|mesh-list
153830325|NCT02595489|Cholecalciferol|cholecalciferol|mesh-list
153830326|NCT02595489|Vitamins|vitamins|mesh-list
153830327|NCT02595489|Micronutrients|micronutrients|mesh-ancestor
153830328|NCT02595489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153830329|NCT02595489|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153830330|NCT02595489|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153830331|NCT00497003|Metoprolol|metoprolol|mesh-list
153830332|NCT00497003|Carvedilol|carvedilol|mesh-list
153830333|NCT00497003|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153830334|NCT00497003|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153830336|NCT00497003|Autonomic Agents|autonomic agents|mesh-ancestor
153830337|NCT00497003|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153830338|NCT00497003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153830339|NCT00497003|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
153830340|NCT00497003|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
153830341|NCT00497003|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
153830342|NCT00497003|Adrenergic Agents|adrenergic agents|mesh-ancestor
153830343|NCT00497003|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153830344|NCT00497003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153830345|NCT00497003|Antioxidants|antioxidants|mesh-ancestor
153888219|NCT00626977|Adrenergic Agents|adrenergic agents|mesh-ancestor
153888222|NCT04303819|Exenatide|exenatide|mesh-list
153830346|NCT00497003|Protective Agents|protective agents|mesh-ancestor
153830347|NCT00497003|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153830348|NCT00497003|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153830349|NCT00497003|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153830350|NCT00497003|Vasodilator Agents|vasodilator agents|mesh-ancestor
153830351|NCT00497003|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
153830352|NCT00497003|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
153830353|NCT00494312|Pioglitazone|pioglitazone|mesh-list
153830354|NCT00494312|Glyburide|glyburide|mesh-list
153830355|NCT00494312|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153830356|NCT00494312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153830357|NCT02595372|Omeprazole|omeprazole|mesh-list
153830358|NCT02595372|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
153830359|NCT02595372|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153830360|NCT02595372|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
153830361|NCT02595372|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153370408|NCT01650246|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153370409|NCT01650246|Uricosuric Agents|uricosuric agents|mesh-ancestor
153370410|NCT01212302|Clopidogrel|clopidogrel|mesh-list
153370411|NCT01212302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153370412|NCT01212302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153370413|NCT01212302|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153370414|NCT01212302|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
153370415|NCT01212302|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
153370416|NCT01212302|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
153370417|NCT01212302|Purinergic Agents|purinergic agents|mesh-ancestor
153370418|NCT01212302|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153370419|NCT01284296|Chrysarobin|chrysarobin|mesh-list
153370420|NCT01284296|Lidocaine|lidocaine|mesh-list
153370421|NCT01284296|Anesthetics, Local|anesthetics, local|mesh-ancestor
153370422|NCT01284296|Anesthetics|anesthetics|mesh-ancestor
153370423|NCT01284296|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153370424|NCT01284296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153830362|NCT02595372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153830363|NCT05142969|Chlorhexidine|chlorhexidine|mesh-list
153830364|NCT05142969|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
153830365|NCT05142969|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153830366|NCT05142969|Disinfectants|disinfectants|mesh-ancestor
153830377|NCT02596503|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153830378|NCT00494429|Morphine|morphine|mesh-list
153830379|NCT00494429|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153830380|NCT00494429|Narcotics|narcotics|mesh-ancestor
153830381|NCT00494429|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153830382|NCT00494429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153830383|NCT00494429|Analgesics|analgesics|mesh-ancestor
153830384|NCT00494429|Sensory System Agents|sensory system agents|mesh-ancestor
153830385|NCT00494429|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153830386|NCT00497120|Acetazolamide|acetazolamide|mesh-list
153830387|NCT00497120|Anticonvulsants|anticonvulsants|mesh-ancestor
153830388|NCT00497120|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
153830389|NCT00497120|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153830390|NCT00497120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153830391|NCT00497120|Diuretics|diuretics|mesh-ancestor
153830392|NCT00497120|Natriuretic Agents|natriuretic agents|mesh-ancestor
153830393|NCT00497120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153830394|NCT00494468|Zolpidem|zolpidem|mesh-list
153830395|NCT00494468|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
153830396|NCT00494468|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153830397|NCT00494468|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153830398|NCT00494468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153830399|NCT00494468|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
153830400|NCT00494468|GABA Agonists|gaba agonists|mesh-ancestor
153830401|NCT00494468|GABA Agents|gaba agents|mesh-ancestor
153830402|NCT00494468|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153830403|NCT00494468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153830404|NCT00497237|Fluticasone|fluticasone|mesh-list
153830405|NCT00497237|Beclomethasone|beclomethasone|mesh-list
153830406|NCT00497237|Formoterol Fumarate|formoterol fumarate|mesh-list
153830407|NCT00497237|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
153830408|NCT00497237|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153370443|NCT01652664|Timolol|timolol|mesh-list
153370444|NCT01652664|Travoprost|travoprost|mesh-list
153370445|NCT01652664|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
153370446|NCT01652664|Ophthalmic Solutions|ophthalmic solutions|mesh-list
153370447|NCT01652664|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
153370448|NCT01652664|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
153370449|NCT01652664|Adrenergic Agents|adrenergic agents|mesh-ancestor
153370450|NCT01652664|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153370451|NCT01652664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153370452|NCT01652664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153370453|NCT01652664|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153370454|NCT01652664|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153370455|NCT04055649|Paclitaxel|paclitaxel|mesh-list
153370456|NCT04055649|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
153370457|NCT04055649|TIC10 compound|tic10 compound|mesh-list
153830429|NCT00497315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153830430|NCT00497315|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153830431|NCT00497315|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153830432|NCT05142072|Vitamin D|vitamin d|mesh-list
153370477|NCT01286402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153370478|NCT01286402|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
153370479|NCT01286402|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153370480|NCT01286402|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153370481|NCT01222832|Bacitracin|bacitracin|mesh-list
153370482|NCT01222832|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
153370483|NCT01222832|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153370484|NCT01222832|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153370486|NCT04297605|Pembrolizumab|pembrolizumab|mesh-list
153370487|NCT04297605|Pemetrexed|pemetrexed|mesh-list
153370488|NCT04297605|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153370489|NCT04297605|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153830443|NCT00497354|Sensory System Agents|sensory system agents|mesh-ancestor
153830444|NCT00497354|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153830445|NCT00494624|Prednisolone|prednisolone|mesh-list
153830446|NCT00494624|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153830447|NCT00494624|Glucocorticoids|glucocorticoids|mesh-ancestor
153830449|NCT00494624|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153830450|NCT00494624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153830451|NCT00494624|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153830452|NCT00494624|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153830453|NCT00494663|Ketoconazole|ketoconazole|mesh-list
153370490|NCT04297605|Tubulin Modulators|tubulin modulators|mesh-ancestor
153370491|NCT04297605|Antimitotic Agents|antimitotic agents|mesh-ancestor
153370492|NCT04297605|Mitosis Modulators|mitosis modulators|mesh-ancestor
153370493|NCT04297605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153370494|NCT04297605|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153370495|NCT04297605|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153370496|NCT04297605|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153370497|NCT04297605|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153370498|NCT04297605|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153370500|NCT02379390|Abiraterone Acetate|abiraterone acetate|mesh-list
153370501|NCT02379390|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153370502|NCT02379390|Glucocorticoids|glucocorticoids|mesh-ancestor
153370503|NCT02379390|Hormones|hormones|mesh-ancestor
153370504|NCT02379390|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153370505|NCT02379390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153370506|NCT02379390|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153370507|NCT02379390|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153370508|NCT02379390|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153370509|NCT02379390|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153370510|NCT02379390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153370515|NCT04932915|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
153370516|NCT04932915|Anthelmintics|anthelmintics|mesh-ancestor
153370517|NCT04932915|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153370518|NCT04932915|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153370519|NCT04932915|Antinematodal Agents|antinematodal agents|mesh-ancestor
153370520|NCT01223378|Latanoprost|latanoprost|mesh-list
153370521|NCT01223378|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
153370522|NCT01223378|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
153370523|NCT03780075|177Lu-EB-PSMA-617|177lu-eb-psma-617|mesh-list
153381097|NCT01602068|Sequestering Agents|sequestering agents|mesh-ancestor
153381119|NCT02978157|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
153381120|NCT01705964|Epinephrine|epinephrine|mesh-list
153381121|NCT01705964|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153830454|NCT00494663|Antifungal Agents|antifungal agents|mesh-ancestor
153830455|NCT00494663|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153830456|NCT00494663|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
153830457|NCT00494663|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153830458|NCT00494663|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153830459|NCT00494663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153830487|NCT00507195|GABA Agents|gaba agents|mesh-ancestor
153830488|NCT00507195|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153370524|NCT03780075|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
153370525|NCT03780075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153370527|NCT01224626|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153370528|NCT01224626|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153370529|NCT01224626|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
153370530|NCT01224626|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153370531|NCT01224626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153370532|NCT01289522|Cetuximab|cetuximab|mesh-list
153370533|NCT01289522|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153370534|NCT01289522|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153370535|NCT01226420|Alefacept|alefacept|mesh-list
153370536|NCT01226420|Dermatologic Agents|dermatologic agents|mesh-ancestor
153370537|NCT01226420|Immunologic Factors|immunologic factors|mesh-ancestor
153370538|NCT01226420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153370539|NCT04743453|Dapagliflozin|dapagliflozin|mesh-list
153370540|NCT04743453|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
153370541|NCT04743453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153370542|NCT04743453|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153370543|NCT04743453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153370544|NCT04274517|Chlorhexidine|chlorhexidine|mesh-list
153370545|NCT04274517|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
153370546|NCT04274517|Povidone-Iodine|povidone-iodine|mesh-list
153370547|NCT04274517|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
153370548|NCT04274517|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153370549|NCT04274517|Disinfectants|disinfectants|mesh-ancestor
153370550|NCT04274517|Dermatologic Agents|dermatologic agents|mesh-ancestor
153370551|NCT00365001|Methotrexate|methotrexate|mesh-list
153830501|NCT00497471|Leprostatic Agents|leprostatic agents|mesh-ancestor
153830502|NCT00497471|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153830503|NCT05146635|Epirubicin|epirubicin|mesh-list
153830504|NCT05146635|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153830505|NCT05146635|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153830506|NCT05146635|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153830507|NCT05146635|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153830508|NCT05146635|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153830509|NCT05146635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153830510|NCT00494741|Mycophenolic Acid|mycophenolic acid|mesh-list
153830511|NCT00494741|Azathioprine|azathioprine|mesh-list
153830512|NCT00494741|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153830513|NCT00494741|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153830514|NCT00494741|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
153830515|NCT00494741|Antitubercular Agents|antitubercular agents|mesh-ancestor
153830516|NCT00494741|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153830517|NCT00494741|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153830518|NCT00494741|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153830519|NCT00494741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153830520|NCT00494741|Antimetabolites|antimetabolites|mesh-ancestor
153830521|NCT00494741|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153830522|NCT00494741|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153830523|NCT00494741|Immunologic Factors|immunologic factors|mesh-ancestor
153370578|NCT01289912|Immunologic Factors|immunologic factors|mesh-ancestor
153370579|NCT01289912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153370580|NCT01289912|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153370581|NCT03192345|Cemiplimab|cemiplimab|mesh-list
153370582|NCT03192345|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153370583|NCT03192345|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153415261|NCT00367471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153370584|NCT03069963|Alginate, aluminium hydroxide, magnesium trisilicate, sodium bicarbonate drug combination|alginate, aluminium hydroxide, magnesium trisilicate, sodium bicarbonate drug combination|mesh-list
153370586|NCT03069963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153370587|NCT03069963|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153370588|NCT01227434|Palbociclib|palbociclib|mesh-list
153370589|NCT01227434|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153370590|NCT01227434|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153370591|NCT01227434|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153370592|NCT01227434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153370593|NCT01714739|Nivolumab|nivolumab|mesh-list
153370594|NCT01714739|Ipilimumab|ipilimumab|mesh-list
153370595|NCT01714739|Immunoglobulins|immunoglobulins|mesh-list
153370596|NCT01714739|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153370597|NCT01714739|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153370598|NCT01714739|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153830534|NCT00507234|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
153830535|NCT00507234|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153830536|NCT00507234|Adrenergic Agents|adrenergic agents|mesh-ancestor
153830537|NCT00507234|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153830538|NCT00507234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153830539|NCT05148546|Nivolumab|nivolumab|mesh-list
153830540|NCT05148546|Ipilimumab|ipilimumab|mesh-list
153830541|NCT05148546|Relatlimab|relatlimab|mesh-list
153830542|NCT05148546|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153888228|NCT04303819|Hormones|hormones|mesh-ancestor
153830543|NCT05148546|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153830544|NCT05148546|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153830545|NCT05148546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153830546|NCT00506532|Pulmonary Surfactants|pulmonary surfactants|mesh-list
153830547|NCT00506532|Calfactant|calfactant|mesh-list
153830548|NCT00506532|Respiratory System Agents|respiratory system agents|mesh-ancestor
153830549|NCT05149560|Ticagrelor|ticagrelor|mesh-list
153830550|NCT05149560|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153830559|NCT00494897|Prednisone|prednisone|mesh-list
153830560|NCT00494897|Cyclophosphamide|cyclophosphamide|mesh-list
153830561|NCT00494897|Methotrexate|methotrexate|mesh-list
153830562|NCT00494897|Vincristine|vincristine|mesh-list
153830563|NCT00494897|Daunorubicin|daunorubicin|mesh-list
153830564|NCT00494897|Asparaginase|asparaginase|mesh-list
153830565|NCT00494897|Mercaptopurine|mercaptopurine|mesh-list
153830566|NCT00494897|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153830567|NCT00494897|Immunologic Factors|immunologic factors|mesh-ancestor
153830568|NCT00494897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153830569|NCT00494897|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153830570|NCT00494897|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153830571|NCT00494897|Alkylating Agents|alkylating agents|mesh-ancestor
153830572|NCT00494897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153830573|NCT00494897|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153830574|NCT00494897|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153830575|NCT00494897|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153830576|NCT00494897|Glucocorticoids|glucocorticoids|mesh-ancestor
153830577|NCT00494897|Hormones|hormones|mesh-ancestor
153370609|NCT02377479|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
153370610|NCT02377479|Hormone Antagonists|hormone antagonists|mesh-ancestor
153370611|NCT02377479|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153370612|NCT02377479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153370613|NCT02377479|Fertility Agents, Female|fertility agents, female|mesh-ancestor
153370614|NCT02377479|Fertility Agents|fertility agents|mesh-ancestor
153370615|NCT02377479|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153370616|NCT02377479|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
153370617|NCT02377479|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
153370619|NCT01291784|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
153370620|NCT01291784|Immunologic Factors|immunologic factors|mesh-ancestor
153370621|NCT01291784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153370622|NCT05457647|Riboflavin|riboflavin|mesh-list
153370623|NCT05457647|Vitamin B Complex|vitamin b complex|mesh-ancestor
153370624|NCT05457647|Vitamins|vitamins|mesh-ancestor
153370625|NCT05457647|Micronutrients|micronutrients|mesh-ancestor
153370626|NCT05457647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153370628|NCT05457647|Dermatologic Agents|dermatologic agents|mesh-ancestor
153370629|NCT01213316|Raltegravir Potassium|raltegravir potassium|mesh-list
153370630|NCT01213316|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153370631|NCT01213316|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153370632|NCT01213316|Antiviral Agents|antiviral agents|mesh-ancestor
153370633|NCT01213316|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153370634|NCT01213316|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
153370635|NCT01213316|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
153370636|NCT01213316|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153370637|NCT01213316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153370638|NCT05439629|Ranibizumab|ranibizumab|mesh-list
153370639|NCT05439629|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153370640|NCT05439629|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153370641|NCT05439629|Growth Substances|growth substances|mesh-ancestor
153370642|NCT05439629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153370644|NCT05439629|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153830578|NCT00494897|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153830579|NCT00494897|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153830580|NCT00494897|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
153830581|NCT00494897|Abortifacient Agents|abortifacient agents|mesh-ancestor
153830582|NCT00494897|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153830583|NCT00494897|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153830584|NCT00494897|Antimetabolites|antimetabolites|mesh-ancestor
153830585|NCT00494897|Dermatologic Agents|dermatologic agents|mesh-ancestor
153830586|NCT00494897|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153830587|NCT00494897|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153830588|NCT00494897|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153830589|NCT00494897|Antiviral Agents|antiviral agents|mesh-ancestor
153830598|NCT00497744|Cefepime|cefepime|mesh-list
153830605|NCT00495092|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
153830606|NCT00495092|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153830607|NCT00495092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153830608|NCT00495092|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
153830609|NCT00495092|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
153830610|NCT00495092|Purinergic Agents|purinergic agents|mesh-ancestor
153830611|NCT00495092|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153830612|NCT00495092|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
153830613|NCT00495092|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
153370646|NCT01229228|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153370647|NCT01229228|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153370648|NCT01229228|Analgesics|analgesics|mesh-ancestor
153370649|NCT01229228|Sensory System Agents|sensory system agents|mesh-ancestor
153370650|NCT01229228|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153370651|NCT01229228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153370652|NCT01229228|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153370653|NCT01229228|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153370654|NCT01229228|Gout Suppressants|gout suppressants|mesh-ancestor
153370655|NCT01229228|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153370656|NCT01229228|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153370657|NCT01229228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153370658|NCT01292252|Teriparatide|teriparatide|mesh-list
153370659|NCT01292252|Parathyroid Hormone|parathyroid hormone|mesh-list
153370660|NCT01292252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153370661|NCT01292252|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153370662|NCT01292252|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153370663|NCT02192684|Pioglitazone|pioglitazone|mesh-list
153370664|NCT02192684|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153370665|NCT02192684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153370666|NCT02243579|Pembrolizumab|pembrolizumab|mesh-list
153370667|NCT02243579|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153370668|NCT02243579|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153370673|NCT00003407|Amifostine|amifostine|mesh-list
153830615|NCT00495092|Autonomic Agents|autonomic agents|mesh-ancestor
153830616|NCT00495092|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153830617|NCT00495092|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
153830618|NCT00495092|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
153830619|NCT00495092|Cholinergic Agents|cholinergic agents|mesh-ancestor
153830620|NCT01244360|Resveratrol|resveratrol|mesh-list
153830621|NCT01244360|Antioxidants|antioxidants|mesh-ancestor
153830622|NCT01244360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153830623|NCT01244360|Protective Agents|protective agents|mesh-ancestor
153830624|NCT01244360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153830625|NCT01244360|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153830626|NCT01244360|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153830627|NCT00506571|Oxaliplatin|oxaliplatin|mesh-list
153830628|NCT00506571|Irinotecan|irinotecan|mesh-list
153830629|NCT00506571|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153830630|NCT00506571|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
153830631|NCT00506571|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153830632|NCT00506571|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153830633|NCT00506571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153830634|NCT00497900|Vitamin D|vitamin d|mesh-list
153830635|NCT00497900|Vitamins|vitamins|mesh-ancestor
153830636|NCT00497900|Micronutrients|micronutrients|mesh-ancestor
153830637|NCT00497900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153830638|NCT00497900|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153830639|NCT05143125|Decitabine|decitabine|mesh-list
153830640|NCT05143125|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153830641|NCT05143125|Antimetabolites|antimetabolites|mesh-ancestor
153370697|NCT01710137|Varenicline|varenicline|mesh-list
153370698|NCT01710137|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
153370699|NCT01710137|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
153370700|NCT01710137|Cholinergic Agents|cholinergic agents|mesh-ancestor
153370701|NCT01710137|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153370702|NCT01710137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153370703|NCT01710137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153370704|NCT01710839|Ranibizumab|ranibizumab|mesh-list
153370705|NCT01710839|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153370706|NCT01710839|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153370707|NCT01710839|Growth Substances|growth substances|mesh-ancestor
153370708|NCT01710839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153370709|NCT01710839|Growth Inhibitors|growth inhibitors|mesh-ancestor
153370710|NCT01710839|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153370711|NCT01215110|Bedaquiline|bedaquiline|mesh-list
153370712|NCT01215110|Antitubercular Agents|antitubercular agents|mesh-ancestor
153370713|NCT01215110|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153370714|NCT01215110|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153370716|NCT02980757|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153370717|NCT02980757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153370719|NCT01229462|Brimonidine Tartrate|brimonidine tartrate|mesh-list
153370720|NCT01229462|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
153830666|NCT00498251|Respiratory System Agents|respiratory system agents|mesh-ancestor
153830667|NCT00498251|Tocolytic Agents|tocolytic agents|mesh-ancestor
153830668|NCT00498251|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153830669|NCT00498251|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
153830670|NCT00498251|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
153830671|NCT00498251|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153830672|NCT00498251|Adrenergic Agents|adrenergic agents|mesh-ancestor
153830673|NCT00498251|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153830674|NCT00498251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153830675|NCT00498251|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
153830676|NCT00498251|Cholinergic Agents|cholinergic agents|mesh-ancestor
153830677|NCT00502658|Vitamins|vitamins|mesh-list
153830678|NCT00502658|Micronutrients|micronutrients|mesh-ancestor
153830679|NCT00502658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153830680|NCT00502736|Ibandronic Acid|ibandronic acid|mesh-list
153830681|NCT00502736|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153830682|NCT00502736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153830683|NCT05146089|Bosentan|bosentan|mesh-list
153830684|NCT05146089|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153830685|NCT05146089|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
153370722|NCT01229462|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
153370723|NCT01229462|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
153370724|NCT01229462|Adrenergic Agents|adrenergic agents|mesh-ancestor
153830688|NCT02954913|Hematinics|hematinics|mesh-ancestor
153830689|NCT00502892|Carboplatin|carboplatin|mesh-list
153830690|NCT00502892|Topotecan|topotecan|mesh-list
153830691|NCT00502892|Ifosfamide|ifosfamide|mesh-list
153830692|NCT00502892|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153830693|NCT00502892|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
153830694|NCT00502892|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153830695|NCT00502892|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153830696|NCT00502892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153830697|NCT00502892|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153830699|NCT00502970|Interferons|interferons|mesh-list
153830700|NCT00502970|Ribavirin|ribavirin|mesh-list
153830701|NCT00502970|Iron-Dextran Complex|iron-dextran complex|mesh-list
153830702|NCT00502970|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153830703|NCT00502970|Antiviral Agents|antiviral agents|mesh-ancestor
153370762|NCT01231334|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153370763|NCT01231334|Antimalarials|antimalarials|mesh-ancestor
153370764|NCT01231334|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153370765|NCT01231334|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153370766|NCT01231334|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153370767|NCT01231334|Leprostatic Agents|leprostatic agents|mesh-ancestor
153370768|NCT01292798|Ranibizumab|ranibizumab|mesh-list
153370769|NCT01292798|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153370770|NCT01292798|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153370771|NCT01292798|Growth Substances|growth substances|mesh-ancestor
153370772|NCT01292798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153370773|NCT01292798|Growth Inhibitors|growth inhibitors|mesh-ancestor
153370774|NCT01292798|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153370775|NCT03009500|Methylprednisolone|methylprednisolone|mesh-list
153370776|NCT03009500|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
153370777|NCT03009500|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
153370778|NCT03009500|Prednisolone|prednisolone|mesh-list
153370779|NCT03009500|Prednisolone acetate|prednisolone acetate|mesh-list
153370781|NCT03009500|Bupivacaine|bupivacaine|mesh-list
153370782|NCT03009500|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
153370783|NCT03009500|Prednisolone phosphate|prednisolone phosphate|mesh-list
153370784|NCT03009500|Anesthetics, Local|anesthetics, local|mesh-ancestor
153370785|NCT03009500|Anesthetics|anesthetics|mesh-ancestor
153830727|NCT00498953|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153888229|NCT04303819|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153888230|NCT01301079|Ketamine|ketamine|mesh-list
153888231|NCT01301079|Analgesics|analgesics|mesh-ancestor
153888232|NCT01301079|Sensory System Agents|sensory system agents|mesh-ancestor
153888233|NCT01301079|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153888234|NCT01301079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153888235|NCT01301079|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
153888236|NCT01301079|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153888237|NCT01301079|Anesthetics, General|anesthetics, general|mesh-ancestor
153888238|NCT01301079|Anesthetics|anesthetics|mesh-ancestor
153888239|NCT01301079|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153370800|NCT03009500|Hormones|hormones|mesh-ancestor
153830755|NCT05145543|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153830756|NCT05145543|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153830757|NCT05145543|Narcotics|narcotics|mesh-ancestor
153830758|NCT05145543|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153888241|NCT01301079|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
153888242|NCT01301079|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153888243|NCT01301079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153888244|NCT05271721|Dexamethasone|dexamethasone|mesh-list
153888245|NCT05271721|Dexamethasone acetate|dexamethasone acetate|mesh-list
153888246|NCT05271721|BB 1101|bb 1101|mesh-list
153888247|NCT05271721|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153830767|NCT00503204|Lomustine|lomustine|mesh-list
153830768|NCT00503204|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153370801|NCT03009500|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153370802|NCT03009500|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
153370803|NCT03009500|Protective Agents|protective agents|mesh-ancestor
153370804|NCT03009500|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153370805|NCT03009500|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153370807|NCT01715207|Aliskiren|aliskiren|mesh-list
153370808|NCT01715207|Renin Inhibitors|renin inhibitors|mesh-ancestor
153370809|NCT01715207|Protease Inhibitors|protease inhibitors|mesh-ancestor
153370810|NCT01715207|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153370811|NCT01715207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153370812|NCT01715207|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153370813|NCT01715207|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153370814|NCT01715207|Sympatholytics|sympatholytics|mesh-ancestor
153370815|NCT01715207|Autonomic Agents|autonomic agents|mesh-ancestor
153370816|NCT01715207|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153370817|NCT01715207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153370829|NCT01716221|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153370830|NCT01716221|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
153830774|NCT00503243|Mesalamine|mesalamine|mesh-list
153830775|NCT00503243|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153830776|NCT00503243|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153830777|NCT00503243|Analgesics|analgesics|mesh-ancestor
153830778|NCT00503243|Sensory System Agents|sensory system agents|mesh-ancestor
153830779|NCT00503243|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153830780|NCT00503243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153830781|NCT00503243|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153830782|NCT00503243|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153830783|NCT00498992|Vitamin E|vitamin e|mesh-list
153830784|NCT00498992|Lidocaine|lidocaine|mesh-list
153830785|NCT00498992|Vitamins|vitamins|mesh-ancestor
153830786|NCT00498992|Micronutrients|micronutrients|mesh-ancestor
153830787|NCT00498992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153830788|NCT00498992|Anesthetics, Local|anesthetics, local|mesh-ancestor
153830789|NCT00498992|Anesthetics|anesthetics|mesh-ancestor
153830790|NCT00498992|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153830793|NCT00498992|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153830794|NCT00498992|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
153830795|NCT00498992|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153830796|NCT00498992|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153830797|NCT00498992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153830798|NCT00498992|Antioxidants|antioxidants|mesh-ancestor
153830799|NCT00498992|Protective Agents|protective agents|mesh-ancestor
153370833|NCT01716221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153370835|NCT01716221|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153370836|NCT01716221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153370837|NCT01716221|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
153370838|NCT01716221|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153370839|NCT01716221|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153370840|NCT01716221|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
153370841|NCT01716221|Serotonin Agents|serotonin agents|mesh-ancestor
153370842|NCT01716221|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
153370843|NCT01716221|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
153370844|NCT01716221|Parasympatholytics|parasympatholytics|mesh-ancestor
153370845|NCT01716221|Autonomic Agents|autonomic agents|mesh-ancestor
153370846|NCT01716221|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153370847|NCT01716221|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
153370848|NCT01716221|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
153370849|NCT01716221|Cholinergic Agents|cholinergic agents|mesh-ancestor
153370850|NCT01215344|Diphosphonates|diphosphonates|mesh-list
153370851|NCT01215344|Dexamethasone|dexamethasone|mesh-list
153370852|NCT01215344|Dexamethasone acetate|dexamethasone acetate|mesh-list
153370853|NCT01215344|Doxorubicin|doxorubicin|mesh-list
153370854|NCT01215344|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
153370855|NCT01215344|Lenalidomide|lenalidomide|mesh-list
153370856|NCT01215344|Bortezomib|bortezomib|mesh-list
153370857|NCT01215344|BB 1101|bb 1101|mesh-list
153370858|NCT01215344|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153370859|NCT01215344|Antiemetics|antiemetics|mesh-ancestor
153370860|NCT01215344|Autonomic Agents|autonomic agents|mesh-ancestor
153370861|NCT01215344|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153370862|NCT01215344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153370863|NCT01215344|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153370864|NCT01215344|Glucocorticoids|glucocorticoids|mesh-ancestor
153830801|NCT02276391|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153830802|NCT02276391|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
153830803|NCT02276391|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
153830804|NCT02276391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153830806|NCT05145270|Dexetimide|dexetimide|mesh-list
153830807|NCT05145270|Citalopram|citalopram|mesh-list
153830808|NCT05145270|Escitalopram|escitalopram|mesh-list
153830809|NCT05145270|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
153830810|NCT05145270|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153830811|NCT05145270|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153830812|NCT05145270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153830813|NCT05145270|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153830814|NCT05145270|Serotonin Agents|serotonin agents|mesh-ancestor
153830815|NCT05145270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153830816|NCT05145270|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
153830817|NCT05145270|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
153830818|NCT05145270|Parasympatholytics|parasympatholytics|mesh-ancestor
153830819|NCT05145270|Autonomic Agents|autonomic agents|mesh-ancestor
153830820|NCT05145270|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153830821|NCT05145270|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
153830822|NCT05145270|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
153830823|NCT05145270|Cholinergic Agents|cholinergic agents|mesh-ancestor
153830824|NCT05145270|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
153830825|NCT05145270|Antidepressive Agents|antidepressive agents|mesh-ancestor
153370876|NCT01215344|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153370877|NCT01215344|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153370878|NCT01215344|Growth Substances|growth substances|mesh-ancestor
153370879|NCT01215344|Growth Inhibitors|growth inhibitors|mesh-ancestor
153370880|NCT01215344|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153370882|NCT01231412|Sirolimus|sirolimus|mesh-list
153370883|NCT01231412|Mycophenolic Acid|mycophenolic acid|mesh-list
153370884|NCT01231412|Fludarabine|fludarabine|mesh-list
153370885|NCT01231412|Fludarabine phosphate|fludarabine phosphate|mesh-list
153370886|NCT01231412|Cyclosporins|cyclosporins|mesh-list
153370887|NCT01231412|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153830830|NCT00503321|polysaccharide-K|polysaccharide-k|mesh-list
153429328|NCT00002618|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153429329|NCT00002618|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153429330|NCT00002618|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153429331|NCT00002618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153429332|NCT00002618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153830831|NCT00503321|Tegafur|tegafur|mesh-list
153830832|NCT00503321|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153830833|NCT00503321|Antimetabolites|antimetabolites|mesh-ancestor
153830834|NCT00503321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153830835|NCT00503321|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153830836|NCT00503321|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153830837|NCT00503321|Immunologic Factors|immunologic factors|mesh-ancestor
153830838|NCT00503321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153830839|NCT00503321|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153429333|NCT00002618|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153429334|NCT00002618|Glucocorticoids|glucocorticoids|mesh-ancestor
153830840|NCT00503321|Antiviral Agents|antiviral agents|mesh-ancestor
153830841|NCT00503321|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153830842|NCT00503321|Interferon Inducers|interferon inducers|mesh-ancestor
153830843|NCT00503321|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
153830844|NCT00503321|Protective Agents|protective agents|mesh-ancestor
153370904|NCT01719653|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
153830859|NCT05144295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153830861|NCT01245452|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
153830862|NCT01245452|Abortifacient Agents|abortifacient agents|mesh-ancestor
153830863|NCT01245452|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153830864|NCT01245452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153830865|NCT01245452|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153830866|NCT01245452|Antimetabolites|antimetabolites|mesh-ancestor
153830867|NCT01245452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153830868|NCT01245452|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153830869|NCT01245452|Dermatologic Agents|dermatologic agents|mesh-ancestor
153830870|NCT01245452|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153370915|NCT04514393|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153370916|NCT04514393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153370917|NCT04514393|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153370919|NCT04514393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153370921|NCT04514393|Dermatologic Agents|dermatologic agents|mesh-ancestor
153370922|NCT04514393|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153370923|NCT04514393|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153370924|NCT04514393|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153370925|NCT04514393|Immunologic Factors|immunologic factors|mesh-ancestor
153370926|NCT04514393|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153370927|NCT04514393|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153370928|NCT04514393|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153370929|NCT04514393|Alkylating Agents|alkylating agents|mesh-ancestor
153370930|NCT04514393|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153370931|NCT04514393|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153370932|NCT01232504|Molgramostim|molgramostim|mesh-list
153370933|NCT01232504|Lenograstim|lenograstim|mesh-list
153370934|NCT01232504|Sargramostim|sargramostim|mesh-list
153370935|NCT01232504|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153370936|NCT01232504|Immunologic Factors|immunologic factors|mesh-ancestor
153830873|NCT01245452|Immunologic Factors|immunologic factors|mesh-ancestor
153830874|NCT01245452|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153830875|NCT01245452|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153830876|NCT00503516|Megestrol|megestrol|mesh-list
153830877|NCT00503516|Megestrol Acetate|megestrol acetate|mesh-list
153830878|NCT00503516|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
153830879|NCT00503516|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
153830880|NCT00503516|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
153830881|NCT00503516|Contraceptive Agents|contraceptive agents|mesh-ancestor
153830882|NCT00503516|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153830883|NCT00503516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153830884|NCT00503516|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
153830885|NCT00503516|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
153830886|NCT00503516|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153830887|NCT00503516|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153830888|NCT00503516|Appetite Stimulants|appetite stimulants|mesh-ancestor
153830895|NCT00499265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153830896|NCT00499265|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153830897|NCT00499265|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153830898|NCT01246622|Cytarabine|cytarabine|mesh-list
153370937|NCT01232504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153370938|NCT01232504|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153370939|NCT01737593|Acetaminophen|acetaminophen|mesh-list
153370940|NCT01737593|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153370941|NCT01737593|Analgesics|analgesics|mesh-ancestor
153370942|NCT01737593|Sensory System Agents|sensory system agents|mesh-ancestor
153370943|NCT01737593|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153370944|NCT01737593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153370945|NCT01737593|Antipyretics|antipyretics|mesh-ancestor
153370946|NCT01217840|Vitamin D|vitamin d|mesh-list
153370947|NCT01217840|Ergocalciferols|ergocalciferols|mesh-list
153370948|NCT01217840|Vitamins|vitamins|mesh-ancestor
153370949|NCT01217840|Micronutrients|micronutrients|mesh-ancestor
153370950|NCT01217840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153370951|NCT01217840|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153370952|NCT01217840|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153370953|NCT01721603|Trametinib|trametinib|mesh-list
153370956|NCT01721603|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153370958|NCT01721603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153370959|NCT01296542|Moxifloxacin|moxifloxacin|mesh-list
153370960|NCT01296542|Besifloxacin|besifloxacin|mesh-list
153370961|NCT01296542|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153370962|NCT01296542|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153370963|NCT01296542|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153370964|NCT01296542|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153370965|NCT01296542|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153370966|NCT01296542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153370967|NCT01296542|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153370968|NCT01234766|Rituximab|rituximab|mesh-list
153830924|NCT05148312|Autonomic Agents|autonomic agents|mesh-ancestor
153830925|NCT05148312|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153830926|NCT05148312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153830927|NCT05148312|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153830928|NCT05148312|Respiratory System Agents|respiratory system agents|mesh-ancestor
153830929|NCT05148312|Glucocorticoids|glucocorticoids|mesh-ancestor
153830930|NCT05148312|Hormones|hormones|mesh-ancestor
153830931|NCT05148312|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153370984|NCT01234922|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
153370985|NCT01234922|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
153370986|NCT01234922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153370987|NCT01234922|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
153370988|NCT01234922|Protease Inhibitors|protease inhibitors|mesh-ancestor
153370989|NCT01234922|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153370990|NCT01234922|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
153370991|NCT01234922|Protective Agents|protective agents|mesh-ancestor
153370995|NCT01337336|Tiotropium Bromide|tiotropium bromide|mesh-list
153370996|NCT01337336|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
153370997|NCT01337336|Ipratropium|ipratropium|mesh-list
153371020|NCT01242644|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
153371022|NCT01242644|Ropivacaine|ropivacaine|mesh-list
153371023|NCT01242644|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153371024|NCT01242644|Narcotics|narcotics|mesh-ancestor
153830953|NCT01245803|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153830954|NCT01245803|Antimetabolites|antimetabolites|mesh-ancestor
153830955|NCT01245803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153830956|NCT01245803|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153830957|NCT01245803|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
153830958|NCT01245803|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153830959|NCT05148975|Dimercaprol|dimercaprol|mesh-list
153830960|NCT05148975|Chelating Agents|chelating agents|mesh-ancestor
153830961|NCT05148975|Sequestering Agents|sequestering agents|mesh-ancestor
153830962|NCT05148975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153830963|NCT00499577|Vaccines|vaccines|mesh-list
153830964|NCT00499577|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
153830965|NCT00499577|Immunologic Factors|immunologic factors|mesh-ancestor
153830967|NCT02274740|Metformin|metformin|mesh-list
153830977|NCT00499733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153830978|NCT00499733|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153830979|NCT00499733|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153830980|NCT06155812|Vasoconstrictor Agents|vasoconstrictor agents|mesh-list
153830981|NCT06155760|Prednisolone|prednisolone|mesh-list
153371025|NCT01242644|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153371026|NCT01242644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153371027|NCT01242644|Analgesics|analgesics|mesh-ancestor
153371028|NCT01242644|Sensory System Agents|sensory system agents|mesh-ancestor
153371029|NCT01242644|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153371030|NCT01242644|Anesthetics, Local|anesthetics, local|mesh-ancestor
153371031|NCT01242644|Anesthetics|anesthetics|mesh-ancestor
153371032|NCT01242644|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153371033|NCT01242644|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153371034|NCT01242644|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153371035|NCT01242644|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153371036|NCT01242644|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153371037|NCT01242644|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153371038|NCT01242644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153371039|NCT01303406|Idebenone|idebenone|mesh-list
153371040|NCT01303406|Antioxidants|antioxidants|mesh-ancestor
153371041|NCT01303406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153371042|NCT01303406|Protective Agents|protective agents|mesh-ancestor
153371043|NCT01303406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153371044|NCT02597907|Aprepitant|aprepitant|mesh-list
153371045|NCT02597907|Palonosetron|palonosetron|mesh-list
153371046|NCT02597907|Ramosetron|ramosetron|mesh-list
153371047|NCT02597907|Antiemetics|antiemetics|mesh-ancestor
153888249|NCT05271721|Autonomic Agents|autonomic agents|mesh-ancestor
153888250|NCT05271721|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153888251|NCT05271721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153888252|NCT05271721|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153888253|NCT05271721|Glucocorticoids|glucocorticoids|mesh-ancestor
153371050|NCT02597907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153371051|NCT02597907|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153830982|NCT06155760|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153830989|NCT06155604|Dapagliflozin|dapagliflozin|mesh-list
153830990|NCT06155604|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
153830991|NCT06155604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153830992|NCT06155604|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153830993|NCT06155604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153830994|NCT06155578|Sodium metabisulfite|sodium metabisulfite|mesh-list
153830995|NCT06155578|Bronchoconstrictor Agents|bronchoconstrictor agents|mesh-ancestor
153830996|NCT06155578|Autonomic Agents|autonomic agents|mesh-ancestor
153830997|NCT06155578|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153830998|NCT06155578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153830999|NCT06155578|Respiratory System Agents|respiratory system agents|mesh-ancestor
153831000|NCT06155279|Carboplatin|carboplatin|mesh-list
153831001|NCT06155279|Pembrolizumab|pembrolizumab|mesh-list
153831002|NCT06155279|Pemetrexed|pemetrexed|mesh-list
153831003|NCT06155279|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153831004|NCT06155279|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153831005|NCT06155279|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153831006|NCT06155279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153831007|NCT06155279|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153831008|NCT06155279|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153831009|NCT06155279|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153831010|NCT06154967|Tislelizumab|tislelizumab|mesh-list
153831011|NCT06154967|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153831012|NCT06154967|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153831013|NCT06154902|Idecabtagene vicleucel|idecabtagene vicleucel|mesh-list
153831014|NCT06154902|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153831015|NCT06154902|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153831016|NCT06154642|Mitogens|mitogens|mesh-list
153831017|NCT06154642|Mitosis Modulators|mitosis modulators|mesh-ancestor
153831018|NCT06154642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153831019|NCT06154590|Tamoxifen|tamoxifen|mesh-list
153831020|NCT06154590|Fluorouracil|fluorouracil|mesh-list
153831021|NCT06154590|Melphalan|melphalan|mesh-list
153371074|NCT02600715|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153371075|NCT02600715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153371076|NCT02600715|Cholinergic Agents|cholinergic agents|mesh-ancestor
153371077|NCT02600715|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153371078|NCT04743297|Dinoprostone|dinoprostone|mesh-list
153371079|NCT04743297|Oxytocics|oxytocics|mesh-ancestor
153371080|NCT04743297|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153371081|NCT04743297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153371082|NCT04176783|Analgesics, Opioid|analgesics, opioid|mesh-list
153371083|NCT04176783|Narcotics|narcotics|mesh-ancestor
153371084|NCT04176783|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153371085|NCT04176783|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153371086|NCT04176783|Analgesics|analgesics|mesh-ancestor
153371087|NCT04176783|Sensory System Agents|sensory system agents|mesh-ancestor
153882718|NCT01580202|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153882719|NCT01580202|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153882720|NCT01649570|Insulin Aspart|insulin aspart|mesh-list
153882721|NCT01649570|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153882722|NCT01649570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153882723|NCT01609881|Ketorolac|ketorolac|mesh-list
153882724|NCT01609881|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153882725|NCT01609881|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153882726|NCT01609881|Analgesics|analgesics|mesh-ancestor
153371088|NCT04176783|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153371089|NCT00365313|Celecoxib|celecoxib|mesh-list
153371090|NCT00365313|Esomeprazole|esomeprazole|mesh-list
153371091|NCT00365313|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153371092|NCT00365313|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153371093|NCT00365313|Analgesics|analgesics|mesh-ancestor
153371094|NCT00365313|Sensory System Agents|sensory system agents|mesh-ancestor
153371095|NCT00365313|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153371096|NCT00365313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153371097|NCT00365313|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153371098|NCT00365313|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153371099|NCT00365313|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
153831038|NCT06154590|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153831039|NCT06154486|Semaglutide|semaglutide|mesh-list
153831040|NCT06154486|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
153831041|NCT06154486|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153831042|NCT06154486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153831043|NCT06154304|Albuterol|albuterol|mesh-list
153831044|NCT06154304|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153831045|NCT06154304|Autonomic Agents|autonomic agents|mesh-ancestor
153831046|NCT06154304|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153831047|NCT06154304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153831048|NCT06154304|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153831049|NCT06154304|Respiratory System Agents|respiratory system agents|mesh-ancestor
153831050|NCT06154304|Tocolytic Agents|tocolytic agents|mesh-ancestor
153831051|NCT06154304|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153831052|NCT06154304|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
153831053|NCT06154304|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
153831054|NCT06154304|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153831055|NCT06154304|Adrenergic Agents|adrenergic agents|mesh-ancestor
153831056|NCT06154304|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153831057|NCT06154304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153831058|NCT06154200|Testosterone|testosterone|mesh-list
153831059|NCT06154200|Androgens|androgens|mesh-list
153831060|NCT06154200|Hormones|hormones|mesh-ancestor
153371107|NCT02605395|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
153371108|NCT02605395|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153371109|NCT02605395|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
153371110|NCT02605395|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153371111|NCT02605395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153371112|NCT04343001|Aspirin|aspirin|mesh-list
153371113|NCT04343001|Losartan|losartan|mesh-list
153371114|NCT04343001|Simvastatin|simvastatin|mesh-list
153371115|NCT04343001|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153371116|NCT04343001|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153888260|NCT05271721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153888261|NCT01301001|Gabapentin|gabapentin|mesh-list
153888262|NCT01301001|Analgesics|analgesics|mesh-ancestor
153888263|NCT01301001|Sensory System Agents|sensory system agents|mesh-ancestor
153888264|NCT01301001|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153888265|NCT01301001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153888266|NCT01301001|Anticonvulsants|anticonvulsants|mesh-ancestor
153888267|NCT01301001|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153888268|NCT01301001|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153888269|NCT01301001|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153888270|NCT01301001|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153429339|NCT00002618|Abortifacient Agents|abortifacient agents|mesh-ancestor
153429340|NCT00002618|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153429341|NCT00002618|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153429342|NCT00002618|Antimetabolites|antimetabolites|mesh-ancestor
153429343|NCT00002618|Dermatologic Agents|dermatologic agents|mesh-ancestor
153429344|NCT00002618|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153429345|NCT00002618|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153429346|NCT00002618|Immunologic Factors|immunologic factors|mesh-ancestor
153371134|NCT04343001|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
153831061|NCT06154200|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153831062|NCT06154200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153831063|NCT06145360|Metformin|metformin|mesh-list
153831064|NCT06145360|Empagliflozin|empagliflozin|mesh-list
153831065|NCT06145360|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
153831066|NCT06145360|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153831067|NCT06145360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153831068|NCT06145360|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
153831069|NCT06145360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153831070|NCT06145360|Protease Inhibitors|protease inhibitors|mesh-ancestor
153831071|NCT06145360|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153831072|NCT06126419|Insulin|insulin|mesh-list
153429347|NCT00002618|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153429348|NCT00002618|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153429349|NCT00002618|Antiviral Agents|antiviral agents|mesh-ancestor
153429350|NCT00002618|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153429361|NCT02145169|Nitrous Oxide|nitrous oxide|mesh-list
153831095|NCT06039566|Free Radical Scavengers|free radical scavengers|mesh-ancestor
153831096|NCT06039566|Antioxidants|antioxidants|mesh-ancestor
153831097|NCT06039566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153831098|NCT06039566|Protective Agents|protective agents|mesh-ancestor
153831099|NCT06039566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153831100|NCT06039566|Antidotes|antidotes|mesh-ancestor
153831101|NCT06030622|Metformin|metformin|mesh-list
153831102|NCT06030622|Digoxin|digoxin|mesh-list
153831103|NCT06030622|Simvastatin|simvastatin|mesh-list
153831104|NCT06030622|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153831105|NCT06030622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153831106|NCT06030622|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153831107|NCT06030622|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153831108|NCT06030622|Antimetabolites|antimetabolites|mesh-ancestor
153831109|NCT06030622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153831110|NCT06030622|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153831111|NCT06030622|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
153831112|NCT06030622|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153831113|NCT06030622|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153371161|NCT01739699|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153371162|NCT01739699|Analgesics|analgesics|mesh-ancestor
153371163|NCT01739699|Sensory System Agents|sensory system agents|mesh-ancestor
153371164|NCT01739699|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153371165|NCT01739699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153371166|NCT01739699|Antipyretics|antipyretics|mesh-ancestor
153371167|NCT04154787|Rituximab|rituximab|mesh-list
153371168|NCT04154787|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153371169|NCT04154787|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153371170|NCT04154787|Immunologic Factors|immunologic factors|mesh-ancestor
153371171|NCT04154787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153371172|NCT04154787|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153371173|NCT01740713|Deferiprone|deferiprone|mesh-list
153371174|NCT01740713|Iron Chelating Agents|iron chelating agents|mesh-ancestor
153371175|NCT01740713|Chelating Agents|chelating agents|mesh-ancestor
153371176|NCT01740713|Sequestering Agents|sequestering agents|mesh-ancestor
153371182|NCT02613117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153371183|NCT01742117|Clopidogrel|clopidogrel|mesh-list
153371185|NCT01742117|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153371186|NCT01742117|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
153371187|NCT01742117|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
153371188|NCT01742117|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
153371189|NCT01742117|Purinergic Agents|purinergic agents|mesh-ancestor
153371190|NCT01742117|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153831114|NCT06030622|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
153831115|NCT06030622|Protective Agents|protective agents|mesh-ancestor
153831116|NCT05929664|Cemiplimab|cemiplimab|mesh-list
153831117|NCT05929664|Immunoglobulins|immunoglobulins|mesh-list
153831118|NCT05929664|Immunoglobulin G|immunoglobulin g|mesh-list
153831119|NCT05929664|Immunologic Factors|immunologic factors|mesh-ancestor
153831130|NCT05915104|Respiratory System Agents|respiratory system agents|mesh-ancestor
153831131|NCT05915104|Glucocorticoids|glucocorticoids|mesh-ancestor
153831132|NCT05915104|Hormones|hormones|mesh-ancestor
153831134|NCT05893225|Metformin|metformin|mesh-list
153831152|NCT05851508|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153831153|NCT05851508|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
153831154|NCT05851508|Protective Agents|protective agents|mesh-ancestor
153831155|NCT05851508|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153831156|NCT05851508|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153831157|NCT05844436|Pritelivir|pritelivir|mesh-list
153831158|NCT05844436|Antiviral Agents|antiviral agents|mesh-ancestor
153831159|NCT05844436|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153371206|NCT02615535|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153371207|NCT02615535|Vasodilator Agents|vasodilator agents|mesh-ancestor
153371208|NCT02615535|Urological Agents|urological agents|mesh-ancestor
153371209|NCT05732181|Lidocaine|lidocaine|mesh-list
153371210|NCT05732181|Anesthetics, Local|anesthetics, local|mesh-ancestor
153371211|NCT05732181|Anesthetics|anesthetics|mesh-ancestor
153371212|NCT05732181|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153371213|NCT05732181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153371214|NCT05732181|Sensory System Agents|sensory system agents|mesh-ancestor
153371215|NCT05732181|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153371216|NCT05732181|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153371217|NCT05732181|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
153371218|NCT05732181|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153371219|NCT05732181|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153371220|NCT05732181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153371221|NCT01342172|Lenalidomide|lenalidomide|mesh-list
153371222|NCT01342172|Immunologic Factors|immunologic factors|mesh-ancestor
153371223|NCT01342172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153371224|NCT01342172|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153371225|NCT01342172|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153371226|NCT01342172|Growth Substances|growth substances|mesh-ancestor
153371227|NCT01342172|Growth Inhibitors|growth inhibitors|mesh-ancestor
153371228|NCT01342172|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153371229|NCT01243112|Lidocaine|lidocaine|mesh-list
153371230|NCT01243112|Epinephrine|epinephrine|mesh-list
153371231|NCT01243112|Racepinephrine|racepinephrine|mesh-list
153371232|NCT01243112|Bupivacaine|bupivacaine|mesh-list
153371233|NCT01243112|Epinephryl borate|epinephryl borate|mesh-list
153371235|NCT01243112|Anesthetics|anesthetics|mesh-ancestor
153831160|NCT05844436|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153831161|NCT05844436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153831162|NCT05809011|Dexamethasone|dexamethasone|mesh-list
153831163|NCT05809011|Prednisone|prednisone|mesh-list
153831164|NCT05809011|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153831165|NCT05809011|Antiemetics|antiemetics|mesh-ancestor
153831166|NCT05809011|Autonomic Agents|autonomic agents|mesh-ancestor
153831167|NCT05809011|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153831168|NCT05809011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153831169|NCT05809011|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153831170|NCT05809011|Glucocorticoids|glucocorticoids|mesh-ancestor
153831179|NCT05801419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153831181|NCT05801419|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
153831182|NCT05801419|Cholinergic Agents|cholinergic agents|mesh-ancestor
153831183|NCT05801419|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153831184|NCT05801419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153831185|NCT05789069|Tislelizumab|tislelizumab|mesh-list
153831186|NCT05789069|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153831187|NCT05789069|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153831188|NCT05763693|Azithromycin|azithromycin|mesh-list
153371237|NCT01243112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153371239|NCT01243112|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153371240|NCT01243112|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153371241|NCT01243112|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
153371242|NCT01243112|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153371243|NCT01243112|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153371244|NCT01243112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153371245|NCT01243112|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153371246|NCT01243112|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153371247|NCT01243112|Adrenergic Agents|adrenergic agents|mesh-ancestor
153371263|NCT01243580|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
153371264|NCT01243580|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153371265|NCT01243580|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153371266|NCT01243580|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153371267|NCT01243580|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153371268|NCT01243580|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153371269|NCT01243580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153371270|NCT01243580|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153371271|NCT01243580|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
153831189|NCT05763693|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153831190|NCT05763693|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153831191|NCT05750264|Ibuprofen|ibuprofen|mesh-list
153831192|NCT05750264|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153831193|NCT05750264|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153831194|NCT05750264|Analgesics|analgesics|mesh-ancestor
153831195|NCT05750264|Sensory System Agents|sensory system agents|mesh-ancestor
153831196|NCT05750264|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153831197|NCT05750264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153831199|NCT05750264|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153831200|NCT05750264|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153831201|NCT05750264|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153831202|NCT05750264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153831203|NCT05646459|Cannabidiol|cannabidiol|mesh-list
153831204|NCT05646459|Anticonvulsants|anticonvulsants|mesh-ancestor
153831205|NCT05638633|Vitamins|vitamins|mesh-list
153831206|NCT05638633|Vitamin B Complex|vitamin b complex|mesh-list
153831207|NCT05638633|Prednisolone|prednisolone|mesh-list
153831208|NCT05638633|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
153831209|NCT05638633|Methylprednisolone|methylprednisolone|mesh-list
153831210|NCT05638633|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
153831219|NCT05638633|Hormones|hormones|mesh-ancestor
153371280|NCT00361803|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153371281|NCT00361803|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153371282|NCT00361803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153371283|NCT00361803|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153371284|NCT00361881|Acyclovir|acyclovir|mesh-list
153371285|NCT00361881|Hydrocortisone|hydrocortisone|mesh-list
153371286|NCT00361881|Antiviral Agents|antiviral agents|mesh-ancestor
153371287|NCT00361881|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153371288|NCT00361881|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153371289|NCT01743677|Moxifloxacin|moxifloxacin|mesh-list
153371290|NCT01743677|Tofacitinib|tofacitinib|mesh-list
153371291|NCT01743677|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153371292|NCT01743677|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153371293|NCT01743677|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153371294|NCT01743677|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153371295|NCT01743677|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153371296|NCT01743677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153371297|NCT01743677|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153371298|NCT01743677|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
153371299|NCT01743677|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153371300|NCT00365937|Monatide (IMS 3015)|monatide (ims 3015)|mesh-list
153371301|NCT00365937|Adjuvants, Immunologic|adjuvants, immunologic|mesh-list
153371302|NCT00365937|Immunologic Factors|immunologic factors|mesh-ancestor
153371303|NCT00365937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153371304|NCT01246076|Lenalidomide|lenalidomide|mesh-list
153371305|NCT01246076|Immunologic Factors|immunologic factors|mesh-ancestor
153831227|NCT05638633|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
153831228|NCT05638633|Protective Agents|protective agents|mesh-ancestor
153831229|NCT05635604|Pituitary Adenylate Cyclase-Activating Polypeptide|pituitary adenylate cyclase-activating polypeptide|mesh-list
153831230|NCT05635604|Growth Substances|growth substances|mesh-ancestor
153831231|NCT05635604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153831232|NCT05635604|Vasodilator Agents|vasodilator agents|mesh-ancestor
153831233|NCT05635604|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153831234|NCT05635604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153831236|NCT05555732|Pembrolizumab|pembrolizumab|mesh-list
153831237|NCT05555732|Pemetrexed|pemetrexed|mesh-list
153831238|NCT05555732|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153831239|NCT05555732|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153831244|NCT05555732|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153831246|NCT05480111|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153423614|NCT02213094|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153423615|NCT02213094|Vasodilator Agents|vasodilator agents|mesh-ancestor
153423616|NCT01629966|Vilazodone Hydrochloride|vilazodone hydrochloride|mesh-list
153423624|NCT01629966|Serotonin Agents|serotonin agents|mesh-ancestor
153831247|NCT05480111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153831248|NCT05439005|Dexmedetomidine|dexmedetomidine|mesh-list
153831249|NCT05439005|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153831250|NCT05439005|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153831251|NCT05439005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153831252|NCT05439005|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153831253|NCT05439005|Analgesics|analgesics|mesh-ancestor
153371313|NCT00364455|Hematinics|hematinics|mesh-ancestor
153371314|NCT01307462|Fluticasone|fluticasone|mesh-list
153371316|NCT01307462|Azithromycin|azithromycin|mesh-list
153371317|NCT01307462|Montelukast|montelukast|mesh-list
153371318|NCT01307462|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153371319|NCT01307462|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153371320|NCT01307462|Autonomic Agents|autonomic agents|mesh-ancestor
153371321|NCT01307462|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153371322|NCT01307462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153371323|NCT01307462|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153371324|NCT01307462|Respiratory System Agents|respiratory system agents|mesh-ancestor
153371325|NCT01307462|Dermatologic Agents|dermatologic agents|mesh-ancestor
153371326|NCT01307462|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
153371327|NCT01307462|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153371328|NCT01307462|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153371329|NCT01307462|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
153371330|NCT01307462|Hormone Antagonists|hormone antagonists|mesh-ancestor
153371331|NCT01307462|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153371332|NCT01307462|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
153371333|NCT01307462|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
153371335|NCT05731089|Aflibercept|aflibercept|mesh-list
153831265|NCT05429580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153831267|NCT05429580|Coagulants|coagulants|mesh-ancestor
153831269|NCT05401565|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
153831270|NCT05401565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153831271|NCT05401565|Natriuretic Agents|natriuretic agents|mesh-ancestor
153831272|NCT05401565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153831273|NCT05362318|Nicotine|nicotine|mesh-list
153831274|NCT05362318|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
153831275|NCT05362318|Autonomic Agents|autonomic agents|mesh-ancestor
153831276|NCT05362318|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153831277|NCT05362318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153831278|NCT05362318|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
153831279|NCT05362318|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
153831280|NCT05362318|Cholinergic Agents|cholinergic agents|mesh-ancestor
153831281|NCT05362318|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153831282|NCT05362318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153831283|NCT05229042|Ricolinostat|ricolinostat|mesh-list
153831284|NCT05229042|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153831285|NCT05229042|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
153831286|NCT05229042|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153371360|NCT01746095|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153371362|NCT05730777|Carboplatin|carboplatin|mesh-list
153831299|NCT05187182|Pembrolizumab|pembrolizumab|mesh-list
153831300|NCT05187182|Nivolumab|nivolumab|mesh-list
153831301|NCT05187182|Trastuzumab|trastuzumab|mesh-list
153831302|NCT05187182|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153831303|NCT05187182|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153831304|NCT05187182|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153831305|NCT05187182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153831306|NCT05146739|Leucovorin|leucovorin|mesh-list
153831307|NCT05146739|Cytarabine|cytarabine|mesh-list
153831308|NCT05146739|Fludarabine|fludarabine|mesh-list
153831309|NCT05146739|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153831310|NCT05146739|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153831311|NCT05146739|Antimetabolites|antimetabolites|mesh-ancestor
153831312|NCT05146739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153831313|NCT05146739|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153831314|NCT05146739|Immunologic Factors|immunologic factors|mesh-ancestor
153831315|NCT05146739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153831316|NCT05146739|Antiviral Agents|antiviral agents|mesh-ancestor
153831317|NCT05146739|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153831318|NCT05146739|Antidotes|antidotes|mesh-ancestor
153831319|NCT05146739|Protective Agents|protective agents|mesh-ancestor
153831320|NCT05146739|Vitamin B Complex|vitamin b complex|mesh-ancestor
153831321|NCT05146739|Vitamins|vitamins|mesh-ancestor
153831322|NCT05146739|Micronutrients|micronutrients|mesh-ancestor
153831323|NCT05135715|Trastuzumab|trastuzumab|mesh-list
153831324|NCT05135715|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153831325|NCT05135715|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153831326|NCT05111002|Doxycycline|doxycycline|mesh-list
153831327|NCT05111002|Lefamulin|lefamulin|mesh-list
153831328|NCT05111002|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153831329|NCT05111002|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153831330|NCT05111002|Antimalarials|antimalarials|mesh-ancestor
153831331|NCT05111002|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153371399|NCT01309802|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153371400|NCT01309802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153371401|NCT01309802|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
153371402|NCT01309802|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153371404|NCT00366093|Zopiclone|zopiclone|mesh-list
153371405|NCT00366093|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153371406|NCT00366093|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153371407|NCT00366093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153371408|NCT04379999|Aspirin|aspirin|mesh-list
153371409|NCT04379999|Atorvastatin|atorvastatin|mesh-list
153371410|NCT04379999|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153371411|NCT04379999|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153371412|NCT04379999|Analgesics|analgesics|mesh-ancestor
153371413|NCT04379999|Sensory System Agents|sensory system agents|mesh-ancestor
153371414|NCT04379999|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153371415|NCT04379999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153371416|NCT04379999|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153371417|NCT04379999|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153371418|NCT04379999|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153371419|NCT04379999|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153831340|NCT05091346|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153831341|NCT05037812|Ketorolac|ketorolac|mesh-list
153831342|NCT05037812|Clonidine|clonidine|mesh-list
153831352|NCT05037812|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153831353|NCT05037812|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153831354|NCT05037812|Adrenergic Agents|adrenergic agents|mesh-ancestor
153831355|NCT05037812|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153831356|NCT05037812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153831357|NCT05037812|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
153831358|NCT05037812|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153831359|NCT05037812|Autonomic Agents|autonomic agents|mesh-ancestor
153831360|NCT05037812|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153831361|NCT05037812|Respiratory System Agents|respiratory system agents|mesh-ancestor
153831362|NCT05037812|Mydriatics|mydriatics|mesh-ancestor
153831363|NCT05037812|Sympathomimetics|sympathomimetics|mesh-ancestor
153831364|NCT05037812|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
153831365|NCT05037812|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153831366|NCT05037812|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153831367|NCT05037812|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153831368|NCT05037812|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153831369|NCT05037812|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153831370|NCT05037812|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153831371|NCT05037812|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153831372|NCT05037812|Sympatholytics|sympatholytics|mesh-ancestor
153831373|NCT05037812|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
153831374|NCT05019638|Ketorolac|ketorolac|mesh-list
153831375|NCT05019638|Epinephrine|epinephrine|mesh-list
153371446|NCT05730621|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153371447|NCT05730621|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153371448|NCT05730621|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153371449|NCT05730621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153371450|NCT05730621|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153371451|NCT05730621|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153371452|NCT05730621|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153371454|NCT05730621|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153371455|NCT05730621|Serotonin Agents|serotonin agents|mesh-ancestor
153371456|NCT05730621|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153371457|NCT01346072|Tolvaptan|tolvaptan|mesh-list
153371458|NCT01346072|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
153371459|NCT01346072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153371461|NCT01346072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153371462|NCT04292483|Nitric Oxide|nitric oxide|mesh-list
153371463|NCT04292483|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153371464|NCT04292483|Autonomic Agents|autonomic agents|mesh-ancestor
153371465|NCT04292483|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153371466|NCT04292483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153371467|NCT04292483|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153371468|NCT04292483|Respiratory System Agents|respiratory system agents|mesh-ancestor
153831389|NCT05019638|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153831390|NCT05019638|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153831391|NCT05019638|Adrenergic Agents|adrenergic agents|mesh-ancestor
153831392|NCT05019638|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153831393|NCT05019638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153831394|NCT05019638|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
153831395|NCT05019638|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153831396|NCT05019638|Autonomic Agents|autonomic agents|mesh-ancestor
153831397|NCT05019638|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153831398|NCT05019638|Respiratory System Agents|respiratory system agents|mesh-ancestor
153831399|NCT05019638|Mydriatics|mydriatics|mesh-ancestor
153831400|NCT05019638|Sympathomimetics|sympathomimetics|mesh-ancestor
153831401|NCT05019638|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
153831402|NCT05019638|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153831403|NCT05019638|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153831404|NCT05019638|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153831412|NCT05019430|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153831413|NCT05019430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153831414|NCT05019430|Sensory System Agents|sensory system agents|mesh-ancestor
153831415|NCT05019430|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153831416|NCT05019430|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
153831417|NCT05019430|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
153831418|NCT05019430|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153831419|NCT05019430|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153371469|NCT04292483|Free Radical Scavengers|free radical scavengers|mesh-ancestor
153371471|NCT04292483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153371472|NCT04292483|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153371483|NCT01347008|Sequestering Agents|sequestering agents|mesh-ancestor
153371484|NCT01347008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153371485|NCT01347008|Vasodilator Agents|vasodilator agents|mesh-ancestor
153831434|NCT04949399|Cholinergic Agents|cholinergic agents|mesh-ancestor
153371486|NCT01347008|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
153371487|NCT01347008|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
153371488|NCT01347008|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153371489|NCT01347008|Urological Agents|urological agents|mesh-ancestor
153371491|NCT05343429|Benzydamine|benzydamine|mesh-list
153371505|NCT05343429|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153371507|NCT01349114|Aliskiren|aliskiren|mesh-list
153371508|NCT01349114|Renin Inhibitors|renin inhibitors|mesh-ancestor
153371509|NCT01349114|Protease Inhibitors|protease inhibitors|mesh-ancestor
153371510|NCT01349114|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153371511|NCT01349114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153371512|NCT01310582|Sevoflurane|sevoflurane|mesh-list
153371513|NCT01310582|Desflurane|desflurane|mesh-list
153371514|NCT01310582|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153371515|NCT01310582|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
153371516|NCT01310582|Anesthetics, General|anesthetics, general|mesh-ancestor
153371517|NCT01310582|Anesthetics|anesthetics|mesh-ancestor
153371518|NCT01310582|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153831447|NCT04893174|Viscosupplements|viscosupplements|mesh-ancestor
153831448|NCT04893174|Protective Agents|protective agents|mesh-ancestor
153831449|NCT04829916|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
153831450|NCT04768881|Pembrolizumab|pembrolizumab|mesh-list
153831451|NCT04768881|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153831452|NCT04768881|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153831453|NCT04768881|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153831454|NCT04768881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153831455|NCT04761822|Vaccines|vaccines|mesh-list
153831456|NCT04761822|Immunologic Factors|immunologic factors|mesh-ancestor
153831457|NCT04761822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153831459|NCT04729543|Interleukin-2|interleukin-2|mesh-list
153831460|NCT04729543|Valproic Acid|valproic acid|mesh-list
153831461|NCT04729543|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153831462|NCT04729543|Antimetabolites|antimetabolites|mesh-ancestor
153831463|NCT04729543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153831464|NCT04729543|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153831465|NCT04729543|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153831466|NCT04729543|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153831467|NCT04729543|Analgesics|analgesics|mesh-ancestor
153831468|NCT04729543|Sensory System Agents|sensory system agents|mesh-ancestor
153371520|NCT01311674|Vaccines|vaccines|mesh-list
153371521|NCT01311674|Immunologic Factors|immunologic factors|mesh-ancestor
153371522|NCT01311674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153371523|NCT05081193|Methyltestosterone|methyltestosterone|mesh-list
153371524|NCT05081193|Testosterone|testosterone|mesh-list
153371525|NCT05081193|Testosterone undecanoate|testosterone undecanoate|mesh-list
153371526|NCT05081193|Testosterone enanthate|testosterone enanthate|mesh-list
153371527|NCT05081193|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
153371528|NCT05081193|Androgens|androgens|mesh-ancestor
153371529|NCT05081193|Hormones|hormones|mesh-ancestor
153371530|NCT05081193|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153371531|NCT05081193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153371532|NCT05081193|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153371533|NCT05081193|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153371535|NCT01349972|Cytarabine|cytarabine|mesh-list
153371538|NCT01349972|Alvocidib|alvocidib|mesh-list
153371540|NCT01349972|Antimetabolites|antimetabolites|mesh-ancestor
153371541|NCT01349972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153371542|NCT01349972|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153371543|NCT01349972|Antiviral Agents|antiviral agents|mesh-ancestor
153371544|NCT01349972|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153371545|NCT01349972|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153371546|NCT01349972|Immunologic Factors|immunologic factors|mesh-ancestor
153371547|NCT01349972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153371548|NCT01349972|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153371549|NCT01349972|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153371550|NCT01349972|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153371551|NCT01349972|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153371552|NCT01349972|Analgesics|analgesics|mesh-ancestor
153371553|NCT01349972|Sensory System Agents|sensory system agents|mesh-ancestor
153371554|NCT01349972|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153371555|NCT01349972|Growth Inhibitors|growth inhibitors|mesh-ancestor
153831469|NCT04729543|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153831470|NCT04729543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153831471|NCT04729543|Anticonvulsants|anticonvulsants|mesh-ancestor
153831472|NCT04729543|GABA Agents|gaba agents|mesh-ancestor
153831473|NCT04729543|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153831474|NCT04729543|Antimanic Agents|antimanic agents|mesh-ancestor
153831475|NCT04729543|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153831476|NCT04729543|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153831477|NCT04729543|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153831479|NCT04692285|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
153831480|NCT04692285|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153831481|NCT04692285|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153831482|NCT04692285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153831483|NCT04692285|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
153831484|NCT04692285|GABA Agonists|gaba agonists|mesh-ancestor
153831485|NCT04692285|GABA Agents|gaba agents|mesh-ancestor
153831486|NCT04692285|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153831487|NCT04692285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153831488|NCT04690855|Atezolizumab|atezolizumab|mesh-list
153831489|NCT04690855|Talazoparib|talazoparib|mesh-list
153831490|NCT04690855|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153831491|NCT04690855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153831492|NCT04690855|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153831493|NCT04690855|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153831494|NCT04690855|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
153831496|NCT04634539|Paclitaxel|paclitaxel|mesh-list
153831497|NCT04634539|Gemcitabine|gemcitabine|mesh-list
153831498|NCT04634539|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153831499|NCT04634539|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153831500|NCT04634539|Tubulin Modulators|tubulin modulators|mesh-ancestor
153831501|NCT04634539|Antimitotic Agents|antimitotic agents|mesh-ancestor
153831502|NCT04634539|Mitosis Modulators|mitosis modulators|mesh-ancestor
153831503|NCT04634539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153831504|NCT04634539|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153831505|NCT04634539|Antimetabolites|antimetabolites|mesh-ancestor
153371556|NCT01349972|Growth Substances|growth substances|mesh-ancestor
153371557|NCT01349972|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153371558|NCT01248104|Tranexamic Acid|tranexamic acid|mesh-list
153371559|NCT01248104|Aminocaproic Acid|aminocaproic acid|mesh-list
153371560|NCT01248104|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
153371561|NCT01248104|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153371562|NCT01248104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153371563|NCT01248104|Hemostatics|hemostatics|mesh-ancestor
153371564|NCT01248104|Coagulants|coagulants|mesh-ancestor
153371565|NCT01748045|Nitric Oxide|nitric oxide|mesh-list
153371566|NCT01748045|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153371567|NCT01748045|Autonomic Agents|autonomic agents|mesh-ancestor
153371568|NCT01748045|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153371580|NCT01312766|Menotropins|menotropins|mesh-list
153371581|NCT01312766|Fertility Agents, Female|fertility agents, female|mesh-ancestor
153371582|NCT01312766|Fertility Agents|fertility agents|mesh-ancestor
153371583|NCT01312766|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153371584|NCT01312766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153371585|NCT01749215|Topiramate|topiramate|mesh-list
153371586|NCT01749215|Anticonvulsants|anticonvulsants|mesh-ancestor
153371587|NCT01749215|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153371588|NCT01749215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153371589|NCT04522167|Aflibercept|aflibercept|mesh-list
153371590|NCT04522167|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153371591|NCT04522167|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153831506|NCT04557878|Mitogens|mitogens|mesh-list
153831507|NCT04557878|Mitosis Modulators|mitosis modulators|mesh-ancestor
153831508|NCT04557878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153831509|NCT04513912|Quetiapine Fumarate|quetiapine fumarate|mesh-list
153831510|NCT04513912|Antidepressive Agents|antidepressive agents|mesh-ancestor
153831511|NCT04513912|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153831512|NCT04513912|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153831513|NCT04513912|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153831514|NCT04513912|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153831515|NCT04513912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153831516|NCT04510311|3-Iodobenzylguanidine|3-iodobenzylguanidine|mesh-list
153831517|NCT04510311|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153831518|NCT04510311|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153831519|NCT04510311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153831520|NCT04510311|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
153831521|NCT04484337|Cabotegravir|cabotegravir|mesh-list
153831522|NCT04484337|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
153831524|NCT04484337|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
153831525|NCT04484337|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
153831526|NCT04484337|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153831527|NCT04484337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153831528|NCT04484337|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153831529|NCT04484337|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153831530|NCT04484337|Antiviral Agents|antiviral agents|mesh-ancestor
153831531|NCT04484337|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153831532|NCT04484337|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153831533|NCT04484337|Analgesics|analgesics|mesh-ancestor
153831534|NCT04484337|Sensory System Agents|sensory system agents|mesh-ancestor
153831535|NCT04484337|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153831536|NCT04484337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153831537|NCT04484337|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153831538|NCT04473053|Nafamostat|nafamostat|mesh-list
153831539|NCT04473053|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153371592|NCT04522167|Growth Substances|growth substances|mesh-ancestor
153371593|NCT04522167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153371594|NCT04522167|Growth Inhibitors|growth inhibitors|mesh-ancestor
153371595|NCT04522167|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153371596|NCT01248416|Letrozole|letrozole|mesh-list
153371597|NCT01248416|Anastrozole|anastrozole|mesh-list
153371599|NCT01248416|Aromatase Inhibitors|aromatase inhibitors|mesh-list
153371600|NCT01248416|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153371601|NCT01248416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153371602|NCT01248416|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153371603|NCT01248416|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153371627|NCT01250210|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153371629|NCT01250210|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
153371630|NCT01250210|Contraceptive Agents|contraceptive agents|mesh-ancestor
153371631|NCT01250210|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153371632|NCT01250210|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
153371633|NCT01250210|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
153371634|NCT01250210|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
153371635|NCT01250210|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
153371636|NCT01250210|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
153371637|NCT01749605|Ciprofloxacin|ciprofloxacin|mesh-list
153371638|NCT01749605|Nitrofurantoin|nitrofurantoin|mesh-list
153371639|NCT01749605|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153371640|NCT01749605|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153371641|NCT01749605|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153831572|NCT04387201|Micronutrients|micronutrients|mesh-ancestor
153831573|NCT04387201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153831574|NCT04387201|Vitamin B Complex|vitamin b complex|mesh-ancestor
153831575|NCT04387201|Hematinics|hematinics|mesh-ancestor
153831576|NCT04387201|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
153831577|NCT04387201|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153831578|NCT04331288|Ethanol|ethanol|mesh-list
153831579|NCT04331288|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
153831580|NCT04331288|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153831581|NCT04331288|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153831582|NCT04331288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153831583|NCT04230759|Fluorouracil|fluorouracil|mesh-list
153371659|NCT01312844|Cholinergic Agents|cholinergic agents|mesh-ancestor
153371660|NCT01312844|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153371661|NCT01312844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153371662|NCT01312844|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
153371663|NCT01312844|Parasympatholytics|parasympatholytics|mesh-ancestor
153371664|NCT01750931|Meloxicam|meloxicam|mesh-list
153831604|NCT04177095|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153831605|NCT04177095|Glucocorticoids|glucocorticoids|mesh-ancestor
153831606|NCT04177095|Hormones|hormones|mesh-ancestor
153831607|NCT04177095|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153831608|NCT04177095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153831609|NCT04177095|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153831610|NCT04177095|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153831611|NCT04177095|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
153831612|NCT04177095|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153371670|NCT01750931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153371671|NCT01750931|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153371672|NCT01750931|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153371673|NCT01750931|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
153371674|NCT01750931|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153371675|NCT01750931|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153371676|NCT01750931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153371678|NCT01731041|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153371679|NCT01731041|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
153371680|NCT01731041|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
153371681|NCT01731041|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
153371682|NCT01731041|Purinergic Agents|purinergic agents|mesh-ancestor
153371683|NCT01731041|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153371684|NCT01731041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153371685|NCT01731041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153371686|NCT01313936|3-Iodobenzylguanidine|3-iodobenzylguanidine|mesh-list
153371687|NCT01313936|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153371688|NCT01313936|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153371689|NCT01313936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153371690|NCT01313936|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
153371691|NCT01752413|Ferrous gluconate|ferrous gluconate|mesh-list
153371692|NCT01752413|Hematinics|hematinics|mesh-ancestor
153371693|NCT01731119|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
153371694|NCT01731119|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153831627|NCT04158050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153831628|NCT04158050|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
153831629|NCT04158050|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153831630|NCT04158050|Respiratory System Agents|respiratory system agents|mesh-ancestor
153831638|NCT04150731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153831639|NCT04150731|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
153831640|NCT04150731|Contraceptive Agents|contraceptive agents|mesh-ancestor
153831641|NCT04150731|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153831642|NCT04150731|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
153831643|NCT04083183|Mycophenolic Acid|mycophenolic acid|mesh-list
153831644|NCT04083183|Sirolimus|sirolimus|mesh-list
153381122|NCT01705964|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153381123|NCT01705964|Adrenergic Agents|adrenergic agents|mesh-ancestor
153381124|NCT01705964|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153381125|NCT01705964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153381126|NCT01705964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153381127|NCT01705964|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
153381128|NCT01705964|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153381129|NCT01705964|Autonomic Agents|autonomic agents|mesh-ancestor
153381130|NCT01705964|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153381131|NCT01705964|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153831645|NCT04083183|Vidarabine|vidarabine|mesh-list
153831646|NCT04083183|Cyclophosphamide|cyclophosphamide|mesh-list
153831647|NCT04083183|Fludarabine|fludarabine|mesh-list
153371697|NCT01731119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153371698|NCT01731119|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153371699|NCT01731119|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
153371700|NCT01731119|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
153371701|NCT01731119|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
153371702|NCT01731119|Adrenergic Agents|adrenergic agents|mesh-ancestor
153371703|NCT01731119|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153371704|NCT01731119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153371705|NCT01731119|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
153371706|NCT01731119|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153371707|NCT01731119|Serotonin Agents|serotonin agents|mesh-ancestor
153371708|NCT01731119|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
153371709|NCT01731119|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
153371715|NCT01732445|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153371716|NCT01732445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153371717|NCT01732445|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153371718|NCT01732445|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153371719|NCT01732445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153371721|NCT01250834|Atorvastatin|atorvastatin|mesh-list
153371722|NCT01250834|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153371723|NCT01250834|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153371724|NCT01250834|Antimetabolites|antimetabolites|mesh-ancestor
153371725|NCT01250834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153371726|NCT01250834|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153371727|NCT01250834|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
153371728|NCT01250834|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153371729|NCT01250834|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
153371730|NCT01250834|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153831648|NCT04083183|Fludarabine phosphate|fludarabine phosphate|mesh-list
153831649|NCT04083183|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
153831650|NCT04083183|Thymoglobulin|thymoglobulin|mesh-list
153831651|NCT04083183|Antilymphocyte Serum|antilymphocyte serum|mesh-list
153831653|NCT04083183|Immunoglobulins|immunoglobulins|mesh-list
153831654|NCT04083183|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
153831655|NCT04083183|gamma-Globulins|gamma-globulins|mesh-list
153831656|NCT04083183|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
153831657|NCT04083183|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
153831658|NCT04083183|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153831659|NCT04083183|Immunologic Factors|immunologic factors|mesh-ancestor
153831661|NCT04083183|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153831662|NCT04083183|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153831663|NCT04083183|Alkylating Agents|alkylating agents|mesh-ancestor
153831664|NCT04083183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153831665|NCT04083183|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153831666|NCT04083183|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153831667|NCT04083183|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153831668|NCT04083183|Antimetabolites|antimetabolites|mesh-ancestor
153831669|NCT04083183|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153831670|NCT04083183|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
153831674|NCT04083183|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153831675|NCT04083183|Antifungal Agents|antifungal agents|mesh-ancestor
153831676|NCT04083183|Antiviral Agents|antiviral agents|mesh-ancestor
153831677|NCT04069273|Paclitaxel|paclitaxel|mesh-list
153831678|NCT04069273|Pembrolizumab|pembrolizumab|mesh-list
153831679|NCT04069273|Ramucirumab|ramucirumab|mesh-list
153831680|NCT04069273|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153831681|NCT04069273|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153831682|NCT04069273|Tubulin Modulators|tubulin modulators|mesh-ancestor
153831696|NCT04052334|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153831698|NCT04052334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153831699|NCT04052334|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153831700|NCT04052334|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153831701|NCT04052334|Alkylating Agents|alkylating agents|mesh-ancestor
153831702|NCT04052334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153831703|NCT04052334|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153831706|NCT04052334|Analgesics|analgesics|mesh-ancestor
153371764|NCT02990975|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
153371765|NCT02990975|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153371766|NCT02990975|Anesthetics, General|anesthetics, general|mesh-ancestor
153371768|NCT02990975|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153371769|NCT02990975|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
153371770|NCT02990975|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
153371771|NCT02990975|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153371772|NCT02990975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153371774|NCT01315574|Latanoprost|latanoprost|mesh-list
153371775|NCT01315574|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
153371776|NCT01315574|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
153371777|NCT01315574|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153371778|NCT00422331|Lithium Carbonate|lithium carbonate|mesh-list
153371779|NCT00422331|Antidepressive Agents|antidepressive agents|mesh-ancestor
153371780|NCT00422331|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153371781|NCT00422331|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153371782|NCT00422331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153371783|NCT00422331|Antimanic Agents|antimanic agents|mesh-ancestor
153371784|NCT00422331|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153371785|NCT00422331|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153371787|NCT01316042|Metformin|metformin|mesh-list
153371788|NCT01316042|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153371789|NCT01316042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153371790|NCT01754909|Enalapril|enalapril|mesh-list
153371791|NCT01754909|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
153371792|NCT01754909|Protease Inhibitors|protease inhibitors|mesh-ancestor
153371793|NCT01754909|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153371794|NCT01754909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153371795|NCT01754909|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153371796|NCT04340349|Hydroxychloroquine|hydroxychloroquine|mesh-list
153371797|NCT04340349|Bromhexine|bromhexine|mesh-list
153371798|NCT04340349|Antimalarials|antimalarials|mesh-ancestor
153371799|NCT04340349|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153371800|NCT04340349|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153371801|NCT04340349|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153371802|NCT04340349|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153371803|NCT04340349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153371804|NCT04340349|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153371805|NCT04340349|Expectorants|expectorants|mesh-ancestor
153371806|NCT04340349|Respiratory System Agents|respiratory system agents|mesh-ancestor
153371807|NCT04267809|Vitamin D|vitamin d|mesh-list
153371808|NCT04267809|Metformin|metformin|mesh-list
153371809|NCT04267809|Calcium|calcium|mesh-list
153371810|NCT04267809|Vitamins|vitamins|mesh-ancestor
153371811|NCT04267809|Micronutrients|micronutrients|mesh-ancestor
153371812|NCT04267809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153371813|NCT04267809|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153371814|NCT04267809|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153371815|NCT04267809|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153831747|NCT03733067|Immunologic Factors|immunologic factors|mesh-ancestor
153831748|NCT03733067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153831749|NCT03733067|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153831751|NCT03664895|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153831752|NCT03664895|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153371831|NCT05317325|Immunologic Factors|immunologic factors|mesh-ancestor
153371832|NCT05317325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153371835|NCT04182399|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153371836|NCT04182399|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153831783|NCT03241732|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
153831784|NCT03241732|N-monoacetylcystine|n-monoacetylcystine|mesh-list
153831785|NCT03241732|Antiviral Agents|antiviral agents|mesh-ancestor
153831786|NCT03241732|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153831788|NCT03241732|Respiratory System Agents|respiratory system agents|mesh-ancestor
153831789|NCT03241732|Free Radical Scavengers|free radical scavengers|mesh-ancestor
153831790|NCT03241732|Antioxidants|antioxidants|mesh-ancestor
153831791|NCT03241732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153831792|NCT03241732|Protective Agents|protective agents|mesh-ancestor
153831793|NCT03241732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153831794|NCT03241732|Antidotes|antidotes|mesh-ancestor
153831795|NCT03215706|Paclitaxel|paclitaxel|mesh-list
153831796|NCT03215706|Carboplatin|carboplatin|mesh-list
153831797|NCT03215706|Nivolumab|nivolumab|mesh-list
153831798|NCT03215706|Pemetrexed|pemetrexed|mesh-list
153831799|NCT03215706|Ipilimumab|ipilimumab|mesh-list
153831800|NCT03215706|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153831801|NCT03215706|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153371850|NCT04246619|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153371851|NCT04246619|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153371852|NCT04246619|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153371853|NCT04246619|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153371877|NCT05316857|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
153371878|NCT05316857|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153831802|NCT03215706|Tubulin Modulators|tubulin modulators|mesh-ancestor
153831803|NCT03215706|Antimitotic Agents|antimitotic agents|mesh-ancestor
153831804|NCT03215706|Mitosis Modulators|mitosis modulators|mesh-ancestor
153831805|NCT03215706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153831815|NCT03214354|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153831816|NCT03214354|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153831817|NCT03214354|Antifungal Agents|antifungal agents|mesh-ancestor
153831818|NCT03214354|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153831819|NCT03214354|Immunologic Factors|immunologic factors|mesh-ancestor
153831820|NCT03214354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153831821|NCT03214354|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153831823|NCT03151005|Liraglutide|liraglutide|mesh-list
153831825|NCT03151005|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-list
153831826|NCT03151005|Contraceptive Agents|contraceptive agents|mesh-list
153831827|NCT03151005|Contraceptives, Oral|contraceptives, oral|mesh-list
153831828|NCT03151005|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153831829|NCT03151005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153831830|NCT03151005|Incretins|incretins|mesh-ancestor
153831831|NCT03151005|Hormones|hormones|mesh-ancestor
153831832|NCT03151005|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153371880|NCT05316857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153371881|NCT05316857|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153371882|NCT05316857|Hormone Antagonists|hormone antagonists|mesh-ancestor
153371883|NCT05316857|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153371884|NCT05316857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153371885|NCT05316857|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
153371886|NCT05316857|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
153371887|NCT05316857|Antitubercular Agents|antitubercular agents|mesh-ancestor
153371888|NCT05316857|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153371889|NCT05316857|Leprostatic Agents|leprostatic agents|mesh-ancestor
153371890|NCT05316857|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153831849|NCT02927392|Fertility Agents, Female|fertility agents, female|mesh-ancestor
153831850|NCT02927392|Fertility Agents|fertility agents|mesh-ancestor
153831851|NCT02927392|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153831852|NCT02927392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153831853|NCT02927392|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153831854|NCT02927392|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153831855|NCT02902757|Deoxyglucose|deoxyglucose|mesh-list
153831856|NCT02902757|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
153831857|NCT02902757|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
153371905|NCT02618343|Autonomic Agents|autonomic agents|mesh-ancestor
153371906|NCT02618343|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153371907|NCT02618343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153371918|NCT02991053|Sensory System Agents|sensory system agents|mesh-ancestor
153371919|NCT02991053|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153371920|NCT02991053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153371921|NCT02991053|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
153371922|NCT02991053|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153371923|NCT02991053|Anesthetics, General|anesthetics, general|mesh-ancestor
153371925|NCT02991053|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153371926|NCT02991053|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
153371927|NCT02991053|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
153429362|NCT02145169|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
153371928|NCT02991053|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153371939|NCT02620683|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153371940|NCT02620683|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153371941|NCT02620683|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
153371942|NCT02620683|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153371943|NCT02620683|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153371944|NCT02620683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153429363|NCT02145169|Anesthetics, General|anesthetics, general|mesh-ancestor
153429364|NCT02145169|Anesthetics|anesthetics|mesh-ancestor
153429365|NCT02145169|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153429366|NCT02145169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153429367|NCT02145169|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153429368|NCT02145169|Analgesics|analgesics|mesh-ancestor
153429369|NCT02145169|Sensory System Agents|sensory system agents|mesh-ancestor
153429370|NCT02145169|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153429372|NCT00002630|Cyclophosphamide|cyclophosphamide|mesh-list
153429374|NCT00002630|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153429375|NCT00002630|Immunologic Factors|immunologic factors|mesh-ancestor
153429376|NCT00002630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153888271|NCT01301001|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
153888272|NCT01301001|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
153888273|NCT01301001|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153888274|NCT01301001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153371946|NCT01355588|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
153371947|NCT01355588|Lidocaine|lidocaine|mesh-list
153371948|NCT01355588|Anesthetics, Local|anesthetics, local|mesh-ancestor
153371949|NCT01355588|Anesthetics|anesthetics|mesh-ancestor
153371950|NCT01355588|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153371951|NCT01355588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153371952|NCT01355588|Sensory System Agents|sensory system agents|mesh-ancestor
153371953|NCT01355588|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153371954|NCT01355588|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153371955|NCT01355588|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
153371956|NCT01355588|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153831895|NCT02721732|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153831896|NCT02721732|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153831897|NCT02721732|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153831898|NCT02721732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153831899|NCT02414399|Azithromycin|azithromycin|mesh-list
153831900|NCT02414399|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153831901|NCT02414399|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153831902|NCT02363374|Leucovorin|leucovorin|mesh-list
153831903|NCT02363374|Folic Acid|folic acid|mesh-list
153831904|NCT02363374|Fluorouracil|fluorouracil|mesh-list
153831905|NCT02363374|Oxaliplatin|oxaliplatin|mesh-list
153831906|NCT02363374|Levoleucovorin|levoleucovorin|mesh-list
153831907|NCT02363374|Antimetabolites|antimetabolites|mesh-ancestor
153831908|NCT02363374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153831909|NCT02363374|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153831910|NCT02363374|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153831911|NCT02363374|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153831912|NCT02363374|Immunologic Factors|immunologic factors|mesh-ancestor
153831913|NCT02363374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153831914|NCT02363374|Antidotes|antidotes|mesh-ancestor
153831915|NCT02363374|Protective Agents|protective agents|mesh-ancestor
153371961|NCT01355588|Analgesics|analgesics|mesh-ancestor
153831930|NCT02314481|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153831931|NCT02314481|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153831932|NCT02314481|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153831933|NCT02314481|Tubulin Modulators|tubulin modulators|mesh-ancestor
153831934|NCT02314481|Antimitotic Agents|antimitotic agents|mesh-ancestor
153831935|NCT02314481|Mitosis Modulators|mitosis modulators|mesh-ancestor
153831936|NCT02314481|Immunotoxins|immunotoxins|mesh-ancestor
153831937|NCT02314481|Immunoconjugates|immunoconjugates|mesh-ancestor
153831938|NCT02314481|Immunologic Factors|immunologic factors|mesh-ancestor
153831939|NCT02314481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153831940|NCT02314481|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153831941|NCT02174666|Vitamin D|vitamin d|mesh-list
153831942|NCT02174666|Ergocalciferols|ergocalciferols|mesh-list
153831943|NCT02174666|Cholecalciferol|cholecalciferol|mesh-list
153831944|NCT02174666|Vitamins|vitamins|mesh-list
153831945|NCT02174666|Genistein|genistein|mesh-list
153831946|NCT02174666|Biochanin A|biochanin a|mesh-list
153831947|NCT02174666|Daidzein|daidzein|mesh-list
153371990|NCT01357148|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153371991|NCT01357148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153371992|NCT01357148|Incretins|incretins|mesh-ancestor
153371993|NCT01357148|Hormones|hormones|mesh-ancestor
153371994|NCT01357148|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153371995|NCT01357148|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
153371996|NCT01357148|Protease Inhibitors|protease inhibitors|mesh-ancestor
153371997|NCT01357148|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153371998|NCT01357148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153371999|NCT02623803|Lidocaine|lidocaine|mesh-list
153372000|NCT02623803|Anesthetics, Local|anesthetics, local|mesh-ancestor
153372001|NCT02623803|Anesthetics|anesthetics|mesh-ancestor
153372002|NCT02623803|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153372003|NCT02623803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153372004|NCT02623803|Sensory System Agents|sensory system agents|mesh-ancestor
153372005|NCT02623803|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153372006|NCT02623803|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153372007|NCT02623803|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
153831972|NCT02074631|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153831973|NCT02074631|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153831974|NCT01991379|Imatinib Mesylate|imatinib mesylate|mesh-list
153831975|NCT01991379|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153372015|NCT02322788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153372016|NCT02322788|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153372017|NCT02322788|Respiratory System Agents|respiratory system agents|mesh-ancestor
153372018|NCT02322788|Sympathomimetics|sympathomimetics|mesh-ancestor
153372019|NCT02322788|Tocolytic Agents|tocolytic agents|mesh-ancestor
153372020|NCT02322788|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153372021|NCT02322788|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
153372022|NCT02322788|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
153372023|NCT02322788|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153372024|NCT02322788|Adrenergic Agents|adrenergic agents|mesh-ancestor
153372025|NCT02322788|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153372026|NCT02322788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153372027|NCT02625207|Maraviroc|maraviroc|mesh-list
153372028|NCT02625207|Darunavir|darunavir|mesh-list
153372029|NCT02625207|Cobicistat|cobicistat|mesh-list
153831977|NCT01991379|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153831978|NCT01991379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153831979|NCT01991379|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153831980|NCT01859858|Curcumin|curcumin|mesh-list
153831981|NCT01859858|Irinotecan|irinotecan|mesh-list
153831982|NCT01859858|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
153831983|NCT01859858|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153831984|NCT01859858|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153831985|NCT01859858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153831986|NCT01859858|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153831987|NCT01859858|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153831988|NCT01859858|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153831989|NCT01859858|Analgesics|analgesics|mesh-ancestor
153831990|NCT01859858|Sensory System Agents|sensory system agents|mesh-ancestor
153372030|NCT02625207|Cobicistat mixture with darunavir|cobicistat mixture with darunavir|mesh-list
153372031|NCT02625207|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
153372032|NCT02625207|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
153372033|NCT02625207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153372034|NCT02625207|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153372035|NCT02625207|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153372036|NCT02625207|Antiviral Agents|antiviral agents|mesh-ancestor
153372037|NCT02625207|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153372038|NCT02625207|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
153372039|NCT02625207|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
153372040|NCT02625207|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
153372041|NCT02625207|Protease Inhibitors|protease inhibitors|mesh-ancestor
153372042|NCT02625207|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153372043|NCT02625207|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
153372044|NCT02625207|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153372046|NCT02253173|Estrogens|estrogens|mesh-ancestor
153831992|NCT01859858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153831993|NCT01859858|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153831994|NCT01859858|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153831996|NCT01613118|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153831997|NCT01613118|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
153831998|NCT01613118|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
153831999|NCT01613118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153832000|NCT01300962|Capecitabine|capecitabine|mesh-list
153832001|NCT01300962|Trastuzumab|trastuzumab|mesh-list
153832002|NCT01300962|Lapatinib|lapatinib|mesh-list
153832003|NCT01300962|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153832004|NCT01300962|Antimetabolites|antimetabolites|mesh-ancestor
153832005|NCT01300962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153832006|NCT01300962|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153832007|NCT01300962|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153832008|NCT01300962|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153832009|NCT01300962|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153832010|NCT01300962|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153832011|NCT00752479|Cyclosporine|cyclosporine|mesh-list
153832012|NCT00752479|Mycophenolic Acid|mycophenolic acid|mesh-list
153832013|NCT00752479|Methylprednisolone|methylprednisolone|mesh-list
153832014|NCT00752479|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
153832015|NCT00752479|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
153832016|NCT00752479|Prednisolone|prednisolone|mesh-list
153832017|NCT00752479|Prednisolone acetate|prednisolone acetate|mesh-list
153832018|NCT00752479|Cyclosporins|cyclosporins|mesh-list
153832019|NCT00752479|Basiliximab|basiliximab|mesh-list
153832020|NCT00752479|Thymoglobulin|thymoglobulin|mesh-list
153832024|NCT00752479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153832025|NCT00752479|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153832026|NCT00752479|Immunologic Factors|immunologic factors|mesh-ancestor
153832027|NCT00752479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153832028|NCT00752479|Antifungal Agents|antifungal agents|mesh-ancestor
153832029|NCT00752479|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153832030|NCT00752479|Dermatologic Agents|dermatologic agents|mesh-ancestor
153832031|NCT00752479|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153372073|NCT01767155|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153372074|NCT01767155|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153372075|NCT01767155|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153372076|NCT01767155|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153372077|NCT01767155|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153372078|NCT01767155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153372079|NCT01362686|Rivastigmine|rivastigmine|mesh-list
153372080|NCT01362686|Donepezil|donepezil|mesh-list
153372081|NCT01362686|Galantamine|galantamine|mesh-list
153372082|NCT01362686|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
153372083|NCT01362686|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153372084|NCT01362686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153372085|NCT01362686|Cholinergic Agents|cholinergic agents|mesh-ancestor
153372086|NCT01362686|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153372087|NCT01362686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153372088|NCT01362686|Nootropic Agents|nootropic agents|mesh-ancestor
153372089|NCT01362686|Parasympathomimetics|parasympathomimetics|mesh-ancestor
153372090|NCT01362686|Autonomic Agents|autonomic agents|mesh-ancestor
153372091|NCT01362686|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153372092|NCT01362686|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
153832058|NCT00589875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153832059|NCT00589875|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153832060|NCT00589875|Antiviral Agents|antiviral agents|mesh-ancestor
153832061|NCT00589875|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153832062|NCT00503594|Cytarabine|cytarabine|mesh-list
153832063|NCT00503594|Methotrexate|methotrexate|mesh-list
153832064|NCT00503594|Vincristine|vincristine|mesh-list
153832065|NCT00503594|Temozolomide|temozolomide|mesh-list
153832066|NCT00503594|Procarbazine|procarbazine|mesh-list
153832067|NCT00503594|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
153832068|NCT00503594|Abortifacient Agents|abortifacient agents|mesh-ancestor
153832069|NCT00503594|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153832070|NCT00503594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153832079|NCT00503594|Immunologic Factors|immunologic factors|mesh-ancestor
153832080|NCT00503594|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153832081|NCT00503594|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153832082|NCT00503594|Antiviral Agents|antiviral agents|mesh-ancestor
153832083|NCT00503594|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153832084|NCT00503594|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153832085|NCT00503594|Tubulin Modulators|tubulin modulators|mesh-ancestor
153832086|NCT00503594|Antimitotic Agents|antimitotic agents|mesh-ancestor
153832087|NCT00503594|Mitosis Modulators|mitosis modulators|mesh-ancestor
153832088|NCT00503594|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153832089|NCT00503594|Alkylating Agents|alkylating agents|mesh-ancestor
153832093|NCT00499811|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153888286|NCT02890173|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
153888287|NCT02890173|Diuretics|diuretics|mesh-ancestor
153888288|NCT02890173|Natriuretic Agents|natriuretic agents|mesh-ancestor
153888289|NCT02890173|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153888291|NCT01300455|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
153888292|NCT01300455|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153888293|NCT01300455|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153888294|NCT01300455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153888295|NCT01300455|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
153832094|NCT00499811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153832095|NCT00499850|Leucovorin|leucovorin|mesh-list
153832096|NCT00499850|Fluorouracil|fluorouracil|mesh-list
153832097|NCT00499850|Oxaliplatin|oxaliplatin|mesh-list
153832098|NCT00499850|Antimetabolites|antimetabolites|mesh-ancestor
153832099|NCT00499850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153832100|NCT00499850|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153832101|NCT00499850|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153832102|NCT00499850|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153832103|NCT00499850|Immunologic Factors|immunologic factors|mesh-ancestor
153832104|NCT00499850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153832105|NCT00499850|Antidotes|antidotes|mesh-ancestor
153832106|NCT00499850|Protective Agents|protective agents|mesh-ancestor
153832107|NCT00499850|Vitamin B Complex|vitamin b complex|mesh-ancestor
153832108|NCT00499850|Vitamins|vitamins|mesh-ancestor
153372151|NCT04351724|Amebicides|amebicides|mesh-ancestor
153372152|NCT04351724|Antimetabolites|antimetabolites|mesh-ancestor
153372153|NCT01767701|Raltegravir Potassium|raltegravir potassium|mesh-list
153372154|NCT01767701|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153372155|NCT01767701|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153372156|NCT01767701|Antiviral Agents|antiviral agents|mesh-ancestor
153372157|NCT01767701|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153372172|NCT01364090|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153372173|NCT01364090|Antiviral Agents|antiviral agents|mesh-ancestor
153372174|NCT01364090|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153372175|NCT01364090|Antimetabolites|antimetabolites|mesh-ancestor
153372176|NCT01364090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153372177|NCT01364090|Immunologic Factors|immunologic factors|mesh-ancestor
153372178|NCT01364090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153372179|NCT03684785|Pembrolizumab|pembrolizumab|mesh-list
153372180|NCT03684785|Cemiplimab|cemiplimab|mesh-list
153372181|NCT03684785|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153372182|NCT03684785|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153832113|NCT05146713|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153832114|NCT05146713|Disinfectants|disinfectants|mesh-ancestor
153832115|NCT00503828|Naproxen|naproxen|mesh-list
153832116|NCT00503828|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153832117|NCT00503828|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153832118|NCT00503828|Analgesics|analgesics|mesh-ancestor
153832119|NCT00503828|Sensory System Agents|sensory system agents|mesh-ancestor
153832120|NCT00503828|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153832121|NCT00503828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153832122|NCT00503828|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153832123|NCT00503828|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153832124|NCT00503828|Gout Suppressants|gout suppressants|mesh-ancestor
153832125|NCT00503828|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153832126|NCT00503828|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153832127|NCT00503828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153832128|NCT00500006|Dasatinib|dasatinib|mesh-list
153832129|NCT00500006|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153832130|NCT00500006|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153832131|NCT00500006|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153832132|NCT00500006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153832133|NCT00500006|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153832134|NCT00506727|Amphetamine|amphetamine|mesh-list
153832135|NCT00506727|Adderall|adderall|mesh-list
153832150|NCT04696536|Listerine|listerine|mesh-list
153832151|NCT04696536|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
153832152|NCT04696536|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153832153|NCT00500279|Celecoxib|celecoxib|mesh-list
153372210|NCT01323140|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153372211|NCT01323140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153372212|NCT03516305|Alprazolam|alprazolam|mesh-list
153372213|NCT03516305|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153372214|NCT03516305|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153372215|NCT03516305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153372216|NCT03516305|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153372217|NCT03516305|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153372218|NCT03516305|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153372219|NCT03516305|GABA Modulators|gaba modulators|mesh-ancestor
153372220|NCT03516305|GABA Agents|gaba agents|mesh-ancestor
153372221|NCT03516305|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153372222|NCT03516305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153372223|NCT03823287|Aflibercept|aflibercept|mesh-list
153372224|NCT03823287|Faricimab|faricimab|mesh-list
153372225|NCT03823287|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153372226|NCT03823287|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153372227|NCT03823287|Growth Substances|growth substances|mesh-ancestor
153832169|NCT01245881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153832175|NCT03458247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153832176|NCT03458247|Hormone Antagonists|hormone antagonists|mesh-ancestor
153832177|NCT03458247|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153832178|NCT03458247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153832179|NCT03458247|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153832180|NCT01247558|Vitamin B 12|vitamin b 12|mesh-list
153832181|NCT01247558|Vitamin B Complex|vitamin b complex|mesh-ancestor
153832182|NCT01247558|Vitamins|vitamins|mesh-ancestor
153832183|NCT01247558|Micronutrients|micronutrients|mesh-ancestor
153832184|NCT01247558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153832185|NCT00500552|Perhexiline|perhexiline|mesh-list
153832186|NCT00500552|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153832187|NCT00500552|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153832188|NCT00500552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153372236|NCT02244671|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153372237|NCT02244671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153372238|NCT02626611|Omalizumab|omalizumab|mesh-list
153372239|NCT02626611|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
153372240|NCT02626611|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153372241|NCT02626611|Respiratory System Agents|respiratory system agents|mesh-ancestor
153372242|NCT01260662|Ketamine|ketamine|mesh-list
153372243|NCT01260662|Propofol|propofol|mesh-list
153372244|NCT01260662|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153372245|NCT01260662|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153372246|NCT01260662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153372247|NCT01260662|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153372248|NCT01260662|Anesthetics, General|anesthetics, general|mesh-ancestor
153372249|NCT01260662|Anesthetics|anesthetics|mesh-ancestor
153372250|NCT01260662|Analgesics|analgesics|mesh-ancestor
153832200|NCT00507585|Oxaliplatin|oxaliplatin|mesh-list
153832202|NCT00507585|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153832235|NCT00507663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153832236|NCT00507663|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
153372284|NCT01365650|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153372285|NCT01365650|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153832249|NCT00508287|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153832251|NCT00508326|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153832252|NCT00508326|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153832253|NCT00508326|Tubulin Modulators|tubulin modulators|mesh-ancestor
153832254|NCT00508326|Antimitotic Agents|antimitotic agents|mesh-ancestor
153372303|NCT01324700|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153372304|NCT01324700|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153372305|NCT01324700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153372306|NCT01324700|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153372308|NCT01324700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153372309|NCT01324700|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
153372310|NCT01324700|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
153372311|NCT01324700|Parasympatholytics|parasympatholytics|mesh-ancestor
153372312|NCT01324700|Autonomic Agents|autonomic agents|mesh-ancestor
153372313|NCT01324700|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153372314|NCT01324700|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
153372315|NCT01324700|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
153832259|NCT00507858|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153832261|NCT00507858|Autonomic Agents|autonomic agents|mesh-ancestor
153832262|NCT00507858|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153832263|NCT00507858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153832264|NCT00507858|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153832265|NCT00507858|Glucocorticoids|glucocorticoids|mesh-ancestor
153832266|NCT00507858|Hormones|hormones|mesh-ancestor
153832267|NCT00507858|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153832268|NCT00507858|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153832269|NCT00507858|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153832270|NCT00507858|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153832271|NCT00507858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153832272|NCT00507858|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153832273|NCT00507858|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153832274|NCT00508365|Carvedilol|carvedilol|mesh-list
153832275|NCT00508365|Lisinopril|lisinopril|mesh-list
153832276|NCT00508365|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
153832277|NCT00508365|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
153832278|NCT00508365|Adrenergic Agents|adrenergic agents|mesh-ancestor
153832279|NCT00508365|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153372330|NCT04769297|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153372331|NCT04769297|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
153372332|NCT04769297|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
153372333|NCT04769297|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153372334|NCT04769297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153372335|NCT02631057|Warfarin|warfarin|mesh-list
153372336|NCT02631057|Dabigatran|dabigatran|mesh-list
153372338|NCT02631057|Antithrombins|antithrombins|mesh-ancestor
153372339|NCT02631057|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
153372340|NCT02631057|Protease Inhibitors|protease inhibitors|mesh-ancestor
153372341|NCT02631057|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153372342|NCT02631057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153372343|NCT02631525|Propofol|propofol|mesh-list
153372344|NCT02631525|Desflurane|desflurane|mesh-list
153832282|NCT00508365|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153832283|NCT00508365|Antioxidants|antioxidants|mesh-ancestor
153832284|NCT00508365|Protective Agents|protective agents|mesh-ancestor
153832285|NCT00508365|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153832286|NCT00508365|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153832287|NCT00508365|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153832288|NCT00508365|Vasodilator Agents|vasodilator agents|mesh-ancestor
153832289|NCT00508365|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
153832290|NCT00508365|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
153832291|NCT00508365|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
153832292|NCT00508365|Protease Inhibitors|protease inhibitors|mesh-ancestor
153832293|NCT00508365|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153832294|NCT00508365|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
153832295|NCT00500864|Magnesium Sulfate|magnesium sulfate|mesh-list
153372345|NCT02631525|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153372346|NCT02631525|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153372347|NCT02631525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153372348|NCT02631525|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153372349|NCT02631525|Anesthetics, General|anesthetics, general|mesh-ancestor
153372350|NCT02631525|Anesthetics|anesthetics|mesh-ancestor
153372351|NCT02631525|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
153372352|NCT03162497|Azithromycin|azithromycin|mesh-list
153372353|NCT03162497|Doxycycline|doxycycline|mesh-list
153372354|NCT03162497|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153372355|NCT03162497|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153372356|NCT03162497|Antimalarials|antimalarials|mesh-ancestor
153832302|NCT00500864|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153832303|NCT00500864|Anticonvulsants|anticonvulsants|mesh-ancestor
153832304|NCT00500864|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153832305|NCT00500864|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153832306|NCT00500864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153832307|NCT00500864|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153832308|NCT00500864|Tocolytic Agents|tocolytic agents|mesh-ancestor
153832309|NCT00500864|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153832311|NCT00507975|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
153832312|NCT00507975|Autonomic Agents|autonomic agents|mesh-ancestor
153832313|NCT00507975|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153832314|NCT00507975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153832315|NCT00507975|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
153832316|NCT00507975|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
153832317|NCT00507975|Cholinergic Agents|cholinergic agents|mesh-ancestor
153832318|NCT00507975|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153372368|NCT05167643|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153372369|NCT05167643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153372371|NCT01366196|Analgesics|analgesics|mesh-ancestor
153372372|NCT01366196|Sensory System Agents|sensory system agents|mesh-ancestor
153372373|NCT01366196|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153372374|NCT01366196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153372375|NCT01366196|Anticonvulsants|anticonvulsants|mesh-ancestor
153372376|NCT01366196|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153372377|NCT01366196|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153372378|NCT01366196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153372379|NCT01366196|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153372380|NCT01366196|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153372381|NCT01366196|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153372382|NCT01366196|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153372383|NCT01366196|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153372384|NCT01366976|Acetaminophen|acetaminophen|mesh-list
153372385|NCT01366976|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153832324|NCT01247909|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153832325|NCT01247909|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
153832326|NCT01247909|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153832327|NCT01247909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153832328|NCT01247909|Third Generation Cephalosporins|third generation cephalosporins|mesh-ancestor
153832329|NCT01247909|Beta Lactam Antibiotics|beta lactam antibiotics|mesh-ancestor
153832332|NCT01245998|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
153832333|NCT01245998|Anticoagulants|anticoagulants|mesh-ancestor
153832334|NCT01245998|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153832335|NCT01245998|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153832336|NCT01245998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153832337|NCT02954484|Acetaminophen|acetaminophen|mesh-list
153832338|NCT02954484|Etoricoxib|etoricoxib|mesh-list
153372398|NCT01777217|Urological Agents|urological agents|mesh-ancestor
153372399|NCT02251379|Fluticasone|fluticasone|mesh-list
153372400|NCT02251379|Xhance|xhance|mesh-list
153372401|NCT02251379|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
153372402|NCT02251379|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153372403|NCT02251379|Autonomic Agents|autonomic agents|mesh-ancestor
153372404|NCT02251379|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153372405|NCT02251379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153372406|NCT02251379|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153372407|NCT02251379|Respiratory System Agents|respiratory system agents|mesh-ancestor
153372408|NCT02251379|Glucocorticoids|glucocorticoids|mesh-ancestor
153372409|NCT02251379|Hormones|hormones|mesh-ancestor
153832357|NCT02954484|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153832358|NCT02954484|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153832359|NCT02954484|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153832360|NCT02954484|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153832361|NCT02954484|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153832362|NCT02954484|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153888296|NCT01300455|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153888297|NCT01300455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153888298|NCT01101178|Oxycodone|oxycodone|mesh-list
153888299|NCT01101178|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153888300|NCT01101178|Narcotics|narcotics|mesh-ancestor
153888301|NCT01101178|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153888302|NCT01101178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153888303|NCT01101178|Analgesics|analgesics|mesh-ancestor
153832364|NCT02954484|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
153832365|NCT02954484|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153832366|NCT02954484|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153832368|NCT00501020|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153372418|NCT02255513|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
153372419|NCT02255513|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153372420|NCT02255513|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153372421|NCT02255513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153372422|NCT02255513|Dopamine Agents|dopamine agents|mesh-ancestor
153372423|NCT02255513|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153372424|NCT01778465|Salicylic Acid|salicylic acid|mesh-list
153372425|NCT01778465|Salicylates|salicylates|mesh-list
153372426|NCT01778465|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153372427|NCT01778465|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153372428|NCT01778465|Analgesics|analgesics|mesh-ancestor
153372429|NCT01778465|Sensory System Agents|sensory system agents|mesh-ancestor
153372430|NCT01778465|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153372431|NCT01778465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153372432|NCT01778465|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153372433|NCT01778465|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153372434|NCT01778465|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153372435|NCT01778465|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153372436|NCT01778465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153372441|NCT01779167|Thalidomide|thalidomide|mesh-list
153372447|NCT01779167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153372448|NCT01779167|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153832369|NCT00501020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153832380|NCT01248260|Vitamin B Complex|vitamin b complex|mesh-ancestor
153832381|NCT01248260|Vitamins|vitamins|mesh-ancestor
153832382|NCT01248260|Micronutrients|micronutrients|mesh-ancestor
153832383|NCT01248260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153832384|NCT01246037|Bisoprolol|bisoprolol|mesh-list
153832385|NCT01246037|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153832386|NCT01246037|Sympatholytics|sympatholytics|mesh-ancestor
153832387|NCT01246037|Autonomic Agents|autonomic agents|mesh-ancestor
153832388|NCT01246037|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153832389|NCT01246037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153832390|NCT01246037|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
153832391|NCT01246037|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
153832392|NCT01246037|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
153832393|NCT01246037|Adrenergic Agents|adrenergic agents|mesh-ancestor
153832394|NCT01246037|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153832395|NCT01246037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153832396|NCT00501215|Parathyroid Hormone|parathyroid hormone|mesh-list
153832397|NCT00501215|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153832398|NCT00501215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153832399|NCT00509184|Rituximab|rituximab|mesh-list
153832400|NCT00509184|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153832401|NCT00509184|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153832402|NCT00509184|Immunologic Factors|immunologic factors|mesh-ancestor
153832403|NCT00509184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153832404|NCT00509184|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153832405|NCT00501254|Aspirin|aspirin|mesh-list
153832406|NCT00501254|Salicylic Acid|salicylic acid|mesh-list
153832407|NCT00501254|Salicylates|salicylates|mesh-list
153832408|NCT00501254|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153832409|NCT00501254|Antifungal Agents|antifungal agents|mesh-ancestor
153832410|NCT00501254|Keratolytic Agents|keratolytic agents|mesh-ancestor
153832411|NCT00501254|Dermatologic Agents|dermatologic agents|mesh-ancestor
153832412|NCT00501254|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153372461|NCT02251613|Olopatadine Hydrochloride|olopatadine hydrochloride|mesh-list
153372462|NCT02251613|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
153372463|NCT02251613|Ophthalmic Solutions|ophthalmic solutions|mesh-list
153372464|NCT02251613|Epinastine|epinastine|mesh-list
153372465|NCT02251613|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153372466|NCT02251613|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153372467|NCT02251613|Analgesics|analgesics|mesh-ancestor
153372468|NCT02251613|Sensory System Agents|sensory system agents|mesh-ancestor
153372469|NCT02251613|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153372470|NCT02251613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153372471|NCT02251613|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153372472|NCT02251613|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153372473|NCT02251613|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
153372474|NCT02251613|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
153372475|NCT02251613|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
153372476|NCT02251613|Histamine Antagonists|histamine antagonists|mesh-ancestor
153372477|NCT02251613|Histamine Agents|histamine agents|mesh-ancestor
153372478|NCT02251613|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153832426|NCT00501254|Antipyretics|antipyretics|mesh-ancestor
153832427|NCT01248338|Metoprolol|metoprolol|mesh-list
153832428|NCT01248338|Nebivolol|nebivolol|mesh-list
153832429|NCT01248338|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153832430|NCT01248338|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153832431|NCT01248338|Sympatholytics|sympatholytics|mesh-ancestor
153832432|NCT01248338|Autonomic Agents|autonomic agents|mesh-ancestor
153832433|NCT01248338|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153832434|NCT01248338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153372483|NCT02865473|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153372498|NCT01783847|Prednisolone|prednisolone|mesh-list
153372499|NCT01783847|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
153372500|NCT01783847|Methylprednisolone|methylprednisolone|mesh-list
153372501|NCT01783847|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
153372502|NCT01783847|Prednisolone acetate|prednisolone acetate|mesh-list
153372503|NCT01783847|Epoetin Alfa|epoetin alfa|mesh-list
153372504|NCT01783847|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
153372505|NCT01783847|Prednisolone phosphate|prednisolone phosphate|mesh-list
153372506|NCT01783847|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153832443|NCT01248338|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
153832444|NCT01248338|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153832446|NCT02953743|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153832447|NCT02953743|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153832448|NCT02953743|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153832449|NCT02953743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153832450|NCT00509379|Rituximab|rituximab|mesh-list
153832451|NCT00509379|Bortezomib|bortezomib|mesh-list
153832452|NCT00509379|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153832453|NCT00509379|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153832454|NCT00509379|Immunologic Factors|immunologic factors|mesh-ancestor
153832455|NCT00509379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153832457|NCT02274974|Lidocaine|lidocaine|mesh-list
153372516|NCT01783847|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153372517|NCT01783847|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
153372518|NCT01783847|Protective Agents|protective agents|mesh-ancestor
153372519|NCT01783847|Hematinics|hematinics|mesh-ancestor
153372520|NCT02585375|Latanoprost|latanoprost|mesh-list
153372521|NCT02585375|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
153372522|NCT02585375|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
153372523|NCT02516813|Peposertib|peposertib|mesh-list
153372524|NCT02516813|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153372525|NCT02516813|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153372526|NCT02516813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153372527|NCT01785095|Hormones|hormones|mesh-list
153372528|NCT01785095|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
153372529|NCT01785095|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153372530|NCT01785095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153372531|NCT01786343|Decitabine|decitabine|mesh-list
153372532|NCT01786343|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153372533|NCT01786343|Antimetabolites|antimetabolites|mesh-ancestor
153372534|NCT01786343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153372535|NCT01786343|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153372536|NCT01786343|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153372537|NCT03362775|Propofol|propofol|mesh-list
153372538|NCT03362775|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153372539|NCT03362775|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153372540|NCT03362775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153832459|NCT02274974|Anesthetics, Local|anesthetics, local|mesh-list
153832481|NCT02274974|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
153832482|NCT02274545|Vaccines|vaccines|mesh-list
153832483|NCT02274545|Immunologic Factors|immunologic factors|mesh-ancestor
153832484|NCT02274545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153832485|NCT02275013|Simendan|simendan|mesh-list
153832486|NCT02275013|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
153832487|NCT02275013|Vasodilator Agents|vasodilator agents|mesh-ancestor
153832488|NCT02275013|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
153832489|NCT02275013|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
153832490|NCT02275013|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153832491|NCT02275013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153832492|NCT02275013|Protective Agents|protective agents|mesh-ancestor
153832493|NCT02275013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153832494|NCT02274623|Calcifediol|calcifediol|mesh-list
153832495|NCT02274623|Vitamins|vitamins|mesh-ancestor
153832496|NCT02274623|Micronutrients|micronutrients|mesh-ancestor
153832497|NCT02274623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153372547|NCT01786967|Cholinergic Agents|cholinergic agents|mesh-ancestor
153372548|NCT01786967|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153372549|NCT01786967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153372550|NCT01786967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153372551|NCT01786967|Urological Agents|urological agents|mesh-ancestor
153372553|NCT02392871|Dabrafenib|dabrafenib|mesh-list
153372554|NCT02392871|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153372555|NCT02392871|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153372556|NCT02392871|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153372557|NCT02392871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153372558|NCT02382575|Rituximab|rituximab|mesh-list
153372559|NCT02382575|Tacrolimus|tacrolimus|mesh-list
153372560|NCT02382575|Calcineurin Inhibitors|calcineurin inhibitors|mesh-list
153372561|NCT02382575|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153372562|NCT02382575|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153372569|NCT01807871|Nicotine|nicotine|mesh-list
153832516|NCT00501410|Dasatinib|dasatinib|mesh-list
153832517|NCT00501410|Antimetabolites|antimetabolites|mesh-ancestor
153832518|NCT00501410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153832519|NCT00501410|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153832520|NCT00501410|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153832521|NCT00501410|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153832522|NCT00501410|Immunologic Factors|immunologic factors|mesh-ancestor
153372572|NCT01807871|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153372573|NCT01807871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153372574|NCT01807871|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
153372575|NCT01807871|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
153372576|NCT01807871|Cholinergic Agents|cholinergic agents|mesh-ancestor
153372577|NCT01807871|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153372578|NCT01807871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153372579|NCT01263938|Atorvastatin|atorvastatin|mesh-list
153372580|NCT01263938|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153372581|NCT01263938|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153372582|NCT01263938|Antimetabolites|antimetabolites|mesh-ancestor
153372583|NCT01263938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153372584|NCT01263938|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153372585|NCT01263938|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
153372586|NCT01263938|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153372587|NCT02327741|Clopidogrel|clopidogrel|mesh-list
153372588|NCT02327741|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153372589|NCT02327741|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
153372590|NCT02327741|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
153372591|NCT02327741|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
153372592|NCT02327741|Purinergic Agents|purinergic agents|mesh-ancestor
153372593|NCT02327741|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153372594|NCT02327741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153832523|NCT00501410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153832524|NCT00501410|Antidotes|antidotes|mesh-ancestor
153832525|NCT00501410|Protective Agents|protective agents|mesh-ancestor
153832526|NCT00501410|Vitamin B Complex|vitamin b complex|mesh-ancestor
153832529|NCT00501410|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153832530|NCT00501410|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153832531|NCT00501410|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153832533|NCT02953275|Pentoxifylline|pentoxifylline|mesh-list
153832534|NCT02953275|Vedolizumab|vedolizumab|mesh-list
153832535|NCT02953275|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
153832536|NCT02953275|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153832537|NCT02953275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153832538|NCT02953275|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153832539|NCT02953275|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
153832540|NCT02953275|Protective Agents|protective agents|mesh-ancestor
153832541|NCT02953275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153832542|NCT02953275|Vasodilator Agents|vasodilator agents|mesh-ancestor
153832543|NCT02953275|Free Radical Scavengers|free radical scavengers|mesh-ancestor
153832544|NCT02953275|Antioxidants|antioxidants|mesh-ancestor
153832545|NCT02953275|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153832546|NCT00501488|Rosiglitazone|rosiglitazone|mesh-list
153832547|NCT00501488|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153832548|NCT00501488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153832549|NCT00508911|Contraceptive Agents|contraceptive agents|mesh-list
153832550|NCT00508911|Contraceptives, Oral|contraceptives, oral|mesh-list
153832551|NCT00508911|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153832552|NCT00508911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153832554|NCT02955719|Sertraline|sertraline|mesh-list
153372625|NCT01267136|Antipyretics|antipyretics|mesh-ancestor
153372626|NCT01267136|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153372627|NCT01267136|Narcotics|narcotics|mesh-ancestor
153372628|NCT01267136|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153372629|NCT01267136|Antitussive Agents|antitussive agents|mesh-ancestor
153372630|NCT01267136|Respiratory System Agents|respiratory system agents|mesh-ancestor
153372631|NCT01370564|Diuretics|diuretics|mesh-list
153372632|NCT01370564|Natriuretic Agents|natriuretic agents|mesh-ancestor
153372633|NCT01370564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153372635|NCT00367263|Glucocorticoids|glucocorticoids|mesh-ancestor
153372636|NCT00367263|Hormones|hormones|mesh-ancestor
153372637|NCT00367263|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153372638|NCT00367263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153372639|NCT00367263|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
153372640|NCT02637999|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
153372641|NCT02637999|Interferon alpha-2|interferon alpha-2|mesh-list
153372642|NCT02637999|Antiviral Agents|antiviral agents|mesh-ancestor
153372643|NCT02637999|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153372644|NCT02637999|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153372645|NCT01371110|Midazolam|midazolam|mesh-list
153372646|NCT01371110|Ketamine|ketamine|mesh-list
153372647|NCT01371110|Analgesics|analgesics|mesh-ancestor
153372648|NCT01371110|Sensory System Agents|sensory system agents|mesh-ancestor
153372649|NCT01371110|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153372650|NCT01371110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153372651|NCT01371110|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
153372652|NCT01371110|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153372653|NCT01371110|Anesthetics, General|anesthetics, general|mesh-ancestor
153372654|NCT01371110|Anesthetics|anesthetics|mesh-ancestor
153372655|NCT01371110|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153832581|NCT02955524|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153832582|NCT02955524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153832584|NCT02953041|Bromides|bromides|mesh-list
153832585|NCT02953041|Anticonvulsants|anticonvulsants|mesh-ancestor
153832586|NCT02953041|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153832587|NCT02953041|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
153832588|NCT02953041|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
153832589|NCT02953041|Cholinergic Agents|cholinergic agents|mesh-ancestor
153832590|NCT02953041|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153832591|NCT02953041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153832592|NCT02953041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153832593|NCT00501566|Satavaptan|satavaptan|mesh-list
153832594|NCT00501566|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
153832595|NCT00501566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153832596|NCT00501566|Natriuretic Agents|natriuretic agents|mesh-ancestor
153832597|NCT00501566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153832598|NCT00501605|Cediranib|cediranib|mesh-list
153832599|NCT00501605|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153832600|NCT00501605|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153832601|NCT00501605|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153832602|NCT00501605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153832603|NCT00509847|Lactoferrin|lactoferrin|mesh-list
153372656|NCT01371110|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
153372657|NCT01371110|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
153372658|NCT01371110|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153372659|NCT01371110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153372660|NCT01371110|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153372661|NCT01371110|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153372676|NCT00367419|Erythromycin|erythromycin|mesh-list
153372677|NCT00367419|Erythromycin Estolate|erythromycin estolate|mesh-list
153372678|NCT00367419|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
153372679|NCT00367419|Erythromycin stearate|erythromycin stearate|mesh-list
153372680|NCT00367419|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153372681|NCT00367419|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153372682|NCT00367419|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153372683|NCT00367419|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
153372684|NCT00367419|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153372685|NCT00367419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153372687|NCT01372202|Fluorouracil|fluorouracil|mesh-list
153372688|NCT01372202|Oxaliplatin|oxaliplatin|mesh-list
153372689|NCT01372202|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153372690|NCT01372202|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153372691|NCT01372202|Tubulin Modulators|tubulin modulators|mesh-ancestor
153832604|NCT00509847|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153832606|NCT01248494|Dactolisib|dactolisib|mesh-list
153832607|NCT01248494|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153832608|NCT01248494|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
153832609|NCT01248494|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153832610|NCT01248494|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153832611|NCT01248494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153832612|NCT01248494|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
153832613|NCT01248494|Hormone Antagonists|hormone antagonists|mesh-ancestor
153832634|NCT00501722|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
153832635|NCT00501722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153832636|NCT00501722|Natriuretic Agents|natriuretic agents|mesh-ancestor
153832637|NCT00501722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153832639|NCT01248611|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153372692|NCT01372202|Antimitotic Agents|antimitotic agents|mesh-ancestor
153372693|NCT01372202|Mitosis Modulators|mitosis modulators|mesh-ancestor
153372694|NCT01372202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153372695|NCT01372202|Antimetabolites|antimetabolites|mesh-ancestor
153372696|NCT01372202|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153372697|NCT01372202|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153372698|NCT01372202|Immunologic Factors|immunologic factors|mesh-ancestor
153372699|NCT01372202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153372700|NCT01811147|Norepinephrine|norepinephrine|mesh-list
153372701|NCT01811147|Serotonin|serotonin|mesh-list
153372702|NCT01811147|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-list
153372703|NCT01811147|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153372704|NCT01811147|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153372705|NCT01811147|Adrenergic Agents|adrenergic agents|mesh-ancestor
153372706|NCT01811147|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153372707|NCT01811147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153372708|NCT01811147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153372709|NCT01811147|Sympathomimetics|sympathomimetics|mesh-ancestor
153372710|NCT01811147|Autonomic Agents|autonomic agents|mesh-ancestor
153372711|NCT01811147|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153372712|NCT01811147|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
153372713|NCT01811147|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
153372714|NCT01811147|Serotonin Agents|serotonin agents|mesh-ancestor
153372715|NCT01811147|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153372716|NCT01811147|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153372717|NCT01373450|Liraglutide|liraglutide|mesh-list
153372718|NCT01373450|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
153372719|NCT01373450|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153832641|NCT01248611|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153832642|NCT01248611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153832643|NCT01248611|Analgesics|analgesics|mesh-ancestor
153832644|NCT01248611|Sensory System Agents|sensory system agents|mesh-ancestor
153832645|NCT01248611|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153832646|NCT01248611|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153832647|NCT01248611|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153832648|NCT01248611|Anesthetics, General|anesthetics, general|mesh-ancestor
153832649|NCT01248611|Anesthetics|anesthetics|mesh-ancestor
153832650|NCT00509964|Irinotecan|irinotecan|mesh-list
153832651|NCT00509964|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
153832652|NCT00509964|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153832653|NCT00509964|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153832654|NCT00509964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153832655|NCT00509964|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153832656|NCT00510471|Immunoglobulins|immunoglobulins|mesh-list
153832657|NCT00510471|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
153832658|NCT00510471|Antibodies|antibodies|mesh-list
153832659|NCT00510471|Immunoglobulin Idiotypes|immunoglobulin idiotypes|mesh-list
153832660|NCT00510471|Immunologic Factors|immunologic factors|mesh-ancestor
153832661|NCT00510471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153832662|NCT00501839|Clomiphene|clomiphene|mesh-list
153832663|NCT00501839|Enclomiphene|enclomiphene|mesh-list
153832664|NCT00501839|Zuclomiphene|zuclomiphene|mesh-list
153832665|NCT00501839|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
153832666|NCT00501839|Hormone Antagonists|hormone antagonists|mesh-ancestor
153832667|NCT00501839|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153832668|NCT00501839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153832669|NCT00501839|Fertility Agents, Female|fertility agents, female|mesh-ancestor
153832670|NCT00501839|Fertility Agents|fertility agents|mesh-ancestor
153832671|NCT00501839|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153832673|NCT00501839|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
153372734|NCT01793285|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153372735|NCT01793285|Immunologic Factors|immunologic factors|mesh-ancestor
153372736|NCT01811693|Nitroglycerin|nitroglycerin|mesh-list
153372737|NCT01811693|Vasodilator Agents|vasodilator agents|mesh-ancestor
153372738|NCT02639637|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
153372739|NCT02639637|Valsartan|valsartan|mesh-list
153372740|NCT02639637|Enalaprilat|enalaprilat|mesh-list
153372741|NCT02639637|Enalapril|enalapril|mesh-list
153372742|NCT02639637|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153372743|NCT02639637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153832683|NCT00510003|Dermatologic Agents|dermatologic agents|mesh-ancestor
153832684|NCT00510003|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153832685|NCT00510003|Immunologic Factors|immunologic factors|mesh-ancestor
153832686|NCT00510003|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
153832687|NCT00510003|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153832688|NCT00510003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153832689|NCT00501878|Phenylephrine|phenylephrine|mesh-list
153832690|NCT00501878|Oxymetazoline|oxymetazoline|mesh-list
153832691|NCT00501878|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
153832692|NCT00501878|Mydriatics|mydriatics|mesh-ancestor
153832693|NCT00501878|Autonomic Agents|autonomic agents|mesh-ancestor
153832694|NCT00501878|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153832695|NCT00501878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153832696|NCT00501878|Sympathomimetics|sympathomimetics|mesh-ancestor
153832697|NCT00501878|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
153832698|NCT00501878|Nasal Decongestants|nasal decongestants|mesh-ancestor
153832699|NCT00501878|Respiratory System Agents|respiratory system agents|mesh-ancestor
153832725|NCT00502034|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153832726|NCT00502034|Immunologic Factors|immunologic factors|mesh-ancestor
153832727|NCT00502034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153832728|NCT00502034|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153832729|NCT00502034|Analgesics|analgesics|mesh-ancestor
153832730|NCT00502034|Sensory System Agents|sensory system agents|mesh-ancestor
153832731|NCT00502034|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153832732|NCT00510666|Tramadol|tramadol|mesh-list
153832733|NCT00510666|Butorphanol|butorphanol|mesh-list
153832734|NCT00510666|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153832735|NCT00510666|Narcotics|narcotics|mesh-ancestor
153832736|NCT00510666|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153832737|NCT00510666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153832738|NCT00510666|Analgesics|analgesics|mesh-ancestor
153832739|NCT00510666|Sensory System Agents|sensory system agents|mesh-ancestor
153832740|NCT00510666|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153832741|NCT00510666|Antitussive Agents|antitussive agents|mesh-ancestor
153832742|NCT00510666|Respiratory System Agents|respiratory system agents|mesh-ancestor
153832743|NCT00510666|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
153832744|NCT00508092|Anesthetics|anesthetics|mesh-list
153832745|NCT00508092|Anesthetics, Local|anesthetics, local|mesh-list
153832746|NCT00508092|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153832747|NCT00508092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153832748|NCT00508092|Sensory System Agents|sensory system agents|mesh-ancestor
153832749|NCT00508092|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153372796|NCT01332500|Serotonin Agents|serotonin agents|mesh-ancestor
153372797|NCT01332500|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153888304|NCT01101178|Sensory System Agents|sensory system agents|mesh-ancestor
153888305|NCT01101178|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153888306|NCT05637645|Bupivacaine|bupivacaine|mesh-list
153888307|NCT05637645|Anesthetics, Local|anesthetics, local|mesh-ancestor
153429379|NCT00002630|Alkylating Agents|alkylating agents|mesh-ancestor
153429380|NCT00002630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153429381|NCT00002630|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153429382|NCT00002630|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153429383|NCT00002630|Trace Elements|trace elements|mesh-ancestor
153429384|NCT00002630|Micronutrients|micronutrients|mesh-ancestor
153429385|NCT02047747|Dacomitinib|dacomitinib|mesh-list
153429386|NCT02047747|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153429387|NCT02047747|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153429388|NCT02047747|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153429397|NCT00002642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153429398|NCT00002642|Trace Elements|trace elements|mesh-ancestor
153372800|NCT01812005|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153372819|NCT01332578|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
153372821|NCT01332578|Autonomic Agents|autonomic agents|mesh-ancestor
153372822|NCT01332578|Sympathomimetics|sympathomimetics|mesh-ancestor
153372823|NCT01332578|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
153372824|NCT01332578|Nasal Decongestants|nasal decongestants|mesh-ancestor
153372825|NCT01332578|Respiratory System Agents|respiratory system agents|mesh-ancestor
153372826|NCT01332578|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
153372827|NCT01332578|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153372828|NCT01332578|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153832750|NCT00510705|Metformin|metformin|mesh-list
153832751|NCT00510705|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153832752|NCT00510705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153832753|NCT00502073|Cyclosporine|cyclosporine|mesh-list
153832754|NCT00502073|Cyclosporins|cyclosporins|mesh-list
153832755|NCT00502073|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153832756|NCT00502073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153832757|NCT00502073|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153832758|NCT00502073|Immunologic Factors|immunologic factors|mesh-ancestor
153832759|NCT00502073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153832760|NCT00502073|Antifungal Agents|antifungal agents|mesh-ancestor
153832761|NCT00502073|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153429400|NCT00002642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153429401|NCT03983941|Ropivacaine|ropivacaine|mesh-list
153429402|NCT03983941|Anesthetics, Local|anesthetics, local|mesh-ancestor
153429403|NCT03983941|Anesthetics|anesthetics|mesh-ancestor
153832762|NCT00502073|Dermatologic Agents|dermatologic agents|mesh-ancestor
153832763|NCT00502073|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153832764|NCT00502073|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
153832766|NCT01248923|Bortezomib|bortezomib|mesh-list
153832767|NCT01248923|Filanesib|filanesib|mesh-list
153832768|NCT01248923|Lenograstim|lenograstim|mesh-list
153832769|NCT01248923|Proteasome Inhibitors|proteasome inhibitors|mesh-list
153832770|NCT01248923|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153832771|NCT01248923|Antiemetics|antiemetics|mesh-ancestor
153832772|NCT01248923|Autonomic Agents|autonomic agents|mesh-ancestor
153832773|NCT01248923|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153832774|NCT01248923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153832775|NCT01248923|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153832776|NCT01248923|Glucocorticoids|glucocorticoids|mesh-ancestor
153832777|NCT01248923|Hormones|hormones|mesh-ancestor
153832780|NCT01248923|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153832781|NCT01248923|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153832782|NCT01248923|Immunologic Factors|immunologic factors|mesh-ancestor
153832783|NCT01248923|Protease Inhibitors|protease inhibitors|mesh-ancestor
153832784|NCT01248923|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153832785|NCT01248923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153832786|NCT01248923|Antimitotic Agents|antimitotic agents|mesh-ancestor
153832787|NCT01248923|Mitosis Modulators|mitosis modulators|mesh-ancestor
153832788|NCT01249001|Aprepitant|aprepitant|mesh-list
153832789|NCT01249001|Fosaprepitant|fosaprepitant|mesh-list
153832790|NCT01249001|Antiemetics|antiemetics|mesh-ancestor
153832791|NCT01249001|Autonomic Agents|autonomic agents|mesh-ancestor
153832792|NCT01249001|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153832793|NCT01249001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153832794|NCT01249001|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153372842|NCT01267292|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153372843|NCT01267292|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153372844|NCT01267292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153372845|NCT01267292|Dopamine Agents|dopamine agents|mesh-ancestor
153372846|NCT01267292|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153372847|NCT01267292|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153372848|NCT01267292|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153372849|NCT01267292|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153372850|NCT01267292|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153372851|NCT01267292|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
153372852|NCT01267292|Serotonin Agents|serotonin agents|mesh-ancestor
153372853|NCT01734161|Dexamethasone|dexamethasone|mesh-list
153372854|NCT01734161|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153372855|NCT01734161|Antiemetics|antiemetics|mesh-ancestor
153372856|NCT01734161|Autonomic Agents|autonomic agents|mesh-ancestor
153372857|NCT01734161|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153372858|NCT01734161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153372859|NCT01734161|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153372860|NCT01734161|Glucocorticoids|glucocorticoids|mesh-ancestor
153372861|NCT01734161|Hormones|hormones|mesh-ancestor
153372865|NCT01734239|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
153372866|NCT01734239|Immunologic Factors|immunologic factors|mesh-ancestor
153372867|NCT01734239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153372868|NCT01797575|Aspirin|aspirin|mesh-list
153832795|NCT01249001|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
153832796|NCT01249001|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153832797|NCT01249001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153832798|NCT00502112|Lenalidomide|lenalidomide|mesh-list
153832799|NCT00502112|Lintuzumab|lintuzumab|mesh-list
153832800|NCT00502112|Immunologic Factors|immunologic factors|mesh-ancestor
153832801|NCT00502112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153888308|NCT05637645|Anesthetics|anesthetics|mesh-ancestor
153888309|NCT05637645|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153888310|NCT05637645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153832802|NCT00502112|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153832803|NCT00502112|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153832804|NCT00502112|Growth Substances|growth substances|mesh-ancestor
153832805|NCT00502112|Growth Inhibitors|growth inhibitors|mesh-ancestor
153832806|NCT00502112|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153832807|NCT00502112|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153832809|NCT00502190|Trace Elements|trace elements|mesh-ancestor
153832810|NCT00502190|Micronutrients|micronutrients|mesh-ancestor
153832811|NCT00502190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153832812|NCT00502229|Metformin|metformin|mesh-list
153832813|NCT00502229|Clomiphene|clomiphene|mesh-list
153832814|NCT00502229|Enclomiphene|enclomiphene|mesh-list
153832815|NCT00502229|Zuclomiphene|zuclomiphene|mesh-list
153832816|NCT00502229|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153832817|NCT00502229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153832818|NCT00502229|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
153832819|NCT00502229|Hormone Antagonists|hormone antagonists|mesh-ancestor
153832820|NCT00502229|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153832821|NCT00502229|Fertility Agents, Female|fertility agents, female|mesh-ancestor
153832822|NCT00502229|Fertility Agents|fertility agents|mesh-ancestor
153832823|NCT00502229|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153832824|NCT00502229|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
153832825|NCT00502229|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
153832826|NCT00502268|1 alpha-hydroxyergocalciferol|1 alpha-hydroxyergocalciferol|mesh-list
153832829|NCT00502268|Micronutrients|micronutrients|mesh-ancestor
153832830|NCT00502268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153832831|NCT00502268|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153832832|NCT00502268|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153832833|NCT00510081|Calcium|calcium|mesh-list
153832834|NCT00510081|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153832835|NCT00510081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153832836|NCT00502385|Cediranib|cediranib|mesh-list
153832837|NCT00502385|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153832838|NCT00502385|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153832839|NCT00502385|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153372885|NCT01797575|Antipyretics|antipyretics|mesh-ancestor
153372886|NCT01797575|Antiviral Agents|antiviral agents|mesh-ancestor
153372887|NCT01797575|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153372888|NCT01797575|Expectorants|expectorants|mesh-ancestor
153372889|NCT01797575|Respiratory System Agents|respiratory system agents|mesh-ancestor
153372890|NCT01797575|Free Radical Scavengers|free radical scavengers|mesh-ancestor
153372891|NCT01797575|Antioxidants|antioxidants|mesh-ancestor
153372892|NCT01797575|Protective Agents|protective agents|mesh-ancestor
153372893|NCT01797575|Antidotes|antidotes|mesh-ancestor
153372894|NCT02641353|Thalidomide|thalidomide|mesh-list
153372896|NCT02641353|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153372897|NCT02641353|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153372898|NCT02641353|Analgesics|analgesics|mesh-ancestor
153372899|NCT02641353|Sensory System Agents|sensory system agents|mesh-ancestor
153372900|NCT02641353|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153372901|NCT02641353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153372902|NCT02641353|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153372903|NCT02641353|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153372904|NCT02641353|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
153372905|NCT02641353|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
153372906|NCT02641353|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153372907|NCT02641353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153372908|NCT02641353|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153372909|NCT02641353|Immunologic Factors|immunologic factors|mesh-ancestor
153372910|NCT02641353|Leprostatic Agents|leprostatic agents|mesh-ancestor
153372911|NCT02641353|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153372918|NCT01378520|Ketoconazole|ketoconazole|mesh-list
153372919|NCT01378520|Antifungal Agents|antifungal agents|mesh-ancestor
153372920|NCT01378520|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153832840|NCT00502385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153832841|NCT00510159|Artesunate|artesunate|mesh-list
153832842|NCT00510159|Sulfalene|sulfalene|mesh-list
153832843|NCT00510159|Praziquantel|praziquantel|mesh-list
153832844|NCT00510159|Antimalarials|antimalarials|mesh-ancestor
153832845|NCT00510159|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153832846|NCT00510159|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153832847|NCT00510159|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153832848|NCT00510159|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153832849|NCT00510159|Antiviral Agents|antiviral agents|mesh-ancestor
153832850|NCT00510159|Schistosomicides|schistosomicides|mesh-ancestor
153832851|NCT00510159|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
153832852|NCT00510159|Anthelmintics|anthelmintics|mesh-ancestor
153832853|NCT00510159|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
153832854|NCT02952807|Misoprostol|misoprostol|mesh-list
153832855|NCT02952807|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
153832856|NCT02952807|Abortifacient Agents|abortifacient agents|mesh-ancestor
153832857|NCT02952807|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153832858|NCT02952807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153832859|NCT02952807|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
153832860|NCT02952807|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153832866|NCT02275130|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153832867|NCT03459417|Morphine|morphine|mesh-list
153832868|NCT03459417|Sulpiride|sulpiride|mesh-list
153832869|NCT03459417|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153832870|NCT03459417|Narcotics|narcotics|mesh-ancestor
153832871|NCT03459417|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153832872|NCT03459417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153832873|NCT03459417|Analgesics|analgesics|mesh-ancestor
153832874|NCT03459417|Sensory System Agents|sensory system agents|mesh-ancestor
153832875|NCT03459417|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153372921|NCT01378520|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
153372922|NCT01378520|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153372923|NCT01378520|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153372924|NCT01378520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153372925|NCT01378520|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153372926|NCT01378520|Hormone Antagonists|hormone antagonists|mesh-ancestor
153372927|NCT01378520|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153372928|NCT01378520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153372929|NCT01378520|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
153372930|NCT01378988|Dexmedetomidine|dexmedetomidine|mesh-list
153372931|NCT01378988|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153372932|NCT01378988|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153372933|NCT01378988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153372934|NCT01378988|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153372935|NCT01378988|Analgesics|analgesics|mesh-ancestor
153372936|NCT01378988|Sensory System Agents|sensory system agents|mesh-ancestor
153372937|NCT01378988|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153372938|NCT01378988|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
153372939|NCT01378988|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153372940|NCT01378988|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153372941|NCT01378988|Adrenergic Agents|adrenergic agents|mesh-ancestor
153372942|NCT01378988|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153372944|NCT01335620|Tenofovir|tenofovir|mesh-list
153372949|NCT01335620|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153832876|NCT03459417|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153832877|NCT03459417|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153832878|NCT03459417|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153832879|NCT03459417|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
153832880|NCT03459417|Dopamine Agents|dopamine agents|mesh-ancestor
153832881|NCT03459417|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153832882|NCT03459417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153832883|NCT03459417|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
153832884|NCT03459417|Antidepressive Agents|antidepressive agents|mesh-ancestor
153832885|NCT00502541|Fluocinolone Acetonide|fluocinolone acetonide|mesh-list
153832886|NCT00502541|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153832887|NCT00502541|Glucocorticoids|glucocorticoids|mesh-ancestor
153832888|NCT00502541|Hormones|hormones|mesh-ancestor
153832889|NCT00502541|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153832890|NCT00502541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153832891|NCT01249430|Cytarabine|cytarabine|mesh-list
153832892|NCT01249430|Etoposide|etoposide|mesh-list
153832893|NCT01249430|Mitoxantrone|mitoxantrone|mesh-list
153832894|NCT01249430|Azacitidine|azacitidine|mesh-list
153832895|NCT01249430|Etoposide phosphate|etoposide phosphate|mesh-list
153832896|NCT01249430|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153832898|NCT01249430|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153832899|NCT01249430|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153372967|NCT01273766|Sequestering Agents|sequestering agents|mesh-ancestor
153372968|NCT01273766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153372969|NCT01403246|Lenalidomide|lenalidomide|mesh-list
153372970|NCT01403246|Chlorambucil|chlorambucil|mesh-list
153372971|NCT01403246|Immunologic Factors|immunologic factors|mesh-ancestor
153372972|NCT01403246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153372973|NCT01403246|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153372974|NCT01403246|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153372975|NCT01403246|Growth Substances|growth substances|mesh-ancestor
153372976|NCT01403246|Growth Inhibitors|growth inhibitors|mesh-ancestor
153372977|NCT01403246|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153372979|NCT01403246|Alkylating Agents|alkylating agents|mesh-ancestor
153372980|NCT01403246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153372981|NCT01734551|Clonidine|clonidine|mesh-list
153372982|NCT01734551|Morphine|morphine|mesh-list
153372983|NCT01734551|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153372984|NCT01734551|Narcotics|narcotics|mesh-ancestor
153372985|NCT01734551|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153372986|NCT01734551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153372987|NCT01734551|Analgesics|analgesics|mesh-ancestor
153372988|NCT01734551|Sensory System Agents|sensory system agents|mesh-ancestor
153372989|NCT01734551|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153372990|NCT01734551|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153372991|NCT01734551|Sympatholytics|sympatholytics|mesh-ancestor
153832919|NCT02952963|Cathartics|cathartics|mesh-ancestor
153832920|NCT02952963|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153832921|NCT00510939|Bortezomib|bortezomib|mesh-list
153832922|NCT00510939|Tipifarnib|tipifarnib|mesh-list
153832923|NCT00510939|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153832924|NCT00504062|Fluticasone|fluticasone|mesh-list
153832925|NCT00504062|Budesonide|budesonide|mesh-list
153832926|NCT00504062|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153832927|NCT00504062|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153832928|NCT00504062|Autonomic Agents|autonomic agents|mesh-ancestor
153832929|NCT00504062|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153832930|NCT00504062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153832933|NCT00504062|Dermatologic Agents|dermatologic agents|mesh-ancestor
153832934|NCT00504062|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
153832935|NCT00504062|Glucocorticoids|glucocorticoids|mesh-ancestor
153832936|NCT00504062|Hormones|hormones|mesh-ancestor
153832937|NCT00504062|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153832938|NCT00504101|Bortezomib|bortezomib|mesh-list
153832939|NCT00504101|Melphalan|melphalan|mesh-list
153832940|NCT00504101|Arsenic Trioxide|arsenic trioxide|mesh-list
153832941|NCT00504101|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153832942|NCT00504101|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153832943|NCT00504101|Alkylating Agents|alkylating agents|mesh-ancestor
153832944|NCT00504101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153832945|NCT00504101|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153832946|NCT00504101|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153832947|NCT00504101|Immunologic Factors|immunologic factors|mesh-ancestor
153832948|NCT00504101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153832949|NCT00504140|Interferons|interferons|mesh-list
153832950|NCT00504140|Interferon-alpha|interferon-alpha|mesh-list
153832951|NCT00504140|Etoposide|etoposide|mesh-list
153832952|NCT00504140|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153832953|NCT00504140|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153832954|NCT00504140|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153832955|NCT00504140|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153832956|NCT00504140|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153832957|NCT00504140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153832958|NCT00504140|Antiviral Agents|antiviral agents|mesh-ancestor
153832959|NCT00504140|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153832960|NCT00504140|Immunologic Factors|immunologic factors|mesh-ancestor
153832961|NCT00504140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153832962|NCT00511017|1 alpha-hydroxyergocalciferol|1 alpha-hydroxyergocalciferol|mesh-list
153832963|NCT00511017|Vitamins|vitamins|mesh-ancestor
153832964|NCT00511017|Micronutrients|micronutrients|mesh-ancestor
153373006|NCT01404260|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153373007|NCT01404260|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153888311|NCT05637645|Sensory System Agents|sensory system agents|mesh-ancestor
153373015|NCT02235909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153373016|NCT01404572|Atazanavir Sulfate|atazanavir sulfate|mesh-list
153373017|NCT01404572|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
153373018|NCT01404572|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
153373019|NCT01404572|Protease Inhibitors|protease inhibitors|mesh-ancestor
153373020|NCT01404572|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153373021|NCT01404572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153373038|NCT01799213|Meloxicam|meloxicam|mesh-list
153832965|NCT00511017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153832966|NCT00511017|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153832967|NCT00511212|Immunoglobulins|immunoglobulins|mesh-list
153832968|NCT00511212|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
153832969|NCT00511212|Antibodies|antibodies|mesh-list
153832970|NCT00511212|gamma-Globulins|gamma-globulins|mesh-list
153832971|NCT00511212|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
153832982|NCT01241006|Glucocorticoids|glucocorticoids|mesh-list
153832983|NCT01241006|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153832984|NCT01241006|Antiemetics|antiemetics|mesh-ancestor
153832985|NCT01241006|Autonomic Agents|autonomic agents|mesh-ancestor
153832986|NCT01241006|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153832987|NCT01241006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153832988|NCT01241006|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153832989|NCT01241006|Hormones|hormones|mesh-ancestor
153832990|NCT01241006|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153832991|NCT01241006|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153832992|NCT01241006|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153832993|NCT00510393|Everolimus|everolimus|mesh-list
153832994|NCT00510393|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
153832995|NCT00510393|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153832996|NCT00510393|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153832997|NCT00510393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153832998|NCT00510393|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153832999|NCT00510393|Immunologic Factors|immunologic factors|mesh-ancestor
153833000|NCT00510393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153833001|NCT00510393|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153833002|NCT01249547|Axitinib|axitinib|mesh-list
153833003|NCT01249547|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153833004|NCT01249547|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153833005|NCT01249547|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153833006|NCT01249547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153833007|NCT00511719|Insulin|insulin|mesh-list
153833008|NCT00511719|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
153833009|NCT00511719|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153833010|NCT00511719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153833011|NCT01246232|Amisulpride|amisulpride|mesh-list
153833012|NCT01246232|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153833013|NCT01246232|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153833014|NCT01246232|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153833015|NCT01246232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153833016|NCT01246232|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153833017|NCT01246232|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
153833018|NCT01246232|Dopamine Agents|dopamine agents|mesh-ancestor
153833019|NCT01246232|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153833020|NCT01246232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153833021|NCT01246232|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
153373062|NCT01383200|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153373063|NCT01383200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153373064|NCT05588037|Dexamethasone|dexamethasone|mesh-list
153373065|NCT05588037|Dexamethasone acetate|dexamethasone acetate|mesh-list
153373066|NCT05588037|BB 1101|bb 1101|mesh-list
153373067|NCT05588037|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153373068|NCT05588037|Antiemetics|antiemetics|mesh-ancestor
153373070|NCT05588037|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153373071|NCT05588037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153373072|NCT05588037|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153373073|NCT05588037|Glucocorticoids|glucocorticoids|mesh-ancestor
153373074|NCT05588037|Hormones|hormones|mesh-ancestor
153373086|NCT02194088|Sensory System Agents|sensory system agents|mesh-ancestor
153373087|NCT02194088|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153373088|NCT02194088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153373089|NCT02194088|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153373090|NCT02194088|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153373091|NCT02194088|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153373092|NCT02194088|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153373093|NCT02194088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153373094|NCT02194088|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153373095|NCT02194088|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153373096|NCT02194088|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153373097|NCT02194088|Autonomic Agents|autonomic agents|mesh-ancestor
153373098|NCT02194088|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153833022|NCT01246232|Antidepressive Agents|antidepressive agents|mesh-ancestor
153833023|NCT01248962|Carboplatin|carboplatin|mesh-list
153833024|NCT01248962|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153833032|NCT00511446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153833033|NCT00511446|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153833034|NCT00511446|Antimetabolites|antimetabolites|mesh-ancestor
153833035|NCT02955446|Gamma Secretase Inhibitors and Modulators|gamma secretase inhibitors and modulators|mesh-list
153833036|NCT02955446|Nirogacestat|nirogacestat|mesh-list
153833037|NCT02955446|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153833038|NCT02955446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153833039|NCT00511602|Insulin|insulin|mesh-list
153833040|NCT00511602|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153833041|NCT00511602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153833042|NCT00511953|Gabapentin|gabapentin|mesh-list
153833043|NCT00511953|Analgesics|analgesics|mesh-ancestor
153833044|NCT00511953|Sensory System Agents|sensory system agents|mesh-ancestor
153833045|NCT00511953|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153833046|NCT00511953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153833047|NCT00511953|Anticonvulsants|anticonvulsants|mesh-ancestor
153833048|NCT00511953|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153833049|NCT00511953|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153833050|NCT00511953|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153833052|NCT00511953|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
153833053|NCT00511953|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
153833054|NCT00511953|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153833055|NCT00511953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153833056|NCT00511953|Antimanic Agents|antimanic agents|mesh-ancestor
153833057|NCT01249820|Anidulafungin|anidulafungin|mesh-list
153833058|NCT01249820|Antifungal Agents|antifungal agents|mesh-ancestor
153373099|NCT02194088|Respiratory System Agents|respiratory system agents|mesh-ancestor
153373100|NCT02194088|Mydriatics|mydriatics|mesh-ancestor
153373101|NCT02194088|Parasympatholytics|parasympatholytics|mesh-ancestor
153373102|NCT02194088|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
153373103|NCT02194088|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
153373114|NCT02023593|Immunologic Factors|immunologic factors|mesh-ancestor
153373115|NCT02023593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153373116|NCT02023593|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
153373117|NCT02023593|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153373118|NCT02023593|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153373119|NCT02023593|Antidotes|antidotes|mesh-ancestor
153373120|NCT02023593|Protective Agents|protective agents|mesh-ancestor
153373121|NCT02023593|Vitamin B Complex|vitamin b complex|mesh-ancestor
153373122|NCT02023593|Vitamins|vitamins|mesh-ancestor
153373123|NCT02023593|Micronutrients|micronutrients|mesh-ancestor
153373124|NCT01978431|Cocaine|cocaine|mesh-list
153373125|NCT01978431|Methylphenidate|methylphenidate|mesh-list
153373126|NCT01978431|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
153373127|NCT01978431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153373128|NCT01978431|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
153373129|NCT01978431|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153373130|NCT01978431|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153373131|NCT01978431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153373132|NCT01978431|Dopamine Agents|dopamine agents|mesh-ancestor
153373133|NCT01978431|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153373134|NCT01978431|Anesthetics, Local|anesthetics, local|mesh-ancestor
153833059|NCT01249820|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153833060|NCT01247090|Vasopressins|vasopressins|mesh-list
153833061|NCT01247090|Arginine Vasopressin|arginine vasopressin|mesh-list
153833062|NCT01247090|Hemostatics|hemostatics|mesh-ancestor
153833063|NCT01247090|Coagulants|coagulants|mesh-ancestor
153833064|NCT01247090|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
153833065|NCT01247090|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
153833066|NCT01247090|Natriuretic Agents|natriuretic agents|mesh-ancestor
153833067|NCT01247090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153833068|NCT00504764|Arsenic Trioxide|arsenic trioxide|mesh-list
153833069|NCT00504764|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153833070|NCT02951754|Methylphenidate|methylphenidate|mesh-list
153833071|NCT02951754|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
153833077|NCT02951754|Dopamine Agents|dopamine agents|mesh-ancestor
153833078|NCT02951754|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153833080|NCT00504413|Midazolam|midazolam|mesh-list
153833081|NCT00504413|Methadone|methadone|mesh-list
153833082|NCT00504413|Bupropion|bupropion|mesh-list
153833083|NCT00504413|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153833084|NCT00504413|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153833085|NCT00504413|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153833086|NCT00504413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153833087|NCT00504413|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153833088|NCT00504413|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153833089|NCT00504413|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153833090|NCT00504413|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153833091|NCT00504413|Anesthetics, General|anesthetics, general|mesh-ancestor
153833092|NCT00504413|Anesthetics|anesthetics|mesh-ancestor
153833093|NCT00504413|GABA Modulators|gaba modulators|mesh-ancestor
153833094|NCT00504413|GABA Agents|gaba agents|mesh-ancestor
153833095|NCT00504413|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153833096|NCT00504413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153373137|NCT01978431|Sensory System Agents|sensory system agents|mesh-ancestor
153373138|NCT01978431|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153373139|NCT01978431|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
153373140|NCT01406444|Risedronic Acid|risedronic acid|mesh-list
153373141|NCT01406444|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153373142|NCT01406444|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153373143|NCT01406444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153373144|NCT01406444|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153373145|NCT01406444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153373146|NCT01406444|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153373147|NCT02685267|Prednisone|prednisone|mesh-list
153373148|NCT02685267|Docetaxel|docetaxel|mesh-list
153373149|NCT02685267|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153373150|NCT02685267|Tubulin Modulators|tubulin modulators|mesh-ancestor
153373151|NCT02685267|Antimitotic Agents|antimitotic agents|mesh-ancestor
153373152|NCT02685267|Mitosis Modulators|mitosis modulators|mesh-ancestor
153373153|NCT02685267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153833101|NCT00504413|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153833102|NCT00504413|Dopamine Agents|dopamine agents|mesh-ancestor
153833103|NCT00504413|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
153833104|NCT00504413|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153833105|NCT00504413|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153833106|NCT00504413|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153833107|NCT00504413|Narcotics|narcotics|mesh-ancestor
153833108|NCT00504413|Analgesics|analgesics|mesh-ancestor
153833109|NCT00504413|Sensory System Agents|sensory system agents|mesh-ancestor
153833110|NCT00504413|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153833111|NCT00504413|Antitussive Agents|antitussive agents|mesh-ancestor
153833112|NCT00504413|Respiratory System Agents|respiratory system agents|mesh-ancestor
153833113|NCT00504413|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153833114|NCT00504413|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
153833115|NCT00504413|Protective Agents|protective agents|mesh-ancestor
153833116|NCT02951793|Psychotropic Drugs|psychotropic drugs|mesh-list
153833118|NCT01243658|Oxytocics|oxytocics|mesh-ancestor
153833119|NCT01243658|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153373159|NCT02685267|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153373160|NCT02257541|Imatinib Mesylate|imatinib mesylate|mesh-list
153373161|NCT02257541|Infigratinib|infigratinib|mesh-list
153373162|NCT02257541|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153373163|NCT02257541|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153373164|NCT02257541|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153373165|NCT02257541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153373166|NCT02257541|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153373168|NCT01817855|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153373169|NCT01817855|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153373170|NCT01817855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153373171|NCT00368121|Dexamethasone|dexamethasone|mesh-list
153373172|NCT00368121|Cetuximab|cetuximab|mesh-list
153373173|NCT00368121|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153833144|NCT00513201|Insulin|insulin|mesh-list
153833145|NCT00513201|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
153373184|NCT00368121|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153373185|NCT00367497|Cytarabine|cytarabine|mesh-list
153373186|NCT00367497|Methylprednisolone|methylprednisolone|mesh-list
153373187|NCT00367497|Rituximab|rituximab|mesh-list
153373188|NCT00367497|Etoposide|etoposide|mesh-list
153373189|NCT00367497|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153373190|NCT00367497|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153373191|NCT00367497|Immunologic Factors|immunologic factors|mesh-ancestor
153373192|NCT00367497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153373193|NCT00367497|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153373194|NCT00367497|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153373195|NCT00367497|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153373196|NCT00367497|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153373197|NCT00367497|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153373198|NCT00367497|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153373199|NCT00367497|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153373206|NCT00367497|Autonomic Agents|autonomic agents|mesh-ancestor
153373207|NCT00367497|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153373208|NCT00367497|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153373209|NCT00367497|Glucocorticoids|glucocorticoids|mesh-ancestor
153373211|NCT00367497|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153373212|NCT00367497|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
153373213|NCT00367497|Protective Agents|protective agents|mesh-ancestor
153373214|NCT01387178|Fluticasone|fluticasone|mesh-list
153373227|NCT01387178|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
153373228|NCT01387178|Parasympatholytics|parasympatholytics|mesh-ancestor
153373229|NCT01387178|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
153373230|NCT01387178|Cholinergic Agents|cholinergic agents|mesh-ancestor
153373231|NCT01387178|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153373236|NCT01387178|Adrenergic Agents|adrenergic agents|mesh-ancestor
153373237|NCT01387178|Anticonvulsants|anticonvulsants|mesh-ancestor
153373239|NCT01389284|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153373240|NCT01389284|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153373241|NCT01389284|Analgesics|analgesics|mesh-ancestor
153373242|NCT01389284|Sensory System Agents|sensory system agents|mesh-ancestor
153373243|NCT01389284|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153373244|NCT01389284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153373245|NCT01389284|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153373246|NCT01389284|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153373247|NCT01389284|Gout Suppressants|gout suppressants|mesh-ancestor
153373248|NCT01389284|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153373249|NCT01389284|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153373250|NCT01389284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153373251|NCT01794143|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
153373252|NCT01794143|Liraglutide|liraglutide|mesh-list
153373253|NCT01794143|Glimepiride|glimepiride|mesh-list
153373254|NCT01794143|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
153373255|NCT01794143|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-list
153833203|NCT00513552|Clarithromycin|clarithromycin|mesh-list
153833204|NCT00513552|Rifabutin|rifabutin|mesh-list
153833205|NCT00513552|Clofazimine|clofazimine|mesh-list
153833213|NCT00513552|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
153833214|NCT00513552|Antitubercular Agents|antitubercular agents|mesh-ancestor
153373256|NCT01794143|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153373257|NCT01794143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153373259|NCT01794143|Hormones|hormones|mesh-ancestor
153373260|NCT01794143|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153373261|NCT01794143|Protease Inhibitors|protease inhibitors|mesh-ancestor
153373262|NCT01794143|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153373263|NCT01794143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153373264|NCT01794143|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153373265|NCT01794143|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153373266|NCT01794143|Immunologic Factors|immunologic factors|mesh-ancestor
153373267|NCT01547741|Paclitaxel|paclitaxel|mesh-list
153373268|NCT01547741|Docetaxel|docetaxel|mesh-list
153373269|NCT01547741|Cyclophosphamide|cyclophosphamide|mesh-list
153373270|NCT01547741|Doxorubicin|doxorubicin|mesh-list
153373271|NCT01547741|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153373272|NCT01547741|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153373273|NCT01547741|Tubulin Modulators|tubulin modulators|mesh-ancestor
153373274|NCT01547741|Antimitotic Agents|antimitotic agents|mesh-ancestor
153373275|NCT01547741|Mitosis Modulators|mitosis modulators|mesh-ancestor
153373276|NCT01547741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153373277|NCT01547741|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153373278|NCT01547741|Immunologic Factors|immunologic factors|mesh-ancestor
153373279|NCT01547741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153373280|NCT01547741|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153833223|NCT02275247|Anesthetics|anesthetics|mesh-ancestor
153833224|NCT02275247|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153833225|NCT02275247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153833226|NCT02275247|Sensory System Agents|sensory system agents|mesh-ancestor
153833227|NCT02275247|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153833228|NCT04515719|Belimumab|belimumab|mesh-list
153833229|NCT04515719|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153833230|NCT04515719|Immunologic Factors|immunologic factors|mesh-ancestor
153833231|NCT04515719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153833232|NCT00513786|Paclitaxel|paclitaxel|mesh-list
153833233|NCT00513786|Bevacizumab|bevacizumab|mesh-list
153833234|NCT00513786|Carboplatin|carboplatin|mesh-list
153833235|NCT00513786|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153833236|NCT00513786|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153833237|NCT00513786|Tubulin Modulators|tubulin modulators|mesh-ancestor
153833238|NCT00513786|Antimitotic Agents|antimitotic agents|mesh-ancestor
153373292|NCT01473368|Amoxicillin|amoxicillin|mesh-list
153833246|NCT00513786|Growth Inhibitors|growth inhibitors|mesh-ancestor
153833247|NCT00504491|Rituximab|rituximab|mesh-list
153833248|NCT00504491|Alemtuzumab|alemtuzumab|mesh-list
153833249|NCT00504491|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153833250|NCT00504491|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153833251|NCT00504491|Immunologic Factors|immunologic factors|mesh-ancestor
153833252|NCT00504491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153833253|NCT00504491|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153833254|NCT00512811|Furosemide|furosemide|mesh-list
153833255|NCT00512811|Diuretics|diuretics|mesh-ancestor
153833256|NCT00512811|Natriuretic Agents|natriuretic agents|mesh-ancestor
153833257|NCT00512811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153833258|NCT00512811|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
153833259|NCT00512811|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153833260|NCT00512811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153833261|NCT00513864|Morphine|morphine|mesh-list
153833262|NCT00513864|Levomethorphan|levomethorphan|mesh-list
153373304|NCT04351490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153373305|NCT04351490|Vitamins|vitamins|mesh-ancestor
153373306|NCT04351490|Micronutrients|micronutrients|mesh-ancestor
153373307|NCT04351490|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153373308|NCT01391312|Botulinum Toxins|botulinum toxins|mesh-list
153373309|NCT01391312|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
153373310|NCT01391312|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
153373311|NCT01391312|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
153373312|NCT01391312|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153373313|NCT01391312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153833270|NCT00513864|Sensory System Agents|sensory system agents|mesh-ancestor
153833271|NCT00513864|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153833272|NCT00513864|Antitussive Agents|antitussive agents|mesh-ancestor
153833273|NCT00513864|Respiratory System Agents|respiratory system agents|mesh-ancestor
153833274|NCT00513864|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
153833275|NCT00513864|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
153833276|NCT00513864|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153833277|NCT00513864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153833278|NCT01248884|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
153833279|NCT01248884|Immunologic Factors|immunologic factors|mesh-ancestor
153833280|NCT01248884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153833281|NCT00512850|Folic Acid|folic acid|mesh-list
153373324|NCT05328635|Candesartan cilexetil|candesartan cilexetil|mesh-list
153373325|NCT05328635|Gabapentin|gabapentin|mesh-list
153373326|NCT05328635|Analgesics|analgesics|mesh-ancestor
153373327|NCT05328635|Sensory System Agents|sensory system agents|mesh-ancestor
153373328|NCT05328635|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153373329|NCT05328635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153373330|NCT05328635|Anticonvulsants|anticonvulsants|mesh-ancestor
153373331|NCT05328635|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153373332|NCT05328635|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153373333|NCT05328635|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153373334|NCT05328635|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153373335|NCT05328635|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
153373336|NCT05328635|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
153373337|NCT05328635|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153373338|NCT05328635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153373339|NCT05328635|Antimanic Agents|antimanic agents|mesh-ancestor
153373340|NCT05328635|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153373341|NCT05328635|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
153373347|NCT01391858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153373349|NCT01391858|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153373350|NCT01391858|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153373351|NCT01391858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153373352|NCT01391858|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153373353|NCT01391858|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153373354|NCT01391858|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153373355|NCT01391858|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153373356|NCT01391858|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153373357|NCT05587257|Minoxidil|minoxidil|mesh-list
153373358|NCT05587257|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153373359|NCT05587257|Vasodilator Agents|vasodilator agents|mesh-ancestor
153373360|NCT01825655|Cetirizine|cetirizine|mesh-list
153373361|NCT01825655|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
153373362|NCT01825655|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
153373363|NCT01825655|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
153373364|NCT01825655|Histamine Antagonists|histamine antagonists|mesh-ancestor
153373365|NCT01825655|Histamine Agents|histamine agents|mesh-ancestor
153373366|NCT01825655|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153373367|NCT01825655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153373368|NCT01825655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153373369|NCT02249663|Fluticasone|fluticasone|mesh-list
153373370|NCT02249663|Xhance|xhance|mesh-list
153833320|NCT00514605|Antibodies|antibodies|mesh-list
153833321|NCT00514605|Immunoglobulins|immunoglobulins|mesh-list
153833322|NCT00514605|Immunologic Factors|immunologic factors|mesh-ancestor
153833323|NCT00514605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153833324|NCT00513981|Leucovorin|leucovorin|mesh-list
153833325|NCT00513981|Methotrexate|methotrexate|mesh-list
153833326|NCT00513981|Calcium|calcium|mesh-list
153833327|NCT00513981|Levoleucovorin|levoleucovorin|mesh-list
153833328|NCT00513981|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153833329|NCT00513981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153833330|NCT00513981|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
153833331|NCT00513981|Abortifacient Agents|abortifacient agents|mesh-ancestor
153373384|NCT02249663|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
153373385|NCT02249663|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
153373386|NCT02249663|Histamine Antagonists|histamine antagonists|mesh-ancestor
153373387|NCT02249663|Histamine Agents|histamine agents|mesh-ancestor
153373388|NCT02249663|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153373390|NCT01825889|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153373391|NCT01825889|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153373392|NCT01825889|Antimetabolites|antimetabolites|mesh-ancestor
153373393|NCT01825889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153833352|NCT00514761|Capecitabine|capecitabine|mesh-list
153833353|NCT00514761|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153833354|NCT00514761|Antimetabolites|antimetabolites|mesh-ancestor
153373394|NCT01825889|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153373396|NCT02692755|Fulvestrant|fulvestrant|mesh-list
153373397|NCT02692755|Palbociclib|palbociclib|mesh-list
153373398|NCT02692755|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153373399|NCT02692755|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
153373400|NCT02692755|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153373401|NCT02692755|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153373402|NCT02692755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153373403|NCT02692755|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
153373404|NCT02692755|Hormone Antagonists|hormone antagonists|mesh-ancestor
153373405|NCT02692755|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153373406|NCT02692755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153373407|NCT02692755|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153373408|NCT02692755|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
153373409|NCT02692755|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153373410|NCT01829399|Epinephrine|epinephrine|mesh-list
153373411|NCT01829399|Bupivacaine|bupivacaine|mesh-list
153373412|NCT01829399|Anesthetics, Local|anesthetics, local|mesh-ancestor
153373413|NCT01829399|Anesthetics|anesthetics|mesh-ancestor
153373414|NCT01829399|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153373415|NCT01829399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153373416|NCT01829399|Sensory System Agents|sensory system agents|mesh-ancestor
153373417|NCT01829399|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153373418|NCT01829399|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153833378|NCT01245101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153833380|NCT01245062|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153833381|NCT01245062|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153373421|NCT01829399|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153373422|NCT01829399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153373423|NCT01829399|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
153373426|NCT01829399|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153373427|NCT01829399|Respiratory System Agents|respiratory system agents|mesh-ancestor
153373428|NCT01829399|Mydriatics|mydriatics|mesh-ancestor
153373429|NCT01829399|Sympathomimetics|sympathomimetics|mesh-ancestor
153373430|NCT01829399|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
153373431|NCT01394510|Acetylcysteine|acetylcysteine|mesh-list
153373432|NCT01394510|N-monoacetylcystine|n-monoacetylcystine|mesh-list
153373433|NCT01394510|Antiviral Agents|antiviral agents|mesh-ancestor
153373434|NCT01394510|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153373435|NCT01394510|Expectorants|expectorants|mesh-ancestor
153373436|NCT01394510|Respiratory System Agents|respiratory system agents|mesh-ancestor
153373437|NCT01394510|Free Radical Scavengers|free radical scavengers|mesh-ancestor
153373438|NCT01394510|Antioxidants|antioxidants|mesh-ancestor
153373439|NCT01394510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153381132|NCT01705964|Respiratory System Agents|respiratory system agents|mesh-ancestor
153381133|NCT01705964|Mydriatics|mydriatics|mesh-ancestor
153381134|NCT01705964|Sympathomimetics|sympathomimetics|mesh-ancestor
153381135|NCT01705964|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
153381136|NCT02341482|Itraconazole|itraconazole|mesh-list
153381137|NCT02341482|Antifungal Agents|antifungal agents|mesh-ancestor
153381138|NCT02341482|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153381139|NCT02341482|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
153381140|NCT02341482|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153381141|NCT02341482|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153381142|NCT02341482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153381143|NCT02341482|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153373440|NCT01394510|Protective Agents|protective agents|mesh-ancestor
153373441|NCT01394510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153373442|NCT01394510|Antidotes|antidotes|mesh-ancestor
153373443|NCT05580549|Ethanol|ethanol|mesh-list
153373444|NCT05580549|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
153373453|NCT00367731|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
153373454|NCT00367731|Antiviral Agents|antiviral agents|mesh-ancestor
153373455|NCT00367731|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153373456|NCT05326841|Vitamin D|vitamin d|mesh-list
153373457|NCT05326841|Cholecalciferol|cholecalciferol|mesh-list
153373458|NCT05326841|Vitamins|vitamins|mesh-ancestor
153373459|NCT05326841|Micronutrients|micronutrients|mesh-ancestor
153373460|NCT05326841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153373461|NCT05326841|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153373462|NCT05326841|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153373463|NCT01412372|Mesalamine|mesalamine|mesh-list
153373464|NCT01412372|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153373465|NCT01412372|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153373466|NCT01412372|Analgesics|analgesics|mesh-ancestor
153373467|NCT01412372|Sensory System Agents|sensory system agents|mesh-ancestor
153373468|NCT01412372|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153373469|NCT01412372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153373470|NCT01412372|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153833412|NCT01243775|Docetaxel|docetaxel|mesh-list
153833413|NCT01243775|Oxaliplatin|oxaliplatin|mesh-list
153833414|NCT01243775|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153833415|NCT01243775|Tubulin Modulators|tubulin modulators|mesh-ancestor
153833416|NCT01243775|Antimitotic Agents|antimitotic agents|mesh-ancestor
153833417|NCT01243775|Mitosis Modulators|mitosis modulators|mesh-ancestor
153833418|NCT01243775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153833419|NCT00514293|Carboplatin|carboplatin|mesh-list
153833420|NCT00514293|Docetaxel|docetaxel|mesh-list
153833421|NCT00514293|Capecitabine|capecitabine|mesh-list
153833422|NCT00514293|Tretinoin|tretinoin|mesh-list
153833423|NCT00514293|Bexarotene|bexarotene|mesh-list
153833424|NCT00514293|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153833425|NCT00514293|Tubulin Modulators|tubulin modulators|mesh-ancestor
153833426|NCT00514293|Antimitotic Agents|antimitotic agents|mesh-ancestor
153833427|NCT00514293|Mitosis Modulators|mitosis modulators|mesh-ancestor
153833428|NCT00514293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153833429|NCT00514293|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153833430|NCT00514293|Antimetabolites|antimetabolites|mesh-ancestor
153833431|NCT00514293|Keratolytic Agents|keratolytic agents|mesh-ancestor
153833432|NCT00514293|Dermatologic Agents|dermatologic agents|mesh-ancestor
153373471|NCT01412372|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153373472|NCT01414010|Amoxicillin|amoxicillin|mesh-list
153373473|NCT01414010|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153373516|NCT02698215|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
153833472|NCT00515151|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
153833473|NCT00515151|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153833474|NCT00515151|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153833493|NCT00514410|Micronutrients|micronutrients|mesh-ancestor
153833494|NCT00514410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153833495|NCT01241318|Chlorhexidine|chlorhexidine|mesh-list
153833496|NCT01241318|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
153833497|NCT01241318|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
153833498|NCT01241318|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153373537|NCT04172961|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
153373540|NCT01480232|Nicotine|nicotine|mesh-list
153373541|NCT01480232|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
153373542|NCT01480232|Autonomic Agents|autonomic agents|mesh-ancestor
153373543|NCT01480232|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153373544|NCT01480232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153373545|NCT01480232|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
153373546|NCT01480232|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
153373547|NCT01480232|Cholinergic Agents|cholinergic agents|mesh-ancestor
153373548|NCT01480232|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153373549|NCT01480232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153373550|NCT01399268|Hydrocortisone|hydrocortisone|mesh-list
153373551|NCT01399268|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153373552|NCT03008876|Acetaminophen|acetaminophen|mesh-list
153373553|NCT03008876|Ibuprofen|ibuprofen|mesh-list
153373554|NCT03008876|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153373555|NCT03008876|Analgesics|analgesics|mesh-ancestor
153373556|NCT03008876|Sensory System Agents|sensory system agents|mesh-ancestor
153373557|NCT03008876|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153373558|NCT03008876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153373559|NCT03008876|Antipyretics|antipyretics|mesh-ancestor
153373560|NCT03008876|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153373561|NCT03008876|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153373562|NCT03008876|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153373563|NCT03008876|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153373564|NCT03008876|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153373565|NCT03008876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153373566|NCT05414487|Ofatumumab|ofatumumab|mesh-list
153373567|NCT05414487|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153373569|NCT02701257|Pancrelipase|pancrelipase|mesh-list
153373570|NCT02701257|Pancreatin|pancreatin|mesh-list
153373571|NCT02701257|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
153373572|NCT02701257|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153373573|NCT02701257|Hormones|hormones|mesh-ancestor
153833508|NCT00514527|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153833509|NCT00514527|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153833510|NCT01241240|Timolol|timolol|mesh-list
153833511|NCT01241240|Brimonidine Tartrate|brimonidine tartrate|mesh-list
153833512|NCT01241240|Bimatoprost|bimatoprost|mesh-list
153833513|NCT01241240|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
153833514|NCT01241240|Ophthalmic Solutions|ophthalmic solutions|mesh-list
153833515|NCT01241240|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
153833516|NCT01241240|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
153833517|NCT01241240|Adrenergic Agents|adrenergic agents|mesh-ancestor
153833518|NCT01241240|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153833519|NCT01241240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153833520|NCT01241240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153833521|NCT01241240|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153833522|NCT01241240|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153833523|NCT01241240|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
153833524|NCT01241240|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153833525|NCT01241240|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153833526|NCT02950623|Titanium dioxide|titanium dioxide|mesh-list
153833527|NCT02950623|Sunscreening Agents|sunscreening agents|mesh-ancestor
153833528|NCT02950623|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
153833529|NCT02950623|Protective Agents|protective agents|mesh-ancestor
153373600|NCT02706249|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153373601|NCT02706249|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153373602|NCT02706249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153373603|NCT04740021|Carboplatin|carboplatin|mesh-list
153373605|NCT04740021|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153373606|NCT04740021|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153373607|NCT04740021|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153373608|NCT04740021|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153833537|NCT00516009|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153833538|NCT00516009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153833539|NCT00516009|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153833540|NCT00516009|Glucocorticoids|glucocorticoids|mesh-ancestor
153833541|NCT00516009|Hormones|hormones|mesh-ancestor
153882727|NCT01609881|Sensory System Agents|sensory system agents|mesh-ancestor
153882728|NCT01609881|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153882729|NCT01609881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153882730|NCT01609881|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153882731|NCT01609881|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153882732|NCT01609881|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153882733|NCT01609881|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153882734|NCT01609881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153882735|NCT01609959|Valsartan|valsartan|mesh-list
153833542|NCT00516009|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153833543|NCT00516009|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153833544|NCT00516009|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153833545|NCT02950584|Titanium dioxide|titanium dioxide|mesh-list
153833546|NCT02950584|Sunscreening Agents|sunscreening agents|mesh-ancestor
153833547|NCT02950584|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
153833548|NCT02950584|Protective Agents|protective agents|mesh-ancestor
153833549|NCT02950584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153833550|NCT02950584|Dermatologic Agents|dermatologic agents|mesh-ancestor
153833551|NCT02950584|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
153833553|NCT01240811|Levonorgestrel|levonorgestrel|mesh-list
153833554|NCT01240811|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
153833559|NCT01240811|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
153833560|NCT01240811|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
153833561|NCT01240811|Trace Elements|trace elements|mesh-ancestor
153833562|NCT01240811|Micronutrients|micronutrients|mesh-ancestor
153833563|NCT03459144|Ranibizumab|ranibizumab|mesh-list
153833564|NCT03459144|Verteporfin|verteporfin|mesh-list
153833565|NCT03459144|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153833566|NCT03459144|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153833567|NCT03459144|Growth Substances|growth substances|mesh-ancestor
153833568|NCT03459144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153833569|NCT03459144|Growth Inhibitors|growth inhibitors|mesh-ancestor
153833570|NCT03459144|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153833571|NCT03459144|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
153373610|NCT04740021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153373611|NCT02708433|Lidocaine|lidocaine|mesh-list
153373612|NCT02708433|Anesthetics, Local|anesthetics, local|mesh-ancestor
153373613|NCT02708433|Anesthetics|anesthetics|mesh-ancestor
153373614|NCT02708433|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153373615|NCT02708433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153373616|NCT02708433|Sensory System Agents|sensory system agents|mesh-ancestor
153373617|NCT02708433|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153373618|NCT02708433|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153373619|NCT02708433|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
153373620|NCT02708433|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153373621|NCT02708433|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153373623|NCT00559637|Epoetin Alfa|epoetin alfa|mesh-list
153373643|NCT03349281|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153373644|NCT03349281|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153373645|NCT03349281|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153373647|NCT03349281|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153373648|NCT03349281|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153373649|NCT03349281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153373650|NCT03349281|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
153373651|NCT03349281|Abortifacient Agents|abortifacient agents|mesh-ancestor
153373652|NCT03349281|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153373653|NCT03349281|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153373654|NCT03349281|Antimetabolites|antimetabolites|mesh-ancestor
153373655|NCT03349281|Dermatologic Agents|dermatologic agents|mesh-ancestor
153833615|NCT01243073|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153833616|NCT01243073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153381146|NCT02341482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153381147|NCT02341482|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
153381148|NCT03140631|Protamines|protamines|mesh-list
153381149|NCT03140631|Heparin Antagonists|heparin antagonists|mesh-ancestor
153381211|NCT01603940|Protease Inhibitors|protease inhibitors|mesh-ancestor
153833617|NCT01243073|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153833618|NCT00516243|Epigallocatechin gallate|epigallocatechin gallate|mesh-list
153373656|NCT03349281|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153373657|NCT03349281|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153373658|NCT03349281|Immunologic Factors|immunologic factors|mesh-ancestor
153373659|NCT03349281|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153373660|NCT03349281|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153373661|NCT03349281|Antiviral Agents|antiviral agents|mesh-ancestor
153373662|NCT03349281|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153373663|NCT03349281|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153373664|NCT03349281|Tubulin Modulators|tubulin modulators|mesh-ancestor
153373665|NCT03349281|Antimitotic Agents|antimitotic agents|mesh-ancestor
153373666|NCT03349281|Mitosis Modulators|mitosis modulators|mesh-ancestor
153373668|NCT03206151|Folic Acid|folic acid|mesh-list
153373669|NCT03206151|Fluorouracil|fluorouracil|mesh-list
153373670|NCT03206151|Irinotecan|irinotecan|mesh-list
153373671|NCT03206151|Levoleucovorin|levoleucovorin|mesh-list
153373672|NCT03206151|Antimetabolites|antimetabolites|mesh-ancestor
153373673|NCT03206151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153373674|NCT03206151|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153373675|NCT03206151|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153373676|NCT03206151|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153373677|NCT03206151|Immunologic Factors|immunologic factors|mesh-ancestor
153373678|NCT03206151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153373679|NCT03206151|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
153373696|NCT02714283|Erythromycin|erythromycin|mesh-list
153373697|NCT02714283|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153373698|NCT02714283|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153373699|NCT02714283|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153373700|NCT02714283|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
153373701|NCT02714283|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153373702|NCT02714283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153373703|NCT04810949|Vitamin D|vitamin d|mesh-list
153373704|NCT04810949|Cholecalciferol|cholecalciferol|mesh-list
153373705|NCT04810949|Vitamins|vitamins|mesh-ancestor
153373706|NCT04810949|Micronutrients|micronutrients|mesh-ancestor
153373707|NCT04810949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153373708|NCT04810949|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153373709|NCT04810949|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153373710|NCT04795583|Prednisone|prednisone|mesh-list
153833647|NCT01249521|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153833648|NCT01249521|Growth Substances|growth substances|mesh-ancestor
153833649|NCT01249521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153833650|NCT01249521|Growth Inhibitors|growth inhibitors|mesh-ancestor
153833651|NCT01249677|Insulin Glargine|insulin glargine|mesh-list
153833652|NCT01249677|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153833653|NCT01249677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153833654|NCT04511975|Azacitidine|azacitidine|mesh-list
153833655|NCT04511975|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153833656|NCT04511975|Antimetabolites|antimetabolites|mesh-ancestor
153833657|NCT04511975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153833658|NCT04511975|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153833659|NCT04511975|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153833660|NCT04511897|Expectorants|expectorants|mesh-list
153833661|NCT04511897|Respiratory System Agents|respiratory system agents|mesh-ancestor
153833662|NCT04519463|Lidocaine|lidocaine|mesh-list
153833663|NCT04519463|Anesthetics, Local|anesthetics, local|mesh-ancestor
153833664|NCT04519463|Anesthetics|anesthetics|mesh-ancestor
153833665|NCT04519463|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153833666|NCT04519463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153833667|NCT04519463|Sensory System Agents|sensory system agents|mesh-ancestor
153833685|NCT01244256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153833686|NCT01244256|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153833687|NCT01244256|Glucocorticoids|glucocorticoids|mesh-ancestor
153833688|NCT01244256|Hormones|hormones|mesh-ancestor
153833689|NCT01244256|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153833690|NCT01244256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153833691|NCT01244256|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153833692|NCT01244256|Respiratory System Agents|respiratory system agents|mesh-ancestor
153833693|NCT01244256|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
153833694|NCT01244256|Antifungal Agents|antifungal agents|mesh-ancestor
153833695|NCT01244256|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
153833696|NCT01244256|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153373737|NCT05084859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153373738|NCT05084859|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153373740|NCT05084859|Hormones|hormones|mesh-ancestor
153373741|NCT05084859|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153373742|NCT05084859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153373743|NCT05084859|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153373744|NCT05084859|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153373745|NCT01846871|Tivozanib|tivozanib|mesh-list
153373746|NCT01846871|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153373747|NCT01846871|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153373748|NCT01846871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153373749|NCT02431260|INCB054329|incb054329|mesh-list
153373750|NCT02431260|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153373751|NCT02055963|Minocycline|minocycline|mesh-list
153373752|NCT02055963|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153833718|NCT01249404|Cholinergic Agents|cholinergic agents|mesh-ancestor
153833719|NCT01249404|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153833720|NCT01249404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153833721|NCT01249404|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
153833722|NCT01249404|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153833723|NCT04511000|Atorvastatin|atorvastatin|mesh-list
153833724|NCT04511000|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153833725|NCT04511000|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153833726|NCT04511000|Antimetabolites|antimetabolites|mesh-ancestor
153833727|NCT04511000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153833728|NCT04511000|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153833729|NCT04511000|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
153833730|NCT04511000|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153833731|NCT04519385|Dexamethasone|dexamethasone|mesh-list
153833732|NCT04519385|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153833733|NCT04519385|Antiemetics|antiemetics|mesh-ancestor
153833734|NCT04519385|Autonomic Agents|autonomic agents|mesh-ancestor
153373779|NCT02724033|Autonomic Agents|autonomic agents|mesh-ancestor
153373780|NCT02724033|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153373781|NCT02724033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153373782|NCT02724033|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153373792|NCT02724033|Sensory System Agents|sensory system agents|mesh-ancestor
153373793|NCT02724033|Antipruritics|antipruritics|mesh-ancestor
153373794|NCT02724033|Dermatologic Agents|dermatologic agents|mesh-ancestor
153373795|NCT02724033|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
153833740|NCT04519385|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153833741|NCT04519385|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153833742|NCT04519385|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153833743|NCT00506051|Pemetrexed|pemetrexed|mesh-list
153833744|NCT00506051|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153833745|NCT00506051|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153833746|NCT00506051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153833747|NCT00506051|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153833748|NCT00506051|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153833749|NCT00504465|Dinoprostone|dinoprostone|mesh-list
153833750|NCT00504465|Oxytocics|oxytocics|mesh-ancestor
153833751|NCT00504465|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153833752|NCT00504465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153833753|NCT00516360|Chlorhexidine|chlorhexidine|mesh-list
153833754|NCT00516360|Anti-Infective Agents, Local|anti-infective agents, local|mesh-list
153833755|NCT00516360|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153373799|NCT02724423|Diazepam|diazepam|mesh-list
153373800|NCT02724423|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153373801|NCT02724423|Anticonvulsants|anticonvulsants|mesh-ancestor
153373802|NCT02724423|Antiemetics|antiemetics|mesh-ancestor
153373803|NCT02724423|Autonomic Agents|autonomic agents|mesh-ancestor
153373804|NCT02724423|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153373805|NCT02724423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153373806|NCT02724423|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153373807|NCT02724423|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153373808|NCT02724423|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153373809|NCT02724423|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
153373810|NCT02724423|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
153373811|NCT02724423|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153373812|NCT02724423|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153373813|NCT02724423|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153373814|NCT02724423|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153833770|NCT04510649|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
153833772|NCT04510649|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
153833773|NCT04510649|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
153833774|NCT04510649|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
153833775|NCT04510649|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
153833776|NCT01249092|Pentoxifylline|pentoxifylline|mesh-list
153833777|NCT01249092|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
153833778|NCT01249092|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153833779|NCT01249092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153833780|NCT01249092|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153833781|NCT01249092|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
153833782|NCT01249092|Protective Agents|protective agents|mesh-ancestor
153373838|NCT01848899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153373840|NCT02731833|Fluorides|fluorides|mesh-list
153373841|NCT02731833|Tin Fluorides|tin fluorides|mesh-list
153373842|NCT02731833|Fluorophosphate|fluorophosphate|mesh-list
153373843|NCT02731833|Cariostatic Agents|cariostatic agents|mesh-ancestor
153373844|NCT02731833|Protective Agents|protective agents|mesh-ancestor
153373845|NCT02731833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153373846|NCT01852019|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
153373847|NCT01852019|Cangrelor|cangrelor|mesh-list
153373848|NCT01852019|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153373861|NCT01852175|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
153373862|NCT01852175|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
153373863|NCT01852175|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
153373864|NCT01852175|Purinergic Agents|purinergic agents|mesh-ancestor
153373865|NCT01852175|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153373866|NCT01852175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153373867|NCT01852175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153373868|NCT02429934|Abatacept|abatacept|mesh-list
153373869|NCT02429934|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153373870|NCT02429934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153373871|NCT02429934|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153373872|NCT02429934|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153373873|NCT02429934|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153373874|NCT02429934|Immunologic Factors|immunologic factors|mesh-ancestor
153833813|NCT01248780|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153833814|NCT01248780|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153833815|NCT01248780|Immunologic Factors|immunologic factors|mesh-ancestor
153833816|NCT01248780|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153833817|NCT01248780|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153833818|NCT01248780|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
153833819|NCT01248780|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153833821|NCT01248468|Acetaminophen|acetaminophen|mesh-list
153833822|NCT01248468|Sumatriptan|sumatriptan|mesh-list
153833823|NCT01248468|Caffeine|caffeine|mesh-list
153833824|NCT01248468|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153833825|NCT01248468|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153833826|NCT01248468|Analgesics|analgesics|mesh-ancestor
153833827|NCT01248468|Sensory System Agents|sensory system agents|mesh-ancestor
153373876|NCT02429934|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153373898|NCT02401230|Antiviral Agents|antiviral agents|mesh-ancestor
153373899|NCT02401230|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153373900|NCT02401230|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153833835|NCT01248468|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153833836|NCT01248468|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153833837|NCT01248468|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153833838|NCT01248468|Antipyretics|antipyretics|mesh-ancestor
153833839|NCT01248468|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
153833840|NCT01248468|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
153833841|NCT01248468|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
153833842|NCT01248468|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
153833843|NCT01248468|Purinergic Agents|purinergic agents|mesh-ancestor
153833844|NCT01248468|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153833845|NCT01248468|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
153833859|NCT02275299|Dermatologic Agents|dermatologic agents|mesh-ancestor
153833860|NCT02275299|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153833861|NCT02275299|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153833862|NCT02275299|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153833863|NCT02275299|Immunologic Factors|immunologic factors|mesh-ancestor
153833864|NCT02275299|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153833865|NCT02275299|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153833866|NCT01247922|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
153833867|NCT01247922|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153833868|NCT01247922|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153833869|NCT01247922|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153833870|NCT01247922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153833871|NCT01247922|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153373920|NCT01855997|Interferon alpha-2|interferon alpha-2|mesh-list
153373921|NCT01855997|Antiviral Agents|antiviral agents|mesh-ancestor
153373922|NCT01855997|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153373923|NCT01855997|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153373924|NCT02734953|Nitric Oxide|nitric oxide|mesh-list
153373925|NCT02734953|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153373926|NCT02734953|Autonomic Agents|autonomic agents|mesh-ancestor
153373927|NCT02734953|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153373928|NCT02734953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153373929|NCT02734953|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153833899|NCT01244490|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153373948|NCT02735187|Vitamin D|vitamin d|mesh-list
153373949|NCT02735187|Vitamins|vitamins|mesh-ancestor
153373950|NCT02735187|Micronutrients|micronutrients|mesh-ancestor
153373951|NCT02735187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153373952|NCT02735187|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153373953|NCT02428296|Sirolimus|sirolimus|mesh-list
153373954|NCT02428296|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153373955|NCT02428296|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153373956|NCT02428296|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153373957|NCT02428296|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153373958|NCT02428296|Antifungal Agents|antifungal agents|mesh-ancestor
153373959|NCT02428296|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153373960|NCT02428296|Immunologic Factors|immunologic factors|mesh-ancestor
153373961|NCT02428296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153373962|NCT02643615|Propofol|propofol|mesh-list
153373963|NCT02643615|Desflurane|desflurane|mesh-list
153373964|NCT02643615|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153373965|NCT02643615|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153373966|NCT02643615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153373967|NCT02643615|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153373968|NCT02643615|Anesthetics, General|anesthetics, general|mesh-ancestor
153373969|NCT02643615|Anesthetics|anesthetics|mesh-ancestor
153373970|NCT02643615|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
153373971|NCT02265341|Ponatinib|ponatinib|mesh-list
153373972|NCT02265341|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153373973|NCT02265341|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153373974|NCT02265341|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153373975|NCT02265341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153373976|NCT02265341|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153373977|NCT01421186|Dexamethasone|dexamethasone|mesh-list
153373978|NCT01421186|Lenalidomide|lenalidomide|mesh-list
153373979|NCT01421186|Pomalidomide|pomalidomide|mesh-list
153833900|NCT01244490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153833901|NCT01244490|Adrenergic Agents|adrenergic agents|mesh-ancestor
153833902|NCT01244490|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153833903|NCT01244490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153833906|NCT01244490|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153833907|NCT01244490|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153833908|NCT01243944|Lenalidomide|lenalidomide|mesh-list
153833909|NCT01243944|Pomalidomide|pomalidomide|mesh-list
153833910|NCT01243944|Hydroxyurea|hydroxyurea|mesh-list
153833912|NCT01243944|Anagrelide|anagrelide|mesh-list
153833913|NCT01243944|Immunologic Factors|immunologic factors|mesh-ancestor
153833914|NCT01243944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153833915|NCT01243944|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153833916|NCT01243944|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153833917|NCT01243944|Growth Substances|growth substances|mesh-ancestor
153833918|NCT01243944|Growth Inhibitors|growth inhibitors|mesh-ancestor
153833919|NCT01243944|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153833920|NCT01243944|Antisickling Agents|antisickling agents|mesh-ancestor
153833921|NCT01243944|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153833922|NCT01243944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153833923|NCT01243944|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153833924|NCT01243944|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153833925|NCT01243944|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153833926|NCT01243944|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153833927|NCT01243944|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153833928|NCT01243944|Alkylating Agents|alkylating agents|mesh-ancestor
153833929|NCT00516399|Povidone-Iodine|povidone-iodine|mesh-list
153833930|NCT00516399|Natamycin|natamycin|mesh-list
153833931|NCT00516399|Povidone|povidone|mesh-list
153833932|NCT00516399|Ophthalmic Solutions|ophthalmic solutions|mesh-list
153833933|NCT00516399|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
153833934|NCT00516399|Plasma Substitutes|plasma substitutes|mesh-ancestor
153833935|NCT00516399|Blood Substitutes|blood substitutes|mesh-ancestor
153833936|NCT00516399|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
153833937|NCT00516399|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153833938|NCT00516399|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153833939|NCT00516399|Antifungal Agents|antifungal agents|mesh-ancestor
153833941|NCT00516438|Olaparib|olaparib|mesh-list
153833942|NCT00516438|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
153833957|NCT02950155|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153833958|NCT02950155|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153833959|NCT02950155|Immunologic Factors|immunologic factors|mesh-ancestor
153833960|NCT02950155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153374010|NCT01422200|Immunologic Factors|immunologic factors|mesh-ancestor
153374011|NCT01422200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153374012|NCT01860521|Sufentanil|sufentanil|mesh-list
153374013|NCT01860521|Levobupivacaine|levobupivacaine|mesh-list
153374014|NCT01860521|Gemeprost|gemeprost|mesh-list
153374025|NCT01860521|Anesthetics|anesthetics|mesh-ancestor
153374026|NCT01860521|Anesthetics, Local|anesthetics, local|mesh-ancestor
153374027|NCT01860521|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
153374028|NCT01860521|Abortifacient Agents|abortifacient agents|mesh-ancestor
153374029|NCT01860521|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153374030|NCT01400906|Fluticasone|fluticasone|mesh-list
153374032|NCT01400906|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153374033|NCT01400906|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153374034|NCT01400906|Autonomic Agents|autonomic agents|mesh-ancestor
153374035|NCT01400906|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153374036|NCT01400906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153374037|NCT01400906|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153374038|NCT01400906|Respiratory System Agents|respiratory system agents|mesh-ancestor
153374039|NCT01400906|Dermatologic Agents|dermatologic agents|mesh-ancestor
153374040|NCT01400906|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
153374041|NCT00367653|Azithromycin|azithromycin|mesh-list
153374042|NCT00367653|Chloroquine|chloroquine|mesh-list
153374043|NCT00367653|Mefloquine|mefloquine|mesh-list
153374044|NCT00367653|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153833975|NCT00516750|Doxorubicin|doxorubicin|mesh-list
153833976|NCT00516750|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
153833977|NCT00516750|Methotrexate|methotrexate|mesh-list
153833978|NCT00516750|Vinblastine|vinblastine|mesh-list
153833979|NCT00516750|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153833980|NCT00516750|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153833981|NCT00516750|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153833982|NCT00516750|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153381212|NCT01603940|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153882736|NCT01609959|Azilsartan medoxomil|azilsartan medoxomil|mesh-list
153882737|NCT01609959|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153882738|NCT01609959|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
153882739|NCT01609959|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
153882740|NCT01609959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153882741|NCT01609998|Vaccines|vaccines|mesh-list
153882742|NCT01609998|Immunologic Factors|immunologic factors|mesh-ancestor
153882743|NCT01609998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153423633|NCT02177838|Immunologic Factors|immunologic factors|mesh-ancestor
153423634|NCT02177838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153423635|NCT02177838|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153423636|NCT03283436|Bupivacaine|bupivacaine|mesh-list
153833983|NCT00516750|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153833984|NCT00516750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153833988|NCT00516750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153833989|NCT00516750|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153833990|NCT00516750|Antimetabolites|antimetabolites|mesh-ancestor
153833991|NCT00516750|Dermatologic Agents|dermatologic agents|mesh-ancestor
153833992|NCT00516750|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153833993|NCT00516750|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153374046|NCT00367653|Amebicides|amebicides|mesh-ancestor
153374047|NCT00367653|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153374048|NCT00367653|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153374049|NCT00367653|Antimalarials|antimalarials|mesh-ancestor
153374050|NCT00367653|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153374051|NCT01485380|Dexmedetomidine|dexmedetomidine|mesh-list
153374052|NCT01485380|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153374053|NCT01485380|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153374054|NCT01485380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153374055|NCT01485380|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153374056|NCT01485380|Analgesics|analgesics|mesh-ancestor
153374057|NCT01485380|Sensory System Agents|sensory system agents|mesh-ancestor
153374058|NCT01485380|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153374065|NCT05445297|Amiodarone|amiodarone|mesh-list
153834005|NCT00505427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153834006|NCT00505427|Vitamin B Complex|vitamin b complex|mesh-ancestor
153834007|NCT00505427|Vitamins|vitamins|mesh-ancestor
153834008|NCT00505427|Micronutrients|micronutrients|mesh-ancestor
153834009|NCT00506168|Capecitabine|capecitabine|mesh-list
153834010|NCT00506168|Irinotecan|irinotecan|mesh-list
153834011|NCT00506168|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153834012|NCT00506168|Antimetabolites|antimetabolites|mesh-ancestor
153834013|NCT00506168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153834014|NCT00506168|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153834015|NCT00506168|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
153834016|NCT00506168|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153834017|NCT00506168|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153834018|NCT02950038|Nivolumab|nivolumab|mesh-list
153834019|NCT02950038|Ibrutinib|ibrutinib|mesh-list
153374071|NCT05445297|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153374072|NCT05445297|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
153374073|NCT05445297|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153374074|NCT05445297|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153374075|NCT05445297|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
153374076|NCT05445297|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
153374077|NCT05445297|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
153374078|NCT00556673|Fluticasone|fluticasone|mesh-list
153374079|NCT00556673|Mometasone Furoate|mometasone furoate|mesh-list
153374080|NCT00556673|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
153374081|NCT00556673|Maleic acid|maleic acid|mesh-list
153374082|NCT00556673|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153423637|NCT03283436|Anesthetics, Local|anesthetics, local|mesh-ancestor
153423638|NCT03283436|Anesthetics|anesthetics|mesh-ancestor
153381213|NCT01605032|Bortezomib|bortezomib|mesh-list
153381214|NCT01605032|Melphalan|melphalan|mesh-list
153381215|NCT01605032|Busulfan|busulfan|mesh-list
153381216|NCT01605032|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153381217|NCT01605032|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153381218|NCT01605032|Alkylating Agents|alkylating agents|mesh-ancestor
153381219|NCT01605032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153381220|NCT01605032|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153381221|NCT01605032|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153381222|NCT01605032|Immunologic Factors|immunologic factors|mesh-ancestor
153381223|NCT01605032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153381224|NCT01706666|Dexamethasone|dexamethasone|mesh-list
153381225|NCT01706666|Cyclophosphamide|cyclophosphamide|mesh-list
153381226|NCT01706666|Lenalidomide|lenalidomide|mesh-list
153381297|NCT01605890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153381298|NCT01605890|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153381299|NCT01605890|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153381327|NCT05738993|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153381328|NCT05738993|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153381330|NCT01709474|Ergocalciferols|ergocalciferols|mesh-list
153374083|NCT00556673|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153374084|NCT00556673|Autonomic Agents|autonomic agents|mesh-ancestor
153374085|NCT00556673|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153374086|NCT00556673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153374087|NCT00556673|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153374088|NCT00556673|Respiratory System Agents|respiratory system agents|mesh-ancestor
153374089|NCT00556673|Dermatologic Agents|dermatologic agents|mesh-ancestor
153374090|NCT00556673|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
153374091|NCT00556673|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
153374100|NCT05437029|Immunologic Factors|immunologic factors|mesh-ancestor
153374101|NCT05437029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153374103|NCT05437029|Hemagglutinins|hemagglutinins|mesh-ancestor
153834020|NCT02950038|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153834021|NCT02950038|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153834022|NCT02950038|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153834023|NCT02950038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153834024|NCT02950038|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153834025|NCT02950038|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153834050|NCT04510337|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153834051|NCT04510337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153374104|NCT01422434|Calcitriol|calcitriol|mesh-list
153374105|NCT01422434|Betamethasone|betamethasone|mesh-list
153374119|NCT01422434|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153374120|NCT01422434|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
153374121|NCT01422434|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153374122|NCT01422434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153374123|NCT01422434|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
153374124|NCT01422434|Vitamins|vitamins|mesh-ancestor
153374125|NCT01422434|Micronutrients|micronutrients|mesh-ancestor
153374129|NCT02270255|Lidocaine|lidocaine|mesh-list
153374207|NCT04338633|Calcium|calcium|mesh-list
153834321|NCT00519870|Losartan|losartan|mesh-list
153834331|NCT00519870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153834332|NCT00519870|Vasodilator Agents|vasodilator agents|mesh-ancestor
153834333|NCT00519870|Tocolytic Agents|tocolytic agents|mesh-ancestor
153834334|NCT00519870|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153834335|NCT00519909|Calcium|calcium|mesh-list
153834336|NCT00519909|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153834337|NCT00519909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153834338|NCT02949492|Interleukin-2|interleukin-2|mesh-list
153834339|NCT02949492|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153834340|NCT02949492|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153834341|NCT02949492|Analgesics|analgesics|mesh-ancestor
153374398|NCT03024437|Bevacizumab|bevacizumab|mesh-list
153374399|NCT03024437|Atezolizumab|atezolizumab|mesh-list
153374400|NCT03024437|Entinostat|entinostat|mesh-list
153374401|NCT03024437|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153374402|NCT03024437|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153374403|NCT03024437|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153374404|NCT03024437|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153374405|NCT03024437|Growth Substances|growth substances|mesh-ancestor
153374406|NCT03024437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153834438|NCT00520338|Celecoxib|celecoxib|mesh-list
153834491|NCT00520455|Contraceptive Agents|contraceptive agents|mesh-ancestor
153834496|NCT00520455|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
153834520|NCT00519246|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153834524|NCT00519987|Ketamine|ketamine|mesh-list
153834542|NCT00519324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153834573|NCT00519480|Metformin|metformin|mesh-list
153834604|NCT00505739|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
153374787|NCT04732455|Lidocaine|lidocaine|mesh-list
153374807|NCT04306965|Apremilast|apremilast|mesh-list
153834746|NCT00505700|Antiviral Agents|antiviral agents|mesh-ancestor
153834849|NCT00521859|Antimetabolites|antimetabolites|mesh-ancestor
153834850|NCT00521859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153834989|NCT05148689|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153375093|NCT00370539|Growth Substances|growth substances|mesh-ancestor
153375159|NCT05454345|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153375160|NCT05454345|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153375161|NCT05454345|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153375162|NCT05454345|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153375163|NCT05454345|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153375164|NCT05454345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153375165|NCT05454345|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153375166|NCT05454345|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
153375167|NCT05454345|Antitubercular Agents|antitubercular agents|mesh-ancestor
153375168|NCT05454345|Leprostatic Agents|leprostatic agents|mesh-ancestor
153375169|NCT05454345|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153375170|NCT05454345|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
153375171|NCT05454345|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
153375172|NCT05454345|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
153375173|NCT05454345|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
153375174|NCT05454345|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
153835108|NCT05148377|Heparin|heparin|mesh-list
153835132|NCT00523068|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153835187|NCT00524667|Valproic Acid|valproic acid|mesh-list
153835188|NCT00524667|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153835189|NCT00524667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153835190|NCT00524667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153835191|NCT00524667|Anticonvulsants|anticonvulsants|mesh-ancestor
153835192|NCT00524667|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153835193|NCT00524667|GABA Agents|gaba agents|mesh-ancestor
153835194|NCT00524667|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153835195|NCT00524667|Antimanic Agents|antimanic agents|mesh-ancestor
153835196|NCT00524667|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153835292|NCT02954549|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153835293|NCT05145608|Lamotrigine|lamotrigine|mesh-list
153375431|NCT00371553|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153375438|NCT01507220|Morphine|morphine|mesh-list
153375578|NCT05349045|Antibodies|antibodies|mesh-list
153375626|NCT01451996|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
153375675|NCT05450055|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153375698|NCT00372099|Vasodilator Agents|vasodilator agents|mesh-ancestor
153375958|NCT06195306|Hormone Antagonists|hormone antagonists|mesh-ancestor
153375960|NCT06195306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153836358|NCT00513656|Analgesics|analgesics|mesh-ancestor
153836362|NCT00530127|Deferiprone|deferiprone|mesh-list
153836378|NCT00512057|Protective Agents|protective agents|mesh-ancestor
153836590|NCT00531063|Immunologic Factors|immunologic factors|mesh-ancestor
153376666|NCT05726916|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
153376667|NCT05726916|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153376668|NCT05726916|Immunologic Factors|immunologic factors|mesh-ancestor
153376669|NCT05726916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153376670|NCT05721235|Dexmethylphenidate Hydrochloride|dexmethylphenidate hydrochloride|mesh-list
153376671|NCT05721235|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
153376672|NCT05721235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153376673|NCT05721235|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
153376674|NCT05721235|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153836616|NCT00514748|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153836617|NCT00514748|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153836618|NCT00514748|Analgesics|analgesics|mesh-ancestor
153836619|NCT00514748|Sensory System Agents|sensory system agents|mesh-ancestor
153836640|NCT02943135|Anesthetics, Local|anesthetics, local|mesh-ancestor
153836655|NCT02951234|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153376733|NCT05685277|Ramipril|ramipril|mesh-list
153376734|NCT05685277|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153376735|NCT05685277|Diuretics|diuretics|mesh-ancestor
153376736|NCT05685277|Natriuretic Agents|natriuretic agents|mesh-ancestor
153376737|NCT05685277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153376738|NCT05685277|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
153836669|NCT02951234|Antipyretics|antipyretics|mesh-ancestor
153836670|NCT02951234|Immunologic Factors|immunologic factors|mesh-ancestor
153836689|NCT00514982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153836702|NCT00514982|Sensory System Agents|sensory system agents|mesh-ancestor
153836704|NCT00531999|Ritonavir|ritonavir|mesh-list
153836796|NCT00516152|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153836797|NCT00516152|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153836798|NCT00516152|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
153376871|NCT05570409|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153376921|NCT05494762|Tislelizumab|tislelizumab|mesh-list
153376957|NCT05455697|Alkylating Agents|alkylating agents|mesh-ancestor
153376987|NCT05444543|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
153376988|NCT05444543|Glucocorticoids|glucocorticoids|mesh-ancestor
153376989|NCT05444543|Hormones|hormones|mesh-ancestor
153376990|NCT05444543|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153376991|NCT05443971|Durvalumab|durvalumab|mesh-list
153376992|NCT05443971|Immunoglobulins|immunoglobulins|mesh-list
153376993|NCT05443971|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
153376994|NCT05443971|Immunoglobulin G|immunoglobulin g|mesh-list
153376995|NCT05443971|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153377002|NCT05418868|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153377062|NCT05351541|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
153377147|NCT05248984|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153377148|NCT05248984|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153377149|NCT05248984|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153377150|NCT05248984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153377152|NCT05237349|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153377153|NCT05221502|Bedaquiline|bedaquiline|mesh-list
153377154|NCT05221502|Diarylquinolines|diarylquinolines|mesh-list
153377332|NCT04831320|Paclitaxel|paclitaxel|mesh-list
153837551|NCT00521612|Anesthetics, General|anesthetics, general|mesh-ancestor
153837552|NCT00521612|Anesthetics|anesthetics|mesh-ancestor
153837553|NCT00521612|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153837554|NCT00521612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153837555|NCT00521261|Antibodies|antibodies|mesh-list
153377804|NCT03754049|Autonomic Agents|autonomic agents|mesh-ancestor
153378228|NCT02477826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153378230|NCT02477826|Antimetabolites|antimetabolites|mesh-ancestor
153838528|NCT00526877|Risperidone|risperidone|mesh-list
153838591|NCT04692740|Chlorambucil|chlorambucil|mesh-list
153838592|NCT04692740|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153838607|NCT02945696|Anesthetics, Local|anesthetics, local|mesh-ancestor
153838608|NCT02945696|Anesthetics|anesthetics|mesh-ancestor
153838609|NCT02945696|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153838610|NCT02945696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153838611|NCT02945696|Sensory System Agents|sensory system agents|mesh-ancestor
153838613|NCT02924766|Prednisone|prednisone|mesh-list
153838627|NCT02924766|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153838644|NCT01580501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153838645|NCT01580501|Urological Agents|urological agents|mesh-ancestor
153838646|NCT02924532|Hormones|hormones|mesh-list
153838647|NCT02924532|Parathyroid Hormone|parathyroid hormone|mesh-list
153838696|NCT00527267|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153838698|NCT02924454|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
153838699|NCT02924454|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
153838700|NCT02924454|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-list
153838701|NCT02924454|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153838710|NCT02924454|Adrenergic Agents|adrenergic agents|mesh-ancestor
153838711|NCT02924454|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153838712|NCT02924454|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153838713|NCT02924454|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
153838774|NCT04691687|Furosemide|furosemide|mesh-list
153838793|NCT00527540|Interferons|interferons|mesh-list
153838794|NCT00527540|Ribavirin|ribavirin|mesh-list
153838852|NCT00529022|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153839013|NCT00531128|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153839035|NCT02922075|Amoxicillin|amoxicillin|mesh-list
153379168|NCT01589978|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153379200|NCT00551291|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
153379201|NCT00551291|Antitubercular Agents|antitubercular agents|mesh-ancestor
153379202|NCT00551291|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153379203|NCT00551291|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153379204|NCT00551291|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153379205|NCT00551291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153379249|NCT01595516|Metoprolol|metoprolol|mesh-list
153839175|NCT00531557|Darunavir|darunavir|mesh-list
153839176|NCT00531557|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
153379277|NCT01596842|Micronutrients|micronutrients|mesh-ancestor
153379407|NCT02918097|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153379408|NCT02918097|Antimanic Agents|antimanic agents|mesh-ancestor
153379409|NCT02918097|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
153379410|NCT02918097|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
153379415|NCT02999204|Vitamin D|vitamin d|mesh-list
153839337|NCT02917005|Exemestane|exemestane|mesh-list
153839408|NCT02916654|Iron|iron|mesh-list
153379573|NCT02859441|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153379606|NCT02860845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153379607|NCT02860845|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
153379608|NCT02860845|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
153379609|NCT02860845|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153379610|NCT02860845|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153379611|NCT02860845|Hormone Antagonists|hormone antagonists|mesh-ancestor
153379612|NCT02860845|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153379613|NCT02860845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153379614|NCT02860845|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
153379615|NCT02860845|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
153379616|NCT03003884|Propofol|propofol|mesh-list
153379617|NCT03003884|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153379632|NCT01881113|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153379633|NCT01881113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153379634|NCT01881113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153379635|NCT05140694|Empagliflozin|empagliflozin|mesh-list
153379636|NCT05140694|Dulaglutide|dulaglutide|mesh-list
153379637|NCT05140694|Immunoglobulin Fc Fragments|immunoglobulin fc fragments|mesh-list
153379638|NCT05140694|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
153839616|NCT06025825|Racepinephrine|racepinephrine|mesh-list
153839617|NCT06025825|Carticaine|carticaine|mesh-list
153839618|NCT06025825|Epinephryl borate|epinephryl borate|mesh-list
153839619|NCT06025825|Anesthetics, Local|anesthetics, local|mesh-ancestor
153839620|NCT06025825|Anesthetics|anesthetics|mesh-ancestor
153839621|NCT06025825|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153839622|NCT06025825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153839623|NCT06025825|Sensory System Agents|sensory system agents|mesh-ancestor
153839624|NCT06025825|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153839625|NCT06025825|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153839626|NCT06025825|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
153839627|NCT06025825|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153839628|NCT06025825|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153839629|NCT06025825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153839630|NCT06025825|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153839631|NCT06025825|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153839632|NCT06025825|Adrenergic Agents|adrenergic agents|mesh-ancestor
153839633|NCT06025825|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153839634|NCT06025825|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
153839679|NCT06025474|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153839680|NCT06025474|Serotonin Agents|serotonin agents|mesh-ancestor
153839684|NCT06025474|Dopamine Agents|dopamine agents|mesh-ancestor
153379854|NCT02927223|Atropine|atropine|mesh-list
153839718|NCT06025214|Adrenergic Agents|adrenergic agents|mesh-ancestor
153839719|NCT06025214|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153839720|NCT06025214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153839721|NCT06025214|Glucocorticoids|glucocorticoids|mesh-ancestor
153839722|NCT06025214|Hormones|hormones|mesh-ancestor
153839723|NCT06025214|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153839724|NCT06025214|Sympathomimetics|sympathomimetics|mesh-ancestor
153839725|NCT06025162|Enoxaparin|enoxaparin|mesh-list
153839726|NCT06025162|Anticoagulants|anticoagulants|mesh-ancestor
153839727|NCT06025162|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153839728|NCT06025162|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153839729|NCT06025162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153839730|NCT06025084|Titanium dioxide|titanium dioxide|mesh-list
153839731|NCT06025084|Sunscreening Agents|sunscreening agents|mesh-ancestor
153839732|NCT06025084|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
153839733|NCT06025084|Protective Agents|protective agents|mesh-ancestor
153839734|NCT06025084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153839735|NCT06025084|Dermatologic Agents|dermatologic agents|mesh-ancestor
153839736|NCT06025084|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
153839737|NCT06025071|Colchicine|colchicine|mesh-list
153839738|NCT06025071|Gout Suppressants|gout suppressants|mesh-ancestor
153839739|NCT06025071|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153839745|NCT06024915|Itraconazole|itraconazole|mesh-list
153379874|NCT02927457|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153379875|NCT02927457|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153379876|NCT02927457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153379877|NCT01891331|Fluconazole|fluconazole|mesh-list
153379878|NCT01891331|Antifungal Agents|antifungal agents|mesh-ancestor
153379879|NCT01891331|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153379945|NCT03002090|Trace Elements|trace elements|mesh-ancestor
153379946|NCT03002090|Micronutrients|micronutrients|mesh-ancestor
153379947|NCT03002090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153379948|NCT02328755|Methotrexate|methotrexate|mesh-list
153379949|NCT02328755|Tacrolimus|tacrolimus|mesh-list
153379950|NCT02328755|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
153379951|NCT02328755|Abortifacient Agents|abortifacient agents|mesh-ancestor
153379952|NCT02328755|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153839844|NCT06022939|Antiemetics|antiemetics|mesh-ancestor
153839845|NCT06022939|Autonomic Agents|autonomic agents|mesh-ancestor
153839846|NCT06022939|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153839847|NCT06022939|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153839927|NCT06012734|LB100|lb100|mesh-list
153839928|NCT06012734|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153839929|NCT06012734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153839930|NCT06012734|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153380033|NCT02872857|Autonomic Agents|autonomic agents|mesh-ancestor
153380034|NCT02872857|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153380035|NCT02872857|Nootropic Agents|nootropic agents|mesh-ancestor
153380036|NCT02996318|Sirolimus|sirolimus|mesh-list
153840000|NCT05971810|Disinfectants|disinfectants|mesh-ancestor
153840001|NCT05942313|Buprenorphine|buprenorphine|mesh-list
153840002|NCT05942313|Methadone|methadone|mesh-list
153840003|NCT05942313|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153840004|NCT05942313|Narcotics|narcotics|mesh-ancestor
153840005|NCT05942313|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153840006|NCT05942313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153840007|NCT05942313|Analgesics|analgesics|mesh-ancestor
153840008|NCT05942313|Sensory System Agents|sensory system agents|mesh-ancestor
153840009|NCT05942313|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153840010|NCT05942313|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
153380131|NCT01907321|Capsaicin|capsaicin|mesh-list
153840045|NCT05917275|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153840046|NCT05917275|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153840047|NCT05917275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153840048|NCT05917275|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153840049|NCT05917275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153840050|NCT05917275|Vasodilator Agents|vasodilator agents|mesh-ancestor
153840052|NCT05917275|Natriuretic Agents|natriuretic agents|mesh-ancestor
153840053|NCT05917275|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
153840054|NCT05917275|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
153840055|NCT05917275|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
153380166|NCT03686657|Analgesics|analgesics|mesh-ancestor
153380167|NCT03686657|Sensory System Agents|sensory system agents|mesh-ancestor
153380168|NCT03686657|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153380169|NCT03686657|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153380170|NCT03686657|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153380171|NCT03686657|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
153380172|NCT03686657|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153380173|NCT03686657|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153380175|NCT03686657|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153840147|NCT05869812|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153840148|NCT05869812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153840149|NCT05869812|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153840151|NCT05839899|Mifepristone|mifepristone|mesh-list
153840152|NCT05839899|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
153840153|NCT05839899|Abortifacient Agents|abortifacient agents|mesh-ancestor
153840154|NCT05839899|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153840155|NCT05839899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153840156|NCT05839899|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
153840179|NCT05838560|Protective Agents|protective agents|mesh-ancestor
153840180|NCT05838560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153840182|NCT05835011|Magrolimab|magrolimab|mesh-list
153840183|NCT05835011|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153840184|NCT05835011|Antimetabolites|antimetabolites|mesh-ancestor
153840185|NCT05835011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153840186|NCT05835011|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153840303|NCT05526586|Anti-Infective Agents, Local|anti-infective agents, local|mesh-list
153840307|NCT05497843|Chiauranib|chiauranib|mesh-list
153840399|NCT05296772|Immunoglobulins|immunoglobulins|mesh-list
153840400|NCT05296772|Immunologic Factors|immunologic factors|mesh-ancestor
153840403|NCT05296772|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153840476|NCT05168475|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153840477|NCT05168475|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
153840478|NCT05168475|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153840479|NCT05168475|Dermatologic Agents|dermatologic agents|mesh-ancestor
153840480|NCT05168475|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153840481|NCT05164861|Vitamins|vitamins|mesh-list
153840482|NCT05164861|Micronutrients|micronutrients|mesh-ancestor
153840483|NCT05164861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153840484|NCT05159453|Insulin|insulin|mesh-list
153840485|NCT05159453|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
153840486|NCT05159453|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153840487|NCT05159453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153840488|NCT05149287|Ceftriaxone|ceftriaxone|mesh-list
153840489|NCT05149287|Lidocaine|lidocaine|mesh-list
153840490|NCT05149287|Anesthetics, Local|anesthetics, local|mesh-ancestor
153840491|NCT05149287|Anesthetics|anesthetics|mesh-ancestor
153840492|NCT05149287|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153840493|NCT05149287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153840494|NCT05149287|Sensory System Agents|sensory system agents|mesh-ancestor
153840495|NCT05149287|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153840496|NCT05149287|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153380620|NCT02958345|Vaccines|vaccines|mesh-list
153840502|NCT05149287|Beta Lactam Antibiotics|beta lactam antibiotics|mesh-ancestor
153840503|NCT05149287|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153840557|NCT05080322|Xhance|xhance|mesh-list
153380728|NCT03078075|Naltrexone|naltrexone|mesh-list
153380729|NCT03078075|Bupropion|bupropion|mesh-list
153840731|NCT04751812|Anesthetics|anesthetics|mesh-list
153840732|NCT04751812|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153840733|NCT04751812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153840734|NCT04751812|Narcotics|narcotics|mesh-ancestor
153840735|NCT04751812|Analgesics|analgesics|mesh-ancestor
153840736|NCT04751812|Sensory System Agents|sensory system agents|mesh-ancestor
153840737|NCT04751812|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153840738|NCT04742634|Decitabine|decitabine|mesh-list
153840739|NCT04742634|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153840740|NCT04742634|Antimetabolites|antimetabolites|mesh-ancestor
153840741|NCT04742634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153840742|NCT04742634|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153840743|NCT04742634|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153840744|NCT04736966|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
153840745|NCT04736966|Immunologic Factors|immunologic factors|mesh-ancestor
153840746|NCT04736966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153840747|NCT04707469|Semaglutide|semaglutide|mesh-list
153840748|NCT04707469|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
153380950|NCT04350281|Hydroxychloroquine|hydroxychloroquine|mesh-list
153380951|NCT04350281|Interferon beta-1b|interferon beta-1b|mesh-list
153380952|NCT04350281|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153380953|NCT04350281|Antiviral Agents|antiviral agents|mesh-ancestor
153380954|NCT04350281|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153380955|NCT04350281|Antimalarials|antimalarials|mesh-ancestor
153380956|NCT04350281|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153380957|NCT04350281|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153380958|NCT04350281|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153380959|NCT04350281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153840817|NCT04562558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153840818|NCT04562558|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153840819|NCT04562558|Dermatologic Agents|dermatologic agents|mesh-ancestor
153840820|NCT04562558|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153840821|NCT04562558|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153840849|NCT04530409|Methylprednisolone|methylprednisolone|mesh-list
153840850|NCT04530409|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153840851|NCT04530409|Antiemetics|antiemetics|mesh-ancestor
153840852|NCT04530409|Autonomic Agents|autonomic agents|mesh-ancestor
153840853|NCT04530409|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153840854|NCT04530409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153840855|NCT04530409|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153840856|NCT04530409|Glucocorticoids|glucocorticoids|mesh-ancestor
153840857|NCT04530409|Hormones|hormones|mesh-ancestor
153840858|NCT04530409|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153840859|NCT04530409|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153840860|NCT04530409|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153840861|NCT04530409|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
153840862|NCT04530409|Protective Agents|protective agents|mesh-ancestor
153840863|NCT04528329|Dexamethasone|dexamethasone|mesh-list
153840864|NCT04528329|Dexamethasone acetate|dexamethasone acetate|mesh-list
153840865|NCT04528329|BB 1101|bb 1101|mesh-list
153840873|NCT04528329|Hormones|hormones|mesh-ancestor
153381073|NCT04707027|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153381074|NCT04707027|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153381532|NCT01651442|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153381533|NCT01651442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153381534|NCT01651442|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153381535|NCT01651442|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153381536|NCT01651442|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153381537|NCT01651442|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
153381538|NCT01651442|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153381539|NCT01651442|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153381540|NCT01651442|Serotonin Agents|serotonin agents|mesh-ancestor
153381541|NCT01651442|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
153381542|NCT01651442|Antidepressive Agents|antidepressive agents|mesh-ancestor
153381543|NCT04868045|Hormones|hormones|mesh-list
153381544|NCT04868045|Thyrotropin-Releasing Hormone|thyrotropin-releasing hormone|mesh-list
153841434|NCT03304080|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153841435|NCT03304080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153381559|NCT01658228|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153841475|NCT03267680|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153841542|NCT02980510|Vitamins|vitamins|mesh-ancestor
153381696|NCT02992028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153381723|NCT01662908|Antithrombins|antithrombins|mesh-ancestor
153381766|NCT04316871|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153381767|NCT04316871|Narcotics|narcotics|mesh-ancestor
153381768|NCT04316871|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153381769|NCT04316871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153381770|NCT04316871|Analgesics|analgesics|mesh-ancestor
153381771|NCT04316871|Sensory System Agents|sensory system agents|mesh-ancestor
153381803|NCT01665950|Antimetabolites|antimetabolites|mesh-ancestor
153381804|NCT01665950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153381805|NCT01665950|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153381806|NCT01665950|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
153381807|NCT01665950|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153381808|NCT01667978|Ritonavir|ritonavir|mesh-list
153381809|NCT01667978|Atazanavir Sulfate|atazanavir sulfate|mesh-list
153381810|NCT01667978|Norethindrone|norethindrone|mesh-list
153381811|NCT01667978|Norethindrone Acetate|norethindrone acetate|mesh-list
153381812|NCT01667978|Protease Inhibitors|protease inhibitors|mesh-list
153381813|NCT01667978|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
153381814|NCT01667978|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
153381815|NCT01667978|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153381816|NCT01667978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153381817|NCT01667978|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153381818|NCT01667978|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153382219|NCT04499573|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153382220|NCT04499573|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153382221|NCT04499573|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153382222|NCT04499573|Antiemetics|antiemetics|mesh-ancestor
153382223|NCT04499573|Autonomic Agents|autonomic agents|mesh-ancestor
153381331|NCT01709474|Cholecalciferol|cholecalciferol|mesh-list
153381332|NCT01709474|Vitamins|vitamins|mesh-list
153381333|NCT01709474|Micronutrients|micronutrients|mesh-ancestor
153381334|NCT01709474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153381337|NCT02992808|Menotropins|menotropins|mesh-list
153381341|NCT02992808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153381342|NCT02992886|Raltitrexed|raltitrexed|mesh-list
153381343|NCT02992886|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153381344|NCT02992886|Antimetabolites|antimetabolites|mesh-ancestor
153382224|NCT04499573|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153382225|NCT04499573|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153382226|NCT04499573|Glucocorticoids|glucocorticoids|mesh-ancestor
153382227|NCT04499573|Hormones|hormones|mesh-ancestor
153382228|NCT04499573|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153842168|NCT03458078|Sensory System Agents|sensory system agents|mesh-ancestor
153842169|NCT03458078|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153842170|NCT03458078|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153842177|NCT04690556|Ranibizumab|ranibizumab|mesh-list
153842406|NCT01290679|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153842714|NCT02935985|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
153842715|NCT02935985|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153382824|NCT01710332|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153382825|NCT01710332|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153382826|NCT01710332|Growth Substances|growth substances|mesh-ancestor
153382827|NCT01710332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153382828|NCT01710332|Growth Inhibitors|growth inhibitors|mesh-ancestor
153382829|NCT01710332|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153382830|NCT02311907|Paclitaxel|paclitaxel|mesh-list
153382831|NCT02311907|Carboplatin|carboplatin|mesh-list
153382832|NCT02311907|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
153382833|NCT02311907|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153842740|NCT02935959|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
153842741|NCT02935959|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153842742|NCT02935959|Anesthetics, General|anesthetics, general|mesh-ancestor
153842743|NCT02935959|Anesthetics|anesthetics|mesh-ancestor
153842744|NCT02935959|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
153842745|NCT02935959|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
153842746|NCT02935959|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153842747|NCT02935959|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153842748|NCT02935959|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153842749|NCT02935959|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153842750|NCT02935959|GABA Modulators|gaba modulators|mesh-ancestor
153842751|NCT02935959|GABA Agents|gaba agents|mesh-ancestor
153842752|NCT02935322|Chlorhexidine|chlorhexidine|mesh-list
153842753|NCT02935322|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
153842754|NCT02935322|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
153382863|NCT01982123|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
153382864|NCT01982123|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
153382865|NCT02061683|Bimatoprost|bimatoprost|mesh-list
153382866|NCT02061683|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153382867|NCT01712360|Naftifine|naftifine|mesh-list
153382868|NCT01712360|Antifungal Agents|antifungal agents|mesh-ancestor
153382869|NCT01712360|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153382870|NCT02396147|Relugolix|relugolix|mesh-list
153382871|NCT02396147|Androgen Antagonists|androgen antagonists|mesh-ancestor
153382872|NCT02396147|Hormone Antagonists|hormone antagonists|mesh-ancestor
153382873|NCT02396147|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153382880|NCT02018627|Glucagon|glucagon|mesh-list
153842757|NCT02935322|Dermatologic Agents|dermatologic agents|mesh-ancestor
153842758|NCT02935647|Propofol|propofol|mesh-list
153842759|NCT02935647|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153842760|NCT02935647|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153842761|NCT02935647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153842770|NCT02912247|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
153842771|NCT02912247|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153842772|NCT02912247|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153842773|NCT02935010|Amoxicillin|amoxicillin|mesh-list
153842774|NCT02935010|Metronidazole|metronidazole|mesh-list
153842775|NCT02935010|Clarithromycin|clarithromycin|mesh-list
153842776|NCT02935010|Levofloxacin|levofloxacin|mesh-list
153842777|NCT02935010|Potassium Citrate|potassium citrate|mesh-list
153842778|NCT02935010|Esomeprazole|esomeprazole|mesh-list
153842779|NCT02935010|Bismuth|bismuth|mesh-list
153842780|NCT02935010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153842781|NCT02935010|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153842782|NCT02935010|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153842783|NCT02935010|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153842784|NCT02935010|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153842785|NCT02935010|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
153842786|NCT02935010|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153842787|NCT02935010|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
153842788|NCT02935010|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153842789|NCT02935010|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
153842790|NCT02935010|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
153842791|NCT02935010|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153382899|NCT01717742|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153382900|NCT01717742|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153382901|NCT01717742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153382902|NCT01717898|Prednisone|prednisone|mesh-list
153382903|NCT01717898|Abiraterone Acetate|abiraterone acetate|mesh-list
153382904|NCT01717898|Dactolisib|dactolisib|mesh-list
153382905|NCT01717898|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153382906|NCT01717898|Glucocorticoids|glucocorticoids|mesh-ancestor
153382907|NCT01717898|Hormones|hormones|mesh-ancestor
153382908|NCT01717898|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153382909|NCT01717898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153382910|NCT01717898|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153382911|NCT01717898|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153382912|NCT01717898|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153382913|NCT01717898|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153382914|NCT01717898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153382915|NCT01717898|Hormone Antagonists|hormone antagonists|mesh-ancestor
153842792|NCT02935010|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
153842793|NCT02935010|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153842794|NCT02935010|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153842795|NCT02935010|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153842796|NCT02935010|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
153842797|NCT02935010|Antacids|antacids|mesh-ancestor
153842798|NCT02935010|Diuretics|diuretics|mesh-ancestor
153842804|NCT02935530|Tinzaparin|tinzaparin|mesh-list
153842810|NCT02935530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153842811|NCT02935530|Antithrombins|antithrombins|mesh-ancestor
153842812|NCT02935530|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
153842813|NCT02935530|Protease Inhibitors|protease inhibitors|mesh-ancestor
153842814|NCT02935530|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153842815|NCT02935530|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153842816|NCT02934464|Leucovorin|leucovorin|mesh-list
153842817|NCT02934464|Paclitaxel|paclitaxel|mesh-list
153842818|NCT02934464|Ramucirumab|ramucirumab|mesh-list
153842819|NCT02934464|Oxaliplatin|oxaliplatin|mesh-list
153842820|NCT02934464|Levoleucovorin|levoleucovorin|mesh-list
153842821|NCT02934464|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153842822|NCT02934464|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153842823|NCT02934464|Tubulin Modulators|tubulin modulators|mesh-ancestor
153842824|NCT02934464|Antimitotic Agents|antimitotic agents|mesh-ancestor
153842836|NCT02934464|Growth Inhibitors|growth inhibitors|mesh-ancestor
153842837|NCT02934035|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
153842838|NCT02934035|Fluoxetine|fluoxetine|mesh-list
153842839|NCT02934035|Paroxetine|paroxetine|mesh-list
153842840|NCT02934035|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
153842841|NCT02934035|Antidepressive Agents|antidepressive agents|mesh-list
153842842|NCT02934035|Escitalopram|escitalopram|mesh-list
153842843|NCT02934035|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
153842844|NCT02934035|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153842845|NCT02934035|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153842846|NCT02934035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153842847|NCT02934035|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153842848|NCT02934035|Serotonin Agents|serotonin agents|mesh-ancestor
153842849|NCT02934035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153842850|NCT02934035|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153382953|NCT02068157|Dihematoporphyrin Ether|dihematoporphyrin ether|mesh-list
153382955|NCT02068157|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153382956|NCT02068157|Dermatologic Agents|dermatologic agents|mesh-ancestor
153382957|NCT02068157|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
153382958|NCT01741454|Tamsulosin|tamsulosin|mesh-list
153382959|NCT01741454|Tolterodine Tartrate|tolterodine tartrate|mesh-list
153381345|NCT02992886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153381346|NCT02992886|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153783556|NCT00236483|Sensory System Agents|sensory system agents|mesh-ancestor
153783557|NCT00236483|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153783558|NCT00236483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153381377|NCT03029273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153382960|NCT01741454|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
153382961|NCT01741454|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
153382962|NCT01741454|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
153382963|NCT01741454|Adrenergic Agents|adrenergic agents|mesh-ancestor
153382964|NCT01741454|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153382965|NCT01741454|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153382966|NCT01741454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153382967|NCT01741454|Urological Agents|urological agents|mesh-ancestor
153382968|NCT01741454|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
153842851|NCT02934035|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
153382969|NCT01741454|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
153382971|NCT01720316|Glycine|glycine|mesh-list
153842852|NCT02934035|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153842853|NCT02934035|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
153842854|NCT02934035|Analgesics|analgesics|mesh-ancestor
153842857|NCT02934035|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
153842858|NCT02934035|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153842859|NCT02934035|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153842860|NCT02934152|Amoxicillin|amoxicillin|mesh-list
153842861|NCT02934152|Clarithromycin|clarithromycin|mesh-list
153842872|NCT02934152|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
153842873|NCT02935335|Menotropins|menotropins|mesh-list
153842874|NCT02935335|Fertility Agents, Female|fertility agents, female|mesh-ancestor
153842875|NCT02935335|Fertility Agents|fertility agents|mesh-ancestor
153842876|NCT02935335|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153842877|NCT02935335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153842878|NCT02911662|Cephalexin|cephalexin|mesh-list
153842879|NCT02911662|Nitrofurantoin|nitrofurantoin|mesh-list
153842880|NCT02911662|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153842881|NCT02911662|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153842882|NCT02911662|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
153842883|NCT02935101|Prednisolone|prednisolone|mesh-list
153842884|NCT02935101|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
153842885|NCT02935101|Methylprednisolone|methylprednisolone|mesh-list
153842886|NCT02935101|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
153842887|NCT02935101|Prednisolone acetate|prednisolone acetate|mesh-list
153842888|NCT02935101|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
153842889|NCT02935101|Prednisolone phosphate|prednisolone phosphate|mesh-list
153842890|NCT02935101|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153842891|NCT02935101|Glucocorticoids|glucocorticoids|mesh-ancestor
153842892|NCT02935101|Hormones|hormones|mesh-ancestor
153842894|NCT02935101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153842895|NCT02935101|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153842896|NCT02935101|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153842897|NCT02935101|Antiemetics|antiemetics|mesh-ancestor
153842898|NCT02935101|Autonomic Agents|autonomic agents|mesh-ancestor
153842899|NCT02935101|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153842900|NCT02935101|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153842901|NCT02935101|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
153842902|NCT02935101|Protective Agents|protective agents|mesh-ancestor
153842903|NCT04689971|Vitamins|vitamins|mesh-list
153842904|NCT04689971|Vitamin B Complex|vitamin b complex|mesh-list
153842905|NCT04689971|Micronutrients|micronutrients|mesh-ancestor
153842906|NCT04689971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153842907|NCT02934945|Budesonide|budesonide|mesh-list
153383010|NCT02400437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153383011|NCT02024477|Saxagliptin|saxagliptin|mesh-list
153383012|NCT02024477|Incretins|incretins|mesh-ancestor
153383013|NCT02024477|Hormones|hormones|mesh-ancestor
153383014|NCT02024477|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153383015|NCT02024477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153383016|NCT02024477|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
153383017|NCT02024477|Protease Inhibitors|protease inhibitors|mesh-ancestor
153383018|NCT02024477|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153383019|NCT02024477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153383020|NCT02024477|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153383021|NCT02024711|Hyaluronic Acid|hyaluronic acid|mesh-list
153383022|NCT02024711|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153383023|NCT02024711|Immunologic Factors|immunologic factors|mesh-ancestor
153383024|NCT02024711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153383025|NCT02024711|Viscosupplements|viscosupplements|mesh-ancestor
153383026|NCT02024711|Protective Agents|protective agents|mesh-ancestor
153383027|NCT02071823|Opicapone|opicapone|mesh-list
153383028|NCT02071823|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
153383029|NCT02071823|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153383030|NCT02071823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153842916|NCT02934945|Glucocorticoids|glucocorticoids|mesh-ancestor
153842918|NCT02934945|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153842919|NCT02934945|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
153842920|NCT02934945|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
153842921|NCT02934945|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153842922|NCT02934945|Adrenergic Agents|adrenergic agents|mesh-ancestor
153842923|NCT02934945|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153842924|NCT02934945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153842926|NCT02933645|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
153842927|NCT02933645|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153842928|NCT02933645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153842929|NCT02933684|Cycloserine|cycloserine|mesh-list
153842930|NCT02933684|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
153842931|NCT02933684|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153842932|NCT02933684|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
153842933|NCT02933684|Antitubercular Agents|antitubercular agents|mesh-ancestor
153842934|NCT02933684|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153842935|NCT02933684|Antimetabolites|antimetabolites|mesh-ancestor
153842936|NCT02933684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153842937|NCT02933333|Molgramostim|molgramostim|mesh-list
153842938|NCT02933333|Lenograstim|lenograstim|mesh-list
153842939|NCT02933333|Sargramostim|sargramostim|mesh-list
153842940|NCT02933333|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153842941|NCT02933333|Immunologic Factors|immunologic factors|mesh-ancestor
153383042|NCT02406443|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153383043|NCT02406443|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
153383044|NCT02406443|Protease Inhibitors|protease inhibitors|mesh-ancestor
153383045|NCT02406443|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153383046|NCT02406443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153383047|NCT02032433|Naltrexone|naltrexone|mesh-list
153383048|NCT02032433|Buprenorphine|buprenorphine|mesh-list
153383049|NCT02032433|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
153383050|NCT02032433|Naloxone|naloxone|mesh-list
153383051|NCT02032433|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153383052|NCT02032433|Narcotics|narcotics|mesh-ancestor
153383053|NCT02032433|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153383054|NCT02032433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153383055|NCT02032433|Analgesics|analgesics|mesh-ancestor
153383056|NCT02032433|Sensory System Agents|sensory system agents|mesh-ancestor
153383057|NCT02032433|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153842942|NCT02933333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153842943|NCT02933333|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153842944|NCT02670252|Cyclophosphamide|cyclophosphamide|mesh-list
153842945|NCT02670252|Busulfan|busulfan|mesh-list
153842946|NCT02670252|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153842947|NCT02670252|Immunologic Factors|immunologic factors|mesh-ancestor
153842948|NCT02670252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153842949|NCT02670252|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153842950|NCT02670252|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153842951|NCT02670252|Alkylating Agents|alkylating agents|mesh-ancestor
153842952|NCT02670252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153842965|NCT02933099|BB 1101|bb 1101|mesh-list
153383086|NCT02343575|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153383087|NCT02343575|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153383088|NCT02343575|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153383089|NCT02343575|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
153383091|NCT02343575|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153383092|NCT02343575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153381378|NCT03029273|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153381379|NCT03029273|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153381380|NCT05738759|Anesthetics|anesthetics|mesh-list
153882744|NCT01649921|Interferons|interferons|mesh-list
153882745|NCT01649921|Interferon-gamma|interferon-gamma|mesh-list
153882746|NCT01649921|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153882747|NCT01649921|Antiviral Agents|antiviral agents|mesh-ancestor
153882748|NCT01649921|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153882749|NCT01606566|Bleomycin|bleomycin|mesh-list
153882750|NCT01606566|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153882751|NCT01606566|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153882752|NCT01605162|10-((4-hydroxypiperidin-1-yl)methyl)chromeno(4,3,2-de)phthalazin-3(2H)-one|10-((4-hydroxypiperidin-1-yl)methyl)chromeno(4,3,2-de)phthalazin-3(2h)-one|mesh-list
153882753|NCT01605162|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
153882754|NCT01605162|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153882755|NCT01605162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153882756|NCT01605162|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153882757|NCT01649999|Peficitinib|peficitinib|mesh-list
153383093|NCT02343575|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
153383094|NCT02343575|Anticonvulsants|anticonvulsants|mesh-ancestor
153383095|NCT02343575|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153383097|NCT02343575|Antimanic Agents|antimanic agents|mesh-ancestor
153383098|NCT01744574|Progesterone|progesterone|mesh-list
153383099|NCT01744574|Progestins|progestins|mesh-ancestor
153842982|NCT02933099|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
153842983|NCT02933099|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153842984|NCT02933099|Serotonin Agents|serotonin agents|mesh-ancestor
153842985|NCT02934906|Immunoglobulins|immunoglobulins|mesh-list
153842986|NCT02934906|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
153842987|NCT02934906|Antibodies|antibodies|mesh-list
153842988|NCT02934906|gamma-Globulins|gamma-globulins|mesh-list
153842989|NCT02934906|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
153842990|NCT02934906|Immunologic Factors|immunologic factors|mesh-ancestor
153842991|NCT02934906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153842992|NCT02911350|Paclitaxel|paclitaxel|mesh-list
153842993|NCT02911350|Hormones|hormones|mesh-list
153842994|NCT02911350|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153842995|NCT02911350|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153842996|NCT02911350|Tubulin Modulators|tubulin modulators|mesh-ancestor
153383108|NCT01744730|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
153383109|NCT01744730|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153383110|NCT01744730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153383111|NCT00354965|Amoxicillin|amoxicillin|mesh-list
153383112|NCT00354965|Clavulanic Acid|clavulanic acid|mesh-list
153383113|NCT00354965|Clavulanic Acids|clavulanic acids|mesh-list
153383114|NCT00354965|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
153383115|NCT00354965|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153383116|NCT00354965|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153383125|NCT02037425|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
153383126|NCT02037425|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153383127|NCT02037425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153383128|NCT02037425|Cholinergic Agents|cholinergic agents|mesh-ancestor
153383129|NCT02037425|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153383130|NCT00355043|Zinc Sulfate|zinc sulfate|mesh-list
153383131|NCT00355043|Astringents|astringents|mesh-ancestor
153383132|NCT00355043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153843006|NCT02932397|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153843026|NCT02932007|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153882758|NCT01649999|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153882761|NCT01649999|Immunologic Factors|immunologic factors|mesh-ancestor
153381381|NCT05738759|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153381382|NCT05738759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153381384|NCT05738681|N-monoacetylcystine|n-monoacetylcystine|mesh-list
153381385|NCT05738681|Antiviral Agents|antiviral agents|mesh-ancestor
153381386|NCT05738681|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153381387|NCT05738681|Expectorants|expectorants|mesh-ancestor
153381388|NCT05738681|Respiratory System Agents|respiratory system agents|mesh-ancestor
153381389|NCT05738681|Free Radical Scavengers|free radical scavengers|mesh-ancestor
153843027|NCT02932007|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153843028|NCT02932007|Analgesics|analgesics|mesh-ancestor
153843029|NCT02932007|Sensory System Agents|sensory system agents|mesh-ancestor
153843030|NCT02932007|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153843031|NCT02932007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153843032|NCT02932007|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153843033|NCT02932007|Filaricides|filaricides|mesh-ancestor
153843034|NCT02932007|Antinematodal Agents|antinematodal agents|mesh-ancestor
153843035|NCT02932007|Anthelmintics|anthelmintics|mesh-ancestor
153843036|NCT02910882|Gemcitabine|gemcitabine|mesh-list
153843037|NCT02910882|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153843038|NCT02910882|Antimetabolites|antimetabolites|mesh-ancestor
153843039|NCT02910882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153843040|NCT02910882|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153843041|NCT02910765|Methylene Blue|methylene blue|mesh-list
153843042|NCT02910765|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153843043|NCT02910765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153843044|NCT02925026|Lactoferrin|lactoferrin|mesh-list
153843045|NCT02925026|Muramidase|muramidase|mesh-list
153843046|NCT02925026|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153843047|NCT02924987|Aflibercept|aflibercept|mesh-list
153843048|NCT02924987|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153843049|NCT02924987|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153843050|NCT02924987|Growth Substances|growth substances|mesh-ancestor
153843051|NCT02924987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153843052|NCT02924987|Growth Inhibitors|growth inhibitors|mesh-ancestor
153843053|NCT02924987|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153383155|NCT02041325|Growth Substances|growth substances|mesh-ancestor
153383156|NCT02041325|Growth Inhibitors|growth inhibitors|mesh-ancestor
153383157|NCT02041325|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153383158|NCT01723514|Erenumab|erenumab|mesh-list
153383159|NCT01723514|Calcitonin Gene-Related Peptide Receptor Antagonists|calcitonin gene-related peptide receptor antagonists|mesh-ancestor
153383161|NCT01723514|Analgesics|analgesics|mesh-ancestor
153383170|NCT02044367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153383171|NCT02044367|Anticoagulants|anticoagulants|mesh-ancestor
153383172|NCT01745822|Tenofovir|tenofovir|mesh-list
153383173|NCT01745822|Antiviral Agents|antiviral agents|mesh-ancestor
153383174|NCT01745822|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153383175|NCT01745822|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153383176|NCT01745822|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153383177|NCT01745822|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153888312|NCT05637645|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153888313|NCT01101022|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
153383178|NCT01745822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153383179|NCT01745822|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153383180|NCT01745822|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153383181|NCT02354339|Magnesium Oxide|magnesium oxide|mesh-list
153383183|NCT02354339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153383184|NCT02354339|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153383186|NCT01747850|Nabiximols|nabiximols|mesh-list
153383187|NCT01747850|Dronabinol|dronabinol|mesh-list
153383188|NCT01747850|Cannabidiol|cannabidiol|mesh-list
153843054|NCT02924909|Paclitaxel|paclitaxel|mesh-list
153843055|NCT02924909|Carboplatin|carboplatin|mesh-list
153383189|NCT01747850|Peppermint oil|peppermint oil|mesh-list
153843056|NCT02924909|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153888314|NCT01101022|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
153888315|NCT01101022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153843057|NCT02924909|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153843058|NCT02924909|Tubulin Modulators|tubulin modulators|mesh-ancestor
153843059|NCT02924909|Antimitotic Agents|antimitotic agents|mesh-ancestor
153843060|NCT02924909|Mitosis Modulators|mitosis modulators|mesh-ancestor
153843061|NCT02924909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153843062|NCT02934321|Erythritol|erythritol|mesh-list
153843063|NCT02934321|Vasodilator Agents|vasodilator agents|mesh-ancestor
153843064|NCT02924753|Cyclophosphamide|cyclophosphamide|mesh-list
153843065|NCT02924753|Fludarabine|fludarabine|mesh-list
153843066|NCT02924753|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153843067|NCT02924753|Immunologic Factors|immunologic factors|mesh-ancestor
153843068|NCT02924753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153843069|NCT02924753|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153843070|NCT02924753|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153843071|NCT02924753|Alkylating Agents|alkylating agents|mesh-ancestor
153843072|NCT02924753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153843073|NCT02924753|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153843074|NCT02924753|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153843075|NCT02924675|Pregabalin|pregabalin|mesh-list
153843076|NCT02924675|Analgesics|analgesics|mesh-ancestor
153843077|NCT02924675|Sensory System Agents|sensory system agents|mesh-ancestor
153843078|NCT02924675|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153843079|NCT02924675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153888316|NCT01101022|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
153843080|NCT02924675|Anticonvulsants|anticonvulsants|mesh-ancestor
153843081|NCT02924675|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153843082|NCT02924675|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153888317|NCT01101022|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153843083|NCT02924675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153843084|NCT02924675|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153843085|NCT02924675|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153843086|NCT02924675|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153843087|NCT02924675|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153843088|NCT02924675|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153843089|NCT03847545|4-Aminopyridine|4-aminopyridine|mesh-list
153843090|NCT03847545|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
153843091|NCT03847545|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153843092|NCT03847545|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153383195|NCT01747850|Analgesics|analgesics|mesh-ancestor
153383196|NCT01747850|Sensory System Agents|sensory system agents|mesh-ancestor
153383197|NCT01747850|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153383198|NCT01747850|Hallucinogens|hallucinogens|mesh-ancestor
153383199|NCT01747850|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153383200|NCT01747850|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153383201|NCT01747850|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
153383202|NCT01747850|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
153383203|NCT01747850|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153383204|NCT01747850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153383205|NCT01747850|Hormones|hormones|mesh-ancestor
153383207|NCT01747850|Antiemetics|antiemetics|mesh-ancestor
153383208|NCT01747850|Autonomic Agents|autonomic agents|mesh-ancestor
153383209|NCT01747850|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153383210|NCT01747850|Parasympatholytics|parasympatholytics|mesh-ancestor
153383211|NCT01727414|Methylphenidate|methylphenidate|mesh-list
153383212|NCT01727414|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
153383213|NCT01727414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153383214|NCT01727414|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
153383215|NCT01727414|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153383216|NCT01727414|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153383217|NCT01727414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153383218|NCT01727414|Dopamine Agents|dopamine agents|mesh-ancestor
153843093|NCT02924285|Amiodarone|amiodarone|mesh-list
153843094|NCT02924285|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153843095|NCT02924285|Vasodilator Agents|vasodilator agents|mesh-ancestor
153843096|NCT02924285|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
153843097|NCT02924285|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153843098|NCT02924285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153843099|NCT02924285|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153843100|NCT02924285|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
153843101|NCT02924285|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153843102|NCT02924285|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153843103|NCT02924285|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
153843104|NCT02924285|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
153843105|NCT02924285|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
153843106|NCT01287520|Carboplatin|carboplatin|mesh-list
153843107|NCT01287520|Pemetrexed|pemetrexed|mesh-list
153843108|NCT01287520|Ranitidine|ranitidine|mesh-list
153843109|NCT01287520|Ranitidine bismuth citrate|ranitidine bismuth citrate|mesh-list
153843110|NCT01287520|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153843111|NCT01287520|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153843113|NCT01287520|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153843123|NCT00623740|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
153843124|NCT00623740|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
153843125|NCT00623740|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
153843126|NCT00623740|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153843127|NCT01287364|Mometasone Furoate|mometasone furoate|mesh-list
153843128|NCT01287364|Ciclesonide|ciclesonide|mesh-list
153843129|NCT01287364|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153843130|NCT01287364|Dermatologic Agents|dermatologic agents|mesh-ancestor
153843131|NCT01287364|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
153843132|NCT01287364|Glucocorticoids|glucocorticoids|mesh-ancestor
153843133|NCT01287364|Hormones|hormones|mesh-ancestor
153843134|NCT01287364|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153843135|NCT01287364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153843136|NCT02889835|Chlorhexidine|chlorhexidine|mesh-list
153843137|NCT02889835|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
153843138|NCT02889835|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153843139|NCT02889835|Disinfectants|disinfectants|mesh-ancestor
153843140|NCT02924090|Ketamine|ketamine|mesh-list
153843141|NCT02924090|Etomidate|etomidate|mesh-list
153383242|NCT01727726|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153383243|NCT01727726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153383244|NCT01727726|Dopamine Agonists|dopamine agonists|mesh-ancestor
153383245|NCT01727726|Dopamine Agents|dopamine agents|mesh-ancestor
153383246|NCT02355821|Bisoprolol|bisoprolol|mesh-list
153383247|NCT02355821|Moxonidine|moxonidine|mesh-list
153383248|NCT02355821|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153383249|NCT02355821|Sympatholytics|sympatholytics|mesh-ancestor
153383250|NCT02355821|Autonomic Agents|autonomic agents|mesh-ancestor
153383251|NCT02355821|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153383252|NCT02355821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153383253|NCT02355821|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
153383254|NCT02355821|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
153383255|NCT02355821|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
153383256|NCT02355821|Adrenergic Agents|adrenergic agents|mesh-ancestor
153383257|NCT02355821|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153383258|NCT02355821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153383260|NCT01748240|Vorinostat|vorinostat|mesh-list
153383261|NCT01748240|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153383262|NCT01748240|Antimetabolites|antimetabolites|mesh-ancestor
153383263|NCT01748240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153383264|NCT01748240|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153383265|NCT01748240|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153383267|NCT01748942|Dexamethasone|dexamethasone|mesh-list
153843142|NCT02924090|Analgesics|analgesics|mesh-ancestor
153843143|NCT02924090|Sensory System Agents|sensory system agents|mesh-ancestor
153843144|NCT02924090|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153843145|NCT02924090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153843146|NCT02924090|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
153843147|NCT02924090|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153843148|NCT02924090|Anesthetics, General|anesthetics, general|mesh-ancestor
153843149|NCT02924090|Anesthetics|anesthetics|mesh-ancestor
153843150|NCT02924090|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153843151|NCT02924090|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
153843152|NCT02924090|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
153843153|NCT02924090|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153843154|NCT02924090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153843155|NCT02924090|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153843157|NCT04137770|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153843158|NCT04137770|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153843159|NCT04137770|Analgesics|analgesics|mesh-ancestor
153843160|NCT04137770|Sensory System Agents|sensory system agents|mesh-ancestor
153843161|NCT04137770|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153843162|NCT04137770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153843173|NCT01286740|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153843174|NCT01286740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153843175|NCT01286740|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153843176|NCT01286740|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153843177|NCT02923856|Clarithromycin|clarithromycin|mesh-list
153843178|NCT02923856|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153843179|NCT02923856|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153843180|NCT02923856|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
153843181|NCT02923856|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153843182|NCT02923856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153843183|NCT02923856|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
153843184|NCT02923856|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153843185|NCT02934204|Methotrexate|methotrexate|mesh-list
153843186|NCT02934204|Temozolomide|temozolomide|mesh-list
153843187|NCT02934204|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
153843188|NCT02934204|Abortifacient Agents|abortifacient agents|mesh-ancestor
153383292|NCT01749410|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
153383293|NCT01749410|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
153383294|NCT01749410|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153383295|NCT01749410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153383296|NCT01749410|Cholinergic Agents|cholinergic agents|mesh-ancestor
153383297|NCT01749410|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153383298|NCT01749410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153383299|NCT01749410|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
153383300|NCT01749410|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153383301|NCT01729598|Valproic Acid|valproic acid|mesh-list
153383302|NCT01729598|Anticonvulsants|anticonvulsants|mesh-ancestor
153383303|NCT01729598|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153383304|NCT01729598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153383305|NCT01729598|GABA Agents|gaba agents|mesh-ancestor
153383306|NCT01729598|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153383307|NCT01729598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153383308|NCT01729598|Antimanic Agents|antimanic agents|mesh-ancestor
153383309|NCT01729598|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153383311|NCT01729598|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153843191|NCT02934204|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153383322|NCT05718011|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153383323|NCT05718011|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153383324|NCT05718011|Adrenergic Agents|adrenergic agents|mesh-ancestor
153383325|NCT05718011|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153383326|NCT05718011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153383327|NCT05718011|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
153383328|NCT05718011|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153383329|NCT05718011|Anesthetics, General|anesthetics, general|mesh-ancestor
153383330|NCT05718011|Anesthetics|anesthetics|mesh-ancestor
153383331|NCT05718011|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
153383332|NCT05718011|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
153383333|NCT05717933|Hormones|hormones|mesh-list
153383334|NCT05717933|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153383335|NCT05717933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153383336|NCT01730846|Doxazosin|doxazosin|mesh-list
153383337|NCT01730846|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153383338|NCT01730846|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
153383339|NCT01730846|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
153383340|NCT01730846|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
153383341|NCT01730846|Adrenergic Agents|adrenergic agents|mesh-ancestor
153383342|NCT01730846|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153882762|NCT01649999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153882763|NCT01604889|Ipilimumab|ipilimumab|mesh-list
153423653|NCT00376064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153423654|NCT00376064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153423656|NCT03581084|N-monoacetylcystine|n-monoacetylcystine|mesh-list
153423657|NCT03581084|Antiviral Agents|antiviral agents|mesh-ancestor
153423658|NCT03581084|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153423659|NCT03581084|Expectorants|expectorants|mesh-ancestor
153423660|NCT03581084|Respiratory System Agents|respiratory system agents|mesh-ancestor
153423661|NCT03581084|Free Radical Scavengers|free radical scavengers|mesh-ancestor
153423662|NCT03581084|Antioxidants|antioxidants|mesh-ancestor
153423663|NCT03581084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153383343|NCT01730846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153843229|NCT02933814|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153843230|NCT02933775|Cyclophosphamide|cyclophosphamide|mesh-list
153843231|NCT02933775|Fludarabine|fludarabine|mesh-list
153843232|NCT02933775|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153843240|NCT02933775|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153843241|NCT02923583|Abatacept|abatacept|mesh-list
153383344|NCT01730846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153383345|NCT02314403|Rituximab|rituximab|mesh-list
153383350|NCT02314403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153383352|NCT02314403|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153383353|NCT02314403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153383354|NCT02314403|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153383355|NCT02052557|Bupivacaine|bupivacaine|mesh-list
153383356|NCT02052557|Anesthetics, Local|anesthetics, local|mesh-ancestor
153383357|NCT02052557|Anesthetics|anesthetics|mesh-ancestor
153383358|NCT02052557|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153383359|NCT02052557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153383360|NCT02052557|Sensory System Agents|sensory system agents|mesh-ancestor
153383361|NCT02052557|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153383362|NCT02052635|Clopidogrel|clopidogrel|mesh-list
153383363|NCT02052635|Ticagrelor|ticagrelor|mesh-list
153383367|NCT02052635|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
153843242|NCT02923583|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153843243|NCT02923583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153843244|NCT02923583|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153843245|NCT02923583|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153843246|NCT02923583|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153843247|NCT02923583|Immunologic Factors|immunologic factors|mesh-ancestor
153843248|NCT02923583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153843249|NCT02923583|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153843250|NCT02933580|JNJ-56136379|jnj-56136379|mesh-list
153843251|NCT02933580|Antiviral Agents|antiviral agents|mesh-ancestor
153843252|NCT02933580|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153843253|NCT02923388|Vitamins|vitamins|mesh-list
153843254|NCT02923388|Vitamin B 12|vitamin b 12|mesh-list
153843255|NCT02923388|Pyridoxine|pyridoxine|mesh-list
153843256|NCT02923388|Vitamin B 6|vitamin b 6|mesh-list
153843257|NCT02923388|Vitamin B Complex|vitamin b complex|mesh-list
153843258|NCT02923388|Micronutrients|micronutrients|mesh-ancestor
153843259|NCT02923388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153843260|NCT02933658|Amlodipine|amlodipine|mesh-list
153843261|NCT02933658|Telmisartan|telmisartan|mesh-list
153843262|NCT02933658|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
153843263|NCT02933658|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153843264|NCT02933658|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153843265|NCT02933658|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153843266|NCT02933658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153843267|NCT02933658|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153381421|NCT01642238|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153381422|NCT01642238|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153381423|NCT01642238|Antipyretics|antipyretics|mesh-ancestor
153843268|NCT02933658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153843269|NCT02933658|Vasodilator Agents|vasodilator agents|mesh-ancestor
153843270|NCT02933658|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153843271|NCT02933658|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153843272|NCT02933658|Antimetabolites|antimetabolites|mesh-ancestor
153843273|NCT02933658|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153843274|NCT02933658|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
153843275|NCT02933658|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153843276|NCT02933658|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
153843277|NCT02933658|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
153843278|NCT02933853|Insulin|insulin|mesh-list
153843279|NCT02933853|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
153843280|NCT02933853|Insulin Aspart|insulin aspart|mesh-list
153843281|NCT02933853|Insulin, Long-Acting|insulin, long-acting|mesh-list
153843282|NCT02933853|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
153843283|NCT02933853|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153383415|NCT01749956|Growth Inhibitors|growth inhibitors|mesh-ancestor
153383416|NCT02365961|Clonidine|clonidine|mesh-list
153383417|NCT02365961|Epinephrine|epinephrine|mesh-list
153383418|NCT02365961|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153383419|NCT02365961|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153383420|NCT02365961|Adrenergic Agents|adrenergic agents|mesh-ancestor
153383421|NCT02365961|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153383422|NCT02365961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153383423|NCT02365961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153383424|NCT02365961|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
153383425|NCT02365961|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153383426|NCT02365961|Autonomic Agents|autonomic agents|mesh-ancestor
153383427|NCT02365961|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153383428|NCT02365961|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153843296|NCT00532272|Goserelin|goserelin|mesh-list
153843297|NCT00532272|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153843298|NCT00532272|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
153843299|NCT00532272|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153843300|NCT00532272|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153843301|NCT00532272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153843302|NCT00532272|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
153843303|NCT00532272|Hormone Antagonists|hormone antagonists|mesh-ancestor
153843304|NCT00532272|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153843305|NCT00532272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153843306|NCT00532272|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153843307|NCT02922803|Calcium, Dietary|calcium, dietary|mesh-list
153843308|NCT02922803|Vitamin D|vitamin d|mesh-list
153843309|NCT02922803|Ergocalciferols|ergocalciferols|mesh-list
153843310|NCT02922803|Cholecalciferol|cholecalciferol|mesh-list
153843311|NCT02922803|Vitamins|vitamins|mesh-list
153843312|NCT02922803|Calcium|calcium|mesh-list
153843313|NCT02922803|Micronutrients|micronutrients|mesh-ancestor
153843314|NCT02922803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153843315|NCT02922803|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153843316|NCT02922803|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153843317|NCT02834559|Fluorouracil|fluorouracil|mesh-list
153843318|NCT02834559|Heparin|heparin|mesh-list
153843319|NCT02834559|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
153843320|NCT02834559|Tinzaparin|tinzaparin|mesh-list
153843321|NCT02834559|Dalteparin|dalteparin|mesh-list
153843322|NCT02834559|Antimetabolites|antimetabolites|mesh-ancestor
153843323|NCT02834559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153843324|NCT02834559|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153843325|NCT02834559|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153843326|NCT02834559|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153381424|NCT01642238|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
153381425|NCT01642238|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
153381426|NCT01642238|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
153381427|NCT01642238|Purinergic Agents|purinergic agents|mesh-ancestor
153381428|NCT01642238|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153381429|NCT01642238|Antithrombins|antithrombins|mesh-ancestor
153381430|NCT01642238|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
153843332|NCT02922686|Floxacillin|floxacillin|mesh-list
153383475|NCT02366663|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153383476|NCT02366663|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153383477|NCT02366663|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153383479|NCT02366663|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153383480|NCT01754480|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
153383481|NCT01754480|Hemostatics|hemostatics|mesh-ancestor
153383482|NCT01754480|Coagulants|coagulants|mesh-ancestor
153383483|NCT02367599|Vitamin D|vitamin d|mesh-list
153383484|NCT02367599|Vitamins|vitamins|mesh-ancestor
153383485|NCT02367599|Micronutrients|micronutrients|mesh-ancestor
153383486|NCT02367599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153383487|NCT02367599|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153383488|NCT02368457|Tocopherols|tocopherols|mesh-list
153383489|NCT02368457|Vitamin E|vitamin e|mesh-list
153843374|NCT03981341|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
153843375|NCT03981341|Hormone Antagonists|hormone antagonists|mesh-ancestor
153843376|NCT03981341|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153383502|NCT02368457|Antioxidants|antioxidants|mesh-ancestor
153383503|NCT02368457|Vitamins|vitamins|mesh-ancestor
153383504|NCT02368457|Micronutrients|micronutrients|mesh-ancestor
153383505|NCT02371187|Dapagliflozin|dapagliflozin|mesh-list
153383506|NCT02371187|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
153383507|NCT02371187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153383508|NCT02371187|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153383509|NCT02371187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153383510|NCT02373137|Ofloxacin|ofloxacin|mesh-list
153383511|NCT02373137|Prednisolone|prednisolone|mesh-list
153383512|NCT02373137|Phenylephrine|phenylephrine|mesh-list
153383513|NCT02373137|Oxymetazoline|oxymetazoline|mesh-list
153383514|NCT02373137|Tropicamide|tropicamide|mesh-list
153383515|NCT02373137|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153383516|NCT02373137|Glucocorticoids|glucocorticoids|mesh-ancestor
153383517|NCT02373137|Hormones|hormones|mesh-ancestor
153383518|NCT02373137|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153383519|NCT02373137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153383520|NCT02373137|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153383521|NCT02373137|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153383522|NCT02373137|Autonomic Agents|autonomic agents|mesh-ancestor
153383523|NCT02373137|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153383524|NCT02373137|Protective Agents|protective agents|mesh-ancestor
153383525|NCT02373137|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
153383526|NCT02373137|Mydriatics|mydriatics|mesh-ancestor
153843413|NCT01283971|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153843414|NCT01283971|Antimetabolites|antimetabolites|mesh-ancestor
153843415|NCT01283971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153843416|NCT01283971|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153843417|NCT01283971|Dermatologic Agents|dermatologic agents|mesh-ancestor
153843418|NCT01283971|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153843419|NCT01283971|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153843420|NCT01283971|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153843421|NCT01283971|Immunologic Factors|immunologic factors|mesh-ancestor
153383528|NCT02373137|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
153383529|NCT02373137|Nasal Decongestants|nasal decongestants|mesh-ancestor
153383530|NCT02373137|Respiratory System Agents|respiratory system agents|mesh-ancestor
153383531|NCT02373137|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
153383532|NCT02373137|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153383533|NCT02373137|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153383534|NCT02373137|Adrenergic Agents|adrenergic agents|mesh-ancestor
153383535|NCT02373137|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153383536|NCT02373137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153383537|NCT02373137|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
153381431|NCT01642238|Protease Inhibitors|protease inhibitors|mesh-ancestor
153381432|NCT01642238|Anticoagulants|anticoagulants|mesh-ancestor
153381433|NCT05259995|Oxymetazoline|oxymetazoline|mesh-list
153381434|NCT05259995|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153381435|NCT05259995|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153381507|NCT04997525|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153381509|NCT04997525|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153383538|NCT02373137|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
153383539|NCT02373137|Cholinergic Agents|cholinergic agents|mesh-ancestor
153383540|NCT02373137|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
153383541|NCT02373137|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153383542|NCT02373137|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153383543|NCT02373137|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153843429|NCT02921360|Analgesics|analgesics|mesh-ancestor
153843430|NCT02921360|Sensory System Agents|sensory system agents|mesh-ancestor
153843431|NCT02921360|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153843432|NCT02921360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153843433|NCT02921360|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153843434|NCT02921360|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153843435|NCT02921360|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153843436|NCT02921360|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153843437|NCT02921360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153843438|NCT02921360|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153843439|NCT02921360|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153843440|NCT02921360|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153843441|NCT02921360|Antipyretics|antipyretics|mesh-ancestor
153843442|NCT02932605|Cannabidiol|cannabidiol|mesh-list
153843443|NCT02932605|Anticonvulsants|anticonvulsants|mesh-ancestor
153843445|NCT02921204|Vitamins|vitamins|mesh-ancestor
153843446|NCT02921204|Micronutrients|micronutrients|mesh-ancestor
153843447|NCT02921204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153843448|NCT02921204|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153843449|NCT01283581|Vancomycin|vancomycin|mesh-list
153843450|NCT01283581|Linezolid|linezolid|mesh-list
153843451|NCT01283581|Delafloxacin|delafloxacin|mesh-list
153843452|NCT01283581|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153843453|NCT01283581|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153843454|NCT01283581|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
153843455|NCT01283581|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153843456|NCT01283581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153843457|NCT01283542|Pasireotide|pasireotide|mesh-list
153843458|NCT01283542|Hormones|hormones|mesh-ancestor
153843459|NCT01283542|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153843460|NCT01283542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153843461|NCT02932488|Sumatriptan|sumatriptan|mesh-list
153383577|NCT00354809|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
153383578|NCT00354809|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153383579|NCT00354809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153383580|NCT04769258|Vaccines|vaccines|mesh-list
153383581|NCT04769258|Immunologic Factors|immunologic factors|mesh-ancestor
153383582|NCT04769258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153383583|NCT01762904|Ethanol|ethanol|mesh-list
153383584|NCT01762904|Chlorhexidine|chlorhexidine|mesh-list
153383585|NCT01762904|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
153383586|NCT01762904|Triclosan|triclosan|mesh-list
153383587|NCT01762904|Anti-Infective Agents, Local|anti-infective agents, local|mesh-list
153383588|NCT01762904|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153383589|NCT01762904|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153383590|NCT01762904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153383591|NCT01762904|Disinfectants|disinfectants|mesh-ancestor
153383592|NCT01762904|Dermatologic Agents|dermatologic agents|mesh-ancestor
153383593|NCT01762904|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
153383594|NCT01762904|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153383595|NCT01762904|Antimetabolites|antimetabolites|mesh-ancestor
153383596|NCT01762904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153383597|NCT01762904|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153383598|NCT02376257|Cycloserine|cycloserine|mesh-list
153381510|NCT04997525|Progestins|progestins|mesh-ancestor
153381511|NCT01649180|Axitinib|axitinib|mesh-list
153381512|NCT01649180|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-list
153381513|NCT01649180|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153843467|NCT02932488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153843468|NCT02932488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153843469|NCT02921165|Aspirin|aspirin|mesh-list
153843470|NCT02921165|Analgesics|analgesics|mesh-list
153843471|NCT02921165|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153843472|NCT02921165|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153843473|NCT02921165|Sensory System Agents|sensory system agents|mesh-ancestor
153843474|NCT02921165|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153843475|NCT02921165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153843476|NCT02921165|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153843477|NCT02921165|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153843478|NCT02921165|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153843481|NCT02921165|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153843482|NCT02921165|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153843483|NCT02921165|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153843484|NCT02921165|Antipyretics|antipyretics|mesh-ancestor
153843485|NCT01283386|Cyclophosphamide|cyclophosphamide|mesh-list
153843486|NCT01283386|Chlorambucil|chlorambucil|mesh-list
153843487|NCT01283386|Rituximab|rituximab|mesh-list
153843488|NCT01283386|Fludarabine|fludarabine|mesh-list
153843489|NCT01283386|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153843490|NCT01283386|Immunologic Factors|immunologic factors|mesh-ancestor
153843491|NCT01283386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153843492|NCT01283386|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153843493|NCT01283386|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153843494|NCT01283386|Alkylating Agents|alkylating agents|mesh-ancestor
153843495|NCT01283386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153843496|NCT01283386|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153843497|NCT01283386|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153843498|NCT01283386|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153843499|NCT02920931|Tenofovir|tenofovir|mesh-list
153843500|NCT02920931|Antiviral Agents|antiviral agents|mesh-ancestor
153843501|NCT02920931|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153843502|NCT02920931|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153843503|NCT02920931|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153843504|NCT02920931|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153843505|NCT02920931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153843506|NCT02920931|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153843507|NCT02920931|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153843508|NCT01283152|Lactulose|lactulose|mesh-list
153843509|NCT01283152|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
153843510|NCT01283152|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153843511|NCT01283152|Laxatives|laxatives|mesh-ancestor
153843512|NCT01283464|Vitamin A|vitamin a|mesh-list
153383629|NCT01763606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153383630|NCT01763606|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153383632|NCT01763606|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153383633|NCT01763606|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153383634|NCT01763606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153383635|NCT01763606|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153383636|NCT01763606|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153383637|NCT01763606|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153383639|NCT01763606|Anticoagulants|anticoagulants|mesh-ancestor
153383640|NCT03161756|Denosumab|denosumab|mesh-list
153383641|NCT03161756|Nivolumab|nivolumab|mesh-list
153383642|NCT03161756|Ipilimumab|ipilimumab|mesh-list
153383643|NCT03161756|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153383644|NCT03161756|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153383645|NCT03161756|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153383646|NCT03161756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153843514|NCT01283464|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153843515|NCT01283464|Keratolytic Agents|keratolytic agents|mesh-ancestor
153843516|NCT01283464|Dermatologic Agents|dermatologic agents|mesh-ancestor
153843517|NCT01283464|Vitamins|vitamins|mesh-ancestor
153882764|NCT01604889|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153882765|NCT01604889|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153882766|NCT01604889|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153882767|NCT01604889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153882768|NCT01685762|Metformin|metformin|mesh-list
153843518|NCT01283464|Micronutrients|micronutrients|mesh-ancestor
153843519|NCT01283464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153843520|NCT01282801|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
153843521|NCT01282801|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
153843522|NCT01282801|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153843523|NCT01282801|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153843524|NCT01282801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153843525|NCT01282801|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153843526|NCT01282801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153843537|NCT00532350|Parasympatholytics|parasympatholytics|mesh-ancestor
153843538|NCT00532350|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
153843539|NCT00532350|Cholinergic Agents|cholinergic agents|mesh-ancestor
153843540|NCT00532350|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153843541|NCT00532350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153843542|NCT02932566|Pirfenidone|pirfenidone|mesh-list
153843543|NCT02932566|Analgesics|analgesics|mesh-ancestor
153843544|NCT02932566|Sensory System Agents|sensory system agents|mesh-ancestor
153843545|NCT02932566|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153843546|NCT02932566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153843547|NCT02932566|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153843548|NCT02932566|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153843549|NCT02932566|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153843550|NCT02932566|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153843551|NCT02932566|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153843552|NCT00532389|Panobinostat|panobinostat|mesh-list
153843553|NCT00532389|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153843554|NCT00532389|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
153843555|NCT00532389|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153843556|NCT00532389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153843557|NCT02932644|Vitamin D|vitamin d|mesh-list
153383664|NCT02383043|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
153383682|NCT01768520|Celecoxib|celecoxib|mesh-list
153843558|NCT02932644|Ergocalciferols|ergocalciferols|mesh-list
153843559|NCT02932644|Cholecalciferol|cholecalciferol|mesh-list
153843560|NCT02932644|Vitamins|vitamins|mesh-list
153843561|NCT02932644|Micronutrients|micronutrients|mesh-ancestor
153843562|NCT02932644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153843563|NCT02932644|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153843564|NCT02932644|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153843565|NCT05466708|Dexmedetomidine|dexmedetomidine|mesh-list
153843566|NCT05466708|Ketamine|ketamine|mesh-list
153843567|NCT05466708|Esketamine|esketamine|mesh-list
153843568|NCT05466708|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153843569|NCT05466708|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153843570|NCT05466708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153843571|NCT05466708|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153843572|NCT05466708|Analgesics|analgesics|mesh-ancestor
153843573|NCT05466708|Sensory System Agents|sensory system agents|mesh-ancestor
153843574|NCT05466708|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153843575|NCT05466708|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
153843576|NCT05466708|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153843577|NCT05466708|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153843578|NCT05466708|Adrenergic Agents|adrenergic agents|mesh-ancestor
153843579|NCT05466708|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153843580|NCT05466708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153843581|NCT05466708|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
153843582|NCT05466708|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153843583|NCT05466708|Anesthetics, General|anesthetics, general|mesh-ancestor
153843584|NCT05466708|Anesthetics|anesthetics|mesh-ancestor
153843585|NCT05466708|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
153843586|NCT05466708|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
153843587|NCT05466708|Antidepressive Agents|antidepressive agents|mesh-ancestor
153383707|NCT02386319|Melatonin|melatonin|mesh-list
153383708|NCT02386319|Antioxidants|antioxidants|mesh-ancestor
153383709|NCT02386319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153383710|NCT02386319|Protective Agents|protective agents|mesh-ancestor
153383711|NCT02386319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153383712|NCT02386319|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153383713|NCT02240888|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
153383714|NCT02240888|Immunologic Factors|immunologic factors|mesh-ancestor
153383715|NCT02240888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153383716|NCT02387801|Ixekizumab|ixekizumab|mesh-list
153383717|NCT02387801|Dermatologic Agents|dermatologic agents|mesh-ancestor
153383718|NCT02259608|BCG Vaccine|bcg vaccine|mesh-list
153383719|NCT02259608|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153383720|NCT02259608|Immunologic Factors|immunologic factors|mesh-ancestor
153383721|NCT02259608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153383722|NCT05284097|Smallpox and monkeypox vaccine modified vaccinia ankara-bavarian nordic|smallpox and monkeypox vaccine modified vaccinia ankara-bavarian nordic|mesh-list
153383723|NCT05284097|Antiviral Agents|antiviral agents|mesh-ancestor
153383724|NCT05284097|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153383725|NCT02326844|Talazoparib|talazoparib|mesh-list
153383726|NCT02326844|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
153383727|NCT02326844|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153383728|NCT02326844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153383729|NCT02326844|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153383730|NCT02239874|Vitamin D|vitamin d|mesh-list
153383731|NCT02239874|Ergocalciferols|ergocalciferols|mesh-list
153843612|NCT02920658|Betamethasone Valerate|betamethasone valerate|mesh-list
153843613|NCT02920658|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
153843614|NCT02920658|Betamethasone benzoate|betamethasone benzoate|mesh-list
153843615|NCT02920658|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
153843616|NCT02920658|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153843617|NCT02920658|Glucocorticoids|glucocorticoids|mesh-ancestor
153843618|NCT02920658|Hormones|hormones|mesh-ancestor
153843619|NCT02920658|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153843620|NCT02920658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153843621|NCT02920658|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153843622|NCT02920658|Respiratory System Agents|respiratory system agents|mesh-ancestor
153843623|NCT01281202|Vigabatrin|vigabatrin|mesh-list
153843624|NCT01281202|Anticonvulsants|anticonvulsants|mesh-ancestor
153843625|NCT01281202|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153843626|NCT01281202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153843627|NCT01281202|GABA Agents|gaba agents|mesh-ancestor
153843628|NCT01281202|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153843629|NCT01281202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153843630|NCT01281124|Azacitidine|azacitidine|mesh-list
153843631|NCT01281124|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153843632|NCT01281124|Antimetabolites|antimetabolites|mesh-ancestor
153843633|NCT01281124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153843634|NCT01281124|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153843635|NCT01281124|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153843636|NCT00623857|Vitamins|vitamins|mesh-list
153843637|NCT00623857|Zinc|zinc|mesh-list
153383741|NCT01771952|Immunologic Factors|immunologic factors|mesh-ancestor
153383742|NCT01771952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153383743|NCT01771952|Viscosupplements|viscosupplements|mesh-ancestor
153383744|NCT01771952|Protective Agents|protective agents|mesh-ancestor
153383745|NCT02389361|Acetaminophen|acetaminophen|mesh-list
153383746|NCT02389361|Tramadol|tramadol|mesh-list
153383747|NCT02389361|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153383748|NCT02389361|Analgesics|analgesics|mesh-ancestor
153383749|NCT02389361|Sensory System Agents|sensory system agents|mesh-ancestor
153383751|NCT02389361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153383754|NCT02389361|Narcotics|narcotics|mesh-ancestor
153383755|NCT02389361|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153383756|NCT02252354|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
153383757|NCT02252354|Relugolix|relugolix|mesh-list
153383758|NCT02252354|Androgen Antagonists|androgen antagonists|mesh-ancestor
153383759|NCT02252354|Hormone Antagonists|hormone antagonists|mesh-ancestor
153383760|NCT02252354|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153383761|NCT02252354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153383762|NCT02393339|Acetaminophen|acetaminophen|mesh-list
153383763|NCT02393339|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153383764|NCT02393339|Analgesics|analgesics|mesh-ancestor
153383765|NCT02393339|Sensory System Agents|sensory system agents|mesh-ancestor
153882769|NCT01685762|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153882770|NCT01685762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153882771|NCT01602822|Ritonavir|ritonavir|mesh-list
153882772|NCT01602822|Atazanavir Sulfate|atazanavir sulfate|mesh-list
153882773|NCT01602822|Tenofovir|tenofovir|mesh-list
153882774|NCT01602822|Emtricitabine|emtricitabine|mesh-list
153423664|NCT03581084|Protective Agents|protective agents|mesh-ancestor
153423665|NCT03581084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153423667|NCT03383588|Epinephrine|epinephrine|mesh-list
153383766|NCT02393339|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153383767|NCT02393339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153383768|NCT02393339|Antipyretics|antipyretics|mesh-ancestor
153383769|NCT05235191|Methadone|methadone|mesh-list
153383770|NCT05235191|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153843638|NCT00623857|Micronutrients|micronutrients|mesh-ancestor
153843642|NCT01280968|Vaccines|vaccines|mesh-list
153843678|NCT02932020|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153843679|NCT02932020|Glucocorticoids|glucocorticoids|mesh-ancestor
153843680|NCT02932020|Hormones|hormones|mesh-ancestor
153843681|NCT02932020|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153843682|NCT02932020|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
153843683|NCT02932020|Protective Agents|protective agents|mesh-ancestor
153383786|NCT01774604|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153383787|NCT01774604|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153383788|NCT01774604|Gout Suppressants|gout suppressants|mesh-ancestor
153383789|NCT01774604|Tocolytic Agents|tocolytic agents|mesh-ancestor
153383790|NCT01774604|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153383791|NCT01774604|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153383792|NCT01774604|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153383793|NCT01774604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153383794|NCT01777412|Bevacizumab|bevacizumab|mesh-list
153383795|NCT01777412|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153383796|NCT01777412|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153383797|NCT01777412|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153383798|NCT01777412|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153383799|NCT01777412|Growth Substances|growth substances|mesh-ancestor
153383800|NCT01777412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153383801|NCT01777412|Growth Inhibitors|growth inhibitors|mesh-ancestor
153383802|NCT04873349|Oleuropein|oleuropein|mesh-list
153383803|NCT04873349|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153383804|NCT04873349|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153383805|NCT04873349|Vasodilator Agents|vasodilator agents|mesh-ancestor
153843684|NCT02932020|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153843685|NCT02932020|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153843686|NCT01280656|Interferons|interferons|mesh-list
153843687|NCT01280656|Ribavirin|ribavirin|mesh-list
153843688|NCT01280656|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
153843689|NCT01280656|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
153843690|NCT01280656|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153843692|NCT01280656|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153843693|NCT01280656|Antimetabolites|antimetabolites|mesh-ancestor
153843694|NCT01280656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153843695|NCT03741530|Glyburide|glyburide|mesh-list
153843696|NCT03741530|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153843697|NCT03741530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153843698|NCT01280617|Thymoglobulin|thymoglobulin|mesh-list
153843699|NCT01280617|Antilymphocyte Serum|antilymphocyte serum|mesh-list
153843700|NCT01280617|Immunologic Factors|immunologic factors|mesh-ancestor
153843701|NCT01280617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153843702|NCT01280617|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153843703|NCT02932137|Interleukin-2|interleukin-2|mesh-list
153843704|NCT02932137|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153843705|NCT02932137|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153843706|NCT02932137|Analgesics|analgesics|mesh-ancestor
153843707|NCT02932137|Sensory System Agents|sensory system agents|mesh-ancestor
153843708|NCT02932137|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153843709|NCT02932137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153843710|NCT01280266|Amlodipine|amlodipine|mesh-list
153843711|NCT01280266|Udenafil|udenafil|mesh-list
153843712|NCT01280266|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153423668|NCT03383588|Fentanyl|fentanyl|mesh-list
153423669|NCT03383588|Morphine|morphine|mesh-list
153423670|NCT03383588|Bupivacaine|bupivacaine|mesh-list
153423671|NCT03383588|Anesthetics, Local|anesthetics, local|mesh-ancestor
153423672|NCT03383588|Anesthetics|anesthetics|mesh-ancestor
153423673|NCT03383588|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153843713|NCT01280266|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153843714|NCT01280266|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153843715|NCT01280266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153383819|NCT00355667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153383820|NCT00355667|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
153383821|NCT00355667|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153383827|NCT04419948|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153383828|NCT04419948|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153383829|NCT04419948|Analgesics|analgesics|mesh-ancestor
153383830|NCT04419948|Sensory System Agents|sensory system agents|mesh-ancestor
153383831|NCT04419948|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153383832|NCT04419948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153383833|NCT04419948|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153383834|NCT04419948|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153383835|NCT04419948|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153383836|NCT04419948|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153383838|NCT01312922|Dexetimide|dexetimide|mesh-list
153383845|NCT01312922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153383846|NCT01312922|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153383847|NCT01312922|Serotonin Agents|serotonin agents|mesh-ancestor
153383848|NCT01312922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153383849|NCT01312922|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
153383850|NCT01312922|Antidepressive Agents|antidepressive agents|mesh-ancestor
153383851|NCT01312922|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153383852|NCT01312922|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
153383853|NCT01312922|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
153383854|NCT01312922|Parasympatholytics|parasympatholytics|mesh-ancestor
153383855|NCT01312922|Autonomic Agents|autonomic agents|mesh-ancestor
153383856|NCT01312922|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153843747|NCT02920190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153843748|NCT02920190|Incretins|incretins|mesh-ancestor
153843750|NCT02920190|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153843751|NCT02919878|Gemcitabine|gemcitabine|mesh-list
153843752|NCT02919878|Capecitabine|capecitabine|mesh-list
153843753|NCT02919878|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153843754|NCT02919878|Antimetabolites|antimetabolites|mesh-ancestor
153843755|NCT02919878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153383857|NCT01312922|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
153383858|NCT01312922|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
153383859|NCT01312922|Cholinergic Agents|cholinergic agents|mesh-ancestor
153383860|NCT01312922|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153383861|NCT01312922|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153383862|NCT01312922|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153383863|NCT01312922|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153383864|NCT01783574|Methyltestosterone|methyltestosterone|mesh-list
153383865|NCT01783574|Testosterone|testosterone|mesh-list
153383866|NCT01783574|Testosterone undecanoate|testosterone undecanoate|mesh-list
153383867|NCT01783574|Testosterone enanthate|testosterone enanthate|mesh-list
153383868|NCT01783574|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
153383870|NCT01783574|Hormones|hormones|mesh-ancestor
153383871|NCT01783574|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153383872|NCT01783574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153383873|NCT01783574|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153383874|NCT01783574|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153383875|NCT01783574|Anabolic Agents|anabolic agents|mesh-ancestor
153383876|NCT03656783|Tenofovir|tenofovir|mesh-list
153383877|NCT03656783|Emtricitabine|emtricitabine|mesh-list
153383878|NCT03656783|Emtricitabine tenofovir alafenamide|emtricitabine tenofovir alafenamide|mesh-list
153383879|NCT03656783|Antiviral Agents|antiviral agents|mesh-ancestor
153383880|NCT03656783|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153383881|NCT03656783|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153383882|NCT03656783|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153383883|NCT03656783|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153383884|NCT03656783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153383885|NCT03656783|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153843756|NCT02919878|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153843757|NCT02931786|Ketamine|ketamine|mesh-list
153843758|NCT02931786|Propofol|propofol|mesh-list
153843759|NCT02931786|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153843760|NCT02931786|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153843761|NCT02931786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153843762|NCT02931786|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153843763|NCT02931786|Anesthetics, General|anesthetics, general|mesh-ancestor
153843764|NCT02931786|Anesthetics|anesthetics|mesh-ancestor
153843787|NCT05465733|Pemetrexed|pemetrexed|mesh-list
153843788|NCT05465733|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153843789|NCT05465733|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153843790|NCT05465733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153843791|NCT05465733|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153843792|NCT05465733|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153843793|NCT03673787|Atezolizumab|atezolizumab|mesh-list
153843794|NCT03673787|Ipatasertib|ipatasertib|mesh-list
153843795|NCT03673787|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153843796|NCT03673787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153843797|NCT03673787|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153843798|NCT03673787|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153843799|NCT03673787|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153383902|NCT04296695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153383903|NCT04296695|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153383904|NCT04296695|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153383905|NCT04296695|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
153383906|NCT04296695|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153383907|NCT04296695|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
153383908|NCT04296695|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
153383909|NCT04296695|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
153383910|NCT04296695|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
153383911|NCT04259645|Bupivacaine|bupivacaine|mesh-list
153383912|NCT04259645|Anesthetics, Local|anesthetics, local|mesh-ancestor
153383913|NCT04259645|Anesthetics|anesthetics|mesh-ancestor
153383914|NCT04259645|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153383915|NCT04259645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153383916|NCT04259645|Sensory System Agents|sensory system agents|mesh-ancestor
153383917|NCT04259645|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153383918|NCT01787006|Fluorouracil|fluorouracil|mesh-list
153383919|NCT01787006|Cetuximab|cetuximab|mesh-list
153383920|NCT01787006|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153383926|NCT01787006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153383927|NCT01787006|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153383928|NCT02260622|Aspirin|aspirin|mesh-list
153383929|NCT02260622|Rivaroxaban|rivaroxaban|mesh-list
153383930|NCT02260622|Clopidogrel|clopidogrel|mesh-list
153383932|NCT02260622|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153843800|NCT03673787|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153843801|NCT03571802|Simvastatin|simvastatin|mesh-list
153843802|NCT03571802|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153843803|NCT03571802|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153843804|NCT03571802|Antimetabolites|antimetabolites|mesh-ancestor
153843805|NCT03571802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153843806|NCT03571802|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153843807|NCT03571802|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
153843808|NCT03571802|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153843809|NCT02919332|Deoxyglucose|deoxyglucose|mesh-list
153843810|NCT02919332|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
153843811|NCT02919332|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
153843812|NCT02919332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153843813|NCT02919332|Antimetabolites|antimetabolites|mesh-ancestor
153843814|NCT02919332|Antiviral Agents|antiviral agents|mesh-ancestor
153843815|NCT02919332|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153843816|NCT02919293|Vaccines|vaccines|mesh-list
153843817|NCT02919293|Immunologic Factors|immunologic factors|mesh-ancestor
153843818|NCT02919293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153843819|NCT02919371|Bevacizumab|bevacizumab|mesh-list
153843820|NCT02919371|Sunitinib|sunitinib|mesh-list
153843821|NCT02919371|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153843822|NCT02919371|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153843823|NCT02919371|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153843824|NCT02919371|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153843825|NCT02919371|Growth Substances|growth substances|mesh-ancestor
153843826|NCT02919371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153843840|NCT04736901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153888318|NCT01101022|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153888319|NCT01101022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153888320|NCT01101022|Dopamine Agents|dopamine agents|mesh-ancestor
153888321|NCT01101022|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153888322|NCT02879110|Sulforaphane|sulforaphane|mesh-list
153888323|NCT02879110|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
153888327|NCT04207515|Anesthetics|anesthetics|mesh-list
153888328|NCT04207515|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153888329|NCT04207515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153888330|NCT01100944|Cyclophosphamide|cyclophosphamide|mesh-list
153429404|NCT03983941|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153429405|NCT03983941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153429406|NCT03983941|Sensory System Agents|sensory system agents|mesh-ancestor
153843842|NCT04736901|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153383942|NCT02260622|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153383943|NCT02260622|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153383944|NCT02260622|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153383945|NCT02260622|Antipyretics|antipyretics|mesh-ancestor
153383946|NCT02260622|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
153383947|NCT02260622|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
153383948|NCT02260622|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
153383949|NCT02260622|Purinergic Agents|purinergic agents|mesh-ancestor
153383950|NCT02260622|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153383951|NCT02260622|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
153383952|NCT02260622|Antithrombins|antithrombins|mesh-ancestor
153383953|NCT02260622|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
153383954|NCT02260622|Protease Inhibitors|protease inhibitors|mesh-ancestor
153383955|NCT02260622|Anticoagulants|anticoagulants|mesh-ancestor
153383956|NCT03186209|Benralizumab|benralizumab|mesh-list
153383957|NCT03186209|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153383958|NCT03186209|Respiratory System Agents|respiratory system agents|mesh-ancestor
153383959|NCT02261948|Simendan|simendan|mesh-list
153383960|NCT02261948|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
153383961|NCT02261948|Vasodilator Agents|vasodilator agents|mesh-ancestor
153383962|NCT02261948|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
153843843|NCT04736901|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153843844|NCT02919176|Pioglitazone|pioglitazone|mesh-list
153843845|NCT02919176|Mirabegron|mirabegron|mesh-list
153843846|NCT02919176|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153843847|NCT02919176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153843848|NCT02919176|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
153843849|NCT02919176|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
153843850|NCT02919176|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153843851|NCT02919176|Adrenergic Agents|adrenergic agents|mesh-ancestor
153843852|NCT02919176|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153843853|NCT02919176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153843854|NCT02919176|Urological Agents|urological agents|mesh-ancestor
153843855|NCT04734678|Infliximab|infliximab|mesh-list
153843856|NCT04734678|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
153843857|NCT04734678|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153843858|NCT04734678|Dermatologic Agents|dermatologic agents|mesh-ancestor
153843859|NCT04734678|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153843860|NCT04734678|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153843861|NCT02919059|Dapagliflozin|dapagliflozin|mesh-list
153843862|NCT02919059|Glimepiride|glimepiride|mesh-list
153843863|NCT02919059|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
153383963|NCT02261948|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
153383964|NCT02261948|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153383965|NCT02261948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153381514|NCT01649180|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153381516|NCT01649180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153381547|NCT04803539|Capecitabine|capecitabine|mesh-list
153381548|NCT04803539|Apatinib|apatinib|mesh-list
153381549|NCT04803539|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153383966|NCT02261948|Protective Agents|protective agents|mesh-ancestor
153383967|NCT02261948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153383968|NCT01787240|Escitalopram|escitalopram|mesh-list
153383969|NCT01787240|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
153383975|NCT01787240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153383977|NCT00357149|Docetaxel|docetaxel|mesh-list
153383978|NCT00357149|Fluorouracil|fluorouracil|mesh-list
153383979|NCT00357149|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153383980|NCT00357149|Tubulin Modulators|tubulin modulators|mesh-ancestor
153383981|NCT00357149|Antimitotic Agents|antimitotic agents|mesh-ancestor
153383982|NCT00357149|Mitosis Modulators|mitosis modulators|mesh-ancestor
153383983|NCT00357149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153383984|NCT00357149|Antimetabolites|antimetabolites|mesh-ancestor
153843864|NCT02919059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153843865|NCT02919059|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153843866|NCT02919059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153843867|NCT02919059|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153843868|NCT02919059|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153843879|NCT02918825|Autonomic Agents|autonomic agents|mesh-ancestor
153843880|NCT02918825|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153843881|NCT02918825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153843882|NCT02918825|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153843883|NCT02918825|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153843884|NCT02918825|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153843885|NCT02918825|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153843886|NCT02918825|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153843887|NCT02918825|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
153843888|NCT02918825|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153843889|NCT02918825|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153843890|NCT02918825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153843891|NCT02918825|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153843892|NCT02918825|Serotonin Agents|serotonin agents|mesh-ancestor
153843893|NCT02918825|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
153843894|NCT02918825|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153843895|NCT02918825|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
153843896|NCT02918825|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
153843897|NCT02918825|Dopamine Agents|dopamine agents|mesh-ancestor
153843898|NCT02918747|Dexamethasone|dexamethasone|mesh-list
153843899|NCT02918747|Prednisone|prednisone|mesh-list
153843900|NCT02918747|Cyclophosphamide|cyclophosphamide|mesh-list
153843901|NCT02918747|Gemcitabine|gemcitabine|mesh-list
153843902|NCT02918747|Doxorubicin|doxorubicin|mesh-list
153843903|NCT02918747|Oxaliplatin|oxaliplatin|mesh-list
153843904|NCT02918747|Vincristine|vincristine|mesh-list
153843905|NCT02918747|Pegaspargase|pegaspargase|mesh-list
153843906|NCT02918747|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153843907|NCT02918747|Immunologic Factors|immunologic factors|mesh-ancestor
153843908|NCT02918747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153843909|NCT02918747|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153843910|NCT02918747|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153843911|NCT02918747|Alkylating Agents|alkylating agents|mesh-ancestor
153843912|NCT02918747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153384015|NCT03064295|Purinergic Agents|purinergic agents|mesh-ancestor
153384016|NCT03064295|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153384017|NCT03064295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153384018|NCT03064295|Adenosine A2 Receptor Agonists|adenosine a2 receptor agonists|mesh-ancestor
153384019|NCT01789814|Clopidogrel|clopidogrel|mesh-list
153384020|NCT01789814|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
153384021|NCT01789814|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153384022|NCT01789814|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
153384023|NCT01789814|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
153384024|NCT01789814|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
153384025|NCT01789814|Purinergic Agents|purinergic agents|mesh-ancestor
153384026|NCT01789814|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153384027|NCT01789814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153384028|NCT01789814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153384030|NCT00356447|Estrogens|estrogens|mesh-ancestor
153384031|NCT00356447|Hormones|hormones|mesh-ancestor
153384032|NCT00356447|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153384033|NCT00356447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153384034|NCT01736852|Oxytocin|oxytocin|mesh-list
153384035|NCT01736852|Oxytocics|oxytocics|mesh-ancestor
153384036|NCT01736852|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153843932|NCT02918747|Antimitotic Agents|antimitotic agents|mesh-ancestor
153843933|NCT02918747|Mitosis Modulators|mitosis modulators|mesh-ancestor
153843934|NCT02918708|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
153843935|NCT02918708|Immunologic Factors|immunologic factors|mesh-ancestor
153843936|NCT02918708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153843937|NCT02918591|Empagliflozin|empagliflozin|mesh-list
153843938|NCT02918591|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
153843939|NCT02918591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153843940|NCT02918591|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153843941|NCT02918591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153843942|NCT02918045|Cellulose, Oxidized|cellulose, oxidized|mesh-list
153843943|NCT02918045|Hemostatics|hemostatics|mesh-ancestor
153843944|NCT02918045|Coagulants|coagulants|mesh-ancestor
153843945|NCT00532545|Teriparatide|teriparatide|mesh-list
153843946|NCT00532545|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153843947|NCT00532545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153843948|NCT00532545|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153843949|NCT00533520|Ranibizumab|ranibizumab|mesh-list
153843950|NCT00533520|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153843951|NCT00533520|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153843952|NCT00533520|Growth Substances|growth substances|mesh-ancestor
153843953|NCT00533520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153843954|NCT00533520|Growth Inhibitors|growth inhibitors|mesh-ancestor
153843955|NCT00533520|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153384054|NCT01877642|Anticonvulsants|anticonvulsants|mesh-ancestor
153384055|NCT01877642|Antiemetics|antiemetics|mesh-ancestor
153384056|NCT01877642|Autonomic Agents|autonomic agents|mesh-ancestor
153384057|NCT01877642|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153384058|NCT01877642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153384059|NCT01877642|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153384060|NCT01877642|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153384061|NCT01877642|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153384078|NCT01878656|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153384079|NCT01878656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153384080|NCT01811654|Hyaluronic Acid|hyaluronic acid|mesh-list
153384081|NCT01811654|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153384082|NCT01811654|Immunologic Factors|immunologic factors|mesh-ancestor
153384083|NCT01811654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153384084|NCT01811654|Viscosupplements|viscosupplements|mesh-ancestor
153384085|NCT01811654|Protective Agents|protective agents|mesh-ancestor
153384086|NCT02266472|Metformin|metformin|mesh-list
153384087|NCT02266472|Empagliflozin|empagliflozin|mesh-list
153384088|NCT02266472|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153384089|NCT02266472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153843957|NCT00533559|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153843958|NCT03685253|Niacinamide|niacinamide|mesh-list
153843959|NCT03685253|Vitamin B Complex|vitamin b complex|mesh-ancestor
153843960|NCT03685253|Vitamins|vitamins|mesh-ancestor
153843961|NCT03685253|Micronutrients|micronutrients|mesh-ancestor
153843962|NCT03685253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153843963|NCT00532220|Ibandronic Acid|ibandronic acid|mesh-list
153843964|NCT00532220|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153843965|NCT00532220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153843966|NCT00532584|Beclomethasone|beclomethasone|mesh-list
153843967|NCT00532584|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153843968|NCT00532584|Glucocorticoids|glucocorticoids|mesh-ancestor
153843969|NCT00532584|Hormones|hormones|mesh-ancestor
153843970|NCT00532584|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153843983|NCT05467709|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153843984|NCT05467709|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153843985|NCT05467709|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153843986|NCT05467709|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153843987|NCT05467709|Anesthetics, General|anesthetics, general|mesh-ancestor
153843988|NCT05467709|Anesthetics|anesthetics|mesh-ancestor
153843989|NCT05467709|GABA Modulators|gaba modulators|mesh-ancestor
153843990|NCT05467709|GABA Agents|gaba agents|mesh-ancestor
153843991|NCT05467709|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153384090|NCT02266472|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
153384091|NCT02266472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153384092|NCT03500289|Midazolam|midazolam|mesh-list
153384093|NCT03500289|Ketamine|ketamine|mesh-list
153384100|NCT03500289|Anesthetics, General|anesthetics, general|mesh-ancestor
153384101|NCT03500289|Anesthetics|anesthetics|mesh-ancestor
153384102|NCT03500289|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153384103|NCT03500289|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
153384104|NCT03500289|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
153384105|NCT03500289|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153384106|NCT03500289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153384107|NCT03500289|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153384108|NCT03500289|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153384109|NCT03500289|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153384110|NCT03500289|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153384111|NCT03500289|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153384112|NCT03500289|GABA Modulators|gaba modulators|mesh-ancestor
153384113|NCT03500289|GABA Agents|gaba agents|mesh-ancestor
153384114|NCT01812044|Lidocaine|lidocaine|mesh-list
153384115|NCT01812044|Bupivacaine|bupivacaine|mesh-list
153384116|NCT01812044|Anesthetics, Local|anesthetics, local|mesh-list
153384117|NCT01812044|Anesthetics|anesthetics|mesh-list
153384118|NCT01812044|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153384119|NCT01812044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153384120|NCT01812044|Sensory System Agents|sensory system agents|mesh-ancestor
153843992|NCT05467709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153843993|NCT00532623|Gemcitabine|gemcitabine|mesh-list
153843994|NCT00532623|Vinorelbine|vinorelbine|mesh-list
153843995|NCT00532623|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153843996|NCT00532623|Antimetabolites|antimetabolites|mesh-ancestor
153844019|NCT05467436|Anesthetics, Local|anesthetics, local|mesh-list
153844020|NCT05467436|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153844021|NCT05467436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153844022|NCT05467436|Sensory System Agents|sensory system agents|mesh-ancestor
153844023|NCT05467436|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153844024|NCT00533676|Oxymetazoline|oxymetazoline|mesh-list
153844025|NCT00533676|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153844026|NCT00533676|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153844027|NCT00533676|Adrenergic Agents|adrenergic agents|mesh-ancestor
153844028|NCT00533676|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153844029|NCT00533676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153844030|NCT00533676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153844051|NCT00532701|Interferon-alpha|interferon-alpha|mesh-list
153844053|NCT00532701|Antiviral Agents|antiviral agents|mesh-ancestor
153844054|NCT00532701|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153844055|NCT00532701|Immunologic Factors|immunologic factors|mesh-ancestor
153844056|NCT00532701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153844057|NCT00532701|Antimetabolites|antimetabolites|mesh-ancestor
153844058|NCT00532701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153844059|NCT01276639|Tofacitinib|tofacitinib|mesh-list
153844060|NCT01276639|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
153844061|NCT01276639|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153844062|NCT01276639|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153844063|NCT01276639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153844064|NCT00532415|Triamcinolone|triamcinolone|mesh-list
153844065|NCT00532415|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
153844066|NCT00532415|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
153844067|NCT00532415|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
153844068|NCT00532415|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153844069|NCT00532415|Glucocorticoids|glucocorticoids|mesh-ancestor
153844070|NCT00532415|Hormones|hormones|mesh-ancestor
153844071|NCT00532415|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153844072|NCT00532415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153844073|NCT00532415|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153844074|NCT00532415|Immunologic Factors|immunologic factors|mesh-ancestor
153844075|NCT00532415|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153844076|NCT00532415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153844077|NCT00532454|Tamoxifen|tamoxifen|mesh-list
153384178|NCT00357305|Cytarabine|cytarabine|mesh-list
153384179|NCT00357305|Etoposide|etoposide|mesh-list
153381550|NCT04803539|Antimetabolites|antimetabolites|mesh-ancestor
153381551|NCT04803539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153381552|NCT04803539|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153381553|NCT04803539|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153381554|NCT04803539|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153381555|NCT01658228|Donepezil|donepezil|mesh-list
153381556|NCT01658228|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
153381557|NCT01658228|Citalopram|citalopram|mesh-list
153381590|NCT01659866|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153384180|NCT00357305|Etoposide phosphate|etoposide phosphate|mesh-list
153384181|NCT00357305|Vorinostat|vorinostat|mesh-list
153384182|NCT00357305|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153384186|NCT00357305|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153384187|NCT00357305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153384188|NCT00357305|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153384189|NCT00357305|Antimetabolites|antimetabolites|mesh-ancestor
153384190|NCT00357305|Antiviral Agents|antiviral agents|mesh-ancestor
153384191|NCT00357305|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153384192|NCT00357305|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153384193|NCT00357305|Immunologic Factors|immunologic factors|mesh-ancestor
153384194|NCT00357305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153384195|NCT00357305|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
153384196|NCT02340000|Amoxicillin|amoxicillin|mesh-list
153384197|NCT02340000|Clavulanic Acid|clavulanic acid|mesh-list
153384198|NCT02340000|Clavulanic Acids|clavulanic acids|mesh-list
153384199|NCT02340000|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
153384200|NCT02340000|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153384201|NCT02340000|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153384202|NCT02340000|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
153384203|NCT02340000|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153384204|NCT02340000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153384205|NCT01813214|Vemurafenib|vemurafenib|mesh-list
153384206|NCT01813214|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153384207|NCT01813214|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153384208|NCT01813214|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153384209|NCT01813214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153844078|NCT00532454|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
153844079|NCT00532454|Hormone Antagonists|hormone antagonists|mesh-ancestor
153844115|NCT04686825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153384218|NCT01815008|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153384219|NCT01815008|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153384220|NCT01815008|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153384221|NCT01815008|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153384222|NCT01815008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153384223|NCT01815008|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153384224|NCT01815008|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153384225|NCT01815008|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153384226|NCT01815008|Antipyretics|antipyretics|mesh-ancestor
153384227|NCT01815008|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
153384228|NCT01815008|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
153384229|NCT01815008|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
153384230|NCT01815008|Purinergic Agents|purinergic agents|mesh-ancestor
153384232|NCT01801124|Bupivacaine|bupivacaine|mesh-list
153384233|NCT01801124|Anesthetics, Local|anesthetics, local|mesh-ancestor
153384234|NCT01801124|Anesthetics|anesthetics|mesh-ancestor
153384235|NCT01801124|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153384236|NCT01801124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153384237|NCT01801124|Sensory System Agents|sensory system agents|mesh-ancestor
153384238|NCT01801124|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153384239|NCT00357461|Ipilimumab|ipilimumab|mesh-list
153384240|NCT00357461|Vaccines|vaccines|mesh-list
153384241|NCT00357461|Freund's Adjuvant|freund's adjuvant|mesh-list
153384242|NCT00357461|Immunologic Factors|immunologic factors|mesh-ancestor
153384243|NCT00357461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153384244|NCT00357461|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153381591|NCT01659866|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153381592|NCT01659866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153381593|NCT01659866|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153381594|NCT01659866|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
153381595|NCT01659866|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153381596|NCT01659866|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
153381597|NCT01659866|Third Generation Cephalosporins|third generation cephalosporins|mesh-ancestor
153381598|NCT01659866|Beta Lactam Antibiotics|beta lactam antibiotics|mesh-ancestor
153381599|NCT01659866|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
153381635|NCT01660802|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153381636|NCT02899325|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
153423674|NCT03383588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153384248|NCT00357461|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153384249|NCT00357539|Azithromycin|azithromycin|mesh-list
153384250|NCT00357539|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153384251|NCT00357539|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153384252|NCT03331965|Metoclopramide|metoclopramide|mesh-list
153384253|NCT03331965|Antiemetics|antiemetics|mesh-ancestor
153844117|NCT00533988|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
153844118|NCT00533637|Cetirizine|cetirizine|mesh-list
153844119|NCT00533637|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
153844120|NCT00533637|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
153844121|NCT00533637|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
153844122|NCT00533637|Histamine Antagonists|histamine antagonists|mesh-ancestor
153844123|NCT00533637|Histamine Agents|histamine agents|mesh-ancestor
153844124|NCT00533637|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153844125|NCT00533637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153844140|NCT00532532|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
153844141|NCT00532532|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153844142|NCT00532571|Coenzyme Q10|coenzyme q10|mesh-list
153844143|NCT00532571|Vitamins|vitamins|mesh-ancestor
153844144|NCT00532571|Micronutrients|micronutrients|mesh-ancestor
153844145|NCT00532571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153844146|NCT04322565|Colchicine|colchicine|mesh-list
153844147|NCT04322565|Gout Suppressants|gout suppressants|mesh-ancestor
153844148|NCT04322565|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153844149|NCT04322565|Tubulin Modulators|tubulin modulators|mesh-ancestor
153844150|NCT04322565|Antimitotic Agents|antimitotic agents|mesh-ancestor
153844151|NCT04322565|Mitosis Modulators|mitosis modulators|mesh-ancestor
153844152|NCT04322565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153844153|NCT04322565|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153384254|NCT03331965|Autonomic Agents|autonomic agents|mesh-ancestor
153384255|NCT03331965|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153384256|NCT03331965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153384257|NCT03331965|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153384258|NCT03331965|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
153384259|NCT03331965|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
153384260|NCT03331965|Dopamine Agents|dopamine agents|mesh-ancestor
153384261|NCT03331965|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153384262|NCT03331965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153384263|NCT03278223|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
153384264|NCT03279237|Leucovorin|leucovorin|mesh-list
153384265|NCT03279237|Paclitaxel|paclitaxel|mesh-list
153384266|NCT03279237|Carboplatin|carboplatin|mesh-list
153384267|NCT03279237|Fluorouracil|fluorouracil|mesh-list
153384268|NCT03279237|Oxaliplatin|oxaliplatin|mesh-list
153384269|NCT03279237|Irinotecan|irinotecan|mesh-list
153384270|NCT03279237|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153384271|NCT03279237|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153384272|NCT03279237|Tubulin Modulators|tubulin modulators|mesh-ancestor
153844154|NCT00532688|Acetylcysteine|acetylcysteine|mesh-list
153384273|NCT03279237|Antimitotic Agents|antimitotic agents|mesh-ancestor
153844155|NCT00532688|N-monoacetylcystine|n-monoacetylcystine|mesh-list
153423675|NCT03383588|Sensory System Agents|sensory system agents|mesh-ancestor
153423676|NCT03383588|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153423677|NCT03383588|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153423678|NCT03383588|Narcotics|narcotics|mesh-ancestor
153423680|NCT03383588|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153381638|NCT02899325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153844156|NCT00532688|Antiviral Agents|antiviral agents|mesh-ancestor
153844157|NCT00532688|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153844158|NCT00532688|Expectorants|expectorants|mesh-ancestor
153844159|NCT00532688|Respiratory System Agents|respiratory system agents|mesh-ancestor
153844160|NCT00532688|Free Radical Scavengers|free radical scavengers|mesh-ancestor
153844161|NCT00532688|Antioxidants|antioxidants|mesh-ancestor
153844162|NCT00532688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153844163|NCT00532688|Protective Agents|protective agents|mesh-ancestor
153844164|NCT00532688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153844165|NCT00532688|Antidotes|antidotes|mesh-ancestor
153844166|NCT00534144|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
153844167|NCT00534144|Ferric gluconate|ferric gluconate|mesh-list
153844168|NCT00534144|Hematinics|hematinics|mesh-ancestor
153844169|NCT00534183|Haloperidol|haloperidol|mesh-list
153844170|NCT00534183|Olanzapine|olanzapine|mesh-list
153844171|NCT00534183|Risperidone|risperidone|mesh-list
153844172|NCT00534183|Haloperidol decanoate|haloperidol decanoate|mesh-list
153844173|NCT00534183|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153844174|NCT00534183|Serotonin Agents|serotonin agents|mesh-ancestor
153844175|NCT00534183|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153844176|NCT00534183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153844180|NCT00534183|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153844196|NCT00532727|Antimitotic Agents|antimitotic agents|mesh-ancestor
153844197|NCT00532727|Mitosis Modulators|mitosis modulators|mesh-ancestor
153844198|NCT00532727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153844199|NCT04261218|Paclitaxel|paclitaxel|mesh-list
153844200|NCT04261218|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153844201|NCT04261218|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153844202|NCT04261218|Tubulin Modulators|tubulin modulators|mesh-ancestor
153844203|NCT04261218|Antimitotic Agents|antimitotic agents|mesh-ancestor
153844204|NCT04261218|Mitosis Modulators|mitosis modulators|mesh-ancestor
153844205|NCT04261218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153844206|NCT04687449|Curcumin|curcumin|mesh-list
153844207|NCT04687449|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153844208|NCT04687449|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153844209|NCT04687449|Analgesics|analgesics|mesh-ancestor
153844210|NCT04687449|Sensory System Agents|sensory system agents|mesh-ancestor
153384310|NCT03336645|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153384311|NCT03336645|Anesthetics, General|anesthetics, general|mesh-ancestor
153384312|NCT03336645|Anesthetics|anesthetics|mesh-ancestor
153384313|NCT03336645|GABA Modulators|gaba modulators|mesh-ancestor
153384314|NCT03336645|GABA Agents|gaba agents|mesh-ancestor
153384315|NCT03336645|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153384316|NCT03336645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153384317|NCT00376311|Calcitonin|calcitonin|mesh-list
153384318|NCT00376311|Salmon calcitonin|salmon calcitonin|mesh-list
153384319|NCT00376311|Calcitonin Gene-Related Peptide|calcitonin gene-related peptide|mesh-list
153384320|NCT00376311|Katacalcin|katacalcin|mesh-list
153384321|NCT00376311|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153384322|NCT00376311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153844211|NCT04687449|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153844212|NCT04687449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153844214|NCT04687449|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153844215|NCT04687449|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153844216|NCT04687449|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153844217|NCT04687449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153844218|NCT00532818|Hydralazine|hydralazine|mesh-list
153844219|NCT00532818|Valproic Acid|valproic acid|mesh-list
153844220|NCT00532818|Anticonvulsants|anticonvulsants|mesh-ancestor
153844221|NCT00532818|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153844222|NCT00532818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153381639|NCT01661114|Gemcitabine|gemcitabine|mesh-list
153381789|NCT03325647|Testosterone|testosterone|mesh-list
153844223|NCT00532818|GABA Agents|gaba agents|mesh-ancestor
153844224|NCT00532818|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153844225|NCT00532818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153844226|NCT00532818|Antimanic Agents|antimanic agents|mesh-ancestor
153844227|NCT00532818|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153844228|NCT00532818|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153844229|NCT00532818|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153844230|NCT00532818|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153844231|NCT00532818|Vasodilator Agents|vasodilator agents|mesh-ancestor
153844232|NCT05209035|Trazodone|trazodone|mesh-list
153844233|NCT05209035|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153844234|NCT05209035|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153844235|NCT05209035|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153844236|NCT05209035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153844237|NCT05209035|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153844238|NCT05209035|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
153844239|NCT05209035|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153384341|NCT00376077|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153384342|NCT00376077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153384343|NCT00376077|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153384344|NCT00376077|Glucocorticoids|glucocorticoids|mesh-ancestor
153384345|NCT00376077|Hormones|hormones|mesh-ancestor
153384346|NCT00376077|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153384347|NCT00376077|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
153384348|NCT00376077|Protective Agents|protective agents|mesh-ancestor
153384349|NCT00376077|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153384350|NCT00376077|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153384351|NCT00376077|Immunologic Factors|immunologic factors|mesh-ancestor
153384370|NCT03521505|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153384371|NCT03521505|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
153844250|NCT00534261|Antiviral Agents|antiviral agents|mesh-ancestor
153844251|NCT00534261|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153844252|NCT00534261|Immunologic Factors|immunologic factors|mesh-ancestor
153844253|NCT00534261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153844254|NCT00534261|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153844256|NCT00532857|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
153844257|NCT00532857|Gemcitabine|gemcitabine|mesh-list
153844258|NCT00532857|Trastuzumab|trastuzumab|mesh-list
153844259|NCT00532857|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153844260|NCT00532857|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153844261|NCT00532857|Tubulin Modulators|tubulin modulators|mesh-ancestor
153844262|NCT00532857|Antimitotic Agents|antimitotic agents|mesh-ancestor
153844263|NCT00532857|Mitosis Modulators|mitosis modulators|mesh-ancestor
153844264|NCT00532857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153844265|NCT00532857|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153844266|NCT00532857|Antimetabolites|antimetabolites|mesh-ancestor
153844267|NCT00532857|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153844268|NCT05152004|Amoxicillin|amoxicillin|mesh-list
153844269|NCT05152004|Metronidazole|metronidazole|mesh-list
153844270|NCT05152004|Clarithromycin|clarithromycin|mesh-list
153844271|NCT05152004|Rabeprazole|rabeprazole|mesh-list
153844272|NCT05152004|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153844273|NCT05152004|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153844274|NCT05152004|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153844275|NCT05152004|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153844276|NCT05152004|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
153844277|NCT05152004|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153844278|NCT05152004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153384388|NCT03530631|Adderall|adderall|mesh-list
153384396|NCT03351933|gamma-Globulins|gamma-globulins|mesh-list
153384397|NCT03351933|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
153384398|NCT03351933|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
153384399|NCT03351933|Immunologic Factors|immunologic factors|mesh-ancestor
153384400|NCT03351933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153384401|NCT03594045|Apixaban|apixaban|mesh-list
153384402|NCT03594045|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
153384403|NCT03594045|Antithrombins|antithrombins|mesh-ancestor
153384404|NCT03594045|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
153844310|NCT05131997|Ezetimibe|ezetimibe|mesh-list
153844311|NCT05131997|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153844312|NCT05131997|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153844313|NCT05131997|Antimetabolites|antimetabolites|mesh-ancestor
153844314|NCT05131997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153844315|NCT05131997|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153844316|NCT05131997|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
153844317|NCT05131997|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153844318|NCT00534456|Darbepoetin alfa|darbepoetin alfa|mesh-list
153844319|NCT00534456|Hematinics|hematinics|mesh-ancestor
153844320|NCT00532961|Loteprednol Etabonate|loteprednol etabonate|mesh-list
153844321|NCT00532961|Tobramycin|tobramycin|mesh-list
153384421|NCT03597009|Nivolumab|nivolumab|mesh-list
153384422|NCT03597009|Talimogene laherparepvec|talimogene laherparepvec|mesh-list
153384423|NCT03597009|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153384424|NCT03597009|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153384435|NCT03352323|Sympathomimetics|sympathomimetics|mesh-ancestor
153844322|NCT00532961|Dexamethasone|dexamethasone|mesh-list
153844323|NCT00532961|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153844324|NCT00532961|Antiemetics|antiemetics|mesh-ancestor
153844325|NCT00532961|Autonomic Agents|autonomic agents|mesh-ancestor
153844326|NCT00532961|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153844327|NCT00532961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153844328|NCT00532961|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153844329|NCT00532961|Glucocorticoids|glucocorticoids|mesh-ancestor
153844330|NCT00532961|Hormones|hormones|mesh-ancestor
153844331|NCT00532961|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153844332|NCT00532961|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153844333|NCT00532961|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153844334|NCT00532961|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153844335|NCT00532961|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153844336|NCT00532961|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
153844337|NCT00534573|Amisulpride|amisulpride|mesh-list
153844338|NCT00534573|Moclobemide|moclobemide|mesh-list
153844339|NCT00534573|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153844340|NCT00534573|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153844341|NCT00534573|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153844342|NCT00534573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153844343|NCT00534573|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153844344|NCT00534573|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
153844345|NCT00534573|Dopamine Agents|dopamine agents|mesh-ancestor
153844346|NCT00534573|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153844347|NCT00534573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153844348|NCT00534573|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
153844349|NCT00534573|Antidepressive Agents|antidepressive agents|mesh-ancestor
153844350|NCT00534573|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
153844351|NCT00534573|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153844352|NCT04686890|Acetaminophen|acetaminophen|mesh-list
153844353|NCT04686890|Tramadol|tramadol|mesh-list
153844354|NCT04686890|Analgesics|analgesics|mesh-list
153844355|NCT04686890|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153844356|NCT04686890|Sensory System Agents|sensory system agents|mesh-ancestor
153844357|NCT04686890|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153844358|NCT04686890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153844359|NCT04686890|Antipyretics|antipyretics|mesh-ancestor
153844360|NCT04686890|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153844361|NCT04686890|Narcotics|narcotics|mesh-ancestor
153844371|NCT05103306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153844373|NCT00534651|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153384500|NCT03556761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153384501|NCT03559179|Analgesics, Opioid|analgesics, opioid|mesh-list
153384502|NCT03559179|Narcotics|narcotics|mesh-ancestor
153384503|NCT03559179|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153384504|NCT03559179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153384505|NCT03559179|Analgesics|analgesics|mesh-ancestor
153384506|NCT03559179|Sensory System Agents|sensory system agents|mesh-ancestor
153384508|NCT03366207|Ciprofloxacin|ciprofloxacin|mesh-list
153844381|NCT05080959|Anesthetics|anesthetics|mesh-ancestor
153844382|NCT05080959|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153844383|NCT05080959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153381792|NCT03325647|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
153381794|NCT03325647|Hormones|hormones|mesh-ancestor
153381795|NCT03325647|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153381796|NCT03325647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153844384|NCT05080959|Sensory System Agents|sensory system agents|mesh-ancestor
153844385|NCT05080959|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153844386|NCT04942730|Mycophenolic Acid|mycophenolic acid|mesh-list
153844387|NCT04942730|Cyclophosphamide|cyclophosphamide|mesh-list
153844389|NCT04942730|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
153844390|NCT04942730|Fludarabine|fludarabine|mesh-list
153844391|NCT04942730|Tacrolimus|tacrolimus|mesh-list
153844392|NCT04942730|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153844393|NCT04942730|Immunologic Factors|immunologic factors|mesh-ancestor
153844394|NCT04942730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153844395|NCT04942730|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153844396|NCT04942730|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153844397|NCT04942730|Alkylating Agents|alkylating agents|mesh-ancestor
153844398|NCT04942730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153844399|NCT04942730|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153844400|NCT04942730|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153844401|NCT04942730|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
153844402|NCT04942730|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153844403|NCT04942730|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153844404|NCT04942730|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
153844405|NCT04942730|Antitubercular Agents|antitubercular agents|mesh-ancestor
153844406|NCT04942730|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153844407|NCT04942730|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153844409|NCT01272193|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
153844410|NCT01272193|Insulin Glargine|insulin glargine|mesh-list
153844411|NCT01272193|Insulin Aspart|insulin aspart|mesh-list
153844412|NCT01272193|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153844413|NCT01272193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153844414|NCT04899206|Antidepressive Agents|antidepressive agents|mesh-list
153844415|NCT04899206|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153844416|NCT04687163|Oxaliplatin|oxaliplatin|mesh-list
153844417|NCT04687163|Fluorouracil|fluorouracil|mesh-list
153844418|NCT04687163|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153844419|NCT04687163|Antimetabolites|antimetabolites|mesh-ancestor
153844420|NCT04687163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153844421|NCT04687163|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153844422|NCT04687163|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153844423|NCT04687163|Immunologic Factors|immunologic factors|mesh-ancestor
153844424|NCT04687163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153384531|NCT03615807|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153384532|NCT02310672|Macitentan|macitentan|mesh-list
153384533|NCT02310672|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
153384534|NCT02310672|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
153384535|NCT02310672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153384536|NCT02310672|Endothelin B Receptor Antagonists|endothelin b receptor antagonists|mesh-ancestor
153384537|NCT03626415|Abrocitinib|abrocitinib|mesh-list
153384538|NCT03626415|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153384539|NCT03626415|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153384540|NCT03626415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153384542|NCT04373421|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
153384543|NCT04373421|Benzydamine|benzydamine|mesh-list
153384544|NCT04373421|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
153384545|NCT04373421|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153384546|NCT04373421|Disinfectants|disinfectants|mesh-ancestor
153384547|NCT04373421|Dermatologic Agents|dermatologic agents|mesh-ancestor
153384548|NCT04373421|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153384549|NCT03632109|Gentamicins|gentamicins|mesh-list
153384550|NCT03632109|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153384556|NCT02363946|Promethazine|promethazine|mesh-list
153844430|NCT01270828|Anticonvulsants|anticonvulsants|mesh-ancestor
153844431|NCT01270828|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153844432|NCT01270828|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153381797|NCT03325647|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153381798|NCT03325647|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153381799|NCT03325647|Anabolic Agents|anabolic agents|mesh-ancestor
153381800|NCT01665950|Simvastatin|simvastatin|mesh-list
153844433|NCT01270828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153844434|NCT01270828|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153844435|NCT01270828|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153844436|NCT01270828|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153844437|NCT01270828|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153844438|NCT01270828|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153844445|NCT03982407|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
153844446|NCT03982407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153844447|NCT01269385|Rituximab|rituximab|mesh-list
153844448|NCT01269385|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
153844449|NCT01269385|Alemtuzumab|alemtuzumab|mesh-list
153844450|NCT01269385|Antibodies|antibodies|mesh-list
153844451|NCT01269385|Immunoglobulins|immunoglobulins|mesh-list
153844452|NCT01269385|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
153844453|NCT01269385|Immunologic Factors|immunologic factors|mesh-ancestor
153844454|NCT01269385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153844455|NCT01269385|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153844456|NCT01269385|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153844457|NCT02071862|Paclitaxel|paclitaxel|mesh-list
153844458|NCT02071862|Docetaxel|docetaxel|mesh-list
153844460|NCT02071862|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153844461|NCT02071862|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153844462|NCT02071862|Tubulin Modulators|tubulin modulators|mesh-ancestor
153844463|NCT02071862|Antimitotic Agents|antimitotic agents|mesh-ancestor
153844464|NCT02071862|Mitosis Modulators|mitosis modulators|mesh-ancestor
153844465|NCT02071862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153844466|NCT02071862|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
153844467|NCT02071862|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153844468|NCT02071862|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153844469|NCT02071862|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153844470|NCT02071862|Immunologic Factors|immunologic factors|mesh-ancestor
153844471|NCT02071862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153844472|NCT00535691|Tacrolimus|tacrolimus|mesh-list
153844473|NCT00535691|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153844474|NCT00535691|Immunologic Factors|immunologic factors|mesh-ancestor
153844475|NCT00535691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153384575|NCT02363946|Dermatologic Agents|dermatologic agents|mesh-ancestor
153384576|NCT02363478|Buspirone|buspirone|mesh-list
153384577|NCT02363478|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153384578|NCT02363478|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153384579|NCT02363478|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153384580|NCT02363478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153384581|NCT02363478|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153384582|NCT02363478|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
153384583|NCT02363478|Serotonin Agents|serotonin agents|mesh-ancestor
153384584|NCT02363478|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153384585|NCT02363478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153384586|NCT02338362|Fluticasone|fluticasone|mesh-list
153384588|NCT02338362|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153384589|NCT02338362|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153384590|NCT02338362|Autonomic Agents|autonomic agents|mesh-ancestor
153384591|NCT02338362|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153384592|NCT02338362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153384593|NCT02338362|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153384594|NCT02338362|Respiratory System Agents|respiratory system agents|mesh-ancestor
153384595|NCT02338362|Dermatologic Agents|dermatologic agents|mesh-ancestor
153384596|NCT02338362|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
153384597|NCT01803074|Ritonavir|ritonavir|mesh-list
153384598|NCT01803074|Atazanavir Sulfate|atazanavir sulfate|mesh-list
153384599|NCT01803074|Tenofovir|tenofovir|mesh-list
153384600|NCT01803074|Emtricitabine|emtricitabine|mesh-list
153384601|NCT01803074|BMS-955176|bms-955176|mesh-list
153844480|NCT01268683|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153844481|NCT01268683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153384602|NCT01803074|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
153384603|NCT01803074|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
153844482|NCT02021474|Phenol|phenol|mesh-list
153844483|NCT02021474|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
153844484|NCT02021474|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153844485|NCT02021474|Disinfectants|disinfectants|mesh-ancestor
153844486|NCT02021474|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
153844487|NCT02021474|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
153844488|NCT04959825|Melatonin|melatonin|mesh-list
153844499|NCT05471453|Immunologic Factors|immunologic factors|mesh-ancestor
153844500|NCT05471453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153844501|NCT05471453|Antioxidants|antioxidants|mesh-ancestor
153844502|NCT05471453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153844503|NCT05471453|Protective Agents|protective agents|mesh-ancestor
153844504|NCT05471453|Vitamins|vitamins|mesh-ancestor
153844505|NCT05471453|Micronutrients|micronutrients|mesh-ancestor
153844506|NCT03457233|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
153844507|NCT03457233|Cetrorelix|cetrorelix|mesh-list
153844508|NCT03457233|Menotropins|menotropins|mesh-list
153844509|NCT03457233|Progesterone|progesterone|mesh-list
153844510|NCT03457233|Progestins|progestins|mesh-ancestor
153844511|NCT03457233|Hormones|hormones|mesh-ancestor
153844512|NCT03457233|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153844513|NCT03457233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153844514|NCT03457233|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153844515|NCT03457233|Fertility Agents, Female|fertility agents, female|mesh-ancestor
153844516|NCT03457233|Fertility Agents|fertility agents|mesh-ancestor
153844517|NCT03457233|Hormone Antagonists|hormone antagonists|mesh-ancestor
153844518|NCT00535808|Nitroprusside|nitroprusside|mesh-list
153384631|NCT01822886|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153384632|NCT01822886|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153384633|NCT01822886|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
153384634|NCT01822886|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153384635|NCT01823510|Aspirin|aspirin|mesh-list
153384636|NCT01823510|Clopidogrel|clopidogrel|mesh-list
153384637|NCT01823510|Ticagrelor|ticagrelor|mesh-list
153384638|NCT01823510|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153384639|NCT01823510|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153384640|NCT01823510|Analgesics|analgesics|mesh-ancestor
153384641|NCT01823510|Sensory System Agents|sensory system agents|mesh-ancestor
153384642|NCT01823510|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153384643|NCT01823510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153384644|NCT01823510|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153384645|NCT01823510|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153384646|NCT01823510|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153384647|NCT01823510|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153384648|NCT01823510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153384649|NCT01823510|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153384650|NCT01823510|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153384651|NCT01823510|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153844529|NCT00535808|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
153844530|NCT00535808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153844531|NCT05471063|Fluconazole|fluconazole|mesh-list
153844532|NCT05471063|Amphotericin B|amphotericin b|mesh-list
153844533|NCT05471063|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
153844534|NCT05471063|Flucytosine|flucytosine|mesh-list
153844535|NCT05471063|Cholesteryl sulfate|cholesteryl sulfate|mesh-list
153844543|NCT05471063|Hormone Antagonists|hormone antagonists|mesh-ancestor
153844544|NCT05471063|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153844545|NCT05471063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153844546|NCT05471063|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
153844547|NCT05471063|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
153844548|NCT05471063|Amebicides|amebicides|mesh-ancestor
153844549|NCT05471063|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153844550|NCT05471063|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153844551|NCT05471063|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153844552|NCT05471063|Antimetabolites|antimetabolites|mesh-ancestor
153844553|NCT05471063|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
153844554|NCT05471063|Protease Inhibitors|protease inhibitors|mesh-ancestor
153844555|NCT05471063|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
153844556|NCT05471063|Protective Agents|protective agents|mesh-ancestor
153844557|NCT05471063|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153844558|NCT04910100|Timolol|timolol|mesh-list
153844559|NCT04910100|Nebivolol|nebivolol|mesh-list
153844560|NCT04910100|Ophthalmic Solutions|ophthalmic solutions|mesh-list
153844561|NCT04910100|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
153844562|NCT04910100|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
153844563|NCT04910100|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
153844564|NCT04910100|Adrenergic Agents|adrenergic agents|mesh-ancestor
153844565|NCT04910100|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153844566|NCT04910100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153844567|NCT04910100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153384671|NCT02271698|Dexamethasone acetate|dexamethasone acetate|mesh-list
153384672|NCT02271698|BB 1101|bb 1101|mesh-list
153384673|NCT02271698|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153384674|NCT02271698|Antiemetics|antiemetics|mesh-ancestor
153384675|NCT02271698|Autonomic Agents|autonomic agents|mesh-ancestor
153384676|NCT02271698|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153384677|NCT02271698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153384678|NCT02271698|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153384679|NCT02271698|Glucocorticoids|glucocorticoids|mesh-ancestor
153384680|NCT02271698|Hormones|hormones|mesh-ancestor
153384681|NCT02271698|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153384682|NCT02271698|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153384683|NCT02271698|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153384684|NCT02271698|Protease Inhibitors|protease inhibitors|mesh-ancestor
153384685|NCT02271698|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153384686|NCT02271698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153384687|NCT02328404|Vitamin D|vitamin d|mesh-list
153384688|NCT02328404|Cholecalciferol|cholecalciferol|mesh-list
153384689|NCT02328404|Vitamins|vitamins|mesh-ancestor
153384690|NCT02328404|Micronutrients|micronutrients|mesh-ancestor
153384691|NCT02328404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153384692|NCT02328404|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153384693|NCT02328404|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153384694|NCT01829516|Oxytocin|oxytocin|mesh-list
153384695|NCT01829516|Oxytocics|oxytocics|mesh-ancestor
153384696|NCT01829516|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153384697|NCT01829516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153384698|NCT01830140|Bimatoprost|bimatoprost|mesh-list
153384699|NCT01830140|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153384700|NCT01830842|Nicotine|nicotine|mesh-list
153384701|NCT01830842|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
153844573|NCT04910100|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153384702|NCT01830842|Autonomic Agents|autonomic agents|mesh-ancestor
153384705|NCT01830842|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
153844574|NCT01268059|Paclitaxel|paclitaxel|mesh-list
153844575|NCT01268059|Carboplatin|carboplatin|mesh-list
153844581|NCT01268059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153844584|NCT01267825|Anesthetics|anesthetics|mesh-ancestor
153844585|NCT01267825|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153844586|NCT01267825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153844587|NCT01267825|Sensory System Agents|sensory system agents|mesh-ancestor
153844588|NCT01267825|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153844589|NCT00536003|Progesterone|progesterone|mesh-list
153844590|NCT00536003|Progestins|progestins|mesh-ancestor
153844591|NCT00536003|Hormones|hormones|mesh-ancestor
153844592|NCT00536003|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153844593|NCT00536003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153844594|NCT00533091|Sifalimumab|sifalimumab|mesh-list
153844595|NCT00533091|Immunologic Factors|immunologic factors|mesh-ancestor
153844596|NCT00533091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153844597|NCT00536042|Minocycline|minocycline|mesh-list
153844598|NCT00536042|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153844599|NCT00536042|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153844600|NCT01606384|Vasopressins|vasopressins|mesh-list
153844601|NCT01606384|Arginine Vasopressin|arginine vasopressin|mesh-list
153844602|NCT01606384|Hemostatics|hemostatics|mesh-ancestor
153844603|NCT01606384|Coagulants|coagulants|mesh-ancestor
153844604|NCT01606384|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
153384724|NCT01831232|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153384725|NCT01831232|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153384726|NCT01831232|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153384727|NCT01831232|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153384728|NCT01831232|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153384729|NCT01831232|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
153384730|NCT01831934|Vaccines|vaccines|mesh-list
153384731|NCT01831934|Immunologic Factors|immunologic factors|mesh-ancestor
153384732|NCT01831934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153384733|NCT01833026|Albuterol|albuterol|mesh-list
153384734|NCT01833026|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153384735|NCT01833026|Autonomic Agents|autonomic agents|mesh-ancestor
153384736|NCT01833026|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153384737|NCT01833026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153384738|NCT01833026|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153384739|NCT01833026|Respiratory System Agents|respiratory system agents|mesh-ancestor
153844614|NCT01606540|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153844615|NCT01606540|Analgesics|analgesics|mesh-ancestor
153844616|NCT01606540|Sensory System Agents|sensory system agents|mesh-ancestor
153844617|NCT01606540|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153844618|NCT01606540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153844619|NCT01606540|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153844620|NCT01606540|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153844621|NCT01606540|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153844622|NCT01606540|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153844623|NCT01606540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153844624|NCT00533169|Tretinoin|tretinoin|mesh-list
153844625|NCT00533169|Isotretinoin|isotretinoin|mesh-list
153844626|NCT00533169|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153844627|NCT00533169|Keratolytic Agents|keratolytic agents|mesh-ancestor
153844628|NCT00533169|Dermatologic Agents|dermatologic agents|mesh-ancestor
153844629|NCT00593710|Losartan|losartan|mesh-list
153844630|NCT00593710|Atenolol|atenolol|mesh-list
153844631|NCT00593710|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153844632|NCT00593710|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153844633|NCT00593710|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
153844634|NCT00593710|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
153844635|NCT00593710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153844636|NCT00593710|Sympatholytics|sympatholytics|mesh-ancestor
153844637|NCT00593710|Autonomic Agents|autonomic agents|mesh-ancestor
153844638|NCT00593710|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153844639|NCT00593710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153844640|NCT00593710|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
153844652|NCT04885686|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153844653|NCT04885686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153844654|NCT04885686|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153844655|NCT04885686|Glucocorticoids|glucocorticoids|mesh-ancestor
153844656|NCT04885686|Hormones|hormones|mesh-ancestor
153384751|NCT03383523|Anthelmintics|anthelmintics|mesh-ancestor
153384752|NCT03383523|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153384753|NCT03383523|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153384754|NCT03383523|Coccidiostats|coccidiostats|mesh-ancestor
153384755|NCT03383523|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153384757|NCT00377091|Fondaparinux|fondaparinux|mesh-list
153384758|NCT00377091|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
153384759|NCT00377091|Antithrombins|antithrombins|mesh-ancestor
153384760|NCT00377091|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
153384761|NCT00377091|Protease Inhibitors|protease inhibitors|mesh-ancestor
153384762|NCT00377091|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153384763|NCT00377091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153384764|NCT00377091|Anticoagulants|anticoagulants|mesh-ancestor
153384765|NCT00377091|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153384766|NCT00377091|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153384767|NCT01835912|Citric Acid|citric acid|mesh-list
153384768|NCT01835912|Sodium Citrate|sodium citrate|mesh-list
153384769|NCT01835912|Anticoagulants|anticoagulants|mesh-ancestor
153384770|NCT01835912|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
153384771|NCT01835912|Chelating Agents|chelating agents|mesh-ancestor
153384772|NCT01835912|Sequestering Agents|sequestering agents|mesh-ancestor
153384773|NCT01835912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153384774|NCT05747768|Midazolam|midazolam|mesh-list
153384775|NCT05747768|Dabigatran|dabigatran|mesh-list
153384776|NCT05747768|Atorvastatin|atorvastatin|mesh-list
153384777|NCT05747768|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
153384778|NCT05747768|Pitavastatin|pitavastatin|mesh-list
153384779|NCT05747768|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153384780|NCT05747768|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153844657|NCT04885686|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153384781|NCT05747768|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153384782|NCT05747768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153844667|NCT00594217|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153844668|NCT00594217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153844669|NCT00536237|Niacin|niacin|mesh-list
153844670|NCT00536237|Niacinamide|niacinamide|mesh-list
153844671|NCT00536237|Nicotinic Acids|nicotinic acids|mesh-list
153844672|NCT00536237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153844673|NCT00536237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153844674|NCT00536237|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153844675|NCT00536237|Antimetabolites|antimetabolites|mesh-ancestor
153844676|NCT00536237|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153844677|NCT00536237|Vasodilator Agents|vasodilator agents|mesh-ancestor
153844678|NCT00536237|Vitamin B Complex|vitamin b complex|mesh-ancestor
153844679|NCT00536237|Vitamins|vitamins|mesh-ancestor
153844680|NCT00536237|Micronutrients|micronutrients|mesh-ancestor
153844681|NCT00533247|Celecoxib|celecoxib|mesh-list
153844682|NCT00533247|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153844683|NCT00533247|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153844684|NCT00533247|Analgesics|analgesics|mesh-ancestor
153844685|NCT00533247|Sensory System Agents|sensory system agents|mesh-ancestor
153844686|NCT00533247|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153844687|NCT00533247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153844688|NCT00533247|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153844689|NCT00533247|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153844690|NCT00533247|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
153844691|NCT00533247|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153844692|NCT00533247|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153844693|NCT00533247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153844694|NCT01260181|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
153844695|NCT01260181|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153844696|NCT01260181|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153844697|NCT01260181|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153844698|NCT01260181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153844699|NCT01260181|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153384797|NCT05747768|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
153384798|NCT05747768|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153384799|NCT05747768|Antithrombins|antithrombins|mesh-ancestor
153384800|NCT05747768|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
153384801|NCT05747768|Protease Inhibitors|protease inhibitors|mesh-ancestor
153384802|NCT05747768|Anticoagulants|anticoagulants|mesh-ancestor
153384803|NCT04410159|Povidone-Iodine|povidone-iodine|mesh-list
153384804|NCT04410159|Listerine|listerine|mesh-list
153384805|NCT04410159|Povidone|povidone|mesh-list
153384806|NCT04410159|Plasma Substitutes|plasma substitutes|mesh-ancestor
153384807|NCT04410159|Blood Substitutes|blood substitutes|mesh-ancestor
153384808|NCT04410159|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
153384809|NCT04410159|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153384810|NCT03398421|Itraconazole|itraconazole|mesh-list
153384811|NCT03398421|Nemiralisib|nemiralisib|mesh-list
153384812|NCT03398421|Antifungal Agents|antifungal agents|mesh-ancestor
153384813|NCT03398421|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153384814|NCT03398421|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
153844701|NCT00536276|Ergocalciferols|ergocalciferols|mesh-list
153844702|NCT00536276|Cholecalciferol|cholecalciferol|mesh-list
153844703|NCT00536276|Vitamins|vitamins|mesh-list
153844704|NCT00536276|Micronutrients|micronutrients|mesh-ancestor
153844705|NCT00536276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153844706|NCT00536276|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153844707|NCT00536276|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153844708|NCT00594373|Tenofovir|tenofovir|mesh-list
153844709|NCT00594373|Antiviral Agents|antiviral agents|mesh-ancestor
153844710|NCT00594373|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153844711|NCT00594373|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153844712|NCT00594373|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153844713|NCT00594373|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153844714|NCT00594373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153844715|NCT00594373|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153844716|NCT00594373|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153844717|NCT05470166|Lidocaine|lidocaine|mesh-list
153844718|NCT05470166|Anesthetics, Local|anesthetics, local|mesh-ancestor
153844719|NCT05470166|Anesthetics|anesthetics|mesh-ancestor
153844720|NCT05470166|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153844721|NCT05470166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153844722|NCT05470166|Sensory System Agents|sensory system agents|mesh-ancestor
153844723|NCT05470166|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153844724|NCT05470166|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153844725|NCT05470166|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
153844726|NCT05470166|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153844727|NCT05470166|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153844728|NCT05470166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153844729|NCT01260142|Propofol|propofol|mesh-list
153844730|NCT01260142|Fospropofol|fospropofol|mesh-list
153844731|NCT01260142|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153844732|NCT01260142|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153844733|NCT01260142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153844734|NCT01260142|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153844735|NCT01260142|Anesthetics, General|anesthetics, general|mesh-ancestor
153844736|NCT01260142|Anesthetics|anesthetics|mesh-ancestor
153844737|NCT05469659|Metformin|metformin|mesh-list
153844738|NCT05469659|6-((4-ethylphenyl)methyl)-3',4',5',6'-tetrahydro-6'-(hydroxymethyl)spiro(isobenzofuran-1(3H),2'-(2H)pyran)-3',4',5'-triol|6-((4-ethylphenyl)methyl)-3',4',5',6'-tetrahydro-6'-(hydroxymethyl)spiro(isobenzofuran-1(3h),2'-(2h)pyran)-3',4',5'-triol|mesh-list
153844739|NCT05469659|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153844740|NCT05469659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153844741|NCT05469659|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
153844742|NCT05469659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153844743|NCT01808820|Imiquimod|imiquimod|mesh-list
153844744|NCT01808820|Vaccines|vaccines|mesh-list
153844745|NCT01808820|Immunologic Factors|immunologic factors|mesh-ancestor
153844747|NCT01808820|Toll-Like Receptor Agonists|toll-like receptor agonists|mesh-ancestor
153384846|NCT01841606|Autonomic Agents|autonomic agents|mesh-ancestor
153384847|NCT01841606|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153384848|NCT01841606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153384849|NCT01841606|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153384850|NCT01841606|Antipruritics|antipruritics|mesh-ancestor
153384851|NCT01841606|Dermatologic Agents|dermatologic agents|mesh-ancestor
153384852|NCT01841606|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
153384853|NCT01841606|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153844765|NCT01462890|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153844766|NCT01462890|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153844768|NCT01462890|Antimitotic Agents|antimitotic agents|mesh-ancestor
153844769|NCT01462890|Mitosis Modulators|mitosis modulators|mesh-ancestor
153844770|NCT01462890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153844771|NCT01462890|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153844772|NCT01462890|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153844773|NCT01462890|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153844774|NCT01462890|Growth Substances|growth substances|mesh-ancestor
153844775|NCT01462890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153844776|NCT01462890|Growth Inhibitors|growth inhibitors|mesh-ancestor
153844777|NCT05469113|Repaglinide|repaglinide|mesh-list
153844778|NCT05469113|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153844779|NCT05469113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153844780|NCT01259713|Amphotericin B|amphotericin b|mesh-list
153844781|NCT01259713|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
153844782|NCT01259713|Amebicides|amebicides|mesh-ancestor
153844783|NCT01259713|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153844784|NCT01259713|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153844785|NCT01259713|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153844802|NCT05471427|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153844803|NCT05471427|Tubulin Modulators|tubulin modulators|mesh-ancestor
153844804|NCT05471427|Antimitotic Agents|antimitotic agents|mesh-ancestor
153844805|NCT05471427|Mitosis Modulators|mitosis modulators|mesh-ancestor
153844806|NCT05471427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153844807|NCT04326985|Hyaluronic Acid|hyaluronic acid|mesh-list
153844808|NCT04326985|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153384910|NCT02335242|Vasodilator Agents|vasodilator agents|mesh-ancestor
153384911|NCT02335242|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
153384912|NCT02335242|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
153384913|NCT02335242|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153384914|NCT02335242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153384915|NCT02335242|Urological Agents|urological agents|mesh-ancestor
153384916|NCT02334384|Anti-Infective Agents|anti-infective agents|mesh-list
153384917|NCT02334384|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
153384918|NCT02305758|Bevacizumab|bevacizumab|mesh-list
153384919|NCT02305758|Fluorouracil|fluorouracil|mesh-list
153384920|NCT02305758|Veliparib|veliparib|mesh-list
153384921|NCT02305758|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153384922|NCT02305758|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153384923|NCT02305758|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153384924|NCT02305758|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153384925|NCT02305758|Growth Substances|growth substances|mesh-ancestor
153384926|NCT02305758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153384927|NCT02305758|Growth Inhibitors|growth inhibitors|mesh-ancestor
153384928|NCT02305758|Antimetabolites|antimetabolites|mesh-ancestor
153384929|NCT02305758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153384930|NCT02305758|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153384931|NCT02305758|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153384932|NCT02305758|Immunologic Factors|immunologic factors|mesh-ancestor
153384933|NCT02305758|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
153384934|NCT02305758|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153384935|NCT04392219|Molnupiravir|molnupiravir|mesh-list
153384936|NCT04392219|Antiviral Agents|antiviral agents|mesh-ancestor
153384937|NCT04392219|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153844819|NCT00536393|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153844820|NCT00536393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153844821|NCT00595543|Diclofenac|diclofenac|mesh-list
153844822|NCT00595543|Ketorolac|ketorolac|mesh-list
153844823|NCT00595543|Bromfenac|bromfenac|mesh-list
153844824|NCT00595543|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153844825|NCT00595543|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153844826|NCT00595543|Analgesics|analgesics|mesh-ancestor
153844827|NCT00595543|Sensory System Agents|sensory system agents|mesh-ancestor
153844828|NCT00595543|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153844829|NCT00595543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153844830|NCT00595543|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153844831|NCT00595543|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153844832|NCT00595543|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153844833|NCT00595543|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153844834|NCT00595543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153844835|NCT04326868|Albendazole|albendazole|mesh-list
153844836|NCT04326868|Mebendazole|mebendazole|mesh-list
153844837|NCT04326868|Benzimidazole|benzimidazole|mesh-list
153844838|NCT04326868|Pyrantel|pyrantel|mesh-list
153844839|NCT04326868|Anthelmintics|anthelmintics|mesh-list
153844840|NCT04326868|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153844841|NCT04326868|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153844842|NCT04326868|Anticestodal Agents|anticestodal agents|mesh-ancestor
153384944|NCT03654417|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153384945|NCT03654417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153384946|NCT03654417|Sensory System Agents|sensory system agents|mesh-ancestor
153384947|NCT03654417|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153384948|NCT03654417|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153384949|NCT03654417|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
153384950|NCT03654417|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153384951|NCT03654417|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153384952|NCT03654417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153384953|NCT00376701|Bevacizumab|bevacizumab|mesh-list
153384954|NCT00376701|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153384955|NCT00376701|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153384956|NCT00376701|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153384957|NCT00376701|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153384958|NCT00376701|Growth Substances|growth substances|mesh-ancestor
153384959|NCT00376701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153384960|NCT00376701|Growth Inhibitors|growth inhibitors|mesh-ancestor
153384961|NCT04358991|Ceftazidime|ceftazidime|mesh-list
153384962|NCT04358991|Avibactam, ceftazidime drug combination|avibactam, ceftazidime drug combination|mesh-list
153844843|NCT04326868|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
153844844|NCT04326868|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153844845|NCT04326868|Tubulin Modulators|tubulin modulators|mesh-ancestor
153844846|NCT04326868|Antimitotic Agents|antimitotic agents|mesh-ancestor
153844847|NCT04326868|Mitosis Modulators|mitosis modulators|mesh-ancestor
153844848|NCT04326868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153844849|NCT04326868|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153844850|NCT04326868|Antinematodal Agents|antinematodal agents|mesh-ancestor
153844851|NCT04326868|Neuromuscular Depolarizing Agents|neuromuscular depolarizing agents|mesh-ancestor
153844852|NCT04326868|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
153844853|NCT04326868|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
153844854|NCT04326868|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153844855|NCT04326868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153844856|NCT00595972|Endostar protein|endostar protein|mesh-list
153844857|NCT00595972|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153844871|NCT00596050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153844873|NCT00596050|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153844874|NCT00596050|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153844875|NCT00596050|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
153844876|NCT00596050|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153844877|NCT00596050|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153844878|NCT00596050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153844879|NCT00596050|Analgesics|analgesics|mesh-ancestor
153844880|NCT00596050|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
153844881|NCT00596050|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153844882|NCT00596050|Anesthetics, General|anesthetics, general|mesh-ancestor
153844883|NCT00596050|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
153844884|NCT00596050|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
153844885|NCT00596050|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153844886|NCT00596050|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153384986|NCT02303262|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153384987|NCT02303262|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
153384988|NCT02303262|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153384989|NCT00558896|Dexamethasone|dexamethasone|mesh-list
153384990|NCT00558896|Pomalidomide|pomalidomide|mesh-list
153384991|NCT00558896|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153384992|NCT00558896|Antiemetics|antiemetics|mesh-ancestor
153384993|NCT00558896|Autonomic Agents|autonomic agents|mesh-ancestor
153384994|NCT00558896|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153384995|NCT00558896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153384996|NCT00558896|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153384997|NCT00558896|Glucocorticoids|glucocorticoids|mesh-ancestor
153384998|NCT00558896|Hormones|hormones|mesh-ancestor
153384999|NCT00558896|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153385000|NCT00558896|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153385001|NCT00558896|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153385002|NCT00558896|Immunologic Factors|immunologic factors|mesh-ancestor
153385003|NCT00558896|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153385008|NCT01857362|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153385009|NCT01857362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153385010|NCT02265224|Acetylcysteine|acetylcysteine|mesh-list
153385011|NCT02265224|N-monoacetylcystine|n-monoacetylcystine|mesh-list
153385012|NCT02265224|Antiviral Agents|antiviral agents|mesh-ancestor
153385013|NCT02265224|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153385014|NCT02265224|Expectorants|expectorants|mesh-ancestor
153844889|NCT00596050|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153844890|NCT00596050|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153844891|NCT00596050|GABA Modulators|gaba modulators|mesh-ancestor
153844892|NCT00596050|GABA Agents|gaba agents|mesh-ancestor
153844893|NCT00596050|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153844894|NCT00596050|Narcotics|narcotics|mesh-ancestor
153844895|NCT02888899|Loperamide|loperamide|mesh-list
153844896|NCT02888899|Antidiarrheals|antidiarrheals|mesh-list
153844897|NCT02888899|Calcium polycarbophil|calcium polycarbophil|mesh-list
153844898|NCT02888899|Psyllium|psyllium|mesh-list
153844899|NCT02888899|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153844900|NCT02888899|Cathartics|cathartics|mesh-ancestor
153844901|NCT00596128|Insulin|insulin|mesh-list
153844902|NCT00596128|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153844903|NCT00596128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153844904|NCT00596206|Leflunomide|leflunomide|mesh-list
153844905|NCT00596206|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153844907|NCT00596206|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153844913|NCT00624130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153844914|NCT00624130|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
153844915|NCT00624130|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
153844916|NCT00624130|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
153844917|NCT00624130|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153844919|NCT05468450|Sclerosing Solutions|sclerosing solutions|mesh-list
153844920|NCT05468450|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
153844921|NCT00535860|Teriparatide|teriparatide|mesh-list
153844922|NCT00535860|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153882775|NCT01602822|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
153882776|NCT01602822|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
153882777|NCT01602822|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
153882778|NCT01602822|Protease Inhibitors|protease inhibitors|mesh-ancestor
153882779|NCT01602822|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153882780|NCT01602822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153882781|NCT01602822|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153882782|NCT01602822|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153385022|NCT01859078|Digoxin|digoxin|mesh-list
153385023|NCT01859078|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153385024|NCT01859078|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
153385025|NCT01859078|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153385026|NCT01859078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153385027|NCT01859078|Protective Agents|protective agents|mesh-ancestor
153385028|NCT01859078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153385029|NCT00558428|Amlodipine|amlodipine|mesh-list
153385030|NCT00558428|Telmisartan|telmisartan|mesh-list
153385031|NCT00558428|Telmisartan amlodipine combination|telmisartan amlodipine combination|mesh-list
153385032|NCT00558428|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153385033|NCT00558428|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153385034|NCT00558428|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153385035|NCT00558428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153385036|NCT00558428|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153385037|NCT00558428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153385038|NCT00558428|Vasodilator Agents|vasodilator agents|mesh-ancestor
153385039|NCT00558428|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
153385040|NCT00558428|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
153385041|NCT05314725|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
153385042|NCT05314725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153385043|NCT05314725|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153385044|NCT05314725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153385045|NCT04310085|Lumefantrine|lumefantrine|mesh-list
153844923|NCT00535860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153844924|NCT00535860|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153844926|NCT00596479|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153844927|NCT00596479|Immunologic Factors|immunologic factors|mesh-ancestor
153844928|NCT00596479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153844929|NCT04207957|Olorofim|olorofim|mesh-list
153844939|NCT00596557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153844940|NCT00596557|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153844941|NCT00596596|Prucalopride|prucalopride|mesh-list
153844942|NCT00596596|Laxatives|laxatives|mesh-ancestor
153844943|NCT00596596|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153844944|NCT00596596|Serotonin 5-HT4 Receptor Agonists|serotonin 5-ht4 receptor agonists|mesh-ancestor
153844945|NCT00596596|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
153844946|NCT00596596|Serotonin Agents|serotonin agents|mesh-ancestor
153844947|NCT00596596|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153844948|NCT00596596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153844950|NCT05468294|Nivolumab|nivolumab|mesh-list
153385068|NCT03407625|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153385069|NCT03407625|Oxytocics|oxytocics|mesh-ancestor
153385071|NCT03666663|Bupivacaine|bupivacaine|mesh-list
153385072|NCT03666663|Ropivacaine|ropivacaine|mesh-list
153385073|NCT03666663|Anesthetics, Local|anesthetics, local|mesh-ancestor
153385074|NCT03666663|Anesthetics|anesthetics|mesh-ancestor
153385075|NCT03666663|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153385076|NCT03666663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153385077|NCT03666663|Sensory System Agents|sensory system agents|mesh-ancestor
153385078|NCT03666663|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153385079|NCT03666663|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153385080|NCT03666663|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
153385081|NCT03666663|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153385082|NCT03666663|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153882783|NCT01602822|Antiviral Agents|antiviral agents|mesh-ancestor
153385083|NCT03666663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153385084|NCT01863134|Eptifibatide|eptifibatide|mesh-list
153385085|NCT01863134|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153385087|NCT03415581|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153385088|NCT03415581|Narcotics|narcotics|mesh-ancestor
153385089|NCT03415581|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153385090|NCT03415581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153385091|NCT03415581|Analgesics|analgesics|mesh-ancestor
153385092|NCT03415581|Sensory System Agents|sensory system agents|mesh-ancestor
153385093|NCT03415581|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153385094|NCT00557492|Bevacizumab|bevacizumab|mesh-list
153385095|NCT00557492|Gemcitabine|gemcitabine|mesh-list
153385096|NCT00557492|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153385106|NCT01865708|Ethanol|ethanol|mesh-list
153844970|NCT05312866|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153844971|NCT05312866|Anesthetics, Local|anesthetics, local|mesh-ancestor
153844972|NCT05312866|Anesthetics|anesthetics|mesh-ancestor
153844986|NCT05312866|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153844987|NCT05312866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153844988|NCT05312866|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153844989|NCT05312866|Tocolytic Agents|tocolytic agents|mesh-ancestor
153844990|NCT05312866|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153844991|NCT04326790|Colchicine|colchicine|mesh-list
153844992|NCT04326790|Gout Suppressants|gout suppressants|mesh-ancestor
153844993|NCT04326790|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153844994|NCT04326790|Tubulin Modulators|tubulin modulators|mesh-ancestor
153844995|NCT04326790|Antimitotic Agents|antimitotic agents|mesh-ancestor
153844996|NCT04326790|Mitosis Modulators|mitosis modulators|mesh-ancestor
153844997|NCT04326790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153844998|NCT04326790|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153844999|NCT00596986|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
153845000|NCT00596986|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
153385142|NCT05314257|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153385143|NCT05314257|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
153385144|NCT05314257|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153385145|NCT05314257|Serotonin Agents|serotonin agents|mesh-ancestor
153385146|NCT05314257|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153845014|NCT00597064|Glucocorticoids|glucocorticoids|mesh-ancestor
153845015|NCT00597064|Hormones|hormones|mesh-ancestor
153845016|NCT00597064|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153845017|NCT00597064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153845018|NCT00597064|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153845019|NCT00597064|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153845020|NCT00597181|Mitomycins|mitomycins|mesh-list
153845021|NCT00597181|Mitomycin|mitomycin|mesh-list
153845047|NCT05470764|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
153845049|NCT00597415|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153845050|NCT00597415|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153845051|NCT00597415|Analgesics|analgesics|mesh-ancestor
153845052|NCT00597415|Sensory System Agents|sensory system agents|mesh-ancestor
153845053|NCT00597415|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153385153|NCT01866410|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
153385154|NCT01866410|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153385155|NCT01866410|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153385156|NCT01866410|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153385157|NCT01866410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153385158|NCT01866410|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153385160|NCT00377325|Cyclosporins|cyclosporins|mesh-list
153385161|NCT00377325|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153385162|NCT00377325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153385163|NCT00377325|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153385164|NCT00377325|Immunologic Factors|immunologic factors|mesh-ancestor
153385165|NCT00377325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153385166|NCT00377325|Antifungal Agents|antifungal agents|mesh-ancestor
153385167|NCT00377325|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153385168|NCT00377325|Dermatologic Agents|dermatologic agents|mesh-ancestor
153385169|NCT00377325|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153385170|NCT00377325|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
153385171|NCT02332824|Candesartan|candesartan|mesh-list
153385172|NCT02332824|Candesartan cilexetil|candesartan cilexetil|mesh-list
153385173|NCT02332824|Imarikiren hydrochloride|imarikiren hydrochloride|mesh-list
153385174|NCT02332824|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153882784|NCT01602822|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153385175|NCT02332824|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
153385176|NCT02332824|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
153385177|NCT02332824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153385178|NCT02332824|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153845054|NCT00597415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153845055|NCT00597415|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153845056|NCT00597415|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153845057|NCT00597415|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
153845058|NCT00597415|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153845059|NCT00597415|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153845060|NCT00597415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153845061|NCT00597688|Chlorhexidine|chlorhexidine|mesh-list
153845062|NCT00597688|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
153845063|NCT00597688|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153845064|NCT00597688|Disinfectants|disinfectants|mesh-ancestor
153845065|NCT05470530|Dexamethasone|dexamethasone|mesh-list
153845066|NCT05470530|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153845067|NCT05470530|Antiemetics|antiemetics|mesh-ancestor
153845068|NCT05470530|Autonomic Agents|autonomic agents|mesh-ancestor
153845069|NCT05470530|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153845070|NCT05470530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153845071|NCT05470530|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153845072|NCT05470530|Glucocorticoids|glucocorticoids|mesh-ancestor
153845073|NCT05470530|Hormones|hormones|mesh-ancestor
153845074|NCT05470530|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153845075|NCT05470530|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153845076|NCT05470530|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153845077|NCT02891980|Vaccines|vaccines|mesh-list
153845078|NCT02891980|Immunologic Factors|immunologic factors|mesh-ancestor
153845079|NCT02891980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153845080|NCT05467826|Ribavirin|ribavirin|mesh-list
153845081|NCT05467826|Sofosbuvir|sofosbuvir|mesh-list
153845082|NCT05467826|Sofosbuvir-velpatasvir drug combination|sofosbuvir-velpatasvir drug combination|mesh-list
153845083|NCT05467826|Velpatasvir|velpatasvir|mesh-list
153385189|NCT03705273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153385190|NCT03705273|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153385191|NCT03705273|Glucocorticoids|glucocorticoids|mesh-ancestor
153385192|NCT03705273|Hormones|hormones|mesh-ancestor
153385193|NCT03705273|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153385194|NCT03705273|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153385195|NCT03705273|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153385196|NCT03705273|Protease Inhibitors|protease inhibitors|mesh-ancestor
153385198|NCT03705273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153385199|NCT04184271|Fluorides|fluorides|mesh-list
153385200|NCT04184271|Cariostatic Agents|cariostatic agents|mesh-ancestor
153385201|NCT04184271|Protective Agents|protective agents|mesh-ancestor
153385202|NCT04184271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153385203|NCT03936387|Ropivacaine|ropivacaine|mesh-list
153385204|NCT03936387|Anesthetics, Local|anesthetics, local|mesh-ancestor
153385205|NCT03936387|Anesthetics|anesthetics|mesh-ancestor
153385206|NCT03936387|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153385207|NCT03936387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153385208|NCT03936387|Sensory System Agents|sensory system agents|mesh-ancestor
153385209|NCT03936387|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153385210|NCT04173429|Nadroparin|nadroparin|mesh-list
153385211|NCT04173429|Warfarin|warfarin|mesh-list
153385212|NCT04173429|Calcium|calcium|mesh-list
153385213|NCT04173429|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153385214|NCT04173429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153385215|NCT04173429|Anticoagulants|anticoagulants|mesh-ancestor
153385216|NCT04173429|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153385227|NCT04167189|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153385228|NCT04167189|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153385236|NCT03929367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153385238|NCT04149405|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153385239|NCT04149405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153385240|NCT00556712|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
153385241|NCT00556712|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153385242|NCT00556712|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153385243|NCT00556712|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153385244|NCT00556712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153385245|NCT00556712|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153882785|NCT01602822|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
153385246|NCT03717051|Nicotine|nicotine|mesh-list
153385247|NCT03717051|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
153385248|NCT03717051|Autonomic Agents|autonomic agents|mesh-ancestor
153385256|NCT04350320|Colchicine|colchicine|mesh-list
153845119|NCT00598234|Sensory System Agents|sensory system agents|mesh-ancestor
153845120|NCT00598234|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153845121|NCT00598234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153845122|NCT00598234|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153845123|NCT00598234|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153845124|NCT00598234|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
153845125|NCT00598234|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153845126|NCT00598234|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153845127|NCT00598234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153845128|NCT00598429|Alprostadil|alprostadil|mesh-list
153845129|NCT00598429|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153845130|NCT00598429|Vasodilator Agents|vasodilator agents|mesh-ancestor
153845131|NCT00598429|Urological Agents|urological agents|mesh-ancestor
153845132|NCT00598624|Treosulfan|treosulfan|mesh-list
153845133|NCT00598624|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153845150|NCT00598858|Glucocorticoids|glucocorticoids|mesh-ancestor
153845151|NCT00598858|Hormones|hormones|mesh-ancestor
153845152|NCT00598858|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153845153|NCT00598858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153845154|NCT00598858|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153845155|NCT02909166|Aliskiren|aliskiren|mesh-list
153845156|NCT02909166|Renin Inhibitors|renin inhibitors|mesh-ancestor
153845157|NCT02909166|Protease Inhibitors|protease inhibitors|mesh-ancestor
153845158|NCT02909166|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153845159|NCT02909166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153845160|NCT05466305|Cobalt|cobalt|mesh-list
153845161|NCT05466305|Trace Elements|trace elements|mesh-ancestor
153385262|NCT04350320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153385263|NCT04350320|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153385264|NCT04143945|Semaglutide|semaglutide|mesh-list
153385265|NCT04143945|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
153385266|NCT04143945|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153385267|NCT04143945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153385268|NCT03920865|Risdiplam|risdiplam|mesh-list
153385269|NCT03920865|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
153385270|NCT03920865|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153385271|NCT03920865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153385272|NCT00556322|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
153845162|NCT05466305|Micronutrients|micronutrients|mesh-ancestor
153845163|NCT05466305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153845164|NCT04207684|Testosterone|testosterone|mesh-list
153845165|NCT04207684|Androgens|androgens|mesh-ancestor
153845166|NCT04207684|Hormones|hormones|mesh-ancestor
153845167|NCT04207684|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153845168|NCT04207684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153845169|NCT02909400|6-hydroxy-2,5,7,8-tetramethylchroman-2-carboxylic acid|6-hydroxy-2,5,7,8-tetramethylchroman-2-carboxylic acid|mesh-list
153845170|NCT02909400|Antioxidants|antioxidants|mesh-ancestor
153845171|NCT02909400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153845172|NCT02909400|Protective Agents|protective agents|mesh-ancestor
153845173|NCT02909400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153845174|NCT02909478|Dexamethasone|dexamethasone|mesh-list
153845175|NCT02909478|Aprepitant|aprepitant|mesh-list
153845176|NCT02909478|Tropisetron|tropisetron|mesh-list
153845177|NCT02909478|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153845178|NCT02909478|Antiemetics|antiemetics|mesh-ancestor
153845179|NCT02909478|Autonomic Agents|autonomic agents|mesh-ancestor
153845180|NCT02909478|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153845181|NCT02909478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153845182|NCT02909478|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153845183|NCT02909478|Glucocorticoids|glucocorticoids|mesh-ancestor
153845184|NCT02909478|Hormones|hormones|mesh-ancestor
153845185|NCT02909478|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153845186|NCT02909478|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153845187|NCT02909478|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153385289|NCT04136145|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153385291|NCT04136145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153385292|NCT01869686|Denosumab|denosumab|mesh-list
153385293|NCT01869686|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153385294|NCT01869686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153385295|NCT03360890|Docetaxel|docetaxel|mesh-list
153845195|NCT00536211|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153845196|NCT00536211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153845197|NCT00536705|Montelukast|montelukast|mesh-list
153845198|NCT00536705|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153845199|NCT00536705|Respiratory System Agents|respiratory system agents|mesh-ancestor
153845200|NCT00536705|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
153845201|NCT00536705|Hormone Antagonists|hormone antagonists|mesh-ancestor
153845202|NCT00536705|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153845203|NCT00536705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153845204|NCT00536705|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
153845205|NCT00536705|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
153845206|NCT00536705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153845207|NCT00624208|Droperidol|droperidol|mesh-list
153845208|NCT00624208|Ondansetron|ondansetron|mesh-list
153845209|NCT00624208|Antiemetics|antiemetics|mesh-ancestor
153845224|NCT00624208|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153845226|NCT00624208|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
153845227|NCT00624208|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
153845228|NCT00624208|Dopamine Agents|dopamine agents|mesh-ancestor
153845229|NCT00536783|Quetiapine Fumarate|quetiapine fumarate|mesh-list
153845230|NCT00536783|Antidepressive Agents|antidepressive agents|mesh-ancestor
153845231|NCT00536783|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153845232|NCT00536783|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153845233|NCT00536783|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153845234|NCT00536783|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153845235|NCT00536783|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153845236|NCT04685642|Aspirin|aspirin|mesh-list
153845237|NCT04685642|Atorvastatin|atorvastatin|mesh-list
153845238|NCT04685642|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153845239|NCT04685642|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153845240|NCT04685642|Analgesics|analgesics|mesh-ancestor
153845241|NCT04685642|Sensory System Agents|sensory system agents|mesh-ancestor
153845242|NCT04685642|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153845243|NCT04685642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153845244|NCT04685642|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153845245|NCT04685642|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153845246|NCT04685642|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153385351|NCT03054038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153385352|NCT03054038|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153385353|NCT03054038|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153385354|NCT02302716|Hypoglycemic Agents|hypoglycemic agents|mesh-list
153385355|NCT02302716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153385356|NCT03958071|Pirfenidone|pirfenidone|mesh-list
153385357|NCT03958071|Nintedanib|nintedanib|mesh-list
153385358|NCT03958071|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153385359|NCT03958071|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153385368|NCT03958071|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153385378|NCT04066647|Hormones|hormones|mesh-ancestor
153385379|NCT04066647|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153845247|NCT04685642|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153845248|NCT04685642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153845249|NCT04685642|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153845250|NCT04685642|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153845251|NCT04685642|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153845252|NCT04685642|Antipyretics|antipyretics|mesh-ancestor
153385396|NCT02354508|Hormones|hormones|mesh-ancestor
153385397|NCT02354508|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153385398|NCT02354508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153385399|NCT00554216|Topiramate|topiramate|mesh-list
153385400|NCT00554216|Phentermine|phentermine|mesh-list
153385401|NCT00554216|Anticonvulsants|anticonvulsants|mesh-ancestor
153385402|NCT00554216|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153385403|NCT00554216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153385404|NCT00554216|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
153385405|NCT00554216|Appetite Depressants|appetite depressants|mesh-ancestor
153385406|NCT00554216|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
153385407|NCT00554216|Sympathomimetics|sympathomimetics|mesh-ancestor
153385408|NCT00554216|Autonomic Agents|autonomic agents|mesh-ancestor
153385409|NCT00554216|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153845292|NCT00537173|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153845293|NCT00537173|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153845294|NCT00537173|Tubulin Modulators|tubulin modulators|mesh-ancestor
153845295|NCT00537173|Antimitotic Agents|antimitotic agents|mesh-ancestor
153845296|NCT00537173|Mitosis Modulators|mitosis modulators|mesh-ancestor
153845297|NCT00537173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153845298|NCT00537173|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153845299|NCT00537173|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153845300|NCT00537173|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153845301|NCT00537173|Growth Substances|growth substances|mesh-ancestor
153845302|NCT00537173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153845303|NCT00537173|Growth Inhibitors|growth inhibitors|mesh-ancestor
153845304|NCT02503839|Etoricoxib|etoricoxib|mesh-list
153845306|NCT02503839|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153845321|NCT05469750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153845322|NCT05469750|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153845323|NCT05469750|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
153845324|NCT05469750|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153845325|NCT05469750|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153845326|NCT05469750|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
153845327|NCT05469750|Hormone Antagonists|hormone antagonists|mesh-ancestor
153845328|NCT05469750|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153845329|NCT05469750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153845330|NCT00537251|Insulin Glargine|insulin glargine|mesh-list
153845331|NCT00537251|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153845332|NCT00537251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153845333|NCT04319926|Lidocaine|lidocaine|mesh-list
153845334|NCT04319926|Anesthetics, Local|anesthetics, local|mesh-ancestor
153845335|NCT04319926|Anesthetics|anesthetics|mesh-ancestor
153845336|NCT04319926|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153845337|NCT04319926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153845338|NCT04319926|Sensory System Agents|sensory system agents|mesh-ancestor
153845339|NCT04319926|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153845340|NCT04319926|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153385468|NCT03881163|Antioxidants|antioxidants|mesh-ancestor
153385469|NCT03881163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153385470|NCT03881163|Protective Agents|protective agents|mesh-ancestor
153385471|NCT03881163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153385472|NCT03881163|Antidotes|antidotes|mesh-ancestor
153385473|NCT03848871|Betamethasone|betamethasone|mesh-list
153385474|NCT03848871|Betamethasone Valerate|betamethasone valerate|mesh-list
153385475|NCT03848871|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
153385476|NCT03848871|Betamethasone benzoate|betamethasone benzoate|mesh-list
153385477|NCT03848871|Calcipotriene|calcipotriene|mesh-list
153385478|NCT03848871|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
153385479|NCT03848871|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153385480|NCT03848871|Glucocorticoids|glucocorticoids|mesh-ancestor
153385481|NCT03848871|Hormones|hormones|mesh-ancestor
153385482|NCT03848871|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153385483|NCT03848871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153385484|NCT03848871|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153385485|NCT03848871|Respiratory System Agents|respiratory system agents|mesh-ancestor
153385486|NCT03848871|Dermatologic Agents|dermatologic agents|mesh-ancestor
153385487|NCT04032327|Bupivacaine|bupivacaine|mesh-list
153385488|NCT04032327|Anesthetics, Local|anesthetics, local|mesh-ancestor
153385489|NCT04032327|Anesthetics|anesthetics|mesh-ancestor
153845350|NCT01313923|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153845351|NCT01313923|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153845352|NCT01313923|Antifungal Agents|antifungal agents|mesh-ancestor
153845353|NCT01313923|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153845354|NCT01313923|Immunologic Factors|immunologic factors|mesh-ancestor
153845355|NCT01313923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153845356|NCT01313923|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153845357|NCT01313923|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153845358|NCT01313923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153845364|NCT01313884|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153845365|NCT01313884|Immunologic Factors|immunologic factors|mesh-ancestor
153845366|NCT01313884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153845367|NCT01313884|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153845368|NCT01313884|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153845372|NCT01313884|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153845373|NCT01313884|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153845374|NCT01313884|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153845375|NCT01313884|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153845376|NCT01313884|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153845377|NCT01313884|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
153845378|NCT01313884|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153845379|NCT01313884|Tubulin Modulators|tubulin modulators|mesh-ancestor
153845380|NCT01313884|Antimitotic Agents|antimitotic agents|mesh-ancestor
153845381|NCT01313884|Mitosis Modulators|mitosis modulators|mesh-ancestor
153845382|NCT00537524|Vaccines|vaccines|mesh-list
153845383|NCT00537524|Immunologic Factors|immunologic factors|mesh-ancestor
153845384|NCT00537524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153845385|NCT00537563|Telithromycin|telithromycin|mesh-list
153845386|NCT00537563|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153845387|NCT00537563|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153845388|NCT00537602|Miglustat|miglustat|mesh-list
153845389|NCT00537602|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153845390|NCT00537602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153385497|NCT04041219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153385498|NCT04041219|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
153385499|NCT04041219|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153385500|NCT04041219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153385501|NCT00552344|Certolizumab Pegol|certolizumab pegol|mesh-list
153385502|NCT00552344|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
153385503|NCT00552344|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153385508|NCT02814968|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
153385509|NCT02814968|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
153385510|NCT02814968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153385511|NCT03879603|Aluminum Hydroxide|aluminum hydroxide|mesh-list
153385512|NCT03879603|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153385513|NCT03879603|Immunologic Factors|immunologic factors|mesh-ancestor
153385514|NCT03879603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153385515|NCT03879603|Antacids|antacids|mesh-ancestor
153385516|NCT03879603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153385517|NCT03879603|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153385518|NCT00553514|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
153385519|NCT00553514|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
153385520|NCT00553514|Hormones|hormones|mesh-ancestor
153385521|NCT00553514|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153385522|NCT00553514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153385523|NCT00553514|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153385524|NCT02813642|Mitogens|mitogens|mesh-list
153385525|NCT02813642|Mitosis Modulators|mitosis modulators|mesh-ancestor
153385526|NCT02813642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153385527|NCT02542514|Ibrutinib|ibrutinib|mesh-list
153385528|NCT02542514|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153385529|NCT02542514|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153385530|NCT02542514|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153845391|NCT00537602|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153845392|NCT00537602|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153845393|NCT00537602|Antiviral Agents|antiviral agents|mesh-ancestor
153845394|NCT00537602|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153845395|NCT00537602|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
153845396|NCT00537602|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153845397|NCT00537602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153845398|NCT01259284|Atorvastatin|atorvastatin|mesh-list
153845399|NCT01259284|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153845400|NCT01259284|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153845401|NCT01259284|Antimetabolites|antimetabolites|mesh-ancestor
153845402|NCT01259284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153845403|NCT01259284|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153845404|NCT01259284|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
153845405|NCT01259284|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153845406|NCT03457025|Antiviral Agents|antiviral agents|mesh-list
153845407|NCT03457025|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153845408|NCT00537836|Estradiol|estradiol|mesh-list
153845409|NCT00537836|Estrogens|estrogens|mesh-ancestor
153845416|NCT02277171|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153845417|NCT02277171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153845418|NCT02277171|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153845419|NCT02277171|Respiratory System Agents|respiratory system agents|mesh-ancestor
153845420|NCT02277171|Free Radical Scavengers|free radical scavengers|mesh-ancestor
153845421|NCT02277171|Antioxidants|antioxidants|mesh-ancestor
153845422|NCT02277171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153845423|NCT02277171|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153845424|NCT02277171|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
153385531|NCT02542514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153385532|NCT03852537|Methylprednisolone|methylprednisolone|mesh-list
153385533|NCT03852537|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
153385534|NCT03852537|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
153385535|NCT03852537|Prednisolone|prednisolone|mesh-list
153385536|NCT03852537|Prednisolone acetate|prednisolone acetate|mesh-list
153385537|NCT03852537|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
153385538|NCT03852537|Prednisolone phosphate|prednisolone phosphate|mesh-list
153385539|NCT03852537|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153385540|NCT03852537|Antiemetics|antiemetics|mesh-ancestor
153385542|NCT03852537|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153385543|NCT03852537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153385544|NCT03852537|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153385545|NCT03852537|Glucocorticoids|glucocorticoids|mesh-ancestor
153385546|NCT03852537|Hormones|hormones|mesh-ancestor
153385547|NCT03852537|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153385548|NCT03852537|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
153385549|NCT03852537|Protective Agents|protective agents|mesh-ancestor
153385550|NCT03852537|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153385551|NCT03852537|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153385552|NCT03875859|Benzoic Acid|benzoic acid|mesh-list
153385553|NCT03875859|Antifungal Agents|antifungal agents|mesh-ancestor
153385554|NCT03875859|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153385555|NCT00553202|Cyclosporine|cyclosporine|mesh-list
153385556|NCT00553202|Methylprednisolone|methylprednisolone|mesh-list
153385557|NCT00553202|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
153385558|NCT00553202|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
153385559|NCT00553202|Prednisolone|prednisolone|mesh-list
153385560|NCT00553202|Prednisolone acetate|prednisolone acetate|mesh-list
153385561|NCT00553202|Cyclophosphamide|cyclophosphamide|mesh-list
153385562|NCT00553202|Busulfan|busulfan|mesh-list
153385563|NCT00553202|Methotrexate|methotrexate|mesh-list
153385564|NCT00553202|Tacrolimus|tacrolimus|mesh-list
153385565|NCT00553202|Cyclosporins|cyclosporins|mesh-list
153385566|NCT00553202|Thymoglobulin|thymoglobulin|mesh-list
153845425|NCT02277171|Vasodilator Agents|vasodilator agents|mesh-ancestor
153845426|NCT02277171|Gasotransmitters|gasotransmitters|mesh-ancestor
153845427|NCT02277171|Protective Agents|protective agents|mesh-ancestor
153845428|NCT00551564|Rosiglitazone|rosiglitazone|mesh-list
153845429|NCT00551564|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153845430|NCT00551564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153845431|NCT05105061|Ketamine|ketamine|mesh-list
153845432|NCT05105061|Analgesics|analgesics|mesh-ancestor
153845433|NCT05105061|Sensory System Agents|sensory system agents|mesh-ancestor
153845434|NCT05105061|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153845435|NCT05105061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153845436|NCT05105061|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
153845437|NCT05105061|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153845438|NCT05105061|Anesthetics, General|anesthetics, general|mesh-ancestor
153845439|NCT05105061|Anesthetics|anesthetics|mesh-ancestor
153845440|NCT05105061|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153845441|NCT05105061|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
153845442|NCT05105061|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
153845443|NCT05105061|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153845444|NCT05105061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153845446|NCT05056584|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153845447|NCT05056584|Hormones|hormones|mesh-ancestor
153845448|NCT05056584|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153845449|NCT05056584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153845450|NCT00551954|Acarbose|acarbose|mesh-list
153845451|NCT00551954|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
153845452|NCT00551954|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153845453|NCT00551954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153845454|NCT00551954|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153845455|NCT00551954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153845456|NCT00552149|Cetuximab|cetuximab|mesh-list
153845457|NCT00552149|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153845458|NCT00552149|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153845459|NCT05467878|Anesthetics|anesthetics|mesh-list
153845460|NCT05467878|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153845461|NCT05467878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153845462|NCT00536640|Bevacizumab|bevacizumab|mesh-list
153845463|NCT00536640|Gemcitabine|gemcitabine|mesh-list
153845464|NCT00536640|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
153385572|NCT00553202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153385587|NCT00553202|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153385588|NCT00553202|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
153385589|NCT00553202|Antifungal Agents|antifungal agents|mesh-ancestor
153385590|NCT00553202|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153385591|NCT00553202|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153845465|NCT00536640|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153845466|NCT00536640|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153845467|NCT00536640|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153845468|NCT00536640|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153845469|NCT00536640|Growth Substances|growth substances|mesh-ancestor
153845470|NCT00536640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153845471|NCT00536640|Growth Inhibitors|growth inhibitors|mesh-ancestor
153845472|NCT00536640|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153845473|NCT00536640|Antimetabolites|antimetabolites|mesh-ancestor
153845474|NCT00536640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153845475|NCT00536640|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153845476|NCT00536640|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153845477|NCT00536640|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153845478|NCT00552227|Ruboxistaurin|ruboxistaurin|mesh-list
153845479|NCT00552227|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153845480|NCT00552227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153845481|NCT01259089|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
153845482|NCT01259089|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153845483|NCT01259089|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153845484|NCT01259089|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153845485|NCT01259089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153845503|NCT04943757|Alkylating Agents|alkylating agents|mesh-ancestor
153845504|NCT04943757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153845505|NCT04943757|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153845506|NCT04943757|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153845507|NCT00552500|Valproic Acid|valproic acid|mesh-list
153845508|NCT00552500|Anticonvulsants|anticonvulsants|mesh-ancestor
153845509|NCT00552500|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153845510|NCT00552500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153845511|NCT00552500|GABA Agents|gaba agents|mesh-ancestor
153845512|NCT00552500|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153845513|NCT00552500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153845514|NCT00552500|Antimanic Agents|antimanic agents|mesh-ancestor
153845515|NCT00552500|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153385624|NCT00552110|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153385625|NCT00552110|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153385626|NCT00552110|Adrenergic Agents|adrenergic agents|mesh-ancestor
153385627|NCT00552110|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153385628|NCT00552110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153385629|NCT00552110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153385630|NCT00552110|Sympathomimetics|sympathomimetics|mesh-ancestor
153385631|NCT00552110|Autonomic Agents|autonomic agents|mesh-ancestor
153385632|NCT00552110|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153385633|NCT00552110|Nasal Decongestants|nasal decongestants|mesh-ancestor
153845516|NCT00552500|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153845517|NCT00552500|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153845519|NCT01258738|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-list
153845520|NCT01258738|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153845522|NCT01258738|Sensory System Agents|sensory system agents|mesh-ancestor
153845523|NCT01258738|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153845524|NCT01258738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153845525|NCT01258738|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153845526|NCT01258738|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153845527|NCT01258738|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153845528|NCT01258738|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153845529|NCT01258738|Immunologic Factors|immunologic factors|mesh-ancestor
153845530|NCT00552656|Sirolimus|sirolimus|mesh-list
153845531|NCT00552656|Temsirolimus|temsirolimus|mesh-list
153845532|NCT00552656|MTOR Inhibitors|mtor inhibitors|mesh-list
153845533|NCT00552656|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153845534|NCT00552656|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153845535|NCT00552656|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153845536|NCT00552656|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153845537|NCT00552656|Antifungal Agents|antifungal agents|mesh-ancestor
153845538|NCT00552656|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153845539|NCT00552656|Immunologic Factors|immunologic factors|mesh-ancestor
153845540|NCT00552656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153845544|NCT01824537|Vaccines|vaccines|mesh-list
153385675|NCT02351934|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153385676|NCT02351934|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153385677|NCT02351934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153385678|NCT02351934|Anticonvulsants|anticonvulsants|mesh-ancestor
153385679|NCT02351934|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153845550|NCT04863339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153385680|NCT02351934|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153845551|NCT04863339|Hemostatics|hemostatics|mesh-ancestor
153845552|NCT04863339|Coagulants|coagulants|mesh-ancestor
153845553|NCT04684277|Antidepressive Agents|antidepressive agents|mesh-list
153845554|NCT04684277|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153845555|NCT00552734|Insulin|insulin|mesh-list
153845556|NCT00552734|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
153845557|NCT00552734|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153845558|NCT00552734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153845559|NCT04543682|Iloprost|iloprost|mesh-list
153845560|NCT04543682|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153845561|NCT04543682|Vasodilator Agents|vasodilator agents|mesh-ancestor
153845562|NCT04802616|Broncho-Vaxom|broncho-vaxom|mesh-list
153845563|NCT04802616|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153845564|NCT04802616|Immunologic Factors|immunologic factors|mesh-ancestor
153845565|NCT04802616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153845566|NCT01258660|Folic Acid|folic acid|mesh-list
153845567|NCT01258660|Vitamin B Complex|vitamin b complex|mesh-list
153845568|NCT01258660|Drospirenone|drospirenone|mesh-list
153845569|NCT01258660|Hematinics|hematinics|mesh-ancestor
153845570|NCT01258660|Vitamins|vitamins|mesh-ancestor
153845571|NCT01258660|Micronutrients|micronutrients|mesh-ancestor
153845572|NCT01258660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153845573|NCT01258660|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
153845574|NCT01258660|Hormone Antagonists|hormone antagonists|mesh-ancestor
153845575|NCT01258660|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153845576|NCT01258660|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
153845577|NCT01258660|Diuretics|diuretics|mesh-ancestor
153845578|NCT01258660|Natriuretic Agents|natriuretic agents|mesh-ancestor
153845579|NCT04772274|Ustekinumab|ustekinumab|mesh-list
153845580|NCT04772274|Dermatologic Agents|dermatologic agents|mesh-ancestor
153845581|NCT04362527|Milrinone|milrinone|mesh-list
153845582|NCT04362527|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
153845584|NCT04362527|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153845585|NCT04362527|Vasodilator Agents|vasodilator agents|mesh-ancestor
153845586|NCT04362527|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
153845587|NCT04362527|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
153845588|NCT04362527|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153845589|NCT04362527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153845590|NCT04362527|Protective Agents|protective agents|mesh-ancestor
153845591|NCT04362527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153845592|NCT01614171|Hormones|hormones|mesh-list
153845593|NCT01614171|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153845594|NCT01614171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153845595|NCT05567367|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
153845596|NCT05567367|Vasodilator Agents|vasodilator agents|mesh-ancestor
153845597|NCT05567367|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
153845598|NCT05567367|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
153845599|NCT05567367|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153845600|NCT05567367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153845601|NCT05567367|Urological Agents|urological agents|mesh-ancestor
153845602|NCT04656951|Daratumumab|daratumumab|mesh-list
153845603|NCT04656951|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153385714|NCT04763408|Lenvatinib|lenvatinib|mesh-list
153385715|NCT04763408|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153385716|NCT04763408|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153385717|NCT04763408|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153385719|NCT03825939|Tranexamic Acid|tranexamic acid|mesh-list
153385737|NCT00551642|Free Radical Scavengers|free radical scavengers|mesh-ancestor
153385738|NCT00551642|Antioxidants|antioxidants|mesh-ancestor
153385739|NCT00551642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153385740|NCT00551642|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153385741|NCT00551642|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
153385742|NCT00551642|Vasodilator Agents|vasodilator agents|mesh-ancestor
153385743|NCT00551642|Gasotransmitters|gasotransmitters|mesh-ancestor
153385744|NCT00551642|Protective Agents|protective agents|mesh-ancestor
153385745|NCT02648282|Cyclophosphamide|cyclophosphamide|mesh-list
153845604|NCT04173533|Azacitidine|azacitidine|mesh-list
153845605|NCT04173533|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153385746|NCT02648282|Pembrolizumab|pembrolizumab|mesh-list
153385747|NCT02648282|Vaccines|vaccines|mesh-list
153385748|NCT02648282|Immunologic Factors|immunologic factors|mesh-ancestor
153845606|NCT04173533|Antimetabolites|antimetabolites|mesh-ancestor
153845607|NCT04173533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153845608|NCT04173533|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153845609|NCT04173533|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153845610|NCT01258348|Sunitinib|sunitinib|mesh-list
153845611|NCT01258348|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153845612|NCT01258348|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153845613|NCT01258348|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153845614|NCT01258348|Growth Substances|growth substances|mesh-ancestor
153845615|NCT01258348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153845616|NCT01258348|Growth Inhibitors|growth inhibitors|mesh-ancestor
153845617|NCT01258348|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153845618|NCT01258348|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153845619|NCT01258348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153845620|NCT01258075|Colesevelam Hydrochloride|colesevelam hydrochloride|mesh-list
153845621|NCT01258075|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153845622|NCT01258075|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153845623|NCT01258075|Antimetabolites|antimetabolites|mesh-ancestor
153845624|NCT01258075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153845625|NCT01258075|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153845626|NCT04687878|Insulin|insulin|mesh-list
153845632|NCT01256671|Immunologic Factors|immunologic factors|mesh-ancestor
153845633|NCT01256671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153845634|NCT04687566|Levomethorphan|levomethorphan|mesh-list
153845635|NCT04687566|Memantine|memantine|mesh-list
153845636|NCT04687566|Dextromethorphan|dextromethorphan|mesh-list
153845637|NCT04687566|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
153845638|NCT04687566|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
153845639|NCT04687566|Dopamine Agents|dopamine agents|mesh-ancestor
153845640|NCT04687566|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153845641|NCT04687566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153385752|NCT02648282|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153385753|NCT02648282|Alkylating Agents|alkylating agents|mesh-ancestor
153385754|NCT02648282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153385755|NCT02648282|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153385756|NCT02648282|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153385757|NCT02648282|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153385758|NCT02648282|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153385759|NCT04004481|Morphine|morphine|mesh-list
153385760|NCT04004481|Tramadol|tramadol|mesh-list
153385761|NCT04004481|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153385762|NCT04004481|Narcotics|narcotics|mesh-ancestor
153385763|NCT04004481|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153385764|NCT04004481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153385775|NCT03989427|Listerine|listerine|mesh-list
153845654|NCT01256476|Pitavastatin|pitavastatin|mesh-list
153845655|NCT01256476|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153845656|NCT01256476|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153845657|NCT01256476|Antimetabolites|antimetabolites|mesh-ancestor
153845658|NCT01256476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153845659|NCT01256476|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153845660|NCT01256476|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
153845664|NCT05507892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153845666|NCT05507892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153845667|NCT04106999|Dexmedetomidine|dexmedetomidine|mesh-list
153845668|NCT04106999|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153845669|NCT04106999|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153845670|NCT04106999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153845671|NCT04106999|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153845672|NCT04106999|Analgesics|analgesics|mesh-ancestor
153845673|NCT04106999|Sensory System Agents|sensory system agents|mesh-ancestor
153845674|NCT04106999|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153845675|NCT04106999|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
153845676|NCT04106999|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153845677|NCT04106999|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153845678|NCT04106999|Adrenergic Agents|adrenergic agents|mesh-ancestor
153845679|NCT04106999|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153845680|NCT04106999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153845681|NCT05003089|Prednisolone|prednisolone|mesh-list
153845682|NCT05003089|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153845683|NCT05003089|Glucocorticoids|glucocorticoids|mesh-ancestor
153845684|NCT05003089|Hormones|hormones|mesh-ancestor
153845685|NCT05003089|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153845686|NCT05003089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153385799|NCT02988362|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
153385800|NCT02988362|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
153385802|NCT02988440|Spartalizumab|spartalizumab|mesh-list
153385803|NCT02988440|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153385804|NCT02988440|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153385805|NCT02988440|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153385806|NCT02988440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153385807|NCT02988440|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153385808|NCT02988440|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153385809|NCT05405192|Dostarlimab|dostarlimab|mesh-list
153385810|NCT05405192|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153385811|NCT00550550|Fluticasone|fluticasone|mesh-list
153385812|NCT00550550|Mometasone Furoate|mometasone furoate|mesh-list
153385813|NCT00550550|Loratadine|loratadine|mesh-list
153385814|NCT00550550|Olopatadine Hydrochloride|olopatadine hydrochloride|mesh-list
153385815|NCT00550550|Prednisone|prednisone|mesh-list
153385816|NCT00550550|Albuterol|albuterol|mesh-list
153385817|NCT00550550|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153385818|NCT00550550|Glucocorticoids|glucocorticoids|mesh-ancestor
153385819|NCT00550550|Hormones|hormones|mesh-ancestor
153385820|NCT00550550|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153385821|NCT00550550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153385822|NCT00550550|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153385823|NCT00550550|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153385824|NCT00550550|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153385825|NCT00550550|Autonomic Agents|autonomic agents|mesh-ancestor
153845687|NCT05003089|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153845688|NCT05003089|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153845689|NCT04207021|Curcumin|curcumin|mesh-list
153385826|NCT00550550|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153385827|NCT00550550|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153845690|NCT04207021|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153845691|NCT04207021|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153845692|NCT04207021|Analgesics|analgesics|mesh-ancestor
153845693|NCT04207021|Sensory System Agents|sensory system agents|mesh-ancestor
153845696|NCT04207021|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153845697|NCT04207021|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153845698|NCT04207021|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153845699|NCT04207021|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153845700|NCT04207021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153845702|NCT01255423|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153845703|NCT01255423|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153845704|NCT01255423|Analgesics|analgesics|mesh-ancestor
153845705|NCT01255423|Sensory System Agents|sensory system agents|mesh-ancestor
153845713|NCT01255306|Brimonidine Tartrate|brimonidine tartrate|mesh-list
153845714|NCT01255306|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153845715|NCT01255306|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
153845716|NCT01255306|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153845717|NCT01255306|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153845718|NCT01255306|Adrenergic Agents|adrenergic agents|mesh-ancestor
153845719|NCT01255306|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153845720|NCT01255306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153845721|NCT01255306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153845722|NCT01254721|Quetiapine Fumarate|quetiapine fumarate|mesh-list
153845723|NCT01254721|Antidepressive Agents|antidepressive agents|mesh-ancestor
153845724|NCT01254721|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153385852|NCT01590680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153385853|NCT01590680|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
153385854|NCT02971839|Ivacaftor|ivacaftor|mesh-list
153385855|NCT02971839|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
153385856|NCT02971839|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153385857|NCT02971839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153385858|NCT02974803|Trametinib|trametinib|mesh-list
153385859|NCT02974803|Dabrafenib|dabrafenib|mesh-list
153385860|NCT02974803|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153385861|NCT02974803|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153385862|NCT02974803|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153385863|NCT02974803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153385864|NCT02281136|Aminolevulinic Acid|aminolevulinic acid|mesh-list
153385865|NCT02281136|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
153385866|NCT02281136|Dermatologic Agents|dermatologic agents|mesh-ancestor
153385867|NCT02301156|Ibrutinib|ibrutinib|mesh-list
153385868|NCT02301156|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153385869|NCT02301156|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153385870|NCT02301156|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153385871|NCT02301156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153385872|NCT00558038|Lactulose|lactulose|mesh-list
153385873|NCT00558038|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153385874|NCT01507233|Morphine|morphine|mesh-list
153385875|NCT01507233|Bupivacaine|bupivacaine|mesh-list
153385876|NCT01507233|Anesthetics, Local|anesthetics, local|mesh-ancestor
153385877|NCT01507233|Anesthetics|anesthetics|mesh-ancestor
153845731|NCT01254604|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
153845732|NCT01254604|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
153845733|NCT01254604|Adrenergic Agents|adrenergic agents|mesh-ancestor
153845734|NCT01254604|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153845735|NCT01254604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153845736|NCT01254604|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153845737|NCT01254604|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153845738|NCT04390698|Analgesics, Opioid|analgesics, opioid|mesh-list
153845739|NCT04390698|Anesthetics|anesthetics|mesh-list
153845740|NCT04390698|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153845744|NCT04390698|Sensory System Agents|sensory system agents|mesh-ancestor
153845745|NCT04390698|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153845747|NCT04673578|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153845748|NCT04673578|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153845749|NCT04673578|Analgesics|analgesics|mesh-ancestor
153845750|NCT04673578|Sensory System Agents|sensory system agents|mesh-ancestor
153845751|NCT04673578|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153845752|NCT04673578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153845753|NCT04673578|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153845754|NCT04673578|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153845755|NCT04673578|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
153845756|NCT04673578|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153845757|NCT04673578|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153845758|NCT04673578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153845759|NCT05414058|Methylphenidate|methylphenidate|mesh-list
153845760|NCT05414058|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
153845761|NCT05414058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153845762|NCT05414058|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
153385890|NCT02301390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153385892|NCT02301390|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
153385893|NCT02301390|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153385894|NCT02301390|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153385895|NCT02301390|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
153385896|NCT02301390|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
153385897|NCT02301390|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
153385898|NCT02278562|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
153385899|NCT02278562|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153385900|NCT00378417|Vaccines|vaccines|mesh-list
153385901|NCT00378417|Immunologic Factors|immunologic factors|mesh-ancestor
153385902|NCT00378417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153385903|NCT01487499|Cisplatin|cisplatin|mesh-list
153385904|NCT01487499|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153385905|NCT01483209|Botulinum Toxins|botulinum toxins|mesh-list
153385906|NCT01483209|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
153385907|NCT01483209|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
153385908|NCT01483209|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
153385909|NCT01483209|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153385910|NCT01483209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153845765|NCT05414058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153845766|NCT05414058|Dopamine Agents|dopamine agents|mesh-ancestor
153845767|NCT05414058|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153845768|NCT03757403|Mebendazole|mebendazole|mesh-list
153845769|NCT03757403|Piperazine|piperazine|mesh-list
153845770|NCT03757403|Piperazine citrate|piperazine citrate|mesh-list
153845771|NCT03757403|DMP 777|dmp 777|mesh-list
153845772|NCT03757403|Antinematodal Agents|antinematodal agents|mesh-ancestor
153845773|NCT03757403|Anthelmintics|anthelmintics|mesh-ancestor
153845774|NCT03757403|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153845775|NCT03757403|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153845776|NCT03757403|Tubulin Modulators|tubulin modulators|mesh-ancestor
153845777|NCT03757403|Antimitotic Agents|antimitotic agents|mesh-ancestor
153845778|NCT03757403|Mitosis Modulators|mitosis modulators|mesh-ancestor
153845779|NCT03757403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153845780|NCT03757403|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153845781|NCT03757403|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153845782|NCT00537342|Immunomodulating Agents|immunomodulating agents|mesh-list
153845783|NCT00537342|Immunologic Factors|immunologic factors|mesh-ancestor
153845784|NCT00537342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153845785|NCT00537420|Sibutramine|sibutramine|mesh-list
153845786|NCT00537420|Antidepressive Agents|antidepressive agents|mesh-ancestor
153845787|NCT00537420|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153845788|NCT00537420|Appetite Depressants|appetite depressants|mesh-ancestor
153845789|NCT00537420|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
153845790|NCT01254292|Levonorgestrel|levonorgestrel|mesh-list
153845791|NCT01254292|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
153845792|NCT01254292|Contraceptive Agents|contraceptive agents|mesh-ancestor
153845793|NCT01254292|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153385926|NCT02281448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153385927|NCT02281448|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
153385929|NCT00378729|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153385930|NCT00378729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153385931|NCT00378495|Miltefosine|miltefosine|mesh-list
153385932|NCT00378495|Antifungal Agents|antifungal agents|mesh-ancestor
153385933|NCT00378495|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153385934|NCT00378495|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153385935|NCT00378495|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153385936|NCT00378495|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153385937|NCT02281526|Eslicarbazepine acetate|eslicarbazepine acetate|mesh-list
153385938|NCT02281526|Anticonvulsants|anticonvulsants|mesh-ancestor
153385939|NCT02281526|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
153385940|NCT02281526|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153385943|NCT03802227|Oxycodone|oxycodone|mesh-list
153845806|NCT01253317|Mecasermin|mecasermin|mesh-list
153845807|NCT01253317|Growth Substances|growth substances|mesh-ancestor
153845808|NCT01253317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153845809|NCT00537537|Telbivudine|telbivudine|mesh-list
153845810|NCT00537537|Antiviral Agents|antiviral agents|mesh-ancestor
153845811|NCT00537537|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153845812|NCT00537537|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153845813|NCT00537537|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153845814|NCT00537537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153845815|NCT04319770|Hyaluronic Acid|hyaluronic acid|mesh-list
153845816|NCT04319770|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153845817|NCT04319770|Immunologic Factors|immunologic factors|mesh-ancestor
153845818|NCT04319770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153845843|NCT04320589|Analgesics|analgesics|mesh-ancestor
153845844|NCT04320589|Sensory System Agents|sensory system agents|mesh-ancestor
153845845|NCT04320589|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153845846|NCT04320589|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
153845847|NCT04320589|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153845848|NCT04320589|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153845849|NCT04320589|Adrenergic Agents|adrenergic agents|mesh-ancestor
153845850|NCT04320589|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153845851|NCT04320589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153845852|NCT04397692|Nitric Oxide|nitric oxide|mesh-list
153385965|NCT02746263|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153385966|NCT02746263|Narcotics|narcotics|mesh-ancestor
153385967|NCT02746263|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153385968|NCT02746263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153385969|NCT02746263|Analgesics|analgesics|mesh-ancestor
153385970|NCT02746263|Sensory System Agents|sensory system agents|mesh-ancestor
153385971|NCT02746263|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153385972|NCT02746263|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153385974|NCT01394211|Anastrozole|anastrozole|mesh-list
153385975|NCT01394211|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153385976|NCT01394211|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153385977|NCT01394211|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
153385978|NCT01394211|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153385981|NCT01394211|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
153385982|NCT01394211|Hormone Antagonists|hormone antagonists|mesh-ancestor
153385983|NCT01394211|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153385984|NCT01394211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153385987|NCT02717949|Ledipasvir|ledipasvir|mesh-list
153385988|NCT02717949|Antimetabolites|antimetabolites|mesh-ancestor
153385989|NCT02717949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153385990|NCT02717949|Antiviral Agents|antiviral agents|mesh-ancestor
153385991|NCT02717949|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153845853|NCT04397692|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153845854|NCT04397692|Autonomic Agents|autonomic agents|mesh-ancestor
153845855|NCT04397692|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153845856|NCT04397692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153845857|NCT04397692|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153845858|NCT04397692|Respiratory System Agents|respiratory system agents|mesh-ancestor
153845859|NCT04397692|Free Radical Scavengers|free radical scavengers|mesh-ancestor
153845860|NCT04397692|Antioxidants|antioxidants|mesh-ancestor
153845861|NCT04397692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153845862|NCT04397692|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153845863|NCT04397692|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
153845864|NCT04397692|Vasodilator Agents|vasodilator agents|mesh-ancestor
153845865|NCT04397692|Gasotransmitters|gasotransmitters|mesh-ancestor
153845866|NCT04397692|Protective Agents|protective agents|mesh-ancestor
153845867|NCT01252186|Contraceptive Agents|contraceptive agents|mesh-list
153845868|NCT01252186|Levonorgestrel|levonorgestrel|mesh-list
153845869|NCT01252186|Desogestrel|desogestrel|mesh-list
153845870|NCT01252186|Contraceptives, Oral|contraceptives, oral|mesh-list
153845871|NCT01252186|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153845872|NCT01252186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153845873|NCT01252186|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
153845874|NCT01252186|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
153845881|NCT01731782|Anesthetics, Local|anesthetics, local|mesh-ancestor
153845882|NCT01731782|Anesthetics|anesthetics|mesh-ancestor
153845883|NCT01731782|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153845884|NCT01731782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153845885|NCT01731782|Sensory System Agents|sensory system agents|mesh-ancestor
153845886|NCT01731782|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153845887|NCT01251952|Denileukin diftitox|denileukin diftitox|mesh-list
153845888|NCT01251952|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153845890|NCT04356430|Goserelin|goserelin|mesh-list
153845891|NCT04356430|Abiraterone Acetate|abiraterone acetate|mesh-list
153845892|NCT04356430|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153845893|NCT04356430|Glucocorticoids|glucocorticoids|mesh-ancestor
153845894|NCT04356430|Hormones|hormones|mesh-ancestor
153845895|NCT04356430|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153845896|NCT04356430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153845897|NCT04356430|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153845898|NCT04356430|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153845899|NCT04356430|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153386012|NCT01880840|Histamine Agents|histamine agents|mesh-ancestor
153386013|NCT01880840|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153386015|NCT01377441|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-list
153386016|NCT01377441|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
153386017|NCT01377441|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153386018|NCT01377441|Analgesics|analgesics|mesh-ancestor
153386019|NCT01377441|Sensory System Agents|sensory system agents|mesh-ancestor
153386022|NCT01377441|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153386044|NCT01882868|Micronutrients|micronutrients|mesh-ancestor
153386045|NCT01383447|Imatinib Mesylate|imatinib mesylate|mesh-list
153386046|NCT01383447|Entinostat|entinostat|mesh-list
153845900|NCT04356430|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153845901|NCT04356430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153845902|NCT04356430|Hormone Antagonists|hormone antagonists|mesh-ancestor
153845903|NCT04356430|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153845904|NCT04320238|Interferons|interferons|mesh-list
153845905|NCT04320238|Interferon-alpha|interferon-alpha|mesh-list
153845906|NCT04320238|Interferon-alfa-1b|interferon-alfa-1b|mesh-list
153845907|NCT04320238|Thymalfasin|thymalfasin|mesh-list
153845908|NCT04320238|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153845909|NCT04320238|Antiviral Agents|antiviral agents|mesh-ancestor
153845910|NCT04320238|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153845911|NCT04320238|Immunologic Factors|immunologic factors|mesh-ancestor
153845912|NCT04320238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153845913|NCT04320238|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153845914|NCT01229072|Heparin|heparin|mesh-list
153845915|NCT01229072|Calcium heparin|calcium heparin|mesh-list
153845916|NCT01229072|Anticoagulants|anticoagulants|mesh-ancestor
153845917|NCT01229072|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153845918|NCT01229072|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153845919|NCT01229072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153845920|NCT01199978|Losartan|losartan|mesh-list
153845921|NCT01199978|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153845922|NCT01199978|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153845926|NCT00532116|Selegiline|selegiline|mesh-list
153386059|NCT02300298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153386060|NCT02300298|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153386061|NCT02300298|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153386063|NCT02300220|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153386064|NCT02300220|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153386065|NCT02300220|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153386066|NCT02300220|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153386067|NCT02300220|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153386068|NCT02300220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153386069|NCT02300220|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153386070|NCT02300220|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
153386071|NCT02300220|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153386073|NCT01379469|Anticonvulsants|anticonvulsants|mesh-ancestor
153386074|NCT01379469|Antimanic Agents|antimanic agents|mesh-ancestor
153386075|NCT01379469|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153386076|NCT01379469|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153386077|NCT01379469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153386078|NCT01379469|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153845962|NCT04685148|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153845964|NCT02888548|Botulinum Toxins|botulinum toxins|mesh-list
153845965|NCT02888548|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
153845966|NCT02888548|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
153845967|NCT02888548|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
153845968|NCT02888548|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153845969|NCT02888548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153845970|NCT02888548|Cholinergic Agents|cholinergic agents|mesh-ancestor
153845971|NCT02888548|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153845972|NCT02888548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153845973|NCT02888548|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
153845974|NCT02888548|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153845975|NCT03888222|Bosutinib|bosutinib|mesh-list
153845976|NCT03888222|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153845977|NCT03888222|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153845978|NCT03888222|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153845979|NCT03888222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153845980|NCT03883893|Acetaminophen|acetaminophen|mesh-list
153845981|NCT03883893|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153845982|NCT03883893|Analgesics|analgesics|mesh-ancestor
153845983|NCT03883893|Sensory System Agents|sensory system agents|mesh-ancestor
153386098|NCT01309581|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153845984|NCT03883893|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153845985|NCT03883893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153845986|NCT03883893|Antipyretics|antipyretics|mesh-ancestor
153845987|NCT00537732|Omeprazole|omeprazole|mesh-list
153845988|NCT00537732|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
153845989|NCT00537732|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153845990|NCT00537732|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
153845991|NCT00537732|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153845992|NCT00537732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153845993|NCT04180436|Rivaroxaban|rivaroxaban|mesh-list
153845994|NCT04180436|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
153845995|NCT04180436|Antithrombins|antithrombins|mesh-ancestor
153845996|NCT04180436|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
153845997|NCT04180436|Protease Inhibitors|protease inhibitors|mesh-ancestor
153845998|NCT04180436|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153845999|NCT04180436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153846000|NCT04180436|Anticoagulants|anticoagulants|mesh-ancestor
153846001|NCT01250119|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
153846002|NCT01250119|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153846003|NCT01250119|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153846004|NCT01250119|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153846005|NCT01250119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153846006|NCT01250119|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153386121|NCT02987738|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
153386122|NCT02987738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153386123|NCT02987738|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153386124|NCT02987738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153386126|NCT01292265|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
153386127|NCT01292265|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153386128|NCT01292265|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153386129|NCT01292265|Immunologic Factors|immunologic factors|mesh-ancestor
153386130|NCT01292265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153386131|NCT01292265|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153386132|NCT01885910|Doxycycline|doxycycline|mesh-list
153386133|NCT01885910|Dapsone|dapsone|mesh-list
153386134|NCT01885910|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153386135|NCT01885910|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153386136|NCT01885910|Antimalarials|antimalarials|mesh-ancestor
153386137|NCT01885910|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153386138|NCT01885910|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153386139|NCT01885910|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153386140|NCT01885910|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153386141|NCT01885910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153386142|NCT01885910|Leprostatic Agents|leprostatic agents|mesh-ancestor
153386143|NCT02658357|Risperidone|risperidone|mesh-list
153386144|NCT02658357|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153386145|NCT02658357|Serotonin Agents|serotonin agents|mesh-ancestor
153386146|NCT02658357|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153386147|NCT02658357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153386148|NCT02658357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153846017|NCT04320277|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153846018|NCT04320277|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
153846019|NCT04320277|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153846020|NCT01250002|Lidocaine|lidocaine|mesh-list
153846021|NCT01250002|Anesthetics, Local|anesthetics, local|mesh-ancestor
153846022|NCT01250002|Anesthetics|anesthetics|mesh-ancestor
153846023|NCT01250002|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153846024|NCT01250002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153846025|NCT01250002|Sensory System Agents|sensory system agents|mesh-ancestor
153846026|NCT01250002|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153846027|NCT01250002|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153846028|NCT01250002|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
153846029|NCT01250002|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153846030|NCT01250002|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153846031|NCT01250002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153846032|NCT04157153|Sirolimus|sirolimus|mesh-list
153846033|NCT04157153|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153846034|NCT04157153|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153846035|NCT04157153|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153846036|NCT04157153|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153846037|NCT04157153|Antifungal Agents|antifungal agents|mesh-ancestor
153846038|NCT04157153|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153846039|NCT04157153|Immunologic Factors|immunologic factors|mesh-ancestor
153846040|NCT04157153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153846041|NCT05329116|Lidocaine|lidocaine|mesh-list
153846042|NCT05329116|Pentoxifylline|pentoxifylline|mesh-list
153846043|NCT05329116|Anesthetics, Local|anesthetics, local|mesh-ancestor
153846044|NCT05329116|Anesthetics|anesthetics|mesh-ancestor
153846045|NCT05329116|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153386162|NCT02988908|Nootropic Agents|nootropic agents|mesh-ancestor
153386175|NCT02349048|Simeprevir|simeprevir|mesh-list
153386176|NCT02349048|Antiviral Agents|antiviral agents|mesh-ancestor
153386177|NCT02349048|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153386178|NCT02349048|Protease Inhibitors|protease inhibitors|mesh-ancestor
153386179|NCT02349048|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153386180|NCT02349048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153386181|NCT01280643|Leucovorin|leucovorin|mesh-list
153386182|NCT01280643|Bevacizumab|bevacizumab|mesh-list
153386183|NCT01280643|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
153386184|NCT01280643|Cetuximab|cetuximab|mesh-list
153386185|NCT01280643|Capecitabine|capecitabine|mesh-list
153386186|NCT01280643|Fluorouracil|fluorouracil|mesh-list
153386187|NCT01280643|Oxaliplatin|oxaliplatin|mesh-list
153386188|NCT01280643|Irinotecan|irinotecan|mesh-list
153386189|NCT01280643|Antibodies|antibodies|mesh-list
153386190|NCT01280643|Immunoglobulins|immunoglobulins|mesh-list
153386191|NCT01280643|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
153846048|NCT05329116|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153846049|NCT05329116|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153846050|NCT05329116|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
153846051|NCT05329116|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153846052|NCT05329116|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153846053|NCT05329116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153846054|NCT05329116|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
153846055|NCT05329116|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153846056|NCT05329116|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153846057|NCT05329116|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
153846058|NCT05329116|Protective Agents|protective agents|mesh-ancestor
153846059|NCT05329116|Vasodilator Agents|vasodilator agents|mesh-ancestor
153846060|NCT05329116|Free Radical Scavengers|free radical scavengers|mesh-ancestor
153846061|NCT05329116|Antioxidants|antioxidants|mesh-ancestor
153846062|NCT00537888|Fluconazole|fluconazole|mesh-list
153846063|NCT00537888|Antifungal Agents|antifungal agents|mesh-ancestor
153846074|NCT00537888|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
153846075|NCT05264142|Voriconazole|voriconazole|mesh-list
153846076|NCT05264142|Fluvoxamine|fluvoxamine|mesh-list
153846077|NCT05264142|Omeprazole|omeprazole|mesh-list
153846078|NCT05264142|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
153846079|NCT05264142|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153846080|NCT05264142|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
153846081|NCT05264142|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153846082|NCT05264142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153846083|NCT05264142|Antifungal Agents|antifungal agents|mesh-ancestor
153846084|NCT05264142|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153846085|NCT05264142|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
153846086|NCT05264142|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153846087|NCT05264142|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153846088|NCT05264142|Hormone Antagonists|hormone antagonists|mesh-ancestor
153846089|NCT05264142|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153846090|NCT05264142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153386212|NCT01888952|Prednisone|prednisone|mesh-list
153386213|NCT01888952|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153386214|NCT01888952|Glucocorticoids|glucocorticoids|mesh-ancestor
153386215|NCT01888952|Hormones|hormones|mesh-ancestor
153386216|NCT01888952|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153386217|NCT01888952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153386218|NCT01888952|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153386219|NCT01888952|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153386220|NCT02299206|Zinc Oxide|zinc oxide|mesh-list
153386221|NCT02299206|Dermatologic Agents|dermatologic agents|mesh-ancestor
153386222|NCT02299206|Sunscreening Agents|sunscreening agents|mesh-ancestor
153386223|NCT02299206|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
153386224|NCT02299206|Protective Agents|protective agents|mesh-ancestor
153386226|NCT02640573|Hydroxyurea|hydroxyurea|mesh-list
153386238|NCT02298192|Hormones|hormones|mesh-ancestor
153386239|NCT02298192|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153386240|NCT01893632|Gabapentin|gabapentin|mesh-list
153386241|NCT01893632|Analgesics|analgesics|mesh-ancestor
153386242|NCT01893632|Sensory System Agents|sensory system agents|mesh-ancestor
153386243|NCT01893632|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153386244|NCT01893632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153386245|NCT01893632|Anticonvulsants|anticonvulsants|mesh-ancestor
153386246|NCT01893632|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153386247|NCT01893632|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153846091|NCT05264142|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
153846092|NCT05264142|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153846093|NCT05264142|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153846094|NCT05264142|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153846095|NCT05264142|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153846096|NCT05264142|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
153846097|NCT05264142|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153846098|NCT05264142|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153846099|NCT05264142|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153846100|NCT05264142|Serotonin Agents|serotonin agents|mesh-ancestor
153846101|NCT05264142|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
153846102|NCT05264142|Antidepressive Agents|antidepressive agents|mesh-ancestor
153846103|NCT05264142|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
153846104|NCT05264142|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
153846105|NCT01246960|Leucovorin|leucovorin|mesh-list
153846127|NCT00544986|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153846128|NCT00544986|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
153386250|NCT01893632|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
153386251|NCT01893632|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
153386252|NCT01893632|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153386253|NCT01893632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153386254|NCT01893632|Antimanic Agents|antimanic agents|mesh-ancestor
153386255|NCT01272141|Everolimus|everolimus|mesh-list
153386256|NCT01272141|Lapatinib|lapatinib|mesh-list
153386257|NCT01272141|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
153386258|NCT01272141|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153386259|NCT01272141|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153386260|NCT01272141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153386261|NCT01272141|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153386262|NCT01272141|Immunologic Factors|immunologic factors|mesh-ancestor
153386263|NCT01272141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153386264|NCT01272141|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153386265|NCT01272141|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153386267|NCT01895036|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
153386268|NCT01895036|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
153386269|NCT01895036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153386270|NCT01895036|Sensory System Agents|sensory system agents|mesh-ancestor
153386271|NCT01895036|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153386272|NCT03781479|Amifampridine|amifampridine|mesh-list
153386273|NCT03781479|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
153386274|NCT03781479|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153386275|NCT03781479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153846129|NCT00544986|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153846130|NCT00544986|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153846131|NCT00544986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153846132|NCT00544986|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
153846143|NCT01244620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153846144|NCT01244620|Urological Agents|urological agents|mesh-ancestor
153846145|NCT01244620|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
153846146|NCT04319692|Acetic Acid|acetic acid|mesh-list
153846147|NCT04319692|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153846148|NCT04319692|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153846149|NCT00545142|Valproic Acid|valproic acid|mesh-list
153846150|NCT00545142|Aripiprazole|aripiprazole|mesh-list
153846151|NCT00545142|Antidepressive Agents|antidepressive agents|mesh-ancestor
153846152|NCT00545142|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153846153|NCT00545142|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153846154|NCT00545142|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153846155|NCT00545142|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153846156|NCT00545142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153846157|NCT00545142|Dopamine Agonists|dopamine agonists|mesh-ancestor
153846158|NCT00545142|Dopamine Agents|dopamine agents|mesh-ancestor
153846159|NCT00545142|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153846160|NCT00545142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153846161|NCT00545142|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
153846162|NCT00545142|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
153846163|NCT00545142|Serotonin Agents|serotonin agents|mesh-ancestor
153846164|NCT00545142|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
153846165|NCT00545142|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153846166|NCT00545142|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
153846167|NCT00545142|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
153846168|NCT00545142|Anticonvulsants|anticonvulsants|mesh-ancestor
153846169|NCT00545142|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153846170|NCT00545142|GABA Agents|gaba agents|mesh-ancestor
153846171|NCT00545142|Antimanic Agents|antimanic agents|mesh-ancestor
153846172|NCT01267201|Methylprednisolone|methylprednisolone|mesh-list
153846173|NCT01267201|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
153846174|NCT01267201|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
153846175|NCT01267201|Prednisolone|prednisolone|mesh-list
153846176|NCT01267201|Prednisolone acetate|prednisolone acetate|mesh-list
153386300|NCT01189071|Darifenacin|darifenacin|mesh-list
153386301|NCT01189071|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
153386302|NCT01189071|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
153386303|NCT01189071|Cholinergic Agents|cholinergic agents|mesh-ancestor
153386304|NCT01189071|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153386305|NCT01189071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153386306|NCT01189071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153386307|NCT01189071|Urological Agents|urological agents|mesh-ancestor
153386308|NCT02515851|Bupivacaine|bupivacaine|mesh-list
153386309|NCT02515851|Anesthetics, Local|anesthetics, local|mesh-ancestor
153386310|NCT02515851|Anesthetics|anesthetics|mesh-ancestor
153386311|NCT02515851|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153386312|NCT02515851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153386313|NCT02515851|Sensory System Agents|sensory system agents|mesh-ancestor
153386314|NCT02515851|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153386315|NCT02492295|Propofol|propofol|mesh-list
153386316|NCT02492295|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153386317|NCT02492295|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153386318|NCT02492295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153386319|NCT02492295|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153846177|NCT01267201|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
153846178|NCT01267201|Prednisolone phosphate|prednisolone phosphate|mesh-list
153846179|NCT01267201|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153846180|NCT01267201|Antiemetics|antiemetics|mesh-ancestor
153846181|NCT01267201|Autonomic Agents|autonomic agents|mesh-ancestor
153846182|NCT01267201|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153846183|NCT01267201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153846184|NCT01267201|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153846185|NCT01267201|Glucocorticoids|glucocorticoids|mesh-ancestor
153846186|NCT01267201|Hormones|hormones|mesh-ancestor
153846203|NCT03736616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153846204|NCT03736616|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153846205|NCT03736616|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153846206|NCT03736616|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153846207|NCT03736616|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153846208|NCT03736616|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153846209|NCT03736616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153846210|NCT03736616|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153846211|NCT03736616|Antimetabolites|antimetabolites|mesh-ancestor
153846212|NCT03736616|Antiviral Agents|antiviral agents|mesh-ancestor
153846213|NCT03736616|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153846214|NCT03736616|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153846216|NCT03736616|Alkylating Agents|alkylating agents|mesh-ancestor
153846250|NCT00537966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153846251|NCT00537966|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153846252|NCT00537966|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153846253|NCT00537966|Antiviral Agents|antiviral agents|mesh-ancestor
153846254|NCT00537966|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153846255|NCT00537966|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
153846256|NCT00537966|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153846257|NCT00537966|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153846258|NCT00537966|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153846259|NCT00537966|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
153846260|NCT00537966|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
153846261|NCT01266967|Dabrafenib|dabrafenib|mesh-list
153846262|NCT01266967|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153846263|NCT01266967|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153846264|NCT01266967|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153846265|NCT01266967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153846266|NCT00538005|Bevacizumab|bevacizumab|mesh-list
153846267|NCT00538005|Oxaliplatin|oxaliplatin|mesh-list
153846268|NCT00538005|Sorafenib|sorafenib|mesh-list
153846269|NCT00538005|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153846270|NCT00538005|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153846271|NCT00538005|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153846272|NCT00538005|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153846273|NCT00538005|Growth Substances|growth substances|mesh-ancestor
153846275|NCT00538005|Growth Inhibitors|growth inhibitors|mesh-ancestor
153386414|NCT01085643|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153386415|NCT01085643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153386416|NCT03028766|Adavosertib|adavosertib|mesh-list
153386417|NCT03028766|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153386418|NCT03028766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153386419|NCT01071993|Atorvastatin|atorvastatin|mesh-list
153386420|NCT01071993|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153386421|NCT01071993|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153386422|NCT01071993|Antimetabolites|antimetabolites|mesh-ancestor
153386423|NCT01071993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153386424|NCT01071993|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153386425|NCT01071993|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
153386426|NCT01071993|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153386427|NCT03756818|Paclitaxel|paclitaxel|mesh-list
153386428|NCT03756818|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
153386429|NCT03756818|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-list
153386430|NCT03756818|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153386431|NCT03756818|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153386432|NCT03756818|Tubulin Modulators|tubulin modulators|mesh-ancestor
153386433|NCT03756818|Antimitotic Agents|antimitotic agents|mesh-ancestor
153386434|NCT03756818|Mitosis Modulators|mitosis modulators|mesh-ancestor
153386435|NCT03756818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153386436|NCT03756818|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153846287|NCT00538044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153846288|NCT00538044|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153846289|NCT00538044|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
153846291|NCT00545493|Tacrolimus|tacrolimus|mesh-list
153846308|NCT01266265|Treprostinil|treprostinil|mesh-list
153846309|NCT01266265|Bosentan|bosentan|mesh-list
153846310|NCT01266265|Ambrisentan|ambrisentan|mesh-list
153846324|NCT01266265|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153846325|NCT01266148|Cyclosporine|cyclosporine|mesh-list
153846326|NCT01266148|Mycophenolic Acid|mycophenolic acid|mesh-list
153386440|NCT01065051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153386442|NCT02379585|Docetaxel|docetaxel|mesh-list
153386443|NCT02379585|Cyclophosphamide|cyclophosphamide|mesh-list
153386444|NCT02379585|Doxorubicin|doxorubicin|mesh-list
153386445|NCT02379585|Trastuzumab|trastuzumab|mesh-list
153386446|NCT02379585|Pertuzumab|pertuzumab|mesh-list
153386447|NCT02379585|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153386448|NCT02379585|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153386449|NCT02379585|Tubulin Modulators|tubulin modulators|mesh-ancestor
153386450|NCT02379585|Antimitotic Agents|antimitotic agents|mesh-ancestor
153386451|NCT02379585|Mitosis Modulators|mitosis modulators|mesh-ancestor
153386454|NCT02379585|Immunologic Factors|immunologic factors|mesh-ancestor
153386472|NCT01048125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153386473|NCT01048125|Sympathomimetics|sympathomimetics|mesh-ancestor
153846328|NCT01266148|Cyclosporins|cyclosporins|mesh-list
153846329|NCT01266148|Antilymphocyte Serum|antilymphocyte serum|mesh-list
153846330|NCT01266148|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153846331|NCT01266148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153846332|NCT01266148|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153846333|NCT01266148|Immunologic Factors|immunologic factors|mesh-ancestor
153846334|NCT01266148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153846335|NCT01266148|Antifungal Agents|antifungal agents|mesh-ancestor
153846336|NCT01266148|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153846337|NCT01266148|Dermatologic Agents|dermatologic agents|mesh-ancestor
153846338|NCT01266148|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153846339|NCT01266148|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
153846340|NCT01266148|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
153846341|NCT01266148|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153846342|NCT01266148|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153846343|NCT01266148|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153846344|NCT01266148|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
153846345|NCT01266148|Antitubercular Agents|antitubercular agents|mesh-ancestor
153846346|NCT01266148|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153846347|NCT00538239|Sirolimus|sirolimus|mesh-list
153846348|NCT00538239|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153846349|NCT00538239|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153846350|NCT00538239|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153846351|NCT00538239|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153846352|NCT00538239|Antifungal Agents|antifungal agents|mesh-ancestor
153846353|NCT00538239|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153846354|NCT00538239|Immunologic Factors|immunologic factors|mesh-ancestor
153846355|NCT00538239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153846357|NCT00538317|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153846358|NCT00538317|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153846363|NCT01265953|Protective Agents|protective agents|mesh-ancestor
153846364|NCT01265953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153846365|NCT01265953|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153846367|NCT01265875|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153846368|NCT01265875|Hormones|hormones|mesh-ancestor
153846369|NCT01265875|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153846370|NCT01265875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153846371|NCT00538395|Cyclophosphamide|cyclophosphamide|mesh-list
153846372|NCT00538395|Doxorubicin|doxorubicin|mesh-list
153846373|NCT00538395|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
153846374|NCT00538395|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153846375|NCT00538395|Immunologic Factors|immunologic factors|mesh-ancestor
153846376|NCT00538395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153846377|NCT00538395|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153846385|NCT00538395|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153846386|NCT00538395|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153846387|NCT01265563|Acetylcysteine|acetylcysteine|mesh-list
153846388|NCT01265563|Silybin|silybin|mesh-list
153846392|NCT01265563|Expectorants|expectorants|mesh-ancestor
153386515|NCT01902758|Theophylline|theophylline|mesh-list
153386516|NCT01902758|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153386517|NCT01902758|Autonomic Agents|autonomic agents|mesh-ancestor
153386518|NCT01902758|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153386519|NCT01902758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153386520|NCT01902758|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153386521|NCT01902758|Respiratory System Agents|respiratory system agents|mesh-ancestor
153386522|NCT01902758|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
153386523|NCT01902758|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153386524|NCT01902758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153386525|NCT01902758|Vasodilator Agents|vasodilator agents|mesh-ancestor
153386526|NCT01902758|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
153386527|NCT01902758|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
153386528|NCT01902758|Purinergic Agents|purinergic agents|mesh-ancestor
153386529|NCT01902758|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153386530|NCT01902758|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153386531|NCT02318901|Pembrolizumab|pembrolizumab|mesh-list
153386532|NCT02318901|Trastuzumab|trastuzumab|mesh-list
153846397|NCT01265563|Protective Agents|protective agents|mesh-ancestor
153846398|NCT01265563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153846399|NCT01265563|Antidotes|antidotes|mesh-ancestor
153846400|NCT01265563|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153846401|NCT01265563|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153846402|NCT01265056|Gabapentin|gabapentin|mesh-list
153846403|NCT01265056|Analgesics|analgesics|mesh-ancestor
153846404|NCT01265056|Sensory System Agents|sensory system agents|mesh-ancestor
153846405|NCT01265056|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153846427|NCT00545961|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
153846428|NCT00545961|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153846429|NCT00545961|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153846430|NCT00545961|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
153846431|NCT00545961|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153846432|NCT00545961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153846433|NCT01264939|Omalizumab|omalizumab|mesh-list
153846434|NCT01264939|Diphenhydramine|diphenhydramine|mesh-list
153846435|NCT01264939|Promethazine|promethazine|mesh-list
153846436|NCT01264939|Leukotriene Antagonists|leukotriene antagonists|mesh-list
153846437|NCT01264939|Histamine H1 Antagonists|histamine h1 antagonists|mesh-list
153846438|NCT01264939|Histamine Antagonists|histamine antagonists|mesh-list
153846439|NCT01264939|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
153846440|NCT01264939|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153846441|NCT01264939|Respiratory System Agents|respiratory system agents|mesh-ancestor
153846442|NCT01264939|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
153846443|NCT01264939|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153846444|NCT01264939|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153846445|NCT01264939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153386558|NCT01016847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153386559|NCT01016847|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
153386560|NCT01016847|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
153386561|NCT01016847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153386563|NCT00989937|Oxytocics|oxytocics|mesh-ancestor
153386564|NCT00989937|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153386565|NCT00989937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153386566|NCT00982995|Palonosetron|palonosetron|mesh-list
153386575|NCT00982995|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153386576|NCT00982995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153386578|NCT00965055|Ezetimibe|ezetimibe|mesh-list
153386579|NCT00965055|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153386580|NCT00965055|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153386581|NCT00965055|Antimetabolites|antimetabolites|mesh-ancestor
153386582|NCT00965055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153846446|NCT01264939|Anesthetics, Local|anesthetics, local|mesh-ancestor
153846447|NCT01264939|Anesthetics|anesthetics|mesh-ancestor
153846448|NCT01264939|Sensory System Agents|sensory system agents|mesh-ancestor
153846449|NCT01264939|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153846450|NCT01264939|Antiemetics|antiemetics|mesh-ancestor
153846451|NCT01264939|Autonomic Agents|autonomic agents|mesh-ancestor
153846452|NCT01264939|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153846453|NCT01264939|Histamine Agents|histamine agents|mesh-ancestor
153846454|NCT01264939|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153846455|NCT01264939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153846456|NCT01264939|Antipruritics|antipruritics|mesh-ancestor
153846457|NCT01264939|Dermatologic Agents|dermatologic agents|mesh-ancestor
153846458|NCT01264939|Hormone Antagonists|hormone antagonists|mesh-ancestor
153846459|NCT01264939|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153846474|NCT00546039|Hormones|hormones|mesh-ancestor
153846475|NCT00546039|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153846476|NCT01264081|Lapatinib|lapatinib|mesh-list
153846477|NCT01264081|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153846478|NCT01264081|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153846479|NCT01264081|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153846480|NCT01264081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153846481|NCT01264081|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153846482|NCT02711969|Apatinib|apatinib|mesh-list
153846483|NCT02711969|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153846484|NCT02711969|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153846485|NCT02711969|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153846486|NCT02711969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153846487|NCT01263925|Pentoxifylline|pentoxifylline|mesh-list
153846488|NCT01263925|Alprostadil|alprostadil|mesh-list
153846489|NCT01263925|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
153846490|NCT01263925|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153846491|NCT01263925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153846492|NCT01263925|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153846493|NCT01263925|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
153386606|NCT00378183|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153386608|NCT00378183|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
153386609|NCT00378183|Dopamine Agents|dopamine agents|mesh-ancestor
153386610|NCT01906658|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
153386611|NCT01906658|Hormones|hormones|mesh-ancestor
153386612|NCT01906658|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153386613|NCT01906658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153386614|NCT01908062|Naltrexone|naltrexone|mesh-list
153386615|NCT01908062|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
153386616|NCT01908062|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
153386617|NCT01908062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153386618|NCT01908062|Sensory System Agents|sensory system agents|mesh-ancestor
153386619|NCT01908062|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153386626|NCT00924807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153386628|NCT00924807|Fertility Agents|fertility agents|mesh-ancestor
153846494|NCT01263925|Protective Agents|protective agents|mesh-ancestor
153846495|NCT01263925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153846496|NCT01263925|Vasodilator Agents|vasodilator agents|mesh-ancestor
153846497|NCT01263925|Free Radical Scavengers|free radical scavengers|mesh-ancestor
153846498|NCT01263925|Antioxidants|antioxidants|mesh-ancestor
153846499|NCT01263925|Urological Agents|urological agents|mesh-ancestor
153846500|NCT04323631|Hydroxychloroquine|hydroxychloroquine|mesh-list
153846501|NCT04323631|Antimalarials|antimalarials|mesh-ancestor
153846502|NCT04323631|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153846503|NCT04323631|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153846504|NCT04323631|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153846505|NCT04323631|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153846506|NCT04323631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153846507|NCT04323631|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153846508|NCT00546234|Tiotropium Bromide|tiotropium bromide|mesh-list
153846509|NCT00546234|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153846510|NCT00546234|Autonomic Agents|autonomic agents|mesh-ancestor
153846511|NCT00546234|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153846512|NCT00546234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153846513|NCT00546234|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153846514|NCT00546234|Respiratory System Agents|respiratory system agents|mesh-ancestor
153846515|NCT00546234|Parasympatholytics|parasympatholytics|mesh-ancestor
153846516|NCT00546234|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
153846517|NCT00546234|Cholinergic Agents|cholinergic agents|mesh-ancestor
153846518|NCT00546234|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153846519|NCT00546234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153846520|NCT02623439|Cyclophosphamide|cyclophosphamide|mesh-list
153846521|NCT02623439|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153846522|NCT02623439|Immunologic Factors|immunologic factors|mesh-ancestor
153846523|NCT02623439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153846525|NCT02623439|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153846531|NCT00539331|Carboplatin|carboplatin|mesh-list
153846533|NCT00539331|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153846534|NCT00539331|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153846535|NCT00539331|Tubulin Modulators|tubulin modulators|mesh-ancestor
153846536|NCT00539331|Antimitotic Agents|antimitotic agents|mesh-ancestor
153846537|NCT00539331|Mitosis Modulators|mitosis modulators|mesh-ancestor
153846538|NCT00539331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153846539|NCT00539331|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153846540|NCT00539331|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153846541|NCT02236013|Cytarabine|cytarabine|mesh-list
153846542|NCT02236013|Daunorubicin|daunorubicin|mesh-list
153846543|NCT02236013|Idarubicin|idarubicin|mesh-list
153846544|NCT02236013|Gilteritinib|gilteritinib|mesh-list
153846545|NCT02236013|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153846546|NCT02236013|Antimetabolites|antimetabolites|mesh-ancestor
153386658|NCT01908842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153386659|NCT01908842|Analgesics|analgesics|mesh-ancestor
153386660|NCT01908842|Sensory System Agents|sensory system agents|mesh-ancestor
153386661|NCT01908842|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153386662|NCT01908842|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
153386663|NCT00833859|Gemcitabine|gemcitabine|mesh-list
153386664|NCT00833859|Capecitabine|capecitabine|mesh-list
153386665|NCT00833859|Docetaxel|docetaxel|mesh-list
153386666|NCT00833859|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153386667|NCT00833859|Antimetabolites|antimetabolites|mesh-ancestor
153386668|NCT00833859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153386669|NCT00833859|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153386673|NCT00832299|Leucovorin|leucovorin|mesh-list
153846547|NCT02236013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153846548|NCT02236013|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153846550|NCT02236013|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153888344|NCT01100944|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153888345|NCT01100944|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153888346|NCT01100944|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
153888347|NCT01100320|Oxycodone|oxycodone|mesh-list
153888348|NCT01100320|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153888349|NCT01100320|Narcotics|narcotics|mesh-ancestor
153888350|NCT01100320|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153888351|NCT01100320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153888352|NCT01100320|Analgesics|analgesics|mesh-ancestor
153888353|NCT01100320|Sensory System Agents|sensory system agents|mesh-ancestor
153888354|NCT01100320|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153846561|NCT00539409|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
153846562|NCT00539409|Insulin Aspart|insulin aspart|mesh-list
153846563|NCT00539409|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153846564|NCT00539409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153846565|NCT02178410|Vitamin D|vitamin d|mesh-list
153846566|NCT02178410|Ergocalciferols|ergocalciferols|mesh-list
153846567|NCT02178410|Cholecalciferol|cholecalciferol|mesh-list
153846568|NCT02178410|Vitamins|vitamins|mesh-list
153846569|NCT02178410|Micronutrients|micronutrients|mesh-ancestor
153846570|NCT02178410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153846571|NCT02178410|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153846572|NCT02178410|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153386684|NCT00832299|Protective Agents|protective agents|mesh-ancestor
153386685|NCT00832299|Vitamin B Complex|vitamin b complex|mesh-ancestor
153386687|NCT00832299|Micronutrients|micronutrients|mesh-ancestor
153386688|NCT03723447|Dexamethasone|dexamethasone|mesh-list
153386689|NCT03723447|Epinephrine|epinephrine|mesh-list
153386690|NCT03723447|Bupivacaine|bupivacaine|mesh-list
153386691|NCT03723447|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153386692|NCT03723447|Antiemetics|antiemetics|mesh-ancestor
153386693|NCT03723447|Autonomic Agents|autonomic agents|mesh-ancestor
153386694|NCT03723447|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153386695|NCT03723447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153386696|NCT03723447|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153386697|NCT03723447|Glucocorticoids|glucocorticoids|mesh-ancestor
153386699|NCT03723447|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153386700|NCT03723447|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153386701|NCT03723447|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153386702|NCT03723447|Anesthetics, Local|anesthetics, local|mesh-ancestor
153386703|NCT03723447|Anesthetics|anesthetics|mesh-ancestor
153386704|NCT03723447|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153386705|NCT03723447|Sensory System Agents|sensory system agents|mesh-ancestor
153386706|NCT03723447|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153386707|NCT03723447|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153386708|NCT03723447|Adrenergic Agents|adrenergic agents|mesh-ancestor
153386709|NCT03723447|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153846594|NCT01540253|Tubulin Modulators|tubulin modulators|mesh-ancestor
153846595|NCT01540253|Antimitotic Agents|antimitotic agents|mesh-ancestor
153846596|NCT01540253|Mitosis Modulators|mitosis modulators|mesh-ancestor
153846597|NCT01540253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153846598|NCT01497392|Gemcitabine|gemcitabine|mesh-list
153846599|NCT01497392|Capecitabine|capecitabine|mesh-list
153846600|NCT01497392|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-list
153846601|NCT01497392|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153846602|NCT01497392|Antimetabolites|antimetabolites|mesh-ancestor
153846603|NCT01497392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153846604|NCT01497392|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153846605|NCT01497392|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153846606|NCT01497392|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153846607|NCT01310192|Choline|choline|mesh-list
153846608|NCT01310192|Lipotropic Agents|lipotropic agents|mesh-ancestor
153846609|NCT01310192|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153846610|NCT01310192|Antimetabolites|antimetabolites|mesh-ancestor
153386722|NCT00836355|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153386723|NCT00836355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153386724|NCT00836355|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153386725|NCT00836355|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153386726|NCT00816777|Irinotecan|irinotecan|mesh-list
153846611|NCT01310192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153846612|NCT01310192|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153846613|NCT01310192|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153846614|NCT01310192|Nootropic Agents|nootropic agents|mesh-ancestor
153846615|NCT00539565|Prednisolone|prednisolone|mesh-list
153846616|NCT00539565|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153846617|NCT00539565|Glucocorticoids|glucocorticoids|mesh-ancestor
153846618|NCT00539565|Hormones|hormones|mesh-ancestor
153846619|NCT00539565|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153846620|NCT00539565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153846621|NCT00539565|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153846622|NCT00539565|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153846623|NCT00539799|Prednisolone|prednisolone|mesh-list
153846624|NCT00539799|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153846625|NCT00539799|Glucocorticoids|glucocorticoids|mesh-ancestor
153846626|NCT00539799|Hormones|hormones|mesh-ancestor
153846627|NCT00539799|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153846628|NCT00539799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153846629|NCT00539799|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153386763|NCT00760461|Autonomic Agents|autonomic agents|mesh-ancestor
153386764|NCT00760461|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153386765|NCT00760461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153386766|NCT00760461|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153386767|NCT00760461|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
153386768|NCT00760461|Dopamine Agents|dopamine agents|mesh-ancestor
153386769|NCT00760461|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153386791|NCT01901679|Celecoxib|celecoxib|mesh-list
153846637|NCT00546507|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153888355|NCT04309708|Nimodipine|nimodipine|mesh-list
153888356|NCT04309708|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153888357|NCT04309708|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153888358|NCT04309708|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153888359|NCT04309708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153888360|NCT04309708|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153888361|NCT04309708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153846638|NCT00546507|Analgesics|analgesics|mesh-ancestor
153846639|NCT00546507|Sensory System Agents|sensory system agents|mesh-ancestor
153846640|NCT00546507|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153888362|NCT04309708|Vasodilator Agents|vasodilator agents|mesh-ancestor
153846641|NCT00546507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153846642|NCT00546507|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153846643|NCT00546507|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153846644|NCT00546507|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
153846645|NCT00546507|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153846646|NCT00546507|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153846647|NCT00546507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153846684|NCT02581007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153888363|NCT01100086|Oxycodone|oxycodone|mesh-list
153888364|NCT01100086|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153846685|NCT02581007|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153846686|NCT02581007|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153386797|NCT01901679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153386798|NCT01901679|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153386799|NCT01901679|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153386800|NCT01901679|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
153386801|NCT01901679|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153386802|NCT01901679|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153386803|NCT01901679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153386804|NCT00688935|Melatonin|melatonin|mesh-list
153888365|NCT01100086|Narcotics|narcotics|mesh-ancestor
153888366|NCT01100086|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153888367|NCT01100086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153888368|NCT01100086|Analgesics|analgesics|mesh-ancestor
153888369|NCT01100086|Sensory System Agents|sensory system agents|mesh-ancestor
153888370|NCT01100086|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153386805|NCT00688935|Antioxidants|antioxidants|mesh-ancestor
153386806|NCT00688935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153386807|NCT00688935|Protective Agents|protective agents|mesh-ancestor
153386808|NCT00688935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153386809|NCT00688935|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153846713|NCT01263496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153846714|NCT01263496|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
153846715|NCT04681937|Methylprednisolone|methylprednisolone|mesh-list
153846716|NCT04681937|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
153846717|NCT04681937|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
153846719|NCT04681937|Prednisolone acetate|prednisolone acetate|mesh-list
153846720|NCT04681937|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
153386831|NCT01856361|Protease Inhibitors|protease inhibitors|mesh-ancestor
153386832|NCT01856361|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153386833|NCT01856361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153386834|NCT01856361|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153386835|NCT00642603|Bevacizumab|bevacizumab|mesh-list
153386836|NCT00642603|Capecitabine|capecitabine|mesh-list
153386837|NCT00642603|Oxaliplatin|oxaliplatin|mesh-list
153386838|NCT00642603|Irinotecan|irinotecan|mesh-list
153386839|NCT00642603|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153846721|NCT04681937|Prednisolone phosphate|prednisolone phosphate|mesh-list
153846722|NCT04681937|Hyaluronic Acid|hyaluronic acid|mesh-list
153846723|NCT04681937|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153846724|NCT04681937|Antiemetics|antiemetics|mesh-ancestor
153846725|NCT04681937|Autonomic Agents|autonomic agents|mesh-ancestor
153846726|NCT04681937|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153846727|NCT04681937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153846728|NCT04681937|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153846729|NCT04681937|Glucocorticoids|glucocorticoids|mesh-ancestor
153846730|NCT04681937|Hormones|hormones|mesh-ancestor
153846731|NCT04681937|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153846732|NCT04681937|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
153846733|NCT04681937|Protective Agents|protective agents|mesh-ancestor
153846734|NCT04681937|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153846735|NCT04681937|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153846736|NCT04681937|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153846737|NCT04681937|Immunologic Factors|immunologic factors|mesh-ancestor
153846738|NCT04681937|Viscosupplements|viscosupplements|mesh-ancestor
153846739|NCT00547053|Amiloride|amiloride|mesh-list
153846740|NCT00547053|Diuretics|diuretics|mesh-ancestor
153846741|NCT00547053|Natriuretic Agents|natriuretic agents|mesh-ancestor
153846742|NCT00547053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153846743|NCT00547053|Acid Sensing Ion Channel Blockers|acid sensing ion channel blockers|mesh-ancestor
153846744|NCT00547053|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153846745|NCT00547053|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153386857|NCT01841931|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153386858|NCT01841931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153386860|NCT01841931|Sensory System Agents|sensory system agents|mesh-ancestor
153386861|NCT01841931|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153386862|NCT01841931|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
153386863|NCT04713891|Atezolizumab|atezolizumab|mesh-list
153386864|NCT04713891|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
153386865|NCT04713891|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153386866|NCT04713891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153386867|NCT04713891|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153386868|NCT04713891|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153386869|NCT04713891|Immunologic Factors|immunologic factors|mesh-ancestor
153386870|NCT04713891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153386872|NCT00379509|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153386873|NCT00379509|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153386874|NCT00379509|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153386875|NCT00379509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153386876|NCT00379509|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153386877|NCT04706247|Anesthetics|anesthetics|mesh-list
153386878|NCT04706247|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153386879|NCT04706247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153386880|NCT00597909|Sodium Benzoate|sodium benzoate|mesh-list
153386881|NCT00597909|Phenylacetic acid|phenylacetic acid|mesh-list
153386882|NCT00597909|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153386883|NCT00597909|Antimetabolites|antimetabolites|mesh-ancestor
153386884|NCT00597909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153386885|NCT00597909|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153386886|NCT00597909|Antifungal Agents|antifungal agents|mesh-ancestor
153386888|NCT00422955|Rosiglitazone|rosiglitazone|mesh-list
153846746|NCT00547053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153846747|NCT00547053|Epithelial Sodium Channel Blockers|epithelial sodium channel blockers|mesh-ancestor
153846748|NCT00547053|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
153846749|NCT00547092|Sildenafil Citrate|sildenafil citrate|mesh-list
153846750|NCT00547092|Tadalafil|tadalafil|mesh-list
153888371|NCT01297959|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
153846751|NCT00547092|Vasodilator Agents|vasodilator agents|mesh-ancestor
153846752|NCT00547092|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
153846753|NCT00547092|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
153846754|NCT00547092|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153846755|NCT00547092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153846756|NCT00547092|Urological Agents|urological agents|mesh-ancestor
153846757|NCT00547131|Temozolomide|temozolomide|mesh-list
153846758|NCT00547131|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153846759|NCT00547131|Alkylating Agents|alkylating agents|mesh-ancestor
153846760|NCT00547131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153846761|NCT00547131|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153846762|NCT01964495|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
153846763|NCT01964495|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
153846764|NCT01964495|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153846765|NCT01964495|Antitubercular Agents|antitubercular agents|mesh-ancestor
153846766|NCT00547170|Doxycycline|doxycycline|mesh-list
153846767|NCT00547170|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153846768|NCT00547170|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153386895|NCT00588471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153386896|NCT00588471|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153386897|NCT00588471|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
153386898|NCT00588471|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153386899|NCT05600673|Bimatoprost|bimatoprost|mesh-list
153386900|NCT05600673|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153386901|NCT01784991|Morphine|morphine|mesh-list
153386902|NCT01784991|Hydromorphone|hydromorphone|mesh-list
153386903|NCT01784991|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153386904|NCT01784991|Narcotics|narcotics|mesh-ancestor
153386905|NCT01784991|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153386906|NCT01784991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153386907|NCT01784991|Analgesics|analgesics|mesh-ancestor
153386908|NCT01784991|Sensory System Agents|sensory system agents|mesh-ancestor
153386909|NCT01784991|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153386910|NCT01760889|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
153386911|NCT01760889|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
153386912|NCT01760889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153386913|NCT01760889|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
153386914|NCT01760889|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153386915|NCT01760889|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153386916|NCT01760889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153386917|NCT01760889|Dopamine Agents|dopamine agents|mesh-ancestor
153386918|NCT01760889|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153386919|NCT05600517|Fluorides|fluorides|mesh-list
153386920|NCT05600517|Cariostatic Agents|cariostatic agents|mesh-ancestor
153386921|NCT05600517|Protective Agents|protective agents|mesh-ancestor
153888372|NCT00626080|Insulin|insulin|mesh-list
153386922|NCT05600517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153386923|NCT01745913|Fludarabine|fludarabine|mesh-list
153888373|NCT00626080|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
153888374|NCT00626080|Insulin Detemir|insulin detemir|mesh-list
153888375|NCT00626080|Isophane Insulin, Human|isophane insulin, human|mesh-list
153888376|NCT00626080|Insulin, Isophane|insulin, isophane|mesh-list
153888377|NCT00626080|Isophane insulin, beef|isophane insulin, beef|mesh-list
153386924|NCT01745913|Melphalan|melphalan|mesh-list
153846778|NCT00547209|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153846779|NCT00547209|Analgesics|analgesics|mesh-ancestor
153846780|NCT00547209|Sensory System Agents|sensory system agents|mesh-ancestor
153846785|NCT00547287|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
153846786|NCT00547287|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
153846787|NCT00547287|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153846788|NCT00547287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153846789|NCT00547287|Urological Agents|urological agents|mesh-ancestor
153846790|NCT01263106|Theophylline|theophylline|mesh-list
153846791|NCT01263106|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153846792|NCT01263106|Autonomic Agents|autonomic agents|mesh-ancestor
153846793|NCT01263106|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153846794|NCT01263106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153846795|NCT01263106|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153846796|NCT01263106|Respiratory System Agents|respiratory system agents|mesh-ancestor
153846797|NCT01263106|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
153846798|NCT01263106|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153846799|NCT01263106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153846800|NCT01263106|Vasodilator Agents|vasodilator agents|mesh-ancestor
153846801|NCT01263106|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
153846802|NCT01263106|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
153846803|NCT01263106|Purinergic Agents|purinergic agents|mesh-ancestor
153846804|NCT01263106|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153846805|NCT01263028|Ergocalciferols|ergocalciferols|mesh-list
153846807|NCT01263028|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153846808|NCT01263028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153846809|NCT01263028|Vitamins|vitamins|mesh-ancestor
153846810|NCT01263028|Micronutrients|micronutrients|mesh-ancestor
153846811|NCT01263028|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153846812|NCT00547443|Paclitaxel|paclitaxel|mesh-list
153386925|NCT01745913|Thymoglobulin|thymoglobulin|mesh-list
153386926|NCT01745913|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153386940|NCT01691079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153386941|NCT01691079|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153386942|NCT01691079|Respiratory System Agents|respiratory system agents|mesh-ancestor
153386943|NCT01691079|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
153386945|NCT01691079|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153386946|NCT01691079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153386947|NCT01673061|Lidocaine|lidocaine|mesh-list
153386948|NCT01673061|Epinephrine|epinephrine|mesh-list
153386949|NCT01673061|Norflurane|norflurane|mesh-list
153386950|NCT01673061|Anesthetics, Local|anesthetics, local|mesh-ancestor
153386951|NCT01673061|Anesthetics|anesthetics|mesh-ancestor
153846813|NCT00547443|Carboplatin|carboplatin|mesh-list
153846814|NCT00547443|Sorafenib|sorafenib|mesh-list
153846815|NCT00547443|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153888382|NCT04309240|Antithrombins|antithrombins|mesh-ancestor
153888383|NCT04309240|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
153888384|NCT04309240|Protease Inhibitors|protease inhibitors|mesh-ancestor
153888385|NCT04309240|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153429455|NCT01402531|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153429456|NCT01402531|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153429457|NCT01402531|Growth Substances|growth substances|mesh-ancestor
153429458|NCT01402531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153386954|NCT01673061|Sensory System Agents|sensory system agents|mesh-ancestor
153386955|NCT01673061|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153386956|NCT01673061|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153386957|NCT01673061|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
153386958|NCT01673061|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153386959|NCT01673061|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153386960|NCT01673061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153386961|NCT01673061|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153386962|NCT01673061|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153386963|NCT01673061|Adrenergic Agents|adrenergic agents|mesh-ancestor
153386964|NCT01673061|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153386965|NCT01673061|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
153386966|NCT01673061|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153386968|NCT01673061|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153386969|NCT01673061|Respiratory System Agents|respiratory system agents|mesh-ancestor
153386970|NCT01673061|Mydriatics|mydriatics|mesh-ancestor
153386971|NCT01673061|Sympathomimetics|sympathomimetics|mesh-ancestor
153386972|NCT01673061|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
153386974|NCT01621737|Oxytocics|oxytocics|mesh-ancestor
153386975|NCT01621737|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153386976|NCT01621737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153386977|NCT00379665|Cisplatin|cisplatin|mesh-list
153386978|NCT00379665|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153386979|NCT00357383|Azithromycin|azithromycin|mesh-list
153386980|NCT00357383|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153386981|NCT00357383|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153386982|NCT01598025|Fludarabine|fludarabine|mesh-list
153846849|NCT02908295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153846850|NCT02908295|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
153846851|NCT02908295|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153846852|NCT02908295|Oxytocics|oxytocics|mesh-ancestor
153846853|NCT03809442|Dexamethasone|dexamethasone|mesh-list
153846854|NCT03809442|Midazolam|midazolam|mesh-list
153846855|NCT03809442|Dexmedetomidine|dexmedetomidine|mesh-list
153846856|NCT03809442|Ketamine|ketamine|mesh-list
153846857|NCT03809442|Tramadol|tramadol|mesh-list
153846858|NCT03809442|Ropivacaine|ropivacaine|mesh-list
153846859|NCT03809442|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153846860|NCT03809442|Antiemetics|antiemetics|mesh-ancestor
153846861|NCT03809442|Autonomic Agents|autonomic agents|mesh-ancestor
153846862|NCT03809442|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153846863|NCT03809442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153846864|NCT03809442|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153846865|NCT03809442|Glucocorticoids|glucocorticoids|mesh-ancestor
153846883|NCT03809442|Anesthetics, General|anesthetics, general|mesh-ancestor
153846884|NCT03809442|Anesthetics|anesthetics|mesh-ancestor
153846885|NCT03809442|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
153846886|NCT03809442|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
153846887|NCT03809442|Anesthetics, Local|anesthetics, local|mesh-ancestor
153846888|NCT03809442|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153846889|NCT03809442|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153846890|NCT03809442|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153846891|NCT03809442|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153429473|NCT00002678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153429474|NCT00002678|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153429475|NCT00002678|Glucocorticoids|glucocorticoids|mesh-ancestor
153429476|NCT00002678|Hormones|hormones|mesh-ancestor
153429477|NCT00002678|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153429478|NCT00002678|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153846892|NCT03809442|GABA Modulators|gaba modulators|mesh-ancestor
153846893|NCT03809442|GABA Agents|gaba agents|mesh-ancestor
153846894|NCT03809442|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153846895|NCT03809442|Narcotics|narcotics|mesh-ancestor
153846896|NCT00534729|Carboplatin|carboplatin|mesh-list
153846897|NCT00534729|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153846898|NCT00547989|Bupivacaine|bupivacaine|mesh-list
153846899|NCT00547989|Ropivacaine|ropivacaine|mesh-list
153846900|NCT00547989|Anesthetics, Local|anesthetics, local|mesh-ancestor
153846901|NCT00547989|Anesthetics|anesthetics|mesh-ancestor
153846902|NCT00547989|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153846903|NCT00547989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153387048|NCT00357617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153387050|NCT01548651|Incretins|incretins|mesh-ancestor
153387051|NCT01548651|Hormones|hormones|mesh-ancestor
153387052|NCT01548651|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153387053|NCT01548651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153387054|NCT01548651|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
153387055|NCT01548651|Protease Inhibitors|protease inhibitors|mesh-ancestor
153387056|NCT01548651|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153387057|NCT01548651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153387058|NCT01548651|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153387059|NCT01533753|Gabapentin|gabapentin|mesh-list
153387060|NCT01533753|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
153387061|NCT01533753|Analgesics|analgesics|mesh-ancestor
153846924|NCT00534846|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
153846925|NCT00534846|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
153846926|NCT00534846|Hormone Antagonists|hormone antagonists|mesh-ancestor
153846927|NCT00534846|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153846928|NCT00534846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153846929|NCT00534846|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153846930|NCT00548067|Amlodipine|amlodipine|mesh-list
153846942|NCT00548067|Diuretics|diuretics|mesh-ancestor
153846951|NCT02907749|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
153846953|NCT02907749|Natriuretic Agents|natriuretic agents|mesh-ancestor
153846954|NCT02907749|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
153846955|NCT02907749|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
153846956|NCT02907749|Adrenergic Agents|adrenergic agents|mesh-ancestor
153846957|NCT02907749|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153846958|NCT02907749|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153846959|NCT02907749|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153846960|NCT02907749|Antioxidants|antioxidants|mesh-ancestor
153846981|NCT00548301|Cyclosporine|cyclosporine|mesh-list
153846982|NCT00548301|Cyclosporins|cyclosporins|mesh-list
153846983|NCT00548301|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153846984|NCT00548301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153846985|NCT00548301|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153846986|NCT00548301|Immunologic Factors|immunologic factors|mesh-ancestor
153846987|NCT00548301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153846988|NCT00548301|Antifungal Agents|antifungal agents|mesh-ancestor
153846989|NCT00548301|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153846990|NCT00548301|Dermatologic Agents|dermatologic agents|mesh-ancestor
153846991|NCT00548301|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153846992|NCT00548301|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
153846993|NCT02907710|Endostar protein|endostar protein|mesh-list
153846994|NCT02907710|Endostatins|endostatins|mesh-list
153847019|NCT04972617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153847020|NCT04972617|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
153847021|NCT04972617|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153847022|NCT04972617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153847023|NCT04682210|Bevacizumab|bevacizumab|mesh-list
153847024|NCT04682210|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153847025|NCT04682210|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153847026|NCT04682210|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153847027|NCT04682210|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153847028|NCT04682210|Growth Substances|growth substances|mesh-ancestor
153847029|NCT04682210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153847030|NCT04682210|Growth Inhibitors|growth inhibitors|mesh-ancestor
153847032|NCT04682132|Immunologic Factors|immunologic factors|mesh-ancestor
153847033|NCT04682132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153847034|NCT02907554|Cyclosporine|cyclosporine|mesh-list
153847035|NCT02907554|Cyclosporins|cyclosporins|mesh-list
153847036|NCT02907554|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153847037|NCT02907554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153847038|NCT02907554|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153847046|NCT02907632|Metoclopramide|metoclopramide|mesh-list
153387184|NCT00523809|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153387185|NCT00523809|Antimetabolites|antimetabolites|mesh-ancestor
153387186|NCT00523809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153387187|NCT00523809|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153387188|NCT00523809|Immunologic Factors|immunologic factors|mesh-ancestor
153387189|NCT00523809|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153387190|NCT00523809|Alkylating Agents|alkylating agents|mesh-ancestor
153847058|NCT02907437|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153847059|NCT02907437|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153847061|NCT01262872|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
153847062|NCT01262872|Immunologic Factors|immunologic factors|mesh-ancestor
153847063|NCT01262872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153847064|NCT00548574|Mesalamine|mesalamine|mesh-list
153847107|NCT00535080|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
153847109|NCT01262638|8-hydroxy-2,2,14,14-tetramethylpentadecanedioic acid|8-hydroxy-2,2,14,14-tetramethylpentadecanedioic acid|mesh-list
153387224|NCT00356187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153387225|NCT00356187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153387226|NCT00356187|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153387227|NCT00356187|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153387228|NCT00356187|Vasodilator Agents|vasodilator agents|mesh-ancestor
153387230|NCT02973399|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153387231|NCT02973399|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153387232|NCT02973399|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153847126|NCT00535119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153847127|NCT00535119|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
153847128|NCT00535119|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153847129|NCT00535158|Vitamin D|vitamin d|mesh-list
153847130|NCT00535158|Ergocalciferols|ergocalciferols|mesh-list
153847131|NCT00535158|Vitamins|vitamins|mesh-ancestor
153847132|NCT00535158|Micronutrients|micronutrients|mesh-ancestor
153847133|NCT00535158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153847134|NCT00535158|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153847135|NCT00535158|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153847136|NCT04207450|Glutaral|glutaral|mesh-list
153847137|NCT04207450|Disinfectants|disinfectants|mesh-ancestor
153847138|NCT04207450|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153847139|NCT04043494|Cytarabine|cytarabine|mesh-list
153847140|NCT04043494|Dexamethasone|dexamethasone|mesh-list
153847141|NCT04043494|Prednisone|prednisone|mesh-list
153847142|NCT04043494|Prednisolone|prednisolone|mesh-list
153847143|NCT04043494|Cyclophosphamide|cyclophosphamide|mesh-list
153847144|NCT04043494|Ifosfamide|ifosfamide|mesh-list
153847145|NCT04043494|Doxorubicin|doxorubicin|mesh-list
153847146|NCT04043494|Methotrexate|methotrexate|mesh-list
153847147|NCT04043494|Vincristine|vincristine|mesh-list
153847148|NCT04043494|Daunorubicin|daunorubicin|mesh-list
153847149|NCT04043494|Asparaginase|asparaginase|mesh-list
153847150|NCT04043494|Mercaptopurine|mercaptopurine|mesh-list
153847151|NCT04043494|Thioguanine|thioguanine|mesh-list
153847152|NCT04043494|Pegaspargase|pegaspargase|mesh-list
153387287|NCT03312530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153847154|NCT04043494|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153847155|NCT04043494|Immunologic Factors|immunologic factors|mesh-ancestor
153847156|NCT04043494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153387289|NCT03312530|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153847157|NCT04043494|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153847158|NCT04043494|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153847159|NCT04043494|Alkylating Agents|alkylating agents|mesh-ancestor
153847160|NCT04043494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153847161|NCT04043494|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153847162|NCT04043494|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153847163|NCT04043494|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153847164|NCT04043494|Antiemetics|antiemetics|mesh-ancestor
153387311|NCT05719961|Insulin, Long-Acting|insulin, long-acting|mesh-list
153387312|NCT05719961|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
153387313|NCT05719961|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153387314|NCT05719961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153387315|NCT01910636|Sofosbuvir|sofosbuvir|mesh-list
153387316|NCT01910636|Antiviral Agents|antiviral agents|mesh-ancestor
153387317|NCT01910636|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153387318|NCT00118053|Carboplatin|carboplatin|mesh-list
153387319|NCT00118053|Docetaxel|docetaxel|mesh-list
153387320|NCT00118053|Trastuzumab|trastuzumab|mesh-list
153387321|NCT00118053|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153387322|NCT00118053|Tubulin Modulators|tubulin modulators|mesh-ancestor
153387323|NCT00118053|Antimitotic Agents|antimitotic agents|mesh-ancestor
153387324|NCT00118053|Mitosis Modulators|mitosis modulators|mesh-ancestor
153387325|NCT00118053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153387326|NCT00118053|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153387327|NCT04225611|Dexamethasone|dexamethasone|mesh-list
153387328|NCT04225611|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153387329|NCT04225611|Antiemetics|antiemetics|mesh-ancestor
153387330|NCT04225611|Autonomic Agents|autonomic agents|mesh-ancestor
153847200|NCT04322422|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
153847201|NCT04322422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153847202|NCT02899169|Tretinoin|tretinoin|mesh-list
153847229|NCT00548964|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153847230|NCT00548964|Antimanic Agents|antimanic agents|mesh-ancestor
153847231|NCT00548964|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153847232|NCT02898779|Primaquine|primaquine|mesh-list
153847233|NCT02898779|Antimalarials|antimalarials|mesh-ancestor
153847234|NCT02898779|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153847235|NCT02898779|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153847236|NCT02898779|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153847237|NCT00549120|Propranolol|propranolol|mesh-list
153847238|NCT00549120|Albuterol|albuterol|mesh-list
153847239|NCT00549120|Ipratropium|ipratropium|mesh-list
153847240|NCT00549120|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
153847242|NCT00549120|Adrenergic Agents|adrenergic agents|mesh-ancestor
153847265|NCT04680884|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
153847266|NCT04680884|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
153847267|NCT04680884|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153847268|NCT04680884|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153847269|NCT04680884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153847270|NCT04680884|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153847271|NCT04680884|Hormone Antagonists|hormone antagonists|mesh-ancestor
153847272|NCT04680884|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153847273|NCT04680884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153847274|NCT04680884|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
153847275|NCT04680884|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
153847276|NCT00535470|Mechlorethamine|mechlorethamine|mesh-list
153847277|NCT00535470|Alkylating Agents|alkylating agents|mesh-ancestor
153847278|NCT00535470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153847281|NCT00535509|Cisplatin|cisplatin|mesh-list
153387434|NCT00000189|Antidepressive Agents|antidepressive agents|mesh-ancestor
153387435|NCT00000189|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153387436|NCT00000189|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153387437|NCT00000189|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153847298|NCT00535665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153847299|NCT03971110|Goserelin|goserelin|mesh-list
153847300|NCT03971110|Bicalutamide|bicalutamide|mesh-list
153847301|NCT03971110|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153847302|NCT03971110|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153387440|NCT00000189|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
153847303|NCT03971110|Androgen Antagonists|androgen antagonists|mesh-ancestor
153847304|NCT03971110|Hormone Antagonists|hormone antagonists|mesh-ancestor
153847305|NCT03971110|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153847306|NCT03971110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153847307|NCT01262287|Dutasteride|dutasteride|mesh-list
153847308|NCT01262287|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
153847309|NCT01262287|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153847310|NCT01262287|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153847311|NCT01262287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153847312|NCT01262287|Hormone Antagonists|hormone antagonists|mesh-ancestor
153847313|NCT01262287|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153847314|NCT01262287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153847315|NCT01262092|Buprenorphine|buprenorphine|mesh-list
153847316|NCT01262092|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153847317|NCT01262092|Narcotics|narcotics|mesh-ancestor
153847318|NCT01262092|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153847319|NCT01262092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153847320|NCT01262092|Analgesics|analgesics|mesh-ancestor
153847321|NCT01262092|Sensory System Agents|sensory system agents|mesh-ancestor
153847322|NCT01262092|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153847323|NCT01262092|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
153847324|NCT04680962|Rituximab|rituximab|mesh-list
153847325|NCT04680962|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153847326|NCT04680962|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153847327|NCT04680962|Immunologic Factors|immunologic factors|mesh-ancestor
153847329|NCT04680962|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153847330|NCT00549471|Botulinum Toxins|botulinum toxins|mesh-list
153847331|NCT00549471|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
153847332|NCT00549471|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
153847333|NCT00549471|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
153847334|NCT00549471|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153847335|NCT00549471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153847336|NCT00549471|Cholinergic Agents|cholinergic agents|mesh-ancestor
153847337|NCT00549471|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153847338|NCT00549471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153847339|NCT00549471|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
153847340|NCT00549471|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153847341|NCT03088410|Zidovudine|zidovudine|mesh-list
153387455|NCT00000201|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
153387456|NCT00000201|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153387457|NCT00000201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153387458|NCT00000201|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
153387459|NCT00000201|Protective Agents|protective agents|mesh-ancestor
153387460|NCT00000201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153387461|NCT00000207|Buprenorphine|buprenorphine|mesh-list
153387462|NCT00000207|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153847356|NCT02897765|Immunologic Factors|immunologic factors|mesh-ancestor
153847357|NCT02897765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153847358|NCT02897765|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153847359|NCT02897765|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153847360|NCT02897765|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153847361|NCT02897765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153847362|NCT02897765|Interferon Inducers|interferon inducers|mesh-ancestor
153847363|NCT00549588|Sunscreening Agents|sunscreening agents|mesh-list
153847364|NCT00549588|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
153847365|NCT00549588|Protective Agents|protective agents|mesh-ancestor
153847366|NCT00549588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153847367|NCT00549588|Dermatologic Agents|dermatologic agents|mesh-ancestor
153847368|NCT04321642|Nitrous Oxide|nitrous oxide|mesh-list
153847369|NCT04321642|Entonox|entonox|mesh-list
153847370|NCT04321642|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
153847393|NCT04321837|Vitamins|vitamins|mesh-ancestor
153847394|NCT04321837|Micronutrients|micronutrients|mesh-ancestor
153847395|NCT04321837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153847396|NCT04321837|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153847397|NCT04321837|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153847399|NCT02896829|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153847400|NCT02896829|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153847401|NCT02896829|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153847402|NCT02896829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153847403|NCT02896829|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153847404|NCT00549666|Moxifloxacin|moxifloxacin|mesh-list
153847405|NCT00549666|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
153847406|NCT00549666|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
153847407|NCT00549666|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153847408|NCT00549666|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153847409|NCT00549666|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153847410|NCT00549666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153847411|NCT00549666|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153847412|NCT00549666|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
153847413|NCT00549666|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
153847414|NCT00549666|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
153847415|NCT00549666|Adrenergic Agents|adrenergic agents|mesh-ancestor
153847416|NCT00549666|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153847417|NCT00549666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153847418|NCT00549666|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
153847419|NCT00549666|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153847420|NCT00549666|Serotonin Agents|serotonin agents|mesh-ancestor
153847421|NCT00549666|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
153847422|NCT00549666|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
153847423|NCT00549666|Dopamine Agents|dopamine agents|mesh-ancestor
153847424|NCT00549666|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
153847425|NCT00549666|Contraceptive Agents|contraceptive agents|mesh-ancestor
153847428|NCT00549666|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
153847429|NCT00549666|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
153847430|NCT00549666|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153847431|NCT00549666|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153847432|NCT00549666|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153847433|NCT00549666|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153847434|NCT00549666|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153847435|NCT00549666|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153847436|NCT00551538|Insulin Glargine|insulin glargine|mesh-list
153847437|NCT00551538|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153387551|NCT00000213|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153387552|NCT00000213|Serotonin Agents|serotonin agents|mesh-ancestor
153387553|NCT00000213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153888392|NCT01035229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153888393|NCT01035229|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153888394|NCT01035229|Immunologic Factors|immunologic factors|mesh-ancestor
153888395|NCT01035229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153888396|NCT01035229|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153888397|NCT01059799|Insulin|insulin|mesh-list
153888398|NCT01059799|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
153387554|NCT00000213|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
153387555|NCT00000213|Antidepressive Agents|antidepressive agents|mesh-ancestor
153888424|NCT04307290|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153888425|NCT04307290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153888426|NCT01325207|Trastuzumab|trastuzumab|mesh-list
153888427|NCT01325207|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153888428|NCT01325207|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153429501|NCT00002684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153429502|NCT00002684|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153429503|NCT00002684|Alkylating Agents|alkylating agents|mesh-ancestor
153429504|NCT02972918|Simendan|simendan|mesh-list
153429505|NCT02972918|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
153429506|NCT02972918|Vasodilator Agents|vasodilator agents|mesh-ancestor
153387556|NCT00000213|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153429507|NCT02972918|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
153429508|NCT02972918|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
153429509|NCT02972918|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153387557|NCT00000213|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
153387558|NCT00000213|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153387559|NCT00000213|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153387560|NCT00000219|Buprenorphine|buprenorphine|mesh-list
153387561|NCT00000219|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153387562|NCT00000219|Narcotics|narcotics|mesh-ancestor
153387563|NCT00000219|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153847460|NCT03556696|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153847461|NCT03556696|Narcotics|narcotics|mesh-ancestor
153847462|NCT03556696|Analgesics|analgesics|mesh-ancestor
153847463|NCT03556696|Sensory System Agents|sensory system agents|mesh-ancestor
153847464|NCT03556696|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153847466|NCT04320706|Oxytocics|oxytocics|mesh-ancestor
153847467|NCT04320706|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153847468|NCT04320706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153847469|NCT00553709|Nicotine|nicotine|mesh-list
153847470|NCT00553709|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
153847471|NCT00553709|Autonomic Agents|autonomic agents|mesh-ancestor
153847472|NCT00553709|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153847473|NCT00553709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153847474|NCT00553709|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
153847475|NCT00553709|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
153847476|NCT00553709|Cholinergic Agents|cholinergic agents|mesh-ancestor
153847477|NCT00553709|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153847478|NCT00553709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153847480|NCT00551733|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
153387627|NCT05637671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153387628|NCT05637671|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
153387629|NCT05637671|Antidepressive Agents|antidepressive agents|mesh-ancestor
153387630|NCT05637671|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153387631|NCT05637671|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
153387632|NCT05637671|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153387633|NCT05637671|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153387634|NCT05637671|Parasympatholytics|parasympatholytics|mesh-ancestor
153387635|NCT05637671|Autonomic Agents|autonomic agents|mesh-ancestor
153387636|NCT05637671|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153387637|NCT05637671|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
153387638|NCT05637671|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
153387639|NCT05637671|Cholinergic Agents|cholinergic agents|mesh-ancestor
153847497|NCT02896205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153847498|NCT04922424|Atorvastatin|atorvastatin|mesh-list
153847499|NCT04922424|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153847500|NCT04922424|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153847501|NCT04922424|Antimetabolites|antimetabolites|mesh-ancestor
153847503|NCT04922424|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153914602|NCT02709187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153914603|NCT02709187|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153914604|NCT02709187|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
153914605|NCT02709187|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153914606|NCT02709187|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153914607|NCT02709187|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
153387640|NCT05637671|Urological Agents|urological agents|mesh-ancestor
153387641|NCT02322216|Olopatadine Hydrochloride|olopatadine hydrochloride|mesh-list
153387642|NCT02322216|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
153387643|NCT02322216|Ophthalmic Solutions|ophthalmic solutions|mesh-list
153387644|NCT02322216|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153387645|NCT02322216|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153387646|NCT02322216|Analgesics|analgesics|mesh-ancestor
153387647|NCT02322216|Sensory System Agents|sensory system agents|mesh-ancestor
153387648|NCT02322216|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153387649|NCT02322216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153387650|NCT02322216|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153387651|NCT02322216|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153387652|NCT02322216|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
153387653|NCT02322216|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
153387656|NCT02322216|Histamine Agents|histamine agents|mesh-ancestor
153847529|NCT00551889|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153847530|NCT00551889|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153847531|NCT00551889|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153847533|NCT00551889|Sensory System Agents|sensory system agents|mesh-ancestor
153847534|NCT00551889|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153847535|NCT00551889|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153429510|NCT02972918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153429511|NCT02972918|Protective Agents|protective agents|mesh-ancestor
153429513|NCT05600491|Temozolomide|temozolomide|mesh-list
153847536|NCT00551889|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
153847537|NCT00551889|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153847538|NCT00551889|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153847540|NCT00550212|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153847541|NCT00550212|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153847542|NCT00550212|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153847543|NCT00550212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153847544|NCT03455764|Trametinib|trametinib|mesh-list
153847545|NCT03455764|Dabrafenib|dabrafenib|mesh-list
153847546|NCT03455764|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153847547|NCT03455764|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153847548|NCT03455764|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153847549|NCT03455764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153847550|NCT04902495|Pemetrexed|pemetrexed|mesh-list
153847551|NCT04902495|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153847552|NCT04902495|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153847553|NCT04902495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153847556|NCT02895659|Norepinephrine|norepinephrine|mesh-list
153387698|NCT00000237|Analgesics|analgesics|mesh-ancestor
153387699|NCT00000237|Sensory System Agents|sensory system agents|mesh-ancestor
153387700|NCT00000237|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153387701|NCT00000237|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
153387702|NCT00000765|Zidovudine|zidovudine|mesh-list
153387703|NCT00000765|Antimetabolites|antimetabolites|mesh-ancestor
153387704|NCT00000765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153387705|NCT00000765|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153387707|NCT00000765|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153847558|NCT02895659|Racepinephrine|racepinephrine|mesh-list
153847559|NCT02895659|Epinephryl borate|epinephryl borate|mesh-list
153847560|NCT02895659|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153847561|NCT02895659|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153847562|NCT02895659|Adrenergic Agents|adrenergic agents|mesh-ancestor
153847563|NCT02895659|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153847564|NCT02895659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153847565|NCT02895659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153847566|NCT02895659|Sympathomimetics|sympathomimetics|mesh-ancestor
153847567|NCT02895659|Autonomic Agents|autonomic agents|mesh-ancestor
153847568|NCT02895659|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153847569|NCT02895659|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
153847570|NCT02895659|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
153847571|NCT02895659|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153847572|NCT02895659|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153847573|NCT02895659|Respiratory System Agents|respiratory system agents|mesh-ancestor
153847574|NCT02895659|Mydriatics|mydriatics|mesh-ancestor
153847575|NCT00552201|Tacrolimus|tacrolimus|mesh-list
153847576|NCT00552201|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153847577|NCT00552201|Immunologic Factors|immunologic factors|mesh-ancestor
153847578|NCT00552201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153847579|NCT00552201|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
153847593|NCT00550329|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153847594|NCT00550329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153847595|NCT00550485|Escitalopram|escitalopram|mesh-list
153847596|NCT00550485|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
153847597|NCT00550485|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153847598|NCT00550485|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153847599|NCT00550485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153847600|NCT00550485|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153847601|NCT00550485|Serotonin Agents|serotonin agents|mesh-ancestor
153847602|NCT00550485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153847603|NCT00550563|Cholecalciferol|cholecalciferol|mesh-list
153387726|NCT00000249|Nitrous Oxide|nitrous oxide|mesh-list
153387727|NCT00000249|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
153387728|NCT00000249|Anesthetics, General|anesthetics, general|mesh-ancestor
153387739|NCT00000261|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
153387740|NCT00000261|Anesthetics, General|anesthetics, general|mesh-ancestor
153387741|NCT00000261|Anesthetics|anesthetics|mesh-ancestor
153387760|NCT00000801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153387761|NCT00000801|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153387762|NCT00000801|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153847605|NCT00550563|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153847606|NCT00550563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153847607|NCT00550563|Vitamins|vitamins|mesh-ancestor
153847608|NCT00550563|Micronutrients|micronutrients|mesh-ancestor
153847609|NCT00550563|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153847610|NCT02895191|Urinastatin|urinastatin|mesh-list
153847611|NCT02895191|Trypsin Inhibitors|trypsin inhibitors|mesh-list
153847612|NCT02895191|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
153847613|NCT02895191|Protease Inhibitors|protease inhibitors|mesh-ancestor
153847614|NCT02895191|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153847615|NCT02895191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153847616|NCT04680650|Anesthetics|anesthetics|mesh-list
153847617|NCT04680650|Propofol|propofol|mesh-list
153847618|NCT04680650|Sevoflurane|sevoflurane|mesh-list
153847619|NCT04680650|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153847620|NCT04680650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153847621|NCT04680650|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153847622|NCT04680650|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153847623|NCT04680650|Anesthetics, General|anesthetics, general|mesh-ancestor
153847624|NCT04680650|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153847625|NCT04680650|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
153847626|NCT02895113|Aspirin|aspirin|mesh-list
153387769|NCT00000801|Hormones|hormones|mesh-ancestor
153387772|NCT00000801|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153387773|NCT00000801|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153387774|NCT00000801|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153387775|NCT00000801|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153387776|NCT00000801|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153387777|NCT00000801|Antimetabolites|antimetabolites|mesh-ancestor
153387778|NCT00000801|Antiviral Agents|antiviral agents|mesh-ancestor
153387779|NCT00000801|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153387780|NCT00000801|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153387781|NCT00000801|Tubulin Modulators|tubulin modulators|mesh-ancestor
153387782|NCT00000801|Antimitotic Agents|antimitotic agents|mesh-ancestor
153387783|NCT00000801|Mitosis Modulators|mitosis modulators|mesh-ancestor
153387784|NCT00000267|Risperidone|risperidone|mesh-list
153387785|NCT00000267|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153387786|NCT00000267|Serotonin Agents|serotonin agents|mesh-ancestor
153387787|NCT00000267|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153387788|NCT00000267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153387789|NCT00000267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153387790|NCT00000267|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153387791|NCT00000267|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153387792|NCT00000267|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153387793|NCT00000267|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153387794|NCT00000267|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
153387795|NCT00000267|Dopamine Agents|dopamine agents|mesh-ancestor
153387796|NCT00000807|Etoposide|etoposide|mesh-list
153847641|NCT02895113|Antipyretics|antipyretics|mesh-ancestor
153847642|NCT00552630|Penicillamine|penicillamine|mesh-list
153847666|NCT00550992|Cyclophosphamide|cyclophosphamide|mesh-list
153847667|NCT00550992|Melphalan|melphalan|mesh-list
153847668|NCT00550992|Busulfan|busulfan|mesh-list
153847669|NCT00550992|Methotrexate|methotrexate|mesh-list
153847670|NCT00550992|Etoposide|etoposide|mesh-list
153847671|NCT00550992|Vincristine|vincristine|mesh-list
153847672|NCT00550992|Daunorubicin|daunorubicin|mesh-list
153847673|NCT00550992|Asparaginase|asparaginase|mesh-list
153847674|NCT00550992|Mercaptopurine|mercaptopurine|mesh-list
153847675|NCT00550992|Mitoxantrone|mitoxantrone|mesh-list
153847676|NCT00550992|Pegaspargase|pegaspargase|mesh-list
153847677|NCT00550992|Thioguanine|thioguanine|mesh-list
153847678|NCT00550992|Cyclosporins|cyclosporins|mesh-list
153847679|NCT00550992|Antilymphocyte Serum|antilymphocyte serum|mesh-list
153847680|NCT00550992|Levoleucovorin|levoleucovorin|mesh-list
153847681|NCT00550992|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153847682|NCT00550992|Immunologic Factors|immunologic factors|mesh-ancestor
153847683|NCT00550992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153847699|NCT00550992|Antimetabolites|antimetabolites|mesh-ancestor
153847700|NCT00550992|Dermatologic Agents|dermatologic agents|mesh-ancestor
153847702|NCT00550992|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153847703|NCT00550992|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153847704|NCT00550992|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153847705|NCT00550992|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153847706|NCT00550992|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153847707|NCT00550992|Antiviral Agents|antiviral agents|mesh-ancestor
153847708|NCT00550992|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153847709|NCT00550992|Antidotes|antidotes|mesh-ancestor
153847710|NCT00550992|Protective Agents|protective agents|mesh-ancestor
153847711|NCT00550992|Vitamin B Complex|vitamin b complex|mesh-ancestor
153847712|NCT00550992|Vitamins|vitamins|mesh-ancestor
153847713|NCT00550992|Micronutrients|micronutrients|mesh-ancestor
153847714|NCT00550992|Tubulin Modulators|tubulin modulators|mesh-ancestor
153847715|NCT00550992|Antimitotic Agents|antimitotic agents|mesh-ancestor
153847716|NCT00550992|Mitosis Modulators|mitosis modulators|mesh-ancestor
153847717|NCT00550992|Antifungal Agents|antifungal agents|mesh-ancestor
153847718|NCT00550992|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
153847719|NCT00550992|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153847721|NCT00550992|Analgesics|analgesics|mesh-ancestor
153387874|NCT00000279|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153387875|NCT00000279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153387876|NCT00000825|Aldesleukin|aldesleukin|mesh-list
153387877|NCT00000825|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153387878|NCT00000825|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153387879|NCT00000825|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153387880|NCT00000825|Antiviral Agents|antiviral agents|mesh-ancestor
153387881|NCT00000825|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153387882|NCT00000285|Phenytoin|phenytoin|mesh-list
153387883|NCT00000285|Anticonvulsants|anticonvulsants|mesh-ancestor
153387885|NCT00000285|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153847731|NCT02895074|Cholinergic Agents|cholinergic agents|mesh-ancestor
153847732|NCT02895074|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153847733|NCT02895074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153847734|NCT02895074|Anesthetics, Local|anesthetics, local|mesh-ancestor
153847735|NCT02895074|Anesthetics|anesthetics|mesh-ancestor
153847736|NCT02895074|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153847737|NCT02895074|Sensory System Agents|sensory system agents|mesh-ancestor
153847738|NCT02894918|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
153387896|NCT00001737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153387897|NCT00001737|Antifungal Agents|antifungal agents|mesh-ancestor
153387898|NCT00001737|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153387899|NCT00001737|Dermatologic Agents|dermatologic agents|mesh-ancestor
153387900|NCT00001737|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153387901|NCT00001737|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
153387902|NCT00000843|Adefovir|adefovir|mesh-list
153387903|NCT00000843|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
153387904|NCT00000843|Antiviral Agents|antiviral agents|mesh-ancestor
153387905|NCT00000843|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153387906|NCT00000843|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153387907|NCT00000843|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153387908|NCT00000843|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153387909|NCT00000843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153387910|NCT05362487|Bromides|bromides|mesh-list
153387911|NCT05362487|Tiotropium Bromide|tiotropium bromide|mesh-list
153387912|NCT05362487|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153387913|NCT05362487|Autonomic Agents|autonomic agents|mesh-ancestor
153387914|NCT05362487|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153387915|NCT05362487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153387916|NCT05362487|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153387917|NCT05362487|Respiratory System Agents|respiratory system agents|mesh-ancestor
153387919|NCT05362487|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
153387920|NCT05362487|Cholinergic Agents|cholinergic agents|mesh-ancestor
153387921|NCT05362487|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153387923|NCT05362487|Anticonvulsants|anticonvulsants|mesh-ancestor
153847772|NCT00551382|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153847781|NCT02894684|Aztreonam|aztreonam|mesh-list
153847789|NCT02894645|Methotrexate|methotrexate|mesh-list
153847790|NCT02894645|Fludarabine|fludarabine|mesh-list
153847791|NCT02894645|Vincristine|vincristine|mesh-list
153847792|NCT02894645|Daunorubicin|daunorubicin|mesh-list
153847793|NCT02894645|Asparaginase|asparaginase|mesh-list
153847794|NCT02894645|Mercaptopurine|mercaptopurine|mesh-list
153847795|NCT02894645|Thioguanine|thioguanine|mesh-list
153847796|NCT02894645|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153847797|NCT02894645|Immunologic Factors|immunologic factors|mesh-ancestor
153847798|NCT02894645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153847799|NCT02894645|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153847800|NCT02894645|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153847801|NCT02894645|Alkylating Agents|alkylating agents|mesh-ancestor
153847802|NCT02894645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153847803|NCT02894645|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153847804|NCT02894645|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153847805|NCT02894645|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153847806|NCT02894645|Antiemetics|antiemetics|mesh-ancestor
153847807|NCT02894645|Autonomic Agents|autonomic agents|mesh-ancestor
153847808|NCT02894645|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153847809|NCT02894645|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153847810|NCT02894645|Glucocorticoids|glucocorticoids|mesh-ancestor
153847811|NCT02894645|Hormones|hormones|mesh-ancestor
153847812|NCT02894645|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153387957|NCT00000297|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153387958|NCT00000297|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
153387959|NCT00000297|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
153847814|NCT02894645|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153847815|NCT02894645|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153847816|NCT02894645|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153847817|NCT02894645|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153847818|NCT02894645|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
153847819|NCT02894645|Abortifacient Agents|abortifacient agents|mesh-ancestor
153847820|NCT02894645|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153847821|NCT02894645|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153847822|NCT02894645|Antimetabolites|antimetabolites|mesh-ancestor
153847826|NCT02894645|Antiviral Agents|antiviral agents|mesh-ancestor
153387973|NCT00000303|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
153387974|NCT00000303|GABA Agonists|gaba agonists|mesh-ancestor
153387975|NCT00000303|GABA Agents|gaba agents|mesh-ancestor
153387976|NCT00000303|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153387977|NCT00000303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153387978|NCT00001785|Interferons|interferons|mesh-list
153387979|NCT00001785|Interferon-beta|interferon-beta|mesh-list
153387980|NCT00001785|Interferon beta-1a|interferon beta-1a|mesh-list
153387981|NCT00001785|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153387982|NCT00001785|Antiviral Agents|antiviral agents|mesh-ancestor
153387983|NCT00001785|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153387984|NCT00001785|Immunologic Factors|immunologic factors|mesh-ancestor
153387985|NCT00001785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153387986|NCT00001785|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153387987|NCT00001827|Aldesleukin|aldesleukin|mesh-list
153387988|NCT00001827|Sargramostim|sargramostim|mesh-list
153387989|NCT00001827|Freund's Adjuvant|freund's adjuvant|mesh-list
153387990|NCT00001827|Immunologic Factors|immunologic factors|mesh-ancestor
153387998|NCT01647516|Ozanimod|ozanimod|mesh-list
153847844|NCT05427617|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153847845|NCT05427617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153847846|NCT05427617|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153847847|NCT05427617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153847848|NCT05427500|Bupivacaine|bupivacaine|mesh-list
153847849|NCT05427500|Anesthetics, Local|anesthetics, local|mesh-ancestor
153847850|NCT05427500|Anesthetics|anesthetics|mesh-ancestor
153847851|NCT05427500|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153847852|NCT05427500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153847853|NCT05427500|Sensory System Agents|sensory system agents|mesh-ancestor
153847854|NCT05427500|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153847855|NCT05427305|Bevacizumab|bevacizumab|mesh-list
153847856|NCT05427305|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153847857|NCT05427305|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153847858|NCT05427305|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153847859|NCT05427305|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153847866|NCT01099449|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153847867|NCT01099449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153847868|NCT01099449|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153847869|NCT01099449|Analgesics|analgesics|mesh-ancestor
153847870|NCT01099449|Sensory System Agents|sensory system agents|mesh-ancestor
153847871|NCT01099449|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153847872|NCT01099449|Anesthetics|anesthetics|mesh-ancestor
153847873|NCT01099449|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153847874|NCT01099449|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153847875|NCT01099449|Anticonvulsants|anticonvulsants|mesh-ancestor
153847876|NCT01099449|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153847877|NCT01099449|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153847878|NCT01099449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153847879|NCT01099449|Tocolytic Agents|tocolytic agents|mesh-ancestor
153847880|NCT01099449|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153847881|NCT04680143|Epoetin Alfa|epoetin alfa|mesh-list
153847882|NCT04680143|Hematinics|hematinics|mesh-ancestor
153847883|NCT05426798|Azacitidine|azacitidine|mesh-list
153847884|NCT05426798|Decitabine|decitabine|mesh-list
153847885|NCT05426798|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153847886|NCT05426798|Antimetabolites|antimetabolites|mesh-ancestor
153388005|NCT00001839|Cyclosporins|cyclosporins|mesh-list
153388006|NCT00001839|Antilymphocyte Serum|antilymphocyte serum|mesh-list
153388007|NCT00001839|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153388008|NCT00001839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153388009|NCT00001839|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153388018|NCT00000885|Zidovudine|zidovudine|mesh-list
153388031|NCT00000885|Antiviral Agents|antiviral agents|mesh-ancestor
153388032|NCT00000885|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153388033|NCT00000885|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153847887|NCT05426798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153847888|NCT05426798|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153847889|NCT05426798|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153847890|NCT01234402|Capecitabine|capecitabine|mesh-list
153847891|NCT01234402|Ramucirumab|ramucirumab|mesh-list
153847892|NCT01234402|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153847893|NCT01234402|Antimetabolites|antimetabolites|mesh-ancestor
153847894|NCT01234402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153847895|NCT01234402|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153847896|NCT01234402|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153847897|NCT01234402|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153847898|NCT01234402|Growth Substances|growth substances|mesh-ancestor
153847899|NCT01234402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153847901|NCT01260922|Donepezil|donepezil|mesh-list
153847902|NCT01260922|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
153847903|NCT01260922|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153388040|NCT00000885|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
153388041|NCT00000885|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
153388042|NCT00000885|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
153388043|NCT00000885|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
153388044|NCT00000885|Protease Inhibitors|protease inhibitors|mesh-ancestor
153388045|NCT01647282|Minocycline|minocycline|mesh-list
153388046|NCT01647282|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153388047|NCT01647282|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153388048|NCT00000897|Zidovudine|zidovudine|mesh-list
153388049|NCT00000897|Antimetabolites|antimetabolites|mesh-ancestor
153388050|NCT00000897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153388051|NCT00000897|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153388052|NCT00000897|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153388053|NCT00000897|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153388054|NCT00000897|Antiviral Agents|antiviral agents|mesh-ancestor
153388055|NCT00000897|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153388056|NCT00000897|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153388057|NCT00000897|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153388058|NCT05347979|Dabigatran|dabigatran|mesh-list
153388059|NCT05347979|Antithrombins|antithrombins|mesh-ancestor
153388060|NCT05347979|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
153388061|NCT05347979|Protease Inhibitors|protease inhibitors|mesh-ancestor
153388064|NCT05347979|Anticoagulants|anticoagulants|mesh-ancestor
153847913|NCT01212094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153847914|NCT01212094|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153847915|NCT05409885|Anesthetics|anesthetics|mesh-list
153847927|NCT01211665|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
153847928|NCT01211665|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
153847929|NCT01211665|Prednisolone|prednisolone|mesh-list
153847930|NCT01211665|Prednisolone acetate|prednisolone acetate|mesh-list
153847931|NCT01211665|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
153847932|NCT01211665|Prednisolone phosphate|prednisolone phosphate|mesh-list
153847933|NCT01211665|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153847934|NCT01211665|Antiemetics|antiemetics|mesh-ancestor
153847935|NCT01211665|Autonomic Agents|autonomic agents|mesh-ancestor
153847936|NCT01211665|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153847937|NCT01211665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153847938|NCT01211665|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153847939|NCT01211665|Glucocorticoids|glucocorticoids|mesh-ancestor
153847940|NCT01211665|Hormones|hormones|mesh-ancestor
153847941|NCT01211665|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153847942|NCT01211665|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
153847943|NCT01211665|Protective Agents|protective agents|mesh-ancestor
153847944|NCT01211665|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153847945|NCT01211665|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153847946|NCT04401176|Lidocaine|lidocaine|mesh-list
153847947|NCT04401176|Heparin|heparin|mesh-list
153847948|NCT04401176|Anesthetics, Local|anesthetics, local|mesh-ancestor
153847949|NCT04401176|Anesthetics|anesthetics|mesh-ancestor
153847950|NCT04401176|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153847951|NCT04401176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153847952|NCT04401176|Sensory System Agents|sensory system agents|mesh-ancestor
153847953|NCT04401176|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153847954|NCT04401176|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153847955|NCT04401176|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
153847956|NCT04401176|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153388092|NCT02321436|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153388093|NCT02321436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153388094|NCT02321436|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
153388095|NCT02321436|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153388096|NCT05325515|Alendronate|alendronate|mesh-list
153388097|NCT05325515|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153388098|NCT05325515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153388099|NCT00000939|Efavirenz|efavirenz|mesh-list
153388100|NCT00000939|Didanosine|didanosine|mesh-list
153388101|NCT00000939|Stavudine|stavudine|mesh-list
153388102|NCT00000939|Hydroxyurea|hydroxyurea|mesh-list
153847957|NCT04401176|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153847958|NCT04401176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153847959|NCT04401176|Anticoagulants|anticoagulants|mesh-ancestor
153847960|NCT04401176|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153847961|NCT04401176|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153847962|NCT01232491|Insulin Detemir|insulin detemir|mesh-list
153847963|NCT01232491|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153847964|NCT01232491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153847965|NCT04335305|Pembrolizumab|pembrolizumab|mesh-list
153847966|NCT04335305|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153847999|NCT00553137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153848000|NCT00553137|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153388136|NCT00000963|Didanosine|didanosine|mesh-list
153388137|NCT00000963|Antimetabolites|antimetabolites|mesh-ancestor
153388138|NCT00000963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153388153|NCT00001893|Etanercept|etanercept|mesh-list
153848026|NCT04041011|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
153848027|NCT04041011|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153848028|NCT04041011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153848029|NCT04041011|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153848030|NCT00554138|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
153848031|NCT00554138|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153848032|NCT00554138|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153848033|NCT00554138|Antimetabolites|antimetabolites|mesh-ancestor
153848034|NCT00554138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153848035|NCT00554138|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153848036|NCT00554138|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
153848037|NCT00554138|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153848038|NCT01231555|Efavirenz|efavirenz|mesh-list
153848039|NCT01231555|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153848040|NCT01231555|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153848041|NCT01231555|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153848042|NCT01231555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153848043|NCT01231555|Antiviral Agents|antiviral agents|mesh-ancestor
153388172|NCT02280096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153388173|NCT00001905|Interferons|interferons|mesh-list
153388174|NCT00001905|Interferon-gamma|interferon-gamma|mesh-list
153388175|NCT00001905|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153388176|NCT00001905|Antiviral Agents|antiviral agents|mesh-ancestor
153388177|NCT00001905|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153388178|NCT00000987|Zidovudine|zidovudine|mesh-list
153848048|NCT01231555|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
153848049|NCT01231555|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
153848050|NCT01231555|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
153848051|NCT05288907|Lidocaine|lidocaine|mesh-list
153848052|NCT05288907|Anesthetics, Local|anesthetics, local|mesh-ancestor
153848053|NCT05288907|Anesthetics|anesthetics|mesh-ancestor
153848054|NCT05288907|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153848055|NCT05288907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153848056|NCT05288907|Sensory System Agents|sensory system agents|mesh-ancestor
153848057|NCT05288907|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153848058|NCT05288907|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153848059|NCT05288907|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
153848060|NCT05288907|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153848061|NCT05288907|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153848062|NCT05288907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153848063|NCT03911336|Acetaminophen|acetaminophen|mesh-list
153848064|NCT03911336|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-list
153848065|NCT03911336|Ketoprofen|ketoprofen|mesh-list
153848066|NCT03911336|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153848067|NCT03911336|Analgesics|analgesics|mesh-ancestor
153848068|NCT03911336|Sensory System Agents|sensory system agents|mesh-ancestor
153848069|NCT03911336|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153848070|NCT03911336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153848071|NCT03911336|Antipyretics|antipyretics|mesh-ancestor
153848072|NCT03911336|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153848073|NCT03911336|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153848074|NCT03911336|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153848075|NCT03911336|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153848076|NCT03911336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153848077|NCT03850535|Cytarabine|cytarabine|mesh-list
153848078|NCT03850535|Daunorubicin|daunorubicin|mesh-list
153848079|NCT03850535|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153848080|NCT03850535|Antimetabolites|antimetabolites|mesh-ancestor
153888441|NCT01095094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153888442|NCT01095094|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153888443|NCT01095094|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153888444|NCT01095094|Antiviral Agents|antiviral agents|mesh-ancestor
153888445|NCT01095094|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153888452|NCT00623285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153888453|NCT00623285|Anticonvulsants|anticonvulsants|mesh-ancestor
153888454|NCT00623285|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153888455|NCT00623285|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153888456|NCT00623285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153888457|NCT00623285|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153888458|NCT00623285|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153429531|NCT00002696|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153429532|NCT00002696|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153429533|NCT00002696|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153429534|NCT00002696|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153429535|NCT00002696|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153429536|NCT00002696|Antimetabolites|antimetabolites|mesh-ancestor
153429537|NCT00002696|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153429538|NCT00002696|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
153848081|NCT03850535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153848086|NCT03850535|Immunologic Factors|immunologic factors|mesh-ancestor
153848087|NCT03850535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153848088|NCT03850535|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153848089|NCT03850535|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153848090|NCT03850535|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153848091|NCT03850535|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153848093|NCT05255367|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
153388224|NCT00000993|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153388225|NCT00000993|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153388226|NCT00000993|Antiviral Agents|antiviral agents|mesh-ancestor
153388227|NCT00000993|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153388228|NCT00000993|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153388229|NCT00000993|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153388230|NCT00359177|Casopitant|casopitant|mesh-list
153388231|NCT00359177|Antiemetics|antiemetics|mesh-ancestor
153388232|NCT00359177|Autonomic Agents|autonomic agents|mesh-ancestor
153388233|NCT00359177|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153388234|NCT00359177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153388235|NCT00359177|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153388258|NCT02279862|Ipilimumab|ipilimumab|mesh-list
153848115|NCT05172531|Cisatracurium|cisatracurium|mesh-list
153848116|NCT05172531|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
153848117|NCT05172531|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
153848118|NCT05172531|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153848119|NCT05172531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153848120|NCT03570983|Cytarabine|cytarabine|mesh-list
153848121|NCT03570983|Etoposide|etoposide|mesh-list
153848122|NCT03570983|Melphalan|melphalan|mesh-list
153848123|NCT03570983|Carmustine|carmustine|mesh-list
153848124|NCT03570983|Allopurinol|allopurinol|mesh-list
153848125|NCT03570983|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153848126|NCT03570983|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153848127|NCT03570983|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153848128|NCT03570983|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153848129|NCT03570983|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153848130|NCT03570983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153848131|NCT03570983|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153848132|NCT03570983|Antimetabolites|antimetabolites|mesh-ancestor
153848144|NCT03570983|Antioxidants|antioxidants|mesh-ancestor
153848145|NCT03570983|Protective Agents|protective agents|mesh-ancestor
153848147|NCT03540758|Nicotinic Acids|nicotinic acids|mesh-list
153848148|NCT03540758|Niacinamide|niacinamide|mesh-list
153848149|NCT03540758|Diazoxide|diazoxide|mesh-list
153848150|NCT03540758|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153848151|NCT03540758|Antimetabolites|antimetabolites|mesh-ancestor
153848152|NCT03540758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153848153|NCT03540758|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153429554|NCT01315873|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153429555|NCT01315873|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153429556|NCT01315873|Alkylating Agents|alkylating agents|mesh-ancestor
153848157|NCT03540758|Micronutrients|micronutrients|mesh-ancestor
153848158|NCT03540758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153848159|NCT03540758|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153848161|NCT03187379|Anesthetics, Local|anesthetics, local|mesh-ancestor
153848162|NCT03187379|Anesthetics|anesthetics|mesh-ancestor
153848163|NCT03187379|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153848164|NCT03187379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153848165|NCT03187379|Sensory System Agents|sensory system agents|mesh-ancestor
153848166|NCT03187379|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153848167|NCT03182231|Exenatide|exenatide|mesh-list
153388305|NCT05503901|Timolol|timolol|mesh-list
153388306|NCT05503901|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
153388307|NCT05503901|Ophthalmic Solutions|ophthalmic solutions|mesh-list
153388308|NCT05503901|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
153388309|NCT05503901|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
153388310|NCT05503901|Adrenergic Agents|adrenergic agents|mesh-ancestor
153388311|NCT05503901|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153388312|NCT05503901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153388313|NCT05503901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153388314|NCT05503901|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153388315|NCT05503901|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153388316|NCT00001053|Aluminum Hydroxide|aluminum hydroxide|mesh-list
153388317|NCT00001053|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153388318|NCT00001053|Immunologic Factors|immunologic factors|mesh-ancestor
153388319|NCT00001053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153388320|NCT00001053|Antacids|antacids|mesh-ancestor
153388321|NCT00001053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153388322|NCT00001053|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153388323|NCT00001989|Zidovudine|zidovudine|mesh-list
153388324|NCT00001989|Trichosanthin|trichosanthin|mesh-list
153388325|NCT00001989|Antimetabolites|antimetabolites|mesh-ancestor
153388326|NCT00001989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153388327|NCT00001989|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153388328|NCT00001989|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153388329|NCT00001989|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153388330|NCT00001989|Antiviral Agents|antiviral agents|mesh-ancestor
153429557|NCT01315873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153429558|NCT01895959|Hyaluronic Acid|hyaluronic acid|mesh-list
153848171|NCT03182231|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
153848172|NCT03182231|Incretins|incretins|mesh-ancestor
153848173|NCT03182231|Hormones|hormones|mesh-ancestor
153848186|NCT02837042|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153848187|NCT02837042|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153848188|NCT02837042|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153848189|NCT02837042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153848190|NCT02710643|Ofatumumab|ofatumumab|mesh-list
153848191|NCT02710643|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153848211|NCT05093205|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153381832|NCT03282669|Hydromorphone|hydromorphone|mesh-list
153381833|NCT03282669|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153848212|NCT05093205|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153848213|NCT05093205|Antimetabolites|antimetabolites|mesh-ancestor
153848214|NCT05093205|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153848215|NCT05093205|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
153848216|NCT05093205|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153848218|NCT05093205|Hormones|hormones|mesh-ancestor
153848219|NCT05093205|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153848220|NCT05093205|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
153848221|NCT05093205|Contraceptive Agents|contraceptive agents|mesh-ancestor
153848222|NCT05093205|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153848223|NCT05093205|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
153848224|NCT05093205|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
153848225|NCT05093205|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
153848226|NCT05093205|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
153848227|NCT02623751|Exemestane|exemestane|mesh-list
153848228|NCT02623751|Entinostat|entinostat|mesh-list
153848229|NCT02623751|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153848230|NCT02623751|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
153848231|NCT02623751|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153848232|NCT02623751|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153848233|NCT02623751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153848234|NCT02623751|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
153848239|NCT02469155|Risperidone|risperidone|mesh-list
153388388|NCT00002007|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153388389|NCT00002007|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153388390|NCT00002007|Antiviral Agents|antiviral agents|mesh-ancestor
153388391|NCT00002007|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153388392|NCT00002007|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153388393|NCT00002007|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153388394|NCT00002007|Immunologic Factors|immunologic factors|mesh-ancestor
153388395|NCT00002007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153388396|NCT00001095|Lamivudine|lamivudine|mesh-list
153388397|NCT00001095|Zidovudine|zidovudine|mesh-list
153388398|NCT00001095|Nevirapine|nevirapine|mesh-list
153388400|NCT00001095|Indinavir|indinavir|mesh-list
153388401|NCT00001095|Amprenavir|amprenavir|mesh-list
153388402|NCT00001095|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153388403|NCT00001095|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153388404|NCT00001095|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153388405|NCT00001095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153848259|NCT02465606|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153848260|NCT02465606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153848261|NCT02465606|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153848265|NCT05080530|Vitamin D|vitamin d|mesh-list
153848293|NCT05073627|Dicloxacillin|dicloxacillin|mesh-list
153848294|NCT05073627|Dabigatran|dabigatran|mesh-list
153848295|NCT05073627|Antithrombins|antithrombins|mesh-ancestor
153848296|NCT05073627|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
153848297|NCT05073627|Protease Inhibitors|protease inhibitors|mesh-ancestor
153848298|NCT05073627|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153848299|NCT05073627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153848300|NCT05073627|Anticoagulants|anticoagulants|mesh-ancestor
153848301|NCT05073627|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153848302|NCT05073627|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153848303|NCT04678739|Remdesivir|remdesivir|mesh-list
153848304|NCT04678739|Antimetabolites|antimetabolites|mesh-ancestor
153848305|NCT04678739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153848306|NCT04678739|Antiviral Agents|antiviral agents|mesh-ancestor
153848307|NCT04678739|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153848308|NCT03368196|Trastuzumab deruxtecan|trastuzumab deruxtecan|mesh-list
153848309|NCT03368196|Immunoconjugates|immunoconjugates|mesh-ancestor
153848310|NCT03368196|Immunologic Factors|immunologic factors|mesh-ancestor
153848311|NCT03368196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153848312|NCT03230565|Ropivacaine|ropivacaine|mesh-list
153848313|NCT03230565|Anesthetics, Local|anesthetics, local|mesh-ancestor
153388446|NCT00359333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153388447|NCT00359333|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153388448|NCT00359333|Tubulin Modulators|tubulin modulators|mesh-ancestor
153388449|NCT00359333|Antimitotic Agents|antimitotic agents|mesh-ancestor
153388450|NCT00359333|Mitosis Modulators|mitosis modulators|mesh-ancestor
153388451|NCT00001101|Doxycycline|doxycycline|mesh-list
153388473|NCT00001107|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
153381834|NCT03282669|Narcotics|narcotics|mesh-ancestor
153381835|NCT03282669|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153388474|NCT00001107|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153848314|NCT03230565|Anesthetics|anesthetics|mesh-ancestor
153848315|NCT03230565|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153848316|NCT03230565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153848317|NCT03230565|Sensory System Agents|sensory system agents|mesh-ancestor
153848318|NCT03230565|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153848319|NCT02389985|Paclitaxel|paclitaxel|mesh-list
153848320|NCT02389985|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153848321|NCT02389985|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153848322|NCT02389985|Tubulin Modulators|tubulin modulators|mesh-ancestor
153848323|NCT02389985|Antimitotic Agents|antimitotic agents|mesh-ancestor
153848324|NCT02389985|Mitosis Modulators|mitosis modulators|mesh-ancestor
153848325|NCT02389985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153848326|NCT02377895|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
153848327|NCT03455075|Levonorgestrel|levonorgestrel|mesh-list
153388503|NCT00001155|Alkylating Agents|alkylating agents|mesh-ancestor
153388504|NCT00001155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153388505|NCT00001155|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153388506|NCT00001155|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153388507|NCT00002037|Trifluridine|trifluridine|mesh-list
153388508|NCT00002037|Antimetabolites|antimetabolites|mesh-ancestor
153388509|NCT00002037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153388510|NCT00002037|Antiviral Agents|antiviral agents|mesh-ancestor
153388511|NCT00002037|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153388512|NCT00001197|Hydroxyurea|hydroxyurea|mesh-list
153388513|NCT00001197|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153388514|NCT00001197|Antisickling Agents|antisickling agents|mesh-ancestor
153848357|NCT00554528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153848358|NCT00554528|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153848359|NCT00554528|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153848360|NCT00554528|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
153848361|NCT00554528|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153848362|NCT00554528|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153848363|NCT00554528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153848364|NCT04683198|Carboplatin|carboplatin|mesh-list
153888459|NCT00623285|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153888460|NCT00623285|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153848365|NCT04683198|Etoposide|etoposide|mesh-list
153848366|NCT04683198|Apatinib|apatinib|mesh-list
153848367|NCT04683198|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153848372|NCT04683198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153848373|NCT04683198|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153848375|NCT02342249|Antiviral Agents|antiviral agents|mesh-ancestor
153848376|NCT02342249|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153848377|NCT02342249|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153848378|NCT02342249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153848379|NCT02339129|Ibuprofen|ibuprofen|mesh-list
153388515|NCT00001197|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153388516|NCT00001197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153388517|NCT00001197|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153388518|NCT00002043|Dapsone|dapsone|mesh-list
153388519|NCT00002043|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153388520|NCT00002043|Antimalarials|antimalarials|mesh-ancestor
153388521|NCT00002043|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153388522|NCT00002043|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153388523|NCT00002043|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153388524|NCT00002043|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153388525|NCT00002043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153388526|NCT00002043|Leprostatic Agents|leprostatic agents|mesh-ancestor
153388527|NCT00002043|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153388528|NCT00001209|Cyclophosphamide|cyclophosphamide|mesh-list
153388529|NCT00001209|Ifosfamide|ifosfamide|mesh-list
153388530|NCT00001209|Vincristine|vincristine|mesh-list
153388531|NCT00001209|Doxorubicin|doxorubicin|mesh-list
153388532|NCT00001209|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
153388533|NCT00001209|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153388534|NCT00001209|Immunologic Factors|immunologic factors|mesh-ancestor
153388535|NCT00001209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153388536|NCT00001209|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153882786|NCT01602822|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153388537|NCT00001209|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153388538|NCT00001209|Alkylating Agents|alkylating agents|mesh-ancestor
153388540|NCT00001209|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153388549|NCT00001209|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153388550|NCT00002049|Thymopentin|thymopentin|mesh-list
153848380|NCT02339129|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153848381|NCT02339129|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153848382|NCT02339129|Analgesics|analgesics|mesh-ancestor
153848383|NCT02339129|Sensory System Agents|sensory system agents|mesh-ancestor
153848384|NCT02339129|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153848385|NCT02339129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153848386|NCT02339129|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153848387|NCT02339129|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153848388|NCT02339129|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153848389|NCT02339129|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153848390|NCT02339129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153848391|NCT02884206|Valsartan|valsartan|mesh-list
153848392|NCT02884206|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
153848393|NCT02884206|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153848394|NCT02884206|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
153848395|NCT02884206|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
153848396|NCT02884206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153848397|NCT04961541|Vaccines|vaccines|mesh-list
153848398|NCT04961541|Immunologic Factors|immunologic factors|mesh-ancestor
153848399|NCT04961541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153848400|NCT02326454|Talaporfin|talaporfin|mesh-list
153848401|NCT02326454|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153848402|NCT02326454|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
153848403|NCT02326454|Dermatologic Agents|dermatologic agents|mesh-ancestor
153848404|NCT02324309|Insulin Lispro|insulin lispro|mesh-list
153848405|NCT02324309|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153388553|NCT00002049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153388554|NCT05044637|Primaquine|primaquine|mesh-list
153388555|NCT05044637|Antimalarials|antimalarials|mesh-ancestor
153388556|NCT05044637|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153388557|NCT05044637|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153388558|NCT05044637|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153388559|NCT05043077|Phenylephrine|phenylephrine|mesh-list
153388560|NCT05043077|Oxymetazoline|oxymetazoline|mesh-list
153388561|NCT05043077|Tropicamide|tropicamide|mesh-list
153388562|NCT05043077|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
153388563|NCT05043077|Mydriatics|mydriatics|mesh-ancestor
153388564|NCT05043077|Autonomic Agents|autonomic agents|mesh-ancestor
153388565|NCT05043077|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153388566|NCT05043077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153388567|NCT05043077|Sympathomimetics|sympathomimetics|mesh-ancestor
153388568|NCT05043077|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
153848441|NCT02289716|Immunologic Factors|immunologic factors|mesh-ancestor
153848442|NCT02289716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153848444|NCT04678076|Ketoprofen lysine|ketoprofen lysine|mesh-list
153848445|NCT04678076|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153848446|NCT04678076|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153848448|NCT04678076|Sensory System Agents|sensory system agents|mesh-ancestor
153888461|NCT00623285|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153888462|NCT01097044|Afamelanotide|afamelanotide|mesh-list
153888463|NCT01097044|Dermatologic Agents|dermatologic agents|mesh-ancestor
153888464|NCT01322009|Acetylcysteine|acetylcysteine|mesh-list
153888465|NCT01322009|Probenecid|probenecid|mesh-list
153888466|NCT01322009|N-monoacetylcystine|n-monoacetylcystine|mesh-list
153888467|NCT01322009|Antiviral Agents|antiviral agents|mesh-ancestor
153888468|NCT01322009|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153888469|NCT01322009|Expectorants|expectorants|mesh-ancestor
153888470|NCT01322009|Respiratory System Agents|respiratory system agents|mesh-ancestor
153888471|NCT01322009|Free Radical Scavengers|free radical scavengers|mesh-ancestor
153848450|NCT04678076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153848451|NCT04678076|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153848452|NCT04678076|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153388590|NCT05031455|Analgesics|analgesics|mesh-ancestor
153388591|NCT05031455|Sensory System Agents|sensory system agents|mesh-ancestor
153388592|NCT05031455|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153388593|NCT05031455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153388594|NCT05031455|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153388595|NCT05031455|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153848455|NCT04678076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153848456|NCT02257619|Docetaxel|docetaxel|mesh-list
153848457|NCT02257619|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153848458|NCT02257619|Tubulin Modulators|tubulin modulators|mesh-ancestor
153848459|NCT02257619|Antimitotic Agents|antimitotic agents|mesh-ancestor
153848460|NCT02257619|Mitosis Modulators|mitosis modulators|mesh-ancestor
153848461|NCT02257619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153848462|NCT04891302|Clevudine|clevudine|mesh-list
153848463|NCT04891302|Antiviral Agents|antiviral agents|mesh-ancestor
153848464|NCT04891302|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153848465|NCT02224235|Aspirin|aspirin|mesh-list
153848466|NCT02224235|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153848467|NCT02224235|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153848468|NCT02224235|Analgesics|analgesics|mesh-ancestor
153848469|NCT02224235|Sensory System Agents|sensory system agents|mesh-ancestor
153848470|NCT02224235|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153848471|NCT02224235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153848472|NCT02224235|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153848473|NCT02224235|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153848474|NCT02224235|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153848475|NCT02224235|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153848476|NCT02224235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153848477|NCT02224235|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153848478|NCT02224235|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153848479|NCT02224235|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153848480|NCT02224235|Antipyretics|antipyretics|mesh-ancestor
153848481|NCT02529852|Prednisone|prednisone|mesh-list
153848482|NCT02529852|Cyclophosphamide|cyclophosphamide|mesh-list
153848483|NCT02529852|Doxorubicin|doxorubicin|mesh-list
153848484|NCT02529852|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
153388623|NCT00002067|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153388624|NCT00002067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153388636|NCT00001311|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153388637|NCT00001311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153388638|NCT05016713|Chlorhexidine|chlorhexidine|mesh-list
153388639|NCT05016713|Fluorides|fluorides|mesh-list
153388640|NCT05016713|Cariostatic Agents|cariostatic agents|mesh-ancestor
153388641|NCT05016713|Protective Agents|protective agents|mesh-ancestor
153388642|NCT05016713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153388643|NCT05016713|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
153388644|NCT05016713|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153388645|NCT05016713|Disinfectants|disinfectants|mesh-ancestor
153388646|NCT00002073|Epoetin Alfa|epoetin alfa|mesh-list
153388648|NCT00001317|Interferons|interferons|mesh-list
153388649|NCT00001317|Interferon-gamma|interferon-gamma|mesh-list
153388650|NCT00001317|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153388651|NCT00001317|Antiviral Agents|antiviral agents|mesh-ancestor
153388652|NCT00001317|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153388653|NCT00001335|Topotecan|topotecan|mesh-list
153388654|NCT00001335|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
153388655|NCT00001335|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153388656|NCT00001335|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153388657|NCT00001335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153388658|NCT00001335|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153388659|NCT00002079|Miglustat|miglustat|mesh-list
153388660|NCT00002079|Zidovudine|zidovudine|mesh-list
153848485|NCT02529852|Vincristine|vincristine|mesh-list
153848486|NCT02529852|Lenalidomide|lenalidomide|mesh-list
153848487|NCT02529852|Obinutuzumab|obinutuzumab|mesh-list
153848488|NCT02529852|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153848489|NCT02529852|Immunologic Factors|immunologic factors|mesh-ancestor
153848490|NCT02529852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153848491|NCT02529852|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153848492|NCT02529852|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153848493|NCT02529852|Alkylating Agents|alkylating agents|mesh-ancestor
153848494|NCT02529852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153848495|NCT02529852|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153848496|NCT02529852|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153848497|NCT02529852|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153848499|NCT02529852|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153848500|NCT02529852|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153848501|NCT02529852|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153848502|NCT02529852|Glucocorticoids|glucocorticoids|mesh-ancestor
153848503|NCT02529852|Hormones|hormones|mesh-ancestor
153848504|NCT02529852|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153848505|NCT02529852|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153882787|NCT01602822|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153423682|NCT03383588|Anesthetics, General|anesthetics, general|mesh-ancestor
153423683|NCT03383588|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153423684|NCT03383588|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153423685|NCT03383588|Adrenergic Agents|adrenergic agents|mesh-ancestor
153423686|NCT03383588|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153423688|NCT03383588|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
153381837|NCT03282669|Analgesics|analgesics|mesh-ancestor
153848506|NCT02529852|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153848507|NCT02529852|Tubulin Modulators|tubulin modulators|mesh-ancestor
153848508|NCT02529852|Antimitotic Agents|antimitotic agents|mesh-ancestor
153848509|NCT02529852|Mitosis Modulators|mitosis modulators|mesh-ancestor
153848510|NCT02529852|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153848511|NCT02529852|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153848512|NCT02529852|Growth Substances|growth substances|mesh-ancestor
153848513|NCT02529852|Growth Inhibitors|growth inhibitors|mesh-ancestor
153848514|NCT02529852|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153848515|NCT02221232|Ethanol|ethanol|mesh-list
153388676|NCT00001383|Paclitaxel|paclitaxel|mesh-list
153848524|NCT02206100|Enoxaparin|enoxaparin|mesh-list
153848525|NCT02206100|Anticoagulants|anticoagulants|mesh-ancestor
153848526|NCT02206100|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153848527|NCT02206100|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153848528|NCT02206100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153848529|NCT01231516|Raltegravir Potassium|raltegravir potassium|mesh-list
153848530|NCT01231516|Dolutegravir|dolutegravir|mesh-list
153848531|NCT01231516|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153848532|NCT01231516|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153848533|NCT01231516|Antiviral Agents|antiviral agents|mesh-ancestor
153848534|NCT01231516|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153848535|NCT01231516|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
153848536|NCT01231516|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
153848537|NCT01231516|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153848538|NCT01231516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153848539|NCT01231321|Adalimumab|adalimumab|mesh-list
153848540|NCT01231321|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
153848541|NCT01231321|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153848542|NCT01231321|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153848543|NCT01210222|Trebananib|trebananib|mesh-list
153848544|NCT01210222|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153848545|NCT01210222|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153848546|NCT01210222|Growth Substances|growth substances|mesh-ancestor
153388715|NCT00002103|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153388716|NCT00002103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153388718|NCT00002103|Protective Agents|protective agents|mesh-ancestor
153388719|NCT00002103|Vitamin B Complex|vitamin b complex|mesh-ancestor
153388720|NCT00002103|Vitamins|vitamins|mesh-ancestor
153388721|NCT00002103|Micronutrients|micronutrients|mesh-ancestor
153388722|NCT00002103|Antifungal Agents|antifungal agents|mesh-ancestor
153388723|NCT00002103|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153388724|NCT00002103|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153388725|NCT00002103|Antimetabolites|antimetabolites|mesh-ancestor
153388726|NCT00002103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153388727|NCT00002103|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153388728|NCT00002103|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153388729|NCT00002103|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153388730|NCT00001437|Pentoxifylline|pentoxifylline|mesh-list
153388731|NCT00001437|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
153388732|NCT00001437|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153388733|NCT00001437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153388734|NCT00001437|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153848564|NCT01209949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153848585|NCT01209832|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153388739|NCT00001437|Free Radical Scavengers|free radical scavengers|mesh-ancestor
153388741|NCT00360191|Buspirone|buspirone|mesh-list
153848605|NCT04683159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153848606|NCT04683159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153848608|NCT01230892|Nebivolol|nebivolol|mesh-list
153848609|NCT01230892|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153848610|NCT01230892|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153848611|NCT01230892|Sympatholytics|sympatholytics|mesh-ancestor
153848612|NCT01230892|Autonomic Agents|autonomic agents|mesh-ancestor
153848613|NCT01230892|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153848614|NCT01230892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153848615|NCT01230892|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
153848616|NCT01230892|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
153848617|NCT01230892|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
153848618|NCT01230892|Adrenergic Agents|adrenergic agents|mesh-ancestor
153848619|NCT01230892|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153848620|NCT01230892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153848621|NCT01230892|Vasodilator Agents|vasodilator agents|mesh-ancestor
153848622|NCT01230892|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
153848623|NCT01230892|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
153848624|NCT01230892|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153848625|NCT04667624|Telmisartan amlodipine combination|telmisartan amlodipine combination|mesh-list
153848626|NCT04667624|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153388770|NCT00001449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153388772|NCT00001449|Vitamins|vitamins|mesh-ancestor
153848627|NCT04667624|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
153848628|NCT04667624|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
153848629|NCT04667624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153848630|NCT04667351|Fluorouracil|fluorouracil|mesh-list
153848631|NCT04667351|Antimetabolites|antimetabolites|mesh-ancestor
153848632|NCT04667351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153848633|NCT04667351|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153848634|NCT04667351|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153848635|NCT04667351|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153848636|NCT04667351|Immunologic Factors|immunologic factors|mesh-ancestor
153848637|NCT04667351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153848638|NCT01230814|Metronidazole|metronidazole|mesh-list
153848639|NCT01230814|Miconazole|miconazole|mesh-list
153848640|NCT01230814|Clotrimazole|clotrimazole|mesh-list
153848641|NCT01230814|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153848642|NCT01230814|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153848643|NCT01230814|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153848644|NCT01230814|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153848645|NCT01230814|Antifungal Agents|antifungal agents|mesh-ancestor
153848646|NCT01230814|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
153388802|NCT00359567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153388803|NCT00381147|Clarithromycin|clarithromycin|mesh-list
153388804|NCT00381147|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153388805|NCT00381147|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153388815|NCT05210465|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153388816|NCT05210465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153388817|NCT05210465|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
153388818|NCT05210465|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
153388819|NCT05210465|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153388820|NCT05210465|Adrenergic Agents|adrenergic agents|mesh-ancestor
153388821|NCT05210465|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153848648|NCT01230814|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153848649|NCT01230814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153848650|NCT01230814|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153848662|NCT01230307|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153848663|NCT01230307|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153848664|NCT01209598|Palbociclib|palbociclib|mesh-list
153848665|NCT01209598|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153848666|NCT01209598|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153848667|NCT01209598|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153848668|NCT01209598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153848669|NCT00556634|Efavirenz|efavirenz|mesh-list
153848670|NCT00556634|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153848671|NCT00556634|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153848672|NCT00556634|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153848673|NCT00556634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153848674|NCT00556634|Antiviral Agents|antiviral agents|mesh-ancestor
153388822|NCT05210465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153388823|NCT05210465|Protective Agents|protective agents|mesh-ancestor
153388824|NCT00002115|Adefovir|adefovir|mesh-list
153381838|NCT03282669|Sensory System Agents|sensory system agents|mesh-ancestor
153388825|NCT00002115|Antiviral Agents|antiviral agents|mesh-ancestor
153388826|NCT00002115|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153388827|NCT00002115|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153388828|NCT00002115|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153388829|NCT00002115|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153388830|NCT00002115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153388831|NCT00001569|Paclitaxel|paclitaxel|mesh-list
153388832|NCT00001569|Cisplatin|cisplatin|mesh-list
153388833|NCT00001569|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153388834|NCT00001569|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153388835|NCT00001569|Tubulin Modulators|tubulin modulators|mesh-ancestor
153388836|NCT00001569|Antimitotic Agents|antimitotic agents|mesh-ancestor
153388839|NCT00001587|Melphalan|melphalan|mesh-list
153848688|NCT01209520|Azacitidine|azacitidine|mesh-list
153848689|NCT01209520|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153848690|NCT01209520|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153848691|NCT01209520|Tubulin Modulators|tubulin modulators|mesh-ancestor
153848692|NCT01209520|Antimitotic Agents|antimitotic agents|mesh-ancestor
153848693|NCT01209520|Mitosis Modulators|mitosis modulators|mesh-ancestor
153848694|NCT01209520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153848695|NCT01209520|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153848696|NCT01209520|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153848697|NCT01209520|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153848698|NCT01209520|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153848699|NCT01209520|Antimetabolites|antimetabolites|mesh-ancestor
153848700|NCT04805541|Tropicamide|tropicamide|mesh-list
153848701|NCT04805541|Mydriatics|mydriatics|mesh-list
153848702|NCT04805541|Autonomic Agents|autonomic agents|mesh-ancestor
153848703|NCT04805541|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153848704|NCT04805541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153848705|NCT04805541|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
153848706|NCT04805541|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
153848708|NCT04805541|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153848710|NCT04784754|Melatonin|melatonin|mesh-list
153848716|NCT04666805|Tamoxifen|tamoxifen|mesh-list
153388885|NCT00002133|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
153388886|NCT00002133|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153388887|NCT00002133|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153388888|NCT00002133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153388889|NCT00002133|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153388890|NCT00002133|Hormone Antagonists|hormone antagonists|mesh-ancestor
153388891|NCT00002133|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153388892|NCT00002133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153388893|NCT00002133|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
153388895|NCT00001629|Giapreza|giapreza|mesh-list
153388896|NCT00001629|Angiotensinogen|angiotensinogen|mesh-list
153388897|NCT00001629|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-list
153848739|NCT04721457|Eusol|eusol|mesh-list
153848772|NCT04665830|Protease Inhibitors|protease inhibitors|mesh-ancestor
153848773|NCT04665830|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153848774|NCT04665830|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153848775|NCT04683237|Liraglutide|liraglutide|mesh-list
153848776|NCT04683237|Megestrol|megestrol|mesh-list
153848777|NCT04683237|Megestrol Acetate|megestrol acetate|mesh-list
153848778|NCT04683237|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
153388922|NCT00002301|Phosphonoacetic Acid|phosphonoacetic acid|mesh-list
153388923|NCT00002301|Antiviral Agents|antiviral agents|mesh-ancestor
153388924|NCT00002301|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153388925|NCT00002301|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153388926|NCT00002301|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153388927|NCT00002301|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153388928|NCT00002301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153388929|NCT00002307|Zidovudine|zidovudine|mesh-list
153388930|NCT00002307|Stavudine|stavudine|mesh-list
153388931|NCT00002307|Antimetabolites|antimetabolites|mesh-ancestor
153388932|NCT00002307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153388933|NCT00002307|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153388934|NCT00002307|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153848779|NCT04683237|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153848780|NCT04683237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153848781|NCT04683237|Incretins|incretins|mesh-ancestor
153848782|NCT04683237|Hormones|hormones|mesh-ancestor
153916650|NCT00993915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153848783|NCT04683237|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153848784|NCT04683237|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
153848785|NCT04683237|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
153848786|NCT04683237|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
153848787|NCT04683237|Contraceptive Agents|contraceptive agents|mesh-ancestor
153848788|NCT04683237|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153848789|NCT04683237|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
153848801|NCT04665362|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153848802|NCT04665362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153848803|NCT04665284|Empagliflozin|empagliflozin|mesh-list
153848804|NCT04665284|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
153848805|NCT04665284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153848806|NCT04665284|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153848807|NCT04665284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153848808|NCT04432974|Anesthetics|anesthetics|mesh-list
153848809|NCT04432974|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153848810|NCT04432974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153848812|NCT04664894|Sofosbuvir|sofosbuvir|mesh-list
153848813|NCT04664894|Velpatasvir|velpatasvir|mesh-list
153848814|NCT04664894|Antimetabolites|antimetabolites|mesh-ancestor
153848815|NCT04664894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153848816|NCT04664894|Antiviral Agents|antiviral agents|mesh-ancestor
153848817|NCT04664894|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153848818|NCT00557102|Leucovorin|leucovorin|mesh-list
153848819|NCT00557102|Fluorouracil|fluorouracil|mesh-list
153848820|NCT00557102|Irinotecan|irinotecan|mesh-list
153848821|NCT00557102|Cetuximab|cetuximab|mesh-list
153848822|NCT00557102|Calcium|calcium|mesh-list
153848823|NCT00557102|Levoleucovorin|levoleucovorin|mesh-list
153848824|NCT00557102|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153389002|NCT00002331|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
153389004|NCT00002331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153389005|NCT00002331|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
153389006|NCT00002331|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153389007|NCT00002331|Antitubercular Agents|antitubercular agents|mesh-ancestor
153389008|NCT00002331|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153389009|NCT00002331|Leprostatic Agents|leprostatic agents|mesh-ancestor
153389010|NCT00002337|Vesnarinone|vesnarinone|mesh-list
153389011|NCT00002337|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153848869|NCT04351737|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153848870|NCT04351737|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153848871|NCT04351737|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
153848872|NCT04351737|Protective Agents|protective agents|mesh-ancestor
153848873|NCT04347915|Clevudine|clevudine|mesh-list
153848874|NCT04347915|Antiviral Agents|antiviral agents|mesh-ancestor
153848875|NCT04347915|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153848876|NCT04185051|Aticaprant|aticaprant|mesh-list
153848877|NCT04185051|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
153389018|NCT00002337|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
153389019|NCT00002337|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153389020|NCT00002337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153389021|NCT00002337|Protective Agents|protective agents|mesh-ancestor
153389023|NCT00002169|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
153389024|NCT00002169|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
153389025|NCT00002169|Protease Inhibitors|protease inhibitors|mesh-ancestor
153389026|NCT00002169|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153389027|NCT00002169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153389028|NCT00002169|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153389029|NCT00002169|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153389030|NCT00002169|Antiviral Agents|antiviral agents|mesh-ancestor
153389031|NCT00002169|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153848878|NCT04185051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153848879|NCT04185051|Sensory System Agents|sensory system agents|mesh-ancestor
153848880|NCT04185051|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153848881|NCT04662788|Antibodies|antibodies|mesh-list
153848882|NCT04662788|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
153848883|NCT04662788|Immunologic Factors|immunologic factors|mesh-ancestor
153848884|NCT04662788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153848885|NCT04662866|Metformin|metformin|mesh-list
153848886|NCT04662866|Pioglitazone|pioglitazone|mesh-list
153848887|NCT04662866|Empagliflozin|empagliflozin|mesh-list
153848888|NCT04662866|Linagliptin|linagliptin|mesh-list
153848889|NCT04662866|Biguanides|biguanides|mesh-list
153848890|NCT04662866|Protease Inhibitors|protease inhibitors|mesh-list
153389032|NCT02293902|Folic Acid|folic acid|mesh-list
153848893|NCT04662866|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
153848894|NCT04662866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153848895|NCT04662866|Incretins|incretins|mesh-ancestor
153848896|NCT04662866|Hormones|hormones|mesh-ancestor
153888472|NCT01322009|Antioxidants|antioxidants|mesh-ancestor
153888473|NCT01322009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153888474|NCT01322009|Protective Agents|protective agents|mesh-ancestor
153888475|NCT01322009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153888476|NCT01322009|Antidotes|antidotes|mesh-ancestor
153888477|NCT01322009|Uricosuric Agents|uricosuric agents|mesh-ancestor
153848897|NCT04662866|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153848898|NCT04662866|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
153848899|NCT04662866|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153888478|NCT01322009|Gout Suppressants|gout suppressants|mesh-ancestor
153888479|NCT01322009|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153888480|NCT01320683|Leucovorin|leucovorin|mesh-list
153888481|NCT01320683|Bevacizumab|bevacizumab|mesh-list
153888482|NCT01320683|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
153888483|NCT01320683|Fluorouracil|fluorouracil|mesh-list
153888484|NCT01320683|Oxaliplatin|oxaliplatin|mesh-list
153888485|NCT01320683|Irinotecan|irinotecan|mesh-list
153848900|NCT04662476|Vitamin D|vitamin d|mesh-list
153848901|NCT04662476|Cholecalciferol|cholecalciferol|mesh-list
153848902|NCT04662476|Vitamins|vitamins|mesh-ancestor
153848903|NCT04662476|Micronutrients|micronutrients|mesh-ancestor
153848904|NCT04662476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153848905|NCT04662476|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153389070|NCT00002355|Antiviral Agents|antiviral agents|mesh-ancestor
153389071|NCT00002355|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153888486|NCT01320683|Antibodies|antibodies|mesh-list
153888487|NCT01320683|Immunoglobulins|immunoglobulins|mesh-list
153848918|NCT00557180|Tiotropium Bromide|tiotropium bromide|mesh-list
153848919|NCT00557180|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
153848920|NCT00557180|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153848921|NCT00557180|Autonomic Agents|autonomic agents|mesh-ancestor
153848922|NCT00557180|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153848923|NCT00557180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153848924|NCT00557180|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153848925|NCT00557180|Respiratory System Agents|respiratory system agents|mesh-ancestor
153848926|NCT00557180|Parasympatholytics|parasympatholytics|mesh-ancestor
153848927|NCT00557180|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
153848928|NCT00557180|Cholinergic Agents|cholinergic agents|mesh-ancestor
153848929|NCT00557180|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153389072|NCT02278614|Timolol|timolol|mesh-list
153389073|NCT02278614|Ophthalmic Solutions|ophthalmic solutions|mesh-list
153389074|NCT02278614|Latanoprost|latanoprost|mesh-list
153389075|NCT02278614|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
153389076|NCT02278614|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
153389077|NCT02278614|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
153389078|NCT02278614|Adrenergic Agents|adrenergic agents|mesh-ancestor
153389079|NCT02278614|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153389080|NCT02278614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153389081|NCT02278614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153389082|NCT02278614|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153389083|NCT02278614|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153389084|NCT00002361|Ritonavir|ritonavir|mesh-list
153389085|NCT00002361|Indinavir|indinavir|mesh-list
153389086|NCT00002361|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
153389087|NCT00002361|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
153389088|NCT00002361|Protease Inhibitors|protease inhibitors|mesh-ancestor
153389089|NCT00002361|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153389090|NCT00002361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153389091|NCT00002361|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153389093|NCT00002361|Antiviral Agents|antiviral agents|mesh-ancestor
153848943|NCT00557219|Vasodilator Agents|vasodilator agents|mesh-ancestor
153848944|NCT00557219|Dopamine Agonists|dopamine agonists|mesh-ancestor
153848945|NCT00557219|Dopamine Agents|dopamine agents|mesh-ancestor
153848946|NCT00557219|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153848947|NCT00557219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153848948|NCT00557219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153848949|NCT00557219|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153848950|NCT00557219|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153848951|NCT00557219|Serotonin Agents|serotonin agents|mesh-ancestor
153848961|NCT03798405|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153848964|NCT04661696|Paclitaxel|paclitaxel|mesh-list
153848973|NCT06087289|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153848975|NCT06087211|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
153848976|NCT06087211|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
153848977|NCT06087211|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153848978|NCT06087211|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153848979|NCT06087211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153848980|NCT06087211|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153848981|NCT06087211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153848982|NCT06087211|Analgesics|analgesics|mesh-ancestor
153848983|NCT06087211|Sensory System Agents|sensory system agents|mesh-ancestor
153848984|NCT06087211|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153848985|NCT06087211|Antidepressive Agents|antidepressive agents|mesh-ancestor
153848986|NCT06087211|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153848987|NCT06087211|Dopamine Agents|dopamine agents|mesh-ancestor
153848988|NCT06087211|Anesthetics|anesthetics|mesh-ancestor
153848989|NCT06087211|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153848990|NCT06087211|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153848991|NCT06087211|Anticonvulsants|anticonvulsants|mesh-ancestor
153848992|NCT06087211|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153389140|NCT00002379|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
153389141|NCT00002379|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
153389142|NCT00002379|Protease Inhibitors|protease inhibitors|mesh-ancestor
153389143|NCT00359723|Methylphenidate|methylphenidate|mesh-list
153389144|NCT00359723|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
153389145|NCT00359723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153389146|NCT00359723|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
153389147|NCT00359723|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153389148|NCT00359723|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153389149|NCT00359723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153389150|NCT00359723|Dopamine Agents|dopamine agents|mesh-ancestor
153389151|NCT00359723|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153389152|NCT00002193|Amprenavir|amprenavir|mesh-list
153389153|NCT00002193|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
153389154|NCT00002193|Antitubercular Agents|antitubercular agents|mesh-ancestor
153389155|NCT00002193|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153389156|NCT00002193|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153389157|NCT00002193|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
153389158|NCT00002193|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
153389159|NCT00002193|Protease Inhibitors|protease inhibitors|mesh-ancestor
153389160|NCT00002193|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153848999|NCT06087055|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
153849000|NCT06087055|Protease Inhibitors|protease inhibitors|mesh-ancestor
153849001|NCT06087055|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153849002|NCT06087055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153849003|NCT06087055|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153849004|NCT06087055|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153849006|NCT06087055|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153849007|NCT06087055|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
153849008|NCT06087055|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153849009|NCT06087055|Antifungal Agents|antifungal agents|mesh-ancestor
153849010|NCT06087055|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
153849011|NCT06087055|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153849012|NCT06087055|Hormone Antagonists|hormone antagonists|mesh-ancestor
153849013|NCT06087055|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153849014|NCT06087055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153849015|NCT06087003|Thymoglobulin|thymoglobulin|mesh-list
153849016|NCT06087003|Basiliximab|basiliximab|mesh-list
153849017|NCT06087003|Immunologic Factors|immunologic factors|mesh-ancestor
153849018|NCT06087003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153849019|NCT06087003|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153849020|NCT06086665|Niraparib|niraparib|mesh-list
153849021|NCT06086665|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
153849022|NCT06086665|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153849023|NCT06086665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153389170|NCT00002391|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153389171|NCT00002391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153389173|NCT00002391|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153389174|NCT00002391|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153389175|NCT00002391|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153389176|NCT00002391|Antimetabolites|antimetabolites|mesh-ancestor
153389177|NCT00002199|Lamivudine|lamivudine|mesh-list
153389178|NCT00002199|Zidovudine|zidovudine|mesh-list
153389179|NCT00002199|Abacavir|abacavir|mesh-list
153381839|NCT03282669|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153381840|NCT00375843|Sertraline|sertraline|mesh-list
153389184|NCT00002199|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153389185|NCT00002199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153389186|NCT00002199|Antiviral Agents|antiviral agents|mesh-ancestor
153389187|NCT00002199|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153389188|NCT00002199|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153389189|NCT00002199|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153389190|NCT00002199|Antimetabolites|antimetabolites|mesh-ancestor
153389191|NCT00002199|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
153389192|NCT00002199|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
153389193|NCT00002199|Protease Inhibitors|protease inhibitors|mesh-ancestor
153389195|NCT00002397|Stavudine|stavudine|mesh-list
153849024|NCT06086665|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153849025|NCT06086483|Ropivacaine|ropivacaine|mesh-list
153849026|NCT06086483|Anesthetics, Local|anesthetics, local|mesh-ancestor
153849027|NCT06086483|Anesthetics|anesthetics|mesh-ancestor
153849028|NCT06086483|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153849029|NCT06086483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153849030|NCT06086483|Sensory System Agents|sensory system agents|mesh-ancestor
153849031|NCT06086483|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153849032|NCT06086288|Carboplatin|carboplatin|mesh-list
153849033|NCT06086288|Pembrolizumab|pembrolizumab|mesh-list
153849034|NCT06086288|Etoposide|etoposide|mesh-list
153849035|NCT06086288|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153849036|NCT06086288|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153849037|NCT06086288|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153849038|NCT06086288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153849039|NCT06086288|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153849040|NCT06086288|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153849041|NCT06086288|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153849042|NCT06086288|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153849043|NCT06086106|Analgesics, Opioid|analgesics, opioid|mesh-list
153849045|NCT06086106|Anesthetics|anesthetics|mesh-list
153849046|NCT06086106|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153849047|NCT06086106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153849048|NCT06086106|Narcotics|narcotics|mesh-ancestor
153389196|NCT00002397|Nelfinavir|nelfinavir|mesh-list
153389197|NCT00002397|Saquinavir|saquinavir|mesh-list
153389198|NCT00002397|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153389199|NCT00002397|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153389200|NCT00002397|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153389201|NCT00002397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153389202|NCT00002397|Antiviral Agents|antiviral agents|mesh-ancestor
153389203|NCT00002397|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153389204|NCT00002397|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153389205|NCT00002397|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153389206|NCT00002397|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
153389215|NCT00002205|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153849049|NCT06086106|Sensory System Agents|sensory system agents|mesh-ancestor
153849050|NCT06086106|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153849051|NCT06085976|Octreotide|octreotide|mesh-list
153849052|NCT06085976|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153849053|NCT06085976|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153849054|NCT06085976|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153849055|NCT06085937|Ketamine|ketamine|mesh-list
153849056|NCT06085937|Analgesics|analgesics|mesh-ancestor
153849057|NCT06085937|Sensory System Agents|sensory system agents|mesh-ancestor
153849058|NCT06085937|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153849059|NCT06085937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153849060|NCT06085937|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
153849061|NCT06085937|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153849062|NCT06085937|Anesthetics, General|anesthetics, general|mesh-ancestor
153849063|NCT06085937|Anesthetics|anesthetics|mesh-ancestor
153849064|NCT06085937|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153849065|NCT06085937|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
153849066|NCT06085937|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
153849067|NCT06085937|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153849068|NCT06085937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153849069|NCT06085703|Metformin|metformin|mesh-list
153849070|NCT06085703|Gliclazide|gliclazide|mesh-list
153849071|NCT06085703|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153849072|NCT06085703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153849073|NCT06085417|Dexamethasone|dexamethasone|mesh-list
153381841|NCT00375843|Escitalopram|escitalopram|mesh-list
153381903|NCT00375687|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
153389228|NCT02977169|Cisplatin|cisplatin|mesh-list
153389231|NCT02977169|Vinorelbine|vinorelbine|mesh-list
153389232|NCT02977169|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153389233|NCT02977169|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153389234|NCT02977169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153389235|NCT02977169|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153888488|NCT01320683|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
153888489|NCT01320683|Levoleucovorin|levoleucovorin|mesh-list
153429559|NCT01895959|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153429560|NCT01895959|Immunologic Factors|immunologic factors|mesh-ancestor
153429561|NCT01895959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153429562|NCT01895959|Viscosupplements|viscosupplements|mesh-ancestor
153429563|NCT01895959|Protective Agents|protective agents|mesh-ancestor
153429564|NCT01303003|Dexamethasone|dexamethasone|mesh-list
153429565|NCT01303003|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153429566|NCT01303003|Antiemetics|antiemetics|mesh-ancestor
153429567|NCT01303003|Autonomic Agents|autonomic agents|mesh-ancestor
153429568|NCT01303003|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153389236|NCT02977169|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153389237|NCT02977169|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153389238|NCT02977169|Tubulin Modulators|tubulin modulators|mesh-ancestor
153389239|NCT02977169|Antimitotic Agents|antimitotic agents|mesh-ancestor
153389240|NCT02977169|Mitosis Modulators|mitosis modulators|mesh-ancestor
153389242|NCT00002409|Zidovudine|zidovudine|mesh-list
153389243|NCT00002409|Abacavir|abacavir|mesh-list
153389244|NCT00002409|Lamivudine, zidovudine drug combination|lamivudine, zidovudine drug combination|mesh-list
153389245|NCT00002409|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153849085|NCT06085417|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153849086|NCT06085417|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153849087|NCT06085417|Anesthetics, Local|anesthetics, local|mesh-ancestor
153849088|NCT06085417|Anesthetics|anesthetics|mesh-ancestor
153849089|NCT06085417|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153849090|NCT06085417|Sensory System Agents|sensory system agents|mesh-ancestor
153849091|NCT06085417|Analgesics|analgesics|mesh-ancestor
153849092|NCT06085417|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153849093|NCT06085417|Anticonvulsants|anticonvulsants|mesh-ancestor
153849094|NCT06085417|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153849095|NCT06085417|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153849096|NCT06085417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153849097|NCT06085417|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153849098|NCT06085417|Tocolytic Agents|tocolytic agents|mesh-ancestor
153389246|NCT00002409|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153389247|NCT00002409|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153389248|NCT00002409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153389249|NCT00002409|Antiviral Agents|antiviral agents|mesh-ancestor
153389250|NCT00002409|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153389262|NCT00002211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153389264|NCT00002211|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153389265|NCT00002211|Antiviral Agents|antiviral agents|mesh-ancestor
153389266|NCT00002211|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153389267|NCT00002211|Antimetabolites|antimetabolites|mesh-ancestor
153389268|NCT00002211|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153389269|NCT00002211|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153389270|NCT00002415|Tenofovir|tenofovir|mesh-list
153389271|NCT00002415|Antiviral Agents|antiviral agents|mesh-ancestor
153389272|NCT00002415|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153389273|NCT00002415|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153389274|NCT00002415|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153389275|NCT00002415|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153389276|NCT00002415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153849099|NCT06085417|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153849100|NCT06084520|Analgesics, Opioid|analgesics, opioid|mesh-list
153849101|NCT06084520|Narcotics|narcotics|mesh-ancestor
153849102|NCT06084520|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153849103|NCT06084520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153849104|NCT06084520|Analgesics|analgesics|mesh-ancestor
153849105|NCT06084520|Sensory System Agents|sensory system agents|mesh-ancestor
153849106|NCT06084520|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153849107|NCT06084000|Paclitaxel|paclitaxel|mesh-list
153849116|NCT06078969|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153849117|NCT06078969|Glucocorticoids|glucocorticoids|mesh-ancestor
153849119|NCT06078969|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153849120|NCT06078969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153849121|NCT06078969|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153849122|NCT06078969|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153849123|NCT06078306|Azacitidine|azacitidine|mesh-list
153849124|NCT06078306|Venetoclax|venetoclax|mesh-list
153849125|NCT06078306|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153849126|NCT06078306|Antimetabolites|antimetabolites|mesh-ancestor
153849127|NCT06078306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153389277|NCT00002415|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153389278|NCT00002415|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153389279|NCT00381537|Carbamazepine|carbamazepine|mesh-list
153389280|NCT00381537|Phenobarbital|phenobarbital|mesh-list
153389281|NCT00381537|Anticonvulsants|anticonvulsants|mesh-ancestor
153389282|NCT00381537|Antimanic Agents|antimanic agents|mesh-ancestor
153389283|NCT00381537|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153389284|NCT00381537|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153389285|NCT00381537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153389286|NCT00381537|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153389287|NCT00381537|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153389288|NCT00381537|Analgesics|analgesics|mesh-ancestor
153389289|NCT00381537|Sensory System Agents|sensory system agents|mesh-ancestor
153389290|NCT00381537|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153389291|NCT00381537|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153389292|NCT00381537|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153429575|NCT01303003|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153429576|NCT00002714|Prednisone|prednisone|mesh-list
153429577|NCT00002714|Doxorubicin|doxorubicin|mesh-list
153849128|NCT06078306|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153849139|NCT06078228|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153849140|NCT06078228|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153849141|NCT06078228|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153849142|NCT06078228|Anesthetics, General|anesthetics, general|mesh-ancestor
153849143|NCT06078228|Anesthetics|anesthetics|mesh-ancestor
153849144|NCT06078228|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153849145|NCT06078228|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153389294|NCT00381537|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
153389295|NCT00381537|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
153389296|NCT00381537|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153389297|NCT00381537|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
153389298|NCT00381537|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
153389299|NCT00381537|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153389300|NCT00381537|GABA Modulators|gaba modulators|mesh-ancestor
153389301|NCT00381537|GABA Agents|gaba agents|mesh-ancestor
153389302|NCT00381537|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
153389304|NCT00002427|Stavudine|stavudine|mesh-list
153389305|NCT00002427|Hydroxyurea|hydroxyurea|mesh-list
153389306|NCT00002427|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153389307|NCT00002427|Antisickling Agents|antisickling agents|mesh-ancestor
153389308|NCT00002427|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153389309|NCT00002427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153389310|NCT00002427|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153389311|NCT00002427|Antimetabolites|antimetabolites|mesh-ancestor
153389312|NCT00002427|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153389313|NCT00002427|Antiviral Agents|antiviral agents|mesh-ancestor
153389314|NCT00002427|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153389315|NCT00002427|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153389316|NCT00002427|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153389318|NCT00002223|Indinavir|indinavir|mesh-list
153389343|NCT00002229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153389344|NCT00002229|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153389345|NCT00002229|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153389346|NCT00002229|Antiviral Agents|antiviral agents|mesh-ancestor
153389347|NCT00002229|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153389348|NCT00002229|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
153389349|NCT00002229|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153389350|NCT00002451|Ritonavir|ritonavir|mesh-list
153389351|NCT00002451|Indinavir|indinavir|mesh-list
153389352|NCT00002451|Lamivudine|lamivudine|mesh-list
153389353|NCT00002451|Stavudine|stavudine|mesh-list
153389354|NCT00002451|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
153389355|NCT00002451|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
153389356|NCT00002451|Protease Inhibitors|protease inhibitors|mesh-ancestor
153389357|NCT00002451|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153389358|NCT00002451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153389359|NCT00002451|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153849202|NCT06049160|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153849203|NCT06049160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153849204|NCT06049160|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
153849205|NCT06049160|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153849207|NCT06047834|Lofexidine|lofexidine|mesh-list
153849208|NCT06047834|Clonidine|clonidine|mesh-list
153849211|NCT06047834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153849212|NCT06047834|Sensory System Agents|sensory system agents|mesh-ancestor
153849213|NCT06047834|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153849214|NCT06047834|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
153849215|NCT06047834|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153849216|NCT06047834|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153849217|NCT06047834|Adrenergic Agents|adrenergic agents|mesh-ancestor
153849218|NCT06047834|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153849219|NCT06047834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153849220|NCT06047834|Analgesics|analgesics|mesh-ancestor
153849221|NCT06047834|Sympatholytics|sympatholytics|mesh-ancestor
153849222|NCT06047834|Autonomic Agents|autonomic agents|mesh-ancestor
153389374|NCT00002235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153389375|NCT00002235|Antiviral Agents|antiviral agents|mesh-ancestor
153389376|NCT00002235|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153389377|NCT00002235|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
153389378|NCT00002235|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153389379|NCT00002235|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
153389380|NCT00002235|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
153389381|NCT00002235|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
153389382|NCT00002235|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
153389383|NCT00002235|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
153389384|NCT00002235|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
153389385|NCT00002235|Protease Inhibitors|protease inhibitors|mesh-ancestor
153849230|NCT06046937|Cariostatic Agents|cariostatic agents|mesh-ancestor
153849231|NCT06046937|Protective Agents|protective agents|mesh-ancestor
153849232|NCT06046937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153849233|NCT06036108|Brexpiprazole|brexpiprazole|mesh-list
153849234|NCT06036108|Serotonin Agents|serotonin agents|mesh-ancestor
153849235|NCT06036108|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153849236|NCT06036108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153849237|NCT06036108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153849238|NCT06036108|Dopamine Agonists|dopamine agonists|mesh-ancestor
153849239|NCT06036108|Dopamine Agents|dopamine agents|mesh-ancestor
153849240|NCT05986266|Carbetocin|carbetocin|mesh-list
153849241|NCT05986266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153849242|NCT05986266|Oxytocics|oxytocics|mesh-ancestor
153849243|NCT05986266|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153849244|NCT05978687|Lidocaine|lidocaine|mesh-list
153849245|NCT05978687|Epinephrine|epinephrine|mesh-list
153849246|NCT05978687|Anesthetics, Local|anesthetics, local|mesh-ancestor
153849247|NCT05978687|Anesthetics|anesthetics|mesh-ancestor
153849248|NCT05978687|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153849249|NCT05978687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153849250|NCT05978687|Sensory System Agents|sensory system agents|mesh-ancestor
153849251|NCT05978687|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153849252|NCT05978687|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153849253|NCT05978687|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
153849254|NCT05978687|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153389405|NCT00002463|Abortifacient Agents|abortifacient agents|mesh-ancestor
153389406|NCT00002463|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153389407|NCT00002463|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153389408|NCT00002463|Antimetabolites|antimetabolites|mesh-ancestor
153389409|NCT00002463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153389410|NCT00002463|Dermatologic Agents|dermatologic agents|mesh-ancestor
153389411|NCT00002463|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153389412|NCT00002463|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153389413|NCT00002463|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153389414|NCT00002463|Immunologic Factors|immunologic factors|mesh-ancestor
153389415|NCT00002463|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153389416|NCT00002463|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153389417|NCT00002463|Antidotes|antidotes|mesh-ancestor
153389418|NCT00002463|Protective Agents|protective agents|mesh-ancestor
153389419|NCT00002463|Vitamin B Complex|vitamin b complex|mesh-ancestor
153389420|NCT00002463|Vitamins|vitamins|mesh-ancestor
153389421|NCT00002463|Micronutrients|micronutrients|mesh-ancestor
153389422|NCT00002463|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153389423|NCT00002463|Tubulin Modulators|tubulin modulators|mesh-ancestor
153389424|NCT00002463|Antimitotic Agents|antimitotic agents|mesh-ancestor
153849262|NCT05978687|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153849263|NCT05978687|Autonomic Agents|autonomic agents|mesh-ancestor
153849264|NCT05978687|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153849265|NCT05978687|Respiratory System Agents|respiratory system agents|mesh-ancestor
153849266|NCT05978687|Mydriatics|mydriatics|mesh-ancestor
153849267|NCT05978687|Sympathomimetics|sympathomimetics|mesh-ancestor
153849268|NCT05978687|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
153849269|NCT05961059|Detox adjuvant|detox adjuvant|mesh-list
153849270|NCT05961059|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153849271|NCT05961059|Immunologic Factors|immunologic factors|mesh-ancestor
153849272|NCT05961059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153849273|NCT05948813|Osimertinib|osimertinib|mesh-list
153849274|NCT05948813|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153389425|NCT00002463|Mitosis Modulators|mitosis modulators|mesh-ancestor
153389426|NCT00002463|Alkylating Agents|alkylating agents|mesh-ancestor
153849275|NCT05948813|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153849276|NCT05948813|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153849277|NCT05948813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153888490|NCT01320683|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153888491|NCT01320683|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153888492|NCT01320683|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153849279|NCT05944965|Oxybutynin|oxybutynin|mesh-list
153849280|NCT05944965|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
153849281|NCT05944965|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
153849282|NCT05944965|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153849283|NCT05944965|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153849284|NCT05944965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153849285|NCT05944965|Adrenergic Agents|adrenergic agents|mesh-ancestor
153849286|NCT05944965|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153849287|NCT05944965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153849288|NCT05944965|Parasympatholytics|parasympatholytics|mesh-ancestor
153849289|NCT05944965|Autonomic Agents|autonomic agents|mesh-ancestor
153849290|NCT05944965|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153389444|NCT00002475|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153389445|NCT00002475|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153389446|NCT00002475|Alkylating Agents|alkylating agents|mesh-ancestor
153389447|NCT00002475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153389448|NCT00002475|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153389449|NCT00002475|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153389450|NCT00002475|Antiviral Agents|antiviral agents|mesh-ancestor
153389463|NCT00002481|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153389464|NCT00002481|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153389465|NCT00002481|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153389466|NCT00002481|Antiemetics|antiemetics|mesh-ancestor
153389467|NCT00002481|Autonomic Agents|autonomic agents|mesh-ancestor
153389468|NCT00002481|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153389469|NCT00002481|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153389470|NCT00002481|Glucocorticoids|glucocorticoids|mesh-ancestor
153389471|NCT00002481|Hormones|hormones|mesh-ancestor
153461737|NCT03193866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153849291|NCT05944965|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
153849292|NCT05944965|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
153849293|NCT05944965|Cholinergic Agents|cholinergic agents|mesh-ancestor
153849294|NCT05944965|Urological Agents|urological agents|mesh-ancestor
153849295|NCT05921149|Paclitaxel|paclitaxel|mesh-list
153849296|NCT05921149|Carboplatin|carboplatin|mesh-list
153849297|NCT05921149|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153849298|NCT05921149|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153849299|NCT05921149|Tubulin Modulators|tubulin modulators|mesh-ancestor
153849300|NCT05921149|Antimitotic Agents|antimitotic agents|mesh-ancestor
153849301|NCT05921149|Mitosis Modulators|mitosis modulators|mesh-ancestor
153849302|NCT05921149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153849304|NCT05867030|Lenalidomide|lenalidomide|mesh-list
153849305|NCT05867030|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153849306|NCT05867030|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153849307|NCT05867030|Immunologic Factors|immunologic factors|mesh-ancestor
153849308|NCT05867030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153849309|NCT05867030|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153849310|NCT05867030|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153849311|NCT05867030|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153849312|NCT05867030|Growth Substances|growth substances|mesh-ancestor
153849313|NCT05867030|Growth Inhibitors|growth inhibitors|mesh-ancestor
153849314|NCT05756673|Listerine|listerine|mesh-list
153849315|NCT05756673|Anti-Infective Agents, Local|anti-infective agents, local|mesh-list
153849316|NCT05756673|Sodium Fluoride|sodium fluoride|mesh-list
153849317|NCT05756673|Cariostatic Agents|cariostatic agents|mesh-ancestor
153849318|NCT05756673|Protective Agents|protective agents|mesh-ancestor
153389472|NCT00002481|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153389473|NCT00002481|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153389474|NCT00002481|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153389475|NCT00002481|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153389476|NCT00002481|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153389477|NCT00002481|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153389478|NCT00002481|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153849333|NCT05692271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153389488|NCT00002487|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
153389489|NCT00002487|Abortifacient Agents|abortifacient agents|mesh-ancestor
153389490|NCT00002487|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153389491|NCT00002487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153389492|NCT00002487|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153389493|NCT00002487|Antimetabolites|antimetabolites|mesh-ancestor
153389494|NCT00002487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153389495|NCT00002487|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153389496|NCT00002487|Dermatologic Agents|dermatologic agents|mesh-ancestor
153389497|NCT00002487|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153389498|NCT00002487|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153389499|NCT00002487|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153389500|NCT00002487|Immunologic Factors|immunologic factors|mesh-ancestor
153849334|NCT05692271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153849335|NCT05692271|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153849347|NCT05647889|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153849348|NCT05647889|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153849349|NCT05647889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153849351|NCT05526469|Anesthetics, Local|anesthetics, local|mesh-ancestor
153849352|NCT05526469|Anesthetics|anesthetics|mesh-ancestor
153389505|NCT00002487|Vasodilator Agents|vasodilator agents|mesh-ancestor
153389506|NCT00002493|Doxorubicin|doxorubicin|mesh-list
153389508|NCT00002493|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153389509|NCT00002493|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153389510|NCT00002493|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153389511|NCT00002493|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153389513|NCT00002493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153389514|NCT00002259|Mitoxantrone|mitoxantrone|mesh-list
153389515|NCT00002259|Analgesics|analgesics|mesh-ancestor
153389516|NCT00002259|Sensory System Agents|sensory system agents|mesh-ancestor
153389517|NCT00002259|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153389518|NCT00002259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153389519|NCT00002259|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153389520|NCT00002259|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153389521|NCT00002259|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153389522|NCT00002259|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153389523|NCT00002259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153389524|NCT00002499|Cytarabine|cytarabine|mesh-list
153389525|NCT00002499|Dexamethasone|dexamethasone|mesh-list
153389526|NCT00002499|Prednisone|prednisone|mesh-list
153389527|NCT00002499|Methotrexate|methotrexate|mesh-list
153389528|NCT00002499|Vincristine|vincristine|mesh-list
153389529|NCT00002499|Daunorubicin|daunorubicin|mesh-list
153389530|NCT00002499|Asparaginase|asparaginase|mesh-list
153389531|NCT00002499|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153389532|NCT00002499|Antiemetics|antiemetics|mesh-ancestor
153389533|NCT00002499|Autonomic Agents|autonomic agents|mesh-ancestor
153389534|NCT00002499|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153849365|NCT05490511|Anticonvulsants|anticonvulsants|mesh-ancestor
153849366|NCT05488067|Atorvastatin|atorvastatin|mesh-list
153849367|NCT05488067|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153849368|NCT05488067|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153849369|NCT05488067|Antimetabolites|antimetabolites|mesh-ancestor
153849370|NCT05488067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153849371|NCT05488067|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153849372|NCT05488067|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
153849373|NCT05488067|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153849374|NCT05423210|Atezolizumab|atezolizumab|mesh-list
153849375|NCT05423210|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153849376|NCT05423210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153849377|NCT05423210|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153849378|NCT05423210|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153849379|NCT05419362|Avelumab|avelumab|mesh-list
153389535|NCT00002499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153389536|NCT00002499|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153389537|NCT00002499|Glucocorticoids|glucocorticoids|mesh-ancestor
153389539|NCT00002499|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153389540|NCT00002499|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153389541|NCT00002499|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153389542|NCT00002499|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
153389543|NCT00002499|Abortifacient Agents|abortifacient agents|mesh-ancestor
153389544|NCT00002499|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153389545|NCT00002499|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153888493|NCT01320683|Growth Substances|growth substances|mesh-ancestor
153888494|NCT01320683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153888495|NCT01320683|Growth Inhibitors|growth inhibitors|mesh-ancestor
153888496|NCT01320683|Immunologic Factors|immunologic factors|mesh-ancestor
153888497|NCT01320683|Antimetabolites|antimetabolites|mesh-ancestor
153888498|NCT01320683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153389546|NCT00002499|Antimetabolites|antimetabolites|mesh-ancestor
153849386|NCT05359731|Autonomic Agents|autonomic agents|mesh-ancestor
153849387|NCT05359731|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153849388|NCT05359731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153849389|NCT05359731|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153849390|NCT05359731|Glucocorticoids|glucocorticoids|mesh-ancestor
153429584|NCT00002714|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153849392|NCT05359731|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153849393|NCT05359731|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153849394|NCT05359731|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153849395|NCT05359731|Anesthetics, Local|anesthetics, local|mesh-ancestor
153849396|NCT05359731|Anesthetics|anesthetics|mesh-ancestor
153849397|NCT05359731|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153849398|NCT05359731|Sensory System Agents|sensory system agents|mesh-ancestor
153849399|NCT05355337|Pramipexole|pramipexole|mesh-list
153849400|NCT05355337|Dexpramipexole|dexpramipexole|mesh-list
153849401|NCT05355337|Antioxidants|antioxidants|mesh-ancestor
153849402|NCT05355337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153849403|NCT05355337|Protective Agents|protective agents|mesh-ancestor
153849404|NCT05355337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153849405|NCT05355337|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
153849406|NCT05355337|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
153849407|NCT05355337|Dopamine Agonists|dopamine agonists|mesh-ancestor
153849408|NCT05355337|Dopamine Agents|dopamine agents|mesh-ancestor
153849409|NCT05355337|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153849410|NCT05341817|Letrozole|letrozole|mesh-list
153849411|NCT05341817|Mifepristone|mifepristone|mesh-list
153849412|NCT05341817|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153849413|NCT05341817|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
153389588|NCT00002517|Daunorubicin|daunorubicin|mesh-list
153389589|NCT00002517|Mitoxantrone|mitoxantrone|mesh-list
153389591|NCT00002517|Thioguanine|thioguanine|mesh-list
153389592|NCT00002517|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153389593|NCT00002517|Antiemetics|antiemetics|mesh-ancestor
153389594|NCT00002517|Autonomic Agents|autonomic agents|mesh-ancestor
153389595|NCT00002517|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153389596|NCT00002517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153389597|NCT00002517|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153389598|NCT00002517|Glucocorticoids|glucocorticoids|mesh-ancestor
153389599|NCT00002517|Hormones|hormones|mesh-ancestor
153389600|NCT00002517|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153389601|NCT00002517|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153389602|NCT00002517|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153389603|NCT00002517|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153389604|NCT00002517|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153389605|NCT00002517|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153389606|NCT00002517|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153849417|NCT05341817|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
153849418|NCT05341817|Hormone Antagonists|hormone antagonists|mesh-ancestor
153849419|NCT05341817|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153849420|NCT05341817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153849421|NCT05341817|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
153849422|NCT05341817|Abortifacient Agents|abortifacient agents|mesh-ancestor
153849423|NCT05341817|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153849424|NCT05341817|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
153849425|NCT05341817|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
153849440|NCT05290090|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153849441|NCT05290090|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153849442|NCT05290090|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153849443|NCT05290090|Growth Substances|growth substances|mesh-ancestor
153849444|NCT05290090|Growth Inhibitors|growth inhibitors|mesh-ancestor
153849445|NCT05290090|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153849446|NCT05290090|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153849447|NCT05290090|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153849448|NCT05290090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153849449|NCT05275725|Sildenafil Citrate|sildenafil citrate|mesh-list
153849450|NCT05275725|Vasodilator Agents|vasodilator agents|mesh-ancestor
153849451|NCT05275725|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
153389608|NCT00002517|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153389610|NCT00002517|Antiviral Agents|antiviral agents|mesh-ancestor
153389611|NCT00002517|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153389612|NCT00002517|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153389613|NCT00002517|Immunologic Factors|immunologic factors|mesh-ancestor
153389614|NCT00002517|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153389615|NCT00002517|Analgesics|analgesics|mesh-ancestor
153389616|NCT00002517|Sensory System Agents|sensory system agents|mesh-ancestor
153389617|NCT00002277|Fluconazole|fluconazole|mesh-list
153389618|NCT00002277|Amphotericin B|amphotericin b|mesh-list
153389619|NCT00002277|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
153389620|NCT00002277|Antifungal Agents|antifungal agents|mesh-ancestor
153389621|NCT00002277|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153389633|NCT00002277|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153389634|NCT00002277|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153389635|NCT00002277|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153849452|NCT05275725|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
153849453|NCT05275725|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153849454|NCT05275725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153849455|NCT05275725|Urological Agents|urological agents|mesh-ancestor
153849457|NCT05259319|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153849458|NCT05259319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153849459|NCT05259319|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153849460|NCT05259319|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153849461|NCT05204290|Pembrolizumab|pembrolizumab|mesh-list
153849462|NCT05204290|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153849463|NCT05204290|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153849464|NCT05204290|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153849465|NCT05204290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153849466|NCT05197426|Azacitidine|azacitidine|mesh-list
153849467|NCT05197426|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153849468|NCT05197426|Antimetabolites|antimetabolites|mesh-ancestor
153849469|NCT05197426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153849470|NCT05197426|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153849471|NCT05197426|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153849472|NCT05193227|Lidocaine|lidocaine|mesh-list
153849473|NCT05193227|Bupivacaine|bupivacaine|mesh-list
153849474|NCT05193227|Anesthetics, Local|anesthetics, local|mesh-ancestor
153849475|NCT05193227|Anesthetics|anesthetics|mesh-ancestor
153849476|NCT05193227|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153849477|NCT05193227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153389636|NCT00002523|Leucovorin|leucovorin|mesh-list
153389637|NCT00002523|Fluorouracil|fluorouracil|mesh-list
153389638|NCT00002523|Calcium|calcium|mesh-list
153389639|NCT00002523|Levoleucovorin|levoleucovorin|mesh-list
153389640|NCT00002523|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153389641|NCT00002523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153389642|NCT00002523|Antimetabolites|antimetabolites|mesh-ancestor
153389644|NCT00002523|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153849491|NCT05097599|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153849492|NCT05097599|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153849493|NCT05097599|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153389653|NCT00002529|Tamoxifen|tamoxifen|mesh-list
153389654|NCT00002529|Toremifene|toremifene|mesh-list
153389655|NCT00002529|Cyclophosphamide|cyclophosphamide|mesh-list
153389656|NCT00002529|Doxorubicin|doxorubicin|mesh-list
153389657|NCT00002529|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
153389658|NCT00002529|Epirubicin|epirubicin|mesh-list
153389659|NCT00002529|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153389660|NCT00002529|Immunologic Factors|immunologic factors|mesh-ancestor
153389661|NCT00002529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153389662|NCT00002529|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153389663|NCT00002529|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153389664|NCT00002529|Alkylating Agents|alkylating agents|mesh-ancestor
153389665|NCT00002529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153389666|NCT00002529|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153389667|NCT00002529|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153389668|NCT00002529|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153389669|NCT00002529|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153389670|NCT00002529|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153389671|NCT00002529|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153389672|NCT00002529|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
153389673|NCT00002529|Hormone Antagonists|hormone antagonists|mesh-ancestor
153849507|NCT05048498|Antimetabolites|antimetabolites|mesh-ancestor
153849508|NCT05048498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153849509|NCT05048498|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153849510|NCT05048498|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153849511|NCT05009862|Aspirin|aspirin|mesh-list
153849512|NCT05009862|Rivaroxaban|rivaroxaban|mesh-list
153849513|NCT05009862|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153389674|NCT00002529|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153389675|NCT00002529|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153389676|NCT00002529|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
153389677|NCT00002529|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
153389678|NCT00002529|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153389691|NCT00002217|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153389692|NCT00002217|Antimetabolites|antimetabolites|mesh-ancestor
153389693|NCT00002217|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
153389694|NCT00002217|Antitubercular Agents|antitubercular agents|mesh-ancestor
153389695|NCT00002217|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153849514|NCT05009862|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153849515|NCT05009862|Analgesics|analgesics|mesh-ancestor
153849516|NCT05009862|Sensory System Agents|sensory system agents|mesh-ancestor
153849517|NCT05009862|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153849530|NCT05009862|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
153849531|NCT05009862|Protease Inhibitors|protease inhibitors|mesh-ancestor
153849532|NCT05009862|Anticoagulants|anticoagulants|mesh-ancestor
153849533|NCT04938583|Paclitaxel|paclitaxel|mesh-list
153849534|NCT04938583|Bevacizumab|bevacizumab|mesh-list
153849535|NCT04938583|Carboplatin|carboplatin|mesh-list
153849536|NCT04938583|Oregovomab|oregovomab|mesh-list
153849537|NCT04938583|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153389696|NCT00002217|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
153389697|NCT00002217|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
153389698|NCT00002217|Protease Inhibitors|protease inhibitors|mesh-ancestor
153389700|NCT00002283|Dapsone|dapsone|mesh-list
153389701|NCT00002283|Sulfamethoxazole|sulfamethoxazole|mesh-list
153389702|NCT00002283|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
153389703|NCT00002283|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153389704|NCT00002283|Antimalarials|antimalarials|mesh-ancestor
153849539|NCT04938583|Tubulin Modulators|tubulin modulators|mesh-ancestor
153849540|NCT04938583|Antimitotic Agents|antimitotic agents|mesh-ancestor
153849541|NCT04938583|Mitosis Modulators|mitosis modulators|mesh-ancestor
153849542|NCT04938583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153849543|NCT04938583|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153849544|NCT04938583|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153849545|NCT04938583|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153849546|NCT04938583|Growth Substances|growth substances|mesh-ancestor
153849547|NCT04938583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153849548|NCT04938583|Growth Inhibitors|growth inhibitors|mesh-ancestor
153849549|NCT04763564|Liraglutide|liraglutide|mesh-list
153849550|NCT04763564|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
153849551|NCT04763564|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153849552|NCT04763564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153849553|NCT04763564|Incretins|incretins|mesh-ancestor
153429616|NCT01821859|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153429617|NCT01821859|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153389711|NCT00002283|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
153389712|NCT00002283|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153389713|NCT00002283|Leprostatic Agents|leprostatic agents|mesh-ancestor
153389714|NCT00002283|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153389717|NCT04826237|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
153389718|NCT04826237|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
153389719|NCT04826237|Prednisolone|prednisolone|mesh-list
153389720|NCT04826237|Prednisolone acetate|prednisolone acetate|mesh-list
153389721|NCT04826237|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-list
153389722|NCT04826237|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
153389723|NCT04826237|Prednisolone phosphate|prednisolone phosphate|mesh-list
153389724|NCT04826237|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153389725|NCT04826237|Antiemetics|antiemetics|mesh-ancestor
153389726|NCT04826237|Autonomic Agents|autonomic agents|mesh-ancestor
153389727|NCT04826237|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153389728|NCT04826237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153849560|NCT04743505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153849562|NCT04742504|Benralizumab|benralizumab|mesh-list
153849563|NCT04742504|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153849564|NCT04742504|Respiratory System Agents|respiratory system agents|mesh-ancestor
153849565|NCT04683315|Paclitaxel|paclitaxel|mesh-list
153849566|NCT04683315|Gemcitabine|gemcitabine|mesh-list
153849567|NCT04683315|Fluorouracil|fluorouracil|mesh-list
153849568|NCT04683315|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153849569|NCT04683315|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153849570|NCT04683315|Tubulin Modulators|tubulin modulators|mesh-ancestor
153849571|NCT04683315|Antimitotic Agents|antimitotic agents|mesh-ancestor
153849572|NCT04683315|Mitosis Modulators|mitosis modulators|mesh-ancestor
153849573|NCT04683315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153849574|NCT04683315|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153849575|NCT04683315|Antimetabolites|antimetabolites|mesh-ancestor
153389735|NCT04826237|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
153389736|NCT04826237|Protective Agents|protective agents|mesh-ancestor
153389737|NCT04826237|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153389738|NCT04826237|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153389739|NCT04826237|Antimetabolites|antimetabolites|mesh-ancestor
153389740|NCT04826237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153389741|NCT04826237|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153888528|NCT05644691|Emollients|emollients|mesh-list
153849577|NCT04683315|Immunologic Factors|immunologic factors|mesh-ancestor
153849578|NCT04683315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153849579|NCT04645667|Tacrolimus|tacrolimus|mesh-list
153849580|NCT04645667|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153849581|NCT04645667|Immunologic Factors|immunologic factors|mesh-ancestor
153849582|NCT04645667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153849583|NCT04645667|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
153849584|NCT04645667|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153849585|NCT04645667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153849586|NCT04644029|Tenofovir|tenofovir|mesh-list
153849587|NCT04644029|Emtricitabine|emtricitabine|mesh-list
153849588|NCT04644029|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
153849589|NCT04644029|Islatravir|islatravir|mesh-list
153389750|NCT00002535|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153389751|NCT00002535|Alkylating Agents|alkylating agents|mesh-ancestor
153389760|NCT00002535|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153389762|NCT00002535|Sensory System Agents|sensory system agents|mesh-ancestor
153389763|NCT00002535|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153849590|NCT04644029|Antiviral Agents|antiviral agents|mesh-ancestor
153849591|NCT04644029|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153849592|NCT04644029|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153849593|NCT04644029|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153849594|NCT04644029|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153849595|NCT04644029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153849596|NCT04644029|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153849597|NCT04644029|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153849598|NCT04621526|Dexmedetomidine|dexmedetomidine|mesh-list
153849600|NCT04621526|Propofol|propofol|mesh-list
153849601|NCT04621526|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153849602|NCT04621526|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153849603|NCT04621526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153849604|NCT04621526|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153389764|NCT00002535|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153389765|NCT00002535|Gout Suppressants|gout suppressants|mesh-ancestor
153389766|NCT00002535|Tocolytic Agents|tocolytic agents|mesh-ancestor
153389767|NCT00002535|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153389768|NCT00002535|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153389769|NCT00002535|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153389780|NCT00002547|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153389784|NCT00002547|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153389785|NCT00002547|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
153389786|NCT00002547|Abortifacient Agents|abortifacient agents|mesh-ancestor
153849605|NCT04621526|Analgesics|analgesics|mesh-ancestor
153849606|NCT04621526|Sensory System Agents|sensory system agents|mesh-ancestor
153849607|NCT04621526|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153849608|NCT04621526|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
153849609|NCT04621526|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153849610|NCT04621526|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153849611|NCT04621526|Adrenergic Agents|adrenergic agents|mesh-ancestor
153849612|NCT04621526|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153849613|NCT04621526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153849614|NCT04621526|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153849615|NCT04621526|Anesthetics, General|anesthetics, general|mesh-ancestor
153849616|NCT04621526|Anesthetics|anesthetics|mesh-ancestor
153849617|NCT04621526|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
153849618|NCT04621526|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
153389788|NCT00002547|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153389790|NCT00002547|Dermatologic Agents|dermatologic agents|mesh-ancestor
153389791|NCT00002547|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153389792|NCT00002547|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153389793|NCT00002547|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153389794|NCT00002547|Antiviral Agents|antiviral agents|mesh-ancestor
153389795|NCT00002547|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153389796|NCT00002547|Antifungal Agents|antifungal agents|mesh-ancestor
153389797|NCT00002547|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
153389799|NCT00002289|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153389800|NCT00002289|Immunologic Factors|immunologic factors|mesh-ancestor
153389801|NCT00002289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153389803|NCT00002553|Cyclophosphamide|cyclophosphamide|mesh-list
153849627|NCT04592809|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153849628|NCT04592809|Anesthetics, General|anesthetics, general|mesh-ancestor
153849629|NCT04592809|Anesthetics|anesthetics|mesh-ancestor
153849630|NCT04592809|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153849631|NCT04592809|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
153849632|NCT04592809|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
153849633|NCT04592809|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153849634|NCT04592809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153849635|NCT04592809|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153849636|NCT04592809|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153849637|NCT04592809|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153849638|NCT04592809|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153849639|NCT04592809|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153849640|NCT04592809|GABA Modulators|gaba modulators|mesh-ancestor
153849641|NCT04592809|GABA Agents|gaba agents|mesh-ancestor
153389804|NCT00002553|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153389805|NCT00002553|Immunologic Factors|immunologic factors|mesh-ancestor
153389806|NCT00002553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153389807|NCT00002553|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153849642|NCT04584255|Niraparib|niraparib|mesh-list
153849643|NCT04584255|Dostarlimab|dostarlimab|mesh-list
153849644|NCT04584255|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
153849645|NCT04584255|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153849646|NCT04584255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153849647|NCT04584255|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153849648|NCT04567407|Ropivacaine|ropivacaine|mesh-list
153849649|NCT04567407|Anesthetics, Local|anesthetics, local|mesh-ancestor
153849650|NCT04567407|Anesthetics|anesthetics|mesh-ancestor
153389822|NCT00002559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153389824|NCT00002559|Alkylating Agents|alkylating agents|mesh-ancestor
153389825|NCT00002565|Cytarabine|cytarabine|mesh-list
153389826|NCT00002565|Prednisone|prednisone|mesh-list
153389829|NCT00002565|Ifosfamide|ifosfamide|mesh-list
153389830|NCT00002565|Doxorubicin|doxorubicin|mesh-list
153429623|NCT05600023|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153429624|NCT05600023|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
153389831|NCT00002565|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
153389832|NCT00002565|Etoposide|etoposide|mesh-list
153389833|NCT00002565|Vincristine|vincristine|mesh-list
153389834|NCT00002565|Mitoxantrone|mitoxantrone|mesh-list
153389835|NCT00002565|Idarubicin|idarubicin|mesh-list
153389836|NCT00002565|Bleomycin|bleomycin|mesh-list
153389837|NCT00002565|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153389838|NCT00002565|Immunologic Factors|immunologic factors|mesh-ancestor
153389839|NCT00002565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153389840|NCT00002565|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153389841|NCT00002565|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153389842|NCT00002565|Alkylating Agents|alkylating agents|mesh-ancestor
153849659|NCT04465097|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153849660|NCT04465097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153849661|NCT04465097|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
153849662|NCT04465097|Hormone Antagonists|hormone antagonists|mesh-ancestor
153849663|NCT04465097|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153849664|NCT04465097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153849665|NCT04462588|Metronidazole|metronidazole|mesh-list
153849666|NCT04462588|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153849667|NCT04462588|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153849668|NCT04462588|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153849669|NCT04462588|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153849670|NCT04404140|Docetaxel|docetaxel|mesh-list
153849671|NCT04404140|Atezolizumab|atezolizumab|mesh-list
153849672|NCT04404140|Ipatasertib|ipatasertib|mesh-list
153849673|NCT04404140|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153849674|NCT04404140|Tubulin Modulators|tubulin modulators|mesh-ancestor
153849675|NCT04404140|Antimitotic Agents|antimitotic agents|mesh-ancestor
153849676|NCT04404140|Mitosis Modulators|mitosis modulators|mesh-ancestor
153849677|NCT04404140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153389843|NCT00002565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153389844|NCT00002565|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153389845|NCT00002565|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153389870|NCT00002565|Sensory System Agents|sensory system agents|mesh-ancestor
153389871|NCT00002571|Leucovorin|leucovorin|mesh-list
153389872|NCT00002571|Cytarabine|cytarabine|mesh-list
153389873|NCT00002571|Trimethoprim|trimethoprim|mesh-list
153389874|NCT00002571|Sulfamethoxazole|sulfamethoxazole|mesh-list
153389875|NCT00002571|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
153389876|NCT00002571|Prednisone|prednisone|mesh-list
153389877|NCT00002571|Cyclophosphamide|cyclophosphamide|mesh-list
153389878|NCT00002571|Doxorubicin|doxorubicin|mesh-list
153389879|NCT00002571|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
153389880|NCT00002571|Methotrexate|methotrexate|mesh-list
153849678|NCT04404140|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153849679|NCT04404140|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153849680|NCT04404140|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153849681|NCT04404140|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153849683|NCT04346654|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153849684|NCT04346654|Antiemetics|antiemetics|mesh-ancestor
153849685|NCT04346654|Autonomic Agents|autonomic agents|mesh-ancestor
153849686|NCT04346654|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153849687|NCT04346654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153849688|NCT04346654|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153849689|NCT04346654|Glucocorticoids|glucocorticoids|mesh-ancestor
153849690|NCT04346654|Hormones|hormones|mesh-ancestor
153849691|NCT04346654|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153849692|NCT04346654|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153849693|NCT04346654|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153849694|NCT04291508|Acetaminophen|acetaminophen|mesh-list
153849695|NCT04291508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153849696|NCT04291508|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153849697|NCT04291508|Analgesics|analgesics|mesh-ancestor
153849698|NCT04291508|Sensory System Agents|sensory system agents|mesh-ancestor
153849699|NCT04291508|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153849700|NCT04291508|Antipyretics|antipyretics|mesh-ancestor
153849701|NCT04169191|Sildenafil Citrate|sildenafil citrate|mesh-list
153849705|NCT04169191|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
153849706|NCT04169191|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153849707|NCT04169191|Urological Agents|urological agents|mesh-ancestor
153849708|NCT04160325|Azathioprine|azathioprine|mesh-list
153849709|NCT04160325|Antimetabolites|antimetabolites|mesh-ancestor
153849710|NCT04160325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153849711|NCT04160325|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153849712|NCT04160325|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153849713|NCT04160325|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153389881|NCT00002571|Etoposide|etoposide|mesh-list
153389882|NCT00002571|Vincristine|vincristine|mesh-list
153389883|NCT00002571|Bleomycin|bleomycin|mesh-list
153389884|NCT00002571|Levoleucovorin|levoleucovorin|mesh-list
153389885|NCT00002571|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153389886|NCT00002571|Immunologic Factors|immunologic factors|mesh-ancestor
153389887|NCT00002571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153389888|NCT00002571|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153389889|NCT00002571|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153389890|NCT00002571|Alkylating Agents|alkylating agents|mesh-ancestor
153389891|NCT00002571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153389892|NCT00002571|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153389893|NCT00002571|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153389894|NCT00002571|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153389895|NCT00002571|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153389896|NCT00002571|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153389897|NCT00002571|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153389898|NCT00002571|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153389899|NCT00002571|Glucocorticoids|glucocorticoids|mesh-ancestor
153389900|NCT00002571|Hormones|hormones|mesh-ancestor
153389901|NCT00002571|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153389916|NCT00002571|Vitamin B Complex|vitamin b complex|mesh-ancestor
153389917|NCT00002571|Vitamins|vitamins|mesh-ancestor
153849714|NCT04160325|Immunologic Factors|immunologic factors|mesh-ancestor
153849723|NCT04154189|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153849724|NCT04154189|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153849725|NCT04154189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153849726|NCT04154189|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153849727|NCT04154189|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153849728|NCT04154189|Alkylating Agents|alkylating agents|mesh-ancestor
153849729|NCT04108481|Durvalumab|durvalumab|mesh-list
153849730|NCT04108481|Methamphetamine|methamphetamine|mesh-list
153849731|NCT04108481|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
153849732|NCT04108481|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153849733|NCT04108481|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153849734|NCT04108481|Immunologic Factors|immunologic factors|mesh-ancestor
153849735|NCT04108481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153849736|NCT04108481|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
153389930|NCT00360815|Insulin|insulin|mesh-list
153389931|NCT00360815|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153389932|NCT00360815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153389933|NCT00002583|Vinorelbine|vinorelbine|mesh-list
153389934|NCT00002583|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153389935|NCT00002583|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153389936|NCT00002583|Tubulin Modulators|tubulin modulators|mesh-ancestor
153389937|NCT00002583|Antimitotic Agents|antimitotic agents|mesh-ancestor
153389938|NCT00002583|Mitosis Modulators|mitosis modulators|mesh-ancestor
153389939|NCT00002583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153389940|NCT00002589|Aldesleukin|aldesleukin|mesh-list
153389941|NCT00002589|Muromonab-CD3|muromonab-cd3|mesh-list
153849751|NCT04073303|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
153849752|NCT04073303|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153849753|NCT04073303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153849754|NCT04073303|Cholinergic Agents|cholinergic agents|mesh-ancestor
153849755|NCT04073303|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153849756|NCT04073303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153849757|NCT04073303|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
153849758|NCT04073303|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153849759|NCT04048161|Mycophenolic Acid|mycophenolic acid|mesh-list
153849760|NCT04048161|Tacrolimus|tacrolimus|mesh-list
153849761|NCT04048161|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153849762|NCT04048161|Immunologic Factors|immunologic factors|mesh-ancestor
153849763|NCT04048161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153849764|NCT04048161|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
153849765|NCT04048161|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153849766|NCT04048161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153849767|NCT04048161|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153849768|NCT04048161|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153849769|NCT04048161|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
153849770|NCT04048161|Antitubercular Agents|antitubercular agents|mesh-ancestor
153849771|NCT04048161|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153389942|NCT00002589|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153389943|NCT00002589|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153389944|NCT00002589|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153389945|NCT00002589|Antiviral Agents|antiviral agents|mesh-ancestor
153389946|NCT00002589|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153389947|NCT00002589|Immunologic Factors|immunologic factors|mesh-ancestor
153389948|NCT00002589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153389949|NCT00002589|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153849772|NCT04048161|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153849773|NCT04032964|Doxorubicin|doxorubicin|mesh-list
153849774|NCT04032964|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153849777|NCT04032964|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153849778|NCT04032964|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153849779|NCT04032964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153849780|NCT03949673|Celecoxib|celecoxib|mesh-list
153381904|NCT00375687|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153849781|NCT03949673|Diclofenac|diclofenac|mesh-list
153849782|NCT03949673|Naproxen|naproxen|mesh-list
153849783|NCT03949673|Fasinumab|fasinumab|mesh-list
153849784|NCT03949673|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153849785|NCT03949673|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153849787|NCT03949673|Sensory System Agents|sensory system agents|mesh-ancestor
153849788|NCT03949673|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153849789|NCT03949673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153849790|NCT03949673|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153849791|NCT03949673|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153849792|NCT03949673|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
153849793|NCT03949673|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153849794|NCT03949673|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153849795|NCT03949673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153849797|NCT03919955|Oxybutynin|oxybutynin|mesh-list
153389990|NCT00002625|Topotecan|topotecan|mesh-list
153389991|NCT00002625|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
153389992|NCT00002625|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153389993|NCT00002625|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153389994|NCT00002625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153389995|NCT00002625|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153849804|NCT03919955|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153849805|NCT03919955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153849806|NCT03919955|Parasympatholytics|parasympatholytics|mesh-ancestor
153849807|NCT03919955|Autonomic Agents|autonomic agents|mesh-ancestor
153849808|NCT03919955|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153849809|NCT03919955|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
153849810|NCT03919955|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
153849811|NCT03919955|Cholinergic Agents|cholinergic agents|mesh-ancestor
153849812|NCT03919955|Urological Agents|urological agents|mesh-ancestor
153849813|NCT03830164|Vitamins|vitamins|mesh-list
153849814|NCT03830164|Vitamin E|vitamin e|mesh-list
153849815|NCT03830164|Tocopherols|tocopherols|mesh-list
153849816|NCT03830164|Tocotrienols|tocotrienols|mesh-list
153849818|NCT03830164|Pentoxifylline|pentoxifylline|mesh-list
153849819|NCT03830164|Atorvastatin|atorvastatin|mesh-list
153849820|NCT03830164|Micronutrients|micronutrients|mesh-ancestor
153849821|NCT03830164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153849822|NCT03830164|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153849823|NCT03830164|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153849824|NCT03830164|Antimetabolites|antimetabolites|mesh-ancestor
153914608|NCT02709187|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
153389996|NCT00360737|Antitoxins|antitoxins|mesh-list
153389997|NCT00360737|Botulinum Antitoxin|botulinum antitoxin|mesh-list
153389998|NCT00360737|Immunologic Factors|immunologic factors|mesh-ancestor
153389999|NCT00360737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153390000|NCT04343729|Methylprednisolone|methylprednisolone|mesh-list
153390001|NCT04343729|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
153390002|NCT04343729|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
153390003|NCT04343729|Prednisolone|prednisolone|mesh-list
153390004|NCT04343729|Prednisolone acetate|prednisolone acetate|mesh-list
153390005|NCT04343729|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
153390006|NCT04343729|Prednisolone phosphate|prednisolone phosphate|mesh-list
153390007|NCT04343729|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153390008|NCT04343729|Antiemetics|antiemetics|mesh-ancestor
153390009|NCT04343729|Autonomic Agents|autonomic agents|mesh-ancestor
153390010|NCT04343729|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153390012|NCT04343729|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153849826|NCT03830164|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153849827|NCT03830164|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
153849828|NCT03830164|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153849829|NCT03830164|Antioxidants|antioxidants|mesh-ancestor
153849830|NCT03830164|Protective Agents|protective agents|mesh-ancestor
153849831|NCT03830164|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
153849832|NCT03830164|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153849833|NCT03830164|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
153849834|NCT03830164|Vasodilator Agents|vasodilator agents|mesh-ancestor
153849835|NCT03830164|Free Radical Scavengers|free radical scavengers|mesh-ancestor
153849836|NCT03795311|Bevacizumab|bevacizumab|mesh-list
153849837|NCT03795311|Folfirinox|folfirinox|mesh-list
153849849|NCT03776136|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153849850|NCT03776136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153849851|NCT03776136|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153849852|NCT03776136|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153381905|NCT00375687|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153849854|NCT03769181|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153849855|NCT03769181|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153390030|NCT00002637|Interferon-gamma|interferon-gamma|mesh-list
153390031|NCT00002637|Vaccines|vaccines|mesh-list
153390032|NCT00002637|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153390033|NCT00002637|Antiviral Agents|antiviral agents|mesh-ancestor
153390034|NCT00002637|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153390036|NCT00002637|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153390037|NCT00002637|Immunologic Factors|immunologic factors|mesh-ancestor
153390038|NCT00002637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153390039|NCT02977013|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
153390040|NCT02977013|Dalteparin|dalteparin|mesh-list
153390041|NCT02977013|Anticoagulants|anticoagulants|mesh-ancestor
153390042|NCT02977013|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153390043|NCT02977013|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153390044|NCT02977013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153390045|NCT05806918|Interferons|interferons|mesh-list
153390046|NCT05806918|Interferon alpha-2|interferon alpha-2|mesh-list
153390047|NCT05806918|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153390048|NCT05806918|Antiviral Agents|antiviral agents|mesh-ancestor
153390049|NCT05806918|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153390050|NCT00002241|Ritonavir|ritonavir|mesh-list
153390051|NCT00002241|Indinavir|indinavir|mesh-list
153390052|NCT00002241|Lamivudine|lamivudine|mesh-list
153390053|NCT00002241|Stavudine|stavudine|mesh-list
153390054|NCT00002241|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
153390055|NCT00002241|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
153390056|NCT00002241|Protease Inhibitors|protease inhibitors|mesh-ancestor
153390057|NCT00002241|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153390058|NCT00002241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153390059|NCT00002241|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153390060|NCT00002241|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153390061|NCT00002241|Antiviral Agents|antiviral agents|mesh-ancestor
153390062|NCT00002241|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153849856|NCT03638297|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-list
153849857|NCT03638297|Antibodies|antibodies|mesh-list
153849858|NCT03638297|Immunologic Factors|immunologic factors|mesh-ancestor
153849859|NCT03638297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153849860|NCT03638297|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153849861|NCT03638297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153849862|NCT03638297|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153849863|NCT03638297|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153849864|NCT03638297|Analgesics|analgesics|mesh-ancestor
153849865|NCT03638297|Sensory System Agents|sensory system agents|mesh-ancestor
153849866|NCT03638297|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153849867|NCT03638297|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153849868|NCT03638297|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153849869|NCT03621696|Cisplatin|cisplatin|mesh-list
153849870|NCT03621696|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153849886|NCT03386539|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153849887|NCT03386539|Immunologic Factors|immunologic factors|mesh-ancestor
153849888|NCT03386539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153390082|NCT05806671|Fulvestrant|fulvestrant|mesh-list
153390085|NCT05806671|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
153390086|NCT05806671|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
153390087|NCT05806671|Hormone Antagonists|hormone antagonists|mesh-ancestor
153390088|NCT05806671|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153390089|NCT05806671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153390090|NCT05806476|Caffeine|caffeine|mesh-list
153390091|NCT05806476|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
153390092|NCT05806476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153390093|NCT05806476|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
153390094|NCT05806476|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153390095|NCT05806476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153390096|NCT05806476|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
153390097|NCT05806476|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
153390098|NCT05806476|Purinergic Agents|purinergic agents|mesh-ancestor
153390099|NCT05806476|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153390100|NCT05806307|Vasopressins|vasopressins|mesh-list
153390101|NCT05806307|Arginine Vasopressin|arginine vasopressin|mesh-list
153390102|NCT05806307|Epinephrine|epinephrine|mesh-list
153390103|NCT05806307|Bupivacaine|bupivacaine|mesh-list
153390104|NCT05806307|Misoprostol|misoprostol|mesh-list
153390105|NCT05806307|Ethamsylate|ethamsylate|mesh-list
153390106|NCT05806307|Oxytocin|oxytocin|mesh-list
153390107|NCT05806307|Carbetocin|carbetocin|mesh-list
153390108|NCT05806307|Anesthetics, Local|anesthetics, local|mesh-ancestor
153849899|NCT03386539|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153849900|NCT03366103|Navitoclax|navitoclax|mesh-list
153849901|NCT03366103|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153849902|NCT03304821|Sargramostim|sargramostim|mesh-list
153849905|NCT03267121|Apatinib|apatinib|mesh-list
153849918|NCT03095352|Trastuzumab|trastuzumab|mesh-list
153849919|NCT03095352|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153849920|NCT03095352|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153849921|NCT03095352|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153849922|NCT03095352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153849923|NCT03088813|Irinotecan|irinotecan|mesh-list
153849924|NCT03088813|Topotecan|topotecan|mesh-list
153849925|NCT03088813|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
153849926|NCT03088813|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153849927|NCT03088813|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153849928|NCT03088813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153849929|NCT03088813|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153849930|NCT03061474|Niacinamide|niacinamide|mesh-list
153849931|NCT03061474|Niacin|niacin|mesh-list
153390113|NCT05806307|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153390114|NCT05806307|Oxytocics|oxytocics|mesh-ancestor
153390115|NCT05806307|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153390116|NCT05806307|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153390117|NCT05806307|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153390118|NCT05806307|Adrenergic Agents|adrenergic agents|mesh-ancestor
153849935|NCT03061474|Micronutrients|micronutrients|mesh-ancestor
153849936|NCT03061474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153849937|NCT03061474|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153849938|NCT03061474|Antimetabolites|antimetabolites|mesh-ancestor
153849939|NCT03061474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153849940|NCT03061474|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153849941|NCT03061474|Vasodilator Agents|vasodilator agents|mesh-ancestor
153849942|NCT03040726|Palonosetron|palonosetron|mesh-list
153849943|NCT03040726|Antiemetics|antiemetics|mesh-ancestor
153849944|NCT03040726|Autonomic Agents|autonomic agents|mesh-ancestor
153849945|NCT03040726|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153849946|NCT03040726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153849947|NCT03040726|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153849948|NCT03040726|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
153849949|NCT03040726|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153849950|NCT03040726|Serotonin Agents|serotonin agents|mesh-ancestor
153849951|NCT03040726|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153849952|NCT03040726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153849953|NCT02899728|Cisplatin|cisplatin|mesh-list
153849954|NCT02899728|Carboplatin|carboplatin|mesh-list
153849955|NCT02899728|Etoposide|etoposide|mesh-list
153849956|NCT02899728|Etoposide phosphate|etoposide phosphate|mesh-list
153849957|NCT02899728|Olaparib|olaparib|mesh-list
153390162|NCT05805553|Propranolol|propranolol|mesh-list
153390163|NCT05805553|Nandrolone|nandrolone|mesh-list
153390164|NCT05805553|Nandrolone phenpropionate|nandrolone phenpropionate|mesh-list
153390165|NCT05805553|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
153390166|NCT05805553|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
153390167|NCT05805553|Adrenergic Agents|adrenergic agents|mesh-ancestor
153390168|NCT05805553|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153390169|NCT05805553|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153390170|NCT05805553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153849976|NCT02780804|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
153849977|NCT02780804|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153849978|NCT02780804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153849979|NCT02604459|Fentanyl|fentanyl|mesh-list
153849980|NCT02604459|Anesthetics|anesthetics|mesh-list
153849981|NCT02604459|Propofol|propofol|mesh-list
153849982|NCT02604459|Sevoflurane|sevoflurane|mesh-list
153849983|NCT02604459|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153888549|NCT01093222|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153888550|NCT01093222|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153888551|NCT01093222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153888552|NCT01093222|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153849984|NCT02604459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153849985|NCT02604459|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153849986|NCT02604459|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153849988|NCT02604459|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153849989|NCT02604459|Narcotics|narcotics|mesh-ancestor
153849990|NCT02604459|Analgesics|analgesics|mesh-ancestor
153849991|NCT02604459|Sensory System Agents|sensory system agents|mesh-ancestor
153381906|NCT01658241|Panobinostat|panobinostat|mesh-list
153381907|NCT01658241|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153381908|NCT01658241|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
153382086|NCT02333045|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
153849992|NCT02604459|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153849993|NCT02604459|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153849994|NCT02604459|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153849995|NCT02604459|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
153849996|NCT02543268|Smallpox and monkeypox vaccine modified vaccinia ankara-bavarian nordic|smallpox and monkeypox vaccine modified vaccinia ankara-bavarian nordic|mesh-list
153849997|NCT02543268|Antiviral Agents|antiviral agents|mesh-ancestor
153390171|NCT05805553|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153390172|NCT05805553|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153390173|NCT05805553|Vasodilator Agents|vasodilator agents|mesh-ancestor
153390175|NCT05805553|Hormones|hormones|mesh-ancestor
153390177|NCT05805553|Anabolic Agents|anabolic agents|mesh-ancestor
153850005|NCT02136147|Guanfacine|guanfacine|mesh-list
153850006|NCT02136147|Methylphenidate|methylphenidate|mesh-list
153850007|NCT02136147|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
153850008|NCT02136147|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
153850009|NCT02136147|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
153850010|NCT02136147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153850011|NCT02136147|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
153850012|NCT02136147|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153850013|NCT02136147|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153850014|NCT02136147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153850015|NCT02136147|Dopamine Agents|dopamine agents|mesh-ancestor
153850016|NCT02136147|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153850017|NCT02136147|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
153850018|NCT02136147|Adrenergic Agents|adrenergic agents|mesh-ancestor
153850019|NCT02136147|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153850020|NCT02136147|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
153850021|NCT02136147|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153850022|NCT02136147|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153850023|NCT02090101|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
153850024|NCT02090101|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153850025|NCT02017704|Leucovorin|leucovorin|mesh-list
153850026|NCT02017704|Capecitabine|capecitabine|mesh-list
153850027|NCT02017704|Fluorouracil|fluorouracil|mesh-list
153850028|NCT02017704|Oxaliplatin|oxaliplatin|mesh-list
153850029|NCT02017704|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153390228|NCT05751044|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153390229|NCT05751044|Antiemetics|antiemetics|mesh-ancestor
153390230|NCT05751044|Autonomic Agents|autonomic agents|mesh-ancestor
153390231|NCT05751044|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153850038|NCT02017704|Vitamin B Complex|vitamin b complex|mesh-ancestor
153850039|NCT02017704|Vitamins|vitamins|mesh-ancestor
153850040|NCT02017704|Micronutrients|micronutrients|mesh-ancestor
153390232|NCT05751044|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153390234|NCT05751044|Hormones|hormones|mesh-ancestor
153850041|NCT02005471|Rituximab|rituximab|mesh-list
153850042|NCT02005471|Venetoclax|venetoclax|mesh-list
153850043|NCT02005471|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
153850044|NCT02005471|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153850045|NCT02005471|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153850046|NCT02005471|Immunologic Factors|immunologic factors|mesh-ancestor
153850047|NCT02005471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153850048|NCT02005471|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153850049|NCT02005471|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153850050|NCT02005471|Alkylating Agents|alkylating agents|mesh-ancestor
153850052|NCT01933932|Docetaxel|docetaxel|mesh-list
153850088|NCT04661345|Coagulase|coagulase|mesh-list
153850089|NCT04661345|Coagulants|coagulants|mesh-ancestor
153850090|NCT00540072|Daptomycin|daptomycin|mesh-list
153850091|NCT00540072|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153390267|NCT05648201|Raltegravir Potassium|raltegravir potassium|mesh-list
153390268|NCT05648201|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153390269|NCT05648201|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153390270|NCT05648201|Antiviral Agents|antiviral agents|mesh-ancestor
153390271|NCT05648201|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153390272|NCT05648201|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
153390273|NCT05648201|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
153390274|NCT05648201|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153390275|NCT05648201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153390276|NCT05511870|Etripamil|etripamil|mesh-list
153390277|NCT05511870|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153390278|NCT05511870|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153390282|NCT05492851|Hylan|hylan|mesh-list
153850124|NCT01208038|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153850125|NCT01208038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153850126|NCT01208038|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153850127|NCT01208038|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153850128|NCT01208038|Anabolic Agents|anabolic agents|mesh-ancestor
153850129|NCT04659785|Apatinib|apatinib|mesh-list
153850130|NCT04659785|Fluzoparib|fluzoparib|mesh-list
153850131|NCT04659785|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153850132|NCT04659785|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153850133|NCT04659785|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153850176|NCT01207414|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153850177|NCT01207414|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153850178|NCT01207414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153850179|NCT01207414|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153850180|NCT00540384|Darbepoetin alfa|darbepoetin alfa|mesh-list
153850181|NCT00540384|Hematinics|hematinics|mesh-ancestor
153850182|NCT04659551|Cyclophosphamide|cyclophosphamide|mesh-list
153850183|NCT04659551|Nivolumab|nivolumab|mesh-list
153850184|NCT04659551|Epirubicin|epirubicin|mesh-list
153850185|NCT04659551|Exemestane|exemestane|mesh-list
153850186|NCT04659551|Triptorelin Pamoate|triptorelin pamoate|mesh-list
153850187|NCT04659551|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153850188|NCT04659551|Immunologic Factors|immunologic factors|mesh-ancestor
153850189|NCT04659551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153850190|NCT04659551|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153390418|NCT04368988|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
153390419|NCT04365257|Prazosin|prazosin|mesh-list
153390420|NCT04365257|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-list
153390421|NCT04365257|Adrenergic Antagonists|adrenergic antagonists|mesh-list
153390422|NCT04365257|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153390423|NCT04365257|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
153390424|NCT04365257|Adrenergic Agents|adrenergic agents|mesh-ancestor
153390425|NCT04365257|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153390426|NCT04365257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153390427|NCT04365257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153390428|NCT04341545|Letrozole|letrozole|mesh-list
153850217|NCT01206517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153850218|NCT01206517|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153850219|NCT01206439|Nebivolol|nebivolol|mesh-list
153850220|NCT01206439|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153850221|NCT01206439|Vasodilator Agents|vasodilator agents|mesh-ancestor
153850222|NCT01206439|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
153850223|NCT01206439|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
153850224|NCT01206439|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153850225|NCT01206439|Adrenergic Agents|adrenergic agents|mesh-ancestor
153850226|NCT01206439|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153850227|NCT01206439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153850228|NCT01206439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153850229|NCT01206322|Insulin|insulin|mesh-list
153850231|NCT01206322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153850232|NCT00540501|Oseltamivir|oseltamivir|mesh-list
153850233|NCT00540501|Zanamivir|zanamivir|mesh-list
153850234|NCT00540501|Antiviral Agents|antiviral agents|mesh-ancestor
153850235|NCT00540501|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153850236|NCT00540501|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153850237|NCT00540501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153850238|NCT00557453|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
153850239|NCT00557453|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
153850240|NCT00557453|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153850241|NCT00557453|Antitubercular Agents|antitubercular agents|mesh-ancestor
153850242|NCT01207102|Paclitaxel|paclitaxel|mesh-list
153850243|NCT01207102|Carboplatin|carboplatin|mesh-list
153850244|NCT01207102|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
153850245|NCT01207102|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153850246|NCT01207102|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153850247|NCT01207102|Tubulin Modulators|tubulin modulators|mesh-ancestor
153850248|NCT01207102|Antimitotic Agents|antimitotic agents|mesh-ancestor
153850249|NCT01207102|Mitosis Modulators|mitosis modulators|mesh-ancestor
153390429|NCT04341545|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153390430|NCT04341545|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
153390431|NCT04341545|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153390458|NCT04186299|Respiratory System Agents|respiratory system agents|mesh-ancestor
153390459|NCT04186299|Mydriatics|mydriatics|mesh-ancestor
153390460|NCT04186299|Sympathomimetics|sympathomimetics|mesh-ancestor
153390461|NCT04186299|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
153390462|NCT04186299|Analgesics|analgesics|mesh-ancestor
153390463|NCT04186299|Sensory System Agents|sensory system agents|mesh-ancestor
153390464|NCT04186299|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153390465|NCT04186299|Sympatholytics|sympatholytics|mesh-ancestor
153390466|NCT04186299|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
153850300|NCT00540891|Urological Agents|urological agents|mesh-ancestor
153850301|NCT04658225|Chlorhexidine|chlorhexidine|mesh-list
153850302|NCT04658225|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
153390483|NCT03822663|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153390484|NCT03822663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153390485|NCT03822663|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
153390486|NCT03822663|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
153390487|NCT03822663|Purinergic Agents|purinergic agents|mesh-ancestor
153390488|NCT03822663|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153390489|NCT03801525|Venetoclax|venetoclax|mesh-list
153390490|NCT03801525|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153850340|NCT04657484|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
153850341|NCT04657484|Methylprednisolone|methylprednisolone|mesh-list
153850342|NCT04657484|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
153850343|NCT04657484|Prednisolone acetate|prednisolone acetate|mesh-list
153850344|NCT04657484|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
153850345|NCT04657484|Prednisolone phosphate|prednisolone phosphate|mesh-list
153850346|NCT04657484|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153850358|NCT04657484|Protective Agents|protective agents|mesh-ancestor
153850359|NCT00541125|Leucovorin|leucovorin|mesh-list
153850360|NCT00541125|Bevacizumab|bevacizumab|mesh-list
153850361|NCT00541125|Fluorouracil|fluorouracil|mesh-list
153850362|NCT00541125|Irinotecan|irinotecan|mesh-list
153850363|NCT00541125|Calcium|calcium|mesh-list
153850364|NCT00541125|Levoleucovorin|levoleucovorin|mesh-list
153850365|NCT00541125|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153850366|NCT00541125|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153850367|NCT00541125|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153850368|NCT00541125|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153850369|NCT00541125|Growth Substances|growth substances|mesh-ancestor
153850370|NCT00541125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153850371|NCT00541125|Growth Inhibitors|growth inhibitors|mesh-ancestor
153850372|NCT00541125|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153850373|NCT00541125|Antimetabolites|antimetabolites|mesh-ancestor
153850374|NCT00541125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153390554|NCT03192397|Sirolimus|sirolimus|mesh-list
153390555|NCT03192397|Cyclophosphamide|cyclophosphamide|mesh-list
153390556|NCT03192397|Melphalan|melphalan|mesh-list
153390557|NCT03192397|Fludarabine|fludarabine|mesh-list
153390558|NCT03192397|Fludarabine phosphate|fludarabine phosphate|mesh-list
153390559|NCT03192397|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153390560|NCT03192397|Immunologic Factors|immunologic factors|mesh-ancestor
153390561|NCT03192397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153390562|NCT03192397|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153390563|NCT03192397|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153390575|NCT03192397|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153390576|NCT03192397|Antifungal Agents|antifungal agents|mesh-ancestor
153390577|NCT02975492|Vitamin D|vitamin d|mesh-list
153390578|NCT02975492|Ergocalciferols|ergocalciferols|mesh-list
153390606|NCT02821832|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
153390607|NCT02821832|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
153390608|NCT02821832|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153390610|NCT02821832|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153390611|NCT02813148|Naloxegol|naloxegol|mesh-list
153390612|NCT02813148|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
153390613|NCT02813148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153390614|NCT02813148|Sensory System Agents|sensory system agents|mesh-ancestor
153390615|NCT02813148|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153390617|NCT02756611|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153390618|NCT02673359|Progesterone|progesterone|mesh-list
153390619|NCT02673359|Progestins|progestins|mesh-ancestor
153850408|NCT00541320|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
153850409|NCT00541320|Antithrombins|antithrombins|mesh-ancestor
153850410|NCT00541320|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
153850411|NCT00541320|Protease Inhibitors|protease inhibitors|mesh-ancestor
153850412|NCT00541320|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153850413|NCT00541320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153850414|NCT00541320|Anticoagulants|anticoagulants|mesh-ancestor
153850415|NCT04657172|Pilocarpine|pilocarpine|mesh-list
153850416|NCT04657172|Miotics|miotics|mesh-ancestor
153850417|NCT04657172|Autonomic Agents|autonomic agents|mesh-ancestor
153850420|NCT04657172|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
153850447|NCT04656665|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153850448|NCT04656665|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153850449|NCT04656665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153850450|NCT04656665|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153390631|NCT02624518|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153390632|NCT02287623|Bupivacaine|bupivacaine|mesh-list
153390633|NCT02287623|Anesthetics, Local|anesthetics, local|mesh-ancestor
153390634|NCT02287623|Anesthetics|anesthetics|mesh-ancestor
153390635|NCT02287623|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153390636|NCT02287623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153390637|NCT02287623|Sensory System Agents|sensory system agents|mesh-ancestor
153390638|NCT02287623|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153390639|NCT01794520|Dexamethasone|dexamethasone|mesh-list
153390640|NCT01794520|Venetoclax|venetoclax|mesh-list
153390641|NCT01794520|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153390642|NCT01794520|Antiemetics|antiemetics|mesh-ancestor
153390643|NCT01794520|Autonomic Agents|autonomic agents|mesh-ancestor
153390644|NCT01794520|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153390645|NCT01794520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153390648|NCT01794520|Hormones|hormones|mesh-ancestor
153850462|NCT03014622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153850511|NCT00541710|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153850512|NCT00541710|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153850513|NCT00541710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153850514|NCT00541710|Phytoestrogens|phytoestrogens|mesh-ancestor
153850515|NCT00541710|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
153850516|NCT00541710|Estrogens|estrogens|mesh-ancestor
153850517|NCT00541710|Hormones|hormones|mesh-ancestor
153850518|NCT00541710|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153850519|NCT04654676|Vildagliptin|vildagliptin|mesh-list
153850520|NCT04654676|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153850521|NCT04654676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153850522|NCT04654676|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
153850523|NCT04654676|Protease Inhibitors|protease inhibitors|mesh-ancestor
153850524|NCT04654676|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153850526|NCT00541905|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
153850544|NCT00542022|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153850545|NCT00542022|Nasal Decongestants|nasal decongestants|mesh-ancestor
153850546|NCT00542022|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
153850547|NCT00542022|Respiratory System Agents|respiratory system agents|mesh-ancestor
153850549|NCT01205581|Immunologic Factors|immunologic factors|mesh-ancestor
153850550|NCT01205581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153850551|NCT00542139|Betamethasone|betamethasone|mesh-list
153850552|NCT00542139|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153850553|NCT00542139|Glucocorticoids|glucocorticoids|mesh-ancestor
153850554|NCT00542139|Hormones|hormones|mesh-ancestor
153850555|NCT00542139|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153850556|NCT00542139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153850557|NCT00542139|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153850559|NCT00542295|Mebeverine|mebeverine|mesh-list
153850588|NCT04653506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153850589|NCT04653506|Antipyretics|antipyretics|mesh-ancestor
153850590|NCT00542412|Riluzole|riluzole|mesh-list
153850591|NCT00542412|Anticonvulsants|anticonvulsants|mesh-ancestor
153850592|NCT00542412|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
153850593|NCT00542412|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
153850594|NCT00542412|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153850595|NCT00542412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153850596|NCT00542412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153390835|NCT00002649|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153390837|NCT00002649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153390838|NCT00002649|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153390839|NCT00002649|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153390840|NCT00002649|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153390841|NCT00002649|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153390842|NCT00002649|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153390876|NCT00995059|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153390877|NCT00995059|Alkylating Agents|alkylating agents|mesh-ancestor
153390896|NCT00002679|Immunologic Factors|immunologic factors|mesh-ancestor
153390897|NCT00002679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153390898|NCT00002679|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153390899|NCT00002679|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153390900|NCT00002679|Alkylating Agents|alkylating agents|mesh-ancestor
153390901|NCT00002679|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153390902|NCT00002679|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153390903|NCT00002679|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153390914|NCT00002691|Cytarabine|cytarabine|mesh-list
153850742|NCT04651049|Propranolol|propranolol|mesh-list
153850743|NCT04651049|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
153850744|NCT04651049|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
153850745|NCT04651049|Adrenergic Agents|adrenergic agents|mesh-ancestor
153850758|NCT03456648|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
153850787|NCT00557921|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153850788|NCT00557921|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
153850789|NCT00557921|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153850790|NCT00557921|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
153850791|NCT02324283|Propofol|propofol|mesh-list
153850792|NCT02324283|Desflurane|desflurane|mesh-list
153850793|NCT02324283|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153850794|NCT02324283|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153850795|NCT02324283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153390978|NCT00002697|Immunologic Factors|immunologic factors|mesh-ancestor
153390979|NCT00002697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153390980|NCT00002697|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153390981|NCT00002697|Alkylating Agents|alkylating agents|mesh-ancestor
153390983|NCT00002715|Doxorubicin|doxorubicin|mesh-list
153390984|NCT00002715|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
153390985|NCT00002715|Bleomycin|bleomycin|mesh-list
153390986|NCT00002715|Etoposide|etoposide|mesh-list
153390987|NCT00002715|Vincristine|vincristine|mesh-list
153390988|NCT00002715|Vinblastine|vinblastine|mesh-list
153850815|NCT00557960|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
153850817|NCT00558077|Clomiphene|clomiphene|mesh-list
153850818|NCT00558077|Enclomiphene|enclomiphene|mesh-list
153850819|NCT00558077|Zuclomiphene|zuclomiphene|mesh-list
153850820|NCT00558077|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153850821|NCT00558077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153850822|NCT00558077|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
153850823|NCT00558077|Hormone Antagonists|hormone antagonists|mesh-ancestor
153850824|NCT00558077|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153850825|NCT00558077|Fertility Agents, Female|fertility agents, female|mesh-ancestor
153850826|NCT00558077|Fertility Agents|fertility agents|mesh-ancestor
153850881|NCT00544011|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153850882|NCT00544050|Levetiracetam|levetiracetam|mesh-list
153850883|NCT00544050|Anticonvulsants|anticonvulsants|mesh-ancestor
153850884|NCT00544050|Nootropic Agents|nootropic agents|mesh-ancestor
153850885|NCT04649723|Rifampin|rifampin|mesh-list
153850886|NCT04649723|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
153850887|NCT04649723|Antitubercular Agents|antitubercular agents|mesh-ancestor
153850888|NCT04649723|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153850889|NCT04649723|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153850890|NCT04649723|Leprostatic Agents|leprostatic agents|mesh-ancestor
153850891|NCT04649723|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153850892|NCT04649723|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153850900|NCT02909088|Ecopipam|ecopipam|mesh-list
153391174|NCT01631149|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153391175|NCT01631149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153850983|NCT02888275|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153850984|NCT02888275|Analgesics|analgesics|mesh-ancestor
153850985|NCT02888275|Sensory System Agents|sensory system agents|mesh-ancestor
153850986|NCT02888275|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153850987|NCT02888275|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
153391176|NCT01631149|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
153391177|NCT01631149|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
153391178|NCT01631149|Cholinergic Agents|cholinergic agents|mesh-ancestor
153391179|NCT01631149|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153391180|NCT01631149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153391181|NCT00002787|Aldesleukin|aldesleukin|mesh-list
153391182|NCT00002787|Interleukin-2|interleukin-2|mesh-list
153391183|NCT00002787|Vaccines|vaccines|mesh-list
153391184|NCT00002787|Immunoglobulins|immunoglobulins|mesh-list
153391185|NCT00002787|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
153391186|NCT00002787|Antibodies|antibodies|mesh-list
153391187|NCT00002787|Sargramostim|sargramostim|mesh-list
153391188|NCT00002787|Keyhole-limpet hemocyanin|keyhole-limpet hemocyanin|mesh-list
153391189|NCT00002787|Immunoglobulin Idiotypes|immunoglobulin idiotypes|mesh-list
153391190|NCT00002787|Immunologic Factors|immunologic factors|mesh-ancestor
153391191|NCT00002787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153391192|NCT00002787|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153391193|NCT00002787|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153391194|NCT00002787|Analgesics|analgesics|mesh-ancestor
153391195|NCT00002787|Sensory System Agents|sensory system agents|mesh-ancestor
153391196|NCT00002787|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153850996|NCT03456531|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153850997|NCT03456531|Sensory System Agents|sensory system agents|mesh-ancestor
153850998|NCT03456531|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153851049|NCT01229449|Narcotics|narcotics|mesh-ancestor
153851050|NCT01229449|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153851051|NCT01229449|Antitussive Agents|antitussive agents|mesh-ancestor
153851052|NCT01229449|Respiratory System Agents|respiratory system agents|mesh-ancestor
153851053|NCT01238575|Guanfacine|guanfacine|mesh-list
153851054|NCT01238575|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153851055|NCT01238575|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
153851056|NCT01238575|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153851057|NCT01238575|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153851070|NCT06022237|Vitamin D|vitamin d|mesh-list
153851110|NCT06021756|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
153851111|NCT06021756|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
153851112|NCT06021756|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153851113|NCT06021756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153851114|NCT06021717|Ketamine|ketamine|mesh-list
153851115|NCT06021717|Morphine|morphine|mesh-list
153391370|NCT00382239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153391371|NCT00382239|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
153391373|NCT00382239|Hormones|hormones|mesh-ancestor
153391374|NCT00382239|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153391430|NCT05513937|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153391431|NCT05513937|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153391432|NCT05513937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153391433|NCT05513937|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153391434|NCT05513937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153391435|NCT05513937|Vasodilator Agents|vasodilator agents|mesh-ancestor
153391436|NCT05513937|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
153391437|NCT05513937|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
153391438|NCT05513937|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153391439|NCT05513937|Adrenergic Agents|adrenergic agents|mesh-ancestor
153391440|NCT05513937|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153391441|NCT01642147|Anesthetics|anesthetics|mesh-list
153391442|NCT01642147|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153851304|NCT05669833|Immunologic Factors|immunologic factors|mesh-ancestor
153851305|NCT05669833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153851306|NCT05657496|Triamcinolone|triamcinolone|mesh-list
153391501|NCT03251924|Ipilimumab|ipilimumab|mesh-list
153391502|NCT03251924|Antibodies|antibodies|mesh-list
153391503|NCT03251924|Immunoglobulins|immunoglobulins|mesh-list
153391504|NCT03251924|Antibodies, Blocking|antibodies, blocking|mesh-list
153391505|NCT03251924|Immunologic Factors|immunologic factors|mesh-ancestor
153391506|NCT03251924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153391507|NCT03251924|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153391508|NCT03251924|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153391509|NCT03251924|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153391510|NCT03251924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153391511|NCT01651351|Protease Inhibitors|protease inhibitors|mesh-list
153391517|NCT03762317|Clonidine|clonidine|mesh-list
153851345|NCT05591755|Histamine Antagonists|histamine antagonists|mesh-ancestor
153851346|NCT05591755|Histamine Agents|histamine agents|mesh-ancestor
153851373|NCT05548361|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153851375|NCT05548361|Dermatologic Agents|dermatologic agents|mesh-ancestor
153851376|NCT05542667|Fluorides|fluorides|mesh-list
153851378|NCT05542667|Cariostatic Agents|cariostatic agents|mesh-ancestor
153851379|NCT05542667|Protective Agents|protective agents|mesh-ancestor
153851380|NCT05542667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153851381|NCT05481684|Progesterone|progesterone|mesh-list
153851382|NCT05481684|Progestins|progestins|mesh-ancestor
153851383|NCT05481684|Hormones|hormones|mesh-ancestor
153851384|NCT05481684|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153851385|NCT05481684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153851407|NCT05320380|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
153851408|NCT05320380|Prednisolone acetate|prednisolone acetate|mesh-list
153851409|NCT05320380|Hydrocortisone|hydrocortisone|mesh-list
153851410|NCT05320380|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
153851411|NCT05320380|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
153851412|NCT05320380|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
153851413|NCT05320380|Cortisone|cortisone|mesh-list
153851414|NCT05320380|Methotrexate|methotrexate|mesh-list
153851416|NCT05320380|Fludarabine|fludarabine|mesh-list
153851435|NCT05320380|Antiviral Agents|antiviral agents|mesh-ancestor
153851436|NCT05320380|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153851437|NCT05320380|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153851438|NCT05320380|Glucocorticoids|glucocorticoids|mesh-ancestor
153391843|NCT01919996|Azithromycin|azithromycin|mesh-list
153851620|NCT04324307|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
153851621|NCT04324307|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153851622|NCT04324307|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153851623|NCT04216628|Oxytocin|oxytocin|mesh-list
153851624|NCT04216628|Oxytocics|oxytocics|mesh-ancestor
153851625|NCT04216628|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153851626|NCT04216628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153851627|NCT04192019|Glucagon|glucagon|mesh-list
153851628|NCT04192019|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
153851629|NCT04192019|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153851630|NCT04192019|Hormones|hormones|mesh-ancestor
153851631|NCT04192019|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153851632|NCT04192019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153851633|NCT04192019|Incretins|incretins|mesh-ancestor
153851634|NCT04174170|Sertraline|sertraline|mesh-list
153851635|NCT04174170|Brexpiprazole|brexpiprazole|mesh-list
153851636|NCT04174170|Antidepressive Agents|antidepressive agents|mesh-ancestor
153851637|NCT04174170|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153851638|NCT04174170|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
153851639|NCT04174170|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153851640|NCT04174170|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153851641|NCT04174170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153851642|NCT04174170|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153851643|NCT04174170|Serotonin Agents|serotonin agents|mesh-ancestor
153851644|NCT04174170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153391861|NCT01667029|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153391862|NCT01667029|Analgesics|analgesics|mesh-ancestor
153391863|NCT01667029|Sensory System Agents|sensory system agents|mesh-ancestor
153391864|NCT01667029|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153391865|NCT01667029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153391866|NCT01667029|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153851702|NCT03889795|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
153851703|NCT03889795|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153851704|NCT03889795|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153851705|NCT03889795|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
153851706|NCT03889795|Protective Agents|protective agents|mesh-ancestor
153391904|NCT00000339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153391905|NCT00000339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153391906|NCT00000339|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153391907|NCT00000339|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153391908|NCT00000339|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153391909|NCT00000339|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153391910|NCT00000339|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
153391911|NCT00000339|Dopamine Agents|dopamine agents|mesh-ancestor
153391913|NCT00000345|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153391914|NCT00000345|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
153391916|NCT00000345|Sensory System Agents|sensory system agents|mesh-ancestor
153851723|NCT03777462|Gemcitabine|gemcitabine|mesh-list
153851755|NCT03730181|Antimetabolites|antimetabolites|mesh-ancestor
153851756|NCT03730181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153851757|NCT03730181|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153851758|NCT03730181|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
153851760|NCT03674671|Ketamine|ketamine|mesh-list
153851761|NCT03674671|Analgesics|analgesics|mesh-ancestor
153851787|NCT03653364|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153851788|NCT03653364|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153851789|NCT03653364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153851790|NCT03624244|Letrozole|letrozole|mesh-list
153851791|NCT03624244|Exemestane|exemestane|mesh-list
153851792|NCT03624244|Aromatase Inhibitors|aromatase inhibitors|mesh-list
153851793|NCT03624244|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153851794|NCT03624244|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153851795|NCT03624244|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153851796|NCT03624244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153851797|NCT03624244|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
153851798|NCT03624244|Hormone Antagonists|hormone antagonists|mesh-ancestor
153851799|NCT03624244|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153851818|NCT03321734|Caffeine|caffeine|mesh-list
153851819|NCT03321734|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
153851820|NCT03321734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153392144|NCT00000483|Estrogens|estrogens|mesh-list
153392145|NCT00000483|Hormones|hormones|mesh-ancestor
153392147|NCT00000483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153392181|NCT01951118|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
153392182|NCT01951118|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153392183|NCT01951118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153392185|NCT01951118|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153392186|NCT01951118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153392188|NCT01951820|Lidocaine|lidocaine|mesh-list
153392189|NCT01951820|Tetracaine|tetracaine|mesh-list
153392190|NCT01951820|Carticaine|carticaine|mesh-list
153392191|NCT01951820|Benzocaine|benzocaine|mesh-list
153392192|NCT01951820|Anesthetics, Local|anesthetics, local|mesh-ancestor
153392193|NCT01951820|Anesthetics|anesthetics|mesh-ancestor
153392194|NCT01951820|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153392195|NCT01951820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153392196|NCT01951820|Sensory System Agents|sensory system agents|mesh-ancestor
153392197|NCT01951820|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153392198|NCT01951820|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153392199|NCT01951820|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
153392203|NCT01952444|Ciprofloxacin|ciprofloxacin|mesh-list
153851995|NCT01237951|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153851996|NCT01237951|Immunologic Factors|immunologic factors|mesh-ancestor
153851997|NCT02908581|Folic Acid|folic acid|mesh-list
153851998|NCT02908581|Vitamin B Complex|vitamin b complex|mesh-list
153851999|NCT02908581|Hematinics|hematinics|mesh-ancestor
153852000|NCT02908581|Vitamins|vitamins|mesh-ancestor
153852001|NCT02908581|Micronutrients|micronutrients|mesh-ancestor
153852002|NCT02908581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153852003|NCT00544362|Fluorouracil|fluorouracil|mesh-list
153852012|NCT00544362|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153852014|NCT01239394|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153852015|NCT00553293|Hormones|hormones|mesh-list
153852016|NCT00553293|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
153852017|NCT00553293|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153852018|NCT00553293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153852019|NCT00544518|Metformin|metformin|mesh-list
153852020|NCT00544518|Benfluorex|benfluorex|mesh-list
153852021|NCT00544518|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153852081|NCT04647773|Sensory System Agents|sensory system agents|mesh-ancestor
153852082|NCT04647773|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153852083|NCT04647773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153852084|NCT04647773|Anticonvulsants|anticonvulsants|mesh-ancestor
153852085|NCT04647773|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153852086|NCT04647773|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153852087|NCT04647773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153852088|NCT04647773|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153852089|NCT04647773|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153852090|NCT04647773|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153392402|NCT01701505|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153392403|NCT01701505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153392440|NCT04942899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153392441|NCT04942899|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153392473|NCT02987270|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153392474|NCT02987270|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153392475|NCT00000699|Ribavirin|ribavirin|mesh-list
153392476|NCT00000699|Inosine Pranobex|inosine pranobex|mesh-list
153392477|NCT00000699|Antimetabolites|antimetabolites|mesh-ancestor
153392478|NCT00000699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153392479|NCT00000699|Antiviral Agents|antiviral agents|mesh-ancestor
153392480|NCT00000699|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153392481|NCT00000699|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153392482|NCT00000699|Immunologic Factors|immunologic factors|mesh-ancestor
153852265|NCT06237660|Chelating Agents|chelating agents|mesh-ancestor
153852266|NCT06237660|Sequestering Agents|sequestering agents|mesh-ancestor
153852267|NCT06237660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153852268|NCT06237647|Hyaluronic Acid|hyaluronic acid|mesh-list
153852269|NCT06237647|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153852270|NCT06237647|Immunologic Factors|immunologic factors|mesh-ancestor
153852271|NCT06237647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153852272|NCT06237647|Viscosupplements|viscosupplements|mesh-ancestor
153852273|NCT06237647|Protective Agents|protective agents|mesh-ancestor
153852275|NCT06237569|Ketamine|ketamine|mesh-list
153852276|NCT06237569|Anesthetics|anesthetics|mesh-ancestor
153852277|NCT06237569|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153852278|NCT06237569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153852279|NCT06237569|Analgesics|analgesics|mesh-ancestor
153852280|NCT06237569|Sensory System Agents|sensory system agents|mesh-ancestor
153392483|NCT00000699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153392527|NCT00000723|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153392529|NCT00000723|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153392530|NCT02329964|Neostigmine|neostigmine|mesh-list
153392531|NCT02329964|Pyridostigmine Bromide|pyridostigmine bromide|mesh-list
153392532|NCT02329964|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
153392533|NCT02329964|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153852326|NCT06237153|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
153852327|NCT06237153|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
153852328|NCT06237153|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
153852329|NCT06237153|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153852330|NCT06237153|Glucocorticoids|glucocorticoids|mesh-ancestor
153852331|NCT06237153|Hormones|hormones|mesh-ancestor
153852337|NCT06237153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153392548|NCT04750395|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153392549|NCT04750395|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153392550|NCT04750395|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153392551|NCT04750395|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153392552|NCT04750395|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153392553|NCT04750395|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
153392554|NCT04750395|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153392555|NCT04750395|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153392648|NCT05681702|Analgesics|analgesics|mesh-ancestor
153392649|NCT05681702|Sensory System Agents|sensory system agents|mesh-ancestor
153392650|NCT05681702|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153392651|NCT05681702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153392652|NCT05681702|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153392653|NCT05681702|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153392654|NCT05681702|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153392655|NCT05681702|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153392656|NCT05681702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153392657|NCT05681702|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153852417|NCT06236152|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153852418|NCT06236152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153852419|NCT06236152|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153392666|NCT04675983|Capecitabine|capecitabine|mesh-list
153392667|NCT04675983|Fluorouracil|fluorouracil|mesh-list
153392668|NCT04675983|Oxaliplatin|oxaliplatin|mesh-list
153392693|NCT03668951|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153392694|NCT03668951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153392696|NCT04889703|Salicylates|salicylates|mesh-list
153392697|NCT04889703|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153392698|NCT04889703|Antifungal Agents|antifungal agents|mesh-ancestor
153852473|NCT06235931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153852476|NCT06235931|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153852477|NCT06235931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153392727|NCT01706263|Dermatologic Agents|dermatologic agents|mesh-ancestor
153392768|NCT01690663|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153392769|NCT01690663|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153392770|NCT01690663|Anesthetics, Local|anesthetics, local|mesh-ancestor
153392771|NCT01690663|Anesthetics|anesthetics|mesh-ancestor
153392774|NCT05738564|Lidocaine|lidocaine|mesh-list
153392787|NCT05738564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153392788|NCT05738564|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153392789|NCT05738564|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153392790|NCT05738564|Adrenergic Agents|adrenergic agents|mesh-ancestor
153392791|NCT05738564|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153392796|NCT05738564|Respiratory System Agents|respiratory system agents|mesh-ancestor
153392798|NCT05738564|Sympathomimetics|sympathomimetics|mesh-ancestor
153392799|NCT05738564|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
153392800|NCT05738564|Nasal Decongestants|nasal decongestants|mesh-ancestor
153392801|NCT04350086|Dexmedetomidine|dexmedetomidine|mesh-list
153392802|NCT04350086|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153392803|NCT04350086|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153392804|NCT04350086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153392805|NCT04350086|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153392806|NCT04350086|Analgesics|analgesics|mesh-ancestor
153392807|NCT04350086|Sensory System Agents|sensory system agents|mesh-ancestor
153392811|NCT04350086|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153852587|NCT06207305|Sensory System Agents|sensory system agents|mesh-ancestor
153852588|NCT06207305|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
153852589|NCT06207305|Histamine Antagonists|histamine antagonists|mesh-ancestor
153852590|NCT06207305|Histamine Agents|histamine agents|mesh-ancestor
153852591|NCT06207305|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153852592|NCT06207305|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
153852593|NCT06207305|Antipruritics|antipruritics|mesh-ancestor
153852594|NCT06207305|Dermatologic Agents|dermatologic agents|mesh-ancestor
153852595|NCT06207305|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
153392825|NCT01352117|Tenofovir|tenofovir|mesh-list
153852615|NCT06189833|Growth Substances|growth substances|mesh-ancestor
153852616|NCT06189833|Growth Inhibitors|growth inhibitors|mesh-ancestor
153852643|NCT06135259|Triamcinolone|triamcinolone|mesh-list
153852644|NCT06135259|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
153852645|NCT06135259|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
153852646|NCT06135259|Epoetin Alfa|epoetin alfa|mesh-list
153852647|NCT06135259|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
153852648|NCT06135259|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153852649|NCT06135259|Glucocorticoids|glucocorticoids|mesh-ancestor
153852650|NCT06135259|Hormones|hormones|mesh-ancestor
153852651|NCT06135259|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153852652|NCT06135259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153852653|NCT06135259|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153852654|NCT06135259|Immunologic Factors|immunologic factors|mesh-ancestor
153852655|NCT06135259|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153392868|NCT03340727|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
153392869|NCT03340727|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
153852671|NCT06126991|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153852672|NCT06126991|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153852673|NCT06126991|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153392937|NCT04230681|Narcotics|narcotics|mesh-ancestor
153392938|NCT04230681|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153392939|NCT04230681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153392940|NCT04230681|Analgesics|analgesics|mesh-ancestor
153392942|NCT04230681|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153392943|NCT04230681|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153392944|NCT04230681|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153392945|NCT04230681|Anesthetics, General|anesthetics, general|mesh-ancestor
153392946|NCT04230681|Anesthetics|anesthetics|mesh-ancestor
153392947|NCT01708603|Ustekinumab|ustekinumab|mesh-list
153392948|NCT01708603|Brodalumab|brodalumab|mesh-list
153392949|NCT01708603|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
153392950|NCT01708603|Dermatologic Agents|dermatologic agents|mesh-ancestor
153392951|NCT01708603|Immunologic Factors|immunologic factors|mesh-ancestor
153392952|NCT01708603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153392953|NCT00362765|Metformin|metformin|mesh-list
153392954|NCT00362765|Fenofibrate|fenofibrate|mesh-list
153392955|NCT00362765|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153392956|NCT00362765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153392957|NCT00362765|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153392958|NCT00362765|Antimetabolites|antimetabolites|mesh-ancestor
153392959|NCT00362765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153392960|NCT00362765|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153392962|NCT05033756|Olaparib|olaparib|mesh-list
153392963|NCT05033756|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153392964|NCT05033756|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153392965|NCT05033756|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153392969|NCT03522077|Hemostatics|hemostatics|mesh-list
153852763|NCT06040255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153392978|NCT03266393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153392979|NCT03266393|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
153392981|NCT03266393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153392982|NCT00421967|Ketorolac|ketorolac|mesh-list
153392983|NCT00421967|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
153392984|NCT00421967|Epinephrine|epinephrine|mesh-list
153852770|NCT06040255|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
153852771|NCT06040255|Protective Agents|protective agents|mesh-ancestor
153852772|NCT06029023|Propolis|propolis|mesh-list
153852773|NCT06029023|Curcumin|curcumin|mesh-list
153852774|NCT06029023|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153852776|NCT06029023|Analgesics|analgesics|mesh-ancestor
153852789|NCT05970263|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153852790|NCT05970263|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153852791|NCT05970263|Autonomic Agents|autonomic agents|mesh-ancestor
153852792|NCT05970263|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153852793|NCT05970263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153852794|NCT05970263|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153852795|NCT05970263|Respiratory System Agents|respiratory system agents|mesh-ancestor
153852796|NCT05970263|Glucocorticoids|glucocorticoids|mesh-ancestor
153852797|NCT05970263|Hormones|hormones|mesh-ancestor
153852798|NCT05970263|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153393011|NCT00421967|Mydriatics|mydriatics|mesh-ancestor
153393021|NCT04997798|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153393022|NCT04997798|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153393023|NCT04997798|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
153393024|NCT04997798|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153393025|NCT04997798|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153393026|NCT04997798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153393027|NCT04997798|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
153393028|NCT04997798|Hormone Antagonists|hormone antagonists|mesh-ancestor
153393029|NCT04997798|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153393039|NCT00362531|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153393040|NCT00362531|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153393041|NCT00362531|Immunologic Factors|immunologic factors|mesh-ancestor
153393042|NCT00362531|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
153393043|NCT00362531|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153393044|NCT00362531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153393045|NCT04330443|Pulmonary Surfactants|pulmonary surfactants|mesh-list
153393046|NCT04330443|Respiratory System Agents|respiratory system agents|mesh-ancestor
153393047|NCT04330677|Oxytocin|oxytocin|mesh-list
153393048|NCT04330677|Estrogens|estrogens|mesh-list
153393049|NCT04330677|Oxytocics|oxytocics|mesh-ancestor
153393050|NCT04330677|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153429631|NCT01194427|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153429632|NCT01194427|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153429633|NCT01194427|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
153852848|NCT05854537|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153852849|NCT05854537|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
153393061|NCT02259517|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
153393062|NCT02259517|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
153393063|NCT02259517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153393064|NCT02259517|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
153393065|NCT02259517|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153429644|NCT00002738|Calcium|calcium|mesh-list
153429645|NCT00002738|Levoleucovorin|levoleucovorin|mesh-list
153393066|NCT02259517|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153393067|NCT02259517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153852868|NCT05814523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153852869|NCT05814523|GABA Modulators|gaba modulators|mesh-ancestor
153852870|NCT05814523|GABA Agents|gaba agents|mesh-ancestor
153852871|NCT05784753|8-chloro-cyclic adenosine monophosphate|8-chloro-cyclic adenosine monophosphate|mesh-list
153852872|NCT05784753|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153852873|NCT05784753|Immunologic Factors|immunologic factors|mesh-ancestor
153852874|NCT05784753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153852875|NCT05776979|Lenalidomide|lenalidomide|mesh-list
153852876|NCT05776979|Immunologic Factors|immunologic factors|mesh-ancestor
153852877|NCT05776979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153852878|NCT05776979|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153852904|NCT05688215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153852905|NCT05688215|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153852906|NCT05688215|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153852907|NCT05688215|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153393116|NCT04195256|Analgesics|analgesics|mesh-ancestor
153393117|NCT04195256|Sensory System Agents|sensory system agents|mesh-ancestor
153393128|NCT04195256|Anesthetics|anesthetics|mesh-ancestor
153852914|NCT05688215|Vitamin B Complex|vitamin b complex|mesh-ancestor
153852915|NCT05688215|Vitamins|vitamins|mesh-ancestor
153852916|NCT05688215|Micronutrients|micronutrients|mesh-ancestor
153852917|NCT05688215|Hematinics|hematinics|mesh-ancestor
153852918|NCT05688215|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153852919|NCT05688215|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153852954|NCT05631236|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
153852955|NCT05631236|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153852956|NCT05631236|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153852957|NCT05631236|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
153852959|NCT05624918|Gemcitabine|gemcitabine|mesh-list
153852960|NCT05624918|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153852961|NCT05624918|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153852962|NCT05624918|Tubulin Modulators|tubulin modulators|mesh-ancestor
153852963|NCT05624918|Antimitotic Agents|antimitotic agents|mesh-ancestor
153852964|NCT05624918|Mitosis Modulators|mitosis modulators|mesh-ancestor
153852971|NCT05616013|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
153852972|NCT05616013|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153853014|NCT05477576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153853016|NCT05477576|Immunologic Factors|immunologic factors|mesh-ancestor
153853017|NCT05477576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153853018|NCT05477576|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153853019|NCT05477576|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153853021|NCT05477576|Growth Substances|growth substances|mesh-ancestor
153393270|NCT03135860|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153393271|NCT03135860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153393272|NCT03135860|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153393273|NCT03135860|Respiratory System Agents|respiratory system agents|mesh-ancestor
153393274|NCT03135860|Free Radical Scavengers|free radical scavengers|mesh-ancestor
153393275|NCT03135860|Antioxidants|antioxidants|mesh-ancestor
153393276|NCT03135860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153393277|NCT03135860|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153393279|NCT03135860|Vasodilator Agents|vasodilator agents|mesh-ancestor
153853071|NCT05342974|Abortifacient Agents|abortifacient agents|mesh-ancestor
153853072|NCT05342974|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153853073|NCT05342974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153853074|NCT05342974|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
153853075|NCT05342974|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153393289|NCT01646268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153393290|NCT03988634|Valsartan|valsartan|mesh-list
153393291|NCT03988634|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
153393292|NCT03988634|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153393293|NCT03988634|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
153393296|NCT02294630|Pulmonary Surfactants|pulmonary surfactants|mesh-list
153853085|NCT05338320|Sensory System Agents|sensory system agents|mesh-ancestor
153853086|NCT05338320|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153853087|NCT05338320|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153853088|NCT05338320|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153853089|NCT05338320|Anesthetics, General|anesthetics, general|mesh-ancestor
153853105|NCT05323396|Anthelmintics|anthelmintics|mesh-ancestor
153853106|NCT05323396|Anticestodal Agents|anticestodal agents|mesh-ancestor
153853107|NCT05323396|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
153853108|NCT05323396|Tubulin Modulators|tubulin modulators|mesh-ancestor
153853109|NCT05323396|Antimitotic Agents|antimitotic agents|mesh-ancestor
153853110|NCT05323396|Mitosis Modulators|mitosis modulators|mesh-ancestor
153853111|NCT05323396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153853112|NCT05323396|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153853113|NCT05312398|Irinotecan|irinotecan|mesh-list
153853114|NCT05312398|Cetuximab|cetuximab|mesh-list
153853115|NCT05312398|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
153853116|NCT05312398|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153853117|NCT05312398|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153393331|NCT02296346|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153393332|NCT02296346|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153393333|NCT02296346|Antiemetics|antiemetics|mesh-ancestor
153393334|NCT02296346|Autonomic Agents|autonomic agents|mesh-ancestor
153393335|NCT02296346|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153393336|NCT02296346|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153393337|NCT01726621|Insulin|insulin|mesh-list
153393338|NCT01726621|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153393339|NCT01726621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153393340|NCT02501330|Bosutinib|bosutinib|mesh-list
153393341|NCT02501330|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153853158|NCT05174065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153853159|NCT05174065|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153853160|NCT05174065|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153853161|NCT05174065|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
153393387|NCT01727791|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153393388|NCT01727791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153393389|NCT01727791|Anticonvulsants|anticonvulsants|mesh-ancestor
153393390|NCT01727791|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153393391|NCT01727791|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153393392|NCT01727791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153393393|NCT01727791|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153393394|NCT01727791|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153853182|NCT05084599|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153853183|NCT05084599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153853184|NCT05084599|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
153853185|NCT05084599|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
153853186|NCT05084599|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153853213|NCT04977271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153853214|NCT04977271|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153853215|NCT04977271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153853216|NCT04977271|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
153853217|NCT04977271|Antidepressive Agents|antidepressive agents|mesh-ancestor
153853218|NCT04977271|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153853233|NCT04908579|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153853234|NCT04908579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153853235|NCT04908579|Sensory System Agents|sensory system agents|mesh-ancestor
153853236|NCT04908579|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153853238|NCT04908579|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
153853239|NCT04908579|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153853240|NCT04908579|Anesthetics, General|anesthetics, general|mesh-ancestor
153853241|NCT04908579|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
153853242|NCT04908579|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
153853243|NCT04908579|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153393463|NCT04341935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153393465|NCT05317039|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153393466|NCT05317039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153393475|NCT05316883|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153393476|NCT05316883|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153393477|NCT05316883|GABA Antagonists|gaba antagonists|mesh-ancestor
153393478|NCT05316883|GABA Agents|gaba agents|mesh-ancestor
153853264|NCT04844866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153853265|NCT04844866|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153853266|NCT04844866|Alkylating Agents|alkylating agents|mesh-ancestor
153853267|NCT04840394|Pembrolizumab|pembrolizumab|mesh-list
153853268|NCT04840394|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153853269|NCT04840394|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153853270|NCT04840394|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153853271|NCT04840394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153853272|NCT04814368|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
153853273|NCT04814368|Immunologic Factors|immunologic factors|mesh-ancestor
153853274|NCT04814368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153853275|NCT04810572|Silymarin|silymarin|mesh-list
153393496|NCT03990363|Antioxidants|antioxidants|mesh-ancestor
153393497|NCT03990363|Protective Agents|protective agents|mesh-ancestor
153853325|NCT04757571|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
153853326|NCT04757571|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153853328|NCT04757571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153853329|NCT04757571|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153393553|NCT00383799|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153393554|NCT00383799|Vasodilator Agents|vasodilator agents|mesh-ancestor
153393555|NCT00383799|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
153393556|NCT00383799|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153393557|NCT00383799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153393566|NCT04545541|Heparin|heparin|mesh-list
153853331|NCT04757571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153853332|NCT04757571|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
153853333|NCT04757571|Antidepressive Agents|antidepressive agents|mesh-ancestor
153853334|NCT04757571|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153853335|NCT04757571|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
153853336|NCT04757571|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153853337|NCT04757571|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153853339|NCT04749914|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
153853340|NCT04749914|Lasmiditan|lasmiditan|mesh-list
153853341|NCT04749914|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153853342|NCT04749914|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153853343|NCT04749914|Antimetabolites|antimetabolites|mesh-ancestor
153853344|NCT04749914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153853345|NCT04749914|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153853346|NCT04749914|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
153853347|NCT04749914|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153853348|NCT04749914|Antithrombins|antithrombins|mesh-ancestor
153853349|NCT04749914|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
153853350|NCT04749914|Protease Inhibitors|protease inhibitors|mesh-ancestor
153853351|NCT04749914|Anticoagulants|anticoagulants|mesh-ancestor
153853352|NCT04749914|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
153853353|NCT04749914|Serotonin Agents|serotonin agents|mesh-ancestor
153853354|NCT04749914|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153853355|NCT04749914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153853356|NCT04746547|Dolutegravir|dolutegravir|mesh-list
153853358|NCT04746547|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
153853359|NCT04746547|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153853360|NCT04746547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153393583|NCT00002925|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153393584|NCT00002925|Antiviral Agents|antiviral agents|mesh-ancestor
153393585|NCT00002925|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153393586|NCT00002937|Paclitaxel|paclitaxel|mesh-list
153393587|NCT00002937|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153393588|NCT00002937|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153393590|NCT00002937|Antimitotic Agents|antimitotic agents|mesh-ancestor
153393591|NCT00002937|Mitosis Modulators|mitosis modulators|mesh-ancestor
153393592|NCT00002937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153393594|NCT02918955|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153393595|NCT00002943|Cyclophosphamide|cyclophosphamide|mesh-list
153393596|NCT00002943|Carboplatin|carboplatin|mesh-list
153393597|NCT00002943|Etoposide|etoposide|mesh-list
153393598|NCT00002943|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153393599|NCT00002943|Immunologic Factors|immunologic factors|mesh-ancestor
153393600|NCT00002943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153393601|NCT00002943|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153393602|NCT00002943|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153393603|NCT00002943|Alkylating Agents|alkylating agents|mesh-ancestor
153853379|NCT04634071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153853380|NCT04634071|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
153853381|NCT04634071|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
153853382|NCT04634071|Cholinergic Agents|cholinergic agents|mesh-ancestor
153853383|NCT04634071|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153853384|NCT04634071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153853385|NCT04634071|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
153853386|NCT04634071|Antidepressive Agents|antidepressive agents|mesh-ancestor
153853387|NCT04634071|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153853388|NCT04634071|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
153393611|NCT00002949|Paclitaxel|paclitaxel|mesh-list
153393612|NCT00002949|Vinorelbine|vinorelbine|mesh-list
153393613|NCT00002949|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153393614|NCT00002949|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153393615|NCT00002949|Tubulin Modulators|tubulin modulators|mesh-ancestor
153393616|NCT00002949|Antimitotic Agents|antimitotic agents|mesh-ancestor
153393617|NCT00002949|Mitosis Modulators|mitosis modulators|mesh-ancestor
153393618|NCT00002949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153393619|NCT05315557|Terlipressin|terlipressin|mesh-list
153393620|NCT05315557|Vasopressins|vasopressins|mesh-list
153393621|NCT05315557|Arginine Vasopressin|arginine vasopressin|mesh-list
153853406|NCT04560894|Sorafenib|sorafenib|mesh-list
153853407|NCT04560894|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153853408|NCT04560894|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153853409|NCT04560894|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153853410|NCT04560894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153853411|NCT04549311|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
153853412|NCT04549311|Amoxicillin|amoxicillin|mesh-list
153853413|NCT04549311|Metronidazole|metronidazole|mesh-list
153853414|NCT04549311|Ciprofloxacin|ciprofloxacin|mesh-list
153853415|NCT04549311|Clavulanic Acids|clavulanic acids|mesh-list
153853416|NCT04549311|Clavulanic Acid|clavulanic acid|mesh-list
153853417|NCT04549311|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
153853418|NCT04549311|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
153853419|NCT04549311|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153853420|NCT04549311|Antitubercular Agents|antitubercular agents|mesh-ancestor
153853421|NCT04549311|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153853422|NCT04549311|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153853423|NCT04549311|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153853424|NCT04549311|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153853426|NCT04549311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153853427|NCT04549311|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153853428|NCT04549311|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
153853429|NCT04549311|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153853430|NCT04549311|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
153853431|NCT04548661|Povidone-Iodine|povidone-iodine|mesh-list
153853432|NCT04548661|Povidone|povidone|mesh-list
153853433|NCT04548661|Plasma Substitutes|plasma substitutes|mesh-ancestor
153853434|NCT04548661|Blood Substitutes|blood substitutes|mesh-ancestor
153853435|NCT04548661|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
153853436|NCT04548661|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153853437|NCT04500665|Colchicine|colchicine|mesh-list
153393664|NCT00002961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153393665|NCT00002961|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153393666|NCT00002961|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153393667|NCT00002961|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
153393669|NCT00002961|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153393670|NCT00002961|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153393671|NCT00002961|Antimetabolites|antimetabolites|mesh-ancestor
153393672|NCT00002961|Dermatologic Agents|dermatologic agents|mesh-ancestor
153853472|NCT04377386|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153853473|NCT04358393|Azacitidine|azacitidine|mesh-list
153853474|NCT04358393|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153853475|NCT04358393|Antimetabolites|antimetabolites|mesh-ancestor
153853476|NCT04358393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153853477|NCT04358393|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153393703|NCT00002967|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153393704|NCT00002967|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
153393705|NCT00002967|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
153393706|NCT00002967|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153393707|NCT00002967|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153393709|NCT00002973|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153393710|NCT00002973|Alkylating Agents|alkylating agents|mesh-ancestor
153393711|NCT00002973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153393712|NCT00002973|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153393713|NCT00002973|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153393714|NCT00002973|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153853479|NCT04332068|Ivermectin|ivermectin|mesh-list
153853480|NCT04332068|Permethrin|permethrin|mesh-list
153853481|NCT04332068|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153853482|NCT04332068|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153853483|NCT04332068|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153853484|NCT04332068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153853485|NCT04283916|Botulinum Toxins|botulinum toxins|mesh-list
153853486|NCT04283916|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
153853487|NCT04283916|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153853488|NCT04283916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153853489|NCT04283916|Cholinergic Agents|cholinergic agents|mesh-ancestor
153853492|NCT04274023|Dostarlimab|dostarlimab|mesh-list
153853493|NCT04274023|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153853494|NCT04264208|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
153853495|NCT04264208|Bombesin|bombesin|mesh-list
153853496|NCT04264208|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
153853497|NCT04264208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153853498|NCT04264208|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153853499|NCT04264208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153853500|NCT04213794|Sodium thiosulfate|sodium thiosulfate|mesh-list
153853501|NCT04213794|Cisplatin|cisplatin|mesh-list
153853502|NCT04213794|Doxorubicin|doxorubicin|mesh-list
153853503|NCT04213794|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
153853504|NCT04213794|Daunorubicin|daunorubicin|mesh-list
153393728|NCT00363389|Abortifacient Agents|abortifacient agents|mesh-ancestor
153393729|NCT00363389|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153393730|NCT00363389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153393731|NCT00363389|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
153393732|NCT00363389|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153393733|NCT00363389|Oxytocics|oxytocics|mesh-ancestor
153393734|NCT00003003|Mitoxantrone|mitoxantrone|mesh-list
153393735|NCT00003003|Mitomycins|mitomycins|mesh-list
153393736|NCT00003003|Mitomycin|mitomycin|mesh-list
153393737|NCT00003003|Sargramostim|sargramostim|mesh-list
153393738|NCT00003003|Immunologic Factors|immunologic factors|mesh-ancestor
153393739|NCT00003003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153853505|NCT04213794|Antidotes|antidotes|mesh-list
153853506|NCT04213794|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153853507|NCT04213794|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153853508|NCT04213794|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153853509|NCT04213794|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153853510|NCT04213794|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153853511|NCT04213794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153853512|NCT04213794|Protective Agents|protective agents|mesh-ancestor
153853524|NCT04196530|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153853525|NCT04180488|Histamine Antagonists|histamine antagonists|mesh-list
153853526|NCT04180488|Histamine H1 Antagonists|histamine h1 antagonists|mesh-list
153853527|NCT04180488|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-list
153853528|NCT04180488|Histamine Agents|histamine agents|mesh-ancestor
153853529|NCT04180488|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153853530|NCT04180488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153853531|NCT04180488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153853533|NCT04120766|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153853534|NCT04120766|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153853535|NCT04120766|Vasodilator Agents|vasodilator agents|mesh-ancestor
153853536|NCT04120766|Vitamin B Complex|vitamin b complex|mesh-ancestor
153853537|NCT04120766|Vitamins|vitamins|mesh-ancestor
153853538|NCT04120766|Micronutrients|micronutrients|mesh-ancestor
153853539|NCT04120766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153853540|NCT04114539|Ecopipam|ecopipam|mesh-list
153853541|NCT04114539|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153853554|NCT04027647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153853555|NCT03959176|Brimonidine Tartrate|brimonidine tartrate|mesh-list
153853556|NCT03959176|Phenylephrine|phenylephrine|mesh-list
153853557|NCT03959176|Oxymetazoline|oxymetazoline|mesh-list
153853558|NCT03959176|Tropicamide|tropicamide|mesh-list
153853559|NCT03959176|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
153853560|NCT03959176|Mydriatics|mydriatics|mesh-ancestor
153853561|NCT03959176|Autonomic Agents|autonomic agents|mesh-ancestor
153853562|NCT03959176|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153393802|NCT00003063|Antidotes|antidotes|mesh-ancestor
153393803|NCT00003063|Protective Agents|protective agents|mesh-ancestor
153393804|NCT00003063|Vitamin B Complex|vitamin b complex|mesh-ancestor
153393805|NCT00003063|Vitamins|vitamins|mesh-ancestor
153393806|NCT00003063|Micronutrients|micronutrients|mesh-ancestor
153393807|NCT00003063|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153393808|NCT00003063|Antinematodal Agents|antinematodal agents|mesh-ancestor
153393809|NCT00003063|Anthelmintics|anthelmintics|mesh-ancestor
153393810|NCT00003063|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153393811|NCT00003063|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153393812|NCT00003075|Fenretinide|fenretinide|mesh-list
153393813|NCT00003075|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153393814|NCT00003075|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
153393815|NCT00003075|Protective Agents|protective agents|mesh-ancestor
153393816|NCT00003075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153393817|NCT00003081|Melphalan|melphalan|mesh-list
153393818|NCT00003081|Busulfan|busulfan|mesh-list
153393819|NCT00003081|Thiotepa|thiotepa|mesh-list
153393820|NCT00003081|Immunologic Factors|immunologic factors|mesh-ancestor
153393821|NCT00003081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153853582|NCT03891953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153853583|NCT03891953|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153853584|NCT03891953|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153853585|NCT03891238|Avelumab|avelumab|mesh-list
153853586|NCT03891238|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153853587|NCT03891238|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153853588|NCT03805477|Nintedanib|nintedanib|mesh-list
153853589|NCT03805477|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153853590|NCT03805477|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153853591|NCT03805477|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153853592|NCT03805477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153853593|NCT03798626|Leucovorin|leucovorin|mesh-list
153853594|NCT03798626|Paclitaxel|paclitaxel|mesh-list
153853595|NCT03798626|Bevacizumab|bevacizumab|mesh-list
153853596|NCT03798626|Fluorouracil|fluorouracil|mesh-list
153853597|NCT03798626|Oxaliplatin|oxaliplatin|mesh-list
153393822|NCT00003081|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153393824|NCT00003081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153393825|NCT00003081|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153393826|NCT00003081|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153393827|NCT00003081|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153853645|NCT03486301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153853646|NCT03467373|Prednisone|prednisone|mesh-list
153853647|NCT03467373|Cyclophosphamide|cyclophosphamide|mesh-list
153853648|NCT03467373|Rituximab|rituximab|mesh-list
153853649|NCT03467373|Doxorubicin|doxorubicin|mesh-list
153853650|NCT03467373|Vincristine|vincristine|mesh-list
153853651|NCT03467373|Obinutuzumab|obinutuzumab|mesh-list
153853652|NCT03467373|Polatuzumab vedotin|polatuzumab vedotin|mesh-list
153853653|NCT03467373|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153853654|NCT03467373|Immunologic Factors|immunologic factors|mesh-ancestor
153853655|NCT03467373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153853656|NCT03467373|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153393881|NCT00003099|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153393882|NCT00003099|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153393884|NCT00003099|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
153853661|NCT03467373|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153853662|NCT03467373|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153853663|NCT03467373|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153853664|NCT03467373|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153853665|NCT03467373|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153853666|NCT03467373|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153853667|NCT03467373|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153853668|NCT03467373|Glucocorticoids|glucocorticoids|mesh-ancestor
153853669|NCT03467373|Hormones|hormones|mesh-ancestor
153853670|NCT03467373|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153853671|NCT03467373|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153853672|NCT03467373|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153853673|NCT03467373|Tubulin Modulators|tubulin modulators|mesh-ancestor
153393898|NCT00003105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153393899|NCT00003105|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153393900|NCT00003105|Antimetabolites|antimetabolites|mesh-ancestor
153393901|NCT00003105|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153393929|NCT02240329|Dermatologic Agents|dermatologic agents|mesh-ancestor
153393930|NCT02240329|Sensory System Agents|sensory system agents|mesh-ancestor
153393931|NCT02240329|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153393932|NCT02240329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153393933|NCT00003123|Amifostine|amifostine|mesh-list
153393934|NCT00003123|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
153393935|NCT00003123|Protective Agents|protective agents|mesh-ancestor
153393936|NCT00003123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153393937|NCT03965923|Tenofovir|tenofovir|mesh-list
153393938|NCT03965923|Emtricitabine|emtricitabine|mesh-list
153393939|NCT03965923|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
153393940|NCT03965923|Dapivirine|dapivirine|mesh-list
153393941|NCT03965923|Antiviral Agents|antiviral agents|mesh-ancestor
153393942|NCT03965923|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153393943|NCT03965923|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153393944|NCT03965923|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153393945|NCT03965923|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153393946|NCT03965923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153393947|NCT03965923|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153393948|NCT03965923|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153393949|NCT03962725|Dexmedetomidine|dexmedetomidine|mesh-list
153853726|NCT03057431|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
153853727|NCT03057431|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153853728|NCT03057431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153853729|NCT03020199|Betamethasone|betamethasone|mesh-list
153853730|NCT03020199|Calcipotriene|calcipotriene|mesh-list
153853731|NCT03020199|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153853732|NCT03020199|Glucocorticoids|glucocorticoids|mesh-ancestor
153853733|NCT03020199|Hormones|hormones|mesh-ancestor
153393963|NCT03962725|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153393964|NCT03962725|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153393965|NCT03962725|Adrenergic Agents|adrenergic agents|mesh-ancestor
153393966|NCT03962725|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153393967|NCT03962725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153393968|NCT03962725|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153393969|NCT03962725|Anesthetics, General|anesthetics, general|mesh-ancestor
153393970|NCT03962725|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
153393975|NCT02210559|Paclitaxel|paclitaxel|mesh-list
153853736|NCT03020199|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153853737|NCT03020199|Respiratory System Agents|respiratory system agents|mesh-ancestor
153853738|NCT03020199|Dermatologic Agents|dermatologic agents|mesh-ancestor
153853739|NCT02967692|Trametinib|trametinib|mesh-list
153853740|NCT02967692|Dabrafenib|dabrafenib|mesh-list
153853741|NCT02967692|Spartalizumab|spartalizumab|mesh-list
153853742|NCT02967692|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153853743|NCT02967692|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153853744|NCT02967692|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153853745|NCT02967692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153853746|NCT02967692|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153853747|NCT02967692|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153853748|NCT02953457|Durvalumab|durvalumab|mesh-list
153853749|NCT02953457|Ipilimumab|ipilimumab|mesh-list
153853750|NCT02953457|Olaparib|olaparib|mesh-list
153853751|NCT02953457|Tremelimumab|tremelimumab|mesh-list
153853752|NCT02953457|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
153853753|NCT02953457|Immunoglobulins|immunoglobulins|mesh-list
153853754|NCT02953457|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
153853755|NCT02953457|Immunoglobulin G|immunoglobulin g|mesh-list
153853756|NCT02953457|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153853757|NCT02953457|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153853758|NCT02953457|Immunologic Factors|immunologic factors|mesh-ancestor
153853759|NCT02953457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153393989|NCT00003135|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153394010|NCT00003141|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153394011|NCT00003141|Alkylating Agents|alkylating agents|mesh-ancestor
153394012|NCT00003141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153394013|NCT00003141|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153394014|NCT00003141|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153394015|NCT00003141|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153394016|NCT00003141|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153394017|NCT00003141|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153394018|NCT00003141|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153394019|NCT00003141|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153394020|NCT00003141|Tubulin Modulators|tubulin modulators|mesh-ancestor
153394021|NCT00003141|Antimitotic Agents|antimitotic agents|mesh-ancestor
153394022|NCT00003141|Mitosis Modulators|mitosis modulators|mesh-ancestor
153394023|NCT04867135|Amikacin|amikacin|mesh-list
153394024|NCT04867135|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153394025|NCT04867135|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153394026|NCT01740817|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
153394027|NCT01740817|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
153394028|NCT01740817|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
153394029|NCT01740817|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
153394030|NCT04581343|Paclitaxel|paclitaxel|mesh-list
153394031|NCT04581343|Gemcitabine|gemcitabine|mesh-list
153394032|NCT04581343|Spartalizumab|spartalizumab|mesh-list
153394033|NCT04581343|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153394040|NCT04581343|Antimetabolites|antimetabolites|mesh-ancestor
153853790|NCT02705196|Gemcitabine|gemcitabine|mesh-list
153853791|NCT02705196|Atezolizumab|atezolizumab|mesh-list
153853792|NCT02705196|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153853793|NCT02705196|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153853794|NCT02705196|Tubulin Modulators|tubulin modulators|mesh-ancestor
153853795|NCT02705196|Antimitotic Agents|antimitotic agents|mesh-ancestor
153853796|NCT02705196|Mitosis Modulators|mitosis modulators|mesh-ancestor
153853797|NCT02705196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153853798|NCT02705196|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153853799|NCT02705196|Antimetabolites|antimetabolites|mesh-ancestor
153853800|NCT02705196|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153853801|NCT02705196|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153853802|NCT02658097|Pembrolizumab|pembrolizumab|mesh-list
153853803|NCT02658097|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153853804|NCT02658097|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153853805|NCT02658097|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153853806|NCT02658097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153853807|NCT02646475|Angiotensin I (1-7)|angiotensin i (1-7)|mesh-list
153853808|NCT02646475|Angiotensin II|angiotensin ii|mesh-list
153853809|NCT02646475|Angiotensinogen|angiotensinogen|mesh-list
153853810|NCT02646475|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153853811|NCT02646475|Vasodilator Agents|vasodilator agents|mesh-ancestor
153853812|NCT02646475|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
153853814|NCT02646475|Protease Inhibitors|protease inhibitors|mesh-ancestor
153853827|NCT02564978|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153853829|NCT02519348|Durvalumab|durvalumab|mesh-list
153853830|NCT02519348|Tremelimumab|tremelimumab|mesh-list
153853831|NCT02519348|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153394061|NCT01746043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153394062|NCT01746043|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
153394063|NCT01746043|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
153394064|NCT01746043|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
153394065|NCT01746043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153394066|NCT05635903|Diazepam|diazepam|mesh-list
153394067|NCT05635903|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153394068|NCT05635903|Anticonvulsants|anticonvulsants|mesh-ancestor
153394069|NCT05635903|Antiemetics|antiemetics|mesh-ancestor
153394070|NCT05635903|Autonomic Agents|autonomic agents|mesh-ancestor
153394071|NCT05635903|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153853833|NCT02519348|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153853834|NCT02519348|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153853835|NCT02519348|Growth Substances|growth substances|mesh-ancestor
153853836|NCT02519348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153853837|NCT02519348|Growth Inhibitors|growth inhibitors|mesh-ancestor
153853839|NCT02492464|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
153853840|NCT02492464|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153853841|NCT02492464|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153853842|NCT02492464|Antimetabolites|antimetabolites|mesh-ancestor
153853843|NCT02492464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153853844|NCT02492464|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153853845|NCT02492464|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153853846|NCT02486718|Gemcitabine|gemcitabine|mesh-list
153853847|NCT02486718|Docetaxel|docetaxel|mesh-list
153853848|NCT02486718|Pemetrexed|pemetrexed|mesh-list
153853849|NCT02486718|Atezolizumab|atezolizumab|mesh-list
153853850|NCT02486718|Vinorelbine|vinorelbine|mesh-list
153394088|NCT01746511|Glycerol|glycerol|mesh-list
153853861|NCT02486718|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153853862|NCT02486718|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153853863|NCT02486718|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153853864|NCT02477696|Acalabrutinib|acalabrutinib|mesh-list
153853865|NCT02477696|Ibrutinib|ibrutinib|mesh-list
153853866|NCT02477696|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153853867|NCT02477696|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153853868|NCT02477696|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153853869|NCT02477696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153853870|NCT02477696|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153853871|NCT02133885|Minocycline|minocycline|mesh-list
153853872|NCT02133885|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153853873|NCT02133885|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153853874|NCT01988883|Propranolol|propranolol|mesh-list
153853875|NCT01988883|Modafinil|modafinil|mesh-list
153853876|NCT01988883|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
153853877|NCT01988883|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
153853878|NCT01988883|Adrenergic Agents|adrenergic agents|mesh-ancestor
153853879|NCT01988883|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153853880|NCT01988883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153853881|NCT01988883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153853882|NCT01988883|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153853883|NCT01988883|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153853884|NCT01988883|Vasodilator Agents|vasodilator agents|mesh-ancestor
153394121|NCT01754389|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153394122|NCT01754389|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153394123|NCT01754389|Antifungal Agents|antifungal agents|mesh-ancestor
153394125|NCT01754623|Capecitabine|capecitabine|mesh-list
153394126|NCT01754623|Fluorouracil|fluorouracil|mesh-list
153394127|NCT01754623|Docetaxel|docetaxel|mesh-list
153394128|NCT01754623|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153394129|NCT01754623|Antimetabolites|antimetabolites|mesh-ancestor
153394130|NCT01754623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153394131|NCT01754623|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153394132|NCT01754623|Tubulin Modulators|tubulin modulators|mesh-ancestor
153394133|NCT01754623|Antimitotic Agents|antimitotic agents|mesh-ancestor
153394134|NCT01754623|Mitosis Modulators|mitosis modulators|mesh-ancestor
153394135|NCT01754623|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153394136|NCT01754623|Immunologic Factors|immunologic factors|mesh-ancestor
153394137|NCT01754623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153394139|NCT01755169|Analgesics|analgesics|mesh-ancestor
153394140|NCT01755169|Sensory System Agents|sensory system agents|mesh-ancestor
153853892|NCT01955499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153853893|NCT01955499|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153853894|NCT01955499|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153853895|NCT01955499|Growth Substances|growth substances|mesh-ancestor
153853896|NCT01955499|Growth Inhibitors|growth inhibitors|mesh-ancestor
153853897|NCT01955499|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153853898|NCT01955499|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153853899|NCT01955499|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153853900|NCT01955499|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153853901|NCT01955499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153853903|NCT01829568|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
153853904|NCT01829568|Lenalidomide|lenalidomide|mesh-list
153853905|NCT01829568|Antibodies|antibodies|mesh-list
153853906|NCT01829568|Immunoglobulins|immunoglobulins|mesh-list
153853907|NCT01829568|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
153853908|NCT01829568|Ibrutinib|ibrutinib|mesh-list
153853909|NCT01829568|Immunologic Factors|immunologic factors|mesh-ancestor
153853910|NCT01829568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153394141|NCT01755169|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153394142|NCT01755169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153853917|NCT01829568|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153853975|NCT01186328|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153853976|NCT01186328|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153853977|NCT01186328|Immunologic Factors|immunologic factors|mesh-ancestor
153853978|NCT01186328|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153853979|NCT01186328|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153853980|NCT01186328|Antiviral Agents|antiviral agents|mesh-ancestor
153853981|NCT01186328|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153853982|NCT01186328|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153853983|NCT01186328|Tubulin Modulators|tubulin modulators|mesh-ancestor
153853984|NCT01186328|Antimitotic Agents|antimitotic agents|mesh-ancestor
153853985|NCT01186328|Mitosis Modulators|mitosis modulators|mesh-ancestor
153853986|NCT01130519|Bevacizumab|bevacizumab|mesh-list
153853987|NCT01130519|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
153853988|NCT01130519|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153394220|NCT04005079|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
153394221|NCT04005079|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153394222|NCT04005079|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153854043|NCT00408005|Cytarabine|cytarabine|mesh-list
153854069|NCT00408005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153854070|NCT00408005|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153854071|NCT00408005|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153854072|NCT00408005|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153854073|NCT00408005|Antiemetics|antiemetics|mesh-ancestor
153854074|NCT00408005|Autonomic Agents|autonomic agents|mesh-ancestor
153394305|NCT01769209|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153394306|NCT01769209|Antiviral Agents|antiviral agents|mesh-ancestor
153394307|NCT01769209|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153394308|NCT01769209|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153394309|NCT01769209|Tubulin Modulators|tubulin modulators|mesh-ancestor
153394310|NCT01769209|Antimitotic Agents|antimitotic agents|mesh-ancestor
153854085|NCT00408005|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153854086|NCT00408005|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153394320|NCT01769365|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
153394321|NCT01769365|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153394323|NCT01769365|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
153394338|NCT01771627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153394339|NCT03749629|Psychotropic Drugs|psychotropic drugs|mesh-list
153394340|NCT03682393|Hydrocortisone|hydrocortisone|mesh-list
153394341|NCT03682393|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153394343|NCT03499483|Emtricitabine|emtricitabine|mesh-list
153394344|NCT03499483|Emtricitabine tenofovir alafenamide|emtricitabine tenofovir alafenamide|mesh-list
153394357|NCT01673867|Docetaxel|docetaxel|mesh-list
153394367|NCT01777945|Capecitabine|capecitabine|mesh-list
153394368|NCT01777945|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153394369|NCT01777945|Tubulin Modulators|tubulin modulators|mesh-ancestor
153394370|NCT01777945|Antimitotic Agents|antimitotic agents|mesh-ancestor
153394371|NCT01777945|Mitosis Modulators|mitosis modulators|mesh-ancestor
153394372|NCT01777945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153394373|NCT01777945|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153394374|NCT01777945|Antimetabolites|antimetabolites|mesh-ancestor
153394375|NCT05451043|Paclitaxel|paclitaxel|mesh-list
153854137|NCT04645940|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153854138|NCT04645940|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
153854139|NCT04645940|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153854140|NCT04645940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153394376|NCT05451043|Gemcitabine|gemcitabine|mesh-list
153394377|NCT05451043|Durvalumab|durvalumab|mesh-list
153394378|NCT05451043|Tremelimumab|tremelimumab|mesh-list
153394379|NCT05451043|Propranolol|propranolol|mesh-list
153394380|NCT05451043|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153394381|NCT05451043|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153394382|NCT05451043|Tubulin Modulators|tubulin modulators|mesh-ancestor
153394383|NCT05451043|Antimitotic Agents|antimitotic agents|mesh-ancestor
153394384|NCT05451043|Mitosis Modulators|mitosis modulators|mesh-ancestor
153394385|NCT05451043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153394386|NCT05451043|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153394387|NCT05451043|Antimetabolites|antimetabolites|mesh-ancestor
153394388|NCT05451043|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153394389|NCT05451043|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
153394390|NCT05451043|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
153394391|NCT05451043|Adrenergic Agents|adrenergic agents|mesh-ancestor
153394392|NCT05451043|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153394393|NCT05451043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153854142|NCT00558506|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153854143|NCT00558506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153854144|NCT00558506|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153854145|NCT00558506|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153854146|NCT00558506|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153854147|NCT00558506|Immunologic Factors|immunologic factors|mesh-ancestor
153854148|NCT00558506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153854150|NCT00558623|Calcium Carbonate|calcium carbonate|mesh-list
153854151|NCT00558623|Calcium|calcium|mesh-list
153854152|NCT00558623|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153854153|NCT00558623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153854154|NCT00558623|Antacids|antacids|mesh-ancestor
153854155|NCT00558623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153854156|NCT00558623|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153854157|NCT00558662|Monensin|monensin|mesh-list
153854158|NCT00558662|Antifungal Agents|antifungal agents|mesh-ancestor
153854159|NCT00558662|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153854160|NCT00558662|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153854161|NCT00558662|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153854180|NCT02905890|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
153854181|NCT02906163|Gefitinib|gefitinib|mesh-list
153854182|NCT02906163|Afatinib|afatinib|mesh-list
153854183|NCT02906163|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-list
153854184|NCT02906163|Thymalfasin|thymalfasin|mesh-list
153854185|NCT02906163|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153854193|NCT04645745|Inositol|inositol|mesh-list
153854194|NCT04645745|Hematinics|hematinics|mesh-ancestor
153854195|NCT04645745|Vitamin B Complex|vitamin b complex|mesh-ancestor
153854196|NCT04645745|Vitamins|vitamins|mesh-ancestor
153854197|NCT04645745|Micronutrients|micronutrients|mesh-ancestor
153854198|NCT04645745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153854199|NCT02905695|Levobupivacaine|levobupivacaine|mesh-list
153854200|NCT02905695|Anesthetics, Local|anesthetics, local|mesh-ancestor
153854201|NCT02905695|Anesthetics|anesthetics|mesh-ancestor
153394434|NCT04744727|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153394435|NCT04744727|Narcotics|narcotics|mesh-ancestor
153394436|NCT04744727|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153394437|NCT04744727|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153394438|NCT02454179|Pembrolizumab|pembrolizumab|mesh-list
153394439|NCT02454179|Acalabrutinib|acalabrutinib|mesh-list
153394440|NCT02454179|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153394441|NCT02454179|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153394442|NCT02454179|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153394443|NCT02454179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153394444|NCT02454179|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153854210|NCT04681911|Paclitaxel|paclitaxel|mesh-list
153854211|NCT04681911|Vinorelbine|vinorelbine|mesh-list
153854212|NCT04681911|Carboplatin|carboplatin|mesh-list
153854213|NCT04681911|Gemcitabine|gemcitabine|mesh-list
153854214|NCT04681911|Capecitabine|capecitabine|mesh-list
153854215|NCT04681911|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153854216|NCT04681911|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153854217|NCT04681911|Tubulin Modulators|tubulin modulators|mesh-ancestor
153854218|NCT04681911|Antimitotic Agents|antimitotic agents|mesh-ancestor
153854219|NCT04681911|Mitosis Modulators|mitosis modulators|mesh-ancestor
153394454|NCT02041533|Tubulin Modulators|tubulin modulators|mesh-ancestor
153854247|NCT02905305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153394481|NCT02115997|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
153394482|NCT02115997|Prednisolone phosphate|prednisolone phosphate|mesh-list
153394483|NCT02115997|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153394484|NCT02115997|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153394485|NCT02115997|Immunologic Factors|immunologic factors|mesh-ancestor
153394486|NCT02115997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153394487|NCT02115997|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153394488|NCT02115997|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153394489|NCT02115997|Glucocorticoids|glucocorticoids|mesh-ancestor
153394490|NCT02115997|Hormones|hormones|mesh-ancestor
153394491|NCT02115997|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153394492|NCT02115997|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153854260|NCT02899182|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153854261|NCT02899182|Analgesics|analgesics|mesh-ancestor
153854262|NCT02899182|Sensory System Agents|sensory system agents|mesh-ancestor
153854263|NCT02899182|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153854264|NCT02905227|Zolmitriptan|zolmitriptan|mesh-list
153854265|NCT02905227|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
153854266|NCT02905227|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
153854267|NCT02905227|Serotonin Agents|serotonin agents|mesh-ancestor
153854268|NCT02905227|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153854269|NCT02905227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153854270|NCT02905227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153854271|NCT04643483|Adalimumab|adalimumab|mesh-list
153854272|NCT04643483|Certolizumab Pegol|certolizumab pegol|mesh-list
153854275|NCT04643483|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153854276|NCT04643483|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153854277|NCT04643483|Immunologic Factors|immunologic factors|mesh-ancestor
153854278|NCT04643483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153854280|NCT00559052|Pancreatin|pancreatin|mesh-list
153854281|NCT00559052|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153854282|NCT02899104|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
153854283|NCT02899104|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153854284|NCT04643132|Ketamine|ketamine|mesh-list
153854285|NCT04643132|Esketamine|esketamine|mesh-list
153854286|NCT04643132|Analgesics|analgesics|mesh-ancestor
153854287|NCT04643132|Sensory System Agents|sensory system agents|mesh-ancestor
153854288|NCT04643132|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153854289|NCT04643132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153854290|NCT04643132|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
153854293|NCT04643132|Anesthetics|anesthetics|mesh-ancestor
153854325|NCT04642664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153394559|NCT01808755|Sulfamethoxazole|sulfamethoxazole|mesh-list
153394560|NCT01808755|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
153394561|NCT01808755|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153394562|NCT01808755|Antimalarials|antimalarials|mesh-ancestor
153394563|NCT01808755|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153394564|NCT01808755|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153394565|NCT01808755|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153394566|NCT01808755|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153394567|NCT01808755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153394568|NCT01808755|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
153394569|NCT01808755|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
153394570|NCT01808755|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153394571|NCT02694809|Bazedoxifene|bazedoxifene|mesh-list
153854346|NCT02904564|Immunologic Factors|immunologic factors|mesh-ancestor
153854347|NCT02904564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153854348|NCT04642001|Listerine|listerine|mesh-list
153854349|NCT04642001|Sodium Fluoride|sodium fluoride|mesh-list
153854350|NCT04642001|Cariostatic Agents|cariostatic agents|mesh-ancestor
153854351|NCT04642001|Protective Agents|protective agents|mesh-ancestor
153854352|NCT04642001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153854353|NCT04642001|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
153854354|NCT04642001|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153854355|NCT00559286|Telmisartan|telmisartan|mesh-list
153854356|NCT00559286|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153854357|NCT00559286|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
153394589|NCT00362687|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153394590|NCT01790659|Gentamicins|gentamicins|mesh-list
153394591|NCT01790659|Paromomycin|paromomycin|mesh-list
153394592|NCT01790659|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153394593|NCT01790659|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153394594|NCT01790659|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
153394595|NCT01790659|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153394599|NCT02469701|Nivolumab|nivolumab|mesh-list
153394600|NCT02469701|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153394601|NCT02469701|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153394602|NCT02469701|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153394604|NCT01733953|Atorvastatin|atorvastatin|mesh-list
153394605|NCT01733953|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153394606|NCT01733953|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153394607|NCT01733953|Antimetabolites|antimetabolites|mesh-ancestor
153394608|NCT01733953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153394609|NCT01733953|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153394610|NCT01733953|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
153394611|NCT01733953|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153394612|NCT00362921|Carmustine|carmustine|mesh-list
153394613|NCT00362921|O(6)-benzylguanine|o(6)-benzylguanine|mesh-list
153394614|NCT00362921|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153394615|NCT00362921|Alkylating Agents|alkylating agents|mesh-ancestor
153394616|NCT00362921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153394617|NCT00362921|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153394618|NCT00362921|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153394619|NCT01734889|Nitisinone|nitisinone|mesh-list
153394620|NCT01734889|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153394621|NCT01734889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153394622|NCT01736527|Loteprednol Etabonate|loteprednol etabonate|mesh-list
153394623|NCT01736527|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
153394624|NCT01796665|Clindamycin|clindamycin|mesh-list
153394625|NCT01796665|Clindamycin palmitate|clindamycin palmitate|mesh-list
153394626|NCT01796665|Clindamycin phosphate|clindamycin phosphate|mesh-list
153394627|NCT01796665|Benzoyl Peroxide|benzoyl peroxide|mesh-list
153394628|NCT01796665|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153394629|NCT01796665|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153394630|NCT01796665|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
153394631|NCT01796665|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153854371|NCT02897934|Sensory System Agents|sensory system agents|mesh-ancestor
153854372|NCT02897934|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153854389|NCT02898012|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153854390|NCT02898012|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153854391|NCT02898012|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153854392|NCT02898012|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153854393|NCT02898012|Growth Substances|growth substances|mesh-ancestor
153854394|NCT02898012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153854395|NCT02898012|Growth Inhibitors|growth inhibitors|mesh-ancestor
153854396|NCT02898012|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153854397|NCT02898012|Alkylating Agents|alkylating agents|mesh-ancestor
153854398|NCT02898012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153854399|NCT04640324|Vitamin D|vitamin d|mesh-list
153854400|NCT04640324|Vitamins|vitamins|mesh-list
153854401|NCT04640324|Vitamin E|vitamin e|mesh-list
153854402|NCT04640324|Silybin|silybin|mesh-list
153854403|NCT04640324|Micronutrients|micronutrients|mesh-ancestor
153854404|NCT04640324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153854405|NCT04640324|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153854406|NCT04640324|Antioxidants|antioxidants|mesh-ancestor
153854407|NCT04640324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153854408|NCT04640324|Protective Agents|protective agents|mesh-ancestor
153854409|NCT04640324|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153854410|NCT04640324|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153854411|NCT04640285|Menthol|menthol|mesh-list
153854412|NCT04640285|Nicotine|nicotine|mesh-list
153854413|NCT04640285|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
153854414|NCT04640285|Autonomic Agents|autonomic agents|mesh-ancestor
153854415|NCT04640285|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153394649|NCT01800877|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153394650|NCT01800877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153394651|NCT01800877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153394652|NCT01800877|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
153394653|NCT01800877|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153394654|NCT01800877|Autonomic Agents|autonomic agents|mesh-ancestor
153854427|NCT00559481|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
153394672|NCT02471651|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153394673|NCT02471651|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153394674|NCT02471651|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153394675|NCT02471651|Growth Substances|growth substances|mesh-ancestor
153394676|NCT02471651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153394677|NCT02471651|Growth Inhibitors|growth inhibitors|mesh-ancestor
153394678|NCT02471651|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153394679|NCT02471651|Antiemetics|antiemetics|mesh-ancestor
153394680|NCT02471651|Autonomic Agents|autonomic agents|mesh-ancestor
153394681|NCT02471651|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153394682|NCT02471651|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153394683|NCT02471651|Glucocorticoids|glucocorticoids|mesh-ancestor
153394685|NCT02471651|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153394702|NCT04744571|Clopidogrel|clopidogrel|mesh-list
153394704|NCT04744571|Atorvastatin|atorvastatin|mesh-list
153394705|NCT04744571|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
153394706|NCT04744571|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153394707|NCT04744571|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153394708|NCT04744571|Analgesics|analgesics|mesh-ancestor
153394709|NCT04744571|Sensory System Agents|sensory system agents|mesh-ancestor
153394710|NCT04744571|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153394711|NCT04744571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153394712|NCT04744571|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153394713|NCT04744571|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153394714|NCT04744571|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153394715|NCT04744571|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153394716|NCT04744571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153394717|NCT04744571|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153394718|NCT04744571|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153394719|NCT04744571|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153394720|NCT04744571|Antipyretics|antipyretics|mesh-ancestor
153854475|NCT04639817|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
153854476|NCT04639817|Sulfamethoxazole|sulfamethoxazole|mesh-list
153854477|NCT04639817|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
153854478|NCT04639817|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153854479|NCT04639817|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153854480|NCT04639817|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153854481|NCT04639817|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153854482|NCT04639817|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153854483|NCT04639817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153854484|NCT04639817|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153394721|NCT04744571|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153394722|NCT04744571|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153394723|NCT04744571|Antimetabolites|antimetabolites|mesh-ancestor
153394724|NCT04744571|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153394725|NCT04744571|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
153394726|NCT04744571|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
153394727|NCT04744571|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
153394728|NCT04744571|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
153394729|NCT04744571|Purinergic Agents|purinergic agents|mesh-ancestor
153394730|NCT04744571|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153394731|NCT04744571|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153394732|NCT04744571|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153854506|NCT01229254|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153854507|NCT01229254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153854510|NCT01229254|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153854511|NCT01229254|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153854512|NCT01229254|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
153854513|NCT01229254|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
153854514|NCT01229254|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
153854515|NCT01229254|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
153854516|NCT01229254|Antithrombins|antithrombins|mesh-ancestor
153854517|NCT01229254|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
153854518|NCT01229254|Protease Inhibitors|protease inhibitors|mesh-ancestor
153854519|NCT01229254|Anticoagulants|anticoagulants|mesh-ancestor
153854520|NCT04639232|Probenecid|probenecid|mesh-list
153394758|NCT02257957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153394759|NCT02257957|Viscosupplements|viscosupplements|mesh-ancestor
153394760|NCT02257957|Protective Agents|protective agents|mesh-ancestor
153394763|NCT02524769|Hormones|hormones|mesh-ancestor
153854531|NCT01235728|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
153854532|NCT01235728|Vitamins|vitamins|mesh-ancestor
153854533|NCT01235728|Micronutrients|micronutrients|mesh-ancestor
153394772|NCT02525549|Sensory System Agents|sensory system agents|mesh-ancestor
153394773|NCT02525549|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153394774|NCT02525549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153394795|NCT01804075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153394796|NCT01804075|Analgesics|analgesics|mesh-ancestor
153394797|NCT01804075|Sensory System Agents|sensory system agents|mesh-ancestor
153394798|NCT01804075|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153394799|NCT01804075|Antitussive Agents|antitussive agents|mesh-ancestor
153394800|NCT01804075|Respiratory System Agents|respiratory system agents|mesh-ancestor
153394801|NCT02416193|Vitamin D|vitamin d|mesh-list
153394802|NCT02416193|Ergocalciferols|ergocalciferols|mesh-list
153394803|NCT02416193|Cholecalciferol|cholecalciferol|mesh-list
153394804|NCT02416193|Vitamins|vitamins|mesh-list
153394805|NCT02416193|Micronutrients|micronutrients|mesh-ancestor
153394806|NCT02416193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153394807|NCT02416193|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153394808|NCT02416193|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153394809|NCT02530151|Clonidine|clonidine|mesh-list
153854572|NCT04639193|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153854573|NCT04639193|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153854574|NCT04639193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153854575|NCT04639193|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153854576|NCT04639193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153914615|NCT00930046|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153394817|NCT02530151|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153394818|NCT02530151|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153394819|NCT02530151|Sympatholytics|sympatholytics|mesh-ancestor
153394820|NCT02530151|Autonomic Agents|autonomic agents|mesh-ancestor
153394821|NCT02530151|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
153394822|NCT02530151|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153394823|NCT02530151|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153394824|NCT02530151|Adrenergic Agents|adrenergic agents|mesh-ancestor
153394825|NCT02530151|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153854617|NCT00559715|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153854618|NCT00559715|Growth Substances|growth substances|mesh-ancestor
153854619|NCT00559715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153854620|NCT00559715|Growth Inhibitors|growth inhibitors|mesh-ancestor
153854621|NCT02896803|Fluorouracil|fluorouracil|mesh-list
153854622|NCT02896803|Oxaliplatin|oxaliplatin|mesh-list
153854623|NCT02896803|Antimetabolites|antimetabolites|mesh-ancestor
153854624|NCT02896803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153854659|NCT02896413|Dexmedetomidine|dexmedetomidine|mesh-list
153854660|NCT02896413|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153854661|NCT02896413|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153854662|NCT02896413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153854663|NCT02896413|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153854664|NCT02896413|Analgesics|analgesics|mesh-ancestor
153854665|NCT02896413|Sensory System Agents|sensory system agents|mesh-ancestor
153854666|NCT02896413|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153854667|NCT02896413|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
153854668|NCT02896413|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153854669|NCT02896413|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153854670|NCT02896413|Adrenergic Agents|adrenergic agents|mesh-ancestor
153854671|NCT02896413|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153854672|NCT02896413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153394912|NCT02533427|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153394913|NCT02533427|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
153394915|NCT02533427|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
153854689|NCT01235338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153854690|NCT01235338|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
153854691|NCT01235338|Antidepressive Agents|antidepressive agents|mesh-ancestor
153854692|NCT01235338|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153854693|NCT01235338|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
153854694|NCT01235338|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
153854696|NCT01234675|Milnacipran|milnacipran|mesh-list
153854697|NCT01234675|Levomilnacipran|levomilnacipran|mesh-list
153854698|NCT01234675|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
153394941|NCT02533505|Adrenergic Agents|adrenergic agents|mesh-ancestor
153394942|NCT02533505|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153394943|NCT02533505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153394944|NCT02420015|Bupropion|bupropion|mesh-list
153394945|NCT02420015|Nicotine|nicotine|mesh-list
153394946|NCT02420015|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
153394947|NCT02420015|Autonomic Agents|autonomic agents|mesh-ancestor
153394948|NCT02420015|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153394949|NCT02420015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153394950|NCT02420015|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
153394951|NCT02420015|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
153394952|NCT02420015|Cholinergic Agents|cholinergic agents|mesh-ancestor
153394953|NCT02420015|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153394954|NCT02420015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153854701|NCT01234675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153854702|NCT01234675|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153854703|NCT01234675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153854704|NCT01234675|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153854705|NCT01234675|Analgesics|analgesics|mesh-ancestor
153854706|NCT01234675|Sensory System Agents|sensory system agents|mesh-ancestor
153854707|NCT01234675|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153854708|NCT01234675|Antidepressive Agents|antidepressive agents|mesh-ancestor
153854709|NCT01234675|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153854710|NCT02896101|Pimecrolimus|pimecrolimus|mesh-list
153854711|NCT02896101|Tacrolimus|tacrolimus|mesh-list
153854712|NCT02896101|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153854713|NCT02896101|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153394955|NCT02420015|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
153394956|NCT02420015|Antidepressive Agents|antidepressive agents|mesh-ancestor
153394957|NCT02420015|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153394958|NCT02420015|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
153394959|NCT02420015|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153394960|NCT02420015|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153394961|NCT02420015|Dopamine Agents|dopamine agents|mesh-ancestor
153394962|NCT02420015|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
153394976|NCT05326867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153394979|NCT05324995|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153394980|NCT05324995|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153394981|NCT05324995|Adrenergic Agents|adrenergic agents|mesh-ancestor
153394982|NCT05324995|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153394983|NCT05324995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153394984|NCT05324995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153394985|NCT05324995|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
153394986|NCT05324995|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153394987|NCT05324995|Autonomic Agents|autonomic agents|mesh-ancestor
153394988|NCT05324995|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153394989|NCT05324995|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153394990|NCT05324995|Respiratory System Agents|respiratory system agents|mesh-ancestor
153854751|NCT01227967|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153854752|NCT01227967|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153854753|NCT01227967|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
153854754|NCT01227967|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
153854755|NCT01227967|Dopamine Agents|dopamine agents|mesh-ancestor
153854756|NCT01227967|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153854757|NCT01227967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153854758|NCT01227967|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153854759|NCT01227967|Analgesics|analgesics|mesh-ancestor
153854760|NCT01227967|Sensory System Agents|sensory system agents|mesh-ancestor
153854761|NCT01227967|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153854762|NCT00560144|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
153854763|NCT00560144|Immunologic Factors|immunologic factors|mesh-ancestor
153854764|NCT00560144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153854765|NCT04637204|Axitinib|axitinib|mesh-list
153854766|NCT04637204|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153854767|NCT04637204|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153854768|NCT04637204|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153395009|NCT05318521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153395010|NCT05318521|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153395011|NCT05318521|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153395012|NCT05318521|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153854776|NCT04637360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153854777|NCT04637360|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
153854778|NCT04637360|Vitamins|vitamins|mesh-ancestor
153854779|NCT04637360|Micronutrients|micronutrients|mesh-ancestor
153854780|NCT04637360|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153854781|NCT04637360|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
153854782|NCT04637360|Hormone Antagonists|hormone antagonists|mesh-ancestor
153854783|NCT04637360|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153854784|NCT04317703|Metformin|metformin|mesh-list
153854785|NCT04317703|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153854816|NCT00560300|Sequestering Agents|sequestering agents|mesh-ancestor
153854817|NCT02904369|Tenofovir|tenofovir|mesh-list
153854818|NCT02904369|Emtricitabine|emtricitabine|mesh-list
153854819|NCT02904369|Antiviral Agents|antiviral agents|mesh-ancestor
153914616|NCT05244031|Analgesics, Opioid|analgesics, opioid|mesh-list
153914617|NCT05244031|Narcotics|narcotics|mesh-ancestor
153914618|NCT05244031|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153914619|NCT05244031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153914620|NCT05244031|Analgesics|analgesics|mesh-ancestor
153914621|NCT05244031|Sensory System Agents|sensory system agents|mesh-ancestor
153914622|NCT05244031|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153914623|NCT04712071|Ketamine|ketamine|mesh-list
153914624|NCT04712071|Analgesics|analgesics|mesh-ancestor
153914625|NCT04712071|Sensory System Agents|sensory system agents|mesh-ancestor
153914626|NCT04712071|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153854821|NCT02904369|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153854822|NCT02904369|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153854823|NCT02904369|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153854824|NCT02904369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153854825|NCT02904369|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153854826|NCT02904369|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153854827|NCT00560378|Tacrolimus|tacrolimus|mesh-list
153854828|NCT00560378|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153854829|NCT00560378|Immunologic Factors|immunologic factors|mesh-ancestor
153854830|NCT00560378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153395071|NCT00363935|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153395072|NCT00363935|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153395073|NCT00363935|Adrenergic Agents|adrenergic agents|mesh-ancestor
153395074|NCT00363935|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153395075|NCT00363935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153395076|NCT05747521|Doxorubicin|doxorubicin|mesh-list
153395077|NCT05747521|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
153395078|NCT05747521|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153395079|NCT05747521|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153395080|NCT05747521|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153395081|NCT05747521|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153395082|NCT05747521|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153461744|NCT04195776|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153854833|NCT00560378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153854834|NCT02895321|Listerine|listerine|mesh-list
153854835|NCT02895321|Sodium Fluoride|sodium fluoride|mesh-list
153854836|NCT02895321|Cariostatic Agents|cariostatic agents|mesh-ancestor
153854837|NCT02895321|Protective Agents|protective agents|mesh-ancestor
153854838|NCT02895321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153854839|NCT02895321|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
153854840|NCT02895321|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153854841|NCT02894892|Esomeprazole|esomeprazole|mesh-list
153854856|NCT04635293|Simendan|simendan|mesh-list
153854857|NCT04635293|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
153854858|NCT04635293|Vasodilator Agents|vasodilator agents|mesh-ancestor
153854859|NCT04635293|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
153854860|NCT04635293|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
153395097|NCT02537873|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153395099|NCT02537951|Prilocaine|prilocaine|mesh-list
153395100|NCT02537951|Lidocaine, Prilocaine Drug Combination|lidocaine, prilocaine drug combination|mesh-list
153395101|NCT02537951|Capsaicin|capsaicin|mesh-list
153395102|NCT02537951|Anesthetics, Local|anesthetics, local|mesh-ancestor
153395103|NCT02537951|Anesthetics|anesthetics|mesh-ancestor
153395104|NCT02537951|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153395105|NCT02537951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153395106|NCT02537951|Sensory System Agents|sensory system agents|mesh-ancestor
153395107|NCT02537951|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153395108|NCT02537951|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153395109|NCT02537951|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
153854864|NCT04635293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153854865|NCT01227889|Dacarbazine|dacarbazine|mesh-list
153854866|NCT01227889|Dabrafenib|dabrafenib|mesh-list
153854867|NCT01227889|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153854868|NCT01227889|Alkylating Agents|alkylating agents|mesh-ancestor
153854869|NCT01227889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153854870|NCT01227889|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153854871|NCT01227889|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153854872|NCT01227889|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153395110|NCT02537951|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153395111|NCT02537951|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153395112|NCT02537951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153395113|NCT02537951|Antipruritics|antipruritics|mesh-ancestor
153395114|NCT02537951|Dermatologic Agents|dermatologic agents|mesh-ancestor
153395115|NCT02537951|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
153395116|NCT02487485|Sirolimus|sirolimus|mesh-list
153395117|NCT02487485|Ketamine|ketamine|mesh-list
153395118|NCT02487485|Analgesics|analgesics|mesh-ancestor
153395119|NCT02487485|Sensory System Agents|sensory system agents|mesh-ancestor
153395120|NCT02487485|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153395121|NCT02487485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153395122|NCT02487485|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
153395123|NCT02487485|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153854884|NCT00624676|Benzoyl Peroxide|benzoyl peroxide|mesh-list
153854885|NCT00624676|Dermatologic Agents|dermatologic agents|mesh-ancestor
153854886|NCT00624676|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153854887|NCT00624676|Antifungal Agents|antifungal agents|mesh-ancestor
153854888|NCT00624676|Keratolytic Agents|keratolytic agents|mesh-ancestor
153854889|NCT00624676|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153854890|NCT00624676|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153854892|NCT00624676|Sensory System Agents|sensory system agents|mesh-ancestor
153854893|NCT00624676|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153395182|NCT02430389|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153395183|NCT02430389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153854918|NCT00560690|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153854919|NCT00560690|Antiviral Agents|antiviral agents|mesh-ancestor
153854920|NCT00560690|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153854921|NCT00560690|Antimetabolites|antimetabolites|mesh-ancestor
153854922|NCT00560690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153854923|NCT01227421|Nitazoxanide|nitazoxanide|mesh-list
153854924|NCT01227421|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153854925|NCT01227421|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153854926|NCT02903901|Melatonin|melatonin|mesh-list
153854927|NCT02903901|Antioxidants|antioxidants|mesh-ancestor
153854928|NCT02903901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153854929|NCT02903901|Protective Agents|protective agents|mesh-ancestor
153854930|NCT02903901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153854931|NCT02903901|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153854932|NCT04634981|Anesthetics|anesthetics|mesh-list
153854933|NCT04634981|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153854934|NCT04634981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153854935|NCT00553449|Rabeprazole|rabeprazole|mesh-list
153854936|NCT00553449|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
153854937|NCT00553449|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153854938|NCT00553449|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
153854939|NCT00553449|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153854940|NCT00553449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153854941|NCT04633850|Dexamethasone|dexamethasone|mesh-list
153854942|NCT04633850|Bupivacaine|bupivacaine|mesh-list
153854943|NCT04633850|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153854944|NCT04633850|Antiemetics|antiemetics|mesh-ancestor
153854945|NCT04633850|Autonomic Agents|autonomic agents|mesh-ancestor
153854946|NCT04633850|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153854947|NCT04633850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153854948|NCT04633850|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153854949|NCT04633850|Glucocorticoids|glucocorticoids|mesh-ancestor
153854950|NCT04633850|Hormones|hormones|mesh-ancestor
153395185|NCT02430389|Sensory System Agents|sensory system agents|mesh-ancestor
153854974|NCT05427903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153854975|NCT05427903|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153854976|NCT05427903|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153854977|NCT05427903|Adrenergic Agents|adrenergic agents|mesh-ancestor
153854978|NCT05427903|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153854979|NCT05427903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153854980|NCT05427903|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
153854981|NCT05427903|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153854982|NCT05427903|Autonomic Agents|autonomic agents|mesh-ancestor
153854983|NCT05427903|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153854984|NCT05427903|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153854985|NCT05427903|Respiratory System Agents|respiratory system agents|mesh-ancestor
153854987|NCT05427903|Sympathomimetics|sympathomimetics|mesh-ancestor
153855030|NCT02903004|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
153855031|NCT02903004|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153855032|NCT02903004|Alkylating Agents|alkylating agents|mesh-ancestor
153855033|NCT00445796|Artesunate|artesunate|mesh-list
153855034|NCT00445796|Amodiaquine|amodiaquine|mesh-list
153395274|NCT04969627|Incretins|incretins|mesh-ancestor
153395290|NCT02499497|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153395291|NCT02499497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153395292|NCT01827475|Acetaminophen|acetaminophen|mesh-list
153395293|NCT01827475|Ibuprofen|ibuprofen|mesh-list
153395294|NCT01827475|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153395295|NCT01827475|Analgesics|analgesics|mesh-ancestor
153395296|NCT01827475|Sensory System Agents|sensory system agents|mesh-ancestor
153395297|NCT01827475|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153395298|NCT01827475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153395299|NCT01827475|Antipyretics|antipyretics|mesh-ancestor
153395300|NCT01827475|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153855040|NCT00445796|Antiviral Agents|antiviral agents|mesh-ancestor
153855041|NCT00445796|Schistosomicides|schistosomicides|mesh-ancestor
153855042|NCT00445796|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
153855043|NCT00445796|Anthelmintics|anthelmintics|mesh-ancestor
153855044|NCT01225822|Enoxaparin|enoxaparin|mesh-list
153855045|NCT01225822|Dabigatran|dabigatran|mesh-list
153855046|NCT01225822|Anticoagulants|anticoagulants|mesh-ancestor
153855054|NCT00445874|Ketotifen|ketotifen|mesh-list
153855056|NCT00445874|Dermatologic Agents|dermatologic agents|mesh-ancestor
153855057|NCT00445874|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
153855058|NCT00445874|Histamine Antagonists|histamine antagonists|mesh-ancestor
153855059|NCT00445874|Histamine Agents|histamine agents|mesh-ancestor
153855060|NCT00445874|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153855061|NCT00445874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153855062|NCT00445874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153855063|NCT00445874|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
153855064|NCT02902731|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
153855065|NCT02902731|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153855086|NCT00446069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153855087|NCT00446069|Analgesics|analgesics|mesh-ancestor
153855088|NCT00446069|Sensory System Agents|sensory system agents|mesh-ancestor
153855089|NCT00446069|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153855090|NCT02902653|Misoprostol|misoprostol|mesh-list
153855091|NCT02902653|Dinoprostone|dinoprostone|mesh-list
153855092|NCT02902653|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
153855093|NCT02902653|Abortifacient Agents|abortifacient agents|mesh-ancestor
153855094|NCT02902653|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153855095|NCT02902653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153855096|NCT02902653|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
153855097|NCT02902653|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153855098|NCT02902653|Oxytocics|oxytocics|mesh-ancestor
153395330|NCT02550743|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153395331|NCT02550743|Antimetabolites|antimetabolites|mesh-ancestor
153395332|NCT02550743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153395333|NCT02550743|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153395334|NCT02437253|Adalimumab|adalimumab|mesh-list
153395335|NCT02437253|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
153395342|NCT01829503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153395344|NCT01829503|Antiviral Agents|antiviral agents|mesh-ancestor
153395345|NCT01829503|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153395346|NCT01829503|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153395347|NCT01829503|Immunologic Factors|immunologic factors|mesh-ancestor
153395351|NCT05742763|Ibuprofen|ibuprofen|mesh-list
153855102|NCT00446303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153855103|NCT00446303|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153855104|NCT00446303|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153855105|NCT01223404|Mecamylamine|mecamylamine|mesh-list
153855106|NCT01223404|Nicotine|nicotine|mesh-list
153855107|NCT01223404|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
153855108|NCT01223404|Autonomic Agents|autonomic agents|mesh-ancestor
153855109|NCT01223404|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153855110|NCT01223404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153855111|NCT01223404|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
153855112|NCT01223404|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
153855113|NCT01223404|Cholinergic Agents|cholinergic agents|mesh-ancestor
153855114|NCT01223404|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153855115|NCT01223404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153855116|NCT01223404|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153855117|NCT01223404|Ganglionic Blockers|ganglionic blockers|mesh-ancestor
153855118|NCT01223404|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
153855119|NCT01223404|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
153855120|NCT00446420|Midazolam|midazolam|mesh-list
153855121|NCT00446420|Fentanyl|fentanyl|mesh-list
153395354|NCT05742763|Sensory System Agents|sensory system agents|mesh-ancestor
153395355|NCT05742763|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153395356|NCT05742763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153395357|NCT05742763|Antipyretics|antipyretics|mesh-ancestor
153395358|NCT05742763|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153395359|NCT05742763|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153395360|NCT05742763|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153395361|NCT05742763|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153395362|NCT05742763|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153855127|NCT00446420|Anesthetics, General|anesthetics, general|mesh-ancestor
153855128|NCT00446420|Anesthetics|anesthetics|mesh-ancestor
153855129|NCT00446420|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153855130|NCT00446420|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153855131|NCT00446420|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153855132|NCT00446420|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153855133|NCT00446420|GABA Modulators|gaba modulators|mesh-ancestor
153855134|NCT00446420|GABA Agents|gaba agents|mesh-ancestor
153855135|NCT00446420|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153855136|NCT00446420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153855137|NCT00446420|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153855138|NCT00446420|Narcotics|narcotics|mesh-ancestor
153395369|NCT02504723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153395370|NCT02504723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153395371|NCT02504723|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153395372|NCT02504723|Antioxidants|antioxidants|mesh-ancestor
153395373|NCT02504723|Protective Agents|protective agents|mesh-ancestor
153395374|NCT02504723|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153395375|NCT02504723|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153395376|NCT02504723|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153395377|NCT02504723|Vasodilator Agents|vasodilator agents|mesh-ancestor
153855147|NCT00446537|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153855148|NCT00446537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153855149|NCT00446537|Dopamine Agents|dopamine agents|mesh-ancestor
153855150|NCT00446537|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153855151|NCT00446576|Epoetin Alfa|epoetin alfa|mesh-list
153855152|NCT00446576|Hematinics|hematinics|mesh-ancestor
153855153|NCT02902302|Ibuprofen|ibuprofen|mesh-list
153855154|NCT02902302|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153855155|NCT02902302|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153855156|NCT02902302|Analgesics|analgesics|mesh-ancestor
153855157|NCT02902302|Sensory System Agents|sensory system agents|mesh-ancestor
153855158|NCT02902302|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153395389|NCT02439281|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153395390|NCT02439281|Sympatholytics|sympatholytics|mesh-ancestor
153395391|NCT02439281|Autonomic Agents|autonomic agents|mesh-ancestor
153395393|NCT02439281|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153855181|NCT04319419|Trace Elements|trace elements|mesh-list
153855182|NCT04319419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153855183|NCT05657704|Dexketoprofen trometamol|dexketoprofen trometamol|mesh-list
153855184|NCT05657704|Tramadol|tramadol|mesh-list
153855185|NCT05657704|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153855186|NCT05657704|Narcotics|narcotics|mesh-ancestor
153855187|NCT05657704|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153395418|NCT00422123|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153395419|NCT00422123|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153395420|NCT00422123|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153395421|NCT00422123|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153395422|NCT00422123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153395423|NCT00559273|Darbepoetin alfa|darbepoetin alfa|mesh-list
153395424|NCT00559273|Hematinics|hematinics|mesh-ancestor
153395425|NCT02506673|Midazolam|midazolam|mesh-list
153395426|NCT02506673|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153395454|NCT02508077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153855188|NCT05657704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153395455|NCT02508077|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153395456|NCT02508077|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153855189|NCT05657704|Analgesics|analgesics|mesh-ancestor
153855190|NCT05657704|Sensory System Agents|sensory system agents|mesh-ancestor
153855191|NCT05657704|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153855192|NCT05657704|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153855193|NCT05657704|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153855194|NCT05657704|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153855195|NCT05657704|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153855196|NCT00446771|Mannitol|mannitol|mesh-list
153855197|NCT00446771|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
153855198|NCT00446771|Diuretics|diuretics|mesh-ancestor
153855199|NCT00446771|Natriuretic Agents|natriuretic agents|mesh-ancestor
153855200|NCT00446771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153855201|NCT04317157|Caffeine|caffeine|mesh-list
153855202|NCT04317157|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
153855203|NCT04317157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153855204|NCT04317157|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
153855205|NCT04317157|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153855218|NCT03277430|Tacrolimus|tacrolimus|mesh-list
153395478|NCT00558259|Anticoagulants|anticoagulants|mesh-ancestor
153395479|NCT02508389|Avasopasem manganese|avasopasem manganese|mesh-list
153395480|NCT02508389|Free Radical Scavengers|free radical scavengers|mesh-ancestor
153395481|NCT02508389|Antioxidants|antioxidants|mesh-ancestor
153395482|NCT02508389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153395483|NCT02508389|Protective Agents|protective agents|mesh-ancestor
153395484|NCT02508389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153395485|NCT02509481|Ivermectin|ivermectin|mesh-list
153395486|NCT02509481|Albendazole|albendazole|mesh-list
153395487|NCT02509481|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153395488|NCT02509481|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153395489|NCT02509481|Anthelmintics|anthelmintics|mesh-ancestor
153395490|NCT02509481|Anticestodal Agents|anticestodal agents|mesh-ancestor
153395491|NCT02509481|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
153395492|NCT02509481|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153395493|NCT02509481|Tubulin Modulators|tubulin modulators|mesh-ancestor
153395494|NCT02509481|Antimitotic Agents|antimitotic agents|mesh-ancestor
153395495|NCT02509481|Mitosis Modulators|mitosis modulators|mesh-ancestor
153395496|NCT02509481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153395497|NCT02509481|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153395499|NCT04341077|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
153395500|NCT04341077|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153395501|NCT04341077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153395502|NCT04341077|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153395503|NCT02561897|Warfarin|warfarin|mesh-list
153395504|NCT02561897|Edoxaban|edoxaban|mesh-list
153855237|NCT02902380|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153855238|NCT02902380|Analgesics|analgesics|mesh-ancestor
153855239|NCT02902380|Sensory System Agents|sensory system agents|mesh-ancestor
153395505|NCT02561897|Anticoagulants|anticoagulants|mesh-ancestor
153395506|NCT02561897|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
153395507|NCT02561897|Antithrombins|antithrombins|mesh-ancestor
153395508|NCT02561897|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
153855240|NCT02902380|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153855241|NCT02902380|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
153855246|NCT02902380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153855247|NCT01221727|Denosumab|denosumab|mesh-list
153855248|NCT01221727|Midazolam|midazolam|mesh-list
153855249|NCT01221727|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153855250|NCT01221727|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153855251|NCT01221727|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153855252|NCT01221727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153855253|NCT01221727|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153855254|NCT01221727|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153855255|NCT01221727|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153855256|NCT01221727|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153855257|NCT01221727|Anesthetics, General|anesthetics, general|mesh-ancestor
153855258|NCT01221727|Anesthetics|anesthetics|mesh-ancestor
153855259|NCT01221727|GABA Modulators|gaba modulators|mesh-ancestor
153855260|NCT01221727|GABA Agents|gaba agents|mesh-ancestor
153855261|NCT01221727|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153855269|NCT03277079|Ezetimibe|ezetimibe|mesh-list
153855270|NCT03277079|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-list
153395547|NCT00363857|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
153395548|NCT00363857|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
153395549|NCT00363857|Dopamine Agonists|dopamine agonists|mesh-ancestor
153395550|NCT00363857|Dopamine Agents|dopamine agents|mesh-ancestor
153395551|NCT00363857|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153395552|NCT00363857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153395553|NCT00363857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153395554|NCT00558103|Lapatinib|lapatinib|mesh-list
153395555|NCT00558103|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153395556|NCT00558103|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153395557|NCT00558103|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153855285|NCT04317001|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
153855286|NCT04317001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153855287|NCT05426499|Fluconazole|fluconazole|mesh-list
153855288|NCT05426499|Isavuconazole|isavuconazole|mesh-list
153855289|NCT05426499|Anidulafungin|anidulafungin|mesh-list
153855290|NCT05426499|Meropenem|meropenem|mesh-list
153855291|NCT05426499|Cefotaxime|cefotaxime|mesh-list
153855292|NCT05426499|Cefoxitin|cefoxitin|mesh-list
153855293|NCT05426499|Antifungal Agents|antifungal agents|mesh-ancestor
153855294|NCT05426499|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153855295|NCT05426499|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
153855296|NCT05426499|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153855297|NCT05426499|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153855298|NCT05426499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153855299|NCT05426499|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153855300|NCT05426499|Hormone Antagonists|hormone antagonists|mesh-ancestor
153855302|NCT05426499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153855321|NCT01220167|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
153395559|NCT00558103|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153395560|NCT02974361|Ibuprofen|ibuprofen|mesh-list
153395561|NCT02974361|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153395562|NCT02974361|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153395563|NCT02974361|Analgesics|analgesics|mesh-ancestor
153395564|NCT02974361|Sensory System Agents|sensory system agents|mesh-ancestor
153395565|NCT02974361|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153395566|NCT02974361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153395567|NCT02974361|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153395568|NCT02974361|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153395569|NCT02974361|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153395570|NCT02974361|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153395571|NCT02974361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153855345|NCT00447473|Mitoxantrone|mitoxantrone|mesh-list
153855346|NCT00447473|Analgesics|analgesics|mesh-ancestor
153855347|NCT00447473|Sensory System Agents|sensory system agents|mesh-ancestor
153855348|NCT00447473|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153855349|NCT00447473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153855350|NCT00447473|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153855351|NCT00447473|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153855352|NCT00447473|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153855353|NCT00447473|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153855354|NCT00447473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153855355|NCT00447473|Antifungal Agents|antifungal agents|mesh-ancestor
153855356|NCT00447473|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153855357|NCT00447473|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
153855358|NCT00447473|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153855359|NCT00447473|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153855360|NCT00447473|Hormone Antagonists|hormone antagonists|mesh-ancestor
153855361|NCT00447473|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153855362|NCT00447473|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
153855364|NCT00553488|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
153855365|NCT00553488|Insulin Lispro|insulin lispro|mesh-list
153855366|NCT00553488|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153855367|NCT00553488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153395604|NCT00558025|Protective Agents|protective agents|mesh-ancestor
153395605|NCT00558025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153395606|NCT00558025|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
153395607|NCT00558025|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
153395608|NCT00558025|Dopamine Agonists|dopamine agonists|mesh-ancestor
153395625|NCT02576249|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153395626|NCT02576249|Antiemetics|antiemetics|mesh-ancestor
153395627|NCT02576249|Autonomic Agents|autonomic agents|mesh-ancestor
153395628|NCT02576249|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153395629|NCT02576249|Glucocorticoids|glucocorticoids|mesh-ancestor
153395631|NCT02576249|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153395632|NCT02576249|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
153395633|NCT02576249|Protective Agents|protective agents|mesh-ancestor
153395634|NCT02576249|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153395635|NCT02576249|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153855368|NCT03455322|Octreotide|octreotide|mesh-list
153855369|NCT03455322|Norepinephrine|norepinephrine|mesh-list
153855370|NCT03455322|Midodrine|midodrine|mesh-list
153855371|NCT03455322|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153855372|NCT03455322|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153855373|NCT03455322|Adrenergic Agents|adrenergic agents|mesh-ancestor
153855374|NCT03455322|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153855375|NCT03455322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153855376|NCT03455322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153855377|NCT03455322|Sympathomimetics|sympathomimetics|mesh-ancestor
153855378|NCT03455322|Autonomic Agents|autonomic agents|mesh-ancestor
153855379|NCT03455322|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153855380|NCT03455322|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
153855381|NCT03455322|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153855382|NCT03455322|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153395647|NCT01834261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153395649|NCT02578901|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
153395650|NCT02578901|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153395651|NCT02578901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153395653|NCT02578901|Coagulants|coagulants|mesh-ancestor
153395654|NCT02579057|Furosemide|furosemide|mesh-list
153395655|NCT02579057|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
153395656|NCT02579057|Diuretics|diuretics|mesh-ancestor
153395657|NCT02579057|Natriuretic Agents|natriuretic agents|mesh-ancestor
153395658|NCT02579057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153395659|NCT02579057|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
153395660|NCT02579057|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153395661|NCT02579057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153395662|NCT00557245|Tenofovir|tenofovir|mesh-list
153395663|NCT00557245|Emtricitabine|emtricitabine|mesh-list
153395664|NCT00557245|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
153395665|NCT00557245|Antiviral Agents|antiviral agents|mesh-ancestor
153395666|NCT00557245|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153395667|NCT00557245|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153395668|NCT00557245|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153395669|NCT00557245|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153395670|NCT00557245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153395671|NCT00557245|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153395672|NCT00557245|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153395673|NCT00364091|Ophthalmic Solutions|ophthalmic solutions|mesh-list
153395694|NCT01836133|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153395695|NCT01836133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153395696|NCT01836133|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153395697|NCT00365183|Pemetrexed|pemetrexed|mesh-list
153395698|NCT00365183|Motexafin gadolinium|motexafin gadolinium|mesh-list
153395699|NCT00365183|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153395700|NCT00365183|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153395701|NCT00365183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153395702|NCT00365183|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153395703|NCT00365183|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153855440|NCT03276689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153855441|NCT03276689|Anticonvulsants|anticonvulsants|mesh-ancestor
153855442|NCT03276689|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153855443|NCT03276689|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153855444|NCT03276689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153855445|NCT03276689|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153855446|NCT03276689|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153855447|NCT03276689|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153395715|NCT01837069|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
153395716|NCT01837069|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153395717|NCT01837069|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153395718|NCT01837069|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153395719|NCT01837069|Sympatholytics|sympatholytics|mesh-ancestor
153395720|NCT01837069|Autonomic Agents|autonomic agents|mesh-ancestor
153395721|NCT01837069|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153395722|NCT01837069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153395723|NCT01837069|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
153395724|NCT01837069|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
153395725|NCT01837069|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
153395726|NCT01837069|Adrenergic Agents|adrenergic agents|mesh-ancestor
153395727|NCT01837069|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153395728|NCT01837069|Protease Inhibitors|protease inhibitors|mesh-ancestor
153395729|NCT01837069|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
153395730|NCT01837069|Protective Agents|protective agents|mesh-ancestor
153395731|NCT02289690|Carboplatin|carboplatin|mesh-list
153395732|NCT02289690|Etoposide|etoposide|mesh-list
153395733|NCT02289690|Veliparib|veliparib|mesh-list
153395741|NCT02268955|Ibuprofen|ibuprofen|mesh-list
153855500|NCT04698941|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
153855502|NCT02901288|Levofloxacin|levofloxacin|mesh-list
153855503|NCT02901288|Rifampin|rifampin|mesh-list
153855504|NCT02901288|Isoniazid|isoniazid|mesh-list
153855505|NCT02901288|Pyrazinamide|pyrazinamide|mesh-list
153855506|NCT02901288|Ethambutol|ethambutol|mesh-list
153855507|NCT02901288|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
153855508|NCT02901288|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153855509|NCT02901288|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153855510|NCT02901288|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153855511|NCT02901288|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153855512|NCT02901288|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153855513|NCT02901288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153855514|NCT02901288|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153855534|NCT05424393|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153855535|NCT05424393|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153855536|NCT05424393|Analgesics|analgesics|mesh-ancestor
153855537|NCT05424393|Sensory System Agents|sensory system agents|mesh-ancestor
153855538|NCT05424393|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153855539|NCT05424393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153855540|NCT05424393|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153855541|NCT05424393|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153855542|NCT05424393|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153855543|NCT05424393|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153855544|NCT05424393|Immunologic Factors|immunologic factors|mesh-ancestor
153855545|NCT00448838|Gemcitabine|gemcitabine|mesh-list
153855546|NCT00448838|Oxaliplatin|oxaliplatin|mesh-list
153855547|NCT00448838|Cetuximab|cetuximab|mesh-list
153855548|NCT00448838|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153855549|NCT00448838|Antimetabolites|antimetabolites|mesh-ancestor
153855550|NCT00448838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153855551|NCT00448838|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153855552|NCT00448838|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153855553|NCT01219933|Methylprednisolone|methylprednisolone|mesh-list
153888560|NCT02878018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153888561|NCT02878018|Immunologic Factors|immunologic factors|mesh-ancestor
153855554|NCT01219933|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
153855567|NCT01219933|Hormones|hormones|mesh-ancestor
153395820|NCT02429375|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153395821|NCT02429375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153395822|NCT02289456|Paclitaxel|paclitaxel|mesh-list
153395823|NCT02289456|Carboplatin|carboplatin|mesh-list
153395824|NCT02289456|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153855569|NCT01219933|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
153855570|NCT01219933|Protective Agents|protective agents|mesh-ancestor
153855571|NCT01219933|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153855572|NCT01219933|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153855573|NCT05368441|Midazolam|midazolam|mesh-list
153855574|NCT05368441|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153855575|NCT05368441|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153855576|NCT05368441|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153855577|NCT05368441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153855578|NCT05368441|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153855597|NCT01218802|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
153855598|NCT01218802|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153855599|NCT02887222|Bupivacaine|bupivacaine|mesh-list
153855600|NCT02887222|Anesthetics, Local|anesthetics, local|mesh-ancestor
153855601|NCT02887222|Anesthetics|anesthetics|mesh-ancestor
153855602|NCT02887222|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153855603|NCT02887222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153855604|NCT02887222|Sensory System Agents|sensory system agents|mesh-ancestor
153855605|NCT02887222|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153855606|NCT01218646|Vaccines|vaccines|mesh-list
153855607|NCT01218646|Immunologic Factors|immunologic factors|mesh-ancestor
153855608|NCT01218646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153855609|NCT00449423|Acipimox|acipimox|mesh-list
153855610|NCT00449423|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153855611|NCT00449423|Antimetabolites|antimetabolites|mesh-ancestor
153855612|NCT00449423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153855613|NCT00449423|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153855614|NCT00449501|Budesonide|budesonide|mesh-list
153855615|NCT00449501|Formoterol Fumarate|formoterol fumarate|mesh-list
153855616|NCT00449501|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153855617|NCT00449501|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153855618|NCT00449501|Autonomic Agents|autonomic agents|mesh-ancestor
153855621|NCT00449501|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153395882|NCT02596451|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153395883|NCT02596451|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153395884|NCT02596451|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153395885|NCT02596451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153395886|NCT01839799|Paclitaxel|paclitaxel|mesh-list
153395887|NCT01839799|Gemcitabine|gemcitabine|mesh-list
153395888|NCT01839799|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
153395889|NCT01839799|Folfirinox|folfirinox|mesh-list
153395890|NCT01839799|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153395891|NCT01839799|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153395892|NCT01839799|Tubulin Modulators|tubulin modulators|mesh-ancestor
153395893|NCT01839799|Antimitotic Agents|antimitotic agents|mesh-ancestor
153395894|NCT01839799|Mitosis Modulators|mitosis modulators|mesh-ancestor
153395895|NCT01839799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153395896|NCT01839799|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153395897|NCT01839799|Antimetabolites|antimetabolites|mesh-ancestor
153395898|NCT03062059|Gemcitabine|gemcitabine|mesh-list
153395899|NCT03062059|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153855668|NCT01188538|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153855669|NCT01188538|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153855670|NCT01188538|Analgesics|analgesics|mesh-ancestor
153855671|NCT01188538|Sensory System Agents|sensory system agents|mesh-ancestor
153855672|NCT01188538|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153855673|NCT01188538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153395909|NCT02597543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153888562|NCT02878018|Protease Inhibitors|protease inhibitors|mesh-ancestor
153395910|NCT02597543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153395912|NCT00553501|Epratuzumab|epratuzumab|mesh-list
153395913|NCT00553501|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153395914|NCT00553501|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153395915|NCT00553501|Immunologic Factors|immunologic factors|mesh-ancestor
153395916|NCT00553501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153395917|NCT00553501|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153395918|NCT02599649|Nivolumab|nivolumab|mesh-list
153395919|NCT02599649|Azacitidine|azacitidine|mesh-list
153395920|NCT02599649|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153395921|NCT02599649|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153395922|NCT02599649|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153395925|NCT02599649|Antimetabolites|antimetabolites|mesh-ancestor
153855690|NCT04318444|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153855691|NCT04318444|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153855702|NCT03276143|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
153855703|NCT03276143|Antithrombins|antithrombins|mesh-ancestor
153855704|NCT03276143|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
153855705|NCT03276143|Protease Inhibitors|protease inhibitors|mesh-ancestor
153855706|NCT03276143|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153855707|NCT00449774|Lamotrigine|lamotrigine|mesh-list
153855708|NCT00449774|Anticonvulsants|anticonvulsants|mesh-list
153855709|NCT00449774|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153855710|NCT00449774|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153855711|NCT00449774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153855712|NCT00449774|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153855713|NCT00449774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153855714|NCT00449774|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153395951|NCT00553267|Telmisartan amlodipine combination|telmisartan amlodipine combination|mesh-list
153395952|NCT00553267|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153395953|NCT00553267|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153395954|NCT00553267|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153395955|NCT00553267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153395956|NCT00553267|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153395957|NCT00553267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153395958|NCT00553267|Vasodilator Agents|vasodilator agents|mesh-ancestor
153395962|NCT00364559|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153395963|NCT00364559|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153395964|NCT00364559|Antimetabolites|antimetabolites|mesh-ancestor
153395965|NCT00364559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153395966|NCT00364559|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153395967|NCT00364559|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
153395968|NCT00364559|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153395969|NCT02271984|Praziquantel|praziquantel|mesh-list
153395970|NCT02271984|Anthelmintics|anthelmintics|mesh-ancestor
153395971|NCT02271984|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153395972|NCT02271984|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153395973|NCT02604173|Budesonide|budesonide|mesh-list
153395974|NCT02604173|Acetazolamide|acetazolamide|mesh-list
153395975|NCT02604173|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153395976|NCT02604173|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153395977|NCT02604173|Autonomic Agents|autonomic agents|mesh-ancestor
153395978|NCT02604173|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153395979|NCT02604173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153395980|NCT02604173|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153395981|NCT02604173|Respiratory System Agents|respiratory system agents|mesh-ancestor
153395982|NCT02604173|Glucocorticoids|glucocorticoids|mesh-ancestor
153395983|NCT02604173|Hormones|hormones|mesh-ancestor
153395985|NCT02604173|Anticonvulsants|anticonvulsants|mesh-ancestor
153855715|NCT00449774|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153855716|NCT00449774|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153855717|NCT00449774|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153855742|NCT01218100|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153855743|NCT01218100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153855744|NCT01218100|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153855745|NCT01218100|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
153855746|NCT01218100|Protective Agents|protective agents|mesh-ancestor
153855747|NCT01218100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153855748|NCT01218100|Vasodilator Agents|vasodilator agents|mesh-ancestor
153855749|NCT01218100|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
153855750|NCT01218100|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
153855751|NCT01218100|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153855752|NCT01218100|Adrenergic Agents|adrenergic agents|mesh-ancestor
153855753|NCT01218100|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153855754|NCT00450008|Thalidomide|thalidomide|mesh-list
153395988|NCT02604173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153395990|NCT02604173|Natriuretic Agents|natriuretic agents|mesh-ancestor
153395991|NCT02287038|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
153395992|NCT02287038|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
153395993|NCT02287038|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153395994|NCT02287038|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153395995|NCT02287038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153395996|NCT02287038|Adrenergic Agents|adrenergic agents|mesh-ancestor
153395997|NCT02287038|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153395998|NCT02287038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153395999|NCT00365339|Ritonavir|ritonavir|mesh-list
153396000|NCT00365339|Atazanavir Sulfate|atazanavir sulfate|mesh-list
153396001|NCT00365339|Tenofovir|tenofovir|mesh-list
153855755|NCT00450008|Docetaxel|docetaxel|mesh-list
153396023|NCT00365339|Dopamine Agonists|dopamine agonists|mesh-ancestor
153855756|NCT00450008|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153855757|NCT00450008|Tubulin Modulators|tubulin modulators|mesh-ancestor
153855758|NCT00450008|Antimitotic Agents|antimitotic agents|mesh-ancestor
153855759|NCT00450008|Mitosis Modulators|mitosis modulators|mesh-ancestor
153855760|NCT00450008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153855761|NCT00450008|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153855762|NCT00450008|Immunologic Factors|immunologic factors|mesh-ancestor
153855763|NCT00450008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153396051|NCT00366119|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153396052|NCT05371301|Paclitaxel|paclitaxel|mesh-list
153396053|NCT05371301|Carboplatin|carboplatin|mesh-list
153396054|NCT05371301|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153396055|NCT05371301|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153396056|NCT05371301|Tubulin Modulators|tubulin modulators|mesh-ancestor
153396057|NCT05371301|Antimitotic Agents|antimitotic agents|mesh-ancestor
153396058|NCT05371301|Mitosis Modulators|mitosis modulators|mesh-ancestor
153396060|NCT02285166|Hypolipidemic Agents|hypolipidemic agents|mesh-list
153855792|NCT05422911|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153855793|NCT05422911|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153855794|NCT05422911|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153855795|NCT05422911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153855796|NCT05422911|Hormone Antagonists|hormone antagonists|mesh-ancestor
153888571|NCT01092832|Antifungal Agents|antifungal agents|mesh-ancestor
153888572|NCT01092832|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153429646|NCT00002738|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153429647|NCT00002738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153429648|NCT00002738|Antidotes|antidotes|mesh-ancestor
153429649|NCT00002738|Protective Agents|protective agents|mesh-ancestor
153429650|NCT00002738|Vitamin B Complex|vitamin b complex|mesh-ancestor
153429651|NCT00002738|Vitamins|vitamins|mesh-ancestor
153429652|NCT00002738|Micronutrients|micronutrients|mesh-ancestor
153429653|NCT00002738|Antifungal Agents|antifungal agents|mesh-ancestor
153429654|NCT00002738|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153855797|NCT05422911|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153855798|NCT05422911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153855799|NCT05422911|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153855800|NCT00450164|Nadolol|nadolol|mesh-list
153855801|NCT00450164|Prazosin|prazosin|mesh-list
153855802|NCT00450164|Isosorbide|isosorbide|mesh-list
153855803|NCT00450164|Isosorbide Dinitrate|isosorbide dinitrate|mesh-list
153855804|NCT00450164|Isosorbide-5-mononitrate|isosorbide-5-mononitrate|mesh-list
153855805|NCT00450164|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
153855806|NCT00450164|Diuretics|diuretics|mesh-ancestor
153855807|NCT00450164|Natriuretic Agents|natriuretic agents|mesh-ancestor
153855808|NCT00450164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153855809|NCT00450164|Vasodilator Agents|vasodilator agents|mesh-ancestor
153855810|NCT00450164|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
153855811|NCT00450164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153855812|NCT00450164|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153855813|NCT00450164|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
153855816|NCT00450164|Adrenergic Agents|adrenergic agents|mesh-ancestor
153855826|NCT02900430|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153855827|NCT02900430|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
153855828|NCT02900430|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
153855829|NCT02900430|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153855830|NCT02900430|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153914632|NCT04712071|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153396068|NCT02605187|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153396069|NCT02605187|Narcotics|narcotics|mesh-ancestor
153396070|NCT02605187|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153396071|NCT02605187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153396072|NCT02605187|Analgesics|analgesics|mesh-ancestor
153396073|NCT02605187|Sensory System Agents|sensory system agents|mesh-ancestor
153396074|NCT02605187|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153396075|NCT02605187|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153396076|NCT02605187|Antipyretics|antipyretics|mesh-ancestor
153396077|NCT02605187|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153396078|NCT02605187|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153396079|NCT02605187|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153396080|NCT02605187|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153396081|NCT02605187|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153396082|NCT02605187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153855854|NCT00450203|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153855855|NCT00450203|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153855856|NCT00450203|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153855857|NCT00450203|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153855858|NCT00450281|Antibodies|antibodies|mesh-list
153855859|NCT00450281|Immunologic Factors|immunologic factors|mesh-ancestor
153855860|NCT00450281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153855861|NCT04699097|Azithromycin|azithromycin|mesh-list
153855862|NCT04699097|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153855863|NCT04699097|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153855864|NCT00450320|Sirolimus|sirolimus|mesh-list
153855865|NCT00450320|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153855866|NCT00450320|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153855867|NCT00450320|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153855868|NCT00450320|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153855869|NCT00450320|Antifungal Agents|antifungal agents|mesh-ancestor
153855870|NCT00450320|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153855871|NCT00450320|Immunologic Factors|immunologic factors|mesh-ancestor
153855872|NCT00450320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153855873|NCT00450398|polysaccharide-K|polysaccharide-k|mesh-list
153429655|NCT00002738|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153429656|NCT00002738|Antimetabolites|antimetabolites|mesh-ancestor
153429657|NCT00002738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153429658|NCT00002738|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153429659|NCT00002738|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153855874|NCT00450398|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153855876|NCT00450398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153855877|NCT00450398|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153855878|NCT00450398|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153855879|NCT00450398|Antiviral Agents|antiviral agents|mesh-ancestor
153855880|NCT00450398|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153855881|NCT00450398|Interferon Inducers|interferon inducers|mesh-ancestor
153855882|NCT00450398|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
153855883|NCT00450398|Protective Agents|protective agents|mesh-ancestor
153396123|NCT01642212|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153396124|NCT01642212|Autonomic Agents|autonomic agents|mesh-ancestor
153396127|NCT01642212|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153396141|NCT05649618|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153396142|NCT05649618|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153396143|NCT00552175|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
153396144|NCT00552175|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
153396145|NCT00552175|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153396146|NCT00552175|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153461746|NCT04195776|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153396149|NCT00552175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153396150|NCT00552175|Analgesics|analgesics|mesh-ancestor
153396151|NCT00552175|Sensory System Agents|sensory system agents|mesh-ancestor
153396152|NCT00552175|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153396153|NCT00552175|Antidepressive Agents|antidepressive agents|mesh-ancestor
153396154|NCT00552175|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153396155|NCT00552175|Dopamine Agents|dopamine agents|mesh-ancestor
153396156|NCT01644474|Ezetimibe|ezetimibe|mesh-list
153396157|NCT01644474|Alirocumab|alirocumab|mesh-list
153396158|NCT01644474|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
153396159|NCT01644474|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153396178|NCT01847131|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153396191|NCT01847131|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
153396192|NCT01847131|Protective Agents|protective agents|mesh-ancestor
153396193|NCT02285010|Pregabalin|pregabalin|mesh-list
153396194|NCT02285010|Analgesics|analgesics|mesh-ancestor
153396195|NCT02285010|Sensory System Agents|sensory system agents|mesh-ancestor
153396196|NCT02285010|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153396197|NCT02285010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153396198|NCT02285010|Anticonvulsants|anticonvulsants|mesh-ancestor
153396199|NCT02285010|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153855945|NCT04262817|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
153855946|NCT04262817|Cholinergic Agents|cholinergic agents|mesh-ancestor
153855947|NCT04262817|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153855948|NCT04262817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153855949|NCT01217944|Ranibizumab|ranibizumab|mesh-list
153855950|NCT01217944|Verteporfin|verteporfin|mesh-list
153855951|NCT01217944|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153855952|NCT01217944|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153855953|NCT01217944|Growth Substances|growth substances|mesh-ancestor
153855954|NCT01217944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153855955|NCT01217944|Growth Inhibitors|growth inhibitors|mesh-ancestor
153855963|NCT01187446|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
153396200|NCT02285010|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153396201|NCT02285010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153396202|NCT02285010|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153396203|NCT02285010|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153396204|NCT02285010|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153396205|NCT02285010|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153396206|NCT02285010|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153396207|NCT02617667|Cyclosporine|cyclosporine|mesh-list
153396208|NCT02617667|Cyclosporins|cyclosporins|mesh-list
153396209|NCT02617667|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153396210|NCT02617667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153396211|NCT02617667|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153396212|NCT02617667|Immunologic Factors|immunologic factors|mesh-ancestor
153396213|NCT02617667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153396214|NCT02617667|Antifungal Agents|antifungal agents|mesh-ancestor
153396215|NCT02617667|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153396216|NCT02617667|Dermatologic Agents|dermatologic agents|mesh-ancestor
153396217|NCT02617667|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153396218|NCT02617667|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
153396220|NCT01848067|Abiraterone Acetate|abiraterone acetate|mesh-list
153396221|NCT01848067|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153396222|NCT01848067|Glucocorticoids|glucocorticoids|mesh-ancestor
153855965|NCT01187446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153855967|NCT02931071|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153855968|NCT02931071|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153855969|NCT02931071|Antiviral Agents|antiviral agents|mesh-ancestor
153855970|NCT02931071|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153855971|NCT01187407|Serotonin|serotonin|mesh-list
153855972|NCT01187407|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-list
153855973|NCT01187407|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
153855974|NCT01187407|Serotonin Agents|serotonin agents|mesh-ancestor
153855975|NCT01187407|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153855976|NCT01187407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153855977|NCT01187407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153855978|NCT01187407|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153855979|NCT01187407|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153855980|NCT01186939|Azacitidine|azacitidine|mesh-list
153855981|NCT01186939|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153855982|NCT01186939|Antimetabolites|antimetabolites|mesh-ancestor
153855983|NCT01186939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153855984|NCT01186939|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153396249|NCT00364871|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153396250|NCT00364871|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153396252|NCT00364871|Dopamine Agents|dopamine agents|mesh-ancestor
153855986|NCT04447040|Acetaminophen|acetaminophen|mesh-list
153855987|NCT04447040|Naproxen|naproxen|mesh-list
153855988|NCT04447040|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153855989|NCT04447040|Analgesics|analgesics|mesh-ancestor
153855990|NCT04447040|Sensory System Agents|sensory system agents|mesh-ancestor
153855991|NCT04447040|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153855992|NCT04447040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153855993|NCT04447040|Antipyretics|antipyretics|mesh-ancestor
153855994|NCT04447040|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153855995|NCT04447040|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153855996|NCT04447040|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153855997|NCT04447040|Gout Suppressants|gout suppressants|mesh-ancestor
153855998|NCT04447040|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153855999|NCT04447040|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153856000|NCT04447040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153856001|NCT02930954|Bevacizumab|bevacizumab|mesh-list
153856002|NCT02930954|Carboplatin|carboplatin|mesh-list
153856003|NCT02930954|Gemcitabine|gemcitabine|mesh-list
153856004|NCT02930954|Pemetrexed|pemetrexed|mesh-list
153856005|NCT02930954|Gefitinib|gefitinib|mesh-list
153856006|NCT02930954|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153396281|NCT00550771|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153396282|NCT00550771|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153396283|NCT00550771|Alkylating Agents|alkylating agents|mesh-ancestor
153396284|NCT00550771|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153396285|NCT00550771|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153856032|NCT02930057|Respiratory System Agents|respiratory system agents|mesh-ancestor
153856033|NCT02929901|Caffeine|caffeine|mesh-list
153856034|NCT02929901|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
153856035|NCT02929901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153856036|NCT02929901|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
153856037|NCT02929901|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153856038|NCT02929901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153856039|NCT02929901|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
153856040|NCT02929901|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
153856041|NCT02929901|Purinergic Agents|purinergic agents|mesh-ancestor
153856042|NCT02929901|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153856043|NCT02929706|Azathioprine|azathioprine|mesh-list
153856044|NCT02929706|Antimetabolites|antimetabolites|mesh-ancestor
153856045|NCT02929706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153856046|NCT02929706|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153856047|NCT02929706|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153856048|NCT02929706|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153856049|NCT02929706|Immunologic Factors|immunologic factors|mesh-ancestor
153396286|NCT00550771|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153396287|NCT00550771|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153396288|NCT00550771|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153396289|NCT00550771|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153396290|NCT01852669|Furosemide|furosemide|mesh-list
153396291|NCT01852669|Diuretics|diuretics|mesh-ancestor
153396292|NCT01852669|Natriuretic Agents|natriuretic agents|mesh-ancestor
153856058|NCT00553878|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153856060|NCT00624325|Interferons|interferons|mesh-list
153856061|NCT00624325|Interferon-alpha|interferon-alpha|mesh-list
153856062|NCT00624325|Interferon alpha-2|interferon alpha-2|mesh-list
153856068|NCT04689893|1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid|1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid|mesh-list
153856069|NCT04689893|Chelating Agents|chelating agents|mesh-ancestor
153856070|NCT04689893|Sequestering Agents|sequestering agents|mesh-ancestor
153856071|NCT04689893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153856073|NCT05184192|Analgesics|analgesics|mesh-ancestor
153856074|NCT05184192|Sensory System Agents|sensory system agents|mesh-ancestor
153856075|NCT05184192|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153856076|NCT05184192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153856077|NCT05184192|Anticonvulsants|anticonvulsants|mesh-ancestor
153856078|NCT05184192|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153856079|NCT05184192|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153856080|NCT05184192|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153856081|NCT05184192|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153856082|NCT05184192|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
153856083|NCT05184192|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
153856084|NCT05184192|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153856085|NCT05184192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153856086|NCT05184192|Antimanic Agents|antimanic agents|mesh-ancestor
153856087|NCT02929121|Doxycycline|doxycycline|mesh-list
153856088|NCT02929121|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153856089|NCT02929121|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153856090|NCT02929121|Antimalarials|antimalarials|mesh-ancestor
153856091|NCT02929121|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153856092|NCT02929121|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153856093|NCT02929394|Trabectedin|trabectedin|mesh-list
153856094|NCT02929394|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153856095|NCT02929394|Alkylating Agents|alkylating agents|mesh-ancestor
153856113|NCT04679142|GABA Agents|gaba agents|mesh-ancestor
153856114|NCT04679142|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153856115|NCT04679142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153396355|NCT04734197|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153396356|NCT04734197|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153396357|NCT04734197|Respiratory System Agents|respiratory system agents|mesh-ancestor
153396358|NCT04734197|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153396359|NCT04734197|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153396360|NCT04734197|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
153396361|NCT04734197|Antitubercular Agents|antitubercular agents|mesh-ancestor
153396362|NCT04734197|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153396363|NCT00550147|Quetiapine Fumarate|quetiapine fumarate|mesh-list
153396364|NCT00550147|Methylphenidate|methylphenidate|mesh-list
153396365|NCT00550147|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
153396366|NCT00550147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153396367|NCT00550147|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
153396368|NCT00550147|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153396369|NCT00550147|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153396370|NCT00550147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153396371|NCT00550147|Dopamine Agents|dopamine agents|mesh-ancestor
153396372|NCT00550147|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153396373|NCT00550147|Antidepressive Agents|antidepressive agents|mesh-ancestor
153396374|NCT00550147|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153396375|NCT00550147|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153856130|NCT02928614|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153856131|NCT03685500|Emtricitabine|emtricitabine|mesh-list
153856133|NCT03685500|Cobicistat|cobicistat|mesh-list
153856134|NCT03685500|Antiviral Agents|antiviral agents|mesh-ancestor
153856135|NCT03685500|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153856136|NCT03685500|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153856137|NCT03685500|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153856138|NCT03685500|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153856139|NCT03685500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153856140|NCT03685500|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153856141|NCT03685500|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153856142|NCT03685500|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
153856143|NCT03685500|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
153856144|NCT03685500|Protease Inhibitors|protease inhibitors|mesh-ancestor
153856145|NCT03685500|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
153856146|NCT03685500|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153856147|NCT02928575|Temozolomide|temozolomide|mesh-list
153856148|NCT02928575|Sunitinib|sunitinib|mesh-list
153856149|NCT02928575|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153856150|NCT02928575|Alkylating Agents|alkylating agents|mesh-ancestor
153856151|NCT02928575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153856152|NCT02928575|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153856153|NCT02928575|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153396435|NCT04992143|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153396436|NCT04992143|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153396437|NCT04992143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153396439|NCT04485065|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153396441|NCT04485065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153396442|NCT04485065|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153856177|NCT02927405|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153856178|NCT02927405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153856179|NCT02927405|Anticonvulsants|anticonvulsants|mesh-ancestor
153856180|NCT02927405|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153856181|NCT02927405|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153856182|NCT02927405|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153856183|NCT02927405|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153856184|NCT02927405|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
153856185|NCT02927405|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
153856186|NCT02927405|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153856187|NCT02927405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153856188|NCT02927405|Antimanic Agents|antimanic agents|mesh-ancestor
153856189|NCT02927444|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
153856190|NCT02927444|Immunologic Factors|immunologic factors|mesh-ancestor
153856191|NCT02927444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153856192|NCT02927522|Donepezil|donepezil|mesh-list
153856193|NCT02927522|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
153856194|NCT02927522|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153856195|NCT02927522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153856196|NCT02927522|Cholinergic Agents|cholinergic agents|mesh-ancestor
153856197|NCT02927522|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153856198|NCT02927522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153856199|NCT02927522|Nootropic Agents|nootropic agents|mesh-ancestor
153856200|NCT02926976|Valproic Acid|valproic acid|mesh-list
153396455|NCT01866943|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
153396456|NCT01866943|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153396457|NCT01866943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153396458|NCT01866943|Hemostatics|hemostatics|mesh-ancestor
153396459|NCT01866943|Coagulants|coagulants|mesh-ancestor
153396460|NCT01868425|Acetaminophen|acetaminophen|mesh-list
153396461|NCT01868425|Ketamine|ketamine|mesh-list
153396462|NCT01868425|Gabapentin|gabapentin|mesh-list
153856217|NCT02926976|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
153856218|NCT02926976|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
153856219|NCT02926976|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
153856220|NCT02926976|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
153396463|NCT01868425|Bupivacaine|bupivacaine|mesh-list
153396464|NCT01868425|Anesthetics, Local|anesthetics, local|mesh-ancestor
153396465|NCT01868425|Anesthetics|anesthetics|mesh-ancestor
153396466|NCT01868425|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153396467|NCT01868425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153429664|NCT04706455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153429665|NCT04706455|Viscosupplements|viscosupplements|mesh-ancestor
153429666|NCT04706455|Protective Agents|protective agents|mesh-ancestor
153429667|NCT00002744|Cobalt|cobalt|mesh-list
153429668|NCT00002744|Cytarabine|cytarabine|mesh-list
153429669|NCT00002744|Dexamethasone|dexamethasone|mesh-list
153396468|NCT01868425|Sensory System Agents|sensory system agents|mesh-ancestor
153396469|NCT01868425|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153396470|NCT01868425|Analgesics|analgesics|mesh-ancestor
153396471|NCT01868425|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
153396472|NCT01868425|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153396473|NCT01868425|Anesthetics, General|anesthetics, general|mesh-ancestor
153396474|NCT01868425|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
153396475|NCT01868425|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
153396476|NCT01868425|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153396477|NCT01868425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153396478|NCT01868425|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153396479|NCT01868425|Antipyretics|antipyretics|mesh-ancestor
153396480|NCT01868425|Anticonvulsants|anticonvulsants|mesh-ancestor
153396481|NCT01868425|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153396482|NCT01868425|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153856230|NCT04680195|Immunologic Factors|immunologic factors|mesh-ancestor
153856231|NCT04680195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153856232|NCT04680195|Leprostatic Agents|leprostatic agents|mesh-ancestor
153856233|NCT04680195|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153856234|NCT04680195|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153856244|NCT04864431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153856245|NCT04864431|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153856246|NCT04864431|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153856247|NCT00553995|Salicylsalicylic acid|salicylsalicylic acid|mesh-list
153396524|NCT02280811|Immunologic Factors|immunologic factors|mesh-ancestor
153396525|NCT02280811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153396526|NCT02280811|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153396527|NCT02280811|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153396528|NCT02280811|Alkylating Agents|alkylating agents|mesh-ancestor
153396529|NCT02280811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153396530|NCT02280811|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153396531|NCT02280811|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153396532|NCT02280811|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153396533|NCT02280811|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153396534|NCT02280811|Antiviral Agents|antiviral agents|mesh-ancestor
153396535|NCT02280811|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153396536|NCT01930747|Remifentanil|remifentanil|mesh-list
153396537|NCT01930747|Sevoflurane|sevoflurane|mesh-list
153396538|NCT01930747|Rocuronium|rocuronium|mesh-list
153396539|NCT01930747|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153396540|NCT01930747|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
153396541|NCT01930747|Anesthetics, General|anesthetics, general|mesh-ancestor
153396542|NCT01930747|Anesthetics|anesthetics|mesh-ancestor
153396543|NCT01930747|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153396544|NCT01930747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153856274|NCT04798287|Immunologic Factors|immunologic factors|mesh-ancestor
153856275|NCT04798287|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
153856276|NCT04798287|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153856277|NCT04798287|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153856284|NCT02925299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153856285|NCT02925533|Pembrolizumab|pembrolizumab|mesh-list
153856286|NCT02925533|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153856287|NCT02925533|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153856288|NCT02925533|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153856289|NCT02925533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153856290|NCT02917889|Caffeine|caffeine|mesh-list
153856291|NCT02917889|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
153856292|NCT02917889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153856293|NCT02917889|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
153856294|NCT02917889|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153856295|NCT02917889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153856296|NCT02917889|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
153856297|NCT02917889|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
153856298|NCT02917889|Purinergic Agents|purinergic agents|mesh-ancestor
153856299|NCT02917889|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153856300|NCT02917967|Botulinum Toxins|botulinum toxins|mesh-list
153856301|NCT02917967|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
153856302|NCT02917967|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153856303|NCT02917967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153856304|NCT02917967|Cholinergic Agents|cholinergic agents|mesh-ancestor
153856305|NCT02917967|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153856306|NCT02917967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153396545|NCT01930747|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
153856317|NCT04485273|Sensory System Agents|sensory system agents|mesh-ancestor
153856318|NCT04485273|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153856319|NCT02205528|Metformin|metformin|mesh-list
153856320|NCT02205528|Liraglutide|liraglutide|mesh-list
153856323|NCT02205528|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
153856324|NCT02205528|Incretins|incretins|mesh-ancestor
153856325|NCT02205528|Hormones|hormones|mesh-ancestor
153856326|NCT02205528|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153856327|NCT03532022|Dexamethasone|dexamethasone|mesh-list
153856328|NCT03532022|Prednisone|prednisone|mesh-list
153856329|NCT03532022|Prednisolone|prednisolone|mesh-list
153856330|NCT03532022|Hydrocortisone|hydrocortisone|mesh-list
153856331|NCT03532022|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
153856332|NCT03532022|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
153856333|NCT03532022|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
153856334|NCT03532022|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153856335|NCT03532022|Antiemetics|antiemetics|mesh-ancestor
153856336|NCT03532022|Autonomic Agents|autonomic agents|mesh-ancestor
153396576|NCT04893629|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153396577|NCT04893629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153396578|NCT04893629|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153396579|NCT04893629|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
153396580|NCT04893629|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153396581|NCT04893629|Protective Agents|protective agents|mesh-ancestor
153396582|NCT04893629|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
153396583|NCT04893629|Protease Inhibitors|protease inhibitors|mesh-ancestor
153396584|NCT04893629|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153396585|NCT01936519|Cyclosporine|cyclosporine|mesh-list
153396586|NCT01936519|Mycophenolic Acid|mycophenolic acid|mesh-list
153856340|NCT03532022|Glucocorticoids|glucocorticoids|mesh-ancestor
153856341|NCT03532022|Hormones|hormones|mesh-ancestor
153856342|NCT03532022|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153856343|NCT03532022|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153856344|NCT03532022|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153856345|NCT02200380|Plerixafor|plerixafor|mesh-list
153856346|NCT02200380|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153856347|NCT02200380|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153856348|NCT02200380|Antiviral Agents|antiviral agents|mesh-ancestor
153856349|NCT02200380|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153856350|NCT02191878|TKM-080301|tkm-080301|mesh-list
153856351|NCT02191878|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153856352|NCT02191878|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153856353|NCT02191878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153856354|NCT02160678|Tazarotene|tazarotene|mesh-list
153856355|NCT02160678|Dermatologic Agents|dermatologic agents|mesh-ancestor
153856356|NCT02160678|Keratolytic Agents|keratolytic agents|mesh-ancestor
153856357|NCT02153502|Quinidine|quinidine|mesh-list
153856358|NCT02153502|Quinidine gluconate|quinidine gluconate|mesh-list
153856359|NCT02153502|Levomethorphan|levomethorphan|mesh-list
153856360|NCT02153502|Dextromethorphan|dextromethorphan|mesh-list
153856361|NCT02153502|Antitussive Agents|antitussive agents|mesh-ancestor
153856362|NCT02153502|Respiratory System Agents|respiratory system agents|mesh-ancestor
153396603|NCT01936519|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153396604|NCT01936519|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
153396605|NCT01936519|Antitubercular Agents|antitubercular agents|mesh-ancestor
153396606|NCT01936519|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153396608|NCT04507841|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
153396609|NCT04507841|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153396610|NCT04507841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153856373|NCT02153502|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153856374|NCT02153502|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
153396616|NCT01938079|Analgesics|analgesics|mesh-ancestor
153396617|NCT01938079|Sensory System Agents|sensory system agents|mesh-ancestor
153396618|NCT01938079|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153396619|NCT01938079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153396620|NCT01938079|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
153396621|NCT01938079|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153396622|NCT01938079|Anesthetics, General|anesthetics, general|mesh-ancestor
153396623|NCT01938079|Anesthetics|anesthetics|mesh-ancestor
153396624|NCT01938079|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153396625|NCT01938079|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
153396626|NCT01938079|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
153396627|NCT01938079|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153856385|NCT02153502|Cholinergic Agents|cholinergic agents|mesh-ancestor
153856386|NCT02153502|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
153856387|NCT02153502|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153396628|NCT01938079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153396630|NCT02641691|Tetrahydrofolates|tetrahydrofolates|mesh-list
153396631|NCT02641691|Formyltetrahydrofolates|formyltetrahydrofolates|mesh-list
153396633|NCT02641691|Oxaliplatin|oxaliplatin|mesh-list
153396634|NCT02641691|Levoleucovorin|levoleucovorin|mesh-list
153396635|NCT02641691|Antimetabolites|antimetabolites|mesh-ancestor
153396636|NCT02641691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153396637|NCT02641691|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153396638|NCT02641691|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153396639|NCT02641691|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153396640|NCT02641691|Immunologic Factors|immunologic factors|mesh-ancestor
153396641|NCT02641691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153396642|NCT02641691|Antidotes|antidotes|mesh-ancestor
153396643|NCT02641691|Protective Agents|protective agents|mesh-ancestor
153396644|NCT02641691|Vitamin B Complex|vitamin b complex|mesh-ancestor
153396645|NCT02641691|Vitamins|vitamins|mesh-ancestor
153396646|NCT02641691|Micronutrients|micronutrients|mesh-ancestor
153396647|NCT05588999|Salicylic Acid|salicylic acid|mesh-list
153396648|NCT05588999|Salicylates|salicylates|mesh-list
153396649|NCT05588999|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153396650|NCT05588999|Antifungal Agents|antifungal agents|mesh-ancestor
153396651|NCT05588999|Keratolytic Agents|keratolytic agents|mesh-ancestor
153396652|NCT05588999|Dermatologic Agents|dermatologic agents|mesh-ancestor
153396653|NCT05588999|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153396654|NCT05588999|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153396655|NCT05588999|Analgesics|analgesics|mesh-ancestor
153396656|NCT05588999|Sensory System Agents|sensory system agents|mesh-ancestor
153856389|NCT02153502|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
153856390|NCT02153502|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153856392|NCT02130687|Aprepitant|aprepitant|mesh-list
153856393|NCT02130687|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153856394|NCT02130687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153856395|NCT02130687|Incretins|incretins|mesh-ancestor
153856396|NCT02130687|Hormones|hormones|mesh-ancestor
153856397|NCT02130687|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153856398|NCT02130687|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
153856399|NCT02130687|Protease Inhibitors|protease inhibitors|mesh-ancestor
153856400|NCT02130687|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153856401|NCT02130687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153856402|NCT02130687|Antiemetics|antiemetics|mesh-ancestor
153856403|NCT02130687|Autonomic Agents|autonomic agents|mesh-ancestor
153856404|NCT02130687|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153856405|NCT02130687|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153856406|NCT02130687|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
153856407|NCT02130687|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153856408|NCT01228656|Mometasone Furoate|mometasone furoate|mesh-list
153856409|NCT01228656|Salicylic Acid|salicylic acid|mesh-list
153856410|NCT01228656|Salicylates|salicylates|mesh-list
153856411|NCT01228656|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153856412|NCT01228656|Dermatologic Agents|dermatologic agents|mesh-ancestor
153856413|NCT01228656|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
153856414|NCT01228656|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153396664|NCT01643928|Rituximab|rituximab|mesh-list
153396672|NCT03750071|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153396673|NCT04339829|Dacomitinib|dacomitinib|mesh-list
153396674|NCT04339829|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153396675|NCT04339829|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153396676|NCT04339829|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153396677|NCT04339829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153396678|NCT05588531|Cefepime|cefepime|mesh-list
153396679|NCT05588531|Avibactam|avibactam|mesh-list
153396680|NCT05588531|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153396681|NCT05588531|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153396682|NCT05588531|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
153396683|NCT05588531|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153396690|NCT05588297|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153396691|NCT05588297|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153396692|NCT05588297|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153396693|NCT05588297|Growth Substances|growth substances|mesh-ancestor
153396694|NCT05588297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153396695|NCT05588297|Growth Inhibitors|growth inhibitors|mesh-ancestor
153396696|NCT05588297|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153396697|NCT05588297|Antimetabolites|antimetabolites|mesh-ancestor
153396698|NCT05588297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153396699|NCT05588297|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153396700|NCT02303405|Pioglitazone|pioglitazone|mesh-list
153396701|NCT02303405|Hydroxychloroquine|hydroxychloroquine|mesh-list
153396702|NCT02303405|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153396703|NCT02303405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153396704|NCT02303405|Antimalarials|antimalarials|mesh-ancestor
153396705|NCT02303405|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153396706|NCT02303405|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153396707|NCT02303405|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153856442|NCT02125266|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153396708|NCT02303405|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153856443|NCT02116998|Aluminum Hydroxide|aluminum hydroxide|mesh-list
153856444|NCT02116998|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153856445|NCT02116998|Immunologic Factors|immunologic factors|mesh-ancestor
153856446|NCT02116998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153856472|NCT01709214|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153856473|NCT01709214|Narcotics|narcotics|mesh-ancestor
153856474|NCT01709214|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153856475|NCT01709214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153856476|NCT01709214|Analgesics|analgesics|mesh-ancestor
153856477|NCT01709214|Sensory System Agents|sensory system agents|mesh-ancestor
153856478|NCT01709214|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153856480|NCT02916602|Amlodipine|amlodipine|mesh-list
153856481|NCT02916602|Chlorthalidone|chlorthalidone|mesh-list
153856482|NCT02916602|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153856483|NCT02916602|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153856484|NCT02916602|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153856485|NCT02916602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153856486|NCT02916602|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153856487|NCT02916602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153856488|NCT02916602|Vasodilator Agents|vasodilator agents|mesh-ancestor
153856489|NCT02916602|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153856490|NCT02916602|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
153396733|NCT00702481|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153396734|NCT00702481|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153396735|NCT00367211|Naproxen|naproxen|mesh-list
153396736|NCT00367211|Omeprazole|omeprazole|mesh-list
153396737|NCT00367211|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
153396738|NCT00367211|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153396739|NCT00367211|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
153396740|NCT00367211|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153396741|NCT00367211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153396742|NCT00367211|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153396743|NCT00367211|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153396744|NCT00367211|Analgesics|analgesics|mesh-ancestor
153396745|NCT00367211|Sensory System Agents|sensory system agents|mesh-ancestor
153396746|NCT00367211|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153396747|NCT00367211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153396748|NCT00367211|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153856493|NCT02916602|Natriuretic Agents|natriuretic agents|mesh-ancestor
153856494|NCT02916602|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
153856496|NCT02916251|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
153856497|NCT02916251|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153856498|NCT02916251|Hormones|hormones|mesh-ancestor
153856506|NCT02106546|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153856508|NCT02106546|Antimitotic Agents|antimitotic agents|mesh-ancestor
153856509|NCT02106546|Mitosis Modulators|mitosis modulators|mesh-ancestor
153856510|NCT02106546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153856512|NCT02106546|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153856513|NCT02916173|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
153856514|NCT02916173|Hormones|hormones|mesh-list
153856515|NCT02916173|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153856516|NCT02916173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153856528|NCT02104245|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
153856529|NCT02104245|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153856530|NCT01699737|Glimepiride|glimepiride|mesh-list
153856531|NCT01699737|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153856532|NCT01699737|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153856533|NCT01699737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153856534|NCT01699737|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153856535|NCT01699737|Immunologic Factors|immunologic factors|mesh-ancestor
153856536|NCT04688723|Dabigatran|dabigatran|mesh-list
153856537|NCT04688723|Clopidogrel|clopidogrel|mesh-list
153856538|NCT04688723|Ticagrelor|ticagrelor|mesh-list
153856539|NCT04688723|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153396796|NCT02655653|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
153396797|NCT02655653|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153396798|NCT02655653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153856554|NCT01699464|Ophthalmic Solutions|ophthalmic solutions|mesh-list
153396822|NCT00367913|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153396823|NCT00367913|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
153396824|NCT00367913|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153396825|NCT00367913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153396826|NCT00367913|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
153396827|NCT00367913|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153396828|NCT00367913|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153396829|NCT00367913|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153396830|NCT00367913|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153396831|NCT00367913|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
153396832|NCT00367913|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
153396833|NCT00367913|Antitubercular Agents|antitubercular agents|mesh-ancestor
153396834|NCT00367913|Leprostatic Agents|leprostatic agents|mesh-ancestor
153396835|NCT00367913|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153396836|NCT00367913|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
153396837|NCT00367913|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
153396838|NCT00367913|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
153396839|NCT00367913|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
153396840|NCT00367913|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
153396841|NCT00367913|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
153396842|NCT02659787|Buprenorphine|buprenorphine|mesh-list
153396843|NCT02659787|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153396844|NCT02659787|Narcotics|narcotics|mesh-ancestor
153396845|NCT02659787|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153396846|NCT02659787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153856587|NCT02915666|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153856588|NCT02915666|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153856589|NCT02915666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153856590|NCT02915666|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153856591|NCT02915666|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
153856592|NCT02915666|Protective Agents|protective agents|mesh-ancestor
153856593|NCT02915666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153856594|NCT02092935|Vancomycin|vancomycin|mesh-list
153856595|NCT02092935|Ridinilazole|ridinilazole|mesh-list
153856598|NCT01666977|Carboplatin|carboplatin|mesh-list
153856599|NCT01666977|Pemetrexed|pemetrexed|mesh-list
153856600|NCT01666977|Trebananib|trebananib|mesh-list
153856602|NCT01666977|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153396863|NCT05044871|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153396872|NCT04931693|Analgesics|analgesics|mesh-ancestor
153396873|NCT04931693|Sensory System Agents|sensory system agents|mesh-ancestor
153396874|NCT04931693|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153396875|NCT04931693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153396876|NCT04931693|Antipyretics|antipyretics|mesh-ancestor
153396877|NCT02271594|Insulin|insulin|mesh-list
153396878|NCT02271594|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153396879|NCT02271594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153856609|NCT01666977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153856610|NCT01666977|Growth Inhibitors|growth inhibitors|mesh-ancestor
153856611|NCT02915354|Etanercept|etanercept|mesh-list
153856612|NCT02915354|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153856613|NCT02915354|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153856614|NCT02915354|Analgesics|analgesics|mesh-ancestor
153856615|NCT02915354|Sensory System Agents|sensory system agents|mesh-ancestor
153856616|NCT02915354|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153856617|NCT02915354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153856618|NCT02915354|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153856619|NCT02915354|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153856620|NCT02915354|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153856621|NCT02915354|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153856622|NCT02915354|Immunologic Factors|immunologic factors|mesh-ancestor
153856623|NCT01661634|Ularitide|ularitide|mesh-list
153856624|NCT01661634|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153856625|NCT01661634|Autonomic Agents|autonomic agents|mesh-ancestor
153856626|NCT01661634|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153856627|NCT01661634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153856628|NCT01661634|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153856629|NCT01661634|Respiratory System Agents|respiratory system agents|mesh-ancestor
153856630|NCT01661634|Diuretics|diuretics|mesh-ancestor
153856631|NCT01661634|Natriuretic Agents|natriuretic agents|mesh-ancestor
153856632|NCT01661166|Fesoterodine|fesoterodine|mesh-list
153856633|NCT01661166|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
153856634|NCT01661166|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
153396880|NCT02350517|Paclitaxel|paclitaxel|mesh-list
153856641|NCT02915042|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153856642|NCT02915042|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153856643|NCT02915042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153856644|NCT02915042|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153856645|NCT02915042|Analgesics|analgesics|mesh-ancestor
153856646|NCT02915042|Sensory System Agents|sensory system agents|mesh-ancestor
153856647|NCT02915042|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153856648|NCT02915042|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
153856649|NCT02915042|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153856650|NCT02915042|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153856651|NCT02915042|Adrenergic Agents|adrenergic agents|mesh-ancestor
153856655|NCT01658826|Pritelivir|pritelivir|mesh-list
153856661|NCT02092077|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153856665|NCT02914886|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153856666|NCT02914886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153856667|NCT01643226|Riboflavin|riboflavin|mesh-list
153856668|NCT01643226|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
153856669|NCT01643226|Vitamin B Complex|vitamin b complex|mesh-ancestor
153856670|NCT01643226|Vitamins|vitamins|mesh-ancestor
153396910|NCT04651595|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153396911|NCT04651595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153396925|NCT02672111|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153396926|NCT02672111|Narcotics|narcotics|mesh-ancestor
153396936|NCT05432843|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153396937|NCT05432843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153396938|NCT05432843|Anticonvulsants|anticonvulsants|mesh-ancestor
153396939|NCT05432843|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153396940|NCT05432843|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153396941|NCT05432843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153396942|NCT05432843|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153396943|NCT05432843|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153396944|NCT05432843|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153396945|NCT05432843|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153396946|NCT05432843|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153396948|NCT02679911|Amorolfine|amorolfine|mesh-list
153396949|NCT02679911|Antifungal Agents|antifungal agents|mesh-ancestor
153396950|NCT02679911|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153396951|NCT02680301|Triamcinolone|triamcinolone|mesh-list
153396952|NCT02680301|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
153396953|NCT02680301|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
153396954|NCT02680301|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
153396955|NCT02680301|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153396956|NCT02680301|Glucocorticoids|glucocorticoids|mesh-ancestor
153396957|NCT02680301|Hormones|hormones|mesh-ancestor
153396958|NCT02680301|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153856703|NCT02077881|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153856704|NCT02077881|Tubulin Modulators|tubulin modulators|mesh-ancestor
153856705|NCT02077881|Antimitotic Agents|antimitotic agents|mesh-ancestor
153856706|NCT02077881|Mitosis Modulators|mitosis modulators|mesh-ancestor
153856707|NCT02077881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153856708|NCT02077881|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153856709|NCT02077881|Antimetabolites|antimetabolites|mesh-ancestor
153888573|NCT01092832|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
153856710|NCT02077881|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
153856711|NCT02077881|Antidepressive Agents|antidepressive agents|mesh-ancestor
153856712|NCT02077881|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153856713|NCT01632228|Bevacizumab|bevacizumab|mesh-list
153856714|NCT01632228|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153856715|NCT01632228|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153856716|NCT01632228|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153856717|NCT01632228|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153856718|NCT01632228|Growth Substances|growth substances|mesh-ancestor
153856719|NCT01632228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153856720|NCT01632228|Growth Inhibitors|growth inhibitors|mesh-ancestor
153396959|NCT02680301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153396960|NCT02680301|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153396961|NCT02680301|Immunologic Factors|immunologic factors|mesh-ancestor
153396962|NCT02680301|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153856730|NCT01628094|Antiviral Agents|antiviral agents|mesh-ancestor
153856731|NCT01628094|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153856732|NCT01628094|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
153856734|NCT01628094|Antimetabolites|antimetabolites|mesh-ancestor
153856747|NCT02914145|Artenimol|artenimol|mesh-list
153856748|NCT02914145|Antimalarials|antimalarials|mesh-ancestor
153856749|NCT02914145|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153856750|NCT02914145|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153856751|NCT02914145|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153856752|NCT02914028|Acetaminophen|acetaminophen|mesh-list
153856753|NCT02914028|Tramadol|tramadol|mesh-list
153856754|NCT02914028|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153856755|NCT02914028|Analgesics|analgesics|mesh-ancestor
153856756|NCT02914028|Sensory System Agents|sensory system agents|mesh-ancestor
153856757|NCT02914028|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153856758|NCT02914028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153856765|NCT02063997|Colchicine|colchicine|mesh-list
153397017|NCT05648994|Paclitaxel|paclitaxel|mesh-list
153397018|NCT05648994|Cyclophosphamide|cyclophosphamide|mesh-list
153397019|NCT05648994|Fludarabine|fludarabine|mesh-list
153397020|NCT05648994|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
153397021|NCT05648994|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153397022|NCT05648994|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153397023|NCT05648994|Tubulin Modulators|tubulin modulators|mesh-ancestor
153397024|NCT05648994|Antimitotic Agents|antimitotic agents|mesh-ancestor
153397025|NCT05648994|Mitosis Modulators|mitosis modulators|mesh-ancestor
153397026|NCT05648994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153397027|NCT05648994|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153397028|NCT05648994|Immunologic Factors|immunologic factors|mesh-ancestor
153397029|NCT05648994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153397030|NCT05648994|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153397031|NCT05648994|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153397032|NCT05648994|Alkylating Agents|alkylating agents|mesh-ancestor
153397033|NCT05648994|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153397034|NCT04869306|Hyaluronic Acid|hyaluronic acid|mesh-list
153397035|NCT04869306|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153397036|NCT04869306|Immunologic Factors|immunologic factors|mesh-ancestor
153397037|NCT04869306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153397038|NCT04869306|Viscosupplements|viscosupplements|mesh-ancestor
153397039|NCT04869306|Protective Agents|protective agents|mesh-ancestor
153856786|NCT02063685|Immunologic Factors|immunologic factors|mesh-ancestor
153856787|NCT02063685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153856788|NCT02063685|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153856789|NCT02063685|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153856790|NCT02063685|Alkylating Agents|alkylating agents|mesh-ancestor
153856791|NCT02063685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153856792|NCT02063685|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153856793|NCT02063685|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153856794|NCT02063685|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153856795|NCT02063685|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153856796|NCT02063685|Glucocorticoids|glucocorticoids|mesh-ancestor
153856797|NCT02063685|Hormones|hormones|mesh-ancestor
153397051|NCT02703779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153397053|NCT02703779|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153397054|NCT02703779|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153397055|NCT02703779|Antiviral Agents|antiviral agents|mesh-ancestor
153397056|NCT02703779|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153397057|NCT04738955|Micafungin|micafungin|mesh-list
153397058|NCT04738955|Antifungal Agents|antifungal agents|mesh-ancestor
153397059|NCT04738955|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153397060|NCT02268396|Glycopyrrolate|glycopyrrolate|mesh-list
153397061|NCT02268396|Formoterol Fumarate|formoterol fumarate|mesh-list
153397062|NCT02268396|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153397063|NCT02268396|Autonomic Agents|autonomic agents|mesh-ancestor
153397064|NCT02268396|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153397065|NCT02268396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153397067|NCT02268396|Respiratory System Agents|respiratory system agents|mesh-ancestor
153397068|NCT02268396|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
153397069|NCT02268396|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
153856806|NCT02063295|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153856807|NCT02057172|Liraglutide|liraglutide|mesh-list
153856809|NCT02057172|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
153856810|NCT02057172|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153856811|NCT02057172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153856812|NCT02057172|Incretins|incretins|mesh-ancestor
153856813|NCT02057172|Hormones|hormones|mesh-ancestor
153856814|NCT02057172|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153856815|NCT02057172|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
153856816|NCT02894307|Rivaroxaban|rivaroxaban|mesh-list
153856817|NCT02894307|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
153856818|NCT02894307|Antithrombins|antithrombins|mesh-ancestor
153856819|NCT02894307|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
153856820|NCT02894307|Protease Inhibitors|protease inhibitors|mesh-ancestor
153856821|NCT02894307|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153856822|NCT02894307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153856823|NCT02894307|Anticoagulants|anticoagulants|mesh-ancestor
153397070|NCT02268396|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153397071|NCT02268396|Adrenergic Agents|adrenergic agents|mesh-ancestor
153397072|NCT02268396|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153397073|NCT02268396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153397074|NCT02268396|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153397075|NCT02268396|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
153397111|NCT02712047|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153397112|NCT02712047|Autonomic Agents|autonomic agents|mesh-ancestor
153397113|NCT02712047|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153397114|NCT02712047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153397115|NCT02712047|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153397116|NCT02712047|Respiratory System Agents|respiratory system agents|mesh-ancestor
153397117|NCT02712047|Dermatologic Agents|dermatologic agents|mesh-ancestor
153397118|NCT02712047|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
153397119|NCT02717273|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
153397120|NCT02717273|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
153397121|NCT02717273|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153397122|NCT02717273|Antitubercular Agents|antitubercular agents|mesh-ancestor
153397123|NCT00369239|Risperidone|risperidone|mesh-list
153397124|NCT00369239|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153914636|NCT04712071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153914637|NCT00609388|Tacrolimus|tacrolimus|mesh-list
153914638|NCT00609388|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153914639|NCT00609388|Immunologic Factors|immunologic factors|mesh-ancestor
153397151|NCT05159687|Adrenergic Agents|adrenergic agents|mesh-ancestor
153397152|NCT05159687|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153397153|NCT05159687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153397154|NCT02721017|Fentanyl|fentanyl|mesh-list
153397155|NCT02721017|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153397156|NCT02721017|Narcotics|narcotics|mesh-ancestor
153397157|NCT02721017|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153397158|NCT02721017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153397159|NCT02721017|Analgesics|analgesics|mesh-ancestor
153397160|NCT02721017|Sensory System Agents|sensory system agents|mesh-ancestor
153397161|NCT02721017|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153397162|NCT02721017|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153397163|NCT02721017|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153397164|NCT02721017|Anesthetics, General|anesthetics, general|mesh-ancestor
153397165|NCT02721017|Anesthetics|anesthetics|mesh-ancestor
153397166|NCT02721641|Trastuzumab|trastuzumab|mesh-list
153397167|NCT02721641|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153397168|NCT02721641|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153397169|NCT03649061|Etanercept|etanercept|mesh-list
153397170|NCT03649061|Leflunomide|leflunomide|mesh-list
153397171|NCT03649061|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153397172|NCT03649061|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153397173|NCT03649061|Analgesics|analgesics|mesh-ancestor
153397174|NCT03649061|Sensory System Agents|sensory system agents|mesh-ancestor
153397175|NCT03649061|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153397176|NCT03649061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153397177|NCT03649061|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153397178|NCT03649061|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153397179|NCT03649061|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153397180|NCT03649061|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153856912|NCT02912702|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153856915|NCT02912702|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153856916|NCT02912702|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153856917|NCT02912702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153856918|NCT02912702|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153856919|NCT02912702|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
153856920|NCT02912702|Protective Agents|protective agents|mesh-ancestor
153856921|NCT02010333|Benzyl Alcohol|benzyl alcohol|mesh-list
153856922|NCT02010333|Anesthetics, Local|anesthetics, local|mesh-ancestor
153856923|NCT02010333|Anesthetics|anesthetics|mesh-ancestor
153856924|NCT02010333|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153856925|NCT02010333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153856926|NCT02010333|Sensory System Agents|sensory system agents|mesh-ancestor
153856927|NCT02010333|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153856928|NCT02008344|Favipiravir|favipiravir|mesh-list
153856929|NCT02008344|Antiviral Agents|antiviral agents|mesh-ancestor
153856930|NCT02008344|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153882788|NCT01602822|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153856931|NCT02912156|Voriconazole|voriconazole|mesh-list
153856932|NCT02912156|Antifungal Agents|antifungal agents|mesh-ancestor
153856933|NCT02912156|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153856934|NCT02912156|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
153856935|NCT02912156|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153856936|NCT02912156|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153856937|NCT02912156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153856938|NCT02912156|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153856939|NCT02912156|Hormone Antagonists|hormone antagonists|mesh-ancestor
153856943|NCT03455049|Andrographolide|andrographolide|mesh-list
153397216|NCT00085735|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153397217|NCT00085735|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153856952|NCT03455049|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153856953|NCT03455049|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153856954|NCT03455049|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153856955|NCT03455049|Antiviral Agents|antiviral agents|mesh-ancestor
153856956|NCT03455049|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153856957|NCT02912234|Clarithromycin|clarithromycin|mesh-list
153856959|NCT02912234|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153856960|NCT02912234|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153856961|NCT02912234|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
153856962|NCT02912234|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153856963|NCT02912234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153856964|NCT02912234|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
153856965|NCT02912234|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153856967|NCT02912234|Antithrombins|antithrombins|mesh-ancestor
153856968|NCT02912234|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
153856969|NCT02912234|Protease Inhibitors|protease inhibitors|mesh-ancestor
153856970|NCT02912234|Anticoagulants|anticoagulants|mesh-ancestor
153856971|NCT04676139|Fluoxetine|fluoxetine|mesh-list
153856972|NCT04676139|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
153856973|NCT04676139|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153856974|NCT04676139|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153856975|NCT04676139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153856976|NCT04676139|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153856977|NCT04676139|Serotonin Agents|serotonin agents|mesh-ancestor
153856978|NCT04676139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153856979|NCT04676139|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
153856980|NCT04676139|Antidepressive Agents|antidepressive agents|mesh-ancestor
153397227|NCT03578783|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153397228|NCT03578783|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
153397229|NCT05544786|Ritonavir|ritonavir|mesh-list
153397230|NCT05544786|Nirmatrelvir|nirmatrelvir|mesh-list
153397231|NCT05544786|Nirmatrelvir and ritonavir drug combination|nirmatrelvir and ritonavir drug combination|mesh-list
153397232|NCT05544786|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
153397233|NCT05544786|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
153397246|NCT02726789|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
153397247|NCT02726789|Entecavir|entecavir|mesh-list
153397248|NCT02726789|REP 2139|rep 2139|mesh-list
153397249|NCT02726789|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153397250|NCT02726789|Antiviral Agents|antiviral agents|mesh-ancestor
153397254|NCT02731313|Trastuzumab|trastuzumab|mesh-list
153856991|NCT01999764|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153856993|NCT02911961|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153856994|NCT02911961|Analgesics|analgesics|mesh-ancestor
153856995|NCT02911961|Sensory System Agents|sensory system agents|mesh-ancestor
153856996|NCT02911961|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153856997|NCT02911961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153856998|NCT02911961|Antipyretics|antipyretics|mesh-ancestor
153856999|NCT01998828|N-(cyanomethyl)-4-(2-((4-(4-morpholinyl)phenyl)amino)-4-pyrimidinyl)benzamide|n-(cyanomethyl)-4-(2-((4-(4-morpholinyl)phenyl)amino)-4-pyrimidinyl)benzamide|mesh-list
153857000|NCT01998828|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153857001|NCT01998828|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153857002|NCT01998828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153857003|NCT04675944|Treprostinil|treprostinil|mesh-list
153857004|NCT04675944|Zamicastat|zamicastat|mesh-list
153857005|NCT04675944|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153857006|NCT04675944|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153857007|NCT04675944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153857008|NCT02911766|Chlorhexidine|chlorhexidine|mesh-list
153857009|NCT02911766|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
153857010|NCT02911766|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
153857011|NCT02911766|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153857012|NCT02911766|Disinfectants|disinfectants|mesh-ancestor
153857013|NCT02911766|Dermatologic Agents|dermatologic agents|mesh-ancestor
153397287|NCT02734355|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153397288|NCT02734355|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153397289|NCT02734355|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153397290|NCT02734355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153397291|NCT02734355|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153397292|NCT02734355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153397293|NCT02734355|Vasodilator Agents|vasodilator agents|mesh-ancestor
153397294|NCT02734355|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
153397295|NCT02734355|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
153857014|NCT01993641|Azacitidine|azacitidine|mesh-list
153857015|NCT01993641|Decitabine|decitabine|mesh-list
153857016|NCT01993641|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153857017|NCT01993641|Antimetabolites|antimetabolites|mesh-ancestor
153857018|NCT01993641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153857019|NCT01993641|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153857020|NCT01993641|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153857021|NCT01989429|Vitamin D|vitamin d|mesh-list
153857022|NCT01989429|Vitamins|vitamins|mesh-ancestor
153857023|NCT01989429|Micronutrients|micronutrients|mesh-ancestor
153857024|NCT01989429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153857025|NCT01989429|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153857026|NCT02911298|Metronidazole|metronidazole|mesh-list
153857027|NCT02911298|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153857031|NCT01983306|Dolcanatide|dolcanatide|mesh-list
153857055|NCT01185964|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153857056|NCT01185964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153857057|NCT01972854|Riboflavin|riboflavin|mesh-list
153857058|NCT01972854|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
153857059|NCT01972854|Vitamin B Complex|vitamin b complex|mesh-ancestor
153857060|NCT01972854|Vitamins|vitamins|mesh-ancestor
153857061|NCT01972854|Micronutrients|micronutrients|mesh-ancestor
153857062|NCT01972854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153857063|NCT01972854|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
153857064|NCT01972854|Dermatologic Agents|dermatologic agents|mesh-ancestor
153857065|NCT02550470|Sevoflurane|sevoflurane|mesh-list
153857066|NCT02550470|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153857067|NCT02550470|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
153857068|NCT02550470|Anesthetics, General|anesthetics, general|mesh-ancestor
153397311|NCT01948141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153397312|NCT04938323|BCG Vaccine|bcg vaccine|mesh-list
153397313|NCT04938323|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153397314|NCT04938323|Immunologic Factors|immunologic factors|mesh-ancestor
153397315|NCT04938323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153397316|NCT05446493|Tadalafil|tadalafil|mesh-list
153397317|NCT05446493|Vasodilator Agents|vasodilator agents|mesh-ancestor
153397318|NCT05446493|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
153857143|NCT02886988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153857144|NCT02886988|Cholinergic Agents|cholinergic agents|mesh-ancestor
153857145|NCT02886988|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153857146|NCT02886988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153857147|NCT02886988|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
153857148|NCT02886988|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153857149|NCT06227325|Disitamab vedotin|disitamab vedotin|mesh-list
153857150|NCT06227325|Immunoconjugates|immunoconjugates|mesh-ancestor
153857151|NCT06227325|Immunologic Factors|immunologic factors|mesh-ancestor
153857152|NCT06227325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153857153|NCT06227221|Sorafenib|sorafenib|mesh-list
153857154|NCT06227221|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153857155|NCT06227221|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153857156|NCT06227221|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153857157|NCT06227221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153857158|NCT06227156|Disitamab vedotin|disitamab vedotin|mesh-list
153857159|NCT06227156|Immunoconjugates|immunoconjugates|mesh-ancestor
153857160|NCT06227156|Immunologic Factors|immunologic factors|mesh-ancestor
153857161|NCT06227156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153857162|NCT06227065|Gemcitabine|gemcitabine|mesh-list
153857163|NCT06227065|Docetaxel|docetaxel|mesh-list
153857164|NCT06227065|Epirubicin|epirubicin|mesh-list
153397404|NCT00369551|Growth Substances|growth substances|mesh-ancestor
153397405|NCT00369551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153397406|NCT00369551|Growth Inhibitors|growth inhibitors|mesh-ancestor
153397419|NCT05447039|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153882789|NCT02273154|Buspirone|buspirone|mesh-list
153397420|NCT05447039|Respiratory System Agents|respiratory system agents|mesh-ancestor
153397421|NCT05447039|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
153397423|NCT05447039|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153397424|NCT05447039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153397425|NCT05447039|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
153857174|NCT06227065|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153857175|NCT06227065|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153857176|NCT06227065|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153857177|NCT06227065|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153857178|NCT06227065|Alkylating Agents|alkylating agents|mesh-ancestor
153857179|NCT06227065|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153857180|NCT06226532|Lidocaine|lidocaine|mesh-list
153857181|NCT06226532|Anesthetics, Local|anesthetics, local|mesh-ancestor
153857182|NCT06226532|Anesthetics|anesthetics|mesh-ancestor
153857183|NCT06226532|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153857184|NCT06226532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153857185|NCT06226532|Sensory System Agents|sensory system agents|mesh-ancestor
153857186|NCT06226532|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153397426|NCT05447039|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
153397427|NCT05447039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153397429|NCT05446805|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153397430|NCT05446415|Glucagon|glucagon|mesh-list
153397431|NCT05446415|Incretins|incretins|mesh-list
153397432|NCT05446415|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153397433|NCT05446415|Hormones|hormones|mesh-ancestor
153397434|NCT05446415|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153397443|NCT00370799|Glucocorticoids|glucocorticoids|mesh-ancestor
153397444|NCT00370799|Hormones|hormones|mesh-ancestor
153397455|NCT02661971|Tubulin Modulators|tubulin modulators|mesh-ancestor
153397456|NCT02661971|Antimitotic Agents|antimitotic agents|mesh-ancestor
153397457|NCT02661971|Mitosis Modulators|mitosis modulators|mesh-ancestor
153397458|NCT02661971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153397459|NCT02661971|Antimetabolites|antimetabolites|mesh-ancestor
153397460|NCT02661971|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153397461|NCT02661971|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153397462|NCT02661971|Immunologic Factors|immunologic factors|mesh-ancestor
153397463|NCT02661971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153397465|NCT02661971|Protective Agents|protective agents|mesh-ancestor
153397466|NCT02661971|Vitamin B Complex|vitamin b complex|mesh-ancestor
153397467|NCT02661971|Vitamins|vitamins|mesh-ancestor
153397468|NCT02661971|Micronutrients|micronutrients|mesh-ancestor
153397469|NCT02661971|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153397470|NCT02661971|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153397471|NCT02661971|Growth Substances|growth substances|mesh-ancestor
153397472|NCT02661971|Growth Inhibitors|growth inhibitors|mesh-ancestor
153397473|NCT05442905|Anesthetics|anesthetics|mesh-list
153397474|NCT05442905|Propofol|propofol|mesh-list
153397475|NCT05442905|Sevoflurane|sevoflurane|mesh-list
153397476|NCT05442905|Atracurium|atracurium|mesh-list
153397477|NCT05442905|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153397478|NCT05442905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153857219|NCT06225895|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153857220|NCT06225570|Tetracycline|tetracycline|mesh-list
153857221|NCT06225570|Isotretinoin|isotretinoin|mesh-list
153857222|NCT06225570|Dermatologic Agents|dermatologic agents|mesh-ancestor
153857223|NCT06225570|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153857224|NCT06225570|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153857225|NCT06225570|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
153857226|NCT06225570|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153857227|NCT06225570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153857228|NCT06225544|Lumasiran|lumasiran|mesh-list
153857229|NCT06225544|Renal Agents|renal agents|mesh-ancestor
153857230|NCT06225440|Palmidrol|palmidrol|mesh-list
153857231|NCT06225440|Analgesics|analgesics|mesh-ancestor
153857232|NCT06225440|Sensory System Agents|sensory system agents|mesh-ancestor
153857233|NCT06225440|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153857234|NCT06225440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153857235|NCT06225440|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153397479|NCT05442905|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153397480|NCT05442905|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153397481|NCT05442905|Anesthetics, General|anesthetics, general|mesh-ancestor
153397482|NCT05442905|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153397483|NCT05442905|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
153397484|NCT05442905|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
153882790|NCT02273154|Paroxetine|paroxetine|mesh-list
153882791|NCT02273154|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
153397493|NCT00369863|Triamcinolone|triamcinolone|mesh-list
153397516|NCT02588027|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153397517|NCT02588027|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153397518|NCT02588027|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153397519|NCT02588027|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153397520|NCT02588027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153397523|NCT04449965|Plasma Substitutes|plasma substitutes|mesh-ancestor
153397524|NCT04449965|Blood Substitutes|blood substitutes|mesh-ancestor
153397525|NCT04449965|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
153397526|NCT04449965|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153397527|NCT05431673|Doxycycline|doxycycline|mesh-list
153397528|NCT05431673|Ciprofloxacin|ciprofloxacin|mesh-list
153397529|NCT05431673|Rifampin|rifampin|mesh-list
153857284|NCT06205628|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-list
153857285|NCT06205628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153857286|NCT06205407|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
153397531|NCT05431673|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153397532|NCT05431673|Antimalarials|antimalarials|mesh-ancestor
153397533|NCT05431673|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153397534|NCT05431673|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153397535|NCT05431673|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153397536|NCT05431673|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153397537|NCT05431673|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153397538|NCT05431673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153397539|NCT05431673|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153397540|NCT05431673|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
153397541|NCT05431673|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153397542|NCT05431673|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
153397543|NCT05431673|Antitubercular Agents|antitubercular agents|mesh-ancestor
153397544|NCT05431673|Leprostatic Agents|leprostatic agents|mesh-ancestor
153397545|NCT05431673|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153397546|NCT05431673|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
153397547|NCT05431673|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
153397560|NCT01951651|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153857287|NCT06205407|Spironolactone|spironolactone|mesh-list
153857288|NCT06205407|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153857289|NCT06205407|Diuretics|diuretics|mesh-ancestor
153857290|NCT06205407|Natriuretic Agents|natriuretic agents|mesh-ancestor
153857291|NCT06205407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153857292|NCT06205407|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
153857293|NCT06205407|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153857294|NCT06205407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153857295|NCT06205407|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
153857296|NCT06205407|Hormone Antagonists|hormone antagonists|mesh-ancestor
153857297|NCT06205407|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153857298|NCT06205407|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
153857299|NCT06199466|Paclitaxel|paclitaxel|mesh-list
153857300|NCT06199466|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
153857301|NCT06199466|Gemcitabine|gemcitabine|mesh-list
153857302|NCT06199466|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153857303|NCT06199466|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153857304|NCT06199466|Tubulin Modulators|tubulin modulators|mesh-ancestor
153857305|NCT06199466|Antimitotic Agents|antimitotic agents|mesh-ancestor
153857306|NCT06199466|Mitosis Modulators|mitosis modulators|mesh-ancestor
153857307|NCT06199466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153888574|NCT01092832|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153888575|NCT01092832|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153888577|NCT01092832|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153857308|NCT06199466|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153397584|NCT02466581|Protective Agents|protective agents|mesh-ancestor
153397585|NCT02466581|Antimalarials|antimalarials|mesh-ancestor
153397586|NCT02466581|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153397587|NCT02466581|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153397588|NCT02466581|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153397589|NCT02466581|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153857336|NCT06048718|Immunoconjugates|immunoconjugates|mesh-ancestor
153857337|NCT06048718|Immunologic Factors|immunologic factors|mesh-ancestor
153857338|NCT06048718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153857339|NCT06044311|Carboplatin|carboplatin|mesh-list
153857340|NCT06044311|Vactosertib|vactosertib|mesh-list
153857341|NCT06044311|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153857342|NCT06044311|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153857343|NCT06044311|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153857344|NCT06044311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153857345|NCT06004037|Delpazolid|delpazolid|mesh-list
153397590|NCT02466581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153397591|NCT02466581|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153397592|NCT02466581|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153397593|NCT02466581|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153397594|NCT02466581|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153397595|NCT02466581|Immunologic Factors|immunologic factors|mesh-ancestor
153397596|NCT02466581|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
153397598|NCT02466581|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153857381|NCT05900245|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
153857382|NCT05900245|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153857383|NCT05892744|Sertraline|sertraline|mesh-list
153888580|NCT01092832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153888581|NCT01092832|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
153888582|NCT02878564|Praziquantel|praziquantel|mesh-list
153888583|NCT02878564|Anthelmintics|anthelmintics|mesh-ancestor
153888584|NCT02878564|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153857384|NCT05892744|Antidepressive Agents|antidepressive agents|mesh-ancestor
153857385|NCT05892744|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153857386|NCT05892744|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
153857387|NCT05892744|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153857388|NCT05892744|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153397633|NCT01894555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153397634|NCT01894555|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153397635|NCT01894555|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153397636|NCT01894555|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153397637|NCT01894555|Antipyretics|antipyretics|mesh-ancestor
153397638|NCT01953211|Contraceptive Agents|contraceptive agents|mesh-list
153397639|NCT01953211|Norinyl|norinyl|mesh-list
153397640|NCT01953211|Contraceptives, Oral|contraceptives, oral|mesh-list
153397641|NCT01953211|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-list
153397642|NCT01953211|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153857392|NCT05892744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153857393|NCT05864118|Antibodies|antibodies|mesh-list
153857394|NCT05864118|Immunologic Factors|immunologic factors|mesh-ancestor
153857395|NCT05864118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153857396|NCT05815160|Carboplatin|carboplatin|mesh-list
153857397|NCT05815160|Etoposide|etoposide|mesh-list
153857398|NCT05815160|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153857399|NCT05815160|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153857400|NCT05815160|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153857401|NCT05815160|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153857402|NCT05815160|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153857403|NCT05815160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153857404|NCT05794555|Lactulose|lactulose|mesh-list
153857405|NCT05794555|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153397650|NCT05735197|Dapagliflozin|dapagliflozin|mesh-list
153397651|NCT05735197|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
153397652|NCT05735197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153397653|NCT05735197|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153397654|NCT05735197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153397655|NCT00370097|Fluticasone|fluticasone|mesh-list
153397656|NCT00370097|Xhance|xhance|mesh-list
153397657|NCT00370097|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153397658|NCT00370097|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153397681|NCT00370253|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153397683|NCT01491815|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153397684|NCT01491815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153888586|NCT04308070|Hemostatics|hemostatics|mesh-list
153397685|NCT01491815|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153397686|NCT01491815|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153397687|NCT01491815|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153397688|NCT01491815|Immunologic Factors|immunologic factors|mesh-ancestor
153397689|NCT01491815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153397690|NCT01491815|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153397691|NCT04359953|Azithromycin|azithromycin|mesh-list
153397692|NCT04359953|Hydroxychloroquine|hydroxychloroquine|mesh-list
153397693|NCT04359953|Telmisartan|telmisartan|mesh-list
153397694|NCT04359953|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153882792|NCT02273154|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153397695|NCT04359953|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153397696|NCT04359953|Antimalarials|antimalarials|mesh-ancestor
153397697|NCT04359953|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153857428|NCT05741060|Phytoestrogens|phytoestrogens|mesh-ancestor
153857429|NCT05741060|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
153857430|NCT05741060|Estrogens|estrogens|mesh-ancestor
153857431|NCT05741060|Hormones|hormones|mesh-ancestor
153857432|NCT05741060|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153857433|NCT05741060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153857434|NCT05721144|Nitric Oxide|nitric oxide|mesh-list
153857435|NCT05721144|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153857436|NCT05721144|Autonomic Agents|autonomic agents|mesh-ancestor
153857437|NCT05721144|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153857438|NCT05721144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153857439|NCT05721144|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153857440|NCT05721144|Respiratory System Agents|respiratory system agents|mesh-ancestor
153857441|NCT05721144|Free Radical Scavengers|free radical scavengers|mesh-ancestor
153857442|NCT05721144|Antioxidants|antioxidants|mesh-ancestor
153857443|NCT05721144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153857444|NCT05721144|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153857445|NCT05721144|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
153857461|NCT05502315|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153857462|NCT05502315|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153857463|NCT05502315|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153857464|NCT05502315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153857465|NCT05489926|Pamiparib|pamiparib|mesh-list
153857466|NCT05489926|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
153857467|NCT05489926|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153857468|NCT05489926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153857470|NCT05446870|Paclitaxel|paclitaxel|mesh-list
153857481|NCT05446870|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153857482|NCT05446870|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153397746|NCT05454683|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153397759|NCT05453435|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153397761|NCT03029845|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
153397762|NCT03029845|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
153397763|NCT03029845|Adrenergic Agents|adrenergic agents|mesh-ancestor
153397764|NCT03029845|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153397765|NCT03029845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153397767|NCT03029845|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153397768|NCT03029845|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153397769|NCT03029845|Vasodilator Agents|vasodilator agents|mesh-ancestor
153397770|NCT05451719|Capecitabine|capecitabine|mesh-list
153397771|NCT05451719|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153397772|NCT05451719|Antimetabolites|antimetabolites|mesh-ancestor
153857506|NCT05384262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153857507|NCT05384262|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153857508|NCT05384262|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
153857509|NCT05384262|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153857511|NCT05367245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153857512|NCT05367245|Histamine Antagonists|histamine antagonists|mesh-ancestor
153857513|NCT05367245|Histamine Agents|histamine agents|mesh-ancestor
153857514|NCT05367245|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153857515|NCT05367245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153857516|NCT05232708|Semaglutide|semaglutide|mesh-list
153857549|NCT05206500|Cephalosporins|cephalosporins|mesh-list
153397795|NCT05062577|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
153397796|NCT05062577|ASP8062|asp8062|mesh-list
153397797|NCT05062577|Naloxone|naloxone|mesh-list
153397798|NCT05062577|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153397799|NCT05062577|Narcotics|narcotics|mesh-ancestor
153397800|NCT05062577|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153397801|NCT05062577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153397802|NCT05062577|Analgesics|analgesics|mesh-ancestor
153397803|NCT05062577|Sensory System Agents|sensory system agents|mesh-ancestor
153397804|NCT05062577|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153397805|NCT05062577|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
153397810|NCT05448989|Atropine|atropine|mesh-list
153397811|NCT05448989|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153397812|NCT05448989|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153882793|NCT02273154|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153882794|NCT02273154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153882795|NCT02273154|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153882796|NCT02273154|Serotonin Agents|serotonin agents|mesh-ancestor
153882797|NCT02273154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153382088|NCT02333045|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153382089|NCT02333045|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153382090|NCT02333045|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153382091|NCT02333045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153382092|NCT02333045|Antiviral Agents|antiviral agents|mesh-ancestor
153382093|NCT02333045|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153382094|NCT02333045|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153382095|NCT02333045|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153382096|NCT02333045|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
153382097|NCT02333045|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
153382098|NCT02333045|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
153382099|NCT01684748|Olmesartan|olmesartan|mesh-list
153382100|NCT01684748|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
153382101|NCT01684748|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153382102|NCT01684748|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
153397813|NCT05448989|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153857556|NCT05206500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153857557|NCT05206500|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
153857558|NCT05206500|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153857559|NCT05170399|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
153857560|NCT05170399|Immunologic Factors|immunologic factors|mesh-ancestor
153857561|NCT05170399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153857562|NCT05069974|Linezolid|linezolid|mesh-list
153857563|NCT05069974|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153857564|NCT05069974|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153857565|NCT05069974|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
153857566|NCT05069974|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153857567|NCT05069974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153857568|NCT05065411|Everolimus|everolimus|mesh-list
153857569|NCT05065411|Fulvestrant|fulvestrant|mesh-list
153397817|NCT05448989|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153397818|NCT05448989|Respiratory System Agents|respiratory system agents|mesh-ancestor
153397819|NCT05448989|Mydriatics|mydriatics|mesh-ancestor
153397820|NCT05448989|Parasympatholytics|parasympatholytics|mesh-ancestor
153397821|NCT05448989|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
153397822|NCT05448989|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
153397823|NCT05448989|Cholinergic Agents|cholinergic agents|mesh-ancestor
153397824|NCT05448989|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153397825|NCT05448989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153397826|NCT00370565|Insulin|insulin|mesh-list
153397827|NCT00370565|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
153397828|NCT00370565|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153397829|NCT00370565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153397830|NCT05039723|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
153397831|NCT05039723|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
153397832|NCT05039723|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153382103|NCT01684748|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
153397833|NCT05039723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153397834|NCT05039723|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
153397835|NCT05039723|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153397839|NCT00370019|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
153397841|NCT00370019|Estradiol|estradiol|mesh-list
153397842|NCT00370019|Estrogens|estrogens|mesh-ancestor
153397843|NCT00370019|Hormones|hormones|mesh-ancestor
153397844|NCT00370019|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153397845|NCT00370019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153397850|NCT00370019|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
153397851|NCT00370019|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
153397852|NCT00370019|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
153397853|NCT00370019|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
153397854|NCT00370019|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153397855|NCT00370019|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153397856|NCT03888131|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
153397857|NCT03888131|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153397858|NCT03888131|Respiratory System Agents|respiratory system agents|mesh-ancestor
153397859|NCT01900249|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
153397860|NCT01900249|Ophthalmic Solutions|ophthalmic solutions|mesh-list
153397861|NCT04969211|Iloperidone|iloperidone|mesh-list
153397862|NCT04969211|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153397863|NCT04969211|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153397864|NCT04969211|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153857627|NCT04948749|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153857628|NCT04948749|Immunologic Factors|immunologic factors|mesh-ancestor
153857629|NCT04948749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153857630|NCT04908423|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
153857631|NCT04908423|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
153857632|NCT04908423|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153857633|NCT04908423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153397883|NCT01901809|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
153397884|NCT01901809|Sympathomimetics|sympathomimetics|mesh-ancestor
153397885|NCT01901809|Autonomic Agents|autonomic agents|mesh-ancestor
153397886|NCT01901809|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153397887|NCT01901809|Dopamine Agents|dopamine agents|mesh-ancestor
153397888|NCT01901809|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153397889|NCT01901809|Protective Agents|protective agents|mesh-ancestor
153397891|NCT03029533|Fertility Agents, Female|fertility agents, female|mesh-ancestor
153397892|NCT03029533|Fertility Agents|fertility agents|mesh-ancestor
153857663|NCT04840823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153397914|NCT01907113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153397916|NCT01907113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153397918|NCT00370643|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
153397919|NCT00370643|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153397920|NCT00370643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153397921|NCT01908127|Salicylic Acid|salicylic acid|mesh-list
153397922|NCT01908127|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153397923|NCT01908127|Antifungal Agents|antifungal agents|mesh-ancestor
153397924|NCT01908127|Keratolytic Agents|keratolytic agents|mesh-ancestor
153857669|NCT04838743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153857670|NCT04838743|Incretins|incretins|mesh-ancestor
153857671|NCT04838743|Hormones|hormones|mesh-ancestor
153857672|NCT04838743|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153857673|NCT04827979|Daratumumab|daratumumab|mesh-list
153857674|NCT04827979|Abatacept|abatacept|mesh-list
153397925|NCT01908127|Dermatologic Agents|dermatologic agents|mesh-ancestor
153397926|NCT04679831|Praziquantel|praziquantel|mesh-list
153397927|NCT04679831|Anthelmintics|anthelmintics|mesh-ancestor
153397928|NCT04679831|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153397929|NCT04679831|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153397930|NCT01908751|Vitamin D|vitamin d|mesh-list
153397931|NCT01908751|Ergocalciferols|ergocalciferols|mesh-list
153397932|NCT01908751|Cholecalciferol|cholecalciferol|mesh-list
153397933|NCT01908751|Vitamins|vitamins|mesh-list
153397934|NCT01908751|Micronutrients|micronutrients|mesh-ancestor
153397935|NCT01908751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153397936|NCT01908751|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153397937|NCT01908751|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153397938|NCT00370721|Bevacizumab|bevacizumab|mesh-list
153857696|NCT04821141|Estrogens|estrogens|mesh-list
153857697|NCT04821141|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
153857698|NCT04821141|Hormones|hormones|mesh-ancestor
153914640|NCT00609388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153914641|NCT00609388|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
153914642|NCT00609388|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153397952|NCT01909141|Zuclomiphene|zuclomiphene|mesh-list
153397953|NCT01909141|Hormones|hormones|mesh-list
153857709|NCT04801368|Sensory System Agents|sensory system agents|mesh-ancestor
153857710|NCT04801368|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153397964|NCT01909141|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153397965|NCT01909141|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
153397966|NCT01909141|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153397967|NCT01909141|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153397968|NCT01909141|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
153397969|NCT01909141|Hormone Antagonists|hormone antagonists|mesh-ancestor
153397970|NCT01909141|Androgens|androgens|mesh-ancestor
153397983|NCT04486859|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153397984|NCT04486859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153397985|NCT04486859|Anticoagulants|anticoagulants|mesh-ancestor
153398007|NCT04404959|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153398008|NCT04403711|Dexmedetomidine|dexmedetomidine|mesh-list
153398009|NCT04403711|Anesthetics|anesthetics|mesh-list
153398010|NCT04403711|Anesthetics, Local|anesthetics, local|mesh-list
153398011|NCT04403711|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153398012|NCT04403711|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153398013|NCT04403711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153398015|NCT04403711|Analgesics|analgesics|mesh-ancestor
153398076|NCT00371501|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153398077|NCT00371501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153398078|NCT00371501|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153398079|NCT00371501|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153398080|NCT00371501|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153398081|NCT00371501|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153398084|NCT00371501|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153398169|NCT02284555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153398170|NCT03029689|Raltegravir Potassium|raltegravir potassium|mesh-list
153398172|NCT03029689|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153398173|NCT03029689|Antiviral Agents|antiviral agents|mesh-ancestor
153398174|NCT03029689|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153398175|NCT03029689|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
153398176|NCT03029689|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
153398177|NCT03029689|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153398178|NCT03029689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153398179|NCT02287909|Clopidogrel|clopidogrel|mesh-list
153398180|NCT02287909|Ticagrelor|ticagrelor|mesh-list
153398181|NCT02287909|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153398182|NCT02287909|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
153398183|NCT02287909|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
153398184|NCT02287909|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
153857932|NCT03504241|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153857933|NCT03504241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153857934|NCT03504241|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153857935|NCT03504241|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153857936|NCT03504241|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153857937|NCT03504241|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
153398187|NCT02287909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153398188|NCT02287909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153398189|NCT00371579|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
153398190|NCT00371579|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153398191|NCT00371579|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153398192|NCT00371579|Antimetabolites|antimetabolites|mesh-ancestor
153398193|NCT00371579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153398194|NCT00371579|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153398195|NCT00371579|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
153398196|NCT00371579|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153398198|NCT02833805|Cyclophosphamide|cyclophosphamide|mesh-list
153398199|NCT02833805|Fludarabine|fludarabine|mesh-list
153858001|NCT03073304|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
153858002|NCT02999022|Lithium Carbonate|lithium carbonate|mesh-list
153858003|NCT02999022|Antidepressive Agents|antidepressive agents|mesh-ancestor
153858016|NCT02927301|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153858017|NCT02927301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153858018|NCT02927301|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153858019|NCT02927301|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153858020|NCT02892123|Paclitaxel|paclitaxel|mesh-list
153858021|NCT02892123|Vinorelbine|vinorelbine|mesh-list
153398276|NCT05417659|Antimetabolites|antimetabolites|mesh-ancestor
153398277|NCT05417659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153858035|NCT02659930|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
153858036|NCT02659930|Pomalidomide|pomalidomide|mesh-list
153858037|NCT02659930|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153858038|NCT02659930|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153858039|NCT02659930|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153858057|NCT02611037|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153858058|NCT02611037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153858059|NCT02611037|Dermatologic Agents|dermatologic agents|mesh-ancestor
153858060|NCT02611037|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153858061|NCT02611037|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153858062|NCT02611037|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153858063|NCT02611037|Immunologic Factors|immunologic factors|mesh-ancestor
153858064|NCT02611037|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153858065|NCT02611037|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153858066|NCT02607202|Paclitaxel|paclitaxel|mesh-list
153858067|NCT02607202|Carboplatin|carboplatin|mesh-list
153398325|NCT04337099|TEMPOL-H|tempol-h|mesh-list
153858069|NCT02607202|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153858070|NCT02607202|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153858072|NCT02607202|Antimitotic Agents|antimitotic agents|mesh-ancestor
153858077|NCT02402660|Vitamin A|vitamin a|mesh-list
153858087|NCT02162420|Cyclophosphamide|cyclophosphamide|mesh-list
153858088|NCT02162420|Fludarabine|fludarabine|mesh-list
153858089|NCT02162420|Alemtuzumab|alemtuzumab|mesh-list
153858090|NCT02162420|Antilymphocyte Serum|antilymphocyte serum|mesh-list
153858091|NCT02162420|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153858092|NCT02162420|Immunologic Factors|immunologic factors|mesh-ancestor
153858093|NCT02162420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153858094|NCT02162420|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153858097|NCT02162420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153858098|NCT02162420|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153858099|NCT02162420|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153858100|NCT02162420|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153858101|NCT02040376|Metformin|metformin|mesh-list
153858102|NCT02040376|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153858103|NCT02040376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153858108|NCT01850888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153858109|NCT01850888|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
153382105|NCT01685684|Oxycodone|oxycodone|mesh-list
153382106|NCT01685684|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153382107|NCT01685684|Narcotics|narcotics|mesh-ancestor
153382108|NCT01685684|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153858110|NCT01652092|Vidarabine|vidarabine|mesh-list
153858111|NCT01652092|Cyclophosphamide|cyclophosphamide|mesh-list
153858122|NCT01652092|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153858124|NCT01652092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153858125|NCT01652092|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153858126|NCT01652092|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153858127|NCT01652092|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153858147|NCT01081951|Mitosis Modulators|mitosis modulators|mesh-ancestor
153858148|NCT01081951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153858149|NCT01081951|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
153858150|NCT01081951|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153858151|NCT00777582|Olaparib|olaparib|mesh-list
153858152|NCT00777582|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
153858153|NCT00777582|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153858154|NCT00777582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153858155|NCT00777582|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153858156|NCT00736385|Metformin|metformin|mesh-list
153858159|NCT00392327|Vitamin A|vitamin a|mesh-list
153858181|NCT00392327|Antimitotic Agents|antimitotic agents|mesh-ancestor
153858182|NCT00392327|Mitosis Modulators|mitosis modulators|mesh-ancestor
153858183|NCT00392327|Keratolytic Agents|keratolytic agents|mesh-ancestor
153858184|NCT00392327|Dermatologic Agents|dermatologic agents|mesh-ancestor
153858185|NCT00357565|Cyclosporine|cyclosporine|mesh-list
153858395|NCT01940991|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
153858396|NCT01940991|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
153858397|NCT01940991|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
153858398|NCT01940991|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153858418|NCT02909465|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
153858419|NCT02909465|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
153858420|NCT02909465|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153858430|NCT02909465|Autonomic Agents|autonomic agents|mesh-ancestor
153858431|NCT02909465|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153858432|NCT02909465|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153858433|NCT02909465|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
153858434|NCT02909465|Dopamine Agents|dopamine agents|mesh-ancestor
153858435|NCT02909465|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
153858436|NCT04312555|Alprostadil|alprostadil|mesh-list
153858449|NCT04674423|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153858450|NCT04674423|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153858451|NCT04674423|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153858452|NCT04674423|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153858453|NCT04674423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153858454|NCT04674423|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153858455|NCT04674423|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153858456|NCT00555867|Anastrozole|anastrozole|mesh-list
153398735|NCT01996657|Anticoagulants|anticoagulants|mesh-ancestor
153858471|NCT00555984|Sevoflurane|sevoflurane|mesh-list
153858472|NCT00555984|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153858475|NCT00555984|Anesthetics, General|anesthetics, general|mesh-ancestor
153398879|NCT02895035|Respiratory System Agents|respiratory system agents|mesh-ancestor
153398881|NCT02895035|Sympathomimetics|sympathomimetics|mesh-ancestor
153398882|NCT02895035|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
153398901|NCT02802449|Micronutrients|micronutrients|mesh-ancestor
153398902|NCT02802449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153398903|NCT02802449|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153398904|NCT02802449|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153398905|NCT02803229|Amphetamine|amphetamine|mesh-list
153398906|NCT02803229|Adderall|adderall|mesh-list
153398907|NCT02803229|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
153398908|NCT02803229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153398909|NCT02803229|Sympathomimetics|sympathomimetics|mesh-ancestor
153398910|NCT02803229|Autonomic Agents|autonomic agents|mesh-ancestor
153398911|NCT02803229|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153382109|NCT01685684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153382110|NCT01685684|Analgesics|analgesics|mesh-ancestor
153382111|NCT01685684|Sensory System Agents|sensory system agents|mesh-ancestor
153382112|NCT01685684|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153382113|NCT03978767|Acetaminophen|acetaminophen|mesh-list
153382247|NCT01926041|Varenicline|varenicline|mesh-list
153382248|NCT01926041|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
153382249|NCT01926041|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
153382250|NCT01926041|Cholinergic Agents|cholinergic agents|mesh-ancestor
153382251|NCT01926041|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153382252|NCT01926041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153398912|NCT02803229|Dopamine Agents|dopamine agents|mesh-ancestor
153398916|NCT02803229|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
153398917|NCT02803229|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153398918|NCT02803229|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153398946|NCT04147351|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153398947|NCT04147351|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153398948|NCT04147351|Growth Substances|growth substances|mesh-ancestor
153398949|NCT04147351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153398950|NCT04147351|Growth Inhibitors|growth inhibitors|mesh-ancestor
153858690|NCT01785771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153858691|NCT01785771|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
153398959|NCT02004613|Sensory System Agents|sensory system agents|mesh-ancestor
153398960|NCT02004613|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153858706|NCT04607252|Contraceptive Agents|contraceptive agents|mesh-ancestor
153858718|NCT01782729|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
153858719|NCT01782729|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153858739|NCT01780428|Histamine Antagonists|histamine antagonists|mesh-ancestor
153858740|NCT01780428|Histamine Agents|histamine agents|mesh-ancestor
153858741|NCT01780428|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153858742|NCT01780428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153858743|NCT01780428|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
153858744|NCT01780428|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
153858745|NCT01780428|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153858746|NCT01780428|Anesthetics, Local|anesthetics, local|mesh-ancestor
153858747|NCT01780428|Anesthetics|anesthetics|mesh-ancestor
153858748|NCT01780428|Antiemetics|antiemetics|mesh-ancestor
153858749|NCT01780428|Autonomic Agents|autonomic agents|mesh-ancestor
153858750|NCT01780428|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153858751|NCT04671420|Rituximab|rituximab|mesh-list
153858752|NCT04671420|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153858753|NCT04671420|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153858754|NCT04671420|Immunologic Factors|immunologic factors|mesh-ancestor
153399026|NCT02005549|Mitosis Modulators|mitosis modulators|mesh-ancestor
153399027|NCT02005549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153399028|NCT02005549|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153399029|NCT02005549|Antimetabolites|antimetabolites|mesh-ancestor
153399030|NCT04349696|Mitiglinide|mitiglinide|mesh-list
153399050|NCT04492358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153399075|NCT01959685|Fertility Agents|fertility agents|mesh-ancestor
153399076|NCT01959685|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153399077|NCT01959685|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
153399078|NCT01959685|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
153399100|NCT03417986|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
153399101|NCT03417986|Dopamine Agents|dopamine agents|mesh-ancestor
153399102|NCT03417986|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153399103|NCT03417986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153858840|NCT04322123|Antimalarials|antimalarials|mesh-ancestor
153858841|NCT04322123|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153858842|NCT04322123|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153399118|NCT02301416|Appetite Depressants|appetite depressants|mesh-ancestor
153399119|NCT02301416|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
153399120|NCT02301416|Sympathomimetics|sympathomimetics|mesh-ancestor
153382253|NCT01926041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153382254|NCT01769027|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
153382255|NCT01769027|Azithromycin|azithromycin|mesh-list
153382256|NCT01769027|Penicillins|penicillins|mesh-list
153382257|NCT01769027|Sertraline|sertraline|mesh-list
153382258|NCT01769027|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
153399121|NCT02301416|Autonomic Agents|autonomic agents|mesh-ancestor
153399122|NCT02301416|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153399123|NCT02301416|Adrenergic Agents|adrenergic agents|mesh-ancestor
153399124|NCT02301416|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153399125|NCT02301416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153399127|NCT02815709|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153858844|NCT04322123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153858846|NCT01741155|Docetaxel|docetaxel|mesh-list
153858847|NCT01741155|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153858848|NCT01741155|Tubulin Modulators|tubulin modulators|mesh-ancestor
153858849|NCT01741155|Antimitotic Agents|antimitotic agents|mesh-ancestor
153858850|NCT01741155|Mitosis Modulators|mitosis modulators|mesh-ancestor
153858852|NCT04244630|Antioxidants|antioxidants|mesh-list
153858918|NCT00532025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153858920|NCT04669392|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
153858921|NCT04669392|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153858924|NCT00532142|Triamcinolone|triamcinolone|mesh-list
153858958|NCT00556296|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
153858959|NCT00556296|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153858960|NCT00556296|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153858961|NCT00556296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153858962|NCT00556296|Dopamine Agents|dopamine agents|mesh-ancestor
153858963|NCT00556296|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153858964|NCT04668456|Lidocaine|lidocaine|mesh-list
153858965|NCT04668456|Dexmedetomidine|dexmedetomidine|mesh-list
153399378|NCT02002832|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
153399379|NCT02002832|Dopamine Agents|dopamine agents|mesh-ancestor
153859113|NCT00533936|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153859114|NCT00533936|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153859115|NCT00557544|Ketoprofen|ketoprofen|mesh-list
153859116|NCT00557544|Metoclopramide|metoclopramide|mesh-list
153859117|NCT00557544|Antiemetics|antiemetics|mesh-ancestor
153859118|NCT00557544|Autonomic Agents|autonomic agents|mesh-ancestor
153859119|NCT00557544|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153859120|NCT00557544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153859169|NCT04168502|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153859170|NCT04168502|Immunotoxins|immunotoxins|mesh-ancestor
153859171|NCT04168502|Immunoconjugates|immunoconjugates|mesh-ancestor
153859172|NCT04168502|Immunologic Factors|immunologic factors|mesh-ancestor
153859173|NCT04168502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153859174|NCT01215916|Pemetrexed|pemetrexed|mesh-list
153399558|NCT01973348|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
153399559|NCT01973348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153399560|NCT01973348|Sympathomimetics|sympathomimetics|mesh-ancestor
153399561|NCT01973348|Autonomic Agents|autonomic agents|mesh-ancestor
153399562|NCT01973348|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153399563|NCT01973348|Dopamine Agents|dopamine agents|mesh-ancestor
153399564|NCT01973348|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153399565|NCT01973348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153399566|NCT01973348|Adrenergic Agents|adrenergic agents|mesh-ancestor
153399567|NCT01973348|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
153399568|NCT01973348|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153859305|NCT01215097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153859307|NCT01215097|Hormones|hormones|mesh-ancestor
153859308|NCT01215097|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153399586|NCT02925611|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153399587|NCT02925611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153399588|NCT01973335|Spironolactone|spironolactone|mesh-list
153399589|NCT01973335|Acetazolamide|acetazolamide|mesh-list
153859313|NCT03527576|Dexamethasone|dexamethasone|mesh-list
153859314|NCT03527576|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153859315|NCT03527576|Antiemetics|antiemetics|mesh-ancestor
153859316|NCT03527576|Autonomic Agents|autonomic agents|mesh-ancestor
153382259|NCT01769027|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153382326|NCT00376155|Amodiaquine|amodiaquine|mesh-list
153382327|NCT00376155|Antimalarials|antimalarials|mesh-ancestor
153382328|NCT00376155|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153382329|NCT00376155|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153382330|NCT00376155|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153382331|NCT00376155|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153382332|NCT00376155|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153382333|NCT00376155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153783559|NCT00236483|Antipyretics|antipyretics|mesh-ancestor
153783560|NCT00236483|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153783561|NCT00236483|Narcotics|narcotics|mesh-ancestor
153382334|NCT00376155|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
153382335|NCT01989221|Granisetron|granisetron|mesh-list
153382336|NCT01989221|Antiemetics|antiemetics|mesh-ancestor
153382337|NCT01989221|Autonomic Agents|autonomic agents|mesh-ancestor
153382338|NCT01989221|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153382339|NCT01989221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153382366|NCT01990703|Contraceptive Agents|contraceptive agents|mesh-ancestor
153382367|NCT01990703|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153382368|NCT01990703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153382369|NCT01990703|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
153382370|NCT01990703|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
153382371|NCT01990703|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
153382372|NCT03230175|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
153382373|NCT03230175|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153859317|NCT03527576|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153859318|NCT03527576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153859319|NCT03527576|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153859320|NCT03527576|Glucocorticoids|glucocorticoids|mesh-ancestor
153859321|NCT03527576|Hormones|hormones|mesh-ancestor
153399601|NCT01973335|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153859340|NCT04664010|Protective Agents|protective agents|mesh-ancestor
153859341|NCT04664127|Valacyclovir|valacyclovir|mesh-list
153859342|NCT04664127|Antiviral Agents|antiviral agents|mesh-ancestor
153859343|NCT04664127|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153859344|NCT04664088|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
153859345|NCT04664088|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
153859346|NCT04664088|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153859347|NCT04664088|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153859348|NCT04664088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153859349|NCT04664088|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153859350|NCT04664088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153859362|NCT04663386|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153399733|NCT02939651|Pembrolizumab|pembrolizumab|mesh-list
153399734|NCT02939651|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153399735|NCT02939651|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153399736|NCT02939651|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153399737|NCT02939651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153399738|NCT02026297|Tranexamic Acid|tranexamic acid|mesh-list
153399742|NCT02026297|Hemostatics|hemostatics|mesh-ancestor
153399763|NCT02015234|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153399765|NCT02869451|Nicotine|nicotine|mesh-list
153399766|NCT02869451|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
153399767|NCT02869451|Autonomic Agents|autonomic agents|mesh-ancestor
153399768|NCT02869451|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153399769|NCT02869451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153399770|NCT02869451|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
153399771|NCT02869451|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
153399772|NCT02869451|Cholinergic Agents|cholinergic agents|mesh-ancestor
153399773|NCT02869451|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153399774|NCT02869451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153399775|NCT02869451|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
153399776|NCT02869451|Antidepressive Agents|antidepressive agents|mesh-ancestor
153399777|NCT02869451|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153399778|NCT02869451|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
153399779|NCT02869451|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153399780|NCT02869451|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153399781|NCT02869451|Dopamine Agents|dopamine agents|mesh-ancestor
153399782|NCT02869451|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
153399783|NCT02869451|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153399784|NCT02869451|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153399785|NCT02305316|Opicapone|opicapone|mesh-list
153399786|NCT02305316|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
153399787|NCT02305316|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153399788|NCT02305316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153859481|NCT01183780|Antidotes|antidotes|mesh-ancestor
153859482|NCT01183780|Protective Agents|protective agents|mesh-ancestor
153859483|NCT01183780|Vitamin B Complex|vitamin b complex|mesh-ancestor
153859484|NCT01183780|Vitamins|vitamins|mesh-ancestor
153859485|NCT01183780|Micronutrients|micronutrients|mesh-ancestor
153859499|NCT04678830|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
153859500|NCT04678830|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
153859502|NCT04678830|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153859532|NCT01183390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153859533|NCT01183390|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
153859534|NCT01183390|Hormone Antagonists|hormone antagonists|mesh-ancestor
153859535|NCT01183390|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153859536|NCT01183390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153859537|NCT02887807|Cyclosporine|cyclosporine|mesh-list
153859538|NCT02887807|Cyclosporins|cyclosporins|mesh-list
153859539|NCT02887807|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153859540|NCT02887807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153859541|NCT02887807|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153859542|NCT02887807|Immunologic Factors|immunologic factors|mesh-ancestor
153859543|NCT02887807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153399821|NCT01979276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153399822|NCT02871011|Nitric Oxide|nitric oxide|mesh-list
153399823|NCT02871011|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153399824|NCT02871011|Autonomic Agents|autonomic agents|mesh-ancestor
153399825|NCT02871011|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153399826|NCT02871011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153399827|NCT02871011|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153399828|NCT02871011|Respiratory System Agents|respiratory system agents|mesh-ancestor
153399829|NCT02871011|Free Radical Scavengers|free radical scavengers|mesh-ancestor
153399830|NCT02871011|Antioxidants|antioxidants|mesh-ancestor
153399831|NCT02871011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153399834|NCT02871011|Vasodilator Agents|vasodilator agents|mesh-ancestor
153399840|NCT02344238|Micronutrients|micronutrients|mesh-ancestor
153399841|NCT02344238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153399842|NCT02344238|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
153399843|NCT02344238|Dermatologic Agents|dermatologic agents|mesh-ancestor
153399857|NCT02019758|Budesonide|budesonide|mesh-list
153859588|NCT05226299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153859589|NCT00557232|Bevacizumab|bevacizumab|mesh-list
153399869|NCT02019758|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153399870|NCT01980589|Dexamethasone|dexamethasone|mesh-list
153399871|NCT01980589|Cyclophosphamide|cyclophosphamide|mesh-list
153399872|NCT01980589|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153399873|NCT01980589|Immunologic Factors|immunologic factors|mesh-ancestor
153399874|NCT01980589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153859614|NCT00538070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153859615|NCT00538109|Imatinib Mesylate|imatinib mesylate|mesh-list
153859616|NCT00538109|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153859617|NCT00538109|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153859618|NCT00538109|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153859619|NCT00538109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153859620|NCT00538109|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153859621|NCT00538148|Telithromycin|telithromycin|mesh-list
153399902|NCT01980524|Acipimox|acipimox|mesh-list
153399903|NCT01980524|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153399904|NCT01980524|Antimetabolites|antimetabolites|mesh-ancestor
153399905|NCT01980524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153399906|NCT01980524|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153399907|NCT01982539|Diclofenac|diclofenac|mesh-list
153399908|NCT01982539|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153399909|NCT01982539|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153399910|NCT01982539|Analgesics|analgesics|mesh-ancestor
153399911|NCT01982539|Sensory System Agents|sensory system agents|mesh-ancestor
153399919|NCT01982695|Losartan|losartan|mesh-list
153859623|NCT00538148|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153859624|NCT04661670|Salicylic Acid|salicylic acid|mesh-list
153859625|NCT04661670|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153859626|NCT04661670|Antifungal Agents|antifungal agents|mesh-ancestor
153859627|NCT04661670|Keratolytic Agents|keratolytic agents|mesh-ancestor
153859628|NCT04661670|Dermatologic Agents|dermatologic agents|mesh-ancestor
153859629|NCT05110391|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
153859630|NCT05110391|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153859631|NCT05110391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153859632|NCT00538187|Bortezomib|bortezomib|mesh-list
153859633|NCT00538187|Obatoclax|obatoclax|mesh-list
153859634|NCT00538187|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153859635|NCT00538187|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153859636|NCT00538187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153859637|NCT04661709|Aspirin|aspirin|mesh-list
153859638|NCT04661709|Metoprolol|metoprolol|mesh-list
153859639|NCT04661709|Isosorbide|isosorbide|mesh-list
153859640|NCT04661709|Isosorbide Dinitrate|isosorbide dinitrate|mesh-list
153859641|NCT04661709|Isosorbide-5-mononitrate|isosorbide-5-mononitrate|mesh-list
153859642|NCT04661709|Nitroglycerin|nitroglycerin|mesh-list
153859643|NCT04661709|Trimetazidine|trimetazidine|mesh-list
153859644|NCT04661709|Clopidogrel|clopidogrel|mesh-list
153859645|NCT04661709|Atorvastatin|atorvastatin|mesh-list
153859646|NCT04661709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153399981|NCT02348918|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153399982|NCT02348918|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153399983|NCT02348918|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153399984|NCT02348918|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153399985|NCT02348918|Growth Substances|growth substances|mesh-ancestor
153400037|NCT02349152|Narcotics|narcotics|mesh-ancestor
153400038|NCT02349152|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153400039|NCT02349152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153400062|NCT01983020|Ketamine|ketamine|mesh-list
153400063|NCT01983020|Anesthetics, Local|anesthetics, local|mesh-ancestor
153400064|NCT01983020|Anesthetics|anesthetics|mesh-ancestor
153400065|NCT01983020|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153400066|NCT01983020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153400067|NCT01983020|Sensory System Agents|sensory system agents|mesh-ancestor
153400068|NCT01983020|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153400094|NCT01983878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153400095|NCT01983878|Growth Inhibitors|growth inhibitors|mesh-ancestor
153400096|NCT01983878|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153400098|NCT02396732|Enoxaparin|enoxaparin|mesh-list
153400099|NCT02396732|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153400100|NCT02396732|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153400101|NCT02396732|Analgesics|analgesics|mesh-ancestor
153400102|NCT02396732|Sensory System Agents|sensory system agents|mesh-ancestor
153400103|NCT02396732|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153400111|NCT02396732|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153400112|NCT02396732|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153400113|NCT02396732|Antipyretics|antipyretics|mesh-ancestor
153400114|NCT02396732|Anticoagulants|anticoagulants|mesh-ancestor
153400115|NCT02352974|Vitamin D|vitamin d|mesh-list
153400116|NCT02352974|Vitamins|vitamins|mesh-ancestor
153400117|NCT02352974|Micronutrients|micronutrients|mesh-ancestor
153400118|NCT02352974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153400119|NCT02352974|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153400120|NCT02353754|Morphine|morphine|mesh-list
153400121|NCT02353754|Bupivacaine|bupivacaine|mesh-list
153400122|NCT02353754|Anesthetics, Local|anesthetics, local|mesh-ancestor
153400123|NCT02353754|Anesthetics|anesthetics|mesh-ancestor
153400124|NCT02353754|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153400125|NCT02353754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153400126|NCT02353754|Sensory System Agents|sensory system agents|mesh-ancestor
153400127|NCT02353754|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153400128|NCT02353754|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153400129|NCT02353754|Narcotics|narcotics|mesh-ancestor
153400130|NCT02353754|Analgesics|analgesics|mesh-ancestor
153400131|NCT02354378|Dexmedetomidine|dexmedetomidine|mesh-list
153400132|NCT02354378|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153859827|NCT00538811|Antiviral Agents|antiviral agents|mesh-ancestor
153859828|NCT00538811|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153859829|NCT00538811|Antimetabolites|antimetabolites|mesh-ancestor
153859830|NCT00538811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153859831|NCT00538811|Immunologic Factors|immunologic factors|mesh-ancestor
153859832|NCT00538811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153859833|NCT00538811|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
153859834|NCT00538811|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
153859835|NCT00538811|Dopamine Agents|dopamine agents|mesh-ancestor
153859836|NCT00538811|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153859837|NCT00538811|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153859838|NCT00538811|Analgesics|analgesics|mesh-ancestor
153859839|NCT00538811|Sensory System Agents|sensory system agents|mesh-ancestor
153400175|NCT02354534|Schistosomicides|schistosomicides|mesh-ancestor
153400176|NCT02354534|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
153400177|NCT02354534|Anthelmintics|anthelmintics|mesh-ancestor
153400178|NCT02355158|Clonidine|clonidine|mesh-list
153400179|NCT02355158|Analgesics|analgesics|mesh-ancestor
153400180|NCT02355158|Sensory System Agents|sensory system agents|mesh-ancestor
153400181|NCT02355158|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153400182|NCT02355158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153400183|NCT02355158|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153400184|NCT02355158|Sympatholytics|sympatholytics|mesh-ancestor
153400185|NCT02355158|Autonomic Agents|autonomic agents|mesh-ancestor
153400186|NCT02355158|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
153400187|NCT02355158|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153400188|NCT02355158|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153400189|NCT02355158|Adrenergic Agents|adrenergic agents|mesh-ancestor
153400190|NCT02355158|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153859873|NCT02413827|Interferon Inducers|interferon inducers|mesh-ancestor
153859874|NCT02413827|Immunologic Factors|immunologic factors|mesh-ancestor
153859875|NCT02413827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153859876|NCT00538967|Doxycycline|doxycycline|mesh-list
153859879|NCT00538967|Antimalarials|antimalarials|mesh-ancestor
153400199|NCT02061397|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153400201|NCT02061397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153400202|NCT02061397|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153859935|NCT00554424|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153859936|NCT00554424|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153859960|NCT00540098|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153859961|NCT00540098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153859962|NCT00540098|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153382374|NCT01992185|Sunscreening Agents|sunscreening agents|mesh-list
153859963|NCT00540098|Serotonin Agents|serotonin agents|mesh-ancestor
153859964|NCT00540098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153859965|NCT00540098|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
153859976|NCT00540137|Protease Inhibitors|protease inhibitors|mesh-ancestor
153859977|NCT00540137|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153859978|NCT00540137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153859979|NCT00540137|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153859980|NCT00540137|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153859981|NCT00540137|Antiviral Agents|antiviral agents|mesh-ancestor
153400271|NCT02312882|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
153400272|NCT02312882|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153400273|NCT02312882|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153400274|NCT02312882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153400276|NCT02877095|Diuretics|diuretics|mesh-ancestor
153400277|NCT02877095|Natriuretic Agents|natriuretic agents|mesh-ancestor
153400278|NCT02877095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153400279|NCT02877095|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
153400280|NCT02877095|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153400281|NCT02877095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153429678|NCT00002744|Methotrexate|methotrexate|mesh-list
153429679|NCT00002744|Vincristine|vincristine|mesh-list
153429680|NCT00002744|Daunorubicin|daunorubicin|mesh-list
153429681|NCT00002744|Asparaginase|asparaginase|mesh-list
153429682|NCT00002744|Mercaptopurine|mercaptopurine|mesh-list
153429683|NCT00002744|Pegaspargase|pegaspargase|mesh-list
153429684|NCT00002744|Thioguanine|thioguanine|mesh-list
153429685|NCT00002744|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153429686|NCT00002744|Immunologic Factors|immunologic factors|mesh-ancestor
153429687|NCT00002744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153400283|NCT02877485|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
153400284|NCT02877485|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
153400288|NCT02877485|Hormones|hormones|mesh-ancestor
153400301|NCT03023891|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153400303|NCT03023891|Hormones|hormones|mesh-ancestor
153400304|NCT03023891|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153400305|NCT03023891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153400323|NCT02359058|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153400324|NCT02359058|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153400325|NCT02359058|Antimetabolites|antimetabolites|mesh-ancestor
153400350|NCT03114995|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153400351|NCT02959853|Anastrozole|anastrozole|mesh-list
153400352|NCT02959853|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153400381|NCT02039726|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153400382|NCT02039726|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153860142|NCT02324985|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153860158|NCT04659642|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153860159|NCT04659642|Analgesics|analgesics|mesh-ancestor
153860160|NCT04659642|Sensory System Agents|sensory system agents|mesh-ancestor
153860161|NCT04659642|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153860162|NCT04659642|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
153860169|NCT04659642|Narcotics|narcotics|mesh-ancestor
153860262|NCT00542555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153860263|NCT00542555|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153860264|NCT00542555|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153860265|NCT00542555|Gout Suppressants|gout suppressants|mesh-ancestor
153860266|NCT00542555|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153860267|NCT00542555|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153860268|NCT00542555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153860292|NCT02257983|Micronutrients|micronutrients|mesh-ancestor
153860293|NCT02257983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153860294|NCT00543023|Teriparatide|teriparatide|mesh-list
153860295|NCT00543023|Calcitonin|calcitonin|mesh-list
153860296|NCT00543023|Salmon calcitonin|salmon calcitonin|mesh-list
153860297|NCT00543023|Calcitonin Gene-Related Peptide|calcitonin gene-related peptide|mesh-list
153860298|NCT00543023|Katacalcin|katacalcin|mesh-list
153860299|NCT00543023|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153429689|NCT00002744|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153429690|NCT00002744|Alkylating Agents|alkylating agents|mesh-ancestor
153429691|NCT00002744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153429692|NCT00002744|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153860300|NCT00543023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153860301|NCT00543023|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153860302|NCT00543023|Vasodilator Agents|vasodilator agents|mesh-ancestor
153860373|NCT00543335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153860374|NCT00543413|Enalapril|enalapril|mesh-list
153860375|NCT00543413|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
153860376|NCT00543413|Protease Inhibitors|protease inhibitors|mesh-ancestor
153860377|NCT00543413|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153860378|NCT00543413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153400688|NCT02415608|Ibrutinib|ibrutinib|mesh-list
153400689|NCT02415608|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153400690|NCT02415608|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153400691|NCT02415608|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153400692|NCT02415608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153400693|NCT03144635|Grazoprevir|grazoprevir|mesh-list
153400694|NCT03144635|Antiviral Agents|antiviral agents|mesh-ancestor
153400695|NCT03144635|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153400696|NCT03145259|Diclofenac|diclofenac|mesh-list
153400697|NCT03145259|Diclofenac hydroxyethylpyrrolidine|diclofenac hydroxyethylpyrrolidine|mesh-list
153400698|NCT03145259|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
153400699|NCT03145259|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153400700|NCT03145259|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153860386|NCT00554658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153860389|NCT00543608|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153860390|NCT00543608|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153860391|NCT00543608|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153860392|NCT00543608|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153860393|NCT00543608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153860394|NCT00554775|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
153860395|NCT00554775|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153860396|NCT00554775|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153860397|NCT00554775|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153860398|NCT00554775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153860399|NCT00554775|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153860400|NCT00543647|Fenofibrate|fenofibrate|mesh-list
153860401|NCT00543647|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153860402|NCT00543647|Antimetabolites|antimetabolites|mesh-ancestor
153860403|NCT00543647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153860404|NCT00543647|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153860405|NCT04647669|Interferons|interferons|mesh-list
153860406|NCT04647669|Interferon-beta|interferon-beta|mesh-list
153860407|NCT04647669|Interferon beta-1a|interferon beta-1a|mesh-list
153860408|NCT04647669|Remdesivir|remdesivir|mesh-list
153860409|NCT04647669|Acalabrutinib|acalabrutinib|mesh-list
153860410|NCT04647669|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153860411|NCT04647669|Antiviral Agents|antiviral agents|mesh-ancestor
153860412|NCT04647669|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153860420|NCT04647669|Antimetabolites|antimetabolites|mesh-ancestor
153860421|NCT00543686|Fluticasone|fluticasone|mesh-list
153860422|NCT00543686|Montelukast|montelukast|mesh-list
153860423|NCT00543686|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153860424|NCT00543686|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153860425|NCT00543686|Autonomic Agents|autonomic agents|mesh-ancestor
153860426|NCT00543686|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153860427|NCT00543686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153860428|NCT00543686|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153860429|NCT00543686|Respiratory System Agents|respiratory system agents|mesh-ancestor
153860430|NCT00543686|Dermatologic Agents|dermatologic agents|mesh-ancestor
153860431|NCT00543686|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
153860432|NCT00543686|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
153400731|NCT02052752|Benzoyl Peroxide|benzoyl peroxide|mesh-list
153860439|NCT00543842|Capecitabine|capecitabine|mesh-list
153860440|NCT00543842|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
153860441|NCT00543842|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153860442|NCT00543842|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153860443|NCT00543842|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153860444|NCT00543842|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153860445|NCT00543842|Growth Substances|growth substances|mesh-ancestor
153860446|NCT00543842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153860447|NCT00543842|Growth Inhibitors|growth inhibitors|mesh-ancestor
153860448|NCT00543842|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153860449|NCT00543842|Antimetabolites|antimetabolites|mesh-ancestor
153860450|NCT00543842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153860451|NCT00543842|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153860452|NCT00543842|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153860453|NCT00543842|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153860454|NCT00543959|Pioglitazone|pioglitazone|mesh-list
153400752|NCT02996591|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153400753|NCT02996591|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153400754|NCT02996591|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153400755|NCT02996591|Protease Inhibitors|protease inhibitors|mesh-ancestor
153400756|NCT02996591|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153400757|NCT02996591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153400758|NCT02996591|Anesthetics, Local|anesthetics, local|mesh-ancestor
153400759|NCT02996591|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153400760|NCT02996591|Sensory System Agents|sensory system agents|mesh-ancestor
153400761|NCT02996591|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153400762|NCT02996591|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153400763|NCT02996591|Anesthetics, General|anesthetics, general|mesh-ancestor
153400765|NCT02996591|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
153400766|NCT02996591|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
153400767|NCT02996591|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
153400781|NCT03066947|Interferon-alpha|interferon-alpha|mesh-list
153400782|NCT03066947|Interferon alpha-2|interferon alpha-2|mesh-list
153860455|NCT00543959|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153860456|NCT00543959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153860457|NCT00544037|Interferons|interferons|mesh-list
153860458|NCT00544037|Interferon-beta|interferon-beta|mesh-list
153860459|NCT00544037|Interferon beta-1b|interferon beta-1b|mesh-list
153860460|NCT00544037|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153860461|NCT00544037|Antiviral Agents|antiviral agents|mesh-ancestor
153860462|NCT00544037|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153860463|NCT00544037|Immunologic Factors|immunologic factors|mesh-ancestor
153860464|NCT00544037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153860467|NCT00544154|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
153860468|NCT00544154|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153860469|NCT00544154|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153860470|NCT00544154|Immunologic Factors|immunologic factors|mesh-ancestor
153860471|NCT00544154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153860472|NCT00544154|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153860473|NCT04638582|Paclitaxel|paclitaxel|mesh-list
153860474|NCT04638582|Carboplatin|carboplatin|mesh-list
153860475|NCT04638582|Pembrolizumab|pembrolizumab|mesh-list
153860476|NCT04638582|Pemetrexed|pemetrexed|mesh-list
153860477|NCT04638582|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153860478|NCT04638582|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153860479|NCT04638582|Tubulin Modulators|tubulin modulators|mesh-ancestor
153860480|NCT04638582|Antimitotic Agents|antimitotic agents|mesh-ancestor
153860481|NCT04638582|Mitosis Modulators|mitosis modulators|mesh-ancestor
153860482|NCT04638582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153860483|NCT04638582|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153860484|NCT04638582|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153860485|NCT04638582|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153860493|NCT00544232|Paclitaxel|paclitaxel|mesh-list
153860494|NCT00544232|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
153860495|NCT00544232|Cyclophosphamide|cyclophosphamide|mesh-list
153860496|NCT00544232|Methotrexate|methotrexate|mesh-list
153860497|NCT00544232|Epirubicin|epirubicin|mesh-list
153860498|NCT00544232|Darbepoetin alfa|darbepoetin alfa|mesh-list
153400795|NCT02043145|Botulinum Toxins|botulinum toxins|mesh-list
153400796|NCT02043145|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
153400797|NCT02043145|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
153400798|NCT02043145|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
153400799|NCT02043145|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153400800|NCT02043145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153400801|NCT02043145|Cholinergic Agents|cholinergic agents|mesh-ancestor
153400802|NCT02043145|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153400803|NCT02043145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153400804|NCT02043145|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
153400805|NCT02043145|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153400806|NCT02062801|Ephedrine|ephedrine|mesh-list
153400807|NCT02062801|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
153400808|NCT02062801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153400809|NCT02062801|Sympathomimetics|sympathomimetics|mesh-ancestor
153400810|NCT02062801|Autonomic Agents|autonomic agents|mesh-ancestor
153400811|NCT02062801|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153400812|NCT02062801|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
153400813|NCT02062801|Adrenergic Agents|adrenergic agents|mesh-ancestor
153860514|NCT00544232|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153860515|NCT00544232|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153400822|NCT02063035|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
153400823|NCT02063035|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153400824|NCT02063035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153400825|NCT02063035|Hemostatics|hemostatics|mesh-ancestor
153400826|NCT02063035|Coagulants|coagulants|mesh-ancestor
153400827|NCT00375245|Sirolimus|sirolimus|mesh-list
153400828|NCT00375245|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153400829|NCT00375245|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153400836|NCT02043379|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
153400837|NCT02043379|Immunologic Factors|immunologic factors|mesh-ancestor
153400838|NCT02043379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153400840|NCT02054156|Tobramycin|tobramycin|mesh-list
153400841|NCT02054156|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153400842|NCT02054156|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153400843|NCT03159143|Docetaxel|docetaxel|mesh-list
153400844|NCT03159143|Oxaliplatin|oxaliplatin|mesh-list
153400845|NCT03159143|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153400846|NCT03159143|Tubulin Modulators|tubulin modulators|mesh-ancestor
153400847|NCT03159143|Antimitotic Agents|antimitotic agents|mesh-ancestor
153400848|NCT03159143|Mitosis Modulators|mitosis modulators|mesh-ancestor
153400849|NCT03159143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153400850|NCT03068897|Ibuprofen|ibuprofen|mesh-list
153400851|NCT03068897|Tizanidine|tizanidine|mesh-list
153400852|NCT03068897|Baclofen|baclofen|mesh-list
153400853|NCT03068897|Metaxalone|metaxalone|mesh-list
153400854|NCT03068897|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153400855|NCT03068897|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153400856|NCT03068897|Analgesics|analgesics|mesh-ancestor
153400857|NCT03068897|Sensory System Agents|sensory system agents|mesh-ancestor
153400858|NCT03068897|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153400859|NCT03068897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153860547|NCT00544349|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153860548|NCT00544349|Immunologic Factors|immunologic factors|mesh-ancestor
153860549|NCT00544349|Antidotes|antidotes|mesh-ancestor
153860550|NCT00544349|Protective Agents|protective agents|mesh-ancestor
153860552|NCT00544349|Vitamins|vitamins|mesh-ancestor
153860553|NCT00544349|Micronutrients|micronutrients|mesh-ancestor
153860554|NCT00544349|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153860555|NCT01191190|Ofatumumab|ofatumumab|mesh-list
153860556|NCT01191190|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153860557|NCT00544388|Levocetirizine|levocetirizine|mesh-list
153400861|NCT03068897|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153400862|NCT03068897|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153400863|NCT03068897|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153400864|NCT03068897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153400865|NCT03068897|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
153400866|NCT03068897|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
153400867|NCT03068897|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
153400868|NCT03068897|GABA Agonists|gaba agonists|mesh-ancestor
153400869|NCT03068897|GABA Agents|gaba agents|mesh-ancestor
153400870|NCT03068897|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153400871|NCT03068897|Anticonvulsants|anticonvulsants|mesh-ancestor
153400872|NCT03068897|Parasympatholytics|parasympatholytics|mesh-ancestor
153400873|NCT03068897|Autonomic Agents|autonomic agents|mesh-ancestor
153400874|NCT03068897|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
153400875|NCT03068897|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153400876|NCT03068897|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153400884|NCT02049476|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153400885|NCT02049476|Glucocorticoids|glucocorticoids|mesh-ancestor
153400887|NCT02049476|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153400888|NCT02049476|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153400889|NCT02049476|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153400890|NCT02299297|Tofacitinib|tofacitinib|mesh-list
153400891|NCT02299297|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
153400892|NCT02299297|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153400893|NCT02299297|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153860565|NCT00544505|Cyclophosphamide|cyclophosphamide|mesh-list
153860566|NCT00544505|Fluorouracil|fluorouracil|mesh-list
153860567|NCT00544505|Epirubicin|epirubicin|mesh-list
153860586|NCT00544700|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153860587|NCT00544700|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153860588|NCT00544700|Growth Substances|growth substances|mesh-ancestor
153860589|NCT00544700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153860590|NCT00544700|Growth Inhibitors|growth inhibitors|mesh-ancestor
153429701|NCT00002744|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153429702|NCT00002744|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153429703|NCT00002744|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153429704|NCT00002744|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153888595|NCT01313273|Nonsteroidal Anti-Androgens|nonsteroidal anti-androgens|mesh-list
153888596|NCT01313273|Hormones|hormones|mesh-ancestor
153888597|NCT01313273|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153888598|NCT01313273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153888599|NCT01313273|Antioxidants|antioxidants|mesh-ancestor
153860592|NCT05824481|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-list
153860593|NCT05824481|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153860594|NCT05824481|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153860595|NCT05824481|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153860596|NCT05824481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153400894|NCT02299297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153400895|NCT03069677|Midazolam|midazolam|mesh-list
153400896|NCT03069677|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153400897|NCT03069677|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153860615|NCT05824312|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-list
153860616|NCT05824312|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153400926|NCT05405465|Immunologic Factors|immunologic factors|mesh-ancestor
153400927|NCT05405465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153400928|NCT02064907|Dexlansoprazole|dexlansoprazole|mesh-list
153400929|NCT02064907|Lansoprazole|lansoprazole|mesh-list
153400930|NCT02064907|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
153400931|NCT02064907|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153400932|NCT02064907|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
153400933|NCT02064907|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153400934|NCT02064907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153400935|NCT02064985|Ticagrelor|ticagrelor|mesh-list
153400936|NCT02064985|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153400937|NCT02064985|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
153400938|NCT02064985|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
153400939|NCT02064985|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
153400950|NCT03170219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153400951|NCT00375557|Valproic Acid|valproic acid|mesh-list
153400952|NCT00375557|Quetiapine Fumarate|quetiapine fumarate|mesh-list
153400953|NCT00375557|Antidepressive Agents|antidepressive agents|mesh-ancestor
153860642|NCT05823701|Sensory System Agents|sensory system agents|mesh-ancestor
153860643|NCT05823701|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153860644|NCT05823701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153860645|NCT05823701|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153860646|NCT05823701|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153860647|NCT05823701|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153860648|NCT05823168|Anticonvulsants|anticonvulsants|mesh-list
153860649|NCT05823155|Penicillins|penicillins|mesh-list
153860650|NCT05823155|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153860651|NCT05823155|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153860652|NCT05822882|Anesthetics|anesthetics|mesh-list
153860653|NCT05822882|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153860654|NCT05822882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153860655|NCT05822713|Amisulpride|amisulpride|mesh-list
153860656|NCT05822713|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153400954|NCT00375557|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153400955|NCT00375557|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153400956|NCT00375557|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153400957|NCT00375557|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153400958|NCT00375557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153400959|NCT00375557|Anticonvulsants|anticonvulsants|mesh-ancestor
153400960|NCT00375557|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153400961|NCT00375557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153400962|NCT00375557|GABA Agents|gaba agents|mesh-ancestor
153400963|NCT00375557|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153400964|NCT00375557|Antimanic Agents|antimanic agents|mesh-ancestor
153400965|NCT03177395|Acetylcysteine|acetylcysteine|mesh-list
153400966|NCT03177395|N-monoacetylcystine|n-monoacetylcystine|mesh-list
153400967|NCT03177395|Antiviral Agents|antiviral agents|mesh-ancestor
153400968|NCT03177395|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153401011|NCT03086213|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153401012|NCT03086213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153401013|NCT03086213|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153860721|NCT05751629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153860722|NCT05751629|Growth Inhibitors|growth inhibitors|mesh-ancestor
153860723|NCT05751629|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
153860724|NCT05751629|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153860725|NCT05751629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153860726|NCT05736640|Denosumab|denosumab|mesh-list
153860727|NCT05736640|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153860728|NCT05736640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153860729|NCT05728294|Ropivacaine|ropivacaine|mesh-list
153860730|NCT05728294|Anesthetics, Local|anesthetics, local|mesh-ancestor
153860731|NCT05728294|Anesthetics|anesthetics|mesh-ancestor
153860732|NCT05728294|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153860745|NCT05564221|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153401047|NCT02382848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153401048|NCT02382848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153401050|NCT02065687|Paclitaxel|paclitaxel|mesh-list
153401051|NCT02065687|Carboplatin|carboplatin|mesh-list
153401052|NCT02065687|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
153401053|NCT02065687|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153401054|NCT02065687|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153401055|NCT02065687|Tubulin Modulators|tubulin modulators|mesh-ancestor
153860756|NCT05410301|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153860757|NCT05410301|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153860758|NCT05410301|Growth Substances|growth substances|mesh-ancestor
153860759|NCT05410301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153860760|NCT05410301|Growth Inhibitors|growth inhibitors|mesh-ancestor
153860761|NCT05410301|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153860762|NCT05410301|Alkylating Agents|alkylating agents|mesh-ancestor
153860763|NCT05410301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153860764|NCT05297578|Vaccines|vaccines|mesh-list
153860765|NCT05297578|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
153860766|NCT05297578|Immunologic Factors|immunologic factors|mesh-ancestor
153860767|NCT05297578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153860768|NCT05065294|Psilocybin|psilocybin|mesh-list
153860769|NCT05065294|N,N-Dimethyltryptamine|n,n-dimethyltryptamine|mesh-list
153860770|NCT05065294|Hallucinogens|hallucinogens|mesh-ancestor
153860771|NCT05065294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153860772|NCT05065294|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153860773|NCT05065294|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153401077|NCT04736927|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153401078|NCT04736927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153401079|NCT04736927|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153401080|NCT04736927|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153401081|NCT04736927|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153401082|NCT04736927|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153401083|NCT04736927|Anesthetics, General|anesthetics, general|mesh-ancestor
153401084|NCT04736927|Anesthetics|anesthetics|mesh-ancestor
153401085|NCT04736927|GABA Modulators|gaba modulators|mesh-ancestor
153401086|NCT04736927|GABA Agents|gaba agents|mesh-ancestor
153401103|NCT03810703|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
153401105|NCT02389088|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153401106|NCT02389088|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
153860798|NCT04968899|Dexamethasone|dexamethasone|mesh-list
153860799|NCT04968899|Immunoglobulins|immunoglobulins|mesh-list
153860800|NCT04968899|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
153882835|NCT02270424|Fluticasone|fluticasone|mesh-list
153860801|NCT04968899|Antibodies|antibodies|mesh-list
153860802|NCT04968899|gamma-Globulins|gamma-globulins|mesh-list
153401112|NCT02389088|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153401113|NCT02389088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153401115|NCT02068027|Analgesics|analgesics|mesh-ancestor
153401116|NCT02068027|Sensory System Agents|sensory system agents|mesh-ancestor
153401117|NCT02068027|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153401118|NCT02068027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153401119|NCT02068027|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153401130|NCT02392208|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153401131|NCT05185583|Methylphenidate|methylphenidate|mesh-list
153401132|NCT05185583|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
153401133|NCT05185583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153401134|NCT05185583|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
153401135|NCT05185583|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153401136|NCT05185583|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153401137|NCT05185583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153401138|NCT05185583|Dopamine Agents|dopamine agents|mesh-ancestor
153401139|NCT05185583|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153401140|NCT04645121|Carbon Monoxide|carbon monoxide|mesh-list
153401141|NCT04645121|Antimetabolites|antimetabolites|mesh-ancestor
153401142|NCT04645121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153401143|NCT04645121|Gasotransmitters|gasotransmitters|mesh-ancestor
153401144|NCT04645121|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153401145|NCT04645121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153401146|NCT02392286|Prednisone|prednisone|mesh-list
153401147|NCT02392286|Methylprednisolone|methylprednisolone|mesh-list
153401148|NCT02392286|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153401149|NCT02392286|Glucocorticoids|glucocorticoids|mesh-ancestor
153401150|NCT02392286|Hormones|hormones|mesh-ancestor
153401151|NCT02392286|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153401152|NCT02392286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153401153|NCT02392286|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153401154|NCT02392286|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153401155|NCT02392286|Antiemetics|antiemetics|mesh-ancestor
153401156|NCT02392286|Autonomic Agents|autonomic agents|mesh-ancestor
153401158|NCT02392286|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153401159|NCT02392286|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
153401160|NCT02392286|Protective Agents|protective agents|mesh-ancestor
153401162|NCT04586153|Antiviral Agents|antiviral agents|mesh-ancestor
153401163|NCT04586153|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153401165|NCT02393378|Adalimumab|adalimumab|mesh-list
153401166|NCT02393378|Methotrexate|methotrexate|mesh-list
153401167|NCT02393378|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
153401168|NCT02393378|Abortifacient Agents|abortifacient agents|mesh-ancestor
153401169|NCT02393378|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153401170|NCT02393378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153401171|NCT02393378|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153401191|NCT04949477|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153401192|NCT04949477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153401194|NCT04949477|Analgesics|analgesics|mesh-ancestor
153401195|NCT04949477|Sensory System Agents|sensory system agents|mesh-ancestor
153401196|NCT04949477|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153401197|NCT04949477|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
153401198|NCT04949477|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153401199|NCT04949477|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153401200|NCT04949477|Adrenergic Agents|adrenergic agents|mesh-ancestor
153401201|NCT04949477|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153401202|NCT04949477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153401203|NCT04949477|Antipyretics|antipyretics|mesh-ancestor
153860871|NCT04813653|Dermatologic Agents|dermatologic agents|mesh-ancestor
153860882|NCT04790474|Ixazomib|ixazomib|mesh-list
153860883|NCT04790474|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153382375|NCT01992185|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
153382376|NCT01992185|Protective Agents|protective agents|mesh-ancestor
153882855|NCT02270424|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153860884|NCT04790474|Antiemetics|antiemetics|mesh-ancestor
153860885|NCT04790474|Autonomic Agents|autonomic agents|mesh-ancestor
153860886|NCT04790474|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153860887|NCT04790474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153860888|NCT04790474|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153860889|NCT04790474|Glucocorticoids|glucocorticoids|mesh-ancestor
153860890|NCT04790474|Hormones|hormones|mesh-ancestor
153860891|NCT04790474|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153860892|NCT04790474|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153860893|NCT04790474|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153860894|NCT04790474|Immunologic Factors|immunologic factors|mesh-ancestor
153860895|NCT04790474|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153860896|NCT04790474|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153860897|NCT04790474|Growth Substances|growth substances|mesh-ancestor
153860898|NCT04790474|Growth Inhibitors|growth inhibitors|mesh-ancestor
153860899|NCT04790474|Protease Inhibitors|protease inhibitors|mesh-ancestor
153401205|NCT05717582|Hormones|hormones|mesh-ancestor
153401206|NCT05717582|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153401207|NCT05717582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153401208|NCT03101033|Betamethasone|betamethasone|mesh-list
153401209|NCT03101033|Betamethasone Valerate|betamethasone valerate|mesh-list
153401210|NCT03101033|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
153401211|NCT03101033|Betamethasone benzoate|betamethasone benzoate|mesh-list
153401212|NCT03101033|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
153401213|NCT03101033|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153401214|NCT03101033|Glucocorticoids|glucocorticoids|mesh-ancestor
153401215|NCT03101033|Hormones|hormones|mesh-ancestor
153401216|NCT03101033|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153401217|NCT03101033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153401218|NCT03101033|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153401219|NCT03101033|Respiratory System Agents|respiratory system agents|mesh-ancestor
153401220|NCT02069041|Leucovorin|leucovorin|mesh-list
153401221|NCT02069041|Fluorouracil|fluorouracil|mesh-list
153401222|NCT02069041|Oxaliplatin|oxaliplatin|mesh-list
153860906|NCT04743570|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153860907|NCT04718025|Aspirin|aspirin|mesh-list
153860908|NCT04718025|Ticagrelor|ticagrelor|mesh-list
153860909|NCT04718025|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153860910|NCT04718025|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153860911|NCT04718025|Analgesics|analgesics|mesh-ancestor
153860912|NCT04718025|Sensory System Agents|sensory system agents|mesh-ancestor
153860913|NCT04718025|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153860914|NCT04718025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153860915|NCT04718025|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153860917|NCT04718025|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153860918|NCT04718025|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153860919|NCT04718025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153860920|NCT04718025|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153860921|NCT04718025|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153860922|NCT04718025|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153860924|NCT04718025|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
153860925|NCT04718025|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
153860926|NCT04718025|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
153860927|NCT04718025|Purinergic Agents|purinergic agents|mesh-ancestor
153860928|NCT04718025|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153860929|NCT04666948|Vancomycin|vancomycin|mesh-list
153860930|NCT04666948|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153401238|NCT02069041|Growth Substances|growth substances|mesh-ancestor
153401239|NCT02069041|Growth Inhibitors|growth inhibitors|mesh-ancestor
153401240|NCT03101111|Vaccines|vaccines|mesh-list
153401241|NCT03101111|Immunologic Factors|immunologic factors|mesh-ancestor
153401242|NCT03101111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153401243|NCT05423834|Tenofovir|tenofovir|mesh-list
153882856|NCT02270424|Sympathomimetics|sympathomimetics|mesh-ancestor
153882857|NCT01686347|Ropivacaine|ropivacaine|mesh-list
153882858|NCT01686347|Anesthetics, Local|anesthetics, local|mesh-ancestor
153882859|NCT01686347|Anesthetics|anesthetics|mesh-ancestor
153882860|NCT01686347|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153882861|NCT01686347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153423766|NCT02136576|Protective Agents|protective agents|mesh-ancestor
153423767|NCT02136576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153423768|NCT02136576|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
153401244|NCT05423834|Entecavir|entecavir|mesh-list
153401245|NCT05423834|Antiviral Agents|antiviral agents|mesh-ancestor
153401246|NCT05423834|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153860955|NCT04557189|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153860956|NCT04557189|Serotonin Agents|serotonin agents|mesh-ancestor
153860957|NCT04557189|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153860958|NCT04557189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153860959|NCT04530838|Vaccines|vaccines|mesh-list
153860960|NCT04530838|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
153860961|NCT04530838|Immunologic Factors|immunologic factors|mesh-ancestor
153401273|NCT00355862|Immunologic Factors|immunologic factors|mesh-ancestor
153401284|NCT00355862|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153401285|NCT00355862|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153401286|NCT00355862|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153401287|NCT00355862|Glucocorticoids|glucocorticoids|mesh-ancestor
153401288|NCT00355862|Hormones|hormones|mesh-ancestor
153861006|NCT04129086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153861008|NCT04000555|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153861009|NCT04000555|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153861010|NCT03994393|Durvalumab|durvalumab|mesh-list
153861011|NCT03994393|Tremelimumab|tremelimumab|mesh-list
153861012|NCT03994393|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153861013|NCT03994393|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153401353|NCT03286829|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
153861029|NCT03762018|Carboplatin|carboplatin|mesh-list
153861030|NCT03762018|Pemetrexed|pemetrexed|mesh-list
153861031|NCT03762018|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153861032|NCT03762018|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153861033|NCT03762018|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153861034|NCT03762018|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153861035|NCT03762018|Growth Substances|growth substances|mesh-ancestor
153861036|NCT03762018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153861037|NCT03762018|Growth Inhibitors|growth inhibitors|mesh-ancestor
153861074|NCT03313544|Nivolumab|nivolumab|mesh-list
153861075|NCT03313544|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153861076|NCT03313544|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153861077|NCT03313544|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153861078|NCT03313544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153861079|NCT03251859|Ticagrelor|ticagrelor|mesh-list
153861080|NCT03251859|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153861081|NCT03251859|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
153861082|NCT03251859|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
153861083|NCT03251859|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
153861084|NCT03251859|Purinergic Agents|purinergic agents|mesh-ancestor
153861085|NCT03251859|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153861086|NCT03251859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153861087|NCT03251859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153861088|NCT02918409|Tobramycin|tobramycin|mesh-list
153861089|NCT02918409|Colistin|colistin|mesh-list
153861090|NCT02918409|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153861091|NCT02918409|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153861092|NCT02859792|Riluzole|riluzole|mesh-list
153861093|NCT02859792|Anticonvulsants|anticonvulsants|mesh-ancestor
153861098|NCT02859792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153861100|NCT02859792|Protective Agents|protective agents|mesh-ancestor
153861101|NCT02774005|Idebenone|idebenone|mesh-list
153861102|NCT02774005|Antioxidants|antioxidants|mesh-ancestor
153861103|NCT02774005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153861104|NCT02774005|Protective Agents|protective agents|mesh-ancestor
153861105|NCT02774005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153861106|NCT02700828|Hydrocortisone|hydrocortisone|mesh-list
153861107|NCT02700828|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
153861108|NCT02700828|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153861109|NCT02695771|Gemcitabine|gemcitabine|mesh-list
153861110|NCT02695771|Mitomycins|mitomycins|mesh-list
153861111|NCT02695771|Mitomycin|mitomycin|mesh-list
153861112|NCT02695771|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153861113|NCT02695771|Antimetabolites|antimetabolites|mesh-ancestor
153861114|NCT02695771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153861115|NCT02695771|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153401432|NCT03296345|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153401433|NCT03296345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153401434|NCT03296345|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
153401435|NCT03296345|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153401436|NCT03296345|Anesthetics, General|anesthetics, general|mesh-ancestor
153861141|NCT01669915|Vitamin D|vitamin d|mesh-list
153861142|NCT01669915|Ergocalciferols|ergocalciferols|mesh-list
153861143|NCT01669915|Cholecalciferol|cholecalciferol|mesh-list
153861144|NCT01669915|Vitamins|vitamins|mesh-list
153861145|NCT01669915|Micronutrients|micronutrients|mesh-ancestor
153861146|NCT01669915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153861147|NCT01669915|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153861148|NCT01669915|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153861149|NCT01653223|Simvastatin|simvastatin|mesh-list
153861150|NCT01653223|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153861151|NCT01653223|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153861152|NCT01653223|Antimetabolites|antimetabolites|mesh-ancestor
153861153|NCT01653223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153861154|NCT01653223|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153861155|NCT01653223|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
153861158|NCT01549587|Cetylpyridinium|cetylpyridinium|mesh-list
153861159|NCT01549587|Fluorides|fluorides|mesh-list
153861160|NCT01549587|Sodium Fluoride|sodium fluoride|mesh-list
153861161|NCT01549587|Tin Fluorides|tin fluorides|mesh-list
153861162|NCT01549587|Cariostatic Agents|cariostatic agents|mesh-ancestor
153861163|NCT01549587|Protective Agents|protective agents|mesh-ancestor
153861164|NCT01549587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153861165|NCT01549587|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
153861166|NCT01549587|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153861167|NCT01047540|Pritelivir|pritelivir|mesh-list
153861168|NCT01047540|Antiviral Agents|antiviral agents|mesh-ancestor
153861169|NCT01047540|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153861170|NCT01047540|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153861171|NCT01047540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153401484|NCT04736381|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153861189|NCT00521222|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153401501|NCT02769611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153401503|NCT04525820|Ergocalciferols|ergocalciferols|mesh-list
153401504|NCT04525820|Cholecalciferol|cholecalciferol|mesh-list
153401505|NCT04525820|Vitamins|vitamins|mesh-list
153401506|NCT04525820|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
153401507|NCT04525820|Micronutrients|micronutrients|mesh-ancestor
153401508|NCT04525820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153401509|NCT04525820|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153401510|NCT04525820|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153401511|NCT03305159|Chlorhexidine|chlorhexidine|mesh-list
153401512|NCT03305159|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
153401513|NCT03305159|Povidone-Iodine|povidone-iodine|mesh-list
153401514|NCT03305159|Povidone|povidone|mesh-list
153401515|NCT03305159|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
153401516|NCT03305159|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153401531|NCT00356252|Antioxidants|antioxidants|mesh-ancestor
153401532|NCT00356252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153861190|NCT00521222|Adrenergic Agents|adrenergic agents|mesh-ancestor
153861191|NCT00521222|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153861192|NCT00521222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153861193|NCT00521222|Tocolytic Agents|tocolytic agents|mesh-ancestor
153861194|NCT00521222|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153861195|NCT00521222|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
153861196|NCT00521222|Cholinergic Agents|cholinergic agents|mesh-ancestor
153401548|NCT02342197|Luteolytic Agents|luteolytic agents|mesh-ancestor
153401549|NCT02342197|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
153401550|NCT02342197|Contraceptive Agents|contraceptive agents|mesh-ancestor
153401551|NCT02342197|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153401552|NCT02342197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153401553|NCT02342197|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
153401554|NCT02342197|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153861231|NCT03456401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153861254|NCT00545558|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
153861255|NCT00545558|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
153861256|NCT00545558|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
153861257|NCT00545558|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
153861258|NCT04684667|Propranolol|propranolol|mesh-list
153401574|NCT02344225|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
153401575|NCT02344225|Purinergic Agents|purinergic agents|mesh-ancestor
153401576|NCT02344225|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153401577|NCT04319588|Anesthetics|anesthetics|mesh-list
153401578|NCT04319588|Anesthetics, Local|anesthetics, local|mesh-list
153401579|NCT04319588|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153401580|NCT04319588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153401594|NCT03319277|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153401596|NCT03319277|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153401597|NCT03319277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153401598|NCT03319277|Analgesics|analgesics|mesh-ancestor
153401599|NCT03319277|Sensory System Agents|sensory system agents|mesh-ancestor
153401600|NCT03319277|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153401601|NCT04624295|Aspirin|aspirin|mesh-list
153401602|NCT04624295|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153401632|NCT02352259|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153401633|NCT03326999|Bupivacaine|bupivacaine|mesh-list
153401634|NCT03326999|Anesthetics, Local|anesthetics, local|mesh-ancestor
153401635|NCT03326999|Anesthetics|anesthetics|mesh-ancestor
153401645|NCT00356720|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153401647|NCT04121780|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153401648|NCT04121780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153401676|NCT05993858|Cetuximab|cetuximab|mesh-list
153401677|NCT05993858|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153401678|NCT05993858|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153401679|NCT05993767|Tenofovir|tenofovir|mesh-list
153401680|NCT05993767|Emtricitabine|emtricitabine|mesh-list
153401681|NCT05993767|Dolutegravir|dolutegravir|mesh-list
153401682|NCT05993767|Antiviral Agents|antiviral agents|mesh-ancestor
153861353|NCT00546494|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
153861354|NCT00546494|Antidepressive Agents|antidepressive agents|mesh-ancestor
153861356|NCT00546533|Etanercept|etanercept|mesh-list
153861357|NCT00546533|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153861358|NCT00546533|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153861359|NCT00546533|Analgesics|analgesics|mesh-ancestor
153861360|NCT00546533|Sensory System Agents|sensory system agents|mesh-ancestor
153861361|NCT00546533|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153861362|NCT00546533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153861363|NCT00546533|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153401687|NCT05993767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153401688|NCT05993767|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153401689|NCT05993767|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153401701|NCT05993299|Immunologic Factors|immunologic factors|mesh-ancestor
153401702|NCT05993299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153401703|NCT05993299|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153401704|NCT05993299|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153401705|NCT05993299|Alkylating Agents|alkylating agents|mesh-ancestor
153401706|NCT05993299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153401707|NCT05993299|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153861373|NCT00558480|Antioxidants|antioxidants|mesh-ancestor
153861374|NCT00558480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153861393|NCT00546923|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
153861396|NCT00547001|Estradiol|estradiol|mesh-list
153861397|NCT00547001|Estrogens|estrogens|mesh-ancestor
153861398|NCT00547001|Hormones|hormones|mesh-ancestor
153861399|NCT00547001|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153861400|NCT00547001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153861401|NCT00547352|Sildenafil Citrate|sildenafil citrate|mesh-list
153861402|NCT00547352|Tadalafil|tadalafil|mesh-list
153888600|NCT01313273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153888601|NCT01313273|Protective Agents|protective agents|mesh-ancestor
153888602|NCT01313273|Vitamins|vitamins|mesh-ancestor
153888603|NCT01313273|Micronutrients|micronutrients|mesh-ancestor
153888604|NCT01313273|Estrogens|estrogens|mesh-ancestor
153888605|NCT01313273|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153888609|NCT01091974|Modafinil|modafinil|mesh-list
153861432|NCT00547547|Antioxidants|antioxidants|mesh-ancestor
153861433|NCT00547547|Protective Agents|protective agents|mesh-ancestor
153861434|NCT00547547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153401759|NCT05992220|Growth Inhibitors|growth inhibitors|mesh-ancestor
153401760|NCT05992220|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153401761|NCT05992220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153401778|NCT05990894|Antiemetics|antiemetics|mesh-ancestor
153861437|NCT00547625|Tadalafil|tadalafil|mesh-list
153861438|NCT00547625|Vasodilator Agents|vasodilator agents|mesh-ancestor
153861446|NCT00547664|Narcotics|narcotics|mesh-ancestor
153861447|NCT00547664|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153861448|NCT00547664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153861449|NCT00547664|Analgesics|analgesics|mesh-ancestor
153401785|NCT05990894|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153401786|NCT05990894|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
153401787|NCT05990894|Protective Agents|protective agents|mesh-ancestor
153401788|NCT05990894|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153401789|NCT05990894|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153401790|NCT05989386|Povidone-Iodine|povidone-iodine|mesh-list
153401791|NCT05989386|Povidone|povidone|mesh-list
153401792|NCT05989386|Plasma Substitutes|plasma substitutes|mesh-ancestor
153401793|NCT05989386|Blood Substitutes|blood substitutes|mesh-ancestor
153861456|NCT00560430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153861457|NCT00560547|Epoetin Alfa|epoetin alfa|mesh-list
153861458|NCT00560547|Hematinics|hematinics|mesh-ancestor
153861459|NCT04636125|Doxycycline|doxycycline|mesh-list
153861460|NCT04636125|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153861461|NCT04636125|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153861462|NCT04636125|Antimalarials|antimalarials|mesh-ancestor
153861463|NCT04636125|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153861464|NCT04636125|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153861465|NCT04636242|Aminolevulinic Acid|aminolevulinic acid|mesh-list
153861466|NCT04636242|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
153861467|NCT04636242|Dermatologic Agents|dermatologic agents|mesh-ancestor
153861468|NCT00548288|Pamidronate|pamidronate|mesh-list
153888615|NCT01091974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153888616|NCT01313117|Thioctic Acid|thioctic acid|mesh-list
153888617|NCT01313117|Antioxidants|antioxidants|mesh-ancestor
153888618|NCT01313117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153888619|NCT01313117|Protective Agents|protective agents|mesh-ancestor
153888620|NCT01313117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153888621|NCT01313117|Vitamin B Complex|vitamin b complex|mesh-ancestor
153888622|NCT01313117|Vitamins|vitamins|mesh-ancestor
153888623|NCT01313117|Micronutrients|micronutrients|mesh-ancestor
153888624|NCT01091662|Eslicarbazepine acetate|eslicarbazepine acetate|mesh-list
153861469|NCT00548288|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153861470|NCT00548288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153861472|NCT04644354|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153861473|NCT04644354|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153401799|NCT05988788|Disinfectants|disinfectants|mesh-ancestor
153401800|NCT05988788|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153401801|NCT05988788|Antioxidants|antioxidants|mesh-ancestor
153401802|NCT05988788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153401803|NCT05988788|Protective Agents|protective agents|mesh-ancestor
153888625|NCT01091662|Anticonvulsants|anticonvulsants|mesh-ancestor
153888626|NCT01091662|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
153429705|NCT00002744|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153429706|NCT00002744|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153429707|NCT00002744|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
153429708|NCT00002744|Abortifacient Agents|abortifacient agents|mesh-ancestor
153429709|NCT00002744|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153429710|NCT00002744|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153429711|NCT00002744|Antimetabolites|antimetabolites|mesh-ancestor
153429712|NCT00002744|Dermatologic Agents|dermatologic agents|mesh-ancestor
153401860|NCT05987176|Lutetium Lu 177 dotatate|lutetium lu 177 dotatate|mesh-list
153401861|NCT05987176|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
153401862|NCT05987176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153401863|NCT05986968|Aspirin|aspirin|mesh-list
153401864|NCT05986968|Ticagrelor|ticagrelor|mesh-list
153401865|NCT05986968|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153401866|NCT05986968|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153401867|NCT05986968|Analgesics|analgesics|mesh-ancestor
153401868|NCT05986968|Sensory System Agents|sensory system agents|mesh-ancestor
153401869|NCT05986968|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153401870|NCT05986968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153401872|NCT05986968|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153861530|NCT00548678|Sensory System Agents|sensory system agents|mesh-ancestor
153861531|NCT00548678|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153861532|NCT00548678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153861533|NCT00548678|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153861534|NCT00548678|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153861535|NCT00548678|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153861536|NCT00548678|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153861537|NCT00548678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153861538|NCT00548678|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153861539|NCT00548678|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153861540|NCT00548678|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153861542|NCT00548834|Certolizumab Pegol|certolizumab pegol|mesh-list
153861543|NCT00548834|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
153861544|NCT00548834|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153861545|NCT00548834|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153861546|NCT00548834|Immunologic Factors|immunologic factors|mesh-ancestor
153861547|NCT00548834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153861548|NCT00548834|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153861549|NCT04684199|Melatonin|melatonin|mesh-list
153401977|NCT05970380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153401978|NCT05969756|Fluorides|fluorides|mesh-list
153401979|NCT05969756|Fluorides, Topical|fluorides, topical|mesh-list
153401980|NCT05969756|Cariostatic Agents|cariostatic agents|mesh-ancestor
153401981|NCT05969756|Protective Agents|protective agents|mesh-ancestor
153401982|NCT05969756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153401983|NCT05955222|Polymethyl Methacrylate|polymethyl methacrylate|mesh-list
153401984|NCT05955222|Vasodilator Agents|vasodilator agents|mesh-ancestor
153401985|NCT05955222|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
153401986|NCT05955222|Protective Agents|protective agents|mesh-ancestor
153401987|NCT05955222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153401988|NCT05916287|Antihypertensive Agents|antihypertensive agents|mesh-list
153401989|NCT05911594|Solifenacin Succinate|solifenacin succinate|mesh-list
153861641|NCT04643691|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
153861642|NCT04643691|Diuretics|diuretics|mesh-ancestor
153861643|NCT04643691|Natriuretic Agents|natriuretic agents|mesh-ancestor
153861644|NCT03455972|Immunomodulating Agents|immunomodulating agents|mesh-list
153861645|NCT03455972|Immunologic Factors|immunologic factors|mesh-ancestor
153861646|NCT03455972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153861647|NCT00549536|Calcium, Dietary|calcium, dietary|mesh-list
153861648|NCT00549536|Calcium|calcium|mesh-list
153861649|NCT00549536|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153861650|NCT00549536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153861651|NCT00549536|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153861652|NCT00549614|Acipimox|acipimox|mesh-list
153861653|NCT00549614|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153861654|NCT00549614|Antimetabolites|antimetabolites|mesh-ancestor
153861655|NCT00549614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153401991|NCT05911594|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
153401992|NCT05911594|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
153401993|NCT05911594|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153401994|NCT05911594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153401995|NCT05911594|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
153401996|NCT05911594|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153401997|NCT05911594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153401998|NCT05911594|Cholinergic Agents|cholinergic agents|mesh-ancestor
153401999|NCT05911594|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153402000|NCT05911594|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
153402052|NCT05840861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153402053|NCT05840861|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153429713|NCT00002744|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153429714|NCT00002744|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153861700|NCT00550160|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153429715|NCT00002744|Antiviral Agents|antiviral agents|mesh-ancestor
153429716|NCT00002744|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153429718|NCT00002744|Tubulin Modulators|tubulin modulators|mesh-ancestor
153861717|NCT04643301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153402054|NCT05840861|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
153402055|NCT05840861|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153402079|NCT05814640|Sertraline|sertraline|mesh-list
153402080|NCT05814640|Fluoxetine|fluoxetine|mesh-list
153402081|NCT05814640|Antiemetics|antiemetics|mesh-ancestor
153402082|NCT05814640|Autonomic Agents|autonomic agents|mesh-ancestor
153402083|NCT05814640|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153402084|NCT05814640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153861722|NCT00550433|Estrogens|estrogens|mesh-list
153861723|NCT00550433|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
153861724|NCT00550433|Hormones|hormones|mesh-ancestor
153861725|NCT00550433|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153861726|NCT00550433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153861727|NCT00550433|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
153861728|NCT00550433|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
153861729|NCT00550433|Hormone Antagonists|hormone antagonists|mesh-ancestor
153861730|NCT00550433|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153861731|NCT04642989|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
153861732|NCT04642989|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153861733|NCT04634058|Antibodies|antibodies|mesh-list
153861734|NCT04634058|Immunoglobulins|immunoglobulins|mesh-list
153861735|NCT04634058|Immunologic Factors|immunologic factors|mesh-ancestor
153861736|NCT04634058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153861737|NCT00550628|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
153861738|NCT00550628|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
153861739|NCT00550628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153861740|NCT00560820|Deferasirox|deferasirox|mesh-list
153861741|NCT00560820|Iron Chelating Agents|iron chelating agents|mesh-ancestor
153861742|NCT00560820|Chelating Agents|chelating agents|mesh-ancestor
153861743|NCT00560820|Sequestering Agents|sequestering agents|mesh-ancestor
153861744|NCT00560820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153861745|NCT00550784|Paclitaxel|paclitaxel|mesh-list
153861746|NCT00550784|Cyclophosphamide|cyclophosphamide|mesh-list
153861747|NCT00550784|Melphalan|melphalan|mesh-list
153861748|NCT00550784|Topotecan|topotecan|mesh-list
153861749|NCT00550784|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153402105|NCT05814640|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
153402106|NCT05814640|Analgesics|analgesics|mesh-ancestor
153402107|NCT05814640|Sensory System Agents|sensory system agents|mesh-ancestor
153402108|NCT05814640|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
153402109|NCT05814640|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
153429722|NCT00002744|Micronutrients|micronutrients|mesh-ancestor
153429723|NCT01788475|Dexamethasone|dexamethasone|mesh-list
153429724|NCT01788475|Dexamethasone acetate|dexamethasone acetate|mesh-list
153429726|NCT01788475|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153429727|NCT01788475|Antiemetics|antiemetics|mesh-ancestor
153429728|NCT01788475|Autonomic Agents|autonomic agents|mesh-ancestor
153429729|NCT01788475|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153429730|NCT01788475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153861864|NCT04640181|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
153402196|NCT05692960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153402197|NCT05661955|Tislelizumab|tislelizumab|mesh-list
153402198|NCT05661955|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153402199|NCT05661955|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153402200|NCT05646082|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
153861868|NCT04640181|Anticoagulants|anticoagulants|mesh-ancestor
153861869|NCT04640181|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153861870|NCT04640181|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153861871|NCT00559455|Leucovorin|leucovorin|mesh-list
153861872|NCT00559455|Fluorouracil|fluorouracil|mesh-list
153861873|NCT00559455|Oxaliplatin|oxaliplatin|mesh-list
153861874|NCT00559455|Antimetabolites|antimetabolites|mesh-ancestor
153861875|NCT00559455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153861876|NCT00559455|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153861877|NCT00559455|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153402207|NCT05621811|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
153402208|NCT05621811|Serotonin Agents|serotonin agents|mesh-ancestor
153402209|NCT05621811|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153402210|NCT05621811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153402211|NCT05621811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153402212|NCT05603429|Antioxidants|antioxidants|mesh-list
153402213|NCT05603429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153402214|NCT05603429|Protective Agents|protective agents|mesh-ancestor
153402215|NCT05603429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153402216|NCT05586776|Chlorhexidine|chlorhexidine|mesh-list
153402217|NCT05586776|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
153402218|NCT05586776|Anti-Infective Agents, Local|anti-infective agents, local|mesh-list
153402219|NCT05586776|Mupirocin|mupirocin|mesh-list
153861903|NCT05186675|Respiratory System Agents|respiratory system agents|mesh-ancestor
153861905|NCT05186675|Sympathomimetics|sympathomimetics|mesh-ancestor
153861906|NCT05186675|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
153402236|NCT05576207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153402237|NCT05543850|Pancrelipase|pancrelipase|mesh-list
153402238|NCT05543850|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153861926|NCT00559689|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153861927|NCT00559689|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153402257|NCT05520138|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153402258|NCT05520138|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153402259|NCT05520138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153888641|NCT01312961|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153888642|NCT01312961|Respiratory System Agents|respiratory system agents|mesh-ancestor
153888643|NCT01312961|Dermatologic Agents|dermatologic agents|mesh-ancestor
153402260|NCT05520138|Hormone Antagonists|hormone antagonists|mesh-ancestor
153888644|NCT01312961|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
153888645|NCT01312961|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
153402261|NCT05520138|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153402262|NCT05520138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153888646|NCT01312961|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
153402277|NCT05510427|Growth Substances|growth substances|mesh-ancestor
153402278|NCT05510427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153402279|NCT05510427|Growth Inhibitors|growth inhibitors|mesh-ancestor
153402280|NCT05510427|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153402281|NCT05510427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153402282|NCT05505292|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
153402283|NCT05505292|Lifitegrast|lifitegrast|mesh-list
153888650|NCT01312961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153888651|NCT01312961|Tocolytic Agents|tocolytic agents|mesh-ancestor
153429731|NCT01788475|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153429732|NCT01788475|Glucocorticoids|glucocorticoids|mesh-ancestor
153402351|NCT05414240|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153402352|NCT05414240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153402353|NCT05414240|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153402354|NCT05414240|Vasodilator Agents|vasodilator agents|mesh-ancestor
153402355|NCT05401227|Ketamine|ketamine|mesh-list
153862003|NCT04628676|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153862004|NCT04628676|Adrenergic Agents|adrenergic agents|mesh-ancestor
153862005|NCT04628676|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153862006|NCT04628676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153862007|NCT04628676|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
153862008|NCT04628676|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153862009|NCT04628676|Autonomic Agents|autonomic agents|mesh-ancestor
153862010|NCT04628676|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153862011|NCT04628676|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153862012|NCT04628676|Respiratory System Agents|respiratory system agents|mesh-ancestor
153862014|NCT04628676|Sympathomimetics|sympathomimetics|mesh-ancestor
153862015|NCT04628676|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
153862016|NCT04628676|Antidepressive Agents|antidepressive agents|mesh-ancestor
153862017|NCT04628676|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153862018|NCT04628676|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
153862019|NCT04628676|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153862020|NCT04628676|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153862021|NCT04628676|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153862022|NCT04628676|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153862023|NCT04628325|Furosemide|furosemide|mesh-list
153862024|NCT04628325|Diuretics|diuretics|mesh-ancestor
153862025|NCT04628325|Natriuretic Agents|natriuretic agents|mesh-ancestor
153402358|NCT05401227|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153402359|NCT05401227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153402360|NCT05401227|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
153402361|NCT05401227|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153402362|NCT05401227|Anesthetics, General|anesthetics, general|mesh-ancestor
153402363|NCT05401227|Anesthetics|anesthetics|mesh-ancestor
153402364|NCT05401227|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153402365|NCT05401227|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
153402366|NCT05401227|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
153402367|NCT05401227|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153402368|NCT05401227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153402369|NCT05398653|Cyclosporine|cyclosporine|mesh-list
153402370|NCT05398653|Cyclosporins|cyclosporins|mesh-list
153402371|NCT05398653|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153402372|NCT05398653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153862027|NCT04628325|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
153862028|NCT04628325|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153862029|NCT04628325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153862030|NCT04657497|Camostat|camostat|mesh-list
153862031|NCT04657497|Protease Inhibitors|protease inhibitors|mesh-ancestor
153862032|NCT04657497|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153862033|NCT04657497|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153862034|NCT04657497|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
153402388|NCT05378555|Anesthetics, General|anesthetics, general|mesh-ancestor
153862060|NCT01214044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153862061|NCT01214044|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
153862062|NCT01214044|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
153862063|NCT01214044|Parasympatholytics|parasympatholytics|mesh-ancestor
153862064|NCT01214044|Autonomic Agents|autonomic agents|mesh-ancestor
153862065|NCT01214044|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153862066|NCT01214044|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
153862067|NCT01214044|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
153862068|NCT01214044|Cholinergic Agents|cholinergic agents|mesh-ancestor
153402403|NCT05319756|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153402405|NCT05319756|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153402406|NCT05319756|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153402407|NCT05319756|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153402408|NCT05319756|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
153402409|NCT05319756|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
153402410|NCT05319756|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153402411|NCT05319756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153402412|NCT05319756|Antimanic Agents|antimanic agents|mesh-ancestor
153402413|NCT05308901|Pembrolizumab|pembrolizumab|mesh-list
153402415|NCT05308901|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153402416|NCT05308901|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153402435|NCT05280340|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153402437|NCT05273567|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153402438|NCT05273567|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
153402439|NCT05273567|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153402440|NCT05273567|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153402441|NCT05273567|Adrenergic Agents|adrenergic agents|mesh-ancestor
153402442|NCT05273567|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153402443|NCT05273567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153402444|NCT05273567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153402445|NCT05266729|Polyene phosphatidylcholine|polyene phosphatidylcholine|mesh-list
153402446|NCT05266729|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153429737|NCT01788475|Protease Inhibitors|protease inhibitors|mesh-ancestor
153429738|NCT01788475|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153429739|NCT01788475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153862109|NCT00561717|Dermatologic Agents|dermatologic agents|mesh-ancestor
153862110|NCT00561717|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153862111|NCT00561717|Autonomic Agents|autonomic agents|mesh-ancestor
153862112|NCT00561717|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153402447|NCT05266729|Antimetabolites|antimetabolites|mesh-ancestor
153402448|NCT05266729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153402449|NCT05266729|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153402450|NCT05257018|Doxorubicin|doxorubicin|mesh-list
153402451|NCT05257018|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153402452|NCT05257018|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153402453|NCT05257018|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153402454|NCT05257018|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153402455|NCT05257018|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153402456|NCT05257018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153402457|NCT05243862|Atezolizumab|atezolizumab|mesh-list
153402458|NCT05243862|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153402459|NCT05243862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153402460|NCT05243862|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153402461|NCT05243862|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153402462|NCT05227196|Semaglutide|semaglutide|mesh-list
153402463|NCT05227196|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
153402464|NCT05227196|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153402465|NCT05227196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153402467|NCT05186779|Hormones|hormones|mesh-ancestor
153402470|NCT05177146|Ketamine|ketamine|mesh-list
153862125|NCT04683146|Disinfectants|disinfectants|mesh-ancestor
153862126|NCT04683146|Dermatologic Agents|dermatologic agents|mesh-ancestor
153862127|NCT04683146|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
153862128|NCT04683146|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
153862129|NCT04683146|Adrenergic Agents|adrenergic agents|mesh-ancestor
153862130|NCT04683146|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153862142|NCT04800302|Sensory System Agents|sensory system agents|mesh-ancestor
153862143|NCT04800302|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153862144|NCT04711304|Hyaluronic Acid|hyaluronic acid|mesh-list
153402479|NCT05177146|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153402480|NCT05177146|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
153402481|NCT05177146|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
153402482|NCT05177146|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153402483|NCT05177146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153402484|NCT05166421|Cilgavimab and tixagevimab drug combination|cilgavimab and tixagevimab drug combination|mesh-list
153402485|NCT05166421|Antiviral Agents|antiviral agents|mesh-ancestor
153402486|NCT05166421|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153402487|NCT05156788|Lenvatinib|lenvatinib|mesh-list
153402488|NCT05156788|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153402489|NCT05156788|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153402490|NCT05156788|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153862170|NCT04627779|Sensory System Agents|sensory system agents|mesh-ancestor
153862171|NCT04627779|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153862172|NCT04627779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153402505|NCT05152576|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
153402506|NCT05152576|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
153402507|NCT05152576|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153402508|NCT05152576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153402509|NCT05152576|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
153402510|NCT05152576|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153402511|NCT05152576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153402512|NCT05152576|Cholinergic Agents|cholinergic agents|mesh-ancestor
153402513|NCT05152576|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153402514|NCT05137938|Ketamine|ketamine|mesh-list
153402515|NCT05137938|Analgesics|analgesics|mesh-ancestor
153402516|NCT05137938|Sensory System Agents|sensory system agents|mesh-ancestor
153402517|NCT05137938|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153402518|NCT05137938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153402519|NCT05137938|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
153862189|NCT04627467|Amebicides|amebicides|mesh-ancestor
153862190|NCT04627467|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153862191|NCT04627467|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153862192|NCT04627467|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153862193|NCT04627467|Antimalarials|antimalarials|mesh-ancestor
153862194|NCT04627467|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153402548|NCT05105841|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153402549|NCT05105841|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153402550|NCT05105841|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153402551|NCT05105841|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153402552|NCT05105841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153402553|NCT05105841|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153402554|NCT05099848|Leucovorin|leucovorin|mesh-list
153402555|NCT05099848|Fluorouracil|fluorouracil|mesh-list
153862216|NCT04655040|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
153862217|NCT04655040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153862218|NCT04655040|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
153862219|NCT04655040|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153862220|NCT04655040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153862221|NCT04655040|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
153862222|NCT04655040|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
153862223|NCT04655040|Purinergic Agents|purinergic agents|mesh-ancestor
153402556|NCT05099848|Oxaliplatin|oxaliplatin|mesh-list
153402557|NCT05099848|Apatinib|apatinib|mesh-list
153402558|NCT05099848|Antimetabolites|antimetabolites|mesh-ancestor
153402559|NCT05099848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153402560|NCT05099848|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153402561|NCT05099848|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153402562|NCT05099848|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153402563|NCT05099848|Immunologic Factors|immunologic factors|mesh-ancestor
153402564|NCT05099848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153402565|NCT05099848|Antidotes|antidotes|mesh-ancestor
153402566|NCT05099848|Protective Agents|protective agents|mesh-ancestor
153402567|NCT05099848|Vitamin B Complex|vitamin b complex|mesh-ancestor
153402568|NCT05099848|Vitamins|vitamins|mesh-ancestor
153402569|NCT05099848|Micronutrients|micronutrients|mesh-ancestor
153402570|NCT05099848|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153402571|NCT05099848|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153423769|NCT02136576|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153423770|NCT03398330|Oxycodone|oxycodone|mesh-list
153402572|NCT05098327|Pioglitazone|pioglitazone|mesh-list
153402573|NCT05098327|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153402574|NCT05098327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153402575|NCT05082610|Pembrolizumab|pembrolizumab|mesh-list
153402576|NCT05082610|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153402577|NCT05082610|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153402578|NCT05082610|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153402579|NCT05082610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153402580|NCT05074589|Leucovorin|leucovorin|mesh-list
153402581|NCT05074589|Fluorouracil|fluorouracil|mesh-list
153402582|NCT05074589|Irinotecan|irinotecan|mesh-list
153862259|NCT04654416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153862260|NCT04654416|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153862262|NCT02906150|Carboplatin|carboplatin|mesh-list
153862263|NCT02906150|Pemetrexed|pemetrexed|mesh-list
153862264|NCT02906150|Thymalfasin|thymalfasin|mesh-list
153862265|NCT02906150|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153862266|NCT02906150|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153862267|NCT02906150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153402603|NCT05061654|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153402604|NCT05061654|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
153402605|NCT05061654|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153402606|NCT05061654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153402607|NCT05061654|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
153402608|NCT05060965|Nicotine|nicotine|mesh-list
153402609|NCT05060965|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
153402610|NCT05060965|Autonomic Agents|autonomic agents|mesh-ancestor
153402611|NCT05060965|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153402612|NCT05060965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153402613|NCT05060965|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
153402640|NCT05049616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153402641|NCT05049616|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153862290|NCT02905994|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153862291|NCT02905682|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
153862293|NCT02905682|Coagulants|coagulants|mesh-ancestor
153862294|NCT02905682|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
153862295|NCT02905682|Natriuretic Agents|natriuretic agents|mesh-ancestor
153862296|NCT02905682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153862297|NCT04626258|Fluconazole|fluconazole|mesh-list
153862298|NCT04626258|Antifungal Agents|antifungal agents|mesh-ancestor
153862299|NCT04626258|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153862300|NCT04626258|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
153862301|NCT04626258|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153862302|NCT04626258|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153862303|NCT04626258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153862307|NCT04626258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153402642|NCT05049616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153402643|NCT05049616|Vasodilator Agents|vasodilator agents|mesh-ancestor
153402644|NCT05049616|Tocolytic Agents|tocolytic agents|mesh-ancestor
153402645|NCT05049616|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153402646|NCT05049616|Natriuretic Agents|natriuretic agents|mesh-ancestor
153862311|NCT04626063|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-list
153862312|NCT04626063|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
153862313|NCT04626063|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153862315|NCT04626063|Sensory System Agents|sensory system agents|mesh-ancestor
153862316|NCT04626063|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153862317|NCT04626063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153862318|NCT04626063|Antipyretics|antipyretics|mesh-ancestor
153862319|NCT04626063|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153862321|NCT04625985|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153862322|NCT04625985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153862323|NCT02905760|Furosemide|furosemide|mesh-list
153862324|NCT02905760|Diuretics|diuretics|mesh-list
153862325|NCT02905760|Natriuretic Agents|natriuretic agents|mesh-ancestor
153862326|NCT02905760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153862327|NCT02905760|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
153402663|NCT05025605|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
153402664|NCT05025605|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153402665|NCT05025605|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153402666|NCT05025605|Adrenergic Agents|adrenergic agents|mesh-ancestor
153423771|NCT03398330|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153423772|NCT03398330|Narcotics|narcotics|mesh-ancestor
153423773|NCT03398330|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153423774|NCT03398330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153423775|NCT03398330|Analgesics|analgesics|mesh-ancestor
153423776|NCT03398330|Sensory System Agents|sensory system agents|mesh-ancestor
153423777|NCT03398330|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153423778|NCT00376766|Levetiracetam|levetiracetam|mesh-list
153423779|NCT00376766|Anticonvulsants|anticonvulsants|mesh-ancestor
153423780|NCT00376766|Nootropic Agents|nootropic agents|mesh-ancestor
153402667|NCT05025605|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153402668|NCT05025605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153402670|NCT05020600|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
153402671|NCT05020600|Amitriptyline|amitriptyline|mesh-list
153402672|NCT05020600|Analgesics|analgesics|mesh-ancestor
153402673|NCT05020600|Sensory System Agents|sensory system agents|mesh-ancestor
153402674|NCT05020600|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153402675|NCT05020600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153402676|NCT05020600|Anticonvulsants|anticonvulsants|mesh-ancestor
153402677|NCT05020600|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153402678|NCT05020600|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153402679|NCT05020600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153402680|NCT05020600|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153862328|NCT02905760|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153862329|NCT02905760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153862331|NCT02905526|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153862332|NCT02905526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153862333|NCT04654182|Chlorhexidine|chlorhexidine|mesh-list
153862334|NCT04654182|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
153862335|NCT04654182|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
153862336|NCT04654182|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153862337|NCT04654182|Disinfectants|disinfectants|mesh-ancestor
153862338|NCT04654182|Dermatologic Agents|dermatologic agents|mesh-ancestor
153862339|NCT04654026|Aspirin|aspirin|mesh-list
153862340|NCT04654026|Clopidogrel|clopidogrel|mesh-list
153862341|NCT04654026|Ticagrelor|ticagrelor|mesh-list
153862342|NCT04654026|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153862343|NCT04654026|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153862344|NCT04654026|Analgesics|analgesics|mesh-ancestor
153862345|NCT04654026|Sensory System Agents|sensory system agents|mesh-ancestor
153402688|NCT05020600|Antidepressive Agents|antidepressive agents|mesh-ancestor
153402689|NCT05020600|Dopamine Agents|dopamine agents|mesh-ancestor
153402690|NCT05020600|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
153402691|NCT05020600|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153402692|NCT05020600|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
153402693|NCT05020600|Adrenergic Agents|adrenergic agents|mesh-ancestor
153402694|NCT05011266|Buprenorphine|buprenorphine|mesh-list
153402695|NCT05011266|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
153402696|NCT05011266|Naloxone|naloxone|mesh-list
153402697|NCT05011266|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153402698|NCT05011266|Narcotics|narcotics|mesh-ancestor
153402699|NCT05011266|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153402700|NCT05011266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153402701|NCT05011266|Analgesics|analgesics|mesh-ancestor
153402702|NCT05011266|Sensory System Agents|sensory system agents|mesh-ancestor
153402703|NCT05011266|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153402704|NCT05011266|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
153402705|NCT05000450|Cyclophosphamide|cyclophosphamide|mesh-list
153402706|NCT05000450|Fludarabine|fludarabine|mesh-list
153402707|NCT05000450|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153402708|NCT05000450|Immunologic Factors|immunologic factors|mesh-ancestor
153402709|NCT05000450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153402710|NCT05000450|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153402711|NCT05000450|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153402712|NCT05000450|Alkylating Agents|alkylating agents|mesh-ancestor
153402713|NCT05000450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153402714|NCT05000450|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153402715|NCT05000450|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153402716|NCT04998279|Lenograstim|lenograstim|mesh-list
153402717|NCT04998279|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153402718|NCT04998279|Immunologic Factors|immunologic factors|mesh-ancestor
153402719|NCT04998279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153402720|NCT04965077|Antibodies|antibodies|mesh-list
153402721|NCT04965077|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
153402722|NCT04965077|Immunologic Factors|immunologic factors|mesh-ancestor
153862355|NCT04654026|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153862360|NCT04654026|Purinergic Agents|purinergic agents|mesh-ancestor
153862361|NCT04654026|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153862362|NCT04625595|Methyldopa|methyldopa|mesh-list
153862363|NCT04625595|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153862364|NCT04625595|Sympatholytics|sympatholytics|mesh-ancestor
153862365|NCT04625595|Autonomic Agents|autonomic agents|mesh-ancestor
153862380|NCT02905058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153862381|NCT02905058|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153862382|NCT02905058|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153862383|NCT02905058|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153862384|NCT02905058|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153862385|NCT02905058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153862386|NCT04653792|Pregabalin|pregabalin|mesh-list
153862387|NCT04653792|Analgesics|analgesics|mesh-ancestor
153402724|NCT04956120|Dialysis Solutions|dialysis solutions|mesh-list
153402725|NCT04956120|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
153402726|NCT04953962|Nivolumab|nivolumab|mesh-list
153402727|NCT04953962|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153402728|NCT04953962|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153402729|NCT04953962|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153402730|NCT04953962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153402752|NCT04927780|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153402753|NCT04927780|Antidotes|antidotes|mesh-ancestor
153402754|NCT04927780|Protective Agents|protective agents|mesh-ancestor
153402755|NCT04927780|Vitamin B Complex|vitamin b complex|mesh-ancestor
153402756|NCT04927780|Vitamins|vitamins|mesh-ancestor
153402757|NCT04927780|Micronutrients|micronutrients|mesh-ancestor
153402758|NCT04925557|Ocrelizumab|ocrelizumab|mesh-list
153862394|NCT04653792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153862395|NCT04653792|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153862396|NCT04653792|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153862397|NCT04653792|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153862398|NCT04653792|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153862399|NCT04653792|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153862400|NCT00557700|Bromides|bromides|mesh-list
153862401|NCT00557700|Tiotropium Bromide|tiotropium bromide|mesh-list
153862402|NCT00557700|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153862403|NCT00557700|Autonomic Agents|autonomic agents|mesh-ancestor
153862404|NCT00557700|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153862405|NCT00557700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153862406|NCT00557700|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153862407|NCT00557700|Respiratory System Agents|respiratory system agents|mesh-ancestor
153862408|NCT00557700|Parasympatholytics|parasympatholytics|mesh-ancestor
153862409|NCT00557700|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
153862410|NCT00557700|Cholinergic Agents|cholinergic agents|mesh-ancestor
153862411|NCT00557700|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153862412|NCT00557700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153862413|NCT00557700|Anticonvulsants|anticonvulsants|mesh-ancestor
153862414|NCT00557739|Mometasone Furoate|mometasone furoate|mesh-list
153862415|NCT00557739|Nortriptyline|nortriptyline|mesh-list
153862416|NCT00557739|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153862417|NCT00557739|Dermatologic Agents|dermatologic agents|mesh-ancestor
153862418|NCT00557739|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
153862423|NCT00557739|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153862424|NCT00557739|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153402764|NCT04871529|Carboplatin|carboplatin|mesh-list
153402765|NCT04871529|Gemcitabine|gemcitabine|mesh-list
153402766|NCT04871529|Avelumab|avelumab|mesh-list
153402767|NCT04871529|Immunoglobulins|immunoglobulins|mesh-list
153402768|NCT04871529|Immunoglobulin G|immunoglobulin g|mesh-list
153402769|NCT04871529|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
153402770|NCT04871529|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153402771|NCT04871529|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153402772|NCT04871529|Antimetabolites|antimetabolites|mesh-ancestor
153402773|NCT04871529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153402774|NCT04871529|Immunologic Factors|immunologic factors|mesh-ancestor
153402775|NCT04871529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153402776|NCT04871529|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153862448|NCT04652739|Glucocorticoids|glucocorticoids|mesh-ancestor
153862449|NCT04652739|Hormones|hormones|mesh-ancestor
153402791|NCT04864444|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153402793|NCT04853043|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153402794|NCT04853043|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153402795|NCT04826133|Calcitriol|calcitriol|mesh-list
153402796|NCT04826133|Dihydroxycholecalciferols|dihydroxycholecalciferols|mesh-list
153402797|NCT04826133|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153402798|NCT04826133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153402799|NCT04826133|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
153402800|NCT04826133|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153402801|NCT04826133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153402802|NCT04826133|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
153402803|NCT04826133|Vitamins|vitamins|mesh-ancestor
153402804|NCT04826133|Micronutrients|micronutrients|mesh-ancestor
153402805|NCT04826133|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153402806|NCT04792645|Memantine|memantine|mesh-list
153402807|NCT04792645|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
153402808|NCT04792645|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
153402826|NCT04768296|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153862451|NCT04652739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153862452|NCT04652739|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153862453|NCT04652739|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153862454|NCT04652739|Protective Agents|protective agents|mesh-ancestor
153862455|NCT04652739|Antioxidants|antioxidants|mesh-ancestor
153862456|NCT04652739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153862457|NCT04652739|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
153862458|NCT04652739|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
153862459|NCT02903498|Tegafur|tegafur|mesh-list
153862460|NCT02903498|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153862461|NCT02903498|Antimetabolites|antimetabolites|mesh-ancestor
153862462|NCT02903498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153862463|NCT02903498|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153862464|NCT04652427|Dexmedetomidine|dexmedetomidine|mesh-list
153862465|NCT04652427|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153862466|NCT04652427|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153429746|NCT00381914|Vitamins|vitamins|mesh-list
153862467|NCT04652427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153862468|NCT04652427|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153862470|NCT04652427|Sensory System Agents|sensory system agents|mesh-ancestor
153429753|NCT00423007|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153862471|NCT04652427|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153862472|NCT04652427|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
153862473|NCT04652427|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153862474|NCT04652427|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153862475|NCT04652427|Adrenergic Agents|adrenergic agents|mesh-ancestor
153862476|NCT04652427|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153862477|NCT04652427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153862478|NCT04623879|Ivacaftor|ivacaftor|mesh-list
153862479|NCT04623879|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
153862480|NCT04623879|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153862481|NCT04623879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153862482|NCT00562068|Prednisolone|prednisolone|mesh-list
153862483|NCT00562068|Cyclophosphamide|cyclophosphamide|mesh-list
153862484|NCT00562068|Doxorubicin|doxorubicin|mesh-list
153402828|NCT04768296|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153402839|NCT04751500|Mifepristone|mifepristone|mesh-list
153402840|NCT04751500|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153402841|NCT04751500|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153402842|NCT04751500|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153402856|NCT04751500|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
153402857|NCT04751500|Contraceptive Agents|contraceptive agents|mesh-ancestor
153402858|NCT04751500|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
153402859|NCT04751500|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
153402860|NCT04751500|Hormone Antagonists|hormone antagonists|mesh-ancestor
153862485|NCT00562068|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
153862487|NCT00562068|Alemtuzumab|alemtuzumab|mesh-list
153862488|NCT00562068|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153862489|NCT00562068|Immunologic Factors|immunologic factors|mesh-ancestor
153862490|NCT00562068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153862491|NCT00562068|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153402861|NCT04751500|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153862492|NCT00562068|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153423781|NCT03403712|Dexamethasone|dexamethasone|mesh-list
153862493|NCT00562068|Alkylating Agents|alkylating agents|mesh-ancestor
153862494|NCT00562068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153862495|NCT00562068|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153862498|NCT00562068|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153862499|NCT00562068|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153862500|NCT00562068|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153862501|NCT00562068|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153862502|NCT00562068|Tubulin Modulators|tubulin modulators|mesh-ancestor
153862503|NCT00562068|Antimitotic Agents|antimitotic agents|mesh-ancestor
153862504|NCT00562068|Mitosis Modulators|mitosis modulators|mesh-ancestor
153862505|NCT00562068|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153862506|NCT00562068|Glucocorticoids|glucocorticoids|mesh-ancestor
153862507|NCT00562068|Hormones|hormones|mesh-ancestor
153402900|NCT04669197|Paclitaxel|paclitaxel|mesh-list
153862557|NCT02902640|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153862558|NCT02902640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153862560|NCT02902640|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
153402911|NCT04669197|Antimalarials|antimalarials|mesh-ancestor
153402912|NCT04669197|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153402913|NCT04669197|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153402914|NCT04669197|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153402915|NCT04669197|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153402916|NCT04669197|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153402917|NCT04660812|Bevacizumab|bevacizumab|mesh-list
153402918|NCT04660812|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153402919|NCT04660812|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153402920|NCT04660812|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153402921|NCT04660812|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153402922|NCT04660812|Growth Substances|growth substances|mesh-ancestor
153402923|NCT04660812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153402924|NCT04660812|Growth Inhibitors|growth inhibitors|mesh-ancestor
153402925|NCT04640831|N,N-Dimethyltryptamine|n,n-dimethyltryptamine|mesh-list
153862575|NCT02902523|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153862576|NCT02902523|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153862577|NCT02902523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153862578|NCT02902523|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153862579|NCT02902523|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153862580|NCT02902289|Ibuprofen|ibuprofen|mesh-list
153862581|NCT02902289|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153862582|NCT02902289|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153862583|NCT02902289|Analgesics|analgesics|mesh-ancestor
153862584|NCT02902289|Sensory System Agents|sensory system agents|mesh-ancestor
153862595|NCT02902133|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153402945|NCT04610398|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153402946|NCT04610398|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153402947|NCT04607460|Coal Tar|coal tar|mesh-list
153402948|NCT04607460|Keratolytic Agents|keratolytic agents|mesh-ancestor
153402949|NCT04607460|Dermatologic Agents|dermatologic agents|mesh-ancestor
153402950|NCT04606069|Regadenoson|regadenoson|mesh-list
153402951|NCT04606069|Adenosine A2 Receptor Agonists|adenosine a2 receptor agonists|mesh-ancestor
153402952|NCT04606069|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
153402953|NCT04606069|Purinergic Agonists|purinergic agonists|mesh-ancestor
153402954|NCT04606069|Purinergic Agents|purinergic agents|mesh-ancestor
153402955|NCT04606069|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153402956|NCT04606069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153402957|NCT04606069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153402958|NCT04595981|Cisplatin|cisplatin|mesh-list
153402959|NCT04595981|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153402960|NCT04575311|Quemliclustat|quemliclustat|mesh-list
153402961|NCT04575311|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153862601|NCT04623021|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153862602|NCT04623021|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153862603|NCT04623021|Analgesics|analgesics|mesh-ancestor
153862604|NCT04623021|Sensory System Agents|sensory system agents|mesh-ancestor
153862605|NCT04623021|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153862606|NCT04623021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153862607|NCT04623021|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153862608|NCT04623021|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153862609|NCT04623021|Anticoagulants|anticoagulants|mesh-ancestor
153862610|NCT04623021|Protease Inhibitors|protease inhibitors|mesh-ancestor
153862611|NCT04623021|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153862612|NCT04623021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153862665|NCT02901587|Quetiapine Fumarate|quetiapine fumarate|mesh-list
153862666|NCT02901587|Antidepressive Agents|antidepressive agents|mesh-ancestor
153862667|NCT02901587|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153862668|NCT02901587|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153862669|NCT02901587|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153862670|NCT02901587|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153862671|NCT02901587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153862672|NCT04622397|Tranexamic Acid|tranexamic acid|mesh-list
153403020|NCT04316702|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153403021|NCT04316702|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153403022|NCT04316702|Antidepressive Agents|antidepressive agents|mesh-ancestor
153403025|NCT04292457|Sevoflurane|sevoflurane|mesh-list
153403026|NCT04292457|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153403027|NCT04292457|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153862686|NCT02901353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153862687|NCT04621461|Zinc Sulfate|zinc sulfate|mesh-list
153862688|NCT04621461|Astringents|astringents|mesh-ancestor
153403036|NCT04274179|Ethosuximide|ethosuximide|mesh-list
153403037|NCT04274179|Anticonvulsants|anticonvulsants|mesh-ancestor
153403038|NCT04274179|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153403039|NCT04274179|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153403040|NCT04274179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153403041|NCT04274179|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153403042|NCT04274179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153403043|NCT04274179|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153403045|NCT04274179|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153403046|NCT04274179|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153403047|NCT04274179|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153403048|NCT04274179|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153403049|NCT04274179|GABA Agents|gaba agents|mesh-ancestor
153403050|NCT04274179|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153403051|NCT04274179|Antimanic Agents|antimanic agents|mesh-ancestor
153403052|NCT04273932|Lithium Carbonate|lithium carbonate|mesh-list
153403053|NCT04273932|Antidepressive Agents|antidepressive agents|mesh-ancestor
153403054|NCT04273932|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153403055|NCT04273932|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153403056|NCT04273932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153403057|NCT04273932|Antimanic Agents|antimanic agents|mesh-ancestor
153403058|NCT04273932|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153403059|NCT04273932|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153403060|NCT04273932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153403061|NCT04272086|Bupivacaine|bupivacaine|mesh-list
153403062|NCT04272086|Anesthetics, Local|anesthetics, local|mesh-ancestor
153403063|NCT04272086|Anesthetics|anesthetics|mesh-ancestor
153403064|NCT04272086|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153403065|NCT04272086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153403066|NCT04272086|Sensory System Agents|sensory system agents|mesh-ancestor
153403067|NCT04272086|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153403068|NCT04256707|Docetaxel|docetaxel|mesh-list
153403069|NCT04256707|Pembrolizumab|pembrolizumab|mesh-list
153403070|NCT04256707|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153403071|NCT04256707|Tubulin Modulators|tubulin modulators|mesh-ancestor
153862689|NCT04621461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153862690|NCT04621461|Dermatologic Agents|dermatologic agents|mesh-ancestor
153862691|NCT02901236|Antifibrotic Agents|antifibrotic agents|mesh-list
153403072|NCT04256707|Antimitotic Agents|antimitotic agents|mesh-ancestor
153862692|NCT02901236|Bevacizumab|bevacizumab|mesh-list
153862693|NCT02901236|Mitomycins|mitomycins|mesh-list
153862694|NCT02901236|Mitomycin|mitomycin|mesh-list
153862695|NCT02901236|Antimetabolites|antimetabolites|mesh-list
153862696|NCT02901236|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153862697|NCT02901236|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153862698|NCT02901236|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153862699|NCT02901236|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153862700|NCT02901236|Growth Substances|growth substances|mesh-ancestor
153403084|NCT04233229|Insulin|insulin|mesh-list
153403085|NCT04233229|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153403086|NCT04233229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153862727|NCT01212757|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153862728|NCT01212757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153862729|NCT01212757|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153862730|NCT01212757|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153862731|NCT01212757|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
153862742|NCT01212757|Growth Substances|growth substances|mesh-ancestor
153862743|NCT01212757|Growth Inhibitors|growth inhibitors|mesh-ancestor
153862744|NCT01212757|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153862745|NCT00562419|Irinotecan|irinotecan|mesh-list
153423782|NCT03403712|Palonosetron|palonosetron|mesh-list
153423783|NCT03403712|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153423784|NCT03403712|Antiemetics|antiemetics|mesh-ancestor
153423785|NCT03403712|Autonomic Agents|autonomic agents|mesh-ancestor
153423786|NCT03403712|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153382378|NCT01992185|Dermatologic Agents|dermatologic agents|mesh-ancestor
153382379|NCT04332627|Neostigmine|neostigmine|mesh-list
153382380|NCT04332627|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
153382381|NCT04332627|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153862746|NCT00562419|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
153862747|NCT00562419|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153862748|NCT00562419|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153862749|NCT00562419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153403130|NCT04173780|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153403131|NCT04173780|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153403132|NCT04173780|Autonomic Agents|autonomic agents|mesh-ancestor
153403133|NCT04173780|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153862763|NCT02900729|Amlodipine|amlodipine|mesh-list
153862764|NCT02900729|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
153862765|NCT02900729|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153862766|NCT02900729|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153862767|NCT02900729|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153862768|NCT02900729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153862769|NCT02900729|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153862771|NCT02900729|Vasodilator Agents|vasodilator agents|mesh-ancestor
153862783|NCT01190410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153403139|NCT04173780|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
153403140|NCT04173780|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
153403141|NCT04173780|Cholinergic Agents|cholinergic agents|mesh-ancestor
153403142|NCT04173780|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153403143|NCT04173780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153403144|NCT04167111|Vitamin D|vitamin d|mesh-list
153403145|NCT04167111|Cholecalciferol|cholecalciferol|mesh-list
153403146|NCT04167111|Vitamins|vitamins|mesh-ancestor
153862790|NCT01190254|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153862791|NCT04620954|Nivolumab|nivolumab|mesh-list
153862792|NCT04620954|Oregovomab|oregovomab|mesh-list
153862793|NCT04620954|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153862794|NCT04620954|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153862795|NCT04620954|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153862796|NCT04620954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153403153|NCT04139304|Cyclophosphamide|cyclophosphamide|mesh-list
153403154|NCT04139304|Doxorubicin|doxorubicin|mesh-list
153403155|NCT04139304|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
153403156|NCT04139304|Etoposide|etoposide|mesh-list
153403157|NCT04139304|Vincristine|vincristine|mesh-list
153403158|NCT04139304|Etoposide phosphate|etoposide phosphate|mesh-list
153403159|NCT04139304|Daunorubicin|daunorubicin|mesh-list
153403160|NCT04139304|Daratumumab|daratumumab|mesh-list
153403161|NCT04139304|Podophyllotoxin|podophyllotoxin|mesh-list
153403162|NCT04139304|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153403163|NCT04139304|Immunologic Factors|immunologic factors|mesh-ancestor
153403164|NCT04139304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153403165|NCT04139304|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153403166|NCT04139304|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153403167|NCT04139304|Alkylating Agents|alkylating agents|mesh-ancestor
153403168|NCT04139304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153862821|NCT04621110|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
153862822|NCT04621110|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
153862823|NCT04621110|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153862824|NCT04621110|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153862825|NCT04621110|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153862826|NCT04621110|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153862827|NCT04621110|GABA Modulators|gaba modulators|mesh-ancestor
153862828|NCT04621110|GABA Agents|gaba agents|mesh-ancestor
153862829|NCT04621110|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153382382|NCT04332627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153382383|NCT04332627|Cholinergic Agents|cholinergic agents|mesh-ancestor
153382384|NCT04332627|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153382385|NCT04332627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153382386|NCT04332627|Parasympathomimetics|parasympathomimetics|mesh-ancestor
153382387|NCT04332627|Autonomic Agents|autonomic agents|mesh-ancestor
153382388|NCT04332627|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153382389|NCT03440229|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
153382418|NCT03232749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153382419|NCT03232749|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153382420|NCT03232749|Glucocorticoids|glucocorticoids|mesh-ancestor
153382421|NCT03232749|Hormones|hormones|mesh-ancestor
153382422|NCT03232749|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153382423|NCT03232749|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
153382424|NCT03232749|Protective Agents|protective agents|mesh-ancestor
153382425|NCT01687400|Decitabine|decitabine|mesh-list
153882865|NCT05140655|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153862830|NCT04621110|Narcotics|narcotics|mesh-ancestor
153862831|NCT04620720|Gabapentin|gabapentin|mesh-list
153862832|NCT04620720|Analgesics|analgesics|mesh-ancestor
153862833|NCT04620720|Sensory System Agents|sensory system agents|mesh-ancestor
153862834|NCT04620720|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153862835|NCT04620720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153862836|NCT04620720|Anticonvulsants|anticonvulsants|mesh-ancestor
153862837|NCT04620720|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153862838|NCT04620720|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153862839|NCT04620720|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153862840|NCT04620720|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153862841|NCT04620720|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
153862842|NCT04620720|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
153862843|NCT04620720|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153862845|NCT04620720|Antimanic Agents|antimanic agents|mesh-ancestor
153403210|NCT04109924|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153403211|NCT04109924|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153403212|NCT04109924|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153403213|NCT04109924|Growth Substances|growth substances|mesh-ancestor
153403214|NCT04109924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153403215|NCT04109924|Growth Inhibitors|growth inhibitors|mesh-ancestor
153403216|NCT04109924|Immunologic Factors|immunologic factors|mesh-ancestor
153403217|NCT04109924|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
153403218|NCT04109924|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153403219|NCT04109924|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153888653|NCT01312961|Immunologic Factors|immunologic factors|mesh-ancestor
153888654|NCT01312961|Glucocorticoids|glucocorticoids|mesh-ancestor
153862864|NCT02900105|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
153862865|NCT02900105|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153862866|NCT02900105|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153862867|NCT02900105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153862868|NCT02900105|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
153862869|NCT02900105|Hormone Antagonists|hormone antagonists|mesh-ancestor
153862870|NCT02900105|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153862871|NCT02900105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153862872|NCT04619862|Gabapentin|gabapentin|mesh-list
153862873|NCT04619862|Analgesics|analgesics|mesh-ancestor
153862874|NCT04619862|Sensory System Agents|sensory system agents|mesh-ancestor
153862875|NCT04619862|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153862876|NCT04619862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153862877|NCT04619862|Anticonvulsants|anticonvulsants|mesh-ancestor
153862878|NCT04619862|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153403236|NCT04093596|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153403237|NCT04093596|Gamma Secretase Inhibitors and Modulators|gamma secretase inhibitors and modulators|mesh-ancestor
153403238|NCT04093596|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153403240|NCT04091750|Ipilimumab|ipilimumab|mesh-list
153403242|NCT04091750|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153862881|NCT04619862|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153862882|NCT04619862|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
153862883|NCT04619862|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
153862884|NCT04619862|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153862885|NCT04619862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153862886|NCT04619862|Antimanic Agents|antimanic agents|mesh-ancestor
153862887|NCT01190839|Infliximab|infliximab|mesh-list
153862888|NCT01190839|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
153862889|NCT01190839|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153862890|NCT01190839|Dermatologic Agents|dermatologic agents|mesh-ancestor
153862891|NCT01190839|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153862892|NCT01190839|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153862893|NCT00562770|Valacyclovir|valacyclovir|mesh-list
153862894|NCT00562770|Valganciclovir|valganciclovir|mesh-list
153862895|NCT00562770|Antiviral Agents|antiviral agents|mesh-ancestor
153862896|NCT00562770|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153862897|NCT05424692|Formyltetrahydrofolates|formyltetrahydrofolates|mesh-list
153862898|NCT05424692|Fluorouracil|fluorouracil|mesh-list
153862899|NCT05424692|Oxaliplatin|oxaliplatin|mesh-list
153862903|NCT05424692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153862904|NCT05424692|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153862905|NCT05424692|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153862906|NCT05424692|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153862907|NCT05424692|Immunologic Factors|immunologic factors|mesh-ancestor
153862908|NCT05424692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153862909|NCT05424692|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
153862910|NCT05424692|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153862911|NCT05424692|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153862912|NCT05424692|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153862913|NCT05424692|Vitamin B Complex|vitamin b complex|mesh-ancestor
153862914|NCT05424692|Vitamins|vitamins|mesh-ancestor
153403271|NCT04031729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153403272|NCT04031729|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153403282|NCT04024163|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153403283|NCT04024163|Immunologic Factors|immunologic factors|mesh-ancestor
153403284|NCT04024163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153403285|NCT04024163|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
153403286|NCT04024163|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153403287|NCT04024163|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153403288|NCT04024163|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153403290|NCT04023019|Hemostatics|hemostatics|mesh-ancestor
153403291|NCT04023019|Coagulants|coagulants|mesh-ancestor
153403292|NCT04014387|Zolpidem|zolpidem|mesh-list
153403293|NCT04014387|Suvorexant|suvorexant|mesh-list
153403294|NCT04014387|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
153403295|NCT04014387|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153403296|NCT04014387|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153403297|NCT04014387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153403298|NCT04014387|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
153403299|NCT04014387|GABA Agonists|gaba agonists|mesh-ancestor
153403300|NCT04014387|GABA Agents|gaba agents|mesh-ancestor
153403301|NCT04014387|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153862920|NCT04618965|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153862921|NCT04618965|Analgesics|analgesics|mesh-ancestor
153862922|NCT04618965|Sensory System Agents|sensory system agents|mesh-ancestor
153862923|NCT04618965|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153862924|NCT04618965|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
153862925|NCT04618965|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153862926|NCT04618965|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153862927|NCT04618965|Adrenergic Agents|adrenergic agents|mesh-ancestor
153862928|NCT04618965|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153862929|NCT04618965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153862930|NCT01190449|Ofatumumab|ofatumumab|mesh-list
153862931|NCT01190449|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153862932|NCT00562809|Irbesartan|irbesartan|mesh-list
153862933|NCT00562809|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153862934|NCT00562809|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
153862935|NCT00562809|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
153862936|NCT00562809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153862937|NCT01190098|Lacosamide|lacosamide|mesh-list
153862938|NCT01190098|Anticonvulsants|anticonvulsants|mesh-ancestor
153862939|NCT01190098|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
153862940|NCT01190098|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153862941|NCT01190098|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153862942|NCT01190098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153403303|NCT04014387|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
153403329|NCT03981796|Mitosis Modulators|mitosis modulators|mesh-ancestor
153403330|NCT03981796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153403331|NCT03981796|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
153403332|NCT03981796|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153403333|NCT03961698|Paclitaxel|paclitaxel|mesh-list
153862945|NCT04314739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153862946|NCT04314739|Protective Agents|protective agents|mesh-ancestor
153862947|NCT04314739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153862948|NCT04314739|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153403336|NCT03961698|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153862949|NCT04314739|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153862950|NCT02885740|Adenosine|adenosine|mesh-list
153862952|NCT02885740|Sensory System Agents|sensory system agents|mesh-ancestor
153862953|NCT02885740|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153862963|NCT05309785|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
153862964|NCT05309785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153862966|NCT05309785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153862974|NCT01189435|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153862975|NCT01189435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153862976|NCT01189435|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153862977|NCT01165996|Decitabine|decitabine|mesh-list
153862978|NCT01165996|Azacitidine|azacitidine|mesh-list
153862979|NCT01165996|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153862980|NCT01165996|Antimetabolites|antimetabolites|mesh-ancestor
153403343|NCT03961698|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153403344|NCT03961698|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153403345|NCT03961698|Growth Substances|growth substances|mesh-ancestor
153403346|NCT03961698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153403347|NCT03961698|Growth Inhibitors|growth inhibitors|mesh-ancestor
153403348|NCT03961698|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153403349|NCT03945643|Sildenafil Citrate|sildenafil citrate|mesh-list
153403350|NCT03945643|Vasodilator Agents|vasodilator agents|mesh-ancestor
153403351|NCT03945643|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
153403352|NCT03945643|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
153403353|NCT03945643|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153403354|NCT03945643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153403355|NCT03945643|Urological Agents|urological agents|mesh-ancestor
153403356|NCT03938389|Valsartan|valsartan|mesh-list
153403357|NCT03938389|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
153403358|NCT03938389|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153403359|NCT03938389|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
153403360|NCT03938389|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
153403363|NCT03908736|Iron Chelating Agents|iron chelating agents|mesh-ancestor
153403364|NCT03908736|Chelating Agents|chelating agents|mesh-ancestor
153403365|NCT03908736|Sequestering Agents|sequestering agents|mesh-ancestor
153403366|NCT03908736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153403367|NCT03905928|Nicotine|nicotine|mesh-list
153403368|NCT03905928|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
153403369|NCT03905928|Autonomic Agents|autonomic agents|mesh-ancestor
153403370|NCT03905928|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153403371|NCT03905928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153403372|NCT03905928|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
153403373|NCT03905928|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
153403374|NCT03905928|Cholinergic Agents|cholinergic agents|mesh-ancestor
153403375|NCT03905928|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153403376|NCT03905928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153403377|NCT03872700|Fentanyl|fentanyl|mesh-list
153862981|NCT01165996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153862982|NCT01165996|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153862983|NCT01165996|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153862984|NCT04619433|Carboplatin|carboplatin|mesh-list
153862985|NCT04619433|Pemetrexed|pemetrexed|mesh-list
153863010|NCT01189201|Empagliflozin|empagliflozin|mesh-list
153863011|NCT01189201|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153863012|NCT01189201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153863013|NCT01189201|Incretins|incretins|mesh-ancestor
153863014|NCT01189201|Hormones|hormones|mesh-ancestor
153863015|NCT01189201|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153863016|NCT01189201|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
153403378|NCT03872700|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153403379|NCT03872700|Narcotics|narcotics|mesh-ancestor
153403380|NCT03872700|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153403382|NCT03872700|Analgesics|analgesics|mesh-ancestor
153403383|NCT03872700|Sensory System Agents|sensory system agents|mesh-ancestor
153403384|NCT03872700|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153403385|NCT03872700|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153403386|NCT03872700|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153403387|NCT03872700|Anesthetics, General|anesthetics, general|mesh-ancestor
153403388|NCT03872700|Anesthetics|anesthetics|mesh-ancestor
153403389|NCT03846310|Carboplatin|carboplatin|mesh-list
153403390|NCT03846310|Pembrolizumab|pembrolizumab|mesh-list
153403392|NCT03846310|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153403393|NCT03846310|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153403401|NCT03719326|Paclitaxel|paclitaxel|mesh-list
153403402|NCT03719326|Doxorubicin|doxorubicin|mesh-list
153403403|NCT03719326|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
153403404|NCT03719326|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
153403405|NCT03719326|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153403406|NCT03719326|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153863025|NCT01188811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153863026|NCT01188811|Vitamin B Complex|vitamin b complex|mesh-ancestor
153863027|NCT01188811|Vitamins|vitamins|mesh-ancestor
153863028|NCT01188811|Micronutrients|micronutrients|mesh-ancestor
153863029|NCT01183234|Methylphenidate|methylphenidate|mesh-list
153863030|NCT01183234|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
153863031|NCT01183234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153863032|NCT01183234|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
153863033|NCT01183234|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153863034|NCT01183234|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153863035|NCT01183234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153863036|NCT01183234|Dopamine Agents|dopamine agents|mesh-ancestor
153863037|NCT01183234|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153863038|NCT04618497|Ketorolac|ketorolac|mesh-list
153863039|NCT04618497|Methoxyflurane|methoxyflurane|mesh-list
153863040|NCT04618497|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153863041|NCT04618497|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153863042|NCT04618497|Analgesics|analgesics|mesh-ancestor
153863043|NCT04618497|Sensory System Agents|sensory system agents|mesh-ancestor
153403415|NCT03717909|Valproic Acid|valproic acid|mesh-list
153403416|NCT03717909|Anticonvulsants|anticonvulsants|mesh-ancestor
153403417|NCT03717909|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153403418|NCT03717909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153403420|NCT03717909|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153403421|NCT03717909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153403422|NCT03717909|Antimanic Agents|antimanic agents|mesh-ancestor
153403423|NCT03717909|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153403424|NCT03717909|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153403425|NCT03717909|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153403426|NCT03715478|Dexamethasone|dexamethasone|mesh-list
153403427|NCT03715478|Pomalidomide|pomalidomide|mesh-list
153403428|NCT03715478|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153403429|NCT03715478|Antiemetics|antiemetics|mesh-ancestor
153403430|NCT03715478|Autonomic Agents|autonomic agents|mesh-ancestor
153403431|NCT03715478|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153403432|NCT03715478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153403433|NCT03715478|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153403434|NCT03715478|Glucocorticoids|glucocorticoids|mesh-ancestor
153403435|NCT03715478|Hormones|hormones|mesh-ancestor
153863052|NCT04618497|Anesthetics, General|anesthetics, general|mesh-ancestor
153863053|NCT04618497|Anesthetics|anesthetics|mesh-ancestor
153863054|NCT04618497|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153863055|NCT04618575|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
153863065|NCT04651959|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153863066|NCT01165216|Paclitaxel|paclitaxel|mesh-list
153863067|NCT01165216|Carboplatin|carboplatin|mesh-list
153863068|NCT01165216|Ipilimumab|ipilimumab|mesh-list
153863069|NCT01165216|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153863070|NCT01165216|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153403436|NCT03715478|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153403437|NCT03715478|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153882866|NCT05140655|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153882867|NCT05140655|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
153882868|NCT05140655|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
153882869|NCT05140655|Hormone Antagonists|hormone antagonists|mesh-ancestor
153882870|NCT05140655|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153882871|NCT05140655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153882872|NCT01688570|Cyproheptadine|cyproheptadine|mesh-list
153882873|NCT01688570|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
153882874|NCT01688570|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
153382426|NCT01687400|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153382427|NCT01687400|Antimetabolites|antimetabolites|mesh-ancestor
153382428|NCT01687400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153382429|NCT01687400|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153382430|NCT01687400|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153382431|NCT01688102|Vitamin D|vitamin d|mesh-list
153382432|NCT01688102|Cholecalciferol|cholecalciferol|mesh-list
153382433|NCT01688102|Vitamins|vitamins|mesh-ancestor
153382434|NCT01688102|Micronutrients|micronutrients|mesh-ancestor
153382435|NCT01688102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153403438|NCT03715478|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153403439|NCT03715478|Immunologic Factors|immunologic factors|mesh-ancestor
153403440|NCT03715478|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153403441|NCT03715478|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153863076|NCT01165216|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153863077|NCT04652115|Defibrotide|defibrotide|mesh-list
153863078|NCT04652115|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153863079|NCT04652115|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153863080|NCT04652115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153863088|NCT04618146|Bupivacaine|bupivacaine|mesh-list
153863089|NCT04618146|Anesthetics, Local|anesthetics, local|mesh-ancestor
153863090|NCT04618146|Anesthetics|anesthetics|mesh-ancestor
153863091|NCT04618146|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153863092|NCT04618146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153863093|NCT04618146|Sensory System Agents|sensory system agents|mesh-ancestor
153863094|NCT04618146|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153863095|NCT04618146|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153403461|NCT03688464|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153403462|NCT03688464|Anesthetics, Local|anesthetics, local|mesh-ancestor
153403463|NCT03688464|Anesthetics|anesthetics|mesh-ancestor
153403464|NCT03688464|Sensory System Agents|sensory system agents|mesh-ancestor
153403465|NCT03688464|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153403466|NCT03688464|Antiemetics|antiemetics|mesh-ancestor
153403467|NCT03688464|Autonomic Agents|autonomic agents|mesh-ancestor
153403468|NCT03688464|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153403469|NCT03688464|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
153403470|NCT03688464|Histamine Antagonists|histamine antagonists|mesh-ancestor
153403471|NCT03688464|Histamine Agents|histamine agents|mesh-ancestor
153403472|NCT03688464|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153403473|NCT03688464|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
153403474|NCT03688464|Antipruritics|antipruritics|mesh-ancestor
153403475|NCT03688464|Dermatologic Agents|dermatologic agents|mesh-ancestor
153403476|NCT03677973|Quemliclustat|quemliclustat|mesh-list
153403477|NCT03677973|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153403478|NCT03677973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153863096|NCT04618146|Narcotics|narcotics|mesh-ancestor
153863097|NCT04618146|Analgesics|analgesics|mesh-ancestor
153863098|NCT04651842|Insulin|insulin|mesh-list
153863099|NCT04651842|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153863100|NCT04651842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153863102|NCT05421962|Ketamine|ketamine|mesh-list
153863103|NCT05421962|Analgesics|analgesics|mesh-ancestor
153863104|NCT05421962|Sensory System Agents|sensory system agents|mesh-ancestor
153863105|NCT05421962|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153863112|NCT05421962|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
153863113|NCT05421962|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
153863114|NCT05421962|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153863115|NCT05421962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153863116|NCT05421962|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153863117|NCT05421962|Narcotics|narcotics|mesh-ancestor
153863118|NCT05421962|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153863119|NCT00557817|Darbepoetin alfa|darbepoetin alfa|mesh-list
153863120|NCT00557817|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
153863121|NCT00557817|Hematinics|hematinics|mesh-ancestor
153863122|NCT05419583|Aspirin|aspirin|mesh-list
153863123|NCT05419583|Warfarin|warfarin|mesh-list
153863124|NCT05419583|Apixaban|apixaban|mesh-list
153863125|NCT05419583|Anticoagulants|anticoagulants|mesh-list
153863126|NCT05419583|Edoxaban|edoxaban|mesh-list
153863127|NCT05419583|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-list
153863128|NCT05419583|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-list
153863129|NCT05419583|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153863130|NCT05419583|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153863131|NCT05419583|Analgesics|analgesics|mesh-ancestor
153863132|NCT05419583|Sensory System Agents|sensory system agents|mesh-ancestor
153863133|NCT05419583|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153403481|NCT03666065|Insulin|insulin|mesh-list
153863134|NCT05419583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153863135|NCT05419583|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153863136|NCT05419583|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153863137|NCT05419583|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153863138|NCT05419583|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153863139|NCT05419583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153863140|NCT05419583|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153863141|NCT05419583|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153863142|NCT05419583|Antipyretics|antipyretics|mesh-ancestor
153863143|NCT05419583|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
153863144|NCT05419583|Antithrombins|antithrombins|mesh-ancestor
153863153|NCT05387408|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153403516|NCT03493412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153403517|NCT03493412|Vasodilator Agents|vasodilator agents|mesh-ancestor
153403518|NCT03474198|Levofloxacin|levofloxacin|mesh-list
153403519|NCT03474198|Rifampin|rifampin|mesh-list
153403520|NCT03474198|Isoniazid|isoniazid|mesh-list
153403521|NCT03474198|Linezolid|linezolid|mesh-list
153403522|NCT03474198|Pyrazinamide|pyrazinamide|mesh-list
153403523|NCT03474198|Ethambutol|ethambutol|mesh-list
153403524|NCT03474198|Rifapentine|rifapentine|mesh-list
153403525|NCT03474198|Bedaquiline|bedaquiline|mesh-list
153403526|NCT03474198|Clofazimine|clofazimine|mesh-list
153403527|NCT03474198|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
153403528|NCT03474198|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153403529|NCT03474198|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153403530|NCT03474198|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153403531|NCT03474198|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153403532|NCT03474198|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153403533|NCT03474198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153403534|NCT03474198|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153403535|NCT03474198|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
153403536|NCT03474198|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153403537|NCT03474198|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
153403538|NCT03474198|Antitubercular Agents|antitubercular agents|mesh-ancestor
153403539|NCT03474198|Leprostatic Agents|leprostatic agents|mesh-ancestor
153403540|NCT03474198|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153403541|NCT03474198|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
153403542|NCT03474198|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
153403543|NCT03474198|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
153403544|NCT03474198|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
153403548|NCT03474198|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153863164|NCT05376761|Sensory System Agents|sensory system agents|mesh-ancestor
153863165|NCT05376761|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153863166|NCT05376761|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
153863167|NCT05376761|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153382436|NCT01688102|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153382465|NCT01688336|Protective Agents|protective agents|mesh-ancestor
153882883|NCT01688570|Antidepressive Agents|antidepressive agents|mesh-ancestor
153882884|NCT01688570|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153882885|NCT01688570|Dopamine Agents|dopamine agents|mesh-ancestor
153882886|NCT01688570|Antipruritics|antipruritics|mesh-ancestor
153882887|NCT01688570|Dermatologic Agents|dermatologic agents|mesh-ancestor
153882888|NCT01688570|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153882889|NCT01688570|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
153882890|NCT01688570|Histamine Antagonists|histamine antagonists|mesh-ancestor
153882891|NCT01688570|Histamine Agents|histamine agents|mesh-ancestor
153882892|NCT01688570|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153882893|NCT01688570|Serotonin Agents|serotonin agents|mesh-ancestor
153882894|NCT01688570|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
153882895|NCT01686464|Valacyclovir|valacyclovir|mesh-list
153882896|NCT01686464|Prednisone|prednisone|mesh-list
153882897|NCT01686464|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153882898|NCT01686464|Glucocorticoids|glucocorticoids|mesh-ancestor
153882899|NCT01686464|Hormones|hormones|mesh-ancestor
153863168|NCT05376761|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153863185|NCT04617561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153863186|NCT04617561|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153863188|NCT04617561|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153863189|NCT04617561|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
153863190|NCT04617561|Protective Agents|protective agents|mesh-ancestor
153863191|NCT04617561|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153863192|NCT04617561|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153403558|NCT03421288|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153403560|NCT03421288|Antimitotic Agents|antimitotic agents|mesh-ancestor
153403561|NCT03421288|Mitosis Modulators|mitosis modulators|mesh-ancestor
153403562|NCT03421288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153403563|NCT03421288|Antimetabolites|antimetabolites|mesh-ancestor
153403564|NCT03421288|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153403565|NCT03421288|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153403566|NCT03421288|Immunologic Factors|immunologic factors|mesh-ancestor
153403567|NCT03421288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153403568|NCT03421288|Antidotes|antidotes|mesh-ancestor
153403569|NCT03421288|Protective Agents|protective agents|mesh-ancestor
153403570|NCT03421288|Vitamin B Complex|vitamin b complex|mesh-ancestor
153403571|NCT03421288|Vitamins|vitamins|mesh-ancestor
153403572|NCT03421288|Micronutrients|micronutrients|mesh-ancestor
153403573|NCT03421288|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153403574|NCT03421288|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153403575|NCT03418922|Nivolumab|nivolumab|mesh-list
153403576|NCT03418922|Lenvatinib|lenvatinib|mesh-list
153403577|NCT03418922|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153863211|NCT00557934|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
153863212|NCT00557934|Sympathomimetics|sympathomimetics|mesh-ancestor
153863213|NCT00557934|Autonomic Agents|autonomic agents|mesh-ancestor
153863214|NCT00557934|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153863215|NCT00557934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153863216|NCT00557934|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
153403581|NCT03418922|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153403582|NCT03418922|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153403583|NCT03342027|Bupropion|bupropion|mesh-list
153403584|NCT03342027|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
153403585|NCT03342027|Antidepressive Agents|antidepressive agents|mesh-ancestor
153403586|NCT03342027|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153403587|NCT03342027|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
153863217|NCT00557934|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
153863218|NCT00557934|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153863219|NCT00557934|Adrenergic Agents|adrenergic agents|mesh-ancestor
153863220|NCT00557934|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153863221|NCT00557934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153863222|NCT00557934|Protective Agents|protective agents|mesh-ancestor
153863223|NCT00558051|Vaccines|vaccines|mesh-list
153863224|NCT00558051|Immunologic Factors|immunologic factors|mesh-ancestor
153863225|NCT00558051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153863226|NCT00558090|Morphine|morphine|mesh-list
153863227|NCT00558090|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153863228|NCT00558090|Narcotics|narcotics|mesh-ancestor
153863229|NCT00558090|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153863230|NCT00558090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153863231|NCT00558090|Analgesics|analgesics|mesh-ancestor
153863232|NCT00558090|Sensory System Agents|sensory system agents|mesh-ancestor
153863233|NCT00558090|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153863234|NCT04650828|Tenofovir|tenofovir|mesh-list
153403597|NCT03245541|Durvalumab|durvalumab|mesh-list
153403598|NCT03245541|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153403599|NCT03245541|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153403600|NCT03240809|Brodalumab|brodalumab|mesh-list
153403611|NCT03192995|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153863235|NCT04650828|Antiviral Agents|antiviral agents|mesh-ancestor
153863236|NCT04650828|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153863237|NCT04650828|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153863238|NCT04650828|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153863239|NCT04650828|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153863240|NCT04650828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153863241|NCT04650828|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153863242|NCT04650828|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153863244|NCT04650555|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
153863251|NCT04650555|Phytoestrogens|phytoestrogens|mesh-ancestor
153863252|NCT04650555|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
153863253|NCT04650555|Estrogens|estrogens|mesh-ancestor
153863254|NCT04650555|Hormones|hormones|mesh-ancestor
153863255|NCT04650555|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153863256|NCT05181683|Casirivimab and imdevimab drug combination|casirivimab and imdevimab drug combination|mesh-list
153863257|NCT05181683|Antiviral Agents|antiviral agents|mesh-ancestor
153403621|NCT03174977|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153403622|NCT03174977|Antiviral Agents|antiviral agents|mesh-ancestor
153403623|NCT03174977|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153403624|NCT03174977|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
153403625|NCT03174977|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
153403626|NCT03174977|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153403627|NCT03174977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153403628|NCT03150511|Tesamorelin|tesamorelin|mesh-list
153403629|NCT03150511|Growth Substances|growth substances|mesh-ancestor
153403630|NCT03150511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153403631|NCT03121677|Poly I-C|poly i-c|mesh-list
153403632|NCT03121677|Rituximab|rituximab|mesh-list
153403633|NCT03121677|Nivolumab|nivolumab|mesh-list
153403634|NCT03121677|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
153403635|NCT03121677|Poly ICLC|poly iclc|mesh-list
153403636|NCT03121677|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153403637|NCT03121677|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153403638|NCT03121677|Immunologic Factors|immunologic factors|mesh-ancestor
153403639|NCT03121677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153403640|NCT03121677|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153863260|NCT04650321|Immunologic Factors|immunologic factors|mesh-ancestor
153863261|NCT04650321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153863303|NCT04616859|Ethanol|ethanol|mesh-list
153863304|NCT04616859|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
153863305|NCT04616859|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153863306|NCT04616859|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153403700|NCT02913313|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153403701|NCT02913313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153403702|NCT02908477|Docetaxel|docetaxel|mesh-list
153403703|NCT02908477|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153403704|NCT02908477|Tubulin Modulators|tubulin modulators|mesh-ancestor
153403705|NCT02908477|Antimitotic Agents|antimitotic agents|mesh-ancestor
153403706|NCT02908477|Mitosis Modulators|mitosis modulators|mesh-ancestor
153863324|NCT00553943|Antiviral Agents|antiviral agents|mesh-ancestor
153863325|NCT00553943|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153863326|NCT00553943|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153863329|NCT00563160|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153863330|NCT00563160|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153863331|NCT00563160|Antimetabolites|antimetabolites|mesh-ancestor
153863332|NCT00563160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153863333|NCT00563238|Metoprolol|metoprolol|mesh-list
153863334|NCT00563238|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153863335|NCT00563238|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153863336|NCT00563238|Sympatholytics|sympatholytics|mesh-ancestor
153863337|NCT00563238|Autonomic Agents|autonomic agents|mesh-ancestor
153863338|NCT00563238|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153863339|NCT00563238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153403707|NCT02908477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153403708|NCT02754726|Paclitaxel|paclitaxel|mesh-list
153403709|NCT02754726|Gemcitabine|gemcitabine|mesh-list
153403710|NCT02754726|Nivolumab|nivolumab|mesh-list
153403711|NCT02754726|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
153403712|NCT02754726|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153403713|NCT02754726|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153403714|NCT02754726|Tubulin Modulators|tubulin modulators|mesh-ancestor
153403715|NCT02754726|Antimitotic Agents|antimitotic agents|mesh-ancestor
153403716|NCT02754726|Mitosis Modulators|mitosis modulators|mesh-ancestor
153403717|NCT02754726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153403718|NCT02754726|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153403719|NCT02754726|Antimetabolites|antimetabolites|mesh-ancestor
153403720|NCT02754726|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153403721|NCT02754726|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153403722|NCT02733185|Vitamins|vitamins|mesh-list
153403723|NCT02733185|Edetic Acid|edetic acid|mesh-list
153403724|NCT02733185|Pentetic Acid|pentetic acid|mesh-list
153403725|NCT02733185|Micronutrients|micronutrients|mesh-ancestor
153403726|NCT02733185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153403727|NCT02733185|Anticoagulants|anticoagulants|mesh-ancestor
153403728|NCT02733185|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
153403729|NCT02733185|Chelating Agents|chelating agents|mesh-ancestor
153403730|NCT02733185|Sequestering Agents|sequestering agents|mesh-ancestor
153863342|NCT00563238|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
153863344|NCT00563238|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153863345|NCT00563238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153863346|NCT04679558|Chlorhexidine|chlorhexidine|mesh-list
153863353|NCT04934228|Diuretics|diuretics|mesh-ancestor
153863354|NCT04934228|Natriuretic Agents|natriuretic agents|mesh-ancestor
153863355|NCT04934228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153863356|NCT04934228|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
153863357|NCT04934228|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153863358|NCT04934228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153863359|NCT04934228|Analgesics|analgesics|mesh-ancestor
153863360|NCT04934228|Sensory System Agents|sensory system agents|mesh-ancestor
153863361|NCT04934228|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153403731|NCT02733185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153403732|NCT02733185|Antidotes|antidotes|mesh-ancestor
153403733|NCT02733185|Protective Agents|protective agents|mesh-ancestor
153403734|NCT02733185|Iron Chelating Agents|iron chelating agents|mesh-ancestor
153403735|NCT02713997|Etanercept|etanercept|mesh-list
153403736|NCT02713997|Alpha 1-Antitrypsin|alpha 1-antitrypsin|mesh-list
153403737|NCT02713997|Protein C Inhibitor|protein c inhibitor|mesh-list
153403738|NCT02713997|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153403739|NCT02713997|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153403740|NCT02713997|Analgesics|analgesics|mesh-ancestor
153403741|NCT02713997|Sensory System Agents|sensory system agents|mesh-ancestor
153403742|NCT02713997|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153403743|NCT02713997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153403744|NCT02713997|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153403745|NCT02713997|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153403746|NCT02713997|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153403747|NCT02713997|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153403748|NCT02713997|Immunologic Factors|immunologic factors|mesh-ancestor
153403749|NCT02713997|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
153863362|NCT04934228|Sympatholytics|sympatholytics|mesh-ancestor
153863363|NCT04934228|Autonomic Agents|autonomic agents|mesh-ancestor
153863364|NCT04934228|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
153863365|NCT04934228|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153863366|NCT04934228|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153863367|NCT04934228|Adrenergic Agents|adrenergic agents|mesh-ancestor
153863368|NCT04934228|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153863369|NCT03454503|Imatinib Mesylate|imatinib mesylate|mesh-list
153863370|NCT03454503|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153863371|NCT03454503|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153863372|NCT03454503|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153863373|NCT03454503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153863374|NCT03454503|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153863375|NCT04616391|Insulin|insulin|mesh-list
153863376|NCT04616391|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153863377|NCT04616391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153863378|NCT04615962|Mometasone Furoate|mometasone furoate|mesh-list
153863379|NCT04615962|Hydrocortisone|hydrocortisone|mesh-list
153863380|NCT04615962|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
153403750|NCT02713997|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
153403751|NCT02713997|Protease Inhibitors|protease inhibitors|mesh-ancestor
153403752|NCT02713997|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153403753|NCT02713997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153863402|NCT04615611|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153863403|NCT04615611|Respiratory System Agents|respiratory system agents|mesh-ancestor
153863404|NCT04615611|Tocolytic Agents|tocolytic agents|mesh-ancestor
153863405|NCT04615611|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153863406|NCT04615611|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
153863407|NCT04615611|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
153863408|NCT04615611|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153403777|NCT02623972|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153403778|NCT02623972|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153403779|NCT02568618|Analgesics|analgesics|mesh-list
153888664|NCT01310777|Brimonidine Tartrate|brimonidine tartrate|mesh-list
153403803|NCT02514382|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153403804|NCT02514382|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153403805|NCT02514382|Protease Inhibitors|protease inhibitors|mesh-ancestor
153403831|NCT02409147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153403832|NCT02409147|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153403833|NCT02409147|Immunologic Factors|immunologic factors|mesh-ancestor
153403834|NCT02409147|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153403835|NCT02409147|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153403836|NCT02409147|Antifungal Agents|antifungal agents|mesh-ancestor
153403837|NCT02409147|Ionophores|ionophores|mesh-ancestor
153403838|NCT02409147|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153403839|NCT02402439|Pancrelipase|pancrelipase|mesh-list
153403843|NCT02392026|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153403844|NCT02392026|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153403845|NCT02392026|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153403846|NCT02392026|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153403847|NCT02389036|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
153403848|NCT02389036|Ciprofloxacin|ciprofloxacin|mesh-list
153403849|NCT02389036|Ceftriaxone|ceftriaxone|mesh-list
153403850|NCT02389036|Tobramycin|tobramycin|mesh-list
153403851|NCT02389036|Colistin|colistin|mesh-list
153403852|NCT02389036|Nystatin|nystatin|mesh-list
153403853|NCT02389036|Cefotaxime|cefotaxime|mesh-list
153403854|NCT02389036|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153403855|NCT02389036|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153403856|NCT02389036|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153403857|NCT02389036|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153403858|NCT02389036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153403859|NCT02389036|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153403860|NCT02389036|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
153403861|NCT02389036|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153403862|NCT02389036|Third Generation Cephalosporins|third generation cephalosporins|mesh-ancestor
153863499|NCT04587947|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
153863501|NCT04587947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153863502|NCT04612998|Atropine|atropine|mesh-list
153863503|NCT04612998|Ephedrine|ephedrine|mesh-list
153863504|NCT04612998|Metoclopramide|metoclopramide|mesh-list
153403914|NCT02079181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153863533|NCT00563589|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
153863534|NCT00563589|Abortifacient Agents|abortifacient agents|mesh-ancestor
153863536|NCT00563589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153863537|NCT00563589|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153863538|NCT00563589|Antimetabolites|antimetabolites|mesh-ancestor
153863539|NCT00563589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153403916|NCT02043457|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153403917|NCT02043457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153403918|NCT01860937|Cyclophosphamide|cyclophosphamide|mesh-list
153403919|NCT01860937|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153403920|NCT01860937|Immunologic Factors|immunologic factors|mesh-ancestor
153403921|NCT01860937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153403922|NCT01860937|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153403923|NCT01860937|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153403924|NCT01860937|Alkylating Agents|alkylating agents|mesh-ancestor
153403925|NCT01860937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153403926|NCT01860937|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153403927|NCT01860937|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153403928|NCT01770145|Levodopa|levodopa|mesh-list
153403929|NCT01770145|Carbidopa|carbidopa|mesh-list
153403930|NCT01770145|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
153403931|NCT01770145|Trimethobenzamide|trimethobenzamide|mesh-list
153403932|NCT01770145|Apomorphine|apomorphine|mesh-list
153403933|NCT01770145|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
153403934|NCT01770145|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
153403935|NCT01770145|Dopamine Agents|dopamine agents|mesh-ancestor
153403936|NCT01770145|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153403937|NCT01770145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153403938|NCT01770145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153403939|NCT01770145|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
153403940|NCT01770145|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153403941|NCT01770145|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153863541|NCT00563589|Dermatologic Agents|dermatologic agents|mesh-ancestor
153863542|NCT00563589|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153863543|NCT00563589|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153863544|NCT00563589|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153863545|NCT00563589|Immunologic Factors|immunologic factors|mesh-ancestor
153863546|NCT00563589|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153863547|NCT00563589|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153863554|NCT00563589|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153863555|NCT04612803|Histamine Antagonists|histamine antagonists|mesh-list
153863556|NCT04612803|Histamine H1 Antagonists|histamine h1 antagonists|mesh-list
153863557|NCT04612803|Histamine Agents|histamine agents|mesh-ancestor
153863568|NCT02204345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153863571|NCT02187302|Everolimus|everolimus|mesh-list
153863572|NCT02187302|Sorafenib|sorafenib|mesh-list
153863573|NCT02187302|Axitinib|axitinib|mesh-list
153863574|NCT02187302|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153403951|NCT01758081|Cholecalciferol|cholecalciferol|mesh-list
153403952|NCT01758081|Vitamins|vitamins|mesh-list
153403953|NCT01758081|Micronutrients|micronutrients|mesh-ancestor
153403954|NCT01758081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153403955|NCT01758081|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153403956|NCT01758081|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153403957|NCT01726582|Leucovorin|leucovorin|mesh-list
153403958|NCT01726582|Paclitaxel|paclitaxel|mesh-list
153403959|NCT01726582|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
153403960|NCT01726582|Gemcitabine|gemcitabine|mesh-list
153403961|NCT01726582|Capecitabine|capecitabine|mesh-list
153403962|NCT01726582|Fluorouracil|fluorouracil|mesh-list
153403963|NCT01726582|Oxaliplatin|oxaliplatin|mesh-list
153403964|NCT01726582|Irinotecan|irinotecan|mesh-list
153403965|NCT01726582|Cisplatin|cisplatin|mesh-list
153403966|NCT01726582|Folfirinox|folfirinox|mesh-list
153863578|NCT02187302|Growth Substances|growth substances|mesh-ancestor
153863579|NCT02187302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153863580|NCT02187302|Growth Inhibitors|growth inhibitors|mesh-ancestor
153863581|NCT02187302|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
153863582|NCT02187302|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153863583|NCT02187302|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153863584|NCT02187302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153863585|NCT02187302|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153863586|NCT02187302|Immunologic Factors|immunologic factors|mesh-ancestor
153863588|NCT02179151|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153863589|NCT02179151|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153863590|NCT02179151|Growth Substances|growth substances|mesh-ancestor
153863591|NCT02179151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153863592|NCT02179151|Growth Inhibitors|growth inhibitors|mesh-ancestor
153863593|NCT02179151|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153863594|NCT02160665|Tazarotene|tazarotene|mesh-list
153863595|NCT02160665|Dermatologic Agents|dermatologic agents|mesh-ancestor
153863596|NCT02160665|Keratolytic Agents|keratolytic agents|mesh-ancestor
153863597|NCT02138630|Capsaicin|capsaicin|mesh-list
153863598|NCT02138630|Antipruritics|antipruritics|mesh-ancestor
153863599|NCT02138630|Dermatologic Agents|dermatologic agents|mesh-ancestor
153863600|NCT02138630|Sensory System Agents|sensory system agents|mesh-ancestor
153863601|NCT02138630|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153863602|NCT02138630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153863603|NCT02137343|Capecitabine|capecitabine|mesh-list
153863604|NCT02137343|Rilotumumab|rilotumumab|mesh-list
153863605|NCT02137343|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153403985|NCT01726582|Micronutrients|micronutrients|mesh-ancestor
153403986|NCT01687127|Folic Acid|folic acid|mesh-list
153403988|NCT01687127|Calcium|calcium|mesh-list
153863693|NCT02072954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153404074|NCT00675844|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153404075|NCT00675844|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153404076|NCT00675844|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153404077|NCT00571714|Ribavirin|ribavirin|mesh-list
153404078|NCT00571714|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
153404079|NCT00571714|Interferon-alpha|interferon-alpha|mesh-list
153404080|NCT00571714|Betaine|betaine|mesh-list
153404082|NCT00571714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153404083|NCT00571714|Antiviral Agents|antiviral agents|mesh-ancestor
153404084|NCT00571714|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153404085|NCT00571714|Immunologic Factors|immunologic factors|mesh-ancestor
153404086|NCT00571714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153404087|NCT00571714|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153404088|NCT00571714|Lipotropic Agents|lipotropic agents|mesh-ancestor
153404089|NCT00571714|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153404090|NCT00571714|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153404091|NCT00506662|Insulin|insulin|mesh-list
153404092|NCT00506662|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
153404093|NCT00506662|Insulin Detemir|insulin detemir|mesh-list
153404094|NCT00506662|Isophane Insulin, Human|isophane insulin, human|mesh-list
153404095|NCT00506662|Insulin, Isophane|insulin, isophane|mesh-list
153404096|NCT00506662|Isophane insulin, beef|isophane insulin, beef|mesh-list
153404097|NCT00506662|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153404098|NCT00506662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153404099|NCT00455039|Lapatinib|lapatinib|mesh-list
153863706|NCT00554918|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153863707|NCT00554918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153863708|NCT00554918|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153863709|NCT00554918|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153863710|NCT04631874|Varenicline|varenicline|mesh-list
153863711|NCT04631874|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
153863712|NCT04631874|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
153863713|NCT04631874|Cholinergic Agents|cholinergic agents|mesh-ancestor
153404104|NCT00455039|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153404106|NCT00410956|Bevacizumab|bevacizumab|mesh-list
153404107|NCT00410956|Floxuridine|floxuridine|mesh-list
153404108|NCT00410956|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153404109|NCT00410956|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153404110|NCT00410956|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153404111|NCT00410956|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153404112|NCT00410956|Growth Substances|growth substances|mesh-ancestor
153404113|NCT00410956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153404114|NCT00410956|Growth Inhibitors|growth inhibitors|mesh-ancestor
153404115|NCT00410956|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153404116|NCT00410956|Antiemetics|antiemetics|mesh-ancestor
153404117|NCT00410956|Autonomic Agents|autonomic agents|mesh-ancestor
153404118|NCT00410956|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153404119|NCT00410956|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153404120|NCT00410956|Glucocorticoids|glucocorticoids|mesh-ancestor
153404121|NCT00410956|Hormones|hormones|mesh-ancestor
153404125|NCT00410956|Antimetabolites|antimetabolites|mesh-ancestor
153404126|NCT00410956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153863719|NCT02057315|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153863722|NCT02057315|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153863723|NCT02057315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153863724|NCT02057315|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153863725|NCT02057315|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153863726|NCT02057315|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153863727|NCT02057315|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153863728|NCT02057315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153863729|NCT02047214|Bevacizumab|bevacizumab|mesh-list
153863730|NCT02047214|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153863731|NCT02047214|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153863732|NCT02047214|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153863733|NCT02047214|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153863734|NCT02047214|Growth Substances|growth substances|mesh-ancestor
153863735|NCT02047214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153863736|NCT02047214|Growth Inhibitors|growth inhibitors|mesh-ancestor
153863737|NCT02032277|Paclitaxel|paclitaxel|mesh-list
153863759|NCT02032277|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
153863760|NCT00560976|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
153863761|NCT00560976|Ferric gluconate|ferric gluconate|mesh-list
153863766|NCT04611126|Cyclophosphamide|cyclophosphamide|mesh-list
153863768|NCT04611126|Fludarabine|fludarabine|mesh-list
153863769|NCT04611126|Fludarabine phosphate|fludarabine phosphate|mesh-list
153863770|NCT04611126|Ipilimumab|ipilimumab|mesh-list
153863771|NCT04611126|Relatlimab|relatlimab|mesh-list
153863772|NCT04611126|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153863773|NCT04611126|Immunologic Factors|immunologic factors|mesh-ancestor
153863774|NCT04611126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153863775|NCT04611126|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153863776|NCT04611126|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153863777|NCT04611126|Alkylating Agents|alkylating agents|mesh-ancestor
153863778|NCT04611126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153404174|NCT00006436|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153404175|NCT00006436|Glucocorticoids|glucocorticoids|mesh-ancestor
153404177|NCT00006436|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153404178|NCT00006436|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153404179|NCT00006436|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153404180|NCT00006436|Tubulin Modulators|tubulin modulators|mesh-ancestor
153404181|NCT00006436|Antimitotic Agents|antimitotic agents|mesh-ancestor
153404182|NCT00006436|Mitosis Modulators|mitosis modulators|mesh-ancestor
153404183|NCT02399917|Azacitidine|azacitidine|mesh-list
153404184|NCT02399917|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153404185|NCT02399917|Antimetabolites|antimetabolites|mesh-ancestor
153863804|NCT01998035|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153404186|NCT02399917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153404187|NCT02399917|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153404188|NCT02399917|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153404190|NCT00356486|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
153404191|NCT00356486|Interferon-alpha|interferon-alpha|mesh-list
153404192|NCT00356486|Antimetabolites|antimetabolites|mesh-ancestor
153404193|NCT00356486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153404194|NCT00356486|Antiviral Agents|antiviral agents|mesh-ancestor
153404195|NCT00356486|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153404196|NCT00356486|Immunologic Factors|immunologic factors|mesh-ancestor
153888678|NCT01309997|Rituximab|rituximab|mesh-list
153404223|NCT02354833|Adrenergic Agents|adrenergic agents|mesh-ancestor
153404224|NCT02354833|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153404225|NCT02354833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153404226|NCT02354833|Protective Agents|protective agents|mesh-ancestor
153404227|NCT03838484|Nicotine|nicotine|mesh-list
153404228|NCT03838484|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
153404229|NCT03838484|Autonomic Agents|autonomic agents|mesh-ancestor
153404230|NCT03838484|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153404232|NCT03838484|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
153863838|NCT04630548|Copper|copper|mesh-list
153863839|NCT04630548|Trace Elements|trace elements|mesh-ancestor
153863840|NCT04630548|Micronutrients|micronutrients|mesh-ancestor
153863841|NCT04630548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153863842|NCT01975610|Spebrutinib|spebrutinib|mesh-list
153863843|NCT01975610|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153863844|NCT01975610|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153863845|NCT01975610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153863846|NCT01969838|N-(cyanomethyl)-4-(2-((4-(4-morpholinyl)phenyl)amino)-4-pyrimidinyl)benzamide|n-(cyanomethyl)-4-(2-((4-(4-morpholinyl)phenyl)amino)-4-pyrimidinyl)benzamide|mesh-list
153863847|NCT01969838|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153863848|NCT01969838|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153863849|NCT01969838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153863850|NCT01967810|Bevacizumab|bevacizumab|mesh-list
153863851|NCT01967810|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153863857|NCT01967810|Growth Inhibitors|growth inhibitors|mesh-ancestor
153863858|NCT01165138|Fluticasone|fluticasone|mesh-list
153863860|NCT01165138|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153863861|NCT01165138|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153863862|NCT01165138|Autonomic Agents|autonomic agents|mesh-ancestor
153404277|NCT02358889|Immunologic Factors|immunologic factors|mesh-ancestor
153404278|NCT00358124|Metformin|metformin|mesh-list
153404279|NCT00358124|Insulin Glargine|insulin glargine|mesh-list
153404280|NCT00358124|Rosiglitazone|rosiglitazone|mesh-list
153404281|NCT00358124|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153404282|NCT00358124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153404283|NCT00358202|Ceftriaxone|ceftriaxone|mesh-list
153404284|NCT00358202|Cefepime|cefepime|mesh-list
153404285|NCT00358202|Third Generation Cephalosporins|third generation cephalosporins|mesh-ancestor
153404286|NCT00358202|Beta Lactam Antibiotics|beta lactam antibiotics|mesh-ancestor
153404287|NCT00358202|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153404288|NCT00358202|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153863912|NCT00561132|Magnesium Oxide|magnesium oxide|mesh-list
153863913|NCT00561132|Antacids|antacids|mesh-ancestor
153863914|NCT00561132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153863915|NCT00561132|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153863916|NCT00561132|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153863917|NCT00561132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153863918|NCT01956812|Gemcitabine|gemcitabine|mesh-list
153863919|NCT01956812|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153863920|NCT01956812|Antimetabolites|antimetabolites|mesh-ancestor
153863921|NCT01956812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153863922|NCT01956812|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153404321|NCT00357188|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
153404322|NCT00357188|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
153863923|NCT01952990|Phenylephrine|phenylephrine|mesh-list
153863924|NCT01952990|Oxymetazoline|oxymetazoline|mesh-list
153863925|NCT01952990|Tetracaine|tetracaine|mesh-list
153863926|NCT01952990|Anesthetics, Local|anesthetics, local|mesh-ancestor
153863927|NCT01952990|Anesthetics|anesthetics|mesh-ancestor
153863928|NCT01952990|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153863929|NCT01952990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153863930|NCT01952990|Sensory System Agents|sensory system agents|mesh-ancestor
153863931|NCT01952990|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153863932|NCT01952990|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153863933|NCT01952990|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153863934|NCT01952990|Adrenergic Agents|adrenergic agents|mesh-ancestor
153863935|NCT01952990|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153863936|NCT01952990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153863937|NCT01952990|Sympathomimetics|sympathomimetics|mesh-ancestor
153863938|NCT01952990|Autonomic Agents|autonomic agents|mesh-ancestor
153863940|NCT01952990|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
153863941|NCT01952990|Respiratory System Agents|respiratory system agents|mesh-ancestor
153863942|NCT01952990|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
153863943|NCT01952990|Mydriatics|mydriatics|mesh-ancestor
153863944|NCT01952990|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
153863948|NCT04314310|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153863949|NCT04314310|Analgesics|analgesics|mesh-ancestor
153863950|NCT04314310|Sensory System Agents|sensory system agents|mesh-ancestor
153863951|NCT04314310|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153863952|NCT04314310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153863953|NCT04314310|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153863954|NCT04314310|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153863955|NCT04314310|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153863956|NCT04314310|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153863957|NCT04314310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153863958|NCT04610307|Anesthetics|anesthetics|mesh-list
153863959|NCT04610307|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153863960|NCT04610307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153863961|NCT04610502|Immunoglobulins|immunoglobulins|mesh-list
153404351|NCT01349192|Rifampin|rifampin|mesh-list
153404352|NCT01349192|Trimethoprim|trimethoprim|mesh-list
153404353|NCT01349192|Sulfamethoxazole|sulfamethoxazole|mesh-list
153404355|NCT01349192|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
153404356|NCT01349192|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153863968|NCT01164475|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153863969|NCT01164475|Immunologic Factors|immunologic factors|mesh-ancestor
153863970|NCT01164475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153863971|NCT01164475|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153863972|NCT01164475|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153863973|NCT01164475|Antiviral Agents|antiviral agents|mesh-ancestor
153863974|NCT01164475|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153863976|NCT01164007|Dacarbazine|dacarbazine|mesh-list
153863977|NCT01164007|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153863978|NCT01164007|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153404404|NCT00354991|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153404406|NCT02112578|Dimenhydrinate|dimenhydrinate|mesh-list
153404407|NCT02112578|Antiemetics|antiemetics|mesh-ancestor
153404408|NCT02112578|Autonomic Agents|autonomic agents|mesh-ancestor
153404409|NCT02112578|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153404410|NCT02112578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153404411|NCT02112578|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153404412|NCT02112578|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
153404413|NCT02112578|Histamine Antagonists|histamine antagonists|mesh-ancestor
153404414|NCT02112578|Histamine Agents|histamine agents|mesh-ancestor
153864018|NCT01917383|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
153864019|NCT01163617|Adalimumab|adalimumab|mesh-list
153864020|NCT01163617|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
153864021|NCT01163617|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153864022|NCT01163617|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153864023|NCT01911767|Dimethyl Fumarate|dimethyl fumarate|mesh-list
153864024|NCT01911767|Dermatologic Agents|dermatologic agents|mesh-ancestor
153864025|NCT01911767|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153864026|NCT01911767|Immunologic Factors|immunologic factors|mesh-ancestor
153864027|NCT01911767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153864028|NCT04629846|Docetaxel|docetaxel|mesh-list
153404421|NCT00358280|Ropivacaine|ropivacaine|mesh-list
153404422|NCT00358280|Anesthetics, Local|anesthetics, local|mesh-ancestor
153404423|NCT00358280|Anesthetics|anesthetics|mesh-ancestor
153404424|NCT00358280|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153404425|NCT00358280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153404426|NCT00358280|Sensory System Agents|sensory system agents|mesh-ancestor
153404427|NCT00358280|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153404428|NCT02363803|Lidocaine|lidocaine|mesh-list
153404429|NCT02363803|Anesthetics, Local|anesthetics, local|mesh-ancestor
153404430|NCT02363803|Anesthetics|anesthetics|mesh-ancestor
153404431|NCT02363803|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153404432|NCT02363803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153404433|NCT02363803|Sensory System Agents|sensory system agents|mesh-ancestor
153404434|NCT02363803|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153404435|NCT02363803|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153404436|NCT02363803|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
153404437|NCT02363803|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153404438|NCT02363803|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153404439|NCT02363803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153404440|NCT03417193|Analgesics, Opioid|analgesics, opioid|mesh-list
153864030|NCT04629846|Pertuzumab|pertuzumab|mesh-list
153864031|NCT04629846|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153864032|NCT04629846|Tubulin Modulators|tubulin modulators|mesh-ancestor
153864033|NCT04629846|Antimitotic Agents|antimitotic agents|mesh-ancestor
153864034|NCT04629846|Mitosis Modulators|mitosis modulators|mesh-ancestor
153864044|NCT01909427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153864045|NCT01909427|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153864046|NCT01909427|Dermatologic Agents|dermatologic agents|mesh-ancestor
153864047|NCT01909427|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153864048|NCT01909427|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153864049|NCT01909427|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153864050|NCT01909427|Immunologic Factors|immunologic factors|mesh-ancestor
153864051|NCT01909427|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153864052|NCT01909427|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153864053|NCT04629573|Anesthetics|anesthetics|mesh-list
153404444|NCT03417193|Narcotics|narcotics|mesh-ancestor
153404445|NCT03417193|Analgesics|analgesics|mesh-ancestor
153404446|NCT03417193|Sensory System Agents|sensory system agents|mesh-ancestor
153404447|NCT03417193|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153404448|NCT02368093|Levomethorphan|levomethorphan|mesh-list
153404449|NCT02368093|Dextromethorphan|dextromethorphan|mesh-list
153404461|NCT02368093|Sensory System Agents|sensory system agents|mesh-ancestor
153404462|NCT02368093|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153404463|NCT03342937|Pembrolizumab|pembrolizumab|mesh-list
153404464|NCT03342937|Capecitabine|capecitabine|mesh-list
153404465|NCT03342937|Oxaliplatin|oxaliplatin|mesh-list
153404466|NCT03342937|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153404467|NCT03342937|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153404468|NCT03342937|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153404469|NCT03342937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153864054|NCT04629573|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153864055|NCT04629573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153864056|NCT00564174|Aspirin|aspirin|mesh-list
153864057|NCT00564174|Heparin|heparin|mesh-list
153864058|NCT00564174|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
153864059|NCT00564174|Tinzaparin|tinzaparin|mesh-list
153864060|NCT00564174|Dalteparin|dalteparin|mesh-list
153864061|NCT00564174|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153864062|NCT00564174|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153864063|NCT00564174|Analgesics|analgesics|mesh-ancestor
153864064|NCT00564174|Sensory System Agents|sensory system agents|mesh-ancestor
153864065|NCT00564174|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153864066|NCT00564174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153882900|NCT01686464|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153882901|NCT01686464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153882902|NCT01686464|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153882903|NCT01686464|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153882904|NCT01686464|Antiviral Agents|antiviral agents|mesh-ancestor
153423823|NCT03523988|Ibuprofen|ibuprofen|mesh-list
153382466|NCT01688336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153864067|NCT00564174|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153864068|NCT00564174|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153864069|NCT00564174|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153864070|NCT00564174|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153864071|NCT00564174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153864072|NCT00564174|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153864073|NCT00564174|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153864074|NCT00564174|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153864075|NCT00564174|Antipyretics|antipyretics|mesh-ancestor
153864076|NCT00564174|Anticoagulants|anticoagulants|mesh-ancestor
153864077|NCT01163266|Vortioxetine|vortioxetine|mesh-list
153864078|NCT01163266|Antidepressive Agents|antidepressive agents|mesh-ancestor
153864079|NCT01163266|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153404483|NCT05718661|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153404484|NCT05718661|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153404485|NCT05718661|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
153404487|NCT00354757|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
153404488|NCT00354757|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153404491|NCT00354757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153404492|NCT02376283|Clopidogrel|clopidogrel|mesh-list
153404494|NCT02376283|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
153404495|NCT02376283|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153404496|NCT02376283|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
153404497|NCT02376283|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
153404498|NCT02376283|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
153404499|NCT02376283|Purinergic Agents|purinergic agents|mesh-ancestor
153404511|NCT00355303|Dinoprostone|dinoprostone|mesh-list
153404512|NCT00355303|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
153404513|NCT00355303|Abortifacient Agents|abortifacient agents|mesh-ancestor
153404514|NCT00355303|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153404515|NCT00355303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153404516|NCT00355303|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
153404517|NCT00355303|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153404518|NCT00355303|Oxytocics|oxytocics|mesh-ancestor
153404519|NCT05717569|Vitamin D|vitamin d|mesh-list
153404520|NCT05717569|Vitamins|vitamins|mesh-ancestor
153404521|NCT05717569|Micronutrients|micronutrients|mesh-ancestor
153864098|NCT01873703|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153864100|NCT01870505|Letrozole|letrozole|mesh-list
153864101|NCT01870505|Exemestane|exemestane|mesh-list
153864102|NCT01870505|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153864103|NCT01870505|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
153864104|NCT01870505|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153864105|NCT01870505|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153864106|NCT01870505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153864107|NCT01870505|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
153864121|NCT00564213|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153864122|NCT01861847|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
153864123|NCT01861847|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153864124|NCT01861847|Immunologic Factors|immunologic factors|mesh-ancestor
153864125|NCT01861847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153864126|NCT00564252|Finasteride|finasteride|mesh-list
153864127|NCT00564252|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
153864128|NCT00564252|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153404522|NCT05717569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153404523|NCT05717569|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153404524|NCT02385097|Ropivacaine|ropivacaine|mesh-list
153404525|NCT02385097|Chloroprocaine|chloroprocaine|mesh-list
153404526|NCT02385097|Anesthetics, Local|anesthetics, local|mesh-ancestor
153404527|NCT02385097|Anesthetics|anesthetics|mesh-ancestor
153888689|NCT01309841|Naloxegol|naloxegol|mesh-list
153404541|NCT00355459|Antimalarials|antimalarials|mesh-ancestor
153404542|NCT00355459|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153404543|NCT00355459|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153404544|NCT00355459|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
153404545|NCT00355459|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153404546|NCT00355459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153404547|NCT02393677|Dexmedetomidine|dexmedetomidine|mesh-list
153864129|NCT00564252|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153864130|NCT00564252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153864131|NCT00564252|Hormone Antagonists|hormone antagonists|mesh-ancestor
153864132|NCT00564252|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153864133|NCT00564252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153864134|NCT00564252|Urological Agents|urological agents|mesh-ancestor
153864135|NCT04629144|Belimumab|belimumab|mesh-list
153864136|NCT04629144|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153864137|NCT04629144|Immunologic Factors|immunologic factors|mesh-ancestor
153864138|NCT04629144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153404552|NCT02393677|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153404554|NCT02393677|Sensory System Agents|sensory system agents|mesh-ancestor
153404555|NCT02393677|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153404556|NCT02393677|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
153404557|NCT02393677|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153404558|NCT02393677|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153404559|NCT02393677|Adrenergic Agents|adrenergic agents|mesh-ancestor
153404560|NCT02393677|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153404561|NCT02393677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153404562|NCT02393677|Anesthetics, Local|anesthetics, local|mesh-ancestor
153404563|NCT02393677|Anesthetics|anesthetics|mesh-ancestor
153404564|NCT02394457|Cosyntropin|cosyntropin|mesh-list
153404565|NCT02394457|Hormones|hormones|mesh-ancestor
153404570|NCT00355771|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
153404571|NCT00355771|Histamine Antagonists|histamine antagonists|mesh-ancestor
153404572|NCT00355771|Histamine Agents|histamine agents|mesh-ancestor
153404573|NCT00355771|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153404574|NCT00355771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153404575|NCT00355771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153404577|NCT05664139|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153404578|NCT05664139|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153404579|NCT05664139|Tubulin Modulators|tubulin modulators|mesh-ancestor
153404580|NCT05664139|Antimitotic Agents|antimitotic agents|mesh-ancestor
153404581|NCT05664139|Mitosis Modulators|mitosis modulators|mesh-ancestor
153404582|NCT05664139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153404583|NCT03224351|Ivacaftor|ivacaftor|mesh-list
153404584|NCT03224351|VX-659|vx-659|mesh-list
153404585|NCT03224351|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
153404586|NCT03224351|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153404587|NCT03224351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153404588|NCT05658055|Amoxicillin|amoxicillin|mesh-list
153404589|NCT05658055|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153404590|NCT05658055|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153864185|NCT04609293|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153864186|NCT04609293|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153864187|NCT04609293|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153864188|NCT04609293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153864189|NCT04676789|Pegaspargase|pegaspargase|mesh-list
153864190|NCT04676789|Antibodies|antibodies|mesh-list
153864191|NCT04676789|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
153864192|NCT04676789|Immunologic Factors|immunologic factors|mesh-ancestor
153864193|NCT04676789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153864194|NCT04676789|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153864195|NCT01811576|Hormones|hormones|mesh-list
153864196|NCT01811576|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153864197|NCT01811576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153404591|NCT01721876|Cytarabine|cytarabine|mesh-list
153404592|NCT01721876|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153404593|NCT01721876|Antimetabolites|antimetabolites|mesh-ancestor
153404594|NCT01721876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153404595|NCT01721876|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153864203|NCT01804829|Immunoglobulin G|immunoglobulin g|mesh-list
153864204|NCT01804829|Immunologic Factors|immunologic factors|mesh-ancestor
153864205|NCT01804829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153864206|NCT00565422|Escitalopram|escitalopram|mesh-list
153864207|NCT00565422|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
153864208|NCT00565422|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153864209|NCT00565422|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153864210|NCT00565422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153864211|NCT00565422|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153864212|NCT00565422|Serotonin Agents|serotonin agents|mesh-ancestor
153864213|NCT00565422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153864214|NCT01802723|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
153864215|NCT01802723|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153864216|NCT01802723|Autonomic Agents|autonomic agents|mesh-ancestor
153864217|NCT01802723|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153864218|NCT01802723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153864219|NCT01802723|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153864220|NCT01802723|Respiratory System Agents|respiratory system agents|mesh-ancestor
153864221|NCT01802723|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
153864222|NCT01802723|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
153864223|NCT01802723|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153864224|NCT01802723|Adrenergic Agents|adrenergic agents|mesh-ancestor
153864225|NCT01802723|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153864226|NCT01802723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153864227|NCT01789736|Travoprost|travoprost|mesh-list
153864228|NCT01789736|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
153864229|NCT01789736|Ophthalmic Solutions|ophthalmic solutions|mesh-list
153864230|NCT01789736|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153864231|NCT00564330|Esomeprazole|esomeprazole|mesh-list
153864232|NCT00564330|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
153864233|NCT00564330|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153864234|NCT00564330|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
153864235|NCT00564330|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153864236|NCT00564330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153864237|NCT01779947|Estradiol|estradiol|mesh-list
153864238|NCT01779947|Estrogens|estrogens|mesh-ancestor
153864239|NCT01779947|Hormones|hormones|mesh-ancestor
153864240|NCT01779947|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153864241|NCT01779947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153864242|NCT00564408|Carbachol|carbachol|mesh-list
153864243|NCT00564408|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
153864244|NCT00564408|Miotics|miotics|mesh-ancestor
153404643|NCT05419297|Buprenorphine|buprenorphine|mesh-list
153404646|NCT05419297|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153404647|NCT05419297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153404648|NCT05419297|Analgesics|analgesics|mesh-ancestor
153404649|NCT05419297|Sensory System Agents|sensory system agents|mesh-ancestor
153404650|NCT05419297|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153404651|NCT05419297|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
153404652|NCT03226457|Empagliflozin|empagliflozin|mesh-list
153404654|NCT03226457|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
153404655|NCT03226457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153404656|NCT03226457|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153404657|NCT03226457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153864268|NCT01758458|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153864269|NCT01758458|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153404672|NCT00003159|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153404674|NCT00003159|Antimitotic Agents|antimitotic agents|mesh-ancestor
153404675|NCT00003159|Mitosis Modulators|mitosis modulators|mesh-ancestor
153404676|NCT00003159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153404677|NCT00003159|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153404678|NCT00003159|Antimetabolites|antimetabolites|mesh-ancestor
153404679|NCT00003159|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153404680|NCT00003159|Alkylating Agents|alkylating agents|mesh-ancestor
153404681|NCT00003159|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153404682|NCT00003159|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153404683|NCT00003159|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153864274|NCT01758458|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153864292|NCT04608981|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153864293|NCT04608981|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153864294|NCT04608981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153864295|NCT01737905|Epinephrine|epinephrine|mesh-list
153864296|NCT01737905|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153864297|NCT01737905|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153864298|NCT01737905|Adrenergic Agents|adrenergic agents|mesh-ancestor
153864299|NCT01737905|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153864300|NCT01737905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153864301|NCT01737905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153864302|NCT01737905|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
153864303|NCT01737905|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153864304|NCT01737905|Autonomic Agents|autonomic agents|mesh-ancestor
153864305|NCT01737905|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153864306|NCT01737905|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153864385|NCT01697072|Capecitabine|capecitabine|mesh-list
153864386|NCT01697072|Epirubicin|epirubicin|mesh-list
153864387|NCT01697072|Rilotumumab|rilotumumab|mesh-list
153429779|NCT00002756|Vincristine|vincristine|mesh-list
153864388|NCT01697072|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153864389|NCT01697072|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153864390|NCT01697072|Antimetabolites|antimetabolites|mesh-ancestor
153404787|NCT01805271|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153864400|NCT00565500|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153864401|NCT00565500|Analgesics|analgesics|mesh-ancestor
153864402|NCT00565500|Sensory System Agents|sensory system agents|mesh-ancestor
153864403|NCT00565500|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153864404|NCT00565500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153864405|NCT00565500|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153864406|NCT00565500|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153864407|NCT00565500|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153864408|NCT00565500|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153404806|NCT00376493|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153404807|NCT00376493|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153404808|NCT00376493|Antimalarials|antimalarials|mesh-ancestor
153404809|NCT00003195|Interferons|interferons|mesh-list
153404810|NCT00003195|Interferon-alpha|interferon-alpha|mesh-list
153404812|NCT00003195|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153404813|NCT00003195|Antiviral Agents|antiviral agents|mesh-ancestor
153404814|NCT00003195|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153404815|NCT00003195|Immunologic Factors|immunologic factors|mesh-ancestor
153404816|NCT00003195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153404817|NCT00003195|Alkylating Agents|alkylating agents|mesh-ancestor
153404818|NCT00003195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153404819|NCT00003195|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153404820|NCT00003195|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153864409|NCT00565500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153864410|NCT00565500|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
153864411|NCT04608084|Ophthalmic Solutions|ophthalmic solutions|mesh-list
153864412|NCT04608084|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
153864413|NCT01691846|Metformin|metformin|mesh-list
153864414|NCT01691846|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153864415|NCT01691846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153864416|NCT01658501|Metformin|metformin|mesh-list
153864417|NCT01658501|Liraglutide|liraglutide|mesh-list
153864418|NCT01658501|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153864419|NCT01658501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153864420|NCT01658501|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
153864421|NCT01658501|Incretins|incretins|mesh-ancestor
153404832|NCT00356083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153404833|NCT00356083|Analgesics|analgesics|mesh-ancestor
153404841|NCT02977832|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
153404842|NCT02977832|Adrenergic Agents|adrenergic agents|mesh-ancestor
153404843|NCT02977832|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153404844|NCT02977832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153404845|NCT02977832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153404846|NCT02977832|Urological Agents|urological agents|mesh-ancestor
153404847|NCT04344236|Chlorhexidine|chlorhexidine|mesh-list
153404848|NCT04344236|Povidone-Iodine|povidone-iodine|mesh-list
153404850|NCT04344236|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
153404851|NCT04344236|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153404852|NCT04344236|Disinfectants|disinfectants|mesh-ancestor
153404853|NCT04344236|Plasma Substitutes|plasma substitutes|mesh-ancestor
153404854|NCT04344236|Blood Substitutes|blood substitutes|mesh-ancestor
153404855|NCT00355537|Testosterone|testosterone|mesh-list
153404856|NCT00355537|Androgens|androgens|mesh-ancestor
153404857|NCT00355537|Hormones|hormones|mesh-ancestor
153404858|NCT00355537|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153404859|NCT00355537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153404860|NCT00003207|Doxorubicin|doxorubicin|mesh-list
153404861|NCT00003207|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
153404862|NCT00003207|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153864437|NCT04608006|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153864438|NCT04608006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153864439|NCT04608006|Sensory System Agents|sensory system agents|mesh-ancestor
153429795|NCT00002756|Hormones|hormones|mesh-ancestor
153429796|NCT00002756|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153864440|NCT04608006|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153864441|NCT04608006|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153864442|NCT04608006|Narcotics|narcotics|mesh-ancestor
153864443|NCT04608006|Analgesics|analgesics|mesh-ancestor
153864444|NCT04608006|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153864445|NCT04608006|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153864446|NCT04608006|Anesthetics, General|anesthetics, general|mesh-ancestor
153864447|NCT04599621|Uric Acid|uric acid|mesh-list
153864448|NCT04599621|Antioxidants|antioxidants|mesh-ancestor
153864449|NCT04599621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153864450|NCT04599621|Protective Agents|protective agents|mesh-ancestor
153864451|NCT04599621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153864452|NCT00564525|Amitriptyline|amitriptyline|mesh-list
153864453|NCT00564525|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
153864454|NCT00564525|Antidepressive Agents|antidepressive agents|mesh-ancestor
153864455|NCT00564525|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153864456|NCT00564525|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153864457|NCT00564525|Analgesics|analgesics|mesh-ancestor
153864458|NCT00564525|Sensory System Agents|sensory system agents|mesh-ancestor
153864459|NCT00564525|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153864460|NCT00564525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153864461|NCT00564525|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
153864462|NCT00564525|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153864463|NCT00564525|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153864464|NCT00564525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153404863|NCT00003207|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153404864|NCT00003207|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153404865|NCT00003207|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153404866|NCT00003207|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153404868|NCT00003387|Paclitaxel|paclitaxel|mesh-list
153404875|NCT00003387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153404876|NCT04706897|Lidocaine|lidocaine|mesh-list
153404877|NCT04706897|Dexmedetomidine|dexmedetomidine|mesh-list
153404889|NCT04706897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153404890|NCT04706897|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153404891|NCT04706897|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153404892|NCT04706897|Analgesics|analgesics|mesh-ancestor
153404893|NCT04706897|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
153864486|NCT01516346|Isosorbide-5-mononitrate|isosorbide-5-mononitrate|mesh-list
153864487|NCT01516346|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
153864488|NCT01516346|Diuretics|diuretics|mesh-ancestor
153864489|NCT01516346|Natriuretic Agents|natriuretic agents|mesh-ancestor
153864490|NCT01516346|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153864491|NCT01516346|Vasodilator Agents|vasodilator agents|mesh-ancestor
153864492|NCT01516346|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
153864493|NCT01516346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153404901|NCT04706897|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
153404902|NCT04706897|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
153404904|NCT00003213|Dexamethasone acetate|dexamethasone acetate|mesh-list
153404906|NCT00003213|Granisetron|granisetron|mesh-list
153404907|NCT00003213|BB 1101|bb 1101|mesh-list
153404908|NCT00003213|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153404909|NCT00003213|Antiemetics|antiemetics|mesh-ancestor
153404910|NCT00003213|Autonomic Agents|autonomic agents|mesh-ancestor
153404911|NCT00003213|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153404912|NCT00003213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153404913|NCT00003213|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153404914|NCT00003213|Glucocorticoids|glucocorticoids|mesh-ancestor
153404915|NCT00003213|Hormones|hormones|mesh-ancestor
153404916|NCT00003213|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153404917|NCT00003213|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153404918|NCT00003213|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153404919|NCT00003213|Protease Inhibitors|protease inhibitors|mesh-ancestor
153404920|NCT00003213|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153404921|NCT00003213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153404922|NCT00003213|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
153404924|NCT00003213|Dopamine Agents|dopamine agents|mesh-ancestor
153404925|NCT00003213|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153404926|NCT00003213|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
153404927|NCT00003213|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153404928|NCT00003213|Serotonin Agents|serotonin agents|mesh-ancestor
153404929|NCT01445067|Calcitonin|calcitonin|mesh-list
153864517|NCT00564564|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153864518|NCT00564564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153864519|NCT00564564|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153864520|NCT00564564|Serotonin Agents|serotonin agents|mesh-ancestor
153864521|NCT02894138|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
153864522|NCT02894138|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153864523|NCT02894138|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153864524|NCT02894138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153864525|NCT00565656|Bevacizumab|bevacizumab|mesh-list
153864526|NCT00565656|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153404941|NCT00003399|Etoposide|etoposide|mesh-list
153404942|NCT00003399|Cyclophosphamide|cyclophosphamide|mesh-list
153404943|NCT00003399|Melphalan|melphalan|mesh-list
153404944|NCT00003399|Carmustine|carmustine|mesh-list
153404945|NCT00003399|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153404963|NCT00003399|Glucocorticoids|glucocorticoids|mesh-ancestor
153404964|NCT00003399|Hormones|hormones|mesh-ancestor
153404965|NCT00003399|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153404966|NCT00003399|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153404967|NCT00003399|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153404968|NCT00003399|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153404969|NCT00003399|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153404970|NCT03376061|Tranexamic Acid|tranexamic acid|mesh-list
153404971|NCT03376061|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
153404972|NCT03376061|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153404973|NCT03376061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153404974|NCT03376061|Hemostatics|hemostatics|mesh-ancestor
153404975|NCT03376061|Coagulants|coagulants|mesh-ancestor
153404976|NCT03376295|Tiotropium Bromide|tiotropium bromide|mesh-list
153404977|NCT03376295|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153404978|NCT03376295|Autonomic Agents|autonomic agents|mesh-ancestor
153404979|NCT03376295|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153404980|NCT03376295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153404981|NCT03376295|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153404982|NCT03376295|Respiratory System Agents|respiratory system agents|mesh-ancestor
153404983|NCT03376295|Parasympatholytics|parasympatholytics|mesh-ancestor
153404984|NCT03376295|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
153404985|NCT03376295|Cholinergic Agents|cholinergic agents|mesh-ancestor
153864551|NCT00555347|Modafinil|modafinil|mesh-list
153864552|NCT00555347|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
153864553|NCT00555347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153864566|NCT00564642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153864568|NCT00564642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153864569|NCT00564642|Antidotes|antidotes|mesh-ancestor
153864570|NCT00555386|Selenium|selenium|mesh-list
153864571|NCT00555386|Antioxidants|antioxidants|mesh-ancestor
153864572|NCT00555386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153864573|NCT00555386|Protective Agents|protective agents|mesh-ancestor
153864582|NCT04676516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153404987|NCT03376295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153404988|NCT00003219|Perillyl alcohol|perillyl alcohol|mesh-list
153404989|NCT00003219|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153404990|NCT00003219|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153404992|NCT05715788|Nitric Oxide|nitric oxide|mesh-list
153864584|NCT04675697|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153864585|NCT04675697|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153864586|NCT04675697|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153864587|NCT04675697|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153864588|NCT04675697|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153864589|NCT04675697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153864590|NCT04606836|Bupivacaine|bupivacaine|mesh-list
153864591|NCT04606836|Anesthetics, Local|anesthetics, local|mesh-ancestor
153864592|NCT04606836|Anesthetics|anesthetics|mesh-ancestor
153864593|NCT04606836|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153864594|NCT04606836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153864595|NCT04606836|Sensory System Agents|sensory system agents|mesh-ancestor
153864596|NCT04606836|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153864597|NCT01163149|Immunoglobulin G|immunoglobulin g|mesh-list
153864598|NCT01163149|Immunologic Factors|immunologic factors|mesh-ancestor
153864599|NCT01163149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153864600|NCT04676126|Dorzolamide|dorzolamide|mesh-list
153864601|NCT04676126|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153864602|NCT04676126|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
153864603|NCT04676126|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153864604|NCT04676126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153864605|NCT04675619|Pirfenidone|pirfenidone|mesh-list
153864606|NCT04675619|Analgesics|analgesics|mesh-ancestor
153405010|NCT00003225|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153405011|NCT00003225|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153405012|NCT00003225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153405013|NCT00003225|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153405014|NCT00003225|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
153405015|NCT00003225|Protective Agents|protective agents|mesh-ancestor
153405016|NCT00003225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153405017|NCT03838094|Calcium|calcium|mesh-list
153405018|NCT03838094|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153405019|NCT03838094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153405020|NCT03441269|Ibuprofen|ibuprofen|mesh-list
153405021|NCT03441269|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153405022|NCT03441269|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153405023|NCT03441269|Analgesics|analgesics|mesh-ancestor
153405024|NCT03441269|Sensory System Agents|sensory system agents|mesh-ancestor
153405025|NCT03441269|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153405026|NCT03441269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153405027|NCT03441269|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153864616|NCT05305300|Somatomedin B|somatomedin b|mesh-list
153864617|NCT05305300|Immunologic Factors|immunologic factors|mesh-ancestor
153864624|NCT04187755|Ceftazidime|ceftazidime|mesh-list
153405036|NCT00358358|Fluticasone|fluticasone|mesh-list
153405038|NCT00358358|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
153405039|NCT00358358|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
153405040|NCT00358358|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153405041|NCT00358358|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153405042|NCT00358358|Autonomic Agents|autonomic agents|mesh-ancestor
153405043|NCT00358358|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153405044|NCT00358358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153405045|NCT00358358|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153405046|NCT00358358|Respiratory System Agents|respiratory system agents|mesh-ancestor
153405047|NCT00358358|Dermatologic Agents|dermatologic agents|mesh-ancestor
153405048|NCT00358358|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
153405049|NCT00358358|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
153405050|NCT00358358|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
153864629|NCT04187755|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153864630|NCT00555542|Rituximab|rituximab|mesh-list
153864631|NCT00555542|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153864632|NCT00555542|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153864633|NCT00555542|Immunologic Factors|immunologic factors|mesh-ancestor
153864634|NCT00555542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153864635|NCT00555542|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153864636|NCT04606563|Losartan|losartan|mesh-list
153864637|NCT04606563|Valsartan|valsartan|mesh-list
153864638|NCT04606563|Telmisartan|telmisartan|mesh-list
153864639|NCT04606563|Candesartan|candesartan|mesh-list
153864640|NCT04606563|Candesartan cilexetil|candesartan cilexetil|mesh-list
153864641|NCT04606563|Olmesartan|olmesartan|mesh-list
153864642|NCT04606563|Irbesartan|irbesartan|mesh-list
153864643|NCT04606563|Eprosartan|eprosartan|mesh-list
153864644|NCT04606563|Azilsartan medoxomil|azilsartan medoxomil|mesh-list
153864645|NCT04606563|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153864646|NCT04606563|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
153864647|NCT04606563|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
153864648|NCT04606563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153864658|NCT00565968|Alkylating Agents|alkylating agents|mesh-ancestor
153864659|NCT00565968|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153864660|NCT00565968|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153864661|NCT00565968|Immunologic Factors|immunologic factors|mesh-ancestor
153864662|NCT00565968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153864663|NCT01162486|Rifampin|rifampin|mesh-list
153864664|NCT01162486|Rifapentine|rifapentine|mesh-list
153864665|NCT01162486|Midazolam|midazolam|mesh-list
153864666|NCT01162486|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153405083|NCT02265510|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153405084|NCT02265510|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153405085|NCT02265510|Antimetabolites|antimetabolites|mesh-ancestor
153405086|NCT02265510|Immunologic Factors|immunologic factors|mesh-ancestor
153405087|NCT02265510|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153405088|NCT02265510|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153405089|NCT02265510|Growth Substances|growth substances|mesh-ancestor
153405090|NCT02265510|Growth Inhibitors|growth inhibitors|mesh-ancestor
153405091|NCT02265510|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153405092|NCT03254147|Warfarin|warfarin|mesh-list
153405093|NCT03254147|Rivaroxaban|rivaroxaban|mesh-list
153405094|NCT03254147|Dabigatran|dabigatran|mesh-list
153405095|NCT03254147|Apixaban|apixaban|mesh-list
153405096|NCT03254147|Edoxaban|edoxaban|mesh-list
153405097|NCT03254147|Anticoagulants|anticoagulants|mesh-ancestor
153405098|NCT03254147|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
153405099|NCT03254147|Antithrombins|antithrombins|mesh-ancestor
153864675|NCT01162486|Anesthetics|anesthetics|mesh-ancestor
153864676|NCT01162486|GABA Modulators|gaba modulators|mesh-ancestor
153864677|NCT01162486|GABA Agents|gaba agents|mesh-ancestor
153864678|NCT01162486|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153864679|NCT01162486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153864680|NCT01162486|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
153864681|NCT01162486|Antitubercular Agents|antitubercular agents|mesh-ancestor
153864682|NCT01162486|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153864683|NCT01162486|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153864684|NCT01162486|Leprostatic Agents|leprostatic agents|mesh-ancestor
153864695|NCT01162135|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
153864696|NCT01162135|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153864697|NCT01162135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153864698|NCT01162135|Protective Agents|protective agents|mesh-ancestor
153864699|NCT01162135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153864700|NCT00555776|Gabapentin|gabapentin|mesh-list
153864701|NCT00555776|Analgesics|analgesics|mesh-ancestor
153864702|NCT00555776|Sensory System Agents|sensory system agents|mesh-ancestor
153864703|NCT00555776|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153864704|NCT00555776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153864705|NCT00555776|Anticonvulsants|anticonvulsants|mesh-ancestor
153864706|NCT00555776|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153864707|NCT00555776|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153864708|NCT00555776|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153864709|NCT00555776|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153864710|NCT00555776|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
153864711|NCT00555776|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
153864712|NCT00555776|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153864713|NCT00555776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153864714|NCT00555776|Antimanic Agents|antimanic agents|mesh-ancestor
153864715|NCT01161628|Rituximab|rituximab|mesh-list
153864721|NCT04314505|Analgesics, Opioid|analgesics, opioid|mesh-list
153864722|NCT04314505|Narcotics|narcotics|mesh-ancestor
153405128|NCT03256253|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153405129|NCT03256253|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153405130|NCT03256253|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153405131|NCT03256253|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153405132|NCT03256253|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153405134|NCT03256799|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
153405135|NCT03256799|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153405136|NCT03256799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153405137|NCT01238211|Cytarabine|cytarabine|mesh-list
153405138|NCT01238211|Daunorubicin|daunorubicin|mesh-list
153405139|NCT01238211|Dasatinib|dasatinib|mesh-list
153405140|NCT01238211|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153405141|NCT01238211|Antimetabolites|antimetabolites|mesh-ancestor
153405142|NCT01238211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153405143|NCT01238211|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153864730|NCT01161472|Fesoterodine|fesoterodine|mesh-list
153864731|NCT01161472|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153864732|NCT01161472|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153864733|NCT01161472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153864734|NCT01161472|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153864735|NCT01161472|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153864736|NCT01161472|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153864755|NCT04598061|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153864756|NCT04598061|Analgesics|analgesics|mesh-ancestor
153864757|NCT04598061|Sensory System Agents|sensory system agents|mesh-ancestor
153864758|NCT04598061|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153864759|NCT04598061|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
153864760|NCT04598061|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153864761|NCT04598061|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153864762|NCT04598061|Adrenergic Agents|adrenergic agents|mesh-ancestor
153864763|NCT04598061|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153864764|NCT04598061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153864765|NCT04674956|Paclitaxel|paclitaxel|mesh-list
153864766|NCT04674956|Gemcitabine|gemcitabine|mesh-list
153864767|NCT04674956|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153864768|NCT04674956|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153864769|NCT04674956|Tubulin Modulators|tubulin modulators|mesh-ancestor
153864770|NCT04674956|Antimitotic Agents|antimitotic agents|mesh-ancestor
153864771|NCT04674956|Mitosis Modulators|mitosis modulators|mesh-ancestor
153864772|NCT04674956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153864773|NCT04674956|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153864774|NCT04674956|Antimetabolites|antimetabolites|mesh-ancestor
153864775|NCT00564720|Gemcitabine|gemcitabine|mesh-list
153864776|NCT00564720|Oxaliplatin|oxaliplatin|mesh-list
153864777|NCT00564720|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
153864778|NCT00564720|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153864779|NCT00564720|Antimetabolites|antimetabolites|mesh-ancestor
153864780|NCT00564720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153864781|NCT00564720|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153864782|NCT00564720|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153864783|NCT00564720|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153864799|NCT00566046|Nootropic Agents|nootropic agents|mesh-ancestor
153864800|NCT01160614|Oxycodone|oxycodone|mesh-list
153405208|NCT00003243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153405209|NCT00003243|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153405210|NCT00003243|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153405211|NCT00003243|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153405212|NCT00003243|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153405213|NCT00003243|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153405214|NCT00003243|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153405215|NCT00003243|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153405216|NCT00003243|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153405217|NCT00003243|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153405218|NCT00003243|Antiviral Agents|antiviral agents|mesh-ancestor
153405219|NCT00003243|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153405220|NCT04344158|Sorafenib|sorafenib|mesh-list
153405221|NCT04344158|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153864812|NCT00566124|Isophane Insulin, Human|isophane insulin, human|mesh-list
153864813|NCT00566124|Insulin, Isophane|insulin, isophane|mesh-list
153405233|NCT00003249|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153405234|NCT00003249|Hormone Antagonists|hormone antagonists|mesh-ancestor
153405235|NCT00003249|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153405236|NCT00003249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153864821|NCT01159912|Autonomic Agents|autonomic agents|mesh-ancestor
153864822|NCT01159912|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153864823|NCT01159912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153864824|NCT01159912|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153476660|NCT00974376|Gabapentin|gabapentin|mesh-list
153864825|NCT01159912|Respiratory System Agents|respiratory system agents|mesh-ancestor
153864826|NCT01159912|Dermatologic Agents|dermatologic agents|mesh-ancestor
153864827|NCT01159912|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
153864829|NCT04606212|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153405242|NCT00003255|Carboplatin|carboplatin|mesh-list
153405243|NCT00003255|Topotecan|topotecan|mesh-list
153405244|NCT00003255|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153405245|NCT00003255|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
153405246|NCT00003255|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153405249|NCT03269435|Metoclopramide|metoclopramide|mesh-list
153864833|NCT04606212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153864834|NCT04606017|Calcium Carbonate|calcium carbonate|mesh-list
153864835|NCT04606017|Antacids|antacids|mesh-ancestor
153864836|NCT04606017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153864837|NCT04606017|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153864838|NCT04631822|Dexamethasone|dexamethasone|mesh-list
153864839|NCT04631822|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153864840|NCT04631822|Antiemetics|antiemetics|mesh-ancestor
153864841|NCT04631822|Autonomic Agents|autonomic agents|mesh-ancestor
153864845|NCT04631822|Glucocorticoids|glucocorticoids|mesh-ancestor
153864859|NCT00560924|Estradiol|estradiol|mesh-list
153864860|NCT00560924|Estrogens|estrogens|mesh-ancestor
153864861|NCT00560924|Hormones|hormones|mesh-ancestor
153864862|NCT00560924|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153405274|NCT00003261|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153405275|NCT00003261|Dermatologic Agents|dermatologic agents|mesh-ancestor
153405276|NCT00003261|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153405277|NCT00003261|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153405278|NCT00003261|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153405279|NCT00003261|Immunologic Factors|immunologic factors|mesh-ancestor
153405280|NCT00003261|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153405281|NCT00003261|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153405282|NCT00003261|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153405283|NCT00003261|Antiviral Agents|antiviral agents|mesh-ancestor
153405284|NCT00003261|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153405285|NCT00003261|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153405286|NCT00003261|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153405287|NCT03279731|Liraglutide|liraglutide|mesh-list
153405288|NCT03279731|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
153405294|NCT05267821|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
153405295|NCT05267821|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153405296|NCT02264574|Obinutuzumab|obinutuzumab|mesh-list
153405297|NCT02264574|Chlorambucil|chlorambucil|mesh-list
153405299|NCT02264574|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153405300|NCT02264574|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153864869|NCT00560963|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153864870|NCT00560963|Immunologic Factors|immunologic factors|mesh-ancestor
153864871|NCT00560963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153864872|NCT00560963|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153864897|NCT01159171|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153405301|NCT02264574|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153405302|NCT02264574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153405303|NCT02264574|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153405304|NCT02264574|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153405305|NCT02264574|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153405306|NCT02264574|Alkylating Agents|alkylating agents|mesh-ancestor
153405308|NCT04412863|Interferon-alpha|interferon-alpha|mesh-list
153405309|NCT04412863|Interferon alpha-2|interferon alpha-2|mesh-list
153405310|NCT04412863|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
153405311|NCT04412863|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153405312|NCT04412863|Antiviral Agents|antiviral agents|mesh-ancestor
153405313|NCT04412863|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153405323|NCT03400475|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153405324|NCT01641900|Eszopiclone|eszopiclone|mesh-list
153405325|NCT01641900|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153405326|NCT01641900|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153405327|NCT01641900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153405328|NCT03834571|Paclitaxel|paclitaxel|mesh-list
153405329|NCT03834571|Cisplatin|cisplatin|mesh-list
153864921|NCT04631315|Hormones|hormones|mesh-ancestor
153864922|NCT04631315|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153864923|NCT04631315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153864924|NCT04631315|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153864925|NCT04631315|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153405330|NCT03834571|Carboplatin|carboplatin|mesh-list
153477000|NCT01017042|Tubulin Modulators|tubulin modulators|mesh-ancestor
153477001|NCT01017042|Antimitotic Agents|antimitotic agents|mesh-ancestor
153405331|NCT03834571|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
153405332|NCT03834571|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153405333|NCT03834571|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153405334|NCT03834571|Tubulin Modulators|tubulin modulators|mesh-ancestor
153405335|NCT03834571|Antimitotic Agents|antimitotic agents|mesh-ancestor
153405336|NCT03834571|Mitosis Modulators|mitosis modulators|mesh-ancestor
153405337|NCT03834571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153405339|NCT00376727|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153405340|NCT00376727|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153405341|NCT05468606|Imiquimod|imiquimod|mesh-list
153405342|NCT05468606|Toll-Like Receptor Agonists|toll-like receptor agonists|mesh-ancestor
153405343|NCT05468606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153405344|NCT05468606|Immunomodulating Agents|immunomodulating agents|mesh-ancestor
153405345|NCT05468606|Immunologic Factors|immunologic factors|mesh-ancestor
153405346|NCT05468606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153405347|NCT05468606|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153405348|NCT05468606|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153405349|NCT05468606|Interferon Inducers|interferon inducers|mesh-ancestor
153405350|NCT04290871|Nitric Oxide|nitric oxide|mesh-list
153405351|NCT04290871|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153405352|NCT04290871|Autonomic Agents|autonomic agents|mesh-ancestor
153405353|NCT04290871|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153405354|NCT04290871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153405355|NCT04290871|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153405356|NCT04290871|Respiratory System Agents|respiratory system agents|mesh-ancestor
153405357|NCT04290871|Free Radical Scavengers|free radical scavengers|mesh-ancestor
153405358|NCT04290871|Antioxidants|antioxidants|mesh-ancestor
153405359|NCT04290871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153405360|NCT04290871|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153405361|NCT04290871|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
153405362|NCT04290871|Vasodilator Agents|vasodilator agents|mesh-ancestor
153405363|NCT04290871|Gasotransmitters|gasotransmitters|mesh-ancestor
153864953|NCT01158118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153864954|NCT01158118|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153864955|NCT01158118|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153864956|NCT01158118|Antiviral Agents|antiviral agents|mesh-ancestor
153405371|NCT03465787|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153405372|NCT03465787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153888697|NCT01308749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153888698|NCT01307891|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
153888699|NCT01307891|Paclitaxel|paclitaxel|mesh-list
153888700|NCT01307891|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153888702|NCT01307891|Tubulin Modulators|tubulin modulators|mesh-ancestor
153405373|NCT03465787|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
153405374|NCT03465787|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
153405375|NCT03465787|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
153405376|NCT03465787|Adrenergic Agents|adrenergic agents|mesh-ancestor
153405377|NCT03465787|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153405378|NCT03465787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153405379|NCT03465787|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
153405380|NCT03465787|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153405381|NCT03465787|Serotonin Agents|serotonin agents|mesh-ancestor
153405382|NCT03465787|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
153864960|NCT00566241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153864961|NCT00561119|Paclitaxel|paclitaxel|mesh-list
153864962|NCT00561119|Gemcitabine|gemcitabine|mesh-list
153864963|NCT00561119|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153864964|NCT00561119|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153864965|NCT00561119|Tubulin Modulators|tubulin modulators|mesh-ancestor
153864966|NCT00561119|Antimitotic Agents|antimitotic agents|mesh-ancestor
153864967|NCT00561119|Mitosis Modulators|mitosis modulators|mesh-ancestor
153864969|NCT00561119|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153405390|NCT05071352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153405391|NCT00376025|Antioxidants|antioxidants|mesh-list
153405392|NCT00376025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153405394|NCT00376025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153405396|NCT00376103|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153405397|NCT00376103|Alkylating Agents|alkylating agents|mesh-ancestor
153477549|NCT05498116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153477550|NCT05498116|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
153405398|NCT00376103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153405399|NCT00376103|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153405400|NCT03403517|Dexamethasone|dexamethasone|mesh-list
153405401|NCT03403517|Methylprednisolone|methylprednisolone|mesh-list
153405402|NCT03403517|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
153405403|NCT03403517|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
153405404|NCT03403517|Prednisolone|prednisolone|mesh-list
153405405|NCT03403517|Prednisolone acetate|prednisolone acetate|mesh-list
153405406|NCT03403517|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
153405407|NCT03403517|Prednisolone phosphate|prednisolone phosphate|mesh-list
153405408|NCT03403517|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153405409|NCT03403517|Antiemetics|antiemetics|mesh-ancestor
153405410|NCT03403517|Autonomic Agents|autonomic agents|mesh-ancestor
153405411|NCT03403517|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153405412|NCT03403517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153405413|NCT03403517|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153865005|NCT04604886|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
153865006|NCT04604886|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
153865007|NCT04604886|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153865008|NCT04604886|Adrenergic Agents|adrenergic agents|mesh-ancestor
153405414|NCT03403517|Glucocorticoids|glucocorticoids|mesh-ancestor
153405415|NCT03403517|Hormones|hormones|mesh-ancestor
153405426|NCT02263326|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153405427|NCT02263326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153405428|NCT02263326|Antiviral Agents|antiviral agents|mesh-ancestor
153405429|NCT02263326|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153405430|NCT02263326|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153405431|NCT02263326|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
153405432|NCT02263326|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
153405433|NCT00356395|Candesartan|candesartan|mesh-list
153405434|NCT00356395|Candesartan cilexetil|candesartan cilexetil|mesh-list
153865009|NCT04604886|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153865010|NCT04604886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153865011|NCT04604886|Protective Agents|protective agents|mesh-ancestor
153865012|NCT04595877|Dipyrone|dipyrone|mesh-list
153865013|NCT04595877|Endorphins|endorphins|mesh-list
153865024|NCT04595877|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153865025|NCT04595877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153865026|NCT00561509|Antidepressive Agents|antidepressive agents|mesh-list
153865027|NCT00561509|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153865028|NCT00566553|Grape Seed Extract|grape seed extract|mesh-list
153865029|NCT00566553|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153405436|NCT00356395|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153405437|NCT00356395|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
153405438|NCT00356395|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
153405439|NCT00356395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153405440|NCT00356395|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
153405469|NCT05445440|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
153405480|NCT05445440|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153405481|NCT05445440|Immunologic Factors|immunologic factors|mesh-ancestor
153405482|NCT05445440|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153405483|NCT05445440|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153405484|NCT05445440|Antidotes|antidotes|mesh-ancestor
153405485|NCT05445440|Protective Agents|protective agents|mesh-ancestor
153405486|NCT05445440|Vitamin B Complex|vitamin b complex|mesh-ancestor
153405487|NCT05445440|Vitamins|vitamins|mesh-ancestor
153405488|NCT05445440|Micronutrients|micronutrients|mesh-ancestor
153405489|NCT05445440|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153405490|NCT05445440|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153888706|NCT05644301|Minocycline|minocycline|mesh-list
153405493|NCT05445440|Sensory System Agents|sensory system agents|mesh-ancestor
153405494|NCT05445440|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153405495|NCT05445440|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153405496|NCT05445440|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153865062|NCT00566592|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153865063|NCT00566592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153865064|NCT01156792|Montelukast|montelukast|mesh-list
153865065|NCT01156792|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153865066|NCT01156792|Respiratory System Agents|respiratory system agents|mesh-ancestor
153865067|NCT01156792|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
153865068|NCT01156792|Hormone Antagonists|hormone antagonists|mesh-ancestor
153865069|NCT01156792|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153865070|NCT01156792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153865074|NCT04604223|Pioglitazone|pioglitazone|mesh-list
153865076|NCT04604223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153865077|NCT04628624|Antioxidants|antioxidants|mesh-list
153865078|NCT04628624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153865079|NCT04628624|Protective Agents|protective agents|mesh-ancestor
153865080|NCT04628624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153865081|NCT04604028|Cyclophosphamide|cyclophosphamide|mesh-list
153865082|NCT04604028|Lenalidomide|lenalidomide|mesh-list
153865083|NCT04604028|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153865084|NCT04604028|Immunologic Factors|immunologic factors|mesh-ancestor
153865085|NCT04604028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153865086|NCT04604028|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153405504|NCT05041322|Serotonin Agents|serotonin agents|mesh-ancestor
153405505|NCT05041322|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153405506|NCT05041322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153405507|NCT00422825|Imatinib Mesylate|imatinib mesylate|mesh-list
153405508|NCT00422825|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153405509|NCT00422825|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153405510|NCT00422825|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153405511|NCT00422825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153405512|NCT00422825|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153405513|NCT05229614|Pembrolizumab|pembrolizumab|mesh-list
153405529|NCT05647278|Esomeprazole|esomeprazole|mesh-list
153405530|NCT05647278|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
153405531|NCT05647278|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153405532|NCT05647278|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
153865087|NCT04604028|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153865088|NCT04604028|Alkylating Agents|alkylating agents|mesh-ancestor
153865089|NCT04604028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153865090|NCT04604028|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153865091|NCT04604028|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153865092|NCT04604028|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153865093|NCT04604028|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153865094|NCT04604028|Growth Substances|growth substances|mesh-ancestor
153865095|NCT04604028|Growth Inhibitors|growth inhibitors|mesh-ancestor
153865096|NCT01156480|Hydrocortisone|hydrocortisone|mesh-list
153865097|NCT01156480|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153865098|NCT00561587|Quetiapine Fumarate|quetiapine fumarate|mesh-list
153865099|NCT00561587|Antidepressive Agents|antidepressive agents|mesh-ancestor
153865100|NCT00561587|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153865101|NCT00561587|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153865102|NCT00561587|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153865103|NCT00561587|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153865104|NCT00561587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153865105|NCT01156363|Epoetin Alfa|epoetin alfa|mesh-list
153865106|NCT01156363|Hematinics|hematinics|mesh-ancestor
153865107|NCT02884921|Acetaminophen|acetaminophen|mesh-list
153865108|NCT02884921|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153865109|NCT02884921|Analgesics|analgesics|mesh-ancestor
153865110|NCT02884921|Sensory System Agents|sensory system agents|mesh-ancestor
153865111|NCT02884921|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153865112|NCT02884921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153865113|NCT02884921|Antipyretics|antipyretics|mesh-ancestor
153865114|NCT00561704|Losartan|losartan|mesh-list
153865115|NCT00561704|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153865116|NCT00561704|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153865117|NCT00561704|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
153865118|NCT00561704|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
153865119|NCT00561704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153865120|NCT01156051|Guanfacine|guanfacine|mesh-list
153865121|NCT01156051|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153865122|NCT01156051|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
153865123|NCT01156051|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153405534|NCT05647278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153405535|NCT00358748|Hydrocortisone|hydrocortisone|mesh-list
153405536|NCT00358748|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153405537|NCT00359606|Tetrahydrouridine|tetrahydrouridine|mesh-list
153405538|NCT00359606|Antimetabolites|antimetabolites|mesh-ancestor
153405539|NCT00359606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153405540|NCT00359840|Darbepoetin alfa|darbepoetin alfa|mesh-list
153405541|NCT00359840|Hematinics|hematinics|mesh-ancestor
153405542|NCT02259582|Carboplatin|carboplatin|mesh-list
153405544|NCT02259582|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153405552|NCT00360386|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
153405553|NCT00360386|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
153865124|NCT01156051|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153865125|NCT01156051|Adrenergic Agents|adrenergic agents|mesh-ancestor
153865126|NCT01156051|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153865127|NCT01156051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153865128|NCT01156051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153865129|NCT04595409|Ustekinumab|ustekinumab|mesh-list
153865130|NCT04595409|Dermatologic Agents|dermatologic agents|mesh-ancestor
153865132|NCT04628000|Ergocalciferols|ergocalciferols|mesh-list
153865133|NCT04628000|Cholecalciferol|cholecalciferol|mesh-list
153865134|NCT04628000|Vitamins|vitamins|mesh-list
153865135|NCT04628000|Micronutrients|micronutrients|mesh-ancestor
153865139|NCT01155661|Phenylethyl Alcohol|phenylethyl alcohol|mesh-list
153405555|NCT00360386|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153405556|NCT00360386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153405557|NCT00360386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153405558|NCT02977208|Gabapentin|gabapentin|mesh-list
153405559|NCT02977208|Analgesics|analgesics|mesh-ancestor
153405560|NCT02977208|Sensory System Agents|sensory system agents|mesh-ancestor
153405561|NCT02977208|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153405562|NCT02977208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153405563|NCT02977208|Anticonvulsants|anticonvulsants|mesh-ancestor
153405564|NCT02977208|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153405565|NCT02977208|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153405566|NCT02977208|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153405567|NCT02977208|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153405568|NCT02977208|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
153405569|NCT02977208|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
153405570|NCT02977208|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153405571|NCT02977208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153405572|NCT02977208|Antimanic Agents|antimanic agents|mesh-ancestor
153405573|NCT04866108|Capecitabine|capecitabine|mesh-list
153405574|NCT04866108|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153405575|NCT04866108|Antimetabolites|antimetabolites|mesh-ancestor
153405576|NCT04866108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153405577|NCT04866108|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153405578|NCT04343768|Interferons|interferons|mesh-list
153405579|NCT04343768|Ritonavir|ritonavir|mesh-list
153405580|NCT04343768|Lopinavir|lopinavir|mesh-list
153865156|NCT00565188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153865157|NCT00565188|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153865158|NCT00565188|Vasodilator Agents|vasodilator agents|mesh-ancestor
153865159|NCT00565188|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
153865160|NCT00565188|Purinergic Agonists|purinergic agonists|mesh-ancestor
153405587|NCT04343768|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153405588|NCT04343768|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
153405589|NCT04343768|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
153405590|NCT04343768|Protease Inhibitors|protease inhibitors|mesh-ancestor
153405591|NCT04343768|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153405592|NCT04343768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153405593|NCT04343768|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153405594|NCT04343768|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153405595|NCT04343768|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
153405596|NCT04343768|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153405597|NCT04343768|Antimalarials|antimalarials|mesh-ancestor
153405598|NCT04343768|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153405599|NCT04343768|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153405600|NCT04343768|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153405601|NCT04343768|Immunologic Factors|immunologic factors|mesh-ancestor
153405602|NCT04343768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153405603|NCT04343768|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153405604|NCT05925790|Antibodies|antibodies|mesh-list
153405605|NCT05925790|Immunologic Factors|immunologic factors|mesh-ancestor
153405606|NCT05925790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153865171|NCT04603872|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153865172|NCT04603872|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153865173|NCT04603872|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153865174|NCT04603872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153865175|NCT04603872|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153865176|NCT04603794|Chlorhexidine|chlorhexidine|mesh-list
153865177|NCT04603794|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
153865178|NCT04603794|Povidone-Iodine|povidone-iodine|mesh-list
153429806|NCT00002756|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153865179|NCT04603794|Hydrogen Peroxide|hydrogen peroxide|mesh-list
153865180|NCT04603794|Povidone|povidone|mesh-list
153865181|NCT04603794|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
153865182|NCT04603794|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153865183|NCT04603794|Disinfectants|disinfectants|mesh-ancestor
153865184|NCT04603794|Dermatologic Agents|dermatologic agents|mesh-ancestor
153865185|NCT04603794|Plasma Substitutes|plasma substitutes|mesh-ancestor
153865186|NCT04603794|Blood Substitutes|blood substitutes|mesh-ancestor
153865187|NCT01155583|Dexamethasone|dexamethasone|mesh-list
153865188|NCT01155583|Lenalidomide|lenalidomide|mesh-list
153865189|NCT01155583|Azacitidine|azacitidine|mesh-list
153865190|NCT01155583|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153865191|NCT01155583|Antiemetics|antiemetics|mesh-ancestor
153865192|NCT01155583|Autonomic Agents|autonomic agents|mesh-ancestor
153865200|NCT01155583|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153865201|NCT01155583|Immunologic Factors|immunologic factors|mesh-ancestor
153865202|NCT01155583|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153865203|NCT01155583|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153865204|NCT01155583|Growth Substances|growth substances|mesh-ancestor
153865205|NCT01155583|Growth Inhibitors|growth inhibitors|mesh-ancestor
153865206|NCT01155583|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153865208|NCT01155583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153865209|NCT01155583|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153865210|NCT04603131|Vaccines|vaccines|mesh-list
153865211|NCT04603131|Immunologic Factors|immunologic factors|mesh-ancestor
153865212|NCT04603131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153865213|NCT04627181|Hydroxocobalamin|hydroxocobalamin|mesh-list
153865214|NCT04627181|Vitamin B 12|vitamin b 12|mesh-list
153865215|NCT04627181|Hematinics|hematinics|mesh-ancestor
153405640|NCT05924165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153405641|NCT05924165|Analgesics|analgesics|mesh-ancestor
153405642|NCT05924165|Sensory System Agents|sensory system agents|mesh-ancestor
153405643|NCT05924165|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153405644|NCT05924165|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153405645|NCT05924165|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153405646|NCT05924165|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153405647|NCT05924165|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153405648|NCT05924165|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153405649|NCT05924165|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153405650|NCT05924165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153405651|NCT05924100|Luspatercept|luspatercept|mesh-list
153405652|NCT05924100|Hematinics|hematinics|mesh-ancestor
153405653|NCT05923879|Rituximab|rituximab|mesh-list
153405654|NCT05923879|Lenalidomide|lenalidomide|mesh-list
153405655|NCT05923879|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153405656|NCT05923879|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153405657|NCT05923879|Immunologic Factors|immunologic factors|mesh-ancestor
153405658|NCT05923879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153405659|NCT05923879|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153405660|NCT05923879|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153405661|NCT05923879|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153405662|NCT05923879|Growth Substances|growth substances|mesh-ancestor
153405663|NCT05923879|Growth Inhibitors|growth inhibitors|mesh-ancestor
153405664|NCT05923021|Sertraline|sertraline|mesh-list
153405665|NCT05923021|Antidepressive Agents|antidepressive agents|mesh-ancestor
153405666|NCT05923021|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153405667|NCT05923021|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
153865236|NCT01155466|Protective Agents|protective agents|mesh-ancestor
153865237|NCT01155466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153865238|NCT00561899|Piperaquine|piperaquine|mesh-list
153865239|NCT00561899|Amodiaquine|amodiaquine|mesh-list
153865240|NCT00561899|Artenimol|artenimol|mesh-list
153865241|NCT00561899|Antimalarials|antimalarials|mesh-ancestor
153865242|NCT00561899|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153865244|NCT00561899|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153865245|NCT01155388|Ferrous fumarate|ferrous fumarate|mesh-list
153865246|NCT01155388|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
153865247|NCT01155388|Hematinics|hematinics|mesh-ancestor
153865248|NCT01155388|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
153865249|NCT01155388|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
153865250|NCT01155388|Trace Elements|trace elements|mesh-ancestor
153865251|NCT01155388|Micronutrients|micronutrients|mesh-ancestor
153405671|NCT05923021|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153405672|NCT05923021|Serotonin Agents|serotonin agents|mesh-ancestor
153405673|NCT05923021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153405674|NCT05922839|Zanubrutinib|zanubrutinib|mesh-list
153405675|NCT05922839|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153405676|NCT05922839|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153479388|NCT01295112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153405677|NCT05922839|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153405678|NCT05922839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153405679|NCT05922839|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153865259|NCT00565227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153865262|NCT04602273|Azacitidine|azacitidine|mesh-list
153865263|NCT04602273|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153865264|NCT04602273|Antimetabolites|antimetabolites|mesh-ancestor
153865265|NCT04602273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153865266|NCT04602273|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153865267|NCT04602273|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153865268|NCT04313764|Bupivacaine|bupivacaine|mesh-list
153865269|NCT04313764|Anesthetics, Local|anesthetics, local|mesh-ancestor
153865270|NCT04313764|Anesthetics|anesthetics|mesh-ancestor
153865271|NCT04313764|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153865272|NCT04313764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153865273|NCT04313764|Sensory System Agents|sensory system agents|mesh-ancestor
153865274|NCT04313764|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153865275|NCT04626089|Metformin|metformin|mesh-list
153865276|NCT04626089|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153865277|NCT04626089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153865278|NCT04601688|Dexamethasone|dexamethasone|mesh-list
153865279|NCT04601688|Bevacizumab|bevacizumab|mesh-list
153865280|NCT04601688|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153865281|NCT04601688|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153865282|NCT04601688|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153865283|NCT04601688|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153865284|NCT04601688|Growth Substances|growth substances|mesh-ancestor
153865285|NCT04601688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153865286|NCT04601688|Growth Inhibitors|growth inhibitors|mesh-ancestor
153865287|NCT04601688|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153865288|NCT04601688|Antiemetics|antiemetics|mesh-ancestor
153865289|NCT04601688|Autonomic Agents|autonomic agents|mesh-ancestor
153865290|NCT04601688|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153865291|NCT04601688|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153865292|NCT04601688|Glucocorticoids|glucocorticoids|mesh-ancestor
153865293|NCT04601688|Hormones|hormones|mesh-ancestor
153865294|NCT04601688|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153865295|NCT04601688|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153865296|NCT01154452|2,2-dimethyl-N-(6-oxo-6,7-dihydro-5H-dibenzo(b,d)azepin-7-yl)-N'-(2,2,3,3,3-pentafluoropropyl)malonamide|2,2-dimethyl-n-(6-oxo-6,7-dihydro-5h-dibenzo(b,d)azepin-7-yl)-n'-(2,2,3,3,3-pentafluoropropyl)malonamide|mesh-list
153865297|NCT01154452|Gamma Secretase Inhibitors and Modulators|gamma secretase inhibitors and modulators|mesh-list
153865298|NCT01154452|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153865299|NCT01154452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153865300|NCT04313452|Insulin|insulin|mesh-list
153865301|NCT04313452|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153865302|NCT04313452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153865303|NCT01154218|Crizotinib|crizotinib|mesh-list
153865310|NCT04601142|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
153865311|NCT04601142|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
153865312|NCT04601142|Prednisolone|prednisolone|mesh-list
153865313|NCT04601142|Prednisolone acetate|prednisolone acetate|mesh-list
153865314|NCT04601142|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
153865315|NCT04601142|Prednisolone phosphate|prednisolone phosphate|mesh-list
153865316|NCT04601142|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153865317|NCT04601142|Antiemetics|antiemetics|mesh-ancestor
153865318|NCT04601142|Autonomic Agents|autonomic agents|mesh-ancestor
153405729|NCT05922306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153405730|NCT05921292|Lidocaine|lidocaine|mesh-list
153405731|NCT05921292|Anesthetics, Local|anesthetics, local|mesh-ancestor
153405732|NCT05921292|Anesthetics|anesthetics|mesh-ancestor
153405733|NCT05921292|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153405734|NCT05921292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153405735|NCT05921292|Sensory System Agents|sensory system agents|mesh-ancestor
153405736|NCT05921292|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153405737|NCT05921292|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153405738|NCT05921292|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
153405739|NCT05921292|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153405740|NCT05921292|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153405741|NCT05921292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153405742|NCT05921097|Histamine|histamine|mesh-list
153405743|NCT05921097|Histamine Agonists|histamine agonists|mesh-ancestor
153405744|NCT05921097|Histamine Agents|histamine agents|mesh-ancestor
153479768|NCT06244485|Immunoconjugates|immunoconjugates|mesh-ancestor
153479769|NCT06244485|Immunologic Factors|immunologic factors|mesh-ancestor
153405745|NCT05921097|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153405746|NCT05921097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153405747|NCT05921097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153405748|NCT05921071|Tranexamic Acid|tranexamic acid|mesh-list
153405749|NCT05921071|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
153405750|NCT05921071|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153405751|NCT05921071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153405752|NCT05921071|Hemostatics|hemostatics|mesh-ancestor
153405753|NCT05921071|Coagulants|coagulants|mesh-ancestor
153405754|NCT05920980|Lidocaine|lidocaine|mesh-list
153405755|NCT05920980|Anesthetics, Local|anesthetics, local|mesh-ancestor
153405756|NCT05920980|Anesthetics|anesthetics|mesh-ancestor
153405757|NCT05920980|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153405758|NCT05920980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153405759|NCT05920980|Sensory System Agents|sensory system agents|mesh-ancestor
153405760|NCT05920980|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153405761|NCT05920980|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153865319|NCT04601142|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153865320|NCT04601142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153865321|NCT04601142|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153865322|NCT04601142|Glucocorticoids|glucocorticoids|mesh-ancestor
153865323|NCT04601142|Hormones|hormones|mesh-ancestor
153865324|NCT04601142|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153865325|NCT04601142|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
153865338|NCT04601259|Salicylic Acid|salicylic acid|mesh-list
153865339|NCT04601259|Salicylates|salicylates|mesh-list
153865340|NCT04601259|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153865341|NCT04601259|Antifungal Agents|antifungal agents|mesh-ancestor
153865342|NCT04601259|Keratolytic Agents|keratolytic agents|mesh-ancestor
153865343|NCT04601259|Dermatologic Agents|dermatologic agents|mesh-ancestor
153865344|NCT04601259|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153405772|NCT05920889|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
153405774|NCT05920889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153405775|NCT05920876|Antibodies, Bispecific|antibodies, bispecific|mesh-list
153405776|NCT05920876|Immunologic Factors|immunologic factors|mesh-ancestor
153405779|NCT05920707|Arginine Vasopressin|arginine vasopressin|mesh-list
153405780|NCT05920707|Oxytocin|oxytocin|mesh-list
153405790|NCT05920538|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153865353|NCT04601259|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153865354|NCT04601259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153865355|NCT00565383|Fentanyl|fentanyl|mesh-list
153865356|NCT00565383|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153429821|NCT01183429|Tretinoin|tretinoin|mesh-list
153429822|NCT01183429|Isotretinoin|isotretinoin|mesh-list
153429823|NCT01183429|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153429824|NCT01183429|Keratolytic Agents|keratolytic agents|mesh-ancestor
153429825|NCT01183429|Dermatologic Agents|dermatologic agents|mesh-ancestor
153865373|NCT04625114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153865374|NCT04625114|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
153865375|NCT04625114|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
153865377|NCT00567099|Aripiprazole|aripiprazole|mesh-list
153865378|NCT00567099|Antidepressive Agents|antidepressive agents|mesh-ancestor
153865379|NCT00567099|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153865380|NCT00567099|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153865381|NCT00567099|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153865382|NCT00567099|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153865383|NCT00567099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153865384|NCT00567099|Dopamine Agonists|dopamine agonists|mesh-ancestor
153865385|NCT00567099|Dopamine Agents|dopamine agents|mesh-ancestor
153865386|NCT00567099|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153865387|NCT00567099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153865388|NCT00567099|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
153865389|NCT00567099|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
153865390|NCT00567099|Serotonin Agents|serotonin agents|mesh-ancestor
153865391|NCT00567099|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
153865392|NCT00567099|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153865393|NCT00567099|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
153865394|NCT00567099|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
153865395|NCT00567177|Cyclosporine|cyclosporine|mesh-list
153865396|NCT00567177|Cyclosporins|cyclosporins|mesh-list
153865397|NCT00567177|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153405808|NCT05918133|Paclitaxel|paclitaxel|mesh-list
153405809|NCT05918133|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153405810|NCT05918133|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153405811|NCT05918133|Tubulin Modulators|tubulin modulators|mesh-ancestor
153405812|NCT05918133|Antimitotic Agents|antimitotic agents|mesh-ancestor
153405813|NCT05918133|Mitosis Modulators|mitosis modulators|mesh-ancestor
153405815|NCT05918107|Carboplatin|carboplatin|mesh-list
153865398|NCT00567177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153865399|NCT00567177|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153865400|NCT00567177|Immunologic Factors|immunologic factors|mesh-ancestor
153865401|NCT00567177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153865402|NCT00567177|Antifungal Agents|antifungal agents|mesh-ancestor
153865403|NCT00567177|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153865404|NCT00567177|Dermatologic Agents|dermatologic agents|mesh-ancestor
153865415|NCT00567216|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153865416|NCT00567216|Sympatholytics|sympatholytics|mesh-ancestor
153865417|NCT00567216|Autonomic Agents|autonomic agents|mesh-ancestor
153865418|NCT00567216|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153865419|NCT00562055|Reboxetine|reboxetine|mesh-list
153865420|NCT00562055|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
153865421|NCT00562055|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
153865422|NCT00562055|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153865423|NCT00562055|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153865424|NCT00562055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153865425|NCT00562055|Adrenergic Agents|adrenergic agents|mesh-ancestor
153865426|NCT00562055|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153865427|NCT00562055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153865428|NCT00562055|Antidepressive Agents|antidepressive agents|mesh-ancestor
153865429|NCT00562055|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153865430|NCT04623866|Valsartan|valsartan|mesh-list
153865431|NCT04623866|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153865433|NCT04623866|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
153405844|NCT05891379|Immunologic Factors|immunologic factors|mesh-ancestor
153405845|NCT05891379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153405847|NCT05883852|Carboplatin|carboplatin|mesh-list
153405848|NCT05883852|Docetaxel|docetaxel|mesh-list
153405849|NCT05883852|Trastuzumab|trastuzumab|mesh-list
153405850|NCT05883852|Epirubicin|epirubicin|mesh-list
153405851|NCT05883852|Pertuzumab|pertuzumab|mesh-list
153405852|NCT05883852|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153405853|NCT05883852|Immunologic Factors|immunologic factors|mesh-ancestor
153405854|NCT05883852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153405855|NCT05883852|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153405856|NCT05883852|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153405857|NCT05883852|Alkylating Agents|alkylating agents|mesh-ancestor
153405858|NCT05883852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153405859|NCT05883852|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153405860|NCT05883852|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153405861|NCT05883852|Tubulin Modulators|tubulin modulators|mesh-ancestor
153405862|NCT05883852|Antimitotic Agents|antimitotic agents|mesh-ancestor
153405863|NCT05883852|Mitosis Modulators|mitosis modulators|mesh-ancestor
153405864|NCT05883852|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153405865|NCT05883852|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153405866|NCT05883852|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153405867|NCT05883852|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153405884|NCT05832892|Paclitaxel|paclitaxel|mesh-list
153405885|NCT05832892|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
153405886|NCT05832892|Gemcitabine|gemcitabine|mesh-list
153405887|NCT05832892|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153405888|NCT05832892|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153405889|NCT05832892|Tubulin Modulators|tubulin modulators|mesh-ancestor
153405890|NCT05832892|Antimitotic Agents|antimitotic agents|mesh-ancestor
153405891|NCT05832892|Mitosis Modulators|mitosis modulators|mesh-ancestor
153405892|NCT05832892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153405893|NCT05832892|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153405894|NCT05832892|Antimetabolites|antimetabolites|mesh-ancestor
153405895|NCT05832398|Leucovorin|leucovorin|mesh-list
153405896|NCT05832398|Fluorouracil|fluorouracil|mesh-list
153405897|NCT05832398|Oxaliplatin|oxaliplatin|mesh-list
153405898|NCT05832398|Irinotecan|irinotecan|mesh-list
153405899|NCT05832398|Antimetabolites|antimetabolites|mesh-ancestor
153405900|NCT05832398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153405901|NCT05832398|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153405902|NCT05832398|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153888717|NCT05644301|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153405903|NCT05832398|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153480459|NCT05631899|Tubulin Modulators|tubulin modulators|mesh-ancestor
153480462|NCT05602636|Midazolam|midazolam|mesh-list
153480528|NCT05536856|Immunologic Factors|immunologic factors|mesh-ancestor
153405904|NCT05832398|Immunologic Factors|immunologic factors|mesh-ancestor
153405905|NCT05832398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153405906|NCT05832398|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
153865468|NCT00567450|Anesthetics, Local|anesthetics, local|mesh-ancestor
153865469|NCT00567450|Anesthetics|anesthetics|mesh-ancestor
153865470|NCT00567450|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153865471|NCT00567450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153865472|NCT00567450|Sensory System Agents|sensory system agents|mesh-ancestor
153865473|NCT00567450|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153865474|NCT00567528|Ibuprofen|ibuprofen|mesh-list
153865475|NCT00567528|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153865476|NCT00567528|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153865477|NCT00567528|Analgesics|analgesics|mesh-ancestor
153865478|NCT00567528|Sensory System Agents|sensory system agents|mesh-ancestor
153865479|NCT00567528|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153865480|NCT00567528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153865481|NCT00567528|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153865482|NCT00567528|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153865483|NCT00567528|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153865484|NCT00567528|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153865485|NCT00567528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153865486|NCT04590612|Levodopa|levodopa|mesh-list
153865487|NCT04590612|Carbidopa|carbidopa|mesh-list
153865489|NCT04590612|Citalopram|citalopram|mesh-list
153865493|NCT04590612|Dopamine Agents|dopamine agents|mesh-ancestor
153865494|NCT04590612|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153865495|NCT04590612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153865496|NCT04590612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153865497|NCT04590612|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
153865498|NCT04590612|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153865499|NCT04590612|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
153405915|NCT05823987|Tislelizumab|tislelizumab|mesh-list
153405916|NCT05823987|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153405917|NCT05823987|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153405918|NCT05823987|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153888718|NCT05644301|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153405931|NCT05823467|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
153405932|NCT05823467|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
153405933|NCT05823467|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153405935|NCT05823337|Antioxidants|antioxidants|mesh-ancestor
153405936|NCT05823337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153405937|NCT05823337|Protective Agents|protective agents|mesh-ancestor
153405938|NCT05823337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153405939|NCT05823337|Trace Elements|trace elements|mesh-ancestor
153888719|NCT05644301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153405947|NCT05796791|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153405948|NCT05796791|Anesthetics, General|anesthetics, general|mesh-ancestor
153405949|NCT05796791|Anesthetics|anesthetics|mesh-ancestor
153405950|NCT05796791|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153405951|NCT05796791|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
153405952|NCT05796791|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
153405953|NCT05796791|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153405954|NCT05796791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153405955|NCT05759364|Papaverine|papaverine|mesh-list
153405956|NCT05759364|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
153405957|NCT05759364|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153405958|NCT05759364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153405959|NCT05759364|Vasodilator Agents|vasodilator agents|mesh-ancestor
153405960|NCT05759364|Urological Agents|urological agents|mesh-ancestor
153405968|NCT05730205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153405969|NCT05730205|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
153405972|NCT05706233|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153405973|NCT05706233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153405974|NCT05705050|Aminophylline|aminophylline|mesh-list
153405975|NCT05705050|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153405976|NCT05705050|Autonomic Agents|autonomic agents|mesh-ancestor
153405977|NCT05705050|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153382469|NCT01688336|Micronutrients|micronutrients|mesh-ancestor
153382470|NCT01963481|Cyclophosphamide|cyclophosphamide|mesh-list
153382471|NCT01963481|Exemestane|exemestane|mesh-list
153382472|NCT01963481|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153382473|NCT01963481|Immunologic Factors|immunologic factors|mesh-ancestor
153382474|NCT01963481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153382475|NCT01963481|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153382476|NCT01963481|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153382477|NCT01963481|Alkylating Agents|alkylating agents|mesh-ancestor
153382478|NCT01963481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153382479|NCT01963481|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153405978|NCT05705050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153405979|NCT05705050|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153405980|NCT05705050|Respiratory System Agents|respiratory system agents|mesh-ancestor
153405981|NCT05705050|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
153405982|NCT05705050|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
153405983|NCT05705050|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153405984|NCT05705050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153405985|NCT05705050|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
153865550|NCT00562289|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
153865551|NCT00562289|Vasodilator Agents|vasodilator agents|mesh-ancestor
153865552|NCT04313218|Misoprostol|misoprostol|mesh-list
153865553|NCT04313218|Carbetocin|carbetocin|mesh-list
153865554|NCT04313218|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
153865555|NCT04313218|Abortifacient Agents|abortifacient agents|mesh-ancestor
153865556|NCT04313218|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153865559|NCT04313218|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153888735|NCT01307579|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153888737|NCT01307579|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153865560|NCT04313218|Oxytocics|oxytocics|mesh-ancestor
153865561|NCT00624871|Ascorbic Acid|ascorbic acid|mesh-list
153865562|NCT00624871|Ibuprofen|ibuprofen|mesh-list
153865563|NCT00624871|Vitamins|vitamins|mesh-ancestor
153865564|NCT00624871|Micronutrients|micronutrients|mesh-ancestor
153865565|NCT00624871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153865566|NCT00624871|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153865567|NCT00624871|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153865568|NCT00624871|Analgesics|analgesics|mesh-ancestor
153865569|NCT00624871|Sensory System Agents|sensory system agents|mesh-ancestor
153865570|NCT00624871|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153865571|NCT00624871|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153405986|NCT05705050|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
153405987|NCT05705050|Purinergic Agents|purinergic agents|mesh-ancestor
153405988|NCT05705050|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153405989|NCT05705050|Protective Agents|protective agents|mesh-ancestor
153405990|NCT05693454|Tramadol|tramadol|mesh-list
153405991|NCT05693454|Levobupivacaine|levobupivacaine|mesh-list
153405992|NCT05693454|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153405993|NCT05693454|Narcotics|narcotics|mesh-ancestor
153405994|NCT05693454|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153405995|NCT05693454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153406006|NCT05672108|Alkylating Agents|alkylating agents|mesh-ancestor
153406007|NCT05672108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153406008|NCT05672108|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153406009|NCT05672108|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153406010|NCT05668429|Ibrexafungerp|ibrexafungerp|mesh-list
153406011|NCT05668429|Antifungal Agents|antifungal agents|mesh-ancestor
153406012|NCT05668429|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153406013|NCT05613426|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
153406014|NCT05613426|Evolocumab|evolocumab|mesh-list
153406015|NCT05613426|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153406016|NCT05613426|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153406017|NCT05613426|Antimetabolites|antimetabolites|mesh-ancestor
153382480|NCT01963481|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153382481|NCT01963481|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
153382482|NCT01963481|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153382483|NCT01963481|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153382484|NCT01963481|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
153382485|NCT01963481|Hormone Antagonists|hormone antagonists|mesh-ancestor
153382513|NCT03449433|Insulin, Long-Acting|insulin, long-acting|mesh-list
153382514|NCT03449433|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
153382515|NCT03449433|Insulin Lispro|insulin lispro|mesh-list
153382516|NCT03449433|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153382517|NCT03449433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153382519|NCT03241485|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153481195|NCT04051203|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
153865575|NCT00624871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153865577|NCT00624871|Protective Agents|protective agents|mesh-ancestor
153865578|NCT01153984|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
153865579|NCT01153984|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153865580|NCT01153984|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153865581|NCT01153984|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153865582|NCT01153984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153865583|NCT01153984|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153865584|NCT04590183|Prednisolone|prednisolone|mesh-list
153865585|NCT04590183|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
153865586|NCT04590183|Methylprednisolone|methylprednisolone|mesh-list
153865587|NCT04590183|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
153865588|NCT04590183|Prednisolone acetate|prednisolone acetate|mesh-list
153865590|NCT04590183|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
153865591|NCT04590183|Prednisolone phosphate|prednisolone phosphate|mesh-list
153865592|NCT04590183|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153865593|NCT04590183|Immunologic Factors|immunologic factors|mesh-ancestor
153865594|NCT04590183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153865595|NCT04590183|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
153865596|NCT04590183|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153865597|NCT04590183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153865598|NCT04590183|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153865599|NCT04590183|Glucocorticoids|glucocorticoids|mesh-ancestor
153865600|NCT04590183|Hormones|hormones|mesh-ancestor
153406018|NCT05613426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153406019|NCT05613426|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153406020|NCT05613426|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
153406021|NCT05613426|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153406022|NCT05613426|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
153406023|NCT05613426|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
153406025|NCT05603065|Paclitaxel|paclitaxel|mesh-list
153406032|NCT05603065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153406033|NCT05603065|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153406035|NCT05601700|Carboplatin|carboplatin|mesh-list
153406036|NCT05601700|Letrozole|letrozole|mesh-list
153406037|NCT05601700|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153406038|NCT05601700|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153406039|NCT05601700|Tubulin Modulators|tubulin modulators|mesh-ancestor
153406048|NCT05601700|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153406049|NCT05601700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153406051|NCT05558150|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153865601|NCT04590183|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153865602|NCT04590183|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153865603|NCT04590183|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153865605|NCT04590183|Autonomic Agents|autonomic agents|mesh-ancestor
153865606|NCT04590183|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153481754|NCT00936936|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153865607|NCT04590183|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153865608|NCT04590183|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
153865609|NCT04590183|Protective Agents|protective agents|mesh-ancestor
153865610|NCT04622618|Gabapentin|gabapentin|mesh-list
153865611|NCT04622618|Analgesics|analgesics|mesh-ancestor
153865612|NCT04622618|Sensory System Agents|sensory system agents|mesh-ancestor
153865613|NCT04622618|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153865631|NCT04622891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153429839|NCT05749016|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153406059|NCT05467748|Pembrolizumab|pembrolizumab|mesh-list
153406060|NCT05467748|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153406061|NCT05467748|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153406062|NCT05467748|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153406063|NCT05467748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153406065|NCT05460871|Analgesics|analgesics|mesh-ancestor
153406066|NCT05460871|Sensory System Agents|sensory system agents|mesh-ancestor
153406067|NCT05460871|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153406068|NCT05460871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153406069|NCT05460871|Anticonvulsants|anticonvulsants|mesh-ancestor
153406070|NCT05460871|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153406071|NCT05460871|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153406072|NCT05460871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153406073|NCT05460871|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153406074|NCT05460871|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153406075|NCT05460871|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153406076|NCT05460871|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153406077|NCT05460871|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153406078|NCT05457998|Flutemetamol|flutemetamol|mesh-list
153406079|NCT05457998|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
153865640|NCT04622579|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153865641|NCT04622579|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153865642|NCT04622579|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153865643|NCT04622579|Growth Substances|growth substances|mesh-ancestor
153865644|NCT04622579|Growth Inhibitors|growth inhibitors|mesh-ancestor
153865645|NCT01153009|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
153865646|NCT01153009|Vortioxetine|vortioxetine|mesh-list
153406097|NCT05353140|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153406098|NCT05353140|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153406099|NCT05353140|Analgesics|analgesics|mesh-ancestor
153406100|NCT05353140|Sensory System Agents|sensory system agents|mesh-ancestor
153406101|NCT05353140|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153406102|NCT05353140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153406103|NCT05353140|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153406104|NCT05353140|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153406105|NCT05353140|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153406106|NCT05353140|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153429847|NCT01126801|Estradiol|estradiol|mesh-list
153429848|NCT01126801|Estrogens|estrogens|mesh-ancestor
153429849|NCT01126801|Hormones|hormones|mesh-ancestor
153865662|NCT01153009|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
153865663|NCT01153009|Serotonin Agents|serotonin agents|mesh-ancestor
153865664|NCT01153009|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
153865665|NCT01153009|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
153865673|NCT01152580|Melatonin|melatonin|mesh-list
153865674|NCT01152580|Antioxidants|antioxidants|mesh-ancestor
153865675|NCT01152580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153865686|NCT04621799|Coagulants|coagulants|mesh-ancestor
153865687|NCT04621370|Capecitabine|capecitabine|mesh-list
153865688|NCT04621370|Durvalumab|durvalumab|mesh-list
153406107|NCT05353140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153406108|NCT05353140|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153406109|NCT05353140|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153406110|NCT05353140|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153406111|NCT05353140|Antipyretics|antipyretics|mesh-ancestor
153406112|NCT05353140|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
153406113|NCT05353140|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
153406114|NCT05353140|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
153406115|NCT05353140|Purinergic Agents|purinergic agents|mesh-ancestor
153406116|NCT05353140|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153406117|NCT05353140|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
153406119|NCT05353140|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
153406120|NCT05353140|Protease Inhibitors|protease inhibitors|mesh-ancestor
153482095|NCT01399008|Mitosis Modulators|mitosis modulators|mesh-ancestor
153482097|NCT01399008|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153406121|NCT05353140|Anticoagulants|anticoagulants|mesh-ancestor
153406122|NCT05351944|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
153888749|NCT01057693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153888750|NCT01057693|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153888752|NCT01057693|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153888753|NCT01057693|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153888754|NCT01057693|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153888755|NCT04325009|Atorvastatin|atorvastatin|mesh-list
153888756|NCT04325009|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153888757|NCT04325009|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153888758|NCT04325009|Antimetabolites|antimetabolites|mesh-ancestor
153888759|NCT04325009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153888760|NCT04325009|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153406124|NCT05351944|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153406125|NCT05351944|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153406126|NCT05351944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153406127|NCT05351944|Adrenergic Agents|adrenergic agents|mesh-ancestor
153406128|NCT05351944|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153406129|NCT05351944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153406130|NCT05340465|Iron|iron|mesh-list
153406131|NCT05340465|Dextrans|dextrans|mesh-list
153406132|NCT05340465|Darbepoetin alfa|darbepoetin alfa|mesh-list
153406133|NCT05340465|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
153406134|NCT05340465|Iron-Dextran Complex|iron-dextran complex|mesh-list
153406135|NCT05340465|Trace Elements|trace elements|mesh-ancestor
153406136|NCT05340465|Micronutrients|micronutrients|mesh-ancestor
153406137|NCT05340465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153406138|NCT05340465|Hematinics|hematinics|mesh-ancestor
153406139|NCT05340465|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
153406140|NCT05340465|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
153406141|NCT05340465|Anticoagulants|anticoagulants|mesh-ancestor
153406142|NCT05340465|Plasma Substitutes|plasma substitutes|mesh-ancestor
153406143|NCT05340465|Blood Substitutes|blood substitutes|mesh-ancestor
153406144|NCT05303090|Lenvatinib|lenvatinib|mesh-list
153406145|NCT05303090|Tislelizumab|tislelizumab|mesh-list
153406146|NCT05303090|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153865729|NCT01151410|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153865730|NCT00562406|Ranibizumab|ranibizumab|mesh-list
153865731|NCT00562406|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153865732|NCT00562406|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153865733|NCT00562406|Growth Substances|growth substances|mesh-ancestor
153865734|NCT00562406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153865735|NCT00562406|Growth Inhibitors|growth inhibitors|mesh-ancestor
153865736|NCT00562406|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153865737|NCT04621409|Anti-Infective Agents|anti-infective agents|mesh-list
153865738|NCT04621409|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
153406158|NCT05237297|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153406159|NCT05237297|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153406160|NCT05237297|Analgesics|analgesics|mesh-ancestor
153406161|NCT05237297|Sensory System Agents|sensory system agents|mesh-ancestor
153406162|NCT05237297|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153406163|NCT05237297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153406164|NCT05237297|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153406165|NCT05237297|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153406166|NCT05237297|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
153406167|NCT05237297|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153406168|NCT05237297|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153406169|NCT05237297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153406170|NCT05237297|Gout Suppressants|gout suppressants|mesh-ancestor
153406171|NCT05216952|Misoprostol|misoprostol|mesh-list
153406172|NCT05216952|Ulipristal acetate|ulipristal acetate|mesh-list
153865752|NCT04588935|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
153865753|NCT04588935|Protease Inhibitors|protease inhibitors|mesh-ancestor
153865754|NCT04588935|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153865756|NCT00562523|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153865757|NCT00562523|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153406200|NCT05206110|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153406201|NCT05206110|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153865780|NCT04621253|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153865781|NCT04621253|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153865784|NCT00567762|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153382520|NCT03241485|Narcotics|narcotics|mesh-ancestor
153382521|NCT03241485|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153382522|NCT03241485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153382523|NCT03241485|Analgesics|analgesics|mesh-ancestor
153382524|NCT03241485|Sensory System Agents|sensory system agents|mesh-ancestor
153382525|NCT03241485|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153382526|NCT01996943|Ethanol|ethanol|mesh-list
153882906|NCT02270970|Belimumab|belimumab|mesh-list
153882907|NCT02270970|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153882908|NCT02270970|Immunologic Factors|immunologic factors|mesh-ancestor
153882909|NCT02270970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153865785|NCT00567762|Immunologic Factors|immunologic factors|mesh-ancestor
153406203|NCT05206110|Sensory System Agents|sensory system agents|mesh-ancestor
153406204|NCT05206110|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153406205|NCT05206110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153406206|NCT05206110|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153406207|NCT05206110|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153406208|NCT05206110|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153406209|NCT05206110|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153406210|NCT05206110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153406211|NCT05144243|Azacitidine|azacitidine|mesh-list
153406212|NCT05144243|Venetoclax|venetoclax|mesh-list
153406213|NCT05144243|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153406214|NCT05144243|Antimetabolites|antimetabolites|mesh-ancestor
153406215|NCT05144243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153406216|NCT05144243|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153406217|NCT05144243|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153406218|NCT05139238|Labetalol|labetalol|mesh-list
153406243|NCT05138614|Sensory System Agents|sensory system agents|mesh-ancestor
153406244|NCT05138614|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153865801|NCT04691063|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153865802|NCT04691063|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153865803|NCT04691063|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153865804|NCT04691063|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153865805|NCT04691063|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153865806|NCT04691063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153865808|NCT01151215|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153865809|NCT01151215|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153865810|NCT01151215|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
153865829|NCT04588389|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153406252|NCT05103904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153406254|NCT05093582|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153406255|NCT05093582|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153406257|NCT05093582|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153406258|NCT05093582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153406259|NCT05093582|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153406260|NCT05093582|Respiratory System Agents|respiratory system agents|mesh-ancestor
153406261|NCT05093582|Parasympatholytics|parasympatholytics|mesh-ancestor
153406262|NCT05093582|Vasodilator Agents|vasodilator agents|mesh-ancestor
153406264|NCT05090384|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153406265|NCT05090384|Glucocorticoids|glucocorticoids|mesh-ancestor
153865860|NCT02940314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153406287|NCT04927884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153406288|NCT04927884|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153406289|NCT04927884|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153406290|NCT04927884|Alkylating Agents|alkylating agents|mesh-ancestor
153406295|NCT04868773|Trifluridine|trifluridine|mesh-list
153406302|NCT04865029|Estradiol|estradiol|mesh-list
153406303|NCT04865029|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
153406304|NCT04865029|Progesterone|progesterone|mesh-list
153406305|NCT04865029|Estrogens|estrogens|mesh-ancestor
153406306|NCT04865029|Hormones|hormones|mesh-ancestor
153406307|NCT04865029|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153406308|NCT04865029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153406309|NCT04865029|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
153406310|NCT04865029|Contraceptive Agents|contraceptive agents|mesh-ancestor
153406311|NCT04865029|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153406312|NCT04865029|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
153406313|NCT04865029|Progestins|progestins|mesh-ancestor
153406314|NCT04805957|Sulforaphane|sulforaphane|mesh-list
153406315|NCT04805957|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
153406316|NCT04805957|Protective Agents|protective agents|mesh-ancestor
153406317|NCT04805957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153406318|NCT04805957|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153406319|NCT04796779|Ferrous fumarate|ferrous fumarate|mesh-list
153406320|NCT04796779|Trace Elements|trace elements|mesh-ancestor
153865861|NCT02940314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153865862|NCT02940314|Urological Agents|urological agents|mesh-ancestor
153865863|NCT04581213|Anesthetics|anesthetics|mesh-list
153865864|NCT04581213|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153865865|NCT04581213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153865866|NCT01151137|Dronedarone|dronedarone|mesh-list
153865867|NCT01151137|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153865880|NCT04619303|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153865881|NCT04619303|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153865882|NCT04619303|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153865883|NCT04619303|Growth Substances|growth substances|mesh-ancestor
153865884|NCT04619303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153865885|NCT04619303|Growth Inhibitors|growth inhibitors|mesh-ancestor
153865886|NCT04619303|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153865887|NCT04619303|Antiemetics|antiemetics|mesh-ancestor
153865888|NCT04619303|Autonomic Agents|autonomic agents|mesh-ancestor
153865889|NCT04619303|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153865890|NCT04619303|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153865891|NCT04619303|Glucocorticoids|glucocorticoids|mesh-ancestor
153865893|NCT04619303|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153865894|NCT04619303|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153406321|NCT04796779|Micronutrients|micronutrients|mesh-ancestor
153406322|NCT04796779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153406323|NCT04793815|Pembrolizumab|pembrolizumab|mesh-list
153406324|NCT04793815|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153406325|NCT04793815|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153406326|NCT04793815|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153406327|NCT04793815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153406328|NCT04762134|Doxycycline|doxycycline|mesh-list
153406329|NCT04762134|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153406330|NCT04762134|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153406331|NCT04762134|Antimalarials|antimalarials|mesh-ancestor
153406349|NCT04721548|Vasodilator Agents|vasodilator agents|mesh-ancestor
153406351|NCT04717089|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153406352|NCT04717089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153406353|NCT04712799|Xylometazoline|xylometazoline|mesh-list
153406354|NCT04712799|Nasal Decongestants|nasal decongestants|mesh-ancestor
153406355|NCT04712799|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
153865923|NCT00568503|Parasympatholytics|parasympatholytics|mesh-ancestor
153865924|NCT00568503|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
153865925|NCT00568503|Cholinergic Agents|cholinergic agents|mesh-ancestor
153865926|NCT00568503|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153865927|NCT00568503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153406356|NCT04712799|Respiratory System Agents|respiratory system agents|mesh-ancestor
153406357|NCT04712734|Iloperidone|iloperidone|mesh-list
153406358|NCT04712734|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153406359|NCT04712734|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153406360|NCT04712734|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153406361|NCT04712734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153406362|NCT04712734|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153406363|NCT04687098|Idarubicin|idarubicin|mesh-list
153406373|NCT04683406|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153406374|NCT04683406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153406375|NCT04676087|Mogamulizumab|mogamulizumab|mesh-list
153406376|NCT04676087|Immunoglobulins|immunoglobulins|mesh-list
153865928|NCT00568503|Anticonvulsants|anticonvulsants|mesh-ancestor
153865929|NCT00568542|Epoetin Alfa|epoetin alfa|mesh-list
153865930|NCT00568542|Hematinics|hematinics|mesh-ancestor
153406384|NCT04662086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153406385|NCT04662086|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
153406386|NCT04662086|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
153406387|NCT04662073|Camostat|camostat|mesh-list
153406388|NCT04662073|Protease Inhibitors|protease inhibitors|mesh-ancestor
153406389|NCT04662073|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153406402|NCT04608539|Hematinics|hematinics|mesh-ancestor
153406403|NCT04586166|Imidacloprid|imidacloprid|mesh-list
153865955|NCT04586790|Norepinephrine|norepinephrine|mesh-list
153865956|NCT04586790|Epinephryl borate|epinephryl borate|mesh-list
153865957|NCT04586790|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153865958|NCT04586790|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153865959|NCT04586790|Adrenergic Agents|adrenergic agents|mesh-ancestor
153865960|NCT04586790|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153865961|NCT04586790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153865962|NCT04586790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153865963|NCT04586790|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
153865964|NCT04586790|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153865965|NCT04586790|Autonomic Agents|autonomic agents|mesh-ancestor
153865966|NCT04586790|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153865967|NCT04586790|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153865968|NCT04586790|Respiratory System Agents|respiratory system agents|mesh-ancestor
153865969|NCT04586790|Mydriatics|mydriatics|mesh-ancestor
153865970|NCT04586790|Sympathomimetics|sympathomimetics|mesh-ancestor
153865971|NCT04586790|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
153865972|NCT04586790|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
153865973|NCT04586790|Hemostatics|hemostatics|mesh-ancestor
153865974|NCT04586790|Coagulants|coagulants|mesh-ancestor
153865975|NCT04586790|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
153865976|NCT04586790|Natriuretic Agents|natriuretic agents|mesh-ancestor
153865986|NCT00568971|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153865987|NCT00568971|Tubulin Modulators|tubulin modulators|mesh-ancestor
153865988|NCT00568971|Antimitotic Agents|antimitotic agents|mesh-ancestor
153406414|NCT04562792|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153406415|NCT04562792|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153406422|NCT04501367|Prednisone|prednisone|mesh-list
153406434|NCT04501367|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153406435|NCT04501367|Protease Inhibitors|protease inhibitors|mesh-ancestor
153406436|NCT04501367|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153406437|NCT04501367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153406438|NCT04491617|Analgesics, Opioid|analgesics, opioid|mesh-list
153406439|NCT04491617|Narcotics|narcotics|mesh-ancestor
153406440|NCT04491617|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153406441|NCT04491617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153406442|NCT04491617|Analgesics|analgesics|mesh-ancestor
153406443|NCT04491617|Sensory System Agents|sensory system agents|mesh-ancestor
153406444|NCT04491617|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153406445|NCT04487392|Estrogens|estrogens|mesh-list
153406446|NCT04487392|Hormones|hormones|mesh-ancestor
153406447|NCT04487392|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153865989|NCT00568971|Mitosis Modulators|mitosis modulators|mesh-ancestor
153865990|NCT00568971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153865991|NCT00562913|Sorafenib|sorafenib|mesh-list
153865992|NCT00562913|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153865993|NCT00562913|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153865994|NCT00562913|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153865995|NCT00562913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153865996|NCT00569088|Mannitol|mannitol|mesh-list
153865997|NCT00569088|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
153865998|NCT00569088|Diuretics|diuretics|mesh-ancestor
153865999|NCT00569088|Natriuretic Agents|natriuretic agents|mesh-ancestor
153866000|NCT00569088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153866001|NCT00569244|Drospirenone and ethinyl estradiol combination|drospirenone and ethinyl estradiol combination|mesh-list
153866002|NCT00569244|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153866003|NCT00569244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153866004|NCT04586361|Hyaluronic Acid|hyaluronic acid|mesh-list
153866006|NCT04586361|Immunologic Factors|immunologic factors|mesh-ancestor
153866007|NCT04586361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153866008|NCT04586361|Viscosupplements|viscosupplements|mesh-ancestor
153866009|NCT04586361|Protective Agents|protective agents|mesh-ancestor
153866011|NCT04618952|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153866012|NCT04618952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153866013|NCT04619069|Hormones|hormones|mesh-list
153866014|NCT04619069|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153866015|NCT04619069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153482837|NCT06112938|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
153866016|NCT04585932|Leuprolide|leuprolide|mesh-list
153866017|NCT04585932|Fertility Agents, Female|fertility agents, female|mesh-ancestor
153866018|NCT04585932|Fertility Agents|fertility agents|mesh-ancestor
153866019|NCT04585932|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153866020|NCT04585932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153866021|NCT04585932|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153406448|NCT04487392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153406449|NCT04485546|Ophthalmic Solutions|ophthalmic solutions|mesh-list
153406450|NCT04485546|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
153406451|NCT04427293|Pembrolizumab|pembrolizumab|mesh-list
153406452|NCT04427293|Lenvatinib|lenvatinib|mesh-list
153406453|NCT04427293|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153866024|NCT00569400|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
153866025|NCT00569400|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153866026|NCT00569400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153866027|NCT00562952|Telmisartan|telmisartan|mesh-list
153866028|NCT00562952|Bisoprolol|bisoprolol|mesh-list
153866029|NCT00562952|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153866030|NCT00562952|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
153866031|NCT00562952|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
153866032|NCT00562952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153866033|NCT00562952|Sympatholytics|sympatholytics|mesh-ancestor
153866034|NCT00562952|Autonomic Agents|autonomic agents|mesh-ancestor
153866035|NCT00562952|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153866036|NCT00562952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153866037|NCT00562952|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
153866038|NCT00562952|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
153866039|NCT00562952|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
153866040|NCT00562952|Adrenergic Agents|adrenergic agents|mesh-ancestor
153866041|NCT00562952|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153866042|NCT04618601|Spironolactone|spironolactone|mesh-list
153866044|NCT04618601|Hormone Antagonists|hormone antagonists|mesh-ancestor
153406492|NCT04360681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153406493|NCT04330248|Carbamazepine|carbamazepine|mesh-list
153406494|NCT04330248|Anticonvulsants|anticonvulsants|mesh-ancestor
153406495|NCT04330248|Antimanic Agents|antimanic agents|mesh-ancestor
153406496|NCT04330248|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153406497|NCT04330248|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153406498|NCT04330248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153406499|NCT04330248|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153406500|NCT04330248|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153406501|NCT04330248|Analgesics|analgesics|mesh-ancestor
153406502|NCT04330248|Sensory System Agents|sensory system agents|mesh-ancestor
153406503|NCT04330248|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153406504|NCT04330248|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153406505|NCT04330248|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153406506|NCT04330248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153406507|NCT04330248|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
153406508|NCT04330248|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
153406509|NCT04328844|Pemetrexed|pemetrexed|mesh-list
153406510|NCT04328844|Avelumab|avelumab|mesh-list
153406511|NCT04328844|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153406512|NCT04328844|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153406513|NCT04328844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153406514|NCT04328844|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153406515|NCT04328844|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153866075|NCT00569712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153866076|NCT00569712|Chelating Agents|chelating agents|mesh-ancestor
153866077|NCT00569712|Sequestering Agents|sequestering agents|mesh-ancestor
153866078|NCT00569751|Paclitaxel|paclitaxel|mesh-list
153866079|NCT00569751|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153866080|NCT00569751|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153866081|NCT00569751|Tubulin Modulators|tubulin modulators|mesh-ancestor
153866082|NCT00569751|Antimitotic Agents|antimitotic agents|mesh-ancestor
153866083|NCT00569751|Mitosis Modulators|mitosis modulators|mesh-ancestor
153866084|NCT00569751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153866085|NCT00569790|Bevacizumab|bevacizumab|mesh-list
153866086|NCT00569790|Irinotecan|irinotecan|mesh-list
153429863|NCT00002768|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
153866107|NCT02940002|Clobetasol|clobetasol|mesh-list
153406569|NCT04294459|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153406571|NCT04294459|Autonomic Agents|autonomic agents|mesh-ancestor
153406572|NCT04294459|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153483166|NCT04681833|Vaccines|vaccines|mesh-list
153406573|NCT04294459|Glucocorticoids|glucocorticoids|mesh-ancestor
153406574|NCT04294459|Hormones|hormones|mesh-ancestor
153406575|NCT04294459|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153406576|NCT04294459|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
153406577|NCT04294459|Protective Agents|protective agents|mesh-ancestor
153406578|NCT04294459|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153406579|NCT04294459|Respiratory System Agents|respiratory system agents|mesh-ancestor
153406580|NCT04294459|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
153406581|NCT04294459|Hormone Antagonists|hormone antagonists|mesh-ancestor
153866118|NCT04618328|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153866119|NCT04618328|Keratolytic Agents|keratolytic agents|mesh-ancestor
153866120|NCT04618328|Dermatologic Agents|dermatologic agents|mesh-ancestor
153866121|NCT04617782|Donepezil|donepezil|mesh-list
153866122|NCT04617782|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
153866123|NCT04617782|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153866130|NCT00569985|Carmustine|carmustine|mesh-list
153866131|NCT00569985|Etoposide|etoposide|mesh-list
153866132|NCT00569985|Etoposide phosphate|etoposide phosphate|mesh-list
153866133|NCT00569985|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153866134|NCT00569985|Immunologic Factors|immunologic factors|mesh-ancestor
153866135|NCT00569985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153866136|NCT00569985|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153866137|NCT00569985|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153866138|NCT00569985|Alkylating Agents|alkylating agents|mesh-ancestor
153866139|NCT00569985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153866140|NCT00569985|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153866141|NCT00569985|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153866142|NCT00569985|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153866143|NCT00569985|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153866144|NCT00569985|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153866145|NCT00569985|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153866146|NCT04617626|Azithromycin|azithromycin|mesh-list
153866148|NCT04617626|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153866149|NCT04585230|Mineral Oil|mineral oil|mesh-list
153866150|NCT04585230|Emollients|emollients|mesh-ancestor
153406582|NCT04294459|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
153406583|NCT04294459|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
153406584|NCT04294459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153406585|NCT04294459|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
153406586|NCT04294459|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153406587|NCT04294459|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153406588|NCT04294459|Anesthetics, Local|anesthetics, local|mesh-ancestor
153406589|NCT04294459|Anesthetics|anesthetics|mesh-ancestor
153406590|NCT04294459|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
153406591|NCT04294459|Histamine Antagonists|histamine antagonists|mesh-ancestor
153406592|NCT04294459|Histamine Agents|histamine agents|mesh-ancestor
153406593|NCT04294459|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153406594|NCT04294459|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
153406595|NCT04294459|Antipruritics|antipruritics|mesh-ancestor
153406596|NCT04294459|Dermatologic Agents|dermatologic agents|mesh-ancestor
153406597|NCT04294459|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
153406598|NCT04294459|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
153406599|NCT04268121|Cisplatin|cisplatin|mesh-list
153866151|NCT04585230|Dermatologic Agents|dermatologic agents|mesh-ancestor
153866152|NCT00570180|Bortezomib|bortezomib|mesh-list
153866153|NCT00570180|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153866154|NCT02939846|Trametinib|trametinib|mesh-list
153866155|NCT02939846|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153866156|NCT02939846|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153866157|NCT02939846|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153866158|NCT02939846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153866159|NCT02939495|Sildenafil Citrate|sildenafil citrate|mesh-list
153866160|NCT02939495|Vasodilator Agents|vasodilator agents|mesh-ancestor
153866161|NCT02939495|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
153866162|NCT02939495|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
153866163|NCT02939495|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153866164|NCT02939495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153866165|NCT02939495|Urological Agents|urological agents|mesh-ancestor
153866166|NCT00570219|Valproic Acid|valproic acid|mesh-list
153866167|NCT00570219|Anticonvulsants|anticonvulsants|mesh-ancestor
153406617|NCT04210505|Povidone|povidone|mesh-list
153866186|NCT00568074|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153866187|NCT00568074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153866188|NCT00568074|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
153866189|NCT00568074|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153483621|NCT00687453|Insulin Glargine|insulin glargine|mesh-list
153866191|NCT00568113|Acetylcysteine|acetylcysteine|mesh-list
153406633|NCT04194528|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153406634|NCT04194528|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153406635|NCT04194528|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153406636|NCT04194528|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153406637|NCT04189614|Cofetuzumab pelidotin|cofetuzumab pelidotin|mesh-list
153406650|NCT04158440|Carboplatin|carboplatin|mesh-list
153406651|NCT04158440|Pemetrexed|pemetrexed|mesh-list
153406652|NCT04158440|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153406653|NCT04158440|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153406654|NCT04158440|Tubulin Modulators|tubulin modulators|mesh-ancestor
153406655|NCT04158440|Antimitotic Agents|antimitotic agents|mesh-ancestor
153406656|NCT04158440|Mitosis Modulators|mitosis modulators|mesh-ancestor
153406657|NCT04158440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153406658|NCT04158440|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153406659|NCT04158440|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153406660|NCT04158440|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153406661|NCT04111978|Letrozole|letrozole|mesh-list
153406662|NCT04111978|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153406663|NCT04111978|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
153406664|NCT04111978|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153866206|NCT00568152|Analgesics|analgesics|mesh-ancestor
153866207|NCT00568152|Sensory System Agents|sensory system agents|mesh-ancestor
153866208|NCT00568152|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153866209|NCT00568152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153866210|NCT00568152|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153866211|NCT00568152|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153866212|NCT00568152|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153866213|NCT00568152|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153866214|NCT00568152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153866215|NCT00568152|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153866216|NCT00568152|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153866217|NCT00568152|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153866218|NCT00568152|Antipyretics|antipyretics|mesh-ancestor
153866219|NCT04610879|Carbamazepine|carbamazepine|mesh-list
153866220|NCT04610879|Levetiracetam|levetiracetam|mesh-list
153866221|NCT04610879|Anticonvulsants|anticonvulsants|mesh-ancestor
153866222|NCT04610879|Nootropic Agents|nootropic agents|mesh-ancestor
153866223|NCT04610879|Antimanic Agents|antimanic agents|mesh-ancestor
153866224|NCT04610879|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153866225|NCT04610879|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153866226|NCT04610879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153866227|NCT04610879|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153866228|NCT04610879|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153866245|NCT00570726|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153406681|NCT03974217|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153406683|NCT03974217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153406684|NCT03974217|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153406685|NCT03974217|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153406686|NCT03974217|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
153406687|NCT03971045|Cyclophosphamide|cyclophosphamide|mesh-list
153406688|NCT03971045|Pembrolizumab|pembrolizumab|mesh-list
153406689|NCT03971045|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153406690|NCT03971045|Immunologic Factors|immunologic factors|mesh-ancestor
153406691|NCT03971045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153406692|NCT03971045|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153406693|NCT03971045|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153406694|NCT03971045|Alkylating Agents|alkylating agents|mesh-ancestor
153406695|NCT03971045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153406696|NCT03971045|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153406697|NCT03971045|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153406698|NCT03971045|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153406699|NCT03971045|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153406700|NCT03940235|Androgens|androgens|mesh-list
153406701|NCT03940235|Hormones|hormones|mesh-ancestor
153406702|NCT03940235|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153406703|NCT03940235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153406704|NCT03935893|Cyclophosphamide|cyclophosphamide|mesh-list
153406705|NCT03935893|Fludarabine|fludarabine|mesh-list
153406706|NCT03935893|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153406707|NCT03935893|Immunologic Factors|immunologic factors|mesh-ancestor
153406716|NCT03916510|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153406717|NCT03916510|Antimetabolites|antimetabolites|mesh-ancestor
153484072|NCT05672394|Mydriatics|mydriatics|mesh-ancestor
153406733|NCT03853317|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153406734|NCT03845010|Verapamil|verapamil|mesh-list
153406735|NCT03845010|Flecainide|flecainide|mesh-list
153406736|NCT03845010|Sotalol|sotalol|mesh-list
153406737|NCT03845010|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153406738|NCT03845010|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153406739|NCT03845010|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153406740|NCT03845010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153406741|NCT03845010|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153406742|NCT03845010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153406743|NCT03845010|Vasodilator Agents|vasodilator agents|mesh-ancestor
153406744|NCT03845010|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
153406745|NCT03845010|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153866290|NCT00563147|MTOR Inhibitors|mtor inhibitors|mesh-list
153866291|NCT00563147|Tivozanib|tivozanib|mesh-list
153866292|NCT00563147|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153866293|NCT00563147|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153866294|NCT00563147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153866295|NCT00563147|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153866296|NCT00563147|Immunologic Factors|immunologic factors|mesh-ancestor
153866297|NCT00563147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153866298|NCT00563147|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153866299|NCT00563147|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153866300|NCT00563147|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153866301|NCT00563147|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153866302|NCT00563147|Antifungal Agents|antifungal agents|mesh-ancestor
153406784|NCT03743428|Bevacizumab|bevacizumab|mesh-list
153406785|NCT03743428|Apatinib|apatinib|mesh-list
153406786|NCT03743428|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153406787|NCT03743428|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153406788|NCT03743428|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153406789|NCT03743428|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153406790|NCT03743428|Growth Substances|growth substances|mesh-ancestor
153406791|NCT03743428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153406792|NCT03743428|Growth Inhibitors|growth inhibitors|mesh-ancestor
153406793|NCT03743428|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153406794|NCT03743428|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153406795|NCT03743428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153406796|NCT03739710|Docetaxel|docetaxel|mesh-list
153866326|NCT00571116|Acetaldehyde Dehydrogenase Inhibitors|acetaldehyde dehydrogenase inhibitors|mesh-ancestor
153866327|NCT00571116|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153866328|NCT00571116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153866329|NCT00571155|Levetiracetam|levetiracetam|mesh-list
153866330|NCT00571155|Anticonvulsants|anticonvulsants|mesh-ancestor
153866331|NCT00571155|Nootropic Agents|nootropic agents|mesh-ancestor
153866332|NCT04615481|Metronidazole|metronidazole|mesh-list
153866333|NCT04615481|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153866334|NCT04615481|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153866335|NCT04615481|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153866336|NCT04615481|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153866337|NCT00563303|Hydrocortisone|hydrocortisone|mesh-list
153866338|NCT00563303|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153866339|NCT00571506|Pioglitazone|pioglitazone|mesh-list
153866340|NCT00571506|Rosiglitazone|rosiglitazone|mesh-list
153866341|NCT00571506|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153866344|NCT04613609|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
153866345|NCT04613609|Autonomic Agents|autonomic agents|mesh-ancestor
153866346|NCT04613609|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153866358|NCT00571740|Calcium|calcium|mesh-list
153866359|NCT00571740|Levoleucovorin|levoleucovorin|mesh-list
153866360|NCT00571740|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153866361|NCT00571740|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153866362|NCT00571740|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153866363|NCT00571740|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153866364|NCT00571740|Growth Substances|growth substances|mesh-ancestor
153406800|NCT03739710|Tubulin Modulators|tubulin modulators|mesh-ancestor
153406801|NCT03739710|Antimitotic Agents|antimitotic agents|mesh-ancestor
153406802|NCT03739710|Mitosis Modulators|mitosis modulators|mesh-ancestor
153406803|NCT03739710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153406804|NCT03739710|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153406805|NCT03739710|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153406806|NCT03691064|Lutetium Lu 177 dotatate|lutetium lu 177 dotatate|mesh-list
153406807|NCT03691064|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
153916651|NCT00993915|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153484313|NCT01631682|Adrenergic Agents|adrenergic agents|mesh-ancestor
153484314|NCT01631682|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153406808|NCT03691064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153406809|NCT03690921|Cisplatin|cisplatin|mesh-list
153406810|NCT03690921|Fluorouracil|fluorouracil|mesh-list
153406811|NCT03690921|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153406812|NCT03690921|Antimetabolites|antimetabolites|mesh-ancestor
153888768|NCT01034137|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153888769|NCT01034137|Antimetabolites|antimetabolites|mesh-ancestor
153888770|NCT01034137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153866390|NCT04582929|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
153866391|NCT04582929|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153866392|NCT04582929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153866394|NCT04582929|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153866395|NCT04613726|Ondansetron|ondansetron|mesh-list
153866396|NCT04613726|Granisetron|granisetron|mesh-list
153866397|NCT04613726|Antiemetics|antiemetics|mesh-ancestor
153866398|NCT04613726|Autonomic Agents|autonomic agents|mesh-ancestor
153866399|NCT04613726|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153866400|NCT04613726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153866401|NCT04613726|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153866402|NCT04613726|Antipruritics|antipruritics|mesh-ancestor
153866403|NCT04613726|Dermatologic Agents|dermatologic agents|mesh-ancestor
153866404|NCT04613726|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
153866405|NCT04613726|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153406850|NCT03617705|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
153406851|NCT03617705|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153406852|NCT03617705|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153866421|NCT00563615|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
153406858|NCT03576885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153406859|NCT03576885|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153406860|NCT03576885|Respiratory System Agents|respiratory system agents|mesh-ancestor
153429872|NCT00002768|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153429873|NCT00002768|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153866434|NCT00563654|Urological Agents|urological agents|mesh-ancestor
153866435|NCT04613180|Montelukast|montelukast|mesh-list
153866436|NCT04613180|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153866437|NCT04613180|Respiratory System Agents|respiratory system agents|mesh-ancestor
153866438|NCT04613180|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
153866439|NCT04613180|Hormone Antagonists|hormone antagonists|mesh-ancestor
153866440|NCT04613180|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153866445|NCT00571935|Insulin|insulin|mesh-list
153406915|NCT03427125|Chelating Agents|chelating agents|mesh-ancestor
153406916|NCT03427125|Sequestering Agents|sequestering agents|mesh-ancestor
153406917|NCT03427125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153406918|NCT03359863|Pirfenidone|pirfenidone|mesh-list
153406919|NCT03359863|Analgesics|analgesics|mesh-ancestor
153406920|NCT03359863|Sensory System Agents|sensory system agents|mesh-ancestor
153406921|NCT03359863|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153406922|NCT03359863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153866474|NCT00568347|Adrenergic Agents|adrenergic agents|mesh-ancestor
153866475|NCT00568347|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153866476|NCT00568347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153866477|NCT00568347|Glucocorticoids|glucocorticoids|mesh-ancestor
153866478|NCT00568347|Hormones|hormones|mesh-ancestor
153866479|NCT00568347|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153866480|NCT00568347|Sympathomimetics|sympathomimetics|mesh-ancestor
153866481|NCT04611971|Belimumab|belimumab|mesh-list
153866482|NCT04611971|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153406974|NCT03144804|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153406975|NCT03144804|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153406976|NCT03142334|Pembrolizumab|pembrolizumab|mesh-list
153406977|NCT03142334|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153406978|NCT03142334|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153406979|NCT03142334|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153406980|NCT03142334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153406981|NCT03126539|Sulforaphane|sulforaphane|mesh-list
153406982|NCT03126539|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
153406983|NCT03126539|Protective Agents|protective agents|mesh-ancestor
153406985|NCT03126539|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153406987|NCT03107923|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
153406988|NCT03107923|Sympathomimetics|sympathomimetics|mesh-ancestor
153882910|NCT01688648|Lidocaine|lidocaine|mesh-list
153406989|NCT03107923|Autonomic Agents|autonomic agents|mesh-ancestor
153406990|NCT03107923|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153406991|NCT03107923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153406992|NCT03107923|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
153406993|NCT03107923|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
153406994|NCT03107923|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153406995|NCT03107923|Adrenergic Agents|adrenergic agents|mesh-ancestor
153406996|NCT03107923|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153406997|NCT03107923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153866563|NCT04611776|Carboplatin|carboplatin|mesh-list
153866564|NCT04611776|Gemcitabine|gemcitabine|mesh-list
153866565|NCT04611776|Pemetrexed|pemetrexed|mesh-list
153866566|NCT04611776|Atezolizumab|atezolizumab|mesh-list
153866567|NCT04611776|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153866568|NCT04611776|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153866569|NCT04611776|Tubulin Modulators|tubulin modulators|mesh-ancestor
153866570|NCT04611776|Antimitotic Agents|antimitotic agents|mesh-ancestor
153866571|NCT04611776|Mitosis Modulators|mitosis modulators|mesh-ancestor
153866572|NCT04611776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153866573|NCT04611776|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153866574|NCT04611776|Antimetabolites|antimetabolites|mesh-ancestor
153866575|NCT04611776|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153866576|NCT04611776|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153407019|NCT02969681|Micronutrients|micronutrients|mesh-ancestor
153407020|NCT02969681|Antioxidants|antioxidants|mesh-ancestor
153407021|NCT02969681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153407022|NCT02969681|Protective Agents|protective agents|mesh-ancestor
153407023|NCT02956590|Pitavastatin|pitavastatin|mesh-list
153407024|NCT02956590|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
153407025|NCT02956590|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153866581|NCT00572637|Proteasome Inhibitors|proteasome inhibitors|mesh-ancestor
153866582|NCT00572637|Protease Inhibitors|protease inhibitors|mesh-ancestor
153866583|NCT00572637|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153866584|NCT00572637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153866585|NCT01149655|Aripiprazole|aripiprazole|mesh-list
153866586|NCT01149655|Antidepressive Agents|antidepressive agents|mesh-ancestor
153866587|NCT01149655|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153866588|NCT01149655|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153866590|NCT01149655|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153866591|NCT01149655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153866592|NCT01149655|Dopamine Agonists|dopamine agonists|mesh-ancestor
153866593|NCT01149655|Dopamine Agents|dopamine agents|mesh-ancestor
153866594|NCT01149655|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153866595|NCT01149655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153866596|NCT01149655|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
153407039|NCT02947087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153407040|NCT02864550|Doxycycline|doxycycline|mesh-list
153407041|NCT02864550|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153407042|NCT02864550|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153407043|NCT02864550|Antimalarials|antimalarials|mesh-ancestor
153407044|NCT02864550|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153407045|NCT02864550|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153407046|NCT02841995|Belumosudil|belumosudil|mesh-list
153407047|NCT02841995|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153407048|NCT02841995|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153407049|NCT02841995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153407050|NCT02640534|Metformin|metformin|mesh-list
153407051|NCT02640534|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153407052|NCT02640534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153407053|NCT02628366|Dialysis Solutions|dialysis solutions|mesh-list
153407054|NCT02628366|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
153407055|NCT02586038|Thalidomide|thalidomide|mesh-list
153407056|NCT02586038|Dexamethasone|dexamethasone|mesh-list
153407057|NCT02586038|Cyclophosphamide|cyclophosphamide|mesh-list
153407058|NCT02586038|Ixazomib|ixazomib|mesh-list
153866613|NCT00575406|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153866614|NCT00575406|Alkylating Agents|alkylating agents|mesh-ancestor
153866615|NCT00575406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153407059|NCT02586038|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153407060|NCT02586038|Immunologic Factors|immunologic factors|mesh-ancestor
153407061|NCT02586038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153407062|NCT02586038|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153407063|NCT02586038|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153407064|NCT02586038|Alkylating Agents|alkylating agents|mesh-ancestor
153407065|NCT02586038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153407066|NCT02586038|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153407067|NCT02586038|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153407068|NCT02586038|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153407069|NCT02586038|Antiemetics|antiemetics|mesh-ancestor
153407070|NCT02586038|Autonomic Agents|autonomic agents|mesh-ancestor
153407071|NCT02586038|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153407072|NCT02586038|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153407073|NCT02586038|Glucocorticoids|glucocorticoids|mesh-ancestor
153407074|NCT02586038|Hormones|hormones|mesh-ancestor
153407075|NCT02586038|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153407076|NCT02586038|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153407077|NCT02586038|Leprostatic Agents|leprostatic agents|mesh-ancestor
153866616|NCT00575406|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153866617|NCT00575406|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153866618|NCT00575406|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153866619|NCT00575406|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153866620|NCT00575406|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153866626|NCT00575406|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153866627|NCT00575406|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153866628|NCT00575406|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153866629|NCT00575406|Tubulin Modulators|tubulin modulators|mesh-ancestor
153866630|NCT00575406|Antimitotic Agents|antimitotic agents|mesh-ancestor
153866631|NCT00575406|Mitosis Modulators|mitosis modulators|mesh-ancestor
153407085|NCT02586038|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153407086|NCT02579811|Axitinib|axitinib|mesh-list
153407087|NCT02579811|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153407088|NCT02579811|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153407089|NCT02579811|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153407090|NCT02579811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153407091|NCT02554383|Amoxicillin|amoxicillin|mesh-list
153407092|NCT02554383|Clavulanic Acid|clavulanic acid|mesh-list
153407093|NCT02554383|Clavulanic Acids|clavulanic acids|mesh-list
153407094|NCT02554383|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
153407095|NCT02554383|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153407096|NCT02554383|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153407097|NCT02554383|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
153407098|NCT02554383|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153407133|NCT02215980|Hormones|hormones|mesh-ancestor
153407134|NCT02215980|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153407135|NCT02215980|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153407136|NCT02215980|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153407137|NCT02215980|Immunologic Factors|immunologic factors|mesh-ancestor
153407138|NCT02215980|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153407139|NCT02215980|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153866667|NCT00575601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153866668|NCT00575601|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153866669|NCT00575601|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
153866670|NCT00575601|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153866682|NCT04600271|Adrenergic Agents|adrenergic agents|mesh-ancestor
153866683|NCT04600271|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153866684|NCT04600271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153866685|NCT04600271|Sympathomimetics|sympathomimetics|mesh-ancestor
153866686|NCT04600271|Autonomic Agents|autonomic agents|mesh-ancestor
153866687|NCT04600271|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
153866688|NCT04600271|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153866689|NCT04600271|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153866690|NCT00575640|Hydralazine|hydralazine|mesh-list
153866691|NCT00575640|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153866692|NCT00575640|Vasodilator Agents|vasodilator agents|mesh-ancestor
153866693|NCT04599959|Hydrocortisone|hydrocortisone|mesh-list
153866694|NCT04599959|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153407140|NCT02215980|Growth Substances|growth substances|mesh-ancestor
153407141|NCT02215980|Growth Inhibitors|growth inhibitors|mesh-ancestor
153407142|NCT02101021|Paclitaxel|paclitaxel|mesh-list
153407154|NCT02101021|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153407155|NCT02088632|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
153407156|NCT02088632|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
153407157|NCT02088632|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153407158|NCT02088632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153485185|NCT01785186|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
153407159|NCT02088632|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
153407160|NCT02088632|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153866696|NCT04579731|Cathartics|cathartics|mesh-ancestor
153866704|NCT00565487|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153866705|NCT00565487|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153866706|NCT00565487|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153866707|NCT04600115|Adenosine|adenosine|mesh-list
153866708|NCT04600115|Regadenoson|regadenoson|mesh-list
153866709|NCT04600115|Analgesics|analgesics|mesh-ancestor
153866710|NCT04600115|Sensory System Agents|sensory system agents|mesh-ancestor
153866711|NCT04600115|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153866712|NCT04600115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153866713|NCT04600115|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153866714|NCT04600115|Vasodilator Agents|vasodilator agents|mesh-ancestor
153866715|NCT04600115|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
153866716|NCT04600115|Purinergic Agonists|purinergic agonists|mesh-ancestor
153866717|NCT04600115|Purinergic Agents|purinergic agents|mesh-ancestor
153866718|NCT04600115|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153866719|NCT04600115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153866720|NCT04600115|Adenosine A2 Receptor Agonists|adenosine a2 receptor agonists|mesh-ancestor
153866721|NCT04600037|Pregabalin|pregabalin|mesh-list
153866722|NCT04600037|Analgesics|analgesics|mesh-ancestor
153866723|NCT04600037|Sensory System Agents|sensory system agents|mesh-ancestor
153866724|NCT04600037|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153866725|NCT04600037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153866726|NCT04600037|Anticonvulsants|anticonvulsants|mesh-ancestor
153866727|NCT04600037|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153407170|NCT02031536|Immunologic Factors|immunologic factors|mesh-ancestor
153407171|NCT02031536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153407172|NCT02031536|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153407173|NCT02023996|Trastuzumab|trastuzumab|mesh-list
153407174|NCT02023996|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153407175|NCT02023996|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153407176|NCT02020720|Fluorides|fluorides|mesh-list
153407177|NCT02020720|Cariostatic Agents|cariostatic agents|mesh-ancestor
153407178|NCT02020720|Protective Agents|protective agents|mesh-ancestor
153407179|NCT02020720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153407180|NCT01968200|Enalapril|enalapril|mesh-list
153407181|NCT01968200|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
153407182|NCT01968200|Protease Inhibitors|protease inhibitors|mesh-ancestor
153407183|NCT01968200|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153407184|NCT01968200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153407185|NCT01968200|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153407186|NCT01964430|Paclitaxel|paclitaxel|mesh-list
153407187|NCT01964430|Gemcitabine|gemcitabine|mesh-list
153407188|NCT01964430|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153407189|NCT01964430|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153407190|NCT01964430|Tubulin Modulators|tubulin modulators|mesh-ancestor
153407192|NCT01964430|Mitosis Modulators|mitosis modulators|mesh-ancestor
153407193|NCT01964430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153407194|NCT01964430|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153407195|NCT01964430|Antimetabolites|antimetabolites|mesh-ancestor
153407196|NCT01934868|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
153407197|NCT01841359|Pramlintide|pramlintide|mesh-list
153407198|NCT01841359|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153407199|NCT01841359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153407200|NCT01579734|Tamoxifen|tamoxifen|mesh-list
153407201|NCT01579734|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
153407202|NCT01579734|Hormone Antagonists|hormone antagonists|mesh-ancestor
153866748|NCT00575835|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153866749|NCT00575835|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153866750|NCT00573222|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
153866751|NCT00573222|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153866752|NCT00573222|Respiratory System Agents|respiratory system agents|mesh-ancestor
153866753|NCT00575874|Pioglitazone|pioglitazone|mesh-list
153407204|NCT01579734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153407206|NCT01579734|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153407207|NCT01579734|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
153407208|NCT01579734|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
153407209|NCT01579734|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153407212|NCT01566240|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153407213|NCT01566240|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153382527|NCT01996943|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
153382528|NCT01996943|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153382529|NCT01996943|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153382540|NCT04812626|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153485651|NCT05633147|Anesthetics|anesthetics|mesh-ancestor
153407214|NCT01566240|Tubulin Modulators|tubulin modulators|mesh-ancestor
153866766|NCT00575913|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
153866768|NCT00575913|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
153866769|NCT00575913|Adrenergic Agents|adrenergic agents|mesh-ancestor
153866770|NCT00575913|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153866771|NCT00575913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153407215|NCT01566240|Antimitotic Agents|antimitotic agents|mesh-ancestor
153407216|NCT01566240|Mitosis Modulators|mitosis modulators|mesh-ancestor
153407218|NCT01390584|Prednisone|prednisone|mesh-list
153407219|NCT01390584|Cyclophosphamide|cyclophosphamide|mesh-list
153407220|NCT01390584|Dacarbazine|dacarbazine|mesh-list
153407221|NCT01390584|Doxorubicin|doxorubicin|mesh-list
153407222|NCT01390584|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
153407223|NCT01390584|Etoposide|etoposide|mesh-list
153407224|NCT01390584|Vincristine|vincristine|mesh-list
153407225|NCT01390584|Etoposide phosphate|etoposide phosphate|mesh-list
153407226|NCT01390584|Bleomycin|bleomycin|mesh-list
153407227|NCT01390584|Vinblastine|vinblastine|mesh-list
153407228|NCT01390584|Podophyllotoxin|podophyllotoxin|mesh-list
153407229|NCT01390584|Procarbazine|procarbazine|mesh-list
153407230|NCT01390584|Imidazole|imidazole|mesh-list
153407231|NCT01390584|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153407232|NCT01390584|Immunologic Factors|immunologic factors|mesh-ancestor
153407233|NCT01390584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153407234|NCT01390584|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153407235|NCT01390584|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153407236|NCT01390584|Alkylating Agents|alkylating agents|mesh-ancestor
153407237|NCT01390584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153407238|NCT01390584|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153407239|NCT01390584|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153407240|NCT01390584|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153407241|NCT01390584|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153407242|NCT01390584|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153407243|NCT01390584|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153866793|NCT00565682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153866795|NCT00575952|Doxorubicin|doxorubicin|mesh-list
153866796|NCT00575952|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
153866797|NCT00575952|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153407245|NCT01390584|Glucocorticoids|glucocorticoids|mesh-ancestor
153407247|NCT01390584|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153407248|NCT01390584|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153407249|NCT01390584|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153407250|NCT01390584|Tubulin Modulators|tubulin modulators|mesh-ancestor
153407251|NCT01390584|Antimitotic Agents|antimitotic agents|mesh-ancestor
153407252|NCT01390584|Mitosis Modulators|mitosis modulators|mesh-ancestor
153407253|NCT01390584|Keratolytic Agents|keratolytic agents|mesh-ancestor
153866811|NCT00573417|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
153866812|NCT00573417|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
153866813|NCT00573417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153866815|NCT00573495|Cysteine Proteinase Inhibitors|cysteine proteinase inhibitors|mesh-ancestor
153866824|NCT00565955|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153866825|NCT00565955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153866826|NCT00565955|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
153866827|NCT00565955|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
153866828|NCT00565955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153866829|NCT04598594|Nicotine|nicotine|mesh-list
153866830|NCT04598594|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
153866831|NCT04598594|Autonomic Agents|autonomic agents|mesh-ancestor
153866832|NCT04598594|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153866833|NCT04598594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153866834|NCT04598594|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
153866835|NCT04598594|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
153866836|NCT04598594|Cholinergic Agents|cholinergic agents|mesh-ancestor
153866837|NCT04598594|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153407289|NCT01166113|Alkylating Agents|alkylating agents|mesh-ancestor
153407290|NCT01166113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153407291|NCT01166113|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153407292|NCT01166113|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153407293|NCT01166113|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153407294|NCT01166113|Glucocorticoids|glucocorticoids|mesh-ancestor
153407296|NCT01166113|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153407297|NCT01166113|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153407298|NCT01166113|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153407299|NCT01166113|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153407300|NCT01166113|Growth Substances|growth substances|mesh-ancestor
153407301|NCT01166113|Growth Inhibitors|growth inhibitors|mesh-ancestor
153407302|NCT01160107|Prednisone|prednisone|mesh-list
153407303|NCT01160107|Melphalan|melphalan|mesh-list
153407304|NCT01160107|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153407305|NCT01160107|Glucocorticoids|glucocorticoids|mesh-ancestor
153407306|NCT01160107|Hormones|hormones|mesh-ancestor
153407307|NCT01160107|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153407308|NCT01160107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153407309|NCT01160107|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153866838|NCT04598594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153866839|NCT00573690|Carboplatin|carboplatin|mesh-list
153866840|NCT00573690|Etoposide|etoposide|mesh-list
153407316|NCT01160107|Immunologic Factors|immunologic factors|mesh-ancestor
153407317|NCT01145495|Rituximab|rituximab|mesh-list
153407318|NCT01145495|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
153407319|NCT01145495|Lenalidomide|lenalidomide|mesh-list
153407320|NCT01145495|Antibodies|antibodies|mesh-list
153407321|NCT01145495|Immunoglobulins|immunoglobulins|mesh-list
153407322|NCT01145495|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
153407323|NCT01145495|Immunologic Factors|immunologic factors|mesh-ancestor
153407324|NCT01145495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153407325|NCT01145495|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153407326|NCT01145495|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153407327|NCT01145495|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153407328|NCT01145495|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153407329|NCT01145495|Growth Substances|growth substances|mesh-ancestor
153407330|NCT01145495|Growth Inhibitors|growth inhibitors|mesh-ancestor
153407331|NCT01124695|Tamoxifen|tamoxifen|mesh-list
153866868|NCT00576459|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153866869|NCT00576459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153866876|NCT04597775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153866877|NCT04597775|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153866878|NCT00573885|Epigallocatechin gallate|epigallocatechin gallate|mesh-list
153866879|NCT00573885|Antioxidants|antioxidants|mesh-ancestor
153866880|NCT00573885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153866881|NCT00573885|Protective Agents|protective agents|mesh-ancestor
153866882|NCT00573885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153866883|NCT00573885|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
153866884|NCT00573885|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
153866885|NCT00573885|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153866886|NCT00573885|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
153866887|NCT00573924|Lansoprazole|lansoprazole|mesh-list
153866888|NCT00573924|Dexlansoprazole|dexlansoprazole|mesh-list
153866889|NCT00573924|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
153866890|NCT00573924|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
153866891|NCT00573924|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153866892|NCT00573924|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153866893|NCT00573924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153866894|NCT00573963|Ropivacaine|ropivacaine|mesh-list
153866895|NCT00573963|Anesthetics, Local|anesthetics, local|mesh-ancestor
153866896|NCT00573963|Anesthetics|anesthetics|mesh-ancestor
153866897|NCT00573963|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153866898|NCT00573963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153866899|NCT00573963|Sensory System Agents|sensory system agents|mesh-ancestor
153866900|NCT00573963|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153866901|NCT00576615|Propofol|propofol|mesh-list
153407363|NCT01079780|Growth Inhibitors|growth inhibitors|mesh-ancestor
153407364|NCT01063179|Thalidomide|thalidomide|mesh-list
153407365|NCT01063179|Prednisone|prednisone|mesh-list
153407366|NCT01063179|Bortezomib|bortezomib|mesh-list
153407367|NCT01063179|Melphalan|melphalan|mesh-list
153486483|NCT00160680|Levocetirizine|levocetirizine|mesh-list
153407371|NCT01063179|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153407372|NCT01063179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153407373|NCT01063179|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153407374|NCT01063179|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153407375|NCT01063179|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153407377|NCT01063179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153407378|NCT01063179|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153407379|NCT01063179|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153407380|NCT01063179|Immunologic Factors|immunologic factors|mesh-ancestor
153407381|NCT01063179|Leprostatic Agents|leprostatic agents|mesh-ancestor
153407382|NCT01063179|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153407383|NCT01063179|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153407384|NCT01063179|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153866922|NCT00566267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153866924|NCT00566267|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
153866925|NCT00566267|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153866926|NCT00574353|Misonidazole|misonidazole|mesh-list
153866927|NCT00574353|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153866928|NCT00574353|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153866929|NCT00574353|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153866930|NCT00574353|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153866931|NCT04596839|Remdesivir|remdesivir|mesh-list
153866932|NCT04596839|Antimetabolites|antimetabolites|mesh-ancestor
153407386|NCT01063179|Growth Substances|growth substances|mesh-ancestor
153407387|NCT01063179|Growth Inhibitors|growth inhibitors|mesh-ancestor
153407389|NCT01013961|Alemtuzumab|alemtuzumab|mesh-list
153407390|NCT01013961|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153407391|NCT01013961|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153407392|NCT01013961|Immunologic Factors|immunologic factors|mesh-ancestor
153407393|NCT01013961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153407394|NCT01013961|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153407395|NCT00834093|Immunomodulating Agents|immunomodulating agents|mesh-list
153407396|NCT00834093|Immunologic Factors|immunologic factors|mesh-ancestor
153407397|NCT00834093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153407398|NCT00779194|Sirolimus|sirolimus|mesh-list
153407399|NCT00779194|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153407400|NCT00779194|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153407401|NCT00779194|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153407402|NCT00779194|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153407403|NCT00779194|Antifungal Agents|antifungal agents|mesh-ancestor
153407404|NCT00779194|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153866962|NCT00577161|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153407417|NCT00665600|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
153407418|NCT00665600|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
153407419|NCT00665600|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153407420|NCT00665600|Adrenergic Agents|adrenergic agents|mesh-ancestor
153407421|NCT00665600|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153407422|NCT00665600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153407424|NCT00606294|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153407425|NCT00606294|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153407426|NCT00606294|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153407427|NCT00606294|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153407428|NCT00551928|Prednisone|prednisone|mesh-list
153407429|NCT00551928|Lenalidomide|lenalidomide|mesh-list
153407430|NCT00551928|Melphalan|melphalan|mesh-list
153407431|NCT00551928|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153407432|NCT00551928|Glucocorticoids|glucocorticoids|mesh-ancestor
153407433|NCT00551928|Hormones|hormones|mesh-ancestor
153407434|NCT00551928|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153407435|NCT00551928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153407459|NCT00316888|Fluorouracil|fluorouracil|mesh-list
153407460|NCT00316888|Cetuximab|cetuximab|mesh-list
153407461|NCT00316888|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153407462|NCT00316888|Antimetabolites|antimetabolites|mesh-ancestor
153407463|NCT00316888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153407464|NCT00316888|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153407465|NCT00316888|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153407475|NCT00309478|Immunologic Factors|immunologic factors|mesh-ancestor
153407476|NCT00309478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153407477|NCT00309478|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153407478|NCT00309478|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153407479|NCT00309478|Alkylating Agents|alkylating agents|mesh-ancestor
153486683|NCT01843920|Polymyxins|polymyxins|mesh-list
153407480|NCT00309478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153407481|NCT00309478|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153407482|NCT00309478|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153407483|NCT00309478|Antimetabolites|antimetabolites|mesh-ancestor
153407484|NCT00309478|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153407485|NCT00309478|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
153867018|NCT00577668|Autonomic Agents|autonomic agents|mesh-ancestor
153867019|NCT00577668|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153867020|NCT00577668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153867021|NCT00577668|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153867022|NCT00577668|Glucocorticoids|glucocorticoids|mesh-ancestor
153867024|NCT00577668|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153867025|NCT00577668|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153867026|NCT00577668|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153867027|NCT00577668|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153407486|NCT00309478|Abortifacient Agents|abortifacient agents|mesh-ancestor
153407487|NCT00309478|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153407488|NCT00309478|Dermatologic Agents|dermatologic agents|mesh-ancestor
153407489|NCT00309478|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153407490|NCT00309478|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153407491|NCT00309478|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153407492|NCT00309478|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
153407493|NCT00309478|Hormone Antagonists|hormone antagonists|mesh-ancestor
153407494|NCT00309478|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153407495|NCT00309478|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153407496|NCT00309478|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
153407497|NCT00309478|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
153407498|NCT00309478|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153407499|NCT00274924|Prednisone|prednisone|mesh-list
153407500|NCT00274924|Cyclophosphamide|cyclophosphamide|mesh-list
153407501|NCT00274924|Ifosfamide|ifosfamide|mesh-list
153407502|NCT00274924|Rituximab|rituximab|mesh-list
153407503|NCT00274924|Carboplatin|carboplatin|mesh-list
153407504|NCT00274924|Doxorubicin|doxorubicin|mesh-list
153407505|NCT00274924|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
153407506|NCT00274924|Etoposide|etoposide|mesh-list
153407507|NCT00274924|Vincristine|vincristine|mesh-list
153407508|NCT00274924|Podophyllotoxin|podophyllotoxin|mesh-list
153407509|NCT00274924|Lenograstim|lenograstim|mesh-list
153407510|NCT00274924|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153407511|NCT00274924|Immunologic Factors|immunologic factors|mesh-ancestor
153407512|NCT00274924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153407513|NCT00274924|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153407514|NCT00274924|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153407515|NCT00274924|Alkylating Agents|alkylating agents|mesh-ancestor
153407516|NCT00274924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153407517|NCT00274924|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153867054|NCT01147744|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153867055|NCT01147744|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
153867056|NCT01147744|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
153867057|NCT01147744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153867058|NCT04313374|Dexketoprofen trometamol|dexketoprofen trometamol|mesh-list
153407518|NCT00274924|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153407519|NCT00274924|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153407520|NCT00274924|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153407521|NCT00274924|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153407522|NCT00274924|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153407524|NCT00274924|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153407525|NCT00274924|Glucocorticoids|glucocorticoids|mesh-ancestor
153407526|NCT00274924|Hormones|hormones|mesh-ancestor
153407539|NCT00104884|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
153407541|NCT00104884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153407542|NCT00096174|Cisplatin|cisplatin|mesh-list
153867080|NCT04594343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153867082|NCT01147393|Veltuzumab|veltuzumab|mesh-list
153407553|NCT00074282|Alemtuzumab|alemtuzumab|mesh-list
153407554|NCT00074282|Pentostatin|pentostatin|mesh-list
153429890|NCT00002774|Antimetabolites|antimetabolites|mesh-ancestor
153407555|NCT00074282|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153407556|NCT00074282|Immunologic Factors|immunologic factors|mesh-ancestor
153407557|NCT00074282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153407558|NCT00074282|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153382541|NCT04812626|Immunologic Factors|immunologic factors|mesh-ancestor
153382542|NCT04812626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153382543|NCT04812626|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153382544|NCT04812626|Glucocorticoids|glucocorticoids|mesh-ancestor
153382545|NCT04812626|Hormones|hormones|mesh-ancestor
153382546|NCT04812626|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153382547|NCT04812626|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153382548|NCT04197986|Infigratinib|infigratinib|mesh-list
153382549|NCT04197986|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153382550|NCT01997411|Glucagon|glucagon|mesh-list
153382551|NCT01997411|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
153882911|NCT01688648|Dexmedetomidine|dexmedetomidine|mesh-list
153882912|NCT01688648|Anesthetics, Local|anesthetics, local|mesh-ancestor
153882913|NCT01688648|Anesthetics|anesthetics|mesh-ancestor
153882914|NCT01688648|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153882915|NCT01688648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153882916|NCT01688648|Sensory System Agents|sensory system agents|mesh-ancestor
153882917|NCT01688648|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153882918|NCT01688648|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153882920|NCT01688648|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153882921|NCT01688648|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153882922|NCT01688648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153882923|NCT01688648|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153882924|NCT01688648|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153423833|NCT03523988|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153423834|NCT03523988|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153423835|NCT03523988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153423837|NCT03525548|Elexacaftor|elexacaftor|mesh-list
153423838|NCT03525548|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
153423839|NCT03525548|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153423840|NCT03525548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153423841|NCT03528512|Midazolam|midazolam|mesh-list
153423842|NCT03528512|Fentanyl|fentanyl|mesh-list
153423843|NCT03528512|Ketamine|ketamine|mesh-list
153423844|NCT03528512|Analgesics|analgesics|mesh-ancestor
153423845|NCT03528512|Sensory System Agents|sensory system agents|mesh-ancestor
153487139|NCT01907334|Fluticasone|fluticasone|mesh-list
153407559|NCT00074282|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153407560|NCT00074282|Alkylating Agents|alkylating agents|mesh-ancestor
153407561|NCT00074282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153407562|NCT00074282|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153407563|NCT00074282|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153407564|NCT00074282|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153407566|NCT00074282|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153867084|NCT01147393|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153867085|NCT01147393|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153867086|NCT01147393|Chelating Agents|chelating agents|mesh-ancestor
153867087|NCT01147393|Sequestering Agents|sequestering agents|mesh-ancestor
153867088|NCT01147393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153867089|NCT00578097|Botulinum Toxins|botulinum toxins|mesh-list
153867090|NCT00578097|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
153867091|NCT00578097|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
153867092|NCT00578097|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
153867093|NCT00578097|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153867094|NCT00578097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153867095|NCT00578097|Cholinergic Agents|cholinergic agents|mesh-ancestor
153867096|NCT00578097|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153867097|NCT00578097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153867098|NCT00578097|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
153867099|NCT00578097|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153867100|NCT00578370|Cyclosporine|cyclosporine|mesh-list
153867101|NCT00578370|Betamethasone|betamethasone|mesh-list
153867102|NCT00578370|Calcipotriene|calcipotriene|mesh-list
153867103|NCT00578370|Cyclosporins|cyclosporins|mesh-list
153867104|NCT00578370|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153867105|NCT00578370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153867106|NCT00578370|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153867107|NCT00578370|Immunologic Factors|immunologic factors|mesh-ancestor
153407628|NCT00057954|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153407629|NCT00057954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153407630|NCT00057954|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153407632|NCT00057954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153407633|NCT00057954|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153407634|NCT00057954|Dermatologic Agents|dermatologic agents|mesh-ancestor
153407635|NCT00057954|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153407636|NCT00057954|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153867153|NCT00566891|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
153867154|NCT00566891|Purinergic Agents|purinergic agents|mesh-ancestor
153867155|NCT00566891|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153867156|NCT00566891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153867157|NCT00566891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153867158|NCT00566891|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153867159|NCT00566891|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153867160|NCT00578760|Aspirin|aspirin|mesh-list
153867161|NCT00578760|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153867162|NCT00578760|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153867163|NCT00578760|Analgesics|analgesics|mesh-ancestor
153867164|NCT00578760|Sensory System Agents|sensory system agents|mesh-ancestor
153867165|NCT00578760|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153867166|NCT00578760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153407654|NCT00049530|Antiviral Agents|antiviral agents|mesh-ancestor
153407655|NCT00049530|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153407656|NCT00049530|Immunologic Factors|immunologic factors|mesh-ancestor
153407657|NCT00049530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153407658|NCT00045305|Cyclosporine|cyclosporine|mesh-list
153407659|NCT00045305|Mycophenolic Acid|mycophenolic acid|mesh-list
153407660|NCT00045305|Methotrexate|methotrexate|mesh-list
153407661|NCT00045305|Pentostatin|pentostatin|mesh-list
153407662|NCT00045305|Methoxsalen|methoxsalen|mesh-list
153407663|NCT00045305|Cyclosporins|cyclosporins|mesh-list
153407664|NCT00045305|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
153407665|NCT00045305|Abortifacient Agents|abortifacient agents|mesh-ancestor
153407666|NCT00045305|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153407667|NCT00045305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153407668|NCT00045305|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153407669|NCT00045305|Antimetabolites|antimetabolites|mesh-ancestor
153407670|NCT00045305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153867189|NCT00567047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153382554|NCT01997411|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153382555|NCT01997411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153382556|NCT01997411|Incretins|incretins|mesh-ancestor
153382557|NCT03534635|Pembrolizumab|pembrolizumab|mesh-list
153382558|NCT03534635|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153382589|NCT01971593|Hormone Antagonists|hormone antagonists|mesh-ancestor
153382590|NCT01971593|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153382591|NCT01971593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153382592|NCT01971593|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
153382593|NCT01971593|Diuretics|diuretics|mesh-ancestor
153382621|NCT02986451|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153382622|NCT03245463|Hyaluronic Acid|hyaluronic acid|mesh-list
153382623|NCT03245463|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153487643|NCT01086540|Anesthetics, Local|anesthetics, local|mesh-ancestor
153867191|NCT04592666|Pemetrexed|pemetrexed|mesh-list
153867192|NCT04592666|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153867193|NCT04592666|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153867194|NCT04592666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153867195|NCT04592666|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153867196|NCT04592666|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153867197|NCT04592198|Palonosetron|palonosetron|mesh-list
153867198|NCT04592198|Antiemetics|antiemetics|mesh-ancestor
153867199|NCT04592198|Autonomic Agents|autonomic agents|mesh-ancestor
153867200|NCT04592198|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153867201|NCT04592198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153867202|NCT04592198|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153867203|NCT04592198|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
153867204|NCT04592198|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153867205|NCT04592198|Serotonin Agents|serotonin agents|mesh-ancestor
153867206|NCT04592198|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153867207|NCT04592198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153867208|NCT04592081|Dexamethasone|dexamethasone|mesh-list
153407671|NCT00045305|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153407672|NCT00045305|Dermatologic Agents|dermatologic agents|mesh-ancestor
153407673|NCT00045305|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153407674|NCT00045305|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153407675|NCT00045305|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153407685|NCT00045305|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153407686|NCT00045305|Adenosine Deaminase Inhibitors|adenosine deaminase inhibitors|mesh-ancestor
153407687|NCT00045305|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
153407688|NCT00033657|Paclitaxel|paclitaxel|mesh-list
153407689|NCT00033657|Camptothecin|camptothecin|mesh-list
153407690|NCT00033657|Cisplatin|cisplatin|mesh-list
153407691|NCT00033657|Irinotecan|irinotecan|mesh-list
153407692|NCT00033657|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153407703|NCT00003389|Dacarbazine|dacarbazine|mesh-list
153407704|NCT00003389|Mechlorethamine|mechlorethamine|mesh-list
153867209|NCT04592081|Dexamethasone acetate|dexamethasone acetate|mesh-list
153867210|NCT04592081|BB 1101|bb 1101|mesh-list
153867211|NCT04592081|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153867212|NCT04592081|Antiemetics|antiemetics|mesh-ancestor
153867213|NCT04592081|Autonomic Agents|autonomic agents|mesh-ancestor
153867214|NCT04592081|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153867215|NCT04592081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153867216|NCT04592081|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153867217|NCT04592081|Glucocorticoids|glucocorticoids|mesh-ancestor
153867218|NCT04592081|Hormones|hormones|mesh-ancestor
153867219|NCT04592081|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153867220|NCT04592081|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153867221|NCT04592081|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153382624|NCT03245463|Immunologic Factors|immunologic factors|mesh-ancestor
153487996|NCT02054754|Hallucinogens|hallucinogens|mesh-ancestor
153867222|NCT04592081|Protease Inhibitors|protease inhibitors|mesh-ancestor
153867223|NCT04592081|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153867224|NCT04592081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153867225|NCT04591847|Vitamin D|vitamin d|mesh-list
153867226|NCT04591847|Ergocalciferols|ergocalciferols|mesh-list
153867227|NCT04591847|Vitamins|vitamins|mesh-ancestor
153867228|NCT04591847|Micronutrients|micronutrients|mesh-ancestor
153867229|NCT04591847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153867230|NCT04591847|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153867231|NCT04591847|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153867232|NCT04591535|Levodopa|levodopa|mesh-list
153867233|NCT04591535|Carbidopa|carbidopa|mesh-list
153867234|NCT04591535|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
153867235|NCT04591535|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
153867236|NCT04591535|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
153867237|NCT04591535|Dopamine Agents|dopamine agents|mesh-ancestor
153867238|NCT04591535|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153867239|NCT04591535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153867240|NCT04591535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153867241|NCT04591535|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
153867242|NCT04591535|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153407721|NCT00003389|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153407722|NCT00003389|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153407723|NCT00003389|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153407724|NCT00003389|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153407725|NCT00003389|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153407726|NCT00003389|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153407727|NCT00003389|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153407728|NCT00003389|Glucocorticoids|glucocorticoids|mesh-ancestor
153407729|NCT00003389|Hormones|hormones|mesh-ancestor
153407730|NCT00003389|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153407731|NCT00003389|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153407732|NCT00003389|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153407733|NCT00003389|Tubulin Modulators|tubulin modulators|mesh-ancestor
153407734|NCT00003389|Antimitotic Agents|antimitotic agents|mesh-ancestor
153407735|NCT00003389|Mitosis Modulators|mitosis modulators|mesh-ancestor
153407736|NCT00003389|Keratolytic Agents|keratolytic agents|mesh-ancestor
153407737|NCT00003389|Dermatologic Agents|dermatologic agents|mesh-ancestor
153407738|NCT00003138|Epoetin Alfa|epoetin alfa|mesh-list
153407739|NCT00003138|Lenograstim|lenograstim|mesh-list
153407740|NCT00003138|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153407741|NCT00003138|Immunologic Factors|immunologic factors|mesh-ancestor
153407742|NCT00003138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153407743|NCT00003138|Hematinics|hematinics|mesh-ancestor
153407744|NCT00002525|Leucovorin|leucovorin|mesh-list
153867280|NCT00580905|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153867281|NCT00580905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153867282|NCT00580905|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153867283|NCT00580905|Vasodilator Agents|vasodilator agents|mesh-ancestor
153867284|NCT00580905|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
153867285|NCT00580905|Purinergic Agonists|purinergic agonists|mesh-ancestor
153867286|NCT00580905|Purinergic Agents|purinergic agents|mesh-ancestor
153867287|NCT00580905|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153867288|NCT00580905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153867289|NCT00580905|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153867290|NCT00580905|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
153867291|NCT04590638|Epinephrine|epinephrine|mesh-list
153407785|NCT02259348|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153407786|NCT02259348|Antimetabolites|antimetabolites|mesh-ancestor
153407787|NCT02259348|Antiviral Agents|antiviral agents|mesh-ancestor
153407788|NCT02259348|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153407789|NCT02259348|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153867293|NCT04590638|Epinephryl borate|epinephryl borate|mesh-list
153867294|NCT04590638|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153867295|NCT04590638|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153867296|NCT04590638|Adrenergic Agents|adrenergic agents|mesh-ancestor
153867297|NCT04590638|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153867298|NCT04590638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153867299|NCT04590638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153867300|NCT04590638|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
153867301|NCT04590638|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153488573|NCT02271906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153867302|NCT04590638|Autonomic Agents|autonomic agents|mesh-ancestor
153867303|NCT04590638|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153867304|NCT04590638|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153867305|NCT04590638|Respiratory System Agents|respiratory system agents|mesh-ancestor
153867306|NCT04590638|Mydriatics|mydriatics|mesh-ancestor
153407798|NCT00357019|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153407799|NCT00357019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153407800|NCT00357019|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153867322|NCT00567554|Mitosis Modulators|mitosis modulators|mesh-ancestor
153867323|NCT00567554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153867324|NCT00567554|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153867325|NCT00567554|Immunologic Factors|immunologic factors|mesh-ancestor
153867326|NCT00567554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153867327|NCT00567554|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153867328|NCT00567554|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153867329|NCT00567554|Alkylating Agents|alkylating agents|mesh-ancestor
153867330|NCT00567554|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153867331|NCT00567554|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153867332|NCT00567554|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153867333|NCT00567554|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153867334|NCT00567554|Growth Substances|growth substances|mesh-ancestor
153867335|NCT00567554|Growth Inhibitors|growth inhibitors|mesh-ancestor
153867336|NCT00567554|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
153867337|NCT00567554|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153867338|NCT00567554|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153867339|NCT00567554|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153867340|NCT00567554|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153867341|NCT00567554|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153867342|NCT00567554|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153407814|NCT03994705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153407815|NCT03994705|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153407816|NCT03994705|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153407817|NCT03994705|Alkylating Agents|alkylating agents|mesh-ancestor
153407818|NCT03994705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153407819|NCT03994705|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153407820|NCT03994705|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153407821|NCT03587207|Vaccines|vaccines|mesh-list
153867354|NCT00581217|Laxatives|laxatives|mesh-ancestor
153867362|NCT00567710|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153867363|NCT00567710|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153867364|NCT00567710|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153867365|NCT00567710|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153867366|NCT00567710|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
153867368|NCT04589429|Morphine|morphine|mesh-list
153867369|NCT04589429|Nalbuphine|nalbuphine|mesh-list
153867370|NCT04589429|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153867371|NCT04589429|Narcotics|narcotics|mesh-ancestor
153867372|NCT04589429|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153407843|NCT04332809|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153407844|NCT04332809|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
153407845|NCT04332809|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153407846|NCT04332809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153407847|NCT03596723|Prednisolone|prednisolone|mesh-list
153407848|NCT03596723|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
153407849|NCT03596723|Methylprednisolone|methylprednisolone|mesh-list
153407864|NCT03596723|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153407865|NCT03596723|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
153407866|NCT03596723|Protective Agents|protective agents|mesh-ancestor
153407867|NCT03463889|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
153407868|NCT03463889|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
153407869|NCT03463889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153407870|NCT03472469|Acetaminophen|acetaminophen|mesh-list
153407871|NCT03472469|Ketorolac|ketorolac|mesh-list
153407872|NCT03472469|Naproxen|naproxen|mesh-list
153407873|NCT03472469|Celecoxib|celecoxib|mesh-list
153407874|NCT03472469|Lidocaine|lidocaine|mesh-list
153407875|NCT03472469|Pregabalin|pregabalin|mesh-list
153407876|NCT03472469|Gabapentin|gabapentin|mesh-list
153407877|NCT03472469|Tramadol|tramadol|mesh-list
153407878|NCT03472469|Anesthetics, Local|anesthetics, local|mesh-ancestor
153407879|NCT03472469|Anesthetics|anesthetics|mesh-ancestor
153407880|NCT03472469|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153867373|NCT04589429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153407881|NCT03472469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153488981|NCT02384070|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153488982|NCT02384070|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153488984|NCT02384070|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
153488985|NCT02384070|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
153488986|NCT02384070|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
153488987|NCT02384070|Purinergic Agents|purinergic agents|mesh-ancestor
153488989|NCT02384070|Antithrombins|antithrombins|mesh-ancestor
153867374|NCT04589429|Analgesics|analgesics|mesh-ancestor
153867375|NCT04589429|Sensory System Agents|sensory system agents|mesh-ancestor
153867376|NCT04589429|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153867377|NCT04589390|Selexipag|selexipag|mesh-list
153867378|NCT04589390|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153867379|NCT04577040|Tadalafil|tadalafil|mesh-list
153867380|NCT04577040|Vasodilator Agents|vasodilator agents|mesh-ancestor
153867381|NCT04577040|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
153867382|NCT04577040|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
153867383|NCT04577040|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153867384|NCT04577040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153867385|NCT04577040|Urological Agents|urological agents|mesh-ancestor
153867386|NCT04589234|Gemcitabine|gemcitabine|mesh-list
153867387|NCT04589234|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
153867388|NCT04589234|Folfirinox|folfirinox|mesh-list
153867389|NCT04589234|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153867390|NCT04589234|Antimetabolites|antimetabolites|mesh-ancestor
153867391|NCT04589234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153867392|NCT04589234|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153867393|NCT03453177|Fosfomycin|fosfomycin|mesh-list
153867394|NCT03453177|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153867395|NCT03453177|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153867396|NCT04594629|Nitroglycerin|nitroglycerin|mesh-list
153867397|NCT04594629|Vasodilator Agents|vasodilator agents|mesh-ancestor
153867398|NCT04588532|Doxepin|doxepin|mesh-list
153867399|NCT04588532|Histamine|histamine|mesh-list
153867400|NCT04588532|Histamine Agonists|histamine agonists|mesh-ancestor
153867401|NCT04588532|Histamine Agents|histamine agents|mesh-ancestor
153867402|NCT04588532|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153867403|NCT04588532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153867404|NCT04588532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153429904|NCT00002780|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153407889|NCT03472469|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153867442|NCT00581685|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153867443|NCT00581685|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153867444|NCT00581685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153867445|NCT00581685|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153407921|NCT04926233|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
153407922|NCT04926233|Cholinergic Agents|cholinergic agents|mesh-ancestor
153407923|NCT04926233|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153407924|NCT04926233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153407925|NCT04926233|Anticonvulsants|anticonvulsants|mesh-ancestor
153407926|NCT04943159|Afamelanotide|afamelanotide|mesh-list
153407927|NCT04943159|Dermatologic Agents|dermatologic agents|mesh-ancestor
153407928|NCT04734665|Bevacizumab|bevacizumab|mesh-list
153407929|NCT04734665|Niraparib|niraparib|mesh-list
153407930|NCT04734665|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153407931|NCT04734665|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153407932|NCT04734665|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153407933|NCT04734665|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153407934|NCT04734665|Growth Substances|growth substances|mesh-ancestor
153867455|NCT00581685|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153867456|NCT00581685|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153867457|NCT04588220|Plasminogen|plasminogen|mesh-list
153867458|NCT04588220|Melatonin|melatonin|mesh-list
153867459|NCT04588220|Antioxidants|antioxidants|mesh-ancestor
153867460|NCT04588220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153407936|NCT04734665|Growth Inhibitors|growth inhibitors|mesh-ancestor
153407937|NCT04734665|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
153407939|NCT04734665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153407940|NCT02258334|Vaccines|vaccines|mesh-list
153407942|NCT02258334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153407943|NCT03478163|Clindamycin|clindamycin|mesh-list
153407944|NCT03478163|Clindamycin palmitate|clindamycin palmitate|mesh-list
153407945|NCT03478163|Clindamycin phosphate|clindamycin phosphate|mesh-list
153407946|NCT03478163|Cefazolin|cefazolin|mesh-list
153407947|NCT03478163|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153407948|NCT03478163|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153407949|NCT03478163|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
153407950|NCT03478163|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153407951|NCT03478163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153407952|NCT05646810|Lidocaine|lidocaine|mesh-list
153867476|NCT04586543|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
153867477|NCT04586543|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
153407953|NCT05646810|Anesthetics, Local|anesthetics, local|mesh-ancestor
153407954|NCT05646810|Anesthetics|anesthetics|mesh-ancestor
153407955|NCT05646810|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153867478|NCT04586543|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153867479|NCT04586543|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
153867481|NCT04586543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153867482|NCT04586465|Carboplatin|carboplatin|mesh-list
153867483|NCT04586465|Gemcitabine|gemcitabine|mesh-list
153867484|NCT04586465|Pembrolizumab|pembrolizumab|mesh-list
153867485|NCT04586465|Pemetrexed|pemetrexed|mesh-list
153867486|NCT04586465|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153867487|NCT04586465|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153867488|NCT04586465|Antimetabolites|antimetabolites|mesh-ancestor
153867489|NCT04586465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153867490|NCT04586465|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153407973|NCT04960202|Antiviral Agents|antiviral agents|mesh-ancestor
153407974|NCT04960202|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153407975|NCT04960202|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
153407976|NCT04960202|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153407977|NCT02959112|Indomethacin|indomethacin|mesh-list
153407978|NCT02959112|Epinephrine|epinephrine|mesh-list
153407979|NCT02959112|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153407980|NCT02959112|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153407981|NCT02959112|Adrenergic Agents|adrenergic agents|mesh-ancestor
153407982|NCT02959112|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153407983|NCT02959112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153407984|NCT02959112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153407985|NCT02959112|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
153407986|NCT02959112|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153407987|NCT02959112|Autonomic Agents|autonomic agents|mesh-ancestor
153407988|NCT02959112|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153407989|NCT02959112|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153407990|NCT02959112|Respiratory System Agents|respiratory system agents|mesh-ancestor
153888819|NCT01033747|Chelating Agents|chelating agents|mesh-ancestor
153867495|NCT00566865|Gemfibrozil|gemfibrozil|mesh-list
153867496|NCT00566865|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153867497|NCT00566865|Antimetabolites|antimetabolites|mesh-ancestor
153867498|NCT00566865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153867499|NCT00566865|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153867500|NCT00566865|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
153867501|NCT00566865|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153867502|NCT00566865|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153867503|NCT04585997|Omalizumab|omalizumab|mesh-list
153867504|NCT04585997|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
153867505|NCT04585997|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153867506|NCT04585997|Respiratory System Agents|respiratory system agents|mesh-ancestor
153867507|NCT04593108|Letrozole|letrozole|mesh-list
153867508|NCT04593108|Misoprostol|misoprostol|mesh-list
153867509|NCT04593108|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153867510|NCT04593108|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
153867511|NCT04593108|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153867512|NCT04593108|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153867513|NCT04593108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153867514|NCT04593108|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
153867515|NCT04593108|Hormone Antagonists|hormone antagonists|mesh-ancestor
153867516|NCT04593108|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153867517|NCT04593108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153407994|NCT02959112|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153407995|NCT02959112|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153407996|NCT02959112|Analgesics|analgesics|mesh-ancestor
153407997|NCT02959112|Sensory System Agents|sensory system agents|mesh-ancestor
153408000|NCT02959112|Gout Suppressants|gout suppressants|mesh-ancestor
153408001|NCT02959112|Tocolytic Agents|tocolytic agents|mesh-ancestor
153408002|NCT02959112|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153408003|NCT02959112|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153408004|NCT02959112|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153408005|NCT03622619|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
153408006|NCT03622619|Ophthalmic Solutions|ophthalmic solutions|mesh-list
153408007|NCT03622619|Lubricant Eye Drops|lubricant eye drops|mesh-list
153408008|NCT03622619|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
153408009|NCT03622619|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153867528|NCT04585412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153867529|NCT04585412|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153867530|NCT04585412|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
153867531|NCT04585412|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153867532|NCT04585412|Serotonin Agents|serotonin agents|mesh-ancestor
153867533|NCT04585412|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153867534|NCT04585412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153867539|NCT00567866|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153867540|NCT00567866|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153867541|NCT00567866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153867543|NCT00567983|Cyclosporins|cyclosporins|mesh-list
153408028|NCT01642914|Enzyme Activators|enzyme activators|mesh-ancestor
153408029|NCT01642914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153408030|NCT01642914|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153408031|NCT01642602|Dexlansoprazole|dexlansoprazole|mesh-list
153408032|NCT01642602|Lansoprazole|lansoprazole|mesh-list
153408033|NCT01642602|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
153408034|NCT01642602|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153408035|NCT01642602|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
153408036|NCT01642602|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153408037|NCT01642602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153408038|NCT02256540|Resveratrol|resveratrol|mesh-list
153408040|NCT02256540|Estrogens|estrogens|mesh-ancestor
153408041|NCT02256540|Hormones|hormones|mesh-ancestor
153408042|NCT02256540|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153408043|NCT02256540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153408044|NCT02256540|Antioxidants|antioxidants|mesh-ancestor
153408045|NCT02256540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153408046|NCT02256540|Protective Agents|protective agents|mesh-ancestor
153408047|NCT02256540|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153867547|NCT00567983|Immunologic Factors|immunologic factors|mesh-ancestor
153867548|NCT00567983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153867563|NCT00582582|Tubulin Modulators|tubulin modulators|mesh-ancestor
153867564|NCT00582582|Antimitotic Agents|antimitotic agents|mesh-ancestor
153867565|NCT00582582|Mitosis Modulators|mitosis modulators|mesh-ancestor
153867574|NCT00566904|Sensory System Agents|sensory system agents|mesh-ancestor
153408055|NCT01640184|Micronutrients|micronutrients|mesh-ancestor
153408056|NCT01640184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153408057|NCT01640184|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153408058|NCT04904978|Listerine|listerine|mesh-list
153408069|NCT03631433|Sensory System Agents|sensory system agents|mesh-ancestor
153408070|NCT03631433|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153408071|NCT03631433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153408072|NCT03631433|Antipyretics|antipyretics|mesh-ancestor
153408073|NCT03631433|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153408074|NCT03631433|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153888828|NCT02875015|Sensory System Agents|sensory system agents|mesh-ancestor
153888835|NCT01091428|Paclitaxel|paclitaxel|mesh-list
153867575|NCT00566904|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153867576|NCT00566904|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153867577|NCT00566904|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
153867578|NCT00566904|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153867579|NCT00566904|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153867580|NCT00566904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153867581|NCT00566904|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153867582|NCT00566904|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153408077|NCT03631433|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153408078|NCT03631433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153408080|NCT02973659|Parasympatholytics|parasympatholytics|mesh-ancestor
153408081|NCT02973659|Autonomic Agents|autonomic agents|mesh-ancestor
153408082|NCT02973659|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153408083|NCT02973659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153408084|NCT02973659|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
153408085|NCT02973659|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
153408086|NCT02973659|Cholinergic Agents|cholinergic agents|mesh-ancestor
153408087|NCT02973659|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153408088|NCT02973659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153408089|NCT02973659|Urological Agents|urological agents|mesh-ancestor
153408091|NCT04439396|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
153408093|NCT04439396|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153408094|NCT04439396|Analgesics|analgesics|mesh-ancestor
153408095|NCT04439396|Sensory System Agents|sensory system agents|mesh-ancestor
153408096|NCT04439396|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153408097|NCT04439396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153408098|NCT04439396|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153408099|NCT04439396|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153408111|NCT05651256|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
153408112|NCT05651256|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
153408113|NCT05651256|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153867609|NCT04584515|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
153867610|NCT04584515|Antitubercular Agents|antitubercular agents|mesh-ancestor
153867611|NCT04584515|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153867612|NCT04584515|Leprostatic Agents|leprostatic agents|mesh-ancestor
153867613|NCT04584515|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153867614|NCT04584515|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
153867615|NCT04584515|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
153867616|NCT04584515|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
153867617|NCT04584515|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
153867618|NCT04584515|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
153867619|NCT04584515|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
153867621|NCT04584710|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153867622|NCT04584671|Xenon|xenon|mesh-list
153867623|NCT04584671|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
153867624|NCT04584671|Anesthetics, General|anesthetics, general|mesh-ancestor
153867625|NCT04584671|Anesthetics|anesthetics|mesh-ancestor
153867626|NCT04584671|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153867627|NCT04584671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153867628|NCT04592211|Paclitaxel|paclitaxel|mesh-list
153867629|NCT04592211|Pembrolizumab|pembrolizumab|mesh-list
153867630|NCT04592211|Olaparib|olaparib|mesh-list
153867631|NCT04592211|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153867632|NCT04592211|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153408114|NCT05651256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153408115|NCT05651256|Cholinergic Agents|cholinergic agents|mesh-ancestor
153408116|NCT05651256|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153408117|NCT05651256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153408118|NCT05651256|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
153408119|NCT05651256|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153408120|NCT04297631|Tobramycin|tobramycin|mesh-list
153408121|NCT04297631|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153408122|NCT04297631|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153408123|NCT04812470|Melphalan|melphalan|mesh-list
153408124|NCT04812470|Interleukin-2|interleukin-2|mesh-list
153408125|NCT04812470|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153408126|NCT04812470|Alkylating Agents|alkylating agents|mesh-ancestor
153408127|NCT04812470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153408128|NCT04812470|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153408129|NCT04812470|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153408130|NCT04812470|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153408131|NCT04812470|Immunologic Factors|immunologic factors|mesh-ancestor
153408132|NCT04812470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153408133|NCT04812470|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153408134|NCT04812470|Analgesics|analgesics|mesh-ancestor
153408135|NCT04812470|Sensory System Agents|sensory system agents|mesh-ancestor
153408136|NCT04812470|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153408137|NCT02976194|Ranibizumab|ranibizumab|mesh-list
153408138|NCT02976194|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153408139|NCT02976194|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153408140|NCT02976194|Growth Substances|growth substances|mesh-ancestor
153408141|NCT02976194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153408142|NCT02976194|Growth Inhibitors|growth inhibitors|mesh-ancestor
153408143|NCT02976194|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153408144|NCT00360776|Tipifarnib|tipifarnib|mesh-list
153408145|NCT00360776|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153867633|NCT04592211|Tubulin Modulators|tubulin modulators|mesh-ancestor
153867634|NCT04592211|Antimitotic Agents|antimitotic agents|mesh-ancestor
153867635|NCT04592211|Mitosis Modulators|mitosis modulators|mesh-ancestor
153867636|NCT04592211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153867637|NCT04592211|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153867638|NCT04592211|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153867639|NCT04592211|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
153867641|NCT04583813|Empagliflozin|empagliflozin|mesh-list
153867642|NCT04583813|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
153867643|NCT04583813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153867644|NCT04583813|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153867645|NCT04583813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153867646|NCT04576143|Paclitaxel|paclitaxel|mesh-list
153867647|NCT04576143|Docetaxel|docetaxel|mesh-list
153867648|NCT04576143|Cyclophosphamide|cyclophosphamide|mesh-list
153867649|NCT04576143|Epirubicin|epirubicin|mesh-list
153867650|NCT04576143|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153867651|NCT04576143|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153867652|NCT04576143|Tubulin Modulators|tubulin modulators|mesh-ancestor
153867653|NCT04576143|Antimitotic Agents|antimitotic agents|mesh-ancestor
153867654|NCT04576143|Mitosis Modulators|mitosis modulators|mesh-ancestor
153867655|NCT04576143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153867666|NCT04576143|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153867667|NCT04583267|Tenofovir|tenofovir|mesh-list
153867668|NCT04583267|Emtricitabine|emtricitabine|mesh-list
153867669|NCT04583267|Antiviral Agents|antiviral agents|mesh-ancestor
153867670|NCT04583267|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153867671|NCT04583267|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153867672|NCT04583267|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153408156|NCT04342910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153408157|NCT04342910|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
153408159|NCT04342910|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153408160|NCT04342910|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153408161|NCT04714073|Itraconazole|itraconazole|mesh-list
153408162|NCT04714073|Antifungal Agents|antifungal agents|mesh-ancestor
153408163|NCT04714073|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153408166|NCT04714073|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153408167|NCT04714073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153408168|NCT04714073|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153408169|NCT04714073|Hormone Antagonists|hormone antagonists|mesh-ancestor
153408170|NCT04714073|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153408171|NCT04714073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153408172|NCT04714073|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
153408173|NCT04342676|Panitumumab|panitumumab|mesh-list
153408174|NCT04342676|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153408175|NCT04342676|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153408176|NCT01641822|Tobramycin|tobramycin|mesh-list
153408177|NCT01641822|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153408178|NCT01641822|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153408179|NCT04871958|Insulin|insulin|mesh-list
153408180|NCT04871958|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153408181|NCT04871958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153408182|NCT04342598|Vitamin D|vitamin d|mesh-list
153408183|NCT04342598|Vitamins|vitamins|mesh-ancestor
153408184|NCT04342598|Micronutrients|micronutrients|mesh-ancestor
153867701|NCT01145755|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
153408185|NCT04342598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153408186|NCT04342598|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153408187|NCT00360854|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
153408188|NCT00360854|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153408189|NCT00360854|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153408190|NCT00360854|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153408191|NCT00360854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153408192|NCT00360854|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153408194|NCT05641818|Vitamins|vitamins|mesh-ancestor
153408195|NCT05641818|Micronutrients|micronutrients|mesh-ancestor
153408196|NCT05641818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153408197|NCT05641818|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153408198|NCT04762082|Tadalafil|tadalafil|mesh-list
153408199|NCT04762082|Vasodilator Agents|vasodilator agents|mesh-ancestor
153408200|NCT04762082|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
153408201|NCT04762082|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
153408202|NCT04762082|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153408203|NCT04762082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153408204|NCT04762082|Urological Agents|urological agents|mesh-ancestor
153408205|NCT03514277|Bupivacaine|bupivacaine|mesh-list
153408215|NCT05334108|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153408233|NCT03984656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153408234|NCT03655301|Metformin|metformin|mesh-list
153408235|NCT03655301|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153408236|NCT03655301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153408237|NCT05630586|Semaglutide|semaglutide|mesh-list
153867722|NCT00568217|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153867723|NCT00568217|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153867724|NCT00568217|Analgesics|analgesics|mesh-ancestor
153867725|NCT00568217|Sensory System Agents|sensory system agents|mesh-ancestor
153867726|NCT00568217|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153867727|NCT00568217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153867728|NCT00568217|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153867729|NCT00568217|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153867730|NCT00568217|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153867731|NCT00568217|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153867732|NCT00568217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153867733|NCT00568217|Antipyretics|antipyretics|mesh-ancestor
153867734|NCT00583323|Atropine sulfate-diphenoxylate hydrochloride drug combination|atropine sulfate-diphenoxylate hydrochloride drug combination|mesh-list
153867735|NCT00583323|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153867736|NCT04582604|Decitabine|decitabine|mesh-list
153867737|NCT04582604|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153867738|NCT04582604|Antimetabolites|antimetabolites|mesh-ancestor
153867739|NCT04582604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153867740|NCT04582604|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153867742|NCT00590928|Esomeprazole|esomeprazole|mesh-list
153867743|NCT00590928|Ranitidine|ranitidine|mesh-list
153867744|NCT00590928|Ranitidine bismuth citrate|ranitidine bismuth citrate|mesh-list
153867745|NCT00590928|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
153867746|NCT00590928|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153867747|NCT00590928|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
153867748|NCT00590928|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153867749|NCT00590928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153867750|NCT00590928|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
153867751|NCT00590928|Histamine Antagonists|histamine antagonists|mesh-ancestor
153867752|NCT00590928|Histamine Agents|histamine agents|mesh-ancestor
153408238|NCT05630586|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
153408239|NCT05630586|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153408240|NCT05630586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153408241|NCT04870866|Niacinamide|niacinamide|mesh-list
153408243|NCT04870866|Nicotinic Acids|nicotinic acids|mesh-list
153408244|NCT04870866|Vitamin B Complex|vitamin b complex|mesh-ancestor
153867756|NCT01145482|Insulin Aspart|insulin aspart|mesh-list
153867759|NCT00568295|Acetaminophen|acetaminophen|mesh-list
153867761|NCT00568295|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153867762|NCT00568295|Analgesics|analgesics|mesh-ancestor
153867763|NCT00568295|Sensory System Agents|sensory system agents|mesh-ancestor
153867764|NCT00568295|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153867765|NCT00568295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153867766|NCT00568295|Antipyretics|antipyretics|mesh-ancestor
153867767|NCT00568295|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
153867768|NCT00568295|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153867769|NCT00568295|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153867770|NCT00568295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153867771|NCT00568295|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153867772|NCT00568295|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153867773|NCT00568295|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153867774|NCT00591162|Tetracycline|tetracycline|mesh-list
153867775|NCT00591162|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153867776|NCT00591162|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153867777|NCT00591162|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
153408265|NCT04243616|Cyclophosphamide|cyclophosphamide|mesh-list
153408266|NCT04243616|Carboplatin|carboplatin|mesh-list
153408267|NCT04243616|Doxorubicin|doxorubicin|mesh-list
153408268|NCT04243616|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
153408269|NCT04243616|Cemiplimab|cemiplimab|mesh-list
153408270|NCT04243616|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153408271|NCT04243616|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153408272|NCT04243616|Tubulin Modulators|tubulin modulators|mesh-ancestor
153408273|NCT04243616|Antimitotic Agents|antimitotic agents|mesh-ancestor
153408274|NCT04243616|Mitosis Modulators|mitosis modulators|mesh-ancestor
153429948|NCT05535218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153408275|NCT04243616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153408276|NCT04243616|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153408277|NCT04243616|Immunologic Factors|immunologic factors|mesh-ancestor
153408278|NCT04243616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153408279|NCT04243616|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153408280|NCT04243616|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153408281|NCT04243616|Alkylating Agents|alkylating agents|mesh-ancestor
153867778|NCT00591162|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153867779|NCT00591162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153867780|NCT00583518|Hormones|hormones|mesh-list
153867781|NCT00583518|Parathyroid Hormone|parathyroid hormone|mesh-list
153867789|NCT04582136|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153867790|NCT04582136|Antifungal Agents|antifungal agents|mesh-ancestor
153867791|NCT04582136|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153867792|NCT04582136|Immunologic Factors|immunologic factors|mesh-ancestor
153867793|NCT04582136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153867794|NCT00591201|Infliximab|infliximab|mesh-list
153867795|NCT00591201|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
153867796|NCT00591201|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153867797|NCT00591201|Dermatologic Agents|dermatologic agents|mesh-ancestor
153867798|NCT00591201|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153867799|NCT00591201|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153867800|NCT04582097|Ramipril|ramipril|mesh-list
153867801|NCT04582097|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
153867802|NCT04582097|Protease Inhibitors|protease inhibitors|mesh-ancestor
153867803|NCT04582097|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153867804|NCT04582097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153867805|NCT04582097|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153867806|NCT00591357|Loperamide|loperamide|mesh-list
153867807|NCT00591357|Antidiarrheals|antidiarrheals|mesh-list
153867808|NCT00591357|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153867809|NCT04575675|Dapagliflozin|dapagliflozin|mesh-list
153867810|NCT04575675|Valsartan|valsartan|mesh-list
153867811|NCT04575675|Carvedilol|carvedilol|mesh-list
153867812|NCT04575675|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
153867813|NCT04575675|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
153867814|NCT04575675|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-list
153867815|NCT04575675|Mineralocorticoids|mineralocorticoids|mesh-list
153867816|NCT04575675|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
153408282|NCT04243616|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153867817|NCT04575675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153867818|NCT04575675|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153867819|NCT04575675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153867820|NCT04575675|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153867821|NCT04575675|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
153867822|NCT04575675|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
153867823|NCT04575675|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
153867824|NCT04575675|Adrenergic Agents|adrenergic agents|mesh-ancestor
153867825|NCT04575675|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153867826|NCT04575675|Antioxidants|antioxidants|mesh-ancestor
153867827|NCT04575675|Protective Agents|protective agents|mesh-ancestor
153867828|NCT04575675|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153867829|NCT04575675|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153867830|NCT04575675|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153867831|NCT04575675|Vasodilator Agents|vasodilator agents|mesh-ancestor
153408320|NCT03663101|Cholinergic Agents|cholinergic agents|mesh-ancestor
153408321|NCT03663101|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153429949|NCT05531708|Cyclophosphamide|cyclophosphamide|mesh-list
153408324|NCT05430048|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
153408325|NCT05430048|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153408326|NCT05430048|Sympatholytics|sympatholytics|mesh-ancestor
153408327|NCT05430048|Autonomic Agents|autonomic agents|mesh-ancestor
153408328|NCT05430048|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153408329|NCT05430048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153408330|NCT05430048|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
153408331|NCT05430048|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
153408332|NCT05430048|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
153408333|NCT05430048|Adrenergic Agents|adrenergic agents|mesh-ancestor
153408334|NCT05430048|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153867854|NCT00568412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153867857|NCT00568529|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153867858|NCT00568529|Antimetabolites|antimetabolites|mesh-ancestor
153867859|NCT00568529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153867860|NCT00568529|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153867861|NCT00568568|Hormones|hormones|mesh-list
153867862|NCT00568568|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153867863|NCT00568568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153867864|NCT04575558|Azithromycin|azithromycin|mesh-list
153867865|NCT04575558|Hydroxychloroquine|hydroxychloroquine|mesh-list
153867866|NCT04575558|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153408371|NCT03667547|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153408372|NCT03667547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153408374|NCT00361010|Anticonvulsants|anticonvulsants|mesh-ancestor
153408375|NCT00361010|Nootropic Agents|nootropic agents|mesh-ancestor
153408376|NCT00361088|Bortezomib|bortezomib|mesh-list
153408377|NCT00361088|Tipifarnib|tipifarnib|mesh-list
153408378|NCT00361088|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153408379|NCT04172402|Gemcitabine|gemcitabine|mesh-list
153408380|NCT04172402|Nivolumab|nivolumab|mesh-list
153408381|NCT04172402|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153408382|NCT04172402|Antimetabolites|antimetabolites|mesh-ancestor
153408384|NCT04172402|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153408389|NCT04662242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153867892|NCT00583869|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153867893|NCT00583869|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153867894|NCT00583869|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153867895|NCT00583869|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153867896|NCT00583869|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153867897|NCT00568880|Hydroxychloroquine|hydroxychloroquine|mesh-list
153867898|NCT00568880|Bortezomib|bortezomib|mesh-list
153867899|NCT00568880|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153408391|NCT04662242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153408392|NCT04662242|Trace Elements|trace elements|mesh-ancestor
153408393|NCT04662242|Micronutrients|micronutrients|mesh-ancestor
153408394|NCT03675581|Nintedanib|nintedanib|mesh-list
153867904|NCT00568880|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153867905|NCT00568880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153867906|NCT00568880|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153867907|NCT03451695|Morphine|morphine|mesh-list
153867908|NCT03451695|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153867909|NCT03451695|Narcotics|narcotics|mesh-ancestor
153867910|NCT03451695|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153867911|NCT03451695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153867912|NCT03451695|Analgesics|analgesics|mesh-ancestor
153867913|NCT03451695|Sensory System Agents|sensory system agents|mesh-ancestor
153867914|NCT03451695|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153867915|NCT00569465|Acetylcysteine|acetylcysteine|mesh-list
153867916|NCT00569465|N-monoacetylcystine|n-monoacetylcystine|mesh-list
153408412|NCT03675581|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
153408413|NCT00362102|Cetuximab|cetuximab|mesh-list
153408414|NCT00362102|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153408415|NCT00362102|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153408416|NCT05122026|Isoniazid|isoniazid|mesh-list
153408417|NCT05122026|Rifapentine|rifapentine|mesh-list
153408418|NCT05122026|Antitubercular Agents|antitubercular agents|mesh-ancestor
153408431|NCT02958878|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
153408432|NCT02958878|Adrenergic Agents|adrenergic agents|mesh-ancestor
153408433|NCT02958878|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153408434|NCT02958878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153408435|NCT02958878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153408436|NCT02958878|Urological Agents|urological agents|mesh-ancestor
153867925|NCT00569465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153867926|NCT00569465|Antidotes|antidotes|mesh-ancestor
153867927|NCT00583986|Albuterol|albuterol|mesh-list
153867928|NCT00583986|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153867929|NCT00583986|Autonomic Agents|autonomic agents|mesh-ancestor
153867930|NCT00583986|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153867931|NCT00583986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153867932|NCT00583986|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153867933|NCT00583986|Respiratory System Agents|respiratory system agents|mesh-ancestor
153867934|NCT00583986|Tocolytic Agents|tocolytic agents|mesh-ancestor
153867935|NCT00583986|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153867936|NCT00583986|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
153867937|NCT00583986|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
153867938|NCT00583986|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153867939|NCT00583986|Adrenergic Agents|adrenergic agents|mesh-ancestor
153867940|NCT00583986|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153867941|NCT00583986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153867942|NCT00569621|Moxaverine|moxaverine|mesh-list
153867943|NCT00569621|Parasympatholytics|parasympatholytics|mesh-ancestor
153867944|NCT00569621|Autonomic Agents|autonomic agents|mesh-ancestor
153867945|NCT00569621|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153867946|NCT00569621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153867947|NCT00569699|Bevacizumab|bevacizumab|mesh-list
153867948|NCT00569699|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153408439|NCT02976116|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153408440|NCT02976116|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153408441|NCT02976116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153408459|NCT02975258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153408460|NCT02975258|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153408461|NCT02975258|Respiratory System Agents|respiratory system agents|mesh-ancestor
153408462|NCT02975258|Free Radical Scavengers|free radical scavengers|mesh-ancestor
153408463|NCT02975258|Antioxidants|antioxidants|mesh-ancestor
153408464|NCT02975258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153408465|NCT02975258|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153408466|NCT02975258|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
153408467|NCT02975258|Vasodilator Agents|vasodilator agents|mesh-ancestor
153408468|NCT02975258|Gasotransmitters|gasotransmitters|mesh-ancestor
153408469|NCT02975258|Protective Agents|protective agents|mesh-ancestor
153408470|NCT02975258|Miotics|miotics|mesh-ancestor
153408471|NCT02975258|Parasympathomimetics|parasympathomimetics|mesh-ancestor
153408472|NCT02975258|Bronchoconstrictor Agents|bronchoconstrictor agents|mesh-ancestor
153867949|NCT00569699|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153867950|NCT00569699|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153867951|NCT00569699|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153867960|NCT00569816|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153867961|NCT00569816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153867963|NCT00570050|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
153867964|NCT00570050|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153867965|NCT00570050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153867966|NCT00570245|Nitric Oxide|nitric oxide|mesh-list
153867967|NCT00570245|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153867968|NCT00570245|Autonomic Agents|autonomic agents|mesh-ancestor
153867970|NCT00570245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153867971|NCT00570245|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153867972|NCT00570245|Respiratory System Agents|respiratory system agents|mesh-ancestor
153867973|NCT00570245|Free Radical Scavengers|free radical scavengers|mesh-ancestor
153867974|NCT00570245|Antioxidants|antioxidants|mesh-ancestor
153867975|NCT00570245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153867976|NCT00570245|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153867977|NCT00570245|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
153867978|NCT00570245|Vasodilator Agents|vasodilator agents|mesh-ancestor
153867979|NCT00570245|Gasotransmitters|gasotransmitters|mesh-ancestor
153867980|NCT00570245|Protective Agents|protective agents|mesh-ancestor
153867981|NCT00570284|Panobinostat|panobinostat|mesh-list
153867982|NCT00570284|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153408473|NCT02975258|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
153408474|NCT02975258|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
153408476|NCT04844814|Prednisone|prednisone|mesh-list
153408477|NCT04844814|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
153408478|NCT04844814|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153408479|NCT04844814|Glucocorticoids|glucocorticoids|mesh-ancestor
153408480|NCT04844814|Hormones|hormones|mesh-ancestor
153408481|NCT04844814|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153408482|NCT04844814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153408483|NCT04844814|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153408484|NCT04844814|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153408485|NCT04844814|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153408486|NCT02975102|Ophthalmic Solutions|ophthalmic solutions|mesh-list
153408487|NCT02975102|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
153408488|NCT00376883|Pamidronate|pamidronate|mesh-list
153408489|NCT00376883|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153408490|NCT00376883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153408491|NCT05314673|Bevacizumab|bevacizumab|mesh-list
153408492|NCT05314673|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153408493|NCT05314673|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153408494|NCT05314673|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153408495|NCT05314673|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153408496|NCT05314673|Growth Substances|growth substances|mesh-ancestor
153408497|NCT05314673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153408498|NCT05314673|Growth Inhibitors|growth inhibitors|mesh-ancestor
153408499|NCT04112069|Insulin Lispro|insulin lispro|mesh-list
153408500|NCT04112069|Insulin Aspart|insulin aspart|mesh-list
153408501|NCT04112069|Pancrelipase|pancrelipase|mesh-list
153408502|NCT04112069|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153408503|NCT04112069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153408504|NCT04112069|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153867983|NCT00570284|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
153867984|NCT00570284|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153867985|NCT00570284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153867986|NCT00570440|Levonorgestrel|levonorgestrel|mesh-list
153868006|NCT00570479|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153868007|NCT00584298|Octreotide|octreotide|mesh-list
153868008|NCT00584298|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153868009|NCT00584298|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153868010|NCT00584298|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153868011|NCT00584376|Pregabalin|pregabalin|mesh-list
153868012|NCT00584376|Analgesics|analgesics|mesh-ancestor
153868013|NCT00584376|Sensory System Agents|sensory system agents|mesh-ancestor
153868014|NCT00584376|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153868015|NCT00584376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153868016|NCT00584376|Anticonvulsants|anticonvulsants|mesh-ancestor
153408518|NCT00361790|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153408519|NCT00361790|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153408520|NCT00361790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153408521|NCT00361790|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153408523|NCT00361790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153408524|NCT00361790|Antidepressive Agents|antidepressive agents|mesh-ancestor
153408525|NCT00361790|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153408526|NCT00361790|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153408527|NCT00361790|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153408528|NCT00361790|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153408529|NCT00361790|Dopamine Agonists|dopamine agonists|mesh-ancestor
153408530|NCT00361790|Dopamine Agents|dopamine agents|mesh-ancestor
153408531|NCT00361790|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
153868029|NCT00570830|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153868044|NCT00571142|Temazepam|temazepam|mesh-list
153868045|NCT00571142|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153868046|NCT00571142|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153868047|NCT00571142|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153868048|NCT00571142|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153868049|NCT00571142|Growth Substances|growth substances|mesh-ancestor
153868050|NCT00571142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153868051|NCT00571142|Growth Inhibitors|growth inhibitors|mesh-ancestor
153868052|NCT00571142|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153408546|NCT04564872|Linagliptin|linagliptin|mesh-list
153408547|NCT04564872|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153408548|NCT04564872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153408549|NCT04564872|Incretins|incretins|mesh-ancestor
153408551|NCT04564872|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153408552|NCT04564872|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
153408553|NCT04564872|Protease Inhibitors|protease inhibitors|mesh-ancestor
153408554|NCT04564872|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153408555|NCT04564872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153408556|NCT04343144|Nivolumab|nivolumab|mesh-list
153868063|NCT00584571|Escitalopram|escitalopram|mesh-list
153868064|NCT00584571|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
153868065|NCT00584571|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153868066|NCT00584571|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153868067|NCT00584571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153868068|NCT00584571|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153868069|NCT00584571|Serotonin Agents|serotonin agents|mesh-ancestor
153868080|NCT00584571|Antidepressive Agents|antidepressive agents|mesh-ancestor
153868081|NCT00584571|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153868082|NCT03451500|Levodopa|levodopa|mesh-list
153868083|NCT03451500|Carbidopa|carbidopa|mesh-list
153868084|NCT03451500|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
153868085|NCT03451500|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
153868086|NCT03451500|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
153868087|NCT03451500|Dopamine Agents|dopamine agents|mesh-ancestor
153408565|NCT03743246|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153868088|NCT03451500|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153868089|NCT03451500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153868090|NCT03451500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153868091|NCT03451500|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
153868092|NCT03451500|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153868093|NCT03451500|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153868094|NCT03451500|Immunologic Factors|immunologic factors|mesh-ancestor
153868095|NCT03451500|Dopamine Agonists|dopamine agonists|mesh-ancestor
153868096|NCT00584610|Copper|copper|mesh-list
153868097|NCT00584610|Levonorgestrel|levonorgestrel|mesh-list
153868106|NCT00584610|Micronutrients|micronutrients|mesh-ancestor
153408601|NCT00361166|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153408602|NCT00361166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153408603|NCT00361166|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153408604|NCT00361166|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
153408605|NCT00361166|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153408606|NCT00361166|Serotonin Agents|serotonin agents|mesh-ancestor
153888841|NCT01091428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153408649|NCT05369364|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153868135|NCT04573803|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153868136|NCT04573803|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153868137|NCT04573803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153868138|NCT04573803|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
153868139|NCT04573803|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
153868140|NCT00584688|Quetiapine Fumarate|quetiapine fumarate|mesh-list
153868141|NCT00584688|Antidepressive Agents|antidepressive agents|mesh-ancestor
153868142|NCT00584688|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153868143|NCT00584688|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153868144|NCT00584688|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153868145|NCT00584688|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153868146|NCT00584688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153868147|NCT04573686|Epoetin Alfa|epoetin alfa|mesh-list
153868148|NCT04573686|Hematinics|hematinics|mesh-ancestor
153868149|NCT01143337|Methotrexate|methotrexate|mesh-list
153868150|NCT01143337|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
153868151|NCT01143337|Abortifacient Agents|abortifacient agents|mesh-ancestor
153868152|NCT01143337|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153868153|NCT01143337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153868154|NCT01143337|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153408650|NCT05369364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153408651|NCT05369364|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153408652|NCT05369364|Glucocorticoids|glucocorticoids|mesh-ancestor
153408654|NCT05369364|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153408655|NCT05369364|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153408691|NCT04968522|Dopamine Agents|dopamine agents|mesh-ancestor
153408692|NCT04968522|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153408693|NCT00361322|Clindamycin|clindamycin|mesh-list
153408694|NCT00361322|Clindamycin palmitate|clindamycin palmitate|mesh-list
153408695|NCT00361322|Clindamycin phosphate|clindamycin phosphate|mesh-list
153408701|NCT00361322|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153408702|NCT00361322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153408703|NCT00361322|Antifungal Agents|antifungal agents|mesh-ancestor
153408704|NCT00361322|Keratolytic Agents|keratolytic agents|mesh-ancestor
153408705|NCT00361322|Dermatologic Agents|dermatologic agents|mesh-ancestor
153408706|NCT00361322|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153868189|NCT00572078|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153868191|NCT00572078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153868193|NCT00572312|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153868194|NCT00572312|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153868195|NCT00572312|Antimetabolites|antimetabolites|mesh-ancestor
153868196|NCT00572312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153868197|NCT00572312|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153868198|NCT00572312|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
153868199|NCT00572312|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153868200|NCT00585156|Celecoxib|celecoxib|mesh-list
153868201|NCT00585156|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153868202|NCT00585156|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153868203|NCT00585156|Analgesics|analgesics|mesh-ancestor
153868204|NCT00585156|Sensory System Agents|sensory system agents|mesh-ancestor
153868205|NCT00585156|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153868206|NCT00585156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153868207|NCT00585156|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153868208|NCT00585156|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153868209|NCT00585156|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
153868210|NCT00585156|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153868211|NCT00585156|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153868212|NCT00585156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153868213|NCT01142596|Asenapine|asenapine|mesh-list
153868214|NCT01142596|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153868216|NCT01142596|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153868217|NCT01142596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153868218|NCT01142596|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153868219|NCT00572390|Estrogens|estrogens|mesh-list
153408718|NCT02974712|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153408719|NCT02974712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153408720|NCT02974712|Analgesics|analgesics|mesh-ancestor
153408721|NCT02974712|Sensory System Agents|sensory system agents|mesh-ancestor
153408722|NCT02974712|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153408723|NCT02974712|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153408732|NCT02974556|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153408733|NCT04523142|Ophthalmic Solutions|ophthalmic solutions|mesh-list
153408734|NCT04523142|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
153408735|NCT03557333|Dihydroergotamine|dihydroergotamine|mesh-list
153408736|NCT03557333|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
153868247|NCT00572663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153868249|NCT00572663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153868250|NCT00572663|Antidotes|antidotes|mesh-ancestor
153868251|NCT01140880|Tenofovir|tenofovir|mesh-list
153868252|NCT01140880|Emtricitabine|emtricitabine|mesh-list
153868253|NCT01140880|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
153868254|NCT01140880|Antiviral Agents|antiviral agents|mesh-ancestor
153868255|NCT01140880|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153868256|NCT01140880|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153868257|NCT01140880|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153868258|NCT01140880|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153868259|NCT01140880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153868260|NCT01140880|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153408759|NCT04818450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153408760|NCT04818450|Antimanic Agents|antimanic agents|mesh-ancestor
153408761|NCT05448872|Valsartan|valsartan|mesh-list
153408762|NCT05448872|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
153408763|NCT05448872|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153408764|NCT05448872|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
153408765|NCT05448872|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
153408766|NCT05448872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153408767|NCT00362258|Irbesartan|irbesartan|mesh-list
153408768|NCT00362258|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153408769|NCT00362258|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
153408770|NCT00362258|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
153408771|NCT00362258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153408772|NCT00362726|Rosiglitazone|rosiglitazone|mesh-list
153408774|NCT00362726|Atazanavir Sulfate|atazanavir sulfate|mesh-list
153408775|NCT00362726|Maleic acid|maleic acid|mesh-list
153408776|NCT00362726|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
153408777|NCT00362726|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
153408778|NCT00362726|Protease Inhibitors|protease inhibitors|mesh-ancestor
153408779|NCT00362726|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153408780|NCT00362726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153408781|NCT00362726|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153408782|NCT00362726|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153408783|NCT00362726|Antiviral Agents|antiviral agents|mesh-ancestor
153408784|NCT00362726|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153408785|NCT00362726|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
153408786|NCT00362726|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153408787|NCT00362726|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153408791|NCT05330754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153408792|NCT05330754|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
153868282|NCT03451110|Norethindrone acetate, ethinyl estradiol, ferrous fumarate drug combination|norethindrone acetate, ethinyl estradiol, ferrous fumarate drug combination|mesh-list
153868283|NCT03451110|Antifungal Agents|antifungal agents|mesh-ancestor
153868284|NCT03451110|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153868285|NCT03451110|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
153868286|NCT03451110|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153868287|NCT03451110|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153868288|NCT03451110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153868289|NCT03451110|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153868290|NCT03451110|Hormone Antagonists|hormone antagonists|mesh-ancestor
153868291|NCT03451110|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153868292|NCT03451110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153868293|NCT03451110|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
153868294|NCT03451110|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
153408793|NCT05330754|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153408794|NCT05330754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153408795|NCT05330754|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
153408796|NCT05330754|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
153408797|NCT05330754|Purinergic Agents|purinergic agents|mesh-ancestor
153408798|NCT05330754|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153408799|NCT02271932|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
153408800|NCT02271932|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153408802|NCT04887948|Immunologic Factors|immunologic factors|mesh-ancestor
153408803|NCT04887948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153408804|NCT03829488|Plasma-lyte 148|plasma-lyte 148|mesh-list
153408805|NCT03829488|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
153408806|NCT03829488|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
153408807|NCT04049123|Insulin Lispro|insulin lispro|mesh-list
153408808|NCT04049123|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153408809|NCT04049123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153408810|NCT04051463|Ophthalmic Solutions|ophthalmic solutions|mesh-list
153408811|NCT04051463|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
153408812|NCT04184297|Tiotropium Bromide|tiotropium bromide|mesh-list
153408813|NCT04184297|Olodaterol|olodaterol|mesh-list
153408814|NCT04184297|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153408815|NCT04184297|Autonomic Agents|autonomic agents|mesh-ancestor
153408816|NCT04184297|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153868298|NCT03451110|Histamine Antagonists|histamine antagonists|mesh-ancestor
153868300|NCT03451110|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153868301|NCT03451110|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
153868302|NCT03451110|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
153868311|NCT03451110|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
153868312|NCT03451110|Contraceptives, Oral, Sequential|contraceptives, oral, sequential|mesh-ancestor
153868313|NCT03451110|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
153868314|NCT00585741|Alovudine|alovudine|mesh-list
153868315|NCT00585741|Antiviral Agents|antiviral agents|mesh-ancestor
153408826|NCT04031885|Docetaxel|docetaxel|mesh-list
153408827|NCT04031885|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
153408828|NCT04031885|Capecitabine|capecitabine|mesh-list
153408829|NCT04031885|Fulvestrant|fulvestrant|mesh-list
153408830|NCT04031885|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153408831|NCT04031885|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153408832|NCT04031885|Tubulin Modulators|tubulin modulators|mesh-ancestor
153408833|NCT04031885|Antimitotic Agents|antimitotic agents|mesh-ancestor
153868319|NCT03450798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153868320|NCT00573326|Imatinib Mesylate|imatinib mesylate|mesh-list
153868321|NCT00573326|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153868322|NCT00573326|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153868323|NCT00573326|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153868324|NCT00573326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153868326|NCT01140061|MK 0873|mk 0873|mesh-list
153868327|NCT01140061|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
153868328|NCT01140061|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
153868329|NCT01140061|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153868330|NCT01140061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153868331|NCT04312750|Lidocaine|lidocaine|mesh-list
153868332|NCT04312750|Anesthetics, Local|anesthetics, local|mesh-ancestor
153868333|NCT04312750|Anesthetics|anesthetics|mesh-ancestor
153408835|NCT04031885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153408836|NCT04031885|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153408837|NCT04031885|Antimetabolites|antimetabolites|mesh-ancestor
153408852|NCT01638000|Urological Agents|urological agents|mesh-ancestor
153408878|NCT04023695|Respiratory System Agents|respiratory system agents|mesh-ancestor
153408879|NCT04023695|Mydriatics|mydriatics|mesh-ancestor
153408880|NCT04023695|Sympathomimetics|sympathomimetics|mesh-ancestor
153408881|NCT04023695|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
153408883|NCT04211909|Velpatasvir|velpatasvir|mesh-list
153408884|NCT04211909|Antiviral Agents|antiviral agents|mesh-ancestor
153408885|NCT04211909|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153408886|NCT04223843|Tiotropium Bromide|tiotropium bromide|mesh-list
153868357|NCT01139125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153868358|NCT01139047|Metronidazole|metronidazole|mesh-list
153868359|NCT01139047|Azelaic acid|azelaic acid|mesh-list
153868360|NCT01139047|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153868361|NCT01139047|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153868362|NCT01139047|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153868363|NCT01139047|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153868364|NCT01139047|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153868365|NCT01139047|Dermatologic Agents|dermatologic agents|mesh-ancestor
153868366|NCT01139008|Metronidazole|metronidazole|mesh-list
153868367|NCT01139008|Azelaic acid|azelaic acid|mesh-list
153868368|NCT01139008|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153868369|NCT01139008|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153868370|NCT01139008|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153868371|NCT01139008|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153868372|NCT01139008|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153868375|NCT00573599|Prochlorperazine|prochlorperazine|mesh-list
153868376|NCT00573599|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
153868377|NCT00573599|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153868378|NCT00573599|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153868379|NCT00573599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153868380|NCT00573599|Anesthetics, Local|anesthetics, local|mesh-ancestor
153868381|NCT00573599|Anesthetics|anesthetics|mesh-ancestor
153868382|NCT00573599|Sensory System Agents|sensory system agents|mesh-ancestor
153868383|NCT00573599|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153868384|NCT00573599|Antiemetics|antiemetics|mesh-ancestor
153868385|NCT00573599|Autonomic Agents|autonomic agents|mesh-ancestor
153408887|NCT04223843|Olodaterol|olodaterol|mesh-list
153408888|NCT04223843|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153408889|NCT04223843|Autonomic Agents|autonomic agents|mesh-ancestor
153408897|NCT04223843|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153408898|NCT04223843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153408900|NCT05722951|Levetiracetam|levetiracetam|mesh-list
153408901|NCT05722951|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153408902|NCT05722951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153408903|NCT05722951|Anticonvulsants|anticonvulsants|mesh-ancestor
153408904|NCT05722951|Nootropic Agents|nootropic agents|mesh-ancestor
153408905|NCT04838652|Pembrolizumab|pembrolizumab|mesh-list
153408906|NCT04838652|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153408907|NCT04838652|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153408908|NCT04838652|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153408909|NCT04838652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153408916|NCT04810494|Lidocaine|lidocaine|mesh-list
153408917|NCT04810494|Anesthetics, Local|anesthetics, local|mesh-ancestor
153408918|NCT04810494|Anesthetics|anesthetics|mesh-ancestor
153408919|NCT04810494|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153408920|NCT04810494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153408921|NCT04810494|Sensory System Agents|sensory system agents|mesh-ancestor
153408922|NCT04810494|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153868386|NCT00573599|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153868387|NCT00573599|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
153868388|NCT00573599|Histamine Antagonists|histamine antagonists|mesh-ancestor
153868389|NCT00573599|Histamine Agents|histamine agents|mesh-ancestor
153868390|NCT00573599|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153868391|NCT00573599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153868392|NCT00573599|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
153868393|NCT00573599|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153868394|NCT00573599|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153868395|NCT00573599|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153868396|NCT00573599|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
153868397|NCT00573599|Dopamine Agents|dopamine agents|mesh-ancestor
153868398|NCT04572516|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
153868399|NCT04572516|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
153868400|NCT04572516|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
153868401|NCT04572516|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153868402|NCT04572516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153868403|NCT04572516|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
153868404|NCT04572516|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153868405|NCT04572516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153868406|NCT04572516|Cholinergic Agents|cholinergic agents|mesh-ancestor
153868407|NCT04572516|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153868408|NCT00573638|Ophthalmic Solutions|ophthalmic solutions|mesh-list
153868409|NCT00573638|Latanoprost|latanoprost|mesh-list
153868410|NCT00573638|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
153868411|NCT01138657|Prednisone|prednisone|mesh-list
153868412|NCT01138657|Adalimumab|adalimumab|mesh-list
153868413|NCT01138657|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153868416|NCT01138657|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153868417|NCT01138657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153868418|NCT01138657|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153868419|NCT01138657|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153868420|NCT01138657|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
153868421|NCT01138657|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153868422|NCT01138501|Factor VIII|factor viii|mesh-list
153868423|NCT01138501|Coagulants|coagulants|mesh-ancestor
153408925|NCT04810494|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153408926|NCT04810494|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153408927|NCT04810494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153408928|NCT05722405|Lenalidomide|lenalidomide|mesh-list
153408929|NCT05722405|Ixazomib|ixazomib|mesh-list
153408930|NCT05722405|Glycine|glycine|mesh-list
153408931|NCT05722405|Immunologic Factors|immunologic factors|mesh-ancestor
153408932|NCT05722405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153408933|NCT05722405|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153408934|NCT05722405|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153408935|NCT05722405|Growth Substances|growth substances|mesh-ancestor
153408936|NCT05722405|Growth Inhibitors|growth inhibitors|mesh-ancestor
153408937|NCT05722405|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153408938|NCT05722405|Protease Inhibitors|protease inhibitors|mesh-ancestor
153408939|NCT05722405|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153408940|NCT05722405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153408941|NCT05722405|Glycine Agents|glycine agents|mesh-ancestor
153408948|NCT04419246|Tranexamic Acid|tranexamic acid|mesh-list
153408949|NCT04419246|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
153408950|NCT04419246|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153408951|NCT04419246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153408952|NCT04419246|Hemostatics|hemostatics|mesh-ancestor
153408953|NCT04419246|Coagulants|coagulants|mesh-ancestor
153408954|NCT04229303|Voriconazole|voriconazole|mesh-list
153408955|NCT04229303|Antifungal Agents|antifungal agents|mesh-ancestor
153408956|NCT04229303|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153408957|NCT04229303|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
153408958|NCT04229303|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153408959|NCT04229303|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153868424|NCT01138150|Naproxen|naproxen|mesh-list
153868425|NCT01138150|Sumatriptan|sumatriptan|mesh-list
153868426|NCT01138150|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153868427|NCT01138150|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153868428|NCT01138150|Analgesics|analgesics|mesh-ancestor
153868429|NCT01138150|Sensory System Agents|sensory system agents|mesh-ancestor
153868430|NCT01138150|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153868431|NCT01138150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153868432|NCT01138150|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153868442|NCT01138150|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153868443|NCT00586092|Bevacizumab|bevacizumab|mesh-list
153868444|NCT00586092|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153868445|NCT00586092|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153868446|NCT00586092|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153868447|NCT00586092|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153868448|NCT00586092|Growth Substances|growth substances|mesh-ancestor
153868449|NCT00586092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153868452|NCT01137955|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153868453|NCT01137955|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153868454|NCT01137955|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153868455|NCT00573950|Cilostazol|cilostazol|mesh-list
153868456|NCT00573950|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153868457|NCT00573950|Autonomic Agents|autonomic agents|mesh-ancestor
153868458|NCT00573950|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153408960|NCT04229303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153408961|NCT04229303|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153408963|NCT04229303|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153408967|NCT05263986|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153408968|NCT00357643|Vitamin D|vitamin d|mesh-list
153408969|NCT00357643|Calcium|calcium|mesh-list
153408970|NCT00357643|Vitamins|vitamins|mesh-ancestor
153408971|NCT00357643|Micronutrients|micronutrients|mesh-ancestor
153408972|NCT00357643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153408973|NCT00357643|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153408974|NCT00357643|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153408975|NCT00357721|Atazanavir Sulfate|atazanavir sulfate|mesh-list
153408976|NCT00357721|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
153408977|NCT00357721|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
153408978|NCT00357721|Protease Inhibitors|protease inhibitors|mesh-ancestor
153408979|NCT00357721|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153408980|NCT00357721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153408981|NCT00357721|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153408982|NCT00357721|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153408983|NCT00357721|Antiviral Agents|antiviral agents|mesh-ancestor
153408984|NCT00357721|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153408985|NCT03504410|Cytarabine|cytarabine|mesh-list
153408986|NCT03504410|Fludarabine|fludarabine|mesh-list
153408987|NCT03504410|Etoposide|etoposide|mesh-list
153408988|NCT03504410|Mitoxantrone|mitoxantrone|mesh-list
153408989|NCT03504410|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153408990|NCT03504410|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153408991|NCT03504410|Antimetabolites|antimetabolites|mesh-ancestor
153868470|NCT00573950|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
153868471|NCT00573950|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153868473|NCT00586131|Sodium Citrate|sodium citrate|mesh-list
153868474|NCT00586131|Anticoagulants|anticoagulants|mesh-ancestor
153868475|NCT00586131|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
153868476|NCT00586131|Chelating Agents|chelating agents|mesh-ancestor
153868477|NCT00586131|Sequestering Agents|sequestering agents|mesh-ancestor
153868478|NCT00586131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153868479|NCT00586287|Phenprocoumon|phenprocoumon|mesh-list
153868480|NCT00586287|Anticoagulants|anticoagulants|mesh-ancestor
153868481|NCT00586365|Naproxen|naproxen|mesh-list
153868482|NCT00586365|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153868483|NCT00586365|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153868484|NCT00586365|Analgesics|analgesics|mesh-ancestor
153408993|NCT03504410|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153408994|NCT03504410|Immunologic Factors|immunologic factors|mesh-ancestor
153408995|NCT03504410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153408996|NCT03504410|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153408997|NCT03504410|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153408998|NCT03504410|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153408999|NCT03504410|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153409001|NCT03504410|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153409002|NCT03504410|Analgesics|analgesics|mesh-ancestor
153409003|NCT03504410|Sensory System Agents|sensory system agents|mesh-ancestor
153409004|NCT03504410|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153409005|NCT02464969|Apixaban|apixaban|mesh-list
153409006|NCT02464969|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
153409007|NCT02464969|Antithrombins|antithrombins|mesh-ancestor
153409008|NCT02464969|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
153409009|NCT02464969|Protease Inhibitors|protease inhibitors|mesh-ancestor
153409010|NCT02464969|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153409011|NCT02464969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153409012|NCT02464969|Anticoagulants|anticoagulants|mesh-ancestor
153409013|NCT05392530|Macitentan|macitentan|mesh-list
153409014|NCT05392530|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
153409015|NCT05392530|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
153409016|NCT05392530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153868490|NCT00586365|Gout Suppressants|gout suppressants|mesh-ancestor
153868491|NCT00586365|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153868492|NCT00586365|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153868493|NCT00586365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153868494|NCT00574652|Aldesleukin|aldesleukin|mesh-list
153868495|NCT00574652|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153868496|NCT00574652|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153868497|NCT00574652|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153868498|NCT00574652|Antiviral Agents|antiviral agents|mesh-ancestor
153868499|NCT00574652|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153868500|NCT00574769|Bevacizumab|bevacizumab|mesh-list
153868501|NCT00574769|Docetaxel|docetaxel|mesh-list
153868512|NCT00574769|Mitosis Modulators|mitosis modulators|mesh-ancestor
153409023|NCT03498014|Sensory System Agents|sensory system agents|mesh-ancestor
153409024|NCT03498014|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153409026|NCT02460133|Ribavirin|ribavirin|mesh-list
153409027|NCT02460133|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
153409028|NCT02460133|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
153409029|NCT02460133|Protease Inhibitors|protease inhibitors|mesh-ancestor
153409030|NCT02460133|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153868515|NCT00574769|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153868516|NCT00574769|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153868517|NCT00574769|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153868518|NCT00574769|Immunologic Factors|immunologic factors|mesh-ancestor
153868519|NCT00586443|Bevacizumab|bevacizumab|mesh-list
153868520|NCT00586443|Panitumumab|panitumumab|mesh-list
153868521|NCT00586443|Everolimus|everolimus|mesh-list
153868522|NCT00586443|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153868523|NCT00586443|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153868524|NCT00586443|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153868525|NCT00586443|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153868526|NCT00586443|Growth Substances|growth substances|mesh-ancestor
153868527|NCT00586443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153868528|NCT00586443|Growth Inhibitors|growth inhibitors|mesh-ancestor
153868529|NCT00586443|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
153868530|NCT00586443|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153868531|NCT00586443|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153868532|NCT00586443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153409036|NCT02460133|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
153409037|NCT02460133|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153409039|NCT02220452|Anesthetics|anesthetics|mesh-list
153409040|NCT02220452|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153409041|NCT02220452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153409042|NCT04256603|Gabapentin|gabapentin|mesh-list
153868533|NCT00586443|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153868534|NCT00586443|Immunologic Factors|immunologic factors|mesh-ancestor
153409071|NCT02068430|Vitamin B Complex|vitamin b complex|mesh-ancestor
153409072|NCT02068430|Vitamins|vitamins|mesh-ancestor
153409073|NCT02068430|Micronutrients|micronutrients|mesh-ancestor
153409074|NCT02068430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153409075|NCT02068430|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
153409076|NCT02068430|Dermatologic Agents|dermatologic agents|mesh-ancestor
153409077|NCT03127592|Etodolac|etodolac|mesh-list
153409078|NCT03127592|Cyclobenzaprine|cyclobenzaprine|mesh-list
153409079|NCT03127592|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
153409080|NCT03127592|Antidepressive Agents|antidepressive agents|mesh-ancestor
153409081|NCT03127592|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153409082|NCT03127592|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
153409083|NCT03127592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153409084|NCT03127592|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
153409085|NCT03127592|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153409086|NCT03127592|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153409087|NCT03127592|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153409088|NCT03127592|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153409089|NCT03127592|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153409090|NCT03127592|Analgesics|analgesics|mesh-ancestor
153409091|NCT03127592|Sensory System Agents|sensory system agents|mesh-ancestor
153868566|NCT00586794|Sildenafil Citrate|sildenafil citrate|mesh-list
153868567|NCT00586794|Vasodilator Agents|vasodilator agents|mesh-ancestor
153868568|NCT00586794|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
153868569|NCT00586794|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
153868570|NCT00586794|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153868571|NCT00586794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153868572|NCT00586794|Urological Agents|urological agents|mesh-ancestor
153868573|NCT00586833|Neurotransmitter Agents|neurotransmitter agents|mesh-list
153868575|NCT00586833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153409102|NCT02444234|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
153409103|NCT02444234|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153409104|NCT02444234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153409105|NCT02444936|Vaccines|vaccines|mesh-list
153409106|NCT02444936|Immunologic Factors|immunologic factors|mesh-ancestor
153409107|NCT02444936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153409108|NCT02445326|Dexamethasone|dexamethasone|mesh-list
153409109|NCT02445326|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153409110|NCT02445326|Antiemetics|antiemetics|mesh-ancestor
153409111|NCT02445326|Autonomic Agents|autonomic agents|mesh-ancestor
153409112|NCT02445326|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153409113|NCT02445326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153409114|NCT02445326|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153409115|NCT02445326|Glucocorticoids|glucocorticoids|mesh-ancestor
153409116|NCT02445326|Hormones|hormones|mesh-ancestor
153409117|NCT02445326|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153409118|NCT02445326|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153409119|NCT02445326|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153409120|NCT04344457|Hydroxychloroquine|hydroxychloroquine|mesh-list
153409121|NCT04344457|Azithromycin|azithromycin|mesh-list
153868602|NCT00575627|Antiviral Agents|antiviral agents|mesh-ancestor
153868603|NCT00575627|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153868604|NCT00575627|Antimetabolites|antimetabolites|mesh-ancestor
153868605|NCT00575627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153868606|NCT00575627|Immunologic Factors|immunologic factors|mesh-ancestor
153868607|NCT00575627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153868608|NCT00555854|Benzocaine|benzocaine|mesh-list
153868609|NCT00555854|Anesthetics, Local|anesthetics, local|mesh-ancestor
153868610|NCT00555854|Anesthetics|anesthetics|mesh-ancestor
153382625|NCT03245463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153382626|NCT03245463|Viscosupplements|viscosupplements|mesh-ancestor
153382627|NCT03245463|Protective Agents|protective agents|mesh-ancestor
153382628|NCT01974245|Cholecalciferol|cholecalciferol|mesh-list
153382630|NCT01974245|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153382631|NCT01974245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153382632|NCT01974245|Vitamins|vitamins|mesh-ancestor
153382633|NCT01974245|Micronutrients|micronutrients|mesh-ancestor
153382634|NCT01974245|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153382635|NCT03307005|Zolpidem|zolpidem|mesh-list
153382636|NCT03307005|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
153382637|NCT03307005|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153382638|NCT03307005|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153868611|NCT00555854|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153868612|NCT00555854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153868613|NCT00555854|Sensory System Agents|sensory system agents|mesh-ancestor
153868614|NCT00555854|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153868615|NCT04674332|Insulin, Long-Acting|insulin, long-acting|mesh-list
153868616|NCT04674332|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153409135|NCT04344457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153409136|NCT04344457|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153409138|NCT04344457|Tocolytic Agents|tocolytic agents|mesh-ancestor
153409139|NCT04344457|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153409140|NCT04344457|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153409141|NCT04344457|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153409142|NCT05720533|Disitamab vedotin|disitamab vedotin|mesh-list
153409143|NCT05720533|Immunoconjugates|immunoconjugates|mesh-ancestor
153409144|NCT05720533|Immunologic Factors|immunologic factors|mesh-ancestor
153409145|NCT05720533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153409147|NCT02446496|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153409148|NCT02446496|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153409149|NCT00355693|Propofol|propofol|mesh-list
153409150|NCT00355693|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153409151|NCT00355693|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153409152|NCT00355693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153409153|NCT00355693|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153409154|NCT00355693|Anesthetics, General|anesthetics, general|mesh-ancestor
153409155|NCT00355693|Anesthetics|anesthetics|mesh-ancestor
153868623|NCT00587145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153868624|NCT04674176|Rifaximin|rifaximin|mesh-list
153868625|NCT04674176|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153868626|NCT04674176|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153868636|NCT00199836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153868638|NCT00199797|Fluorouracil|fluorouracil|mesh-list
153868639|NCT00199797|Oxaliplatin|oxaliplatin|mesh-list
153868640|NCT00199797|Antimetabolites|antimetabolites|mesh-ancestor
153868641|NCT00199797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153868642|NCT00199797|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153868643|NCT00199797|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153868644|NCT00199797|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153868645|NCT00199797|Immunologic Factors|immunologic factors|mesh-ancestor
153868646|NCT00199797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153868647|NCT00199797|Antidotes|antidotes|mesh-ancestor
153868648|NCT00199797|Protective Agents|protective agents|mesh-ancestor
153868649|NCT00199797|Vitamin B Complex|vitamin b complex|mesh-ancestor
153409156|NCT02448368|Verinurad|verinurad|mesh-list
153409157|NCT02448368|Gout Suppressants|gout suppressants|mesh-ancestor
153409158|NCT02448368|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153409159|NCT02448914|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
153409160|NCT02448914|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153409161|NCT02448914|Immunologic Factors|immunologic factors|mesh-ancestor
153409162|NCT02448914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153409163|NCT02448914|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
153409164|NCT02448914|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
153409165|NCT02448914|Dopamine Agonists|dopamine agonists|mesh-ancestor
153409166|NCT02448914|Dopamine Agents|dopamine agents|mesh-ancestor
153409167|NCT02448914|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153409168|NCT02448914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153409169|NCT05002309|Antidepressive Agents|antidepressive agents|mesh-list
153409170|NCT05002309|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153409171|NCT01152541|Riboflavin|riboflavin|mesh-list
153409188|NCT01638546|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153868650|NCT00199797|Vitamins|vitamins|mesh-ancestor
153868651|NCT00199797|Micronutrients|micronutrients|mesh-ancestor
153868677|NCT00198822|Protective Agents|protective agents|mesh-ancestor
153868678|NCT00198822|Provitamins|provitamins|mesh-ancestor
153868679|NCT05214976|Paclitaxel|paclitaxel|mesh-list
153868680|NCT05214976|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153868681|NCT05214976|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153868682|NCT05214976|Tubulin Modulators|tubulin modulators|mesh-ancestor
153409189|NCT01638546|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
153409190|NCT01638546|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153409192|NCT04948489|Norethindrone Acetate|norethindrone acetate|mesh-list
153409193|NCT04948489|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
153409196|NCT04948489|Contraceptive Agents|contraceptive agents|mesh-ancestor
153409197|NCT04948489|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153409198|NCT04948489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153409199|NCT04948489|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
153409200|NCT04948489|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
153409201|NCT00363350|Rituximab|rituximab|mesh-list
153409202|NCT00363350|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153409203|NCT00363350|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153409204|NCT00363350|Immunologic Factors|immunologic factors|mesh-ancestor
153409205|NCT00363350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153409206|NCT00363350|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153409207|NCT05717335|Thrombin|thrombin|mesh-list
153409208|NCT05717335|Hemostatics|hemostatics|mesh-ancestor
153409209|NCT05717335|Coagulants|coagulants|mesh-ancestor
153409221|NCT04341818|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153409222|NCT04341818|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153409223|NCT00362804|Tetrabenazine|tetrabenazine|mesh-list
153409224|NCT00362804|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
153409225|NCT00362804|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153409226|NCT00362804|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153409227|NCT00362804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153409228|NCT00362804|Adrenergic Agents|adrenergic agents|mesh-ancestor
153409229|NCT00362804|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153409230|NCT00362804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153409231|NCT02451488|Sargramostim|sargramostim|mesh-list
153409232|NCT02451488|Immunologic Factors|immunologic factors|mesh-ancestor
153409233|NCT02451488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153409234|NCT03172494|Insulin|insulin|mesh-list
153409235|NCT03172494|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
153409236|NCT03172494|Liraglutide|liraglutide|mesh-list
153409237|NCT03172494|Insulin, Long-Acting|insulin, long-acting|mesh-list
153409238|NCT03172494|Xultophy|xultophy|mesh-list
153868712|NCT02883478|Vitamins|vitamins|mesh-ancestor
153868713|NCT02883478|Micronutrients|micronutrients|mesh-ancestor
153409247|NCT02452346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153868714|NCT02883478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153868715|NCT02883478|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
153868716|NCT02883478|Dermatologic Agents|dermatologic agents|mesh-ancestor
153868717|NCT00197145|Aplaviroc|aplaviroc|mesh-list
153868718|NCT00197145|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
153868719|NCT00197145|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
153868720|NCT00197145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153868723|NCT00197145|Antiviral Agents|antiviral agents|mesh-ancestor
153868724|NCT00197145|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153868726|NCT04674137|Glutarimide|glutarimide|mesh-list
153868727|NCT04674137|Histamine Agonists|histamine agonists|mesh-ancestor
153868728|NCT04674137|Histamine Agents|histamine agents|mesh-ancestor
153868729|NCT04674137|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153868730|NCT04674137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153868731|NCT04674137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153868732|NCT04674137|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
153868733|NCT04674137|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153868734|NCT04312438|Caseins|caseins|mesh-list
153868735|NCT04312438|Chelating Agents|chelating agents|mesh-ancestor
153868736|NCT04312438|Sequestering Agents|sequestering agents|mesh-ancestor
153868737|NCT04312438|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153868738|NCT00197106|Fluticasone|fluticasone|mesh-list
153868740|NCT00197106|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
153868741|NCT00197106|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153409257|NCT05716945|Antiemetics|antiemetics|mesh-ancestor
153409258|NCT05716945|Autonomic Agents|autonomic agents|mesh-ancestor
153409259|NCT05716945|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153409286|NCT02453360|Anesthetics|anesthetics|mesh-ancestor
153409287|NCT02453360|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153409288|NCT02453360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153409289|NCT02453360|Sensory System Agents|sensory system agents|mesh-ancestor
153868747|NCT00197106|Respiratory System Agents|respiratory system agents|mesh-ancestor
153868748|NCT00197106|Dermatologic Agents|dermatologic agents|mesh-ancestor
153868749|NCT00197106|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
153868750|NCT00197106|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
153868751|NCT00197106|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
153868752|NCT00197106|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153868753|NCT00197106|Adrenergic Agents|adrenergic agents|mesh-ancestor
153868754|NCT00197106|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153868755|NCT00197106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153868756|NCT01136746|Insulin|insulin|mesh-list
153868757|NCT01136746|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
153868758|NCT01136746|Insulin Glargine|insulin glargine|mesh-list
153868759|NCT01136746|Insulin Lispro|insulin lispro|mesh-list
153868760|NCT01136746|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153868761|NCT01136746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153868762|NCT01136356|Morphine|morphine|mesh-list
153868763|NCT01136356|Buprenorphine|buprenorphine|mesh-list
153868764|NCT01136356|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153868765|NCT01136356|Narcotics|narcotics|mesh-ancestor
153868766|NCT01136356|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153868767|NCT01136356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153868768|NCT01136356|Analgesics|analgesics|mesh-ancestor
153868769|NCT01136356|Sensory System Agents|sensory system agents|mesh-ancestor
153868778|NCT00587379|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
153868779|NCT00587379|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153868780|NCT04673396|Norcantharidin|norcantharidin|mesh-list
153409290|NCT02453360|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153409291|NCT02453672|Bevacizumab|bevacizumab|mesh-list
153409292|NCT02453672|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153409293|NCT02453672|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153409294|NCT02453672|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153409295|NCT02453672|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153409296|NCT02453672|Growth Substances|growth substances|mesh-ancestor
153409297|NCT02453672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153409298|NCT02453672|Growth Inhibitors|growth inhibitors|mesh-ancestor
153409299|NCT03119064|Irinotecan|irinotecan|mesh-list
153409300|NCT03119064|Temozolomide|temozolomide|mesh-list
153409301|NCT03119064|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
153409302|NCT03119064|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153409303|NCT03119064|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153409304|NCT03119064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153409305|NCT03119064|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153409306|NCT03119064|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153409307|NCT03119064|Alkylating Agents|alkylating agents|mesh-ancestor
153409308|NCT02453750|Bronchodilator Agents|bronchodilator agents|mesh-list
153409309|NCT02453750|Autonomic Agents|autonomic agents|mesh-ancestor
153409310|NCT02453750|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153409311|NCT02453750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153409312|NCT02453750|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153409313|NCT02453750|Respiratory System Agents|respiratory system agents|mesh-ancestor
153409314|NCT02454296|Lidocaine|lidocaine|mesh-list
153409315|NCT02454296|Anesthetics, Local|anesthetics, local|mesh-ancestor
153409316|NCT02454296|Anesthetics|anesthetics|mesh-ancestor
153409317|NCT02454296|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153409318|NCT02454296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153409319|NCT02454296|Sensory System Agents|sensory system agents|mesh-ancestor
153868785|NCT00637390|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153868786|NCT00637390|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153868788|NCT00196326|Ethinyl Estradiol|ethinyl estradiol|mesh-list
153868790|NCT00196326|Estrogens|estrogens|mesh-ancestor
153868791|NCT00196326|Hormones|hormones|mesh-ancestor
153868792|NCT00196326|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153868793|NCT00196326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153868794|NCT00196326|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
153868795|NCT00196326|Contraceptive Agents|contraceptive agents|mesh-ancestor
153868796|NCT00196326|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153868797|NCT00196326|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
153868798|NCT00196326|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
153868799|NCT00196326|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
153868800|NCT00196326|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
153868801|NCT00587496|Aspirin|aspirin|mesh-list
153868802|NCT00587496|Valacyclovir|valacyclovir|mesh-list
153868803|NCT00587496|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153868804|NCT00587496|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153868805|NCT00587496|Analgesics|analgesics|mesh-ancestor
153868806|NCT00587496|Sensory System Agents|sensory system agents|mesh-ancestor
153868807|NCT00587496|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153868809|NCT00587496|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153409335|NCT05710471|Aflibercept|aflibercept|mesh-list
153409336|NCT05710471|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153409337|NCT05710471|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153409338|NCT05710471|Growth Substances|growth substances|mesh-ancestor
153409339|NCT05710471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153409340|NCT05710471|Growth Inhibitors|growth inhibitors|mesh-ancestor
153409341|NCT05710471|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153409342|NCT00358969|Guanfacine|guanfacine|mesh-list
153429974|NCT00378937|Codeine|codeine|mesh-list
153868822|NCT00195663|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
153868823|NCT00195663|Abortifacient Agents|abortifacient agents|mesh-ancestor
153868824|NCT00195663|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153868825|NCT00195663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153868826|NCT00195663|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153868827|NCT00195663|Antimetabolites|antimetabolites|mesh-ancestor
153868828|NCT00195663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153868829|NCT00195663|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153868830|NCT00195663|Dermatologic Agents|dermatologic agents|mesh-ancestor
153868831|NCT00195663|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153868832|NCT00195663|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153409343|NCT00358969|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153409344|NCT00358969|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
153409345|NCT00358969|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153409346|NCT00358969|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153409361|NCT05346601|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153409362|NCT05346601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153409363|NCT04344379|Azithromycin|azithromycin|mesh-list
153409364|NCT04344379|Hydroxychloroquine|hydroxychloroquine|mesh-list
153409365|NCT04344379|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153409366|NCT04344379|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153409367|NCT04344379|Antimalarials|antimalarials|mesh-ancestor
153409368|NCT04344379|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153409369|NCT04344379|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153409370|NCT04344379|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153409371|NCT04344379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153409372|NCT04344379|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153409373|NCT00359125|Mifepristone|mifepristone|mesh-list
153868833|NCT00195663|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153868834|NCT00195663|Immunologic Factors|immunologic factors|mesh-ancestor
153868835|NCT00195663|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153868836|NCT00195663|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153868837|NCT00195663|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
153868838|NCT00195663|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153868839|NCT01135498|Bevacizumab|bevacizumab|mesh-list
153868840|NCT01135498|Capecitabine|capecitabine|mesh-list
153868841|NCT01135498|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
153868842|NCT01135498|Oxaliplatin|oxaliplatin|mesh-list
153868843|NCT01135498|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153868844|NCT01135498|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153868845|NCT01135498|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153868846|NCT01135498|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153868847|NCT01135498|Growth Substances|growth substances|mesh-ancestor
153868848|NCT01135498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153868849|NCT01135498|Growth Inhibitors|growth inhibitors|mesh-ancestor
153868850|NCT01135498|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153868851|NCT01135498|Antimetabolites|antimetabolites|mesh-ancestor
153868852|NCT01135498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153868853|NCT01135498|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153868854|NCT01135498|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153868855|NCT01135498|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153868856|NCT04610567|Methotrexate|methotrexate|mesh-list
153868857|NCT04610567|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
153409379|NCT00359125|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
153409380|NCT00359125|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
153409381|NCT00359125|Contraceptive Agents|contraceptive agents|mesh-ancestor
153409382|NCT00359125|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
153409383|NCT00359125|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
153409384|NCT00359125|Hormone Antagonists|hormone antagonists|mesh-ancestor
153409385|NCT00359125|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153409386|NCT00359125|Luteolytic Agents|luteolytic agents|mesh-ancestor
153409387|NCT00359125|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
153409388|NCT00359125|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
153409389|NCT03042468|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
153409391|NCT03042468|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
153868879|NCT02883439|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153868880|NCT02883439|Respiratory System Agents|respiratory system agents|mesh-ancestor
153868881|NCT02883439|Dermatologic Agents|dermatologic agents|mesh-ancestor
153868882|NCT02883439|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
153409399|NCT05679193|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
153409400|NCT05679193|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
153409416|NCT04795752|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153409417|NCT04795752|Dermatologic Agents|dermatologic agents|mesh-ancestor
153409418|NCT04795752|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153409419|NCT04795752|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
153409421|NCT02977741|Antiemetics|antiemetics|mesh-ancestor
153409422|NCT02977741|Autonomic Agents|autonomic agents|mesh-ancestor
153409423|NCT02977741|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153409424|NCT02977741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153409425|NCT02977741|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153409426|NCT02977741|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153409427|NCT02977741|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153409428|NCT02977741|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153409429|NCT02977741|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153868889|NCT00195507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153868890|NCT00195507|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153868891|NCT00195507|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153868892|NCT00195507|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153868893|NCT00195507|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153868894|NCT00195507|Immunologic Factors|immunologic factors|mesh-ancestor
153868895|NCT00195351|Metronidazole|metronidazole|mesh-list
153868896|NCT00195351|Ceftriaxone|ceftriaxone|mesh-list
153868897|NCT00195351|Tigecycline|tigecycline|mesh-list
153868898|NCT00195351|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153868899|NCT00195351|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153868900|NCT00195351|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153868901|NCT00195351|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153868902|NCT00195351|Third Generation Cephalosporins|third generation cephalosporins|mesh-ancestor
153868903|NCT00195351|Beta Lactam Antibiotics|beta lactam antibiotics|mesh-ancestor
153868904|NCT00195351|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
153868905|NCT00195351|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153868906|NCT00195351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153868907|NCT04609748|Nimesulide|nimesulide|mesh-list
153868908|NCT04609748|Cannabidiol|cannabidiol|mesh-list
153868909|NCT04609748|Anticonvulsants|anticonvulsants|mesh-ancestor
153868910|NCT04609748|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153868911|NCT04609748|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153868912|NCT04609748|Analgesics|analgesics|mesh-ancestor
153868913|NCT04609748|Sensory System Agents|sensory system agents|mesh-ancestor
153868914|NCT04609748|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153409433|NCT02977741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153409434|NCT02977741|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153409435|NCT02977741|Serotonin Agents|serotonin agents|mesh-ancestor
153409436|NCT05292001|Dextrans|dextrans|mesh-list
153409437|NCT05292001|Iron-Dextran Complex|iron-dextran complex|mesh-list
153409438|NCT05292001|Anticoagulants|anticoagulants|mesh-ancestor
153409439|NCT05292001|Plasma Substitutes|plasma substitutes|mesh-ancestor
153409440|NCT05292001|Blood Substitutes|blood substitutes|mesh-ancestor
153409441|NCT05292001|Hematinics|hematinics|mesh-ancestor
153409442|NCT01634178|Apremilast|apremilast|mesh-list
153409443|NCT01634178|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153409444|NCT01634178|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153409445|NCT01634178|Analgesics|analgesics|mesh-ancestor
153409446|NCT01634178|Sensory System Agents|sensory system agents|mesh-ancestor
153409447|NCT01634178|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153409448|NCT01634178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153409449|NCT01634178|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153409450|NCT01634178|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153409451|NCT01634178|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
153409452|NCT01634178|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
153868932|NCT00195273|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153868933|NCT00195273|Dermatologic Agents|dermatologic agents|mesh-ancestor
153868934|NCT00195273|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153868935|NCT00195273|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
153868936|NCT00195273|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153868937|NCT00195273|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153868938|NCT00195273|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
153868939|NCT00195273|Antitubercular Agents|antitubercular agents|mesh-ancestor
153868940|NCT00195273|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153868942|NCT00564200|Fludarabine|fludarabine|mesh-list
153868943|NCT00564200|Bortezomib|bortezomib|mesh-list
153868944|NCT00564200|Melphalan|melphalan|mesh-list
153868945|NCT00564200|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153868946|NCT00564200|Antiemetics|antiemetics|mesh-ancestor
153409454|NCT01634178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153409456|NCT00359359|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153409457|NCT04782804|Capecitabine|capecitabine|mesh-list
153409458|NCT04782804|Tislelizumab|tislelizumab|mesh-list
153409459|NCT04782804|Antibodies|antibodies|mesh-list
153409460|NCT04782804|Immunologic Factors|immunologic factors|mesh-ancestor
153409461|NCT04782804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153409462|NCT04782804|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153409463|NCT04782804|Antimetabolites|antimetabolites|mesh-ancestor
153409464|NCT04782804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153409465|NCT04782804|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153409466|NCT04782804|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153409467|NCT02978443|Nivolumab|nivolumab|mesh-list
153409468|NCT02978443|Ipilimumab|ipilimumab|mesh-list
153409469|NCT02978443|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153409470|NCT02978443|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153409471|NCT02978443|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153868952|NCT00564200|Hormones|hormones|mesh-ancestor
153868953|NCT00564200|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153868954|NCT00564200|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153868955|NCT00564200|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153868956|NCT00564200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153888876|NCT04301557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153888877|NCT04301557|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153888878|NCT02874313|Hypoglycemic Agents|hypoglycemic agents|mesh-list
153888879|NCT02874313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153888880|NCT01029535|Hyaluronic Acid|hyaluronic acid|mesh-list
153409502|NCT04802382|Hemostatics|hemostatics|mesh-ancestor
153409503|NCT04802382|Coagulants|coagulants|mesh-ancestor
153409504|NCT05648916|Celecoxib|celecoxib|mesh-list
153409505|NCT05648916|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153409506|NCT05648916|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153409507|NCT05648916|Analgesics|analgesics|mesh-ancestor
153409508|NCT05648916|Sensory System Agents|sensory system agents|mesh-ancestor
153409509|NCT05648916|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153409510|NCT05648916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153409511|NCT05648916|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153409512|NCT05648916|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153409513|NCT05648916|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
153409514|NCT05648916|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153409515|NCT05648916|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153409516|NCT05648916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153409517|NCT05648058|Diphenhydramine|diphenhydramine|mesh-list
153868999|NCT00193206|Antimitotic Agents|antimitotic agents|mesh-ancestor
153869000|NCT00193206|Mitosis Modulators|mitosis modulators|mesh-ancestor
153869001|NCT00193206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153869002|NCT00193206|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153869003|NCT00193206|Antimetabolites|antimetabolites|mesh-ancestor
153869004|NCT00193206|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153869005|NCT00193206|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153869006|NCT00193206|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153869007|NCT00193206|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153869008|NCT00193050|Gemcitabine|gemcitabine|mesh-list
153869024|NCT04608734|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153869025|NCT04608734|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153869026|NCT04608734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153382639|NCT03307005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153382640|NCT03307005|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
153382675|NCT02305277|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
153382709|NCT03468933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153382710|NCT03472287|Diacerein|diacerein|mesh-list
153382711|NCT03472287|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153382712|NCT02219984|Anticoagulants|anticoagulants|mesh-list
153382713|NCT02067416|Paclitaxel|paclitaxel|mesh-list
153382714|NCT02067416|Docetaxel|docetaxel|mesh-list
153382715|NCT02067416|Epirubicin|epirubicin|mesh-list
153382716|NCT02067416|Taxane|taxane|mesh-list
153382747|NCT02010203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153382748|NCT03261999|Leuprolide|leuprolide|mesh-list
153382749|NCT03261999|Fertility Agents, Female|fertility agents, female|mesh-ancestor
153382750|NCT03261999|Fertility Agents|fertility agents|mesh-ancestor
153382751|NCT03261999|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153382752|NCT03261999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153382753|NCT03261999|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153382754|NCT03261999|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153382755|NCT03482973|Bupivacaine|bupivacaine|mesh-list
153382756|NCT03482973|Anesthetics, Local|anesthetics, local|mesh-ancestor
153382757|NCT03482973|Anesthetics|anesthetics|mesh-ancestor
153382758|NCT03482973|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153382759|NCT03482973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153869027|NCT04608734|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153869028|NCT04608734|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153869029|NCT04608734|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153409538|NCT05648058|Dermatologic Agents|dermatologic agents|mesh-ancestor
153409539|NCT05648058|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153409540|NCT05648058|Analgesics|analgesics|mesh-ancestor
153409542|NCT05210101|Antiviral Agents|antiviral agents|mesh-ancestor
153409543|NCT05210101|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153409544|NCT02959411|Tolvaptan|tolvaptan|mesh-list
153409545|NCT02959411|Diuretics|diuretics|mesh-list
153409546|NCT02959411|Natriuretic Agents|natriuretic agents|mesh-ancestor
153409547|NCT02959411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153409548|NCT02959411|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
153888890|NCT01023217|Adefovir|adefovir|mesh-list
153409549|NCT02959411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153409550|NCT05426161|Botulinum Toxins|botulinum toxins|mesh-list
153409551|NCT05426161|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
153409552|NCT05426161|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
153409553|NCT05426161|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
153409554|NCT05426161|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153409555|NCT05426161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153409556|NCT05426161|Cholinergic Agents|cholinergic agents|mesh-ancestor
153409557|NCT05426161|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153409558|NCT05426161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153409559|NCT05426161|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
153409560|NCT05426161|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153409561|NCT05630833|Nitrofurantoin|nitrofurantoin|mesh-list
153409562|NCT05630833|Gepotidacin|gepotidacin|mesh-list
153409563|NCT05630833|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
153409564|NCT05630833|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153409565|NCT05630833|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153409566|NCT05630833|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153409567|NCT05630833|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153869030|NCT04608734|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153869031|NCT04608734|Anesthetics, General|anesthetics, general|mesh-ancestor
153869032|NCT04608734|Anesthetics|anesthetics|mesh-ancestor
153869033|NCT04608734|GABA Modulators|gaba modulators|mesh-ancestor
153869034|NCT04608734|GABA Agents|gaba agents|mesh-ancestor
153869035|NCT04608734|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153869052|NCT00192075|Hematinics|hematinics|mesh-ancestor
153869053|NCT00192036|Gemcitabine|gemcitabine|mesh-list
153869054|NCT00192036|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153869055|NCT00192036|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153869056|NCT00192036|Antimetabolites|antimetabolites|mesh-ancestor
153869057|NCT00192036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153869058|NCT00191724|Drotrecogin alfa activated|drotrecogin alfa activated|mesh-list
153869060|NCT00191724|Protein C|protein c|mesh-list
153869061|NCT00191724|Anticoagulants|anticoagulants|mesh-ancestor
153409568|NCT05630833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153409569|NCT05630833|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153409570|NCT00359671|Docetaxel|docetaxel|mesh-list
153409571|NCT00359671|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153409586|NCT00359905|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153409587|NCT00359905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153409588|NCT00359905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153869062|NCT00191724|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153869063|NCT00191724|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153869064|NCT00191724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153869065|NCT00191724|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153869066|NCT00191646|Paclitaxel|paclitaxel|mesh-list
153869067|NCT00191646|Carboplatin|carboplatin|mesh-list
153869068|NCT00191646|Gemcitabine|gemcitabine|mesh-list
153869069|NCT00191646|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153869070|NCT00191646|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153869071|NCT00191646|Tubulin Modulators|tubulin modulators|mesh-ancestor
153409602|NCT00358813|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
153409603|NCT00358813|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153409604|NCT00358813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153409605|NCT04871191|Rituximab|rituximab|mesh-list
153409606|NCT04871191|Abatacept|abatacept|mesh-list
153409607|NCT04871191|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153409608|NCT04871191|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153409609|NCT04871191|Immunologic Factors|immunologic factors|mesh-ancestor
153869103|NCT00191139|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153869104|NCT00191139|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153409612|NCT04871191|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153409613|NCT04871191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153409614|NCT04871191|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153409615|NCT02976805|Bisacodyl|bisacodyl|mesh-list
153409616|NCT02976805|Cathartics|cathartics|mesh-ancestor
153409617|NCT02976805|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153409618|NCT02976805|Laxatives|laxatives|mesh-ancestor
153409619|NCT04835623|Cyclosporine|cyclosporine|mesh-list
153409620|NCT04835623|Ophthalmic Solutions|ophthalmic solutions|mesh-list
153409621|NCT04835623|Cyclosporins|cyclosporins|mesh-list
153409622|NCT04835623|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153409623|NCT04835623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153409624|NCT04835623|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153869114|NCT00564512|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153869115|NCT00564512|Alkylating Agents|alkylating agents|mesh-ancestor
153869116|NCT00564512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153869117|NCT00564512|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153409625|NCT04835623|Immunologic Factors|immunologic factors|mesh-ancestor
153409626|NCT04835623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153409627|NCT04835623|Antifungal Agents|antifungal agents|mesh-ancestor
153409628|NCT04835623|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153409629|NCT04835623|Dermatologic Agents|dermatologic agents|mesh-ancestor
153409630|NCT04835623|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153409631|NCT04835623|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
153409632|NCT04835623|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
153409634|NCT04500613|Dexamethasone acetate|dexamethasone acetate|mesh-list
153409636|NCT04500613|BB 1101|bb 1101|mesh-list
153409637|NCT04500613|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153409638|NCT04500613|Antiemetics|antiemetics|mesh-ancestor
153409639|NCT04500613|Autonomic Agents|autonomic agents|mesh-ancestor
153409640|NCT04500613|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153382760|NCT03482973|Sensory System Agents|sensory system agents|mesh-ancestor
153382761|NCT03482973|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153382762|NCT03483675|Immunosuppressive Agents|immunosuppressive agents|mesh-list
153382763|NCT03483675|Immunologic Factors|immunologic factors|mesh-ancestor
153382764|NCT03483675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153382765|NCT03327051|Omeprazole|omeprazole|mesh-list
153382766|NCT03327051|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
153382767|NCT03327051|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153409641|NCT04500613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153409642|NCT04500613|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153409643|NCT04500613|Glucocorticoids|glucocorticoids|mesh-ancestor
153888893|NCT01023217|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153869118|NCT00564512|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153869119|NCT00564512|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153869120|NCT00564551|Calcium, Dietary|calcium, dietary|mesh-list
153869121|NCT00564551|Calcium|calcium|mesh-list
153869122|NCT00564551|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153869130|NCT00190983|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153869131|NCT00190749|Olanzapine|olanzapine|mesh-list
153869132|NCT00190749|Risperidone|risperidone|mesh-list
153869133|NCT00190749|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153409644|NCT04500613|Hormones|hormones|mesh-ancestor
153409645|NCT04500613|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153409646|NCT04500613|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153409647|NCT04500613|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153409648|NCT04500613|Protease Inhibitors|protease inhibitors|mesh-ancestor
153409649|NCT04500613|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153409650|NCT04500613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153409651|NCT04500613|Anesthetics, Local|anesthetics, local|mesh-ancestor
153409652|NCT04500613|Anesthetics|anesthetics|mesh-ancestor
153409653|NCT04500613|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153409654|NCT04500613|Sensory System Agents|sensory system agents|mesh-ancestor
153869136|NCT00190749|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153869137|NCT00190749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153869138|NCT00190749|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153869139|NCT00190749|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153869140|NCT00190749|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153869141|NCT00190749|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153869142|NCT00190749|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
153869143|NCT00190749|Dopamine Agents|dopamine agents|mesh-ancestor
153869145|NCT00190749|Autonomic Agents|autonomic agents|mesh-ancestor
153869146|NCT00190749|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153869147|NCT00190749|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153869148|NCT00190749|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
153869149|NCT00190749|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153869150|NCT00190749|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153869151|NCT04607447|Dexamethasone|dexamethasone|mesh-list
153869152|NCT04607447|Atorvastatin|atorvastatin|mesh-list
153869153|NCT04607447|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153869154|NCT04607447|Antiemetics|antiemetics|mesh-ancestor
153869155|NCT04607447|Autonomic Agents|autonomic agents|mesh-ancestor
153869156|NCT04607447|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153409669|NCT02976727|Prilocaine|prilocaine|mesh-list
153409670|NCT02976727|Lidocaine, Prilocaine Drug Combination|lidocaine, prilocaine drug combination|mesh-list
153409671|NCT02976727|Calcipotriene|calcipotriene|mesh-list
153409672|NCT02976727|Vitamins|vitamins|mesh-ancestor
153409673|NCT02976727|Micronutrients|micronutrients|mesh-ancestor
153409674|NCT02976727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153409696|NCT00360607|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153409697|NCT00360607|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153409698|NCT00360607|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153409699|NCT00360607|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153409700|NCT00360607|Third Generation Cephalosporins|third generation cephalosporins|mesh-ancestor
153409701|NCT00360607|Beta Lactam Antibiotics|beta lactam antibiotics|mesh-ancestor
153409702|NCT00360607|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
153409703|NCT00360607|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153409704|NCT00360607|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153409705|NCT00360607|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
153409706|NCT00360763|Candesartan|candesartan|mesh-list
153409707|NCT00360763|Candesartan cilexetil|candesartan cilexetil|mesh-list
153409708|NCT00360763|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153409709|NCT00360763|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
153409710|NCT00360763|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
153409712|NCT04010305|Dexmedetomidine|dexmedetomidine|mesh-list
153869177|NCT00190671|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153869178|NCT00190671|Alkylating Agents|alkylating agents|mesh-ancestor
153869179|NCT00190671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153869180|NCT00190671|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153869181|NCT00190671|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153869182|NCT00190671|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153869183|NCT00190671|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153869184|NCT00190671|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153869185|NCT04607525|Dexmedetomidine|dexmedetomidine|mesh-list
153869186|NCT04607525|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153869204|NCT04607642|Micronutrients|micronutrients|mesh-ancestor
153869205|NCT04607642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153869206|NCT00588003|Anastrozole|anastrozole|mesh-list
153409720|NCT04010305|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
153409721|NCT04010305|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153409722|NCT04010305|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153409723|NCT04010305|Adrenergic Agents|adrenergic agents|mesh-ancestor
153409724|NCT04010305|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153409725|NCT04010305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153409726|NCT00361933|Valganciclovir|valganciclovir|mesh-list
153409727|NCT00361933|Antiviral Agents|antiviral agents|mesh-ancestor
153409728|NCT00361933|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153409729|NCT02976571|Bupivacaine|bupivacaine|mesh-list
153409730|NCT02976571|Anesthetics, Local|anesthetics, local|mesh-ancestor
153409731|NCT02976571|Anesthetics|anesthetics|mesh-ancestor
153409732|NCT02976571|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153409733|NCT02976571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153409734|NCT02976571|Sensory System Agents|sensory system agents|mesh-ancestor
153409735|NCT02976571|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153409736|NCT04731025|Vancomycin|vancomycin|mesh-list
153409737|NCT04731025|Gentamicins|gentamicins|mesh-list
153409738|NCT04731025|Cefazolin|cefazolin|mesh-list
153409739|NCT04731025|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153409740|NCT04731025|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153409741|NCT04731025|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
153409742|NCT04731025|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153409743|NCT04731025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153409744|NCT04730635|Donepezil|donepezil|mesh-list
153409745|NCT04730635|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
153409746|NCT04730635|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153409747|NCT04730635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153869207|NCT00588003|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153869208|NCT00588003|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153869209|NCT00588003|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
153869210|NCT00588003|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153869211|NCT00588003|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153869212|NCT00588003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153869213|NCT00588003|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
153869214|NCT00588003|Hormone Antagonists|hormone antagonists|mesh-ancestor
153869215|NCT00588003|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153869216|NCT00588003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153869217|NCT04607057|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-list
153869218|NCT04607057|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
153869221|NCT00564590|Antioxidants|antioxidants|mesh-ancestor
153869222|NCT00564590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153869223|NCT00564590|Protective Agents|protective agents|mesh-ancestor
153869224|NCT00564590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153869225|NCT00564590|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153869226|NCT00564590|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
153869227|NCT00564590|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153869228|NCT00564590|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
153869229|NCT00564590|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153869230|NCT00564668|Insulin Aspart|insulin aspart|mesh-list
153869231|NCT00564668|Biphasic Insulins|biphasic insulins|mesh-list
153869232|NCT00564668|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153409759|NCT04676035|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153382768|NCT03327051|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
153382769|NCT03327051|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153382770|NCT03327051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153382771|NCT02057939|Leuprolide|leuprolide|mesh-list
153382795|NCT03329937|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
153382796|NCT03329937|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153382797|NCT03329937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153382798|NCT03329937|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153382799|NCT01710254|Regadenoson|regadenoson|mesh-list
153409760|NCT04676035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153409761|NCT04676035|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153409762|NCT04676035|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153409763|NCT04676035|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153409764|NCT04676035|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153409765|NCT04676035|Anesthetics, General|anesthetics, general|mesh-ancestor
153409766|NCT04676035|Anesthetics|anesthetics|mesh-ancestor
153409767|NCT04676035|GABA Modulators|gaba modulators|mesh-ancestor
153409768|NCT04676035|GABA Agents|gaba agents|mesh-ancestor
153409769|NCT04676035|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153409770|NCT04676035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153409771|NCT04676035|Anticoagulants|anticoagulants|mesh-ancestor
153409772|NCT04676035|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
153409773|NCT04676035|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153409774|NCT04676035|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
153409775|NCT04676035|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153409776|NCT04676035|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
153409777|NCT04676035|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153409778|NCT04676035|Hemostatics|hemostatics|mesh-ancestor
153409779|NCT04676035|Coagulants|coagulants|mesh-ancestor
153409780|NCT04676035|Vitamins|vitamins|mesh-ancestor
153409781|NCT04676035|Micronutrients|micronutrients|mesh-ancestor
153869235|NCT00564707|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
153869236|NCT00564707|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
153869237|NCT00564707|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
153869238|NCT00564707|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153869239|NCT00564707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153869243|NCT00564707|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
153869244|NCT00564707|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153869245|NCT04606082|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
153869246|NCT04606082|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153869247|NCT04606082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153869249|NCT04605770|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153869250|NCT04605770|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153869251|NCT04605770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153869252|NCT04605770|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153869253|NCT04605770|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153869254|NCT04605887|Angiotensin I (1-7)|angiotensin i (1-7)|mesh-list
153869255|NCT04605887|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153869256|NCT04605887|Vasodilator Agents|vasodilator agents|mesh-ancestor
153869257|NCT04605419|Calcium|calcium|mesh-list
153869258|NCT04605419|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153869259|NCT04605419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153869260|NCT04605575|Vinorelbine|vinorelbine|mesh-list
153869261|NCT04605575|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153409783|NCT04359199|Pembrolizumab|pembrolizumab|mesh-list
153409784|NCT04359199|Nivolumab|nivolumab|mesh-list
153409790|NCT04359199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153409792|NCT00361075|Estrogens|estrogens|mesh-list
153409793|NCT00361075|Progesterone|progesterone|mesh-list
153409794|NCT00361075|Hormones|hormones|mesh-ancestor
153409795|NCT00361075|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153409796|NCT00361075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153409797|NCT00361075|Progestins|progestins|mesh-ancestor
153409798|NCT03844633|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
153409799|NCT03844633|Medroxyprogesterone|medroxyprogesterone|mesh-list
153382807|NCT03496545|Acetaminophen|acetaminophen|mesh-list
153382811|NCT03496545|Sensory System Agents|sensory system agents|mesh-ancestor
153382812|NCT03496545|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153382813|NCT03496545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153382814|NCT03496545|Antipyretics|antipyretics|mesh-ancestor
153382815|NCT03496545|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
153382816|NCT03496545|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
153382817|NCT03496545|Hormone Antagonists|hormone antagonists|mesh-ancestor
153382818|NCT03496545|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153382819|NCT03496545|Dopamine Agonists|dopamine agonists|mesh-ancestor
153382820|NCT03496545|Dopamine Agents|dopamine agents|mesh-ancestor
153409800|NCT03844633|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
153409801|NCT03844633|Contraceptive Agents|contraceptive agents|mesh-ancestor
153409802|NCT03844633|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153409803|NCT03844633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153409804|NCT03844633|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
153409805|NCT03844633|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
153409806|NCT03844633|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153409807|NCT03844633|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153409808|NCT03844633|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
153409809|NCT03844633|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
153409810|NCT03844633|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
153409811|NCT00362089|Dronabinol|dronabinol|mesh-list
153409812|NCT00362089|Hallucinogens|hallucinogens|mesh-ancestor
153869262|NCT04605575|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153869263|NCT04605575|Tubulin Modulators|tubulin modulators|mesh-ancestor
153869264|NCT04605575|Antimitotic Agents|antimitotic agents|mesh-ancestor
153869265|NCT04605575|Mitosis Modulators|mitosis modulators|mesh-ancestor
153869266|NCT04605575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153869267|NCT00589134|Ganirelix|ganirelix|mesh-list
153869268|NCT00589134|Hormone Antagonists|hormone antagonists|mesh-ancestor
153869269|NCT00589134|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153869270|NCT00589134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153869271|NCT00589251|Penicillins|penicillins|mesh-list
153869272|NCT00589251|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153869273|NCT00589251|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153409813|NCT00362089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153869274|NCT00564824|Caffeine|caffeine|mesh-list
153869275|NCT00564824|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
153869276|NCT00564824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153869277|NCT00564824|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
153429990|NCT00002792|Busulfan|busulfan|mesh-list
153869305|NCT00590070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153869306|NCT00590070|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153869307|NCT00590070|Vasodilator Agents|vasodilator agents|mesh-ancestor
153869308|NCT00590070|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
153869309|NCT00590070|Purinergic Agonists|purinergic agonists|mesh-ancestor
153869310|NCT00590070|Purinergic Agents|purinergic agents|mesh-ancestor
153869311|NCT00590070|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153869312|NCT00590070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153869313|NCT00590070|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153869314|NCT00590070|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
153869315|NCT00565019|Triamcinolone|triamcinolone|mesh-list
153869316|NCT00565019|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
153869317|NCT00565019|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
153869318|NCT00565019|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
153869319|NCT00565019|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153869320|NCT00565019|Glucocorticoids|glucocorticoids|mesh-ancestor
153869321|NCT00565019|Hormones|hormones|mesh-ancestor
153869322|NCT00565019|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153869323|NCT00565019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153869324|NCT00565019|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153869325|NCT00565019|Immunologic Factors|immunologic factors|mesh-ancestor
153869326|NCT00565019|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153409849|NCT05444101|Nicotine|nicotine|mesh-list
153409869|NCT05616468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153409870|NCT05616468|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153409871|NCT05616468|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153409872|NCT01352221|Ferric maltol|ferric maltol|mesh-list
153409873|NCT01352221|Hematinics|hematinics|mesh-ancestor
153409874|NCT05195034|Dexmedetomidine|dexmedetomidine|mesh-list
153409875|NCT05195034|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153409876|NCT05195034|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153409877|NCT05195034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153409878|NCT05195034|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153409879|NCT05195034|Analgesics|analgesics|mesh-ancestor
153409880|NCT05195034|Sensory System Agents|sensory system agents|mesh-ancestor
153409881|NCT05195034|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153409882|NCT05195034|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
153409883|NCT05195034|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153409884|NCT05195034|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153869327|NCT00565019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153869328|NCT00565097|Lanreotide|lanreotide|mesh-list
153869329|NCT00565097|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153869330|NCT04604756|Losartan|losartan|mesh-list
153869331|NCT04604756|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153869332|NCT04604756|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153869333|NCT04604756|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
153869334|NCT04604756|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
153869335|NCT04604756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153869336|NCT00590343|Vatalanib|vatalanib|mesh-list
153869337|NCT00590343|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153869338|NCT00590343|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153869339|NCT00590343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153869340|NCT04604678|Metformin|metformin|mesh-list
153869341|NCT04604678|Naltrexone|naltrexone|mesh-list
153869342|NCT04604678|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153869343|NCT04604678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153869344|NCT04604678|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
153869345|NCT04604678|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
153869346|NCT04604678|Sensory System Agents|sensory system agents|mesh-ancestor
153869347|NCT04604678|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153869348|NCT04604327|Bemiparin|bemiparin|mesh-list
153869349|NCT04604327|Anticoagulants|anticoagulants|mesh-ancestor
153869350|NCT00590694|Ranibizumab|ranibizumab|mesh-list
153429991|NCT00002792|Methotrexate|methotrexate|mesh-list
153409903|NCT03518034|Testosterone|testosterone|mesh-list
153409904|NCT03518034|Androgens|androgens|mesh-ancestor
153409905|NCT03518034|Hormones|hormones|mesh-ancestor
153409906|NCT03518034|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153409907|NCT03518034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153409908|NCT02389218|Flecainide|flecainide|mesh-list
153409909|NCT02389218|Sotalol|sotalol|mesh-list
153409910|NCT02389218|Propafenone|propafenone|mesh-list
153409911|NCT02389218|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153409912|NCT02389218|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
153409913|NCT02389218|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153409914|NCT02389218|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153409915|NCT02389218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153409916|NCT02389218|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
153409917|NCT02389218|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
153409918|NCT02389218|Adrenergic Agents|adrenergic agents|mesh-ancestor
153869366|NCT00477165|Citalopram|citalopram|mesh-list
153869367|NCT00477165|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
153869368|NCT00477165|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153869369|NCT00477165|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153869370|NCT00477165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153869371|NCT00477165|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153869372|NCT00477165|Serotonin Agents|serotonin agents|mesh-ancestor
153869373|NCT00477165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153869374|NCT00477165|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
153869375|NCT00477165|Antidepressive Agents|antidepressive agents|mesh-ancestor
153429996|NCT00002792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153869386|NCT00476229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153869387|NCT00476229|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153869388|NCT00476229|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153869389|NCT04603976|Erenumab|erenumab|mesh-list
153869390|NCT04603976|Calcitonin Gene-Related Peptide Receptor Antagonists|calcitonin gene-related peptide receptor antagonists|mesh-ancestor
153869391|NCT04603976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153869392|NCT04603976|Analgesics|analgesics|mesh-ancestor
153869393|NCT04603976|Sensory System Agents|sensory system agents|mesh-ancestor
153869394|NCT04603976|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153409920|NCT02389218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153409921|NCT02389218|Sympatholytics|sympatholytics|mesh-ancestor
153409922|NCT02389218|Autonomic Agents|autonomic agents|mesh-ancestor
153409923|NCT02389218|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153409924|NCT01953120|Abatacept|abatacept|mesh-list
153409925|NCT01953120|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153409926|NCT01953120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153409927|NCT01953120|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153409928|NCT01953120|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153409929|NCT01953120|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153409930|NCT01953120|Immunologic Factors|immunologic factors|mesh-ancestor
153409931|NCT01953120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153409932|NCT01953120|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153409933|NCT01634100|Empagliflozin|empagliflozin|mesh-list
153409934|NCT01634100|Rifampin|rifampin|mesh-list
153409935|NCT01634100|Probenecid|probenecid|mesh-list
153409939|NCT01634100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153409940|NCT01634100|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
153409941|NCT01634100|Antitubercular Agents|antitubercular agents|mesh-ancestor
153409942|NCT01634100|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153409943|NCT01634100|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153409944|NCT01634100|Leprostatic Agents|leprostatic agents|mesh-ancestor
153409945|NCT01634100|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153409946|NCT01634100|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153409947|NCT01634100|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
153409948|NCT01634100|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
153409949|NCT01634100|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
153409950|NCT01634100|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
153869395|NCT04603976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153869396|NCT00476151|Ketamine|ketamine|mesh-list
153869397|NCT00476151|Amitriptyline|amitriptyline|mesh-list
153869398|NCT00476151|Analgesics|analgesics|mesh-ancestor
153869399|NCT00476151|Sensory System Agents|sensory system agents|mesh-ancestor
153409966|NCT04592419|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153409967|NCT04592419|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153409968|NCT04592419|Growth Substances|growth substances|mesh-ancestor
153409969|NCT04592419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153409970|NCT04592419|Growth Inhibitors|growth inhibitors|mesh-ancestor
153409971|NCT04592419|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153409973|NCT00589316|Mycophenolic Acid|mycophenolic acid|mesh-list
153409974|NCT00589316|Cadexomer iodine|cadexomer iodine|mesh-list
153409975|NCT00589316|Cyclophosphamide|cyclophosphamide|mesh-list
153409976|NCT00589316|Fludarabine|fludarabine|mesh-list
153409977|NCT00589316|Fludarabine phosphate|fludarabine phosphate|mesh-list
153409978|NCT00589316|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
153409979|NCT00589316|Tacrolimus|tacrolimus|mesh-list
153869437|NCT00474903|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153869438|NCT00474903|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153869439|NCT00474903|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153869440|NCT00474903|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153869441|NCT00474903|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153869442|NCT00474903|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153869443|NCT00474903|Antipyretics|antipyretics|mesh-ancestor
153869444|NCT01134055|Ranibizumab|ranibizumab|mesh-list
153869445|NCT01134055|Ophthalmic Solutions|ophthalmic solutions|mesh-list
153869446|NCT01134055|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153869447|NCT01134055|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153869448|NCT01134055|Growth Substances|growth substances|mesh-ancestor
153869449|NCT01134055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153869450|NCT01134055|Growth Inhibitors|growth inhibitors|mesh-ancestor
153869451|NCT01134055|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153869452|NCT01134055|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
153869453|NCT00474708|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
153869454|NCT00474708|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
153869455|NCT00474708|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153869457|NCT00474708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153869458|NCT00474708|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153869459|NCT00474708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153869460|NCT00474708|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
153869461|NCT00474708|Antidepressive Agents|antidepressive agents|mesh-ancestor
153869462|NCT00474708|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153869463|NCT00474240|Atorvastatin|atorvastatin|mesh-list
153869464|NCT00474240|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153869465|NCT00474240|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153869466|NCT00474240|Antimetabolites|antimetabolites|mesh-ancestor
153869467|NCT00474240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153869468|NCT00474240|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153869469|NCT00474240|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
153869470|NCT00474240|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153869471|NCT00473889|Paclitaxel|paclitaxel|mesh-list
153869472|NCT00473889|Carboplatin|carboplatin|mesh-list
153869473|NCT00473889|Vorinostat|vorinostat|mesh-list
153869474|NCT00473889|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153869475|NCT00473889|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153869476|NCT00473889|Tubulin Modulators|tubulin modulators|mesh-ancestor
153869477|NCT00473889|Antimitotic Agents|antimitotic agents|mesh-ancestor
153869478|NCT00473889|Mitosis Modulators|mitosis modulators|mesh-ancestor
153409980|NCT00589316|Antibodies|antibodies|mesh-list
153409981|NCT00589316|Immunoglobulins|immunoglobulins|mesh-list
153410004|NCT00362245|Amikacin|amikacin|mesh-list
153869479|NCT00473889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153869480|NCT00473889|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
153869481|NCT00473889|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153869482|NCT00565214|Vitamins|vitamins|mesh-list
153869483|NCT00565214|Vitamin E|vitamin e|mesh-list
153869484|NCT00565214|Selenium|selenium|mesh-list
153869485|NCT00565214|Micronutrients|micronutrients|mesh-ancestor
153869486|NCT00565214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153869487|NCT00565214|Antioxidants|antioxidants|mesh-ancestor
153869488|NCT00565214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153869489|NCT00565214|Protective Agents|protective agents|mesh-ancestor
153869490|NCT00565214|Trace Elements|trace elements|mesh-ancestor
153869491|NCT00565253|Nitric Oxide|nitric oxide|mesh-list
153869492|NCT00565253|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153410029|NCT00003423|Mercaptopurine|mercaptopurine|mesh-list
153410030|NCT00003423|Thioguanine|thioguanine|mesh-list
153410031|NCT00003423|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153410032|NCT00003423|Immunologic Factors|immunologic factors|mesh-ancestor
153410033|NCT00003423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153410034|NCT00003423|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153410035|NCT00003423|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153410036|NCT00003423|Alkylating Agents|alkylating agents|mesh-ancestor
153410037|NCT00003423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153410038|NCT00003423|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153410039|NCT00003423|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153410040|NCT00003423|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153410041|NCT00003423|Antiemetics|antiemetics|mesh-ancestor
153410042|NCT00003423|Autonomic Agents|autonomic agents|mesh-ancestor
153410043|NCT00003423|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153410044|NCT00003423|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153869495|NCT00565253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153869496|NCT00565253|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153869497|NCT00565253|Respiratory System Agents|respiratory system agents|mesh-ancestor
153869498|NCT00565253|Free Radical Scavengers|free radical scavengers|mesh-ancestor
153869499|NCT00565253|Antioxidants|antioxidants|mesh-ancestor
153869500|NCT00565253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153869501|NCT00565253|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153869502|NCT00565253|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
153869503|NCT00565253|Vasodilator Agents|vasodilator agents|mesh-ancestor
153869504|NCT00565253|Gasotransmitters|gasotransmitters|mesh-ancestor
153869505|NCT00565253|Protective Agents|protective agents|mesh-ancestor
153869506|NCT02277600|Darunavir|darunavir|mesh-list
153869507|NCT02277600|Cobicistat|cobicistat|mesh-list
153869508|NCT02277600|Fostemsavir|fostemsavir|mesh-list
153869509|NCT02277600|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
153869510|NCT02277600|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
153869511|NCT02277600|Protease Inhibitors|protease inhibitors|mesh-ancestor
153869512|NCT02277600|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153869513|NCT02277600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153869515|NCT02277600|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153869516|NCT02277600|Antiviral Agents|antiviral agents|mesh-ancestor
153869517|NCT02277600|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153869518|NCT02277600|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
153869519|NCT02277600|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153869520|NCT02277600|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
153869521|NCT02277600|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
153869522|NCT04602143|Testosterone|testosterone|mesh-list
153869523|NCT04602143|Androgens|androgens|mesh-ancestor
153869524|NCT04602143|Hormones|hormones|mesh-ancestor
153869525|NCT04602143|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153869526|NCT04602143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153869527|NCT02277678|Morphine|morphine|mesh-list
153869528|NCT02277678|Oxycodone|oxycodone|mesh-list
153869529|NCT02277678|Analgesics, Opioid|analgesics, opioid|mesh-list
153410061|NCT00003423|Antiviral Agents|antiviral agents|mesh-ancestor
153410062|NCT00003423|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153410063|NCT00003423|Tubulin Modulators|tubulin modulators|mesh-ancestor
153410064|NCT00003423|Antimitotic Agents|antimitotic agents|mesh-ancestor
153410065|NCT00003423|Mitosis Modulators|mitosis modulators|mesh-ancestor
153410066|NCT00003423|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153410067|NCT00003273|Leucovorin|leucovorin|mesh-list
153410068|NCT00003273|Cyclophosphamide|cyclophosphamide|mesh-list
153410069|NCT00003273|Temozolomide|temozolomide|mesh-list
153410070|NCT00003273|Thiotepa|thiotepa|mesh-list
153410071|NCT00003273|Carboplatin|carboplatin|mesh-list
153410072|NCT00003273|Methotrexate|methotrexate|mesh-list
153410073|NCT00003273|Etoposide|etoposide|mesh-list
153410074|NCT00003273|Vincristine|vincristine|mesh-list
153410075|NCT00003273|Levoleucovorin|levoleucovorin|mesh-list
153410076|NCT00003273|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153410077|NCT00003273|Immunologic Factors|immunologic factors|mesh-ancestor
153410078|NCT00003273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153410079|NCT00003273|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153410080|NCT00003273|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153410081|NCT00003273|Alkylating Agents|alkylating agents|mesh-ancestor
153410082|NCT00003273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153410083|NCT00003273|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153410084|NCT00003273|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153869530|NCT02277678|Narcotics|narcotics|mesh-ancestor
153869531|NCT02277678|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153869542|NCT04601675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153869543|NCT04601675|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153869544|NCT04601675|Glucocorticoids|glucocorticoids|mesh-ancestor
153869545|NCT04601675|Hormones|hormones|mesh-ancestor
153869546|NCT04601675|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153869547|NCT04601675|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153869548|NCT04601675|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153410085|NCT00003273|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
153410086|NCT00003273|Abortifacient Agents|abortifacient agents|mesh-ancestor
153869549|NCT04601675|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153869550|NCT04601675|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153869551|NCT04601675|Growth Substances|growth substances|mesh-ancestor
153869552|NCT04601675|Growth Inhibitors|growth inhibitors|mesh-ancestor
153410089|NCT00003273|Antimetabolites|antimetabolites|mesh-ancestor
153869553|NCT00565292|Anacetrapib|anacetrapib|mesh-list
153869554|NCT00565292|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153869555|NCT00565292|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153869556|NCT00565292|Antimetabolites|antimetabolites|mesh-ancestor
153869557|NCT00565292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153869558|NCT00565292|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153869559|NCT01580865|Mycophenolic Acid|mycophenolic acid|mesh-list
153869560|NCT01580865|Tacrolimus|tacrolimus|mesh-list
153869561|NCT01580865|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153869562|NCT01580865|Immunologic Factors|immunologic factors|mesh-ancestor
153869563|NCT01580865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153869564|NCT01580865|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
153869565|NCT01580865|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153869566|NCT01580865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153869567|NCT01580865|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153869568|NCT01580865|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153869569|NCT01580865|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
153869570|NCT01580865|Antitubercular Agents|antitubercular agents|mesh-ancestor
153410124|NCT00383487|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153410125|NCT00383487|Analgesics|analgesics|mesh-ancestor
153410126|NCT00383487|Sensory System Agents|sensory system agents|mesh-ancestor
153869586|NCT00473694|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153869587|NCT00473694|Parasympathomimetics|parasympathomimetics|mesh-ancestor
153869588|NCT00473694|Autonomic Agents|autonomic agents|mesh-ancestor
153869589|NCT00473694|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153869590|NCT00473694|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
153869591|NCT00473694|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
153410128|NCT00383487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153410129|NCT00383487|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153410130|NCT00383487|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153410131|NCT00383487|Gout Suppressants|gout suppressants|mesh-ancestor
153410132|NCT00383487|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153410133|NCT00383487|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153869615|NCT00473382|Growth Inhibitors|growth inhibitors|mesh-ancestor
153869616|NCT00473382|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153869617|NCT02210325|Azithromycin|azithromycin|mesh-list
153869618|NCT02210325|Ceftriaxone|ceftriaxone|mesh-list
153869619|NCT02210325|Solithromycin|solithromycin|mesh-list
153869620|NCT02210325|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153869621|NCT02210325|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153869622|NCT02210325|Third Generation Cephalosporins|third generation cephalosporins|mesh-ancestor
153869623|NCT02210325|Beta Lactam Antibiotics|beta lactam antibiotics|mesh-ancestor
153869624|NCT00473265|Teriparatide|teriparatide|mesh-list
153869625|NCT00473265|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153869636|NCT00472641|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153869637|NCT00472641|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153869638|NCT00472641|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
153410176|NCT00002805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153410177|NCT00002805|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153410178|NCT00002805|Antimetabolites|antimetabolites|mesh-ancestor
153410179|NCT00002805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153410180|NCT00002805|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153410181|NCT00002805|Dermatologic Agents|dermatologic agents|mesh-ancestor
153410182|NCT00002805|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153410183|NCT00002805|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153410184|NCT00002805|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153410185|NCT00002805|Immunologic Factors|immunologic factors|mesh-ancestor
153410207|NCT00003297|Analgesics|analgesics|mesh-ancestor
153410208|NCT00003297|Sensory System Agents|sensory system agents|mesh-ancestor
153410209|NCT00003297|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153410210|NCT00003297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153869658|NCT01133977|Alkylating Agents|alkylating agents|mesh-ancestor
153869659|NCT00583193|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
153869660|NCT00583193|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
153869661|NCT00583193|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153869662|NCT00583193|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153869663|NCT00583193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153869664|NCT00583193|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153869665|NCT00583193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153869666|NCT00583193|Analgesics|analgesics|mesh-ancestor
153869667|NCT00583193|Sensory System Agents|sensory system agents|mesh-ancestor
153869668|NCT00583193|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153869669|NCT00583193|Antidepressive Agents|antidepressive agents|mesh-ancestor
153869670|NCT00583193|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153410211|NCT00003297|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153410212|NCT00003297|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153410213|NCT00003297|Alkylating Agents|alkylating agents|mesh-ancestor
153410214|NCT00003297|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153410215|NCT00003297|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153410216|NCT00003297|Immunologic Factors|immunologic factors|mesh-ancestor
153410217|NCT00003447|Gemcitabine|gemcitabine|mesh-list
153410218|NCT00003447|Vinorelbine|vinorelbine|mesh-list
153410219|NCT00003447|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153869685|NCT00583271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153869686|NCT00583271|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
153869687|NCT00583271|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153869696|NCT01133665|Lenalidomide|lenalidomide|mesh-list
153869697|NCT01133665|Cetuximab|cetuximab|mesh-list
153869698|NCT01133665|Immunologic Factors|immunologic factors|mesh-ancestor
153869699|NCT01133665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153869700|NCT01133665|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153410243|NCT00003465|Alkylating Agents|alkylating agents|mesh-ancestor
153410244|NCT00003465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153410252|NCT00002823|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153410253|NCT00002823|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153410254|NCT00002823|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153410255|NCT00002823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153410256|NCT00002823|Tubulin Modulators|tubulin modulators|mesh-ancestor
153410257|NCT00002823|Antimitotic Agents|antimitotic agents|mesh-ancestor
153410258|NCT00002823|Mitosis Modulators|mitosis modulators|mesh-ancestor
153410259|NCT00361621|Prednisone|prednisone|mesh-list
153410260|NCT00361621|Cyclophosphamide|cyclophosphamide|mesh-list
153410261|NCT00361621|Rituximab|rituximab|mesh-list
153410262|NCT00361621|Doxorubicin|doxorubicin|mesh-list
153869701|NCT01133665|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153382821|NCT03496545|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153382822|NCT03496545|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153382859|NCT01982123|Sequestering Agents|sequestering agents|mesh-ancestor
153382860|NCT01982123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153382861|NCT01982123|Iron Chelating Agents|iron chelating agents|mesh-ancestor
153382862|NCT01982123|Anticoagulants|anticoagulants|mesh-ancestor
153382916|NCT01717898|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153382917|NCT01737944|Methotrexate|methotrexate|mesh-list
153382918|NCT01737944|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
153382919|NCT01737944|Abortifacient Agents|abortifacient agents|mesh-ancestor
153382920|NCT01737944|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153382921|NCT01737944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153382922|NCT01737944|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153382923|NCT01737944|Antimetabolites|antimetabolites|mesh-ancestor
153869702|NCT01133665|Growth Substances|growth substances|mesh-ancestor
153869703|NCT01133665|Growth Inhibitors|growth inhibitors|mesh-ancestor
153869704|NCT01133665|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153869705|NCT01133665|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153869706|NCT00583427|Glucuronyl glucosamine glycan sulfate|glucuronyl glucosamine glycan sulfate|mesh-list
153869707|NCT00583427|Anticoagulants|anticoagulants|mesh-ancestor
153869708|NCT00583427|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153869709|NCT00583427|Antimetabolites|antimetabolites|mesh-ancestor
153869710|NCT00583427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153869711|NCT00583427|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153869712|NCT00583427|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153869713|NCT00583427|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153869714|NCT00583427|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153869715|NCT00583427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153869717|NCT01133626|Beclomethasone|beclomethasone|mesh-list
153869718|NCT01133626|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153410264|NCT00361621|Bortezomib|bortezomib|mesh-list
153410265|NCT00361621|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153410266|NCT00361621|Immunologic Factors|immunologic factors|mesh-ancestor
153869722|NCT01133626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153869723|NCT01133626|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153869725|NCT01133626|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153869726|NCT01133626|Respiratory System Agents|respiratory system agents|mesh-ancestor
153869727|NCT01133392|Insulin|insulin|mesh-list
153869728|NCT01133392|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
153869729|NCT01133392|Insulin Lispro|insulin lispro|mesh-list
153410289|NCT00003327|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153410290|NCT00003327|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153410291|NCT00003327|Tubulin Modulators|tubulin modulators|mesh-ancestor
153410292|NCT00003327|Antimitotic Agents|antimitotic agents|mesh-ancestor
153410293|NCT00003327|Mitosis Modulators|mitosis modulators|mesh-ancestor
153410294|NCT00003327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153869754|NCT02210364|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153869755|NCT00471315|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
153869756|NCT00471315|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
153869757|NCT00471315|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153869758|NCT00471315|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153869759|NCT00471315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153869760|NCT00471315|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153869761|NCT00471315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153869762|NCT00471315|Analgesics|analgesics|mesh-ancestor
153869763|NCT00471315|Sensory System Agents|sensory system agents|mesh-ancestor
153869764|NCT00471315|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153410329|NCT03614221|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153410330|NCT03614221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153410331|NCT00003345|Irinotecan|irinotecan|mesh-list
153410332|NCT00003345|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153410333|NCT00003345|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
153410334|NCT00003345|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153410335|NCT00003345|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153410336|NCT00003345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153410337|NCT03596905|Plecanatide|plecanatide|mesh-list
153410338|NCT03596905|Guanylyl Cyclase C Agonists|guanylyl cyclase c agonists|mesh-ancestor
153410339|NCT03596905|Enzyme Activators|enzyme activators|mesh-ancestor
153869790|NCT04570449|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153869791|NCT04570449|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153869793|NCT00470847|Lapatinib|lapatinib|mesh-list
153869794|NCT00470847|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153869795|NCT00470847|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153410347|NCT00002835|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
153410348|NCT00002835|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
153410349|NCT00002835|Prednisolone|prednisolone|mesh-list
153410350|NCT00002835|Prednisolone acetate|prednisolone acetate|mesh-list
153410351|NCT00002835|Cyclophosphamide|cyclophosphamide|mesh-list
153410352|NCT00002835|Melphalan|melphalan|mesh-list
153410353|NCT00002835|Ifosfamide|ifosfamide|mesh-list
153410354|NCT00002835|Carmustine|carmustine|mesh-list
153410355|NCT00002835|Cisplatin|cisplatin|mesh-list
153410356|NCT00002835|Methotrexate|methotrexate|mesh-list
153410357|NCT00002835|Etoposide|etoposide|mesh-list
153410358|NCT00002835|Vincristine|vincristine|mesh-list
153410359|NCT00002835|Mitoxantrone|mitoxantrone|mesh-list
153410360|NCT00002835|Idarubicin|idarubicin|mesh-list
153410361|NCT00002835|Bleomycin|bleomycin|mesh-list
153410362|NCT00002835|Levoleucovorin|levoleucovorin|mesh-list
153410363|NCT00002835|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
153869813|NCT00584168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153869814|NCT00584168|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153869815|NCT00584168|Glucocorticoids|glucocorticoids|mesh-ancestor
153869816|NCT00584168|Hormones|hormones|mesh-ancestor
153410372|NCT00002835|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153410373|NCT00002835|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153410374|NCT00002835|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
153410388|NCT00002835|Antidotes|antidotes|mesh-ancestor
153410389|NCT00002835|Protective Agents|protective agents|mesh-ancestor
153410390|NCT00002835|Vitamin B Complex|vitamin b complex|mesh-ancestor
153410391|NCT00002835|Vitamins|vitamins|mesh-ancestor
153410392|NCT00002835|Micronutrients|micronutrients|mesh-ancestor
153410394|NCT00002835|Antimitotic Agents|antimitotic agents|mesh-ancestor
153869817|NCT00584168|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153869818|NCT00584168|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153869819|NCT00584168|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153869820|NCT00470535|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
153869821|NCT00470535|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153869822|NCT00470535|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153869823|NCT00470535|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153869824|NCT00470535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153869825|NCT00470535|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153869826|NCT01133275|Prednisone|prednisone|mesh-list
153869827|NCT01133275|Lenalidomide|lenalidomide|mesh-list
153869828|NCT01133275|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153869829|NCT01133275|Glucocorticoids|glucocorticoids|mesh-ancestor
153869830|NCT01133275|Hormones|hormones|mesh-ancestor
153869831|NCT01133275|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153869832|NCT01133275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153869833|NCT01133275|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153869834|NCT01133275|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153869835|NCT01133275|Immunologic Factors|immunologic factors|mesh-ancestor
153869836|NCT01133275|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153869837|NCT01133275|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153869838|NCT01133275|Growth Substances|growth substances|mesh-ancestor
153410407|NCT00002835|Sensory System Agents|sensory system agents|mesh-ancestor
153410408|NCT00002835|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153410410|NCT00003351|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
153410411|NCT00003351|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153410412|NCT00003351|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153410413|NCT00003351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153410414|NCT00003351|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153410415|NCT00361153|Colesevelam Hydrochloride|colesevelam hydrochloride|mesh-list
153410416|NCT00361153|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153410417|NCT00361153|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153410418|NCT00361153|Antimetabolites|antimetabolites|mesh-ancestor
153410419|NCT00361153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153410420|NCT00361153|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153410421|NCT00002847|Interferons|interferons|mesh-list
153410422|NCT00002847|Interferon-alpha|interferon-alpha|mesh-list
153410423|NCT00002847|Aldesleukin|aldesleukin|mesh-list
153410424|NCT00002847|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153410425|NCT00002847|Antiviral Agents|antiviral agents|mesh-ancestor
153869879|NCT00584636|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153869880|NCT00584636|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153869881|NCT00584636|Autonomic Agents|autonomic agents|mesh-ancestor
153869882|NCT00584636|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153869883|NCT00584636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153869884|NCT00584636|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153410442|NCT03576001|Anabolic Agents|anabolic agents|mesh-ancestor
153410443|NCT04220827|Paclitaxel|paclitaxel|mesh-list
153410444|NCT04220827|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
153410445|NCT04220827|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153410446|NCT04220827|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153410447|NCT04220827|Tubulin Modulators|tubulin modulators|mesh-ancestor
153410448|NCT04220827|Antimitotic Agents|antimitotic agents|mesh-ancestor
153410449|NCT04220827|Mitosis Modulators|mitosis modulators|mesh-ancestor
153410450|NCT04220827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153410451|NCT00002865|Leucovorin|leucovorin|mesh-list
153410452|NCT00002865|Cobalt|cobalt|mesh-list
153410453|NCT00002865|Cytarabine|cytarabine|mesh-list
153410454|NCT00002865|Dexamethasone|dexamethasone|mesh-list
153410455|NCT00002865|Hydrocortisone|hydrocortisone|mesh-list
153410457|NCT00002865|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
153410458|NCT00002865|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
153410459|NCT00002865|Cyclophosphamide|cyclophosphamide|mesh-list
153410460|NCT00002865|Ifosfamide|ifosfamide|mesh-list
153410461|NCT00002865|Doxorubicin|doxorubicin|mesh-list
153410462|NCT00002865|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
153869898|NCT00479817|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153869899|NCT00479817|Growth Substances|growth substances|mesh-ancestor
153869900|NCT00479817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153869901|NCT00479817|Growth Inhibitors|growth inhibitors|mesh-ancestor
153869902|NCT04575194|Liraglutide|liraglutide|mesh-list
153869903|NCT04575194|Naltrexone|naltrexone|mesh-list
153410463|NCT00002865|Methotrexate|methotrexate|mesh-list
153410465|NCT00002865|Vincristine|vincristine|mesh-list
153430014|NCT00002792|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153430015|NCT01090141|Micafungin|micafungin|mesh-list
153869905|NCT04575194|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
153869906|NCT04575194|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
153869907|NCT04575194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153869908|NCT04575194|Sensory System Agents|sensory system agents|mesh-ancestor
153869909|NCT04575194|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153869910|NCT04575194|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
153869911|NCT04575194|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153869912|NCT04575194|Incretins|incretins|mesh-ancestor
153869913|NCT04575194|Hormones|hormones|mesh-ancestor
153869914|NCT04575194|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153869915|NCT04575194|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
153869916|NCT04575194|Antidepressive Agents|antidepressive agents|mesh-ancestor
153869917|NCT04575194|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153869918|NCT04575194|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
153410479|NCT00002865|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153410480|NCT00002865|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153410482|NCT00002865|Hormones|hormones|mesh-ancestor
153410483|NCT00002865|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153410484|NCT00002865|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153410485|NCT00002865|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153410486|NCT00002865|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153410487|NCT00002865|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153869929|NCT00478179|Anesthetics|anesthetics|mesh-ancestor
153869930|NCT00478179|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153869931|NCT00478179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153869932|NCT00478179|Sensory System Agents|sensory system agents|mesh-ancestor
153869933|NCT00478179|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153869934|NCT00585143|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
153410496|NCT00002865|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153410497|NCT00002865|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153410499|NCT00002865|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153410513|NCT00361309|Growth Substances|growth substances|mesh-ancestor
153410514|NCT00361309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153410515|NCT00361309|Growth Inhibitors|growth inhibitors|mesh-ancestor
153410516|NCT00361309|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153410517|NCT00361309|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153410518|NCT00361309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153410520|NCT04154943|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153410521|NCT04154943|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153410522|NCT00361387|Methylphenidate|methylphenidate|mesh-list
153410523|NCT00361387|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
153410524|NCT00361387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153869946|NCT00585260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153869948|NCT00475020|Fludarabine phosphate|fludarabine phosphate|mesh-list
153410540|NCT04342351|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
153410541|NCT04342351|Protease Inhibitors|protease inhibitors|mesh-ancestor
153869963|NCT00585455|Antidepressive Agents|antidepressive agents|mesh-ancestor
153869964|NCT00585455|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153869965|NCT00585455|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
153869967|NCT00585455|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153869968|NCT00585455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153869969|NCT00585455|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153869970|NCT00585455|Serotonin Agents|serotonin agents|mesh-ancestor
153869971|NCT00585455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153869972|NCT01132807|Prednisone|prednisone|mesh-list
153869973|NCT01132807|Cyclophosphamide|cyclophosphamide|mesh-list
153869974|NCT01132807|Dacarbazine|dacarbazine|mesh-list
153869975|NCT01132807|Doxorubicin|doxorubicin|mesh-list
153869976|NCT01132807|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
153869977|NCT01132807|Etoposide|etoposide|mesh-list
153869978|NCT01132807|Bleomycin|bleomycin|mesh-list
153869979|NCT01132807|Vinblastine|vinblastine|mesh-list
153869980|NCT01132807|Etoposide phosphate|etoposide phosphate|mesh-list
153869981|NCT01132807|Procarbazine|procarbazine|mesh-list
153869982|NCT01132807|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
153869983|NCT01132807|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153869984|NCT01132807|Immunologic Factors|immunologic factors|mesh-ancestor
153869985|NCT01132807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153410565|NCT03498391|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153410566|NCT03498391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153410567|NCT03498391|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153410568|NCT03498391|Anesthetics, General|anesthetics, general|mesh-ancestor
153410569|NCT03498391|Anesthetics|anesthetics|mesh-ancestor
153410570|NCT03498391|Analgesics|analgesics|mesh-ancestor
153410571|NCT03498391|Sensory System Agents|sensory system agents|mesh-ancestor
153410572|NCT03498391|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153410573|NCT03498391|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
153410574|NCT03498391|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
153410575|NCT03498391|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
153410576|NCT03498391|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153410577|NCT03498391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153410578|NCT00003939|Trabectedin|trabectedin|mesh-list
153410579|NCT00003939|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153410580|NCT00003939|Alkylating Agents|alkylating agents|mesh-ancestor
153870003|NCT01132807|Tubulin Modulators|tubulin modulators|mesh-ancestor
153870004|NCT01132807|Antimitotic Agents|antimitotic agents|mesh-ancestor
153870005|NCT01132807|Mitosis Modulators|mitosis modulators|mesh-ancestor
153870006|NCT04569513|Parathyroid Hormone|parathyroid hormone|mesh-list
153870007|NCT04569513|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153870008|NCT04569513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153870009|NCT01089543|Rabeprazole|rabeprazole|mesh-list
153870010|NCT01089543|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
153870011|NCT01089543|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153870012|NCT01089543|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
153870013|NCT01089543|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153870014|NCT01089543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153870015|NCT04569630|Hypoglycemic Agents|hypoglycemic agents|mesh-list
153870016|NCT04569630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153870017|NCT01089504|Phenobarbital|phenobarbital|mesh-list
153870018|NCT01089504|Anticonvulsants|anticonvulsants|mesh-ancestor
153410581|NCT00003939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153410582|NCT00003939|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153410583|NCT00003543|Fluorouracil|fluorouracil|mesh-list
153410584|NCT00003543|Vincristine|vincristine|mesh-list
153410585|NCT00003543|Carmustine|carmustine|mesh-list
153410586|NCT00003543|Streptozocin|streptozocin|mesh-list
153410587|NCT00003543|Antibodies|antibodies|mesh-list
153410588|NCT00003543|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
153410589|NCT00003543|Immunologic Factors|immunologic factors|mesh-ancestor
153410590|NCT00003543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153870045|NCT00586118|Sevoflurane|sevoflurane|mesh-list
153870046|NCT00586118|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153870047|NCT00586118|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153870048|NCT00586118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153870049|NCT00586118|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153870050|NCT00586118|Anesthetics, General|anesthetics, general|mesh-ancestor
153870051|NCT00586118|Anesthetics|anesthetics|mesh-ancestor
153870052|NCT00586118|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153870053|NCT00586118|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
153410628|NCT00002883|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153410630|NCT00002883|Immunologic Factors|immunologic factors|mesh-ancestor
153410631|NCT00002883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153410633|NCT03492463|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
153410634|NCT03492463|Autonomic Agents|autonomic agents|mesh-ancestor
153410650|NCT00003951|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153410651|NCT00003951|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153410652|NCT00003951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153410653|NCT00003951|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153410654|NCT00003957|Cytarabine|cytarabine|mesh-list
153410655|NCT00003957|Paclitaxel|paclitaxel|mesh-list
153410656|NCT00003957|Etoposide|etoposide|mesh-list
153410657|NCT00003957|Cyclophosphamide|cyclophosphamide|mesh-list
153410658|NCT00003957|Melphalan|melphalan|mesh-list
153410659|NCT00003957|Mitoxantrone|mitoxantrone|mesh-list
153410660|NCT00003957|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153410661|NCT00003957|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153410662|NCT00003957|Tubulin Modulators|tubulin modulators|mesh-ancestor
153870067|NCT01088529|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153870068|NCT01088529|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153870069|NCT01088529|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153870070|NCT01088529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153870071|NCT01088529|Hormone Antagonists|hormone antagonists|mesh-ancestor
153870072|NCT01088529|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153870073|NCT00586274|Fludarabine|fludarabine|mesh-list
153870074|NCT00586274|Alemtuzumab|alemtuzumab|mesh-list
153870075|NCT00586274|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153870076|NCT00586274|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153870078|NCT00586430|Anticonvulsants|anticonvulsants|mesh-ancestor
153870079|NCT00586430|Antiemetics|antiemetics|mesh-ancestor
153870080|NCT00586430|Autonomic Agents|autonomic agents|mesh-ancestor
153870081|NCT00586430|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153870082|NCT00586430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153870083|NCT00586430|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153870094|NCT04569279|Rivaroxaban|rivaroxaban|mesh-list
153410675|NCT00003957|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153410676|NCT00003957|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153410677|NCT00003957|Antimetabolites|antimetabolites|mesh-ancestor
153410678|NCT00003957|Antiviral Agents|antiviral agents|mesh-ancestor
153410679|NCT00003957|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153410680|NCT00003957|Analgesics|analgesics|mesh-ancestor
153410681|NCT00003957|Sensory System Agents|sensory system agents|mesh-ancestor
153410682|NCT00003957|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153870116|NCT04312282|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153870117|NCT04312282|Hormone Antagonists|hormone antagonists|mesh-ancestor
153870118|NCT04312282|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153870119|NCT04312282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153870120|NCT04312282|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
153870121|NCT04312282|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
153870129|NCT04312282|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
153870130|NCT04312282|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
153870131|NCT04312282|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
153870132|NCT01087905|Nicotine|nicotine|mesh-list
153870137|NCT01087905|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
153410708|NCT00003963|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153410709|NCT00003963|Tubulin Modulators|tubulin modulators|mesh-ancestor
153410710|NCT00003963|Antimitotic Agents|antimitotic agents|mesh-ancestor
153410711|NCT00003963|Mitosis Modulators|mitosis modulators|mesh-ancestor
153410712|NCT00003963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153410715|NCT00004845|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153410716|NCT00004845|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153410717|NCT00004845|Analgesics|analgesics|mesh-ancestor
153410718|NCT00004845|Sensory System Agents|sensory system agents|mesh-ancestor
153410719|NCT00004845|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153410720|NCT00004845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153410721|NCT00004845|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153410722|NCT00004845|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153410723|NCT00004845|Gout Suppressants|gout suppressants|mesh-ancestor
153410724|NCT00004845|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153410725|NCT00004845|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153410726|NCT00004845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153410727|NCT00004845|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
153870138|NCT01087905|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
153870139|NCT01087905|Cholinergic Agents|cholinergic agents|mesh-ancestor
153870140|NCT01087905|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153870141|NCT01087905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153870142|NCT01087788|Certolizumab Pegol|certolizumab pegol|mesh-list
153870143|NCT01087788|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
153870144|NCT01087788|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153870145|NCT01087788|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153410735|NCT00003993|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153410736|NCT00003993|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153410737|NCT00003993|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153410738|NCT00003993|Antiviral Agents|antiviral agents|mesh-ancestor
153410739|NCT00003993|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153410740|NCT00003993|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153410741|NCT00003993|Immunologic Factors|immunologic factors|mesh-ancestor
153410742|NCT00003993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153410743|NCT00004857|Fludarabine|fludarabine|mesh-list
153410744|NCT00004857|Fludarabine phosphate|fludarabine phosphate|mesh-list
153410745|NCT00004857|Alemtuzumab|alemtuzumab|mesh-list
153410746|NCT00004857|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153410747|NCT00004857|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153410748|NCT00004857|Antimetabolites|antimetabolites|mesh-ancestor
153870170|NCT04568772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153870171|NCT04568772|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153870173|NCT04568772|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153870174|NCT04568772|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153870175|NCT04568772|Antimetabolites|antimetabolites|mesh-ancestor
153870176|NCT04575389|Uric Acid|uric acid|mesh-list
153870177|NCT04575389|Antioxidants|antioxidants|mesh-ancestor
153870178|NCT04575389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153870179|NCT04575389|Protective Agents|protective agents|mesh-ancestor
153410749|NCT00004857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153410751|NCT00004857|Immunologic Factors|immunologic factors|mesh-ancestor
153410752|NCT00004857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153410753|NCT00004857|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153410754|NCT03476239|Blinatumomab|blinatumomab|mesh-list
153410765|NCT00004875|Anticoagulants|anticoagulants|mesh-ancestor
153410766|NCT00004875|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153870180|NCT04575389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153870182|NCT01086150|Anesthetics, Local|anesthetics, local|mesh-ancestor
153870183|NCT01086150|Anesthetics|anesthetics|mesh-ancestor
153870184|NCT01086150|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153870185|NCT01086150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153870186|NCT01086150|Sensory System Agents|sensory system agents|mesh-ancestor
153870187|NCT01086150|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153870188|NCT01086150|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153870189|NCT01086150|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
153870190|NCT01086150|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153870191|NCT01086150|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153870192|NCT01086150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153870193|NCT00587249|Aluminum Hydroxide|aluminum hydroxide|mesh-list
153870194|NCT00587249|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153870195|NCT00587249|Immunologic Factors|immunologic factors|mesh-ancestor
153410767|NCT00004875|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153410768|NCT00004875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153410769|NCT00003561|Interferons|interferons|mesh-list
153410770|NCT00003561|Interferon-alpha|interferon-alpha|mesh-list
153410771|NCT00003561|Sargramostim|sargramostim|mesh-list
153410772|NCT00003561|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153410773|NCT00003561|Antiviral Agents|antiviral agents|mesh-ancestor
153410774|NCT00003561|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153410794|NCT00003573|Immunologic Factors|immunologic factors|mesh-ancestor
153410795|NCT00003573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153410796|NCT00003573|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153870196|NCT00587249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153870198|NCT00587249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153870199|NCT00587249|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153870200|NCT00587327|Atosiban|atosiban|mesh-list
153870201|NCT00587327|Hormone Antagonists|hormone antagonists|mesh-ancestor
153870202|NCT00587327|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153870203|NCT00587327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153870204|NCT00587327|Tocolytic Agents|tocolytic agents|mesh-ancestor
153870205|NCT00587327|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153870206|NCT00587444|Heparin|heparin|mesh-list
153870207|NCT00587444|Calcium heparin|calcium heparin|mesh-list
153870208|NCT00587444|Anticoagulants|anticoagulants|mesh-ancestor
153870209|NCT00587444|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153870210|NCT00587444|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153870211|NCT00587444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153870212|NCT02278302|Ethanol|ethanol|mesh-list
153870213|NCT02278302|Aspirin, Dipyridamole Drug Combination|aspirin, dipyridamole drug combination|mesh-list
153870214|NCT02278302|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
153870215|NCT02278302|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153870216|NCT02278302|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153870217|NCT02278302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153870218|NCT02278302|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153870219|NCT01085136|Afatinib|afatinib|mesh-list
153870220|NCT01085136|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153870221|NCT01085136|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153870222|NCT01085136|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153410797|NCT00003573|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153410805|NCT00003573|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153410806|NCT00003573|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153410807|NCT00003573|Tubulin Modulators|tubulin modulators|mesh-ancestor
153410808|NCT00003573|Antimitotic Agents|antimitotic agents|mesh-ancestor
153410809|NCT00003573|Mitosis Modulators|mitosis modulators|mesh-ancestor
153410810|NCT00003585|Interferons|interferons|mesh-list
153410811|NCT00003585|Interferon-alpha|interferon-alpha|mesh-list
153410812|NCT00003585|Aldesleukin|aldesleukin|mesh-list
153410813|NCT00003585|Fluorouracil|fluorouracil|mesh-list
153410814|NCT00003585|Isotretinoin|isotretinoin|mesh-list
153870233|NCT00587873|Abortifacient Agents|abortifacient agents|mesh-ancestor
153870234|NCT00587873|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153870235|NCT00587873|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153870236|NCT00587873|Antimetabolites|antimetabolites|mesh-ancestor
153870237|NCT00587873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153870238|NCT00587873|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153870239|NCT00587873|Dermatologic Agents|dermatologic agents|mesh-ancestor
153410816|NCT00003585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153410817|NCT00003585|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153410818|NCT00003585|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153410819|NCT00003585|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153410820|NCT00003585|Immunologic Factors|immunologic factors|mesh-ancestor
153410821|NCT00003585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153410822|NCT00003585|Antiviral Agents|antiviral agents|mesh-ancestor
153410823|NCT00003585|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153410824|NCT00003585|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153870240|NCT00587873|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153870241|NCT00587873|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153870242|NCT00587873|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153870243|NCT00587873|Immunologic Factors|immunologic factors|mesh-ancestor
153870244|NCT00587873|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153870245|NCT00587873|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153870246|NCT00587873|Antidotes|antidotes|mesh-ancestor
153870247|NCT00587873|Protective Agents|protective agents|mesh-ancestor
153870258|NCT01084707|Cholinergic Agents|cholinergic agents|mesh-ancestor
153410833|NCT00003591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153410835|NCT02975323|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
153410836|NCT02975323|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
153410837|NCT02975323|Adrenergic Agents|adrenergic agents|mesh-ancestor
153410838|NCT02975323|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153410839|NCT02975323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153410840|NCT02975323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153410841|NCT02975323|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153410842|NCT02975323|Antioxidants|antioxidants|mesh-ancestor
153410843|NCT02975323|Protective Agents|protective agents|mesh-ancestor
153410844|NCT02975323|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153888919|NCT01023061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153888920|NCT01023061|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153888921|NCT01023061|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153888922|NCT01023061|Fertility Agents, Female|fertility agents, female|mesh-ancestor
153888923|NCT01023061|Fertility Agents|fertility agents|mesh-ancestor
153888924|NCT01023061|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153888925|NCT01023061|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153888926|NCT01023061|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153888928|NCT01023061|Hormone Antagonists|hormone antagonists|mesh-ancestor
153870259|NCT01084707|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153870260|NCT01084707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153870261|NCT02210598|Oxytocin|oxytocin|mesh-list
153870262|NCT02210598|Oxytocics|oxytocics|mesh-ancestor
153870263|NCT02210598|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153870264|NCT02210598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153870265|NCT03452657|Ranibizumab|ranibizumab|mesh-list
153870266|NCT03452657|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153870267|NCT03452657|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153870268|NCT03452657|Growth Substances|growth substances|mesh-ancestor
153870269|NCT03452657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153870270|NCT03452657|Growth Inhibitors|growth inhibitors|mesh-ancestor
153410845|NCT02975323|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153410846|NCT02975323|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153410868|NCT00004005|Calcium|calcium|mesh-list
153410869|NCT00004005|Levoleucovorin|levoleucovorin|mesh-list
153410870|NCT00004005|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153410871|NCT00004005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153410872|NCT00004005|Antimetabolites|antimetabolites|mesh-ancestor
153410873|NCT00004005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153410874|NCT00004005|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153410875|NCT00004005|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153410882|NCT00004005|Protective Agents|protective agents|mesh-ancestor
153410883|NCT00004005|Vitamin B Complex|vitamin b complex|mesh-ancestor
153410885|NCT00004005|Micronutrients|micronutrients|mesh-ancestor
153410886|NCT00003603|Dexamethasone|dexamethasone|mesh-list
153870302|NCT01083810|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153870303|NCT01083810|Antiviral Agents|antiviral agents|mesh-ancestor
153870304|NCT01083810|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153870305|NCT01083810|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
153870306|NCT01083810|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153870307|NCT00588926|Remifentanil|remifentanil|mesh-list
153870308|NCT00588926|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153870309|NCT00588926|Narcotics|narcotics|mesh-ancestor
153870310|NCT00588926|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153410887|NCT00003603|Prednisolone|prednisolone|mesh-list
153410888|NCT00003603|Cyclophosphamide|cyclophosphamide|mesh-list
153410889|NCT00003603|Melphalan|melphalan|mesh-list
153410903|NCT00003603|Autonomic Agents|autonomic agents|mesh-ancestor
153410904|NCT00003603|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153410905|NCT00003603|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153410906|NCT00003603|Glucocorticoids|glucocorticoids|mesh-ancestor
153410907|NCT00003603|Hormones|hormones|mesh-ancestor
153870326|NCT00589238|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
153870327|NCT00589238|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153870328|NCT00589238|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153870329|NCT00589238|Tubulin Modulators|tubulin modulators|mesh-ancestor
153870330|NCT00589238|Antimitotic Agents|antimitotic agents|mesh-ancestor
153410908|NCT00003603|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153410909|NCT00003603|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153410910|NCT00003603|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153410911|NCT00003603|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153410912|NCT00003603|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153410913|NCT00003603|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153410914|NCT00004887|Paclitaxel|paclitaxel|mesh-list
153410915|NCT00004887|Vinblastine|vinblastine|mesh-list
153410916|NCT00004887|Carboplatin|carboplatin|mesh-list
153410917|NCT00004887|Ifosfamide|ifosfamide|mesh-list
153410918|NCT00004887|Mitomycins|mitomycins|mesh-list
153870331|NCT00589238|Mitosis Modulators|mitosis modulators|mesh-ancestor
153870332|NCT00589238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153870333|NCT00589238|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153870334|NCT00589238|Immunologic Factors|immunologic factors|mesh-ancestor
153870335|NCT00589238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153870336|NCT00589238|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153870337|NCT00589238|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153870338|NCT00589238|Alkylating Agents|alkylating agents|mesh-ancestor
153870339|NCT00589238|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153870340|NCT00589238|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153410936|NCT00004893|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153410937|NCT00004893|Growth Substances|growth substances|mesh-ancestor
153410938|NCT00004893|Growth Inhibitors|growth inhibitors|mesh-ancestor
153410939|NCT00004893|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153410940|NCT00004011|Paclitaxel|paclitaxel|mesh-list
153410941|NCT00004011|Carboplatin|carboplatin|mesh-list
153410942|NCT00004011|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153410943|NCT00004011|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153410956|NCT00004905|Etoposide|etoposide|mesh-list
153410957|NCT00004905|Idarubicin|idarubicin|mesh-list
153410958|NCT00004905|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153410959|NCT00004905|Immunologic Factors|immunologic factors|mesh-ancestor
153870353|NCT01083576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153870354|NCT01083576|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153870355|NCT01083576|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153870356|NCT04568265|Entecavir|entecavir|mesh-list
153870357|NCT04568265|Antiviral Agents|antiviral agents|mesh-ancestor
153870358|NCT04568265|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153870359|NCT04568304|Carboplatin|carboplatin|mesh-list
153870360|NCT04568304|Gemcitabine|gemcitabine|mesh-list
153870361|NCT04568304|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153870362|NCT04568304|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153870363|NCT04568304|Antimetabolites|antimetabolites|mesh-ancestor
153870364|NCT04568304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153870365|NCT01082640|Febuxostat|febuxostat|mesh-list
153870366|NCT01082640|Gout Suppressants|gout suppressants|mesh-ancestor
153870367|NCT01082640|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153870368|NCT00589862|Clopidogrel|clopidogrel|mesh-list
153870369|NCT00589862|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153870370|NCT00589862|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
153870371|NCT00589862|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
153870372|NCT00589862|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
153870373|NCT00589862|Purinergic Agents|purinergic agents|mesh-ancestor
153870375|NCT00589862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153870376|NCT00589862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153870377|NCT00589901|Cyclophosphamide|cyclophosphamide|mesh-list
153870379|NCT00589901|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153410969|NCT00004905|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153410970|NCT00004905|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153410971|NCT00004905|Antiviral Agents|antiviral agents|mesh-ancestor
153410972|NCT00004905|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153410973|NCT00004905|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153410974|NCT00004905|Antimetabolites|antimetabolites|mesh-ancestor
153410975|NCT00004905|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153410976|NCT00004029|Sargramostim|sargramostim|mesh-list
153410977|NCT00004029|Vaccines|vaccines|mesh-list
153410978|NCT00004029|Immunologic Factors|immunologic factors|mesh-ancestor
153410979|NCT00004029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153410980|NCT00362323|Metformin|metformin|mesh-list
153410981|NCT00362323|Fenofibrate|fenofibrate|mesh-list
153410982|NCT00362323|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153410983|NCT00362323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153410984|NCT00362323|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153410985|NCT00362323|Antimetabolites|antimetabolites|mesh-ancestor
153410986|NCT00362323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153410987|NCT00362323|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153410988|NCT00004917|Epoetin Alfa|epoetin alfa|mesh-list
153410989|NCT00004917|Hematinics|hematinics|mesh-ancestor
153410990|NCT00421915|Etanercept|etanercept|mesh-list
153410991|NCT00421915|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153410992|NCT00421915|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153410993|NCT00421915|Analgesics|analgesics|mesh-ancestor
153410994|NCT00421915|Sensory System Agents|sensory system agents|mesh-ancestor
153870380|NCT00589901|Immunologic Factors|immunologic factors|mesh-ancestor
153870381|NCT00589901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153870382|NCT00589901|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153870383|NCT00589901|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153870384|NCT00589901|Alkylating Agents|alkylating agents|mesh-ancestor
153870385|NCT00589901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153870386|NCT00589901|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153870389|NCT00589901|Antimetabolites|antimetabolites|mesh-ancestor
153870390|NCT00590174|Aspirin|aspirin|mesh-list
153870391|NCT00590174|Clopidogrel|clopidogrel|mesh-list
153870392|NCT00590174|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153870393|NCT00590174|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153870394|NCT00590174|Analgesics|analgesics|mesh-ancestor
153870395|NCT00590174|Sensory System Agents|sensory system agents|mesh-ancestor
153870396|NCT00590174|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153870397|NCT00590174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153870398|NCT00590174|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153870399|NCT00590174|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153870400|NCT00590174|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153870403|NCT00590174|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153870404|NCT00590174|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153870405|NCT00590174|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153870406|NCT00590174|Antipyretics|antipyretics|mesh-ancestor
153870407|NCT00590174|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
153870408|NCT00590174|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
153870409|NCT00590174|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
153870410|NCT00590174|Purinergic Agents|purinergic agents|mesh-ancestor
153870411|NCT00590174|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153410995|NCT00421915|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153410996|NCT00421915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153411006|NCT00362713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153411010|NCT00004047|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153411011|NCT00004047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153411012|NCT00004047|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153411014|NCT00003627|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153411015|NCT00003627|Antimetabolites|antimetabolites|mesh-ancestor
153411016|NCT00003627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153411017|NCT00003627|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153411018|NCT00003627|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153411019|NCT00003627|Immunologic Factors|immunologic factors|mesh-ancestor
153411020|NCT00003627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153411021|NCT00004059|Fluorouracil|fluorouracil|mesh-list
153870412|NCT00590213|Bicalutamide|bicalutamide|mesh-list
153870413|NCT00590213|Androgen Antagonists|androgen antagonists|mesh-ancestor
153870414|NCT00590213|Hormone Antagonists|hormone antagonists|mesh-ancestor
153870415|NCT00590213|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153870416|NCT00590213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153870417|NCT00590213|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153870418|NCT00590408|Ubiquinone|ubiquinone|mesh-list
153870419|NCT00590408|Coenzyme Q10|coenzyme q10|mesh-list
153870420|NCT00590408|Micronutrients|micronutrients|mesh-ancestor
153870421|NCT00590408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153870422|NCT00590408|Vitamins|vitamins|mesh-ancestor
153870423|NCT00590447|Rituximab|rituximab|mesh-list
153870432|NCT01081626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153870433|NCT01080768|Amlodipine|amlodipine|mesh-list
153870434|NCT01080768|Aliskiren|aliskiren|mesh-list
153870435|NCT01080768|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153870436|NCT01080768|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153870437|NCT01080768|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153870438|NCT01080768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153411023|NCT00004059|Antimetabolites|antimetabolites|mesh-ancestor
153411024|NCT00004059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153411025|NCT00004059|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153411026|NCT00004059|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153411027|NCT00004059|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153411028|NCT00004059|Immunologic Factors|immunologic factors|mesh-ancestor
153411029|NCT00004059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153411030|NCT00004059|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153411032|NCT00003633|Prednisone|prednisone|mesh-list
153411036|NCT00003633|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153411037|NCT00003633|Tubulin Modulators|tubulin modulators|mesh-ancestor
153411038|NCT00003633|Antimitotic Agents|antimitotic agents|mesh-ancestor
153411039|NCT00003633|Mitosis Modulators|mitosis modulators|mesh-ancestor
153411040|NCT00003633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153411041|NCT00003633|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153411042|NCT00003633|Glucocorticoids|glucocorticoids|mesh-ancestor
153411044|NCT00003633|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153411045|NCT00003633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153411046|NCT00003633|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153411047|NCT00003633|Analgesics|analgesics|mesh-ancestor
153411048|NCT00003633|Sensory System Agents|sensory system agents|mesh-ancestor
153411049|NCT00003633|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153411050|NCT00003633|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153411051|NCT00003633|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153411052|NCT00003633|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153411053|NCT00003633|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153411054|NCT00003633|Alkylating Agents|alkylating agents|mesh-ancestor
153411055|NCT00003639|Interferons|interferons|mesh-list
153411056|NCT00003639|Interferon-alpha|interferon-alpha|mesh-list
153411057|NCT00003639|Dexamethasone|dexamethasone|mesh-list
153870439|NCT01080768|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153870440|NCT01080768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153430066|NCT05594407|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153430067|NCT05594407|Narcotics|narcotics|mesh-ancestor
153870458|NCT01080300|Analgesics|analgesics|mesh-ancestor
153870459|NCT01080300|Sensory System Agents|sensory system agents|mesh-ancestor
153870460|NCT01080300|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153870461|NCT01080300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153870462|NCT01080300|Anticonvulsants|anticonvulsants|mesh-ancestor
153870463|NCT01080300|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153870464|NCT01080300|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153870465|NCT01080300|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153870466|NCT01080300|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153870467|NCT01080300|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
153870468|NCT01080300|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
153870469|NCT01080300|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153870470|NCT01080300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153870471|NCT01080300|Antimanic Agents|antimanic agents|mesh-ancestor
153870472|NCT00590603|Ascorbic Acid|ascorbic acid|mesh-list
153411059|NCT00003639|Chlorambucil|chlorambucil|mesh-list
153411060|NCT00003639|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153411061|NCT00003639|Antiemetics|antiemetics|mesh-ancestor
153411062|NCT00003639|Autonomic Agents|autonomic agents|mesh-ancestor
153411063|NCT00003639|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153411064|NCT00003639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153411065|NCT00003639|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153411066|NCT00003639|Glucocorticoids|glucocorticoids|mesh-ancestor
153411067|NCT00003639|Hormones|hormones|mesh-ancestor
153411068|NCT00003639|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153411069|NCT00003639|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153411070|NCT00003639|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153411071|NCT00003639|Antiviral Agents|antiviral agents|mesh-ancestor
153411072|NCT00003639|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153411073|NCT00003639|Immunologic Factors|immunologic factors|mesh-ancestor
153411074|NCT00003639|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153411075|NCT00003639|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153411081|NCT00004923|Docetaxel|docetaxel|mesh-list
153411082|NCT00004923|Irinotecan|irinotecan|mesh-list
153411083|NCT00004923|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153411084|NCT00004923|Tubulin Modulators|tubulin modulators|mesh-ancestor
153411085|NCT00004923|Antimitotic Agents|antimitotic agents|mesh-ancestor
153411086|NCT00004923|Mitosis Modulators|mitosis modulators|mesh-ancestor
153411087|NCT00004923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153411088|NCT00004923|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
153411089|NCT00004923|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153411090|NCT00004923|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153411091|NCT00004071|Prednisone|prednisone|mesh-list
153411092|NCT00004071|Mitoxantrone|mitoxantrone|mesh-list
153411093|NCT00004071|Leflunomide|leflunomide|mesh-list
153411094|NCT00004071|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153411095|NCT00004071|Glucocorticoids|glucocorticoids|mesh-ancestor
153411096|NCT00004071|Hormones|hormones|mesh-ancestor
153411097|NCT00004071|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153411098|NCT00004071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153411099|NCT00004071|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153411100|NCT00004071|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153411101|NCT00004071|Analgesics|analgesics|mesh-ancestor
153411102|NCT00004071|Sensory System Agents|sensory system agents|mesh-ancestor
153411103|NCT00004071|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153411104|NCT00004071|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153411105|NCT00004071|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153870493|NCT01085097|Hormones|hormones|mesh-ancestor
153888974|NCT01294449|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153888975|NCT01294449|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153888976|NCT01294449|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
153411125|NCT00004941|Immunologic Factors|immunologic factors|mesh-ancestor
153870571|NCT01081782|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153870572|NCT01081782|Immunologic Factors|immunologic factors|mesh-ancestor
153870573|NCT01081782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153411164|NCT00004095|Gemcitabine|gemcitabine|mesh-list
153411165|NCT00004095|Irinotecan|irinotecan|mesh-list
153411166|NCT00004095|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153411167|NCT00004095|Antimetabolites|antimetabolites|mesh-ancestor
153411168|NCT00004095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153411169|NCT00004095|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153411170|NCT00004095|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
153411171|NCT00004095|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153411172|NCT00004095|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153411173|NCT00003663|Dexamethasone|dexamethasone|mesh-list
153411174|NCT00003663|Rituximab|rituximab|mesh-list
153411175|NCT00003663|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153411176|NCT00003663|Antiemetics|antiemetics|mesh-ancestor
153411177|NCT00003663|Autonomic Agents|autonomic agents|mesh-ancestor
153411178|NCT00003663|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153411179|NCT00003663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153411180|NCT00003663|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153411181|NCT00003663|Glucocorticoids|glucocorticoids|mesh-ancestor
153411182|NCT00003663|Hormones|hormones|mesh-ancestor
153411183|NCT00003663|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153411184|NCT00003663|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153870598|NCT02210754|Glycerol|glycerol|mesh-list
153870599|NCT02210754|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
153870600|NCT02210754|Autonomic Agents|autonomic agents|mesh-ancestor
153870601|NCT02210754|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153870602|NCT02210754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153870603|NCT02210754|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
153870604|NCT02210754|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
153411194|NCT00004107|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153870614|NCT02210871|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153411226|NCT00005007|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153870615|NCT02210871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153870616|NCT04574141|Melatonin|melatonin|mesh-list
153870617|NCT04574141|Antioxidants|antioxidants|mesh-ancestor
153870618|NCT04574141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153870619|NCT04574141|Protective Agents|protective agents|mesh-ancestor
153870620|NCT04574141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153870621|NCT04574141|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153870622|NCT04998981|Fenofibrate|fenofibrate|mesh-list
153870623|NCT04998981|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153870624|NCT04998981|Antimetabolites|antimetabolites|mesh-ancestor
153870625|NCT04998981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153870626|NCT04998981|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153870627|NCT04573049|Simendan|simendan|mesh-list
153870628|NCT04573049|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
153870629|NCT04573049|Vasodilator Agents|vasodilator agents|mesh-ancestor
153870630|NCT04573049|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
153870631|NCT04573049|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
153870632|NCT04573049|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153870633|NCT04573049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153870634|NCT04573049|Protective Agents|protective agents|mesh-ancestor
153870635|NCT04573049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153870636|NCT04572698|Endothelial Growth Factors|endothelial growth factors|mesh-list
153870637|NCT04572698|Growth Substances|growth substances|mesh-ancestor
153870638|NCT04572698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153870639|NCT04572542|Paclitaxel|paclitaxel|mesh-list
153870640|NCT04572542|Apatinib|apatinib|mesh-list
153870641|NCT04572542|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153870642|NCT04572542|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153870643|NCT04572542|Tubulin Modulators|tubulin modulators|mesh-ancestor
153870644|NCT04572542|Antimitotic Agents|antimitotic agents|mesh-ancestor
153870645|NCT04572542|Mitosis Modulators|mitosis modulators|mesh-ancestor
153411238|NCT00384579|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
153411239|NCT00384579|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153411240|NCT00384579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153411241|NCT00384579|Cholinergic Agents|cholinergic agents|mesh-ancestor
153411242|NCT00384579|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153411243|NCT00384579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153411244|NCT00004149|Arsenic Trioxide|arsenic trioxide|mesh-list
153870651|NCT04572620|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153870652|NCT04572620|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153870653|NCT04572620|Immunologic Factors|immunologic factors|mesh-ancestor
153870654|NCT04572620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153870655|NCT04572620|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153870656|NCT04572620|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153382924|NCT01737944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153382925|NCT01737944|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153382926|NCT01737944|Dermatologic Agents|dermatologic agents|mesh-ancestor
153382927|NCT01737944|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153382928|NCT01737944|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153382929|NCT01737944|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153382930|NCT01737944|Immunologic Factors|immunologic factors|mesh-ancestor
153870657|NCT04572620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153870658|NCT04572620|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153870659|NCT03451019|Sevelamer|sevelamer|mesh-list
153870661|NCT03451019|Sequestering Agents|sequestering agents|mesh-ancestor
153870662|NCT03451019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153870663|NCT03450863|Insulin Aspart|insulin aspart|mesh-list
153870664|NCT03450863|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153870665|NCT03450863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153870666|NCT02211066|Clopidogrel|clopidogrel|mesh-list
153870667|NCT02211066|Ticagrelor|ticagrelor|mesh-list
153870668|NCT02211066|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153870669|NCT02211066|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
153411262|NCT00004161|Fenretinide|fenretinide|mesh-list
153411263|NCT00004161|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153411264|NCT00004161|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
153411265|NCT00004161|Protective Agents|protective agents|mesh-ancestor
153411266|NCT00004161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153411268|NCT00004173|Oxaliplatin|oxaliplatin|mesh-list
153411269|NCT00004173|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153411270|NCT00004173|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153411271|NCT00004173|Tubulin Modulators|tubulin modulators|mesh-ancestor
153411272|NCT00004173|Antimitotic Agents|antimitotic agents|mesh-ancestor
153411273|NCT00004173|Mitosis Modulators|mitosis modulators|mesh-ancestor
153411274|NCT00004173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153411275|NCT00005025|Ganciclovir|ganciclovir|mesh-list
153411276|NCT00005025|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
153411308|NCT00004179|Tubulin Modulators|tubulin modulators|mesh-ancestor
153411309|NCT00004179|Antimitotic Agents|antimitotic agents|mesh-ancestor
153411310|NCT00004179|Mitosis Modulators|mitosis modulators|mesh-ancestor
153411311|NCT00003687|Morphine|morphine|mesh-list
153411312|NCT00003687|Levomethorphan|levomethorphan|mesh-list
153411313|NCT00003687|Dextromethorphan|dextromethorphan|mesh-list
153411314|NCT00003687|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153411315|NCT00003687|Narcotics|narcotics|mesh-ancestor
153411316|NCT00003687|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153411317|NCT00003687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153411318|NCT00003687|Analgesics|analgesics|mesh-ancestor
153411319|NCT00003687|Sensory System Agents|sensory system agents|mesh-ancestor
153411320|NCT00003687|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153411321|NCT00003687|Antitussive Agents|antitussive agents|mesh-ancestor
153411322|NCT00003687|Respiratory System Agents|respiratory system agents|mesh-ancestor
153870716|NCT04565184|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153870717|NCT04565184|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153870718|NCT04565184|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153870719|NCT04565184|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153870720|NCT04565184|Antiviral Agents|antiviral agents|mesh-ancestor
153870721|NCT04565184|Schistosomicides|schistosomicides|mesh-ancestor
153870722|NCT04565184|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
153870723|NCT04565184|Anthelmintics|anthelmintics|mesh-ancestor
153870724|NCT03452579|Bevacizumab|bevacizumab|mesh-list
153870725|NCT03452579|Nivolumab|nivolumab|mesh-list
153870726|NCT03452579|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153870727|NCT03452579|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153870728|NCT03452579|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153870729|NCT03452579|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153411323|NCT00003687|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
153411324|NCT00003687|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
153411325|NCT00003687|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153411329|NCT00003693|Tubulin Modulators|tubulin modulators|mesh-ancestor
153411330|NCT00003693|Antimitotic Agents|antimitotic agents|mesh-ancestor
153411331|NCT00003693|Mitosis Modulators|mitosis modulators|mesh-ancestor
153411332|NCT00003693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153411333|NCT00005031|Irofulven|irofulven|mesh-list
153411334|NCT00005031|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153411335|NCT00005031|Alkylating Agents|alkylating agents|mesh-ancestor
153411337|NCT00005031|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153411338|NCT00005037|Temozolomide|temozolomide|mesh-list
153411339|NCT00005037|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153411340|NCT00005037|Alkylating Agents|alkylating agents|mesh-ancestor
153411341|NCT00005037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153411342|NCT00005037|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153411343|NCT00004203|Oxaliplatin|oxaliplatin|mesh-list
153411344|NCT00004203|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153411345|NCT00004209|Mitomycins|mitomycins|mesh-list
153411346|NCT00004209|Mitomycin|mitomycin|mesh-list
153411347|NCT00004209|Vinblastine|vinblastine|mesh-list
153411373|NCT00004215|Immunologic Factors|immunologic factors|mesh-ancestor
153411374|NCT00004215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153411375|NCT00004215|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153411376|NCT00004215|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153411377|NCT00004215|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153411378|NCT00004215|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153411380|NCT00004221|Cyclophosphamide|cyclophosphamide|mesh-list
153411381|NCT00004221|Carboplatin|carboplatin|mesh-list
153870767|NCT03456791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153870769|NCT04564638|Cyclosporins|cyclosporins|mesh-list
153870770|NCT04564638|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153870771|NCT04564638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153870772|NCT04564638|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153870773|NCT04564638|Immunologic Factors|immunologic factors|mesh-ancestor
153870774|NCT04564638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153870775|NCT04564638|Antifungal Agents|antifungal agents|mesh-ancestor
153870776|NCT04564638|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153870777|NCT04564638|Dermatologic Agents|dermatologic agents|mesh-ancestor
153870778|NCT04564638|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153870779|NCT04564638|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
153870780|NCT04564326|Fentanyl|fentanyl|mesh-list
153870781|NCT04564326|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153870782|NCT04564326|Narcotics|narcotics|mesh-ancestor
153870783|NCT04564326|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153870784|NCT04564326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153870785|NCT04564326|Analgesics|analgesics|mesh-ancestor
153411382|NCT00004221|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
153411383|NCT00004221|Topotecan|topotecan|mesh-list
153411384|NCT00004221|Lenograstim|lenograstim|mesh-list
153411385|NCT00004221|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153411386|NCT00004221|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153411387|NCT00004221|Tubulin Modulators|tubulin modulators|mesh-ancestor
153411388|NCT00004221|Antimitotic Agents|antimitotic agents|mesh-ancestor
153411389|NCT00004221|Mitosis Modulators|mitosis modulators|mesh-ancestor
153411390|NCT00004221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153411391|NCT00004221|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153411392|NCT00004221|Immunologic Factors|immunologic factors|mesh-ancestor
153411393|NCT00004221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153411394|NCT00004221|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153411395|NCT00004221|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153411396|NCT00004221|Alkylating Agents|alkylating agents|mesh-ancestor
153411397|NCT00004221|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153411398|NCT00004221|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153411399|NCT00004221|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
153411400|NCT00004221|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153411401|NCT00004221|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153411402|NCT00003711|Irinotecan|irinotecan|mesh-list
153411403|NCT00003711|Pemetrexed|pemetrexed|mesh-list
153411404|NCT00003711|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
153411405|NCT00003711|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153411406|NCT00003711|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153411407|NCT00003711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153411408|NCT00003711|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153411409|NCT00003711|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153870786|NCT04564326|Sensory System Agents|sensory system agents|mesh-ancestor
153870787|NCT04564326|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153870788|NCT04564326|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153870789|NCT04564326|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153870790|NCT04564326|Anesthetics, General|anesthetics, general|mesh-ancestor
153870791|NCT04564326|Anesthetics|anesthetics|mesh-ancestor
153870792|NCT03453164|Nivolumab|nivolumab|mesh-list
153870797|NCT03450434|Histamine|histamine|mesh-list
153870800|NCT03450434|Histamine Agents|histamine agents|mesh-ancestor
153870803|NCT03450434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153870804|NCT03450434|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
153870805|NCT03450434|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153870807|NCT00198029|Viscosupplements|viscosupplements|mesh-ancestor
153870808|NCT00198029|Protective Agents|protective agents|mesh-ancestor
153870809|NCT00198029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153870810|NCT02215122|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
153870811|NCT02215122|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153870812|NCT02215122|Autonomic Agents|autonomic agents|mesh-ancestor
153411410|NCT00003711|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153411412|NCT00004227|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153411413|NCT00004227|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153411414|NCT00003621|Etoposide|etoposide|mesh-list
153411415|NCT00003621|Carmustine|carmustine|mesh-list
153411416|NCT00003621|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153411417|NCT00003621|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153411418|NCT00003621|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153411419|NCT00003621|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153870813|NCT02215122|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153870814|NCT02215122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153870815|NCT02215122|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153870816|NCT02215122|Respiratory System Agents|respiratory system agents|mesh-ancestor
153870817|NCT02215122|Glucocorticoids|glucocorticoids|mesh-ancestor
153870818|NCT02215122|Hormones|hormones|mesh-ancestor
153870819|NCT02215122|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153870820|NCT02215122|Sympathomimetics|sympathomimetics|mesh-ancestor
153870821|NCT00196976|Edetic Acid|edetic acid|mesh-list
153870822|NCT00196976|Vaccines|vaccines|mesh-list
153870823|NCT00196976|Pentetic Acid|pentetic acid|mesh-list
153870824|NCT00196976|Immunologic Factors|immunologic factors|mesh-ancestor
153870825|NCT00196976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153870826|NCT00196976|Antidotes|antidotes|mesh-ancestor
153870827|NCT00196976|Protective Agents|protective agents|mesh-ancestor
153870828|NCT00196976|Chelating Agents|chelating agents|mesh-ancestor
153870829|NCT00196976|Sequestering Agents|sequestering agents|mesh-ancestor
153870830|NCT00196976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153870831|NCT00196976|Iron Chelating Agents|iron chelating agents|mesh-ancestor
153870832|NCT00196976|Anticoagulants|anticoagulants|mesh-ancestor
153870833|NCT00196976|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
153870834|NCT04563936|Goserelin|goserelin|mesh-list
153870835|NCT04563936|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153870836|NCT04563936|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153870837|NCT04563975|Paclitaxel|paclitaxel|mesh-list
153870838|NCT04563975|Docetaxel|docetaxel|mesh-list
153870839|NCT04563975|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153870840|NCT04563975|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153870841|NCT04563975|Tubulin Modulators|tubulin modulators|mesh-ancestor
153870842|NCT04563975|Antimitotic Agents|antimitotic agents|mesh-ancestor
153870843|NCT04563975|Mitosis Modulators|mitosis modulators|mesh-ancestor
153870844|NCT04563975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153870845|NCT00196313|Levonorgestrel|levonorgestrel|mesh-list
153870846|NCT00196313|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
153870847|NCT00196313|Contraceptive Agents|contraceptive agents|mesh-ancestor
153870848|NCT00196313|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153870849|NCT00196313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153870850|NCT00196313|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
153870851|NCT00196313|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
153411449|NCT00004233|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153411450|NCT00004233|Immunologic Factors|immunologic factors|mesh-ancestor
153411451|NCT00004233|Antidotes|antidotes|mesh-ancestor
153888985|NCT01293123|Emtricitabine|emtricitabine|mesh-list
153888986|NCT01293123|Efavirenz|efavirenz|mesh-list
153888987|NCT01293123|Raltegravir Potassium|raltegravir potassium|mesh-list
153888988|NCT01293123|Antiviral Agents|antiviral agents|mesh-ancestor
153870864|NCT04560465|Hemostatics|hemostatics|mesh-ancestor
153870865|NCT04560465|Coagulants|coagulants|mesh-ancestor
153870866|NCT00195494|Etanercept|etanercept|mesh-list
153870867|NCT00195494|Methotrexate|methotrexate|mesh-list
153411465|NCT00003717|Alkylating Agents|alkylating agents|mesh-ancestor
153411466|NCT00003717|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153411468|NCT00003723|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153411484|NCT00004245|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153411485|NCT00004245|Analgesics|analgesics|mesh-ancestor
153411486|NCT00004245|Sensory System Agents|sensory system agents|mesh-ancestor
153870868|NCT00195494|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
153870869|NCT00195494|Abortifacient Agents|abortifacient agents|mesh-ancestor
153870870|NCT00195494|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153870871|NCT00195494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153870873|NCT00195494|Antimetabolites|antimetabolites|mesh-ancestor
153870877|NCT00195494|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153870878|NCT00195494|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153870879|NCT00195494|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153870880|NCT00195494|Immunologic Factors|immunologic factors|mesh-ancestor
153870881|NCT00195494|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153870882|NCT00195494|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153870883|NCT00195494|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153870884|NCT00195494|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153870885|NCT00195494|Analgesics|analgesics|mesh-ancestor
153870886|NCT00195494|Sensory System Agents|sensory system agents|mesh-ancestor
153870887|NCT00195494|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153411487|NCT00004245|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153411488|NCT00004245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153411490|NCT00004245|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153411491|NCT00004245|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153411492|NCT00004245|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153411493|NCT00004245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153411494|NCT00004251|Letrozole|letrozole|mesh-list
153411495|NCT00004251|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153411496|NCT00004251|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
153870901|NCT00194987|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153411501|NCT00004251|Hormone Antagonists|hormone antagonists|mesh-ancestor
153411502|NCT00004251|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153411503|NCT00004251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153411505|NCT00005067|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
153411506|NCT00005067|Dermatologic Agents|dermatologic agents|mesh-ancestor
153411507|NCT00003729|Cytarabine|cytarabine|mesh-list
153411508|NCT00003729|Fludarabine|fludarabine|mesh-list
153411509|NCT00003729|Fludarabine phosphate|fludarabine phosphate|mesh-list
153411510|NCT00003729|Idarubicin|idarubicin|mesh-list
153411511|NCT00003729|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153411512|NCT00003729|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153411513|NCT00003729|Antimetabolites|antimetabolites|mesh-ancestor
153411514|NCT00003729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153411515|NCT00003729|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153411516|NCT00003729|Immunologic Factors|immunologic factors|mesh-ancestor
153411517|NCT00003729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153411518|NCT00003729|Antiviral Agents|antiviral agents|mesh-ancestor
153411519|NCT00003729|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153411520|NCT00003729|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153411521|NCT00003729|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153411522|NCT00003729|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153411523|NCT00003729|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153411524|NCT00004263|Cytarabine|cytarabine|mesh-list
153411525|NCT00004263|7-hydroxystaurosporine|7-hydroxystaurosporine|mesh-list
153430099|NCT04403516|Prednisolone phosphate|prednisolone phosphate|mesh-list
153430100|NCT04403516|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153430101|NCT04403516|Antiemetics|antiemetics|mesh-ancestor
153870925|NCT00194792|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153870926|NCT00194792|Immunologic Factors|immunologic factors|mesh-ancestor
153870927|NCT00194792|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153411526|NCT00004263|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153411528|NCT00004263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153411529|NCT00004263|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153411530|NCT00004263|Antiviral Agents|antiviral agents|mesh-ancestor
153411531|NCT00004263|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153411532|NCT00004263|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153411533|NCT00004263|Immunologic Factors|immunologic factors|mesh-ancestor
153411534|NCT00004263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153411535|NCT00004263|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153411536|NCT00004263|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153411538|NCT00003735|10-hydroxycamptothecin|10-hydroxycamptothecin|mesh-list
153411539|NCT00003735|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
153411540|NCT00003735|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153411541|NCT00003735|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153411544|NCT00003735|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153411545|NCT00005073|Zoledronic Acid|zoledronic acid|mesh-list
153870947|NCT02486367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153870950|NCT00194675|Dutasteride|dutasteride|mesh-list
153870951|NCT00194675|Androgens|androgens|mesh-ancestor
153870952|NCT00194675|Hormones|hormones|mesh-ancestor
153870953|NCT00194675|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153870955|NCT00194675|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
153870956|NCT00194675|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153411557|NCT00003741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153411558|NCT00003747|Carboplatin|carboplatin|mesh-list
153411559|NCT00003747|Temozolomide|temozolomide|mesh-list
153411560|NCT00003747|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153411561|NCT00003747|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153411562|NCT00003747|Alkylating Agents|alkylating agents|mesh-ancestor
153411563|NCT00003747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153411564|NCT00004311|Leuprolide|leuprolide|mesh-list
153411565|NCT00004311|Spironolactone|spironolactone|mesh-list
153411566|NCT00004311|Fertility Agents, Female|fertility agents, female|mesh-ancestor
153411567|NCT00004311|Fertility Agents|fertility agents|mesh-ancestor
153411568|NCT00004311|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153411569|NCT00004311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153411570|NCT00004311|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153411571|NCT00004311|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153411572|NCT00004311|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
153411573|NCT00004311|Hormone Antagonists|hormone antagonists|mesh-ancestor
153411574|NCT00004311|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153411575|NCT00004311|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
153411576|NCT00004311|Diuretics|diuretics|mesh-ancestor
153411577|NCT00004311|Natriuretic Agents|natriuretic agents|mesh-ancestor
153411578|NCT00004317|Leucovorin|leucovorin|mesh-list
153870957|NCT00194675|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153870958|NCT00194675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153870959|NCT00194675|Hormone Antagonists|hormone antagonists|mesh-ancestor
153870961|NCT00194012|Antidepressive Agents|antidepressive agents|mesh-ancestor
153870962|NCT00194012|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153870963|NCT00194012|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153870964|NCT00194012|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153870965|NCT00194012|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153870966|NCT00194012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153870967|NCT00194012|Dopamine Agonists|dopamine agonists|mesh-ancestor
153870968|NCT00194012|Dopamine Agents|dopamine agents|mesh-ancestor
153870969|NCT00194012|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153870970|NCT00194012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153870971|NCT00194012|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
153870972|NCT00194012|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
153870973|NCT00194012|Serotonin Agents|serotonin agents|mesh-ancestor
153870974|NCT00194012|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
153870975|NCT00194012|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153870976|NCT00194012|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
153870977|NCT00194012|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
153411579|NCT00004317|Pyrimethamine|pyrimethamine|mesh-list
153411580|NCT00004317|Sulfadiazine|sulfadiazine|mesh-list
153411581|NCT00004317|Spiramycin|spiramycin|mesh-list
153411582|NCT00004317|Calcium|calcium|mesh-list
153411583|NCT00004317|Levoleucovorin|levoleucovorin|mesh-list
153411584|NCT00004317|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153411585|NCT00004317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153411586|NCT00004317|Antidotes|antidotes|mesh-ancestor
153411587|NCT00004317|Protective Agents|protective agents|mesh-ancestor
153411588|NCT00004317|Vitamin B Complex|vitamin b complex|mesh-ancestor
153411589|NCT00004317|Vitamins|vitamins|mesh-ancestor
153411594|NCT00004317|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153411595|NCT00004317|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153411596|NCT00004317|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153411597|NCT00004317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153411598|NCT00004317|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153411599|NCT00004317|Coccidiostats|coccidiostats|mesh-ancestor
153870993|NCT04563429|Vitamins|vitamins|mesh-ancestor
153870994|NCT04563429|Micronutrients|micronutrients|mesh-ancestor
153870995|NCT04563429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153870996|NCT00192023|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
153411601|NCT00005091|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
153411602|NCT00005091|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153411603|NCT00005091|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153411604|NCT00005091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153411605|NCT00005091|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153411606|NCT00004323|Cyclosporine|cyclosporine|mesh-list
153411607|NCT00004323|Methylprednisolone|methylprednisolone|mesh-list
153411608|NCT00004323|Cyclophosphamide|cyclophosphamide|mesh-list
153411609|NCT00004323|Methotrexate|methotrexate|mesh-list
153411610|NCT00004323|Cyclosporins|cyclosporins|mesh-list
153411611|NCT00004323|Antilymphocyte Serum|antilymphocyte serum|mesh-list
153411612|NCT00004323|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153411613|NCT00004323|Immunologic Factors|immunologic factors|mesh-ancestor
153411614|NCT00004323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153411621|NCT00004323|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
153411622|NCT00004323|Abortifacient Agents|abortifacient agents|mesh-ancestor
153411623|NCT00004323|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153411624|NCT00004323|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153411626|NCT00004323|Dermatologic Agents|dermatologic agents|mesh-ancestor
153411627|NCT00004323|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153411628|NCT00004323|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153411629|NCT00004323|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153411630|NCT00004323|Antifungal Agents|antifungal agents|mesh-ancestor
153411631|NCT00004323|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153411632|NCT00004323|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
153411633|NCT00004323|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153411634|NCT00004323|Antiemetics|antiemetics|mesh-ancestor
153411635|NCT00004323|Autonomic Agents|autonomic agents|mesh-ancestor
153411644|NCT00003753|Irinotecan|irinotecan|mesh-list
153411645|NCT00003753|Floxuridine|floxuridine|mesh-list
153411646|NCT00003753|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153411647|NCT00003753|Antiemetics|antiemetics|mesh-ancestor
153411648|NCT00003753|Autonomic Agents|autonomic agents|mesh-ancestor
153411649|NCT00003753|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153411650|NCT00003753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153411652|NCT00003753|Glucocorticoids|glucocorticoids|mesh-ancestor
153411653|NCT00003753|Hormones|hormones|mesh-ancestor
153411654|NCT00003753|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153411655|NCT00003753|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153411656|NCT00003753|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153411657|NCT00003753|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
153411658|NCT00003753|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153411659|NCT00003753|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153411660|NCT00003753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153411661|NCT00003753|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153411662|NCT00003753|Antimetabolites|antimetabolites|mesh-ancestor
153411663|NCT00003759|Valrubicin|valrubicin|mesh-list
153411664|NCT00003759|BCG Vaccine|bcg vaccine|mesh-list
153411665|NCT00003759|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153411666|NCT00003759|Immunologic Factors|immunologic factors|mesh-ancestor
153411667|NCT00003759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153411668|NCT00003759|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153411669|NCT00003759|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153411670|NCT00003759|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153871030|NCT00191789|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153871031|NCT00191789|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153871032|NCT00191789|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153871033|NCT00191789|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153871034|NCT00191282|Insulin|insulin|mesh-list
153871042|NCT00191282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153871043|NCT04560231|Remdesivir|remdesivir|mesh-list
153871044|NCT04560231|Antimetabolites|antimetabolites|mesh-ancestor
153871045|NCT04560231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153871046|NCT04560231|Antiviral Agents|antiviral agents|mesh-ancestor
153871047|NCT04560231|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153871048|NCT00190775|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
153871049|NCT00190775|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
153871050|NCT00190775|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153871051|NCT00190775|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153871052|NCT00190775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153871053|NCT00190775|Adrenergic Agents|adrenergic agents|mesh-ancestor
153871054|NCT00190775|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153871058|NCT00198263|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153871059|NCT00198107|Cycloserine|cycloserine|mesh-list
153871060|NCT00198107|Aripiprazole|aripiprazole|mesh-list
153871061|NCT00198107|Antidepressive Agents|antidepressive agents|mesh-ancestor
153871062|NCT00198107|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153871063|NCT00198107|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153411671|NCT00003759|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153411672|NCT00003759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153411673|NCT00003765|Carmustine|carmustine|mesh-list
153411674|NCT00003765|O(6)-benzylguanine|o(6)-benzylguanine|mesh-list
153411675|NCT00003765|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153411676|NCT00003765|Alkylating Agents|alkylating agents|mesh-ancestor
153411691|NCT00003771|Contraceptive Agents|contraceptive agents|mesh-ancestor
153411692|NCT00003771|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153411693|NCT00003771|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
153411694|NCT00003771|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
153411695|NCT00003771|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
153411696|NCT00003771|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
153411697|NCT00004359|Methoxsalen|methoxsalen|mesh-list
153411698|NCT00004359|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
153411699|NCT00004359|Dermatologic Agents|dermatologic agents|mesh-ancestor
153871064|NCT00198107|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153871067|NCT00198107|Dopamine Agonists|dopamine agonists|mesh-ancestor
153411719|NCT00003783|Levoleucovorin|levoleucovorin|mesh-list
153411720|NCT00003783|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153411721|NCT00003783|Immunologic Factors|immunologic factors|mesh-ancestor
153411722|NCT00003783|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153411723|NCT00003783|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153871092|NCT00178256|Paclitaxel|paclitaxel|mesh-list
153888996|NCT01293123|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
153871093|NCT00178256|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153871094|NCT00178256|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153871095|NCT00178256|Tubulin Modulators|tubulin modulators|mesh-ancestor
153411724|NCT00003783|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153411725|NCT00003783|Alkylating Agents|alkylating agents|mesh-ancestor
153411726|NCT00003783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153411727|NCT00003783|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153411728|NCT00003783|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153411729|NCT00003783|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153411731|NCT00003783|Autonomic Agents|autonomic agents|mesh-ancestor
153411732|NCT00003783|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153411733|NCT00003783|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153411734|NCT00003783|Glucocorticoids|glucocorticoids|mesh-ancestor
153411735|NCT00003783|Hormones|hormones|mesh-ancestor
153411736|NCT00003783|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153411737|NCT00003783|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153411752|NCT00003783|Antidotes|antidotes|mesh-ancestor
153871128|NCT00177164|Dopamine Agonists|dopamine agonists|mesh-ancestor
153871129|NCT00177164|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
153871130|NCT00177164|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
153871131|NCT00177164|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
153871132|NCT00177164|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
153871133|NCT04559841|Simvastatin|simvastatin|mesh-list
153871134|NCT04559841|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153871135|NCT04559841|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153871136|NCT04559841|Antimetabolites|antimetabolites|mesh-ancestor
153871137|NCT04559841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153871138|NCT04559841|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153871140|NCT04559841|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153411782|NCT00004431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153871162|NCT00176462|Cytarabine|cytarabine|mesh-list
153871163|NCT00176462|Dexamethasone|dexamethasone|mesh-list
153871164|NCT00176462|Hydrocortisone|hydrocortisone|mesh-list
153871165|NCT00176462|Cyclophosphamide|cyclophosphamide|mesh-list
153871166|NCT00176462|Methotrexate|methotrexate|mesh-list
153871167|NCT00176462|Vincristine|vincristine|mesh-list
153871168|NCT00176462|Asparaginase|asparaginase|mesh-list
153871169|NCT00176462|Mercaptopurine|mercaptopurine|mesh-list
153871170|NCT00176462|Thioguanine|thioguanine|mesh-list
153871171|NCT00176462|Daunorubicin|daunorubicin|mesh-list
153871172|NCT00176462|Aminopterin|aminopterin|mesh-list
153871174|NCT00176462|Immunologic Factors|immunologic factors|mesh-ancestor
153871175|NCT00176462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153871176|NCT00176462|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153871177|NCT00176462|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153871178|NCT00176462|Alkylating Agents|alkylating agents|mesh-ancestor
153871179|NCT00176462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153871180|NCT00176462|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153871181|NCT00176462|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153871182|NCT00176462|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153871183|NCT00176462|Antiemetics|antiemetics|mesh-ancestor
153871190|NCT00176462|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153871191|NCT00176462|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
153871192|NCT00176462|Abortifacient Agents|abortifacient agents|mesh-ancestor
153871193|NCT00176462|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153871194|NCT00176462|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153871195|NCT00176462|Antimetabolites|antimetabolites|mesh-ancestor
153871196|NCT00176462|Dermatologic Agents|dermatologic agents|mesh-ancestor
153871197|NCT00176462|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153871198|NCT00176462|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153871199|NCT00176462|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153871200|NCT00176462|Antiviral Agents|antiviral agents|mesh-ancestor
153871201|NCT00176462|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153871202|NCT00176462|Antidotes|antidotes|mesh-ancestor
153871203|NCT00176462|Protective Agents|protective agents|mesh-ancestor
153871204|NCT00176462|Vitamin B Complex|vitamin b complex|mesh-ancestor
153871205|NCT00176462|Vitamins|vitamins|mesh-ancestor
153871206|NCT00176462|Micronutrients|micronutrients|mesh-ancestor
153871207|NCT00176462|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153871208|NCT00176462|Tubulin Modulators|tubulin modulators|mesh-ancestor
153871209|NCT00176462|Antimitotic Agents|antimitotic agents|mesh-ancestor
153411829|NCT00004467|Respiratory System Agents|respiratory system agents|mesh-ancestor
153411830|NCT00004467|Free Radical Scavengers|free radical scavengers|mesh-ancestor
153411831|NCT00004467|Antioxidants|antioxidants|mesh-ancestor
153411832|NCT00004467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153411833|NCT00004467|Protective Agents|protective agents|mesh-ancestor
153411834|NCT00004467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153411835|NCT00004467|Antidotes|antidotes|mesh-ancestor
153411836|NCT00004479|Midodrine|midodrine|mesh-list
153411837|NCT00004479|Sympathomimetics|sympathomimetics|mesh-ancestor
153411838|NCT00004479|Autonomic Agents|autonomic agents|mesh-ancestor
153411839|NCT00004479|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153411840|NCT00004479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153411841|NCT00004479|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
153411842|NCT00004479|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
153411843|NCT00004479|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153411844|NCT00004479|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153411845|NCT00004479|Adrenergic Agents|adrenergic agents|mesh-ancestor
153411846|NCT00004479|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153411847|NCT00004479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153411848|NCT00004485|Cyclosporine|cyclosporine|mesh-list
153411849|NCT00004485|Mycophenolic Acid|mycophenolic acid|mesh-list
153871211|NCT00176462|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153871212|NCT00176462|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153871213|NCT00176462|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153871218|NCT00175019|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153871219|NCT00175019|Gout Suppressants|gout suppressants|mesh-ancestor
153871220|NCT00175019|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153871221|NCT00175019|Free Radical Scavengers|free radical scavengers|mesh-ancestor
153871222|NCT00175019|Antioxidants|antioxidants|mesh-ancestor
153871223|NCT00175019|Protective Agents|protective agents|mesh-ancestor
153871224|NCT00175019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153871225|NCT00174941|Febuxostat|febuxostat|mesh-list
153871226|NCT00174941|Gout Suppressants|gout suppressants|mesh-ancestor
153871227|NCT00174941|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153871228|NCT00171704|Tamoxifen|tamoxifen|mesh-list
153871229|NCT00171704|Letrozole|letrozole|mesh-list
153871230|NCT00171704|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153871231|NCT00171704|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
153871238|NCT00171704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153871239|NCT00171704|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153871240|NCT00171704|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
153871241|NCT00171704|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
153871242|NCT00171704|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153871243|NCT00171314|Zoledronic Acid|zoledronic acid|mesh-list
153871247|NCT00171314|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153871249|NCT00171314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153871250|NCT00171314|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
153871263|NCT00170846|Calcineurin Inhibitors|calcineurin inhibitors|mesh-list
153871264|NCT00170846|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
153871265|NCT00170846|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153871266|NCT00170846|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153871267|NCT00170846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153871268|NCT00170846|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153871269|NCT00170846|Immunologic Factors|immunologic factors|mesh-ancestor
153871270|NCT00170846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153871271|NCT00170846|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153871290|NCT04562103|Autonomic Agents|autonomic agents|mesh-ancestor
153871291|NCT04562103|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153871292|NCT04562103|Respiratory System Agents|respiratory system agents|mesh-ancestor
153871293|NCT04562103|Mydriatics|mydriatics|mesh-ancestor
153871294|NCT04562103|Sympathomimetics|sympathomimetics|mesh-ancestor
153871295|NCT04562103|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
153871296|NCT04561635|Micronutrients|micronutrients|mesh-list
153871297|NCT04561635|Trace Elements|trace elements|mesh-list
153871298|NCT04561635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153871299|NCT00479882|Simvastatin|simvastatin|mesh-list
153871300|NCT00479882|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153871301|NCT00479882|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153871302|NCT00479882|Antimetabolites|antimetabolites|mesh-ancestor
153411916|NCT00004575|Kininogens|kininogens|mesh-list
153871324|NCT00479336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153871325|NCT00478244|Cyclophosphamide|cyclophosphamide|mesh-list
153871327|NCT00478244|Fludarabine|fludarabine|mesh-list
153871328|NCT00478244|Fludarabine phosphate|fludarabine phosphate|mesh-list
153871329|NCT00478244|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153871330|NCT00478244|Immunologic Factors|immunologic factors|mesh-ancestor
153871331|NCT00478244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153871332|NCT00478244|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153871333|NCT00478244|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153871334|NCT00478244|Alkylating Agents|alkylating agents|mesh-ancestor
153889004|NCT01292187|Calcitonin|calcitonin|mesh-list
153889005|NCT01292187|Salmon calcitonin|salmon calcitonin|mesh-list
153411960|NCT00004647|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153411961|NCT00004647|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
153411962|NCT00004647|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153411963|NCT00004647|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153411964|NCT00004647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153411965|NCT02469116|Carboplatin|carboplatin|mesh-list
153411966|NCT02469116|Docetaxel|docetaxel|mesh-list
153411967|NCT02469116|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153411968|NCT02469116|Tubulin Modulators|tubulin modulators|mesh-ancestor
153411978|NCT00362960|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
153411979|NCT00362960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153411980|NCT00003867|Capecitabine|capecitabine|mesh-list
153411981|NCT00003867|Irinotecan|irinotecan|mesh-list
153411982|NCT00003867|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153871358|NCT00477971|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153871359|NCT00477971|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153889007|NCT01292187|Katacalcin|katacalcin|mesh-list
153871371|NCT00477464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153411983|NCT00003867|Antimetabolites|antimetabolites|mesh-ancestor
153411984|NCT00003867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153411985|NCT00003867|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153411986|NCT00003867|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
153411987|NCT00003867|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153411988|NCT00003867|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153411989|NCT00004665|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
153411990|NCT00004665|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153411991|NCT00004665|Immunologic Factors|immunologic factors|mesh-ancestor
153411992|NCT00004665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153411994|NCT00363584|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153411995|NCT00363584|Antimetabolites|antimetabolites|mesh-ancestor
153411997|NCT00363584|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153411998|NCT00003873|Fluorouracil|fluorouracil|mesh-list
153411999|NCT00003873|Eniluracil|eniluracil|mesh-list
153412000|NCT00003873|Antimetabolites|antimetabolites|mesh-ancestor
153412001|NCT00003873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153412002|NCT00003873|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153412003|NCT00003873|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153412004|NCT00003873|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153412005|NCT00003873|Immunologic Factors|immunologic factors|mesh-ancestor
153412006|NCT00003873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153412007|NCT00003873|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153412008|NCT00363116|Daclizumab|daclizumab|mesh-list
153412009|NCT00363116|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153412010|NCT00363116|Immunologic Factors|immunologic factors|mesh-ancestor
153412011|NCT00363116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153412012|NCT00004689|Clarithromycin|clarithromycin|mesh-list
153412013|NCT00004689|Rifampin|rifampin|mesh-list
153412014|NCT00004689|Ethambutol|ethambutol|mesh-list
153412015|NCT00004689|Streptomycin|streptomycin|mesh-list
153871372|NCT00477464|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153871373|NCT00477464|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153871374|NCT00477464|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153871375|NCT00477464|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153871376|NCT00477386|Decitabine|decitabine|mesh-list
153871377|NCT00477386|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153871378|NCT00477386|Antimetabolites|antimetabolites|mesh-ancestor
153871379|NCT00477386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153871380|NCT00477386|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153412023|NCT00004689|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153412024|NCT00004689|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
153871407|NCT00476957|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153871408|NCT00476957|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153871409|NCT00476957|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153871410|NCT00476957|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153871411|NCT00476957|Antifungal Agents|antifungal agents|mesh-ancestor
153871412|NCT00476957|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153871413|NCT00476957|Immunologic Factors|immunologic factors|mesh-ancestor
153871414|NCT00476957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153871415|NCT00475865|Teriflunomide|teriflunomide|mesh-list
153412057|NCT00004755|Free Radical Scavengers|free radical scavengers|mesh-ancestor
153412059|NCT00004755|Protective Agents|protective agents|mesh-ancestor
153412060|NCT00004755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153412061|NCT00004755|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153412062|NCT00004755|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153412063|NCT00004755|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153412064|NCT00003897|Sargramostim|sargramostim|mesh-list
153412065|NCT00003897|Immunologic Factors|immunologic factors|mesh-ancestor
153412066|NCT00003897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153412067|NCT00003909|Motexafin gadolinium|motexafin gadolinium|mesh-list
153871434|NCT00475670|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153871435|NCT00475670|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153871436|NCT00475670|Tubulin Modulators|tubulin modulators|mesh-ancestor
153871437|NCT00475670|Antimitotic Agents|antimitotic agents|mesh-ancestor
153871438|NCT00475670|Mitosis Modulators|mitosis modulators|mesh-ancestor
153871439|NCT00475670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153871440|NCT00475670|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153871441|NCT04556760|Prednisolone|prednisolone|mesh-list
153871442|NCT04556760|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153871443|NCT04556760|Glucocorticoids|glucocorticoids|mesh-ancestor
153871444|NCT04556760|Hormones|hormones|mesh-ancestor
153871445|NCT04556760|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153871446|NCT04556760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153871447|NCT04556760|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153871448|NCT04556760|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153871449|NCT00474929|Everolimus|everolimus|mesh-list
153871450|NCT00474929|Sorafenib|sorafenib|mesh-list
153871451|NCT00474929|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
153871452|NCT00474929|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153871453|NCT00474929|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153412079|NCT00004767|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153412081|NCT00004785|Methylprednisolone|methylprednisolone|mesh-list
153412082|NCT00004785|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
153412083|NCT00004785|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
153412084|NCT00004785|Prednisolone|prednisolone|mesh-list
153412086|NCT00004785|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
153412087|NCT00004785|Prednisolone phosphate|prednisolone phosphate|mesh-list
153412088|NCT00004785|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153871455|NCT00474929|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153871456|NCT00474929|Immunologic Factors|immunologic factors|mesh-ancestor
153871457|NCT00474929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153871458|NCT00474929|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153871459|NCT00474812|Dasatinib|dasatinib|mesh-list
153871460|NCT00474812|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153871461|NCT00474812|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153871462|NCT00474812|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153871463|NCT00474812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153871464|NCT00474812|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153871478|NCT00472199|Antioxidants|antioxidants|mesh-ancestor
153871479|NCT00472199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153871480|NCT00472199|Protective Agents|protective agents|mesh-ancestor
153871481|NCT00472199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153871482|NCT00472199|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
153871483|NCT00472199|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
153871484|NCT00472199|Dopamine Agonists|dopamine agonists|mesh-ancestor
153871485|NCT00472199|Dopamine Agents|dopamine agents|mesh-ancestor
153871486|NCT00472199|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153871487|NCT00471887|Tremelimumab|tremelimumab|mesh-list
153871488|NCT00471887|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153871489|NCT04556058|Perindopril|perindopril|mesh-list
153871490|NCT04556058|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
153871491|NCT04556058|Protease Inhibitors|protease inhibitors|mesh-ancestor
153871492|NCT04556058|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153871493|NCT04556058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153412110|NCT04040361|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153412111|NCT04040361|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153412112|NCT04040361|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153412113|NCT04040361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153412119|NCT00386061|Rimonabant|rimonabant|mesh-list
153871497|NCT00470834|Androgen Antagonists|androgen antagonists|mesh-ancestor
153871498|NCT00470834|Hormone Antagonists|hormone antagonists|mesh-ancestor
153871499|NCT00470834|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153871500|NCT00470834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153871501|NCT00470834|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153871502|NCT00470834|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
153871503|NCT00470834|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153871504|NCT00470834|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153871505|NCT00470834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153871507|NCT00470366|Ifosfamide|ifosfamide|mesh-list
153871508|NCT00470366|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153871509|NCT00470366|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153871510|NCT00470366|Tubulin Modulators|tubulin modulators|mesh-ancestor
153871511|NCT00470366|Antimitotic Agents|antimitotic agents|mesh-ancestor
153871512|NCT00470366|Mitosis Modulators|mitosis modulators|mesh-ancestor
153871513|NCT00470366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153871514|NCT00470366|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153871515|NCT00470366|Alkylating Agents|alkylating agents|mesh-ancestor
153871516|NCT02212431|Cysteamine|cysteamine|mesh-list
153871517|NCT02212431|Cystine Depleting Agents|cystine depleting agents|mesh-ancestor
153871519|NCT00470093|Interferons|interferons|mesh-list
153871528|NCT00470054|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153871529|NCT00478595|Hypoglycemic Agents|hypoglycemic agents|mesh-list
153871530|NCT00478595|Rimonabant|rimonabant|mesh-list
153871531|NCT00478595|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
153871532|NCT00478595|Cannabinoid Receptor Antagonists|cannabinoid receptor antagonists|mesh-ancestor
153871533|NCT00478595|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
153871534|NCT00478595|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153871535|NCT00478595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153871536|NCT00478595|Hormones|hormones|mesh-ancestor
153871537|NCT00478595|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153871538|NCT00478595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153871539|NCT04555707|Betamethasone|betamethasone|mesh-list
153871540|NCT04555707|Betamethasone Valerate|betamethasone valerate|mesh-list
153871541|NCT04555707|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
153871542|NCT04555707|Betamethasone benzoate|betamethasone benzoate|mesh-list
153871544|NCT04555707|Calcipotriene|calcipotriene|mesh-list
153412163|NCT00005589|Alkylating Agents|alkylating agents|mesh-ancestor
153412164|NCT00005589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153412165|NCT00005589|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153412166|NCT00005589|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153412167|NCT00005589|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153412168|NCT00005589|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153412169|NCT00005589|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153412170|NCT00005589|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153412171|NCT00005589|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153412172|NCT00005589|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153412173|NCT00005589|Antimetabolites|antimetabolites|mesh-ancestor
153412174|NCT00005589|Antiviral Agents|antiviral agents|mesh-ancestor
153412175|NCT00005589|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153412176|NCT00005601|Cytarabine|cytarabine|mesh-list
153412177|NCT00005601|Dexamethasone|dexamethasone|mesh-list
153412178|NCT00005601|Rituximab|rituximab|mesh-list
153412179|NCT00005601|Sargramostim|sargramostim|mesh-list
153412180|NCT00005601|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153871546|NCT04555707|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153871547|NCT04555707|Glucocorticoids|glucocorticoids|mesh-ancestor
153871548|NCT04555707|Hormones|hormones|mesh-ancestor
153871549|NCT04555707|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153871550|NCT04555707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153871551|NCT04555707|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153871552|NCT04555707|Respiratory System Agents|respiratory system agents|mesh-ancestor
153871553|NCT04555707|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153871554|NCT04555707|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153382931|NCT01737944|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153382932|NCT01737944|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153382933|NCT01740206|Methylphenidate|methylphenidate|mesh-list
153382934|NCT01740206|Amphetamine|amphetamine|mesh-list
153382935|NCT01740206|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
153382936|NCT01740206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153382937|NCT01740206|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
153382938|NCT01740206|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153382939|NCT01740206|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153382940|NCT01740206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153382941|NCT01740206|Dopamine Agents|dopamine agents|mesh-ancestor
153382942|NCT01740206|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153382943|NCT01740206|Sympathomimetics|sympathomimetics|mesh-ancestor
153871555|NCT04555707|Analgesics|analgesics|mesh-ancestor
153871556|NCT04555707|Sensory System Agents|sensory system agents|mesh-ancestor
153871557|NCT04555707|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153871558|NCT04555707|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153871559|NCT04555707|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
153871560|NCT04555707|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
153871561|NCT04555707|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153871562|NCT04555707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153871563|NCT04555707|Dermatologic Agents|dermatologic agents|mesh-ancestor
153412185|NCT00005601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153412186|NCT00005601|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153412187|NCT00005601|Glucocorticoids|glucocorticoids|mesh-ancestor
153412188|NCT00005601|Hormones|hormones|mesh-ancestor
153412189|NCT00005601|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153871574|NCT00474188|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153871575|NCT00474188|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153871577|NCT00474188|Immunologic Factors|immunologic factors|mesh-ancestor
153871578|NCT00474188|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153871579|NCT00474188|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153871580|NCT00474188|Growth Substances|growth substances|mesh-ancestor
153871581|NCT00474188|Growth Inhibitors|growth inhibitors|mesh-ancestor
153871582|NCT01089647|Budesonide|budesonide|mesh-list
153871583|NCT01089647|Montelukast|montelukast|mesh-list
153871584|NCT01089647|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153871585|NCT01089647|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153871603|NCT04673240|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153871604|NCT04673240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153871605|NCT04673240|Cholinergic Agents|cholinergic agents|mesh-ancestor
153871606|NCT04673240|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153412230|NCT00005613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153412231|NCT00005613|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153412232|NCT00005613|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153412233|NCT00005613|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153412234|NCT00005613|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153412235|NCT00005613|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153412236|NCT00005613|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153412238|NCT00005625|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153412239|NCT00005625|Alkylating Agents|alkylating agents|mesh-ancestor
153412240|NCT00005625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153412241|NCT00005625|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153412242|NCT00005631|Rituximab|rituximab|mesh-list
153412243|NCT00005631|Carboplatin|carboplatin|mesh-list
153412244|NCT00005631|Etoposide|etoposide|mesh-list
153412245|NCT00005631|Ifosfamide|ifosfamide|mesh-list
153412249|NCT00005631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153412250|NCT00005631|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153412251|NCT00005631|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153412252|NCT00005631|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153412253|NCT00005631|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153412254|NCT00005631|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153412255|NCT00005631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153412256|NCT00005631|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153412257|NCT00005631|Alkylating Agents|alkylating agents|mesh-ancestor
153412258|NCT00005637|Temozolomide|temozolomide|mesh-list
153871607|NCT04673240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153871608|NCT04673240|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
153871609|NCT04673240|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153871610|NCT01089608|Azithromycin|azithromycin|mesh-list
153871611|NCT01089608|Povidone|povidone|mesh-list
153871612|NCT01089608|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153871613|NCT01089608|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153871614|NCT01089608|Plasma Substitutes|plasma substitutes|mesh-ancestor
153871615|NCT01089608|Blood Substitutes|blood substitutes|mesh-ancestor
153871616|NCT04554654|Progesterone|progesterone|mesh-list
153871617|NCT04554654|Progestins|progestins|mesh-ancestor
153871618|NCT04554654|Hormones|hormones|mesh-ancestor
153871619|NCT04554654|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153871621|NCT04554615|Insulin|insulin|mesh-list
153871643|NCT01088984|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153871644|NCT01088984|Alkylating Agents|alkylating agents|mesh-ancestor
153871645|NCT01088984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153871646|NCT01088984|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153871647|NCT02212821|Erythromycin|erythromycin|mesh-list
153871648|NCT02212821|Erythromycin Estolate|erythromycin estolate|mesh-list
153871649|NCT02212821|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
153871650|NCT02212821|Erythromycin stearate|erythromycin stearate|mesh-list
153871651|NCT02212821|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153871652|NCT02212821|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153412278|NCT00005649|Mitosis Modulators|mitosis modulators|mesh-ancestor
153412280|NCT00005649|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153871685|NCT01088048|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153871686|NCT01088048|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153871687|NCT01088048|Immunologic Factors|immunologic factors|mesh-ancestor
153871688|NCT01088048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153871689|NCT01088048|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153871690|NCT01088048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153871691|NCT01088048|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153871692|NCT01088048|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153871693|NCT01088048|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153871694|NCT01088048|Growth Substances|growth substances|mesh-ancestor
153871695|NCT01088048|Growth Inhibitors|growth inhibitors|mesh-ancestor
153430130|NCT01035073|Antidepressive Agents|antidepressive agents|mesh-ancestor
153430131|NCT01035073|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153430132|NCT01035073|Dopamine Agents|dopamine agents|mesh-ancestor
153430133|NCT04331743|Mitoxantrone|mitoxantrone|mesh-list
153430134|NCT04331743|Analgesics|analgesics|mesh-ancestor
153430135|NCT04331743|Sensory System Agents|sensory system agents|mesh-ancestor
153871697|NCT01088048|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153871698|NCT01088048|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153871699|NCT01088048|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153871700|NCT01088048|Alkylating Agents|alkylating agents|mesh-ancestor
153871701|NCT01087970|Carboplatin|carboplatin|mesh-list
153871702|NCT01087970|Pemetrexed|pemetrexed|mesh-list
153871703|NCT01087970|Cetuximab|cetuximab|mesh-list
153871704|NCT01087970|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153871705|NCT01087970|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153871720|NCT01087814|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
153412347|NCT00005799|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153412348|NCT00005799|Antimetabolites|antimetabolites|mesh-ancestor
153412349|NCT00005799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153412350|NCT00005799|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153412351|NCT00005799|Immunologic Factors|immunologic factors|mesh-ancestor
153412352|NCT00005799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153412356|NCT00005799|Dermatologic Agents|dermatologic agents|mesh-ancestor
153412357|NCT00005799|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153412358|NCT00005799|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
153412359|NCT00005799|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153412360|NCT00005799|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
153871721|NCT01087814|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
153871722|NCT01087814|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
153871723|NCT04554030|Immunomodulating Agents|immunomodulating agents|mesh-list
153871724|NCT04554030|Immunologic Factors|immunologic factors|mesh-ancestor
153871725|NCT04554030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153871726|NCT01087502|Glimepiride|glimepiride|mesh-list
153871727|NCT01087502|Linagliptin|linagliptin|mesh-list
153871728|NCT01087502|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153871729|NCT01087502|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153871730|NCT01087502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153871731|NCT01087502|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153871732|NCT01087502|Immunologic Factors|immunologic factors|mesh-ancestor
153871733|NCT01087502|Incretins|incretins|mesh-ancestor
153871734|NCT01087502|Hormones|hormones|mesh-ancestor
153871735|NCT01087502|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153412361|NCT00005799|Antitubercular Agents|antitubercular agents|mesh-ancestor
153412362|NCT00005799|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153412363|NCT00386373|Imatinib Mesylate|imatinib mesylate|mesh-list
153412367|NCT00386373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153412368|NCT00386373|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153412370|NCT00005811|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
153412371|NCT00005811|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153412372|NCT00005811|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153412373|NCT00005811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153871736|NCT01087502|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
153871737|NCT01087502|Protease Inhibitors|protease inhibitors|mesh-ancestor
153871738|NCT01087502|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153871739|NCT01087502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153871740|NCT02213211|Lumefantrine|lumefantrine|mesh-list
153871741|NCT02213211|Artemether|artemether|mesh-list
153871742|NCT02213211|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
153871743|NCT02213211|Artemisinins|artemisinins|mesh-list
153871744|NCT02213211|Artemisinin|artemisinin|mesh-list
153871745|NCT02213211|Antimalarials|antimalarials|mesh-ancestor
153871746|NCT02213211|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153871747|NCT02213211|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153871748|NCT02213211|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153871749|NCT01086410|Fluticasone|fluticasone|mesh-list
153412374|NCT00005811|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153412375|NCT02520518|Dapagliflozin|dapagliflozin|mesh-list
153871767|NCT04553601|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
153871768|NCT04553601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153871769|NCT04553328|Bupivacaine|bupivacaine|mesh-list
153871770|NCT04553328|Anesthetics, Local|anesthetics, local|mesh-ancestor
153871771|NCT04553328|Anesthetics|anesthetics|mesh-ancestor
153871772|NCT04553328|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153871773|NCT04553328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153871774|NCT04553328|Sensory System Agents|sensory system agents|mesh-ancestor
153871775|NCT04553328|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153871776|NCT01085591|Vancomycin|vancomycin|mesh-list
153871777|NCT01085591|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153871778|NCT01085591|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153871779|NCT04552977|Temozolomide|temozolomide|mesh-list
153871780|NCT04552977|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153871781|NCT04552977|Alkylating Agents|alkylating agents|mesh-ancestor
153871782|NCT04552977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153871783|NCT04552977|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153871784|NCT01085201|Regadenoson|regadenoson|mesh-list
153871785|NCT01085201|Adenosine A2 Receptor Agonists|adenosine a2 receptor agonists|mesh-ancestor
153871786|NCT01085201|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
153871787|NCT01085201|Purinergic Agonists|purinergic agonists|mesh-ancestor
153871788|NCT01085201|Purinergic Agents|purinergic agents|mesh-ancestor
153871789|NCT01085201|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153871790|NCT01085201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153871792|NCT02213718|Sufentanil|sufentanil|mesh-list
153871793|NCT02213718|Propofol|propofol|mesh-list
153871794|NCT02213718|Desflurane|desflurane|mesh-list
153871795|NCT02213718|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153871796|NCT02213718|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153871797|NCT02213718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153871798|NCT02213718|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153871799|NCT02213718|Anesthetics, General|anesthetics, general|mesh-ancestor
153871801|NCT02213718|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153871802|NCT02213718|Narcotics|narcotics|mesh-ancestor
153871803|NCT02213718|Analgesics|analgesics|mesh-ancestor
153871804|NCT02213718|Sensory System Agents|sensory system agents|mesh-ancestor
153871805|NCT02213718|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153871806|NCT02213718|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153412383|NCT01689987|Dexamethasone acetate|dexamethasone acetate|mesh-list
153871807|NCT02213718|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
153871808|NCT01085045|Bromides|bromides|mesh-list
153871809|NCT01085045|Formoterol Fumarate|formoterol fumarate|mesh-list
153871810|NCT01085045|Tiotropium Bromide|tiotropium bromide|mesh-list
153871811|NCT01085045|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153871812|NCT01085045|Autonomic Agents|autonomic agents|mesh-ancestor
153871813|NCT01085045|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153871815|NCT01085045|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153412441|NCT02483000|Etoposide|etoposide|mesh-list
153412442|NCT02483000|Podophyllotoxin|podophyllotoxin|mesh-list
153412443|NCT02483000|Etoposide phosphate|etoposide phosphate|mesh-list
153412444|NCT02483000|Melphalan|melphalan|mesh-list
153412445|NCT02483000|Mechlorethamine|mechlorethamine|mesh-list
153412446|NCT02483000|Carmustine|carmustine|mesh-list
153412447|NCT02483000|Nitrogen Mustard Compounds|nitrogen mustard compounds|mesh-list
153412448|NCT02483000|1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid|1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid|mesh-list
153412449|NCT02483000|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153412450|NCT02483000|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153412451|NCT02483000|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153412452|NCT02483000|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153412453|NCT02483000|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153412454|NCT02483000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153412455|NCT02483000|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153871816|NCT01085045|Respiratory System Agents|respiratory system agents|mesh-ancestor
153871819|NCT01085045|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153871820|NCT01085045|Adrenergic Agents|adrenergic agents|mesh-ancestor
153871821|NCT01085045|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153871822|NCT01085045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153871823|NCT01085045|Parasympatholytics|parasympatholytics|mesh-ancestor
153871824|NCT01085045|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
153871825|NCT01085045|Cholinergic Agents|cholinergic agents|mesh-ancestor
153871826|NCT01085045|Anticonvulsants|anticonvulsants|mesh-ancestor
153871827|NCT02213796|Meropenem|meropenem|mesh-list
153871828|NCT02213796|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153871829|NCT02213796|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153871830|NCT00179673|Lenalidomide|lenalidomide|mesh-list
153412456|NCT02483000|Antimetabolites|antimetabolites|mesh-ancestor
153412457|NCT02483000|Antiviral Agents|antiviral agents|mesh-ancestor
153412458|NCT02483000|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153412459|NCT02483000|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153412460|NCT02483000|Immunologic Factors|immunologic factors|mesh-ancestor
153412461|NCT02483000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153412462|NCT02483000|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153412463|NCT02483000|Alkylating Agents|alkylating agents|mesh-ancestor
153412464|NCT02483000|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153412465|NCT02483000|Chelating Agents|chelating agents|mesh-ancestor
153412466|NCT02483000|Sequestering Agents|sequestering agents|mesh-ancestor
153412467|NCT02483000|Keratolytic Agents|keratolytic agents|mesh-ancestor
153412468|NCT02483000|Dermatologic Agents|dermatologic agents|mesh-ancestor
153412469|NCT02483000|Tubulin Modulators|tubulin modulators|mesh-ancestor
153412470|NCT02483000|Antimitotic Agents|antimitotic agents|mesh-ancestor
153412471|NCT02483000|Mitosis Modulators|mitosis modulators|mesh-ancestor
153412472|NCT02483000|Vitamin B Complex|vitamin b complex|mesh-ancestor
153412473|NCT02483000|Vitamins|vitamins|mesh-ancestor
153412474|NCT02483000|Micronutrients|micronutrients|mesh-ancestor
153412475|NCT02420210|Dexamethasone|dexamethasone|mesh-list
153412476|NCT02420210|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
153412477|NCT02420210|Obinutuzumab|obinutuzumab|mesh-list
153412478|NCT02420210|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153412479|NCT02420210|Antiemetics|antiemetics|mesh-ancestor
153412480|NCT02420210|Autonomic Agents|autonomic agents|mesh-ancestor
153412481|NCT02420210|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153412486|NCT02420210|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153871832|NCT00179673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153871833|NCT00179673|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153412492|NCT02420210|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153871834|NCT00179673|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153871835|NCT00179673|Growth Substances|growth substances|mesh-ancestor
153871836|NCT00179673|Growth Inhibitors|growth inhibitors|mesh-ancestor
153871837|NCT00179673|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153871838|NCT01084655|Prednisone|prednisone|mesh-list
153871839|NCT01084655|Docetaxel|docetaxel|mesh-list
153871840|NCT01084655|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153871841|NCT01084655|Tubulin Modulators|tubulin modulators|mesh-ancestor
153871842|NCT01084655|Antimitotic Agents|antimitotic agents|mesh-ancestor
153871843|NCT01084655|Mitosis Modulators|mitosis modulators|mesh-ancestor
153871844|NCT01084655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153871845|NCT01084655|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153871846|NCT01084655|Glucocorticoids|glucocorticoids|mesh-ancestor
153871847|NCT01084655|Hormones|hormones|mesh-ancestor
153871849|NCT01084655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153412497|NCT04829799|Anesthetics, Local|anesthetics, local|mesh-ancestor
153412498|NCT04829799|Anesthetics|anesthetics|mesh-ancestor
153412499|NCT04829799|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153412500|NCT04829799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153412501|NCT04829799|Sensory System Agents|sensory system agents|mesh-ancestor
153412502|NCT04829799|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153412503|NCT04829799|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153412504|NCT04829799|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
153412505|NCT04829799|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153412506|NCT04829799|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153412507|NCT04829799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153412508|NCT04829799|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153412509|NCT04829799|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153412510|NCT04829799|Analgesics|analgesics|mesh-ancestor
153412511|NCT04829799|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153871867|NCT04552431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153871868|NCT04552431|Urological Agents|urological agents|mesh-ancestor
153871869|NCT01084538|Ergocalciferols|ergocalciferols|mesh-list
153871870|NCT01084538|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153871871|NCT01084538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153871872|NCT01084538|Vitamins|vitamins|mesh-ancestor
153871873|NCT01084538|Micronutrients|micronutrients|mesh-ancestor
153871874|NCT01084538|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153871875|NCT00179517|Anastrozole|anastrozole|mesh-list
153871876|NCT00179517|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153871877|NCT00179517|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153871878|NCT00179517|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
153871879|NCT00179517|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153871880|NCT00179517|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153871881|NCT00179517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153871882|NCT00179517|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
153871883|NCT00179517|Hormone Antagonists|hormone antagonists|mesh-ancestor
153412512|NCT04829799|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153412513|NCT04829799|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153412514|NCT04829799|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153412515|NCT04829799|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
153412517|NCT04829799|Autonomic Agents|autonomic agents|mesh-ancestor
153412518|NCT04829799|Sympathomimetics|sympathomimetics|mesh-ancestor
153412519|NCT04829799|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
153412520|NCT04829799|Nasal Decongestants|nasal decongestants|mesh-ancestor
153412521|NCT04829799|Respiratory System Agents|respiratory system agents|mesh-ancestor
153412522|NCT04829799|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
153412523|NCT04829799|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153871884|NCT00179517|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153871885|NCT00179517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153871886|NCT01083641|Estradiol|estradiol|mesh-list
153871887|NCT01083641|Estrogens|estrogens|mesh-ancestor
153871888|NCT01083641|Hormones|hormones|mesh-ancestor
153871889|NCT01083641|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153871890|NCT01083641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153871891|NCT00179010|Adenosine|adenosine|mesh-list
153871893|NCT00179010|Sensory System Agents|sensory system agents|mesh-ancestor
153871894|NCT00179010|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153871895|NCT00179010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153412524|NCT04829799|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153871906|NCT01083602|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153871908|NCT01083602|Autonomic Agents|autonomic agents|mesh-ancestor
153871909|NCT01083602|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153871910|NCT01083602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153871911|NCT01083602|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153412541|NCT02524106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153412542|NCT02524106|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153412543|NCT01761877|Sulindac|sulindac|mesh-list
153412544|NCT01761877|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153412545|NCT01761877|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153412546|NCT01761877|Analgesics|analgesics|mesh-ancestor
153412547|NCT01761877|Sensory System Agents|sensory system agents|mesh-ancestor
153412548|NCT01761877|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153412549|NCT01761877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153412550|NCT01761877|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153412551|NCT01761877|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153412552|NCT01761877|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153412553|NCT01761877|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153412554|NCT01761877|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153412555|NCT01761877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153412556|NCT02488070|Edetic Acid|edetic acid|mesh-list
153412557|NCT02488070|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
153412558|NCT02488070|Chelating Agents|chelating agents|mesh-ancestor
153871912|NCT01083602|Glucocorticoids|glucocorticoids|mesh-ancestor
153871913|NCT01083602|Hormones|hormones|mesh-ancestor
153871914|NCT01083602|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153871915|NCT01083602|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153871916|NCT01083602|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153871917|NCT01083602|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
153871918|NCT01083602|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153871919|NCT01083602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153871920|NCT00178464|Aspirin|aspirin|mesh-list
153871921|NCT00178464|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153871922|NCT00178464|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153871926|NCT00178464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153871927|NCT00178464|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153871928|NCT00178464|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153412559|NCT02488070|Sequestering Agents|sequestering agents|mesh-ancestor
153412560|NCT02488070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153412561|NCT02488070|Anticoagulants|anticoagulants|mesh-ancestor
153412562|NCT02488070|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
153412563|NCT02488070|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
153412564|NCT00362869|Levofloxacin|levofloxacin|mesh-list
153412565|NCT00362869|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
153412566|NCT00362869|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153412567|NCT00362869|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153412568|NCT00362869|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153412569|NCT00362869|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153412570|NCT00362869|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153412571|NCT00362869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153412572|NCT00362869|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153412573|NCT00362869|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
153412574|NCT00362869|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153871929|NCT00178464|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153871930|NCT00178464|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153871931|NCT00178464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153871932|NCT00178464|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153871933|NCT00178464|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153871934|NCT00178464|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153871935|NCT00178464|Antipyretics|antipyretics|mesh-ancestor
153871936|NCT04671914|Hyaluronic Acid|hyaluronic acid|mesh-list
153871937|NCT04671914|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153871938|NCT04671914|Immunologic Factors|immunologic factors|mesh-ancestor
153871939|NCT04671914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153871942|NCT01083485|Oxycodone|oxycodone|mesh-list
153412584|NCT02422940|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
153412585|NCT02422940|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153412586|NCT02422940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153412588|NCT00588523|Busulfan|busulfan|mesh-list
153412589|NCT00588523|Thiotepa|thiotepa|mesh-list
153412590|NCT00588523|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153412591|NCT00588523|Alkylating Agents|alkylating agents|mesh-ancestor
153412592|NCT00588523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153412593|NCT00588523|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153412594|NCT00588523|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153412595|NCT00588523|Immunologic Factors|immunologic factors|mesh-ancestor
153412596|NCT00588523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153412597|NCT00588523|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153412598|NCT02974387|Loteprednol Etabonate|loteprednol etabonate|mesh-list
153412599|NCT02974387|Fluorometholone|fluorometholone|mesh-list
153871948|NCT01083485|Analgesics|analgesics|mesh-ancestor
153871949|NCT01083485|Sensory System Agents|sensory system agents|mesh-ancestor
153871950|NCT01083485|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153871951|NCT01083485|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
153871952|NCT04551924|Ropivacaine|ropivacaine|mesh-list
153871953|NCT04551924|Anesthetics, Local|anesthetics, local|mesh-ancestor
153871954|NCT04551924|Anesthetics|anesthetics|mesh-ancestor
153871955|NCT04551924|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153871956|NCT04551924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153871957|NCT04551924|Sensory System Agents|sensory system agents|mesh-ancestor
153871958|NCT04551924|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153889012|NCT01026493|Temozolomide|temozolomide|mesh-list
153889013|NCT01026493|Veliparib|veliparib|mesh-list
153889014|NCT01026493|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153889015|NCT01026493|Alkylating Agents|alkylating agents|mesh-ancestor
153871959|NCT04671836|Lorazepam|lorazepam|mesh-list
153871960|NCT04671836|Anticonvulsants|anticonvulsants|mesh-ancestor
153871961|NCT04671836|Antiemetics|antiemetics|mesh-ancestor
153871962|NCT04671836|Autonomic Agents|autonomic agents|mesh-ancestor
153871963|NCT04671836|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153871964|NCT04671836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153871965|NCT04671836|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153871971|NCT04671836|GABA Modulators|gaba modulators|mesh-ancestor
153412600|NCT02974387|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
153412601|NCT02974387|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153412602|NCT02974387|Glucocorticoids|glucocorticoids|mesh-ancestor
153412603|NCT02974387|Hormones|hormones|mesh-ancestor
153412604|NCT02974387|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153412605|NCT02974387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153412606|NCT00430183|Docetaxel|docetaxel|mesh-list
153412607|NCT00430183|Leuprolide|leuprolide|mesh-list
153412608|NCT00430183|Goserelin|goserelin|mesh-list
153412609|NCT00430183|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153412610|NCT00430183|Tubulin Modulators|tubulin modulators|mesh-ancestor
153412611|NCT00430183|Antimitotic Agents|antimitotic agents|mesh-ancestor
153412612|NCT00430183|Mitosis Modulators|mitosis modulators|mesh-ancestor
153412613|NCT00430183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153412614|NCT00430183|Fertility Agents, Female|fertility agents, female|mesh-ancestor
153412615|NCT00430183|Fertility Agents|fertility agents|mesh-ancestor
153412616|NCT00430183|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153412617|NCT00430183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153871972|NCT04671836|GABA Agents|gaba agents|mesh-ancestor
153871973|NCT04671836|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153871974|NCT04671836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153871975|NCT00556088|Paclitaxel|paclitaxel|mesh-list
153871976|NCT00556088|Bevacizumab|bevacizumab|mesh-list
153871977|NCT00556088|Carboplatin|carboplatin|mesh-list
153871978|NCT00556088|Panobinostat|panobinostat|mesh-list
153871979|NCT00556088|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153871980|NCT00556088|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153871981|NCT00556088|Tubulin Modulators|tubulin modulators|mesh-ancestor
153871982|NCT00556088|Antimitotic Agents|antimitotic agents|mesh-ancestor
153871983|NCT00556088|Mitosis Modulators|mitosis modulators|mesh-ancestor
153871984|NCT00556088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153871985|NCT00556088|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153871986|NCT00556088|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153871987|NCT00556088|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153412619|NCT00362947|Parnaparin|parnaparin|mesh-list
153412621|NCT00362947|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153412622|NCT00362947|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153412623|NCT00362947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153412624|NCT00363025|Daunorubicin|daunorubicin|mesh-list
153412626|NCT00363025|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153412627|NCT00363025|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153412628|NCT00363025|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153412629|NCT00363025|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153412630|NCT00363025|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153412631|NCT00363025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153412633|NCT02444143|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153871989|NCT00556088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153871990|NCT00556088|Growth Inhibitors|growth inhibitors|mesh-ancestor
153871991|NCT00556088|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
153871992|NCT00556088|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153871993|NCT00177294|Escitalopram|escitalopram|mesh-list
153871994|NCT00177294|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
153871995|NCT00177294|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153871996|NCT00177294|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153871997|NCT00177294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153871998|NCT00177294|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153871999|NCT00177294|Serotonin Agents|serotonin agents|mesh-ancestor
153872000|NCT00177294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153872001|NCT01082081|Acetaminophen|acetaminophen|mesh-list
153872002|NCT01082081|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153872003|NCT01082081|Analgesics|analgesics|mesh-ancestor
153412634|NCT02444143|Immunologic Factors|immunologic factors|mesh-ancestor
153412635|NCT02444143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153412636|NCT02444143|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
153412637|NCT02444143|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153412638|NCT02444143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153412645|NCT02446483|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153412646|NCT02446483|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
153412647|NCT02446483|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153412648|NCT02446483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153412649|NCT00362635|Clevudine|clevudine|mesh-list
153872004|NCT01082081|Sensory System Agents|sensory system agents|mesh-ancestor
153872005|NCT01082081|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153872006|NCT01082081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153872007|NCT01082081|Antipyretics|antipyretics|mesh-ancestor
153872008|NCT00177216|Zolpidem|zolpidem|mesh-list
153872009|NCT00177216|Escitalopram|escitalopram|mesh-list
153872010|NCT00177216|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
153872011|NCT00177216|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153872012|NCT00177216|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153872013|NCT00177216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153872014|NCT00177216|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153872015|NCT00177216|Serotonin Agents|serotonin agents|mesh-ancestor
153872016|NCT00177216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153872017|NCT00177216|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
153412650|NCT00362635|Antiviral Agents|antiviral agents|mesh-ancestor
153412651|NCT00362635|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153412652|NCT04744753|Calcimycin|calcimycin|mesh-list
153412653|NCT04744753|Calcium|calcium|mesh-list
153412654|NCT04744753|Ionophores|ionophores|mesh-list
153412655|NCT04744753|Calcium Ionophores|calcium ionophores|mesh-list
153412657|NCT04744753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153872031|NCT01081769|Serotonin Agents|serotonin agents|mesh-ancestor
153872032|NCT01081769|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153412667|NCT02420041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153412668|NCT02420041|Sensory System Agents|sensory system agents|mesh-ancestor
153412669|NCT02420041|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153412670|NCT02420041|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153412671|NCT02420041|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
153412672|NCT02420041|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153412673|NCT02420041|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153412674|NCT02420041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153412675|NCT02420041|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153412676|NCT02420041|Glucocorticoids|glucocorticoids|mesh-ancestor
153412678|NCT02420041|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153412679|NCT02421211|Sofosbuvir|sofosbuvir|mesh-list
153412680|NCT02421211|Ledipasvir|ledipasvir|mesh-list
153412681|NCT02421211|Simeprevir|simeprevir|mesh-list
153412682|NCT02421211|Antiviral Agents|antiviral agents|mesh-ancestor
153412683|NCT02421211|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153412685|NCT02421211|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153412686|NCT02421211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153412687|NCT00363259|Ribavirin|ribavirin|mesh-list
153412688|NCT00363259|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
153412689|NCT00363259|Antimetabolites|antimetabolites|mesh-ancestor
153412690|NCT00363259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153412691|NCT00363259|Antiviral Agents|antiviral agents|mesh-ancestor
153412692|NCT00363259|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153412693|NCT02424968|Cyclosporine|cyclosporine|mesh-list
153872041|NCT04551768|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153872042|NCT04671563|Tenofovir|tenofovir|mesh-list
153872043|NCT04671563|Antiviral Agents|antiviral agents|mesh-ancestor
153872044|NCT04671563|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153872045|NCT04671563|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153872046|NCT04671563|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153872047|NCT04671563|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153872048|NCT04671563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153872049|NCT04671563|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153872050|NCT04671563|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153872051|NCT04551573|Rifapentine|rifapentine|mesh-list
153872052|NCT04551573|Rifampin|rifampin|mesh-list
153872053|NCT04551573|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
153872054|NCT04551573|Antitubercular Agents|antitubercular agents|mesh-ancestor
153872055|NCT04551573|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153872056|NCT04551573|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153872057|NCT04551573|Leprostatic Agents|leprostatic agents|mesh-ancestor
153872058|NCT04551573|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153872059|NCT04551573|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153872060|NCT04551573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153872061|NCT04551573|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
153872062|NCT04551573|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
153412700|NCT02424968|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153412701|NCT02424968|Immunologic Factors|immunologic factors|mesh-ancestor
153412702|NCT02424968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153412703|NCT02424968|Antifungal Agents|antifungal agents|mesh-ancestor
153412704|NCT02424968|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153412705|NCT02424968|Dermatologic Agents|dermatologic agents|mesh-ancestor
153412706|NCT02424968|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153412707|NCT02424968|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
153412708|NCT02424968|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153412709|NCT02424968|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153412710|NCT02424968|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
153412711|NCT02424968|Antitubercular Agents|antitubercular agents|mesh-ancestor
153412712|NCT02424968|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153412713|NCT02424799|GSK2646264|gsk2646264|mesh-list
153412714|NCT02424799|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153412719|NCT02492750|Lenalidomide|lenalidomide|mesh-list
153412720|NCT02492750|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
153412721|NCT02492750|Ichthammol|ichthammol|mesh-list
153412722|NCT02492750|BB 1101|bb 1101|mesh-list
153412723|NCT02492750|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153412724|NCT02492750|Antiemetics|antiemetics|mesh-ancestor
153412725|NCT02492750|Autonomic Agents|autonomic agents|mesh-ancestor
153412726|NCT02492750|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153412727|NCT02492750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153872075|NCT01081145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153872076|NCT00174915|Allopurinol|allopurinol|mesh-list
153872077|NCT00174915|Febuxostat|febuxostat|mesh-list
153872078|NCT00174915|Antimetabolites|antimetabolites|mesh-ancestor
153872079|NCT00174915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153872080|NCT00174915|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153872081|NCT00174915|Gout Suppressants|gout suppressants|mesh-ancestor
153872082|NCT00174915|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153872083|NCT00174915|Free Radical Scavengers|free radical scavengers|mesh-ancestor
153872084|NCT00174915|Antioxidants|antioxidants|mesh-ancestor
153872085|NCT00174915|Protective Agents|protective agents|mesh-ancestor
153872086|NCT00174915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153872087|NCT01080716|Vaccines|vaccines|mesh-list
153872088|NCT01080716|Complement Factor H|complement factor h|mesh-list
153872089|NCT01080716|Immunologic Factors|immunologic factors|mesh-ancestor
153872090|NCT01080716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153872091|NCT01080716|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
153872092|NCT01080716|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153889018|NCT01026493|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
153889020|NCT01291173|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
153872093|NCT04671446|Autoantibodies|autoantibodies|mesh-list
153872094|NCT04671446|Immunologic Factors|immunologic factors|mesh-ancestor
153872095|NCT04671446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153872096|NCT04571489|Gemcitabine|gemcitabine|mesh-list
153872097|NCT04571489|Tegafur|tegafur|mesh-list
153872098|NCT04571489|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153412737|NCT02492750|Growth Substances|growth substances|mesh-ancestor
153412738|NCT02492750|Growth Inhibitors|growth inhibitors|mesh-ancestor
153412739|NCT02492750|Protease Inhibitors|protease inhibitors|mesh-ancestor
153412740|NCT02492750|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153412741|NCT02492750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153412742|NCT02492750|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153412743|NCT02492750|Dermatologic Agents|dermatologic agents|mesh-ancestor
153412744|NCT00363337|Aripiprazole|aripiprazole|mesh-list
153412745|NCT00363337|Antidepressive Agents|antidepressive agents|mesh-ancestor
153412746|NCT00363337|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153412747|NCT00363337|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153889021|NCT01291173|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
153889022|NCT01291173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153889023|NCT01291173|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
153889024|NCT01291173|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153872100|NCT04571489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153872102|NCT00172185|Teduglutide|teduglutide|mesh-list
153872103|NCT00172185|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153872104|NCT00172185|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
153872105|NCT00172185|Protective Agents|protective agents|mesh-ancestor
153872106|NCT00172185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153872107|NCT00171951|Pasireotide|pasireotide|mesh-list
153872108|NCT00171951|Hormones|hormones|mesh-ancestor
153872109|NCT00171951|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153872110|NCT00171951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153872111|NCT01080131|Triamcinolone|triamcinolone|mesh-list
153872112|NCT01080131|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
153872113|NCT01080131|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
153872114|NCT01080131|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
153412753|NCT00363337|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153412754|NCT00363337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153412755|NCT00363337|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
153412756|NCT00363337|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
153412757|NCT00363337|Serotonin Agents|serotonin agents|mesh-ancestor
153412758|NCT00363337|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
153412759|NCT00363337|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153412760|NCT00363337|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
153412761|NCT00363337|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
153412762|NCT02493452|Plecanatide|plecanatide|mesh-list
153412763|NCT02493452|Guanylyl Cyclase C Agonists|guanylyl cyclase c agonists|mesh-ancestor
153412764|NCT02493452|Enzyme Activators|enzyme activators|mesh-ancestor
153889027|NCT01291173|Dopamine Agents|dopamine agents|mesh-ancestor
153889028|NCT01291173|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153889029|NCT01291017|Palbociclib|palbociclib|mesh-list
153889030|NCT01291017|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153889031|NCT01291017|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153889032|NCT01291017|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153430137|NCT04331743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153430138|NCT04331743|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153412765|NCT02493452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153872129|NCT01087151|Rituximab|rituximab|mesh-list
153412766|NCT02493452|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153412767|NCT02429869|Everolimus|everolimus|mesh-list
153412768|NCT02429869|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
153412769|NCT02429869|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153430139|NCT04331743|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153430140|NCT04331743|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153430141|NCT04331743|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153430142|NCT04331743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153430144|NCT05296759|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
153412770|NCT02429869|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153412771|NCT02429869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153412772|NCT02429869|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153412773|NCT02429869|Immunologic Factors|immunologic factors|mesh-ancestor
153412774|NCT02429869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153412776|NCT02428478|Desipramine|desipramine|mesh-list
153412777|NCT02428478|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
153412778|NCT02428478|Antidepressive Agents|antidepressive agents|mesh-ancestor
153412779|NCT02428478|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153412780|NCT02428478|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153412781|NCT02428478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153412782|NCT02428478|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
153412783|NCT02428478|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153412784|NCT02428478|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153412785|NCT02428478|Adrenergic Agents|adrenergic agents|mesh-ancestor
153412786|NCT02428478|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153412787|NCT02428478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153872131|NCT01087151|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153872132|NCT01087151|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153412791|NCT04341493|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153412792|NCT04341493|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153430145|NCT05296759|Botulinum Toxins|botulinum toxins|mesh-list
153430146|NCT05296759|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
153430147|NCT05296759|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
153430148|NCT05296759|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
153412793|NCT04341493|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153412794|NCT04341493|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153412795|NCT04341493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153412796|NCT04341493|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153412797|NCT02432287|Metformin|metformin|mesh-list
153412798|NCT02432287|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153412799|NCT02432287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153412800|NCT02532998|Fludrocortisone|fludrocortisone|mesh-list
153412801|NCT02532998|Eplerenone|eplerenone|mesh-list
153872153|NCT00171249|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153872154|NCT00171249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153872155|NCT00171249|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153872160|NCT01082549|Gemcitabine|gemcitabine|mesh-list
153872161|NCT01082549|Iniparib|iniparib|mesh-list
153872162|NCT01082549|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153872163|NCT01082549|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153872164|NCT01082549|Antimetabolites|antimetabolites|mesh-ancestor
153872165|NCT01082549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153412802|NCT02532998|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
153412803|NCT02532998|Hormone Antagonists|hormone antagonists|mesh-ancestor
153412804|NCT02532998|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153412824|NCT02974244|Exenatide|exenatide|mesh-list
153412825|NCT02974244|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153412826|NCT02974244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153412827|NCT02974244|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
153412828|NCT02974244|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
153412829|NCT02974244|Incretins|incretins|mesh-ancestor
153872166|NCT01082549|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
153872167|NCT01082549|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153872168|NCT04550949|Denosumab|denosumab|mesh-list
153872169|NCT04550949|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153872170|NCT04550949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153872171|NCT01085630|Pemetrexed|pemetrexed|mesh-list
153872172|NCT01085630|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153872173|NCT01085630|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153872174|NCT01085630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153872175|NCT01085630|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153872176|NCT01085630|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153872177|NCT00171210|Deferasirox|deferasirox|mesh-list
153872178|NCT00171210|Iron Chelating Agents|iron chelating agents|mesh-ancestor
153872179|NCT00171210|Chelating Agents|chelating agents|mesh-ancestor
153872180|NCT00171210|Sequestering Agents|sequestering agents|mesh-ancestor
153872182|NCT00171054|Amlodipine|amlodipine|mesh-list
153412848|NCT02454283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153412849|NCT02454283|Dopamine Agents|dopamine agents|mesh-ancestor
153412850|NCT02454283|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153872192|NCT00171054|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
153872193|NCT00171054|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
153872194|NCT00171054|Diuretics|diuretics|mesh-ancestor
153872195|NCT00171054|Natriuretic Agents|natriuretic agents|mesh-ancestor
153872196|NCT00171054|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
153872197|NCT00174837|Tirapazamine|tirapazamine|mesh-list
153872198|NCT00174837|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153872199|NCT00179400|Pioglitazone|pioglitazone|mesh-list
153872200|NCT00179400|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153872201|NCT00179400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153872202|NCT04550793|Botulinum Toxins|botulinum toxins|mesh-list
153872203|NCT04550793|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
153872204|NCT04550793|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153872205|NCT04550793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153872206|NCT04550793|Cholinergic Agents|cholinergic agents|mesh-ancestor
153872207|NCT04550793|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153872226|NCT04997759|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153872227|NCT04997759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153872228|NCT04997759|Cholinergic Agents|cholinergic agents|mesh-ancestor
153872229|NCT04997759|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153412870|NCT02430818|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153412871|NCT02430818|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
153412872|NCT02430818|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
153412873|NCT02430818|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153412874|NCT02430818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153412875|NCT02430818|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153412876|NCT02430818|Narcotics|narcotics|mesh-ancestor
153412877|NCT02455453|Estradiol|estradiol|mesh-list
153412878|NCT02455453|Estrogens|estrogens|mesh-ancestor
153412879|NCT02455453|Hormones|hormones|mesh-ancestor
153412880|NCT02455453|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153872230|NCT04997759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153872231|NCT04997759|Parasympathomimetics|parasympathomimetics|mesh-ancestor
153872232|NCT04997759|Autonomic Agents|autonomic agents|mesh-ancestor
153872233|NCT04997759|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153872234|NCT00479466|Metformin|metformin|mesh-list
153872235|NCT00479466|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153872236|NCT00479466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153872237|NCT04991948|Pembrolizumab|pembrolizumab|mesh-list
153872253|NCT00479388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153872254|NCT00479388|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153412895|NCT02519023|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153412896|NCT02519023|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153412897|NCT02519023|Analgesics|analgesics|mesh-ancestor
153412898|NCT02519023|Antipyretics|antipyretics|mesh-ancestor
153412899|NCT02519023|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153412900|NCT02519023|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153412901|NCT02519023|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153412902|NCT02519023|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153412903|NCT02519023|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153412904|NCT02519023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153412905|NCT02519023|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153412906|NCT02519023|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153412907|NCT02519023|Adrenergic Agents|adrenergic agents|mesh-ancestor
153412908|NCT02519023|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153412909|NCT02519023|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
153412910|NCT02519023|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153872271|NCT00478881|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
153872272|NCT00478881|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
153872273|NCT00478881|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153872274|NCT00478881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153872275|NCT00478881|Urological Agents|urological agents|mesh-ancestor
153872277|NCT00556127|Dexamethasone|dexamethasone|mesh-list
153872278|NCT00556127|Prednisone|prednisone|mesh-list
153872279|NCT00556127|Cyclophosphamide|cyclophosphamide|mesh-list
153872280|NCT00556127|Melphalan|melphalan|mesh-list
153872281|NCT00556127|Carmustine|carmustine|mesh-list
153872282|NCT00556127|Rituximab|rituximab|mesh-list
153872283|NCT00556127|Etoposide|etoposide|mesh-list
153872284|NCT00556127|Vincristine|vincristine|mesh-list
153872285|NCT00556127|Epirubicin|epirubicin|mesh-list
153872286|NCT00556127|Mitoxantrone|mitoxantrone|mesh-list
153412926|NCT02497040|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153412927|NCT02523235|Ropivacaine|ropivacaine|mesh-list
153412928|NCT02523235|Anesthetics, Local|anesthetics, local|mesh-ancestor
153412929|NCT02523235|Anesthetics|anesthetics|mesh-ancestor
153412930|NCT02523235|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153412931|NCT02523235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153872296|NCT00556127|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153872297|NCT00556127|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153872298|NCT00556127|Antiemetics|antiemetics|mesh-ancestor
153872299|NCT00556127|Autonomic Agents|autonomic agents|mesh-ancestor
153872302|NCT00556127|Glucocorticoids|glucocorticoids|mesh-ancestor
153872303|NCT00556127|Hormones|hormones|mesh-ancestor
153872304|NCT00556127|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153872305|NCT00556127|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153872306|NCT00556127|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153872307|NCT00556127|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153872308|NCT00556127|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153872309|NCT00556127|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153872310|NCT00556127|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153412952|NCT02459275|Autonomic Agents|autonomic agents|mesh-ancestor
153412959|NCT02459275|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153412960|NCT02459275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153412962|NCT02524561|Progesterone|progesterone|mesh-list
153412963|NCT02524561|Estrogens|estrogens|mesh-ancestor
153412964|NCT02524561|Hormones|hormones|mesh-ancestor
153872312|NCT00556127|Antimetabolites|antimetabolites|mesh-ancestor
153872313|NCT00556127|Antiviral Agents|antiviral agents|mesh-ancestor
153872314|NCT00556127|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153872315|NCT00556127|Tubulin Modulators|tubulin modulators|mesh-ancestor
153872316|NCT00556127|Antimitotic Agents|antimitotic agents|mesh-ancestor
153872317|NCT00556127|Mitosis Modulators|mitosis modulators|mesh-ancestor
153872318|NCT00556127|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153872319|NCT00556127|Analgesics|analgesics|mesh-ancestor
153872320|NCT00556127|Sensory System Agents|sensory system agents|mesh-ancestor
153872321|NCT00556127|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153872322|NCT00556205|Bevacizumab|bevacizumab|mesh-list
153872323|NCT00556205|Sunitinib|sunitinib|mesh-list
153872324|NCT00556205|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153872325|NCT00556205|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153872326|NCT00556205|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153872327|NCT00556205|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153872328|NCT00556205|Growth Substances|growth substances|mesh-ancestor
153872329|NCT00556205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153872330|NCT00556205|Growth Inhibitors|growth inhibitors|mesh-ancestor
153872331|NCT00556205|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153872332|NCT00556205|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153872333|NCT00556205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153872334|NCT00478608|Sirolimus|sirolimus|mesh-list
153872335|NCT00478608|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153872336|NCT00478608|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153872337|NCT00478608|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153412979|NCT04743739|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153412980|NCT04743739|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153412981|NCT04743739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153412982|NCT04743739|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153412988|NCT02461693|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
153412989|NCT02461693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153412990|NCT02461693|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
153412991|NCT02461693|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153412992|NCT02461693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153412993|NCT02461693|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
153412994|NCT02461693|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
153412995|NCT02461693|Purinergic Agents|purinergic agents|mesh-ancestor
153412996|NCT02461693|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153412997|NCT02525653|Paclitaxel|paclitaxel|mesh-list
153412998|NCT02525653|Gemcitabine|gemcitabine|mesh-list
153412999|NCT02525653|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
153872350|NCT00478023|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153413021|NCT02526667|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153872365|NCT00477750|Glucocorticoids|glucocorticoids|mesh-ancestor
153872366|NCT00477750|Hormones|hormones|mesh-ancestor
153872367|NCT00477750|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153872368|NCT00477750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153872369|NCT00477750|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153872370|NCT00477750|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153872371|NCT00477750|Immunologic Factors|immunologic factors|mesh-ancestor
153872372|NCT00477750|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153872373|NCT00477750|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153872374|NCT00477750|Growth Substances|growth substances|mesh-ancestor
153872375|NCT00477750|Growth Inhibitors|growth inhibitors|mesh-ancestor
153413023|NCT02526667|Dermatologic Agents|dermatologic agents|mesh-ancestor
153413024|NCT02535806|Cytarabine|cytarabine|mesh-list
153413025|NCT02535806|Dexamethasone|dexamethasone|mesh-list
153413026|NCT02535806|Hydrocortisone|hydrocortisone|mesh-list
153413027|NCT02535806|Methotrexate|methotrexate|mesh-list
153413028|NCT02535806|Vincristine|vincristine|mesh-list
153413029|NCT02535806|Bortezomib|bortezomib|mesh-list
153413030|NCT02535806|Mitoxantrone|mitoxantrone|mesh-list
153413031|NCT02535806|Pegaspargase|pegaspargase|mesh-list
153889033|NCT01291017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153889034|NCT01290315|Dextrans|dextrans|mesh-list
153889035|NCT01290315|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
153889036|NCT01290315|Iron-Dextran Complex|iron-dextran complex|mesh-list
153889037|NCT01290315|Hematinics|hematinics|mesh-ancestor
153889038|NCT01290315|Anticoagulants|anticoagulants|mesh-ancestor
153889039|NCT01290315|Plasma Substitutes|plasma substitutes|mesh-ancestor
153889040|NCT01290315|Blood Substitutes|blood substitutes|mesh-ancestor
153889041|NCT01289847|gamma-Globulins|gamma-globulins|mesh-list
153413032|NCT02535806|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153872389|NCT00477672|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
153872390|NCT00477672|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153872391|NCT00477672|Serotonin Agents|serotonin agents|mesh-ancestor
153872392|NCT00477672|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153872393|NCT00477672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153872394|NCT04549935|Prednisolone|prednisolone|mesh-list
153872395|NCT04549935|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153872396|NCT04549935|Glucocorticoids|glucocorticoids|mesh-ancestor
153872397|NCT04549935|Hormones|hormones|mesh-ancestor
153872398|NCT04549935|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153872399|NCT04549935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153872400|NCT04549935|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153872401|NCT04549935|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153413045|NCT02535806|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153413046|NCT02535806|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153413047|NCT02535806|Antimetabolites|antimetabolites|mesh-ancestor
153872418|NCT04541823|Desflurane|desflurane|mesh-list
153872419|NCT04541823|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153872420|NCT04541823|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153872421|NCT04541823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153872422|NCT04541823|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153872423|NCT04541823|Anesthetics, General|anesthetics, general|mesh-ancestor
153872424|NCT04541823|Anesthetics|anesthetics|mesh-ancestor
153872425|NCT04541823|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
153872426|NCT00556361|Ketamine|ketamine|mesh-list
153872427|NCT00556361|Analgesics|analgesics|mesh-ancestor
153872428|NCT00556361|Sensory System Agents|sensory system agents|mesh-ancestor
153872429|NCT00556361|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153413072|NCT02537444|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153413073|NCT02537444|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153413074|NCT02537444|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153413075|NCT02537444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153413076|NCT02537444|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153413077|NCT02537444|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153413078|NCT02537444|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153413079|NCT02464033|Vitamin D|vitamin d|mesh-list
153413080|NCT02464033|Cholecalciferol|cholecalciferol|mesh-list
153413081|NCT02464033|Etanercept|etanercept|mesh-list
153413082|NCT02464033|Vitamins|vitamins|mesh-ancestor
153413083|NCT02464033|Micronutrients|micronutrients|mesh-ancestor
153413100|NCT02432456|Narcotics|narcotics|mesh-list
153413101|NCT02432456|Methocarbamol|methocarbamol|mesh-list
153413102|NCT02432456|Pantoprazole|pantoprazole|mesh-list
153413103|NCT02432456|Analgesics|analgesics|mesh-ancestor
153413104|NCT02432456|Sensory System Agents|sensory system agents|mesh-ancestor
153413105|NCT02432456|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153413106|NCT02432456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153413107|NCT02432456|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
153872443|NCT04571606|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153872444|NCT04571606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153872445|NCT04571606|Sensory System Agents|sensory system agents|mesh-ancestor
153872446|NCT04571606|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153872447|NCT04541277|Cytarabine|cytarabine|mesh-list
153872448|NCT04541277|Azacitidine|azacitidine|mesh-list
153872449|NCT04541277|Decitabine|decitabine|mesh-list
153872450|NCT04541277|Tislelizumab|tislelizumab|mesh-list
153872451|NCT04541277|Idarubicin|idarubicin|mesh-list
153872452|NCT04541277|Lenograstim|lenograstim|mesh-list
153872453|NCT04541277|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153872454|NCT04541277|Antimetabolites|antimetabolites|mesh-ancestor
153872455|NCT04541277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153872473|NCT04540926|Immunologic Factors|immunologic factors|mesh-ancestor
153872474|NCT04540926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153872475|NCT04540926|Antifungal Agents|antifungal agents|mesh-ancestor
153872476|NCT04540926|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153872477|NCT04540926|Dermatologic Agents|dermatologic agents|mesh-ancestor
153872478|NCT04540926|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153872479|NCT04540926|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
153413124|NCT02432456|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153413125|NCT02432456|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
153413126|NCT02432456|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
153413127|NCT02432456|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
153413128|NCT02531971|Fentanyl|fentanyl|mesh-list
153413129|NCT02531971|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153413130|NCT02531971|Narcotics|narcotics|mesh-ancestor
153413131|NCT02531971|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153413132|NCT02531971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153413133|NCT02531971|Analgesics|analgesics|mesh-ancestor
153413134|NCT02531971|Sensory System Agents|sensory system agents|mesh-ancestor
153413135|NCT02531971|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153413136|NCT02531971|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153413137|NCT02531971|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153413138|NCT02531971|Anesthetics, General|anesthetics, general|mesh-ancestor
153413139|NCT02531971|Anesthetics|anesthetics|mesh-ancestor
153413140|NCT02464657|Cytarabine|cytarabine|mesh-list
153413141|NCT02464657|Dexamethasone|dexamethasone|mesh-list
153413142|NCT02464657|Methylprednisolone|methylprednisolone|mesh-list
153413143|NCT02464657|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
153872480|NCT04540965|Famotidine|famotidine|mesh-list
153872481|NCT04540965|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
153872482|NCT04540965|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153413145|NCT02464657|Prednisolone|prednisolone|mesh-list
153382944|NCT01740206|Autonomic Agents|autonomic agents|mesh-ancestor
153382945|NCT01740206|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153382946|NCT01740206|Adrenergic Agents|adrenergic agents|mesh-ancestor
153382947|NCT01740206|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
153382948|NCT01740362|Tofacitinib|tofacitinib|mesh-list
153382949|NCT01740362|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
153382950|NCT01740362|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153382951|NCT01740362|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153387719|NCT00000243|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153413146|NCT02464657|Prednisolone acetate|prednisolone acetate|mesh-list
153413147|NCT02464657|Nivolumab|nivolumab|mesh-list
153413148|NCT02464657|Idarubicin|idarubicin|mesh-list
153413149|NCT02464657|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
153413150|NCT02464657|Prednisolone phosphate|prednisolone phosphate|mesh-list
153413151|NCT02464657|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153413152|NCT02464657|Antiemetics|antiemetics|mesh-ancestor
153413153|NCT02464657|Autonomic Agents|autonomic agents|mesh-ancestor
153413154|NCT02464657|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153413155|NCT02464657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153413156|NCT02464657|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153872499|NCT04570592|Autonomic Agents|autonomic agents|mesh-ancestor
153872500|NCT04570592|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153872501|NCT04570592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153872502|NCT04570592|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153872503|NCT04570592|Glucocorticoids|glucocorticoids|mesh-ancestor
153872504|NCT04570592|Hormones|hormones|mesh-ancestor
153872505|NCT04570592|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153872506|NCT04570592|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153872507|NCT04570592|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153872508|NCT04570592|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
153872509|NCT04570592|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153413158|NCT02464657|Hormones|hormones|mesh-ancestor
153413173|NCT02464657|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153413174|NCT02464657|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153413175|NCT02464657|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153413176|NCT02464657|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153413178|NCT02535949|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
153413179|NCT02535949|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153413180|NCT02535949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153413181|NCT02535949|Hemostatics|hemostatics|mesh-ancestor
153413182|NCT02535949|Coagulants|coagulants|mesh-ancestor
153413183|NCT02536105|Methylphenidate|methylphenidate|mesh-list
153413184|NCT02536105|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
153413186|NCT02536105|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
153413187|NCT02536105|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153413188|NCT02536105|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153413189|NCT02536105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153413191|NCT02536105|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153413192|NCT02758951|Bevacizumab|bevacizumab|mesh-list
153413193|NCT02758951|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153413194|NCT02758951|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153413195|NCT02758951|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153413196|NCT02758951|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153413197|NCT02758951|Growth Substances|growth substances|mesh-ancestor
153413198|NCT02758951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153413199|NCT02758951|Growth Inhibitors|growth inhibitors|mesh-ancestor
153413200|NCT02436668|Paclitaxel|paclitaxel|mesh-list
153413201|NCT02436668|Gemcitabine|gemcitabine|mesh-list
153872521|NCT02215395|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153413202|NCT02436668|Ibrutinib|ibrutinib|mesh-list
153889042|NCT01289847|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
153872522|NCT02215395|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
153872523|NCT02215395|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
153872524|NCT02215395|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
153872531|NCT02215434|Hormones|hormones|mesh-ancestor
153872532|NCT02215434|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153872533|NCT02215434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153872534|NCT02215434|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153872535|NCT02215434|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153872536|NCT02215434|Anabolic Agents|anabolic agents|mesh-ancestor
153872537|NCT04561076|Myeloma Proteins|myeloma proteins|mesh-list
153872538|NCT04561076|Paraproteins|paraproteins|mesh-list
153872539|NCT04561076|Immunologic Factors|immunologic factors|mesh-ancestor
153872540|NCT04561076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153872541|NCT02215473|Chlorhexidine|chlorhexidine|mesh-list
153872542|NCT02215473|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
153872543|NCT02215473|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
153872544|NCT02215473|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153872545|NCT02215473|Disinfectants|disinfectants|mesh-ancestor
153872546|NCT02215473|Dermatologic Agents|dermatologic agents|mesh-ancestor
153872547|NCT04547829|Lenograstim|lenograstim|mesh-list
153872548|NCT04547829|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153872549|NCT04547829|Immunologic Factors|immunologic factors|mesh-ancestor
153872550|NCT04547829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153872551|NCT02211911|Bisacodyl|bisacodyl|mesh-list
153872552|NCT02211911|Picosulfate sodium|picosulfate sodium|mesh-list
153872553|NCT02211911|Cathartics|cathartics|mesh-ancestor
153872554|NCT02211911|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153872555|NCT02211911|Laxatives|laxatives|mesh-ancestor
153872556|NCT01131676|Empagliflozin|empagliflozin|mesh-list
153872557|NCT01131676|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
153413204|NCT02436668|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153413225|NCT02506634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153413226|NCT02506868|Darbepoetin alfa|darbepoetin alfa|mesh-list
153413227|NCT02506868|Hematinics|hematinics|mesh-ancestor
153413228|NCT02541422|Acetylcysteine|acetylcysteine|mesh-list
153872559|NCT01131676|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153872560|NCT01131676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153872561|NCT04560569|Antibodies|antibodies|mesh-list
153872562|NCT04560569|Immunologic Factors|immunologic factors|mesh-ancestor
153872563|NCT04560569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153872564|NCT01131325|Nilotinib|nilotinib|mesh-list
153872565|NCT01131325|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153872566|NCT01131325|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153872567|NCT01131325|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153872568|NCT01131325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153889043|NCT01289847|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
153872569|NCT04560101|Botulinum Toxins|botulinum toxins|mesh-list
153872570|NCT04560101|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
153872571|NCT04560101|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
153872572|NCT04560101|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
153872573|NCT04560101|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153872574|NCT04560101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153872575|NCT04560101|Cholinergic Agents|cholinergic agents|mesh-ancestor
153872576|NCT04560101|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153872579|NCT04560101|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153413251|NCT02439164|GABA Modulators|gaba modulators|mesh-ancestor
153413253|NCT02439164|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153413254|NCT02439164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153413255|NCT02440178|Micafungin|micafungin|mesh-list
153413256|NCT02440178|Antifungal Agents|antifungal agents|mesh-ancestor
153413257|NCT02440178|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153413258|NCT05078606|Anesthetics|anesthetics|mesh-list
153872582|NCT02214498|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153872583|NCT02214498|Diuretics|diuretics|mesh-ancestor
153872584|NCT02214498|Natriuretic Agents|natriuretic agents|mesh-ancestor
153872585|NCT02214498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153872586|NCT02214498|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
153872587|NCT02214498|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153872588|NCT02214498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153872589|NCT02214498|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
153872590|NCT02214498|Protease Inhibitors|protease inhibitors|mesh-ancestor
153872591|NCT02214498|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153872592|NCT04560218|Misoprostol|misoprostol|mesh-list
153872593|NCT04560218|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
153872594|NCT04560218|Abortifacient Agents|abortifacient agents|mesh-ancestor
153872595|NCT04560218|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153413259|NCT05078606|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153872596|NCT04560218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153872597|NCT04560218|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
153872598|NCT04560218|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153872620|NCT01129960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153872621|NCT04559165|Chitosan|chitosan|mesh-list
153872622|NCT04559165|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153872623|NCT04559165|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153872624|NCT04559165|Antimetabolites|antimetabolites|mesh-ancestor
153413277|NCT02510144|Dermatologic Agents|dermatologic agents|mesh-ancestor
153413278|NCT02538679|Epinephrine|epinephrine|mesh-list
153413279|NCT02538679|Racepinephrine|racepinephrine|mesh-list
153413280|NCT02538679|Bupivacaine|bupivacaine|mesh-list
153413281|NCT02538679|Epinephryl borate|epinephryl borate|mesh-list
153413282|NCT02538679|Anesthetics, Local|anesthetics, local|mesh-ancestor
153413283|NCT02538679|Anesthetics|anesthetics|mesh-ancestor
153413284|NCT02538679|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153413285|NCT02538679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153413286|NCT02538679|Sensory System Agents|sensory system agents|mesh-ancestor
153413287|NCT02538679|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153413288|NCT02538679|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153413289|NCT02538679|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153413290|NCT02538679|Adrenergic Agents|adrenergic agents|mesh-ancestor
153413291|NCT02538679|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153413292|NCT02538679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153413293|NCT02538679|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
153413294|NCT02538679|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153413295|NCT02538679|Autonomic Agents|autonomic agents|mesh-ancestor
153413296|NCT02538679|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153413297|NCT02538679|Respiratory System Agents|respiratory system agents|mesh-ancestor
153413298|NCT02538679|Mydriatics|mydriatics|mesh-ancestor
153413299|NCT02538679|Sympathomimetics|sympathomimetics|mesh-ancestor
153413300|NCT02538679|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
153872642|NCT04311697|Vasoactive Intestinal Peptide|vasoactive intestinal peptide|mesh-list
153872643|NCT04311697|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
153872644|NCT04311697|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
153872645|NCT04311697|Adrenergic Agents|adrenergic agents|mesh-ancestor
153872646|NCT04311697|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153872647|NCT04311697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153872648|NCT04311697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153872649|NCT04311697|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153872650|NCT04311697|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153413304|NCT02511236|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153413305|NCT02511236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153413306|NCT02511236|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
153413307|NCT02511236|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
153413308|NCT02511236|Cholinergic Agents|cholinergic agents|mesh-ancestor
153413336|NCT02514044|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
153872668|NCT00575861|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153872669|NCT04547088|Apatinib|apatinib|mesh-list
153872670|NCT04547088|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153872671|NCT04547088|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153872672|NCT04547088|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153872673|NCT04547088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153872674|NCT01129882|Aripiprazole|aripiprazole|mesh-list
153872675|NCT01129882|Antidepressive Agents|antidepressive agents|mesh-ancestor
153872676|NCT01129882|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153872677|NCT01129882|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153872678|NCT01129882|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153872679|NCT01129882|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153872680|NCT01129882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153872681|NCT01129882|Dopamine Agonists|dopamine agonists|mesh-ancestor
153872682|NCT01129882|Dopamine Agents|dopamine agents|mesh-ancestor
153872683|NCT01129882|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153413337|NCT02514044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153413338|NCT02514044|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
153413339|NCT02514044|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153413340|NCT02514044|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153413341|NCT02514044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153413342|NCT02514044|Dopamine Agents|dopamine agents|mesh-ancestor
153413343|NCT02514044|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153413344|NCT02555228|Simethicone|simethicone|mesh-list
153413345|NCT02555228|Antifoaming Agents|antifoaming agents|mesh-ancestor
153413346|NCT02555228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153413347|NCT02555228|Emollients|emollients|mesh-ancestor
153413348|NCT02555228|Dermatologic Agents|dermatologic agents|mesh-ancestor
153413349|NCT02556788|Trifarotene|trifarotene|mesh-list
153413350|NCT02556788|Dermatologic Agents|dermatologic agents|mesh-ancestor
153413351|NCT02516150|Ethanol|ethanol|mesh-list
153413352|NCT02516150|Glucagon|glucagon|mesh-list
153413353|NCT02516150|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
153413354|NCT02516150|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153413355|NCT02516150|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153413356|NCT02516150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153413357|NCT02516150|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153413358|NCT02516150|Hormones|hormones|mesh-ancestor
153413359|NCT02516150|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153413360|NCT04025060|Caffeine|caffeine|mesh-list
153413361|NCT04025060|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
153413362|NCT04025060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153413363|NCT04025060|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
153413364|NCT04025060|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153872684|NCT01129882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153872685|NCT01129882|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
153872686|NCT01129882|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
153872687|NCT01129882|Serotonin Agents|serotonin agents|mesh-ancestor
153872688|NCT01129882|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
153872689|NCT01129882|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153872690|NCT01129882|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
153872691|NCT01129882|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
153872692|NCT02278419|Sofosbuvir|sofosbuvir|mesh-list
153872693|NCT02278419|Simeprevir|simeprevir|mesh-list
153872694|NCT02278419|Antiviral Agents|antiviral agents|mesh-ancestor
153872695|NCT02278419|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153872696|NCT02278419|Protease Inhibitors|protease inhibitors|mesh-ancestor
153872697|NCT02278419|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153872698|NCT02278419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153872699|NCT02882737|Glucagon|glucagon|mesh-list
153872700|NCT02882737|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
153872701|NCT02882737|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153872702|NCT02882737|Hormones|hormones|mesh-ancestor
153872704|NCT02882737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153413365|NCT04025060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153413366|NCT04025060|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
153413367|NCT04025060|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
153413368|NCT04025060|Purinergic Agents|purinergic agents|mesh-ancestor
153413370|NCT04542434|Niclosamide|niclosamide|mesh-list
153413371|NCT04542434|Anticestodal Agents|anticestodal agents|mesh-ancestor
153413372|NCT04542434|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
153413373|NCT04542434|Anthelmintics|anthelmintics|mesh-ancestor
153413374|NCT04542434|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153413375|NCT04542434|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153413376|NCT04542434|Antinematodal Agents|antinematodal agents|mesh-ancestor
153430156|NCT05296759|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153413377|NCT04186286|Propranolol|propranolol|mesh-list
153413378|NCT04186286|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
153413379|NCT04186286|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
153413380|NCT04186286|Adrenergic Agents|adrenergic agents|mesh-ancestor
153413381|NCT04186286|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153413382|NCT04186286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153413387|NCT04341038|Methylprednisolone|methylprednisolone|mesh-list
153430157|NCT05296759|Anticonvulsants|anticonvulsants|mesh-ancestor
153430158|NCT05296759|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153430159|NCT05296759|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153413397|NCT04341038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153413398|NCT04341038|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
153413399|NCT04341038|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153413400|NCT04341038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153413401|NCT04341038|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153413402|NCT04341038|Antiemetics|antiemetics|mesh-ancestor
153413403|NCT04341038|Autonomic Agents|autonomic agents|mesh-ancestor
153413404|NCT04341038|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153413405|NCT04341038|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153413406|NCT04341038|Glucocorticoids|glucocorticoids|mesh-ancestor
153413407|NCT04341038|Hormones|hormones|mesh-ancestor
153413408|NCT04341038|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153413409|NCT04341038|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
153413410|NCT04341038|Protective Agents|protective agents|mesh-ancestor
153413411|NCT04341038|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153413412|NCT04341038|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153413413|NCT02561702|Mexiletine|mexiletine|mesh-list
153413414|NCT02561702|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153430161|NCT05296759|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153872735|NCT04539054|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
153872737|NCT04539054|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
153413423|NCT02563496|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153413424|NCT02563496|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153413425|NCT02563496|Antimalarials|antimalarials|mesh-ancestor
153413426|NCT02563496|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153413427|NCT02540161|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
153413428|NCT02540161|Immunologic Factors|immunologic factors|mesh-ancestor
153413429|NCT02540161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153413430|NCT02568644|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
153413431|NCT02568644|Ketoprofen|ketoprofen|mesh-list
153413432|NCT02568644|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-list
153413433|NCT02568644|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153413434|NCT02568644|Analgesics|analgesics|mesh-ancestor
153413435|NCT02568644|Sensory System Agents|sensory system agents|mesh-ancestor
153413436|NCT02568644|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153413437|NCT02568644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153413438|NCT02568644|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153413439|NCT02568644|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153413440|NCT02568644|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153413441|NCT02568644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153413442|NCT02541409|Interferons|interferons|mesh-list
153872759|NCT04558580|Rufinamide|rufinamide|mesh-list
153872760|NCT04558580|Anticonvulsants|anticonvulsants|mesh-ancestor
153872761|NCT04558580|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
153413443|NCT02541409|Ribavirin|ribavirin|mesh-list
153872762|NCT04558580|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153872763|NCT04558580|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153872764|NCT04558580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153872765|NCT02278458|Gemcitabine|gemcitabine|mesh-list
153872770|NCT01128595|Fluticasone|fluticasone|mesh-list
153872783|NCT01129336|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153872784|NCT01129336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153872785|NCT01128244|Pyridoxine|pyridoxine|mesh-list
153872786|NCT01128244|Pyridoxal|pyridoxal|mesh-list
153872787|NCT01128244|Vitamin B 6|vitamin b 6|mesh-list
153872788|NCT01128244|Vitamins|vitamins|mesh-ancestor
153872789|NCT01128244|Micronutrients|micronutrients|mesh-ancestor
153872790|NCT01128244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153872791|NCT01128244|Vitamin B Complex|vitamin b complex|mesh-ancestor
153872792|NCT01127893|Tanezumab|tanezumab|mesh-list
153872793|NCT01127893|Analgesics|analgesics|mesh-ancestor
153872794|NCT01127893|Sensory System Agents|sensory system agents|mesh-ancestor
153872795|NCT01127893|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153872796|NCT01127893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153872797|NCT00576173|Acetaminophen|acetaminophen|mesh-list
153872798|NCT00576173|Tramadol|tramadol|mesh-list
153872799|NCT00576173|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153872800|NCT00576173|Analgesics|analgesics|mesh-ancestor
153872801|NCT00576173|Sensory System Agents|sensory system agents|mesh-ancestor
153872802|NCT00576173|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153872803|NCT00576173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153872804|NCT00576173|Antipyretics|antipyretics|mesh-ancestor
153413462|NCT02541565|Cortisone|cortisone|mesh-list
153413463|NCT02541565|Cyclophosphamide|cyclophosphamide|mesh-list
153413464|NCT02541565|Rituximab|rituximab|mesh-list
153413465|NCT02541565|Doxorubicin|doxorubicin|mesh-list
153413466|NCT02541565|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
153413467|NCT02541565|Pembrolizumab|pembrolizumab|mesh-list
153413468|NCT02541565|Vincristine|vincristine|mesh-list
153413469|NCT02541565|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
153430163|NCT05296759|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
153430165|NCT05296759|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
153430166|NCT05296759|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153430167|NCT05296759|Antidepressive Agents|antidepressive agents|mesh-ancestor
153430168|NCT05296759|Dopamine Agents|dopamine agents|mesh-ancestor
153430169|NCT05296759|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
153430170|NCT05546047|Tacrolimus|tacrolimus|mesh-list
153413491|NCT02541565|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153413492|NCT02541565|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153872805|NCT00576173|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153872806|NCT00576173|Narcotics|narcotics|mesh-ancestor
153872807|NCT00576173|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153872808|NCT00625339|Lamivudine|lamivudine|mesh-list
153872809|NCT00625339|Entecavir|entecavir|mesh-list
153872810|NCT00625339|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153872811|NCT00625339|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153413493|NCT02541565|Tubulin Modulators|tubulin modulators|mesh-ancestor
153872812|NCT00625339|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153872813|NCT00625339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153872814|NCT00625339|Antiviral Agents|antiviral agents|mesh-ancestor
153872815|NCT00625339|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153872816|NCT00625339|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153872817|NCT00625339|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153872818|NCT02215863|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
153872819|NCT02215863|Immunologic Factors|immunologic factors|mesh-ancestor
153872820|NCT02215863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153872821|NCT04558463|Oseltamivir|oseltamivir|mesh-list
153872822|NCT04558463|Favipiravir|favipiravir|mesh-list
153872836|NCT01126879|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
153872838|NCT01126879|Hormones|hormones|mesh-ancestor
153872839|NCT01126879|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153872840|NCT04311658|Isosorbide|isosorbide|mesh-list
153872841|NCT04311658|Isosorbide Dinitrate|isosorbide dinitrate|mesh-list
153413507|NCT04044560|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153413508|NCT03256916|Nelfinavir|nelfinavir|mesh-list
153413509|NCT03256916|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
153413510|NCT03256916|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
153413511|NCT03256916|Protease Inhibitors|protease inhibitors|mesh-ancestor
153413512|NCT03256916|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153413513|NCT03256916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153413514|NCT03256916|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153413515|NCT03256916|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153413516|NCT03256916|Antiviral Agents|antiviral agents|mesh-ancestor
153413517|NCT03256916|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153413518|NCT02579876|Immunomodulating Agents|immunomodulating agents|mesh-list
153413519|NCT02579876|Immunologic Factors|immunologic factors|mesh-list
153889048|NCT01021813|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153413520|NCT02579876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153413521|NCT00364052|Valganciclovir|valganciclovir|mesh-list
153413522|NCT00364052|Ganciclovir|ganciclovir|mesh-list
153872846|NCT04311658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153872864|NCT04539444|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153889049|NCT01021813|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153889050|NCT01021813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153872866|NCT04539444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153872867|NCT00576329|Ketorolac|ketorolac|mesh-list
153872868|NCT00576329|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153872869|NCT00576329|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153872870|NCT00576329|Analgesics|analgesics|mesh-ancestor
153872871|NCT00576329|Sensory System Agents|sensory system agents|mesh-ancestor
153872872|NCT00576329|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153872873|NCT00576329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153872874|NCT00576329|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153872875|NCT00576329|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153872876|NCT00576329|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153872877|NCT00576329|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153413523|NCT00364052|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
153413524|NCT00364052|Antiviral Agents|antiviral agents|mesh-ancestor
153413578|NCT02596022|Anesthetics, General|anesthetics, general|mesh-ancestor
153889052|NCT01021813|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153413579|NCT02596022|Anesthetics|anesthetics|mesh-ancestor
153413580|NCT02596022|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153413581|NCT02596022|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
153872898|NCT00637468|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153872899|NCT00637468|Analgesics|analgesics|mesh-ancestor
153872900|NCT00637468|Sensory System Agents|sensory system agents|mesh-ancestor
153872901|NCT00637468|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153872902|NCT00637468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153872903|NCT00637468|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153872904|NCT00637468|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153872905|NCT00637468|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153872906|NCT00637468|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153872907|NCT00637468|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153872908|NCT00637468|Antipyretics|antipyretics|mesh-ancestor
153872909|NCT00637468|Anticonvulsants|anticonvulsants|mesh-ancestor
153872910|NCT00637468|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
153872911|NCT00637468|Diuretics|diuretics|mesh-ancestor
153872912|NCT00637468|Natriuretic Agents|natriuretic agents|mesh-ancestor
153872913|NCT00637468|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
153872914|NCT00637468|Adrenergic Agents|adrenergic agents|mesh-ancestor
153872915|NCT00637468|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153872916|NCT02212067|Semaglutide|semaglutide|mesh-list
153413607|NCT05371574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153413608|NCT05371574|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153413609|NCT05371574|Sympatholytics|sympatholytics|mesh-ancestor
153413610|NCT05371574|Autonomic Agents|autonomic agents|mesh-ancestor
153413611|NCT05371574|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
153872921|NCT02278575|Antithrombin III|antithrombin iii|mesh-list
153872922|NCT02278575|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
153872923|NCT02278575|Protease Inhibitors|protease inhibitors|mesh-ancestor
153872924|NCT02278575|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153872925|NCT02278575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153872926|NCT02278575|Anticoagulants|anticoagulants|mesh-ancestor
153872927|NCT01126060|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
153872928|NCT01126060|Hemostatics|hemostatics|mesh-ancestor
153872929|NCT01126060|Coagulants|coagulants|mesh-ancestor
153872930|NCT01125748|Omalizumab|omalizumab|mesh-list
153872931|NCT01125748|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
153872932|NCT01125748|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153872933|NCT01125748|Respiratory System Agents|respiratory system agents|mesh-ancestor
153872934|NCT04558268|Folic Acid|folic acid|mesh-list
153872935|NCT04558268|Prednisone|prednisone|mesh-list
153872936|NCT04558268|Progesterone|progesterone|mesh-list
153872939|NCT04558268|Hormones|hormones|mesh-ancestor
153413630|NCT00366002|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
153413631|NCT00366002|Cholinergic Agents|cholinergic agents|mesh-ancestor
153413632|NCT00366002|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153872954|NCT01125514|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
153872955|NCT01125514|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153872956|NCT01125514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153872957|NCT01125514|Renin Inhibitors|renin inhibitors|mesh-ancestor
153872958|NCT01125514|Protease Inhibitors|protease inhibitors|mesh-ancestor
153872959|NCT01125514|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153872960|NCT04545879|Allicin|allicin|mesh-list
153872961|NCT04545879|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153872962|NCT04545879|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153872963|NCT04545879|Antimetabolites|antimetabolites|mesh-ancestor
153872966|NCT04545879|Antioxidants|antioxidants|mesh-ancestor
153872967|NCT04545879|Protective Agents|protective agents|mesh-ancestor
153872968|NCT04545879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153872969|NCT04545879|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153872970|NCT04545879|Free Radical Scavengers|free radical scavengers|mesh-ancestor
153872971|NCT04578782|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
153872972|NCT04578782|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
153872973|NCT04578782|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
153413633|NCT00366002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153413636|NCT00422240|Adapalene|adapalene|mesh-list
153413637|NCT00422240|Adapalene, Benzoyl Peroxide Drug Combination|adapalene, benzoyl peroxide drug combination|mesh-list
153413638|NCT00422240|Benzoyl Peroxide|benzoyl peroxide|mesh-list
153413639|NCT00422240|Dermatologic Agents|dermatologic agents|mesh-ancestor
153413640|NCT00422240|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153413641|NCT00422240|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153413642|NCT00422240|Analgesics|analgesics|mesh-ancestor
153413643|NCT00422240|Sensory System Agents|sensory system agents|mesh-ancestor
153413644|NCT00422240|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153413645|NCT00422240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153413646|NCT00422240|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153413647|NCT00422240|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153413648|NCT02605304|Ribavirin|ribavirin|mesh-list
153413649|NCT02605304|Sofosbuvir|sofosbuvir|mesh-list
153413650|NCT02605304|Ledipasvir, sofosbuvir drug combination|ledipasvir, sofosbuvir drug combination|mesh-list
153413651|NCT02605304|Ledipasvir|ledipasvir|mesh-list
153889053|NCT01021813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153413652|NCT02605304|Antimetabolites|antimetabolites|mesh-ancestor
153413653|NCT02605304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153413654|NCT02605304|Antiviral Agents|antiviral agents|mesh-ancestor
153413655|NCT02605304|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153413656|NCT05365880|Lidocaine|lidocaine|mesh-list
153413657|NCT05365880|Anesthetics, Local|anesthetics, local|mesh-ancestor
153413658|NCT05365880|Anesthetics|anesthetics|mesh-ancestor
153413659|NCT05365880|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153413660|NCT05365880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153872974|NCT04578782|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153872975|NCT04578782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153872976|NCT04578782|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
153872977|NCT04578782|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153872978|NCT04578782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153872979|NCT04578782|Cholinergic Agents|cholinergic agents|mesh-ancestor
153872980|NCT04578782|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153872981|NCT04538391|Bupivacaine|bupivacaine|mesh-list
153872982|NCT04538391|Anesthetics, Local|anesthetics, local|mesh-ancestor
153413668|NCT02607254|Pregabalin|pregabalin|mesh-list
153413669|NCT02607254|Analgesics|analgesics|mesh-ancestor
153413670|NCT02607254|Sensory System Agents|sensory system agents|mesh-ancestor
153413671|NCT02607254|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153413672|NCT02607254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153413673|NCT02607254|Anticonvulsants|anticonvulsants|mesh-ancestor
153413674|NCT02607254|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153889054|NCT01025635|Azelaic acid|azelaic acid|mesh-list
153889055|NCT01025635|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153889056|NCT01025635|Dermatologic Agents|dermatologic agents|mesh-ancestor
153889057|NCT01021423|Lenalidomide|lenalidomide|mesh-list
153889058|NCT01021423|Immunologic Factors|immunologic factors|mesh-ancestor
153889059|NCT01021423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153889060|NCT01021423|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153413676|NCT02607254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153413677|NCT02607254|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153413678|NCT02607254|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153413679|NCT02607254|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153413680|NCT02607254|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153413681|NCT02607254|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153413682|NCT02611154|Testosterone|testosterone|mesh-list
153413683|NCT02611154|Androgens|androgens|mesh-ancestor
153413684|NCT02611154|Hormones|hormones|mesh-ancestor
153413685|NCT02611154|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153873001|NCT04545801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153873002|NCT04558424|Ascorbic Acid|ascorbic acid|mesh-list
153873035|NCT01125046|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
153873037|NCT01125046|Immunoglobulins|immunoglobulins|mesh-list
153873038|NCT01125046|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
153873039|NCT01125046|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153873040|NCT01125046|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153873041|NCT01125046|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153873042|NCT01125046|Growth Substances|growth substances|mesh-ancestor
153873043|NCT01125046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153873044|NCT01125046|Growth Inhibitors|growth inhibitors|mesh-ancestor
153873045|NCT01125046|Immunologic Factors|immunologic factors|mesh-ancestor
153873046|NCT01124734|Temozolomide|temozolomide|mesh-list
153873047|NCT01124734|Interleukin-2|interleukin-2|mesh-list
153873048|NCT01124734|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153413707|NCT00365612|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
153413708|NCT00365612|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
153413709|NCT02974166|Ibuprofen|ibuprofen|mesh-list
153413710|NCT02974166|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
153413711|NCT02974166|Cyclobenzaprine|cyclobenzaprine|mesh-list
153413712|NCT02974166|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153413713|NCT02974166|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153413714|NCT02974166|Analgesics|analgesics|mesh-ancestor
153413715|NCT02974166|Sensory System Agents|sensory system agents|mesh-ancestor
153413716|NCT02974166|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153413717|NCT02974166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153413718|NCT02974166|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153413719|NCT02974166|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153413720|NCT02974166|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153413721|NCT02974166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153413722|NCT02974166|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
153413723|NCT02974166|Antidepressive Agents|antidepressive agents|mesh-ancestor
153413724|NCT02974166|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153413725|NCT02974166|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
153413726|NCT02974166|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
153889061|NCT01021423|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153889062|NCT01021423|Growth Substances|growth substances|mesh-ancestor
153430174|NCT05546047|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
153430175|NCT05546047|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153430176|NCT05546047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153413731|NCT05731778|Sodium Fluoride|sodium fluoride|mesh-list
153413732|NCT05731778|Tin Fluorides|tin fluorides|mesh-list
153413733|NCT05731778|Cariostatic Agents|cariostatic agents|mesh-ancestor
153413734|NCT05731778|Protective Agents|protective agents|mesh-ancestor
153873049|NCT01124734|Alkylating Agents|alkylating agents|mesh-ancestor
153873050|NCT01124734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153873051|NCT01124734|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153873052|NCT01124734|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153873053|NCT01124734|Analgesics|analgesics|mesh-ancestor
153873054|NCT01124734|Sensory System Agents|sensory system agents|mesh-ancestor
153873055|NCT01124734|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153873056|NCT01124734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153873057|NCT04545450|Methyltestosterone|methyltestosterone|mesh-list
153873058|NCT04545450|Testosterone|testosterone|mesh-list
153430177|NCT01532635|Mycophenolic Acid|mycophenolic acid|mesh-list
153873059|NCT04545450|Testosterone undecanoate|testosterone undecanoate|mesh-list
153873060|NCT04545450|Testosterone enanthate|testosterone enanthate|mesh-list
153873061|NCT04545450|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
153873062|NCT04545450|Dutasteride|dutasteride|mesh-list
153873063|NCT04545450|Androgens|androgens|mesh-ancestor
153873064|NCT04545450|Hormones|hormones|mesh-ancestor
153873066|NCT04545450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153413748|NCT00364754|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153413749|NCT00364754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153413750|NCT00364754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153413751|NCT00364754|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153413753|NCT00366236|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153413754|NCT00366236|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153413755|NCT04741880|Lidocaine|lidocaine|mesh-list
153413756|NCT04741880|Anesthetics, Local|anesthetics, local|mesh-ancestor
153430178|NCT01532635|Cyclophosphamide|cyclophosphamide|mesh-list
153413757|NCT04741880|Anesthetics|anesthetics|mesh-ancestor
153413758|NCT04741880|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153413759|NCT04741880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153873076|NCT04579133|Olaparib|olaparib|mesh-list
153873122|NCT04205890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153873123|NCT04205890|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
153413782|NCT05360030|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
153413783|NCT05360030|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
153413784|NCT05360030|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153413785|NCT05360030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153430179|NCT01532635|Tacrolimus|tacrolimus|mesh-list
153430180|NCT01532635|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153430181|NCT01532635|Immunologic Factors|immunologic factors|mesh-ancestor
153413786|NCT05360030|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
153413788|NCT05272202|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153413789|NCT05272202|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153413790|NCT05272202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153413791|NCT05272202|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153413792|NCT05272202|Anesthetics, General|anesthetics, general|mesh-ancestor
153413793|NCT05272202|Anesthetics|anesthetics|mesh-ancestor
153413794|NCT05707442|Acetazolamide|acetazolamide|mesh-list
153413795|NCT05707442|Anticonvulsants|anticonvulsants|mesh-ancestor
153413796|NCT05707442|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
153413797|NCT05707442|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153413798|NCT05707442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153413799|NCT05707442|Diuretics|diuretics|mesh-ancestor
153413800|NCT05707442|Natriuretic Agents|natriuretic agents|mesh-ancestor
153413801|NCT05707442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153413802|NCT04604132|Paclitaxel|paclitaxel|mesh-list
153413803|NCT04604132|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
153873124|NCT04205890|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153873125|NCT04205890|Anesthetics, General|anesthetics, general|mesh-ancestor
153873126|NCT04205890|Anesthetics|anesthetics|mesh-ancestor
153873127|NCT04205890|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153873128|NCT04205890|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
153873129|NCT04205890|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
153873130|NCT04205890|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153873144|NCT00577109|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153413804|NCT04604132|Atezolizumab|atezolizumab|mesh-list
153413805|NCT04604132|Ramucirumab|ramucirumab|mesh-list
153413806|NCT04604132|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
153413807|NCT04604132|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153413808|NCT04604132|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153413809|NCT04604132|Tubulin Modulators|tubulin modulators|mesh-ancestor
153413810|NCT04604132|Antimitotic Agents|antimitotic agents|mesh-ancestor
153413811|NCT04604132|Mitosis Modulators|mitosis modulators|mesh-ancestor
153413812|NCT04604132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153413813|NCT04604132|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153413814|NCT04604132|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153413815|NCT04604132|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153413816|NCT04604132|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153413817|NCT04604132|Growth Substances|growth substances|mesh-ancestor
153413818|NCT04604132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153413819|NCT04604132|Growth Inhibitors|growth inhibitors|mesh-ancestor
153413820|NCT04604132|Immunologic Factors|immunologic factors|mesh-ancestor
153413821|NCT05193188|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
153413822|NCT05193188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153413823|NCT05193188|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153413824|NCT05193188|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153413825|NCT04799262|Prednisone|prednisone|mesh-list
153413826|NCT04799262|Tofacitinib|tofacitinib|mesh-list
153413827|NCT04799262|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153413828|NCT04799262|Glucocorticoids|glucocorticoids|mesh-ancestor
153413829|NCT04799262|Hormones|hormones|mesh-ancestor
153873160|NCT01124422|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153873161|NCT01124422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153873162|NCT01124422|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153873163|NCT01124422|Respiratory System Agents|respiratory system agents|mesh-ancestor
153873164|NCT01124422|Dermatologic Agents|dermatologic agents|mesh-ancestor
153873165|NCT01124422|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
153873166|NCT01124422|Parasympatholytics|parasympatholytics|mesh-ancestor
153873167|NCT01124422|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
153873168|NCT01124422|Cholinergic Agents|cholinergic agents|mesh-ancestor
153873172|NCT01124422|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
153873173|NCT01124422|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153873174|NCT01124422|Adrenergic Agents|adrenergic agents|mesh-ancestor
153873177|NCT00625495|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
153873178|NCT00625495|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153873179|NCT00625495|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
153873180|NCT00625495|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153873181|NCT00625495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153873183|NCT02882425|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153873184|NCT00577304|Nitroglycerin|nitroglycerin|mesh-list
153873185|NCT00577304|Vasodilator Agents|vasodilator agents|mesh-ancestor
153873186|NCT01124149|Mesalamine|mesalamine|mesh-list
153873187|NCT01124149|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153873188|NCT01124149|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153413846|NCT00366470|Cholecalciferol|cholecalciferol|mesh-list
153413847|NCT00366470|Vitamin D|vitamin d|mesh-list
153413848|NCT00366470|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153413849|NCT00366470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153413850|NCT00366470|Vitamins|vitamins|mesh-ancestor
153413851|NCT00366470|Micronutrients|micronutrients|mesh-ancestor
153413852|NCT00366470|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153413856|NCT02620904|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153413857|NCT02620904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153413858|NCT02620904|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
153413859|NCT02620904|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
153413860|NCT02620904|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
153413861|NCT02620904|Contraceptive Agents|contraceptive agents|mesh-ancestor
153413862|NCT02620904|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
153413863|NCT02620904|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
153413864|NCT02620904|Hormone Antagonists|hormone antagonists|mesh-ancestor
153413865|NCT02620904|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153413866|NCT02620904|Luteolytic Agents|luteolytic agents|mesh-ancestor
153873190|NCT01124149|Sensory System Agents|sensory system agents|mesh-ancestor
153873191|NCT01124149|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153873192|NCT01124149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153873193|NCT01124149|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153873194|NCT01124149|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153873195|NCT04545099|Neostigmine|neostigmine|mesh-list
153873196|NCT04545099|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
153873197|NCT04545099|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153873198|NCT04545099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153873199|NCT04545099|Cholinergic Agents|cholinergic agents|mesh-ancestor
153873200|NCT04545099|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153873201|NCT04545099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153873202|NCT04545099|Parasympathomimetics|parasympathomimetics|mesh-ancestor
153873203|NCT04545099|Autonomic Agents|autonomic agents|mesh-ancestor
153873204|NCT04545099|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153873205|NCT02882269|Capecitabine|capecitabine|mesh-list
153873206|NCT02882269|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153873207|NCT02882269|Antimetabolites|antimetabolites|mesh-ancestor
153873208|NCT02882269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153873209|NCT02882269|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153873210|NCT01122862|Chlorhexidine|chlorhexidine|mesh-list
153873214|NCT04537767|Esmolol|esmolol|mesh-list
153873215|NCT04537767|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
153873216|NCT04537767|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
153873217|NCT04537767|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
153873218|NCT04537767|Adrenergic Agents|adrenergic agents|mesh-ancestor
153873219|NCT04537767|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153873220|NCT04537767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153873221|NCT04537767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153873222|NCT01121926|Trazodone|trazodone|mesh-list
153873223|NCT01121926|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153873224|NCT01121926|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153873225|NCT01121926|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153873226|NCT01121926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153873227|NCT01121926|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153873228|NCT01121926|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
153873229|NCT01121926|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153873230|NCT01121926|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153873231|NCT01121926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153873232|NCT01121926|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153873233|NCT01121926|Serotonin Agents|serotonin agents|mesh-ancestor
153873234|NCT01121926|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
153873236|NCT00577421|Risedronic Acid|risedronic acid|mesh-list
153873237|NCT00577421|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153413923|NCT02629094|Natriuretic Agents|natriuretic agents|mesh-ancestor
153413924|NCT02629094|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153413925|NCT02630030|Ixazomib|ixazomib|mesh-list
153413926|NCT02630030|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153413927|NCT02630030|Protease Inhibitors|protease inhibitors|mesh-ancestor
153413928|NCT02630030|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153413929|NCT02630030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153413930|NCT04289792|Paclitaxel|paclitaxel|mesh-list
153413931|NCT04289792|Gemcitabine|gemcitabine|mesh-list
153413932|NCT04289792|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153873239|NCT00577421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153873240|NCT00577421|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153873241|NCT00577421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153873242|NCT00577421|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153873243|NCT00577694|Clofarabine|clofarabine|mesh-list
153873244|NCT00577694|Gemtuzumab|gemtuzumab|mesh-list
153873245|NCT00577694|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153873246|NCT00577694|Antimetabolites|antimetabolites|mesh-ancestor
153413947|NCT02252406|Ranolazine|ranolazine|mesh-list
153873275|NCT00577850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153873277|NCT00577967|Gabapentin|gabapentin|mesh-list
153873278|NCT00577967|Analgesics|analgesics|mesh-ancestor
153873279|NCT00577967|Sensory System Agents|sensory system agents|mesh-ancestor
153873280|NCT00577967|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153873281|NCT00577967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153873282|NCT00577967|Anticonvulsants|anticonvulsants|mesh-ancestor
153873292|NCT00578201|Cetuximab|cetuximab|mesh-list
153413974|NCT02544607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153413975|NCT02544607|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
153413976|NCT02544607|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153413977|NCT02544607|Anesthetics, General|anesthetics, general|mesh-ancestor
153413978|NCT02544607|Anesthetics|anesthetics|mesh-ancestor
153413979|NCT02544607|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153413980|NCT02544607|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
153413984|NCT00363571|Acetazolamide|acetazolamide|mesh-list
153873293|NCT00578201|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153873294|NCT00578201|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153873295|NCT04544319|Dapagliflozin|dapagliflozin|mesh-list
153873296|NCT04544319|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
153873297|NCT04544319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153873298|NCT04544319|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153873299|NCT04544319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153873300|NCT04578470|Vitamin D|vitamin d|mesh-list
153873301|NCT04578470|Vitamins|vitamins|mesh-ancestor
153873302|NCT04578470|Micronutrients|micronutrients|mesh-ancestor
153873303|NCT04578470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153873304|NCT04578470|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153873305|NCT00578435|Cyclophosphamide|cyclophosphamide|mesh-list
153873306|NCT00578435|Busulfan|busulfan|mesh-list
153873307|NCT00578435|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153873308|NCT00578435|Immunologic Factors|immunologic factors|mesh-ancestor
153873309|NCT00578435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153873310|NCT00578435|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153873311|NCT00578435|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153873312|NCT00578435|Alkylating Agents|alkylating agents|mesh-ancestor
153873313|NCT00578435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153873314|NCT00578435|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153873315|NCT00578435|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153873316|NCT04537065|Mydriatics|mydriatics|mesh-list
153873317|NCT04537065|Autonomic Agents|autonomic agents|mesh-ancestor
153873318|NCT04537065|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153873320|NCT04544163|Lidocaine|lidocaine|mesh-list
153873324|NCT04544163|Anesthetics|anesthetics|mesh-ancestor
153873325|NCT04544163|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153873326|NCT04544163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153873327|NCT04544163|Sensory System Agents|sensory system agents|mesh-ancestor
153873328|NCT04544163|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153873329|NCT04544163|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153873330|NCT04544163|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
153873331|NCT04544163|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153873333|NCT04544163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153873334|NCT04544163|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153873335|NCT04544163|Narcotics|narcotics|mesh-ancestor
153873336|NCT04544163|Analgesics|analgesics|mesh-ancestor
153873337|NCT04544163|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153873338|NCT04544163|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153873339|NCT04544163|Anesthetics, General|anesthetics, general|mesh-ancestor
153873340|NCT04544163|Anticonvulsants|anticonvulsants|mesh-ancestor
153873341|NCT04544163|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153414006|NCT02471521|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
153414007|NCT02471521|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
153414008|NCT02471521|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
153414009|NCT02471521|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153414010|NCT02471521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153414011|NCT02624479|Sodium thiosulfate|sodium thiosulfate|mesh-list
153414012|NCT02624479|Antidotes|antidotes|mesh-ancestor
153414037|NCT02247960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153873342|NCT04544163|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153873343|NCT04544163|Tocolytic Agents|tocolytic agents|mesh-ancestor
153873344|NCT04544163|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153873345|NCT04543851|Carbon Fiber|carbon fiber|mesh-list
153873346|NCT04543851|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
153873347|NCT04543851|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153873348|NCT00578591|Rituximab|rituximab|mesh-list
153873349|NCT00578591|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153873350|NCT00578591|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153873351|NCT00578591|Immunologic Factors|immunologic factors|mesh-ancestor
153873352|NCT00578591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153873353|NCT00578591|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153873354|NCT04536948|Methyl salicylate|methyl salicylate|mesh-list
153873355|NCT04536948|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153873356|NCT04543890|Etoposide|etoposide|mesh-list
153873357|NCT04543890|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153873358|NCT04543890|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153873359|NCT04543890|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153873360|NCT04543890|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153873361|NCT04543890|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153873362|NCT04543890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153873363|NCT04536831|Vitamin D|vitamin d|mesh-list
153873364|NCT04536831|Ergocalciferols|ergocalciferols|mesh-list
153873365|NCT04536831|Cholecalciferol|cholecalciferol|mesh-list
153873366|NCT04536831|Vitamins|vitamins|mesh-list
153873367|NCT04536831|Micronutrients|micronutrients|mesh-ancestor
153414051|NCT02247804|Timolol|timolol|mesh-list
153414052|NCT02247804|Bimatoprost|bimatoprost|mesh-list
153414053|NCT02247804|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
153414054|NCT02247804|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
153414055|NCT02247804|Adrenergic Agents|adrenergic agents|mesh-ancestor
153414056|NCT02247804|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153414057|NCT02247804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153414058|NCT02247804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153414059|NCT02247804|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153414060|NCT02247804|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153414061|NCT00366938|Lumiracoxib|lumiracoxib|mesh-list
153414062|NCT00366938|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
153414063|NCT00366938|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153414064|NCT00366938|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153414065|NCT00366938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153414066|NCT00366938|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153414067|NCT00366938|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153414068|NCT00366938|Analgesics|analgesics|mesh-ancestor
153414069|NCT00366938|Sensory System Agents|sensory system agents|mesh-ancestor
153414070|NCT00366938|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153873374|NCT02214966|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
153873375|NCT02214966|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
153873376|NCT02214966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153873377|NCT02214966|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
153873378|NCT02214966|Protease Inhibitors|protease inhibitors|mesh-ancestor
153873379|NCT02214966|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153873380|NCT04536558|Olanzapine|olanzapine|mesh-list
153873381|NCT04536558|Fosaprepitant|fosaprepitant|mesh-list
153873382|NCT04536558|Aprepitant|aprepitant|mesh-list
153873383|NCT04536558|Antiemetics|antiemetics|mesh-ancestor
153873384|NCT04536558|Autonomic Agents|autonomic agents|mesh-ancestor
153873385|NCT04536558|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153873386|NCT04536558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153873387|NCT04536558|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153873389|NCT04536558|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153873390|NCT04536558|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153873391|NCT04536558|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153873392|NCT04536558|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
153873393|NCT04536558|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153873394|NCT04536558|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153873395|NCT04536558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153873396|NCT04536558|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153873397|NCT04536558|Serotonin Agents|serotonin agents|mesh-ancestor
153873398|NCT04536558|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
153873400|NCT04557137|Hormones|hormones|mesh-ancestor
153873401|NCT04557137|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153873402|NCT04557137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153873403|NCT04536675|Bromides|bromides|mesh-list
153873404|NCT04536675|Anticonvulsants|anticonvulsants|mesh-ancestor
153873405|NCT00578825|Ritonavir|ritonavir|mesh-list
153873406|NCT00578825|Lopinavir|lopinavir|mesh-list
153873407|NCT00578825|Ribavirin|ribavirin|mesh-list
153873408|NCT00578825|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
153873409|NCT00578825|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
153873410|NCT00578825|Protease Inhibitors|protease inhibitors|mesh-ancestor
153889068|NCT01020877|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153889069|NCT01020877|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153889070|NCT01020799|Escitalopram|escitalopram|mesh-list
153889071|NCT01020799|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
153873411|NCT00578825|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153889072|NCT01020799|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153873412|NCT00578825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153414077|NCT05026320|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153414078|NCT05026320|Analgesics|analgesics|mesh-ancestor
153414079|NCT05026320|Sensory System Agents|sensory system agents|mesh-ancestor
153414099|NCT02243202|Appetite Depressants|appetite depressants|mesh-ancestor
153873413|NCT00578825|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153873414|NCT00578825|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153873415|NCT00578825|Antiviral Agents|antiviral agents|mesh-ancestor
153873416|NCT00578825|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153873417|NCT00578825|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
153889073|NCT01020799|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153889074|NCT01020799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153889075|NCT01020799|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153889076|NCT01020799|Serotonin Agents|serotonin agents|mesh-ancestor
153889077|NCT01020799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153889078|NCT02872597|Dexamethasone|dexamethasone|mesh-list
153889079|NCT02872597|Prednisone|prednisone|mesh-list
153430184|NCT01532635|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153430185|NCT01532635|Alkylating Agents|alkylating agents|mesh-ancestor
153430186|NCT01532635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153430187|NCT01532635|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153430188|NCT01532635|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153430189|NCT01532635|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
153430190|NCT01532635|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153430191|NCT01532635|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153430192|NCT01532635|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
153430193|NCT01532635|Antitubercular Agents|antitubercular agents|mesh-ancestor
153430194|NCT01532635|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153873418|NCT00578825|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153873419|NCT00578825|Antimetabolites|antimetabolites|mesh-ancestor
153873420|NCT04536129|Hydrocortisone|hydrocortisone|mesh-list
153873421|NCT04536129|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153873422|NCT04556708|Chlorhexidine|chlorhexidine|mesh-list
153873423|NCT04556708|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
153873424|NCT04556708|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153873425|NCT04556708|Disinfectants|disinfectants|mesh-ancestor
153873426|NCT04535973|Hormones|hormones|mesh-list
153873427|NCT04535973|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153873428|NCT04535973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153873429|NCT04536051|Acetaminophen|acetaminophen|mesh-list
153873430|NCT04536051|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153873431|NCT04536051|Analgesics|analgesics|mesh-ancestor
153873432|NCT04536051|Sensory System Agents|sensory system agents|mesh-ancestor
153873434|NCT04536051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153873436|NCT02215005|Telmisartan|telmisartan|mesh-list
153414100|NCT02243202|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
153414101|NCT02243202|Sympathomimetics|sympathomimetics|mesh-ancestor
153414106|NCT02207946|Botulinum Toxins|botulinum toxins|mesh-list
153414107|NCT02207946|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
153414108|NCT02207946|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
153414109|NCT02207946|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
153414110|NCT02207946|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
153414111|NCT02207946|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153414112|NCT02207946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153414113|NCT02207946|Cholinergic Agents|cholinergic agents|mesh-ancestor
153414114|NCT02207946|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153414115|NCT02207946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153414116|NCT02207946|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
153414117|NCT02207946|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153414118|NCT04235036|Rituximab|rituximab|mesh-list
153414119|NCT04235036|Ibrutinib|ibrutinib|mesh-list
153414120|NCT04235036|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153414121|NCT04235036|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153414122|NCT04235036|Immunologic Factors|immunologic factors|mesh-ancestor
153414123|NCT04235036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153414124|NCT04235036|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153414125|NCT04235036|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153414126|NCT04235036|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153414127|NCT04235036|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153414128|NCT04235036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153873437|NCT02215005|Ramipril|ramipril|mesh-list
153873438|NCT02215005|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153873439|NCT02215005|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
153873440|NCT02215005|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
153873441|NCT02215005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153430197|NCT00986947|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153430198|NCT00986947|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153430199|NCT00986947|Immunologic Factors|immunologic factors|mesh-ancestor
153430200|NCT00986947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153430201|NCT00986947|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153430202|NCT00539617|Leucovorin|leucovorin|mesh-list
153873442|NCT02215005|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
153873443|NCT02215005|Protease Inhibitors|protease inhibitors|mesh-ancestor
153873444|NCT02215005|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153873445|NCT02215044|Gemcitabine|gemcitabine|mesh-list
153873446|NCT02215044|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153873447|NCT02215044|Antimetabolites|antimetabolites|mesh-ancestor
153873448|NCT02215044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153873449|NCT02215044|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153873450|NCT04556279|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-list
153873455|NCT04556279|Diuretics|diuretics|mesh-ancestor
153430203|NCT00539617|Fluorouracil|fluorouracil|mesh-list
153430204|NCT00539617|Oxaliplatin|oxaliplatin|mesh-list
153430205|NCT00539617|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
153430206|NCT00539617|Antimetabolites|antimetabolites|mesh-ancestor
153414132|NCT02560051|Estramustine|estramustine|mesh-list
153414133|NCT02560051|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153414134|NCT02560051|Tubulin Modulators|tubulin modulators|mesh-ancestor
153414135|NCT02560051|Antimitotic Agents|antimitotic agents|mesh-ancestor
153414136|NCT02560051|Mitosis Modulators|mitosis modulators|mesh-ancestor
153414137|NCT02560051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153414138|NCT02560051|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153414139|NCT02560051|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153414140|NCT02560051|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153414141|NCT02560051|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153414142|NCT02560051|Antifungal Agents|antifungal agents|mesh-ancestor
153414143|NCT02560051|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153414144|NCT02560051|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
153414145|NCT02560051|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153414146|NCT02560051|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153414147|NCT02560051|Hormone Antagonists|hormone antagonists|mesh-ancestor
153414148|NCT02560051|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153414149|NCT02560051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153414151|NCT02560051|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153414153|NCT02560051|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153414154|NCT03786770|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
153414155|NCT03786770|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
153414156|NCT03786770|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
153414157|NCT03786770|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153414158|NCT03786770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153414159|NCT03786770|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
153414160|NCT03786770|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153414161|NCT03786770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153873464|NCT02216331|Leprostatic Agents|leprostatic agents|mesh-ancestor
153414162|NCT03786770|Cholinergic Agents|cholinergic agents|mesh-ancestor
153873465|NCT02216331|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153873466|NCT02216331|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153873467|NCT02216331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153873468|NCT02216331|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
153873469|NCT02216331|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
153430207|NCT00539617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153430208|NCT00539617|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153873480|NCT04578236|Isotretinoin|isotretinoin|mesh-list
153873481|NCT04578236|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153873482|NCT04578236|Keratolytic Agents|keratolytic agents|mesh-ancestor
153873483|NCT04578236|Dermatologic Agents|dermatologic agents|mesh-ancestor
153873484|NCT04578236|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
153873490|NCT04542759|Ophthalmic Solutions|ophthalmic solutions|mesh-list
153873491|NCT04542759|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
153873492|NCT04542759|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153873493|NCT04542759|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153873494|NCT04542759|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153873495|NCT04542759|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153873496|NCT04542759|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153873497|NCT04542759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153873498|NCT04542759|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153873499|NCT04542213|Insulin|insulin|mesh-list
153414163|NCT03786770|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153414164|NCT00367718|Bortezomib|bortezomib|mesh-list
153414165|NCT00367718|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153414166|NCT02474407|Diazepam|diazepam|mesh-list
153414167|NCT02474407|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153414168|NCT02474407|Anticonvulsants|anticonvulsants|mesh-ancestor
153414169|NCT02474407|Antiemetics|antiemetics|mesh-ancestor
153414170|NCT02474407|Autonomic Agents|autonomic agents|mesh-ancestor
153414171|NCT02474407|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153414172|NCT02474407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153414173|NCT02474407|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153414174|NCT02474407|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153414175|NCT02474407|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153414176|NCT02474407|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
153414177|NCT02474407|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
153414178|NCT02474407|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153414179|NCT02474407|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153414180|NCT02474407|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153414181|NCT02474407|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153414182|NCT02474407|Anesthetics, General|anesthetics, general|mesh-ancestor
153414183|NCT02474407|Anesthetics|anesthetics|mesh-ancestor
153414184|NCT02474407|GABA Modulators|gaba modulators|mesh-ancestor
153414185|NCT02474407|GABA Agents|gaba agents|mesh-ancestor
153414186|NCT02474407|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153414187|NCT02474407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153414188|NCT05588492|Rifamycins|rifamycins|mesh-list
153414189|NCT05588492|Rifamycin SV|rifamycin sv|mesh-list
153414190|NCT05588492|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153414191|NCT05588492|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153414192|NCT05588492|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153414193|NCT03777956|Lacosamide|lacosamide|mesh-list
153414194|NCT03777956|Anticonvulsants|anticonvulsants|mesh-ancestor
153414195|NCT03777956|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
153414196|NCT03777956|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153414197|NCT03777956|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153873535|NCT04532775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153873536|NCT04532775|Sensory System Agents|sensory system agents|mesh-ancestor
153873537|NCT04532775|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153873538|NCT04532775|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153414204|NCT02481505|Sensory System Agents|sensory system agents|mesh-ancestor
153414205|NCT02481505|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153414207|NCT02563093|Immunologic Factors|immunologic factors|mesh-ancestor
153414208|NCT02563093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153414209|NCT02564029|Lorazepam|lorazepam|mesh-list
153414210|NCT02564029|PF-06372865|pf-06372865|mesh-list
153414211|NCT02564029|Anticonvulsants|anticonvulsants|mesh-ancestor
153414212|NCT02564029|Antiemetics|antiemetics|mesh-ancestor
153414213|NCT02564029|Autonomic Agents|autonomic agents|mesh-ancestor
153414214|NCT02564029|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153414215|NCT02564029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153414216|NCT02564029|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153414217|NCT02564029|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153414218|NCT02564029|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153414219|NCT02564029|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153414220|NCT02564029|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153414221|NCT02564029|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153414222|NCT02564029|GABA Modulators|gaba modulators|mesh-ancestor
153873553|NCT04532775|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153873554|NCT04532775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153873555|NCT04532775|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153873556|NCT04532775|Tocolytic Agents|tocolytic agents|mesh-ancestor
153873557|NCT04532775|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153873558|NCT04578158|Quercetin|quercetin|mesh-list
153873559|NCT04578158|Antioxidants|antioxidants|mesh-ancestor
153873560|NCT04578158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153873561|NCT04578158|Protective Agents|protective agents|mesh-ancestor
153414230|NCT05588336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153414234|NCT02564497|Abatacept|abatacept|mesh-list
153873562|NCT04578158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153873563|NCT04532736|Mometasone Furoate|mometasone furoate|mesh-list
153873564|NCT04532736|Methylprednisolone|methylprednisolone|mesh-list
153873565|NCT04532736|Methotrexate|methotrexate|mesh-list
153873566|NCT04532736|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
153873567|NCT04532736|Abortifacient Agents|abortifacient agents|mesh-ancestor
153873568|NCT04532736|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153873569|NCT04532736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153873570|NCT04532736|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153873571|NCT04532736|Antimetabolites|antimetabolites|mesh-ancestor
153873572|NCT04532736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153873573|NCT04532736|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153873574|NCT04532736|Dermatologic Agents|dermatologic agents|mesh-ancestor
153873575|NCT04532736|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153873576|NCT04532736|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153873577|NCT04532736|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153873578|NCT04532736|Immunologic Factors|immunologic factors|mesh-ancestor
153873579|NCT04532736|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153873580|NCT04532736|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153873581|NCT04532736|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153873582|NCT04532736|Antiemetics|antiemetics|mesh-ancestor
153414260|NCT03926624|Etoposide|etoposide|mesh-list
153414261|NCT03926624|Azacitidine|azacitidine|mesh-list
153414262|NCT03926624|Venetoclax|venetoclax|mesh-list
153414263|NCT03926624|Decitabine|decitabine|mesh-list
153414264|NCT03926624|Mitoxantrone|mitoxantrone|mesh-list
153414265|NCT03926624|Idarubicin|idarubicin|mesh-list
153414266|NCT03926624|Cladribine|cladribine|mesh-list
153414267|NCT03926624|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153414268|NCT03926624|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153414269|NCT03926624|Antimetabolites|antimetabolites|mesh-ancestor
153414275|NCT03926624|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153873587|NCT04532736|Hormones|hormones|mesh-ancestor
153873588|NCT04532736|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153873589|NCT04532736|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
153873590|NCT04532736|Protective Agents|protective agents|mesh-ancestor
153873591|NCT04532736|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
153873592|NCT04555733|Lemborexant|lemborexant|mesh-list
153873593|NCT04555733|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
153873594|NCT04555733|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153873595|NCT04555733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153873596|NCT04555733|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
153873597|NCT04555733|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153873598|NCT04555733|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153414290|NCT03551210|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153414291|NCT03551210|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153414292|NCT03551210|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153414293|NCT03551210|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153414294|NCT03551210|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153414295|NCT03551210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153889084|NCT02872597|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153889085|NCT02872597|Antiemetics|antiemetics|mesh-ancestor
153889086|NCT02872597|Autonomic Agents|autonomic agents|mesh-ancestor
153889087|NCT02872597|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153889088|NCT02872597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153889089|NCT02872597|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153889090|NCT02872597|Glucocorticoids|glucocorticoids|mesh-ancestor
153889091|NCT02872597|Hormones|hormones|mesh-ancestor
153414298|NCT03551210|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153414299|NCT02482675|Caseins|caseins|mesh-list
153414300|NCT02482675|Chelating Agents|chelating agents|mesh-ancestor
153414301|NCT02482675|Sequestering Agents|sequestering agents|mesh-ancestor
153873606|NCT02212613|Serotonin Agents|serotonin agents|mesh-ancestor
153873607|NCT02212613|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153873608|NCT02212613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153873609|NCT02212613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153873610|NCT02212613|Dopamine Agonists|dopamine agonists|mesh-ancestor
153873611|NCT02212613|Dopamine Agents|dopamine agents|mesh-ancestor
153873612|NCT02217189|Zinc Sulfate|zinc sulfate|mesh-list
153414314|NCT02570425|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
153414315|NCT02570425|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153414316|NCT02570425|Respiratory System Agents|respiratory system agents|mesh-ancestor
153414317|NCT02571439|Ropivacaine|ropivacaine|mesh-list
153414318|NCT02571439|Anesthetics, Local|anesthetics, local|mesh-ancestor
153414319|NCT02571439|Anesthetics|anesthetics|mesh-ancestor
153414320|NCT02571439|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153414321|NCT02571439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153414322|NCT02571439|Sensory System Agents|sensory system agents|mesh-ancestor
153414323|NCT02571439|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153414324|NCT02573857|Artefenomel|artefenomel|mesh-list
153414325|NCT02573857|Antimalarials|antimalarials|mesh-ancestor
153414326|NCT02573857|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153414327|NCT02573857|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153414328|NCT02573857|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153414329|NCT03678428|Leucovorin|leucovorin|mesh-list
153414330|NCT03678428|Oxaliplatin|oxaliplatin|mesh-list
153414331|NCT03678428|Irinotecan|irinotecan|mesh-list
153414332|NCT03678428|Floxuridine|floxuridine|mesh-list
153414333|NCT03678428|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153414334|NCT03678428|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
153873632|NCT04531800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153873633|NCT00579995|Acetylcysteine|acetylcysteine|mesh-list
153873634|NCT00579995|N-monoacetylcystine|n-monoacetylcystine|mesh-list
153873635|NCT00579995|Antiviral Agents|antiviral agents|mesh-ancestor
153873636|NCT00579995|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153873637|NCT00579995|Expectorants|expectorants|mesh-ancestor
153873638|NCT00579995|Respiratory System Agents|respiratory system agents|mesh-ancestor
153873652|NCT04531371|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153873653|NCT04531371|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
153873654|NCT04531371|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153873656|NCT04531371|Adrenergic Agents|adrenergic agents|mesh-ancestor
153873657|NCT04531371|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153873658|NCT04531371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153873659|NCT00580112|Dexamethasone|dexamethasone|mesh-list
153873660|NCT00580112|Trabectedin|trabectedin|mesh-list
153873661|NCT00580112|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153873662|NCT00580112|Antiemetics|antiemetics|mesh-ancestor
153873663|NCT00580112|Autonomic Agents|autonomic agents|mesh-ancestor
153414336|NCT03678428|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153873669|NCT00580112|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153873670|NCT00580112|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153873672|NCT00580112|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153873673|NCT00580112|Alkylating Agents|alkylating agents|mesh-ancestor
153873674|NCT00580112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153873675|NCT04531332|Linezolid|linezolid|mesh-list
153873676|NCT04531332|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153873678|NCT04531332|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
153873680|NCT04531332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153873681|NCT04530864|Dexamethasone|dexamethasone|mesh-list
153873682|NCT04530864|Dexamethasone acetate|dexamethasone acetate|mesh-list
153873683|NCT04530864|BB 1101|bb 1101|mesh-list
153873684|NCT04530864|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153873685|NCT04530864|Antiemetics|antiemetics|mesh-ancestor
153873686|NCT04530864|Autonomic Agents|autonomic agents|mesh-ancestor
153873687|NCT04530864|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153873688|NCT04530864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153873689|NCT04530864|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153873690|NCT04530864|Glucocorticoids|glucocorticoids|mesh-ancestor
153873691|NCT04530864|Hormones|hormones|mesh-ancestor
153873692|NCT04530864|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153889100|NCT02872597|Respiratory System Agents|respiratory system agents|mesh-ancestor
153873693|NCT04530864|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153873694|NCT04530864|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153873695|NCT04530864|Protease Inhibitors|protease inhibitors|mesh-ancestor
153873696|NCT04530864|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153414354|NCT02577601|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153414355|NCT02577601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153873697|NCT04530864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153873705|NCT00580190|GABA Modulators|gaba modulators|mesh-ancestor
153873706|NCT00580190|GABA Agents|gaba agents|mesh-ancestor
153873707|NCT00580190|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153873708|NCT00580190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153873709|NCT04530903|Clonidine|clonidine|mesh-list
153873710|NCT04530903|Levobupivacaine|levobupivacaine|mesh-list
153873711|NCT04530903|Analgesics|analgesics|mesh-ancestor
153873712|NCT04530903|Sensory System Agents|sensory system agents|mesh-ancestor
153873713|NCT04530903|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153430216|NCT00539617|Vitamins|vitamins|mesh-ancestor
153430221|NCT05467514|Liraglutide|liraglutide|mesh-list
153430222|NCT05467514|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
153430223|NCT05467514|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153430224|NCT05467514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153430225|NCT05467514|Incretins|incretins|mesh-ancestor
153430226|NCT05467514|Hormones|hormones|mesh-ancestor
153430227|NCT05467514|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153430228|NCT00976339|Vitamin D|vitamin d|mesh-list
153430229|NCT00976339|Cholecalciferol|cholecalciferol|mesh-list
153430230|NCT00976339|Vitamins|vitamins|mesh-ancestor
153430231|NCT00976339|Micronutrients|micronutrients|mesh-ancestor
153873728|NCT04530474|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153873729|NCT04530474|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153873730|NCT04554680|Trametinib|trametinib|mesh-list
153873731|NCT04554680|Dabrafenib|dabrafenib|mesh-list
153873732|NCT04554680|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153873733|NCT04554680|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153873734|NCT04554680|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153873735|NCT04554680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153873736|NCT00580424|Norethindrone|norethindrone|mesh-list
153873737|NCT00580424|Norethindrone Acetate|norethindrone acetate|mesh-list
153873738|NCT00580424|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
153873739|NCT00580424|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
153873740|NCT00580424|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
153873741|NCT00580424|Contraceptive Agents|contraceptive agents|mesh-ancestor
153873742|NCT00580424|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153873743|NCT00580424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153873744|NCT00580424|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
153873745|NCT00580424|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
153873746|NCT01121575|Crizotinib|crizotinib|mesh-list
153873747|NCT01121575|Dacomitinib|dacomitinib|mesh-list
153873748|NCT01121575|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153873749|NCT01121575|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153873750|NCT01121575|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153873751|NCT01121575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153873752|NCT01121575|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153430235|NCT04579640|Vitamin D|vitamin d|mesh-list
153873762|NCT02882113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153873763|NCT02882113|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
153873764|NCT02882113|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153873767|NCT04530045|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153873768|NCT04530045|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153873770|NCT01121536|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
153873771|NCT01121536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153414447|NCT00367250|Cetuximab|cetuximab|mesh-list
153414448|NCT00367250|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153414449|NCT00367250|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153414450|NCT02489227|Adalimumab|adalimumab|mesh-list
153414451|NCT02489227|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
153414452|NCT02489227|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153414453|NCT02489227|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153414454|NCT02490631|Chlorhexidine|chlorhexidine|mesh-list
153889112|NCT02873065|Potassium Citrate|potassium citrate|mesh-list
153889113|NCT02873065|Bismuth|bismuth|mesh-list
153889114|NCT02873065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153889115|NCT02873065|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153889116|NCT02873065|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153889117|NCT02873065|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
153889118|NCT02873065|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153414455|NCT02490631|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
153414456|NCT02490631|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
153414457|NCT02490631|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153414458|NCT02490631|Disinfectants|disinfectants|mesh-ancestor
153414459|NCT02490631|Dermatologic Agents|dermatologic agents|mesh-ancestor
153414460|NCT02207556|Doxycycline|doxycycline|mesh-list
153414461|NCT02207556|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153414462|NCT02207556|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153414463|NCT02207556|Antimalarials|antimalarials|mesh-ancestor
153414464|NCT02207556|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153414465|NCT02207556|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153414467|NCT02572609|Expectorants|expectorants|mesh-ancestor
153414468|NCT02572609|Respiratory System Agents|respiratory system agents|mesh-ancestor
153414469|NCT02587117|Prednisolone|prednisolone|mesh-list
153414470|NCT02587117|Lycopene|lycopene|mesh-list
153414471|NCT02587117|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153414472|NCT02587117|Glucocorticoids|glucocorticoids|mesh-ancestor
153414473|NCT02587117|Hormones|hormones|mesh-ancestor
153873772|NCT01121536|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
153873773|NCT01121536|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
153873774|NCT01121536|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
153873775|NCT01121536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153873776|NCT00580619|Methyldopa|methyldopa|mesh-list
153873777|NCT00580619|Trimethaphan|trimethaphan|mesh-list
153873778|NCT00580619|Trimethaphan camsylate|trimethaphan camsylate|mesh-list
153873791|NCT00580619|Ganglionic Blockers|ganglionic blockers|mesh-ancestor
153873792|NCT00580619|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
153873793|NCT00580619|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
153873794|NCT00580619|Cholinergic Agents|cholinergic agents|mesh-ancestor
153873795|NCT00580619|Vasodilator Agents|vasodilator agents|mesh-ancestor
153873796|NCT04554524|Paclitaxel|paclitaxel|mesh-list
153889119|NCT02873065|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
153889120|NCT02873065|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153889121|NCT02873065|Antacids|antacids|mesh-ancestor
153873797|NCT04554524|Pembrolizumab|pembrolizumab|mesh-list
153873802|NCT04554524|Mitosis Modulators|mitosis modulators|mesh-ancestor
153873803|NCT04554524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153873804|NCT04554524|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153873805|NCT04554524|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153873806|NCT02212652|Vitamin D|vitamin d|mesh-list
153873807|NCT02212652|Ergocalciferols|ergocalciferols|mesh-list
153873808|NCT02212652|Cholecalciferol|cholecalciferol|mesh-list
153873809|NCT02212652|Vitamins|vitamins|mesh-list
153873810|NCT02212652|Micronutrients|micronutrients|mesh-ancestor
153882940|NCT02271126|Heparin|heparin|mesh-list
153882941|NCT02271126|Thromboplastin|thromboplastin|mesh-list
153882942|NCT02271126|Anticoagulants|anticoagulants|mesh-ancestor
153882943|NCT02271126|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153882944|NCT02271126|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153882945|NCT02271126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153882946|NCT02271126|Hemostatics|hemostatics|mesh-ancestor
153882947|NCT02271126|Coagulants|coagulants|mesh-ancestor
153873811|NCT02212652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153873812|NCT02212652|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153873813|NCT02212652|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153873814|NCT02212769|Losartan|losartan|mesh-list
153414492|NCT02587351|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
153414493|NCT02587351|Adrenergic Agents|adrenergic agents|mesh-ancestor
153414494|NCT02587351|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153414495|NCT02587351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153414496|NCT00422396|Fenofibrate|fenofibrate|mesh-list
153414497|NCT00422396|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153414499|NCT00422396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153414500|NCT00422396|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153414501|NCT00364273|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
153414502|NCT00364273|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153414503|NCT00364273|Autonomic Agents|autonomic agents|mesh-ancestor
153414504|NCT00364273|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153414505|NCT00364273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153414506|NCT00364273|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153414507|NCT00364273|Respiratory System Agents|respiratory system agents|mesh-ancestor
153414508|NCT00364273|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
153414509|NCT00364273|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
153414510|NCT00364273|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153414511|NCT00364273|Adrenergic Agents|adrenergic agents|mesh-ancestor
153414512|NCT00364273|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153414513|NCT00364273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153414514|NCT02495467|Nitroglycerin|nitroglycerin|mesh-list
153414515|NCT02495467|Vasodilator Agents|vasodilator agents|mesh-ancestor
153873815|NCT02212769|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153873816|NCT02212769|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153873817|NCT02212769|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
153873818|NCT02212769|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
153873819|NCT02212769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153889136|NCT00628225|Cholinergic Agents|cholinergic agents|mesh-ancestor
153889137|NCT00628225|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153889138|NCT00628225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153873820|NCT02212808|Anti-Infective Agents|anti-infective agents|mesh-list
153889139|NCT00628225|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
153873821|NCT02212808|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
153889140|NCT00628225|Antidepressive Agents|antidepressive agents|mesh-ancestor
153889141|NCT00628225|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153889142|NCT00628225|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
153873825|NCT02217852|Nitrendipine|nitrendipine|mesh-list
153873826|NCT02217852|Diuretics|diuretics|mesh-ancestor
153873838|NCT02217930|Moxifloxacin|moxifloxacin|mesh-list
153873849|NCT04577846|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153873850|NCT04577846|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153873851|NCT04529811|Rifaximin|rifaximin|mesh-list
153873852|NCT04529811|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153873853|NCT04529811|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153873854|NCT04529811|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153873855|NCT02218047|Interferons|interferons|mesh-list
153873856|NCT02218047|Interferon-alpha|interferon-alpha|mesh-list
153873857|NCT02218047|Interferon alpha-2|interferon alpha-2|mesh-list
153873858|NCT02218047|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153873859|NCT02218047|Antiviral Agents|antiviral agents|mesh-ancestor
153873860|NCT02218047|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153873861|NCT02218047|Immunologic Factors|immunologic factors|mesh-ancestor
153873862|NCT02218047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153873863|NCT00580814|Methylphenidate|methylphenidate|mesh-list
153414542|NCT02502487|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153414544|NCT02632045|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153414545|NCT02632045|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153414546|NCT02632045|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
153414547|NCT02632045|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
153414548|NCT02632045|Hormone Antagonists|hormone antagonists|mesh-ancestor
153414549|NCT02632045|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153414550|NCT02632045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153414551|NCT02503735|Sofosbuvir|sofosbuvir|mesh-list
153414552|NCT02503735|Ledipasvir|ledipasvir|mesh-list
153414553|NCT02503735|Antiviral Agents|antiviral agents|mesh-ancestor
153414554|NCT02503735|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153414555|NCT04001881|Anesthetics|anesthetics|mesh-list
153414558|NCT03019640|Cytarabine|cytarabine|mesh-list
153873868|NCT00580814|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153873869|NCT00580814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153873870|NCT00580814|Dopamine Agents|dopamine agents|mesh-ancestor
153873871|NCT00580814|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153873872|NCT01120600|Vitamin D|vitamin d|mesh-list
153873873|NCT01120600|Cholecalciferol|cholecalciferol|mesh-list
153873874|NCT01120600|Calcium Carbonate|calcium carbonate|mesh-list
153873875|NCT01120600|Calcium|calcium|mesh-list
153873876|NCT01120600|Vitamins|vitamins|mesh-ancestor
153873877|NCT01120600|Micronutrients|micronutrients|mesh-ancestor
153873878|NCT01120600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153873880|NCT01120600|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153873881|NCT01120600|Antacids|antacids|mesh-ancestor
153873882|NCT01120600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153414564|NCT03019640|Melphalan|melphalan|mesh-list
153414565|NCT03019640|Mechlorethamine|mechlorethamine|mesh-list
153414566|NCT03019640|Carmustine|carmustine|mesh-list
153414567|NCT03019640|Podophyllotoxin|podophyllotoxin|mesh-list
153414568|NCT03019640|Nitrogen Mustard Compounds|nitrogen mustard compounds|mesh-list
153414569|NCT03019640|Antibodies|antibodies|mesh-list
153414570|NCT03019640|Immunoglobulins|immunoglobulins|mesh-list
153414571|NCT03019640|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
153414572|NCT03019640|Lenograstim|lenograstim|mesh-list
153414573|NCT03019640|Immunologic Factors|immunologic factors|mesh-ancestor
153414574|NCT03019640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153414575|NCT03019640|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153414576|NCT03019640|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153414577|NCT03019640|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153414578|NCT03019640|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153414579|NCT03019640|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153414580|NCT03019640|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153430253|NCT00382538|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153430254|NCT00382538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153430255|NCT00382538|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
153430256|NCT00382538|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
153430257|NCT00382538|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
153414599|NCT03019640|Mitosis Modulators|mitosis modulators|mesh-ancestor
153414600|NCT02136901|Hyaluronic Acid|hyaluronic acid|mesh-list
153414601|NCT02136901|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153414602|NCT02136901|Immunologic Factors|immunologic factors|mesh-ancestor
153414603|NCT02136901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153414604|NCT02136901|Viscosupplements|viscosupplements|mesh-ancestor
153414605|NCT02136901|Protective Agents|protective agents|mesh-ancestor
153414606|NCT02507011|Carvedilol|carvedilol|mesh-list
153414607|NCT02507011|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
153414608|NCT02507011|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
153414609|NCT02507011|Adrenergic Agents|adrenergic agents|mesh-ancestor
153414610|NCT02507011|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153414611|NCT02507011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153414612|NCT02507011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153414613|NCT02507011|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153414614|NCT02507011|Antioxidants|antioxidants|mesh-ancestor
153414615|NCT02507011|Protective Agents|protective agents|mesh-ancestor
153414616|NCT02507011|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153873897|NCT04577885|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
153873898|NCT04577885|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
153873899|NCT00580931|Niacinamide|niacinamide|mesh-list
153873900|NCT00580931|Niacin|niacin|mesh-list
153873901|NCT00580931|Nicotinic Acids|nicotinic acids|mesh-list
153873902|NCT00580931|Vitamin B Complex|vitamin b complex|mesh-ancestor
153873903|NCT00580931|Vitamins|vitamins|mesh-ancestor
153873904|NCT00580931|Micronutrients|micronutrients|mesh-ancestor
153873905|NCT00580931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153873917|NCT01120093|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153873918|NCT01120093|Respiratory System Agents|respiratory system agents|mesh-ancestor
153873919|NCT01120093|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
153873920|NCT01120093|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
153873921|NCT01120093|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153873922|NCT01120093|Adrenergic Agents|adrenergic agents|mesh-ancestor
153430258|NCT00382538|Contraceptive Agents|contraceptive agents|mesh-ancestor
153430259|NCT00382538|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
153430260|NCT00382538|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
153430261|NCT00382538|Hormone Antagonists|hormone antagonists|mesh-ancestor
153430262|NCT00382538|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153430263|NCT00382538|Luteolytic Agents|luteolytic agents|mesh-ancestor
153414619|NCT02507011|Vasodilator Agents|vasodilator agents|mesh-ancestor
153414620|NCT02507011|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
153414621|NCT02507011|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
153414622|NCT02977286|Methylnaltrexone|methylnaltrexone|mesh-list
153414623|NCT02977286|Naloxegol|naloxegol|mesh-list
153414624|NCT02977286|Bisacodyl|bisacodyl|mesh-list
153414625|NCT02977286|Magnesium citrate|magnesium citrate|mesh-list
153414626|NCT02977286|Bismuth subsalicylate|bismuth subsalicylate|mesh-list
153414627|NCT02977286|Cathartics|cathartics|mesh-ancestor
153414628|NCT02977286|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153414629|NCT02977286|Laxatives|laxatives|mesh-ancestor
153414632|NCT02977286|Sensory System Agents|sensory system agents|mesh-ancestor
153414633|NCT02977286|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153414634|NCT02977286|Antidiarrheals|antidiarrheals|mesh-ancestor
153414635|NCT05345210|Amoxicillin|amoxicillin|mesh-list
153873956|NCT02218398|Autonomic Agents|autonomic agents|mesh-ancestor
153873957|NCT02218398|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153873958|NCT02218398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153414647|NCT05345210|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
153414648|NCT05345210|Antitrichomonal Agents|antitrichomonal agents|mesh-ancestor
153414650|NCT05345210|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153414651|NCT05345210|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
153414652|NCT02976896|Apatinib|apatinib|mesh-list
153414653|NCT02976896|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153414654|NCT02976896|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153414655|NCT02976896|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153414656|NCT02976896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153414657|NCT01810705|Asparaginase|asparaginase|mesh-list
153414658|NCT01810705|Eryaspase|eryaspase|mesh-list
153414659|NCT01810705|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153414660|NCT02508103|Oxytocin|oxytocin|mesh-list
153414661|NCT02508103|Oxytocics|oxytocics|mesh-ancestor
153414662|NCT02508103|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153414663|NCT02508103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153414664|NCT02508259|Suramin|suramin|mesh-list
153414665|NCT02508259|Antinematodal Agents|antinematodal agents|mesh-ancestor
153414666|NCT02508259|Anthelmintics|anthelmintics|mesh-ancestor
153414667|NCT02508259|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153414668|NCT02508259|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153873971|NCT02218671|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153873982|NCT01119937|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
153873983|NCT01119937|Cholinergic Agents|cholinergic agents|mesh-ancestor
153873984|NCT01119937|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153873985|NCT01119937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153873986|NCT01119937|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153873987|NCT01119937|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
153873988|NCT01119898|Diclofenac|diclofenac|mesh-list
153873989|NCT01119898|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153873990|NCT01119898|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153873991|NCT01119898|Analgesics|analgesics|mesh-ancestor
153873992|NCT01119898|Sensory System Agents|sensory system agents|mesh-ancestor
153873993|NCT01119898|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153873994|NCT01119898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153873995|NCT01119898|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153873996|NCT01119898|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153873997|NCT01119898|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153414688|NCT00534469|Immunologic Factors|immunologic factors|mesh-ancestor
153414689|NCT00534469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153414690|NCT00534469|Alkylating Agents|alkylating agents|mesh-ancestor
153414691|NCT00534469|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153414692|NCT00534469|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153414693|NCT00534469|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153414694|NCT00534469|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153414695|NCT00534469|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153414696|NCT02240628|Lidocaine|lidocaine|mesh-list
153414697|NCT02240628|Tetracaine|tetracaine|mesh-list
153874010|NCT02882230|Dolutegravir|dolutegravir|mesh-list
153874011|NCT02882230|Rilpivirine|rilpivirine|mesh-list
153874012|NCT02882230|Elvitegravir|elvitegravir|mesh-list
153874013|NCT02882230|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
153874014|NCT02882230|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
153874038|NCT04561947|Mitosis Modulators|mitosis modulators|mesh-ancestor
153874039|NCT04561947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153874040|NCT01118962|Lacosamide|lacosamide|mesh-list
153874041|NCT01118962|Anticonvulsants|anticonvulsants|mesh-ancestor
153874046|NCT00581165|Etanercept|etanercept|mesh-list
153414765|NCT02513095|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
153414766|NCT02513095|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153414767|NCT02513719|Everolimus|everolimus|mesh-list
153414768|NCT02513719|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
153414770|NCT02513719|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153414771|NCT02513719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153414772|NCT02513719|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153414773|NCT02513719|Immunologic Factors|immunologic factors|mesh-ancestor
153874047|NCT00581165|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153874049|NCT00581165|Analgesics|analgesics|mesh-ancestor
153874050|NCT00581165|Sensory System Agents|sensory system agents|mesh-ancestor
153874051|NCT00581165|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153874052|NCT00581165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153874053|NCT00581165|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153874054|NCT00581165|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153874055|NCT00581165|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153874056|NCT00581165|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153874057|NCT00581165|Immunologic Factors|immunologic factors|mesh-ancestor
153874058|NCT05092984|Spironolactone|spironolactone|mesh-list
153874060|NCT05092984|Hormone Antagonists|hormone antagonists|mesh-ancestor
153414776|NCT00363727|Ropinirole|ropinirole|mesh-list
153414777|NCT00363727|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
153414778|NCT00363727|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
153414779|NCT00363727|Dopamine Agonists|dopamine agonists|mesh-ancestor
153414780|NCT00363727|Dopamine Agents|dopamine agents|mesh-ancestor
153414781|NCT00363727|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153414782|NCT00363727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153414783|NCT00363727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153414784|NCT04340869|Theobromine|theobromine|mesh-list
153414785|NCT04340869|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153414786|NCT04340869|Autonomic Agents|autonomic agents|mesh-ancestor
153414787|NCT04340869|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153414788|NCT04340869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153414789|NCT04340869|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153414790|NCT04340869|Respiratory System Agents|respiratory system agents|mesh-ancestor
153414791|NCT04340869|Vasodilator Agents|vasodilator agents|mesh-ancestor
153414797|NCT00366067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153414798|NCT00366067|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
153414799|NCT00366067|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
153414801|NCT00364429|Risperidone|risperidone|mesh-list
153414802|NCT00364429|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153414803|NCT00364429|Serotonin Agents|serotonin agents|mesh-ancestor
153414804|NCT00364429|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153414805|NCT00364429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153414806|NCT00364429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153414807|NCT00364429|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153414808|NCT00364429|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153414809|NCT00364429|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153414810|NCT00364429|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153414811|NCT00364429|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
153414812|NCT00364429|Dopamine Agents|dopamine agents|mesh-ancestor
153414813|NCT00364429|Anticonvulsants|anticonvulsants|mesh-ancestor
153414814|NCT00364429|Antiemetics|antiemetics|mesh-ancestor
153414815|NCT00364429|Autonomic Agents|autonomic agents|mesh-ancestor
153414816|NCT00364429|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153414817|NCT00364429|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153414818|NCT00364429|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153414819|NCT00364429|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153874143|NCT04577378|Tretinoin|tretinoin|mesh-list
153414846|NCT02596867|Vasodilator Agents|vasodilator agents|mesh-ancestor
153414847|NCT02597101|Metformin|metformin|mesh-list
153414848|NCT02597101|Saxagliptin|saxagliptin|mesh-list
153414849|NCT02597101|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153414850|NCT02597101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153414856|NCT02597101|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153414857|NCT02597101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153414858|NCT02600611|Vancomycin|vancomycin|mesh-list
153414859|NCT02600611|Iclaprim|iclaprim|mesh-list
153414860|NCT02600611|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153414861|NCT02600611|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153414862|NCT02600611|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153414863|NCT02600611|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153414864|NCT02600611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153414865|NCT02600767|Lumefantrine|lumefantrine|mesh-list
153874154|NCT04577378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153874155|NCT04577378|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
153874156|NCT04577378|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153874157|NCT04577378|Keratolytic Agents|keratolytic agents|mesh-ancestor
153874158|NCT04577378|Dermatologic Agents|dermatologic agents|mesh-ancestor
153874160|NCT02219412|Ticagrelor|ticagrelor|mesh-list
153874162|NCT02219412|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153874179|NCT02219412|Purinergic Agents|purinergic agents|mesh-ancestor
153874180|NCT02219412|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153874182|NCT04577027|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153874183|NCT02211690|Tenofovir|tenofovir|mesh-list
153874184|NCT02211690|Emtricitabine|emtricitabine|mesh-list
153874185|NCT02211690|Dolutegravir|dolutegravir|mesh-list
153874186|NCT02211690|Antiviral Agents|antiviral agents|mesh-ancestor
153874187|NCT02211690|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153874188|NCT02211690|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153414887|NCT00365287|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153414903|NCT04743193|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153414904|NCT04743193|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
153414905|NCT04743193|Anesthetics, General|anesthetics, general|mesh-ancestor
153414907|NCT02608177|Glipizide|glipizide|mesh-list
153414908|NCT02608177|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153414909|NCT02608177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153414910|NCT02608177|Incretins|incretins|mesh-ancestor
153414911|NCT02608177|Hormones|hormones|mesh-ancestor
153414912|NCT02608177|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153414913|NCT02608177|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
153414914|NCT02608177|Protease Inhibitors|protease inhibitors|mesh-ancestor
153414915|NCT02608177|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153874189|NCT02211690|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153874190|NCT02211690|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153874191|NCT02211690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153874192|NCT02211690|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153874193|NCT02211690|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153874194|NCT02211690|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
153874195|NCT02211690|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
153874196|NCT04553393|Decitabine|decitabine|mesh-list
153874197|NCT04553393|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153874198|NCT04553393|Antimetabolites|antimetabolites|mesh-ancestor
153874199|NCT04553393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153874222|NCT04553510|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153874223|NCT04553510|Growth Substances|growth substances|mesh-ancestor
153874224|NCT04553510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153874225|NCT04553510|Growth Inhibitors|growth inhibitors|mesh-ancestor
153874226|NCT03453281|Aflibercept|aflibercept|mesh-list
153874227|NCT03453281|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153874228|NCT03453281|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153414946|NCT02616523|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
153414947|NCT02616523|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153414949|NCT02616523|Adrenergic Agents|adrenergic agents|mesh-ancestor
153414950|NCT02616523|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153414951|NCT02616523|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153414952|NCT02616523|Narcotics|narcotics|mesh-ancestor
153414953|NCT02616523|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153414954|NCT02616523|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153414955|NCT02616523|Anesthetics, General|anesthetics, general|mesh-ancestor
153414956|NCT05732155|N-Methyl-3,4-methylenedioxyamphetamine|n-methyl-3,4-methylenedioxyamphetamine|mesh-list
153414977|NCT05480293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153414978|NCT05480293|Growth Inhibitors|growth inhibitors|mesh-ancestor
153414979|NCT05480293|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153382952|NCT01740362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153382972|NCT01720316|Glycine Agents|glycine agents|mesh-ancestor
153382973|NCT01720316|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153382974|NCT01720316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153382975|NCT01720316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153382976|NCT02399345|Ritonavir|ritonavir|mesh-list
153382977|NCT02399345|Ribavirin|ribavirin|mesh-list
153382978|NCT02399345|Sofosbuvir|sofosbuvir|mesh-list
153382979|NCT02399345|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
153382980|NCT02399345|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
153382981|NCT02399345|Protease Inhibitors|protease inhibitors|mesh-ancestor
153382982|NCT02399345|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153414980|NCT00365755|Cyclophosphamide|cyclophosphamide|mesh-list
153414981|NCT00365755|Melphalan|melphalan|mesh-list
153414982|NCT00365755|Carboplatin|carboplatin|mesh-list
153414983|NCT00365755|Etoposide|etoposide|mesh-list
153414984|NCT00365755|Vincristine|vincristine|mesh-list
153414985|NCT00365755|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153414986|NCT00365755|Immunologic Factors|immunologic factors|mesh-ancestor
153414987|NCT00365755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153874280|NCT01117987|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153874281|NCT01117987|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153874282|NCT01117987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153874283|NCT01117987|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153874285|NCT02219490|Ribavirin|ribavirin|mesh-list
153874286|NCT02219490|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
153874287|NCT02219490|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
153874288|NCT02219490|Protease Inhibitors|protease inhibitors|mesh-ancestor
153874289|NCT02219490|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153874290|NCT02219490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153874291|NCT02219490|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153874292|NCT02219490|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153874293|NCT02219490|Antiviral Agents|antiviral agents|mesh-ancestor
153874295|NCT02219490|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
153874296|NCT02219490|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153874298|NCT01117051|Prucalopride|prucalopride|mesh-list
153874299|NCT01117051|Laxatives|laxatives|mesh-ancestor
153874300|NCT01117051|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153874301|NCT01117051|Serotonin 5-HT4 Receptor Agonists|serotonin 5-ht4 receptor agonists|mesh-ancestor
153874302|NCT01117051|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
153874303|NCT01117051|Serotonin Agents|serotonin agents|mesh-ancestor
153874304|NCT01117051|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153874305|NCT01117051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153415036|NCT04622839|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153415037|NCT04622839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153415046|NCT02619799|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153415047|NCT02619799|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153415048|NCT02619799|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153415049|NCT02619799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153415050|NCT02619799|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153415051|NCT02619799|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153874317|NCT02211417|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153874318|NCT02211417|Antimetabolites|antimetabolites|mesh-ancestor
153874319|NCT02211417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153874320|NCT02211417|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153874321|NCT02211417|Dermatologic Agents|dermatologic agents|mesh-ancestor
153415053|NCT02619799|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153415054|NCT02619799|Anesthetics, General|anesthetics, general|mesh-ancestor
153415056|NCT02619799|GABA Modulators|gaba modulators|mesh-ancestor
153415057|NCT02619799|GABA Agents|gaba agents|mesh-ancestor
153415058|NCT02619799|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153415059|NCT02619799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153415060|NCT02619799|Analgesics|analgesics|mesh-ancestor
153415098|NCT02625181|Hydrocodone|hydrocodone|mesh-list
153415099|NCT02625181|Alfentanil|alfentanil|mesh-list
153415100|NCT02625181|Haloperidol|haloperidol|mesh-list
153415101|NCT02625181|Ondansetron|ondansetron|mesh-list
153415115|NCT02625181|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153415116|NCT02625181|Antiemetics|antiemetics|mesh-ancestor
153874478|NCT04529226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153415186|NCT02630719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153415187|NCT02630719|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153415188|NCT02630719|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153415190|NCT02633371|Parasympatholytics|parasympatholytics|mesh-ancestor
153415191|NCT02633371|Autonomic Agents|autonomic agents|mesh-ancestor
153415192|NCT02633371|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153415193|NCT02633371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153415194|NCT02633371|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
153415195|NCT02633371|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
153415196|NCT02633371|Cholinergic Agents|cholinergic agents|mesh-ancestor
153415197|NCT02633371|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153415198|NCT02633371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153415199|NCT02633371|Urological Agents|urological agents|mesh-ancestor
153415201|NCT04159519|Albuterol|albuterol|mesh-list
153415202|NCT04159519|Formoterol Fumarate|formoterol fumarate|mesh-list
153415203|NCT04159519|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
153415204|NCT04159519|Benralizumab|benralizumab|mesh-list
153874498|NCT04310683|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153874499|NCT04310683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153874500|NCT04550702|Mirabegron|mirabegron|mesh-list
153388695|NCT00001407|Interferon-gamma|interferon-gamma|mesh-list
153388696|NCT00001407|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153388697|NCT00001407|Antiviral Agents|antiviral agents|mesh-ancestor
153388698|NCT00001407|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153388699|NCT00002097|Nystatin|nystatin|mesh-list
153388700|NCT00002097|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153388701|NCT00002097|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153388702|NCT00002097|Antifungal Agents|antifungal agents|mesh-ancestor
153388840|NCT00001587|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153388841|NCT00001587|Alkylating Agents|alkylating agents|mesh-ancestor
153388842|NCT00001587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153388845|NCT00001587|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153388846|NCT00001587|Immunologic Factors|immunologic factors|mesh-ancestor
153388847|NCT00001587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153390070|NCT05806853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153390072|NCT05806723|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153390073|NCT05806723|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153390745|NCT01322139|Analgesics|analgesics|mesh-ancestor
153390746|NCT01322139|Sensory System Agents|sensory system agents|mesh-ancestor
153390747|NCT01322139|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153390748|NCT01019850|Vorinostat|vorinostat|mesh-list
153390749|NCT01019850|3-Iodobenzylguanidine|3-iodobenzylguanidine|mesh-list
153390750|NCT01019850|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153390751|NCT01019850|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
153390752|NCT01019850|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153390753|NCT01019850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153390754|NCT01019850|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
153390755|NCT00885326|Zoledronic Acid|zoledronic acid|mesh-list
153390756|NCT00885326|Cyclophosphamide|cyclophosphamide|mesh-list
153390757|NCT00885326|Bevacizumab|bevacizumab|mesh-list
153390758|NCT00885326|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153390759|NCT00885326|Immunologic Factors|immunologic factors|mesh-ancestor
153390760|NCT00885326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153390761|NCT00885326|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153390778|NCT00606138|Growth Inhibitors|growth inhibitors|mesh-ancestor
153783598|NCT00261729|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153783599|NCT00261729|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153390779|NCT00606138|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153390780|NCT00005835|Melphalan|melphalan|mesh-list
153390781|NCT00005835|Buthionine Sulfoximine|buthionine sulfoximine|mesh-list
153390782|NCT00005835|Immunologic Factors|immunologic factors|mesh-ancestor
153390783|NCT00005835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153390784|NCT00005835|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153390785|NCT00005835|Alkylating Agents|alkylating agents|mesh-ancestor
153390786|NCT00005835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153391330|NCT01636063|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
153391331|NCT01636063|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
153391332|NCT01636063|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
153391333|NCT01636063|Contraceptive Agents|contraceptive agents|mesh-ancestor
153391334|NCT01636063|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
153391335|NCT01636063|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
153391336|NCT01636063|Hormone Antagonists|hormone antagonists|mesh-ancestor
153391337|NCT01636063|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153391338|NCT01636063|Luteolytic Agents|luteolytic agents|mesh-ancestor
153391339|NCT01636063|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
153391340|NCT01636063|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
153391341|NCT05635305|Zoliflodacin|zoliflodacin|mesh-list
153391342|NCT05635305|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153391343|NCT05635305|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153391344|NCT05635305|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153391345|NCT05635305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153391346|NCT05635305|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153391347|NCT05749575|Paclitaxel|paclitaxel|mesh-list
153391349|NCT05749575|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153391350|NCT05749575|Tubulin Modulators|tubulin modulators|mesh-ancestor
153391351|NCT05749575|Antimitotic Agents|antimitotic agents|mesh-ancestor
153391377|NCT04004845|Oxytocics|oxytocics|mesh-ancestor
153391378|NCT04004845|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153391379|NCT04004845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153391380|NCT04004845|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
153391381|NCT04004845|Abortifacient Agents|abortifacient agents|mesh-ancestor
153391382|NCT04004845|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
153391383|NCT04004845|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153391384|NCT01637935|Pioglitazone|pioglitazone|mesh-list
153391856|NCT05735132|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153391857|NCT05735132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153391860|NCT01667029|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153395216|NCT02495831|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153395217|NCT02495831|Analgesics|analgesics|mesh-ancestor
153395218|NCT02495831|Sensory System Agents|sensory system agents|mesh-ancestor
153396087|NCT02605187|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
153396088|NCT02605187|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
153396095|NCT05592197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153396096|NCT02989207|Mitomycins|mitomycins|mesh-list
153396097|NCT02989207|Mitomycin|mitomycin|mesh-list
153396098|NCT02989207|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153396099|NCT02989207|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153396110|NCT02608229|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153396112|NCT02608229|Tubulin Modulators|tubulin modulators|mesh-ancestor
153396113|NCT02608229|Antimitotic Agents|antimitotic agents|mesh-ancestor
153396114|NCT02608229|Mitosis Modulators|mitosis modulators|mesh-ancestor
153396115|NCT02608229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153396116|NCT02608229|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153396117|NCT02608229|Antimetabolites|antimetabolites|mesh-ancestor
153396118|NCT00555061|Retapamulin|retapamulin|mesh-list
153396119|NCT00555061|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153396120|NCT00555061|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153396121|NCT01642212|Budesonide|budesonide|mesh-list
153396122|NCT01642212|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153396251|NCT00364871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153396253|NCT00364871|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153397190|NCT05109143|Analgesics|analgesics|mesh-ancestor
153397191|NCT05109143|Sensory System Agents|sensory system agents|mesh-ancestor
153397192|NCT05109143|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153397193|NCT05109143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153397194|NCT05109143|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153397195|NCT05109143|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153397296|NCT00369395|Volociximab|volociximab|mesh-list
153397297|NCT00369395|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153397561|NCT02466581|Hydroxychloroquine|hydroxychloroquine|mesh-list
153397562|NCT02466581|Sulfasalazine|sulfasalazine|mesh-list
153397563|NCT02466581|Prednisolone|prednisolone|mesh-list
153397564|NCT02466581|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
153397565|NCT02466581|Methylprednisolone|methylprednisolone|mesh-list
153397566|NCT02466581|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
153397567|NCT02466581|Prednisolone acetate|prednisolone acetate|mesh-list
153397568|NCT02466581|Certolizumab Pegol|certolizumab pegol|mesh-list
153397569|NCT02466581|Abatacept|abatacept|mesh-list
153397571|NCT02466581|Prednisolone phosphate|prednisolone phosphate|mesh-list
153398456|NCT04757675|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153398457|NCT04757675|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
153398458|NCT04757675|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153398460|NCT04757675|Adrenergic Agents|adrenergic agents|mesh-ancestor
153398461|NCT04757675|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153398462|NCT04757675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153398463|NCT04757675|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
153398464|NCT04757675|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153398465|NCT04757675|Anesthetics, General|anesthetics, general|mesh-ancestor
153398466|NCT04757675|Anesthetics|anesthetics|mesh-ancestor
153398467|NCT04757675|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
153398468|NCT04757675|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
153400728|NCT02039947|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153400783|NCT03066947|Cyclophosphamide|cyclophosphamide|mesh-list
153400784|NCT03066947|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153400785|NCT03066947|Immunologic Factors|immunologic factors|mesh-ancestor
153400786|NCT03066947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153400787|NCT03066947|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153400788|NCT03066947|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153400789|NCT03066947|Alkylating Agents|alkylating agents|mesh-ancestor
153400790|NCT03066947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153400791|NCT03066947|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153400792|NCT03066947|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153400793|NCT03066947|Antiviral Agents|antiviral agents|mesh-ancestor
153400794|NCT03066947|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153402862|NCT04751500|Luteolytic Agents|luteolytic agents|mesh-ancestor
153402863|NCT04751500|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
153402864|NCT04751500|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
153402865|NCT04751500|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
153402867|NCT04729725|Antibodies|antibodies|mesh-list
153402868|NCT04729725|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
153402905|NCT04669197|Tubulin Modulators|tubulin modulators|mesh-ancestor
153402906|NCT04669197|Antimitotic Agents|antimitotic agents|mesh-ancestor
153402907|NCT04669197|Mitosis Modulators|mitosis modulators|mesh-ancestor
153402908|NCT04669197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153402909|NCT04669197|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153403073|NCT04256707|Mitosis Modulators|mitosis modulators|mesh-ancestor
153403074|NCT04256707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153403075|NCT04256707|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153403337|NCT03961698|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153403338|NCT03961698|Tubulin Modulators|tubulin modulators|mesh-ancestor
153403339|NCT03961698|Antimitotic Agents|antimitotic agents|mesh-ancestor
153403340|NCT03961698|Mitosis Modulators|mitosis modulators|mesh-ancestor
153403341|NCT03961698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153403342|NCT03961698|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153403504|NCT03532477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153403506|NCT03532477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153403507|NCT03532477|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
153403508|NCT03532477|Antidepressive Agents|antidepressive agents|mesh-ancestor
153403509|NCT03532477|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153403511|NCT03493412|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153403512|NCT03493412|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153403513|NCT03493412|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153403514|NCT03493412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153403515|NCT03493412|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153403550|NCT03474198|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153403551|NCT03474198|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
153403552|NCT03474198|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153403554|NCT03421288|Docetaxel|docetaxel|mesh-list
153404741|NCT00376337|Hormone Antagonists|hormone antagonists|mesh-ancestor
153404742|NCT00376337|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153404743|NCT00376337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153404744|NCT00376337|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
153404745|NCT00376337|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
153404747|NCT00003165|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153404748|NCT00003165|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153404749|NCT00003165|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153404750|NCT00003165|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153404751|NCT00003165|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153405166|NCT00003405|Bromodeoxyuridine|bromodeoxyuridine|mesh-list
153405167|NCT00003405|5-bromouridine|5-bromouridine|mesh-list
153405168|NCT00003405|Idoxuridine|idoxuridine|mesh-list
153405169|NCT00003405|Mitoxantrone|mitoxantrone|mesh-list
153405170|NCT00003405|Idarubicin|idarubicin|mesh-list
153405171|NCT00003405|Isotretinoin|isotretinoin|mesh-list
153405172|NCT00003405|Amifostine|amifostine|mesh-list
153405173|NCT00003405|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153405174|NCT00003405|Antiviral Agents|antiviral agents|mesh-ancestor
153405175|NCT00003405|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153405176|NCT00003405|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153405177|NCT00003405|Antimetabolites|antimetabolites|mesh-ancestor
153405182|NCT00003405|Analgesics|analgesics|mesh-ancestor
153783608|NCT00236561|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
153405204|NCT00003243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153405205|NCT00003243|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153405206|NCT00003243|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153405207|NCT00003243|Alkylating Agents|alkylating agents|mesh-ancestor
153405533|NCT05647278|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153405608|NCT05925491|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153405609|NCT05925491|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153405610|NCT05925491|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153405611|NCT05925491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153405612|NCT05925283|Midazolam|midazolam|mesh-list
153405613|NCT05925283|Esketamine|esketamine|mesh-list
153405614|NCT05925283|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153405615|NCT05925283|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153405618|NCT05925283|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153405619|NCT05925283|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153405620|NCT05925283|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153405621|NCT05925283|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153405622|NCT05925283|Anesthetics, General|anesthetics, general|mesh-ancestor
153405623|NCT05925283|Anesthetics|anesthetics|mesh-ancestor
153405624|NCT05925283|GABA Modulators|gaba modulators|mesh-ancestor
153405625|NCT05925283|GABA Agents|gaba agents|mesh-ancestor
153405626|NCT05925283|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153405627|NCT05925283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153405628|NCT05925283|Antidepressive Agents|antidepressive agents|mesh-ancestor
153405629|NCT05924893|Naltrexone|naltrexone|mesh-list
153405694|NCT05922436|Clevidipine|clevidipine|mesh-list
153405695|NCT05922436|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153405696|NCT05922436|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153405697|NCT05922436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153405698|NCT05922436|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153405699|NCT05922436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153405700|NCT05922384|Etoposide|etoposide|mesh-list
153405701|NCT05922384|Melphalan|melphalan|mesh-list
153405702|NCT05922384|Carmustine|carmustine|mesh-list
153405703|NCT05922384|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153405704|NCT05922384|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153405705|NCT05922384|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153405706|NCT05922384|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153405707|NCT05922384|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153405708|NCT05922384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153405709|NCT05922384|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153405710|NCT05922384|Alkylating Agents|alkylating agents|mesh-ancestor
153405711|NCT05922384|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153406055|NCT05558150|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153406056|NCT05558150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153406483|NCT04360681|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
153406484|NCT04360681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153406485|NCT04360681|Sensory System Agents|sensory system agents|mesh-ancestor
153406486|NCT04360681|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153406760|NCT03829371|Antiemetics|antiemetics|mesh-ancestor
153406761|NCT03829371|Autonomic Agents|autonomic agents|mesh-ancestor
153406797|NCT03739710|Ipilimumab|ipilimumab|mesh-list
153406798|NCT03739710|Dostarlimab|dostarlimab|mesh-list
153407275|NCT01216683|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153407276|NCT01216683|Growth Substances|growth substances|mesh-ancestor
153407277|NCT01216683|Growth Inhibitors|growth inhibitors|mesh-ancestor
153407278|NCT01216683|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153407279|NCT01216683|Alkylating Agents|alkylating agents|mesh-ancestor
153407280|NCT01216683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153407282|NCT01166113|Cyclophosphamide|cyclophosphamide|mesh-list
153407283|NCT01166113|Pomalidomide|pomalidomide|mesh-list
153407284|NCT01166113|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153407285|NCT01166113|Immunologic Factors|immunologic factors|mesh-ancestor
153407286|NCT01166113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153407287|NCT01166113|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153407565|NCT00074282|Adenosine Deaminase Inhibitors|adenosine deaminase inhibitors|mesh-ancestor
153407567|NCT00071981|Molgramostim|molgramostim|mesh-list
153407568|NCT00071981|Vaccines|vaccines|mesh-list
153407569|NCT00071981|Sargramostim|sargramostim|mesh-list
153407570|NCT00071981|Freund's Adjuvant|freund's adjuvant|mesh-list
153407571|NCT00071981|Immunologic Factors|immunologic factors|mesh-ancestor
153407572|NCT00071981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153407578|NCT00070291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153408285|NCT04243616|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153408287|NCT04243616|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153408289|NCT03952130|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
153408290|NCT03952130|Insulin Glargine|insulin glargine|mesh-list
153408291|NCT03952130|Insulin Lispro|insulin lispro|mesh-list
153408292|NCT03952130|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153408293|NCT03952130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153408294|NCT03661541|Squaric acid dibutyl ester|squaric acid dibutyl ester|mesh-list
153408295|NCT03661541|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153408296|NCT03661541|Immunologic Factors|immunologic factors|mesh-ancestor
153408297|NCT03661541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153408300|NCT03925532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153408301|NCT01640964|Terlipressin|terlipressin|mesh-list
153408302|NCT01640964|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153408303|NCT01640964|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
153408304|NCT03663101|Lidocaine|lidocaine|mesh-list
153408305|NCT03663101|Botulinum Toxins|botulinum toxins|mesh-list
153408306|NCT03663101|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
153408307|NCT03663101|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
153408308|NCT03663101|Anesthetics, Local|anesthetics, local|mesh-ancestor
153408309|NCT03663101|Anesthetics|anesthetics|mesh-ancestor
153408310|NCT03663101|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153408311|NCT03663101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153408312|NCT03663101|Sensory System Agents|sensory system agents|mesh-ancestor
153408313|NCT03663101|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153408314|NCT03663101|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153408315|NCT03663101|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
153408316|NCT03663101|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153408317|NCT03663101|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153408318|NCT03663101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153408319|NCT03663101|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
153408505|NCT04098575|Empagliflozin|empagliflozin|mesh-list
153408506|NCT04098575|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
153408507|NCT04098575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153408508|NCT04098575|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153408509|NCT04098575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153408510|NCT03776240|Trastuzumab|trastuzumab|mesh-list
153408511|NCT03776240|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153408512|NCT03776240|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153408513|NCT02976272|Bortezomib|bortezomib|mesh-list
153408514|NCT02976272|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153408515|NCT00361790|Aripiprazole|aripiprazole|mesh-list
153408516|NCT00361790|Escitalopram|escitalopram|mesh-list
153408566|NCT03743246|Immunologic Factors|immunologic factors|mesh-ancestor
153408567|NCT03743246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153408568|NCT03743246|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153408569|NCT03743246|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153408570|NCT03743246|Alkylating Agents|alkylating agents|mesh-ancestor
153408571|NCT03743246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153408572|NCT03743246|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153408573|NCT03743246|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153408574|NCT05346666|Midazolam|midazolam|mesh-list
153408575|NCT05346666|Phenobarbital|phenobarbital|mesh-list
153408576|NCT05346666|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153408577|NCT05346666|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153408578|NCT05346666|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153408579|NCT05346666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153408580|NCT05346666|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153408581|NCT05346666|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153408582|NCT05346666|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153408583|NCT05346666|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153408584|NCT05346666|Anesthetics, General|anesthetics, general|mesh-ancestor
153408585|NCT05346666|Anesthetics|anesthetics|mesh-ancestor
153408586|NCT05346666|GABA Modulators|gaba modulators|mesh-ancestor
153382983|NCT02399345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153382984|NCT02399345|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153382985|NCT02399345|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153382986|NCT02399345|Antiviral Agents|antiviral agents|mesh-ancestor
153382987|NCT02399345|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153382988|NCT02399345|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
153382989|NCT02399345|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153382990|NCT02399345|Antimetabolites|antimetabolites|mesh-ancestor
153408587|NCT05346666|GABA Agents|gaba agents|mesh-ancestor
153408588|NCT05346666|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153408589|NCT05346666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153408590|NCT05346666|Anticonvulsants|anticonvulsants|mesh-ancestor
153408591|NCT05346666|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
153408592|NCT05346666|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
153408593|NCT05346666|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
153408594|NCT05346666|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
153408595|NCT05346666|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
153408596|NCT00361166|Pimavanserin|pimavanserin|mesh-list
153408597|NCT00361166|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
153408598|NCT00361166|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
153408599|NCT00361166|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153408600|NCT00361166|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153408923|NCT04810494|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153408924|NCT04810494|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
153409248|NCT02959255|Esomeprazole|esomeprazole|mesh-list
153409249|NCT02959255|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
153409485|NCT00608972|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153409818|NCT00362089|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153409819|NCT00362089|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
153409820|NCT00362089|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
153409821|NCT00362089|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153409822|NCT00362089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153409823|NCT00362089|Hormones|hormones|mesh-ancestor
153409824|NCT00362089|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153409825|NCT03822637|Acetylcysteine|acetylcysteine|mesh-list
153409885|NCT05195034|Adrenergic Agents|adrenergic agents|mesh-ancestor
153409886|NCT05195034|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153409887|NCT05195034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153409888|NCT05496894|Mitoxantrone|mitoxantrone|mesh-list
153409889|NCT05496894|Analgesics|analgesics|mesh-ancestor
153409951|NCT01634100|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
153409952|NCT01634100|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
153409953|NCT01634100|Uricosuric Agents|uricosuric agents|mesh-ancestor
153409954|NCT01634100|Gout Suppressants|gout suppressants|mesh-ancestor
153409955|NCT01634100|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153409956|NCT01633944|Buprenorphine|buprenorphine|mesh-list
153409957|NCT01633944|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153409958|NCT01633944|Narcotics|narcotics|mesh-ancestor
153409959|NCT01633944|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153409961|NCT01633944|Analgesics|analgesics|mesh-ancestor
153409962|NCT01633944|Sensory System Agents|sensory system agents|mesh-ancestor
153409963|NCT01633944|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153409982|NCT00589316|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
153409983|NCT00589316|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153409984|NCT00589316|Immunologic Factors|immunologic factors|mesh-ancestor
153409985|NCT00589316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153409986|NCT00589316|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153409987|NCT00589316|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153409988|NCT00589316|Alkylating Agents|alkylating agents|mesh-ancestor
153409990|NCT00589316|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153409993|NCT00589316|Antimetabolites|antimetabolites|mesh-ancestor
153409994|NCT00589316|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
153409995|NCT00589316|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153409996|NCT00589316|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153783610|NCT00236561|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153409997|NCT00589316|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
153409998|NCT00589316|Antitubercular Agents|antitubercular agents|mesh-ancestor
153409999|NCT00589316|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153410000|NCT00589316|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153410001|NCT00589316|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
153410002|NCT00589316|Trace Elements|trace elements|mesh-ancestor
153410003|NCT00589316|Micronutrients|micronutrients|mesh-ancestor
153410005|NCT00362245|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153410006|NCT00362245|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153410007|NCT00361543|Raloxifene Hydrochloride|raloxifene hydrochloride|mesh-list
153410008|NCT00361543|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
153410009|NCT00361543|Hormone Antagonists|hormone antagonists|mesh-ancestor
153410010|NCT00361543|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153410011|NCT00361543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153410012|NCT00361543|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
153410013|NCT00361543|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
153410014|NCT00361543|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153410015|NCT00003417|Carmustine|carmustine|mesh-list
153410103|NCT00003273|Antimitotic Agents|antimitotic agents|mesh-ancestor
153410104|NCT00003273|Mitosis Modulators|mitosis modulators|mesh-ancestor
153410105|NCT04329585|Flumazenil|flumazenil|mesh-list
153410106|NCT04329585|Antidotes|antidotes|mesh-ancestor
153410108|NCT04329585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153410109|NCT04329585|GABA Modulators|gaba modulators|mesh-ancestor
153410627|NCT00002883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153411227|NCT00005007|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153411228|NCT00005007|Analgesics|analgesics|mesh-ancestor
153411229|NCT00005007|Sensory System Agents|sensory system agents|mesh-ancestor
153411230|NCT00005007|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153411231|NCT00005007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153411232|NCT00005007|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153411233|NCT00005007|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153411234|NCT00005007|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153411235|NCT00005007|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153411236|NCT00005007|Immunologic Factors|immunologic factors|mesh-ancestor
153411783|NCT00004431|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
153411784|NCT00004431|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153411785|NCT00004431|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
153411786|NCT00004431|GABA Agonists|gaba agonists|mesh-ancestor
153411787|NCT00004431|GABA Agents|gaba agents|mesh-ancestor
153411792|NCT00384891|Immunologic Factors|immunologic factors|mesh-ancestor
153411793|NCT00384891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153411795|NCT00384969|Everolimus|everolimus|mesh-list
153783611|NCT00236561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153411796|NCT00384969|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153412301|NCT02974933|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153412302|NCT02974933|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153412303|NCT02974933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153412304|NCT02974933|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153412305|NCT02974933|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153412306|NCT02974933|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153412307|NCT00005769|Hormones|hormones|mesh-list
153412308|NCT00005769|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153412309|NCT00005769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153412310|NCT00005775|Amino-acid, glucose, and electrolyte solution|amino-acid, glucose, and electrolyte solution|mesh-list
153412311|NCT00005775|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
153412312|NCT00005775|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
153412313|NCT00005787|Epoetin Alfa|epoetin alfa|mesh-list
153412314|NCT00005787|Flt3 ligand protein|flt3 ligand protein|mesh-list
153412315|NCT00005787|Sargramostim|sargramostim|mesh-list
153412316|NCT00005787|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153412317|NCT00005787|Immunologic Factors|immunologic factors|mesh-ancestor
153412318|NCT00005787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153412319|NCT00005787|Hematinics|hematinics|mesh-ancestor
153412320|NCT00005787|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
153889144|NCT00628225|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153889145|NCT00628225|Dopamine Agents|dopamine agents|mesh-ancestor
153412321|NCT00005787|Protective Agents|protective agents|mesh-ancestor
153412322|NCT00005793|Cytarabine|cytarabine|mesh-list
153412323|NCT00005793|Etoposide|etoposide|mesh-list
153412324|NCT00005793|Daunorubicin|daunorubicin|mesh-list
153412325|NCT00005793|Topotecan|topotecan|mesh-list
153889146|NCT00628225|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
153889147|NCT00628225|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153889148|NCT00628225|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153382991|NCT02400437|Dexamethasone|dexamethasone|mesh-list
153382992|NCT02400437|Rituximab|rituximab|mesh-list
153382993|NCT02400437|Ixazomib|ixazomib|mesh-list
153882948|NCT02271165|Immunoglobulins|immunoglobulins|mesh-list
153882949|NCT02271165|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
153889149|NCT01014013|Ceftriaxone|ceftriaxone|mesh-list
153889150|NCT01014013|Ertapenem|ertapenem|mesh-list
153412326|NCT00005793|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153412327|NCT00005793|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153412328|NCT00005793|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153412329|NCT00005793|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153412330|NCT00005793|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153412395|NCT01689987|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153412396|NCT01689987|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153412397|NCT01689987|Antiemetics|antiemetics|mesh-ancestor
153412398|NCT01689987|Autonomic Agents|autonomic agents|mesh-ancestor
153412399|NCT01689987|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153412400|NCT01689987|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153412401|NCT01689987|Glucocorticoids|glucocorticoids|mesh-ancestor
153412402|NCT01689987|Hormones|hormones|mesh-ancestor
153412403|NCT01689987|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153412404|NCT01689987|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153412405|NCT01689987|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153412406|NCT01689987|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153412410|NCT01689987|Antimalarials|antimalarials|mesh-ancestor
153412411|NCT01689987|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153412412|NCT01689987|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153412413|NCT01689987|Protease Inhibitors|protease inhibitors|mesh-ancestor
153412414|NCT01689987|Dermatologic Agents|dermatologic agents|mesh-ancestor
153412415|NCT01680939|Ibuprofen|ibuprofen|mesh-list
153412416|NCT01680939|Morphine|morphine|mesh-list
153412417|NCT01680939|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153413262|NCT02546570|Oxytocics|oxytocics|mesh-ancestor
153413263|NCT02546570|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153413264|NCT02546570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153413265|NCT02548910|Sodium Citrate|sodium citrate|mesh-list
153430276|NCT00954187|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153430277|NCT00954187|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153413266|NCT02548910|Citric Acid|citric acid|mesh-list
153413267|NCT02548910|Anticoagulants|anticoagulants|mesh-ancestor
153413268|NCT02548910|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
153413269|NCT02548910|Chelating Agents|chelating agents|mesh-ancestor
153413270|NCT02548910|Sequestering Agents|sequestering agents|mesh-ancestor
153413271|NCT02548910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153413272|NCT02510144|Chlorhexidine|chlorhexidine|mesh-list
153413273|NCT02510144|Benzoyl Peroxide|benzoyl peroxide|mesh-list
153413274|NCT02510144|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
153413275|NCT02510144|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153413445|NCT02541409|Interferon alpha-2|interferon alpha-2|mesh-list
153413446|NCT02541409|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
153413448|NCT02541409|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153413449|NCT02541409|Antiviral Agents|antiviral agents|mesh-ancestor
153413535|NCT00364988|Losartan|losartan|mesh-list
153413541|NCT00364988|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
153413542|NCT00364988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153413543|NCT00365222|Temozolomide|temozolomide|mesh-list
153413544|NCT00365222|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153413545|NCT00365222|Alkylating Agents|alkylating agents|mesh-ancestor
153413546|NCT00365222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153413547|NCT00365222|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153430278|NCT00954187|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153430279|NCT00954187|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153430280|NCT00954187|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153430281|NCT00954187|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
153430282|NCT00954187|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
153430283|NCT00954187|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153430284|NCT00954187|Antimanic Agents|antimanic agents|mesh-ancestor
153430285|NCT00947791|Midazolam|midazolam|mesh-list
153413552|NCT02791568|Hematinics|hematinics|mesh-ancestor
153413553|NCT02791568|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
153413554|NCT02791568|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
153413555|NCT05247554|Hydroxychloroquine|hydroxychloroquine|mesh-list
153413556|NCT05247554|Prednisone|prednisone|mesh-list
153413557|NCT05247554|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153413686|NCT02611154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153413687|NCT02617784|Oseltamivir|oseltamivir|mesh-list
153413688|NCT02617784|Antiviral Agents|antiviral agents|mesh-ancestor
153413689|NCT02617784|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153413690|NCT02617784|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153413691|NCT02617784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153413692|NCT00365612|Tenofovir|tenofovir|mesh-list
153413693|NCT00365612|Emtricitabine|emtricitabine|mesh-list
153413694|NCT00365612|Efavirenz|efavirenz|mesh-list
153413695|NCT00365612|Antiviral Agents|antiviral agents|mesh-ancestor
153413696|NCT00365612|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153413697|NCT00365612|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153413698|NCT00365612|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153413699|NCT00365612|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153413700|NCT00365612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153413701|NCT00365612|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153413702|NCT00365612|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153413703|NCT00365612|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
153413706|NCT00365612|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
153413762|NCT04741880|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153413763|NCT04741880|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
153413766|NCT04741880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153413767|NCT00365924|Teriparatide|teriparatide|mesh-list
153413768|NCT00365924|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153413769|NCT00365924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153413770|NCT00365924|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153413771|NCT05360030|Ketamine|ketamine|mesh-list
153413772|NCT05360030|Naloxone|naloxone|mesh-list
153413773|NCT05360030|Analgesics|analgesics|mesh-ancestor
153413774|NCT05360030|Sensory System Agents|sensory system agents|mesh-ancestor
153413775|NCT05360030|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153889169|NCT01020019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153889170|NCT01020019|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153889171|NCT01020019|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153889172|NCT01020019|Analgesics|analgesics|mesh-ancestor
153889173|NCT01020019|Sensory System Agents|sensory system agents|mesh-ancestor
153889174|NCT01020019|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153889175|NCT01020019|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
153889176|NCT01020019|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
153413776|NCT05360030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153413777|NCT05360030|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
153413778|NCT05360030|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153413780|NCT05360030|Anesthetics|anesthetics|mesh-ancestor
153413781|NCT05360030|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153413835|NCT04799262|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153413836|NCT04799262|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153413837|NCT04799262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153413838|NCT00851136|Bevacizumab|bevacizumab|mesh-list
153413839|NCT00851136|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153783615|NCT00236561|Vasodilator Agents|vasodilator agents|mesh-ancestor
153413875|NCT02621060|Magnesium Oxide|magnesium oxide|mesh-list
153413876|NCT02621060|Antacids|antacids|mesh-ancestor
153413877|NCT02621060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153413878|NCT02621060|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153413879|NCT04740554|Prednisone|prednisone|mesh-list
153413880|NCT04740554|Deflazacort|deflazacort|mesh-list
153413881|NCT04740554|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153413882|NCT04740554|Glucocorticoids|glucocorticoids|mesh-ancestor
153413883|NCT04740554|Hormones|hormones|mesh-ancestor
153413884|NCT04740554|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153413885|NCT04740554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153413886|NCT04740554|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153413887|NCT04740554|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153413888|NCT04740554|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153413889|NCT04740554|Immunologic Factors|immunologic factors|mesh-ancestor
153413890|NCT02624180|Colchicine|colchicine|mesh-list
153413891|NCT02624180|Gout Suppressants|gout suppressants|mesh-ancestor
153413892|NCT02624180|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153413893|NCT02624180|Tubulin Modulators|tubulin modulators|mesh-ancestor
153413894|NCT02624180|Antimitotic Agents|antimitotic agents|mesh-ancestor
153413895|NCT02624180|Mitosis Modulators|mitosis modulators|mesh-ancestor
153413896|NCT02624180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153413897|NCT02624180|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153414074|NCT05026320|Diclofenac|diclofenac|mesh-list
153414075|NCT05026320|Naproxen|naproxen|mesh-list
153414076|NCT05026320|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153414200|NCT02481505|Anesthetics, Local|anesthetics, local|mesh-ancestor
153414201|NCT02481505|Anesthetics|anesthetics|mesh-ancestor
153414202|NCT02481505|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153414203|NCT02481505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153414231|NCT05588336|Analgesics|analgesics|mesh-ancestor
153783616|NCT00236561|Anticonvulsants|anticonvulsants|mesh-ancestor
153783617|NCT00236561|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153414232|NCT05588336|Sensory System Agents|sensory system agents|mesh-ancestor
153414233|NCT05588336|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153414235|NCT02564497|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153414236|NCT02564497|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153414237|NCT02564497|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153414238|NCT02564497|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153414239|NCT02564497|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153414240|NCT02564497|Immunologic Factors|immunologic factors|mesh-ancestor
153414244|NCT02565901|Carboplatin|carboplatin|mesh-list
153414245|NCT02565901|Docetaxel|docetaxel|mesh-list
153414246|NCT02565901|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153414247|NCT02565901|Tubulin Modulators|tubulin modulators|mesh-ancestor
153414248|NCT02565901|Antimitotic Agents|antimitotic agents|mesh-ancestor
153414249|NCT02565901|Mitosis Modulators|mitosis modulators|mesh-ancestor
153414250|NCT02565901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153414251|NCT02565901|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153414357|NCT02577601|Contraceptive Agents|contraceptive agents|mesh-ancestor
153414358|NCT02577601|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153414359|NCT02577601|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
153414360|NCT02577601|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
153414361|NCT02577601|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
153414363|NCT02577991|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153414364|NCT02577991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153414367|NCT02577991|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153414368|NCT02207634|Evolocumab|evolocumab|mesh-list
153414369|NCT02207634|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
153414370|NCT02207634|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153414371|NCT02207634|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153889177|NCT01020019|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153889178|NCT01020019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153889179|NCT01020019|Hormones|hormones|mesh-ancestor
153414372|NCT02207634|Antimetabolites|antimetabolites|mesh-ancestor
153414373|NCT02207634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153414374|NCT02207634|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
153414375|NCT02207634|Protease Inhibitors|protease inhibitors|mesh-ancestor
153889187|NCT00627835|Cisplatin|cisplatin|mesh-list
153414376|NCT02207634|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153414377|NCT02207634|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153414378|NCT04341727|Azithromycin|azithromycin|mesh-list
153414379|NCT04341727|Hydroxychloroquine|hydroxychloroquine|mesh-list
153414380|NCT04341727|Chloroquine|chloroquine|mesh-list
153414381|NCT04341727|Chloroquine diphosphate|chloroquine diphosphate|mesh-list
153414382|NCT04341727|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153414383|NCT04341727|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153414384|NCT04341727|Antimalarials|antimalarials|mesh-ancestor
153414385|NCT04341727|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153414386|NCT04341727|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153414413|NCT02581111|Naloxone|naloxone|mesh-list
153889192|NCT00627835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153889193|NCT01019317|Cytarabine|cytarabine|mesh-list
153889194|NCT01019317|Fludarabine|fludarabine|mesh-list
153382994|NCT02400437|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153382995|NCT02400437|Antiemetics|antiemetics|mesh-ancestor
153889195|NCT01019317|Fludarabine phosphate|fludarabine phosphate|mesh-list
153889196|NCT01019317|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153889197|NCT01019317|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153414430|NCT05587400|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
153414431|NCT05587400|Vasodilator Agents|vasodilator agents|mesh-ancestor
153414432|NCT05587400|Gasotransmitters|gasotransmitters|mesh-ancestor
153414433|NCT05587400|Protective Agents|protective agents|mesh-ancestor
153414434|NCT05587400|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
153414435|NCT05587400|Sympathomimetics|sympathomimetics|mesh-ancestor
153414436|NCT05587400|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
153414437|NCT05587400|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
153414438|NCT05587400|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153414439|NCT05587400|Adrenergic Agents|adrenergic agents|mesh-ancestor
153414440|NCT04339868|Terlipressin|terlipressin|mesh-list
153414441|NCT04339868|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153414442|NCT04339868|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
153414443|NCT00367172|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
153414444|NCT00367172|Antiviral Agents|antiviral agents|mesh-ancestor
153414445|NCT00367172|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153414477|NCT02587117|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153414478|NCT02587117|Protective Agents|protective agents|mesh-ancestor
153414480|NCT02587117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153414481|NCT02587117|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
153414482|NCT02587117|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
153414483|NCT02587351|Metoprolol|metoprolol|mesh-list
153414484|NCT02587351|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153414485|NCT02587351|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153414486|NCT02587351|Sympatholytics|sympatholytics|mesh-ancestor
153430323|NCT00379015|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153430324|NCT00379015|Alkylating Agents|alkylating agents|mesh-ancestor
153430325|NCT00379015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153430326|NCT00379015|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153414488|NCT02587351|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153430327|NCT00379015|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153414489|NCT02587351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153414490|NCT02587351|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
153414491|NCT02587351|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
153414517|NCT05249023|Histamine Antagonists|histamine antagonists|mesh-ancestor
153414518|NCT05249023|Histamine Agents|histamine agents|mesh-ancestor
153414519|NCT05249023|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153415243|NCT00367393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153414520|NCT05249023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153414521|NCT05249023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153414522|NCT02495779|Tenofovir|tenofovir|mesh-list
153414523|NCT02495779|Emtricitabine|emtricitabine|mesh-list
153414524|NCT02495779|Antiviral Agents|antiviral agents|mesh-ancestor
153414525|NCT02495779|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153414526|NCT02495779|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153414527|NCT02495779|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153430328|NCT00379015|Tubulin Modulators|tubulin modulators|mesh-ancestor
153414528|NCT02495779|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153414529|NCT02495779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153414530|NCT02495779|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153414531|NCT02495779|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153414532|NCT05216497|Pentanedioic acid imidazolyl ethanamide|pentanedioic acid imidazolyl ethanamide|mesh-list
153414533|NCT05216497|Antiviral Agents|antiviral agents|mesh-ancestor
153414534|NCT05216497|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153414535|NCT02502487|Ropivacaine|ropivacaine|mesh-list
153414536|NCT02502487|Tetracaine|tetracaine|mesh-list
153414537|NCT02502487|Anesthetics, Local|anesthetics, local|mesh-ancestor
153414538|NCT02502487|Anesthetics|anesthetics|mesh-ancestor
153414539|NCT02502487|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153414540|NCT02502487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153430329|NCT00379015|Antimitotic Agents|antimitotic agents|mesh-ancestor
153430330|NCT00379015|Mitosis Modulators|mitosis modulators|mesh-ancestor
153415011|NCT04340401|Oxaliplatin|oxaliplatin|mesh-list
153415012|NCT04340401|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153415013|NCT04340401|Antimetabolites|antimetabolites|mesh-ancestor
153415014|NCT04340401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153415015|NCT04340401|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153415016|NCT04143607|Gefitinib|gefitinib|mesh-list
153415017|NCT04143607|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153415312|NCT02641561|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153415314|NCT02641561|Sensory System Agents|sensory system agents|mesh-ancestor
153415315|NCT02641561|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153415316|NCT02641561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153415317|NCT02641561|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153415318|NCT02641561|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153415319|NCT02641561|Gout Suppressants|gout suppressants|mesh-ancestor
153415320|NCT02641561|Tocolytic Agents|tocolytic agents|mesh-ancestor
153415321|NCT02641561|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153415322|NCT02641561|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153415323|NCT02641561|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153415324|NCT02641561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153415325|NCT02206152|Acetylcysteine|acetylcysteine|mesh-list
153415326|NCT02206152|N-monoacetylcystine|n-monoacetylcystine|mesh-list
153415327|NCT02206152|Antiviral Agents|antiviral agents|mesh-ancestor
153416037|NCT02659501|Autonomic Agents|autonomic agents|mesh-ancestor
153416038|NCT02659501|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153416039|NCT02659501|Respiratory System Agents|respiratory system agents|mesh-ancestor
153416040|NCT02659501|Mydriatics|mydriatics|mesh-ancestor
153416056|NCT02659501|GABA Modulators|gaba modulators|mesh-ancestor
153416057|NCT02659501|GABA Agents|gaba agents|mesh-ancestor
153416058|NCT02659501|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153416059|NCT02659501|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153416060|NCT02659501|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153416061|NCT00367939|Amlodipine|amlodipine|mesh-list
153416062|NCT00367939|Valsartan|valsartan|mesh-list
153416063|NCT00367939|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153416064|NCT00367939|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153416065|NCT00367939|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153416067|NCT00367939|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153416068|NCT00367939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153889212|NCT01288911|Bicalutamide|bicalutamide|mesh-list
153889213|NCT01288911|Androgen Antagonists|androgen antagonists|mesh-ancestor
153889214|NCT01288911|Hormone Antagonists|hormone antagonists|mesh-ancestor
153889215|NCT01288911|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153889216|NCT01288911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153889217|NCT01288911|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153889218|NCT01288443|Atorvastatin|atorvastatin|mesh-list
153416069|NCT00367939|Vasodilator Agents|vasodilator agents|mesh-ancestor
153416070|NCT00367939|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
153416071|NCT00367939|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
153416072|NCT02720107|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
153416073|NCT02720107|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
153416118|NCT02714504|Voriconazole|voriconazole|mesh-list
153416119|NCT02714504|Posaconazole|posaconazole|mesh-list
153416120|NCT02714504|Antifungal Agents|antifungal agents|mesh-ancestor
153416121|NCT02714504|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153416122|NCT02714504|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
153416123|NCT02714504|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153416124|NCT02714504|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153416125|NCT02714504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153416126|NCT02714504|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153416127|NCT02714504|Hormone Antagonists|hormone antagonists|mesh-ancestor
153416128|NCT02714504|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153416129|NCT02714504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153416130|NCT02714504|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
153416131|NCT02714504|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
153416132|NCT02714504|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153416133|NCT02714504|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153416135|NCT00368576|Phospholipase A2 Inhibitors|phospholipase a2 inhibitors|mesh-ancestor
153416136|NCT00368576|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153416137|NCT00368576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153416138|NCT02730247|Paclitaxel|paclitaxel|mesh-list
153417109|NCT00370760|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153783621|NCT02215330|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153417110|NCT00370760|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153417112|NCT00370760|Anticoagulants|anticoagulants|mesh-ancestor
153417113|NCT00370760|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153417114|NCT00370760|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153417115|NCT00370760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153417116|NCT00370760|Gout Suppressants|gout suppressants|mesh-ancestor
153417117|NCT00370760|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153417118|NCT00370760|Tubulin Modulators|tubulin modulators|mesh-ancestor
153417119|NCT00370760|Antimitotic Agents|antimitotic agents|mesh-ancestor
153417120|NCT00370760|Mitosis Modulators|mitosis modulators|mesh-ancestor
153417121|NCT05203562|Letrozole|letrozole|mesh-list
153417122|NCT05203562|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153417123|NCT05203562|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
153417124|NCT05203562|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153417125|NCT05203562|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153417126|NCT05203562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153417127|NCT05203562|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
153417128|NCT05203562|Hormone Antagonists|hormone antagonists|mesh-ancestor
153417181|NCT05450419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153417182|NCT05450419|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153417183|NCT05450419|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153417184|NCT00370669|Triamcinolone|triamcinolone|mesh-list
153417185|NCT00370669|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
153417186|NCT00370669|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
153417187|NCT00370669|Bevacizumab|bevacizumab|mesh-list
153417188|NCT00370669|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
153417221|NCT00370747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153417223|NCT00370747|Protective Agents|protective agents|mesh-ancestor
153417224|NCT00370747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153417225|NCT00370747|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153417226|NCT02752256|Plasminogen|plasminogen|mesh-list
153417227|NCT02752256|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
153417301|NCT05349032|Sensory System Agents|sensory system agents|mesh-ancestor
153417302|NCT05349032|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153417303|NCT05349032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153417304|NCT05349032|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153417305|NCT05349032|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153417306|NCT05349032|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153417307|NCT05349032|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153417308|NCT05349032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153417309|NCT05057689|Midazolam|midazolam|mesh-list
153417317|NCT05057689|Sensory System Agents|sensory system agents|mesh-ancestor
153417318|NCT05057689|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153417319|NCT05057689|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
153417320|NCT05057689|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153417321|NCT05057689|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153417322|NCT05057689|Adrenergic Agents|adrenergic agents|mesh-ancestor
153417323|NCT05057689|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153417383|NCT02958800|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153417384|NCT02958800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153417385|NCT02958800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153417386|NCT02958800|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153417387|NCT02958800|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153417388|NCT02958800|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153417389|NCT02958800|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
153889219|NCT01288443|Alirocumab|alirocumab|mesh-list
153889220|NCT01288443|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
153889221|NCT01288443|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153889222|NCT01288443|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153889223|NCT01288443|Antimetabolites|antimetabolites|mesh-ancestor
153889224|NCT01288443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153889225|NCT01288443|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153889226|NCT01288443|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
153417390|NCT02958800|Dopamine Agents|dopamine agents|mesh-ancestor
153417391|NCT02958800|Antiemetics|antiemetics|mesh-ancestor
153417392|NCT02958800|Autonomic Agents|autonomic agents|mesh-ancestor
153417393|NCT02958800|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153417394|NCT02958800|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153417444|NCT02753881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153417445|NCT00425360|Gemcitabine|gemcitabine|mesh-list
153417446|NCT00425360|Capecitabine|capecitabine|mesh-list
153417447|NCT00425360|Sargramostim|sargramostim|mesh-list
153783622|NCT02215330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153417449|NCT00425360|Antimetabolites|antimetabolites|mesh-ancestor
153417450|NCT00425360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153417451|NCT00425360|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153417452|NCT00425360|Immunologic Factors|immunologic factors|mesh-ancestor
153417453|NCT00425360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153417454|NCT05348096|Ibrutinib|ibrutinib|mesh-list
153417519|NCT02194062|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153417520|NCT02194062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153417522|NCT02194062|Respiratory System Agents|respiratory system agents|mesh-ancestor
153417523|NCT02194062|Dermatologic Agents|dermatologic agents|mesh-ancestor
153417524|NCT02194062|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
153417525|NCT02194062|Glucocorticoids|glucocorticoids|mesh-ancestor
153430345|NCT04713410|Hormones|hormones|mesh-ancestor
153430346|NCT04713410|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153430347|NCT04713410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153430348|NCT04713410|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153430349|NCT04713410|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153430350|NCT04713332|Vitamin E|vitamin e|mesh-list
153430351|NCT04713332|Tocopherols|tocopherols|mesh-list
153430352|NCT04713332|alpha-Tocopherol|alpha-tocopherol|mesh-list
153430353|NCT04713332|Vitamins|vitamins|mesh-ancestor
153430354|NCT04713332|Micronutrients|micronutrients|mesh-ancestor
153417526|NCT02194062|Hormones|hormones|mesh-ancestor
153417527|NCT02194062|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153417528|NCT02768558|Nivolumab|nivolumab|mesh-list
153417529|NCT02768558|Etoposide|etoposide|mesh-list
153417530|NCT02768558|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153417531|NCT02768558|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153417562|NCT04336891|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
153417563|NCT04336891|Estradiol|estradiol|mesh-list
153417564|NCT04336891|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
153417565|NCT04336891|Testosterone|testosterone|mesh-list
153417567|NCT04336891|Testosterone enanthate|testosterone enanthate|mesh-list
153417568|NCT04336891|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
153417569|NCT04336891|Estrogens|estrogens|mesh-ancestor
153417570|NCT04336891|Hormones|hormones|mesh-ancestor
153417571|NCT04336891|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153417572|NCT04336891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153417573|NCT04336891|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
153417574|NCT04336891|Contraceptive Agents|contraceptive agents|mesh-ancestor
153417575|NCT04336891|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153417576|NCT04336891|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
153430355|NCT04713332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153430356|NCT04713332|Antioxidants|antioxidants|mesh-ancestor
153430357|NCT04713332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153430358|NCT04713332|Protective Agents|protective agents|mesh-ancestor
153430359|NCT00476827|Paclitaxel|paclitaxel|mesh-list
153430360|NCT00476827|Vinorelbine|vinorelbine|mesh-list
153430361|NCT00476827|Docetaxel|docetaxel|mesh-list
153430362|NCT00476827|Bevacizumab|bevacizumab|mesh-list
153889229|NCT01288443|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
153889231|NCT01288443|Immunologic Factors|immunologic factors|mesh-ancestor
153417610|NCT02766517|Antipruritics|antipruritics|mesh-ancestor
153417611|NCT02766517|Dermatologic Agents|dermatologic agents|mesh-ancestor
153417612|NCT02766517|Sensory System Agents|sensory system agents|mesh-ancestor
153417613|NCT02766517|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153417744|NCT04507022|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
153417747|NCT04507022|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
153417749|NCT04507022|Aromatase Inhibitors|aromatase inhibitors|mesh-list
153417750|NCT04507022|Estrogens|estrogens|mesh-ancestor
153417751|NCT04507022|Hormones|hormones|mesh-ancestor
153417752|NCT04507022|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153417753|NCT04507022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153417754|NCT04507022|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
153417755|NCT04507022|Contraceptive Agents|contraceptive agents|mesh-ancestor
153417921|NCT04737655|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153417922|NCT04737655|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
153418323|NCT02786719|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153418324|NCT02786719|Alkylating Agents|alkylating agents|mesh-ancestor
153418325|NCT02786719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153418326|NCT02786719|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153418327|NCT02786719|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153418328|NCT02786719|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153418329|NCT02786719|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153382996|NCT02400437|Autonomic Agents|autonomic agents|mesh-ancestor
153382997|NCT02400437|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153382998|NCT02400437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153382999|NCT02400437|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153383000|NCT02400437|Glucocorticoids|glucocorticoids|mesh-ancestor
153383001|NCT02400437|Hormones|hormones|mesh-ancestor
153383002|NCT02400437|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153383003|NCT02400437|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153383004|NCT02400437|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153383005|NCT02400437|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153383006|NCT02400437|Immunologic Factors|immunologic factors|mesh-ancestor
153383007|NCT02400437|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153383008|NCT02400437|Protease Inhibitors|protease inhibitors|mesh-ancestor
153383009|NCT02400437|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153383133|NCT00355043|Dermatologic Agents|dermatologic agents|mesh-ancestor
153418330|NCT02786719|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153418331|NCT02786719|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153418332|NCT02786719|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153418333|NCT02786719|Tubulin Modulators|tubulin modulators|mesh-ancestor
153418334|NCT02786719|Antimitotic Agents|antimitotic agents|mesh-ancestor
153418335|NCT02786719|Mitosis Modulators|mitosis modulators|mesh-ancestor
153418336|NCT02786719|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
153418338|NCT03003949|Progesterone|progesterone|mesh-list
153418339|NCT03003949|Estrogens|estrogens|mesh-ancestor
153418340|NCT03003949|Hormones|hormones|mesh-ancestor
153418341|NCT03003949|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153418908|NCT05828199|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153418909|NCT05828199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153419209|NCT05322252|Abortifacient Agents|abortifacient agents|mesh-ancestor
153419210|NCT05322252|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153419211|NCT05322252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153419212|NCT05322252|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
153419213|NCT05322252|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153419214|NCT05322252|Oxytocics|oxytocics|mesh-ancestor
153420183|NCT03121820|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153420184|NCT03121820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153420185|NCT03121820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153420186|NCT03121820|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
153420187|NCT03121820|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
153420189|NCT03123614|Prednisolone|prednisolone|mesh-list
153420190|NCT03123614|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
153420411|NCT02867605|Hyaluronic Acid|hyaluronic acid|mesh-list
153420412|NCT02867605|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153420413|NCT02867605|Immunologic Factors|immunologic factors|mesh-ancestor
153423735|NCT02176356|Immunologic Factors|immunologic factors|mesh-ancestor
153423736|NCT02176356|Viscosupplements|viscosupplements|mesh-ancestor
153423737|NCT02176356|Protective Agents|protective agents|mesh-ancestor
153423739|NCT03591068|Xhance|xhance|mesh-list
153423740|NCT03591068|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153423741|NCT03591068|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153423742|NCT03591068|Autonomic Agents|autonomic agents|mesh-ancestor
153423744|NCT03591068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153423746|NCT03591068|Respiratory System Agents|respiratory system agents|mesh-ancestor
153423747|NCT03591068|Dermatologic Agents|dermatologic agents|mesh-ancestor
153423748|NCT03591068|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
153423749|NCT03395990|Chloroprocaine|chloroprocaine|mesh-list
153423750|NCT03395990|Procaine|procaine|mesh-list
153423751|NCT03395990|Anesthetics, Local|anesthetics, local|mesh-ancestor
153423752|NCT03395990|Anesthetics|anesthetics|mesh-ancestor
153423753|NCT03395990|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153423754|NCT03395990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153423755|NCT03395990|Sensory System Agents|sensory system agents|mesh-ancestor
153423756|NCT03395990|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153430363|NCT00476827|Gemcitabine|gemcitabine|mesh-list
153430365|NCT00476827|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153430366|NCT00476827|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153430367|NCT00476827|Tubulin Modulators|tubulin modulators|mesh-ancestor
153430368|NCT00476827|Antimitotic Agents|antimitotic agents|mesh-ancestor
153430369|NCT00476827|Mitosis Modulators|mitosis modulators|mesh-ancestor
153430370|NCT00476827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153430371|NCT00476827|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153430372|NCT00476827|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153430373|NCT00476827|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153430374|NCT00476827|Growth Substances|growth substances|mesh-ancestor
153430375|NCT00476827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153430376|NCT00476827|Growth Inhibitors|growth inhibitors|mesh-ancestor
153423758|NCT02175966|Sofosbuvir|sofosbuvir|mesh-list
153423759|NCT02175966|Antimetabolites|antimetabolites|mesh-ancestor
153423760|NCT02175966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153423761|NCT02175966|Antiviral Agents|antiviral agents|mesh-ancestor
153423762|NCT02175966|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153423763|NCT02136576|Listerine|listerine|mesh-list
153424008|NCT04392362|Adenosine|adenosine|mesh-list
153424381|NCT03373591|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153424382|NCT03373591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153424383|NCT03373591|Sensory System Agents|sensory system agents|mesh-ancestor
153424384|NCT03373591|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153424386|NCT03378973|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153783624|NCT02215330|Diuretics|diuretics|mesh-ancestor
153424387|NCT03378973|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153424727|NCT03771560|Levoleucovorin|levoleucovorin|mesh-list
153424728|NCT03771560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153424729|NCT03771560|Antidotes|antidotes|mesh-ancestor
153424730|NCT03771560|Protective Agents|protective agents|mesh-ancestor
153424731|NCT03771560|Vitamin B Complex|vitamin b complex|mesh-ancestor
153424732|NCT03771560|Vitamins|vitamins|mesh-ancestor
153424733|NCT03771560|Micronutrients|micronutrients|mesh-ancestor
153424734|NCT03771560|Hematinics|hematinics|mesh-ancestor
153424735|NCT03767738|Aflibercept|aflibercept|mesh-list
153424851|NCT03754556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153424852|NCT03754556|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
153424864|NCT01495988|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153424865|NCT01495988|Growth Substances|growth substances|mesh-ancestor
153424866|NCT01495988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153424867|NCT01495988|Growth Inhibitors|growth inhibitors|mesh-ancestor
153424868|NCT01495988|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153424869|NCT01495988|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153424870|NCT01495988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153424871|NCT02934932|Brexpiprazole|brexpiprazole|mesh-list
153424872|NCT02934932|Serotonin Agents|serotonin agents|mesh-ancestor
153424875|NCT02934932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153424876|NCT02934932|Dopamine Agonists|dopamine agonists|mesh-ancestor
153424908|NCT03415243|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153424910|NCT02892500|Betamethasone Valerate|betamethasone valerate|mesh-list
153424911|NCT02892500|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
153424912|NCT02892500|Betamethasone benzoate|betamethasone benzoate|mesh-list
153424913|NCT02892500|Bupivacaine|bupivacaine|mesh-list
153424914|NCT02892500|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
153424915|NCT02892500|Anesthetics, Local|anesthetics, local|mesh-ancestor
153424916|NCT02892500|Anesthetics|anesthetics|mesh-ancestor
153424917|NCT02892500|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153424928|NCT00378872|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
153424972|NCT02734940|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153424973|NCT02734940|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153424974|NCT02734940|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
153424975|NCT02734940|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153424976|NCT02734940|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153424977|NCT02734940|Adrenergic Agents|adrenergic agents|mesh-ancestor
153424978|NCT00378092|Risperidone|risperidone|mesh-list
153424979|NCT00378092|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153424980|NCT00378092|Serotonin Agents|serotonin agents|mesh-ancestor
153424981|NCT00378092|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153424982|NCT00378092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153425006|NCT03723980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153383134|NCT02037893|Antipyrine|antipyrine|mesh-list
153383135|NCT02037893|Benzocaine|benzocaine|mesh-list
153383136|NCT02037893|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
153383137|NCT02037893|Anesthetics, Local|anesthetics, local|mesh-ancestor
153383138|NCT02037893|Anesthetics|anesthetics|mesh-ancestor
153383139|NCT02037893|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153383140|NCT02037893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153383141|NCT02037893|Sensory System Agents|sensory system agents|mesh-ancestor
153383142|NCT02037893|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153383143|NCT02037893|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153383144|NCT02037893|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153383145|NCT02037893|Analgesics|analgesics|mesh-ancestor
153425007|NCT03723980|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153425009|NCT01240304|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153425010|NCT01240304|Antimetabolites|antimetabolites|mesh-ancestor
153425011|NCT01240304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153425012|NCT01240304|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153425013|NCT02614586|Ondansetron|ondansetron|mesh-list
153425014|NCT02614586|Antiemetics|antiemetics|mesh-ancestor
153425015|NCT02614586|Autonomic Agents|autonomic agents|mesh-ancestor
153425016|NCT02614586|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153425017|NCT02614586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153425018|NCT02614586|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153425019|NCT02614586|Antipruritics|antipruritics|mesh-ancestor
153425576|NCT00771602|Immunologic Factors|immunologic factors|mesh-ancestor
153425577|NCT00771602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153425578|NCT00771602|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153425580|NCT01804166|Golimumab|golimumab|mesh-list
153425581|NCT01804166|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
153425582|NCT01804166|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153425583|NCT01804166|Dermatologic Agents|dermatologic agents|mesh-ancestor
153425584|NCT01804166|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153425585|NCT01804166|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153425586|NCT01804166|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153425587|NCT01804166|Immunologic Factors|immunologic factors|mesh-ancestor
153425588|NCT01804166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153425589|NCT04459585|Dabigatran|dabigatran|mesh-list
153425590|NCT04459585|Quizartinib|quizartinib|mesh-list
153425591|NCT04459585|Antithrombins|antithrombins|mesh-ancestor
153425592|NCT04459585|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
153425593|NCT04459585|Protease Inhibitors|protease inhibitors|mesh-ancestor
153425594|NCT04459585|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153425595|NCT04459585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153425596|NCT04459585|Anticoagulants|anticoagulants|mesh-ancestor
153425597|NCT04459585|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153889255|NCT01287117|Respiratory System Agents|respiratory system agents|mesh-ancestor
153889256|NCT01287039|Reslizumab|reslizumab|mesh-list
153889257|NCT01287039|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153889258|NCT01287039|Respiratory System Agents|respiratory system agents|mesh-ancestor
153889259|NCT05572203|Caseins|caseins|mesh-list
153425598|NCT04459585|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153425599|NCT05080556|Carboplatin|carboplatin|mesh-list
153425601|NCT01797380|Escitalopram|escitalopram|mesh-list
153426965|NCT00001016|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153426966|NCT00001016|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153426967|NCT00001016|Antimetabolites|antimetabolites|mesh-ancestor
153426968|NCT00001016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153426969|NCT00001016|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153426970|NCT00001016|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153427389|NCT00001112|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153427390|NCT00001112|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153427391|NCT00001112|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153427392|NCT00002036|Immune Sera|immune sera|mesh-list
153427393|NCT00002036|Immunologic Factors|immunologic factors|mesh-ancestor
153427394|NCT00002036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153427395|NCT03782701|Brimonidine Tartrate|brimonidine tartrate|mesh-list
153427396|NCT03782701|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
153427397|NCT03782701|Ophthalmic Solutions|ophthalmic solutions|mesh-list
153427398|NCT03782701|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153427399|NCT03782701|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
153427400|NCT03782701|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153427401|NCT03782701|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153427402|NCT03782701|Adrenergic Agents|adrenergic agents|mesh-ancestor
153427403|NCT03782701|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153427404|NCT03782701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153427405|NCT03782701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153427406|NCT00000374|Olanzapine|olanzapine|mesh-list
153427407|NCT00000374|Risperidone|risperidone|mesh-list
153427408|NCT00000374|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153427409|NCT00000374|Serotonin Agents|serotonin agents|mesh-ancestor
153427863|NCT04713254|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153889260|NCT05572203|Chelating Agents|chelating agents|mesh-ancestor
153889261|NCT05572203|Sequestering Agents|sequestering agents|mesh-ancestor
153889262|NCT05572203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153889263|NCT01285401|Interferons|interferons|mesh-list
153427864|NCT04713254|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153427865|NCT04713254|Dopamine Agents|dopamine agents|mesh-ancestor
153427866|NCT04713254|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
153889264|NCT01285401|Interferon-beta|interferon-beta|mesh-list
153427867|NCT04713254|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153427868|NCT04713254|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153427869|NCT04713254|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153427957|NCT00000662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153427958|NCT00000662|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153427959|NCT00000662|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153427960|NCT00000662|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153427961|NCT00000662|Antiviral Agents|antiviral agents|mesh-ancestor
153427962|NCT00000662|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153427963|NCT00000662|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153428030|NCT00000698|Ganciclovir|ganciclovir|mesh-list
153428031|NCT00000698|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
153428032|NCT00000698|Antiviral Agents|antiviral agents|mesh-ancestor
153428033|NCT00000698|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153428034|NCT00000698|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153428218|NCT00002312|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153428219|NCT00002312|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153428220|NCT00002312|Antiviral Agents|antiviral agents|mesh-ancestor
153428221|NCT00002312|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153428257|NCT00001628|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
153428258|NCT00001628|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
153428259|NCT00001628|Protease Inhibitors|protease inhibitors|mesh-ancestor
153428260|NCT00001628|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153428261|NCT00001628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153428262|NCT00001628|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
153428444|NCT00378547|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153428445|NCT00378547|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153428469|NCT00002282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153428471|NCT00002282|Hormone Antagonists|hormone antagonists|mesh-ancestor
153428472|NCT00002282|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153428473|NCT00002282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153889265|NCT01285401|Interferon beta-1a|interferon beta-1a|mesh-list
153889266|NCT01285401|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153889267|NCT01285401|Antiviral Agents|antiviral agents|mesh-ancestor
153889268|NCT01285401|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153889269|NCT01285401|Immunologic Factors|immunologic factors|mesh-ancestor
153428479|NCT02658877|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
153428480|NCT02658877|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153428481|NCT02658877|Respiratory System Agents|respiratory system agents|mesh-ancestor
153428482|NCT00002288|Zidovudine|zidovudine|mesh-list
153428483|NCT00002288|Antimetabolites|antimetabolites|mesh-ancestor
153428484|NCT00002288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153428486|NCT00002288|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153428488|NCT00002288|Antiviral Agents|antiviral agents|mesh-ancestor
153428489|NCT00002288|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153428490|NCT00002288|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153428494|NCT00002366|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
153430377|NCT00476827|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153430378|NCT00476827|Antimetabolites|antimetabolites|mesh-ancestor
153430379|NCT00476827|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
153430380|NCT00476827|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153430381|NCT00476827|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153430382|NCT00459121|Paclitaxel|paclitaxel|mesh-list
153430383|NCT00459121|Carboplatin|carboplatin|mesh-list
153430384|NCT00459121|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153428596|NCT02589145|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153430385|NCT00459121|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153428597|NCT02589145|Vitamin B Complex|vitamin b complex|mesh-ancestor
153428598|NCT02589145|Vitamins|vitamins|mesh-ancestor
153428599|NCT02589145|Micronutrients|micronutrients|mesh-ancestor
153428600|NCT00002384|Cidofovir|cidofovir|mesh-list
153428601|NCT00002384|Antiviral Agents|antiviral agents|mesh-ancestor
153428602|NCT00002384|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153428603|NCT00002384|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153428604|NCT00002384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153428605|NCT02568007|Cyproheptadine|cyproheptadine|mesh-list
153428606|NCT02568007|Antipruritics|antipruritics|mesh-ancestor
153428607|NCT02568007|Dermatologic Agents|dermatologic agents|mesh-ancestor
153428608|NCT02568007|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153428609|NCT02568007|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
153428610|NCT02568007|Histamine Antagonists|histamine antagonists|mesh-ancestor
153428611|NCT02568007|Histamine Agents|histamine agents|mesh-ancestor
153428612|NCT02568007|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153428613|NCT02568007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153428614|NCT02568007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153428630|NCT00002396|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153428631|NCT00002396|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153428632|NCT00002396|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153428633|NCT00002396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153428634|NCT00002396|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153428635|NCT00002396|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153428636|NCT00002402|Aluminum Hydroxide|aluminum hydroxide|mesh-list
153428637|NCT00002402|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153428638|NCT00002402|Immunologic Factors|immunologic factors|mesh-ancestor
153428639|NCT00002402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153428640|NCT00002402|Antacids|antacids|mesh-ancestor
153428641|NCT00002402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153428642|NCT00002402|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153428668|NCT05709626|Analgesics|analgesics|mesh-ancestor
153428669|NCT05709626|Sensory System Agents|sensory system agents|mesh-ancestor
153428670|NCT05709626|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153428671|NCT05709626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153428672|NCT05709626|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153428673|NCT05709626|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153428674|NCT05709626|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153428675|NCT05709626|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153428676|NCT05709626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153428677|NCT05709626|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153428678|NCT05709626|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153428679|NCT05709626|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153428680|NCT05709626|Antipyretics|antipyretics|mesh-ancestor
153428681|NCT03538015|Carvedilol|carvedilol|mesh-list
153428690|NCT03538015|Protective Agents|protective agents|mesh-ancestor
153428691|NCT03538015|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153428692|NCT03538015|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153428693|NCT03538015|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153428694|NCT03538015|Vasodilator Agents|vasodilator agents|mesh-ancestor
153428726|NCT00002432|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153428727|NCT00002432|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153428728|NCT00002432|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153428729|NCT00002432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153428731|NCT05701436|Doxorubicin|doxorubicin|mesh-list
153428732|NCT05701436|Fluorouracil|fluorouracil|mesh-list
153428735|NCT05701436|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153428736|NCT05701436|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153428737|NCT05701436|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153428738|NCT05701436|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153428739|NCT05701436|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153428740|NCT05701436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153415245|NCT00367393|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153430386|NCT00459121|Tubulin Modulators|tubulin modulators|mesh-ancestor
153428806|NCT05751746|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153428807|NCT05751746|Tocolytic Agents|tocolytic agents|mesh-ancestor
153428808|NCT05751746|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153428809|NCT00002450|Tenofovir|tenofovir|mesh-list
153428810|NCT00002450|Antiviral Agents|antiviral agents|mesh-ancestor
153428811|NCT00002450|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153428812|NCT00002450|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153428813|NCT00002450|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153428814|NCT00002450|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153428815|NCT00002450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153428816|NCT00002450|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153428817|NCT00002450|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153428818|NCT03277183|Epoetin Alfa|epoetin alfa|mesh-list
153428819|NCT03277183|Hematinics|hematinics|mesh-ancestor
153428820|NCT00002456|Cyclosporine|cyclosporine|mesh-list
153428821|NCT00002456|Methotrexate|methotrexate|mesh-list
153428822|NCT00002456|Cyclosporins|cyclosporins|mesh-list
153428823|NCT00002456|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
153428824|NCT00002456|Abortifacient Agents|abortifacient agents|mesh-ancestor
153428825|NCT00002456|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153428826|NCT00002456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153428835|NCT00002456|Immunologic Factors|immunologic factors|mesh-ancestor
153428836|NCT00002456|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153428894|NCT02373865|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
153428895|NCT02373865|Glimepiride|glimepiride|mesh-list
153428896|NCT02373865|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153428897|NCT02373865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153428898|NCT02373865|Incretins|incretins|mesh-ancestor
153428899|NCT02373865|Hormones|hormones|mesh-ancestor
153428900|NCT02373865|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153428901|NCT02373865|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
153428902|NCT02373865|Protease Inhibitors|protease inhibitors|mesh-ancestor
153428903|NCT02373865|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153428904|NCT02373865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153428914|NCT00002498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153428915|NCT00002498|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153428916|NCT00002498|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153428917|NCT00002498|Alkylating Agents|alkylating agents|mesh-ancestor
153428918|NCT00002498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153428919|NCT00002498|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153428920|NCT00002498|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153428958|NCT00002510|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153429040|NCT02341495|Iron Chelating Agents|iron chelating agents|mesh-ancestor
153429043|NCT00002534|Cytarabine|cytarabine|mesh-list
153429044|NCT00002534|Methylprednisolone|methylprednisolone|mesh-list
153429045|NCT00002534|Cyclophosphamide|cyclophosphamide|mesh-list
153429046|NCT00002534|Thiotepa|thiotepa|mesh-list
153429047|NCT00002534|Antilymphocyte Serum|antilymphocyte serum|mesh-list
153429048|NCT00002534|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153429049|NCT00002534|Immunologic Factors|immunologic factors|mesh-ancestor
153429075|NCT00002546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153429076|NCT00378625|Artesunate|artesunate|mesh-list
153429077|NCT00378625|Antimalarials|antimalarials|mesh-ancestor
153429078|NCT00378625|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153429079|NCT00378625|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153429080|NCT00378625|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153429081|NCT00378625|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153429082|NCT00378625|Antiviral Agents|antiviral agents|mesh-ancestor
153429083|NCT00378625|Schistosomicides|schistosomicides|mesh-ancestor
153429084|NCT00378625|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
153429085|NCT00378625|Anthelmintics|anthelmintics|mesh-ancestor
153429086|NCT04005391|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
153429087|NCT04005391|Contraceptive Agents|contraceptive agents|mesh-list
153429088|NCT04005391|Levonorgestrel|levonorgestrel|mesh-list
153429089|NCT04005391|Medroxyprogesterone|medroxyprogesterone|mesh-list
153429090|NCT04005391|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153429091|NCT04005391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153429092|NCT04005391|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
153429093|NCT04005391|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
153429094|NCT04005391|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
153429095|NCT04005391|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
153429096|NCT04005391|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
153429097|NCT04005391|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
153429098|NCT04005391|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153429426|NCT01401049|Lidocaine|lidocaine|mesh-list
153429433|NCT01401049|Sensory System Agents|sensory system agents|mesh-ancestor
153429434|NCT01401049|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153429435|NCT01401049|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153383146|NCT02037893|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153383147|NCT02037893|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153429436|NCT01401049|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
153429437|NCT01401049|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153429438|NCT01401049|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153429453|NCT01402531|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153429484|NCT00002678|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153429485|NCT00002678|Immunologic Factors|immunologic factors|mesh-ancestor
153429487|NCT01397695|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153429488|NCT01397695|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153429489|NCT01397695|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153429490|NCT01397695|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153429491|NCT01397695|Growth Substances|growth substances|mesh-ancestor
153429492|NCT01397695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153429493|NCT01397695|Growth Inhibitors|growth inhibitors|mesh-ancestor
153429495|NCT00002684|Ifosfamide|ifosfamide|mesh-list
153429496|NCT00002684|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153429497|NCT00002684|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153429498|NCT00002684|Tubulin Modulators|tubulin modulators|mesh-ancestor
153429499|NCT00002684|Antimitotic Agents|antimitotic agents|mesh-ancestor
153429500|NCT00002684|Mitosis Modulators|mitosis modulators|mesh-ancestor
153429916|NCT01692691|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153429917|NCT01692691|Alkylating Agents|alkylating agents|mesh-ancestor
153429918|NCT01692691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153429919|NCT01692691|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153429920|NCT01127503|alpha-Methyltyrosine|alpha-methyltyrosine|mesh-list
153429921|NCT01127503|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153429922|NCT01127503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153889274|NCT01285323|Respiratory System Agents|respiratory system agents|mesh-ancestor
153889275|NCT01284621|Empagliflozin|empagliflozin|mesh-list
153889276|NCT01284621|Ramipril|ramipril|mesh-list
153889277|NCT01284621|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
153889278|NCT01284621|Protease Inhibitors|protease inhibitors|mesh-ancestor
153889279|NCT01284621|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153889280|NCT01284621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153889281|NCT01284621|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153889282|NCT01284621|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
153429929|NCT01122511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153429930|NCT01122511|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153429931|NCT01122511|Glucocorticoids|glucocorticoids|mesh-ancestor
153430064|NCT05594407|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
153430065|NCT05594407|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
153430244|NCT00523939|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153430245|NCT00523939|Antiviral Agents|antiviral agents|mesh-ancestor
153430246|NCT00523939|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153430247|NCT00523939|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153430249|NCT00523939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153430286|NCT00947791|Ketamine|ketamine|mesh-list
153430287|NCT00947791|Analgesics|analgesics|mesh-ancestor
153430288|NCT00947791|Sensory System Agents|sensory system agents|mesh-ancestor
153430289|NCT00947791|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153430290|NCT00947791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153430291|NCT00947791|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
153889283|NCT01284621|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153430292|NCT00947791|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153430293|NCT00947791|Anesthetics, General|anesthetics, general|mesh-ancestor
153815030|NCT00344669|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153430294|NCT00947791|Anesthetics|anesthetics|mesh-ancestor
153430295|NCT00947791|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153430306|NCT00947791|GABA Agents|gaba agents|mesh-ancestor
153430307|NCT05136326|Capecitabine|capecitabine|mesh-list
153430308|NCT05136326|Temozolomide|temozolomide|mesh-list
153430309|NCT05136326|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153430310|NCT05136326|Antimetabolites|antimetabolites|mesh-ancestor
153430311|NCT05136326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153430312|NCT05136326|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153430313|NCT05136326|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153430314|NCT05136326|Alkylating Agents|alkylating agents|mesh-ancestor
153430315|NCT00379015|Cyclophosphamide|cyclophosphamide|mesh-list
153430316|NCT00379015|Docetaxel|docetaxel|mesh-list
153430585|NCT00402883|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153430586|NCT00402883|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153430587|NCT00402883|Hematinics|hematinics|mesh-ancestor
153430588|NCT00402883|Vitamin B Complex|vitamin b complex|mesh-ancestor
153430589|NCT04939844|Lenalidomide|lenalidomide|mesh-list
153430590|NCT04939844|Bortezomib|bortezomib|mesh-list
153430591|NCT04939844|Immunologic Factors|immunologic factors|mesh-ancestor
153431302|NCT06315283|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153431303|NCT06315283|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153431304|NCT06315283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153431305|NCT06315283|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153431306|NCT06315283|Serotonin Agents|serotonin agents|mesh-ancestor
153431308|NCT06315231|Free Radical Scavengers|free radical scavengers|mesh-ancestor
153431441|NCT06288451|Vitamin D|vitamin d|mesh-list
153431442|NCT06288451|Calcitriol|calcitriol|mesh-list
153431443|NCT06288451|Cinacalcet|cinacalcet|mesh-list
153431444|NCT06288451|Vitamins|vitamins|mesh-ancestor
153431445|NCT06288451|Micronutrients|micronutrients|mesh-ancestor
153431608|NCT06057467|Anticoagulants|anticoagulants|mesh-list
153431609|NCT06055075|Daratumumab|daratumumab|mesh-list
153431610|NCT06055075|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153431611|NCT06054477|Pembrolizumab|pembrolizumab|mesh-list
153431612|NCT06054477|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153431613|NCT06054477|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153431707|NCT05992311|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153431708|NCT05992311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153431709|NCT05992311|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
153431710|NCT05992311|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
153431711|NCT05992311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153431712|NCT05981209|Dexamethasone|dexamethasone|mesh-list
153431713|NCT05981209|Dexamethasone acetate|dexamethasone acetate|mesh-list
153431714|NCT05981209|Elotuzumab|elotuzumab|mesh-list
153431715|NCT05981209|Ichthammol|ichthammol|mesh-list
153431716|NCT05981209|BB 1101|bb 1101|mesh-list
153431717|NCT05981209|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153431718|NCT05981209|Antiemetics|antiemetics|mesh-ancestor
153431719|NCT05981209|Autonomic Agents|autonomic agents|mesh-ancestor
153431720|NCT05981209|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153431721|NCT05981209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153431722|NCT05981209|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153431996|NCT05509777|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153431997|NCT05509777|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153431998|NCT05509777|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
153431999|NCT05509777|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153432000|NCT05508867|Gemcitabine|gemcitabine|mesh-list
153432001|NCT05508867|Pembrolizumab|pembrolizumab|mesh-list
153432002|NCT05508867|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
153432003|NCT05508867|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153432004|NCT05508867|Antimetabolites|antimetabolites|mesh-ancestor
153432005|NCT05508867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153432006|NCT05508867|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153432161|NCT05169567|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153432162|NCT05169567|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
153432163|NCT05169567|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
153432164|NCT05169567|Hormone Antagonists|hormone antagonists|mesh-ancestor
153432165|NCT05169567|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153432166|NCT05169567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153432167|NCT05162014|Empagliflozin|empagliflozin|mesh-list
153432168|NCT05162014|Hypoglycemic Agents|hypoglycemic agents|mesh-list
153432169|NCT05162014|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
153432170|NCT05162014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153432171|NCT05162014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153432172|NCT05144854|Capecitabine|capecitabine|mesh-list
153432173|NCT05144854|Tegafur|tegafur|mesh-list
153432174|NCT05144854|Nivolumab|nivolumab|mesh-list
153432175|NCT05144854|Oxaliplatin|oxaliplatin|mesh-list
153432176|NCT05144854|Ipilimumab|ipilimumab|mesh-list
153432177|NCT05144854|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153432178|NCT05144854|Antimetabolites|antimetabolites|mesh-ancestor
153889299|NCT01281813|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
153889300|NCT01281813|Protease Inhibitors|protease inhibitors|mesh-ancestor
153889301|NCT01281813|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153383150|NCT02041325|Lenalidomide|lenalidomide|mesh-list
153383151|NCT02041325|Immunologic Factors|immunologic factors|mesh-ancestor
153383152|NCT02041325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153383153|NCT02041325|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153383154|NCT02041325|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153383190|NCT01747850|Anticonvulsants|anticonvulsants|mesh-ancestor
153889303|NCT01281813|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153432180|NCT05144854|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153432181|NCT05144854|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153432182|NCT05144854|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153432183|NCT05122767|Dolutegravir|dolutegravir|mesh-list
153432184|NCT05122767|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
153432185|NCT05122767|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
153432186|NCT05122767|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153432216|NCT05117242|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153432217|NCT05117242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153432218|NCT05116293|Acetaminophen|acetaminophen|mesh-list
153432220|NCT05116293|Midazolam|midazolam|mesh-list
153432221|NCT05116293|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153432222|NCT05116293|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153432223|NCT05116293|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153432224|NCT05116293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153432225|NCT05116293|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153432226|NCT05116293|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153432227|NCT05116293|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153432228|NCT05116293|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153432229|NCT05116293|Anesthetics, General|anesthetics, general|mesh-ancestor
153432628|NCT04024462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153432630|NCT04024462|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153432631|NCT04024462|Tubulin Modulators|tubulin modulators|mesh-ancestor
153432632|NCT04024462|Antimitotic Agents|antimitotic agents|mesh-ancestor
153432633|NCT04024462|Mitosis Modulators|mitosis modulators|mesh-ancestor
153432634|NCT04024462|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153432635|NCT04024462|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153432636|NCT04024462|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153432637|NCT04024462|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153432865|NCT03490864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153432867|NCT03490864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153432868|NCT03490864|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153432869|NCT03475121|Topotecan|topotecan|mesh-list
153432870|NCT03475121|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
153432871|NCT03475121|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153432872|NCT03475121|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153432873|NCT03475121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153889309|NCT01090414|Idelalisib|idelalisib|mesh-list
153432886|NCT03421353|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153432887|NCT03421353|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153432888|NCT03421353|Tubulin Modulators|tubulin modulators|mesh-ancestor
153432889|NCT03421353|Antimitotic Agents|antimitotic agents|mesh-ancestor
153432890|NCT03421353|Mitosis Modulators|mitosis modulators|mesh-ancestor
153432891|NCT03421353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153432892|NCT03421353|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153432894|NCT03421353|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153432895|NCT03418038|Vitamins|vitamins|mesh-list
153432896|NCT03418038|Ascorbic Acid|ascorbic acid|mesh-list
153432956|NCT03291028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153432957|NCT03291028|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153432959|NCT03274492|Prednisone|prednisone|mesh-list
153432960|NCT03274492|Cyclophosphamide|cyclophosphamide|mesh-list
153432961|NCT03274492|Rituximab|rituximab|mesh-list
153432962|NCT03274492|Doxorubicin|doxorubicin|mesh-list
153432963|NCT03274492|Vincristine|vincristine|mesh-list
153432964|NCT03274492|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
153432965|NCT03274492|Polatuzumab vedotin|polatuzumab vedotin|mesh-list
153432966|NCT03274492|Immunoconjugates|immunoconjugates|mesh-list
153432967|NCT03274492|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153432968|NCT03274492|Immunologic Factors|immunologic factors|mesh-ancestor
153433032|NCT03098355|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153433033|NCT03098355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153433034|NCT03068741|Ceftriaxone|ceftriaxone|mesh-list
153433035|NCT03068741|Third Generation Cephalosporins|third generation cephalosporins|mesh-ancestor
153433036|NCT03068741|Beta Lactam Antibiotics|beta lactam antibiotics|mesh-ancestor
153433037|NCT03068741|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153433038|NCT03068741|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153433039|NCT03049618|Pembrolizumab|pembrolizumab|mesh-list
153433063|NCT02782949|Curcumin|curcumin|mesh-list
153433064|NCT02782949|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153433065|NCT02782949|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153433066|NCT02782949|Analgesics|analgesics|mesh-ancestor
153433067|NCT02782949|Sensory System Agents|sensory system agents|mesh-ancestor
153433068|NCT02782949|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153433069|NCT02782949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153433070|NCT02782949|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153433071|NCT02782949|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153433072|NCT02782949|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153433073|NCT02782949|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153433074|NCT02782949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153433075|NCT02762006|Durvalumab|durvalumab|mesh-list
153815032|NCT04715165|Bupivacaine|bupivacaine|mesh-list
153433076|NCT02762006|Tremelimumab|tremelimumab|mesh-list
153433077|NCT02762006|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153433078|NCT02762006|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153433079|NCT02559856|Rivaroxaban|rivaroxaban|mesh-list
153433080|NCT02559856|Apixaban|apixaban|mesh-list
153433081|NCT02559856|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
153433082|NCT02559856|Antithrombins|antithrombins|mesh-ancestor
153433083|NCT02559856|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
153433084|NCT02559856|Protease Inhibitors|protease inhibitors|mesh-ancestor
153433085|NCT02559856|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153433086|NCT02559856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153433087|NCT02559856|Anticoagulants|anticoagulants|mesh-ancestor
153433088|NCT02411448|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
153433089|NCT02411448|Gefitinib|gefitinib|mesh-list
153433090|NCT02411448|Osimertinib|osimertinib|mesh-list
153433091|NCT02411448|Ramucirumab|ramucirumab|mesh-list
153433128|NCT02339155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153433129|NCT02339155|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
153433130|NCT02339155|Antipruritics|antipruritics|mesh-ancestor
153433131|NCT02339155|Dermatologic Agents|dermatologic agents|mesh-ancestor
153433132|NCT02301286|Aspirin|aspirin|mesh-list
153433133|NCT02301286|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153433134|NCT02301286|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153433177|NCT02081378|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153433178|NCT02081378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153433179|NCT02081378|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153433180|NCT02022215|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
153433181|NCT02000089|Secretin|secretin|mesh-list
153433182|NCT02000089|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153433242|NCT00636519|Botulinum Antitoxin|botulinum antitoxin|mesh-list
153433243|NCT00636519|Immunologic Factors|immunologic factors|mesh-ancestor
153433244|NCT00636519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153433245|NCT00309985|Docetaxel|docetaxel|mesh-list
153433246|NCT00309985|Androgens|androgens|mesh-list
153433247|NCT00309985|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153433257|NCT00053482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153433258|NCT00000811|Azithromycin|azithromycin|mesh-list
153433259|NCT00000811|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
153433296|NCT00000373|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153433329|NCT00000385|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153433330|NCT00000385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153433332|NCT00002894|Carboplatin|carboplatin|mesh-list
153433333|NCT00002894|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153433334|NCT00002894|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153433335|NCT00002894|Tubulin Modulators|tubulin modulators|mesh-ancestor
153433371|NCT00000415|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153433372|NCT00000415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153433374|NCT00000847|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153433375|NCT00000847|Immunologic Factors|immunologic factors|mesh-ancestor
153430437|NCT00314353|Oxaliplatin|oxaliplatin|mesh-list
153430438|NCT00314353|Irinotecan|irinotecan|mesh-list
153430439|NCT00314353|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153430440|NCT00314353|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153430441|NCT00314353|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153433432|NCT00000865|Stavudine|stavudine|mesh-list
153433433|NCT00000865|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153433434|NCT00000865|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153433435|NCT00000865|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153433436|NCT00000865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153433437|NCT00000865|Antiviral Agents|antiviral agents|mesh-ancestor
153433440|NCT00000865|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153433441|NCT00000865|Antimetabolites|antimetabolites|mesh-ancestor
153433442|NCT00000469|Aspirin|aspirin|mesh-list
153433443|NCT00000469|Lovastatin|lovastatin|mesh-list
153433444|NCT00000469|L 647318|l 647318|mesh-list
153433445|NCT00000469|Dihydromevinolin|dihydromevinolin|mesh-list
153433446|NCT00000469|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153433447|NCT00000469|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153433448|NCT00000469|Analgesics|analgesics|mesh-ancestor
153433449|NCT00000469|Sensory System Agents|sensory system agents|mesh-ancestor
153433450|NCT00000469|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153433621|NCT00000649|Antiviral Agents|antiviral agents|mesh-ancestor
153433622|NCT00000649|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153433623|NCT00000649|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153433624|NCT00000649|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153433625|NCT00000649|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
153433626|NCT00000649|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
153433627|NCT00000961|Zidovudine|zidovudine|mesh-list
153433628|NCT00000961|Immune Sera|immune sera|mesh-list
153433629|NCT00000961|Antimetabolites|antimetabolites|mesh-ancestor
153433630|NCT00000961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153433631|NCT00000961|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153433632|NCT00000961|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153433633|NCT00000961|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153433634|NCT00000961|Antiviral Agents|antiviral agents|mesh-ancestor
153433666|NCT02594293|Antiviral Agents|antiviral agents|mesh-ancestor
153889315|NCT01090102|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153889316|NCT01090102|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153889317|NCT01090102|Analgesics|analgesics|mesh-ancestor
153889318|NCT01090102|Sensory System Agents|sensory system agents|mesh-ancestor
153889319|NCT01090102|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153889320|NCT01090102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153889321|NCT01090102|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153889322|NCT01090102|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153889323|NCT01090102|Antitubercular Agents|antitubercular agents|mesh-ancestor
153889324|NCT01090102|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153433676|NCT00000967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153433677|NCT00000967|Antimetabolites|antimetabolites|mesh-ancestor
153433678|NCT00000967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153433679|NCT00000967|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153433701|NCT00000661|GABA Modulators|gaba modulators|mesh-ancestor
153433702|NCT00000661|GABA Agents|gaba agents|mesh-ancestor
153433703|NCT00000661|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153433704|NCT00000979|Zidovudine|zidovudine|mesh-list
153433705|NCT00000979|Didanosine|didanosine|mesh-list
153433706|NCT00000979|Antimetabolites|antimetabolites|mesh-ancestor
153783634|NCT04545892|Antipruritics|antipruritics|mesh-ancestor
153433710|NCT00000979|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153433711|NCT00000979|Antiviral Agents|antiviral agents|mesh-ancestor
153433712|NCT00000979|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153433713|NCT00000979|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153433714|NCT00000979|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153433715|NCT00000991|Zidovudine|zidovudine|mesh-list
153433716|NCT00000991|Trimethoprim|trimethoprim|mesh-list
153433717|NCT00000991|Sulfamethoxazole|sulfamethoxazole|mesh-list
153433718|NCT00000991|Dapsone|dapsone|mesh-list
153433719|NCT00000991|Pentamidine|pentamidine|mesh-list
153433720|NCT00000991|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
153433721|NCT00000991|Antimetabolites|antimetabolites|mesh-ancestor
153433722|NCT00000991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153433723|NCT00000991|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153433724|NCT00000991|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153433725|NCT00000991|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153433726|NCT00000991|Antiviral Agents|antiviral agents|mesh-ancestor
153433727|NCT00000991|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153433728|NCT00000991|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153433729|NCT00000991|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153433730|NCT00000991|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
153433731|NCT00000991|Antimalarials|antimalarials|mesh-ancestor
153433732|NCT00000991|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153433733|NCT00000991|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153433734|NCT00000991|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153433735|NCT00000991|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
153433792|NCT00000997|Antimetabolites|antimetabolites|mesh-ancestor
153433805|NCT00000697|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153433806|NCT00000697|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153433807|NCT00000697|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153433808|NCT00000697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153433810|NCT00001009|Anticoagulants|anticoagulants|mesh-ancestor
153433811|NCT00001009|Plasma Substitutes|plasma substitutes|mesh-ancestor
153433812|NCT00001009|Blood Substitutes|blood substitutes|mesh-ancestor
153433853|NCT00000703|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153433885|NCT00000709|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153433886|NCT00000709|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153433887|NCT00001027|Pentamidine|pentamidine|mesh-list
153433888|NCT00001027|Antifungal Agents|antifungal agents|mesh-ancestor
153433889|NCT00001027|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153433890|NCT00001027|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153433891|NCT00001027|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153433892|NCT00001027|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
153433893|NCT00000727|Zidovudine|zidovudine|mesh-list
153433894|NCT00000727|Pyrimethamine|pyrimethamine|mesh-list
153433895|NCT00000727|Sulfadoxine|sulfadoxine|mesh-list
153433896|NCT00000727|Trimethoprim|trimethoprim|mesh-list
153433897|NCT00000727|Sulfamethoxazole|sulfamethoxazole|mesh-list
153433898|NCT00000727|Pentamidine|pentamidine|mesh-list
153433899|NCT00000727|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
153433900|NCT00000727|Antimetabolites|antimetabolites|mesh-ancestor
153433936|NCT00001057|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153433940|NCT00001057|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153433941|NCT00002293|Nystatin|nystatin|mesh-list
153433942|NCT00002293|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153433943|NCT00002293|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153433976|NCT00002305|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
153433977|NCT00002305|Flucytosine|flucytosine|mesh-list
153433978|NCT00002305|Antifungal Agents|antifungal agents|mesh-ancestor
153433979|NCT00002305|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153433980|NCT00002305|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
153433981|NCT00002305|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153433982|NCT00002305|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153433983|NCT00002305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153433984|NCT00002305|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153433985|NCT00002305|Hormone Antagonists|hormone antagonists|mesh-ancestor
153433986|NCT00002305|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153433987|NCT00002305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153434018|NCT00002317|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153434019|NCT00002317|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153434020|NCT00002317|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153434021|NCT00001123|Ribavirin|ribavirin|mesh-list
153430443|NCT00314353|Growth Substances|growth substances|mesh-ancestor
153430444|NCT00314353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153430445|NCT00314353|Growth Inhibitors|growth inhibitors|mesh-ancestor
153430446|NCT00314353|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153430447|NCT00314353|Antimetabolites|antimetabolites|mesh-ancestor
153430448|NCT00314353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153434081|NCT00383864|Antimetabolites|antimetabolites|mesh-ancestor
153434108|NCT00002341|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
153434111|NCT00002347|Zalcitabine|zalcitabine|mesh-list
153434112|NCT00002347|Saquinavir|saquinavir|mesh-list
153434113|NCT00002347|Antimetabolites|antimetabolites|mesh-ancestor
153434114|NCT00002347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153434115|NCT00002347|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153434116|NCT00002347|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153434117|NCT00002347|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153434118|NCT00002347|Antiviral Agents|antiviral agents|mesh-ancestor
153434119|NCT00002347|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153434122|NCT00002347|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
153434123|NCT00002347|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
153434124|NCT00002347|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
153434157|NCT00001963|Antioxidants|antioxidants|mesh-ancestor
153434160|NCT00001963|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
153434161|NCT00001963|Vasodilator Agents|vasodilator agents|mesh-ancestor
153434162|NCT00001963|Gasotransmitters|gasotransmitters|mesh-ancestor
153434163|NCT00001963|Protective Agents|protective agents|mesh-ancestor
153383191|NCT01747850|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
153383192|NCT01747850|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153383193|NCT01747850|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153383194|NCT01747850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153383219|NCT01727414|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153383220|NCT02048891|Triptorelin Pamoate|triptorelin pamoate|mesh-list
153383221|NCT02048891|Progesterone|progesterone|mesh-list
153383222|NCT02048891|Progestins|progestins|mesh-ancestor
153383223|NCT02048891|Hormones|hormones|mesh-ancestor
153383224|NCT02048891|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153383225|NCT02048891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153383226|NCT02048891|Luteolytic Agents|luteolytic agents|mesh-ancestor
153383227|NCT02048891|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
153434164|NCT00001963|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153434165|NCT00001963|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153434166|NCT00001963|Analgesics|analgesics|mesh-ancestor
153434167|NCT00001963|Sensory System Agents|sensory system agents|mesh-ancestor
153434168|NCT00001963|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153434169|NCT00001963|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153434170|NCT00002377|Valganciclovir|valganciclovir|mesh-list
153434171|NCT00002377|Ganciclovir|ganciclovir|mesh-list
153434172|NCT00002377|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
153434173|NCT00002377|Antiviral Agents|antiviral agents|mesh-ancestor
153434222|NCT00002383|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153434223|NCT00002383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153434224|NCT00002383|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153434225|NCT00002383|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153434263|NCT00002017|Analgesics|analgesics|mesh-ancestor
153434264|NCT00002017|Sensory System Agents|sensory system agents|mesh-ancestor
153434265|NCT00002017|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153434298|NCT00002041|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153889334|NCT01281189|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
153434299|NCT00002041|Antifungal Agents|antifungal agents|mesh-ancestor
153434301|NCT00002047|Antimetabolites|antimetabolites|mesh-ancestor
153434302|NCT00002047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153434303|NCT00002047|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153434304|NCT00002047|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153434305|NCT00002047|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153434306|NCT00002047|Antiviral Agents|antiviral agents|mesh-ancestor
153434432|NCT00002077|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153434433|NCT00002077|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153889335|NCT01281189|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
153889336|NCT01281189|Dopamine Agonists|dopamine agonists|mesh-ancestor
153434436|NCT00002077|Hormone Antagonists|hormone antagonists|mesh-ancestor
153434437|NCT00002077|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153434438|NCT00002077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153434439|NCT00002077|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
153434440|NCT00002077|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
153434441|NCT00002089|Azithromycin|azithromycin|mesh-list
153434442|NCT00002089|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153434443|NCT00002089|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153434444|NCT00002095|Ganciclovir|ganciclovir|mesh-list
153434445|NCT00002095|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
153434446|NCT00002095|Antiviral Agents|antiviral agents|mesh-ancestor
153434447|NCT00002095|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153434448|NCT00002095|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153434449|NCT00002095|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153434450|NCT00002095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153434451|NCT00002101|Clarithromycin|clarithromycin|mesh-list
153434452|NCT00002101|Ethambutol|ethambutol|mesh-list
153434482|NCT00002113|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153434483|NCT00002113|Hormone Antagonists|hormone antagonists|mesh-ancestor
153434484|NCT00002113|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153434485|NCT00002113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153434486|NCT00002113|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
153434487|NCT00002113|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
153434488|NCT00002113|Antimetabolites|antimetabolites|mesh-ancestor
153434489|NCT00002437|Cidofovir|cidofovir|mesh-list
153434490|NCT00002437|Probenecid|probenecid|mesh-list
153434491|NCT00002437|Uricosuric Agents|uricosuric agents|mesh-ancestor
153889337|NCT04306666|Anesthetics|anesthetics|mesh-list
153434527|NCT00002125|Phosphonoacetic Acid|phosphonoacetic acid|mesh-list
153434528|NCT00002125|Antiviral Agents|antiviral agents|mesh-ancestor
153434529|NCT00002125|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153434530|NCT00002125|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153434531|NCT00002125|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153434533|NCT00002125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153430464|NCT00279409|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
153434535|NCT00001579|Fluorouracil|fluorouracil|mesh-list
153434536|NCT00001579|Eniluracil|eniluracil|mesh-list
153434537|NCT00001579|Antimetabolites|antimetabolites|mesh-ancestor
153434538|NCT00001579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153434539|NCT00001579|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153430465|NCT00279409|Serotonin Agents|serotonin agents|mesh-ancestor
153430466|NCT00279409|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
153430467|NCT00279409|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153430468|NCT00279409|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
153430469|NCT00279409|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
153430470|NCT00379249|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
153430471|NCT00379249|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153430472|NCT00379249|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153434540|NCT00001579|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153434541|NCT00001579|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153434696|NCT00002161|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153434697|NCT00002161|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153434698|NCT00002161|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153434699|NCT00002161|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153434700|NCT00002161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153434701|NCT00002167|Tin etiopurpurin|tin etiopurpurin|mesh-list
153434702|NCT00002167|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
153434703|NCT00002167|Dermatologic Agents|dermatologic agents|mesh-ancestor
153434704|NCT03805022|Doxorubicin|doxorubicin|mesh-list
153434705|NCT03805022|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
153434706|NCT03805022|Ifosfamide|ifosfamide|mesh-list
153434744|NCT00003050|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153434804|NCT00002191|Anticestodal Agents|anticestodal agents|mesh-ancestor
153434805|NCT00002191|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
153434806|NCT00002191|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153434807|NCT00002191|Tubulin Modulators|tubulin modulators|mesh-ancestor
153434808|NCT00002191|Antimitotic Agents|antimitotic agents|mesh-ancestor
153430473|NCT00379249|Antimetabolites|antimetabolites|mesh-ancestor
153434810|NCT00002191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153434812|NCT00383396|Cyclosporine|cyclosporine|mesh-list
153434813|NCT00383396|Cyclosporins|cyclosporins|mesh-list
153434814|NCT00383396|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153434815|NCT00383396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153434816|NCT00383396|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153434850|NCT00003068|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153434851|NCT00003068|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153430475|NCT00379249|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153434852|NCT00003068|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
153430476|NCT00379249|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
153430477|NCT00379249|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153430478|NCT00801931|Cyclophosphamide|cyclophosphamide|mesh-list
153430479|NCT00801931|Melphalan|melphalan|mesh-list
153430480|NCT00801931|Busulfan|busulfan|mesh-list
153430481|NCT00801931|Thiotepa|thiotepa|mesh-list
153430482|NCT00801931|Fludarabine|fludarabine|mesh-list
153430483|NCT00801931|Alemtuzumab|alemtuzumab|mesh-list
153430484|NCT00801931|Phenytoin|phenytoin|mesh-list
153430485|NCT00801931|Fosphenytoin|fosphenytoin|mesh-list
153430486|NCT00801931|Thymoglobulin|thymoglobulin|mesh-list
153430487|NCT00801931|Antilymphocyte Serum|antilymphocyte serum|mesh-list
153430488|NCT00801931|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153434853|NCT00003068|Protective Agents|protective agents|mesh-ancestor
153434855|NCT00003080|Melphalan|melphalan|mesh-list
153434856|NCT00003080|Thiotepa|thiotepa|mesh-list
153434857|NCT00003080|Mitoxantrone|mitoxantrone|mesh-list
153434858|NCT00003080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153434859|NCT00003080|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153434887|NCT00002203|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153434890|NCT00002203|Antimetabolites|antimetabolites|mesh-ancestor
153434891|NCT01568918|Tamsulosin|tamsulosin|mesh-list
153434892|NCT01568918|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
153434893|NCT01568918|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
153434894|NCT01568918|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
153434895|NCT01568918|Adrenergic Agents|adrenergic agents|mesh-ancestor
153434896|NCT01568918|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153434897|NCT01568918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153434898|NCT01568918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153434899|NCT01568918|Urological Agents|urological agents|mesh-ancestor
153434901|NCT00003086|Carboplatin|carboplatin|mesh-list
153434902|NCT00003086|Doxorubicin|doxorubicin|mesh-list
153434903|NCT00003086|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
153434904|NCT00003086|Fluorouracil|fluorouracil|mesh-list
153435035|NCT00003116|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
153430489|NCT00801931|Immunologic Factors|immunologic factors|mesh-ancestor
153435036|NCT00002227|Lamivudine|lamivudine|mesh-list
153435037|NCT00002227|Efavirenz|efavirenz|mesh-list
153435041|NCT00002227|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153435073|NCT00002527|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153435074|NCT00002527|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153435075|NCT00002527|Analgesics|analgesics|mesh-ancestor
153435076|NCT00002527|Sensory System Agents|sensory system agents|mesh-ancestor
153435077|NCT00002527|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153435078|NCT00002527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153435079|NCT00002527|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153435153|NCT00002245|Lamivudine|lamivudine|mesh-list
153435154|NCT00002245|Abacavir|abacavir|mesh-list
153435155|NCT00002245|Amprenavir|amprenavir|mesh-list
153435156|NCT00002245|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153435157|NCT00002245|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153435158|NCT00002245|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153435159|NCT00002245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153435160|NCT00002245|Antiviral Agents|antiviral agents|mesh-ancestor
153435161|NCT00002245|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153435162|NCT00002245|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153435198|NCT05751733|Sunitinib|sunitinib|mesh-list
153435199|NCT05751733|Imatinib Mesylate|imatinib mesylate|mesh-list
153435200|NCT05751733|Apatinib|apatinib|mesh-list
153435201|NCT05751733|Dasatinib|dasatinib|mesh-list
153435202|NCT05751733|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153435203|NCT05751733|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153435240|NCT00002798|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153435242|NCT00002798|Autonomic Agents|autonomic agents|mesh-ancestor
153435243|NCT00002798|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153435244|NCT00002798|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153435245|NCT00002798|Glucocorticoids|glucocorticoids|mesh-ancestor
153435246|NCT00002798|Hormones|hormones|mesh-ancestor
153435279|NCT00002257|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153435280|NCT00002257|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153435281|NCT00002257|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153435282|NCT00002257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153435284|NCT00003134|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
153435285|NCT00003134|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153435286|NCT00003134|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153435318|NCT00002804|Micronutrients|micronutrients|mesh-ancestor
153435320|NCT00002810|Immunologic Factors|immunologic factors|mesh-ancestor
153435321|NCT00002810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153783640|NCT02214706|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153435322|NCT00002810|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153435323|NCT00002810|Alkylating Agents|alkylating agents|mesh-ancestor
153435324|NCT00002810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153435325|NCT00002810|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153435326|NCT00002810|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153435327|NCT00002810|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153435328|NCT00003140|Letrozole|letrozole|mesh-list
153435329|NCT00003140|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153435330|NCT00003140|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
153435331|NCT00003140|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153435398|NCT00003398|Alkylating Agents|alkylating agents|mesh-ancestor
153889346|NCT01280721|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
153889347|NCT01280721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153435399|NCT00003398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153435400|NCT00003398|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153435401|NCT00003398|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153435402|NCT00002263|Zidovudine|zidovudine|mesh-list
153435403|NCT00002263|Sargramostim|sargramostim|mesh-list
153435404|NCT00002263|Antimetabolites|antimetabolites|mesh-ancestor
153435405|NCT00002263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153435406|NCT00002263|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153435407|NCT00002263|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153435408|NCT00002263|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153889358|NCT04306354|Oxytocics|oxytocics|mesh-ancestor
153435559|NCT00002281|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153435560|NCT00002281|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153435561|NCT00002281|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153435562|NCT00002281|Antiviral Agents|antiviral agents|mesh-ancestor
153435563|NCT00002281|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153435564|NCT00002281|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153435565|NCT00002281|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153435566|NCT00002281|Hematinics|hematinics|mesh-ancestor
153435567|NCT00002287|Zidovudine|zidovudine|mesh-list
153435568|NCT00002287|Antimetabolites|antimetabolites|mesh-ancestor
153435569|NCT00002287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153435570|NCT00002287|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153435571|NCT00002287|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153435572|NCT00002287|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153435573|NCT00002287|Antiviral Agents|antiviral agents|mesh-ancestor
153435574|NCT00002287|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153435575|NCT00002287|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153435576|NCT00002287|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153435577|NCT00002828|Fluorouracil|fluorouracil|mesh-list
153435578|NCT00002828|Raltitrexed|raltitrexed|mesh-list
153435579|NCT00002828|Antimetabolites|antimetabolites|mesh-ancestor
153435647|NCT00003158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153435648|NCT00003158|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153435649|NCT00003158|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153435650|NCT00003158|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153435651|NCT00003416|Interferons|interferons|mesh-list
153435652|NCT00003416|Interferon-alpha|interferon-alpha|mesh-list
153435653|NCT00003416|Dexamethasone|dexamethasone|mesh-list
153435654|NCT00003416|Melphalan|melphalan|mesh-list
153435655|NCT00003416|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153435656|NCT00003416|Antiemetics|antiemetics|mesh-ancestor
153435657|NCT00003416|Autonomic Agents|autonomic agents|mesh-ancestor
153435658|NCT00003416|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153889361|NCT04306276|Dienogest|dienogest|mesh-list
153435659|NCT00003416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153435661|NCT00003416|Glucocorticoids|glucocorticoids|mesh-ancestor
153435662|NCT00003416|Hormones|hormones|mesh-ancestor
153435663|NCT00003416|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153889372|NCT04306276|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153889373|NCT04306276|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153889374|NCT01078168|Acitretin|acitretin|mesh-list
153889375|NCT01078168|Keratolytic Agents|keratolytic agents|mesh-ancestor
153889376|NCT01078168|Dermatologic Agents|dermatologic agents|mesh-ancestor
153889377|NCT01086358|Naproxen|naproxen|mesh-list
153435664|NCT00003416|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153435665|NCT00003416|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153435666|NCT00003416|Antiviral Agents|antiviral agents|mesh-ancestor
153435667|NCT00003416|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153435668|NCT00003416|Immunologic Factors|immunologic factors|mesh-ancestor
153435669|NCT00003416|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153435670|NCT00003416|Alkylating Agents|alkylating agents|mesh-ancestor
153435671|NCT00003416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153435685|NCT00002840|Vincristine|vincristine|mesh-list
153435687|NCT00002840|Procarbazine|procarbazine|mesh-list
153435688|NCT00002840|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153435689|NCT00002840|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153435690|NCT00002840|Tubulin Modulators|tubulin modulators|mesh-ancestor
153435691|NCT00002840|Antimitotic Agents|antimitotic agents|mesh-ancestor
153435692|NCT00002840|Mitosis Modulators|mitosis modulators|mesh-ancestor
153435704|NCT05720767|Antifungal Agents|antifungal agents|mesh-ancestor
153435705|NCT05720767|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153435706|NCT05720767|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
153435707|NCT05720767|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153435708|NCT05720767|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153435709|NCT05720767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153435710|NCT05720767|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153435711|NCT05720767|Hormone Antagonists|hormone antagonists|mesh-ancestor
153435712|NCT05720767|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153435714|NCT05720767|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
153435715|NCT05720767|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
153435716|NCT05720767|Antitubercular Agents|antitubercular agents|mesh-ancestor
153435717|NCT05720767|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153435718|NCT05720767|Leprostatic Agents|leprostatic agents|mesh-ancestor
153435719|NCT05720767|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153435720|NCT05720767|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
153435721|NCT05720767|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
153435722|NCT05720767|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
153435723|NCT05720767|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
153435724|NCT05720767|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
153435725|NCT05720767|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
153435726|NCT05751031|Raltegravir Potassium|raltegravir potassium|mesh-list
153435727|NCT05751031|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153435728|NCT05751031|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153435729|NCT05751031|Antiviral Agents|antiviral agents|mesh-ancestor
153435755|NCT00003422|Antidotes|antidotes|mesh-ancestor
153435756|NCT00003422|Protective Agents|protective agents|mesh-ancestor
153435757|NCT00003422|Vitamin B Complex|vitamin b complex|mesh-ancestor
153435758|NCT00003422|Vitamins|vitamins|mesh-ancestor
153435759|NCT00003422|Micronutrients|micronutrients|mesh-ancestor
153435760|NCT00003176|Temozolomide|temozolomide|mesh-list
153435761|NCT00003176|Carmustine|carmustine|mesh-list
153435762|NCT00003176|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153435763|NCT00003176|Alkylating Agents|alkylating agents|mesh-ancestor
153435764|NCT00003176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153435765|NCT00003176|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153435766|NCT00002858|Cyclophosphamide|cyclophosphamide|mesh-list
153435767|NCT00002858|Doxorubicin|doxorubicin|mesh-list
153435768|NCT00002858|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
153435769|NCT00002858|Etoposide|etoposide|mesh-list
153435770|NCT00002858|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153435771|NCT00002858|Immunologic Factors|immunologic factors|mesh-ancestor
153435772|NCT00002858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153435773|NCT00002858|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153435774|NCT00002858|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153435775|NCT00002858|Alkylating Agents|alkylating agents|mesh-ancestor
153435776|NCT00002858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153435777|NCT00002858|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153435778|NCT00002858|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153435779|NCT00002858|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153435780|NCT00002858|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153435781|NCT00002858|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153435782|NCT00002858|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153435783|NCT00002858|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153435784|NCT00002864|Tamoxifen|tamoxifen|mesh-list
153435785|NCT00002864|Octreotide|octreotide|mesh-list
153783641|NCT02214706|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153435807|NCT00002870|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153430499|NCT00801931|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
153430500|NCT00801931|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153430501|NCT00801931|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153435810|NCT00002870|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153435811|NCT00002870|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153435812|NCT00002870|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153435813|NCT00002870|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153435814|NCT00002870|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153435816|NCT00002581|Cyclophosphamide|cyclophosphamide|mesh-list
153435817|NCT00002581|Fluorouracil|fluorouracil|mesh-list
153435818|NCT00002581|Methotrexate|methotrexate|mesh-list
153435819|NCT00002581|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153435820|NCT00002581|Immunologic Factors|immunologic factors|mesh-ancestor
153435821|NCT00002581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153435822|NCT00002581|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153435823|NCT00002581|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153435824|NCT00002581|Alkylating Agents|alkylating agents|mesh-ancestor
153435825|NCT00002581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153435826|NCT00002581|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153435827|NCT00002581|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153435828|NCT00002581|Antimetabolites|antimetabolites|mesh-ancestor
153435829|NCT00002581|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153435830|NCT00002581|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
153435858|NCT00002587|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153435859|NCT00002587|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153435874|NCT00002593|Antimetabolites|antimetabolites|mesh-ancestor
153435875|NCT00002593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153435876|NCT00002593|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153435877|NCT00002593|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153435878|NCT00002593|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153435879|NCT00002593|Immunologic Factors|immunologic factors|mesh-ancestor
153435880|NCT00002593|Antidotes|antidotes|mesh-ancestor
153783642|NCT02214706|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153435881|NCT00002593|Protective Agents|protective agents|mesh-ancestor
153435882|NCT00002593|Vitamin B Complex|vitamin b complex|mesh-ancestor
153435883|NCT00002593|Vitamins|vitamins|mesh-ancestor
153435884|NCT00002593|Micronutrients|micronutrients|mesh-ancestor
153435885|NCT00002593|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153435886|NCT00002593|Antinematodal Agents|antinematodal agents|mesh-ancestor
153435887|NCT00002593|Anthelmintics|anthelmintics|mesh-ancestor
153435888|NCT00002593|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153435889|NCT00002593|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153435890|NCT00002593|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153435891|NCT00003194|Cyclophosphamide|cyclophosphamide|mesh-list
153435892|NCT00003194|Thiotepa|thiotepa|mesh-list
153435893|NCT00003194|Carboplatin|carboplatin|mesh-list
153435894|NCT00003194|Etoposide|etoposide|mesh-list
153435895|NCT00003194|Topotecan|topotecan|mesh-list
153435920|NCT00002882|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153435921|NCT00002882|Immunologic Factors|immunologic factors|mesh-ancestor
153435922|NCT00002882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153435923|NCT00002882|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153435956|NCT00002599|Carmustine|carmustine|mesh-list
153435957|NCT00002599|Doxorubicin|doxorubicin|mesh-list
153435958|NCT00002599|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
153435959|NCT00002599|Vincristine|vincristine|mesh-list
153435960|NCT00002599|Sargramostim|sargramostim|mesh-list
153435961|NCT00002599|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153435962|NCT00002599|Immunologic Factors|immunologic factors|mesh-ancestor
153435963|NCT00002599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153435964|NCT00002599|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153435965|NCT00002599|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153435966|NCT00002599|Alkylating Agents|alkylating agents|mesh-ancestor
153435967|NCT00002599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153889380|NCT01086358|Zolmitriptan|zolmitriptan|mesh-list
153889381|NCT01086358|Rizatriptan|rizatriptan|mesh-list
153889382|NCT01086358|Eletriptan|eletriptan|mesh-list
153889383|NCT01086358|Almotriptan|almotriptan|mesh-list
153436015|NCT00003446|Antimetabolites|antimetabolites|mesh-ancestor
153436016|NCT00003446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153436017|NCT00003446|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153436018|NCT00003446|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153436019|NCT00003446|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153436020|NCT00003446|Immunologic Factors|immunologic factors|mesh-ancestor
153436021|NCT00003446|Antidotes|antidotes|mesh-ancestor
153436022|NCT00003446|Protective Agents|protective agents|mesh-ancestor
153436023|NCT00003446|Vitamin B Complex|vitamin b complex|mesh-ancestor
153436024|NCT00003446|Vitamins|vitamins|mesh-ancestor
153436025|NCT00003446|Micronutrients|micronutrients|mesh-ancestor
153436026|NCT00003446|Antifungal Agents|antifungal agents|mesh-ancestor
153436027|NCT00003446|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153436028|NCT00003446|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153436029|NCT00003446|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153436030|NCT00003938|Amphotericin B|amphotericin b|mesh-list
153436031|NCT00003938|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
153436032|NCT00003938|Amebicides|amebicides|mesh-ancestor
153436033|NCT00003938|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153436034|NCT00003938|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153436098|NCT00003950|Cyclosporins|cyclosporins|mesh-list
153436099|NCT00003950|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
153436100|NCT00003950|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153436101|NCT00003950|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153436102|NCT00003950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153436131|NCT00003956|Antimetabolites|antimetabolites|mesh-ancestor
153436132|NCT00003956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153436133|NCT00003956|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153436135|NCT00003956|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153436136|NCT00003956|Immunologic Factors|immunologic factors|mesh-ancestor
153436138|NCT00003956|Protective Agents|protective agents|mesh-ancestor
153436139|NCT00003956|Vitamin B Complex|vitamin b complex|mesh-ancestor
153436141|NCT00003956|Micronutrients|micronutrients|mesh-ancestor
153436142|NCT00003956|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153436143|NCT00002623|Carboplatin|carboplatin|mesh-list
153436144|NCT00002623|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153436145|NCT00003962|Aldesleukin|aldesleukin|mesh-list
153436146|NCT00003962|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153436147|NCT00003962|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153436148|NCT00003962|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153889385|NCT01086358|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153889387|NCT01086358|Sensory System Agents|sensory system agents|mesh-ancestor
153889388|NCT01086358|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153889389|NCT01086358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153889390|NCT01086358|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153889391|NCT01086358|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153889392|NCT01086358|Gout Suppressants|gout suppressants|mesh-ancestor
153889393|NCT01086358|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153889394|NCT01086358|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153889395|NCT01086358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153889396|NCT01086358|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
153889397|NCT01086358|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
153889398|NCT01086358|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
153436149|NCT00003962|Antiviral Agents|antiviral agents|mesh-ancestor
153436172|NCT00003242|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153436174|NCT00003242|Tubulin Modulators|tubulin modulators|mesh-ancestor
153436175|NCT00003242|Antimitotic Agents|antimitotic agents|mesh-ancestor
153436176|NCT00003242|Mitosis Modulators|mitosis modulators|mesh-ancestor
153436177|NCT00003242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153889399|NCT01086358|Serotonin Agents|serotonin agents|mesh-ancestor
153889400|NCT01086358|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153889401|NCT01277601|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
153436181|NCT05664061|Fluticasone|fluticasone|mesh-list
153436251|NCT00003992|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
153436252|NCT00003992|Hormone Antagonists|hormone antagonists|mesh-ancestor
153436253|NCT00003992|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153889402|NCT01277601|Antiviral Agents|antiviral agents|mesh-ancestor
153889403|NCT01277601|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153436254|NCT00003992|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153436255|NCT00003992|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
153436256|NCT00003992|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
153436257|NCT00003992|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153436258|NCT00002647|Verteporfin|verteporfin|mesh-list
153436259|NCT00002647|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
153436260|NCT00002647|Dermatologic Agents|dermatologic agents|mesh-ancestor
153436262|NCT00002653|Cyclophosphamide|cyclophosphamide|mesh-list
153436263|NCT00002653|Melphalan|melphalan|mesh-list
153436264|NCT00002653|Carmustine|carmustine|mesh-list
153436265|NCT00002653|Doxorubicin|doxorubicin|mesh-list
153436266|NCT00002653|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
153436267|NCT00002653|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153436268|NCT00002653|Immunologic Factors|immunologic factors|mesh-ancestor
153436269|NCT00002653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153436270|NCT00002653|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153436271|NCT00002653|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153436273|NCT00002653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153436275|NCT00002653|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153889409|NCT01277523|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153889410|NCT01277523|Respiratory System Agents|respiratory system agents|mesh-ancestor
153889411|NCT01277523|Parasympatholytics|parasympatholytics|mesh-ancestor
153436276|NCT00002653|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153436277|NCT00002653|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153436278|NCT00002653|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153436279|NCT00002653|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153436280|NCT00002653|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153436281|NCT00002653|Glucocorticoids|glucocorticoids|mesh-ancestor
153436295|NCT00002659|Cisplatin|cisplatin|mesh-list
153436296|NCT00002659|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153436297|NCT00003998|Paclitaxel|paclitaxel|mesh-list
153436298|NCT00003998|Docetaxel|docetaxel|mesh-list
153436299|NCT00003998|Carboplatin|carboplatin|mesh-list
153461766|NCT04130802|Glucocorticoids|glucocorticoids|mesh-ancestor
153436319|NCT00003260|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153436320|NCT00003260|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153436321|NCT00003260|Immunologic Factors|immunologic factors|mesh-ancestor
153436322|NCT00003260|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
153436323|NCT00003260|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153436324|NCT00003260|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153436326|NCT00003260|Protective Agents|protective agents|mesh-ancestor
153436327|NCT00003260|Vitamin B Complex|vitamin b complex|mesh-ancestor
153783646|NCT02214706|Immunologic Factors|immunologic factors|mesh-ancestor
153783647|NCT02214706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153436328|NCT00003260|Vitamins|vitamins|mesh-ancestor
153436329|NCT00003260|Micronutrients|micronutrients|mesh-ancestor
153430531|NCT00746239|Dexetimide|dexetimide|mesh-list
153436330|NCT00002665|Leucovorin|leucovorin|mesh-list
153436331|NCT00002665|Cytarabine|cytarabine|mesh-list
153436332|NCT00002665|Dexamethasone|dexamethasone|mesh-list
153436333|NCT00002665|Prednisone|prednisone|mesh-list
153436334|NCT00002665|Cyclophosphamide|cyclophosphamide|mesh-list
153436335|NCT00002665|Doxorubicin|doxorubicin|mesh-list
153436336|NCT00002665|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
153436337|NCT00002665|Methotrexate|methotrexate|mesh-list
153436338|NCT00002665|Etoposide|etoposide|mesh-list
153430545|NCT00746239|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153436339|NCT00002665|Vincristine|vincristine|mesh-list
153436340|NCT00002665|Daunorubicin|daunorubicin|mesh-list
153436341|NCT00002665|Asparaginase|asparaginase|mesh-list
153436342|NCT00002665|Mercaptopurine|mercaptopurine|mesh-list
153436343|NCT00002665|Thioguanine|thioguanine|mesh-list
153436373|NCT00002665|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153436374|NCT00002665|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153436375|NCT00002665|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153436376|NCT00002665|Antiviral Agents|antiviral agents|mesh-ancestor
153436377|NCT00002665|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153436378|NCT00002665|Antidotes|antidotes|mesh-ancestor
153436379|NCT00002665|Protective Agents|protective agents|mesh-ancestor
153436380|NCT00002665|Vitamin B Complex|vitamin b complex|mesh-ancestor
153436382|NCT00002665|Micronutrients|micronutrients|mesh-ancestor
153436383|NCT00002665|Tubulin Modulators|tubulin modulators|mesh-ancestor
153436384|NCT00002665|Antimitotic Agents|antimitotic agents|mesh-ancestor
153436385|NCT00002665|Mitosis Modulators|mitosis modulators|mesh-ancestor
153436386|NCT00003536|Methotrexate|methotrexate|mesh-list
153436387|NCT00003536|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
153436388|NCT00003536|Abortifacient Agents|abortifacient agents|mesh-ancestor
153436389|NCT00003536|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153436390|NCT00003536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153436391|NCT00003536|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153436392|NCT00003536|Antimetabolites|antimetabolites|mesh-ancestor
153436395|NCT00003536|Dermatologic Agents|dermatologic agents|mesh-ancestor
153436462|NCT00003278|Autonomic Agents|autonomic agents|mesh-ancestor
153436463|NCT00003278|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153436464|NCT00003278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153436465|NCT00003278|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153436466|NCT00003278|Glucocorticoids|glucocorticoids|mesh-ancestor
153436488|NCT00003554|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153436489|NCT00003554|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153436490|NCT00003554|Alkylating Agents|alkylating agents|mesh-ancestor
153436491|NCT00003554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153436492|NCT00003554|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153436493|NCT00003554|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153436495|NCT00003284|Etoposide|etoposide|mesh-list
153430546|NCT00746239|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
153430547|NCT00746239|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
153436505|NCT00003284|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153436506|NCT00003284|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153436507|NCT00003284|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153436508|NCT00003284|Alkylating Agents|alkylating agents|mesh-ancestor
153889414|NCT01277523|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153889415|NCT01277523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153889416|NCT01081834|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
153889417|NCT01081834|Canagliflozin|canagliflozin|mesh-list
153889418|NCT01081834|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153436509|NCT00384410|Nabilone|nabilone|mesh-list
153436510|NCT00384410|Antiemetics|antiemetics|mesh-ancestor
153436511|NCT00384410|Autonomic Agents|autonomic agents|mesh-ancestor
153436512|NCT00384410|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153436558|NCT00003572|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153436559|NCT00003572|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153436560|NCT00003572|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
153436561|NCT00003572|Antitubercular Agents|antitubercular agents|mesh-ancestor
153436562|NCT00003572|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153436563|NCT00003572|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153436589|NCT00003296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153436592|NCT00004064|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153436594|NCT00382057|Goserelin|goserelin|mesh-list
153436595|NCT00382057|Testosterone|testosterone|mesh-list
153436596|NCT00382057|Androgens|androgens|mesh-ancestor
153436597|NCT00382057|Hormones|hormones|mesh-ancestor
153436598|NCT00382057|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153436599|NCT00382057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153436600|NCT00382057|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153436601|NCT00382057|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153436602|NCT00382057|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
153436603|NCT00382057|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153436604|NCT00382057|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153436605|NCT00382057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153436606|NCT00382057|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
153436607|NCT00382057|Hormone Antagonists|hormone antagonists|mesh-ancestor
153436608|NCT00003578|Cytarabine|cytarabine|mesh-list
153889419|NCT01081834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153889420|NCT01081834|Incretins|incretins|mesh-ancestor
153436609|NCT00003578|Prednisone|prednisone|mesh-list
153436644|NCT00003584|Estramustine|estramustine|mesh-list
153436645|NCT00003584|Vinorelbine|vinorelbine|mesh-list
153436646|NCT00003584|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153436647|NCT00003584|Glucocorticoids|glucocorticoids|mesh-ancestor
153889421|NCT01081834|Hormones|hormones|mesh-ancestor
153889422|NCT01081834|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153436649|NCT00003584|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153889423|NCT01081834|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
153889424|NCT01081834|Protease Inhibitors|protease inhibitors|mesh-ancestor
153436650|NCT00003584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153436651|NCT00003584|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153436652|NCT00003584|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153889425|NCT01081834|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153889426|NCT01081834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153889427|NCT01081834|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
153436653|NCT00003584|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153436654|NCT00003584|Tubulin Modulators|tubulin modulators|mesh-ancestor
153436655|NCT00003584|Antimitotic Agents|antimitotic agents|mesh-ancestor
153436656|NCT00003584|Mitosis Modulators|mitosis modulators|mesh-ancestor
153436657|NCT00003584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153436658|NCT00003584|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153436659|NCT00003584|Alkylating Agents|alkylating agents|mesh-ancestor
153436661|NCT00002701|Cyclophosphamide|cyclophosphamide|mesh-list
153436662|NCT00002701|Busulfan|busulfan|mesh-list
153436663|NCT00002701|Methotrexate|methotrexate|mesh-list
153436664|NCT00002701|Etoposide|etoposide|mesh-list
153436665|NCT00002701|Mercaptopurine|mercaptopurine|mesh-list
153436666|NCT00002701|Mitoxantrone|mitoxantrone|mesh-list
153436667|NCT00002701|Idarubicin|idarubicin|mesh-list
153436668|NCT00002701|Thioguanine|thioguanine|mesh-list
153436669|NCT00002701|Tretinoin|tretinoin|mesh-list
153436670|NCT00002701|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153783648|NCT00236600|Topiramate|topiramate|mesh-list
153436955|NCT00004142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153436956|NCT00004142|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153436957|NCT00004142|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153436958|NCT00004142|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153436959|NCT00004142|Immunologic Factors|immunologic factors|mesh-ancestor
153436960|NCT00004142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153436961|NCT00002749|Carboplatin|carboplatin|mesh-list
153436990|NCT00003650|Antiemetics|antiemetics|mesh-ancestor
153436991|NCT00003650|Autonomic Agents|autonomic agents|mesh-ancestor
153436992|NCT00003650|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153436993|NCT00003650|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153436994|NCT00003650|Glucocorticoids|glucocorticoids|mesh-ancestor
153436995|NCT00003650|Hormones|hormones|mesh-ancestor
153436996|NCT00003650|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153436997|NCT00003650|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153889428|NCT01079962|Atenolol|atenolol|mesh-list
153889429|NCT01079962|Bisoprolol|bisoprolol|mesh-list
153889430|NCT01079962|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153889431|NCT01079962|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153889432|NCT01079962|Sympatholytics|sympatholytics|mesh-ancestor
153889433|NCT01079962|Autonomic Agents|autonomic agents|mesh-ancestor
153889436|NCT01079962|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
153889437|NCT01079962|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
153889438|NCT01079962|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
153889439|NCT01079962|Adrenergic Agents|adrenergic agents|mesh-ancestor
153889440|NCT01079962|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153889441|NCT01079962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153436998|NCT00003650|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
153436999|NCT00003650|Abortifacient Agents|abortifacient agents|mesh-ancestor
153437000|NCT00003650|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153437102|NCT00003662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153437103|NCT00003662|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153437130|NCT00002767|Interferon-alpha|interferon-alpha|mesh-list
153437131|NCT00002767|Detox adjuvant|detox adjuvant|mesh-list
153437132|NCT00002767|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153437133|NCT00002767|Antiviral Agents|antiviral agents|mesh-ancestor
153437134|NCT00002767|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153437135|NCT00002767|Immunologic Factors|immunologic factors|mesh-ancestor
153437136|NCT00002767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153437137|NCT00002767|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153437138|NCT00002773|Interferons|interferons|mesh-list
153437139|NCT00002773|Interferon-alpha|interferon-alpha|mesh-list
153437140|NCT00002773|Cyclophosphamide|cyclophosphamide|mesh-list
153437141|NCT00002773|Sargramostim|sargramostim|mesh-list
153437142|NCT00002773|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153437143|NCT00002773|Immunologic Factors|immunologic factors|mesh-ancestor
153437144|NCT00002773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153437145|NCT00002773|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153437146|NCT00002773|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153437147|NCT00002773|Alkylating Agents|alkylating agents|mesh-ancestor
153783649|NCT00236600|Anticonvulsants|anticonvulsants|mesh-ancestor
153783650|NCT00236600|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153437148|NCT00002773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153437151|NCT00002773|Antiviral Agents|antiviral agents|mesh-ancestor
153437228|NCT00002785|Leucovorin|leucovorin|mesh-list
153437229|NCT00002785|Cobalt|cobalt|mesh-list
153437230|NCT00002785|Cytarabine|cytarabine|mesh-list
153437231|NCT00002785|Cyclosporine|cyclosporine|mesh-list
153889442|NCT01274637|Dalteparin|dalteparin|mesh-list
153437232|NCT00002785|Dexamethasone|dexamethasone|mesh-list
153437233|NCT00002785|Prednisone|prednisone|mesh-list
153437234|NCT00002785|Methylprednisolone|methylprednisolone|mesh-list
153437235|NCT00002785|Hydrocortisone|hydrocortisone|mesh-list
153437236|NCT00002785|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
153437237|NCT00002785|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
153437238|NCT00002785|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
153437239|NCT00002785|Cyclophosphamide|cyclophosphamide|mesh-list
153437240|NCT00002785|Methotrexate|methotrexate|mesh-list
153437241|NCT00002785|Etoposide|etoposide|mesh-list
153437242|NCT00002785|Vincristine|vincristine|mesh-list
153437243|NCT00002785|Daunorubicin|daunorubicin|mesh-list
153437244|NCT00002785|Asparaginase|asparaginase|mesh-list
153437245|NCT00002785|Mercaptopurine|mercaptopurine|mesh-list
153437246|NCT00002785|Pegaspargase|pegaspargase|mesh-list
153437247|NCT00002785|Cyclosporins|cyclosporins|mesh-list
153437248|NCT00002785|Levoleucovorin|levoleucovorin|mesh-list
153437249|NCT00002785|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153437250|NCT00002785|Immunologic Factors|immunologic factors|mesh-ancestor
153437251|NCT00002785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153437252|NCT00002785|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153437253|NCT00002785|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153461767|NCT04130802|Hormones|hormones|mesh-ancestor
153437307|NCT00003386|Carboplatin|carboplatin|mesh-list
153437308|NCT00003386|Vaccines|vaccines|mesh-list
153437309|NCT00003386|BCG Vaccine|bcg vaccine|mesh-list
153437310|NCT00003386|Immunologic Factors|immunologic factors|mesh-ancestor
153437311|NCT00003386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153437338|NCT00384566|Antioxidants|antioxidants|mesh-ancestor
153437339|NCT00384566|Protective Agents|protective agents|mesh-ancestor
153437340|NCT00384566|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153437341|NCT00384566|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153437342|NCT00384566|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153430561|NCT04977674|Anesthetics|anesthetics|mesh-ancestor
153430562|NCT04977674|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153430563|NCT04977674|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
153430564|NCT04977674|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
153437344|NCT00384566|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
153437345|NCT00384566|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
153437346|NCT00004832|Amifampridine|amifampridine|mesh-list
153437347|NCT00004832|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
153437348|NCT00004832|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153437349|NCT00004832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153437350|NCT00004832|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
153437351|NCT00004832|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153437352|NCT00004832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153437353|NCT00002791|Doxorubicin|doxorubicin|mesh-list
153437354|NCT00002791|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
153437355|NCT00002791|Ifosfamide|ifosfamide|mesh-list
153437356|NCT00002791|Dacarbazine|dacarbazine|mesh-list
153437357|NCT00002791|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153437358|NCT00002791|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153437390|NCT00004202|Tubulin Modulators|tubulin modulators|mesh-ancestor
153437391|NCT00004202|Antimitotic Agents|antimitotic agents|mesh-ancestor
153437392|NCT00004202|Mitosis Modulators|mitosis modulators|mesh-ancestor
153437393|NCT00004202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153437394|NCT00004202|Antisickling Agents|antisickling agents|mesh-ancestor
153437395|NCT00003686|Pilocarpine|pilocarpine|mesh-list
153437396|NCT00003686|Miotics|miotics|mesh-ancestor
153437397|NCT00003686|Autonomic Agents|autonomic agents|mesh-ancestor
153437398|NCT00003686|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153437399|NCT00003686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153437403|NCT00003686|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153437433|NCT00004862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153437434|NCT00004862|Antiviral Agents|antiviral agents|mesh-ancestor
153437435|NCT00004862|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153437436|NCT00004220|Gemcitabine|gemcitabine|mesh-list
153437437|NCT00004220|Oxaliplatin|oxaliplatin|mesh-list
153437438|NCT00004220|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153437439|NCT00004220|Antimetabolites|antimetabolites|mesh-ancestor
153437440|NCT00004220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153430572|NCT00402883|Carboplatin|carboplatin|mesh-list
153430574|NCT00402883|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153430575|NCT00402883|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153437441|NCT00004220|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153437443|NCT00003704|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153437444|NCT00003704|Antimetabolites|antimetabolites|mesh-ancestor
153437445|NCT00003704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153437446|NCT00003704|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153437447|NCT00004868|Semaxinib|semaxinib|mesh-list
153437448|NCT00004868|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153437449|NCT00004868|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153437539|NCT00003728|Hydrocortisone|hydrocortisone|mesh-list
153437540|NCT00003728|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
153437541|NCT00003728|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
153437542|NCT00003728|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
153437543|NCT00003728|Cyclophosphamide|cyclophosphamide|mesh-list
153437544|NCT00003728|Doxorubicin|doxorubicin|mesh-list
153437545|NCT00003728|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
153437546|NCT00003728|Methotrexate|methotrexate|mesh-list
153437547|NCT00003728|Etoposide|etoposide|mesh-list
153437548|NCT00003728|Vincristine|vincristine|mesh-list
153437549|NCT00003728|Daunorubicin|daunorubicin|mesh-list
153889454|NCT02876770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153889455|NCT02876770|Protective Agents|protective agents|mesh-ancestor
153889456|NCT02876770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153889457|NCT02876770|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153889458|NCT01077622|Ofatumumab|ofatumumab|mesh-list
153889459|NCT01077622|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153889460|NCT01313676|Fluticasone|fluticasone|mesh-list
153889461|NCT01313676|Xhance|xhance|mesh-list
153889462|NCT01313676|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153889463|NCT01313676|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153889464|NCT01313676|Autonomic Agents|autonomic agents|mesh-ancestor
153889465|NCT01313676|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153437550|NCT00003728|Asparaginase|asparaginase|mesh-list
153437586|NCT00003728|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153437587|NCT00003728|Antiviral Agents|antiviral agents|mesh-ancestor
153437588|NCT00003728|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153437589|NCT00003728|Antidotes|antidotes|mesh-ancestor
153437591|NCT00003728|Vitamin B Complex|vitamin b complex|mesh-ancestor
153437592|NCT00003728|Vitamins|vitamins|mesh-ancestor
153437593|NCT00003728|Micronutrients|micronutrients|mesh-ancestor
153437594|NCT00003728|Tubulin Modulators|tubulin modulators|mesh-ancestor
153437595|NCT00003728|Antimitotic Agents|antimitotic agents|mesh-ancestor
153437596|NCT00003728|Mitosis Modulators|mitosis modulators|mesh-ancestor
153437597|NCT00003728|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
153437598|NCT00003728|Analgesics|analgesics|mesh-ancestor
153437599|NCT00003728|Sensory System Agents|sensory system agents|mesh-ancestor
153889471|NCT00623376|Dronabinol|dronabinol|mesh-list
153437600|NCT00004886|Docetaxel|docetaxel|mesh-list
153437601|NCT00004886|Dofequidar|dofequidar|mesh-list
153437602|NCT00004886|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153437603|NCT00004886|Tubulin Modulators|tubulin modulators|mesh-ancestor
153437604|NCT00004886|Antimitotic Agents|antimitotic agents|mesh-ancestor
153437605|NCT00004886|Mitosis Modulators|mitosis modulators|mesh-ancestor
153437638|NCT00004268|Sympathomimetics|sympathomimetics|mesh-ancestor
153437639|NCT00004268|Autonomic Agents|autonomic agents|mesh-ancestor
153437640|NCT00004268|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153437641|NCT00004268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153437642|NCT00004268|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
153437643|NCT00004268|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
153437644|NCT00004268|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153437645|NCT00004268|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153437646|NCT00004268|Adrenergic Agents|adrenergic agents|mesh-ancestor
153437670|NCT00004904|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153437671|NCT00004904|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153437672|NCT00004904|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
153437673|NCT00004904|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153437675|NCT00004904|Autonomic Agents|autonomic agents|mesh-ancestor
153437676|NCT00004904|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153437684|NCT00004286|Antibodies|antibodies|mesh-list
153437685|NCT00004286|gamma-Globulins|gamma-globulins|mesh-list
153437686|NCT00004286|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
153437687|NCT00004286|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
153437688|NCT00004286|Immunologic Factors|immunologic factors|mesh-ancestor
153437689|NCT00004286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153437690|NCT00003746|Cladribine|cladribine|mesh-list
153437691|NCT00003746|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153437692|NCT00003746|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153437693|NCT00003746|Immunologic Factors|immunologic factors|mesh-ancestor
153437694|NCT00003746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153437695|NCT00003752|Bexarotene|bexarotene|mesh-list
153437696|NCT00003752|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153437697|NCT00003758|Cytarabine|cytarabine|mesh-list
153437698|NCT00003758|Idarubicin|idarubicin|mesh-list
153437699|NCT00003758|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153437734|NCT00004316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153889478|NCT00623376|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153889479|NCT00623376|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153889480|NCT00623376|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153889481|NCT00623376|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153889482|NCT00623376|Hallucinogens|hallucinogens|mesh-ancestor
153889483|NCT00623376|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153437735|NCT00004928|Zoledronic Acid|zoledronic acid|mesh-list
153437736|NCT00004928|Calcitriol|calcitriol|mesh-list
153783651|NCT00236600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153889484|NCT00623376|Analgesics|analgesics|mesh-ancestor
153437738|NCT00004928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153437739|NCT00004928|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153437787|NCT00003776|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153437788|NCT00003776|Antimetabolites|antimetabolites|mesh-ancestor
153437789|NCT00003776|Dermatologic Agents|dermatologic agents|mesh-ancestor
153437790|NCT00003776|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153437791|NCT00003776|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153437792|NCT00003776|Immunologic Factors|immunologic factors|mesh-ancestor
153437793|NCT00003776|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153437794|NCT00003776|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153889486|NCT00623376|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
153889487|NCT00623376|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
153889488|NCT00623376|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153889489|NCT00623376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153889490|NCT00623376|Hormones|hormones|mesh-ancestor
153437827|NCT00004346|Chenodeoxycholic Acid|chenodeoxycholic acid|mesh-list
153889491|NCT00623376|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153889492|NCT01313286|Globalagliatin|globalagliatin|mesh-list
153430606|NCT05286320|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153430607|NCT05286320|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153437830|NCT00004346|Dihydromevinolin|dihydromevinolin|mesh-list
153437831|NCT00004346|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153437832|NCT00004346|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153437833|NCT00004346|Antimetabolites|antimetabolites|mesh-ancestor
153437834|NCT00004346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153437835|NCT00004346|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153437836|NCT00004346|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
153430608|NCT05286320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153430609|NCT05286320|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153437837|NCT00004346|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153430610|NCT05286320|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153437970|NCT00005018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153437971|NCT00005018|Antiviral Agents|antiviral agents|mesh-ancestor
153437972|NCT00005018|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153437973|NCT00005018|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
153438041|NCT00004424|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153438042|NCT00004424|GABA Modulators|gaba modulators|mesh-ancestor
153430614|NCT00728845|Carboplatin|carboplatin|mesh-list
153430615|NCT00728845|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153430616|NCT00728845|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153430617|NCT00728845|Tubulin Modulators|tubulin modulators|mesh-ancestor
153430618|NCT00728845|Antimitotic Agents|antimitotic agents|mesh-ancestor
153430619|NCT00728845|Mitosis Modulators|mitosis modulators|mesh-ancestor
153430620|NCT00728845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153430621|NCT00728845|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153430622|NCT00728845|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153430623|NCT00728845|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153430624|NCT00728845|Growth Substances|growth substances|mesh-ancestor
153430625|NCT00728845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153438043|NCT00004424|GABA Agents|gaba agents|mesh-ancestor
153438044|NCT00004424|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153438045|NCT00004424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153438046|NCT00004424|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153438047|NCT00004424|Narcotics|narcotics|mesh-ancestor
153430626|NCT00728845|Growth Inhibitors|growth inhibitors|mesh-ancestor
153430627|NCT00728845|Antimalarials|antimalarials|mesh-ancestor
153438048|NCT00004424|Analgesics|analgesics|mesh-ancestor
153438049|NCT00004424|Sensory System Agents|sensory system agents|mesh-ancestor
153438050|NCT00004424|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153438078|NCT00005036|Immunologic Factors|immunologic factors|mesh-ancestor
153438079|NCT00005036|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
153438080|NCT00005036|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153438081|NCT00005036|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153438082|NCT00005036|Antidotes|antidotes|mesh-ancestor
153438083|NCT00005036|Protective Agents|protective agents|mesh-ancestor
153438084|NCT00005036|Vitamin B Complex|vitamin b complex|mesh-ancestor
153438086|NCT00005036|Micronutrients|micronutrients|mesh-ancestor
153438087|NCT00004436|Prednisone|prednisone|mesh-list
153438088|NCT00004436|Leuprolide|leuprolide|mesh-list
153438089|NCT00004436|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153438090|NCT00004436|Glucocorticoids|glucocorticoids|mesh-ancestor
153438091|NCT00004436|Hormones|hormones|mesh-ancestor
153438092|NCT00004436|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153438093|NCT00004436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153438097|NCT00004436|Fertility Agents|fertility agents|mesh-ancestor
153438204|NCT00004496|Melanocyte-Stimulating Hormones|melanocyte-stimulating hormones|mesh-list
153438206|NCT00004496|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153438207|NCT00004496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153438208|NCT00004496|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153438209|NCT00004496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153438211|NCT00003902|Vinorelbine|vinorelbine|mesh-list
153438212|NCT00003902|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153438213|NCT00003902|Antimetabolites|antimetabolites|mesh-ancestor
153438214|NCT00003902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153438215|NCT00003902|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153438216|NCT00003902|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153438248|NCT00003920|Immunoglobulins|immunoglobulins|mesh-list
153438250|NCT00003920|Cyclosporins|cyclosporins|mesh-list
153438348|NCT00005108|Progestins|progestins|mesh-ancestor
153438349|NCT00004652|Pimozide|pimozide|mesh-list
153438350|NCT00004652|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153438351|NCT00004652|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153438388|NCT00004688|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153438389|NCT00004688|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153438390|NCT00004688|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153438392|NCT00004688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153438393|NCT00004688|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153438394|NCT00004688|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153438395|NCT00004688|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153438396|NCT00004688|Alkylating Agents|alkylating agents|mesh-ancestor
153438397|NCT00004688|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153438398|NCT00004694|Heparin|heparin|mesh-list
153438399|NCT00004694|Anticoagulants|anticoagulants|mesh-ancestor
153438400|NCT00004694|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153438401|NCT00004694|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153438402|NCT00004694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153438403|NCT00004700|Mitogens|mitogens|mesh-list
153438404|NCT00004700|Mitosis Modulators|mitosis modulators|mesh-ancestor
153438405|NCT00004700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153438436|NCT00004736|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153438437|NCT00004736|Antimetabolites|antimetabolites|mesh-ancestor
153438438|NCT00004736|Antitubercular Agents|antitubercular agents|mesh-ancestor
153438439|NCT00004736|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153438440|NCT00004736|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
153438441|NCT00004736|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153438442|NCT00004736|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153438443|NCT00004736|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
153438444|NCT00004736|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
153438445|NCT00004736|Protease Inhibitors|protease inhibitors|mesh-ancestor
153438446|NCT00004736|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
153438448|NCT00004748|Colchicine|colchicine|mesh-list
153438449|NCT00004748|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
153438450|NCT00004748|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
153438451|NCT00004748|Abortifacient Agents|abortifacient agents|mesh-ancestor
153438452|NCT00004748|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153438453|NCT00004748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153438454|NCT00004748|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153889493|NCT01313286|Enzyme Activators|enzyme activators|mesh-ancestor
153889494|NCT01313286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153889495|NCT01313208|Etanercept|etanercept|mesh-list
153889496|NCT01313208|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153889497|NCT01313208|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153889498|NCT01313208|Analgesics|analgesics|mesh-ancestor
153889499|NCT01313208|Sensory System Agents|sensory system agents|mesh-ancestor
153889500|NCT01313208|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153889501|NCT01313208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153889502|NCT01313208|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153889503|NCT01313208|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153889504|NCT01313208|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153889505|NCT01313208|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153889506|NCT01313208|Immunologic Factors|immunologic factors|mesh-ancestor
153889507|NCT01075984|Posaconazole|posaconazole|mesh-list
153889508|NCT01075984|Antifungal Agents|antifungal agents|mesh-ancestor
153438458|NCT00004748|Dermatologic Agents|dermatologic agents|mesh-ancestor
153438459|NCT00004748|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153438460|NCT00004748|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153438461|NCT00004748|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153438462|NCT00004748|Immunologic Factors|immunologic factors|mesh-ancestor
153438463|NCT00004748|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153438495|NCT04713163|Vaccines|vaccines|mesh-list
153438496|NCT04713163|Immunologic Factors|immunologic factors|mesh-ancestor
153438497|NCT04713163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153438498|NCT00004772|Immunoglobulins|immunoglobulins|mesh-list
153438499|NCT00004772|Antibodies|antibodies|mesh-list
153438500|NCT00004772|gamma-Globulins|gamma-globulins|mesh-list
153438501|NCT00004772|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
153438502|NCT00004772|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
153438507|NCT04712929|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153438508|NCT04712929|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
153438509|NCT04712929|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153438510|NCT04712929|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153889511|NCT01075984|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153889512|NCT01075984|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153889513|NCT01075984|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
153889514|NCT01075984|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153438511|NCT04712929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153438534|NCT00004784|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153438536|NCT00004784|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153438538|NCT00004796|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153438539|NCT00004802|Dichlorphenamide|dichlorphenamide|mesh-list
153438540|NCT00004802|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
153438541|NCT00004802|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153438542|NCT00004802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153438543|NCT00004808|Fluconazole|fluconazole|mesh-list
153438544|NCT00004808|Antifungal Agents|antifungal agents|mesh-ancestor
153438545|NCT00004808|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153438546|NCT00004808|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
153438547|NCT00004808|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153438548|NCT00004808|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153438549|NCT00004808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153438550|NCT00004808|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153438551|NCT00004808|Hormone Antagonists|hormone antagonists|mesh-ancestor
153383228|NCT02048891|Contraceptive Agents|contraceptive agents|mesh-ancestor
153383229|NCT02048891|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153383230|NCT02048891|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
153383231|NCT02048891|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153383232|NCT02048891|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153383233|NCT01727726|Quetiapine Fumarate|quetiapine fumarate|mesh-list
153383234|NCT01727726|Brexpiprazole|brexpiprazole|mesh-list
153383235|NCT01727726|Antidepressive Agents|antidepressive agents|mesh-ancestor
153438552|NCT00004808|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153438553|NCT00004808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153438554|NCT00004808|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
153438555|NCT00004808|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
153783656|NCT04545463|Psyllium|psyllium|mesh-list
153783657|NCT04545463|Cathartics|cathartics|mesh-ancestor
153438557|NCT00004814|(T,G)-A-L|(t,g)-a-l|mesh-list
153438558|NCT00004814|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153438559|NCT00004814|Immunologic Factors|immunologic factors|mesh-ancestor
153438590|NCT00004778|Respiratory System Agents|respiratory system agents|mesh-ancestor
153438592|NCT00005612|Etoposide|etoposide|mesh-list
153438596|NCT00005612|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153438597|NCT00005612|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153438598|NCT00005612|Tubulin Modulators|tubulin modulators|mesh-ancestor
153438599|NCT00005612|Antimitotic Agents|antimitotic agents|mesh-ancestor
153438600|NCT00005612|Mitosis Modulators|mitosis modulators|mesh-ancestor
153438601|NCT00005612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153438602|NCT00005612|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153438603|NCT00005612|Immunologic Factors|immunologic factors|mesh-ancestor
153889515|NCT01075984|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153430628|NCT00728845|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153430629|NCT00728845|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153430630|NCT00728845|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153430631|NCT00728845|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153430632|NCT00728845|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153430633|NCT00726037|Denileukin diftitox|denileukin diftitox|mesh-list
153430634|NCT00726037|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153430635|NCT00703885|Alprazolam|alprazolam|mesh-list
153430636|NCT00703885|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153430637|NCT00703885|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153430638|NCT00703885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153438623|NCT00385502|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
153438624|NCT00385502|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153438626|NCT00385502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153438627|NCT00385502|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153438628|NCT00385502|Hormone Antagonists|hormone antagonists|mesh-ancestor
153438629|NCT00385502|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153438630|NCT00385502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153438631|NCT00005630|Sargramostim|sargramostim|mesh-list
153438632|NCT00005630|Immunologic Factors|immunologic factors|mesh-ancestor
153438633|NCT00005630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153438634|NCT00005636|Pemetrexed|pemetrexed|mesh-list
153438635|NCT00005636|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153438636|NCT00005636|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153438637|NCT00005636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153438638|NCT00005636|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153438641|NCT00005642|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153438642|NCT00005642|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153438643|NCT00005642|Growth Substances|growth substances|mesh-ancestor
153438654|NCT00005648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153438655|NCT00005648|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153438656|NCT00005654|Metformin|metformin|mesh-list
153438657|NCT00005654|Clomiphene|clomiphene|mesh-list
153438658|NCT00005654|Enclomiphene|enclomiphene|mesh-list
153438659|NCT00005654|Zuclomiphene|zuclomiphene|mesh-list
153438660|NCT00005654|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153438661|NCT00005654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153438662|NCT00005654|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
153383237|NCT01727726|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153383238|NCT01727726|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153383239|NCT01727726|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153383240|NCT01727726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153383241|NCT01727726|Serotonin Agents|serotonin agents|mesh-ancestor
153383266|NCT01748240|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
153383268|NCT01748942|Dexamethasone acetate|dexamethasone acetate|mesh-list
153383269|NCT01748942|Ichthammol|ichthammol|mesh-list
153383270|NCT01748942|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
153383271|NCT01748942|BB 1101|bb 1101|mesh-list
153383272|NCT01748942|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153383273|NCT01748942|Antiemetics|antiemetics|mesh-ancestor
153438691|NCT00386282|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
153438693|NCT00386282|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153438694|NCT00386282|Luteolytic Agents|luteolytic agents|mesh-ancestor
153438695|NCT00386282|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
153438696|NCT00386282|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
153438697|NCT00385658|Simvastatin|simvastatin|mesh-list
153438698|NCT00385658|Ezetimibe|ezetimibe|mesh-list
153438699|NCT00385658|Fenofibrate|fenofibrate|mesh-list
153438700|NCT00385658|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153438701|NCT00385658|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153438702|NCT00385658|Antimetabolites|antimetabolites|mesh-ancestor
153438703|NCT00385658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153438704|NCT00385658|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153438705|NCT00385658|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
153438706|NCT00385658|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153438738|NCT00005774|Pulmonary Surfactants|pulmonary surfactants|mesh-list
153438864|NCT04568876|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153438865|NCT04568876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153438866|NCT04568876|Hormones|hormones|mesh-ancestor
153438867|NCT04568876|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153438868|NCT02210702|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
153438869|NCT02210702|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
153438870|NCT02210702|Ethinyl Estradiol|ethinyl estradiol|mesh-list
153438871|NCT02210702|Norethindrone|norethindrone|mesh-list
153438872|NCT02210702|Norethindrone Acetate|norethindrone acetate|mesh-list
153438908|NCT02278172|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153438909|NCT04971031|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
153430640|NCT00703885|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153430641|NCT00703885|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153430643|NCT00703885|GABA Agents|gaba agents|mesh-ancestor
153430644|NCT00703885|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153438910|NCT04971031|Ophthalmic Solutions|ophthalmic solutions|mesh-list
153438911|NCT04566224|Pyrithione zinc|pyrithione zinc|mesh-list
153438912|NCT04566224|Keratolytic Agents|keratolytic agents|mesh-ancestor
153438942|NCT00005804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153438943|NCT00005804|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153438944|NCT00005804|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153438945|NCT00005804|Alkylating Agents|alkylating agents|mesh-ancestor
153438946|NCT00005804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153438947|NCT00005804|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153438948|NCT00005804|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153438949|NCT04563962|Methamphetamine|methamphetamine|mesh-list
153438950|NCT04563962|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
153438951|NCT04563962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153438952|NCT04563962|Sympathomimetics|sympathomimetics|mesh-ancestor
153438953|NCT04563962|Autonomic Agents|autonomic agents|mesh-ancestor
153438954|NCT04563962|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153438955|NCT04563962|Dopamine Agents|dopamine agents|mesh-ancestor
153438956|NCT04563962|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153438957|NCT04563962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153438958|NCT04563962|Adrenergic Agents|adrenergic agents|mesh-ancestor
153438981|NCT04330495|Hydroxychloroquine|hydroxychloroquine|mesh-list
153438982|NCT04330495|Antimalarials|antimalarials|mesh-ancestor
153438989|NCT04563260|Palonosetron|palonosetron|mesh-list
153438990|NCT04563260|Antiemetics|antiemetics|mesh-ancestor
153438991|NCT04563260|Autonomic Agents|autonomic agents|mesh-ancestor
153438992|NCT04563260|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153438993|NCT04563260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153438994|NCT04563260|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153783658|NCT04545463|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153783659|NCT00236678|Epoetin Alfa|epoetin alfa|mesh-list
153438999|NCT04563260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153439002|NCT04173793|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153439003|NCT04173793|Antimetabolites|antimetabolites|mesh-ancestor
153439004|NCT04173793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153439005|NCT04173793|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153439006|NCT04561856|Dexamethasone|dexamethasone|mesh-list
153439007|NCT04561856|Dexamethasone acetate|dexamethasone acetate|mesh-list
153439008|NCT04561856|BB 1101|bb 1101|mesh-list
153439009|NCT04561856|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153439010|NCT04561856|Antiemetics|antiemetics|mesh-ancestor
153439011|NCT04561856|Autonomic Agents|autonomic agents|mesh-ancestor
153439012|NCT04561856|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153439013|NCT04561856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153439047|NCT04123717|Analgesics|analgesics|mesh-ancestor
153439048|NCT04123717|Sensory System Agents|sensory system agents|mesh-ancestor
153439049|NCT04123717|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153439050|NCT04123717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153439051|NCT04123717|Antipyretics|antipyretics|mesh-ancestor
153439087|NCT00002893|Calcium|calcium|mesh-list
153439090|NCT00002893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153439092|NCT00002893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153439093|NCT00002893|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153439094|NCT00002893|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153439095|NCT00002893|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153439096|NCT00002893|Immunologic Factors|immunologic factors|mesh-ancestor
153439098|NCT00002893|Protective Agents|protective agents|mesh-ancestor
153439099|NCT00002893|Vitamin B Complex|vitamin b complex|mesh-ancestor
153439100|NCT00002893|Vitamins|vitamins|mesh-ancestor
153439101|NCT00002893|Micronutrients|micronutrients|mesh-ancestor
153439132|NCT00002905|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153439133|NCT00002905|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153439134|NCT00002905|Antimetabolites|antimetabolites|mesh-ancestor
153439135|NCT00002905|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153439136|NCT00002905|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153439137|NCT00002905|Antiviral Agents|antiviral agents|mesh-ancestor
153439138|NCT00002905|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153439139|NCT00002905|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153439140|NCT00002905|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153439141|NCT00002905|Analgesics|analgesics|mesh-ancestor
153439142|NCT00002905|Sensory System Agents|sensory system agents|mesh-ancestor
153439143|NCT00002905|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153439145|NCT00002911|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153439146|NCT00002911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153439147|NCT00002917|Paclitaxel|paclitaxel|mesh-list
153439174|NCT00383851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153439175|NCT00383851|Growth Inhibitors|growth inhibitors|mesh-ancestor
153439176|NCT00002923|KRN 5500|krn 5500|mesh-list
153439177|NCT00002923|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153439178|NCT00002923|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
153439179|NCT00002923|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153439194|NCT00002935|Trioxsalen|trioxsalen|mesh-list
153439195|NCT00002935|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153439214|NCT00002953|Paclitaxel|paclitaxel|mesh-list
153439215|NCT00002953|Cyclophosphamide|cyclophosphamide|mesh-list
153439216|NCT00002953|Epirubicin|epirubicin|mesh-list
153439217|NCT00002953|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153439218|NCT00002953|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153439219|NCT00002953|Tubulin Modulators|tubulin modulators|mesh-ancestor
153439220|NCT00002953|Antimitotic Agents|antimitotic agents|mesh-ancestor
153439221|NCT00002953|Mitosis Modulators|mitosis modulators|mesh-ancestor
153439222|NCT00002953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153439223|NCT00002953|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153439224|NCT00002953|Immunologic Factors|immunologic factors|mesh-ancestor
153439225|NCT00002953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153439227|NCT00002953|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153439228|NCT00002953|Alkylating Agents|alkylating agents|mesh-ancestor
153439229|NCT00002953|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153439230|NCT00002953|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153439231|NCT00002953|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153439232|NCT00002953|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153439233|NCT00002953|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153439235|NCT03693781|Gout Suppressants|gout suppressants|mesh-ancestor
153439243|NCT02283853|Interferon-beta|interferon-beta|mesh-list
153439244|NCT02283853|Interferon beta-1a|interferon beta-1a|mesh-list
153439245|NCT02283853|Dimethyl Fumarate|dimethyl fumarate|mesh-list
153889518|NCT01075984|Hormone Antagonists|hormone antagonists|mesh-ancestor
153889519|NCT01075984|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153889520|NCT01075984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153430662|NCT04828057|Timolol|timolol|mesh-list
153430663|NCT04828057|Bimatoprost|bimatoprost|mesh-list
153430664|NCT04828057|Travoprost|travoprost|mesh-list
153889521|NCT01024231|Nivolumab|nivolumab|mesh-list
153889522|NCT01024231|Ipilimumab|ipilimumab|mesh-list
153439246|NCT02283853|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153439247|NCT02283853|Antiviral Agents|antiviral agents|mesh-ancestor
153439248|NCT02283853|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153439249|NCT02283853|Dermatologic Agents|dermatologic agents|mesh-ancestor
153439250|NCT02283853|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153439251|NCT02283853|Immunologic Factors|immunologic factors|mesh-ancestor
153439252|NCT02283853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153439253|NCT02283853|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153439254|NCT00002971|O(6)-benzylguanine|o(6)-benzylguanine|mesh-list
153439286|NCT00003397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153439288|NCT00003397|Immunologic Factors|immunologic factors|mesh-ancestor
153439289|NCT00003397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153439290|NCT00003397|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153439291|NCT00003397|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153439292|NCT00003397|Alkylating Agents|alkylating agents|mesh-ancestor
153439293|NCT00003397|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153439294|NCT00003397|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153439295|NCT00003397|Antiemetics|antiemetics|mesh-ancestor
153439296|NCT00003397|Autonomic Agents|autonomic agents|mesh-ancestor
153439297|NCT00003397|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153439298|NCT00003397|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153439383|NCT00003421|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
153439385|NCT00003421|Etoposide|etoposide|mesh-list
153439386|NCT00003421|Vincristine|vincristine|mesh-list
153439387|NCT00003421|Dacarbazine|dacarbazine|mesh-list
153439388|NCT00003421|Vinblastine|vinblastine|mesh-list
153439389|NCT00003421|Procarbazine|procarbazine|mesh-list
153439390|NCT00003421|Chlorambucil|chlorambucil|mesh-list
153439391|NCT00003421|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153439392|NCT00003421|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153439393|NCT00003421|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153439516|NCT00003451|Growth Inhibitors|growth inhibitors|mesh-ancestor
153439517|NCT00003463|Irinotecan|irinotecan|mesh-list
153439518|NCT00003463|Carmustine|carmustine|mesh-list
153439519|NCT00003463|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
153439520|NCT00003463|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153439521|NCT00003463|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153439522|NCT00003463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153439523|NCT00003463|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153439524|NCT00003463|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153439525|NCT00003463|Alkylating Agents|alkylating agents|mesh-ancestor
153439526|NCT00003019|Methotrexate|methotrexate|mesh-list
153439527|NCT00003019|Vinblastine|vinblastine|mesh-list
153439591|NCT00003031|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
153439592|NCT00003031|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153439594|NCT00003517|Flutamide|flutamide|mesh-list
153439595|NCT00003517|Bicalutamide|bicalutamide|mesh-list
153439596|NCT00003517|Hormones|hormones|mesh-list
153439597|NCT00003517|Androgen Antagonists|androgen antagonists|mesh-list
153439598|NCT00003517|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153439599|NCT00003517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153439600|NCT00003517|Fertility Agents, Female|fertility agents, female|mesh-ancestor
153439643|NCT00383929|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
153439644|NCT00383929|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153439647|NCT00383929|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
153439648|NCT00003541|Prednisone|prednisone|mesh-list
153439649|NCT00003541|Cyclophosphamide|cyclophosphamide|mesh-list
153439650|NCT00003541|Ifosfamide|ifosfamide|mesh-list
153439651|NCT00003541|Carboplatin|carboplatin|mesh-list
153439652|NCT00003541|Doxorubicin|doxorubicin|mesh-list
153439691|NCT00002809|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153439692|NCT00002809|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153439693|NCT00002809|Alkylating Agents|alkylating agents|mesh-ancestor
153439694|NCT00002809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153439719|NCT00002827|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153439720|NCT00002827|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153439721|NCT00002827|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153439722|NCT00002827|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153783663|NCT00269334|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
153439723|NCT00002827|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153439724|NCT00002827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153439725|NCT00002827|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153439726|NCT00002827|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153439727|NCT00002827|Immunologic Factors|immunologic factors|mesh-ancestor
153439728|NCT00002827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153439729|NCT00002827|Tubulin Modulators|tubulin modulators|mesh-ancestor
153439730|NCT00002827|Antimitotic Agents|antimitotic agents|mesh-ancestor
153439745|NCT00003565|Antimitotic Agents|antimitotic agents|mesh-ancestor
153439746|NCT00003565|Mitosis Modulators|mitosis modulators|mesh-ancestor
153439747|NCT00003565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153439748|NCT00003049|Leucovorin|leucovorin|mesh-list
153439749|NCT00003049|Fluorouracil|fluorouracil|mesh-list
153439750|NCT00003049|Calcium|calcium|mesh-list
153439788|NCT00002833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153439790|NCT00002833|Immunologic Factors|immunologic factors|mesh-ancestor
153439791|NCT00002833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153439792|NCT00002833|Antiviral Agents|antiviral agents|mesh-ancestor
153439793|NCT00002833|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153439816|NCT00003061|Abortifacient Agents|abortifacient agents|mesh-ancestor
153439817|NCT00003061|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153439818|NCT00003061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153439819|NCT00003061|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153439820|NCT00003061|Antimetabolites|antimetabolites|mesh-ancestor
153439821|NCT00003061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153439822|NCT00003061|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153889538|NCT01012999|Sensory System Agents|sensory system agents|mesh-ancestor
153889539|NCT01012999|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153889540|NCT01012999|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153889541|NCT01012999|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153889542|NCT01012999|Anesthetics, General|anesthetics, general|mesh-ancestor
153889543|NCT01012999|Anesthetics|anesthetics|mesh-ancestor
153889544|NCT00637663|Lamivudine|lamivudine|mesh-list
153889545|NCT00637663|Entecavir|entecavir|mesh-list
153439827|NCT00003061|Immunologic Factors|immunologic factors|mesh-ancestor
153439828|NCT00003061|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153439829|NCT00003061|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153439830|NCT00003061|Antiviral Agents|antiviral agents|mesh-ancestor
153439831|NCT00003061|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153439876|NCT00002845|Aldesleukin|aldesleukin|mesh-list
153439877|NCT00002845|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153439878|NCT00002845|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153439879|NCT00002845|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153439880|NCT00002845|Antiviral Agents|antiviral agents|mesh-ancestor
153439881|NCT00002845|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153439882|NCT00003067|Aldesleukin|aldesleukin|mesh-list
153439883|NCT00003067|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153439884|NCT00003067|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153439885|NCT00003067|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153439886|NCT00003067|Antiviral Agents|antiviral agents|mesh-ancestor
153439887|NCT00003067|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153439889|NCT00003589|Gemcitabine|gemcitabine|mesh-list
153439890|NCT00003589|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153439891|NCT00003589|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153439892|NCT00003589|Tubulin Modulators|tubulin modulators|mesh-ancestor
153439893|NCT00003589|Antimitotic Agents|antimitotic agents|mesh-ancestor
153439894|NCT00003589|Mitosis Modulators|mitosis modulators|mesh-ancestor
153439895|NCT00003589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153439896|NCT00003589|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153439897|NCT00003589|Antimetabolites|antimetabolites|mesh-ancestor
153439957|NCT00002869|Antimetabolites|antimetabolites|mesh-ancestor
153440037|NCT00003619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153440038|NCT00003619|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153440039|NCT00003619|Immunologic Factors|immunologic factors|mesh-ancestor
153440040|NCT00003619|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153440041|NCT00003619|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153440042|NCT00003619|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153440043|NCT00003619|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153440044|NCT00003619|Antiviral Agents|antiviral agents|mesh-ancestor
153440045|NCT00003619|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153440046|NCT00003619|Alkylating Agents|alkylating agents|mesh-ancestor
153440047|NCT00003619|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153440048|NCT00003619|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153440049|NCT00003619|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
153440050|NCT00003619|Antioxidants|antioxidants|mesh-ancestor
153440051|NCT00003619|Protective Agents|protective agents|mesh-ancestor
153440052|NCT00003619|Dermatologic Agents|dermatologic agents|mesh-ancestor
153440053|NCT00002887|Etoposide|etoposide|mesh-list
153440054|NCT00002887|Vinorelbine|vinorelbine|mesh-list
153440055|NCT00002887|Hydroxyurea|hydroxyurea|mesh-list
153440057|NCT00002887|Vindesine|vindesine|mesh-list
153440215|NCT00003661|Antilymphocyte Serum|antilymphocyte serum|mesh-list
153440216|NCT00003661|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153440217|NCT00003661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153440218|NCT00003661|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153440219|NCT00003661|Immunologic Factors|immunologic factors|mesh-ancestor
153440220|NCT00003661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153440221|NCT00003661|Antifungal Agents|antifungal agents|mesh-ancestor
153440250|NCT00003115|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153440251|NCT00003115|Narcotics|narcotics|mesh-ancestor
153440261|NCT00003667|Dexrazoxane|dexrazoxane|mesh-list
153440263|NCT00003667|Glycerol|glycerol|mesh-list
153440264|NCT00003667|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153440265|NCT00003667|Immunologic Factors|immunologic factors|mesh-ancestor
153440266|NCT00003667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153440267|NCT00003667|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153440268|NCT00003667|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153440269|NCT00003667|Alkylating Agents|alkylating agents|mesh-ancestor
153440305|NCT00003679|Tubulin Modulators|tubulin modulators|mesh-ancestor
153440306|NCT00003679|Antimitotic Agents|antimitotic agents|mesh-ancestor
153440307|NCT00003679|Mitosis Modulators|mitosis modulators|mesh-ancestor
153440308|NCT00003679|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153440309|NCT00003679|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153440345|NCT00003997|Alkylating Agents|alkylating agents|mesh-ancestor
153440346|NCT00003997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153440348|NCT00384631|Bevacizumab|bevacizumab|mesh-list
153440419|NCT00003697|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153440420|NCT02972983|Daptomycin|daptomycin|mesh-list
153440421|NCT02972983|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153440422|NCT02972983|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153440423|NCT00003709|Carbendazim|carbendazim|mesh-list
153440424|NCT00003709|Antinematodal Agents|antinematodal agents|mesh-ancestor
153440425|NCT00003709|Anthelmintics|anthelmintics|mesh-ancestor
153440426|NCT00003709|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153440427|NCT00003709|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153440428|NCT00003145|Cyclosporine|cyclosporine|mesh-list
153440429|NCT00003145|Mycophenolic Acid|mycophenolic acid|mesh-list
153440519|NCT00003715|Alkylating Agents|alkylating agents|mesh-ancestor
153440520|NCT00003715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153440521|NCT00003715|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153440522|NCT00003715|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153440523|NCT00003715|Antiviral Agents|antiviral agents|mesh-ancestor
153440524|NCT00003715|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153440525|NCT00003715|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153440527|NCT00004051|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
153440528|NCT00004051|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153440529|NCT00004051|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153440530|NCT00004051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153440700|NCT00003187|Cyclosporine|cyclosporine|mesh-list
153440831|NCT00003211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153440833|NCT00003211|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153440836|NCT00003211|Antimitotic Agents|antimitotic agents|mesh-ancestor
153440837|NCT00003211|Mitosis Modulators|mitosis modulators|mesh-ancestor
153440838|NCT00003211|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
153440839|NCT00003211|Protective Agents|protective agents|mesh-ancestor
153440840|NCT00003805|Vancomycin|vancomycin|mesh-list
153440841|NCT00003805|Tazobactam|tazobactam|mesh-list
153440842|NCT00003805|Piperacillin|piperacillin|mesh-list
153440843|NCT00003805|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
153440844|NCT00003805|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153440845|NCT00003805|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153440846|NCT00003805|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
153440847|NCT00003805|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153440848|NCT00003805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153440849|NCT00004159|Paclitaxel|paclitaxel|mesh-list
153440850|NCT00004159|Gemcitabine|gemcitabine|mesh-list
153440883|NCT00003817|Antiemetics|antiemetics|mesh-ancestor
153440884|NCT00003817|Autonomic Agents|autonomic agents|mesh-ancestor
153440885|NCT00003817|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153440886|NCT00003817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153440887|NCT00003817|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153440888|NCT00003817|Antipruritics|antipruritics|mesh-ancestor
153440889|NCT00003817|Dermatologic Agents|dermatologic agents|mesh-ancestor
153440890|NCT00003817|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
153440891|NCT00003817|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153889547|NCT00637663|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153889548|NCT00637663|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153889549|NCT00637663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153889550|NCT00637663|Antiviral Agents|antiviral agents|mesh-ancestor
153889551|NCT00637663|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153889552|NCT00637663|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153889553|NCT00637663|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153430670|NCT04828057|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153430671|NCT04828057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153440892|NCT00003817|Serotonin Agents|serotonin agents|mesh-ancestor
153440893|NCT00003817|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153440894|NCT00003817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153440930|NCT00003217|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153440931|NCT00003217|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153440932|NCT00003217|Alkylating Agents|alkylating agents|mesh-ancestor
153440934|NCT00003217|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153440935|NCT00003217|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153440936|NCT00003217|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153440937|NCT00003217|Antiemetics|antiemetics|mesh-ancestor
153440985|NCT00003835|Irinotecan|irinotecan|mesh-list
153440986|NCT00003835|Calcium|calcium|mesh-list
153440987|NCT00003835|Levoleucovorin|levoleucovorin|mesh-list
153440988|NCT00003835|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153440989|NCT00003835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153440990|NCT00003835|Antimetabolites|antimetabolites|mesh-ancestor
153440991|NCT00003835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153440992|NCT00003835|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153783665|NCT00269334|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153440993|NCT00003835|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153440994|NCT00003835|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153440995|NCT00003835|Immunologic Factors|immunologic factors|mesh-ancestor
153440996|NCT00003835|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
153440997|NCT00003835|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153440998|NCT00003835|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153440999|NCT00003835|Antidotes|antidotes|mesh-ancestor
153441241|NCT00004255|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
153441242|NCT00004255|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153441243|NCT00004255|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153441245|NCT00004255|Autonomic Agents|autonomic agents|mesh-ancestor
153441246|NCT00004255|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153441247|NCT00004255|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153441248|NCT00004255|Glucocorticoids|glucocorticoids|mesh-ancestor
153441249|NCT00004255|Hormones|hormones|mesh-ancestor
153441250|NCT00004255|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153441282|NCT00004855|Nevirapine|nevirapine|mesh-list
153441283|NCT00004855|Abacavir|abacavir|mesh-list
153441284|NCT00004855|Stavudine|stavudine|mesh-list
153441285|NCT00004855|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
153441287|NCT00004855|Protease Inhibitors|protease inhibitors|mesh-ancestor
153441288|NCT00004855|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153441291|NCT00004855|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153441566|NCT00004999|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
153441605|NCT00004381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153441607|NCT00005005|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153430672|NCT04828057|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153441611|NCT00004393|Serotonin Agents|serotonin agents|mesh-ancestor
153441612|NCT00004393|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153441613|NCT00004393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153441614|NCT00004393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153441615|NCT00004393|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153783666|NCT00269334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153441616|NCT00004393|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153441617|NCT00004393|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153441618|NCT00004393|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153441619|NCT00004393|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
153441620|NCT00004393|Dopamine Agents|dopamine agents|mesh-ancestor
153441621|NCT00004399|Magnesium Sulfate|magnesium sulfate|mesh-list
153441622|NCT00004399|Nimodipine|nimodipine|mesh-list
153441623|NCT00004399|Analgesics|analgesics|mesh-ancestor
153441624|NCT00004399|Sensory System Agents|sensory system agents|mesh-ancestor
153441625|NCT00004399|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153441626|NCT00004399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153441627|NCT00004399|Anesthetics|anesthetics|mesh-ancestor
153441628|NCT00004399|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153441629|NCT00004399|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153441630|NCT00004399|Anticonvulsants|anticonvulsants|mesh-ancestor
153441631|NCT00004399|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153441874|NCT00005113|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
153441875|NCT00005113|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153441876|NCT00005113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153441877|NCT00005113|Antifungal Agents|antifungal agents|mesh-ancestor
153441878|NCT00005113|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153441879|NCT00005113|Dermatologic Agents|dermatologic agents|mesh-ancestor
153441880|NCT00005113|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153441881|NCT00005113|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153442099|NCT00004825|Mitogens|mitogens|mesh-list
153442100|NCT00004825|Mecasermin|mecasermin|mesh-list
153442101|NCT00004825|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153442102|NCT00004825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153442103|NCT00004825|Mitosis Modulators|mitosis modulators|mesh-ancestor
153442104|NCT00004825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153442105|NCT00004825|Growth Substances|growth substances|mesh-ancestor
153442106|NCT00385645|Atazanavir Sulfate|atazanavir sulfate|mesh-list
153442107|NCT00385645|Lamivudine, zidovudine drug combination|lamivudine, zidovudine drug combination|mesh-list
153442108|NCT00385645|Zidovudine|zidovudine|mesh-list
153442109|NCT00385645|Lamivudine|lamivudine|mesh-list
153442110|NCT00385645|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
153442111|NCT00385645|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
153442112|NCT00385645|Protease Inhibitors|protease inhibitors|mesh-ancestor
153442113|NCT00385645|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153442165|NCT00005791|Immunologic Factors|immunologic factors|mesh-ancestor
153442166|NCT00005791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153442167|NCT00005791|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
153442168|NCT00005791|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153442169|NCT00005791|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153442170|NCT00005797|Cyclophosphamide|cyclophosphamide|mesh-list
153442172|NCT00005797|Etoposide|etoposide|mesh-list
153442173|NCT00005797|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153442328|NCT02100696|Etrolizumab|etrolizumab|mesh-list
153442329|NCT02100696|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153442330|NCT02100696|Immunologic Factors|immunologic factors|mesh-ancestor
153442331|NCT02100696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153442332|NCT02123472|Cephalexin|cephalexin|mesh-list
153442333|NCT02123472|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153442334|NCT02123472|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153442335|NCT02145078|Gemcitabine|gemcitabine|mesh-list
153442336|NCT02145078|Docetaxel|docetaxel|mesh-list
153442337|NCT02145078|Pemetrexed|pemetrexed|mesh-list
153442338|NCT02145078|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153442342|NCT02145078|Tubulin Modulators|tubulin modulators|mesh-ancestor
153442343|NCT02145078|Antimitotic Agents|antimitotic agents|mesh-ancestor
153442344|NCT02145078|Mitosis Modulators|mitosis modulators|mesh-ancestor
153442345|NCT02145078|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153442347|NCT02145078|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153442348|NCT02100228|Vitamin K|vitamin k|mesh-list
153442349|NCT02100228|Heparin|heparin|mesh-list
153442387|NCT02122770|Docetaxel|docetaxel|mesh-list
153442388|NCT02122770|Carboplatin|carboplatin|mesh-list
153442389|NCT02122770|Pevonedistat|pevonedistat|mesh-list
153442390|NCT02122770|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153442391|NCT02122770|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153442392|NCT02122770|Tubulin Modulators|tubulin modulators|mesh-ancestor
153442393|NCT02122770|Antimitotic Agents|antimitotic agents|mesh-ancestor
153442394|NCT02122770|Mitosis Modulators|mitosis modulators|mesh-ancestor
153442458|NCT01627860|Anticonvulsants|anticonvulsants|mesh-ancestor
153442459|NCT01627860|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153442460|NCT01627860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153442461|NCT01627782|Ketamine|ketamine|mesh-list
153442462|NCT01627782|Analgesics|analgesics|mesh-ancestor
153442487|NCT02119416|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
153442488|NCT02119416|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
153442489|NCT02119416|Purinergic Agents|purinergic agents|mesh-ancestor
153442490|NCT02119416|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153442491|NCT02140164|Minocycline|minocycline|mesh-list
153442492|NCT02140164|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153442493|NCT02140164|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153442494|NCT02119260|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
153442495|NCT02119104|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
153442496|NCT02119104|Immunologic Factors|immunologic factors|mesh-ancestor
153442497|NCT02119104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153442498|NCT02119026|Bevacizumab|bevacizumab|mesh-list
153442499|NCT02119026|Capecitabine|capecitabine|mesh-list
153442500|NCT02119026|Oxaliplatin|oxaliplatin|mesh-list
153442502|NCT02119026|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153442503|NCT02119026|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153442504|NCT02119026|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153442505|NCT02119026|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153442506|NCT02119026|Growth Substances|growth substances|mesh-ancestor
153442507|NCT02119026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153442508|NCT02119026|Growth Inhibitors|growth inhibitors|mesh-ancestor
153442509|NCT02119026|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153442510|NCT02119026|Antimetabolites|antimetabolites|mesh-ancestor
153442665|NCT04730856|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153442666|NCT04730856|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153442667|NCT04730856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153442668|NCT02114892|Resveratrol|resveratrol|mesh-list
153442669|NCT02114892|Antioxidants|antioxidants|mesh-ancestor
153442670|NCT02114892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153442671|NCT02114892|Protective Agents|protective agents|mesh-ancestor
153442672|NCT02114892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153442673|NCT02114892|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153442674|NCT02114892|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153442675|NCT02070744|Ivacaftor|ivacaftor|mesh-list
153442676|NCT02070744|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
153442677|NCT02070744|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153442678|NCT02070744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153442679|NCT04741698|Propranolol|propranolol|mesh-list
153442680|NCT04741698|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
153442681|NCT04741698|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
153442682|NCT04741698|Adrenergic Agents|adrenergic agents|mesh-ancestor
153442745|NCT02083926|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
153442746|NCT02083926|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153442747|NCT02083926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153442750|NCT02083380|Antimalarials|antimalarials|mesh-ancestor
153442751|NCT02083380|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153442752|NCT02083380|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153442851|NCT02064816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153442852|NCT02064816|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153442853|NCT02064816|Antiviral Agents|antiviral agents|mesh-ancestor
153442854|NCT02064816|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153442967|NCT02043366|Flurbiprofen|flurbiprofen|mesh-list
153442992|NCT02043366|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
153442994|NCT02060370|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153442995|NCT02060370|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153442996|NCT02060370|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153442997|NCT02060370|Growth Substances|growth substances|mesh-ancestor
153442998|NCT02060370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153442999|NCT02060370|Growth Inhibitors|growth inhibitors|mesh-ancestor
153443000|NCT02060370|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153443001|NCT02060370|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153443002|NCT02060370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153443003|NCT01622088|Pramipexole|pramipexole|mesh-list
153443004|NCT01622088|Dexpramipexole|dexpramipexole|mesh-list
153443005|NCT01622088|Antioxidants|antioxidants|mesh-ancestor
153443006|NCT01622088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153443007|NCT01622088|Protective Agents|protective agents|mesh-ancestor
153443008|NCT01622088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153443009|NCT01622088|Dopamine Agents|dopamine agents|mesh-ancestor
153443010|NCT01622088|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153443011|NCT01622088|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
153443012|NCT01622088|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
153443013|NCT01622088|Dopamine Agonists|dopamine agonists|mesh-ancestor
153443014|NCT02021292|Macitentan|macitentan|mesh-list
153443015|NCT02021292|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
153443099|NCT02039778|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153443101|NCT02015676|Trastuzumab|trastuzumab|mesh-list
153443102|NCT02015676|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153443103|NCT02015676|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153443104|NCT02015676|Tubulin Modulators|tubulin modulators|mesh-ancestor
153443563|NCT01989546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153443564|NCT01989546|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153443565|NCT01989468|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
153443566|NCT01989468|Immunologic Factors|immunologic factors|mesh-ancestor
153443576|NCT01965834|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153443577|NCT01965834|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153443578|NCT01996332|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
153443588|NCT01964898|Nicotine|nicotine|mesh-list
153443853|NCT01980888|Alkylating Agents|alkylating agents|mesh-ancestor
153443854|NCT01980888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153443855|NCT01980888|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153443856|NCT04650282|Lidocaine|lidocaine|mesh-list
153444104|NCT03888755|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153444105|NCT03888755|Bradykinin B2 Receptor Antagonists|bradykinin b2 receptor antagonists|mesh-ancestor
153444106|NCT03888755|Bradykinin Receptor Antagonists|bradykinin receptor antagonists|mesh-ancestor
153444107|NCT03888755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153444108|NCT03888755|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
153444109|NCT03888755|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153444110|NCT03888755|Immunologic Factors|immunologic factors|mesh-ancestor
153444112|NCT00378755|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153444114|NCT00378833|Niacinamide|niacinamide|mesh-list
153444115|NCT00378833|Nicotinic Acids|nicotinic acids|mesh-list
153444116|NCT00378833|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153444117|NCT00378833|Antimetabolites|antimetabolites|mesh-ancestor
153444118|NCT00378833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153444119|NCT00378833|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153444120|NCT00378833|Vasodilator Agents|vasodilator agents|mesh-ancestor
153444121|NCT00378833|Vitamin B Complex|vitamin b complex|mesh-ancestor
153444122|NCT00378833|Vitamins|vitamins|mesh-ancestor
153444123|NCT00378833|Micronutrients|micronutrients|mesh-ancestor
153444124|NCT00378833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153444125|NCT02995967|Botulinum Toxins|botulinum toxins|mesh-list
153444126|NCT02995967|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
153444127|NCT02995967|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
153444128|NCT02995967|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
153444129|NCT02995967|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153444130|NCT02995967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153444358|NCT02687165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153444359|NCT02687165|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153444360|NCT02687165|Analgesics|analgesics|mesh-ancestor
153444361|NCT02687165|Sensory System Agents|sensory system agents|mesh-ancestor
153444369|NCT01169753|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
153444370|NCT01169753|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
153444371|NCT01169753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153444400|NCT01133639|Ketorolac|ketorolac|mesh-list
153444401|NCT01133639|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153444402|NCT01133639|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153444403|NCT01133639|Analgesics|analgesics|mesh-ancestor
153430699|NCT00655057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153430700|NCT00655057|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153444404|NCT01133639|Sensory System Agents|sensory system agents|mesh-ancestor
153444405|NCT01133639|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153444406|NCT01133639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153444407|NCT01133639|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153444619|NCT00920309|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153444620|NCT00920309|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153444621|NCT00920309|Antifungal Agents|antifungal agents|mesh-ancestor
153444622|NCT00920309|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153444623|NCT00920309|Immunologic Factors|immunologic factors|mesh-ancestor
153444624|NCT00920309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153444625|NCT02075411|Bupivacaine|bupivacaine|mesh-list
153444626|NCT02075411|Anesthetics, Local|anesthetics, local|mesh-ancestor
153444627|NCT02075411|Anesthetics|anesthetics|mesh-ancestor
153444628|NCT02075411|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153444629|NCT02075411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153444630|NCT02075411|Sensory System Agents|sensory system agents|mesh-ancestor
153444631|NCT02075411|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153444632|NCT03753113|Minoxidil|minoxidil|mesh-list
153444633|NCT03753113|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153444634|NCT03753113|Vasodilator Agents|vasodilator agents|mesh-ancestor
153444656|NCT00378677|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153444657|NCT00378677|Immunologic Factors|immunologic factors|mesh-ancestor
153444658|NCT00378677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153444659|NCT00378677|Antifungal Agents|antifungal agents|mesh-ancestor
153444660|NCT00378677|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153444661|NCT00378677|Dermatologic Agents|dermatologic agents|mesh-ancestor
153444662|NCT00378677|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153444663|NCT00378677|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
153444664|NCT00850421|Botulinum Toxins|botulinum toxins|mesh-list
153444665|NCT00850421|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
153444674|NCT00850421|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153444675|NCT02017379|Erythromycin|erythromycin|mesh-list
153444676|NCT02017379|Erythromycin Estolate|erythromycin estolate|mesh-list
153444677|NCT02017379|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
153444678|NCT02017379|Erythromycin stearate|erythromycin stearate|mesh-list
153444679|NCT02017379|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153444680|NCT02017379|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153444681|NCT02017379|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153444682|NCT02017379|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
153444683|NCT02017379|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153444684|NCT02017379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153444685|NCT01997567|Ropivacaine|ropivacaine|mesh-list
153783670|NCT00269334|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
153444686|NCT01997567|Anesthetics, Local|anesthetics, local|mesh-ancestor
153444688|NCT01997567|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153444689|NCT01997567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153444690|NCT01997567|Sensory System Agents|sensory system agents|mesh-ancestor
153444691|NCT01997567|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153444692|NCT00825227|Modafinil|modafinil|mesh-list
153444693|NCT00825227|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
153444694|NCT00825227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153445419|NCT00000881|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153445420|NCT00000881|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153445421|NCT00000881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153445422|NCT00000887|Lamivudine|lamivudine|mesh-list
153445423|NCT00000887|Zidovudine|zidovudine|mesh-list
153445424|NCT00000887|Nelfinavir|nelfinavir|mesh-list
153445425|NCT00000887|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153446135|NCT00001991|Atovaquone|atovaquone|mesh-list
153446148|NCT00001997|Sensory System Agents|sensory system agents|mesh-ancestor
153446149|NCT00001997|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153446150|NCT00001997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153446151|NCT00001997|Antimetabolites|antimetabolites|mesh-ancestor
153446152|NCT00001997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153446153|NCT00001997|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153446154|NCT00001997|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153446155|NCT00001997|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153446156|NCT00001997|Antiviral Agents|antiviral agents|mesh-ancestor
153446157|NCT00001997|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153446158|NCT00001997|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153446159|NCT00001997|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153446160|NCT00002003|Etoposide|etoposide|mesh-list
153446161|NCT00002003|Mitoxantrone|mitoxantrone|mesh-list
153446162|NCT00002003|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153446163|NCT00002003|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153446164|NCT00002003|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153446167|NCT00002003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153446169|NCT00002003|Sensory System Agents|sensory system agents|mesh-ancestor
153446170|NCT00002003|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153446171|NCT00002003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153446199|NCT00000647|Antiviral Agents|antiviral agents|mesh-ancestor
153446200|NCT00000647|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153446201|NCT00000647|Immunologic Factors|immunologic factors|mesh-ancestor
153446202|NCT00000647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153446203|NCT00000647|Antimetabolites|antimetabolites|mesh-ancestor
153446204|NCT00000647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153446205|NCT00000647|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153446206|NCT00000647|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153446214|NCT00000653|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153446215|NCT00000653|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153446216|NCT00000653|Antiviral Agents|antiviral agents|mesh-ancestor
153446217|NCT00000653|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153446218|NCT00000653|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153446219|NCT00000653|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153446220|NCT00001409|Interleukin-2|interleukin-2|mesh-list
153446221|NCT00001409|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153446471|NCT00002093|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153446473|NCT00002093|Antimitotic Agents|antimitotic agents|mesh-ancestor
153446474|NCT00002093|Mitosis Modulators|mitosis modulators|mesh-ancestor
153446475|NCT00002099|Didanosine|didanosine|mesh-list
153446476|NCT00002099|Lentinan|lentinan|mesh-list
153446477|NCT00002099|Antimetabolites|antimetabolites|mesh-ancestor
153783671|NCT00269334|Antidepressive Agents|antidepressive agents|mesh-ancestor
153783672|NCT00269334|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153446478|NCT00002099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153446479|NCT00002099|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153446480|NCT00002099|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153446481|NCT00002099|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153446482|NCT00002099|Antiviral Agents|antiviral agents|mesh-ancestor
153446483|NCT00002099|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153446484|NCT00002099|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153446485|NCT00002099|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153446821|NCT00002435|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153446822|NCT00002435|Antiviral Agents|antiviral agents|mesh-ancestor
153446823|NCT00002435|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153446824|NCT00002435|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153446827|NCT00002447|Saquinavir|saquinavir|mesh-list
153446828|NCT00002447|Efavirenz|efavirenz|mesh-list
153446829|NCT00002447|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
153446830|NCT00002447|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
153446831|NCT00002447|Protease Inhibitors|protease inhibitors|mesh-ancestor
153446832|NCT00002447|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153446833|NCT00002447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153446834|NCT00002447|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153446835|NCT00002447|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153446836|NCT00002447|Antiviral Agents|antiviral agents|mesh-ancestor
153446837|NCT00002447|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153446838|NCT00002447|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
153446839|NCT00002447|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153446840|NCT00002447|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153446841|NCT00002447|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153446842|NCT00002447|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
153446843|NCT00002447|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
153446844|NCT00002447|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
153889570|NCT01016977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153889572|NCT02871661|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
153889573|NCT02871661|Antidepressive Agents|antidepressive agents|mesh-ancestor
153889574|NCT02871661|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153446849|NCT00002453|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153446850|NCT00002453|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153446851|NCT00002453|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153446852|NCT00002453|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153447003|NCT00002501|Immunologic Factors|immunologic factors|mesh-ancestor
153447004|NCT00002501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153447007|NCT00002501|Alkylating Agents|alkylating agents|mesh-ancestor
153447019|NCT00002159|Itraconazole|itraconazole|mesh-list
153447020|NCT00002159|Amphotericin B|amphotericin b|mesh-list
153447021|NCT00002159|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
153447022|NCT00002159|Antifungal Agents|antifungal agents|mesh-ancestor
153447023|NCT00002159|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153447024|NCT00002159|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
153889575|NCT02871661|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153889576|NCT02871661|Analgesics|analgesics|mesh-ancestor
153889577|NCT02871661|Sensory System Agents|sensory system agents|mesh-ancestor
153447025|NCT00002159|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153447026|NCT00002159|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153447027|NCT00002159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153447028|NCT00002159|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153447029|NCT00002159|Hormone Antagonists|hormone antagonists|mesh-ancestor
153447030|NCT00002159|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153447031|NCT00002159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153447185|NCT00002225|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
153783673|NCT00269334|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
153447186|NCT00002225|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
153447187|NCT00002225|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
153447188|NCT00002225|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
153447189|NCT00002225|Antimetabolites|antimetabolites|mesh-ancestor
153447190|NCT00002225|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153447191|NCT00002225|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153447192|NCT00002243|Calanolide A|calanolide a|mesh-list
153447193|NCT00002243|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153447194|NCT00002243|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153447195|NCT00002243|Antiviral Agents|antiviral agents|mesh-ancestor
153447196|NCT00002243|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153447197|NCT00002249|Levofloxacin|levofloxacin|mesh-list
153889580|NCT02871661|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
153889590|NCT01012765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153889591|NCT01012765|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153889592|NCT01012765|Respiratory System Agents|respiratory system agents|mesh-ancestor
153448319|NCT00003035|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153448321|NCT00003041|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153448322|NCT00003053|Etoposide|etoposide|mesh-list
153448323|NCT00003053|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153448324|NCT00003053|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153448325|NCT00003053|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153449132|NCT00003995|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153449486|NCT00003281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153450097|NCT00004733|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153450098|NCT00004733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153450099|NCT00004733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153450100|NCT00004739|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
153450102|NCT00004739|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153450103|NCT00005057|Ganciclovir|ganciclovir|mesh-list
153450104|NCT00005057|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
153450105|NCT00005057|Antiviral Agents|antiviral agents|mesh-ancestor
153450106|NCT00005057|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153450107|NCT00005057|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153450108|NCT00005057|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153450109|NCT00005057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153450110|NCT00004757|Acyclovir|acyclovir|mesh-list
153450111|NCT00004757|Antiviral Agents|antiviral agents|mesh-ancestor
153889593|NCT01012765|Parasympatholytics|parasympatholytics|mesh-ancestor
153889594|NCT01012765|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
153889595|NCT01012765|Cholinergic Agents|cholinergic agents|mesh-ancestor
153889596|NCT01012765|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153889597|NCT01012765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153889598|NCT00628459|Micronutrients|micronutrients|mesh-list
153889599|NCT00628459|Trace Elements|trace elements|mesh-list
153889600|NCT00628459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153889601|NCT00627913|Anesthetics|anesthetics|mesh-list
153889602|NCT00627913|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153889603|NCT00627913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153889604|NCT00627991|Valsartan|valsartan|mesh-list
153430724|NCT00000217|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153430725|NCT00000217|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153430726|NCT00000217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153450112|NCT00004757|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153430727|NCT00000217|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153430728|NCT00000217|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153450113|NCT00005069|Arsenic Trioxide|arsenic trioxide|mesh-list
153450114|NCT00005069|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153450204|NCT00385385|KRM 1648|krm 1648|mesh-list
153430730|NCT00000217|Sensory System Agents|sensory system agents|mesh-ancestor
153430738|NCT00000223|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153430739|NCT00000223|Narcotics|narcotics|mesh-ancestor
153450365|NCT00005615|Interferon-alpha|interferon-alpha|mesh-list
153450366|NCT00005615|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153450367|NCT00005615|Antiviral Agents|antiviral agents|mesh-ancestor
153450368|NCT00005615|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153450369|NCT00005615|Immunologic Factors|immunologic factors|mesh-ancestor
153450370|NCT00005615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153450371|NCT00005627|Carboplatin|carboplatin|mesh-list
153450373|NCT00005627|Estramustine|estramustine|mesh-list
153450374|NCT00005627|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153450375|NCT00005627|Tubulin Modulators|tubulin modulators|mesh-ancestor
153450376|NCT00005627|Antimitotic Agents|antimitotic agents|mesh-ancestor
153450377|NCT00005627|Mitosis Modulators|mitosis modulators|mesh-ancestor
153450378|NCT00005627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153450379|NCT00005627|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153450380|NCT00005627|Alkylating Agents|alkylating agents|mesh-ancestor
153450381|NCT00005627|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153450382|NCT00005639|Azacitidine|azacitidine|mesh-list
153430740|NCT00000223|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153430741|NCT00000223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153450383|NCT00005639|4-phenylbutyric acid|4-phenylbutyric acid|mesh-list
153450384|NCT00005639|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153450415|NCT00005777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153450416|NCT00005777|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153450418|NCT00005777|Hormones|hormones|mesh-ancestor
153450419|NCT00005777|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153450420|NCT00005777|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153450421|NCT00005777|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153450422|NCT00385931|Valsartan|valsartan|mesh-list
153450581|NCT05885230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153450614|NCT05727098|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
153450615|NCT05727098|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153450616|NCT05727098|Anesthetics, General|anesthetics, general|mesh-ancestor
153889608|NCT00627991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153889610|NCT01006291|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
153889611|NCT01006291|Insulin Glargine|insulin glargine|mesh-list
153889612|NCT01006291|Insulin, Long-Acting|insulin, long-acting|mesh-list
153889613|NCT01006291|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153450729|NCT05249452|Hydroxyurea|hydroxyurea|mesh-list
153450730|NCT05249452|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153450731|NCT05249452|Antisickling Agents|antisickling agents|mesh-ancestor
153450732|NCT05249452|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153450882|NCT04666272|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153889614|NCT01006291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153889615|NCT02871349|Propranolol|propranolol|mesh-list
153889616|NCT02871349|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
153889617|NCT02871349|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
153889618|NCT02871349|Adrenergic Agents|adrenergic agents|mesh-ancestor
153889619|NCT02871349|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153889620|NCT02871349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153889621|NCT02871349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153889622|NCT02871349|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153889623|NCT02871349|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153430746|NCT00000229|Buprenorphine|buprenorphine|mesh-list
153450883|NCT04666272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153450884|NCT04649060|Dexamethasone|dexamethasone|mesh-list
153450885|NCT04649060|Melphalan|melphalan|mesh-list
153450886|NCT04649060|Daratumumab|daratumumab|mesh-list
153450887|NCT04649060|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153450888|NCT04649060|Antiemetics|antiemetics|mesh-ancestor
153450889|NCT04649060|Autonomic Agents|autonomic agents|mesh-ancestor
153450890|NCT04649060|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153450891|NCT04649060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153450893|NCT04649060|Glucocorticoids|glucocorticoids|mesh-ancestor
153450894|NCT04649060|Hormones|hormones|mesh-ancestor
153450895|NCT04649060|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153450896|NCT04649060|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153450897|NCT04649060|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153450909|NCT04608487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153450910|NCT04608487|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153450911|NCT04608487|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153450912|NCT04608487|Alkylating Agents|alkylating agents|mesh-ancestor
153450913|NCT04608487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153451121|NCT03864042|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153451122|NCT03864042|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153451123|NCT03864042|Dopamine Agents|dopamine agents|mesh-ancestor
153451124|NCT03864042|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
153451125|NCT03864042|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153451126|NCT03864042|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
153451127|NCT03864042|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
153451128|NCT03864042|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
153451129|NCT03864042|Antitussive Agents|antitussive agents|mesh-ancestor
153451130|NCT03864042|Respiratory System Agents|respiratory system agents|mesh-ancestor
153451131|NCT03864042|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
153451244|NCT02246920|Fluticasone|fluticasone|mesh-list
153451246|NCT02246920|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153451247|NCT02246920|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153451248|NCT02246920|Autonomic Agents|autonomic agents|mesh-ancestor
153451249|NCT02246920|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153451250|NCT02246920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153451251|NCT02246920|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153451252|NCT02246920|Respiratory System Agents|respiratory system agents|mesh-ancestor
153451253|NCT02246920|Dermatologic Agents|dermatologic agents|mesh-ancestor
153451254|NCT02246920|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
153451255|NCT01832402|Fentanyl|fentanyl|mesh-list
153451256|NCT01832402|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153451257|NCT01832402|Narcotics|narcotics|mesh-ancestor
153451258|NCT01832402|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153451259|NCT01832402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153451260|NCT01832402|Analgesics|analgesics|mesh-ancestor
153451261|NCT01832402|Sensory System Agents|sensory system agents|mesh-ancestor
153451262|NCT01832402|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153451263|NCT01832402|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153451369|NCT00003683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153451370|NCT00003683|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153451371|NCT00003683|Alkylating Agents|alkylating agents|mesh-ancestor
153451372|NCT00003707|Gemcitabine|gemcitabine|mesh-list
153451373|NCT00003707|Tipifarnib|tipifarnib|mesh-list
153451374|NCT00003707|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153451465|NCT00003815|Hormones|hormones|mesh-ancestor
153451466|NCT00003815|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153451467|NCT00003815|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153451468|NCT00003821|Aminopterin|aminopterin|mesh-list
153451469|NCT00003821|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153451470|NCT00003821|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153451471|NCT00003821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153451472|NCT00003827|Cytarabine|cytarabine|mesh-list
153451473|NCT00003827|Topotecan|topotecan|mesh-list
153451474|NCT00003827|Amifostine|amifostine|mesh-list
153451530|NCT00003893|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153451531|NCT00003893|Dermatologic Agents|dermatologic agents|mesh-ancestor
153451532|NCT00003893|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153451533|NCT00003893|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153451534|NCT00003893|Analgesics|analgesics|mesh-ancestor
153889625|NCT01012609|Irinotecan|irinotecan|mesh-list
153451547|NCT00003899|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153451548|NCT00003899|Immunologic Factors|immunologic factors|mesh-ancestor
153451549|NCT00003899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153451550|NCT00003899|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153451551|NCT00003899|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153451552|NCT00003899|Alkylating Agents|alkylating agents|mesh-ancestor
153451553|NCT00003899|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153451554|NCT00003917|Topotecan|topotecan|mesh-list
153451555|NCT00003917|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
153451556|NCT00003917|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153783674|NCT00269334|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153451558|NCT00003917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153451559|NCT00003917|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153451560|NCT00003923|Dihematoporphyrin Ether|dihematoporphyrin ether|mesh-list
153451898|NCT01912872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153451900|NCT01911780|Amlodipine|amlodipine|mesh-list
153451901|NCT01911780|Telmisartan|telmisartan|mesh-list
153451902|NCT01911780|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
153451903|NCT01911780|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153451904|NCT01911780|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153451905|NCT01911780|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153451906|NCT01911780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153451907|NCT01911780|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153451908|NCT01911780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153451909|NCT01911780|Vasodilator Agents|vasodilator agents|mesh-ancestor
153451910|NCT01911780|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
153451918|NCT01911546|Immunologic Factors|immunologic factors|mesh-ancestor
153451919|NCT01911546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153451920|NCT01911546|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
153451921|NCT01911546|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153451922|NCT01911546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153451923|NCT01911546|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
153451924|NCT01911546|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153451925|NCT01911546|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153451926|NCT01908816|Ranibizumab|ranibizumab|mesh-list
153451927|NCT01908816|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153451928|NCT01908816|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153451929|NCT01908816|Growth Substances|growth substances|mesh-ancestor
153451930|NCT01908816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153451931|NCT01908816|Growth Inhibitors|growth inhibitors|mesh-ancestor
153451932|NCT01908816|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153451933|NCT01908582|Rifampin|rifampin|mesh-list
153451935|NCT01908582|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
153451936|NCT01908582|Antitubercular Agents|antitubercular agents|mesh-ancestor
153451937|NCT01908582|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153889658|NCT01012219|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153889659|NCT01012219|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153889660|NCT01012219|Antimetabolites|antimetabolites|mesh-ancestor
153889661|NCT01012219|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153430782|NCT00000253|Analgesics|analgesics|mesh-ancestor
153430787|NCT00000259|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153451938|NCT01908582|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153430796|NCT00000259|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153452092|NCT01862250|Autonomic Agents|autonomic agents|mesh-ancestor
153452093|NCT01862250|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
153452094|NCT01862250|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153452095|NCT01862250|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153452154|NCT01873950|Quinidine gluconate|quinidine gluconate|mesh-list
153452155|NCT01873950|Verapamil|verapamil|mesh-list
153452156|NCT01873950|Dofetilide|dofetilide|mesh-list
153452157|NCT01873950|Ranolazine|ranolazine|mesh-list
153452158|NCT01873950|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153452159|NCT01873950|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153452160|NCT01873950|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153452161|NCT01873950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153430797|NCT00379405|Ritonavir|ritonavir|mesh-list
153430798|NCT00379405|Saquinavir|saquinavir|mesh-list
153452361|NCT01851330|Antiviral Agents|antiviral agents|mesh-ancestor
153452362|NCT01851330|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153452363|NCT01868022|Paclitaxel|paclitaxel|mesh-list
153452364|NCT01868022|Docetaxel|docetaxel|mesh-list
153452365|NCT01868022|Carboplatin|carboplatin|mesh-list
153452366|NCT01868022|Pemetrexed|pemetrexed|mesh-list
153452429|NCT04414956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153452430|NCT04414956|Hemostatics|hemostatics|mesh-ancestor
153452431|NCT04414956|Coagulants|coagulants|mesh-ancestor
153452432|NCT04414956|Immunologic Factors|immunologic factors|mesh-ancestor
153452433|NCT01848990|Insulin|insulin|mesh-list
153452434|NCT01848990|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
153452477|NCT01803282|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153452479|NCT01803282|Tubulin Modulators|tubulin modulators|mesh-ancestor
153452480|NCT01803282|Antimitotic Agents|antimitotic agents|mesh-ancestor
153452481|NCT01803282|Mitosis Modulators|mitosis modulators|mesh-ancestor
153452482|NCT01803282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153452483|NCT01803282|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153452485|NCT01803282|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153889662|NCT01012219|Vasodilator Agents|vasodilator agents|mesh-ancestor
153889663|NCT01012219|Vitamin B Complex|vitamin b complex|mesh-ancestor
153889664|NCT01012219|Vitamins|vitamins|mesh-ancestor
153889665|NCT01012219|Micronutrients|micronutrients|mesh-ancestor
153889666|NCT01011907|Varenicline|varenicline|mesh-list
153889667|NCT01011907|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
153889668|NCT01011907|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
153452651|NCT01794780|Formoterol Fumarate|formoterol fumarate|mesh-list
153452652|NCT01794780|Tiotropium Bromide|tiotropium bromide|mesh-list
153452653|NCT01794780|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
153452654|NCT01794780|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153452655|NCT01794780|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153452656|NCT01794780|Autonomic Agents|autonomic agents|mesh-ancestor
153452657|NCT01794780|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153452658|NCT01794780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153452659|NCT01794780|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153452660|NCT01794780|Respiratory System Agents|respiratory system agents|mesh-ancestor
153430807|NCT00379405|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153430808|NCT00379405|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
153430809|NCT00379405|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153430810|NCT00379483|Deferasirox|deferasirox|mesh-list
153452661|NCT01794780|Dermatologic Agents|dermatologic agents|mesh-ancestor
153452662|NCT01794780|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
153452663|NCT01794780|Glucocorticoids|glucocorticoids|mesh-ancestor
153783562|NCT00236483|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153383274|NCT01748942|Autonomic Agents|autonomic agents|mesh-ancestor
153383275|NCT01748942|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153383276|NCT01748942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153383277|NCT01748942|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153383278|NCT01748942|Glucocorticoids|glucocorticoids|mesh-ancestor
153383279|NCT01748942|Hormones|hormones|mesh-ancestor
153383280|NCT01748942|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153430811|NCT00379483|Iron Chelating Agents|iron chelating agents|mesh-ancestor
153430812|NCT00379483|Chelating Agents|chelating agents|mesh-ancestor
153430813|NCT00379483|Sequestering Agents|sequestering agents|mesh-ancestor
153452664|NCT01794780|Hormones|hormones|mesh-ancestor
153452729|NCT01818258|Lopinavir|lopinavir|mesh-list
153452730|NCT01818258|Lamivudine|lamivudine|mesh-list
153452731|NCT01818258|Zidovudine|zidovudine|mesh-list
153452732|NCT01818258|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
153430814|NCT00379483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153452734|NCT01818258|Protease Inhibitors|protease inhibitors|mesh-ancestor
153452769|NCT01792518|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153452770|NCT01792518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153452771|NCT01792518|Incretins|incretins|mesh-ancestor
153452772|NCT01792518|Hormones|hormones|mesh-ancestor
153452773|NCT01792518|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153452774|NCT01792518|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
153452775|NCT01792518|Protease Inhibitors|protease inhibitors|mesh-ancestor
153430815|NCT00607477|Minoxidil|minoxidil|mesh-list
153430816|NCT00607477|Hydralazine|hydralazine|mesh-list
153430817|NCT00607477|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153430818|NCT00607477|Vasodilator Agents|vasodilator agents|mesh-ancestor
153430819|NCT04423861|Nitazoxanide|nitazoxanide|mesh-list
153430820|NCT04423861|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153430821|NCT04423861|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153452776|NCT01792518|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153452777|NCT01792518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153452778|NCT01792284|Insulin|insulin|mesh-list
153452779|NCT01792284|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
153452780|NCT01792284|Insulin Lispro|insulin lispro|mesh-list
153452781|NCT01792284|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153452782|NCT01792284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153452783|NCT04414566|Cisplatin|cisplatin|mesh-list
153452784|NCT04414566|Gemcitabine|gemcitabine|mesh-list
153452785|NCT04414566|Docetaxel|docetaxel|mesh-list
153452786|NCT04414566|Fluorouracil|fluorouracil|mesh-list
153430822|NCT00000271|Desipramine|desipramine|mesh-list
153430823|NCT00000271|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
153430824|NCT00000271|Antidepressive Agents|antidepressive agents|mesh-ancestor
153430825|NCT00000271|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153452822|NCT01836276|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153452823|NCT01836276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153452824|NCT01836276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153452825|NCT01790568|Methotrexate|methotrexate|mesh-list
153452826|NCT01790568|Vorinostat|vorinostat|mesh-list
153452827|NCT01790568|Tacrolimus|tacrolimus|mesh-list
153452828|NCT01790568|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
153452829|NCT01790568|Abortifacient Agents|abortifacient agents|mesh-ancestor
153452830|NCT01790568|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153452831|NCT01790568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153452832|NCT01790568|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153452833|NCT01790568|Antimetabolites|antimetabolites|mesh-ancestor
153452836|NCT01790568|Dermatologic Agents|dermatologic agents|mesh-ancestor
153452837|NCT01790568|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153452838|NCT01790568|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153452839|NCT01790568|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153452840|NCT01790568|Immunologic Factors|immunologic factors|mesh-ancestor
153452904|NCT01606800|Antiviral Agents|antiviral agents|mesh-ancestor
153452905|NCT01606800|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153889685|NCT01011673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153889686|NCT01011673|Antiemetics|antiemetics|mesh-ancestor
153889687|NCT01011673|Autonomic Agents|autonomic agents|mesh-ancestor
153889688|NCT01011673|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153889689|NCT01011673|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
153452929|NCT01814046|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153452930|NCT01814046|Alkylating Agents|alkylating agents|mesh-ancestor
153452931|NCT01814046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153452932|NCT01814046|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153452933|NCT01814046|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153452934|NCT01814046|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153452935|NCT01814046|Analgesics|analgesics|mesh-ancestor
153452936|NCT01814046|Sensory System Agents|sensory system agents|mesh-ancestor
153452937|NCT01814046|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153452938|NCT01814046|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153452939|NCT01814046|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153452940|NCT01814046|Antiviral Agents|antiviral agents|mesh-ancestor
153452941|NCT01814046|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153452942|NCT01813890|Tapentadol|tapentadol|mesh-list
153452943|NCT01813890|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153452944|NCT01813890|Narcotics|narcotics|mesh-ancestor
153452945|NCT01813890|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153452946|NCT01813890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153452947|NCT01813890|Analgesics|analgesics|mesh-ancestor
153452948|NCT01813890|Sensory System Agents|sensory system agents|mesh-ancestor
153452949|NCT01813890|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153452950|NCT01813890|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
153452951|NCT01813890|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153452952|NCT01813890|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153452953|NCT01813890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153452954|NCT01813890|Adrenergic Agents|adrenergic agents|mesh-ancestor
153452955|NCT01813890|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153452956|NCT01813422|Evolocumab|evolocumab|mesh-list
153452957|NCT01813422|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
153452958|NCT01813422|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153452959|NCT01813422|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153452960|NCT01813422|Antimetabolites|antimetabolites|mesh-ancestor
153452980|NCT01770912|Glucocorticoids|glucocorticoids|mesh-ancestor
153452981|NCT01770912|Hormones|hormones|mesh-ancestor
153889690|NCT01011673|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
153430833|NCT00000271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153452982|NCT01770912|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153452983|NCT01770912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153452984|NCT01770912|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153452985|NCT01770912|Immunologic Factors|immunologic factors|mesh-ancestor
153452986|NCT01770912|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153452987|NCT01770912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153452989|NCT01811706|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
153452990|NCT01811706|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153452991|NCT01811706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153452992|NCT01811238|Oxycodone|oxycodone|mesh-list
153452993|NCT01811238|Naloxone|naloxone|mesh-list
153452994|NCT01811238|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153452995|NCT01811238|Narcotics|narcotics|mesh-ancestor
153452996|NCT01811238|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153452997|NCT01811238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153452998|NCT01811238|Analgesics|analgesics|mesh-ancestor
153452999|NCT01811238|Sensory System Agents|sensory system agents|mesh-ancestor
153453000|NCT01811238|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153453001|NCT01811238|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
153453002|NCT01769508|Fluorouracil|fluorouracil|mesh-list
153453003|NCT01769508|Oxaliplatin|oxaliplatin|mesh-list
153453004|NCT01769508|Lapatinib|lapatinib|mesh-list
153453005|NCT01769508|Antimetabolites|antimetabolites|mesh-ancestor
153453007|NCT01769508|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153453008|NCT01769508|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153453009|NCT01769508|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153453010|NCT01769508|Immunologic Factors|immunologic factors|mesh-ancestor
153783678|NCT04541251|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153783679|NCT04541251|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153453011|NCT01769508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153453012|NCT01769508|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153453013|NCT01769508|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153453070|NCT01768572|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153453071|NCT01768572|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153453073|NCT01783548|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153453074|NCT01783548|Glucocorticoids|glucocorticoids|mesh-ancestor
153453075|NCT01783548|Hormones|hormones|mesh-ancestor
153453076|NCT01783548|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153453077|NCT01783548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153453078|NCT01783548|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153453079|NCT01783548|Respiratory System Agents|respiratory system agents|mesh-ancestor
153453080|NCT01809210|Carboplatin|carboplatin|mesh-list
153453081|NCT01809210|Gemcitabine|gemcitabine|mesh-list
153453082|NCT01809210|Pemetrexed|pemetrexed|mesh-list
153453083|NCT01809210|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153453084|NCT01809210|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153453085|NCT01809210|Antimetabolites|antimetabolites|mesh-ancestor
153453086|NCT01809210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153453087|NCT01809210|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153453088|NCT01809210|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153453089|NCT01809210|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153453090|NCT01809132|Zinc|zinc|mesh-list
153453091|NCT01809132|Methylprednisolone|methylprednisolone|mesh-list
153453092|NCT01809132|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
153430837|NCT00000277|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
153430838|NCT00000277|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153453141|NCT01808196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153453142|NCT01808196|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
153453144|NCT01808118|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
153453145|NCT01808118|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153453146|NCT01808118|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153453147|NCT01782690|Gemcitabine|gemcitabine|mesh-list
153453175|NCT01807182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153453176|NCT01807182|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153453177|NCT01807182|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153453178|NCT01807182|Alkylating Agents|alkylating agents|mesh-ancestor
153453179|NCT01807182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153453180|NCT01807182|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153453181|NCT01807182|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153453182|NCT01807182|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153453183|NCT01807182|Antimetabolites|antimetabolites|mesh-ancestor
153453184|NCT01807182|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153453185|NCT01807182|Analgesics|analgesics|mesh-ancestor
153453186|NCT01807182|Sensory System Agents|sensory system agents|mesh-ancestor
153453187|NCT01807182|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153453189|NCT01807182|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153453190|NCT01807182|Antiviral Agents|antiviral agents|mesh-ancestor
153453191|NCT01807182|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153453192|NCT01765764|Bimatoprost|bimatoprost|mesh-list
153453193|NCT01765764|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
153453194|NCT01765764|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153453196|NCT01780974|Antioxidants|antioxidants|mesh-ancestor
153453197|NCT01780974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153453233|NCT01762800|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153453234|NCT01762800|Respiratory System Agents|respiratory system agents|mesh-ancestor
153453235|NCT01762800|Dermatologic Agents|dermatologic agents|mesh-ancestor
153453236|NCT01762800|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
153453237|NCT01762800|Parasympatholytics|parasympatholytics|mesh-ancestor
153889705|NCT02871193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153889706|NCT02871193|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153889707|NCT02871193|Glucocorticoids|glucocorticoids|mesh-ancestor
153889708|NCT02871193|Hormones|hormones|mesh-ancestor
153889709|NCT02871193|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153889710|NCT02871193|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153889713|NCT02871193|Anesthetics|anesthetics|mesh-ancestor
153889714|NCT02871193|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153889715|NCT02871193|Sensory System Agents|sensory system agents|mesh-ancestor
153889716|NCT01310868|Carmustine|carmustine|mesh-list
153889717|NCT01310868|Aminolevulinic Acid|aminolevulinic acid|mesh-list
153889718|NCT01310868|Levulinic acid|levulinic acid|mesh-list
153889719|NCT01310868|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153889720|NCT01310868|Alkylating Agents|alkylating agents|mesh-ancestor
153889721|NCT01310868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153453256|NCT01778010|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
153453257|NCT01778010|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
153453258|NCT01778010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153453295|NCT01777542|Growth Substances|growth substances|mesh-ancestor
153453318|NCT01777152|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153453319|NCT01777152|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153453320|NCT01777152|Tubulin Modulators|tubulin modulators|mesh-ancestor
153453321|NCT01777152|Antimitotic Agents|antimitotic agents|mesh-ancestor
153453322|NCT01777152|Mitosis Modulators|mitosis modulators|mesh-ancestor
153453323|NCT01777152|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153453324|NCT01777152|Immunotoxins|immunotoxins|mesh-ancestor
153453325|NCT01777152|Immunoconjugates|immunoconjugates|mesh-ancestor
153453326|NCT01775124|Ranibizumab|ranibizumab|mesh-list
153453327|NCT01775124|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153453328|NCT01775124|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153453329|NCT01775124|Growth Substances|growth substances|mesh-ancestor
153453330|NCT01775124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153453331|NCT01775124|Growth Inhibitors|growth inhibitors|mesh-ancestor
153453332|NCT01775124|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153889722|NCT01310868|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153889723|NCT01310868|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
153889725|NCT01310868|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153889726|NCT01273155|Belinostat|belinostat|mesh-list
153889727|NCT01273155|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153430850|NCT00599131|Antimitotic Agents|antimitotic agents|mesh-ancestor
153430851|NCT00599131|Mitosis Modulators|mitosis modulators|mesh-ancestor
153430852|NCT00599131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153453386|NCT01732458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153453387|NCT01732458|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153453460|NCT01754376|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153453461|NCT01754376|Analgesics|analgesics|mesh-ancestor
153453462|NCT01754376|Sensory System Agents|sensory system agents|mesh-ancestor
153453463|NCT01754376|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153430857|NCT00599131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153430872|NCT00584935|Immunologic Factors|immunologic factors|mesh-ancestor
153430873|NCT00584935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153453476|NCT01605396|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153453526|NCT01706250|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153453527|NCT01706250|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153453529|NCT01706250|Sensory System Agents|sensory system agents|mesh-ancestor
153453530|NCT01706250|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153453531|NCT01706250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153453532|NCT01706250|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153453534|NCT01706250|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153453535|NCT01706250|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153430874|NCT00584935|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153430875|NCT00000289|Ondansetron|ondansetron|mesh-list
153430876|NCT00000289|Antiemetics|antiemetics|mesh-ancestor
153430877|NCT00000289|Autonomic Agents|autonomic agents|mesh-ancestor
153453584|NCT01751802|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
153453585|NCT01751802|Dopamine Agents|dopamine agents|mesh-ancestor
153889728|NCT01273155|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
153453586|NCT01751802|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153453587|NCT01751802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153453588|NCT01703286|Glimepiride|glimepiride|mesh-list
153453589|NCT01703286|Linagliptin|linagliptin|mesh-list
153453590|NCT01703286|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153453591|NCT01703286|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153453592|NCT01703286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153453628|NCT01725126|Liraglutide|liraglutide|mesh-list
153453630|NCT01725126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153453631|NCT01725126|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
153889729|NCT01273155|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153453671|NCT01751178|Dermatologic Agents|dermatologic agents|mesh-ancestor
153453672|NCT01606254|Paliperidone Palmitate|paliperidone palmitate|mesh-list
153453673|NCT01606254|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153453674|NCT01606254|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153453675|NCT01606254|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153453704|NCT01722162|Histamine Antagonists|histamine antagonists|mesh-ancestor
153453706|NCT01722162|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153453708|NCT01721772|Dacarbazine|dacarbazine|mesh-list
153453709|NCT01721772|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153453710|NCT01721772|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153453711|NCT01721772|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153453712|NCT01721772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153453713|NCT01721772|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153453714|NCT01721772|Alkylating Agents|alkylating agents|mesh-ancestor
153453715|NCT01702428|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
153889730|NCT01273155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153889731|NCT05557851|14-O-phosphonooxymethyltriptolide disodium salt|14-o-phosphonooxymethyltriptolide disodium salt|mesh-list
153889732|NCT05557851|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153889733|NCT05557851|Alkylating Agents|alkylating agents|mesh-ancestor
153889734|NCT05557851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153889735|NCT05557851|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153889736|NCT01005901|Glycopyrrolate|glycopyrrolate|mesh-list
153889737|NCT01005901|Bromides|bromides|mesh-list
153889738|NCT01005901|Anticonvulsants|anticonvulsants|mesh-ancestor
153453716|NCT01702428|Immunologic Factors|immunologic factors|mesh-ancestor
153453717|NCT01702428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153453718|NCT01701258|Amisulpride|amisulpride|mesh-list
153889739|NCT01005901|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153453719|NCT01701258|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153453720|NCT01701258|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153453792|NCT01748994|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153453793|NCT01748994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153453794|NCT01721070|Ketoconazole|ketoconazole|mesh-list
153453796|NCT01721070|Dsuvia|dsuvia|mesh-list
153889740|NCT01005901|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
153889741|NCT01005901|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
153889742|NCT01005901|Cholinergic Agents|cholinergic agents|mesh-ancestor
153889743|NCT01005901|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153453797|NCT01721070|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153453798|NCT01721070|Narcotics|narcotics|mesh-ancestor
153453799|NCT01721070|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153453800|NCT01721070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153453801|NCT01721070|Analgesics|analgesics|mesh-ancestor
153453802|NCT01721070|Sensory System Agents|sensory system agents|mesh-ancestor
153453859|NCT01746732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153453860|NCT01746732|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
153453861|NCT01746732|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
153453862|NCT01746732|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
153453863|NCT01720524|Sildenafil Citrate|sildenafil citrate|mesh-list
153453864|NCT01720524|Vasodilator Agents|vasodilator agents|mesh-ancestor
153453865|NCT01720524|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
153453872|NCT01720446|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153453873|NCT01720446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153453962|NCT01695954|Efavirenz|efavirenz|mesh-list
153453963|NCT01695954|Pitavastatin|pitavastatin|mesh-list
153453964|NCT01695954|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
153453965|NCT01695954|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
153453966|NCT01695954|Protease Inhibitors|protease inhibitors|mesh-ancestor
153453967|NCT01695954|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153783680|NCT04541251|Tubulin Modulators|tubulin modulators|mesh-ancestor
153783681|NCT04541251|Antimitotic Agents|antimitotic agents|mesh-ancestor
153453968|NCT01695954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153453969|NCT01695954|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153453970|NCT01695954|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153453971|NCT01695954|Antiviral Agents|antiviral agents|mesh-ancestor
153453972|NCT01695954|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153453973|NCT01695954|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
153453974|NCT01695954|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153453976|NCT01695954|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153453977|NCT01695954|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
153889745|NCT01005901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153430898|NCT04246723|Ritonavir|ritonavir|mesh-list
153430899|NCT04246723|Sofosbuvir|sofosbuvir|mesh-list
153454038|NCT01691508|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153454039|NCT01691508|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153454040|NCT01682460|Ophthalmic Solutions|ophthalmic solutions|mesh-list
153454041|NCT01682460|Lubricant Eye Drops|lubricant eye drops|mesh-list
153454042|NCT01682460|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
153454043|NCT01709838|Deferasirox|deferasirox|mesh-list
153454044|NCT01709838|Iron Chelating Agents|iron chelating agents|mesh-ancestor
153454045|NCT01709838|Chelating Agents|chelating agents|mesh-ancestor
153454046|NCT01709838|Sequestering Agents|sequestering agents|mesh-ancestor
153454047|NCT01709838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153454048|NCT01688466|Pomalidomide|pomalidomide|mesh-list
153454071|NCT01737840|Ranitidine|ranitidine|mesh-list
153454072|NCT01737840|Ranitidine bismuth citrate|ranitidine bismuth citrate|mesh-list
153454073|NCT01737840|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
153454074|NCT01737840|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153430900|NCT04246723|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
153430901|NCT04246723|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
153430902|NCT04246723|Protease Inhibitors|protease inhibitors|mesh-ancestor
153454081|NCT01737840|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153454082|NCT01737840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153454083|NCT01687998|Evacetrapib|evacetrapib|mesh-list
153454084|NCT01687998|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153454085|NCT01687998|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153454086|NCT01687998|Antimetabolites|antimetabolites|mesh-ancestor
153454087|NCT01687998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153454088|NCT01687998|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153454089|NCT01681212|Ipilimumab|ipilimumab|mesh-list
153454090|NCT01681212|Dacarbazine|dacarbazine|mesh-list
153454091|NCT01681212|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153454092|NCT01681212|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153454093|NCT01681212|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153454094|NCT01681212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153454162|NCT01568034|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
153454163|NCT01568034|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153454164|NCT01568034|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
153454165|NCT01687218|Tenofovir|tenofovir|mesh-list
153454166|NCT01687218|Emtricitabine|emtricitabine|mesh-list
153454167|NCT01687218|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
153454168|NCT01687218|Glycerol|glycerol|mesh-list
153454169|NCT01687218|Antiviral Agents|antiviral agents|mesh-ancestor
153783682|NCT04541251|Mitosis Modulators|mitosis modulators|mesh-ancestor
153889753|NCT02889549|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153889754|NCT02889549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153889755|NCT02889549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153454170|NCT01687218|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153454171|NCT01687218|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153454172|NCT01687218|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153454173|NCT01687218|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153454174|NCT01687218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153454175|NCT01687218|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153889757|NCT01309386|Tapentadol|tapentadol|mesh-list
153454176|NCT01687218|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153454177|NCT01687218|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
153454178|NCT01687218|Protective Agents|protective agents|mesh-ancestor
153454179|NCT01687218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153454180|NCT01686828|Letrozole|letrozole|mesh-list
153454181|NCT01686828|Methyltestosterone|methyltestosterone|mesh-list
153454182|NCT01686828|Acyline|acyline|mesh-list
153454250|NCT01592292|Analgesics|analgesics|mesh-ancestor
153454251|NCT01592292|Sensory System Agents|sensory system agents|mesh-ancestor
153454252|NCT01592292|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153454253|NCT01592292|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153454254|NCT01565850|Darunavir|darunavir|mesh-list
153454255|NCT01565850|Cobicistat|cobicistat|mesh-list
153454256|NCT01565850|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153454257|NCT01565850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153454258|NCT01565850|Antiviral Agents|antiviral agents|mesh-ancestor
153454259|NCT01565850|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153454260|NCT01565850|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153454261|NCT01565850|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153454262|NCT01565850|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
153454330|NCT01539642|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153889758|NCT01309386|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153454331|NCT01539642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153454333|NCT01539642|Sensory System Agents|sensory system agents|mesh-ancestor
153454334|NCT01539642|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153454335|NCT01539642|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153454395|NCT01585428|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153454396|NCT01585428|Alkylating Agents|alkylating agents|mesh-ancestor
153454397|NCT01585428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153454426|NCT01585038|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
153454427|NCT01585038|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
153454428|NCT01585038|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
153454429|NCT01585038|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153889759|NCT01309386|Narcotics|narcotics|mesh-ancestor
153889760|NCT01309386|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153889761|NCT01309386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153889771|NCT04295317|Capecitabine|capecitabine|mesh-list
153454430|NCT01585038|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153889772|NCT04295317|Antibodies|antibodies|mesh-list
153454432|NCT01559844|Sofosbuvir|sofosbuvir|mesh-list
153454433|NCT01559844|Antimetabolites|antimetabolites|mesh-ancestor
153454434|NCT01559844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153454435|NCT01559844|Antiviral Agents|antiviral agents|mesh-ancestor
153454436|NCT01559844|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153454437|NCT01584648|Trametinib|trametinib|mesh-list
153454438|NCT01584648|Dabrafenib|dabrafenib|mesh-list
153454439|NCT01584648|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153454440|NCT01584648|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153454441|NCT01584648|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153454442|NCT01584648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153454443|NCT01559454|Buprenorphine|buprenorphine|mesh-list
153454468|NCT01583166|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153889773|NCT04295317|Antibodies, Blocking|antibodies, blocking|mesh-list
153889774|NCT04295317|Immunologic Factors|immunologic factors|mesh-ancestor
153454491|NCT01582308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153454492|NCT01582308|Incretins|incretins|mesh-ancestor
153454493|NCT01582308|Hormones|hormones|mesh-ancestor
153454494|NCT01582308|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153454495|NCT01582308|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
153454506|NCT01558674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153454508|NCT01535040|Memantine|memantine|mesh-list
153454509|NCT01535040|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
153454510|NCT01535040|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
153454511|NCT01535040|Dopamine Agents|dopamine agents|mesh-ancestor
153454512|NCT01535040|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153454513|NCT01535040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153454514|NCT01535040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153454515|NCT01535040|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
153454516|NCT01535040|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
153454518|NCT01534962|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153454519|NCT01534962|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153454520|NCT01534962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153454521|NCT01582152|Bevacizumab|bevacizumab|mesh-list
153454522|NCT01582152|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153454523|NCT01582152|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153454524|NCT01582152|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153454525|NCT01582152|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153454526|NCT01582152|Growth Substances|growth substances|mesh-ancestor
153454539|NCT01557504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153454541|NCT01580670|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
153454542|NCT01580670|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153454543|NCT01580670|Dermatologic Agents|dermatologic agents|mesh-ancestor
153454544|NCT01580670|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153454545|NCT01580670|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153454546|NCT01534260|Bortezomib|bortezomib|mesh-list
153454547|NCT01534260|Sorafenib|sorafenib|mesh-list
153454548|NCT01534260|Vorinostat|vorinostat|mesh-list
153454549|NCT01534260|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153454550|NCT01534260|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153454551|NCT01534260|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153454552|NCT01534260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153454553|NCT01534260|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
153454554|NCT01534182|Interferons|interferons|mesh-list
153454555|NCT01534182|Interferon-beta|interferon-beta|mesh-list
153454556|NCT01534182|Glatiramer Acetate|glatiramer acetate|mesh-list
153889775|NCT04295317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153889776|NCT04295317|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153889777|NCT04295317|Antimetabolites|antimetabolites|mesh-ancestor
153889778|NCT04295317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153889779|NCT04295317|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153889780|NCT01266603|Aldesleukin|aldesleukin|mesh-list
153889781|NCT01266603|Interleukin-2|interleukin-2|mesh-list
153430908|NCT04246723|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153454588|NCT01555164|Metformin|metformin|mesh-list
153454589|NCT01555164|Ranolazine|ranolazine|mesh-list
153454590|NCT01555164|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153815038|NCT04715165|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153454591|NCT01555164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153454592|NCT01555164|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153454593|NCT01555164|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153454594|NCT01555164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153454595|NCT03028428|Hyaluronic Acid|hyaluronic acid|mesh-list
153454596|NCT03028428|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153454601|NCT01578330|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
153454602|NCT01578330|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
153454603|NCT01578330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153454604|NCT01578330|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153454605|NCT01578330|Immunologic Factors|immunologic factors|mesh-ancestor
153454606|NCT01578330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153454607|NCT01577160|Paliperidone Palmitate|paliperidone palmitate|mesh-list
153454608|NCT01577160|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153454609|NCT01577160|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153454610|NCT01577160|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153454611|NCT01577160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153454612|NCT01577160|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153454613|NCT01577160|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
153454614|NCT01577160|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153454720|NCT01528254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153454721|NCT01528254|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
153454723|NCT01528254|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153454951|NCT01516008|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
153454952|NCT01516008|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153454981|NCT01514370|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153454982|NCT01514370|Antiviral Agents|antiviral agents|mesh-ancestor
153454983|NCT01514370|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153454997|NCT01519674|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
153454998|NCT01519674|Metformin|metformin|mesh-list
153454999|NCT01519674|Insulin Aspart|insulin aspart|mesh-list
153455000|NCT01519674|Insulin, Long-Acting|insulin, long-acting|mesh-list
153455033|NCT01518972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153455034|NCT01518972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153455035|NCT01513590|Insulin|insulin|mesh-list
153455081|NCT04080882|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153455082|NCT04080882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153455084|NCT04080882|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153455085|NCT04080882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153455086|NCT04080882|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
153455087|NCT04080882|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153455088|NCT01484496|Belimumab|belimumab|mesh-list
153455089|NCT01484496|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153455090|NCT01484496|Immunologic Factors|immunologic factors|mesh-ancestor
153455292|NCT06175377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153455293|NCT06175377|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153455294|NCT06175377|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153455295|NCT06175377|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153455296|NCT06175377|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153455297|NCT06175377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153455360|NCT06174792|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
153455362|NCT06174792|Natriuretic Agents|natriuretic agents|mesh-ancestor
153455363|NCT06174753|Dapagliflozin|dapagliflozin|mesh-list
153455364|NCT06174753|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
153455365|NCT06174753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153455478|NCT06034314|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153455479|NCT06034314|Analgesics|analgesics|mesh-ancestor
153455480|NCT06034314|Sensory System Agents|sensory system agents|mesh-ancestor
153455481|NCT06034314|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153455482|NCT06034314|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
153455483|NCT06034314|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
153455484|NCT06034314|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153455485|NCT06034314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153455534|NCT05834777|Icatibant|icatibant|mesh-list
153455535|NCT05834777|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153455536|NCT05834777|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153455537|NCT05834777|Analgesics|analgesics|mesh-ancestor
153455538|NCT05834777|Sensory System Agents|sensory system agents|mesh-ancestor
153455539|NCT05834777|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153455540|NCT05834777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153455541|NCT05834777|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153455542|NCT05834777|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153455543|NCT05834777|Bradykinin B2 Receptor Antagonists|bradykinin b2 receptor antagonists|mesh-ancestor
153455544|NCT05834777|Bradykinin Receptor Antagonists|bradykinin receptor antagonists|mesh-ancestor
153456035|NCT04060277|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153456036|NCT04060277|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
153889782|NCT01266603|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153889783|NCT01266603|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153430909|NCT04246723|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
153456038|NCT04060277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153456039|NCT04060277|Antiviral Agents|antiviral agents|mesh-ancestor
153456040|NCT04043520|Estradiol|estradiol|mesh-list
153456041|NCT04043520|Estrogens|estrogens|mesh-list
153456042|NCT04043520|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
153456043|NCT04043520|Hormones|hormones|mesh-ancestor
153456044|NCT04043520|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153456045|NCT04043520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153456046|NCT04034056|Obinutuzumab|obinutuzumab|mesh-list
153456047|NCT04034056|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153456048|NCT04034056|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153456049|NCT03943537|Insulin|insulin|mesh-list
153456050|NCT03943537|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153456051|NCT03943537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153456052|NCT03935256|Paclitaxel|paclitaxel|mesh-list
153456053|NCT03935256|Carboplatin|carboplatin|mesh-list
153456099|NCT03759366|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
153456100|NCT03759366|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153456101|NCT03759366|Immunologic Factors|immunologic factors|mesh-ancestor
153456102|NCT03759366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153456103|NCT03725059|Paclitaxel|paclitaxel|mesh-list
153456104|NCT03725059|Cyclophosphamide|cyclophosphamide|mesh-list
153456105|NCT03725059|Doxorubicin|doxorubicin|mesh-list
153456106|NCT03725059|Pembrolizumab|pembrolizumab|mesh-list
153456107|NCT03725059|Epirubicin|epirubicin|mesh-list
153456108|NCT03725059|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153456109|NCT03725059|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153456110|NCT03725059|Tubulin Modulators|tubulin modulators|mesh-ancestor
153456479|NCT01453140|Sirolimus|sirolimus|mesh-list
153456480|NCT01453140|Cyclophosphamide|cyclophosphamide|mesh-list
153456481|NCT01453140|Temsirolimus|temsirolimus|mesh-list
153456482|NCT01453140|Interleukin-2|interleukin-2|mesh-list
153456483|NCT01453140|Azacitidine|azacitidine|mesh-list
153456484|NCT01453140|MTOR Inhibitors|mtor inhibitors|mesh-list
153456485|NCT01453140|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153456486|NCT01453140|Immunologic Factors|immunologic factors|mesh-ancestor
153456487|NCT01453140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153456488|NCT01453140|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153456489|NCT01453140|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153456490|NCT01453140|Alkylating Agents|alkylating agents|mesh-ancestor
153456491|NCT01453140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153456492|NCT01453140|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153456493|NCT01453140|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153456494|NCT01453140|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153456495|NCT01453140|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153456496|NCT01453140|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153456497|NCT01453140|Antifungal Agents|antifungal agents|mesh-ancestor
153456498|NCT01453140|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153456499|NCT01453140|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153456500|NCT01453140|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153456595|NCT02985606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153456596|NCT02985606|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
153456597|NCT02985606|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
153783684|NCT00236717|Topiramate|topiramate|mesh-list
153783685|NCT00236717|Carbamazepine|carbamazepine|mesh-list
153456598|NCT02985606|Purinergic Agents|purinergic agents|mesh-ancestor
153456599|NCT02985606|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153456602|NCT01473732|Tacrolimus|tacrolimus|mesh-list
153456603|NCT01473732|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153456604|NCT01473732|Immunologic Factors|immunologic factors|mesh-ancestor
153456605|NCT01473732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153456606|NCT01473732|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
153456607|NCT01473732|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153456608|NCT01473732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153456609|NCT01473732|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
153456610|NCT01473732|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153456611|NCT01473732|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153456612|NCT01473732|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153456613|NCT01473732|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
153456614|NCT01473732|Antitubercular Agents|antitubercular agents|mesh-ancestor
153456715|NCT01490580|Parasympatholytics|parasympatholytics|mesh-ancestor
153456716|NCT01490580|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
153456717|NCT01490580|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
153456718|NCT01490580|Cholinergic Agents|cholinergic agents|mesh-ancestor
153456719|NCT01490580|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153456720|NCT01490580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153456721|NCT01490580|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
153456722|NCT01490580|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
153456723|NCT01490580|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
153456724|NCT01490580|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
153456726|NCT01490190|Etonogestrel|etonogestrel|mesh-list
153456728|NCT01490190|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
153456729|NCT01490190|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
153456730|NCT01490190|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
153456731|NCT01490190|Contraceptive Agents|contraceptive agents|mesh-ancestor
153456732|NCT01490190|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153456733|NCT01490190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153456735|NCT01490190|Estrogens|estrogens|mesh-ancestor
153456736|NCT01490190|Hormones|hormones|mesh-ancestor
153456737|NCT01490190|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153456738|NCT01446042|Methyltestosterone|methyltestosterone|mesh-list
153456739|NCT01446042|Testosterone|testosterone|mesh-list
153456740|NCT01446042|Testosterone undecanoate|testosterone undecanoate|mesh-list
153456741|NCT01446042|Testosterone enanthate|testosterone enanthate|mesh-list
153456742|NCT01446042|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
153456743|NCT01446042|Androgens|androgens|mesh-ancestor
153456744|NCT01446042|Hormones|hormones|mesh-ancestor
153456745|NCT01446042|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153456746|NCT01446042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153456747|NCT01446042|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153456748|NCT01446042|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153456781|NCT04089852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153456782|NCT04089852|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153456783|NCT04089852|Analgesics|analgesics|mesh-ancestor
153456784|NCT04089852|Sensory System Agents|sensory system agents|mesh-ancestor
153456785|NCT04089852|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153456787|NCT03026244|Caseins|caseins|mesh-list
153456788|NCT03026244|Vitamins|vitamins|mesh-ancestor
153456789|NCT03026244|Micronutrients|micronutrients|mesh-ancestor
153456790|NCT03026244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153456861|NCT01468818|Fludarabine|fludarabine|mesh-list
153456862|NCT01468818|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153456863|NCT01468818|Immunologic Factors|immunologic factors|mesh-ancestor
153456888|NCT01442064|Growth Substances|growth substances|mesh-ancestor
153456889|NCT01442064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153456890|NCT01442064|Growth Inhibitors|growth inhibitors|mesh-ancestor
153456891|NCT01442064|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153456892|NCT01441596|Vinorelbine|vinorelbine|mesh-list
153456893|NCT01441596|Afatinib|afatinib|mesh-list
153456894|NCT01441596|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153456895|NCT01441596|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153456896|NCT01441596|Tubulin Modulators|tubulin modulators|mesh-ancestor
153456897|NCT01441596|Antimitotic Agents|antimitotic agents|mesh-ancestor
153456898|NCT01441596|Mitosis Modulators|mitosis modulators|mesh-ancestor
153456900|NCT01441596|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153456901|NCT01441596|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153456903|NCT01441440|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
153456904|NCT01441440|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
153456905|NCT01441440|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153456906|NCT01441440|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153456907|NCT01441440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153456908|NCT01441440|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153456909|NCT01441440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153456910|NCT01441440|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
153457263|NCT01402284|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153457264|NCT01402284|Glucocorticoids|glucocorticoids|mesh-ancestor
153457265|NCT01402284|Hormones|hormones|mesh-ancestor
153457266|NCT01402284|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153457267|NCT01402284|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153457268|NCT01402284|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153457269|NCT01402284|Immunologic Factors|immunologic factors|mesh-ancestor
153457270|NCT01402284|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153457271|NCT01402284|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153457273|NCT01402284|Growth Inhibitors|growth inhibitors|mesh-ancestor
153457275|NCT01388790|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153457710|NCT03594162|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153457711|NCT04407312|Aspirin|aspirin|mesh-list
153457712|NCT04407312|Cilostazol|cilostazol|mesh-list
153457713|NCT04407312|Clopidogrel|clopidogrel|mesh-list
153457714|NCT04407312|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153457715|NCT04407312|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153457716|NCT04407312|Analgesics|analgesics|mesh-ancestor
153457717|NCT04407312|Sensory System Agents|sensory system agents|mesh-ancestor
153457746|NCT04326738|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153457747|NCT04326738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153457748|NCT04326738|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153457749|NCT04326738|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153457750|NCT04326738|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153457751|NCT04326738|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153457826|NCT03599778|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153457827|NCT03599778|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153457828|NCT03599778|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153457829|NCT03599778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153457830|NCT04008264|Scopolamine|scopolamine|mesh-list
153457831|NCT04008264|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
153457832|NCT04008264|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153457833|NCT04008264|Antiemetics|antiemetics|mesh-ancestor
153457834|NCT04008264|Autonomic Agents|autonomic agents|mesh-ancestor
153457835|NCT04008264|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153457836|NCT04008264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153457838|NCT04008264|Mydriatics|mydriatics|mesh-ancestor
153457941|NCT03596970|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153457942|NCT03596970|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153457943|NCT03596970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153457944|NCT03596970|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153457945|NCT03596970|Immunologic Factors|immunologic factors|mesh-ancestor
153457946|NCT03596970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153457947|NCT03596970|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153457948|NCT03596892|Cyclophosphamide|cyclophosphamide|mesh-list
153457979|NCT04197570|Sensory System Agents|sensory system agents|mesh-ancestor
153457980|NCT04197570|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153457982|NCT04197882|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153457983|NCT03024060|Aminolevulinic Acid|aminolevulinic acid|mesh-list
153457984|NCT03024060|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
153457985|NCT03024060|Dermatologic Agents|dermatologic agents|mesh-ancestor
153457986|NCT03024216|Atezolizumab|atezolizumab|mesh-list
153457987|NCT03024216|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153457988|NCT03024216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153457989|NCT03024216|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153457990|NCT03024216|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153457991|NCT03981744|Ustekinumab|ustekinumab|mesh-list
153457992|NCT03981744|Dermatologic Agents|dermatologic agents|mesh-ancestor
153457993|NCT03591900|Insulin|insulin|mesh-list
153457995|NCT03591900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153457996|NCT03591744|Dexamethasone|dexamethasone|mesh-list
153458583|NCT04148898|Growth Substances|growth substances|mesh-ancestor
153458584|NCT04148898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153458585|NCT04148898|Growth Inhibitors|growth inhibitors|mesh-ancestor
153458586|NCT04148898|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153458587|NCT04148898|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153458588|NCT04148898|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153458589|NCT04148898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153458590|NCT04148820|Aspirin|aspirin|mesh-list
153458591|NCT04148820|Perindopril|perindopril|mesh-list
153458592|NCT04148820|Atorvastatin|atorvastatin|mesh-list
153458594|NCT04148820|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153458595|NCT04148820|Analgesics|analgesics|mesh-ancestor
153458596|NCT04148820|Sensory System Agents|sensory system agents|mesh-ancestor
153459201|NCT01675986|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153459202|NCT01675986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153459203|NCT01675986|Anticonvulsants|anticonvulsants|mesh-ancestor
153459204|NCT01675986|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153459205|NCT01675986|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153459206|NCT01675986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153459207|NCT01675986|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153459208|NCT01675986|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153459209|NCT01675986|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153783687|NCT00236717|Anticonvulsants|anticonvulsants|mesh-ancestor
153783688|NCT00236717|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153459210|NCT01675986|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153459211|NCT01675986|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153459212|NCT01675986|Antipruritics|antipruritics|mesh-ancestor
153459803|NCT05972512|Vitamins|vitamins|mesh-ancestor
153460049|NCT04865419|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
153460050|NCT04827966|Calcium, Dietary|calcium, dietary|mesh-list
153460051|NCT04827966|Listerine|listerine|mesh-list
153460052|NCT04827966|Calcium|calcium|mesh-list
153460053|NCT04827966|Fluorides|fluorides|mesh-list
153460054|NCT04827966|Sodium Fluoride|sodium fluoride|mesh-list
153460055|NCT04827966|Caseins|caseins|mesh-list
153460056|NCT04827966|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153460057|NCT04827966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153460058|NCT04827966|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153460059|NCT04827966|Cariostatic Agents|cariostatic agents|mesh-ancestor
153460060|NCT04827966|Protective Agents|protective agents|mesh-ancestor
153460061|NCT04827966|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
153460062|NCT04827966|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153460063|NCT04827966|Chelating Agents|chelating agents|mesh-ancestor
153460064|NCT04827966|Sequestering Agents|sequestering agents|mesh-ancestor
153460065|NCT04827966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153460066|NCT04796194|Pembrolizumab|pembrolizumab|mesh-list
153460067|NCT04796194|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153460068|NCT04796194|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153460069|NCT04796194|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153460577|NCT02369406|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153460578|NCT02369406|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153460579|NCT02369406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153460580|NCT02369406|Antiviral Agents|antiviral agents|mesh-ancestor
153460581|NCT02369406|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153460582|NCT02369406|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153460583|NCT02369406|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153460584|NCT02369406|Antimetabolites|antimetabolites|mesh-ancestor
153460585|NCT02369406|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
153460586|NCT02369406|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
153460587|NCT02127073|Oxytocin|oxytocin|mesh-list
153460588|NCT02127073|Oxytocics|oxytocics|mesh-ancestor
153460589|NCT02127073|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153460590|NCT02127073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153460591|NCT02112214|Bismuth|bismuth|mesh-list
153460592|NCT02112214|Antacids|antacids|mesh-ancestor
153460593|NCT02112214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153460594|NCT02112214|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153460595|NCT02074267|Gabapentin|gabapentin|mesh-list
153460596|NCT02074267|Analgesics|analgesics|mesh-ancestor
153460597|NCT02074267|Sensory System Agents|sensory system agents|mesh-ancestor
153460598|NCT02074267|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153460599|NCT02074267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153460769|NCT03458598|Sensory System Agents|sensory system agents|mesh-ancestor
153460770|NCT03458598|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153460772|NCT03791736|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153460773|NCT03791736|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153461039|NCT03087942|Plant Growth Regulators|plant growth regulators|mesh-ancestor
153461041|NCT03087942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153461042|NCT01678092|Omalizumab|omalizumab|mesh-list
153461043|NCT01678092|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
153461044|NCT01678092|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153461045|NCT01678092|Respiratory System Agents|respiratory system agents|mesh-ancestor
153461046|NCT04402320|Midazolam|midazolam|mesh-list
153461047|NCT04402320|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153461048|NCT04402320|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153461049|NCT04402320|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153461050|NCT04402320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153461051|NCT04402320|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153461052|NCT04402320|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153461053|NCT04402320|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153461054|NCT04402320|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153461450|NCT04401852|Analgesics|analgesics|mesh-ancestor
153383282|NCT01748942|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153383283|NCT01748942|Protease Inhibitors|protease inhibitors|mesh-ancestor
153383284|NCT01748942|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153461451|NCT04401852|Sensory System Agents|sensory system agents|mesh-ancestor
153461575|NCT03831984|Sensory System Agents|sensory system agents|mesh-ancestor
153461576|NCT03831984|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153461577|NCT03831984|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153461578|NCT03831984|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153461580|NCT02084706|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
153461581|NCT02084706|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
153461582|NCT02084706|Lidocaine|lidocaine|mesh-list
153461583|NCT02084706|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
153461584|NCT02084706|Anesthetics, Local|anesthetics, local|mesh-ancestor
153461585|NCT02084706|Anesthetics|anesthetics|mesh-ancestor
153461586|NCT02084706|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153461587|NCT02084706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153461639|NCT03249558|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153461640|NCT03249558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153461641|NCT03249558|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153461642|NCT03249558|Antidepressive Agents|antidepressive agents|mesh-ancestor
153461643|NCT03249558|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153360334|NCT05089526|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153360335|NCT04382846|Nitazoxanide|nitazoxanide|mesh-list
153889784|NCT01266603|Analgesics|analgesics|mesh-ancestor
153889785|NCT01266603|Sensory System Agents|sensory system agents|mesh-ancestor
153360336|NCT04382846|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153360337|NCT04382846|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153360339|NCT01274897|Cathartics|cathartics|mesh-ancestor
153360340|NCT01274897|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153360687|NCT01365611|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153360688|NCT01365611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153360689|NCT01365611|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153360690|NCT01365611|Respiratory System Agents|respiratory system agents|mesh-ancestor
153360691|NCT01365611|Dermatologic Agents|dermatologic agents|mesh-ancestor
153360692|NCT01365611|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
153360693|NCT01365611|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153360694|NCT01365611|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153360696|NCT01365611|Sensory System Agents|sensory system agents|mesh-ancestor
153360697|NCT01365611|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153360698|NCT01365611|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153360699|NCT01365611|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153360700|NCT01365611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153360702|NCT01472549|Chlorhexidine|chlorhexidine|mesh-list
153360703|NCT01472549|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
153360704|NCT01472549|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153360705|NCT01472549|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153360706|NCT01472549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153360707|NCT01472549|Disinfectants|disinfectants|mesh-ancestor
153360708|NCT00852644|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
153360709|NCT00852644|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
153360710|NCT00852644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153360711|NCT01404923|Mebeverine|mebeverine|mesh-list
153360712|NCT01404923|Alverine|alverine|mesh-list
153783773|NCT02215447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153783774|NCT00236990|Pentosan Sulfuric Polyester|pentosan sulfuric polyester|mesh-list
153783776|NCT00237068|Lansoprazole|lansoprazole|mesh-list
153783777|NCT00237068|Dexlansoprazole|dexlansoprazole|mesh-list
153783778|NCT00237068|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
153882955|NCT02271204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153882956|NCT02271282|Toremifene|toremifene|mesh-list
153882957|NCT02271282|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153882965|NCT01688960|Aflibercept|aflibercept|mesh-list
153383285|NCT01748942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153383287|NCT02355977|Minocycline|minocycline|mesh-list
153383288|NCT02355977|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153383289|NCT02355977|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153383290|NCT01749410|Botulinum Toxins|botulinum toxins|mesh-list
153383364|NCT02052635|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153783779|NCT00237068|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153783780|NCT00237068|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
153783781|NCT00237068|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153889799|NCT04295551|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153430920|NCT00000301|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153430921|NCT00000301|Analgesics|analgesics|mesh-ancestor
153430990|NCT00380263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153361071|NCT01379183|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153821170|NCT00482079|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153914601|NCT02709187|Antimetabolites|antimetabolites|mesh-ancestor
153361118|NCT00820664|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153361119|NCT00820664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153361120|NCT00820664|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
153361121|NCT00820664|Contraceptive Agents|contraceptive agents|mesh-ancestor
153361122|NCT00820664|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153361123|NCT00820664|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
153361124|NCT01380743|1-Deoxynojirimycin|1-deoxynojirimycin|mesh-list
153361125|NCT01380743|Antiviral Agents|antiviral agents|mesh-ancestor
153361126|NCT01380743|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153361127|NCT01380743|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153361128|NCT01380743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153361129|NCT01419977|Dalteparin|dalteparin|mesh-list
153361130|NCT01419977|Tinzaparin|tinzaparin|mesh-list
153361131|NCT01419977|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
153821181|NCT00437372|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153821182|NCT00437372|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153821183|NCT00437372|Growth Substances|growth substances|mesh-ancestor
153821184|NCT00437372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153361132|NCT01419977|Anticoagulants|anticoagulants|mesh-ancestor
153361133|NCT01419977|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153361134|NCT01419977|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153361135|NCT01419977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153361136|NCT01499147|Vidarabine|vidarabine|mesh-list
153361137|NCT01499147|Fludarabine|fludarabine|mesh-list
153361138|NCT01499147|Fludarabine phosphate|fludarabine phosphate|mesh-list
153361139|NCT01499147|Melphalan|melphalan|mesh-list
153361140|NCT01499147|Busulfan|busulfan|mesh-list
153361141|NCT01499147|Thymoglobulin|thymoglobulin|mesh-list
153361142|NCT01499147|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153361143|NCT01499147|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153361144|NCT01499147|Antimetabolites|antimetabolites|mesh-ancestor
153361145|NCT01499147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153821202|NCT00482313|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
153821203|NCT00482313|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153821204|NCT00482313|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153361154|NCT00823082|Antithrombins|antithrombins|mesh-list
153361155|NCT00823082|Antithrombin III|antithrombin iii|mesh-list
153361156|NCT00823082|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
153361157|NCT00823082|Protease Inhibitors|protease inhibitors|mesh-ancestor
153361158|NCT00823082|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153361181|NCT05236634|Adrenergic Agents|adrenergic agents|mesh-ancestor
153361182|NCT05236634|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153361183|NCT05236634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153361184|NCT01422161|Botulinum Toxins|botulinum toxins|mesh-list
153361185|NCT01422161|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
153361186|NCT01422161|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
153361187|NCT01422161|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153361188|NCT01422161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153361189|NCT01422161|Cholinergic Agents|cholinergic agents|mesh-ancestor
153361190|NCT01422161|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153361191|NCT01422161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153361192|NCT01422161|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
153361193|NCT01422161|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153361194|NCT05236166|Anticonvulsants|anticonvulsants|mesh-list
153361195|NCT01502813|Cytidine Diphosphate Choline|cytidine diphosphate choline|mesh-list
153361196|NCT01502813|Nootropic Agents|nootropic agents|mesh-ancestor
153361198|NCT00865202|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
153361199|NCT00865202|Antidepressive Agents|antidepressive agents|mesh-ancestor
153361200|NCT00865202|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153361202|NCT01424033|N-monoacetylcystine|n-monoacetylcystine|mesh-list
153361203|NCT01424033|Antiviral Agents|antiviral agents|mesh-ancestor
153361204|NCT01424033|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153821226|NCT00437762|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153821227|NCT00482508|Omalizumab|omalizumab|mesh-list
153821228|NCT00482508|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
153821230|NCT00482508|Respiratory System Agents|respiratory system agents|mesh-ancestor
153821232|NCT00437918|Nateglinide|nateglinide|mesh-list
153821233|NCT00437918|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
153821234|NCT00437918|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153821235|NCT00437918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153821236|NCT00437918|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153821237|NCT00437918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153821238|NCT00437957|Temozolomide|temozolomide|mesh-list
153821239|NCT00437957|Valproic Acid|valproic acid|mesh-list
153821240|NCT00437957|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153821241|NCT00437957|Alkylating Agents|alkylating agents|mesh-ancestor
153821254|NCT03270176|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153821255|NCT03270176|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153821256|NCT00474279|Hormones|hormones|mesh-list
153821257|NCT00474279|Secretagogues|secretagogues|mesh-list
153361205|NCT01424033|Expectorants|expectorants|mesh-ancestor
153361214|NCT01503749|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153361215|NCT01503749|Immunologic Factors|immunologic factors|mesh-ancestor
153361216|NCT01503749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153361217|NCT00867932|Eculizumab|eculizumab|mesh-list
153361218|NCT00867932|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
153361219|NCT00867932|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153361220|NCT00867932|Immunologic Factors|immunologic factors|mesh-ancestor
153361229|NCT01385189|Aluminum Hydroxide|aluminum hydroxide|mesh-list
153431107|NCT06316336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153821278|NCT00437996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153821279|NCT00437996|Analgesics|analgesics|mesh-ancestor
153821280|NCT00437996|Sensory System Agents|sensory system agents|mesh-ancestor
153821281|NCT00437996|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153821282|NCT00437996|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153821283|NCT00437996|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153821284|NCT00437996|Anesthetics, General|anesthetics, general|mesh-ancestor
153821285|NCT00437996|Anesthetics|anesthetics|mesh-ancestor
153821286|NCT00437996|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153821287|NCT00437996|Sympatholytics|sympatholytics|mesh-ancestor
153821288|NCT00437996|Autonomic Agents|autonomic agents|mesh-ancestor
153821289|NCT00437996|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
153821290|NCT00437996|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153821291|NCT00437996|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153821292|NCT00437996|Adrenergic Agents|adrenergic agents|mesh-ancestor
153821293|NCT00437996|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153361241|NCT01386983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153361242|NCT01386983|Hormone Antagonists|hormone antagonists|mesh-ancestor
153361244|NCT01386983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153361245|NCT01386983|Urological Agents|urological agents|mesh-ancestor
153361246|NCT01387139|Ketamine|ketamine|mesh-list
153361247|NCT01387139|Propofol|propofol|mesh-list
153361248|NCT01387139|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153361249|NCT01387139|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153361250|NCT01387139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153361251|NCT01387139|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153361252|NCT01387139|Anesthetics, General|anesthetics, general|mesh-ancestor
153361253|NCT01387139|Anesthetics|anesthetics|mesh-ancestor
153361254|NCT01387139|Analgesics|analgesics|mesh-ancestor
153361264|NCT00870896|Autonomic Agents|autonomic agents|mesh-ancestor
153361265|NCT00870896|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153361266|NCT00870896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153821301|NCT04701242|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153821302|NCT00474435|Tenofovir|tenofovir|mesh-list
153821303|NCT00474435|Emtricitabine|emtricitabine|mesh-list
153821304|NCT00474435|Efavirenz|efavirenz|mesh-list
153821305|NCT00474435|Antiviral Agents|antiviral agents|mesh-ancestor
153821306|NCT00474435|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153821307|NCT00474435|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153821308|NCT00474435|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153821309|NCT00474435|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153821310|NCT00474435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153821311|NCT00474435|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153821315|NCT00474435|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
153821316|NCT00474435|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
153821317|NCT00474435|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
153821318|NCT00474435|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
153361267|NCT00870896|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153361277|NCT00825344|Analgesics|analgesics|mesh-ancestor
153361278|NCT00825344|Sensory System Agents|sensory system agents|mesh-ancestor
153361279|NCT00825344|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153361280|NCT00825344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153361308|NCT01505933|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153361309|NCT01505933|Analgesics|analgesics|mesh-ancestor
153821362|NCT00438152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153821363|NCT00438152|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153821364|NCT00438152|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153821365|NCT00438152|Antiviral Agents|antiviral agents|mesh-ancestor
153821366|NCT00438152|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153821367|NCT00438152|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
153821368|NCT00438152|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153821370|NCT00438230|Anticoagulants|anticoagulants|mesh-ancestor
153821371|NCT00438269|Metronidazole|metronidazole|mesh-list
153821372|NCT00438269|Ciprofloxacin|ciprofloxacin|mesh-list
153821373|NCT00438269|Meropenem|meropenem|mesh-list
153821374|NCT00438269|Cefazolin|cefazolin|mesh-list
153821375|NCT00438269|Tazobactam|tazobactam|mesh-list
153821376|NCT00438269|Piperacillin|piperacillin|mesh-list
153821377|NCT00438269|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
153821378|NCT00438269|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153821379|NCT00438269|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153821380|NCT00438269|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153821381|NCT00438269|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153821382|NCT00438269|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153821383|NCT00438269|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153821384|NCT00438269|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153821385|NCT00438269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153821386|NCT00438269|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153821387|NCT00438269|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
153821388|NCT00438269|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153821389|NCT00438269|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
153361388|NCT02512302|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
153361389|NCT02512302|Cholinergic Agents|cholinergic agents|mesh-ancestor
153361390|NCT02512302|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153361391|NCT02512302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153361392|NCT02512302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153361393|NCT02512302|Antidotes|antidotes|mesh-ancestor
153361394|NCT02512302|Protective Agents|protective agents|mesh-ancestor
153361395|NCT01507181|Midazolam|midazolam|mesh-list
153361396|NCT01507181|Ketamine|ketamine|mesh-list
153821426|NCT00438386|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153821427|NCT00438386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153821428|NCT00438386|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
153821429|NCT00438386|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
153821430|NCT00438386|Serotonin Agents|serotonin agents|mesh-ancestor
153821431|NCT00438386|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
153821432|NCT00438386|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153821433|NCT00438386|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
153821434|NCT00438386|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
153821436|NCT00475059|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
153821437|NCT00475059|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153821438|NCT00475059|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
153821439|NCT00475059|Histamine Antagonists|histamine antagonists|mesh-ancestor
153821440|NCT00475059|Histamine Agents|histamine agents|mesh-ancestor
153821441|NCT00475059|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153821442|NCT00475059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153821443|NCT00475059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153821444|NCT00475059|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
153821447|NCT00475098|Tinzaparin|tinzaparin|mesh-list
153361408|NCT01507181|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
153361409|NCT01507181|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153361410|NCT01507181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153361411|NCT01507181|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153361412|NCT01507181|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153361413|NCT01507181|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153361414|NCT01507181|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153361415|NCT01507181|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153361416|NCT01507181|GABA Modulators|gaba modulators|mesh-ancestor
153361417|NCT01507181|GABA Agents|gaba agents|mesh-ancestor
153361418|NCT01507181|Excitatory Amino Acid Agonists|excitatory amino acid agonists|mesh-ancestor
153361420|NCT01428245|Estrogens|estrogens|mesh-list
153361421|NCT01428245|Progesterone|progesterone|mesh-list
153361422|NCT01428245|Hormones|hormones|mesh-ancestor
153361423|NCT01428245|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153361424|NCT01428245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153361425|NCT01428245|Progestins|progestins|mesh-ancestor
153361426|NCT00877370|Ertapenem|ertapenem|mesh-list
153361427|NCT00877370|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153361428|NCT00877370|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153361429|NCT00877604|Ursodoxicoltaurine|ursodoxicoltaurine|mesh-list
153361430|NCT00877604|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
153361431|NCT00877604|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153821454|NCT00475137|Lamotrigine|lamotrigine|mesh-list
153821455|NCT00475137|Anticonvulsants|anticonvulsants|mesh-list
153821456|NCT00475137|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153821457|NCT00475137|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153821458|NCT00475137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153821459|NCT00475137|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153821460|NCT00475137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153821461|NCT00475137|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153821462|NCT00475137|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153821463|NCT00475137|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153821464|NCT00475137|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153821475|NCT00438737|Fluorouracil|fluorouracil|mesh-list
153821476|NCT00438737|Oxaliplatin|oxaliplatin|mesh-list
153821478|NCT00438737|Levoleucovorin|levoleucovorin|mesh-list
153821479|NCT00438737|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153821480|NCT00438737|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153821481|NCT00438737|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153821482|NCT00438737|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153821483|NCT00438737|Growth Substances|growth substances|mesh-ancestor
153821484|NCT00438737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153821485|NCT00438737|Growth Inhibitors|growth inhibitors|mesh-ancestor
153821486|NCT00438737|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153821487|NCT00438737|Antimetabolites|antimetabolites|mesh-ancestor
153821488|NCT00438737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153821489|NCT00438737|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153821490|NCT00438737|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153821491|NCT00438737|Immunologic Factors|immunologic factors|mesh-ancestor
153821531|NCT00475527|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153821533|NCT00475566|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
153821534|NCT00475566|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153821535|NCT00475566|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153821536|NCT00475566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153821537|NCT00475566|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153821538|NCT00475566|Immunologic Factors|immunologic factors|mesh-ancestor
153821539|NCT00475566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153821540|NCT00475566|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153361490|NCT01393457|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
153361491|NCT01393457|Dopamine Agents|dopamine agents|mesh-ancestor
153361495|NCT01393457|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
153361496|NCT01393457|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153361497|NCT01393457|Dopamine Agonists|dopamine agonists|mesh-ancestor
153361498|NCT02518464|Ticagrelor|ticagrelor|mesh-list
153361499|NCT02518464|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153361502|NCT02518464|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
153821541|NCT00439166|Doxycycline|doxycycline|mesh-list
153821542|NCT00439166|Rifampin|rifampin|mesh-list
153821543|NCT00439166|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153821544|NCT00439166|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153821545|NCT00439166|Antimalarials|antimalarials|mesh-ancestor
153821546|NCT00439166|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153821547|NCT00439166|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153821548|NCT00439166|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
153821549|NCT00439166|Antitubercular Agents|antitubercular agents|mesh-ancestor
153821550|NCT00439166|Leprostatic Agents|leprostatic agents|mesh-ancestor
153821551|NCT00439166|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153821552|NCT00439166|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153821553|NCT00439166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153821554|NCT00439166|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
153821555|NCT00439166|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
153821591|NCT00475800|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153821592|NCT00475800|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153821593|NCT00439361|Carboplatin|carboplatin|mesh-list
153821594|NCT00439361|Etoposide|etoposide|mesh-list
153821595|NCT00439361|Bortezomib|bortezomib|mesh-list
153821596|NCT00439361|Ifosfamide|ifosfamide|mesh-list
153821597|NCT00439361|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153821598|NCT00439361|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153821599|NCT00439361|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153821600|NCT00439361|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153821601|NCT00439361|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153914681|NCT01215851|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153361554|NCT01363986|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153361555|NCT01363986|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153361556|NCT01510457|Milnacipran|milnacipran|mesh-list
153361575|NCT02478372|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153361576|NCT02478372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153361578|NCT02478372|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153361579|NCT01511315|Ustekinumab|ustekinumab|mesh-list
153361580|NCT01511315|Dermatologic Agents|dermatologic agents|mesh-ancestor
153361581|NCT01654536|Ciclesonide|ciclesonide|mesh-list
153361582|NCT01654536|Glucocorticoids|glucocorticoids|mesh-ancestor
153361583|NCT01654536|Hormones|hormones|mesh-ancestor
153361584|NCT01654536|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153361585|NCT01654536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153361586|NCT01654536|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
153361587|NCT01654380|Insulin Glargine|insulin glargine|mesh-list
153361588|NCT01654380|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153361589|NCT01654380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153361590|NCT02509026|Etanercept|etanercept|mesh-list
153361593|NCT02509026|Analgesics|analgesics|mesh-ancestor
153821620|NCT00439400|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153821621|NCT00439400|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153821622|NCT00475956|Cediranib|cediranib|mesh-list
153821623|NCT00475956|Saracatinib|saracatinib|mesh-list
153821624|NCT00475956|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153821625|NCT00475956|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153821626|NCT00475956|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153821627|NCT00475956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153821628|NCT00476034|Lumiracoxib|lumiracoxib|mesh-list
153821629|NCT00476034|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
153821630|NCT00476034|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153821631|NCT00476034|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153821632|NCT00476034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153821633|NCT00476034|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153821634|NCT00476034|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153821635|NCT00476034|Analgesics|analgesics|mesh-ancestor
153821636|NCT00476034|Sensory System Agents|sensory system agents|mesh-ancestor
153821637|NCT00476034|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153821638|NCT00476034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153821639|NCT00476034|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153821640|NCT00476034|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153361652|NCT04382300|Growth Substances|growth substances|mesh-ancestor
153361653|NCT04382300|Growth Inhibitors|growth inhibitors|mesh-ancestor
153361681|NCT01395329|Acetylcholine|acetylcholine|mesh-list
153361682|NCT01395329|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153361683|NCT01395329|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153361684|NCT01395329|Sympatholytics|sympatholytics|mesh-ancestor
153361685|NCT01395329|Autonomic Agents|autonomic agents|mesh-ancestor
153361686|NCT01395329|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153361687|NCT01395329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153361688|NCT01395329|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
153361689|NCT01395329|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
153461757|NCT03708588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153890139|NCT04021017|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153821742|NCT00439829|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153821743|NCT00439829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153821744|NCT00439829|Hormone Antagonists|hormone antagonists|mesh-ancestor
153821745|NCT00439829|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153821746|NCT03277248|Teriflunomide|teriflunomide|mesh-list
153821747|NCT03277248|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153821748|NCT03277248|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153821749|NCT03277248|Analgesics|analgesics|mesh-ancestor
153821750|NCT03277248|Sensory System Agents|sensory system agents|mesh-ancestor
153914682|NCT01215851|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153361709|NCT00882206|Imatinib Mesylate|imatinib mesylate|mesh-list
153361710|NCT00882206|Decitabine|decitabine|mesh-list
153361711|NCT00882206|Asparaginase|asparaginase|mesh-list
153361712|NCT00882206|Vorinostat|vorinostat|mesh-list
153361713|NCT00882206|Pegaspargase|pegaspargase|mesh-list
153361714|NCT00882206|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153361715|NCT00882206|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153361716|NCT00882206|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153361717|NCT00882206|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153361718|NCT00882206|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153361719|NCT00882206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153361720|NCT00882206|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153361721|NCT00882206|Glucocorticoids|glucocorticoids|mesh-ancestor
153361722|NCT00882206|Hormones|hormones|mesh-ancestor
153361723|NCT00882206|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153361724|NCT00882206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153361725|NCT00882206|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153361728|NCT00882206|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153361729|NCT00882206|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153361730|NCT00882206|Antimetabolites|antimetabolites|mesh-ancestor
153361731|NCT00882206|Dermatologic Agents|dermatologic agents|mesh-ancestor
153361732|NCT00882206|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153361733|NCT00882206|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153361734|NCT00882206|Immunologic Factors|immunologic factors|mesh-ancestor
153361735|NCT00882206|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153361736|NCT00882206|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153890142|NCT04021017|Contraceptive Agents|contraceptive agents|mesh-ancestor
153890143|NCT04021017|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153821776|NCT00440102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153821778|NCT00476541|Gemtuzumab|gemtuzumab|mesh-list
153821779|NCT00476541|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153821780|NCT00476541|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153821781|NCT00476541|Immunotoxins|immunotoxins|mesh-ancestor
153821782|NCT00476541|Immunoconjugates|immunoconjugates|mesh-ancestor
153821783|NCT00476541|Immunologic Factors|immunologic factors|mesh-ancestor
153821784|NCT00476541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153361741|NCT00882206|Antimitotic Agents|antimitotic agents|mesh-ancestor
153361742|NCT00882206|Mitosis Modulators|mitosis modulators|mesh-ancestor
153361743|NCT00882206|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153361744|NCT00882206|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153361745|NCT00882206|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
153361746|NCT00831272|Naltrexone|naltrexone|mesh-list
153361747|NCT00831272|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
153361748|NCT00831272|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
153361749|NCT00831272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153361750|NCT00831272|Sensory System Agents|sensory system agents|mesh-ancestor
153361781|NCT05620940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153361782|NCT05620940|Sensory System Agents|sensory system agents|mesh-ancestor
153361783|NCT05620940|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153361784|NCT01395797|Pioglitazone|pioglitazone|mesh-list
153361785|NCT01395797|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153361786|NCT01395797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153361787|NCT05124704|Ropivacaine|ropivacaine|mesh-list
153361800|NCT02203019|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153361802|NCT02203019|Sensory System Agents|sensory system agents|mesh-ancestor
153821856|NCT00440414|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153821857|NCT00440414|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153821858|NCT00440414|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153821859|NCT03270462|Tacrolimus|tacrolimus|mesh-list
153821860|NCT03270462|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153821861|NCT03270462|Immunologic Factors|immunologic factors|mesh-ancestor
153821862|NCT03270462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153383365|NCT02052635|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
153383366|NCT02052635|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
153383368|NCT02052635|Purinergic Agents|purinergic agents|mesh-ancestor
153383369|NCT02052635|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153383370|NCT02052635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153383371|NCT02052635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153383372|NCT01732718|Atorvastatin|atorvastatin|mesh-list
153383373|NCT01732718|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153383374|NCT01732718|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153383375|NCT01732718|Antimetabolites|antimetabolites|mesh-ancestor
153383376|NCT01732718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153383377|NCT01732718|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153383378|NCT01732718|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
153383379|NCT01732718|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153821863|NCT03270462|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
153821864|NCT03270462|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153821865|NCT03270462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153821866|NCT00440609|Ranibizumab|ranibizumab|mesh-list
153821867|NCT00440609|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153821868|NCT00440609|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153821869|NCT00440609|Growth Substances|growth substances|mesh-ancestor
153821870|NCT00440609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153361828|NCT00887510|Natriuretic Agents|natriuretic agents|mesh-ancestor
153361829|NCT00887510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153361830|NCT00887510|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
153821885|NCT00440687|Dermatologic Agents|dermatologic agents|mesh-ancestor
153821886|NCT00440687|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
153821887|NCT03271047|Nivolumab|nivolumab|mesh-list
153361845|NCT03855332|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
153361846|NCT03855332|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
153361847|NCT03855332|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153361848|NCT03855332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153361849|NCT03855332|Urological Agents|urological agents|mesh-ancestor
153361850|NCT03855332|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153361851|NCT03855332|Autonomic Agents|autonomic agents|mesh-ancestor
153361852|NCT03855332|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153361853|NCT03855332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153361854|NCT03855332|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153361855|NCT03855332|Respiratory System Agents|respiratory system agents|mesh-ancestor
153361856|NCT03855332|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153361857|NCT03855332|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153821888|NCT03271047|Ipilimumab|ipilimumab|mesh-list
153821893|NCT00440765|Bortezomib|bortezomib|mesh-list
153361861|NCT03855332|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
153361862|NCT02335580|Somatostatin|somatostatin|mesh-list
153361863|NCT02335580|Hormones|hormones|mesh-ancestor
153361864|NCT02335580|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153361865|NCT02335580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153361866|NCT02476968|Olaparib|olaparib|mesh-list
153361867|NCT02476968|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
153361868|NCT02476968|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153361869|NCT02476968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153821913|NCT00440843|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153361870|NCT02476968|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153361871|NCT01514513|Permethrin|permethrin|mesh-list
153361872|NCT01514513|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153361873|NCT01514513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153361874|NCT01432145|Methotrexate|methotrexate|mesh-list
153361875|NCT01432145|Mercaptopurine|mercaptopurine|mesh-list
153361876|NCT01432145|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
153361877|NCT01432145|Abortifacient Agents|abortifacient agents|mesh-ancestor
153361878|NCT01432145|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153361879|NCT01432145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153361880|NCT01432145|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153361881|NCT01432145|Antimetabolites|antimetabolites|mesh-ancestor
153361882|NCT01432145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153361883|NCT01432145|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153361884|NCT01432145|Dermatologic Agents|dermatologic agents|mesh-ancestor
153361885|NCT01432145|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153361886|NCT01432145|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153361887|NCT01432145|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153361888|NCT01432145|Immunologic Factors|immunologic factors|mesh-ancestor
153361897|NCT01432379|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153361898|NCT01432379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153361899|NCT01432379|Cholinergic Agents|cholinergic agents|mesh-ancestor
153361900|NCT01432379|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153361901|NCT01432379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153361902|NCT01432379|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
153821959|NCT00438828|Dexamethasone|dexamethasone|mesh-list
153821960|NCT00438828|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153821961|NCT00438828|Antiemetics|antiemetics|mesh-ancestor
153361916|NCT05946772|Cyclosporine|cyclosporine|mesh-list
153361917|NCT05946772|Cyclosporins|cyclosporins|mesh-list
153361918|NCT05946772|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153361919|NCT05946772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153361920|NCT05946772|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153361921|NCT05946772|Immunologic Factors|immunologic factors|mesh-ancestor
153361922|NCT05946772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153361923|NCT05946772|Antifungal Agents|antifungal agents|mesh-ancestor
153361924|NCT05946772|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153361925|NCT05946772|Dermatologic Agents|dermatologic agents|mesh-ancestor
153361926|NCT05946772|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153361927|NCT05946772|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
153361928|NCT05946564|Pioglitazone|pioglitazone|mesh-list
153361929|NCT05946564|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153361930|NCT05946564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153361932|NCT05946486|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153890153|NCT03764553|Antimetabolites|antimetabolites|mesh-ancestor
153914645|NCT02709031|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153821977|NCT00441155|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153821978|NCT00106002|Pemetrexed|pemetrexed|mesh-list
153821979|NCT00106002|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153821980|NCT00106002|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153361950|NCT05946135|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153361951|NCT05946135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153361952|NCT05946122|Atorvastatin|atorvastatin|mesh-list
153361953|NCT05946122|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153361963|NCT05946005|Anesthetics, Local|anesthetics, local|mesh-ancestor
153361964|NCT05946005|Anesthetics|anesthetics|mesh-ancestor
153361965|NCT05946005|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153431150|NCT06316076|Fludarabine|fludarabine|mesh-list
153431151|NCT06316076|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153822017|NCT00438984|Immunologic Factors|immunologic factors|mesh-ancestor
153361975|NCT05946005|Blood Substitutes|blood substitutes|mesh-ancestor
153361976|NCT05946005|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
153361977|NCT05946005|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153361978|NCT05945979|Biotin|biotin|mesh-list
153361979|NCT05945979|Vitamin B Complex|vitamin b complex|mesh-ancestor
153361982|NCT05945979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153361983|NCT05945771|Grape Seed Extract|grape seed extract|mesh-list
153361984|NCT05945771|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153890157|NCT03764553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153431154|NCT06316076|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153822026|NCT00438984|Analgesics|analgesics|mesh-ancestor
153361992|NCT05945745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153361993|NCT05945420|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
153361994|NCT05945420|Hemostatics|hemostatics|mesh-ancestor
153361995|NCT05945420|Coagulants|coagulants|mesh-ancestor
153361996|NCT05945420|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
153361997|NCT05945420|Natriuretic Agents|natriuretic agents|mesh-ancestor
153361998|NCT05945420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153361999|NCT05945368|Trastuzumab|trastuzumab|mesh-list
153362001|NCT05945368|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153431155|NCT06316076|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153822040|NCT00441662|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153822041|NCT00441662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153822043|NCT00439062|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153822044|NCT00439062|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153362002|NCT05945368|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153362004|NCT05945173|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
153362005|NCT05945173|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153362006|NCT05945173|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153362007|NCT05945173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153362009|NCT05944107|Anticoagulants|anticoagulants|mesh-ancestor
153362010|NCT05944107|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153362011|NCT05944107|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153362012|NCT05944107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153362013|NCT05943080|Epinephrine|epinephrine|mesh-list
153362014|NCT05943080|Racepinephrine|racepinephrine|mesh-list
153362015|NCT05943080|Bupivacaine|bupivacaine|mesh-list
153362016|NCT05943080|Epinephryl borate|epinephryl borate|mesh-list
153362017|NCT05943080|Anesthetics, Local|anesthetics, local|mesh-ancestor
153362018|NCT05943080|Anesthetics|anesthetics|mesh-ancestor
153362019|NCT05943080|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153362020|NCT05943080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153362021|NCT05943080|Sensory System Agents|sensory system agents|mesh-ancestor
153362022|NCT05943080|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153362023|NCT05943080|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153362024|NCT05943080|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153362025|NCT05943080|Adrenergic Agents|adrenergic agents|mesh-ancestor
153362026|NCT05943080|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153362027|NCT05943080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153362028|NCT05943080|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
153362029|NCT05943080|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153362030|NCT05943080|Autonomic Agents|autonomic agents|mesh-ancestor
153362031|NCT05943080|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153822054|NCT00441740|Docetaxel|docetaxel|mesh-list
153822055|NCT00441740|Vinorelbine|vinorelbine|mesh-list
153822056|NCT00441740|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153822057|NCT00441740|Antimetabolites|antimetabolites|mesh-ancestor
153822058|NCT00441740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153822059|NCT00441740|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153822060|NCT00441740|Tubulin Modulators|tubulin modulators|mesh-ancestor
153822061|NCT00441740|Antimitotic Agents|antimitotic agents|mesh-ancestor
153822062|NCT00441740|Mitosis Modulators|mitosis modulators|mesh-ancestor
153822063|NCT00441740|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153822064|NCT02274012|Paclitaxel|paclitaxel|mesh-list
153822065|NCT02274012|Afatinib|afatinib|mesh-list
153822066|NCT02274012|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153822067|NCT02274012|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153822068|NCT02274012|Tubulin Modulators|tubulin modulators|mesh-ancestor
153822069|NCT02274012|Antimitotic Agents|antimitotic agents|mesh-ancestor
153822070|NCT02274012|Mitosis Modulators|mitosis modulators|mesh-ancestor
153822071|NCT02274012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153822072|NCT02274012|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153890161|NCT03764553|Antidotes|antidotes|mesh-ancestor
153822073|NCT02274012|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153822074|NCT02274012|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153822075|NCT00477048|Saquinavir|saquinavir|mesh-list
153822076|NCT00477048|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
153822077|NCT00477048|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
153822078|NCT00477048|Protease Inhibitors|protease inhibitors|mesh-ancestor
153822079|NCT00477048|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153822080|NCT00477048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153822081|NCT00477048|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153822082|NCT00477048|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153822083|NCT00477048|Antiviral Agents|antiviral agents|mesh-ancestor
153822084|NCT00477048|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153822085|NCT00477048|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
153822086|NCT00477048|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153822087|NCT00477126|Ritonavir|ritonavir|mesh-list
153362056|NCT05867147|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
153362057|NCT05867147|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153362058|NCT05867147|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153362059|NCT05867147|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153362060|NCT05867147|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153362061|NCT05867147|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153362062|NCT05867147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153362063|NCT05867147|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153362064|NCT05867147|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
153362065|NCT05867147|Contraceptive Agents|contraceptive agents|mesh-ancestor
153362066|NCT05867147|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153362067|NCT05867147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153362068|NCT05867147|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
153362070|NCT05867147|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
153362072|NCT05827484|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153362073|NCT05827484|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153362074|NCT05827484|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
153362075|NCT05827484|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
153362076|NCT05827484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153362077|NCT05820841|Acalabrutinib|acalabrutinib|mesh-list
153822123|NCT00442052|Analgesics|analgesics|mesh-ancestor
153822124|NCT00442052|Sensory System Agents|sensory system agents|mesh-ancestor
153822126|NCT00442052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153822127|NCT00442052|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153822128|NCT00442052|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153822129|NCT00442052|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153822130|NCT00442052|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153822131|NCT00442052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153822132|NCT00442052|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153822133|NCT00442052|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153822134|NCT00442052|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153822135|NCT00442052|Antipyretics|antipyretics|mesh-ancestor
153822136|NCT00442052|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
153822137|NCT00442052|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153362092|NCT05731518|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153362093|NCT05696795|Abrocitinib|abrocitinib|mesh-list
153362094|NCT05696795|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153362095|NCT05696795|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153362096|NCT05696795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153362097|NCT05687110|Novobiocin|novobiocin|mesh-list
153362098|NCT05687110|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153362099|NCT05687110|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153362100|NCT05687110|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153362109|NCT05674565|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153362110|NCT05674565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153362111|NCT05674565|Anesthetics|anesthetics|mesh-ancestor
153362112|NCT05674565|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153362113|NCT05674565|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153822138|NCT00442052|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
153822139|NCT00477282|Topotecan|topotecan|mesh-list
153822140|NCT00477282|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
153822141|NCT00477282|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153822142|NCT00477282|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153822143|NCT00477282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153822144|NCT00477282|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153822145|NCT00439530|Oseltamivir|oseltamivir|mesh-list
153822146|NCT00439530|Probenecid|probenecid|mesh-list
153822147|NCT00439530|Antiviral Agents|antiviral agents|mesh-ancestor
153822148|NCT00439530|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153822149|NCT00439530|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153822150|NCT00439530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153822151|NCT00439530|Uricosuric Agents|uricosuric agents|mesh-ancestor
153822152|NCT00439530|Gout Suppressants|gout suppressants|mesh-ancestor
153822153|NCT00439530|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153822154|NCT00442325|Atorvastatin|atorvastatin|mesh-list
153822155|NCT00442325|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153822156|NCT00442325|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153822157|NCT00442325|Antimetabolites|antimetabolites|mesh-ancestor
153822159|NCT00442325|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153362136|NCT05531942|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153362137|NCT05531942|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153362138|NCT05531942|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153362139|NCT05531942|Antipyretics|antipyretics|mesh-ancestor
153362140|NCT05479916|Caseins|caseins|mesh-list
153362141|NCT05479916|Chelating Agents|chelating agents|mesh-ancestor
153362142|NCT05479916|Sequestering Agents|sequestering agents|mesh-ancestor
153362143|NCT05479916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153822161|NCT00442325|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153822165|NCT00477516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153822166|NCT00477516|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
153822167|NCT00477711|Capecitabine|capecitabine|mesh-list
153822168|NCT00477711|Cetuximab|cetuximab|mesh-list
153822172|NCT00477711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153890163|NCT03764553|Vitamin B Complex|vitamin b complex|mesh-ancestor
153431157|NCT06316076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153431158|NCT06316076|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153431159|NCT06316076|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153431160|NCT06315933|Anesthetics|anesthetics|mesh-list
153431161|NCT06315933|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153431162|NCT06315933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153431163|NCT06315920|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
153431164|NCT06315920|Parecoxib|parecoxib|mesh-list
153431165|NCT06315920|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-list
153431166|NCT06315920|Morphine|morphine|mesh-list
153431167|NCT06315920|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153431168|NCT06315920|Narcotics|narcotics|mesh-ancestor
153431169|NCT06315920|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153431170|NCT06315920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153822173|NCT00477711|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153822174|NCT00442403|Chloroquine|chloroquine|mesh-list
153822175|NCT00442403|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
153822176|NCT00442403|Amebicides|amebicides|mesh-ancestor
153822177|NCT00442403|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153822178|NCT00442403|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153822179|NCT00442403|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153822180|NCT00442403|Antimalarials|antimalarials|mesh-ancestor
153822181|NCT00442403|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153822182|NCT00442403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153822183|NCT00442403|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153822184|NCT00442403|Immunologic Factors|immunologic factors|mesh-ancestor
153822185|NCT00477789|Allopurinol|allopurinol|mesh-list
153822186|NCT00477789|Antimetabolites|antimetabolites|mesh-ancestor
153822187|NCT00477789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153822188|NCT00477789|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153822189|NCT00477789|Gout Suppressants|gout suppressants|mesh-ancestor
153822190|NCT00477789|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153362144|NCT05451940|Hydroxyurea|hydroxyurea|mesh-list
153362145|NCT05451940|Epoetin Alfa|epoetin alfa|mesh-list
153362146|NCT05451940|Hematinics|hematinics|mesh-list
153362147|NCT05451940|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153362148|NCT05451940|Antisickling Agents|antisickling agents|mesh-ancestor
153362149|NCT05451940|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153362150|NCT05451940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153362151|NCT05451940|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153362152|NCT05447559|Cefazolin|cefazolin|mesh-list
153362153|NCT05447559|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153362154|NCT05447559|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153362155|NCT05422664|Lacosamide|lacosamide|mesh-list
153362156|NCT05422664|Anticonvulsants|anticonvulsants|mesh-ancestor
153362157|NCT05422664|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
153890164|NCT03764553|Vitamins|vitamins|mesh-ancestor
153890165|NCT03764553|Micronutrients|micronutrients|mesh-ancestor
153890166|NCT04320225|Dexamethasone|dexamethasone|mesh-list
153890167|NCT04320225|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153890168|NCT04320225|Antiemetics|antiemetics|mesh-ancestor
153890169|NCT04320225|Autonomic Agents|autonomic agents|mesh-ancestor
153890170|NCT04320225|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153890171|NCT04320225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153890172|NCT04320225|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153890173|NCT04320225|Glucocorticoids|glucocorticoids|mesh-ancestor
153890174|NCT04320225|Hormones|hormones|mesh-ancestor
153890175|NCT04320225|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153890176|NCT04320225|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153890177|NCT04320225|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153362160|NCT05422664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153362161|NCT05341583|Ensartinib|ensartinib|mesh-list
153362162|NCT05341583|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153362163|NCT05341583|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153362164|NCT05341583|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153362173|NCT05155436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153362174|NCT05155436|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153822191|NCT00477789|Free Radical Scavengers|free radical scavengers|mesh-ancestor
153822192|NCT00477789|Antioxidants|antioxidants|mesh-ancestor
153822193|NCT00477789|Protective Agents|protective agents|mesh-ancestor
153822194|NCT00477789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153822195|NCT00442481|Escitalopram|escitalopram|mesh-list
153822196|NCT00442481|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
153822197|NCT00442481|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153822198|NCT00442481|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153822201|NCT00442481|Serotonin Agents|serotonin agents|mesh-ancestor
153822202|NCT00442481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153822203|NCT00442637|Bevacizumab|bevacizumab|mesh-list
153822204|NCT00442637|Capecitabine|capecitabine|mesh-list
153822205|NCT00442637|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153822206|NCT00442637|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153822207|NCT00442637|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153822208|NCT00442637|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153822209|NCT00442637|Growth Substances|growth substances|mesh-ancestor
153822210|NCT00442637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153822211|NCT00442637|Growth Inhibitors|growth inhibitors|mesh-ancestor
153890178|NCT03219177|Analgesics, Opioid|analgesics, opioid|mesh-list
153822212|NCT00442637|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153822213|NCT00442637|Antimetabolites|antimetabolites|mesh-ancestor
153822214|NCT00442637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153822215|NCT00442676|Celecoxib|celecoxib|mesh-list
153822216|NCT00442676|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153822217|NCT00442676|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153822218|NCT00442676|Analgesics|analgesics|mesh-ancestor
153822219|NCT00442676|Sensory System Agents|sensory system agents|mesh-ancestor
153822220|NCT00442676|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153822221|NCT00442676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153362176|NCT05155436|Vasodilator Agents|vasodilator agents|mesh-ancestor
153362177|NCT05155436|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
153362178|NCT05155436|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
153362179|NCT05103696|Propofol|propofol|mesh-list
153362180|NCT05103696|Etomidate|etomidate|mesh-list
153362181|NCT05103696|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153362182|NCT05103696|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153362183|NCT05103696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153362184|NCT05103696|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153362185|NCT05103696|Anesthetics, General|anesthetics, general|mesh-ancestor
153362186|NCT05103696|Anesthetics|anesthetics|mesh-ancestor
153362187|NCT04981041|Clopidogrel|clopidogrel|mesh-list
153362189|NCT04981041|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
153362190|NCT04981041|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153362191|NCT04981041|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
153362192|NCT04981041|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
153362193|NCT04981041|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
153362194|NCT04981041|Purinergic Agents|purinergic agents|mesh-ancestor
153822229|NCT00477945|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153822230|NCT00477945|Antimetabolites|antimetabolites|mesh-ancestor
153822231|NCT00477945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153822232|NCT00477945|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153822233|NCT00442793|Epoetin Alfa|epoetin alfa|mesh-list
153822234|NCT00442793|Hematinics|hematinics|mesh-ancestor
153822235|NCT00442832|Vancomycin|vancomycin|mesh-list
153822236|NCT00442832|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153822237|NCT00442832|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153822238|NCT00477984|Ethanol|ethanol|mesh-list
153822239|NCT00477984|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
153822240|NCT00477984|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153362195|NCT04981041|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153362196|NCT04981041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153362197|NCT04981041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153362198|NCT04898725|Vitamin D|vitamin d|mesh-list
153362199|NCT04898725|Cholecalciferol|cholecalciferol|mesh-list
153362200|NCT04898725|Vitamins|vitamins|mesh-ancestor
153362201|NCT04898725|Micronutrients|micronutrients|mesh-ancestor
153362202|NCT04898725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153362203|NCT04898725|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153362204|NCT04898725|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153362205|NCT04840550|Lansoprazole|lansoprazole|mesh-list
153362206|NCT04840550|Dexlansoprazole|dexlansoprazole|mesh-list
153362207|NCT04840550|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
153362208|NCT04840550|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153362209|NCT04840550|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
153362210|NCT04840550|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153362211|NCT04840550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153890183|NCT03219177|Sensory System Agents|sensory system agents|mesh-ancestor
153890184|NCT03219177|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153890185|NCT02866071|Ketamine|ketamine|mesh-list
153890186|NCT02866071|Analgesics|analgesics|mesh-ancestor
153822247|NCT00478101|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153822248|NCT00478101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153822250|NCT00478101|Sensory System Agents|sensory system agents|mesh-ancestor
153822251|NCT00478101|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153822252|NCT00478101|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153822253|NCT00478101|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153822254|NCT00478101|Anesthetics, General|anesthetics, general|mesh-ancestor
153822255|NCT00478101|Anesthetics|anesthetics|mesh-ancestor
153822256|NCT00440076|Bortezomib|bortezomib|mesh-list
153822257|NCT00440076|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153822258|NCT00443105|Tacrolimus|tacrolimus|mesh-list
153362212|NCT04736745|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
153362213|NCT04736745|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
153362214|NCT04736745|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153362215|NCT04736745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153362216|NCT04736745|Cholinergic Agents|cholinergic agents|mesh-ancestor
153362217|NCT04736745|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153362218|NCT04736745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153362220|NCT04731844|Piperine|piperine|mesh-list
153362221|NCT04731844|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153362222|NCT04731844|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153362223|NCT04731844|Analgesics|analgesics|mesh-ancestor
153362224|NCT04731844|Sensory System Agents|sensory system agents|mesh-ancestor
153362225|NCT04731844|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153362226|NCT04731844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153890207|NCT02890602|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153890208|NCT02890602|Alkylating Agents|alkylating agents|mesh-ancestor
153890209|NCT02890602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153890210|NCT02890602|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153890211|NCT02890602|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153890212|NCT02890602|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153822272|NCT00440154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153362245|NCT04512365|Hormones|hormones|mesh-ancestor
153890218|NCT02890602|Hormones|hormones|mesh-ancestor
153890219|NCT02890602|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153890220|NCT02890602|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153890221|NCT02890602|Hematinics|hematinics|mesh-ancestor
153890222|NCT01259115|Ketoconazole|ketoconazole|mesh-list
153890223|NCT01259115|Buprenorphine|buprenorphine|mesh-list
153890224|NCT01259115|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153890225|NCT01259115|Narcotics|narcotics|mesh-ancestor
153890226|NCT01259115|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153890227|NCT01259115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153890228|NCT01259115|Analgesics|analgesics|mesh-ancestor
153890229|NCT01259115|Sensory System Agents|sensory system agents|mesh-ancestor
153890230|NCT01259115|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153890231|NCT01259115|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
153890232|NCT01259115|Antifungal Agents|antifungal agents|mesh-ancestor
153890233|NCT01259115|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153362246|NCT04512365|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153362247|NCT04480853|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
153890234|NCT01259115|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
153890235|NCT01259115|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153890236|NCT01259115|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153890237|NCT01259115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153890238|NCT01259115|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153431231|NCT06315634|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
153431232|NCT06315634|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153822286|NCT00478452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153822288|NCT00478452|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153822289|NCT00478452|Alkylating Agents|alkylating agents|mesh-ancestor
153822290|NCT00478452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153822291|NCT00478452|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153822292|NCT00478452|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153822293|NCT03279549|Mitogens|mitogens|mesh-list
153822294|NCT03279549|Mitosis Modulators|mitosis modulators|mesh-ancestor
153362248|NCT04480853|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
153362249|NCT04480853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153362250|NCT04480853|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153362251|NCT04480853|Immunologic Factors|immunologic factors|mesh-ancestor
153362252|NCT04480853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153383380|NCT02362373|Levonorgestrel|levonorgestrel|mesh-list
153383381|NCT02362373|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
153383382|NCT02362373|Contraceptive Agents|contraceptive agents|mesh-ancestor
153383383|NCT02362373|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153383384|NCT02362373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153383385|NCT02362373|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
153383386|NCT02362373|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
153383387|NCT02362373|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
153383388|NCT02363621|Ranibizumab|ranibizumab|mesh-list
153383390|NCT02363621|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153362253|NCT04452214|Carboplatin|carboplatin|mesh-list
153890239|NCT01259115|Hormone Antagonists|hormone antagonists|mesh-ancestor
153890240|NCT01259115|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153890241|NCT01259115|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
153890242|NCT01302054|Fesoterodine|fesoterodine|mesh-list
153890243|NCT01302054|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
153890255|NCT01300572|Cyclosporine|cyclosporine|mesh-list
153362256|NCT04452214|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153362257|NCT04452214|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153362258|NCT04452214|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153362259|NCT04452214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153362260|NCT04452214|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153362261|NCT04452214|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153362262|NCT04452214|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153362263|NCT04398719|Capsaicin|capsaicin|mesh-list
153362264|NCT04398719|Antipruritics|antipruritics|mesh-ancestor
153362265|NCT04398719|Dermatologic Agents|dermatologic agents|mesh-ancestor
153362266|NCT04398719|Sensory System Agents|sensory system agents|mesh-ancestor
153822309|NCT00440349|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153822310|NCT00440349|Glucocorticoids|glucocorticoids|mesh-ancestor
153822311|NCT00440349|Hormones|hormones|mesh-ancestor
153822312|NCT00440349|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153822313|NCT00440349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153362269|NCT04339270|Azithromycin|azithromycin|mesh-list
153362270|NCT04339270|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153362271|NCT04339270|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153362272|NCT04080427|Dronabinol|dronabinol|mesh-list
153362273|NCT04080427|Hallucinogens|hallucinogens|mesh-ancestor
153362274|NCT04080427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153362275|NCT04080427|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153362276|NCT04080427|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153362277|NCT04080427|Analgesics|analgesics|mesh-ancestor
153362278|NCT04080427|Sensory System Agents|sensory system agents|mesh-ancestor
153362279|NCT04080427|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153362280|NCT04080427|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
153362281|NCT04080427|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
153362282|NCT04080427|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153362283|NCT04080427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153362284|NCT04080427|Hormones|hormones|mesh-ancestor
153362285|NCT04080427|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153362286|NCT03933631|Ofloxacin|ofloxacin|mesh-list
153362287|NCT03933631|Prednisolone|prednisolone|mesh-list
153362288|NCT03933631|Prednisolone acetate|prednisolone acetate|mesh-list
153362289|NCT03933631|Pilocarpine|pilocarpine|mesh-list
153362290|NCT03933631|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153362291|NCT03933631|Glucocorticoids|glucocorticoids|mesh-ancestor
153822321|NCT00443339|Darbepoetin alfa|darbepoetin alfa|mesh-list
153822323|NCT04700228|Dexmedetomidine|dexmedetomidine|mesh-list
153822324|NCT04700228|Bupivacaine|bupivacaine|mesh-list
153822325|NCT04700228|Anesthetics, Local|anesthetics, local|mesh-ancestor
153822326|NCT04700228|Anesthetics|anesthetics|mesh-ancestor
153822327|NCT04700228|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153822328|NCT04700228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153822329|NCT04700228|Sensory System Agents|sensory system agents|mesh-ancestor
153822330|NCT04700228|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153822331|NCT04700228|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153822332|NCT04700228|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153822333|NCT04700228|Analgesics|analgesics|mesh-ancestor
153822334|NCT04700228|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
153822335|NCT04700228|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153822336|NCT04700228|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153362297|NCT03933631|Autonomic Agents|autonomic agents|mesh-ancestor
153362298|NCT03933631|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153890310|NCT01300260|Hormones|hormones|mesh-ancestor
153362321|NCT03919435|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153362322|NCT03919435|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153362323|NCT03919435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153362324|NCT03919435|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
153362325|NCT03919435|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
153362326|NCT03919435|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153362327|NCT03919435|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153362330|NCT03911414|N-monoacetylcystine|n-monoacetylcystine|mesh-list
153362331|NCT03911414|Antiviral Agents|antiviral agents|mesh-ancestor
153431337|NCT06314698|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153431338|NCT06314698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153431339|NCT06314685|Vaccines|vaccines|mesh-list
153431340|NCT06314685|Immunologic Factors|immunologic factors|mesh-ancestor
153890320|NCT01256385|Immunoglobulins|immunoglobulins|mesh-list
153890321|NCT01256385|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
153890322|NCT01256385|Immunologic Factors|immunologic factors|mesh-ancestor
153890323|NCT01256385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153890324|NCT01256385|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153890325|NCT01256385|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153890326|NCT01256385|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153890327|NCT01256385|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153890328|NCT01256385|Antifungal Agents|antifungal agents|mesh-ancestor
153890329|NCT01256385|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153890330|NCT01256385|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153890331|NCT01256385|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153890332|NCT01256385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153890333|NCT00637182|Anastrozole|anastrozole|mesh-list
153890334|NCT00637182|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153362337|NCT03911414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153362339|NCT03911414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153362340|NCT03911414|Antidotes|antidotes|mesh-ancestor
153362341|NCT03911414|Vitamin B Complex|vitamin b complex|mesh-ancestor
153362342|NCT03911414|Vitamins|vitamins|mesh-ancestor
153362343|NCT03911414|Micronutrients|micronutrients|mesh-ancestor
153362344|NCT03900754|Oxytocin|oxytocin|mesh-list
153362345|NCT03900754|Oxytocics|oxytocics|mesh-ancestor
153362346|NCT03900754|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153362347|NCT03900754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153362348|NCT03861091|Risedronic Acid|risedronic acid|mesh-list
153362349|NCT03861091|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153362350|NCT03861091|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153362351|NCT03861091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153362352|NCT03861091|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153362353|NCT03861091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153362354|NCT03861091|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153362355|NCT03772717|Immunoglobulins|immunoglobulins|mesh-list
153362356|NCT03772717|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
153431366|NCT06310824|Denosumab|denosumab|mesh-list
153431367|NCT06310824|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153431368|NCT06310824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153890346|NCT01298778|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153890348|NCT01298778|Sensory System Agents|sensory system agents|mesh-ancestor
153890349|NCT01298778|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153890350|NCT01298778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153890351|NCT01298778|Antipyretics|antipyretics|mesh-ancestor
153890352|NCT01298778|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153890353|NCT01298778|Narcotics|narcotics|mesh-ancestor
153890354|NCT01298778|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153890355|NCT01298700|Bimatoprost|bimatoprost|mesh-list
153890356|NCT01298700|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
153890357|NCT01298700|Ophthalmic Solutions|ophthalmic solutions|mesh-list
153890358|NCT01298700|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153890359|NCT01297920|Brimonidine Tartrate|brimonidine tartrate|mesh-list
153822405|NCT00443612|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
153822406|NCT00443612|Irbesartan|irbesartan|mesh-list
153822407|NCT00443612|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153383391|NCT02363621|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153383392|NCT02363621|Growth Substances|growth substances|mesh-ancestor
153383393|NCT02363621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153383394|NCT02363621|Growth Inhibitors|growth inhibitors|mesh-ancestor
153383395|NCT02363621|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153383429|NCT02365961|Respiratory System Agents|respiratory system agents|mesh-ancestor
153383430|NCT02365961|Mydriatics|mydriatics|mesh-ancestor
153383431|NCT02365961|Sympathomimetics|sympathomimetics|mesh-ancestor
153383432|NCT02365961|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
153383433|NCT02365961|Analgesics|analgesics|mesh-ancestor
153383434|NCT02365961|Sensory System Agents|sensory system agents|mesh-ancestor
153383435|NCT02365961|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153383436|NCT02365961|Sympatholytics|sympatholytics|mesh-ancestor
153822408|NCT00443612|Diuretics|diuretics|mesh-ancestor
153822409|NCT00443612|Natriuretic Agents|natriuretic agents|mesh-ancestor
153822410|NCT00443612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153822411|NCT00443612|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
153822412|NCT00443612|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153822413|NCT00443612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153822414|NCT00443612|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
153822415|NCT00443612|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
153822416|NCT00443690|Rolofylline|rolofylline|mesh-list
153822417|NCT00443690|Diuretics|diuretics|mesh-ancestor
153822418|NCT00443690|Natriuretic Agents|natriuretic agents|mesh-ancestor
153822419|NCT00443690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153822420|NCT00440895|Abciximab|abciximab|mesh-list
153822421|NCT00440895|Anticoagulants|anticoagulants|mesh-ancestor
153822422|NCT00440895|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153822423|NCT00440973|Bevacizumab|bevacizumab|mesh-list
153431399|NCT06305754|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153431400|NCT06305754|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153431401|NCT06305754|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153431402|NCT06305754|Analgesics|analgesics|mesh-ancestor
153890376|NCT01255761|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153890377|NCT01255761|Immunologic Factors|immunologic factors|mesh-ancestor
153890378|NCT01255761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153890379|NCT01255761|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153890380|NCT01297062|Exenatide|exenatide|mesh-list
153890381|NCT01297062|Moxifloxacin|moxifloxacin|mesh-list
153890382|NCT01297062|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153890383|NCT01297062|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153890384|NCT01297062|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153890385|NCT01297062|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153890386|NCT01297062|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153890387|NCT01297062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153890388|NCT01297062|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153890389|NCT01297062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153890390|NCT01297062|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
153890391|NCT01297062|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153890392|NCT01297062|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
153822436|NCT00443924|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
153822437|NCT00443924|Ophthalmic Solutions|ophthalmic solutions|mesh-list
153822438|NCT00441051|Diclofenac|diclofenac|mesh-list
153822439|NCT00441051|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153822440|NCT00441051|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153822441|NCT00441051|Analgesics|analgesics|mesh-ancestor
153822442|NCT00441051|Sensory System Agents|sensory system agents|mesh-ancestor
153822443|NCT00441051|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153822444|NCT00441051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153362399|NCT03356483|Hallucinogens|hallucinogens|mesh-ancestor
153362400|NCT03356483|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153362401|NCT03326063|Ifetroban|ifetroban|mesh-list
153362402|NCT03326063|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153362403|NCT03324984|Bupivacaine|bupivacaine|mesh-list
153362404|NCT03324984|Chloroprocaine|chloroprocaine|mesh-list
153362405|NCT03324984|Anesthetics, Local|anesthetics, local|mesh-ancestor
153362406|NCT03324984|Anesthetics|anesthetics|mesh-ancestor
153362407|NCT03324984|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153362408|NCT03324984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153362409|NCT03324984|Sensory System Agents|sensory system agents|mesh-ancestor
153362410|NCT03324984|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153362411|NCT03275857|Cisplatin|cisplatin|mesh-list
153431459|NCT06285357|Vitamins|vitamins|mesh-ancestor
153431460|NCT06285357|Micronutrients|micronutrients|mesh-ancestor
153431461|NCT06285357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153431462|NCT06285240|Donepezil|donepezil|mesh-list
153431463|NCT06285240|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
153822471|NCT00444041|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153822472|NCT00444041|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153822473|NCT00444041|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153822474|NCT00444041|Growth Substances|growth substances|mesh-ancestor
153822475|NCT00444041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153822476|NCT00444041|Growth Inhibitors|growth inhibitors|mesh-ancestor
153822477|NCT00441246|Phenylpropanolamine|phenylpropanolamine|mesh-list
153822478|NCT00441246|Pseudoephedrine|pseudoephedrine|mesh-list
153822479|NCT00441246|Ephedrine|ephedrine|mesh-list
153822486|NCT00441246|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153822487|NCT00441246|Respiratory System Agents|respiratory system agents|mesh-ancestor
153822488|NCT00441246|Nasal Decongestants|nasal decongestants|mesh-ancestor
153822489|NCT00441246|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
153822490|NCT00441246|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
153822491|NCT00441246|Sympathomimetics|sympathomimetics|mesh-ancestor
153362446|NCT02340962|Antimetabolites|antimetabolites|mesh-ancestor
153362447|NCT02340962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153362448|NCT02340962|Immunologic Factors|immunologic factors|mesh-ancestor
153362449|NCT02340962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153362450|NCT02309645|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
153362451|NCT02309645|Hemostatics|hemostatics|mesh-ancestor
153362452|NCT02309645|Coagulants|coagulants|mesh-ancestor
153362453|NCT00788125|Carboplatin|carboplatin|mesh-list
153362454|NCT00788125|Etoposide|etoposide|mesh-list
153362455|NCT00788125|Dasatinib|dasatinib|mesh-list
153362456|NCT00788125|Ifosfamide|ifosfamide|mesh-list
153362457|NCT00788125|Etoposide phosphate|etoposide phosphate|mesh-list
153362458|NCT00788125|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153362459|NCT00788125|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153362460|NCT00788125|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153890447|NCT04324086|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153890448|NCT01295034|Vitamin D|vitamin d|mesh-list
153890449|NCT01295034|Ergocalciferols|ergocalciferols|mesh-list
153890450|NCT01295034|Cholecalciferol|cholecalciferol|mesh-list
153890451|NCT01295034|Vitamins|vitamins|mesh-list
153890452|NCT01295034|Micronutrients|micronutrients|mesh-ancestor
153890453|NCT01295034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153890454|NCT01295034|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153890455|NCT01295034|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153890456|NCT01253421|Amisulpride|amisulpride|mesh-list
153890457|NCT01253421|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153890458|NCT01253421|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153890459|NCT01253421|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153890460|NCT01253421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153890461|NCT01253421|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153890462|NCT01253421|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
153890463|NCT01253421|Dopamine Agents|dopamine agents|mesh-ancestor
153890464|NCT01253421|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153431464|NCT06285240|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153431465|NCT06285240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153362461|NCT00788125|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153362462|NCT00788125|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153362463|NCT00788125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153362464|NCT00788125|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153362465|NCT00788125|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153362466|NCT00788125|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153362467|NCT00788125|Alkylating Agents|alkylating agents|mesh-ancestor
153362468|NCT00890162|Omalizumab|omalizumab|mesh-list
153362469|NCT00890162|Epinephrine|epinephrine|mesh-list
153362470|NCT00890162|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153362471|NCT00890162|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153822504|NCT00478959|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153822505|NCT00478959|Growth Substances|growth substances|mesh-ancestor
153822506|NCT00478959|Growth Inhibitors|growth inhibitors|mesh-ancestor
153822507|NCT00478959|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153822508|NCT00444236|Esomeprazole|esomeprazole|mesh-list
153822509|NCT00444236|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
153822510|NCT00444236|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153822511|NCT00444236|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
153431475|NCT06278285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153822513|NCT00444236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153822515|NCT00478998|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
153822516|NCT00478998|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
153822517|NCT00478998|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
153822518|NCT00478998|Adrenergic Agents|adrenergic agents|mesh-ancestor
153822519|NCT00478998|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153822520|NCT00478998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153822521|NCT00478998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153822522|NCT00478998|Urological Agents|urological agents|mesh-ancestor
153822523|NCT02957279|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
153822524|NCT02957279|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153822525|NCT00479076|Aflibercept|aflibercept|mesh-list
153822526|NCT00479076|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153822527|NCT00479076|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153822528|NCT00479076|Growth Substances|growth substances|mesh-ancestor
153362484|NCT00890162|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
153362485|NCT00890162|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
153362486|NCT01433081|Magnesium Sulfate|magnesium sulfate|mesh-list
153362487|NCT01433081|Analgesics|analgesics|mesh-ancestor
153362488|NCT01433081|Sensory System Agents|sensory system agents|mesh-ancestor
153362489|NCT01433081|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153362490|NCT01433081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153362491|NCT01433081|Anesthetics|anesthetics|mesh-ancestor
153362492|NCT01433081|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153362493|NCT01433081|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153362494|NCT01433081|Anticonvulsants|anticonvulsants|mesh-ancestor
153362495|NCT01433081|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153362496|NCT01433081|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153362497|NCT01433081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153362498|NCT01433081|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153362499|NCT01433081|Tocolytic Agents|tocolytic agents|mesh-ancestor
153362500|NCT01433081|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153362501|NCT00890396|Hydroxyurea|hydroxyurea|mesh-list
153362502|NCT00890396|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153362503|NCT00890396|Antisickling Agents|antisickling agents|mesh-ancestor
153362504|NCT00890396|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153822541|NCT00441519|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153822542|NCT00441519|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153822543|NCT00441519|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153822544|NCT00441519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153822545|NCT00441519|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153822546|NCT00441519|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153822547|NCT00441519|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153822548|NCT00441519|Antipyretics|antipyretics|mesh-ancestor
153822549|NCT00441519|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
153822550|NCT00441519|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153822551|NCT00441519|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
153822552|NCT00441597|Atorvastatin|atorvastatin|mesh-list
153822553|NCT00441597|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153822554|NCT00441597|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153822555|NCT00441597|Antimetabolites|antimetabolites|mesh-ancestor
153822556|NCT00441597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153822557|NCT00441597|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153822558|NCT00441597|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
153822559|NCT00441597|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153822561|NCT00479193|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
153822562|NCT00479193|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153822563|NCT00479193|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153822564|NCT03278015|Paclitaxel|paclitaxel|mesh-list
153822565|NCT03278015|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
153431518|NCT06219915|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153431519|NCT06219915|Immunologic Factors|immunologic factors|mesh-ancestor
153431520|NCT06219915|Dopamine Agonists|dopamine agonists|mesh-ancestor
153890499|NCT01253187|Tetrahydrofolates|tetrahydrofolates|mesh-list
153890500|NCT01253187|Drospirenone|drospirenone|mesh-list
153890501|NCT01253187|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
153890502|NCT01253187|Hormone Antagonists|hormone antagonists|mesh-ancestor
153890503|NCT01253187|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153890504|NCT01253187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153822566|NCT03278015|Gemcitabine|gemcitabine|mesh-list
153822567|NCT03278015|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153822568|NCT03278015|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153822569|NCT03278015|Tubulin Modulators|tubulin modulators|mesh-ancestor
153822570|NCT03278015|Antimitotic Agents|antimitotic agents|mesh-ancestor
153822571|NCT03278015|Mitosis Modulators|mitosis modulators|mesh-ancestor
153362537|NCT01519271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153362538|NCT01519271|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
153362539|NCT01519271|Protective Agents|protective agents|mesh-ancestor
153362540|NCT01436279|Mifepristone|mifepristone|mesh-list
153362541|NCT01436279|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
153362542|NCT01436279|Abortifacient Agents|abortifacient agents|mesh-ancestor
153362543|NCT01436279|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153362544|NCT01436279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153362545|NCT01436279|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
153362546|NCT01436279|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
153362547|NCT01436279|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
153362548|NCT01436279|Contraceptive Agents|contraceptive agents|mesh-ancestor
153362549|NCT01436279|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
153362550|NCT01436279|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
153362551|NCT01436279|Hormone Antagonists|hormone antagonists|mesh-ancestor
153362552|NCT01436279|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153362553|NCT01436279|Luteolytic Agents|luteolytic agents|mesh-ancestor
153362554|NCT01436279|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
153362555|NCT01436279|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
153362556|NCT02210195|Aprepitant|aprepitant|mesh-list
153362557|NCT02210195|Antiemetics|antiemetics|mesh-ancestor
153362558|NCT02210195|Autonomic Agents|autonomic agents|mesh-ancestor
153362559|NCT02210195|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153362560|NCT02210195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153362565|NCT00836888|Nivolumab|nivolumab|mesh-list
153822601|NCT00444548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153822602|NCT00444548|Adrenergic Agents|adrenergic agents|mesh-ancestor
153822603|NCT00444548|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153822604|NCT00444548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153822605|NCT00444665|Travoprost|travoprost|mesh-list
153822606|NCT00444665|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153822607|NCT04699643|Pembrolizumab|pembrolizumab|mesh-list
153822608|NCT04699643|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153890505|NCT01253187|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
153890506|NCT01253187|Diuretics|diuretics|mesh-ancestor
153822609|NCT04699643|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153822610|NCT04699643|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153822611|NCT04699643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153822613|NCT02274090|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153822614|NCT02274090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153822615|NCT00479661|Dexmedetomidine|dexmedetomidine|mesh-list
153822616|NCT00479661|Propofol|propofol|mesh-list
153822617|NCT00479661|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153822618|NCT00479661|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153822619|NCT00479661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153362571|NCT02262026|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153362572|NCT02262026|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153362573|NCT02262026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153362574|NCT00889226|Atorvastatin|atorvastatin|mesh-list
153362575|NCT00889226|Pitavastatin|pitavastatin|mesh-list
153362576|NCT00889226|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153362577|NCT00889226|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153822624|NCT00479661|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
153822625|NCT00479661|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153822626|NCT00479661|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153822627|NCT00479661|Adrenergic Agents|adrenergic agents|mesh-ancestor
153822628|NCT00479661|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153822629|NCT00479661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153822630|NCT00479661|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153822631|NCT00479661|Anesthetics, General|anesthetics, general|mesh-ancestor
153822632|NCT00479661|Anesthetics|anesthetics|mesh-ancestor
153822633|NCT04700670|Platelet Factor 4|platelet factor 4|mesh-list
153822634|NCT04700670|Coagulants|coagulants|mesh-ancestor
153822635|NCT00441870|Folic Acid|folic acid|mesh-list
153822636|NCT00441870|Vitamin B Complex|vitamin b complex|mesh-list
153822637|NCT00441870|Hematinics|hematinics|mesh-ancestor
153822638|NCT00441870|Vitamins|vitamins|mesh-ancestor
153822639|NCT00441870|Micronutrients|micronutrients|mesh-ancestor
153431543|NCT06115070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153431545|NCT06112522|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153890518|NCT01252563|Vasodilator Agents|vasodilator agents|mesh-ancestor
153890519|NCT01292226|Cyclosporine|cyclosporine|mesh-list
153890520|NCT01292226|Mycophenolic Acid|mycophenolic acid|mesh-list
153890521|NCT01292226|Antibodies|antibodies|mesh-list
153890522|NCT01292226|Cyclosporins|cyclosporins|mesh-list
153890523|NCT01292226|Immunologic Factors|immunologic factors|mesh-ancestor
153890524|NCT01292226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153890525|NCT01292226|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153890526|NCT01292226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153890527|NCT01292226|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153890528|NCT01292226|Antifungal Agents|antifungal agents|mesh-ancestor
153890529|NCT01292226|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153890530|NCT01292226|Dermatologic Agents|dermatologic agents|mesh-ancestor
153890531|NCT01292226|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153822640|NCT00441870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153822641|NCT04700592|Ketamine|ketamine|mesh-list
153822642|NCT04700592|Gabapentin|gabapentin|mesh-list
153822643|NCT04700592|Analgesics|analgesics|mesh-ancestor
153822644|NCT04700592|Sensory System Agents|sensory system agents|mesh-ancestor
153822645|NCT04700592|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153822646|NCT04700592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153822647|NCT04700592|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
153822648|NCT04700592|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153822649|NCT04700592|Anesthetics, General|anesthetics, general|mesh-ancestor
153822650|NCT04700592|Anesthetics|anesthetics|mesh-ancestor
153822651|NCT04700592|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153822652|NCT04700592|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
153362628|NCT01437605|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153362629|NCT01541735|Pantoprazole|pantoprazole|mesh-list
153362630|NCT01541735|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
153362631|NCT01541735|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153362632|NCT01541735|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
153362633|NCT01541735|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153362634|NCT01541735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153362635|NCT01541891|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
153362636|NCT01541891|Ophthalmic Solutions|ophthalmic solutions|mesh-list
153362637|NCT01520207|Mannitol|mannitol|mesh-list
153890532|NCT01292226|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
153890533|NCT01292226|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153890534|NCT01292226|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153890535|NCT01292226|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
153890536|NCT01292226|Antitubercular Agents|antitubercular agents|mesh-ancestor
153890537|NCT01292226|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153890538|NCT01075048|Irinotecan|irinotecan|mesh-list
153890539|NCT01075048|Cetuximab|cetuximab|mesh-list
153890540|NCT01075048|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
153890541|NCT01075048|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153890542|NCT01075048|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153431546|NCT06112522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153431547|NCT06097364|Prednisone|prednisone|mesh-list
153431548|NCT06097364|Cyclophosphamide|cyclophosphamide|mesh-list
153362642|NCT01203722|Mycophenolic Acid|mycophenolic acid|mesh-list
153362643|NCT01203722|Sirolimus|sirolimus|mesh-list
153362644|NCT01203722|Fludarabine|fludarabine|mesh-list
153362645|NCT01203722|Cyclophosphamide|cyclophosphamide|mesh-list
153362646|NCT01203722|Tacrolimus|tacrolimus|mesh-list
153362647|NCT01203722|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153362648|NCT01203722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153362649|NCT01203722|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153362650|NCT01203722|Immunologic Factors|immunologic factors|mesh-ancestor
153362651|NCT01203722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153362652|NCT01203722|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
153362653|NCT01203722|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153362654|NCT01203722|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153362655|NCT01203722|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153362656|NCT01203722|Alkylating Agents|alkylating agents|mesh-ancestor
153362657|NCT01203722|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153362658|NCT01203722|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153362659|NCT01203722|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
153362660|NCT01203722|Antitubercular Agents|antitubercular agents|mesh-ancestor
153362661|NCT01203722|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153362662|NCT01203722|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153362663|NCT01203722|Antifungal Agents|antifungal agents|mesh-ancestor
153362664|NCT01520519|Rituximab|rituximab|mesh-list
153822704|NCT00479739|Adrenergic Agents|adrenergic agents|mesh-ancestor
153822705|NCT00479739|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153822706|NCT00479739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153822707|NCT00445094|Vancomycin|vancomycin|mesh-list
153822708|NCT00445094|Imipenem|imipenem|mesh-list
153822709|NCT00445094|Amikacin|amikacin|mesh-list
153822710|NCT00445094|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
153822711|NCT00445094|Cilastatin, Imipenem Drug Combination|cilastatin, imipenem drug combination|mesh-list
153822712|NCT00445094|Cilastatin|cilastatin|mesh-list
153822713|NCT00445094|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153822714|NCT00445094|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153822715|NCT00445094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153822716|NCT00445094|Protease Inhibitors|protease inhibitors|mesh-ancestor
153822717|NCT00445094|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153822718|NCT00445094|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
153822719|NCT00479778|Bazedoxifene|bazedoxifene|mesh-list
153822720|NCT00479778|Estrogens|estrogens|mesh-list
153822721|NCT00479778|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
153822722|NCT00479778|Hormones|hormones|mesh-ancestor
153822723|NCT00479778|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153822724|NCT00479778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153362674|NCT01520519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153362676|NCT03008057|Ergocalciferols|ergocalciferols|mesh-list
153362677|NCT03008057|Cholecalciferol|cholecalciferol|mesh-list
153362678|NCT03008057|Vitamins|vitamins|mesh-list
153362679|NCT03008057|Micronutrients|micronutrients|mesh-ancestor
153362680|NCT03008057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153362681|NCT03008057|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153362682|NCT03008057|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153362683|NCT01542125|Lidocaine|lidocaine|mesh-list
153362684|NCT01542125|Anesthetics, Local|anesthetics, local|mesh-ancestor
153362685|NCT01542125|Anesthetics|anesthetics|mesh-ancestor
153362695|NCT03216668|Silymarin|silymarin|mesh-list
153362696|NCT03216668|Antioxidants|antioxidants|mesh-ancestor
153362697|NCT03216668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153362698|NCT03216668|Protective Agents|protective agents|mesh-ancestor
153362699|NCT03216668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153362700|NCT02548832|Bezafibrate|bezafibrate|mesh-list
153362701|NCT02548832|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153362702|NCT02548832|Antimetabolites|antimetabolites|mesh-ancestor
153362703|NCT02548832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153362724|NCT05310344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153362725|NCT05310344|Growth Inhibitors|growth inhibitors|mesh-ancestor
153362726|NCT04381520|Antihypertensive Agents|antihypertensive agents|mesh-list
153362727|NCT00837902|Atenolol|atenolol|mesh-list
153362728|NCT00837902|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153822775|NCT00442182|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
153822776|NCT00442182|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153822777|NCT00442182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153822778|NCT03274700|Tamsulosin|tamsulosin|mesh-list
153362729|NCT00837902|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153362730|NCT00837902|Sympatholytics|sympatholytics|mesh-ancestor
153362731|NCT00837902|Autonomic Agents|autonomic agents|mesh-ancestor
153362732|NCT00837902|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153362733|NCT00837902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153362734|NCT00837902|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
153362735|NCT00837902|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
153362736|NCT00837902|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
153362737|NCT00837902|Adrenergic Agents|adrenergic agents|mesh-ancestor
153362738|NCT00837902|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153362739|NCT00837902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153362740|NCT04382144|Bupivacaine|bupivacaine|mesh-list
153362741|NCT04382144|Anesthetics, Local|anesthetics, local|mesh-ancestor
153362742|NCT04382144|Anesthetics|anesthetics|mesh-ancestor
153362743|NCT04382144|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153362744|NCT04382144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153362745|NCT04382144|Sensory System Agents|sensory system agents|mesh-ancestor
153362746|NCT04382144|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153362747|NCT03215966|Tadalafil|tadalafil|mesh-list
153362748|NCT03215966|Macitentan|macitentan|mesh-list
153362749|NCT03215966|Vasodilator Agents|vasodilator agents|mesh-ancestor
153431584|NCT06067828|Autonomic Agents|autonomic agents|mesh-ancestor
153362773|NCT00891878|Antimetabolites|antimetabolites|mesh-ancestor
153362774|NCT00891878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153362775|NCT00891878|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153362776|NCT00891878|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153822835|NCT03278808|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153822836|NCT03278808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153362793|NCT01526213|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
153362794|NCT01526213|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
153362795|NCT01526213|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
153362796|NCT01526213|Histamine Antagonists|histamine antagonists|mesh-ancestor
153362797|NCT01526213|Histamine Agents|histamine agents|mesh-ancestor
153362798|NCT01526213|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153362799|NCT01526213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153362800|NCT01526213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153362801|NCT01549223|Misoprostol|misoprostol|mesh-list
153362802|NCT01549223|Oxytocin|oxytocin|mesh-list
153362803|NCT01549223|Carboprost|carboprost|mesh-list
153362804|NCT01549223|Carboprost tromethamine|carboprost tromethamine|mesh-list
153362805|NCT01549223|Methylergonovine|methylergonovine|mesh-list
153362806|NCT01549223|Maleic acid|maleic acid|mesh-list
153362807|NCT01549223|Oxytocics|oxytocics|mesh-ancestor
153822839|NCT03278808|Antinematodal Agents|antinematodal agents|mesh-ancestor
153822840|NCT03278808|Anthelmintics|anthelmintics|mesh-ancestor
153822841|NCT03278808|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153431626|NCT06045364|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153431631|NCT06045364|Analgesics|analgesics|mesh-ancestor
153822857|NCT00454883|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153822858|NCT00454883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153362808|NCT01549223|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153362809|NCT01549223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153362810|NCT01549223|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
153362812|NCT01549223|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
153362813|NCT01549223|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153362814|NCT01549223|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153362815|NCT01549223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153362823|NCT00895934|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153362824|NCT00895934|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153362825|NCT00895934|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
153362826|NCT00895934|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153362827|NCT00895934|Immunotoxins|immunotoxins|mesh-ancestor
153362828|NCT00895934|Immunoconjugates|immunoconjugates|mesh-ancestor
153362829|NCT00895934|Immunologic Factors|immunologic factors|mesh-ancestor
153822884|NCT00442455|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153822885|NCT00442455|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153822886|NCT00442455|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153822887|NCT00442455|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153822888|NCT00442455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153822889|NCT02956655|Insulin|insulin|mesh-list
153822890|NCT02956655|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
153822891|NCT02956655|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153822892|NCT02956655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153822893|NCT00480246|Perphenazine|perphenazine|mesh-list
153822903|NCT00455117|Parecoxib|parecoxib|mesh-list
153362869|NCT01447511|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
153362870|NCT01447511|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
153362875|NCT01447511|Hormone Antagonists|hormone antagonists|mesh-ancestor
153362876|NCT01447511|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153362877|NCT01447511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153362878|NCT01447511|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
153362879|NCT01447511|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
153362880|NCT01831622|Methylphenidate|methylphenidate|mesh-list
153362881|NCT01831622|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
153362882|NCT01831622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153362886|NCT01831622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153822954|NCT00480363|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153822955|NCT00480363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153890691|NCT04305028|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153362929|NCT01831700|Lisinopril|lisinopril|mesh-list
153362930|NCT01831700|Hydrochlorothiazide, lisinopril drug combination|hydrochlorothiazide, lisinopril drug combination|mesh-list
153362931|NCT01831700|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153362932|NCT01831700|Diuretics|diuretics|mesh-ancestor
153362933|NCT01831700|Natriuretic Agents|natriuretic agents|mesh-ancestor
153822973|NCT00442845|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153822974|NCT00442845|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
153822975|NCT00442845|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153822976|NCT00455507|Istradefylline|istradefylline|mesh-list
153822977|NCT00455507|Adenosine A2 Receptor Antagonists|adenosine a2 receptor antagonists|mesh-ancestor
153822978|NCT00455507|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
153822979|NCT00455507|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
153822980|NCT00455507|Purinergic Agents|purinergic agents|mesh-ancestor
153822981|NCT00455507|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153822982|NCT00455507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153822983|NCT00455507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153822984|NCT00480402|Progesterone|progesterone|mesh-list
153822985|NCT00480402|Progestins|progestins|mesh-ancestor
153822986|NCT00480402|Hormones|hormones|mesh-ancestor
153822987|NCT00480402|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153362941|NCT01831700|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
153362942|NCT01831700|Protective Agents|protective agents|mesh-ancestor
153362943|NCT01531439|Naloxone|naloxone|mesh-list
153362944|NCT01531439|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
153362945|NCT01531439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153362946|NCT01531439|Sensory System Agents|sensory system agents|mesh-ancestor
153362947|NCT01531439|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153362948|NCT03214874|Torsemide|torsemide|mesh-list
153362949|NCT03214874|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153362952|NCT03214874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153362953|NCT03214874|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
153362954|NCT03214874|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153362955|NCT03214874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153362956|NCT02504268|Methotrexate|methotrexate|mesh-list
153362957|NCT02504268|Abatacept|abatacept|mesh-list
153362958|NCT02504268|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
153362959|NCT02504268|Abortifacient Agents|abortifacient agents|mesh-ancestor
153362960|NCT02504268|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153362961|NCT02504268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153362962|NCT02504268|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153362963|NCT02504268|Antimetabolites|antimetabolites|mesh-ancestor
153890718|NCT01283334|Cetuximab|cetuximab|mesh-list
153890719|NCT01283334|Everolimus|everolimus|mesh-list
153890720|NCT01283334|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153890721|NCT01283334|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153890722|NCT01283334|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
153890723|NCT01283334|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153890724|NCT01283334|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153890725|NCT01283334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153890726|NCT01283334|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153890727|NCT01283334|Immunologic Factors|immunologic factors|mesh-ancestor
153890728|NCT01283334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153890729|NCT04304716|Anesthetics|anesthetics|mesh-list
153890730|NCT04304716|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153890731|NCT04304716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153890732|NCT01282476|Rituximab|rituximab|mesh-list
153822994|NCT00455585|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153822995|NCT00455585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153822996|NCT00455585|Antiviral Agents|antiviral agents|mesh-ancestor
153822997|NCT00455585|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153822998|NCT00455585|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153822999|NCT00455585|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153823000|NCT00455585|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
153823001|NCT00455585|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
153823002|NCT00455585|Antimetabolites|antimetabolites|mesh-ancestor
153823004|NCT00455624|Hormones|hormones|mesh-ancestor
153823005|NCT00455624|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153823006|NCT00455624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153823007|NCT00455897|Rituximab|rituximab|mesh-list
153823008|NCT00455897|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153823009|NCT00455897|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153823010|NCT00455897|Immunologic Factors|immunologic factors|mesh-ancestor
153823011|NCT00455897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153823012|NCT00455897|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153362987|NCT01654302|Tetracaine|tetracaine|mesh-list
153362988|NCT01654302|Anesthetics, Local|anesthetics, local|mesh-ancestor
153362989|NCT01654302|Anesthetics|anesthetics|mesh-ancestor
153362990|NCT01654302|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153362991|NCT01654302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153362992|NCT01654302|Sensory System Agents|sensory system agents|mesh-ancestor
153362993|NCT01654302|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153362994|NCT01654302|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153362995|NCT01654302|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
153362996|NCT01654302|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153362997|NCT01654302|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153362998|NCT01654302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153362999|NCT01832558|Eplerenone|eplerenone|mesh-list
153431746|NCT05943990|Immunologic Factors|immunologic factors|mesh-ancestor
153431747|NCT05943990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153431748|NCT05943990|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153431750|NCT05943990|Alkylating Agents|alkylating agents|mesh-ancestor
153431751|NCT05943990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153431752|NCT05943990|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153431753|NCT05943990|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153431755|NCT05928806|Ipilimumab|ipilimumab|mesh-list
153823026|NCT00443235|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153823027|NCT00443235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153823028|NCT00443235|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153823029|NCT00443235|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153823030|NCT00443235|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153823031|NCT00443235|Alkylating Agents|alkylating agents|mesh-ancestor
153823032|NCT00443235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153823033|NCT00443235|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153823034|NCT00443235|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153823035|NCT00443235|Immunologic Factors|immunologic factors|mesh-ancestor
153823036|NCT00443235|Leprostatic Agents|leprostatic agents|mesh-ancestor
153823037|NCT00443235|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153823038|NCT00443235|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153823039|NCT00443235|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153823040|NCT00443235|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153823041|NCT00443235|Growth Substances|growth substances|mesh-ancestor
153823048|NCT00456248|Antimetabolites|antimetabolites|mesh-ancestor
153823049|NCT00456248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153823050|NCT00456248|Antiviral Agents|antiviral agents|mesh-ancestor
153823051|NCT00456248|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153823053|NCT00480558|Immunologic Factors|immunologic factors|mesh-ancestor
153823054|NCT00480558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153823055|NCT04700709|Mycophenolic Acid|mycophenolic acid|mesh-list
153823056|NCT04700709|Sirolimus|sirolimus|mesh-list
153823057|NCT04700709|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153890740|NCT01282476|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153890741|NCT01282476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153890742|NCT02889822|Alprostadil|alprostadil|mesh-list
153890743|NCT02889822|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153363028|NCT01552343|Natriuretic Agents|natriuretic agents|mesh-ancestor
153431800|NCT05831124|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
153431801|NCT05831124|Immunologic Factors|immunologic factors|mesh-ancestor
153363055|NCT01553201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153363056|NCT01553201|Cholinergic Agents|cholinergic agents|mesh-ancestor
153363057|NCT01553201|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153363058|NCT01553201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153363059|NCT03214172|Rivaroxaban|rivaroxaban|mesh-list
153363060|NCT03214172|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
153363063|NCT03214172|Protease Inhibitors|protease inhibitors|mesh-ancestor
153363064|NCT03214172|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153363065|NCT03214172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153363066|NCT03214172|Anticoagulants|anticoagulants|mesh-ancestor
153363067|NCT01832948|Leucovorin|leucovorin|mesh-list
153363068|NCT01832948|Folic Acid|folic acid|mesh-list
153363069|NCT01832948|Oxaliplatin|oxaliplatin|mesh-list
153363070|NCT01832948|Endostar protein|endostar protein|mesh-list
153363071|NCT01832948|Levoleucovorin|levoleucovorin|mesh-list
153890775|NCT04302532|Zuclomiphene|zuclomiphene|mesh-list
153890776|NCT04302532|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
153890777|NCT04302532|Hormone Antagonists|hormone antagonists|mesh-ancestor
153363072|NCT01832948|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153363073|NCT01832948|Antidotes|antidotes|mesh-ancestor
153363074|NCT01832948|Protective Agents|protective agents|mesh-ancestor
153363075|NCT01832948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153363076|NCT01832948|Vitamin B Complex|vitamin b complex|mesh-ancestor
153363077|NCT01832948|Vitamins|vitamins|mesh-ancestor
153363078|NCT01832948|Micronutrients|micronutrients|mesh-ancestor
153363079|NCT01832948|Hematinics|hematinics|mesh-ancestor
153363080|NCT01832948|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153363081|NCT01832948|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153363082|NCT01832948|Growth Substances|growth substances|mesh-ancestor
153363097|NCT01533077|Immunologic Factors|immunologic factors|mesh-ancestor
153890806|NCT01067326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153383437|NCT02365961|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
153383438|NCT03809234|Ondansetron|ondansetron|mesh-list
153383439|NCT03809234|Antiemetics|antiemetics|mesh-ancestor
153383556|NCT00354653|Antiviral Agents|antiviral agents|mesh-ancestor
153383557|NCT00354653|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153383558|NCT00354653|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153383559|NCT00354653|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153383560|NCT00354731|Pentoxifylline|pentoxifylline|mesh-list
153383561|NCT00354731|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
153383562|NCT00354731|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153383563|NCT00354731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153387720|NCT00000243|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
153890807|NCT04319601|Rituximab|rituximab|mesh-list
153363101|NCT01534013|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
153363102|NCT01534013|Pancrelipase|pancrelipase|mesh-list
153363103|NCT01534013|Pancreatin|pancreatin|mesh-list
153363104|NCT01534013|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153363105|NCT01534013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153363106|NCT01534013|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153363107|NCT03211988|Entinostat|entinostat|mesh-list
153363108|NCT03211988|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153890831|NCT01273818|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153890832|NCT01273818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153890833|NCT01037218|Udenafil|udenafil|mesh-list
153890834|NCT01037218|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
153890835|NCT01037218|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
153890836|NCT01037218|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153914646|NCT02709031|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153431845|NCT05740371|Argatroban|argatroban|mesh-list
153431846|NCT05740371|Antithrombins|antithrombins|mesh-ancestor
153431847|NCT05740371|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
153431848|NCT05740371|Protease Inhibitors|protease inhibitors|mesh-ancestor
153431849|NCT05740371|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153431850|NCT05740371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153431851|NCT05740371|Anticoagulants|anticoagulants|mesh-ancestor
153431852|NCT05740371|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153890839|NCT01038856|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153890840|NCT01038856|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153890841|NCT01038856|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153890842|NCT01038856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153890843|NCT01038856|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153890845|NCT01269918|Remifentanil|remifentanil|mesh-list
153890846|NCT01269918|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153431884|NCT05657613|Hormone Antagonists|hormone antagonists|mesh-ancestor
153431885|NCT05657613|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153431886|NCT05657613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153363137|NCT03219710|Olanzapine|olanzapine|mesh-list
153363138|NCT03219710|Aprepitant|aprepitant|mesh-list
153363139|NCT03219710|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153363140|NCT03219710|Antiemetics|antiemetics|mesh-ancestor
153363141|NCT03219710|Autonomic Agents|autonomic agents|mesh-ancestor
153363142|NCT03219710|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153363143|NCT03219710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153363144|NCT03219710|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153363145|NCT03219710|Glucocorticoids|glucocorticoids|mesh-ancestor
153890856|NCT01269918|Adrenergic Agents|adrenergic agents|mesh-ancestor
153890857|NCT01269918|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153890858|NCT01269918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153890859|NCT01269918|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153890861|NCT01036594|Ketoconazole|ketoconazole|mesh-list
153890862|NCT01036594|Dexamethasone|dexamethasone|mesh-list
153890884|NCT01036594|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153890885|NCT01036594|Hormone Antagonists|hormone antagonists|mesh-ancestor
153890886|NCT01036594|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
153890888|NCT04301908|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153431929|NCT05600426|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153431930|NCT05600426|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153431931|NCT05600426|Antimetabolites|antimetabolites|mesh-ancestor
153890897|NCT04304248|Antimitotic Agents|antimitotic agents|mesh-ancestor
153890898|NCT04304248|Mitosis Modulators|mitosis modulators|mesh-ancestor
153823234|NCT00457145|Growth Inhibitors|growth inhibitors|mesh-ancestor
153823235|NCT00457145|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153823236|NCT00457223|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
153823238|NCT00457223|Coagulants|coagulants|mesh-ancestor
153823239|NCT00443508|Everolimus|everolimus|mesh-list
153823240|NCT00443508|Tacrolimus|tacrolimus|mesh-list
153823241|NCT00443508|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153823242|NCT00443508|Immunologic Factors|immunologic factors|mesh-ancestor
153823243|NCT00443508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153823244|NCT00443508|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
153823245|NCT00443508|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153823246|NCT00443508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153823247|NCT00443508|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
153823248|NCT00443508|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153823249|NCT00443508|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153823250|NCT00457340|Atorvastatin|atorvastatin|mesh-list
153823251|NCT00457340|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153823252|NCT00457340|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153823253|NCT00457340|Antimetabolites|antimetabolites|mesh-ancestor
153823254|NCT00457340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153823255|NCT00457340|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153363203|NCT01554371|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153363204|NCT01554371|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153363205|NCT01451411|Conivaptan|conivaptan|mesh-list
153363206|NCT01451411|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
153890902|NCT01268046|Estradiol|estradiol|mesh-list
153363207|NCT01451411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153363208|NCT01451411|Natriuretic Agents|natriuretic agents|mesh-ancestor
153363215|NCT01554683|Nootropic Agents|nootropic agents|mesh-ancestor
153363216|NCT00905060|Temozolomide|temozolomide|mesh-list
153363217|NCT00905060|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153363218|NCT00905060|Alkylating Agents|alkylating agents|mesh-ancestor
153363219|NCT00905060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153363220|NCT00905060|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153363221|NCT01535573|Dexetimide|dexetimide|mesh-list
153363222|NCT01535573|Citalopram|citalopram|mesh-list
153363223|NCT01535573|Escitalopram|escitalopram|mesh-list
153363224|NCT01535573|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
153363225|NCT01535573|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153363226|NCT01535573|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153363227|NCT01535573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153363228|NCT01535573|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153363229|NCT01535573|Serotonin Agents|serotonin agents|mesh-ancestor
153363230|NCT01535573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153363231|NCT01535573|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
153363232|NCT01535573|Antidepressive Agents|antidepressive agents|mesh-ancestor
153363233|NCT01535573|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153363234|NCT01535573|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
153823256|NCT00457340|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
153823257|NCT00457340|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153823258|NCT03278379|Avelumab|avelumab|mesh-list
153431943|NCT05581004|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153431944|NCT05581004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153431945|NCT05581004|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153431946|NCT05581004|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153431948|NCT05574712|Abiraterone Acetate|abiraterone acetate|mesh-list
153431949|NCT05574712|Belzutifan|belzutifan|mesh-list
153431950|NCT05574712|Fertility Agents, Female|fertility agents, female|mesh-ancestor
153431951|NCT05574712|Fertility Agents|fertility agents|mesh-ancestor
153823284|NCT00457769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153823285|NCT00457769|Cholinergic Agents|cholinergic agents|mesh-ancestor
153823286|NCT00457769|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153823287|NCT00457769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153823288|NCT00457769|Nootropic Agents|nootropic agents|mesh-ancestor
153823289|NCT00457808|Sirolimus|sirolimus|mesh-list
153823290|NCT00457808|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153823291|NCT00457808|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153823292|NCT00457808|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153823293|NCT00457808|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153823294|NCT00457808|Antifungal Agents|antifungal agents|mesh-ancestor
153823295|NCT00457808|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153823296|NCT00457808|Immunologic Factors|immunologic factors|mesh-ancestor
153363244|NCT01834508|Antiviral Agents|antiviral agents|mesh-ancestor
153363245|NCT01834508|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153363246|NCT01834508|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153363247|NCT01834508|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153363248|NCT01834508|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153363249|NCT01834508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153363257|NCT03218852|Prednisone|prednisone|mesh-list
153363267|NCT03218852|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153363268|NCT03218852|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153363269|NCT03218852|Glucocorticoids|glucocorticoids|mesh-ancestor
153363270|NCT03218852|Hormones|hormones|mesh-ancestor
153890924|NCT01034176|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153890925|NCT01034176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153890926|NCT01034176|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153890927|NCT01034176|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
153890928|NCT01034176|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153890929|NCT02889432|Melatonin|melatonin|mesh-list
153890930|NCT02889432|Antioxidants|antioxidants|mesh-ancestor
153890931|NCT02889432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153890932|NCT02889432|Protective Agents|protective agents|mesh-ancestor
153890933|NCT02889432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153363271|NCT03218852|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153363280|NCT01834898|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153823324|NCT00481182|Fosamprenavir|fosamprenavir|mesh-list
153823325|NCT00481182|Methadone|methadone|mesh-list
153823326|NCT00481182|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
153823327|NCT00481182|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
153823328|NCT00481182|Protease Inhibitors|protease inhibitors|mesh-ancestor
153823329|NCT00481182|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153823330|NCT00481182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153823331|NCT00481182|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153823332|NCT00481182|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153823333|NCT00481182|Antiviral Agents|antiviral agents|mesh-ancestor
153823334|NCT00481182|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153363282|NCT01557959|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
153363283|NCT01557959|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153363284|NCT01557959|Tubulin Modulators|tubulin modulators|mesh-ancestor
153363285|NCT01557959|Antimitotic Agents|antimitotic agents|mesh-ancestor
153363286|NCT01557959|Mitosis Modulators|mitosis modulators|mesh-ancestor
153363287|NCT01557959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153363288|NCT01557959|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153363289|NCT01557959|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153363290|NCT01557959|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153363291|NCT03212456|Analgesics, Opioid|analgesics, opioid|mesh-list
153363292|NCT03212456|Ropivacaine|ropivacaine|mesh-list
153363293|NCT03212456|Anesthetics, Local|anesthetics, local|mesh-ancestor
153363294|NCT03212456|Anesthetics|anesthetics|mesh-ancestor
153363295|NCT03212456|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153823369|NCT00458315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153823370|NCT00458315|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153823371|NCT00458315|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153363321|NCT02502864|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153363322|NCT02502864|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153363323|NCT02502864|Alkylating Agents|alkylating agents|mesh-ancestor
153363325|NCT02502864|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153363338|NCT03217292|Sensory System Agents|sensory system agents|mesh-ancestor
153363339|NCT03217292|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153363342|NCT03217448|Anticoagulants|anticoagulants|mesh-ancestor
153363343|NCT03217448|Antithrombins|antithrombins|mesh-ancestor
153363344|NCT03217448|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
153823380|NCT00444015|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153823383|NCT00444015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153823384|NCT00444015|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153823385|NCT00458510|Fentanyl|fentanyl|mesh-list
153823386|NCT00458510|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153823387|NCT00458510|Narcotics|narcotics|mesh-ancestor
153823388|NCT00458510|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153823389|NCT00458510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153823390|NCT00458510|Analgesics|analgesics|mesh-ancestor
153823391|NCT00458510|Sensory System Agents|sensory system agents|mesh-ancestor
153823392|NCT00458510|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153823393|NCT00458510|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153363345|NCT03217448|Protease Inhibitors|protease inhibitors|mesh-ancestor
153363346|NCT03217448|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153363347|NCT03217448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153363348|NCT01457573|Tamsulosin|tamsulosin|mesh-list
153363349|NCT01457573|Solifenacin Succinate|solifenacin succinate|mesh-list
153363350|NCT01457573|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
153363351|NCT01457573|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
153823399|NCT00444132|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
153823400|NCT00444132|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
153823420|NCT00488163|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153823421|NCT00488163|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153823422|NCT00488163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153823423|NCT00488163|Adrenergic Agents|adrenergic agents|mesh-ancestor
153823424|NCT00488163|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153823425|NCT00488163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153823426|NCT00459173|Rimonabant|rimonabant|mesh-list
153823427|NCT00459173|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
153823428|NCT00459173|Cannabinoid Receptor Antagonists|cannabinoid receptor antagonists|mesh-ancestor
153823429|NCT00459173|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
153823430|NCT00459173|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153823431|NCT00459173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153823432|NCT00459173|Hormones|hormones|mesh-ancestor
153363385|NCT01836536|Growth Substances|growth substances|mesh-ancestor
153363386|NCT01836536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153363387|NCT01836536|Growth Inhibitors|growth inhibitors|mesh-ancestor
153363388|NCT03216980|Antioxidants|antioxidants|mesh-list
153363389|NCT03216980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153363390|NCT03216980|Protective Agents|protective agents|mesh-ancestor
153363391|NCT03216980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153363393|NCT00895232|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
153363394|NCT00895232|Trace Elements|trace elements|mesh-ancestor
153363395|NCT00895232|Micronutrients|micronutrients|mesh-ancestor
153363396|NCT00895232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153363397|NCT00895232|Hematinics|hematinics|mesh-ancestor
153363399|NCT03211052|Fertility Agents, Female|fertility agents, female|mesh-ancestor
153363400|NCT03211052|Fertility Agents|fertility agents|mesh-ancestor
153363401|NCT03211052|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153363402|NCT03211052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153363405|NCT01560923|Tryptophan|tryptophan|mesh-list
153363406|NCT01560923|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
153363407|NCT01560923|Antidepressive Agents|antidepressive agents|mesh-ancestor
153363408|NCT01560923|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153363409|NCT01839032|Vinorelbine|vinorelbine|mesh-list
153363410|NCT01839032|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153363411|NCT01839032|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153363412|NCT01839032|Tubulin Modulators|tubulin modulators|mesh-ancestor
153363413|NCT01839032|Antimitotic Agents|antimitotic agents|mesh-ancestor
153363414|NCT01839032|Mitosis Modulators|mitosis modulators|mesh-ancestor
153363415|NCT01839032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153363416|NCT01457885|Busulfan|busulfan|mesh-list
153363417|NCT01457885|Clofarabine|clofarabine|mesh-list
153823450|NCT03278262|Aflibercept|aflibercept|mesh-list
153823451|NCT03278262|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153823452|NCT03278262|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153823453|NCT03278262|Growth Substances|growth substances|mesh-ancestor
153823454|NCT03278262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153823455|NCT03278262|Growth Inhibitors|growth inhibitors|mesh-ancestor
153823456|NCT03278262|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153823457|NCT00459485|Zinc Sulfate|zinc sulfate|mesh-list
153363419|NCT01457885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153363420|NCT01457885|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153363430|NCT01460225|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153363431|NCT01460225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153363433|NCT01561469|Linezolid|linezolid|mesh-list
153363434|NCT01561469|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153363435|NCT01561469|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153363436|NCT01561469|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
153363437|NCT01561469|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153363438|NCT01561469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153823466|NCT00459563|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153823467|NCT00459563|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153823468|NCT00459563|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
153823469|NCT00459563|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153823470|NCT00459563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153823471|NCT00459563|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
153823472|NCT01242384|Silicon|silicon|mesh-list
153823473|NCT01242384|Trace Elements|trace elements|mesh-ancestor
153823474|NCT01242384|Micronutrients|micronutrients|mesh-ancestor
153823475|NCT01242384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153823476|NCT00488436|Cyclosporine|cyclosporine|mesh-list
153823477|NCT00488436|Cyclosporins|cyclosporins|mesh-list
153823478|NCT00488436|Antilymphocyte Serum|antilymphocyte serum|mesh-list
153823479|NCT00488436|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153823480|NCT00488436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153823481|NCT00488436|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153823482|NCT00488436|Immunologic Factors|immunologic factors|mesh-ancestor
153823483|NCT00488436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153823484|NCT00488436|Antifungal Agents|antifungal agents|mesh-ancestor
153823486|NCT00488436|Dermatologic Agents|dermatologic agents|mesh-ancestor
153363485|NCT01837394|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153363486|NCT01837394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153363487|NCT01837394|Analgesics|analgesics|mesh-ancestor
153823523|NCT00459836|Gemcitabine|gemcitabine|mesh-list
153823524|NCT00459836|Docetaxel|docetaxel|mesh-list
153823525|NCT00459836|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153823526|NCT00459836|Antimetabolites|antimetabolites|mesh-ancestor
153823529|NCT00459836|Tubulin Modulators|tubulin modulators|mesh-ancestor
153363509|NCT01462565|Vasodilator Agents|vasodilator agents|mesh-ancestor
153363511|NCT01837628|Mineral Oil|mineral oil|mesh-list
153363512|NCT01837628|Anesthetics, Local|anesthetics, local|mesh-ancestor
153363513|NCT01837628|Anesthetics|anesthetics|mesh-ancestor
153363514|NCT01837628|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153363515|NCT01837628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153363516|NCT01837628|Sensory System Agents|sensory system agents|mesh-ancestor
153363517|NCT01837628|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153363518|NCT01837628|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153363519|NCT01837628|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
153363520|NCT01837628|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153823560|NCT00495339|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153823579|NCT00460226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153823581|NCT00460226|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153823582|NCT00460226|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153823583|NCT00460226|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153823584|NCT00460226|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153823585|NCT00495378|Epoetin Alfa|epoetin alfa|mesh-list
153823586|NCT00495378|Hematinics|hematinics|mesh-ancestor
153823587|NCT00460304|Pramlintide|pramlintide|mesh-list
153823588|NCT00460304|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153363567|NCT02205983|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153363568|NCT02205983|Narcotics|narcotics|mesh-ancestor
153363569|NCT02205983|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153363570|NCT01839968|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
153363571|NCT01839968|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153363572|NCT03210038|Lidocaine|lidocaine|mesh-list
153363573|NCT03210038|Anesthetics, Local|anesthetics, local|mesh-ancestor
153363575|NCT03210038|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153363576|NCT03210038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153363577|NCT03210038|Sensory System Agents|sensory system agents|mesh-ancestor
153363578|NCT03210038|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153363579|NCT03210038|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153363580|NCT03210038|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
153363581|NCT03210038|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153363582|NCT03210038|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153363583|NCT03210038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153363584|NCT02472756|Rituximab|rituximab|mesh-list
153363585|NCT02472756|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153363586|NCT02472756|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153363587|NCT02472756|Immunologic Factors|immunologic factors|mesh-ancestor
153363588|NCT02472756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153363589|NCT02472756|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153363590|NCT01464359|Cyclophosphamide|cyclophosphamide|mesh-list
153823599|NCT00460382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153823600|NCT00460382|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153823601|NCT00460382|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153823602|NCT00460382|Antiviral Agents|antiviral agents|mesh-ancestor
153823603|NCT00460382|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153823604|NCT00460382|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
153823605|NCT00460382|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153823606|NCT00460382|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
153823607|NCT00460382|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
153823608|NCT00460382|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153823609|NCT00460382|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153823610|NCT00460382|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
153823611|NCT00460382|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
153823613|NCT01242579|Dapivirine|dapivirine|mesh-list
153823614|NCT01242579|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
153823615|NCT01242579|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
153823616|NCT01242579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153823617|NCT01242579|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153823618|NCT01242579|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153823619|NCT01242579|Antiviral Agents|antiviral agents|mesh-ancestor
153823620|NCT01242579|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153823621|NCT01242579|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
153823622|NCT00460499|Insulin|insulin|mesh-list
153823623|NCT00460499|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153823624|NCT00460499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153823625|NCT00495573|Acyclovir|acyclovir|mesh-list
153823626|NCT00495573|Antiviral Agents|antiviral agents|mesh-ancestor
153823627|NCT00495573|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153823628|NCT00488787|Ketamine|ketamine|mesh-list
153823629|NCT00488787|Analgesics|analgesics|mesh-ancestor
153823630|NCT00488787|Sensory System Agents|sensory system agents|mesh-ancestor
153823631|NCT00488787|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153823632|NCT00488787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153823633|NCT00488787|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
153823634|NCT00488787|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153823635|NCT00488787|Anesthetics, General|anesthetics, general|mesh-ancestor
153363592|NCT01464359|Fludarabine|fludarabine|mesh-list
153363593|NCT01464359|Interleukin-2|interleukin-2|mesh-list
153363594|NCT01464359|Allopurinol|allopurinol|mesh-list
153363595|NCT01464359|Levetiracetam|levetiracetam|mesh-list
153363596|NCT01464359|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153363597|NCT01464359|Immunologic Factors|immunologic factors|mesh-ancestor
153363598|NCT01464359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153363599|NCT01464359|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153363600|NCT01464359|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153363601|NCT01464359|Alkylating Agents|alkylating agents|mesh-ancestor
153363618|NCT01838252|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153363619|NCT01838252|Immunologic Factors|immunologic factors|mesh-ancestor
153363620|NCT01838252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153363621|NCT01838252|Viscosupplements|viscosupplements|mesh-ancestor
153363622|NCT01838252|Protective Agents|protective agents|mesh-ancestor
153363623|NCT01838330|Psyllium|psyllium|mesh-list
153363624|NCT01838330|Cathartics|cathartics|mesh-ancestor
153363625|NCT01838330|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153363626|NCT02498652|Allopurinol|allopurinol|mesh-list
153363627|NCT02498652|Verinurad|verinurad|mesh-list
153823636|NCT00488787|Anesthetics|anesthetics|mesh-ancestor
153823637|NCT00488787|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153363628|NCT02498652|Antimetabolites|antimetabolites|mesh-ancestor
153363629|NCT02498652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153823638|NCT00488787|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
153823639|NCT00488787|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
153823640|NCT00488787|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153823641|NCT00488787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153823642|NCT00460616|Cabergoline|cabergoline|mesh-list
153363638|NCT03213158|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153363639|NCT03213158|Protease Inhibitors|protease inhibitors|mesh-ancestor
153363640|NCT03213158|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153363641|NCT03213158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153363643|NCT02498418|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153363644|NCT02498418|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153363645|NCT02498418|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153363646|NCT03219476|Tamoxifen|tamoxifen|mesh-list
153363647|NCT03219476|Letrozole|letrozole|mesh-list
153363648|NCT03219476|Anastrozole|anastrozole|mesh-list
153363649|NCT03219476|Exemestane|exemestane|mesh-list
153363650|NCT03219476|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153363651|NCT03219476|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
153363652|NCT03219476|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153363653|NCT03219476|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153363654|NCT03219476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153363655|NCT03219476|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
153363656|NCT03219476|Hormone Antagonists|hormone antagonists|mesh-ancestor
153363657|NCT03219476|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153363658|NCT03219476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153363659|NCT03219476|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153363660|NCT03219476|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
153363661|NCT03219476|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
153363662|NCT03219476|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153363663|NCT02472366|Fluocinolone Acetonide|fluocinolone acetonide|mesh-list
153363664|NCT02472366|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153363665|NCT02472366|Glucocorticoids|glucocorticoids|mesh-ancestor
153363666|NCT02472366|Hormones|hormones|mesh-ancestor
153823674|NCT00460850|Antiviral Agents|antiviral agents|mesh-ancestor
153823675|NCT00460850|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153823676|NCT00495729|Simvastatin|simvastatin|mesh-list
153823677|NCT00495729|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153890942|NCT01033942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153823679|NCT00495729|Antimetabolites|antimetabolites|mesh-ancestor
153823680|NCT00495729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153823684|NCT00460928|Immunoglobulins|immunoglobulins|mesh-list
153823686|NCT00460928|gamma-Globulins|gamma-globulins|mesh-list
153823687|NCT00460928|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
153823688|NCT00460928|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
153823689|NCT00460928|Immunologic Factors|immunologic factors|mesh-ancestor
153823690|NCT00460928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153823691|NCT00461084|Clarithromycin|clarithromycin|mesh-list
153823692|NCT00461084|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153823693|NCT00461084|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153823694|NCT00461084|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
153823695|NCT00461084|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153823696|NCT00461084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153823697|NCT00461084|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
153823698|NCT00461084|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153823699|NCT00495846|Octreotide|octreotide|mesh-list
153823700|NCT00495846|Lanreotide|lanreotide|mesh-list
153823701|NCT00495846|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153823702|NCT00495846|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153823703|NCT00495846|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153823704|NCT00105482|Naltrexone|naltrexone|mesh-list
153823705|NCT00105482|Nicotine|nicotine|mesh-list
153823706|NCT00105482|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
153823707|NCT00105482|Autonomic Agents|autonomic agents|mesh-ancestor
153823708|NCT00105482|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153823709|NCT00105482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153823710|NCT00105482|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
153823711|NCT00105482|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
153823712|NCT00105482|Cholinergic Agents|cholinergic agents|mesh-ancestor
153823713|NCT00105482|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153363671|NCT01724606|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153363672|NCT01724606|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153363680|NCT01720238|Entecavir|entecavir|mesh-list
153363681|NCT01720238|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153363682|NCT01720238|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153363683|NCT01720238|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153363684|NCT01720238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153363685|NCT01720238|Antiviral Agents|antiviral agents|mesh-ancestor
153363686|NCT01720238|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153363687|NCT01720238|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153363688|NCT01720238|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153363689|NCT03836222|Pentoxifylline|pentoxifylline|mesh-list
153363690|NCT03836222|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
153363691|NCT03836222|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153363692|NCT03836222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153363693|NCT03836222|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153363694|NCT03836222|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
153363695|NCT03836222|Protective Agents|protective agents|mesh-ancestor
153363696|NCT03836222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153363697|NCT03836222|Vasodilator Agents|vasodilator agents|mesh-ancestor
153363698|NCT03836222|Free Radical Scavengers|free radical scavengers|mesh-ancestor
153363699|NCT03836222|Antioxidants|antioxidants|mesh-ancestor
153363700|NCT01830218|Anesthetics|anesthetics|mesh-list
153363701|NCT01830218|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153823716|NCT00105482|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
153823717|NCT00105482|Sensory System Agents|sensory system agents|mesh-ancestor
153823719|NCT00496002|Clevudine|clevudine|mesh-list
153823720|NCT00496002|Antiviral Agents|antiviral agents|mesh-ancestor
153823721|NCT00496002|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153823722|NCT00496002|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153823723|NCT00496002|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153823724|NCT00496002|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153823725|NCT00496002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153823726|NCT00489099|Vaccines|vaccines|mesh-list
153823727|NCT00489099|Immunologic Factors|immunologic factors|mesh-ancestor
153823728|NCT00489099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153823729|NCT00496158|Adefovir|adefovir|mesh-list
153823730|NCT00496158|Clevudine|clevudine|mesh-list
153363712|NCT01566539|Arginine Vasopressin|arginine vasopressin|mesh-list
153363713|NCT01566539|Lorazepam|lorazepam|mesh-list
153363714|NCT01566539|Oxytocin|oxytocin|mesh-list
153363715|NCT01566539|Oxytocics|oxytocics|mesh-ancestor
153363716|NCT01566539|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153363717|NCT01566539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153363718|NCT01566539|Anticonvulsants|anticonvulsants|mesh-ancestor
153363719|NCT01566539|Antiemetics|antiemetics|mesh-ancestor
153363720|NCT01566539|Autonomic Agents|autonomic agents|mesh-ancestor
153363721|NCT01566539|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153363722|NCT01566539|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153363723|NCT01566539|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153363724|NCT01566539|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153363725|NCT01566539|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153363726|NCT01566539|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153363727|NCT01566539|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153823753|NCT01327651|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153823755|NCT01327651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153823756|NCT01327651|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153823757|NCT01327651|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153823758|NCT00496275|Cisplatin|cisplatin|mesh-list
153823759|NCT00496275|Gemcitabine|gemcitabine|mesh-list
153823760|NCT00496275|Vinorelbine|vinorelbine|mesh-list
153823761|NCT00496275|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153823762|NCT00496275|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153823763|NCT00496275|Antimetabolites|antimetabolites|mesh-ancestor
153823764|NCT00496275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153823765|NCT00496275|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153823766|NCT00496275|Tubulin Modulators|tubulin modulators|mesh-ancestor
153823767|NCT00496275|Antimitotic Agents|antimitotic agents|mesh-ancestor
153823768|NCT00496275|Mitosis Modulators|mitosis modulators|mesh-ancestor
153823769|NCT00591604|Vitamin D|vitamin d|mesh-list
153363728|NCT01566539|GABA Modulators|gaba modulators|mesh-ancestor
153363729|NCT01566539|GABA Agents|gaba agents|mesh-ancestor
153363730|NCT01566539|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153823785|NCT00591643|Autonomic Agents|autonomic agents|mesh-ancestor
153823786|NCT00591643|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153823787|NCT00591643|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153823788|NCT00591643|Respiratory System Agents|respiratory system agents|mesh-ancestor
153363749|NCT01830296|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153363751|NCT01830296|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153363752|NCT01830296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153363753|NCT01830296|Analgesics|analgesics|mesh-ancestor
153363754|NCT01830296|Sensory System Agents|sensory system agents|mesh-ancestor
153363755|NCT01830296|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153363756|NCT05564819|Acetaminophen|acetaminophen|mesh-list
153363757|NCT05564819|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153363758|NCT05564819|Analgesics|analgesics|mesh-ancestor
153363759|NCT05564819|Sensory System Agents|sensory system agents|mesh-ancestor
153363760|NCT05564819|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153363761|NCT05564819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153363762|NCT05564819|Antipyretics|antipyretics|mesh-ancestor
153363763|NCT01720394|Dinoprostone|dinoprostone|mesh-list
153363764|NCT01720394|Oxytocics|oxytocics|mesh-ancestor
153363765|NCT01720394|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153363766|NCT01720394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153363767|NCT01467947|Complement C1 Inactivator Proteins|complement c1 inactivator proteins|mesh-list
153363768|NCT01467947|Complement C1 Inhibitor Protein|complement c1 inhibitor protein|mesh-list
153823797|NCT00461747|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153823808|NCT00461747|Protease Inhibitors|protease inhibitors|mesh-ancestor
153823809|NCT00461747|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153823810|NCT00461747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153823811|NCT00461747|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153823812|NCT00461747|Immunologic Factors|immunologic factors|mesh-ancestor
153823813|NCT00461747|Leprostatic Agents|leprostatic agents|mesh-ancestor
153823814|NCT00461747|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153823815|NCT00461747|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153823816|NCT00461747|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153823817|NCT00461747|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153823818|NCT00461747|Growth Substances|growth substances|mesh-ancestor
153823819|NCT00461747|Growth Inhibitors|growth inhibitors|mesh-ancestor
153823820|NCT00461825|Cyclosporine|cyclosporine|mesh-list
153823821|NCT00461825|Mycophenolic Acid|mycophenolic acid|mesh-list
153823822|NCT00461825|Azathioprine|azathioprine|mesh-list
153823823|NCT00461825|Cyclosporins|cyclosporins|mesh-list
153823824|NCT00461825|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153823825|NCT00461825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153823826|NCT00461825|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153823827|NCT00461825|Immunologic Factors|immunologic factors|mesh-ancestor
153823828|NCT00461825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153823829|NCT00461825|Antifungal Agents|antifungal agents|mesh-ancestor
153823834|NCT00461825|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153823835|NCT00461825|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153823836|NCT00461825|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
153823837|NCT00461825|Antitubercular Agents|antitubercular agents|mesh-ancestor
153363796|NCT01569191|Anti-Allergic Agents|anti-allergic agents|mesh-list
153363797|NCT01569191|Ophthalmic Solutions|ophthalmic solutions|mesh-list
153363798|NCT01569191|Lubricant Eye Drops|lubricant eye drops|mesh-list
153363799|NCT01569191|Epinastine|epinastine|mesh-list
153363800|NCT01569191|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
153363801|NCT01569191|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
153363802|NCT01569191|Histamine Antagonists|histamine antagonists|mesh-ancestor
153363803|NCT01569191|Histamine Agents|histamine agents|mesh-ancestor
153363804|NCT01569191|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153363805|NCT01569191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153363806|NCT01569191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153363807|NCT03409874|Diclofenac|diclofenac|mesh-list
153363808|NCT03409874|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153363809|NCT03409874|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153363810|NCT03409874|Analgesics|analgesics|mesh-ancestor
153363811|NCT03409874|Sensory System Agents|sensory system agents|mesh-ancestor
153363812|NCT03409874|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153363831|NCT00911612|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153363833|NCT01726478|Oxytocics|oxytocics|mesh-ancestor
153363834|NCT01726478|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153363835|NCT01726478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153363836|NCT04379492|Hydroxychloroquine|hydroxychloroquine|mesh-list
153363837|NCT04379492|Antimalarials|antimalarials|mesh-ancestor
153363874|NCT02497404|Immunologic Factors|immunologic factors|mesh-ancestor
153363875|NCT02497404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153363876|NCT02497404|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153363877|NCT02497404|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153363878|NCT02497404|Alkylating Agents|alkylating agents|mesh-ancestor
153363879|NCT02497404|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153363880|NCT02497404|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153363881|NCT01573169|Enoxaparin|enoxaparin|mesh-list
153363882|NCT01573169|Anticoagulants|anticoagulants|mesh-ancestor
153363883|NCT01573169|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153363884|NCT01573169|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153823922|NCT00497016|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153823923|NCT00497016|Antimetabolites|antimetabolites|mesh-ancestor
153823924|NCT00497016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153823925|NCT00497016|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153823926|NCT00497016|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
153363885|NCT01573169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153363887|NCT04205994|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
153363888|NCT04205994|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
153363889|NCT04205994|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
153363890|NCT04205994|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153890999|NCT01033240|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153891023|NCT01029652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153432034|NCT05469412|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153432035|NCT05469412|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153432036|NCT05469412|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153432037|NCT05469412|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153432038|NCT05469412|Anesthetics, General|anesthetics, general|mesh-ancestor
153432039|NCT05469412|Anesthetics|anesthetics|mesh-ancestor
153432040|NCT05469412|GABA Modulators|gaba modulators|mesh-ancestor
153432041|NCT05469412|GABA Agents|gaba agents|mesh-ancestor
153432042|NCT05469412|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153432043|NCT05469412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153363905|NCT01722110|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153363906|NCT01722110|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153363907|NCT01722110|Gout Suppressants|gout suppressants|mesh-ancestor
153363908|NCT01722110|Tocolytic Agents|tocolytic agents|mesh-ancestor
153363909|NCT01722110|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153363910|NCT01722110|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153363911|NCT01722110|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153363912|NCT01722110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153363914|NCT01573949|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153363915|NCT01573949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153363918|NCT01574183|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153823927|NCT00497016|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153823928|NCT00222872|Hormones|hormones|mesh-list
153823929|NCT00222872|Parathyroid Hormone|parathyroid hormone|mesh-list
153823930|NCT00222872|Parathyroid Hormone-Related Protein|parathyroid hormone-related protein|mesh-list
153823931|NCT00222872|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153823932|NCT00222872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153823944|NCT03273296|Azithromycin|azithromycin|mesh-list
153823945|NCT03273296|Vancomycin|vancomycin|mesh-list
153823946|NCT03273296|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153823947|NCT03273296|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153823948|NCT00497250|Gefitinib|gefitinib|mesh-list
153823949|NCT00497250|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153823950|NCT00497250|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153823951|NCT00497250|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153823952|NCT00497250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153823953|NCT00497250|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153823954|NCT00462878|Vancomycin|vancomycin|mesh-list
153823955|NCT00462878|Meropenem|meropenem|mesh-list
153823956|NCT00462878|Teicoplanin|teicoplanin|mesh-list
153823957|NCT00462878|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153823958|NCT00462878|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153823959|NCT00462956|Lapatinib|lapatinib|mesh-list
153823960|NCT00462956|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153823961|NCT00462956|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153823962|NCT00462956|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153823963|NCT00462956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153823964|NCT00462956|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153823965|NCT00462995|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
153823966|NCT00462995|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153823967|NCT00462995|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153363923|NCT01574183|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153363924|NCT01574183|Serotonin Agents|serotonin agents|mesh-ancestor
153363925|NCT01574183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153363926|NCT01574183|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
153363927|NCT01574183|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
153363928|NCT01574807|Lidocaine|lidocaine|mesh-list
153363929|NCT01574807|Mepivacaine|mepivacaine|mesh-list
153363930|NCT01574807|Anesthetics, Local|anesthetics, local|mesh-ancestor
153363931|NCT01574807|Anesthetics|anesthetics|mesh-ancestor
153363932|NCT01574807|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153363933|NCT01574807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153363934|NCT01574807|Sensory System Agents|sensory system agents|mesh-ancestor
153363935|NCT01574807|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153363936|NCT01574807|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153363940|NCT01574807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153363942|NCT01575275|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
153363943|NCT01575275|Dermatologic Agents|dermatologic agents|mesh-ancestor
153363944|NCT01728272|Metoprolol|metoprolol|mesh-list
153363945|NCT01728272|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153823971|NCT00489528|Hormones|hormones|mesh-list
153823972|NCT00489528|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153823973|NCT00489528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153823974|NCT00463073|Bevacizumab|bevacizumab|mesh-list
153823975|NCT00463073|Cetuximab|cetuximab|mesh-list
153823976|NCT00463073|Irinotecan|irinotecan|mesh-list
153823977|NCT00463073|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153823978|NCT00463073|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153823979|NCT00463073|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153823980|NCT00463073|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153823981|NCT00463073|Growth Substances|growth substances|mesh-ancestor
153823982|NCT00463073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153823983|NCT00463073|Growth Inhibitors|growth inhibitors|mesh-ancestor
153823984|NCT00463073|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
153823985|NCT00463073|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153823986|NCT00463073|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153823987|NCT00463073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153823988|NCT00463112|Sibutramine|sibutramine|mesh-list
153823989|NCT00463112|Antidepressive Agents|antidepressive agents|mesh-ancestor
153363968|NCT01728818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153363970|NCT01728818|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153823992|NCT00463112|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
153823993|NCT00223028|Sirolimus|sirolimus|mesh-list
153823994|NCT00223028|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153823995|NCT00223028|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153823996|NCT00223028|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153823997|NCT00223028|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153823998|NCT00223028|Antifungal Agents|antifungal agents|mesh-ancestor
153823999|NCT00223028|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153824000|NCT00223028|Immunologic Factors|immunologic factors|mesh-ancestor
153824001|NCT00223028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153824002|NCT00489645|Pramlintide|pramlintide|mesh-list
153824003|NCT00489645|Islet Amyloid Polypeptide|islet amyloid polypeptide|mesh-list
153824004|NCT00489645|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153824005|NCT00489645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153824006|NCT00489645|Appetite Depressants|appetite depressants|mesh-ancestor
153824007|NCT00489645|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
153824008|NCT00489645|Amylin Receptor Agonists|amylin receptor agonists|mesh-ancestor
153824009|NCT00489645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153824010|NCT00463268|Vitamin D|vitamin d|mesh-list
153824011|NCT00463268|Alendronate|alendronate|mesh-list
153824012|NCT00463268|Calcium|calcium|mesh-list
153824039|NCT00489840|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153824040|NCT00489840|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153824041|NCT00463502|Metformin|metformin|mesh-list
153824042|NCT00463502|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153364000|NCT04379180|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
153364001|NCT04379180|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
153364002|NCT04379180|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153364003|NCT04379180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153364004|NCT04379180|Urological Agents|urological agents|mesh-ancestor
153364005|NCT04379180|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153364006|NCT04379180|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
153364007|NCT01576523|Complement C1s|complement c1s|mesh-list
153364008|NCT01576523|Complement C1 Inhibitor Protein|complement c1 inhibitor protein|mesh-list
153364009|NCT01576523|Complement C1 Inactivator Proteins|complement c1 inactivator proteins|mesh-list
153364010|NCT01576523|Immunologic Factors|immunologic factors|mesh-ancestor
153364011|NCT01576523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153364012|NCT01576523|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
153364013|NCT01576523|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153364014|NCT03406676|Methylene Blue|methylene blue|mesh-list
153364015|NCT03406676|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153364016|NCT03406676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153364017|NCT03001739|Urapidil|urapidil|mesh-list
153364018|NCT03001739|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153364019|NCT03001739|Vasodilator Agents|vasodilator agents|mesh-ancestor
153364020|NCT03001739|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
153364021|NCT03001739|Serotonin Agents|serotonin agents|mesh-ancestor
153364022|NCT03001739|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153364023|NCT03001739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153824043|NCT00463502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153824044|NCT00489996|Gemcitabine|gemcitabine|mesh-list
153824045|NCT00489996|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153824046|NCT00489996|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153824047|NCT00489996|Antimetabolites|antimetabolites|mesh-ancestor
153824048|NCT00489996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153824049|NCT00463541|Solifenacin Succinate|solifenacin succinate|mesh-list
153824050|NCT00463541|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
153824051|NCT00463541|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
153824052|NCT00463541|Cholinergic Agents|cholinergic agents|mesh-ancestor
153824053|NCT00463541|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153824054|NCT00463541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153824055|NCT00463541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153824056|NCT00463541|Urological Agents|urological agents|mesh-ancestor
153824057|NCT00490113|Pyridoxamine|pyridoxamine|mesh-list
153824058|NCT00490113|Vitamin B Complex|vitamin b complex|mesh-ancestor
153824059|NCT00490113|Vitamins|vitamins|mesh-ancestor
153824060|NCT00490113|Micronutrients|micronutrients|mesh-ancestor
153824061|NCT00490113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153824062|NCT01243203|Varenicline|varenicline|mesh-list
153824063|NCT01243203|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
153824064|NCT01243203|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
153824069|NCT00497328|Acetylcysteine|acetylcysteine|mesh-list
153364069|NCT01723670|1-(3',4'-dichloro-2-fluoro(1,1'-biphenyl)-4-yl)cyclopropanecarboxylic acid|1-(3',4'-dichloro-2-fluoro(1,1'-biphenyl)-4-yl)cyclopropanecarboxylic acid|mesh-list
153364070|NCT01723670|Gamma Secretase Inhibitors and Modulators|gamma secretase inhibitors and modulators|mesh-ancestor
153364071|NCT01723670|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153364072|NCT01723670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153364074|NCT01723748|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153364075|NCT01723748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153364076|NCT02469090|Apomorphine|apomorphine|mesh-list
153364077|NCT02469090|Emetics|emetics|mesh-ancestor
153824105|NCT00490308|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
153824106|NCT00490308|Estradiol|estradiol|mesh-list
153824107|NCT00490308|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
153824108|NCT00490308|Estrogens|estrogens|mesh-ancestor
153824109|NCT00490308|Hormones|hormones|mesh-ancestor
153824110|NCT00490308|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153824111|NCT00490308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153824112|NCT00490308|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
153824113|NCT00490308|Contraceptive Agents|contraceptive agents|mesh-ancestor
153824114|NCT00490308|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153824115|NCT00490308|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
153824116|NCT00463736|Magnesium Sulfate|magnesium sulfate|mesh-list
153824117|NCT00463736|Analgesics|analgesics|mesh-ancestor
153824118|NCT00463736|Sensory System Agents|sensory system agents|mesh-ancestor
153824119|NCT00463736|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153824120|NCT00463736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153824121|NCT00463736|Anesthetics|anesthetics|mesh-ancestor
153364078|NCT02469090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153364079|NCT02469090|Autonomic Agents|autonomic agents|mesh-ancestor
153364080|NCT02469090|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153364081|NCT02469090|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153364082|NCT02469090|Dopamine Agonists|dopamine agonists|mesh-ancestor
153364083|NCT02469090|Dopamine Agents|dopamine agents|mesh-ancestor
153364084|NCT02469090|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153364085|NCT02469090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153364086|NCT02496000|Insulin|insulin|mesh-list
153364087|NCT02496000|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153364088|NCT02496000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153364089|NCT02517528|Ritonavir|ritonavir|mesh-list
153364090|NCT02517528|Ribavirin|ribavirin|mesh-list
153824139|NCT00497523|Beclomethasone|beclomethasone|mesh-list
153364100|NCT02517528|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
153364101|NCT02517528|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153364102|NCT02517528|Antimetabolites|antimetabolites|mesh-ancestor
153364103|NCT01727336|Axitinib|axitinib|mesh-list
153364104|NCT01727336|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153364105|NCT01727336|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153364106|NCT01727336|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153364107|NCT01727336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153364108|NCT01578707|Ofatumumab|ofatumumab|mesh-list
153364109|NCT01578707|Ibrutinib|ibrutinib|mesh-list
153364110|NCT01578707|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153364111|NCT01578707|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153364112|NCT01578707|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153364113|NCT01578707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153364114|NCT01578707|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153364115|NCT03835442|Baclofen|baclofen|mesh-list
153364116|NCT03835442|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
153364117|NCT03835442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153364118|NCT03835442|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
153364119|NCT03835442|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153364120|NCT03835442|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
153364121|NCT03835442|GABA Agonists|gaba agonists|mesh-ancestor
153364122|NCT03835442|GABA Agents|gaba agents|mesh-ancestor
153364123|NCT03835442|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153364124|NCT03835442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153364125|NCT01722656|Aflibercept|aflibercept|mesh-list
153364126|NCT01722656|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153364128|NCT01722656|Growth Substances|growth substances|mesh-ancestor
153824154|NCT00497523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153824155|NCT00497523|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153824156|NCT00497523|Glucocorticoids|glucocorticoids|mesh-ancestor
153824157|NCT00497523|Hormones|hormones|mesh-ancestor
153824158|NCT00497523|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153824159|NCT00463775|Topiramate|topiramate|mesh-list
153824160|NCT00463775|Anticonvulsants|anticonvulsants|mesh-ancestor
153824161|NCT00463775|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153824162|NCT00463775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153824163|NCT00490620|Antiviral Agents|antiviral agents|mesh-list
153891024|NCT01029340|Factor VIII|factor viii|mesh-list
153891025|NCT01029340|Coagulants|coagulants|mesh-ancestor
153891026|NCT01265550|Baclofen|baclofen|mesh-list
153891027|NCT01265550|Desipramine|desipramine|mesh-list
153891028|NCT01265550|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
153891029|NCT01265550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153824164|NCT00490620|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153824165|NCT00466232|Sorafenib|sorafenib|mesh-list
153824166|NCT00466232|Topotecan|topotecan|mesh-list
153824167|NCT00466232|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153824168|NCT00466232|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153824169|NCT00466232|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153824170|NCT00466232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153824171|NCT00466232|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
153824172|NCT00466232|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153824173|NCT00490659|Gemcitabine|gemcitabine|mesh-list
153824174|NCT00490659|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153824175|NCT00490659|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153824176|NCT00490659|Antimetabolites|antimetabolites|mesh-ancestor
153824177|NCT00490659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153824178|NCT00490737|Daptomycin|daptomycin|mesh-list
153824179|NCT00490737|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153824180|NCT00490737|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153824181|NCT00497562|Tramadol|tramadol|mesh-list
153824182|NCT00497562|Amitriptyline|amitriptyline|mesh-list
153824203|NCT00497562|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153824204|NCT00497562|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153824205|NCT00497562|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
153824206|NCT00497562|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153824207|NCT00497562|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
153824208|NCT00497562|Adrenergic Agents|adrenergic agents|mesh-ancestor
153364172|NCT02980913|Ophthalmic Solutions|ophthalmic solutions|mesh-list
153364173|NCT02980913|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
153364174|NCT02981303|Pembrolizumab|pembrolizumab|mesh-list
153364175|NCT02981303|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153364176|NCT02981303|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153364177|NCT02981303|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153364178|NCT02981303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153364180|NCT02981459|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
153364181|NCT02981459|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
153364182|NCT02981459|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153824225|NCT00466388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153824227|NCT00466388|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
153824228|NCT00466388|Cholinergic Agents|cholinergic agents|mesh-ancestor
153824229|NCT00466388|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153824230|NCT00466388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153824231|NCT00466466|Everolimus|everolimus|mesh-list
153824232|NCT00466466|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
153824233|NCT00466466|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153824234|NCT00466466|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153824235|NCT00466466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153824236|NCT00466466|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153824237|NCT00466466|Immunologic Factors|immunologic factors|mesh-ancestor
153824238|NCT00466466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153824239|NCT00466466|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153824240|NCT00490854|Insulin|insulin|mesh-list
153824241|NCT00490854|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
153824242|NCT00490854|Insulin, Isophane|insulin, isophane|mesh-list
153824243|NCT00490854|Isophane Insulin, Human|isophane insulin, human|mesh-list
153824244|NCT00490854|Isophane insulin, beef|isophane insulin, beef|mesh-list
153824245|NCT00490854|Protamines|protamines|mesh-list
153824246|NCT00490854|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153364211|NCT01580423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153364212|NCT01049984|Rasagiline|rasagiline|mesh-list
153364213|NCT01049984|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
153364214|NCT01049984|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153891030|NCT01265550|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
153364217|NCT01049984|Protective Agents|protective agents|mesh-ancestor
153364218|NCT01049984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153364219|NCT03001271|Angiotensin I (1-7)|angiotensin i (1-7)|mesh-list
153364244|NCT01049360|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153364245|NCT01049360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153364246|NCT02494596|Capecitabine|capecitabine|mesh-list
153364247|NCT02494596|Pertuzumab|pertuzumab|mesh-list
153364248|NCT02494596|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153364249|NCT02494596|Antimetabolites|antimetabolites|mesh-ancestor
153364250|NCT02494596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153364251|NCT02494596|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153364252|NCT02494596|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153364253|NCT01048502|Fenofibrate|fenofibrate|mesh-list
153364254|NCT01048502|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153364255|NCT01048502|Antimetabolites|antimetabolites|mesh-ancestor
153364256|NCT01048502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153364257|NCT01048502|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153364258|NCT01583543|Olaparib|olaparib|mesh-list
153364259|NCT01583543|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
153824277|NCT00464165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153824279|NCT00464165|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153824280|NCT00464165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153824281|NCT00497913|Botulinum Toxins|botulinum toxins|mesh-list
153824282|NCT00497913|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
153824283|NCT00497913|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
153824284|NCT00497913|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
153824285|NCT00497913|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153824286|NCT00497913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153824287|NCT00497913|Cholinergic Agents|cholinergic agents|mesh-ancestor
153364262|NCT01583543|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153364263|NCT01724372|Aripiprazole|aripiprazole|mesh-list
153364264|NCT01724372|Antipsychotic Agents|antipsychotic agents|mesh-list
153364266|NCT01724372|Antidepressive Agents|antidepressive agents|mesh-list
153364267|NCT01724372|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153364268|NCT01724372|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153364269|NCT01724372|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153364270|NCT01724372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153364271|NCT01724372|Dopamine Agonists|dopamine agonists|mesh-ancestor
153824305|NCT00491127|Glucocorticoids|glucocorticoids|mesh-ancestor
153824306|NCT00491127|Hormones|hormones|mesh-ancestor
153824307|NCT00491127|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153824308|NCT00491127|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153824309|NCT00491127|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153824310|NCT00491127|Antimetabolites|antimetabolites|mesh-ancestor
153824311|NCT00491127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153824312|NCT00491166|Bromfenac|bromfenac|mesh-list
153824313|NCT00491166|Ophthalmic Solutions|ophthalmic solutions|mesh-list
153364279|NCT01724372|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153364280|NCT01724372|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
153364281|NCT01724372|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
153364282|NCT01724372|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
153364283|NCT01724372|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153364284|NCT01724372|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153364285|NCT01724372|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
153364286|NCT01724372|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
153364287|NCT01724372|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153824325|NCT03273062|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
153824326|NCT03273062|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
153824327|NCT03273062|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153824328|NCT03273062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153824329|NCT00498108|Rotigotine|rotigotine|mesh-list
153824330|NCT00498108|Dopamine Agonists|dopamine agonists|mesh-ancestor
153824331|NCT00498108|Dopamine Agents|dopamine agents|mesh-ancestor
153364297|NCT03006419|Basiliximab|basiliximab|mesh-list
153364298|NCT03006419|Immunologic Factors|immunologic factors|mesh-ancestor
153364316|NCT03405194|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
153364317|NCT03405194|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
153364318|NCT03405194|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
153364319|NCT03405194|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
153364320|NCT03405194|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153364321|NCT03405194|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153364322|NCT03405194|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
153364323|NCT03405194|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
153364324|NCT03006107|Piroxicam|piroxicam|mesh-list
153364325|NCT03006107|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153364326|NCT03006107|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153364327|NCT03006107|Analgesics|analgesics|mesh-ancestor
153364328|NCT03006107|Sensory System Agents|sensory system agents|mesh-ancestor
153364329|NCT03006107|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153364330|NCT03006107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153364331|NCT03006107|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153824332|NCT00498108|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153824333|NCT00498108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153824334|NCT00498108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153824335|NCT00464321|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
153824336|NCT00464321|Immunologic Factors|immunologic factors|mesh-ancestor
153824337|NCT00464321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153824360|NCT01327612|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153824361|NCT01327612|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153824363|NCT01327612|Antidotes|antidotes|mesh-ancestor
153824364|NCT01327612|Protective Agents|protective agents|mesh-ancestor
153824365|NCT01327612|Vitamin B Complex|vitamin b complex|mesh-ancestor
153824366|NCT01327612|Vitamins|vitamins|mesh-ancestor
153364333|NCT03006107|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153364334|NCT03006107|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153364335|NCT03006107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153364336|NCT01046396|Adapalene|adapalene|mesh-list
153364343|NCT01046396|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153364344|NCT01046396|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153364345|NCT01046396|Dermatologic Agents|dermatologic agents|mesh-ancestor
153364346|NCT01046084|Lansoprazole|lansoprazole|mesh-list
153364347|NCT01046084|Dexlansoprazole|dexlansoprazole|mesh-list
153364348|NCT01046084|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
153364349|NCT01046084|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153364350|NCT01046084|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
153364351|NCT01046084|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153364352|NCT01046084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153364353|NCT01045694|Triamcinolone|triamcinolone|mesh-list
153364354|NCT01045694|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
153364355|NCT01045694|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
153364356|NCT01045694|Lidocaine|lidocaine|mesh-list
153364357|NCT01045694|Botulinum Toxins|botulinum toxins|mesh-list
153824389|NCT04132882|Chelating Agents|chelating agents|mesh-ancestor
153824390|NCT04132882|Sequestering Agents|sequestering agents|mesh-ancestor
153824391|NCT01243359|Bevacizumab|bevacizumab|mesh-list
153824392|NCT01243359|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
153824393|NCT01243359|Sunitinib|sunitinib|mesh-list
153824394|NCT01243359|Antibodies|antibodies|mesh-list
153824395|NCT01243359|Immunoglobulins|immunoglobulins|mesh-list
153824396|NCT01243359|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
153824397|NCT01243359|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153824398|NCT01243359|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153824399|NCT01243359|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153824400|NCT01243359|Growth Substances|growth substances|mesh-ancestor
153824401|NCT01243359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153824402|NCT01243359|Growth Inhibitors|growth inhibitors|mesh-ancestor
153824403|NCT01243359|Immunologic Factors|immunologic factors|mesh-ancestor
153824404|NCT01243359|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153364369|NCT01045694|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153364370|NCT01045694|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153364371|NCT01045694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153364372|NCT01045694|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
153364373|NCT01045694|Cholinergic Agents|cholinergic agents|mesh-ancestor
153364374|NCT01045694|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153364375|NCT01045694|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
153364376|NCT01045694|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153364377|NCT01045694|Glucocorticoids|glucocorticoids|mesh-ancestor
153364379|NCT01045694|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153364380|NCT01045694|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153364381|NCT01045694|Immunologic Factors|immunologic factors|mesh-ancestor
153364382|NCT01045694|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153364383|NCT01586975|Aspirin|aspirin|mesh-list
153364384|NCT01586975|Clopidogrel|clopidogrel|mesh-list
153824416|NCT00498342|Protective Agents|protective agents|mesh-ancestor
153824417|NCT00498342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153824418|NCT00498342|Antidotes|antidotes|mesh-ancestor
153824419|NCT00466856|Octreotide|octreotide|mesh-list
153824420|NCT00466856|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153824421|NCT00466856|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153824440|NCT00591994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153824441|NCT00464594|Metformin|metformin|mesh-list
153824442|NCT00464594|Acarbose|acarbose|mesh-list
153824443|NCT00464594|Gliclazide|gliclazide|mesh-list
153824444|NCT00464594|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153824445|NCT00464594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153824446|NCT00464594|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
153824447|NCT00464594|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153432061|NCT05469204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153432062|NCT05469204|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153432063|NCT05469204|Analgesics|analgesics|mesh-ancestor
153432064|NCT05469204|Sensory System Agents|sensory system agents|mesh-ancestor
153824448|NCT00464594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153824449|NCT04397302|Valsartan|valsartan|mesh-list
153364443|NCT01588457|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153364444|NCT01588457|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153364445|NCT01588457|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153364446|NCT01588457|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153364447|NCT01588457|GABA Agents|gaba agents|mesh-ancestor
153824450|NCT04397302|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
153824451|NCT04397302|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153824452|NCT04397302|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
153824453|NCT04397302|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
153824454|NCT04397302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153824455|NCT00466895|Lenalidomide|lenalidomide|mesh-list
153824463|NCT02893540|Capecitabine|capecitabine|mesh-list
153824509|NCT00491517|Antifungal Agents|antifungal agents|mesh-ancestor
153364478|NCT01591733|Capecitabine|capecitabine|mesh-list
153364479|NCT01591733|Oxaliplatin|oxaliplatin|mesh-list
153364481|NCT01591733|Folfirinox|folfirinox|mesh-list
153364483|NCT01591733|Antimetabolites|antimetabolites|mesh-ancestor
153364494|NCT03005405|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
153364496|NCT03005405|Autonomic Agents|autonomic agents|mesh-ancestor
153364497|NCT03005405|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153364498|NCT03005405|Dopamine Agents|dopamine agents|mesh-ancestor
153364499|NCT03005405|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153461730|NCT03193866|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153824542|NCT01327495|Methyltestosterone|methyltestosterone|mesh-list
153824543|NCT01327495|Testosterone|testosterone|mesh-list
153824544|NCT01327495|Testosterone undecanoate|testosterone undecanoate|mesh-list
153824545|NCT01327495|Testosterone enanthate|testosterone enanthate|mesh-list
153824555|NCT01327495|Hormone Antagonists|hormone antagonists|mesh-ancestor
153824556|NCT00491634|Treosulfan|treosulfan|mesh-list
153824557|NCT00491634|Busulfan|busulfan|mesh-list
153824558|NCT00491634|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153364533|NCT03005483|Antimanic Agents|antimanic agents|mesh-ancestor
153364534|NCT01593215|Yohimbine|yohimbine|mesh-list
153364535|NCT01593215|Mydriatics|mydriatics|mesh-ancestor
153364536|NCT01593215|Autonomic Agents|autonomic agents|mesh-ancestor
153364537|NCT01593215|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153364538|NCT01593215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153364539|NCT01593215|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
153364540|NCT01593215|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
153364541|NCT01593215|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
153364542|NCT01593215|Adrenergic Agents|adrenergic agents|mesh-ancestor
153364543|NCT01593215|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153364544|NCT01593215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153824580|NCT01327300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153824581|NCT01327300|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153824582|NCT01327300|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153824583|NCT00467207|Botulinum Toxins|botulinum toxins|mesh-list
153824584|NCT00467207|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
153824585|NCT00467207|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
153824586|NCT00467207|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
153824587|NCT00467207|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153824612|NCT00592111|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153824613|NCT00592111|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153824614|NCT00592111|Glucocorticoids|glucocorticoids|mesh-ancestor
153824615|NCT00592111|Hormones|hormones|mesh-ancestor
153824616|NCT00592111|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153364582|NCT01041638|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153364583|NCT01041638|Immunologic Factors|immunologic factors|mesh-ancestor
153364584|NCT01041638|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153364585|NCT01041638|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153364586|NCT01041638|Antiviral Agents|antiviral agents|mesh-ancestor
153364587|NCT01041638|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153364588|NCT01041638|Keratolytic Agents|keratolytic agents|mesh-ancestor
153364589|NCT01041638|Dermatologic Agents|dermatologic agents|mesh-ancestor
153364590|NCT03004625|Ribavirin|ribavirin|mesh-list
153364591|NCT03004625|Asunaprevir|asunaprevir|mesh-list
153364592|NCT03004625|Antimetabolites|antimetabolites|mesh-ancestor
153364593|NCT03004625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153364594|NCT03004625|Antiviral Agents|antiviral agents|mesh-ancestor
153364595|NCT03004625|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153824617|NCT00592111|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153824618|NCT00592111|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153824619|NCT00592111|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153824620|NCT00592111|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153824621|NCT00592111|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153824623|NCT00592111|Antimitotic Agents|antimitotic agents|mesh-ancestor
153824624|NCT00592111|Mitosis Modulators|mitosis modulators|mesh-ancestor
153824626|NCT00592150|Fenoldopam|fenoldopam|mesh-list
153824627|NCT00592150|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153824628|NCT00592150|Vasodilator Agents|vasodilator agents|mesh-ancestor
153824629|NCT00592150|Dopamine Agonists|dopamine agonists|mesh-ancestor
153824630|NCT00592150|Dopamine Agents|dopamine agents|mesh-ancestor
153824631|NCT00592150|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153824632|NCT00592150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153824633|NCT00592150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153824634|NCT00592306|Thymoglobulin|thymoglobulin|mesh-list
153824635|NCT00592306|Antilymphocyte Serum|antilymphocyte serum|mesh-list
153824636|NCT00592306|Immunologic Factors|immunologic factors|mesh-ancestor
153364604|NCT01725542|Antimetabolites|antimetabolites|mesh-ancestor
153364605|NCT01725542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153364606|NCT01725542|Antiviral Agents|antiviral agents|mesh-ancestor
153364607|NCT01725542|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153364608|NCT01725542|Protease Inhibitors|protease inhibitors|mesh-ancestor
153364609|NCT01725542|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153364610|NCT01725620|Etanercept|etanercept|mesh-list
153364612|NCT01725620|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153824647|NCT04377295|Growth Inhibitors|growth inhibitors|mesh-ancestor
153824648|NCT04377295|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153824649|NCT00491712|Triamcinolone|triamcinolone|mesh-list
153824650|NCT00491712|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153824651|NCT00491712|Glucocorticoids|glucocorticoids|mesh-ancestor
153824652|NCT00491712|Hormones|hormones|mesh-ancestor
153364620|NCT01725620|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153364621|NCT01725620|Immunologic Factors|immunologic factors|mesh-ancestor
153364622|NCT01045460|Cyclophosphamide|cyclophosphamide|mesh-list
153364623|NCT01045460|Melphalan|melphalan|mesh-list
153364624|NCT01045460|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153364625|NCT01045460|Immunologic Factors|immunologic factors|mesh-ancestor
153364626|NCT01045460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153364627|NCT01045460|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153364628|NCT01045460|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153364629|NCT01045460|Alkylating Agents|alkylating agents|mesh-ancestor
153364630|NCT01045460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153364631|NCT01045460|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153364632|NCT01045460|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153364633|NCT03403790|Quetiapine Fumarate|quetiapine fumarate|mesh-list
153364634|NCT03403790|Antidepressive Agents|antidepressive agents|mesh-ancestor
153364635|NCT03403790|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153364636|NCT03403790|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153364637|NCT03403790|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153364638|NCT03403790|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153364639|NCT03403790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153364641|NCT05014919|Antidepressive Agents|antidepressive agents|mesh-ancestor
153364642|NCT05014919|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153364643|NCT05014919|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153364644|NCT05014919|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153824674|NCT00491790|Hormone Antagonists|hormone antagonists|mesh-ancestor
153824675|NCT00491790|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153824676|NCT00491790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153824677|NCT00491790|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
153824678|NCT00491790|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
153824679|NCT00491790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153824680|NCT03272009|Interferons|interferons|mesh-list
153824681|NCT03272009|Interferon-alpha|interferon-alpha|mesh-list
153364649|NCT05014919|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153364650|NCT05014919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153364651|NCT05014919|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153364652|NCT05014919|Serotonin Agents|serotonin agents|mesh-ancestor
153364653|NCT05014919|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
153364654|NCT05014919|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
153364655|NCT05014919|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
153364656|NCT05014919|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153364657|NCT05672537|Gemcitabine|gemcitabine|mesh-list
153364658|NCT05672537|Durvalumab|durvalumab|mesh-list
153364659|NCT05672537|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153364660|NCT05672537|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153364661|NCT05672537|Antimetabolites|antimetabolites|mesh-ancestor
153364662|NCT05672537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153364663|NCT05672537|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153364664|NCT03400592|Irinotecan|irinotecan|mesh-list
153364666|NCT03400592|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
153364667|NCT03400592|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153364668|NCT03400592|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153824695|NCT00498888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153824696|NCT00498888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153824697|NCT00498888|Urological Agents|urological agents|mesh-ancestor
153824698|NCT00491868|Epoetin Alfa|epoetin alfa|mesh-list
153824699|NCT00491868|Hematinics|hematinics|mesh-ancestor
153824700|NCT00491907|Folic Acid|folic acid|mesh-list
153824701|NCT00491907|Hematinics|hematinics|mesh-ancestor
153824702|NCT00491907|Vitamin B Complex|vitamin b complex|mesh-ancestor
153824703|NCT00491907|Vitamins|vitamins|mesh-ancestor
153824704|NCT00491907|Micronutrients|micronutrients|mesh-ancestor
153364677|NCT00919802|Oxytocin|oxytocin|mesh-list
153364678|NCT00919802|Oxytocics|oxytocics|mesh-ancestor
153364679|NCT00919802|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153364680|NCT00919802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153364681|NCT02222129|Bupivacaine|bupivacaine|mesh-list
153364682|NCT02222129|Anesthetics, Local|anesthetics, local|mesh-ancestor
153364683|NCT02222129|Anesthetics|anesthetics|mesh-ancestor
153364684|NCT02222129|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153364685|NCT02222129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153364686|NCT02222129|Sensory System Agents|sensory system agents|mesh-ancestor
153364687|NCT02222129|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153364688|NCT03003611|Anesthetics|anesthetics|mesh-list
153364689|NCT03003611|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153364690|NCT03003611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153364691|NCT03402698|Cholecalciferol|cholecalciferol|mesh-list
153364692|NCT03402698|Vitamin D|vitamin d|mesh-list
153364693|NCT03402698|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153364694|NCT03402698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153364695|NCT03402698|Vitamins|vitamins|mesh-ancestor
153364696|NCT03402698|Micronutrients|micronutrients|mesh-ancestor
153364697|NCT03402698|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153364698|NCT03406520|Chlorhexidine|chlorhexidine|mesh-list
153364699|NCT03406520|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
153364700|NCT03406520|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153364701|NCT03406520|Disinfectants|disinfectants|mesh-ancestor
153364702|NCT02248181|Pramipexole|pramipexole|mesh-list
153364703|NCT02248181|Dexpramipexole|dexpramipexole|mesh-list
153364704|NCT02248181|Antioxidants|antioxidants|mesh-ancestor
153824712|NCT00491946|Vincristine|vincristine|mesh-list
153364711|NCT02248181|Dopamine Agents|dopamine agents|mesh-ancestor
153824713|NCT00491946|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153824714|NCT00491946|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153824715|NCT00491946|Tubulin Modulators|tubulin modulators|mesh-ancestor
153824716|NCT00491946|Antimitotic Agents|antimitotic agents|mesh-ancestor
153824717|NCT00491946|Mitosis Modulators|mitosis modulators|mesh-ancestor
153824727|NCT00491985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153824728|NCT02892916|Ketamine|ketamine|mesh-list
153824729|NCT02892916|Analgesics|analgesics|mesh-ancestor
153824730|NCT02892916|Sensory System Agents|sensory system agents|mesh-ancestor
153824731|NCT02892916|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153824732|NCT02892916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153824733|NCT02892916|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
153824734|NCT02892916|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153824735|NCT02892916|Anesthetics, General|anesthetics, general|mesh-ancestor
153824736|NCT02892916|Anesthetics|anesthetics|mesh-ancestor
153824737|NCT02892916|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153824738|NCT02892916|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
153824739|NCT02892916|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
153824740|NCT02892916|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153824741|NCT02892916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153824742|NCT00492102|Montelukast|montelukast|mesh-list
153824743|NCT00492102|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153824744|NCT00492102|Respiratory System Agents|respiratory system agents|mesh-ancestor
153824745|NCT00492102|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
153824746|NCT00492102|Hormone Antagonists|hormone antagonists|mesh-ancestor
153824747|NCT00492102|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153824748|NCT00492102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153824749|NCT00492102|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
153824750|NCT00492102|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
153824751|NCT00492102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153824752|NCT00467636|Insulin glulisine|insulin glulisine|mesh-list
153824753|NCT00467636|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153364721|NCT02462928|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153364722|NCT02462928|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153364723|NCT02462928|Growth Substances|growth substances|mesh-ancestor
153364724|NCT02462928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153364729|NCT03002831|Antimetabolites|antimetabolites|mesh-ancestor
153364730|NCT03002831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153364731|NCT03002831|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153364732|NCT04526951|Aspirin|aspirin|mesh-list
153364733|NCT04526951|Tenecteplase|tenecteplase|mesh-list
153364734|NCT04526951|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153364735|NCT04526951|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153364736|NCT04526951|Analgesics|analgesics|mesh-ancestor
153364737|NCT04526951|Sensory System Agents|sensory system agents|mesh-ancestor
153364738|NCT04526951|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153364739|NCT04526951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153364740|NCT04526951|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153364741|NCT04526951|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153364742|NCT04526951|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153364743|NCT04526951|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153364744|NCT04526951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153364745|NCT04526951|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153364746|NCT04526951|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153364747|NCT04526951|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153364748|NCT04526951|Antipyretics|antipyretics|mesh-ancestor
153364749|NCT02248415|Anesthetics|anesthetics|mesh-list
153824760|NCT00492141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153824761|NCT00492141|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153824762|NCT00492141|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153824763|NCT00492141|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
153824764|NCT00492141|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153824765|NCT00492141|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153824766|NCT04327726|Dexmedetomidine|dexmedetomidine|mesh-list
153824767|NCT04327726|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153824768|NCT04327726|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153824769|NCT04327726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153824770|NCT04327726|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153824771|NCT04327726|Analgesics|analgesics|mesh-ancestor
153824772|NCT04327726|Sensory System Agents|sensory system agents|mesh-ancestor
153824773|NCT04327726|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153824774|NCT04327726|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
153824775|NCT04327726|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153824776|NCT04327726|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153824777|NCT04327726|Adrenergic Agents|adrenergic agents|mesh-ancestor
153824778|NCT04327726|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153824779|NCT04327726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153824780|NCT00492219|Cimetidine|cimetidine|mesh-list
153824781|NCT00492219|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
153824782|NCT00492219|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153364750|NCT02248415|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153364751|NCT02248415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153364752|NCT02248571|Bevacizumab|bevacizumab|mesh-list
153364753|NCT02248571|Capecitabine|capecitabine|mesh-list
153364754|NCT02248571|Everolimus|everolimus|mesh-list
153364755|NCT02248571|Exemestane|exemestane|mesh-list
153364756|NCT02248571|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153364764|NCT02248571|Antimetabolites|antimetabolites|mesh-ancestor
153824801|NCT00465257|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
153824802|NCT00465257|Anthelmintics|anthelmintics|mesh-ancestor
153364769|NCT02248571|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153364770|NCT02248571|Immunologic Factors|immunologic factors|mesh-ancestor
153364771|NCT02248571|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
153364772|NCT02248571|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153364773|NCT02248571|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
153364774|NCT02248571|Hormone Antagonists|hormone antagonists|mesh-ancestor
153364775|NCT02248571|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153364776|NCT00019604|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
153364777|NCT00019604|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
153364778|NCT00019604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153364779|NCT03002675|Exenatide|exenatide|mesh-list
153364780|NCT03002675|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
153824813|NCT00492258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153824815|NCT02955810|Cyclophosphamide|cyclophosphamide|mesh-list
153824816|NCT02955810|Bortezomib|bortezomib|mesh-list
153364781|NCT03002675|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153364794|NCT02247557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153364796|NCT02247557|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153364797|NCT04374188|Ciprofloxacin|ciprofloxacin|mesh-list
153364798|NCT04374188|Levofloxacin|levofloxacin|mesh-list
153824819|NCT02955810|Immunologic Factors|immunologic factors|mesh-ancestor
153824820|NCT02955810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153824821|NCT02955810|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153824822|NCT02955810|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153824823|NCT02955810|Alkylating Agents|alkylating agents|mesh-ancestor
153824824|NCT02955810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153824825|NCT02955810|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153824826|NCT02955810|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153824827|NCT02955810|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153824828|NCT02955810|Antiemetics|antiemetics|mesh-ancestor
153824829|NCT02955810|Autonomic Agents|autonomic agents|mesh-ancestor
153824830|NCT02955810|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153824831|NCT02955810|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153824832|NCT02955810|Glucocorticoids|glucocorticoids|mesh-ancestor
153891041|NCT01265550|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
153891042|NCT01265550|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153891043|NCT01265550|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153824833|NCT02955810|Hormones|hormones|mesh-ancestor
153824834|NCT02955810|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153824835|NCT02955810|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153824836|NCT00465296|Rosiglitazone|rosiglitazone|mesh-list
153824837|NCT00465296|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153364802|NCT04374188|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153364803|NCT04374188|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153364804|NCT04374188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153364805|NCT04374188|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153364806|NCT04374188|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
153364807|NCT04374188|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153364808|NCT04374188|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
153364809|NCT04374032|Enkephalin, Methionine|enkephalin, methionine|mesh-list
153364810|NCT04374032|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153364811|NCT04374032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153364812|NCT04374032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153364813|NCT03401606|Dexmedetomidine|dexmedetomidine|mesh-list
153824865|NCT00467948|Cefazolin|cefazolin|mesh-list
153824866|NCT00467948|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153824867|NCT00467948|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153824868|NCT00592579|2-Methoxyestradiol|2-methoxyestradiol|mesh-list
153824869|NCT00592579|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153824870|NCT00592579|Tubulin Modulators|tubulin modulators|mesh-ancestor
153824871|NCT00592579|Antimitotic Agents|antimitotic agents|mesh-ancestor
153824872|NCT00592579|Mitosis Modulators|mitosis modulators|mesh-ancestor
153364836|NCT02516592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153364837|NCT02516592|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153364838|NCT02516592|Respiratory System Agents|respiratory system agents|mesh-ancestor
153364839|NCT02516592|Dermatologic Agents|dermatologic agents|mesh-ancestor
153364840|NCT02516592|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
153364841|NCT02516592|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
153364842|NCT02516592|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
153364843|NCT02516592|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153364844|NCT02516592|Adrenergic Agents|adrenergic agents|mesh-ancestor
153364845|NCT02516592|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153364846|NCT02516592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153364847|NCT03401372|Doxycycline|doxycycline|mesh-list
153364848|NCT03401372|Dexamethasone|dexamethasone|mesh-list
153364849|NCT03401372|Cyclophosphamide|cyclophosphamide|mesh-list
153364850|NCT03401372|Bortezomib|bortezomib|mesh-list
153364851|NCT03401372|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153364852|NCT03401372|Immunologic Factors|immunologic factors|mesh-ancestor
153364853|NCT03401372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153824878|NCT00592618|Expectorants|expectorants|mesh-ancestor
153824879|NCT00592618|Respiratory System Agents|respiratory system agents|mesh-ancestor
153824880|NCT00592618|Free Radical Scavengers|free radical scavengers|mesh-ancestor
153824881|NCT00592618|Antioxidants|antioxidants|mesh-ancestor
153824882|NCT00592618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153824883|NCT00592618|Protective Agents|protective agents|mesh-ancestor
153824884|NCT00592618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153824885|NCT00592618|Antidotes|antidotes|mesh-ancestor
153824886|NCT01243710|Taurolidine|taurolidine|mesh-list
153824887|NCT01243710|Heparin|heparin|mesh-list
153824888|NCT01243710|Anticoagulants|anticoagulants|mesh-ancestor
153824889|NCT01243710|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153824890|NCT01243710|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153824891|NCT01243710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153824892|NCT01243710|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153824893|NCT01243710|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
153824894|NCT01243710|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153824895|NCT00622843|Vaccines|vaccines|mesh-list
153824896|NCT00622843|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
153824897|NCT00622843|Immunologic Factors|immunologic factors|mesh-ancestor
153824898|NCT00622843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153824899|NCT01245543|Docetaxel|docetaxel|mesh-list
153824900|NCT01245543|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153824901|NCT01245543|Tubulin Modulators|tubulin modulators|mesh-ancestor
153364865|NCT03401372|Glucocorticoids|glucocorticoids|mesh-ancestor
153364866|NCT03401372|Hormones|hormones|mesh-ancestor
153364867|NCT03401372|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153364868|NCT03401372|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153364869|NCT03401372|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153364882|NCT02219321|Anesthetics, Local|anesthetics, local|mesh-ancestor
153364883|NCT02219321|Anesthetics|anesthetics|mesh-ancestor
153364884|NCT02219321|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153364885|NCT02219321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153364886|NCT02219321|Sensory System Agents|sensory system agents|mesh-ancestor
153364887|NCT02219321|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153824925|NCT00592969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153824927|NCT01245582|Oxaliplatin|oxaliplatin|mesh-list
153824928|NCT01245582|Sorafenib|sorafenib|mesh-list
153824930|NCT01245582|Antimetabolites|antimetabolites|mesh-ancestor
153364893|NCT04955574|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
153364895|NCT04955574|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
153364896|NCT04955574|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153364897|NCT04955574|Antitubercular Agents|antitubercular agents|mesh-ancestor
153364898|NCT04955574|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153364899|NCT04955574|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153364919|NCT02461290|Rituximab|rituximab|mesh-list
153364920|NCT02461290|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153364921|NCT02461290|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153364922|NCT02461290|Immunologic Factors|immunologic factors|mesh-ancestor
153364923|NCT02461290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153364924|NCT02461290|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153364932|NCT04376528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153364933|NCT04376528|Antifungal Agents|antifungal agents|mesh-ancestor
153364934|NCT04376528|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153364935|NCT04376528|Dermatologic Agents|dermatologic agents|mesh-ancestor
153364936|NCT04376528|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153364937|NCT04376528|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
153364947|NCT02461134|Immunologic Factors|immunologic factors|mesh-ancestor
153364948|NCT02461134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153364949|NCT04373018|Chlorhexidine|chlorhexidine|mesh-list
153364950|NCT04373018|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
153364951|NCT04373018|Hydrogen Peroxide|hydrogen peroxide|mesh-list
153364952|NCT04373018|Sodium Hypochlorite|sodium hypochlorite|mesh-list
153364953|NCT04373018|Eusol|eusol|mesh-list
153364954|NCT04373018|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
153825022|NCT00465452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153825023|NCT00465452|Protective Agents|protective agents|mesh-ancestor
153825025|NCT01379521|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
153825026|NCT01379521|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153825027|NCT01379521|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153365007|NCT04372316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153365008|NCT02221739|Ipilimumab|ipilimumab|mesh-list
153365009|NCT02221739|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153825076|NCT01245816|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153825077|NCT01245816|Analgesics|analgesics|mesh-ancestor
153825078|NCT01245816|Sensory System Agents|sensory system agents|mesh-ancestor
153825079|NCT01245816|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153825080|NCT01245816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153825081|NCT01245816|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153825082|NCT01245816|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153825083|NCT01245816|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153825084|NCT00492687|Tamoxifen|tamoxifen|mesh-list
153825085|NCT00492687|Carboplatin|carboplatin|mesh-list
153825086|NCT00492687|Temozolomide|temozolomide|mesh-list
153825087|NCT00492687|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153825088|NCT00492687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153825089|NCT00492687|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153825090|NCT00492687|Alkylating Agents|alkylating agents|mesh-ancestor
153825091|NCT00492687|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
153825092|NCT00492687|Hormone Antagonists|hormone antagonists|mesh-ancestor
153365056|NCT04372082|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
153365058|NCT04372082|Antinematodal Agents|antinematodal agents|mesh-ancestor
153365059|NCT02489448|Durvalumab|durvalumab|mesh-list
153365060|NCT02489448|Tremelimumab|tremelimumab|mesh-list
153365061|NCT02489448|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153365062|NCT02489448|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153365063|NCT00926588|Analgesics|analgesics|mesh-list
153365064|NCT00926588|Sensory System Agents|sensory system agents|mesh-ancestor
153365065|NCT00926588|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153365066|NCT00926588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153365067|NCT04371926|Hydroxychloroquine|hydroxychloroquine|mesh-list
153365068|NCT04371926|Antimalarials|antimalarials|mesh-ancestor
153365069|NCT04371926|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153365070|NCT04371926|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153365071|NCT04371926|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153365072|NCT04371926|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153365073|NCT04371926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153365074|NCT04371926|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153365075|NCT02248883|Moxifloxacin|moxifloxacin|mesh-list
153365076|NCT02248883|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153365077|NCT02248883|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153365078|NCT02248883|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153365079|NCT02248883|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153365082|NCT02248883|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153365083|NCT04364906|Anesthetics|anesthetics|mesh-list
153365089|NCT02488980|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153365090|NCT02488980|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153365091|NCT02488980|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153365092|NCT02227667|Durvalumab|durvalumab|mesh-list
153432082|NCT05377255|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153432083|NCT05361915|Abivertinib|abivertinib|mesh-list
153825126|NCT00492765|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
153365093|NCT02227667|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153365095|NCT02242214|Misoprostol|misoprostol|mesh-list
153365096|NCT02242214|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
153365097|NCT02242214|Abortifacient Agents|abortifacient agents|mesh-ancestor
153365098|NCT02242214|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153365099|NCT02242214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153365100|NCT02242214|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
153365101|NCT02242214|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153365102|NCT02242214|Oxytocics|oxytocics|mesh-ancestor
153365103|NCT02245256|Dexmedetomidine|dexmedetomidine|mesh-list
153365104|NCT02245256|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153365105|NCT02245256|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153365106|NCT02245256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153365107|NCT02245256|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153825139|NCT00468533|Dopamine Agents|dopamine agents|mesh-ancestor
153825140|NCT00468533|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153825141|NCT00468533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153825142|NCT00468533|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
153825143|NCT00468533|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
153825144|NCT00468533|Serotonin Agents|serotonin agents|mesh-ancestor
153825145|NCT00468533|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
153825146|NCT00468533|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153825147|NCT00468533|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
153825148|NCT00468533|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
153825149|NCT00473720|Paclitaxel|paclitaxel|mesh-list
153365116|NCT02245256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153365118|NCT05208983|Immunologic Factors|immunologic factors|mesh-ancestor
153365119|NCT05208983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153365120|NCT02242292|Scopolamine|scopolamine|mesh-list
153365121|NCT02242292|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
153365122|NCT02242292|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153365123|NCT02242292|Antiemetics|antiemetics|mesh-ancestor
153365124|NCT02242292|Autonomic Agents|autonomic agents|mesh-ancestor
153365125|NCT02242292|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153365126|NCT02242292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153365127|NCT02242292|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153365128|NCT02242292|Mydriatics|mydriatics|mesh-ancestor
153365129|NCT02242292|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
153365130|NCT02242292|Cholinergic Agents|cholinergic agents|mesh-ancestor
153365131|NCT02242292|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153365132|NCT02242292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153365133|NCT02242292|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
153365134|NCT02242292|Parasympatholytics|parasympatholytics|mesh-ancestor
153365135|NCT02242370|Telmisartan|telmisartan|mesh-list
153365139|NCT02242370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153365141|NCT04371146|Reboxetine|reboxetine|mesh-list
153365142|NCT04371146|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
153365143|NCT04371146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153365144|NCT04371146|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
153365145|NCT04371146|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153365146|NCT04371146|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153365147|NCT04371146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153365148|NCT04371146|Dopamine Agents|dopamine agents|mesh-ancestor
153825150|NCT00473720|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
153825151|NCT00473720|Satraplatin|satraplatin|mesh-list
153825152|NCT00473720|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153825153|NCT00473720|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153825156|NCT00473720|Mitosis Modulators|mitosis modulators|mesh-ancestor
153825157|NCT00473720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153825158|NCT00499668|Ondansetron|ondansetron|mesh-list
153825159|NCT00499668|Aprepitant|aprepitant|mesh-list
153825160|NCT00499668|Antiemetics|antiemetics|mesh-ancestor
153825161|NCT00499668|Autonomic Agents|autonomic agents|mesh-ancestor
153825162|NCT00499668|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153825163|NCT00499668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153825164|NCT00499668|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153825165|NCT00499668|Antipruritics|antipruritics|mesh-ancestor
153825166|NCT00499668|Dermatologic Agents|dermatologic agents|mesh-ancestor
153825167|NCT00499668|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
153825168|NCT00499668|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153825169|NCT00499668|Serotonin Agents|serotonin agents|mesh-ancestor
153825170|NCT00499668|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153825171|NCT00499668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153825172|NCT00499668|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
153825174|NCT00499707|Rosiglitazone|rosiglitazone|mesh-list
153825175|NCT00499707|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153825176|NCT00499707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153825177|NCT01366534|Vaccines|vaccines|mesh-list
153825178|NCT01366534|Immunologic Factors|immunologic factors|mesh-ancestor
153825179|NCT01366534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153825180|NCT00492843|Ibandronic Acid|ibandronic acid|mesh-list
153825181|NCT00492843|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153825182|NCT00492843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153825183|NCT01605487|Cyproheptadine|cyproheptadine|mesh-list
153825184|NCT01605487|Antipruritics|antipruritics|mesh-ancestor
153825185|NCT01605487|Dermatologic Agents|dermatologic agents|mesh-ancestor
153825186|NCT01605487|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153825187|NCT01605487|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
153825188|NCT01605487|Histamine Antagonists|histamine antagonists|mesh-ancestor
153825189|NCT01605487|Histamine Agents|histamine agents|mesh-ancestor
153365153|NCT04371146|Adrenergic Agents|adrenergic agents|mesh-ancestor
153365154|NCT01623479|Bimatoprost|bimatoprost|mesh-list
153365155|NCT01623479|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153365156|NCT04347200|Anticoagulants|anticoagulants|mesh-list
153365157|NCT04347200|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-list
153365158|NCT04364516|Vitamin K|vitamin k|mesh-list
153365159|NCT04364516|Anticoagulants|anticoagulants|mesh-list
153365160|NCT04364516|Vitamins|vitamins|mesh-ancestor
153365161|NCT04364516|Micronutrients|micronutrients|mesh-ancestor
153365162|NCT04364516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153365163|NCT04364516|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
153365164|NCT04364516|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153365165|NCT04364516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153365166|NCT04364516|Hemostatics|hemostatics|mesh-ancestor
153365167|NCT04364516|Coagulants|coagulants|mesh-ancestor
153365168|NCT01623869|Trebananib|trebananib|mesh-list
153365169|NCT01623869|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153365170|NCT01623869|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153825196|NCT01365910|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-list
153825197|NCT01365910|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153825198|NCT01365910|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153825199|NCT01365910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153825200|NCT01605526|Doxorubicin|doxorubicin|mesh-list
153825201|NCT01605526|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153825202|NCT01605526|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153825203|NCT01605526|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153825204|NCT01605526|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153825205|NCT01605526|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153825206|NCT01605526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153825207|NCT00468689|Ketoconazole|ketoconazole|mesh-list
153825208|NCT00468689|Antifungal Agents|antifungal agents|mesh-ancestor
153825209|NCT00468689|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153365174|NCT01623869|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153365175|NCT02242838|Telmisartan|telmisartan|mesh-list
153365176|NCT02242838|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153365177|NCT02242838|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
153365178|NCT02242838|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
153365179|NCT02242838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153365181|NCT03207347|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
153825219|NCT00473915|Fluticasone|fluticasone|mesh-list
153825220|NCT00473915|Xhance|xhance|mesh-list
153825221|NCT00473915|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153825222|NCT00473915|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153825223|NCT00473915|Autonomic Agents|autonomic agents|mesh-ancestor
153825224|NCT00473915|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153825225|NCT00473915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153825226|NCT00473915|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153825227|NCT00473915|Respiratory System Agents|respiratory system agents|mesh-ancestor
153365193|NCT02249039|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
153365194|NCT02249039|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153365195|NCT02249039|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153365196|NCT02249039|Adrenergic Agents|adrenergic agents|mesh-ancestor
153365197|NCT02249039|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153365198|NCT02249039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153365199|NCT04370288|Acetylcysteine|acetylcysteine|mesh-list
153365200|NCT04370288|N-monoacetylcystine|n-monoacetylcystine|mesh-list
153365201|NCT04370288|Methylene Blue|methylene blue|mesh-list
153365202|NCT04370288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153365203|NCT04370288|Antioxidants|antioxidants|mesh-ancestor
153365204|NCT04370288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153365205|NCT04370288|Protective Agents|protective agents|mesh-ancestor
153365206|NCT04370288|Antiviral Agents|antiviral agents|mesh-ancestor
153825242|NCT00474071|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153365209|NCT04370288|Respiratory System Agents|respiratory system agents|mesh-ancestor
153365210|NCT04370288|Free Radical Scavengers|free radical scavengers|mesh-ancestor
153365211|NCT04370288|Antidotes|antidotes|mesh-ancestor
153365212|NCT04370288|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153365213|NCT02993705|Trabectedin|trabectedin|mesh-list
153365214|NCT02993705|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153365215|NCT02993705|Alkylating Agents|alkylating agents|mesh-ancestor
153365216|NCT02993705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153365217|NCT02993705|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153365218|NCT02243618|Rebamipide|rebamipide|mesh-list
153365219|NCT02243618|Polaprezinc|polaprezinc|mesh-list
153365220|NCT02243618|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
153365221|NCT02243618|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153365222|NCT02243618|Antioxidants|antioxidants|mesh-ancestor
153365223|NCT02243618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153365228|NCT02243852|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153365229|NCT02243852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153365231|NCT04369586|Antiviral Agents|antiviral agents|mesh-ancestor
153365232|NCT04369586|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153365233|NCT02231177|Tiotropium Bromide|tiotropium bromide|mesh-list
153365234|NCT02231177|Olodaterol|olodaterol|mesh-list
153365235|NCT02231177|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153365236|NCT02231177|Autonomic Agents|autonomic agents|mesh-ancestor
153365237|NCT02231177|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153365238|NCT02231177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153365239|NCT02231177|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153365240|NCT02231177|Respiratory System Agents|respiratory system agents|mesh-ancestor
153365241|NCT02231177|Parasympatholytics|parasympatholytics|mesh-ancestor
153825243|NCT00474071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153825244|NCT00474071|Analgesics|analgesics|mesh-ancestor
153825245|NCT00474071|Sensory System Agents|sensory system agents|mesh-ancestor
153825246|NCT00474071|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153825247|NCT00474110|Ketamine|ketamine|mesh-list
153825248|NCT00474110|Hydromorphone|hydromorphone|mesh-list
153825249|NCT00474110|Analgesics|analgesics|mesh-ancestor
153825250|NCT00474110|Sensory System Agents|sensory system agents|mesh-ancestor
153825251|NCT00474110|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153825252|NCT00474110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153825265|NCT00500058|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153825266|NCT00500058|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153825267|NCT00500058|Immunologic Factors|immunologic factors|mesh-ancestor
153825268|NCT00500058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153825269|NCT00500058|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153825270|NCT00468923|Candesartan|candesartan|mesh-list
153825271|NCT00468923|Candesartan cilexetil|candesartan cilexetil|mesh-list
153825272|NCT00468923|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
153825273|NCT00468923|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153825274|NCT00468923|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153825275|NCT00468923|Antimetabolites|antimetabolites|mesh-ancestor
153825276|NCT00468923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153825277|NCT00468923|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153365242|NCT02231177|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
153365243|NCT02231177|Cholinergic Agents|cholinergic agents|mesh-ancestor
153365244|NCT02231177|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153365245|NCT02231177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153365247|NCT03283007|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153365248|NCT03283007|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153365249|NCT03283007|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153365250|NCT03283007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153365251|NCT02244086|Bupivacaine|bupivacaine|mesh-list
153365252|NCT02244086|Anesthetics, Local|anesthetics, local|mesh-ancestor
153365253|NCT02244086|Anesthetics|anesthetics|mesh-ancestor
153365254|NCT02244086|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153365255|NCT02244086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153365256|NCT02244086|Sensory System Agents|sensory system agents|mesh-ancestor
153365257|NCT02244086|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153365258|NCT01630109|Metoclopramide|metoclopramide|mesh-list
153365259|NCT01630109|Antiemetics|antiemetics|mesh-ancestor
153365260|NCT01630109|Autonomic Agents|autonomic agents|mesh-ancestor
153365261|NCT01630109|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153825289|NCT01365481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153825290|NCT01365481|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153825291|NCT01365481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153825292|NCT01365481|Vasodilator Agents|vasodilator agents|mesh-ancestor
153825293|NCT01365481|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
153825294|NCT01365481|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
153825295|NCT01365481|Diuretics|diuretics|mesh-ancestor
153825296|NCT01365481|Natriuretic Agents|natriuretic agents|mesh-ancestor
153825297|NCT01365481|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
153825298|NCT00493116|Interferons|interferons|mesh-list
153825299|NCT00493116|Interferon-beta|interferon-beta|mesh-list
153365267|NCT01630109|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153365268|NCT01630109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153365269|NCT04367948|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
153365270|NCT04367948|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
153365271|NCT04367948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153365272|NCT01632215|Gabapentin|gabapentin|mesh-list
153365273|NCT01632215|Anticonvulsants|anticonvulsants|mesh-list
153365274|NCT01632215|Analgesics|analgesics|mesh-ancestor
153365275|NCT01632215|Sensory System Agents|sensory system agents|mesh-ancestor
153365276|NCT01632215|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153365277|NCT01632215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153365278|NCT01632215|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153365279|NCT01632215|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153365280|NCT01632215|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153365281|NCT01632215|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153365282|NCT01632215|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
153365283|NCT01632215|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
153365284|NCT01632215|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153825310|NCT00493116|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153825311|NCT00493116|Glucocorticoids|glucocorticoids|mesh-ancestor
153825312|NCT00493116|Hormones|hormones|mesh-ancestor
153825313|NCT00493116|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153825314|NCT00493116|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
153825315|NCT00493116|Protective Agents|protective agents|mesh-ancestor
153825316|NCT00493116|Immunologic Factors|immunologic factors|mesh-ancestor
153825317|NCT00493116|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153365293|NCT02244242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153365294|NCT02244242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153365295|NCT02244242|Urological Agents|urological agents|mesh-ancestor
153365296|NCT02244320|Tamsulosin|tamsulosin|mesh-list
153365297|NCT02244320|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
153365298|NCT02244320|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
153365299|NCT02244320|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
153365300|NCT02244320|Adrenergic Agents|adrenergic agents|mesh-ancestor
153365301|NCT02244320|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153365302|NCT02244320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153365303|NCT02244320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153365304|NCT02244320|Urological Agents|urological agents|mesh-ancestor
153825329|NCT00493194|Dermatologic Agents|dermatologic agents|mesh-ancestor
153825330|NCT00493194|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153825331|NCT00493194|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
153825332|NCT00493194|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153825333|NCT00493194|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153825334|NCT00493194|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153825335|NCT01605721|Everolimus|everolimus|mesh-list
153825336|NCT01605721|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
153825337|NCT01605721|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153825338|NCT01605721|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153825339|NCT01605721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153825340|NCT01605721|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153825341|NCT01605721|Immunologic Factors|immunologic factors|mesh-ancestor
153825342|NCT01605721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153825343|NCT01605721|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153825344|NCT01605760|Immunomodulating Agents|immunomodulating agents|mesh-list
153825345|NCT01605760|Immunologic Factors|immunologic factors|mesh-ancestor
153825346|NCT01605760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153825347|NCT01350271|Mebendazole|mebendazole|mesh-list
153825348|NCT01350271|Piperazine|piperazine|mesh-list
153825349|NCT01350271|Piperazine citrate|piperazine citrate|mesh-list
153825350|NCT01350271|DMP 777|dmp 777|mesh-list
153825351|NCT01350271|Antinematodal Agents|antinematodal agents|mesh-ancestor
153825352|NCT01350271|Anthelmintics|anthelmintics|mesh-ancestor
153825353|NCT01350271|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153825354|NCT01350271|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153825355|NCT01350271|Tubulin Modulators|tubulin modulators|mesh-ancestor
153825356|NCT01350271|Antimitotic Agents|antimitotic agents|mesh-ancestor
153825357|NCT01350271|Mitosis Modulators|mitosis modulators|mesh-ancestor
153825358|NCT01350271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153825359|NCT01350271|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153825360|NCT01350271|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153825361|NCT00493233|Olanzapine|olanzapine|mesh-list
153825362|NCT00493233|Risperidone|risperidone|mesh-list
153825363|NCT00493233|Quetiapine Fumarate|quetiapine fumarate|mesh-list
153825364|NCT00493233|Antipsychotic Agents|antipsychotic agents|mesh-list
153825365|NCT00493233|Clozapine|clozapine|mesh-list
153825366|NCT00493233|Perphenazine|perphenazine|mesh-list
153825368|NCT00493233|Serotonin Agents|serotonin agents|mesh-ancestor
153365345|NCT04362332|Chloroquine|chloroquine|mesh-list
153365346|NCT04362332|Chloroquine diphosphate|chloroquine diphosphate|mesh-list
153365347|NCT04362332|Antimalarials|antimalarials|mesh-ancestor
153365348|NCT04362332|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153365349|NCT04362332|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153365350|NCT04362332|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153365351|NCT04362332|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153825378|NCT00493233|Autonomic Agents|autonomic agents|mesh-ancestor
153825384|NCT00493233|Antidepressive Agents|antidepressive agents|mesh-ancestor
153825385|NCT00493233|GABA Antagonists|gaba antagonists|mesh-ancestor
153825386|NCT00493233|GABA Agents|gaba agents|mesh-ancestor
153825387|NCT00500253|Nitric Oxide|nitric oxide|mesh-list
153825388|NCT00500253|Methacholine Chloride|methacholine chloride|mesh-list
153365352|NCT04362332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153365353|NCT04362332|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153365354|NCT04362332|Amebicides|amebicides|mesh-ancestor
153365355|NCT04362332|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153365356|NCT04362332|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153365357|NCT04362332|Analgesics|analgesics|mesh-ancestor
153365358|NCT04362332|Sensory System Agents|sensory system agents|mesh-ancestor
153365359|NCT04362332|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153365360|NCT04362332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153365361|NCT04362332|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153365362|NCT04362332|Filaricides|filaricides|mesh-ancestor
153365363|NCT04362332|Antinematodal Agents|antinematodal agents|mesh-ancestor
153365364|NCT04362332|Anthelmintics|anthelmintics|mesh-ancestor
153365365|NCT02308241|Ribavirin|ribavirin|mesh-list
153365366|NCT02308241|Antimetabolites|antimetabolites|mesh-ancestor
153365367|NCT02308241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153365368|NCT02308241|Antiviral Agents|antiviral agents|mesh-ancestor
153365369|NCT02308241|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153365370|NCT00932282|Omalizumab|omalizumab|mesh-list
153365371|NCT00932282|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
153365372|NCT00932282|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153365373|NCT00932282|Respiratory System Agents|respiratory system agents|mesh-ancestor
153365388|NCT02245022|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153365389|NCT02245022|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153365390|NCT02245022|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153365391|NCT02245022|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153365392|NCT02245022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153365393|NCT02245022|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153365394|NCT02245022|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153365395|NCT02245022|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
153365396|NCT02245022|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153365397|NCT02245022|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
153365421|NCT01633853|Vitamins|vitamins|mesh-list
153365422|NCT01633853|Micronutrients|micronutrients|mesh-ancestor
153365423|NCT01633853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153365424|NCT01633853|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153825438|NCT01243827|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153825439|NCT01243827|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153825440|NCT01243827|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153825441|NCT01243827|Vasodilator Agents|vasodilator agents|mesh-ancestor
153825442|NCT01243827|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
153825443|NCT01243827|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
153825444|NCT01243827|Sympatholytics|sympatholytics|mesh-ancestor
153825445|NCT01243827|Autonomic Agents|autonomic agents|mesh-ancestor
153825446|NCT01243827|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153825447|NCT01243827|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
153825449|NCT00500409|Vitamins|vitamins|mesh-ancestor
153825450|NCT00500409|Micronutrients|micronutrients|mesh-ancestor
153825451|NCT00500409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153825452|NCT00500409|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153825453|NCT00469352|Ranibizumab|ranibizumab|mesh-list
153825454|NCT00469352|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153825455|NCT00469352|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153825456|NCT00469352|Growth Substances|growth substances|mesh-ancestor
153825457|NCT00469352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153825458|NCT00469352|Growth Inhibitors|growth inhibitors|mesh-ancestor
153825459|NCT00469352|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153825460|NCT00469430|Metronidazole|metronidazole|mesh-list
153365425|NCT01633853|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153365426|NCT04361552|Immunoglobulins|immunoglobulins|mesh-list
153365427|NCT04361552|Immunoglobulin G|immunoglobulin g|mesh-list
153365428|NCT04361552|Immunologic Factors|immunologic factors|mesh-ancestor
153365429|NCT04361552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153365430|NCT04376216|Prednisone|prednisone|mesh-list
153365431|NCT04376216|Prednisolone|prednisolone|mesh-list
153365432|NCT04376216|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153365433|NCT04376216|Glucocorticoids|glucocorticoids|mesh-ancestor
153383564|NCT00354731|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153383565|NCT00354731|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
153383566|NCT00354731|Protective Agents|protective agents|mesh-ancestor
153383567|NCT00354731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153365434|NCT04376216|Hormones|hormones|mesh-ancestor
153365435|NCT04376216|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153365436|NCT04376216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153365437|NCT04376216|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153365438|NCT04376216|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153365439|NCT02452320|Acetaminophen|acetaminophen|mesh-list
153365440|NCT02452320|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153365441|NCT02452320|Analgesics|analgesics|mesh-ancestor
153365442|NCT02452320|Sensory System Agents|sensory system agents|mesh-ancestor
153365443|NCT02452320|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153365444|NCT02452320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153365445|NCT02452320|Antipyretics|antipyretics|mesh-ancestor
153365446|NCT02459964|Fentanyl|fentanyl|mesh-list
153365447|NCT02459964|Hydromorphone|hydromorphone|mesh-list
153365448|NCT02459964|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153365449|NCT02459964|Narcotics|narcotics|mesh-ancestor
153365450|NCT02459964|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153365451|NCT02459964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153365452|NCT02459964|Analgesics|analgesics|mesh-ancestor
153365453|NCT02459964|Sensory System Agents|sensory system agents|mesh-ancestor
153365454|NCT02459964|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153365455|NCT02459964|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153365456|NCT02459964|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153365467|NCT02087111|Ribavirin|ribavirin|mesh-list
153825463|NCT00469430|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153825464|NCT00469430|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153825465|NCT00469430|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153825466|NCT00469469|Bevacizumab|bevacizumab|mesh-list
153825467|NCT00469469|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153825468|NCT00469469|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153825469|NCT00469469|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153825470|NCT00469469|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153825471|NCT00469469|Growth Substances|growth substances|mesh-ancestor
153825472|NCT00469469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153825473|NCT00469469|Growth Inhibitors|growth inhibitors|mesh-ancestor
153825474|NCT00500565|Bupivacaine|bupivacaine|mesh-list
153825475|NCT00500565|Anesthetics, Local|anesthetics, local|mesh-ancestor
153825476|NCT00500565|Anesthetics|anesthetics|mesh-ancestor
153825477|NCT00500565|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153825478|NCT00500565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153825481|NCT00469547|Ethanol|ethanol|mesh-list
153825482|NCT00469547|Anti-Infective Agents|anti-infective agents|mesh-list
153825483|NCT00469547|Emollients|emollients|mesh-list
153825484|NCT00469547|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
153825485|NCT00469547|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153825486|NCT00469547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153825487|NCT00469547|Dermatologic Agents|dermatologic agents|mesh-ancestor
153825488|NCT00500604|Valsartan|valsartan|mesh-list
153825489|NCT00500604|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
153825490|NCT00500604|Irbesartan|irbesartan|mesh-list
153825491|NCT00500604|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153825492|NCT00500604|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
153825493|NCT00500604|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
153825494|NCT00500604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153825495|NCT00500604|Diuretics|diuretics|mesh-ancestor
153825496|NCT00500604|Natriuretic Agents|natriuretic agents|mesh-ancestor
153825497|NCT00500604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153825498|NCT00500604|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
153825499|NCT00500604|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153825500|NCT00493389|Hormones|hormones|mesh-list
153825501|NCT00493389|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
153825502|NCT00493389|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153383568|NCT00354731|Vasodilator Agents|vasodilator agents|mesh-ancestor
153383569|NCT00354731|Free Radical Scavengers|free radical scavengers|mesh-ancestor
153383570|NCT00354731|Antioxidants|antioxidants|mesh-ancestor
153383599|NCT02376257|Modafinil|modafinil|mesh-list
153383600|NCT02376257|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
153383601|NCT02376257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153383602|NCT02376257|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
153383603|NCT02376257|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
153383604|NCT02376257|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
153383605|NCT02376257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153383606|NCT02376257|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
153383607|NCT02376257|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153383608|NCT02376257|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
153383609|NCT02376257|Antitubercular Agents|antitubercular agents|mesh-ancestor
153383610|NCT02376257|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153825503|NCT00493389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153825504|NCT01605994|Antacids|antacids|mesh-list
153365475|NCT02087111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153365476|NCT02087111|Immunologic Factors|immunologic factors|mesh-ancestor
153365477|NCT02087111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153365478|NCT00932438|Leucovorin|leucovorin|mesh-list
153365479|NCT00932438|Bevacizumab|bevacizumab|mesh-list
153365480|NCT00932438|Fluorouracil|fluorouracil|mesh-list
153365481|NCT00932438|Oxaliplatin|oxaliplatin|mesh-list
153365482|NCT00932438|Irinotecan|irinotecan|mesh-list
153365483|NCT00932438|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153825507|NCT00500721|Desipramine|desipramine|mesh-list
153825508|NCT00500721|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
153825509|NCT00500721|Antidepressive Agents|antidepressive agents|mesh-ancestor
153825510|NCT00500721|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153825511|NCT00500721|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153825512|NCT00500721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153825513|NCT00500721|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
153825514|NCT00500721|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153825515|NCT00500721|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153825516|NCT00500721|Adrenergic Agents|adrenergic agents|mesh-ancestor
153825517|NCT00500721|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153825518|NCT00500721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153365487|NCT00932438|Growth Substances|growth substances|mesh-ancestor
153365488|NCT00932438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153365489|NCT00932438|Growth Inhibitors|growth inhibitors|mesh-ancestor
153365490|NCT00932438|Antimetabolites|antimetabolites|mesh-ancestor
153365491|NCT00932438|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153365492|NCT00932438|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153365493|NCT00932438|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153365494|NCT00932438|Immunologic Factors|immunologic factors|mesh-ancestor
153365495|NCT00932438|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
153365496|NCT00932438|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153365497|NCT00932438|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153365499|NCT00932438|Protective Agents|protective agents|mesh-ancestor
153365500|NCT00932438|Vitamin B Complex|vitamin b complex|mesh-ancestor
153365501|NCT00932438|Vitamins|vitamins|mesh-ancestor
153365502|NCT00932438|Micronutrients|micronutrients|mesh-ancestor
153365503|NCT01869413|Tranexamic Acid|tranexamic acid|mesh-list
153365504|NCT01869413|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
153825541|NCT00493428|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153825542|NCT00493428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153825543|NCT01342510|Lidocaine|lidocaine|mesh-list
153825544|NCT01342510|Magnesium Sulfate|magnesium sulfate|mesh-list
153825545|NCT01342510|Anesthetics, Local|anesthetics, local|mesh-ancestor
153825546|NCT01342510|Anesthetics|anesthetics|mesh-ancestor
153825547|NCT01342510|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153365515|NCT02982512|Sensory System Agents|sensory system agents|mesh-ancestor
153365516|NCT02982512|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153365517|NCT02982512|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
153365518|NCT02982512|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153365520|NCT02982512|Adrenergic Agents|adrenergic agents|mesh-ancestor
153365521|NCT02982512|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153365522|NCT02982512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153365523|NCT01555697|Memantine|memantine|mesh-list
153365524|NCT01555697|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
153365525|NCT01555697|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
153365526|NCT01555697|Dopamine Agents|dopamine agents|mesh-ancestor
153365527|NCT01555697|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153365528|NCT01555697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153365529|NCT01555697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153825558|NCT01342510|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153825559|NCT01342510|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153825560|NCT01342510|Tocolytic Agents|tocolytic agents|mesh-ancestor
153825561|NCT01342510|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153825562|NCT01606345|Valrubicin|valrubicin|mesh-list
153365537|NCT02982434|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153365538|NCT02982434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153365539|NCT02451930|Pembrolizumab|pembrolizumab|mesh-list
153365543|NCT02451930|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153365544|NCT02451930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153365545|NCT04358120|Hyaluronic Acid|hyaluronic acid|mesh-list
153365546|NCT04358120|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153365547|NCT04358120|Immunologic Factors|immunologic factors|mesh-ancestor
153365548|NCT04358120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153365549|NCT04358120|Viscosupplements|viscosupplements|mesh-ancestor
153365550|NCT04358120|Protective Agents|protective agents|mesh-ancestor
153365551|NCT00932828|Immunomodulating Agents|immunomodulating agents|mesh-list
153365552|NCT00932828|Immunologic Factors|immunologic factors|mesh-list
153825570|NCT01245894|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153825571|NCT01245894|Antimetabolites|antimetabolites|mesh-ancestor
153825572|NCT01245894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153825573|NCT01245894|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153825574|NCT01245894|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
153825575|NCT01245894|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153825576|NCT00469664|Guanfacine|guanfacine|mesh-list
153825577|NCT00469664|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153825578|NCT00469664|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
153825579|NCT00469664|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153825580|NCT00469664|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153825581|NCT00469664|Adrenergic Agents|adrenergic agents|mesh-ancestor
153825582|NCT00469664|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153825583|NCT00469664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153825584|NCT00469664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153365553|NCT00932828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153365555|NCT00928694|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153365556|NCT00928694|Antimetabolites|antimetabolites|mesh-ancestor
153825594|NCT00469703|Growth Substances|growth substances|mesh-ancestor
153825595|NCT00469703|Growth Inhibitors|growth inhibitors|mesh-ancestor
153825596|NCT00469703|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153825597|NCT01244100|Aspirin|aspirin|mesh-list
153825598|NCT01244100|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153825599|NCT01244100|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153825600|NCT01244100|Analgesics|analgesics|mesh-ancestor
153825601|NCT01244100|Sensory System Agents|sensory system agents|mesh-ancestor
153825602|NCT01244100|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153825603|NCT01244100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153825604|NCT01244100|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153825605|NCT01244100|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153825606|NCT01244100|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153825607|NCT01244100|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153365577|NCT02451696|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153825621|NCT00469781|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
153825622|NCT00469781|Prednisolone phosphate|prednisolone phosphate|mesh-list
153825623|NCT00469781|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153825624|NCT00469781|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153825625|NCT00469781|Analgesics|analgesics|mesh-ancestor
153825626|NCT00469781|Sensory System Agents|sensory system agents|mesh-ancestor
153825627|NCT00469781|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153825628|NCT00469781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153825629|NCT00469781|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153825630|NCT00469781|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153825631|NCT00469781|Antiemetics|antiemetics|mesh-ancestor
153365601|NCT04361318|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153365602|NCT04361318|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153365603|NCT04361318|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153365605|NCT04361318|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153365606|NCT04925076|Ethanol|ethanol|mesh-list
153365607|NCT04925076|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
153365608|NCT04925076|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153365609|NCT04925076|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153365610|NCT04925076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153365611|NCT01598207|Dronabinol|dronabinol|mesh-list
153365612|NCT01598207|Hallucinogens|hallucinogens|mesh-ancestor
153365613|NCT01598207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153365614|NCT01598207|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153365615|NCT01598207|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153365616|NCT01598207|Analgesics|analgesics|mesh-ancestor
153365618|NCT01598207|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153365619|NCT01598207|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
153365620|NCT01598207|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
153365621|NCT01598207|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153365622|NCT01598207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153365623|NCT01598207|Hormones|hormones|mesh-ancestor
153365624|NCT01598207|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153365625|NCT01640171|Ketorolac|ketorolac|mesh-list
153365626|NCT01640171|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
153365627|NCT01640171|Lidocaine|lidocaine|mesh-list
153365628|NCT01640171|Proxymetacaine|proxymetacaine|mesh-list
153825632|NCT00469781|Autonomic Agents|autonomic agents|mesh-ancestor
153825633|NCT00469781|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153825634|NCT00469781|Glucocorticoids|glucocorticoids|mesh-ancestor
153825635|NCT00469781|Hormones|hormones|mesh-ancestor
153825636|NCT00469781|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153825637|NCT00469781|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
153825638|NCT00469781|Protective Agents|protective agents|mesh-ancestor
153825639|NCT00469781|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153825640|NCT00469781|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153825641|NCT00474695|Ranibizumab|ranibizumab|mesh-list
153825642|NCT00474695|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153825656|NCT00474773|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153825657|NCT00474773|Analgesics|analgesics|mesh-ancestor
153825658|NCT00474773|Sensory System Agents|sensory system agents|mesh-ancestor
153825659|NCT00474773|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153825660|NCT00474773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153825661|NCT00474773|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153825662|NCT00474773|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153825665|NCT00474773|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153825666|NCT00474773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153825668|NCT00474890|Ephedrine|ephedrine|mesh-list
153825669|NCT00474890|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153825670|NCT00474890|Autonomic Agents|autonomic agents|mesh-ancestor
153825671|NCT00474890|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153825672|NCT00474890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153825673|NCT00474890|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153825674|NCT00474890|Respiratory System Agents|respiratory system agents|mesh-ancestor
153825675|NCT00474890|Nasal Decongestants|nasal decongestants|mesh-ancestor
153825676|NCT00474890|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
153825677|NCT00474890|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
153365646|NCT04361474|Budesonide|budesonide|mesh-list
153365647|NCT04361474|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153365648|NCT04361474|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153365649|NCT04361474|Autonomic Agents|autonomic agents|mesh-ancestor
153365650|NCT04361474|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153365651|NCT04361474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153365652|NCT04361474|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153365653|NCT04361474|Respiratory System Agents|respiratory system agents|mesh-ancestor
153365654|NCT04361474|Glucocorticoids|glucocorticoids|mesh-ancestor
153365655|NCT04361474|Hormones|hormones|mesh-ancestor
153365656|NCT04361474|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153365657|NCT04366622|Riociguat|riociguat|mesh-list
153365658|NCT04366622|Enzyme Activators|enzyme activators|mesh-ancestor
153365659|NCT04366622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153365660|NCT02245334|Povidone-Iodine|povidone-iodine|mesh-list
153365661|NCT02245334|Povidone|povidone|mesh-list
153365662|NCT02245334|Plasma Substitutes|plasma substitutes|mesh-ancestor
153365663|NCT02245334|Blood Substitutes|blood substitutes|mesh-ancestor
153365664|NCT02245334|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
153365665|NCT02245334|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153365666|NCT02487498|Glycopyrrolate|glycopyrrolate|mesh-list
153365667|NCT02487498|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153365668|NCT02487498|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
153825679|NCT00474890|Adrenergic Agents|adrenergic agents|mesh-ancestor
153825680|NCT00474890|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153825681|NCT00474890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153825682|NCT00501111|Donepezil|donepezil|mesh-list
153825683|NCT00501111|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
153825684|NCT00501111|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153825685|NCT00501111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153825686|NCT00501111|Cholinergic Agents|cholinergic agents|mesh-ancestor
153825687|NCT00501111|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153825697|NCT01340209|Parasympatholytics|parasympatholytics|mesh-ancestor
153825698|NCT01340209|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
153825699|NCT01340209|Cholinergic Agents|cholinergic agents|mesh-ancestor
153825700|NCT01340209|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153825701|NCT01340209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153825702|NCT01246089|Ranibizumab|ranibizumab|mesh-list
153825703|NCT01246089|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153825704|NCT01246089|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153825705|NCT01246089|Growth Substances|growth substances|mesh-ancestor
153825706|NCT01246089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153825707|NCT01246089|Growth Inhibitors|growth inhibitors|mesh-ancestor
153825708|NCT01246089|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153825709|NCT00598897|Clarithromycin|clarithromycin|mesh-list
153365679|NCT04356872|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153365680|NCT04356872|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153365681|NCT04356872|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153365682|NCT04356872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153365683|NCT04356872|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153365684|NCT04356872|Alkylating Agents|alkylating agents|mesh-ancestor
153365686|NCT02487108|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
153365687|NCT02487108|Hydrocodone|hydrocodone|mesh-list
153365688|NCT02487108|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153365689|NCT02487108|Analgesics|analgesics|mesh-ancestor
153365690|NCT02487108|Sensory System Agents|sensory system agents|mesh-ancestor
153365691|NCT02487108|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153365692|NCT02487108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153365693|NCT02487108|Antipyretics|antipyretics|mesh-ancestor
153365694|NCT02487108|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153365695|NCT02487108|Narcotics|narcotics|mesh-ancestor
153365696|NCT02487108|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153365697|NCT02487108|Antitussive Agents|antitussive agents|mesh-ancestor
153365698|NCT02487108|Respiratory System Agents|respiratory system agents|mesh-ancestor
153365699|NCT02487108|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153365701|NCT02487108|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153825710|NCT00598897|Rifabutin|rifabutin|mesh-list
153825711|NCT00598897|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153825712|NCT00598897|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153825713|NCT00598897|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
153825714|NCT00598897|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153825715|NCT00598897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153825716|NCT00598897|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
153825717|NCT00598897|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153825727|NCT00501267|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153825728|NCT00501267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153825729|NCT00501267|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
153825730|NCT00501267|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
153825731|NCT00501267|Cholinergic Agents|cholinergic agents|mesh-ancestor
153825732|NCT00501267|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153825733|NCT00501267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153825734|NCT00501267|Urological Agents|urological agents|mesh-ancestor
153825735|NCT00501267|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
153825736|NCT00501267|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
153825737|NCT00501267|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153825738|NCT00501267|Adrenergic Agents|adrenergic agents|mesh-ancestor
153825739|NCT00469937|Lithium Carbonate|lithium carbonate|mesh-list
153825744|NCT00469937|Antimanic Agents|antimanic agents|mesh-ancestor
153825745|NCT00469937|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153825746|NCT00469937|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153825747|NCT00469937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153825748|NCT00599287|Haloperidol|haloperidol|mesh-list
153825749|NCT00599287|Haloperidol decanoate|haloperidol decanoate|mesh-list
153825750|NCT00599287|Methylphenidate|methylphenidate|mesh-list
153825751|NCT00599287|Rivastigmine|rivastigmine|mesh-list
153825752|NCT00599287|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
153825753|NCT00599287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153825754|NCT00599287|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
153825755|NCT00599287|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153825756|NCT00599287|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153825757|NCT00599287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153825758|NCT00599287|Dopamine Agents|dopamine agents|mesh-ancestor
153825759|NCT00599287|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153825760|NCT00599287|Antiemetics|antiemetics|mesh-ancestor
153825761|NCT00599287|Autonomic Agents|autonomic agents|mesh-ancestor
153365732|NCT02486952|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153365733|NCT02486952|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153365734|NCT02486952|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153365735|NCT02486952|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153365737|NCT02486796|Coenzyme Q10|coenzyme q10|mesh-list
153365738|NCT02486796|Melatonin|melatonin|mesh-list
153365739|NCT02486796|Antioxidants|antioxidants|mesh-ancestor
153365740|NCT02486796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153365741|NCT02486796|Protective Agents|protective agents|mesh-ancestor
153365742|NCT02486796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153365743|NCT02486796|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153365744|NCT02486796|Micronutrients|micronutrients|mesh-ancestor
153365745|NCT02486796|Vitamins|vitamins|mesh-ancestor
153365746|NCT00620477|Levobupivacaine|levobupivacaine|mesh-list
153365747|NCT00620477|Anesthetics, Local|anesthetics, local|mesh-ancestor
153365748|NCT00620477|Anesthetics|anesthetics|mesh-ancestor
153365749|NCT00620477|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153365750|NCT00620477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153365751|NCT00620477|Sensory System Agents|sensory system agents|mesh-ancestor
153365752|NCT00620477|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153825762|NCT00599287|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153365753|NCT01641653|Midazolam|midazolam|mesh-list
153825763|NCT00599287|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153825764|NCT00599287|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153825765|NCT00599287|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153825766|NCT00599287|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153825767|NCT00599287|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153825768|NCT00599287|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
153825769|NCT00599287|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
153825784|NCT00599560|Arginine Vasopressin|arginine vasopressin|mesh-list
153825785|NCT00599560|Hemostatics|hemostatics|mesh-ancestor
153825786|NCT00599560|Coagulants|coagulants|mesh-ancestor
153825787|NCT00599560|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
153825788|NCT00599560|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
153825789|NCT00599560|Natriuretic Agents|natriuretic agents|mesh-ancestor
153825790|NCT00599560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153825791|NCT00599716|Hyaluronic Acid|hyaluronic acid|mesh-list
153825792|NCT00599716|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153825793|NCT00599716|Immunologic Factors|immunologic factors|mesh-ancestor
153825794|NCT00599716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153825795|NCT00599716|Viscosupplements|viscosupplements|mesh-ancestor
153825796|NCT00599716|Protective Agents|protective agents|mesh-ancestor
153825797|NCT01246284|Triamcinolone|triamcinolone|mesh-list
153825798|NCT01246284|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
153825799|NCT01246284|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
153825800|NCT01246284|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
153825801|NCT01246284|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153825802|NCT01246284|Glucocorticoids|glucocorticoids|mesh-ancestor
153825803|NCT01246284|Hormones|hormones|mesh-ancestor
153825804|NCT01246284|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153825812|NCT00599833|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153825813|NCT00469976|Bevacizumab|bevacizumab|mesh-list
153825814|NCT00469976|Carboplatin|carboplatin|mesh-list
153825815|NCT00469976|Gemcitabine|gemcitabine|mesh-list
153365784|NCT02450526|Cholinergic Agents|cholinergic agents|mesh-ancestor
153365785|NCT02450526|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153365786|NCT02450526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153365787|NCT02450526|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
153383611|NCT02376257|Antimetabolites|antimetabolites|mesh-ancestor
153383612|NCT01762982|Benzalkonium Compounds|benzalkonium compounds|mesh-list
153383613|NCT01762982|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
153383614|NCT01762982|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153383615|NCT03211286|Tranexamic Acid|tranexamic acid|mesh-list
153383616|NCT03211286|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
153383647|NCT03161756|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153383648|NCT03161756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153383649|NCT01766024|Interferons|interferons|mesh-list
153383650|NCT01766024|Interferon-beta|interferon-beta|mesh-list
153383694|NCT01768520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153383695|NCT00355589|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
153383696|NCT00355589|Ramipril|ramipril|mesh-list
153383697|NCT00355589|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153383698|NCT00355589|Diuretics|diuretics|mesh-ancestor
153365788|NCT02450526|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153365789|NCT01605539|Cannabidiol|cannabidiol|mesh-list
153365804|NCT01691339|Immunologic Factors|immunologic factors|mesh-ancestor
153365805|NCT01691339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153365806|NCT02233751|Methyltestosterone|methyltestosterone|mesh-list
153365807|NCT02233751|Testosterone|testosterone|mesh-list
153365808|NCT02233751|Testosterone undecanoate|testosterone undecanoate|mesh-list
153365809|NCT02233751|Testosterone enanthate|testosterone enanthate|mesh-list
153365810|NCT02233751|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
153365811|NCT02233751|Androgens|androgens|mesh-ancestor
153365812|NCT02233751|Hormones|hormones|mesh-ancestor
153365813|NCT02233751|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153365814|NCT02233751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153365815|NCT02233751|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153365816|NCT02233751|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153365817|NCT02233751|Anabolic Agents|anabolic agents|mesh-ancestor
153365818|NCT01607645|Cytarabine|cytarabine|mesh-list
153365819|NCT01607645|Decitabine|decitabine|mesh-list
153365820|NCT01607645|Azacitidine|azacitidine|mesh-list
153365821|NCT01607645|Idarubicin|idarubicin|mesh-list
153825816|NCT00469976|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153825817|NCT00469976|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153825818|NCT00469976|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153825819|NCT00469976|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153825820|NCT00469976|Growth Substances|growth substances|mesh-ancestor
153825821|NCT00469976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153825822|NCT00469976|Growth Inhibitors|growth inhibitors|mesh-ancestor
153825823|NCT00469976|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153825824|NCT00469976|Antimetabolites|antimetabolites|mesh-ancestor
153825825|NCT00469976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153825826|NCT00599911|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
153825827|NCT00599911|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
153825828|NCT00599911|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153825829|NCT00599911|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153825830|NCT00599911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153825831|NCT00599911|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153825832|NCT00599911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153825833|NCT00599911|Analgesics|analgesics|mesh-ancestor
153365822|NCT01607645|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153365824|NCT01607645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153365825|NCT01607645|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153365826|NCT01607645|Antiviral Agents|antiviral agents|mesh-ancestor
153365827|NCT01607645|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153365828|NCT01607645|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153365829|NCT01607645|Immunologic Factors|immunologic factors|mesh-ancestor
153383699|NCT00355589|Natriuretic Agents|natriuretic agents|mesh-ancestor
153383700|NCT00355589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153383701|NCT00355589|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
153383702|NCT00355589|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153383703|NCT00355589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153423906|NCT03626714|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153423907|NCT03626714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153365833|NCT01607645|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153365835|NCT01647581|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
153365836|NCT01647581|Melanocyte-Stimulating Hormones|melanocyte-stimulating hormones|mesh-list
153365837|NCT01647581|beta-Endorphin|beta-endorphin|mesh-list
153365838|NCT01647581|Hormones|hormones|mesh-ancestor
153365846|NCT01608659|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
153365847|NCT01608659|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153365848|NCT01608659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153365849|NCT01608659|Cholinergic Agents|cholinergic agents|mesh-ancestor
153365850|NCT01608659|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153365851|NCT01608659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153365852|NCT01608659|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
153365853|NCT01608659|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153365854|NCT01649609|Mycophenolic Acid|mycophenolic acid|mesh-list
153365855|NCT01649609|Sirolimus|sirolimus|mesh-list
153365856|NCT01649609|Tacrolimus|tacrolimus|mesh-list
153365857|NCT01649609|Antimetabolites|antimetabolites|mesh-list
153365858|NCT01649609|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153365859|NCT01649609|Immunologic Factors|immunologic factors|mesh-ancestor
153365860|NCT01649609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153365861|NCT01649609|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
153891053|NCT01029262|Growth Substances|growth substances|mesh-ancestor
153891054|NCT01029262|Growth Inhibitors|growth inhibitors|mesh-ancestor
153891055|NCT01029262|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153365871|NCT02449902|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
153365872|NCT02449902|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
153365873|NCT02449902|Estradiol|estradiol|mesh-list
153365874|NCT02449902|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
153825870|NCT00470015|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153825871|NCT00470015|Analgesics|analgesics|mesh-ancestor
153825872|NCT00470015|Sensory System Agents|sensory system agents|mesh-ancestor
153825873|NCT00470015|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153825874|NCT00470015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153825875|NCT00470015|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153825876|NCT00470015|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153825877|NCT00470015|Antiviral Agents|antiviral agents|mesh-ancestor
153825878|NCT00470015|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153825879|NCT00600262|Bevacizumab|bevacizumab|mesh-list
153825880|NCT00600262|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153825881|NCT00600262|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153825882|NCT00600262|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153825883|NCT00600262|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153825884|NCT00600262|Growth Substances|growth substances|mesh-ancestor
153825885|NCT00600262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153825886|NCT00600262|Growth Inhibitors|growth inhibitors|mesh-ancestor
153825887|NCT00600301|Triamcinolone|triamcinolone|mesh-list
153825888|NCT00600301|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
153825889|NCT00600301|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
153825890|NCT00600301|Bevacizumab|bevacizumab|mesh-list
153825891|NCT00600301|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
153825892|NCT00600301|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153825893|NCT00600301|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153825894|NCT00600301|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153825895|NCT00600301|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153825896|NCT00600301|Growth Substances|growth substances|mesh-ancestor
153825897|NCT00600301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153825898|NCT00600301|Growth Inhibitors|growth inhibitors|mesh-ancestor
153825899|NCT00600301|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153825900|NCT00600301|Glucocorticoids|glucocorticoids|mesh-ancestor
153825901|NCT00600301|Hormones|hormones|mesh-ancestor
153423909|NCT03538808|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
153423910|NCT03538808|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
153423911|NCT03538808|Cholinergic Agents|cholinergic agents|mesh-ancestor
153383704|NCT00355589|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
153383771|NCT05235191|Narcotics|narcotics|mesh-ancestor
153383772|NCT05235191|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153383773|NCT05235191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153383774|NCT05235191|Analgesics|analgesics|mesh-ancestor
153383775|NCT05235191|Sensory System Agents|sensory system agents|mesh-ancestor
153383776|NCT05235191|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153383777|NCT05235191|Antitussive Agents|antitussive agents|mesh-ancestor
153825902|NCT00600301|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153825903|NCT00600301|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153825904|NCT00600301|Immunologic Factors|immunologic factors|mesh-ancestor
153825905|NCT00600301|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153825906|NCT00600301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153825919|NCT00501579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153825920|NCT00501579|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153825921|NCT00501579|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153825922|NCT00501579|Antiemetics|antiemetics|mesh-ancestor
153825923|NCT00501579|Autonomic Agents|autonomic agents|mesh-ancestor
153825924|NCT00501579|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153825925|NCT00501579|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153825926|NCT00501579|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
153825927|NCT00501579|Protective Agents|protective agents|mesh-ancestor
153825928|NCT00501618|Clozapine|clozapine|mesh-list
153825929|NCT00501618|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153825930|NCT00501618|Serotonin Agents|serotonin agents|mesh-ancestor
153825931|NCT00501618|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153825932|NCT00501618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153365913|NCT02229461|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153365914|NCT02229461|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153365915|NCT02229461|Analgesics|analgesics|mesh-ancestor
153365916|NCT02229461|Sensory System Agents|sensory system agents|mesh-ancestor
153365917|NCT02229461|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153365918|NCT02229461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153365919|NCT02229461|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153365920|NCT02229461|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153365921|NCT02229461|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153365922|NCT02229461|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153365923|NCT02229461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153825937|NCT00501618|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153825938|NCT00501618|GABA Antagonists|gaba antagonists|mesh-ancestor
153825939|NCT00501618|GABA Agents|gaba agents|mesh-ancestor
153825940|NCT00600535|Abiraterone Acetate|abiraterone acetate|mesh-list
153825941|NCT00600535|Glucocorticoids|glucocorticoids|mesh-list
153825942|NCT00600535|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153825943|NCT00600535|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153825944|NCT00600535|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153825945|NCT00600535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153825946|NCT00600535|Hormone Antagonists|hormone antagonists|mesh-ancestor
153825947|NCT00600535|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153825948|NCT00600535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153825949|NCT00600535|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153825950|NCT00600535|Hormones|hormones|mesh-ancestor
153825951|NCT00600691|Finasteride|finasteride|mesh-list
153825952|NCT00600691|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
153825953|NCT00600691|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153825954|NCT00600691|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153365928|NCT02229461|Gout Suppressants|gout suppressants|mesh-ancestor
153365929|NCT04641104|Thiamine|thiamine|mesh-list
153365930|NCT04641104|Vitamin B Complex|vitamin b complex|mesh-ancestor
153365931|NCT04641104|Vitamins|vitamins|mesh-ancestor
153365932|NCT04641104|Micronutrients|micronutrients|mesh-ancestor
153365933|NCT04641104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153365934|NCT02237417|Aripiprazole|aripiprazole|mesh-list
153365935|NCT02237417|Antipsychotic Agents|antipsychotic agents|mesh-list
153365936|NCT02237417|Antidepressive Agents|antidepressive agents|mesh-ancestor
153365937|NCT02237417|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153365938|NCT02237417|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153365939|NCT02237417|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153365940|NCT02237417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153365941|NCT02237417|Dopamine Agonists|dopamine agonists|mesh-ancestor
153365942|NCT02237417|Dopamine Agents|dopamine agents|mesh-ancestor
153365943|NCT02237417|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153365944|NCT02237417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153365945|NCT02237417|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
153365952|NCT02245490|Tamsulosin|tamsulosin|mesh-list
153365953|NCT02245490|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
153365954|NCT02245490|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
153365955|NCT02245490|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
153365956|NCT02245490|Adrenergic Agents|adrenergic agents|mesh-ancestor
153365957|NCT02245490|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153825955|NCT00600691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153825956|NCT00600691|Hormone Antagonists|hormone antagonists|mesh-ancestor
153825957|NCT00600691|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153825958|NCT00600691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153825959|NCT00600691|Urological Agents|urological agents|mesh-ancestor
153825960|NCT00623077|Etoposide|etoposide|mesh-list
153825961|NCT00623077|Melphalan|melphalan|mesh-list
153825962|NCT00623077|Busulfan|busulfan|mesh-list
153825963|NCT00623077|Ifosfamide|ifosfamide|mesh-list
153825980|NCT00475358|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
153825981|NCT00475358|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
153825982|NCT00475358|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153365958|NCT02245490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153365959|NCT02245490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153365960|NCT02245490|Urological Agents|urological agents|mesh-ancestor
153365962|NCT04355936|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153365963|NCT04355936|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
153365964|NCT04355936|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
153365965|NCT04355936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153365966|NCT00934934|Anidulafungin|anidulafungin|mesh-list
153365967|NCT00934934|Antifungal Agents|antifungal agents|mesh-ancestor
153365968|NCT00934934|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153365969|NCT01651793|Caffeine|caffeine|mesh-list
153365970|NCT01651793|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
153365971|NCT01651793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153365972|NCT01651793|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
153365973|NCT01651793|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153365974|NCT01651793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153365975|NCT01651793|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
153365976|NCT01651793|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
153365977|NCT01651793|Purinergic Agents|purinergic agents|mesh-ancestor
153365978|NCT01651793|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153365979|NCT01652495|Methylprednisolone|methylprednisolone|mesh-list
153365980|NCT01652495|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
153365981|NCT01652495|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
153365983|NCT01652495|Prednisolone acetate|prednisolone acetate|mesh-list
153365984|NCT01652495|Triamcinolone|triamcinolone|mesh-list
153365985|NCT01652495|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
153365986|NCT01652495|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
153365987|NCT01652495|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
153365988|NCT01652495|Prednisolone phosphate|prednisolone phosphate|mesh-list
153365989|NCT01652495|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
153825983|NCT00475358|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153825984|NCT00475358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153825985|NCT00475358|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153825986|NCT00475358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153825987|NCT00475358|Analgesics|analgesics|mesh-ancestor
153825988|NCT00475358|Sensory System Agents|sensory system agents|mesh-ancestor
153825998|NCT00623116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153825999|NCT00623155|Pyrimethamine|pyrimethamine|mesh-list
153826000|NCT00623155|Sulfadoxine|sulfadoxine|mesh-list
153826001|NCT00623155|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
153826002|NCT00623155|Antimalarials|antimalarials|mesh-ancestor
153826003|NCT00623155|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153826004|NCT00623155|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153826005|NCT00623155|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153826006|NCT00623155|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153826007|NCT00623155|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153826008|NCT00623155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153826009|NCT00623155|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
153826010|NCT00600730|Hypoglycemic Agents|hypoglycemic agents|mesh-list
153826011|NCT00600730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153826012|NCT00600769|Clarithromycin|clarithromycin|mesh-list
153826013|NCT00600769|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153826014|NCT00600769|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153826015|NCT00600769|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
153826016|NCT00600769|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153826017|NCT00600769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153826018|NCT00600769|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
153826019|NCT00600769|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153826020|NCT00470210|Ribavirin|ribavirin|mesh-list
153826021|NCT00470210|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
153826022|NCT00470210|Antimetabolites|antimetabolites|mesh-ancestor
153366000|NCT01652495|Protective Agents|protective agents|mesh-ancestor
153366014|NCT00935792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153366015|NCT00935792|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153366017|NCT00935792|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153366018|NCT00935792|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153366019|NCT00935792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153366020|NCT00935792|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153366021|NCT01699607|Amphetamine|amphetamine|mesh-list
153366022|NCT01699607|Dextroamphetamine|dextroamphetamine|mesh-list
153366023|NCT01699607|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
153366024|NCT01699607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153366025|NCT01699607|Sympathomimetics|sympathomimetics|mesh-ancestor
153366026|NCT01699607|Autonomic Agents|autonomic agents|mesh-ancestor
153366027|NCT01699607|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153366028|NCT01699607|Dopamine Agents|dopamine agents|mesh-ancestor
153366029|NCT01699607|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153366030|NCT01699607|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153366031|NCT01699607|Adrenergic Agents|adrenergic agents|mesh-ancestor
153366032|NCT01699607|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
153826023|NCT00470210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153826039|NCT00600847|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
153826040|NCT04325932|Kallikreins|kallikreins|mesh-list
153826041|NCT04325932|Coagulants|coagulants|mesh-ancestor
153826042|NCT04325932|Fertility Agents, Male|fertility agents, male|mesh-ancestor
153826043|NCT04325932|Fertility Agents|fertility agents|mesh-ancestor
153826044|NCT04325932|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153826045|NCT04325932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153826046|NCT00501657|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
153826047|NCT00501657|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153826048|NCT00501657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153826049|NCT00501657|Incretins|incretins|mesh-ancestor
153826050|NCT00501657|Hormones|hormones|mesh-ancestor
153826051|NCT00501657|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153826052|NCT00501657|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
153826053|NCT00501657|Protease Inhibitors|protease inhibitors|mesh-ancestor
153826054|NCT00501657|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153826055|NCT00501657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153826056|NCT00600964|Obatoclax|obatoclax|mesh-list
153826057|NCT00600964|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153366034|NCT01699607|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153366035|NCT01699607|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
153366036|NCT04355468|Analgesics, Opioid|analgesics, opioid|mesh-list
153366037|NCT04355468|Anesthetics|anesthetics|mesh-list
153366038|NCT04355468|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153366039|NCT04355468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153366040|NCT04355468|Narcotics|narcotics|mesh-ancestor
153366041|NCT04355468|Analgesics|analgesics|mesh-ancestor
153366042|NCT04355468|Sensory System Agents|sensory system agents|mesh-ancestor
153366043|NCT04355468|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153366044|NCT01653509|Acyclovir|acyclovir|mesh-list
153366045|NCT01653509|Antiviral Agents|antiviral agents|mesh-ancestor
153366046|NCT01653509|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153366047|NCT01614509|Triamcinolone|triamcinolone|mesh-list
153366048|NCT01614509|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
153366049|NCT01614509|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
153366050|NCT01614509|Bevacizumab|bevacizumab|mesh-list
153366051|NCT01614509|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
153366052|NCT01614509|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153366053|NCT01614509|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153366054|NCT01614509|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153366055|NCT01614509|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153366056|NCT01614509|Growth Substances|growth substances|mesh-ancestor
153366057|NCT01614509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153366058|NCT01614509|Growth Inhibitors|growth inhibitors|mesh-ancestor
153366059|NCT01614509|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153366061|NCT01614509|Hormones|hormones|mesh-ancestor
153366062|NCT01614509|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153366063|NCT01614509|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153366064|NCT01614509|Immunologic Factors|immunologic factors|mesh-ancestor
153366065|NCT01614509|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153366066|NCT01614509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153366067|NCT01614743|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
153366068|NCT01614743|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
153366069|NCT01614743|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153826060|NCT00475397|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
153826061|NCT00475397|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153826062|NCT00475397|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153826063|NCT00475397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153826064|NCT00475397|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153826065|NCT00475397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153826066|NCT00475397|Analgesics|analgesics|mesh-ancestor
153826067|NCT00475397|Sensory System Agents|sensory system agents|mesh-ancestor
153826068|NCT00475397|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153826069|NCT00475397|Antidepressive Agents|antidepressive agents|mesh-ancestor
153826070|NCT00475397|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153826071|NCT00475397|Dopamine Agents|dopamine agents|mesh-ancestor
153826072|NCT00601042|Lobeline|lobeline|mesh-list
153826073|NCT00601042|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
153826074|NCT00601042|Autonomic Agents|autonomic agents|mesh-ancestor
153826075|NCT00601042|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153826076|NCT00601042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153826077|NCT00601042|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
153826078|NCT00601042|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
153826079|NCT00601042|Cholinergic Agents|cholinergic agents|mesh-ancestor
153826080|NCT00601042|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153826081|NCT00601042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153826082|NCT00601042|Respiratory System Agents|respiratory system agents|mesh-ancestor
153826083|NCT00501696|Naltrexone|naltrexone|mesh-list
153826084|NCT00501696|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
153826085|NCT00501696|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
153826086|NCT00501696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153826087|NCT00501696|Sensory System Agents|sensory system agents|mesh-ancestor
153826088|NCT00501696|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153826089|NCT00601276|Leuprolide|leuprolide|mesh-list
153826090|NCT00601276|Cyproterone Acetate|cyproterone acetate|mesh-list
153826091|NCT00601276|Cyproterone|cyproterone|mesh-list
153826095|NCT00601276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153826096|NCT00601276|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153366071|NCT01614743|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
153366072|NCT01614743|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153366073|NCT01614743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153366074|NCT01614743|Cholinergic Agents|cholinergic agents|mesh-ancestor
153366075|NCT01614743|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153366076|NCT00943202|Vaccines|vaccines|mesh-list
153366077|NCT00943202|Immunologic Factors|immunologic factors|mesh-ancestor
153366078|NCT00943202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153366079|NCT01614821|Ibrutinib|ibrutinib|mesh-list
153366080|NCT01614821|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153366081|NCT01614821|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153366082|NCT01614821|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153366083|NCT01614821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153366084|NCT01654445|Tenecteplase|tenecteplase|mesh-list
153366085|NCT01654445|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153366086|NCT01654445|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153366087|NCT01654445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153366088|NCT01703039|Riluzole|riluzole|mesh-list
153366089|NCT01703039|Sertraline|sertraline|mesh-list
153366090|NCT01703039|Antidepressive Agents|antidepressive agents|mesh-ancestor
153366091|NCT01703039|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153366092|NCT01703039|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
153366093|NCT01703039|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153366094|NCT01703039|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153366095|NCT01703039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153366096|NCT01703039|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153366097|NCT01703039|Serotonin Agents|serotonin agents|mesh-ancestor
153826097|NCT00601276|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153826098|NCT00601276|Androgen Antagonists|androgen antagonists|mesh-ancestor
153826099|NCT00601276|Hormone Antagonists|hormone antagonists|mesh-ancestor
153826100|NCT00601276|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153826101|NCT00601276|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
153826102|NCT00601276|Contraceptive Agents|contraceptive agents|mesh-ancestor
153826104|NCT00601315|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153826105|NCT00601315|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153826106|NCT00601315|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
153826107|NCT00601315|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153826108|NCT00601315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153826109|NCT00601315|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
153826110|NCT00601315|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153826111|NCT00470249|Carboplatin|carboplatin|mesh-list
153826112|NCT00470249|Gemcitabine|gemcitabine|mesh-list
153826113|NCT00470249|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153826114|NCT00470249|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153826115|NCT00470249|Antimetabolites|antimetabolites|mesh-ancestor
153826116|NCT00470249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153826118|NCT04325893|Antimalarials|antimalarials|mesh-ancestor
153826119|NCT04325893|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153826125|NCT00601432|Levofloxacin|levofloxacin|mesh-list
153366135|NCT02158520|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153366136|NCT01704521|Ribavirin|ribavirin|mesh-list
153366137|NCT01704521|Antimetabolites|antimetabolites|mesh-ancestor
153366138|NCT01704521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153366139|NCT01704521|Antiviral Agents|antiviral agents|mesh-ancestor
153366140|NCT01704521|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153826130|NCT00601432|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153826131|NCT00601432|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153826132|NCT00601432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153826133|NCT00601432|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153826134|NCT00601432|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
153826135|NCT00601432|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153826136|NCT00601510|Capecitabine|capecitabine|mesh-list
153826137|NCT00601510|Imatinib Mesylate|imatinib mesylate|mesh-list
153826138|NCT00601510|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153826139|NCT00601510|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153826140|NCT00601510|Antimetabolites|antimetabolites|mesh-ancestor
153826141|NCT00601510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153826142|NCT00601510|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153826143|NCT00601510|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153826144|NCT00601510|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153826145|NCT00601588|Sertraline|sertraline|mesh-list
153826146|NCT00601588|Antidepressive Agents|antidepressive agents|mesh-ancestor
153826147|NCT00601588|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153826148|NCT00601588|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
153826149|NCT00601588|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153826150|NCT00601588|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153432103|NCT05325593|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153432104|NCT05325593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153432105|NCT05303532|Durvalumab|durvalumab|mesh-list
153432106|NCT05303532|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153432107|NCT05303532|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153826151|NCT00601588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153826152|NCT00601588|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153826153|NCT00601588|Serotonin Agents|serotonin agents|mesh-ancestor
153826154|NCT00601588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153826155|NCT00601666|Zolpidem|zolpidem|mesh-list
153826156|NCT00601666|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
153826157|NCT00601666|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153826158|NCT00601666|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153826159|NCT00601666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153826160|NCT00601666|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
153826161|NCT00601666|GABA Agonists|gaba agonists|mesh-ancestor
153826162|NCT00601666|GABA Agents|gaba agents|mesh-ancestor
153826163|NCT00601666|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153826180|NCT00470405|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153826181|NCT00470405|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153826182|NCT00470405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153826183|NCT00470405|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153366162|NCT01658657|Vasodilator Agents|vasodilator agents|mesh-ancestor
153366163|NCT01658657|Diuretics|diuretics|mesh-ancestor
153366164|NCT01658657|Natriuretic Agents|natriuretic agents|mesh-ancestor
153366165|NCT01658657|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
153366166|NCT01658657|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153366167|NCT01658657|Sympatholytics|sympatholytics|mesh-ancestor
153366168|NCT01658657|Autonomic Agents|autonomic agents|mesh-ancestor
153366169|NCT01658657|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153366170|NCT01658657|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
153366171|NCT01658657|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
153366172|NCT01658657|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
153366173|NCT01658657|Adrenergic Agents|adrenergic agents|mesh-ancestor
153366174|NCT01658657|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153366175|NCT01658657|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
153366176|NCT01658657|Protease Inhibitors|protease inhibitors|mesh-ancestor
153366177|NCT01658657|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153366178|NCT01658657|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
153366179|NCT01658657|Protective Agents|protective agents|mesh-ancestor
153366180|NCT04359212|Heparin|heparin|mesh-list
153826192|NCT00601978|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153826193|NCT00601978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153826194|NCT00601978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153826195|NCT00601978|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
153826196|NCT00601978|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153826197|NCT00601978|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
153826198|NCT00601978|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153826199|NCT00601978|Immunologic Factors|immunologic factors|mesh-ancestor
153826200|NCT00601978|Dopamine Agonists|dopamine agonists|mesh-ancestor
153826201|NCT00601159|Gemcitabine|gemcitabine|mesh-list
153826202|NCT00601159|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153366214|NCT00944450|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153366216|NCT00944450|Protease Inhibitors|protease inhibitors|mesh-ancestor
153366217|NCT00944450|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153461732|NCT03193866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153826206|NCT00602017|Amlodipine|amlodipine|mesh-list
153826207|NCT00602017|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153826208|NCT00602017|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153826209|NCT00602017|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153826210|NCT00602017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153826211|NCT00602017|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153826212|NCT00602017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153826213|NCT00602017|Vasodilator Agents|vasodilator agents|mesh-ancestor
153826214|NCT00470483|Paroxetine|paroxetine|mesh-list
153826215|NCT00470483|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
153826216|NCT00470483|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153826217|NCT00470483|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153826218|NCT00470483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153826219|NCT00470483|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153826220|NCT00470483|Serotonin Agents|serotonin agents|mesh-ancestor
153826221|NCT00470483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153826222|NCT00470483|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
153826223|NCT00470483|Antidepressive Agents|antidepressive agents|mesh-ancestor
153826224|NCT00470483|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153826225|NCT00470483|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
153826226|NCT00470483|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153826227|NCT00470483|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153826228|NCT00602095|Misoprostol|misoprostol|mesh-list
153826229|NCT00602095|Dinoprostone|dinoprostone|mesh-list
153826230|NCT00602095|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
153826231|NCT00602095|Abortifacient Agents|abortifacient agents|mesh-ancestor
153826232|NCT00602095|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153826233|NCT00602095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153366218|NCT00944450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153366220|NCT01661621|Tolterodine Tartrate|tolterodine tartrate|mesh-list
153366221|NCT01661621|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153366222|NCT01661621|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
153366223|NCT01661621|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
153366224|NCT01661621|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
153366225|NCT01661621|Adrenergic Agents|adrenergic agents|mesh-ancestor
153366226|NCT01661621|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153826237|NCT00475553|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
153826238|NCT00475553|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
153826239|NCT00475553|Ethinyl Estradiol|ethinyl estradiol|mesh-list
153826240|NCT00475553|Etonogestrel|etonogestrel|mesh-list
153826241|NCT00475553|Desogestrel|desogestrel|mesh-list
153826242|NCT00475553|NuvaRing|nuvaring|mesh-list
153826243|NCT00475553|Estradiol|estradiol|mesh-list
153826244|NCT00475553|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
153826245|NCT00475553|Estrogens|estrogens|mesh-ancestor
153826246|NCT00475553|Hormones|hormones|mesh-ancestor
153826247|NCT00475553|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153826248|NCT00475553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153826249|NCT00475553|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
153826254|NCT00475553|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
153826255|NCT00475553|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
153826256|NCT00475553|Progestins|progestins|mesh-ancestor
153826257|NCT01326481|Capecitabine|capecitabine|mesh-list
153826258|NCT01326481|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153826259|NCT01326481|Antimetabolites|antimetabolites|mesh-ancestor
153826260|NCT01326481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153826261|NCT01326481|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153826262|NCT00502164|Cediranib|cediranib|mesh-list
153826263|NCT00502164|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153366248|NCT04358354|Oxaliplatin|oxaliplatin|mesh-list
153366249|NCT04358354|Irinotecan|irinotecan|mesh-list
153366250|NCT04358354|Antimetabolites|antimetabolites|mesh-ancestor
153366251|NCT04358354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153366252|NCT04358354|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153366253|NCT04358354|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153366254|NCT04358354|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153366255|NCT04358354|Immunologic Factors|immunologic factors|mesh-ancestor
153366256|NCT04358354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153366257|NCT04358354|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
153366258|NCT04358354|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153366259|NCT04358354|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153366260|NCT03516968|Cholecalciferol|cholecalciferol|mesh-list
153826273|NCT00470522|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153826274|NCT00470522|Antimetabolites|antimetabolites|mesh-ancestor
153826275|NCT00470522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153826276|NCT00470522|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153826277|NCT00470522|Dermatologic Agents|dermatologic agents|mesh-ancestor
153826278|NCT00470522|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153826279|NCT00470522|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153826280|NCT00470522|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153826281|NCT00470522|Immunologic Factors|immunologic factors|mesh-ancestor
153826282|NCT00470522|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153826283|NCT00470522|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153826284|NCT00470522|Hematinics|hematinics|mesh-ancestor
153826285|NCT00470522|Vitamin B Complex|vitamin b complex|mesh-ancestor
153826286|NCT00470522|Vitamins|vitamins|mesh-ancestor
153826288|NCT01244178|Insulin|insulin|mesh-list
153366298|NCT02777372|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153366299|NCT02777372|Serotonin Agents|serotonin agents|mesh-ancestor
153366300|NCT02777372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153366301|NCT03032042|Azithromycin|azithromycin|mesh-list
153366302|NCT03032042|Albendazole|albendazole|mesh-list
153366303|NCT03032042|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153366304|NCT03032042|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153366305|NCT03032042|Anthelmintics|anthelmintics|mesh-ancestor
153366306|NCT03032042|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153366307|NCT03032042|Anticestodal Agents|anticestodal agents|mesh-ancestor
153366308|NCT03032042|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
153366309|NCT03032042|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153366310|NCT03032042|Tubulin Modulators|tubulin modulators|mesh-ancestor
153366311|NCT03032042|Antimitotic Agents|antimitotic agents|mesh-ancestor
153366312|NCT03032042|Mitosis Modulators|mitosis modulators|mesh-ancestor
153366313|NCT03032042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153366314|NCT03032042|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153366315|NCT01623323|Fluticasone|fluticasone|mesh-list
153826297|NCT00470561|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153826298|NCT00470561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153826299|NCT00470561|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153826300|NCT00470561|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153826301|NCT00470561|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153826302|NCT00470561|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153826303|NCT00470561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153826304|NCT00470561|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153826305|NCT00470561|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153826306|NCT00470561|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153826307|NCT00470561|Antipyretics|antipyretics|mesh-ancestor
153826308|NCT00475826|Ezetimibe|ezetimibe|mesh-list
153826311|NCT00475826|Antimetabolites|antimetabolites|mesh-ancestor
153826312|NCT00475826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153826313|NCT00475826|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153826314|NCT00502437|Granisetron|granisetron|mesh-list
153826315|NCT00502437|Antiemetics|antiemetics|mesh-ancestor
153826316|NCT00502437|Autonomic Agents|autonomic agents|mesh-ancestor
153826317|NCT00502437|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153826318|NCT00502437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153826319|NCT00502437|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153826320|NCT00502437|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
153826321|NCT00502437|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153826322|NCT00502437|Serotonin Agents|serotonin agents|mesh-ancestor
153826323|NCT00502437|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153826324|NCT00502437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153826325|NCT00470678|Ranibizumab|ranibizumab|mesh-list
153826326|NCT00470678|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153826327|NCT00470678|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153891074|NCT01028014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153891075|NCT01028014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153891076|NCT01028014|Urological Agents|urological agents|mesh-ancestor
153891077|NCT01028014|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
153891078|NCT01028014|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
153891079|NCT01028014|Cholinergic Agents|cholinergic agents|mesh-ancestor
153891080|NCT01028014|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153891081|NCT01028014|Autonomic Agents|autonomic agents|mesh-ancestor
153891082|NCT01028014|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153891083|NCT01028014|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153826328|NCT00470678|Growth Substances|growth substances|mesh-ancestor
153826329|NCT00470678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153826330|NCT00470678|Growth Inhibitors|growth inhibitors|mesh-ancestor
153826331|NCT00470678|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153826332|NCT00502476|Chlorhexidine|chlorhexidine|mesh-list
153366317|NCT01623323|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153366318|NCT01623323|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153366319|NCT01623323|Autonomic Agents|autonomic agents|mesh-ancestor
153366320|NCT01623323|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153366321|NCT01623323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153366322|NCT01623323|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153366323|NCT01623323|Respiratory System Agents|respiratory system agents|mesh-ancestor
153366324|NCT01623323|Dermatologic Agents|dermatologic agents|mesh-ancestor
153366325|NCT01623323|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
153366326|NCT01709747|Hydromorphone|hydromorphone|mesh-list
153366327|NCT01709747|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153366328|NCT01709747|Narcotics|narcotics|mesh-ancestor
153366329|NCT01709747|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153366330|NCT01709747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153366331|NCT01709747|Analgesics|analgesics|mesh-ancestor
153366332|NCT01709747|Sensory System Agents|sensory system agents|mesh-ancestor
153366333|NCT01709747|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153366334|NCT03031808|Lidocaine|lidocaine|mesh-list
153366335|NCT03031808|Rocuronium|rocuronium|mesh-list
153366336|NCT03031808|Anesthetics, Local|anesthetics, local|mesh-ancestor
153366337|NCT03031808|Anesthetics|anesthetics|mesh-ancestor
153366338|NCT03031808|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153366339|NCT03031808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153366340|NCT03031808|Sensory System Agents|sensory system agents|mesh-ancestor
153366341|NCT03031808|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153366342|NCT03031808|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153366343|NCT03031808|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
153366344|NCT03031808|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153366345|NCT03031808|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153366346|NCT03031808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153366347|NCT03031808|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
153826333|NCT00502476|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
153826334|NCT00502476|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153826335|NCT00502476|Disinfectants|disinfectants|mesh-ancestor
153826336|NCT00493545|Poly ICLC|poly iclc|mesh-list
153826337|NCT00493545|Interferon Inducers|interferon inducers|mesh-ancestor
153366348|NCT03031808|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
153366350|NCT01662791|Rifaximin|rifaximin|mesh-list
153826338|NCT00493545|Immunologic Factors|immunologic factors|mesh-ancestor
153826349|NCT00493623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153826351|NCT00476099|Beclomethasone|beclomethasone|mesh-list
153826352|NCT00476099|Formoterol Fumarate|formoterol fumarate|mesh-list
153826353|NCT00476099|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153826355|NCT00476099|Autonomic Agents|autonomic agents|mesh-ancestor
153826361|NCT00476099|Hormones|hormones|mesh-ancestor
153826362|NCT00476099|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153826363|NCT00476099|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
153826364|NCT00476099|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
153826365|NCT00476099|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153826366|NCT00476099|Adrenergic Agents|adrenergic agents|mesh-ancestor
153826367|NCT00476099|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153826368|NCT00476099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153826369|NCT00493662|Hyaluronic Acid|hyaluronic acid|mesh-list
153826370|NCT00493662|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153826371|NCT00493662|Immunologic Factors|immunologic factors|mesh-ancestor
153366357|NCT03035084|Vitamins|vitamins|mesh-list
153366358|NCT03035084|Micronutrients|micronutrients|mesh-ancestor
153366359|NCT03035084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153366360|NCT03035084|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153366361|NCT03035084|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153366362|NCT03034850|Doxorubicin|doxorubicin|mesh-list
153366363|NCT03034850|Fluorouracil|fluorouracil|mesh-list
153366364|NCT03034850|Ifosfamide|ifosfamide|mesh-list
153366365|NCT03034850|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153366366|NCT03034850|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153366367|NCT03034850|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153366368|NCT03034850|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153366369|NCT03034850|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153366376|NCT03034850|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153366377|NCT03034850|Alkylating Agents|alkylating agents|mesh-ancestor
153366378|NCT01663259|Cetuximab|cetuximab|mesh-list
153366379|NCT01663259|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153366380|NCT01663259|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153366381|NCT03031184|Mirtazapine|mirtazapine|mesh-list
153366382|NCT03031184|Antidepressive Agents|antidepressive agents|mesh-ancestor
153366383|NCT03031184|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153366384|NCT03031184|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
153366385|NCT03031184|Histamine Antagonists|histamine antagonists|mesh-ancestor
153366394|NCT03031184|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
153366395|NCT03031184|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
153826392|NCT00470990|Hormone Antagonists|hormone antagonists|mesh-ancestor
153826393|NCT00470990|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153826394|NCT00470990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153826395|NCT01246440|Catumaxomab|catumaxomab|mesh-list
153826396|NCT01246440|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153826397|NCT00471029|Esomeprazole|esomeprazole|mesh-list
153826398|NCT00471029|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
153826399|NCT00471029|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153826400|NCT00471029|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
153826401|NCT00471029|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153826402|NCT00471029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153826403|NCT00476216|Fondaparinux|fondaparinux|mesh-list
153826404|NCT00476216|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
153826405|NCT00476216|Antithrombins|antithrombins|mesh-ancestor
153826406|NCT00476216|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
153826407|NCT00476216|Protease Inhibitors|protease inhibitors|mesh-ancestor
153826408|NCT00476216|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153826409|NCT00476216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153366396|NCT03031184|Adrenergic Agents|adrenergic agents|mesh-ancestor
153366397|NCT03031184|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
153366398|NCT03031184|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153366399|NCT03031184|Serotonin Agents|serotonin agents|mesh-ancestor
153366400|NCT03031184|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
153366418|NCT03034382|Lidocaine|lidocaine|mesh-list
153826410|NCT00476216|Anticoagulants|anticoagulants|mesh-ancestor
153826411|NCT00471185|Acyline|acyline|mesh-list
153826412|NCT00471185|Hormone Antagonists|hormone antagonists|mesh-ancestor
153826413|NCT00471185|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153826414|NCT00471185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153826415|NCT01325701|Ibrutinib|ibrutinib|mesh-list
153826416|NCT01325701|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153826417|NCT01325701|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153826418|NCT01325701|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153826419|NCT01325701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153826420|NCT00493857|Nimotuzumab|nimotuzumab|mesh-list
153826421|NCT00493857|Antibodies|antibodies|mesh-list
153826422|NCT00493857|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
153826423|NCT00493857|Immunologic Factors|immunologic factors|mesh-ancestor
153366428|NCT03034382|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153366429|NCT03034382|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153366430|NCT03034382|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
153366431|NCT03034382|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153366432|NCT03034382|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153366433|NCT03034382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153826438|NCT00602134|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153826439|NCT00602134|Immunologic Factors|immunologic factors|mesh-ancestor
153826440|NCT00602134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153826441|NCT00602134|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153826442|NCT00602134|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153826443|NCT00494208|Testosterone|testosterone|mesh-list
153826444|NCT00494208|Androgens|androgens|mesh-ancestor
153826445|NCT00494208|Hormones|hormones|mesh-ancestor
153826446|NCT00494208|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153826447|NCT00494208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153826448|NCT00471341|Celecoxib|celecoxib|mesh-list
153826449|NCT00471341|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153826450|NCT00471341|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153826451|NCT00471341|Analgesics|analgesics|mesh-ancestor
153826452|NCT00471341|Sensory System Agents|sensory system agents|mesh-ancestor
153826453|NCT00471341|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153826454|NCT00471341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153826455|NCT00471341|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153826456|NCT00471341|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153366444|NCT03034382|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153366445|NCT03034382|Respiratory System Agents|respiratory system agents|mesh-ancestor
153366446|NCT03034382|Mydriatics|mydriatics|mesh-ancestor
153432123|NCT05280314|Pembrolizumab|pembrolizumab|mesh-list
153826464|NCT01325428|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153826465|NCT01325428|Tubulin Modulators|tubulin modulators|mesh-ancestor
153826466|NCT01325428|Antimitotic Agents|antimitotic agents|mesh-ancestor
153826467|NCT01325428|Mitosis Modulators|mitosis modulators|mesh-ancestor
153826468|NCT01325428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153826469|NCT01325428|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153826470|NCT01325428|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153826471|NCT01325428|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153826472|NCT00494247|Antibodies|antibodies|mesh-list
153366461|NCT03030950|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153366462|NCT03030950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153366463|NCT03030950|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153366464|NCT03030950|Analgesics|analgesics|mesh-ancestor
153366465|NCT03030950|Sensory System Agents|sensory system agents|mesh-ancestor
153366466|NCT03030950|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153366467|NCT03030950|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
153366468|NCT03030950|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153366469|NCT03030950|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153366470|NCT03030950|Adrenergic Agents|adrenergic agents|mesh-ancestor
153366471|NCT03030950|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153366472|NCT03030950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153366473|NCT02022644|Irinotecan|irinotecan|mesh-list
153366474|NCT02022644|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
153366475|NCT02022644|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153366476|NCT02022644|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153366477|NCT02022644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153366479|NCT01664897|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
153366480|NCT01664897|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153366481|NCT01664897|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153366482|NCT01664897|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153366483|NCT01664897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153826478|NCT00471419|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153826479|NCT00471419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153383778|NCT05235191|Respiratory System Agents|respiratory system agents|mesh-ancestor
153383779|NCT01774604|Indomethacin|indomethacin|mesh-list
153383780|NCT01774604|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153383781|NCT01774604|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153383782|NCT01774604|Analgesics|analgesics|mesh-ancestor
153383783|NCT01774604|Sensory System Agents|sensory system agents|mesh-ancestor
153383784|NCT01774604|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153383785|NCT01774604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153383886|NCT03656783|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153826480|NCT01325350|Bimatoprost|bimatoprost|mesh-list
153826482|NCT01325350|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
153826483|NCT01325350|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153826484|NCT01325350|Vasodilator Agents|vasodilator agents|mesh-ancestor
153826485|NCT01324999|Tadalafil|tadalafil|mesh-list
153826486|NCT01324999|Vasodilator Agents|vasodilator agents|mesh-ancestor
153826487|NCT01324999|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
153826488|NCT01324999|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
153826489|NCT01324999|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153826490|NCT01324999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153826491|NCT01324999|Urological Agents|urological agents|mesh-ancestor
153826492|NCT01324570|Buprenorphine|buprenorphine|mesh-list
153826493|NCT01324570|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153826494|NCT01324570|Narcotics|narcotics|mesh-ancestor
153826495|NCT01324570|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153826496|NCT01324570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153826497|NCT01324570|Analgesics|analgesics|mesh-ancestor
153826498|NCT01324570|Sensory System Agents|sensory system agents|mesh-ancestor
153826499|NCT01324570|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153826500|NCT01324570|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
153826501|NCT04325698|Paclitaxel|paclitaxel|mesh-list
153826502|NCT04325698|Bevacizumab|bevacizumab|mesh-list
153826503|NCT04325698|Carboplatin|carboplatin|mesh-list
153366490|NCT03030716|Antioxidants|antioxidants|mesh-ancestor
153366491|NCT03030716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153366492|NCT03030716|Protective Agents|protective agents|mesh-ancestor
153366493|NCT03030716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153366494|NCT03030716|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153366495|NCT03030716|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153366496|NCT03030716|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153366497|NCT04353362|Amoxicillin|amoxicillin|mesh-list
153366498|NCT04353362|Metronidazole|metronidazole|mesh-list
153366499|NCT04353362|Ofloxacin|ofloxacin|mesh-list
153366500|NCT04353362|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153366501|NCT04353362|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153366502|NCT04353362|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153366503|NCT04353362|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153366505|NCT04353362|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153826521|NCT01324141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153826522|NCT01324141|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153366509|NCT04353362|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153366510|NCT04353362|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
153366511|NCT04353362|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153366512|NCT00946478|Pimecrolimus|pimecrolimus|mesh-list
153366513|NCT00946478|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153366514|NCT00946478|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153366515|NCT00946478|Analgesics|analgesics|mesh-ancestor
153366516|NCT00946478|Sensory System Agents|sensory system agents|mesh-ancestor
153366517|NCT00946478|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153366518|NCT00946478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153366519|NCT00946478|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153366520|NCT00946478|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153366521|NCT00946478|Dermatologic Agents|dermatologic agents|mesh-ancestor
153432132|NCT05263206|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
153432133|NCT05263206|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
153432134|NCT05263206|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
153432135|NCT05263206|Histamine Antagonists|histamine antagonists|mesh-ancestor
153432136|NCT05263206|Histamine Agents|histamine agents|mesh-ancestor
153891095|NCT01028014|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153891096|NCT01028014|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
153891097|NCT01028014|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153366522|NCT00946478|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153366523|NCT00946478|Immunologic Factors|immunologic factors|mesh-ancestor
153366524|NCT00946478|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
153366525|NCT00946478|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153366526|NCT00946478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153366527|NCT02249741|Ibandronic Acid|ibandronic acid|mesh-list
153366533|NCT03033836|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153366534|NCT03033836|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153366535|NCT03033836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153366537|NCT03033836|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153366538|NCT03033836|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153366539|NCT03033836|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153366540|NCT03033836|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
153366541|NCT03033836|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
153366543|NCT03030560|Anesthetics, Local|anesthetics, local|mesh-ancestor
153366545|NCT03030560|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153461733|NCT03193866|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153366564|NCT03031262|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153366565|NCT03031262|Antimetabolites|antimetabolites|mesh-ancestor
153366566|NCT03031262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153366567|NCT03031262|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153366568|NCT03031262|Antiviral Agents|antiviral agents|mesh-ancestor
153366569|NCT03031262|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153366570|NCT03031262|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153826570|NCT00494598|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153826571|NCT00494598|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153826572|NCT00494598|Anesthetics, General|anesthetics, general|mesh-ancestor
153826573|NCT00494598|Anesthetics|anesthetics|mesh-ancestor
153826574|NCT00503412|Cediranib|cediranib|mesh-list
153826575|NCT00503412|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153826576|NCT00503412|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153826577|NCT00503412|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153826578|NCT00503412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153826579|NCT00503451|Panobinostat|panobinostat|mesh-list
153826580|NCT00503451|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153826581|NCT00503451|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
153826582|NCT00503451|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153826583|NCT00503451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153826584|NCT00471809|Azithromycin|azithromycin|mesh-list
153826585|NCT00471809|Budesonide|budesonide|mesh-list
153366571|NCT03031262|Immunologic Factors|immunologic factors|mesh-ancestor
153366572|NCT03031262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153366573|NCT03032978|Calcium, Dietary|calcium, dietary|mesh-list
153366574|NCT03032978|Calcium|calcium|mesh-list
153366575|NCT03032978|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153366576|NCT03032978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153366577|NCT03032978|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153366578|NCT03030248|Vancomycin|vancomycin|mesh-list
153366579|NCT03030248|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153366580|NCT03030248|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153366581|NCT03028532|Clomiphene|clomiphene|mesh-list
153366582|NCT03028532|Enclomiphene|enclomiphene|mesh-list
153366583|NCT03028532|Zuclomiphene|zuclomiphene|mesh-list
153366584|NCT03028532|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
153366585|NCT03028532|Hormone Antagonists|hormone antagonists|mesh-ancestor
153366586|NCT03028532|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153366595|NCT03017768|Antidepressive Agents|antidepressive agents|mesh-ancestor
153366596|NCT03017768|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153366597|NCT01006538|Ranibizumab|ranibizumab|mesh-list
153826586|NCT00471809|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
153826587|NCT00471809|Montelukast|montelukast|mesh-list
153826588|NCT00471809|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153826589|NCT00471809|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153826590|NCT00471809|Autonomic Agents|autonomic agents|mesh-ancestor
153826591|NCT00471809|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153826600|NCT00471809|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
153826602|NCT00471809|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153826603|NCT00471809|Adrenergic Agents|adrenergic agents|mesh-ancestor
153826604|NCT00471809|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153826605|NCT00471809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153826606|NCT00471809|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
153826607|NCT00471809|Hormone Antagonists|hormone antagonists|mesh-ancestor
153826608|NCT00471809|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
153826609|NCT00471809|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
153366598|NCT01006538|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153366599|NCT01006538|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153366600|NCT01006538|Growth Substances|growth substances|mesh-ancestor
153366601|NCT01006538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153366602|NCT01006538|Growth Inhibitors|growth inhibitors|mesh-ancestor
153366603|NCT01006538|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153366604|NCT03017222|Ondansetron|ondansetron|mesh-list
153366605|NCT03017222|Ramosetron|ramosetron|mesh-list
153366606|NCT03017222|Antiemetics|antiemetics|mesh-ancestor
153366607|NCT03017222|Autonomic Agents|autonomic agents|mesh-ancestor
153366608|NCT03017222|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153366609|NCT03017222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153366610|NCT03017222|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153366611|NCT03017222|Antipruritics|antipruritics|mesh-ancestor
153366612|NCT03017222|Dermatologic Agents|dermatologic agents|mesh-ancestor
153366613|NCT03017222|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
153366614|NCT03017222|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153366615|NCT03017222|Serotonin Agents|serotonin agents|mesh-ancestor
153366617|NCT03017222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153366618|NCT03025724|Aminolevulinic Acid|aminolevulinic acid|mesh-list
153366619|NCT03025724|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
153366620|NCT03025724|Dermatologic Agents|dermatologic agents|mesh-ancestor
153366621|NCT01010282|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
153366629|NCT01010282|Laxatives|laxatives|mesh-ancestor
153366630|NCT01010282|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153366631|NCT03016988|Cytarabine|cytarabine|mesh-list
153366632|NCT03016988|Fludarabine|fludarabine|mesh-list
153366633|NCT03016988|Bortezomib|bortezomib|mesh-list
153366634|NCT03016988|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153366635|NCT03016988|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153366636|NCT03016988|Antimetabolites|antimetabolites|mesh-ancestor
153366637|NCT03016988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153366638|NCT03016988|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153366639|NCT03016988|Immunologic Factors|immunologic factors|mesh-ancestor
153366640|NCT03016988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153366641|NCT03016988|Antiviral Agents|antiviral agents|mesh-ancestor
153366642|NCT03016988|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153366644|NCT03017066|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153366645|NCT03017066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153826659|NCT00494715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153826660|NCT00494715|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
153826661|NCT00494715|Protease Inhibitors|protease inhibitors|mesh-ancestor
153826662|NCT00494715|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153826663|NCT00472043|Methyl 5-aminolevulinate|methyl 5-aminolevulinate|mesh-list
153826664|NCT00472043|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
153826665|NCT00472043|Dermatologic Agents|dermatologic agents|mesh-ancestor
153826667|NCT03271073|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153826668|NCT03271073|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153826669|NCT03271073|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153826670|NCT03271073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153826671|NCT01246557|Dexamethasone|dexamethasone|mesh-list
153826672|NCT01246557|Lenalidomide|lenalidomide|mesh-list
153826673|NCT01246557|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153826674|NCT01246557|Antiemetics|antiemetics|mesh-ancestor
153826675|NCT01246557|Autonomic Agents|autonomic agents|mesh-ancestor
153826676|NCT01246557|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153826677|NCT01246557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153826678|NCT01246557|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153826679|NCT01246557|Glucocorticoids|glucocorticoids|mesh-ancestor
153826680|NCT01246557|Hormones|hormones|mesh-ancestor
153826681|NCT01246557|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153826682|NCT01246557|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153826683|NCT01246557|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153826684|NCT01246557|Immunologic Factors|immunologic factors|mesh-ancestor
153826685|NCT01246557|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153366673|NCT01010984|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153366678|NCT01011218|Modafinil|modafinil|mesh-list
153366691|NCT05710367|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
153366692|NCT05710367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153366693|NCT05710367|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153366694|NCT05710367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153366695|NCT00957242|Warfarin|warfarin|mesh-list
153826702|NCT01323790|Naloxegol|naloxegol|mesh-list
153826703|NCT01323790|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
153826704|NCT01323790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153826705|NCT01323790|Sensory System Agents|sensory system agents|mesh-ancestor
153826706|NCT01323790|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153826707|NCT00477035|Cyclophosphamide|cyclophosphamide|mesh-list
153826708|NCT00477035|Melphalan|melphalan|mesh-list
153826709|NCT00477035|Carmustine|carmustine|mesh-list
153826710|NCT00477035|Gemcitabine|gemcitabine|mesh-list
153826711|NCT00477035|Etoposide|etoposide|mesh-list
153366696|NCT00957242|Anticoagulants|anticoagulants|mesh-ancestor
153366697|NCT01014728|Propofol|propofol|mesh-list
153366698|NCT01014728|Sevoflurane|sevoflurane|mesh-list
153366699|NCT01014728|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153366700|NCT01014728|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153366701|NCT01014728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153366702|NCT01014728|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153366704|NCT01014728|Anesthetics|anesthetics|mesh-ancestor
153366720|NCT01676831|Toll-Like Receptor Agonists|toll-like receptor agonists|mesh-ancestor
153366721|NCT01676831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153366722|NCT01676831|Immunomodulating Agents|immunomodulating agents|mesh-ancestor
153366723|NCT01676831|Immunologic Factors|immunologic factors|mesh-ancestor
153366734|NCT02448810|Antimetabolites|antimetabolites|mesh-ancestor
153366735|NCT02448810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153366736|NCT02448810|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153366737|NCT02448810|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153366738|NCT02448810|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153366739|NCT02448810|Immunologic Factors|immunologic factors|mesh-ancestor
153826738|NCT00494832|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153826739|NCT00494832|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
153826740|NCT00494832|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153826741|NCT00494832|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153826742|NCT00494832|Adrenergic Agents|adrenergic agents|mesh-ancestor
153826743|NCT00494832|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153826744|NCT00494832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153826745|NCT00477074|Dimercaprol|dimercaprol|mesh-list
153826746|NCT00477074|Chelating Agents|chelating agents|mesh-ancestor
153826747|NCT00477074|Sequestering Agents|sequestering agents|mesh-ancestor
153826748|NCT00477074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153826749|NCT01323673|Clobetasol|clobetasol|mesh-list
153826750|NCT01323673|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153826751|NCT01323673|Glucocorticoids|glucocorticoids|mesh-ancestor
153826754|NCT01323673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153366740|NCT02448810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153366741|NCT02448810|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153366743|NCT01680887|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
153366744|NCT01680887|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
153366746|NCT01680887|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153366747|NCT01680887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153366748|NCT01680887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153366750|NCT01016678|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153366751|NCT01016678|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153366752|NCT01016678|Analgesics|analgesics|mesh-ancestor
153366753|NCT01016678|Sensory System Agents|sensory system agents|mesh-ancestor
153366754|NCT01016678|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153826797|NCT00494988|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
153826798|NCT00494988|Insulin Aspart|insulin aspart|mesh-list
153826799|NCT00494988|Isophane Insulin, Human|isophane insulin, human|mesh-list
153826800|NCT00494988|Insulin, Isophane|insulin, isophane|mesh-list
153826801|NCT00494988|Isophane insulin, beef|isophane insulin, beef|mesh-list
153891108|NCT01302080|Sertraline|sertraline|mesh-list
153891121|NCT01032070|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153891122|NCT01032070|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153891123|NCT01032070|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153432137|NCT05263206|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153432138|NCT05263206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153432139|NCT05263206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153432141|NCT05262556|Ipilimumab|ipilimumab|mesh-list
153826802|NCT00494988|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153826803|NCT00494988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153826804|NCT01323478|Vortioxetine|vortioxetine|mesh-list
153826805|NCT01323478|Antidepressive Agents|antidepressive agents|mesh-ancestor
153826806|NCT01323478|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153826807|NCT01323478|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153826808|NCT01323478|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153826809|NCT01323478|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153826810|NCT01323478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153826811|NCT01323478|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
153826812|NCT01323478|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153366798|NCT01682135|Ramucirumab|ramucirumab|mesh-list
153366799|NCT01682135|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153366800|NCT01682135|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153366801|NCT01682135|Growth Substances|growth substances|mesh-ancestor
153366802|NCT01682135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153366803|NCT01682135|Growth Inhibitors|growth inhibitors|mesh-ancestor
153366804|NCT01682135|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153366805|NCT02249897|Cholestyramine Resin|cholestyramine resin|mesh-list
153366806|NCT02249897|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153366807|NCT02249897|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153366808|NCT02249897|Antimetabolites|antimetabolites|mesh-ancestor
153366809|NCT02249897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153366810|NCT02249897|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153366811|NCT00963872|Cyclophosphamide|cyclophosphamide|mesh-list
153366812|NCT00963872|Fludarabine|fludarabine|mesh-list
153366813|NCT00963872|Fludarabine phosphate|fludarabine phosphate|mesh-list
153366824|NCT00963872|Antimetabolites|antimetabolites|mesh-ancestor
153366825|NCT00964496|Thalidomide|thalidomide|mesh-list
153366826|NCT00964496|Ferrous succinate|ferrous succinate|mesh-list
153366827|NCT00964496|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153366828|NCT00964496|Immunologic Factors|immunologic factors|mesh-ancestor
153366829|NCT00964496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153366830|NCT00964496|Leprostatic Agents|leprostatic agents|mesh-ancestor
153366831|NCT00964496|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153826813|NCT01323478|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153826814|NCT01323478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153826815|NCT01323478|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153826816|NCT01323478|Serotonin Agents|serotonin agents|mesh-ancestor
153826817|NCT01323478|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
153826818|NCT01323478|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
153826819|NCT01323478|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
153826820|NCT01323478|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153826821|NCT00472355|Apomorphine|apomorphine|mesh-list
153826822|NCT00472355|Emetics|emetics|mesh-ancestor
153826823|NCT00472355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153826824|NCT00472355|Autonomic Agents|autonomic agents|mesh-ancestor
153826825|NCT00472355|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153826826|NCT00472355|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153826827|NCT00472355|Dopamine Agonists|dopamine agonists|mesh-ancestor
153826828|NCT00472355|Dopamine Agents|dopamine agents|mesh-ancestor
153366859|NCT01685411|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153366860|NCT01685411|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
153366861|NCT01685411|Antitubercular Agents|antitubercular agents|mesh-ancestor
153366862|NCT01685411|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153432142|NCT05262556|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153366863|NCT01685411|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153366864|NCT01685411|Anticonvulsants|anticonvulsants|mesh-ancestor
153366865|NCT01685411|Nootropic Agents|nootropic agents|mesh-ancestor
153366866|NCT01685411|Antimetabolites|antimetabolites|mesh-ancestor
153366867|NCT01685411|Gout Suppressants|gout suppressants|mesh-ancestor
153826852|NCT00472472|Paclitaxel|paclitaxel|mesh-list
153826853|NCT00472472|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153826854|NCT00472472|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153826855|NCT00472472|Tubulin Modulators|tubulin modulators|mesh-ancestor
153826856|NCT00472472|Antimitotic Agents|antimitotic agents|mesh-ancestor
153826857|NCT00472472|Mitosis Modulators|mitosis modulators|mesh-ancestor
153826858|NCT00472472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153826859|NCT00503568|Vaccines|vaccines|mesh-list
153826860|NCT00503568|Immunologic Factors|immunologic factors|mesh-ancestor
153826862|NCT00472550|Esomeprazole|esomeprazole|mesh-list
153366872|NCT02243813|Hallucinogens|hallucinogens|mesh-ancestor
153366873|NCT02243813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153366874|NCT02243813|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153366875|NCT02991209|Testosterone|testosterone|mesh-list
153366876|NCT02991209|Androgens|androgens|mesh-ancestor
153366877|NCT02991209|Hormones|hormones|mesh-ancestor
153366878|NCT02991209|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153366879|NCT02991209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153366880|NCT03019562|Fentanyl|fentanyl|mesh-list
153366881|NCT03019562|Oxycodone|oxycodone|mesh-list
153366882|NCT03019562|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153366883|NCT03019562|Narcotics|narcotics|mesh-ancestor
153383887|NCT01784666|Isradipine|isradipine|mesh-list
153383888|NCT01784666|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153383889|NCT01784666|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153383890|NCT01784666|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153383891|NCT01784666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153366884|NCT03019562|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153366885|NCT03019562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153366886|NCT03019562|Analgesics|analgesics|mesh-ancestor
153366887|NCT03019562|Sensory System Agents|sensory system agents|mesh-ancestor
153366888|NCT03019562|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153366889|NCT03019562|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153366890|NCT03019562|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153366891|NCT03019562|Anesthetics, General|anesthetics, general|mesh-ancestor
153366892|NCT03019562|Anesthetics|anesthetics|mesh-ancestor
153366893|NCT00969878|Aluminum Hydroxide|aluminum hydroxide|mesh-list
153366894|NCT00969878|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
153826892|NCT01244334|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153826893|NCT01244334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153826894|NCT01244334|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153826895|NCT01244334|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153826897|NCT01244334|Autonomic Agents|autonomic agents|mesh-ancestor
153826898|NCT01244334|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153826899|NCT01244334|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153826900|NCT01244334|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
153826901|NCT01244334|Protective Agents|protective agents|mesh-ancestor
153826902|NCT00477542|Clofarabine|clofarabine|mesh-list
153826903|NCT00477542|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153826904|NCT00477542|Antimetabolites|antimetabolites|mesh-ancestor
153826905|NCT00477542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153366895|NCT00969878|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153366896|NCT00969878|Immunologic Factors|immunologic factors|mesh-ancestor
153366897|NCT00969878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153366898|NCT00969878|Antacids|antacids|mesh-ancestor
153366899|NCT00969878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153366900|NCT00969878|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153366901|NCT00970814|Levetiracetam|levetiracetam|mesh-list
153366902|NCT00970814|Anticonvulsants|anticonvulsants|mesh-ancestor
153366903|NCT00970814|Nootropic Agents|nootropic agents|mesh-ancestor
153366904|NCT02486406|Ritonavir|ritonavir|mesh-list
153366905|NCT02486406|Ribavirin|ribavirin|mesh-list
153366906|NCT02486406|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
153366907|NCT02486406|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
153366913|NCT02486406|Antiviral Agents|antiviral agents|mesh-ancestor
153366914|NCT02486406|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153366915|NCT02486406|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
153366916|NCT02486406|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153366917|NCT02486406|Antimetabolites|antimetabolites|mesh-ancestor
153366918|NCT01688609|Paclitaxel|paclitaxel|mesh-list
153366919|NCT01688609|Trastuzumab|trastuzumab|mesh-list
153366920|NCT01688609|Lapatinib|lapatinib|mesh-list
153366921|NCT01688609|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153366922|NCT01688609|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153366923|NCT01688609|Tubulin Modulators|tubulin modulators|mesh-ancestor
153366924|NCT01688609|Antimitotic Agents|antimitotic agents|mesh-ancestor
153366925|NCT01688609|Mitosis Modulators|mitosis modulators|mesh-ancestor
153366926|NCT01688609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153366927|NCT01688609|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153366928|NCT01688609|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153366929|NCT01688609|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153826906|NCT00477542|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153826907|NCT00503763|Simvastatin|simvastatin|mesh-list
153826908|NCT00503763|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153826909|NCT00503763|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153826910|NCT00503763|Antimetabolites|antimetabolites|mesh-ancestor
153826911|NCT00503763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153783563|NCT04545970|Sunscreening Agents|sunscreening agents|mesh-list
153383892|NCT01784666|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153383893|NCT01784666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153383894|NCT01784666|Vasodilator Agents|vasodilator agents|mesh-ancestor
153383895|NCT04296695|Tenofovir|tenofovir|mesh-list
153383896|NCT04296695|Efavirenz|efavirenz|mesh-list
153383897|NCT04296695|Antiviral Agents|antiviral agents|mesh-ancestor
153383898|NCT04296695|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153383899|NCT04296695|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153383900|NCT04296695|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153383901|NCT04296695|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153826912|NCT00503763|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153826913|NCT00503763|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
153826914|NCT00503763|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153826915|NCT00477581|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
153826916|NCT00477581|Exenatide|exenatide|mesh-list
153826917|NCT00477581|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153826929|NCT00477737|Sevoflurane|sevoflurane|mesh-list
153826930|NCT00477737|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153826931|NCT00477737|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153826932|NCT00477737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153826933|NCT00477737|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153826934|NCT00477737|Anesthetics, General|anesthetics, general|mesh-ancestor
153826935|NCT00477737|Anesthetics|anesthetics|mesh-ancestor
153826936|NCT00477737|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153826937|NCT00477737|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
153826938|NCT00477776|Metoclopramide|metoclopramide|mesh-list
153826939|NCT00477776|Antiemetics|antiemetics|mesh-ancestor
153826940|NCT00477776|Autonomic Agents|autonomic agents|mesh-ancestor
153366930|NCT01688609|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153366931|NCT02485158|Dronabinol|dronabinol|mesh-list
153366954|NCT02485158|Hormones|hormones|mesh-ancestor
153366955|NCT02485158|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153366956|NCT02455518|Acetaminophen|acetaminophen|mesh-list
153366957|NCT02455518|Ibuprofen|ibuprofen|mesh-list
153366958|NCT02455518|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
153366959|NCT02455518|Oxycodone|oxycodone|mesh-list
153366960|NCT02455518|Hydrocodone|hydrocodone|mesh-list
153366961|NCT02455518|Codeine|codeine|mesh-list
153826941|NCT00477776|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153826942|NCT00477776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153826943|NCT00477776|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153826944|NCT00477776|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
153826945|NCT00477776|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
153826946|NCT00477776|Dopamine Agents|dopamine agents|mesh-ancestor
153826947|NCT00477776|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153826948|NCT00477776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153826949|NCT00477815|Rituximab|rituximab|mesh-list
153826950|NCT00477815|Melphalan|melphalan|mesh-list
153826951|NCT00477815|Sargramostim|sargramostim|mesh-list
153826952|NCT00477815|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
153826953|NCT00477815|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153826954|NCT00477815|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153826955|NCT00477815|Immunologic Factors|immunologic factors|mesh-ancestor
153826960|NCT00477815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153826962|NCT00477815|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153826963|NCT00477854|Chromium|chromium|mesh-list
153826964|NCT00477854|Picolinic acid|picolinic acid|mesh-list
153826965|NCT00477854|Trace Elements|trace elements|mesh-ancestor
153826966|NCT00477854|Micronutrients|micronutrients|mesh-ancestor
153826967|NCT00477854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153826968|NCT00477854|Iron Chelating Agents|iron chelating agents|mesh-ancestor
153826969|NCT00477854|Chelating Agents|chelating agents|mesh-ancestor
153826970|NCT00477854|Sequestering Agents|sequestering agents|mesh-ancestor
153826972|NCT00477893|Adalimumab|adalimumab|mesh-list
153366968|NCT02455518|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153366969|NCT02455518|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153366970|NCT02455518|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153366971|NCT02455518|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153366972|NCT02455518|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153366973|NCT02455518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153366974|NCT02455518|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153366975|NCT02455518|Narcotics|narcotics|mesh-ancestor
153366976|NCT02455518|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153366977|NCT02455518|Antitussive Agents|antitussive agents|mesh-ancestor
153366978|NCT02455518|Respiratory System Agents|respiratory system agents|mesh-ancestor
153366979|NCT00972374|Brimonidine Tartrate|brimonidine tartrate|mesh-list
153366980|NCT00972374|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153366981|NCT00972374|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
153366982|NCT00972374|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153366983|NCT00972374|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153366984|NCT00972374|Adrenergic Agents|adrenergic agents|mesh-ancestor
153366985|NCT00972374|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153366986|NCT00972374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153366987|NCT00972374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153366988|NCT03018626|Prednisone|prednisone|mesh-list
153366989|NCT03018626|Cyclophosphamide|cyclophosphamide|mesh-list
153366990|NCT03018626|Rituximab|rituximab|mesh-list
153366991|NCT03018626|Doxorubicin|doxorubicin|mesh-list
153826982|NCT01247337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153826984|NCT01247337|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153826985|NCT00478049|Docetaxel|docetaxel|mesh-list
153826986|NCT00478049|Gefitinib|gefitinib|mesh-list
153826987|NCT00478049|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153826988|NCT00478049|Tubulin Modulators|tubulin modulators|mesh-ancestor
153826989|NCT00478049|Antimitotic Agents|antimitotic agents|mesh-ancestor
153826990|NCT00478049|Mitosis Modulators|mitosis modulators|mesh-ancestor
153826991|NCT00478049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153826992|NCT00478049|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153826993|NCT00478049|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153826994|NCT00478049|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153826995|NCT01248975|Montelukast|montelukast|mesh-list
153826996|NCT01248975|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153826997|NCT01248975|Respiratory System Agents|respiratory system agents|mesh-ancestor
153826998|NCT01248975|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
153826999|NCT01248975|Hormone Antagonists|hormone antagonists|mesh-ancestor
153827000|NCT01248975|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153827001|NCT01248975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153827002|NCT01248975|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
153366992|NCT03018626|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
153366993|NCT03018626|Etoposide|etoposide|mesh-list
153366994|NCT03018626|Vincristine|vincristine|mesh-list
153366995|NCT03018626|Bleomycin|bleomycin|mesh-list
153366996|NCT03018626|Vindesine|vindesine|mesh-list
153366997|NCT03018626|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153366998|NCT03018626|Immunologic Factors|immunologic factors|mesh-ancestor
153366999|NCT03018626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153367000|NCT03018626|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153367001|NCT03018626|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153827009|NCT02955927|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153827010|NCT02955927|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153827011|NCT02955927|Autonomic Agents|autonomic agents|mesh-ancestor
153827012|NCT02955927|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153827013|NCT02955927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153827014|NCT02955927|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153827015|NCT02955927|Respiratory System Agents|respiratory system agents|mesh-ancestor
153827016|NCT02955927|Mydriatics|mydriatics|mesh-ancestor
153827017|NCT02955927|Parasympatholytics|parasympatholytics|mesh-ancestor
153827018|NCT02955927|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
153367039|NCT00974246|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153367040|NCT00974246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153367041|NCT00974246|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153367042|NCT00974246|Respiratory System Agents|respiratory system agents|mesh-ancestor
153367043|NCT00974246|Glucocorticoids|glucocorticoids|mesh-ancestor
153367044|NCT00974246|Hormones|hormones|mesh-ancestor
153367045|NCT00974246|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153367046|NCT00974246|Sympathomimetics|sympathomimetics|mesh-ancestor
153367047|NCT00974480|Tretinoin|tretinoin|mesh-list
153367048|NCT00974480|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153367049|NCT00974480|Keratolytic Agents|keratolytic agents|mesh-ancestor
153827026|NCT01247493|Fludarabine|fludarabine|mesh-list
153827027|NCT01247493|Idarubicin|idarubicin|mesh-list
153827028|NCT01247493|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153827029|NCT01247493|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153827030|NCT01247493|Antimetabolites|antimetabolites|mesh-ancestor
153827031|NCT01247493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153827032|NCT01247493|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153827033|NCT01247493|Immunologic Factors|immunologic factors|mesh-ancestor
153891128|NCT01237899|Eplerenone|eplerenone|mesh-list
153827034|NCT01247493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153827035|NCT01247493|Antiviral Agents|antiviral agents|mesh-ancestor
153367061|NCT00979940|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153367062|NCT00979940|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
153367070|NCT03018236|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153367071|NCT03018236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153367072|NCT03018236|Antiviral Agents|antiviral agents|mesh-ancestor
153367073|NCT03018236|Expectorants|expectorants|mesh-ancestor
153367074|NCT03018236|Respiratory System Agents|respiratory system agents|mesh-ancestor
153367075|NCT03018236|Free Radical Scavengers|free radical scavengers|mesh-ancestor
153367076|NCT03018236|Antioxidants|antioxidants|mesh-ancestor
153367077|NCT03018236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153367078|NCT03018236|Protective Agents|protective agents|mesh-ancestor
153367079|NCT03018236|Antidotes|antidotes|mesh-ancestor
153367080|NCT03018236|Anesthetics, Local|anesthetics, local|mesh-ancestor
153367081|NCT03018236|Anesthetics|anesthetics|mesh-ancestor
153367082|NCT03018236|Sensory System Agents|sensory system agents|mesh-ancestor
153367083|NCT03018236|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153367084|NCT03018236|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
153827065|NCT01321723|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153827066|NCT00478634|Irinotecan|irinotecan|mesh-list
153827067|NCT00478634|Cetuximab|cetuximab|mesh-list
153827068|NCT00478634|Everolimus|everolimus|mesh-list
153827069|NCT00478634|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
153827070|NCT00478634|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153827071|NCT00478634|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153827072|NCT00478634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153827073|NCT00478634|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153827074|NCT00478634|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153827075|NCT00478634|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
153827076|NCT00478634|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153827077|NCT00478634|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153827078|NCT00478634|Immunologic Factors|immunologic factors|mesh-ancestor
153827079|NCT00478634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153827080|NCT01247688|Fludarabine|fludarabine|mesh-list
153827081|NCT01247688|Cyclophosphamide|cyclophosphamide|mesh-list
153827082|NCT01247688|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153827083|NCT01247688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153827084|NCT01247688|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153827085|NCT01247688|Immunologic Factors|immunologic factors|mesh-ancestor
153827086|NCT01247688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153827087|NCT01247688|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153827088|NCT01247688|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153827089|NCT01247688|Alkylating Agents|alkylating agents|mesh-ancestor
153827090|NCT01247688|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153827091|NCT00478907|Ketamine|ketamine|mesh-list
153827092|NCT00478907|Thiopental|thiopental|mesh-list
153827093|NCT00478907|Propofol|propofol|mesh-list
153827094|NCT00478907|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153827095|NCT00478907|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153827096|NCT00478907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153827097|NCT00478907|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153827098|NCT00478907|Anesthetics, General|anesthetics, general|mesh-ancestor
153827099|NCT00478907|Anesthetics|anesthetics|mesh-ancestor
153827100|NCT00478907|Analgesics|analgesics|mesh-ancestor
153827101|NCT00478907|Sensory System Agents|sensory system agents|mesh-ancestor
153367102|NCT00982592|Immunologic Factors|immunologic factors|mesh-ancestor
153367103|NCT00982592|Antidotes|antidotes|mesh-ancestor
153367104|NCT00982592|Protective Agents|protective agents|mesh-ancestor
153367105|NCT00982592|Vitamin B Complex|vitamin b complex|mesh-ancestor
153367106|NCT00982592|Vitamins|vitamins|mesh-ancestor
153367107|NCT00982592|Micronutrients|micronutrients|mesh-ancestor
153367108|NCT00983216|Ketoconazole|ketoconazole|mesh-list
153367109|NCT00983216|Colchicine|colchicine|mesh-list
153367110|NCT00983216|Gout Suppressants|gout suppressants|mesh-ancestor
153367111|NCT00983216|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153367112|NCT00983216|Tubulin Modulators|tubulin modulators|mesh-ancestor
153367113|NCT00983216|Antimitotic Agents|antimitotic agents|mesh-ancestor
153367114|NCT00983216|Mitosis Modulators|mitosis modulators|mesh-ancestor
153367115|NCT00983216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153367116|NCT00983216|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153827114|NCT00478946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153827115|NCT00478946|Vitamin B Complex|vitamin b complex|mesh-ancestor
153827117|NCT00478946|Micronutrients|micronutrients|mesh-ancestor
153827118|NCT01247961|Dexamethasone|dexamethasone|mesh-list
153827119|NCT01247961|Dexamethasone acetate|dexamethasone acetate|mesh-list
153827120|NCT01247961|BB 1101|bb 1101|mesh-list
153827121|NCT01247961|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153827122|NCT01247961|Antiemetics|antiemetics|mesh-ancestor
153827123|NCT01247961|Autonomic Agents|autonomic agents|mesh-ancestor
153827124|NCT01247961|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153827125|NCT01247961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153827126|NCT01247961|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153827127|NCT01247961|Glucocorticoids|glucocorticoids|mesh-ancestor
153827128|NCT01247961|Hormones|hormones|mesh-ancestor
153367117|NCT00983216|Antifungal Agents|antifungal agents|mesh-ancestor
153367118|NCT00983216|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153367119|NCT00983216|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
153367120|NCT00983216|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153367121|NCT00983216|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153367122|NCT00983216|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153367123|NCT00983216|Hormone Antagonists|hormone antagonists|mesh-ancestor
153367124|NCT00983216|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153367125|NCT00983216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153367126|NCT00983216|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
153367130|NCT02249585|Trace Elements|trace elements|mesh-ancestor
153827136|NCT01248078|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153827137|NCT01248078|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153827138|NCT00472823|Vitamin D|vitamin d|mesh-list
153827139|NCT00472823|Cholecalciferol|cholecalciferol|mesh-list
153827140|NCT00472823|Calcium|calcium|mesh-list
153827141|NCT00472823|Vitamins|vitamins|mesh-ancestor
153827142|NCT00472823|Micronutrients|micronutrients|mesh-ancestor
153827143|NCT00472823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153827144|NCT00472823|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153827145|NCT00472823|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153827146|NCT02275416|Ipilimumab|ipilimumab|mesh-list
153827147|NCT02275416|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153827148|NCT02275416|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153827149|NCT02275416|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153827150|NCT02275416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153827151|NCT00472901|Afamelanotide|afamelanotide|mesh-list
153827152|NCT00472901|Dermatologic Agents|dermatologic agents|mesh-ancestor
153827153|NCT02482233|Nicotine|nicotine|mesh-list
153827154|NCT02482233|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
153827155|NCT02482233|Autonomic Agents|autonomic agents|mesh-ancestor
153827156|NCT02482233|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153827157|NCT02482233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153827158|NCT02482233|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
153827159|NCT02482233|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
153827160|NCT02482233|Cholinergic Agents|cholinergic agents|mesh-ancestor
153827161|NCT02482233|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153827162|NCT02482233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153827163|NCT01248117|Ranibizumab|ranibizumab|mesh-list
153827164|NCT01248117|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153827165|NCT01248117|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153827167|NCT01248117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153827168|NCT01248117|Growth Inhibitors|growth inhibitors|mesh-ancestor
153827169|NCT01248117|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153827170|NCT01248234|Propofol|propofol|mesh-list
153827171|NCT01248234|Etomidate|etomidate|mesh-list
153827172|NCT01248234|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153827175|NCT01248234|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153827176|NCT01248234|Anesthetics, General|anesthetics, general|mesh-ancestor
153827177|NCT01248234|Anesthetics|anesthetics|mesh-ancestor
153367166|NCT01024010|Vidarabine|vidarabine|mesh-list
153367167|NCT01024010|Cyclophosphamide|cyclophosphamide|mesh-list
153367168|NCT01024010|Ofatumumab|ofatumumab|mesh-list
153367169|NCT01024010|Pentostatin|pentostatin|mesh-list
153367170|NCT01024010|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
153367171|NCT01024010|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153367172|NCT01024010|Immunologic Factors|immunologic factors|mesh-ancestor
153367173|NCT01024010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153367174|NCT01024010|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153367180|NCT01024010|Adenosine Deaminase Inhibitors|adenosine deaminase inhibitors|mesh-ancestor
153367181|NCT01024010|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153367182|NCT01024010|Antimetabolites|antimetabolites|mesh-ancestor
153367183|NCT01024010|Antiviral Agents|antiviral agents|mesh-ancestor
153367184|NCT01024010|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153367185|NCT02484690|Ranibizumab|ranibizumab|mesh-list
153367186|NCT02484690|Faricimab|faricimab|mesh-list
153367187|NCT02484690|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153367188|NCT02484690|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153367189|NCT02484690|Growth Substances|growth substances|mesh-ancestor
153367190|NCT02484690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153367191|NCT02484690|Growth Inhibitors|growth inhibitors|mesh-ancestor
153367192|NCT02484690|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153367199|NCT01654224|Vaccines|vaccines|mesh-list
153827178|NCT01248273|Adjuvants, Immunologic|adjuvants, immunologic|mesh-list
153827179|NCT01248273|Immunologic Factors|immunologic factors|mesh-ancestor
153827180|NCT01248273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153827181|NCT00473174|Ramipril|ramipril|mesh-list
153827182|NCT00473174|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
153827183|NCT00473174|Protease Inhibitors|protease inhibitors|mesh-ancestor
153827184|NCT00473174|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153827185|NCT00473174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153827186|NCT00473174|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153827187|NCT00473213|Interferons|interferons|mesh-list
153827188|NCT00473213|Interferon-beta|interferon-beta|mesh-list
153827189|NCT00473213|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153827190|NCT00473213|Antiviral Agents|antiviral agents|mesh-ancestor
153827191|NCT00473213|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153827192|NCT00473213|Immunologic Factors|immunologic factors|mesh-ancestor
153827193|NCT00473213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153827194|NCT01320202|Dialysis Solutions|dialysis solutions|mesh-list
153827195|NCT01320202|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
153827196|NCT01319383|Vorinostat|vorinostat|mesh-list
153827197|NCT01319383|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153827198|NCT01319383|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
153827199|NCT01319383|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153827200|NCT01319383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153827201|NCT00479609|Testosterone|testosterone|mesh-list
153827202|NCT00479609|Androgens|androgens|mesh-ancestor
153827203|NCT00479609|Hormones|hormones|mesh-ancestor
153827204|NCT00479609|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153827205|NCT00479609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153827206|NCT04325113|Levobupivacaine|levobupivacaine|mesh-list
153827207|NCT04325113|Anesthetics, Local|anesthetics, local|mesh-ancestor
153827208|NCT04325113|Anesthetics|anesthetics|mesh-ancestor
153827209|NCT04325113|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153827210|NCT04325113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153827211|NCT04325113|Sensory System Agents|sensory system agents|mesh-ancestor
153827212|NCT04325113|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153367226|NCT00993200|Anticoagulants|anticoagulants|mesh-ancestor
153367227|NCT00993824|Colesevelam Hydrochloride|colesevelam hydrochloride|mesh-list
153367228|NCT00993824|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153367229|NCT00993824|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153367230|NCT00993824|Antimetabolites|antimetabolites|mesh-ancestor
153367231|NCT00993824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153367232|NCT00993824|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153367233|NCT02447172|Gentamicins|gentamicins|mesh-list
153367234|NCT02447172|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153367235|NCT02447172|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153367236|NCT02447172|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
153367237|NCT02447172|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153367238|NCT02447172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153367239|NCT02163824|Loteprednol Etabonate|loteprednol etabonate|mesh-list
153367240|NCT02163824|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
153367241|NCT04200066|Tamoxifen|tamoxifen|mesh-list
153827227|NCT02955732|Dexmedetomidine|dexmedetomidine|mesh-list
153827228|NCT02955732|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153827229|NCT02955732|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153827230|NCT02955732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153827231|NCT02955732|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153827232|NCT02955732|Analgesics|analgesics|mesh-ancestor
153827233|NCT02955732|Sensory System Agents|sensory system agents|mesh-ancestor
153827234|NCT02955732|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153827235|NCT02955732|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
153827236|NCT02955732|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153827237|NCT02955732|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153827238|NCT02955732|Adrenergic Agents|adrenergic agents|mesh-ancestor
153827239|NCT02955732|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153367264|NCT02455050|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
153367266|NCT02455050|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
153367267|NCT02455050|Laxatives|laxatives|mesh-ancestor
153367268|NCT02455050|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153367269|NCT00994760|Fentanyl|fentanyl|mesh-list
153367270|NCT00994760|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153367271|NCT00994760|Narcotics|narcotics|mesh-ancestor
153367272|NCT00994760|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153367273|NCT00994760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153367274|NCT00994760|Analgesics|analgesics|mesh-ancestor
153367275|NCT00994760|Sensory System Agents|sensory system agents|mesh-ancestor
153367276|NCT00994760|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153827262|NCT00479726|Dopamine Agents|dopamine agents|mesh-ancestor
153827263|NCT01315249|Fluticasone|fluticasone|mesh-list
153827265|NCT01315249|Glycopyrrolate|glycopyrrolate|mesh-list
153827266|NCT01315249|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
153827267|NCT01315249|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
153827268|NCT01315249|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153827269|NCT01315249|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153827270|NCT01315249|Autonomic Agents|autonomic agents|mesh-ancestor
153827271|NCT01315249|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153827272|NCT01315249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153827273|NCT01315249|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153827279|NCT01315249|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153827280|NCT01315249|Adrenergic Agents|adrenergic agents|mesh-ancestor
153827281|NCT01315249|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153827282|NCT01315249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153827283|NCT01315249|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153827284|NCT01315249|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
153827285|NCT01315249|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
153827287|NCT01315249|Glucocorticoids|glucocorticoids|mesh-ancestor
153827288|NCT01315249|Hormones|hormones|mesh-ancestor
153827289|NCT01315249|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153827290|NCT01315249|Sympathomimetics|sympathomimetics|mesh-ancestor
153827291|NCT04207411|Lidocaine|lidocaine|mesh-list
153827292|NCT04207411|Bupivacaine|bupivacaine|mesh-list
153827293|NCT04207411|Anesthetics, Local|anesthetics, local|mesh-ancestor
153827294|NCT04207411|Anesthetics|anesthetics|mesh-ancestor
153827295|NCT04207411|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153827296|NCT04207411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153827297|NCT04207411|Sensory System Agents|sensory system agents|mesh-ancestor
153827298|NCT04207411|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153367297|NCT00995072|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
153367298|NCT00995072|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153367299|NCT01031420|Doxorubicin|doxorubicin|mesh-list
153367300|NCT01031420|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
153367301|NCT01031420|Methotrexate|methotrexate|mesh-list
153367302|NCT01031420|Vinblastine|vinblastine|mesh-list
153367303|NCT01031420|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153367304|NCT01031420|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153367305|NCT01031420|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153367306|NCT01031420|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153367307|NCT01031420|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153367308|NCT01031420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153367309|NCT01031420|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
153367310|NCT01031420|Abortifacient Agents|abortifacient agents|mesh-ancestor
153367311|NCT01031420|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153367312|NCT01031420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153367313|NCT01031420|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153367314|NCT01031420|Antimetabolites|antimetabolites|mesh-ancestor
153367315|NCT01031420|Dermatologic Agents|dermatologic agents|mesh-ancestor
153367316|NCT01031420|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153367317|NCT01031420|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153367318|NCT01031420|Immunologic Factors|immunologic factors|mesh-ancestor
153367319|NCT01031420|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153367322|NCT01031420|Tubulin Modulators|tubulin modulators|mesh-ancestor
153367323|NCT01031420|Antimitotic Agents|antimitotic agents|mesh-ancestor
153367324|NCT01031420|Mitosis Modulators|mitosis modulators|mesh-ancestor
153367325|NCT01031498|Ondansetron|ondansetron|mesh-list
153367326|NCT01031498|Palonosetron|palonosetron|mesh-list
153367327|NCT01031498|Antiemetics|antiemetics|mesh-ancestor
153367328|NCT01031498|Autonomic Agents|autonomic agents|mesh-ancestor
153367329|NCT01031498|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153461734|NCT03193866|Antiviral Agents|antiviral agents|mesh-ancestor
153827309|NCT00473486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153827310|NCT00473486|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153827311|NCT00473486|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153827312|NCT00473486|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153827314|NCT05644483|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153827315|NCT05644483|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153827316|NCT05644483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153827317|NCT05644483|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153827318|NCT05644483|Anesthetics, General|anesthetics, general|mesh-ancestor
153827319|NCT05644483|Anesthetics|anesthetics|mesh-ancestor
153827320|NCT01248819|Ropivacaine|ropivacaine|mesh-list
153827321|NCT01248819|Anesthetics, Local|anesthetics, local|mesh-ancestor
153827322|NCT01248819|Anesthetics|anesthetics|mesh-ancestor
153827323|NCT01248819|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153827324|NCT01248819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153367347|NCT01031810|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153367348|NCT01031810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153367349|NCT00998426|Immunoglobulins|immunoglobulins|mesh-list
153367350|NCT00998426|Antibodies|antibodies|mesh-list
153367351|NCT00998426|gamma-Globulins|gamma-globulins|mesh-list
153367352|NCT00998426|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
153367353|NCT00998426|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
153367354|NCT00998426|Immunoglobulin G|immunoglobulin g|mesh-list
153367355|NCT00998426|Immunologic Factors|immunologic factors|mesh-ancestor
153367356|NCT00998426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153367357|NCT00998582|Tenofovir|tenofovir|mesh-list
153367358|NCT00998582|Antiviral Agents|antiviral agents|mesh-ancestor
153367359|NCT00998582|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153827342|NCT01248858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153827344|NCT01313728|Tretinoin|tretinoin|mesh-list
153827345|NCT01313728|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153827346|NCT01313728|Keratolytic Agents|keratolytic agents|mesh-ancestor
153827347|NCT01313728|Dermatologic Agents|dermatologic agents|mesh-ancestor
153827348|NCT01313728|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153827349|NCT01313728|Antimalarials|antimalarials|mesh-ancestor
153827350|NCT01313728|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153827351|NCT01313728|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153827352|NCT01313728|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153827353|NCT01313728|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153827354|NCT01313728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153827355|NCT01313728|Leprostatic Agents|leprostatic agents|mesh-ancestor
153827356|NCT01313728|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153827357|NCT00481364|Atorvastatin|atorvastatin|mesh-list
153827358|NCT00481364|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153827359|NCT00481364|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153827360|NCT00481364|Antimetabolites|antimetabolites|mesh-ancestor
153827361|NCT00481364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153827362|NCT00481364|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153827363|NCT00481364|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
153827372|NCT00481442|Sympathomimetics|sympathomimetics|mesh-ancestor
153827373|NCT00481442|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
153827374|NCT00481442|Nasal Decongestants|nasal decongestants|mesh-ancestor
153367364|NCT00998582|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153367365|NCT00998582|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153367366|NCT02168660|Vitamin D|vitamin d|mesh-list
153367367|NCT02168660|Cholecalciferol|cholecalciferol|mesh-list
153367368|NCT02168660|Vitamins|vitamins|mesh-ancestor
153367369|NCT02168660|Micronutrients|micronutrients|mesh-ancestor
153367370|NCT02168660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153367371|NCT02168660|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153367372|NCT02168660|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153367373|NCT01003106|Ranibizumab|ranibizumab|mesh-list
153367374|NCT01003106|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153367375|NCT01003106|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153367376|NCT01003106|Growth Substances|growth substances|mesh-ancestor
153367377|NCT01003106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153367378|NCT01003106|Growth Inhibitors|growth inhibitors|mesh-ancestor
153367379|NCT01003106|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153367380|NCT01003418|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
153367381|NCT01003418|Immunologic Factors|immunologic factors|mesh-ancestor
153367382|NCT01003418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153367383|NCT01004042|Botulinum Toxins|botulinum toxins|mesh-list
153367384|NCT01004042|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
153367385|NCT01004042|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
153367386|NCT01004042|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
153367387|NCT01004042|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153367388|NCT01004042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153827375|NCT00481442|Respiratory System Agents|respiratory system agents|mesh-ancestor
153827383|NCT04697537|Dexmedetomidine|dexmedetomidine|mesh-list
153827384|NCT04697537|Ropivacaine|ropivacaine|mesh-list
153827385|NCT04697537|Anesthetics|anesthetics|mesh-ancestor
153827386|NCT04697537|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153827387|NCT04697537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153827388|NCT04697537|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153827389|NCT04697537|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153827390|NCT04697537|Analgesics|analgesics|mesh-ancestor
153827391|NCT04697537|Sensory System Agents|sensory system agents|mesh-ancestor
153827392|NCT04697537|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153827393|NCT04697537|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
153827394|NCT04697537|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153827395|NCT04697537|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153827396|NCT04697537|Adrenergic Agents|adrenergic agents|mesh-ancestor
153827397|NCT04697537|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153827398|NCT04697537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153827399|NCT04697537|Anesthetics, Local|anesthetics, local|mesh-ancestor
153827400|NCT00481481|Tacrolimus|tacrolimus|mesh-list
153827401|NCT00481481|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153827402|NCT00481481|Immunologic Factors|immunologic factors|mesh-ancestor
153827403|NCT00481481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153827404|NCT00481481|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
153827405|NCT00481481|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153827406|NCT00481481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153827408|NCT04516317|Quinine|quinine|mesh-list
153827409|NCT04516317|Antimalarials|antimalarials|mesh-ancestor
153827410|NCT04516317|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153827411|NCT04516317|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153827412|NCT04516317|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153827413|NCT04516317|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153827414|NCT04516317|Antiviral Agents|antiviral agents|mesh-ancestor
153827415|NCT04516317|Schistosomicides|schistosomicides|mesh-ancestor
153827416|NCT04516317|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
153827417|NCT04516317|Anthelmintics|anthelmintics|mesh-ancestor
153827418|NCT04516317|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
153827419|NCT04516317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153827420|NCT04516317|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
153827421|NCT04516317|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153827422|NCT04516317|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153827423|NCT04516317|Analgesics|analgesics|mesh-ancestor
153367413|NCT02417064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153367414|NCT02417064|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153367415|NCT02417064|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
153367416|NCT02417064|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153367417|NCT02417064|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
153367418|NCT02417064|Analgesics|analgesics|mesh-ancestor
153367419|NCT02417064|Sensory System Agents|sensory system agents|mesh-ancestor
153367420|NCT02417064|Dopamine Agents|dopamine agents|mesh-ancestor
153367421|NCT01004744|Anastrozole|anastrozole|mesh-list
153367422|NCT01004744|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153367423|NCT01004744|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153367424|NCT01004744|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
153367425|NCT01004744|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153367426|NCT01004744|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153367428|NCT01004744|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
153367436|NCT01005290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153367437|NCT01005290|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153367438|NCT05592860|Insulin|insulin|mesh-list
153367439|NCT05592860|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153367440|NCT05592860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153367441|NCT01051778|Aspirin|aspirin|mesh-list
153367442|NCT01051778|Heparin|heparin|mesh-list
153367443|NCT01051778|Enoxaparin|enoxaparin|mesh-list
153367444|NCT01051778|Calcium heparin|calcium heparin|mesh-list
153367445|NCT01051778|Calcium|calcium|mesh-list
153367446|NCT01051778|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153367447|NCT01051778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153827424|NCT04516317|Sensory System Agents|sensory system agents|mesh-ancestor
153827425|NCT02891083|Paclitaxel|paclitaxel|mesh-list
153827426|NCT02891083|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
153827427|NCT02891083|Cisplatin|cisplatin|mesh-list
153827428|NCT02891083|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153827429|NCT02891083|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153827430|NCT02891083|Tubulin Modulators|tubulin modulators|mesh-ancestor
153827431|NCT02891083|Antimitotic Agents|antimitotic agents|mesh-ancestor
153827432|NCT02891083|Mitosis Modulators|mitosis modulators|mesh-ancestor
153827433|NCT02891083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153827434|NCT02891005|Paclitaxel|paclitaxel|mesh-list
153827435|NCT02891005|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153827436|NCT02891005|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153827437|NCT02891005|Tubulin Modulators|tubulin modulators|mesh-ancestor
153827438|NCT02891005|Antimitotic Agents|antimitotic agents|mesh-ancestor
153827439|NCT02891005|Mitosis Modulators|mitosis modulators|mesh-ancestor
153827440|NCT02891005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153827442|NCT00504816|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
153827452|NCT00480116|Vaccines|vaccines|mesh-list
153827453|NCT00480116|Immunologic Factors|immunologic factors|mesh-ancestor
153827454|NCT00480116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153827455|NCT00504855|Calpastatin|calpastatin|mesh-list
153827456|NCT00504855|Cysteine Proteinase Inhibitors|cysteine proteinase inhibitors|mesh-ancestor
153827457|NCT00504855|Protease Inhibitors|protease inhibitors|mesh-ancestor
153827458|NCT00504855|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153827459|NCT00504855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153367449|NCT01051778|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153367450|NCT01051778|Analgesics|analgesics|mesh-ancestor
153367451|NCT01051778|Sensory System Agents|sensory system agents|mesh-ancestor
153367452|NCT01051778|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153367453|NCT01051778|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153367454|NCT01051778|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153367455|NCT01051778|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153367456|NCT01051778|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153367457|NCT01051778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153367458|NCT01051778|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153367459|NCT01051778|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153367460|NCT01051778|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153367461|NCT01051778|Antipyretics|antipyretics|mesh-ancestor
153367462|NCT01051778|Anticoagulants|anticoagulants|mesh-ancestor
153367463|NCT02169440|Opicapone|opicapone|mesh-list
153367474|NCT03015350|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
153367476|NCT03015350|Anesthetics|anesthetics|mesh-ancestor
153827460|NCT00504933|Cetirizine|cetirizine|mesh-list
153827461|NCT00504933|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
153827462|NCT00504933|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
153827463|NCT00504933|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
153827464|NCT00504933|Histamine Antagonists|histamine antagonists|mesh-ancestor
153827465|NCT00504933|Histamine Agents|histamine agents|mesh-ancestor
153827466|NCT00504933|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153827467|NCT00504933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153827468|NCT00504933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153827469|NCT01313299|Botulinum Toxins|botulinum toxins|mesh-list
153827470|NCT01313299|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
153827471|NCT01313299|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
153827472|NCT01313299|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
153827473|NCT01313299|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153827474|NCT01313299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153827475|NCT01313299|Cholinergic Agents|cholinergic agents|mesh-ancestor
153827476|NCT01313299|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153827477|NCT01313299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153827478|NCT01313299|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
153827480|NCT01313221|Etanercept|etanercept|mesh-list
153827490|NCT01313221|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153367481|NCT01054742|Antimetabolites|antimetabolites|mesh-ancestor
153367482|NCT01054742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153367483|NCT01054742|Antiviral Agents|antiviral agents|mesh-ancestor
153367484|NCT01054742|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153367486|NCT04171466|Ciprofloxacin|ciprofloxacin|mesh-list
153367487|NCT04171466|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153367488|NCT04171466|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153367489|NCT04171466|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153367490|NCT04171466|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153367491|NCT04171466|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153891148|NCT01263444|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153891149|NCT01263444|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153891150|NCT01263444|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
153891151|NCT01263444|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
153432158|NCT05200988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153891152|NCT01263444|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
153891153|NCT01263444|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153891154|NCT01031836|Sifalimumab|sifalimumab|mesh-list
153891155|NCT01031836|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
153891156|NCT01031836|Immunologic Factors|immunologic factors|mesh-ancestor
153367492|NCT04171466|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153367493|NCT04171466|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153367494|NCT04171466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153367495|NCT04171466|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153367496|NCT04171466|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
153367497|NCT04171466|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153367498|NCT02170376|Levodopa|levodopa|mesh-list
153367499|NCT02170376|Carbidopa|carbidopa|mesh-list
153367500|NCT02170376|Opicapone|opicapone|mesh-list
153367501|NCT02170376|Entacapone|entacapone|mesh-list
153367502|NCT02170376|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
153367503|NCT02170376|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
153367504|NCT02170376|Dopamine Agents|dopamine agents|mesh-ancestor
153827492|NCT01313182|Povidone-Iodine|povidone-iodine|mesh-list
153827493|NCT01313182|Anti-Infective Agents, Local|anti-infective agents, local|mesh-list
153827494|NCT01313182|Mupirocin|mupirocin|mesh-list
153827495|NCT01313182|Povidone|povidone|mesh-list
153827496|NCT01313182|Calcium|calcium|mesh-list
153827497|NCT01313182|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153827498|NCT01313182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153827499|NCT01313182|Plasma Substitutes|plasma substitutes|mesh-ancestor
153827500|NCT01313182|Blood Substitutes|blood substitutes|mesh-ancestor
153827501|NCT01313182|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153827502|NCT01313182|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153827503|NCT01313182|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
153827504|NCT01313182|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153827505|NCT01313182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153827506|NCT00480194|Xylometazoline|xylometazoline|mesh-list
153827507|NCT00480194|Bromides|bromides|mesh-list
153827508|NCT00480194|Ipratropium|ipratropium|mesh-list
153827509|NCT00480194|Anticonvulsants|anticonvulsants|mesh-ancestor
153827510|NCT00480194|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153827511|NCT00480194|Autonomic Agents|autonomic agents|mesh-ancestor
153827512|NCT00480194|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153827513|NCT00480194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153827514|NCT00480194|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153827515|NCT00480194|Respiratory System Agents|respiratory system agents|mesh-ancestor
153827516|NCT00480194|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
153827517|NCT00480194|Cholinergic Agents|cholinergic agents|mesh-ancestor
153827518|NCT00480194|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153827519|NCT00480194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153827520|NCT00480194|Nasal Decongestants|nasal decongestants|mesh-ancestor
153367512|NCT02170532|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153367513|NCT02170532|Autonomic Agents|autonomic agents|mesh-ancestor
153367515|NCT02170532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153367516|NCT02170532|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153367517|NCT02170532|Respiratory System Agents|respiratory system agents|mesh-ancestor
153367518|NCT02170532|Tocolytic Agents|tocolytic agents|mesh-ancestor
153367519|NCT02170532|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153367520|NCT02170532|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
153367521|NCT02170532|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
153367522|NCT02170532|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153367523|NCT02170532|Adrenergic Agents|adrenergic agents|mesh-ancestor
153367524|NCT02170532|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153367525|NCT02170532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153367526|NCT04079582|Dialysis Solutions|dialysis solutions|mesh-list
153367527|NCT04079582|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
153367528|NCT02175212|Ascorbic Acid|ascorbic acid|mesh-list
153827529|NCT00505167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153827530|NCT00505167|Cholinergic Agents|cholinergic agents|mesh-ancestor
153827531|NCT00505167|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153827532|NCT00505167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153827533|NCT00505167|Nootropic Agents|nootropic agents|mesh-ancestor
153827534|NCT00505167|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
153827535|NCT00505167|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
153827536|NCT00505167|Dopamine Agents|dopamine agents|mesh-ancestor
153827537|NCT00505167|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
153827538|NCT00505167|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
153367529|NCT02175212|Methyltestosterone|methyltestosterone|mesh-list
153367530|NCT02175212|Androgens|androgens|mesh-list
153367531|NCT02175212|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
153367532|NCT02175212|Hormones|hormones|mesh-ancestor
153367533|NCT02175212|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153367534|NCT02175212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153367535|NCT02175212|Antioxidants|antioxidants|mesh-ancestor
153367536|NCT02175212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153367537|NCT02175212|Protective Agents|protective agents|mesh-ancestor
153367538|NCT02175212|Vitamins|vitamins|mesh-ancestor
153367539|NCT02175212|Micronutrients|micronutrients|mesh-ancestor
153367540|NCT02175212|Estrogens|estrogens|mesh-ancestor
153367541|NCT02175212|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153367542|NCT02175212|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153367543|NCT02175212|Anabolic Agents|anabolic agents|mesh-ancestor
153367544|NCT03014882|Acetylcysteine|acetylcysteine|mesh-list
153367545|NCT03014882|N-monoacetylcystine|n-monoacetylcystine|mesh-list
153367546|NCT03014882|Antiviral Agents|antiviral agents|mesh-ancestor
153367547|NCT03014882|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153367548|NCT03014882|Expectorants|expectorants|mesh-ancestor
153367549|NCT03014882|Respiratory System Agents|respiratory system agents|mesh-ancestor
153367550|NCT03014882|Free Radical Scavengers|free radical scavengers|mesh-ancestor
153367551|NCT03014882|Antioxidants|antioxidants|mesh-ancestor
153367552|NCT03014882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153827554|NCT00480389|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153827556|NCT00480389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153827557|NCT00482027|Vaccines|vaccines|mesh-list
153827558|NCT00482027|Immunologic Factors|immunologic factors|mesh-ancestor
153827559|NCT00482027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153827560|NCT00482066|Abatacept|abatacept|mesh-list
153827561|NCT00482066|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153827562|NCT00482066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153827563|NCT00482066|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153827564|NCT00482066|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153827565|NCT00482066|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153827566|NCT00482066|Immunologic Factors|immunologic factors|mesh-ancestor
153827567|NCT00482066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153827568|NCT00482066|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153827569|NCT00482183|Pioglitazone|pioglitazone|mesh-list
153827570|NCT00482183|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153827571|NCT00482183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153827572|NCT01312909|Varenicline|varenicline|mesh-list
153827573|NCT01312909|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
153827574|NCT01312909|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
153827575|NCT01312909|Cholinergic Agents|cholinergic agents|mesh-ancestor
153827576|NCT01312909|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153827577|NCT01312909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153827578|NCT01312909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153367569|NCT01061528|Cholinergic Agents|cholinergic agents|mesh-ancestor
153367570|NCT01061528|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153367571|NCT01061528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153367573|NCT01062230|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153367574|NCT01064882|Bimatoprost|bimatoprost|mesh-list
153367575|NCT01064882|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
153367576|NCT01064882|Ophthalmic Solutions|ophthalmic solutions|mesh-list
153367577|NCT01064882|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153367578|NCT01065506|Nicotine|nicotine|mesh-list
153367579|NCT01065506|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
153367580|NCT01065506|Autonomic Agents|autonomic agents|mesh-ancestor
153367581|NCT01065506|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153367582|NCT01065506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153367583|NCT01065506|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
153367584|NCT01065506|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
153367585|NCT01065506|Cholinergic Agents|cholinergic agents|mesh-ancestor
153367586|NCT01065506|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153367587|NCT01065506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153367588|NCT03817736|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
153367589|NCT03817736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153367590|NCT03817736|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153367591|NCT03817736|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153367592|NCT01066364|Colesevelam Hydrochloride|colesevelam hydrochloride|mesh-list
153367593|NCT01066364|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153367594|NCT01066364|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153367595|NCT01066364|Antimetabolites|antimetabolites|mesh-ancestor
153367596|NCT01066364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153367597|NCT01066364|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153367598|NCT01066520|Diclofenac|diclofenac|mesh-list
153367599|NCT01066520|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153367600|NCT01066520|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153367601|NCT01066520|Analgesics|analgesics|mesh-ancestor
153367602|NCT01066520|Sensory System Agents|sensory system agents|mesh-ancestor
153827588|NCT00482222|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153827590|NCT00482222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153827591|NCT00482222|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153827612|NCT04518852|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153827613|NCT04518852|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153827614|NCT04518852|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153367603|NCT01066520|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153367604|NCT01066520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153367606|NCT01066520|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153367607|NCT01066520|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153367608|NCT01066520|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153367609|NCT01066520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153367611|NCT03014804|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153367612|NCT03014804|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153367613|NCT03014804|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153367614|NCT03014804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153367615|NCT05224388|Heparin|heparin|mesh-list
153367616|NCT05224388|Enoxaparin|enoxaparin|mesh-list
153367617|NCT05224388|Anticoagulants|anticoagulants|mesh-ancestor
153367618|NCT05224388|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153367619|NCT05224388|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153367620|NCT05224388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153367621|NCT02416908|Cytarabine|cytarabine|mesh-list
153367622|NCT02416908|Plerixafor|plerixafor|mesh-list
153367623|NCT02416908|2'-deoxyadenosine|2'-deoxyadenosine|mesh-list
153367624|NCT02416908|Cladribine|cladribine|mesh-list
153367625|NCT02416908|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153367626|NCT02416908|Antimetabolites|antimetabolites|mesh-ancestor
153367627|NCT02416908|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153367628|NCT02416908|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153367629|NCT02416908|Antiviral Agents|antiviral agents|mesh-ancestor
153367630|NCT02416908|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153367631|NCT02416908|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153367632|NCT02416908|Immunologic Factors|immunologic factors|mesh-ancestor
153367633|NCT02416908|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153827631|NCT00482261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153827633|NCT00482261|Glucocorticoids|glucocorticoids|mesh-ancestor
153827634|NCT00482261|Hormones|hormones|mesh-ancestor
153827635|NCT00482261|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153827636|NCT00482261|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153367640|NCT01070810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153367641|NCT01071044|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
153367642|NCT01071044|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
153367643|NCT01071044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153827659|NCT04518618|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153827660|NCT04518618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153827662|NCT04518618|Sensory System Agents|sensory system agents|mesh-ancestor
153827663|NCT04518618|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153827664|NCT04518618|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153827665|NCT04518618|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153827666|NCT04518618|Anesthetics, General|anesthetics, general|mesh-ancestor
153827667|NCT04518618|Anesthetics|anesthetics|mesh-ancestor
153827668|NCT04518618|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
153827669|NCT00480584|Gemcitabine|gemcitabine|mesh-list
153827670|NCT00480584|Capecitabine|capecitabine|mesh-list
153827671|NCT00480584|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
153827672|NCT00480584|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153827673|NCT00480584|Antimetabolites|antimetabolites|mesh-ancestor
153367661|NCT05150756|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153367662|NCT05150756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153367663|NCT05150756|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153367664|NCT05150756|Narcotics|narcotics|mesh-ancestor
153367675|NCT05135858|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153367676|NCT05135858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153367677|NCT05135858|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153367679|NCT05135858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153367680|NCT05135858|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153367681|NCT05135858|Dermatologic Agents|dermatologic agents|mesh-ancestor
153367682|NCT05135858|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153367683|NCT05135858|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153367684|NCT05135858|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153367685|NCT05135858|Immunologic Factors|immunologic factors|mesh-ancestor
153367686|NCT05135858|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153367687|NCT05135858|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153367688|NCT03005444|Enoxaparin|enoxaparin|mesh-list
153367689|NCT03005444|Nadroparin|nadroparin|mesh-list
153367690|NCT03005444|Rivaroxaban|rivaroxaban|mesh-list
153367691|NCT03005444|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
153367700|NCT01076270|Plerixafor|plerixafor|mesh-list
153827674|NCT00480584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153827675|NCT00480584|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153827676|NCT00480584|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153827677|NCT00480584|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153827678|NCT00480584|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153827679|NCT01311505|Rifampin|rifampin|mesh-list
153827680|NCT01311505|Isoniazid|isoniazid|mesh-list
153827681|NCT01311505|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
153827682|NCT01311505|Antitubercular Agents|antitubercular agents|mesh-ancestor
153827683|NCT01311505|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153827684|NCT01311505|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153827685|NCT01311505|Leprostatic Agents|leprostatic agents|mesh-ancestor
153827686|NCT01311505|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153827687|NCT01311505|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153827688|NCT01311505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153827689|NCT01311505|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
153827690|NCT01311505|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
153827691|NCT01311505|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
153827692|NCT01311505|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
153367719|NCT01076972|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
153367720|NCT01076972|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153367721|NCT02174432|Nalbuphine|nalbuphine|mesh-list
153367722|NCT02174432|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153367723|NCT02174432|Narcotics|narcotics|mesh-ancestor
153367724|NCT02174432|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153367725|NCT02174432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153367726|NCT02174432|Analgesics|analgesics|mesh-ancestor
153827740|NCT04518189|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
153827741|NCT04518189|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153827742|NCT04518189|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153827743|NCT04518189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153827745|NCT00482378|Pamidronate|pamidronate|mesh-list
153827746|NCT00482378|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153827747|NCT00482378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153827748|NCT00482456|Nitrous Oxide|nitrous oxide|mesh-list
153827749|NCT00482456|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
153827750|NCT00482456|Anesthetics, General|anesthetics, general|mesh-ancestor
153827751|NCT00482456|Anesthetics|anesthetics|mesh-ancestor
153827752|NCT00482456|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153827753|NCT00482456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153827754|NCT00482456|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153827755|NCT00482456|Analgesics|analgesics|mesh-ancestor
153827756|NCT00482456|Sensory System Agents|sensory system agents|mesh-ancestor
153827757|NCT00482456|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153367748|NCT01077596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153367765|NCT02414958|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153367767|NCT02414958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153367768|NCT03016208|Misoprostol|misoprostol|mesh-list
153367769|NCT03016208|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
153367770|NCT03016208|Abortifacient Agents|abortifacient agents|mesh-ancestor
153367771|NCT03016208|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153367772|NCT03016208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153367773|NCT03016208|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
153367774|NCT03016208|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153367775|NCT03016208|Oxytocics|oxytocics|mesh-ancestor
153367776|NCT03013790|Melatonin|melatonin|mesh-list
153827758|NCT00480896|Tacrolimus|tacrolimus|mesh-list
153827759|NCT00480896|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153827760|NCT00480896|Immunologic Factors|immunologic factors|mesh-ancestor
153827761|NCT00480896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153827762|NCT00480896|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
153827763|NCT00480896|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153827764|NCT00480896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153827765|NCT01309828|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
153827775|NCT01309828|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153827776|NCT01309828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153827777|NCT01309828|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
153827778|NCT01309828|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
153827779|NCT00482495|Bevacizumab|bevacizumab|mesh-list
153827780|NCT00482495|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153827781|NCT00482495|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153827782|NCT00482495|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153827783|NCT00482495|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153827784|NCT00482495|Growth Substances|growth substances|mesh-ancestor
153827785|NCT00482495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153827786|NCT00482495|Growth Inhibitors|growth inhibitors|mesh-ancestor
153827787|NCT00480935|Sunitinib|sunitinib|mesh-list
153827788|NCT00480935|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153827789|NCT00480935|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153827790|NCT00480935|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153827791|NCT00480935|Growth Substances|growth substances|mesh-ancestor
153827792|NCT00480935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153827793|NCT00480935|Growth Inhibitors|growth inhibitors|mesh-ancestor
153827794|NCT00480935|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153827795|NCT00480935|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153827810|NCT00482573|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153827811|NCT00482573|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153827812|NCT00482573|Respiratory System Agents|respiratory system agents|mesh-ancestor
153827813|NCT00482573|Mydriatics|mydriatics|mesh-ancestor
153827816|NCT00482976|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153827817|NCT00482976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153827818|NCT00481013|Valproic Acid|valproic acid|mesh-list
153827819|NCT00481013|Anticonvulsants|anticonvulsants|mesh-ancestor
153827820|NCT00481013|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153827821|NCT00481013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153367813|NCT01082588|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153367814|NCT01082588|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153367815|NCT01082588|Antimetabolites|antimetabolites|mesh-ancestor
153367816|NCT01082588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153367817|NCT01082588|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153367818|NCT01082588|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
153367819|NCT01082588|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153367820|NCT02413398|Dapagliflozin|dapagliflozin|mesh-list
153367821|NCT02413398|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
153367822|NCT02413398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153367823|NCT02413398|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153367824|NCT02413398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153367825|NCT02441946|Anastrozole|anastrozole|mesh-list
153367828|NCT02441946|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153367829|NCT02441946|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153367830|NCT02441946|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
153827822|NCT00481013|GABA Agents|gaba agents|mesh-ancestor
153827823|NCT00481013|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153827824|NCT00481013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153827825|NCT00481013|Antimanic Agents|antimanic agents|mesh-ancestor
153827826|NCT00481013|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153827834|NCT01309243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153827835|NCT01309243|Antiviral Agents|antiviral agents|mesh-ancestor
153827836|NCT01309243|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153827837|NCT01309243|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153827838|NCT01309243|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153367831|NCT02441946|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153367832|NCT02441946|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153367833|NCT02441946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153367834|NCT02441946|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
153367835|NCT02441946|Hormone Antagonists|hormone antagonists|mesh-ancestor
153367836|NCT02441946|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153367837|NCT02441946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153367838|NCT02441946|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153367840|NCT01083368|Bevacizumab|bevacizumab|mesh-list
153367841|NCT01083368|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
153367842|NCT01083368|Temsirolimus|temsirolimus|mesh-list
153367843|NCT01083368|MTOR Inhibitors|mtor inhibitors|mesh-list
153367844|NCT01083368|Antibodies|antibodies|mesh-list
153367845|NCT01083368|Immunoglobulins|immunoglobulins|mesh-list
153367846|NCT01083368|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
153827839|NCT01240109|Remifentanil|remifentanil|mesh-list
153827840|NCT01240109|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153827841|NCT01240109|Narcotics|narcotics|mesh-ancestor
153827842|NCT01240109|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153827843|NCT01240109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153827844|NCT01240109|Analgesics|analgesics|mesh-ancestor
153827845|NCT01240109|Sensory System Agents|sensory system agents|mesh-ancestor
153827846|NCT01240109|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153827847|NCT04517526|Bevacizumab|bevacizumab|mesh-list
153827848|NCT04517526|Durvalumab|durvalumab|mesh-list
153827849|NCT04517526|Carboplatin|carboplatin|mesh-list
153827850|NCT04517526|Pemetrexed|pemetrexed|mesh-list
153827851|NCT04517526|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153827852|NCT04517526|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153827853|NCT04517526|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153827854|NCT04517526|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153367847|NCT01083368|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153367848|NCT01083368|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153367849|NCT01083368|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153827869|NCT01309204|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153827870|NCT01309204|Adrenergic Agents|adrenergic agents|mesh-ancestor
153827871|NCT01309204|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153827872|NCT01309204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153827873|NCT01309204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153827874|NCT01309204|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
153827875|NCT01309204|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153827876|NCT01240148|Lidocaine|lidocaine|mesh-list
153827877|NCT01240148|Anesthetics, Local|anesthetics, local|mesh-ancestor
153827878|NCT01240148|Anesthetics|anesthetics|mesh-ancestor
153827879|NCT01240148|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153367887|NCT01085786|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153367888|NCT01085786|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153367889|NCT01085786|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153367890|NCT01085786|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
153367891|NCT01085786|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153367892|NCT01085786|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
153367893|NCT01085786|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153367894|NCT01085786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153367895|NCT01085786|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
153367906|NCT02170220|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153367907|NCT02170220|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153367908|NCT02170220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153367910|NCT02170220|Serotonin Agents|serotonin agents|mesh-ancestor
153367911|NCT02170220|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
153367912|NCT02170220|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
153367913|NCT02170220|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
153367914|NCT02170220|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153367915|NCT01036802|Warfarin|warfarin|mesh-list
153367916|NCT01036802|Anticoagulants|anticoagulants|mesh-ancestor
153367917|NCT01037192|Vancomycin|vancomycin|mesh-list
153367918|NCT01037192|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153367919|NCT01037192|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153367920|NCT02386098|Ritonavir|ritonavir|mesh-list
153827924|NCT00483054|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153827925|NCT00483054|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153367921|NCT02386098|Atazanavir Sulfate|atazanavir sulfate|mesh-list
153367923|NCT02386098|Dolutegravir|dolutegravir|mesh-list
153367924|NCT02386098|BMS-955176|bms-955176|mesh-list
153367925|NCT02386098|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
153367926|NCT02386098|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
153367927|NCT02386098|Protease Inhibitors|protease inhibitors|mesh-ancestor
153367928|NCT02386098|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153367929|NCT02386098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153367931|NCT02386098|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153367932|NCT02386098|Antiviral Agents|antiviral agents|mesh-ancestor
153367933|NCT02386098|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153367945|NCT01089062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153367947|NCT01089062|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153367948|NCT01089062|Analgesics|analgesics|mesh-ancestor
153827926|NCT00483054|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153827927|NCT00483054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153827928|NCT00483054|Antiviral Agents|antiviral agents|mesh-ancestor
153827929|NCT00483054|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153827930|NCT00483054|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
153827931|NCT00483054|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153827932|NCT00483054|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
153827933|NCT00483054|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
153827934|NCT00483054|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
153827935|NCT00483054|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
153827936|NCT00483054|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153827937|NCT00483054|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153827938|NCT01240226|Ketoconazole|ketoconazole|mesh-list
153827939|NCT01240226|Antifungal Agents|antifungal agents|mesh-ancestor
153827940|NCT01240226|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153827941|NCT01240226|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
153827942|NCT01240226|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153827943|NCT01240226|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153827944|NCT01240226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153827945|NCT01240226|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153827946|NCT01240226|Hormone Antagonists|hormone antagonists|mesh-ancestor
153827947|NCT01240226|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153827948|NCT01240226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153827949|NCT01240226|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
153367949|NCT01089062|Sensory System Agents|sensory system agents|mesh-ancestor
153367950|NCT01089062|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153367951|NCT02412618|Misoprostol|misoprostol|mesh-list
153367952|NCT02412618|Mifepristone|mifepristone|mesh-list
153367961|NCT02412618|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
153367962|NCT02412618|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
153367963|NCT02412618|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
153367964|NCT02412618|Contraceptive Agents|contraceptive agents|mesh-ancestor
153367965|NCT02412618|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
153367966|NCT02412618|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
153827950|NCT01240824|Aminophylline|aminophylline|mesh-list
153827951|NCT01240824|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153827952|NCT01240824|Autonomic Agents|autonomic agents|mesh-ancestor
153827953|NCT01240824|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153827954|NCT01240824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153827955|NCT01240824|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153827956|NCT01240824|Respiratory System Agents|respiratory system agents|mesh-ancestor
153827957|NCT01240824|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
153827958|NCT01240824|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
153367979|NCT02179892|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153367983|NCT02179892|Hormones|hormones|mesh-ancestor
153367984|NCT02179892|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153367985|NCT02179892|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153367986|NCT02179892|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153367987|NCT02179892|Anesthetics, Local|anesthetics, local|mesh-ancestor
153367988|NCT02179892|Anesthetics|anesthetics|mesh-ancestor
153367989|NCT02179892|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153367990|NCT02179892|Sensory System Agents|sensory system agents|mesh-ancestor
153367991|NCT02179892|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153367992|NCT02179892|Analgesics|analgesics|mesh-ancestor
153367993|NCT02179892|Antipyretics|antipyretics|mesh-ancestor
153367994|NCT01092338|Vitamin D|vitamin d|mesh-list
153367995|NCT01092338|Cholecalciferol|cholecalciferol|mesh-list
153367996|NCT01092338|Vitamins|vitamins|mesh-ancestor
153367997|NCT01092338|Micronutrients|micronutrients|mesh-ancestor
153367998|NCT01092338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153367999|NCT01092338|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153368000|NCT01092338|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153368001|NCT01110434|Topiramate|topiramate|mesh-list
153368002|NCT01110434|Anticonvulsants|anticonvulsants|mesh-ancestor
153368003|NCT01110434|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153368004|NCT01110434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153368005|NCT01042496|Lamotrigine|lamotrigine|mesh-list
153368006|NCT01042496|Anticonvulsants|anticonvulsants|mesh-ancestor
153827980|NCT00482963|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153827981|NCT00482963|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153827982|NCT00482963|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153827983|NCT00482963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153828001|NCT01241019|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153828002|NCT01241019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153368007|NCT01042496|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153368008|NCT01042496|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153368009|NCT01042496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153368010|NCT01042496|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153368011|NCT01042496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153368012|NCT01042496|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153368013|NCT01042496|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153368014|NCT01042496|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153368015|NCT01042496|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153368016|NCT01042496|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153368017|NCT01111058|Everolimus|everolimus|mesh-list
153368018|NCT01111058|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
153368019|NCT01111058|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153368020|NCT01111058|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153368021|NCT01111058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153368022|NCT01111058|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153368023|NCT01111058|Immunologic Factors|immunologic factors|mesh-ancestor
153368024|NCT01111058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153368025|NCT01111058|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153368026|NCT01094522|Morphine|morphine|mesh-list
153368027|NCT01094522|Methadone|methadone|mesh-list
153368029|NCT01094522|Narcotics|narcotics|mesh-ancestor
153828004|NCT01240928|Goserelin|goserelin|mesh-list
153828005|NCT01240928|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153828006|NCT01240928|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
153828007|NCT01240928|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153828020|NCT00481169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153828021|NCT00481169|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153828023|NCT00483093|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153828024|NCT00483132|Interferons|interferons|mesh-list
153368030|NCT01094522|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153368031|NCT01094522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153368033|NCT01094522|Sensory System Agents|sensory system agents|mesh-ancestor
153368034|NCT01094522|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153368035|NCT01094522|Antitussive Agents|antitussive agents|mesh-ancestor
153368036|NCT01094522|Respiratory System Agents|respiratory system agents|mesh-ancestor
153368037|NCT02178800|Cabotegravir|cabotegravir|mesh-list
153368038|NCT02178800|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
153368039|NCT02178800|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
153368040|NCT02178800|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153368041|NCT02178800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153368042|NCT02178800|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153368043|NCT02178800|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153368044|NCT02178800|Antiviral Agents|antiviral agents|mesh-ancestor
153368045|NCT02178800|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153368046|NCT01044212|Psyllium|psyllium|mesh-list
153368047|NCT01044212|Bismuth subsalicylate|bismuth subsalicylate|mesh-list
153368048|NCT01044212|Cathartics|cathartics|mesh-ancestor
153368049|NCT01044212|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153368050|NCT01044212|Antidiarrheals|antidiarrheals|mesh-ancestor
153368051|NCT02174510|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
153439806|NCT00002833|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153439807|NCT00002833|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
153439808|NCT00002833|Protective Agents|protective agents|mesh-ancestor
153439809|NCT00002833|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153439810|NCT00002833|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153439811|NCT00002833|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153439812|NCT00002833|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153439814|NCT00003061|Methotrexate|methotrexate|mesh-list
153898499|NCT00605605|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153898500|NCT00605605|Analgesics|analgesics|mesh-ancestor
153898501|NCT00605605|Sensory System Agents|sensory system agents|mesh-ancestor
153898502|NCT00605605|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153898503|NCT04267237|Atezolizumab|atezolizumab|mesh-list
153898504|NCT04267237|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153898505|NCT04267237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153898506|NCT04267237|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153468248|NCT06299462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153468249|NCT06299462|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153468250|NCT06299462|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153468252|NCT06299371|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
153468253|NCT06299371|Carboplatin|carboplatin|mesh-list
153468254|NCT06299371|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153468255|NCT06299371|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153468256|NCT06299371|Tubulin Modulators|tubulin modulators|mesh-ancestor
153919493|NCT01273610|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153919494|NCT01273610|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153919495|NCT01273610|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153919496|NCT01273610|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153919497|NCT01273610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153919498|NCT00999804|Trastuzumab|trastuzumab|mesh-list
153919499|NCT00999804|Letrozole|letrozole|mesh-list
153919500|NCT00999804|Lapatinib|lapatinib|mesh-list
153898507|NCT04267237|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153898508|NCT00605995|Simvastatin|simvastatin|mesh-list
153898509|NCT00605995|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153898510|NCT00605995|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153898517|NCT00605683|Pramipexole|pramipexole|mesh-list
153898518|NCT00605683|Ropinirole|ropinirole|mesh-list
153898519|NCT00605683|Bromocriptine|bromocriptine|mesh-list
153898520|NCT00605683|Lisuride|lisuride|mesh-list
153898521|NCT00605683|Apomorphine|apomorphine|mesh-list
153898522|NCT00605683|Pergolide|pergolide|mesh-list
153439864|NCT00002839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153439865|NCT00003583|Etoposide|etoposide|mesh-list
153439866|NCT00003583|Amifostine|amifostine|mesh-list
153439867|NCT00003583|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153439868|NCT00003583|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153439869|NCT00003583|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153439870|NCT00003583|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153439871|NCT00003583|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153439872|NCT00003583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153439888|NCT00003589|Paclitaxel|paclitaxel|mesh-list
153898553|NCT01266824|Anesthetics, Local|anesthetics, local|mesh-ancestor
153898554|NCT01266824|Anesthetics|anesthetics|mesh-ancestor
153898555|NCT01266824|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153898556|NCT01266824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153898557|NCT01266824|Sensory System Agents|sensory system agents|mesh-ancestor
153898558|NCT01266824|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153898559|NCT04253119|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
153898560|NCT04253119|Antiviral Agents|antiviral agents|mesh-ancestor
153898561|NCT04253119|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153898562|NCT01266590|Digoxin|digoxin|mesh-list
153898563|NCT01266590|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153898564|NCT01266590|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
153898595|NCT01263704|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153898596|NCT01263704|Immunologic Factors|immunologic factors|mesh-ancestor
153898597|NCT01263704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153898598|NCT01263704|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153898599|NCT01263704|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153898600|NCT01263704|Alkylating Agents|alkylating agents|mesh-ancestor
153898601|NCT01263704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153439899|NCT00003595|Cyclophosphamide|cyclophosphamide|mesh-list
153439900|NCT00003595|Rituximab|rituximab|mesh-list
153439901|NCT00003595|Doxorubicin|doxorubicin|mesh-list
153439902|NCT00003595|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
153439903|NCT00003595|Vincristine|vincristine|mesh-list
153439904|NCT00003595|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153439905|NCT00003595|Immunologic Factors|immunologic factors|mesh-ancestor
153439906|NCT00003595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153439907|NCT00003595|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153439908|NCT00003595|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153439909|NCT00003595|Alkylating Agents|alkylating agents|mesh-ancestor
153439910|NCT00003595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153439911|NCT00003595|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153439912|NCT00003595|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153439913|NCT00003595|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153439914|NCT00003595|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153439915|NCT00003595|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153439916|NCT00003595|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153439917|NCT00003595|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153439918|NCT00003595|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153439919|NCT00003595|Glucocorticoids|glucocorticoids|mesh-ancestor
153898602|NCT01263704|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153898603|NCT01263704|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153898604|NCT01263704|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153898605|NCT01263470|Alogliptin|alogliptin|mesh-list
153898606|NCT01263470|Voglibose|voglibose|mesh-list
153898607|NCT01263470|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153898608|NCT01263470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153898609|NCT01263470|Incretins|incretins|mesh-ancestor
153898610|NCT01263470|Hormones|hormones|mesh-ancestor
153898618|NCT04322786|Protease Inhibitors|protease inhibitors|mesh-ancestor
153898619|NCT04322786|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153898620|NCT04322786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153898621|NCT04322240|Thioctic Acid|thioctic acid|mesh-list
153898627|NCT04322240|Vitamins|vitamins|mesh-ancestor
153439941|NCT00003079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153439942|NCT00003079|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153439943|NCT00003079|Antiviral Agents|antiviral agents|mesh-ancestor
153439944|NCT00003079|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153439945|NCT00003079|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153439946|NCT00003079|Immunologic Factors|immunologic factors|mesh-ancestor
153439947|NCT00003079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153439948|NCT00003079|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153439949|NCT00002869|Interferons|interferons|mesh-list
153439950|NCT00002869|Cytarabine|cytarabine|mesh-list
153439951|NCT00002869|Interferon-alpha|interferon-alpha|mesh-list
153439952|NCT00002869|Hydroxyurea|hydroxyurea|mesh-list
153439953|NCT00002869|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153439954|NCT00002869|Antiviral Agents|antiviral agents|mesh-ancestor
153898634|NCT01262456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153898635|NCT04321694|Mogamulizumab|mogamulizumab|mesh-list
153898636|NCT04321694|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153898638|NCT04321850|Zinc Sulfate|zinc sulfate|mesh-list
153898639|NCT04321850|Trace Elements|trace elements|mesh-ancestor
153898640|NCT04321850|Micronutrients|micronutrients|mesh-ancestor
153898641|NCT04321850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153898642|NCT04321850|Astringents|astringents|mesh-ancestor
153898643|NCT04321850|Dermatologic Agents|dermatologic agents|mesh-ancestor
153898644|NCT04321616|Hydroxychloroquine|hydroxychloroquine|mesh-list
153898645|NCT04321616|Remdesivir|remdesivir|mesh-list
153898646|NCT04321616|Antimalarials|antimalarials|mesh-ancestor
153898647|NCT04321616|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153898648|NCT04321616|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153898649|NCT04321616|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153898655|NCT00932893|Docetaxel|docetaxel|mesh-list
153898671|NCT04321070|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153898672|NCT04321070|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153898673|NCT04321070|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
153898674|NCT04321070|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153898675|NCT04321070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153898676|NCT02889224|Hydrocortisone|hydrocortisone|mesh-list
153898677|NCT02889224|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153898678|NCT01260896|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
153898679|NCT01260896|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
153898680|NCT01260896|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153898681|NCT01260896|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153898682|NCT01260896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153898683|NCT01260896|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153898684|NCT01260896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153898685|NCT01260896|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
153439984|NCT00003613|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153898686|NCT01260896|Antidepressive Agents|antidepressive agents|mesh-ancestor
153898687|NCT01260896|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153898688|NCT00939523|Lapatinib|lapatinib|mesh-list
153898689|NCT00939523|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153898690|NCT00939523|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153898691|NCT00939523|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153898692|NCT00939523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153898696|NCT01260584|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153898697|NCT01260584|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
153898698|NCT01260584|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
153898699|NCT01260584|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
153898700|NCT01260584|Purinergic Agents|purinergic agents|mesh-ancestor
153898701|NCT01260584|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153440026|NCT00003619|Fludarabine phosphate|fludarabine phosphate|mesh-list
153440028|NCT00003619|Busulfan|busulfan|mesh-list
153440029|NCT00003619|Topotecan|topotecan|mesh-list
153898710|NCT04262635|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153898711|NCT00608101|Dexamethasone|dexamethasone|mesh-list
153898712|NCT00608101|Fludrocortisone|fludrocortisone|mesh-list
153898713|NCT00608101|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153898714|NCT00608101|Antiemetics|antiemetics|mesh-ancestor
153898715|NCT00608101|Autonomic Agents|autonomic agents|mesh-ancestor
153898716|NCT00608101|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153898717|NCT00608101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153898718|NCT00608101|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153898719|NCT00608101|Glucocorticoids|glucocorticoids|mesh-ancestor
153898720|NCT00608101|Hormones|hormones|mesh-ancestor
153898721|NCT00608101|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153898722|NCT00608101|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153898723|NCT00608101|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153898724|NCT04264039|Fludarabine|fludarabine|mesh-list
153898725|NCT04264039|Cyclophosphamide|cyclophosphamide|mesh-list
153898726|NCT04264039|Melphalan|melphalan|mesh-list
153898727|NCT04264039|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153898728|NCT04264039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153898729|NCT04264039|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153898730|NCT04264039|Immunologic Factors|immunologic factors|mesh-ancestor
153898756|NCT05938374|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
153898757|NCT05938374|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153898758|NCT05938374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153898759|NCT05938374|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153898760|NCT05938140|Ritonavir|ritonavir|mesh-list
153898761|NCT05938140|Nirmatrelvir|nirmatrelvir|mesh-list
153898762|NCT05938140|Nirmatrelvir and ritonavir drug combination|nirmatrelvir and ritonavir drug combination|mesh-list
153440065|NCT00002887|Antimitotic Agents|antimitotic agents|mesh-ancestor
153440066|NCT00002887|Mitosis Modulators|mitosis modulators|mesh-ancestor
153440067|NCT00002887|Antisickling Agents|antisickling agents|mesh-ancestor
153440068|NCT00002887|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153440070|NCT00003937|Doxorubicin|doxorubicin|mesh-list
153440071|NCT00003937|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
153440072|NCT00003937|Methotrexate|methotrexate|mesh-list
153440073|NCT00003937|Etoposide|etoposide|mesh-list
153440074|NCT00003937|Ifosfamide|ifosfamide|mesh-list
153440075|NCT00003937|Dexrazoxane|dexrazoxane|mesh-list
153440076|NCT00003937|Razoxane|razoxane|mesh-list
153440077|NCT00003937|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153440078|NCT00003937|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153440079|NCT00003937|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153440080|NCT00003937|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153440081|NCT00003937|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153440082|NCT00003937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153440083|NCT00003937|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
153440084|NCT00003937|Abortifacient Agents|abortifacient agents|mesh-ancestor
153898763|NCT05938140|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
153898764|NCT05938140|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
153898765|NCT05938140|Protease Inhibitors|protease inhibitors|mesh-ancestor
153898766|NCT05938140|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153898767|NCT05938140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153898768|NCT05938140|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153898769|NCT05938140|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153898770|NCT05938140|Antiviral Agents|antiviral agents|mesh-ancestor
153898771|NCT05938140|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153898772|NCT05938140|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
153898773|NCT05938140|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153898774|NCT05937880|Leflunomide|leflunomide|mesh-list
153898775|NCT05937880|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153898781|NCT05937841|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153440116|NCT00003625|Immunologic Factors|immunologic factors|mesh-ancestor
153440117|NCT00003625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153440118|NCT00003625|Antifungal Agents|antifungal agents|mesh-ancestor
153440119|NCT00003625|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153440120|NCT00003625|Dermatologic Agents|dermatologic agents|mesh-ancestor
153440121|NCT00003625|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153440122|NCT00003625|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
153440123|NCT00003637|Fluorouracil|fluorouracil|mesh-list
153440124|NCT00003637|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153440125|NCT00003637|Antimetabolites|antimetabolites|mesh-ancestor
153440126|NCT00003637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153440127|NCT00003637|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153440128|NCT00003637|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153440129|NCT00003637|Immunologic Factors|immunologic factors|mesh-ancestor
153440130|NCT00003637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153440131|NCT00003943|Paclitaxel|paclitaxel|mesh-list
153440132|NCT00003943|Cyclophosphamide|cyclophosphamide|mesh-list
153898792|NCT05937711|Antidepressive Agents|antidepressive agents|mesh-ancestor
153898793|NCT05937711|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153898794|NCT05937711|Dopamine Agents|dopamine agents|mesh-ancestor
153898795|NCT05937568|Imetelstat|imetelstat|mesh-list
153898796|NCT05937568|Motesanib diphosphate|motesanib diphosphate|mesh-list
153898797|NCT05937568|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153898798|NCT05937568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153898799|NCT05937568|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153898800|NCT05937490|Leuprolide|leuprolide|mesh-list
153898801|NCT05937490|Dienogest|dienogest|mesh-list
153898812|NCT05937490|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
153898813|NCT05937490|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
153898814|NCT05937490|Hormone Antagonists|hormone antagonists|mesh-ancestor
153898815|NCT05937490|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153898816|NCT05937438|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
153898817|NCT05937438|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153898818|NCT05937438|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153898819|NCT05937438|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153898820|NCT05937191|Leflunomide|leflunomide|mesh-list
153898821|NCT05937191|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153898822|NCT05937191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153898823|NCT05937191|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153440133|NCT00003943|Carboplatin|carboplatin|mesh-list
153440134|NCT00003943|Topotecan|topotecan|mesh-list
153440135|NCT00003943|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153440136|NCT00003943|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153440137|NCT00003943|Tubulin Modulators|tubulin modulators|mesh-ancestor
153440138|NCT00003943|Antimitotic Agents|antimitotic agents|mesh-ancestor
153440139|NCT00003943|Mitosis Modulators|mitosis modulators|mesh-ancestor
153440140|NCT00003943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153440141|NCT00003943|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153440142|NCT00003943|Immunologic Factors|immunologic factors|mesh-ancestor
153440143|NCT00003943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153440144|NCT00003943|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153440145|NCT00003943|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153440146|NCT00003943|Alkylating Agents|alkylating agents|mesh-ancestor
153440147|NCT00003943|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153440151|NCT00003955|Dactinomycin|dactinomycin|mesh-list
153898825|NCT05937191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153898826|NCT05937126|Anti-Infective Agents|anti-infective agents|mesh-list
153898827|NCT05937126|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
153898828|NCT05937100|Hyaluronic Acid|hyaluronic acid|mesh-list
153898829|NCT05937100|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153898830|NCT05937100|Immunologic Factors|immunologic factors|mesh-ancestor
153898831|NCT05937100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153898832|NCT05937100|Viscosupplements|viscosupplements|mesh-ancestor
153898833|NCT05937100|Protective Agents|protective agents|mesh-ancestor
153440163|NCT00003955|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153440164|NCT00003955|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153440165|NCT00003955|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
153898834|NCT05936853|Anesthetics|anesthetics|mesh-list
153898835|NCT05936853|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153898836|NCT05936853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153898837|NCT05935059|Pregabalin|pregabalin|mesh-list
153898838|NCT05935059|Anticonvulsants|anticonvulsants|mesh-list
153898839|NCT05935059|Tianeptine|tianeptine|mesh-list
153898840|NCT05935059|Antidepressive Agents|antidepressive agents|mesh-list
153898841|NCT05935059|Analgesics|analgesics|mesh-ancestor
153898842|NCT05935059|Sensory System Agents|sensory system agents|mesh-ancestor
153898843|NCT05935059|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153898844|NCT05935059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153898845|NCT05935059|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153898846|NCT05935059|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153898847|NCT05935059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153898848|NCT05935059|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153898849|NCT05935059|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153898850|NCT05935059|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153898851|NCT05935059|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153898852|NCT05935059|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153898853|NCT05935059|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
153898854|NCT05928962|Tremelimumab|tremelimumab|mesh-list
153898855|NCT05928962|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153898856|NCT05910190|Buprenorphine|buprenorphine|mesh-list
153898857|NCT05910190|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153919501|NCT00999804|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153919502|NCT00999804|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153898859|NCT05910190|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153898860|NCT05910190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153898861|NCT05910190|Analgesics|analgesics|mesh-ancestor
153898862|NCT05910190|Sensory System Agents|sensory system agents|mesh-ancestor
153898863|NCT05910190|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153898864|NCT05910190|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
153898865|NCT05898919|Neostigmine|neostigmine|mesh-list
153440176|NCT00003955|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153440177|NCT00003103|Docetaxel|docetaxel|mesh-list
153440178|NCT00003103|Oblimersen|oblimersen|mesh-list
153440179|NCT00003103|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153440180|NCT00003103|Tubulin Modulators|tubulin modulators|mesh-ancestor
153440181|NCT00003103|Antimitotic Agents|antimitotic agents|mesh-ancestor
153440182|NCT00003103|Mitosis Modulators|mitosis modulators|mesh-ancestor
153440183|NCT00003103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153440184|NCT00003109|Irinotecan|irinotecan|mesh-list
153440185|NCT00003109|Raltitrexed|raltitrexed|mesh-list
153440186|NCT00003109|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
153440187|NCT00003109|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153440188|NCT00003109|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153440189|NCT00003109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153440190|NCT00003109|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153440191|NCT00003109|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153440192|NCT00003109|Antimetabolites|antimetabolites|mesh-ancestor
153440193|NCT00003109|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153440194|NCT00003643|Paclitaxel|paclitaxel|mesh-list
153440195|NCT00003643|Etoposide|etoposide|mesh-list
153440196|NCT00003643|Bleomycin|bleomycin|mesh-list
153440197|NCT00003643|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153440198|NCT00003643|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153440199|NCT00003643|Tubulin Modulators|tubulin modulators|mesh-ancestor
153440200|NCT00003643|Antimitotic Agents|antimitotic agents|mesh-ancestor
153919509|NCT00999804|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153919510|NCT00999804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153919511|NCT00999804|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153919512|NCT00999804|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153919513|NCT00130221|Chlorhexidine|chlorhexidine|mesh-list
153919514|NCT00130221|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
153919515|NCT00130221|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
153919516|NCT00130221|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153919517|NCT00130221|Disinfectants|disinfectants|mesh-ancestor
153919518|NCT00130221|Dermatologic Agents|dermatologic agents|mesh-ancestor
153440201|NCT00003643|Mitosis Modulators|mitosis modulators|mesh-ancestor
153440202|NCT00003643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153440203|NCT00003643|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153440204|NCT00003643|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153440205|NCT00003643|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153440206|NCT00003643|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153898866|NCT05898919|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
153898867|NCT05898919|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153898868|NCT05898919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153898869|NCT05898919|Cholinergic Agents|cholinergic agents|mesh-ancestor
153898870|NCT05898919|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153898871|NCT05898919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153898872|NCT05898919|Parasympathomimetics|parasympathomimetics|mesh-ancestor
153898873|NCT05898919|Autonomic Agents|autonomic agents|mesh-ancestor
153898874|NCT05898919|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153898875|NCT05881291|Alfentanil|alfentanil|mesh-list
153898876|NCT05881291|Propofol|propofol|mesh-list
153898877|NCT05881291|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153898878|NCT05881291|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153898879|NCT05881291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153440207|NCT00003961|Sargramostim|sargramostim|mesh-list
153898880|NCT05881291|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153898881|NCT05881291|Anesthetics, General|anesthetics, general|mesh-ancestor
153898882|NCT05881291|Anesthetics|anesthetics|mesh-ancestor
153898883|NCT05881291|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153898884|NCT05881291|Narcotics|narcotics|mesh-ancestor
153898885|NCT05881291|Analgesics|analgesics|mesh-ancestor
153898886|NCT05881291|Sensory System Agents|sensory system agents|mesh-ancestor
153919520|NCT00077129|Carboplatin|carboplatin|mesh-list
153919521|NCT00077129|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153919522|NCT00077129|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153919523|NCT00077129|Tubulin Modulators|tubulin modulators|mesh-ancestor
153919524|NCT00077129|Antimitotic Agents|antimitotic agents|mesh-ancestor
153919525|NCT00077129|Mitosis Modulators|mitosis modulators|mesh-ancestor
153919526|NCT00077129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153919527|NCT00052884|Melphalan|melphalan|mesh-list
153919528|NCT00052884|Amifostine|amifostine|mesh-list
153919529|NCT00052884|Immunologic Factors|immunologic factors|mesh-ancestor
153919530|NCT00052884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153919531|NCT00052884|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153919532|NCT00052884|Alkylating Agents|alkylating agents|mesh-ancestor
153919533|NCT00052884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153919534|NCT00052884|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153919535|NCT00052884|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153919536|NCT00052884|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153919537|NCT00052884|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
153919538|NCT00052884|Protective Agents|protective agents|mesh-ancestor
153898887|NCT05881291|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153898888|NCT05867342|Lidocaine|lidocaine|mesh-list
153898889|NCT05867342|Epinephrine|epinephrine|mesh-list
153898890|NCT05867342|Racepinephrine|racepinephrine|mesh-list
153898891|NCT05867342|Epinephryl borate|epinephryl borate|mesh-list
153898892|NCT05867342|Anesthetics, Local|anesthetics, local|mesh-ancestor
153898893|NCT05867342|Anesthetics|anesthetics|mesh-ancestor
153898894|NCT05867342|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153898895|NCT05867342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153898896|NCT05867342|Sensory System Agents|sensory system agents|mesh-ancestor
153898897|NCT05867342|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153898898|NCT05867342|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153898899|NCT05867342|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
153898900|NCT05867342|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153898901|NCT05867342|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153898902|NCT05867342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153898903|NCT05867342|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153898904|NCT05867342|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153898905|NCT05867342|Adrenergic Agents|adrenergic agents|mesh-ancestor
153898906|NCT05867342|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153898907|NCT05867342|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
153898908|NCT05867342|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153440222|NCT00003661|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153440223|NCT00003661|Dermatologic Agents|dermatologic agents|mesh-ancestor
153440224|NCT00003661|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153440225|NCT00003661|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
153440226|NCT00003661|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153440227|NCT00003661|Antiemetics|antiemetics|mesh-ancestor
153440228|NCT00003661|Autonomic Agents|autonomic agents|mesh-ancestor
153440229|NCT00003661|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153440230|NCT00003661|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153440232|NCT00003661|Hormones|hormones|mesh-ancestor
153440243|NCT00003967|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153440244|NCT00003967|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153440245|NCT00003967|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153440246|NCT00003967|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153440247|NCT00003967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153440248|NCT00003967|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
153440249|NCT00003115|Hydromorphone|hydromorphone|mesh-list
153898909|NCT05867342|Autonomic Agents|autonomic agents|mesh-ancestor
153898910|NCT05867342|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153898911|NCT05867342|Respiratory System Agents|respiratory system agents|mesh-ancestor
153898912|NCT05867342|Mydriatics|mydriatics|mesh-ancestor
153898913|NCT05867342|Sympathomimetics|sympathomimetics|mesh-ancestor
153898914|NCT05867342|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
153898915|NCT05843448|Pembrolizumab|pembrolizumab|mesh-list
153898916|NCT05843448|Vaccines|vaccines|mesh-list
153898917|NCT05843448|Immunologic Factors|immunologic factors|mesh-ancestor
153898918|NCT05843448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153898919|NCT05843448|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153898920|NCT05843448|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153898921|NCT05843448|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153898922|NCT05843448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153898923|NCT05810480|Immunoglobulins|immunoglobulins|mesh-list
153898924|NCT05810480|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
153898925|NCT05810480|Antibodies|antibodies|mesh-list
153898926|NCT05810480|Immunoglobulin G|immunoglobulin g|mesh-list
153898927|NCT05810480|Autoantibodies|autoantibodies|mesh-list
153898928|NCT05810480|Immunologic Factors|immunologic factors|mesh-ancestor
153898929|NCT05810480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153440262|NCT00003667|Razoxane|razoxane|mesh-list
153898930|NCT05798533|Tislelizumab|tislelizumab|mesh-list
153898931|NCT05798533|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153898932|NCT05798533|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153898933|NCT05793632|Quetiapine Fumarate|quetiapine fumarate|mesh-list
153898934|NCT05793632|Antidepressive Agents|antidepressive agents|mesh-ancestor
153440270|NCT00003667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153440272|NCT00003667|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153440273|NCT00003667|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153440274|NCT00003667|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153440275|NCT00003667|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153440276|NCT00003667|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153440277|NCT00003667|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153440278|NCT00003667|Tubulin Modulators|tubulin modulators|mesh-ancestor
153440279|NCT00003667|Antimitotic Agents|antimitotic agents|mesh-ancestor
153440280|NCT00003667|Mitosis Modulators|mitosis modulators|mesh-ancestor
153440281|NCT00003667|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
153440282|NCT00003667|Protective Agents|protective agents|mesh-ancestor
153440283|NCT00003667|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
153440284|NCT00003673|Gemtuzumab|gemtuzumab|mesh-list
153440285|NCT00003673|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153440286|NCT00003673|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153440287|NCT00003673|Immunotoxins|immunotoxins|mesh-ancestor
153440288|NCT00003673|Immunoconjugates|immunoconjugates|mesh-ancestor
153440289|NCT00003673|Immunologic Factors|immunologic factors|mesh-ancestor
153440290|NCT00003673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153440298|NCT00003679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153440300|NCT00003679|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153440301|NCT00003679|Alkylating Agents|alkylating agents|mesh-ancestor
153440302|NCT00003679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153440303|NCT00003679|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153898957|NCT05635110|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153898958|NCT05635110|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
153898959|NCT05635110|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153898960|NCT05635110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153898961|NCT05635110|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
153898962|NCT05635110|Antitubercular Agents|antitubercular agents|mesh-ancestor
153440304|NCT00003679|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153898963|NCT05635110|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153898964|NCT05635110|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153898965|NCT05635110|Leprostatic Agents|leprostatic agents|mesh-ancestor
153898966|NCT05635110|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153898967|NCT05635110|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
153898968|NCT05635110|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
153898969|NCT05635110|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
153898970|NCT05635110|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
153898972|NCT05635110|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
153898973|NCT05615025|Propofol|propofol|mesh-list
153898974|NCT05615025|Sevoflurane|sevoflurane|mesh-list
153898975|NCT05615025|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153898976|NCT05615025|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153898977|NCT05615025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153898978|NCT05615025|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153898979|NCT05615025|Anesthetics, General|anesthetics, general|mesh-ancestor
153898980|NCT05615025|Anesthetics|anesthetics|mesh-ancestor
153898981|NCT05615025|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153898987|NCT05381753|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153898988|NCT05381753|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153898989|NCT05381753|Growth Substances|growth substances|mesh-ancestor
153898990|NCT05381753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153898991|NCT05381753|Growth Inhibitors|growth inhibitors|mesh-ancestor
153898992|NCT05381753|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153898993|NCT05381753|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153898994|NCT05381753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153440310|NCT00003679|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153440311|NCT00003679|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153440312|NCT00003679|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
153440313|NCT00003679|Hormone Antagonists|hormone antagonists|mesh-ancestor
153440314|NCT00003679|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153440315|NCT00003679|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153440316|NCT00003679|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
153440317|NCT00003679|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
153440318|NCT00003679|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153440320|NCT00003985|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153440321|NCT00003985|Immunologic Factors|immunologic factors|mesh-ancestor
153440322|NCT00003985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153440323|NCT00003985|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153440324|NCT00384553|Rituximab|rituximab|mesh-list
153440325|NCT00384553|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153440326|NCT00384553|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153440327|NCT00384553|Immunologic Factors|immunologic factors|mesh-ancestor
153440328|NCT00384553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153440329|NCT00384553|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153440330|NCT00003991|Aldesleukin|aldesleukin|mesh-list
153440331|NCT00003991|Histamine|histamine|mesh-list
153440332|NCT00003991|Histamine phosphate|histamine phosphate|mesh-list
153440333|NCT00003991|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153919539|NCT00040807|Docetaxel|docetaxel|mesh-list
153919540|NCT00040807|Irinotecan|irinotecan|mesh-list
153919541|NCT00040807|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153919542|NCT00040807|Tubulin Modulators|tubulin modulators|mesh-ancestor
153919543|NCT00040807|Antimitotic Agents|antimitotic agents|mesh-ancestor
153919544|NCT00040807|Mitosis Modulators|mitosis modulators|mesh-ancestor
153919545|NCT00040807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153919546|NCT00040807|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
153919547|NCT00040807|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153919548|NCT00040807|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153468257|NCT06299371|Antimitotic Agents|antimitotic agents|mesh-ancestor
153440334|NCT00003991|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153440335|NCT00003991|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153440336|NCT00003991|Antiviral Agents|antiviral agents|mesh-ancestor
153440337|NCT00003991|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153440338|NCT00003991|Histamine Agonists|histamine agonists|mesh-ancestor
153440339|NCT00003991|Histamine Agents|histamine agents|mesh-ancestor
153440340|NCT00003991|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153440341|NCT00003991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153440342|NCT00003991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153440343|NCT00003997|Irofulven|irofulven|mesh-list
153898995|NCT05276206|Anesthetics|anesthetics|mesh-list
153898996|NCT05276206|Anesthetics, Local|anesthetics, local|mesh-list
153898997|NCT05276206|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153898998|NCT05276206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153898999|NCT05276206|Sensory System Agents|sensory system agents|mesh-ancestor
153440344|NCT00003997|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153899000|NCT05276206|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153899001|NCT05246111|Topotecan|topotecan|mesh-list
153899002|NCT05246111|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
153899003|NCT05246111|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153899004|NCT05246111|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153899007|NCT05207436|Oxytocin|oxytocin|mesh-list
153899008|NCT05207436|Oxytocics|oxytocics|mesh-ancestor
153899009|NCT05207436|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153899010|NCT05207436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153899011|NCT05054842|Metformin|metformin|mesh-list
153899012|NCT05054842|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153899013|NCT05054842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153899014|NCT04915508|Hormones|hormones|mesh-list
153899015|NCT04915508|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153899016|NCT04915508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153899017|NCT04793867|Xenon|xenon|mesh-list
153899018|NCT04793867|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
153899019|NCT04793867|Anesthetics, General|anesthetics, general|mesh-ancestor
153899020|NCT04793867|Anesthetics|anesthetics|mesh-ancestor
153919549|NCT00028678|Dalteparin|dalteparin|mesh-list
153899021|NCT04793867|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153899022|NCT04793867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153899024|NCT04520490|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
153899025|NCT04520490|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153899026|NCT04520490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153899027|NCT04520490|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
153899028|NCT04520490|Incretins|incretins|mesh-ancestor
153899030|NCT04520490|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153899031|NCT04483778|Pembrolizumab|pembrolizumab|mesh-list
153440349|NCT00384631|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153440350|NCT00384631|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153440351|NCT00384631|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153440352|NCT00384631|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153440353|NCT00384631|Growth Substances|growth substances|mesh-ancestor
153440354|NCT00384631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153440355|NCT00384631|Growth Inhibitors|growth inhibitors|mesh-ancestor
153440356|NCT00003127|Paclitaxel|paclitaxel|mesh-list
153440357|NCT00003127|Carboplatin|carboplatin|mesh-list
153440358|NCT00003127|Amifostine|amifostine|mesh-list
153440359|NCT00003127|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153440360|NCT00003127|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153440361|NCT00003127|Tubulin Modulators|tubulin modulators|mesh-ancestor
153440362|NCT00003127|Antimitotic Agents|antimitotic agents|mesh-ancestor
153440363|NCT00003127|Mitosis Modulators|mitosis modulators|mesh-ancestor
153440364|NCT00003127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153440365|NCT00003127|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
153440366|NCT00003127|Protective Agents|protective agents|mesh-ancestor
153440367|NCT00003127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153440368|NCT00004003|Gemcitabine|gemcitabine|mesh-list
153440369|NCT00004003|Fluorouracil|fluorouracil|mesh-list
153440370|NCT00004003|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153440371|NCT00004003|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153440377|NCT00004009|Tipifarnib|tipifarnib|mesh-list
153440378|NCT00004009|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153440379|NCT00003133|Paclitaxel|paclitaxel|mesh-list
153440380|NCT00003133|Gemcitabine|gemcitabine|mesh-list
153440381|NCT00003133|Doxorubicin|doxorubicin|mesh-list
153440382|NCT00003133|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
153440383|NCT00003133|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153440384|NCT00003133|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153440385|NCT00003133|Tubulin Modulators|tubulin modulators|mesh-ancestor
153899032|NCT04483778|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153899033|NCT04483778|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153899034|NCT04483778|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153899035|NCT04483778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153899036|NCT04480554|Naltrexone|naltrexone|mesh-list
153899037|NCT04480554|Buprenorphine|buprenorphine|mesh-list
153899038|NCT04480554|Methadone|methadone|mesh-list
153440398|NCT00003691|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153440399|NCT00003691|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153440400|NCT00003691|Tubulin Modulators|tubulin modulators|mesh-ancestor
153440401|NCT00003691|Antimitotic Agents|antimitotic agents|mesh-ancestor
153440402|NCT00003691|Mitosis Modulators|mitosis modulators|mesh-ancestor
153440403|NCT00003691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153440404|NCT00003691|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153440405|NCT00003691|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153899069|NCT04268498|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153899101|NCT04220931|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153899102|NCT04220931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153899104|NCT04220931|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153899105|NCT04220931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153899106|NCT04194775|Lenvatinib|lenvatinib|mesh-list
153899107|NCT04194775|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153899108|NCT04194775|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153440434|NCT00003145|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153440435|NCT00003145|Antimetabolites|antimetabolites|mesh-ancestor
153440437|NCT00003145|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153899117|NCT03906136|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
153899118|NCT03906136|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153899119|NCT03906136|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153899120|NCT03800524|Ursodoxicoltaurine|ursodoxicoltaurine|mesh-list
153899121|NCT03800524|Antiviral Agents|antiviral agents|mesh-ancestor
153899122|NCT03800524|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153899123|NCT03800524|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
153899124|NCT03800524|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153899125|NCT03695744|Dexamethasone|dexamethasone|mesh-list
153899126|NCT03695744|Bortezomib|bortezomib|mesh-list
153899127|NCT03695744|Daratumumab|daratumumab|mesh-list
153899128|NCT03695744|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153899129|NCT03695744|Antiemetics|antiemetics|mesh-ancestor
153899130|NCT03695744|Autonomic Agents|autonomic agents|mesh-ancestor
153899131|NCT03695744|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153899132|NCT03695744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153899133|NCT03695744|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153899134|NCT03695744|Glucocorticoids|glucocorticoids|mesh-ancestor
153899135|NCT03695744|Hormones|hormones|mesh-ancestor
153899136|NCT03695744|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153899137|NCT03695744|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153899138|NCT03695744|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153899139|NCT03690869|Cemiplimab|cemiplimab|mesh-list
153440462|NCT00004039|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153440463|NCT00004039|Alkylating Agents|alkylating agents|mesh-ancestor
153440464|NCT00004039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153440465|NCT00004039|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153440466|NCT00004039|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153899204|NCT06268652|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153440531|NCT00004051|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153440533|NCT00003727|Interferon-alpha|interferon-alpha|mesh-list
153440534|NCT00003727|Cyclophosphamide|cyclophosphamide|mesh-list
153899209|NCT06268587|Sensory System Agents|sensory system agents|mesh-ancestor
153899210|NCT06268587|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153899211|NCT06268587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153899212|NCT06268483|Propolis|propolis|mesh-list
153899213|NCT06268483|Curcumin|curcumin|mesh-list
153899214|NCT06268483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153899215|NCT06268483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153899216|NCT06268483|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153899217|NCT06268483|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153899218|NCT06268483|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153899219|NCT06268483|Analgesics|analgesics|mesh-ancestor
153899220|NCT06268483|Sensory System Agents|sensory system agents|mesh-ancestor
153899221|NCT06268483|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153899222|NCT06268483|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153899223|NCT06268483|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153899224|NCT06268483|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153899225|NCT06268483|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153899226|NCT06268457|Doxorubicin|doxorubicin|mesh-list
153440597|NCT00003745|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
153440598|NCT00003745|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153440599|NCT00003745|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153440600|NCT00003745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153440601|NCT00003745|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153440602|NCT00003163|Cyclophosphamide|cyclophosphamide|mesh-list
153440604|NCT00003163|Sargramostim|sargramostim|mesh-list
153899275|NCT06268210|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153899276|NCT06268210|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153899278|NCT06268093|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153899279|NCT06268093|Immunologic Factors|immunologic factors|mesh-ancestor
153899280|NCT06268093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153899281|NCT06268093|Leprostatic Agents|leprostatic agents|mesh-ancestor
153899282|NCT06268093|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153899283|NCT06268093|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153899284|NCT06268093|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153899285|NCT06268093|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153440637|NCT00003757|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153440638|NCT00003757|Immunologic Factors|immunologic factors|mesh-ancestor
153440639|NCT00003757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153440640|NCT00003757|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153440641|NCT00003175|Fluorouracil|fluorouracil|mesh-list
153440642|NCT00003175|Antimetabolites|antimetabolites|mesh-ancestor
153440643|NCT00003175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153440644|NCT00003175|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153440645|NCT00003175|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153440646|NCT00003175|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153440647|NCT00003175|Immunologic Factors|immunologic factors|mesh-ancestor
153440648|NCT00003175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153440649|NCT00004099|Leucovorin|leucovorin|mesh-list
153440650|NCT00004099|Fluorouracil|fluorouracil|mesh-list
153440651|NCT00004099|Calcium|calcium|mesh-list
153440652|NCT00004099|Levoleucovorin|levoleucovorin|mesh-list
153899322|NCT06267794|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153899323|NCT06267794|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153899324|NCT06267794|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153899325|NCT06267794|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153899326|NCT06267287|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
153899327|NCT06267287|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
153899328|NCT06267287|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153899329|NCT06267287|Antitubercular Agents|antitubercular agents|mesh-ancestor
153440666|NCT00003763|Folic Acid|folic acid|mesh-list
153440667|NCT00003763|Hematinics|hematinics|mesh-ancestor
153899344|NCT06267118|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153899345|NCT06267118|Autonomic Agents|autonomic agents|mesh-ancestor
153899346|NCT06267118|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153899347|NCT06267118|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153899348|NCT06267118|Respiratory System Agents|respiratory system agents|mesh-ancestor
153899349|NCT06267118|Mydriatics|mydriatics|mesh-ancestor
153899350|NCT06267118|Sympathomimetics|sympathomimetics|mesh-ancestor
153899351|NCT06267118|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
153899352|NCT06267066|Betamethasone|betamethasone|mesh-list
153899353|NCT06267066|Betamethasone Valerate|betamethasone valerate|mesh-list
153899354|NCT06267066|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
153899355|NCT06267066|Betamethasone benzoate|betamethasone benzoate|mesh-list
153899357|NCT06267066|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
153899358|NCT06267066|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153899372|NCT06267053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153899373|NCT06267053|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153899374|NCT06267053|Hematinics|hematinics|mesh-ancestor
153899375|NCT06267053|Vitamin B Complex|vitamin b complex|mesh-ancestor
153899376|NCT06266988|Valsartan|valsartan|mesh-list
153899377|NCT06266988|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
153899378|NCT06266988|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153899379|NCT06266988|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
153899380|NCT06266988|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
153899381|NCT06266988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153899382|NCT06266975|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-list
153899383|NCT06266975|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153899384|NCT06266975|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153899386|NCT06266962|Atropine|atropine|mesh-list
153440754|NCT00004123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153440756|NCT00003781|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153440757|NCT00003781|Tubulin Modulators|tubulin modulators|mesh-ancestor
153440758|NCT00003781|Antimitotic Agents|antimitotic agents|mesh-ancestor
153440759|NCT00003781|Mitosis Modulators|mitosis modulators|mesh-ancestor
153899417|NCT06266832|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153899418|NCT06266767|Fentanyl|fentanyl|mesh-list
153899419|NCT06266767|Levobupivacaine|levobupivacaine|mesh-list
153899420|NCT06266767|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153899421|NCT06266767|Narcotics|narcotics|mesh-ancestor
153440760|NCT00003781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153440761|NCT00003193|Paclitaxel|paclitaxel|mesh-list
153440762|NCT00003193|Amifostine|amifostine|mesh-list
153440763|NCT00003193|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153440764|NCT00003193|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153440765|NCT00003193|Tubulin Modulators|tubulin modulators|mesh-ancestor
153440766|NCT00003193|Antimitotic Agents|antimitotic agents|mesh-ancestor
153440767|NCT00003193|Mitosis Modulators|mitosis modulators|mesh-ancestor
153440768|NCT00003193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153440769|NCT00003193|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
153440770|NCT00003193|Protective Agents|protective agents|mesh-ancestor
153440772|NCT00004135|Cyclophosphamide|cyclophosphamide|mesh-list
153899444|NCT06265870|Antimitotic Agents|antimitotic agents|mesh-ancestor
153899445|NCT06265870|Mitosis Modulators|mitosis modulators|mesh-ancestor
153899446|NCT06265870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153899447|NCT06265870|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153899448|NCT06264414|Tamsulosin|tamsulosin|mesh-list
153899449|NCT06264414|Dutasteride|dutasteride|mesh-list
153899450|NCT06264414|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
153899451|NCT06264414|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
153899452|NCT06264414|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
153899453|NCT06264414|Adrenergic Agents|adrenergic agents|mesh-ancestor
153899454|NCT06264414|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153899455|NCT06264414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153899456|NCT06264414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153899457|NCT06264414|Urological Agents|urological agents|mesh-ancestor
153899458|NCT06264414|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
153899459|NCT06264414|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153899460|NCT06264414|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153899461|NCT06264414|Hormone Antagonists|hormone antagonists|mesh-ancestor
153899462|NCT06264414|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153899469|NCT06263816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153899470|NCT06263816|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153899471|NCT06263816|Antioxidants|antioxidants|mesh-ancestor
153899472|NCT06263816|Protective Agents|protective agents|mesh-ancestor
153899473|NCT06263816|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153899474|NCT06263816|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153899475|NCT06263816|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153899476|NCT06263816|Vasodilator Agents|vasodilator agents|mesh-ancestor
153899477|NCT06263816|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
153899478|NCT06263816|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
153899479|NCT06257212|Vaccines|vaccines|mesh-list
153899480|NCT06257212|BCG Vaccine|bcg vaccine|mesh-list
153899481|NCT06257212|Immunologic Factors|immunologic factors|mesh-ancestor
153899482|NCT06257212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153899483|NCT06257212|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153899484|NCT06254014|Exenatide|exenatide|mesh-list
153899485|NCT06254014|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
153899486|NCT06254014|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153899487|NCT06254014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153899488|NCT06254014|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
153899489|NCT06254014|Incretins|incretins|mesh-ancestor
153899490|NCT06254014|Hormones|hormones|mesh-ancestor
153899491|NCT06254014|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153899492|NCT06244550|Metformin|metformin|mesh-list
153899493|NCT06244550|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153899494|NCT06244550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153899495|NCT06242288|Isotretinoin|isotretinoin|mesh-list
153899496|NCT06242288|Dermatologic Agents|dermatologic agents|mesh-ancestor
153899497|NCT06238245|Cyclophosphamide|cyclophosphamide|mesh-list
153440856|NCT00004159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153440857|NCT00004159|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153440858|NCT00004159|Antimetabolites|antimetabolites|mesh-ancestor
153440859|NCT00003811|Etoposide|etoposide|mesh-list
153440860|NCT00003811|Bleomycin|bleomycin|mesh-list
153440861|NCT00003811|Amifostine|amifostine|mesh-list
153440862|NCT00003811|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153440863|NCT00003811|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153440864|NCT00003811|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153440865|NCT00003811|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153440866|NCT00003811|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153440867|NCT00003811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153440868|NCT00003811|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153440869|NCT00003811|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
153899545|NCT06191692|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153440902|NCT00003829|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153440903|NCT00003829|Alkylating Agents|alkylating agents|mesh-ancestor
153440904|NCT00003829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153440905|NCT00003829|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153440906|NCT00003829|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153899565|NCT06174961|Heparin|heparin|mesh-list
153899566|NCT06174961|Calcium heparin|calcium heparin|mesh-list
153899567|NCT06174961|Anticoagulants|anticoagulants|mesh-ancestor
153899568|NCT06174961|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153899569|NCT06174961|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153899570|NCT06174961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153899571|NCT06170125|Tiotropium Bromide|tiotropium bromide|mesh-list
153899572|NCT06170125|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153899573|NCT06170125|Autonomic Agents|autonomic agents|mesh-ancestor
153899574|NCT06170125|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153899575|NCT06170125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153899576|NCT06170125|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153899577|NCT06170125|Respiratory System Agents|respiratory system agents|mesh-ancestor
153899578|NCT06170125|Parasympatholytics|parasympatholytics|mesh-ancestor
153899579|NCT06170125|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
153899580|NCT06170125|Cholinergic Agents|cholinergic agents|mesh-ancestor
153899581|NCT06170125|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153899582|NCT06170125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153899583|NCT06155981|Cocaine|cocaine|mesh-list
153899584|NCT06155981|Anesthetics, Local|anesthetics, local|mesh-ancestor
153899585|NCT06155981|Anesthetics|anesthetics|mesh-ancestor
153899586|NCT06155981|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153440974|NCT00003223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153440975|NCT00004189|Cisplatin|cisplatin|mesh-list
153440976|NCT00004189|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153440977|NCT00003229|Aldesleukin|aldesleukin|mesh-list
153440978|NCT00003229|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153440979|NCT00003229|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153440980|NCT00003229|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153899611|NCT06137287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153899612|NCT06137287|Cholinergic Agents|cholinergic agents|mesh-ancestor
153899613|NCT06137287|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153899614|NCT06128109|Lidocaine|lidocaine|mesh-list
153899615|NCT06128109|Anesthetics, Local|anesthetics, local|mesh-ancestor
153899616|NCT06128109|Anesthetics|anesthetics|mesh-ancestor
153899617|NCT06128109|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153899618|NCT06128109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153899619|NCT06128109|Sensory System Agents|sensory system agents|mesh-ancestor
153899620|NCT06128109|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153899621|NCT06128109|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153899655|NCT06112353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153899656|NCT06112353|Cholinergic Agents|cholinergic agents|mesh-ancestor
153899657|NCT06112353|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153441011|NCT00003847|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153441012|NCT00003847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153441013|NCT00003847|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153441025|NCT00385021|Oxaliplatin|oxaliplatin|mesh-list
153441026|NCT00385021|Bevacizumab|bevacizumab|mesh-list
153441027|NCT00385021|Antimetabolites|antimetabolites|mesh-ancestor
153441028|NCT00385021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153441029|NCT00385021|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153441030|NCT00385021|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153441031|NCT00385021|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153441032|NCT00385021|Immunologic Factors|immunologic factors|mesh-ancestor
153441033|NCT00385021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153441034|NCT00385021|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153441035|NCT00385021|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153441036|NCT00385021|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153441037|NCT00385021|Growth Substances|growth substances|mesh-ancestor
153441042|NCT00385021|Vitamins|vitamins|mesh-ancestor
153899658|NCT06112353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153899659|NCT06112353|Parasympathomimetics|parasympathomimetics|mesh-ancestor
153899660|NCT06112353|Autonomic Agents|autonomic agents|mesh-ancestor
153899661|NCT06112353|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153899662|NCT06112353|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153899663|NCT06112353|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
153899664|NCT06112353|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
153899665|NCT06107062|Cannabidiol|cannabidiol|mesh-list
153899666|NCT06107062|Anticonvulsants|anticonvulsants|mesh-ancestor
153899667|NCT06089317|Lubricant Eye Drops|lubricant eye drops|mesh-list
153899668|NCT06089317|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
153899669|NCT06089317|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
153899670|NCT06065670|Clemastine|clemastine|mesh-list
153899671|NCT06065670|Antipruritics|antipruritics|mesh-ancestor
153899672|NCT06065670|Dermatologic Agents|dermatologic agents|mesh-ancestor
153899673|NCT06065670|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
153441072|NCT00003859|Tubulin Modulators|tubulin modulators|mesh-ancestor
153441073|NCT00003859|Antimitotic Agents|antimitotic agents|mesh-ancestor
153441074|NCT00003859|Mitosis Modulators|mitosis modulators|mesh-ancestor
153441076|NCT00003865|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153441085|NCT00004207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153441086|NCT00004207|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153441087|NCT00004207|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153441088|NCT00004207|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153441089|NCT00004207|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153441111|NCT00003877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153441112|NCT00003877|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153441113|NCT00003877|Immunologic Factors|immunologic factors|mesh-ancestor
153441114|NCT00003877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153441115|NCT00003877|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153441116|NCT00003877|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153441117|NCT00003877|Alkylating Agents|alkylating agents|mesh-ancestor
153441118|NCT00003877|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153441119|NCT00003883|Itraconazole|itraconazole|mesh-list
153441120|NCT00003883|Fluconazole|fluconazole|mesh-list
153441121|NCT00003883|Antifungal Agents|antifungal agents|mesh-ancestor
153441122|NCT00003883|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153899768|NCT05894564|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153899769|NCT05894564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153899770|NCT05894564|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153899771|NCT05894564|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
153899772|NCT05894564|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153899773|NCT05894564|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153899774|NCT05894564|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153899775|NCT05894564|Serotonin Agents|serotonin agents|mesh-ancestor
153899776|NCT05894564|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
153899777|NCT05894564|Antidepressive Agents|antidepressive agents|mesh-ancestor
153899778|NCT05894564|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
153899779|NCT05894564|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153899780|NCT05894564|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
153899781|NCT05885685|Nabilone|nabilone|mesh-list
153899782|NCT05885685|Antiemetics|antiemetics|mesh-ancestor
153899783|NCT05885685|Autonomic Agents|autonomic agents|mesh-ancestor
153899784|NCT05885685|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153899785|NCT05885685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153899786|NCT05885685|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153899787|NCT05885685|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153899788|NCT05885685|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153899789|NCT05885685|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153899790|NCT05885685|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153899792|NCT05876377|Immunologic Factors|immunologic factors|mesh-ancestor
153899793|NCT05876377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153899794|NCT05870917|Dexamethasone|dexamethasone|mesh-list
153899795|NCT05870917|Lenalidomide|lenalidomide|mesh-list
153899796|NCT05870917|Bortezomib|bortezomib|mesh-list
153899797|NCT05870917|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153441184|NCT00003913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153441185|NCT00003913|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153441186|NCT00003913|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153441187|NCT00003913|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153441188|NCT00003913|Antiemetics|antiemetics|mesh-ancestor
153441189|NCT00003913|Autonomic Agents|autonomic agents|mesh-ancestor
153441190|NCT00003913|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153441191|NCT00003913|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153441192|NCT00003913|Glucocorticoids|glucocorticoids|mesh-ancestor
153441193|NCT00003913|Hormones|hormones|mesh-ancestor
153441194|NCT00003913|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153441195|NCT00003913|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
153441197|NCT00004243|Docetaxel|docetaxel|mesh-list
153441198|NCT00004243|Oxaliplatin|oxaliplatin|mesh-list
153441199|NCT00004243|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153441200|NCT00004243|Tubulin Modulators|tubulin modulators|mesh-ancestor
153441201|NCT00004243|Antimitotic Agents|antimitotic agents|mesh-ancestor
153441202|NCT00004243|Mitosis Modulators|mitosis modulators|mesh-ancestor
153899809|NCT05870917|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153899810|NCT05870917|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153899811|NCT05870917|Growth Substances|growth substances|mesh-ancestor
153899813|NCT05864144|Cemiplimab|cemiplimab|mesh-list
153899834|NCT05812807|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153899879|NCT05759949|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
153899880|NCT05759949|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
153899881|NCT05759949|Hormone Antagonists|hormone antagonists|mesh-ancestor
153441254|NCT00004261|Immunologic Factors|immunologic factors|mesh-ancestor
153441255|NCT00004261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153441256|NCT00004297|Diazepam|diazepam|mesh-list
153441257|NCT00004297|Lorazepam|lorazepam|mesh-list
153441258|NCT00004297|Anticonvulsants|anticonvulsants|mesh-ancestor
153441259|NCT00004297|Antiemetics|antiemetics|mesh-ancestor
153441260|NCT00004297|Autonomic Agents|autonomic agents|mesh-ancestor
153441261|NCT00004297|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153441262|NCT00004297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153899921|NCT05720637|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153899922|NCT05720637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153899923|NCT05720637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153899924|NCT05718934|Glycopyrrolate|glycopyrrolate|mesh-list
153899925|NCT05718934|Neostigmine|neostigmine|mesh-list
153899926|NCT05718934|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
153899927|NCT05718934|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153899928|NCT05718934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153899929|NCT05718934|Cholinergic Agents|cholinergic agents|mesh-ancestor
153441300|NCT00004855|Antimetabolites|antimetabolites|mesh-ancestor
153899942|NCT05707468|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153899943|NCT05707468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153899963|NCT05667454|Atropine|atropine|mesh-list
153899964|NCT05667454|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153899965|NCT05667454|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153899966|NCT05667454|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153899967|NCT05667454|Autonomic Agents|autonomic agents|mesh-ancestor
153899968|NCT05667454|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153899969|NCT05667454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153899970|NCT05667454|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153899971|NCT05667454|Respiratory System Agents|respiratory system agents|mesh-ancestor
153899972|NCT05667454|Mydriatics|mydriatics|mesh-ancestor
153899973|NCT05667454|Parasympatholytics|parasympatholytics|mesh-ancestor
153899974|NCT05667454|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
153899975|NCT05667454|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
153899976|NCT05667454|Cholinergic Agents|cholinergic agents|mesh-ancestor
153899977|NCT05667454|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153899978|NCT05667454|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153899979|NCT05647265|Nivolumab|nivolumab|mesh-list
153899980|NCT05647265|Ipilimumab|ipilimumab|mesh-list
153899981|NCT05647265|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153441405|NCT00004885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153441407|NCT00004885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153441408|NCT00004885|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153441409|NCT00004885|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153441410|NCT00004885|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153441411|NCT00004885|Immunologic Factors|immunologic factors|mesh-ancestor
153441412|NCT00004885|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
153441413|NCT00004885|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153441414|NCT00004885|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153441415|NCT00004885|Antidotes|antidotes|mesh-ancestor
153441420|NCT00004891|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
153441421|NCT00004891|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
153441432|NCT00003343|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153441434|NCT00003343|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153441435|NCT00003343|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153441436|NCT00003343|Analgesics|analgesics|mesh-ancestor
153441437|NCT00003343|Sensory System Agents|sensory system agents|mesh-ancestor
153900054|NCT05610163|Vitamin B Complex|vitamin b complex|mesh-ancestor
153900055|NCT05610163|Vitamins|vitamins|mesh-ancestor
153900056|NCT05610163|Micronutrients|micronutrients|mesh-ancestor
153900057|NCT05577910|Ophthalmic Solutions|ophthalmic solutions|mesh-list
153900058|NCT05577910|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
153900059|NCT05575505|Pentoxifylline|pentoxifylline|mesh-list
153900060|NCT05575505|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
153900061|NCT05575505|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153900062|NCT05575505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153900063|NCT05575505|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153900064|NCT05575505|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
153900065|NCT05575505|Protective Agents|protective agents|mesh-ancestor
153900068|NCT05575505|Free Radical Scavengers|free radical scavengers|mesh-ancestor
153900069|NCT05575505|Antioxidants|antioxidants|mesh-ancestor
153900070|NCT05574387|Metformin|metformin|mesh-list
153900071|NCT05574387|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153900091|NCT05550402|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
153900092|NCT05550402|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153900093|NCT05550402|Adrenergic Agents|adrenergic agents|mesh-ancestor
153900094|NCT05550402|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153900096|NCT05550402|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
153900126|NCT05384015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153900127|NCT05384015|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153900128|NCT05384015|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153900129|NCT05384015|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153900130|NCT05384015|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153900131|NCT05384015|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153900133|NCT05362877|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153900134|NCT05362877|Antifungal Agents|antifungal agents|mesh-ancestor
153900135|NCT05362877|Keratolytic Agents|keratolytic agents|mesh-ancestor
153900136|NCT05362877|Dermatologic Agents|dermatologic agents|mesh-ancestor
153900137|NCT05361941|Tobramycin|tobramycin|mesh-list
153900138|NCT05361941|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153900140|NCT05303792|Cytarabine|cytarabine|mesh-list
153441537|NCT00004981|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153441538|NCT00004981|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153441539|NCT00004981|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153441540|NCT00004981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153441541|NCT00004981|Antiviral Agents|antiviral agents|mesh-ancestor
153441542|NCT00004981|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153441543|NCT00004981|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153441544|NCT00004981|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153441573|NCT00003361|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153441574|NCT00003367|Vitamin E|vitamin e|mesh-list
153441575|NCT00003367|Vitamins|vitamins|mesh-ancestor
153441576|NCT00003367|Micronutrients|micronutrients|mesh-ancestor
153441577|NCT00003367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153441578|NCT00003367|Antioxidants|antioxidants|mesh-ancestor
153441579|NCT00003367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153441580|NCT00003367|Protective Agents|protective agents|mesh-ancestor
153441581|NCT00003379|Paclitaxel|paclitaxel|mesh-list
153441582|NCT00003379|Cisplatin|cisplatin|mesh-list
153441583|NCT00003379|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153441584|NCT00003379|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153441585|NCT00003379|Tubulin Modulators|tubulin modulators|mesh-ancestor
153900193|NCT05251909|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153900194|NCT05251909|Respiratory System Agents|respiratory system agents|mesh-ancestor
153900195|NCT05247905|Capecitabine|capecitabine|mesh-list
153900196|NCT05247905|Temozolomide|temozolomide|mesh-list
153900197|NCT05247905|Lutetium Lu 177 dotatate|lutetium lu 177 dotatate|mesh-list
153900198|NCT05247905|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153900199|NCT05247905|Antimetabolites|antimetabolites|mesh-ancestor
153900200|NCT05247905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153900201|NCT05247905|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153900202|NCT05247905|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153900203|NCT05247905|Alkylating Agents|alkylating agents|mesh-ancestor
153900204|NCT05247905|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
153900205|NCT05220410|Psilocybin|psilocybin|mesh-list
153900206|NCT05220410|Hallucinogens|hallucinogens|mesh-ancestor
153900207|NCT05220410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153900226|NCT05168865|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153383931|NCT02260622|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153383933|NCT02260622|Analgesics|analgesics|mesh-ancestor
153383934|NCT02260622|Sensory System Agents|sensory system agents|mesh-ancestor
153383935|NCT02260622|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153383936|NCT02260622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153383937|NCT02260622|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153383938|NCT02260622|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153383939|NCT02260622|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153383940|NCT02260622|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153900228|NCT05168865|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153900229|NCT05168865|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
153900230|NCT05168865|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153900231|NCT05168865|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153900232|NCT05168865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153900233|NCT05168865|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
153900234|NCT05168865|Hormone Antagonists|hormone antagonists|mesh-ancestor
153900235|NCT05168865|Progestins|progestins|mesh-ancestor
153900237|NCT05145283|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
153900239|NCT05145283|Immunologic Factors|immunologic factors|mesh-ancestor
153900240|NCT05145283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153900241|NCT05104255|Anesthetics|anesthetics|mesh-list
153900242|NCT05104255|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153900243|NCT05104255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153441604|NCT00004381|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153441606|NCT00005005|Alendronate|alendronate|mesh-list
153441652|NCT00005017|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153441653|NCT00005017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153441654|NCT00005017|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153441655|NCT00005017|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153441656|NCT00005017|Antiviral Agents|antiviral agents|mesh-ancestor
153441657|NCT00005017|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153441658|NCT00005017|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
153441659|NCT00005017|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153441660|NCT00005017|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153441661|NCT00005017|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153441662|NCT00005017|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
153441671|NCT00005023|Sargramostim|sargramostim|mesh-list
153441672|NCT00005023|Immunologic Factors|immunologic factors|mesh-ancestor
153441673|NCT00005023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153441674|NCT00005029|Topotecan|topotecan|mesh-list
153441675|NCT00005029|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
153441676|NCT00005029|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153441677|NCT00005029|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153441678|NCT00005029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153441679|NCT00005029|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153900288|NCT04993677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153900289|NCT04993677|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153900290|NCT04993677|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153441707|NCT00005569|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
153441708|NCT00005575|Imipramine|imipramine|mesh-list
153441709|NCT00005575|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
153441710|NCT00005575|Antidepressive Agents|antidepressive agents|mesh-ancestor
153441711|NCT00005575|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153441712|NCT00005575|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
153441713|NCT00005575|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153441714|NCT00005575|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153900307|NCT04939090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153900308|NCT04939090|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153441730|NCT00005065|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153441731|NCT00005065|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153441732|NCT00005065|Tubulin Modulators|tubulin modulators|mesh-ancestor
153441733|NCT00005065|Antimitotic Agents|antimitotic agents|mesh-ancestor
153441734|NCT00005065|Mitosis Modulators|mitosis modulators|mesh-ancestor
153441735|NCT00005065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153441736|NCT00005065|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
153441737|NCT00005065|Dermatologic Agents|dermatologic agents|mesh-ancestor
153441738|NCT00386191|Clopidogrel|clopidogrel|mesh-list
153441739|NCT00386191|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153441740|NCT00386191|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
153441741|NCT00386191|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
153441742|NCT00386191|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
153900368|NCT04886453|Narcotics|narcotics|mesh-ancestor
153900369|NCT04886453|Analgesics|analgesics|mesh-ancestor
153441745|NCT00386191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153441746|NCT00386191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153441748|NCT00386269|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153441749|NCT00386269|Narcotics|narcotics|mesh-ancestor
153441750|NCT00386269|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153441759|NCT00005581|Fluorouracil|fluorouracil|mesh-list
153441760|NCT00005581|Epirubicin|epirubicin|mesh-list
153441761|NCT00005581|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153441762|NCT00005581|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153900383|NCT04799288|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153900384|NCT04799288|Analgesics|analgesics|mesh-ancestor
153900385|NCT04799288|Sensory System Agents|sensory system agents|mesh-ancestor
153900386|NCT04799288|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153900387|NCT04799288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153900388|NCT04799288|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153900389|NCT04799288|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153900390|NCT04799288|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153900391|NCT04799288|Immunologic Factors|immunologic factors|mesh-ancestor
153900392|NCT04757376|Denosumab|denosumab|mesh-list
153900393|NCT04757376|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153900394|NCT04757376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153900395|NCT04740294|Magnesium Sulfate|magnesium sulfate|mesh-list
153900396|NCT04740294|Analgesics|analgesics|mesh-ancestor
153900397|NCT04740294|Sensory System Agents|sensory system agents|mesh-ancestor
153900398|NCT04740294|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153900399|NCT04740294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153900400|NCT04740294|Anesthetics|anesthetics|mesh-ancestor
153900401|NCT04740294|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153441778|NCT00005581|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153441779|NCT00005581|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153441780|NCT00005077|Oxaliplatin|oxaliplatin|mesh-list
153441781|NCT00005077|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153441782|NCT00004489|Cholecalciferol|cholecalciferol|mesh-list
153441783|NCT00004489|Vitamin D|vitamin d|mesh-list
153441784|NCT00004489|Alendronate|alendronate|mesh-list
153441785|NCT00004489|Calcium Carbonate|calcium carbonate|mesh-list
153441786|NCT00004489|Calcium|calcium|mesh-list
153441787|NCT00004489|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153441788|NCT00004489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153441789|NCT00004489|Vitamins|vitamins|mesh-ancestor
153441790|NCT00004489|Micronutrients|micronutrients|mesh-ancestor
153441804|NCT00005593|Immunologic Factors|immunologic factors|mesh-ancestor
153441805|NCT00005593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153441806|NCT00005593|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
153441807|NCT00005593|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153441808|NCT00005593|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153441809|NCT00004495|Folic Acid|folic acid|mesh-list
153441810|NCT00004495|Pyridoxine|pyridoxine|mesh-list
153441811|NCT00004495|Vitamin B 12|vitamin b 12|mesh-list
153441812|NCT00004495|Hydroxocobalamin|hydroxocobalamin|mesh-list
153441814|NCT00004495|Vitamin B Complex|vitamin b complex|mesh-ancestor
153900402|NCT04740294|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153900403|NCT04740294|Anticonvulsants|anticonvulsants|mesh-ancestor
153900404|NCT04740294|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153900405|NCT04740294|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153900408|NCT04740294|Tocolytic Agents|tocolytic agents|mesh-ancestor
153441820|NCT00005089|Rituximab|rituximab|mesh-list
153441821|NCT00005089|Doxorubicin|doxorubicin|mesh-list
153441822|NCT00005089|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
153441823|NCT00005089|Vincristine|vincristine|mesh-list
153441824|NCT00005089|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153441837|NCT00005089|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153441838|NCT00005089|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153441839|NCT00005089|Glucocorticoids|glucocorticoids|mesh-ancestor
153441840|NCT00005089|Hormones|hormones|mesh-ancestor
153441841|NCT00005089|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153441842|NCT00005089|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153441843|NCT00005089|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153441854|NCT00005599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153441855|NCT00005599|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153441856|NCT00005599|Immunologic Factors|immunologic factors|mesh-ancestor
153441857|NCT00005599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153441859|NCT00004567|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153441860|NCT00004567|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153441861|NCT00004567|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
153900475|NCT04570150|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153900476|NCT04570150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153900477|NCT04570150|Parasympathomimetics|parasympathomimetics|mesh-ancestor
153900478|NCT04570150|Autonomic Agents|autonomic agents|mesh-ancestor
153900479|NCT04570150|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153900480|NCT04569032|Prednisone|prednisone|mesh-list
153900481|NCT04569032|Cyclophosphamide|cyclophosphamide|mesh-list
153900482|NCT04569032|Doxorubicin|doxorubicin|mesh-list
153900483|NCT04569032|Brentuximab Vedotin|brentuximab vedotin|mesh-list
153900484|NCT04569032|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153900485|NCT04569032|Immunologic Factors|immunologic factors|mesh-ancestor
153900486|NCT04569032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153900487|NCT04569032|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153900488|NCT04569032|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153900489|NCT04569032|Alkylating Agents|alkylating agents|mesh-ancestor
153900490|NCT04569032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153441919|NCT00004585|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
153900534|NCT04424225|Niacin|niacin|mesh-list
153441949|NCT00005641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153441950|NCT00005641|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153441951|NCT00005641|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153441952|NCT00005641|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
153441953|NCT00005641|Abortifacient Agents|abortifacient agents|mesh-ancestor
153441954|NCT00005641|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153900540|NCT04424225|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153441964|NCT00005641|Vitamins|vitamins|mesh-ancestor
153441965|NCT00005641|Micronutrients|micronutrients|mesh-ancestor
153441966|NCT00005641|Antifungal Agents|antifungal agents|mesh-ancestor
153441967|NCT00005641|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153441968|NCT00005641|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
153441969|NCT00005641|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153441970|NCT00005641|Antiemetics|antiemetics|mesh-ancestor
153441971|NCT00005641|Autonomic Agents|autonomic agents|mesh-ancestor
153441972|NCT00005641|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153441973|NCT00005641|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153441974|NCT00005641|Glucocorticoids|glucocorticoids|mesh-ancestor
153441975|NCT00005641|Hormones|hormones|mesh-ancestor
153441978|NCT00005647|Paclitaxel|paclitaxel|mesh-list
153900601|NCT04224545|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153900602|NCT04194203|Paclitaxel|paclitaxel|mesh-list
153900607|NCT04194203|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153900609|NCT04194203|Tubulin Modulators|tubulin modulators|mesh-ancestor
153900610|NCT04194203|Antimitotic Agents|antimitotic agents|mesh-ancestor
153900611|NCT04194203|Mitosis Modulators|mitosis modulators|mesh-ancestor
153900614|NCT04194203|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153900646|NCT04061798|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153900647|NCT04061798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153900648|NCT04032301|Ketamine|ketamine|mesh-list
153900649|NCT04032301|Analgesics|analgesics|mesh-ancestor
153900650|NCT04032301|Sensory System Agents|sensory system agents|mesh-ancestor
153900651|NCT04032301|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153900652|NCT04032301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153900654|NCT04032301|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153442084|NCT00004807|Nootropic Agents|nootropic agents|mesh-ancestor
153442085|NCT00004807|Anticonvulsants|anticonvulsants|mesh-ancestor
153442086|NCT00004807|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153442087|NCT00004807|Antitussive Agents|antitussive agents|mesh-ancestor
153442092|NCT00004807|Narcotics|narcotics|mesh-ancestor
153442133|NCT00005107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153442135|NCT00005773|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153442136|NCT00005773|Autonomic Agents|autonomic agents|mesh-ancestor
153442137|NCT00005773|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153900781|NCT03642665|Estradiol|estradiol|mesh-list
153900800|NCT03500380|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153900801|NCT03500380|Antimetabolites|antimetabolites|mesh-ancestor
153900802|NCT03500380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153900803|NCT03500380|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153900804|NCT03500380|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153900805|NCT03500380|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153900806|NCT03500380|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153900807|NCT03485677|Eliglustat|eliglustat|mesh-list
153900818|NCT03376646|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153900819|NCT03376646|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153900820|NCT03376646|Tubulin Modulators|tubulin modulators|mesh-ancestor
153900821|NCT03376646|Antimitotic Agents|antimitotic agents|mesh-ancestor
153900822|NCT03376646|Mitosis Modulators|mitosis modulators|mesh-ancestor
153900823|NCT03376646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153900824|NCT03367741|Nivolumab|nivolumab|mesh-list
153900825|NCT03367741|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153900826|NCT03367741|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153900836|NCT03355482|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153900837|NCT03355482|Antiemetics|antiemetics|mesh-ancestor
153900838|NCT03355482|Autonomic Agents|autonomic agents|mesh-ancestor
153900839|NCT03355482|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153900840|NCT03355482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153900841|NCT03355482|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153900842|NCT03355482|Glucocorticoids|glucocorticoids|mesh-ancestor
153900843|NCT03355482|Hormones|hormones|mesh-ancestor
153900844|NCT03355482|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153900845|NCT03355482|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
153900846|NCT03355482|Protective Agents|protective agents|mesh-ancestor
153900847|NCT03355482|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153900848|NCT03355482|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153442294|NCT02125734|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153442295|NCT02125734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153432188|NCT05122767|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153442297|NCT02125734|Respiratory System Agents|respiratory system agents|mesh-ancestor
153442298|NCT02125734|Parasympatholytics|parasympatholytics|mesh-ancestor
153442299|NCT02125734|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
153442300|NCT02125734|Cholinergic Agents|cholinergic agents|mesh-ancestor
153442301|NCT02125734|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153442312|NCT02146248|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-list
153442313|NCT02146248|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153442314|NCT02146248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153442315|NCT02146248|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
153442356|NCT02100228|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153442357|NCT02100228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153442358|NCT02100228|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
153442359|NCT02100228|Antithrombins|antithrombins|mesh-ancestor
153900988|NCT03004183|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153901019|NCT02719574|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153901020|NCT02719574|Antimetabolites|antimetabolites|mesh-ancestor
153901021|NCT02719574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153901022|NCT02719574|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153901023|NCT02719574|Antiviral Agents|antiviral agents|mesh-ancestor
153442423|NCT02121756|Vasodilator Agents|vasodilator agents|mesh-ancestor
153442424|NCT02141490|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
153442425|NCT02141490|Hematinics|hematinics|mesh-ancestor
153442426|NCT02141490|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
153442427|NCT02141490|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
153442428|NCT02097108|Raltegravir Potassium|raltegravir potassium|mesh-list
153442429|NCT02097108|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153442430|NCT02097108|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153901043|NCT02675452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153901044|NCT02675452|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
153901045|NCT02363335|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
153901046|NCT02363335|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153901047|NCT02363335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153901086|NCT01973452|Dexmedetomidine|dexmedetomidine|mesh-list
153901087|NCT01973452|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153901088|NCT01973452|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153901091|NCT01973452|Analgesics|analgesics|mesh-ancestor
153901117|NCT01910402|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153901118|NCT01910402|Antiviral Agents|antiviral agents|mesh-ancestor
153901119|NCT01910402|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153901120|NCT01910402|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
153901121|NCT01910402|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153901122|NCT01910402|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153901123|NCT01910402|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153901124|NCT01910402|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
153901125|NCT01910402|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
153901126|NCT01857115|Dexamethasone|dexamethasone|mesh-list
153901127|NCT01857115|Cyclophosphamide|cyclophosphamide|mesh-list
153901128|NCT01857115|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153901129|NCT01857115|Immunologic Factors|immunologic factors|mesh-ancestor
153901130|NCT01857115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153901131|NCT01857115|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153901132|NCT01857115|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153901133|NCT01857115|Alkylating Agents|alkylating agents|mesh-ancestor
153901134|NCT01857115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153901135|NCT01857115|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153901136|NCT01857115|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153442588|NCT02091414|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
153442589|NCT02091414|Antitubercular Agents|antitubercular agents|mesh-ancestor
153442590|NCT02091414|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153442598|NCT04731558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153442600|NCT02116530|Cyclophosphamide|cyclophosphamide|mesh-list
153442641|NCT02116530|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153442642|NCT02116530|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153442643|NCT02116530|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
153442644|NCT02072226|Aspirin|aspirin|mesh-list
153442645|NCT02072226|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
153442646|NCT02072226|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153442647|NCT02072226|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153442648|NCT02072226|Analgesics|analgesics|mesh-ancestor
153442649|NCT02072226|Sensory System Agents|sensory system agents|mesh-ancestor
153442650|NCT02072226|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153442651|NCT02072226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153442652|NCT02072226|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153442653|NCT02072226|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153901270|NCT02697344|Dexamethasone|dexamethasone|mesh-list
153901271|NCT02697344|Dexamethasone acetate|dexamethasone acetate|mesh-list
153901272|NCT02697344|Lenalidomide|lenalidomide|mesh-list
153901273|NCT02697344|Retinol acetate|retinol acetate|mesh-list
153901274|NCT02697344|Gossypol acetic acid|gossypol acetic acid|mesh-list
153901295|NCT02697344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153901296|NCT02697344|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153901297|NCT02697344|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153901298|NCT02697344|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153901299|NCT02697344|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
153901300|NCT02697344|Protective Agents|protective agents|mesh-ancestor
153901301|NCT02697344|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
153901302|NCT02697344|Contraceptive Agents|contraceptive agents|mesh-ancestor
153901303|NCT02697344|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153901304|NCT02697344|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153901305|NCT02697344|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
153901306|NCT02697344|Spermatocidal Agents|spermatocidal agents|mesh-ancestor
153442712|NCT02085252|Fertility Agents, Female|fertility agents, female|mesh-ancestor
153901324|NCT02623426|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153901351|NCT02580058|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153901352|NCT02539394|Methylprednisolone|methylprednisolone|mesh-list
153901353|NCT02539394|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
153901354|NCT02539394|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
153901355|NCT02539394|Prednisolone|prednisolone|mesh-list
153901356|NCT02539394|Prednisolone acetate|prednisolone acetate|mesh-list
153901357|NCT02539394|Hemostatics|hemostatics|mesh-list
153901358|NCT02539394|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
153901359|NCT02539394|Prednisolone phosphate|prednisolone phosphate|mesh-list
153901360|NCT02539394|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153901361|NCT02539394|Antiemetics|antiemetics|mesh-ancestor
153901362|NCT02539394|Autonomic Agents|autonomic agents|mesh-ancestor
153901363|NCT02539394|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153901364|NCT02539394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153901365|NCT02539394|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153901366|NCT02539394|Glucocorticoids|glucocorticoids|mesh-ancestor
153901367|NCT02539394|Hormones|hormones|mesh-ancestor
153901368|NCT02539394|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153901369|NCT02539394|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
153442815|NCT01624974|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
153442816|NCT01624974|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
153442817|NCT01624974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153901377|NCT02530437|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153901378|NCT02530437|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153901379|NCT02530437|Tubulin Modulators|tubulin modulators|mesh-ancestor
153901380|NCT02530437|Antimitotic Agents|antimitotic agents|mesh-ancestor
153901381|NCT02530437|Mitosis Modulators|mitosis modulators|mesh-ancestor
153901382|NCT02530437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153901383|NCT02412670|Cisplatin|cisplatin|mesh-list
153442840|NCT02064894|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153442841|NCT02064894|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153442881|NCT02079246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153442882|NCT02079246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153442883|NCT02047110|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
153442884|NCT02047110|Immunologic Factors|immunologic factors|mesh-ancestor
153442885|NCT02047110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153442886|NCT02045862|Solifenacin Succinate|solifenacin succinate|mesh-list
153442939|NCT02044302|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153442940|NCT02044302|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153442941|NCT02044302|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
153442942|NCT02044302|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153442944|NCT02044302|Cholinergic Agents|cholinergic agents|mesh-ancestor
153901547|NCT05939180|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153901548|NCT05939180|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153901549|NCT05939076|Flecainide|flecainide|mesh-list
153901550|NCT05939076|Sotalol|sotalol|mesh-list
153901551|NCT05939076|Dronedarone|dronedarone|mesh-list
153901552|NCT05939076|Propafenone|propafenone|mesh-list
153901553|NCT05939076|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153901554|NCT05939076|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
153901555|NCT05939076|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153901556|NCT05939076|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153901557|NCT05939076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153442968|NCT02043366|Flurbiprofen axetil|flurbiprofen axetil|mesh-list
153442969|NCT02043366|Sufentanil|sufentanil|mesh-list
153442970|NCT02043366|Remifentanil|remifentanil|mesh-list
153442971|NCT02043366|Butorphanol|butorphanol|mesh-list
153442972|NCT02043366|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153442973|NCT02043366|Narcotics|narcotics|mesh-ancestor
153901572|NCT05938972|Omalizumab|omalizumab|mesh-list
153901584|NCT05937282|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153901585|NCT05937282|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153442991|NCT02043366|Respiratory System Agents|respiratory system agents|mesh-ancestor
153901618|NCT05935787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153901619|NCT05935787|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153901620|NCT05935787|Vasodilator Agents|vasodilator agents|mesh-ancestor
153901621|NCT05935787|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
153901622|NCT05935787|Dermatologic Agents|dermatologic agents|mesh-ancestor
153901623|NCT05933642|Aminophylline|aminophylline|mesh-list
153901624|NCT05933642|Furosemide|furosemide|mesh-list
153901658|NCT05928520|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153901659|NCT05928520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153901660|NCT05928520|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153443148|NCT02014740|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153443149|NCT02014740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153901744|NCT05881083|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153901745|NCT05881083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153901746|NCT05870683|Amoxicillin|amoxicillin|mesh-list
153901747|NCT05870683|Esomeprazole|esomeprazole|mesh-list
153901748|NCT05870683|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153901749|NCT05870683|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153901750|NCT05870683|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
153901751|NCT05870683|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153443168|NCT02057250|Hydroxychloroquine|hydroxychloroquine|mesh-list
153901761|NCT05833776|Fentanyl|fentanyl|mesh-list
153901776|NCT05816616|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
153443240|NCT02056392|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153443241|NCT02056392|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153443242|NCT02056392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153443243|NCT02056392|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153443244|NCT02034552|Prednisone|prednisone|mesh-list
153443262|NCT02011386|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153443263|NCT02011386|Immunologic Factors|immunologic factors|mesh-ancestor
153443264|NCT02011386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153443265|NCT02034162|Mebendazole|mebendazole|mesh-list
153443266|NCT02034162|Piperazine|piperazine|mesh-list
153443267|NCT02034162|Piperazine citrate|piperazine citrate|mesh-list
153443268|NCT02034162|DMP 777|dmp 777|mesh-list
153443269|NCT02034162|Antinematodal Agents|antinematodal agents|mesh-ancestor
153443270|NCT02034162|Anthelmintics|anthelmintics|mesh-ancestor
153901876|NCT05340868|Semaglutide|semaglutide|mesh-list
153901877|NCT05340868|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
153443293|NCT02052960|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153443294|NCT02052960|Immunologic Factors|immunologic factors|mesh-ancestor
153443295|NCT02052960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153443296|NCT02052960|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153443297|NCT02008890|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
153443298|NCT02008890|Immunologic Factors|immunologic factors|mesh-ancestor
153443299|NCT02008890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153443300|NCT02052414|Gabapentin|gabapentin|mesh-list
153443301|NCT02052414|Analgesics|analgesics|mesh-ancestor
153443302|NCT02052414|Sensory System Agents|sensory system agents|mesh-ancestor
153443303|NCT02052414|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153443304|NCT02052414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153443305|NCT02052414|Anticonvulsants|anticonvulsants|mesh-ancestor
153443306|NCT02052414|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153901885|NCT05323981|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153901887|NCT05311475|Mometasone Furoate|mometasone furoate|mesh-list
153901888|NCT05311475|Azelastine|azelastine|mesh-list
153901889|NCT05311475|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153901890|NCT05311475|Dermatologic Agents|dermatologic agents|mesh-ancestor
153901891|NCT05311475|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
153901892|NCT05311475|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153901930|NCT05255146|Anesthetics|anesthetics|mesh-ancestor
153901931|NCT05255146|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153901932|NCT05255146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153901933|NCT05255146|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153901934|NCT05255146|Analgesics|analgesics|mesh-ancestor
153901935|NCT05255146|Sensory System Agents|sensory system agents|mesh-ancestor
153901936|NCT05255146|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153901937|NCT05198609|Apatinib|apatinib|mesh-list
153901938|NCT05198609|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153901939|NCT05198609|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153901940|NCT05198609|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153901941|NCT05198609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153901942|NCT05191004|Fulvestrant|fulvestrant|mesh-list
153901943|NCT05191004|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153901944|NCT05191004|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153901945|NCT05191004|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
153443426|NCT02029638|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
153443427|NCT02029638|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153443428|NCT02029638|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153443429|NCT02029638|Anesthetics, Local|anesthetics, local|mesh-ancestor
153443447|NCT02047734|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153443448|NCT02047734|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
153443449|NCT02047734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153443450|NCT02047734|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153443475|NCT01994226|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153443476|NCT01994226|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153443477|NCT01994226|Gout Suppressants|gout suppressants|mesh-ancestor
153902060|NCT04591353|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153902061|NCT04591353|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
153443484|NCT01994226|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153443486|NCT02002884|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
153443487|NCT02002884|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
153443488|NCT02002884|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
153443489|NCT02002884|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
153443490|NCT02002884|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153443491|NCT02002884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153443492|NCT02002884|Cholinergic Agents|cholinergic agents|mesh-ancestor
153443493|NCT02002884|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153902077|NCT04402385|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153902078|NCT04402385|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153902079|NCT04402385|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153902080|NCT04402385|Antipyretics|antipyretics|mesh-ancestor
153902081|NCT04396730|Cannabidiol|cannabidiol|mesh-list
153902082|NCT04396730|Contraceptive Agents|contraceptive agents|mesh-list
153902083|NCT04396730|Contraceptives, Oral|contraceptives, oral|mesh-list
153902104|NCT04166877|Sensory System Agents|sensory system agents|mesh-ancestor
153902105|NCT04166877|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153902106|NCT04166877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153902107|NCT04166877|Anesthetics|anesthetics|mesh-ancestor
153902108|NCT04166877|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153902109|NCT04166877|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153902110|NCT04166877|Anticonvulsants|anticonvulsants|mesh-ancestor
153902111|NCT04166877|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153902115|NCT04166877|Tocolytic Agents|tocolytic agents|mesh-ancestor
153902149|NCT04098003|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
153902150|NCT04098003|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153902151|NCT04098003|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153902152|NCT04098003|Antimetabolites|antimetabolites|mesh-ancestor
153902153|NCT04098003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153902154|NCT04098003|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153902155|NCT04098003|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
153902156|NCT04098003|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153902157|NCT04049851|Ivermectin|ivermectin|mesh-list
153902178|NCT03785210|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153902179|NCT03785210|Vasodilator Agents|vasodilator agents|mesh-ancestor
153443643|NCT01986114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153443644|NCT01986114|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
153443645|NCT01986114|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153443646|NCT01986114|Serotonin Agents|serotonin agents|mesh-ancestor
153443647|NCT01986114|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
153443648|NCT01986114|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
153443649|NCT01986114|Dopamine Agents|dopamine agents|mesh-ancestor
153443650|NCT01945242|Alogliptin|alogliptin|mesh-list
153443651|NCT01945242|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153443652|NCT01945242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153443653|NCT01945242|Incretins|incretins|mesh-ancestor
153443654|NCT01945242|Hormones|hormones|mesh-ancestor
153902203|NCT03722498|Vitamins|vitamins|mesh-ancestor
153443664|NCT01963728|Insulin Glargine|insulin glargine|mesh-list
153443665|NCT01963728|Insulin, Isophane|insulin, isophane|mesh-list
153443666|NCT01963728|Isophane Insulin, Human|isophane insulin, human|mesh-list
153443667|NCT01963728|Isophane insulin, beef|isophane insulin, beef|mesh-list
153443668|NCT01963728|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153443669|NCT01963728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153443677|NCT01985334|Glycopyrrolate|glycopyrrolate|mesh-list
153443698|NCT01944462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153443699|NCT01942590|Clenbuterol|clenbuterol|mesh-list
153443700|NCT01942590|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
153443701|NCT01942590|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153443702|NCT01942590|Adrenergic Agents|adrenergic agents|mesh-ancestor
153443703|NCT01942590|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153443704|NCT01942590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153443705|NCT01942590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153443706|NCT01942590|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153443707|NCT01942590|Autonomic Agents|autonomic agents|mesh-ancestor
153443708|NCT01942590|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153443709|NCT01942590|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153443711|NCT01942590|Sympathomimetics|sympathomimetics|mesh-ancestor
153902301|NCT02432274|Etoposide phosphate|etoposide phosphate|mesh-list
153443723|NCT01984242|Growth Inhibitors|growth inhibitors|mesh-ancestor
153443724|NCT01984242|Immunologic Factors|immunologic factors|mesh-ancestor
153443725|NCT01984242|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153443726|NCT01984242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153443727|NCT01984242|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153443728|NCT01984242|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153443730|NCT01960842|Carbidopa|carbidopa|mesh-list
153443731|NCT01960842|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
153443732|NCT01960842|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
153443743|NCT01984164|Candesartan|candesartan|mesh-list
153902328|NCT01359592|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
153902329|NCT01359592|Vincristine|vincristine|mesh-list
153902330|NCT01359592|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
153902331|NCT01359592|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153902332|NCT01359592|Immunologic Factors|immunologic factors|mesh-ancestor
153902333|NCT01359592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153902334|NCT01359592|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153902335|NCT01359592|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153902341|NCT01359592|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153902342|NCT01359592|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153902343|NCT01359592|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153902344|NCT01359592|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153902345|NCT01359592|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153902346|NCT01359592|Glucocorticoids|glucocorticoids|mesh-ancestor
153902348|NCT01359592|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153902349|NCT01359592|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153902351|NCT01359592|Tubulin Modulators|tubulin modulators|mesh-ancestor
153902371|NCT01331018|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153902372|NCT01331018|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153902373|NCT01331018|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153902374|NCT01331018|Immunologic Factors|immunologic factors|mesh-ancestor
153902376|NCT01331018|Autonomic Agents|autonomic agents|mesh-ancestor
153902377|NCT01331018|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153902378|NCT01331018|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153902379|NCT01331018|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
153902380|NCT01331018|Protective Agents|protective agents|mesh-ancestor
153902381|NCT01331018|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153902382|NCT01331018|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153902383|NCT01331018|Antiviral Agents|antiviral agents|mesh-ancestor
153902384|NCT01331018|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153902385|NCT00840853|Acetaminophen|acetaminophen|mesh-list
153902386|NCT00840853|Diphenhydramine|diphenhydramine|mesh-list
153902387|NCT00840853|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153902388|NCT00840853|Analgesics|analgesics|mesh-ancestor
153902392|NCT00840853|Antipyretics|antipyretics|mesh-ancestor
153443846|NCT01980888|Idelalisib|idelalisib|mesh-list
153443847|NCT01980888|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153443848|NCT01980888|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153902399|NCT00840853|Autonomic Agents|autonomic agents|mesh-ancestor
153902400|NCT00840853|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153902485|NCT00931801|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153902486|NCT00931801|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153902487|NCT00931801|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
153902488|NCT00931801|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
153902489|NCT00931801|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
153902504|NCT05025397|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153902505|NCT05025397|Anesthetics, General|anesthetics, general|mesh-ancestor
153902506|NCT05025397|Anesthetics|anesthetics|mesh-ancestor
153902507|NCT05025397|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153902508|NCT05025397|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
153902509|NCT00608803|Doxorubicin|doxorubicin|mesh-list
153902510|NCT00608803|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153902511|NCT00608803|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153902512|NCT00608803|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153902513|NCT00608803|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153902514|NCT00608803|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153902515|NCT00608803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153443935|NCT01935336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153902517|NCT00931255|Tacrolimus|tacrolimus|mesh-list
153902518|NCT00931255|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153902519|NCT00931255|Immunologic Factors|immunologic factors|mesh-ancestor
153902520|NCT00931255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153443995|NCT01931202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153902573|NCT00929695|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153902574|NCT00929695|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153902575|NCT00929695|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
153902576|NCT00929695|Protective Agents|protective agents|mesh-ancestor
153902577|NCT00609895|Insulin Glargine|insulin glargine|mesh-list
153902578|NCT00609895|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153443996|NCT01931202|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153443997|NCT01931202|Serotonin Agents|serotonin agents|mesh-ancestor
153443998|NCT01931202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153443999|NCT01930890|Mycophenolic Acid|mycophenolic acid|mesh-list
153444000|NCT01930890|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153444001|NCT01930890|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153444002|NCT01930890|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
153444003|NCT01930890|Antitubercular Agents|antitubercular agents|mesh-ancestor
153902579|NCT00609895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153902581|NCT04261465|Carboplatin|carboplatin|mesh-list
153902582|NCT04261465|Olaparib|olaparib|mesh-list
153902583|NCT04261465|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153902584|NCT04261465|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153902585|NCT04261465|Tubulin Modulators|tubulin modulators|mesh-ancestor
153902586|NCT04261465|Antimitotic Agents|antimitotic agents|mesh-ancestor
153902587|NCT04261465|Mitosis Modulators|mitosis modulators|mesh-ancestor
153902588|NCT04261465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153902589|NCT04261465|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
153902590|NCT04261465|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153902591|NCT00927355|Pioglitazone|pioglitazone|mesh-list
153902592|NCT00927355|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153902593|NCT00927355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153902594|NCT00923845|Sirolimus|sirolimus|mesh-list
153902595|NCT00923845|Cyclophosphamide|cyclophosphamide|mesh-list
153902599|NCT00923845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153902600|NCT00923845|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153902601|NCT00923845|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153902602|NCT00923845|Alkylating Agents|alkylating agents|mesh-ancestor
153902603|NCT00923845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153902604|NCT00923845|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153902605|NCT00923845|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153902606|NCT00923845|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153902607|NCT00923845|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153902608|NCT00923845|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153902609|NCT00923845|Antifungal Agents|antifungal agents|mesh-ancestor
153902610|NCT00923845|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153902611|NCT00923845|Adenosine Deaminase Inhibitors|adenosine deaminase inhibitors|mesh-ancestor
153902622|NCT05052541|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153902623|NCT05052541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153902624|NCT05052541|Hormones|hormones|mesh-ancestor
153902625|NCT05052541|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153902626|NCT04260685|Lidocaine|lidocaine|mesh-list
153902627|NCT04260685|Esmolol|esmolol|mesh-list
153902628|NCT04260685|Anesthetics, Local|anesthetics, local|mesh-ancestor
153902629|NCT04260685|Anesthetics|anesthetics|mesh-ancestor
153902630|NCT04260685|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153444050|NCT01929876|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
153444052|NCT01928940|Dabrafenib|dabrafenib|mesh-list
153444053|NCT01928940|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153444054|NCT01928940|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153444055|NCT01928940|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153444056|NCT01928940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153444057|NCT01954056|Hydrocortisone|hydrocortisone|mesh-list
153444058|NCT01954056|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153444059|NCT01975272|Iron|iron|mesh-list
153444060|NCT01975272|Ferrous fumarate|ferrous fumarate|mesh-list
153444065|NCT01975272|Hematinics|hematinics|mesh-ancestor
153902655|NCT05013463|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153902656|NCT05013463|Diuretics|diuretics|mesh-ancestor
153902657|NCT05013463|Natriuretic Agents|natriuretic agents|mesh-ancestor
153902658|NCT05013463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153902659|NCT05013463|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
153444080|NCT03571607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153444081|NCT03993119|Anticoagulants|anticoagulants|mesh-list
153444082|NCT03910439|Avelumab|avelumab|mesh-list
153444083|NCT03910439|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153444084|NCT03910439|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153444085|NCT03895307|Anesthetics|anesthetics|mesh-list
153444086|NCT03895307|Anesthetics, Local|anesthetics, local|mesh-list
153902692|NCT04255771|Cisplatin|cisplatin|mesh-list
153902693|NCT04255771|Gemcitabine|gemcitabine|mesh-list
153902694|NCT04255771|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153902695|NCT04255771|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153902696|NCT04255771|Antimetabolites|antimetabolites|mesh-ancestor
153902697|NCT04255771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153902698|NCT01218204|Atorvastatin|atorvastatin|mesh-list
153902699|NCT01218204|Ezetimibe|ezetimibe|mesh-list
153902700|NCT01218204|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153902701|NCT01218204|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153902702|NCT01218204|Antimetabolites|antimetabolites|mesh-ancestor
153902703|NCT01218204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153902704|NCT01218204|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153902705|NCT01218204|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
153902706|NCT01218204|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153902707|NCT00926575|Beclomethasone|beclomethasone|mesh-list
153444131|NCT02995967|Cholinergic Agents|cholinergic agents|mesh-ancestor
153902708|NCT00926575|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153902709|NCT00926575|Glucocorticoids|glucocorticoids|mesh-ancestor
153902710|NCT00926575|Hormones|hormones|mesh-ancestor
153902758|NCT01217190|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153902759|NCT01217190|Antipruritics|antipruritics|mesh-ancestor
153902760|NCT01217190|Dermatologic Agents|dermatologic agents|mesh-ancestor
153902761|NCT01217190|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
153902762|NCT01217190|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153902763|NCT01217190|Serotonin Agents|serotonin agents|mesh-ancestor
153902764|NCT01217190|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153902765|NCT01217190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153902767|NCT01136733|Lenvatinib|lenvatinib|mesh-list
153902768|NCT01136733|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
153444195|NCT00378443|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153444196|NCT00378443|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
153444197|NCT00378443|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
153444198|NCT00378443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153444199|NCT00378443|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
153444200|NCT00378443|Protease Inhibitors|protease inhibitors|mesh-ancestor
153444201|NCT00378443|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153444202|NCT01340573|Interferons|interferons|mesh-list
153444203|NCT01340573|Ribavirin|ribavirin|mesh-list
153902769|NCT01136733|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153902770|NCT01136733|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153902771|NCT01136733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153902772|NCT01136733|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153902773|NCT01136733|Immunologic Factors|immunologic factors|mesh-ancestor
153444277|NCT02708849|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153902845|NCT00922207|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153902846|NCT00922207|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153902847|NCT00922207|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153444278|NCT02708849|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153902862|NCT01216176|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153902863|NCT01216176|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
153902864|NCT01216176|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153902865|NCT01216176|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153902866|NCT01216176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153902867|NCT01216176|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
153902868|NCT01216176|Hormone Antagonists|hormone antagonists|mesh-ancestor
153444300|NCT01219673|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153444301|NCT01219673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153444302|NCT01219673|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
153444303|NCT01219673|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153444304|NCT01219673|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153444305|NCT01219673|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153902877|NCT01133847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153902878|NCT01133847|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
153902879|NCT01133847|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153902880|NCT01133847|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153902881|NCT01133847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153902883|NCT01133847|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153902884|NCT01133847|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
153902885|NCT01133847|Adrenergic Agents|adrenergic agents|mesh-ancestor
153902886|NCT01133847|Sympathomimetics|sympathomimetics|mesh-ancestor
153902887|NCT01133847|Autonomic Agents|autonomic agents|mesh-ancestor
153902888|NCT01133847|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153902889|NCT01133847|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153902890|NCT01133847|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
153902891|NCT01133847|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153902904|NCT00637455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153902905|NCT00637455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153902906|NCT00919711|Denosumab|denosumab|mesh-list
153902907|NCT00919711|Risedronic Acid|risedronic acid|mesh-list
153902908|NCT00919711|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153902909|NCT00919711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153902910|NCT00919711|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153902911|NCT00919711|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153902912|NCT00919711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153902913|NCT00919711|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153902914|NCT01131585|Ranibizumab|ranibizumab|mesh-list
153902944|NCT00926029|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
153902945|NCT00926029|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153902946|NCT00926029|Antimetabolites|antimetabolites|mesh-ancestor
153902947|NCT00926029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153902948|NCT00926029|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153444445|NCT02499887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153444446|NCT02499887|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153902987|NCT04252963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153902988|NCT04258657|Paclitaxel|paclitaxel|mesh-list
153902989|NCT04258657|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153902990|NCT04258657|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153902991|NCT04258657|Tubulin Modulators|tubulin modulators|mesh-ancestor
153902992|NCT04258657|Antimitotic Agents|antimitotic agents|mesh-ancestor
153902993|NCT04258657|Mitosis Modulators|mitosis modulators|mesh-ancestor
153902994|NCT04258657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153444483|NCT01094561|Hormones|hormones|mesh-ancestor
153444484|NCT01094561|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153444485|NCT01094561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153444486|NCT01074437|Prednisolone|prednisolone|mesh-list
153444487|NCT01074437|Propranolol|propranolol|mesh-list
153444488|NCT01074437|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153444489|NCT01074437|Glucocorticoids|glucocorticoids|mesh-ancestor
153444490|NCT01074437|Hormones|hormones|mesh-ancestor
153444491|NCT01074437|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153444492|NCT01074437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153444493|NCT01074437|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153444503|NCT03807245|Aluminum Hydroxide|aluminum hydroxide|mesh-list
153444504|NCT03807245|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153444505|NCT03807245|Immunologic Factors|immunologic factors|mesh-ancestor
153444506|NCT03807245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153444507|NCT03807245|Antacids|antacids|mesh-ancestor
153444525|NCT03793751|Adrenergic Agents|adrenergic agents|mesh-ancestor
153444526|NCT03793751|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153444527|NCT03793751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153444528|NCT01016561|Cisplatin|cisplatin|mesh-list
153444529|NCT01016561|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153444530|NCT01009931|Dexamethasone|dexamethasone|mesh-list
153444531|NCT01009931|Dexamethasone acetate|dexamethasone acetate|mesh-list
153444532|NCT01009931|Choline magnesium trisalicylate|choline magnesium trisalicylate|mesh-list
153444533|NCT01009931|Choline|choline|mesh-list
153444534|NCT01009931|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
153444535|NCT01009931|BB 1101|bb 1101|mesh-list
153444536|NCT01009931|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153444537|NCT01009931|Antiemetics|antiemetics|mesh-ancestor
153444538|NCT01009931|Autonomic Agents|autonomic agents|mesh-ancestor
153444539|NCT01009931|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153444540|NCT01009931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153444541|NCT01009931|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153444542|NCT01009931|Glucocorticoids|glucocorticoids|mesh-ancestor
153444543|NCT01009931|Hormones|hormones|mesh-ancestor
153444544|NCT01009931|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153444545|NCT01009931|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153444546|NCT01009931|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153444547|NCT01009931|Protease Inhibitors|protease inhibitors|mesh-ancestor
153444548|NCT01009931|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153444549|NCT01009931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153444552|NCT01009931|Antimetabolites|antimetabolites|mesh-ancestor
153903099|NCT04962841|Vasodilator Agents|vasodilator agents|mesh-ancestor
153903100|NCT04962841|Antidepressive Agents|antidepressive agents|mesh-ancestor
153903101|NCT04962841|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153903102|NCT04962841|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
153903103|NCT04962841|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153903104|NCT04962841|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153903105|NCT04962841|Serotonin Agents|serotonin agents|mesh-ancestor
153903106|NCT04962841|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
153903107|NCT04962841|Protease Inhibitors|protease inhibitors|mesh-ancestor
153903108|NCT04962841|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153903109|NCT04962841|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
153903110|NCT04962841|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
153903111|NCT04962841|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153903112|NCT04962841|Adrenergic Agents|adrenergic agents|mesh-ancestor
153903113|NCT04962841|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
153903114|NCT04962841|Cholinergic Agents|cholinergic agents|mesh-ancestor
153903115|NCT04962841|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
153903116|NCT04962841|Protective Agents|protective agents|mesh-ancestor
153903117|NCT00919867|Guanfacine|guanfacine|mesh-list
153903118|NCT00919867|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
153444565|NCT03792191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153444567|NCT03792191|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153444568|NCT03792191|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153444569|NCT03792191|Narcotics|narcotics|mesh-ancestor
153444570|NCT03792191|Analgesics|analgesics|mesh-ancestor
153444575|NCT00986999|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153444576|NCT00986999|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153444577|NCT00986999|Antimetabolites|antimetabolites|mesh-ancestor
153444578|NCT00986999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153444579|NCT00986999|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153444580|NCT00986999|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
153444581|NCT00986999|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153444582|NCT00983645|Cyclosporine|cyclosporine|mesh-list
153444584|NCT00983645|Cyclosporins|cyclosporins|mesh-list
153444585|NCT00983645|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153444586|NCT00983645|Immunologic Factors|immunologic factors|mesh-ancestor
153444587|NCT00983645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153444588|NCT00983645|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
153444592|NCT00983645|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153444593|NCT00983645|Dermatologic Agents|dermatologic agents|mesh-ancestor
153444594|NCT00983645|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153444595|NCT00978419|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
153444596|NCT00978419|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153444597|NCT00978419|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153444598|NCT00978419|Antimetabolites|antimetabolites|mesh-ancestor
153444599|NCT00978419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153444600|NCT00978419|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153444601|NCT00978419|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
153444602|NCT00978419|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153903186|NCT05330065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153903187|NCT05330065|Growth Inhibitors|growth inhibitors|mesh-ancestor
153903188|NCT01128543|Vinorelbine|vinorelbine|mesh-list
153903189|NCT01128543|Lapatinib|lapatinib|mesh-list
153903192|NCT01128543|Tubulin Modulators|tubulin modulators|mesh-ancestor
153903240|NCT01127607|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153903241|NCT01127607|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153903242|NCT01127607|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153903243|NCT01127607|Dopamine Agents|dopamine agents|mesh-ancestor
153903244|NCT01127607|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153903245|NCT00924781|Epoetin Alfa|epoetin alfa|mesh-list
153903246|NCT00924781|Hematinics|hematinics|mesh-ancestor
153903247|NCT01127451|Denileukin diftitox|denileukin diftitox|mesh-list
153903248|NCT01127451|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153903249|NCT01214616|Vinorelbine|vinorelbine|mesh-list
153903250|NCT01214616|Afatinib|afatinib|mesh-list
153903251|NCT01214616|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153903252|NCT01214616|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153444695|NCT00825227|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
153444696|NCT00825227|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
153444697|NCT00825227|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
153444698|NCT00825227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153444700|NCT01978535|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
153444701|NCT01978535|Trace Elements|trace elements|mesh-ancestor
153444702|NCT01978535|Micronutrients|micronutrients|mesh-ancestor
153903276|NCT01213524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153903277|NCT01212588|Mifepristone|mifepristone|mesh-list
153903285|NCT01212588|Contraceptive Agents|contraceptive agents|mesh-ancestor
153444774|NCT00780455|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153444775|NCT00780455|Antiviral Agents|antiviral agents|mesh-ancestor
153444776|NCT00780455|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153444777|NCT00780455|Immunologic Factors|immunologic factors|mesh-ancestor
153444826|NCT03426137|Analgesics|analgesics|mesh-ancestor
153903620|NCT05566223|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153904000|NCT04293172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153904055|NCT00996658|Linagliptin|linagliptin|mesh-list
153904176|NCT01255787|Serotonin Agents|serotonin agents|mesh-ancestor
153904329|NCT04319471|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153904345|NCT00993616|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
153904441|NCT01252355|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153445973|NCT00380939|Antimetabolites|antimetabolites|mesh-ancestor
153446118|NCT00000623|Decitabine|decitabine|mesh-list
153446269|NCT00000695|Interferon beta-1b|interferon beta-1b|mesh-list
153446299|NCT00000725|Zidovudine|zidovudine|mesh-list
153446464|NCT00002093|Vincristine|vincristine|mesh-list
153446729|NCT00002393|Protease Inhibitors|protease inhibitors|mesh-ancestor
153906096|NCT02866396|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153906229|NCT02864602|Dexamethasone|dexamethasone|mesh-list
153906309|NCT00906373|Immunologic Factors|immunologic factors|mesh-ancestor
153906330|NCT04220203|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153906351|NCT02850211|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
153906392|NCT05324215|Anesthetics, General|anesthetics, general|mesh-ancestor
153906393|NCT05324215|Anesthetics|anesthetics|mesh-ancestor
153448054|NCT00002897|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153448097|NCT00002933|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153448126|NCT00002945|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153448177|NCT00002969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153448205|NCT00002987|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153448206|NCT00002987|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153448298|NCT00003035|Tamoxifen|tamoxifen|mesh-list
153448397|NCT00003113|Lomustine|lomustine|mesh-list
153907644|NCT00895843|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153907765|NCT02834845|Desflurane|desflurane|mesh-list
153907766|NCT02834845|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153907842|NCT02836639|Alkylating Agents|alkylating agents|mesh-ancestor
153907906|NCT05170672|Immunologic Factors|immunologic factors|mesh-ancestor
153907922|NCT00970684|Tubulin Modulators|tubulin modulators|mesh-ancestor
153907976|NCT04285528|Ketamine|ketamine|mesh-list
153908002|NCT00629824|Interferon-alpha|interferon-alpha|mesh-list
153449667|NCT00004229|Growth Inhibitors|growth inhibitors|mesh-ancestor
153449694|NCT00003335|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153449696|NCT00003335|Autonomic Agents|autonomic agents|mesh-ancestor
153449697|NCT00003335|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153449753|NCT00004865|Paclitaxel|paclitaxel|mesh-list
153449774|NCT00004361|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
153449834|NCT00004889|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153449866|NCT00004913|Leucovorin|leucovorin|mesh-list
153449890|NCT00004919|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
153450015|NCT00004643|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153450016|NCT00004643|Antiviral Agents|antiviral agents|mesh-ancestor
153450156|NCT00004799|Vaccines|vaccines|mesh-list
153450222|NCT00385463|Autonomic Agents|autonomic agents|mesh-ancestor
153450224|NCT00385463|Glucocorticoids|glucocorticoids|mesh-ancestor
153450356|NCT00005603|Antimitotic Agents|antimitotic agents|mesh-ancestor
153908860|NCT04642651|Analgesics|analgesics|mesh-ancestor
153908861|NCT04642651|Sensory System Agents|sensory system agents|mesh-ancestor
153908862|NCT04642651|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153908863|NCT04642651|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
153908864|NCT04642651|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153908865|NCT04642651|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153908866|NCT04642651|Adrenergic Agents|adrenergic agents|mesh-ancestor
153908867|NCT04642651|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153908868|NCT04642651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153908869|NCT01061151|Ritonavir|ritonavir|mesh-list
153909012|NCT02874963|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153909235|NCT01233050|Ethanol|ethanol|mesh-list
153909282|NCT01230788|Rituximab|rituximab|mesh-list
153909321|NCT02811055|Aprepitant|aprepitant|mesh-list
153909354|NCT02810275|Antidotes|antidotes|mesh-ancestor
153909385|NCT02858206|Antimitotic Agents|antimitotic agents|mesh-ancestor
153452419|NCT01832532|Incretins|incretins|mesh-ancestor
153452420|NCT01832532|Hormones|hormones|mesh-ancestor
153910732|NCT05322031|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
153452520|NCT01611090|Alkylating Agents|alkylating agents|mesh-ancestor
153452521|NCT01611090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153452524|NCT01611090|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153452638|NCT01797120|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
153452719|NCT01818726|Iron Chelating Agents|iron chelating agents|mesh-ancestor
153911021|NCT04771741|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
153911098|NCT02771509|Mitogens|mitogens|mesh-list
153911475|NCT02758249|Sevoflurane|sevoflurane|mesh-list
153911715|NCT00061282|Clotrimazole|clotrimazole|mesh-list
153911716|NCT00061282|Miconazole|miconazole|mesh-list
153911717|NCT00061282|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
153911719|NCT00061282|Antifungal Agents|antifungal agents|mesh-ancestor
153911803|NCT01187550|Hormones|hormones|mesh-list
153911843|NCT00638209|Insulin|insulin|mesh-list
153911877|NCT01185366|Everolimus|everolimus|mesh-list
153911920|NCT01183884|Tretinoin|tretinoin|mesh-list
153911965|NCT01190436|Bisoprolol|bisoprolol|mesh-list
153912042|NCT01189500|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
153912068|NCT00604396|Insulin, Isophane|insulin, isophane|mesh-list
153912069|NCT00604396|Isophane insulin, beef|isophane insulin, beef|mesh-list
153912070|NCT00604396|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153912119|NCT01022853|Nintedanib|nintedanib|mesh-list
153912216|NCT00604864|Immunologic Factors|immunologic factors|mesh-ancestor
153912340|NCT01032837|Oseltamivir|oseltamivir|mesh-list
153912454|NCT02760901|Mannitol|mannitol|mesh-list
153912529|NCT04219579|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153912576|NCT01028391|Protease Inhibitors|protease inhibitors|mesh-ancestor
153912637|NCT01179516|Vortioxetine|vortioxetine|mesh-list
153912853|NCT04359979|Tamsulosin|tamsulosin|mesh-list
153912923|NCT02748265|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153912961|NCT02695381|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153913023|NCT02281981|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153913075|NCT00636259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153454858|NCT01522950|Atenolol|atenolol|mesh-list
153454885|NCT01570686|Renin Inhibitors|renin inhibitors|mesh-ancestor
153455124|NCT04087590|Formoterol Fumarate|formoterol fumarate|mesh-list
153455180|NCT01461096|Vaccines|vaccines|mesh-list
153455207|NCT01505868|Carboplatin|carboplatin|mesh-list
153455208|NCT01505868|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153455209|NCT01505634|Ciprofloxacin|ciprofloxacin|mesh-list
153455213|NCT01505634|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153455235|NCT01459614|Gemcitabine|gemcitabine|mesh-list
153455307|NCT06175156|Anesthetics|anesthetics|mesh-list
153455335|NCT06174922|Glucocorticoids|glucocorticoids|mesh-ancestor
153455447|NCT06131905|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153455497|NCT05894603|Protease Inhibitors|protease inhibitors|mesh-ancestor
153455498|NCT05894603|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153455515|NCT05877430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153455516|NCT05874141|Hormones|hormones|mesh-list
153455517|NCT05874141|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153455518|NCT05874141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153455519|NCT05846724|Pembrolizumab|pembrolizumab|mesh-list
153455520|NCT05846724|Lenvatinib|lenvatinib|mesh-list
153455828|NCT04756401|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153455974|NCT04197687|Trastuzumab biosimilar HLX02|trastuzumab biosimilar hlx02|mesh-list
153455975|NCT04197687|Vaccines|vaccines|mesh-list
153455996|NCT04186494|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153914361|NCT01025817|Antitubercular Agents|antitubercular agents|mesh-ancestor
153914380|NCT00605410|Cholinergic Agents|cholinergic agents|mesh-ancestor
153914401|NCT00611689|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153914402|NCT00611689|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153914403|NCT00611689|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153914404|NCT00611689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153914414|NCT05264077|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153914415|NCT05264077|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
153914416|NCT05264077|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153914417|NCT05264077|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153914418|NCT05264077|Adrenergic Agents|adrenergic agents|mesh-ancestor
153914419|NCT05264077|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153914420|NCT05264077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153456213|NCT03404778|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153456214|NCT03404778|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
153456215|NCT03404778|Histamine Antagonists|histamine antagonists|mesh-ancestor
153456216|NCT03404778|Histamine Agents|histamine agents|mesh-ancestor
153456217|NCT03404778|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153456218|NCT03404778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153456219|NCT03404778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153456220|NCT03404778|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
153456221|NCT03404778|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153456222|NCT03404778|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153456223|NCT03386929|Palbociclib|palbociclib|mesh-list
153456224|NCT03386929|Avelumab|avelumab|mesh-list
153457154|NCT01405950|Anticonvulsants|anticonvulsants|mesh-ancestor
153457158|NCT01405950|Autonomic Agents|autonomic agents|mesh-ancestor
153457170|NCT01405560|Antiviral Agents|antiviral agents|mesh-ancestor
153457197|NCT01442688|Analgesics|analgesics|mesh-ancestor
153457216|NCT03814200|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
153457288|NCT01400958|Modafinil|modafinil|mesh-list
153457329|NCT01422720|Anticonvulsants|anticonvulsants|mesh-ancestor
153457380|NCT01386606|Clomiphene|clomiphene|mesh-list
153457422|NCT01384734|Tenofovir|tenofovir|mesh-list
153457423|NCT01384734|Raltegravir Potassium|raltegravir potassium|mesh-list
153457448|NCT01383954|Diclofenac|diclofenac|mesh-list
153457481|NCT01396278|Fluticasone|fluticasone|mesh-list
153457496|NCT05365074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153457497|NCT05365074|Sensory System Agents|sensory system agents|mesh-ancestor
153457498|NCT05365074|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153457511|NCT01382940|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153457512|NCT01382940|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153457548|NCT01381926|Incretins|incretins|mesh-ancestor
153457579|NCT01381692|BB 1101|bb 1101|mesh-list
153457602|NCT01395030|Choline|choline|mesh-list
153457691|NCT05630274|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153457692|NCT05630274|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153457731|NCT04407312|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
153457863|NCT03599466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153458054|NCT03023436|Capecitabine|capecitabine|mesh-list
153458095|NCT04194294|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153458251|NCT04190160|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153458254|NCT04190160|Hormones|hormones|mesh-ancestor
153458278|NCT04406610|Immunologic Factors|immunologic factors|mesh-ancestor
153458304|NCT04020666|Fertility Agents|fertility agents|mesh-ancestor
153458305|NCT04020666|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153458307|NCT04021992|Rituximab|rituximab|mesh-list
153458334|NCT04020588|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153458335|NCT04020588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153458336|NCT04020588|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153458337|NCT04020588|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153816998|NCT00427388|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153816999|NCT00427388|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
153817000|NCT00427388|Protective Agents|protective agents|mesh-ancestor
153458415|NCT04144218|Anticonvulsants|anticonvulsants|mesh-ancestor
153458434|NCT04143906|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153458463|NCT04143282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153458504|NCT04141410|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
153458535|NCT04149132|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153458567|NCT04146324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153458568|NCT03588936|Nivolumab|nivolumab|mesh-list
153458569|NCT03588936|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153458570|NCT03588936|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153817193|NCT00460785|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153817194|NCT01054976|Galantamine|galantamine|mesh-list
153817195|NCT01054976|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
153817196|NCT01054976|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153817197|NCT01054976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153817198|NCT01054976|Cholinergic Agents|cholinergic agents|mesh-ancestor
153817199|NCT01054976|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153817200|NCT01054976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153817201|NCT01054976|Parasympathomimetics|parasympathomimetics|mesh-ancestor
153817202|NCT01054976|Autonomic Agents|autonomic agents|mesh-ancestor
153817203|NCT01054976|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153817204|NCT01054976|Nootropic Agents|nootropic agents|mesh-ancestor
153817205|NCT00469443|Leucovorin|leucovorin|mesh-list
153817206|NCT00469443|Bevacizumab|bevacizumab|mesh-list
153817207|NCT00469443|Capecitabine|capecitabine|mesh-list
153817208|NCT00469443|Fluorouracil|fluorouracil|mesh-list
153817209|NCT00469443|Irinotecan|irinotecan|mesh-list
153817210|NCT00469443|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153817211|NCT00469443|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153817212|NCT00469443|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153817213|NCT00469443|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153817214|NCT00469443|Growth Substances|growth substances|mesh-ancestor
153458573|NCT03022500|Durvalumab|durvalumab|mesh-list
153817238|NCT00428909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153817240|NCT00428909|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153817241|NCT00428909|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153817242|NCT00428909|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153458607|NCT04148820|Antipyretics|antipyretics|mesh-ancestor
153817269|NCT06189404|Theophylline|theophylline|mesh-list
153817282|NCT06189404|Purinergic Agents|purinergic agents|mesh-ancestor
153817304|NCT06188767|Anabolic Agents|anabolic agents|mesh-ancestor
153817347|NCT06188546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153817364|NCT06188442|Antimalarials|antimalarials|mesh-ancestor
153817365|NCT06188442|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153817366|NCT06188442|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153458729|NCT03589326|Dexamethasone|dexamethasone|mesh-list
153817380|NCT06188221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153817394|NCT06188195|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153458774|NCT03585036|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153458775|NCT03585036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153458776|NCT03585036|Analgesics|analgesics|mesh-ancestor
153458777|NCT03585036|Sensory System Agents|sensory system agents|mesh-ancestor
153458778|NCT03585036|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153458779|NCT03585036|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153458780|NCT03585036|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153458781|NCT03585036|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153458782|NCT03585036|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153458783|NCT03155568|Bupivacaine|bupivacaine|mesh-list
153458784|NCT03155568|Anesthetics, Local|anesthetics, local|mesh-ancestor
153458785|NCT03155568|Anesthetics|anesthetics|mesh-ancestor
153458786|NCT03155568|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153458787|NCT03155568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153458788|NCT03155568|Sensory System Agents|sensory system agents|mesh-ancestor
153919553|NCT00028678|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153919554|NCT00028678|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153919555|NCT00028678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153919556|NCT00004223|Gemcitabine|gemcitabine|mesh-list
153919557|NCT00004223|Docetaxel|docetaxel|mesh-list
153468315|NCT06298123|Antibodies|antibodies|mesh-list
153468316|NCT06298123|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
153468317|NCT06298123|Immunologic Factors|immunologic factors|mesh-ancestor
153468318|NCT06298123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153817671|NCT06174402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153817673|NCT06165900|Paclitaxel|paclitaxel|mesh-list
153817674|NCT06165900|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
153817675|NCT06165900|Carboplatin|carboplatin|mesh-list
153817676|NCT06165900|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153817677|NCT06165900|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153459079|NCT05353062|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153459080|NCT05353062|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153459081|NCT05353062|Adrenergic Agents|adrenergic agents|mesh-ancestor
153459117|NCT01674738|Bevacizumab|bevacizumab|mesh-list
153460655|NCT00634634|Hormone Antagonists|hormone antagonists|mesh-ancestor
153460681|NCT00049595|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153460682|NCT00049595|Immunologic Factors|immunologic factors|mesh-ancestor
153460801|NCT03524508|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153460835|NCT03779646|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
153460836|NCT03779646|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
153819467|NCT01004978|Doxorubicin|doxorubicin|mesh-list
153461038|NCT03087942|Indoleacetic Acids|indoleacetic acids|mesh-list
153819612|NCT00226421|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153819643|NCT00066703|Tamoxifen|tamoxifen|mesh-list
153891201|NCT01030900|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153891202|NCT01030900|Alkylating Agents|alkylating agents|mesh-ancestor
153891203|NCT01030900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153891204|NCT01030900|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153891205|NCT01030900|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153891206|NCT01030900|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153891207|NCT01030900|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153891208|NCT01030900|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153820601|NCT00472368|Panobinostat|panobinostat|mesh-list
153820698|NCT00434135|Pemetrexed|pemetrexed|mesh-list
153820700|NCT00434135|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153891209|NCT01030900|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153891210|NCT01030900|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153891211|NCT01030900|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153891212|NCT01030900|Glucocorticoids|glucocorticoids|mesh-ancestor
153891213|NCT01030900|Hormones|hormones|mesh-ancestor
153891214|NCT01030900|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153891215|NCT01030900|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153668041|NCT00030654|Docetaxel|docetaxel|mesh-list
153668042|NCT00030654|Doxorubicin|doxorubicin|mesh-list
153668043|NCT00030654|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
153668044|NCT00030654|Bicalutamide|bicalutamide|mesh-list
153668045|NCT00030654|Flutamide|flutamide|mesh-list
153668046|NCT00030654|Estramustine|estramustine|mesh-list
153668047|NCT00030654|Hormones|hormones|mesh-list
153668048|NCT00030654|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153668049|NCT00030654|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153668050|NCT00030654|Tubulin Modulators|tubulin modulators|mesh-ancestor
153668051|NCT00030654|Antimitotic Agents|antimitotic agents|mesh-ancestor
153668052|NCT00030654|Mitosis Modulators|mitosis modulators|mesh-ancestor
153668053|NCT00030654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153668054|NCT00030654|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153668055|NCT00030654|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153668056|NCT00030654|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153668057|NCT00030654|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153668058|NCT00030654|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153668059|NCT00030654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153668060|NCT00030654|Antifungal Agents|antifungal agents|mesh-ancestor
153668061|NCT00030654|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153668062|NCT00030654|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
153668063|NCT00030654|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153668064|NCT00030654|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153668065|NCT00030654|Hormone Antagonists|hormone antagonists|mesh-ancestor
153668066|NCT00030654|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
153668067|NCT00030654|Androgen Antagonists|androgen antagonists|mesh-ancestor
153668069|NCT00030654|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153668070|NCT00030654|Alkylating Agents|alkylating agents|mesh-ancestor
153668073|NCT03852407|Fludarabine|fludarabine|mesh-list
153668074|NCT03852407|Thymoglobulin|thymoglobulin|mesh-list
153668075|NCT03852407|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153668076|NCT03852407|Immunologic Factors|immunologic factors|mesh-ancestor
153668077|NCT03852407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153668078|NCT03852407|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153668079|NCT03852407|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153668080|NCT03852407|Alkylating Agents|alkylating agents|mesh-ancestor
153668081|NCT03852407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153668082|NCT03852407|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153668083|NCT03852407|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153668084|NCT00030693|Metronidazole|metronidazole|mesh-list
153668085|NCT00030693|Vaccines|vaccines|mesh-list
153668086|NCT00030693|Immunologic Factors|immunologic factors|mesh-ancestor
153668087|NCT00030693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153668088|NCT00030693|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153668089|NCT00030693|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153668090|NCT00030693|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153505048|NCT02659306|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153668091|NCT00030693|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153668092|NCT03823274|Aspirin|aspirin|mesh-list
153668093|NCT03823274|Clopidogrel|clopidogrel|mesh-list
153668094|NCT03823274|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153668095|NCT03823274|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153668096|NCT03823274|Analgesics|analgesics|mesh-ancestor
153668097|NCT03823274|Sensory System Agents|sensory system agents|mesh-ancestor
153668098|NCT03823274|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153668099|NCT03823274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153668119|NCT00030732|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153668120|NCT00030810|Docetaxel|docetaxel|mesh-list
153668121|NCT00030810|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153668122|NCT00030810|Tubulin Modulators|tubulin modulators|mesh-ancestor
153668123|NCT00030810|Antimitotic Agents|antimitotic agents|mesh-ancestor
153668124|NCT00030810|Mitosis Modulators|mitosis modulators|mesh-ancestor
153668125|NCT00030810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153668126|NCT00030849|Interferons|interferons|mesh-list
153668127|NCT00030849|Interferon-alpha|interferon-alpha|mesh-list
153668128|NCT00030849|Bexarotene|bexarotene|mesh-list
153668129|NCT00030849|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153668130|NCT00030849|Antiviral Agents|antiviral agents|mesh-ancestor
153668131|NCT00030849|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153668132|NCT00030849|Immunologic Factors|immunologic factors|mesh-ancestor
153668133|NCT00030849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153668134|NCT00030888|7-hydroxystaurosporine|7-hydroxystaurosporine|mesh-list
153668135|NCT00030888|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153668136|NCT00030888|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153668137|NCT00030888|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153668138|NCT00030888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153668139|NCT00030966|Natalizumab|natalizumab|mesh-list
153668140|NCT00030966|Immunologic Factors|immunologic factors|mesh-ancestor
153668141|NCT00030966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153668142|NCT03715205|Pembrolizumab|pembrolizumab|mesh-list
153668143|NCT03715205|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153668144|NCT03715205|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153668145|NCT03715205|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153668146|NCT03715205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153668147|NCT00031044|Enfuvirtide|enfuvirtide|mesh-list
153668148|NCT00031044|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
153668149|NCT00031044|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
153668150|NCT00031044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153668151|NCT00031044|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153668152|NCT00031044|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153668153|NCT00031044|Antiviral Agents|antiviral agents|mesh-ancestor
153668154|NCT00031044|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153668157|NCT03698006|Anesthetics, Local|anesthetics, local|mesh-ancestor
153668158|NCT03698006|Anesthetics|anesthetics|mesh-ancestor
153668159|NCT03698006|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153668160|NCT03698006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153668161|NCT03698006|Sensory System Agents|sensory system agents|mesh-ancestor
153668162|NCT03698006|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153668163|NCT00031083|Interferons|interferons|mesh-list
153668164|NCT00031083|Interferon-beta|interferon-beta|mesh-list
153505126|NCT01763671|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153668165|NCT00031083|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153668166|NCT00031083|Antiviral Agents|antiviral agents|mesh-ancestor
153668167|NCT00031083|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153668168|NCT00031083|Immunologic Factors|immunologic factors|mesh-ancestor
153668169|NCT00031083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153668170|NCT03559985|Acetaminophen|acetaminophen|mesh-list
153668171|NCT03559985|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153668172|NCT03559985|Analgesics|analgesics|mesh-ancestor
153668173|NCT03559985|Sensory System Agents|sensory system agents|mesh-ancestor
153668174|NCT03559985|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153668175|NCT03559985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153668176|NCT03559985|Antipyretics|antipyretics|mesh-ancestor
153668177|NCT04711863|Fluvoxamine|fluvoxamine|mesh-list
153668178|NCT04711863|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153668179|NCT04711863|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153668180|NCT04711863|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153668181|NCT04711863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153668182|NCT04711863|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153668183|NCT04711863|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
153668184|NCT04711863|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153668185|NCT04711863|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153668186|NCT04711863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153668187|NCT04711863|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153668188|NCT04711863|Serotonin Agents|serotonin agents|mesh-ancestor
153668189|NCT04711863|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
153668190|NCT04711863|Antidepressive Agents|antidepressive agents|mesh-ancestor
153668194|NCT04711863|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
153668195|NCT00392912|Methyltestosterone|methyltestosterone|mesh-list
153668196|NCT00392912|Testosterone|testosterone|mesh-list
153668197|NCT00392912|Testosterone undecanoate|testosterone undecanoate|mesh-list
153668198|NCT00392912|Testosterone enanthate|testosterone enanthate|mesh-list
153668199|NCT00392912|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
153668200|NCT00392912|Androgens|androgens|mesh-ancestor
153668201|NCT00392912|Hormones|hormones|mesh-ancestor
153668202|NCT00392912|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153668203|NCT00392912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153668204|NCT00392912|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153668205|NCT00392912|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153668206|NCT00392912|Anabolic Agents|anabolic agents|mesh-ancestor
153668207|NCT04712058|Tenofovir|tenofovir|mesh-list
153668208|NCT04712058|Emtricitabine|emtricitabine|mesh-list
153668209|NCT04712058|Emtricitabine tenofovir alafenamide|emtricitabine tenofovir alafenamide|mesh-list
153668210|NCT04712058|Antiviral Agents|antiviral agents|mesh-ancestor
153668211|NCT04712058|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153668212|NCT04712058|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153668213|NCT04712058|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153668214|NCT04712058|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153668215|NCT04712058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153668216|NCT04712058|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153668217|NCT04712058|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153668218|NCT00393107|Cyclophosphamide|cyclophosphamide|mesh-list
153668219|NCT00393107|Rituximab|rituximab|mesh-list
153668220|NCT00393107|Fludarabine|fludarabine|mesh-list
153668221|NCT00393107|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153668222|NCT00393107|Immunologic Factors|immunologic factors|mesh-ancestor
153668223|NCT00393107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153668224|NCT00393107|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153668225|NCT00393107|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153668226|NCT00393107|Alkylating Agents|alkylating agents|mesh-ancestor
153668235|NCT04711668|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153668236|NCT04711668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153668237|NCT04711668|Sensory System Agents|sensory system agents|mesh-ancestor
153668238|NCT04711668|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153668239|NCT04711668|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153668240|NCT04711668|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
153668241|NCT04711668|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153668242|NCT04711668|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153668243|NCT04711668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153668245|NCT04711668|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
153668246|NCT04711668|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153668247|NCT04711668|Anesthetics, General|anesthetics, general|mesh-ancestor
153668248|NCT04711668|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
153668249|NCT04711668|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
153668250|NCT04711668|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153668252|NCT00031161|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153668253|NCT00031161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153668254|NCT00031278|Trastuzumab|trastuzumab|mesh-list
153668255|NCT00031278|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153668256|NCT00031278|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153668257|NCT00031317|Clozapine|clozapine|mesh-list
153668258|NCT00031317|Paroxetine|paroxetine|mesh-list
153668259|NCT00031317|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
153668260|NCT00031317|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153668261|NCT00031317|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153668262|NCT00031317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153668263|NCT00031317|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153668264|NCT00031317|Serotonin Agents|serotonin agents|mesh-ancestor
153668265|NCT00031317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153668266|NCT00031317|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
153668272|NCT00031317|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153668273|NCT00031317|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153668274|NCT00031317|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153668275|NCT00031317|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153668276|NCT00031317|GABA Antagonists|gaba antagonists|mesh-ancestor
153668277|NCT00031317|GABA Agents|gaba agents|mesh-ancestor
153668278|NCT00396045|Lenalidomide|lenalidomide|mesh-list
153668279|NCT00396045|Immunologic Factors|immunologic factors|mesh-ancestor
153668280|NCT00396045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153668281|NCT00396045|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153668282|NCT00396045|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153668283|NCT00396045|Growth Substances|growth substances|mesh-ancestor
153668284|NCT00396045|Growth Inhibitors|growth inhibitors|mesh-ancestor
153668285|NCT00396045|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153668286|NCT00396240|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
153668287|NCT00396240|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153668288|NCT00396240|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153668331|NCT03152123|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153668332|NCT03152123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153668333|NCT00031473|Ribavirin|ribavirin|mesh-list
153668334|NCT00031473|Antimetabolites|antimetabolites|mesh-ancestor
153668335|NCT00031473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153668336|NCT00031473|Antiviral Agents|antiviral agents|mesh-ancestor
153668337|NCT00031473|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153668338|NCT00031629|Gemcitabine|gemcitabine|mesh-list
153668339|NCT00031629|Docetaxel|docetaxel|mesh-list
153668340|NCT00031629|Lenograstim|lenograstim|mesh-list
153668341|NCT00031629|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153668342|NCT00031629|Antimetabolites|antimetabolites|mesh-ancestor
153668343|NCT00031629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153668344|NCT00031629|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153668345|NCT00031629|Tubulin Modulators|tubulin modulators|mesh-ancestor
153668346|NCT00031629|Antimitotic Agents|antimitotic agents|mesh-ancestor
153668347|NCT00031629|Mitosis Modulators|mitosis modulators|mesh-ancestor
153668348|NCT00031629|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153668349|NCT00031629|Immunologic Factors|immunologic factors|mesh-ancestor
153668350|NCT00031629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153668351|NCT03152084|Dapagliflozin|dapagliflozin|mesh-list
153668384|NCT00031785|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153668386|NCT00031785|Appetite Stimulants|appetite stimulants|mesh-ancestor
153668387|NCT00031785|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
153668388|NCT03151772|Metformin|metformin|mesh-list
153668389|NCT03151772|Disulfiram|disulfiram|mesh-list
153668390|NCT03151772|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153668391|NCT03151772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153668392|NCT03151772|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
153668393|NCT03151772|Acetaldehyde Dehydrogenase Inhibitors|acetaldehyde dehydrogenase inhibitors|mesh-ancestor
153668394|NCT03151772|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153668395|NCT03151772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153668396|NCT02971644|Cobalt|cobalt|mesh-list
153668397|NCT02971644|Trace Elements|trace elements|mesh-ancestor
153668398|NCT02971644|Micronutrients|micronutrients|mesh-ancestor
153668399|NCT02971644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153668400|NCT00031824|Cyclosporine|cyclosporine|mesh-list
153668401|NCT00031824|Hydroxychloroquine|hydroxychloroquine|mesh-list
153668402|NCT00031824|Prednisone|prednisone|mesh-list
153668403|NCT00031824|Tacrolimus|tacrolimus|mesh-list
153668404|NCT00031824|Cyclosporins|cyclosporins|mesh-list
153668405|NCT00031824|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153668406|NCT00031824|Glucocorticoids|glucocorticoids|mesh-ancestor
153668407|NCT00031824|Hormones|hormones|mesh-ancestor
153668408|NCT00031824|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153668409|NCT00031824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153668410|NCT00031824|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153668411|NCT00031824|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153668412|NCT00031824|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153668413|NCT00031824|Immunologic Factors|immunologic factors|mesh-ancestor
153668414|NCT00031824|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
153668415|NCT00031824|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153668416|NCT00031824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153668417|NCT00031824|Antifungal Agents|antifungal agents|mesh-ancestor
153668418|NCT00031824|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153668419|NCT00031824|Dermatologic Agents|dermatologic agents|mesh-ancestor
153668420|NCT00031824|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153668421|NCT00031824|Antimalarials|antimalarials|mesh-ancestor
153668422|NCT00031824|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153668423|NCT00031824|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153668424|NCT00031863|Rofecoxib|rofecoxib|mesh-list
153668425|NCT00031863|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
153668426|NCT00031863|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153668427|NCT00031863|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153668428|NCT00031863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153668429|NCT00031863|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153668430|NCT00031863|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153668431|NCT00031863|Analgesics|analgesics|mesh-ancestor
153668432|NCT00031863|Sensory System Agents|sensory system agents|mesh-ancestor
153668433|NCT00031863|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153668434|NCT00031863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153668435|NCT00031863|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153668436|NCT00031863|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153668437|NCT03151616|Cholinergic Antagonists|cholinergic antagonists|mesh-list
153668438|NCT03151616|Cholinergic Agents|cholinergic agents|mesh-ancestor
153668439|NCT03151616|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153668440|NCT03151616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153668441|NCT03151616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153668442|NCT00031902|Prednisolone|prednisolone|mesh-list
153668443|NCT00031902|Rituximab|rituximab|mesh-list
153668444|NCT00031902|Vincristine|vincristine|mesh-list
153668445|NCT00031902|Bleomycin|bleomycin|mesh-list
153668446|NCT00031902|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153668447|NCT00031902|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153668448|NCT00031902|Immunologic Factors|immunologic factors|mesh-ancestor
153668449|NCT00031902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153668450|NCT00031902|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153668451|NCT00031902|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153668452|NCT00031902|Tubulin Modulators|tubulin modulators|mesh-ancestor
153668453|NCT00031902|Antimitotic Agents|antimitotic agents|mesh-ancestor
153668454|NCT00031902|Mitosis Modulators|mitosis modulators|mesh-ancestor
153668455|NCT00031902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153668456|NCT00031902|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153668457|NCT00031902|Glucocorticoids|glucocorticoids|mesh-ancestor
153668460|NCT00031902|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153668461|NCT00031902|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153668463|NCT00031941|Immunologic Factors|immunologic factors|mesh-ancestor
153668464|NCT00031941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153668465|NCT00031941|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153668466|NCT00031941|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153668467|NCT00031941|Growth Substances|growth substances|mesh-ancestor
153668468|NCT00031941|Growth Inhibitors|growth inhibitors|mesh-ancestor
153668469|NCT00031941|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153668470|NCT00031980|Cyclosporine|cyclosporine|mesh-list
153668471|NCT00031980|Cyclosporins|cyclosporins|mesh-list
153668472|NCT00031980|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153668473|NCT00031980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153668474|NCT00031980|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153668475|NCT00031980|Immunologic Factors|immunologic factors|mesh-ancestor
153668476|NCT00031980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153668477|NCT00031980|Antifungal Agents|antifungal agents|mesh-ancestor
153668478|NCT00031980|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153668479|NCT00031980|Dermatologic Agents|dermatologic agents|mesh-ancestor
153668480|NCT00031980|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153668481|NCT00031980|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
153668482|NCT00032019|Prednisone|prednisone|mesh-list
153668483|NCT00032019|Cyclophosphamide|cyclophosphamide|mesh-list
153668484|NCT00032019|Rituximab|rituximab|mesh-list
153668485|NCT00032019|Doxorubicin|doxorubicin|mesh-list
153668486|NCT00032019|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
153668487|NCT00032019|Etoposide|etoposide|mesh-list
153668505|NCT00032019|Hormones|hormones|mesh-ancestor
153668507|NCT00032019|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153668508|NCT00032019|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153668509|NCT00032019|Tubulin Modulators|tubulin modulators|mesh-ancestor
153668510|NCT00032019|Antimitotic Agents|antimitotic agents|mesh-ancestor
153668511|NCT00032019|Mitosis Modulators|mitosis modulators|mesh-ancestor
153668512|NCT03151460|Dopamine|dopamine|mesh-list
153668513|NCT03151460|Dopamine Agents|dopamine agents|mesh-list
153668514|NCT03151460|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
153668515|NCT03151460|Sympathomimetics|sympathomimetics|mesh-ancestor
153668516|NCT03151460|Autonomic Agents|autonomic agents|mesh-ancestor
153668517|NCT03151460|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153383941|NCT02260622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153383985|NCT00357149|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153383986|NCT00357149|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153383987|NCT00357149|Immunologic Factors|immunologic factors|mesh-ancestor
153383988|NCT00357149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153383989|NCT04903652|Vinorelbine|vinorelbine|mesh-list
153668518|NCT03151460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153668519|NCT03151460|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153668520|NCT03151460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153668521|NCT03151460|Protective Agents|protective agents|mesh-ancestor
153668522|NCT00032097|Motexafin gadolinium|motexafin gadolinium|mesh-list
153668523|NCT00032097|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153668524|NCT00032097|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
153668525|NCT00032097|Dermatologic Agents|dermatologic agents|mesh-ancestor
153668526|NCT03151382|Tandospirone|tandospirone|mesh-list
153668527|NCT03151382|Donepezil|donepezil|mesh-list
153668528|NCT03151382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153668529|NCT03151382|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
153668530|NCT03151382|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153668531|NCT03151382|Cholinergic Agents|cholinergic agents|mesh-ancestor
153668532|NCT03151382|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153668533|NCT03151382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153668534|NCT03151382|Nootropic Agents|nootropic agents|mesh-ancestor
153668535|NCT03151382|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153668536|NCT03151382|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153668537|NCT03151382|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153668538|NCT03151382|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153668539|NCT03151382|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
153668548|NCT00032136|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153668549|NCT00032136|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153668550|NCT00032136|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
153668551|NCT00032136|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
153668552|NCT00032136|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153668554|NCT00032136|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153668555|NCT00032136|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153668556|NCT03151343|Empagliflozin|empagliflozin|mesh-list
153668557|NCT03151343|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
153668558|NCT03151343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153668559|NCT03151343|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153668560|NCT03151343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153668561|NCT00032175|Gemcitabine|gemcitabine|mesh-list
153668562|NCT00032175|Capecitabine|capecitabine|mesh-list
153668606|NCT03150680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153505602|NCT01386658|Icatibant|icatibant|mesh-list
153668607|NCT00396396|Acetylcysteine|acetylcysteine|mesh-list
153668608|NCT00396396|N-monoacetylcystine|n-monoacetylcystine|mesh-list
153668609|NCT00396396|Antiviral Agents|antiviral agents|mesh-ancestor
153668610|NCT00396396|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153668611|NCT00396396|Expectorants|expectorants|mesh-ancestor
153668612|NCT00396396|Respiratory System Agents|respiratory system agents|mesh-ancestor
153668613|NCT00396396|Free Radical Scavengers|free radical scavengers|mesh-ancestor
153668614|NCT00396396|Antioxidants|antioxidants|mesh-ancestor
153668616|NCT00396396|Protective Agents|protective agents|mesh-ancestor
153668669|NCT00033072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153668670|NCT03150290|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
153668671|NCT03150290|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
153668672|NCT03150290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153668673|NCT00033111|Cabergoline|cabergoline|mesh-list
153668674|NCT00033111|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
153668675|NCT00033111|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
153668676|NCT00033111|Dopamine Agonists|dopamine agonists|mesh-ancestor
153668677|NCT00033111|Dopamine Agents|dopamine agents|mesh-ancestor
153668678|NCT00033111|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153668679|NCT00033111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153668680|NCT00033111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153668681|NCT00033189|Ubiquinone|ubiquinone|mesh-list
153505651|NCT01386996|Glucocorticoids|glucocorticoids|mesh-ancestor
153668682|NCT00033189|Coenzyme Q10|coenzyme q10|mesh-list
153668683|NCT00033189|Micronutrients|micronutrients|mesh-ancestor
153668685|NCT00033189|Vitamins|vitamins|mesh-ancestor
153668728|NCT00033345|Indole-3-carbinol|indole-3-carbinol|mesh-list
153668729|NCT00033345|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
153668730|NCT00033345|Protective Agents|protective agents|mesh-ancestor
153668731|NCT00033345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153668732|NCT00033345|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153668734|NCT00033423|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153668735|NCT00033423|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153668736|NCT00033423|Immunologic Factors|immunologic factors|mesh-ancestor
153668737|NCT00033423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153668738|NCT00033423|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153668742|NCT00033462|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153668791|NCT00033735|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153668792|NCT00033735|Immunologic Factors|immunologic factors|mesh-ancestor
153668793|NCT00033735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153668794|NCT00033735|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153668795|NCT00033735|Alkylating Agents|alkylating agents|mesh-ancestor
153668796|NCT00033813|Oxatomide|oxatomide|mesh-list
153668797|NCT00033813|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
153668798|NCT00033813|Histamine Antagonists|histamine antagonists|mesh-ancestor
153668799|NCT00033813|Histamine Agents|histamine agents|mesh-ancestor
153668800|NCT00033813|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153668801|NCT00033813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153668802|NCT00033813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153668803|NCT00033813|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
153668804|NCT00033813|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153668805|NCT00033813|Respiratory System Agents|respiratory system agents|mesh-ancestor
153668806|NCT00033891|Infliximab|infliximab|mesh-list
153668807|NCT00033891|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
153668808|NCT00033891|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153668809|NCT00033891|Dermatologic Agents|dermatologic agents|mesh-ancestor
153668810|NCT00033891|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153668811|NCT00033891|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153668812|NCT02271893|Levomethorphan|levomethorphan|mesh-list
153668813|NCT02271893|Dextromethorphan|dextromethorphan|mesh-list
153668814|NCT02271893|Antitussive Agents|antitussive agents|mesh-ancestor
153668815|NCT02271893|Respiratory System Agents|respiratory system agents|mesh-ancestor
153668816|NCT02271893|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
153668817|NCT02271893|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
153668818|NCT02271893|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153668819|NCT02271893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153668820|NCT02271893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153668821|NCT02271893|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153668822|NCT02271893|Narcotics|narcotics|mesh-ancestor
153668823|NCT02271893|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153668833|NCT02971410|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153668834|NCT02971410|Antimetabolites|antimetabolites|mesh-ancestor
153668835|NCT02971410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153668836|NCT02971410|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153668837|NCT02971410|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
153668838|NCT02971410|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153668839|NCT02035397|Botulinum Toxins|botulinum toxins|mesh-list
153668840|NCT02035397|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
153668841|NCT02035397|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
153668842|NCT02035397|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
153668843|NCT02035397|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153668844|NCT02035397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153668845|NCT02035397|Cholinergic Agents|cholinergic agents|mesh-ancestor
153668846|NCT02035397|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153668847|NCT02035397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153668848|NCT02035397|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
153668849|NCT02035397|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153668850|NCT00034047|Nafarelin|nafarelin|mesh-list
153668851|NCT00034047|Fertility Agents, Female|fertility agents, female|mesh-ancestor
153668852|NCT00034047|Fertility Agents|fertility agents|mesh-ancestor
153668853|NCT00034047|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153668854|NCT00034047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153668855|NCT00034086|Ritonavir|ritonavir|mesh-list
153668856|NCT00034086|Lopinavir|lopinavir|mesh-list
153668857|NCT00034086|Tenofovir|tenofovir|mesh-list
153668858|NCT00034086|Lamivudine|lamivudine|mesh-list
153668859|NCT00034086|Zidovudine|zidovudine|mesh-list
153668860|NCT00034086|Stavudine|stavudine|mesh-list
153668879|NCT00034086|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153668880|NCT00034086|Antimetabolites|antimetabolites|mesh-ancestor
153668882|NCT00034125|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
153668883|NCT00034125|Hormone Antagonists|hormone antagonists|mesh-ancestor
153668884|NCT00034125|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153668885|NCT00034125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153668886|NCT00034125|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153668887|NCT00034125|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153668888|NCT00034125|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
153668889|NCT00034125|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
153668890|NCT00034125|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153668891|NCT00034164|Paclitaxel|paclitaxel|mesh-list
153668892|NCT00034164|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153668893|NCT00034164|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153668894|NCT00034164|Tubulin Modulators|tubulin modulators|mesh-ancestor
153668895|NCT00034164|Antimitotic Agents|antimitotic agents|mesh-ancestor
153668896|NCT00034164|Mitosis Modulators|mitosis modulators|mesh-ancestor
153668897|NCT00034164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153668898|NCT00034242|Immunoglobulins|immunoglobulins|mesh-list
153668899|NCT00034242|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
153668900|NCT00034242|Antibodies|antibodies|mesh-list
153668901|NCT00034242|gamma-Globulins|gamma-globulins|mesh-list
153668902|NCT00034242|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
153668903|NCT00034242|Immunologic Factors|immunologic factors|mesh-ancestor
153668925|NCT01807286|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153668926|NCT01807286|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153668928|NCT01807286|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153668929|NCT01807286|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153668930|NCT01807286|Growth Substances|growth substances|mesh-ancestor
153668931|NCT01807286|Growth Inhibitors|growth inhibitors|mesh-ancestor
153668932|NCT00034359|Lamivudine|lamivudine|mesh-list
153668933|NCT00034359|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153668934|NCT00034359|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153668935|NCT00034359|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153668936|NCT00034359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153668937|NCT00034359|Antiviral Agents|antiviral agents|mesh-ancestor
153668938|NCT00034359|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153668939|NCT00034359|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153668940|NCT00034359|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153668941|NCT00034593|Gemcitabine|gemcitabine|mesh-list
153668942|NCT00034593|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153668943|NCT00034593|Antimetabolites|antimetabolites|mesh-ancestor
153668944|NCT00034593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153668945|NCT00034593|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153668946|NCT00034632|Posaconazole|posaconazole|mesh-list
153668947|NCT00034632|Antifungal Agents|antifungal agents|mesh-ancestor
153668948|NCT00034632|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153668949|NCT00034632|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
153668950|NCT00034632|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153668951|NCT00034632|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153668952|NCT00034632|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
153668953|NCT00034632|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153668954|NCT00034632|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153668955|NCT00034632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153668966|NCT00034671|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
153668967|NCT00034671|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153668968|NCT00034671|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153668969|NCT00034671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153668970|NCT00034671|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153668971|NCT00034671|Hormone Antagonists|hormone antagonists|mesh-ancestor
153668972|NCT00034671|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153668973|NCT00034671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153668975|NCT01806857|Levomethorphan|levomethorphan|mesh-list
153668976|NCT01806857|Dextromethorphan|dextromethorphan|mesh-list
153668977|NCT01806857|Antitussive Agents|antitussive agents|mesh-ancestor
153668978|NCT01806857|Respiratory System Agents|respiratory system agents|mesh-ancestor
153668979|NCT01806857|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
153668980|NCT01806857|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
153668981|NCT01806857|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153668982|NCT01806857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153668983|NCT01806857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153668984|NCT01806857|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153668985|NCT01806857|Narcotics|narcotics|mesh-ancestor
153668986|NCT01806857|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153668987|NCT01806857|Analgesics|analgesics|mesh-ancestor
153668988|NCT01806857|Sensory System Agents|sensory system agents|mesh-ancestor
153668989|NCT01806857|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153668990|NCT01806857|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
153668991|NCT01806857|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
153668992|NCT01806857|Adrenergic Agents|adrenergic agents|mesh-ancestor
153668993|NCT01806857|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153668994|NCT01806857|Antimalarials|antimalarials|mesh-ancestor
153668995|NCT01806857|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153668996|NCT01806857|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153668997|NCT01806857|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153668998|NCT01806857|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153668999|NCT01806857|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
153669003|NCT01806857|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153669004|NCT01806857|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153669005|NCT01806857|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
153669006|NCT01806857|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153669008|NCT00034710|Antipruritics|antipruritics|mesh-ancestor
153669009|NCT00034710|Dermatologic Agents|dermatologic agents|mesh-ancestor
153669010|NCT00034710|Sensory System Agents|sensory system agents|mesh-ancestor
153669011|NCT00034710|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153669012|NCT00034710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153669013|NCT00034749|Risperidone|risperidone|mesh-list
153669014|NCT00034749|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153669015|NCT00034749|Serotonin Agents|serotonin agents|mesh-ancestor
153669016|NCT00034749|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153669017|NCT00034749|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153669018|NCT00034749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153669019|NCT00034749|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153669020|NCT00034749|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153669021|NCT00034749|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153669022|NCT00034749|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153669023|NCT00034749|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
153669024|NCT00034749|Dopamine Agents|dopamine agents|mesh-ancestor
153669025|NCT00034788|Becaplermin|becaplermin|mesh-list
153669026|NCT00034788|Anticoagulants|anticoagulants|mesh-ancestor
153669027|NCT00034788|Angiogenesis Inducing Agents|angiogenesis inducing agents|mesh-ancestor
153669028|NCT00034788|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153669029|NCT00034788|Growth Substances|growth substances|mesh-ancestor
153669030|NCT00034788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153669031|NCT00034866|Tipranavir|tipranavir|mesh-list
153669032|NCT00034866|HIV Protease Inhibitors|hiv protease inhibitors|mesh-list
153669033|NCT00034866|Protease Inhibitors|protease inhibitors|mesh-list
153669034|NCT00034866|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153669045|NCT00034905|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153669046|NCT00034905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153669047|NCT00034905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153669048|NCT00034905|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153669049|NCT00034905|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153669050|NCT00034905|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153669051|NCT00034905|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153669052|NCT00034905|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
153669053|NCT00034905|Dopamine Agents|dopamine agents|mesh-ancestor
153669054|NCT00034905|Antidepressive Agents|antidepressive agents|mesh-ancestor
153669056|NCT01806311|Candesartan|candesartan|mesh-list
153669057|NCT01806311|Candesartan cilexetil|candesartan cilexetil|mesh-list
153669058|NCT01806311|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153669059|NCT01806311|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153669060|NCT01806311|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153669061|NCT01806311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153669062|NCT01806311|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153669063|NCT01806311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153669064|NCT01806311|Vasodilator Agents|vasodilator agents|mesh-ancestor
153669065|NCT01806311|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
153669066|NCT01806311|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
153669067|NCT00034944|Aprepitant|aprepitant|mesh-list
153669068|NCT00034944|Antiemetics|antiemetics|mesh-ancestor
153669069|NCT00034944|Autonomic Agents|autonomic agents|mesh-ancestor
153669070|NCT00034944|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153669076|NCT01806272|Vitamin B 12|vitamin b 12|mesh-list
153669091|NCT00034983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153669092|NCT00034983|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
153669093|NCT00034983|Antidepressive Agents|antidepressive agents|mesh-ancestor
153669094|NCT00034983|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153669095|NCT00034983|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
153669096|NCT00034983|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153669097|NCT00034983|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153669098|NCT00034983|Antiemetics|antiemetics|mesh-ancestor
153669099|NCT00034983|Autonomic Agents|autonomic agents|mesh-ancestor
153669100|NCT00034983|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153669101|NCT00034983|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153669102|NCT00034983|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
153669103|NCT00035061|Pemetrexed|pemetrexed|mesh-list
153669104|NCT00035061|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153669105|NCT00035061|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153669106|NCT00035061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153669107|NCT00035061|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153669108|NCT00035061|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153669109|NCT00393497|Bevacizumab|bevacizumab|mesh-list
153669110|NCT00393497|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153669111|NCT00393497|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153669112|NCT00393497|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153669113|NCT00393497|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153669114|NCT00393497|Growth Substances|growth substances|mesh-ancestor
153669115|NCT00393497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153669116|NCT00393497|Growth Inhibitors|growth inhibitors|mesh-ancestor
153669117|NCT00035100|Epothilones|epothilones|mesh-list
153669118|NCT00035100|Epothilone B|epothilone b|mesh-list
153669119|NCT00035100|Tubulin Modulators|tubulin modulators|mesh-ancestor
153669120|NCT00035100|Antimitotic Agents|antimitotic agents|mesh-ancestor
153669121|NCT00035100|Mitosis Modulators|mitosis modulators|mesh-ancestor
153669131|NCT00035139|Dopamine Agents|dopamine agents|mesh-ancestor
153669132|NCT00035139|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153669133|NCT00035178|Argatroban|argatroban|mesh-list
153669134|NCT00035178|Antithrombins|antithrombins|mesh-ancestor
153669135|NCT00035178|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
153669136|NCT00035178|Protease Inhibitors|protease inhibitors|mesh-ancestor
153669137|NCT00035178|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153669138|NCT00035178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153669139|NCT00035178|Anticoagulants|anticoagulants|mesh-ancestor
153669140|NCT00035178|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153669141|NCT00393614|Levetiracetam|levetiracetam|mesh-list
153669142|NCT00393614|Anticonvulsants|anticonvulsants|mesh-ancestor
153669143|NCT00393614|Nootropic Agents|nootropic agents|mesh-ancestor
153669144|NCT00035256|Teriparatide|teriparatide|mesh-list
153669145|NCT00035256|Raloxifene Hydrochloride|raloxifene hydrochloride|mesh-list
153669146|NCT00035256|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153669147|NCT00035256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153669148|NCT00035256|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153669149|NCT00035256|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
153669150|NCT00035256|Hormone Antagonists|hormone antagonists|mesh-ancestor
153669185|NCT01805999|Calcium polycarbophil|calcium polycarbophil|mesh-list
153669186|NCT01805999|Cathartics|cathartics|mesh-ancestor
153669187|NCT01805999|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153669188|NCT01805999|Antidiarrheals|antidiarrheals|mesh-ancestor
153669189|NCT00035490|Azimilide|azimilide|mesh-list
153669190|NCT00035490|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153669191|NCT00035490|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153669192|NCT00035490|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153669193|NCT00035490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153669194|NCT00035490|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153669195|NCT00035490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153669196|NCT00035607|Darbepoetin alfa|darbepoetin alfa|mesh-list
153669197|NCT00035607|Hematinics|hematinics|mesh-ancestor
153669198|NCT02971254|Sevoflurane|sevoflurane|mesh-list
153669199|NCT02971254|Desflurane|desflurane|mesh-list
153669200|NCT02971254|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153669201|NCT02971254|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
153669202|NCT02971254|Anesthetics, General|anesthetics, general|mesh-ancestor
153669203|NCT02971254|Anesthetics|anesthetics|mesh-ancestor
153669204|NCT02971254|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153506170|NCT01390324|Naproxen|naproxen|mesh-list
153669205|NCT02971254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153669206|NCT01805882|Sofosbuvir|sofosbuvir|mesh-list
153669207|NCT01805882|Ledipasvir|ledipasvir|mesh-list
153669208|NCT01805882|Antiviral Agents|antiviral agents|mesh-ancestor
153669209|NCT01805882|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153669210|NCT00035802|Topiramate|topiramate|mesh-list
153669235|NCT01805726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153669236|NCT01805726|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153669238|NCT01805726|Sensory System Agents|sensory system agents|mesh-ancestor
153669239|NCT01805726|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153669240|NCT01805726|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
153669241|NCT01805726|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153669242|NCT01805726|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153669243|NCT01805726|Adrenergic Agents|adrenergic agents|mesh-ancestor
153669244|NCT01805726|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153669245|NCT01805726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153669246|NCT01805726|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153669248|NCT01805726|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153669249|NCT01805726|Anesthetics, General|anesthetics, general|mesh-ancestor
153669250|NCT01805726|Anesthetics|anesthetics|mesh-ancestor
153669251|NCT00035958|Prednisone|prednisone|mesh-list
153669252|NCT00035958|Etanercept|etanercept|mesh-list
153669253|NCT00035958|Methotrexate|methotrexate|mesh-list
153669291|NCT01805687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153669292|NCT01805687|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
153669293|NCT01805687|Hormone Antagonists|hormone antagonists|mesh-ancestor
153669294|NCT01805687|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153669295|NCT00035997|Zoledronic Acid|zoledronic acid|mesh-list
153669296|NCT00035997|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153669297|NCT00035997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153669298|NCT01805570|Ticagrelor|ticagrelor|mesh-list
153669299|NCT01805570|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
153669300|NCT01805570|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153669301|NCT01805570|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
153669302|NCT01805570|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
153669303|NCT01805570|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
153669304|NCT01805570|Purinergic Agents|purinergic agents|mesh-ancestor
153669305|NCT01805570|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153669306|NCT01805570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153669307|NCT01805570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153669308|NCT01805531|Rivaroxaban|rivaroxaban|mesh-list
153669309|NCT01805531|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
153669310|NCT01805531|Antithrombins|antithrombins|mesh-ancestor
153669311|NCT01805531|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
153669312|NCT01805531|Protease Inhibitors|protease inhibitors|mesh-ancestor
153669313|NCT01805531|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153669314|NCT01805531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153669315|NCT01805531|Anticoagulants|anticoagulants|mesh-ancestor
153669316|NCT00036114|Aripiprazole|aripiprazole|mesh-list
153669317|NCT00036114|Antidepressive Agents|antidepressive agents|mesh-ancestor
153669318|NCT00036114|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153669319|NCT00036114|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153669324|NCT00036114|Dopamine Agents|dopamine agents|mesh-ancestor
153669332|NCT00036114|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
153669333|NCT00036114|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
153669334|NCT01805453|Losartan|losartan|mesh-list
153669335|NCT01805453|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153669336|NCT01805453|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153669337|NCT01805453|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
153669338|NCT01805453|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
153669339|NCT01805453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153669340|NCT00036153|Methotrexate|methotrexate|mesh-list
153669341|NCT00036153|Tacrolimus|tacrolimus|mesh-list
153669342|NCT00036153|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
153669343|NCT00036153|Abortifacient Agents|abortifacient agents|mesh-ancestor
153669344|NCT00036153|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153669345|NCT00036153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153669346|NCT00036153|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153669347|NCT00036153|Antimetabolites|antimetabolites|mesh-ancestor
153669348|NCT00036153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153669349|NCT00036153|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153669350|NCT00036153|Dermatologic Agents|dermatologic agents|mesh-ancestor
153506339|NCT01391156|Minoxidil|minoxidil|mesh-list
153669351|NCT00036153|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153669352|NCT00036153|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153669353|NCT00036153|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153669354|NCT00036153|Immunologic Factors|immunologic factors|mesh-ancestor
153669355|NCT00036153|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153669356|NCT00036153|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153669357|NCT00036153|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
153669358|NCT00036231|Secretin|secretin|mesh-list
153669359|NCT00036231|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153669360|NCT00036231|Hormones|hormones|mesh-ancestor
153669361|NCT00036231|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153669362|NCT00036231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153669369|NCT00036309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153669370|NCT00036309|Analgesics|analgesics|mesh-ancestor
153669371|NCT00036309|Sensory System Agents|sensory system agents|mesh-ancestor
153669372|NCT00036309|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153669373|NCT00036309|Antidepressive Agents|antidepressive agents|mesh-ancestor
153669374|NCT00036309|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153669375|NCT00036309|Dopamine Agents|dopamine agents|mesh-ancestor
153669376|NCT00036348|Aripiprazole|aripiprazole|mesh-list
153669377|NCT00036348|Antidepressive Agents|antidepressive agents|mesh-ancestor
153669378|NCT00036348|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153669379|NCT00036348|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153669380|NCT00036348|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153669381|NCT00036348|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153669382|NCT00036348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153669383|NCT00036348|Dopamine Agonists|dopamine agonists|mesh-ancestor
153669384|NCT00036348|Dopamine Agents|dopamine agents|mesh-ancestor
153669385|NCT00036348|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153669386|NCT00036348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153669387|NCT00036348|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
153669388|NCT00036348|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
153669389|NCT00036348|Serotonin Agents|serotonin agents|mesh-ancestor
153669390|NCT00036348|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
153669391|NCT00036348|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153669392|NCT00036348|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
153669419|NCT00036543|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153669420|NCT00036543|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
153669421|NCT00036543|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
153669422|NCT00036543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153669423|NCT01466231|Everolimus|everolimus|mesh-list
153669424|NCT01466231|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
153669425|NCT01466231|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153669426|NCT01466231|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153669427|NCT01466231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153669428|NCT01466231|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153669429|NCT01466231|Immunologic Factors|immunologic factors|mesh-ancestor
153669430|NCT01466231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153669431|NCT01466231|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153669432|NCT00036582|Clozapine|clozapine|mesh-list
153669433|NCT00036582|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153669434|NCT00036582|Serotonin Agents|serotonin agents|mesh-ancestor
153669435|NCT00036582|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153669436|NCT00036582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153669437|NCT00036582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153669438|NCT00036582|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153669439|NCT00036582|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153669440|NCT00036582|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153669443|NCT00036582|GABA Agents|gaba agents|mesh-ancestor
153669469|NCT01465919|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153669470|NCT01465919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153669471|NCT01465919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153669472|NCT01465919|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153669473|NCT01465919|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153669474|NCT01465919|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153669475|NCT01465919|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
153669476|NCT01465919|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
153669477|NCT01465919|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
153669478|NCT01465919|Adrenergic Agents|adrenergic agents|mesh-ancestor
153669479|NCT01465919|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
153669480|NCT01465919|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153669481|NCT01465919|Serotonin Agents|serotonin agents|mesh-ancestor
153669482|NCT01465919|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
153669483|NCT00396513|Metformin|metformin|mesh-list
153669484|NCT00396513|Simvastatin|simvastatin|mesh-list
153669485|NCT00396513|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153669486|NCT00396513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153669487|NCT00396513|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153669488|NCT00396513|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153669521|NCT01465685|Serotonin Agents|serotonin agents|mesh-ancestor
153669522|NCT01465685|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
153669523|NCT01465685|Adrenergic Agents|adrenergic agents|mesh-ancestor
153669525|NCT00037011|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
153669526|NCT00037011|Immunologic Factors|immunologic factors|mesh-ancestor
153669527|NCT00037011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153669528|NCT00037050|Vancomycin|vancomycin|mesh-list
153669529|NCT00037050|Linezolid|linezolid|mesh-list
153669530|NCT00037050|Oxacillin|oxacillin|mesh-list
153669531|NCT00037050|Dicloxacillin|dicloxacillin|mesh-list
153669532|NCT00037050|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153669533|NCT00037050|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153669534|NCT00037050|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
153669535|NCT00037050|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153669536|NCT00037050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153669537|NCT00037089|Tegafur|tegafur|mesh-list
153669538|NCT00037089|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153669539|NCT00037089|Antimetabolites|antimetabolites|mesh-ancestor
153669540|NCT00037089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153669541|NCT00037089|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153669542|NCT01465568|Denosumab|denosumab|mesh-list
153669543|NCT01465568|Diphosphonates|diphosphonates|mesh-list
153669544|NCT01465568|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153669545|NCT01465568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153669546|NCT00037206|Anidulafungin|anidulafungin|mesh-list
153669547|NCT00037206|Antifungal Agents|antifungal agents|mesh-ancestor
153669548|NCT00037206|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153669549|NCT01465412|Adenosine|adenosine|mesh-list
153669550|NCT01465412|Analgesics|analgesics|mesh-ancestor
153669551|NCT01465412|Sensory System Agents|sensory system agents|mesh-ancestor
153669552|NCT01465412|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153669553|NCT01465412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153669554|NCT01465412|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153669555|NCT01465412|Vasodilator Agents|vasodilator agents|mesh-ancestor
153669556|NCT01465412|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
153669557|NCT01465412|Purinergic Agonists|purinergic agonists|mesh-ancestor
153669558|NCT01465412|Purinergic Agents|purinergic agents|mesh-ancestor
153360715|NCT01404923|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153669559|NCT01465412|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153669560|NCT01465412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153669561|NCT01465373|Progesterone|progesterone|mesh-list
153669562|NCT01465373|Progestins|progestins|mesh-ancestor
153669563|NCT01465373|Hormones|hormones|mesh-ancestor
153669564|NCT01465373|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153669565|NCT01465373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153669566|NCT01465256|Aspirin|aspirin|mesh-list
153669567|NCT01465256|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153669568|NCT01465256|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153669569|NCT01465256|Analgesics|analgesics|mesh-ancestor
153669570|NCT01465256|Sensory System Agents|sensory system agents|mesh-ancestor
153669571|NCT01465256|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153669572|NCT01465256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153669573|NCT01465256|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153506543|NCT01392755|Ritonavir|ritonavir|mesh-list
153669574|NCT01465256|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153669575|NCT01465256|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153669576|NCT01465256|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153669577|NCT01465256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153669578|NCT01465256|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153669579|NCT01465256|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153669580|NCT01465256|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153669581|NCT01465256|Antipyretics|antipyretics|mesh-ancestor
153669582|NCT00037479|Ceftriaxone|ceftriaxone|mesh-list
153669583|NCT00037479|Third Generation Cephalosporins|third generation cephalosporins|mesh-ancestor
153669584|NCT00037479|Beta Lactam Antibiotics|beta lactam antibiotics|mesh-ancestor
153669585|NCT00037479|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153669586|NCT00037479|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153669587|NCT01464983|Aspirin|aspirin|mesh-list
153669588|NCT01464983|Ibuprofen|ibuprofen|mesh-list
153669589|NCT01464983|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153669590|NCT01464983|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153669591|NCT01464983|Analgesics|analgesics|mesh-ancestor
153669598|NCT01464983|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153669599|NCT01464983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153669600|NCT01464983|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153669601|NCT01464983|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153669602|NCT01464983|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153669603|NCT01464983|Antipyretics|antipyretics|mesh-ancestor
153669605|NCT00037518|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153669606|NCT00037518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153669607|NCT00037518|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
153669608|NCT00037518|Hormone Antagonists|hormone antagonists|mesh-ancestor
153669609|NCT00037518|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153669610|NCT01464944|Aspirin|aspirin|mesh-list
153669611|NCT01464944|Acetaminophen|acetaminophen|mesh-list
153669612|NCT01464944|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153669613|NCT01464944|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153669614|NCT01464944|Analgesics|analgesics|mesh-ancestor
153669626|NCT01464944|Antipyretics|antipyretics|mesh-ancestor
153669654|NCT00037752|Appetite Depressants|appetite depressants|mesh-ancestor
153669655|NCT00037752|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
153669657|NCT01464671|Bivalirudin|bivalirudin|mesh-list
153669658|NCT01464671|Anticoagulants|anticoagulants|mesh-ancestor
153669659|NCT01464671|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153669660|NCT01464671|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153669661|NCT01464671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153669662|NCT01464671|Antithrombins|antithrombins|mesh-ancestor
153669663|NCT01464671|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
153669664|NCT01464671|Protease Inhibitors|protease inhibitors|mesh-ancestor
153669665|NCT01464671|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153669666|NCT00037869|3-Iodobenzylguanidine|3-iodobenzylguanidine|mesh-list
153669667|NCT00037869|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153669668|NCT00037869|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153669669|NCT00037869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153669670|NCT00037869|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
153669671|NCT00393731|Misoprostol|misoprostol|mesh-list
153669672|NCT00393731|Oxytocin|oxytocin|mesh-list
153669673|NCT00393731|Oxytocics|oxytocics|mesh-ancestor
153669674|NCT00393731|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153669675|NCT00393731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153669676|NCT00393731|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
153669677|NCT00393731|Abortifacient Agents|abortifacient agents|mesh-ancestor
153669710|NCT00038220|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
153669711|NCT00038220|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
153669712|NCT00038220|Protease Inhibitors|protease inhibitors|mesh-ancestor
153669713|NCT00038220|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153669714|NCT00038220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153669715|NCT00038220|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153669716|NCT00038220|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153669717|NCT00038220|Antiviral Agents|antiviral agents|mesh-ancestor
153669718|NCT00038220|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153669719|NCT00038220|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
153669720|NCT00038220|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153669721|NCT00038220|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153669722|NCT00038220|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153669723|NCT00038220|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
153669724|NCT00038220|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
153669729|NCT00038259|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153669766|NCT00396669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153669767|NCT00396669|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
153669768|NCT00396669|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153669769|NCT00396669|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153669771|NCT00846989|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
153669772|NCT00846989|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
153669773|NCT00396747|Methylprednisolone|methylprednisolone|mesh-list
153669774|NCT00396747|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
153669775|NCT00396747|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
153891219|NCT01030900|Mitosis Modulators|mitosis modulators|mesh-ancestor
153669776|NCT00396747|Prednisolone|prednisolone|mesh-list
153669777|NCT00396747|Prednisolone acetate|prednisolone acetate|mesh-list
153669778|NCT00396747|Infliximab|infliximab|mesh-list
153669779|NCT00396747|Methotrexate|methotrexate|mesh-list
153669780|NCT00396747|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
153669781|NCT00396747|Prednisolone phosphate|prednisolone phosphate|mesh-list
153669782|NCT00396747|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
153669783|NCT00396747|Abortifacient Agents|abortifacient agents|mesh-ancestor
153669784|NCT00396747|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153669787|NCT00396747|Antimetabolites|antimetabolites|mesh-ancestor
153669822|NCT00846950|GABA Modulators|gaba modulators|mesh-ancestor
153669823|NCT00846950|GABA Agents|gaba agents|mesh-ancestor
153669824|NCT00846950|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153669825|NCT00846950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153669826|NCT00846950|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
153669827|NCT00846950|Histamine Antagonists|histamine antagonists|mesh-ancestor
153669828|NCT00846950|Histamine Agents|histamine agents|mesh-ancestor
153669829|NCT00846911|Moxifloxacin|moxifloxacin|mesh-list
153669830|NCT00846911|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
153669831|NCT00846911|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153669832|NCT00846911|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153669833|NCT00846911|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153669835|NCT00846911|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153669882|NCT05428683|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153669883|NCT05428683|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153669884|NCT05428683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153669885|NCT05428683|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153669886|NCT05428683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153669887|NCT05428683|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153669888|NCT05428683|Glucocorticoids|glucocorticoids|mesh-ancestor
153669889|NCT05428683|Hormones|hormones|mesh-ancestor
153669890|NCT05428683|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153669891|NCT05424549|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
153669892|NCT05424549|Ophthalmic Solutions|ophthalmic solutions|mesh-list
153669893|NCT00846443|Cisplatin|cisplatin|mesh-list
153669894|NCT00846443|Pemetrexed|pemetrexed|mesh-list
153669895|NCT00846443|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153669896|NCT00846443|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153669897|NCT00846443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153669898|NCT00846443|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153669899|NCT00846443|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153669900|NCT00846326|Fluticasone|fluticasone|mesh-list
153669902|NCT00846326|Phenylephrine|phenylephrine|mesh-list
153669903|NCT00846326|Oxymetazoline|oxymetazoline|mesh-list
153669904|NCT00846326|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153669905|NCT00846326|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153669906|NCT00846326|Autonomic Agents|autonomic agents|mesh-ancestor
153669907|NCT00846326|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153669908|NCT00846326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153669909|NCT00846326|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153669910|NCT00846326|Respiratory System Agents|respiratory system agents|mesh-ancestor
153669911|NCT00846326|Dermatologic Agents|dermatologic agents|mesh-ancestor
153669912|NCT00846326|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
153669913|NCT00846326|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153669914|NCT00846326|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153669915|NCT00846326|Adrenergic Agents|adrenergic agents|mesh-ancestor
153669916|NCT00846326|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153669918|NCT00846326|Sympathomimetics|sympathomimetics|mesh-ancestor
153669922|NCT00846326|Mydriatics|mydriatics|mesh-ancestor
153669923|NCT00846326|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
153669924|NCT00846326|Protective Agents|protective agents|mesh-ancestor
153669925|NCT05330013|Dapagliflozin|dapagliflozin|mesh-list
153669926|NCT05330013|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
153669927|NCT05330013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153669928|NCT05330013|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153669929|NCT05330013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153669930|NCT00846248|Chromium|chromium|mesh-list
153669931|NCT00846248|Trace Elements|trace elements|mesh-ancestor
153669932|NCT00846248|Micronutrients|micronutrients|mesh-ancestor
153669933|NCT00846248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153669934|NCT00846131|Sorafenib|sorafenib|mesh-list
153669935|NCT00846131|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153669936|NCT00846131|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153669937|NCT00846131|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153669938|NCT00846131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153669940|NCT05116059|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
153669941|NCT05116059|Amebicides|amebicides|mesh-ancestor
153669976|NCT00277043|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153669977|NCT00277043|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153669978|NCT00277043|Tubulin Modulators|tubulin modulators|mesh-ancestor
153669979|NCT00277043|Antimitotic Agents|antimitotic agents|mesh-ancestor
153669980|NCT00277043|Mitosis Modulators|mitosis modulators|mesh-ancestor
153669981|NCT00277043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153669982|NCT00276965|Lithium Carbonate|lithium carbonate|mesh-list
153669983|NCT00276965|Sertraline|sertraline|mesh-list
153669984|NCT00276965|Antidepressive Agents|antidepressive agents|mesh-ancestor
153669985|NCT00276965|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153669986|NCT00276965|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
153669987|NCT00276965|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153669988|NCT00276965|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153669989|NCT00276965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153669990|NCT00276965|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153669991|NCT00276965|Serotonin Agents|serotonin agents|mesh-ancestor
153669992|NCT00276965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153669993|NCT00276965|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153669994|NCT00276965|Antimanic Agents|antimanic agents|mesh-ancestor
153669995|NCT00276965|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153669996|NCT00276965|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153669997|NCT00276926|Imatinib Mesylate|imatinib mesylate|mesh-list
153669998|NCT00276926|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153670026|NCT00276848|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153670027|NCT00276848|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153670028|NCT00276848|Antimetabolites|antimetabolites|mesh-ancestor
153670029|NCT00276848|Antiviral Agents|antiviral agents|mesh-ancestor
153670030|NCT00276848|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153670031|NCT00276809|Cytarabine|cytarabine|mesh-list
153670032|NCT00276809|Dexamethasone|dexamethasone|mesh-list
153670033|NCT00276809|Cyclophosphamide|cyclophosphamide|mesh-list
153670034|NCT00276809|Melphalan|melphalan|mesh-list
153670035|NCT00276809|Carmustine|carmustine|mesh-list
153670036|NCT00276809|Fludarabine|fludarabine|mesh-list
153670037|NCT00276809|Fludarabine phosphate|fludarabine phosphate|mesh-list
153670038|NCT00276809|Etoposide|etoposide|mesh-list
153670039|NCT00276809|Alemtuzumab|alemtuzumab|mesh-list
153670040|NCT00276809|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153670041|NCT00276809|Immunologic Factors|immunologic factors|mesh-ancestor
153670042|NCT00276809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153670088|NCT00276731|Tubulin Modulators|tubulin modulators|mesh-ancestor
153670089|NCT00276731|Antimitotic Agents|antimitotic agents|mesh-ancestor
153670090|NCT00276731|Mitosis Modulators|mitosis modulators|mesh-ancestor
153670091|NCT00276692|Irinotecan|irinotecan|mesh-list
153670092|NCT00276692|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
153670093|NCT00276692|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153670094|NCT00276692|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153670095|NCT00276692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153670096|NCT00276692|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153670097|NCT00276575|Bevacizumab|bevacizumab|mesh-list
153670098|NCT00276575|Everolimus|everolimus|mesh-list
153670099|NCT00276575|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
153670100|NCT00276575|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153670150|NCT04201665|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153670151|NCT04201665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153670153|NCT00276068|Desipramine|desipramine|mesh-list
153670154|NCT00276068|Anesthetics, Local|anesthetics, local|mesh-ancestor
153670155|NCT00276068|Anesthetics|anesthetics|mesh-ancestor
153670156|NCT00276068|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153670157|NCT00276068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153670158|NCT00276068|Sensory System Agents|sensory system agents|mesh-ancestor
153670159|NCT00276068|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153670160|NCT00276068|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153670161|NCT00276068|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
153670162|NCT00276068|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153670163|NCT00276068|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153670164|NCT00276068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153670167|NCT00276068|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153670205|NCT00397098|Amibegron hydrochloride|amibegron hydrochloride|mesh-list
153670206|NCT00397098|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
153670207|NCT00397098|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153670208|NCT00397098|Adrenergic Agents|adrenergic agents|mesh-ancestor
153670209|NCT00397098|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153670210|NCT00397098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153670211|NCT00397098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153670212|NCT00397098|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
153670214|NCT00275834|Anticonvulsants|anticonvulsants|mesh-ancestor
153670215|NCT00275834|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153670216|NCT00275834|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153670217|NCT00275834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153670218|NCT00275834|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153670219|NCT00275834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153670220|NCT00397176|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
153670221|NCT00397176|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
153670222|NCT00397176|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153670223|NCT00397176|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153670224|NCT00397176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153670225|NCT00397176|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153670226|NCT00397176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153670227|NCT00397176|Antidepressive Agents|antidepressive agents|mesh-ancestor
153670229|NCT00275756|Timolol|timolol|mesh-list
153670250|NCT00275639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153670251|NCT03957057|Iron|iron|mesh-list
153670252|NCT03957057|Iron isomaltoside 1000|iron isomaltoside 1000|mesh-list
153670253|NCT03957057|Trace Elements|trace elements|mesh-ancestor
153670254|NCT03957057|Micronutrients|micronutrients|mesh-ancestor
153670255|NCT03957057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153670256|NCT03957057|Hematinics|hematinics|mesh-ancestor
153670257|NCT00275600|Vitamin E|vitamin e|mesh-list
153670258|NCT00275600|Vitamins|vitamins|mesh-ancestor
153670259|NCT00275600|Micronutrients|micronutrients|mesh-ancestor
153670260|NCT00275600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153670261|NCT00275600|Antioxidants|antioxidants|mesh-ancestor
153670262|NCT00275600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153670263|NCT00275600|Protective Agents|protective agents|mesh-ancestor
153670264|NCT00275522|Sirolimus|sirolimus|mesh-list
153670265|NCT00275522|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153670266|NCT00275522|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153670267|NCT00275522|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153670268|NCT00275522|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153670269|NCT00275522|Antifungal Agents|antifungal agents|mesh-ancestor
153670270|NCT00275522|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153670271|NCT00275522|Immunologic Factors|immunologic factors|mesh-ancestor
153670273|NCT00275405|Allyl sulfide|allyl sulfide|mesh-list
153670305|NCT00041574|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153670306|NCT00041574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153670307|NCT00041574|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153670308|NCT00041574|Respiratory System Agents|respiratory system agents|mesh-ancestor
153670309|NCT00041574|Free Radical Scavengers|free radical scavengers|mesh-ancestor
153670310|NCT00041574|Antioxidants|antioxidants|mesh-ancestor
153670311|NCT00041574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153670312|NCT00041574|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153670313|NCT00041574|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
153670314|NCT00041574|Vasodilator Agents|vasodilator agents|mesh-ancestor
153670315|NCT00041574|Gasotransmitters|gasotransmitters|mesh-ancestor
153670316|NCT00041574|Protective Agents|protective agents|mesh-ancestor
153670317|NCT00275132|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
153670318|NCT00275132|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153670319|NCT00275132|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153670320|NCT00275132|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153670321|NCT00275132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153670322|NCT00275132|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153670323|NCT00275093|Sirolimus|sirolimus|mesh-list
153670324|NCT00275093|Temsirolimus|temsirolimus|mesh-list
153670325|NCT00275093|MTOR Inhibitors|mtor inhibitors|mesh-list
153670326|NCT00275093|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153670327|NCT00275093|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153670354|NCT03430596|Cholinergic Agents|cholinergic agents|mesh-ancestor
153670355|NCT00275054|Cyclophosphamide|cyclophosphamide|mesh-list
153670356|NCT00275054|Rituximab|rituximab|mesh-list
153670357|NCT00275054|Fludarabine|fludarabine|mesh-list
153670358|NCT00275054|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153670359|NCT00275054|Immunologic Factors|immunologic factors|mesh-ancestor
153670360|NCT00275054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153670361|NCT00275054|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153670362|NCT00275054|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153670363|NCT00275054|Alkylating Agents|alkylating agents|mesh-ancestor
153670364|NCT00275054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153670366|NCT00275054|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153670367|NCT00275054|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153670368|NCT03208179|Azithromycin|azithromycin|mesh-list
153670369|NCT03208179|Pyrimethamine|pyrimethamine|mesh-list
153670370|NCT03208179|Piperaquine|piperaquine|mesh-list
153670371|NCT03208179|Sulfadoxine|sulfadoxine|mesh-list
153670372|NCT03208179|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
153670373|NCT03208179|Artenimol|artenimol|mesh-list
153670374|NCT03208179|Artemisinins|artemisinins|mesh-list
153670375|NCT03208179|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153670376|NCT03208179|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153670377|NCT03208179|Antimalarials|antimalarials|mesh-ancestor
153670378|NCT03208179|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153670379|NCT03208179|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153670380|NCT03208179|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153670381|NCT03208179|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153670382|NCT03208179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153670383|NCT03208179|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
153670384|NCT00275015|Cytarabine|cytarabine|mesh-list
153670385|NCT00275015|Dexamethasone|dexamethasone|mesh-list
153670386|NCT00275015|Cyclophosphamide|cyclophosphamide|mesh-list
153670387|NCT00275015|Melphalan|melphalan|mesh-list
153670388|NCT00275015|Carmustine|carmustine|mesh-list
153670389|NCT00275015|Fludarabine|fludarabine|mesh-list
153670396|NCT00275015|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153670397|NCT00275015|Alkylating Agents|alkylating agents|mesh-ancestor
153670398|NCT00275015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153670399|NCT00275015|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153670400|NCT00275015|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153670401|NCT00275015|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153670402|NCT00275015|Antiemetics|antiemetics|mesh-ancestor
153670403|NCT00275015|Autonomic Agents|autonomic agents|mesh-ancestor
153670404|NCT00275015|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153670405|NCT00275015|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153670406|NCT00275015|Glucocorticoids|glucocorticoids|mesh-ancestor
153670407|NCT00275015|Hormones|hormones|mesh-ancestor
153670408|NCT00275015|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153670409|NCT00275015|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153670410|NCT00275015|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153670411|NCT00275015|Antimetabolites|antimetabolites|mesh-ancestor
153670412|NCT00275015|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153670413|NCT00275015|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153670414|NCT00275015|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153670415|NCT00275015|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153670416|NCT00275015|Antiviral Agents|antiviral agents|mesh-ancestor
153670417|NCT00275015|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153670418|NCT00274976|Alemtuzumab|alemtuzumab|mesh-list
153670419|NCT00274976|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153670420|NCT00274976|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153670421|NCT00130403|Risedronic Acid|risedronic acid|mesh-list
153670422|NCT00130403|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153670423|NCT00130403|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153670424|NCT00130403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153670425|NCT00130403|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153670426|NCT00130403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153670436|NCT03062826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153670437|NCT03062826|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153670438|NCT03062826|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153670439|NCT03062826|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153670440|NCT03062826|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153670441|NCT03062826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153670442|NCT03062826|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153670443|NCT03062826|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153670444|NCT03062826|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153670445|NCT03062826|Antipyretics|antipyretics|mesh-ancestor
153670446|NCT03062826|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
153670447|NCT03062826|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
153670448|NCT03062826|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
153670449|NCT03062826|Purinergic Agents|purinergic agents|mesh-ancestor
153670450|NCT03062826|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153670451|NCT00130364|Pimecrolimus|pimecrolimus|mesh-list
153670452|NCT00130364|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153670453|NCT00130364|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153670454|NCT00130364|Analgesics|analgesics|mesh-ancestor
153670455|NCT00130364|Sensory System Agents|sensory system agents|mesh-ancestor
153670456|NCT00130364|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153670457|NCT00130364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153670458|NCT00130364|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153670459|NCT00130364|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153670460|NCT00130364|Dermatologic Agents|dermatologic agents|mesh-ancestor
153670461|NCT00130364|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153670462|NCT00130364|Immunologic Factors|immunologic factors|mesh-ancestor
153670463|NCT00130364|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
153670464|NCT00130364|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153670465|NCT00130364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153670477|NCT00041691|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153670480|NCT00394394|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
153670481|NCT00394394|Protease Inhibitors|protease inhibitors|mesh-ancestor
153670482|NCT00394394|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153670483|NCT00394394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153670484|NCT00394394|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153670485|NCT00394394|Diuretics|diuretics|mesh-ancestor
153670486|NCT00394394|Natriuretic Agents|natriuretic agents|mesh-ancestor
153670487|NCT00394394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153670488|NCT00394394|Acid Sensing Ion Channel Blockers|acid sensing ion channel blockers|mesh-ancestor
153670489|NCT00394394|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153670490|NCT00394394|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153670491|NCT00394394|Epithelial Sodium Channel Blockers|epithelial sodium channel blockers|mesh-ancestor
153670492|NCT00394394|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
153670493|NCT00130091|Clonidine|clonidine|mesh-list
153670494|NCT00130091|Analgesics|analgesics|mesh-ancestor
153670495|NCT00130091|Sensory System Agents|sensory system agents|mesh-ancestor
153670496|NCT00130091|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153670497|NCT00130091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153670498|NCT00130091|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153670499|NCT00130091|Sympatholytics|sympatholytics|mesh-ancestor
153670500|NCT00130091|Autonomic Agents|autonomic agents|mesh-ancestor
153670501|NCT00130091|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
153670502|NCT00130091|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153670503|NCT00130091|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153670504|NCT00130091|Adrenergic Agents|adrenergic agents|mesh-ancestor
153670505|NCT00130091|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153670506|NCT00130091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153670507|NCT00130013|Amoxicillin|amoxicillin|mesh-list
153670508|NCT00130013|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153670509|NCT00130013|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153670510|NCT00129857|HU 211|hu 211|mesh-list
153670517|NCT00129857|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
153670518|NCT00129857|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
153670519|NCT00129857|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153670520|NCT00129857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153670521|NCT00129857|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
153670522|NCT00129857|Protective Agents|protective agents|mesh-ancestor
153670524|NCT00129818|Antiviral Agents|antiviral agents|mesh-ancestor
153670525|NCT00129818|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153670526|NCT00129818|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153670527|NCT00129818|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153670528|NCT00129818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153670530|NCT00129740|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153670531|NCT00129740|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153670532|NCT00129740|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153670533|NCT00129740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153670534|NCT00129506|Methotrexate|methotrexate|mesh-list
153670535|NCT00129506|Misoprostol|misoprostol|mesh-list
153670536|NCT00129506|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
153670537|NCT00129506|Abortifacient Agents|abortifacient agents|mesh-ancestor
153670538|NCT00129506|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153670539|NCT00129506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153670540|NCT00129506|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153670541|NCT00129506|Antimetabolites|antimetabolites|mesh-ancestor
153670543|NCT00129506|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153670563|NCT00129233|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
153670564|NCT00129233|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
153670565|NCT00129155|Treosulfan|treosulfan|mesh-list
153670566|NCT00129155|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153670567|NCT00129155|Alkylating Agents|alkylating agents|mesh-ancestor
153670568|NCT00129155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153670569|NCT00129155|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153670570|NCT00042003|Decitabine|decitabine|mesh-list
153670571|NCT00042003|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153670572|NCT00042003|Antimetabolites|antimetabolites|mesh-ancestor
153670573|NCT00042003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153670574|NCT00042003|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153670575|NCT00042003|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153670576|NCT00129038|Aspirin|aspirin|mesh-list
153670577|NCT00129038|Dipyridamole|dipyridamole|mesh-list
153670578|NCT00129038|Aspirin, Dipyridamole Drug Combination|aspirin, dipyridamole drug combination|mesh-list
153670579|NCT00129038|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153670580|NCT00129038|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153670581|NCT00129038|Analgesics|analgesics|mesh-ancestor
153670582|NCT00129038|Sensory System Agents|sensory system agents|mesh-ancestor
153670583|NCT00129038|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153670584|NCT00129038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153670585|NCT00129038|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153670586|NCT00129038|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153670587|NCT00129038|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153670588|NCT00129038|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153670610|NCT00128804|Provitamins|provitamins|mesh-ancestor
153670612|NCT00128804|Micronutrients|micronutrients|mesh-ancestor
153670613|NCT00097851|Docetaxel|docetaxel|mesh-list
153670614|NCT00097851|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153670615|NCT00097851|Tubulin Modulators|tubulin modulators|mesh-ancestor
153670616|NCT00097851|Antimitotic Agents|antimitotic agents|mesh-ancestor
153670617|NCT00097851|Mitosis Modulators|mitosis modulators|mesh-ancestor
153432287|NCT05087914|Dopamine Agents|dopamine agents|mesh-ancestor
153670618|NCT00097851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153670619|NCT00038376|Interferons|interferons|mesh-list
153670620|NCT00038376|Interferon-alpha|interferon-alpha|mesh-list
153670621|NCT00038376|Interferon alpha-2|interferon alpha-2|mesh-list
153670622|NCT00038376|Isotretinoin|isotretinoin|mesh-list
153670623|NCT00038376|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153507588|NCT06049576|Nivolumab|nivolumab|mesh-list
153670624|NCT00038376|Antiviral Agents|antiviral agents|mesh-ancestor
153670625|NCT00038376|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153670626|NCT00038376|Immunologic Factors|immunologic factors|mesh-ancestor
153670627|NCT00038376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153670628|NCT00038376|Dermatologic Agents|dermatologic agents|mesh-ancestor
153670629|NCT00128531|Leuprolide|leuprolide|mesh-list
153670630|NCT00128531|Fertility Agents, Female|fertility agents, female|mesh-ancestor
153670631|NCT00128531|Fertility Agents|fertility agents|mesh-ancestor
153670632|NCT00128531|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153670633|NCT00128531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153670634|NCT00128531|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153670635|NCT00128531|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153670636|NCT00038454|Chrysarobin|chrysarobin|mesh-list
153670637|NCT00038454|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153670638|NCT00038454|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153670639|NCT00038454|Analgesics|analgesics|mesh-ancestor
153670640|NCT00038454|Sensory System Agents|sensory system agents|mesh-ancestor
153670656|NCT00128414|Tubulin Modulators|tubulin modulators|mesh-ancestor
153670657|NCT00128414|Antimitotic Agents|antimitotic agents|mesh-ancestor
153670658|NCT00128414|Mitosis Modulators|mitosis modulators|mesh-ancestor
153670659|NCT00128414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153670660|NCT00128414|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153670662|NCT00038493|Lonafarnib|lonafarnib|mesh-list
153670663|NCT00038493|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153670664|NCT00038493|Alkylating Agents|alkylating agents|mesh-ancestor
153670665|NCT00038493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153670666|NCT00038493|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153670667|NCT00038493|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153670668|NCT00038532|Ritonavir|ritonavir|mesh-list
153670669|NCT00038532|Saquinavir|saquinavir|mesh-list
153670670|NCT00038532|Amprenavir|amprenavir|mesh-list
153670671|NCT00038532|Efavirenz|efavirenz|mesh-list
153670672|NCT00038532|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
153670693|NCT00038571|Bortezomib|bortezomib|mesh-list
153670713|NCT05769738|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153670714|NCT05769738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153670716|NCT05769725|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153670717|NCT05769725|Tubulin Modulators|tubulin modulators|mesh-ancestor
153670718|NCT05769725|Antimitotic Agents|antimitotic agents|mesh-ancestor
153670719|NCT05769725|Mitosis Modulators|mitosis modulators|mesh-ancestor
153670720|NCT05769725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153670721|NCT05769660|Temozolomide|temozolomide|mesh-list
153670722|NCT05769660|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153670723|NCT05769660|Alkylating Agents|alkylating agents|mesh-ancestor
153670724|NCT05769660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153670725|NCT05769660|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153670726|NCT05769569|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
153670727|NCT05769569|Antiviral Agents|antiviral agents|mesh-ancestor
153670728|NCT05769569|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153670729|NCT05768997|Darbepoetin alfa|darbepoetin alfa|mesh-list
153670769|NCT05744674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153670770|NCT05744674|Sensory System Agents|sensory system agents|mesh-ancestor
153670771|NCT05744674|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153670774|NCT05736978|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153670775|NCT05736978|Antimetabolites|antimetabolites|mesh-ancestor
153670776|NCT05736978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153670777|NCT05736978|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153670778|NCT05736978|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153670779|NCT05736965|Azacitidine|azacitidine|mesh-list
153670780|NCT05736965|Venetoclax|venetoclax|mesh-list
153670781|NCT05736965|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153670782|NCT05736965|Antimetabolites|antimetabolites|mesh-ancestor
153670783|NCT05736965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153670784|NCT05736965|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153670785|NCT05736965|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153670786|NCT05657860|Guanfacine|guanfacine|mesh-list
153670787|NCT05657860|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153670788|NCT05657860|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
153670789|NCT05657860|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153670790|NCT05657860|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153670791|NCT05657860|Adrenergic Agents|adrenergic agents|mesh-ancestor
153670792|NCT05657860|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153670793|NCT05657860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153670794|NCT05657860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153670795|NCT05595603|Gentamicins|gentamicins|mesh-list
153670796|NCT05595603|Polymethyl Methacrylate|polymethyl methacrylate|mesh-list
153670797|NCT05595603|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153670798|NCT05595603|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153670813|NCT05453955|Anesthetics, General|anesthetics, general|mesh-ancestor
153670814|NCT05453955|Anesthetics|anesthetics|mesh-ancestor
153670815|NCT05427786|Nicorandil|nicorandil|mesh-list
153670816|NCT05427786|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153670817|NCT05427786|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153670818|NCT05427786|Vasodilator Agents|vasodilator agents|mesh-ancestor
153670819|NCT05427786|Vitamin B Complex|vitamin b complex|mesh-ancestor
153670820|NCT05427786|Vitamins|vitamins|mesh-ancestor
153670821|NCT05427786|Micronutrients|micronutrients|mesh-ancestor
153670822|NCT05427786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153670823|NCT05417776|Gadolinium 1,4,7,10-tetraazacyclododecane-N,N',N'',N'''-tetraacetate|gadolinium 1,4,7,10-tetraazacyclododecane-n,n',n'',n'''-tetraacetate|mesh-list
153670824|NCT05417776|Chelating Agents|chelating agents|mesh-ancestor
153670825|NCT05417776|Sequestering Agents|sequestering agents|mesh-ancestor
153670874|NCT05298696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153670875|NCT05298696|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153670876|NCT05298696|Vasodilator Agents|vasodilator agents|mesh-ancestor
153670877|NCT05298696|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
153670878|NCT05298696|Protective Agents|protective agents|mesh-ancestor
153670879|NCT05298696|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
153670880|NCT05298696|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
153670881|NCT05298696|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153670882|NCT05287425|Ciprofloxacin|ciprofloxacin|mesh-list
153670883|NCT05287425|Gentamicins|gentamicins|mesh-list
153670884|NCT05287425|Benzalkonium Compounds|benzalkonium compounds|mesh-list
153670886|NCT05287425|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153670887|NCT05287425|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153670888|NCT05287425|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153670889|NCT05287425|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153670890|NCT05287425|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153670891|NCT05287425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153670892|NCT05287425|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153670893|NCT05287425|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
153670894|NCT05287425|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153670899|NCT05258721|Fluorides|fluorides|mesh-list
153670926|NCT05020444|Cyclophosphamide|cyclophosphamide|mesh-list
153670927|NCT05020444|Fludarabine|fludarabine|mesh-list
153670928|NCT05020444|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153670929|NCT05020444|Immunologic Factors|immunologic factors|mesh-ancestor
153670930|NCT05020444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153670931|NCT05020444|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153670932|NCT05020444|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153670933|NCT05020444|Alkylating Agents|alkylating agents|mesh-ancestor
153670934|NCT05020444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153670935|NCT05020444|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153670936|NCT05020444|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153670937|NCT05012189|Oseltamivir|oseltamivir|mesh-list
153670939|NCT05012189|Antiviral Agents|antiviral agents|mesh-ancestor
153670940|NCT05012189|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153670941|NCT05012189|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153670942|NCT05012189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153670943|NCT04985721|Tislelizumab|tislelizumab|mesh-list
153670944|NCT04985721|Pamiparib|pamiparib|mesh-list
153670945|NCT04985721|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153432294|NCT05058651|Carboplatin|carboplatin|mesh-list
153432295|NCT05058651|Etoposide|etoposide|mesh-list
153432296|NCT05058651|Etoposide phosphate|etoposide phosphate|mesh-list
153432297|NCT05058651|Atezolizumab|atezolizumab|mesh-list
153432298|NCT05058651|Podophyllotoxin|podophyllotoxin|mesh-list
153670980|NCT04857684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153670981|NCT04857684|Growth Inhibitors|growth inhibitors|mesh-ancestor
153670982|NCT04857684|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153670983|NCT04857684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153670984|NCT04846348|Diphenhydramine|diphenhydramine|mesh-list
153670985|NCT04846348|Promethazine|promethazine|mesh-list
153670986|NCT04846348|Cromolyn Sodium|cromolyn sodium|mesh-list
153670987|NCT04846348|Salicylates|salicylates|mesh-list
153670988|NCT04846348|Emollients|emollients|mesh-list
153670989|NCT04846348|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
153670990|NCT04846348|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153670991|NCT04846348|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153670992|NCT04846348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153670993|NCT04846348|Anesthetics, Local|anesthetics, local|mesh-ancestor
153670994|NCT04846348|Anesthetics|anesthetics|mesh-ancestor
153670995|NCT04846348|Sensory System Agents|sensory system agents|mesh-ancestor
153670996|NCT04846348|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153670997|NCT04846348|Antiemetics|antiemetics|mesh-ancestor
153670998|NCT04846348|Autonomic Agents|autonomic agents|mesh-ancestor
153670999|NCT04846348|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153671000|NCT04846348|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
153671001|NCT04846348|Histamine Antagonists|histamine antagonists|mesh-ancestor
153671002|NCT04846348|Histamine Agents|histamine agents|mesh-ancestor
153671003|NCT04846348|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153671004|NCT04846348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153671005|NCT04846348|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
153671006|NCT04846348|Antipruritics|antipruritics|mesh-ancestor
153671007|NCT04846348|Dermatologic Agents|dermatologic agents|mesh-ancestor
153671029|NCT04771520|Mitosis Modulators|mitosis modulators|mesh-ancestor
153671030|NCT04771520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153671031|NCT04771520|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153671032|NCT04771520|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153671033|NCT04769453|Hyaluronic Acid|hyaluronic acid|mesh-list
153671034|NCT04769453|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153671035|NCT04769453|Immunologic Factors|immunologic factors|mesh-ancestor
153671036|NCT04769453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153671037|NCT04769453|Viscosupplements|viscosupplements|mesh-ancestor
153671038|NCT04769453|Protective Agents|protective agents|mesh-ancestor
153671039|NCT04742699|Lemborexant|lemborexant|mesh-list
153671040|NCT04742699|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
153671041|NCT04742699|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153671042|NCT04742699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153671043|NCT04742699|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
153671044|NCT04742699|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153671045|NCT04742699|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153671048|NCT04629534|Vitamin D|vitamin d|mesh-list
153671087|NCT04584112|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153671088|NCT04584112|Alkylating Agents|alkylating agents|mesh-ancestor
153671089|NCT04584112|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153671090|NCT04584112|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153671091|NCT04584112|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153671092|NCT04584112|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153671093|NCT04584112|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153671094|NCT04584112|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153671095|NCT04584112|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153671096|NCT04584112|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153671098|NCT04573777|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
153671099|NCT04573777|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153671100|NCT04573777|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153671101|NCT04573777|Antimetabolites|antimetabolites|mesh-ancestor
153671102|NCT04573777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153671103|NCT04573777|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
153671105|NCT04573777|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153671106|NCT04573777|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153671107|NCT04507711|Palonosetron|palonosetron|mesh-list
153671108|NCT04507711|Antiemetics|antiemetics|mesh-ancestor
153671109|NCT04507711|Autonomic Agents|autonomic agents|mesh-ancestor
153671110|NCT04507711|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153671111|NCT04507711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153671112|NCT04507711|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153671113|NCT04507711|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
153671114|NCT04507711|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153671115|NCT04507711|Serotonin Agents|serotonin agents|mesh-ancestor
153671116|NCT04507711|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153671117|NCT04507711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153671118|NCT04499274|Ondansetron|ondansetron|mesh-list
153671119|NCT04499274|Antiemetics|antiemetics|mesh-ancestor
153671120|NCT04499274|Autonomic Agents|autonomic agents|mesh-ancestor
153671121|NCT04499274|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153671122|NCT04499274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153671125|NCT04499274|Dermatologic Agents|dermatologic agents|mesh-ancestor
153671126|NCT04499274|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
153671127|NCT04499274|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153671128|NCT04499274|Serotonin Agents|serotonin agents|mesh-ancestor
153671129|NCT04499274|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153671130|NCT04499274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153671131|NCT04376827|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
153671132|NCT04376827|Immunologic Factors|immunologic factors|mesh-ancestor
153671133|NCT04376827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153671134|NCT04266236|Ropivacaine|ropivacaine|mesh-list
153671190|NCT03965195|Vaccines|vaccines|mesh-list
153671191|NCT03965195|Immunologic Factors|immunologic factors|mesh-ancestor
153671192|NCT03965195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153671193|NCT03878082|Acetaminophen|acetaminophen|mesh-list
153671194|NCT03878082|Propacetamol|propacetamol|mesh-list
153671195|NCT03878082|Analgesics|analgesics|mesh-ancestor
153671196|NCT03878082|Sensory System Agents|sensory system agents|mesh-ancestor
153671197|NCT03878082|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153671198|NCT03878082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153671199|NCT03878082|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153671200|NCT03878082|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153671201|NCT03878082|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153671202|NCT03878082|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153671203|NCT03878082|Antipyretics|antipyretics|mesh-ancestor
153671204|NCT03814941|Anesthetics|anesthetics|mesh-list
153671205|NCT03814941|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153671206|NCT03814941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153671207|NCT03759938|Rivaroxaban|rivaroxaban|mesh-list
153671208|NCT03759938|Apixaban|apixaban|mesh-list
153671209|NCT03759938|Edoxaban|edoxaban|mesh-list
153671210|NCT03759938|Dabigatran|dabigatran|mesh-list
153671211|NCT03759938|Anticoagulants|anticoagulants|mesh-list
153671212|NCT03759938|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
153671213|NCT03759938|Antithrombins|antithrombins|mesh-ancestor
153671214|NCT03759938|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
153671215|NCT03759938|Protease Inhibitors|protease inhibitors|mesh-ancestor
153671216|NCT03759938|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153671217|NCT03759938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153671218|NCT03596164|Teduglutide|teduglutide|mesh-list
153671219|NCT03596164|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153671220|NCT03596164|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
153671221|NCT03596164|Protective Agents|protective agents|mesh-ancestor
153671222|NCT03596164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153671223|NCT03525873|Methylphenidate|methylphenidate|mesh-list
153671224|NCT03525873|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
153671225|NCT03525873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153671226|NCT03525873|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
153671228|NCT03525873|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153671229|NCT03525873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153671230|NCT03525873|Dopamine Agents|dopamine agents|mesh-ancestor
153671231|NCT03525873|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153671232|NCT03492125|Rituximab|rituximab|mesh-list
153671233|NCT03492125|Obinutuzumab|obinutuzumab|mesh-list
153671234|NCT03492125|Venetoclax|venetoclax|mesh-list
153671235|NCT03492125|Acalabrutinib|acalabrutinib|mesh-list
153671236|NCT03492125|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153671237|NCT03492125|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153671238|NCT03492125|Immunologic Factors|immunologic factors|mesh-ancestor
153671239|NCT03492125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153671241|NCT03492125|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153671242|NCT03492125|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153671243|NCT03492125|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153671289|NCT03098225|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153671290|NCT03098225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153671291|NCT03098225|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153671292|NCT03098225|Glucocorticoids|glucocorticoids|mesh-ancestor
153671293|NCT03098225|Hormones|hormones|mesh-ancestor
153671294|NCT03098225|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153671295|NCT03098225|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
153671296|NCT03098225|Protective Agents|protective agents|mesh-ancestor
153671297|NCT03098225|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153671298|NCT03098225|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153671299|NCT02990468|Cisplatin|cisplatin|mesh-list
153671300|NCT02990468|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153671301|NCT02882100|Vaccines|vaccines|mesh-list
153671302|NCT02882100|Immunologic Factors|immunologic factors|mesh-ancestor
153671303|NCT02882100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153671349|NCT02438007|3-hydroxy-17-(1H-benzimidazole-1-yl)androsta-5,16-diene|3-hydroxy-17-(1h-benzimidazole-1-yl)androsta-5,16-diene|mesh-list
153671351|NCT02438007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153671352|NCT02409342|Carboplatin|carboplatin|mesh-list
153671353|NCT02409342|Gemcitabine|gemcitabine|mesh-list
153671354|NCT02409342|Pemetrexed|pemetrexed|mesh-list
153671355|NCT02409342|Atezolizumab|atezolizumab|mesh-list
153671356|NCT02409342|Antibodies|antibodies|mesh-list
153671357|NCT02409342|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
153671358|NCT02409342|Immunologic Factors|immunologic factors|mesh-ancestor
153671359|NCT02409342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153671360|NCT02409342|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153671361|NCT02409342|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153671362|NCT02409342|Antimetabolites|antimetabolites|mesh-ancestor
153671363|NCT02409342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153671364|NCT02409342|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153671365|NCT02409342|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153671366|NCT02409342|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153671367|NCT02409342|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153671368|NCT02409342|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153671369|NCT02255409|Vaccines|vaccines|mesh-list
153671370|NCT02255409|Immunologic Factors|immunologic factors|mesh-ancestor
153671371|NCT02255409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153671372|NCT02213757|Estrogens|estrogens|mesh-list
153671373|NCT02213757|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
153671374|NCT02213757|Hormones|hormones|mesh-ancestor
153671375|NCT02213757|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153671376|NCT02213757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153671377|NCT02102243|Insulin|insulin|mesh-list
153508340|NCT04453449|Anesthetics|anesthetics|mesh-ancestor
153671392|NCT01969227|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
153671393|NCT01969227|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153671394|NCT01969227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153671395|NCT01709734|3-hydroxy-17-(1H-benzimidazole-1-yl)androsta-5,16-diene|3-hydroxy-17-(1h-benzimidazole-1-yl)androsta-5,16-diene|mesh-list
153671396|NCT01709734|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153671397|NCT01709734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153671398|NCT01604135|Riboflavin|riboflavin|mesh-list
153671399|NCT01604135|Dextrans|dextrans|mesh-list
153671400|NCT01604135|Vitamin B Complex|vitamin b complex|mesh-ancestor
153671401|NCT01604135|Vitamins|vitamins|mesh-ancestor
153671402|NCT01604135|Micronutrients|micronutrients|mesh-ancestor
153671403|NCT01604135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153891258|NCT01026220|Antimitotic Agents|antimitotic agents|mesh-ancestor
153891259|NCT01026220|Mitosis Modulators|mitosis modulators|mesh-ancestor
153891260|NCT01026142|Capecitabine|capecitabine|mesh-list
153891261|NCT01026142|Trastuzumab|trastuzumab|mesh-list
153891262|NCT01026142|Pertuzumab|pertuzumab|mesh-list
153891263|NCT01026142|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153891264|NCT01026142|Antimetabolites|antimetabolites|mesh-ancestor
153671404|NCT01604135|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
153671405|NCT01604135|Dermatologic Agents|dermatologic agents|mesh-ancestor
153671406|NCT01604135|Anticoagulants|anticoagulants|mesh-ancestor
153671407|NCT01604135|Plasma Substitutes|plasma substitutes|mesh-ancestor
153671408|NCT01604135|Blood Substitutes|blood substitutes|mesh-ancestor
153671409|NCT00644189|Clofarabine|clofarabine|mesh-list
153671410|NCT00644189|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153671411|NCT00644189|Antimetabolites|antimetabolites|mesh-ancestor
153671414|NCT00465517|Ganaxolone|ganaxolone|mesh-list
153671445|NCT05772832|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153671446|NCT05772832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153671447|NCT05772832|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153671448|NCT05772832|Narcotics|narcotics|mesh-ancestor
153671449|NCT05772728|Azacitidine|azacitidine|mesh-list
153671450|NCT05772728|Mitoxantrone|mitoxantrone|mesh-list
153671451|NCT05772728|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153671452|NCT05772728|Antimetabolites|antimetabolites|mesh-ancestor
153671453|NCT05772728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153671454|NCT05772728|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153671455|NCT05772728|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153671456|NCT05772728|Analgesics|analgesics|mesh-ancestor
153671457|NCT05772728|Sensory System Agents|sensory system agents|mesh-ancestor
153671458|NCT05772728|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153671459|NCT05772728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153671460|NCT05772728|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153671461|NCT05772728|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153671462|NCT05772676|Aprepitant|aprepitant|mesh-list
153671463|NCT05772676|Antiemetics|antiemetics|mesh-ancestor
153671464|NCT05772676|Autonomic Agents|autonomic agents|mesh-ancestor
153671465|NCT05772676|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153671466|NCT05772676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153671467|NCT05772676|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153671468|NCT05772676|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
153671469|NCT05772676|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153671470|NCT05772676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153671471|NCT05772624|Nivolumab|nivolumab|mesh-list
153671472|NCT05772624|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153671473|NCT05772624|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153671474|NCT05772624|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153671475|NCT05772624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153671476|NCT05772377|Carboplatin|carboplatin|mesh-list
153671487|NCT05772039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153671488|NCT05772039|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
153671489|NCT05772039|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153671490|NCT05772013|Azithromycin|azithromycin|mesh-list
153671491|NCT05772013|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153671492|NCT05772013|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153671493|NCT05771675|Simvastatin|simvastatin|mesh-list
153671494|NCT05771675|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153671495|NCT05771675|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153383991|NCT04903652|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153383992|NCT04903652|Tubulin Modulators|tubulin modulators|mesh-ancestor
153383993|NCT04903652|Antimitotic Agents|antimitotic agents|mesh-ancestor
153671496|NCT05771675|Antimetabolites|antimetabolites|mesh-ancestor
153671497|NCT05771675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153671498|NCT05771675|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153671499|NCT05771675|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
153671500|NCT05771675|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153671501|NCT05771194|Lubricant Eye Drops|lubricant eye drops|mesh-list
153671502|NCT05771194|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
153671503|NCT05771194|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
153671504|NCT05771181|Vitamin E|vitamin e|mesh-list
153671545|NCT05768282|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153671546|NCT05768282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153671547|NCT05768282|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153671548|NCT05768282|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153671549|NCT05766800|Paclitaxel|paclitaxel|mesh-list
153671550|NCT05766800|Carboplatin|carboplatin|mesh-list
153671551|NCT05766800|Pemetrexed|pemetrexed|mesh-list
153671552|NCT05766800|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153671553|NCT05766800|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153671554|NCT05766800|Tubulin Modulators|tubulin modulators|mesh-ancestor
153671555|NCT05766800|Antimitotic Agents|antimitotic agents|mesh-ancestor
153671556|NCT05766800|Mitosis Modulators|mitosis modulators|mesh-ancestor
153671557|NCT05766800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153671558|NCT05766800|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153671559|NCT05766800|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153671560|NCT05766800|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153671562|NCT05766410|Palbociclib|palbociclib|mesh-list
153671563|NCT05766410|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153671564|NCT05766410|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
153671565|NCT05766410|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153671566|NCT05766410|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153671567|NCT05766410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153671568|NCT05766410|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
153671570|NCT05766410|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153671571|NCT05766410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153671572|NCT05766410|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153671589|NCT05750875|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153671590|NCT05750875|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153671591|NCT05750875|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
153671592|NCT05750875|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
153671593|NCT05750875|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153671594|NCT05750875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153671595|NCT05750875|Antimanic Agents|antimanic agents|mesh-ancestor
153671596|NCT05750875|Antipruritics|antipruritics|mesh-ancestor
153671597|NCT05750875|Dermatologic Agents|dermatologic agents|mesh-ancestor
153671598|NCT05750875|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
153671599|NCT05750875|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
153671600|NCT05750875|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
153671601|NCT05750875|Histamine Antagonists|histamine antagonists|mesh-ancestor
153671602|NCT05750875|Histamine Agents|histamine agents|mesh-ancestor
153671603|NCT05680584|Melatonin|melatonin|mesh-list
153671604|NCT05680584|Hydroxyzine|hydroxyzine|mesh-list
153671605|NCT05680584|Antioxidants|antioxidants|mesh-ancestor
153671606|NCT05680584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153671607|NCT05680584|Protective Agents|protective agents|mesh-ancestor
153671608|NCT05680584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153671609|NCT05680584|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153671610|NCT05680584|Antipruritics|antipruritics|mesh-ancestor
153671611|NCT05680584|Dermatologic Agents|dermatologic agents|mesh-ancestor
153671612|NCT05680584|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
153671613|NCT05680584|Histamine Antagonists|histamine antagonists|mesh-ancestor
153671614|NCT05680584|Histamine Agents|histamine agents|mesh-ancestor
153671637|NCT05533684|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153671638|NCT05533684|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153671639|NCT05533684|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153671640|NCT05533684|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153671641|NCT05533684|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
153671642|NCT05533684|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
153671643|NCT05533684|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153671644|NCT05533684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153671645|NCT05533684|Antimanic Agents|antimanic agents|mesh-ancestor
153671646|NCT05408247|Acetylcysteine|acetylcysteine|mesh-list
153671647|NCT05408247|N-monoacetylcystine|n-monoacetylcystine|mesh-list
153671648|NCT05408247|Antiviral Agents|antiviral agents|mesh-ancestor
153671649|NCT05408247|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153671650|NCT05408247|Expectorants|expectorants|mesh-ancestor
153671651|NCT05408247|Respiratory System Agents|respiratory system agents|mesh-ancestor
153671652|NCT05408247|Free Radical Scavengers|free radical scavengers|mesh-ancestor
153671697|NCT04892511|Mydriatics|mydriatics|mesh-ancestor
153671698|NCT04892511|Autonomic Agents|autonomic agents|mesh-ancestor
153671699|NCT04892511|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153671700|NCT04892511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153671701|NCT04892511|Sympathomimetics|sympathomimetics|mesh-ancestor
153671702|NCT04892511|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
153671703|NCT04892511|Nasal Decongestants|nasal decongestants|mesh-ancestor
153671704|NCT04892511|Respiratory System Agents|respiratory system agents|mesh-ancestor
153671705|NCT04892511|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
153671706|NCT04892511|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153671720|NCT04892511|Serotonin Agents|serotonin agents|mesh-ancestor
153671762|NCT04702256|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153671763|NCT04702256|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
153671764|NCT04702256|Antitubercular Agents|antitubercular agents|mesh-ancestor
153671765|NCT04702256|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153671766|NCT04702256|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153671767|NCT04702256|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153671768|NCT04702256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153671769|NCT04702256|Antiemetics|antiemetics|mesh-ancestor
153671770|NCT04702256|Autonomic Agents|autonomic agents|mesh-ancestor
153671771|NCT04702256|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153671772|NCT04702256|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153671773|NCT04702256|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
153671774|NCT04702256|Protective Agents|protective agents|mesh-ancestor
153671775|NCT04702256|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153671776|NCT04702256|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
153671777|NCT04702256|Histamine Antagonists|histamine antagonists|mesh-ancestor
153671778|NCT04702256|Histamine Agents|histamine agents|mesh-ancestor
153671779|NCT04702256|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153671780|NCT04641702|Atropine|atropine|mesh-list
153671781|NCT04641702|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153671782|NCT04641702|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153671783|NCT04641702|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153671784|NCT04641702|Autonomic Agents|autonomic agents|mesh-ancestor
153671785|NCT04641702|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153671786|NCT04641702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153671787|NCT04641702|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153671788|NCT04641702|Respiratory System Agents|respiratory system agents|mesh-ancestor
153671789|NCT04641702|Mydriatics|mydriatics|mesh-ancestor
153671790|NCT04641702|Parasympatholytics|parasympatholytics|mesh-ancestor
153671791|NCT04641702|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
153671792|NCT04641702|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
153671793|NCT04641702|Cholinergic Agents|cholinergic agents|mesh-ancestor
153671794|NCT04641702|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153671796|NCT04622553|Mexiletine|mexiletine|mesh-list
153671801|NCT04622553|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153671802|NCT04616807|Mexiletine|mexiletine|mesh-list
153671803|NCT04616807|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153671804|NCT04616807|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
153671805|NCT04616807|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153671806|NCT04616807|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153671807|NCT04616807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153671808|NCT04608630|Zoledronic Acid|zoledronic acid|mesh-list
153671809|NCT04608630|Denosumab|denosumab|mesh-list
153671810|NCT04608630|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153671811|NCT04608630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153671812|NCT04580134|Risperidone|risperidone|mesh-list
153671813|NCT04580134|Clozapine|clozapine|mesh-list
153671814|NCT04580134|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153671815|NCT04580134|Serotonin Agents|serotonin agents|mesh-ancestor
153671816|NCT04580134|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153671817|NCT04580134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153671818|NCT04580134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153671819|NCT04580134|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153671820|NCT04580134|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153671821|NCT04580134|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153671822|NCT04580134|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153671823|NCT04580134|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
153671824|NCT04580134|Dopamine Agents|dopamine agents|mesh-ancestor
153671825|NCT04580134|GABA Antagonists|gaba antagonists|mesh-ancestor
153671826|NCT04580134|GABA Agents|gaba agents|mesh-ancestor
153671827|NCT04541108|Pembrolizumab|pembrolizumab|mesh-list
153671832|NCT04512079|Enoxaparin|enoxaparin|mesh-list
153671848|NCT04323657|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153671849|NCT04323657|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153671850|NCT04323657|Alkylating Agents|alkylating agents|mesh-ancestor
153671851|NCT04323657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153671852|NCT04323657|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153671853|NCT04323657|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153671854|NCT04318691|Dimercaprol|dimercaprol|mesh-list
153671855|NCT04318691|Chelating Agents|chelating agents|mesh-ancestor
153671856|NCT04318691|Sequestering Agents|sequestering agents|mesh-ancestor
153671857|NCT04318691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153671859|NCT04278092|Cetuximab|cetuximab|mesh-list
153671860|NCT04278092|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153671861|NCT04278092|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153671862|NCT04278092|Tubulin Modulators|tubulin modulators|mesh-ancestor
153671863|NCT04278092|Antimitotic Agents|antimitotic agents|mesh-ancestor
153671864|NCT04278092|Mitosis Modulators|mitosis modulators|mesh-ancestor
153671866|NCT04278092|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153671907|NCT03589729|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153671908|NCT03589729|Antiviral Agents|antiviral agents|mesh-ancestor
153671909|NCT03589729|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153671910|NCT03589729|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153671911|NCT03589729|Immunologic Factors|immunologic factors|mesh-ancestor
153671912|NCT03589729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153671913|NCT03589729|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153671914|NCT03589729|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153671915|NCT03589729|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153671916|NCT03589729|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153671917|NCT03589729|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153671918|NCT03589729|Immunotoxins|immunotoxins|mesh-ancestor
153671919|NCT03589729|Immunoconjugates|immunoconjugates|mesh-ancestor
153671920|NCT03589729|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
153671921|NCT03589729|Protective Agents|protective agents|mesh-ancestor
153671966|NCT03387787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153671967|NCT03364036|Cladribine|cladribine|mesh-list
153671968|NCT03364036|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153671969|NCT03364036|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153671970|NCT03364036|Immunologic Factors|immunologic factors|mesh-ancestor
153671971|NCT03364036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153671972|NCT03315897|Epoetin Alfa|epoetin alfa|mesh-list
153671973|NCT03315897|Hematinics|hematinics|mesh-ancestor
153671974|NCT03299660|Capecitabine|capecitabine|mesh-list
153671975|NCT03299660|Fluorouracil|fluorouracil|mesh-list
153671976|NCT03299660|Avelumab|avelumab|mesh-list
153671977|NCT03299660|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153671978|NCT03299660|Antimetabolites|antimetabolites|mesh-ancestor
153671979|NCT03299660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153671980|NCT03299660|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153671981|NCT03299660|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153671982|NCT03299660|Immunologic Factors|immunologic factors|mesh-ancestor
153671983|NCT03299660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153671984|NCT03299660|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153671985|NCT03140358|Atropine|atropine|mesh-list
153672021|NCT02899611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153672023|NCT02899611|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153672024|NCT02899611|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153672025|NCT02899611|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153672026|NCT02750202|Vaccines|vaccines|mesh-list
153672027|NCT02750202|Immunologic Factors|immunologic factors|mesh-ancestor
153672028|NCT02750202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153672029|NCT02634294|Interferons|interferons|mesh-list
153672030|NCT02634294|Interferon-alpha|interferon-alpha|mesh-list
153672031|NCT02634294|Interferon alpha-2|interferon alpha-2|mesh-list
153672032|NCT02634294|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
153672033|NCT02634294|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153672034|NCT02634294|Antiviral Agents|antiviral agents|mesh-ancestor
153672035|NCT02634294|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153672036|NCT02634294|Immunologic Factors|immunologic factors|mesh-ancestor
153672037|NCT02634294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153672038|NCT02575677|Oxycodone|oxycodone|mesh-list
153672039|NCT02575677|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153672040|NCT02575677|Narcotics|narcotics|mesh-ancestor
153672041|NCT02575677|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153672078|NCT02511418|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153672079|NCT02511418|Antimetabolites|antimetabolites|mesh-ancestor
153672080|NCT02511418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153672081|NCT02511418|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153672082|NCT02511418|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
153672083|NCT02511418|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153672084|NCT02278250|Carboplatin|carboplatin|mesh-list
153672085|NCT02278250|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153672087|NCT02250326|Azacitidine|azacitidine|mesh-list
153672088|NCT02250326|Cc-486|cc-486|mesh-list
153672089|NCT02250326|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153672090|NCT02250326|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153672091|NCT02250326|Tubulin Modulators|tubulin modulators|mesh-ancestor
153672092|NCT02250326|Antimitotic Agents|antimitotic agents|mesh-ancestor
153672093|NCT02250326|Mitosis Modulators|mitosis modulators|mesh-ancestor
153672094|NCT02250326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153672095|NCT02250326|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153672096|NCT02250326|Antimetabolites|antimetabolites|mesh-ancestor
153672097|NCT02250326|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153672098|NCT02225600|Oxytocin|oxytocin|mesh-list
153672099|NCT02225600|Oxytocics|oxytocics|mesh-ancestor
153672100|NCT02225600|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153672101|NCT02225600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153672102|NCT02211742|Dapagliflozin|dapagliflozin|mesh-list
153672103|NCT02211742|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
153672104|NCT02211742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153672105|NCT02211742|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153672106|NCT02211742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153672107|NCT02081404|Esomeprazole|esomeprazole|mesh-list
153672108|NCT02081404|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
153672109|NCT02081404|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153672110|NCT02081404|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
153672111|NCT02081404|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153672112|NCT02081404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153672113|NCT00038766|Semapimod|semapimod|mesh-list
153672114|NCT00038766|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153360716|NCT01404923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153672115|NCT00038766|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153672116|NCT00038766|Analgesics|analgesics|mesh-ancestor
153672117|NCT00038766|Sensory System Agents|sensory system agents|mesh-ancestor
153672118|NCT00038766|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153672119|NCT00038766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153672120|NCT00038766|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153672121|NCT00038766|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153672122|NCT00038766|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153672123|NCT00038766|Immunologic Factors|immunologic factors|mesh-ancestor
153672124|NCT00070070|Sargramostim|sargramostim|mesh-list
153672125|NCT00070070|BCG Vaccine|bcg vaccine|mesh-list
153672126|NCT00070070|Immunologic Factors|immunologic factors|mesh-ancestor
153672127|NCT00070070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153672128|NCT00070070|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153672129|NCT02573909|Oxycodone|oxycodone|mesh-list
153672130|NCT02573909|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153672131|NCT02573909|Narcotics|narcotics|mesh-ancestor
153672132|NCT02573909|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153672133|NCT02573909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153672134|NCT02573909|Analgesics|analgesics|mesh-ancestor
153672135|NCT02573909|Sensory System Agents|sensory system agents|mesh-ancestor
153672136|NCT02573909|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153672137|NCT00042315|Vinorelbine|vinorelbine|mesh-list
153672144|NCT00018668|Olanzapine|olanzapine|mesh-list
153672167|NCT00042354|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153672168|NCT00042354|Antimetabolites|antimetabolites|mesh-ancestor
153672169|NCT00042354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153672170|NCT00042354|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153672171|NCT00042393|Adefovir|adefovir|mesh-list
153672172|NCT00042393|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
153672173|NCT00042393|Antiviral Agents|antiviral agents|mesh-ancestor
153672174|NCT00042393|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153672175|NCT00042393|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153672176|NCT00042393|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153672177|NCT00042393|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153672178|NCT00042393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153672179|NCT00042471|Pramlintide|pramlintide|mesh-list
153672180|NCT00042471|Islet Amyloid Polypeptide|islet amyloid polypeptide|mesh-list
153672181|NCT00042471|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153672182|NCT00042471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153672183|NCT00042471|Appetite Depressants|appetite depressants|mesh-ancestor
153672184|NCT00042471|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
153672185|NCT00042471|Amylin Receptor Agonists|amylin receptor agonists|mesh-ancestor
153672186|NCT00042471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153672187|NCT00042549|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
153672188|NCT00042549|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
153672189|NCT00042549|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153672190|NCT00042588|Antibodies|antibodies|mesh-list
153672218|NCT00038844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153672219|NCT00038844|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153672220|NCT00038844|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153672221|NCT00038844|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153672222|NCT00038844|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153672223|NCT00038844|Antimetabolites|antimetabolites|mesh-ancestor
153672224|NCT00018863|Methylphenidate|methylphenidate|mesh-list
153672225|NCT00018863|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
153672226|NCT00018863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153672227|NCT00018863|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
153672228|NCT00018863|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153672229|NCT00018863|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153672230|NCT00018863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153672231|NCT00018863|Dopamine Agents|dopamine agents|mesh-ancestor
153672232|NCT00018863|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153672233|NCT00038883|Alemtuzumab|alemtuzumab|mesh-list
153672234|NCT00038883|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153672235|NCT00038883|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153672236|NCT00018902|Fluoxetine|fluoxetine|mesh-list
153672237|NCT00018902|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
153672238|NCT00018902|Citalopram|citalopram|mesh-list
153672239|NCT00018902|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
153672240|NCT00018902|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153672241|NCT00018902|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153672242|NCT00018902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153672243|NCT00018902|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153672244|NCT00018902|Serotonin Agents|serotonin agents|mesh-ancestor
153672245|NCT00018902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153672253|NCT00038922|Oprelvekin|oprelvekin|mesh-list
153672259|NCT00018941|Antiviral Agents|antiviral agents|mesh-ancestor
153672260|NCT00018941|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153672261|NCT00038961|PENTA|penta|mesh-list
153672262|NCT00038961|Fondaparinux|fondaparinux|mesh-list
153672263|NCT00038961|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
153672264|NCT00038961|Antithrombins|antithrombins|mesh-ancestor
153672265|NCT00038961|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
153672266|NCT00038961|Protease Inhibitors|protease inhibitors|mesh-ancestor
153672267|NCT00038961|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153672268|NCT00038961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153672269|NCT00038961|Anticoagulants|anticoagulants|mesh-ancestor
153672270|NCT00038961|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153672271|NCT00038961|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153672272|NCT00019019|Paclitaxel|paclitaxel|mesh-list
153672273|NCT00019019|Carboxyamido-triazole|carboxyamido-triazole|mesh-list
153672274|NCT00019019|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153672275|NCT00019019|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153672276|NCT00019019|Tubulin Modulators|tubulin modulators|mesh-ancestor
153672277|NCT00019019|Antimitotic Agents|antimitotic agents|mesh-ancestor
153672278|NCT00019019|Mitosis Modulators|mitosis modulators|mesh-ancestor
153672279|NCT00019019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153672280|NCT00019019|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153672281|NCT00019019|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153672282|NCT00019019|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153672283|NCT00019019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153672284|NCT00019058|Hydroxyurea|hydroxyurea|mesh-list
153672285|NCT00019058|Pentoxifylline|pentoxifylline|mesh-list
153672286|NCT00019058|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153672287|NCT00019058|Antisickling Agents|antisickling agents|mesh-ancestor
153672288|NCT00019058|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153509250|NCT03203876|Nivolumab|nivolumab|mesh-list
153672289|NCT00019058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153672290|NCT00019058|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153672291|NCT00019058|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
153672292|NCT00019058|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153672297|NCT00019058|Free Radical Scavengers|free radical scavengers|mesh-ancestor
153672299|NCT00039039|Paclitaxel|paclitaxel|mesh-list
153672300|NCT00039039|Carboplatin|carboplatin|mesh-list
153672301|NCT00039039|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153672302|NCT00039039|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153672303|NCT00039039|Tubulin Modulators|tubulin modulators|mesh-ancestor
153672304|NCT00039039|Antimitotic Agents|antimitotic agents|mesh-ancestor
153672305|NCT00039039|Mitosis Modulators|mitosis modulators|mesh-ancestor
153672306|NCT00039039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153672307|NCT00019136|Aldesleukin|aldesleukin|mesh-list
153672308|NCT00019136|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153672309|NCT00019136|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153672310|NCT00019136|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153672311|NCT00019136|Antiviral Agents|antiviral agents|mesh-ancestor
153672312|NCT00019136|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153672313|NCT00039117|Cytarabine|cytarabine|mesh-list
153672314|NCT00039117|Daunorubicin|daunorubicin|mesh-list
153672315|NCT00039117|Oblimersen|oblimersen|mesh-list
153672316|NCT00039117|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153672317|NCT00039117|Antimetabolites|antimetabolites|mesh-ancestor
153672318|NCT00039117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153672319|NCT00039117|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153672320|NCT00039117|Antiviral Agents|antiviral agents|mesh-ancestor
153672321|NCT00039117|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153672322|NCT00039117|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153672323|NCT00039117|Immunologic Factors|immunologic factors|mesh-ancestor
153672324|NCT00039117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153672325|NCT00039117|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153672326|NCT00039117|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153672327|NCT00039117|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153672328|NCT00039117|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153672329|NCT00019175|Aldesleukin|aldesleukin|mesh-list
153672330|NCT00019175|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153672331|NCT00019175|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153672332|NCT00019175|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153672333|NCT00019175|Antiviral Agents|antiviral agents|mesh-ancestor
153672335|NCT00039156|IDN 5109|idn 5109|mesh-list
153672339|NCT00019214|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153672340|NCT00019214|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153672341|NCT00019214|Antiviral Agents|antiviral agents|mesh-ancestor
153672342|NCT00019214|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153672343|NCT00039234|Aldesleukin|aldesleukin|mesh-list
153672345|NCT00039234|Histamine phosphate|histamine phosphate|mesh-list
153672346|NCT00039234|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153672347|NCT00039234|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153672348|NCT00039234|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153672349|NCT00039234|Antiviral Agents|antiviral agents|mesh-ancestor
153672350|NCT00039234|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153672351|NCT00039234|Histamine Agonists|histamine agonists|mesh-ancestor
153672352|NCT00039234|Histamine Agents|histamine agents|mesh-ancestor
153672353|NCT00039234|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153672354|NCT00039234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153672355|NCT00039234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153672356|NCT00019331|Aldesleukin|aldesleukin|mesh-list
153672357|NCT00019331|Sargramostim|sargramostim|mesh-list
153672358|NCT00019331|Immunologic Factors|immunologic factors|mesh-ancestor
153672359|NCT00019331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153672360|NCT00019331|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153672361|NCT00019331|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153672362|NCT00019331|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153672363|NCT00019331|Antiviral Agents|antiviral agents|mesh-ancestor
153672364|NCT00019331|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153509339|NCT03012672|Cytarabine|cytarabine|mesh-list
153672365|NCT00039273|Panitumumab|panitumumab|mesh-list
153672366|NCT00039273|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153672367|NCT00039273|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153672368|NCT00019409|Cytarabine|cytarabine|mesh-list
153672369|NCT00019409|Prednisone|prednisone|mesh-list
153672370|NCT00019409|Hydrocortisone|hydrocortisone|mesh-list
153672372|NCT00019409|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
153672384|NCT00019409|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153672386|NCT00019409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153672387|NCT00019409|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153672388|NCT00019409|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153672389|NCT00019409|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153672390|NCT00019409|Glucocorticoids|glucocorticoids|mesh-ancestor
153672391|NCT00019409|Hormones|hormones|mesh-ancestor
153672392|NCT00019409|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153672393|NCT00019409|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153672394|NCT00019409|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
153672395|NCT00019409|Abortifacient Agents|abortifacient agents|mesh-ancestor
153672396|NCT00019409|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153672397|NCT00019409|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153672398|NCT00019409|Antimetabolites|antimetabolites|mesh-ancestor
153672399|NCT00019409|Dermatologic Agents|dermatologic agents|mesh-ancestor
153672400|NCT00019409|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153672401|NCT00019409|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153672402|NCT00019409|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153672403|NCT00019409|Antiviral Agents|antiviral agents|mesh-ancestor
153672404|NCT00019409|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153672436|NCT00039351|Hormones|hormones|mesh-ancestor
153672437|NCT00039351|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153672438|NCT00039351|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153672439|NCT00039351|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153509397|NCT03011775|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
153672440|NCT00039351|Tubulin Modulators|tubulin modulators|mesh-ancestor
153672441|NCT00039351|Antimitotic Agents|antimitotic agents|mesh-ancestor
153672442|NCT00039351|Mitosis Modulators|mitosis modulators|mesh-ancestor
153672443|NCT00019565|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
153672444|NCT00019565|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
153672445|NCT00019565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153672446|NCT00039390|Capecitabine|capecitabine|mesh-list
153672447|NCT00039390|Gefitinib|gefitinib|mesh-list
153672448|NCT00039390|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153672449|NCT00039390|Antimetabolites|antimetabolites|mesh-ancestor
153672450|NCT00039390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153672451|NCT00039390|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153672452|NCT00039390|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153672453|NCT00039390|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153672454|NCT00039390|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153672455|NCT00019721|Aldesleukin|aldesleukin|mesh-list
153672456|NCT00019721|Freund's Adjuvant|freund's adjuvant|mesh-list
153672457|NCT00019721|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153672458|NCT00019721|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153672459|NCT00019721|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153672465|NCT00039468|Thalidomide|thalidomide|mesh-list
153672483|NCT00019838|Fludarabine phosphate|fludarabine phosphate|mesh-list
153672484|NCT00019838|7-hydroxystaurosporine|7-hydroxystaurosporine|mesh-list
153672485|NCT00019838|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153672486|NCT00019838|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153672487|NCT00019838|Antimetabolites|antimetabolites|mesh-ancestor
153672488|NCT00019838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153672489|NCT00019838|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153672490|NCT00019838|Immunologic Factors|immunologic factors|mesh-ancestor
153672491|NCT00019838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153672492|NCT00019838|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153672493|NCT00019838|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153672547|NCT00039663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153672548|NCT00039663|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153672549|NCT00039663|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
153672550|NCT00039663|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153672551|NCT00039663|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
153672552|NCT00039663|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153672553|NCT00020111|Arsenic Trioxide|arsenic trioxide|mesh-list
153672554|NCT00020111|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153672555|NCT00020150|Temozolomide|temozolomide|mesh-list
153672556|NCT00020150|O(6)-benzylguanine|o(6)-benzylguanine|mesh-list
153672557|NCT00020150|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153672558|NCT00020150|Alkylating Agents|alkylating agents|mesh-ancestor
153672559|NCT00020150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153672560|NCT00020150|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153672561|NCT00020150|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153672562|NCT00039858|Argatroban|argatroban|mesh-list
153672563|NCT00039858|Antithrombins|antithrombins|mesh-ancestor
153672564|NCT00039858|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
153672565|NCT00039858|Protease Inhibitors|protease inhibitors|mesh-ancestor
153672566|NCT00039858|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153672567|NCT00039858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153672568|NCT00039858|Anticoagulants|anticoagulants|mesh-ancestor
153672569|NCT00039858|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153672570|NCT00020189|Aspirin|aspirin|mesh-list
153672571|NCT00020189|Alvocidib|alvocidib|mesh-list
153672572|NCT00020189|Clopidogrel|clopidogrel|mesh-list
153672573|NCT00020189|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153672574|NCT00020189|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
153672575|NCT00020189|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
153672576|NCT00020189|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
153672577|NCT00020189|Purinergic Agents|purinergic agents|mesh-ancestor
153672578|NCT00020189|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153672586|NCT00020189|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153672587|NCT00020189|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153672588|NCT00020189|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153672589|NCT00020189|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153672590|NCT00020189|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153672591|NCT00020189|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153672593|NCT00020189|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153672594|NCT00020189|Growth Inhibitors|growth inhibitors|mesh-ancestor
153672595|NCT00020189|Growth Substances|growth substances|mesh-ancestor
153672596|NCT00020189|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153672597|NCT00039975|Ritonavir|ritonavir|mesh-list
153672598|NCT00039975|Indinavir|indinavir|mesh-list
153672599|NCT00039975|Amlodipine|amlodipine|mesh-list
153672600|NCT00039975|Diltiazem|diltiazem|mesh-list
153672601|NCT00039975|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
153672602|NCT00039975|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
153672603|NCT00039975|Protease Inhibitors|protease inhibitors|mesh-ancestor
153672604|NCT00039975|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153672605|NCT00039975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153672606|NCT00039975|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153672607|NCT00039975|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153672608|NCT00039975|Antiviral Agents|antiviral agents|mesh-ancestor
153672609|NCT00039975|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153672610|NCT00039975|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
153672611|NCT00039975|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153672612|NCT00039975|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153672613|NCT00039975|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153672614|NCT00039975|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153672615|NCT00039975|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153672631|NCT00040053|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153672632|NCT00040053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153672633|NCT00040053|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153672634|NCT00040053|Antipruritics|antipruritics|mesh-ancestor
153672635|NCT00040053|Dermatologic Agents|dermatologic agents|mesh-ancestor
153672636|NCT00040053|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
153672637|NCT00040053|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153672638|NCT00040053|Serotonin Agents|serotonin agents|mesh-ancestor
153672639|NCT00040053|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153672640|NCT00040053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153672641|NCT00020462|Aldesleukin|aldesleukin|mesh-list
153672642|NCT00020462|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153672643|NCT00020462|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153672644|NCT00020462|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153672645|NCT00020462|Antiviral Agents|antiviral agents|mesh-ancestor
153672646|NCT00020462|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153672647|NCT00020501|Leucovorin|leucovorin|mesh-list
153672648|NCT00020501|Fluorouracil|fluorouracil|mesh-list
153672649|NCT00020501|Floxuridine|floxuridine|mesh-list
153672650|NCT00020501|Irinotecan|irinotecan|mesh-list
153672651|NCT00020501|Melphalan|melphalan|mesh-list
153672652|NCT00020501|Calcium|calcium|mesh-list
153672653|NCT00020501|Levoleucovorin|levoleucovorin|mesh-list
153672654|NCT00020501|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153672655|NCT00020501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153672656|NCT00020501|Antimetabolites|antimetabolites|mesh-ancestor
153672657|NCT00020501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153672658|NCT00020501|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153672659|NCT00020501|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153672660|NCT00020501|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153672661|NCT00020501|Immunologic Factors|immunologic factors|mesh-ancestor
153672662|NCT00020501|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
153672663|NCT00020501|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153672674|NCT00020540|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153672675|NCT00020540|Immunologic Factors|immunologic factors|mesh-ancestor
153672676|NCT00020540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153672677|NCT00020540|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
153672678|NCT00020540|Protective Agents|protective agents|mesh-ancestor
153672680|NCT00020579|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153672681|NCT00020579|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
153672682|NCT00020579|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153672683|NCT00020579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153672684|NCT00040209|Levodopa|levodopa|mesh-list
153672685|NCT00040209|Apomorphine|apomorphine|mesh-list
153672686|NCT00040209|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
153672687|NCT00040209|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
153672688|NCT00040209|Dopamine Agents|dopamine agents|mesh-ancestor
153672689|NCT00040209|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153672690|NCT00040209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153672691|NCT00040209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153672692|NCT00040209|Emetics|emetics|mesh-ancestor
153672693|NCT00040209|Autonomic Agents|autonomic agents|mesh-ancestor
153672694|NCT00040209|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153672695|NCT00040209|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153672696|NCT00040209|Dopamine Agonists|dopamine agonists|mesh-ancestor
153672727|NCT00020657|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153672728|NCT00020657|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153672729|NCT00020657|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
153672730|NCT00020657|Dopamine Agents|dopamine agents|mesh-ancestor
153672731|NCT00040326|Anticonvulsants|anticonvulsants|mesh-list
153672732|NCT00020696|Tirapazamine|tirapazamine|mesh-list
153672733|NCT00020696|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153672735|NCT02970630|Tacrolimus|tacrolimus|mesh-list
153672736|NCT02970630|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153672737|NCT02970630|Immunologic Factors|immunologic factors|mesh-ancestor
153672738|NCT02970630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153672739|NCT02970630|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
153672740|NCT02970630|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153672741|NCT02970630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153672742|NCT02970630|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
153672743|NCT02970630|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153672744|NCT02970630|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153672745|NCT00020735|Toremifene|toremifene|mesh-list
153672746|NCT00020735|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153672747|NCT00020735|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153672748|NCT00020735|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
153672749|NCT00020735|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
153672750|NCT00020735|Hormone Antagonists|hormone antagonists|mesh-ancestor
153672751|NCT00020735|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153672752|NCT00020735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153672753|NCT00020735|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153672754|NCT00040482|Cyclophosphamide|cyclophosphamide|mesh-list
153672755|NCT00040482|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153672756|NCT00040482|Immunologic Factors|immunologic factors|mesh-ancestor
153672757|NCT00040482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153672758|NCT00040482|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153672759|NCT00040482|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153672760|NCT00040482|Alkylating Agents|alkylating agents|mesh-ancestor
153672762|NCT00040482|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153672766|NCT00020774|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153672767|NCT00020774|Antimetabolites|antimetabolites|mesh-ancestor
153672768|NCT00020774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153672769|NCT00020774|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153672770|NCT00020774|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153672771|NCT00040521|Oprelvekin|oprelvekin|mesh-list
153672772|NCT00040521|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153672773|NCT00040599|Labetuzumab|labetuzumab|mesh-list
153672774|NCT00040599|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153672775|NCT00040599|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153672776|NCT00020930|Cetuximab|cetuximab|mesh-list
153672777|NCT00020930|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153672778|NCT00020930|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153672779|NCT00020969|Arsenic Trioxide|arsenic trioxide|mesh-list
153672780|NCT00020969|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153672781|NCT00040794|Paclitaxel|paclitaxel|mesh-list
153672782|NCT00040794|Carboplatin|carboplatin|mesh-list
153672783|NCT00040794|Gefitinib|gefitinib|mesh-list
153672784|NCT00040794|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153672785|NCT00040794|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153672786|NCT00040794|Tubulin Modulators|tubulin modulators|mesh-ancestor
153672787|NCT00040794|Antimitotic Agents|antimitotic agents|mesh-ancestor
153672788|NCT00040794|Mitosis Modulators|mitosis modulators|mesh-ancestor
153672789|NCT00040794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153672790|NCT00040794|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153672791|NCT00040794|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153672793|NCT00021047|Carboplatin|carboplatin|mesh-list
153672814|NCT00040872|Cyclophosphamide|cyclophosphamide|mesh-list
153672816|NCT00040872|Carboplatin|carboplatin|mesh-list
153672817|NCT00040872|Doxorubicin|doxorubicin|mesh-list
153672818|NCT00040872|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
153672819|NCT00040872|Etoposide|etoposide|mesh-list
153672820|NCT00040872|Vincristine|vincristine|mesh-list
153672821|NCT00040872|Topotecan|topotecan|mesh-list
153672822|NCT00040872|Isotretinoin|isotretinoin|mesh-list
153672823|NCT00040872|Antibodies|antibodies|mesh-list
153672824|NCT00040872|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
153672825|NCT00040872|Sargramostim|sargramostim|mesh-list
153672826|NCT00040872|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153672827|NCT00040872|Immunologic Factors|immunologic factors|mesh-ancestor
153672828|NCT00040872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153672829|NCT00040872|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153672830|NCT00040872|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153672831|NCT00040872|Alkylating Agents|alkylating agents|mesh-ancestor
153672832|NCT00040872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153672833|NCT00040872|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153672834|NCT00040872|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153672835|NCT00040872|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153672836|NCT00040872|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153672837|NCT00040872|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153672838|NCT00040872|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153672839|NCT00040872|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153672840|NCT00040872|Tubulin Modulators|tubulin modulators|mesh-ancestor
153672866|NCT00021281|Antimetabolites|antimetabolites|mesh-ancestor
153672867|NCT00021281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153672868|NCT00021281|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153672869|NCT00021281|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153672870|NCT00021281|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153672871|NCT00021281|Immunologic Factors|immunologic factors|mesh-ancestor
153672872|NCT00021281|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
153672873|NCT00021281|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153672874|NCT00021281|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153672875|NCT00021281|Antidotes|antidotes|mesh-ancestor
153672876|NCT00021281|Protective Agents|protective agents|mesh-ancestor
153672877|NCT00021281|Vitamin B Complex|vitamin b complex|mesh-ancestor
153672878|NCT00021281|Vitamins|vitamins|mesh-ancestor
153672879|NCT00021281|Micronutrients|micronutrients|mesh-ancestor
153672880|NCT00041106|Gemcitabine|gemcitabine|mesh-list
153672881|NCT00041106|Gefitinib|gefitinib|mesh-list
153672882|NCT00041106|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153672883|NCT00041106|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153672884|NCT00041106|Antimetabolites|antimetabolites|mesh-ancestor
153672889|NCT00021320|Paclitaxel|paclitaxel|mesh-list
153672923|NCT00021359|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153672924|NCT00021359|Dermatologic Agents|dermatologic agents|mesh-ancestor
153672925|NCT00041262|Fluorouracil|fluorouracil|mesh-list
153672926|NCT00041262|Epirubicin|epirubicin|mesh-list
153672927|NCT00041262|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153672928|NCT00041262|Antimetabolites|antimetabolites|mesh-ancestor
153672929|NCT00041262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153672930|NCT00041262|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153672931|NCT00041262|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153672932|NCT00041262|Immunologic Factors|immunologic factors|mesh-ancestor
153672933|NCT00041262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153672934|NCT00041262|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153672935|NCT00041262|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153672936|NCT00041262|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153672937|NCT00041262|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153672938|NCT00021398|Leucovorin|leucovorin|mesh-list
153672939|NCT00021398|Fluorouracil|fluorouracil|mesh-list
153672940|NCT00021398|Calcium|calcium|mesh-list
153672941|NCT00021398|Levoleucovorin|levoleucovorin|mesh-list
153672942|NCT00021398|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153383994|NCT04903652|Mitosis Modulators|mitosis modulators|mesh-ancestor
153423933|NCT04501640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153423934|NCT04501640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153423935|NCT04501640|Urological Agents|urological agents|mesh-ancestor
153423936|NCT03633344|Silicon|silicon|mesh-list
153423937|NCT03633344|Trace Elements|trace elements|mesh-ancestor
153883004|NCT02271399|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153883005|NCT02271399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153672943|NCT00021398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153672944|NCT00021398|Antimetabolites|antimetabolites|mesh-ancestor
153672945|NCT00021398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153672946|NCT00021398|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153672947|NCT00021398|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153672948|NCT00021398|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153672949|NCT00021398|Immunologic Factors|immunologic factors|mesh-ancestor
153672950|NCT00021398|Antidotes|antidotes|mesh-ancestor
153672951|NCT00021398|Protective Agents|protective agents|mesh-ancestor
153672970|NCT00049023|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153672971|NCT00049023|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
153672972|NCT00049023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153672973|NCT00021671|Metronidazole|metronidazole|mesh-list
153672974|NCT00021671|Nevirapine|nevirapine|mesh-list
153672975|NCT00021671|Erythromycin|erythromycin|mesh-list
153672976|NCT00021671|Erythromycin Estolate|erythromycin estolate|mesh-list
153672977|NCT00021671|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
153509926|NCT01397630|Oxytocin|oxytocin|mesh-list
153672979|NCT00021671|Ampicillin|ampicillin|mesh-list
153672980|NCT00021671|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153672981|NCT00021671|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153672982|NCT00021671|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153672983|NCT00021671|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153672984|NCT00021671|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153672985|NCT00021671|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153672986|NCT00021671|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153672987|NCT00021671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153672988|NCT00021671|Antiviral Agents|antiviral agents|mesh-ancestor
153672989|NCT00021671|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153672990|NCT00021671|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153672991|NCT00021671|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
153672992|NCT00021671|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
153672993|NCT00021671|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153673020|NCT00049101|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153673021|NCT00049101|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153673022|NCT00049101|Immunologic Factors|immunologic factors|mesh-ancestor
153673023|NCT00049101|Antidotes|antidotes|mesh-ancestor
153673024|NCT00049101|Protective Agents|protective agents|mesh-ancestor
153673025|NCT00049101|Vitamin B Complex|vitamin b complex|mesh-ancestor
153673026|NCT00049101|Vitamins|vitamins|mesh-ancestor
153673027|NCT00049101|Micronutrients|micronutrients|mesh-ancestor
153673028|NCT00049101|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153673029|NCT00049101|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153673030|NCT00049101|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153673031|NCT00394628|Temozolomide|temozolomide|mesh-list
153673032|NCT00394628|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153673033|NCT00394628|Alkylating Agents|alkylating agents|mesh-ancestor
153673034|NCT00394628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153673035|NCT00394628|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153673037|NCT00049179|Gemtuzumab|gemtuzumab|mesh-list
153673038|NCT00049179|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153673039|NCT00049179|Antimetabolites|antimetabolites|mesh-ancestor
153673040|NCT00049179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153673041|NCT00049179|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153673042|NCT00049179|Antiviral Agents|antiviral agents|mesh-ancestor
153673043|NCT00049179|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153673044|NCT00049179|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153673045|NCT00049179|Immunologic Factors|immunologic factors|mesh-ancestor
153673068|NCT00049296|Mitosis Modulators|mitosis modulators|mesh-ancestor
153673069|NCT00049296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153673070|NCT00049296|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153673071|NCT00049296|Immunologic Factors|immunologic factors|mesh-ancestor
153673072|NCT00049296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153673073|NCT00049296|Leprostatic Agents|leprostatic agents|mesh-ancestor
153673074|NCT00049296|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153673075|NCT00049296|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153673076|NCT00049296|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153673077|NCT00049296|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153673078|NCT00049296|Growth Substances|growth substances|mesh-ancestor
153673079|NCT00049296|Growth Inhibitors|growth inhibitors|mesh-ancestor
153673080|NCT00021827|Hormones|hormones|mesh-list
153673081|NCT00021827|Parathyroid Hormone|parathyroid hormone|mesh-list
153673082|NCT00021827|Parathyroid Hormone-Related Protein|parathyroid hormone-related protein|mesh-list
153673083|NCT00021827|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153673084|NCT00021827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153673086|NCT00049335|Capecitabine|capecitabine|mesh-list
153673123|NCT00049413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153673124|NCT00049413|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153673125|NCT00049413|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153673126|NCT00049413|Alkylating Agents|alkylating agents|mesh-ancestor
153673127|NCT00049413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153673128|NCT00049413|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153673129|NCT00049413|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153673130|NCT00049413|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153673131|NCT00049413|Adenosine Deaminase Inhibitors|adenosine deaminase inhibitors|mesh-ancestor
153673132|NCT00049413|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153673133|NCT00022022|Docetaxel|docetaxel|mesh-list
153673134|NCT00022022|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153673135|NCT00022022|Tubulin Modulators|tubulin modulators|mesh-ancestor
153673136|NCT00022022|Antimitotic Agents|antimitotic agents|mesh-ancestor
153673137|NCT00022022|Mitosis Modulators|mitosis modulators|mesh-ancestor
153673138|NCT00022022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153673139|NCT00049452|Zoledronic Acid|zoledronic acid|mesh-list
153673140|NCT00049452|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153673180|NCT00049569|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153673181|NCT00049569|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153673182|NCT00049569|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153673183|NCT00049569|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153673184|NCT00049569|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153673185|NCT00049569|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153673186|NCT00049569|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153673187|NCT00049569|Glucocorticoids|glucocorticoids|mesh-ancestor
153673188|NCT00049569|Hormones|hormones|mesh-ancestor
153673189|NCT00049569|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153673190|NCT00049569|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153673191|NCT00049569|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
153673192|NCT00049569|Abortifacient Agents|abortifacient agents|mesh-ancestor
153673193|NCT00049569|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153673194|NCT00049569|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153673195|NCT00049569|Antimetabolites|antimetabolites|mesh-ancestor
153673196|NCT00049569|Dermatologic Agents|dermatologic agents|mesh-ancestor
153673197|NCT00049569|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153673198|NCT00049569|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153673199|NCT00049569|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153673200|NCT00049569|Antiviral Agents|antiviral agents|mesh-ancestor
153673233|NCT00022178|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153673234|NCT00022178|Tubulin Modulators|tubulin modulators|mesh-ancestor
153673235|NCT00022178|Antimitotic Agents|antimitotic agents|mesh-ancestor
153673236|NCT00022178|Mitosis Modulators|mitosis modulators|mesh-ancestor
153673237|NCT00049608|Gemcitabine|gemcitabine|mesh-list
153673238|NCT00049608|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153673239|NCT00049608|Antimetabolites|antimetabolites|mesh-ancestor
153673240|NCT00049608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153673241|NCT00049608|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153673243|NCT00022217|Carboplatin|carboplatin|mesh-list
153673244|NCT00022217|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153673245|NCT00022217|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153673246|NCT00022217|Tubulin Modulators|tubulin modulators|mesh-ancestor
153673247|NCT00022217|Antimitotic Agents|antimitotic agents|mesh-ancestor
153673248|NCT00022217|Mitosis Modulators|mitosis modulators|mesh-ancestor
153673249|NCT00022217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153673250|NCT00022256|Motexafin gadolinium|motexafin gadolinium|mesh-list
153673251|NCT00022256|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153673252|NCT00022256|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
153673253|NCT00022256|Dermatologic Agents|dermatologic agents|mesh-ancestor
153673254|NCT00049725|Daclizumab|daclizumab|mesh-list
153673255|NCT00049725|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153673256|NCT00049725|Immunologic Factors|immunologic factors|mesh-ancestor
153673257|NCT00049725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153673258|NCT00049764|Drotrecogin alfa activated|drotrecogin alfa activated|mesh-list
153673259|NCT00049764|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153673260|NCT00049803|Sodium Oxybate|sodium oxybate|mesh-list
153673261|NCT00049803|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153673262|NCT00049803|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153673263|NCT00049803|Anesthetics, General|anesthetics, general|mesh-ancestor
153673276|NCT00397761|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153673277|NCT00397761|Antimetabolites|antimetabolites|mesh-ancestor
153673278|NCT00022412|1 alpha-hydroxyergocalciferol|1 alpha-hydroxyergocalciferol|mesh-list
153673279|NCT00022412|Vitamins|vitamins|mesh-ancestor
153673280|NCT00022412|Micronutrients|micronutrients|mesh-ancestor
153673281|NCT00022412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153673282|NCT00022412|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153673283|NCT00397800|Cyclophosphamide|cyclophosphamide|mesh-list
153673284|NCT00397800|Rituximab|rituximab|mesh-list
153673285|NCT00397800|Fludarabine|fludarabine|mesh-list
153673286|NCT00397800|Fludarabine phosphate|fludarabine phosphate|mesh-list
153673287|NCT00397800|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153673288|NCT00397800|Immunologic Factors|immunologic factors|mesh-ancestor
153673289|NCT00397800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153673290|NCT00397800|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153673291|NCT00397800|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153673292|NCT00397800|Alkylating Agents|alkylating agents|mesh-ancestor
153673293|NCT00397800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153673294|NCT00397800|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153673295|NCT00397800|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153673296|NCT00397800|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153673297|NCT00397800|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153673298|NCT00397800|Antimetabolites|antimetabolites|mesh-ancestor
153673299|NCT00022451|Tipifarnib|tipifarnib|mesh-list
153673300|NCT00022451|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153673301|NCT00022529|Trastuzumab|trastuzumab|mesh-list
153673304|NCT00022607|Thalidomide|thalidomide|mesh-list
153673324|NCT00022646|Gemcitabine|gemcitabine|mesh-list
153673325|NCT00022646|Pemetrexed|pemetrexed|mesh-list
153673326|NCT00022646|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153673327|NCT00022646|Antimetabolites|antimetabolites|mesh-ancestor
153673328|NCT00022646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153673329|NCT00022646|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153673330|NCT00022646|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153673331|NCT00022646|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153673332|NCT00022646|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153673333|NCT00022685|Epratuzumab|epratuzumab|mesh-list
153673334|NCT00022685|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153673335|NCT00022685|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153673336|NCT00022724|Sirolimus|sirolimus|mesh-list
153673337|NCT00022724|Temsirolimus|temsirolimus|mesh-list
153673338|NCT00022724|MTOR Inhibitors|mtor inhibitors|mesh-list
153673339|NCT00022724|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153673340|NCT00022724|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153673341|NCT00022724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153673342|NCT00022724|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153673343|NCT00022724|Immunologic Factors|immunologic factors|mesh-ancestor
153673344|NCT00022724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153673345|NCT00022724|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153673346|NCT00022724|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153673347|NCT00022724|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153673348|NCT00022724|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153673349|NCT00022724|Antifungal Agents|antifungal agents|mesh-ancestor
153673351|NCT00050154|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153673352|NCT00022841|Pamidronate|pamidronate|mesh-list
153673353|NCT00022841|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153673354|NCT00022841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153510303|NCT01400568|Xhance|xhance|mesh-list
153673355|NCT00022880|Tositumomab I-131|tositumomab i-131|mesh-list
153673356|NCT00022880|Antibodies|antibodies|mesh-list
153383995|NCT04903652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153383996|NCT04071821|Cetirizine|cetirizine|mesh-list
153383997|NCT04071821|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
153383998|NCT04071821|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
153383999|NCT04071821|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
153384000|NCT04071821|Histamine Antagonists|histamine antagonists|mesh-ancestor
153384001|NCT04071821|Histamine Agents|histamine agents|mesh-ancestor
153384002|NCT04071821|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153384003|NCT04071821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153384004|NCT04071821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153673357|NCT00022880|Immunologic Factors|immunologic factors|mesh-ancestor
153673364|NCT00050271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153673365|NCT00050271|Nootropic Agents|nootropic agents|mesh-ancestor
153673366|NCT00022958|Tositumomab I-131|tositumomab i-131|mesh-list
153673367|NCT00022958|Antibodies|antibodies|mesh-list
153673368|NCT00022958|Immunologic Factors|immunologic factors|mesh-ancestor
153673369|NCT00022958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153673370|NCT00022958|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153673371|NCT00050349|Epothilones|epothilones|mesh-list
153673372|NCT00050349|Epothilone B|epothilone b|mesh-list
153673373|NCT00050349|Tubulin Modulators|tubulin modulators|mesh-ancestor
153673374|NCT00050349|Antimitotic Agents|antimitotic agents|mesh-ancestor
153673375|NCT00050349|Mitosis Modulators|mitosis modulators|mesh-ancestor
153673376|NCT00050349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153673377|NCT00050349|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153673378|NCT00050427|Trabectedin|trabectedin|mesh-list
153673379|NCT00050427|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153673380|NCT00050427|Alkylating Agents|alkylating agents|mesh-ancestor
153673381|NCT00050427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153673382|NCT00050427|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153673383|NCT00023153|Adefovir|adefovir|mesh-list
153673384|NCT00023153|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
153673385|NCT00023153|Antiviral Agents|antiviral agents|mesh-ancestor
153673386|NCT00023153|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153673387|NCT00023153|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153673388|NCT00023153|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153673389|NCT00023153|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153673390|NCT00023153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153673391|NCT00050505|Vaccines|vaccines|mesh-list
153673392|NCT00050505|Immunologic Factors|immunologic factors|mesh-ancestor
153673393|NCT00050505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153673394|NCT00050661|Daclizumab|daclizumab|mesh-list
153673395|NCT00050661|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153673398|NCT00050817|Clopidogrel|clopidogrel|mesh-list
153673406|NCT00050817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153673407|NCT00023231|Mycophenolic Acid|mycophenolic acid|mesh-list
153673408|NCT00023231|Sirolimus|sirolimus|mesh-list
153673409|NCT00023231|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
153673410|NCT00023231|Ganciclovir|ganciclovir|mesh-list
153673411|NCT00023231|Prednisone|prednisone|mesh-list
153673412|NCT00023231|Methylprednisolone|methylprednisolone|mesh-list
153673414|NCT00023231|Daclizumab|daclizumab|mesh-list
153673415|NCT00023231|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153673416|NCT00023231|Glucocorticoids|glucocorticoids|mesh-ancestor
153673417|NCT00023231|Hormones|hormones|mesh-ancestor
153673418|NCT00023231|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153673419|NCT00023231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153673420|NCT00023231|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153673421|NCT00023231|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153673422|NCT00023231|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153673423|NCT00023231|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
153673424|NCT00023231|Antitubercular Agents|antitubercular agents|mesh-ancestor
153673425|NCT00023231|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153673426|NCT00023231|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153673427|NCT00023231|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153673428|NCT00023231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153673429|NCT00023231|Antifungal Agents|antifungal agents|mesh-ancestor
153673430|NCT00023231|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153673431|NCT00023231|Immunologic Factors|immunologic factors|mesh-ancestor
153673432|NCT00023231|Antiemetics|antiemetics|mesh-ancestor
153673433|NCT00023231|Autonomic Agents|autonomic agents|mesh-ancestor
153673434|NCT00023231|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153673435|NCT00023231|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153673436|NCT00023231|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
153673437|NCT00023231|Protective Agents|protective agents|mesh-ancestor
153673438|NCT00023231|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153673439|NCT00023231|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153673440|NCT00023231|Antimetabolites|antimetabolites|mesh-ancestor
153673441|NCT00023231|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153673443|NCT00023231|Antiviral Agents|antiviral agents|mesh-ancestor
153673444|NCT00023231|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
153673445|NCT00023231|Antimalarials|antimalarials|mesh-ancestor
153673446|NCT00023231|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153673447|NCT00023231|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153673448|NCT00050856|Enfuvirtide|enfuvirtide|mesh-list
153673449|NCT00050856|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
153673450|NCT00050856|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
153673451|NCT00050856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153673452|NCT00050856|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153673453|NCT00050856|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153673454|NCT00050856|Antiviral Agents|antiviral agents|mesh-ancestor
153673455|NCT00050856|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153673457|NCT00023348|Rifabutin|rifabutin|mesh-list
153673458|NCT00023348|Antitubercular Agents|antitubercular agents|mesh-ancestor
153673459|NCT00023348|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153673460|NCT00023348|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153673461|NCT00023348|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
153673462|NCT00023348|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153673463|NCT00023348|Antimetabolites|antimetabolites|mesh-ancestor
153673464|NCT00023348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153673465|NCT00023348|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153673498|NCT00023387|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153673499|NCT00023387|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
153673500|NCT00023387|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153673501|NCT00023387|Antimetabolites|antimetabolites|mesh-ancestor
153510456|NCT01401192|Cisplatin|cisplatin|mesh-list
153673502|NCT00023387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153673503|NCT00023387|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153673504|NCT00023387|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
153673505|NCT00023387|Leprostatic Agents|leprostatic agents|mesh-ancestor
153673506|NCT00023387|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153673508|NCT00023387|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
153673509|NCT00023387|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
153673510|NCT00023387|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
153673511|NCT00023387|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
153673512|NCT00023387|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
153673513|NCT00023387|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
153673514|NCT00050934|Oxcarbazepine|oxcarbazepine|mesh-list
153673515|NCT00050934|Anticonvulsants|anticonvulsants|mesh-ancestor
153673516|NCT00050934|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
153673517|NCT00050934|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153673518|NCT00050934|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153673519|NCT00050934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153673520|NCT00050934|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
153673521|NCT00050934|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
153673522|NCT00023426|Rifapentine|rifapentine|mesh-list
153673523|NCT00023426|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
153673524|NCT00023426|Antitubercular Agents|antitubercular agents|mesh-ancestor
153673525|NCT00023426|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153673526|NCT00023426|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153673527|NCT00023426|Leprostatic Agents|leprostatic agents|mesh-ancestor
153673528|NCT00050973|Bexarotene|bexarotene|mesh-list
153673529|NCT00050973|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153673530|NCT00023504|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
153673531|NCT00023504|Immunologic Factors|immunologic factors|mesh-ancestor
153673532|NCT00023504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153673533|NCT00051051|Canertinib dihydrochloride|canertinib dihydrochloride|mesh-list
153673534|NCT00051051|Anesthetics, Local|anesthetics, local|mesh-ancestor
153673535|NCT00051051|Anesthetics|anesthetics|mesh-ancestor
153384005|NCT03064295|Adenosine|adenosine|mesh-list
153384006|NCT03064295|Regadenoson|regadenoson|mesh-list
153384007|NCT03064295|Analgesics|analgesics|mesh-ancestor
153384008|NCT03064295|Sensory System Agents|sensory system agents|mesh-ancestor
153384009|NCT03064295|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153384010|NCT03064295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153384011|NCT03064295|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153384045|NCT01810952|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153384046|NCT01810952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153384047|NCT04059887|Atezolizumab|atezolizumab|mesh-list
153384048|NCT04059887|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153384049|NCT04059887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153673536|NCT00051051|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153673537|NCT00051051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153673538|NCT00051051|Sensory System Agents|sensory system agents|mesh-ancestor
153673539|NCT00051051|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153673540|NCT00051051|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153673541|NCT00051051|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
153673542|NCT00051051|Protective Agents|protective agents|mesh-ancestor
153673543|NCT00051090|Lamivudine|lamivudine|mesh-list
153673544|NCT00051090|Efavirenz|efavirenz|mesh-list
153673545|NCT00051090|Abacavir|abacavir|mesh-list
153673546|NCT00051090|Didanosine|didanosine|mesh-list
153673547|NCT00051090|Telbivudine|telbivudine|mesh-list
153673548|NCT00051090|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153673549|NCT00051090|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153673550|NCT00051090|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153673551|NCT00051090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153673552|NCT00051090|Antiviral Agents|antiviral agents|mesh-ancestor
153673553|NCT00051090|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153673554|NCT00051090|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153673555|NCT00051090|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153673556|NCT00051090|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
153673583|NCT00023660|Immunologic Factors|immunologic factors|mesh-ancestor
153673584|NCT00023660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153673585|NCT00023660|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153673586|NCT00023660|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153673587|NCT00023660|Analgesics|analgesics|mesh-ancestor
153673588|NCT00023660|Sensory System Agents|sensory system agents|mesh-ancestor
153673589|NCT00023660|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153673590|NCT00023660|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153673591|NCT00023660|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153673592|NCT00023660|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
153673593|NCT00023660|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153673648|NCT00023777|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153673649|NCT00023816|Carbendazim|carbendazim|mesh-list
153673650|NCT00023816|Antinematodal Agents|antinematodal agents|mesh-ancestor
153673651|NCT00023816|Anthelmintics|anthelmintics|mesh-ancestor
153673652|NCT00023816|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153510594|NCT01402297|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153673653|NCT00023816|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153673654|NCT00023855|Doxorubicin|doxorubicin|mesh-list
153673655|NCT00023855|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
153673657|NCT00023855|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153673658|NCT00023855|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153673659|NCT00023855|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153673660|NCT00023855|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153673661|NCT00023855|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153673662|NCT00023855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153673663|NCT00023894|Alvocidib|alvocidib|mesh-list
153673664|NCT00023894|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153673665|NCT00023894|Growth Inhibitors|growth inhibitors|mesh-ancestor
153673666|NCT00023894|Growth Substances|growth substances|mesh-ancestor
153673667|NCT00023894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153673668|NCT00023894|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153673669|NCT00023894|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153673670|NCT00023894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153673671|NCT00023933|Antibodies|antibodies|mesh-list
153673672|NCT00023933|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
153673673|NCT00023933|Immunologic Factors|immunologic factors|mesh-ancestor
153673674|NCT00023933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153673675|NCT00051597|Antibodies|antibodies|mesh-list
153673676|NCT00051597|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
153673677|NCT00051597|Immunologic Factors|immunologic factors|mesh-ancestor
153673694|NCT00051753|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
153673695|NCT00051753|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153673696|NCT00051753|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153673697|NCT00051753|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
153673698|NCT00051753|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153673699|NCT00051753|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153673700|NCT00051753|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153673701|NCT00051753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153673702|NCT00051753|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153673703|NCT00051753|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
153673704|NCT00051753|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153673705|NCT00051753|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
153673706|NCT00024050|Cyclosporine|cyclosporine|mesh-list
153673707|NCT00024050|Cyclophosphamide|cyclophosphamide|mesh-list
153673708|NCT00024050|Busulfan|busulfan|mesh-list
153673709|NCT00024050|Methotrexate|methotrexate|mesh-list
153673710|NCT00024050|Cyclosporins|cyclosporins|mesh-list
153673711|NCT00024050|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153673712|NCT00024050|Immunologic Factors|immunologic factors|mesh-ancestor
153673713|NCT00024050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153673714|NCT00024050|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153673715|NCT00024050|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153673716|NCT00024050|Alkylating Agents|alkylating agents|mesh-ancestor
153673717|NCT00024050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153673718|NCT00024050|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153673719|NCT00024050|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153673720|NCT00024050|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
153673721|NCT00024050|Abortifacient Agents|abortifacient agents|mesh-ancestor
153673722|NCT00024050|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153673723|NCT00024050|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153673724|NCT00024050|Antimetabolites|antimetabolites|mesh-ancestor
153673725|NCT00024050|Dermatologic Agents|dermatologic agents|mesh-ancestor
153673726|NCT00024050|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153673727|NCT00024050|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153673729|NCT00024050|Antifungal Agents|antifungal agents|mesh-ancestor
153673731|NCT00024050|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
153673733|NCT00024089|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153673734|NCT00024089|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153673735|NCT00024089|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153673736|NCT00024089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153673737|NCT00024089|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153673739|NCT00051831|Saquinavir|saquinavir|mesh-list
153673740|NCT00051831|Tenofovir|tenofovir|mesh-list
153673741|NCT00051831|Emtricitabine|emtricitabine|mesh-list
153673742|NCT00051831|Enfuvirtide|enfuvirtide|mesh-list
153673743|NCT00051831|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
153673744|NCT00051831|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
153673745|NCT00051831|Protease Inhibitors|protease inhibitors|mesh-ancestor
153673746|NCT00051831|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153673747|NCT00051831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153673748|NCT00051831|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153673749|NCT00051831|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153673750|NCT00051831|Antiviral Agents|antiviral agents|mesh-ancestor
153673751|NCT00051831|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153673752|NCT00051831|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
153673753|NCT00051831|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153673754|NCT00051831|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153673755|NCT00051831|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153673756|NCT00051831|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
153673757|NCT00051831|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
153673758|NCT00024128|Cyclosporine|cyclosporine|mesh-list
153673759|NCT00024128|Cyclophosphamide|cyclophosphamide|mesh-list
153673760|NCT00024128|Cyclosporins|cyclosporins|mesh-list
153673761|NCT00024128|Antilymphocyte Serum|antilymphocyte serum|mesh-list
153673762|NCT00024128|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153673763|NCT00024128|Immunologic Factors|immunologic factors|mesh-ancestor
153673764|NCT00024128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153673765|NCT00024128|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153673770|NCT00024128|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153673771|NCT00024128|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153673772|NCT00024128|Antifungal Agents|antifungal agents|mesh-ancestor
153673773|NCT00024128|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153673774|NCT00024128|Dermatologic Agents|dermatologic agents|mesh-ancestor
153673775|NCT00024128|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
153673776|NCT00024206|Orantinib|orantinib|mesh-list
153673777|NCT00024206|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153673778|NCT00024206|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153673779|NCT00024206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153673780|NCT00024245|Probenecid|probenecid|mesh-list
153673781|NCT00024245|Uricosuric Agents|uricosuric agents|mesh-ancestor
153673782|NCT00024245|Gout Suppressants|gout suppressants|mesh-ancestor
153673783|NCT00024245|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153673784|NCT00051987|Bortezomib|bortezomib|mesh-list
153673785|NCT00051987|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153673786|NCT00024284|Carboplatin|carboplatin|mesh-list
153673787|NCT00024284|Irinotecan|irinotecan|mesh-list
153673788|NCT00024284|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153673789|NCT00024284|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
153673790|NCT00024284|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153673791|NCT00024284|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153673792|NCT00024284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153673793|NCT00052026|Carvedilol|carvedilol|mesh-list
153673794|NCT00052026|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
153673795|NCT00052026|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
153673796|NCT00052026|Adrenergic Agents|adrenergic agents|mesh-ancestor
153673797|NCT00052026|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153673798|NCT00052026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153673799|NCT00052026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153673800|NCT00052026|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153673801|NCT00052026|Antioxidants|antioxidants|mesh-ancestor
153673802|NCT00052026|Protective Agents|protective agents|mesh-ancestor
153673803|NCT00052026|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153673804|NCT00052026|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153673810|NCT00024323|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153673811|NCT00024362|BBR 3464|bbr 3464|mesh-list
153673812|NCT00024362|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153673813|NCT00024401|Paclitaxel|paclitaxel|mesh-list
153673814|NCT00024401|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153673815|NCT00024401|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153673816|NCT00024401|Tubulin Modulators|tubulin modulators|mesh-ancestor
153673817|NCT00024401|Antimitotic Agents|antimitotic agents|mesh-ancestor
153673818|NCT00024401|Mitosis Modulators|mitosis modulators|mesh-ancestor
153673819|NCT00024401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153673820|NCT00024440|Cyclophosphamide|cyclophosphamide|mesh-list
153673821|NCT00024440|Fludarabine|fludarabine|mesh-list
153673822|NCT00024440|Fludarabine phosphate|fludarabine phosphate|mesh-list
153673823|NCT00024440|Oblimersen|oblimersen|mesh-list
153673824|NCT00024440|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153673825|NCT00024440|Immunologic Factors|immunologic factors|mesh-ancestor
153673826|NCT00024440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153673827|NCT00024440|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153673828|NCT00024440|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153673829|NCT00024440|Alkylating Agents|alkylating agents|mesh-ancestor
153673866|NCT00052299|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153673867|NCT00052299|Immunotoxins|immunotoxins|mesh-ancestor
153673868|NCT00052299|Immunoconjugates|immunoconjugates|mesh-ancestor
153673869|NCT00052338|Carboplatin|carboplatin|mesh-list
153673870|NCT00052338|Gemcitabine|gemcitabine|mesh-list
153673871|NCT00052338|Bortezomib|bortezomib|mesh-list
153673872|NCT00052338|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153673873|NCT00052338|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153673874|NCT00052338|Antimetabolites|antimetabolites|mesh-ancestor
153673875|NCT00052338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153673876|NCT04733066|Teduglutide|teduglutide|mesh-list
153673877|NCT04733066|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153673878|NCT04733066|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
153673879|NCT04733066|Protective Agents|protective agents|mesh-ancestor
153673880|NCT04733066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153510837|NCT01403818|Calcium|calcium|mesh-list
153673881|NCT00052377|Aldesleukin|aldesleukin|mesh-list
153673882|NCT00052377|Interleukin-2|interleukin-2|mesh-list
153673883|NCT00052377|Interleukin-12|interleukin-12|mesh-list
153673884|NCT00052377|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153673885|NCT00052377|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153673887|NCT00052377|Sensory System Agents|sensory system agents|mesh-ancestor
153673922|NCT00052455|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153673923|NCT00052455|Alkylating Agents|alkylating agents|mesh-ancestor
153673924|NCT00052494|Irinotecan|irinotecan|mesh-list
153673925|NCT00052494|Imatinib Mesylate|imatinib mesylate|mesh-list
153673926|NCT00052494|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153673927|NCT00052494|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
153673928|NCT00052494|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153673929|NCT00052494|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153673930|NCT00052494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153673931|NCT00052494|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153673932|NCT00052494|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153673933|NCT00395174|Hemagglutinins|hemagglutinins|mesh-list
153673934|NCT00395174|Agglutinins|agglutinins|mesh-ancestor
153673935|NCT00395174|Immunologic Factors|immunologic factors|mesh-ancestor
153673936|NCT00395174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153673937|NCT00395174|Coagulants|coagulants|mesh-ancestor
153673938|NCT00395213|Norepinephrine|norepinephrine|mesh-list
153673939|NCT00395213|Serotonin|serotonin|mesh-list
153673940|NCT00395213|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-list
153673941|NCT00395213|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153673942|NCT00395213|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153673943|NCT00395213|Adrenergic Agents|adrenergic agents|mesh-ancestor
153673944|NCT00395213|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153673945|NCT00395213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153673946|NCT00395213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153673947|NCT00395213|Sympathomimetics|sympathomimetics|mesh-ancestor
153673948|NCT00395213|Autonomic Agents|autonomic agents|mesh-ancestor
153673949|NCT00395213|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153673950|NCT00395213|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
153673951|NCT00395213|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
153673952|NCT00395213|Serotonin Agents|serotonin agents|mesh-ancestor
153673953|NCT00395213|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153673962|NCT00052611|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153673963|NCT00052611|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153673964|NCT00052611|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
153673965|NCT00052611|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153673966|NCT00052611|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153673967|NCT00052611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153673968|NCT00395252|Gemcitabine|gemcitabine|mesh-list
153673970|NCT00395252|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153673971|NCT00395252|Antimetabolites|antimetabolites|mesh-ancestor
153673972|NCT00395252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153673973|NCT00395252|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153673974|NCT00395252|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153673975|NCT00052689|Gemcitabine|gemcitabine|mesh-list
153673976|NCT00052689|Bortezomib|bortezomib|mesh-list
153673977|NCT00052689|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153673978|NCT00052689|Antimetabolites|antimetabolites|mesh-ancestor
153673979|NCT00052689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153673980|NCT00052689|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153673981|NCT00052728|Tamoxifen|tamoxifen|mesh-list
153673982|NCT00052728|Tipifarnib|tipifarnib|mesh-list
153673983|NCT00052728|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
153674013|NCT00052845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153674014|NCT00052845|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153674015|NCT00052845|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153674016|NCT00052845|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153674017|NCT00052845|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153674018|NCT00052845|Analgesics|analgesics|mesh-ancestor
153674019|NCT00052845|Sensory System Agents|sensory system agents|mesh-ancestor
153674020|NCT00052845|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153674021|NCT00052845|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153674022|NCT00052845|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153674023|NCT00024986|Tenofovir|tenofovir|mesh-list
153674024|NCT00024986|Antiviral Agents|antiviral agents|mesh-ancestor
153674025|NCT00024986|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153674026|NCT00024986|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153674027|NCT00024986|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153674028|NCT00024986|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153674029|NCT00024986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153674030|NCT00024986|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153674031|NCT00024986|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153674032|NCT00052923|Cyclophosphamide|cyclophosphamide|mesh-list
153674034|NCT00052923|Rituximab|rituximab|mesh-list
153674069|NCT00025064|Tubulin Modulators|tubulin modulators|mesh-ancestor
153674070|NCT00025064|Antimitotic Agents|antimitotic agents|mesh-ancestor
153674071|NCT00025064|Mitosis Modulators|mitosis modulators|mesh-ancestor
153674072|NCT00025064|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153674073|NCT00025064|Alkylating Agents|alkylating agents|mesh-ancestor
153674074|NCT00025064|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153674075|NCT00025064|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153674076|NCT00025064|Immunologic Factors|immunologic factors|mesh-ancestor
153674077|NCT00025064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153674078|NCT00025064|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153674079|NCT00025064|Glucocorticoids|glucocorticoids|mesh-ancestor
153674080|NCT00025064|Hormones|hormones|mesh-ancestor
153674081|NCT00025064|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153674082|NCT00025064|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153674083|NCT00053001|Thalidomide|thalidomide|mesh-list
153674084|NCT00053001|Epoetin Alfa|epoetin alfa|mesh-list
153674085|NCT00053001|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153674086|NCT00053001|Immunologic Factors|immunologic factors|mesh-ancestor
153674087|NCT00053001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153674088|NCT00053001|Leprostatic Agents|leprostatic agents|mesh-ancestor
153674089|NCT00053001|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153674090|NCT00053001|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153674091|NCT00053001|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153674092|NCT00053001|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153674093|NCT00053001|Growth Substances|growth substances|mesh-ancestor
153674094|NCT00053001|Growth Inhibitors|growth inhibitors|mesh-ancestor
153674095|NCT00053001|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153674096|NCT00053001|Hematinics|hematinics|mesh-ancestor
153674097|NCT00025103|Dactinomycin|dactinomycin|mesh-list
153674098|NCT00025103|Cyclophosphamide|cyclophosphamide|mesh-list
153674100|NCT00025103|Carboplatin|carboplatin|mesh-list
153674101|NCT00025103|Doxorubicin|doxorubicin|mesh-list
153674102|NCT00025103|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
153674103|NCT00025103|Etoposide|etoposide|mesh-list
153674104|NCT00025103|Vincristine|vincristine|mesh-list
153674105|NCT00025103|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153674106|NCT00025103|Immunologic Factors|immunologic factors|mesh-ancestor
153674108|NCT00025103|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153674109|NCT00025103|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153674110|NCT00025103|Alkylating Agents|alkylating agents|mesh-ancestor
153674111|NCT00025103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153674112|NCT00025103|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153674113|NCT00025103|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153674114|NCT00025103|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153674115|NCT00025103|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153674116|NCT00025103|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153674117|NCT00025103|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153674118|NCT00025103|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153674119|NCT00025103|Tubulin Modulators|tubulin modulators|mesh-ancestor
153674120|NCT00025103|Antimitotic Agents|antimitotic agents|mesh-ancestor
153674121|NCT00025103|Mitosis Modulators|mitosis modulators|mesh-ancestor
153674122|NCT00025103|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153674123|NCT00025103|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153674124|NCT00025103|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
153674125|NCT00025103|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153674128|NCT00025142|Oxaliplatin|oxaliplatin|mesh-list
153674129|NCT00025142|Gefitinib|gefitinib|mesh-list
153674130|NCT00025142|Calcium|calcium|mesh-list
153674131|NCT00025142|Levoleucovorin|levoleucovorin|mesh-list
153674132|NCT00025142|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153674133|NCT00025142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153674134|NCT00025142|Antimetabolites|antimetabolites|mesh-ancestor
153674135|NCT00025142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153674136|NCT00025142|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153674137|NCT00025142|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153674138|NCT00025142|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153674139|NCT00025142|Immunologic Factors|immunologic factors|mesh-ancestor
153674140|NCT00025142|Antidotes|antidotes|mesh-ancestor
153674141|NCT00025142|Protective Agents|protective agents|mesh-ancestor
153674142|NCT00025142|Vitamin B Complex|vitamin b complex|mesh-ancestor
153674143|NCT00025142|Vitamins|vitamins|mesh-ancestor
153674144|NCT00025142|Micronutrients|micronutrients|mesh-ancestor
153674145|NCT00025142|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153674146|NCT00025142|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153674147|NCT00025142|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153674148|NCT00053118|Carboplatin|carboplatin|mesh-list
153674149|NCT00053118|Etoposide|etoposide|mesh-list
153674150|NCT00053118|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153674151|NCT00053118|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153674152|NCT00053118|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153674153|NCT00053118|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153674154|NCT00053118|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153674155|NCT00053118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153674156|NCT00025181|Ipilimumab|ipilimumab|mesh-list
153674157|NCT00025181|Freund's Adjuvant|freund's adjuvant|mesh-list
153674158|NCT00025181|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153674159|NCT00025181|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153674160|NCT00025181|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153674161|NCT00025181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153674162|NCT00025181|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153674163|NCT00025181|Immunologic Factors|immunologic factors|mesh-ancestor
153674164|NCT00025181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153674165|NCT00025220|Thalidomide|thalidomide|mesh-list
153674166|NCT00025220|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153674167|NCT00025220|Immunologic Factors|immunologic factors|mesh-ancestor
153674168|NCT00025220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153674169|NCT00025220|Leprostatic Agents|leprostatic agents|mesh-ancestor
153674170|NCT00025220|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153674196|NCT00053196|Busulfan|busulfan|mesh-list
153674197|NCT00053196|Allopurinol|allopurinol|mesh-list
153674198|NCT00053196|Tacrolimus|tacrolimus|mesh-list
153674199|NCT00053196|Antilymphocyte Serum|antilymphocyte serum|mesh-list
153674200|NCT00053196|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
153674201|NCT00053196|Abortifacient Agents|abortifacient agents|mesh-ancestor
153674202|NCT00053196|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153674203|NCT00053196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153674204|NCT00053196|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153674205|NCT00053196|Antimetabolites|antimetabolites|mesh-ancestor
153674206|NCT00053196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153674207|NCT00053196|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153674208|NCT00053196|Dermatologic Agents|dermatologic agents|mesh-ancestor
153674209|NCT00053196|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153674210|NCT00053196|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153674211|NCT00053196|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153674212|NCT00053196|Immunologic Factors|immunologic factors|mesh-ancestor
153674213|NCT00053196|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153674214|NCT00053196|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153674215|NCT00053196|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
153674216|NCT00053196|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153674217|NCT00053196|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
153674250|NCT00025337|Vitamin B Complex|vitamin b complex|mesh-ancestor
153674251|NCT00025337|Vitamins|vitamins|mesh-ancestor
153674252|NCT00025337|Micronutrients|micronutrients|mesh-ancestor
153674253|NCT00025376|Bortezomib|bortezomib|mesh-list
153674254|NCT00025376|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153674255|NCT00025415|Imatinib Mesylate|imatinib mesylate|mesh-list
153674256|NCT00025415|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153674257|NCT00025415|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153674258|NCT00025415|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153674259|NCT00025415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153674260|NCT00025415|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153674261|NCT00025454|Tipifarnib|tipifarnib|mesh-list
153674262|NCT00025454|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153674263|NCT00025493|Docetaxel|docetaxel|mesh-list
153674264|NCT00025493|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153674265|NCT00025493|Tubulin Modulators|tubulin modulators|mesh-ancestor
153674266|NCT00025493|Antimitotic Agents|antimitotic agents|mesh-ancestor
153674267|NCT00025493|Mitosis Modulators|mitosis modulators|mesh-ancestor
153674268|NCT00025493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153674269|NCT00025532|Antibodies|antibodies|mesh-list
153674270|NCT00025532|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
153674271|NCT00025532|Immunologic Factors|immunologic factors|mesh-ancestor
153674272|NCT00025532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153674273|NCT00053430|Thalidomide|thalidomide|mesh-list
153674274|NCT00053430|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153674275|NCT00053430|Immunologic Factors|immunologic factors|mesh-ancestor
153674276|NCT00053430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153384050|NCT04059887|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153384051|NCT04059887|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153384052|NCT01877642|Lorazepam|lorazepam|mesh-list
153384121|NCT01812044|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153384122|NCT01812044|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153384123|NCT01812044|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
153384125|NCT01812044|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153674277|NCT00053430|Leprostatic Agents|leprostatic agents|mesh-ancestor
153674278|NCT00053430|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153674285|NCT00025610|Cyclophosphamide|cyclophosphamide|mesh-list
153674298|NCT00025610|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153674299|NCT00025610|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153674300|NCT00025610|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153674301|NCT00025610|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153674302|NCT00025610|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153674303|NCT00025610|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153674304|NCT00025610|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153674305|NCT00025610|Tubulin Modulators|tubulin modulators|mesh-ancestor
153674306|NCT00025610|Antimitotic Agents|antimitotic agents|mesh-ancestor
153674307|NCT00025610|Mitosis Modulators|mitosis modulators|mesh-ancestor
153674308|NCT00025649|Cyclophosphamide|cyclophosphamide|mesh-list
153674309|NCT00025649|Melphalan|melphalan|mesh-list
153674310|NCT00025649|Busulfan|busulfan|mesh-list
153674311|NCT00025649|Carboplatin|carboplatin|mesh-list
153674312|NCT00025649|Doxorubicin|doxorubicin|mesh-list
153674313|NCT00025649|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
153674314|NCT00025649|Etoposide|etoposide|mesh-list
153674315|NCT00025649|Vincristine|vincristine|mesh-list
153674316|NCT00025649|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153674317|NCT00025649|Immunologic Factors|immunologic factors|mesh-ancestor
153674318|NCT00025649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153674319|NCT00025649|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153674320|NCT00025649|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153674321|NCT00025649|Alkylating Agents|alkylating agents|mesh-ancestor
153674322|NCT00025649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153674323|NCT00025649|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153674324|NCT00025649|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153674325|NCT00025649|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153674326|NCT00025649|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153674327|NCT00025649|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153674328|NCT00025649|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153674329|NCT00025649|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153674330|NCT00025649|Tubulin Modulators|tubulin modulators|mesh-ancestor
153674331|NCT00025649|Antimitotic Agents|antimitotic agents|mesh-ancestor
153674340|NCT00025688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153674341|NCT00025727|Ritonavir|ritonavir|mesh-list
153674342|NCT00025727|Lopinavir|lopinavir|mesh-list
153674343|NCT00025727|Fosamprenavir|fosamprenavir|mesh-list
153674344|NCT00025727|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
153674345|NCT00025727|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
153674346|NCT00025727|Protease Inhibitors|protease inhibitors|mesh-ancestor
153674347|NCT00025727|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153674348|NCT00025727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153674349|NCT00025727|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153674350|NCT00025727|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153674351|NCT00025727|Antiviral Agents|antiviral agents|mesh-ancestor
153674352|NCT00025727|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153674353|NCT00025727|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
153674354|NCT00025727|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153674355|NCT00053820|Interferons|interferons|mesh-list
153674356|NCT00053820|Interferon-alpha|interferon-alpha|mesh-list
153674357|NCT00053820|Aldesleukin|aldesleukin|mesh-list
153674399|NCT00053976|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153674400|NCT00053976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153674401|NCT00053976|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153674402|NCT00053976|Glucocorticoids|glucocorticoids|mesh-ancestor
153674403|NCT00053976|Hormones|hormones|mesh-ancestor
153674404|NCT00053976|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153674405|NCT00053976|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
153674406|NCT00053976|Protective Agents|protective agents|mesh-ancestor
153674407|NCT00053976|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153674408|NCT00053976|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153674409|NCT00053976|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153674410|NCT00053976|Immunologic Factors|immunologic factors|mesh-ancestor
153674411|NCT04733573|Salicylic Acid|salicylic acid|mesh-list
153674412|NCT04733573|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153674413|NCT04733573|Antifungal Agents|antifungal agents|mesh-ancestor
153674414|NCT04733573|Keratolytic Agents|keratolytic agents|mesh-ancestor
153674415|NCT04733573|Dermatologic Agents|dermatologic agents|mesh-ancestor
153674416|NCT00054054|Docetaxel|docetaxel|mesh-list
153674417|NCT00054054|Fluorouracil|fluorouracil|mesh-list
153674418|NCT00054054|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153674419|NCT00054054|Tubulin Modulators|tubulin modulators|mesh-ancestor
153674420|NCT00054054|Antimitotic Agents|antimitotic agents|mesh-ancestor
153674421|NCT00054054|Mitosis Modulators|mitosis modulators|mesh-ancestor
153674422|NCT00054054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153674423|NCT00054054|Antimetabolites|antimetabolites|mesh-ancestor
153674428|NCT00026078|Docetaxel|docetaxel|mesh-list
153674447|NCT00026156|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153674448|NCT00054171|Aminolevulinic Acid|aminolevulinic acid|mesh-list
153674449|NCT00054171|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
153674450|NCT00054171|Dermatologic Agents|dermatologic agents|mesh-ancestor
153674451|NCT00026195|Irinotecan|irinotecan|mesh-list
153674452|NCT00026195|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
153674453|NCT00026195|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153674454|NCT00026195|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153674455|NCT00026195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153674456|NCT00026195|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153674457|NCT00054210|Paclitaxel|paclitaxel|mesh-list
153674458|NCT00054210|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
153674459|NCT00054210|Carboplatin|carboplatin|mesh-list
153674460|NCT00054210|Paclitaxel poliglumex|paclitaxel poliglumex|mesh-list
153674461|NCT00054210|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153674462|NCT00054210|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153674463|NCT00054210|Tubulin Modulators|tubulin modulators|mesh-ancestor
153674464|NCT00054210|Antimitotic Agents|antimitotic agents|mesh-ancestor
153674465|NCT00054210|Mitosis Modulators|mitosis modulators|mesh-ancestor
153674466|NCT00054210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153674467|NCT00026234|Dexamethasone|dexamethasone|mesh-list
153674468|NCT00026234|Capecitabine|capecitabine|mesh-list
153674502|NCT00026273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153674503|NCT00026273|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153674504|NCT00026273|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153674505|NCT00026273|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153674506|NCT00026273|Immunologic Factors|immunologic factors|mesh-ancestor
153674507|NCT00026273|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
153674508|NCT00026273|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153674509|NCT00026273|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153674510|NCT00026273|Antidotes|antidotes|mesh-ancestor
153674511|NCT00026273|Protective Agents|protective agents|mesh-ancestor
153674512|NCT00026273|Vitamin B Complex|vitamin b complex|mesh-ancestor
153674513|NCT00026273|Vitamins|vitamins|mesh-ancestor
153674514|NCT00026273|Micronutrients|micronutrients|mesh-ancestor
153674515|NCT00054405|Aldesleukin|aldesleukin|mesh-list
153674516|NCT00054405|Interleukin-2|interleukin-2|mesh-list
153674517|NCT00054405|Interleukin-12|interleukin-12|mesh-list
153674518|NCT00054405|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153674519|NCT00054405|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153674520|NCT00054405|Analgesics|analgesics|mesh-ancestor
153674521|NCT00054405|Sensory System Agents|sensory system agents|mesh-ancestor
153674522|NCT00054405|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153674523|NCT00054405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153674524|NCT00054405|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153674525|NCT00054405|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153674526|NCT00054405|Antiviral Agents|antiviral agents|mesh-ancestor
153674527|NCT00054405|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153674528|NCT00054405|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153674529|NCT00054405|Immunologic Factors|immunologic factors|mesh-ancestor
153674530|NCT00054405|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153674531|NCT00054405|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153674532|NCT00054405|Growth Substances|growth substances|mesh-ancestor
153674545|NCT00054444|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153384126|NCT01812044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153384127|NCT03974789|Dexamethasone|dexamethasone|mesh-list
153384128|NCT03974789|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153384129|NCT03974789|Antiemetics|antiemetics|mesh-ancestor
153384130|NCT03974789|Autonomic Agents|autonomic agents|mesh-ancestor
153384131|NCT03974789|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153384132|NCT03974789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153384164|NCT03883763|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153384165|NCT03883763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153783564|NCT04545970|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
153384166|NCT03883763|Sensory System Agents|sensory system agents|mesh-ancestor
153384167|NCT03883763|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153384168|NCT01798394|Progesterone|progesterone|mesh-list
153384169|NCT01798394|Progestins|progestins|mesh-ancestor
153674546|NCT00054444|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
153674547|NCT00054444|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153674548|NCT00054444|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153674549|NCT00054444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153674550|NCT00026429|Denileukin diftitox|denileukin diftitox|mesh-list
153674551|NCT00026429|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153674552|NCT00054483|Bortezomib|bortezomib|mesh-list
153674553|NCT00054483|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153674554|NCT00026468|Sulindac sulfone|sulindac sulfone|mesh-list
153674555|NCT00026468|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153674556|NCT00026468|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
153674557|NCT00026468|Protective Agents|protective agents|mesh-ancestor
153674558|NCT00026468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153674559|NCT00026468|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153674560|NCT00026468|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153674561|NCT00026468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153674562|NCT00026468|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153674563|NCT00026468|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153674564|NCT00026468|Analgesics|analgesics|mesh-ancestor
153674565|NCT00026468|Sensory System Agents|sensory system agents|mesh-ancestor
153674566|NCT00026468|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153674567|NCT00026468|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153674568|NCT00026468|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153674569|NCT00054522|Calcitriol|calcitriol|mesh-list
153674570|NCT00054522|Dexamethasone|dexamethasone|mesh-list
153674571|NCT00054522|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153674572|NCT00054522|Antiemetics|antiemetics|mesh-ancestor
153674574|NCT00054522|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153674575|NCT00054522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153674576|NCT00054522|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153674577|NCT00054522|Glucocorticoids|glucocorticoids|mesh-ancestor
153674578|NCT00054522|Hormones|hormones|mesh-ancestor
153674586|NCT00054522|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
153674587|NCT00054522|Vitamins|vitamins|mesh-ancestor
153674589|NCT00054522|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153674590|NCT00026585|Tamoxifen|tamoxifen|mesh-list
153674591|NCT00026585|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
153674592|NCT00026585|Hormone Antagonists|hormone antagonists|mesh-ancestor
153674593|NCT00026585|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153674594|NCT00026585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153674595|NCT00026585|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153674596|NCT00026585|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153674597|NCT00026585|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
153674598|NCT00026585|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
153674599|NCT00026585|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153674600|NCT00026624|Keyhole-limpet hemocyanin|keyhole-limpet hemocyanin|mesh-list
153674601|NCT00026624|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153674602|NCT00026624|Immunologic Factors|immunologic factors|mesh-ancestor
153674603|NCT00026624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153674604|NCT00054600|Methoxsalen|methoxsalen|mesh-list
153674605|NCT00054600|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
153674606|NCT00054600|Dermatologic Agents|dermatologic agents|mesh-ancestor
153674607|NCT00054795|Motexafin gadolinium|motexafin gadolinium|mesh-list
153674608|NCT00054795|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153674609|NCT00054795|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
153674610|NCT00054795|Dermatologic Agents|dermatologic agents|mesh-ancestor
153674611|NCT00026819|Rofecoxib|rofecoxib|mesh-list
153674612|NCT00026819|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
153674632|NCT00054873|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153674633|NCT00054873|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153674634|NCT00054873|Immunologic Factors|immunologic factors|mesh-ancestor
153674635|NCT00054873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153674636|NCT00054873|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153674638|NCT00398385|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153674639|NCT00398385|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153674640|NCT00398385|Antimetabolites|antimetabolites|mesh-ancestor
153674641|NCT00398385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153674642|NCT00027014|Fentanyl|fentanyl|mesh-list
153674643|NCT00027014|Oxycodone|oxycodone|mesh-list
153674644|NCT00027014|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153674645|NCT00027014|Narcotics|narcotics|mesh-ancestor
153674646|NCT00027014|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153674647|NCT00027014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153674648|NCT00027014|Analgesics|analgesics|mesh-ancestor
153674649|NCT00027014|Sensory System Agents|sensory system agents|mesh-ancestor
153674650|NCT00027014|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153674651|NCT00027014|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153674652|NCT00027014|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153674653|NCT00027014|Anesthetics, General|anesthetics, general|mesh-ancestor
153674654|NCT00027014|Anesthetics|anesthetics|mesh-ancestor
153674655|NCT00398424|Cisplatin|cisplatin|mesh-list
153674656|NCT00398424|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153674657|NCT00027053|Trazodone|trazodone|mesh-list
153674658|NCT00027053|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153674659|NCT00027053|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153674660|NCT00027053|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153674661|NCT00027053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153674662|NCT00027053|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153674663|NCT00027053|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
153674664|NCT00027053|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153674665|NCT00027053|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153674666|NCT00027053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153674667|NCT00027053|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153674669|NCT00027053|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
153674670|NCT00027053|Antidepressive Agents|antidepressive agents|mesh-ancestor
153674671|NCT00055107|Nitazoxanide|nitazoxanide|mesh-list
153674672|NCT00055107|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153674673|NCT00055107|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153674674|NCT00055185|CD4 Immunoadhesins|cd4 immunoadhesins|mesh-list
153674675|NCT00055185|Immunologic Factors|immunologic factors|mesh-ancestor
153674676|NCT00055185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153674677|NCT00055302|Anastrozole|anastrozole|mesh-list
153674678|NCT00055302|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153674679|NCT00055302|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153674680|NCT00055302|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
153674681|NCT00055302|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153674682|NCT00055302|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153674683|NCT00055302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153674685|NCT00055302|Hormone Antagonists|hormone antagonists|mesh-ancestor
153674686|NCT00055302|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153674687|NCT00055302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153674688|NCT00027248|Omiganan pentahydrochloride|omiganan pentahydrochloride|mesh-list
153674689|NCT00027248|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153674690|NCT00055341|Ribavirin|ribavirin|mesh-list
153674691|NCT00055341|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
153674692|NCT00055341|Antimetabolites|antimetabolites|mesh-ancestor
153674693|NCT00055341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153674694|NCT00055341|Antiviral Agents|antiviral agents|mesh-ancestor
153674695|NCT00055341|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153674696|NCT00027287|Vitamin E|vitamin e|mesh-list
153674697|NCT00027287|Vitamins|vitamins|mesh-ancestor
153674698|NCT00027287|Micronutrients|micronutrients|mesh-ancestor
153674699|NCT00027287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153674713|NCT00027443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153674714|NCT00027443|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153674715|NCT00027443|Immunologic Factors|immunologic factors|mesh-ancestor
153674716|NCT00027443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153674717|NCT00027443|Antifungal Agents|antifungal agents|mesh-ancestor
153674718|NCT00027443|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153674719|NCT00027443|Dermatologic Agents|dermatologic agents|mesh-ancestor
153511654|NCT01408186|Rabeprazole|rabeprazole|mesh-list
153674720|NCT00027443|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153674721|NCT00027443|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
153674722|NCT00055614|Topotecan|topotecan|mesh-list
153674723|NCT00055614|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
153674724|NCT00055614|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153674725|NCT00055614|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153674726|NCT00055614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153674727|NCT00055614|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153674728|NCT00027521|Bleomycin|bleomycin|mesh-list
153674729|NCT00027521|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153674730|NCT00027521|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153674731|NCT00027599|Bevacizumab|bevacizumab|mesh-list
153674732|NCT00027599|Sargramostim|sargramostim|mesh-list
153674741|NCT00055653|Cyclosporine|cyclosporine|mesh-list
153674767|NCT00055653|Antiemetics|antiemetics|mesh-ancestor
153674768|NCT00055653|Autonomic Agents|autonomic agents|mesh-ancestor
153674769|NCT00055653|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153674770|NCT00055653|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153674771|NCT00055653|Glucocorticoids|glucocorticoids|mesh-ancestor
153674773|NCT00055653|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153674774|NCT00055653|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
153674775|NCT00055653|Protective Agents|protective agents|mesh-ancestor
153674776|NCT00055770|Docetaxel|docetaxel|mesh-list
153674777|NCT00055770|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
153674778|NCT00055770|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153674779|NCT00055770|Tubulin Modulators|tubulin modulators|mesh-ancestor
153674780|NCT00055770|Antimitotic Agents|antimitotic agents|mesh-ancestor
153674781|NCT00055770|Mitosis Modulators|mitosis modulators|mesh-ancestor
153891265|NCT01026142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153891266|NCT01026142|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153891267|NCT01026142|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153891268|NCT06055348|Paclitaxel|paclitaxel|mesh-list
153891269|NCT06055348|Gemcitabine|gemcitabine|mesh-list
153891271|NCT06055348|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153674782|NCT00055770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153674783|NCT00055770|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153674784|NCT00055770|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153674785|NCT00055770|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153674786|NCT00027638|Thalidomide|thalidomide|mesh-list
153674787|NCT00027638|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153674788|NCT00027638|Immunologic Factors|immunologic factors|mesh-ancestor
153674789|NCT00027638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153674790|NCT00027638|Leprostatic Agents|leprostatic agents|mesh-ancestor
153674820|NCT00027677|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153674821|NCT00027677|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153674822|NCT00027677|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
153674823|NCT00027677|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153674824|NCT00027677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153674825|NCT00027677|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153674826|NCT00027677|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153674827|NCT00027677|Growth Substances|growth substances|mesh-ancestor
153674828|NCT00027677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153674829|NCT00027677|Growth Inhibitors|growth inhibitors|mesh-ancestor
153674830|NCT00027716|Bortezomib|bortezomib|mesh-list
153674831|NCT00027716|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153674832|NCT00055887|Paclitaxel|paclitaxel|mesh-list
153674833|NCT00055887|Vinorelbine|vinorelbine|mesh-list
153674834|NCT00055887|Carboplatin|carboplatin|mesh-list
153674835|NCT00055887|Gemcitabine|gemcitabine|mesh-list
153674836|NCT00055887|Efaproxiral|efaproxiral|mesh-list
153674837|NCT00055887|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153674838|NCT00055887|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153674839|NCT00055887|Tubulin Modulators|tubulin modulators|mesh-ancestor
153674840|NCT00055887|Antimitotic Agents|antimitotic agents|mesh-ancestor
153674841|NCT00055887|Mitosis Modulators|mitosis modulators|mesh-ancestor
153674842|NCT00055887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153674843|NCT00055887|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153674844|NCT00055887|Antimetabolites|antimetabolites|mesh-ancestor
153674845|NCT00055887|Antisickling Agents|antisickling agents|mesh-ancestor
153674846|NCT00026039|Estrogens|estrogens|mesh-list
153674847|NCT00026039|Hormones|hormones|mesh-ancestor
153674848|NCT00026039|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153674849|NCT00026039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153674850|NCT00027404|Fluoxetine|fluoxetine|mesh-list
153674851|NCT00027404|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
153674852|NCT00027404|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153674861|NCT00027404|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
153674862|NCT00027404|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153674863|NCT00027404|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153674864|NCT00055965|Carboplatin|carboplatin|mesh-list
153674865|NCT00055965|Gemcitabine|gemcitabine|mesh-list
153674866|NCT00055965|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153674867|NCT00055965|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153674868|NCT00055965|Antimetabolites|antimetabolites|mesh-ancestor
153674869|NCT00055965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153674870|NCT00027833|Leucovorin|leucovorin|mesh-list
153674871|NCT00027833|Fluorouracil|fluorouracil|mesh-list
153674872|NCT00027833|Irinotecan|irinotecan|mesh-list
153674873|NCT00027833|Calcium|calcium|mesh-list
153674874|NCT00027833|Levoleucovorin|levoleucovorin|mesh-list
153674875|NCT00027833|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153674876|NCT00027833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153674877|NCT00027833|Antimetabolites|antimetabolites|mesh-ancestor
153674878|NCT00027833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153674879|NCT00027833|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153674880|NCT00027833|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153432299|NCT05058651|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
153674881|NCT00027833|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153674916|NCT00056004|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
153674917|NCT00056004|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153674918|NCT00056004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153674919|NCT00056004|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
153674920|NCT00056004|Hormone Antagonists|hormone antagonists|mesh-ancestor
153674921|NCT00056004|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153674923|NCT00028028|Temsirolimus|temsirolimus|mesh-list
153674924|NCT00028028|MTOR Inhibitors|mtor inhibitors|mesh-list
153674925|NCT00028028|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153674926|NCT00028028|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153674927|NCT00028028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153674928|NCT00028028|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153674929|NCT00028028|Immunologic Factors|immunologic factors|mesh-ancestor
153674930|NCT00028028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153674931|NCT00028028|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153674932|NCT00028028|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153674933|NCT00028028|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153674934|NCT00028028|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153674935|NCT00028028|Antifungal Agents|antifungal agents|mesh-ancestor
153674936|NCT00028106|3-Iodobenzylguanidine|3-iodobenzylguanidine|mesh-list
153674937|NCT00028106|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153674938|NCT00028106|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153674939|NCT00028106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153674940|NCT00028106|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
153674941|NCT00056082|Celecoxib|celecoxib|mesh-list
153674942|NCT00056082|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153674943|NCT00056082|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153674944|NCT00056082|Analgesics|analgesics|mesh-ancestor
153674945|NCT00056082|Sensory System Agents|sensory system agents|mesh-ancestor
153674954|NCT04730973|Evolocumab|evolocumab|mesh-list
153674957|NCT04730973|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153674958|NCT04730973|Antimetabolites|antimetabolites|mesh-ancestor
153674959|NCT04730973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153674960|NCT04730973|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
153674961|NCT04730973|Protease Inhibitors|protease inhibitors|mesh-ancestor
153674962|NCT04730973|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153674963|NCT04730973|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153674964|NCT00028418|Clofarabine|clofarabine|mesh-list
153674965|NCT00028418|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153674966|NCT00028418|Antimetabolites|antimetabolites|mesh-ancestor
153674967|NCT00028418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153674968|NCT00028418|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153674969|NCT00028496|Metronidazole|metronidazole|mesh-list
153674970|NCT00028496|Molgramostim|molgramostim|mesh-list
153674972|NCT00028496|Sargramostim|sargramostim|mesh-list
153674973|NCT00028496|Adjuvants, Vaccine|adjuvants, vaccine|mesh-list
153674974|NCT00028496|Immunologic Factors|immunologic factors|mesh-ancestor
153674975|NCT00028496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153674976|NCT00028496|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153675012|NCT00028574|Analgesics|analgesics|mesh-ancestor
153675013|NCT00028574|Sensory System Agents|sensory system agents|mesh-ancestor
153675014|NCT00028574|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153675015|NCT00028574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153675016|NCT00028574|Anticonvulsants|anticonvulsants|mesh-ancestor
153675017|NCT00028574|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153675018|NCT00028574|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153675019|NCT00028574|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153675020|NCT00028574|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153675021|NCT00028574|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
153675022|NCT00028574|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
153675023|NCT00028574|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153675024|NCT00028574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153675025|NCT00028574|Antimanic Agents|antimanic agents|mesh-ancestor
153675026|NCT00056433|Hydroxyurea|hydroxyurea|mesh-list
153675027|NCT00056433|Sildenafil Citrate|sildenafil citrate|mesh-list
153675028|NCT00056433|Vasodilator Agents|vasodilator agents|mesh-ancestor
153675029|NCT00056433|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
153675030|NCT00056433|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
153675031|NCT00056433|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153675032|NCT00056433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153675033|NCT00056433|Urological Agents|urological agents|mesh-ancestor
153675034|NCT00056433|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153675035|NCT00056433|Antisickling Agents|antisickling agents|mesh-ancestor
153675036|NCT00056433|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153675037|NCT00028613|Antibodies|antibodies|mesh-list
153675038|NCT00028613|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
153675039|NCT00028613|Immunologic Factors|immunologic factors|mesh-ancestor
153675040|NCT00028613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153675041|NCT00028652|Interleukin-12|interleukin-12|mesh-list
153675053|NCT00028691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153675054|NCT00028691|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153675055|NCT00028730|Cyclophosphamide|cyclophosphamide|mesh-list
153675056|NCT00028730|Thiotepa|thiotepa|mesh-list
153675057|NCT00028730|Fludarabine|fludarabine|mesh-list
153675058|NCT00028730|Fludarabine phosphate|fludarabine phosphate|mesh-list
153675059|NCT00028730|Antilymphocyte Serum|antilymphocyte serum|mesh-list
153675060|NCT00028730|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153675061|NCT00028730|Immunologic Factors|immunologic factors|mesh-ancestor
153675062|NCT00028730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153675063|NCT00028730|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153675064|NCT00028730|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153675065|NCT00028730|Alkylating Agents|alkylating agents|mesh-ancestor
153675066|NCT00028730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153675067|NCT00028730|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153675068|NCT00028730|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153675069|NCT00028730|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153675070|NCT00028730|Antimetabolites|antimetabolites|mesh-ancestor
153675110|NCT00028886|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153675111|NCT00028886|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153675113|NCT00028886|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153675114|NCT00028886|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153675115|NCT00028886|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153675116|NCT00028886|Antiviral Agents|antiviral agents|mesh-ancestor
153675117|NCT00028886|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153675118|NCT00028886|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153675119|NCT00028886|Tubulin Modulators|tubulin modulators|mesh-ancestor
153675120|NCT00028886|Antimitotic Agents|antimitotic agents|mesh-ancestor
153675121|NCT00028886|Mitosis Modulators|mitosis modulators|mesh-ancestor
153675122|NCT00028886|Leprostatic Agents|leprostatic agents|mesh-ancestor
153675123|NCT00028886|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153675124|NCT00028886|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153675125|NCT00028886|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153675126|NCT00028886|Growth Substances|growth substances|mesh-ancestor
153675127|NCT00028886|Growth Inhibitors|growth inhibitors|mesh-ancestor
153675128|NCT00028925|Carboplatin|carboplatin|mesh-list
153675129|NCT00028925|Topotecan|topotecan|mesh-list
153675130|NCT00028925|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153675131|NCT00028925|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
153675132|NCT00028925|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153675133|NCT00028925|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153675134|NCT00028925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153675135|NCT00398463|polysaccharide-K|polysaccharide-k|mesh-list
153675136|NCT00398463|Tirofiban|tirofiban|mesh-list
153675137|NCT00398463|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153675138|NCT00398463|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153675139|NCT00398463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153675140|NCT00398463|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153675141|NCT00398463|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153675142|NCT00398463|Immunologic Factors|immunologic factors|mesh-ancestor
153675143|NCT00398463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153675149|NCT00398463|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
153675150|NCT00398463|Protective Agents|protective agents|mesh-ancestor
153675152|NCT00028964|Doxorubicin|doxorubicin|mesh-list
153675153|NCT00028964|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
153675154|NCT00028964|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153675155|NCT00028964|Immunologic Factors|immunologic factors|mesh-ancestor
153675156|NCT00028964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153675157|NCT00028964|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153675158|NCT00028964|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153675159|NCT00028964|Alkylating Agents|alkylating agents|mesh-ancestor
153675160|NCT00028964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153675161|NCT00028964|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153675162|NCT00028964|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153675163|NCT00028964|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153675164|NCT00028964|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153675165|NCT00028964|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153675166|NCT00028964|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153675167|NCT00423501|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
153675168|NCT00423501|Incretins|incretins|mesh-ancestor
153675169|NCT00423501|Hormones|hormones|mesh-ancestor
153675170|NCT00423501|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153675171|NCT00423501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153675172|NCT00029003|Gefitinib|gefitinib|mesh-list
153675173|NCT00029003|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153675174|NCT00029003|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153675175|NCT00029003|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153675176|NCT00029003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153675177|NCT00029003|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153675178|NCT00029042|Infliximab|infliximab|mesh-list
153675184|NCT00423540|Magnesium Sulfate|magnesium sulfate|mesh-list
153675192|NCT00423540|Anticonvulsants|anticonvulsants|mesh-ancestor
153675193|NCT00423540|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153675194|NCT00423540|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153675195|NCT00423540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153675196|NCT00423540|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153675197|NCT00423540|Tocolytic Agents|tocolytic agents|mesh-ancestor
153675198|NCT00423540|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153675199|NCT00029159|Estrogens|estrogens|mesh-list
153675200|NCT00029159|Androgens|androgens|mesh-list
153675201|NCT00029159|Hormones|hormones|mesh-ancestor
153675202|NCT00029159|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153675203|NCT00029159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153675204|NCT00423696|Leucovorin|leucovorin|mesh-list
153675205|NCT00423696|Bevacizumab|bevacizumab|mesh-list
153675206|NCT00423696|Capecitabine|capecitabine|mesh-list
153675207|NCT00423696|Fluorouracil|fluorouracil|mesh-list
153675208|NCT00423696|Irinotecan|irinotecan|mesh-list
153675209|NCT00423696|Calcium|calcium|mesh-list
153675210|NCT00423696|Levoleucovorin|levoleucovorin|mesh-list
153675211|NCT00423696|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153675212|NCT00423696|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153675213|NCT00423696|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153675214|NCT00423696|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153675215|NCT00423696|Growth Substances|growth substances|mesh-ancestor
153675216|NCT00423696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153675217|NCT00423696|Growth Inhibitors|growth inhibitors|mesh-ancestor
153675242|NCT00056823|Growth Inhibitors|growth inhibitors|mesh-ancestor
153675243|NCT00056823|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153675244|NCT00029627|Yohimbine|yohimbine|mesh-list
153675245|NCT00029627|Mydriatics|mydriatics|mesh-ancestor
153675246|NCT00029627|Autonomic Agents|autonomic agents|mesh-ancestor
153675247|NCT00029627|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153675248|NCT00029627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153675249|NCT00029627|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
153675250|NCT00029627|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
153675251|NCT00029627|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
153675252|NCT00029627|Adrenergic Agents|adrenergic agents|mesh-ancestor
153675253|NCT00029627|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153675254|NCT00029627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153675255|NCT00029627|Urological Agents|urological agents|mesh-ancestor
153675256|NCT02970084|Vitamin K|vitamin k|mesh-list
153675257|NCT02970084|Vitamin K 2|vitamin k 2|mesh-list
153675258|NCT02970084|Vitamins|vitamins|mesh-ancestor
153675259|NCT02970084|Micronutrients|micronutrients|mesh-ancestor
153675260|NCT02970084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153675261|NCT02970084|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
153675262|NCT02970084|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153675263|NCT02970084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153675264|NCT02970084|Hemostatics|hemostatics|mesh-ancestor
153675265|NCT02970084|Coagulants|coagulants|mesh-ancestor
153675266|NCT00056979|Fludarabine|fludarabine|mesh-list
153675267|NCT00056979|Alemtuzumab|alemtuzumab|mesh-list
153675268|NCT00056979|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153675270|NCT00029822|Alfuzosin|alfuzosin|mesh-list
153675291|NCT00395759|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
153675293|NCT00395915|Antidepressive Agents|antidepressive agents|mesh-ancestor
153675294|NCT00395915|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153675295|NCT00395915|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153675296|NCT00395915|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153675297|NCT00395915|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153675298|NCT00395915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153675299|NCT00395915|Dopamine Agonists|dopamine agonists|mesh-ancestor
153675300|NCT00395915|Dopamine Agents|dopamine agents|mesh-ancestor
153675301|NCT00395915|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153675302|NCT00395915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153675303|NCT00395915|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
153675350|NCT00057447|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153675351|NCT00057447|Antiviral Agents|antiviral agents|mesh-ancestor
153675352|NCT00057447|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153675353|NCT00030095|2-Methoxyestradiol|2-methoxyestradiol|mesh-list
153675354|NCT00030095|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153675355|NCT00030095|Tubulin Modulators|tubulin modulators|mesh-ancestor
153675356|NCT00030095|Antimitotic Agents|antimitotic agents|mesh-ancestor
153675357|NCT00030095|Mitosis Modulators|mitosis modulators|mesh-ancestor
153675358|NCT00030095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153675359|NCT00030173|Epothilones|epothilones|mesh-list
153675360|NCT00030173|Desoxyepothilone B|desoxyepothilone b|mesh-list
153675361|NCT00030173|Tubulin Modulators|tubulin modulators|mesh-ancestor
153675362|NCT00030173|Antimitotic Agents|antimitotic agents|mesh-ancestor
153675363|NCT00030173|Mitosis Modulators|mitosis modulators|mesh-ancestor
153675364|NCT00030173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153675365|NCT00030173|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153675366|NCT00057564|Thalidomide|thalidomide|mesh-list
153675367|NCT00057564|Dexamethasone|dexamethasone|mesh-list
153675368|NCT00057564|Dexamethasone acetate|dexamethasone acetate|mesh-list
153675370|NCT00057564|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153675371|NCT00057564|Antiemetics|antiemetics|mesh-ancestor
153675372|NCT00057564|Autonomic Agents|autonomic agents|mesh-ancestor
153675373|NCT00057564|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153675374|NCT00057564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153675375|NCT00057564|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153675376|NCT00057564|Glucocorticoids|glucocorticoids|mesh-ancestor
153675377|NCT00057564|Hormones|hormones|mesh-ancestor
153675379|NCT00057564|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153675398|NCT00030368|Antimitotic Agents|antimitotic agents|mesh-ancestor
153675399|NCT00030368|Mitosis Modulators|mitosis modulators|mesh-ancestor
153675400|NCT00030368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153675401|NCT00030407|Celecoxib|celecoxib|mesh-list
153675402|NCT00030407|Docetaxel|docetaxel|mesh-list
153675403|NCT00030407|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153675404|NCT00030407|Tubulin Modulators|tubulin modulators|mesh-ancestor
153675405|NCT00030407|Antimitotic Agents|antimitotic agents|mesh-ancestor
153675406|NCT00030407|Mitosis Modulators|mitosis modulators|mesh-ancestor
153675407|NCT00030407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153675408|NCT00030407|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153675409|NCT00030407|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153675410|NCT00030407|Analgesics|analgesics|mesh-ancestor
153675411|NCT00030407|Sensory System Agents|sensory system agents|mesh-ancestor
153675412|NCT00030407|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153675413|NCT00030407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153675414|NCT00030407|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153675415|NCT00030407|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153675416|NCT00030407|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
153675417|NCT00030407|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153675418|NCT00030407|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153675419|NCT00057642|Sertraline|sertraline|mesh-list
153675420|NCT00057642|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
153675421|NCT00057642|Antidepressive Agents|antidepressive agents|mesh-ancestor
153675422|NCT00057642|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153675423|NCT00057642|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
153675424|NCT00057642|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153675425|NCT00057642|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153675426|NCT00057642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153675427|NCT00057642|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153675428|NCT00057642|Serotonin Agents|serotonin agents|mesh-ancestor
153675429|NCT00057642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153675437|NCT00030446|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153675438|NCT00030446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153675439|NCT00030485|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
153675440|NCT00030485|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153675441|NCT00030485|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153675442|NCT00030485|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153675443|NCT00030485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153675444|NCT00030485|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153675445|NCT00057720|Doxorubicin|doxorubicin|mesh-list
153675446|NCT00057720|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
153675447|NCT00057720|Topotecan|topotecan|mesh-list
153675448|NCT00057720|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153675449|NCT00057720|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153675450|NCT00057720|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153675451|NCT00057720|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153675452|NCT00057720|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153675453|NCT00057720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153675454|NCT00057720|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
153675455|NCT00030524|Gefitinib|gefitinib|mesh-list
153675458|NCT00030524|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153675489|NCT00057798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153675490|NCT00057798|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153675491|NCT00057798|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153675492|NCT00057798|Tubulin Modulators|tubulin modulators|mesh-ancestor
153675493|NCT00057798|Antimitotic Agents|antimitotic agents|mesh-ancestor
153675494|NCT00057798|Mitosis Modulators|mitosis modulators|mesh-ancestor
153675496|NCT02969733|Ketamine|ketamine|mesh-list
153675497|NCT02969733|Analgesics|analgesics|mesh-ancestor
153675498|NCT02969733|Sensory System Agents|sensory system agents|mesh-ancestor
153675499|NCT02969733|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153675500|NCT02969733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153675501|NCT02969733|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
153675502|NCT02969733|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153675503|NCT02969733|Anesthetics, General|anesthetics, general|mesh-ancestor
153675504|NCT02969733|Anesthetics|anesthetics|mesh-ancestor
153675510|NCT02969733|Anesthetics, Local|anesthetics, local|mesh-ancestor
153675548|NCT04730895|Vaccines|vaccines|mesh-list
153675549|NCT04730895|Myeloma Proteins|myeloma proteins|mesh-list
153675550|NCT04730895|Paraproteins|paraproteins|mesh-list
153675551|NCT04730895|Immunologic Factors|immunologic factors|mesh-ancestor
153675552|NCT04730895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153675553|NCT04730895|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153675554|NCT04730895|Keratolytic Agents|keratolytic agents|mesh-ancestor
153675555|NCT04730895|Dermatologic Agents|dermatologic agents|mesh-ancestor
153675556|NCT00030797|Irinotecan|irinotecan|mesh-list
153675557|NCT00030797|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
153675558|NCT00030797|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153675559|NCT00030797|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153675560|NCT00030797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153675561|NCT00030797|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153675562|NCT00058071|Amifostine|amifostine|mesh-list
153675563|NCT00058071|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
153675564|NCT00058071|Protective Agents|protective agents|mesh-ancestor
153675565|NCT00058071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153675566|NCT00030914|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
153675567|NCT00030914|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
153675568|NCT00030914|Medroxyprogesterone|medroxyprogesterone|mesh-list
153675588|NCT00058149|Gemcitabine|gemcitabine|mesh-list
153675601|NCT00058227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153675602|NCT00058227|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153675603|NCT00058227|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153675604|NCT00058227|Antimetabolites|antimetabolites|mesh-ancestor
153675605|NCT00058227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153675606|NCT00058227|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153675607|NCT00058227|Growth Inhibitors|growth inhibitors|mesh-ancestor
153675608|NCT00058227|Growth Substances|growth substances|mesh-ancestor
153675609|NCT00058227|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153675610|NCT00058227|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153675611|NCT00031070|Cyclosporine|cyclosporine|mesh-list
153675615|NCT00031070|Abacavir|abacavir|mesh-list
153675616|NCT00031070|Vaccines|vaccines|mesh-list
153675663|NCT00058461|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
153675664|NCT00058461|Abortifacient Agents|abortifacient agents|mesh-ancestor
153675665|NCT00058461|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153432315|NCT05048238|Tofacitinib|tofacitinib|mesh-list
153675666|NCT00058461|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153675667|NCT00058461|Antimetabolites|antimetabolites|mesh-ancestor
153675668|NCT00058461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153675669|NCT00058461|Dermatologic Agents|dermatologic agents|mesh-ancestor
153675670|NCT00058461|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153675671|NCT00058461|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153675672|NCT00058461|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153675673|NCT00058461|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153675674|NCT00058461|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153675675|NCT00058461|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153675676|NCT00058461|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153675677|NCT00058461|Antiviral Agents|antiviral agents|mesh-ancestor
153675678|NCT00058461|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153675679|NCT00058461|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153675680|NCT00058461|Alkylating Agents|alkylating agents|mesh-ancestor
153675681|NCT00058578|Cyclophosphamide|cyclophosphamide|mesh-list
153675682|NCT00058578|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153675683|NCT00058578|Immunologic Factors|immunologic factors|mesh-ancestor
153675684|NCT00058578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153675685|NCT00058578|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153675686|NCT00058578|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153675687|NCT00058578|Alkylating Agents|alkylating agents|mesh-ancestor
153675688|NCT00058578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153675689|NCT00058578|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153675690|NCT00058578|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153675691|NCT00031109|Aluminum Hydroxide|aluminum hydroxide|mesh-list
153675692|NCT00031109|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153675704|NCT00031187|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153675705|NCT00031187|Tubulin Modulators|tubulin modulators|mesh-ancestor
153675706|NCT00031187|Antimitotic Agents|antimitotic agents|mesh-ancestor
153675707|NCT00031187|Mitosis Modulators|mitosis modulators|mesh-ancestor
153675708|NCT00031187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153675709|NCT00031187|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153675710|NCT00031187|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153675711|NCT00031187|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153675712|NCT00031187|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153675713|NCT00031187|Immunologic Factors|immunologic factors|mesh-ancestor
153675714|NCT00031187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153675715|NCT00031343|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
153675716|NCT00031343|Antiviral Agents|antiviral agents|mesh-ancestor
153675717|NCT00031343|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153675718|NCT00058890|Gabapentin|gabapentin|mesh-list
153675719|NCT00058890|Analgesics|analgesics|mesh-ancestor
153675720|NCT00058890|Sensory System Agents|sensory system agents|mesh-ancestor
153675721|NCT00058890|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153675722|NCT00058890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153675723|NCT00058890|Anticonvulsants|anticonvulsants|mesh-ancestor
153675724|NCT00058890|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153675725|NCT00058890|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153675726|NCT00058890|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153675727|NCT00058890|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153675728|NCT00058890|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
153675729|NCT00058890|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
153675730|NCT00058890|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153675731|NCT00058890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153675732|NCT00058890|Antimanic Agents|antimanic agents|mesh-ancestor
153675733|NCT00058929|Treprostinil|treprostinil|mesh-list
153675734|NCT00058929|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153675735|NCT00396071|Vildagliptin|vildagliptin|mesh-list
153675736|NCT00396071|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153675737|NCT00396071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153675743|NCT00058968|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
153675744|NCT00058968|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153675745|NCT00058968|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153675746|NCT00058968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153675747|NCT00058968|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153675748|NCT00058968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153675749|NCT00058968|Analgesics|analgesics|mesh-ancestor
153675750|NCT00058968|Sensory System Agents|sensory system agents|mesh-ancestor
153675751|NCT00058968|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153675752|NCT00058968|Antidepressive Agents|antidepressive agents|mesh-ancestor
153675753|NCT00058968|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153675754|NCT00058968|Dopamine Agents|dopamine agents|mesh-ancestor
153675755|NCT00396227|Pioglitazone|pioglitazone|mesh-list
153675756|NCT00396227|Rosiglitazone|rosiglitazone|mesh-list
153675757|NCT00396227|Vildagliptin|vildagliptin|mesh-list
153675758|NCT00396227|2,4-thiazolidinedione|2,4-thiazolidinedione|mesh-list
153675759|NCT00396227|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153675760|NCT00396227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153675761|NCT00396227|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
153675762|NCT00396227|Protease Inhibitors|protease inhibitors|mesh-ancestor
153675763|NCT00396227|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153675764|NCT00396227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153675765|NCT00396344|Hydrocortisone|hydrocortisone|mesh-list
153675766|NCT00396344|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
153675767|NCT00396344|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
153675768|NCT00396344|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
153675769|NCT00396344|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153675770|NCT00031499|Azithromycin|azithromycin|mesh-list
153675771|NCT00031499|Doxycycline|doxycycline|mesh-list
153675772|NCT00031499|Penicillins|penicillins|mesh-list
153512705|NCT01415765|Hormones|hormones|mesh-ancestor
153675774|NCT00031499|Penicillin G|penicillin g|mesh-list
153675787|NCT00059358|Antiviral Agents|antiviral agents|mesh-ancestor
153675788|NCT00059358|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153675789|NCT00059358|Antimetabolites|antimetabolites|mesh-ancestor
153675790|NCT00059358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153675791|NCT00059358|Immunologic Factors|immunologic factors|mesh-ancestor
153675792|NCT00059358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153675793|NCT00031577|Paclitaxel|paclitaxel|mesh-list
153675794|NCT00031577|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153675795|NCT00031577|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153675796|NCT00031577|Tubulin Modulators|tubulin modulators|mesh-ancestor
153675797|NCT00031577|Antimitotic Agents|antimitotic agents|mesh-ancestor
153675798|NCT00031577|Mitosis Modulators|mitosis modulators|mesh-ancestor
153675799|NCT00031577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153675800|NCT00031616|Brivudine|brivudine|mesh-list
153675801|NCT00031616|Phosphoramidic acid|phosphoramidic acid|mesh-list
153675802|NCT00031616|Antiviral Agents|antiviral agents|mesh-ancestor
153675803|NCT00031616|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153675804|NCT00031616|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153675805|NCT00031616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153675806|NCT02969304|Dimethyl Fumarate|dimethyl fumarate|mesh-list
153675807|NCT02969304|Dermatologic Agents|dermatologic agents|mesh-ancestor
153675808|NCT02969304|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153675809|NCT02969304|Immunologic Factors|immunologic factors|mesh-ancestor
153675810|NCT02969304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153675811|NCT00031655|Cyclosporine|cyclosporine|mesh-list
153675812|NCT00031655|Mycophenolic Acid|mycophenolic acid|mesh-list
153675813|NCT00031655|Fludarabine|fludarabine|mesh-list
153675814|NCT00031655|Fludarabine phosphate|fludarabine phosphate|mesh-list
153675815|NCT00031655|Cyclosporins|cyclosporins|mesh-list
153675816|NCT00031655|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153675817|NCT00031655|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153675818|NCT00031655|Antimetabolites|antimetabolites|mesh-ancestor
153675819|NCT00031655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153675820|NCT00031655|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153675821|NCT00031655|Immunologic Factors|immunologic factors|mesh-ancestor
153675827|NCT00031655|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153675828|NCT00031655|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
153675829|NCT00031655|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153675830|NCT00031655|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
153675831|NCT00031655|Antitubercular Agents|antitubercular agents|mesh-ancestor
153675832|NCT00031655|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153675833|NCT00059592|Valacyclovir|valacyclovir|mesh-list
153675834|NCT00059592|Antiviral Agents|antiviral agents|mesh-ancestor
153675835|NCT00059592|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153675836|NCT00031733|Interleukin-12|interleukin-12|mesh-list
153675837|NCT00031733|Aluminum Hydroxide|aluminum hydroxide|mesh-list
153675838|NCT00031733|Sargramostim|sargramostim|mesh-list
153675839|NCT00031733|Freund's Adjuvant|freund's adjuvant|mesh-list
153675840|NCT00031733|Aluminum sulfate|aluminum sulfate|mesh-list
153675841|NCT00031733|Immunologic Factors|immunologic factors|mesh-ancestor
153675842|NCT00031733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153675843|NCT00031733|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153675844|NCT00031733|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153675845|NCT00031733|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153512776|NCT01416207|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153675846|NCT00031733|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153675848|NCT00031733|Growth Inhibitors|growth inhibitors|mesh-ancestor
153675850|NCT00031733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153675851|NCT00031733|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153675852|NCT02969265|Amlodipine|amlodipine|mesh-list
153675853|NCT02969265|Candesartan cilexetil|candesartan cilexetil|mesh-list
153675854|NCT02969265|Candesartan|candesartan|mesh-list
153675855|NCT02969265|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153675856|NCT02969265|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153675857|NCT02969265|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153675858|NCT02969265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153675859|NCT02969265|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153675860|NCT02969265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153675861|NCT02969265|Vasodilator Agents|vasodilator agents|mesh-ancestor
153360717|NCT01404923|Anticonvulsants|anticonvulsants|mesh-ancestor
153675864|NCT00031811|Raloxifene Hydrochloride|raloxifene hydrochloride|mesh-list
153675865|NCT00031811|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
153675866|NCT00031811|Hormone Antagonists|hormone antagonists|mesh-ancestor
153675867|NCT00031811|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153675868|NCT00031811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153675869|NCT00031811|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
153675870|NCT00031811|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
153675871|NCT00031811|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153675872|NCT00031850|Raloxifene Hydrochloride|raloxifene hydrochloride|mesh-list
153675874|NCT00031850|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153675875|NCT00031850|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153675876|NCT00031850|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
153675877|NCT00031850|Hormone Antagonists|hormone antagonists|mesh-ancestor
153675878|NCT00031850|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153675879|NCT00031850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153675880|NCT00031850|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
153675881|NCT00031850|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
153675882|NCT00031850|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153675883|NCT00059631|Bortezomib|bortezomib|mesh-list
153675884|NCT00059631|Mitoxantrone|mitoxantrone|mesh-list
153675885|NCT00059631|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153675886|NCT00059631|Analgesics|analgesics|mesh-ancestor
153675887|NCT00059631|Sensory System Agents|sensory system agents|mesh-ancestor
153675888|NCT00059631|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153675889|NCT00059631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153675890|NCT00059631|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153675891|NCT00059631|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153675892|NCT00059631|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153675893|NCT00059631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153675894|NCT00031889|Exemestane|exemestane|mesh-list
153675895|NCT00031889|Bicalutamide|bicalutamide|mesh-list
153675896|NCT00031889|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153675897|NCT00031889|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
153675898|NCT00031889|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153360718|NCT01368263|Letrozole|letrozole|mesh-list
153675899|NCT00031889|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153675900|NCT00031889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153675901|NCT00031889|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
153675902|NCT00031889|Hormone Antagonists|hormone antagonists|mesh-ancestor
153675903|NCT00031889|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153675904|NCT00031889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153675905|NCT00031889|Androgen Antagonists|androgen antagonists|mesh-ancestor
153675906|NCT00031928|Mafosfamide|mafosfamide|mesh-list
153675907|NCT00031928|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153675908|NCT00031928|Immunologic Factors|immunologic factors|mesh-ancestor
153675909|NCT00031928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153675910|NCT00031928|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153675911|NCT00031967|Melatonin|melatonin|mesh-list
153675912|NCT00031967|Antioxidants|antioxidants|mesh-ancestor
153675913|NCT00031967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153675914|NCT00031967|Protective Agents|protective agents|mesh-ancestor
153675915|NCT00031967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153675916|NCT00031967|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153675918|NCT00059826|Interferon-alpha|interferon-alpha|mesh-list
153675919|NCT00059826|Interferon alpha-2|interferon alpha-2|mesh-list
153675920|NCT00059826|Fluorouracil|fluorouracil|mesh-list
153675921|NCT00059826|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153675922|NCT00059826|Antimetabolites|antimetabolites|mesh-ancestor
153675923|NCT00059826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153675946|NCT00059865|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153675947|NCT00059865|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153675949|NCT00032084|Nicotine|nicotine|mesh-list
153675950|NCT00032084|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
153675951|NCT00032084|Autonomic Agents|autonomic agents|mesh-ancestor
153675952|NCT00032084|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153675953|NCT00032084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153675954|NCT00032084|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
153675955|NCT00032084|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
153675956|NCT00032084|Cholinergic Agents|cholinergic agents|mesh-ancestor
153675957|NCT00032084|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153675958|NCT00032084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153675959|NCT00032084|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
153675960|NCT00032084|Antidepressive Agents|antidepressive agents|mesh-ancestor
153675961|NCT00032084|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153675962|NCT00032084|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
153675963|NCT00032084|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153675964|NCT00032084|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153675965|NCT00032084|Dopamine Agents|dopamine agents|mesh-ancestor
153675966|NCT00032084|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
153675967|NCT00032084|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153675968|NCT00032084|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153675969|NCT00059904|Aldesleukin|aldesleukin|mesh-list
153675970|NCT00059904|Rituximab|rituximab|mesh-list
153675971|NCT00059904|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153675972|NCT00059904|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153675992|NCT00032162|Carboplatin|carboplatin|mesh-list
153675993|NCT00032162|Doxorubicin|doxorubicin|mesh-list
153675994|NCT00032162|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
153675995|NCT00032162|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153512934|NCT01417364|Hormones|hormones|mesh-ancestor
153675996|NCT00032162|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153675997|NCT00032162|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153675998|NCT00032162|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153675999|NCT00032162|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153676000|NCT00032162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153676001|NCT00032279|Visilizumab|visilizumab|mesh-list
153676002|NCT00032279|Immunologic Factors|immunologic factors|mesh-ancestor
153676003|NCT00032279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153676004|NCT00060138|Zoledronic Acid|zoledronic acid|mesh-list
153676005|NCT00060138|Antibodies|antibodies|mesh-list
153676006|NCT00060138|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
153676007|NCT00060138|Immunologic Factors|immunologic factors|mesh-ancestor
153676008|NCT00060138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153676009|NCT00060138|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153676010|NCT00032396|Fluocinolone Acetonide|fluocinolone acetonide|mesh-list
153676011|NCT00032396|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153676012|NCT00032396|Glucocorticoids|glucocorticoids|mesh-ancestor
153676047|NCT00060372|Immunologic Factors|immunologic factors|mesh-ancestor
153676048|NCT00060372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153676049|NCT00060372|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153676050|NCT00060372|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153676051|NCT00060372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153676053|NCT00060411|Bevacizumab|bevacizumab|mesh-list
153676054|NCT00060411|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
153676055|NCT00060411|Fluorouracil|fluorouracil|mesh-list
153676056|NCT00060411|Oxaliplatin|oxaliplatin|mesh-list
153676057|NCT00060411|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
153676058|NCT00060411|Antibodies|antibodies|mesh-list
153676059|NCT00060411|Immunoglobulins|immunoglobulins|mesh-list
153676110|NCT02968719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153676111|NCT02968719|Cholinergic Agents|cholinergic agents|mesh-ancestor
153676112|NCT02968719|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153676113|NCT02968719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153676114|NCT02968719|Nootropic Agents|nootropic agents|mesh-ancestor
153676116|NCT00060489|Antidepressive Agents|antidepressive agents|mesh-ancestor
153676117|NCT00060489|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153676118|NCT00060489|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153676119|NCT00060489|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153676120|NCT00060489|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153676121|NCT00060489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153676122|NCT00032825|Ketoconazole|ketoconazole|mesh-list
153676123|NCT00032825|Docetaxel|docetaxel|mesh-list
153676124|NCT00032825|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153676125|NCT00032825|Tubulin Modulators|tubulin modulators|mesh-ancestor
153676126|NCT00032825|Antimitotic Agents|antimitotic agents|mesh-ancestor
153676127|NCT00032825|Mitosis Modulators|mitosis modulators|mesh-ancestor
153676128|NCT00032825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153676129|NCT00032825|Antifungal Agents|antifungal agents|mesh-ancestor
153676130|NCT00032825|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153676131|NCT00032825|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
153676132|NCT00032825|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153676133|NCT00032825|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153676134|NCT00032825|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153676135|NCT00032825|Hormone Antagonists|hormone antagonists|mesh-ancestor
153676136|NCT00032825|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153676137|NCT00032825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153676138|NCT00032825|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
153676139|NCT00060645|Sirolimus|sirolimus|mesh-list
153676140|NCT00060645|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153676141|NCT00060645|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153676142|NCT00060645|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153676143|NCT00060645|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153676144|NCT00060645|Antifungal Agents|antifungal agents|mesh-ancestor
153676145|NCT00060645|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153676146|NCT00060645|Immunologic Factors|immunologic factors|mesh-ancestor
153676147|NCT00060645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153676148|NCT00060684|Dexamethasone|dexamethasone|mesh-list
153676149|NCT00060684|Rituximab|rituximab|mesh-list
153676150|NCT00060684|Fludarabine|fludarabine|mesh-list
153676151|NCT00060684|Pixantrone|pixantrone|mesh-list
153676152|NCT00060684|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153676153|NCT00060684|Antiemetics|antiemetics|mesh-ancestor
153676154|NCT00060684|Autonomic Agents|autonomic agents|mesh-ancestor
153676155|NCT00060684|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153676156|NCT00060684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153676157|NCT00060684|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153676158|NCT00060684|Glucocorticoids|glucocorticoids|mesh-ancestor
153676159|NCT00060684|Hormones|hormones|mesh-ancestor
153676160|NCT00060684|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153676161|NCT00060684|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153676162|NCT00060684|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153676163|NCT00060684|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153676164|NCT00060684|Immunologic Factors|immunologic factors|mesh-ancestor
153676165|NCT00060684|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153676166|NCT00060684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153676167|NCT00060684|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153676168|NCT00060684|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153676169|NCT00060684|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153676170|NCT02971475|Analgesics|analgesics|mesh-list
153676171|NCT02971475|Sensory System Agents|sensory system agents|mesh-ancestor
153676172|NCT02971475|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153676173|NCT02971475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153676174|NCT00032942|Lofexidine|lofexidine|mesh-list
153676175|NCT00032942|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153676176|NCT00032942|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
153676177|NCT00032942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153676178|NCT00032942|Sensory System Agents|sensory system agents|mesh-ancestor
153676179|NCT00032942|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153676186|NCT00033059|Tolcapone|tolcapone|mesh-list
153676187|NCT00033059|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
153676188|NCT00033059|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
153676189|NCT00033059|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
153676190|NCT00033059|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153676191|NCT00033059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153676192|NCT00060918|Metoprolol|metoprolol|mesh-list
153676193|NCT00060918|Carvedilol|carvedilol|mesh-list
153676194|NCT00060918|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153676195|NCT00060918|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153676196|NCT00060918|Sympatholytics|sympatholytics|mesh-ancestor
153676197|NCT00060918|Autonomic Agents|autonomic agents|mesh-ancestor
153676198|NCT00060918|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153676214|NCT00033098|Metyrapone|metyrapone|mesh-list
153676247|NCT00060957|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
153676248|NCT00060957|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153676249|NCT00060957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153676250|NCT00060957|Cholinergic Agents|cholinergic agents|mesh-ancestor
153676251|NCT00060957|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153676252|NCT00060957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153676253|NCT00060957|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
153676254|NCT00060957|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153676255|NCT00060996|Treprostinil|treprostinil|mesh-list
153676256|NCT00060996|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153676257|NCT00033254|Thalidomide|thalidomide|mesh-list
153676258|NCT00033254|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153676259|NCT00033254|Immunologic Factors|immunologic factors|mesh-ancestor
153676260|NCT00033254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153676261|NCT00033254|Leprostatic Agents|leprostatic agents|mesh-ancestor
153676262|NCT00033254|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153676263|NCT00033254|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153676264|NCT00033254|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153676265|NCT00033254|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153676266|NCT00033254|Growth Substances|growth substances|mesh-ancestor
153676267|NCT00033254|Growth Inhibitors|growth inhibitors|mesh-ancestor
153676268|NCT00033254|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153676269|NCT00061074|Nicotine|nicotine|mesh-list
153676270|NCT00061074|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
153676271|NCT00061074|Autonomic Agents|autonomic agents|mesh-ancestor
153676272|NCT00061074|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153676273|NCT00061074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153676274|NCT00061074|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
153676275|NCT00061074|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
153676276|NCT00061074|Cholinergic Agents|cholinergic agents|mesh-ancestor
153676277|NCT00061074|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153676278|NCT00061074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153676279|NCT00033332|Zoledronic Acid|zoledronic acid|mesh-list
153676280|NCT00033332|Pamidronate|pamidronate|mesh-list
153676287|NCT00033332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153676288|NCT00033332|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153676289|NCT00033332|Glucocorticoids|glucocorticoids|mesh-ancestor
153676290|NCT00033332|Hormones|hormones|mesh-ancestor
153676291|NCT00033332|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153676292|NCT00033332|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153676293|NCT00033332|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153676294|NCT00033332|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153676295|NCT00033332|Immunologic Factors|immunologic factors|mesh-ancestor
153676296|NCT00033332|Leprostatic Agents|leprostatic agents|mesh-ancestor
153676297|NCT00033332|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153676298|NCT00033332|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153513234|NCT01418794|Sirolimus|sirolimus|mesh-list
153676299|NCT00033332|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153676300|NCT00033332|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153676301|NCT00033332|Growth Substances|growth substances|mesh-ancestor
153676303|NCT00033332|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153676305|NCT00033410|Carboplatin|carboplatin|mesh-list
153676306|NCT00033410|Tirapazamine|tirapazamine|mesh-list
153676307|NCT00033410|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153676308|NCT00033410|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153676309|NCT00033410|Tubulin Modulators|tubulin modulators|mesh-ancestor
153676310|NCT00033410|Antimitotic Agents|antimitotic agents|mesh-ancestor
153676311|NCT00033410|Mitosis Modulators|mitosis modulators|mesh-ancestor
153676312|NCT00033410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153676313|NCT00061113|Fluoxetine|fluoxetine|mesh-list
153676314|NCT00061113|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
153676315|NCT00061113|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153676316|NCT00061113|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153676317|NCT00061113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153676318|NCT00061113|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153676319|NCT00061113|Serotonin Agents|serotonin agents|mesh-ancestor
153676320|NCT00061113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153676321|NCT00061113|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
153676323|NCT00061113|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153676324|NCT00061113|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
153676325|NCT00061113|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153676326|NCT00061113|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153676328|NCT00033449|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153676329|NCT00033449|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153676330|NCT00033449|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153676331|NCT00033449|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153676332|NCT00033449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153676333|NCT00061152|Capsaicin|capsaicin|mesh-list
153676334|NCT00061152|Antipruritics|antipruritics|mesh-ancestor
153676335|NCT00061152|Dermatologic Agents|dermatologic agents|mesh-ancestor
153676336|NCT00061152|Sensory System Agents|sensory system agents|mesh-ancestor
153676337|NCT00061152|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153676338|NCT00061152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153676339|NCT00033566|S 3304|s 3304|mesh-list
153676340|NCT00033566|Matrix Metalloproteinase Inhibitors|matrix metalloproteinase inhibitors|mesh-ancestor
153676341|NCT00033566|Protease Inhibitors|protease inhibitors|mesh-ancestor
153676342|NCT00033566|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153676343|NCT00033566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153676344|NCT00033605|Octreotide|octreotide|mesh-list
153676345|NCT00033605|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153676346|NCT00033605|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153676370|NCT00033683|Epirubicin|epirubicin|mesh-list
153676371|NCT00033683|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153676372|NCT00033683|Immunologic Factors|immunologic factors|mesh-ancestor
153676373|NCT00033683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153676374|NCT00033683|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153676375|NCT00033683|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153676376|NCT00033683|Alkylating Agents|alkylating agents|mesh-ancestor
153676377|NCT00033683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153676378|NCT00033683|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153676379|NCT00033683|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153676380|NCT00033683|Tubulin Modulators|tubulin modulators|mesh-ancestor
153676381|NCT00033683|Antimitotic Agents|antimitotic agents|mesh-ancestor
153676382|NCT00033683|Mitosis Modulators|mitosis modulators|mesh-ancestor
153676383|NCT00033683|Antimetabolites|antimetabolites|mesh-ancestor
153676384|NCT00033683|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153676385|NCT00033683|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
153676386|NCT00033683|Abortifacient Agents|abortifacient agents|mesh-ancestor
153676387|NCT00033683|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153676388|NCT00033683|Dermatologic Agents|dermatologic agents|mesh-ancestor
153676389|NCT00033683|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153676390|NCT00033683|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153676391|NCT00033683|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153676392|NCT00033683|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153676393|NCT00033683|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153676394|NCT00033683|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153676395|NCT00033683|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
153676396|NCT00033683|Hormone Antagonists|hormone antagonists|mesh-ancestor
153676397|NCT00033683|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153676398|NCT00033683|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153676399|NCT00033683|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
153676411|NCT00033722|Folic Acid|folic acid|mesh-list
153676412|NCT00033722|Lometrexol|lometrexol|mesh-list
153676413|NCT00033722|Hematinics|hematinics|mesh-ancestor
153676414|NCT00033722|Vitamin B Complex|vitamin b complex|mesh-ancestor
153676415|NCT00033722|Vitamins|vitamins|mesh-ancestor
153676416|NCT00033722|Micronutrients|micronutrients|mesh-ancestor
153676417|NCT00033722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153676418|NCT00033722|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153676419|NCT00033722|Antimetabolites|antimetabolites|mesh-ancestor
153676420|NCT00033722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153676421|NCT00033722|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153676422|NCT00033722|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153676423|NCT00033722|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153676424|NCT00061425|Epratuzumab|epratuzumab|mesh-list
153676425|NCT00061425|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153676426|NCT00061425|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153676427|NCT00061464|Gemcitabine|gemcitabine|mesh-list
153676428|NCT00061464|Pemetrexed|pemetrexed|mesh-list
153676429|NCT00061464|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153676430|NCT00061464|Antimetabolites|antimetabolites|mesh-ancestor
153676431|NCT00061464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153676432|NCT00061464|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153676433|NCT00061464|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153676434|NCT00061464|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153676435|NCT00061464|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153676437|NCT00061503|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153676438|NCT00061542|Timolol|timolol|mesh-list
153676439|NCT00061542|Betaxolol|betaxolol|mesh-list
153676440|NCT00061542|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
153676441|NCT00061542|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
153676457|NCT00034151|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153676458|NCT00034151|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153676459|NCT00034151|Tubulin Modulators|tubulin modulators|mesh-ancestor
153676460|NCT00034151|Antimitotic Agents|antimitotic agents|mesh-ancestor
153676461|NCT00034151|Mitosis Modulators|mitosis modulators|mesh-ancestor
153676462|NCT00034151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153676463|NCT00034190|Paclitaxel|paclitaxel|mesh-list
153676464|NCT00034190|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153676465|NCT00034190|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153676466|NCT00034190|Tubulin Modulators|tubulin modulators|mesh-ancestor
153676467|NCT00034190|Antimitotic Agents|antimitotic agents|mesh-ancestor
153676468|NCT00034190|Mitosis Modulators|mitosis modulators|mesh-ancestor
153676469|NCT00034190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153676470|NCT00034229|Felbamate|felbamate|mesh-list
153676471|NCT00034229|Anticonvulsants|anticonvulsants|mesh-ancestor
153676472|NCT00034229|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
153676473|NCT00034229|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
153676474|NCT00034229|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153676475|NCT00034229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153676476|NCT00034229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153676477|NCT00034307|Sitaxsentan|sitaxsentan|mesh-list
153676478|NCT00034307|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
153676479|NCT00034307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153676480|NCT00061776|Capsaicin|capsaicin|mesh-list
153676481|NCT00061776|Antipruritics|antipruritics|mesh-ancestor
153676482|NCT00061776|Dermatologic Agents|dermatologic agents|mesh-ancestor
153676483|NCT00061776|Sensory System Agents|sensory system agents|mesh-ancestor
153676486|NCT00034346|Paclitaxel|paclitaxel|mesh-list
153676502|NCT00034463|Vitamin B Complex|vitamin b complex|mesh-ancestor
153676503|NCT02971397|Cytarabine|cytarabine|mesh-list
153676504|NCT02971397|Daunorubicin|daunorubicin|mesh-list
153676505|NCT02971397|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153676506|NCT02971397|Antimetabolites|antimetabolites|mesh-ancestor
153676507|NCT02971397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153676508|NCT02971397|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153676509|NCT02971397|Antiviral Agents|antiviral agents|mesh-ancestor
153676510|NCT02971397|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153676511|NCT02971397|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153676512|NCT02971397|Immunologic Factors|immunologic factors|mesh-ancestor
153676513|NCT02971397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153676514|NCT02971397|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153676515|NCT02971397|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153676516|NCT02971397|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153676517|NCT02971397|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153676518|NCT00396500|Vitamin A|vitamin a|mesh-list
153676519|NCT00396500|Albendazole|albendazole|mesh-list
153676520|NCT00396500|Vitamins|vitamins|mesh-ancestor
153676521|NCT00396500|Micronutrients|micronutrients|mesh-ancestor
153676522|NCT00396500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153676523|NCT00396500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153676524|NCT00396500|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153676525|NCT00396500|Anthelmintics|anthelmintics|mesh-ancestor
153676526|NCT00396500|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153676527|NCT00396500|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153676528|NCT00396500|Anticestodal Agents|anticestodal agents|mesh-ancestor
153676529|NCT00396500|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
153676530|NCT00396500|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153676531|NCT00396500|Tubulin Modulators|tubulin modulators|mesh-ancestor
153676532|NCT00396500|Antimitotic Agents|antimitotic agents|mesh-ancestor
153676533|NCT00396500|Mitosis Modulators|mitosis modulators|mesh-ancestor
153676546|NCT00034541|Antimitotic Agents|antimitotic agents|mesh-ancestor
153676547|NCT00034541|Mitosis Modulators|mitosis modulators|mesh-ancestor
153676548|NCT00034541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153676549|NCT00034541|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153676550|NCT00034580|Olanzapine|olanzapine|mesh-list
153676551|NCT00034580|Risperidone|risperidone|mesh-list
153676552|NCT00034580|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153676553|NCT00034580|Serotonin Agents|serotonin agents|mesh-ancestor
153676554|NCT00034580|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153676555|NCT00034580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153676556|NCT00034580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153676557|NCT00034580|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153676558|NCT00034580|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153676559|NCT00034580|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153676560|NCT00034580|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153676561|NCT00034580|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
153676562|NCT00034580|Dopamine Agents|dopamine agents|mesh-ancestor
153676603|NCT00034658|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153676604|NCT00034658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153676605|NCT00398580|Methyltestosterone|methyltestosterone|mesh-list
153676606|NCT00398580|Testosterone|testosterone|mesh-list
153676607|NCT00398580|Testosterone undecanoate|testosterone undecanoate|mesh-list
153676608|NCT00398580|Testosterone enanthate|testosterone enanthate|mesh-list
153676609|NCT00398580|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
153676610|NCT00398580|Dutasteride|dutasteride|mesh-list
153676611|NCT00398580|Androgens|androgens|mesh-ancestor
153676612|NCT00398580|Hormones|hormones|mesh-ancestor
153676613|NCT00398580|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153676614|NCT00398580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153676615|NCT00398580|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153676616|NCT00398580|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153676617|NCT00398580|Anabolic Agents|anabolic agents|mesh-ancestor
153676618|NCT00398580|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
153676619|NCT00398580|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153676620|NCT00398580|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153676621|NCT00398580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153676622|NCT00398580|Hormone Antagonists|hormone antagonists|mesh-ancestor
153676623|NCT00034697|Temozolomide|temozolomide|mesh-list
153676624|NCT00034697|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153676625|NCT00034697|Alkylating Agents|alkylating agents|mesh-ancestor
153676626|NCT00034697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153676627|NCT00034697|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153676628|NCT00034736|Levofloxacin|levofloxacin|mesh-list
153676629|NCT00034736|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
153676647|NCT02967939|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153676648|NCT00034775|Risperidone|risperidone|mesh-list
153676649|NCT00034775|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153676650|NCT00034775|Serotonin Agents|serotonin agents|mesh-ancestor
153676651|NCT00034775|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153676652|NCT00034775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153676653|NCT00034775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153676654|NCT00034775|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153676655|NCT00034775|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153676656|NCT00034775|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153676657|NCT00034775|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153676658|NCT00034775|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
153676659|NCT00034775|Dopamine Agents|dopamine agents|mesh-ancestor
153676660|NCT00062127|Thalidomide|thalidomide|mesh-list
153676661|NCT00062127|Irinotecan|irinotecan|mesh-list
153676662|NCT00062127|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
153676663|NCT00062127|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153676664|NCT00062127|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153676665|NCT00062127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153676666|NCT00062127|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153676677|NCT00034853|Naproxen|naproxen|mesh-list
153676702|NCT00034892|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153676703|NCT00034892|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
153676704|NCT00034892|Dopamine Agents|dopamine agents|mesh-ancestor
153676705|NCT00034892|Antiemetics|antiemetics|mesh-ancestor
153676706|NCT00034892|Autonomic Agents|autonomic agents|mesh-ancestor
153676707|NCT00034892|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153676708|NCT00034892|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153676709|NCT00034892|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
153676710|NCT00034892|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153676711|NCT00034892|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153676712|NCT00062205|Imatinib Mesylate|imatinib mesylate|mesh-list
153676713|NCT00062205|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153676714|NCT00062205|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153676715|NCT00062205|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153676716|NCT00062205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153676718|NCT00062244|Oblimersen|oblimersen|mesh-list
153676719|NCT00062244|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153676720|NCT00035009|Aprepitant|aprepitant|mesh-list
153676721|NCT00035009|Paroxetine|paroxetine|mesh-list
153676722|NCT00035009|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
153676723|NCT00035009|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153676724|NCT00035009|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153676725|NCT00035009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153676726|NCT00035009|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153676727|NCT00035009|Serotonin Agents|serotonin agents|mesh-ancestor
153676728|NCT00035009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153676729|NCT00035009|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
153676730|NCT00035009|Antidepressive Agents|antidepressive agents|mesh-ancestor
153676731|NCT00035009|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153676732|NCT00035009|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
153676743|NCT00062283|Chelating Agents|chelating agents|mesh-ancestor
153676744|NCT00062283|Sequestering Agents|sequestering agents|mesh-ancestor
153676745|NCT00062283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153676746|NCT00035048|Aprepitant|aprepitant|mesh-list
153676747|NCT00035048|Antiemetics|antiemetics|mesh-ancestor
153676748|NCT00035048|Autonomic Agents|autonomic agents|mesh-ancestor
153676749|NCT00035048|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153676750|NCT00035048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153676751|NCT00035048|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153676752|NCT00035048|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
153676753|NCT00035048|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153676754|NCT00035048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153676755|NCT00035087|Epothilones|epothilones|mesh-list
153676756|NCT00035087|Epothilone B|epothilone b|mesh-list
153676757|NCT00035087|Tubulin Modulators|tubulin modulators|mesh-ancestor
153676758|NCT00035087|Antimitotic Agents|antimitotic agents|mesh-ancestor
153676759|NCT00035087|Mitosis Modulators|mitosis modulators|mesh-ancestor
153676761|NCT00035087|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153676799|NCT00062478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153676800|NCT00035243|Epothilones|epothilones|mesh-list
153676801|NCT00035243|Epothilone B|epothilone b|mesh-list
153676802|NCT00035243|Tubulin Modulators|tubulin modulators|mesh-ancestor
153676803|NCT00035243|Antimitotic Agents|antimitotic agents|mesh-ancestor
153676804|NCT00035243|Mitosis Modulators|mitosis modulators|mesh-ancestor
153676805|NCT00035243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153676806|NCT00035243|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153676807|NCT00035282|Aprepitant|aprepitant|mesh-list
153676808|NCT00035282|Antiemetics|antiemetics|mesh-ancestor
153676809|NCT00035282|Autonomic Agents|autonomic agents|mesh-ancestor
153676810|NCT00035282|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153676811|NCT00035282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153676812|NCT00035282|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153676813|NCT00035282|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
153676814|NCT00035282|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153676815|NCT00035282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153676816|NCT00062556|Niacin|niacin|mesh-list
153676817|NCT00062556|Lovastatin|lovastatin|mesh-list
153676818|NCT00062556|L 647318|l 647318|mesh-list
153676819|NCT00062556|Dihydromevinolin|dihydromevinolin|mesh-list
153676820|NCT00062556|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153676821|NCT00062556|Antimetabolites|antimetabolites|mesh-ancestor
153384171|NCT01798394|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153384172|NCT01798394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153384173|NCT01798550|Enoxaparin|enoxaparin|mesh-list
153384174|NCT01798550|Anticoagulants|anticoagulants|mesh-ancestor
153384175|NCT01798550|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153384176|NCT01798550|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153384177|NCT01798550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153384211|NCT01815008|Clopidogrel|clopidogrel|mesh-list
153676822|NCT00062556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153676823|NCT00062556|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153676824|NCT00062556|Vasodilator Agents|vasodilator agents|mesh-ancestor
153676825|NCT00062556|Vitamin B Complex|vitamin b complex|mesh-ancestor
153676826|NCT00062556|Vitamins|vitamins|mesh-ancestor
153676827|NCT00062556|Micronutrients|micronutrients|mesh-ancestor
153676828|NCT00062556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153676829|NCT00062556|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153676830|NCT00062556|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
153676831|NCT00062556|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153676832|NCT00035321|Olanzapine|olanzapine|mesh-list
153676833|NCT00035321|Fluoxetine|fluoxetine|mesh-list
153676834|NCT00035321|Antiemetics|antiemetics|mesh-ancestor
153676839|NCT00035321|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153676840|NCT00035321|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153676841|NCT00035321|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153676842|NCT00035321|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153676843|NCT00035321|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
153676844|NCT00035321|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153676845|NCT00035321|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153676846|NCT00035321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153676847|NCT00035321|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153676848|NCT00035321|Serotonin Agents|serotonin agents|mesh-ancestor
153676849|NCT00035321|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
153676850|NCT00035321|Antidepressive Agents|antidepressive agents|mesh-ancestor
153676851|NCT00035321|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
153676852|NCT00035321|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153676853|NCT00035321|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153676854|NCT00062595|Vitamin K 1|vitamin k 1|mesh-list
153676855|NCT00062595|Vitamin K|vitamin k|mesh-list
153676856|NCT00062595|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
153676857|NCT00062595|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153676858|NCT00062595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153676859|NCT00062595|Hemostatics|hemostatics|mesh-ancestor
153676860|NCT00062595|Coagulants|coagulants|mesh-ancestor
153676861|NCT00062595|Vitamins|vitamins|mesh-ancestor
153676862|NCT00062595|Micronutrients|micronutrients|mesh-ancestor
153676863|NCT00062595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153676864|NCT00035360|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
153676865|NCT00035360|Antiviral Agents|antiviral agents|mesh-ancestor
153676866|NCT00035360|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153676867|NCT00062673|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
153676882|NCT00035477|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153676883|NCT00035477|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153676884|NCT00035477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153676885|NCT00035477|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153676886|NCT00035477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153676887|NCT00062712|Sirolimus|sirolimus|mesh-list
153676888|NCT00062712|Antilymphocyte Serum|antilymphocyte serum|mesh-list
153676889|NCT00062712|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153676890|NCT00062712|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153676891|NCT00062712|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153676892|NCT00062712|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153676893|NCT00062712|Antifungal Agents|antifungal agents|mesh-ancestor
153676894|NCT00062712|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153676895|NCT00062712|Immunologic Factors|immunologic factors|mesh-ancestor
153676896|NCT00062712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153676897|NCT00062790|Dutasteride|dutasteride|mesh-list
153676898|NCT00062790|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
153676899|NCT00062790|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153676900|NCT00062790|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153676901|NCT00062790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153676902|NCT00062790|Hormone Antagonists|hormone antagonists|mesh-ancestor
153676903|NCT00062790|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153676904|NCT00062790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153676905|NCT00035516|Epothilones|epothilones|mesh-list
153676906|NCT00035516|Tubulin Modulators|tubulin modulators|mesh-ancestor
153676907|NCT00035516|Antimitotic Agents|antimitotic agents|mesh-ancestor
153676927|NCT00035984|Hormones|hormones|mesh-ancestor
153676928|NCT00035984|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153676929|NCT00063141|Irinotecan|irinotecan|mesh-list
153676930|NCT00063141|Cetuximab|cetuximab|mesh-list
153676931|NCT00063141|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
153676932|NCT00063141|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153676933|NCT00063141|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153676934|NCT00063141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153676935|NCT00063141|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153676936|NCT00063141|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153676937|NCT00036023|Darbepoetin alfa|darbepoetin alfa|mesh-list
153676938|NCT00036023|Hematinics|hematinics|mesh-ancestor
153676939|NCT00036062|Sivelestat|sivelestat|mesh-list
153676940|NCT00036062|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
153676941|NCT00036062|Protease Inhibitors|protease inhibitors|mesh-ancestor
153676942|NCT00036062|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153676943|NCT00036062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153676944|NCT00036101|Aripiprazole|aripiprazole|mesh-list
153676945|NCT00036101|Antidepressive Agents|antidepressive agents|mesh-ancestor
153676946|NCT00036101|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153676947|NCT00036101|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153676948|NCT00036101|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153676949|NCT00036101|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153676950|NCT00036101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153676951|NCT00036101|Dopamine Agonists|dopamine agonists|mesh-ancestor
153676953|NCT00036101|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153676954|NCT00036101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153676955|NCT00036101|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
153676956|NCT00036101|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
153676957|NCT00036101|Serotonin Agents|serotonin agents|mesh-ancestor
153676958|NCT00036101|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
153676968|NCT00036218|Dopamine Agonists|dopamine agonists|mesh-ancestor
153676969|NCT00036218|Dopamine Agents|dopamine agents|mesh-ancestor
153676970|NCT00036218|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153676971|NCT00036218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153676972|NCT00036218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153676974|NCT00063453|Vitamin E|vitamin e|mesh-list
153676975|NCT00063453|Tocopherols|tocopherols|mesh-list
153676976|NCT00063453|Tocotrienols|tocotrienols|mesh-list
153676977|NCT00063453|alpha-Tocopherol|alpha-tocopherol|mesh-list
153676978|NCT00063453|Selenium|selenium|mesh-list
153676979|NCT00063453|Micronutrients|micronutrients|mesh-ancestor
153676980|NCT00063453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153676981|NCT00063453|Antioxidants|antioxidants|mesh-ancestor
153676982|NCT00063453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153676983|NCT00063453|Protective Agents|protective agents|mesh-ancestor
153676984|NCT00063453|Trace Elements|trace elements|mesh-ancestor
153676985|NCT00036335|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
153676986|NCT00036335|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
153676987|NCT00036335|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153676988|NCT00036335|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153676989|NCT00036335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153676990|NCT00036335|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153676991|NCT00036335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153676992|NCT00036335|Analgesics|analgesics|mesh-ancestor
153676993|NCT00036335|Sensory System Agents|sensory system agents|mesh-ancestor
153676994|NCT00036335|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153676995|NCT00036335|Antidepressive Agents|antidepressive agents|mesh-ancestor
153676996|NCT00036335|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153676997|NCT00036335|Dopamine Agents|dopamine agents|mesh-ancestor
153676998|NCT00036374|Infliximab|infliximab|mesh-list
153676999|NCT00036374|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
153384212|NCT01815008|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153384213|NCT01815008|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153384214|NCT01815008|Analgesics|analgesics|mesh-ancestor
153384215|NCT01815008|Sensory System Agents|sensory system agents|mesh-ancestor
153384216|NCT01815008|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153384217|NCT01815008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153384274|NCT03279237|Mitosis Modulators|mitosis modulators|mesh-ancestor
153677000|NCT00036374|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153677001|NCT00036374|Dermatologic Agents|dermatologic agents|mesh-ancestor
153677002|NCT00036374|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153677003|NCT00036374|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153677004|NCT00036452|Ritonavir|ritonavir|mesh-list
153677005|NCT00036452|Lopinavir|lopinavir|mesh-list
153677008|NCT00036452|Stavudine|stavudine|mesh-list
153677009|NCT00036452|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
153677010|NCT00036452|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
153677011|NCT00036452|Protease Inhibitors|protease inhibitors|mesh-ancestor
153677012|NCT00036452|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153677013|NCT00036452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153677014|NCT00036452|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153677015|NCT00036452|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153677016|NCT00036452|Antiviral Agents|antiviral agents|mesh-ancestor
153677017|NCT00036452|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153677018|NCT00036452|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
153677019|NCT00036452|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153677020|NCT00036452|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153677021|NCT00036452|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153677022|NCT00036452|Antimetabolites|antimetabolites|mesh-ancestor
153677023|NCT02967276|Metformin|metformin|mesh-list
153677024|NCT02967276|Dexamethasone|dexamethasone|mesh-list
153677025|NCT02967276|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153677026|NCT02967276|Antiemetics|antiemetics|mesh-ancestor
153677027|NCT02967276|Autonomic Agents|autonomic agents|mesh-ancestor
153677028|NCT02967276|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153677029|NCT02967276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153677030|NCT02967276|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153677031|NCT02967276|Glucocorticoids|glucocorticoids|mesh-ancestor
153677032|NCT02967276|Hormones|hormones|mesh-ancestor
153677033|NCT02967276|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153677034|NCT02967276|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153677035|NCT02967276|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153677036|NCT02967276|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153677037|NCT00036491|Rituximab|rituximab|mesh-list
153677038|NCT00036491|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153677039|NCT00036491|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153677040|NCT00036491|Immunologic Factors|immunologic factors|mesh-ancestor
153677041|NCT00036491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153677042|NCT00036491|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153677043|NCT00063609|Zoledronic Acid|zoledronic acid|mesh-list
153677046|NCT02971319|Technetium tc-99m tetrofosmin|technetium tc-99m tetrofosmin|mesh-list
153677047|NCT02971319|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
153677048|NCT02971319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153677049|NCT00036647|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
153677050|NCT00036647|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153677051|NCT00036647|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153677052|NCT00036647|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153677053|NCT00036647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153677054|NCT00036647|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153677056|NCT00063687|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153677057|NCT00063687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153677058|NCT00036764|Epothilones|epothilones|mesh-list
153677059|NCT00036764|Epothilone B|epothilone b|mesh-list
153677060|NCT00036764|Tubulin Modulators|tubulin modulators|mesh-ancestor
153677061|NCT00036764|Antimitotic Agents|antimitotic agents|mesh-ancestor
153677062|NCT00036764|Mitosis Modulators|mitosis modulators|mesh-ancestor
153677063|NCT00036764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153677064|NCT00036764|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153677065|NCT00063726|Bortezomib|bortezomib|mesh-list
153677066|NCT00063726|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153677067|NCT00036842|Arsenic Trioxide|arsenic trioxide|mesh-list
153677068|NCT00036842|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153677069|NCT00036881|Zinc Sulfate|zinc sulfate|mesh-list
153677070|NCT00036881|Astringents|astringents|mesh-ancestor
153677071|NCT00036881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153677072|NCT00036881|Dermatologic Agents|dermatologic agents|mesh-ancestor
153677073|NCT00063804|Ritonavir|ritonavir|mesh-list
153677074|NCT00063804|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
153677075|NCT00063804|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
153677076|NCT00063804|Protease Inhibitors|protease inhibitors|mesh-ancestor
153677077|NCT00063804|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153677078|NCT00063804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153677079|NCT00063804|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153677080|NCT00063804|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153677083|NCT00063804|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
153677084|NCT00063804|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153677085|NCT02967432|Mupirocin|mupirocin|mesh-list
153677086|NCT02967432|Petrolatum|petrolatum|mesh-list
153677087|NCT02967432|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153677088|NCT02967432|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153677089|NCT02967432|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
153677090|NCT02967432|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153677091|NCT02967432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153677092|NCT02967432|Emollients|emollients|mesh-ancestor
153677093|NCT02967432|Dermatologic Agents|dermatologic agents|mesh-ancestor
153677094|NCT00063960|Irinotecan|irinotecan|mesh-list
153677095|NCT00063960|Floxuridine|floxuridine|mesh-list
153677096|NCT00063960|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
153677097|NCT00063960|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153677098|NCT00063960|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153677099|NCT00063960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153677100|NCT00063960|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153677101|NCT00063960|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153677102|NCT00063960|Antimetabolites|antimetabolites|mesh-ancestor
153677103|NCT00064116|Rituximab|rituximab|mesh-list
153677104|NCT00064116|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153677105|NCT00064116|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153677106|NCT00064116|Immunologic Factors|immunologic factors|mesh-ancestor
153677107|NCT00064116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153677108|NCT00064116|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153677133|NCT00037115|Methylprednisolone|methylprednisolone|mesh-list
153677134|NCT00037115|Methotrexate|methotrexate|mesh-list
153677135|NCT00037115|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
153677136|NCT00037115|Abortifacient Agents|abortifacient agents|mesh-ancestor
153677137|NCT00037115|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153677138|NCT00037115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153677139|NCT00037115|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153677140|NCT00037115|Antimetabolites|antimetabolites|mesh-ancestor
153677141|NCT00037115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153677142|NCT00037115|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153677143|NCT00037115|Dermatologic Agents|dermatologic agents|mesh-ancestor
153677144|NCT00037115|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153677145|NCT00037115|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153677146|NCT00037115|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153677147|NCT00037115|Immunologic Factors|immunologic factors|mesh-ancestor
153677148|NCT00037115|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153677149|NCT00037115|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153677150|NCT00037115|Antiviral Agents|antiviral agents|mesh-ancestor
153677151|NCT00037115|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153677187|NCT00064428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153677189|NCT00064428|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153677190|NCT00064428|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153677191|NCT00064467|Bupropion|bupropion|mesh-list
153677192|NCT00064467|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
153677193|NCT00064467|Antidepressive Agents|antidepressive agents|mesh-ancestor
153677194|NCT00064467|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153677195|NCT00064467|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
153677196|NCT00064467|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153677197|NCT00064467|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153677198|NCT00064467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153384275|NCT03279237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153423960|NCT04495712|Diuretics|diuretics|mesh-ancestor
153423961|NCT04495712|Natriuretic Agents|natriuretic agents|mesh-ancestor
153423962|NCT03553940|Vaccines|vaccines|mesh-list
153423963|NCT03553940|Immunologic Factors|immunologic factors|mesh-ancestor
153423964|NCT03553940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153423965|NCT04456634|Lumefantrine|lumefantrine|mesh-list
153423966|NCT04456634|Artemether|artemether|mesh-list
153423967|NCT04456634|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
153423968|NCT04456634|Antimalarials|antimalarials|mesh-ancestor
153423969|NCT04456634|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153883028|NCT02271438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153883029|NCT02271438|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
153883030|NCT02271438|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
153384276|NCT03279237|Antimetabolites|antimetabolites|mesh-ancestor
153677199|NCT00064467|Dopamine Agents|dopamine agents|mesh-ancestor
153677200|NCT00064467|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153677201|NCT00064467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153677202|NCT00064467|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
153677203|NCT00064467|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153677204|NCT00064467|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153677205|NCT00064623|Capsaicin|capsaicin|mesh-list
153677206|NCT00064623|Antipruritics|antipruritics|mesh-ancestor
153677207|NCT00064623|Dermatologic Agents|dermatologic agents|mesh-ancestor
153677208|NCT00064623|Sensory System Agents|sensory system agents|mesh-ancestor
153677209|NCT00064623|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153677210|NCT00064623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153677211|NCT00037544|Factor VIII|factor viii|mesh-list
153677212|NCT00037544|Coagulants|coagulants|mesh-ancestor
153677213|NCT00037583|Gemtuzumab|gemtuzumab|mesh-list
153677214|NCT00037583|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153677215|NCT00037583|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153677216|NCT00037583|Immunotoxins|immunotoxins|mesh-ancestor
153677217|NCT00037583|Immunoconjugates|immunoconjugates|mesh-ancestor
153677218|NCT00037583|Immunologic Factors|immunologic factors|mesh-ancestor
153677229|NCT00037622|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153677230|NCT00037622|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153677231|NCT00037622|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153677232|NCT00037622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153677233|NCT00037622|Antiviral Agents|antiviral agents|mesh-ancestor
153677234|NCT00037622|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153677235|NCT00037622|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153677236|NCT00037622|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153677237|NCT00037661|Ophthalmic Solutions|ophthalmic solutions|mesh-list
153677238|NCT00037661|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
153677242|NCT00037700|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
153677243|NCT00037700|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153677244|NCT00064974|Lenalidomide|lenalidomide|mesh-list
153677245|NCT00064974|Immunologic Factors|immunologic factors|mesh-ancestor
153677246|NCT00064974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153677247|NCT00064974|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153677248|NCT00064974|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153677249|NCT00064974|Growth Substances|growth substances|mesh-ancestor
153677250|NCT00064974|Growth Inhibitors|growth inhibitors|mesh-ancestor
153677286|NCT00065169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153677287|NCT00065169|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153677288|NCT00065169|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153677289|NCT00065169|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
153677290|NCT00065169|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153677291|NCT00065169|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153677292|NCT00065169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153677293|NCT00038012|Carboplatin|carboplatin|mesh-list
153677294|NCT00038012|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153677295|NCT00038051|Lintuzumab|lintuzumab|mesh-list
153677296|NCT00038051|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153677297|NCT00038051|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153677298|NCT00038090|Thalidomide|thalidomide|mesh-list
153677299|NCT00038090|Dexamethasone|dexamethasone|mesh-list
153677300|NCT00038090|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153677301|NCT00038090|Antiemetics|antiemetics|mesh-ancestor
153677302|NCT00038090|Autonomic Agents|autonomic agents|mesh-ancestor
153677303|NCT00038090|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153677342|NCT00038168|Alkylating Agents|alkylating agents|mesh-ancestor
153677343|NCT00038168|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153677345|NCT00398658|Clindamycin palmitate|clindamycin palmitate|mesh-list
153677346|NCT00398658|Clindamycin phosphate|clindamycin phosphate|mesh-list
153677347|NCT00398658|Gentamicins|gentamicins|mesh-list
153677348|NCT00398658|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153677349|NCT00398658|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153677350|NCT00398658|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
153677351|NCT00398658|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153677352|NCT00398658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153677353|NCT00038207|Vincristine|vincristine|mesh-list
153677354|NCT00038207|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153677355|NCT00038207|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153677356|NCT00038207|Tubulin Modulators|tubulin modulators|mesh-ancestor
153677357|NCT00038207|Antimitotic Agents|antimitotic agents|mesh-ancestor
153677358|NCT00038207|Mitosis Modulators|mitosis modulators|mesh-ancestor
153677359|NCT00038207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153677360|NCT00398697|Gemcitabine|gemcitabine|mesh-list
153677361|NCT00398697|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153677362|NCT00398697|Antimetabolites|antimetabolites|mesh-ancestor
153677363|NCT00398697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153677364|NCT00398697|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153677365|NCT00038246|Thalidomide|thalidomide|mesh-list
153677366|NCT00038246|Paclitaxel|paclitaxel|mesh-list
153677367|NCT00038246|Estramustine|estramustine|mesh-list
153677368|NCT00038246|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153677369|NCT00038246|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153677370|NCT00038246|Tubulin Modulators|tubulin modulators|mesh-ancestor
153677371|NCT00038246|Antimitotic Agents|antimitotic agents|mesh-ancestor
153677372|NCT00038246|Mitosis Modulators|mitosis modulators|mesh-ancestor
153677385|NCT00038246|Alkylating Agents|alkylating agents|mesh-ancestor
153677386|NCT00038246|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153677387|NCT00398775|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
153677388|NCT00398775|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153677390|NCT00398814|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153677391|NCT00398814|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153677392|NCT00398814|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153677393|NCT00398814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153677394|NCT00065559|Celecoxib|celecoxib|mesh-list
153677395|NCT00065559|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153677396|NCT00065559|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153677397|NCT00065559|Analgesics|analgesics|mesh-ancestor
153677398|NCT00065559|Sensory System Agents|sensory system agents|mesh-ancestor
153677399|NCT00065559|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153677400|NCT00065559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153677401|NCT00065559|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153677402|NCT00065559|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153677403|NCT00065559|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
153677404|NCT00065559|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153677405|NCT00065559|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153677406|NCT00065559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153677407|NCT00065637|Teriparatide|teriparatide|mesh-list
153677408|NCT00065637|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153677409|NCT00065637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153677410|NCT00065637|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153677432|NCT05433896|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153677433|NCT05433896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153677434|NCT05433896|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153677435|NCT05433896|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153677436|NCT05433896|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153677438|NCT00069888|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153677439|NCT00069888|Tubulin Modulators|tubulin modulators|mesh-ancestor
153677440|NCT00069888|Antimitotic Agents|antimitotic agents|mesh-ancestor
153677441|NCT00069888|Mitosis Modulators|mitosis modulators|mesh-ancestor
153677442|NCT00069888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153677443|NCT05433428|Ophthalmic Solutions|ophthalmic solutions|mesh-list
153677444|NCT05433428|Lubricant Eye Drops|lubricant eye drops|mesh-list
153677445|NCT05433428|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
153677446|NCT00069927|Methylphenidate|methylphenidate|mesh-list
153677447|NCT00069927|Amphetamine|amphetamine|mesh-list
153677448|NCT00069927|Adderall|adderall|mesh-list
153677449|NCT00069927|Dextroamphetamine|dextroamphetamine|mesh-list
153677450|NCT00069927|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
153677451|NCT00069927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153677452|NCT00069927|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
153677453|NCT00069927|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153677456|NCT00069927|Dopamine Agents|dopamine agents|mesh-ancestor
153677484|NCT00069966|Hormones|hormones|mesh-ancestor
153677485|NCT00069966|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153677486|NCT00069966|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
153677487|NCT00069966|Protective Agents|protective agents|mesh-ancestor
153677488|NCT00069966|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153677489|NCT00069966|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153677490|NCT00069966|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153677491|NCT00065871|Contraceptive Agents|contraceptive agents|mesh-list
153677492|NCT00065871|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153677493|NCT00065871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153677495|NCT00065949|Analgesics|analgesics|mesh-ancestor
153677496|NCT00065949|Sensory System Agents|sensory system agents|mesh-ancestor
153677497|NCT00065949|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153677498|NCT00065949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153514416|NCT01425658|Anesthetics|anesthetics|mesh-ancestor
153677499|NCT00065949|Anesthetics|anesthetics|mesh-ancestor
153677500|NCT00065949|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153677501|NCT00065949|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153677502|NCT00065949|Anticonvulsants|anticonvulsants|mesh-ancestor
153677503|NCT00065949|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153677504|NCT00065949|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153677510|NCT00066027|Doxycycline|doxycycline|mesh-list
153677536|NCT00070083|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153677537|NCT00070083|Alkylating Agents|alkylating agents|mesh-ancestor
153677538|NCT00070083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153677539|NCT00070083|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153677540|NCT00070083|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153677541|NCT00070083|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153677542|NCT00070083|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153677543|NCT00070083|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153677544|NCT00070083|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153677545|NCT00070083|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153677546|NCT00070083|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153677547|NCT00070083|Glucocorticoids|glucocorticoids|mesh-ancestor
153677548|NCT00070083|Hormones|hormones|mesh-ancestor
153677549|NCT00070083|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153677550|NCT00070083|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153677551|NCT00070083|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153677552|NCT00070083|Tubulin Modulators|tubulin modulators|mesh-ancestor
153677553|NCT00070083|Antimitotic Agents|antimitotic agents|mesh-ancestor
153677554|NCT00070083|Mitosis Modulators|mitosis modulators|mesh-ancestor
153677590|NCT00070200|Melphalan|melphalan|mesh-list
153677591|NCT00070200|Doxorubicin|doxorubicin|mesh-list
153677592|NCT00070200|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
153677593|NCT00070200|Etoposide|etoposide|mesh-list
153677594|NCT00070200|Vincristine|vincristine|mesh-list
153677595|NCT00070200|Topotecan|topotecan|mesh-list
153677596|NCT00070200|Isotretinoin|isotretinoin|mesh-list
153677597|NCT00070200|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153677598|NCT00070200|Immunologic Factors|immunologic factors|mesh-ancestor
153677599|NCT00070200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153677600|NCT00070200|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153677601|NCT00070200|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153677602|NCT00070200|Alkylating Agents|alkylating agents|mesh-ancestor
153677603|NCT00070200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153677604|NCT00070200|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153677605|NCT00070200|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153677606|NCT00070200|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153677607|NCT00070200|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153677608|NCT00070200|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153677609|NCT00070200|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153677610|NCT00070200|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153677611|NCT00070200|Tubulin Modulators|tubulin modulators|mesh-ancestor
153677612|NCT00070200|Antimitotic Agents|antimitotic agents|mesh-ancestor
153677613|NCT00070200|Mitosis Modulators|mitosis modulators|mesh-ancestor
153677614|NCT00070200|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
153677615|NCT00070200|Dermatologic Agents|dermatologic agents|mesh-ancestor
153677641|NCT00070278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153677643|NCT00070278|Immunologic Factors|immunologic factors|mesh-ancestor
153677644|NCT00070278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153677645|NCT00070278|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153677646|NCT00070278|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153677647|NCT00070278|Alkylating Agents|alkylating agents|mesh-ancestor
153677648|NCT00070278|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153677649|NCT00070278|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153677651|NCT00070278|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153677652|NCT00070278|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153677653|NCT00070278|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153677654|NCT00070278|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153677655|NCT00066378|Gefitinib|gefitinib|mesh-list
153677656|NCT00066378|Anastrozole|anastrozole|mesh-list
153677657|NCT00066378|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153677658|NCT00066378|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153677659|NCT00066378|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153677660|NCT00066378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153677661|NCT00066378|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153677662|NCT00066378|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153677663|NCT00066378|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
153677664|NCT00066378|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153677665|NCT00066378|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
153677689|NCT00066417|Antifungal Agents|antifungal agents|mesh-ancestor
153677690|NCT00066417|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153677691|NCT00066417|Dermatologic Agents|dermatologic agents|mesh-ancestor
153677692|NCT00066417|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
153677693|NCT00066417|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153677694|NCT00066417|Antiemetics|antiemetics|mesh-ancestor
153677695|NCT00066417|Autonomic Agents|autonomic agents|mesh-ancestor
153677696|NCT00066417|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153677697|NCT00066417|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153677698|NCT00066417|Glucocorticoids|glucocorticoids|mesh-ancestor
153677699|NCT00066417|Hormones|hormones|mesh-ancestor
153677700|NCT00066417|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153677701|NCT00066417|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
153677702|NCT00066417|Protective Agents|protective agents|mesh-ancestor
153677703|NCT00066456|Docetaxel|docetaxel|mesh-list
153677705|NCT00066456|Tubulin Modulators|tubulin modulators|mesh-ancestor
153677750|NCT00066612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153677752|NCT00070551|Cytarabine|cytarabine|mesh-list
153677753|NCT00070551|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153677754|NCT00070551|Antimetabolites|antimetabolites|mesh-ancestor
153677755|NCT00070551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153677756|NCT00070551|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153677757|NCT00070551|Antiviral Agents|antiviral agents|mesh-ancestor
153677758|NCT00070551|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153677759|NCT00070551|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153677760|NCT00070551|Immunologic Factors|immunologic factors|mesh-ancestor
153677761|NCT00070551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153677762|NCT00070629|Paclitaxel|paclitaxel|mesh-list
153677763|NCT00070629|Docetaxel|docetaxel|mesh-list
153677764|NCT00070629|Cisplatin|cisplatin|mesh-list
153677765|NCT00070629|Carboplatin|carboplatin|mesh-list
153677812|NCT00066768|Tubulin Modulators|tubulin modulators|mesh-ancestor
153677813|NCT00066768|Antimitotic Agents|antimitotic agents|mesh-ancestor
153677814|NCT00066768|Mitosis Modulators|mitosis modulators|mesh-ancestor
153677815|NCT00066768|Antinematodal Agents|antinematodal agents|mesh-ancestor
153677816|NCT00066768|Anthelmintics|anthelmintics|mesh-ancestor
153677817|NCT00066768|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153677819|NCT00066768|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
153677820|NCT00066768|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153677822|NCT00066846|Bevacizumab|bevacizumab|mesh-list
153677823|NCT00066846|Fluorouracil|fluorouracil|mesh-list
153677824|NCT00066846|Calcium|calcium|mesh-list
153677825|NCT00066846|Levoleucovorin|levoleucovorin|mesh-list
153677826|NCT00066846|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153677827|NCT00066846|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153677828|NCT00066846|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153677829|NCT00066846|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153677830|NCT00066846|Growth Substances|growth substances|mesh-ancestor
153677831|NCT00066846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153677832|NCT00066846|Growth Inhibitors|growth inhibitors|mesh-ancestor
153677833|NCT00066846|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153677834|NCT00066846|Antimetabolites|antimetabolites|mesh-ancestor
153677835|NCT00066846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153677836|NCT00066846|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153677837|NCT00066846|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153677838|NCT00066846|Immunologic Factors|immunologic factors|mesh-ancestor
153677840|NCT00066846|Protective Agents|protective agents|mesh-ancestor
153677841|NCT00066846|Vitamin B Complex|vitamin b complex|mesh-ancestor
153677842|NCT00066846|Vitamins|vitamins|mesh-ancestor
153677843|NCT00066846|Micronutrients|micronutrients|mesh-ancestor
153677844|NCT00066885|Calcitriol|calcitriol|mesh-list
153677845|NCT00066885|Docetaxel|docetaxel|mesh-list
153677846|NCT00066885|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153677847|NCT00066885|Tubulin Modulators|tubulin modulators|mesh-ancestor
153677848|NCT00066885|Antimitotic Agents|antimitotic agents|mesh-ancestor
153677849|NCT00066885|Mitosis Modulators|mitosis modulators|mesh-ancestor
153677851|NCT00066885|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153677852|NCT00066885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153677853|NCT00066885|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
153677854|NCT00066885|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153677855|NCT00066885|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
153677857|NCT00066885|Micronutrients|micronutrients|mesh-ancestor
153677858|NCT00066885|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153677859|NCT04941521|Exenatide|exenatide|mesh-list
153677860|NCT04941521|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
153677861|NCT04941521|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153677862|NCT04941521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153677863|NCT04941521|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
153677864|NCT04941521|Incretins|incretins|mesh-ancestor
153677865|NCT04941521|Hormones|hormones|mesh-ancestor
153677866|NCT04941521|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153677867|NCT02966457|Colistin|colistin|mesh-list
153677868|NCT02966457|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153677869|NCT02966457|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153677870|NCT00067041|Treprostinil|treprostinil|mesh-list
153677871|NCT00067041|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153677872|NCT04732364|Bupivacaine|bupivacaine|mesh-list
153677873|NCT04732364|Anesthetics, Local|anesthetics, local|mesh-ancestor
153677874|NCT04732364|Anesthetics|anesthetics|mesh-ancestor
153677875|NCT04732364|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153677876|NCT04732364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153677877|NCT04732364|Sensory System Agents|sensory system agents|mesh-ancestor
153677878|NCT04732364|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153677879|NCT00067080|Deferasirox|deferasirox|mesh-list
153677880|NCT00067080|Deferoxamine|deferoxamine|mesh-list
153677881|NCT00067080|Iron Chelating Agents|iron chelating agents|mesh-ancestor
153677882|NCT00067080|Chelating Agents|chelating agents|mesh-ancestor
153677884|NCT00067080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153677885|NCT00067080|Siderophores|siderophores|mesh-ancestor
153677886|NCT00396851|Metformin|metformin|mesh-list
153677887|NCT00396851|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153677888|NCT00396851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153677890|NCT00067119|Aspirin, Dipyridamole Drug Combination|aspirin, dipyridamole drug combination|mesh-list
153677891|NCT00067119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153677892|NCT00067119|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153677893|NCT00067119|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153677894|NCT00067119|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
153677895|NCT00067119|Vasodilator Agents|vasodilator agents|mesh-ancestor
153677896|NCT00396929|Paclitaxel|paclitaxel|mesh-list
153677897|NCT00396929|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153677898|NCT00396929|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153677899|NCT00396929|Tubulin Modulators|tubulin modulators|mesh-ancestor
153677900|NCT00396929|Antimitotic Agents|antimitotic agents|mesh-ancestor
153677901|NCT00396929|Mitosis Modulators|mitosis modulators|mesh-ancestor
153677902|NCT00396929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153677903|NCT04750772|1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid|1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid|mesh-list
153677904|NCT04750772|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
153677905|NCT04750772|Chelating Agents|chelating agents|mesh-ancestor
153677906|NCT04750772|Sequestering Agents|sequestering agents|mesh-ancestor
153677907|NCT04750772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153677908|NCT04750772|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
153677909|NCT00399165|Methyltestosterone|methyltestosterone|mesh-list
153677910|NCT00399165|Testosterone|testosterone|mesh-list
153677911|NCT00399165|Testosterone undecanoate|testosterone undecanoate|mesh-list
153677912|NCT00399165|Testosterone enanthate|testosterone enanthate|mesh-list
153677913|NCT00399165|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
153677915|NCT00399165|Androgens|androgens|mesh-ancestor
153677916|NCT00399165|Hormones|hormones|mesh-ancestor
153677917|NCT00399165|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153677918|NCT00399165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153677920|NCT00399165|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153677931|NCT00067158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153677932|NCT00067158|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
153677933|NCT00067158|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
153677934|NCT00067158|Cholinergic Agents|cholinergic agents|mesh-ancestor
153677935|NCT00067158|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153677936|NCT00067158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153677937|NCT00071097|Darunavir|darunavir|mesh-list
153677938|NCT00071097|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
153677939|NCT00071097|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
153677940|NCT00071097|Protease Inhibitors|protease inhibitors|mesh-ancestor
153677941|NCT00071097|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153677942|NCT00071097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153677943|NCT00071097|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153677944|NCT00071097|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153677945|NCT00071097|Antiviral Agents|antiviral agents|mesh-ancestor
153677946|NCT00071097|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153677947|NCT00067353|Fluorides|fluorides|mesh-list
153677948|NCT00067353|Fluorides, Topical|fluorides, topical|mesh-list
153677949|NCT00067353|Cariostatic Agents|cariostatic agents|mesh-ancestor
153677950|NCT00067353|Protective Agents|protective agents|mesh-ancestor
153677951|NCT00067353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153677952|NCT00071136|Gemcitabine|gemcitabine|mesh-list
153677953|NCT00071136|Pemetrexed|pemetrexed|mesh-list
153677954|NCT00071136|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153677955|NCT00071136|Antimetabolites|antimetabolites|mesh-ancestor
153677956|NCT00071136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153677957|NCT00071136|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153677979|NCT00067431|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153677980|NCT00067509|Progesterone|progesterone|mesh-list
153677982|NCT00067509|Progestins|progestins|mesh-ancestor
153677983|NCT00067509|Hormones|hormones|mesh-ancestor
153677984|NCT00067509|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153677985|NCT00067509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153677986|NCT01349673|Budesonide|budesonide|mesh-list
153677987|NCT01349673|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153677988|NCT01349673|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153677989|NCT01349673|Autonomic Agents|autonomic agents|mesh-ancestor
153677990|NCT01349673|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153677991|NCT01349673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153677992|NCT01349673|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153677993|NCT01349673|Respiratory System Agents|respiratory system agents|mesh-ancestor
153677994|NCT01349673|Glucocorticoids|glucocorticoids|mesh-ancestor
153677995|NCT01349673|Hormones|hormones|mesh-ancestor
153677996|NCT01349673|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153677997|NCT00071253|Valproic Acid|valproic acid|mesh-list
153677998|NCT00071253|Olanzapine|olanzapine|mesh-list
153677999|NCT00071253|Antiemetics|antiemetics|mesh-ancestor
153678000|NCT00071253|Autonomic Agents|autonomic agents|mesh-ancestor
153678001|NCT00071253|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153678002|NCT00071253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153678003|NCT00071253|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153678004|NCT00071253|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153678028|NCT00067626|Chromium|chromium|mesh-list
153514942|NCT01426490|Micronutrients|micronutrients|mesh-ancestor
153678029|NCT00067626|Trace Elements|trace elements|mesh-ancestor
153678030|NCT00067626|Micronutrients|micronutrients|mesh-ancestor
153678031|NCT00067626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153678032|NCT00067743|Lenalidomide|lenalidomide|mesh-list
153678033|NCT00067743|Immunologic Factors|immunologic factors|mesh-ancestor
153678034|NCT00067743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153678035|NCT00067743|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153678036|NCT00067743|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153678037|NCT00067743|Growth Substances|growth substances|mesh-ancestor
153678038|NCT00067743|Growth Inhibitors|growth inhibitors|mesh-ancestor
153384277|NCT03279237|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153384278|NCT03279237|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153384280|NCT03279237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153384281|NCT03279237|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
153384282|NCT03279237|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153384283|NCT03279237|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153384284|NCT03279237|Antidotes|antidotes|mesh-ancestor
153384285|NCT03279237|Protective Agents|protective agents|mesh-ancestor
153384286|NCT03279237|Vitamin B Complex|vitamin b complex|mesh-ancestor
153384287|NCT03279237|Vitamins|vitamins|mesh-ancestor
153384288|NCT03279237|Micronutrients|micronutrients|mesh-ancestor
153384289|NCT03282591|Serlopitant|serlopitant|mesh-list
153678039|NCT00067743|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153678040|NCT00396968|Plerixafor|plerixafor|mesh-list
153678041|NCT00396968|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153678042|NCT00396968|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153678043|NCT00396968|Antiviral Agents|antiviral agents|mesh-ancestor
153678044|NCT00396968|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153678045|NCT00067860|Hormones|hormones|mesh-list
153678046|NCT00067860|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153678048|NCT00071448|Insulin|insulin|mesh-list
153678049|NCT00071448|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
153678050|NCT00071448|Insulin Aspart|insulin aspart|mesh-list
153678051|NCT00071448|Insulin Lispro|insulin lispro|mesh-list
153678052|NCT00071448|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153678053|NCT00071448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153678054|NCT00067899|Vitamins|vitamins|mesh-list
153678055|NCT00067899|Vitamin E|vitamin e|mesh-list
153678056|NCT00067899|Micronutrients|micronutrients|mesh-ancestor
153678057|NCT00067899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153678058|NCT00067899|Antioxidants|antioxidants|mesh-ancestor
153678059|NCT00067899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153678060|NCT00067899|Protective Agents|protective agents|mesh-ancestor
153678061|NCT00067938|Lamotrigine|lamotrigine|mesh-list
153678062|NCT00067938|Anticonvulsants|anticonvulsants|mesh-ancestor
153678063|NCT00067938|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153678064|NCT00067938|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153678066|NCT00067938|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153678067|NCT00067938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153678068|NCT00067938|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153678069|NCT00067938|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153678070|NCT00067938|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153678071|NCT00067938|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153678072|NCT00067938|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153678073|NCT02358187|Poly ICLC|poly iclc|mesh-list
153678074|NCT02358187|Interferon Inducers|interferon inducers|mesh-ancestor
153678075|NCT02358187|Immunologic Factors|immunologic factors|mesh-ancestor
153678076|NCT02358187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153678077|NCT01809808|Hormones|hormones|mesh-list
153678078|NCT01809808|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153678079|NCT01809808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153678080|NCT00068055|gamma-Globulins|gamma-globulins|mesh-list
153678081|NCT00068055|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
153678082|NCT00068055|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
153678083|NCT00068055|Immunologic Factors|immunologic factors|mesh-ancestor
153678084|NCT00068055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153678085|NCT01406197|Progesterone|progesterone|mesh-list
153678086|NCT01406197|Progestins|progestins|mesh-ancestor
153678087|NCT01406197|Hormones|hormones|mesh-ancestor
153678088|NCT01406197|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153678089|NCT01406197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153678090|NCT00038402|Paclitaxel|paclitaxel|mesh-list
153678091|NCT00038402|Cyclophosphamide|cyclophosphamide|mesh-list
153678092|NCT00038402|Fluorouracil|fluorouracil|mesh-list
153678093|NCT00038402|Trastuzumab|trastuzumab|mesh-list
153678094|NCT00038402|Epirubicin|epirubicin|mesh-list
153678095|NCT00038402|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153678096|NCT00038402|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153678097|NCT00038402|Tubulin Modulators|tubulin modulators|mesh-ancestor
153678098|NCT00038402|Antimitotic Agents|antimitotic agents|mesh-ancestor
153678099|NCT00038402|Mitosis Modulators|mitosis modulators|mesh-ancestor
153678108|NCT00038402|Antimetabolites|antimetabolites|mesh-ancestor
153678109|NCT00038402|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153678110|NCT00038402|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153678111|NCT00038402|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153678112|NCT00038402|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153678113|NCT00038402|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153678114|NCT00038402|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153678115|NCT00144703|Sirolimus|sirolimus|mesh-list
153678116|NCT00144703|Tacrolimus|tacrolimus|mesh-list
153678117|NCT00144703|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153678118|NCT00144703|Immunologic Factors|immunologic factors|mesh-ancestor
153678119|NCT00144703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153678120|NCT00144703|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
153678121|NCT00144703|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153678165|NCT00202306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153678166|NCT00202306|Antimanic Agents|antimanic agents|mesh-ancestor
153678167|NCT00202306|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153678168|NCT00202306|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153678169|NCT00202306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153678170|NCT00038519|Ritonavir|ritonavir|mesh-list
153678171|NCT00038519|Saquinavir|saquinavir|mesh-list
153678172|NCT00038519|Amprenavir|amprenavir|mesh-list
153678173|NCT00038519|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
153678175|NCT00038519|Protease Inhibitors|protease inhibitors|mesh-ancestor
153678176|NCT00038519|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153678177|NCT00038519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153678178|NCT00038519|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153678179|NCT00038519|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153678180|NCT00038519|Antiviral Agents|antiviral agents|mesh-ancestor
153678181|NCT00038519|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153678182|NCT00038519|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
153678183|NCT00038519|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153678184|NCT00038519|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
153678185|NCT00038519|Antitubercular Agents|antitubercular agents|mesh-ancestor
153678186|NCT00038519|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153678187|NCT00202345|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
153678188|NCT00202345|Hematinics|hematinics|mesh-ancestor
153678189|NCT00202423|Nabiximols|nabiximols|mesh-list
153678190|NCT00202423|Analgesics|analgesics|mesh-ancestor
153678191|NCT00202423|Sensory System Agents|sensory system agents|mesh-ancestor
153678192|NCT00202423|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153678193|NCT00202423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153678194|NCT00202462|Testosterone|testosterone|mesh-list
153678195|NCT00202462|Androgens|androgens|mesh-ancestor
153678196|NCT00202462|Hormones|hormones|mesh-ancestor
153678209|NCT00038558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153678210|NCT00038558|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153678211|NCT00038558|Alkylating Agents|alkylating agents|mesh-ancestor
153678212|NCT00038558|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153678213|NCT00038558|Tubulin Modulators|tubulin modulators|mesh-ancestor
153678214|NCT00038558|Antimitotic Agents|antimitotic agents|mesh-ancestor
153678215|NCT00038558|Mitosis Modulators|mitosis modulators|mesh-ancestor
153678216|NCT00038597|Lonafarnib|lonafarnib|mesh-list
153678217|NCT00038597|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153678218|NCT00038597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153678219|NCT00202618|Amlodipine|amlodipine|mesh-list
153678220|NCT00202618|Valsartan|valsartan|mesh-list
153678221|NCT00202618|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153384290|NCT03282591|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
153678222|NCT00202618|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153678223|NCT00202618|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153678224|NCT00202618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153678225|NCT00202618|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153678226|NCT00202618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153678227|NCT00202618|Vasodilator Agents|vasodilator agents|mesh-ancestor
153678228|NCT00202618|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
153678229|NCT00202618|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
153678230|NCT00202696|Nalmefene|nalmefene|mesh-list
153678231|NCT00202696|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
153678232|NCT00202696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153678233|NCT00202696|Sensory System Agents|sensory system agents|mesh-ancestor
153678234|NCT00202696|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153678235|NCT00038636|Ritonavir|ritonavir|mesh-list
153678236|NCT00038636|Lopinavir|lopinavir|mesh-list
153678237|NCT00038636|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
153678238|NCT00038636|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
153678251|NCT00071838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153678253|NCT00202852|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
153678254|NCT00202852|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153678255|NCT00202852|Dermatologic Agents|dermatologic agents|mesh-ancestor
153678256|NCT00202852|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153678257|NCT00202852|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153678258|NCT00202891|Sisomicin|sisomicin|mesh-list
153678259|NCT00202891|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153678260|NCT00202891|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153678261|NCT00202891|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
153678262|NCT00202891|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153678263|NCT00202891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153678265|NCT00202969|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153678266|NCT00203125|Rasagiline|rasagiline|mesh-list
153678267|NCT00203125|Tyramine|tyramine|mesh-list
153678268|NCT00203125|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
153678269|NCT00203125|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153678270|NCT00203125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153678308|NCT00203281|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153678309|NCT00203320|Etanercept|etanercept|mesh-list
153678310|NCT00203320|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153678311|NCT00203320|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153678312|NCT00203320|Analgesics|analgesics|mesh-ancestor
153678313|NCT00203320|Sensory System Agents|sensory system agents|mesh-ancestor
153678314|NCT00203320|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153678315|NCT00203320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153678316|NCT00203320|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153678317|NCT00203320|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153678318|NCT00203320|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153678319|NCT00203320|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153678320|NCT00203320|Immunologic Factors|immunologic factors|mesh-ancestor
153678321|NCT00038792|Mitogens|mitogens|mesh-list
153678322|NCT00038792|Mitosis Modulators|mitosis modulators|mesh-ancestor
153678323|NCT00038792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153678324|NCT00203359|Etanercept|etanercept|mesh-list
153678325|NCT00203359|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153678326|NCT00203359|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153678327|NCT00203359|Analgesics|analgesics|mesh-ancestor
153678328|NCT00203359|Sensory System Agents|sensory system agents|mesh-ancestor
153678329|NCT00203359|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153678330|NCT00203359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153678331|NCT00203359|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153678332|NCT00203359|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153678333|NCT00203359|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153678334|NCT00203359|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153678335|NCT00203359|Immunologic Factors|immunologic factors|mesh-ancestor
153678336|NCT00410644|Hydromorphone|hydromorphone|mesh-list
153678337|NCT00410644|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153678338|NCT00410644|Narcotics|narcotics|mesh-ancestor
153678339|NCT00410644|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153678340|NCT00410644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153678341|NCT00410644|Analgesics|analgesics|mesh-ancestor
153678350|NCT00038831|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153678351|NCT00038831|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153678352|NCT00038831|Antimetabolites|antimetabolites|mesh-ancestor
153678353|NCT00038831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153678354|NCT00038831|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153678355|NCT00038831|Immunologic Factors|immunologic factors|mesh-ancestor
153678356|NCT00038831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153678357|NCT00038831|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153678358|NCT00038831|Alkylating Agents|alkylating agents|mesh-ancestor
153678359|NCT00038831|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153678360|NCT00038831|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153678361|NCT00038831|Immunotoxins|immunotoxins|mesh-ancestor
153678362|NCT00038831|Immunoconjugates|immunoconjugates|mesh-ancestor
153678363|NCT00071955|Immunoglobulins|immunoglobulins|mesh-list
153678364|NCT00071955|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
153678365|NCT00071955|Antibodies|antibodies|mesh-list
153678366|NCT00071955|Sargramostim|sargramostim|mesh-list
153678367|NCT00071955|Immunoglobulin Idiotypes|immunoglobulin idiotypes|mesh-list
153678368|NCT00071955|Immunologic Factors|immunologic factors|mesh-ancestor
153678369|NCT00071955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153678370|NCT00203554|Polymethyl Methacrylate|polymethyl methacrylate|mesh-list
153678371|NCT00203554|Vasodilator Agents|vasodilator agents|mesh-ancestor
153432317|NCT05048238|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153432318|NCT05048238|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153432319|NCT05048238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153432320|NCT05044429|Lidocaine|lidocaine|mesh-list
153432321|NCT05044429|Anesthetics, Local|anesthetics, local|mesh-ancestor
153432322|NCT05044429|Anesthetics|anesthetics|mesh-ancestor
153432323|NCT05044429|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153432324|NCT05044429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153432325|NCT05044429|Sensory System Agents|sensory system agents|mesh-ancestor
153432326|NCT05044429|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153432327|NCT05044429|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153432328|NCT05044429|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
153432329|NCT05044429|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153678372|NCT00203554|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
153678373|NCT00203554|Protective Agents|protective agents|mesh-ancestor
153678401|NCT00072033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153678402|NCT00203905|Bevacizumab|bevacizumab|mesh-list
153678403|NCT00203905|Fluorouracil|fluorouracil|mesh-list
153678404|NCT00203905|Hydroxyurea|hydroxyurea|mesh-list
153678405|NCT00203905|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153678406|NCT00203905|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153678407|NCT00203905|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153678409|NCT00203905|Growth Substances|growth substances|mesh-ancestor
153678410|NCT00203905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153678411|NCT00203905|Growth Inhibitors|growth inhibitors|mesh-ancestor
153678412|NCT00203905|Antimetabolites|antimetabolites|mesh-ancestor
153678413|NCT00203905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153678414|NCT00203905|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153678415|NCT00203905|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153678416|NCT00203905|Immunologic Factors|immunologic factors|mesh-ancestor
153678417|NCT00203905|Antisickling Agents|antisickling agents|mesh-ancestor
153678418|NCT00203905|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153678419|NCT00203905|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153678420|NCT00072072|Celecoxib|celecoxib|mesh-list
153678421|NCT00072072|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
153678422|NCT00072072|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153678423|NCT00072072|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153678424|NCT00072072|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153678425|NCT00072072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153678426|NCT00072072|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153678427|NCT00072072|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153678428|NCT00072072|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153678446|NCT00204022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153678447|NCT00204022|Antimetabolites|antimetabolites|mesh-ancestor
153678448|NCT00204022|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153678449|NCT00204022|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153678450|NCT00204022|Immunologic Factors|immunologic factors|mesh-ancestor
153678451|NCT00204022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153678452|NCT00204022|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153678453|NCT00204061|Amisulpride|amisulpride|mesh-list
153678454|NCT00204061|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153678455|NCT00204061|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153678456|NCT00204061|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153384291|NCT03282591|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153678457|NCT00204061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153678458|NCT00204061|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153678459|NCT00204061|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
153678460|NCT00204061|Dopamine Agents|dopamine agents|mesh-ancestor
153678461|NCT00204061|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153678462|NCT00204061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153678463|NCT00204061|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
153678464|NCT00204061|Antidepressive Agents|antidepressive agents|mesh-ancestor
153678465|NCT02966652|Methyltestosterone|methyltestosterone|mesh-list
153678466|NCT02966652|Testosterone|testosterone|mesh-list
153678467|NCT02966652|Testosterone undecanoate|testosterone undecanoate|mesh-list
153678468|NCT02966652|Testosterone enanthate|testosterone enanthate|mesh-list
153678469|NCT02966652|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
153678470|NCT02966652|Androgens|androgens|mesh-ancestor
153678471|NCT02966652|Hormones|hormones|mesh-ancestor
153678472|NCT02966652|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153678473|NCT02966652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153678474|NCT02966652|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153678475|NCT02966652|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153678477|NCT00039026|Exenatide|exenatide|mesh-list
153678486|NCT00204256|Hematinics|hematinics|mesh-ancestor
153678487|NCT00072111|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
153678488|NCT00072111|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153678489|NCT00204451|Levonorgestrel|levonorgestrel|mesh-list
153678490|NCT00204451|Ethinyl Estradiol|ethinyl estradiol|mesh-list
153678491|NCT00204451|Estradiol|estradiol|mesh-list
153678492|NCT00204451|Estrogens|estrogens|mesh-ancestor
153678493|NCT00204451|Hormones|hormones|mesh-ancestor
153678494|NCT00204451|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153678495|NCT00204451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153678496|NCT00204451|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
153678497|NCT00204451|Contraceptive Agents|contraceptive agents|mesh-ancestor
153678498|NCT00204451|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153678499|NCT00204451|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
153678500|NCT00204451|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
153678501|NCT00204451|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
153678502|NCT00204451|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
153678503|NCT00204529|Interferons|interferons|mesh-list
153678504|NCT00204529|Interferon-alpha|interferon-alpha|mesh-list
153678505|NCT00204529|Interferon alpha-2|interferon alpha-2|mesh-list
153678506|NCT00204529|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
153678508|NCT00204529|Antiviral Agents|antiviral agents|mesh-ancestor
153678509|NCT00204529|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153678510|NCT00204529|Immunologic Factors|immunologic factors|mesh-ancestor
153678511|NCT00204529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153678512|NCT00039104|Zoledronic Acid|zoledronic acid|mesh-list
153678535|NCT00204646|Ifosfamide|ifosfamide|mesh-list
153678536|NCT00204646|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153678537|NCT00204646|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153678538|NCT00204646|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153678539|NCT00204646|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153678540|NCT00204646|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153678541|NCT00204646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153678542|NCT00204646|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153678543|NCT00204646|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153678544|NCT00204646|Alkylating Agents|alkylating agents|mesh-ancestor
153678545|NCT00039182|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
153678546|NCT00039182|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153678547|NCT00039182|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153678548|NCT00039182|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153678549|NCT00039182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153678550|NCT00039182|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153678551|NCT00410878|Hydromorphone|hydromorphone|mesh-list
153678552|NCT00410878|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153678553|NCT00410878|Narcotics|narcotics|mesh-ancestor
153678554|NCT00410878|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153678555|NCT00410878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153678556|NCT00410878|Analgesics|analgesics|mesh-ancestor
153678557|NCT00410878|Sensory System Agents|sensory system agents|mesh-ancestor
153678558|NCT00410878|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153678559|NCT00410995|Naproxen|naproxen|mesh-list
153678560|NCT00410995|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153678561|NCT00410995|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153678562|NCT00410995|Analgesics|analgesics|mesh-ancestor
153678579|NCT00072228|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153678581|NCT00072267|7-hydroxystaurosporine|7-hydroxystaurosporine|mesh-list
153678582|NCT00072267|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
153678583|NCT00072267|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153678584|NCT00072267|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153678585|NCT00072267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153678586|NCT00072267|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153678587|NCT00072267|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153678588|NCT00039416|Imatinib Mesylate|imatinib mesylate|mesh-list
153678589|NCT00039416|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153678590|NCT00039416|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153678591|NCT00039416|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153678592|NCT00039416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153678593|NCT00039416|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153678594|NCT00072345|Thalidomide|thalidomide|mesh-list
153678595|NCT00072345|Temozolomide|temozolomide|mesh-list
153678596|NCT00072345|Lomustine|lomustine|mesh-list
153678597|NCT00072345|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153678598|NCT00072345|Alkylating Agents|alkylating agents|mesh-ancestor
153678599|NCT00072345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153678600|NCT00072345|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153678601|NCT00072345|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153678602|NCT00072345|Immunologic Factors|immunologic factors|mesh-ancestor
153678628|NCT00205231|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153678629|NCT00205231|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153678630|NCT00205231|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153678631|NCT00205231|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153678632|NCT00205231|Immunologic Factors|immunologic factors|mesh-ancestor
153678634|NCT00072462|Anastrozole|anastrozole|mesh-list
153678635|NCT00072462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153678636|NCT00072462|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
153678637|NCT00072462|Hormone Antagonists|hormone antagonists|mesh-ancestor
153678638|NCT00072462|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153678639|NCT00072462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153678640|NCT00072462|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153678641|NCT00072462|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153678642|NCT00072462|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
153678644|NCT00072462|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153678645|NCT00072462|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
153678646|NCT00072462|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153678647|NCT00072462|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153678648|NCT00205426|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
153678649|NCT00205426|Natriuretic Agents|natriuretic agents|mesh-ancestor
153678678|NCT00205738|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153678679|NCT00205738|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153678681|NCT00205816|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153678682|NCT00205816|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153678683|NCT00205816|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
153678684|NCT00205816|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153678685|NCT00205816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153678686|NCT00072540|Celecoxib|celecoxib|mesh-list
153678687|NCT00072540|Enzyme Inhibitors|enzyme inhibitors|mesh-list
153678688|NCT00072540|Mitogens|mitogens|mesh-list
153678689|NCT00072540|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153678690|NCT00072540|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153678691|NCT00072540|Analgesics|analgesics|mesh-ancestor
153678692|NCT00072540|Sensory System Agents|sensory system agents|mesh-ancestor
153678693|NCT00072540|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153678694|NCT00072540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153678695|NCT00072540|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153678696|NCT00072540|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153678697|NCT00072540|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
153678698|NCT00072540|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153678699|NCT00072540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153678700|NCT00072540|Mitosis Modulators|mitosis modulators|mesh-ancestor
153678701|NCT00206050|Esomeprazole|esomeprazole|mesh-list
153678702|NCT00206050|Pantoprazole|pantoprazole|mesh-list
153678703|NCT00206050|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
153678704|NCT00206050|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153678705|NCT00206050|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
153678706|NCT00206050|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153384292|NCT03282591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153384293|NCT03282591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153384294|NCT03509883|Apixaban|apixaban|mesh-list
153384295|NCT03509883|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
153384296|NCT03509883|Antithrombins|antithrombins|mesh-ancestor
153384297|NCT03509883|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
153384298|NCT03509883|Protease Inhibitors|protease inhibitors|mesh-ancestor
153384299|NCT03509883|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153384300|NCT03509883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153384301|NCT03509883|Anticoagulants|anticoagulants|mesh-ancestor
153384302|NCT03336645|Midazolam|midazolam|mesh-list
153384303|NCT03336645|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153678707|NCT00206050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153678708|NCT00206089|Ximelagatran|ximelagatran|mesh-list
153678709|NCT00206089|Melagatran|melagatran|mesh-list
153678710|NCT00206089|Antithrombins|antithrombins|mesh-ancestor
153678711|NCT00206089|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
153678712|NCT00206089|Protease Inhibitors|protease inhibitors|mesh-ancestor
153678717|NCT00072579|Immunologic Factors|immunologic factors|mesh-ancestor
153678718|NCT00072579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153678719|NCT00206128|Quetiapine Fumarate|quetiapine fumarate|mesh-list
153678720|NCT00206128|Antidepressive Agents|antidepressive agents|mesh-ancestor
153678721|NCT00206128|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153678722|NCT00206128|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153678723|NCT00206128|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153678724|NCT00206128|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153678725|NCT00206128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153678726|NCT00206167|Budesonide|budesonide|mesh-list
153678727|NCT00206167|Formoterol Fumarate|formoterol fumarate|mesh-list
153678728|NCT00206167|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153678729|NCT00206167|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153678730|NCT00206167|Autonomic Agents|autonomic agents|mesh-ancestor
153678731|NCT00206167|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153678732|NCT00206167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153678733|NCT00206167|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153678734|NCT00206167|Respiratory System Agents|respiratory system agents|mesh-ancestor
153678735|NCT00206167|Glucocorticoids|glucocorticoids|mesh-ancestor
153678737|NCT00206167|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153678738|NCT00206167|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
153678771|NCT00039767|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153678772|NCT00039767|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153678773|NCT00072618|Sulindac sulfone|sulindac sulfone|mesh-list
153678774|NCT00072618|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153678775|NCT00072618|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
153678776|NCT00072618|Protective Agents|protective agents|mesh-ancestor
153678777|NCT00072618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153678778|NCT00072618|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153678779|NCT00072618|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153678780|NCT00072618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153678782|NCT00072618|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153678783|NCT00072618|Analgesics|analgesics|mesh-ancestor
153678784|NCT00072618|Sensory System Agents|sensory system agents|mesh-ancestor
153678785|NCT00072618|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153678786|NCT00072618|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153678787|NCT00072618|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153678788|NCT00039884|Darbepoetin alfa|darbepoetin alfa|mesh-list
153678789|NCT00039884|Hematinics|hematinics|mesh-ancestor
153678790|NCT00206401|Insulin Glargine|insulin glargine|mesh-list
153678791|NCT00206401|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153678792|NCT00206401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153678793|NCT00399204|Metformin|metformin|mesh-list
153678794|NCT00399204|Pioglitazone|pioglitazone|mesh-list
153678795|NCT00399204|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153678796|NCT00399204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153678797|NCT00411034|Hydromorphone|hydromorphone|mesh-list
153678798|NCT00411034|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153678817|NCT00411190|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
153678818|NCT00411190|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153678819|NCT00411190|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153678821|NCT00411190|Sensory System Agents|sensory system agents|mesh-ancestor
153678822|NCT00411190|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153678823|NCT00411190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153678824|NCT00411190|Antipyretics|antipyretics|mesh-ancestor
153678886|NCT00206674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153678887|NCT00206713|Sargramostim|sargramostim|mesh-list
153678888|NCT00206713|Immunologic Factors|immunologic factors|mesh-ancestor
153678889|NCT00206713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153678890|NCT00040040|Bupropion|bupropion|mesh-list
153678891|NCT00040040|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
153678892|NCT00040040|Antidepressive Agents|antidepressive agents|mesh-ancestor
153678893|NCT00040040|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153678894|NCT00040040|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
153678895|NCT00040040|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153678896|NCT00040040|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153678897|NCT00040040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153678898|NCT00040040|Dopamine Agents|dopamine agents|mesh-ancestor
153678899|NCT00040040|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153678900|NCT00040040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153678901|NCT00040040|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
153678902|NCT00040040|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153678903|NCT00040040|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153678939|NCT00040157|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153678940|NCT00040157|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153678941|NCT00040157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153678942|NCT00040157|Antiviral Agents|antiviral agents|mesh-ancestor
153678943|NCT00040157|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153678944|NCT00040157|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153678945|NCT00040157|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153678946|NCT00206947|Ziprasidone|ziprasidone|mesh-list
153678947|NCT00206947|Donepezil|donepezil|mesh-list
153678948|NCT00206947|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
153678949|NCT00206947|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153678950|NCT00206947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153678951|NCT00206947|Cholinergic Agents|cholinergic agents|mesh-ancestor
153678952|NCT00206947|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153678953|NCT00206947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153678954|NCT00206947|Nootropic Agents|nootropic agents|mesh-ancestor
153678955|NCT00206947|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153678956|NCT00206947|Serotonin Agents|serotonin agents|mesh-ancestor
153678957|NCT00206947|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153678958|NCT00206947|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153678959|NCT00206947|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153678960|NCT00206947|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153678961|NCT00206947|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
153678962|NCT00206947|Dopamine Agents|dopamine agents|mesh-ancestor
153678963|NCT00068757|Paclitaxel|paclitaxel|mesh-list
153678964|NCT00068757|Trastuzumab|trastuzumab|mesh-list
153678965|NCT00068757|Lonafarnib|lonafarnib|mesh-list
153678966|NCT00068757|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153678967|NCT00068757|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153678986|NCT00206986|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153678987|NCT00206986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153678988|NCT00207064|Quetiapine Fumarate|quetiapine fumarate|mesh-list
153678989|NCT00207064|Antidepressive Agents|antidepressive agents|mesh-ancestor
153678990|NCT00207064|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153678991|NCT00207064|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153678992|NCT00207064|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153678993|NCT00207064|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153678994|NCT00207064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153678995|NCT00040274|Dexelvucitabine|dexelvucitabine|mesh-list
153678996|NCT00040274|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153678997|NCT00040274|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153678998|NCT00040274|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153678999|NCT00040274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153679000|NCT00040274|Antiviral Agents|antiviral agents|mesh-ancestor
153679001|NCT00040274|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153679002|NCT00040274|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153679003|NCT00040274|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153679004|NCT00072852|Irinotecan|irinotecan|mesh-list
153679005|NCT00072852|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
153679006|NCT00072852|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153679007|NCT00072852|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153679008|NCT00072852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153679009|NCT00072852|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153679010|NCT00207532|Folic Acid|folic acid|mesh-list
153679011|NCT00207532|Hematinics|hematinics|mesh-ancestor
153679012|NCT00207532|Vitamin B Complex|vitamin b complex|mesh-ancestor
153679013|NCT00207532|Vitamins|vitamins|mesh-ancestor
153679014|NCT00207532|Micronutrients|micronutrients|mesh-ancestor
153679015|NCT00207532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153679016|NCT00040391|Leucovorin|leucovorin|mesh-list
153679017|NCT00040391|Fluorouracil|fluorouracil|mesh-list
153679029|NCT00040391|Antidotes|antidotes|mesh-ancestor
153679030|NCT00040391|Protective Agents|protective agents|mesh-ancestor
153679031|NCT00040391|Vitamin B Complex|vitamin b complex|mesh-ancestor
153679032|NCT00040391|Vitamins|vitamins|mesh-ancestor
153679033|NCT00040391|Micronutrients|micronutrients|mesh-ancestor
153679034|NCT00207688|Infliximab|infliximab|mesh-list
153679035|NCT00207688|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
153679036|NCT00207688|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153679037|NCT00207688|Dermatologic Agents|dermatologic agents|mesh-ancestor
153679038|NCT00207688|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153679039|NCT00207688|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153679040|NCT00207766|Infliximab|infliximab|mesh-list
153679041|NCT00207766|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
153679042|NCT00207766|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153679043|NCT00207766|Dermatologic Agents|dermatologic agents|mesh-ancestor
153679044|NCT00207766|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153679046|NCT00040469|Cyclophosphamide|cyclophosphamide|mesh-list
153679047|NCT00040469|Busulfan|busulfan|mesh-list
153679048|NCT00040469|Alemtuzumab|alemtuzumab|mesh-list
153679049|NCT00040469|Phenytoin|phenytoin|mesh-list
153679050|NCT00040469|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153679051|NCT00040469|Immunologic Factors|immunologic factors|mesh-ancestor
153679052|NCT00040469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153679053|NCT00040469|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153679054|NCT00040469|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153679055|NCT00040469|Alkylating Agents|alkylating agents|mesh-ancestor
153679056|NCT00040469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153679057|NCT00040469|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153679058|NCT00040469|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153679059|NCT00040469|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153679060|NCT00040469|Anticonvulsants|anticonvulsants|mesh-ancestor
153679061|NCT00040469|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
153679062|NCT00040469|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153679063|NCT00040469|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153679064|NCT00040469|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
153679065|NCT00040469|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
153679067|NCT00207844|Selenious Acid|selenious acid|mesh-list
153679068|NCT00207844|Sodium Selenite|sodium selenite|mesh-list
153679069|NCT00207844|Antioxidants|antioxidants|mesh-ancestor
153679070|NCT00207844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153679071|NCT00207844|Protective Agents|protective agents|mesh-ancestor
153679072|NCT00207844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153679073|NCT00207844|Trace Elements|trace elements|mesh-ancestor
153679074|NCT00207844|Micronutrients|micronutrients|mesh-ancestor
153679075|NCT00072930|Zoledronic Acid|zoledronic acid|mesh-list
153679076|NCT00072930|Prednisone|prednisone|mesh-list
153679077|NCT00072930|Docetaxel|docetaxel|mesh-list
153679078|NCT00072930|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153679132|NCT02962921|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153679133|NCT02962921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153679135|NCT00040586|Antibodies|antibodies|mesh-list
153679136|NCT00040586|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
153679137|NCT00040586|Immunologic Factors|immunologic factors|mesh-ancestor
153679138|NCT00040586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153679139|NCT00040586|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153679140|NCT00040586|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153679141|NCT00040586|Analgesics|analgesics|mesh-ancestor
153679142|NCT00040586|Sensory System Agents|sensory system agents|mesh-ancestor
153679143|NCT00040586|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153679144|NCT00208117|Sertraline|sertraline|mesh-list
153679145|NCT00208117|Simvastatin|simvastatin|mesh-list
153679146|NCT00208117|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153679147|NCT00208117|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153679148|NCT00208117|Antimetabolites|antimetabolites|mesh-ancestor
153679149|NCT00208117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153679150|NCT00208117|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153679151|NCT00208117|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
153679185|NCT00208195|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153679186|NCT00208195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153679187|NCT00208195|GABA Agents|gaba agents|mesh-ancestor
153679188|NCT00208195|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153679189|NCT00208195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153679190|NCT00208195|Antimanic Agents|antimanic agents|mesh-ancestor
153679191|NCT00208195|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153679192|NCT00208195|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153679193|NCT00208195|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153679194|NCT00208234|Omalizumab|omalizumab|mesh-list
153679195|NCT00208234|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
153679196|NCT00208234|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
153679197|NCT00208234|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153679198|NCT00208234|Respiratory System Agents|respiratory system agents|mesh-ancestor
153679199|NCT00208234|Immunologic Factors|immunologic factors|mesh-ancestor
153679200|NCT00208234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153679201|NCT00208273|Letrozole|letrozole|mesh-list
153679202|NCT00208273|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153679203|NCT00208273|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
153679204|NCT00208273|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153679205|NCT00208273|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153679206|NCT00208273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153679207|NCT00208273|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
153679208|NCT00208273|Hormone Antagonists|hormone antagonists|mesh-ancestor
153679209|NCT00208273|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153679210|NCT00208273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153679211|NCT00208312|Adenosine|adenosine|mesh-list
153679212|NCT00208312|Regadenoson|regadenoson|mesh-list
153679213|NCT00208312|Analgesics|analgesics|mesh-ancestor
153679214|NCT00208312|Sensory System Agents|sensory system agents|mesh-ancestor
153679215|NCT00208312|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153679216|NCT00208312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153679217|NCT00208312|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153679218|NCT00208312|Vasodilator Agents|vasodilator agents|mesh-ancestor
153679219|NCT00208312|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
153679220|NCT00208312|Purinergic Agonists|purinergic agonists|mesh-ancestor
153360719|NCT01368263|Anastrozole|anastrozole|mesh-list
153360720|NCT01368263|Goserelin|goserelin|mesh-list
153679221|NCT00208312|Purinergic Agents|purinergic agents|mesh-ancestor
153679222|NCT00208312|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153679223|NCT00208312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153679224|NCT00208312|Adenosine A2 Receptor Agonists|adenosine a2 receptor agonists|mesh-ancestor
153679226|NCT00040781|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153679227|NCT00040781|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153679228|NCT00040781|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153679229|NCT00040781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153679230|NCT00040781|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153679231|NCT00068952|Temozolomide|temozolomide|mesh-list
153679232|NCT00068952|Carmustine|carmustine|mesh-list
153679233|NCT00068952|Lomustine|lomustine|mesh-list
153679234|NCT00068952|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153679235|NCT00068952|Alkylating Agents|alkylating agents|mesh-ancestor
153679236|NCT00068952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153679237|NCT00068952|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153679238|NCT00040820|Oxaliplatin|oxaliplatin|mesh-list
153679239|NCT00040820|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153679276|NCT00208702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153679277|NCT00208702|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153679278|NCT00208702|Serotonin Agents|serotonin agents|mesh-ancestor
153679279|NCT00208702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153679280|NCT00208741|Tiagabine|tiagabine|mesh-list
153679281|NCT00208741|Anticonvulsants|anticonvulsants|mesh-ancestor
153679282|NCT00208741|GABA Uptake Inhibitors|gaba uptake inhibitors|mesh-ancestor
153679283|NCT00208741|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153679284|NCT00208741|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153679285|NCT00208741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153679286|NCT00208741|GABA Agents|gaba agents|mesh-ancestor
153679287|NCT00208741|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153679288|NCT00208741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153679289|NCT00399048|Hydromorphone|hydromorphone|mesh-list
153679290|NCT00399048|Oxycodone|oxycodone|mesh-list
153679291|NCT00399048|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153679292|NCT00399048|Narcotics|narcotics|mesh-ancestor
153679293|NCT00399048|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153679294|NCT00399048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153679295|NCT00399048|Analgesics|analgesics|mesh-ancestor
153679296|NCT00399048|Sensory System Agents|sensory system agents|mesh-ancestor
153679297|NCT00399048|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153679298|NCT00208819|Valproic Acid|valproic acid|mesh-list
153679299|NCT00208819|Olanzapine|olanzapine|mesh-list
153679300|NCT00208819|Risperidone|risperidone|mesh-list
153679301|NCT00208819|Quetiapine Fumarate|quetiapine fumarate|mesh-list
153679302|NCT00208819|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153679303|NCT00208819|Serotonin Agents|serotonin agents|mesh-ancestor
153679304|NCT00208819|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153679306|NCT00208819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153679320|NCT00208819|Antidepressive Agents|antidepressive agents|mesh-ancestor
153679321|NCT00208819|Anticonvulsants|anticonvulsants|mesh-ancestor
153679322|NCT00208819|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153679323|NCT00208819|GABA Agents|gaba agents|mesh-ancestor
153679324|NCT00208819|Antimanic Agents|antimanic agents|mesh-ancestor
153679325|NCT00208858|Topiramate|topiramate|mesh-list
153679326|NCT00208858|Anticonvulsants|anticonvulsants|mesh-ancestor
153679327|NCT00208858|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153679328|NCT00208858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153679329|NCT00041015|Etoposide|etoposide|mesh-list
153679330|NCT00041015|Topotecan|topotecan|mesh-list
153679331|NCT00041015|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153679332|NCT00041015|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153679333|NCT00041015|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153679334|NCT00041015|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153679335|NCT00041015|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153679336|NCT00041015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153679337|NCT00041015|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
153679338|NCT00073047|Daclizumab|daclizumab|mesh-list
153679339|NCT00073047|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153679340|NCT00073047|Immunologic Factors|immunologic factors|mesh-ancestor
153679341|NCT00073047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153679342|NCT00208897|Fluoxetine|fluoxetine|mesh-list
153679343|NCT00208897|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
153679344|NCT00208897|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153679369|NCT00209014|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153679370|NCT00209014|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153679371|NCT00209014|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153679372|NCT00209014|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153679373|NCT00209014|Growth Substances|growth substances|mesh-ancestor
153679374|NCT00209014|Growth Inhibitors|growth inhibitors|mesh-ancestor
153679375|NCT00209014|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153679376|NCT00041054|Sulindac sulfone|sulindac sulfone|mesh-list
153679377|NCT00041054|Carboplatin|carboplatin|mesh-list
153679378|NCT00041054|Etoposide|etoposide|mesh-list
153679379|NCT00041054|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153679380|NCT00041054|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153679381|NCT00041054|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153679382|NCT00041054|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153679383|NCT00041054|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153679384|NCT00041054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153679385|NCT00041054|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
153679428|NCT00209209|Antimitotic Agents|antimitotic agents|mesh-ancestor
153679429|NCT00209209|Mitosis Modulators|mitosis modulators|mesh-ancestor
153679430|NCT00041093|Docetaxel|docetaxel|mesh-list
153679431|NCT00041093|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153679432|NCT00041093|Tubulin Modulators|tubulin modulators|mesh-ancestor
153679433|NCT00041093|Antimitotic Agents|antimitotic agents|mesh-ancestor
153679434|NCT00041093|Mitosis Modulators|mitosis modulators|mesh-ancestor
153679435|NCT00041093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153679436|NCT00399087|Prednisone|prednisone|mesh-list
153679437|NCT00399087|Docetaxel|docetaxel|mesh-list
153679438|NCT00399087|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153679439|NCT00399087|Tubulin Modulators|tubulin modulators|mesh-ancestor
153679440|NCT00399087|Antimitotic Agents|antimitotic agents|mesh-ancestor
153679441|NCT00399087|Mitosis Modulators|mitosis modulators|mesh-ancestor
153679442|NCT00399087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153679443|NCT00399087|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153679444|NCT00399087|Glucocorticoids|glucocorticoids|mesh-ancestor
153679445|NCT00399087|Hormones|hormones|mesh-ancestor
153679487|NCT00209716|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153679488|NCT00209716|Tubulin Modulators|tubulin modulators|mesh-ancestor
153679489|NCT00209716|Antimitotic Agents|antimitotic agents|mesh-ancestor
153679490|NCT00209716|Mitosis Modulators|mitosis modulators|mesh-ancestor
153679491|NCT00209716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153679492|NCT00209716|Antimetabolites|antimetabolites|mesh-ancestor
153679493|NCT00209716|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153679494|NCT00209716|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153679495|NCT00209716|Immunologic Factors|immunologic factors|mesh-ancestor
153679496|NCT00209716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153679497|NCT00209755|Ribavirin|ribavirin|mesh-list
153679498|NCT00209755|Antimetabolites|antimetabolites|mesh-ancestor
153679499|NCT00209755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153679500|NCT00209755|Antiviral Agents|antiviral agents|mesh-ancestor
153679501|NCT00209755|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153679502|NCT00209794|Pyrimethamine|pyrimethamine|mesh-list
153679503|NCT00209794|Sulfadoxine|sulfadoxine|mesh-list
153679504|NCT00209794|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
153679505|NCT00209794|Antimalarials|antimalarials|mesh-ancestor
153679506|NCT00209794|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153679507|NCT00209794|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153679508|NCT00209794|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153679509|NCT00209794|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153679510|NCT00209794|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153679540|NCT00041210|Mechlorethamine|mechlorethamine|mesh-list
153679541|NCT00041210|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153679542|NCT00041210|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153679543|NCT00041210|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153679544|NCT00041210|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153679545|NCT00041210|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153679546|NCT00041210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153679547|NCT00041210|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153679548|NCT00041210|Glucocorticoids|glucocorticoids|mesh-ancestor
153679550|NCT00041210|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153679551|NCT00041210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153679552|NCT00041210|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153679553|NCT00041210|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153679554|NCT00041210|Tubulin Modulators|tubulin modulators|mesh-ancestor
153679555|NCT00041210|Antimitotic Agents|antimitotic agents|mesh-ancestor
153679556|NCT00041210|Mitosis Modulators|mitosis modulators|mesh-ancestor
153679557|NCT00041210|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153679558|NCT00041210|Alkylating Agents|alkylating agents|mesh-ancestor
153679559|NCT00209872|Lidocaine|lidocaine|mesh-list
153679560|NCT00209872|Ketamine|ketamine|mesh-list
153679561|NCT00209872|Gabapentin|gabapentin|mesh-list
153679562|NCT00209872|Esketamine|esketamine|mesh-list
153679563|NCT00209872|Anesthetics, Local|anesthetics, local|mesh-ancestor
153679564|NCT00209872|Anesthetics|anesthetics|mesh-ancestor
153679565|NCT00209872|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153679566|NCT00209872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153679567|NCT00209872|Sensory System Agents|sensory system agents|mesh-ancestor
153679568|NCT00209872|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153679569|NCT00209872|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153679570|NCT00209872|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
153679571|NCT00209872|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153679572|NCT00209872|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153679574|NCT00209872|Analgesics|analgesics|mesh-ancestor
153679580|NCT00209872|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153679581|NCT00209872|Anticonvulsants|anticonvulsants|mesh-ancestor
153679582|NCT00209872|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153679583|NCT00209872|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153679584|NCT00209872|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153679585|NCT00209872|Antimanic Agents|antimanic agents|mesh-ancestor
153679586|NCT00209872|Antidepressive Agents|antidepressive agents|mesh-ancestor
153679587|NCT00209950|Gaboxadol|gaboxadol|mesh-list
153679588|NCT00209950|Analgesics|analgesics|mesh-ancestor
153679589|NCT00209950|Sensory System Agents|sensory system agents|mesh-ancestor
153679590|NCT00209950|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153679591|NCT00209950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153679592|NCT00209950|Anticonvulsants|anticonvulsants|mesh-ancestor
153679593|NCT00209950|GABA Agonists|gaba agonists|mesh-ancestor
153679594|NCT00209950|GABA Agents|gaba agents|mesh-ancestor
153679595|NCT00209950|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153679596|NCT00209950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153679597|NCT00209989|Tipifarnib|tipifarnib|mesh-list
153679598|NCT00209989|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153679599|NCT00210028|Tamoxifen|tamoxifen|mesh-list
153679600|NCT00210028|Tipifarnib|tipifarnib|mesh-list
153679601|NCT00210028|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
153679602|NCT00210028|Hormone Antagonists|hormone antagonists|mesh-ancestor
153679603|NCT00210028|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153679604|NCT00210028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153679605|NCT00210028|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153679606|NCT00210028|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153679607|NCT00210028|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
153679608|NCT00210028|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
153679609|NCT00210028|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153679610|NCT00041288|Cyclosporine|cyclosporine|mesh-list
153679611|NCT00041288|Mycophenolic Acid|mycophenolic acid|mesh-list
153679612|NCT00041288|Cyclophosphamide|cyclophosphamide|mesh-list
153679613|NCT00041288|Methotrexate|methotrexate|mesh-list
153679624|NCT00041288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153679625|NCT00041288|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153679626|NCT00041288|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153679627|NCT00041288|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
153679628|NCT00041288|Abortifacient Agents|abortifacient agents|mesh-ancestor
153679629|NCT00041288|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153679630|NCT00041288|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153679632|NCT00041288|Dermatologic Agents|dermatologic agents|mesh-ancestor
153679633|NCT00041288|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153679634|NCT00041288|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153679635|NCT00041288|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153679636|NCT00041288|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
153679637|NCT00041288|Antifungal Agents|antifungal agents|mesh-ancestor
153679638|NCT00041288|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153679639|NCT00041288|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153679640|NCT00041288|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
153679641|NCT00041288|Antitubercular Agents|antitubercular agents|mesh-ancestor
153679642|NCT00041288|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153679643|NCT00073164|Valproic Acid|valproic acid|mesh-list
153679644|NCT00073164|Olanzapine|olanzapine|mesh-list
153679645|NCT00073164|Risperidone|risperidone|mesh-list
153432330|NCT05044429|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153891280|NCT06055335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153891281|NCT06055257|Clodronic Acid|clodronic acid|mesh-list
153891282|NCT06055257|Tocopherols|tocopherols|mesh-list
153891283|NCT06055257|Pentoxifylline|pentoxifylline|mesh-list
153891284|NCT06055257|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
153891285|NCT06055257|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153891286|NCT06055257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153891287|NCT06055257|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153891288|NCT06055257|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
153891289|NCT06055257|Protective Agents|protective agents|mesh-ancestor
153891290|NCT06055257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153891291|NCT06055257|Vasodilator Agents|vasodilator agents|mesh-ancestor
153891292|NCT06055257|Free Radical Scavengers|free radical scavengers|mesh-ancestor
153679647|NCT00073164|Serotonin Agents|serotonin agents|mesh-ancestor
153679648|NCT00073164|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153679649|NCT00073164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153679650|NCT00073164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153679651|NCT00073164|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153679652|NCT00073164|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153679653|NCT00073164|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153679654|NCT00073164|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153679655|NCT00073164|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
153679656|NCT00073164|Dopamine Agents|dopamine agents|mesh-ancestor
153679657|NCT00073164|Antiemetics|antiemetics|mesh-ancestor
153679658|NCT00073164|Autonomic Agents|autonomic agents|mesh-ancestor
153679659|NCT00073164|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153679660|NCT00073164|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153679661|NCT00073164|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
153679662|NCT00073164|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153679663|NCT00073164|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153679665|NCT00073164|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153679666|NCT00073164|GABA Agents|gaba agents|mesh-ancestor
153679667|NCT00073164|Antimanic Agents|antimanic agents|mesh-ancestor
153679668|NCT00210301|Modafinil|modafinil|mesh-list
153679669|NCT00210301|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
153679670|NCT00210301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153679671|NCT00210301|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
153679672|NCT00210301|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
153679673|NCT00210301|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
153679674|NCT00210301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153679675|NCT00210340|Rituximab|rituximab|mesh-list
153679676|NCT00210340|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153679677|NCT00210340|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153679678|NCT00210340|Immunologic Factors|immunologic factors|mesh-ancestor
153679679|NCT00210340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153679680|NCT00210340|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153679681|NCT00411541|Dexamethasone|dexamethasone|mesh-list
153679682|NCT00411541|Vincristine|vincristine|mesh-list
153679683|NCT00411541|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153679684|NCT00411541|Antiemetics|antiemetics|mesh-ancestor
153679685|NCT00411541|Autonomic Agents|autonomic agents|mesh-ancestor
153679706|NCT00210379|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
153679707|NCT00210379|Abortifacient Agents|abortifacient agents|mesh-ancestor
153679708|NCT00210379|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153679709|NCT00210379|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153679710|NCT00210379|Antimetabolites|antimetabolites|mesh-ancestor
153679711|NCT00210379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153679712|NCT00210379|Dermatologic Agents|dermatologic agents|mesh-ancestor
153679713|NCT00210379|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153679714|NCT00210379|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153679715|NCT00210379|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153679716|NCT00210379|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153679717|NCT00041327|Interferons|interferons|mesh-list
153679718|NCT00041327|Interferon-alpha|interferon-alpha|mesh-list
153679719|NCT00041327|Lamivudine|lamivudine|mesh-list
153679720|NCT00041327|Zidovudine|zidovudine|mesh-list
153679721|NCT00041327|Prednisone|prednisone|mesh-list
153679722|NCT00041327|Cyclophosphamide|cyclophosphamide|mesh-list
153679723|NCT00041327|Doxorubicin|doxorubicin|mesh-list
153679724|NCT00041327|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
153679725|NCT00041327|Etoposide|etoposide|mesh-list
153679726|NCT00041327|Vincristine|vincristine|mesh-list
153679727|NCT00041327|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153679728|NCT00041327|Immunologic Factors|immunologic factors|mesh-ancestor
153679729|NCT00041327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153679730|NCT00041327|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153679731|NCT00041327|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153679732|NCT00041327|Alkylating Agents|alkylating agents|mesh-ancestor
153679733|NCT00041327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153679734|NCT00041327|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153679735|NCT00041327|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153679736|NCT00041327|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153679737|NCT00041327|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153679738|NCT00041327|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153679739|NCT00041327|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153679740|NCT00041327|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153679741|NCT00041327|Glucocorticoids|glucocorticoids|mesh-ancestor
153679742|NCT00041327|Hormones|hormones|mesh-ancestor
153360721|NCT01368263|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153679744|NCT00041327|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153679745|NCT00041327|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153679746|NCT00041327|Antiviral Agents|antiviral agents|mesh-ancestor
153679747|NCT00041327|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153679748|NCT00041327|Tubulin Modulators|tubulin modulators|mesh-ancestor
153679749|NCT00041327|Antimitotic Agents|antimitotic agents|mesh-ancestor
153679750|NCT00041327|Mitosis Modulators|mitosis modulators|mesh-ancestor
153679751|NCT00041327|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153679752|NCT00041327|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153679753|NCT00041327|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153679754|NCT00041327|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153679755|NCT00041327|Antimetabolites|antimetabolites|mesh-ancestor
153679757|NCT00210457|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153679758|NCT00210496|Topiramate|topiramate|mesh-list
153679759|NCT00210496|Almotriptan|almotriptan|mesh-list
153679760|NCT00210496|Anticonvulsants|anticonvulsants|mesh-ancestor
153679761|NCT00210496|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153679762|NCT00210496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153679763|NCT00210496|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
153679764|NCT00210496|Serotonin Agents|serotonin agents|mesh-ancestor
153679765|NCT00210496|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153679766|NCT00210496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153679767|NCT00210535|Topiramate|topiramate|mesh-list
153679768|NCT00210535|Anticonvulsants|anticonvulsants|mesh-ancestor
153679795|NCT00210769|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
153679796|NCT00210769|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153679797|NCT00210769|Serotonin Agents|serotonin agents|mesh-ancestor
153679798|NCT00210769|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153679799|NCT00210769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153679800|NCT00210769|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
153679801|NCT00210769|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
153679802|NCT00210769|Dopamine Agents|dopamine agents|mesh-ancestor
153679804|NCT00210808|Anticonvulsants|anticonvulsants|mesh-ancestor
153679805|NCT00210808|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153679806|NCT00210808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153679807|NCT00210847|Acetaminophen|acetaminophen|mesh-list
153679808|NCT00210847|Tramadol|tramadol|mesh-list
153679809|NCT00210847|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153679810|NCT00210847|Analgesics|analgesics|mesh-ancestor
153679811|NCT00210847|Sensory System Agents|sensory system agents|mesh-ancestor
153679812|NCT00210847|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153679813|NCT00210847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153679814|NCT00210847|Antipyretics|antipyretics|mesh-ancestor
153679815|NCT00210847|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153679816|NCT00210847|Narcotics|narcotics|mesh-ancestor
153679817|NCT00210847|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153679818|NCT00210886|Levofloxacin|levofloxacin|mesh-list
153679819|NCT00210886|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
153679820|NCT00210886|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153679821|NCT00210886|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153679822|NCT00210886|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153679823|NCT00210886|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153679824|NCT00210886|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153679825|NCT00210886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153679826|NCT00210886|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153679827|NCT00210886|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
153679838|NCT00211198|Denileukin diftitox|denileukin diftitox|mesh-list
153679839|NCT00211198|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153679840|NCT00211276|Denileukin diftitox|denileukin diftitox|mesh-list
153679841|NCT00211276|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153679842|NCT00211315|Anecortave|anecortave|mesh-list
153679843|NCT00211315|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153679844|NCT00211315|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153679845|NCT00211315|Growth Substances|growth substances|mesh-ancestor
153516745|NCT01437826|Protective Agents|protective agents|mesh-ancestor
153679846|NCT00211315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153679847|NCT00211315|Growth Inhibitors|growth inhibitors|mesh-ancestor
153679848|NCT00211315|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153679850|NCT00211354|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153679851|NCT00211354|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153679852|NCT00211354|Growth Substances|growth substances|mesh-ancestor
153679853|NCT00211354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153679854|NCT00211354|Growth Inhibitors|growth inhibitors|mesh-ancestor
153679855|NCT00211354|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153679856|NCT00211393|Ketoconazole|ketoconazole|mesh-list
153679857|NCT00211393|Antifungal Agents|antifungal agents|mesh-ancestor
153679858|NCT00211393|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153679859|NCT00211393|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
153679888|NCT00211588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153679890|NCT00211588|Autonomic Agents|autonomic agents|mesh-ancestor
153679891|NCT00211588|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153679892|NCT00211588|Nootropic Agents|nootropic agents|mesh-ancestor
153679893|NCT00211705|Pravastatin|pravastatin|mesh-list
153679894|NCT00211705|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153679895|NCT00211705|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153679896|NCT00211705|Antimetabolites|antimetabolites|mesh-ancestor
153679897|NCT00211705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153679898|NCT00211705|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153679899|NCT00211705|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
153679900|NCT00211705|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153679901|NCT00211744|Topiramate|topiramate|mesh-list
153679902|NCT00211744|Anticonvulsants|anticonvulsants|mesh-ancestor
153679903|NCT00211744|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153679904|NCT00211744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153679905|NCT00211939|Atorvastatin|atorvastatin|mesh-list
153679906|NCT00211939|Calcium|calcium|mesh-list
153679907|NCT00211939|Sevelamer|sevelamer|mesh-list
153679908|NCT00211939|Calcium acetate|calcium acetate|mesh-list
153679909|NCT00211939|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153679910|NCT00211939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153679911|NCT00211939|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153679912|NCT00211939|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153679913|NCT00211939|Antimetabolites|antimetabolites|mesh-ancestor
153679914|NCT00211939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153679915|NCT00211939|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153679934|NCT00212095|Docetaxel|docetaxel|mesh-list
153679935|NCT00212095|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153679936|NCT00212095|Tubulin Modulators|tubulin modulators|mesh-ancestor
153679937|NCT00212095|Antimitotic Agents|antimitotic agents|mesh-ancestor
153679938|NCT00212095|Mitosis Modulators|mitosis modulators|mesh-ancestor
153679939|NCT00212095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153679940|NCT00212095|Antifungal Agents|antifungal agents|mesh-ancestor
153679941|NCT00212095|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153679942|NCT00212095|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
153679943|NCT00212095|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153679944|NCT00212095|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153679945|NCT00212095|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153679946|NCT00212095|Hormone Antagonists|hormone antagonists|mesh-ancestor
153679947|NCT00212095|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153679948|NCT00212095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153679949|NCT00212095|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
153679950|NCT00212173|Sibutramine|sibutramine|mesh-list
153679951|NCT00212173|Antidepressive Agents|antidepressive agents|mesh-ancestor
153679952|NCT00212173|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153679953|NCT00212173|Appetite Depressants|appetite depressants|mesh-ancestor
153679954|NCT00212173|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
153679955|NCT00212212|Selenium|selenium|mesh-list
153679956|NCT00212212|Antioxidants|antioxidants|mesh-ancestor
153679957|NCT00212212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153679958|NCT00212212|Protective Agents|protective agents|mesh-ancestor
153679959|NCT00212212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153679960|NCT00212212|Trace Elements|trace elements|mesh-ancestor
153679961|NCT00212212|Micronutrients|micronutrients|mesh-ancestor
153679962|NCT00212290|Pioglitazone|pioglitazone|mesh-list
153679963|NCT00212290|Nateglinide|nateglinide|mesh-list
153679964|NCT00212290|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153679965|NCT00212290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153679966|NCT00073203|Paroxetine|paroxetine|mesh-list
153679967|NCT00073203|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
153679968|NCT00073203|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153679972|NCT00073203|Serotonin Agents|serotonin agents|mesh-ancestor
153679973|NCT00073203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153679974|NCT00073203|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
153679975|NCT00073203|Antidepressive Agents|antidepressive agents|mesh-ancestor
153679976|NCT00073203|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153679977|NCT00073203|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
153679978|NCT00073203|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153679979|NCT00073203|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153679980|NCT00411736|Azithromycin|azithromycin|mesh-list
153679981|NCT00411736|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153679982|NCT00411736|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153679983|NCT00212602|Aprepitant|aprepitant|mesh-list
153679984|NCT00212602|Fosaprepitant|fosaprepitant|mesh-list
153679985|NCT00212602|Antiemetics|antiemetics|mesh-ancestor
153679986|NCT00212602|Autonomic Agents|autonomic agents|mesh-ancestor
153679987|NCT00212602|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153679988|NCT00212602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153679989|NCT00212602|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153679990|NCT00212602|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
153679991|NCT00212602|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153679992|NCT00212602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153680024|NCT00213226|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153680025|NCT00213226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153680026|NCT00213226|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153680027|NCT00213226|Glucocorticoids|glucocorticoids|mesh-ancestor
153680028|NCT00213226|Hormones|hormones|mesh-ancestor
153680029|NCT00213226|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153680030|NCT00213226|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153680031|NCT00213226|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153680032|NCT00213265|Vaccines|vaccines|mesh-list
153680033|NCT00213265|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
153680034|NCT00213265|Immunologic Factors|immunologic factors|mesh-ancestor
153680035|NCT00213265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153680036|NCT00213538|Methotrexate|methotrexate|mesh-list
153680037|NCT00213538|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
153680038|NCT00213538|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
153680039|NCT00213538|Abortifacient Agents|abortifacient agents|mesh-ancestor
153680040|NCT00213538|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153680041|NCT00213538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153680042|NCT00213538|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153680076|NCT00213694|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153680077|NCT00213694|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153680078|NCT00214084|Allopurinol|allopurinol|mesh-list
153680079|NCT00214084|Antimetabolites|antimetabolites|mesh-ancestor
153680080|NCT00214084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153680081|NCT00214084|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153680082|NCT00214084|Gout Suppressants|gout suppressants|mesh-ancestor
153680083|NCT00214084|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153680084|NCT00214084|Free Radical Scavengers|free radical scavengers|mesh-ancestor
153680086|NCT00214084|Protective Agents|protective agents|mesh-ancestor
153680087|NCT00214084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153680088|NCT00214240|Immunoglobulins|immunoglobulins|mesh-list
153680089|NCT00214240|Antibodies|antibodies|mesh-list
153680090|NCT00214240|gamma-Globulins|gamma-globulins|mesh-list
153680091|NCT00214240|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
153680092|NCT00214240|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
153680093|NCT00214240|Immunologic Factors|immunologic factors|mesh-ancestor
153680094|NCT00214240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153680095|NCT00214318|Metoprolol|metoprolol|mesh-list
153680096|NCT00214318|Carvedilol|carvedilol|mesh-list
153680097|NCT00214318|Terbutaline|terbutaline|mesh-list
153680098|NCT00214318|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153680099|NCT00214318|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153680100|NCT00214318|Sympatholytics|sympatholytics|mesh-ancestor
153680101|NCT00214318|Autonomic Agents|autonomic agents|mesh-ancestor
153680102|NCT00214318|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153680103|NCT00214318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153680104|NCT00214318|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
153680105|NCT00214318|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
153680106|NCT00214318|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
153680107|NCT00214318|Adrenergic Agents|adrenergic agents|mesh-ancestor
153680108|NCT00214318|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153680109|NCT00214318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153680110|NCT00214318|Antioxidants|antioxidants|mesh-ancestor
153680111|NCT00214318|Protective Agents|protective agents|mesh-ancestor
153680112|NCT00214318|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153680113|NCT00214318|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153680114|NCT00214318|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153680115|NCT00214318|Vasodilator Agents|vasodilator agents|mesh-ancestor
153680116|NCT00214318|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
153680117|NCT00214318|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
153680118|NCT00214318|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153680119|NCT00214318|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153680120|NCT00214318|Respiratory System Agents|respiratory system agents|mesh-ancestor
153680121|NCT00214318|Sympathomimetics|sympathomimetics|mesh-ancestor
153680122|NCT00214318|Tocolytic Agents|tocolytic agents|mesh-ancestor
153680123|NCT00214318|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153680124|NCT00214318|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
153680125|NCT00214318|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
153680126|NCT00214318|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153680127|NCT00214435|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
153680128|NCT00214435|Antiviral Agents|antiviral agents|mesh-ancestor
153680129|NCT00214435|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153680130|NCT00214552|Rabeprazole|rabeprazole|mesh-list
153680131|NCT00214552|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
153680132|NCT00214552|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153680133|NCT00214552|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
153680134|NCT00214552|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153680135|NCT00214552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153680137|NCT00069459|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
153680138|NCT00069459|Antidepressive Agents|antidepressive agents|mesh-ancestor
153680139|NCT00069459|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153680140|NCT00069459|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
153680141|NCT00069459|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153680142|NCT00069459|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153680143|NCT00069459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153680144|NCT00069459|Dopamine Agents|dopamine agents|mesh-ancestor
153680145|NCT00069459|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153680146|NCT00069459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153680147|NCT00069459|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
153680149|NCT00069459|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153680150|NCT00214630|Atorvastatin|atorvastatin|mesh-list
153680151|NCT00214630|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
153680152|NCT00214630|Calcium|calcium|mesh-list
153680153|NCT00214630|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153680154|NCT00214630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153680155|NCT00214630|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153680156|NCT00214630|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153680157|NCT00214630|Antimetabolites|antimetabolites|mesh-ancestor
153680158|NCT00214630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153680159|NCT00214630|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153680160|NCT00214630|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
153680161|NCT00214630|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153680162|NCT00214825|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
153680163|NCT00214825|Eplerenone|eplerenone|mesh-list
153680164|NCT00214825|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153680165|NCT00214825|Diuretics|diuretics|mesh-ancestor
153680166|NCT00214825|Natriuretic Agents|natriuretic agents|mesh-ancestor
153680167|NCT00214825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153680168|NCT00214825|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
153680169|NCT00214825|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153680170|NCT00214825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153680171|NCT00214825|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
153680172|NCT00214825|Hormone Antagonists|hormone antagonists|mesh-ancestor
153680173|NCT00214825|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153680174|NCT00214825|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
153680175|NCT00214864|Docetaxel|docetaxel|mesh-list
153680176|NCT00214864|Capecitabine|capecitabine|mesh-list
153680177|NCT00214864|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153680178|NCT00214864|Tubulin Modulators|tubulin modulators|mesh-ancestor
153680179|NCT00214864|Antimitotic Agents|antimitotic agents|mesh-ancestor
153680180|NCT00214864|Mitosis Modulators|mitosis modulators|mesh-ancestor
153680181|NCT00214864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153680182|NCT00214864|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153680183|NCT00214864|Antimetabolites|antimetabolites|mesh-ancestor
153680184|NCT00214942|Fentanyl|fentanyl|mesh-list
153680188|NCT00214942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153680189|NCT00214942|Analgesics|analgesics|mesh-ancestor
153680190|NCT00214942|Sensory System Agents|sensory system agents|mesh-ancestor
153680191|NCT00214942|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153680192|NCT00214942|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153680193|NCT00214942|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153680194|NCT00214942|Anesthetics, General|anesthetics, general|mesh-ancestor
153680195|NCT00214942|Anesthetics|anesthetics|mesh-ancestor
153680196|NCT00069498|Aminosalicylic Acid|aminosalicylic acid|mesh-list
153680197|NCT00069498|Mesalamine|mesalamine|mesh-list
153680198|NCT00069498|Antitubercular Agents|antitubercular agents|mesh-ancestor
153680199|NCT00069498|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153680200|NCT00069498|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153680201|NCT00069498|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153680202|NCT00069498|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153680203|NCT00069498|Analgesics|analgesics|mesh-ancestor
153680204|NCT00069498|Sensory System Agents|sensory system agents|mesh-ancestor
153680205|NCT00069498|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153680206|NCT00069498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153680241|NCT00073320|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153680242|NCT00073320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153680243|NCT00073320|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
153680244|NCT00073320|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
153680245|NCT00073320|Dopamine Agents|dopamine agents|mesh-ancestor
153680246|NCT00215176|Modafinil|modafinil|mesh-list
153680247|NCT00215176|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
153680248|NCT00215176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153680249|NCT00215176|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
153680250|NCT00215176|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
153680251|NCT00215176|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
153680252|NCT00215176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153680253|NCT00215254|Quetiapine Fumarate|quetiapine fumarate|mesh-list
153680254|NCT00215254|Antidepressive Agents|antidepressive agents|mesh-ancestor
153680255|NCT00215254|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153680256|NCT00215254|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153680257|NCT00215254|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153680258|NCT00215254|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153680259|NCT00215254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153680260|NCT00041483|Anecortave|anecortave|mesh-list
153680261|NCT00041483|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153680262|NCT00041483|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153680263|NCT00041483|Growth Substances|growth substances|mesh-ancestor
153680264|NCT00041483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153680265|NCT00041483|Growth Inhibitors|growth inhibitors|mesh-ancestor
153680266|NCT00041483|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153680267|NCT00215371|Formoterol Fumarate|formoterol fumarate|mesh-list
153680268|NCT00215371|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153680269|NCT00215371|Autonomic Agents|autonomic agents|mesh-ancestor
153680282|NCT00215410|Autonomic Agents|autonomic agents|mesh-ancestor
153680283|NCT00215410|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153680284|NCT00215410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153680286|NCT00215410|Respiratory System Agents|respiratory system agents|mesh-ancestor
153680287|NCT00215410|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
153680288|NCT00215410|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
153680289|NCT00215410|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153680290|NCT00215410|Adrenergic Agents|adrenergic agents|mesh-ancestor
153680291|NCT00215410|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153680292|NCT00215410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153680293|NCT00215449|Formoterol Fumarate|formoterol fumarate|mesh-list
153680294|NCT00215449|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153680295|NCT00215449|Autonomic Agents|autonomic agents|mesh-ancestor
153680296|NCT00215449|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153680297|NCT00215449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153680298|NCT00215449|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153680299|NCT00215449|Respiratory System Agents|respiratory system agents|mesh-ancestor
153680300|NCT00215449|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
153680301|NCT00215449|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
153680302|NCT00215449|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153680303|NCT00215449|Adrenergic Agents|adrenergic agents|mesh-ancestor
153680304|NCT00215449|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153680305|NCT00215449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153680307|NCT00215722|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153680308|NCT00215722|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153680309|NCT00215800|poly(I).poly(c12,U)|poly(i).poly(c12,u)|mesh-list
153680310|NCT00215800|Antiviral Agents|antiviral agents|mesh-ancestor
153680328|NCT00215995|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153680329|NCT00215995|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153680330|NCT00215995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153680331|NCT00215995|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153680332|NCT00215995|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153680333|NCT00216034|polysaccharide-K|polysaccharide-k|mesh-list
153680334|NCT00216034|Tegafur|tegafur|mesh-list
153680335|NCT00216034|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153680336|NCT00216034|Antimetabolites|antimetabolites|mesh-ancestor
153680337|NCT00216034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153680338|NCT00216034|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153680339|NCT00216034|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153680340|NCT00216034|Immunologic Factors|immunologic factors|mesh-ancestor
153680341|NCT00216034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153680342|NCT00216034|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153680343|NCT00216034|Antiviral Agents|antiviral agents|mesh-ancestor
153680344|NCT00216034|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153680345|NCT00216034|Interferon Inducers|interferon inducers|mesh-ancestor
153680346|NCT00216034|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
153680347|NCT00216034|Protective Agents|protective agents|mesh-ancestor
153680348|NCT00216073|Capecitabine|capecitabine|mesh-list
153680349|NCT00216073|Oxaliplatin|oxaliplatin|mesh-list
153680350|NCT00216073|Trastuzumab|trastuzumab|mesh-list
153680351|NCT00216073|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153680352|NCT00216073|Antimetabolites|antimetabolites|mesh-ancestor
153680353|NCT00216073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153680354|NCT00216073|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153680355|NCT00216073|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153680356|NCT00216112|Docetaxel|docetaxel|mesh-list
153680357|NCT00216112|Imatinib Mesylate|imatinib mesylate|mesh-list
153680358|NCT00216112|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153680359|NCT00216112|Tubulin Modulators|tubulin modulators|mesh-ancestor
153680360|NCT00216112|Antimitotic Agents|antimitotic agents|mesh-ancestor
153680368|NCT00216151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153680370|NCT00216190|Dexmedetomidine|dexmedetomidine|mesh-list
153680371|NCT00216190|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153680372|NCT00216190|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153680373|NCT00216190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153680374|NCT00216190|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153680375|NCT00216190|Analgesics|analgesics|mesh-ancestor
153680376|NCT00216190|Sensory System Agents|sensory system agents|mesh-ancestor
153680377|NCT00216190|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153680378|NCT00216190|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
153680379|NCT00216190|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153680380|NCT00216190|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153680381|NCT00216190|Adrenergic Agents|adrenergic agents|mesh-ancestor
153680382|NCT00216190|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153680384|NCT00216190|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153680427|NCT00216463|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153680428|NCT00216502|Galantamine|galantamine|mesh-list
153680429|NCT00216502|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
153680430|NCT00216502|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153680431|NCT00216502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153680432|NCT00216502|Cholinergic Agents|cholinergic agents|mesh-ancestor
153680433|NCT00216502|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153680434|NCT00216502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153680435|NCT00216502|Parasympathomimetics|parasympathomimetics|mesh-ancestor
153680436|NCT00216502|Autonomic Agents|autonomic agents|mesh-ancestor
153680437|NCT00216502|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153680438|NCT00216502|Nootropic Agents|nootropic agents|mesh-ancestor
153680439|NCT00216541|Epoetin Alfa|epoetin alfa|mesh-list
153680440|NCT00216541|Hematinics|hematinics|mesh-ancestor
153680441|NCT00216580|Risperidone|risperidone|mesh-list
153680442|NCT00216580|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153680443|NCT00216580|Serotonin Agents|serotonin agents|mesh-ancestor
153680487|NCT00216775|Ribavirin|ribavirin|mesh-list
153680488|NCT00216775|Interferon-alpha|interferon-alpha|mesh-list
153680489|NCT00216775|Interferon alpha-2|interferon alpha-2|mesh-list
153680490|NCT00216775|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153680491|NCT00216775|Antiviral Agents|antiviral agents|mesh-ancestor
153680492|NCT00216775|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153680493|NCT00216775|Antimetabolites|antimetabolites|mesh-ancestor
153680494|NCT00216775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153680495|NCT00216775|Immunologic Factors|immunologic factors|mesh-ancestor
153680496|NCT00216775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153680497|NCT00041639|Labetuzumab|labetuzumab|mesh-list
153680498|NCT00041639|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153680499|NCT00041639|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153680500|NCT00216892|Betamethasone|betamethasone|mesh-list
153680501|NCT00216892|Calcipotriene|calcipotriene|mesh-list
153680502|NCT00216892|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153680503|NCT00216892|Glucocorticoids|glucocorticoids|mesh-ancestor
153680504|NCT00216892|Hormones|hormones|mesh-ancestor
153680505|NCT00216892|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153680545|NCT00412204|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153680546|NCT00412204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153680547|NCT00412204|Anticonvulsants|anticonvulsants|mesh-ancestor
153680548|NCT00041678|Aripiprazole|aripiprazole|mesh-list
153680549|NCT00041678|Antidepressive Agents|antidepressive agents|mesh-ancestor
153680550|NCT00041678|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153680551|NCT00041678|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153680552|NCT00041678|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153680553|NCT00041678|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153680554|NCT00041678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153680555|NCT00041678|Dopamine Agonists|dopamine agonists|mesh-ancestor
153680556|NCT00041678|Dopamine Agents|dopamine agents|mesh-ancestor
153680557|NCT00041678|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153680558|NCT00041678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153680559|NCT00041678|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
153680560|NCT00041678|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
153680561|NCT00041678|Serotonin Agents|serotonin agents|mesh-ancestor
153680562|NCT00041678|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
153680563|NCT00041678|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153680564|NCT00041678|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
153680565|NCT00041678|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
153680567|NCT00217243|Anesthetics, Local|anesthetics, local|mesh-ancestor
153680569|NCT00217243|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153680570|NCT00217243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153680571|NCT00217243|Sensory System Agents|sensory system agents|mesh-ancestor
153680572|NCT00217243|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153680589|NCT00217282|Antimetabolites|antimetabolites|mesh-ancestor
153680590|NCT00217282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153680591|NCT00217477|Gemcitabine|gemcitabine|mesh-list
153680592|NCT00217477|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153680593|NCT00217477|Antimetabolites|antimetabolites|mesh-ancestor
153680594|NCT00217477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153680595|NCT00217477|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153680596|NCT00217516|Selenium|selenium|mesh-list
153680597|NCT00217516|Antioxidants|antioxidants|mesh-ancestor
153680598|NCT00217516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153680599|NCT00217516|Protective Agents|protective agents|mesh-ancestor
153680600|NCT00217516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153680601|NCT00217516|Trace Elements|trace elements|mesh-ancestor
153680602|NCT00217516|Micronutrients|micronutrients|mesh-ancestor
153680603|NCT00217555|Gemcitabine|gemcitabine|mesh-list
153680604|NCT00217555|Topotecan|topotecan|mesh-list
153680605|NCT00217555|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153680606|NCT00217555|Antimetabolites|antimetabolites|mesh-ancestor
153680607|NCT00217555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153680608|NCT00217555|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153680609|NCT00217555|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
153680610|NCT00217555|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153680611|NCT00217555|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153680612|NCT00217711|Capecitabine|capecitabine|mesh-list
153680613|NCT00217711|Oxaliplatin|oxaliplatin|mesh-list
153680614|NCT00217711|Irinotecan|irinotecan|mesh-list
153680615|NCT00217711|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153680616|NCT00217711|Antimetabolites|antimetabolites|mesh-ancestor
153680617|NCT00217711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153680618|NCT00217711|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153680621|NCT00217711|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153680633|NCT00217828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153680634|NCT00217828|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
153680635|NCT00217828|Antidepressive Agents|antidepressive agents|mesh-ancestor
153680636|NCT00217828|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153680637|NCT00041990|Decitabine|decitabine|mesh-list
153680638|NCT00041990|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153680639|NCT00041990|Antimetabolites|antimetabolites|mesh-ancestor
153680640|NCT00041990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153680698|NCT00218374|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
153680699|NCT00218374|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153680700|NCT00218374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153680701|NCT00218374|Antimanic Agents|antimanic agents|mesh-ancestor
153680702|NCT00218413|Vaccines|vaccines|mesh-list
153680703|NCT00218413|Immunologic Factors|immunologic factors|mesh-ancestor
153680704|NCT00218413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153680705|NCT00042068|Meloxicam|meloxicam|mesh-list
153680706|NCT00042068|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153680707|NCT00042068|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153680708|NCT00042068|Analgesics|analgesics|mesh-ancestor
153680709|NCT00042068|Sensory System Agents|sensory system agents|mesh-ancestor
153680710|NCT00042068|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153384305|NCT03336645|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153384306|NCT03336645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153384307|NCT03336645|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153384308|NCT03336645|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153384309|NCT03336645|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153384372|NCT03521505|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153384373|NCT03521505|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153384374|NCT03521505|Adrenergic Agents|adrenergic agents|mesh-ancestor
153680711|NCT00042068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153680712|NCT00042068|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153680714|NCT00042068|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
153680715|NCT00042068|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153680716|NCT00042068|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153680717|NCT00042068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153680718|NCT00218530|Lofexidine|lofexidine|mesh-list
153680719|NCT00218530|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153680720|NCT00218530|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
153680721|NCT00218530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153680722|NCT00218530|Sensory System Agents|sensory system agents|mesh-ancestor
153680723|NCT00218530|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153680724|NCT00218530|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
153680725|NCT00218530|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153680742|NCT00042146|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
153680743|NCT00042146|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153680744|NCT00042146|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153680745|NCT00042146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153680746|NCT00042146|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
153680747|NCT00042146|GABA Agonists|gaba agonists|mesh-ancestor
153680748|NCT00042146|GABA Agents|gaba agents|mesh-ancestor
153680749|NCT00042146|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153680750|NCT00042146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153680751|NCT00412321|Siltuximab|siltuximab|mesh-list
153680752|NCT00412321|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153680753|NCT00219037|Aliskiren|aliskiren|mesh-list
153680754|NCT00219037|Renin Inhibitors|renin inhibitors|mesh-ancestor
153680755|NCT00219037|Protease Inhibitors|protease inhibitors|mesh-ancestor
153680756|NCT00219037|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153680757|NCT00219037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153680758|NCT00219076|Aliskiren|aliskiren|mesh-list
153680759|NCT00219076|Renin Inhibitors|renin inhibitors|mesh-ancestor
153680760|NCT00219076|Protease Inhibitors|protease inhibitors|mesh-ancestor
153680763|NCT00219115|Aliskiren|aliskiren|mesh-list
153680798|NCT00219388|Vasodilator Agents|vasodilator agents|mesh-ancestor
153680799|NCT00219388|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
153680800|NCT00219388|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
153680801|NCT00219388|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153384375|NCT03521505|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153384376|NCT03521505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153384377|NCT03521505|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153384378|NCT03521505|Anesthetics, General|anesthetics, general|mesh-ancestor
153384379|NCT03521505|Anesthetics|anesthetics|mesh-ancestor
153384380|NCT03522441|Clindamycin|clindamycin|mesh-list
153384381|NCT03522441|Clindamycin palmitate|clindamycin palmitate|mesh-list
153384417|NCT03595449|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
153384418|NCT03595449|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153384419|NCT03595449|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153384420|NCT03595449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153384436|NCT03352323|Autonomic Agents|autonomic agents|mesh-ancestor
153384437|NCT03352323|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153680802|NCT00219388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153680803|NCT00219388|Protective Agents|protective agents|mesh-ancestor
153680804|NCT00219388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153680805|NCT00219466|Zinc|zinc|mesh-list
153680806|NCT00219466|Tocopherols|tocopherols|mesh-list
153680807|NCT00219466|Vitamin E|vitamin e|mesh-list
153680808|NCT00219466|Tocotrienols|tocotrienols|mesh-list
153517721|NCT01441505|Sensory System Agents|sensory system agents|mesh-ancestor
153680809|NCT00219466|alpha-Tocopherol|alpha-tocopherol|mesh-list
153680810|NCT00219466|Zinc Oxide|zinc oxide|mesh-list
153680811|NCT00219466|Trace Elements|trace elements|mesh-ancestor
153680812|NCT00219466|Micronutrients|micronutrients|mesh-ancestor
153680813|NCT00219466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153680814|NCT00219466|Antioxidants|antioxidants|mesh-ancestor
153680815|NCT00219466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153680816|NCT00219466|Protective Agents|protective agents|mesh-ancestor
153680817|NCT00219466|Vitamins|vitamins|mesh-ancestor
153680818|NCT00219466|Dermatologic Agents|dermatologic agents|mesh-ancestor
153680819|NCT00219466|Sunscreening Agents|sunscreening agents|mesh-ancestor
153680820|NCT00219466|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
153680821|NCT00042302|Paclitaxel|paclitaxel|mesh-list
153680822|NCT00042302|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
153680823|NCT00042302|Carboplatin|carboplatin|mesh-list
153680824|NCT00042302|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153680825|NCT00042302|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153680826|NCT00042302|Tubulin Modulators|tubulin modulators|mesh-ancestor
153680827|NCT00042302|Antimitotic Agents|antimitotic agents|mesh-ancestor
153680828|NCT00042302|Mitosis Modulators|mitosis modulators|mesh-ancestor
153680842|NCT00219739|Interferons|interferons|mesh-list
153680843|NCT00219739|Cytarabine|cytarabine|mesh-list
153680844|NCT00219739|Imatinib Mesylate|imatinib mesylate|mesh-list
153680845|NCT00219739|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153680846|NCT00219739|Antiviral Agents|antiviral agents|mesh-ancestor
153680847|NCT00219739|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153680848|NCT00219739|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153680849|NCT00219739|Antimetabolites|antimetabolites|mesh-ancestor
153680850|NCT00219739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153384438|NCT03352323|Nasal Decongestants|nasal decongestants|mesh-ancestor
153384439|NCT03352323|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
153783565|NCT04545970|Protective Agents|protective agents|mesh-ancestor
153783566|NCT04545970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153384440|NCT03352323|Respiratory System Agents|respiratory system agents|mesh-ancestor
153384441|NCT03352323|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
153384442|NCT03352323|Mydriatics|mydriatics|mesh-ancestor
153384443|NCT03352323|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
153384444|NCT03352323|Protective Agents|protective agents|mesh-ancestor
153384446|NCT04734639|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153680851|NCT00219739|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153680852|NCT00219739|Immunologic Factors|immunologic factors|mesh-ancestor
153680853|NCT00219739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153680854|NCT00219739|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153680855|NCT00219739|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153680856|NCT00219739|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153680857|NCT00219778|Mifepristone|mifepristone|mesh-list
153680858|NCT00219778|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
153680859|NCT00219778|Abortifacient Agents|abortifacient agents|mesh-ancestor
153680860|NCT00219778|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153680861|NCT00219778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153680862|NCT00219778|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
153680863|NCT00219778|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
153680864|NCT00219778|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
153680865|NCT00219778|Contraceptive Agents|contraceptive agents|mesh-ancestor
153680866|NCT00219778|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
153680867|NCT00219778|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
153680868|NCT00219778|Hormone Antagonists|hormone antagonists|mesh-ancestor
153680869|NCT00219778|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153680870|NCT00219778|Luteolytic Agents|luteolytic agents|mesh-ancestor
153680871|NCT00219778|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
153680872|NCT00219778|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
153680873|NCT00219856|Propofol|propofol|mesh-list
153680874|NCT00219856|Desflurane|desflurane|mesh-list
153680882|NCT00042458|Pramlintide|pramlintide|mesh-list
153680883|NCT00042458|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153680884|NCT00042458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153680886|NCT00219895|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153680887|NCT00219895|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153680888|NCT00219895|Analgesics|analgesics|mesh-ancestor
153680889|NCT00219895|Sensory System Agents|sensory system agents|mesh-ancestor
153680890|NCT00219895|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153680891|NCT00219895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153680892|NCT00219895|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153680893|NCT00219895|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153680894|NCT00219895|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153680895|NCT00219895|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153680896|NCT00219895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153680897|NCT00077337|Romidepsin|romidepsin|mesh-list
153680898|NCT00077337|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153680899|NCT00077337|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153680900|NCT00077337|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
153680901|NCT00077337|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153384453|NCT03357393|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
153384454|NCT03357393|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153384455|NCT03357393|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153384456|NCT03357393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153384457|NCT03357393|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153384458|NCT03357393|Anesthetics, General|anesthetics, general|mesh-ancestor
153384460|NCT03357393|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153384461|NCT03357393|Narcotics|narcotics|mesh-ancestor
153384462|NCT03357393|Analgesics|analgesics|mesh-ancestor
153384463|NCT03357393|Sensory System Agents|sensory system agents|mesh-ancestor
153384464|NCT03357393|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153384466|NCT03357393|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153384467|NCT03357393|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153384468|NCT03357393|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153384469|NCT03357393|GABA Modulators|gaba modulators|mesh-ancestor
153680902|NCT00077337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153680935|NCT00220129|Capecitabine|capecitabine|mesh-list
153680936|NCT00220129|Epirubicin|epirubicin|mesh-list
153680937|NCT00220129|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153680938|NCT00220129|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153680939|NCT00220129|Antimetabolites|antimetabolites|mesh-ancestor
153680940|NCT00220129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153680941|NCT00220129|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153680942|NCT00220129|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153680943|NCT00220129|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153680944|NCT00220129|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153680945|NCT00220168|Capecitabine|capecitabine|mesh-list
153680946|NCT00220168|Irinotecan|irinotecan|mesh-list
153680947|NCT00220168|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153680948|NCT00220168|Antimetabolites|antimetabolites|mesh-ancestor
153680949|NCT00220168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153680950|NCT00220168|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153680951|NCT00220168|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
153680952|NCT00220168|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153680953|NCT00220168|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153680954|NCT00042575|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
153680955|NCT00042575|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
153680956|NCT00042575|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153680957|NCT00042575|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153680983|NCT00220324|Contraceptive Agents|contraceptive agents|mesh-ancestor
153680984|NCT00220324|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153680985|NCT00220324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153680986|NCT00220324|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
153680987|NCT00220324|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
153384470|NCT03357393|GABA Agents|gaba agents|mesh-ancestor
153384471|NCT03357393|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153384472|NCT03357393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153384473|NCT03357393|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
153384474|NCT03357393|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
153384475|NCT03357393|Cholinergic Agents|cholinergic agents|mesh-ancestor
153384476|NCT03357393|Antiemetics|antiemetics|mesh-ancestor
153384477|NCT03357393|Autonomic Agents|autonomic agents|mesh-ancestor
153384478|NCT03357393|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153384479|NCT03357393|Mydriatics|mydriatics|mesh-ancestor
153384480|NCT03357393|Parasympatholytics|parasympatholytics|mesh-ancestor
153384481|NCT03541941|Bupivacaine|bupivacaine|mesh-list
153384507|NCT03559179|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153384509|NCT03366207|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153384510|NCT03366207|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153384511|NCT03366207|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153384512|NCT03366207|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153384513|NCT03366207|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153384514|NCT03366207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153680988|NCT00220324|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
153680989|NCT00220324|Contraceptives, Postcoital, Hormonal|contraceptives, postcoital, hormonal|mesh-ancestor
153680990|NCT00220324|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
153680991|NCT00220324|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
153680992|NCT00412555|Oseltamivir|oseltamivir|mesh-list
153680993|NCT00412555|Antiviral Agents|antiviral agents|mesh-ancestor
153680994|NCT00412555|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153680995|NCT00412555|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153680996|NCT00412555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153680997|NCT00412633|Sulfamethazine|sulfamethazine|mesh-list
153680998|NCT00412633|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153680999|NCT00042653|Cinacalcet|cinacalcet|mesh-list
153681000|NCT00042653|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153384515|NCT03366207|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153384516|NCT03366207|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
153384517|NCT03366207|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153384518|NCT03368235|Prednisolone|prednisolone|mesh-list
153384519|NCT03368235|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153384520|NCT03368235|Glucocorticoids|glucocorticoids|mesh-ancestor
153384521|NCT03368235|Hormones|hormones|mesh-ancestor
153384522|NCT03368235|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153384523|NCT03368235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153384524|NCT03368235|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153384525|NCT03368235|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153384526|NCT02310750|PF-06700841|pf-06700841|mesh-list
153384551|NCT03632109|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153384552|NCT03632109|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
153384553|NCT03632109|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153384554|NCT03632109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153384555|NCT02363946|Diphenhydramine|diphenhydramine|mesh-list
153384557|NCT02363946|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
153384558|NCT02363946|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153384559|NCT02363946|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153681001|NCT00042653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153681002|NCT00042653|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
153681003|NCT00042653|Hormone Antagonists|hormone antagonists|mesh-ancestor
153681004|NCT00042653|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153681005|NCT00073593|Heparin|heparin|mesh-list
153681006|NCT00073593|Bivalirudin|bivalirudin|mesh-list
153681007|NCT00073593|Protamines|protamines|mesh-list
153384560|NCT02363946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153384561|NCT02363946|Anesthetics, Local|anesthetics, local|mesh-ancestor
153384562|NCT02363946|Anesthetics|anesthetics|mesh-ancestor
153384563|NCT02363946|Sensory System Agents|sensory system agents|mesh-ancestor
153384564|NCT02363946|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153883076|NCT01588704|Pemetrexed|pemetrexed|mesh-list
153384566|NCT02363946|Autonomic Agents|autonomic agents|mesh-ancestor
153384567|NCT02363946|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153384568|NCT02363946|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
153681008|NCT00073593|Anticoagulants|anticoagulants|mesh-ancestor
153681009|NCT00073593|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153681010|NCT00073593|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153681017|NCT00073593|Coagulants|coagulants|mesh-ancestor
153681027|NCT00220675|Hematinics|hematinics|mesh-ancestor
153681028|NCT00042731|Lycopene|lycopene|mesh-list
153681029|NCT00042731|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153681030|NCT00042731|Antioxidants|antioxidants|mesh-ancestor
153681031|NCT00042731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153681032|NCT00042731|Protective Agents|protective agents|mesh-ancestor
153681033|NCT00042731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153517947|NCT01442727|Trace Elements|trace elements|mesh-ancestor
153681034|NCT00042731|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
153681035|NCT00042731|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
153681036|NCT00042731|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153681037|NCT00220714|Antipsychotic Agents|antipsychotic agents|mesh-list
153681038|NCT00220714|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153681039|NCT00220714|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153681040|NCT00220714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153681041|NCT00220714|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153681042|NCT00077493|Antibodies|antibodies|mesh-list
153681043|NCT00077493|Immunoglobulins|immunoglobulins|mesh-list
153681044|NCT00077493|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
153681045|NCT00077493|Immunotoxins|immunotoxins|mesh-list
153681046|NCT00077493|Immunoconjugates|immunoconjugates|mesh-list
153681047|NCT00077493|Immunologic Factors|immunologic factors|mesh-ancestor
153681048|NCT00077493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153681049|NCT00220831|Vitamin E|vitamin e|mesh-list
153681050|NCT00220831|Vitamins|vitamins|mesh-ancestor
153681051|NCT00220831|Micronutrients|micronutrients|mesh-ancestor
153681052|NCT00220831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153681053|NCT00220831|Antioxidants|antioxidants|mesh-ancestor
153681054|NCT00220831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153681055|NCT00220831|Protective Agents|protective agents|mesh-ancestor
153681056|NCT00220909|Lansoprazole|lansoprazole|mesh-list
153681057|NCT00220909|Dexlansoprazole|dexlansoprazole|mesh-list
153681058|NCT00220909|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
153681059|NCT00220909|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153681070|NCT02966067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153681071|NCT00221026|Methoxsalen|methoxsalen|mesh-list
153681072|NCT00221026|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
153681073|NCT00221026|Dermatologic Agents|dermatologic agents|mesh-ancestor
153681074|NCT00042809|Paclitaxel|paclitaxel|mesh-list
153681075|NCT00042809|Trastuzumab|trastuzumab|mesh-list
153681076|NCT00042809|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
153681077|NCT00042809|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153681078|NCT00042809|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153681079|NCT00042809|Tubulin Modulators|tubulin modulators|mesh-ancestor
153681080|NCT00042809|Antimitotic Agents|antimitotic agents|mesh-ancestor
153681081|NCT00042809|Mitosis Modulators|mitosis modulators|mesh-ancestor
153681082|NCT00042809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153384569|NCT02363946|Histamine Antagonists|histamine antagonists|mesh-ancestor
153384570|NCT02363946|Histamine Agents|histamine agents|mesh-ancestor
153384571|NCT02363946|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153387721|NCT00000771|Paromomycin|paromomycin|mesh-list
153384573|NCT02363946|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
153384574|NCT02363946|Antipruritics|antipruritics|mesh-ancestor
153384604|NCT01803074|Protease Inhibitors|protease inhibitors|mesh-ancestor
153384605|NCT01803074|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153384606|NCT01803074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153384607|NCT01803074|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153384608|NCT01803074|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153681083|NCT00042809|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153681084|NCT00042809|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153681085|NCT00042809|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153681086|NCT00042809|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153681087|NCT00073710|Calcitriol|calcitriol|mesh-list
153681088|NCT00073710|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153681089|NCT00073710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153681090|NCT00073710|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
153681091|NCT00073710|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153681092|NCT00073710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153681093|NCT00073710|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
153681095|NCT00073710|Micronutrients|micronutrients|mesh-ancestor
153681096|NCT00073710|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153681097|NCT00042848|Modafinil|modafinil|mesh-list
153681098|NCT00042848|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
153681099|NCT00042848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153681100|NCT00042848|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
153681101|NCT00042848|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
153681110|NCT00402259|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153681111|NCT00402259|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
153681112|NCT00402259|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153681113|NCT00402259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153681114|NCT02965677|Paclitaxel|paclitaxel|mesh-list
153681115|NCT02965677|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153681116|NCT02965677|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153681117|NCT02965677|Tubulin Modulators|tubulin modulators|mesh-ancestor
153681118|NCT02965677|Antimitotic Agents|antimitotic agents|mesh-ancestor
153681119|NCT02965677|Mitosis Modulators|mitosis modulators|mesh-ancestor
153681120|NCT02965677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153681121|NCT00402376|Carvedilol|carvedilol|mesh-list
153681122|NCT00402376|Perindopril|perindopril|mesh-list
153681123|NCT00402376|Pravastatin|pravastatin|mesh-list
153681124|NCT00402376|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
153681125|NCT00402376|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
153681126|NCT00402376|Adrenergic Agents|adrenergic agents|mesh-ancestor
153384609|NCT01803074|Antiviral Agents|antiviral agents|mesh-ancestor
153384610|NCT01803074|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153384611|NCT01803074|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
153384612|NCT01803074|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153384613|NCT01803074|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153384614|NCT01803074|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153384615|NCT05327894|Blinatumomab|blinatumomab|mesh-list
153384616|NCT05327894|Antibodies, Bispecific|antibodies, bispecific|mesh-list
153384617|NCT05327894|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153384618|NCT05327894|Immunologic Factors|immunologic factors|mesh-ancestor
153681127|NCT00402376|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153681128|NCT00402376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153681129|NCT00402376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153681130|NCT00402376|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153681131|NCT00402376|Antioxidants|antioxidants|mesh-ancestor
153681132|NCT00402376|Protective Agents|protective agents|mesh-ancestor
153681133|NCT00402376|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153681134|NCT00402376|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153681135|NCT00402376|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153681136|NCT00402376|Vasodilator Agents|vasodilator agents|mesh-ancestor
153681141|NCT00402376|Antimetabolites|antimetabolites|mesh-ancestor
153681155|NCT00122746|Cisplatin|cisplatin|mesh-list
153681156|NCT00122746|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153681157|NCT00122785|Dexamethasone|dexamethasone|mesh-list
153681158|NCT00122785|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153681159|NCT00122785|Antiemetics|antiemetics|mesh-ancestor
153681160|NCT00122785|Autonomic Agents|autonomic agents|mesh-ancestor
153681161|NCT00122785|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153681162|NCT00122785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153681163|NCT00122785|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153681164|NCT00122785|Glucocorticoids|glucocorticoids|mesh-ancestor
153681165|NCT00122785|Hormones|hormones|mesh-ancestor
153681166|NCT00122785|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153681167|NCT00122785|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153681168|NCT00122785|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153681169|NCT00122824|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
153681170|NCT00122824|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
153681171|NCT00122824|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153681172|NCT00122824|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153681173|NCT00122824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153681174|NCT00122824|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153681175|NCT00122824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153681176|NCT00122824|Analgesics|analgesics|mesh-ancestor
153681177|NCT00122824|Sensory System Agents|sensory system agents|mesh-ancestor
153681178|NCT00122824|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153681179|NCT00122824|Antidepressive Agents|antidepressive agents|mesh-ancestor
153681180|NCT00122824|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153681198|NCT00122863|Analgesics|analgesics|mesh-ancestor
153681199|NCT00122863|Sensory System Agents|sensory system agents|mesh-ancestor
153681200|NCT00122863|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153681201|NCT00122863|Antidepressive Agents|antidepressive agents|mesh-ancestor
153681202|NCT00122863|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153681203|NCT00122863|Dopamine Agents|dopamine agents|mesh-ancestor
153384619|NCT05327894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153384620|NCT05327660|Carbon Monoxide|carbon monoxide|mesh-list
153384621|NCT05327660|Antimetabolites|antimetabolites|mesh-ancestor
153384622|NCT05327660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153384652|NCT01823510|Antipyretics|antipyretics|mesh-ancestor
153384653|NCT01823510|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
153681204|NCT00042926|Technetium Tc 99m Sulfur Colloid|technetium tc 99m sulfur colloid|mesh-list
153681206|NCT00042926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153681207|NCT00122941|Micronutrients|micronutrients|mesh-list
153681208|NCT00122941|Trace Elements|trace elements|mesh-list
153681209|NCT00122941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153681210|NCT00077688|Paclitaxel|paclitaxel|mesh-list
153681211|NCT00077688|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153681212|NCT00077688|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153681213|NCT00077688|Tubulin Modulators|tubulin modulators|mesh-ancestor
153681214|NCT00077688|Antimitotic Agents|antimitotic agents|mesh-ancestor
153681215|NCT00077688|Mitosis Modulators|mitosis modulators|mesh-ancestor
153681216|NCT00077688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153681252|NCT00123175|Hormones|hormones|mesh-ancestor
153681253|NCT00123175|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153681254|NCT00077727|Galantamine|galantamine|mesh-list
153681255|NCT00077727|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
153681256|NCT00077727|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153681257|NCT00077727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153681258|NCT00077727|Cholinergic Agents|cholinergic agents|mesh-ancestor
153681259|NCT00077727|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153681260|NCT00077727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153681261|NCT00077727|Parasympathomimetics|parasympathomimetics|mesh-ancestor
153681262|NCT00077727|Autonomic Agents|autonomic agents|mesh-ancestor
153681263|NCT00077727|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153681264|NCT00077727|Nootropic Agents|nootropic agents|mesh-ancestor
153681265|NCT00123292|Plasminogen|plasminogen|mesh-list
153681266|NCT00123292|Fibrinolysin|fibrinolysin|mesh-list
153681267|NCT00123292|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153681268|NCT00123292|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153681269|NCT00123292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153681270|NCT00043004|Leucovorin|leucovorin|mesh-list
153681271|NCT00043004|Bevacizumab|bevacizumab|mesh-list
153681272|NCT00043004|Fluorouracil|fluorouracil|mesh-list
153681273|NCT00043004|Oxaliplatin|oxaliplatin|mesh-list
153681274|NCT00043004|Calcium|calcium|mesh-list
153681275|NCT00043004|Levoleucovorin|levoleucovorin|mesh-list
153681276|NCT00043004|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153681277|NCT00043004|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153681300|NCT00123331|Immunologic Factors|immunologic factors|mesh-ancestor
153681301|NCT00123331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153681302|NCT00123331|Antifungal Agents|antifungal agents|mesh-ancestor
153681303|NCT00123331|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153681304|NCT00123331|Dermatologic Agents|dermatologic agents|mesh-ancestor
153681305|NCT00123331|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153681306|NCT00123331|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
153681307|NCT00123331|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153681308|NCT00123331|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153681309|NCT00123331|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153681310|NCT00123370|Modafinil|modafinil|mesh-list
153681311|NCT00123370|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
153681312|NCT00123370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153681313|NCT00123370|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
153681314|NCT00123370|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
153681315|NCT00123370|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
153681316|NCT00123370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153681317|NCT00043043|Celecoxib|celecoxib|mesh-list
153681318|NCT00043043|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153681319|NCT00043043|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153681320|NCT00043043|Analgesics|analgesics|mesh-ancestor
153681321|NCT00043043|Sensory System Agents|sensory system agents|mesh-ancestor
153681322|NCT00043043|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153681323|NCT00043043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153681324|NCT00043043|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153681325|NCT00043043|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153681326|NCT00043043|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
153681327|NCT00043043|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153681328|NCT00043043|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153681329|NCT00043043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153681342|NCT00043082|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153681344|NCT00043082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153681345|NCT00123877|Esorubicin|esorubicin|mesh-list
153681346|NCT00123877|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153681347|NCT00123877|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153681348|NCT00123916|Benzonidazole|benzonidazole|mesh-list
153681349|NCT00123916|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153681350|NCT00123916|Immunologic Factors|immunologic factors|mesh-ancestor
153681351|NCT00123916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153681352|NCT00123916|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
153681353|NCT00123916|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153681354|NCT00123916|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153681355|NCT00123916|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153681357|NCT00073827|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153681358|NCT00073827|Autonomic Agents|autonomic agents|mesh-ancestor
153681359|NCT00073827|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153681360|NCT00073827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153681398|NCT00124111|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
153681399|NCT00124111|Abortifacient Agents|abortifacient agents|mesh-ancestor
153681400|NCT00124111|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153681401|NCT00124111|Dermatologic Agents|dermatologic agents|mesh-ancestor
153681402|NCT00124111|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153681403|NCT00124111|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153681404|NCT00124111|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153681405|NCT00124150|Magnesium Sulfate|magnesium sulfate|mesh-list
153681406|NCT00124150|Analgesics|analgesics|mesh-ancestor
153681407|NCT00124150|Sensory System Agents|sensory system agents|mesh-ancestor
153681408|NCT00124150|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153384654|NCT01823510|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
153384655|NCT01823510|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
153384656|NCT01823510|Purinergic Agents|purinergic agents|mesh-ancestor
153384657|NCT01823510|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153384658|NCT05327582|Paclitaxel|paclitaxel|mesh-list
153384659|NCT05327582|Durvalumab|durvalumab|mesh-list
153384660|NCT05327582|Lenvatinib|lenvatinib|mesh-list
153384661|NCT05327582|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153384662|NCT05327582|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153384663|NCT05327582|Tubulin Modulators|tubulin modulators|mesh-ancestor
153384664|NCT05327582|Antimitotic Agents|antimitotic agents|mesh-ancestor
153384665|NCT05327582|Mitosis Modulators|mitosis modulators|mesh-ancestor
153384666|NCT05327582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153384667|NCT05327582|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153384703|NCT01830842|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153384704|NCT01830842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153384706|NCT01830842|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
153384707|NCT01830842|Cholinergic Agents|cholinergic agents|mesh-ancestor
153384708|NCT01830842|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153681409|NCT00124150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153681410|NCT00124150|Anesthetics|anesthetics|mesh-ancestor
153681411|NCT00124150|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153681412|NCT00124150|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153681413|NCT00124150|Anticonvulsants|anticonvulsants|mesh-ancestor
153681414|NCT00124150|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153681415|NCT00124150|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153681416|NCT00124150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153681417|NCT00124150|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153681418|NCT00124150|Tocolytic Agents|tocolytic agents|mesh-ancestor
153681419|NCT00124150|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153681420|NCT02958046|Domperidone|domperidone|mesh-list
153681449|NCT00124267|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153681450|NCT00124267|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153681452|NCT00124267|Sensory System Agents|sensory system agents|mesh-ancestor
153681453|NCT00077844|Enoxaparin|enoxaparin|mesh-list
153681454|NCT00077844|Enoxaparin sodium|enoxaparin sodium|mesh-list
153681455|NCT00077844|Anticoagulants|anticoagulants|mesh-ancestor
153681456|NCT00077844|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153681457|NCT00077844|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153681458|NCT00077844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153681459|NCT00043121|Leucovorin|leucovorin|mesh-list
153681460|NCT00043121|Capecitabine|capecitabine|mesh-list
153681461|NCT00043121|Fluorouracil|fluorouracil|mesh-list
153681462|NCT00043121|Oxaliplatin|oxaliplatin|mesh-list
153681463|NCT00043121|Calcium|calcium|mesh-list
153681464|NCT00043121|Levoleucovorin|levoleucovorin|mesh-list
153681465|NCT00043121|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153681466|NCT00043121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153681507|NCT00124306|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153681508|NCT00124306|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153681510|NCT00124306|Sensory System Agents|sensory system agents|mesh-ancestor
153681511|NCT00124306|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153681512|NCT00124306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153681513|NCT00124306|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
153681514|NCT00124306|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153681515|NCT00124306|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153681516|NCT00124306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153681517|NCT00124306|Adrenergic Agents|adrenergic agents|mesh-ancestor
153681518|NCT00124306|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153681519|NCT00043199|bis-neodecanoato-1,2-diaminocyclohexaneplatinum(II)|bis-neodecanoato-1,2-diaminocyclohexaneplatinum(ii)|mesh-list
153681520|NCT00043199|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153681521|NCT00124384|Modafinil|modafinil|mesh-list
153681522|NCT00124384|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
153681523|NCT00124384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153681524|NCT00124384|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
153681525|NCT00124384|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
153681526|NCT00124384|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
153681527|NCT00124384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153681529|NCT00077883|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153681530|NCT00124540|Misoprostol|misoprostol|mesh-list
153681531|NCT00124540|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
153681532|NCT00124540|Abortifacient Agents|abortifacient agents|mesh-ancestor
153681533|NCT00124540|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153681534|NCT00124540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153681535|NCT00124540|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
153681547|NCT00043277|Antithrombins|antithrombins|mesh-ancestor
153424033|NCT03570476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153424034|NCT03570476|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153424035|NCT03571724|Menthol|menthol|mesh-list
153424036|NCT03571724|Nicotine|nicotine|mesh-list
153681548|NCT00043277|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
153681549|NCT00043277|Protease Inhibitors|protease inhibitors|mesh-ancestor
153681550|NCT00043277|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153681551|NCT00043277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153681554|NCT00074022|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153681555|NCT00074022|Tubulin Modulators|tubulin modulators|mesh-ancestor
153681556|NCT00074022|Antimitotic Agents|antimitotic agents|mesh-ancestor
153681557|NCT00074022|Mitosis Modulators|mitosis modulators|mesh-ancestor
153681558|NCT00074022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153681559|NCT00124813|Thalidomide|thalidomide|mesh-list
153681560|NCT00124813|Idarubicin|idarubicin|mesh-list
153681561|NCT00124813|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153681562|NCT00124813|Immunologic Factors|immunologic factors|mesh-ancestor
153681577|NCT00124930|Olanzapine|olanzapine|mesh-list
153681605|NCT00043316|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153681607|NCT00077961|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153681608|NCT00077961|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153681609|NCT00125008|Vaccines|vaccines|mesh-list
153681610|NCT00125008|Immunologic Factors|immunologic factors|mesh-ancestor
153681611|NCT00125008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153681612|NCT00125047|Vaccines|vaccines|mesh-list
153681613|NCT00125047|Immunologic Factors|immunologic factors|mesh-ancestor
153681614|NCT00125047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153681615|NCT00078000|Sunitinib|sunitinib|mesh-list
153681616|NCT00078000|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153681617|NCT00078000|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153681618|NCT00078000|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153681619|NCT00078000|Growth Substances|growth substances|mesh-ancestor
153681620|NCT00078000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153681621|NCT00078000|Growth Inhibitors|growth inhibitors|mesh-ancestor
153681622|NCT00078000|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153681623|NCT00078000|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153681624|NCT00078000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153681625|NCT00125203|rimabotulinumtoxinB|rimabotulinumtoxinb|mesh-list
153681626|NCT00125203|Botulinum Toxins|botulinum toxins|mesh-list
153681627|NCT00125203|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
153681628|NCT00125203|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
153681629|NCT00125203|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
153681630|NCT00125203|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153681631|NCT00125203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153681632|NCT00125203|Cholinergic Agents|cholinergic agents|mesh-ancestor
153681638|NCT00043355|Interferons|interferons|mesh-list
153681651|NCT04729998|Protease Inhibitors|protease inhibitors|mesh-ancestor
153681652|NCT04729998|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153384741|NCT01833026|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153384742|NCT01833026|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
153384743|NCT01833026|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
153384744|NCT01833026|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153384745|NCT01833026|Adrenergic Agents|adrenergic agents|mesh-ancestor
153384746|NCT01833026|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153384747|NCT01833026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153384748|NCT03383523|Praziquantel|praziquantel|mesh-list
153384749|NCT03383523|Emodepside|emodepside|mesh-list
153384750|NCT03383523|Toltrazuril|toltrazuril|mesh-list
153681653|NCT04729998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153681654|NCT04729998|Anticoagulants|anticoagulants|mesh-ancestor
153681655|NCT00125437|Spironolactone|spironolactone|mesh-list
153681656|NCT00125437|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
153681657|NCT00125437|Hormone Antagonists|hormone antagonists|mesh-ancestor
153681658|NCT00125437|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153681659|NCT00125437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153681660|NCT00125437|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
153681661|NCT00125437|Diuretics|diuretics|mesh-ancestor
153681662|NCT00125437|Natriuretic Agents|natriuretic agents|mesh-ancestor
153681663|NCT00125554|Metyrapone|metyrapone|mesh-list
153681664|NCT00125554|Antimetabolites|antimetabolites|mesh-ancestor
153681665|NCT00125554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153681666|NCT00125554|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153681667|NCT00043394|Trastuzumab|trastuzumab|mesh-list
153681668|NCT00043394|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153681669|NCT00043394|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153681670|NCT00125671|Warfarin|warfarin|mesh-list
153681671|NCT00125671|Anticoagulants|anticoagulants|mesh-ancestor
153681672|NCT00125827|Clofarabine|clofarabine|mesh-list
153681673|NCT00125827|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153681674|NCT00125827|Antimetabolites|antimetabolites|mesh-ancestor
153681675|NCT00125827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153681676|NCT00125827|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153681677|NCT00078039|Paliperidone Palmitate|paliperidone palmitate|mesh-list
153681678|NCT00078039|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153681679|NCT00078039|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153681680|NCT00078039|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153681695|NCT00125905|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153681696|NCT00125905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153681697|NCT00125905|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
153681698|NCT00125905|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
153681699|NCT00125905|Cholinergic Agents|cholinergic agents|mesh-ancestor
153681700|NCT00125905|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153681701|NCT00125905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153681702|NCT00125905|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
153384784|NCT05747768|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153384785|NCT05747768|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153384786|NCT05747768|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153384787|NCT05747768|Anesthetics, General|anesthetics, general|mesh-ancestor
153384788|NCT05747768|Anesthetics|anesthetics|mesh-ancestor
153384789|NCT05747768|GABA Modulators|gaba modulators|mesh-ancestor
153384790|NCT05747768|GABA Agents|gaba agents|mesh-ancestor
153384791|NCT05747768|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153384792|NCT05747768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153384793|NCT05747768|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153681703|NCT00125905|Antidepressive Agents|antidepressive agents|mesh-ancestor
153681704|NCT00125905|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153681705|NCT00125905|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
153681706|NCT00125905|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153681707|NCT00125905|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153681754|NCT00402454|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153681755|NCT00402454|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153681756|NCT00402454|Leprostatic Agents|leprostatic agents|mesh-ancestor
153681757|NCT00402454|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153681758|NCT00402454|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153681759|NCT00402454|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153681760|NCT00402454|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
153681761|NCT00402454|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
153681762|NCT00402454|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
153681763|NCT00402454|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
153681764|NCT00402454|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
153681765|NCT00402454|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
153681766|NCT00402454|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
153681767|NCT00402454|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153681768|NCT00402454|Antimetabolites|antimetabolites|mesh-ancestor
153681769|NCT00402454|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153681771|NCT00402493|Brimonidine Tartrate|brimonidine tartrate|mesh-list
153681772|NCT00402493|Latanoprost|latanoprost|mesh-list
153681773|NCT00402493|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153681774|NCT00402493|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153681775|NCT00402493|Analgesics|analgesics|mesh-ancestor
153681776|NCT00402493|Sensory System Agents|sensory system agents|mesh-ancestor
153681777|NCT00402493|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153681778|NCT00402493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153681779|NCT00402493|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153681780|NCT00402493|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153681781|NCT00402493|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153681782|NCT00402493|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153681783|NCT00402493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153681784|NCT00402493|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
153891295|NCT06055257|Micronutrients|micronutrients|mesh-ancestor
153891296|NCT06055257|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153891297|NCT06055166|Capecitabine|capecitabine|mesh-list
153891298|NCT06055166|Fluzoparib|fluzoparib|mesh-list
153891299|NCT06055166|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153891300|NCT06055166|Antimetabolites|antimetabolites|mesh-ancestor
153681785|NCT00402493|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
153681793|NCT00402532|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
153681794|NCT00402532|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153384794|NCT05747768|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153384795|NCT05747768|Antimetabolites|antimetabolites|mesh-ancestor
153783567|NCT04545970|Dermatologic Agents|dermatologic agents|mesh-ancestor
153783568|NCT04545931|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
153384796|NCT05747768|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153681795|NCT00402532|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153681796|NCT00402532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153681797|NCT00402532|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153681798|NCT00402532|Immunologic Factors|immunologic factors|mesh-ancestor
153681799|NCT00402532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153681800|NCT00402532|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153681802|NCT00126061|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153681803|NCT00126061|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
153681804|NCT00126061|Protective Agents|protective agents|mesh-ancestor
153681805|NCT00126061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153681806|NCT00043589|Donepezil|donepezil|mesh-list
153681807|NCT00043589|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
153681808|NCT00043589|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153681809|NCT00043589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153681810|NCT00043589|Cholinergic Agents|cholinergic agents|mesh-ancestor
153681811|NCT00043589|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153681812|NCT00043589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153681813|NCT00043589|Nootropic Agents|nootropic agents|mesh-ancestor
153681814|NCT00399399|Cyclophosphamide|cyclophosphamide|mesh-list
153681815|NCT00399399|Azathioprine|azathioprine|mesh-list
153681816|NCT00399399|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153681817|NCT00399399|Immunologic Factors|immunologic factors|mesh-ancestor
153681843|NCT00126256|Leucovorin|leucovorin|mesh-list
153681844|NCT00126256|Fluorouracil|fluorouracil|mesh-list
153681845|NCT00126256|Oxaliplatin|oxaliplatin|mesh-list
153681846|NCT00126256|Irinotecan|irinotecan|mesh-list
153681847|NCT00126256|Antimetabolites|antimetabolites|mesh-ancestor
153681848|NCT00126256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153681849|NCT00126256|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153681850|NCT00126256|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153681851|NCT00126256|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153681852|NCT00126256|Immunologic Factors|immunologic factors|mesh-ancestor
153681853|NCT00126256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153681854|NCT00126256|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
153681855|NCT00126256|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153681856|NCT00126256|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153681858|NCT00126256|Protective Agents|protective agents|mesh-ancestor
153681859|NCT00126256|Vitamin B Complex|vitamin b complex|mesh-ancestor
153681860|NCT00126256|Vitamins|vitamins|mesh-ancestor
153681861|NCT00126256|Micronutrients|micronutrients|mesh-ancestor
153681862|NCT00043667|Daclizumab|daclizumab|mesh-list
153681863|NCT00043667|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153681864|NCT00043667|Immunologic Factors|immunologic factors|mesh-ancestor
153681865|NCT00043667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153681866|NCT00074139|Cyclophosphamide|cyclophosphamide|mesh-list
153681867|NCT00074139|Docetaxel|docetaxel|mesh-list
153681868|NCT00074139|Doxorubicin|doxorubicin|mesh-list
153681869|NCT00074139|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
153681870|NCT00074139|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153681871|NCT00074139|Immunologic Factors|immunologic factors|mesh-ancestor
153681872|NCT00074139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153681873|NCT00074139|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153681874|NCT00074139|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153681891|NCT00126373|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153681892|NCT00126373|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153883103|NCT01689311|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153883104|NCT01689311|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153883105|NCT01689311|Vasodilator Agents|vasodilator agents|mesh-ancestor
153883106|NCT01689311|Urological Agents|urological agents|mesh-ancestor
153681893|NCT00126373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153681894|NCT00126373|Dopamine Agents|dopamine agents|mesh-ancestor
153681895|NCT00126373|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153681896|NCT00126373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153681897|NCT00126373|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
153681898|NCT00126373|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153681899|NCT00126373|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153681900|NCT00126412|3-Iodobenzylguanidine|3-iodobenzylguanidine|mesh-list
153681901|NCT00126412|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153681902|NCT00126412|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153681903|NCT00126412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153681904|NCT00126412|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
153681905|NCT00043706|Antibodies|antibodies|mesh-list
153681906|NCT00043706|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
153681907|NCT00043706|Mitogens|mitogens|mesh-list
153681908|NCT00043706|Immunologic Factors|immunologic factors|mesh-ancestor
153681909|NCT00043706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153681910|NCT00043706|Mitosis Modulators|mitosis modulators|mesh-ancestor
153681911|NCT00043706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153681913|NCT00126451|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153681914|NCT00126451|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
153681939|NCT00074178|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153681941|NCT00074178|Hormones|hormones|mesh-ancestor
153681942|NCT00074178|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153681943|NCT00074178|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153384821|NCT03398421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153384822|NCT03398421|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
153384823|NCT03398421|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153384825|NCT01839110|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153384826|NCT01839110|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153384827|NCT01839110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153384829|NCT00559754|Docetaxel|docetaxel|mesh-list
153384830|NCT00559754|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153384831|NCT00559754|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153681944|NCT00074178|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
153681945|NCT00074178|Abortifacient Agents|abortifacient agents|mesh-ancestor
153681946|NCT00074178|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153681947|NCT00074178|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153681948|NCT00074178|Antimetabolites|antimetabolites|mesh-ancestor
153681949|NCT00074178|Dermatologic Agents|dermatologic agents|mesh-ancestor
153681950|NCT00074178|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153681951|NCT00074178|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153681952|NCT00074178|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153681953|NCT00074178|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153681954|NCT00074178|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153681955|NCT00074178|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153681956|NCT00074178|Antiviral Agents|antiviral agents|mesh-ancestor
153681957|NCT00074178|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153681958|NCT00126646|Antibodies|antibodies|mesh-list
153681959|NCT00126646|Immunotoxins|immunotoxins|mesh-list
153681960|NCT00126646|Immunoconjugates|immunoconjugates|mesh-list
153681961|NCT00126646|Immunologic Factors|immunologic factors|mesh-ancestor
153681962|NCT00126646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153681963|NCT00126763|Fentanyl|fentanyl|mesh-list
153681964|NCT00126763|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153681965|NCT00126763|Narcotics|narcotics|mesh-ancestor
153681966|NCT00126763|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153681967|NCT00126763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153681968|NCT00126763|Analgesics|analgesics|mesh-ancestor
153681982|NCT00126880|Lamivudine|lamivudine|mesh-list
153681984|NCT00126880|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153681985|NCT00126880|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153681986|NCT00126880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153681987|NCT00126880|Antiviral Agents|antiviral agents|mesh-ancestor
153681988|NCT00126880|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153681989|NCT00126880|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153681990|NCT00126880|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153681991|NCT02965911|Fenofibrate|fenofibrate|mesh-list
153681992|NCT02965911|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153681993|NCT02965911|Antimetabolites|antimetabolites|mesh-ancestor
153681994|NCT02965911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153681995|NCT02965911|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153681996|NCT00127075|Estradiol|estradiol|mesh-list
153681997|NCT00127075|Estrogens|estrogens|mesh-ancestor
153681998|NCT00127075|Hormones|hormones|mesh-ancestor
153681999|NCT00127075|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153682000|NCT00127075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153682001|NCT00127114|Amantadine|amantadine|mesh-list
153682002|NCT00127114|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
153682003|NCT00127114|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
153682014|NCT00043784|Enoxaparin|enoxaparin|mesh-list
153682039|NCT00127270|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
153682040|NCT00127270|Cholinergic Agents|cholinergic agents|mesh-ancestor
153682041|NCT00127270|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153682042|NCT00127270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153682043|NCT00127270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153682044|NCT00127270|Urological Agents|urological agents|mesh-ancestor
153682045|NCT00043823|Bevacizumab|bevacizumab|mesh-list
153682046|NCT00043823|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
153682047|NCT00043823|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153384832|NCT00559754|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153384833|NCT00559754|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153384834|NCT00559754|Growth Substances|growth substances|mesh-ancestor
153384835|NCT00559754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153384836|NCT00559754|Growth Inhibitors|growth inhibitors|mesh-ancestor
153384837|NCT00559754|Tubulin Modulators|tubulin modulators|mesh-ancestor
153384838|NCT00559754|Antimitotic Agents|antimitotic agents|mesh-ancestor
153682048|NCT00043823|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153682049|NCT00043823|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153682050|NCT00043823|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153682051|NCT00043823|Growth Substances|growth substances|mesh-ancestor
153682052|NCT00043823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153682053|NCT00043823|Growth Inhibitors|growth inhibitors|mesh-ancestor
153682054|NCT00043823|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153682055|NCT00043823|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153682056|NCT00043823|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153682057|NCT00043823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153682058|NCT00074334|Immunotoxins|immunotoxins|mesh-list
153682059|NCT00074334|Immunoconjugates|immunoconjugates|mesh-ancestor
153682060|NCT00074334|Immunologic Factors|immunologic factors|mesh-ancestor
153682061|NCT00074334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153682063|NCT00127387|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153682064|NCT00127387|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153682065|NCT00127387|Analgesics|analgesics|mesh-ancestor
153682066|NCT00127387|Sensory System Agents|sensory system agents|mesh-ancestor
153682067|NCT00127387|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153682068|NCT00127387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153682069|NCT00127387|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153682070|NCT00127387|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153682071|NCT00127387|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153682078|NCT00043862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153682079|NCT00043862|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153682080|NCT00127504|Azithromycin|azithromycin|mesh-list
153682082|NCT00127504|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153682083|NCT00127504|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153682084|NCT00127504|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
153682085|NCT00127504|Antitubercular Agents|antitubercular agents|mesh-ancestor
153682086|NCT00127504|Leprostatic Agents|leprostatic agents|mesh-ancestor
153682087|NCT00127504|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153682088|NCT00127504|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153682089|NCT00127504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153682090|NCT00127504|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
153682091|NCT00127504|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
153682092|NCT00127504|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
153682093|NCT00127504|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
153682094|NCT00127504|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
153682095|NCT00127504|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
153682096|NCT00043901|Lamotrigine|lamotrigine|mesh-list
153682097|NCT00043901|Anticonvulsants|anticonvulsants|mesh-ancestor
153682098|NCT00043901|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153682099|NCT00043901|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153682100|NCT00043901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153682101|NCT00043901|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153682102|NCT00043901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153682103|NCT00043901|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153682104|NCT00043901|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153682105|NCT00043901|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153682106|NCT00043901|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153682107|NCT00043901|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153682108|NCT00127777|Amantadine|amantadine|mesh-list
153682118|NCT00127777|Analgesics|analgesics|mesh-ancestor
153682119|NCT00127777|Sensory System Agents|sensory system agents|mesh-ancestor
153682120|NCT00127777|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153682121|NCT00399633|Sumatriptan|sumatriptan|mesh-list
153682122|NCT00399633|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
153682123|NCT00399633|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
153682124|NCT00399633|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
153682125|NCT00399633|Serotonin Agents|serotonin agents|mesh-ancestor
153682126|NCT00399633|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153682127|NCT00399633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153682128|NCT00399633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153682129|NCT04726657|Insulin|insulin|mesh-list
153682130|NCT04726657|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
153682131|NCT04726657|Insulin, Isophane|insulin, isophane|mesh-list
153682132|NCT04726657|Isophane Insulin, Human|isophane insulin, human|mesh-list
153682133|NCT04726657|Isophane insulin, beef|isophane insulin, beef|mesh-list
153682134|NCT04726657|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153682135|NCT04726657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153682136|NCT00402610|Rifampin|rifampin|mesh-list
153682137|NCT00402610|Isoniazid|isoniazid|mesh-list
153682138|NCT00402610|Pyrazinamide|pyrazinamide|mesh-list
153682139|NCT00402610|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
153682140|NCT00402610|Antitubercular Agents|antitubercular agents|mesh-ancestor
153682141|NCT00402610|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153682142|NCT00402610|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153682169|NCT00402766|Hormones|hormones|mesh-ancestor
153682170|NCT00402766|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153682171|NCT00402766|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153682172|NCT00402766|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153682173|NCT00402766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153682174|NCT00402766|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153682175|NCT00402766|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153682176|NCT00402766|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153682177|NCT00402766|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153682178|NCT00127972|Lamivudine|lamivudine|mesh-list
153682179|NCT00127972|Efavirenz|efavirenz|mesh-list
153682180|NCT00127972|Nevirapine|nevirapine|mesh-list
153682231|NCT00078195|Immunologic Factors|immunologic factors|mesh-list
153682232|NCT00078195|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
153682233|NCT00078195|Immunomodulating Agents|immunomodulating agents|mesh-list
153682234|NCT00078195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153682235|NCT00078195|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
153682236|NCT00078195|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153682237|NCT00078195|Respiratory System Agents|respiratory system agents|mesh-ancestor
153682238|NCT00044291|Toremifene|toremifene|mesh-list
153682239|NCT00044291|Letrozole|letrozole|mesh-list
153682240|NCT00044291|Hormones|hormones|mesh-list
153682241|NCT00044291|Atamestane|atamestane|mesh-list
153682242|NCT00044291|Estrogen Antagonists|estrogen antagonists|mesh-list
153682243|NCT00044291|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-list
153682244|NCT00044291|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-list
153682245|NCT00044291|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153682246|NCT00044291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153682247|NCT00044291|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153682248|NCT00044291|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
153682249|NCT00044291|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153682250|NCT00044291|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153682251|NCT00044291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153682252|NCT00044291|Hormone Antagonists|hormone antagonists|mesh-ancestor
153682253|NCT00044291|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153682254|NCT00044291|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
153682282|NCT05519917|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153682283|NCT05519917|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153682284|NCT05519917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153682285|NCT05519917|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153682287|NCT00078390|Matrix Metalloproteinase Inhibitors|matrix metalloproteinase inhibitors|mesh-ancestor
153682288|NCT00078390|Protease Inhibitors|protease inhibitors|mesh-ancestor
153682289|NCT00078390|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153682290|NCT00078390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153682292|NCT00044486|Antifungal Agents|antifungal agents|mesh-ancestor
153682293|NCT00044486|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153682294|NCT00044486|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
153682295|NCT00044486|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153682296|NCT00044486|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153682297|NCT00044486|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
153682298|NCT00044486|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153682299|NCT00044486|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153682308|NCT00044525|Taxane|taxane|mesh-list
153682336|NCT00044642|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153682337|NCT00044642|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153682338|NCT00044642|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153682339|NCT00044642|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153682340|NCT00044642|GABA Modulators|gaba modulators|mesh-ancestor
153682341|NCT00044642|GABA Agents|gaba agents|mesh-ancestor
153682342|NCT00044642|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153682343|NCT00044642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153682344|NCT00044681|Risperidone|risperidone|mesh-list
153682345|NCT00044681|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153682346|NCT00044681|Serotonin Agents|serotonin agents|mesh-ancestor
153682347|NCT00044681|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153682348|NCT00044681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153682349|NCT00044681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153682350|NCT00044681|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153682351|NCT00044681|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153682352|NCT00044681|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153682353|NCT00044681|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153682354|NCT00044681|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
153682355|NCT00044681|Dopamine Agents|dopamine agents|mesh-ancestor
153682356|NCT00044720|Sirolimus|sirolimus|mesh-list
153682357|NCT00044720|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153682358|NCT00044720|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153682359|NCT00044720|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153682360|NCT00044720|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153682361|NCT00044720|Antifungal Agents|antifungal agents|mesh-ancestor
153682362|NCT00044720|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153682383|NCT00078858|Cyclosporine|cyclosporine|mesh-list
153682384|NCT00078858|Mycophenolic Acid|mycophenolic acid|mesh-list
153682385|NCT00078858|Fludarabine|fludarabine|mesh-list
153682386|NCT00078858|Fludarabine phosphate|fludarabine phosphate|mesh-list
153682387|NCT00078858|Cyclosporins|cyclosporins|mesh-list
153682388|NCT00078858|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153682389|NCT00078858|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153682390|NCT00078858|Antimetabolites|antimetabolites|mesh-ancestor
153682391|NCT00078858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153682392|NCT00078858|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153682393|NCT00078858|Immunologic Factors|immunologic factors|mesh-ancestor
153682394|NCT00078858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153682395|NCT00078858|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153682396|NCT00078858|Antifungal Agents|antifungal agents|mesh-ancestor
153682397|NCT00078858|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153682398|NCT00078858|Dermatologic Agents|dermatologic agents|mesh-ancestor
153682399|NCT00078858|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153682400|NCT00078858|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
153682401|NCT00078858|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153682402|NCT00078858|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
153682403|NCT00078858|Antitubercular Agents|antitubercular agents|mesh-ancestor
153682404|NCT00078858|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153682405|NCT00044759|Tazobactam|tazobactam|mesh-list
153682406|NCT00044759|Piperacillin|piperacillin|mesh-list
153682407|NCT00044759|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
153682408|NCT00044759|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153883107|NCT01588782|Ketoconazole|ketoconazole|mesh-list
153682409|NCT00044759|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153682410|NCT00044759|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
153682411|NCT00044759|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153682412|NCT00044759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153682426|NCT00074841|Chloroquine diphosphate|chloroquine diphosphate|mesh-list
153682427|NCT00074841|Pyrimethamine|pyrimethamine|mesh-list
153682428|NCT00074841|Sulfadoxine|sulfadoxine|mesh-list
153682429|NCT00074841|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
153682430|NCT00074841|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153682431|NCT00074841|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153682432|NCT00074841|Amebicides|amebicides|mesh-ancestor
153682433|NCT00074841|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153682434|NCT00074841|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153682435|NCT00074841|Antimalarials|antimalarials|mesh-ancestor
153682436|NCT00074841|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153682437|NCT00074841|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153682438|NCT00074841|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153682439|NCT00074841|Analgesics|analgesics|mesh-ancestor
153682440|NCT00074841|Sensory System Agents|sensory system agents|mesh-ancestor
153682441|NCT00074841|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153682442|NCT00074841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153682443|NCT00074841|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153682444|NCT00074841|Filaricides|filaricides|mesh-ancestor
153682445|NCT00074841|Antinematodal Agents|antinematodal agents|mesh-ancestor
153682446|NCT00074841|Anthelmintics|anthelmintics|mesh-ancestor
153682447|NCT00074841|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153682465|NCT00044837|Hormones|hormones|mesh-ancestor
153682479|NCT04457557|Anesthetics, Local|anesthetics, local|mesh-list
153682481|NCT04457557|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153682482|NCT04457557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153682483|NCT04457557|Sensory System Agents|sensory system agents|mesh-ancestor
153682484|NCT04457557|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153682485|NCT00044876|Ulipristal acetate|ulipristal acetate|mesh-list
153682486|NCT00044876|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
153682487|NCT00044876|Contraceptive Agents|contraceptive agents|mesh-ancestor
153682488|NCT00044876|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153682489|NCT00044876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153682490|NCT00044876|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
153682491|NCT00079014|Doxorubicin|doxorubicin|mesh-list
153682492|NCT00079014|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
153682493|NCT00079014|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153682494|NCT00079014|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153682495|NCT00079014|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153682496|NCT00079014|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153682497|NCT00079014|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153682498|NCT00079014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153682499|NCT00397475|Cholecalciferol|cholecalciferol|mesh-list
153682500|NCT00397475|Vitamin D|vitamin d|mesh-list
153682531|NCT00044954|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153682532|NCT00044954|Antimetabolites|antimetabolites|mesh-ancestor
153682533|NCT00044954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153682534|NCT00044954|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153682535|NCT00044954|Immunologic Factors|immunologic factors|mesh-ancestor
153682536|NCT00044954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153682537|NCT00044954|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153682538|NCT00044954|Antifungal Agents|antifungal agents|mesh-ancestor
153682539|NCT00044954|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153682540|NCT00044954|Dermatologic Agents|dermatologic agents|mesh-ancestor
153682541|NCT00044954|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153682542|NCT00044954|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
153682543|NCT00044954|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153682544|NCT00044954|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
153384840|NCT00559754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153384841|NCT03402243|Menthol|menthol|mesh-list
153384842|NCT03402243|Antipruritics|antipruritics|mesh-ancestor
153384843|NCT03402243|Dermatologic Agents|dermatologic agents|mesh-ancestor
153384844|NCT01841606|Ondansetron|ondansetron|mesh-list
153384845|NCT01841606|Antiemetics|antiemetics|mesh-ancestor
153384860|NCT04392141|Tubulin Modulators|tubulin modulators|mesh-ancestor
153384861|NCT04392141|Antimitotic Agents|antimitotic agents|mesh-ancestor
153682545|NCT00044954|Antitubercular Agents|antitubercular agents|mesh-ancestor
153682546|NCT00044954|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153682547|NCT00079092|Thalidomide|thalidomide|mesh-list
153682548|NCT00079092|Procarbazine|procarbazine|mesh-list
153682549|NCT00079092|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153682550|NCT00079092|Immunologic Factors|immunologic factors|mesh-ancestor
153682551|NCT00079092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153682552|NCT00079092|Leprostatic Agents|leprostatic agents|mesh-ancestor
153682553|NCT00079092|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153682554|NCT00079092|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153682555|NCT00079092|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153682556|NCT00079092|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153682557|NCT00079092|Growth Substances|growth substances|mesh-ancestor
153682558|NCT00079092|Growth Inhibitors|growth inhibitors|mesh-ancestor
153682559|NCT00079092|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153682560|NCT00044993|Docetaxel|docetaxel|mesh-list
153682561|NCT00044993|Doxorubicin|doxorubicin|mesh-list
153682577|NCT00045149|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153682578|NCT00045149|Antiviral Agents|antiviral agents|mesh-ancestor
153682579|NCT00045149|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153682580|NCT00045188|Imatinib Mesylate|imatinib mesylate|mesh-list
153682581|NCT00045188|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153682582|NCT00045188|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153682583|NCT00045188|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153682584|NCT00045188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153682585|NCT00045188|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153682586|NCT00403156|Ranibizumab|ranibizumab|mesh-list
153682587|NCT00403156|Imatinib Mesylate|imatinib mesylate|mesh-list
153682588|NCT00403156|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153682589|NCT00403156|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153682590|NCT00403156|Growth Substances|growth substances|mesh-ancestor
153682591|NCT00403156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153682592|NCT00403156|Growth Inhibitors|growth inhibitors|mesh-ancestor
153682593|NCT00403156|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153682594|NCT00403156|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153682595|NCT00403156|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153682596|NCT00403156|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153682597|NCT00403156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153682598|NCT00045227|Docetaxel|docetaxel|mesh-list
153682599|NCT00045227|Vaccines|vaccines|mesh-list
153682600|NCT00045227|Sargramostim|sargramostim|mesh-list
153682601|NCT00045227|Immunologic Factors|immunologic factors|mesh-ancestor
153682624|NCT04065451|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153682625|NCT04065451|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153682626|NCT04065451|Respiratory System Agents|respiratory system agents|mesh-ancestor
153682627|NCT04065451|Mydriatics|mydriatics|mesh-ancestor
153682628|NCT04065451|Sympathomimetics|sympathomimetics|mesh-ancestor
153682629|NCT04065451|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
153682630|NCT00045266|Aflibercept|aflibercept|mesh-list
153682631|NCT00045266|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153682632|NCT00045266|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153682633|NCT00045266|Growth Substances|growth substances|mesh-ancestor
153682634|NCT00045266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153682635|NCT00045266|Growth Inhibitors|growth inhibitors|mesh-ancestor
153682636|NCT00045266|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153682637|NCT03948568|Tamoxifen|tamoxifen|mesh-list
153682638|NCT03948568|Letrozole|letrozole|mesh-list
153682639|NCT03948568|Anastrozole|anastrozole|mesh-list
153384862|NCT04392141|Mitosis Modulators|mitosis modulators|mesh-ancestor
153384863|NCT04392141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153384864|NCT04392141|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153384865|NCT04838054|Chlorine dioxide|chlorine dioxide|mesh-list
153384866|NCT04838054|Dental Disinfectants|dental disinfectants|mesh-ancestor
153384867|NCT04838054|Disinfectants|disinfectants|mesh-ancestor
153384868|NCT04838054|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153384869|NCT00559364|Omeprazole|omeprazole|mesh-list
153384870|NCT00559364|Pancrelipase|pancrelipase|mesh-list
153384871|NCT00559364|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
153424051|NCT03572972|Apixaban|apixaban|mesh-list
153424052|NCT03572972|Anticoagulants|anticoagulants|mesh-ancestor
153424053|NCT03572972|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
153424054|NCT03572972|Antithrombins|antithrombins|mesh-ancestor
153424055|NCT03572972|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
153424056|NCT03572972|Protease Inhibitors|protease inhibitors|mesh-ancestor
153424057|NCT03572972|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153424058|NCT03572972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153682640|NCT03948568|Exemestane|exemestane|mesh-list
153682641|NCT03948568|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153682642|NCT03948568|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
153682643|NCT03948568|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153682644|NCT03948568|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153682645|NCT03948568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153682646|NCT03948568|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
153682647|NCT03948568|Hormone Antagonists|hormone antagonists|mesh-ancestor
153682654|NCT03928366|Remifentanil|remifentanil|mesh-list
153682676|NCT00045422|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153682677|NCT00045422|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153682678|NCT00045422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153682679|NCT00075192|Leuprolide|leuprolide|mesh-list
153682680|NCT00075192|Bicalutamide|bicalutamide|mesh-list
153682681|NCT00075192|Tremelimumab|tremelimumab|mesh-list
153682682|NCT00075192|Fertility Agents, Female|fertility agents, female|mesh-ancestor
153682683|NCT00075192|Fertility Agents|fertility agents|mesh-ancestor
153682684|NCT00075192|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153682685|NCT00075192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153682686|NCT00075192|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153682687|NCT00075192|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153682688|NCT00075192|Androgen Antagonists|androgen antagonists|mesh-ancestor
153682689|NCT00075192|Hormone Antagonists|hormone antagonists|mesh-ancestor
153682690|NCT00075192|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153682691|NCT00045461|Carboplatin|carboplatin|mesh-list
153682692|NCT00045461|Ifosfamide|ifosfamide|mesh-list
153682693|NCT00045461|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153682694|NCT00045461|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153682695|NCT00045461|Alkylating Agents|alkylating agents|mesh-ancestor
153682696|NCT00045461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153682697|NCT00075231|Ritonavir|ritonavir|mesh-list
153682698|NCT00075231|Lopinavir|lopinavir|mesh-list
153682727|NCT00403312|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
153682728|NCT00403312|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
153682729|NCT00403312|Cholinergic Agents|cholinergic agents|mesh-ancestor
153424059|NCT04352660|Mitomycins|mitomycins|mesh-list
153424060|NCT04352660|Mitomycin|mitomycin|mesh-list
153883122|NCT02272101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153883123|NCT02272101|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153883124|NCT02278133|Cetuximab|cetuximab|mesh-list
153682730|NCT00403312|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153682731|NCT00403312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153682732|NCT00079170|Docetaxel|docetaxel|mesh-list
153682733|NCT00079170|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153682734|NCT00079170|Tubulin Modulators|tubulin modulators|mesh-ancestor
153682735|NCT00079170|Antimitotic Agents|antimitotic agents|mesh-ancestor
153682736|NCT00079170|Mitosis Modulators|mitosis modulators|mesh-ancestor
153682737|NCT00079170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153682738|NCT00045500|Prednisone|prednisone|mesh-list
153682739|NCT00045500|7-hydroxystaurosporine|7-hydroxystaurosporine|mesh-list
153682740|NCT00045500|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153682741|NCT00045500|Glucocorticoids|glucocorticoids|mesh-ancestor
153682742|NCT00045500|Hormones|hormones|mesh-ancestor
153682743|NCT00045500|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153682744|NCT00045500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153682745|NCT00045500|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153682746|NCT00045500|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153682747|NCT00045500|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153682748|NCT00045500|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153682749|NCT00045500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153682750|NCT00045539|Leucovorin|leucovorin|mesh-list
153519678|NCT05671172|Anesthetics, Local|anesthetics, local|mesh-ancestor
153682775|NCT00045539|Micronutrients|micronutrients|mesh-ancestor
153682776|NCT00045539|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153682777|NCT00045539|Alkylating Agents|alkylating agents|mesh-ancestor
153682778|NCT00045539|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153682779|NCT00079248|Progesterone|progesterone|mesh-list
153682780|NCT00079248|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
153682781|NCT00079248|Estrogens|estrogens|mesh-list
153682782|NCT00079248|Progestins|progestins|mesh-ancestor
153682783|NCT00079248|Hormones|hormones|mesh-ancestor
153682784|NCT00079248|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153682785|NCT00079248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153682786|NCT00045617|Etoposide|etoposide|mesh-list
153682787|NCT00045617|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
153682788|NCT00045617|Vaccines|vaccines|mesh-list
153682789|NCT00045617|Antibodies|antibodies|mesh-list
153682790|NCT00045617|Immunoglobulins|immunoglobulins|mesh-list
153682801|NCT03399838|Midazolam|midazolam|mesh-list
153682836|NCT00079287|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153682837|NCT00079287|Antimetabolites|antimetabolites|mesh-ancestor
153682838|NCT00045695|Bortezomib|bortezomib|mesh-list
153682839|NCT00045695|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153682840|NCT00079365|Gemcitabine|gemcitabine|mesh-list
153682841|NCT00079365|Fluorouracil|fluorouracil|mesh-list
153682842|NCT00079365|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153682844|NCT00079365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153682845|NCT00079365|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153682846|NCT00079365|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153682847|NCT00079365|Immunologic Factors|immunologic factors|mesh-ancestor
153682848|NCT00079365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153682849|NCT00045773|Sertraline|sertraline|mesh-list
153682850|NCT00045773|Antidepressive Agents|antidepressive agents|mesh-ancestor
153682851|NCT00045773|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153682852|NCT00045773|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
153682853|NCT00045773|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153682854|NCT00045773|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153682855|NCT00045773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153682856|NCT00045773|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153682857|NCT00045773|Serotonin Agents|serotonin agents|mesh-ancestor
153682858|NCT00045773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153682859|NCT00045812|Ezetimibe|ezetimibe|mesh-list
153682886|NCT02580838|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
153682887|NCT02580838|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153682888|NCT02580838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153682889|NCT02580838|Cholinergic Agents|cholinergic agents|mesh-ancestor
153682890|NCT02580838|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153682892|NCT00403429|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153682893|NCT00403429|Antimetabolites|antimetabolites|mesh-ancestor
153682894|NCT00403429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153682895|NCT00403429|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153682896|NCT00403624|Oxaliplatin|oxaliplatin|mesh-list
153682898|NCT00079560|Dronabinol|dronabinol|mesh-list
153682947|NCT00046241|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153682948|NCT00046241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153682949|NCT00046241|Dopamine Agents|dopamine agents|mesh-ancestor
153682950|NCT00046241|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153682951|NCT00046241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153682952|NCT00046241|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
153682953|NCT00046241|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153682954|NCT00046241|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153682955|NCT00079716|Dacetuzumab|dacetuzumab|mesh-list
153682956|NCT00079716|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153682957|NCT00079716|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153682958|NCT00130468|Hyaluronic Acid|hyaluronic acid|mesh-list
153682959|NCT00130468|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153682960|NCT00130468|Immunologic Factors|immunologic factors|mesh-ancestor
153682961|NCT00130468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153682962|NCT00130468|Viscosupplements|viscosupplements|mesh-ancestor
153682963|NCT00130468|Protective Agents|protective agents|mesh-ancestor
153682964|NCT00130507|Capecitabine|capecitabine|mesh-list
153682965|NCT00130507|Trastuzumab|trastuzumab|mesh-list
153682966|NCT00130507|Vinorelbine|vinorelbine|mesh-list
153682967|NCT00130507|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153682968|NCT00130507|Antimetabolites|antimetabolites|mesh-ancestor
153682969|NCT00130507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153682970|NCT00130507|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153682971|NCT00130507|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153682972|NCT00130507|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153682973|NCT00130507|Tubulin Modulators|tubulin modulators|mesh-ancestor
153682974|NCT00130507|Antimitotic Agents|antimitotic agents|mesh-ancestor
153682992|NCT00130585|Vitamin B Complex|vitamin b complex|mesh-list
153682993|NCT00130585|Hematinics|hematinics|mesh-ancestor
153682994|NCT00130585|Vitamins|vitamins|mesh-ancestor
153682995|NCT00130585|Micronutrients|micronutrients|mesh-ancestor
153682996|NCT00130585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153682997|NCT00079755|Brentuximab Vedotin|brentuximab vedotin|mesh-list
153682998|NCT00079755|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153682999|NCT00079755|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153683000|NCT00079755|Immunotoxins|immunotoxins|mesh-ancestor
153683001|NCT00079755|Immunoconjugates|immunoconjugates|mesh-ancestor
153683002|NCT00079755|Immunologic Factors|immunologic factors|mesh-ancestor
153683003|NCT00079755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153683004|NCT00130702|Gefitinib|gefitinib|mesh-list
153683005|NCT00130702|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153683006|NCT00130702|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153683007|NCT00130702|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153683008|NCT00130702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153683009|NCT00130702|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153683049|NCT00079872|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153683050|NCT00046358|Ibuprofen|ibuprofen|mesh-list
153683051|NCT00046358|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153883125|NCT02278133|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153883126|NCT02278133|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153883127|NCT01687868|Dexmedetomidine|dexmedetomidine|mesh-list
153883128|NCT01687868|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153883129|NCT01687868|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153883130|NCT01687868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153883131|NCT01687868|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153883132|NCT01687868|Analgesics|analgesics|mesh-ancestor
153883133|NCT01687868|Sensory System Agents|sensory system agents|mesh-ancestor
153883137|NCT01687868|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153883144|NCT01688024|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153883145|NCT01688024|Alkylating Agents|alkylating agents|mesh-ancestor
153883146|NCT01688024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153883147|NCT01688024|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153883148|NCT01688024|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153683052|NCT00046358|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153683053|NCT00046358|Analgesics|analgesics|mesh-ancestor
153683054|NCT00046358|Sensory System Agents|sensory system agents|mesh-ancestor
153683055|NCT00046358|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153683056|NCT00046358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153683057|NCT00046358|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153683058|NCT00046358|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153683059|NCT00046358|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153683060|NCT00046358|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153683061|NCT00046358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153683062|NCT00130936|Carboplatin|carboplatin|mesh-list
153683063|NCT00130936|Capecitabine|capecitabine|mesh-list
153683064|NCT00130936|Epirubicin|epirubicin|mesh-list
153683065|NCT00130936|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153683066|NCT00130936|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153683067|NCT00130936|Antimetabolites|antimetabolites|mesh-ancestor
153683068|NCT00130936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153683069|NCT00130936|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153683070|NCT00130936|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153683071|NCT00130936|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153683072|NCT00130936|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153683073|NCT00130975|Candesartan|candesartan|mesh-list
153683074|NCT00130975|Candesartan cilexetil|candesartan cilexetil|mesh-list
153683075|NCT00130975|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153683076|NCT00130975|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
153683077|NCT00130975|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
153683078|NCT00130975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153683079|NCT00131053|Cytarabine|cytarabine|mesh-list
153683080|NCT00131053|Dexamethasone|dexamethasone|mesh-list
153683081|NCT00131053|Prednisolone|prednisolone|mesh-list
153883149|NCT01689623|Simeprevir|simeprevir|mesh-list
153883150|NCT01689623|Atorvastatin|atorvastatin|mesh-list
153883151|NCT01689623|Simvastatin|simvastatin|mesh-list
153883152|NCT01689623|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153883153|NCT01689623|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153883154|NCT01689623|Antimetabolites|antimetabolites|mesh-ancestor
153883155|NCT01689623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153883156|NCT01689623|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153883157|NCT01689623|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
153883158|NCT01689623|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153883159|NCT01689623|Antiviral Agents|antiviral agents|mesh-ancestor
153883160|NCT01689623|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153883161|NCT01689623|Protease Inhibitors|protease inhibitors|mesh-ancestor
153883162|NCT04055142|Cidofovir|cidofovir|mesh-list
153883163|NCT04055142|Antiviral Agents|antiviral agents|mesh-ancestor
153883164|NCT04055142|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153883165|NCT04055142|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153883166|NCT04055142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153883167|NCT02272647|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
153424086|NCT03964220|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153683082|NCT00131053|Hydrocortisone|hydrocortisone|mesh-list
153683083|NCT00131053|Cyclophosphamide|cyclophosphamide|mesh-list
153683094|NCT00131053|Alkylating Agents|alkylating agents|mesh-ancestor
153683095|NCT00131053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153683096|NCT00131053|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153683097|NCT00131053|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153683098|NCT00131053|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153683099|NCT00131053|Antiemetics|antiemetics|mesh-ancestor
153683100|NCT00131053|Autonomic Agents|autonomic agents|mesh-ancestor
153683101|NCT00131053|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153683102|NCT00131053|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153683103|NCT00131053|Glucocorticoids|glucocorticoids|mesh-ancestor
153683104|NCT00131053|Hormones|hormones|mesh-ancestor
153683106|NCT00131053|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153683144|NCT00079989|Tigecycline|tigecycline|mesh-list
153683145|NCT00079989|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153683146|NCT00079989|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153683147|NCT00079989|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
153683148|NCT00079989|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153683149|NCT00079989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153683151|NCT00131482|Hemostatics|hemostatics|mesh-ancestor
153683152|NCT00131482|Coagulants|coagulants|mesh-ancestor
153683153|NCT00397709|Rifampin|rifampin|mesh-list
153683154|NCT00397709|Isoniazid|isoniazid|mesh-list
153683155|NCT00397709|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
153683156|NCT00397709|Antitubercular Agents|antitubercular agents|mesh-ancestor
153683157|NCT00397709|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153683158|NCT00397709|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153683159|NCT00397709|Leprostatic Agents|leprostatic agents|mesh-ancestor
153683160|NCT00397709|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153683161|NCT00397709|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153683162|NCT00397709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153683163|NCT00397709|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
153683164|NCT00397709|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
153477655|NCT04908371|Mydriatics|mydriatics|mesh-ancestor
153683193|NCT00131716|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153424087|NCT03964220|Respiratory System Agents|respiratory system agents|mesh-ancestor
153424088|NCT03964220|Parasympatholytics|parasympatholytics|mesh-ancestor
153384873|NCT00559364|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153384874|NCT00559364|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153384875|NCT00559364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153384876|NCT05746676|Hyaluronic Acid|hyaluronic acid|mesh-list
153384877|NCT05746676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153384878|NCT05746676|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153384879|NCT05746676|Immunologic Factors|immunologic factors|mesh-ancestor
153384880|NCT05746676|Viscosupplements|viscosupplements|mesh-ancestor
153384881|NCT05746676|Protective Agents|protective agents|mesh-ancestor
153384882|NCT05746598|Cisplatin|cisplatin|mesh-list
153883168|NCT02272647|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
153883169|NCT02272647|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
153883170|NCT02272647|Medroxyprogesterone|medroxyprogesterone|mesh-list
153883171|NCT02272647|Estradiol|estradiol|mesh-list
153883172|NCT02272647|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
153883173|NCT02272647|Progesterone|progesterone|mesh-list
153883174|NCT02272647|Estrogens|estrogens|mesh-ancestor
153683194|NCT00131716|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153683195|NCT00131716|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153683196|NCT00131716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153683197|NCT00131716|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
153683198|NCT00080145|Risperidone|risperidone|mesh-list
153683199|NCT00080145|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153683200|NCT00080145|Serotonin Agents|serotonin agents|mesh-ancestor
153683201|NCT00080145|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153781921|NCT00259662|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153683202|NCT00080145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153683203|NCT00080145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153683204|NCT00080145|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153683205|NCT00080145|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153683206|NCT00080145|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153683207|NCT00080145|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153814289|NCT00338273|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
153814290|NCT00338273|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153814291|NCT00338273|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
153814292|NCT00338273|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
153814293|NCT00338312|Testosterone|testosterone|mesh-list
153814294|NCT00338312|Androgens|androgens|mesh-ancestor
153814295|NCT00338312|Hormones|hormones|mesh-ancestor
153814296|NCT00338312|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153814308|NCT00338390|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153814309|NCT00338390|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153814313|NCT00338390|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153814314|NCT00338390|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153814315|NCT00338390|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153814316|NCT00338390|Antimetabolites|antimetabolites|mesh-ancestor
153814317|NCT00338468|Epoetin Alfa|epoetin alfa|mesh-list
153814330|NCT00338546|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153814331|NCT00338546|Analgesics|analgesics|mesh-ancestor
153814332|NCT00338546|Sensory System Agents|sensory system agents|mesh-ancestor
153814333|NCT00338546|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153891424|NCT06024096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153891426|NCT06024096|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
153883175|NCT02272647|Hormones|hormones|mesh-ancestor
153883176|NCT02272647|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153883177|NCT02272647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153883178|NCT02272647|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
153883179|NCT02272647|Contraceptive Agents|contraceptive agents|mesh-ancestor
153883180|NCT02272647|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153424099|NCT04337138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153424100|NCT00422773|Cetuximab|cetuximab|mesh-list
153891427|NCT06024096|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153891428|NCT05983354|Ibuprofen|ibuprofen|mesh-list
153891429|NCT05983354|Ketorolac|ketorolac|mesh-list
153891430|NCT05983354|Metoclopramide|metoclopramide|mesh-list
153891431|NCT05983354|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153487654|NCT01962870|Arginine Vasopressin|arginine vasopressin|mesh-list
153891482|NCT05943691|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153891483|NCT05943691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153891484|NCT05943691|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153891485|NCT05943691|Glucocorticoids|glucocorticoids|mesh-ancestor
153891486|NCT05943691|Hormones|hormones|mesh-ancestor
153487995|NCT02054754|Protective Agents|protective agents|mesh-ancestor
153432527|NCT04740918|Immunologic Factors|immunologic factors|mesh-ancestor
153432528|NCT04740918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153432529|NCT04643470|Zanubrutinib|zanubrutinib|mesh-list
153432530|NCT04643470|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153432531|NCT04643470|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153432536|NCT04612751|Durvalumab|durvalumab|mesh-list
153432573|NCT04538742|Immunologic Factors|immunologic factors|mesh-ancestor
153488323|NCT02201394|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153891554|NCT05864625|Sevoflurane|sevoflurane|mesh-list
153891555|NCT05864625|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153894287|NCT00624429|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153820755|NCT00464919|Antimetabolites|antimetabolites|mesh-ancestor
153820756|NCT00434174|Pemetrexed|pemetrexed|mesh-list
153820757|NCT00434174|Everolimus|everolimus|mesh-list
153820758|NCT00434174|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153360745|NCT00815360|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153360747|NCT00815360|Immunologic Factors|immunologic factors|mesh-ancestor
153360748|NCT00815360|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153360749|NCT00815360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153360750|NCT01474109|Macitentan|macitentan|mesh-list
153360751|NCT01474109|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
153360752|NCT01474109|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
153360753|NCT01474109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153360754|NCT01474109|Endothelin B Receptor Antagonists|endothelin b receptor antagonists|mesh-ancestor
153360755|NCT01405937|Ribavirin|ribavirin|mesh-list
153360756|NCT01405937|Antimetabolites|antimetabolites|mesh-ancestor
153360757|NCT01405937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153360758|NCT01405937|Antiviral Agents|antiviral agents|mesh-ancestor
153360759|NCT01405937|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153360760|NCT01368653|Nicotine|nicotine|mesh-list
153360761|NCT01368653|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
153360762|NCT01368653|Autonomic Agents|autonomic agents|mesh-ancestor
153814635|NCT00452829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153814636|NCT00452907|Artesunate|artesunate|mesh-list
153814637|NCT00452907|Lumefantrine|lumefantrine|mesh-list
153814638|NCT00452907|Pyrimethamine|pyrimethamine|mesh-list
153360813|NCT01475513|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153360814|NCT01475513|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153360815|NCT01475513|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153437608|NCT00003734|Flutamide|flutamide|mesh-list
153814814|NCT00453648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153814815|NCT00453648|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
153814816|NCT00453648|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153814818|NCT00453648|Micronutrients|micronutrients|mesh-ancestor
153814819|NCT00343421|Vaccines|vaccines|mesh-list
153814982|NCT00447759|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
153814983|NCT00447759|Gout Suppressants|gout suppressants|mesh-ancestor
153424101|NCT00422773|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153424102|NCT00422773|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153424103|NCT03329209|Vedolizumab|vedolizumab|mesh-list
153424104|NCT03329209|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153424105|NCT03661346|Labetalol|labetalol|mesh-list
153424106|NCT03661346|Esmolol|esmolol|mesh-list
153424107|NCT03661346|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
153424108|NCT03661346|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
153782344|NCT00233558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153782346|NCT00233558|Dermatologic Agents|dermatologic agents|mesh-ancestor
153462806|NCT04129008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153462808|NCT04129008|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153462809|NCT04129008|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153462810|NCT04129008|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153462811|NCT04129008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153462812|NCT04129008|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153462813|NCT04129008|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153462814|NCT04129008|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153462816|NCT04128462|Phenylacetic acid|phenylacetic acid|mesh-list
153462817|NCT04128462|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153462981|NCT04393584|Leucovorin|leucovorin|mesh-list
153462982|NCT04393584|Docetaxel|docetaxel|mesh-list
153462983|NCT04393584|Oxaliplatin|oxaliplatin|mesh-list
153462984|NCT04393584|Irinotecan|irinotecan|mesh-list
153462985|NCT04393584|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153462986|NCT04393584|Tubulin Modulators|tubulin modulators|mesh-ancestor
153462987|NCT04393584|Antimitotic Agents|antimitotic agents|mesh-ancestor
153462988|NCT04393584|Mitosis Modulators|mitosis modulators|mesh-ancestor
153462989|NCT04393584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153463120|NCT02952222|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153463133|NCT04391478|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
153463134|NCT04391478|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
153463135|NCT04391478|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153463136|NCT04391478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153463176|NCT01450176|Sensory System Agents|sensory system agents|mesh-ancestor
153463177|NCT01450176|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153463178|NCT01450176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153463179|NCT01450176|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153463180|NCT01450176|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153463378|NCT01455870|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153463379|NCT01455870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153463380|NCT01455870|Incretins|incretins|mesh-ancestor
153463381|NCT01455870|Hormones|hormones|mesh-ancestor
153463382|NCT01455870|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153463383|NCT01455870|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
153463384|NCT01455870|Protease Inhibitors|protease inhibitors|mesh-ancestor
153463385|NCT01455870|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153463386|NCT01455870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153463387|NCT01455870|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
153463388|NCT01455870|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
153463389|NCT01456260|Lansoprazole|lansoprazole|mesh-list
153463390|NCT01456260|Dexlansoprazole|dexlansoprazole|mesh-list
153463391|NCT01456260|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
153914683|NCT01215851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153914684|NCT01215851|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153914685|NCT01215851|Antitubercular Agents|antitubercular agents|mesh-ancestor
153914686|NCT00613093|Temozolomide|temozolomide|mesh-list
153914687|NCT00613093|O(6)-benzylguanine|o(6)-benzylguanine|mesh-list
153914688|NCT00613093|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153914689|NCT00613093|Alkylating Agents|alkylating agents|mesh-ancestor
153914690|NCT00613093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153914691|NCT00613093|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153914692|NCT00613093|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153914693|NCT00607750|Mecamylamine|mecamylamine|mesh-list
153914694|NCT00607750|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153424109|NCT03661346|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
153424110|NCT03661346|Adrenergic Agents|adrenergic agents|mesh-ancestor
153424111|NCT03661346|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153424112|NCT03661346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153424113|NCT03661346|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153424114|NCT03661346|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153424115|NCT03661346|Sympathomimetics|sympathomimetics|mesh-ancestor
153424116|NCT03661346|Autonomic Agents|autonomic agents|mesh-ancestor
153384883|NCT05746598|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153914695|NCT00607750|Ganglionic Blockers|ganglionic blockers|mesh-ancestor
153914696|NCT00607750|Autonomic Agents|autonomic agents|mesh-ancestor
153914697|NCT00607750|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153914698|NCT00607750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153914699|NCT00607750|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
153914700|NCT00607750|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
153919583|NCT00003601|Dermatologic Agents|dermatologic agents|mesh-ancestor
153914707|NCT04908475|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153914708|NCT04908475|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153914709|NCT04908475|Analgesics|analgesics|mesh-ancestor
153914710|NCT04908475|Sensory System Agents|sensory system agents|mesh-ancestor
153914711|NCT04908475|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153914712|NCT04908475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153463392|NCT01456260|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153463393|NCT01456260|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
153463394|NCT01456260|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153463395|NCT01456260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153914725|NCT04570501|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153914726|NCT04570501|Vasodilator Agents|vasodilator agents|mesh-ancestor
153914727|NCT05198791|Eplerenone|eplerenone|mesh-list
153914728|NCT05198791|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
153914729|NCT05198791|Hormone Antagonists|hormone antagonists|mesh-ancestor
153914730|NCT05198791|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153914731|NCT05198791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153914732|NCT05198791|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
153914733|NCT05198791|Diuretics|diuretics|mesh-ancestor
153914734|NCT05198791|Natriuretic Agents|natriuretic agents|mesh-ancestor
153914735|NCT05198791|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153914737|NCT01010061|Obinutuzumab|obinutuzumab|mesh-list
153914738|NCT01010061|Chlorambucil|chlorambucil|mesh-list
153914739|NCT01010061|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153914740|NCT01010061|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153914741|NCT01010061|Immunologic Factors|immunologic factors|mesh-ancestor
153914742|NCT01010061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153914743|NCT01010061|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153914744|NCT01010061|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153914745|NCT01010061|Alkylating Agents|alkylating agents|mesh-ancestor
153463461|NCT04390464|Immunologic Factors|immunologic factors|mesh-ancestor
153463462|NCT04390464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153914753|NCT00607984|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153914754|NCT00607984|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153914755|NCT00607984|Immunologic Factors|immunologic factors|mesh-ancestor
153914756|NCT00607984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153914757|NCT00929734|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
153914758|NCT00929734|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-list
153914759|NCT00929734|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153914760|NCT00929734|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153914761|NCT00929734|Antimetabolites|antimetabolites|mesh-ancestor
153914762|NCT00929734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153914763|NCT00929734|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153914764|NCT00929734|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153914765|NCT00609856|Insulin Glargine|insulin glargine|mesh-list
153914766|NCT00609856|Pioglitazone|pioglitazone|mesh-list
153914767|NCT00609856|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153384884|NCT05745974|Fibrin fragment D|fibrin fragment d|mesh-list
153384885|NCT05745974|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
153384886|NCT05745974|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153384887|NCT05745974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153384888|NCT05745974|Hemostatics|hemostatics|mesh-ancestor
153384889|NCT05745974|Coagulants|coagulants|mesh-ancestor
153384890|NCT02306850|Pembrolizumab|pembrolizumab|mesh-list
153384891|NCT02306850|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153914768|NCT00609856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153914769|NCT04527757|Anesthetics|anesthetics|mesh-list
153914770|NCT04527757|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153463501|NCT01893294|Immunologic Factors|immunologic factors|mesh-ancestor
153914781|NCT00613561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153914782|NCT00613561|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153914783|NCT00613561|Immunologic Factors|immunologic factors|mesh-ancestor
153914784|NCT00613561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153914785|NCT00613561|Alkylating Agents|alkylating agents|mesh-ancestor
153914786|NCT00613561|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153914787|NCT00613561|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153914788|NCT01009983|Paclitaxel|paclitaxel|mesh-list
153463509|NCT01458054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153463510|NCT01458054|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153463511|NCT01458054|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153463512|NCT01458054|Antiviral Agents|antiviral agents|mesh-ancestor
153463513|NCT01458054|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153463514|NCT01458054|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
153463515|NCT01458054|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153463516|NCT01458054|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
153463517|NCT01458054|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153463518|NCT01458054|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
153463519|NCT01893450|Pentoxifylline|pentoxifylline|mesh-list
153463520|NCT01893450|Bromocriptine|bromocriptine|mesh-list
153463521|NCT01893450|Methimazole|methimazole|mesh-list
153463522|NCT01893450|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
153463523|NCT01893450|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153914817|NCT02873091|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153914818|NCT02873091|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153914819|NCT02873091|Narcotics|narcotics|mesh-ancestor
153914820|NCT02873091|Analgesics|analgesics|mesh-ancestor
153914821|NCT02873091|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153914822|NCT02873091|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153914823|NCT02873091|Anesthetics, General|anesthetics, general|mesh-ancestor
153914825|NCT04298775|Anesthetics|anesthetics|mesh-list
153914826|NCT04298775|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153914827|NCT04298775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153914828|NCT04298775|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153914829|NCT04298775|Narcotics|narcotics|mesh-ancestor
153914830|NCT04298775|Analgesics|analgesics|mesh-ancestor
153914831|NCT04298775|Sensory System Agents|sensory system agents|mesh-ancestor
153914832|NCT04298775|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153914833|NCT01215227|Rasagiline|rasagiline|mesh-list
153914851|NCT01214915|Anagrelide|anagrelide|mesh-list
153914852|NCT01214915|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153914853|NCT01214915|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153914854|NCT01214915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153914855|NCT01214915|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153914856|NCT01009203|Sirolimus|sirolimus|mesh-list
153914857|NCT01009203|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
153914859|NCT01009203|MTOR Inhibitors|mtor inhibitors|mesh-list
153914860|NCT01009203|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153914861|NCT01009203|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153914862|NCT01009203|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153914863|NCT01009203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153914864|NCT01009203|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153914865|NCT01009203|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153914866|NCT01009203|Immunologic Factors|immunologic factors|mesh-ancestor
153463584|NCT02742324|Interferon alpha-2|interferon alpha-2|mesh-list
153424117|NCT03661346|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153463585|NCT02742324|Interferon-alfa-1b|interferon-alfa-1b|mesh-list
153463586|NCT02742324|Antiviral Agents|antiviral agents|mesh-ancestor
153463587|NCT02742324|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153463588|NCT02742324|Immunologic Factors|immunologic factors|mesh-ancestor
153463589|NCT02742324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153463590|NCT02742324|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153463592|NCT01459146|Artemether|artemether|mesh-list
153914871|NCT01009203|Antifungal Agents|antifungal agents|mesh-ancestor
153463617|NCT05586750|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153463618|NCT05586750|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153463619|NCT05586750|Antimetabolites|antimetabolites|mesh-ancestor
153463621|NCT05586750|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153914905|NCT01008423|Budesonide|budesonide|mesh-list
153914906|NCT01008423|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153914907|NCT01008423|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153914908|NCT01008423|Autonomic Agents|autonomic agents|mesh-ancestor
153914961|NCT05345119|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
153914962|NCT05345119|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
153914963|NCT05345119|Prednisolone|prednisolone|mesh-list
153914964|NCT05345119|Prednisolone acetate|prednisolone acetate|mesh-list
153914965|NCT05345119|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
153914966|NCT05345119|Prednisolone phosphate|prednisolone phosphate|mesh-list
153914967|NCT05345119|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153914968|NCT05345119|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153914969|NCT05345119|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153914970|NCT05345119|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153463712|NCT02666742|Anticoagulants|anticoagulants|mesh-list
153463716|NCT02666742|Analgesics|analgesics|mesh-ancestor
153463751|NCT04390854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153463752|NCT04390854|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153463753|NCT04390854|Hormone Antagonists|hormone antagonists|mesh-ancestor
153463754|NCT04390854|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153463755|NCT04390854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153463756|NCT04390854|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
153463757|NCT04390854|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
153463758|NCT02630316|Treprostinil|treprostinil|mesh-list
153463759|NCT02630316|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153463778|NCT01451736|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153463779|NCT01451736|Serotonin Agents|serotonin agents|mesh-ancestor
153463780|NCT01451736|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153463781|NCT01451736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153463782|NCT01451736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153463783|NCT01451736|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153915225|NCT00848731|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153915226|NCT00848731|Respiratory System Agents|respiratory system agents|mesh-ancestor
153915227|NCT00848731|Free Radical Scavengers|free radical scavengers|mesh-ancestor
153915228|NCT00848731|Antioxidants|antioxidants|mesh-ancestor
153915229|NCT00848731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153915230|NCT00848731|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153915231|NCT00848731|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
153915232|NCT00848731|Vasodilator Agents|vasodilator agents|mesh-ancestor
153915233|NCT00848731|Gasotransmitters|gasotransmitters|mesh-ancestor
153463929|NCT02283996|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
153463930|NCT02283996|Protective Agents|protective agents|mesh-ancestor
153463931|NCT02283996|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153463932|NCT02283996|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153463933|NCT02369484|Afatinib|afatinib|mesh-list
153463934|NCT02369484|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153463935|NCT02369484|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153463940|NCT04390152|Lopinavir|lopinavir|mesh-list
153915248|NCT01209143|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
153915249|NCT01209143|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
153915250|NCT01209143|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153915251|NCT01209143|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
153915252|NCT00454285|Amoxicillin|amoxicillin|mesh-list
153883181|NCT02272647|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
153883182|NCT02272647|Progestins|progestins|mesh-ancestor
153883183|NCT02272647|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
153883184|NCT02272647|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
153883185|NCT02272647|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
153883186|NCT02272647|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
153883187|NCT02272647|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153883188|NCT02272647|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153883189|NCT02272764|Itraconazole|itraconazole|mesh-list
153915300|NCT02703571|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153915301|NCT02703571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153915302|NCT02703415|Tramadol|tramadol|mesh-list
153915303|NCT02703415|Bupivacaine|bupivacaine|mesh-list
153915304|NCT02703415|Anesthetics, Local|anesthetics, local|mesh-ancestor
153915305|NCT02703415|Anesthetics|anesthetics|mesh-ancestor
153915306|NCT02703415|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153915360|NCT01012713|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153915361|NCT01012713|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
153915362|NCT01012713|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153915363|NCT01012713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153915364|NCT01012713|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
153915366|NCT01012713|Micronutrients|micronutrients|mesh-ancestor
153915367|NCT01012713|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153915368|NCT02698813|Hyaluronic Acid|hyaluronic acid|mesh-list
153915369|NCT02698813|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153464325|NCT01740492|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153915641|NCT05324839|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
153915642|NCT05324839|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
153915643|NCT05324839|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
153915644|NCT05324839|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153915645|NCT05324839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153915646|NCT05324839|Cholinergic Agents|cholinergic agents|mesh-ancestor
153915647|NCT05324839|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153915648|NCT05324839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153915649|NCT05324839|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
153915650|NCT05324839|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153915651|NCT02700685|Methylphenidate|methylphenidate|mesh-list
153915652|NCT02700685|Pycnogenols|pycnogenols|mesh-list
153915653|NCT02700685|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
153915654|NCT02700685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153915655|NCT02700685|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
153915656|NCT02700685|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153915657|NCT02700685|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153915658|NCT02700685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153915659|NCT02700685|Dopamine Agents|dopamine agents|mesh-ancestor
153915660|NCT02700685|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153915661|NCT02700685|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153915662|NCT02700685|Immunologic Factors|immunologic factors|mesh-ancestor
153915663|NCT02700685|Antioxidants|antioxidants|mesh-ancestor
153915664|NCT02700685|Protective Agents|protective agents|mesh-ancestor
153915665|NCT02700685|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153915666|NCT02700763|Dabrafenib|dabrafenib|mesh-list
153915667|NCT02700763|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153915668|NCT02700763|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153915669|NCT02700763|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153915670|NCT02700763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153915671|NCT03151681|Propranolol|propranolol|mesh-list
153915672|NCT03151681|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
153915673|NCT03151681|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
153915674|NCT03151681|Adrenergic Agents|adrenergic agents|mesh-ancestor
153915675|NCT03151681|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153919590|NCT00003266|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
153915676|NCT03151681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153883190|NCT02272764|Hydroxyitraconazole|hydroxyitraconazole|mesh-list
153883191|NCT02272764|Antifungal Agents|antifungal agents|mesh-ancestor
153883192|NCT02272764|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153883193|NCT02272764|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
153883194|NCT02272764|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153883195|NCT02272764|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153883196|NCT02272764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153883197|NCT02272764|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153883198|NCT02272764|Hormone Antagonists|hormone antagonists|mesh-ancestor
153424118|NCT03661346|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
153915677|NCT03151681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153915681|NCT04215445|Empagliflozin|empagliflozin|mesh-list
153915733|NCT02699827|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153915735|NCT02705989|Branebrutinib|branebrutinib|mesh-list
153915736|NCT02705989|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153915737|NCT02705989|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153915738|NCT02705989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153915739|NCT02706067|Orlistat|orlistat|mesh-list
153915740|NCT02706067|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153915741|NCT02706067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153915742|NCT02706067|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
153915743|NCT02706067|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153915744|NCT05323201|Cyclophosphamide|cyclophosphamide|mesh-list
153915745|NCT05323201|Fludarabine|fludarabine|mesh-list
153915747|NCT05323201|Immunologic Factors|immunologic factors|mesh-ancestor
153915771|NCT05322889|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
153916143|NCT04209439|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153916144|NCT04209439|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153916145|NCT04209439|Analgesics|analgesics|mesh-ancestor
153916146|NCT04209439|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153916193|NCT00999921|Analgesics|analgesics|mesh-ancestor
153916758|NCT05392127|Anesthetics|anesthetics|mesh-ancestor
153916813|NCT01201265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153916814|NCT01201265|Growth Inhibitors|growth inhibitors|mesh-ancestor
153916815|NCT01201265|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153916816|NCT01201265|Antimetabolites|antimetabolites|mesh-ancestor
153916817|NCT01201265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153916818|NCT04246801|Clobetasol|clobetasol|mesh-list
153916819|NCT04246801|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153916820|NCT04246801|Glucocorticoids|glucocorticoids|mesh-ancestor
153916821|NCT04246801|Hormones|hormones|mesh-ancestor
153916822|NCT04246801|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153916971|NCT00638833|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
153916972|NCT00638833|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
153916973|NCT00638833|Dopamine Agents|dopamine agents|mesh-ancestor
153916974|NCT00638833|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153916975|NCT00638833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153916976|NCT00638833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153916977|NCT00638833|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
153916978|NCT00638833|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
153916979|NCT01198145|Sulfasalazine|sulfasalazine|mesh-list
153916980|NCT01198145|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153916981|NCT01198145|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153916982|NCT01198145|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153916983|NCT01198145|Analgesics|analgesics|mesh-ancestor
153916984|NCT01198145|Sensory System Agents|sensory system agents|mesh-ancestor
153916985|NCT01198145|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153465764|NCT00241176|Aripiprazole|aripiprazole|mesh-list
153465765|NCT00241176|Antidepressive Agents|antidepressive agents|mesh-ancestor
153465766|NCT00241176|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153465872|NCT00250926|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153465987|NCT00142506|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
153465988|NCT00142506|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153424119|NCT03661346|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
153465989|NCT00142506|Urological Agents|urological agents|mesh-ancestor
153465992|NCT05266794|Antioxidants|antioxidants|mesh-ancestor
153465993|NCT05266794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153465994|NCT05266794|Protective Agents|protective agents|mesh-ancestor
153917236|NCT02680717|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153466034|NCT00147966|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153466035|NCT00147966|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153466036|NCT00147966|Immunologic Factors|immunologic factors|mesh-ancestor
153466037|NCT00147966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153466039|NCT04528212|Glimepiride|glimepiride|mesh-list
153466091|NCT00151320|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153466092|NCT00151320|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153466216|NCT00350142|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153466390|NCT00359736|Urological Agents|urological agents|mesh-ancestor
153466391|NCT00360126|Lamotrigine|lamotrigine|mesh-list
153466392|NCT00360126|Anticonvulsants|anticonvulsants|mesh-ancestor
153466393|NCT00360126|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153466394|NCT00360126|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153466423|NCT01552590|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
153466427|NCT00549978|Cilostazol|cilostazol|mesh-list
153466483|NCT00361140|Antimetabolites|antimetabolites|mesh-ancestor
153466485|NCT00361140|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153917992|NCT02884128|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153917993|NCT02884128|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153917994|NCT02884128|Immunologic Factors|immunologic factors|mesh-ancestor
153918038|NCT01147458|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153918040|NCT01172808|Tiotropium Bromide|tiotropium bromide|mesh-list
153918094|NCT00601705|Antimetabolites|antimetabolites|mesh-ancestor
153918161|NCT01147068|Agglutinins|agglutinins|mesh-ancestor
153466847|NCT00459732|Zinc|zinc|mesh-list
153918162|NCT01147068|Immunologic Factors|immunologic factors|mesh-ancestor
153918163|NCT01147068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153918164|NCT01147068|Coagulants|coagulants|mesh-ancestor
153918218|NCT01146054|Gemcitabine|gemcitabine|mesh-list
153466922|NCT00462228|Memantine|memantine|mesh-list
153918219|NCT01146054|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
153466923|NCT00462228|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
153918220|NCT01146054|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153918263|NCT02883114|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
153918264|NCT02883114|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153918265|NCT02883114|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153918266|NCT02883114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153918267|NCT02883114|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153918268|NCT02883114|Hormone Antagonists|hormone antagonists|mesh-ancestor
153918309|NCT00931918|Alkylating Agents|alkylating agents|mesh-ancestor
153918310|NCT00931918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153918354|NCT02678221|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
153918393|NCT00642187|Respiratory System Agents|respiratory system agents|mesh-ancestor
153918394|NCT00642187|Glucocorticoids|glucocorticoids|mesh-ancestor
153918395|NCT00642187|Hormones|hormones|mesh-ancestor
153918396|NCT00642187|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153918397|NCT05663125|Temozolomide|temozolomide|mesh-list
153918398|NCT05663125|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153918399|NCT05663125|Alkylating Agents|alkylating agents|mesh-ancestor
153918400|NCT05663125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153918401|NCT05663125|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153918402|NCT01132482|Sildenafil Citrate|sildenafil citrate|mesh-list
153918403|NCT01132482|Vasodilator Agents|vasodilator agents|mesh-ancestor
153918404|NCT01132482|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
153424121|NCT03329911|Carboplatin|carboplatin|mesh-list
153424122|NCT03329911|Bevacizumab|bevacizumab|mesh-list
153424123|NCT03329911|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153424124|NCT03329911|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153424125|NCT03329911|Tubulin Modulators|tubulin modulators|mesh-ancestor
153424126|NCT03329911|Antimitotic Agents|antimitotic agents|mesh-ancestor
153424127|NCT03329911|Mitosis Modulators|mitosis modulators|mesh-ancestor
153424128|NCT03329911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153424129|NCT03329911|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153424131|NCT03329911|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153424132|NCT03329911|Growth Substances|growth substances|mesh-ancestor
153918405|NCT01132482|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
153918406|NCT01132482|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153918407|NCT01132482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153918418|NCT00641407|Insulin|insulin|mesh-list
153918436|NCT02677519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153918437|NCT02677519|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
153918438|NCT02677519|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153918499|NCT00975195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153918616|NCT05655221|Mitosis Modulators|mitosis modulators|mesh-ancestor
153918674|NCT00610948|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
153918675|NCT00610948|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153918676|NCT00610948|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153918677|NCT00610948|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153918896|NCT05907902|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153918955|NCT05906576|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153918956|NCT05906576|Dermatologic Agents|dermatologic agents|mesh-ancestor
153918957|NCT05906576|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153918958|NCT05906576|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153918959|NCT05906563|Metformin|metformin|mesh-list
153918960|NCT05906563|Melatonin|melatonin|mesh-list
153918961|NCT05906563|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153918962|NCT05906563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153918963|NCT05906563|Antioxidants|antioxidants|mesh-ancestor
153918964|NCT05906563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153918965|NCT05906563|Protective Agents|protective agents|mesh-ancestor
153918966|NCT05906563|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153919026|NCT05736874|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153467855|NCT00452868|Nootropic Agents|nootropic agents|mesh-ancestor
153467893|NCT00552786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153467894|NCT00552786|Protective Agents|protective agents|mesh-ancestor
153467933|NCT00553098|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153467934|NCT00553410|Letrozole|letrozole|mesh-list
153919228|NCT04410653|Afatinib|afatinib|mesh-list
153468029|NCT00556140|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
153919379|NCT03074045|Contraceptive Agents|contraceptive agents|mesh-ancestor
153919380|NCT03074045|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153919381|NCT03074045|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
153919382|NCT03074045|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
153919383|NCT03074045|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
153919384|NCT03074045|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
153919385|NCT03074045|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
153919388|NCT03074045|Diuretics|diuretics|mesh-ancestor
153919437|NCT02523040|Growth Substances|growth substances|mesh-ancestor
153919504|NCT00999804|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153919505|NCT00999804|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153919506|NCT00999804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153919507|NCT00999804|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
153919508|NCT00999804|Hormone Antagonists|hormone antagonists|mesh-ancestor
153919519|NCT00077129|Paclitaxel|paclitaxel|mesh-list
153424133|NCT03329911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153424134|NCT03329911|Growth Inhibitors|growth inhibitors|mesh-ancestor
153424135|NCT04322396|Azithromycin|azithromycin|mesh-list
153424136|NCT04322396|Hydroxychloroquine|hydroxychloroquine|mesh-list
153424137|NCT04322396|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153424138|NCT04322396|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153883199|NCT02272764|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153919591|NCT00003266|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153919592|NCT00003266|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153919695|NCT00642733|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153919593|NCT00003266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153919594|NCT00003266|Dopamine Agents|dopamine agents|mesh-ancestor
153919833|NCT02674243|Povidone|povidone|mesh-list
153919595|NCT00003266|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153468661|NCT06225505|FAPI-46|fapi-46|mesh-list
153919598|NCT00003236|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153919599|NCT00003236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153919600|NCT00003057|Octreotide|octreotide|mesh-list
153919601|NCT00003057|Loperamide|loperamide|mesh-list
153919602|NCT00003057|Antidiarrheals|antidiarrheals|mesh-list
153469210|NCT05421819|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153469211|NCT05418088|Cyclophosphamide|cyclophosphamide|mesh-list
153469213|NCT05418088|Fludarabine phosphate|fludarabine phosphate|mesh-list
153469214|NCT05418088|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153920449|NCT06331520|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153920450|NCT06331520|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153920451|NCT06331520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153920452|NCT06331520|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153920453|NCT06331520|Serotonin Agents|serotonin agents|mesh-ancestor
153920454|NCT06331520|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
153469282|NCT05298423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153469283|NCT05298423|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153919611|NCT00002922|Mitosis Modulators|mitosis modulators|mesh-ancestor
153919612|NCT00002922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153469455|NCT05034562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153469457|NCT05034562|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
153469458|NCT05034562|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
153469459|NCT05000697|Oxaliplatin|oxaliplatin|mesh-list
153469460|NCT05000697|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153469467|NCT04952753|Leucovorin|leucovorin|mesh-list
153469468|NCT04952753|Bevacizumab|bevacizumab|mesh-list
153469469|NCT04952753|Tislelizumab|tislelizumab|mesh-list
153469470|NCT04952753|Oxaliplatin|oxaliplatin|mesh-list
153469471|NCT04952753|Irinotecan|irinotecan|mesh-list
153920696|NCT06329882|Protease Inhibitors|protease inhibitors|mesh-ancestor
153920701|NCT06329882|Antimalarials|antimalarials|mesh-ancestor
153469576|NCT04798781|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153469577|NCT04798781|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153469578|NCT04798781|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153469579|NCT04798781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153469580|NCT04777357|Cariprazine|cariprazine|mesh-list
153469581|NCT04777357|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153469582|NCT04777357|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153469583|NCT04777357|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153469584|NCT04777357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153920815|NCT06326489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153920816|NCT06325943|Rituximab|rituximab|mesh-list
153920817|NCT06325943|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153920818|NCT06325943|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153469639|NCT04671667|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153469640|NCT04671667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153469642|NCT04663308|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153469643|NCT04659811|Pembrolizumab|pembrolizumab|mesh-list
153469644|NCT04659811|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153919621|NCT00002514|Imatinib Mesylate|imatinib mesylate|mesh-list
153919622|NCT00002514|Daunorubicin|daunorubicin|mesh-list
153883200|NCT02272764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153883201|NCT02272764|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
153883202|NCT01689896|Testosterone|testosterone|mesh-list
153883203|NCT01689896|Androgens|androgens|mesh-ancestor
153919623|NCT00002514|Asparaginase|asparaginase|mesh-list
153919624|NCT00002514|Mercaptopurine|mercaptopurine|mesh-list
153919625|NCT00002514|Thioguanine|thioguanine|mesh-list
153919626|NCT00002514|Sargramostim|sargramostim|mesh-list
153919627|NCT00002514|Levoleucovorin|levoleucovorin|mesh-list
153919628|NCT00002514|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153919629|NCT00002514|Immunologic Factors|immunologic factors|mesh-ancestor
153919630|NCT00002514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153919631|NCT00002514|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153919632|NCT00002514|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153919633|NCT00002514|Alkylating Agents|alkylating agents|mesh-ancestor
153920949|NCT06218511|Durvalumab|durvalumab|mesh-list
153920950|NCT06218511|Monatide (IMS 3015)|monatide (ims 3015)|mesh-list
153920951|NCT06218511|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153920952|NCT06218511|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153920953|NCT06218511|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153919634|NCT00002514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153919635|NCT00002514|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153919636|NCT00002514|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153919637|NCT00002514|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153919638|NCT00002514|Antiemetics|antiemetics|mesh-ancestor
153919639|NCT00002514|Autonomic Agents|autonomic agents|mesh-ancestor
153919640|NCT00002514|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153919641|NCT00002514|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153919642|NCT00002514|Glucocorticoids|glucocorticoids|mesh-ancestor
153919643|NCT00002514|Hormones|hormones|mesh-ancestor
153919644|NCT00002514|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153919645|NCT00002514|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153919646|NCT00002514|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
153919647|NCT00002514|Abortifacient Agents|abortifacient agents|mesh-ancestor
153919648|NCT00002514|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153919649|NCT00002514|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153919650|NCT00002514|Antimetabolites|antimetabolites|mesh-ancestor
153919651|NCT00002514|Dermatologic Agents|dermatologic agents|mesh-ancestor
153919652|NCT00002514|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153919653|NCT00002514|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153920997|NCT06191744|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153919673|NCT00607282|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
153919674|NCT00607282|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153919675|NCT00607282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153919676|NCT00927472|Permethrin|permethrin|mesh-list
153919677|NCT00927472|Malathion|malathion|mesh-list
153919678|NCT00927472|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153919679|NCT00927472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153919680|NCT00927472|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
153919681|NCT00927472|Cholinergic Agents|cholinergic agents|mesh-ancestor
153919682|NCT00927472|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153919683|NCT00927472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153919684|NCT00642655|Rituximab|rituximab|mesh-list
153921053|NCT06161025|Paclitaxel|paclitaxel|mesh-list
153921054|NCT06161025|Gemcitabine|gemcitabine|mesh-list
153921055|NCT06161025|Doxorubicin|doxorubicin|mesh-list
153921056|NCT06161025|Topotecan|topotecan|mesh-list
153921057|NCT06161025|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
153469816|NCT04305054|Lenvatinib|lenvatinib|mesh-list
153469817|NCT04305054|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153469818|NCT04305054|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153469819|NCT04305054|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153919689|NCT00642655|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153919690|NCT00642733|Gemcitabine|gemcitabine|mesh-list
153468447|NCT06297161|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153468448|NCT06297161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153468450|NCT06295562|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
153468451|NCT06295562|Oxybutynin|oxybutynin|mesh-list
153468452|NCT06295562|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
153384892|NCT02306850|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153384893|NCT02306850|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153468453|NCT06295562|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
153468454|NCT06295562|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153919691|NCT00642733|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
153919692|NCT00642733|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153919693|NCT00642733|Antimetabolites|antimetabolites|mesh-ancestor
153919694|NCT00642733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153919696|NCT00642733|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153919697|NCT00642733|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153919698|NCT00642733|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153919699|NCT00927394|Valsartan|valsartan|mesh-list
153919700|NCT00927394|Aliskiren|aliskiren|mesh-list
153919701|NCT00927394|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153919702|NCT00927394|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
153919703|NCT00927394|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
153919704|NCT00927394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153921071|NCT06146101|Acetazolamide|acetazolamide|mesh-list
153919711|NCT00643825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153919712|NCT00643825|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153919714|NCT04178863|Latanoprost|latanoprost|mesh-list
153919715|NCT04178863|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
153919716|NCT04178863|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
153919717|NCT04178863|Adrenergic Agents|adrenergic agents|mesh-ancestor
153919718|NCT04178863|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153919719|NCT04178863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153919720|NCT04178863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153919721|NCT04178863|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153919722|NCT04178863|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153919723|NCT04178863|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
153919724|NCT04178863|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
153919725|NCT04264858|Immunoglobulins|immunoglobulins|mesh-list
153919726|NCT04264858|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
153919727|NCT04264858|Antibodies|antibodies|mesh-list
153919728|NCT04264858|gamma-Globulins|gamma-globulins|mesh-list
153921112|NCT06119529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153921113|NCT06119529|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153921114|NCT06119529|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153469881|NCT04088890|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153919740|NCT00976911|Mitosis Modulators|mitosis modulators|mesh-ancestor
153919741|NCT00976911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153919742|NCT00976911|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153919743|NCT00976911|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153919744|NCT00976911|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153919745|NCT00976911|Growth Substances|growth substances|mesh-ancestor
153919746|NCT00976911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153919747|NCT00976911|Growth Inhibitors|growth inhibitors|mesh-ancestor
153468457|NCT06295562|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153919748|NCT00976911|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153919749|NCT00976911|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153919750|NCT00976911|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153919751|NCT00976911|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153919752|NCT00976911|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
153919753|NCT05336968|Triamcinolone|triamcinolone|mesh-list
153919754|NCT05336968|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
153919755|NCT05336968|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
153468511|NCT06286046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153468512|NCT06285396|Phenylephrine|phenylephrine|mesh-list
153468513|NCT06285396|Oxymetazoline|oxymetazoline|mesh-list
153468514|NCT06285396|Norepinephrine|norepinephrine|mesh-list
153468516|NCT06285396|Oxytocin|oxytocin|mesh-list
153468517|NCT06285396|Oxytocics|oxytocics|mesh-ancestor
153468518|NCT06285396|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153468519|NCT06285396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153919757|NCT05336968|Ropivacaine|ropivacaine|mesh-list
153384894|NCT02306850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153384895|NCT02306694|Factor VIII|factor viii|mesh-list
153384896|NCT02306694|Coagulants|coagulants|mesh-ancestor
153384897|NCT01648140|Interferons|interferons|mesh-list
153384898|NCT01648140|Ribavirin|ribavirin|mesh-list
153384899|NCT01648140|Interferon-alpha|interferon-alpha|mesh-list
153384900|NCT01648140|Interferon alpha-2|interferon alpha-2|mesh-list
153384902|NCT01648140|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153384903|NCT01648140|Antiviral Agents|antiviral agents|mesh-ancestor
153384904|NCT01648140|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153384905|NCT01648140|Antimetabolites|antimetabolites|mesh-ancestor
153384906|NCT01648140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153384907|NCT01648140|Immunologic Factors|immunologic factors|mesh-ancestor
153384908|NCT01648140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153384971|NCT04338009|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
153384973|NCT04338009|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153384974|NCT04338009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153384975|NCT02303574|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
153384976|NCT02354976|Fenofibrate|fenofibrate|mesh-list
153919758|NCT05336968|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
153921134|NCT06107413|Leucovorin|leucovorin|mesh-list
153921135|NCT06107413|Folic Acid|folic acid|mesh-list
153919759|NCT05336968|Anesthetics, Local|anesthetics, local|mesh-ancestor
153919760|NCT05336968|Anesthetics|anesthetics|mesh-ancestor
153919761|NCT05336968|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153919762|NCT05336968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153919763|NCT05336968|Sensory System Agents|sensory system agents|mesh-ancestor
153919764|NCT05336968|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153919765|NCT05336968|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153919766|NCT05336968|Glucocorticoids|glucocorticoids|mesh-ancestor
153919767|NCT05336968|Hormones|hormones|mesh-ancestor
153919768|NCT05336968|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153919769|NCT05336968|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153919770|NCT05336968|Immunologic Factors|immunologic factors|mesh-ancestor
153919771|NCT05336968|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153919772|NCT05336968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153919773|NCT05336968|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153919774|NCT05336968|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153469957|NCT03982485|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153469958|NCT03982485|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153469959|NCT03982485|Tubulin Modulators|tubulin modulators|mesh-ancestor
153469960|NCT03982485|Antimitotic Agents|antimitotic agents|mesh-ancestor
153469961|NCT03982485|Mitosis Modulators|mitosis modulators|mesh-ancestor
153469962|NCT03982485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153469963|NCT03982485|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153469964|NCT03982485|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153921182|NCT06105632|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
153921183|NCT06105632|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
153921184|NCT06105632|Hormone Antagonists|hormone antagonists|mesh-ancestor
153921185|NCT06105632|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153921186|NCT06105632|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
153921187|NCT06105632|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153384977|NCT02354976|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153384978|NCT02354976|Antimetabolites|antimetabolites|mesh-ancestor
153921191|NCT06097728|Carboplatin|carboplatin|mesh-list
153919781|NCT02674555|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153919782|NCT02674555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153919783|NCT00934648|Rituximab|rituximab|mesh-list
153919784|NCT00934648|Methotrexate|methotrexate|mesh-list
153919785|NCT00934648|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153919786|NCT00934648|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153919787|NCT00934648|Immunologic Factors|immunologic factors|mesh-ancestor
153919788|NCT00934648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153919789|NCT00934648|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153919790|NCT00934648|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
153919791|NCT00934648|Abortifacient Agents|abortifacient agents|mesh-ancestor
153919792|NCT00934648|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153919793|NCT00934648|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153919795|NCT00934648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153919796|NCT00934648|Dermatologic Agents|dermatologic agents|mesh-ancestor
153919797|NCT00934648|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153919798|NCT00934648|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153919799|NCT00934648|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153919800|NCT00934648|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153919801|NCT01175213|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
153919802|NCT01175213|gamma-Globulins|gamma-globulins|mesh-list
153919803|NCT01175213|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
153919804|NCT01175213|Immunologic Factors|immunologic factors|mesh-ancestor
153919805|NCT01175213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153921206|NCT06093893|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153921207|NCT06093893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153470004|NCT03850301|Etifoxine|etifoxine|mesh-list
153919806|NCT00644449|Azithromycin|azithromycin|mesh-list
153919807|NCT00644449|Levofloxacin|levofloxacin|mesh-list
153919808|NCT00644449|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153919809|NCT00644449|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153919810|NCT00644449|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
153919811|NCT00644449|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153919812|NCT00644449|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153919813|NCT00644449|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153919814|NCT00644449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153919815|NCT00644449|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153919816|NCT00644449|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
153919817|NCT00644449|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153919834|NCT02674243|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
153919835|NCT02674243|Plasma Substitutes|plasma substitutes|mesh-ancestor
153919836|NCT02674243|Blood Substitutes|blood substitutes|mesh-ancestor
153919837|NCT02674243|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
153919838|NCT02674243|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153919839|NCT04256200|Dienogest|dienogest|mesh-list
153919840|NCT04256200|Contraceptive Agents|contraceptive agents|mesh-list
153919841|NCT04256200|Contraceptives, Oral|contraceptives, oral|mesh-list
153919842|NCT04256200|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-list
153919843|NCT04256200|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153919844|NCT04256200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153919845|NCT04256200|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
153919846|NCT04256200|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
153919847|NCT04256200|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
153919848|NCT04256200|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
153919849|NCT04256200|Hormone Antagonists|hormone antagonists|mesh-ancestor
153919850|NCT04256200|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153919851|NCT04256200|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153919852|NCT04256200|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153919853|NCT00976677|Paclitaxel|paclitaxel|mesh-list
153919854|NCT00976677|Bevacizumab|bevacizumab|mesh-list
153919855|NCT00976677|Carboplatin|carboplatin|mesh-list
153921279|NCT06075147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153921280|NCT06075147|Growth Inhibitors|growth inhibitors|mesh-ancestor
153921281|NCT06075147|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153921282|NCT06073470|Methylphenidate|methylphenidate|mesh-list
153921283|NCT06073470|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
153921284|NCT06073470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153470044|NCT03784326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153470045|NCT03784326|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153470046|NCT03784326|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153470047|NCT03738852|Insulin|insulin|mesh-list
153470048|NCT03738852|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153470049|NCT03738852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153919856|NCT00976677|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
153919857|NCT00976677|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
153919858|NCT00976677|Antibodies|antibodies|mesh-list
153919859|NCT00976677|Immunoglobulins|immunoglobulins|mesh-list
153919873|NCT00976677|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153919874|NCT00976677|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153919876|NCT00642967|Epoetin Alfa|epoetin alfa|mesh-list
153919877|NCT00642967|Hematinics|hematinics|mesh-ancestor
153919878|NCT02865993|Povidone-Iodine|povidone-iodine|mesh-list
153919879|NCT02865993|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
153919880|NCT02865993|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153919881|NCT04287543|Melatonin|melatonin|mesh-list
153919882|NCT04287543|Antioxidants|antioxidants|mesh-ancestor
153919883|NCT04287543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153919884|NCT04287543|Protective Agents|protective agents|mesh-ancestor
153921315|NCT06048133|Gemcitabine|gemcitabine|mesh-list
153921316|NCT06048133|Quemliclustat|quemliclustat|mesh-list
153921317|NCT06048133|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153921318|NCT06048133|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153921319|NCT06048133|Antimetabolites|antimetabolites|mesh-ancestor
153921320|NCT06048133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153921321|NCT06048133|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153919885|NCT04287543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153919886|NCT04287543|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153919888|NCT04287387|Pioglitazone|pioglitazone|mesh-list
153919889|NCT04287387|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
153919890|NCT04287387|Metformin|metformin|mesh-list
153919891|NCT04287387|Glimepiride|glimepiride|mesh-list
153919892|NCT04287387|Acarbose|acarbose|mesh-list
153919893|NCT04287387|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
153919894|NCT04287387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153468649|NCT06236425|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153468650|NCT06236425|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153468651|NCT06236425|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153468652|NCT06236425|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153468653|NCT06236425|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153468654|NCT06236425|Analgesics|analgesics|mesh-ancestor
153468655|NCT06236425|Sensory System Agents|sensory system agents|mesh-ancestor
153468656|NCT06236425|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153468657|NCT06236425|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153921348|NCT06042478|Immunologic Factors|immunologic factors|mesh-ancestor
153921349|NCT06042478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153921350|NCT06042478|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153921351|NCT06042478|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153921352|NCT06042478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153921359|NCT06022068|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153921360|NCT06022068|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153468668|NCT06212271|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153468669|NCT06212271|Tubulin Modulators|tubulin modulators|mesh-ancestor
153468670|NCT06212271|Antimitotic Agents|antimitotic agents|mesh-ancestor
153468671|NCT06212271|Mitosis Modulators|mitosis modulators|mesh-ancestor
153384979|NCT02354976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153384980|NCT02354976|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153384982|NCT02303262|Mocetinostat|mocetinostat|mesh-list
153384983|NCT02303262|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153468672|NCT06212271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153468673|NCT06212271|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153919895|NCT04287387|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153919896|NCT04287387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153919897|NCT04287387|Incretins|incretins|mesh-ancestor
153919898|NCT04287387|Hormones|hormones|mesh-ancestor
153919899|NCT04287387|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153919900|NCT04287387|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
153919901|NCT04287387|Protease Inhibitors|protease inhibitors|mesh-ancestor
153919902|NCT04287387|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153919904|NCT04287387|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153919905|NCT04287387|Immunologic Factors|immunologic factors|mesh-ancestor
153919906|NCT04287387|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
153919907|NCT00644605|Sildenafil Citrate|sildenafil citrate|mesh-list
153919908|NCT00644605|Vasodilator Agents|vasodilator agents|mesh-ancestor
153919909|NCT00644605|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
153919910|NCT00644605|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
153919911|NCT00644605|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153919912|NCT00644605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153919913|NCT00644605|Urological Agents|urological agents|mesh-ancestor
153919914|NCT02865681|Letrozole|letrozole|mesh-list
153919915|NCT02865681|Clomiphene|clomiphene|mesh-list
153919916|NCT02865681|Enclomiphene|enclomiphene|mesh-list
153919917|NCT02865681|Zuclomiphene|zuclomiphene|mesh-list
153919918|NCT02865681|Menotropins|menotropins|mesh-list
153919919|NCT02865681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153919920|NCT02865681|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153468674|NCT06207799|Plerixafor|plerixafor|mesh-list
153919921|NCT02865681|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
153919922|NCT02865681|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153921390|NCT06001762|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
153919923|NCT02865681|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153919924|NCT02865681|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
153919925|NCT02865681|Hormone Antagonists|hormone antagonists|mesh-ancestor
153919926|NCT02865681|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153919927|NCT02865681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153919928|NCT02865681|Fertility Agents, Female|fertility agents, female|mesh-ancestor
153919929|NCT02865681|Fertility Agents|fertility agents|mesh-ancestor
153919930|NCT02865681|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153919931|NCT02865681|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
153919938|NCT00644137|Anticonvulsants|anticonvulsants|mesh-ancestor
153919939|NCT00644137|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153919940|NCT00644137|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153919941|NCT00644137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153919942|NCT00644137|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153468700|NCT06180382|Vedolizumab|vedolizumab|mesh-list
153468701|NCT06180382|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
153468702|NCT06180382|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153468703|NCT06180382|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153468704|NCT06180382|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153468705|NCT06172257|Dexamethasone|dexamethasone|mesh-list
153468707|NCT06172257|BB 1101|bb 1101|mesh-list
153468708|NCT06172257|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153468709|NCT06172257|Antiemetics|antiemetics|mesh-ancestor
153468710|NCT06172257|Autonomic Agents|autonomic agents|mesh-ancestor
153468711|NCT06172257|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153919943|NCT00644137|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153919944|NCT00644137|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153919945|NCT00644137|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153919946|NCT00644137|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153919947|NCT00910195|Acetaminophen|acetaminophen|mesh-list
153384984|NCT02303262|Antimetabolites|antimetabolites|mesh-ancestor
153384985|NCT02303262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153385048|NCT04310085|Antimalarials|antimalarials|mesh-ancestor
153385049|NCT04310085|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153385050|NCT04310085|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153385051|NCT04310085|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153385052|NCT00558272|Zoledronic Acid|zoledronic acid|mesh-list
153385053|NCT00558272|Saracatinib|saracatinib|mesh-list
153385054|NCT00558272|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153385055|NCT00558272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153385056|NCT00558272|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153385057|NCT00558272|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153385058|NCT00558272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153385059|NCT01859312|Hydrocortisone|hydrocortisone|mesh-list
153919948|NCT00910195|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153919949|NCT00910195|Analgesics|analgesics|mesh-ancestor
153919950|NCT00910195|Sensory System Agents|sensory system agents|mesh-ancestor
153919951|NCT00910195|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153919952|NCT00910195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153919953|NCT00910195|Antipyretics|antipyretics|mesh-ancestor
153919954|NCT04176367|Nicergoline|nicergoline|mesh-list
153919955|NCT04176367|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
153919956|NCT04176367|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
153919963|NCT04259476|Ketamine|ketamine|mesh-list
153919964|NCT04259476|Analgesics|analgesics|mesh-ancestor
153919965|NCT04259476|Sensory System Agents|sensory system agents|mesh-ancestor
153470219|NCT03321981|Exemestane|exemestane|mesh-list
153470220|NCT03321981|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153921447|NCT05964335|Sensory System Agents|sensory system agents|mesh-ancestor
153921448|NCT05964335|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153921449|NCT05951725|Vaccines|vaccines|mesh-list
153921450|NCT05951725|Immunologic Factors|immunologic factors|mesh-ancestor
153921451|NCT05951725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153919966|NCT04259476|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153919967|NCT04259476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153919968|NCT04259476|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
153919969|NCT04259476|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153919970|NCT04259476|Anesthetics, General|anesthetics, general|mesh-ancestor
153919971|NCT04259476|Anesthetics|anesthetics|mesh-ancestor
153919972|NCT04259476|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153919973|NCT04259476|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
153919974|NCT04259476|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
153919975|NCT04259476|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153919976|NCT04259476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153919977|NCT00970281|Olanzapine|olanzapine|mesh-list
153919978|NCT00970281|Antiemetics|antiemetics|mesh-ancestor
153921493|NCT05889468|Sensory System Agents|sensory system agents|mesh-ancestor
153921494|NCT05889468|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153921495|NCT05889468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153921496|NCT05889468|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153921497|NCT05889468|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153921498|NCT05889468|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153921499|NCT05889468|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153921500|NCT05889468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153921501|NCT05889468|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153919985|NCT00970281|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153468761|NCT06085638|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153468763|NCT06058299|Bedaquiline|bedaquiline|mesh-list
153468764|NCT06058299|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153468765|NCT06058299|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153385060|NCT01859312|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
153385061|NCT01859312|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153385062|NCT03407625|Misoprostol|misoprostol|mesh-list
153424155|NCT03225313|Anesthetics, Local|anesthetics, local|mesh-ancestor
153424156|NCT03225313|Anesthetics|anesthetics|mesh-ancestor
153424157|NCT03225313|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153424158|NCT03225313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153883218|NCT01316133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153468766|NCT06058299|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
153468767|NCT06058299|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153920004|NCT00976209|Phenylephrine|phenylephrine|mesh-list
153920005|NCT00976209|Oxymetazoline|oxymetazoline|mesh-list
153920006|NCT00976209|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
153920007|NCT00976209|Mydriatics|mydriatics|mesh-ancestor
153920008|NCT00976209|Autonomic Agents|autonomic agents|mesh-ancestor
153920009|NCT00976209|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153920010|NCT00976209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153921583|NCT05800587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153921584|NCT05800587|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153921585|NCT05800587|Antimetabolites|antimetabolites|mesh-ancestor
153921586|NCT05800587|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
153921587|NCT05800587|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153921588|NCT05800587|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153921589|NCT05800587|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153921590|NCT05800587|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153921596|NCT05799612|Paclitaxel|paclitaxel|mesh-list
153920011|NCT00976209|Sympathomimetics|sympathomimetics|mesh-ancestor
153920012|NCT00976209|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
153920013|NCT00976209|Nasal Decongestants|nasal decongestants|mesh-ancestor
153920014|NCT00976209|Respiratory System Agents|respiratory system agents|mesh-ancestor
153920015|NCT00976209|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
153920016|NCT00976209|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153920017|NCT00976209|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153920018|NCT00976209|Adrenergic Agents|adrenergic agents|mesh-ancestor
153920019|NCT00976209|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153920020|NCT00976209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153920021|NCT00976209|Protective Agents|protective agents|mesh-ancestor
153920041|NCT02670655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153920042|NCT02670655|Sensory System Agents|sensory system agents|mesh-ancestor
153920043|NCT02670655|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153920044|NCT02670655|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153920045|NCT02670655|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
153920046|NCT02670655|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153920047|NCT02670655|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153920048|NCT02670655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153920049|NCT02670655|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
153920051|NCT01131078|Capecitabine|capecitabine|mesh-list
153920052|NCT01131078|Irinotecan|irinotecan|mesh-list
153920053|NCT01131078|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153920054|NCT01131078|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153920055|NCT01131078|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153920056|NCT01131078|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153920057|NCT01131078|Growth Substances|growth substances|mesh-ancestor
153920058|NCT01131078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153920059|NCT01131078|Growth Inhibitors|growth inhibitors|mesh-ancestor
153920060|NCT01131078|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153920061|NCT01131078|Antimetabolites|antimetabolites|mesh-ancestor
153470448|NCT01861106|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153470449|NCT01861106|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153470454|NCT01856478|Methotrexate|methotrexate|mesh-list
153920062|NCT01131078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153920063|NCT01131078|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
153920064|NCT01131078|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153920065|NCT01131078|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153468770|NCT06055244|Amantadine|amantadine|mesh-list
153920066|NCT03709017|Ponatinib|ponatinib|mesh-list
153883219|NCT01316133|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
153883221|NCT01316133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153883222|NCT05654064|Fentanyl|fentanyl|mesh-list
153385063|NCT03407625|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
153385064|NCT03407625|Abortifacient Agents|abortifacient agents|mesh-ancestor
153385065|NCT03407625|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153385066|NCT03407625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153920067|NCT03709017|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153920068|NCT03709017|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153920069|NCT03709017|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153920070|NCT03709017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153468830|NCT05962229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153468841|NCT05950334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153468842|NCT05950334|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153468843|NCT05950334|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153920071|NCT03709017|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153920072|NCT03695445|Norepinephrine|norepinephrine|mesh-list
153921713|NCT05702541|Hydrogen Peroxide|hydrogen peroxide|mesh-list
153921714|NCT05702541|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
153921715|NCT05702541|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153921716|NCT05702229|Capecitabine|capecitabine|mesh-list
153921717|NCT05702229|Fluorouracil|fluorouracil|mesh-list
153921718|NCT05702229|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153921719|NCT05702229|Antimetabolites|antimetabolites|mesh-ancestor
153921720|NCT05702229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153921721|NCT05702229|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153921722|NCT05702229|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153921723|NCT05702229|Immunologic Factors|immunologic factors|mesh-ancestor
153921724|NCT05702229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153921725|NCT05692180|Benralizumab|benralizumab|mesh-list
153920073|NCT03695445|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153920074|NCT03695445|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153920076|NCT03695445|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153920077|NCT03695445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153920078|NCT03695445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153920079|NCT03695445|Sympathomimetics|sympathomimetics|mesh-ancestor
153920080|NCT03695445|Autonomic Agents|autonomic agents|mesh-ancestor
153920081|NCT03695445|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153920082|NCT03695445|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
153920083|NCT04177303|Metformin|metformin|mesh-list
153920084|NCT04177303|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153920085|NCT04177303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153920086|NCT01167426|Glatiramer Acetate|glatiramer acetate|mesh-list
153920087|NCT01167426|(T,G)-A-L|(t,g)-a-l|mesh-list
153920088|NCT01167426|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153920089|NCT01167426|Immunologic Factors|immunologic factors|mesh-ancestor
153920090|NCT01167426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153920091|NCT01167426|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153920092|NCT01167426|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153920093|NCT02862873|Ondansetron|ondansetron|mesh-list
153920094|NCT02862873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153920095|NCT02862873|Antiemetics|antiemetics|mesh-ancestor
153920096|NCT02862873|Autonomic Agents|autonomic agents|mesh-ancestor
153920097|NCT02862873|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153920098|NCT02862873|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153920099|NCT02862873|Antipruritics|antipruritics|mesh-ancestor
153920100|NCT02862873|Dermatologic Agents|dermatologic agents|mesh-ancestor
153920101|NCT02862873|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
153920102|NCT02862873|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153920104|NCT02862873|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153883223|NCT05654064|Dexmedetomidine|dexmedetomidine|mesh-list
153883224|NCT05654064|Remifentanil|remifentanil|mesh-list
153883225|NCT05654064|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153883226|NCT05654064|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153883227|NCT05654064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153920133|NCT04033471|Anesthetics|anesthetics|mesh-ancestor
153468891|NCT05922904|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153468892|NCT05922904|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153468893|NCT05922904|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153468894|NCT05922904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153468895|NCT05922904|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153468896|NCT05922904|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153468897|NCT05922904|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153468898|NCT05922904|Alkylating Agents|alkylating agents|mesh-ancestor
153468899|NCT05922904|Immunotoxins|immunotoxins|mesh-ancestor
153468900|NCT05922904|Immunoconjugates|immunoconjugates|mesh-ancestor
153920134|NCT04033471|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153920135|NCT04033471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153920137|NCT04033471|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153920138|NCT04033471|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153920139|NCT04033471|Narcotics|narcotics|mesh-ancestor
153920140|NCT04033471|Analgesics|analgesics|mesh-ancestor
153920141|NCT04033471|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153920142|NCT04033471|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153920143|NCT04033471|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153921825|NCT05666349|Niraparib|niraparib|mesh-list
153921826|NCT05666349|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
153921827|NCT05666349|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153921828|NCT05666349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153921829|NCT05666349|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153921830|NCT05663892|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
153921832|NCT05663892|Estradiol|estradiol|mesh-list
153920151|NCT04033471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153920152|NCT00910351|Ciprofloxacin|ciprofloxacin|mesh-list
153920153|NCT00910351|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153920154|NCT00910351|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153920155|NCT00910351|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153920156|NCT00910351|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153920157|NCT00910351|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153920158|NCT00910351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153920159|NCT00910351|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153920160|NCT00910351|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
153920161|NCT00910351|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153920162|NCT04175665|Semaglutide|semaglutide|mesh-list
153920163|NCT04175665|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
153920164|NCT04175665|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153920165|NCT04175665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153920167|NCT04175587|Arsenic Trioxide|arsenic trioxide|mesh-list
153920168|NCT04175587|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153920169|NCT04175587|Keratolytic Agents|keratolytic agents|mesh-ancestor
153920170|NCT04175587|Dermatologic Agents|dermatologic agents|mesh-ancestor
153920171|NCT02668159|Vitamin D|vitamin d|mesh-list
153920172|NCT02668159|Ergocalciferols|ergocalciferols|mesh-list
153920173|NCT02668159|Cholecalciferol|cholecalciferol|mesh-list
153920174|NCT02668159|Vitamins|vitamins|mesh-list
153920175|NCT02668159|Micronutrients|micronutrients|mesh-ancestor
153920176|NCT02668159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153920177|NCT02668159|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153470624|NCT02129556|Pembrolizumab|pembrolizumab|mesh-list
153470625|NCT02129556|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153470626|NCT02129556|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153470627|NCT02129556|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153470628|NCT02129556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153920178|NCT02668159|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153883228|NCT05654064|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153883229|NCT05654064|Analgesics|analgesics|mesh-ancestor
153883230|NCT05654064|Sensory System Agents|sensory system agents|mesh-ancestor
153883231|NCT05654064|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153883232|NCT05654064|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
153883233|NCT05654064|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153883234|NCT05654064|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153883235|NCT05654064|Adrenergic Agents|adrenergic agents|mesh-ancestor
153424159|NCT03225313|Sensory System Agents|sensory system agents|mesh-ancestor
153424160|NCT03225313|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153424162|NCT03949244|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
153424163|NCT03949244|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
153424164|NCT03948386|Bupivacaine|bupivacaine|mesh-list
153424165|NCT03948386|Mepivacaine|mepivacaine|mesh-list
153424166|NCT03948386|Anesthetics, Local|anesthetics, local|mesh-ancestor
153920179|NCT02670109|Cyclophosphamide|cyclophosphamide|mesh-list
153920180|NCT02670109|Busulfan|busulfan|mesh-list
153920181|NCT02670109|Carmustine|carmustine|mesh-list
153920182|NCT02670109|Carboplatin|carboplatin|mesh-list
153920183|NCT02670109|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153468901|NCT05922904|Immunologic Factors|immunologic factors|mesh-ancestor
153468903|NCT05901519|Prednisone|prednisone|mesh-list
153920184|NCT02670109|Immunologic Factors|immunologic factors|mesh-ancestor
153920185|NCT02670109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153920186|NCT02670109|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153468959|NCT05745038|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153468960|NCT05745038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153468961|NCT05742438|Lidocaine|lidocaine|mesh-list
153468962|NCT05742438|Dexmedetomidine|dexmedetomidine|mesh-list
153920196|NCT00922636|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153921896|NCT05587881|Vaccines|vaccines|mesh-list
153920197|NCT00922636|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153920198|NCT00922636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153920199|NCT00922636|Dopamine Agents|dopamine agents|mesh-ancestor
153920200|NCT00922636|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153920201|NCT02667925|Cisplatin|cisplatin|mesh-list
153920202|NCT02667925|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153920203|NCT02669719|Carboplatin|carboplatin|mesh-list
153920204|NCT02669719|Pemetrexed|pemetrexed|mesh-list
153920205|NCT02669719|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153920206|NCT02669719|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153920207|NCT02669719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153920208|NCT02669719|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153920209|NCT02669719|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153920210|NCT00644761|Adefovir|adefovir|mesh-list
153920211|NCT00644761|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
153920212|NCT00644761|Antiviral Agents|antiviral agents|mesh-ancestor
153920213|NCT00644761|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153920214|NCT00644761|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153920215|NCT00644761|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153920216|NCT00644761|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153920225|NCT00645073|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153920226|NCT00645073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153920227|NCT00645073|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153920228|NCT00645073|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
153920229|NCT00645073|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153920230|NCT00645073|Third Generation Cephalosporins|third generation cephalosporins|mesh-ancestor
153920231|NCT00645073|Beta Lactam Antibiotics|beta lactam antibiotics|mesh-ancestor
153920232|NCT04259008|Manganese|manganese|mesh-list
153920233|NCT04259008|Trace Elements|trace elements|mesh-ancestor
153920234|NCT04259008|Micronutrients|micronutrients|mesh-ancestor
153424167|NCT03948386|Anesthetics|anesthetics|mesh-ancestor
153424168|NCT03948386|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153424169|NCT03948386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153424170|NCT03948386|Sensory System Agents|sensory system agents|mesh-ancestor
153424171|NCT03948386|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153424172|NCT03445195|Imipenem|imipenem|mesh-list
153920235|NCT04259008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153920236|NCT04258930|Calcium|calcium|mesh-list
153920237|NCT04258930|Calcium acetate|calcium acetate|mesh-list
153920238|NCT04258930|Aluminum sulfate|aluminum sulfate|mesh-list
153920251|NCT01175135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153920252|NCT01175135|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153920253|NCT01175135|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153920254|NCT01175135|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153920255|NCT01175135|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153920256|NCT01175135|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
153920257|NCT01175135|Dopamine Agents|dopamine agents|mesh-ancestor
153920258|NCT02669641|Choline|choline|mesh-list
153920259|NCT02669641|Lipotropic Agents|lipotropic agents|mesh-ancestor
153469017|NCT05691478|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153469018|NCT05691478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153469019|NCT05691478|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153469020|NCT05691478|Antimetabolites|antimetabolites|mesh-ancestor
153469021|NCT05691478|Dermatologic Agents|dermatologic agents|mesh-ancestor
153469022|NCT05691478|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153469023|NCT05691478|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153469024|NCT05691478|Immunologic Factors|immunologic factors|mesh-ancestor
153469025|NCT05691478|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153469026|NCT05691478|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153469027|NCT05671081|Magnesium Sulfate|magnesium sulfate|mesh-list
153469028|NCT05671081|Dexmedetomidine|dexmedetomidine|mesh-list
153920260|NCT02669641|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153920261|NCT02669641|Antimetabolites|antimetabolites|mesh-ancestor
153920262|NCT02669641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153920263|NCT02669641|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153920264|NCT02669641|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153920265|NCT02669641|Nootropic Agents|nootropic agents|mesh-ancestor
153920266|NCT00922480|Losartan|losartan|mesh-list
153920267|NCT00922480|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153920268|NCT00922480|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153920269|NCT00922480|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
153920270|NCT00922480|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
153920271|NCT00922480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153920272|NCT04963036|Anesthetics|anesthetics|mesh-list
153920273|NCT04963036|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153920274|NCT04963036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153920275|NCT00973479|Golimumab|golimumab|mesh-list
153920276|NCT00973479|Methotrexate|methotrexate|mesh-list
153920277|NCT00973479|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
153920278|NCT00973479|Abortifacient Agents|abortifacient agents|mesh-ancestor
153920279|NCT00973479|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153920280|NCT00973479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153920281|NCT00973479|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153920282|NCT00973479|Antimetabolites|antimetabolites|mesh-ancestor
153920283|NCT00973479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153920284|NCT00973479|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153920285|NCT00973479|Dermatologic Agents|dermatologic agents|mesh-ancestor
153920286|NCT00973479|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153920287|NCT00973479|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153920297|NCT04173871|Snake venom protein C activator|snake venom protein c activator|mesh-list
153920299|NCT04173871|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153920300|NCT04173871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153385097|NCT00557492|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153920301|NCT02862483|Tadalafil|tadalafil|mesh-list
153920302|NCT02862483|Tamsulosin|tamsulosin|mesh-list
153920303|NCT02862483|Vasodilator Agents|vasodilator agents|mesh-ancestor
153920304|NCT02862483|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
153920305|NCT02862483|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
153920306|NCT02862483|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153920307|NCT02862483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153920308|NCT02862483|Urological Agents|urological agents|mesh-ancestor
153920309|NCT02862483|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
153469029|NCT05671081|Analgesics|analgesics|mesh-list
153920310|NCT02862483|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
153920311|NCT02862483|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
153920312|NCT02862483|Adrenergic Agents|adrenergic agents|mesh-ancestor
153920313|NCT02862483|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153920314|NCT02862483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153920315|NCT02667535|Isosorbide|isosorbide|mesh-list
153920316|NCT02667535|Isosorbide Dinitrate|isosorbide dinitrate|mesh-list
153920317|NCT02667535|Isosorbide-5-mononitrate|isosorbide-5-mononitrate|mesh-list
153920318|NCT02667535|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
153920319|NCT02667535|Diuretics|diuretics|mesh-ancestor
153920320|NCT02667535|Natriuretic Agents|natriuretic agents|mesh-ancestor
153469079|NCT05611593|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
153469080|NCT05611593|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153469081|NCT05611593|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153469082|NCT05611593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153469083|NCT05611593|Hormone Antagonists|hormone antagonists|mesh-ancestor
153469084|NCT05611593|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153469085|NCT05611593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153469086|NCT05611593|Urological Agents|urological agents|mesh-ancestor
153920321|NCT02667535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153920322|NCT02667535|Vasodilator Agents|vasodilator agents|mesh-ancestor
153920323|NCT02667535|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
153920324|NCT02667535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153920325|NCT04286841|Immunomodulating Agents|immunomodulating agents|mesh-list
153920326|NCT04286841|Immunologic Factors|immunologic factors|mesh-ancestor
153920327|NCT04286841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153920328|NCT00645151|Atorvastatin|atorvastatin|mesh-list
153920329|NCT00645151|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153920330|NCT00645151|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153920331|NCT00645151|Antimetabolites|antimetabolites|mesh-ancestor
153920332|NCT00645151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153920333|NCT00645151|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153920334|NCT00645151|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
153920335|NCT00645151|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153920336|NCT00645229|Ziprasidone|ziprasidone|mesh-list
153920337|NCT00645229|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153920338|NCT00645229|Serotonin Agents|serotonin agents|mesh-ancestor
153922126|NCT05283720|Venetoclax|venetoclax|mesh-list
153920339|NCT00645229|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153920340|NCT00645229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153920361|NCT02886299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153920362|NCT02886299|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153920363|NCT02886299|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
153920364|NCT02886299|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153920365|NCT06332040|Gentamicins|gentamicins|mesh-list
153920366|NCT06332040|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153920367|NCT06332040|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153920368|NCT06332040|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
153920369|NCT06332040|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153920370|NCT06332040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153920372|NCT06332014|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153920373|NCT06332014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153470930|NCT00612222|Aldesleukin|aldesleukin|mesh-list
153920374|NCT06331910|Ophthalmic Solutions|ophthalmic solutions|mesh-list
153385098|NCT00557492|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153385099|NCT00557492|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153385100|NCT00557492|Growth Substances|growth substances|mesh-ancestor
153385101|NCT00557492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153385102|NCT00557492|Growth Inhibitors|growth inhibitors|mesh-ancestor
153385103|NCT00557492|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153385104|NCT00557492|Antimetabolites|antimetabolites|mesh-ancestor
153385105|NCT00557492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153920375|NCT06331910|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
153920377|NCT06331845|Gemcitabine|gemcitabine|mesh-list
153920378|NCT06331845|Capecitabine|capecitabine|mesh-list
153920379|NCT06331845|Tislelizumab|tislelizumab|mesh-list
153920380|NCT06331845|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
153920381|NCT06331845|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153920382|NCT06331845|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153920383|NCT06331845|Tubulin Modulators|tubulin modulators|mesh-ancestor
153920384|NCT06331845|Antimitotic Agents|antimitotic agents|mesh-ancestor
153920385|NCT06331845|Mitosis Modulators|mitosis modulators|mesh-ancestor
153469142|NCT05520775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153469144|NCT05504083|Uricosuric Agents|uricosuric agents|mesh-ancestor
153469145|NCT05504083|Gout Suppressants|gout suppressants|mesh-ancestor
153469146|NCT05504083|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153469147|NCT05503797|Cobicistat|cobicistat|mesh-list
153469148|NCT05503797|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153469149|NCT05503797|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153469150|NCT05503797|Antiviral Agents|antiviral agents|mesh-ancestor
153469151|NCT05503797|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153920386|NCT06331845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153920387|NCT06331845|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153922220|NCT05143840|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153922221|NCT05143840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153920393|NCT06331715|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153920394|NCT06331715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153920396|NCT06331702|Immunologic Factors|immunologic factors|mesh-ancestor
153920397|NCT06331702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153920398|NCT06331663|Remifentanil|remifentanil|mesh-list
153920399|NCT06331663|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153920400|NCT06331663|Narcotics|narcotics|mesh-ancestor
153920401|NCT06331663|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153920402|NCT06331663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153920403|NCT06331663|Analgesics|analgesics|mesh-ancestor
153920404|NCT06331663|Sensory System Agents|sensory system agents|mesh-ancestor
153920405|NCT06331663|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153920406|NCT06331624|Tazarotene|tazarotene|mesh-list
153920407|NCT06331624|Dermatologic Agents|dermatologic agents|mesh-ancestor
153920408|NCT06331624|Keratolytic Agents|keratolytic agents|mesh-ancestor
153920409|NCT06331598|Atezolizumab|atezolizumab|mesh-list
153920410|NCT06331598|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153920411|NCT06331598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153920412|NCT06331598|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153920413|NCT06331598|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153920414|NCT06331559|Olaparib|olaparib|mesh-list
153920415|NCT06331559|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
153920416|NCT06331559|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153920438|NCT06331520|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153920440|NCT06331520|Hormones|hormones|mesh-ancestor
153469152|NCT05503797|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
153920441|NCT06331520|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153469167|NCT05452772|Niacin|niacin|mesh-list
153920442|NCT06331520|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153920443|NCT06331520|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153920444|NCT06331520|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153920479|NCT06331390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153920480|NCT06331390|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153920481|NCT06331390|Vasodilator Agents|vasodilator agents|mesh-ancestor
153385107|NCT01865708|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
153385108|NCT01865708|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153385109|NCT01865708|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153385110|NCT01865708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153385111|NCT04203225|Lidocaine|lidocaine|mesh-list
153385112|NCT04203225|Epinephrine|epinephrine|mesh-list
153385147|NCT05314257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153385148|NCT02354586|Niraparib|niraparib|mesh-list
153385149|NCT02354586|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
153883236|NCT05654064|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153883237|NCT05654064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153883238|NCT05654064|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153883240|NCT05654064|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153883241|NCT05654064|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153883242|NCT05654064|Anesthetics, General|anesthetics, general|mesh-ancestor
153883243|NCT05654064|Anesthetics|anesthetics|mesh-ancestor
153883244|NCT01687985|Laxatives|laxatives|mesh-list
153920483|NCT06331299|Mitomycin|mitomycin|mesh-list
153920484|NCT06331299|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153920485|NCT06331299|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153920486|NCT06331299|Alkylating Agents|alkylating agents|mesh-ancestor
153920487|NCT06331299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153920488|NCT06331299|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153920489|NCT06331299|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153920490|NCT06331286|Dulaglutide|dulaglutide|mesh-list
153920491|NCT06331286|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
153920492|NCT06331286|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153920493|NCT06331286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153920494|NCT06331208|Carbon Monoxide|carbon monoxide|mesh-list
153920495|NCT06331208|Antimetabolites|antimetabolites|mesh-ancestor
153920496|NCT06331208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153920497|NCT06331208|Gasotransmitters|gasotransmitters|mesh-ancestor
153922311|NCT05000216|Abortifacient Agents|abortifacient agents|mesh-ancestor
153469278|NCT05298423|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153469279|NCT05298423|Tubulin Modulators|tubulin modulators|mesh-ancestor
153469280|NCT05298423|Antimitotic Agents|antimitotic agents|mesh-ancestor
153469285|NCT05298423|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153469286|NCT05298423|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153469287|NCT05298423|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153469288|NCT05298423|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153469289|NCT05298423|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153469290|NCT05289856|Avelumab|avelumab|mesh-list
153469291|NCT05289856|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153469292|NCT05289856|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153920530|NCT06331156|Vaccines|vaccines|mesh-list
153920531|NCT06331156|Immunologic Factors|immunologic factors|mesh-ancestor
153920532|NCT06331156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153922348|NCT04941898|BAX 855|bax 855|mesh-list
153922349|NCT04941898|Coagulants|coagulants|mesh-ancestor
153922350|NCT04934722|Pembrolizumab|pembrolizumab|mesh-list
153922351|NCT04934722|Androgens|androgens|mesh-list
153922352|NCT04934722|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153922353|NCT04934722|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153922354|NCT04934722|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153922356|NCT04934722|Hormones|hormones|mesh-ancestor
153920547|NCT06330935|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
153920548|NCT06330935|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153920549|NCT06330935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153883245|NCT01687985|Cathartics|cathartics|mesh-list
153883246|NCT01687985|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153883247|NCT01686620|Insulin Lispro|insulin lispro|mesh-list
153883248|NCT01686620|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153883249|NCT01686620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153385151|NCT02354586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153920550|NCT06330935|Hemostatics|hemostatics|mesh-ancestor
153920551|NCT06330935|Coagulants|coagulants|mesh-ancestor
153920552|NCT06330805|Leuprolide|leuprolide|mesh-list
153920553|NCT06330805|Relugolix|relugolix|mesh-list
153920554|NCT06330805|Fertility Agents, Female|fertility agents, female|mesh-ancestor
153920555|NCT06330805|Fertility Agents|fertility agents|mesh-ancestor
153920556|NCT06330805|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153920557|NCT06330805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153920558|NCT06330805|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153920559|NCT06330805|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153920560|NCT06330805|Androgen Antagonists|androgen antagonists|mesh-ancestor
153920561|NCT06330805|Hormone Antagonists|hormone antagonists|mesh-ancestor
153920562|NCT06330805|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153920563|NCT06330662|Hyaluronic Acid|hyaluronic acid|mesh-list
153920564|NCT06330662|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153920565|NCT06330662|Immunologic Factors|immunologic factors|mesh-ancestor
153922374|NCT04925167|Heparin|heparin|mesh-list
153922375|NCT04925167|Calcium heparin|calcium heparin|mesh-list
153922376|NCT04925167|Argatroban|argatroban|mesh-list
153922377|NCT04925167|Anticoagulants|anticoagulants|mesh-ancestor
153922378|NCT04925167|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153922379|NCT04925167|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153922380|NCT04925167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153922381|NCT04925167|Antithrombins|antithrombins|mesh-ancestor
153922382|NCT04925167|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
153922383|NCT04925167|Protease Inhibitors|protease inhibitors|mesh-ancestor
153922384|NCT04925167|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153922385|NCT04925167|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153922394|NCT04899921|Nivolumab|nivolumab|mesh-list
153922395|NCT04899921|Ipilimumab|ipilimumab|mesh-list
153922396|NCT04899921|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153922397|NCT04899921|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153922400|NCT04893785|Temozolomide|temozolomide|mesh-list
153469333|NCT05203913|Mitosis Modulators|mitosis modulators|mesh-ancestor
153469334|NCT05203913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153920576|NCT06330584|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153920577|NCT06330584|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153920578|NCT06330584|Anesthetics, General|anesthetics, general|mesh-ancestor
153920579|NCT06330584|Anesthetics|anesthetics|mesh-ancestor
153920580|NCT06330584|GABA Modulators|gaba modulators|mesh-ancestor
153920581|NCT06330584|GABA Agents|gaba agents|mesh-ancestor
153920582|NCT06330584|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153920583|NCT06330584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153920584|NCT06330519|Dexamethasone|dexamethasone|mesh-list
153920585|NCT06330519|Dexamethasone acetate|dexamethasone acetate|mesh-list
153920586|NCT06330519|Norflurane|norflurane|mesh-list
153920587|NCT06330519|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
153920588|NCT06330519|BB 1101|bb 1101|mesh-list
153920589|NCT06330519|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153920590|NCT06330519|Antiemetics|antiemetics|mesh-ancestor
153920591|NCT06330519|Autonomic Agents|autonomic agents|mesh-ancestor
153920592|NCT06330519|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153920593|NCT06330519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153920594|NCT06330519|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153920595|NCT06330519|Glucocorticoids|glucocorticoids|mesh-ancestor
153920596|NCT06330519|Hormones|hormones|mesh-ancestor
153920597|NCT06330519|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153920598|NCT06330519|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153920599|NCT06330519|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153920600|NCT06330519|Protease Inhibitors|protease inhibitors|mesh-ancestor
153920601|NCT06330519|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153920602|NCT06330519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153920603|NCT06330519|Anesthetics|anesthetics|mesh-ancestor
153920604|NCT06330519|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153920605|NCT06330337|Paclitaxel|paclitaxel|mesh-list
153920606|NCT06330337|Temozolomide|temozolomide|mesh-list
153920607|NCT06330337|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
153920608|NCT06330337|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153920609|NCT06330337|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153920610|NCT06330337|Tubulin Modulators|tubulin modulators|mesh-ancestor
153920611|NCT06330337|Antimitotic Agents|antimitotic agents|mesh-ancestor
153920621|NCT06330220|Growth Inhibitors|growth inhibitors|mesh-ancestor
153920622|NCT06330220|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153920623|NCT06330194|Insulin|insulin|mesh-list
153920624|NCT06330194|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153920625|NCT06330194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153469394|NCT05102591|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153469395|NCT05085028|Pembrolizumab|pembrolizumab|mesh-list
153469396|NCT05085028|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153469397|NCT05085028|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153469408|NCT05080790|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153469409|NCT05080790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153920648|NCT06330077|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
153920649|NCT06330077|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
153920650|NCT06330077|Adrenergic Agents|adrenergic agents|mesh-ancestor
153920651|NCT06330077|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153920652|NCT06330077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153920653|NCT06330077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153920654|NCT06330077|Vasodilator Agents|vasodilator agents|mesh-ancestor
153920655|NCT06330077|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
153920656|NCT06330077|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
153922620|NCT04620382|Sympathomimetics|sympathomimetics|mesh-ancestor
153920687|NCT06329895|Anticoagulants|anticoagulants|mesh-ancestor
153920688|NCT06329882|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
153920689|NCT06329882|Doxycycline|doxycycline|mesh-list
153920690|NCT06329882|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153920691|NCT06329882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153920692|NCT06329882|Incretins|incretins|mesh-ancestor
153920693|NCT06329882|Hormones|hormones|mesh-ancestor
153920694|NCT06329882|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153920695|NCT06329882|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
153469452|NCT05034562|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
153469453|NCT05034562|Chelating Agents|chelating agents|mesh-ancestor
153469454|NCT05034562|Sequestering Agents|sequestering agents|mesh-ancestor
153920697|NCT06329882|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153920698|NCT06329882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153920699|NCT06329882|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153920700|NCT06329882|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153920702|NCT06329882|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153920703|NCT06329882|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153920704|NCT06329869|Sacituzumab govitecan|sacituzumab govitecan|mesh-list
153920705|NCT06329869|Immunoconjugates|immunoconjugates|mesh-ancestor
153920706|NCT06329869|Immunologic Factors|immunologic factors|mesh-ancestor
153920707|NCT06329869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153920726|NCT06329752|Lidocaine|lidocaine|mesh-list
153920727|NCT06329752|Anesthetics, Local|anesthetics, local|mesh-ancestor
153920728|NCT06329752|Anesthetics|anesthetics|mesh-ancestor
153385249|NCT03717051|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153385250|NCT03717051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153385251|NCT03717051|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
153385252|NCT03717051|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
153385253|NCT03717051|Cholinergic Agents|cholinergic agents|mesh-ancestor
153385254|NCT03717051|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153385255|NCT03717051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153920729|NCT06329752|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153920730|NCT06329752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153469472|NCT04952753|Levoleucovorin|levoleucovorin|mesh-list
153920731|NCT06329752|Sensory System Agents|sensory system agents|mesh-ancestor
153469513|NCT04902027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153469514|NCT04902027|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153469515|NCT04902027|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153920752|NCT06329635|Nicardipine|nicardipine|mesh-list
153920753|NCT06329635|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153920754|NCT06329635|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153920755|NCT06329635|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153920756|NCT06329635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153922657|NCT04589611|GABA Agents|gaba agents|mesh-ancestor
153920757|NCT06329635|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153920758|NCT06329635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153920759|NCT06329635|Vasodilator Agents|vasodilator agents|mesh-ancestor
153920760|NCT06329596|Sorbitol|sorbitol|mesh-list
153920761|NCT06329596|Cathartics|cathartics|mesh-ancestor
153920762|NCT06329596|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153920763|NCT06329570|Bevacizumab|bevacizumab|mesh-list
153920764|NCT06329570|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153920765|NCT06329570|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153920766|NCT06329570|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153920767|NCT06329570|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153920768|NCT06329570|Growth Substances|growth substances|mesh-ancestor
153920769|NCT06329570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153920770|NCT06329570|Growth Inhibitors|growth inhibitors|mesh-ancestor
153920771|NCT06329518|Rezafungin|rezafungin|mesh-list
153920772|NCT06329518|Antifungal Agents|antifungal agents|mesh-ancestor
153920781|NCT06328738|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153920782|NCT06328738|Tubulin Modulators|tubulin modulators|mesh-ancestor
153920783|NCT06328738|Antimitotic Agents|antimitotic agents|mesh-ancestor
153920784|NCT06328738|Mitosis Modulators|mitosis modulators|mesh-ancestor
153920785|NCT06328738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153920786|NCT06328738|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153920787|NCT06328738|Antimetabolites|antimetabolites|mesh-ancestor
153920788|NCT06328738|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153920789|NCT06328738|Immunologic Factors|immunologic factors|mesh-ancestor
153920790|NCT06328738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153920791|NCT06328738|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153920793|NCT06328738|Protective Agents|protective agents|mesh-ancestor
153920794|NCT06328738|Vitamin B Complex|vitamin b complex|mesh-ancestor
153920795|NCT06328738|Vitamins|vitamins|mesh-ancestor
153920796|NCT06328738|Micronutrients|micronutrients|mesh-ancestor
153920797|NCT06327685|Decitabine|decitabine|mesh-list
153920798|NCT06327685|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153920799|NCT06327685|Antimetabolites|antimetabolites|mesh-ancestor
153920800|NCT06327685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153920801|NCT06327685|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153920802|NCT06327685|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153469516|NCT04902027|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153920803|NCT06327152|Caffeine|caffeine|mesh-list
153469519|NCT04900766|Mitoxantrone|mitoxantrone|mesh-list
153385257|NCT04350320|Gout Suppressants|gout suppressants|mesh-ancestor
153385258|NCT04350320|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153385259|NCT04350320|Tubulin Modulators|tubulin modulators|mesh-ancestor
153385260|NCT04350320|Antimitotic Agents|antimitotic agents|mesh-ancestor
153385303|NCT03360890|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153783569|NCT04545931|Hemostatics|hemostatics|mesh-ancestor
153783570|NCT04545931|Coagulants|coagulants|mesh-ancestor
153385304|NCT03862755|Heparin|heparin|mesh-list
153385305|NCT03862755|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
153385306|NCT03862755|Tinzaparin|tinzaparin|mesh-list
153385307|NCT03862755|Dalteparin|dalteparin|mesh-list
153920804|NCT06327152|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
153920805|NCT06327152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153920806|NCT06327152|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
153920807|NCT06327152|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153920808|NCT06327152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153920809|NCT06327152|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
153920810|NCT06327152|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
153920811|NCT06327152|Purinergic Agents|purinergic agents|mesh-ancestor
153920812|NCT06327152|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153920813|NCT06326489|Insulin|insulin|mesh-list
153920814|NCT06326489|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153920837|NCT06314620|Calcium heparin|calcium heparin|mesh-list
153920838|NCT06314620|Anticoagulants|anticoagulants|mesh-ancestor
153920839|NCT06314620|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153920840|NCT06314620|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153920841|NCT06314620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153920854|NCT06308913|Pembrolizumab|pembrolizumab|mesh-list
153920855|NCT06308913|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153920856|NCT06308913|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153920857|NCT06308913|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153920858|NCT06308913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153920859|NCT06308653|Psilocybin|psilocybin|mesh-list
153922760|NCT04397679|Chloroquine|chloroquine|mesh-list
153922761|NCT04397679|Temozolomide|temozolomide|mesh-list
153922762|NCT04397679|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153922763|NCT04397679|Alkylating Agents|alkylating agents|mesh-ancestor
153922764|NCT04397679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153922765|NCT04397679|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153922766|NCT04397679|Amebicides|amebicides|mesh-ancestor
153922767|NCT04397679|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153922768|NCT04397679|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153922769|NCT04397679|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153922770|NCT04397679|Antimalarials|antimalarials|mesh-ancestor
153922771|NCT04397679|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153922772|NCT04384484|Rituximab|rituximab|mesh-list
153922773|NCT04384484|Loncastuximab tesirine|loncastuximab tesirine|mesh-list
153920863|NCT06282458|Semaglutide|semaglutide|mesh-list
153920913|NCT06245889|Carboplatin|carboplatin|mesh-list
153920914|NCT06245889|Doxorubicin|doxorubicin|mesh-list
153920915|NCT06245889|Pembrolizumab|pembrolizumab|mesh-list
153920916|NCT06245889|Capecitabine|capecitabine|mesh-list
153920917|NCT06245889|Olaparib|olaparib|mesh-list
153920918|NCT06245889|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153920919|NCT06245889|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153920920|NCT06245889|Tubulin Modulators|tubulin modulators|mesh-ancestor
153920921|NCT06245889|Antimitotic Agents|antimitotic agents|mesh-ancestor
153920922|NCT06245889|Mitosis Modulators|mitosis modulators|mesh-ancestor
153920923|NCT06245889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153920924|NCT06245889|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153920925|NCT06245889|Immunologic Factors|immunologic factors|mesh-ancestor
153920926|NCT06245889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153922809|NCT04329624|Simendan|simendan|mesh-list
153920927|NCT06245889|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153920928|NCT06245889|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153920929|NCT06245889|Alkylating Agents|alkylating agents|mesh-ancestor
153920930|NCT06245889|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153920931|NCT06245889|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153385308|NCT03862755|Anticoagulants|anticoagulants|mesh-ancestor
153385309|NCT03862755|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153385310|NCT03862755|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153385311|NCT03862755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153385312|NCT02332590|Adalimumab|adalimumab|mesh-list
153385313|NCT02332590|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
153920932|NCT06245889|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153920933|NCT06245889|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153920934|NCT06245889|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153920935|NCT06245889|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153920936|NCT06245889|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153920937|NCT06245889|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153920938|NCT06245889|Antimetabolites|antimetabolites|mesh-ancestor
153920939|NCT06245889|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
153920954|NCT06218511|Immunologic Factors|immunologic factors|mesh-ancestor
153920955|NCT06218511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153920956|NCT06209138|Fluorouracil|fluorouracil|mesh-list
153920957|NCT06209138|Antimetabolites|antimetabolites|mesh-ancestor
153920958|NCT06209138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153920959|NCT06209138|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153920960|NCT06209138|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153920961|NCT06209138|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153920962|NCT06209138|Immunologic Factors|immunologic factors|mesh-ancestor
153920963|NCT06209138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153920964|NCT06208462|Gemcitabine|gemcitabine|mesh-list
153920965|NCT06208462|Oxaliplatin|oxaliplatin|mesh-list
153920966|NCT06208462|Lenvatinib|lenvatinib|mesh-list
153922816|NCT04329624|Protective Agents|protective agents|mesh-ancestor
153920968|NCT06208462|Antimetabolites|antimetabolites|mesh-ancestor
153920969|NCT06208462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153920970|NCT06208462|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153920971|NCT06208462|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153920972|NCT06208462|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153920973|NCT06196671|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
153920986|NCT06191744|Immunologic Factors|immunologic factors|mesh-ancestor
153920987|NCT06191744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153920988|NCT06191744|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153920989|NCT06191744|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153920990|NCT06191744|Alkylating Agents|alkylating agents|mesh-ancestor
153920991|NCT06191744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153920992|NCT06191744|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153920993|NCT06191744|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153920994|NCT06191744|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153469768|NCT04439292|Dimethyl Sulfoxide|dimethyl sulfoxide|mesh-list
153469769|NCT04439292|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153469770|NCT04439292|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153469771|NCT04439292|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153469772|NCT04439292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153469773|NCT04439292|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
153469774|NCT04439292|Protective Agents|protective agents|mesh-ancestor
153469775|NCT04439292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153469776|NCT04439292|Free Radical Scavengers|free radical scavengers|mesh-ancestor
153469777|NCT04439292|Antioxidants|antioxidants|mesh-ancestor
153469778|NCT04439188|GSK2636771|gsk2636771|mesh-list
153469779|NCT04439188|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153469780|NCT04439188|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153469781|NCT04439188|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153469782|NCT04439188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153469783|NCT04431388|Levobupivacaine|levobupivacaine|mesh-list
153921004|NCT06191744|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153921005|NCT06191744|Tubulin Modulators|tubulin modulators|mesh-ancestor
153921006|NCT06191744|Antimitotic Agents|antimitotic agents|mesh-ancestor
153921007|NCT06191744|Mitosis Modulators|mitosis modulators|mesh-ancestor
153385315|NCT02332590|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153385316|NCT04076787|Sunitinib|sunitinib|mesh-list
153921008|NCT06191744|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153921009|NCT06191744|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153921010|NCT06191744|Growth Substances|growth substances|mesh-ancestor
153921011|NCT06191744|Growth Inhibitors|growth inhibitors|mesh-ancestor
153921021|NCT06165614|Artesunate|artesunate|mesh-list
153921022|NCT06165614|Antimalarials|antimalarials|mesh-ancestor
153921023|NCT06165614|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153921024|NCT06165614|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153921025|NCT06165614|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153921026|NCT06165614|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153921027|NCT06165614|Antiviral Agents|antiviral agents|mesh-ancestor
153921028|NCT06165614|Schistosomicides|schistosomicides|mesh-ancestor
153921029|NCT06165614|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
153921030|NCT06165614|Anthelmintics|anthelmintics|mesh-ancestor
153921065|NCT06161025|Antimetabolites|antimetabolites|mesh-ancestor
153921066|NCT06161025|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153922900|NCT04182633|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153922920|NCT04179032|Belimumab|belimumab|mesh-list
153922921|NCT04179032|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153922922|NCT04179032|Immunologic Factors|immunologic factors|mesh-ancestor
153922923|NCT04179032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153471702|NCT03330886|Atezolizumab|atezolizumab|mesh-list
153921067|NCT06161025|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153921079|NCT06146101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153921080|NCT06146101|Hallucinogens|hallucinogens|mesh-ancestor
153921081|NCT06146101|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153921082|NCT06146101|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153921083|NCT06146101|Analgesics|analgesics|mesh-ancestor
153921084|NCT06146101|Sensory System Agents|sensory system agents|mesh-ancestor
153921085|NCT06146101|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153921086|NCT06146101|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
153921087|NCT06146101|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
153921088|NCT06146101|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153921089|NCT06146101|Hormones|hormones|mesh-ancestor
153921090|NCT06146101|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153921100|NCT06123715|Ascorbic Acid|ascorbic acid|mesh-list
153921101|NCT06123715|Vitamins|vitamins|mesh-ancestor
153921102|NCT06123715|Micronutrients|micronutrients|mesh-ancestor
153921103|NCT06123715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153921104|NCT06123715|Antioxidants|antioxidants|mesh-ancestor
153921105|NCT06123715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153921106|NCT06123715|Protective Agents|protective agents|mesh-ancestor
153921107|NCT06119529|Prednisone|prednisone|mesh-list
153471703|NCT03330886|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153471707|NCT03282799|Etonogestrel|etonogestrel|mesh-list
153921108|NCT06119529|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153921109|NCT06119529|Glucocorticoids|glucocorticoids|mesh-ancestor
153469882|NCT04088890|Immunologic Factors|immunologic factors|mesh-ancestor
153469883|NCT04088890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153469884|NCT04088890|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153469885|NCT04088890|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153469886|NCT04088890|Alkylating Agents|alkylating agents|mesh-ancestor
153385317|NCT04076787|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153385318|NCT04076787|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153385319|NCT04076787|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153385320|NCT04076787|Growth Substances|growth substances|mesh-ancestor
153385321|NCT04076787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153385322|NCT04076787|Growth Inhibitors|growth inhibitors|mesh-ancestor
153385323|NCT04076787|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153385324|NCT04076787|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153385325|NCT04076787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153385326|NCT00554840|Varenicline|varenicline|mesh-list
153385327|NCT00554840|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
153385328|NCT00554840|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
153385329|NCT00554840|Cholinergic Agents|cholinergic agents|mesh-ancestor
153469888|NCT04088890|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153469889|NCT04088890|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153469891|NCT04053478|Vasopressins|vasopressins|mesh-list
153469892|NCT04053478|Arginine Vasopressin|arginine vasopressin|mesh-list
153469893|NCT04053478|Oxymetazoline|oxymetazoline|mesh-list
153469894|NCT04053478|Norepinephrine|norepinephrine|mesh-list
153469895|NCT04053478|Ephedrine|ephedrine|mesh-list
153469896|NCT04053478|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
153469897|NCT04053478|Mydriatics|mydriatics|mesh-ancestor
153469898|NCT04053478|Autonomic Agents|autonomic agents|mesh-ancestor
153921136|NCT06107413|Bevacizumab|bevacizumab|mesh-list
153921137|NCT06107413|Fluorouracil|fluorouracil|mesh-list
153921138|NCT06107413|Irinotecan|irinotecan|mesh-list
153921139|NCT06107413|Levoleucovorin|levoleucovorin|mesh-list
153921140|NCT06107413|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153921141|NCT06107413|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153921142|NCT06107413|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153921143|NCT06107413|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153921145|NCT06107413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153921146|NCT06107413|Growth Inhibitors|growth inhibitors|mesh-ancestor
153921147|NCT06107413|Antimetabolites|antimetabolites|mesh-ancestor
153921148|NCT06107413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153921164|NCT06106152|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
153469899|NCT04053478|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153921165|NCT06106152|Immunologic Factors|immunologic factors|mesh-ancestor
153921166|NCT06106152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153921167|NCT06106152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153921168|NCT06106152|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153921169|NCT06106152|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153921171|NCT06105632|Fulvestrant|fulvestrant|mesh-list
153921172|NCT06105632|Exemestane|exemestane|mesh-list
153921173|NCT06105632|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
153921174|NCT06105632|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153921175|NCT06105632|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153921176|NCT06105632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153921177|NCT06105632|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153922975|NCT04093323|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153921178|NCT06105632|Immunologic Factors|immunologic factors|mesh-ancestor
153921179|NCT06105632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153921192|NCT06097728|Nivolumab|nivolumab|mesh-list
153921193|NCT06097728|Pemetrexed|pemetrexed|mesh-list
153921194|NCT06097728|Ipilimumab|ipilimumab|mesh-list
153921195|NCT06097728|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153921196|NCT06097728|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153921197|NCT06097728|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153921198|NCT06097728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153921199|NCT06097728|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153921200|NCT06097728|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153921201|NCT06097728|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153921202|NCT06093893|Labetalol|labetalol|mesh-list
153385330|NCT00554840|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153385331|NCT00554840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153385332|NCT00554840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153385333|NCT04069221|Cobicistat|cobicistat|mesh-list
153385334|NCT04069221|Artefenomel|artefenomel|mesh-list
153385335|NCT04069221|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153385336|NCT04069221|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153385337|NCT04069221|Antiviral Agents|antiviral agents|mesh-ancestor
153385338|NCT04069221|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153385339|NCT04069221|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
153883250|NCT01685255|Tamoxifen|tamoxifen|mesh-list
153883251|NCT01685255|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
153883252|NCT01685255|Hormone Antagonists|hormone antagonists|mesh-ancestor
153883253|NCT01685255|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153883254|NCT01685255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153921204|NCT06093893|Dexmedetomidine|dexmedetomidine|mesh-list
153921205|NCT06093893|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153921208|NCT06093893|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153921209|NCT06093893|Analgesics|analgesics|mesh-ancestor
153921210|NCT06093893|Sensory System Agents|sensory system agents|mesh-ancestor
153921211|NCT06093893|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153921212|NCT06093893|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
153921213|NCT06093893|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153921214|NCT06093893|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153921215|NCT06093893|Adrenergic Agents|adrenergic agents|mesh-ancestor
153921216|NCT06093893|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153921217|NCT06093893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153921218|NCT06093893|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
153921219|NCT06093893|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
153921220|NCT06093893|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153921221|NCT06093893|Sympathomimetics|sympathomimetics|mesh-ancestor
153921222|NCT06093893|Autonomic Agents|autonomic agents|mesh-ancestor
153469997|NCT03913104|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
153469998|NCT03913104|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
153469999|NCT03913104|Hormone Antagonists|hormone antagonists|mesh-ancestor
153470000|NCT03913104|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153470001|NCT03913104|Luteolytic Agents|luteolytic agents|mesh-ancestor
153470002|NCT03913104|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
153470003|NCT03913104|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
153470005|NCT03850301|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153470006|NCT03850301|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153470007|NCT03850301|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153921233|NCT06091410|Immunologic Factors|immunologic factors|mesh-ancestor
153921234|NCT06091410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153921235|NCT06091254|Prednisone|prednisone|mesh-list
153921236|NCT06091254|Prednisolone|prednisolone|mesh-list
153921237|NCT06091254|Cyclophosphamide|cyclophosphamide|mesh-list
153921238|NCT06091254|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
153921239|NCT06091254|Rituximab|rituximab|mesh-list
153921240|NCT06091254|Doxorubicin|doxorubicin|mesh-list
153921241|NCT06091254|Vincristine|vincristine|mesh-list
153921242|NCT06091254|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153921243|NCT06091254|Immunologic Factors|immunologic factors|mesh-ancestor
153921244|NCT06091254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153921245|NCT06091254|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153921246|NCT06091254|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153921247|NCT06091254|Alkylating Agents|alkylating agents|mesh-ancestor
153923025|NCT04023669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153923026|NCT04023669|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153921248|NCT06091254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153921249|NCT06091254|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153921250|NCT06091254|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153921251|NCT06091254|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153921252|NCT06091254|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153921253|NCT06091254|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153921254|NCT06091254|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153921266|NCT06081153|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
153470008|NCT03850301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153921267|NCT06081153|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153921268|NCT06081153|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153921269|NCT06081153|Antimetabolites|antimetabolites|mesh-ancestor
153921270|NCT06081153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153923059|NCT03931291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153923060|NCT03931291|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153923061|NCT03931291|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153923062|NCT03919773|Immunoglobulins|immunoglobulins|mesh-list
153923063|NCT03919773|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
153923064|NCT03919773|gamma-Globulins|gamma-globulins|mesh-list
153923065|NCT03919773|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
153923066|NCT03919773|Immunologic Factors|immunologic factors|mesh-ancestor
153921271|NCT06081153|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
153921272|NCT06081153|Protease Inhibitors|protease inhibitors|mesh-ancestor
153921273|NCT06081153|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153921274|NCT06081153|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153921276|NCT06075147|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153921277|NCT06075147|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153921278|NCT06075147|Growth Substances|growth substances|mesh-ancestor
153470050|NCT03698552|Epratuzumab|epratuzumab|mesh-list
153470051|NCT03698552|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153470052|NCT03698552|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153470053|NCT03616236|Buprenorphine|buprenorphine|mesh-list
153470054|NCT03616236|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
153470055|NCT03616236|Naloxone|naloxone|mesh-list
153470056|NCT03616236|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153470057|NCT03616236|Narcotics|narcotics|mesh-ancestor
153470058|NCT03616236|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153470059|NCT03616236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153470060|NCT03616236|Analgesics|analgesics|mesh-ancestor
153470061|NCT03616236|Sensory System Agents|sensory system agents|mesh-ancestor
153470062|NCT03616236|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153470063|NCT03616236|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
153470095|NCT03601455|Durvalumab|durvalumab|mesh-list
153921285|NCT06073470|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
153921286|NCT06073470|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153921287|NCT06073470|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153921288|NCT06073470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153921289|NCT06073470|Dopamine Agents|dopamine agents|mesh-ancestor
153923102|NCT03764540|Hormones|hormones|mesh-ancestor
153923103|NCT03764540|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153923104|NCT03764540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153923105|NCT03764540|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153923106|NCT03747484|Interferons|interferons|mesh-list
153923107|NCT03747484|Interferon-gamma|interferon-gamma|mesh-list
153923108|NCT03747484|Pembrolizumab|pembrolizumab|mesh-list
153923109|NCT03747484|Avelumab|avelumab|mesh-list
153923110|NCT03747484|Immunoglobulins|immunoglobulins|mesh-list
153921300|NCT06065059|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153921322|NCT06048133|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153385340|NCT04069221|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153385341|NCT04069221|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153385342|NCT04069221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153385343|NCT04069221|Antimalarials|antimalarials|mesh-ancestor
153385344|NCT04069221|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153385345|NCT04069221|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153385346|NCT03054038|Afatinib|afatinib|mesh-list
153921323|NCT06046417|Insulin|insulin|mesh-list
153921324|NCT06046417|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
153921325|NCT06046417|Insulin Aspart|insulin aspart|mesh-list
153921326|NCT06046417|Insulin Lispro|insulin lispro|mesh-list
153921327|NCT06046417|Pramlintide|pramlintide|mesh-list
153921328|NCT06046417|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153921329|NCT06046417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153921330|NCT06043713|Cyclophosphamide|cyclophosphamide|mesh-list
153921331|NCT06043713|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
153470096|NCT03601455|Ipilimumab|ipilimumab|mesh-list
153470097|NCT03601455|Tremelimumab|tremelimumab|mesh-list
153470098|NCT03601455|Immunoglobulins|immunoglobulins|mesh-list
153470099|NCT03601455|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
153470100|NCT03601455|Immunoglobulin G|immunoglobulin g|mesh-list
153470101|NCT03601455|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153470102|NCT03601455|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153470103|NCT03601455|Immunologic Factors|immunologic factors|mesh-ancestor
153470104|NCT03601455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153921332|NCT06043713|Fludarabine|fludarabine|mesh-list
153921333|NCT06043713|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153921334|NCT06043713|Immunologic Factors|immunologic factors|mesh-ancestor
153921335|NCT06043713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153921336|NCT06043713|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153921337|NCT06043713|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153921338|NCT06043713|Alkylating Agents|alkylating agents|mesh-ancestor
153921339|NCT06043713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153921340|NCT06043713|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153921341|NCT06043713|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153921342|NCT06042478|Omalizumab|omalizumab|mesh-list
153921343|NCT06042478|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
153921344|NCT06042478|Remibrutinib|remibrutinib|mesh-list
153921345|NCT06042478|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
153921361|NCT06022068|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153921362|NCT06022068|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153921363|NCT06022068|Antifungal Agents|antifungal agents|mesh-ancestor
153921364|NCT06022068|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153921365|NCT06022068|Immunologic Factors|immunologic factors|mesh-ancestor
153921366|NCT06022068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153921371|NCT06003153|Semaglutide|semaglutide|mesh-list
153921372|NCT06003153|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
153921373|NCT06003153|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153921374|NCT06003153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153921375|NCT06001762|Tamoxifen|tamoxifen|mesh-list
153921376|NCT06001762|Letrozole|letrozole|mesh-list
153921377|NCT06001762|Anastrozole|anastrozole|mesh-list
153921378|NCT06001762|Exemestane|exemestane|mesh-list
153921379|NCT06001762|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153921380|NCT06001762|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
153923195|NCT03547973|Carboplatin|carboplatin|mesh-list
153921381|NCT06001762|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153921382|NCT06001762|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153921383|NCT06001762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153921384|NCT06001762|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
153921385|NCT06001762|Hormone Antagonists|hormone antagonists|mesh-ancestor
153921386|NCT06001762|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153470105|NCT03601455|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153385347|NCT03054038|Necitumumab|necitumumab|mesh-list
153385348|NCT03054038|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153385349|NCT03054038|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153385350|NCT03054038|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153385380|NCT04066647|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153385381|NCT04066647|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153385382|NCT04041453|Ivermectin|ivermectin|mesh-list
153385383|NCT04041453|Albendazole|albendazole|mesh-list
153385384|NCT04041453|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153385385|NCT04041453|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153385386|NCT04041453|Anthelmintics|anthelmintics|mesh-ancestor
153385387|NCT04041453|Anticestodal Agents|anticestodal agents|mesh-ancestor
153385388|NCT04041453|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
153385389|NCT04041453|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153385390|NCT04041453|Tubulin Modulators|tubulin modulators|mesh-ancestor
153385391|NCT04041453|Antimitotic Agents|antimitotic agents|mesh-ancestor
153385392|NCT04041453|Mitosis Modulators|mitosis modulators|mesh-ancestor
153385393|NCT04041453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153385394|NCT04041453|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153385410|NCT00554216|Adrenergic Agents|adrenergic agents|mesh-ancestor
153385411|NCT00554216|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153921387|NCT06001762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153921388|NCT06001762|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153921389|NCT06001762|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
153921391|NCT06001762|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153921392|NCT05997238|Triamcinolone|triamcinolone|mesh-list
153921393|NCT05997238|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
153921394|NCT05997238|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
153921395|NCT05997238|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
153470173|NCT03383575|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153470174|NCT03340896|Docetaxel|docetaxel|mesh-list
153470175|NCT03340896|Fluorouracil|fluorouracil|mesh-list
153470176|NCT03340896|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153470177|NCT03340896|Tubulin Modulators|tubulin modulators|mesh-ancestor
153470178|NCT03340896|Antimitotic Agents|antimitotic agents|mesh-ancestor
153470179|NCT03340896|Mitosis Modulators|mitosis modulators|mesh-ancestor
153923221|NCT03499249|Acetylcysteine|acetylcysteine|mesh-list
153470180|NCT03340896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153470182|NCT03340896|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153470183|NCT03340896|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153470184|NCT03340896|Immunologic Factors|immunologic factors|mesh-ancestor
153470186|NCT03338621|Moxifloxacin|moxifloxacin|mesh-list
153921396|NCT05997238|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153921397|NCT05997238|Glucocorticoids|glucocorticoids|mesh-ancestor
153921398|NCT05997238|Hormones|hormones|mesh-ancestor
153921399|NCT05997238|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153921400|NCT05997238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153921408|NCT05995769|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153921409|NCT05992077|Sofosbuvir|sofosbuvir|mesh-list
153921410|NCT05992077|Antiviral Agents|antiviral agents|mesh-ancestor
153921411|NCT05992077|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153921412|NCT05988632|Insulin|insulin|mesh-list
153921413|NCT05988632|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
153923258|NCT03480776|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153921434|NCT05976243|Remibrutinib|remibrutinib|mesh-list
153921435|NCT05976243|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153385412|NCT00554216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153385413|NCT02353572|Dexamethasone|dexamethasone|mesh-list
153385414|NCT02353572|Bortezomib|bortezomib|mesh-list
153385415|NCT02353572|Melphalan|melphalan|mesh-list
153385416|NCT02353572|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153385417|NCT02353572|Antiemetics|antiemetics|mesh-ancestor
153921436|NCT05976243|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153921437|NCT05976243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153921438|NCT05970887|Vaccines|vaccines|mesh-list
153921439|NCT05970887|Immunologic Factors|immunologic factors|mesh-ancestor
153921440|NCT05970887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153921442|NCT05964335|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153921443|NCT05964335|Narcotics|narcotics|mesh-ancestor
153921444|NCT05964335|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153921445|NCT05964335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153921446|NCT05964335|Analgesics|analgesics|mesh-ancestor
153470212|NCT03338621|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153470213|NCT03334539|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
153470214|NCT03334539|Ophthalmic Solutions|ophthalmic solutions|mesh-list
153470215|NCT03321981|Trastuzumab|trastuzumab|mesh-list
153470216|NCT03321981|Letrozole|letrozole|mesh-list
153470217|NCT03321981|Vinorelbine|vinorelbine|mesh-list
153470218|NCT03321981|Fulvestrant|fulvestrant|mesh-list
153921480|NCT05893147|Lactams|lactams|mesh-list
153921481|NCT05893147|Cephalosporins|cephalosporins|mesh-list
153921482|NCT05893147|beta-Lactams|beta-lactams|mesh-list
153921491|NCT05889468|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153921492|NCT05889468|Analgesics|analgesics|mesh-ancestor
153921502|NCT05889468|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153921503|NCT05889468|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153470221|NCT03321981|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153921504|NCT05889468|Antipyretics|antipyretics|mesh-ancestor
153921505|NCT05887492|Pembrolizumab|pembrolizumab|mesh-list
153921506|NCT05887492|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153921507|NCT05887492|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153921508|NCT05887492|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153921509|NCT05887492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153470278|NCT03151499|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153470279|NCT03151499|Leprostatic Agents|leprostatic agents|mesh-ancestor
153470280|NCT03151499|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153470281|NCT03151499|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153921522|NCT05857384|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
153921523|NCT05857384|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153921524|NCT05857384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153921525|NCT05857384|Diuretics|diuretics|mesh-ancestor
153921526|NCT05857384|Natriuretic Agents|natriuretic agents|mesh-ancestor
153921527|NCT05857384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153921528|NCT05857384|Hallucinogens|hallucinogens|mesh-ancestor
153921529|NCT05857384|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153921530|NCT05857384|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153921531|NCT05857384|Analgesics|analgesics|mesh-ancestor
153921532|NCT05857384|Sensory System Agents|sensory system agents|mesh-ancestor
153921533|NCT05857384|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153472171|NCT04371978|Hormones|hormones|mesh-ancestor
153921569|NCT05800587|Paclitaxel|paclitaxel|mesh-list
153921570|NCT05800587|Etoposide|etoposide|mesh-list
153921571|NCT05800587|Docetaxel|docetaxel|mesh-list
153921572|NCT05800587|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
153921573|NCT05800587|Carboplatin|carboplatin|mesh-list
153921574|NCT05800587|Gemcitabine|gemcitabine|mesh-list
153921575|NCT05800587|Irinotecan|irinotecan|mesh-list
153921576|NCT05800587|Pemetrexed|pemetrexed|mesh-list
153921577|NCT05800587|Topotecan|topotecan|mesh-list
153921578|NCT05800587|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153921579|NCT05800587|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153921580|NCT05800587|Tubulin Modulators|tubulin modulators|mesh-ancestor
153470343|NCT02749799|Respiratory System Agents|respiratory system agents|mesh-ancestor
153385418|NCT02353572|Autonomic Agents|autonomic agents|mesh-ancestor
153385419|NCT02353572|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153385420|NCT02353572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153385421|NCT02353572|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153385422|NCT02353572|Glucocorticoids|glucocorticoids|mesh-ancestor
153385423|NCT02353572|Hormones|hormones|mesh-ancestor
153385424|NCT02353572|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153385425|NCT02353572|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153470360|NCT02597998|BI 409306|bi 409306|mesh-list
153470361|NCT02597998|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
153923462|NCT02465268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153923463|NCT02465268|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153923464|NCT02429557|Midodrine|midodrine|mesh-list
153923465|NCT02429557|Sympathomimetics|sympathomimetics|mesh-ancestor
153923466|NCT02429557|Autonomic Agents|autonomic agents|mesh-ancestor
153923467|NCT02429557|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153923468|NCT02429557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153923482|NCT02232399|Simendan|simendan|mesh-list
153470362|NCT02597998|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153470363|NCT02597998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153470364|NCT02527421|Betamethasone|betamethasone|mesh-list
153470365|NCT02527421|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153470366|NCT02527421|Glucocorticoids|glucocorticoids|mesh-ancestor
153470367|NCT02527421|Hormones|hormones|mesh-ancestor
153470368|NCT02527421|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153470369|NCT02527421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153470370|NCT02527421|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153470371|NCT02527421|Respiratory System Agents|respiratory system agents|mesh-ancestor
153470375|NCT02518594|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153470376|NCT02518594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153470377|NCT02514278|Capecitabine|capecitabine|mesh-list
153921581|NCT05800587|Antimitotic Agents|antimitotic agents|mesh-ancestor
153921582|NCT05800587|Mitosis Modulators|mitosis modulators|mesh-ancestor
153472283|NCT04363866|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153472284|NCT04363866|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153472285|NCT04363866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153472286|NCT04363866|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153472289|NCT04362384|Vitamins|vitamins|mesh-ancestor
153472290|NCT04362384|Micronutrients|micronutrients|mesh-ancestor
153923517|NCT01962948|Paclitaxel|paclitaxel|mesh-list
153923518|NCT01962948|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153923519|NCT01962948|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153923520|NCT01962948|Tubulin Modulators|tubulin modulators|mesh-ancestor
153923521|NCT01962948|Antimitotic Agents|antimitotic agents|mesh-ancestor
153923522|NCT01962948|Mitosis Modulators|mitosis modulators|mesh-ancestor
153923523|NCT01962948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153923524|NCT01897571|Prednisolone|prednisolone|mesh-list
153923525|NCT01897571|Prednisolone acetate|prednisolone acetate|mesh-list
153923526|NCT01897571|Prednisolone phosphate|prednisolone phosphate|mesh-list
153923527|NCT01897571|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153921591|NCT05800587|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153921592|NCT05799612|Interferons|interferons|mesh-list
153921593|NCT05799612|Interferon-alpha|interferon-alpha|mesh-list
153921594|NCT05799612|Interferon alpha-2|interferon alpha-2|mesh-list
153921595|NCT05799612|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
153921597|NCT05799612|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153921598|NCT05799612|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153921599|NCT05799612|Tubulin Modulators|tubulin modulators|mesh-ancestor
153921600|NCT05799612|Antimitotic Agents|antimitotic agents|mesh-ancestor
153921601|NCT05799612|Mitosis Modulators|mitosis modulators|mesh-ancestor
153921602|NCT05799612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153921603|NCT05799612|Antiviral Agents|antiviral agents|mesh-ancestor
153921604|NCT05799612|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153921605|NCT05799612|Immunologic Factors|immunologic factors|mesh-ancestor
153921606|NCT05799612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153921607|NCT05789524|Protein C|protein c|mesh-list
153385426|NCT02353572|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153385427|NCT02353572|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153385428|NCT02353572|Alkylating Agents|alkylating agents|mesh-ancestor
153385429|NCT02353572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153385430|NCT02353572|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153385431|NCT02353572|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153385432|NCT02353572|Immunologic Factors|immunologic factors|mesh-ancestor
153385433|NCT03886701|Isoniazid|isoniazid|mesh-list
153385434|NCT03886701|Rifapentine|rifapentine|mesh-list
153385435|NCT03886701|Antitubercular Agents|antitubercular agents|mesh-ancestor
153385436|NCT03886701|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153385437|NCT03886701|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153385438|NCT03886701|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
153385439|NCT03886701|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153385440|NCT03886701|Antimetabolites|antimetabolites|mesh-ancestor
153385441|NCT03886701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153921608|NCT05789524|Anticoagulants|anticoagulants|mesh-ancestor
153921609|NCT05789524|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153921610|NCT05789524|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153921611|NCT05789524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153470378|NCT02514278|Folfirinox|folfirinox|mesh-list
153470379|NCT02514278|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153470380|NCT02514278|Antimetabolites|antimetabolites|mesh-ancestor
153470381|NCT02514278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153470382|NCT02514278|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153470383|NCT02498977|Cyclosporine|cyclosporine|mesh-list
153921622|NCT05767034|Immunologic Factors|immunologic factors|mesh-ancestor
153921623|NCT05767034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153921624|NCT05748483|Topiramate|topiramate|mesh-list
153921625|NCT05748483|Anticonvulsants|anticonvulsants|mesh-ancestor
153921626|NCT05748483|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153921627|NCT05748483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153921629|NCT05738291|Midazolam|midazolam|mesh-list
153921630|NCT05738291|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
153921631|NCT05738291|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153921632|NCT05738291|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153921633|NCT05738291|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153921634|NCT05738291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153921635|NCT05738291|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153921636|NCT05738291|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153921637|NCT05738291|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153923595|NCT01081262|Antibodies|antibodies|mesh-list
153921638|NCT05738291|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153921639|NCT05738291|Anesthetics, General|anesthetics, general|mesh-ancestor
153921640|NCT05738291|Anesthetics|anesthetics|mesh-ancestor
153921641|NCT05738291|GABA Modulators|gaba modulators|mesh-ancestor
153921642|NCT05738291|GABA Agents|gaba agents|mesh-ancestor
153921643|NCT05738291|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153921644|NCT05738291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153921645|NCT05738291|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153921656|NCT05736549|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
153921657|NCT05736549|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
153921658|NCT05736549|Prednisolone|prednisolone|mesh-list
153921659|NCT05736549|Prednisolone acetate|prednisolone acetate|mesh-list
153921660|NCT05736549|Dexamethasone acetate|dexamethasone acetate|mesh-list
153921661|NCT05736549|Bupivacaine|bupivacaine|mesh-list
153921662|NCT05736549|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
153921663|NCT05736549|Prednisolone phosphate|prednisolone phosphate|mesh-list
153921664|NCT05736549|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
153921665|NCT05736549|BB 1101|bb 1101|mesh-list
153921666|NCT05736549|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153921667|NCT05736549|Antiemetics|antiemetics|mesh-ancestor
153923651|NCT00381680|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153921669|NCT05736549|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153921670|NCT05736549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153921671|NCT05736549|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153921672|NCT05736549|Glucocorticoids|glucocorticoids|mesh-ancestor
153921673|NCT05736549|Hormones|hormones|mesh-ancestor
153921674|NCT05736549|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153921675|NCT05736549|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153921676|NCT05736549|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153921677|NCT05736549|Anesthetics, Local|anesthetics, local|mesh-ancestor
153921678|NCT05736549|Anesthetics|anesthetics|mesh-ancestor
153470384|NCT02498977|Mycophenolic Acid|mycophenolic acid|mesh-list
153921679|NCT05736549|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153921680|NCT05736549|Sensory System Agents|sensory system agents|mesh-ancestor
153921681|NCT05736549|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
153921682|NCT05736549|Protective Agents|protective agents|mesh-ancestor
153921683|NCT05736549|Protease Inhibitors|protease inhibitors|mesh-ancestor
153921684|NCT05736549|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153921685|NCT05736549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153921686|NCT05725135|Propofol|propofol|mesh-list
153470447|NCT01861106|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
153470450|NCT01861106|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
153470451|NCT01861106|Antitubercular Agents|antitubercular agents|mesh-ancestor
153470452|NCT01861106|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153470453|NCT01861106|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153470455|NCT01856478|Afatinib|afatinib|mesh-list
153470456|NCT01856478|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
153470457|NCT01856478|Abortifacient Agents|abortifacient agents|mesh-ancestor
153470458|NCT01856478|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153470459|NCT01856478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153470460|NCT01856478|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153470461|NCT01856478|Antimetabolites|antimetabolites|mesh-ancestor
153921694|NCT05724628|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153921695|NCT05715671|Esketamine|esketamine|mesh-list
153921696|NCT05715671|Antidepressive Agents|antidepressive agents|mesh-ancestor
153921697|NCT05715671|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153921726|NCT05692180|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153921727|NCT05692180|Respiratory System Agents|respiratory system agents|mesh-ancestor
153921728|NCT05685602|Paclitaxel|paclitaxel|mesh-list
153921729|NCT05685602|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
153921730|NCT05685602|Gemcitabine|gemcitabine|mesh-list
153921731|NCT05685602|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153921732|NCT05685602|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153921733|NCT05685602|Tubulin Modulators|tubulin modulators|mesh-ancestor
153921734|NCT05685602|Antimitotic Agents|antimitotic agents|mesh-ancestor
153921735|NCT05685602|Mitosis Modulators|mitosis modulators|mesh-ancestor
153921736|NCT05685602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153470499|NCT01695941|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
153470500|NCT01695941|Bortezomib|bortezomib|mesh-list
153470501|NCT01695941|Antibodies|antibodies|mesh-list
153470502|NCT01695941|Immunoglobulins|immunoglobulins|mesh-list
153470503|NCT01695941|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
153470504|NCT01695941|Immunologic Factors|immunologic factors|mesh-ancestor
153470505|NCT01695941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153470506|NCT01695941|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153470507|NCT01695941|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153470508|NCT01638533|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
153470509|NCT01638533|Romidepsin|romidepsin|mesh-list
153470510|NCT01638533|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153470511|NCT01638533|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153470512|NCT01638533|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153424197|NCT03670160|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153424198|NCT03670160|Adrenergic Agents|adrenergic agents|mesh-ancestor
153424199|NCT03670160|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153424200|NCT03670160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153424201|NCT03670160|Anticonvulsants|anticonvulsants|mesh-ancestor
153424202|NCT03670160|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153424203|NCT03670160|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153424204|NCT03670160|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
153424205|NCT03670160|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
153424206|NCT03670160|GABA Modulators|gaba modulators|mesh-ancestor
153385444|NCT03886701|Leprostatic Agents|leprostatic agents|mesh-ancestor
153385445|NCT00552578|Buprenorphine|buprenorphine|mesh-list
153385446|NCT00552578|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
153385448|NCT00552578|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153385449|NCT00552578|Narcotics|narcotics|mesh-ancestor
153385450|NCT00552578|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153385451|NCT00552578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153385452|NCT00552578|Analgesics|analgesics|mesh-ancestor
153470513|NCT01638533|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
153921737|NCT05685602|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153921738|NCT05685602|Antimetabolites|antimetabolites|mesh-ancestor
153921739|NCT05677451|Remibrutinib|remibrutinib|mesh-list
153921740|NCT05677451|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153921741|NCT05677451|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153921742|NCT05677451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153470514|NCT01638533|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153473133|NCT03017430|GABA Agents|gaba agents|mesh-ancestor
153470562|NCT00096434|Sorafenib|sorafenib|mesh-list
153470563|NCT00096434|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153470564|NCT00096434|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153470565|NCT00096434|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153921818|NCT05667662|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153921819|NCT05667662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153921820|NCT05667662|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153921831|NCT05663892|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
153921833|NCT05663892|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
153921834|NCT05663892|Estrogens|estrogens|mesh-ancestor
153921835|NCT05663892|Hormones|hormones|mesh-ancestor
153921836|NCT05663892|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153921837|NCT05663892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153921838|NCT05663892|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
153921839|NCT05663892|Contraceptive Agents|contraceptive agents|mesh-ancestor
153921840|NCT05663892|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153921841|NCT05663892|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
153385453|NCT00552578|Sensory System Agents|sensory system agents|mesh-ancestor
153385454|NCT00552578|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153385490|NCT04032327|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153385491|NCT04032327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153385492|NCT04032327|Sensory System Agents|sensory system agents|mesh-ancestor
153385493|NCT04032327|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153385494|NCT04041219|Tacrolimus|tacrolimus|mesh-list
153385495|NCT04041219|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153385496|NCT04041219|Immunologic Factors|immunologic factors|mesh-ancestor
153385567|NCT00553202|Antilymphocyte Serum|antilymphocyte serum|mesh-list
153385568|NCT00553202|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
153385569|NCT00553202|Prednisolone phosphate|prednisolone phosphate|mesh-list
153470572|NCT00565266|Autonomic Agents|autonomic agents|mesh-ancestor
153470573|NCT00565266|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153921854|NCT05645536|Tamoxifen|tamoxifen|mesh-list
153921855|NCT05645536|Letrozole|letrozole|mesh-list
153921856|NCT05645536|Anastrozole|anastrozole|mesh-list
153921857|NCT05645536|Exemestane|exemestane|mesh-list
153921858|NCT05645536|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153921859|NCT05645536|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
153921860|NCT05645536|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153921861|NCT05645536|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153921862|NCT05645536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153470629|NCT05362500|Tranylcypromine|tranylcypromine|mesh-list
153470630|NCT05362500|Glycolic acid|glycolic acid|mesh-list
153470631|NCT05362500|Tranexamic Acid|tranexamic acid|mesh-list
153470632|NCT05362500|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
153470633|NCT05362500|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153470634|NCT05362500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153470635|NCT05362500|Hemostatics|hemostatics|mesh-ancestor
153470636|NCT05362500|Coagulants|coagulants|mesh-ancestor
153470637|NCT05362500|Keratolytic Agents|keratolytic agents|mesh-ancestor
153921863|NCT05645536|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
153921864|NCT05645536|Hormone Antagonists|hormone antagonists|mesh-ancestor
153921865|NCT05645536|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153921866|NCT05645536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153921867|NCT05645536|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153921868|NCT05645536|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
153921869|NCT05645536|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
153921870|NCT05645536|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153921871|NCT05644561|Ravulizumab|ravulizumab|mesh-list
153921872|NCT05644561|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
153473635|NCT02974920|Anticoagulants|anticoagulants|mesh-ancestor
153921887|NCT05599789|Docetaxel|docetaxel|mesh-list
153921888|NCT05599789|Pembrolizumab|pembrolizumab|mesh-list
153921889|NCT05599789|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153921890|NCT05599789|Tubulin Modulators|tubulin modulators|mesh-ancestor
153921891|NCT05599789|Antimitotic Agents|antimitotic agents|mesh-ancestor
153921892|NCT05599789|Mitosis Modulators|mitosis modulators|mesh-ancestor
153921893|NCT05599789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153921894|NCT05599789|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153921895|NCT05599789|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153921897|NCT05587881|Immunologic Factors|immunologic factors|mesh-ancestor
153921910|NCT05580666|Azithromycin|azithromycin|mesh-list
153921911|NCT05580666|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153921912|NCT05580666|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153470683|NCT05214222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153470684|NCT05198232|Aluminum hydroxide, magnesium hydroxide, simethicone drug combination|aluminum hydroxide, magnesium hydroxide, simethicone drug combination|mesh-list
153470686|NCT05198232|Antioxidants|antioxidants|mesh-ancestor
153470687|NCT05198232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153470688|NCT05198232|Protective Agents|protective agents|mesh-ancestor
153385570|NCT00553202|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153385571|NCT00553202|Immunologic Factors|immunologic factors|mesh-ancestor
153385592|NCT00553202|Antiemetics|antiemetics|mesh-ancestor
153385593|NCT00553202|Autonomic Agents|autonomic agents|mesh-ancestor
153470689|NCT05198232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153470690|NCT05198232|Antacids|antacids|mesh-ancestor
153470691|NCT05198232|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153470692|NCT04747236|Gemcitabine|gemcitabine|mesh-list
153470693|NCT04747236|Azacitidine|azacitidine|mesh-list
153921941|NCT05567952|Ritonavir|ritonavir|mesh-list
153921942|NCT05567952|Nirmatrelvir|nirmatrelvir|mesh-list
153921943|NCT05567952|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
153921944|NCT05567952|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
153921945|NCT05567952|Protease Inhibitors|protease inhibitors|mesh-ancestor
153921946|NCT05567952|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153921947|NCT05567952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153921948|NCT05567952|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153921949|NCT05567952|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153921950|NCT05567952|Antiviral Agents|antiviral agents|mesh-ancestor
153921951|NCT05567952|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153921952|NCT05567952|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
153921953|NCT05567952|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153921963|NCT05564377|Paclitaxel|paclitaxel|mesh-list
153921964|NCT05564377|Fluorouracil|fluorouracil|mesh-list
153921965|NCT05564377|Oxaliplatin|oxaliplatin|mesh-list
153921966|NCT05564377|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
153921967|NCT05564377|Fulvestrant|fulvestrant|mesh-list
153470695|NCT04747236|Belinostat|belinostat|mesh-list
153470696|NCT04747236|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153921968|NCT05564377|Olaparib|olaparib|mesh-list
153921969|NCT05564377|Palbociclib|palbociclib|mesh-list
153921970|NCT05564377|Panitumumab|panitumumab|mesh-list
153921971|NCT05564377|Ipatasertib|ipatasertib|mesh-list
153921972|NCT05564377|Sotorasib|sotorasib|mesh-list
153921973|NCT05564377|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
153921974|NCT05564377|Antibodies|antibodies|mesh-list
153921975|NCT05564377|Immunoglobulins|immunoglobulins|mesh-list
153921976|NCT05564377|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
153921977|NCT05564377|Maleic acid|maleic acid|mesh-list
153921978|NCT05564377|Nilotinib|nilotinib|mesh-list
153921979|NCT05564377|Neratinib|neratinib|mesh-list
153921980|NCT05564377|Phosphoinositide-3 Kinase Inhibitors|phosphoinositide-3 kinase inhibitors|mesh-list
153921981|NCT05564377|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153921982|NCT05564377|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153470751|NCT02783430|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
153470752|NCT02783430|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153470753|NCT02783430|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153470754|NCT02783430|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153470755|NCT02783430|Antidepressive Agents|antidepressive agents|mesh-ancestor
153470756|NCT02783430|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153470757|NCT03642366|Tadalafil|tadalafil|mesh-list
153470758|NCT03642366|Vasodilator Agents|vasodilator agents|mesh-ancestor
153921983|NCT05564377|Tubulin Modulators|tubulin modulators|mesh-ancestor
153921984|NCT05564377|Antimitotic Agents|antimitotic agents|mesh-ancestor
153921985|NCT05564377|Mitosis Modulators|mitosis modulators|mesh-ancestor
153470764|NCT00604968|Doxorubicin|doxorubicin|mesh-list
153921986|NCT05564377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153921987|NCT05564377|Immunologic Factors|immunologic factors|mesh-ancestor
153921988|NCT05564377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153921989|NCT05564377|Antimetabolites|antimetabolites|mesh-ancestor
153921990|NCT05564377|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153921991|NCT05564377|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153921992|NCT05564377|Antidotes|antidotes|mesh-ancestor
153921993|NCT05564377|Protective Agents|protective agents|mesh-ancestor
153921994|NCT05564377|Vitamin B Complex|vitamin b complex|mesh-ancestor
153921995|NCT05564377|Vitamins|vitamins|mesh-ancestor
153921996|NCT05564377|Micronutrients|micronutrients|mesh-ancestor
153921997|NCT05564377|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153883268|NCT01339923|Immunologic Factors|immunologic factors|mesh-ancestor
153883269|NCT01339923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153883270|NCT01380093|Naltrexone|naltrexone|mesh-list
153883271|NCT01380093|Morphine|morphine|mesh-list
153883272|NCT01380093|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153883273|NCT01380093|Narcotics|narcotics|mesh-ancestor
153385594|NCT00553202|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153921998|NCT05564377|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
153921999|NCT05564377|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
153922000|NCT05564377|Hormone Antagonists|hormone antagonists|mesh-ancestor
153922001|NCT05564377|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153922002|NCT05564377|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
153922003|NCT05564377|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153922004|NCT05564377|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153922005|NCT05564377|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153922006|NCT05564377|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153922007|NCT05552508|Benralizumab|benralizumab|mesh-list
153922008|NCT05552508|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153922009|NCT05552508|Respiratory System Agents|respiratory system agents|mesh-ancestor
153922010|NCT05539989|Vaccines|vaccines|mesh-list
153922011|NCT05539989|BCG Vaccine|bcg vaccine|mesh-list
153922012|NCT05539989|Immunologic Factors|immunologic factors|mesh-ancestor
153922013|NCT05539989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153922014|NCT05539989|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153922015|NCT05446467|Pembrolizumab|pembrolizumab|mesh-list
153922016|NCT05446467|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153922017|NCT05446467|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153922018|NCT05446467|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153922019|NCT05446467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153922020|NCT05432791|Temozolomide|temozolomide|mesh-list
153922021|NCT05432791|Trabectedin|trabectedin|mesh-list
153922022|NCT05432791|Olaparib|olaparib|mesh-list
153922023|NCT05432791|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
153922024|NCT05432791|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153922025|NCT05432791|Alkylating Agents|alkylating agents|mesh-ancestor
153922026|NCT05432791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153922027|NCT05432791|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153922028|NCT05432791|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153922029|NCT05424315|Dapagliflozin|dapagliflozin|mesh-list
153922030|NCT05424315|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
153922041|NCT05421065|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153922042|NCT05421065|Anesthetics, General|anesthetics, general|mesh-ancestor
153922043|NCT05421065|Anesthetics|anesthetics|mesh-ancestor
153474748|NCT00720330|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153922044|NCT05421065|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153922045|NCT05421065|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
153922046|NCT05421065|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
153922047|NCT05421065|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153922048|NCT05421065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153922049|NCT05421065|Hallucinogens|hallucinogens|mesh-ancestor
153922050|NCT05421065|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153922052|NCT05371054|Venetoclax|venetoclax|mesh-list
153922053|NCT05371054|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153922054|NCT05371054|Glucocorticoids|glucocorticoids|mesh-ancestor
153922055|NCT05371054|Hormones|hormones|mesh-ancestor
153922056|NCT05371054|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153922057|NCT05371054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153922058|NCT05371054|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153385595|NCT00553202|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153385596|NCT00553202|Glucocorticoids|glucocorticoids|mesh-ancestor
153385598|NCT00553202|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153385599|NCT00553202|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
153385600|NCT00553202|Protective Agents|protective agents|mesh-ancestor
153385601|NCT00553202|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153385602|NCT00552188|Atreleuton|atreleuton|mesh-list
153385603|NCT00552188|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
153385604|NCT00552188|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153385605|NCT00552188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153385606|NCT00377793|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
153385607|NCT00377793|Vasodilator Agents|vasodilator agents|mesh-ancestor
153922059|NCT05371054|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153922060|NCT05368558|Cariprazine|cariprazine|mesh-list
153922061|NCT05368558|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153922062|NCT05368558|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153922063|NCT05368558|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153474886|NCT00736632|Vitamin D|vitamin d|mesh-list
153922064|NCT05368558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153922065|NCT05368558|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153922066|NCT05353439|Pembrolizumab|pembrolizumab|mesh-list
153922067|NCT05353439|Topotecan|topotecan|mesh-list
153922068|NCT05353439|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153922069|NCT05353439|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153922070|NCT05353439|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153922071|NCT05353439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153922072|NCT05353439|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
153922080|NCT05333458|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153922082|NCT05333458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153922083|NCT05321160|Ketamine|ketamine|mesh-list
153922084|NCT05321160|Sevoflurane|sevoflurane|mesh-list
153922085|NCT05321160|Esketamine|esketamine|mesh-list
153922086|NCT05321160|Analgesics|analgesics|mesh-ancestor
153922087|NCT05321160|Sensory System Agents|sensory system agents|mesh-ancestor
153922088|NCT05321160|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153922089|NCT05321160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153922090|NCT05321160|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
153922091|NCT05321160|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153922092|NCT05321160|Anesthetics, General|anesthetics, general|mesh-ancestor
153922093|NCT05321160|Anesthetics|anesthetics|mesh-ancestor
153922094|NCT05321160|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153922095|NCT05321160|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
153922096|NCT05321160|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
153922097|NCT05321160|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153922098|NCT05321160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153922099|NCT05321160|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153922100|NCT05321160|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
153470867|NCT02889666|Antimetabolites|antimetabolites|mesh-ancestor
153470868|NCT02889666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153470869|NCT02889666|Tubulin Modulators|tubulin modulators|mesh-ancestor
153470870|NCT02889666|Antimitotic Agents|antimitotic agents|mesh-ancestor
153470871|NCT02889666|Mitosis Modulators|mitosis modulators|mesh-ancestor
153470872|NCT00609804|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
153470873|NCT00609804|Sorafenib|sorafenib|mesh-list
153470874|NCT00609804|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153470875|NCT00609804|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153470876|NCT00609804|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153475083|NCT00760578|Pioglitazone|pioglitazone|mesh-list
153470877|NCT00609804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153470878|NCT00609804|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153470879|NCT00610428|Prochlorperazine|prochlorperazine|mesh-list
153470880|NCT00610428|Antiemetics|antiemetics|mesh-ancestor
153385608|NCT00377793|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
153385609|NCT00377793|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
153385610|NCT00377793|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153385611|NCT00377793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153385612|NCT00377793|Urological Agents|urological agents|mesh-ancestor
153385613|NCT04027803|Eculizumab|eculizumab|mesh-list
153385614|NCT04027803|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
153385615|NCT04027803|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153385616|NCT04027803|Immunologic Factors|immunologic factors|mesh-ancestor
153385617|NCT04027803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153470881|NCT00610428|Autonomic Agents|autonomic agents|mesh-ancestor
153922101|NCT05321160|Antidepressive Agents|antidepressive agents|mesh-ancestor
153922102|NCT05321160|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153922103|NCT05317416|Lenalidomide|lenalidomide|mesh-list
153922104|NCT05317416|Immunologic Factors|immunologic factors|mesh-ancestor
153922105|NCT05317416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153922106|NCT05317416|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153922107|NCT05317416|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153922108|NCT05317416|Growth Substances|growth substances|mesh-ancestor
153922109|NCT05317416|Growth Inhibitors|growth inhibitors|mesh-ancestor
153922110|NCT05317416|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153922111|NCT05300035|Antibodies|antibodies|mesh-list
153922112|NCT05300035|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
153922113|NCT05300035|Immunologic Factors|immunologic factors|mesh-ancestor
153922114|NCT05300035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153922115|NCT05297864|Niraparib|niraparib|mesh-list
153922116|NCT05297864|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
153922117|NCT05297864|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153922118|NCT05297864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153922119|NCT05297864|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153922120|NCT05283720|Prednisone|prednisone|mesh-list
153922121|NCT05283720|Cyclophosphamide|cyclophosphamide|mesh-list
153922122|NCT05283720|Rituximab|rituximab|mesh-list
153922123|NCT05283720|Doxorubicin|doxorubicin|mesh-list
153922124|NCT05283720|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
153922134|NCT05283720|Alkylating Agents|alkylating agents|mesh-ancestor
153922135|NCT05283720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153922136|NCT05283720|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153922137|NCT05283720|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153922138|NCT05283720|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153922139|NCT05283720|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153922140|NCT05283720|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153922141|NCT05283720|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153922142|NCT05283720|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153922143|NCT05283720|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153470893|NCT00610740|Gemcitabine|gemcitabine|mesh-list
153922144|NCT05283720|Glucocorticoids|glucocorticoids|mesh-ancestor
153922145|NCT05283720|Hormones|hormones|mesh-ancestor
153922146|NCT05283720|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153922147|NCT05283720|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153922148|NCT05283720|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153922149|NCT05283720|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153922150|NCT05283720|Growth Substances|growth substances|mesh-ancestor
153922151|NCT05283720|Growth Inhibitors|growth inhibitors|mesh-ancestor
153922152|NCT05283720|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153922153|NCT05283720|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153922154|NCT05283720|Immunoconjugates|immunoconjugates|mesh-ancestor
153922155|NCT05276973|Paclitaxel|paclitaxel|mesh-list
153922156|NCT05276973|Carboplatin|carboplatin|mesh-list
153922157|NCT05276973|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
153922158|NCT05276973|Ipatasertib|ipatasertib|mesh-list
153922159|NCT05276973|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153922160|NCT05276973|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153922161|NCT05276973|Tubulin Modulators|tubulin modulators|mesh-ancestor
153470927|NCT02136498|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153385618|NCT00552110|Mometasone Furoate|mometasone furoate|mesh-list
153385619|NCT00552110|Phenylephrine|phenylephrine|mesh-list
153385620|NCT00552110|Oxymetazoline|oxymetazoline|mesh-list
153783571|NCT04545931|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
153385621|NCT00552110|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153385622|NCT00552110|Dermatologic Agents|dermatologic agents|mesh-ancestor
153385623|NCT00552110|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
153385681|NCT02351934|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153385682|NCT02351934|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153470928|NCT02136498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153922162|NCT05276973|Antimitotic Agents|antimitotic agents|mesh-ancestor
153922163|NCT05276973|Mitosis Modulators|mitosis modulators|mesh-ancestor
153922164|NCT05276973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153922165|NCT05276973|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153922166|NCT05276973|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153922167|NCT05275439|Azacitidine|azacitidine|mesh-list
153922168|NCT05275439|Venetoclax|venetoclax|mesh-list
153922169|NCT05275439|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153922170|NCT05275439|Antimetabolites|antimetabolites|mesh-ancestor
153922171|NCT05275439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153922172|NCT05275439|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153922173|NCT05275439|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153922174|NCT05196815|Dobutamine|dobutamine|mesh-list
153922175|NCT05196815|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
153922176|NCT05196815|Sympathomimetics|sympathomimetics|mesh-ancestor
153922177|NCT05196815|Autonomic Agents|autonomic agents|mesh-ancestor
153922178|NCT05196815|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153922179|NCT05196815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153922180|NCT05196815|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
153922181|NCT05196815|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
153922182|NCT05196815|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153922183|NCT05196815|Adrenergic Agents|adrenergic agents|mesh-ancestor
153922184|NCT05196815|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153922185|NCT05196815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153922186|NCT05196815|Protective Agents|protective agents|mesh-ancestor
153922188|NCT05172245|Ipatasertib|ipatasertib|mesh-list
153922189|NCT05172245|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153922190|NCT05172245|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153922225|NCT05143840|Micronutrients|micronutrients|mesh-ancestor
153922226|NCT05143840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153922227|NCT05116462|Paclitaxel|paclitaxel|mesh-list
153922228|NCT05116462|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
153922229|NCT05116462|Carboplatin|carboplatin|mesh-list
153922230|NCT05116462|Pemetrexed|pemetrexed|mesh-list
153922231|NCT05116462|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153922232|NCT05116462|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153922233|NCT05116462|Tubulin Modulators|tubulin modulators|mesh-ancestor
153922234|NCT05116462|Antimitotic Agents|antimitotic agents|mesh-ancestor
153922235|NCT05116462|Mitosis Modulators|mitosis modulators|mesh-ancestor
153471000|NCT00614406|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
153471001|NCT00614406|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153471002|NCT00614406|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153471003|NCT00614406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153471006|NCT00614484|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153471007|NCT00614484|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153471008|NCT00614484|Tubulin Modulators|tubulin modulators|mesh-ancestor
153922236|NCT05116462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153922238|NCT05116462|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153922239|NCT05116462|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153922240|NCT05111353|Poly ICLC|poly iclc|mesh-list
153922241|NCT05111353|Interferon Inducers|interferon inducers|mesh-ancestor
153922242|NCT05111353|Immunologic Factors|immunologic factors|mesh-ancestor
153922243|NCT05111353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153385683|NCT02351934|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
153385684|NCT02351934|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
153385685|NCT02351934|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153385686|NCT02351934|Antimanic Agents|antimanic agents|mesh-ancestor
153385687|NCT02351934|Diuretics|diuretics|mesh-ancestor
153385688|NCT02351934|Natriuretic Agents|natriuretic agents|mesh-ancestor
153385689|NCT02351934|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
153385690|NCT02351934|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153385691|NCT00377481|Darbepoetin alfa|darbepoetin alfa|mesh-list
153385692|NCT00377481|Hematinics|hematinics|mesh-ancestor
153385694|NCT00377559|Doxorubicin|doxorubicin|mesh-list
153922244|NCT05098119|Paclitaxel|paclitaxel|mesh-list
153922245|NCT05098119|Carboplatin|carboplatin|mesh-list
153922246|NCT05098119|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153922247|NCT05098119|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153922248|NCT05098119|Tubulin Modulators|tubulin modulators|mesh-ancestor
153922249|NCT05098119|Antimitotic Agents|antimitotic agents|mesh-ancestor
153922250|NCT05098119|Mitosis Modulators|mitosis modulators|mesh-ancestor
153922251|NCT05098119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153922258|NCT05063552|Bevacizumab|bevacizumab|mesh-list
153922259|NCT05063552|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
153922261|NCT05063552|Atezolizumab|atezolizumab|mesh-list
153922262|NCT05063552|Cisplatin|cisplatin|mesh-list
153922263|NCT05063552|Carboplatin|carboplatin|mesh-list
153922264|NCT05063552|Docetaxel|docetaxel|mesh-list
153922265|NCT05063552|Endothelial Growth Factors|endothelial growth factors|mesh-list
153922266|NCT05063552|Antibodies|antibodies|mesh-list
153922267|NCT05063552|Immunoglobulins|immunoglobulins|mesh-list
153922268|NCT05063552|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
153922269|NCT05063552|Immunoglobulin G|immunoglobulin g|mesh-list
153922270|NCT05063552|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153922271|NCT05063552|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153922272|NCT05063552|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153922273|NCT05063552|Growth Substances|growth substances|mesh-ancestor
153922274|NCT05063552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153922275|NCT05063552|Growth Inhibitors|growth inhibitors|mesh-ancestor
153922276|NCT05063552|Immunologic Factors|immunologic factors|mesh-ancestor
153922277|NCT05063552|Tubulin Modulators|tubulin modulators|mesh-ancestor
153922278|NCT05063552|Antimitotic Agents|antimitotic agents|mesh-ancestor
153922279|NCT05063552|Mitosis Modulators|mitosis modulators|mesh-ancestor
153922280|NCT05063552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153922281|NCT05063552|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153922282|NCT05053971|Entinostat|entinostat|mesh-list
153475712|NCT00824460|Iron|iron|mesh-list
153922283|NCT05053971|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-list
153922285|NCT05053971|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153922294|NCT05029882|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153922295|NCT05029882|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153922296|NCT05029882|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153922297|NCT05029882|Growth Substances|growth substances|mesh-ancestor
153922298|NCT05029882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153922299|NCT05029882|Growth Inhibitors|growth inhibitors|mesh-ancestor
153922300|NCT05029882|Antimetabolites|antimetabolites|mesh-ancestor
153922301|NCT05029882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153922302|NCT05029882|Antiviral Agents|antiviral agents|mesh-ancestor
153471066|NCT00616122|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153471068|NCT00616122|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153471069|NCT00616122|Growth Substances|growth substances|mesh-ancestor
153471070|NCT00616122|Growth Inhibitors|growth inhibitors|mesh-ancestor
153475779|NCT00832338|Docetaxel|docetaxel|mesh-list
153471071|NCT00616122|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153471072|NCT00617058|Metformin|metformin|mesh-list
153471073|NCT00617058|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153471074|NCT00617058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153385695|NCT00377559|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
153385696|NCT00377559|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153471076|NCT00618540|Fludarabine phosphate|fludarabine phosphate|mesh-list
153471077|NCT00618540|Melphalan|melphalan|mesh-list
153471078|NCT00618540|Alemtuzumab|alemtuzumab|mesh-list
153471079|NCT00618540|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153471080|NCT00618540|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153471090|NCT00570960|Dextrans|dextrans|mesh-list
153922303|NCT05029882|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153922304|NCT05000216|Mycophenolic Acid|mycophenolic acid|mesh-list
153922305|NCT05000216|Methotrexate|methotrexate|mesh-list
153922306|NCT05000216|Vaccines|vaccines|mesh-list
153922307|NCT05000216|Immunosuppressive Agents|immunosuppressive agents|mesh-list
153922308|NCT05000216|Immunologic Factors|immunologic factors|mesh-ancestor
153922309|NCT05000216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153922310|NCT05000216|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
153922312|NCT05000216|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153922313|NCT05000216|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153922314|NCT05000216|Antimetabolites|antimetabolites|mesh-ancestor
153922315|NCT05000216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153922316|NCT05000216|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153922317|NCT05000216|Dermatologic Agents|dermatologic agents|mesh-ancestor
153922318|NCT05000216|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153922319|NCT05000216|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153922320|NCT05000216|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153922321|NCT05000216|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153922322|NCT05000216|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153922323|NCT05000216|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
153922324|NCT05000216|Antitubercular Agents|antitubercular agents|mesh-ancestor
153922325|NCT05000216|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153922326|NCT05000216|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153922341|NCT04945213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153922342|NCT04945213|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
153922343|NCT04945213|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
153922344|NCT04945213|Cholinergic Agents|cholinergic agents|mesh-ancestor
153922345|NCT04945213|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153922346|NCT04945213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153922347|NCT04941898|Factor VIII|factor viii|mesh-list
153922355|NCT04934722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153922357|NCT04934722|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153415295|NCT02206620|Donepezil|donepezil|mesh-list
153471129|NCT01168219|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
153471130|NCT01168219|Abortifacient Agents|abortifacient agents|mesh-ancestor
153471131|NCT01168219|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153471132|NCT01168219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153471133|NCT01168219|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153471134|NCT01168219|Antimetabolites|antimetabolites|mesh-ancestor
153471135|NCT01168219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153471136|NCT01168219|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153471137|NCT01168219|Dermatologic Agents|dermatologic agents|mesh-ancestor
153471138|NCT01168219|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153471139|NCT01168219|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153471140|NCT01168219|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153471141|NCT01168219|Immunologic Factors|immunologic factors|mesh-ancestor
153471142|NCT01168219|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153471143|NCT01168219|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153471144|NCT01168219|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
153922398|NCT04899921|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153922399|NCT04899921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153922401|NCT04893785|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153922402|NCT04893785|Alkylating Agents|alkylating agents|mesh-ancestor
153874604|NCT04528797|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153471187|NCT05766605|Doxorubicin|doxorubicin|mesh-list
153471188|NCT05766605|Fluorouracil|fluorouracil|mesh-list
153471189|NCT05766605|Oxaliplatin|oxaliplatin|mesh-list
153471190|NCT05766605|Raltitrexed|raltitrexed|mesh-list
153471191|NCT05766605|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153471192|NCT05766605|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153922422|NCT04884360|Olaparib|olaparib|mesh-list
153922423|NCT04884360|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
153922424|NCT04884360|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153922425|NCT04884360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153922426|NCT04884360|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153922430|NCT04838288|Tacrolimus|tacrolimus|mesh-list
153922431|NCT04838288|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153922442|NCT04799275|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
153922443|NCT04799275|Vincristine|vincristine|mesh-list
153922444|NCT04799275|Azacitidine|azacitidine|mesh-list
153922445|NCT04799275|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
153922446|NCT04799275|Antibodies|antibodies|mesh-list
153922447|NCT04799275|Immunoglobulins|immunoglobulins|mesh-list
153922448|NCT04799275|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
153922449|NCT04799275|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153922450|NCT04799275|Immunologic Factors|immunologic factors|mesh-ancestor
153922451|NCT04799275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153922452|NCT04799275|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153922453|NCT04799275|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153922454|NCT04799275|Alkylating Agents|alkylating agents|mesh-ancestor
153922455|NCT04799275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153922456|NCT04799275|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153922457|NCT04799275|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153922458|NCT04799275|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153922459|NCT04799275|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153922460|NCT04799275|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153922461|NCT04799275|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153922462|NCT04799275|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153922463|NCT04799275|Glucocorticoids|glucocorticoids|mesh-ancestor
153922464|NCT04799275|Hormones|hormones|mesh-ancestor
153922465|NCT04799275|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153922466|NCT04799275|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153922467|NCT04799275|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153922468|NCT04799275|Tubulin Modulators|tubulin modulators|mesh-ancestor
153922469|NCT04799275|Antimitotic Agents|antimitotic agents|mesh-ancestor
153922470|NCT04799275|Mitosis Modulators|mitosis modulators|mesh-ancestor
153922471|NCT04799275|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153922472|NCT04799275|Antimetabolites|antimetabolites|mesh-ancestor
153922473|NCT04793646|Acetylcysteine|acetylcysteine|mesh-list
153922474|NCT04793646|N-monoacetylcystine|n-monoacetylcystine|mesh-list
153922475|NCT04793646|Antiviral Agents|antiviral agents|mesh-ancestor
153922476|NCT04793646|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153922477|NCT04793646|Expectorants|expectorants|mesh-ancestor
153415360|NCT05342376|Analgesics|analgesics|mesh-ancestor
153415361|NCT05342376|Sensory System Agents|sensory system agents|mesh-ancestor
153922478|NCT04793646|Respiratory System Agents|respiratory system agents|mesh-ancestor
153922479|NCT04793646|Free Radical Scavengers|free radical scavengers|mesh-ancestor
153922481|NCT04793646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153922482|NCT04793646|Protective Agents|protective agents|mesh-ancestor
153922483|NCT04793646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153471193|NCT05766605|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153471197|NCT05766605|Antimetabolites|antimetabolites|mesh-ancestor
153922484|NCT04793646|Antidotes|antidotes|mesh-ancestor
153922485|NCT04786210|Triamcinolone|triamcinolone|mesh-list
153922486|NCT04786210|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
153922487|NCT04786210|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
153922488|NCT04786210|Fluorouracil|fluorouracil|mesh-list
153922489|NCT04786210|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
153471257|NCT05765747|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153471258|NCT05765747|Analgesics|analgesics|mesh-ancestor
153471259|NCT05765747|Sensory System Agents|sensory system agents|mesh-ancestor
153471260|NCT05765747|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153471261|NCT05765747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153922496|NCT04786210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153922497|NCT04786210|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153922498|NCT04786210|Glucocorticoids|glucocorticoids|mesh-ancestor
153922500|NCT04786210|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153922501|NCT04786210|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153922502|NCT04782830|Midodrine|midodrine|mesh-list
153922503|NCT04782830|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
153922504|NCT04782830|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
153922505|NCT04782830|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153922506|NCT04782830|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153922507|NCT04782830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153922508|NCT04782830|Adrenergic Agents|adrenergic agents|mesh-ancestor
153922509|NCT04782830|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153922510|NCT04782830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153922511|NCT04782830|Sympathomimetics|sympathomimetics|mesh-ancestor
153922512|NCT04782830|Autonomic Agents|autonomic agents|mesh-ancestor
153922513|NCT04782830|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153922514|NCT04782830|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
153922515|NCT04782830|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
153922516|NCT04782830|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153922517|NCT04782830|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153922518|NCT04779151|Niraparib|niraparib|mesh-list
153922519|NCT04779151|Dostarlimab|dostarlimab|mesh-list
153922520|NCT04779151|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
153922521|NCT04779151|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153922522|NCT04779151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153922523|NCT04779151|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153922525|NCT04752033|Hydromorphone|hydromorphone|mesh-list
153922526|NCT04752033|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153922527|NCT04752033|Narcotics|narcotics|mesh-ancestor
153922528|NCT04752033|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153922529|NCT04752033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153922530|NCT04752033|Analgesics|analgesics|mesh-ancestor
153922531|NCT04752033|Sensory System Agents|sensory system agents|mesh-ancestor
153922532|NCT04752033|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153922533|NCT04742101|Azacitidine|azacitidine|mesh-list
153922534|NCT04742101|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153922535|NCT04742101|Antimetabolites|antimetabolites|mesh-ancestor
153922536|NCT04742101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153415403|NCT02169414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153922543|NCT04711252|Anastrozole|anastrozole|mesh-list
153922544|NCT04711252|Hormones|hormones|mesh-list
153922545|NCT04711252|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
153922546|NCT04711252|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153922547|NCT04711252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153922548|NCT04711252|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153922549|NCT04711252|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153922550|NCT04711252|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153922551|NCT04711252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153471320|NCT05764746|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153874699|NCT04548557|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
153922627|NCT04620382|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153922628|NCT04620382|Adrenergic Agents|adrenergic agents|mesh-ancestor
153922629|NCT04620382|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153922630|NCT04620382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153922633|NCT04616560|Trastuzumab deruxtecan|trastuzumab deruxtecan|mesh-list
153922634|NCT04616560|Immunoconjugates|immunoconjugates|mesh-list
153922635|NCT04616560|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153922636|NCT04616560|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153922637|NCT04616560|Immunologic Factors|immunologic factors|mesh-ancestor
153922638|NCT04616560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153922639|NCT04616560|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153922640|NCT04616560|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
153922641|NCT04616560|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153922642|NCT04616560|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153922643|NCT04616560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153922644|NCT04591275|Denosumab|denosumab|mesh-list
153922645|NCT04591275|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153922646|NCT04591275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153922647|NCT04589611|Amobarbital|amobarbital|mesh-list
153922648|NCT04589611|Hyaluronic Acid|hyaluronic acid|mesh-list
153922649|NCT04589611|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153922650|NCT04589611|Immunologic Factors|immunologic factors|mesh-ancestor
153922651|NCT04589611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153922652|NCT04589611|Viscosupplements|viscosupplements|mesh-ancestor
153922653|NCT04589611|Protective Agents|protective agents|mesh-ancestor
153922654|NCT04589611|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153922655|NCT04589611|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153922656|NCT04589611|GABA Modulators|gaba modulators|mesh-ancestor
153922658|NCT04589611|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153922659|NCT04589611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153922660|NCT04560010|Tranexamic Acid|tranexamic acid|mesh-list
153922661|NCT04560010|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
153922662|NCT04560010|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153922663|NCT04560010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153922664|NCT04560010|Hemostatics|hemostatics|mesh-ancestor
153922665|NCT04560010|Coagulants|coagulants|mesh-ancestor
153922666|NCT04557956|Trametinib|trametinib|mesh-list
153922667|NCT04557956|Dabrafenib|dabrafenib|mesh-list
153922668|NCT04557956|Dimethyl Sulfoxide|dimethyl sulfoxide|mesh-list
153922669|NCT04557956|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153922670|NCT04557956|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153922671|NCT04557956|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153922672|NCT04557956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153922673|NCT04557956|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
153922674|NCT04557956|Protective Agents|protective agents|mesh-ancestor
153922675|NCT04557956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153922676|NCT04557956|Free Radical Scavengers|free radical scavengers|mesh-ancestor
153922677|NCT04557956|Antioxidants|antioxidants|mesh-ancestor
153922678|NCT04525014|Irinotecan|irinotecan|mesh-list
153922679|NCT04525014|Temozolomide|temozolomide|mesh-list
153922680|NCT04525014|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
153922681|NCT04525014|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153471397|NCT05510544|Plerixafor|plerixafor|mesh-list
153471398|NCT05510544|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153922682|NCT04525014|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153922683|NCT04525014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153874737|NCT01641510|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153471462|NCT05045664|Obinutuzumab|obinutuzumab|mesh-list
153471463|NCT05045664|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153471464|NCT05045664|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153471465|NCT05037552|Hemostatics|hemostatics|mesh-list
153471466|NCT05037552|Coagulants|coagulants|mesh-ancestor
153471467|NCT05012631|Losartan|losartan|mesh-list
153471468|NCT05012631|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153922690|NCT04483206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153922691|NCT04483206|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153922692|NCT04483206|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153922693|NCT04483206|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153922694|NCT04483206|Immunologic Factors|immunologic factors|mesh-ancestor
153922695|NCT04483206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153922696|NCT04459052|Acetylcysteine|acetylcysteine|mesh-list
153922697|NCT04459052|N-monoacetylcystine|n-monoacetylcystine|mesh-list
153922698|NCT04459052|Antiviral Agents|antiviral agents|mesh-ancestor
153922699|NCT04459052|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153922700|NCT04459052|Expectorants|expectorants|mesh-ancestor
153922701|NCT04459052|Respiratory System Agents|respiratory system agents|mesh-ancestor
153922702|NCT04459052|Free Radical Scavengers|free radical scavengers|mesh-ancestor
153922703|NCT04459052|Antioxidants|antioxidants|mesh-ancestor
153922704|NCT04459052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153922705|NCT04459052|Protective Agents|protective agents|mesh-ancestor
153922706|NCT04459052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153922707|NCT04459052|Antidotes|antidotes|mesh-ancestor
153922708|NCT04439266|Crizotinib|crizotinib|mesh-list
153922709|NCT04439266|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-list
153922710|NCT04439266|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153922711|NCT04439266|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153922712|NCT04439266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153922713|NCT04439266|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153922715|NCT04439253|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-list
153922716|NCT04439253|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153922717|NCT04439253|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153922718|NCT04439253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153922719|NCT04439253|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153922720|NCT04438382|Prednisone|prednisone|mesh-list
153922721|NCT04438382|Methylprednisolone|methylprednisolone|mesh-list
153922722|NCT04438382|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
153922723|NCT04438382|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
153922724|NCT04438382|Prednisolone|prednisolone|mesh-list
153922725|NCT04438382|Prednisolone acetate|prednisolone acetate|mesh-list
153922726|NCT04438382|Infliximab|infliximab|mesh-list
153922727|NCT04438382|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
153922728|NCT04438382|Prednisolone phosphate|prednisolone phosphate|mesh-list
153922729|NCT04438382|Immunoglobulins|immunoglobulins|mesh-list
153922730|NCT04438382|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
153922731|NCT04438382|Antibodies|antibodies|mesh-list
153874773|NCT01641666|Immunologic Factors|immunologic factors|mesh-ancestor
153922732|NCT04438382|gamma-Globulins|gamma-globulins|mesh-list
153922733|NCT04438382|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
153922734|NCT04438382|Immunoglobulin G|immunoglobulin g|mesh-list
153922735|NCT04438382|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153922736|NCT04438382|Glucocorticoids|glucocorticoids|mesh-ancestor
153922737|NCT04438382|Hormones|hormones|mesh-ancestor
153922738|NCT04438382|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153922739|NCT04438382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153922740|NCT04438382|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153922741|NCT04438382|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153922742|NCT04438382|Antiemetics|antiemetics|mesh-ancestor
153922743|NCT04438382|Autonomic Agents|autonomic agents|mesh-ancestor
153922754|NCT04406272|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153471523|NCT04859829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153471524|NCT04851158|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
153471525|NCT04851158|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
153471526|NCT04851158|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153471527|NCT04851158|Antitubercular Agents|antitubercular agents|mesh-ancestor
153471528|NCT04778267|Dexamethasone|dexamethasone|mesh-list
153471529|NCT04778267|Bupivacaine|bupivacaine|mesh-list
153471530|NCT04778267|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
153471531|NCT04778267|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153471532|NCT04778267|Antiemetics|antiemetics|mesh-ancestor
153471533|NCT04778267|Autonomic Agents|autonomic agents|mesh-ancestor
153471534|NCT04778267|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153471535|NCT04778267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153471536|NCT04778267|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153922755|NCT04406272|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153922756|NCT04406272|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153922757|NCT04406272|Growth Substances|growth substances|mesh-ancestor
153922758|NCT04406272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153922759|NCT04406272|Growth Inhibitors|growth inhibitors|mesh-ancestor
153922780|NCT04384484|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153922781|NCT04384484|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153922782|NCT04384484|Antimetabolites|antimetabolites|mesh-ancestor
153385697|NCT00377559|Tubulin Modulators|tubulin modulators|mesh-ancestor
153385698|NCT00377559|Antimitotic Agents|antimitotic agents|mesh-ancestor
153385699|NCT00377559|Mitosis Modulators|mitosis modulators|mesh-ancestor
153385700|NCT00377559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153385701|NCT00377559|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153385702|NCT00377559|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153922783|NCT04384484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153471537|NCT04778267|Glucocorticoids|glucocorticoids|mesh-ancestor
153471538|NCT04778267|Hormones|hormones|mesh-ancestor
153471542|NCT04778267|Anesthetics, Local|anesthetics, local|mesh-ancestor
153922803|NCT04333576|Contraceptive Agents|contraceptive agents|mesh-list
153922804|NCT04333576|Contraceptives, Oral|contraceptives, oral|mesh-list
153922805|NCT04333576|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-list
153922806|NCT04333576|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153922807|NCT04333576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153922808|NCT04333576|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
153922810|NCT04329624|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
153922811|NCT04329624|Vasodilator Agents|vasodilator agents|mesh-ancestor
153922812|NCT04329624|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
153922813|NCT04329624|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
153471583|NCT04521335|Trace Elements|trace elements|mesh-ancestor
153471584|NCT04521335|Micronutrients|micronutrients|mesh-ancestor
153471585|NCT04521335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153471586|NCT04521335|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
153471587|NCT04521335|Acetaldehyde Dehydrogenase Inhibitors|acetaldehyde dehydrogenase inhibitors|mesh-ancestor
153471588|NCT04521335|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153415541|NCT02168478|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
153415542|NCT02168478|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153415544|NCT00367874|Buprenorphine|buprenorphine|mesh-list
153471589|NCT04521335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153471592|NCT04515615|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153471593|NCT04515615|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153471594|NCT04515615|Antimetabolites|antimetabolites|mesh-ancestor
153471595|NCT04515615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153471596|NCT04247126|Paclitaxel|paclitaxel|mesh-list
153471597|NCT04247126|Gemcitabine|gemcitabine|mesh-list
153471599|NCT04247126|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153471600|NCT04247126|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153471601|NCT04247126|Tubulin Modulators|tubulin modulators|mesh-ancestor
153471602|NCT04247126|Antimitotic Agents|antimitotic agents|mesh-ancestor
153471603|NCT04247126|Mitosis Modulators|mitosis modulators|mesh-ancestor
153471604|NCT04247126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153471605|NCT04247126|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153471606|NCT04247126|Antimetabolites|antimetabolites|mesh-ancestor
153471607|NCT04247126|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153922814|NCT04329624|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153922815|NCT04329624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153922817|NCT04329624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153922819|NCT04301934|Estrogens|estrogens|mesh-list
153922820|NCT04301934|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
153922821|NCT04301934|Hormones|hormones|mesh-ancestor
153922822|NCT04301934|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153922823|NCT04301934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153922824|NCT04285567|Cyclophosphamide|cyclophosphamide|mesh-list
153922825|NCT04285567|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
153922826|NCT04285567|Rituximab|rituximab|mesh-list
153922827|NCT04285567|Fludarabine|fludarabine|mesh-list
153922828|NCT04285567|Venetoclax|venetoclax|mesh-list
153922829|NCT04285567|Obinutuzumab|obinutuzumab|mesh-list
153922830|NCT04285567|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153922831|NCT04285567|Immunologic Factors|immunologic factors|mesh-ancestor
153922832|NCT04285567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153922833|NCT04285567|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153874823|NCT04546802|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153922834|NCT04285567|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153922835|NCT04285567|Alkylating Agents|alkylating agents|mesh-ancestor
153385703|NCT00377559|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153385704|NCT00377559|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153385705|NCT03026348|Aluminum phosphate|aluminum phosphate|mesh-list
153385706|NCT03026348|Vaccines|vaccines|mesh-list
153385707|NCT03026348|Immunologic Factors|immunologic factors|mesh-ancestor
153385708|NCT03026348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153883283|NCT01379937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153424207|NCT03670160|GABA Agents|gaba agents|mesh-ancestor
153424208|NCT03670160|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
153922836|NCT04285567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153922837|NCT04285567|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153922838|NCT04285567|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153922839|NCT04285567|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153922840|NCT04276376|Atezolizumab|atezolizumab|mesh-list
153922841|NCT04276376|Rucaparib|rucaparib|mesh-list
153922842|NCT04276376|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153922843|NCT04276376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153922844|NCT04276376|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153922845|NCT04276376|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153922846|NCT04276376|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
153922847|NCT04276376|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153922848|NCT04248829|Gefitinib|gefitinib|mesh-list
153922849|NCT04248829|Lazertinib|lazertinib|mesh-list
153415578|NCT02302976|Hormones|hormones|mesh-ancestor
153922850|NCT04248829|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153922851|NCT04248829|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153922852|NCT04248829|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153922853|NCT04248829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153922854|NCT04248829|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153922855|NCT04229004|Paclitaxel|paclitaxel|mesh-list
153922856|NCT04229004|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
153922857|NCT04229004|Gemcitabine|gemcitabine|mesh-list
153922858|NCT04229004|Spartalizumab|spartalizumab|mesh-list
153922859|NCT04229004|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153922860|NCT04229004|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153922861|NCT04229004|Tubulin Modulators|tubulin modulators|mesh-ancestor
153922862|NCT04229004|Antimitotic Agents|antimitotic agents|mesh-ancestor
153471633|NCT04006119|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153471634|NCT04004793|Dapagliflozin|dapagliflozin|mesh-list
153471635|NCT04004793|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
153471636|NCT04004793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153471637|NCT04004793|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153471638|NCT04004793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153471639|NCT04002011|Warfarin|warfarin|mesh-list
153471640|NCT04002011|Rivaroxaban|rivaroxaban|mesh-list
153471641|NCT04002011|Dabigatran|dabigatran|mesh-list
153922863|NCT04229004|Mitosis Modulators|mitosis modulators|mesh-ancestor
153922864|NCT04229004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153922865|NCT04229004|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153922866|NCT04229004|Antimetabolites|antimetabolites|mesh-ancestor
153922867|NCT04229004|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153922868|NCT04229004|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153922869|NCT04225039|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
153922870|NCT04225039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153922871|NCT04225039|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153922872|NCT04225039|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153922873|NCT04198571|Ceftaroline|ceftaroline|mesh-list
153922879|NCT04188548|Pertuzumab|pertuzumab|mesh-list
153922880|NCT04188548|Everolimus|everolimus|mesh-list
153922881|NCT04188548|Aromatase Inhibitors|aromatase inhibitors|mesh-list
153922882|NCT04188548|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153922883|NCT04188548|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153922884|NCT04188548|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
153922885|NCT04188548|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153922886|NCT04188548|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153922887|NCT04188548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153424209|NCT03670160|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
153424210|NCT03670160|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
153424211|NCT00375895|Cyclosporine|cyclosporine|mesh-list
153424212|NCT00375895|Cyclosporins|cyclosporins|mesh-list
153424213|NCT00375895|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153385710|NCT03026348|Antacids|antacids|mesh-ancestor
153385711|NCT03026348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153385712|NCT03026348|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153385713|NCT04763408|Sorafenib|sorafenib|mesh-list
153922888|NCT04188548|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153922889|NCT04188548|Immunologic Factors|immunologic factors|mesh-ancestor
153922890|NCT04188548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153922891|NCT04188548|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153922892|NCT04188548|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
153922893|NCT04188548|Hormone Antagonists|hormone antagonists|mesh-ancestor
153922894|NCT04188548|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153922895|NCT04182633|Vancomycin|vancomycin|mesh-list
153922896|NCT04182633|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
153922897|NCT04182633|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153922898|NCT04182633|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153922899|NCT04182633|Laxatives|laxatives|mesh-ancestor
153471704|NCT03330886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153471705|NCT03330886|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153471706|NCT03330886|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153471708|NCT03282799|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
153471710|NCT03282799|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153471711|NCT03282799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153471712|NCT03282799|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
153471713|NCT02987543|Olaparib|olaparib|mesh-list
153471714|NCT02987543|Abiraterone Acetate|abiraterone acetate|mesh-list
153471715|NCT02987543|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
153471716|NCT02987543|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153471717|NCT02987543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153471718|NCT02987543|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153471719|NCT02987543|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153471720|NCT02987543|Hormone Antagonists|hormone antagonists|mesh-ancestor
153471721|NCT02987543|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153471722|NCT02987543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153471723|NCT02987543|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153471724|NCT02983045|Paclitaxel|paclitaxel|mesh-list
153471725|NCT02983045|Cisplatin|cisplatin|mesh-list
153471726|NCT02983045|Carboplatin|carboplatin|mesh-list
153471727|NCT02983045|Nivolumab|nivolumab|mesh-list
153471728|NCT02983045|Pemetrexed|pemetrexed|mesh-list
153922929|NCT04172532|Peposertib|peposertib|mesh-list
153922930|NCT04172532|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153922931|NCT04172532|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153922932|NCT04172532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153922942|NCT04164082|Pembrolizumab|pembrolizumab|mesh-list
153922943|NCT04164082|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153922944|NCT04164082|Antimetabolites|antimetabolites|mesh-ancestor
153922945|NCT04164082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153922946|NCT04164082|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153922947|NCT04164082|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153922948|NCT04164082|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153922949|NCT04126031|Ceftazidime|ceftazidime|mesh-list
153922950|NCT04126031|Avibactam, ceftazidime drug combination|avibactam, ceftazidime drug combination|mesh-list
153922951|NCT04126031|Avibactam|avibactam|mesh-list
153922952|NCT04126031|Third Generation Cephalosporins|third generation cephalosporins|mesh-ancestor
153922953|NCT04126031|Beta Lactam Antibiotics|beta lactam antibiotics|mesh-ancestor
153922954|NCT04126031|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153922955|NCT04126031|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153922956|NCT04126031|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
153922957|NCT04126031|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153385749|NCT02648282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153385750|NCT02648282|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153385751|NCT02648282|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153385780|NCT03989427|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
153385781|NCT03989427|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153922958|NCT04126031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153922959|NCT04093323|Interferons|interferons|mesh-list
153922960|NCT04093323|Interferon-alpha|interferon-alpha|mesh-list
153471730|NCT02983045|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153471731|NCT02983045|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153471732|NCT02983045|Tubulin Modulators|tubulin modulators|mesh-ancestor
153471733|NCT02983045|Antimitotic Agents|antimitotic agents|mesh-ancestor
153471734|NCT02983045|Mitosis Modulators|mitosis modulators|mesh-ancestor
153471735|NCT02983045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153471736|NCT02983045|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153471737|NCT02983045|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153471738|NCT02983045|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153471739|NCT02983045|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153922961|NCT04093323|Interferon alpha-2|interferon alpha-2|mesh-list
153922962|NCT04093323|poly(I).poly(c12,U)|poly(i).poly(c12,u)|mesh-list
153922964|NCT04093323|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
153922965|NCT04093323|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153922966|NCT04093323|Antiviral Agents|antiviral agents|mesh-ancestor
153922967|NCT04093323|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153922968|NCT04093323|Immunologic Factors|immunologic factors|mesh-ancestor
153922969|NCT04093323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153922970|NCT04093323|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153922971|NCT04093323|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153922972|NCT04093323|Analgesics|analgesics|mesh-ancestor
153922973|NCT04093323|Sensory System Agents|sensory system agents|mesh-ancestor
153922974|NCT04093323|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153922976|NCT04093323|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153922977|NCT04093323|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
153922978|NCT04093323|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153922979|NCT04093323|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153922980|NCT04093323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153922981|NCT04093323|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153922982|NCT04071366|Axicabtagene ciloleucel|axicabtagene ciloleucel|mesh-list
153922983|NCT04071366|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153922984|NCT04071366|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153922985|NCT04071223|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
153922986|NCT04071223|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153922987|NCT04068181|Pembrolizumab|pembrolizumab|mesh-list
153922988|NCT04068181|Talimogene laherparepvec|talimogene laherparepvec|mesh-list
153922989|NCT04068181|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153922990|NCT04068181|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153922991|NCT04068181|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153922992|NCT04068181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153922993|NCT04058756|Spartalizumab|spartalizumab|mesh-list
153922994|NCT04058756|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153922995|NCT04058756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153922996|NCT04058756|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153922998|NCT04058158|Eculizumab|eculizumab|mesh-list
153922999|NCT04058158|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
153923000|NCT04058158|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153923001|NCT04058158|Immunologic Factors|immunologic factors|mesh-ancestor
153923002|NCT04058158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153923003|NCT04047472|Aflibercept|aflibercept|mesh-list
153923004|NCT04047472|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153923005|NCT04047472|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153923006|NCT04047472|Growth Substances|growth substances|mesh-ancestor
153923007|NCT04047472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153923008|NCT04047472|Growth Inhibitors|growth inhibitors|mesh-ancestor
153923009|NCT04047472|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153471740|NCT02983045|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153415659|NCT02684942|Fentanyl|fentanyl|mesh-list
153415660|NCT02684942|Meperidine|meperidine|mesh-list
153923010|NCT04027946|Pembrolizumab|pembrolizumab|mesh-list
153923011|NCT04027946|LMB-100|lmb-100|mesh-list
153923012|NCT04027946|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153923013|NCT04027946|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153923014|NCT04027946|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153923015|NCT04027946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153923016|NCT04027946|Immunoconjugates|immunoconjugates|mesh-ancestor
153923017|NCT04027946|Immunologic Factors|immunologic factors|mesh-ancestor
153923018|NCT04027946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153923019|NCT04023669|Cyclophosphamide|cyclophosphamide|mesh-list
153471790|NCT02368886|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153471791|NCT02368886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153471795|NCT02126969|Tubulin Modulators|tubulin modulators|mesh-ancestor
153471796|NCT02126969|Antimitotic Agents|antimitotic agents|mesh-ancestor
153471797|NCT02126969|Mitosis Modulators|mitosis modulators|mesh-ancestor
153471798|NCT02126969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153471800|NCT02099188|Docetaxel|docetaxel|mesh-list
153471801|NCT02099188|Doxorubicin|doxorubicin|mesh-list
153471802|NCT02099188|Fluorouracil|fluorouracil|mesh-list
153471803|NCT02099188|Etoposide|etoposide|mesh-list
153471804|NCT02099188|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
153471805|NCT02099188|Ifosfamide|ifosfamide|mesh-list
153471806|NCT02099188|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153471807|NCT02099188|Tubulin Modulators|tubulin modulators|mesh-ancestor
153471808|NCT02099188|Antimitotic Agents|antimitotic agents|mesh-ancestor
153471809|NCT02099188|Mitosis Modulators|mitosis modulators|mesh-ancestor
153471810|NCT02099188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153471811|NCT02099188|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153471812|NCT02099188|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153471813|NCT02099188|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153471814|NCT02099188|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153923020|NCT04023669|Gemcitabine|gemcitabine|mesh-list
153923021|NCT04023669|Lenograstim|lenograstim|mesh-list
153923022|NCT04023669|Prexasertib|prexasertib|mesh-list
153923023|NCT04023669|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153923024|NCT04023669|Immunologic Factors|immunologic factors|mesh-ancestor
153923027|NCT04023669|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153923028|NCT04023669|Alkylating Agents|alkylating agents|mesh-ancestor
153923029|NCT04023669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153923030|NCT04023669|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153923031|NCT04023669|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153923032|NCT04023669|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153923033|NCT04023669|Antimetabolites|antimetabolites|mesh-ancestor
153923034|NCT04023669|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153923035|NCT04023669|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153923036|NCT04023669|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153923037|NCT04007744|Pembrolizumab|pembrolizumab|mesh-list
153923038|NCT04007744|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153923039|NCT04007744|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153923040|NCT04007744|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153923041|NCT04007744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153923042|NCT04004611|Mirikizumab|mirikizumab|mesh-list
153923043|NCT04004611|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153923044|NCT04004611|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153923045|NCT04004611|Analgesics|analgesics|mesh-ancestor
153923046|NCT04004611|Sensory System Agents|sensory system agents|mesh-ancestor
153471815|NCT02099188|Antimetabolites|antimetabolites|mesh-ancestor
153923047|NCT04004611|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153923048|NCT04004611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153923049|NCT04004611|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153923050|NCT04004611|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153385783|NCT03007719|Cariostatic Agents|cariostatic agents|mesh-ancestor
153385784|NCT03007719|Protective Agents|protective agents|mesh-ancestor
153385785|NCT03007719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153415689|NCT02660918|Sensory System Agents|sensory system agents|mesh-ancestor
153923051|NCT04004611|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
153923052|NCT04004611|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153923054|NCT03969004|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153923055|NCT03969004|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153923056|NCT03931291|Azacitidine|azacitidine|mesh-list
153923057|NCT03931291|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153923058|NCT03931291|Antimetabolites|antimetabolites|mesh-ancestor
153923067|NCT03919773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153923068|NCT03874026|Cetuximab|cetuximab|mesh-list
153471844|NCT02099175|Antimetabolites|antimetabolites|mesh-ancestor
153471845|NCT02099175|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153471846|NCT02099175|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153471847|NCT02099175|Immunologic Factors|immunologic factors|mesh-ancestor
153471848|NCT02099175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153471849|NCT02099175|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153471850|NCT02099175|Antidotes|antidotes|mesh-ancestor
153923069|NCT03874026|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153923070|NCT03874026|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153923079|NCT03819153|Semaglutide|semaglutide|mesh-list
153923080|NCT03819153|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
153923081|NCT03819153|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153923087|NCT03816163|Tubulin Modulators|tubulin modulators|mesh-ancestor
153923088|NCT03816163|Antimitotic Agents|antimitotic agents|mesh-ancestor
153923089|NCT03816163|Mitosis Modulators|mitosis modulators|mesh-ancestor
153923090|NCT03816163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153923091|NCT03816163|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153923092|NCT03816163|Antimetabolites|antimetabolites|mesh-ancestor
153923093|NCT03764540|Prednisone|prednisone|mesh-list
153923094|NCT03764540|Docetaxel|docetaxel|mesh-list
153923095|NCT03764540|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153874965|NCT04544969|Cisplatin|cisplatin|mesh-list
153923096|NCT03764540|Tubulin Modulators|tubulin modulators|mesh-ancestor
153923097|NCT03764540|Antimitotic Agents|antimitotic agents|mesh-ancestor
153923098|NCT03764540|Mitosis Modulators|mitosis modulators|mesh-ancestor
153923099|NCT03764540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153923100|NCT03764540|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153923101|NCT03764540|Glucocorticoids|glucocorticoids|mesh-ancestor
153923111|NCT03747484|Immunoglobulin G|immunoglobulin g|mesh-list
153923112|NCT03747484|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
153923113|NCT03747484|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153923114|NCT03747484|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153923115|NCT03747484|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153923116|NCT03747484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153923117|NCT03747484|Antiviral Agents|antiviral agents|mesh-ancestor
153923118|NCT03747484|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153923119|NCT03747484|Immunologic Factors|immunologic factors|mesh-ancestor
153923120|NCT03747484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153923121|NCT03740529|Rituximab|rituximab|mesh-list
153923122|NCT03740529|Venetoclax|venetoclax|mesh-list
153923123|NCT03740529|Pirtobrutinib|pirtobrutinib|mesh-list
153385787|NCT02985801|Pancreatin|pancreatin|mesh-list
153385788|NCT02985801|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153385789|NCT02988362|Amlodipine|amlodipine|mesh-list
153385790|NCT02988362|Candesartan|candesartan|mesh-list
153385791|NCT02988362|Candesartan cilexetil|candesartan cilexetil|mesh-list
153385792|NCT02988362|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153385793|NCT02988362|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153385794|NCT02988362|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153923124|NCT03740529|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153923125|NCT03740529|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153471851|NCT02099175|Protective Agents|protective agents|mesh-ancestor
153923126|NCT03740529|Immunologic Factors|immunologic factors|mesh-ancestor
153923127|NCT03740529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153923128|NCT03740529|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153923129|NCT03740529|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153923130|NCT03740529|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153923131|NCT03740529|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153923132|NCT03740529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153471908|NCT01285817|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153471909|NCT01285817|Analgesics|analgesics|mesh-ancestor
153471910|NCT01285817|Sensory System Agents|sensory system agents|mesh-ancestor
153471911|NCT01285817|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153923142|NCT03709680|Cyclophosphamide|cyclophosphamide|mesh-list
153923143|NCT03709680|Temozolomide|temozolomide|mesh-list
153923145|NCT03709680|Topotecan|topotecan|mesh-list
153923146|NCT03709680|Palbociclib|palbociclib|mesh-list
153923147|NCT03709680|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153923148|NCT03709680|Immunologic Factors|immunologic factors|mesh-ancestor
153923149|NCT03709680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153923150|NCT03709680|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153923151|NCT03709680|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153923152|NCT03709680|Alkylating Agents|alkylating agents|mesh-ancestor
153923153|NCT03709680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153923154|NCT03709680|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153923155|NCT03709680|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153923156|NCT03709680|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
153923157|NCT03709680|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153923158|NCT03709680|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153923159|NCT03709680|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153923160|NCT03699956|Carboplatin|carboplatin|mesh-list
153923161|NCT03699956|Etoposide|etoposide|mesh-list
153923162|NCT03699956|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153923163|NCT03699956|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153923164|NCT03699956|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153923165|NCT03699956|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153923167|NCT03699956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153923168|NCT03644667|Mycophenolic Acid|mycophenolic acid|mesh-list
153923169|NCT03644667|Prednisone|prednisone|mesh-list
153923170|NCT03644667|Methylprednisolone|methylprednisolone|mesh-list
153923171|NCT03644667|Tacrolimus|tacrolimus|mesh-list
153923172|NCT03644667|Calcineurin Inhibitors|calcineurin inhibitors|mesh-list
153923173|NCT03644667|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153415728|NCT05587621|Evolocumab|evolocumab|mesh-list
153923174|NCT03644667|Glucocorticoids|glucocorticoids|mesh-ancestor
153923175|NCT03644667|Hormones|hormones|mesh-ancestor
153923176|NCT03644667|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153923177|NCT03644667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153923178|NCT03644667|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153923179|NCT03644667|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153923180|NCT03644667|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153923181|NCT03644667|Immunologic Factors|immunologic factors|mesh-ancestor
153923182|NCT03644667|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153923183|NCT03644667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153923184|NCT03644667|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153923185|NCT03644667|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
153923186|NCT03644667|Antitubercular Agents|antitubercular agents|mesh-ancestor
153923187|NCT03644667|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153385795|NCT02988362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153385796|NCT02988362|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153385797|NCT02988362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153385798|NCT02988362|Vasodilator Agents|vasodilator agents|mesh-ancestor
153385828|NCT00550550|Respiratory System Agents|respiratory system agents|mesh-ancestor
153385829|NCT00550550|Dermatologic Agents|dermatologic agents|mesh-ancestor
153385830|NCT00550550|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
153385831|NCT00550550|Tocolytic Agents|tocolytic agents|mesh-ancestor
153385832|NCT00550550|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153385833|NCT00550550|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
153385834|NCT00550550|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
153385835|NCT00550550|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153385836|NCT00550550|Adrenergic Agents|adrenergic agents|mesh-ancestor
153385837|NCT00550550|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153923188|NCT03644667|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153923189|NCT03644667|Antiemetics|antiemetics|mesh-ancestor
153923190|NCT03644667|Autonomic Agents|autonomic agents|mesh-ancestor
153923191|NCT03644667|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153923192|NCT03644667|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153923193|NCT03644667|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
153923194|NCT03644667|Protective Agents|protective agents|mesh-ancestor
153923196|NCT03547973|Gemcitabine|gemcitabine|mesh-list
153923197|NCT03547973|Pembrolizumab|pembrolizumab|mesh-list
153923198|NCT03547973|Avelumab|avelumab|mesh-list
153923199|NCT03547973|Sacituzumab govitecan|sacituzumab govitecan|mesh-list
153923200|NCT03547973|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153923201|NCT03547973|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153923202|NCT03547973|Antimetabolites|antimetabolites|mesh-ancestor
153923203|NCT03547973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153923204|NCT03547973|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153923205|NCT03547973|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153923206|NCT03547973|Immunoconjugates|immunoconjugates|mesh-ancestor
153471980|NCT04386876|Lopinavir|lopinavir|mesh-list
153471981|NCT04386876|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
153875010|NCT04544228|Ketamine|ketamine|mesh-list
153471982|NCT04386876|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
153471983|NCT04386876|Protease Inhibitors|protease inhibitors|mesh-ancestor
153471984|NCT04386876|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153471985|NCT04386876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153471986|NCT04386876|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153471987|NCT04386876|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153471988|NCT04386876|Antiviral Agents|antiviral agents|mesh-ancestor
153471989|NCT04386876|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153471990|NCT04386876|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
153471991|NCT04386876|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153471992|NCT04386642|Tranexamic Acid|tranexamic acid|mesh-list
153471993|NCT04386642|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
153471994|NCT04386642|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153471995|NCT04386642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153471996|NCT04386642|Hemostatics|hemostatics|mesh-ancestor
153471997|NCT04386642|Coagulants|coagulants|mesh-ancestor
153471998|NCT04385550|Paclitaxel|paclitaxel|mesh-list
153471999|NCT04385550|Docetaxel|docetaxel|mesh-list
153472000|NCT04385550|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153472001|NCT04385550|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153923207|NCT03547973|Immunologic Factors|immunologic factors|mesh-ancestor
153923208|NCT03547973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153923209|NCT03539952|Penicillamine|penicillamine|mesh-list
153923210|NCT03539952|Trientine|trientine|mesh-list
153923211|NCT03539952|Chelating Agents|chelating agents|mesh-ancestor
153923212|NCT03539952|Sequestering Agents|sequestering agents|mesh-ancestor
153923213|NCT03539952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153923215|NCT03539952|Protective Agents|protective agents|mesh-ancestor
153923216|NCT03539952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153415762|NCT02689063|Antipyretics|antipyretics|mesh-ancestor
153923217|NCT03539952|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153923218|NCT03504774|Immunomodulating Agents|immunomodulating agents|mesh-list
153923231|NCT03499249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153923232|NCT03499249|Antidotes|antidotes|mesh-ancestor
153923233|NCT03482297|Midodrine|midodrine|mesh-list
153923234|NCT03482297|Sympathomimetics|sympathomimetics|mesh-ancestor
153923235|NCT03482297|Autonomic Agents|autonomic agents|mesh-ancestor
153923236|NCT03482297|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153923237|NCT03482297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153923238|NCT03482297|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
153923239|NCT03482297|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
153923240|NCT03482297|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153923241|NCT03482297|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153923242|NCT03482297|Adrenergic Agents|adrenergic agents|mesh-ancestor
153923243|NCT03482297|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153923244|NCT03482297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153923245|NCT03480776|Aspirin|aspirin|mesh-list
153923246|NCT03480776|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153923247|NCT03480776|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153923248|NCT03480776|Analgesics|analgesics|mesh-ancestor
153923249|NCT03480776|Sensory System Agents|sensory system agents|mesh-ancestor
153923250|NCT03480776|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153923251|NCT03480776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153923252|NCT03480776|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153923254|NCT03480776|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153923255|NCT03480776|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153923256|NCT03480776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153923257|NCT03480776|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153923259|NCT03480776|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153472035|NCT04381104|Sensory System Agents|sensory system agents|mesh-ancestor
153472036|NCT04381104|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153472037|NCT04381104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153472038|NCT04381104|Antipyretics|antipyretics|mesh-ancestor
153472039|NCT04380402|Atorvastatin|atorvastatin|mesh-list
153472040|NCT04380402|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153472041|NCT04380402|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153472042|NCT04380402|Antimetabolites|antimetabolites|mesh-ancestor
153472043|NCT04380402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153472044|NCT04380402|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153472045|NCT04380402|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
153472046|NCT04380402|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153472047|NCT04380012|Trastuzumab|trastuzumab|mesh-list
153472048|NCT04380012|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153472050|NCT04379310|Calcium Channel Blockers|calcium channel blockers|mesh-list
153472051|NCT04379310|Calcium|calcium|mesh-list
153472052|NCT04379310|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
153923260|NCT03480776|Antipyretics|antipyretics|mesh-ancestor
153923261|NCT03459846|Durvalumab|durvalumab|mesh-list
153923262|NCT03459846|Olaparib|olaparib|mesh-list
153923263|NCT03459846|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153923264|NCT03459846|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153923265|NCT03459846|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
153923266|NCT03459846|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153923267|NCT03459846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153923292|NCT03404960|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153923293|NCT03404960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153923294|NCT03404960|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
153923295|NCT03404960|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153923296|NCT03304678|Sirolimus|sirolimus|mesh-list
153923297|NCT03304678|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153923298|NCT03304678|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153923299|NCT03304678|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153923300|NCT03304678|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153923301|NCT03304678|Antifungal Agents|antifungal agents|mesh-ancestor
153923302|NCT03304678|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153923303|NCT03304678|Immunologic Factors|immunologic factors|mesh-ancestor
153923315|NCT03290079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153923316|NCT03290079|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153472091|NCT04377048|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153472092|NCT04377048|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153472093|NCT04376814|Ritonavir|ritonavir|mesh-list
153472094|NCT04376814|Lopinavir|lopinavir|mesh-list
153472095|NCT04376814|Hydroxychloroquine|hydroxychloroquine|mesh-list
153472096|NCT04376814|Favipiravir|favipiravir|mesh-list
153472097|NCT04376814|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
153923317|NCT03290079|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153923318|NCT03215511|Selitrectinib|selitrectinib|mesh-list
153923319|NCT03215511|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153923329|NCT03125902|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153923330|NCT03125902|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153923331|NCT03125902|Tubulin Modulators|tubulin modulators|mesh-ancestor
153923332|NCT03125902|Antimitotic Agents|antimitotic agents|mesh-ancestor
153923333|NCT03125902|Mitosis Modulators|mitosis modulators|mesh-ancestor
153415871|NCT02650999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153415873|NCT05502211|Fentanyl|fentanyl|mesh-list
153923334|NCT03125902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153923335|NCT03125902|Immunologic Factors|immunologic factors|mesh-ancestor
153923336|NCT03125902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153923337|NCT03125902|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153923338|NCT03125902|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153923340|NCT03124355|Galantamine|galantamine|mesh-list
153923341|NCT03124355|Pyridostigmine Bromide|pyridostigmine bromide|mesh-list
153923342|NCT03124355|Anticonvulsants|anticonvulsants|mesh-ancestor
153923343|NCT03124355|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
153923344|NCT03124355|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153923345|NCT03124355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153923346|NCT03124355|Cholinergic Agents|cholinergic agents|mesh-ancestor
153923347|NCT03124355|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153923348|NCT03124355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153923349|NCT03124355|Parasympathomimetics|parasympathomimetics|mesh-ancestor
153923350|NCT03124355|Autonomic Agents|autonomic agents|mesh-ancestor
153923351|NCT03124355|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153923352|NCT03124355|Nootropic Agents|nootropic agents|mesh-ancestor
153923353|NCT03064126|Paclitaxel|paclitaxel|mesh-list
153923354|NCT03064126|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
153923355|NCT03064126|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153923356|NCT03064126|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153923357|NCT03064126|Tubulin Modulators|tubulin modulators|mesh-ancestor
153923358|NCT03064126|Antimitotic Agents|antimitotic agents|mesh-ancestor
153923359|NCT03064126|Mitosis Modulators|mitosis modulators|mesh-ancestor
153923360|NCT03064126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153923361|NCT03032601|Acetylcysteine|acetylcysteine|mesh-list
153923362|NCT03032601|N-monoacetylcystine|n-monoacetylcystine|mesh-list
153923363|NCT03032601|Antiviral Agents|antiviral agents|mesh-ancestor
153923364|NCT03032601|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153923365|NCT03032601|Expectorants|expectorants|mesh-ancestor
153923366|NCT03032601|Respiratory System Agents|respiratory system agents|mesh-ancestor
153923367|NCT03032601|Free Radical Scavengers|free radical scavengers|mesh-ancestor
153923368|NCT03032601|Antioxidants|antioxidants|mesh-ancestor
153923369|NCT03032601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153923370|NCT03032601|Protective Agents|protective agents|mesh-ancestor
153923371|NCT03032601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153875165|NCT01647555|Cetuximab|cetuximab|mesh-list
153923373|NCT03028311|Technetium Tc 99m Aggregated Albumin|technetium tc 99m aggregated albumin|mesh-list
153923374|NCT03028311|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
153923375|NCT03028311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153385839|NCT00550550|Antipruritics|antipruritics|mesh-ancestor
153385840|NCT00550550|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
153385841|NCT00550550|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
153385842|NCT00550550|Histamine Antagonists|histamine antagonists|mesh-ancestor
153385843|NCT00550550|Histamine Agents|histamine agents|mesh-ancestor
153472098|NCT04376814|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
153923377|NCT02929589|Analgesics, Opioid|analgesics, opioid|mesh-list
153923378|NCT02929589|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153923379|NCT02929589|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153923380|NCT02929589|Analgesics|analgesics|mesh-ancestor
153923381|NCT02929589|Sensory System Agents|sensory system agents|mesh-ancestor
153923382|NCT02929589|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153923383|NCT02929589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153923400|NCT02897063|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153923401|NCT02897063|Adrenergic Agents|adrenergic agents|mesh-ancestor
153923402|NCT02897063|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153923403|NCT02897063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153923404|NCT02897063|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
153923405|NCT02897063|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
153875209|NCT01647984|Vitamins|vitamins|mesh-list
153923408|NCT02870738|Glucocorticoids|glucocorticoids|mesh-ancestor
153923409|NCT02870738|Hormones|hormones|mesh-ancestor
153923410|NCT02870738|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153923411|NCT02870738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153923412|NCT02811679|Blinatumomab|blinatumomab|mesh-list
153923413|NCT02811679|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153923414|NCT02759835|Osimertinib|osimertinib|mesh-list
153923415|NCT02759835|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153923416|NCT02759835|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153923417|NCT02759835|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153923418|NCT02759835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153923419|NCT02759835|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153923420|NCT02725060|Phenylephrine|phenylephrine|mesh-list
153923421|NCT02725060|Isoproterenol|isoproterenol|mesh-list
153923422|NCT02725060|Oxymetazoline|oxymetazoline|mesh-list
153923423|NCT02725060|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
153875233|NCT02215382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153923424|NCT02725060|Mydriatics|mydriatics|mesh-ancestor
153923425|NCT02725060|Autonomic Agents|autonomic agents|mesh-ancestor
153923426|NCT02725060|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153923427|NCT02725060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153923428|NCT02725060|Sympathomimetics|sympathomimetics|mesh-ancestor
153923429|NCT02725060|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
153923430|NCT02725060|Nasal Decongestants|nasal decongestants|mesh-ancestor
153923431|NCT02725060|Respiratory System Agents|respiratory system agents|mesh-ancestor
153923432|NCT02725060|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
153923433|NCT02725060|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153923434|NCT02725060|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153923435|NCT02725060|Adrenergic Agents|adrenergic agents|mesh-ancestor
153923445|NCT02673333|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153923446|NCT02673333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153923447|NCT02650804|Coenzyme Q10|coenzyme q10|mesh-list
153923448|NCT02650804|Gemcitabine|gemcitabine|mesh-list
153472163|NCT04372836|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
153923449|NCT02650804|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153923450|NCT02650804|Antimetabolites|antimetabolites|mesh-ancestor
153923451|NCT02650804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153923452|NCT02650804|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153385911|NCT01483209|Cholinergic Agents|cholinergic agents|mesh-ancestor
153385912|NCT01483209|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153883284|NCT04820972|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-list
153883285|NCT03558854|Aspirin|aspirin|mesh-list
153883286|NCT03558854|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153883287|NCT03558854|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153883288|NCT03558854|Analgesics|analgesics|mesh-ancestor
153883290|NCT03558854|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153883291|NCT03558854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153883292|NCT03558854|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153883293|NCT03558854|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153472228|NCT04365582|Antimalarials|antimalarials|mesh-ancestor
153472229|NCT04365582|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153472230|NCT04365582|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153472231|NCT04365582|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153472232|NCT04365270|Chlorhexidine|chlorhexidine|mesh-list
153472233|NCT04365270|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
153472234|NCT04365270|Titanium dioxide|titanium dioxide|mesh-list
153472235|NCT04365270|Chitosan|chitosan|mesh-list
153472236|NCT04365270|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
153472237|NCT04365270|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153472238|NCT04365270|Disinfectants|disinfectants|mesh-ancestor
153472239|NCT04365270|Dermatologic Agents|dermatologic agents|mesh-ancestor
153472240|NCT04365270|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153472241|NCT04365270|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153472242|NCT04365270|Antimetabolites|antimetabolites|mesh-ancestor
153472243|NCT04365270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153472244|NCT04365270|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153472245|NCT04365270|Chelating Agents|chelating agents|mesh-ancestor
153472246|NCT04365270|Sequestering Agents|sequestering agents|mesh-ancestor
153923454|NCT02650804|Micronutrients|micronutrients|mesh-ancestor
153923455|NCT02650804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153923456|NCT02545868|Vaccines|vaccines|mesh-list
153923457|NCT02545868|Immunologic Factors|immunologic factors|mesh-ancestor
153923458|NCT02545868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153923460|NCT02465268|Sargramostim|sargramostim|mesh-list
153923461|NCT02465268|Immunologic Factors|immunologic factors|mesh-ancestor
153923469|NCT02429557|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
153923470|NCT02429557|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
153923471|NCT02429557|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153416010|NCT04739917|Immunologic Factors|immunologic factors|mesh-ancestor
153416011|NCT04739917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153923472|NCT02429557|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153923473|NCT02429557|Adrenergic Agents|adrenergic agents|mesh-ancestor
153923474|NCT02429557|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153923475|NCT02429557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153923485|NCT02232399|Vasodilator Agents|vasodilator agents|mesh-ancestor
153923486|NCT02232399|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
153923487|NCT02232399|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
153385914|NCT01483209|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
153385915|NCT01483209|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153385941|NCT02281526|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153923488|NCT02232399|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153472248|NCT04365270|Coagulants|coagulants|mesh-ancestor
153923489|NCT02232399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153923490|NCT02232399|Protective Agents|protective agents|mesh-ancestor
153923491|NCT02232399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153923492|NCT02232399|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153923528|NCT01897571|Glucocorticoids|glucocorticoids|mesh-ancestor
153923529|NCT01897571|Hormones|hormones|mesh-ancestor
153923530|NCT01897571|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153923531|NCT01897571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153923532|NCT01897571|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153923533|NCT01897571|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153923534|NCT01853826|Afatinib|afatinib|mesh-list
153923535|NCT01853826|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153923536|NCT01853826|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153923537|NCT01853826|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153923538|NCT01853826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153923539|NCT01853826|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153923540|NCT01623167|Cyclosporine|cyclosporine|mesh-list
153923541|NCT01623167|Cyclosporins|cyclosporins|mesh-list
153923542|NCT01623167|Antilymphocyte Serum|antilymphocyte serum|mesh-list
153923543|NCT01623167|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153923544|NCT01623167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153923545|NCT01623167|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153923546|NCT01623167|Immunologic Factors|immunologic factors|mesh-ancestor
153923547|NCT01623167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153923548|NCT01623167|Antifungal Agents|antifungal agents|mesh-ancestor
153923549|NCT01623167|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153923550|NCT01623167|Dermatologic Agents|dermatologic agents|mesh-ancestor
153923551|NCT01623167|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153923552|NCT01623167|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
153923554|NCT01578109|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153923555|NCT01578109|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153923556|NCT01578109|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153923557|NCT01578109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153923558|NCT01559935|Clarithromycin|clarithromycin|mesh-list
153923559|NCT01559935|Dexamethasone|dexamethasone|mesh-list
153923560|NCT01559935|Dexamethasone acetate|dexamethasone acetate|mesh-list
153923561|NCT01559935|Lenalidomide|lenalidomide|mesh-list
153923562|NCT01559935|BB 1101|bb 1101|mesh-list
153923563|NCT01559935|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153923564|NCT01559935|Antiemetics|antiemetics|mesh-ancestor
153923565|NCT01559935|Autonomic Agents|autonomic agents|mesh-ancestor
153923566|NCT01559935|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153923567|NCT01559935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153923568|NCT01559935|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153923569|NCT01559935|Glucocorticoids|glucocorticoids|mesh-ancestor
153923570|NCT01559935|Hormones|hormones|mesh-ancestor
153472291|NCT04362384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153385942|NCT02281526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153385944|NCT03802227|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153385945|NCT03802227|Narcotics|narcotics|mesh-ancestor
153385946|NCT03802227|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153385947|NCT03802227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153385948|NCT03802227|Analgesics|analgesics|mesh-ancestor
153385949|NCT03802227|Sensory System Agents|sensory system agents|mesh-ancestor
153385950|NCT03802227|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153385952|NCT02749617|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
153385953|NCT02749617|Antithrombins|antithrombins|mesh-ancestor
153385954|NCT02749617|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
153385955|NCT02749617|Protease Inhibitors|protease inhibitors|mesh-ancestor
153923576|NCT01559935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153923577|NCT01559935|Immunologic Factors|immunologic factors|mesh-ancestor
153923578|NCT01559935|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153923579|NCT01559935|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153923580|NCT01559935|Growth Substances|growth substances|mesh-ancestor
153923581|NCT01559935|Growth Inhibitors|growth inhibitors|mesh-ancestor
153923582|NCT01559935|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153923583|NCT01559935|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153923584|NCT01559935|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
153923585|NCT01559935|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
153923586|NCT01559935|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153923587|NCT01081262|Paclitaxel|paclitaxel|mesh-list
153923588|NCT01081262|Bevacizumab|bevacizumab|mesh-list
153923589|NCT01081262|Carboplatin|carboplatin|mesh-list
153923590|NCT01081262|Capecitabine|capecitabine|mesh-list
153923591|NCT01081262|Oxaliplatin|oxaliplatin|mesh-list
153923592|NCT01081262|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
153923593|NCT01081262|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
153923594|NCT01081262|Endothelial Growth Factors|endothelial growth factors|mesh-list
153923596|NCT01081262|Immunoglobulins|immunoglobulins|mesh-list
153923597|NCT01081262|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
153923598|NCT01081262|Immunoglobulin G|immunoglobulin g|mesh-list
153923599|NCT01081262|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153923600|NCT01081262|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153923601|NCT01081262|Tubulin Modulators|tubulin modulators|mesh-ancestor
153923602|NCT01081262|Antimitotic Agents|antimitotic agents|mesh-ancestor
153923603|NCT01081262|Mitosis Modulators|mitosis modulators|mesh-ancestor
153923604|NCT01081262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153923605|NCT01081262|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153923607|NCT01081262|Growth Substances|growth substances|mesh-ancestor
153923608|NCT01081262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153923609|NCT01081262|Growth Inhibitors|growth inhibitors|mesh-ancestor
153923610|NCT01081262|Immunologic Factors|immunologic factors|mesh-ancestor
153923611|NCT01081262|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153923612|NCT01081262|Antimetabolites|antimetabolites|mesh-ancestor
153923614|NCT00889733|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153923615|NCT00701909|Ketamine|ketamine|mesh-list
153923616|NCT00701909|Morphine|morphine|mesh-list
153923617|NCT00701909|Analgesics|analgesics|mesh-ancestor
153923618|NCT00701909|Sensory System Agents|sensory system agents|mesh-ancestor
153923619|NCT00701909|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153923620|NCT00701909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153923621|NCT00701909|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
153923622|NCT00701909|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153923623|NCT00701909|Anesthetics, General|anesthetics, general|mesh-ancestor
153923624|NCT00701909|Anesthetics|anesthetics|mesh-ancestor
153923625|NCT00701909|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153923626|NCT00701909|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
153923627|NCT00701909|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
153923628|NCT00701909|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153385956|NCT02749617|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153385957|NCT02749617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153385958|NCT02749617|Anticoagulants|anticoagulants|mesh-ancestor
153385959|NCT02749227|Pasireotide|pasireotide|mesh-list
153385961|NCT02749227|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153385962|NCT02749227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153385963|NCT02746263|Acetaminophen|acetaminophen|mesh-list
153385964|NCT02746263|Morphine|morphine|mesh-list
153385992|NCT02300610|Cisplatin|cisplatin|mesh-list
153385993|NCT02300610|Gemcitabine|gemcitabine|mesh-list
153385994|NCT02300610|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153385995|NCT02300610|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153385996|NCT02300610|Antimetabolites|antimetabolites|mesh-ancestor
153385997|NCT02300610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153386007|NCT01880840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153386009|NCT01880840|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
153923629|NCT00701909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153923630|NCT00701909|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153923631|NCT00701909|Narcotics|narcotics|mesh-ancestor
153923632|NCT00381680|Leucovorin|leucovorin|mesh-list
153923633|NCT00381680|Cytarabine|cytarabine|mesh-list
153472425|NCT04355598|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153472427|NCT04355598|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
153472428|NCT04355598|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153472429|NCT04355598|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153923649|NCT00381680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153923650|NCT00381680|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153923652|NCT00381680|Alkylating Agents|alkylating agents|mesh-ancestor
153923653|NCT00381680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153923654|NCT00381680|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153923655|NCT00381680|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153923656|NCT00381680|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153923657|NCT00381680|Antiemetics|antiemetics|mesh-ancestor
153923658|NCT00381680|Autonomic Agents|autonomic agents|mesh-ancestor
153923659|NCT00381680|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153923660|NCT00381680|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153923661|NCT00381680|Glucocorticoids|glucocorticoids|mesh-ancestor
153923662|NCT00381680|Hormones|hormones|mesh-ancestor
153923663|NCT00381680|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153923664|NCT00381680|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153923665|NCT00381680|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153923666|NCT00381680|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153923667|NCT00381680|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153923668|NCT00381680|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153923669|NCT00381680|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
153923670|NCT00381680|Abortifacient Agents|abortifacient agents|mesh-ancestor
153923672|NCT00381680|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153923673|NCT00381680|Antimetabolites|antimetabolites|mesh-ancestor
153923674|NCT00381680|Dermatologic Agents|dermatologic agents|mesh-ancestor
153923675|NCT00381680|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153923676|NCT00381680|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153923677|NCT00381680|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153923678|NCT00381680|Antiviral Agents|antiviral agents|mesh-ancestor
153923679|NCT00381680|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153923680|NCT00381680|Antidotes|antidotes|mesh-ancestor
153923681|NCT00381680|Protective Agents|protective agents|mesh-ancestor
153386010|NCT01880840|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
153783572|NCT04545931|Natriuretic Agents|natriuretic agents|mesh-ancestor
153783573|NCT04545931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153783574|NCT00236522|Levofloxacin|levofloxacin|mesh-list
153783575|NCT00236522|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
153783576|NCT00236522|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153783577|NCT00236522|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153783578|NCT00236522|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153783579|NCT00236522|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153783580|NCT00236522|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153783581|NCT00236522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153783582|NCT00236522|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153424246|NCT03696758|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
153424247|NCT03696758|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
153424248|NCT03696758|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153424249|NCT03696758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153424250|NCT03696758|Urological Agents|urological agents|mesh-ancestor
153424251|NCT03696758|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153424252|NCT03696758|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153424253|NCT03696758|Sympatholytics|sympatholytics|mesh-ancestor
153883299|NCT03558854|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153883300|NCT03558854|Antipyretics|antipyretics|mesh-ancestor
153883301|NCT01335477|Nintedanib|nintedanib|mesh-list
153883302|NCT01335477|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153883309|NCT01371747|Losartan|losartan|mesh-list
153923682|NCT00381680|Vitamin B Complex|vitamin b complex|mesh-ancestor
153923683|NCT00381680|Vitamins|vitamins|mesh-ancestor
153923684|NCT00381680|Micronutrients|micronutrients|mesh-ancestor
153923685|NCT00381680|Tubulin Modulators|tubulin modulators|mesh-ancestor
153923686|NCT00381680|Antimitotic Agents|antimitotic agents|mesh-ancestor
153923687|NCT00381680|Mitosis Modulators|mitosis modulators|mesh-ancestor
153923688|NCT00018057|Fluoxetine|fluoxetine|mesh-list
153923689|NCT00018057|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
153923690|NCT00018057|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153923691|NCT00018057|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153472498|NCT04353336|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153472499|NCT04353336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153472501|NCT04353336|Filaricides|filaricides|mesh-ancestor
153472504|NCT04353180|Tretinoin|tretinoin|mesh-list
153472560|NCT04350684|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153472561|NCT04350684|Antimalarials|antimalarials|mesh-ancestor
153472562|NCT04350684|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153472563|NCT04350684|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153472564|NCT04350684|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153472565|NCT04350684|Immunologic Factors|immunologic factors|mesh-ancestor
153416203|NCT02731820|Natriuretic Agents|natriuretic agents|mesh-ancestor
153472566|NCT04350684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153472567|NCT04350684|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153472568|NCT04350450|Hydroxychloroquine|hydroxychloroquine|mesh-list
153472569|NCT04350450|Antimalarials|antimalarials|mesh-ancestor
153472570|NCT04350450|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153783583|NCT00236522|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
153386047|NCT01383447|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-list
153386048|NCT01383447|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153386049|NCT01383447|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153386050|NCT01383447|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153386051|NCT01383447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153386052|NCT01383447|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153472571|NCT04350450|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153472572|NCT04350450|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153472573|NCT04350450|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153472574|NCT04350450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153472575|NCT04350450|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153472576|NCT04349592|Azithromycin|azithromycin|mesh-list
153472577|NCT04349592|Hydroxychloroquine|hydroxychloroquine|mesh-list
153472578|NCT04349592|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153472579|NCT04349592|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153472580|NCT04349592|Antimalarials|antimalarials|mesh-ancestor
153472581|NCT04349592|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153472582|NCT04349592|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153472616|NCT04345458|Sensory System Agents|sensory system agents|mesh-ancestor
153472617|NCT04345458|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153472618|NCT04345458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153472619|NCT04345458|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153472620|NCT04345458|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153472621|NCT04345458|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153472622|NCT04345458|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153472623|NCT04345458|Immunologic Factors|immunologic factors|mesh-ancestor
153472625|NCT04344756|Calcium heparin|calcium heparin|mesh-list
153472647|NCT04342728|Zinc|zinc|mesh-list
153472817|NCT04334928|Hydroxychloroquine|hydroxychloroquine|mesh-list
153472818|NCT04334928|Antiviral Agents|antiviral agents|mesh-ancestor
153472819|NCT04334928|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153472820|NCT04334928|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153472821|NCT04334928|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153472822|NCT04334928|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153472823|NCT04334928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153472824|NCT04334928|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153472825|NCT04334928|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153472826|NCT04334928|Antimalarials|antimalarials|mesh-ancestor
153472827|NCT04334928|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153472828|NCT04334928|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153472884|NCT04332042|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153472885|NCT04332042|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153472886|NCT04332042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153472887|NCT04341870|Azithromycin|azithromycin|mesh-list
153472888|NCT04341870|Hydroxychloroquine|hydroxychloroquine|mesh-list
153472889|NCT04341870|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153472890|NCT04341870|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153472891|NCT04341870|Antimalarials|antimalarials|mesh-ancestor
153472892|NCT04341870|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153472893|NCT04341870|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153472894|NCT04341870|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153416261|NCT03609008|Cromakalim|cromakalim|mesh-list
153472895|NCT04341870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153472896|NCT04341870|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153472897|NCT04330872|Aspirin|aspirin|mesh-list
153472898|NCT04330872|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153472899|NCT04330872|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153472900|NCT04330872|Analgesics|analgesics|mesh-ancestor
153472901|NCT04330872|Sensory System Agents|sensory system agents|mesh-ancestor
153472902|NCT04330872|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153472905|NCT04330872|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153472937|NCT05278884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153472938|NCT05136690|Nicotine|nicotine|mesh-list
153472939|NCT05136690|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
153472940|NCT05136690|Autonomic Agents|autonomic agents|mesh-ancestor
153386053|NCT02300298|Docetaxel|docetaxel|mesh-list
153386054|NCT02300298|Nintedanib|nintedanib|mesh-list
153386084|NCT01379469|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153386085|NCT01379469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153386086|NCT01379469|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
153386087|NCT01379469|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
153386088|NCT01309581|Ketamine|ketamine|mesh-list
153472941|NCT05136690|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153472942|NCT05136690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153472943|NCT05136690|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
153472944|NCT05136690|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
153472945|NCT05136690|Cholinergic Agents|cholinergic agents|mesh-ancestor
153473076|NCT03018756|Analgesics|analgesics|mesh-ancestor
153473077|NCT03018756|Sensory System Agents|sensory system agents|mesh-ancestor
153473132|NCT03017430|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153473134|NCT03017352|Exenatide|exenatide|mesh-list
153473135|NCT03017352|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
153473136|NCT03017352|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153473137|NCT03017352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153473138|NCT03017352|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
153473139|NCT03017352|Incretins|incretins|mesh-ancestor
153473140|NCT03017352|Hormones|hormones|mesh-ancestor
153473141|NCT03017352|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153473142|NCT03016884|Vaccines|vaccines|mesh-list
153473146|NCT03016806|Melphalan|melphalan|mesh-list
153473199|NCT03015246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153473200|NCT03015246|Analgesics|analgesics|mesh-ancestor
153473201|NCT03015246|Sensory System Agents|sensory system agents|mesh-ancestor
153473202|NCT03015246|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153473203|NCT03015246|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
153473204|NCT03015168|Capecitabine|capecitabine|mesh-list
153473205|NCT03015168|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153473267|NCT03007992|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153473268|NCT03007992|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153473269|NCT03007992|Tubulin Modulators|tubulin modulators|mesh-ancestor
153473270|NCT03007992|Antimitotic Agents|antimitotic agents|mesh-ancestor
153473271|NCT03007992|Mitosis Modulators|mitosis modulators|mesh-ancestor
153473272|NCT03007992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153473273|NCT03007446|Oxaliplatin|oxaliplatin|mesh-list
153473274|NCT03007446|Apatinib|apatinib|mesh-list
153473275|NCT03007446|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153473276|NCT03007446|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153473277|NCT03007446|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153473278|NCT03007446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153473279|NCT03007524|Calcium, Dietary|calcium, dietary|mesh-list
153473280|NCT03007524|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
153473281|NCT03007524|Calcium|calcium|mesh-list
153473299|NCT03005496|Vitamin D|vitamin d|mesh-list
153473342|NCT03005808|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153473343|NCT03005808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153473344|NCT03005808|Sensory System Agents|sensory system agents|mesh-ancestor
153473345|NCT03005808|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153473346|NCT03005340|Cholecalciferol|cholecalciferol|mesh-list
153473347|NCT03005340|Vitamin D|vitamin d|mesh-list
153473348|NCT03005340|Bazedoxifene|bazedoxifene|mesh-list
153473349|NCT03005340|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153473351|NCT03005340|Vitamins|vitamins|mesh-ancestor
153473379|NCT03005184|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
153473381|NCT03005184|Immunologic Factors|immunologic factors|mesh-ancestor
153473383|NCT03004014|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153473384|NCT03004014|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153473385|NCT03004014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153473386|NCT03004014|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153473387|NCT03004014|Anesthetics, General|anesthetics, general|mesh-ancestor
153473388|NCT03004014|Anesthetics|anesthetics|mesh-ancestor
153473445|NCT02995824|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153473446|NCT02995824|Antiviral Agents|antiviral agents|mesh-ancestor
153473447|NCT02995824|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153473448|NCT02995824|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
153473449|NCT02995824|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
153473450|NCT02995824|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153473451|NCT02995824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153473452|NCT02989272|Magnesium Sulfate|magnesium sulfate|mesh-list
153473453|NCT02989272|Analgesics|analgesics|mesh-ancestor
153473454|NCT02989272|Sensory System Agents|sensory system agents|mesh-ancestor
153473455|NCT02989272|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153473456|NCT02989272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153473457|NCT02989272|Anesthetics|anesthetics|mesh-ancestor
153473458|NCT02989272|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153473459|NCT02989272|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153473460|NCT02989272|Anticonvulsants|anticonvulsants|mesh-ancestor
153473461|NCT02989272|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153473462|NCT02989272|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153473463|NCT02989272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153473464|NCT02989272|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153473499|NCT02987244|Immunologic Factors|immunologic factors|mesh-ancestor
153473500|NCT02987244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153473501|NCT02987244|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153473502|NCT02987244|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153473503|NCT02987244|Alkylating Agents|alkylating agents|mesh-ancestor
153473504|NCT02987244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153473505|NCT02987244|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153473506|NCT02987244|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153473507|NCT02987244|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153473508|NCT02987244|Glucocorticoids|glucocorticoids|mesh-ancestor
153473519|NCT02987244|Mitosis Modulators|mitosis modulators|mesh-ancestor
153473520|NCT02987166|Pembrolizumab|pembrolizumab|mesh-list
153473521|NCT02987166|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153473549|NCT02980458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153473551|NCT02978976|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153473552|NCT02978976|Glucocorticoids|glucocorticoids|mesh-ancestor
153473554|NCT02978976|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153473555|NCT02978976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153473556|NCT02978976|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153473616|NCT02974920|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153473617|NCT02974920|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153473618|NCT02974920|Analgesics|analgesics|mesh-ancestor
153473619|NCT02974920|Sensory System Agents|sensory system agents|mesh-ancestor
153473620|NCT02974920|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153473622|NCT02974920|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153473623|NCT02974920|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153473624|NCT02974920|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153473625|NCT02974920|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153473626|NCT02974920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153473627|NCT02974920|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153473628|NCT02974920|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153473629|NCT02974920|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153473631|NCT02974920|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
153473632|NCT02974920|Antithrombins|antithrombins|mesh-ancestor
153473633|NCT02974920|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
153473634|NCT02974920|Protease Inhibitors|protease inhibitors|mesh-ancestor
153473636|NCT02973204|Everolimus|everolimus|mesh-list
153473637|NCT02973204|Sorafenib|sorafenib|mesh-list
153473638|NCT02973204|Octreotide|octreotide|mesh-list
153473640|NCT02973204|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
153473641|NCT02973204|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153473642|NCT02973204|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153473657|NCT02958852|Letrozole|letrozole|mesh-list
153473667|NCT02958852|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153473668|NCT02958852|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
153473669|NCT02958852|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153473670|NCT02958852|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
153473671|NCT02958852|Hormone Antagonists|hormone antagonists|mesh-ancestor
153473672|NCT02958852|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153473673|NCT02958852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153473674|NCT02958852|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153473675|NCT02958852|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
153473676|NCT02641782|Aldesleukin|aldesleukin|mesh-list
153473721|NCT04769778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153473723|NCT04769076|Cisplatin|cisplatin|mesh-list
153473724|NCT04769076|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
153473725|NCT04769076|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153473726|NCT04769076|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153473727|NCT04769076|Tubulin Modulators|tubulin modulators|mesh-ancestor
153473728|NCT04769076|Antimitotic Agents|antimitotic agents|mesh-ancestor
153473729|NCT04769076|Mitosis Modulators|mitosis modulators|mesh-ancestor
153473744|NCT04748562|Hormones|hormones|mesh-ancestor
153473781|NCT04740840|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153473782|NCT04740840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153473783|NCT04740840|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153473784|NCT04740840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153473785|NCT04740840|Vasodilator Agents|vasodilator agents|mesh-ancestor
153473787|NCT04739202|Atezolizumab|atezolizumab|mesh-list
153473788|NCT04739202|Ipatasertib|ipatasertib|mesh-list
153473790|NCT04739202|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153473791|NCT04739202|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153473792|NCT04739202|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153473793|NCT04739202|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153473794|NCT04739202|Growth Substances|growth substances|mesh-ancestor
153473795|NCT04739202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153473796|NCT04739202|Growth Inhibitors|growth inhibitors|mesh-ancestor
153473797|NCT04739202|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153473837|NCT05313828|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153473839|NCT05313750|Levofloxacin|levofloxacin|mesh-list
153473840|NCT05313750|Sitafloxacin|sitafloxacin|mesh-list
153473841|NCT05313750|Anti-Infective Agents|anti-infective agents|mesh-list
153473842|NCT05313750|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
153473843|NCT05313750|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153473844|NCT05313750|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153473845|NCT05313750|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153473846|NCT05313750|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153473847|NCT05313750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153473848|NCT05313750|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153473849|NCT05313750|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
153473850|NCT05313750|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153473851|NCT04662684|Rivaroxaban|rivaroxaban|mesh-list
153473852|NCT04662684|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
153473853|NCT04662684|Antithrombins|antithrombins|mesh-ancestor
153473854|NCT04662684|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
153875599|NCT01683747|Hemostatics|hemostatics|mesh-ancestor
153473855|NCT04662684|Protease Inhibitors|protease inhibitors|mesh-ancestor
153473856|NCT04662684|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153473857|NCT04662684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153473858|NCT04662684|Anticoagulants|anticoagulants|mesh-ancestor
153473859|NCT05139966|Fluorides|fluorides|mesh-list
153473899|NCT00580398|Cholinergic Agents|cholinergic agents|mesh-ancestor
153473900|NCT00580398|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153473901|NCT00580398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153473902|NCT00580398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153473904|NCT00582660|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153473905|NCT00582660|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153473906|NCT00582660|Analgesics|analgesics|mesh-ancestor
153473907|NCT00582660|Sensory System Agents|sensory system agents|mesh-ancestor
153473908|NCT00582660|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153473909|NCT00582660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153473935|NCT00585780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153473936|NCT00585780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153473937|NCT00586482|Nicotine|nicotine|mesh-list
153473938|NCT00586482|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
153473939|NCT00586482|Autonomic Agents|autonomic agents|mesh-ancestor
153473940|NCT00586482|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153473941|NCT00586482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153473942|NCT00586482|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
153473943|NCT00586482|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
153473944|NCT00586482|Cholinergic Agents|cholinergic agents|mesh-ancestor
153473999|NCT00393354|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
153474000|NCT00393354|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153474001|NCT00393354|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153474003|NCT00166530|Simvastatin|simvastatin|mesh-list
153474004|NCT00166530|Ezetimibe|ezetimibe|mesh-list
153474005|NCT00166530|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153474006|NCT00166530|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153474007|NCT00166530|Antimetabolites|antimetabolites|mesh-ancestor
153474008|NCT00166530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153474009|NCT00166530|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153474064|NCT00592176|Growth Inhibitors|growth inhibitors|mesh-ancestor
153474130|NCT00603018|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153474131|NCT00603018|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
153474132|NCT00603018|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153474133|NCT00603018|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153474134|NCT00603408|Cisplatin|cisplatin|mesh-list
153875642|NCT04532333|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153416383|NCT04003987|Anesthetics|anesthetics|mesh-ancestor
153474189|NCT00626886|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153474190|NCT00626886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153474191|NCT00626886|Sensory System Agents|sensory system agents|mesh-ancestor
153474192|NCT00626886|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153474194|NCT00628134|Pulmonary Surfactants|pulmonary surfactants|mesh-ancestor
153474195|NCT00628134|Respiratory System Agents|respiratory system agents|mesh-ancestor
153474196|NCT00632814|Factor VIII|factor viii|mesh-list
153474197|NCT00632814|Coagulants|coagulants|mesh-ancestor
153474198|NCT00632970|Ritonavir|ritonavir|mesh-list
153474199|NCT00632970|Lopinavir|lopinavir|mesh-list
153474200|NCT00632970|Tenofovir|tenofovir|mesh-list
153474201|NCT00632970|Emtricitabine|emtricitabine|mesh-list
153474202|NCT00632970|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
153474249|NCT00638820|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153474250|NCT00638820|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153474251|NCT00638820|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153474252|NCT00638820|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153474253|NCT00638820|Antimetabolites|antimetabolites|mesh-ancestor
153474254|NCT00641862|Vitamin B 12|vitamin b 12|mesh-list
153474255|NCT00641862|Hydroxocobalamin|hydroxocobalamin|mesh-list
153474257|NCT00641862|Micronutrients|micronutrients|mesh-ancestor
153474258|NCT00641862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153474259|NCT00641862|Vitamin B Complex|vitamin b complex|mesh-ancestor
153474260|NCT00641862|Hematinics|hematinics|mesh-ancestor
153474261|NCT00643578|Formoterol Fumarate|formoterol fumarate|mesh-list
153474262|NCT00643578|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153474263|NCT00643578|Autonomic Agents|autonomic agents|mesh-ancestor
153474313|NCT00661674|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153474314|NCT00661674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153474315|NCT00661674|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153474316|NCT00661674|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
153474380|NCT00671970|Bevacizumab|bevacizumab|mesh-list
153474381|NCT00671970|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
153474382|NCT00671970|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153474384|NCT00671970|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153474456|NCT00678834|Tocotrienols|tocotrienols|mesh-list
153474457|NCT00678834|alpha-Tocopherol|alpha-tocopherol|mesh-list
153474458|NCT00678834|Antioxidants|antioxidants|mesh-ancestor
153474459|NCT00678834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153474460|NCT00678834|Protective Agents|protective agents|mesh-ancestor
153474461|NCT00678834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153474463|NCT00678834|Micronutrients|micronutrients|mesh-ancestor
153474464|NCT00679380|Budesonide|budesonide|mesh-list
153474465|NCT00679380|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153474466|NCT00679380|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153474467|NCT00679380|Autonomic Agents|autonomic agents|mesh-ancestor
153474468|NCT00679380|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153474469|NCT00679380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153474470|NCT00679380|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153474471|NCT00679380|Respiratory System Agents|respiratory system agents|mesh-ancestor
153474472|NCT00679380|Glucocorticoids|glucocorticoids|mesh-ancestor
153474473|NCT00679380|Hormones|hormones|mesh-ancestor
153474474|NCT00679380|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153474475|NCT00680706|Thiamine|thiamine|mesh-list
153474476|NCT00680706|Vitamins|vitamins|mesh-ancestor
153474477|NCT00680706|Micronutrients|micronutrients|mesh-ancestor
153474478|NCT00680706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153474479|NCT00680706|Vitamin B Complex|vitamin b complex|mesh-ancestor
153474480|NCT00682734|Diphenhydramine|diphenhydramine|mesh-list
153474481|NCT00682734|Promethazine|promethazine|mesh-list
153474482|NCT00682734|Metoclopramide|metoclopramide|mesh-list
153474483|NCT00682734|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
153474484|NCT00682734|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153474485|NCT00682734|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153474486|NCT00682734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153474487|NCT00682734|Anesthetics, Local|anesthetics, local|mesh-ancestor
153474488|NCT00682734|Anesthetics|anesthetics|mesh-ancestor
153386090|NCT01309581|Analgesics|analgesics|mesh-ancestor
153386091|NCT01309581|Sensory System Agents|sensory system agents|mesh-ancestor
153386092|NCT01309581|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153386093|NCT01309581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153386094|NCT01309581|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
153386095|NCT01309581|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153386096|NCT01309581|Anesthetics, General|anesthetics, general|mesh-ancestor
153386097|NCT01309581|Anesthetics|anesthetics|mesh-ancestor
153386153|NCT02658357|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
153474489|NCT00682734|Sensory System Agents|sensory system agents|mesh-ancestor
153474490|NCT00682734|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153474491|NCT00682734|Antiemetics|antiemetics|mesh-ancestor
153474505|NCT00683046|Fludarabine|fludarabine|mesh-list
153474551|NCT00691002|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
153474552|NCT00691002|Vitamins|vitamins|mesh-ancestor
153474553|NCT00691002|Micronutrients|micronutrients|mesh-ancestor
153875686|NCT01684059|Zinc Sulfate|zinc sulfate|mesh-list
153474555|NCT00695292|Carboplatin|carboplatin|mesh-list
153474556|NCT00695292|Irinotecan|irinotecan|mesh-list
153474557|NCT00695292|Sunitinib|sunitinib|mesh-list
153474558|NCT00695292|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153474559|NCT00695292|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
153474560|NCT00695292|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153474561|NCT00695292|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153474562|NCT00695292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153474563|NCT00695292|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153474564|NCT00695292|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153474565|NCT00695292|Growth Substances|growth substances|mesh-ancestor
153474566|NCT00695292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153474629|NCT00706836|Anticonvulsants|anticonvulsants|mesh-ancestor
153474674|NCT00715884|Antifungal Agents|antifungal agents|mesh-ancestor
153474675|NCT00715884|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153474676|NCT00715884|Immunologic Factors|immunologic factors|mesh-ancestor
153474677|NCT00715884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153474678|NCT00715884|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153474680|NCT00715884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153474681|NCT00716586|Dorzolamide|dorzolamide|mesh-list
153474682|NCT00716586|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153474683|NCT00716586|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
153474684|NCT00716586|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153474685|NCT00716586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153416471|NCT05243953|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153474686|NCT00716742|Bimatoprost|bimatoprost|mesh-list
153474687|NCT00716742|Travoprost|travoprost|mesh-list
153474688|NCT00716742|Latanoprost|latanoprost|mesh-list
153474689|NCT00716742|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
153474690|NCT00716742|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
153474691|NCT00716742|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153474692|NCT00716820|Sunitinib|sunitinib|mesh-list
153474693|NCT00716820|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153474694|NCT00716820|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153474695|NCT00716820|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153474696|NCT00716820|Growth Substances|growth substances|mesh-ancestor
153474697|NCT00716820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153474698|NCT00716820|Growth Inhibitors|growth inhibitors|mesh-ancestor
153474699|NCT00716820|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153474700|NCT00716820|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153474701|NCT00716820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153474721|NCT00717288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153474722|NCT00719160|Esomeprazole|esomeprazole|mesh-list
153474723|NCT00719160|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
153474724|NCT00719160|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153474725|NCT00719160|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
153386154|NCT02658357|Dopamine Agents|dopamine agents|mesh-ancestor
153386155|NCT02988908|Donepezil|donepezil|mesh-list
153386156|NCT02988908|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
153386157|NCT02988908|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153386158|NCT02988908|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153386159|NCT02988908|Cholinergic Agents|cholinergic agents|mesh-ancestor
153386160|NCT02988908|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153386161|NCT02988908|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153386192|NCT01280643|Levoleucovorin|levoleucovorin|mesh-list
153386193|NCT01280643|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153386194|NCT01280643|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153474726|NCT00719160|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153474727|NCT00719160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153474728|NCT00720330|Lidocaine|lidocaine|mesh-list
153474729|NCT00720330|Ketamine|ketamine|mesh-list
153474730|NCT00720330|Ropivacaine|ropivacaine|mesh-list
153474731|NCT00720330|Anesthetics, Local|anesthetics, local|mesh-ancestor
153474744|NCT00720330|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153474745|NCT00720330|Anesthetics, General|anesthetics, general|mesh-ancestor
153474746|NCT00720330|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
153474747|NCT00720330|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
153474749|NCT00721188|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
153474750|NCT00721188|Hematinics|hematinics|mesh-ancestor
153474751|NCT00722436|Tranexamic Acid|tranexamic acid|mesh-list
153474752|NCT00722436|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
153474753|NCT00722436|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153474754|NCT00722436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153474755|NCT00722436|Hemostatics|hemostatics|mesh-ancestor
153474756|NCT00722436|Coagulants|coagulants|mesh-ancestor
153474757|NCT00724464|Interferons|interferons|mesh-list
153474758|NCT00724464|Ribavirin|ribavirin|mesh-list
153474759|NCT00724464|Interferon-alpha|interferon-alpha|mesh-list
153474760|NCT00724464|Interferon alpha-2|interferon alpha-2|mesh-list
153416501|NCT02358356|Alkylating Agents|alkylating agents|mesh-ancestor
153474761|NCT00724464|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
153474762|NCT00724464|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153474763|NCT00724464|Antiviral Agents|antiviral agents|mesh-ancestor
153474764|NCT00724464|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153474765|NCT00724464|Antimetabolites|antimetabolites|mesh-ancestor
153474766|NCT00724464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153474768|NCT00724464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153474770|NCT00726414|Antimalarials|antimalarials|mesh-ancestor
153474771|NCT00726414|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153474820|NCT00729846|Dermatologic Agents|dermatologic agents|mesh-ancestor
153474821|NCT00729924|Raltegravir Potassium|raltegravir potassium|mesh-list
153474822|NCT00729924|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153474823|NCT00729924|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153474824|NCT00729924|Antiviral Agents|antiviral agents|mesh-ancestor
153474825|NCT00729924|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153474826|NCT00729924|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
153474827|NCT00729924|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
153474828|NCT00729924|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153474829|NCT00729924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153474830|NCT00731874|Tacrolimus|tacrolimus|mesh-list
153474831|NCT00731874|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153474832|NCT00731874|Immunologic Factors|immunologic factors|mesh-ancestor
153474833|NCT00731874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153474834|NCT00731874|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
153474835|NCT00731874|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153474836|NCT00731874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153474837|NCT00732654|Immunomodulating Agents|immunomodulating agents|mesh-list
153474838|NCT00732654|Immunologic Factors|immunologic factors|mesh-list
153474839|NCT00732654|Caseins|caseins|mesh-list
153474840|NCT00732654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153474871|NCT00735306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153474872|NCT00735462|Imiquimod|imiquimod|mesh-list
153474882|NCT00736242|Interferon alpha-2|interferon alpha-2|mesh-list
153474883|NCT00736242|Antiviral Agents|antiviral agents|mesh-ancestor
153474884|NCT00736242|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153474885|NCT00736242|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153474887|NCT00736632|Ergocalciferols|ergocalciferols|mesh-list
153474888|NCT00736632|Cholecalciferol|cholecalciferol|mesh-list
153474889|NCT00736632|Vitamins|vitamins|mesh-list
153474890|NCT00736632|Micronutrients|micronutrients|mesh-ancestor
153474891|NCT00736632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153474892|NCT00736632|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153474893|NCT00736632|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153474895|NCT00737178|Trace Elements|trace elements|mesh-ancestor
153474896|NCT00737178|Micronutrients|micronutrients|mesh-ancestor
153474897|NCT00737178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153474898|NCT00741156|Enalaprilat|enalaprilat|mesh-list
153474899|NCT00741156|Enalapril|enalapril|mesh-list
153474900|NCT00741156|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
153474901|NCT00741156|Protease Inhibitors|protease inhibitors|mesh-ancestor
153474902|NCT00741156|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153474903|NCT00741156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153474906|NCT00741468|Midazolam|midazolam|mesh-list
153474907|NCT00741468|Dextromethorphan|dextromethorphan|mesh-list
153474908|NCT00741468|Caffeine|caffeine|mesh-list
153474909|NCT00741468|Omeprazole|omeprazole|mesh-list
153474910|NCT00741468|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153474911|NCT00741468|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153474912|NCT00741468|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153474913|NCT00741468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153474914|NCT00741468|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153474915|NCT00741468|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153474916|NCT00741468|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153474917|NCT00741468|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153474918|NCT00741468|Anesthetics, General|anesthetics, general|mesh-ancestor
153474919|NCT00741468|Anesthetics|anesthetics|mesh-ancestor
153474920|NCT00741468|GABA Modulators|gaba modulators|mesh-ancestor
153474921|NCT00741468|GABA Agents|gaba agents|mesh-ancestor
153474922|NCT00741468|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153474969|NCT00743574|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
153474970|NCT00743574|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
153474971|NCT00743574|Contraceptive Agents|contraceptive agents|mesh-ancestor
153474972|NCT00743574|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153474973|NCT00743574|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
153474974|NCT00743574|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
153474975|NCT00743574|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
153474976|NCT00743574|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153474977|NCT00743574|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153474978|NCT00743730|Morphine|morphine|mesh-list
153474979|NCT00743730|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153474980|NCT00743730|Narcotics|narcotics|mesh-ancestor
153474981|NCT00743730|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153474982|NCT00743730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153416553|NCT00369031|Interferon Inducers|interferon inducers|mesh-ancestor
153474984|NCT00743730|Sensory System Agents|sensory system agents|mesh-ancestor
153474985|NCT00743730|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153474986|NCT00745290|Bupivacaine|bupivacaine|mesh-list
153474987|NCT00745290|Anesthetics, Local|anesthetics, local|mesh-ancestor
153474988|NCT00745290|Anesthetics|anesthetics|mesh-ancestor
153474989|NCT00745290|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153474997|NCT00751530|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153474998|NCT00751530|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
153474999|NCT00751530|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
153475000|NCT00751530|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153475001|NCT00751530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153475002|NCT00753636|Isradipine|isradipine|mesh-list
153475003|NCT00753636|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153475004|NCT00753636|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153475005|NCT00753636|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153475006|NCT00753636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153475007|NCT00753636|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153475008|NCT00753636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153475009|NCT00753636|Vasodilator Agents|vasodilator agents|mesh-ancestor
153475010|NCT00754494|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
153475011|NCT00754494|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153875818|NCT04527276|Disinfectants|disinfectants|mesh-ancestor
153475012|NCT00754494|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153475013|NCT00754494|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153475014|NCT00754494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153475015|NCT00754494|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153475016|NCT00755040|Cyclosporine|cyclosporine|mesh-list
153475065|NCT00759642|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153475066|NCT00759642|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153475067|NCT00759642|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153475068|NCT00759642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153475069|NCT00759642|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153475070|NCT00759798|Cyclophosphamide|cyclophosphamide|mesh-list
153475071|NCT00759798|Rituximab|rituximab|mesh-list
153475072|NCT00759798|Fludarabine|fludarabine|mesh-list
153475073|NCT00759798|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153475074|NCT00759798|Immunologic Factors|immunologic factors|mesh-ancestor
153475075|NCT00759798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153475076|NCT00759798|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153475077|NCT00759798|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153475078|NCT00759798|Alkylating Agents|alkylating agents|mesh-ancestor
153475079|NCT00759798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153475080|NCT00759798|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153475081|NCT00759798|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153475082|NCT00759798|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153475084|NCT00760578|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153475085|NCT00760578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153475086|NCT00761202|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
153475087|NCT00761202|Hyaluronic Acid|hyaluronic acid|mesh-list
153475090|NCT00761202|Immunologic Factors|immunologic factors|mesh-ancestor
153475115|NCT00762450|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
153475116|NCT00762450|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153475117|NCT00762450|Antimetabolites|antimetabolites|mesh-ancestor
153475118|NCT00762450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153475119|NCT00762450|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153475120|NCT00762528|Triclosan|triclosan|mesh-list
153475121|NCT00762528|Fluorides|fluorides|mesh-list
153475122|NCT00762528|Fluorophosphate|fluorophosphate|mesh-list
153475123|NCT00762528|Cariostatic Agents|cariostatic agents|mesh-ancestor
153475124|NCT00762528|Protective Agents|protective agents|mesh-ancestor
153475125|NCT00762528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153475126|NCT00762528|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
153475127|NCT00762528|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153475128|NCT00762528|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
153475129|NCT00762528|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153475130|NCT00762528|Antimetabolites|antimetabolites|mesh-ancestor
153475132|NCT00762528|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153475133|NCT00765648|Labetalol|labetalol|mesh-list
153475134|NCT00765648|Nicardipine|nicardipine|mesh-list
153475135|NCT00765648|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
153475170|NCT00769392|Tetracaine|tetracaine|mesh-list
153475171|NCT00769392|Proxymetacaine|proxymetacaine|mesh-list
153475172|NCT00769392|Anesthetics, Local|anesthetics, local|mesh-ancestor
153475173|NCT00769392|Anesthetics|anesthetics|mesh-ancestor
153475174|NCT00769392|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153475175|NCT00769392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153475176|NCT00769392|Sensory System Agents|sensory system agents|mesh-ancestor
153475177|NCT00769392|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153475178|NCT00769392|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153475179|NCT00769392|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
153475180|NCT00769392|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153475181|NCT00769392|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153475182|NCT00769392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153475184|NCT00770874|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153475185|NCT00772590|Raltegravir Potassium|raltegravir potassium|mesh-list
153475186|NCT00772590|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153475187|NCT00772590|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153475188|NCT00772590|Antiviral Agents|antiviral agents|mesh-ancestor
153475189|NCT00772590|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153475190|NCT00772590|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
153475191|NCT00772590|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
153475192|NCT00772590|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153475194|NCT00775944|Nicotine|nicotine|mesh-list
153475222|NCT00785772|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153475223|NCT00785772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153475224|NCT00785772|Anticonvulsants|anticonvulsants|mesh-ancestor
153475225|NCT00785772|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153475226|NCT00785772|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153475227|NCT00785772|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153386195|NCT01280643|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153883323|NCT01335399|Dexamethasone|dexamethasone|mesh-list
153475228|NCT00785772|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153475229|NCT00785772|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
153475231|NCT00785772|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153475232|NCT00785772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153475233|NCT00785772|Antimanic Agents|antimanic agents|mesh-ancestor
153475235|NCT00787332|Argatroban|argatroban|mesh-list
153475236|NCT00787332|Antithrombins|antithrombins|mesh-ancestor
153475237|NCT00787332|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
153475238|NCT00787332|Protease Inhibitors|protease inhibitors|mesh-ancestor
153475239|NCT00787332|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153475240|NCT00787332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153475241|NCT00787332|Anticoagulants|anticoagulants|mesh-ancestor
153475242|NCT00787332|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153475243|NCT00787332|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153475244|NCT00787332|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153475245|NCT00787722|Methylprednisolone|methylprednisolone|mesh-list
153475246|NCT00787722|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
153475247|NCT00787722|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
153475248|NCT00787722|Prednisolone|prednisolone|mesh-list
153475249|NCT00787722|Prednisolone acetate|prednisolone acetate|mesh-list
153475250|NCT00787722|Cyclophosphamide|cyclophosphamide|mesh-list
153475251|NCT00787722|Rituximab|rituximab|mesh-list
153475252|NCT00787722|Thymoglobulin|thymoglobulin|mesh-list
153475253|NCT00787722|Antilymphocyte Serum|antilymphocyte serum|mesh-list
153475254|NCT00787722|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
153475255|NCT00787722|Prednisolone phosphate|prednisolone phosphate|mesh-list
153475256|NCT00787722|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153475257|NCT00787722|Immunologic Factors|immunologic factors|mesh-ancestor
153475258|NCT00787722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153475259|NCT00787722|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153475260|NCT00787722|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153475261|NCT00787722|Alkylating Agents|alkylating agents|mesh-ancestor
153475262|NCT00787722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153475263|NCT00787722|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153416650|NCT04270214|Cholinergic Agents|cholinergic agents|mesh-ancestor
153475264|NCT00787722|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153475265|NCT00787722|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153475266|NCT00787722|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153475267|NCT00787722|Antiemetics|antiemetics|mesh-ancestor
153475268|NCT00787722|Autonomic Agents|autonomic agents|mesh-ancestor
153475308|NCT00789750|Antimetabolites|antimetabolites|mesh-ancestor
153475309|NCT00789750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153475310|NCT00789750|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153475311|NCT00790062|Oxytocin|oxytocin|mesh-list
153475312|NCT00790062|Oxytocics|oxytocics|mesh-ancestor
153475313|NCT00790062|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153475314|NCT00790062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153475315|NCT00793572|Cyclosporine|cyclosporine|mesh-list
153475316|NCT00793572|Mycophenolic Acid|mycophenolic acid|mesh-list
153475317|NCT00793572|Fludarabine|fludarabine|mesh-list
153475318|NCT00793572|Fludarabine phosphate|fludarabine phosphate|mesh-list
153475319|NCT00793572|Bortezomib|bortezomib|mesh-list
153475320|NCT00793572|Melphalan|melphalan|mesh-list
153475321|NCT00793572|Mechlorethamine|mechlorethamine|mesh-list
153475322|NCT00793572|Nitrogen Mustard Compounds|nitrogen mustard compounds|mesh-list
153475323|NCT00793572|Cyclosporins|cyclosporins|mesh-list
153475324|NCT00793572|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153475325|NCT00793572|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153475326|NCT00793572|Antimetabolites|antimetabolites|mesh-ancestor
153475327|NCT00793572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153475328|NCT00793572|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153475329|NCT00793572|Immunologic Factors|immunologic factors|mesh-ancestor
153475330|NCT00793572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153475331|NCT00793572|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153475332|NCT00793572|Antifungal Agents|antifungal agents|mesh-ancestor
153475333|NCT00793572|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153475334|NCT00793572|Dermatologic Agents|dermatologic agents|mesh-ancestor
153475335|NCT00793572|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153475342|NCT00793572|Alkylating Agents|alkylating agents|mesh-ancestor
153475343|NCT00793572|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153475345|NCT00793650|Melphalan|melphalan|mesh-list
153475346|NCT00793650|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153475347|NCT00793650|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153475348|NCT00793650|Alkylating Agents|alkylating agents|mesh-ancestor
153475349|NCT00793650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153475350|NCT00793650|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153475351|NCT00793650|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153475352|NCT00793650|Immunologic Factors|immunologic factors|mesh-ancestor
153475353|NCT00793650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153475354|NCT00795210|Hormones|hormones|mesh-list
153475355|NCT00795210|Growth Hormone-Releasing Hormone|growth hormone-releasing hormone|mesh-list
153475356|NCT00795210|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153475358|NCT00795288|Simvastatin|simvastatin|mesh-list
153475359|NCT00795288|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153475360|NCT00795288|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153475361|NCT00795288|Antimetabolites|antimetabolites|mesh-ancestor
153475362|NCT00795288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153475363|NCT00795288|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153475364|NCT00795288|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
153475365|NCT00795288|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153475366|NCT00795366|Vasopressins|vasopressins|mesh-list
153475367|NCT00795366|Arginine Vasopressin|arginine vasopressin|mesh-list
153475368|NCT00795366|Hemostatics|hemostatics|mesh-ancestor
153475369|NCT00795366|Coagulants|coagulants|mesh-ancestor
153475370|NCT00795366|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
153475371|NCT00795366|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
153475372|NCT00795366|Natriuretic Agents|natriuretic agents|mesh-ancestor
153416707|NCT05447936|Micronutrients|micronutrients|mesh-ancestor
153475374|NCT00796302|Risperidone|risperidone|mesh-list
153475375|NCT00796302|Methylphenidate|methylphenidate|mesh-list
153475376|NCT00796302|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153475377|NCT00796302|Serotonin Agents|serotonin agents|mesh-ancestor
153475378|NCT00796302|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153475379|NCT00796302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153475380|NCT00796302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153475381|NCT00796302|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153475382|NCT00796302|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153475383|NCT00796302|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153475384|NCT00796302|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153475385|NCT00796302|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
153475386|NCT00796302|Dopamine Agents|dopamine agents|mesh-ancestor
153475387|NCT00796302|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
153475388|NCT00796302|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
153475389|NCT00796302|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153475390|NCT00796302|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153475391|NCT00796926|Ophthalmic Solutions|ophthalmic solutions|mesh-list
153475392|NCT00796926|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
153475393|NCT00798018|Lidocaine|lidocaine|mesh-list
153475394|NCT00798018|Tetracaine|tetracaine|mesh-list
153475395|NCT00798018|Anesthetics, Local|anesthetics, local|mesh-ancestor
153475396|NCT00798018|Anesthetics|anesthetics|mesh-ancestor
153475397|NCT00798018|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153475398|NCT00798018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153475399|NCT00798018|Sensory System Agents|sensory system agents|mesh-ancestor
153475400|NCT00798018|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153475401|NCT00798018|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153475402|NCT00798018|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
153475403|NCT00798018|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153475404|NCT00798018|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153475426|NCT00801138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153475428|NCT00801138|Glucocorticoids|glucocorticoids|mesh-ancestor
153475430|NCT00801138|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153475431|NCT00801138|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153475432|NCT00801138|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153475433|NCT00801138|Anesthetics, Local|anesthetics, local|mesh-ancestor
153475434|NCT00801138|Anesthetics|anesthetics|mesh-ancestor
153475435|NCT00801138|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153475436|NCT00801138|Sensory System Agents|sensory system agents|mesh-ancestor
153475437|NCT00801684|Triptorelin Pamoate|triptorelin pamoate|mesh-list
153475438|NCT00801684|Formoterol Fumarate|formoterol fumarate|mesh-list
153475439|NCT00801684|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153475441|NCT00801684|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153475442|NCT00801684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153475458|NCT00803010|Sirolimus|sirolimus|mesh-list
153475484|NCT00803400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153475485|NCT00803400|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153475486|NCT00803400|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153475487|NCT00803400|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153475489|NCT00803400|GABA Agents|gaba agents|mesh-ancestor
153475490|NCT00803400|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153475491|NCT00803400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153475492|NCT00804648|Timolol|timolol|mesh-list
153475493|NCT00804648|Maleic acid|maleic acid|mesh-list
153475494|NCT00804648|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153416726|NCT05450497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153475503|NCT00806598|Cyclosporine|cyclosporine|mesh-list
153475507|NCT00806598|Prednisolone|prednisolone|mesh-list
153475541|NCT00807768|Tubulin Modulators|tubulin modulators|mesh-ancestor
153475542|NCT00807768|Antimitotic Agents|antimitotic agents|mesh-ancestor
153475543|NCT00807768|Mitosis Modulators|mitosis modulators|mesh-ancestor
153475544|NCT00807768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153475545|NCT00808470|Beta Carotene|beta carotene|mesh-list
153475546|NCT00808470|Carotenoids|carotenoids|mesh-list
153475547|NCT00808470|Vitamins|vitamins|mesh-ancestor
153475548|NCT00808470|Micronutrients|micronutrients|mesh-ancestor
153475549|NCT00808470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153475550|NCT00808470|Antioxidants|antioxidants|mesh-ancestor
153475551|NCT00808470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153475552|NCT00808470|Protective Agents|protective agents|mesh-ancestor
153475553|NCT00808470|Provitamins|provitamins|mesh-ancestor
153475554|NCT00810576|Bortezomib|bortezomib|mesh-list
153475555|NCT00810576|Vorinostat|vorinostat|mesh-list
153475556|NCT00810576|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153475557|NCT00810576|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
153475558|NCT00810576|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153475559|NCT00810576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153475560|NCT00811434|Lactulose|lactulose|mesh-list
153475561|NCT00811434|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153475562|NCT00812604|Analgesics|analgesics|mesh-list
153475563|NCT00812604|Petrolatum|petrolatum|mesh-list
153475564|NCT00812604|Sensory System Agents|sensory system agents|mesh-ancestor
153475565|NCT00812604|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153475566|NCT00812604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153475567|NCT00812604|Emollients|emollients|mesh-ancestor
153475568|NCT00812604|Dermatologic Agents|dermatologic agents|mesh-ancestor
153475569|NCT00812838|Botulinum Toxins|botulinum toxins|mesh-list
153475570|NCT00812838|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
153475571|NCT00812838|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
153475572|NCT00812838|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
153475587|NCT00814788|Immunologic Factors|immunologic factors|mesh-ancestor
153475588|NCT00814788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153475589|NCT00814788|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153475590|NCT00814788|Androgen Antagonists|androgen antagonists|mesh-ancestor
153475591|NCT00814788|Hormone Antagonists|hormone antagonists|mesh-ancestor
153475592|NCT00814788|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153475593|NCT00820872|Carboplatin|carboplatin|mesh-list
153475594|NCT00820872|Docetaxel|docetaxel|mesh-list
153475595|NCT00820872|Trastuzumab|trastuzumab|mesh-list
153475596|NCT00820872|Lapatinib|lapatinib|mesh-list
153475597|NCT00820872|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153475598|NCT00820872|Tubulin Modulators|tubulin modulators|mesh-ancestor
153475599|NCT00820872|Antimitotic Agents|antimitotic agents|mesh-ancestor
153475600|NCT00820872|Mitosis Modulators|mitosis modulators|mesh-ancestor
153475601|NCT00820872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153475602|NCT00820872|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153475603|NCT00820872|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153475604|NCT00820872|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153475605|NCT00820872|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153475606|NCT00821184|Solifenacin Succinate|solifenacin succinate|mesh-list
153475607|NCT00821184|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
153475608|NCT00821184|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
153475609|NCT00821184|Cholinergic Agents|cholinergic agents|mesh-ancestor
153475610|NCT00821184|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153475638|NCT04603248|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153475645|NCT03763656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153475646|NCT03763656|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153475648|NCT02682888|Oxytocics|oxytocics|mesh-ancestor
153475649|NCT02682888|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153475650|NCT02682888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153475651|NCT02641236|Vancomycin|vancomycin|mesh-list
153475652|NCT02641236|Polymyxins|polymyxins|mesh-list
153475653|NCT02641236|Polymyxin B|polymyxin b|mesh-list
153475654|NCT02641236|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153475655|NCT02641236|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153475656|NCT00142272|Ciprofloxacin|ciprofloxacin|mesh-list
153475657|NCT00142272|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153475658|NCT00142272|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153475659|NCT00142272|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153475660|NCT00142272|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153475661|NCT00142272|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153416780|NCT04793659|Vasodilator Agents|vasodilator agents|mesh-ancestor
153475662|NCT00142272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153475663|NCT00142272|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153475664|NCT00142272|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
153475665|NCT00142272|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153475684|NCT00821964|Interferon Inducers|interferon inducers|mesh-ancestor
153475685|NCT00822354|Tadalafil|tadalafil|mesh-list
153475686|NCT00822354|Vasodilator Agents|vasodilator agents|mesh-ancestor
153475687|NCT00822354|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
153475688|NCT00822354|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
153475689|NCT00822354|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153475690|NCT00822354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153475691|NCT00822354|Urological Agents|urological agents|mesh-ancestor
153475692|NCT00824070|Moxifloxacin|moxifloxacin|mesh-list
153475693|NCT00824070|Gatifloxacin|gatifloxacin|mesh-list
153475694|NCT00824070|Besifloxacin|besifloxacin|mesh-list
153475695|NCT00824070|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
153475696|NCT00824070|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153475697|NCT00824070|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153475698|NCT00824070|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153475699|NCT00824070|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153475700|NCT00824070|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153475701|NCT00824070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153475702|NCT00824070|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153475703|NCT00824070|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
153475704|NCT00824070|Contraceptive Agents|contraceptive agents|mesh-ancestor
153475705|NCT00824070|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153475706|NCT00824070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153475707|NCT00824070|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
153475708|NCT00824070|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
153475709|NCT00824070|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
153876045|NCT04535960|Hormones|hormones|mesh-ancestor
153475710|NCT00824070|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
153475711|NCT00824070|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
153475713|NCT00824460|Sevelamer|sevelamer|mesh-list
153475714|NCT00824460|Trace Elements|trace elements|mesh-ancestor
153475715|NCT00824460|Micronutrients|micronutrients|mesh-ancestor
153475716|NCT00824460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153475720|NCT00824538|Sunitinib|sunitinib|mesh-list
153475726|NCT00824538|Growth Inhibitors|growth inhibitors|mesh-ancestor
153475727|NCT00824538|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153475728|NCT00824538|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153386197|NCT01280643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153386198|NCT01280643|Growth Inhibitors|growth inhibitors|mesh-ancestor
153386199|NCT01280643|Immunologic Factors|immunologic factors|mesh-ancestor
153386200|NCT01280643|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153386201|NCT01280643|Antimetabolites|antimetabolites|mesh-ancestor
153386202|NCT01280643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153386203|NCT01280643|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153386204|NCT01280643|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
153475729|NCT00824538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153475730|NCT00825786|Ropivacaine|ropivacaine|mesh-list
153475731|NCT00825786|Mepivacaine|mepivacaine|mesh-list
153475732|NCT00825786|Anesthetics, Local|anesthetics, local|mesh-ancestor
153475733|NCT00825786|Anesthetics|anesthetics|mesh-ancestor
153475739|NCT00826800|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153475740|NCT00826800|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153475741|NCT00826800|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153475742|NCT00826800|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153475744|NCT00826800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153475745|NCT00826800|Growth Inhibitors|growth inhibitors|mesh-ancestor
153475747|NCT00830076|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
153475748|NCT00830076|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153475749|NCT00830076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153475750|NCT00830076|Incretins|incretins|mesh-ancestor
153475751|NCT00830076|Hormones|hormones|mesh-ancestor
153475752|NCT00830076|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153475753|NCT00830076|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
153475754|NCT00830076|Protease Inhibitors|protease inhibitors|mesh-ancestor
153475755|NCT00830076|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153475756|NCT00830076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153475757|NCT00830388|Ketoconazole|ketoconazole|mesh-list
153475758|NCT00830388|Antifungal Agents|antifungal agents|mesh-ancestor
153475759|NCT00830388|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153475767|NCT00830388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153475768|NCT00830388|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
153475769|NCT00831480|Everolimus|everolimus|mesh-list
153475770|NCT00831480|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
153475771|NCT00831480|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153475772|NCT00831480|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153475773|NCT00831480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153475774|NCT00831480|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153475775|NCT00831480|Immunologic Factors|immunologic factors|mesh-ancestor
153475776|NCT00831480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153475777|NCT00831480|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153475778|NCT00832338|Dexamethasone|dexamethasone|mesh-list
153475780|NCT00832338|Cyclophosphamide|cyclophosphamide|mesh-list
153475781|NCT00832338|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153475782|NCT00832338|Antiemetics|antiemetics|mesh-ancestor
153475783|NCT00832338|Autonomic Agents|autonomic agents|mesh-ancestor
153475784|NCT00832338|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153475785|NCT00832338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153475786|NCT00832338|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153475787|NCT00832338|Glucocorticoids|glucocorticoids|mesh-ancestor
153475788|NCT00832338|Hormones|hormones|mesh-ancestor
153475789|NCT00832338|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153475790|NCT00832338|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153475791|NCT00832338|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153475792|NCT00832338|Tubulin Modulators|tubulin modulators|mesh-ancestor
153475793|NCT00832338|Antimitotic Agents|antimitotic agents|mesh-ancestor
153475794|NCT00832338|Mitosis Modulators|mitosis modulators|mesh-ancestor
153475802|NCT00834210|Nicotinic Acids|nicotinic acids|mesh-list
153475813|NCT00834210|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153475814|NCT00834210|Dermatologic Agents|dermatologic agents|mesh-ancestor
153475815|NCT00834210|Keratolytic Agents|keratolytic agents|mesh-ancestor
153386205|NCT01280643|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153386206|NCT01280643|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153386207|NCT01280643|Antidotes|antidotes|mesh-ancestor
153386208|NCT01280643|Protective Agents|protective agents|mesh-ancestor
153386209|NCT01280643|Vitamin B Complex|vitamin b complex|mesh-ancestor
153386210|NCT01280643|Vitamins|vitamins|mesh-ancestor
153386211|NCT01280643|Micronutrients|micronutrients|mesh-ancestor
153386248|NCT01893632|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153386249|NCT01893632|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153386276|NCT03781479|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
153386277|NCT03781479|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153386278|NCT03781479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153386279|NCT01223001|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
153475816|NCT00834210|Vitamin B Complex|vitamin b complex|mesh-ancestor
153475817|NCT00834210|Vitamins|vitamins|mesh-ancestor
153475818|NCT00834210|Micronutrients|micronutrients|mesh-ancestor
153475819|NCT00834210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153475820|NCT00834288|Tramadol|tramadol|mesh-list
153475821|NCT00834288|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153475822|NCT00834288|Narcotics|narcotics|mesh-ancestor
153475823|NCT00834288|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153475824|NCT00834288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153475825|NCT00834288|Analgesics|analgesics|mesh-ancestor
153475826|NCT00834288|Sensory System Agents|sensory system agents|mesh-ancestor
153475827|NCT00834288|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153475828|NCT00834678|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
153415263|NCT00367471|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153415264|NCT00367471|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153415265|NCT00367471|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153415267|NCT02207244|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
153415268|NCT02207244|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
153415269|NCT02207244|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153415270|NCT02207244|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153415271|NCT02207244|Immunologic Factors|immunologic factors|mesh-ancestor
153415272|NCT02207244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153415273|NCT02207088|Ritonavir|ritonavir|mesh-list
153415274|NCT02207088|Ribavirin|ribavirin|mesh-list
153415275|NCT02207088|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
153415276|NCT02207088|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
153415277|NCT02207088|Protease Inhibitors|protease inhibitors|mesh-ancestor
153415278|NCT02207088|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153415279|NCT02207088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153415281|NCT02207088|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153415282|NCT02207088|Antiviral Agents|antiviral agents|mesh-ancestor
153415283|NCT02207088|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153461748|NCT04195776|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153874558|NCT04550078|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153874560|NCT01205035|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153874561|NCT01205035|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153874562|NCT01205035|Growth Substances|growth substances|mesh-ancestor
153874563|NCT01205035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153874564|NCT01205035|Growth Inhibitors|growth inhibitors|mesh-ancestor
153874565|NCT01205035|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153874566|NCT04549844|Bupivacaine|bupivacaine|mesh-list
153874567|NCT04549844|Anesthetics, Local|anesthetics, local|mesh-ancestor
153874568|NCT04549844|Anesthetics|anesthetics|mesh-ancestor
153415288|NCT02638597|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153415289|NCT02638597|Antimetabolites|antimetabolites|mesh-ancestor
153415290|NCT02638597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153415291|NCT02638597|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153415292|NCT02638597|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
153415293|NCT02638597|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153415294|NCT02638597|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153386280|NCT01223001|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
153386281|NCT01223001|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153386282|NCT01223001|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153386283|NCT01223001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153386284|NCT01223001|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153386285|NCT01223001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153386286|NCT01223001|Analgesics|analgesics|mesh-ancestor
153415296|NCT02206620|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
153415297|NCT02206620|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153415298|NCT02206620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153415299|NCT02206620|Cholinergic Agents|cholinergic agents|mesh-ancestor
153415300|NCT02206620|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153415302|NCT02206620|Nootropic Agents|nootropic agents|mesh-ancestor
153415304|NCT02239926|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153415305|NCT02239926|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153415306|NCT02239926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153415307|NCT02239692|Picosulfate sodium|picosulfate sodium|mesh-list
153415308|NCT02239692|Cathartics|cathartics|mesh-ancestor
153415309|NCT02239692|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153415310|NCT02641561|Indomethacin|indomethacin|mesh-list
153415311|NCT02641561|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153415313|NCT02641561|Analgesics|analgesics|mesh-ancestor
153874573|NCT01644084|Hydroxyethyl Starch Derivatives|hydroxyethyl starch derivatives|mesh-list
153874574|NCT01644084|Plasma Substitutes|plasma substitutes|mesh-ancestor
153874575|NCT01644084|Blood Substitutes|blood substitutes|mesh-ancestor
153874576|NCT01204918|Riluzole|riluzole|mesh-list
153874577|NCT01204918|Anticonvulsants|anticonvulsants|mesh-ancestor
153874578|NCT01204918|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
153874579|NCT01204918|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
153874580|NCT01204918|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153874581|NCT01204918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153874582|NCT01204918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153874583|NCT01204918|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
153874584|NCT01204918|Protective Agents|protective agents|mesh-ancestor
153874585|NCT04528797|Methylprednisolone|methylprednisolone|mesh-list
153874586|NCT04528797|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
153874587|NCT04528797|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
153874588|NCT04528797|Prednisolone|prednisolone|mesh-list
153874589|NCT04528797|Prednisolone acetate|prednisolone acetate|mesh-list
153874590|NCT04528797|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
153874591|NCT04528797|Prednisolone phosphate|prednisolone phosphate|mesh-list
153874592|NCT04528797|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153874593|NCT04528797|Antiemetics|antiemetics|mesh-ancestor
153874594|NCT04528797|Autonomic Agents|autonomic agents|mesh-ancestor
153874595|NCT04528797|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153416980|NCT03924518|Granisetron|granisetron|mesh-list
153416981|NCT03924518|Serotonin|serotonin|mesh-list
153874596|NCT04528797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153874597|NCT04528797|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153874598|NCT04528797|Glucocorticoids|glucocorticoids|mesh-ancestor
153874599|NCT04528797|Hormones|hormones|mesh-ancestor
153874600|NCT04528797|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153874601|NCT04528797|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
153874613|NCT04529187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153876230|NCT02216565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153415329|NCT02206152|Expectorants|expectorants|mesh-ancestor
153415330|NCT02206152|Respiratory System Agents|respiratory system agents|mesh-ancestor
153415331|NCT02206152|Free Radical Scavengers|free radical scavengers|mesh-ancestor
153415332|NCT02206152|Antioxidants|antioxidants|mesh-ancestor
153415333|NCT02206152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153415334|NCT02206152|Protective Agents|protective agents|mesh-ancestor
153415335|NCT02206152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153415336|NCT02206152|Antidotes|antidotes|mesh-ancestor
153415337|NCT00367081|Pyrimethamine|pyrimethamine|mesh-list
153415338|NCT00367081|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
153386287|NCT01223001|Sensory System Agents|sensory system agents|mesh-ancestor
153386288|NCT01223001|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153386289|NCT01223001|Antidepressive Agents|antidepressive agents|mesh-ancestor
153386290|NCT01223001|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153783584|NCT00236522|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153386292|NCT02608905|Dapagliflozin|dapagliflozin|mesh-list
153386293|NCT02608905|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
153386294|NCT02608905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153386320|NCT02492295|Anesthetics, General|anesthetics, general|mesh-ancestor
153386321|NCT02492295|Anesthetics|anesthetics|mesh-ancestor
153386322|NCT03763929|Trans-sodium crocetinate|trans-sodium crocetinate|mesh-list
153415339|NCT00367081|Sulfadiazine|sulfadiazine|mesh-list
153415340|NCT00367081|Antimalarials|antimalarials|mesh-ancestor
153415341|NCT00367081|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153415342|NCT00367081|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153415343|NCT00367081|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153415344|NCT00367081|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153415345|NCT00367081|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153415346|NCT00367081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153415347|NCT00367081|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
153415348|NCT00367081|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153415349|NCT00367081|Coccidiostats|coccidiostats|mesh-ancestor
153415351|NCT04146571|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153415352|NCT04146571|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153415353|NCT04146571|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153415354|NCT04146571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153415355|NCT05342376|Dexmedetomidine|dexmedetomidine|mesh-list
153874630|NCT04529187|Anesthetics|anesthetics|mesh-ancestor
153874631|NCT04529187|GABA Modulators|gaba modulators|mesh-ancestor
153874632|NCT04529187|GABA Agents|gaba agents|mesh-ancestor
153874633|NCT04549415|Metformin|metformin|mesh-list
153874634|NCT04549415|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153874635|NCT04549415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153874636|NCT02214368|Propofol|propofol|mesh-list
153874637|NCT02214368|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153874638|NCT02214368|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153415362|NCT05342376|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153415363|NCT05342376|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
153415364|NCT05342376|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153415365|NCT05342376|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153415366|NCT05342376|Adrenergic Agents|adrenergic agents|mesh-ancestor
153415367|NCT05342376|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153415368|NCT05342376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153415369|NCT02237196|Immunomodulating Agents|immunomodulating agents|mesh-list
153415370|NCT02237196|Immunologic Factors|immunologic factors|mesh-list
153415371|NCT02237196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153415372|NCT04776096|Olopatadine Hydrochloride|olopatadine hydrochloride|mesh-list
153415373|NCT04776096|Bepotastine besilate|bepotastine besilate|mesh-list
153876286|NCT01196416|Tubulin Modulators|tubulin modulators|mesh-ancestor
153874653|NCT01204294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153874654|NCT01182181|Anastrozole|anastrozole|mesh-list
153874662|NCT01182181|Hormone Antagonists|hormone antagonists|mesh-ancestor
153415374|NCT04776096|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153415375|NCT04776096|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153415376|NCT04776096|Analgesics|analgesics|mesh-ancestor
153386323|NCT03763929|Antioxidants|antioxidants|mesh-ancestor
153386324|NCT03763929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153386325|NCT03763929|Protective Agents|protective agents|mesh-ancestor
153386326|NCT03763929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153386327|NCT03763929|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
153386328|NCT03763929|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153386329|NCT01118013|Mycophenolic Acid|mycophenolic acid|mesh-list
153386330|NCT01118013|Methotrexate|methotrexate|mesh-list
153415377|NCT04776096|Sensory System Agents|sensory system agents|mesh-ancestor
153415378|NCT04776096|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153415379|NCT04776096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153415393|NCT02203032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153415395|NCT02169414|Carbidopa|carbidopa|mesh-list
153415396|NCT02169414|Opicapone|opicapone|mesh-list
153415397|NCT02169414|Benserazide|benserazide|mesh-list
153415398|NCT02169414|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
153415399|NCT02169414|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
153417097|NCT00370760|Heparin|heparin|mesh-list
153874669|NCT01181986|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
153874670|NCT01181986|Incretins|incretins|mesh-ancestor
153874671|NCT01181986|Hormones|hormones|mesh-ancestor
153874672|NCT01181986|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153874673|NCT04315909|Vitamin E|vitamin e|mesh-list
153874674|NCT04315909|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
153874675|NCT04315909|Vitamins|vitamins|mesh-ancestor
153874676|NCT04315909|Micronutrients|micronutrients|mesh-ancestor
153874677|NCT04315909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153874678|NCT04315909|Antioxidants|antioxidants|mesh-ancestor
153874679|NCT04315909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153874680|NCT04315909|Protective Agents|protective agents|mesh-ancestor
153874681|NCT04315909|Hemostatics|hemostatics|mesh-ancestor
153874682|NCT04315909|Coagulants|coagulants|mesh-ancestor
153874683|NCT01181167|Enoxaparin|enoxaparin|mesh-list
153874684|NCT01181167|Enoxaparin sodium|enoxaparin sodium|mesh-list
153874685|NCT01181167|Edoxaban|edoxaban|mesh-list
153874686|NCT01181167|Anticoagulants|anticoagulants|mesh-ancestor
153874687|NCT01181167|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153874688|NCT01181167|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153415400|NCT02169414|Dopamine Agents|dopamine agents|mesh-ancestor
153415408|NCT02201940|Sofosbuvir-velpatasvir drug combination|sofosbuvir-velpatasvir drug combination|mesh-list
153415410|NCT02201940|Antiviral Agents|antiviral agents|mesh-ancestor
153415411|NCT02201940|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153415412|NCT05588869|Cyclosporine|cyclosporine|mesh-list
153415413|NCT05588869|Cyclosporins|cyclosporins|mesh-list
153415414|NCT05588869|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153415415|NCT05588869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153415416|NCT05588869|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153415417|NCT05588869|Immunologic Factors|immunologic factors|mesh-ancestor
153415418|NCT05588869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153415419|NCT05588869|Antifungal Agents|antifungal agents|mesh-ancestor
153415420|NCT05588869|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153415421|NCT05588869|Dermatologic Agents|dermatologic agents|mesh-ancestor
153876381|NCT02219789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153874703|NCT01181128|Coagulants|coagulants|mesh-ancestor
153874704|NCT04548401|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-list
153874705|NCT04548284|Glucocorticoids|glucocorticoids|mesh-list
153874706|NCT04548284|Hormones|hormones|mesh-ancestor
153874707|NCT04548284|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153874708|NCT04548284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153874709|NCT04547894|TMC-310911|tmc-310911|mesh-list
153874710|NCT04547894|Protease Inhibitors|protease inhibitors|mesh-ancestor
153874711|NCT04547894|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153415422|NCT05588869|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153415423|NCT05588869|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
153415425|NCT02169336|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153415426|NCT02169336|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153415427|NCT02169336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153415436|NCT02169336|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153415437|NCT02169336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153415438|NCT03043807|Docetaxel|docetaxel|mesh-list
153415439|NCT03043807|Leuprolide|leuprolide|mesh-list
153415440|NCT03043807|Abiraterone Acetate|abiraterone acetate|mesh-list
153415441|NCT03043807|Bicalutamide|bicalutamide|mesh-list
153415442|NCT03043807|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153415443|NCT03043807|Tubulin Modulators|tubulin modulators|mesh-ancestor
153417191|NCT00370669|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153874716|NCT01644825|Paclitaxel|paclitaxel|mesh-list
153874717|NCT01644825|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153874718|NCT01644825|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153874719|NCT01644825|Tubulin Modulators|tubulin modulators|mesh-ancestor
153874720|NCT01644825|Antimitotic Agents|antimitotic agents|mesh-ancestor
153874721|NCT01644825|Mitosis Modulators|mitosis modulators|mesh-ancestor
153874722|NCT01644825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153874723|NCT01644864|Ropivacaine|ropivacaine|mesh-list
153874724|NCT01644864|Anesthetics, Local|anesthetics, local|mesh-ancestor
153874725|NCT01644864|Anesthetics|anesthetics|mesh-ancestor
153874726|NCT01644864|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153874727|NCT01644864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153874728|NCT01644864|Sensory System Agents|sensory system agents|mesh-ancestor
153874729|NCT01644864|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153874730|NCT04547855|Temozolomide|temozolomide|mesh-list
153874731|NCT04547855|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153874732|NCT04547855|Alkylating Agents|alkylating agents|mesh-ancestor
153874733|NCT04547855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153874734|NCT04547855|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153874735|NCT01641510|Clopidogrel|clopidogrel|mesh-list
153415447|NCT03043807|Fertility Agents, Female|fertility agents, female|mesh-ancestor
153415448|NCT03043807|Fertility Agents|fertility agents|mesh-ancestor
153415449|NCT03043807|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153415450|NCT03043807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153415451|NCT03043807|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153415452|NCT03043807|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153876485|NCT01195090|Pioglitazone|pioglitazone|mesh-list
153415477|NCT01632306|Tubulin Modulators|tubulin modulators|mesh-ancestor
153415478|NCT01632306|Antimitotic Agents|antimitotic agents|mesh-ancestor
153415479|NCT01632306|Mitosis Modulators|mitosis modulators|mesh-ancestor
153415480|NCT01632306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153415481|NCT01632306|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153415482|NCT01632306|Antimetabolites|antimetabolites|mesh-ancestor
153415483|NCT01632306|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153415484|NCT01632306|Immunologic Factors|immunologic factors|mesh-ancestor
153415485|NCT01632306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153415486|NCT01632306|Antidotes|antidotes|mesh-ancestor
153415487|NCT01632306|Protective Agents|protective agents|mesh-ancestor
153415488|NCT01632306|Vitamin B Complex|vitamin b complex|mesh-ancestor
153415489|NCT01632306|Vitamins|vitamins|mesh-ancestor
153874750|NCT01641549|Fibrinolytic Agents|fibrinolytic agents|mesh-list
153874751|NCT01641549|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153874752|NCT01641549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153874753|NCT04547348|Denosumab|denosumab|mesh-list
153874754|NCT04547348|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153874755|NCT04547348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153874756|NCT04547426|Nicotine|nicotine|mesh-list
153874757|NCT04547426|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
153874758|NCT04547426|Autonomic Agents|autonomic agents|mesh-ancestor
153874759|NCT04547426|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153874769|NCT01641666|Antimetabolites|antimetabolites|mesh-ancestor
153874770|NCT01641666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153874771|NCT01641666|Antiviral Agents|antiviral agents|mesh-ancestor
153874772|NCT01641666|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153874774|NCT01641666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153415490|NCT01632306|Micronutrients|micronutrients|mesh-ancestor
153415492|NCT02201784|Levobupivacaine|levobupivacaine|mesh-list
153415493|NCT02201784|Anesthetics, Local|anesthetics, local|mesh-ancestor
153415494|NCT02201784|Anesthetics|anesthetics|mesh-ancestor
153874778|NCT01203787|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153874779|NCT01203787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153874781|NCT04547504|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153874782|NCT04547504|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153874783|NCT04547504|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153874784|NCT04547504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153874785|NCT01645254|Antimalarials|antimalarials|mesh-list
153874786|NCT01645254|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153415502|NCT05587933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153415504|NCT02018263|Nicotine|nicotine|mesh-list
153386331|NCT01118013|Fludarabine phosphate|fludarabine phosphate|mesh-list
153386332|NCT01118013|Fludarabine|fludarabine|mesh-list
153386333|NCT01118013|Busulfan|busulfan|mesh-list
153386334|NCT01118013|Tacrolimus|tacrolimus|mesh-list
153386335|NCT01118013|Antilymphocyte Serum|antilymphocyte serum|mesh-list
153386336|NCT01118013|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
153386337|NCT01118013|Abortifacient Agents|abortifacient agents|mesh-ancestor
153386338|NCT01118013|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153386339|NCT01118013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153386340|NCT01118013|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153386341|NCT01118013|Antimetabolites|antimetabolites|mesh-ancestor
153415505|NCT02018263|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
153415506|NCT02018263|Autonomic Agents|autonomic agents|mesh-ancestor
153415507|NCT02018263|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153415508|NCT02018263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153415509|NCT02018263|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
153415510|NCT02018263|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
153415511|NCT02018263|Cholinergic Agents|cholinergic agents|mesh-ancestor
153415512|NCT02018263|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153415513|NCT02018263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153415514|NCT02018263|Anesthetics, Local|anesthetics, local|mesh-ancestor
153415515|NCT02018263|Anesthetics|anesthetics|mesh-ancestor
153415516|NCT02018263|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153415517|NCT02018263|Sensory System Agents|sensory system agents|mesh-ancestor
153415518|NCT02018263|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
153415519|NCT02018263|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
153415520|NCT02018263|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153417372|NCT02756624|Histamine Antagonists|histamine antagonists|mesh-ancestor
153874790|NCT01181011|Telmisartan|telmisartan|mesh-list
153874791|NCT01181011|Telmisartan amlodipine combination|telmisartan amlodipine combination|mesh-list
153874792|NCT01181011|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153874793|NCT01181011|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153874794|NCT01181011|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153874795|NCT01181011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153874796|NCT01181011|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153874797|NCT01181011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153874798|NCT01181011|Vasodilator Agents|vasodilator agents|mesh-ancestor
153874799|NCT01181011|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
153874800|NCT01181011|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
153874801|NCT01641783|Paclitaxel|paclitaxel|mesh-list
153874802|NCT01641783|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
153874803|NCT01641783|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153874804|NCT01641783|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153874805|NCT01641783|Tubulin Modulators|tubulin modulators|mesh-ancestor
153874806|NCT01641783|Antimitotic Agents|antimitotic agents|mesh-ancestor
153874807|NCT01641783|Mitosis Modulators|mitosis modulators|mesh-ancestor
153874812|NCT02214602|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153415530|NCT02168946|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153415531|NCT02168946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153415532|NCT02650856|Tranexamic Acid|tranexamic acid|mesh-list
153415533|NCT02650856|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
153415534|NCT02650856|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153415535|NCT02650856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153415536|NCT02650856|Hemostatics|hemostatics|mesh-ancestor
153415537|NCT02650856|Coagulants|coagulants|mesh-ancestor
153415538|NCT02168478|Neomycin|neomycin|mesh-list
153876677|NCT01640990|GW 328267|gw 328267|mesh-list
153415555|NCT00367874|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153415556|NCT00367874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153876717|NCT01641224|Parasympatholytics|parasympatholytics|mesh-ancestor
153874819|NCT01646580|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153874820|NCT04546802|Grazoprevir|grazoprevir|mesh-list
153386342|NCT01118013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153386358|NCT01118013|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153386359|NCT01118013|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153386361|NCT00378027|Fondaparinux|fondaparinux|mesh-list
153386362|NCT00378027|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
153386363|NCT00378027|Antithrombins|antithrombins|mesh-ancestor
153386364|NCT00378027|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
153386365|NCT00378027|Protease Inhibitors|protease inhibitors|mesh-ancestor
153386366|NCT00378027|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153874821|NCT04546802|Elbasvir-grazoprevir drug combination|elbasvir-grazoprevir drug combination|mesh-list
153874822|NCT04546802|Antiviral Agents|antiviral agents|mesh-ancestor
153874824|NCT01580033|Vaccines|vaccines|mesh-list
153874825|NCT01580033|Immunologic Factors|immunologic factors|mesh-ancestor
153874826|NCT01580033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153874827|NCT04546373|Niraparib|niraparib|mesh-list
153874828|NCT04546373|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
153874829|NCT04546373|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153874830|NCT04546373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153874831|NCT04546373|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153874832|NCT01645410|Atorvastatin|atorvastatin|mesh-list
153874833|NCT01645410|Calcium|calcium|mesh-list
153874834|NCT01645410|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153874835|NCT01645410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153874836|NCT01645410|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153874837|NCT01645410|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153874838|NCT01645410|Antimetabolites|antimetabolites|mesh-ancestor
153415557|NCT00367874|GABA Agents|gaba agents|mesh-ancestor
153415558|NCT00367874|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153415559|NCT00367874|Antimanic Agents|antimanic agents|mesh-ancestor
153415561|NCT00367874|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153415563|NCT00367562|Enalapril|enalapril|mesh-list
153415564|NCT00367562|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153415565|NCT00367562|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
153415566|NCT00367562|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
153415567|NCT00367562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153415570|NCT00367562|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153415571|NCT02302976|Exenatide|exenatide|mesh-list
153415572|NCT02302976|Cocaine|cocaine|mesh-list
153415573|NCT02302976|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
153415574|NCT02302976|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153415575|NCT02302976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153415576|NCT02302976|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
153415577|NCT02302976|Incretins|incretins|mesh-ancestor
153415579|NCT02302976|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153415580|NCT02302976|Anesthetics, Local|anesthetics, local|mesh-ancestor
153415581|NCT02302976|Anesthetics|anesthetics|mesh-ancestor
153874849|NCT04546334|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153874850|NCT04546334|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153874851|NCT04546334|Anticonvulsants|anticonvulsants|mesh-ancestor
153874852|NCT04546334|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153874853|NCT04546334|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153874854|NCT04546334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153874855|NCT04546334|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153874856|NCT04546334|Tocolytic Agents|tocolytic agents|mesh-ancestor
153874857|NCT04546334|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153874858|NCT04546256|Fluticasone|fluticasone|mesh-list
153874859|NCT04546256|Xhance|xhance|mesh-list
153874860|NCT04546256|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
153874861|NCT04546256|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
153874862|NCT04546256|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153415590|NCT02302976|Dopamine Agents|dopamine agents|mesh-ancestor
153415591|NCT02302976|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153415593|NCT02244164|Exenatide|exenatide|mesh-list
153415594|NCT02244164|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
153415595|NCT02244164|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
153415596|NCT02244164|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153415597|NCT02244164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153415599|NCT02244164|Hormones|hormones|mesh-ancestor
153415600|NCT02244164|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153415601|NCT02244164|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
153874867|NCT04546256|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153874868|NCT04546256|Respiratory System Agents|respiratory system agents|mesh-ancestor
153874869|NCT04546256|Dermatologic Agents|dermatologic agents|mesh-ancestor
153874870|NCT04546256|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
153874871|NCT04546256|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
153874872|NCT04546256|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
153874874|NCT04546256|Adrenergic Agents|adrenergic agents|mesh-ancestor
153874875|NCT04546256|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153874876|NCT04546256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153874878|NCT04546256|Hormones|hormones|mesh-ancestor
153874879|NCT04546256|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153874880|NCT04546256|Sympathomimetics|sympathomimetics|mesh-ancestor
153874881|NCT01645449|Atorvastatin|atorvastatin|mesh-list
153874882|NCT01645449|Calcium|calcium|mesh-list
153874883|NCT01645449|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153874884|NCT01645449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153874885|NCT01645449|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153415606|NCT02152670|Methylphenidate|methylphenidate|mesh-list
153415607|NCT02152670|alpha-Methyltyrosine|alpha-methyltyrosine|mesh-list
153415608|NCT02152670|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
153415609|NCT02152670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153415610|NCT02152670|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
153415611|NCT02152670|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153415612|NCT02152670|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153415613|NCT02152670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153415614|NCT02152670|Dopamine Agents|dopamine agents|mesh-ancestor
153415615|NCT02152670|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153415616|NCT02152670|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153415617|NCT02152670|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153415618|NCT02152670|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153874887|NCT01645449|Antimetabolites|antimetabolites|mesh-ancestor
153874888|NCT01645449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153874889|NCT01645449|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153874890|NCT01645449|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
153874891|NCT01645449|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153874892|NCT04546022|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
153874893|NCT01645800|Muramidase|muramidase|mesh-list
153874894|NCT01645800|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153874895|NCT02214680|Timolol|timolol|mesh-list
153874896|NCT02214680|Brimonidine Tartrate|brimonidine tartrate|mesh-list
153874897|NCT02214680|Brimonidine Tartrate, Timolol Maleate Drug Combination|brimonidine tartrate, timolol maleate drug combination|mesh-list
153874898|NCT02214680|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
153874899|NCT02214680|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
153874900|NCT02214680|Adrenergic Agents|adrenergic agents|mesh-ancestor
153874908|NCT02214680|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153874909|NCT02756208|Vaccines|vaccines|mesh-list
153874910|NCT02756208|Immunologic Factors|immunologic factors|mesh-ancestor
153874911|NCT02756208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153874912|NCT04545788|Linezolid|linezolid|mesh-list
153415649|NCT04740086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153415650|NCT04739618|Pembrolizumab|pembrolizumab|mesh-list
153417686|NCT02748889|Etoposide|etoposide|mesh-list
153417687|NCT02748889|Atezolizumab|atezolizumab|mesh-list
153874920|NCT04545788|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
153874921|NCT04545788|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
153874922|NCT04545788|Antitubercular Agents|antitubercular agents|mesh-ancestor
153874923|NCT04545788|Antimetabolites|antimetabolites|mesh-ancestor
153874924|NCT02756013|Paclitaxel|paclitaxel|mesh-list
153874925|NCT02756013|Carboplatin|carboplatin|mesh-list
153874926|NCT02756013|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153874927|NCT02756013|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153874928|NCT02756013|Tubulin Modulators|tubulin modulators|mesh-ancestor
153874929|NCT02756013|Antimitotic Agents|antimitotic agents|mesh-ancestor
153415651|NCT04739618|Ipilimumab|ipilimumab|mesh-list
153415652|NCT04739618|Sargramostim|sargramostim|mesh-list
153415653|NCT04739618|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153415654|NCT04739618|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153415655|NCT04739618|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153415656|NCT04739618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153415657|NCT04739618|Immunologic Factors|immunologic factors|mesh-ancestor
153415658|NCT04739618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153415661|NCT02684942|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153415662|NCT02684942|Narcotics|narcotics|mesh-ancestor
153415663|NCT02684942|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153415664|NCT02684942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153415665|NCT02684942|Analgesics|analgesics|mesh-ancestor
153415666|NCT02684942|Sensory System Agents|sensory system agents|mesh-ancestor
153415667|NCT02684942|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153415668|NCT02684942|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153417740|NCT02161458|Cholinergic Agents|cholinergic agents|mesh-ancestor
153874934|NCT01680042|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
153874935|NCT01680042|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153874936|NCT01680042|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153874937|NCT01680042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153874938|NCT01680042|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
153874939|NCT01680042|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
153874941|NCT01646229|Polymyxin B|polymyxin b|mesh-list
153874942|NCT01646229|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153874943|NCT01646229|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153874944|NCT01680081|Adenosine|adenosine|mesh-list
153874945|NCT01680081|Analgesics|analgesics|mesh-ancestor
153874946|NCT01680081|Sensory System Agents|sensory system agents|mesh-ancestor
153874947|NCT01680081|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153874948|NCT01680081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153874949|NCT01680081|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153415670|NCT02684942|Anesthetics, General|anesthetics, general|mesh-ancestor
153415671|NCT02684942|Anesthetics|anesthetics|mesh-ancestor
153415672|NCT04739774|Itraconazole|itraconazole|mesh-list
153415673|NCT04739774|Antifungal Agents|antifungal agents|mesh-ancestor
153415674|NCT04739774|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153415675|NCT04739774|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
153415676|NCT04739774|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153415677|NCT04739774|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153417807|NCT00371995|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
153874955|NCT01680081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153874956|NCT01646307|Atorvastatin|atorvastatin|mesh-list
153874957|NCT01646307|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
153874958|NCT01646307|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153874959|NCT01646307|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153874960|NCT01646307|Antimetabolites|antimetabolites|mesh-ancestor
153874961|NCT01646307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153874962|NCT01646307|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153874963|NCT01646307|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
153874964|NCT01646307|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153874966|NCT04544969|Gemcitabine|gemcitabine|mesh-list
153874968|NCT04544969|Fluorouracil|fluorouracil|mesh-list
153874969|NCT04544969|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153874970|NCT04544969|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153874971|NCT04544969|Antimetabolites|antimetabolites|mesh-ancestor
153874972|NCT04544969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153415693|NCT00367315|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153415694|NCT00367315|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153415695|NCT00367315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153415696|NCT00367315|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153415697|NCT00367315|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153415698|NCT00367315|Analgesics|analgesics|mesh-ancestor
153415699|NCT00367315|Sensory System Agents|sensory system agents|mesh-ancestor
153415700|NCT00367315|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153415701|NCT00367315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153415702|NCT00367315|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153415703|NCT00367315|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153415704|NCT05441761|Dexamethasone|dexamethasone|mesh-list
153415705|NCT05441761|Gemcitabine|gemcitabine|mesh-list
153415706|NCT05441761|Mitoxantrone|mitoxantrone|mesh-list
153415707|NCT05441761|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153415708|NCT05441761|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153415709|NCT05441761|Antiemetics|antiemetics|mesh-ancestor
153415710|NCT05441761|Autonomic Agents|autonomic agents|mesh-ancestor
153415711|NCT05441761|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153415712|NCT05441761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153415713|NCT05441761|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153415714|NCT05441761|Glucocorticoids|glucocorticoids|mesh-ancestor
153415715|NCT05441761|Hormones|hormones|mesh-ancestor
153415716|NCT05441761|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153415717|NCT05441761|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153415722|NCT05441761|Sensory System Agents|sensory system agents|mesh-ancestor
153415723|NCT05441761|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153415724|NCT05441761|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153415725|NCT05441761|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153874977|NCT04544969|Immunologic Factors|immunologic factors|mesh-ancestor
153874978|NCT04544969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153874979|NCT04541732|Anesthetics|anesthetics|mesh-list
153874980|NCT04541732|Propofol|propofol|mesh-list
153874981|NCT04541732|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153874982|NCT04541732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153874984|NCT04541732|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153874985|NCT04541732|Anesthetics, General|anesthetics, general|mesh-ancestor
153874986|NCT01680471|Midazolam|midazolam|mesh-list
153874987|NCT01680471|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153874988|NCT01680471|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153874989|NCT01680471|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153874990|NCT01680471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153874991|NCT01680471|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153874992|NCT01680471|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153874993|NCT01680471|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153874994|NCT01680471|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153874995|NCT01680471|Anesthetics, General|anesthetics, general|mesh-ancestor
153874996|NCT01680471|Anesthetics|anesthetics|mesh-ancestor
153874997|NCT01680471|GABA Modulators|gaba modulators|mesh-ancestor
153874998|NCT01680471|GABA Agents|gaba agents|mesh-ancestor
153874999|NCT01680471|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153875000|NCT01680471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153875001|NCT02279316|Vitamin D|vitamin d|mesh-list
153875002|NCT02279316|Cholecalciferol|cholecalciferol|mesh-list
153875003|NCT02279316|Vitamins|vitamins|mesh-ancestor
153875004|NCT02279316|Micronutrients|micronutrients|mesh-ancestor
153875005|NCT02279316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153875006|NCT02279316|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153875007|NCT02279316|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153875008|NCT04544306|Anti-Infective Agents|anti-infective agents|mesh-list
153415729|NCT05587621|Alirocumab|alirocumab|mesh-list
153415730|NCT05587621|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153415731|NCT05587621|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153415732|NCT05587621|Antimetabolites|antimetabolites|mesh-ancestor
153415733|NCT05587621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153415734|NCT05587621|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153415735|NCT05587621|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
153415736|NCT05587621|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
153415737|NCT05587621|Protease Inhibitors|protease inhibitors|mesh-ancestor
153415739|NCT05587621|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153415740|NCT05587621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153415741|NCT04739215|Dapagliflozin|dapagliflozin|mesh-list
153415742|NCT04739215|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
153415743|NCT04739215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153415744|NCT04739215|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153415745|NCT04739215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153415746|NCT02688829|Sirolimus|sirolimus|mesh-list
153415747|NCT02688829|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153415748|NCT02688829|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153415749|NCT02688829|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153415750|NCT02688829|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153415751|NCT02688829|Antifungal Agents|antifungal agents|mesh-ancestor
153415752|NCT02688829|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153386367|NCT00378027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153386368|NCT00378027|Anticoagulants|anticoagulants|mesh-ancestor
153386369|NCT00378027|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153386370|NCT00378027|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153386371|NCT00552032|Mometasone Furoate|mometasone furoate|mesh-list
153386372|NCT00552032|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153386373|NCT00552032|Dermatologic Agents|dermatologic agents|mesh-ancestor
153386374|NCT00552032|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
153386375|NCT02429583|Vaccines|vaccines|mesh-list
153386376|NCT02429583|Immunologic Factors|immunologic factors|mesh-ancestor
153386377|NCT02429583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153386378|NCT02413047|Methotrexate|methotrexate|mesh-list
153386379|NCT02413047|Mercaptopurine|mercaptopurine|mesh-list
153386380|NCT02413047|Azathioprine|azathioprine|mesh-list
153415753|NCT02688829|Immunologic Factors|immunologic factors|mesh-ancestor
153415754|NCT02688829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153415755|NCT02689063|Acetaminophen|acetaminophen|mesh-list
153415756|NCT02689063|Ibuprofen|ibuprofen|mesh-list
153415757|NCT02689063|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153415758|NCT02689063|Analgesics|analgesics|mesh-ancestor
153875023|NCT04544228|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
153875025|NCT04544228|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153875026|NCT04544228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153875027|NCT04544228|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
153875028|NCT04544228|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153875038|NCT01646736|Alkylating Agents|alkylating agents|mesh-ancestor
153415759|NCT02689063|Sensory System Agents|sensory system agents|mesh-ancestor
153415760|NCT02689063|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153415761|NCT02689063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153415763|NCT02689063|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153415764|NCT02689063|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153415765|NCT02689063|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153415766|NCT02689063|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153415767|NCT02689063|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153415768|NCT02689063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153415769|NCT02690935|Immunomodulating Agents|immunomodulating agents|mesh-list
153415770|NCT02690935|Immunologic Factors|immunologic factors|mesh-ancestor
153415771|NCT02690935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153415772|NCT00367861|Imatinib Mesylate|imatinib mesylate|mesh-list
153415784|NCT02666846|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153415786|NCT02666846|Sensory System Agents|sensory system agents|mesh-ancestor
153415787|NCT02666846|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153415788|NCT02666846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153417939|NCT05055752|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153875041|NCT01646736|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153875043|NCT04542005|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153875044|NCT04542005|Autonomic Agents|autonomic agents|mesh-ancestor
153875045|NCT04542005|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153875046|NCT04542005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153875047|NCT04542005|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153875048|NCT04542005|Respiratory System Agents|respiratory system agents|mesh-ancestor
153875049|NCT04542005|Tocolytic Agents|tocolytic agents|mesh-ancestor
153875050|NCT04542005|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153875051|NCT04542005|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
153875054|NCT04542005|Adrenergic Agents|adrenergic agents|mesh-ancestor
153875055|NCT04542005|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153875056|NCT04542005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153875057|NCT01646775|Fentanyl|fentanyl|mesh-list
153875058|NCT01646775|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153875059|NCT01646775|Narcotics|narcotics|mesh-ancestor
153875060|NCT01646775|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153875061|NCT01646775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153875062|NCT01646775|Analgesics|analgesics|mesh-ancestor
153875063|NCT01646775|Sensory System Agents|sensory system agents|mesh-ancestor
153875064|NCT01646775|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153875065|NCT01646775|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153875066|NCT01646775|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153875068|NCT01646775|Anesthetics|anesthetics|mesh-ancestor
153415789|NCT02666846|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153415791|NCT02666846|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153415792|NCT02666846|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153415793|NCT02666846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153415794|NCT02666846|Antipruritics|antipruritics|mesh-ancestor
153415795|NCT02666846|Dermatologic Agents|dermatologic agents|mesh-ancestor
153415796|NCT02643979|Ketamine|ketamine|mesh-list
153415797|NCT02643979|Propofol|propofol|mesh-list
153415798|NCT02643979|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153415799|NCT02643979|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153415819|NCT02667704|Nintedanib|nintedanib|mesh-list
153415820|NCT02667704|Bosentan|bosentan|mesh-list
153875069|NCT01646853|Fluorouracil|fluorouracil|mesh-list
153875070|NCT01646853|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153875071|NCT01646853|Antimetabolites|antimetabolites|mesh-ancestor
153875072|NCT01646853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153875074|NCT01646853|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153875075|NCT01646853|Immunologic Factors|immunologic factors|mesh-ancestor
153875076|NCT01646853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153875078|NCT01647165|Lenalidomide|lenalidomide|mesh-list
153875079|NCT01647165|Bortezomib|bortezomib|mesh-list
153875080|NCT01647165|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153875081|NCT01647165|Antiemetics|antiemetics|mesh-ancestor
153875082|NCT01647165|Autonomic Agents|autonomic agents|mesh-ancestor
153875083|NCT01647165|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153875084|NCT01647165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153875085|NCT01647165|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153875086|NCT01647165|Glucocorticoids|glucocorticoids|mesh-ancestor
153875087|NCT01647165|Hormones|hormones|mesh-ancestor
153875088|NCT01647165|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153875089|NCT01647165|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153875090|NCT01647165|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153875091|NCT01647165|Immunologic Factors|immunologic factors|mesh-ancestor
153875092|NCT01647165|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153875093|NCT01647165|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153875094|NCT01647165|Growth Substances|growth substances|mesh-ancestor
153875095|NCT01647165|Growth Inhibitors|growth inhibitors|mesh-ancestor
153875096|NCT01681134|Tacrolimus|tacrolimus|mesh-list
153875097|NCT01681134|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153875098|NCT01681134|Immunologic Factors|immunologic factors|mesh-ancestor
153875099|NCT01681134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153415822|NCT02667704|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153415823|NCT02667704|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153415824|NCT02667704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153415825|NCT02667704|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153415826|NCT02667704|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
153415827|NCT02645617|Imidacloprid|imidacloprid|mesh-list
153415829|NCT02645617|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153415834|NCT02694601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153415835|NCT02694601|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
153415836|NCT02694601|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153415837|NCT02694601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153415838|NCT02694601|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
153415839|NCT02694601|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
153415840|NCT02694601|Purinergic Agents|purinergic agents|mesh-ancestor
153415841|NCT02694601|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153415842|NCT05574439|Semaglutide|semaglutide|mesh-list
153415843|NCT05574439|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
153415844|NCT05574439|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153418006|NCT02923466|Interferon-beta|interferon-beta|mesh-list
153875104|NCT04543916|Venetoclax|venetoclax|mesh-list
153875117|NCT02214992|Ramipril|ramipril|mesh-list
153875118|NCT02214992|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153875119|NCT02214992|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
153875120|NCT02214992|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
153875121|NCT02214992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153875122|NCT02214992|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
153875123|NCT02214992|Protease Inhibitors|protease inhibitors|mesh-ancestor
153415845|NCT05574439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153415847|NCT02690948|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153415848|NCT02690948|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153415849|NCT02690948|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153415861|NCT02691416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153415862|NCT02691416|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153415863|NCT02691416|Anesthetics, General|anesthetics, general|mesh-ancestor
153415864|NCT02691416|Anesthetics|anesthetics|mesh-ancestor
153415865|NCT02691416|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153875129|NCT04528095|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153875130|NCT04528095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153875131|NCT04528095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153875132|NCT04528095|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153875133|NCT04528095|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153875134|NCT04528095|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153875135|NCT04528095|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153875136|NCT04528095|GABA Antagonists|gaba antagonists|mesh-ancestor
153875137|NCT04528095|GABA Agents|gaba agents|mesh-ancestor
153875138|NCT04528095|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
153875139|NCT04528095|Dopamine Agents|dopamine agents|mesh-ancestor
153875140|NCT04528095|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
153875141|NCT04528095|Antidepressive Agents|antidepressive agents|mesh-ancestor
153875142|NCT04528056|Sulfasalazine|sulfasalazine|mesh-list
153875143|NCT04528056|Ambrisentan|ambrisentan|mesh-list
153875144|NCT04528056|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153415866|NCT02691416|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
153415868|NCT02650999|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153415869|NCT02650999|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153415870|NCT02650999|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153415874|NCT05502211|Anesthetics, Local|anesthetics, local|mesh-ancestor
153415875|NCT05502211|Anesthetics|anesthetics|mesh-ancestor
153415876|NCT05502211|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153415877|NCT05502211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153415878|NCT05502211|Sensory System Agents|sensory system agents|mesh-ancestor
153415879|NCT05502211|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153415880|NCT05502211|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153415881|NCT05502211|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
153875152|NCT04528056|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153875153|NCT04528056|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153875154|NCT04528056|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153415894|NCT02674412|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153415895|NCT02674412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153415896|NCT02674412|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153415897|NCT02674412|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
153415898|NCT02674412|Serotonin Agents|serotonin agents|mesh-ancestor
153415899|NCT02674412|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153415900|NCT02674412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153415901|NCT04708106|Menthol|menthol|mesh-list
153415902|NCT04708106|Antipruritics|antipruritics|mesh-ancestor
153415903|NCT04708106|Dermatologic Agents|dermatologic agents|mesh-ancestor
153415904|NCT02697188|Methyltestosterone|methyltestosterone|mesh-list
153415905|NCT02697188|Testosterone|testosterone|mesh-list
153415906|NCT02697188|Testosterone undecanoate|testosterone undecanoate|mesh-list
153415907|NCT02697188|Testosterone enanthate|testosterone enanthate|mesh-list
153415908|NCT02697188|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
153415909|NCT02697188|Androgens|androgens|mesh-ancestor
153415910|NCT02697188|Hormones|hormones|mesh-ancestor
153415911|NCT02697188|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153415912|NCT02697188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153415913|NCT02697188|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153415914|NCT02697188|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153415915|NCT02697188|Anabolic Agents|anabolic agents|mesh-ancestor
153415916|NCT04707560|Heparin|heparin|mesh-list
153415917|NCT04707560|Anticoagulants|anticoagulants|mesh-ancestor
153415918|NCT04707560|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153415919|NCT04707560|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153415920|NCT04707560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153875168|NCT04543370|Deflazacort|deflazacort|mesh-list
153875169|NCT04543370|Midazolam|midazolam|mesh-list
153875170|NCT04543370|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153875171|NCT04543370|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153875172|NCT04543370|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153875173|NCT04543370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153386381|NCT02413047|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
153386382|NCT02413047|Abortifacient Agents|abortifacient agents|mesh-ancestor
153386383|NCT02413047|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153386384|NCT02413047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153386385|NCT02413047|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153386386|NCT02413047|Antimetabolites|antimetabolites|mesh-ancestor
153386387|NCT02413047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153386388|NCT02413047|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153875174|NCT04543370|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153875175|NCT04543370|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153875176|NCT04543370|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153875177|NCT04543370|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153875178|NCT04543370|Anesthetics, General|anesthetics, general|mesh-ancestor
153875179|NCT04543370|Anesthetics|anesthetics|mesh-ancestor
153875180|NCT04543370|GABA Modulators|gaba modulators|mesh-ancestor
153875181|NCT04543370|GABA Agents|gaba agents|mesh-ancestor
153875182|NCT04543370|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153875183|NCT04543370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153875185|NCT04543370|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153875186|NCT04543370|Immunologic Factors|immunologic factors|mesh-ancestor
153875187|NCT01681563|Cyclophosphamide|cyclophosphamide|mesh-list
153875188|NCT01681563|Ofatumumab|ofatumumab|mesh-list
153875189|NCT01681563|Pentostatin|pentostatin|mesh-list
153877343|NCT05888896|Sympatholytics|sympatholytics|mesh-ancestor
153877353|NCT05886582|Rotigotine|rotigotine|mesh-list
153875195|NCT01681563|Alkylating Agents|alkylating agents|mesh-ancestor
153875196|NCT01681563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153875197|NCT01681563|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153875198|NCT01681563|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153415921|NCT02653183|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
153415923|NCT02653183|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153415924|NCT02701400|Durvalumab|durvalumab|mesh-list
153415925|NCT02701400|Ipilimumab|ipilimumab|mesh-list
153415926|NCT02701400|Tremelimumab|tremelimumab|mesh-list
153415927|NCT02701400|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153415928|NCT02701400|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153415929|NCT02701400|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153415930|NCT02701400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153415931|NCT05403710|Botulinum Toxins|botulinum toxins|mesh-list
153415932|NCT05403710|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
153415933|NCT05403710|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153461749|NCT04195776|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153875208|NCT01647672|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153875211|NCT01647984|Vitamin B Complex|vitamin b complex|mesh-list
153875212|NCT01647984|Micronutrients|micronutrients|mesh-ancestor
153415934|NCT05403710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153415935|NCT05403710|Cholinergic Agents|cholinergic agents|mesh-ancestor
153415936|NCT05403710|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153415937|NCT05403710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153415938|NCT02703350|Insulin Lispro|insulin lispro|mesh-list
153415939|NCT02703350|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153415940|NCT02703350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153415941|NCT05470465|Oxycodone|oxycodone|mesh-list
153415942|NCT05470465|Paroxetine|paroxetine|mesh-list
153415943|NCT05470465|Escitalopram|escitalopram|mesh-list
153415944|NCT05470465|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153415945|NCT05470465|Narcotics|narcotics|mesh-ancestor
153415946|NCT05470465|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153415947|NCT05470465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153415948|NCT05470465|Analgesics|analgesics|mesh-ancestor
153415949|NCT05470465|Sensory System Agents|sensory system agents|mesh-ancestor
153415950|NCT05470465|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153415951|NCT05470465|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
153415952|NCT05470465|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153415953|NCT05470465|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153415954|NCT05470465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153415955|NCT05470465|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153415957|NCT05470465|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
153415961|NCT05470465|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153415962|NCT05470465|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153415963|NCT00368030|Eszopiclone|eszopiclone|mesh-list
153415964|NCT00368030|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153415965|NCT00368030|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153415966|NCT00368030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153415967|NCT02656069|Glucagon|glucagon|mesh-list
153875213|NCT01647984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153875214|NCT01647984|Antioxidants|antioxidants|mesh-ancestor
153875215|NCT01647984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153875216|NCT01647984|Protective Agents|protective agents|mesh-ancestor
153875217|NCT02215382|Atropine|atropine|mesh-list
153875218|NCT02215382|Neostigmine|neostigmine|mesh-list
153875219|NCT02215382|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153875220|NCT02215382|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153875221|NCT02215382|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153875222|NCT02215382|Autonomic Agents|autonomic agents|mesh-ancestor
153875223|NCT02215382|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153875224|NCT02215382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153875225|NCT02215382|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153875226|NCT02215382|Respiratory System Agents|respiratory system agents|mesh-ancestor
153875227|NCT02215382|Mydriatics|mydriatics|mesh-ancestor
153875230|NCT02215382|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
153875231|NCT02215382|Cholinergic Agents|cholinergic agents|mesh-ancestor
153875232|NCT02215382|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153475839|NCT00835224|Autonomic Agents|autonomic agents|mesh-ancestor
153875234|NCT02215382|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
153875235|NCT02215382|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153875236|NCT02215382|Parasympathomimetics|parasympathomimetics|mesh-ancestor
153875237|NCT01682109|Valacyclovir|valacyclovir|mesh-list
153875238|NCT01682109|Antiviral Agents|antiviral agents|mesh-ancestor
153875239|NCT01682109|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153875240|NCT02215148|Tolvaptan|tolvaptan|mesh-list
153875241|NCT02215148|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
153875242|NCT02215148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153875243|NCT02215148|Natriuretic Agents|natriuretic agents|mesh-ancestor
153875244|NCT02215148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153875245|NCT01682343|Calcium|calcium|mesh-list
153875246|NCT01682343|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153415968|NCT02656069|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
153415969|NCT02656069|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153415970|NCT02656069|Hormones|hormones|mesh-ancestor
153415971|NCT02656069|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153415972|NCT02656069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153415973|NCT02656069|Incretins|incretins|mesh-ancestor
153415974|NCT05351762|Paclitaxel|paclitaxel|mesh-list
153415975|NCT05351762|Nimotuzumab|nimotuzumab|mesh-list
153415976|NCT05351762|Nedaplatin|nedaplatin|mesh-list
153415977|NCT05351762|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153415978|NCT05351762|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153415979|NCT05351762|Tubulin Modulators|tubulin modulators|mesh-ancestor
153415980|NCT05351762|Antimitotic Agents|antimitotic agents|mesh-ancestor
153415981|NCT05351762|Mitosis Modulators|mitosis modulators|mesh-ancestor
153415993|NCT02710981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153875248|NCT01648257|Cabotegravir|cabotegravir|mesh-list
153875249|NCT01648257|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
153875250|NCT01648257|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
153875251|NCT01648257|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153875252|NCT01648257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153875253|NCT01648257|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153875254|NCT01648257|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153875255|NCT01648257|Antiviral Agents|antiviral agents|mesh-ancestor
153875256|NCT01648257|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153875257|NCT02215460|Chlorhexidine|chlorhexidine|mesh-list
153875258|NCT02215460|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
153875259|NCT02215460|Azithromycin|azithromycin|mesh-list
153875260|NCT02215460|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
153875261|NCT02215460|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153875262|NCT02215460|Disinfectants|disinfectants|mesh-ancestor
153875263|NCT02215460|Dermatologic Agents|dermatologic agents|mesh-ancestor
153875264|NCT02215460|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153875265|NCT02215499|Sodium Oxybate|sodium oxybate|mesh-list
153875266|NCT02215499|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153875267|NCT02215499|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153386389|NCT02413047|Dermatologic Agents|dermatologic agents|mesh-ancestor
153386390|NCT02413047|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153386391|NCT02413047|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153386392|NCT02413047|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153386396|NCT02277548|Pregabalin|pregabalin|mesh-list
153386397|NCT02277548|Analgesics|analgesics|mesh-ancestor
153386398|NCT02277548|Sensory System Agents|sensory system agents|mesh-ancestor
153386399|NCT02277548|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153386400|NCT02277548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153386401|NCT02277548|Anticonvulsants|anticonvulsants|mesh-ancestor
153386402|NCT02277548|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153386437|NCT03756818|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153386438|NCT01065051|Riociguat|riociguat|mesh-list
153386439|NCT01065051|Enzyme Activators|enzyme activators|mesh-ancestor
153386534|NCT02318901|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
153386535|NCT02318901|Maytansine|maytansine|mesh-list
153386536|NCT02318901|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153386537|NCT02318901|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153386538|NCT02318901|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153386539|NCT02318901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153386540|NCT02318901|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153386541|NCT02318901|Tubulin Modulators|tubulin modulators|mesh-ancestor
153875268|NCT02215499|Anesthetics, General|anesthetics, general|mesh-ancestor
153875269|NCT02215499|Anesthetics|anesthetics|mesh-ancestor
153875270|NCT02215499|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153875271|NCT02215499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153875272|NCT01648608|Exemestane|exemestane|mesh-list
153875273|NCT01648608|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153875274|NCT01648608|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
153877408|NCT05845450|Durvalumab|durvalumab|mesh-list
153416000|NCT02710981|Hormone Antagonists|hormone antagonists|mesh-ancestor
153416001|NCT02710981|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153416002|NCT02710981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153416003|NCT02710981|Fertility Agents, Female|fertility agents, female|mesh-ancestor
153416004|NCT02710981|Fertility Agents|fertility agents|mesh-ancestor
153416005|NCT02710981|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153416006|NCT02710981|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
153416007|NCT02710981|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
153416008|NCT04739917|Monatide (IMS 3015)|monatide (ims 3015)|mesh-list
153416009|NCT04739917|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153416012|NCT02659501|Acetaminophen|acetaminophen|mesh-list
153416013|NCT02659501|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
153416015|NCT02659501|Diazepam|diazepam|mesh-list
153416016|NCT02659501|Morphine|morphine|mesh-list
153416017|NCT02659501|Hydrocodone|hydrocodone|mesh-list
153416018|NCT02659501|Bupivacaine|bupivacaine|mesh-list
153416019|NCT02659501|Anesthetics, Local|anesthetics, local|mesh-ancestor
153416020|NCT02659501|Anesthetics|anesthetics|mesh-ancestor
153416021|NCT02659501|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153416022|NCT02659501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153416023|NCT02659501|Sensory System Agents|sensory system agents|mesh-ancestor
153416024|NCT02659501|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153416025|NCT02659501|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153416026|NCT02659501|Narcotics|narcotics|mesh-ancestor
153875279|NCT01648608|Hormone Antagonists|hormone antagonists|mesh-ancestor
153875280|NCT01648608|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153875281|NCT01648608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153875282|NCT02215538|Methylphenidate|methylphenidate|mesh-list
153875283|NCT02215538|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
153875284|NCT02215538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153875285|NCT02215538|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
153875286|NCT02215538|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153875287|NCT02215538|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153875288|NCT02215538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153875289|NCT02215538|Dopamine Agents|dopamine agents|mesh-ancestor
153875290|NCT02215538|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153875291|NCT01682421|Dexamethasone|dexamethasone|mesh-list
153875292|NCT01682421|Dexamethasone acetate|dexamethasone acetate|mesh-list
153875293|NCT01682421|BB 1101|bb 1101|mesh-list
153875294|NCT01682421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153875295|NCT01682421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153875296|NCT01682421|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153875297|NCT01682421|Antiemetics|antiemetics|mesh-ancestor
153875298|NCT01682421|Autonomic Agents|autonomic agents|mesh-ancestor
153875299|NCT01682421|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153875300|NCT01682421|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153416028|NCT02659501|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153416029|NCT02659501|Antipyretics|antipyretics|mesh-ancestor
153416030|NCT02659501|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153416031|NCT02659501|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153416032|NCT02659501|Adrenergic Agents|adrenergic agents|mesh-ancestor
153416033|NCT02659501|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153416034|NCT02659501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153416035|NCT02659501|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
153416036|NCT02659501|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153875303|NCT01682421|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153875304|NCT01682421|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153875305|NCT01682421|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153875306|NCT01682421|Protease Inhibitors|protease inhibitors|mesh-ancestor
153875307|NCT01682421|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153875308|NCT01682499|Calcium, Dietary|calcium, dietary|mesh-list
153875309|NCT01682499|Magnesium Sulfate|magnesium sulfate|mesh-list
153875310|NCT01682499|Calcium|calcium|mesh-list
153875311|NCT01682499|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153875312|NCT01682499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153875313|NCT01682499|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153875315|NCT01682499|Sensory System Agents|sensory system agents|mesh-ancestor
153875316|NCT01682499|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153875317|NCT01682499|Anesthetics|anesthetics|mesh-ancestor
153875318|NCT01682499|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153875319|NCT01682499|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153875320|NCT01682499|Anticonvulsants|anticonvulsants|mesh-ancestor
153875321|NCT01682499|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153875322|NCT01682499|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153875323|NCT01682499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153875324|NCT01682499|Tocolytic Agents|tocolytic agents|mesh-ancestor
153875325|NCT01682499|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153875326|NCT04540055|Anesthetics|anesthetics|mesh-list
153875327|NCT04540055|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153875328|NCT04540055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153875329|NCT01180660|Lidocaine|lidocaine|mesh-list
153875330|NCT01180660|Anesthetics, Local|anesthetics, local|mesh-ancestor
153875331|NCT01180660|Anesthetics|anesthetics|mesh-ancestor
153875336|NCT01180660|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153875337|NCT01180660|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
153875338|NCT01180660|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153875339|NCT01180660|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153875340|NCT01180660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153875341|NCT01648881|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
153875342|NCT01648881|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
153875346|NCT01202227|Sensory System Agents|sensory system agents|mesh-ancestor
153875347|NCT01202227|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153875348|NCT01202227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153875350|NCT01202227|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153875351|NCT01202227|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153875352|NCT01202227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153875353|NCT01202227|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153875354|NCT01202227|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153875355|NCT01202227|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153875356|NCT01202227|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153875357|NCT01202227|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153875358|NCT01682733|Botulinum Toxins|botulinum toxins|mesh-list
153875359|NCT01682733|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
153875360|NCT01682733|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153875361|NCT01682733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153875362|NCT01682733|Cholinergic Agents|cholinergic agents|mesh-ancestor
153875363|NCT01682733|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153875364|NCT01682733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153416093|NCT02664961|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153416094|NCT02664961|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153416095|NCT02664961|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153416096|NCT02664961|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153416097|NCT02664961|Growth Substances|growth substances|mesh-ancestor
153416098|NCT02664961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153416099|NCT02664961|Growth Inhibitors|growth inhibitors|mesh-ancestor
153416100|NCT02665273|Bupivacaine|bupivacaine|mesh-list
153416101|NCT02665273|Anesthetics, Local|anesthetics, local|mesh-ancestor
153416102|NCT02665273|Anesthetics|anesthetics|mesh-ancestor
153416103|NCT02665273|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153416104|NCT02665273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153416105|NCT02665273|Sensory System Agents|sensory system agents|mesh-ancestor
153416106|NCT02665273|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153416107|NCT02713178|Bupivacaine|bupivacaine|mesh-list
153416108|NCT02713178|Anesthetics, Local|anesthetics, local|mesh-ancestor
153875366|NCT01682772|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
153875367|NCT01682772|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153875368|NCT01682772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153875369|NCT01682772|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153875370|NCT01649037|Terlipressin|terlipressin|mesh-list
153875372|NCT01649037|Racepinephrine|racepinephrine|mesh-list
153875373|NCT01649037|Norepinephrine|norepinephrine|mesh-list
153875374|NCT01649037|Epinephryl borate|epinephryl borate|mesh-list
153875375|NCT01649037|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153875376|NCT01649037|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153875377|NCT01649037|Adrenergic Agents|adrenergic agents|mesh-ancestor
153875378|NCT01649037|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153875379|NCT01649037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153875380|NCT01649037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153875381|NCT01649037|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
153875383|NCT01649037|Autonomic Agents|autonomic agents|mesh-ancestor
153875384|NCT01649037|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153875385|NCT01649037|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153875404|NCT02279511|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153875405|NCT02279511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153875406|NCT02279511|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153875407|NCT02279511|Vasodilator Agents|vasodilator agents|mesh-ancestor
153875408|NCT02279511|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
153875409|NCT02279511|Purinergic Agonists|purinergic agonists|mesh-ancestor
153875410|NCT02279511|Purinergic Agents|purinergic agents|mesh-ancestor
153875411|NCT02279511|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153875412|NCT02279511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153875414|NCT02279628|Ropivacaine|ropivacaine|mesh-list
153875415|NCT02279628|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153875416|NCT02279628|Narcotics|narcotics|mesh-ancestor
153875417|NCT02279628|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153875418|NCT02279628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153875419|NCT02279628|Analgesics|analgesics|mesh-ancestor
153875420|NCT02279628|Sensory System Agents|sensory system agents|mesh-ancestor
153875421|NCT02279628|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153875422|NCT02279628|Anesthetics, Local|anesthetics, local|mesh-ancestor
153875423|NCT02279628|Anesthetics|anesthetics|mesh-ancestor
153416149|NCT02730247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153416150|NCT02730247|Growth Inhibitors|growth inhibitors|mesh-ancestor
153416152|NCT03889106|Antimetabolites|antimetabolites|mesh-ancestor
153416153|NCT03889106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153416154|NCT03889106|Antiviral Agents|antiviral agents|mesh-ancestor
153877532|NCT05696236|Tin Fluorides|tin fluorides|mesh-list
153875430|NCT04542629|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153875431|NCT04542629|Micronutrients|micronutrients|mesh-ancestor
153875432|NCT01683006|Rocuronium|rocuronium|mesh-list
153875433|NCT01683006|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
153416175|NCT02670343|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153416176|NCT02670343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153416177|NCT02670343|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153416178|NCT02670343|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153416179|NCT02670343|Anabolic Agents|anabolic agents|mesh-ancestor
153416181|NCT02730884|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153416182|NCT02730884|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153416183|NCT02730884|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153416184|NCT02730884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153416185|NCT02732587|Saracatinib|saracatinib|mesh-list
153416186|NCT02732587|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153416187|NCT02732587|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153416188|NCT02732587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153416189|NCT02731820|Vitamin D|vitamin d|mesh-list
153877580|NCT05653401|Analgesics|analgesics|mesh-ancestor
153875445|NCT02215733|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153875446|NCT02215733|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
153875447|NCT02215733|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
153875448|NCT02215733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153875449|NCT02215733|Natriuretic Agents|natriuretic agents|mesh-ancestor
153875450|NCT02215733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153875451|NCT02215733|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
153875452|NCT02215733|Adrenergic Agents|adrenergic agents|mesh-ancestor
153875453|NCT02215733|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153875454|NCT01202188|Glycopyrrolate|glycopyrrolate|mesh-list
153875455|NCT01202188|Tiotropium Bromide|tiotropium bromide|mesh-list
153875456|NCT01202188|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153875457|NCT01202188|Autonomic Agents|autonomic agents|mesh-ancestor
153875458|NCT01202188|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153875459|NCT01202188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153875460|NCT01202188|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153875461|NCT01202188|Respiratory System Agents|respiratory system agents|mesh-ancestor
153875462|NCT01202188|Parasympatholytics|parasympatholytics|mesh-ancestor
153416190|NCT02731820|Cholecalciferol|cholecalciferol|mesh-list
153416191|NCT02731820|Potassium Citrate|potassium citrate|mesh-list
153416192|NCT02731820|Calcium Carbonate|calcium carbonate|mesh-list
153416193|NCT02731820|Calcium|calcium|mesh-list
153416194|NCT02731820|Vitamins|vitamins|mesh-ancestor
153416195|NCT02731820|Micronutrients|micronutrients|mesh-ancestor
153416196|NCT02731820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153416197|NCT02731820|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153416198|NCT02731820|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153416204|NCT02731820|Expectorants|expectorants|mesh-ancestor
153416205|NCT02731820|Respiratory System Agents|respiratory system agents|mesh-ancestor
153416206|NCT02732899|Sirolimus|sirolimus|mesh-list
153416207|NCT02732899|Aflibercept|aflibercept|mesh-list
153416208|NCT02732899|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153416209|NCT02732899|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153416214|NCT02732899|Immunologic Factors|immunologic factors|mesh-ancestor
153416215|NCT02732899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153416216|NCT02732899|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153416217|NCT02732899|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153416218|NCT02732899|Growth Substances|growth substances|mesh-ancestor
153416219|NCT02732899|Growth Inhibitors|growth inhibitors|mesh-ancestor
153416220|NCT02733757|Clonidine|clonidine|mesh-list
153416221|NCT02733757|Analgesics|analgesics|mesh-ancestor
153416222|NCT02733757|Sensory System Agents|sensory system agents|mesh-ancestor
153416223|NCT02733757|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153416224|NCT02733757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153416225|NCT02733757|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153416226|NCT02733757|Sympatholytics|sympatholytics|mesh-ancestor
153416227|NCT02733757|Autonomic Agents|autonomic agents|mesh-ancestor
153461750|NCT03708588|Ticagrelor|ticagrelor|mesh-list
153875463|NCT01202188|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
153875464|NCT01202188|Cholinergic Agents|cholinergic agents|mesh-ancestor
153875465|NCT01202188|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153875466|NCT01202188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153875467|NCT01202188|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153875468|NCT01202188|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
153875469|NCT01179919|Oseltamivir|oseltamivir|mesh-list
153875470|NCT01179919|Antiviral Agents|antiviral agents|mesh-ancestor
153875471|NCT01179919|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153875472|NCT01179919|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153386542|NCT02318901|Antimitotic Agents|antimitotic agents|mesh-ancestor
153386543|NCT02318901|Mitosis Modulators|mitosis modulators|mesh-ancestor
153386544|NCT02318901|Immunotoxins|immunotoxins|mesh-ancestor
153386545|NCT02318901|Immunoconjugates|immunoconjugates|mesh-ancestor
153386546|NCT02318901|Immunologic Factors|immunologic factors|mesh-ancestor
153883329|NCT01335399|Antiemetics|antiemetics|mesh-ancestor
153883330|NCT01335399|Autonomic Agents|autonomic agents|mesh-ancestor
153875473|NCT01179919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153875474|NCT01201798|Prednisolone|prednisolone|mesh-list
153875475|NCT01201798|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
153875476|NCT01201798|Methylprednisolone|methylprednisolone|mesh-list
153875477|NCT01201798|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
153875478|NCT01201798|Prednisolone acetate|prednisolone acetate|mesh-list
153875479|NCT01201798|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
153875480|NCT01201798|Prednisolone phosphate|prednisolone phosphate|mesh-list
153875481|NCT01201798|Difluprednate|difluprednate|mesh-list
153875482|NCT01201798|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153875483|NCT01201798|Glucocorticoids|glucocorticoids|mesh-ancestor
153875484|NCT01201798|Hormones|hormones|mesh-ancestor
153875485|NCT01201798|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153875487|NCT01201798|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153875488|NCT01201798|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153875490|NCT01201798|Autonomic Agents|autonomic agents|mesh-ancestor
153875491|NCT01201798|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153875492|NCT01201798|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153875493|NCT01201798|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
153875494|NCT01201798|Protective Agents|protective agents|mesh-ancestor
153875495|NCT01201759|Salicylsalicylic acid|salicylsalicylic acid|mesh-list
153875496|NCT01201759|Sodium Salicylate|sodium salicylate|mesh-list
153875497|NCT01201759|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153875498|NCT01201759|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153416228|NCT02733757|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
153877633|NCT05525546|Vaccines|vaccines|mesh-list
153416235|NCT00368264|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
153416236|NCT00368264|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153416238|NCT00368264|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153416239|NCT00368264|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153416240|NCT02734147|Ascorbic Acid|ascorbic acid|mesh-list
153416241|NCT02734147|Antioxidants|antioxidants|mesh-ancestor
153416242|NCT02734147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153416243|NCT02734147|Protective Agents|protective agents|mesh-ancestor
153416244|NCT02734147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153416245|NCT02734147|Vitamins|vitamins|mesh-ancestor
153416246|NCT02734147|Micronutrients|micronutrients|mesh-ancestor
153416247|NCT00368342|Azithromycin|azithromycin|mesh-list
153416248|NCT00368342|Clarithromycin|clarithromycin|mesh-list
153416249|NCT00368342|Erythromycin|erythromycin|mesh-list
153416250|NCT00368342|Erythromycin Estolate|erythromycin estolate|mesh-list
153416251|NCT00368342|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
153416252|NCT00368342|Erythromycin stearate|erythromycin stearate|mesh-list
153416253|NCT00368342|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153416257|NCT00368342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153416258|NCT00368342|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
153416259|NCT00368342|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153416260|NCT00368342|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153875501|NCT01201759|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153875502|NCT01201759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153875503|NCT01201759|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153875504|NCT01201759|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153875505|NCT01201759|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153875506|NCT01201759|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153875507|NCT01201759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153883331|NCT01335399|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153883332|NCT01335399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153883333|NCT01335399|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153883334|NCT01335399|Glucocorticoids|glucocorticoids|mesh-ancestor
153875508|NCT04532684|Pregabalin|pregabalin|mesh-list
153875509|NCT04532684|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
153875510|NCT04532684|Analgesics|analgesics|mesh-ancestor
153875511|NCT04532684|Sensory System Agents|sensory system agents|mesh-ancestor
153875512|NCT04532684|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153875513|NCT04532684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153875514|NCT04532684|Anticonvulsants|anticonvulsants|mesh-ancestor
153875515|NCT04532684|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153875516|NCT04532684|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153875517|NCT04532684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153875518|NCT04532684|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153875519|NCT04532684|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153875520|NCT04532684|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153875521|NCT04532684|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153875522|NCT04532684|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153875523|NCT04532684|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
153875524|NCT04532684|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153875525|NCT04532684|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153875526|NCT04532684|Antidepressive Agents|antidepressive agents|mesh-ancestor
153875527|NCT04532684|Dopamine Agents|dopamine agents|mesh-ancestor
153875528|NCT01649466|Insulin|insulin|mesh-list
153875529|NCT01649466|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
153875530|NCT01649466|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153416262|NCT03609008|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153416263|NCT03609008|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153416264|NCT03609008|Autonomic Agents|autonomic agents|mesh-ancestor
153875549|NCT01683552|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153877663|NCT05509569|Analgesics|analgesics|mesh-ancestor
153416281|NCT02734238|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153416282|NCT02734238|Anabolic Agents|anabolic agents|mesh-ancestor
153416283|NCT04707547|Nivolumab|nivolumab|mesh-list
153416284|NCT04707547|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153416285|NCT04707547|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153416286|NCT04707547|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153416287|NCT04707547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153416288|NCT02736175|Dexamethasone|dexamethasone|mesh-list
153416289|NCT02736175|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153416290|NCT02736175|Antiemetics|antiemetics|mesh-ancestor
153416291|NCT02736175|Autonomic Agents|autonomic agents|mesh-ancestor
153416292|NCT02736175|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153416293|NCT02736175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153416294|NCT02736175|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153416295|NCT02736175|Glucocorticoids|glucocorticoids|mesh-ancestor
153416296|NCT02736175|Hormones|hormones|mesh-ancestor
153416297|NCT02736175|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153416298|NCT02736175|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153875554|NCT01683552|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
153875555|NCT01683552|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153875556|NCT01683552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153875557|NCT01683552|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
153875558|NCT01683552|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
153875559|NCT01683552|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
153875560|NCT01683552|Histamine Antagonists|histamine antagonists|mesh-ancestor
153875561|NCT01683552|Histamine Agents|histamine agents|mesh-ancestor
153875562|NCT01649544|Amiodarone|amiodarone|mesh-list
153875563|NCT01649544|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153416314|NCT02681809|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153416315|NCT02681809|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153416316|NCT02681809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153416317|NCT05445661|Mannitol|mannitol|mesh-list
153416318|NCT05445661|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
153416319|NCT05445661|Diuretics|diuretics|mesh-ancestor
153416320|NCT05445661|Natriuretic Agents|natriuretic agents|mesh-ancestor
153875577|NCT04528290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153875578|NCT04528290|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153875579|NCT04528290|Immunologic Factors|immunologic factors|mesh-ancestor
153875580|NCT04528290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153875582|NCT01179334|Riociguat|riociguat|mesh-list
153875583|NCT01179334|Vasodilator Agents|vasodilator agents|mesh-ancestor
153875584|NCT01179334|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
153875585|NCT01179334|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
153875586|NCT01179334|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153416321|NCT05445661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153416322|NCT04805125|Vaccines|vaccines|mesh-list
153416323|NCT04805125|Immunologic Factors|immunologic factors|mesh-ancestor
153416324|NCT04805125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153416325|NCT00368017|Pioglitazone|pioglitazone|mesh-list
153416326|NCT00368017|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153416327|NCT00368017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153416328|NCT00367627|Albendazole|albendazole|mesh-list
153416329|NCT00367627|Anthelmintics|anthelmintics|mesh-ancestor
153416330|NCT00367627|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153416331|NCT00367627|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153416332|NCT00367627|Anticestodal Agents|anticestodal agents|mesh-ancestor
153875598|NCT01683747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153875600|NCT01683747|Coagulants|coagulants|mesh-ancestor
153875601|NCT01178671|Mirtazapine|mirtazapine|mesh-list
153875602|NCT01178671|Sertraline|sertraline|mesh-list
153875603|NCT01178671|Antidepressive Agents|antidepressive agents|mesh-ancestor
153875604|NCT01178671|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153875605|NCT01178671|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
153875606|NCT01178671|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153416342|NCT05443789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153416344|NCT05424523|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
153416345|NCT05424523|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153416346|NCT05424523|Respiratory System Agents|respiratory system agents|mesh-ancestor
153416348|NCT05442931|Pregabalin|pregabalin|mesh-list
153416349|NCT05442931|Nitroglycerin|nitroglycerin|mesh-list
153416350|NCT05442931|Analgesics|analgesics|mesh-ancestor
153416351|NCT05442931|Sensory System Agents|sensory system agents|mesh-ancestor
153416352|NCT05442931|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153416353|NCT05442931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153416354|NCT05442931|Anticonvulsants|anticonvulsants|mesh-ancestor
153416355|NCT05442931|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153416356|NCT05442931|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153877712|NCT05418244|Ondansetron|ondansetron|mesh-list
153875621|NCT01178671|Adrenergic Agents|adrenergic agents|mesh-ancestor
153875622|NCT01178671|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
153416374|NCT05439499|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153416375|NCT05439499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153416376|NCT05439499|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
153416377|NCT05439499|Hormone Antagonists|hormone antagonists|mesh-ancestor
153416378|NCT05439499|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153416379|NCT05439499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153416380|NCT05439499|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153416381|NCT04003987|Bupivacaine|bupivacaine|mesh-list
153875630|NCT04532060|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153875631|NCT04532060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153875632|NCT01649739|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
153875634|NCT01649739|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
153875635|NCT01649739|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
153386549|NCT01904864|Micronutrients|micronutrients|mesh-ancestor
153386550|NCT01904864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153386551|NCT01904864|Trace Elements|trace elements|mesh-ancestor
153386552|NCT01016847|Montelukast|montelukast|mesh-list
153386553|NCT01016847|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153386554|NCT01016847|Respiratory System Agents|respiratory system agents|mesh-ancestor
153386555|NCT01016847|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
153875636|NCT01649739|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153875637|NCT01649739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153875638|NCT01649739|Urological Agents|urological agents|mesh-ancestor
153875639|NCT04532333|Heparin|heparin|mesh-list
153875640|NCT04532333|Bivalirudin|bivalirudin|mesh-list
153875641|NCT04532333|Anticoagulants|anticoagulants|mesh-ancestor
153875643|NCT04532333|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153416382|NCT04003987|Anesthetics, Local|anesthetics, local|mesh-ancestor
153416384|NCT04003987|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153416394|NCT05448001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153416395|NCT05447455|Anesthetics|anesthetics|mesh-list
153416396|NCT05447455|Anesthetics, Local|anesthetics, local|mesh-list
153416397|NCT05447455|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153416398|NCT05447455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153416399|NCT05447455|Sensory System Agents|sensory system agents|mesh-ancestor
153416400|NCT05447455|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153416401|NCT00369733|Darbepoetin alfa|darbepoetin alfa|mesh-list
153416402|NCT00369733|Hematinics|hematinics|mesh-ancestor
153875653|NCT01649895|Antitubercular Agents|antitubercular agents|mesh-ancestor
153875654|NCT01649895|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153875655|NCT01649895|Antimetabolites|antimetabolites|mesh-ancestor
153875658|NCT01649505|Hemostatics|hemostatics|mesh-ancestor
153875659|NCT01649505|Coagulants|coagulants|mesh-ancestor
153875660|NCT01178086|Rituximab|rituximab|mesh-list
153875661|NCT01178086|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153875662|NCT01178086|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153875663|NCT01178086|Immunologic Factors|immunologic factors|mesh-ancestor
153875664|NCT01178086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153875665|NCT01178086|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153875666|NCT04531865|Mycophenolic Acid|mycophenolic acid|mesh-list
153875667|NCT04531865|Rituximab|rituximab|mesh-list
153416406|NCT00368719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153416407|NCT00368719|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
153416408|NCT00368719|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153416409|NCT00368719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153416410|NCT00369811|Fentanyl|fentanyl|mesh-list
153416411|NCT00369811|Oxycodone|oxycodone|mesh-list
153416412|NCT00369811|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153416413|NCT00369811|Narcotics|narcotics|mesh-ancestor
153416414|NCT00369811|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153416415|NCT00369811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153416416|NCT00369811|Analgesics|analgesics|mesh-ancestor
153416417|NCT00369811|Sensory System Agents|sensory system agents|mesh-ancestor
153416418|NCT00369811|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153416419|NCT00369811|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153416420|NCT00369811|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153416421|NCT00369811|Anesthetics, General|anesthetics, general|mesh-ancestor
153416422|NCT00369811|Anesthetics|anesthetics|mesh-ancestor
153416423|NCT03615547|Clomiphene|clomiphene|mesh-list
153416424|NCT03615547|Enclomiphene|enclomiphene|mesh-list
153416425|NCT03615547|Zuclomiphene|zuclomiphene|mesh-list
153416426|NCT03615547|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
153416427|NCT03615547|Hormone Antagonists|hormone antagonists|mesh-ancestor
153416433|NCT03615547|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
153416435|NCT03105128|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
153416436|NCT03105128|Immunologic Factors|immunologic factors|mesh-ancestor
153416437|NCT03105128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153416438|NCT03122509|Durvalumab|durvalumab|mesh-list
153416439|NCT03122509|Tremelimumab|tremelimumab|mesh-list
153386556|NCT01016847|Hormone Antagonists|hormone antagonists|mesh-ancestor
153386557|NCT01016847|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153386583|NCT00965055|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153386584|NCT00965055|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
153386585|NCT00965055|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153386586|NCT02266797|Dexamethasone|dexamethasone|mesh-list
153386587|NCT02266797|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153416440|NCT03122509|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153416442|NCT03113695|Lenalidomide|lenalidomide|mesh-list
153875668|NCT04531865|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153875669|NCT04531865|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153875670|NCT04531865|Immunologic Factors|immunologic factors|mesh-ancestor
153875671|NCT04531865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153875672|NCT04531865|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153875673|NCT04531865|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153875674|NCT04531865|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
153875675|NCT04531865|Antitubercular Agents|antitubercular agents|mesh-ancestor
153875676|NCT04531865|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153875677|NCT04531865|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153875678|NCT04531865|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153875679|NCT04531865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153875680|NCT01643070|Capecitabine|capecitabine|mesh-list
153875681|NCT01643070|Oxaliplatin|oxaliplatin|mesh-list
153875682|NCT01643070|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153875683|NCT01643070|Antimetabolites|antimetabolites|mesh-ancestor
153875684|NCT01643070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153875685|NCT01643070|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153875687|NCT01684059|Astringents|astringents|mesh-ancestor
153875688|NCT01684059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153875692|NCT04531748|Antioxidants|antioxidants|mesh-ancestor
153875693|NCT04531748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153875694|NCT04531748|Protective Agents|protective agents|mesh-ancestor
153875695|NCT04531748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153875696|NCT04531748|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153875697|NCT04531748|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153875698|NCT04531748|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153875699|NCT04531748|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
153875700|NCT04531748|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
153875701|NCT04531748|Hormone Antagonists|hormone antagonists|mesh-ancestor
153416446|NCT03113695|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153416447|NCT03113695|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153416448|NCT03113695|Growth Substances|growth substances|mesh-ancestor
153416449|NCT03113695|Growth Inhibitors|growth inhibitors|mesh-ancestor
153416450|NCT03113695|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153416451|NCT03113695|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153416452|NCT00369434|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
153416453|NCT00369434|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
153416454|NCT00369434|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153416455|NCT00369434|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153416456|NCT00369434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153416457|NCT00369434|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153416458|NCT00369434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153416459|NCT00369434|Antidepressive Agents|antidepressive agents|mesh-ancestor
153416460|NCT00369434|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153416461|NCT05444738|Oxytocin|oxytocin|mesh-list
153416462|NCT05444738|Oxytocics|oxytocics|mesh-ancestor
153875713|NCT01177813|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153875714|NCT01177813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153875715|NCT01177813|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
153875716|NCT04315831|Buprenorphine|buprenorphine|mesh-list
153875719|NCT04315831|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153875720|NCT04315831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153875725|NCT02216045|Ribavirin|ribavirin|mesh-list
153386588|NCT02266797|Antiemetics|antiemetics|mesh-ancestor
153386589|NCT02266797|Autonomic Agents|autonomic agents|mesh-ancestor
153386590|NCT02266797|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153386591|NCT02266797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153386592|NCT02266797|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153386593|NCT02266797|Glucocorticoids|glucocorticoids|mesh-ancestor
153386594|NCT02266797|Hormones|hormones|mesh-ancestor
153386595|NCT02266797|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153386596|NCT02266797|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153875726|NCT02216045|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
153875727|NCT02216045|Interferon-alpha|interferon-alpha|mesh-list
153875728|NCT02216045|Antimetabolites|antimetabolites|mesh-ancestor
153875729|NCT02216045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153875730|NCT02216045|Antiviral Agents|antiviral agents|mesh-ancestor
153875731|NCT02216045|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153875732|NCT02216045|Immunologic Factors|immunologic factors|mesh-ancestor
153875733|NCT02216045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153875734|NCT01684371|Tea Tree Oil|tea tree oil|mesh-list
153875735|NCT01684371|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
153875736|NCT01684371|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
153875737|NCT01684371|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153416479|NCT02757313|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153416480|NCT02757313|Analgesics|analgesics|mesh-ancestor
153416481|NCT02757313|Sensory System Agents|sensory system agents|mesh-ancestor
153416482|NCT02757313|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153416483|NCT02757313|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
153416484|NCT02757313|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
153416485|NCT02757313|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153416486|NCT02757313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153416487|NCT02757313|Hormones|hormones|mesh-ancestor
153416488|NCT02757313|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153416489|NCT02379806|Enoxaparin|enoxaparin|mesh-list
153416490|NCT02379806|Anticoagulants|anticoagulants|mesh-ancestor
153416491|NCT02379806|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153877885|NCT05284643|Bevacizumab|bevacizumab|mesh-list
153416493|NCT02379806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153416494|NCT02358356|Capecitabine|capecitabine|mesh-list
153416495|NCT02358356|Temozolomide|temozolomide|mesh-list
153416496|NCT02358356|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153416497|NCT02358356|Antimetabolites|antimetabolites|mesh-ancestor
153416498|NCT02358356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153416499|NCT02358356|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153416500|NCT02358356|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153416502|NCT04700761|Analgesics, Opioid|analgesics, opioid|mesh-list
153416503|NCT04700761|Anesthetics|anesthetics|mesh-list
153416504|NCT04700761|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153416505|NCT04700761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153416506|NCT04700761|Narcotics|narcotics|mesh-ancestor
153416507|NCT04700761|Analgesics|analgesics|mesh-ancestor
153416508|NCT04700761|Sensory System Agents|sensory system agents|mesh-ancestor
153416509|NCT04700761|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153416510|NCT00368498|Teicoplanin|teicoplanin|mesh-list
153416511|NCT00368498|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153875738|NCT04531397|Dapagliflozin|dapagliflozin|mesh-list
153875739|NCT04531397|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
153416513|NCT05172817|Adalimumab|adalimumab|mesh-list
153875740|NCT04531397|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
153875741|NCT04531397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153875742|NCT04531397|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153875743|NCT04531397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153875744|NCT04531397|Protease Inhibitors|protease inhibitors|mesh-ancestor
153875745|NCT04531397|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153875746|NCT04531475|Lansoprazole|lansoprazole|mesh-list
153875747|NCT04531475|Dexlansoprazole|dexlansoprazole|mesh-list
153875748|NCT04531475|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
153875749|NCT04531475|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153875750|NCT04531475|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
153875751|NCT04531475|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153875752|NCT04531475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153875753|NCT01684449|Sirolimus|sirolimus|mesh-list
153875754|NCT01684449|Gemcitabine|gemcitabine|mesh-list
153875755|NCT01684449|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153875756|NCT01684449|Antimetabolites|antimetabolites|mesh-ancestor
153875757|NCT01684449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153875758|NCT01684449|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153875759|NCT01684449|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153875770|NCT01684683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153416524|NCT00961142|Immunologic Factors|immunologic factors|mesh-ancestor
153416525|NCT00961142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153416526|NCT00961142|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153416527|NCT00961142|Alkylating Agents|alkylating agents|mesh-ancestor
153416528|NCT00961142|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153416529|NCT04338373|Atropine|atropine|mesh-list
153416530|NCT04338373|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153416533|NCT04338373|Autonomic Agents|autonomic agents|mesh-ancestor
153416534|NCT04338373|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153416535|NCT04338373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153416536|NCT04338373|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153416537|NCT04338373|Respiratory System Agents|respiratory system agents|mesh-ancestor
153416538|NCT04338373|Mydriatics|mydriatics|mesh-ancestor
153416539|NCT04338373|Parasympatholytics|parasympatholytics|mesh-ancestor
153875781|NCT01684800|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
153875783|NCT01684800|Coagulants|coagulants|mesh-ancestor
153875784|NCT01684800|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
153875785|NCT01684800|Natriuretic Agents|natriuretic agents|mesh-ancestor
153875786|NCT01684800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153875787|NCT04531163|Acetylcysteine|acetylcysteine|mesh-list
153875788|NCT04531163|N-monoacetylcystine|n-monoacetylcystine|mesh-list
153875789|NCT04531163|Antiviral Agents|antiviral agents|mesh-ancestor
153875790|NCT04531163|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153875791|NCT04531163|Expectorants|expectorants|mesh-ancestor
153875792|NCT04531163|Respiratory System Agents|respiratory system agents|mesh-ancestor
153875793|NCT04531163|Free Radical Scavengers|free radical scavengers|mesh-ancestor
153875794|NCT04531163|Antioxidants|antioxidants|mesh-ancestor
153875795|NCT04531163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153416540|NCT04338373|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
153416541|NCT04338373|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
153416542|NCT04338373|Cholinergic Agents|cholinergic agents|mesh-ancestor
153416543|NCT04338373|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153416544|NCT04338373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153416545|NCT00369031|polysaccharide-K|polysaccharide-k|mesh-list
153416546|NCT00369031|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153416547|NCT00369031|Immunologic Factors|immunologic factors|mesh-ancestor
153416548|NCT00369031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153416549|NCT00369031|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153416550|NCT00369031|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153416551|NCT00369031|Antiviral Agents|antiviral agents|mesh-ancestor
153416552|NCT00369031|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153416554|NCT00369031|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
153416555|NCT00369031|Protective Agents|protective agents|mesh-ancestor
153416556|NCT05061901|Lisinopril|lisinopril|mesh-list
153416557|NCT05061901|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
153416558|NCT05061901|Protease Inhibitors|protease inhibitors|mesh-ancestor
153416559|NCT05061901|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153416560|NCT05061901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153416561|NCT05061901|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153416562|NCT05061901|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
153416563|NCT05061901|Protective Agents|protective agents|mesh-ancestor
153416564|NCT05061901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153416566|NCT04338919|Ticagrelor|ticagrelor|mesh-list
153875798|NCT04531163|Antidotes|antidotes|mesh-ancestor
153875799|NCT01684995|Nicotine|nicotine|mesh-list
153875800|NCT01684995|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
153875801|NCT01684995|Autonomic Agents|autonomic agents|mesh-ancestor
153875802|NCT01684995|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153875803|NCT01684995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153875804|NCT01684995|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
153875805|NCT01684995|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
153875806|NCT01684995|Cholinergic Agents|cholinergic agents|mesh-ancestor
153875807|NCT01684995|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153875808|NCT01684995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153875809|NCT01685502|Acarbose|acarbose|mesh-list
153875810|NCT01685502|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
153875811|NCT01685502|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153875812|NCT01685502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153875813|NCT01685502|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153875814|NCT01685502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153875815|NCT04527276|Chlorhexidine|chlorhexidine|mesh-list
153875816|NCT04527276|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
153875817|NCT04527276|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153875819|NCT01200355|Posaconazole|posaconazole|mesh-list
153875820|NCT01200355|Micafungin|micafungin|mesh-list
153875821|NCT01200355|Antifungal Agents|antifungal agents|mesh-ancestor
153875822|NCT01200355|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153875823|NCT01200355|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
153875824|NCT01200355|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153875825|NCT01200355|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153875826|NCT01200355|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
153875827|NCT01200355|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153875828|NCT01200355|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153875829|NCT01200355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153875830|NCT01200355|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153875831|NCT01200355|Hormone Antagonists|hormone antagonists|mesh-ancestor
153875832|NCT01200355|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153875833|NCT01200355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153416581|NCT04338919|Antipyretics|antipyretics|mesh-ancestor
153416582|NCT04338919|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
153416583|NCT04338919|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
153416584|NCT04338919|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
153416585|NCT04338919|Purinergic Agents|purinergic agents|mesh-ancestor
153416586|NCT04338919|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153416587|NCT05451290|Gemcitabine|gemcitabine|mesh-list
153416588|NCT05451290|Tegafur|tegafur|mesh-list
153416589|NCT05451290|Oxaliplatin|oxaliplatin|mesh-list
153416590|NCT05451290|Apatinib|apatinib|mesh-list
153416591|NCT05451290|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153416592|NCT05451290|Antimetabolites|antimetabolites|mesh-ancestor
153416593|NCT05451290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153416594|NCT05451290|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153416595|NCT05451290|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153416596|NCT05451290|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153416597|NCT00369889|Bevacizumab|bevacizumab|mesh-list
153416598|NCT00369889|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
153416599|NCT00369889|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153416600|NCT00369889|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153416601|NCT00369889|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153875856|NCT04530578|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
153875858|NCT04530578|Dalteparin|dalteparin|mesh-list
153875859|NCT04530578|Anticoagulants|anticoagulants|mesh-ancestor
153875860|NCT04530578|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153875861|NCT04530578|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153878001|NCT05069935|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153416609|NCT00369889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153416610|NCT00369044|Prednisone|prednisone|mesh-list
153416611|NCT00369044|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153416612|NCT00369044|Glucocorticoids|glucocorticoids|mesh-ancestor
153416613|NCT00369044|Hormones|hormones|mesh-ancestor
153416614|NCT00369044|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153416615|NCT00369044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153416616|NCT00369044|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153416617|NCT00369044|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153416618|NCT00370045|Bivalirudin|bivalirudin|mesh-list
153416619|NCT00370045|Eptifibatide|eptifibatide|mesh-list
153416620|NCT00370045|Antithrombins|antithrombins|mesh-ancestor
153416621|NCT00370045|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
153416622|NCT00370045|Protease Inhibitors|protease inhibitors|mesh-ancestor
153416623|NCT00370045|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153416624|NCT00370045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153416625|NCT00370045|Anticoagulants|anticoagulants|mesh-ancestor
153416626|NCT00370045|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153416627|NCT05451056|Sotorasib|sotorasib|mesh-list
153416628|NCT05451056|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153416629|NCT05451056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153416630|NCT05451056|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153416631|NCT05451056|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153416632|NCT05441150|Ketamine|ketamine|mesh-list
153416633|NCT05441150|Analgesics|analgesics|mesh-ancestor
153875880|NCT04530422|Antiviral Agents|antiviral agents|mesh-ancestor
153875881|NCT02887573|Mosapride|mosapride|mesh-list
153875882|NCT02887573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153875883|NCT02887573|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153875884|NCT02887573|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
153875885|NCT02887573|Serotonin Agents|serotonin agents|mesh-ancestor
153875886|NCT02887573|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153875887|NCT02887573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153875888|NCT01685892|Venetoclax|venetoclax|mesh-list
153875889|NCT01685892|Obinutuzumab|obinutuzumab|mesh-list
153875890|NCT01685892|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153875891|NCT01685892|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153416635|NCT05441150|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153416636|NCT05441150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153416637|NCT05441150|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
153416638|NCT05441150|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153416639|NCT05441150|Anesthetics, General|anesthetics, general|mesh-ancestor
153416641|NCT05441150|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153416642|NCT05441150|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
153416644|NCT05441150|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153416645|NCT05441150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153416646|NCT04270214|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
153416647|NCT04270214|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
153416648|NCT04270214|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153416649|NCT04270214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153416651|NCT04270214|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153416652|NCT04270214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153416653|NCT05438810|Fulvestrant|fulvestrant|mesh-list
153416654|NCT05438810|Goserelin|goserelin|mesh-list
153416655|NCT05438810|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153416656|NCT05438810|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153416657|NCT05438810|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
153416658|NCT05438810|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
153416659|NCT05438810|Hormone Antagonists|hormone antagonists|mesh-ancestor
153416660|NCT05438810|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153875907|NCT02887534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153875908|NCT01685931|Paliperidone Palmitate|paliperidone palmitate|mesh-list
153875909|NCT01685931|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153875910|NCT01685931|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153875911|NCT01685931|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153875912|NCT01685931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153875913|NCT01685931|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153875914|NCT01685931|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
153875915|NCT01685931|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153875916|NCT01685931|Serotonin Agents|serotonin agents|mesh-ancestor
153875917|NCT01685931|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153875918|NCT01685931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153416669|NCT05451121|Sensory System Agents|sensory system agents|mesh-ancestor
153416670|NCT05451121|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153416671|NCT05451121|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
153416672|NCT05451121|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153878065|NCT04979611|Exenatide|exenatide|mesh-list
153416682|NCT04967443|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
153416684|NCT04967443|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
153416685|NCT04967443|Adrenergic Agents|adrenergic agents|mesh-ancestor
153416686|NCT04967443|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153416687|NCT04967443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153416688|NCT04967443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153416689|NCT04697017|Salicylic Acid|salicylic acid|mesh-list
153416690|NCT04697017|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153416691|NCT04697017|Antifungal Agents|antifungal agents|mesh-ancestor
153416692|NCT04697017|Keratolytic Agents|keratolytic agents|mesh-ancestor
153875920|NCT01685931|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
153875921|NCT01685931|Dopamine Agents|dopamine agents|mesh-ancestor
153875922|NCT01685970|Picosulfate sodium|picosulfate sodium|mesh-list
153875923|NCT01685970|Cathartics|cathartics|mesh-ancestor
153875924|NCT01685970|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153875925|NCT04530617|Camostat|camostat|mesh-list
153878096|NCT04952792|Anticoagulants|anticoagulants|mesh-ancestor
153875927|NCT04530617|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153875928|NCT04530617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153875929|NCT04530617|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
153875930|NCT04530617|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
153875931|NCT01686009|Ketamine|ketamine|mesh-list
153875932|NCT01686009|Analgesics|analgesics|mesh-ancestor
153875933|NCT01686009|Sensory System Agents|sensory system agents|mesh-ancestor
153875934|NCT01686009|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153875935|NCT01686009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153875936|NCT01686009|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
153875937|NCT01686009|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153875938|NCT01686009|Anesthetics, General|anesthetics, general|mesh-ancestor
153875939|NCT01686009|Anesthetics|anesthetics|mesh-ancestor
153875940|NCT01686009|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153875941|NCT01686009|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
153875942|NCT01686009|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
153875943|NCT01686009|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153875944|NCT01686009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153875945|NCT04536662|Dexamethasone|dexamethasone|mesh-list
153875946|NCT04536662|Prednisone|prednisone|mesh-list
153875947|NCT04536662|Hydrocortisone|hydrocortisone|mesh-list
153875948|NCT04536662|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153875949|NCT04536662|Antiemetics|antiemetics|mesh-ancestor
153875950|NCT04536662|Autonomic Agents|autonomic agents|mesh-ancestor
153875951|NCT04536662|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153416693|NCT04697017|Dermatologic Agents|dermatologic agents|mesh-ancestor
153416694|NCT02230956|Botulinum Toxins|botulinum toxins|mesh-list
153416695|NCT02230956|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
153416696|NCT02230956|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
153416697|NCT02230956|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
153416698|NCT02230956|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153416699|NCT02230956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153416700|NCT02230956|Cholinergic Agents|cholinergic agents|mesh-ancestor
153416701|NCT02230956|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153416702|NCT02230956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153416703|NCT02230956|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
153416711|NCT04739384|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153416712|NCT04739384|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
153416713|NCT04739384|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
153416714|NCT04739384|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
153416715|NCT04739384|Purinergic Agents|purinergic agents|mesh-ancestor
153416716|NCT04739384|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153416717|NCT04739384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153416718|NCT04739384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153416719|NCT04704596|Anesthetics|anesthetics|mesh-list
153416720|NCT04704596|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153416721|NCT04704596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153416722|NCT05450497|Dexmedetomidine|dexmedetomidine|mesh-list
153416724|NCT05450497|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153416725|NCT05450497|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153416727|NCT05450497|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153416728|NCT05450497|Analgesics|analgesics|mesh-ancestor
153416729|NCT05450497|Sensory System Agents|sensory system agents|mesh-ancestor
153416730|NCT05450497|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153416731|NCT05450497|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
153416732|NCT05450497|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153416733|NCT05450497|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153416734|NCT05450497|Adrenergic Agents|adrenergic agents|mesh-ancestor
153416735|NCT05450497|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153416736|NCT05450497|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153416737|NCT05450497|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153416738|NCT05450497|Anesthetics, General|anesthetics, general|mesh-ancestor
153416739|NCT05450497|Anesthetics|anesthetics|mesh-ancestor
153416740|NCT02230332|Alendronate|alendronate|mesh-list
153416741|NCT02230332|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153416742|NCT02230332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153416743|NCT05449028|Bismuth|bismuth|mesh-list
153875970|NCT01199731|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153875971|NCT01199731|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153875973|NCT01199731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153875974|NCT01199731|Antiviral Agents|antiviral agents|mesh-ancestor
153875975|NCT01199731|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153875976|NCT01686555|Venetoclax|venetoclax|mesh-list
153875977|NCT01686555|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153386597|NCT02266797|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153386598|NCT00378183|Risperidone|risperidone|mesh-list
153386599|NCT00378183|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153386600|NCT00378183|Serotonin Agents|serotonin agents|mesh-ancestor
153386602|NCT00378183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153386634|NCT00924807|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153386636|NCT00896025|N-monoacetylcystine|n-monoacetylcystine|mesh-list
153386638|NCT00896025|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153386639|NCT00896025|Expectorants|expectorants|mesh-ancestor
153386640|NCT00896025|Respiratory System Agents|respiratory system agents|mesh-ancestor
153386641|NCT00896025|Free Radical Scavengers|free radical scavengers|mesh-ancestor
153386642|NCT00896025|Antioxidants|antioxidants|mesh-ancestor
153386643|NCT00896025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153386644|NCT00896025|Protective Agents|protective agents|mesh-ancestor
153386645|NCT00896025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153386646|NCT00896025|Antidotes|antidotes|mesh-ancestor
153386647|NCT02162979|Sildenafil Citrate|sildenafil citrate|mesh-list
153386648|NCT02162979|Vasodilator Agents|vasodilator agents|mesh-ancestor
153386649|NCT02162979|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
153875978|NCT01686789|Interferons|interferons|mesh-list
153875979|NCT01686789|Interferon-alpha|interferon-alpha|mesh-list
153875980|NCT01686789|Interferon alpha-2|interferon alpha-2|mesh-list
153875981|NCT01686789|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
153875982|NCT01686789|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153875983|NCT01686789|Antiviral Agents|antiviral agents|mesh-ancestor
153875984|NCT01686789|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153875985|NCT01686789|Immunologic Factors|immunologic factors|mesh-ancestor
153875986|NCT01686789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153875987|NCT02217683|Nitric Oxide|nitric oxide|mesh-list
153875988|NCT02217683|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153875989|NCT02217683|Autonomic Agents|autonomic agents|mesh-ancestor
153875990|NCT02217683|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153875991|NCT02217683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153875992|NCT02217683|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153875993|NCT02217683|Respiratory System Agents|respiratory system agents|mesh-ancestor
153875994|NCT02217683|Free Radical Scavengers|free radical scavengers|mesh-ancestor
153875995|NCT02217683|Antioxidants|antioxidants|mesh-ancestor
153416750|NCT04845139|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153416751|NCT04845139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153416753|NCT04738526|Antidepressive Agents|antidepressive agents|mesh-ancestor
153416758|NCT04738526|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153416759|NCT04738526|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153416760|NCT04738526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153416761|NCT05449483|Paclitaxel|paclitaxel|mesh-list
153416762|NCT05449483|Tislelizumab|tislelizumab|mesh-list
153416763|NCT05449483|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153416764|NCT05449483|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153416765|NCT05449483|Tubulin Modulators|tubulin modulators|mesh-ancestor
153416766|NCT05449483|Antimitotic Agents|antimitotic agents|mesh-ancestor
153416767|NCT05449483|Mitosis Modulators|mitosis modulators|mesh-ancestor
153416768|NCT05449483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153416769|NCT05449483|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153416770|NCT05448404|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
153416771|NCT05448404|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
153475840|NCT00835224|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153416772|NCT05448404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153416773|NCT04793659|Fasudil|fasudil|mesh-list
153416774|NCT04793659|1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine|1-(5-isoquinolinesulfonyl)-2-methylpiperazine|mesh-list
153416775|NCT04793659|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153416776|NCT04793659|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153416777|NCT04793659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153876003|NCT02217722|Amoxicillin|amoxicillin|mesh-list
153876004|NCT02217722|Metronidazole|metronidazole|mesh-list
153876005|NCT02217722|Doxycycline|doxycycline|mesh-list
153876006|NCT02217722|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153876007|NCT02217722|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153876008|NCT02217722|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153876009|NCT02217722|Antimalarials|antimalarials|mesh-ancestor
153876010|NCT01686945|Semaglutide|semaglutide|mesh-list
153876011|NCT01686945|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
153876012|NCT01686945|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153876013|NCT01686945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153876014|NCT02217839|Octreotide|octreotide|mesh-list
153876015|NCT02217839|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153876016|NCT02217839|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153876017|NCT02217839|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153876018|NCT01687062|Fe(III)-EDTA|fe(iii)-edta|mesh-list
153876019|NCT01687062|Iron Chelating Agents|iron chelating agents|mesh-ancestor
153876020|NCT01687062|Chelating Agents|chelating agents|mesh-ancestor
153876021|NCT01687062|Sequestering Agents|sequestering agents|mesh-ancestor
153876022|NCT01687062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153876023|NCT02217956|Bevacizumab|bevacizumab|mesh-list
153876024|NCT02217956|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153876036|NCT01687140|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153418997|NCT05821972|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153418998|NCT05821972|Adrenergic Agents|adrenergic agents|mesh-ancestor
153416778|NCT04793659|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153416779|NCT04793659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153416781|NCT04793659|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153416782|NCT04793659|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153416785|NCT05448937|Dermatologic Agents|dermatologic agents|mesh-ancestor
153416786|NCT05448937|Sunscreening Agents|sunscreening agents|mesh-ancestor
153416787|NCT05448937|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
153416788|NCT05448937|Protective Agents|protective agents|mesh-ancestor
153416789|NCT05448937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153416790|NCT05448937|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153416791|NCT00370201|Colchicine|colchicine|mesh-list
153416792|NCT00370201|Gout Suppressants|gout suppressants|mesh-ancestor
153416793|NCT00370201|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153416794|NCT00370201|Tubulin Modulators|tubulin modulators|mesh-ancestor
153416795|NCT00370201|Antimitotic Agents|antimitotic agents|mesh-ancestor
153416796|NCT00370201|Mitosis Modulators|mitosis modulators|mesh-ancestor
153416797|NCT00370201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153416798|NCT00370201|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153416799|NCT05448781|Paclitaxel|paclitaxel|mesh-list
153416800|NCT05448781|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
153416801|NCT05448781|Carboplatin|carboplatin|mesh-list
153416802|NCT05448781|Pemetrexed|pemetrexed|mesh-list
153416803|NCT05448781|Endostatins|endostatins|mesh-list
153876047|NCT04535960|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
153876048|NCT04535960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153876049|NCT04536428|Hemostatics|hemostatics|mesh-list
153876050|NCT04536428|Coagulants|coagulants|mesh-ancestor
153876051|NCT01687374|Hormones|hormones|mesh-list
153876052|NCT01687374|Parathyroid Hormone|parathyroid hormone|mesh-list
153876053|NCT01687374|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153876054|NCT01687374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153876055|NCT01687374|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153876056|NCT04530188|Propofol|propofol|mesh-list
153876057|NCT04530188|Sevoflurane|sevoflurane|mesh-list
153876058|NCT04530188|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153876059|NCT04530188|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153876060|NCT04530188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153876061|NCT04530188|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153876062|NCT04530188|Anesthetics, General|anesthetics, general|mesh-ancestor
153876063|NCT04530188|Anesthetics|anesthetics|mesh-ancestor
153876064|NCT04530188|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153876065|NCT04530188|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
153876066|NCT01687491|Enoxaparin|enoxaparin|mesh-list
153876067|NCT01687491|Anticoagulants|anticoagulants|mesh-ancestor
153386650|NCT02162979|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
153386651|NCT02162979|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153386652|NCT02162979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153386653|NCT02162979|Urological Agents|urological agents|mesh-ancestor
153386654|NCT01908842|Buprenorphine|buprenorphine|mesh-list
153386655|NCT01908842|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153386656|NCT01908842|Narcotics|narcotics|mesh-ancestor
153386657|NCT01908842|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153386770|NCT00760461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153386771|NCT00750555|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
153386772|NCT00750555|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153386773|NCT00750555|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153416811|NCT05448781|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153416812|NCT05448781|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153416813|NCT05448781|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153416814|NCT05448781|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153416815|NCT05448781|Growth Substances|growth substances|mesh-ancestor
153419013|NCT05748587|Trace Elements|trace elements|mesh-ancestor
153876073|NCT04530227|Pemetrexed|pemetrexed|mesh-list
153876074|NCT04530227|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153876075|NCT04530227|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153876076|NCT04530227|Tubulin Modulators|tubulin modulators|mesh-ancestor
153876077|NCT04530227|Antimitotic Agents|antimitotic agents|mesh-ancestor
153876078|NCT04530227|Mitosis Modulators|mitosis modulators|mesh-ancestor
153876079|NCT04530227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153876080|NCT04530227|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153876081|NCT04530227|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153876082|NCT04530227|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153876083|NCT01199263|Paclitaxel|paclitaxel|mesh-list
153876084|NCT01199263|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
153876085|NCT01199263|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153876086|NCT01199263|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153876087|NCT01199263|Tubulin Modulators|tubulin modulators|mesh-ancestor
153876088|NCT01199263|Antimitotic Agents|antimitotic agents|mesh-ancestor
153876089|NCT01199263|Mitosis Modulators|mitosis modulators|mesh-ancestor
153876090|NCT01199263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153876091|NCT02218034|Nicotinic Acids|nicotinic acids|mesh-list
153876092|NCT02218034|Tazarotene|tazarotene|mesh-list
153876093|NCT02218034|Dermatologic Agents|dermatologic agents|mesh-ancestor
153876094|NCT02218034|Keratolytic Agents|keratolytic agents|mesh-ancestor
153876095|NCT02218034|Vitamin B Complex|vitamin b complex|mesh-ancestor
153876096|NCT02218034|Vitamins|vitamins|mesh-ancestor
153416840|NCT02626130|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153416841|NCT02626130|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153416842|NCT02626130|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153416843|NCT02626130|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153416846|NCT02618720|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153416847|NCT02618720|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153416848|NCT02618720|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153416849|NCT02618720|Antitrichomonal Agents|antitrichomonal agents|mesh-ancestor
153416850|NCT02042989|Vorinostat|vorinostat|mesh-list
153416851|NCT02042989|Ixazomib|ixazomib|mesh-list
153416852|NCT02042989|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153416853|NCT02042989|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
153416854|NCT02042989|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153416855|NCT02042989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153416856|NCT02042989|Protease Inhibitors|protease inhibitors|mesh-ancestor
153416857|NCT04093531|Ustekinumab|ustekinumab|mesh-list
153416858|NCT04093531|Dermatologic Agents|dermatologic agents|mesh-ancestor
153416859|NCT05208944|Cemiplimab|cemiplimab|mesh-list
153416860|NCT05208944|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153416862|NCT01809379|Cisplatin|cisplatin|mesh-list
153416863|NCT01809379|Doxorubicin|doxorubicin|mesh-list
153416864|NCT01809379|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153416865|NCT01809379|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153416866|NCT01809379|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153416867|NCT01809379|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153416868|NCT01809379|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153416869|NCT01809379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153416870|NCT02229396|Dapagliflozin|dapagliflozin|mesh-list
153416871|NCT02229396|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
153876105|NCT01688154|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153876106|NCT01688154|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153876107|NCT01688154|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153876108|NCT01688349|Glucocorticoids|glucocorticoids|mesh-list
153876109|NCT01688349|Hormones|hormones|mesh-ancestor
153876110|NCT01688349|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153876111|NCT01688349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153876112|NCT05138484|Chlorhexidine|chlorhexidine|mesh-list
153876113|NCT05138484|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
153876114|NCT05138484|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
153876115|NCT05138484|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153876116|NCT05138484|Disinfectants|disinfectants|mesh-ancestor
153876117|NCT05138484|Dermatologic Agents|dermatologic agents|mesh-ancestor
153876118|NCT04535804|Aspirin|aspirin|mesh-list
153876119|NCT04535804|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153876120|NCT04535804|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153876121|NCT04535804|Analgesics|analgesics|mesh-ancestor
153876122|NCT04535804|Sensory System Agents|sensory system agents|mesh-ancestor
153876123|NCT04535804|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153876124|NCT04535804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153876125|NCT04535804|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153876126|NCT04535804|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153876127|NCT04535804|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153876128|NCT04535804|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153876129|NCT04535804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153876130|NCT04535804|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153876131|NCT04535804|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153876132|NCT04535804|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153876133|NCT04535804|Antipyretics|antipyretics|mesh-ancestor
153876134|NCT04529525|Ivermectin|ivermectin|mesh-list
153876135|NCT04529525|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153416880|NCT05202158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153416881|NCT00370370|Triamcinolone|triamcinolone|mesh-list
153416882|NCT00370370|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
153416883|NCT00370370|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
153416884|NCT00370370|Bevacizumab|bevacizumab|mesh-list
153416885|NCT00370370|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
153416886|NCT00370370|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153416887|NCT00370370|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153416898|NCT00370370|Immunologic Factors|immunologic factors|mesh-ancestor
153416899|NCT00370370|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153416900|NCT00370370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153416901|NCT02197416|Dabigatran|dabigatran|mesh-list
153416902|NCT02197416|Antithrombins|antithrombins|mesh-ancestor
153416903|NCT02197416|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
153416904|NCT02197416|Protease Inhibitors|protease inhibitors|mesh-ancestor
153416905|NCT02197416|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153876152|NCT05126121|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153876153|NCT05126121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153876154|NCT05126121|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
153876155|NCT05126121|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153876156|NCT05126121|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
153876157|NCT05126121|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153876158|NCT05126121|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153876159|NCT05126121|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153876160|NCT05126121|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
153416906|NCT02197416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153416907|NCT02197416|Anticoagulants|anticoagulants|mesh-ancestor
153416908|NCT00370591|Fluticasone|fluticasone|mesh-list
153416909|NCT00370591|Xhance|xhance|mesh-list
153416910|NCT00370591|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
153416911|NCT00370591|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153416912|NCT00370591|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153416913|NCT00370591|Autonomic Agents|autonomic agents|mesh-ancestor
153416914|NCT00370591|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153416915|NCT00370591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153416916|NCT00370591|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153416917|NCT00370591|Respiratory System Agents|respiratory system agents|mesh-ancestor
153416918|NCT00370591|Dermatologic Agents|dermatologic agents|mesh-ancestor
153416919|NCT00370591|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
153416920|NCT00370591|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
153416921|NCT00370591|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
153416922|NCT00370591|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153416923|NCT00370591|Adrenergic Agents|adrenergic agents|mesh-ancestor
153876161|NCT05126121|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
153876162|NCT05126121|Antitrichomonal Agents|antitrichomonal agents|mesh-ancestor
153876163|NCT05126121|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153876164|NCT05126121|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153876165|NCT05126121|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
153876166|NCT05126121|Alkylating Agents|alkylating agents|mesh-ancestor
153876168|NCT02218658|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153876169|NCT02218658|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153876170|NCT02218658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153876171|NCT01199068|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
153876172|NCT01199068|Efatutazone|efatutazone|mesh-list
153876173|NCT01199068|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153876174|NCT01199068|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153416933|NCT00371527|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153416934|NCT00371527|Respiratory System Agents|respiratory system agents|mesh-ancestor
153416935|NCT00371527|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
153419147|NCT05491187|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153419149|NCT05480878|Nitazoxanide|nitazoxanide|mesh-list
153416938|NCT00371527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153416939|NCT00392756|Hormones|hormones|mesh-list
153416940|NCT00392756|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153416941|NCT00392756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153416942|NCT04027322|Dexamethasone|dexamethasone|mesh-list
153416943|NCT04027322|Budesonide|budesonide|mesh-list
153416944|NCT04027322|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153416945|NCT04027322|Antiemetics|antiemetics|mesh-ancestor
153416946|NCT04027322|Autonomic Agents|autonomic agents|mesh-ancestor
153416947|NCT04027322|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153416948|NCT04027322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153416949|NCT04027322|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153416950|NCT04027322|Glucocorticoids|glucocorticoids|mesh-ancestor
153416951|NCT04027322|Hormones|hormones|mesh-ancestor
153876187|NCT01198795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153876189|NCT02278913|Insulin Glargine|insulin glargine|mesh-list
153876190|NCT02278913|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
153876191|NCT02278913|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153876192|NCT02278913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153876193|NCT02216513|Deferoxamine|deferoxamine|mesh-list
153876194|NCT02216513|Siderophores|siderophores|mesh-ancestor
153876196|NCT02216513|Chelating Agents|chelating agents|mesh-ancestor
153419217|NCT05322252|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
153876197|NCT02216513|Sequestering Agents|sequestering agents|mesh-ancestor
153876198|NCT02216513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153876199|NCT02218775|Aticaprant|aticaprant|mesh-list
153876200|NCT02218775|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
153876201|NCT02218775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153876202|NCT02218775|Sensory System Agents|sensory system agents|mesh-ancestor
153876203|NCT02218775|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153876204|NCT02216552|Resveratrol|resveratrol|mesh-list
153416953|NCT04027322|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153416955|NCT04027322|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153416956|NCT04027322|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153416957|NCT04027322|Respiratory System Agents|respiratory system agents|mesh-ancestor
153416958|NCT03845257|Dimercaprol|dimercaprol|mesh-list
153416959|NCT03845257|Chelating Agents|chelating agents|mesh-ancestor
153416960|NCT03845257|Sequestering Agents|sequestering agents|mesh-ancestor
153416961|NCT03845257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153416962|NCT00371072|Mitomycins|mitomycins|mesh-list
153416963|NCT00371072|Mitomycin|mitomycin|mesh-list
153416964|NCT00371072|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153416965|NCT00371072|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153878442|NCT04329650|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153416969|NCT00371072|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153416970|NCT05454332|Caffeine|caffeine|mesh-list
153416971|NCT05454332|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
153416972|NCT05454332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153386774|NCT00750555|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153416973|NCT05454332|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
153416974|NCT05454332|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153416975|NCT05454332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153416976|NCT05454332|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
153416977|NCT05454332|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
153416978|NCT05454332|Purinergic Agents|purinergic agents|mesh-ancestor
153416979|NCT05454332|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153416982|NCT03924518|Antiemetics|antiemetics|mesh-ancestor
153416983|NCT03924518|Autonomic Agents|autonomic agents|mesh-ancestor
153876218|NCT02216487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153876219|NCT02216487|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153876221|NCT02218814|Anesthetics, Local|anesthetics, local|mesh-ancestor
153876222|NCT02218814|Anesthetics|anesthetics|mesh-ancestor
153876223|NCT02218814|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153876224|NCT02218814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153876225|NCT02218814|Sensory System Agents|sensory system agents|mesh-ancestor
153876226|NCT02218814|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153876227|NCT02216565|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
153876228|NCT02216565|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153876229|NCT02216565|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153876231|NCT04534803|BCG Vaccine|bcg vaccine|mesh-list
153876232|NCT04534803|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153876233|NCT04534803|Immunologic Factors|immunologic factors|mesh-ancestor
153876234|NCT04534803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153876235|NCT01198132|Vitamin D|vitamin d|mesh-list
153876236|NCT01198132|Ergocalciferols|ergocalciferols|mesh-list
153876237|NCT01198132|Cholecalciferol|cholecalciferol|mesh-list
153876238|NCT01198132|Vitamins|vitamins|mesh-list
153416984|NCT03924518|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153416985|NCT03924518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153416986|NCT03924518|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153416987|NCT03924518|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
153416988|NCT03924518|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153416989|NCT03924518|Serotonin Agents|serotonin agents|mesh-ancestor
153416990|NCT03924518|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153416991|NCT03924518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153416992|NCT03924518|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
153416994|NCT05454085|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
153416995|NCT05454085|Estrogens|estrogens|mesh-ancestor
153416996|NCT05454085|Hormones|hormones|mesh-ancestor
153416997|NCT05454085|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153416998|NCT05454085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153416999|NCT05454085|Free Radical Scavengers|free radical scavengers|mesh-ancestor
153417000|NCT05454085|Antioxidants|antioxidants|mesh-ancestor
153417001|NCT05454085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153417002|NCT05454085|Protective Agents|protective agents|mesh-ancestor
153417003|NCT03886922|Cromakalim|cromakalim|mesh-list
153417004|NCT03886922|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153417007|NCT03886922|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153417013|NCT05453552|Cyclophosphamide|cyclophosphamide|mesh-list
153417014|NCT05453552|Busulfan|busulfan|mesh-list
153417015|NCT05453552|Fludarabine|fludarabine|mesh-list
153417016|NCT05453552|Decitabine|decitabine|mesh-list
153417017|NCT05453552|Lenograstim|lenograstim|mesh-list
153417018|NCT05453552|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153876239|NCT01198132|Interferons|interferons|mesh-list
153876240|NCT01198132|Interferon-beta|interferon-beta|mesh-list
153876241|NCT01198132|Interferon beta-1a|interferon beta-1a|mesh-list
153876242|NCT01198132|Micronutrients|micronutrients|mesh-ancestor
153876243|NCT01198132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153876244|NCT01198132|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153876245|NCT01198132|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153876246|NCT01198132|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153876247|NCT01198132|Antiviral Agents|antiviral agents|mesh-ancestor
153876248|NCT01198132|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153876249|NCT01198132|Immunologic Factors|immunologic factors|mesh-ancestor
153876250|NCT01198132|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153386775|NCT00750555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153386776|NCT00750555|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153386777|NCT01941615|Ethinyl estradiol, levonorgestrel drug combination|ethinyl estradiol, levonorgestrel drug combination|mesh-list
153876251|NCT02219165|Immunoglobulins|immunoglobulins|mesh-list
153876252|NCT02219165|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
153876253|NCT02219165|Antibodies|antibodies|mesh-list
153876254|NCT02219165|Immunologic Factors|immunologic factors|mesh-ancestor
153876255|NCT02219165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153876256|NCT04534478|Prednisone|prednisone|mesh-list
153876257|NCT04534478|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153876258|NCT04534478|Glucocorticoids|glucocorticoids|mesh-ancestor
153876259|NCT04534478|Hormones|hormones|mesh-ancestor
153876260|NCT04534478|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153876261|NCT04534478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153876262|NCT04534478|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153876263|NCT04534478|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153876264|NCT02216669|Imidazole|imidazole|mesh-list
153876265|NCT02216669|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153876266|NCT02216669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153876267|NCT03772158|Cetirizine|cetirizine|mesh-list
153876268|NCT03772158|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
153876269|NCT03772158|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
153876270|NCT03772158|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
153876271|NCT03772158|Histamine Antagonists|histamine antagonists|mesh-ancestor
153419295|NCT04987892|Urological Agents|urological agents|mesh-ancestor
153876272|NCT03772158|Histamine Agents|histamine agents|mesh-ancestor
153876273|NCT03772158|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153876274|NCT03772158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153876275|NCT03772158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153876276|NCT01196416|Cisplatin|cisplatin|mesh-list
153417022|NCT05453552|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153417023|NCT05453552|Alkylating Agents|alkylating agents|mesh-ancestor
153417024|NCT05453552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153417025|NCT05453552|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153417026|NCT05453552|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153417027|NCT05453552|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153417028|NCT05453552|Antimetabolites|antimetabolites|mesh-ancestor
153417029|NCT05453552|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153417030|NCT05453552|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153417031|NCT03787082|Chlorhexidine|chlorhexidine|mesh-list
153417032|NCT03787082|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
153417033|NCT03787082|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
153417034|NCT03787082|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153417035|NCT03787082|Disinfectants|disinfectants|mesh-ancestor
153417036|NCT03787082|Dermatologic Agents|dermatologic agents|mesh-ancestor
153417037|NCT02165202|Rilpivirine|rilpivirine|mesh-list
153417038|NCT02165202|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153417039|NCT02165202|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153417040|NCT02165202|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153417041|NCT02165202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153417042|NCT02165202|Antiviral Agents|antiviral agents|mesh-ancestor
153876296|NCT04534322|Dexamethasone|dexamethasone|mesh-list
153876297|NCT04534322|Melphalan|melphalan|mesh-list
153876298|NCT04534322|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153876299|NCT04534322|Antiemetics|antiemetics|mesh-ancestor
153876300|NCT04534322|Autonomic Agents|autonomic agents|mesh-ancestor
153876301|NCT04534322|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153876302|NCT04534322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153876303|NCT04534322|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153876304|NCT04534322|Glucocorticoids|glucocorticoids|mesh-ancestor
153876305|NCT04534322|Hormones|hormones|mesh-ancestor
153417052|NCT01628874|Sensory System Agents|sensory system agents|mesh-ancestor
153417053|NCT01628874|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153417054|NCT01628874|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153417055|NCT01628874|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
153417056|NCT01628874|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153386778|NCT01941615|Ethinyl Estradiol-Norgestrel Combination|ethinyl estradiol-norgestrel combination|mesh-list
153386779|NCT01941615|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
153424294|NCT03473665|Sensory System Agents|sensory system agents|mesh-ancestor
153386781|NCT01941615|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153386782|NCT01941615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153386783|NCT01941615|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
153417057|NCT01628874|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153417058|NCT01628874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153419334|NCT04902950|Hemostatics|hemostatics|mesh-ancestor
153417063|NCT04891718|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153417064|NCT04891718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153417066|NCT03770689|Peposertib|peposertib|mesh-list
153417067|NCT03770689|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153417068|NCT03770689|Antimetabolites|antimetabolites|mesh-ancestor
153417069|NCT03770689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153417070|NCT03770689|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153417071|NCT03770689|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153417072|NCT03770689|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153417073|NCT00371306|Metformin|metformin|mesh-list
153417074|NCT00371306|Glyburide|glyburide|mesh-list
153417075|NCT00371306|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153417076|NCT00371306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153417077|NCT02196714|Glycopyrrolate|glycopyrrolate|mesh-list
153417078|NCT02196714|Formoterol Fumarate|formoterol fumarate|mesh-list
153417079|NCT02196714|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153876321|NCT02219672|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
153876322|NCT02219672|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
153876323|NCT02219672|Protease Inhibitors|protease inhibitors|mesh-ancestor
153876324|NCT02219672|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153876325|NCT02219672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153876326|NCT02219672|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153876327|NCT02219672|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153876328|NCT02219672|Antiviral Agents|antiviral agents|mesh-ancestor
153876329|NCT02219672|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153876330|NCT02219672|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
153876331|NCT02219672|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153876332|NCT02219672|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153876333|NCT02219672|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153876334|NCT02219672|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
153876335|NCT02219672|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
153876336|NCT02219672|Antispermatogenic Agents|antispermatogenic agents|mesh-ancestor
153417084|NCT02196714|Respiratory System Agents|respiratory system agents|mesh-ancestor
153417085|NCT02196714|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
153417086|NCT02196714|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
153417087|NCT02196714|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153417088|NCT02196714|Adrenergic Agents|adrenergic agents|mesh-ancestor
153417089|NCT02196714|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153417090|NCT02196714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153417091|NCT02196714|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153417092|NCT02196714|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
153417093|NCT02196714|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
153417094|NCT02196714|Cholinergic Agents|cholinergic agents|mesh-ancestor
153417095|NCT00370760|Dexamethasone|dexamethasone|mesh-list
153417098|NCT00370760|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
153417099|NCT00370760|Tinzaparin|tinzaparin|mesh-list
153417100|NCT00370760|Dalteparin|dalteparin|mesh-list
153417101|NCT00370760|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153417102|NCT00370760|Antiemetics|antiemetics|mesh-ancestor
153417103|NCT00370760|Autonomic Agents|autonomic agents|mesh-ancestor
153417104|NCT00370760|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153417105|NCT00370760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153417106|NCT00370760|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153417107|NCT00370760|Glucocorticoids|glucocorticoids|mesh-ancestor
153876337|NCT02219672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153876338|NCT02219672|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
153876339|NCT02219672|Contraceptive Agents|contraceptive agents|mesh-ancestor
153876340|NCT02219672|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153876341|NCT02219672|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153876342|NCT02219672|Immunologic Factors|immunologic factors|mesh-ancestor
153876344|NCT02219672|Alkylating Agents|alkylating agents|mesh-ancestor
153876345|NCT02219672|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153876346|NCT03113955|Epirubicin|epirubicin|mesh-list
153876347|NCT03113955|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153876355|NCT02219750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153876357|NCT04534452|Oxymetazoline|oxymetazoline|mesh-list
153876358|NCT04534452|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
153876359|NCT04534452|Mydriatics|mydriatics|mesh-ancestor
153876360|NCT04534452|Autonomic Agents|autonomic agents|mesh-ancestor
153419404|NCT04503460|Autonomic Agents|autonomic agents|mesh-ancestor
153876361|NCT04534452|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153876362|NCT04534452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153876363|NCT04534452|Sympathomimetics|sympathomimetics|mesh-ancestor
153876364|NCT04534452|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
153876365|NCT04534452|Nasal Decongestants|nasal decongestants|mesh-ancestor
153876366|NCT04534452|Respiratory System Agents|respiratory system agents|mesh-ancestor
153876367|NCT04534452|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
153876368|NCT04534452|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153876369|NCT04534452|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153876370|NCT04534452|Adrenergic Agents|adrenergic agents|mesh-ancestor
153876371|NCT04534452|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153876372|NCT04534452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153876373|NCT04534452|Protective Agents|protective agents|mesh-ancestor
153876374|NCT02219789|Fulvestrant|fulvestrant|mesh-list
153876375|NCT02219789|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153876376|NCT02219789|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153876377|NCT02219789|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
153876378|NCT02219789|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
153876379|NCT02219789|Hormone Antagonists|hormone antagonists|mesh-ancestor
153475841|NCT00835224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153876380|NCT02219789|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153876382|NCT02219828|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
153876383|NCT02219828|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153876384|NCT04533867|Ondansetron|ondansetron|mesh-list
153876385|NCT04533867|Palonosetron|palonosetron|mesh-list
153876386|NCT04533867|Antiemetics|antiemetics|mesh-ancestor
153876387|NCT04533867|Autonomic Agents|autonomic agents|mesh-ancestor
153417137|NCT04766762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153417138|NCT04766762|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
153417139|NCT04766762|Histamine Antagonists|histamine antagonists|mesh-ancestor
153417140|NCT04766762|Histamine Agents|histamine agents|mesh-ancestor
153417141|NCT04766762|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153417142|NCT04766762|Vasodilator Agents|vasodilator agents|mesh-ancestor
153417143|NCT04330040|Olaparib|olaparib|mesh-list
153417144|NCT04330040|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
153417145|NCT04330040|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153417146|NCT04330040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153417147|NCT04330040|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153417148|NCT02737891|Metoprolol|metoprolol|mesh-list
153417149|NCT02737891|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153417150|NCT02737891|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153417151|NCT02737891|Sympatholytics|sympatholytics|mesh-ancestor
153417152|NCT02737891|Autonomic Agents|autonomic agents|mesh-ancestor
153417153|NCT02737891|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153417154|NCT02737891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153417155|NCT02737891|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
153876395|NCT04533867|Serotonin Agents|serotonin agents|mesh-ancestor
153876396|NCT04533867|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153876397|NCT04533867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153876399|NCT02219867|Analgesics|analgesics|mesh-ancestor
153876400|NCT02219867|Sensory System Agents|sensory system agents|mesh-ancestor
153876401|NCT02219867|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153876402|NCT02219867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153876403|NCT02219867|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
153876404|NCT02219867|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153876405|NCT02219867|Anesthetics, General|anesthetics, general|mesh-ancestor
153876406|NCT02219867|Anesthetics|anesthetics|mesh-ancestor
153876407|NCT02219867|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153876408|NCT02219867|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
153876409|NCT02219867|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
153876410|NCT02219867|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153876411|NCT02219867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153876412|NCT04533906|Povidone-Iodine|povidone-iodine|mesh-list
153876413|NCT04533906|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
153876414|NCT04533906|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153876415|NCT02219906|Resveratrol|resveratrol|mesh-list
153876416|NCT02219906|Antioxidants|antioxidants|mesh-ancestor
153876417|NCT02219906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153876418|NCT02219906|Protective Agents|protective agents|mesh-ancestor
153876419|NCT02219906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153876420|NCT02219906|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153876421|NCT02219906|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153876422|NCT04533243|Fentanyl|fentanyl|mesh-list
153876423|NCT04533243|Morphine|morphine|mesh-list
153876424|NCT04533243|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153876425|NCT04533243|Narcotics|narcotics|mesh-ancestor
153876426|NCT04533243|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153876427|NCT04533243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153876428|NCT04533243|Analgesics|analgesics|mesh-ancestor
153876429|NCT04533243|Sensory System Agents|sensory system agents|mesh-ancestor
153876430|NCT04533243|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153876431|NCT04533243|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153876432|NCT04533243|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153876433|NCT04533243|Anesthetics, General|anesthetics, general|mesh-ancestor
153876434|NCT04533243|Anesthetics|anesthetics|mesh-ancestor
153876435|NCT04533321|Afatinib|afatinib|mesh-list
153876436|NCT04533321|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153876437|NCT04533321|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153876438|NCT04533321|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153876439|NCT04533321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153417189|NCT00370669|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153417190|NCT00370669|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153417192|NCT00370669|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153417193|NCT00370669|Growth Substances|growth substances|mesh-ancestor
153417194|NCT00370669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153417195|NCT00370669|Growth Inhibitors|growth inhibitors|mesh-ancestor
153417196|NCT00370669|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153417197|NCT00370669|Glucocorticoids|glucocorticoids|mesh-ancestor
153417198|NCT00370669|Hormones|hormones|mesh-ancestor
153417210|NCT02740543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153417211|NCT02740543|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153417212|NCT02740543|Respiratory System Agents|respiratory system agents|mesh-ancestor
153417213|NCT02740543|Dermatologic Agents|dermatologic agents|mesh-ancestor
153417214|NCT02740543|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
153417215|NCT00370747|Ecabet|ecabet|mesh-list
153417216|NCT00370747|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153417217|NCT00370747|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
153417218|NCT00370747|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153417219|NCT00370747|Protease Inhibitors|protease inhibitors|mesh-ancestor
153417220|NCT00370747|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153417222|NCT00370747|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
153876440|NCT04533321|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153876441|NCT01195831|Calcipotriene|calcipotriene|mesh-list
153876442|NCT01195831|Dermatologic Agents|dermatologic agents|mesh-ancestor
153876443|NCT01195675|Empagliflozin|empagliflozin|mesh-list
153876444|NCT01195675|Moxifloxacin|moxifloxacin|mesh-list
153876445|NCT01195675|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153876446|NCT01195675|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153876447|NCT01195675|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153876448|NCT01195675|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153876449|NCT01195675|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153876450|NCT01195675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153876451|NCT01195675|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153876452|NCT01195675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153876453|NCT01195675|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
153876456|NCT04532931|Sofosbuvir|sofosbuvir|mesh-list
153876457|NCT04532931|Artesunate|artesunate|mesh-list
153876458|NCT04532931|Favipiravir|favipiravir|mesh-list
153876459|NCT04532931|Pyronaridine tetraphosphate, artesunate drug combination|pyronaridine tetraphosphate, artesunate drug combination|mesh-list
153876460|NCT04532931|Amodiaquine|amodiaquine|mesh-list
153876461|NCT04532931|Nitazoxanide|nitazoxanide|mesh-list
153876462|NCT04532931|Pyronaridine|pyronaridine|mesh-list
153876463|NCT04532931|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153876464|NCT04532931|Analgesics|analgesics|mesh-ancestor
153876465|NCT04532931|Sensory System Agents|sensory system agents|mesh-ancestor
153876466|NCT04532931|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153876467|NCT04532931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153876468|NCT04532931|Antipyretics|antipyretics|mesh-ancestor
153386784|NCT01941615|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
153386785|NCT01941615|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
153386786|NCT01941615|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
153386787|NCT01941615|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
153386788|NCT01941615|Contraceptives, Postcoital, Hormonal|contraceptives, postcoital, hormonal|mesh-ancestor
153386789|NCT01941615|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
153386790|NCT01941615|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
153876469|NCT04532931|Antiviral Agents|antiviral agents|mesh-ancestor
153876470|NCT04532931|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153876471|NCT04532931|Antimalarials|antimalarials|mesh-ancestor
153876472|NCT04532931|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153876473|NCT04532931|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153876474|NCT04532931|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153876475|NCT04532931|Schistosomicides|schistosomicides|mesh-ancestor
153876482|NCT01195363|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153876483|NCT01195363|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153417231|NCT02227446|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
153417233|NCT02227446|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153417234|NCT04738058|Lactoferrin|lactoferrin|mesh-list
153417235|NCT04738058|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153417236|NCT02227368|Ticagrelor|ticagrelor|mesh-list
153417237|NCT02227368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153417238|NCT02227368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153417239|NCT02227368|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153417240|NCT02227368|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
153417241|NCT02227368|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
153417242|NCT02227368|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
153417243|NCT02227368|Purinergic Agents|purinergic agents|mesh-ancestor
153417244|NCT02227368|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153417245|NCT02162862|Bupropion|bupropion|mesh-list
153417246|NCT02162862|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
153417247|NCT02162862|Antidepressive Agents|antidepressive agents|mesh-ancestor
153417248|NCT02162862|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153417249|NCT02162862|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
153417250|NCT02162862|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153417251|NCT02162862|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153417252|NCT02162862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153878698|NCT03686332|Atezolizumab|atezolizumab|mesh-list
153876490|NCT01195090|Hormones|hormones|mesh-ancestor
153876491|NCT01195090|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153876492|NCT01195090|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
153876493|NCT01195090|Protease Inhibitors|protease inhibitors|mesh-ancestor
153876494|NCT01195090|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153876495|NCT01195090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153876496|NCT02213081|Ulipristal acetate|ulipristal acetate|mesh-list
153876497|NCT02213081|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
153876498|NCT02213081|Contraceptive Agents|contraceptive agents|mesh-ancestor
153876499|NCT02213081|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153876500|NCT02213081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153876501|NCT02213081|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
153876502|NCT02213627|Menotropins|menotropins|mesh-list
153876503|NCT02213627|Fertility Agents, Female|fertility agents, female|mesh-ancestor
153876504|NCT02213627|Fertility Agents|fertility agents|mesh-ancestor
153876505|NCT02213627|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153417254|NCT02162862|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153417255|NCT02162862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153417256|NCT02162862|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
153417257|NCT02162862|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153417258|NCT02162862|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153417259|NCT05277727|Fucoidan|fucoidan|mesh-list
153417260|NCT05277727|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
153417261|NCT05277727|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153417262|NCT05277727|Anticoagulants|anticoagulants|mesh-ancestor
153417263|NCT05277727|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153417264|NCT02226198|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
153386792|NCT01901679|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153386793|NCT01901679|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153386794|NCT01901679|Analgesics|analgesics|mesh-ancestor
153386795|NCT01901679|Sensory System Agents|sensory system agents|mesh-ancestor
153386796|NCT01901679|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153387014|NCT05550519|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153387015|NCT05550519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153387016|NCT05550519|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153387017|NCT05550519|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153419530|NCT03149211|UB-421|ub-421|mesh-list
153419531|NCT03149211|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153419532|NCT03149211|Antiviral Agents|antiviral agents|mesh-ancestor
153419533|NCT03149211|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153876515|NCT02216877|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153876517|NCT02214563|Ergocalciferols|ergocalciferols|mesh-list
153876518|NCT02214563|Cholecalciferol|cholecalciferol|mesh-list
153876521|NCT02214563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153876522|NCT02214563|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153876523|NCT02214563|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153876525|NCT01194973|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
153876526|NCT01194973|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153876527|NCT01194973|Immunologic Factors|immunologic factors|mesh-ancestor
153876528|NCT01194973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153876529|NCT02218619|Ursodoxicoltaurine|ursodoxicoltaurine|mesh-list
153876530|NCT02218619|Antiviral Agents|antiviral agents|mesh-ancestor
153417277|NCT02754518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153417279|NCT02751385|Ethinyl estradiol, levonorgestrel drug combination|ethinyl estradiol, levonorgestrel drug combination|mesh-list
153417280|NCT02751385|Ethinyl Estradiol-Norgestrel Combination|ethinyl estradiol-norgestrel combination|mesh-list
153417281|NCT02751385|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153417282|NCT02751385|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153417283|NCT02751385|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153417284|NCT02751385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153417285|NCT02751385|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
153417286|NCT02751385|Contraceptive Agents|contraceptive agents|mesh-ancestor
153417287|NCT02751385|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153417288|NCT02751385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153417289|NCT02751385|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
153417290|NCT02751385|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
153417291|NCT02751385|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
153417292|NCT02751385|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
153417293|NCT02751385|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
153417294|NCT02751385|Contraceptives, Postcoital, Hormonal|contraceptives, postcoital, hormonal|mesh-ancestor
153417295|NCT02751385|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
153417296|NCT02751385|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
153417298|NCT05349032|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153876531|NCT02218619|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153876532|NCT02218619|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
153876533|NCT02218619|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153876534|NCT02218697|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
153876535|NCT02218697|Immunologic Factors|immunologic factors|mesh-ancestor
153878761|NCT03601897|Paclitaxel|paclitaxel|mesh-list
153876538|NCT02216747|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153876539|NCT02216747|Glucocorticoids|glucocorticoids|mesh-ancestor
153876540|NCT02216747|Hormones|hormones|mesh-ancestor
153876541|NCT02216747|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153876542|NCT02216747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153876543|NCT02216747|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153876544|NCT02216747|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153876545|NCT02216786|Everolimus|everolimus|mesh-list
153876546|NCT02216786|Fulvestrant|fulvestrant|mesh-list
153876547|NCT02216786|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
153876548|NCT02216786|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153387020|NCT01203371|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
153387021|NCT01203371|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
153387022|NCT01203371|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
153387023|NCT01203371|Adrenergic Agents|adrenergic agents|mesh-ancestor
153387024|NCT01203371|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153387031|NCT01203371|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153387032|NCT01203371|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153387033|NCT01549977|Febuxostat|febuxostat|mesh-list
153387034|NCT01549977|Gout Suppressants|gout suppressants|mesh-ancestor
153387062|NCT01533753|Sensory System Agents|sensory system agents|mesh-ancestor
153876549|NCT02216786|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153876550|NCT02216786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153876551|NCT02216786|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153876552|NCT02216786|Immunologic Factors|immunologic factors|mesh-ancestor
153876553|NCT02216786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153876554|NCT02216786|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153876555|NCT02216786|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153876556|NCT02216786|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
153876557|NCT02216786|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
153876558|NCT02216786|Hormone Antagonists|hormone antagonists|mesh-ancestor
153876559|NCT02216786|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153876560|NCT02279147|Neostigmine|neostigmine|mesh-list
153876561|NCT02279147|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
153876562|NCT02279147|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153876563|NCT02279147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153876564|NCT02279147|Cholinergic Agents|cholinergic agents|mesh-ancestor
153876565|NCT02279147|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153876566|NCT02279147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153876567|NCT02279147|Parasympathomimetics|parasympathomimetics|mesh-ancestor
153876568|NCT02279147|Autonomic Agents|autonomic agents|mesh-ancestor
153419599|NCT02429700|Carboplatin|carboplatin|mesh-list
153419600|NCT02429700|Bleomycin|bleomycin|mesh-list
153876578|NCT01177540|Antimetabolites|antimetabolites|mesh-ancestor
153417324|NCT05057689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153417325|NCT05057689|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153417326|NCT05057689|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153417327|NCT05057689|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153417328|NCT05057689|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153417329|NCT05057689|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153417330|NCT05057689|Anesthetics, General|anesthetics, general|mesh-ancestor
153417331|NCT05057689|Anesthetics|anesthetics|mesh-ancestor
153417332|NCT05057689|GABA Modulators|gaba modulators|mesh-ancestor
153417333|NCT05057689|GABA Agents|gaba agents|mesh-ancestor
153417334|NCT05057689|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153417335|NCT05057689|Narcotics|narcotics|mesh-ancestor
153417336|NCT04737980|Dexamethasone|dexamethasone|mesh-list
153417337|NCT04737980|Bupivacaine|bupivacaine|mesh-list
153417338|NCT04737980|Ropivacaine|ropivacaine|mesh-list
153417339|NCT04737980|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153417340|NCT04737980|Antiemetics|antiemetics|mesh-ancestor
153417341|NCT04737980|Autonomic Agents|autonomic agents|mesh-ancestor
153417342|NCT04737980|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153417343|NCT04737980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153417344|NCT04737980|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153417345|NCT04737980|Glucocorticoids|glucocorticoids|mesh-ancestor
153417349|NCT04737980|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153417350|NCT04737980|Anesthetics, Local|anesthetics, local|mesh-ancestor
153417352|NCT04737980|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153417353|NCT04737980|Sensory System Agents|sensory system agents|mesh-ancestor
153417354|NCT00371696|Acetaminophen|acetaminophen|mesh-list
153417355|NCT00371696|Diclofenac|diclofenac|mesh-list
153417356|NCT00371696|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153417357|NCT00371696|Analgesics|analgesics|mesh-ancestor
153417358|NCT00371696|Sensory System Agents|sensory system agents|mesh-ancestor
153417359|NCT00371696|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153387063|NCT01533753|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153387064|NCT01533753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153387065|NCT01533753|Anticonvulsants|anticonvulsants|mesh-ancestor
153387066|NCT01533753|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153387067|NCT01533753|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153387068|NCT01533753|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153387069|NCT01533753|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153387070|NCT01533753|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
153387071|NCT01533753|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
153417360|NCT00371696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153417361|NCT00371696|Antipyretics|antipyretics|mesh-ancestor
153876579|NCT01177540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153876580|NCT01177540|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153876581|NCT01177540|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153876582|NCT01177384|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
153876583|NCT01177384|Glimepiride|glimepiride|mesh-list
153876585|NCT01177384|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153876586|NCT01177384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153876587|NCT01177384|Incretins|incretins|mesh-ancestor
153876589|NCT01177384|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153876590|NCT01177384|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
153876591|NCT01177384|Protease Inhibitors|protease inhibitors|mesh-ancestor
153876592|NCT01177384|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153876593|NCT01177384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153876594|NCT01177384|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153876595|NCT01177384|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153876596|NCT01177384|Immunologic Factors|immunologic factors|mesh-ancestor
153876597|NCT01177384|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
153876600|NCT01640093|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153876601|NCT01640093|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153876602|NCT01640093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153876603|NCT01640093|Hormone Antagonists|hormone antagonists|mesh-ancestor
153876604|NCT01640093|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153876605|NCT01640093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153876606|NCT01640093|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153876608|NCT01194154|Hematinics|hematinics|mesh-ancestor
153876609|NCT01640210|Insulin|insulin|mesh-list
153876610|NCT01640210|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153876611|NCT01640210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153876612|NCT01640405|Bevacizumab|bevacizumab|mesh-list
153417362|NCT00371696|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153417363|NCT00371696|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153417364|NCT00371696|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153417365|NCT00371696|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153417366|NCT00371696|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153417367|NCT00371696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153417368|NCT02756624|Cetirizine|cetirizine|mesh-list
153417369|NCT02756624|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
153417370|NCT02756624|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
153878829|NCT03427814|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153417373|NCT02756624|Histamine Agents|histamine agents|mesh-ancestor
153417374|NCT02756624|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153417375|NCT02756624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153417376|NCT02756624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153417378|NCT02958800|Risperidone|risperidone|mesh-list
153417379|NCT02958800|Quetiapine Fumarate|quetiapine fumarate|mesh-list
153417380|NCT02958800|Antipsychotic Agents|antipsychotic agents|mesh-list
153417381|NCT02958800|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153876613|NCT01640405|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153876614|NCT01640405|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153876615|NCT01640405|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153876616|NCT01640405|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153387072|NCT01533753|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153387073|NCT01533753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153387074|NCT01533753|Antimanic Agents|antimanic agents|mesh-ancestor
153387075|NCT01533753|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
153387076|NCT01533753|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153387077|NCT01533753|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153783585|NCT00261729|Prazosin|prazosin|mesh-list
153387078|NCT01533753|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
153387079|NCT01533753|Antidepressive Agents|antidepressive agents|mesh-ancestor
153876617|NCT01640405|Growth Substances|growth substances|mesh-ancestor
153876618|NCT01640405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153876619|NCT01640405|Growth Inhibitors|growth inhibitors|mesh-ancestor
153876620|NCT01640444|Bevacizumab|bevacizumab|mesh-list
153876621|NCT01640444|Cetuximab|cetuximab|mesh-list
153876622|NCT01640444|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153876623|NCT01640444|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153876624|NCT01640444|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153876625|NCT01640444|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153876626|NCT01640444|Growth Substances|growth substances|mesh-ancestor
153876627|NCT01640444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153876628|NCT01640444|Growth Inhibitors|growth inhibitors|mesh-ancestor
153876630|NCT01642433|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153876631|NCT01642433|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
153876632|NCT01642433|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
153876633|NCT01642433|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
153876634|NCT01642433|Adrenergic Agents|adrenergic agents|mesh-ancestor
153876635|NCT01642433|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153876636|NCT01642433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153876637|NCT01642433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153876638|NCT01642472|Ulipristal acetate|ulipristal acetate|mesh-list
153876639|NCT01642472|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
153876640|NCT01642472|Contraceptive Agents|contraceptive agents|mesh-ancestor
153876641|NCT01642472|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153876642|NCT01642472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153876643|NCT01642472|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
153876645|NCT01640639|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153417382|NCT02958800|Serotonin Agents|serotonin agents|mesh-ancestor
153876646|NCT01640639|Immunologic Factors|immunologic factors|mesh-ancestor
153876647|NCT01640639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153876648|NCT01640639|Leprostatic Agents|leprostatic agents|mesh-ancestor
153876649|NCT01640639|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153876650|NCT01640639|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153876651|NCT01640639|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153876652|NCT01640639|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153876660|NCT01642745|Mannitol|mannitol|mesh-list
153876661|NCT01642745|Methacholine Chloride|methacholine chloride|mesh-list
153876662|NCT01642745|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
153876663|NCT01642745|Diuretics|diuretics|mesh-ancestor
153876664|NCT01642745|Natriuretic Agents|natriuretic agents|mesh-ancestor
153876665|NCT01642745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153417415|NCT04738045|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153417416|NCT04738045|Antimetabolites|antimetabolites|mesh-ancestor
153417417|NCT02226120|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
153417418|NCT02226120|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
153417419|NCT02226120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153417420|NCT04587973|Dexmedetomidine|dexmedetomidine|mesh-list
153417421|NCT04587973|Ropivacaine|ropivacaine|mesh-list
153417422|NCT04587973|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153417423|NCT04587973|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153417424|NCT04587973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153417425|NCT04587973|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153417426|NCT04587973|Analgesics|analgesics|mesh-ancestor
153417427|NCT04587973|Sensory System Agents|sensory system agents|mesh-ancestor
153417428|NCT04587973|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153417429|NCT04587973|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
153417430|NCT04587973|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153876666|NCT01642745|Miotics|miotics|mesh-ancestor
153876667|NCT01642745|Autonomic Agents|autonomic agents|mesh-ancestor
153876668|NCT01642745|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153876669|NCT01642745|Parasympathomimetics|parasympathomimetics|mesh-ancestor
153876670|NCT01642745|Bronchoconstrictor Agents|bronchoconstrictor agents|mesh-ancestor
153878879|NCT03343054|Talazoparib|talazoparib|mesh-list
153876672|NCT01642745|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
153876673|NCT01642745|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
153876674|NCT01642745|Cholinergic Agents|cholinergic agents|mesh-ancestor
153876675|NCT01642745|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153876676|NCT01642745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153876678|NCT01640990|Adenosine A2 Receptor Agonists|adenosine a2 receptor agonists|mesh-ancestor
153876679|NCT01640990|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
153876680|NCT01640990|Purinergic Agonists|purinergic agonists|mesh-ancestor
153876681|NCT01640990|Purinergic Agents|purinergic agents|mesh-ancestor
153876682|NCT01640990|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153876683|NCT01640990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153876684|NCT01640990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153876686|NCT01642862|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153876687|NCT01642862|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153876688|NCT01642862|Antimetabolites|antimetabolites|mesh-ancestor
153876689|NCT01642862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153876690|NCT01642862|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153876691|NCT01642862|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
153876692|NCT01642862|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153876693|NCT01642940|Ticagrelor|ticagrelor|mesh-list
153876694|NCT01642940|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
153876695|NCT01642940|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153876696|NCT01642940|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
153876697|NCT01642940|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
153876698|NCT01642940|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
153876699|NCT01642940|Purinergic Agents|purinergic agents|mesh-ancestor
153876700|NCT01642940|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153876701|NCT01642940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153876702|NCT01642940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153876703|NCT04497519|Hydroxychloroquine|hydroxychloroquine|mesh-list
153876704|NCT04497519|Antimalarials|antimalarials|mesh-ancestor
153876714|NCT01641224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153876715|NCT01641224|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153876716|NCT01641224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153876719|NCT01641224|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153876720|NCT01643135|Tranylcypromine|tranylcypromine|mesh-list
153417471|NCT01190306|Dermatologic Agents|dermatologic agents|mesh-ancestor
153417472|NCT02759575|Pembrolizumab|pembrolizumab|mesh-list
153417473|NCT02759575|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153417474|NCT02759575|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153417475|NCT02759575|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153417476|NCT02759575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153417477|NCT05320718|Ropivacaine|ropivacaine|mesh-list
153417478|NCT05320718|Anesthetics, Local|anesthetics, local|mesh-ancestor
153417479|NCT05320718|Anesthetics|anesthetics|mesh-ancestor
153417480|NCT05320718|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153417481|NCT05320718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153417482|NCT05320718|Sensory System Agents|sensory system agents|mesh-ancestor
153417483|NCT05320718|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153876721|NCT01643135|Tranexamic Acid|tranexamic acid|mesh-list
153876722|NCT01643135|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
153876723|NCT01643135|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153876724|NCT01643135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153876725|NCT01643135|Hemostatics|hemostatics|mesh-ancestor
153876726|NCT01643135|Coagulants|coagulants|mesh-ancestor
153876727|NCT01643135|Antidepressive Agents|antidepressive agents|mesh-ancestor
153876728|NCT01643135|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153876729|NCT01643135|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
153876730|NCT01643135|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153876731|NCT01643135|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153876732|NCT01643135|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153387116|NCT01534143|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153387118|NCT01692171|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
153387119|NCT01692171|Tinzaparin|tinzaparin|mesh-list
153387120|NCT01692171|Dalteparin|dalteparin|mesh-list
153387121|NCT01692171|Anticoagulants|anticoagulants|mesh-ancestor
153883351|NCT04825262|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
153883352|NCT04825262|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153883353|NCT04825262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153876733|NCT01643135|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153876734|NCT01643135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153876735|NCT01641419|Dexamethasone|dexamethasone|mesh-list
153876736|NCT01641419|Dexamethasone acetate|dexamethasone acetate|mesh-list
153876737|NCT01641419|BB 1101|bb 1101|mesh-list
153876738|NCT01641419|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153876740|NCT01641419|Autonomic Agents|autonomic agents|mesh-ancestor
153876741|NCT01641419|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153876742|NCT01641419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153876743|NCT01641419|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153876744|NCT01641419|Glucocorticoids|glucocorticoids|mesh-ancestor
153876745|NCT01641419|Hormones|hormones|mesh-ancestor
153876746|NCT01641419|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153876747|NCT01641419|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153876748|NCT01641419|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153876749|NCT01641419|Protease Inhibitors|protease inhibitors|mesh-ancestor
153876750|NCT01641419|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153876751|NCT01641419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153876752|NCT01643252|Riboflavin|riboflavin|mesh-list
153876753|NCT01643252|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
153876754|NCT01643252|Ophthalmic Solutions|ophthalmic solutions|mesh-list
153876755|NCT01643252|Vitamin B Complex|vitamin b complex|mesh-ancestor
153876756|NCT01643252|Vitamins|vitamins|mesh-ancestor
153876757|NCT01643252|Micronutrients|micronutrients|mesh-ancestor
153876767|NCT01641458|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153876768|NCT01641458|Immunologic Factors|immunologic factors|mesh-ancestor
153876769|NCT01641458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153876770|NCT01641536|Entecavir|entecavir|mesh-list
153876771|NCT01641536|Antiviral Agents|antiviral agents|mesh-ancestor
153876772|NCT01641536|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153876773|NCT01641575|Gemcitabine|gemcitabine|mesh-list
153876774|NCT01641575|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153876775|NCT01641575|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153876776|NCT01641575|Antimetabolites|antimetabolites|mesh-ancestor
153876777|NCT01641575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153876778|NCT01643447|Glycyrrhizic Acid|glycyrrhizic acid|mesh-list
153876779|NCT01643447|Urinastatin|urinastatin|mesh-list
153876780|NCT01643447|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
153876781|NCT01643447|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
153876782|NCT01643447|Protease Inhibitors|protease inhibitors|mesh-ancestor
153876783|NCT01643447|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153876784|NCT01643447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153475842|NCT00835224|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
153417533|NCT02768558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153417534|NCT02768558|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153417535|NCT02768558|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153417536|NCT02768558|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153417537|NCT02768558|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153417538|NCT02192970|Bevacizumab|bevacizumab|mesh-list
153417539|NCT02192970|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153417540|NCT02192970|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153417541|NCT02192970|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153417542|NCT02192970|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153417543|NCT02192970|Growth Substances|growth substances|mesh-ancestor
153417544|NCT02192970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153417545|NCT02192970|Growth Inhibitors|growth inhibitors|mesh-ancestor
153417546|NCT05457296|Hydrocortisone|hydrocortisone|mesh-list
153417547|NCT05457296|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153417548|NCT05456438|Tea Tree Oil|tea tree oil|mesh-list
153417549|NCT05456438|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
153417550|NCT05456438|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153417551|NCT02744846|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
153417552|NCT02744846|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153417553|NCT02762071|Bupivacaine|bupivacaine|mesh-list
153417554|NCT02762071|Anesthetics, Local|anesthetics, local|mesh-ancestor
153417555|NCT02762071|Anesthetics|anesthetics|mesh-ancestor
153417556|NCT02762071|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153417557|NCT02762071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153417558|NCT02762071|Sensory System Agents|sensory system agents|mesh-ancestor
153876785|NCT01643447|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153876786|NCT01643603|Dasatinib|dasatinib|mesh-list
153876787|NCT01643603|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153876788|NCT01643603|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153876789|NCT01643603|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153876790|NCT01643603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153876791|NCT01643603|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153876792|NCT02755844|Metformin|metformin|mesh-list
153876793|NCT02755844|Cyclophosphamide|cyclophosphamide|mesh-list
153876794|NCT02755844|Olaparib|olaparib|mesh-list
153876795|NCT02755844|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153876796|NCT02755844|Immunologic Factors|immunologic factors|mesh-ancestor
153876797|NCT02755844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153876798|NCT02755844|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153876799|NCT02755844|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153876800|NCT02755844|Alkylating Agents|alkylating agents|mesh-ancestor
153417559|NCT02762071|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153417560|NCT04336891|Methyltestosterone|methyltestosterone|mesh-list
153876801|NCT02755844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153417561|NCT04336891|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
153876802|NCT02755844|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153876803|NCT02755844|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153876804|NCT02755844|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153876805|NCT02755844|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
153876806|NCT02755844|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153876807|NCT06032195|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
153876809|NCT06032039|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153876810|NCT06032039|Glucocorticoids|glucocorticoids|mesh-ancestor
153876812|NCT06032039|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153876813|NCT06032039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153876814|NCT06031961|Melatonin|melatonin|mesh-list
153876815|NCT06031961|Antioxidants|antioxidants|mesh-ancestor
153876816|NCT06031961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153876817|NCT06031961|Protective Agents|protective agents|mesh-ancestor
153876818|NCT06031961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153876819|NCT06031961|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153876820|NCT06048926|Paclitaxel|paclitaxel|mesh-list
153876821|NCT06048926|Cisplatin|cisplatin|mesh-list
153876822|NCT06048926|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153876823|NCT06048926|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153876824|NCT06048926|Tubulin Modulators|tubulin modulators|mesh-ancestor
153876825|NCT06048926|Antimitotic Agents|antimitotic agents|mesh-ancestor
153876826|NCT06048926|Mitosis Modulators|mitosis modulators|mesh-ancestor
153876827|NCT06048926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153417578|NCT04336891|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153417579|NCT04336891|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153417580|NCT04336891|Anabolic Agents|anabolic agents|mesh-ancestor
153417582|NCT04337918|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
153417583|NCT04337918|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153417584|NCT04337918|Autonomic Agents|autonomic agents|mesh-ancestor
153417585|NCT04337918|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153417586|NCT04337918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153417587|NCT04337918|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153417588|NCT04337918|Respiratory System Agents|respiratory system agents|mesh-ancestor
153417589|NCT04337918|Free Radical Scavengers|free radical scavengers|mesh-ancestor
153417590|NCT04337918|Antioxidants|antioxidants|mesh-ancestor
153417591|NCT04337918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153417592|NCT04337918|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153417593|NCT04337918|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
153417594|NCT04337918|Vasodilator Agents|vasodilator agents|mesh-ancestor
153417595|NCT04337918|Gasotransmitters|gasotransmitters|mesh-ancestor
153417596|NCT04337918|Protective Agents|protective agents|mesh-ancestor
153417597|NCT02747186|Lidocaine|lidocaine|mesh-list
153417598|NCT02747186|Anesthetics, Local|anesthetics, local|mesh-ancestor
153417599|NCT02747186|Anesthetics|anesthetics|mesh-ancestor
153417600|NCT02747186|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153417601|NCT02747186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153417602|NCT02747186|Sensory System Agents|sensory system agents|mesh-ancestor
153417603|NCT02747186|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153417604|NCT02747186|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153417605|NCT02747186|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
153417606|NCT02747186|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153417607|NCT02747186|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153417608|NCT02747186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153876828|NCT06048913|Nimotuzumab|nimotuzumab|mesh-list
153876830|NCT06048913|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153876831|NCT06048887|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
153876832|NCT06048705|Cyclophosphamide|cyclophosphamide|mesh-list
153876833|NCT06048705|Fludarabine|fludarabine|mesh-list
153876834|NCT06048705|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153876835|NCT06048705|Immunologic Factors|immunologic factors|mesh-ancestor
153876836|NCT06048705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153876845|NCT06048692|Sulbactam|sulbactam|mesh-list
153876846|NCT06048692|Sultamicillin|sultamicillin|mesh-list
153876847|NCT06048692|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153876848|NCT06048692|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153876849|NCT06048692|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
153876850|NCT06048692|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153876851|NCT06048692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153876852|NCT06048367|Iron|iron|mesh-list
153876854|NCT06048367|Micronutrients|micronutrients|mesh-ancestor
153876855|NCT06048367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153876858|NCT06047860|Molgramostim|molgramostim|mesh-list
153876859|NCT06047860|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
153876860|NCT06047860|Sargramostim|sargramostim|mesh-list
153876861|NCT06047860|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153876862|NCT06047860|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153876863|NCT06047860|Analgesics|analgesics|mesh-ancestor
153876864|NCT06047860|Sensory System Agents|sensory system agents|mesh-ancestor
153876865|NCT06047860|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153876866|NCT06047860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153876867|NCT06047860|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153876868|NCT06047860|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153876869|NCT06047860|Growth Substances|growth substances|mesh-ancestor
153876870|NCT06047860|Growth Inhibitors|growth inhibitors|mesh-ancestor
153876871|NCT06047860|Immunologic Factors|immunologic factors|mesh-ancestor
153417623|NCT02766673|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153417624|NCT02766673|Autonomic Agents|autonomic agents|mesh-ancestor
153417625|NCT02766673|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153417626|NCT02766673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153417627|NCT02766673|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153417628|NCT02766673|Respiratory System Agents|respiratory system agents|mesh-ancestor
153417629|NCT02766673|Tocolytic Agents|tocolytic agents|mesh-ancestor
153417630|NCT02766673|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153417631|NCT02766673|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
153417632|NCT02766673|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
153417633|NCT02766673|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153876873|NCT06047860|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153876874|NCT06047535|Isotretinoin|isotretinoin|mesh-list
153876875|NCT06047535|Dermatologic Agents|dermatologic agents|mesh-ancestor
153876876|NCT06047483|Loxoprofen|loxoprofen|mesh-list
153876877|NCT06047483|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153876878|NCT06047483|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153876879|NCT06047483|Analgesics|analgesics|mesh-ancestor
153876880|NCT06047483|Sensory System Agents|sensory system agents|mesh-ancestor
153876881|NCT06047483|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153876882|NCT06047483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153876883|NCT06047483|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153876884|NCT06047483|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153876885|NCT06047327|Liver Extracts|liver extracts|mesh-list
153876886|NCT06047327|Hematinics|hematinics|mesh-ancestor
153876887|NCT06047184|Letrozole|letrozole|mesh-list
153876888|NCT06047184|Fulvestrant|fulvestrant|mesh-list
153876889|NCT06047184|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153876890|NCT06047184|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
153417641|NCT00372008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153417643|NCT02973763|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153417644|NCT02973763|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153387146|NCT00570531|Immunologic Factors|immunologic factors|mesh-ancestor
153387147|NCT05258565|Plasminogen|plasminogen|mesh-list
153387148|NCT05258565|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
153387149|NCT05258565|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153387150|NCT05258565|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153387151|NCT05258565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153387152|NCT05715437|Ketamine|ketamine|mesh-list
153387153|NCT05715437|Bupivacaine|bupivacaine|mesh-list
153417645|NCT02973763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153417646|NCT04337593|Pegaspargase|pegaspargase|mesh-list
153417647|NCT04337593|Basiliximab|basiliximab|mesh-list
153417648|NCT04337593|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153417667|NCT04064684|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153417668|NCT04064684|Respiratory System Agents|respiratory system agents|mesh-ancestor
153417669|NCT04064684|Glucocorticoids|glucocorticoids|mesh-ancestor
153417670|NCT04064684|Hormones|hormones|mesh-ancestor
153417671|NCT04064684|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153417672|NCT02192190|Celecoxib|celecoxib|mesh-list
153417673|NCT02192190|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153876891|NCT06047184|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153876892|NCT06047184|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153879022|NCT03129828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153876893|NCT06047184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153876894|NCT06047184|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
153876895|NCT06047184|Hormone Antagonists|hormone antagonists|mesh-ancestor
153876896|NCT06047184|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153876897|NCT06047184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153876898|NCT06047184|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153876899|NCT06047184|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
153876900|NCT06047015|CPG-oligonucleotide|cpg-oligonucleotide|mesh-list
153876901|NCT06047015|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153876902|NCT06047015|Immunologic Factors|immunologic factors|mesh-ancestor
153876903|NCT06047015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153876905|NCT06046963|Oxaliplatin|oxaliplatin|mesh-list
153876906|NCT06046963|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153876907|NCT06046963|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153876908|NCT06046963|Tubulin Modulators|tubulin modulators|mesh-ancestor
153876909|NCT06046963|Antimitotic Agents|antimitotic agents|mesh-ancestor
153876910|NCT06046963|Mitosis Modulators|mitosis modulators|mesh-ancestor
153876911|NCT06046963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153876912|NCT06046638|Propofol|propofol|mesh-list
153876913|NCT06046638|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153876914|NCT06046638|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153876915|NCT06046638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153876916|NCT06046638|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153876917|NCT06046638|Anesthetics, General|anesthetics, general|mesh-ancestor
153876918|NCT06046638|Anesthetics|anesthetics|mesh-ancestor
153876919|NCT06046612|Empagliflozin|empagliflozin|mesh-list
153876920|NCT06046612|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
153417674|NCT02192190|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153417676|NCT02192190|Sensory System Agents|sensory system agents|mesh-ancestor
153417677|NCT02192190|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153417678|NCT02192190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153419862|NCT02988050|Sensory System Agents|sensory system agents|mesh-ancestor
153417688|NCT02748889|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153417689|NCT02748889|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153417690|NCT02748889|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153417691|NCT02748889|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153387154|NCT05715437|Anesthetics, Local|anesthetics, local|mesh-ancestor
153387155|NCT05715437|Anesthetics|anesthetics|mesh-ancestor
153387156|NCT05715437|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153387157|NCT05715437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153387158|NCT05715437|Sensory System Agents|sensory system agents|mesh-ancestor
153387159|NCT05715437|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153387160|NCT05715437|Analgesics|analgesics|mesh-ancestor
153387161|NCT05715437|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
153417692|NCT02748889|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153417693|NCT02748889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153417694|NCT02748889|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153417695|NCT02748889|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153876921|NCT06046612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153876923|NCT06046612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153876924|NCT06046560|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
153876925|NCT06046560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153876927|NCT06046560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153876928|NCT06046196|Sarpogrelate|sarpogrelate|mesh-list
153876929|NCT06046196|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153876930|NCT06046196|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153876931|NCT06046196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153876932|NCT06046196|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153876933|NCT06046196|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153876934|NCT06046196|Serotonin Agents|serotonin agents|mesh-ancestor
153417716|NCT02973776|Clobetasol|clobetasol|mesh-list
153876935|NCT06046196|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153876936|NCT06046196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153876937|NCT06046105|Ibuprofen|ibuprofen|mesh-list
153876938|NCT06046105|Dexmedetomidine|dexmedetomidine|mesh-list
153876939|NCT06046105|Bupivacaine|bupivacaine|mesh-list
153876940|NCT06046105|Anesthetics, Local|anesthetics, local|mesh-ancestor
153876941|NCT06046105|Anesthetics|anesthetics|mesh-ancestor
153876942|NCT06046105|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153876943|NCT06046105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153876945|NCT06046105|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153876946|NCT06046105|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153876947|NCT06046105|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153876948|NCT06046105|Analgesics|analgesics|mesh-ancestor
153876949|NCT06046105|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
153876950|NCT06046105|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153876951|NCT06046105|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153876952|NCT06046105|Adrenergic Agents|adrenergic agents|mesh-ancestor
153876953|NCT06046105|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153876954|NCT06046105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153876955|NCT06046105|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153876956|NCT06046105|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153876957|NCT06046105|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153876958|NCT06046105|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153876959|NCT06046105|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153876961|NCT06045975|Tremelimumab|tremelimumab|mesh-list
153417717|NCT02973776|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
153417718|NCT02973776|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153417719|NCT02973776|Glucocorticoids|glucocorticoids|mesh-ancestor
153417720|NCT02973776|Hormones|hormones|mesh-ancestor
153417721|NCT02973776|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153417722|NCT02973776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153417723|NCT02161458|Dexetimide|dexetimide|mesh-list
153417724|NCT02161458|Citalopram|citalopram|mesh-list
153417725|NCT02161458|Escitalopram|escitalopram|mesh-list
153417726|NCT02161458|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
153417727|NCT02161458|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153417728|NCT02161458|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153417729|NCT02161458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153417730|NCT02161458|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153417731|NCT02161458|Serotonin Agents|serotonin agents|mesh-ancestor
153417732|NCT02161458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153417733|NCT02161458|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
153417734|NCT02161458|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
153417735|NCT02161458|Parasympatholytics|parasympatholytics|mesh-ancestor
153417737|NCT02161458|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153417738|NCT02161458|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
153417739|NCT02161458|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
153417741|NCT02161458|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
153417742|NCT02161458|Antidepressive Agents|antidepressive agents|mesh-ancestor
153417743|NCT02161458|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153417745|NCT04507022|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
153876962|NCT06045975|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153876963|NCT06045975|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153876965|NCT06045936|Anesthetics, Local|anesthetics, local|mesh-ancestor
153876966|NCT06045936|Anesthetics|anesthetics|mesh-ancestor
153876967|NCT06045936|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153876968|NCT06045936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153876969|NCT06045936|Sensory System Agents|sensory system agents|mesh-ancestor
153876980|NCT06045429|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
153876981|NCT06045429|Hydrogen Peroxide|hydrogen peroxide|mesh-list
153876982|NCT06045429|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
153876983|NCT06045429|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153876984|NCT06045429|Disinfectants|disinfectants|mesh-ancestor
153876985|NCT06045429|Dermatologic Agents|dermatologic agents|mesh-ancestor
153876986|NCT06045286|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
153876988|NCT06045286|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153876989|NCT06045286|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153876990|NCT06045260|Edotreotide lutetium LU-177|edotreotide lutetium lu-177|mesh-list
153876991|NCT06045260|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
153876992|NCT06045260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153876994|NCT06045195|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153876995|NCT06045195|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153876996|NCT06045195|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153876997|NCT06045195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153876998|NCT06045013|Methylprednisolone|methylprednisolone|mesh-list
153876999|NCT06045013|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
153877000|NCT06045013|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
153877001|NCT06045013|Prednisolone|prednisolone|mesh-list
153877002|NCT06045013|Prednisolone acetate|prednisolone acetate|mesh-list
153877003|NCT06045013|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
153877004|NCT06045013|Prednisolone phosphate|prednisolone phosphate|mesh-list
153877005|NCT06045013|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153417764|NCT00372788|Pemetrexed|pemetrexed|mesh-list
153417765|NCT00372788|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153417766|NCT00372788|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153417767|NCT00372788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153417768|NCT00372788|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153417769|NCT00372788|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153417770|NCT00372476|Imatinib Mesylate|imatinib mesylate|mesh-list
153877007|NCT06045013|Autonomic Agents|autonomic agents|mesh-ancestor
153877008|NCT06045013|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153877009|NCT06045013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153877010|NCT06045013|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153877011|NCT06045013|Glucocorticoids|glucocorticoids|mesh-ancestor
153877012|NCT06045013|Hormones|hormones|mesh-ancestor
153877013|NCT06045013|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153877014|NCT06045013|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
153877015|NCT06045013|Protective Agents|protective agents|mesh-ancestor
153877016|NCT06045013|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153877017|NCT06045013|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153877018|NCT06044974|Mitogens|mitogens|mesh-list
153877019|NCT06044974|Mitosis Modulators|mitosis modulators|mesh-ancestor
153877020|NCT06044974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153417795|NCT04737967|Antidepressive Agents|antidepressive agents|mesh-ancestor
153417796|NCT04737967|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153417797|NCT04766918|Hyaluronic Acid|hyaluronic acid|mesh-list
153417798|NCT04766918|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153417799|NCT04766918|Immunologic Factors|immunologic factors|mesh-ancestor
153417800|NCT04766918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153417801|NCT04766918|Viscosupplements|viscosupplements|mesh-ancestor
153417802|NCT04766918|Protective Agents|protective agents|mesh-ancestor
153417803|NCT03365414|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
153417804|NCT04233476|Arginyl-glycyl-aspartic acid|arginyl-glycyl-aspartic acid|mesh-list
153417805|NCT04233476|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153417806|NCT00371995|Amphotericin B|amphotericin b|mesh-list
153417808|NCT00371995|Miltefosine|miltefosine|mesh-list
153417809|NCT00371995|Amebicides|amebicides|mesh-ancestor
153417810|NCT00371995|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153417811|NCT00371995|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153417812|NCT00371995|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153877021|NCT06044883|Botulinum Toxins|botulinum toxins|mesh-list
153877022|NCT06044883|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
153877023|NCT06044883|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153877024|NCT06044883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153877025|NCT06044883|Cholinergic Agents|cholinergic agents|mesh-ancestor
153877026|NCT06044883|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153877027|NCT06044883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153877028|NCT06044844|Tofacitinib|tofacitinib|mesh-list
153877029|NCT06044844|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
153877030|NCT06044844|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153877031|NCT06044844|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153879159|NCT06078839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153877032|NCT06044844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153877033|NCT06044675|N-Methyl-3,4-methylenedioxyamphetamine|n-methyl-3,4-methylenedioxyamphetamine|mesh-list
153877034|NCT06044675|Hallucinogens|hallucinogens|mesh-ancestor
153877035|NCT06044675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153877036|NCT06044675|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153877037|NCT06044675|Serotonin Agents|serotonin agents|mesh-ancestor
153877038|NCT06044675|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153877049|NCT06044480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153877051|NCT06044480|Glucocorticoids|glucocorticoids|mesh-ancestor
153877053|NCT06044480|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153877054|NCT06044480|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153877055|NCT06044480|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153877056|NCT06044467|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
153877057|NCT06044467|Streptococcal polysaccharide type III group B|streptococcal polysaccharide type iii group b|mesh-list
153877058|NCT06044467|Antibodies|antibodies|mesh-list
153417820|NCT00372307|Sensory System Agents|sensory system agents|mesh-ancestor
153417821|NCT00372307|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153417822|NCT00372307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153417823|NCT00372307|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153417824|NCT00372307|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153417825|NCT00372307|Dermatologic Agents|dermatologic agents|mesh-ancestor
153417826|NCT00372307|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153417827|NCT00372307|Immunologic Factors|immunologic factors|mesh-ancestor
153417828|NCT00372307|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
153417829|NCT00372307|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153417830|NCT00372307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153417832|NCT04647110|Ceritinib|ceritinib|mesh-list
153417833|NCT04647110|Alectinib|alectinib|mesh-list
153417834|NCT04647110|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153417835|NCT04647110|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153417836|NCT04647110|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153417837|NCT04647110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153417838|NCT04647110|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153417839|NCT04061330|Ketamine|ketamine|mesh-list
153417840|NCT04061330|Morphine|morphine|mesh-list
153417841|NCT04061330|Analgesics|analgesics|mesh-ancestor
153417842|NCT04061330|Sensory System Agents|sensory system agents|mesh-ancestor
153417843|NCT04061330|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153419993|NCT02865590|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
153877064|NCT06044090|Minocycline|minocycline|mesh-list
153877065|NCT06044090|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153877066|NCT06044090|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153877067|NCT06044077|Vaccines|vaccines|mesh-list
153877068|NCT06044077|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
153877069|NCT06044077|Immunologic Factors|immunologic factors|mesh-ancestor
153877070|NCT06044077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153877072|NCT06043908|Lubricant Eye Drops|lubricant eye drops|mesh-list
153877073|NCT06043908|Ophthalmic Solutions|ophthalmic solutions|mesh-list
153877074|NCT06043908|Cyclosporins|cyclosporins|mesh-list
153877075|NCT06043908|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153417848|NCT04061330|Anesthetics|anesthetics|mesh-ancestor
153417849|NCT04061330|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153417850|NCT04061330|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
153417851|NCT04061330|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
153417852|NCT04061330|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153417853|NCT04061330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153417854|NCT04061330|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153417855|NCT04061330|Narcotics|narcotics|mesh-ancestor
153877093|NCT06043349|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153417856|NCT00372632|Pyrimethamine|pyrimethamine|mesh-list
153417857|NCT00372632|Sulfadoxine|sulfadoxine|mesh-list
153417858|NCT00372632|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
153417859|NCT00372632|Antimalarials|antimalarials|mesh-ancestor
153417860|NCT00372632|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153417861|NCT00372632|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153417862|NCT00372632|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153417876|NCT04792021|Protective Agents|protective agents|mesh-ancestor
153417877|NCT04792021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153417878|NCT04792021|Antidotes|antidotes|mesh-ancestor
153417879|NCT04333927|Immunomodulating Agents|immunomodulating agents|mesh-list
153417880|NCT04333927|Immunologic Factors|immunologic factors|mesh-ancestor
153879278|NCT05943821|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153879279|NCT05943821|Gout Suppressants|gout suppressants|mesh-ancestor
153877104|NCT06043336|Glucocorticoids|glucocorticoids|mesh-ancestor
153877105|NCT06043336|Hormones|hormones|mesh-ancestor
153877107|NCT06043336|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153877108|NCT06043336|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153877109|NCT06043336|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
153877110|NCT06043336|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153877111|NCT06043336|Serotonin Agents|serotonin agents|mesh-ancestor
153877112|NCT06043336|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153877113|NCT06043336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153877114|NCT06043310|Nitroprusside|nitroprusside|mesh-list
153877115|NCT06043310|Acetylcholine|acetylcholine|mesh-list
153877116|NCT06043310|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153877117|NCT06043310|Vasodilator Agents|vasodilator agents|mesh-ancestor
153877118|NCT06043310|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
153877119|NCT06043310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153417881|NCT04333927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153417882|NCT04334005|Vitamin D|vitamin d|mesh-list
153417883|NCT04334005|Vitamins|vitamins|mesh-ancestor
153417884|NCT04334005|Micronutrients|micronutrients|mesh-ancestor
153417885|NCT04334005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153417886|NCT04334005|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153417887|NCT00966914|Paclitaxel|paclitaxel|mesh-list
153417888|NCT00966914|Docetaxel|docetaxel|mesh-list
153417889|NCT00966914|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
153417890|NCT00966914|Cisplatin|cisplatin|mesh-list
153417891|NCT00966914|2,2'-dithiodiethanesulfonic acid|2,2'-dithiodiethanesulfonic acid|mesh-list
153417892|NCT00966914|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153417893|NCT00966914|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153417894|NCT00966914|Tubulin Modulators|tubulin modulators|mesh-ancestor
153417895|NCT00966914|Antimitotic Agents|antimitotic agents|mesh-ancestor
153417896|NCT00966914|Mitosis Modulators|mitosis modulators|mesh-ancestor
153417897|NCT00966914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153417898|NCT00966914|Protective Agents|protective agents|mesh-ancestor
153417901|NCT04430959|Candesartan cilexetil|candesartan cilexetil|mesh-list
153417902|NCT04430959|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153417903|NCT04430959|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
153417904|NCT04430959|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
153417905|NCT04430959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153417906|NCT04737655|Beclomethasone|beclomethasone|mesh-list
153417907|NCT04737655|Glycopyrrolate|glycopyrrolate|mesh-list
153417908|NCT04737655|Formoterol Fumarate|formoterol fumarate|mesh-list
153417909|NCT04737655|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153417910|NCT04737655|Autonomic Agents|autonomic agents|mesh-ancestor
153877120|NCT06043310|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
153877121|NCT06043310|Cholinergic Agents|cholinergic agents|mesh-ancestor
153877122|NCT06043310|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153877123|NCT06043310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153877124|NCT06043024|Salicylic Acid|salicylic acid|mesh-list
153877125|NCT06043024|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153877126|NCT06043024|Antifungal Agents|antifungal agents|mesh-ancestor
153877127|NCT06043024|Keratolytic Agents|keratolytic agents|mesh-ancestor
153877128|NCT06043024|Dermatologic Agents|dermatologic agents|mesh-ancestor
153877129|NCT06042985|Calcium, Dietary|calcium, dietary|mesh-list
153877130|NCT06042985|Calcium Carbonate|calcium carbonate|mesh-list
153417911|NCT04737655|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153877132|NCT06042985|Sodium Citrate|sodium citrate|mesh-list
153877133|NCT06042985|Calcium|calcium|mesh-list
153877134|NCT06042985|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153877135|NCT06042985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153877136|NCT06042985|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153877137|NCT06042985|Anticoagulants|anticoagulants|mesh-ancestor
153877154|NCT06037993|Sensory System Agents|sensory system agents|mesh-ancestor
153877155|NCT06037993|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153877156|NCT06037993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153877157|NCT06037993|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153877158|NCT06037993|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153877159|NCT06037993|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153877177|NCT06034873|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153417938|NCT05055752|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153417940|NCT05055752|Analgesics|analgesics|mesh-ancestor
153417941|NCT05055752|Sensory System Agents|sensory system agents|mesh-ancestor
153417942|NCT05055752|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153417943|NCT05055752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153417944|NCT05055752|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153417945|NCT05055752|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153417946|NCT05055752|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153417947|NCT05055752|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153417948|NCT05055752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153417949|NCT05055752|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153417950|NCT05055752|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153417951|NCT05055752|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153417952|NCT05055752|Antipyretics|antipyretics|mesh-ancestor
153417953|NCT04209140|Lithium Carbonate|lithium carbonate|mesh-list
153417954|NCT04209140|Antidepressive Agents|antidepressive agents|mesh-ancestor
153417955|NCT04209140|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153417956|NCT04209140|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153417957|NCT04209140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153417958|NCT04209140|Antimanic Agents|antimanic agents|mesh-ancestor
153417959|NCT04209140|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153417960|NCT04209140|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153417961|NCT04209140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153417962|NCT00372541|Ceftriaxone|ceftriaxone|mesh-list
153417963|NCT00372541|Third Generation Cephalosporins|third generation cephalosporins|mesh-ancestor
153877187|NCT06034379|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153877188|NCT06034379|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153877189|NCT06034379|Autonomic Agents|autonomic agents|mesh-ancestor
153877190|NCT06034379|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153877191|NCT06034379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153877192|NCT06034379|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153877193|NCT06034379|Respiratory System Agents|respiratory system agents|mesh-ancestor
153877194|NCT06034379|Mydriatics|mydriatics|mesh-ancestor
153877195|NCT06034379|Parasympatholytics|parasympatholytics|mesh-ancestor
153877196|NCT06034379|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
153877197|NCT06034379|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
153877198|NCT06034379|Cholinergic Agents|cholinergic agents|mesh-ancestor
153877199|NCT06034379|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153877200|NCT06034379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153877201|NCT06034158|Propranolol|propranolol|mesh-list
153877202|NCT06034158|Benserazide|benserazide|mesh-list
153877203|NCT06034158|Levodopa|levodopa|mesh-list
153417977|NCT04762381|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153417978|NCT04762381|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153417979|NCT04762381|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153417980|NCT01547468|Analgesics, Opioid|analgesics, opioid|mesh-list
153417981|NCT01547468|Narcotics|narcotics|mesh-ancestor
153417983|NCT01547468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153417984|NCT01547468|Analgesics|analgesics|mesh-ancestor
153417985|NCT01547468|Sensory System Agents|sensory system agents|mesh-ancestor
153417986|NCT01547468|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153417987|NCT04333628|Chloroquine|chloroquine|mesh-list
153417988|NCT04333628|Amebicides|amebicides|mesh-ancestor
153417989|NCT04333628|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153417990|NCT04333628|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153417991|NCT04333628|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153417992|NCT04333628|Antimalarials|antimalarials|mesh-ancestor
153417993|NCT04333628|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153417994|NCT00373412|Vaccines|vaccines|mesh-list
153417995|NCT00373412|Immunologic Factors|immunologic factors|mesh-ancestor
153877230|NCT06018688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153877231|NCT06018688|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153877232|NCT06018688|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153877233|NCT06018688|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153877234|NCT06018688|Antipyretics|antipyretics|mesh-ancestor
153387162|NCT05715437|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153387163|NCT05715437|Anesthetics, General|anesthetics, general|mesh-ancestor
153387164|NCT05715437|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
153387165|NCT05715437|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
153387166|NCT05715437|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153387167|NCT05715437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153387168|NCT05721443|Cetuximab|cetuximab|mesh-list
153387169|NCT05721443|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153387191|NCT00523809|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153387192|NCT00501345|Aspirin|aspirin|mesh-list
153387193|NCT00501345|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153417996|NCT00373412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153417997|NCT00373178|Metformin|metformin|mesh-list
153417998|NCT00373178|Rosiglitazone|rosiglitazone|mesh-list
153417999|NCT00373178|Hypoglycemic Agents|hypoglycemic agents|mesh-list
153418000|NCT00373178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153418001|NCT03254732|Pembrolizumab|pembrolizumab|mesh-list
153418002|NCT03254732|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153418003|NCT03254732|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153418004|NCT03254732|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153418005|NCT03254732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153418007|NCT02923466|Avelumab|avelumab|mesh-list
153418008|NCT02923466|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153418009|NCT02923466|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153418010|NCT02923466|Antiviral Agents|antiviral agents|mesh-ancestor
153418011|NCT02923466|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153418012|NCT02923466|Immunologic Factors|immunologic factors|mesh-ancestor
153418013|NCT02923466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153418014|NCT00813566|Deoxyglucose|deoxyglucose|mesh-list
153418015|NCT00813566|Antimetabolites|antimetabolites|mesh-ancestor
153418016|NCT00813566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153418017|NCT00813566|Antiviral Agents|antiviral agents|mesh-ancestor
153418018|NCT00813566|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153418019|NCT02885012|Ambrisentan|ambrisentan|mesh-list
153877238|NCT06010810|Tranexamic Acid|tranexamic acid|mesh-list
153877240|NCT06010810|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153877254|NCT06007846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153877256|NCT06007846|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
153418020|NCT02885012|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153418049|NCT02885636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153418050|NCT00373087|Entacapone|entacapone|mesh-list
153418051|NCT00373087|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
153418052|NCT00373087|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
153418053|NCT00373087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153877278|NCT05966376|Coagulants|coagulants|mesh-ancestor
153877279|NCT05964452|Methimazole|methimazole|mesh-list
153877280|NCT05964452|Antithyroid Agents|antithyroid agents|mesh-ancestor
153877281|NCT05964452|Hormone Antagonists|hormone antagonists|mesh-ancestor
153877282|NCT05964452|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153877283|NCT05964452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153877284|NCT05944510|Levomethorphan|levomethorphan|mesh-list
153877285|NCT05944510|Dextromethorphan|dextromethorphan|mesh-list
153877286|NCT05944510|Antitussive Agents|antitussive agents|mesh-ancestor
153877287|NCT05944510|Respiratory System Agents|respiratory system agents|mesh-ancestor
153877288|NCT05944510|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
153877289|NCT05944510|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
153877290|NCT05944510|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153418054|NCT00373087|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
153418055|NCT00373087|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153418056|NCT02892110|Varenicline|varenicline|mesh-list
153418057|NCT02892110|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
153418058|NCT02892110|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
153418059|NCT02892110|Cholinergic Agents|cholinergic agents|mesh-ancestor
153418060|NCT02892110|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153418061|NCT02892110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153418062|NCT02892110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153418063|NCT02779166|Celecoxib|celecoxib|mesh-list
153418064|NCT02779166|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153418078|NCT00373165|Antiviral Agents|antiviral agents|mesh-ancestor
153418079|NCT00373165|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153418080|NCT00373165|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153418081|NCT00373165|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153877307|NCT05934253|Sensory System Agents|sensory system agents|mesh-ancestor
153877308|NCT05934253|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153877309|NCT05918822|Maribavir|maribavir|mesh-list
153877310|NCT05918822|Rabeprazole|rabeprazole|mesh-list
153877311|NCT05918822|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
153877312|NCT05918822|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153877313|NCT05918822|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
153877314|NCT05918822|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153877315|NCT05918822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153877316|NCT05918822|Antiviral Agents|antiviral agents|mesh-ancestor
153877317|NCT05918822|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153877318|NCT05895838|Dexamethasone|dexamethasone|mesh-list
153877319|NCT05895838|Olanzapine|olanzapine|mesh-list
153877320|NCT05895838|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153418087|NCT04333550|Sequestering Agents|sequestering agents|mesh-ancestor
153418088|NCT04333550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153418089|NCT02827838|Durvalumab|durvalumab|mesh-list
153418090|NCT02827838|Immunoglobulins|immunoglobulins|mesh-list
153418091|NCT02827838|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
153418092|NCT02827838|Immunoglobulin G|immunoglobulin g|mesh-list
153418093|NCT02827838|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153418094|NCT02827838|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153418095|NCT02827838|Immunologic Factors|immunologic factors|mesh-ancestor
153418096|NCT02827838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153418097|NCT02902172|Acetaminophen|acetaminophen|mesh-list
153418098|NCT02902172|Ibuprofen|ibuprofen|mesh-list
153418099|NCT02902172|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153418100|NCT02902172|Analgesics|analgesics|mesh-ancestor
153418101|NCT02902172|Sensory System Agents|sensory system agents|mesh-ancestor
153418102|NCT02902172|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153418103|NCT02902172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153418104|NCT02902172|Antipyretics|antipyretics|mesh-ancestor
153418105|NCT02902172|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153418106|NCT02902172|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153418107|NCT02902172|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153418111|NCT02777749|Bupivacaine|bupivacaine|mesh-list
153418112|NCT02777749|Anesthetics, Local|anesthetics, local|mesh-ancestor
153418113|NCT02777749|Anesthetics|anesthetics|mesh-ancestor
153418114|NCT02777749|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153418115|NCT02777749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153418116|NCT02777749|Sensory System Agents|sensory system agents|mesh-ancestor
153418117|NCT02777749|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153877321|NCT05895838|Antiemetics|antiemetics|mesh-ancestor
153877322|NCT05895838|Autonomic Agents|autonomic agents|mesh-ancestor
153877323|NCT05895838|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153877324|NCT05895838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153877325|NCT05895838|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153877326|NCT05895838|Glucocorticoids|glucocorticoids|mesh-ancestor
153877327|NCT05895838|Hormones|hormones|mesh-ancestor
153877329|NCT05895838|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153877330|NCT05895838|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153877331|NCT05895838|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153877332|NCT05895838|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153877333|NCT05895838|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153877334|NCT05895838|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153877335|NCT05895838|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
153877336|NCT05895838|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153877337|NCT05895838|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153877338|NCT05895838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153877339|NCT05895838|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153877340|NCT05895838|Serotonin Agents|serotonin agents|mesh-ancestor
153879551|NCT04730947|Dapagliflozin|dapagliflozin|mesh-list
153877347|NCT05888896|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
153877348|NCT05888896|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153877350|NCT05888896|Adrenergic Agents|adrenergic agents|mesh-ancestor
153877351|NCT05888896|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153877352|NCT05888896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153418118|NCT02785172|Clobetasol|clobetasol|mesh-list
153418119|NCT02785172|Halobetasol|halobetasol|mesh-list
153418120|NCT02785172|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
153418121|NCT02785172|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153418122|NCT02785172|Glucocorticoids|glucocorticoids|mesh-ancestor
153418123|NCT02785172|Hormones|hormones|mesh-ancestor
153418124|NCT02785172|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153418125|NCT02785172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153418126|NCT02582125|Nivolumab|nivolumab|mesh-list
153418127|NCT02582125|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153418128|NCT02582125|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153418168|NCT02911844|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
153418169|NCT02911844|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
153418170|NCT02911844|Hormone Antagonists|hormone antagonists|mesh-ancestor
153418199|NCT02888665|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153877430|NCT05802225|Pertuzumab|pertuzumab|mesh-list
153877431|NCT05802225|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153877432|NCT05802225|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153877433|NCT05801835|Cytarabine|cytarabine|mesh-list
153877434|NCT05801835|Daunorubicin|daunorubicin|mesh-list
153877435|NCT05801835|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153877436|NCT05801835|Antimetabolites|antimetabolites|mesh-ancestor
153877437|NCT05801835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153418200|NCT02888665|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153418201|NCT02888665|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153418203|NCT02888665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153418204|NCT02888665|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153418205|NCT02888665|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153418206|NCT02781571|Sofosbuvir|sofosbuvir|mesh-list
153418207|NCT02781571|Sofosbuvir-velpatasvir drug combination|sofosbuvir-velpatasvir drug combination|mesh-list
153418208|NCT02781571|Velpatasvir|velpatasvir|mesh-list
153418209|NCT02781571|Antiviral Agents|antiviral agents|mesh-ancestor
153418210|NCT02781571|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153418211|NCT02918630|Nicotine|nicotine|mesh-list
153418212|NCT02918630|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
153418213|NCT02918630|Autonomic Agents|autonomic agents|mesh-ancestor
153418214|NCT02918630|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153418215|NCT02918630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153418216|NCT02918630|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
153418217|NCT02918630|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
153877440|NCT05801835|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153877441|NCT05801835|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153877442|NCT05801835|Immunologic Factors|immunologic factors|mesh-ancestor
153877443|NCT05801835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153877444|NCT05801835|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153877445|NCT05801835|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153877446|NCT05801835|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153877447|NCT05801835|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153877449|NCT05790681|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153877450|NCT05790681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153877451|NCT05780216|Harmine|harmine|mesh-list
153877452|NCT05780216|Hallucinogens|hallucinogens|mesh-ancestor
153877453|NCT05780216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153877454|NCT05780216|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153877455|NCT05780216|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
153877456|NCT05780216|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153877457|NCT05780216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153877458|NCT05766631|Methadone|methadone|mesh-list
153877459|NCT05766631|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153877460|NCT05766631|Narcotics|narcotics|mesh-ancestor
153418223|NCT02781649|Grazoprevir|grazoprevir|mesh-list
153418224|NCT02781649|Elbasvir-grazoprevir drug combination|elbasvir-grazoprevir drug combination|mesh-list
153418225|NCT02781649|Antimetabolites|antimetabolites|mesh-ancestor
153418226|NCT02781649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153418227|NCT02781649|Antiviral Agents|antiviral agents|mesh-ancestor
153418228|NCT02781649|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153879744|NCT04013854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153877472|NCT05753306|Antimitotic Agents|antimitotic agents|mesh-ancestor
153877473|NCT05753306|Mitosis Modulators|mitosis modulators|mesh-ancestor
153877474|NCT05753306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153877475|NCT05752734|Dexamethasone|dexamethasone|mesh-list
153418245|NCT03002012|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
153418246|NCT03002012|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153418247|NCT03002012|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153877497|NCT05741905|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
153877498|NCT05741905|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153877500|NCT05717049|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153877501|NCT05717049|Autonomic Agents|autonomic agents|mesh-ancestor
153877505|NCT05717049|Respiratory System Agents|respiratory system agents|mesh-ancestor
153877506|NCT05717049|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
153877507|NCT05717049|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153877508|NCT05717049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153877509|NCT05717049|Vasodilator Agents|vasodilator agents|mesh-ancestor
153877510|NCT05717049|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
153877511|NCT05717049|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
153418272|NCT00373646|Growth Inhibitors|growth inhibitors|mesh-ancestor
153418273|NCT00373646|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153418274|NCT03001453|Epinephrine|epinephrine|mesh-list
153418275|NCT03001453|Bupivacaine|bupivacaine|mesh-list
153418276|NCT03001453|Anesthetics, Local|anesthetics, local|mesh-ancestor
153418277|NCT03001453|Anesthetics|anesthetics|mesh-ancestor
153418278|NCT03001453|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153418280|NCT03001453|Sensory System Agents|sensory system agents|mesh-ancestor
153418281|NCT03001453|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153418282|NCT03001453|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153418283|NCT03001453|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153418284|NCT03001453|Adrenergic Agents|adrenergic agents|mesh-ancestor
153418285|NCT03001453|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153418286|NCT03001453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153418287|NCT03001453|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
153418288|NCT03001453|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153418289|NCT03001453|Autonomic Agents|autonomic agents|mesh-ancestor
153418290|NCT03001453|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153418291|NCT03001453|Respiratory System Agents|respiratory system agents|mesh-ancestor
153418292|NCT03001453|Mydriatics|mydriatics|mesh-ancestor
153418293|NCT03001453|Sympathomimetics|sympathomimetics|mesh-ancestor
153879831|NCT03570632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153877512|NCT05717049|Purinergic Agents|purinergic agents|mesh-ancestor
153877513|NCT05717049|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153877514|NCT05698147|Rituximab|rituximab|mesh-list
153877515|NCT05698147|Methotrexate|methotrexate|mesh-list
153877516|NCT05698147|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153877517|NCT05698147|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153877518|NCT05698147|Immunologic Factors|immunologic factors|mesh-ancestor
153877519|NCT05698147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153877520|NCT05698147|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153877521|NCT05698147|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
153877522|NCT05698147|Abortifacient Agents|abortifacient agents|mesh-ancestor
153877523|NCT05698147|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153877524|NCT05698147|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153877525|NCT05698147|Antimetabolites|antimetabolites|mesh-ancestor
153877526|NCT05698147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153877527|NCT05698147|Dermatologic Agents|dermatologic agents|mesh-ancestor
153877528|NCT05698147|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153877529|NCT05698147|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153877530|NCT05698147|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153877531|NCT05698147|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153877533|NCT05696236|Cariostatic Agents|cariostatic agents|mesh-ancestor
153418294|NCT03001453|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
153418296|NCT03001843|Narcotics|narcotics|mesh-list
153418305|NCT03001843|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153418306|NCT03001843|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
153418307|NCT03001843|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
153418308|NCT03001843|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153418309|NCT03001843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153418310|NCT02785159|Tazarotene|tazarotene|mesh-list
153418311|NCT02785159|Dermatologic Agents|dermatologic agents|mesh-ancestor
153418312|NCT02785159|Keratolytic Agents|keratolytic agents|mesh-ancestor
153418313|NCT02786719|Cyclophosphamide|cyclophosphamide|mesh-list
153418314|NCT02786719|Doxorubicin|doxorubicin|mesh-list
153418315|NCT02786719|Etoposide|etoposide|mesh-list
153418316|NCT02786719|Vincristine|vincristine|mesh-list
153418317|NCT02786719|Topotecan|topotecan|mesh-list
153418318|NCT02786719|Sargramostim|sargramostim|mesh-list
153418319|NCT02786719|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153418320|NCT02786719|Immunologic Factors|immunologic factors|mesh-ancestor
153877534|NCT05696236|Protective Agents|protective agents|mesh-ancestor
153387194|NCT00501345|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153387195|NCT00501345|Analgesics|analgesics|mesh-ancestor
153387196|NCT00501345|Sensory System Agents|sensory system agents|mesh-ancestor
153387197|NCT00501345|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153387198|NCT00501345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153387199|NCT00501345|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153877535|NCT05696236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153877536|NCT05672550|Enoxaparin|enoxaparin|mesh-list
153877537|NCT05672550|Enoxaparin sodium|enoxaparin sodium|mesh-list
153877538|NCT05672550|Anticoagulants|anticoagulants|mesh-ancestor
153877539|NCT05672550|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153877540|NCT05672550|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153877541|NCT05672550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153877542|NCT05672407|Tranexamic Acid|tranexamic acid|mesh-list
153877543|NCT05672407|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
153877544|NCT05672407|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153877545|NCT05672407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153877548|NCT05654623|Fulvestrant|fulvestrant|mesh-list
153877549|NCT05654623|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153877550|NCT05654623|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153418321|NCT02786719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153418322|NCT02786719|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153877551|NCT05654623|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
153877552|NCT05654623|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
153877553|NCT05654623|Hormone Antagonists|hormone antagonists|mesh-ancestor
153418337|NCT03003949|Estradiol|estradiol|mesh-list
153877554|NCT05654623|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153877555|NCT05654623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153877556|NCT05654363|Morphine|morphine|mesh-list
153877557|NCT05654363|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153877558|NCT05654363|Narcotics|narcotics|mesh-ancestor
153877559|NCT05654363|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153877560|NCT05654363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153877561|NCT05654363|Analgesics|analgesics|mesh-ancestor
153877562|NCT05654363|Sensory System Agents|sensory system agents|mesh-ancestor
153877563|NCT05654363|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153877564|NCT05653401|Diclofenac|diclofenac|mesh-list
153877565|NCT05653401|Lidocaine|lidocaine|mesh-list
153877574|NCT05653401|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
153877576|NCT05653401|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153877577|NCT05653401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153877578|NCT05653401|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153418342|NCT03003949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153418343|NCT03003949|Progestins|progestins|mesh-ancestor
153418344|NCT03007225|Chlorotrianisene|chlorotrianisene|mesh-list
153418345|NCT03007225|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
153418346|NCT03007225|Estrogens|estrogens|mesh-ancestor
153418348|NCT03007225|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153418349|NCT03007225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153418350|NCT03007225|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153418351|NCT03007225|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153418352|NCT02800148|Azelaic acid|azelaic acid|mesh-list
153418353|NCT02800148|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153418354|NCT02800148|Dermatologic Agents|dermatologic agents|mesh-ancestor
153418355|NCT02902081|Cannabidiol|cannabidiol|mesh-list
153418356|NCT02902081|Anticonvulsants|anticonvulsants|mesh-ancestor
153418357|NCT02791945|Acetylcysteine|acetylcysteine|mesh-list
153418358|NCT02791945|N-monoacetylcystine|n-monoacetylcystine|mesh-list
153418359|NCT02791945|Antiviral Agents|antiviral agents|mesh-ancestor
153418360|NCT02791945|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153418361|NCT02791945|Expectorants|expectorants|mesh-ancestor
153418362|NCT02791945|Respiratory System Agents|respiratory system agents|mesh-ancestor
153418363|NCT02791945|Free Radical Scavengers|free radical scavengers|mesh-ancestor
153418364|NCT02791945|Antioxidants|antioxidants|mesh-ancestor
153418365|NCT02791945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153877589|NCT05653401|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153387201|NCT00501345|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153387202|NCT00501345|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153387203|NCT00501345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153387204|NCT00501345|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153387205|NCT00501345|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153387206|NCT00501345|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153387207|NCT00501345|Antipyretics|antipyretics|mesh-ancestor
153883354|NCT01335009|Antibodies|antibodies|mesh-list
153387209|NCT00357773|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153387210|NCT00357773|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153387211|NCT00487461|Simvastatin|simvastatin|mesh-list
153387212|NCT00487461|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153877590|NCT05619653|Prednisolone|prednisolone|mesh-list
153877591|NCT05619653|Losartan|losartan|mesh-list
153877592|NCT05619653|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153877593|NCT05619653|Glucocorticoids|glucocorticoids|mesh-ancestor
153877594|NCT05619653|Hormones|hormones|mesh-ancestor
153877595|NCT05619653|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153877596|NCT05619653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153877597|NCT05619653|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153877598|NCT05619653|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153877599|NCT05619653|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153877600|NCT05619653|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153877601|NCT05619653|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
153877602|NCT05619653|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
153877603|NCT05619653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153877604|NCT05610657|Mitapivat|mitapivat|mesh-list
153418370|NCT02793817|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
153418372|NCT00374192|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153418373|NCT00374192|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153418374|NCT00374192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153418375|NCT02806544|Tamoxifen|tamoxifen|mesh-list
153418376|NCT02806544|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
153418377|NCT02806544|Hormone Antagonists|hormone antagonists|mesh-ancestor
153418378|NCT02806544|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153418379|NCT02806544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153418380|NCT02806544|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153418381|NCT02806544|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153418382|NCT02806544|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
153879902|NCT03089905|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153877617|NCT05589220|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
153877661|NCT05509569|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153877664|NCT05509569|Sensory System Agents|sensory system agents|mesh-ancestor
153877665|NCT05509569|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153418433|NCT02903407|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153418434|NCT02903407|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153418435|NCT02903407|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153418436|NCT02903407|GABA Modulators|gaba modulators|mesh-ancestor
153418437|NCT02903407|GABA Agents|gaba agents|mesh-ancestor
153418438|NCT02905981|Citric Acid|citric acid|mesh-list
153418439|NCT02905981|Sodium Citrate|sodium citrate|mesh-list
153418440|NCT02905981|Anticoagulants|anticoagulants|mesh-ancestor
153418441|NCT02905981|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
153418442|NCT02905981|Chelating Agents|chelating agents|mesh-ancestor
153418443|NCT02905981|Sequestering Agents|sequestering agents|mesh-ancestor
153418444|NCT02905981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153418446|NCT00374023|Vitamins|vitamins|mesh-ancestor
153418447|NCT00374023|Micronutrients|micronutrients|mesh-ancestor
153418448|NCT00374023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153418449|NCT02812238|Niacinamide|niacinamide|mesh-list
153418450|NCT02812238|Niacin|niacin|mesh-list
153418451|NCT02812238|Nicotinic Acids|nicotinic acids|mesh-list
153387213|NCT00487461|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153387214|NCT00487461|Antimetabolites|antimetabolites|mesh-ancestor
153387215|NCT00487461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153387216|NCT00487461|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153387217|NCT00487461|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
153387218|NCT00487461|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153387219|NCT00356187|Propranolol|propranolol|mesh-list
153387220|NCT00356187|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
153387221|NCT00356187|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
153387222|NCT00356187|Adrenergic Agents|adrenergic agents|mesh-ancestor
153387223|NCT00356187|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153387258|NCT00305643|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153387259|NCT00305643|Analgesics|analgesics|mesh-ancestor
153387260|NCT00305643|Sensory System Agents|sensory system agents|mesh-ancestor
153387261|NCT00305643|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153783586|NCT00261729|Paroxetine|paroxetine|mesh-list
153418452|NCT02812238|Vitamin B Complex|vitamin b complex|mesh-ancestor
153418453|NCT02812238|Vitamins|vitamins|mesh-ancestor
153418454|NCT02812238|Micronutrients|micronutrients|mesh-ancestor
153418455|NCT02812238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153418456|NCT02812238|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153418457|NCT02812238|Antimetabolites|antimetabolites|mesh-ancestor
153418458|NCT02812238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153879988|NCT02654119|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153877676|NCT05506566|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
153877677|NCT05506566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153877678|NCT05500170|Niacinamide|niacinamide|mesh-list
153877679|NCT05500170|Niacin|niacin|mesh-list
153877680|NCT05500170|Nicotinic Acids|nicotinic acids|mesh-list
153877681|NCT05500170|Vitamins|vitamins|mesh-ancestor
153877682|NCT05500170|Micronutrients|micronutrients|mesh-ancestor
153877683|NCT05500170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153877684|NCT05500170|Vitamin B Complex|vitamin b complex|mesh-ancestor
153877685|NCT05500170|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153877687|NCT05500170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153418459|NCT02812238|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153418460|NCT02812238|Vasodilator Agents|vasodilator agents|mesh-ancestor
153418461|NCT03015961|Bupivacaine|bupivacaine|mesh-list
153418462|NCT03015961|Anesthetics, Local|anesthetics, local|mesh-ancestor
153418463|NCT03015961|Anesthetics|anesthetics|mesh-ancestor
153418464|NCT03015961|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153418465|NCT03015961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153418466|NCT03015961|Sensory System Agents|sensory system agents|mesh-ancestor
153420838|NCT05113004|Antimalarials|antimalarials|mesh-ancestor
153418469|NCT03018223|Sirolimus|sirolimus|mesh-list
153418470|NCT03018223|Cyclophosphamide|cyclophosphamide|mesh-list
153418471|NCT03018223|Busulfan|busulfan|mesh-list
153418472|NCT03018223|Fludarabine|fludarabine|mesh-list
153418473|NCT03018223|Lenograstim|lenograstim|mesh-list
153418474|NCT03018223|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153418475|NCT03018223|Immunologic Factors|immunologic factors|mesh-ancestor
153418476|NCT03018223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153420869|NCT03149887|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153420870|NCT02988349|Listerine|listerine|mesh-list
153877701|NCT05440383|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153877702|NCT05431920|Vitamin D|vitamin d|mesh-list
153877703|NCT05431920|Ergocalciferols|ergocalciferols|mesh-list
153877704|NCT05431920|Cholecalciferol|cholecalciferol|mesh-list
153418492|NCT03018925|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
153418493|NCT03018925|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153418494|NCT03018925|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153418500|NCT03019783|Protease Inhibitors|protease inhibitors|mesh-ancestor
153418501|NCT03019783|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153418502|NCT03019783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153418503|NCT03019783|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153418504|NCT03019783|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153418505|NCT03019783|Antiviral Agents|antiviral agents|mesh-ancestor
153418506|NCT03019783|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153418507|NCT03019939|Isavuconazole|isavuconazole|mesh-list
153418508|NCT03019939|Antifungal Agents|antifungal agents|mesh-ancestor
153418509|NCT03019939|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153877726|NCT05411991|Acetazolamide|acetazolamide|mesh-list
153877727|NCT05411991|Bumetanide|bumetanide|mesh-list
153877728|NCT05411991|Diuretics|diuretics|mesh-list
153877729|NCT05411991|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-list
153877730|NCT05411991|Natriuretic Agents|natriuretic agents|mesh-ancestor
153877731|NCT05411991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153877732|NCT05411991|Anticonvulsants|anticonvulsants|mesh-ancestor
153877733|NCT05411991|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
153877734|NCT05411991|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153877735|NCT05411991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153877736|NCT05411991|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153877737|NCT05411991|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
153418511|NCT03020095|Ribavirin|ribavirin|mesh-list
153418512|NCT03020095|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
153418513|NCT03020095|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
153418514|NCT03020095|Protease Inhibitors|protease inhibitors|mesh-ancestor
153418515|NCT03020095|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153418516|NCT03020095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153418517|NCT03020095|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153418531|NCT03021343|Tubulin Modulators|tubulin modulators|mesh-ancestor
153418532|NCT03021343|Antimitotic Agents|antimitotic agents|mesh-ancestor
153418533|NCT03021343|Mitosis Modulators|mitosis modulators|mesh-ancestor
153418534|NCT03021343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153418535|NCT03021343|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153418537|NCT03025945|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153418538|NCT03025945|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153418539|NCT03025945|Analgesics|analgesics|mesh-ancestor
153418540|NCT03025945|Sensory System Agents|sensory system agents|mesh-ancestor
153418541|NCT03025945|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153418542|NCT03025945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153877763|NCT05400863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153877764|NCT05395052|Cyclophosphamide|cyclophosphamide|mesh-list
153877765|NCT05395052|Pembrolizumab|pembrolizumab|mesh-list
153877766|NCT05395052|Nivolumab|nivolumab|mesh-list
153877767|NCT05395052|Trastuzumab|trastuzumab|mesh-list
153877768|NCT05395052|Fludarabine|fludarabine|mesh-list
153877769|NCT05395052|Cetuximab|cetuximab|mesh-list
153877770|NCT05395052|Atezolizumab|atezolizumab|mesh-list
153418544|NCT03025945|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153418545|NCT02937506|Midazolam|midazolam|mesh-list
153418546|NCT02937506|Fentanyl|fentanyl|mesh-list
153418547|NCT02937506|Propofol|propofol|mesh-list
153418548|NCT02937506|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153418549|NCT02937506|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153418550|NCT02937506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153418551|NCT02937506|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153418552|NCT02937506|Anesthetics, General|anesthetics, general|mesh-ancestor
153418553|NCT02937506|Anesthetics|anesthetics|mesh-ancestor
153418554|NCT02937506|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153418555|NCT02937506|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153418556|NCT02937506|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153418557|NCT02937506|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153418558|NCT02937506|GABA Modulators|gaba modulators|mesh-ancestor
153418559|NCT02937506|GABA Agents|gaba agents|mesh-ancestor
153418560|NCT02937506|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153418561|NCT02937506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153418562|NCT02937506|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153877779|NCT05395052|Alkylating Agents|alkylating agents|mesh-ancestor
153877780|NCT05395052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153877781|NCT05395052|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153877782|NCT05395052|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153877783|NCT05395052|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153877784|NCT05395052|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153877785|NCT05395052|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153877787|NCT05395052|Sensory System Agents|sensory system agents|mesh-ancestor
153877788|NCT05395052|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153877789|NCT05370235|Afamelanotide|afamelanotide|mesh-list
153418577|NCT03027661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153418578|NCT03027661|Sensory System Agents|sensory system agents|mesh-ancestor
153418579|NCT03027661|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153418581|NCT03022526|Bupivacaine|bupivacaine|mesh-list
153418582|NCT03022526|Anesthetics, Local|anesthetics, local|mesh-ancestor
153418583|NCT03022526|Anesthetics|anesthetics|mesh-ancestor
153418584|NCT03022526|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153418585|NCT03022526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153877806|NCT05359653|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
153877807|NCT05358704|Leucovorin|leucovorin|mesh-list
153877808|NCT05358704|Capecitabine|capecitabine|mesh-list
153877809|NCT05358704|Fluorouracil|fluorouracil|mesh-list
153877810|NCT05358704|Oxaliplatin|oxaliplatin|mesh-list
153418586|NCT03022526|Sensory System Agents|sensory system agents|mesh-ancestor
153424552|NCT03806270|Anesthetics|anesthetics|mesh-ancestor
153425964|NCT00568802|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153425965|NCT00568802|Antisickling Agents|antisickling agents|mesh-ancestor
153425966|NCT00568802|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153425967|NCT00568802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153425968|NCT00568802|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153425969|NCT03949621|Vedolizumab|vedolizumab|mesh-list
153885009|NCT02272478|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153885010|NCT02272478|Antimetabolites|antimetabolites|mesh-ancestor
153885011|NCT02272478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153885012|NCT02272478|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153885013|NCT02272478|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153425973|NCT04429880|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153425974|NCT04429880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153425976|NCT01692158|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
153425977|NCT01692158|Tinzaparin|tinzaparin|mesh-list
153425978|NCT01692158|Dalteparin|dalteparin|mesh-list
153425979|NCT01692158|Anticoagulants|anticoagulants|mesh-ancestor
153425980|NCT01692158|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153425981|NCT01692158|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153425982|NCT01692158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153425983|NCT01570634|Antidiarrheals|antidiarrheals|mesh-list
153425984|NCT01570634|Loperamide|loperamide|mesh-list
153425985|NCT01570634|Calcium Aluminosilicate|calcium aluminosilicate|mesh-list
153425986|NCT01570634|Calcium|calcium|mesh-list
153425987|NCT01570634|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153425988|NCT01570634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153885032|NCT02272517|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153885033|NCT02272517|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
153885034|NCT02272517|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
153885035|NCT02272517|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
153425989|NCT01570634|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153425996|NCT03928327|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153425997|NCT03928327|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153425998|NCT03928327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153425999|NCT03928327|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153426000|NCT03928327|Hormone Antagonists|hormone antagonists|mesh-ancestor
153426001|NCT03928327|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153426002|NCT03928327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153426003|NCT03928327|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
153426004|NCT03928327|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
153426005|NCT03928327|Antitubercular Agents|antitubercular agents|mesh-ancestor
153426006|NCT03928327|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153426007|NCT03928327|Leprostatic Agents|leprostatic agents|mesh-ancestor
153426008|NCT03928327|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153426009|NCT03928327|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
153426010|NCT03928327|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
153885062|NCT02272868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153885063|NCT02272868|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153885064|NCT02272868|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153885066|NCT02273453|Oxazepam|oxazepam|mesh-list
153885067|NCT02273453|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153885068|NCT02273453|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153885069|NCT02273453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153885070|NCT02273453|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153885071|NCT02273453|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153885072|NCT02273453|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153426037|NCT01055756|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
153426039|NCT01055756|Adrenergic Agents|adrenergic agents|mesh-ancestor
153426040|NCT00652574|Dasatinib|dasatinib|mesh-list
153426041|NCT00652574|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153426042|NCT00652574|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153426043|NCT00652574|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153426044|NCT00652574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153426045|NCT00652574|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153426046|NCT01550510|Ascorbic Acid|ascorbic acid|mesh-list
153426048|NCT01550510|Camptothecin|camptothecin|mesh-list
153426049|NCT01550510|Vitamins|vitamins|mesh-ancestor
153426050|NCT01550510|Micronutrients|micronutrients|mesh-ancestor
153885156|NCT01588847|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153885157|NCT01588847|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153885158|NCT01588847|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153885160|NCT01588847|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153885161|NCT01588847|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
153885162|NCT01588847|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
153885163|NCT01588847|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
153885164|NCT01588847|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
153885165|NCT01588847|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153885166|NCT01588847|Narcotics|narcotics|mesh-ancestor
153885167|NCT01588847|Analgesics|analgesics|mesh-ancestor
153885168|NCT01588847|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153885169|NCT00107900|Edoxaban|edoxaban|mesh-list
153885170|NCT00107900|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
153426125|NCT00379964|Antifungal Agents|antifungal agents|mesh-ancestor
153426126|NCT00379964|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153426127|NCT00379964|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153426139|NCT04713644|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153426140|NCT04713644|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153426141|NCT04713644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153426142|NCT04713644|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153885217|NCT01335698|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153885218|NCT01335698|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
153885219|NCT01335698|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153885220|NCT00107120|Escitalopram|escitalopram|mesh-list
153885221|NCT00107120|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
153426187|NCT03909763|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153426188|NCT03909763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153426189|NCT00484718|Celecoxib|celecoxib|mesh-list
153426190|NCT00484718|Oxycodone|oxycodone|mesh-list
153426191|NCT00484718|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153426192|NCT00484718|Narcotics|narcotics|mesh-ancestor
153426193|NCT00484718|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153426194|NCT00484718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153426195|NCT00484718|Analgesics|analgesics|mesh-ancestor
153426196|NCT00484718|Sensory System Agents|sensory system agents|mesh-ancestor
153426197|NCT00484718|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153426198|NCT00484718|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153885236|NCT00106184|Immunologic Factors|immunologic factors|mesh-ancestor
153885237|NCT00106184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153885238|NCT00106184|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153885240|NCT00598923|Phenytoin|phenytoin|mesh-list
153885241|NCT00598923|Anticonvulsants|anticonvulsants|mesh-ancestor
153885242|NCT00598923|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153426199|NCT00484718|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153885264|NCT01334918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153885265|NCT01334918|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
153885266|NCT00598962|Azithromycin|azithromycin|mesh-list
153885267|NCT00598962|Rifampin|rifampin|mesh-list
153885268|NCT00598962|Rifabutin|rifabutin|mesh-list
153885271|NCT00598962|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
153885272|NCT00598962|Antitubercular Agents|antitubercular agents|mesh-ancestor
153885273|NCT00598962|Leprostatic Agents|leprostatic agents|mesh-ancestor
153885274|NCT00598962|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153426235|NCT00000770|Zidovudine|zidovudine|mesh-list
153426236|NCT00000770|Nevirapine|nevirapine|mesh-list
153426237|NCT00000770|Didanosine|didanosine|mesh-list
153426256|NCT00368654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153426258|NCT00368654|Dermatologic Agents|dermatologic agents|mesh-ancestor
153885287|NCT01332968|Doxorubicin|doxorubicin|mesh-list
153885296|NCT01332968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153885297|NCT01332968|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153885298|NCT01332968|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153885312|NCT01332968|Mitosis Modulators|mitosis modulators|mesh-ancestor
153885313|NCT00599079|Azithromycin|azithromycin|mesh-list
153885314|NCT00599079|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153885315|NCT00599079|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153387302|NCT00183963|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153387303|NCT00183963|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153387304|NCT00183963|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
153387305|NCT00183963|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
153387306|NCT00183963|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153387307|NCT00183963|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
153387308|NCT05719961|Insulin|insulin|mesh-list
153387331|NCT04225611|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153387332|NCT04225611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153387333|NCT04225611|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153387334|NCT04225611|Glucocorticoids|glucocorticoids|mesh-ancestor
153387335|NCT04225611|Hormones|hormones|mesh-ancestor
153885316|NCT00599235|Hydralazine|hydralazine|mesh-list
153885317|NCT00599235|Sildenafil Citrate|sildenafil citrate|mesh-list
153885318|NCT00599235|Vasodilator Agents|vasodilator agents|mesh-ancestor
153885319|NCT00599235|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
153885325|NCT00599274|Interferons|interferons|mesh-list
153885341|NCT01332227|Protease Inhibitors|protease inhibitors|mesh-ancestor
153885342|NCT01332227|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153885343|NCT01332227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153885345|NCT01332227|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153885346|NCT01332227|Antiviral Agents|antiviral agents|mesh-ancestor
153885347|NCT01332227|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153426326|NCT00000800|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153426327|NCT00000800|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153426328|NCT00000800|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153885356|NCT01332149|Sensory System Agents|sensory system agents|mesh-ancestor
153885357|NCT01332149|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153885358|NCT01332149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153885359|NCT01332149|Anticonvulsants|anticonvulsants|mesh-ancestor
153885360|NCT01332149|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153885361|NCT01332149|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153885362|NCT01332149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153885363|NCT01332149|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153426339|NCT03679975|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
153426340|NCT03679975|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
153426341|NCT03679975|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153426342|NCT03679975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153426343|NCT03679975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153426344|NCT03679975|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
153426345|NCT03679975|Protective Agents|protective agents|mesh-ancestor
153426347|NCT03887299|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153426348|NCT03684265|Meloxicam|meloxicam|mesh-list
153426349|NCT03684265|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153426350|NCT03684265|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153426351|NCT03684265|Analgesics|analgesics|mesh-ancestor
153426352|NCT03684265|Sensory System Agents|sensory system agents|mesh-ancestor
153885366|NCT01332149|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153885379|NCT01326702|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153885380|NCT01326702|Alkylating Agents|alkylating agents|mesh-ancestor
153885382|NCT01326702|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
153885397|NCT05649878|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
153885398|NCT05649878|Prednisolone phosphate|prednisolone phosphate|mesh-list
153885399|NCT05649878|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153885400|NCT05649878|Antiemetics|antiemetics|mesh-ancestor
153885401|NCT05649878|Autonomic Agents|autonomic agents|mesh-ancestor
153885402|NCT05649878|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153885403|NCT05649878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153426414|NCT00000818|Antimetabolites|antimetabolites|mesh-ancestor
153426415|NCT00000818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153885430|NCT01380080|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
153885431|NCT01380080|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
153885432|NCT01380080|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
153885433|NCT01380080|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
153885434|NCT01380080|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153885435|NCT01380080|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153885436|NCT01380080|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
153885437|NCT01380080|Antitubercular Agents|antitubercular agents|mesh-ancestor
153885438|NCT01380080|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153885439|NCT01380080|Leprostatic Agents|leprostatic agents|mesh-ancestor
153885440|NCT01380080|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
153885450|NCT01379573|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153426416|NCT00000818|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153426417|NCT00000818|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153426419|NCT00000818|Antiviral Agents|antiviral agents|mesh-ancestor
153426420|NCT00000818|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153885451|NCT01379573|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153885452|NCT01379573|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153885453|NCT01379573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153885454|NCT01379573|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153885455|NCT01371851|Doxazosin|doxazosin|mesh-list
153885456|NCT01371851|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153885457|NCT01371851|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
153426446|NCT00089414|Contraceptive Agents|contraceptive agents|mesh-ancestor
153885468|NCT01371734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153885469|NCT01371734|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153885470|NCT01371734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153885471|NCT01371734|Antidepressive Agents|antidepressive agents|mesh-ancestor
153885472|NCT01371734|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153885474|NCT04328870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153885475|NCT04328870|Oxytocics|oxytocics|mesh-ancestor
153885476|NCT04328870|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153426449|NCT00089414|Progestins|progestins|mesh-ancestor
153426450|NCT00089414|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
153426451|NCT00089414|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
153426452|NCT00089414|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
153426453|NCT00089414|Hormone Antagonists|hormone antagonists|mesh-ancestor
153426464|NCT00075608|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153426465|NCT00075608|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153426467|NCT03704467|Avelumab|avelumab|mesh-list
153885479|NCT00591617|Narcotics|narcotics|mesh-ancestor
153885480|NCT00591617|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153885481|NCT00591617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153885482|NCT00591617|Analgesics|analgesics|mesh-ancestor
153885483|NCT00591617|Sensory System Agents|sensory system agents|mesh-ancestor
153885484|NCT00591617|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153885485|NCT00591617|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
153885486|NCT01357889|rGLP-1 protein|rglp-1 protein|mesh-list
153885487|NCT01357889|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
153885500|NCT01357616|Timolol|timolol|mesh-list
153885501|NCT01357616|Ophthalmic Solutions|ophthalmic solutions|mesh-list
153885502|NCT01357616|Brinzolamide|brinzolamide|mesh-list
153426481|NCT00000848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153426482|NCT00000848|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153426483|NCT00000848|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153426484|NCT00000848|Antiviral Agents|antiviral agents|mesh-ancestor
153426485|NCT00000848|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153426486|NCT00000848|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
153426487|NCT00000848|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153426488|NCT01795586|Carboplatin|carboplatin|mesh-list
153426489|NCT01795586|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153426490|NCT02212574|Cyclophosphamide|cyclophosphamide|mesh-list
153426491|NCT02212574|Lomustine|lomustine|mesh-list
153426492|NCT02212574|Vincristine|vincristine|mesh-list
153426493|NCT02212574|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153426494|NCT02212574|Immunologic Factors|immunologic factors|mesh-ancestor
153426495|NCT02212574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153885552|NCT01342913|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153885553|NCT01342913|Respiratory System Agents|respiratory system agents|mesh-ancestor
153885554|NCT01342913|Dermatologic Agents|dermatologic agents|mesh-ancestor
153885555|NCT01342913|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
153885556|NCT01342913|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
153885557|NCT01342913|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
153885558|NCT01342913|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153885559|NCT01342913|Adrenergic Agents|adrenergic agents|mesh-ancestor
153885560|NCT01342913|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153885561|NCT01342913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153885562|NCT01342796|Vaccines|vaccines|mesh-list
153885563|NCT01342796|Immunologic Factors|immunologic factors|mesh-ancestor
153885564|NCT01342796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153885565|NCT01342640|Epoetin Alfa|epoetin alfa|mesh-list
153885566|NCT01342640|Hematinics|hematinics|mesh-ancestor
153885567|NCT01342484|Linagliptin|linagliptin|mesh-list
153885568|NCT01342484|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153885569|NCT01342484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153885570|NCT01342484|Incretins|incretins|mesh-ancestor
153885571|NCT01342484|Hormones|hormones|mesh-ancestor
153426545|NCT03714919|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153426546|NCT03714919|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153885599|NCT01342094|Adrenergic Agents|adrenergic agents|mesh-ancestor
153885600|NCT01342094|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153475880|NCT00848016|Retinol acetate|retinol acetate|mesh-list
153426595|NCT04204057|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153426603|NCT00000884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153426604|NCT00000884|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153426605|NCT00000884|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153426607|NCT00000884|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153426608|NCT00000884|Interferon Inducers|interferon inducers|mesh-ancestor
153426609|NCT00000884|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
153426610|NCT00000884|Protective Agents|protective agents|mesh-ancestor
153475949|NCT00868452|Valproic Acid|valproic acid|mesh-list
153885648|NCT00598338|Serotonin Agents|serotonin agents|mesh-ancestor
153885649|NCT00598338|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153885651|NCT00598338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153426814|NCT00000950|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
153885806|NCT01169701|Tacrolimus|tacrolimus|mesh-list
153885807|NCT01169701|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153885808|NCT01169701|Immunologic Factors|immunologic factors|mesh-ancestor
153885809|NCT01169701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153885810|NCT01169701|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
153885811|NCT01169701|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153885812|NCT01169701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153885813|NCT01169701|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
153885814|NCT01169701|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153885815|NCT01169701|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153885831|NCT01115491|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153885832|NCT01115491|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153885833|NCT01115491|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153885849|NCT02881177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153885851|NCT02880787|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
153885852|NCT02880787|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
153885853|NCT02880787|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
153885881|NCT04308343|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153885883|NCT04308343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153426882|NCT00000974|Antifungal Agents|antifungal agents|mesh-ancestor
153426883|NCT00000974|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153885884|NCT04308343|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153885885|NCT04308343|Dermatologic Agents|dermatologic agents|mesh-ancestor
153885886|NCT04308343|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153885887|NCT04308343|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153885888|NCT04308343|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153885889|NCT04308343|Immunologic Factors|immunologic factors|mesh-ancestor
153885890|NCT04308343|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153885891|NCT04308343|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153885892|NCT04308343|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
153885893|NCT04308343|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153885894|NCT04308343|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
153885895|NCT04308343|Hormone Antagonists|hormone antagonists|mesh-ancestor
153885896|NCT04308343|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153885897|NCT04308343|Fertility Agents, Female|fertility agents, female|mesh-ancestor
153885898|NCT04308343|Fertility Agents|fertility agents|mesh-ancestor
153426897|NCT00000242|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153426898|NCT00000242|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153885983|NCT04407572|Vitamin B 12|vitamin b 12|mesh-list
153885984|NCT04407572|Hydroxocobalamin|hydroxocobalamin|mesh-list
153885985|NCT04407572|Micronutrients|micronutrients|mesh-ancestor
153885986|NCT04407572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153426986|NCT00001022|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153426987|NCT00001022|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153426989|NCT00001022|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153426990|NCT00001022|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153426991|NCT00001022|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153426992|NCT05218148|Oxaliplatin|oxaliplatin|mesh-list
153426993|NCT05218148|Trastuzumab|trastuzumab|mesh-list
153426994|NCT05218148|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153426995|NCT05218148|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153480248|NCT05839756|Hormones|hormones|mesh-ancestor
153886033|NCT02893280|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
153886034|NCT02893280|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
153886036|NCT02893280|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153886037|NCT02893280|Anticoagulants|anticoagulants|mesh-ancestor
153427039|NCT00001034|Antiviral Agents|antiviral agents|mesh-ancestor
153427040|NCT00001034|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153427041|NCT00001034|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153427042|NCT00001034|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153427043|NCT00001034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153427044|NCT03818815|Amoxicillin|amoxicillin|mesh-list
153427045|NCT03818815|Clavulanic Acid|clavulanic acid|mesh-list
153427046|NCT03818815|Clavulanic Acids|clavulanic acids|mesh-list
153427047|NCT03818815|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
153886045|NCT04328480|Antimitotic Agents|antimitotic agents|mesh-ancestor
153886046|NCT04328480|Mitosis Modulators|mitosis modulators|mesh-ancestor
153886047|NCT04328480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153886048|NCT04328480|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153886049|NCT02893124|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
153886050|NCT02893124|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
153886051|NCT02893124|Antiviral Agents|antiviral agents|mesh-ancestor
153427052|NCT03818815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153427053|NCT00001958|Hydroxyurea|hydroxyurea|mesh-list
153427054|NCT00001958|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153427055|NCT00001958|Antisickling Agents|antisickling agents|mesh-ancestor
153427056|NCT00001958|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153427058|NCT00001958|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153886084|NCT00593138|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153886085|NCT00593138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153427102|NCT00000212|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153427103|NCT00000212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153427105|NCT00000302|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153481838|NCT01339260|Hormones|hormones|mesh-ancestor
153886093|NCT00593294|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153886095|NCT00593294|Diuretics|diuretics|mesh-ancestor
153886096|NCT00593294|Natriuretic Agents|natriuretic agents|mesh-ancestor
153886097|NCT00593294|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
153886098|NCT00593294|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
153886099|NCT00593294|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
153886100|NCT00593294|Contraceptive Agents|contraceptive agents|mesh-ancestor
153886101|NCT00593294|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153886102|NCT00593294|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
153886103|NCT00593294|Estrogens|estrogens|mesh-ancestor
153886104|NCT00593294|Hormones|hormones|mesh-ancestor
153427138|NCT00001058|Antitubercular Agents|antitubercular agents|mesh-ancestor
153427139|NCT00001058|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
153427141|NCT00000308|Dextroamphetamine|dextroamphetamine|mesh-list
153427142|NCT00000308|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
153427143|NCT00000308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153427153|NCT00000308|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153427154|NCT00000308|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
153886125|NCT00596336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153886126|NCT00596336|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153886127|NCT00596336|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153886156|NCT00596804|Veltuzumab|veltuzumab|mesh-list
153886157|NCT00596804|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153886192|NCT00598676|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153886193|NCT00598676|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153886194|NCT00598676|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153886195|NCT00598676|Antifungal Agents|antifungal agents|mesh-ancestor
153886196|NCT00599222|Ranibizumab|ranibizumab|mesh-list
153886197|NCT00599222|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153482664|NCT06115174|Antibodies|antibodies|mesh-list
153427214|NCT00002006|Sargramostim|sargramostim|mesh-list
153427215|NCT00002006|Antimetabolites|antimetabolites|mesh-ancestor
153427216|NCT00002006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153427217|NCT00002006|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153482786|NCT06114121|Anesthetics|anesthetics|mesh-ancestor
153427218|NCT00002006|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153387336|NCT04225611|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153387337|NCT04225611|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153387338|NCT04225611|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153387339|NCT00379977|Vaccines|vaccines|mesh-list
153387340|NCT00379977|Immunologic Factors|immunologic factors|mesh-ancestor
153387341|NCT00379977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153387342|NCT05669885|Sildenafil Citrate|sildenafil citrate|mesh-list
153387343|NCT05669885|Vasodilator Agents|vasodilator agents|mesh-ancestor
153387344|NCT05669885|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
153387345|NCT05669885|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
153387346|NCT05669885|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153387347|NCT05669885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153387348|NCT05669885|Urological Agents|urological agents|mesh-ancestor
153387349|NCT00955929|Sildenafil Citrate|sildenafil citrate|mesh-list
153387350|NCT00955929|Alprostadil|alprostadil|mesh-list
153427219|NCT00002006|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153427221|NCT00002006|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153482950|NCT05829603|Harmine|harmine|mesh-list
153427236|NCT00002012|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153427237|NCT00002012|Antiviral Agents|antiviral agents|mesh-ancestor
153427238|NCT00002012|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153427239|NCT00002012|Immunologic Factors|immunologic factors|mesh-ancestor
153427240|NCT00002012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153427241|NCT00380276|Tarenflurbil|tarenflurbil|mesh-list
153427242|NCT00380276|Gamma Secretase Inhibitors and Modulators|gamma secretase inhibitors and modulators|mesh-ancestor
153886241|NCT04325984|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153886242|NCT00600548|Miltefosine|miltefosine|mesh-list
153886243|NCT00600548|Meglumine Antimoniate|meglumine antimoniate|mesh-list
153886244|NCT00600548|Antifungal Agents|antifungal agents|mesh-ancestor
153886245|NCT00600548|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153886246|NCT00600548|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153886247|NCT00600548|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153886248|NCT00600548|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153886249|NCT00600626|Insulin|insulin|mesh-list
153886250|NCT00600626|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
153483558|NCT01961219|Anesthetics|anesthetics|mesh-list
153427278|NCT00001094|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153427279|NCT00001094|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153427280|NCT00001094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153427281|NCT00001094|Antiviral Agents|antiviral agents|mesh-ancestor
153427282|NCT00001094|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153427283|NCT00001094|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153427297|NCT00001100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153427301|NCT00000332|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153427302|NCT00000332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153427303|NCT00000332|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153427304|NCT00000332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153484298|NCT01621776|Insulin|insulin|mesh-list
153886305|NCT01326026|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
153886306|NCT01326026|Insulin, Long-Acting|insulin, long-acting|mesh-list
153886307|NCT01326026|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153886308|NCT01326026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153886310|NCT01097629|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
153886311|NCT01097629|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153886312|NCT01097629|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153886313|NCT01097629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153886314|NCT01097629|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
153886315|NCT01097629|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153387351|NCT00955929|Vasodilator Agents|vasodilator agents|mesh-ancestor
153387352|NCT00955929|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
153424298|NCT03473665|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153424299|NCT03473665|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
153424300|NCT03473665|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153886316|NCT01097629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153886317|NCT04308031|Digoxin|digoxin|mesh-list
153886318|NCT04308031|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153886319|NCT04308031|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
153886384|NCT01095835|Interferons|interferons|mesh-list
153886385|NCT01095835|Lamivudine|lamivudine|mesh-list
153886386|NCT01095835|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
153886387|NCT01095835|Interferon-alpha|interferon-alpha|mesh-list
153886415|NCT01324232|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153886417|NCT01324232|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153886418|NCT01324232|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153886419|NCT01324232|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153427433|NCT03789175|Micronutrients|micronutrients|mesh-ancestor
153886472|NCT00598377|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153886473|NCT00598377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153886474|NCT00598533|Sirolimus|sirolimus|mesh-list
153886475|NCT00598533|Probucol|probucol|mesh-list
153427494|NCT00000446|Sertraline|sertraline|mesh-list
153886481|NCT00598533|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153886482|NCT00598533|Immunologic Factors|immunologic factors|mesh-ancestor
153886483|NCT00598533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153886495|NCT00600093|Amantadine|amantadine|mesh-list
153486098|NCT04189757|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153427551|NCT00000458|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
153886525|NCT00600405|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153886526|NCT00600405|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153886527|NCT00600405|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153886528|NCT00600405|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153486175|NCT03754933|Immunologic Factors|immunologic factors|mesh-ancestor
153886536|NCT00600405|Adrenergic Agents|adrenergic agents|mesh-ancestor
153886537|NCT00600405|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153427552|NCT00000458|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153427575|NCT00002096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153886538|NCT00600405|Urological Agents|urological agents|mesh-ancestor
153886539|NCT00600639|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
153886540|NCT00600639|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
153886541|NCT00600639|Prednisolone|prednisolone|mesh-list
153886542|NCT00600639|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
153886543|NCT00600639|Methylprednisolone|methylprednisolone|mesh-list
153886544|NCT00600639|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
153886545|NCT00600639|Prednisolone acetate|prednisolone acetate|mesh-list
153886547|NCT00600639|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
153886548|NCT00600639|Prednisolone phosphate|prednisolone phosphate|mesh-list
153886549|NCT00600639|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153886550|NCT00600639|Antitubercular Agents|antitubercular agents|mesh-ancestor
153886551|NCT00600639|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153886552|NCT00600639|Glucocorticoids|glucocorticoids|mesh-ancestor
153427587|NCT00002102|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153427588|NCT00002102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153427589|NCT00002102|Antidotes|antidotes|mesh-ancestor
153427590|NCT00002102|Protective Agents|protective agents|mesh-ancestor
153427591|NCT00002102|Vitamin B Complex|vitamin b complex|mesh-ancestor
153427592|NCT00002102|Vitamins|vitamins|mesh-ancestor
153427593|NCT00002102|Micronutrients|micronutrients|mesh-ancestor
153886572|NCT00600639|Adrenergic Agents|adrenergic agents|mesh-ancestor
153886573|NCT00600639|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153886574|NCT00600639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153886575|NCT00600873|Pramipexole|pramipexole|mesh-list
153886576|NCT00600873|Dexpramipexole|dexpramipexole|mesh-list
153886577|NCT00600873|Antioxidants|antioxidants|mesh-ancestor
153886578|NCT00600873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153886579|NCT00600873|Protective Agents|protective agents|mesh-ancestor
153886580|NCT00600873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153886581|NCT00600873|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
153886582|NCT00600873|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
153486753|NCT01846728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153886601|NCT04325490|Hydrocortisone|hydrocortisone|mesh-list
153886602|NCT04325490|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153886603|NCT00601575|Lithium Carbonate|lithium carbonate|mesh-list
153886604|NCT00601575|Antidepressive Agents|antidepressive agents|mesh-ancestor
153886605|NCT00601575|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153886606|NCT00601575|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153886607|NCT00601575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153886608|NCT00601575|Antimanic Agents|antimanic agents|mesh-ancestor
153886609|NCT00601575|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153427624|NCT00381134|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
153427637|NCT00000506|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153427638|NCT00000506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153427639|NCT00000506|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
153427640|NCT00000506|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153427641|NCT00000506|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153427642|NCT00000506|Serotonin Agents|serotonin agents|mesh-ancestor
153427643|NCT00000512|Niacin|niacin|mesh-list
153427644|NCT00000512|Nicotinic Acids|nicotinic acids|mesh-list
153427645|NCT00000512|Lovastatin|lovastatin|mesh-list
153886610|NCT00601575|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153886611|NCT00601575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153886612|NCT00601887|Meloxicam|meloxicam|mesh-list
153886624|NCT00601887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153886625|NCT01325493|Ketamine|ketamine|mesh-list
153886626|NCT01325493|Analgesics|analgesics|mesh-ancestor
153427648|NCT00000512|Colestipol|colestipol|mesh-list
153427649|NCT00000512|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153427650|NCT00000512|Antimetabolites|antimetabolites|mesh-ancestor
153427651|NCT00000512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153427652|NCT00000512|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153427653|NCT00000512|Vasodilator Agents|vasodilator agents|mesh-ancestor
153427654|NCT00000512|Vitamin B Complex|vitamin b complex|mesh-ancestor
153427655|NCT00000512|Vitamins|vitamins|mesh-ancestor
153427656|NCT00000512|Micronutrients|micronutrients|mesh-ancestor
153427657|NCT00000512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153427658|NCT00000512|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153427672|NCT00000542|Pravastatin|pravastatin|mesh-list
153427673|NCT00000542|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
153427674|NCT00000542|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153427675|NCT00000542|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153427676|NCT00000542|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153427677|NCT00000542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153427678|NCT00000542|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153427679|NCT00000542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153886653|NCT01101841|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
153886654|NCT01101841|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153886655|NCT01101841|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153886656|NCT01101841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153886657|NCT01101841|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153886658|NCT01101841|Serotonin Agents|serotonin agents|mesh-ancestor
153886659|NCT01101841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153427706|NCT00002120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153427707|NCT00002120|Antidotes|antidotes|mesh-ancestor
153427708|NCT00002120|Protective Agents|protective agents|mesh-ancestor
153427709|NCT00002120|Vitamin B Complex|vitamin b complex|mesh-ancestor
153427710|NCT00002120|Vitamins|vitamins|mesh-ancestor
153427711|NCT00002120|Micronutrients|micronutrients|mesh-ancestor
153427712|NCT00002120|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
153427713|NCT00002120|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153427714|NCT00002120|Antimalarials|antimalarials|mesh-ancestor
153427715|NCT00002120|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153427716|NCT00002120|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153427717|NCT00002120|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153427718|NCT00002120|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153886680|NCT01324323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153886681|NCT01324323|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
153886682|NCT01324323|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
153886683|NCT01324323|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
153886687|NCT01324323|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153424301|NCT03473665|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153424302|NCT03473665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153424303|NCT03473665|Gout Suppressants|gout suppressants|mesh-ancestor
153427722|NCT00002120|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153427723|NCT00002120|Leprostatic Agents|leprostatic agents|mesh-ancestor
153427724|NCT00002120|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153427725|NCT00002120|Antifungal Agents|antifungal agents|mesh-ancestor
153487647|NCT01086540|Histamine Agents|histamine agents|mesh-ancestor
153427769|NCT00000578|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153427770|NCT00000578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153427797|NCT03774745|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
153427799|NCT03774745|Hormone Antagonists|hormone antagonists|mesh-ancestor
153427800|NCT03774745|Luteolytic Agents|luteolytic agents|mesh-ancestor
153427801|NCT03774745|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
153427802|NCT03774745|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
153427803|NCT00000584|Immunoglobulins|immunoglobulins|mesh-list
153427804|NCT00000584|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
153427805|NCT00000584|Antibodies|antibodies|mesh-list
153427823|NCT00000626|Doxorubicin|doxorubicin|mesh-list
153427840|NCT03109873|Metformin|metformin|mesh-list
153427886|NCT04092907|Ophthalmic Solutions|ophthalmic solutions|mesh-list
153427887|NCT04092907|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
153427888|NCT00002162|Lamivudine|lamivudine|mesh-list
153427889|NCT00002162|Zidovudine|zidovudine|mesh-list
153427890|NCT00002162|Didanosine|didanosine|mesh-list
153427891|NCT00002162|Stavudine|stavudine|mesh-list
153428094|NCT00000728|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153428125|NCT00002294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153887421|NCT04972396|Metformin|metformin|mesh-list
153887658|NCT04327427|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153887752|NCT00594269|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
153889936|NCT01003639|Diuretics|diuretics|mesh-ancestor
153431001|NCT05440591|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
153431002|NCT05440591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153431003|NCT04099303|Vaccines|vaccines|mesh-list
153889944|NCT01003249|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
153889945|NCT01003249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153889946|NCT01003249|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
153889947|NCT01003249|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153889948|NCT01003249|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
153431012|NCT00000337|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
153889952|NCT01003249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153889953|NCT04297033|Lovastatin|lovastatin|mesh-list
153889954|NCT04297033|L 647318|l 647318|mesh-list
153461847|NCT05244018|Cholecalciferol|cholecalciferol|mesh-list
153461848|NCT05244018|Vitamins|vitamins|mesh-list
153461849|NCT05244018|Micronutrients|micronutrients|mesh-ancestor
153461972|NCT00638508|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153461973|NCT00638508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153461974|NCT00638508|Sensory System Agents|sensory system agents|mesh-ancestor
153461975|NCT00638508|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153462016|NCT01922466|Sensory System Agents|sensory system agents|mesh-ancestor
153462017|NCT01922466|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153462018|NCT01922466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153462019|NCT01922466|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153462020|NCT01922466|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153462022|NCT00637572|Megestrol Acetate|megestrol acetate|mesh-list
153462023|NCT00637572|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
153462035|NCT00637416|Lansoprazole|lansoprazole|mesh-list
153462234|NCT00633360|Hormones|hormones|mesh-ancestor
153418612|NCT02941640|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153462287|NCT01923948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153462288|NCT01923948|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153462290|NCT01923948|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153462291|NCT01923948|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153462292|NCT01923948|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153462293|NCT00989196|Factor VIII|factor viii|mesh-list
153462294|NCT00989196|Coagulants|coagulants|mesh-ancestor
153462295|NCT00631488|Metformin|metformin|mesh-list
153462296|NCT00631488|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
153890009|NCT04322175|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153462407|NCT00983580|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153462408|NCT00983580|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
153462409|NCT00983580|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153462410|NCT00983580|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153462519|NCT04275414|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153462520|NCT04275414|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153462521|NCT04275414|Growth Substances|growth substances|mesh-ancestor
153462522|NCT04275414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153462523|NCT04275414|Growth Inhibitors|growth inhibitors|mesh-ancestor
153462524|NCT04395768|Vitamin D|vitamin d|mesh-list
153462525|NCT04395768|Cholecalciferol|cholecalciferol|mesh-list
153431047|NCT00000805|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
153431048|NCT00000805|Antiviral Agents|antiviral agents|mesh-ancestor
153890010|NCT04322175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153462700|NCT04760262|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153462701|NCT04760262|Anesthetics, General|anesthetics, general|mesh-ancestor
153462702|NCT04760262|Anesthetics|anesthetics|mesh-ancestor
153462703|NCT04760262|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153462704|NCT04760262|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
153462706|NCT04760262|Narcotics|narcotics|mesh-ancestor
153462745|NCT04129788|Laxatives|laxatives|mesh-ancestor
153462746|NCT03831126|Betamethasone|betamethasone|mesh-list
153462747|NCT03831126|Betamethasone Valerate|betamethasone valerate|mesh-list
153462748|NCT03831126|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
153462749|NCT03831126|Betamethasone benzoate|betamethasone benzoate|mesh-list
153462750|NCT03831126|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
153462751|NCT03831126|Glucocorticoids|glucocorticoids|mesh-ancestor
153462753|NCT03831126|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153462754|NCT03831126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153462755|NCT03831126|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153462756|NCT03831126|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153462757|NCT03831126|Respiratory System Agents|respiratory system agents|mesh-ancestor
153462759|NCT04073784|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153462760|NCT04073784|Antimetabolites|antimetabolites|mesh-ancestor
153462761|NCT04073784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153462762|NCT04073784|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153462802|NCT04129008|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153462803|NCT04129008|Analgesics|analgesics|mesh-ancestor
153462804|NCT04129008|Sensory System Agents|sensory system agents|mesh-ancestor
153462805|NCT04129008|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153462818|NCT04128462|Antimetabolites|antimetabolites|mesh-ancestor
153462819|NCT04128462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153462820|NCT04128462|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153462822|NCT04120350|Methotrexate|methotrexate|mesh-list
153462823|NCT04120350|Lenalidomide|lenalidomide|mesh-list
153462824|NCT04120350|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153462825|NCT04120350|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153462826|NCT04120350|Immunologic Factors|immunologic factors|mesh-ancestor
153462827|NCT04120350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153462828|NCT04120350|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153463074|NCT04392648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153463075|NCT04392648|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153463076|NCT04392648|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153463077|NCT04392648|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153463078|NCT04392648|Antiemetics|antiemetics|mesh-ancestor
153463187|NCT01450176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153463189|NCT01454622|Canagliflozin|canagliflozin|mesh-list
153463190|NCT01454622|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153463244|NCT02983344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153463245|NCT02983344|Sensory System Agents|sensory system agents|mesh-ancestor
153463246|NCT02983344|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153463247|NCT02983344|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153463274|NCT01451268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153463356|NCT03822936|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
153463357|NCT03822936|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153463359|NCT03822546|Nicotine|nicotine|mesh-list
153463360|NCT03822546|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
153463361|NCT03822546|Autonomic Agents|autonomic agents|mesh-ancestor
153463362|NCT03822546|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153463363|NCT03822546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153463364|NCT03822546|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
153463365|NCT03822546|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
153463366|NCT03822546|Cholinergic Agents|cholinergic agents|mesh-ancestor
153463367|NCT03822546|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153463368|NCT03822546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153463369|NCT01453686|Hydrocortisone|hydrocortisone|mesh-list
153463370|NCT01453686|Clobetasol|clobetasol|mesh-list
153463371|NCT01453686|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153463372|NCT01453686|Glucocorticoids|glucocorticoids|mesh-ancestor
153463373|NCT01453686|Hormones|hormones|mesh-ancestor
153463374|NCT01453686|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153463375|NCT01453686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153463376|NCT01455870|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
153463396|NCT01890408|Ropivacaine|ropivacaine|mesh-list
153463397|NCT01890408|Anesthetics, Local|anesthetics, local|mesh-ancestor
153463398|NCT01890408|Anesthetics|anesthetics|mesh-ancestor
153463399|NCT01890408|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153463400|NCT01890408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153463435|NCT02859402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153463436|NCT02859402|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153463437|NCT02859402|Immunologic Factors|immunologic factors|mesh-ancestor
153463438|NCT02859402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153463439|NCT02859402|Alkylating Agents|alkylating agents|mesh-ancestor
153463440|NCT02859402|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153463441|NCT02859402|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153914773|NCT00613249|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153914774|NCT00613249|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153914775|NCT00613249|Antiviral Agents|antiviral agents|mesh-ancestor
153914776|NCT00613249|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153914777|NCT00613561|Fludarabine|fludarabine|mesh-list
153914778|NCT00613561|Busulfan|busulfan|mesh-list
153914779|NCT00613561|Antilymphocyte Serum|antilymphocyte serum|mesh-list
153914780|NCT00613561|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153463463|NCT01892748|Vitamin D|vitamin d|mesh-list
153463464|NCT01892748|Cholecalciferol|cholecalciferol|mesh-list
153463473|NCT01893060|Povidone|povidone|mesh-list
153463475|NCT01893060|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153463476|NCT01893060|Disinfectants|disinfectants|mesh-ancestor
153463477|NCT01893060|Dermatologic Agents|dermatologic agents|mesh-ancestor
153463478|NCT01893060|Plasma Substitutes|plasma substitutes|mesh-ancestor
153463479|NCT01893060|Blood Substitutes|blood substitutes|mesh-ancestor
153463480|NCT01457820|Allopurinol|allopurinol|mesh-list
153463481|NCT01457820|Antimetabolites|antimetabolites|mesh-ancestor
153463482|NCT01457820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153463483|NCT01457820|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153890046|NCT00624039|Autonomic Agents|autonomic agents|mesh-ancestor
153431065|NCT04022785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153914839|NCT01215227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153914841|NCT01009515|Carboplatin|carboplatin|mesh-list
153914842|NCT01009515|Temozolomide|temozolomide|mesh-list
153914843|NCT01009515|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153914844|NCT01009515|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153914845|NCT01009515|Tubulin Modulators|tubulin modulators|mesh-ancestor
153914867|NCT01009203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153914868|NCT01009203|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153914869|NCT01009203|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153914870|NCT01009203|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153463557|NCT01458600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153463558|NCT01458600|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153463559|NCT01458600|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153463560|NCT01458600|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153463561|NCT01458600|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153463562|NCT01458600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153463563|NCT01458600|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
153914894|NCT04205097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153914932|NCT03586687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153914933|NCT01212185|Oxytocin|oxytocin|mesh-list
153914934|NCT01212185|Oxytocics|oxytocics|mesh-ancestor
153914935|NCT01212185|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153914936|NCT01212185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153914937|NCT00613717|Vitamin D|vitamin d|mesh-list
153914938|NCT00613717|Vitamins|vitamins|mesh-list
153914939|NCT00613717|Folic Acid|folic acid|mesh-list
153914940|NCT00613717|Vitamin A|vitamin a|mesh-list
153914941|NCT00613717|Iron|iron|mesh-list
153914942|NCT00613717|Vitamin B Complex|vitamin b complex|mesh-list
153914943|NCT00613717|Retinol palmitate|retinol palmitate|mesh-list
153914944|NCT00613717|Micronutrients|micronutrients|mesh-ancestor
153914945|NCT00613717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153914946|NCT00613717|Trace Elements|trace elements|mesh-ancestor
153914947|NCT00613717|Hematinics|hematinics|mesh-ancestor
153914948|NCT00613717|Antioxidants|antioxidants|mesh-ancestor
153463642|NCT01459380|Carboplatin|carboplatin|mesh-list
153463643|NCT01459380|Doxorubicin|doxorubicin|mesh-list
153463644|NCT01459380|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
153463645|NCT01459380|Veliparib|veliparib|mesh-list
153463646|NCT01459380|Endothelial Growth Factors|endothelial growth factors|mesh-list
153463647|NCT01459380|Antibodies|antibodies|mesh-list
153463648|NCT01459380|Immunoglobulins|immunoglobulins|mesh-list
153463649|NCT01459380|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
153463650|NCT01459380|Immunoglobulin G|immunoglobulin g|mesh-list
153914953|NCT00613717|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153914954|NCT03369301|Immunoglobulins|immunoglobulins|mesh-list
153914955|NCT03369301|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
153914956|NCT03369301|Antibodies|antibodies|mesh-list
153914977|NCT05345119|Autonomic Agents|autonomic agents|mesh-ancestor
153914978|NCT05345119|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153914979|NCT05345119|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153914980|NCT05345119|Glucocorticoids|glucocorticoids|mesh-ancestor
153914981|NCT05345119|Hormones|hormones|mesh-ancestor
153914982|NCT05345119|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153914983|NCT05345119|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
153914984|NCT05345119|Protective Agents|protective agents|mesh-ancestor
153914985|NCT05345119|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153914987|NCT03529123|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
153914988|NCT03529123|Metformin|metformin|mesh-list
153914989|NCT03529123|Insulin Glargine|insulin glargine|mesh-list
153914990|NCT03529123|Insulin glulisine|insulin glulisine|mesh-list
153914991|NCT03529123|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153914992|NCT03529123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153914993|NCT04074187|Methylprednisolone|methylprednisolone|mesh-list
153914994|NCT04074187|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
153914995|NCT04074187|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
153914996|NCT04074187|Prednisolone|prednisolone|mesh-list
153914997|NCT04074187|Prednisolone acetate|prednisolone acetate|mesh-list
153914998|NCT04074187|Rituximab|rituximab|mesh-list
153914999|NCT04074187|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
153915000|NCT04074187|Prednisolone phosphate|prednisolone phosphate|mesh-list
153915001|NCT04074187|Immunosuppressive Agents|immunosuppressive agents|mesh-list
153915002|NCT04074187|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153463651|NCT01459380|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153463703|NCT02703948|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153463704|NCT02703948|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
153463705|NCT02703948|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153463706|NCT02703948|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153463707|NCT02703948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153463709|NCT02666742|Rivaroxaban|rivaroxaban|mesh-list
153463710|NCT02666742|Edoxaban|edoxaban|mesh-list
153463711|NCT02666742|Dabigatran|dabigatran|mesh-list
153463714|NCT02666742|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153463715|NCT02666742|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153463717|NCT02666742|Sensory System Agents|sensory system agents|mesh-ancestor
153463718|NCT02666742|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153463719|NCT02666742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153463720|NCT02666742|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153463721|NCT02666742|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153463722|NCT02666742|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153463723|NCT02666742|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153463724|NCT02666742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153915041|NCT02430181|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
153890063|NCT05661240|Antimitotic Agents|antimitotic agents|mesh-ancestor
153463762|NCT02624544|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
153463763|NCT02624544|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153463764|NCT02624544|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
153463765|NCT02624544|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153463766|NCT02624544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153915064|NCT00614653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153915065|NCT00614653|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153915069|NCT03909451|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
153915070|NCT03909451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153915099|NCT05343637|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
153915100|NCT05343637|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
153915101|NCT05343637|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153915102|NCT05343637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153387353|NCT00955929|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
153387355|NCT00955929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153387356|NCT00955929|Urological Agents|urological agents|mesh-ancestor
153387357|NCT00955929|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153387358|NCT00357851|Aprotinin|aprotinin|mesh-list
153387359|NCT00357851|Hemostatics|hemostatics|mesh-ancestor
153915103|NCT05343637|Urological Agents|urological agents|mesh-ancestor
153915104|NCT03776227|(2S,3R,4R,5S,6R)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2H-pyran-3,4,5-triol|(2s,3r,4r,5s,6r)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2h-pyran-3,4,5-triol|mesh-list
153915105|NCT03776227|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
153915106|NCT03776227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153915107|NCT03776227|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153915108|NCT03776227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153915110|NCT00614809|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153915111|NCT00614809|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153915112|NCT00614809|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153915113|NCT00614809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153915114|NCT00614809|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153915115|NCT01211483|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
153915116|NCT01211483|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153915117|NCT01211483|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153431103|NCT06316336|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
153431104|NCT06316336|Adrenergic Agents|adrenergic agents|mesh-ancestor
153431108|NCT06316336|Urological Agents|urological agents|mesh-ancestor
153915118|NCT01211483|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153915119|NCT01211483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153915120|NCT01211483|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153915121|NCT00615823|Atorvastatin|atorvastatin|mesh-list
153915122|NCT00615823|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153915123|NCT00615823|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153915124|NCT00615823|Antimetabolites|antimetabolites|mesh-ancestor
153915125|NCT00615823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153915126|NCT00615823|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153915127|NCT00615823|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
153915128|NCT00615823|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153915129|NCT02699281|Palmidrol|palmidrol|mesh-list
153915130|NCT02699281|Analgesics|analgesics|mesh-ancestor
153915131|NCT02699281|Sensory System Agents|sensory system agents|mesh-ancestor
153915132|NCT02699281|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153915133|NCT02699281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153915134|NCT02699281|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153463842|NCT05585814|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153915137|NCT02699281|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153890104|NCT04479267|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
153915139|NCT02699281|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153915140|NCT02699281|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
153915141|NCT02699281|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
153915142|NCT02699281|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153915143|NCT02699281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153915144|NCT02699281|Hormones|hormones|mesh-ancestor
153915145|NCT02699281|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153915162|NCT00624455|Gabapentin|gabapentin|mesh-list
153915163|NCT00624455|Analgesics|analgesics|mesh-ancestor
153915164|NCT00624455|Sensory System Agents|sensory system agents|mesh-ancestor
153915165|NCT00624455|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153915166|NCT00624455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153915167|NCT00624455|Anticonvulsants|anticonvulsants|mesh-ancestor
153915168|NCT00624455|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153463907|NCT02513784|Chlorhexidine|chlorhexidine|mesh-list
153463908|NCT02513784|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
153387360|NCT00357851|Coagulants|coagulants|mesh-ancestor
153387361|NCT00357851|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
153387362|NCT00357851|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
153387363|NCT00357851|Protease Inhibitors|protease inhibitors|mesh-ancestor
153387392|NCT05663801|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153387393|NCT05663801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153387394|NCT05663801|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153387395|NCT05663801|Anticonvulsants|anticonvulsants|mesh-ancestor
153387396|NCT05663801|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153463909|NCT02513784|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
153463911|NCT02513784|Disinfectants|disinfectants|mesh-ancestor
153463912|NCT02513784|Dermatologic Agents|dermatologic agents|mesh-ancestor
153463913|NCT02283996|Methylprednisolone|methylprednisolone|mesh-list
153915191|NCT02698969|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153915192|NCT02698969|Anesthetics, General|anesthetics, general|mesh-ancestor
153915193|NCT02698969|Anesthetics|anesthetics|mesh-ancestor
153915194|NCT02698969|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153915195|NCT02698969|Narcotics|narcotics|mesh-ancestor
153915196|NCT02698969|Analgesics|analgesics|mesh-ancestor
153915197|NCT02698969|Sensory System Agents|sensory system agents|mesh-ancestor
153915198|NCT02698969|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153915199|NCT02698969|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153915200|NCT02698969|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153915201|NCT02698969|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
153915202|NCT02698969|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
153915203|NCT02698969|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
153915204|NCT02698969|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
153915205|NCT02698969|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153463916|NCT02283996|Prednisolone|prednisolone|mesh-list
153915206|NCT02698969|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153915207|NCT02698969|Autonomic Agents|autonomic agents|mesh-ancestor
153915208|NCT02698969|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153915209|NCT02698969|Respiratory System Agents|respiratory system agents|mesh-ancestor
153915210|NCT02698969|Mydriatics|mydriatics|mesh-ancestor
153915211|NCT02698969|Parasympatholytics|parasympatholytics|mesh-ancestor
153915212|NCT02698969|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
153915213|NCT02698969|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
153463947|NCT04390152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153463950|NCT04390152|Antiviral Agents|antiviral agents|mesh-ancestor
153463951|NCT04390152|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153463966|NCT01953588|Anastrozole|anastrozole|mesh-list
153463967|NCT01953588|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153463968|NCT01953588|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153463969|NCT01953588|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
153463970|NCT01953588|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
153463971|NCT01953588|Hormone Antagonists|hormone antagonists|mesh-ancestor
153463972|NCT01953588|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153463973|NCT01953588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153915261|NCT00614965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153915262|NCT00614965|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153915263|NCT00614965|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153915265|NCT00405613|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153915266|NCT00405613|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153915267|NCT00405613|Analgesics|analgesics|mesh-ancestor
153915268|NCT00405613|Sensory System Agents|sensory system agents|mesh-ancestor
153915269|NCT00405613|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153915270|NCT00405613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153915291|NCT02703649|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153915292|NCT02703649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153915293|NCT02703649|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
153915294|NCT02703649|Hormone Antagonists|hormone antagonists|mesh-ancestor
153915295|NCT02703649|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153463974|NCT01953588|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
153915296|NCT02703649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153915298|NCT02703571|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153915307|NCT02703415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153890111|NCT04479267|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153890112|NCT04479267|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153915322|NCT04215835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153915323|NCT04215835|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
153915324|NCT04215835|Hormone Antagonists|hormone antagonists|mesh-ancestor
153915325|NCT04215835|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153915326|NCT04215835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153915339|NCT01208207|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153915340|NCT01208207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153915341|NCT01208207|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153915342|NCT01208207|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153915343|NCT01208207|Gout Suppressants|gout suppressants|mesh-ancestor
153915344|NCT01208207|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153915345|NCT01208207|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153915346|NCT01208207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153915347|NCT01208207|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
153915348|NCT05420285|Dapagliflozin|dapagliflozin|mesh-list
153915349|NCT05420285|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
153915350|NCT05420285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153915351|NCT05420285|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153915352|NCT05420285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153915353|NCT01012713|Calcitriol|calcitriol|mesh-list
153915354|NCT01012713|Clobetasol|clobetasol|mesh-list
153915355|NCT01012713|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153915356|NCT01012713|Glucocorticoids|glucocorticoids|mesh-ancestor
153915357|NCT01012713|Hormones|hormones|mesh-ancestor
153464084|NCT04757532|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153464086|NCT04757532|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153464087|NCT04757532|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153890117|NCT04479267|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153890118|NCT04479267|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153464088|NCT04757532|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
153464089|NCT04757532|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153464090|NCT04757532|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
153464091|NCT04757532|Hormone Antagonists|hormone antagonists|mesh-ancestor
153464122|NCT02063022|Antimitotic Agents|antimitotic agents|mesh-ancestor
153464123|NCT02063022|Mitosis Modulators|mitosis modulators|mesh-ancestor
153464124|NCT02063022|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153464125|NCT02063022|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153464126|NCT02063022|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
153464127|NCT02063022|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153464128|NCT01895010|Tropisetron|tropisetron|mesh-list
153464129|NCT01895010|Antiemetics|antiemetics|mesh-ancestor
153464130|NCT01895010|Autonomic Agents|autonomic agents|mesh-ancestor
153915404|NCT02691949|Mycophenolic Acid|mycophenolic acid|mesh-list
153915405|NCT02691949|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153915406|NCT02691949|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153915407|NCT02691949|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
153915408|NCT02691949|Antitubercular Agents|antitubercular agents|mesh-ancestor
153915409|NCT02691949|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153915410|NCT02691949|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153915411|NCT02691949|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153915412|NCT02691949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153915413|NCT01006707|Ondansetron|ondansetron|mesh-list
153915414|NCT01006707|Antiemetics|antiemetics|mesh-ancestor
153915415|NCT01006707|Autonomic Agents|autonomic agents|mesh-ancestor
153915416|NCT01006707|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153915417|NCT01006707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153915418|NCT01006707|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153915419|NCT01006707|Antipruritics|antipruritics|mesh-ancestor
153915420|NCT01006707|Dermatologic Agents|dermatologic agents|mesh-ancestor
153464152|NCT02087748|Analgesics|analgesics|mesh-ancestor
153464153|NCT02087748|Sensory System Agents|sensory system agents|mesh-ancestor
153464154|NCT02087748|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153464155|NCT02087748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153464156|NCT02087748|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153464157|NCT02087748|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153464158|NCT02087748|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153464159|NCT02087748|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153464160|NCT02087748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153464162|NCT01490502|Cholecalciferol|cholecalciferol|mesh-list
153464164|NCT01490502|Micronutrients|micronutrients|mesh-ancestor
153464165|NCT01490502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153464166|NCT01490502|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153464167|NCT01490502|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153464169|NCT01428024|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153464170|NCT01428024|Immunologic Factors|immunologic factors|mesh-ancestor
153464172|NCT01428024|Viscosupplements|viscosupplements|mesh-ancestor
153915450|NCT01012323|Immunologic Factors|immunologic factors|mesh-ancestor
153915451|NCT01012323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153890133|NCT04021017|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
153915453|NCT02871765|Anticoagulants|anticoagulants|mesh-ancestor
153915454|NCT02549209|Paclitaxel|paclitaxel|mesh-list
153915455|NCT02549209|Carboplatin|carboplatin|mesh-list
153915456|NCT02549209|Pembrolizumab|pembrolizumab|mesh-list
153915457|NCT02549209|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153915458|NCT02549209|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153915459|NCT02549209|Tubulin Modulators|tubulin modulators|mesh-ancestor
153915460|NCT02549209|Antimitotic Agents|antimitotic agents|mesh-ancestor
153915461|NCT02549209|Mitosis Modulators|mitosis modulators|mesh-ancestor
153915505|NCT04214821|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153915506|NCT04214821|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153915507|NCT04214821|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153915510|NCT04214821|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153915511|NCT04214821|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
153915512|NCT04214821|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
153915513|NCT04214821|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153915515|NCT00616213|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153915517|NCT00616213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153915519|NCT00615667|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153915520|NCT00615667|Immunologic Factors|immunologic factors|mesh-ancestor
153915521|NCT00615667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153915528|NCT02697955|Anesthetics|anesthetics|mesh-ancestor
153915529|NCT02697955|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153915532|NCT02697955|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153915533|NCT02697955|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153915534|NCT02697955|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153915535|NCT02697955|Adrenergic Agents|adrenergic agents|mesh-ancestor
153915536|NCT02697955|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153915537|NCT02697955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153915538|NCT02697955|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
153915539|NCT02697955|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153915540|NCT02697955|Autonomic Agents|autonomic agents|mesh-ancestor
153915541|NCT02697955|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153915542|NCT02697955|Respiratory System Agents|respiratory system agents|mesh-ancestor
153915543|NCT02697955|Mydriatics|mydriatics|mesh-ancestor
153915544|NCT02697955|Sympathomimetics|sympathomimetics|mesh-ancestor
153915545|NCT02697955|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
153915546|NCT04294329|Bupivacaine|bupivacaine|mesh-list
153915547|NCT04294329|Anesthetics, Local|anesthetics, local|mesh-ancestor
153915548|NCT04294329|Anesthetics|anesthetics|mesh-ancestor
153915549|NCT04294329|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153915550|NCT04294329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153915551|NCT04294329|Sensory System Agents|sensory system agents|mesh-ancestor
153915552|NCT04294329|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153915553|NCT02701309|Iron|iron|mesh-list
153915554|NCT02701309|Protoporphyrin IX|protoporphyrin ix|mesh-list
153915555|NCT02701309|Zinc protoporphyrin|zinc protoporphyrin|mesh-list
153915556|NCT02701309|Trace Elements|trace elements|mesh-ancestor
153915557|NCT02701309|Micronutrients|micronutrients|mesh-ancestor
153915558|NCT02701309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153464219|NCT01253070|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153915559|NCT02701309|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
153915560|NCT02701309|Dermatologic Agents|dermatologic agents|mesh-ancestor
153915561|NCT02701309|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153464283|NCT01896180|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
153464285|NCT00981162|Sorafenib|sorafenib|mesh-list
153464286|NCT00981162|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
153464289|NCT00981162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153464290|NCT00981162|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153464291|NCT00981162|Immunologic Factors|immunologic factors|mesh-ancestor
153464292|NCT00981162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153464293|NCT00981162|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153464294|NCT00875004|Epoetin Alfa|epoetin alfa|mesh-list
153464295|NCT00875004|Hematinics|hematinics|mesh-ancestor
153464296|NCT05320692|Apatinib|apatinib|mesh-list
153464297|NCT05320692|Chlorotrianisene|chlorotrianisene|mesh-list
153464299|NCT05320692|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153915568|NCT03250507|Sensory System Agents|sensory system agents|mesh-ancestor
153915569|NCT03250507|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153915570|NCT00997893|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
153915571|NCT00997893|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
153915577|NCT00997893|Phytoestrogens|phytoestrogens|mesh-list
153915578|NCT00997893|Hormones|hormones|mesh-ancestor
153915579|NCT00997893|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153915580|NCT00997893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153915581|NCT00997893|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
153915582|NCT00997893|Contraceptive Agents|contraceptive agents|mesh-ancestor
153464301|NCT05320692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153464302|NCT05320692|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
153464303|NCT05320692|Estrogens|estrogens|mesh-ancestor
153464304|NCT05320692|Hormones|hormones|mesh-ancestor
153890148|NCT03764553|Fluorouracil|fluorouracil|mesh-list
153464312|NCT01763580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153464315|NCT01763580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153464316|NCT01763580|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153464317|NCT01763580|Glucocorticoids|glucocorticoids|mesh-ancestor
153464318|NCT01763580|Hormones|hormones|mesh-ancestor
153464319|NCT01763580|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153915593|NCT02697877|Adenosine A2 Receptor Agonists|adenosine a2 receptor agonists|mesh-ancestor
153915594|NCT02697877|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
153915598|NCT02697877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153915599|NCT02697877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153915600|NCT04214665|Thioctic Acid|thioctic acid|mesh-list
153915601|NCT04214665|Antioxidants|antioxidants|mesh-ancestor
153915605|NCT04214665|Vitamin B Complex|vitamin b complex|mesh-ancestor
153915606|NCT04214665|Vitamins|vitamins|mesh-ancestor
153915607|NCT04214665|Micronutrients|micronutrients|mesh-ancestor
153915608|NCT02870673|Triamcinolone|triamcinolone|mesh-list
153915609|NCT02870673|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
153915610|NCT02870673|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
153915611|NCT02870673|Lidocaine|lidocaine|mesh-list
153915618|NCT02870673|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153915619|NCT02870673|Immunologic Factors|immunologic factors|mesh-ancestor
153915620|NCT02870673|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153915621|NCT02870673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153915622|NCT02870673|Anesthetics, Local|anesthetics, local|mesh-ancestor
153915623|NCT02870673|Anesthetics|anesthetics|mesh-ancestor
153915624|NCT02870673|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153915625|NCT02870673|Sensory System Agents|sensory system agents|mesh-ancestor
153915626|NCT02870673|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153915627|NCT02870673|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153915631|NCT00615745|Efavirenz, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|efavirenz, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
153915632|NCT00615745|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153915633|NCT00615745|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153915634|NCT00615745|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153915635|NCT00615745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153915636|NCT00615745|Antiviral Agents|antiviral agents|mesh-ancestor
153915637|NCT00615745|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153464348|NCT04780152|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
153464349|NCT04780152|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153464350|NCT04780152|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
153464351|NCT04780152|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153464352|NCT04780152|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153431153|NCT06316076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153464360|NCT04779762|Ustekinumab|ustekinumab|mesh-list
153915639|NCT00615745|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153915678|NCT03151681|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153915679|NCT03151681|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153915680|NCT03151681|Vasodilator Agents|vasodilator agents|mesh-ancestor
153915689|NCT00951457|Alkylating Agents|alkylating agents|mesh-ancestor
153915690|NCT00951457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153915691|NCT00951457|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153915692|NCT00951457|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153915693|NCT02691871|Docetaxel|docetaxel|mesh-list
153915694|NCT02691871|Apatinib|apatinib|mesh-list
153915695|NCT02691871|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153464408|NCT01895400|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153464409|NCT01895400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153464410|NCT01895400|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153464411|NCT01895400|Respiratory System Agents|respiratory system agents|mesh-ancestor
153464412|NCT01895400|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153464413|NCT01895400|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153464414|NCT01895400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153464415|NCT01895400|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153464416|NCT01895400|Vasodilator Agents|vasodilator agents|mesh-ancestor
153915708|NCT02700217|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153915716|NCT02700217|Narcotics|narcotics|mesh-ancestor
153915717|NCT02700217|Analgesics|analgesics|mesh-ancestor
153915718|NCT02699827|Magnesium Sulfate|magnesium sulfate|mesh-list
153915719|NCT02699827|Levobupivacaine|levobupivacaine|mesh-list
153915722|NCT02699827|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153915723|NCT02699827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153915724|NCT02699827|Anesthetics|anesthetics|mesh-ancestor
153915725|NCT02699827|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153915726|NCT02699827|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153915727|NCT02699827|Anticonvulsants|anticonvulsants|mesh-ancestor
153915728|NCT02699827|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153915729|NCT02699827|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153915730|NCT02699827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153915731|NCT02699827|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153915746|NCT05323201|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153915748|NCT05323201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153915749|NCT05323201|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153915750|NCT05323201|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153915751|NCT05323201|Alkylating Agents|alkylating agents|mesh-ancestor
153915752|NCT05323201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153915753|NCT05323201|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153915754|NCT05323201|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153915755|NCT01208051|Lenalidomide|lenalidomide|mesh-list
153915756|NCT01208051|Cediranib|cediranib|mesh-list
153464470|NCT03012984|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153464471|NCT03012984|Narcotics|narcotics|mesh-ancestor
153464472|NCT02744430|Mirabegron|mirabegron|mesh-list
153464473|NCT02744430|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
153915759|NCT01208051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153915760|NCT01208051|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153915761|NCT01208051|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153915762|NCT01208051|Growth Substances|growth substances|mesh-ancestor
153915763|NCT01208051|Growth Inhibitors|growth inhibitors|mesh-ancestor
153915764|NCT01208051|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153915765|NCT01208051|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153915766|NCT01208051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153915767|NCT01208051|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153915769|NCT05322889|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153915770|NCT05322889|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
153915773|NCT00616915|Bupropion|bupropion|mesh-list
153915774|NCT00616915|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
153915778|NCT00616915|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153915779|NCT00616915|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153915780|NCT00616915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153915781|NCT00616915|Dopamine Agents|dopamine agents|mesh-ancestor
153915782|NCT00616915|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153915783|NCT00616915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153915784|NCT00616915|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
153915785|NCT00616915|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153915786|NCT00616915|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153915787|NCT05410223|Amoxicillin|amoxicillin|mesh-list
153915788|NCT05410223|Clarithromycin|clarithromycin|mesh-list
153915789|NCT05410223|Doxycycline|doxycycline|mesh-list
153915790|NCT05410223|Furazolidone|furazolidone|mesh-list
153915791|NCT05410223|Bismuth|bismuth|mesh-list
153915792|NCT05410223|Antibodies|antibodies|mesh-list
153915793|NCT05410223|Immunoglobulins|immunoglobulins|mesh-list
153915794|NCT05410223|Immunologic Factors|immunologic factors|mesh-ancestor
153915795|NCT05410223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153431313|NCT06315231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153915796|NCT05410223|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153915797|NCT05410223|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153915798|NCT05410223|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
153915799|NCT05410223|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153915800|NCT05410223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153915801|NCT05410223|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
153915802|NCT05410223|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153915803|NCT05410223|Antimalarials|antimalarials|mesh-ancestor
153915804|NCT05410223|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153915805|NCT05410223|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153915806|NCT05410223|Antacids|antacids|mesh-ancestor
153915807|NCT05410223|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153464522|NCT00056472|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153464523|NCT00056472|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153464524|NCT00056472|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153464525|NCT00056472|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
153464526|NCT00056472|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153464527|NCT00056472|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153464528|NCT00056472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153890338|NCT00637182|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153464533|NCT00056550|Antithrombin III|antithrombin iii|mesh-list
153464534|NCT00056550|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
153464535|NCT00056550|Protease Inhibitors|protease inhibitors|mesh-ancestor
153915808|NCT05410223|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
153915809|NCT05410223|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
153915810|NCT05410223|Antitrichomonal Agents|antitrichomonal agents|mesh-ancestor
153915811|NCT05410223|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
153915812|NCT01206101|Liraglutide|liraglutide|mesh-list
153915813|NCT01206101|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
153915815|NCT01206101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153915816|NCT01206101|Incretins|incretins|mesh-ancestor
153915817|NCT01206101|Hormones|hormones|mesh-ancestor
153915818|NCT01206101|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153915819|NCT00997503|Aspirin|aspirin|mesh-list
153915820|NCT00997503|Paclitaxel|paclitaxel|mesh-list
153915821|NCT00997503|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
153915822|NCT00997503|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153915823|NCT00997503|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153915824|NCT00997503|Tubulin Modulators|tubulin modulators|mesh-ancestor
153915825|NCT00997503|Antimitotic Agents|antimitotic agents|mesh-ancestor
153915826|NCT00997503|Mitosis Modulators|mitosis modulators|mesh-ancestor
153915827|NCT00997503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153915832|NCT00997503|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153915833|NCT00997503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153915834|NCT00997503|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153915835|NCT00997503|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153915836|NCT00997503|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153890404|NCT01296672|Urological Agents|urological agents|mesh-ancestor
153915837|NCT00997503|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153915838|NCT00997503|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153915839|NCT00997503|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153915840|NCT00997503|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153915841|NCT00997503|Antipyretics|antipyretics|mesh-ancestor
153915842|NCT02705053|Insulin|insulin|mesh-list
153915843|NCT02705053|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153915844|NCT02705053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153915845|NCT01204775|Metformin|metformin|mesh-list
153915846|NCT01204775|Saxagliptin|saxagliptin|mesh-list
153915847|NCT01204775|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153915848|NCT01204775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153915849|NCT01204775|Incretins|incretins|mesh-ancestor
153915850|NCT01204775|Hormones|hormones|mesh-ancestor
153915851|NCT01204775|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153464536|NCT00056550|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153915852|NCT01204775|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
153915853|NCT01204775|Protease Inhibitors|protease inhibitors|mesh-ancestor
153915854|NCT01204775|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153915855|NCT01204775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153915856|NCT02844907|Dexamethasone|dexamethasone|mesh-list
153915857|NCT02844907|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153915858|NCT02844907|Antiemetics|antiemetics|mesh-ancestor
153915862|NCT02844907|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153915863|NCT02844907|Glucocorticoids|glucocorticoids|mesh-ancestor
153915864|NCT02844907|Hormones|hormones|mesh-ancestor
153915865|NCT02844907|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153464582|NCT00060528|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153464583|NCT00060528|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153464584|NCT00060528|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153464585|NCT00060528|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153464586|NCT00060528|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153464588|NCT04696224|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
153464589|NCT04696224|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153464590|NCT04696224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153464591|NCT04696224|Hemostatics|hemostatics|mesh-ancestor
153464592|NCT04696224|Coagulants|coagulants|mesh-ancestor
153890513|NCT01252563|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153464593|NCT04753008|Dopamine|dopamine|mesh-list
153464594|NCT04753008|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
153464595|NCT04753008|Sympathomimetics|sympathomimetics|mesh-ancestor
153464596|NCT04753008|Autonomic Agents|autonomic agents|mesh-ancestor
153464597|NCT04753008|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153464598|NCT04753008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153464599|NCT04753008|Dopamine Agents|dopamine agents|mesh-ancestor
153464600|NCT04753008|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153464601|NCT04753008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153464602|NCT04753008|Protective Agents|protective agents|mesh-ancestor
153464603|NCT00063570|Gemcitabine|gemcitabine|mesh-list
153464604|NCT00063570|Pemetrexed|pemetrexed|mesh-list
153464605|NCT00063570|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153464606|NCT00063570|Antimetabolites|antimetabolites|mesh-ancestor
153464607|NCT00063570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153464608|NCT00063570|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153464609|NCT00063570|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153464610|NCT00063570|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153915866|NCT02844907|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153915867|NCT02844907|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153915868|NCT00628719|Amphotericin B|amphotericin b|mesh-list
153915869|NCT00628719|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
153915870|NCT00628719|Amphotericin B, deoxycholate drug combination|amphotericin b, deoxycholate drug combination|mesh-list
153915871|NCT00628719|Deoxycholic Acid|deoxycholic acid|mesh-list
153915872|NCT00628719|Amebicides|amebicides|mesh-ancestor
153464617|NCT04770792|Chlorhexidine|chlorhexidine|mesh-list
153915883|NCT00616993|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153915884|NCT00616993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153915885|NCT02870361|Insulin|insulin|mesh-list
153915886|NCT02870361|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153915887|NCT02870361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153915888|NCT00616681|Oxcarbazepine|oxcarbazepine|mesh-list
153915889|NCT00616681|Anticonvulsants|anticonvulsants|mesh-ancestor
153915890|NCT00616681|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
153915891|NCT00616681|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153915892|NCT00616681|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153915893|NCT00616681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153915894|NCT00616681|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
153915895|NCT00616681|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
153915896|NCT00997035|Voriconazole|voriconazole|mesh-list
153915897|NCT00997035|Antifungal Agents|antifungal agents|mesh-ancestor
153915898|NCT00997035|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153915899|NCT00997035|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
153915900|NCT00997035|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153915901|NCT00997035|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153915902|NCT00997035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153915903|NCT00997035|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153915904|NCT00997035|Hormone Antagonists|hormone antagonists|mesh-ancestor
153915905|NCT00997035|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153915906|NCT00997035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153915907|NCT00997035|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
153464629|NCT00064038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153464630|NCT00064038|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153464631|NCT00064038|Glucocorticoids|glucocorticoids|mesh-ancestor
153464632|NCT00064038|Hormones|hormones|mesh-ancestor
153464633|NCT00064038|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153464634|NCT00064038|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153464635|NCT00064038|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153464636|NCT00064038|Immunologic Factors|immunologic factors|mesh-ancestor
153464637|NCT00064038|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153464638|NCT00064038|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153431749|NCT05943990|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153431754|NCT05928806|Nivolumab|nivolumab|mesh-list
153464639|NCT00064038|Growth Substances|growth substances|mesh-ancestor
153464640|NCT00064038|Growth Inhibitors|growth inhibitors|mesh-ancestor
153464641|NCT01960530|Dexamethasone|dexamethasone|mesh-list
153915909|NCT01204697|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
153915910|NCT01204697|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153915911|NCT01204697|Tubulin Modulators|tubulin modulators|mesh-ancestor
153915912|NCT01204697|Antimitotic Agents|antimitotic agents|mesh-ancestor
153915913|NCT01204697|Mitosis Modulators|mitosis modulators|mesh-ancestor
153915914|NCT01204697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153915916|NCT01204697|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153915917|NCT01204697|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153915919|NCT01203917|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153915920|NCT01203917|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153915921|NCT01203917|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153915922|NCT01203917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153915923|NCT01203917|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153915925|NCT04213495|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153915926|NCT04213495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153915927|NCT04318223|Palbociclib|palbociclib|mesh-list
153915928|NCT04318223|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153915929|NCT04318223|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153915931|NCT04318223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153915932|NCT01202903|Omalizumab|omalizumab|mesh-list
153915933|NCT01202903|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
153915934|NCT01202903|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153890826|NCT01273818|Gentamicins|gentamicins|mesh-list
153915936|NCT00618631|Carfentanil|carfentanil|mesh-list
153915937|NCT00618631|Nicotine|nicotine|mesh-list
153915938|NCT00618631|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
153915939|NCT00618631|Autonomic Agents|autonomic agents|mesh-ancestor
153915940|NCT00618631|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153915941|NCT00618631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153915942|NCT00618631|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
153915943|NCT00618631|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
153915945|NCT00618631|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153915946|NCT00618631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153915947|NCT00618631|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153915948|NCT00618631|Narcotics|narcotics|mesh-ancestor
153915949|NCT00618631|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153915950|NCT00618631|Analgesics|analgesics|mesh-ancestor
153890860|NCT01269918|Narcotics|narcotics|mesh-ancestor
153915954|NCT04213573|Protective Agents|protective agents|mesh-ancestor
153464642|NCT01960530|Hydrocortisone|hydrocortisone|mesh-list
153915955|NCT04213573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153915956|NCT00620269|Irinotecan|irinotecan|mesh-list
153915957|NCT00620269|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
153915958|NCT00620269|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153915960|NCT00620269|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153915961|NCT00620269|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153915962|NCT00620269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153915963|NCT00620269|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153915964|NCT00620269|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153915966|NCT04212403|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
153915967|NCT04212403|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153915968|NCT04212403|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153915969|NCT04212403|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153464689|NCT00074802|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
153464690|NCT00074802|Antidepressive Agents|antidepressive agents|mesh-ancestor
153464691|NCT00074802|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153464692|NCT00074802|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
153464693|NCT00074802|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153464695|NCT00030264|Methotrexate|methotrexate|mesh-list
153464696|NCT00030264|Vinblastine|vinblastine|mesh-list
153464697|NCT00030264|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
153464698|NCT00030264|Abortifacient Agents|abortifacient agents|mesh-ancestor
153464699|NCT00030264|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153464700|NCT00030264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153464701|NCT00030264|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153464702|NCT00030264|Antimetabolites|antimetabolites|mesh-ancestor
153464703|NCT00030264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153464704|NCT00030264|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153464705|NCT00030264|Dermatologic Agents|dermatologic agents|mesh-ancestor
153464706|NCT00030264|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153464707|NCT00030264|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153464708|NCT00030264|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153464709|NCT00030264|Immunologic Factors|immunologic factors|mesh-ancestor
153464710|NCT00030264|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153464711|NCT00030264|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153464712|NCT00030264|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153464713|NCT00030264|Tubulin Modulators|tubulin modulators|mesh-ancestor
153464714|NCT00030264|Antimitotic Agents|antimitotic agents|mesh-ancestor
153464715|NCT00030264|Mitosis Modulators|mitosis modulators|mesh-ancestor
153464716|NCT01897116|Hydroxychloroquine|hydroxychloroquine|mesh-list
153464718|NCT01897116|Antimalarials|antimalarials|mesh-ancestor
153464719|NCT01897116|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153464720|NCT01897116|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153464722|NCT01897116|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153915970|NCT04212403|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153915971|NCT04212403|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153915972|NCT04212403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153915973|NCT04212403|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153915974|NCT04212403|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
153890936|NCT01033942|Emtricitabine|emtricitabine|mesh-list
153890937|NCT01033942|Antiviral Agents|antiviral agents|mesh-ancestor
153890938|NCT01033942|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153890939|NCT01033942|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153890940|NCT01033942|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153890941|NCT01033942|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153464724|NCT01897116|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153915976|NCT00637117|Interferons|interferons|mesh-list
153915977|NCT00637117|Interferon-alpha|interferon-alpha|mesh-list
153915978|NCT00637117|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153915979|NCT00637117|Antiviral Agents|antiviral agents|mesh-ancestor
153915980|NCT00637117|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153915981|NCT00637117|Immunologic Factors|immunologic factors|mesh-ancestor
153915982|NCT00637117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153915984|NCT02052193|Vemurafenib|vemurafenib|mesh-list
153915985|NCT02052193|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153915986|NCT02052193|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153915987|NCT02052193|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153915988|NCT02052193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153915989|NCT00617695|Zolmitriptan|zolmitriptan|mesh-list
153915990|NCT00617695|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
153915991|NCT00617695|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
153915992|NCT00617695|Serotonin Agents|serotonin agents|mesh-ancestor
153915993|NCT00617695|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153915994|NCT00617695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153915995|NCT00617695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153915996|NCT00619021|Gemcitabine|gemcitabine|mesh-list
153915997|NCT00619021|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153915998|NCT00619021|Antimetabolites|antimetabolites|mesh-ancestor
153915999|NCT00619021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153916000|NCT00619021|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153916002|NCT00620347|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153916003|NCT00620347|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153890979|NCT01243671|Adalimumab|adalimumab|mesh-list
153916005|NCT00620347|Growth Substances|growth substances|mesh-ancestor
153916006|NCT00620347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153916007|NCT00620347|Growth Inhibitors|growth inhibitors|mesh-ancestor
153464729|NCT00036738|Fludarabine|fludarabine|mesh-list
153464730|NCT00036738|Fludarabine phosphate|fludarabine phosphate|mesh-list
153464731|NCT00036738|Imatinib Mesylate|imatinib mesylate|mesh-list
153464732|NCT00036738|Dasatinib|dasatinib|mesh-list
153464733|NCT00036738|Cyclosporins|cyclosporins|mesh-list
153464734|NCT00036738|Nilotinib|nilotinib|mesh-list
153464735|NCT00036738|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153464736|NCT00036738|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153916008|NCT00620347|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153916009|NCT00620347|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153916010|NCT00620347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153916011|NCT04213105|Denosumab|denosumab|mesh-list
153916012|NCT04213105|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153916013|NCT04213105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153916014|NCT01887301|Nabiximols|nabiximols|mesh-list
153916015|NCT01887301|Analgesics|analgesics|mesh-ancestor
153916016|NCT01887301|Sensory System Agents|sensory system agents|mesh-ancestor
153916017|NCT01887301|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153916018|NCT01887301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153916019|NCT00996801|Vitamin D|vitamin d|mesh-list
153916020|NCT00996801|Cholecalciferol|cholecalciferol|mesh-list
153916021|NCT00996801|Alendronate|alendronate|mesh-list
153916022|NCT00996801|Calcium Carbonate|calcium carbonate|mesh-list
153916023|NCT00996801|Calcium|calcium|mesh-list
153916024|NCT00996801|Vitamins|vitamins|mesh-ancestor
153916025|NCT00996801|Micronutrients|micronutrients|mesh-ancestor
153916026|NCT00996801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153916027|NCT00996801|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153916029|NCT00996801|Antacids|antacids|mesh-ancestor
153916030|NCT00996801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153916031|NCT00996801|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153916032|NCT00619333|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
153916033|NCT00619333|Hormones|hormones|mesh-ancestor
153916035|NCT00619333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153916036|NCT04924621|Midazolam|midazolam|mesh-list
153916037|NCT04924621|Sufentanil|sufentanil|mesh-list
153916038|NCT04924621|Propofol|propofol|mesh-list
153916039|NCT04924621|Tetracaine|tetracaine|mesh-list
153916040|NCT04924621|Rocuronium|rocuronium|mesh-list
153916041|NCT04924621|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153916042|NCT04924621|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153916043|NCT04924621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153916044|NCT04924621|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153916045|NCT04924621|Anesthetics, General|anesthetics, general|mesh-ancestor
153916046|NCT04924621|Anesthetics|anesthetics|mesh-ancestor
153916047|NCT04924621|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153916048|NCT04924621|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153916049|NCT04924621|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153916050|NCT04924621|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153916052|NCT04924621|GABA Agents|gaba agents|mesh-ancestor
153916053|NCT04924621|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153916054|NCT04924621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153916055|NCT04924621|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
153916056|NCT04924621|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
153916057|NCT04924621|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
153916058|NCT04924621|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153916059|NCT04924621|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153916060|NCT04924621|Narcotics|narcotics|mesh-ancestor
153916061|NCT04924621|Analgesics|analgesics|mesh-ancestor
153916062|NCT04924621|Sensory System Agents|sensory system agents|mesh-ancestor
153916073|NCT00618163|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
153916074|NCT00618163|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153916075|NCT00618163|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153916076|NCT00618163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153464797|NCT00038610|Mitosis Modulators|mitosis modulators|mesh-ancestor
153464798|NCT00038610|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153464799|NCT00038610|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153432131|NCT05263206|Dermatologic Agents|dermatologic agents|mesh-ancestor
153464800|NCT00156936|Naltrexone|naltrexone|mesh-list
153464801|NCT00156936|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
153464802|NCT00156936|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
153464803|NCT00156936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153464804|NCT00156936|Sensory System Agents|sensory system agents|mesh-ancestor
153464805|NCT00156936|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153464806|NCT00046566|Caseins|caseins|mesh-list
153464807|NCT00046566|Chelating Agents|chelating agents|mesh-ancestor
153464808|NCT00046566|Sequestering Agents|sequestering agents|mesh-ancestor
153464809|NCT00046566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153464810|NCT00079326|Trastuzumab|trastuzumab|mesh-list
153464811|NCT00079326|Epothilone B|epothilone b|mesh-list
153916077|NCT00618241|Raltegravir Potassium|raltegravir potassium|mesh-list
153916078|NCT00618241|Lamotrigine|lamotrigine|mesh-list
153916094|NCT00618241|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153916095|NCT00618241|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153916096|NCT00618241|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153916097|NCT00618397|Ketamine|ketamine|mesh-list
153916098|NCT00618397|Analgesics|analgesics|mesh-ancestor
153916099|NCT00618397|Sensory System Agents|sensory system agents|mesh-ancestor
153916100|NCT00618397|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153916101|NCT00618397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153916102|NCT00618397|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
153916103|NCT00618397|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153916104|NCT00618397|Anesthetics, General|anesthetics, general|mesh-ancestor
153916105|NCT00618397|Anesthetics|anesthetics|mesh-ancestor
153916106|NCT00618397|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153916107|NCT00618397|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
153916125|NCT00620581|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
153891227|NCT01026454|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153916128|NCT00620581|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
153916129|NCT00620581|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153916131|NCT01000311|Vaccines|vaccines|mesh-list
153916134|NCT01000311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153916137|NCT04209439|Anesthetics, Local|anesthetics, local|mesh-ancestor
153916138|NCT04209439|Anesthetics|anesthetics|mesh-ancestor
153916139|NCT04209439|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153916159|NCT04160377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153916160|NCT04160377|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153916161|NCT04160377|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153432371|NCT05039619|Histamine Agents|histamine agents|mesh-ancestor
153432372|NCT05039619|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153916162|NCT04160377|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153916163|NCT04160377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153916164|NCT04160377|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153916165|NCT04160377|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
153916166|NCT04160377|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153916167|NCT04160377|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153916168|NCT04160377|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153916169|NCT04160377|Serotonin Agents|serotonin agents|mesh-ancestor
153916179|NCT01000155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153891374|NCT06054321|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
153916182|NCT00999921|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
153464909|NCT00254592|Paclitaxel|paclitaxel|mesh-list
153464910|NCT00254592|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
153464911|NCT00254592|Cyclophosphamide|cyclophosphamide|mesh-list
153464912|NCT00254592|Bevacizumab|bevacizumab|mesh-list
153464913|NCT00254592|Carboplatin|carboplatin|mesh-list
153464914|NCT00254592|Doxorubicin|doxorubicin|mesh-list
153464915|NCT00254592|Trastuzumab|trastuzumab|mesh-list
153464916|NCT00254592|Sargramostim|sargramostim|mesh-list
153464917|NCT00254592|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153464919|NCT00254592|Tubulin Modulators|tubulin modulators|mesh-ancestor
153464920|NCT00254592|Antimitotic Agents|antimitotic agents|mesh-ancestor
153464921|NCT00254592|Mitosis Modulators|mitosis modulators|mesh-ancestor
153464922|NCT00254592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153464929|NCT00254592|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153891433|NCT05983354|Analgesics|analgesics|mesh-ancestor
153916183|NCT00999921|Hormone Antagonists|hormone antagonists|mesh-ancestor
153916184|NCT00999921|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153916185|NCT00999921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153916186|NCT00999921|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153916187|NCT00999921|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153916188|NCT00999921|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
153916189|NCT00999921|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
153916190|NCT00999921|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153916191|NCT00999921|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153916192|NCT00999921|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153916194|NCT00999921|Sensory System Agents|sensory system agents|mesh-ancestor
153916195|NCT00999921|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153916196|NCT00999921|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153916197|NCT00999921|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153916198|NCT00999921|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153916199|NCT00999921|Antimetabolites|antimetabolites|mesh-ancestor
153916200|NCT00999921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153916201|NCT00999921|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153916202|NCT00999921|Dermatologic Agents|dermatologic agents|mesh-ancestor
153916203|NCT02869347|Complement C1s|complement c1s|mesh-list
153916204|NCT02869347|Complement C1 Inhibitor Protein|complement c1 inhibitor protein|mesh-list
153916205|NCT02869347|Complement C1 Inactivator Proteins|complement c1 inactivator proteins|mesh-list
153916206|NCT02869347|Immunologic Factors|immunologic factors|mesh-ancestor
153916207|NCT02869347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153916208|NCT02869347|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
153916209|NCT02869347|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153432535|NCT04612751|Carboplatin|carboplatin|mesh-list
153464931|NCT00254592|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153916210|NCT00621673|Factor VIII|factor viii|mesh-list
153916211|NCT00621673|Coagulants|coagulants|mesh-ancestor
153916212|NCT01002573|Acetaminophen|acetaminophen|mesh-list
153916213|NCT01002573|Ibuprofen|ibuprofen|mesh-list
153916214|NCT01002573|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153916215|NCT01002573|Analgesics|analgesics|mesh-ancestor
153916216|NCT01002573|Sensory System Agents|sensory system agents|mesh-ancestor
153916217|NCT01002573|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153916218|NCT01002573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153916219|NCT01002573|Antipyretics|antipyretics|mesh-ancestor
153916220|NCT01002573|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153916221|NCT01002573|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153387397|NCT05663801|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153387398|NCT05663801|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153387399|NCT05663801|Tocolytic Agents|tocolytic agents|mesh-ancestor
153387400|NCT05663801|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153387401|NCT00000105|Monatide (IMS 3015)|monatide (ims 3015)|mesh-list
153387402|NCT00000105|Freund's Adjuvant|freund's adjuvant|mesh-list
153387403|NCT00000105|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153387404|NCT00000105|Immunologic Factors|immunologic factors|mesh-ancestor
153387405|NCT00000105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153387406|NCT00000117|Immunoglobulins|immunoglobulins|mesh-list
153387407|NCT00000117|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
153387409|NCT00000117|Immunologic Factors|immunologic factors|mesh-ancestor
153916222|NCT01002573|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153891517|NCT05907525|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153916223|NCT01002573|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153916224|NCT01002573|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153916225|NCT01002573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153916226|NCT00620893|Lubricant Eye Drops|lubricant eye drops|mesh-list
153916227|NCT00620893|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
153916228|NCT00620893|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
153916229|NCT04293549|Ophthalmic Solutions|ophthalmic solutions|mesh-list
153916231|NCT04293549|Mitosis Modulators|mitosis modulators|mesh-ancestor
153464973|NCT00256776|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153464974|NCT00256776|Glucocorticoids|glucocorticoids|mesh-ancestor
153464975|NCT00256776|Hormones|hormones|mesh-ancestor
153464976|NCT00256776|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153464977|NCT00256776|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153464978|NCT00256776|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153464979|NCT00256776|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153464980|NCT00256776|Immunologic Factors|immunologic factors|mesh-ancestor
153464981|NCT00256776|Leprostatic Agents|leprostatic agents|mesh-ancestor
153464982|NCT00256776|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153916234|NCT00996333|Gemcitabine|gemcitabine|mesh-list
153916235|NCT00996333|Capecitabine|capecitabine|mesh-list
153916236|NCT00996333|Docetaxel|docetaxel|mesh-list
153916237|NCT00996333|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153916238|NCT00996333|Antimetabolites|antimetabolites|mesh-ancestor
153916239|NCT00996333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153916240|NCT00996333|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153916241|NCT00996333|Tubulin Modulators|tubulin modulators|mesh-ancestor
153891571|NCT05852769|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153916243|NCT00996333|Mitosis Modulators|mitosis modulators|mesh-ancestor
153916244|NCT00621907|Levobupivacaine|levobupivacaine|mesh-list
153916245|NCT00621907|Anesthetics, Local|anesthetics, local|mesh-ancestor
153916246|NCT00621907|Anesthetics|anesthetics|mesh-ancestor
153916247|NCT00621907|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153916248|NCT00621907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153916249|NCT00621907|Sensory System Agents|sensory system agents|mesh-ancestor
153916250|NCT00621907|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153916251|NCT01349101|Mycophenolic Acid|mycophenolic acid|mesh-list
153916252|NCT01349101|Cyclophosphamide|cyclophosphamide|mesh-list
153916253|NCT01349101|Busulfan|busulfan|mesh-list
153916254|NCT01349101|Fludarabine|fludarabine|mesh-list
153916255|NCT01349101|Fludarabine phosphate|fludarabine phosphate|mesh-list
153916256|NCT01349101|Tacrolimus|tacrolimus|mesh-list
153916257|NCT01349101|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153432666|NCT03764098|Guanfacine|guanfacine|mesh-list
153916258|NCT01349101|Immunologic Factors|immunologic factors|mesh-ancestor
153916259|NCT01349101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153916260|NCT01349101|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153916271|NCT01349101|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153916272|NCT01349101|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
153916273|NCT01349101|Antitubercular Agents|antitubercular agents|mesh-ancestor
153916274|NCT01349101|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153916276|NCT00620971|Cisplatin|cisplatin|mesh-list
153916277|NCT00620971|Gemcitabine|gemcitabine|mesh-list
153916278|NCT00620971|Docetaxel|docetaxel|mesh-list
153916279|NCT00620971|Vinorelbine|vinorelbine|mesh-list
153916280|NCT00620971|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153916281|NCT00620971|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153916282|NCT00620971|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153916283|NCT00620971|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153916284|NCT00620971|Growth Substances|growth substances|mesh-ancestor
153916285|NCT00620971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153916286|NCT00620971|Growth Inhibitors|growth inhibitors|mesh-ancestor
153916287|NCT00620971|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153916288|NCT00620971|Antimetabolites|antimetabolites|mesh-ancestor
153891654|NCT05613842|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153465020|NCT00176592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153465021|NCT00176592|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153465022|NCT00176592|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153465023|NCT00176826|Busulfan|busulfan|mesh-list
153465024|NCT00176826|Alkylating Agents|alkylating agents|mesh-ancestor
153465025|NCT00176826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153465026|NCT00176826|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153465027|NCT00176826|Immunologic Factors|immunologic factors|mesh-ancestor
153465028|NCT00176826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153465029|NCT00176826|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153465030|NCT00176826|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153916289|NCT00620971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153916290|NCT00620971|Tubulin Modulators|tubulin modulators|mesh-ancestor
153916291|NCT00620971|Antimitotic Agents|antimitotic agents|mesh-ancestor
153916292|NCT00620971|Mitosis Modulators|mitosis modulators|mesh-ancestor
153916293|NCT00620971|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153916294|NCT04223661|Dexamethasone|dexamethasone|mesh-list
153916295|NCT04223661|Lenalidomide|lenalidomide|mesh-list
153916318|NCT00622141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153916320|NCT00622141|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153916321|NCT00622141|Antiviral Agents|antiviral agents|mesh-ancestor
153916322|NCT00622141|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153916323|NCT00622141|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
153916324|NCT00622141|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153916325|NCT04210765|Clomiphene|clomiphene|mesh-list
153916326|NCT04210765|Enclomiphene|enclomiphene|mesh-list
153916344|NCT00995709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153916346|NCT00629031|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153916347|NCT00629031|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153916348|NCT00629031|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153916349|NCT00629031|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153916356|NCT00621361|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153916357|NCT00621361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153916358|NCT00621361|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153916359|NCT04208581|Fluticasone|fluticasone|mesh-list
153916360|NCT04208581|Xhance|xhance|mesh-list
153916361|NCT04208581|Budesonide|budesonide|mesh-list
153916362|NCT04208581|Bromides|bromides|mesh-list
153916363|NCT04208581|Formoterol Fumarate|formoterol fumarate|mesh-list
153916364|NCT04208581|Tiotropium Bromide|tiotropium bromide|mesh-list
153916365|NCT04208581|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
153916366|NCT04208581|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
153916367|NCT04208581|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153916368|NCT04208581|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153916369|NCT04208581|Autonomic Agents|autonomic agents|mesh-ancestor
153916370|NCT04208581|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153916371|NCT04208581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153916372|NCT04208581|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153916373|NCT04208581|Respiratory System Agents|respiratory system agents|mesh-ancestor
153916374|NCT04208581|Dermatologic Agents|dermatologic agents|mesh-ancestor
153916375|NCT04208581|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
153916376|NCT04208581|Glucocorticoids|glucocorticoids|mesh-ancestor
153916377|NCT04208581|Hormones|hormones|mesh-ancestor
153916384|NCT04208581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153916385|NCT04208581|Parasympatholytics|parasympatholytics|mesh-ancestor
153916386|NCT04208581|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
153916387|NCT04208581|Cholinergic Agents|cholinergic agents|mesh-ancestor
153916388|NCT04208581|Anticonvulsants|anticonvulsants|mesh-ancestor
153916389|NCT05368675|Buprenorphine|buprenorphine|mesh-list
153916391|NCT05368675|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
153916392|NCT05368675|Naloxone|naloxone|mesh-list
153916393|NCT05368675|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153916394|NCT05368675|Narcotics|narcotics|mesh-ancestor
153916395|NCT05368675|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153916396|NCT05368675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153916397|NCT05368675|Analgesics|analgesics|mesh-ancestor
153916398|NCT05368675|Sensory System Agents|sensory system agents|mesh-ancestor
153916399|NCT05368675|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153916400|NCT05368675|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
153916401|NCT05368675|Antitussive Agents|antitussive agents|mesh-ancestor
153916402|NCT05368675|Respiratory System Agents|respiratory system agents|mesh-ancestor
153916403|NCT05368051|Capecitabine|capecitabine|mesh-list
153916404|NCT05368051|Antibodies|antibodies|mesh-list
153916405|NCT05368051|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
153916406|NCT05368051|Immunologic Factors|immunologic factors|mesh-ancestor
153916407|NCT05368051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153916408|NCT05368051|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153916409|NCT05368051|Antimetabolites|antimetabolites|mesh-ancestor
153916410|NCT05368051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153916411|NCT05368051|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153916412|NCT02641873|Leucovorin|leucovorin|mesh-list
153916413|NCT02641873|Bevacizumab|bevacizumab|mesh-list
153916414|NCT02641873|Irinotecan|irinotecan|mesh-list
153916415|NCT02641873|Levoleucovorin|levoleucovorin|mesh-list
153465157|NCT00194610|Botulinum Toxins|botulinum toxins|mesh-list
153465158|NCT00194610|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
153465159|NCT00194610|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
153465160|NCT00194610|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153465161|NCT00194610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153465162|NCT00194610|Cholinergic Agents|cholinergic agents|mesh-ancestor
153465163|NCT00194610|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153465164|NCT00194610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153916422|NCT02641873|Growth Inhibitors|growth inhibitors|mesh-ancestor
153916423|NCT02641873|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
153916424|NCT02641873|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153916425|NCT02641873|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153916426|NCT02641873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153916428|NCT02641873|Protective Agents|protective agents|mesh-ancestor
153916429|NCT02641873|Vitamin B Complex|vitamin b complex|mesh-ancestor
153916430|NCT02641873|Vitamins|vitamins|mesh-ancestor
153916431|NCT02641873|Micronutrients|micronutrients|mesh-ancestor
153916432|NCT00998985|Grazoprevir|grazoprevir|mesh-list
153916434|NCT00998985|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153916435|NCT05240391|Midodrine|midodrine|mesh-list
153916436|NCT05240391|Sympathomimetics|sympathomimetics|mesh-ancestor
153916437|NCT05240391|Autonomic Agents|autonomic agents|mesh-ancestor
153916438|NCT05240391|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153916439|NCT05240391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153916440|NCT05240391|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
153916441|NCT05240391|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
153916442|NCT05240391|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153916443|NCT05240391|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153916444|NCT05240391|Adrenergic Agents|adrenergic agents|mesh-ancestor
153916445|NCT05240391|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153916463|NCT04294953|Antidepressive Agents|antidepressive agents|mesh-ancestor
153916464|NCT04294953|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153916465|NCT04294953|Dopamine Agents|dopamine agents|mesh-ancestor
153916466|NCT02869815|Methylene Blue|methylene blue|mesh-list
153916467|NCT02869815|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153916468|NCT02869815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153916469|NCT04293081|Maleic acid|maleic acid|mesh-list
153916470|NCT04293081|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153465224|NCT00195624|Antifungal Agents|antifungal agents|mesh-ancestor
153465225|NCT00195624|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153916484|NCT02868801|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153916485|NCT02868801|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153916486|NCT01002339|Mycophenolic Acid|mycophenolic acid|mesh-list
153916488|NCT01002339|Prednisone|prednisone|mesh-list
153916489|NCT01002339|Tacrolimus|tacrolimus|mesh-list
153916490|NCT01002339|Basiliximab|basiliximab|mesh-list
153916491|NCT01002339|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153916492|NCT01002339|Immunologic Factors|immunologic factors|mesh-ancestor
153916493|NCT01002339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153916494|NCT01002339|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
153916495|NCT01002339|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153387438|NCT00000189|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153387439|NCT00000189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153783587|NCT00261729|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
153387441|NCT00000189|Serotonin Agents|serotonin agents|mesh-ancestor
153387442|NCT00000189|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153916496|NCT01002339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153891986|NCT04356326|Analgesics|analgesics|mesh-ancestor
153916497|NCT01002339|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153916498|NCT01002339|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153916499|NCT01002339|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
153916500|NCT01002339|Antitubercular Agents|antitubercular agents|mesh-ancestor
153916501|NCT01002339|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153916502|NCT01002339|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153916515|NCT01002105|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153916516|NCT01002105|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
153916517|NCT01002105|GABA Agonists|gaba agonists|mesh-ancestor
153916518|NCT01002105|GABA Agents|gaba agents|mesh-ancestor
153916519|NCT01002105|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153916520|NCT01002105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153916521|NCT02605993|Ravulizumab|ravulizumab|mesh-list
153916522|NCT02605993|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
153916523|NCT02605993|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153916524|NCT02605993|Immunologic Factors|immunologic factors|mesh-ancestor
153916525|NCT02605993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153916526|NCT00995085|Pyridoxine|pyridoxine|mesh-list
153916527|NCT00995085|Metadoxine|metadoxine|mesh-list
153916528|NCT00995085|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
153916529|NCT00995085|Vitamin B Complex|vitamin b complex|mesh-ancestor
153916530|NCT00995085|Vitamins|vitamins|mesh-ancestor
153916531|NCT00995085|Micronutrients|micronutrients|mesh-ancestor
153916532|NCT00995085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153916533|NCT00603733|Mesalamine|mesalamine|mesh-list
153916534|NCT00603733|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153916535|NCT00603733|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153916536|NCT00603733|Analgesics|analgesics|mesh-ancestor
153916537|NCT00603733|Sensory System Agents|sensory system agents|mesh-ancestor
153916538|NCT00603733|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153916539|NCT00603733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153916540|NCT00603733|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153916541|NCT00603733|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153916542|NCT02471911|Dexamethasone|dexamethasone|mesh-list
153916543|NCT02471911|Rituximab|rituximab|mesh-list
153916544|NCT02471911|Carboplatin|carboplatin|mesh-list
153916545|NCT02471911|Etoposide|etoposide|mesh-list
153916546|NCT02471911|Ifosfamide|ifosfamide|mesh-list
153916547|NCT02471911|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153916548|NCT02471911|Antiemetics|antiemetics|mesh-ancestor
153916557|NCT02471911|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153916558|NCT02471911|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153916559|NCT02471911|Immunologic Factors|immunologic factors|mesh-ancestor
153892117|NCT03877549|Glucocorticoids|glucocorticoids|mesh-ancestor
153916560|NCT02471911|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153916561|NCT02471911|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153916562|NCT02471911|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153916563|NCT02471911|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153916564|NCT02471911|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153387443|NCT00000189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153387444|NCT00000195|Naltrexone|naltrexone|mesh-list
153387445|NCT00000195|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
153387446|NCT00000195|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
153387447|NCT00000195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153387448|NCT00000195|Sensory System Agents|sensory system agents|mesh-ancestor
153387449|NCT00000195|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153387450|NCT00000201|Selegiline|selegiline|mesh-list
153387451|NCT00000201|Antidepressive Agents|antidepressive agents|mesh-ancestor
153387452|NCT00000201|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153469239|NCT05335954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153469241|NCT05335954|Autonomic Agents|autonomic agents|mesh-ancestor
153469242|NCT05335954|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153469243|NCT05335954|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
153424313|NCT03717506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153424314|NCT03861338|Buprenorphine|buprenorphine|mesh-list
153424315|NCT03861338|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153424316|NCT03861338|Narcotics|narcotics|mesh-ancestor
153424317|NCT03861338|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153424318|NCT03861338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153469339|NCT05176470|Fludarabine|fludarabine|mesh-list
153469340|NCT05176470|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153469341|NCT05176470|Immunologic Factors|immunologic factors|mesh-ancestor
153469342|NCT05176470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153469344|NCT05176470|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153469345|NCT05176470|Alkylating Agents|alkylating agents|mesh-ancestor
153469346|NCT05176470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153469347|NCT05176470|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153469348|NCT05176470|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153469349|NCT05176470|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153469350|NCT05176470|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153469351|NCT05118477|Caffeine|caffeine|mesh-list
153469352|NCT05118477|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
153469354|NCT05118477|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
153469370|NCT05111860|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153469371|NCT05111860|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153469372|NCT05111860|Growth Substances|growth substances|mesh-ancestor
153469373|NCT05111860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153469374|NCT05111860|Growth Inhibitors|growth inhibitors|mesh-ancestor
153469375|NCT05102591|Ketorolac|ketorolac|mesh-list
153469376|NCT05102591|Metoclopramide|metoclopramide|mesh-list
153469377|NCT05102591|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153469378|NCT05102591|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153469379|NCT05102591|Analgesics|analgesics|mesh-ancestor
153469380|NCT05102591|Sensory System Agents|sensory system agents|mesh-ancestor
153469381|NCT05102591|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153469382|NCT05102591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153883406|NCT01365468|Everolimus|everolimus|mesh-list
153883407|NCT01365468|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
153883408|NCT01365468|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153883409|NCT01365468|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153883410|NCT01365468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153883411|NCT01365468|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153883412|NCT01365468|Immunologic Factors|immunologic factors|mesh-ancestor
153469437|NCT05051449|Ketamine|ketamine|mesh-list
153469486|NCT04952753|Vitamin B Complex|vitamin b complex|mesh-ancestor
153469487|NCT04952753|Vitamins|vitamins|mesh-ancestor
153469488|NCT04952753|Micronutrients|micronutrients|mesh-ancestor
153469505|NCT04924075|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153469506|NCT04913675|Sotrovimab|sotrovimab|mesh-list
153469517|NCT04902027|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153469518|NCT04902027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153469520|NCT04900766|Analgesics|analgesics|mesh-ancestor
153469521|NCT04900766|Sensory System Agents|sensory system agents|mesh-ancestor
153469541|NCT04898894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153469547|NCT04898894|Immunologic Factors|immunologic factors|mesh-ancestor
153469548|NCT04898894|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153469549|NCT04898894|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153469550|NCT04898894|Antiviral Agents|antiviral agents|mesh-ancestor
153469551|NCT04898894|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153469552|NCT04898894|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153469558|NCT04847557|Tirzepatide|tirzepatide|mesh-list
153469660|NCT04632992|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153469661|NCT04632992|Tubulin Modulators|tubulin modulators|mesh-ancestor
153469662|NCT04632992|Antimitotic Agents|antimitotic agents|mesh-ancestor
153469663|NCT04632992|Mitosis Modulators|mitosis modulators|mesh-ancestor
153469664|NCT04632992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153469722|NCT04548700|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153469723|NCT04548700|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153469724|NCT04548700|Tubulin Modulators|tubulin modulators|mesh-ancestor
153469725|NCT04548700|Antimitotic Agents|antimitotic agents|mesh-ancestor
153469726|NCT04548700|Mitosis Modulators|mitosis modulators|mesh-ancestor
153469727|NCT04548700|Analgesics|analgesics|mesh-ancestor
153469728|NCT04548700|Sensory System Agents|sensory system agents|mesh-ancestor
153424411|NCT04121078|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
153469729|NCT04548700|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153469730|NCT04548700|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153469800|NCT04380311|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
153469801|NCT04380311|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153469802|NCT04380311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153469803|NCT04356170|Docetaxel|docetaxel|mesh-list
153469804|NCT04356170|Fluorouracil|fluorouracil|mesh-list
153469805|NCT04356170|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153469806|NCT04356170|Tubulin Modulators|tubulin modulators|mesh-ancestor
153469807|NCT04356170|Antimitotic Agents|antimitotic agents|mesh-ancestor
153469808|NCT04356170|Mitosis Modulators|mitosis modulators|mesh-ancestor
153469809|NCT04356170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153469810|NCT04356170|Antimetabolites|antimetabolites|mesh-ancestor
153469811|NCT04356170|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153469812|NCT04356170|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153469813|NCT04356170|Immunologic Factors|immunologic factors|mesh-ancestor
153469814|NCT04356170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153469815|NCT04305054|Pembrolizumab|pembrolizumab|mesh-list
153469824|NCT04257578|Axicabtagene ciloleucel|axicabtagene ciloleucel|mesh-list
153469825|NCT04257578|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-list
153469826|NCT04257578|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153469827|NCT04257578|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153469828|NCT04257578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153469829|NCT04257578|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153469830|NCT04257578|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153469836|NCT04234048|Fenretinide|fenretinide|mesh-list
153469837|NCT04234048|Retinamide|retinamide|mesh-list
153883484|NCT01351350|Mitosis Modulators|mitosis modulators|mesh-ancestor
153883485|NCT01351350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153883486|NCT01351350|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153883487|NCT02271503|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
153469838|NCT04234048|Tretinoin|tretinoin|mesh-list
153469839|NCT04234048|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153469840|NCT04234048|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
153469841|NCT04234048|Protective Agents|protective agents|mesh-ancestor
153469860|NCT04181359|Free Radical Scavengers|free radical scavengers|mesh-ancestor
153469861|NCT04181359|Antioxidants|antioxidants|mesh-ancestor
153469862|NCT04181359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153469863|NCT04181359|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153469864|NCT04181359|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
153469865|NCT04181359|Vasodilator Agents|vasodilator agents|mesh-ancestor
153469866|NCT04181359|Gasotransmitters|gasotransmitters|mesh-ancestor
153469876|NCT04107038|Anesthetics|anesthetics|mesh-list
153469969|NCT03973333|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153813767|NCT00437229|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
153469970|NCT03963895|Thrombin|thrombin|mesh-list
153469971|NCT03963895|Hemostatics|hemostatics|mesh-ancestor
153469972|NCT03963895|Coagulants|coagulants|mesh-ancestor
153469973|NCT03945591|Cyclophosphamide|cyclophosphamide|mesh-list
153469974|NCT03945591|Bortezomib|bortezomib|mesh-list
153883503|NCT01350804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153470034|NCT03784326|Fluorouracil|fluorouracil|mesh-list
153470035|NCT03784326|Oxaliplatin|oxaliplatin|mesh-list
153470036|NCT03784326|Atezolizumab|atezolizumab|mesh-list
153470037|NCT03784326|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
153470038|NCT03784326|Antimetabolites|antimetabolites|mesh-ancestor
153470039|NCT03784326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153470040|NCT03784326|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153470041|NCT03784326|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153470042|NCT03784326|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153883510|NCT02270957|Abatacept|abatacept|mesh-list
153470043|NCT03784326|Immunologic Factors|immunologic factors|mesh-ancestor
153470128|NCT03469960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153470129|NCT03464097|Ozanimod|ozanimod|mesh-list
153470130|NCT03464097|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
153470131|NCT03464097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153470132|NCT03464097|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153470133|NCT03464097|Immunologic Factors|immunologic factors|mesh-ancestor
153470134|NCT03464097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153470135|NCT03396926|Bevacizumab|bevacizumab|mesh-list
153387497|NCT02977949|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
153470136|NCT03396926|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
153470138|NCT03396926|Capecitabine|capecitabine|mesh-list
153470139|NCT03396926|Endothelial Growth Factors|endothelial growth factors|mesh-list
153470140|NCT03396926|Antibodies|antibodies|mesh-list
153470141|NCT03396926|Immunoglobulins|immunoglobulins|mesh-list
153470142|NCT03396926|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
153470143|NCT03396926|Immunoglobulin G|immunoglobulin g|mesh-list
153470144|NCT03396926|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153470145|NCT03396926|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153470146|NCT03396926|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153470147|NCT03396926|Growth Substances|growth substances|mesh-ancestor
153470148|NCT03396926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153470149|NCT03396926|Growth Inhibitors|growth inhibitors|mesh-ancestor
153470150|NCT03396926|Immunologic Factors|immunologic factors|mesh-ancestor
153470154|NCT03396926|Antimetabolites|antimetabolites|mesh-ancestor
153470195|NCT03338621|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153470203|NCT03338621|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
153470204|NCT03338621|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
153470205|NCT03338621|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
153470206|NCT03338621|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
153470208|NCT03338621|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
153470209|NCT03338621|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
153470210|NCT03338621|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153470211|NCT03338621|Antimetabolites|antimetabolites|mesh-ancestor
153470222|NCT03321981|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
153470223|NCT03321981|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153470224|NCT03321981|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153470226|NCT03321981|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
153883516|NCT02270957|Immunologic Factors|immunologic factors|mesh-ancestor
153883517|NCT02270957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153470276|NCT03151499|Antitubercular Agents|antitubercular agents|mesh-ancestor
153470277|NCT03151499|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153470285|NCT03151499|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
153470286|NCT03151499|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
153470287|NCT03151499|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
153470288|NCT03151499|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
153470289|NCT03151499|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
153470290|NCT02963077|Cholestyramine Resin|cholestyramine resin|mesh-list
153470291|NCT02963077|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153470292|NCT02963077|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153470390|NCT02498977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153470391|NCT02498977|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
153470392|NCT02498977|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153470393|NCT02498977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153470394|NCT02498977|Antifungal Agents|antifungal agents|mesh-ancestor
153470395|NCT02498977|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153470396|NCT02498977|Dermatologic Agents|dermatologic agents|mesh-ancestor
153470397|NCT02498977|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153470398|NCT02498977|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153470399|NCT02498977|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153470400|NCT02498977|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
153470401|NCT02498977|Antitubercular Agents|antitubercular agents|mesh-ancestor
153470402|NCT02498977|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153470403|NCT02498977|Antimetabolites|antimetabolites|mesh-ancestor
153470404|NCT02498977|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153470405|NCT02381561|Ropidoxuridine|ropidoxuridine|mesh-list
153470406|NCT02381561|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153470424|NCT01983241|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
153470425|NCT01983241|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
153470426|NCT01983241|Protease Inhibitors|protease inhibitors|mesh-ancestor
153470427|NCT01983241|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153813770|NCT00437229|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153470428|NCT01983241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153470429|NCT01861106|Mycophenolic Acid|mycophenolic acid|mesh-list
153470430|NCT01861106|Cyclophosphamide|cyclophosphamide|mesh-list
153470431|NCT01861106|Busulfan|busulfan|mesh-list
153470432|NCT01861106|Fludarabine|fludarabine|mesh-list
153470433|NCT01861106|Fludarabine phosphate|fludarabine phosphate|mesh-list
153470434|NCT01861106|Tacrolimus|tacrolimus|mesh-list
153470435|NCT01861106|Antilymphocyte Serum|antilymphocyte serum|mesh-list
153470436|NCT01861106|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153470437|NCT01861106|Immunologic Factors|immunologic factors|mesh-ancestor
153470438|NCT01861106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153470439|NCT01861106|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153470440|NCT01861106|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153470441|NCT01861106|Alkylating Agents|alkylating agents|mesh-ancestor
153470442|NCT01861106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153470443|NCT01861106|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153470444|NCT01861106|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153470445|NCT01861106|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153470446|NCT01861106|Antimetabolites|antimetabolites|mesh-ancestor
153470472|NCT01856478|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153470474|NCT01822314|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
153470475|NCT01822314|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153470476|NCT01822314|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153470492|NCT01711554|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153470493|NCT01711554|Growth Substances|growth substances|mesh-ancestor
153470494|NCT01711554|Growth Inhibitors|growth inhibitors|mesh-ancestor
153470495|NCT01711554|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153470496|NCT01711554|Keratolytic Agents|keratolytic agents|mesh-ancestor
153470497|NCT01711554|Dermatologic Agents|dermatologic agents|mesh-ancestor
153470498|NCT01695941|Rituximab|rituximab|mesh-list
153470515|NCT01638533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153470516|NCT01475123|Nicorandil|nicorandil|mesh-list
153470517|NCT01475123|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153470518|NCT01475123|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153470519|NCT01475123|Vasodilator Agents|vasodilator agents|mesh-ancestor
153470574|NCT00565266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153470575|NCT00565266|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153470576|NCT00565266|Respiratory System Agents|respiratory system agents|mesh-ancestor
153470577|NCT00565266|Parasympatholytics|parasympatholytics|mesh-ancestor
153470578|NCT00565266|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
153470579|NCT00565266|Cholinergic Agents|cholinergic agents|mesh-ancestor
153470580|NCT00565266|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153470581|NCT00565266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153470582|NCT00565266|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
153470583|NCT00565266|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
153470652|NCT05161806|Growth Inhibitors|growth inhibitors|mesh-ancestor
153470653|NCT05161806|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153470654|NCT05362188|Niacinamide|niacinamide|mesh-list
153470655|NCT05362188|Niacin|niacin|mesh-list
153470656|NCT05362188|Nicotinic Acids|nicotinic acids|mesh-list
153470657|NCT05362188|Vitamin B Complex|vitamin b complex|mesh-ancestor
153470658|NCT05362188|Vitamins|vitamins|mesh-ancestor
153470659|NCT05362188|Micronutrients|micronutrients|mesh-ancestor
153470660|NCT05362188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153470761|NCT03642366|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153470762|NCT03642366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153470763|NCT03642366|Urological Agents|urological agents|mesh-ancestor
153470765|NCT00604968|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
153470766|NCT00604968|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153470767|NCT00604968|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153470768|NCT00604968|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153470769|NCT00604968|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153470770|NCT00604968|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153470830|NCT00608634|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153470831|NCT00608634|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153470832|NCT00608634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153470833|NCT02897700|Cyclophosphamide|cyclophosphamide|mesh-list
153470834|NCT02897700|Doxorubicin|doxorubicin|mesh-list
153470835|NCT02897700|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
153470836|NCT02897700|Fluorouracil|fluorouracil|mesh-list
153470837|NCT02897700|Methotrexate|methotrexate|mesh-list
153470838|NCT02897700|Epirubicin|epirubicin|mesh-list
153470839|NCT02897700|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153470840|NCT02897700|Immunologic Factors|immunologic factors|mesh-ancestor
153470841|NCT02897700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153813772|NCT00335192|Tenofovir|tenofovir|mesh-list
153813773|NCT00335192|Lamivudine|lamivudine|mesh-list
153883577|NCT01342341|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153883578|NCT01340664|Metformin|metformin|mesh-list
153470854|NCT02897700|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
153470855|NCT02897700|Abortifacient Agents|abortifacient agents|mesh-ancestor
153470856|NCT02897700|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153470857|NCT02897700|Dermatologic Agents|dermatologic agents|mesh-ancestor
153883587|NCT01340625|Norethindrone|norethindrone|mesh-list
153470858|NCT02897700|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153470859|NCT02897700|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153470860|NCT02889666|Cisplatin|cisplatin|mesh-list
153470861|NCT02889666|Carboplatin|carboplatin|mesh-list
153470862|NCT02889666|Gemcitabine|gemcitabine|mesh-list
153470863|NCT02889666|Docetaxel|docetaxel|mesh-list
153470864|NCT02889666|Oxaliplatin|oxaliplatin|mesh-list
153471028|NCT04142502|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
153424553|NCT03806270|GABA Modulators|gaba modulators|mesh-ancestor
153471096|NCT00571428|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153471097|NCT00571428|Autonomic Agents|autonomic agents|mesh-ancestor
153471098|NCT00571428|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153471099|NCT00571428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153471100|NCT00571428|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153471109|NCT00571974|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
153471110|NCT00571974|Dermatologic Agents|dermatologic agents|mesh-ancestor
153471111|NCT00574236|Doxorubicin|doxorubicin|mesh-list
153471112|NCT00574236|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153471113|NCT00574236|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153471114|NCT00574236|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153471115|NCT00574236|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153471173|NCT01107886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153471174|NCT01107886|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
153471175|NCT01107886|Protease Inhibitors|protease inhibitors|mesh-ancestor
153471176|NCT01107886|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153471177|NCT01107886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153471178|NCT01107886|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153471180|NCT01107457|Dermatologic Agents|dermatologic agents|mesh-ancestor
153471181|NCT05767008|Sunscreening Agents|sunscreening agents|mesh-list
153471182|NCT05767008|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
153471183|NCT05767008|Protective Agents|protective agents|mesh-ancestor
153471184|NCT05767008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153424593|NCT03264157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153424594|NCT04029584|Rifampin|rifampin|mesh-list
153424595|NCT04029584|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
153471185|NCT05767008|Dermatologic Agents|dermatologic agents|mesh-ancestor
153471221|NCT05766436|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153471222|NCT05766436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153471224|NCT05766436|Protective Agents|protective agents|mesh-ancestor
153471226|NCT05766384|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
153471227|NCT05766384|Anesthetics, General|anesthetics, general|mesh-ancestor
153471229|NCT05766384|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153471230|NCT05766384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153471231|NCT05766176|Antibodies|antibodies|mesh-list
153471232|NCT05766176|Immunoglobulins|immunoglobulins|mesh-list
153471233|NCT05766176|Immunologic Factors|immunologic factors|mesh-ancestor
153471237|NCT05766085|Antiemetics|antiemetics|mesh-ancestor
153471255|NCT05765747|Celecoxib|celecoxib|mesh-list
153471256|NCT05765747|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153471269|NCT05765617|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153471270|NCT05765617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153471271|NCT05765617|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
153471272|NCT05765617|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153471273|NCT05765617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153471274|NCT05765617|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
153471275|NCT05765617|Vitamins|vitamins|mesh-ancestor
153471276|NCT05765617|Micronutrients|micronutrients|mesh-ancestor
153471277|NCT05765617|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153471287|NCT05765110|Dopamine|dopamine|mesh-list
153471288|NCT05765110|Dopamine Agonists|dopamine agonists|mesh-list
153360177|NCT01272245|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153471289|NCT05765110|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
153883710|NCT01192399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153471291|NCT05765110|Autonomic Agents|autonomic agents|mesh-ancestor
153471292|NCT05765110|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153471293|NCT05765110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153471294|NCT05765110|Dopamine Agents|dopamine agents|mesh-ancestor
153471295|NCT05765110|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153471296|NCT05765110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153471297|NCT05765110|Protective Agents|protective agents|mesh-ancestor
153471343|NCT05757622|Analgesics|analgesics|mesh-ancestor
153471344|NCT05757622|Sensory System Agents|sensory system agents|mesh-ancestor
153471345|NCT05757622|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153471346|NCT05746650|Hormones|hormones|mesh-list
153471347|NCT05746650|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153471348|NCT05746650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153471349|NCT05731726|Celecoxib|celecoxib|mesh-list
153471350|NCT05731726|Capecitabine|capecitabine|mesh-list
153471351|NCT05731726|Oxaliplatin|oxaliplatin|mesh-list
153471352|NCT05731726|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153471353|NCT05731726|Antimetabolites|antimetabolites|mesh-ancestor
153471354|NCT05731726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153471355|NCT05731726|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153471357|NCT05731726|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153883732|NCT02894268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153883733|NCT02894268|Antimalarials|antimalarials|mesh-ancestor
153883734|NCT02894268|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153883735|NCT02894268|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153883736|NCT02894268|Antacids|antacids|mesh-ancestor
153883737|NCT02894268|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
153471376|NCT05715931|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153471378|NCT05715931|Protective Agents|protective agents|mesh-ancestor
153471379|NCT05715931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153471380|NCT05715931|Vitamin B Complex|vitamin b complex|mesh-ancestor
153471381|NCT05715931|Vitamins|vitamins|mesh-ancestor
153471382|NCT05715931|Micronutrients|micronutrients|mesh-ancestor
153471383|NCT05708183|Micronutrients|micronutrients|mesh-list
153471384|NCT05708183|Trace Elements|trace elements|mesh-list
153471436|NCT05133258|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153471437|NCT05133258|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153471438|NCT05133258|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153471439|NCT05133258|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153471440|NCT05133258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153471441|NCT05133258|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
153471442|NCT05133258|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153471443|NCT05059873|Prednisone|prednisone|mesh-list
153471444|NCT05059873|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153471489|NCT04944290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153471490|NCT04944290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153471492|NCT04944290|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153471493|NCT04937166|Azacitidine|azacitidine|mesh-list
153471494|NCT04937166|Venetoclax|venetoclax|mesh-list
153471495|NCT04937166|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153471496|NCT04937166|Antimetabolites|antimetabolites|mesh-ancestor
153471497|NCT04937166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153471498|NCT04937166|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153471499|NCT04937166|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153471500|NCT04908176|Midazolam|midazolam|mesh-list
153471502|NCT04908176|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153471503|NCT04908176|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153471504|NCT04908176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153471519|NCT04859829|Antibodies|antibodies|mesh-list
153471563|NCT04718181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153471564|NCT04718181|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
153471565|NCT04718181|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153471566|NCT04718181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153471568|NCT04656301|Hallucinogens|hallucinogens|mesh-ancestor
153471569|NCT04656301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153471570|NCT04656301|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153471571|NCT04573504|Clindamycin|clindamycin|mesh-list
153471572|NCT04573504|Clindamycin palmitate|clindamycin palmitate|mesh-list
153471573|NCT04573504|Clindamycin phosphate|clindamycin phosphate|mesh-list
153471574|NCT04573504|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
153471575|NCT04573504|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153471576|NCT04573504|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153471577|NCT04573504|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
153471578|NCT04573504|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153471579|NCT04573504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153471580|NCT04573504|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
153471627|NCT04119453|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153471628|NCT04119453|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153471629|NCT04119453|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153471630|NCT04119453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153471631|NCT04006119|Cemiplimab|cemiplimab|mesh-list
153471632|NCT04006119|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153471642|NCT04002011|Apixaban|apixaban|mesh-list
153471643|NCT04002011|Edoxaban|edoxaban|mesh-list
153471644|NCT04002011|Anticoagulants|anticoagulants|mesh-ancestor
153471645|NCT04002011|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
153471646|NCT04002011|Antithrombins|antithrombins|mesh-ancestor
153471647|NCT04002011|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
153471648|NCT04002011|Protease Inhibitors|protease inhibitors|mesh-ancestor
153471649|NCT04002011|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153471650|NCT04002011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153471651|NCT03903692|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
153471652|NCT03903692|Laxatives|laxatives|mesh-ancestor
153471653|NCT03903692|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153471654|NCT03789591|Hydroxyurea|hydroxyurea|mesh-list
153471655|NCT03789591|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153471656|NCT03789591|Antisickling Agents|antisickling agents|mesh-ancestor
153813780|NCT00335192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153471657|NCT03789591|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153471658|NCT03789591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153471659|NCT03789591|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153471662|NCT03783026|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153471663|NCT03783026|Analgesics|analgesics|mesh-ancestor
153471664|NCT03783026|Sensory System Agents|sensory system agents|mesh-ancestor
153471665|NCT03783026|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153471666|NCT03783026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153471667|NCT03783026|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153471668|NCT03783026|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153471669|NCT03783026|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
153471777|NCT02540018|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153471778|NCT02540018|Tubulin Modulators|tubulin modulators|mesh-ancestor
153471779|NCT02540018|Antimitotic Agents|antimitotic agents|mesh-ancestor
153471780|NCT02540018|Mitosis Modulators|mitosis modulators|mesh-ancestor
153471781|NCT02540018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153471782|NCT02423265|Ranolazine|ranolazine|mesh-list
153471783|NCT02423265|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153471784|NCT02423265|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153471785|NCT02423265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153471786|NCT02368886|Clobetasol|clobetasol|mesh-list
153471868|NCT01715285|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153471869|NCT01715285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153471870|NCT01715285|Hormone Antagonists|hormone antagonists|mesh-ancestor
153471871|NCT01715285|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153471872|NCT01705184|Bevacizumab|bevacizumab|mesh-list
153471873|NCT01705184|Pemetrexed|pemetrexed|mesh-list
153471874|NCT01705184|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153471875|NCT01705184|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153471876|NCT01705184|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153471877|NCT01705184|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153471878|NCT01705184|Growth Substances|growth substances|mesh-ancestor
153471885|NCT01285817|Celecoxib|celecoxib|mesh-list
153471917|NCT01285817|Antimitotic Agents|antimitotic agents|mesh-ancestor
153471918|NCT01285817|Mitosis Modulators|mitosis modulators|mesh-ancestor
153471920|NCT01250496|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153471921|NCT01250496|Autonomic Agents|autonomic agents|mesh-ancestor
153471922|NCT01250496|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153471923|NCT01250496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153471924|NCT01250496|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153471925|NCT01250496|Respiratory System Agents|respiratory system agents|mesh-ancestor
153471926|NCT01250496|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
153471927|NCT01250496|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
153471928|NCT01250496|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153471929|NCT01250496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153471930|NCT01250496|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
153471931|NCT01250496|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
153471932|NCT01250496|Purinergic Agents|purinergic agents|mesh-ancestor
153471933|NCT01250496|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153471934|NCT01250496|Protective Agents|protective agents|mesh-ancestor
153471935|NCT01105975|Atorvastatin|atorvastatin|mesh-list
153471936|NCT01105975|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
153471937|NCT01105975|Simvastatin|simvastatin|mesh-list
153471938|NCT01105975|Evacetrapib|evacetrapib|mesh-list
153471939|NCT01105975|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153471940|NCT01105975|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153471941|NCT01105975|Antimetabolites|antimetabolites|mesh-ancestor
153471942|NCT01105975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153813782|NCT00335192|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153813784|NCT00437307|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
153471955|NCT00651456|Growth Inhibitors|growth inhibitors|mesh-ancestor
153471956|NCT00651456|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153471957|NCT00651456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153471958|NCT00651456|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153471959|NCT00651456|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153471960|NCT00280202|Dimercaprol|dimercaprol|mesh-list
153471961|NCT00280202|Chelating Agents|chelating agents|mesh-ancestor
153471970|NCT00079417|Tubulin Modulators|tubulin modulators|mesh-ancestor
153471971|NCT00079417|Antimitotic Agents|antimitotic agents|mesh-ancestor
153471972|NCT00079417|Mitosis Modulators|mitosis modulators|mesh-ancestor
153471973|NCT00079417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153471974|NCT00079417|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
153471975|NCT00079417|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153471976|NCT00079417|Trace Elements|trace elements|mesh-ancestor
153471977|NCT00079417|Micronutrients|micronutrients|mesh-ancestor
153471978|NCT00079417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153471979|NCT04386876|Ritonavir|ritonavir|mesh-list
153472002|NCT04385550|Tubulin Modulators|tubulin modulators|mesh-ancestor
153472003|NCT04385550|Antimitotic Agents|antimitotic agents|mesh-ancestor
153472004|NCT04385550|Mitosis Modulators|mitosis modulators|mesh-ancestor
153472005|NCT04385550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153472006|NCT04384380|Hydroxychloroquine|hydroxychloroquine|mesh-list
153472007|NCT04384380|Antimalarials|antimalarials|mesh-ancestor
153472008|NCT04384380|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153472009|NCT04384380|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153472010|NCT04384380|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153883965|NCT02273765|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
153472053|NCT04379310|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153472054|NCT04379310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153472055|NCT04379310|Protease Inhibitors|protease inhibitors|mesh-ancestor
153472056|NCT04379310|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153472057|NCT04379310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153472058|NCT04379310|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153472059|NCT04378608|Ribavirin|ribavirin|mesh-list
153472082|NCT04376970|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153472083|NCT04376970|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
153472084|NCT04377048|Gemcitabine|gemcitabine|mesh-list
153472085|NCT04377048|Tegafur|tegafur|mesh-list
153472086|NCT04377048|Nivolumab|nivolumab|mesh-list
153472087|NCT04377048|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153472088|NCT04377048|Antimetabolites|antimetabolites|mesh-ancestor
153472089|NCT04377048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153472090|NCT04377048|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153472099|NCT04376814|Protease Inhibitors|protease inhibitors|mesh-ancestor
153472100|NCT04376814|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153472101|NCT04376814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153472102|NCT04376814|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153472103|NCT04376814|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153472104|NCT04376814|Antiviral Agents|antiviral agents|mesh-ancestor
153472105|NCT04376814|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153472106|NCT04376814|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
153472143|NCT04374552|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153472144|NCT04374006|Propolis|propolis|mesh-list
153472145|NCT04374006|Dienogest|dienogest|mesh-list
153472146|NCT04374006|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153884003|NCT01175824|Heparin Antagonists|heparin antagonists|mesh-ancestor
153472148|NCT04374006|Contraceptive Agents|contraceptive agents|mesh-ancestor
153472149|NCT04374006|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153813785|NCT00437307|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153472150|NCT04374006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153472151|NCT04374006|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
153472152|NCT04374006|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
153472153|NCT04374006|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
153472202|NCT04366596|Paclitaxel|paclitaxel|mesh-list
153472226|NCT04365582|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153472249|NCT04365270|Sunscreening Agents|sunscreening agents|mesh-ancestor
153472250|NCT04365270|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
153813786|NCT00437307|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153360181|NCT01272245|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
153472251|NCT04365270|Protective Agents|protective agents|mesh-ancestor
153472252|NCT04365270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153472253|NCT04365270|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
153472254|NCT04365426|Contraceptive Agents|contraceptive agents|mesh-list
153472255|NCT04365426|Contraceptives, Oral|contraceptives, oral|mesh-list
153472256|NCT04365426|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153472323|NCT04359966|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153472324|NCT04359966|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153472325|NCT04359966|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153472326|NCT04359966|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
153472327|NCT04359966|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153813787|NCT00437307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153472329|NCT04359966|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153472330|NCT04359966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153472587|NCT04347252|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153472588|NCT04347252|Hormones|hormones|mesh-ancestor
153472589|NCT04347252|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153472590|NCT04347252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153472591|NCT04346862|Acetylcarnitine|acetylcarnitine|mesh-list
153472592|NCT04346862|Vitamin B Complex|vitamin b complex|mesh-ancestor
153472593|NCT04346862|Vitamins|vitamins|mesh-ancestor
153472594|NCT04346862|Micronutrients|micronutrients|mesh-ancestor
153472595|NCT04346862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153884120|NCT01601795|Sevoflurane|sevoflurane|mesh-list
153884121|NCT01601795|Isoflurane|isoflurane|mesh-list
153884122|NCT01601795|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153884123|NCT01601795|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
153884124|NCT01601795|Anesthetics, General|anesthetics, general|mesh-ancestor
153884125|NCT01601795|Anesthetics|anesthetics|mesh-ancestor
153884126|NCT01601795|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153360186|NCT00802100|Aripiprazole|aripiprazole|mesh-list
153472700|NCT04340544|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153472701|NCT04340544|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153472703|NCT04340544|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153473065|NCT03019224|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153473066|NCT03018990|Ethanol|ethanol|mesh-list
153473078|NCT03018756|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153473079|NCT03018756|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153473080|NCT03018756|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153473081|NCT03018756|Anesthetics, General|anesthetics, general|mesh-ancestor
153473082|NCT03018756|Anesthetics|anesthetics|mesh-ancestor
153473083|NCT03018444|Atorvastatin|atorvastatin|mesh-list
153473084|NCT03018444|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153473115|NCT03017430|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153473116|NCT03017430|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153473117|NCT03017430|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153473118|NCT03017430|Sympatholytics|sympatholytics|mesh-ancestor
153473409|NCT03002064|Antimitotic Agents|antimitotic agents|mesh-ancestor
153473429|NCT03000660|Hormones|hormones|mesh-ancestor
153473711|NCT02641314|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
153473934|NCT00585780|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153473945|NCT00586482|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153473946|NCT00586482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153473947|NCT03708354|Tocotrienols|tocotrienols|mesh-list
153473948|NCT03708354|Vitamin E|vitamin e|mesh-list
153473949|NCT03708354|Tocopherols|tocopherols|mesh-list
153473950|NCT03708354|Antioxidants|antioxidants|mesh-ancestor
153473954|NCT03708354|Vitamins|vitamins|mesh-ancestor
153473981|NCT01327638|Sensory System Agents|sensory system agents|mesh-ancestor
153473982|NCT01327638|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153473983|NCT01327638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153474042|NCT00590226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153474043|NCT00590460|Fludarabine|fludarabine|mesh-list
153474044|NCT00590460|Alemtuzumab|alemtuzumab|mesh-list
153474045|NCT00590460|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153474046|NCT00590460|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153474047|NCT00590772|Montelukast|montelukast|mesh-list
153474048|NCT00590772|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153474057|NCT00592176|Bevacizumab|bevacizumab|mesh-list
153474099|NCT00597402|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153474100|NCT00597402|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153474101|NCT00597402|Growth Substances|growth substances|mesh-ancestor
153474102|NCT00597402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153474103|NCT00597402|Growth Inhibitors|growth inhibitors|mesh-ancestor
153474104|NCT00597402|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
153474105|NCT00597402|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153474106|NCT00597402|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153474107|NCT00597402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153474108|NCT00597402|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153474109|NCT00597402|Alkylating Agents|alkylating agents|mesh-ancestor
153474663|NCT00711828|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153474857|NCT00733356|Dopamine Agents|dopamine agents|mesh-ancestor
153474858|NCT00733356|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153474859|NCT00735306|Bevacizumab|bevacizumab|mesh-list
153474860|NCT00735306|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
153474861|NCT00735306|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153474862|NCT00735306|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153474863|NCT00735306|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153474864|NCT00735306|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153474865|NCT00735306|Growth Substances|growth substances|mesh-ancestor
153884266|NCT01608347|Folic Acid|folic acid|mesh-list
153884278|NCT01608464|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153884279|NCT01608464|Tubulin Modulators|tubulin modulators|mesh-ancestor
153425220|NCT02367170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153425221|NCT01078844|Memantine|memantine|mesh-list
153425222|NCT01078844|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
153425223|NCT01078844|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
153425224|NCT01078844|Dopamine Agents|dopamine agents|mesh-ancestor
153475504|NCT00806598|Methylprednisolone|methylprednisolone|mesh-list
153475616|NCT05206812|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153475617|NCT05131152|Cyclosporine|cyclosporine|mesh-list
153475618|NCT05131152|Cyclosporins|cyclosporins|mesh-list
153475619|NCT05131152|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153475620|NCT05131152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153475621|NCT05131152|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153475622|NCT05131152|Immunologic Factors|immunologic factors|mesh-ancestor
153475623|NCT05131152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153475624|NCT05131152|Antifungal Agents|antifungal agents|mesh-ancestor
153475719|NCT00824460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153475721|NCT00824538|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153475722|NCT00824538|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153475723|NCT00824538|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153475724|NCT00824538|Growth Substances|growth substances|mesh-ancestor
153475725|NCT00824538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153475760|NCT00830388|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
153475762|NCT00830388|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153476013|NCT00875550|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153476014|NCT00875550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153476015|NCT00875550|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153476016|NCT00875550|Narcotics|narcotics|mesh-ancestor
153476031|NCT00878436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153476032|NCT00878436|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153476033|NCT00878436|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
153476035|NCT00878436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153476036|NCT00878826|Enoxaparin|enoxaparin|mesh-list
153476037|NCT00878826|Anticoagulants|anticoagulants|mesh-ancestor
153476038|NCT00878826|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153425288|NCT03582553|Hormone Antagonists|hormone antagonists|mesh-ancestor
153425289|NCT03582553|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153425290|NCT03582553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153425291|NCT01025492|Fenofibric acid|fenofibric acid|mesh-list
153425292|NCT01025492|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153425293|NCT01025492|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153425294|NCT01025492|Antimetabolites|antimetabolites|mesh-ancestor
153425295|NCT01025492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153425296|NCT01025492|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153425297|NCT04331834|Hydroxychloroquine|hydroxychloroquine|mesh-list
153476171|NCT00898560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153476173|NCT00899574|Toll-Like Receptor Agonists|toll-like receptor agonists|mesh-ancestor
153476187|NCT00900666|Cholinergic Agents|cholinergic agents|mesh-ancestor
153476188|NCT00900666|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153476189|NCT00900666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153476190|NCT00900666|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
153476191|NCT00900666|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153476192|NCT00902226|Escitalopram|escitalopram|mesh-list
153476193|NCT00902226|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
153425322|NCT02200328|Metronidazole|metronidazole|mesh-list
153476216|NCT00903162|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153476217|NCT00904488|Metolazone|metolazone|mesh-list
153476218|NCT00904488|Furosemide|furosemide|mesh-list
153476219|NCT00904488|Diuretics|diuretics|mesh-ancestor
153476220|NCT00904488|Natriuretic Agents|natriuretic agents|mesh-ancestor
153476221|NCT00904488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153476222|NCT00904488|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
153476223|NCT00904488|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153476224|NCT00904488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153476225|NCT00904488|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153476226|NCT00904488|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
153476227|NCT00905580|Pregabalin|pregabalin|mesh-list
153476228|NCT00905580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153476269|NCT00911742|Narcotics|narcotics|mesh-ancestor
153476270|NCT00911742|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153476271|NCT00911742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153476272|NCT00911742|Analgesics|analgesics|mesh-ancestor
153476273|NCT00911742|Sensory System Agents|sensory system agents|mesh-ancestor
153476274|NCT00911742|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153476275|NCT00912990|Cisatracurium|cisatracurium|mesh-list
153476276|NCT00912990|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
153476277|NCT00912990|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
153476278|NCT00912990|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153476279|NCT00912990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153476280|NCT00913068|Lidocaine|lidocaine|mesh-list
153476302|NCT00923910|Keyhole-limpet hemocyanin|keyhole-limpet hemocyanin|mesh-list
153476303|NCT00923910|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153476323|NCT00923910|Antipruritics|antipruritics|mesh-ancestor
153476324|NCT00923910|Dermatologic Agents|dermatologic agents|mesh-ancestor
153476325|NCT00923910|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153476326|NCT00923910|Immunologic Factors|immunologic factors|mesh-ancestor
153476327|NCT00923910|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153476328|NCT00923910|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153476329|NCT00924066|Epothilones|epothilones|mesh-list
153476330|NCT00924066|Tubulin Modulators|tubulin modulators|mesh-ancestor
153476331|NCT00924066|Antimitotic Agents|antimitotic agents|mesh-ancestor
153476332|NCT00924066|Mitosis Modulators|mitosis modulators|mesh-ancestor
153476333|NCT00924066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153476334|NCT00924066|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153476335|NCT00924612|Methyltestosterone|methyltestosterone|mesh-list
153476336|NCT00924612|Testosterone|testosterone|mesh-list
153476337|NCT00924612|Testosterone undecanoate|testosterone undecanoate|mesh-list
153476340|NCT00924612|Androgens|androgens|mesh-ancestor
153476344|NCT00924612|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153476345|NCT00924612|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153476346|NCT00924612|Anabolic Agents|anabolic agents|mesh-ancestor
153476347|NCT00925782|Melphalan|melphalan|mesh-list
153476348|NCT00925782|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153476349|NCT00925782|Alkylating Agents|alkylating agents|mesh-ancestor
153476350|NCT00925782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153476351|NCT00925782|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153476452|NCT00932022|Trospium chloride|trospium chloride|mesh-list
153476453|NCT00932022|Parasympatholytics|parasympatholytics|mesh-ancestor
153476454|NCT00932022|Autonomic Agents|autonomic agents|mesh-ancestor
153476455|NCT00932022|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153476456|NCT00932022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153476457|NCT00932022|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
153476458|NCT00932022|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
153476459|NCT00932022|Cholinergic Agents|cholinergic agents|mesh-ancestor
153476460|NCT00932022|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153476461|NCT00932022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153476462|NCT00932022|Urological Agents|urological agents|mesh-ancestor
153476463|NCT00935064|Aliskiren|aliskiren|mesh-list
153476464|NCT00935064|Renin Inhibitors|renin inhibitors|mesh-ancestor
153476509|NCT00943800|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153476510|NCT00943800|Immunologic Factors|immunologic factors|mesh-ancestor
153476599|NCT00967044|Everolimus|everolimus|mesh-list
153476600|NCT00967044|Panobinostat|panobinostat|mesh-list
153476602|NCT00967044|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153476603|NCT00967044|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153476604|NCT00967044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153476605|NCT00967044|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153476606|NCT00967044|Immunologic Factors|immunologic factors|mesh-ancestor
153476607|NCT00967044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153476608|NCT00967044|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153476609|NCT00967044|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
153476612|NCT00973752|Doxorubicin|doxorubicin|mesh-list
153476613|NCT00973752|Methotrexate|methotrexate|mesh-list
153884414|NCT01609439|Vitamins|vitamins|mesh-ancestor
153884415|NCT01609439|Micronutrients|micronutrients|mesh-ancestor
153476657|NCT00974142|Dermatologic Agents|dermatologic agents|mesh-ancestor
153476658|NCT00974142|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153476659|NCT00974142|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
153476662|NCT00974376|Sensory System Agents|sensory system agents|mesh-ancestor
153476663|NCT00974376|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153476664|NCT00974376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153476665|NCT00974376|Anticonvulsants|anticonvulsants|mesh-ancestor
153476666|NCT00974376|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153476667|NCT00974376|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153476702|NCT00986856|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
153476703|NCT00986856|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153476715|NCT00987480|Alkylating Agents|alkylating agents|mesh-ancestor
153476716|NCT00987480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153476717|NCT00987480|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153813822|NCT00335270|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153476718|NCT00987480|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153476719|NCT00987480|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153476755|NCT00990288|Hemostatics|hemostatics|mesh-list
153476756|NCT00990288|Coagulants|coagulants|mesh-ancestor
153476757|NCT00991458|Cyclosporine|cyclosporine|mesh-list
153476758|NCT00991458|Ophthalmic Solutions|ophthalmic solutions|mesh-list
153476759|NCT00991458|Cyclosporins|cyclosporins|mesh-list
153884441|NCT01609517|Bupivacaine|bupivacaine|mesh-list
153476761|NCT00991458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153476762|NCT00991458|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153476763|NCT00991458|Immunologic Factors|immunologic factors|mesh-ancestor
153476764|NCT00991458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153476765|NCT00991458|Antifungal Agents|antifungal agents|mesh-ancestor
153476766|NCT00991458|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153476767|NCT00991458|Dermatologic Agents|dermatologic agents|mesh-ancestor
153476790|NCT00997932|Levonorgestrel|levonorgestrel|mesh-list
153884450|NCT00593151|Interferon alpha-2|interferon alpha-2|mesh-list
153884451|NCT00593151|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
153884452|NCT00593151|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153884453|NCT00593151|Antiviral Agents|antiviral agents|mesh-ancestor
153884454|NCT00593151|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153884455|NCT00593151|Immunologic Factors|immunologic factors|mesh-ancestor
153884456|NCT00593151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153476856|NCT01003938|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153476857|NCT01003938|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153476858|NCT01003938|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153476859|NCT01003938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153476873|NCT01005576|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153476874|NCT01005576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153476875|NCT01005576|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153476876|NCT01005576|Immunologic Factors|immunologic factors|mesh-ancestor
153476877|NCT01005576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153476878|NCT01005576|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153425414|NCT00845702|Chelating Agents|chelating agents|mesh-ancestor
153884471|NCT01609673|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153884472|NCT01609673|Immunologic Factors|immunologic factors|mesh-ancestor
153884473|NCT01609673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153884474|NCT01609673|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153884475|NCT01173055|Milnacipran|milnacipran|mesh-list
153884476|NCT01173055|Levomilnacipran|levomilnacipran|mesh-list
153884477|NCT01173055|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
153884478|NCT01173055|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153476936|NCT01008462|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153476937|NCT01008462|Alkylating Agents|alkylating agents|mesh-ancestor
153476939|NCT01008462|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153476992|NCT01015170|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153476993|NCT01015170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153476994|NCT01015170|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
153476995|NCT01015170|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153476996|NCT01015170|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153476997|NCT01017042|Colchicine|colchicine|mesh-list
153477011|NCT01018056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153477012|NCT01018056|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
153477013|NCT01018056|Protective Agents|protective agents|mesh-ancestor
153477014|NCT01018134|Desoximetasone|desoximetasone|mesh-list
153477015|NCT01018134|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153477017|NCT01018134|Hormones|hormones|mesh-ancestor
153477018|NCT01018134|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153477019|NCT01018134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153477020|NCT01020006|Gemcitabine|gemcitabine|mesh-list
153477022|NCT01020006|Antimetabolites|antimetabolites|mesh-ancestor
153477049|NCT02406222|Immunologic Factors|immunologic factors|mesh-ancestor
153477050|NCT02406222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153477051|NCT02406222|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153477052|NCT02406222|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153477053|NCT02406222|Alkylating Agents|alkylating agents|mesh-ancestor
153477054|NCT02406222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153477055|NCT02406222|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153477056|NCT02406222|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153477057|NCT02406222|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153477058|NCT02406222|Antiemetics|antiemetics|mesh-ancestor
153477059|NCT02406222|Autonomic Agents|autonomic agents|mesh-ancestor
153477100|NCT01029054|Dexamethasone acetate|dexamethasone acetate|mesh-list
153477102|NCT01029054|BB 1101|bb 1101|mesh-list
153477103|NCT01029054|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153477104|NCT01029054|Antiemetics|antiemetics|mesh-ancestor
153477110|NCT01029054|Hormones|hormones|mesh-ancestor
153477118|NCT01029054|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153477119|NCT01029054|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153477120|NCT01029054|Growth Substances|growth substances|mesh-ancestor
153477121|NCT01029054|Growth Inhibitors|growth inhibitors|mesh-ancestor
153477123|NCT01032954|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
153477210|NCT01044966|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153477211|NCT01044966|Alkylating Agents|alkylating agents|mesh-ancestor
153477212|NCT01044966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153477213|NCT01044966|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153477214|NCT01045122|Dexmedetomidine|dexmedetomidine|mesh-list
153477215|NCT01045122|Propofol|propofol|mesh-list
153477216|NCT01045122|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153477217|NCT01045122|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153477218|NCT01045122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153477219|NCT01045122|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153477220|NCT01045122|Analgesics|analgesics|mesh-ancestor
153477221|NCT01045122|Sensory System Agents|sensory system agents|mesh-ancestor
153477241|NCT01050582|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153477242|NCT01050582|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
153477243|NCT01050582|Dopamine Agents|dopamine agents|mesh-ancestor
153884511|NCT00593580|Vitamins|vitamins|mesh-ancestor
153477269|NCT05822453|Tislelizumab|tislelizumab|mesh-list
153477270|NCT05822453|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153477271|NCT05822453|Antimetabolites|antimetabolites|mesh-ancestor
153477272|NCT05822453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153477273|NCT05822453|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153477274|NCT05822453|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153477275|NCT01028820|Aripiprazole|aripiprazole|mesh-list
153477279|NCT01028820|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153477292|NCT01028820|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
153477293|NCT05822323|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
153477294|NCT05822323|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
153477295|NCT05822323|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
153477296|NCT05822323|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153477297|NCT05822323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153477298|NCT05822323|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
153884540|NCT00593658|Antioxidants|antioxidants|mesh-ancestor
153477339|NCT05821192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153477340|NCT05821192|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153477341|NCT05821192|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153477342|NCT05821192|Antiemetics|antiemetics|mesh-ancestor
153477343|NCT05821192|Autonomic Agents|autonomic agents|mesh-ancestor
153477344|NCT05821192|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153477345|NCT05821192|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153477346|NCT05821192|Glucocorticoids|glucocorticoids|mesh-ancestor
153477347|NCT05821192|Hormones|hormones|mesh-ancestor
153477352|NCT05821192|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153477353|NCT05821192|Antimetabolites|antimetabolites|mesh-ancestor
153477355|NCT05821153|Aldesleukin|aldesleukin|mesh-list
153477377|NCT05821062|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153477378|NCT05821062|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153477379|NCT05821062|Antipyretics|antipyretics|mesh-ancestor
153477380|NCT05821062|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
153477381|NCT05821062|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
153477382|NCT05821062|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
153477383|NCT05821062|Purinergic Agents|purinergic agents|mesh-ancestor
153477384|NCT05821062|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153477385|NCT05817162|Ropivacaine|ropivacaine|mesh-list
153477387|NCT05817162|Anesthetics|anesthetics|mesh-ancestor
153425511|NCT00379262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153425512|NCT00379262|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153425513|NCT00379262|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153477413|NCT05796570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153477414|NCT05796570|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153477415|NCT05796570|Antimetabolites|antimetabolites|mesh-ancestor
153477416|NCT05796570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153477429|NCT06024031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153477673|NCT04838379|Anesthetics, Local|anesthetics, local|mesh-ancestor
153477674|NCT04838379|Anesthetics|anesthetics|mesh-ancestor
153477675|NCT04838379|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153477676|NCT04838379|Sensory System Agents|sensory system agents|mesh-ancestor
153884573|NCT01607294|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153884574|NCT01607294|Antimetabolites|antimetabolites|mesh-ancestor
153884575|NCT01607294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153884576|NCT01607294|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153884580|NCT00594087|Eszopiclone|eszopiclone|mesh-list
153477711|NCT04800107|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153477712|NCT04800107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153477713|NCT04786574|Tolvaptan|tolvaptan|mesh-list
153477714|NCT04786574|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
153477715|NCT04786574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153477716|NCT04786574|Natriuretic Agents|natriuretic agents|mesh-ancestor
153477718|NCT04761159|Ketamine|ketamine|mesh-list
153477818|NCT04432207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153477819|NCT04432207|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153477820|NCT04432207|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153477821|NCT04425447|Anesthetics|anesthetics|mesh-list
153477822|NCT04425447|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153477823|NCT04425447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153477827|NCT04148105|Cilostazol|cilostazol|mesh-list
153477876|NCT03781817|Anesthetics, General|anesthetics, general|mesh-ancestor
153477896|NCT03636451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153477897|NCT03636451|Hemostatics|hemostatics|mesh-ancestor
153477898|NCT03636451|Coagulants|coagulants|mesh-ancestor
153477899|NCT03636451|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
153477900|NCT03636451|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
153477920|NCT03278691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153477921|NCT03278691|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153477922|NCT03278691|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153477923|NCT03278691|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153477924|NCT03278691|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153477925|NCT03278691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153478013|NCT01055184|Vaccines|vaccines|mesh-list
153478014|NCT01055184|Immunologic Factors|immunologic factors|mesh-ancestor
153478015|NCT01055184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153478025|NCT01060098|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
153478026|NCT01060098|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153478027|NCT01060098|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153478028|NCT01060098|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153478029|NCT01060098|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153478030|NCT01060098|Analgesics|analgesics|mesh-ancestor
153478031|NCT01060098|Sensory System Agents|sensory system agents|mesh-ancestor
153478032|NCT01060098|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153478033|NCT01060098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153478034|NCT01060098|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153478035|NCT01060098|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153478036|NCT01060098|Immunologic Factors|immunologic factors|mesh-ancestor
153478037|NCT01061034|Aspirin|aspirin|mesh-list
153884666|NCT01605734|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153884683|NCT00594555|Imatinib Mesylate|imatinib mesylate|mesh-list
153884684|NCT00594555|Cladribine|cladribine|mesh-list
153884685|NCT00594555|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153884686|NCT00594555|Antimetabolites|antimetabolites|mesh-ancestor
153884687|NCT00594555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153884688|NCT00594555|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153478052|NCT01061034|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153478053|NCT01061034|Antipyretics|antipyretics|mesh-ancestor
153478054|NCT01061034|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
153478055|NCT01061034|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153478056|NCT01061034|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
153478057|NCT01065558|Ecopipam|ecopipam|mesh-list
153478058|NCT01065558|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153478111|NCT01093794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153478113|NCT01093794|Hormones|hormones|mesh-ancestor
153478114|NCT01093794|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153478115|NCT01093794|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
153478116|NCT01093794|Protease Inhibitors|protease inhibitors|mesh-ancestor
153478117|NCT01093794|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153478118|NCT01093794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153478119|NCT01094106|Ropivacaine|ropivacaine|mesh-list
153478148|NCT01095510|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153478149|NCT01095510|Immunologic Factors|immunologic factors|mesh-ancestor
153478150|NCT01095510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153478151|NCT01096290|Lubiprostone|lubiprostone|mesh-list
153478152|NCT01096290|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
153478153|NCT01096290|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153478161|NCT01096680|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153478168|NCT01096992|Rituximab|rituximab|mesh-list
153478244|NCT01103934|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153478245|NCT01103934|Autonomic Agents|autonomic agents|mesh-ancestor
153478246|NCT01103934|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153478247|NCT01103934|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153478248|NCT01103934|Respiratory System Agents|respiratory system agents|mesh-ancestor
153478249|NCT01103934|Dermatologic Agents|dermatologic agents|mesh-ancestor
153478252|NCT01105650|Cyclosporine|cyclosporine|mesh-list
153478348|NCT01119222|Anticonvulsants|anticonvulsants|mesh-ancestor
153478349|NCT01119222|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153478350|NCT01119222|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153478351|NCT01119222|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153478352|NCT01119222|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
153478353|NCT01119222|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
153478354|NCT01119222|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153387723|NCT00000771|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153884719|NCT02270606|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153884720|NCT02270606|Immunologic Factors|immunologic factors|mesh-ancestor
153884721|NCT02270606|Antidotes|antidotes|mesh-ancestor
153884723|NCT02270606|Vitamin B Complex|vitamin b complex|mesh-ancestor
153884724|NCT02270606|Vitamins|vitamins|mesh-ancestor
153884726|NCT00594633|Donepezil|donepezil|mesh-list
153478382|NCT01120236|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153478383|NCT01120236|Immunologic Factors|immunologic factors|mesh-ancestor
153478384|NCT01120704|Nicotine|nicotine|mesh-list
153425689|NCT01756586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153425690|NCT01756586|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153425691|NCT01756586|Glucocorticoids|glucocorticoids|mesh-ancestor
153425692|NCT01756586|Hormones|hormones|mesh-ancestor
153478385|NCT01120704|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
153478409|NCT05307042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153478410|NCT04974138|Folic Acid|folic acid|mesh-list
153478411|NCT04974138|Amlodipine|amlodipine|mesh-list
153478412|NCT04974138|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153478434|NCT04142892|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153478435|NCT04142892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153478437|NCT04142892|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153478438|NCT03697356|Dexamethasone|dexamethasone|mesh-list
153478439|NCT03697356|Rituximab|rituximab|mesh-list
153478485|NCT01128192|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153478486|NCT01128192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153478487|NCT01128270|Chloral Hydrate|chloral hydrate|mesh-list
153478488|NCT01128270|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153478489|NCT01128270|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153478491|NCT01128972|Listerine|listerine|mesh-list
153478566|NCT01139190|Sensory System Agents|sensory system agents|mesh-ancestor
153478567|NCT01139190|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153478568|NCT01139190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153478569|NCT01139190|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153478570|NCT01139190|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153478571|NCT01139190|Gout Suppressants|gout suppressants|mesh-ancestor
153478572|NCT01139190|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153478573|NCT01139190|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153478574|NCT01139190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153478575|NCT01140360|Imatinib Mesylate|imatinib mesylate|mesh-list
153478576|NCT01140360|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153478577|NCT01140360|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153478578|NCT01140360|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153478627|NCT01147302|Complement C1 Inactivator Proteins|complement c1 inactivator proteins|mesh-list
153478628|NCT01147302|Immunologic Factors|immunologic factors|mesh-ancestor
153478629|NCT01147302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153478630|NCT01147302|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
153478631|NCT01147302|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153478632|NCT01149876|Tretinoin|tretinoin|mesh-list
153478633|NCT01149876|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153478634|NCT01149876|Keratolytic Agents|keratolytic agents|mesh-ancestor
153884761|NCT00594867|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153884762|NCT00594867|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153884763|NCT00594867|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153884764|NCT00594867|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153884765|NCT00594867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153884766|NCT00594867|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153478695|NCT01168674|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153478696|NCT01168674|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
153478697|NCT01168674|Dopamine Agents|dopamine agents|mesh-ancestor
153478698|NCT01168908|Sildenafil Citrate|sildenafil citrate|mesh-list
153478699|NCT01168908|Vasodilator Agents|vasodilator agents|mesh-ancestor
153478700|NCT01168908|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
153478701|NCT01168908|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
153478702|NCT01168908|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153478724|NCT01134510|Complement C1s|complement c1s|mesh-list
153478725|NCT01134510|Complement C1 Inhibitor Protein|complement c1 inhibitor protein|mesh-list
153884782|NCT02270918|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
153884783|NCT02270918|Antithrombins|antithrombins|mesh-ancestor
153884784|NCT02270918|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
153884785|NCT02270918|Protease Inhibitors|protease inhibitors|mesh-ancestor
153884786|NCT02270918|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153884787|NCT02270918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153478753|NCT01175148|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153478754|NCT01177098|Timolol|timolol|mesh-list
153478755|NCT01177098|Bimatoprost|bimatoprost|mesh-list
153478756|NCT01177098|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
153478757|NCT01177098|Ophthalmic Solutions|ophthalmic solutions|mesh-list
153478849|NCT01198158|Endothelial Growth Factors|endothelial growth factors|mesh-list
153478850|NCT01198158|Antibodies|antibodies|mesh-list
153478851|NCT01198158|Immunoglobulins|immunoglobulins|mesh-list
153478852|NCT01198158|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
153478853|NCT01198158|Immunoglobulin G|immunoglobulin g|mesh-list
153478854|NCT01198158|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153478855|NCT01198158|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153478856|NCT01198158|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153478857|NCT01198158|Growth Substances|growth substances|mesh-ancestor
153478858|NCT01198158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153884818|NCT01606358|Carboplatin|carboplatin|mesh-list
153478862|NCT01198158|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153478923|NCT01215786|Ophthalmic Solutions|ophthalmic solutions|mesh-list
153425784|NCT01705106|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153425785|NCT01705106|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153425786|NCT01705106|Analgesics|analgesics|mesh-ancestor
153478924|NCT01215786|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
153478925|NCT01215786|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
153478926|NCT01215786|Adrenergic Agents|adrenergic agents|mesh-ancestor
153478927|NCT01215786|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153478928|NCT01215786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153478929|NCT01215786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153478930|NCT01215786|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153478931|NCT01215786|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153478932|NCT01216410|Phenylephrine|phenylephrine|mesh-list
153478933|NCT01216410|Oxymetazoline|oxymetazoline|mesh-list
153478934|NCT01216410|Ondansetron|ondansetron|mesh-list
153478935|NCT01216410|Metoclopramide|metoclopramide|mesh-list
153478936|NCT01216410|Antiemetics|antiemetics|mesh-ancestor
153478949|NCT01216410|Mydriatics|mydriatics|mesh-ancestor
153813840|NCT00335348|Dexamethasone|dexamethasone|mesh-list
153478950|NCT01216410|Sympathomimetics|sympathomimetics|mesh-ancestor
153478951|NCT01216410|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
153478952|NCT01216410|Nasal Decongestants|nasal decongestants|mesh-ancestor
153478953|NCT01216410|Respiratory System Agents|respiratory system agents|mesh-ancestor
153478954|NCT01216410|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
153478955|NCT01216410|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153478990|NCT01222260|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153478991|NCT01222260|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153479034|NCT01226706|Cholinergic Agents|cholinergic agents|mesh-ancestor
153479035|NCT01226706|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153479036|NCT01226706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153479037|NCT01226706|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
153884845|NCT00595569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153884846|NCT02271347|Brincidofovir|brincidofovir|mesh-list
153884847|NCT02271347|Antiviral Agents|antiviral agents|mesh-ancestor
153479104|NCT01238640|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
153479105|NCT01238640|Autonomic Agents|autonomic agents|mesh-ancestor
153479106|NCT01238640|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153479107|NCT01238640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153479109|NCT01238640|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
153479110|NCT01238640|Cholinergic Agents|cholinergic agents|mesh-ancestor
153479111|NCT01238640|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153479112|NCT01238640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153479113|NCT01247064|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
153479114|NCT01247220|Ranibizumab|ranibizumab|mesh-list
153479115|NCT01247220|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153479116|NCT01247220|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153479117|NCT01247220|Growth Substances|growth substances|mesh-ancestor
153479118|NCT01247220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153479165|NCT01253460|Alkylating Agents|alkylating agents|mesh-ancestor
153479166|NCT01253460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153479167|NCT01253460|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153479168|NCT01253460|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153479169|NCT01253460|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153479170|NCT01254396|Sildenafil Citrate|sildenafil citrate|mesh-list
153479171|NCT01254396|Vasodilator Agents|vasodilator agents|mesh-ancestor
153479172|NCT01254396|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
153479173|NCT01254396|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
153479174|NCT01254396|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153479175|NCT01254396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153479239|NCT01271244|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
153479240|NCT01271244|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153479241|NCT01271244|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153479242|NCT01271244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153479243|NCT01271244|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153479244|NCT01271244|Serotonin Agents|serotonin agents|mesh-ancestor
153479245|NCT01271244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153479246|NCT01272960|Levonorgestrel|levonorgestrel|mesh-list
153479247|NCT01272960|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
153479248|NCT01272960|Contraceptive Agents|contraceptive agents|mesh-ancestor
153479249|NCT01272960|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153813843|NCT00335348|Antiemetics|antiemetics|mesh-ancestor
153813844|NCT00335348|Autonomic Agents|autonomic agents|mesh-ancestor
153425845|NCT00610532|Anticonvulsants|anticonvulsants|mesh-ancestor
153425846|NCT00610532|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
153425847|NCT00610532|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153425848|NCT00610532|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153425849|NCT00610532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153425850|NCT00610532|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
153425851|NCT00610532|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
153479266|NCT01275300|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153884902|NCT04326894|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153479287|NCT01276314|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153479288|NCT01276314|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153479289|NCT01276314|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153479290|NCT01276314|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153479291|NCT01276314|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153479292|NCT01276314|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153479293|NCT01276314|Analgesics|analgesics|mesh-ancestor
153479295|NCT01276314|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153425864|NCT00379418|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153425865|NCT00379496|Antidepressive Agents|antidepressive agents|mesh-list
153425866|NCT00379496|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153425867|NCT00378716|Leucovorin|leucovorin|mesh-list
153425868|NCT00378716|Fluorouracil|fluorouracil|mesh-list
153479310|NCT01280604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153479311|NCT01280604|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153479312|NCT01282242|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
153479313|NCT01282242|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153479318|NCT01285050|Raltegravir Potassium|raltegravir potassium|mesh-list
153479319|NCT01285050|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
153479346|NCT01287078|Dermatologic Agents|dermatologic agents|mesh-ancestor
153479347|NCT01287078|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153479348|NCT01287078|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
153479350|NCT01291056|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
153479351|NCT01291056|Hormone Antagonists|hormone antagonists|mesh-ancestor
153479352|NCT01291056|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153479353|NCT01291056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153479354|NCT01291056|Fertility Agents, Female|fertility agents, female|mesh-ancestor
153479355|NCT01291056|Fertility Agents|fertility agents|mesh-ancestor
153479356|NCT01291056|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153479357|NCT01291056|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
153479358|NCT01291056|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
153479359|NCT01292304|Tolvaptan|tolvaptan|mesh-list
153479360|NCT01292304|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
153479361|NCT01292304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153884921|NCT01109992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153884922|NCT01109992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153884923|NCT02892357|Omeprazole|omeprazole|mesh-list
153884926|NCT02892357|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
153884927|NCT02892357|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153479401|NCT01295112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153479403|NCT01301742|Gemfibrozil|gemfibrozil|mesh-list
153479404|NCT01301742|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
153479405|NCT01301742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153479406|NCT01301742|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153479408|NCT01301742|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153479425|NCT01304082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153479427|NCT01304238|Lepirudin|lepirudin|mesh-list
153479428|NCT01304238|Danaparoid|danaparoid|mesh-list
153479429|NCT01304238|Fondaparinux|fondaparinux|mesh-list
153479430|NCT01304238|Argatroban|argatroban|mesh-list
153479431|NCT01304238|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
153479432|NCT01304238|Antithrombins|antithrombins|mesh-ancestor
153479433|NCT01304238|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
153479472|NCT01308840|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153479473|NCT01308840|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153479474|NCT01311102|Lidocaine|lidocaine|mesh-list
153479475|NCT01311102|Anesthetics, Local|anesthetics, local|mesh-ancestor
153479476|NCT01311102|Anesthetics|anesthetics|mesh-ancestor
153479477|NCT01311102|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153479478|NCT01311102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153479505|NCT01312818|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153479506|NCT01312818|Glucocorticoids|glucocorticoids|mesh-ancestor
153479520|NCT01312818|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153479521|NCT01312818|Immunologic Factors|immunologic factors|mesh-ancestor
153479522|NCT01312818|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153479523|NCT01312818|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153813847|NCT00335348|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153479524|NCT01312818|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153479525|NCT01312818|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153479526|NCT01312818|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
153479527|NCT01313520|Infliximab|infliximab|mesh-list
153479533|NCT01315002|Nicotine|nicotine|mesh-list
153884971|NCT01172275|Acetylcysteine|acetylcysteine|mesh-list
153479580|NCT01318278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153479581|NCT01318278|Protective Agents|protective agents|mesh-ancestor
153479582|NCT01318356|Doxycycline|doxycycline|mesh-list
153479583|NCT01318356|Tetracycline|tetracycline|mesh-list
153479584|NCT01318356|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153479585|NCT01318356|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153479586|NCT01318356|Antimalarials|antimalarials|mesh-ancestor
153479587|NCT01318356|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153479588|NCT01318356|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153479589|NCT01318356|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
153479590|NCT01318356|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153479593|NCT01324128|Sevelamer|sevelamer|mesh-list
153479601|NCT01328184|Levonorgestrel|levonorgestrel|mesh-list
153479602|NCT01328184|Ethinyl Estradiol|ethinyl estradiol|mesh-list
153479603|NCT01328184|Ethinyl estradiol, levonorgestrel drug combination|ethinyl estradiol, levonorgestrel drug combination|mesh-list
153479604|NCT01328184|Ethinyl Estradiol-Norgestrel Combination|ethinyl estradiol-norgestrel combination|mesh-list
153479605|NCT01328184|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
153479606|NCT01328184|Contraceptive Agents|contraceptive agents|mesh-ancestor
153479607|NCT01328184|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153479608|NCT01328184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153813848|NCT00335348|Glucocorticoids|glucocorticoids|mesh-ancestor
153813849|NCT00335348|Hormones|hormones|mesh-ancestor
153479609|NCT01328184|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
153479610|NCT01328184|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
153479617|NCT01328184|Hormones|hormones|mesh-ancestor
153479634|NCT01328964|Dermatologic Agents|dermatologic agents|mesh-ancestor
153479635|NCT01328964|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
153479651|NCT01330134|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153479652|NCT01330134|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
153479653|NCT01330134|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153479654|NCT01330134|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153884984|NCT05034952|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153884985|NCT05034952|Analgesics|analgesics|mesh-ancestor
153884986|NCT05034952|Sensory System Agents|sensory system agents|mesh-ancestor
153884987|NCT05034952|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153884988|NCT05034952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153884989|NCT05034952|Antipyretics|antipyretics|mesh-ancestor
153884990|NCT00596037|Hormones|hormones|mesh-list
153884991|NCT00596037|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153884992|NCT00596037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153479655|NCT01330134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153479657|NCT01330290|Dopamine Agonists|dopamine agonists|mesh-ancestor
153479665|NCT01331304|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153479666|NCT01331304|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153479667|NCT01331304|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153479668|NCT01331304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153479669|NCT01331694|Fluticasone|fluticasone|mesh-list
153479670|NCT01331694|Bromides|bromides|mesh-list
153479671|NCT01331694|Albuterol|albuterol|mesh-list
153479672|NCT01331694|Tiotropium Bromide|tiotropium bromide|mesh-list
153479673|NCT01331694|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
153479747|NCT06244706|Sensory System Agents|sensory system agents|mesh-ancestor
153479748|NCT06244706|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153479749|NCT06244667|Lidocaine|lidocaine|mesh-list
153479750|NCT06244667|Anesthetics, Local|anesthetics, local|mesh-ancestor
153479751|NCT06244667|Anesthetics|anesthetics|mesh-ancestor
153426057|NCT01550510|Antioxidants|antioxidants|mesh-ancestor
153479752|NCT06244667|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153479753|NCT06244667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153479754|NCT06244667|Sensory System Agents|sensory system agents|mesh-ancestor
153479755|NCT06244667|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153479781|NCT06244290|Cariostatic Agents|cariostatic agents|mesh-ancestor
153479782|NCT06244290|Protective Agents|protective agents|mesh-ancestor
153479783|NCT06244290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153479784|NCT06244290|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
153479835|NCT06243666|Vaccines|vaccines|mesh-list
153479836|NCT06243666|Immunologic Factors|immunologic factors|mesh-ancestor
153479837|NCT06243666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153479838|NCT06243627|Sunscreening Agents|sunscreening agents|mesh-list
153479839|NCT06243627|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
153479840|NCT06243627|Protective Agents|protective agents|mesh-ancestor
153479841|NCT06243627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153479842|NCT06243627|Dermatologic Agents|dermatologic agents|mesh-ancestor
153479843|NCT06243614|Buspirone|buspirone|mesh-list
153479844|NCT06243614|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153479845|NCT06243614|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153479884|NCT06243185|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153479885|NCT06243185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153479886|NCT06243159|Cyclophosphamide|cyclophosphamide|mesh-list
153479887|NCT06243159|Fludarabine|fludarabine|mesh-list
153479888|NCT06243159|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153479889|NCT06243159|Immunologic Factors|immunologic factors|mesh-ancestor
153479890|NCT06243159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153479891|NCT06243159|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153479892|NCT06243159|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153479893|NCT06243159|Alkylating Agents|alkylating agents|mesh-ancestor
153479894|NCT06243159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153479895|NCT06243159|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153479896|NCT06243159|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153479897|NCT06243133|Aspirin|aspirin|mesh-list
153479898|NCT06243133|Clopidogrel|clopidogrel|mesh-list
153479899|NCT06243133|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153479908|NCT06243133|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153479909|NCT06243133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153426108|NCT00521924|Sensory System Agents|sensory system agents|mesh-ancestor
153479911|NCT06243133|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153479912|NCT06243133|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153479913|NCT06243133|Antipyretics|antipyretics|mesh-ancestor
153479914|NCT06243133|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
153479915|NCT06243133|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
153479916|NCT06243133|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
153479917|NCT06243133|Purinergic Agents|purinergic agents|mesh-ancestor
153479942|NCT06235606|Anesthetics|anesthetics|mesh-ancestor
153479943|NCT06235606|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153479944|NCT06235606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153479945|NCT06235606|Sensory System Agents|sensory system agents|mesh-ancestor
153479946|NCT06235606|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153479947|NCT06235606|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153479948|NCT06235606|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153479949|NCT06235606|Analgesics|analgesics|mesh-ancestor
153479950|NCT06235606|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
153479965|NCT06203041|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153479966|NCT06202664|Analgesics, Opioid|analgesics, opioid|mesh-list
153479967|NCT06202664|Analgesics|analgesics|mesh-list
153479968|NCT06202664|Narcotics|narcotics|mesh-ancestor
153479969|NCT06202664|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153479970|NCT06202664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153479971|NCT06202664|Sensory System Agents|sensory system agents|mesh-ancestor
153479972|NCT06202664|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153480007|NCT06133075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153480008|NCT06133075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153480009|NCT06133075|Urological Agents|urological agents|mesh-ancestor
153480010|NCT06076746|Psychotropic Drugs|psychotropic drugs|mesh-list
153480011|NCT06076213|Artesunate|artesunate|mesh-list
153480012|NCT06076213|Lumefantrine|lumefantrine|mesh-list
153480013|NCT06076213|Artemether|artemether|mesh-list
153480014|NCT06076213|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
153480015|NCT06076213|Amodiaquine|amodiaquine|mesh-list
153480016|NCT06076213|Antimalarials|antimalarials|mesh-ancestor
153480017|NCT06076213|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153480018|NCT06076213|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153480019|NCT06076213|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153480020|NCT06076213|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153480021|NCT06076213|Antiviral Agents|antiviral agents|mesh-ancestor
153480065|NCT06022003|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153480067|NCT06022003|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153480068|NCT06022003|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153480069|NCT06018805|Anesthetics|anesthetics|mesh-list
153480070|NCT06018805|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153480071|NCT06018805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153480073|NCT06012331|Mitosis Modulators|mitosis modulators|mesh-ancestor
153480074|NCT06012331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153480075|NCT06010732|Listerine|listerine|mesh-list
153480076|NCT06010732|Fluorides|fluorides|mesh-list
153480077|NCT06010732|Sodium Fluoride|sodium fluoride|mesh-list
153480078|NCT06010732|Cariostatic Agents|cariostatic agents|mesh-ancestor
153480079|NCT06010732|Protective Agents|protective agents|mesh-ancestor
153480080|NCT06010732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153480081|NCT06010732|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
153480082|NCT06010732|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153480083|NCT06006546|MEDI9197|medi9197|mesh-list
153480084|NCT06006546|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153480085|NCT06006546|Immunologic Factors|immunologic factors|mesh-ancestor
153480086|NCT06006546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153480110|NCT05995249|Phenytoin|phenytoin|mesh-list
153480111|NCT05995249|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153480112|NCT05995249|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153480113|NCT05995249|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153480114|NCT05995249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153480115|NCT05995249|Antiviral Agents|antiviral agents|mesh-ancestor
153480116|NCT05995249|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153480148|NCT05988671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153480150|NCT05988671|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153426361|NCT00218036|Dexetimide|dexetimide|mesh-list
153480151|NCT05988671|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153480152|NCT05988671|Analgesics|analgesics|mesh-ancestor
153480153|NCT05988671|Sensory System Agents|sensory system agents|mesh-ancestor
153480154|NCT05988671|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
153480155|NCT05988671|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153480156|NCT05988671|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153480157|NCT05988671|Adrenergic Agents|adrenergic agents|mesh-ancestor
153480187|NCT05949125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153480188|NCT05949125|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153480189|NCT05949125|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153480190|NCT05932472|Aspirin|aspirin|mesh-list
153480191|NCT05932472|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153480192|NCT05932472|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153480193|NCT05932472|Analgesics|analgesics|mesh-ancestor
153480194|NCT05932472|Sensory System Agents|sensory system agents|mesh-ancestor
153480195|NCT05932472|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153480196|NCT05932472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153480197|NCT05932472|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153480198|NCT05932472|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153480199|NCT05932472|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153480200|NCT05932472|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153480201|NCT05932472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153480202|NCT05932472|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153480219|NCT05925140|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153480220|NCT05925140|Antimetabolites|antimetabolites|mesh-ancestor
153480221|NCT05923086|Lidocaine|lidocaine|mesh-list
153480222|NCT05923086|Anesthetics, Local|anesthetics, local|mesh-ancestor
153480223|NCT05923086|Anesthetics|anesthetics|mesh-ancestor
153480224|NCT05923086|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153480225|NCT05923086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153480226|NCT05923086|Sensory System Agents|sensory system agents|mesh-ancestor
153480250|NCT05832255|Psilocybin|psilocybin|mesh-list
153480268|NCT05800275|Tucatinib|tucatinib|mesh-list
153480300|NCT05766124|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153480301|NCT05766124|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153480302|NCT05766124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153480303|NCT05760378|Carboplatin|carboplatin|mesh-list
153480304|NCT05760378|Capecitabine|capecitabine|mesh-list
153480305|NCT05760378|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153480306|NCT05760378|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153480307|NCT05760378|Antimetabolites|antimetabolites|mesh-ancestor
153480308|NCT05760378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153480309|NCT05759572|Apatinib|apatinib|mesh-list
153480310|NCT05759572|Fulvestrant|fulvestrant|mesh-list
153480311|NCT05759572|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153480312|NCT05759572|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153480313|NCT05759572|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153480315|NCT05759572|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153480331|NCT05759546|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153480332|NCT05759546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153480333|NCT05750992|Fentanyl|fentanyl|mesh-list
153480334|NCT05750992|Meperidine|meperidine|mesh-list
153480477|NCT05602636|GABA Modulators|gaba modulators|mesh-ancestor
153480478|NCT05602636|GABA Agents|gaba agents|mesh-ancestor
153480479|NCT05602636|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153480480|NCT05602636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153480481|NCT05594095|Everolimus|everolimus|mesh-list
153426582|NCT00000878|Zidovudine|zidovudine|mesh-list
153480483|NCT05594095|Goserelin|goserelin|mesh-list
153480484|NCT05594095|Fluzoparib|fluzoparib|mesh-list
153480485|NCT05594095|Aromatase Inhibitors|aromatase inhibitors|mesh-list
153480486|NCT05594095|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
153480487|NCT05594095|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153480547|NCT05512754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153480548|NCT05512754|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153480549|NCT05512754|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153480550|NCT05512754|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153480551|NCT05512754|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153480552|NCT05512754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153480553|NCT05501600|Lidocaine|lidocaine|mesh-list
153480554|NCT05501600|Anesthetics, Local|anesthetics, local|mesh-ancestor
153480555|NCT05501600|Anesthetics|anesthetics|mesh-ancestor
153480556|NCT05501600|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153480557|NCT05501600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153480558|NCT05501600|Sensory System Agents|sensory system agents|mesh-ancestor
153480559|NCT05501600|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153480603|NCT05451771|Dexamethasone|dexamethasone|mesh-list
153480604|NCT05451771|Dexamethasone acetate|dexamethasone acetate|mesh-list
153480605|NCT05451771|Venetoclax|venetoclax|mesh-list
153480606|NCT05451771|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
153480607|NCT05451771|Daratumumab|daratumumab|mesh-list
153480608|NCT05451771|Pomalidomide|pomalidomide|mesh-list
153480609|NCT05451771|Ixazomib|ixazomib|mesh-list
153480610|NCT05451771|BB 1101|bb 1101|mesh-list
153480611|NCT05451771|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153480612|NCT05451771|Antiemetics|antiemetics|mesh-ancestor
153480613|NCT05451771|Autonomic Agents|autonomic agents|mesh-ancestor
153480614|NCT05451771|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153480615|NCT05451771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153480616|NCT05451771|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153480617|NCT05451771|Glucocorticoids|glucocorticoids|mesh-ancestor
153480618|NCT05451771|Hormones|hormones|mesh-ancestor
153480619|NCT05451771|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153480620|NCT05451771|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153480672|NCT05382442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153480673|NCT05382442|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153480674|NCT05382442|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153480675|NCT05382442|Immunologic Factors|immunologic factors|mesh-ancestor
153480676|NCT05382442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153480677|NCT05382442|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
153480678|NCT05382442|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153480679|NCT05382442|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153480680|NCT05382442|Antidotes|antidotes|mesh-ancestor
153480681|NCT05382442|Protective Agents|protective agents|mesh-ancestor
153480682|NCT05382442|Vitamin B Complex|vitamin b complex|mesh-ancestor
153480683|NCT05382442|Vitamins|vitamins|mesh-ancestor
153480684|NCT05382442|Micronutrients|micronutrients|mesh-ancestor
153480685|NCT05347212|Nivolumab|nivolumab|mesh-list
153480686|NCT05347212|Relatlimab|relatlimab|mesh-list
153480687|NCT05347212|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153480688|NCT05347212|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153480689|NCT05347212|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153480691|NCT05327530|Avelumab|avelumab|mesh-list
153480730|NCT05289063|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153480732|NCT05226663|Cariostatic Agents|cariostatic agents|mesh-ancestor
153480733|NCT05226663|Protective Agents|protective agents|mesh-ancestor
153480734|NCT05226663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153426686|NCT00000188|Selegiline|selegiline|mesh-list
153480742|NCT05195918|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153480743|NCT05195918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153480744|NCT05195918|Analgesics|analgesics|mesh-ancestor
153480745|NCT05195918|Sensory System Agents|sensory system agents|mesh-ancestor
153480805|NCT04995497|Sensory System Agents|sensory system agents|mesh-ancestor
153480806|NCT04995497|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153480807|NCT04995497|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153480808|NCT04995497|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
153480809|NCT04995497|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153480810|NCT04995497|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153480811|NCT04995497|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153480812|NCT04973605|Dexamethasone|dexamethasone|mesh-list
153480813|NCT04973605|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153480814|NCT04973605|Antiemetics|antiemetics|mesh-ancestor
153480815|NCT04973605|Autonomic Agents|autonomic agents|mesh-ancestor
153480816|NCT04973605|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153480949|NCT04712539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153480950|NCT04706507|Ganciclovir|ganciclovir|mesh-list
153480951|NCT04706507|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
153480952|NCT04706507|Antiviral Agents|antiviral agents|mesh-ancestor
153480953|NCT04706507|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153480984|NCT04625283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153480985|NCT04625283|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
153480986|NCT04625283|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153480987|NCT04625283|Anesthetics, General|anesthetics, general|mesh-ancestor
153480988|NCT04625283|Anesthetics|anesthetics|mesh-ancestor
153480994|NCT04606316|Nivolumab|nivolumab|mesh-list
153481051|NCT04357795|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153481052|NCT04357795|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
153885736|NCT00601302|Amlodipine|amlodipine|mesh-list
153481053|NCT04357795|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
153481055|NCT04344262|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
153481056|NCT04344262|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
153481057|NCT04344262|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
153481058|NCT04344262|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153481059|NCT04344262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153481061|NCT04344262|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
153481062|NCT04344262|Cholinergic Agents|cholinergic agents|mesh-ancestor
153481063|NCT04344262|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153481064|NCT04344262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153481065|NCT04323436|Spartalizumab|spartalizumab|mesh-list
153481144|NCT04084314|Calcitonin Gene-Related Peptide Receptor Antagonists|calcitonin gene-related peptide receptor antagonists|mesh-ancestor
153481145|NCT04084314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153481146|NCT04084314|Analgesics|analgesics|mesh-ancestor
153481147|NCT04084314|Sensory System Agents|sensory system agents|mesh-ancestor
153481148|NCT04084314|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153481149|NCT04084314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153481150|NCT04059484|Tamoxifen|tamoxifen|mesh-list
153481151|NCT04059484|Letrozole|letrozole|mesh-list
153481212|NCT04040452|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153481213|NCT04040452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153360204|NCT00802100|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153481214|NCT04040452|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153481215|NCT04040452|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153481247|NCT03913845|Racepinephrine|racepinephrine|mesh-list
153481248|NCT03913845|Epinephryl borate|epinephryl borate|mesh-list
153481249|NCT03913845|Anesthetics, Local|anesthetics, local|mesh-ancestor
153481250|NCT03913845|Anesthetics|anesthetics|mesh-ancestor
153481251|NCT03913845|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153481256|NCT03913845|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
153481290|NCT03900793|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
153481291|NCT03898180|Pembrolizumab|pembrolizumab|mesh-list
153481292|NCT03898180|Lenvatinib|lenvatinib|mesh-list
153481293|NCT03898180|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153481294|NCT03898180|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153481295|NCT03898180|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153481296|NCT03898180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153481297|NCT03898180|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153481298|NCT03898180|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153481299|NCT03878459|Pioglitazone|pioglitazone|mesh-list
153481300|NCT03878459|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153481301|NCT03878459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153481302|NCT03875638|Levetiracetam|levetiracetam|mesh-list
153481305|NCT03866837|Micronutrients|micronutrients|mesh-list
153481355|NCT03752307|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153481356|NCT03752307|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
153481357|NCT03752307|Protective Agents|protective agents|mesh-ancestor
153481358|NCT03752307|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
153481359|NCT03752307|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153481360|NCT03752307|Adrenergic Agents|adrenergic agents|mesh-ancestor
153481361|NCT03752307|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153481368|NCT03714828|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153481369|NCT03714828|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153481370|NCT03684694|Loncastuximab tesirine|loncastuximab tesirine|mesh-list
153481371|NCT03684694|Ibrutinib|ibrutinib|mesh-list
153481372|NCT03684694|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153481373|NCT03684694|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153481374|NCT03684694|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153481375|NCT03684694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153481376|NCT03684694|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153481377|NCT03684694|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153481378|NCT03628209|Nivolumab|nivolumab|mesh-list
153481379|NCT03628209|Azacitidine|azacitidine|mesh-list
153481380|NCT03628209|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153481381|NCT03628209|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153481382|NCT03628209|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153426869|NCT00000230|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
153481404|NCT03484507|Prednisolone|prednisolone|mesh-list
153481405|NCT03484507|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
153481406|NCT03484507|Methylprednisolone|methylprednisolone|mesh-list
153481407|NCT03484507|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
153481408|NCT03484507|Prednisolone acetate|prednisolone acetate|mesh-list
153481409|NCT03484507|Povidone|povidone|mesh-list
153481410|NCT03484507|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
153481411|NCT03484507|Prednisolone phosphate|prednisolone phosphate|mesh-list
153481419|NCT03484507|Antiemetics|antiemetics|mesh-ancestor
153481420|NCT03484507|Autonomic Agents|autonomic agents|mesh-ancestor
153481421|NCT03484507|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153481422|NCT03484507|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153481423|NCT03484507|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
153481424|NCT03484507|Protective Agents|protective agents|mesh-ancestor
153481425|NCT03484507|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
153481426|NCT03484507|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153481427|NCT03484507|Disinfectants|disinfectants|mesh-ancestor
153481428|NCT03484507|Plasma Substitutes|plasma substitutes|mesh-ancestor
153481429|NCT03484507|Blood Substitutes|blood substitutes|mesh-ancestor
153481430|NCT03457142|Dexamethasone|dexamethasone|mesh-list
153481431|NCT03457142|Dexamethasone acetate|dexamethasone acetate|mesh-list
153481433|NCT03457142|Ixazomib|ixazomib|mesh-list
153481434|NCT03457142|Ichthammol|ichthammol|mesh-list
153481435|NCT03457142|BB 1101|bb 1101|mesh-list
153481440|NCT03457142|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153481441|NCT03457142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153481467|NCT03448393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153481469|NCT03448393|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153481470|NCT03436368|Anesthetics|anesthetics|mesh-list
153481471|NCT03436368|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153481472|NCT03436368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153481473|NCT03396315|Zoledronic Acid|zoledronic acid|mesh-list
153481474|NCT03396315|Alendronate|alendronate|mesh-list
153813852|NCT00335348|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153360205|NCT00802100|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153481475|NCT03396315|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153481476|NCT03396315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153481478|NCT03338205|Analgesics|analgesics|mesh-ancestor
153481479|NCT03338205|Sensory System Agents|sensory system agents|mesh-ancestor
153481487|NCT03338205|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
153481543|NCT03065062|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153481544|NCT03065062|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153481545|NCT03065062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153481547|NCT03036098|Gemcitabine|gemcitabine|mesh-list
153481555|NCT03036098|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153481557|NCT03015129|Tremelimumab|tremelimumab|mesh-list
153481558|NCT03015129|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153481559|NCT03015129|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153481560|NCT02965690|Cimetidine|cimetidine|mesh-list
153481561|NCT02965690|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
153481562|NCT02965690|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153481563|NCT02965690|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
153813853|NCT00334919|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
153813854|NCT00437463|Ramipril|ramipril|mesh-list
153481564|NCT02965690|Histamine Antagonists|histamine antagonists|mesh-ancestor
153481626|NCT02765256|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153481628|NCT02765256|Autonomic Agents|autonomic agents|mesh-ancestor
153481629|NCT02765256|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153481630|NCT02765256|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
153481631|NCT02765256|Laxatives|laxatives|mesh-ancestor
153481633|NCT02500407|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153481634|NCT02500407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153481635|NCT02500407|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153481636|NCT02500407|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153481637|NCT02467270|Ponatinib|ponatinib|mesh-list
153481706|NCT01659606|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153481707|NCT01659606|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153481708|NCT01659606|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
153481709|NCT01659606|Antitubercular Agents|antitubercular agents|mesh-ancestor
153481710|NCT01659606|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153481711|NCT01659606|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153481712|NCT01542437|Afatinib|afatinib|mesh-list
153481713|NCT01542437|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153481714|NCT01542437|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153481715|NCT01542437|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153481716|NCT01542437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153481717|NCT01542437|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153481732|NCT01525082|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153481734|NCT01525082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153481735|NCT01525082|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153481736|NCT01525082|Alkylating Agents|alkylating agents|mesh-ancestor
153481737|NCT00936936|Carboplatin|carboplatin|mesh-list
153481738|NCT00936936|Gemcitabine|gemcitabine|mesh-list
153481739|NCT00936936|Docetaxel|docetaxel|mesh-list
153481740|NCT00936936|Etoposide|etoposide|mesh-list
153481741|NCT00936936|Melphalan|melphalan|mesh-list
153481742|NCT00936936|Ifosfamide|ifosfamide|mesh-list
153481743|NCT00936936|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153481787|NCT00390325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153481788|NCT00104676|Paclitaxel|paclitaxel|mesh-list
153481789|NCT00104676|Etoposide|etoposide|mesh-list
153481790|NCT00104676|Oxaliplatin|oxaliplatin|mesh-list
153481791|NCT00104676|Ifosfamide|ifosfamide|mesh-list
153481792|NCT00104676|Bleomycin|bleomycin|mesh-list
153481793|NCT00104676|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153481794|NCT00104676|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153481795|NCT00104676|Tubulin Modulators|tubulin modulators|mesh-ancestor
153481796|NCT00104676|Antimitotic Agents|antimitotic agents|mesh-ancestor
153481797|NCT00104676|Mitosis Modulators|mitosis modulators|mesh-ancestor
153481847|NCT01340586|Apixaban|apixaban|mesh-list
153481869|NCT01347060|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153481870|NCT01347060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153481871|NCT01347060|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153481872|NCT01347060|Respiratory System Agents|respiratory system agents|mesh-ancestor
153481873|NCT01347060|Dermatologic Agents|dermatologic agents|mesh-ancestor
153481874|NCT01347060|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
153481875|NCT01347060|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
153481876|NCT01347060|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
153481877|NCT01347060|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153481878|NCT01347060|Adrenergic Agents|adrenergic agents|mesh-ancestor
153481879|NCT01347060|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153481880|NCT01347060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153481881|NCT01351740|Ritonavir|ritonavir|mesh-list
153481882|NCT01351740|Atazanavir Sulfate|atazanavir sulfate|mesh-list
153481883|NCT01351740|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
153481884|NCT01351740|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
153481885|NCT01351740|Protease Inhibitors|protease inhibitors|mesh-ancestor
153481932|NCT01363128|Cyclophosphamide|cyclophosphamide|mesh-list
153481933|NCT01363128|Doxorubicin|doxorubicin|mesh-list
153481934|NCT01363128|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
153481935|NCT01363128|Methotrexate|methotrexate|mesh-list
153481936|NCT01363128|Vincristine|vincristine|mesh-list
153481937|NCT01363128|Ofatumumab|ofatumumab|mesh-list
153481950|NCT01363128|Antiemetics|antiemetics|mesh-ancestor
153481951|NCT01363128|Autonomic Agents|autonomic agents|mesh-ancestor
153481952|NCT01363128|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153481953|NCT01363128|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153481954|NCT01363128|Glucocorticoids|glucocorticoids|mesh-ancestor
153481955|NCT01363128|Hormones|hormones|mesh-ancestor
153481956|NCT01363128|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153481957|NCT01363128|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153481969|NCT01363128|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153481970|NCT01363128|Antiviral Agents|antiviral agents|mesh-ancestor
153481971|NCT01363128|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153481972|NCT01363128|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153481973|NCT01363128|Tubulin Modulators|tubulin modulators|mesh-ancestor
153481974|NCT01363128|Antimitotic Agents|antimitotic agents|mesh-ancestor
153481975|NCT01363128|Mitosis Modulators|mitosis modulators|mesh-ancestor
153481976|NCT01363128|Protease Inhibitors|protease inhibitors|mesh-ancestor
153481977|NCT01365624|Ketorolac|ketorolac|mesh-list
153481978|NCT01365624|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
153481979|NCT01365624|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153427171|NCT00000326|Heroin|heroin|mesh-list
153482007|NCT01377636|Autonomic Agents|autonomic agents|mesh-ancestor
153482012|NCT01377636|Sympathomimetics|sympathomimetics|mesh-ancestor
153482019|NCT01378416|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153482020|NCT01379664|Sevoflurane|sevoflurane|mesh-list
153482021|NCT01379664|Isoflurane|isoflurane|mesh-list
153482022|NCT01379664|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153482023|NCT01379664|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
153482024|NCT01379664|Anesthetics, General|anesthetics, general|mesh-ancestor
153482025|NCT01379664|Anesthetics|anesthetics|mesh-ancestor
153482026|NCT01379664|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153482027|NCT01379664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153482028|NCT01380366|Hormones|hormones|mesh-list
153482029|NCT01380366|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153482030|NCT01380366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153482031|NCT01387464|Bromfenac|bromfenac|mesh-list
153482214|NCT01429272|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153482215|NCT01429272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153482216|NCT01429272|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153482217|NCT01429272|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153482218|NCT01429272|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153482219|NCT01429272|Antipyretics|antipyretics|mesh-ancestor
153482220|NCT01429272|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153482221|NCT01429272|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153482222|NCT01429350|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
153482223|NCT01429350|Plasminogen|plasminogen|mesh-list
153482224|NCT01429350|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153482225|NCT01429350|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153482328|NCT01460940|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153482329|NCT01460940|Growth Substances|growth substances|mesh-ancestor
153482330|NCT01460940|Growth Inhibitors|growth inhibitors|mesh-ancestor
153482331|NCT01460940|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153482332|NCT01460940|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153482333|NCT01460940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153482334|NCT01462812|Sumatriptan|sumatriptan|mesh-list
153482335|NCT01462812|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
153482336|NCT01462812|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
153482337|NCT01462812|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
153482475|NCT01495572|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153482477|NCT01504854|Antioxidants|antioxidants|mesh-ancestor
153482478|NCT01504854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153482512|NCT01513122|Raltegravir Potassium|raltegravir potassium|mesh-list
153482513|NCT01513122|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
153482514|NCT01513122|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
153482515|NCT01513122|Protease Inhibitors|protease inhibitors|mesh-ancestor
153482516|NCT01513122|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153482518|NCT01513122|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153482606|NCT01526538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153482607|NCT01529502|Nitric Oxide|nitric oxide|mesh-list
153482608|NCT01529502|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153482609|NCT01529502|Autonomic Agents|autonomic agents|mesh-ancestor
153482610|NCT01529502|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153482611|NCT01529502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153482723|NCT06114940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153482724|NCT06114758|Tranylcypromine|tranylcypromine|mesh-list
153482725|NCT06114758|Misoprostol|misoprostol|mesh-list
153813859|NCT00437463|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153813860|NCT00437502|Vaccines|vaccines|mesh-list
153482726|NCT06114758|Tranexamic Acid|tranexamic acid|mesh-list
153482727|NCT06114758|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
153482728|NCT06114758|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153482856|NCT06087419|Inotuzumab Ozogamicin|inotuzumab ozogamicin|mesh-list
153482857|NCT06087419|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153483039|NCT05475873|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153483046|NCT05475873|Serotonin Agents|serotonin agents|mesh-ancestor
153483047|NCT05475873|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153483048|NCT05475873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153483049|NCT05470595|Atezolizumab|atezolizumab|mesh-list
153483050|NCT05470595|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153483051|NCT05470595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153483052|NCT05470595|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153483054|NCT05412875|Nicotine|nicotine|mesh-list
153483128|NCT04919369|Retinol palmitate|retinol palmitate|mesh-list
153483129|NCT04919369|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
153483130|NCT04919369|Micronutrients|micronutrients|mesh-ancestor
153483131|NCT04919369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153483132|NCT04919369|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153483133|NCT04919369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153483134|NCT04919369|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153483135|NCT04919369|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153483136|NCT04919369|Immunologic Factors|immunologic factors|mesh-ancestor
153483137|NCT04919369|Keratolytic Agents|keratolytic agents|mesh-ancestor
153483138|NCT04919369|Dermatologic Agents|dermatologic agents|mesh-ancestor
153483139|NCT04919369|Antioxidants|antioxidants|mesh-ancestor
153483259|NCT04484623|Growth Inhibitors|growth inhibitors|mesh-ancestor
153483288|NCT04338399|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153483289|NCT04338399|Tubulin Modulators|tubulin modulators|mesh-ancestor
153483290|NCT04338399|Antimitotic Agents|antimitotic agents|mesh-ancestor
153483291|NCT04338399|Mitosis Modulators|mitosis modulators|mesh-ancestor
153483292|NCT04338399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153483294|NCT04306510|Immunoglobulins|immunoglobulins|mesh-list
153483296|NCT04306510|Immunologic Factors|immunologic factors|mesh-ancestor
153483418|NCT03508921|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153483428|NCT03508921|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
153483429|NCT03508921|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
153483430|NCT03508921|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153483431|NCT03401047|Estradiol|estradiol|mesh-list
153483432|NCT03401047|Estrogens|estrogens|mesh-ancestor
153483433|NCT03401047|Hormones|hormones|mesh-ancestor
153483434|NCT03401047|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153483435|NCT03401047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153483437|NCT03349450|Pembrolizumab|pembrolizumab|mesh-list
153483438|NCT03349450|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153483439|NCT03349450|Immunologic Factors|immunologic factors|mesh-ancestor
153483440|NCT03349450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153483441|NCT03349450|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153483442|NCT03349450|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153483464|NCT03220893|Technetium Tc 99m Sestamibi|technetium tc 99m sestamibi|mesh-list
153483466|NCT03220893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153483467|NCT03200236|Nicotine|nicotine|mesh-list
153483468|NCT03200236|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
153483469|NCT03200236|Autonomic Agents|autonomic agents|mesh-ancestor
153483470|NCT03200236|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153483471|NCT03200236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153483472|NCT03200236|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
153483528|NCT02925195|Cholecalciferol|cholecalciferol|mesh-list
153483529|NCT02925195|Vitamins|vitamins|mesh-ancestor
153483530|NCT02925195|Micronutrients|micronutrients|mesh-ancestor
153483531|NCT02925195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153483532|NCT02925195|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153483533|NCT02925195|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153483534|NCT02616185|Tremelimumab|tremelimumab|mesh-list
153483535|NCT02616185|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153483536|NCT02520362|Denosumab|denosumab|mesh-list
153483603|NCT00930228|Hormone Antagonists|hormone antagonists|mesh-ancestor
153483604|NCT00930228|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153813882|NCT00437619|Dermatologic Agents|dermatologic agents|mesh-ancestor
153483605|NCT00930228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153483606|NCT00930228|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153483607|NCT00930228|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153483608|NCT00849316|Insulin Aspart|insulin aspart|mesh-list
153483609|NCT00849316|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153483610|NCT00849316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153483611|NCT00745433|Metformin|metformin|mesh-list
153483612|NCT00745433|Repaglinide|repaglinide|mesh-list
153483714|NCT00267683|Insulin Aspart|insulin aspart|mesh-list
153483715|NCT00267683|Glyburide|glyburide|mesh-list
153483716|NCT00267683|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153483717|NCT00267683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153483718|NCT00101751|Insulin Aspart|insulin aspart|mesh-list
153483719|NCT00101751|Biphasic Insulins|biphasic insulins|mesh-list
153483720|NCT00101751|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153483721|NCT00101751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153886685|NCT01324323|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
153427720|NCT00002120|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
153483749|NCT00077285|Mitosis Modulators|mitosis modulators|mesh-ancestor
153483750|NCT00077285|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
153483751|NCT00077285|Protective Agents|protective agents|mesh-ancestor
153483761|NCT01537926|Protective Agents|protective agents|mesh-ancestor
153483762|NCT01537926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153483763|NCT01537926|Antidotes|antidotes|mesh-ancestor
153483764|NCT01538862|Lenograstim|lenograstim|mesh-list
153483765|NCT01538862|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153483766|NCT01538862|Immunologic Factors|immunologic factors|mesh-ancestor
153483767|NCT01538862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153483769|NCT01541358|Fluorides|fluorides|mesh-list
153483770|NCT01541358|Sodium Fluoride|sodium fluoride|mesh-list
153483771|NCT01541358|Cariostatic Agents|cariostatic agents|mesh-ancestor
153483772|NCT01541358|Protective Agents|protective agents|mesh-ancestor
153483773|NCT01541358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153483774|NCT01541358|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
153483775|NCT01541358|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153483776|NCT01542372|Prazosin|prazosin|mesh-list
153483800|NCT01545336|Anastrozole|anastrozole|mesh-list
153483845|NCT01558128|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
153427776|NCT00000578|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
153427777|NCT00000578|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153427778|NCT00000578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153427779|NCT00000578|Vasodilator Agents|vasodilator agents|mesh-ancestor
153427780|NCT00000578|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
153427781|NCT00000578|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
153427782|NCT00000578|Purinergic Agents|purinergic agents|mesh-ancestor
153427784|NCT03774745|Mifepristone|mifepristone|mesh-list
153886776|NCT01078675|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
153886777|NCT01078675|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153886778|NCT01100437|Naltrexone|naltrexone|mesh-list
153886779|NCT01100437|Morphine|morphine|mesh-list
153886780|NCT01100437|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153886781|NCT01100437|Narcotics|narcotics|mesh-ancestor
153886782|NCT01100437|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153483917|NCT01565616|Alkylating Agents|alkylating agents|mesh-ancestor
153483918|NCT01565616|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153483919|NCT01565616|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153483920|NCT01566162|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
153483921|NCT01566162|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153483922|NCT01566162|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153483923|NCT01566162|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153483924|NCT01566162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153427810|NCT00000590|Antibodies|antibodies|mesh-list
153483976|NCT01580592|Respiratory System Agents|respiratory system agents|mesh-ancestor
153483977|NCT01580592|Immunologic Factors|immunologic factors|mesh-ancestor
153483978|NCT01580592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153483993|NCT01588158|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153484098|NCT03355170|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153484099|NCT03355170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153484100|NCT03355170|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
153484101|NCT03355170|Dopamine Agents|dopamine agents|mesh-ancestor
153484102|NCT03355170|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153484103|NCT02538666|Nivolumab|nivolumab|mesh-list
153484104|NCT02538666|Ipilimumab|ipilimumab|mesh-list
153484105|NCT02538666|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153484106|NCT02538666|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153484151|NCT04175964|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153484152|NCT04175964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153484153|NCT03624270|Ascorbic Acid|ascorbic acid|mesh-list
153484230|NCT01612884|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
153886847|NCT01313637|Anticonvulsants|anticonvulsants|mesh-ancestor
153886848|NCT01320722|Vitamin D|vitamin d|mesh-list
153886849|NCT01320722|Ergocalciferols|ergocalciferols|mesh-list
153886850|NCT01320722|Cholecalciferol|cholecalciferol|mesh-list
153427870|NCT04713254|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153427871|NCT04713254|Sympatholytics|sympatholytics|mesh-ancestor
153427872|NCT04713254|Autonomic Agents|autonomic agents|mesh-ancestor
153427873|NCT04713254|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153427874|NCT04713254|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
153427875|NCT04713254|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
153427876|NCT04713254|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
153427877|NCT04713254|Adrenergic Agents|adrenergic agents|mesh-ancestor
153427878|NCT00002156|Ganciclovir|ganciclovir|mesh-list
153427879|NCT00002156|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
153427881|NCT00002156|Antiviral Agents|antiviral agents|mesh-ancestor
153484231|NCT01612884|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153886860|NCT01320722|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153886861|NCT01320722|Gout Suppressants|gout suppressants|mesh-ancestor
153484267|NCT01619982|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153484269|NCT01620216|Sunitinib|sunitinib|mesh-list
153484270|NCT01620216|Dasatinib|dasatinib|mesh-list
153484271|NCT01620216|Ponatinib|ponatinib|mesh-list
153484272|NCT01620216|Idelalisib|idelalisib|mesh-list
153484273|NCT01620216|Antineoplastic Agents|antineoplastic agents|mesh-list
153484274|NCT01620216|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-list
153484275|NCT01620216|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153484276|NCT01620216|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153484277|NCT01620216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153484278|NCT01620216|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153484279|NCT01620216|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153484412|NCT01643616|Anesthetics, General|anesthetics, general|mesh-ancestor
153484413|NCT01643616|GABA Modulators|gaba modulators|mesh-ancestor
153484414|NCT01643616|GABA Agents|gaba agents|mesh-ancestor
153484415|NCT01643616|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153484417|NCT01644396|Adalimumab|adalimumab|mesh-list
153484552|NCT01680900|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
153484553|NCT01680900|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
153484555|NCT01682538|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153484556|NCT01682538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153484557|NCT01684020|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
153484558|NCT01684020|Hemostatics|hemostatics|mesh-ancestor
153484559|NCT01684020|Coagulants|coagulants|mesh-ancestor
153484655|NCT01708122|Analgesics|analgesics|mesh-ancestor
153484656|NCT01708122|Sensory System Agents|sensory system agents|mesh-ancestor
153484657|NCT01708122|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153484658|NCT01708122|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153484659|NCT01708122|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153484660|NCT01708122|Anesthetics, General|anesthetics, general|mesh-ancestor
153484661|NCT01708122|Anesthetics|anesthetics|mesh-ancestor
153484662|NCT01708278|Folic Acid|folic acid|mesh-list
153484663|NCT01708278|Quercetin|quercetin|mesh-list
153484664|NCT01708278|Hematinics|hematinics|mesh-ancestor
153484665|NCT01708278|Vitamin B Complex|vitamin b complex|mesh-ancestor
153484666|NCT01708278|Vitamins|vitamins|mesh-ancestor
153484667|NCT01708278|Micronutrients|micronutrients|mesh-ancestor
153484668|NCT01708278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153484669|NCT01708278|Antioxidants|antioxidants|mesh-ancestor
153484670|NCT01708278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153484671|NCT01708278|Protective Agents|protective agents|mesh-ancestor
153484749|NCT01309074|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153484750|NCT01309074|Serotonin Agents|serotonin agents|mesh-ancestor
153484751|NCT01074294|Brexpiprazole|brexpiprazole|mesh-list
153484752|NCT01074294|Serotonin Agents|serotonin agents|mesh-ancestor
153484753|NCT01074294|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153484754|NCT01074294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153484755|NCT01074294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153484762|NCT00951132|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153484763|NCT00951132|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153484764|NCT00951132|Antimetabolites|antimetabolites|mesh-ancestor
153484815|NCT01729338|Cyclophosphamide|cyclophosphamide|mesh-list
153484816|NCT01729338|Lenalidomide|lenalidomide|mesh-list
153484817|NCT01729338|Bortezomib|bortezomib|mesh-list
153484818|NCT01729338|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153484819|NCT01729338|Immunologic Factors|immunologic factors|mesh-ancestor
153484820|NCT01729338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153484821|NCT01729338|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153484822|NCT01729338|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153484823|NCT01729338|Alkylating Agents|alkylating agents|mesh-ancestor
153484830|NCT01729338|Growth Inhibitors|growth inhibitors|mesh-ancestor
153484831|NCT01729494|Mycophenolic Acid|mycophenolic acid|mesh-list
153484832|NCT01729494|Prednisone|prednisone|mesh-list
153484833|NCT01729494|Alemtuzumab|alemtuzumab|mesh-list
153484834|NCT01729494|Abatacept|abatacept|mesh-list
153484835|NCT01729494|Tacrolimus|tacrolimus|mesh-list
153484836|NCT01729494|Thymoglobulin|thymoglobulin|mesh-list
153484837|NCT01729494|Antilymphocyte Serum|antilymphocyte serum|mesh-list
153484838|NCT01729494|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153484839|NCT01729494|Glucocorticoids|glucocorticoids|mesh-ancestor
153484840|NCT01729494|Hormones|hormones|mesh-ancestor
153484902|NCT02996760|Mitosis Modulators|mitosis modulators|mesh-ancestor
153484903|NCT02996760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153484904|NCT02987946|Nadroparin|nadroparin|mesh-list
153484905|NCT02987946|Anticoagulants|anticoagulants|mesh-ancestor
153484906|NCT02987946|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153484907|NCT02987946|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153484908|NCT02987946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153484909|NCT02394132|Imiquimod|imiquimod|mesh-list
153484910|NCT02394132|Toll-Like Receptor Agonists|toll-like receptor agonists|mesh-ancestor
153484918|NCT00700596|Salvinorin A|salvinorin a|mesh-list
153484956|NCT01740258|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153484961|NCT01740414|Autonomic Agents|autonomic agents|mesh-ancestor
153485102|NCT01769586|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153485103|NCT01769586|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153485104|NCT01769586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153485105|NCT01769586|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153485106|NCT01769586|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153485107|NCT01769586|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153485110|NCT01769586|Anesthetics|anesthetics|mesh-ancestor
153485111|NCT01769586|GABA Modulators|gaba modulators|mesh-ancestor
153485112|NCT01769586|GABA Agents|gaba agents|mesh-ancestor
153485201|NCT01786902|Hormones|hormones|mesh-list
153485202|NCT01786902|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153485203|NCT01786902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153485204|NCT01787916|Liraglutide|liraglutide|mesh-list
153485205|NCT01787916|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
153485206|NCT01787916|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153485207|NCT01787916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153485208|NCT01787916|Incretins|incretins|mesh-ancestor
153485209|NCT01787916|Hormones|hormones|mesh-ancestor
153485210|NCT01787916|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153485296|NCT01813734|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153485319|NCT06020560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153485320|NCT06020456|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
153485321|NCT06020456|Hemostatics|hemostatics|mesh-ancestor
153887039|NCT01114516|Clindamycin phosphate|clindamycin phosphate|mesh-list
153887040|NCT01114516|Cefazolin|cefazolin|mesh-list
153887041|NCT01114516|Indomethacin|indomethacin|mesh-list
153887042|NCT01114516|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153887043|NCT01114516|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
153887044|NCT01114516|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153887045|NCT01114516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153485322|NCT06020456|Coagulants|coagulants|mesh-ancestor
153485323|NCT06020456|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
153887067|NCT01310036|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
153485383|NCT06019520|Protective Agents|protective agents|mesh-ancestor
153485384|NCT06019520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153485385|NCT06019520|Antidotes|antidotes|mesh-ancestor
153485386|NCT06019286|Hormones|hormones|mesh-list
153485387|NCT06019286|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153485388|NCT06019286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153485389|NCT06019130|Interferons|interferons|mesh-list
153485420|NCT06018948|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153485421|NCT06018948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153485422|NCT06018675|Lidocaine|lidocaine|mesh-list
153485423|NCT06018675|Anesthetics, Local|anesthetics, local|mesh-ancestor
153485424|NCT06018675|Anesthetics|anesthetics|mesh-ancestor
153485425|NCT06018675|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153485426|NCT06018675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153485427|NCT06018675|Sensory System Agents|sensory system agents|mesh-ancestor
153485428|NCT06018675|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153485434|NCT06014944|Antibodies|antibodies|mesh-list
153485446|NCT06014359|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
153485447|NCT06014359|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153485448|NCT06014359|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153485449|NCT06014359|Adrenergic Agents|adrenergic agents|mesh-ancestor
153485450|NCT06014359|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153485451|NCT06014359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153485452|NCT06011746|Ketamine|ketamine|mesh-list
153485453|NCT06011746|Levobupivacaine|levobupivacaine|mesh-list
153485488|NCT05982990|Autonomic Agents|autonomic agents|mesh-ancestor
153485489|NCT05982990|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153485490|NCT05982990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153485491|NCT05982990|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153485492|NCT05982990|Respiratory System Agents|respiratory system agents|mesh-ancestor
153485493|NCT05982990|Dermatologic Agents|dermatologic agents|mesh-ancestor
153485494|NCT05982990|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
153485495|NCT05982990|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
153485522|NCT05962502|Irinotecan|irinotecan|mesh-list
153485593|NCT05727397|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153485594|NCT05727397|Growth Substances|growth substances|mesh-ancestor
153485595|NCT05727397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153485596|NCT05727397|Growth Inhibitors|growth inhibitors|mesh-ancestor
153485597|NCT05727397|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153485598|NCT05677490|Calcium, Dietary|calcium, dietary|mesh-list
153485599|NCT05677490|Leucovorin|leucovorin|mesh-list
153485600|NCT05677490|Tetrahydrofolates|tetrahydrofolates|mesh-list
153485601|NCT05677490|Formyltetrahydrofolates|formyltetrahydrofolates|mesh-list
153485602|NCT05677490|Nivolumab|nivolumab|mesh-list
153485679|NCT05622318|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153485680|NCT05622318|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153485681|NCT05528848|Fentanyl|fentanyl|mesh-list
153485682|NCT05528848|Carfentanil|carfentanil|mesh-list
153485683|NCT05528848|Naloxone|naloxone|mesh-list
153485684|NCT05528848|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
153485685|NCT05528848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153485686|NCT05528848|Sensory System Agents|sensory system agents|mesh-ancestor
153485687|NCT05528848|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153485688|NCT05528848|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153485732|NCT05372367|Itraconazole|itraconazole|mesh-list
153485734|NCT05372367|Antifungal Agents|antifungal agents|mesh-ancestor
153485735|NCT05372367|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153485736|NCT05372367|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
153485737|NCT05372367|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153485738|NCT05372367|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153485739|NCT05372367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153428210|NCT00002222|Valganciclovir|valganciclovir|mesh-list
153485790|NCT05325502|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153485791|NCT05325502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153485792|NCT05325502|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
153485793|NCT05325502|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
153485794|NCT05325502|Purinergic Agents|purinergic agents|mesh-ancestor
153485795|NCT05325502|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153485796|NCT05325502|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
153485797|NCT05325502|Diuretics|diuretics|mesh-ancestor
153485798|NCT05325502|Natriuretic Agents|natriuretic agents|mesh-ancestor
153487089|NCT01887132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153487090|NCT01887132|Nootropic Agents|nootropic agents|mesh-ancestor
153487091|NCT01887990|Ketamine|ketamine|mesh-list
153487092|NCT01887990|Analgesics|analgesics|mesh-ancestor
153487093|NCT01887990|Sensory System Agents|sensory system agents|mesh-ancestor
153487094|NCT01887990|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153487095|NCT01887990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153487096|NCT01887990|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
153487097|NCT01887990|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153487098|NCT01887990|Anesthetics, General|anesthetics, general|mesh-ancestor
153428286|NCT00002324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153428287|NCT00002324|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153428288|NCT00002324|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153428289|NCT00002324|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153428290|NCT00002324|Antiviral Agents|antiviral agents|mesh-ancestor
153428291|NCT00002324|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153887232|NCT01302938|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153487170|NCT01907334|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
153487171|NCT01907334|Cholinergic Agents|cholinergic agents|mesh-ancestor
153487172|NCT01907490|Benzyl Alcohol|benzyl alcohol|mesh-list
153487196|NCT01910064|Adapalene|adapalene|mesh-list
153487252|NCT01929642|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153487253|NCT01929642|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153487254|NCT01929642|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153487255|NCT01929642|Antifungal Agents|antifungal agents|mesh-ancestor
153487257|NCT01932060|Oxytocics|oxytocics|mesh-ancestor
153487258|NCT01932060|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153487259|NCT01932060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153487260|NCT01933464|Cromolyn Sodium|cromolyn sodium|mesh-list
153487261|NCT01933464|Mast Cell Stabilizers|mast cell stabilizers|mesh-ancestor
153487262|NCT01933464|Immunologic Factors|immunologic factors|mesh-ancestor
153487263|NCT01933464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153487264|NCT01933464|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
153487279|NCT01937598|Liraglutide|liraglutide|mesh-list
153487353|NCT01955382|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153487354|NCT01955382|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153487355|NCT01955382|Antiviral Agents|antiviral agents|mesh-ancestor
153487356|NCT01955382|Schistosomicides|schistosomicides|mesh-ancestor
153487357|NCT01955382|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
153487358|NCT01955382|Anthelmintics|anthelmintics|mesh-ancestor
153487359|NCT01955382|Antidotes|antidotes|mesh-ancestor
153487360|NCT01955382|Protective Agents|protective agents|mesh-ancestor
153487361|NCT01955382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153487362|NCT01957410|Ketamine|ketamine|mesh-list
153487363|NCT01957410|Analgesics|analgesics|mesh-ancestor
153487364|NCT01957410|Sensory System Agents|sensory system agents|mesh-ancestor
153487440|NCT05737680|Tubulin Modulators|tubulin modulators|mesh-ancestor
153487441|NCT05737680|Antimitotic Agents|antimitotic agents|mesh-ancestor
153487442|NCT05737680|Mitosis Modulators|mitosis modulators|mesh-ancestor
153487454|NCT05725200|Venetoclax|venetoclax|mesh-list
153487455|NCT05725200|Dasatinib|dasatinib|mesh-list
153487456|NCT05725200|Palbociclib|palbociclib|mesh-list
153487457|NCT05725200|Crizotinib|crizotinib|mesh-list
153487458|NCT05725200|Panobinostat|panobinostat|mesh-list
153487459|NCT05725200|Talazoparib|talazoparib|mesh-list
153487460|NCT05725200|Idelalisib|idelalisib|mesh-list
153487461|NCT05725200|Alectinib|alectinib|mesh-list
153487462|NCT05725200|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153487463|NCT05725200|Antimetabolites|antimetabolites|mesh-ancestor
153887261|NCT01074307|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153887262|NCT01074307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153887263|NCT01076335|Docetaxel|docetaxel|mesh-list
153887264|NCT01076335|Leuprolide|leuprolide|mesh-list
153487479|NCT05725200|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
153487480|NCT05725200|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153487481|NCT05725200|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153487482|NCT05725200|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
153487483|NCT05725200|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
153487484|NCT05574894|Hormones|hormones|mesh-list
153487485|NCT05574894|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153487507|NCT05436288|Protective Agents|protective agents|mesh-ancestor
153487508|NCT05245734|Immunoglobulins|immunoglobulins|mesh-list
153487533|NCT05242692|Anesthetics, General|anesthetics, general|mesh-ancestor
153487534|NCT05242692|Anesthetics|anesthetics|mesh-ancestor
153487535|NCT05242692|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
153487536|NCT05242692|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
153487537|NCT05242692|Antidepressive Agents|antidepressive agents|mesh-ancestor
153487538|NCT05242692|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153487540|NCT05087940|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-list
153487541|NCT05087940|Natriuretic Agents|natriuretic agents|mesh-ancestor
153487542|NCT05087940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153487543|NCT05087940|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153487545|NCT04922658|Vinorelbine|vinorelbine|mesh-list
153487572|NCT03816618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153487574|NCT03551730|Enoxaparin sodium|enoxaparin sodium|mesh-list
153487575|NCT03551730|Anticoagulants|anticoagulants|mesh-ancestor
153487585|NCT03366480|Mitosis Modulators|mitosis modulators|mesh-ancestor
153487594|NCT02534376|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
153487596|NCT02065596|Fludarabine|fludarabine|mesh-list
153487597|NCT02065596|Fludarabine phosphate|fludarabine phosphate|mesh-list
153487598|NCT02065596|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153487678|NCT01967862|Sodium Fluoride|sodium fluoride|mesh-list
153487679|NCT01967862|Cariostatic Agents|cariostatic agents|mesh-ancestor
153487680|NCT01967862|Protective Agents|protective agents|mesh-ancestor
153487681|NCT01967862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153487682|NCT01967862|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
153487683|NCT01967862|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153487684|NCT01976988|Heparin|heparin|mesh-list
153487685|NCT01976988|Anticoagulants|anticoagulants|mesh-ancestor
153487686|NCT01976988|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153487687|NCT01976988|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153487688|NCT01976988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153487689|NCT01980654|Rituximab|rituximab|mesh-list
153487690|NCT01980654|Ibrutinib|ibrutinib|mesh-list
153487692|NCT01980654|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153813920|NCT00335582|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153487848|NCT02020278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153487850|NCT02020278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153487851|NCT02024646|Brodalumab|brodalumab|mesh-list
153487852|NCT02024646|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
153487853|NCT02024646|Dermatologic Agents|dermatologic agents|mesh-ancestor
153487854|NCT02024646|Immunologic Factors|immunologic factors|mesh-ancestor
153487973|NCT02047500|Gemcitabine|gemcitabine|mesh-list
153487974|NCT02047500|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153487975|NCT02047500|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153487976|NCT02047500|Tubulin Modulators|tubulin modulators|mesh-ancestor
153487977|NCT02047500|Antimitotic Agents|antimitotic agents|mesh-ancestor
153487978|NCT02047500|Mitosis Modulators|mitosis modulators|mesh-ancestor
153487979|NCT02047500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153487980|NCT02047500|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153487981|NCT02047500|Antimetabolites|antimetabolites|mesh-ancestor
153488020|NCT02057640|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153813923|NCT00335582|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
153488021|NCT02057640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153488022|NCT02057640|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
153488024|NCT02059902|Anesthetics, Local|anesthetics, local|mesh-ancestor
153488025|NCT02059902|Anesthetics|anesthetics|mesh-ancestor
153488026|NCT02059902|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153488027|NCT02059902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153887321|NCT05320705|Sensory System Agents|sensory system agents|mesh-ancestor
153887322|NCT05320705|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153488028|NCT02059902|Sensory System Agents|sensory system agents|mesh-ancestor
153488078|NCT02062710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153488079|NCT02062710|Protective Agents|protective agents|mesh-ancestor
153488080|NCT02062710|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
153488081|NCT02062710|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153488082|NCT02062710|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153488083|NCT02062710|Anesthetics, Local|anesthetics, local|mesh-ancestor
153488084|NCT02062710|Anesthetics|anesthetics|mesh-ancestor
153488085|NCT02062710|Sensory System Agents|sensory system agents|mesh-ancestor
153488086|NCT02062710|Antiemetics|antiemetics|mesh-ancestor
153428369|NCT02721277|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
153488091|NCT02062710|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
153488092|NCT02062710|Antipruritics|antipruritics|mesh-ancestor
153488093|NCT02062710|Dermatologic Agents|dermatologic agents|mesh-ancestor
153488094|NCT02062710|Antitussive Agents|antitussive agents|mesh-ancestor
153488095|NCT02062710|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
153488096|NCT02062710|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
153488098|NCT02062710|Narcotics|narcotics|mesh-ancestor
153488124|NCT02135016|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153488125|NCT02135016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153488126|NCT02135016|Sensory System Agents|sensory system agents|mesh-ancestor
153488127|NCT02135016|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153488128|NCT02135016|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153488134|NCT02135094|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153488136|NCT02135094|Adrenergic Agents|adrenergic agents|mesh-ancestor
153488137|NCT02135094|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153488138|NCT02135094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153488139|NCT02135094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153488187|NCT02154048|Sensory System Agents|sensory system agents|mesh-ancestor
153488189|NCT02156154|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153488190|NCT02156154|Analgesics|analgesics|mesh-ancestor
153488191|NCT02156154|Sensory System Agents|sensory system agents|mesh-ancestor
153488242|NCT02164422|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153488426|NCT02233296|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
153488427|NCT02233296|Serotonin Agents|serotonin agents|mesh-ancestor
153488428|NCT02233296|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153488429|NCT02233296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153488430|NCT02233296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153488431|NCT02233998|Listerine|listerine|mesh-list
153488440|NCT02237898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153488441|NCT02237898|Gasotransmitters|gasotransmitters|mesh-ancestor
153488442|NCT02237898|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153488506|NCT02251236|Elvitegravir, Cobicistat, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|elvitegravir, cobicistat, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
153488521|NCT02251938|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153488522|NCT02251938|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153488523|NCT02251938|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153488524|NCT02251938|Antifungal Agents|antifungal agents|mesh-ancestor
153488525|NCT02251938|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153488526|NCT02251938|Immunologic Factors|immunologic factors|mesh-ancestor
153488528|NCT02258412|Ethanol|ethanol|mesh-list
153488644|NCT02284386|Anesthetics|anesthetics|mesh-ancestor
153488798|NCT02303184|Growth Inhibitors|growth inhibitors|mesh-ancestor
153488799|NCT02303184|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153488800|NCT02304432|Cycloserine|cycloserine|mesh-list
153488802|NCT02304432|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153488962|NCT02377752|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153488963|NCT02377752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153488964|NCT02379858|Alvimopan|alvimopan|mesh-list
153488965|NCT02379858|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153488966|NCT02384070|Aspirin|aspirin|mesh-list
153488967|NCT02384070|Bivalirudin|bivalirudin|mesh-list
153488968|NCT02384070|Clopidogrel|clopidogrel|mesh-list
153488969|NCT02384070|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153488970|NCT02384070|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153488971|NCT02384070|Analgesics|analgesics|mesh-ancestor
153887349|NCT02880280|Menotropins|menotropins|mesh-list
153887351|NCT02880280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153887352|NCT02880280|Fertility Agents, Female|fertility agents, female|mesh-ancestor
153916565|NCT02471911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153916566|NCT02471911|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153916567|NCT02471911|Alkylating Agents|alkylating agents|mesh-ancestor
153916569|NCT00622375|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153916593|NCT04278625|Sensory System Agents|sensory system agents|mesh-ancestor
153428399|NCT00002354|Protease Inhibitors|protease inhibitors|mesh-ancestor
153428400|NCT00002360|Didanosine|didanosine|mesh-list
153428401|NCT00002360|Antimetabolites|antimetabolites|mesh-ancestor
153916615|NCT02691403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153465356|NCT00216060|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153465358|NCT00282282|Fludarabine|fludarabine|mesh-list
153465359|NCT00282282|Busulfan|busulfan|mesh-list
153465360|NCT00282282|Tacrolimus|tacrolimus|mesh-list
153465361|NCT00282282|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153887354|NCT01104376|Efavirenz|efavirenz|mesh-list
153887355|NCT01104376|Voriconazole|voriconazole|mesh-list
153814190|NCT00444834|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153814191|NCT00444834|Antioxidants|antioxidants|mesh-ancestor
153814192|NCT00444834|Protective Agents|protective agents|mesh-ancestor
153814193|NCT00444834|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153814194|NCT00444834|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153814195|NCT00444834|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153814248|NCT00451230|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153814249|NCT00451230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153814250|NCT00451230|Dopamine Agents|dopamine agents|mesh-ancestor
153814251|NCT00451230|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153368058|NCT02174510|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
153368059|NCT02174510|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
153368060|NCT02174510|Adrenergic Agents|adrenergic agents|mesh-ancestor
153368061|NCT02174510|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153368062|NCT02174510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153368063|NCT02174510|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
153368072|NCT00585195|Antifungal Agents|antifungal agents|mesh-ancestor
153368073|NCT00585195|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153368074|NCT00585195|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
153368075|NCT00585195|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153368076|NCT00585195|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153368077|NCT00585195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153368078|NCT00585195|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153828051|NCT00483158|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153828093|NCT00483600|Protease Inhibitors|protease inhibitors|mesh-ancestor
153828094|NCT00483600|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153368095|NCT00585195|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153368096|NCT00585195|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153368097|NCT01113398|Bevacizumab|bevacizumab|mesh-list
153368098|NCT01113398|Rilotumumab|rilotumumab|mesh-list
153368099|NCT01113398|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153368100|NCT01113398|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153368101|NCT01113398|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153368102|NCT01113398|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153368103|NCT01113398|Growth Substances|growth substances|mesh-ancestor
153368138|NCT03013400|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153368139|NCT03013400|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
153368140|NCT03013400|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153368141|NCT03013400|Antioxidants|antioxidants|mesh-ancestor
153368142|NCT03013400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153368143|NCT03013400|Protective Agents|protective agents|mesh-ancestor
153368144|NCT03013400|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153368145|NCT03013400|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153368146|NCT03013400|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
153368147|NCT02439138|Idelalisib|idelalisib|mesh-list
153368154|NCT01048658|Sevoflurane|sevoflurane|mesh-list
153368155|NCT01048658|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153368207|NCT02415855|Protease Inhibitors|protease inhibitors|mesh-ancestor
153368208|NCT02415855|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153368211|NCT00363285|Cyproterone Acetate|cyproterone acetate|mesh-list
153368213|NCT00363285|Cyproterone|cyproterone|mesh-list
153368214|NCT00363285|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153368216|NCT00363285|Androgen Antagonists|androgen antagonists|mesh-ancestor
153368217|NCT00363285|Hormone Antagonists|hormone antagonists|mesh-ancestor
153368218|NCT00363285|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153368219|NCT00363285|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
153368220|NCT00363285|Contraceptive Agents|contraceptive agents|mesh-ancestor
153368221|NCT00363285|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153368222|NCT02424357|Povidone-Iodine|povidone-iodine|mesh-list
153368252|NCT02435901|Fludarabine|fludarabine|mesh-list
153368253|NCT02435901|Melphalan|melphalan|mesh-list
153368254|NCT02435901|Alemtuzumab|alemtuzumab|mesh-list
153429179|NCT00002576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153368255|NCT02435901|Tacrolimus|tacrolimus|mesh-list
153429180|NCT00002576|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153429181|NCT00002576|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153429182|NCT00002576|Alkylating Agents|alkylating agents|mesh-ancestor
153368256|NCT02435901|Cyclosporins|cyclosporins|mesh-list
153429183|NCT00002576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153429184|NCT00002576|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153368257|NCT02435901|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153368258|NCT02435901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153368293|NCT01099358|Cetuximab|cetuximab|mesh-list
153368305|NCT01118624|Vitamin B Complex|vitamin b complex|mesh-list
153368306|NCT01118624|10-deazaaminopterin|10-deazaaminopterin|mesh-list
153368307|NCT01118624|Aminopterin|aminopterin|mesh-list
153368308|NCT01118624|Micronutrients|micronutrients|mesh-ancestor
153368309|NCT01118624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153368310|NCT01118624|Hematinics|hematinics|mesh-ancestor
153368311|NCT01118624|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153368312|NCT01118624|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153368314|NCT01118624|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153828291|NCT04515420|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153828292|NCT04515420|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
153828293|NCT00488540|Acetaminophen|acetaminophen|mesh-list
153828294|NCT00488540|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153828295|NCT00488540|Analgesics|analgesics|mesh-ancestor
153828296|NCT00488540|Sensory System Agents|sensory system agents|mesh-ancestor
153828297|NCT00488540|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153828298|NCT00488540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153368345|NCT02180828|Clotrimazole|clotrimazole|mesh-list
153368346|NCT02180828|Miconazole|miconazole|mesh-list
153368347|NCT02180828|Antifungal Agents|antifungal agents|mesh-ancestor
153368348|NCT02180828|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153368361|NCT02525523|Alicaforsen|alicaforsen|mesh-list
153828340|NCT01303861|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
153828341|NCT01303861|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153828342|NCT01303861|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153828374|NCT01302964|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
153828375|NCT01302964|Histamine Antagonists|histamine antagonists|mesh-ancestor
153828376|NCT01302964|Histamine Agents|histamine agents|mesh-ancestor
153828377|NCT01302964|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153828378|NCT01302964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153828379|NCT01302964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153828380|NCT01302964|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153828381|NCT01302964|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153368405|NCT02980094|Vitamins|vitamins|mesh-list
153828421|NCT05643820|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153828434|NCT01241162|Decitabine|decitabine|mesh-list
153828435|NCT01241162|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153828436|NCT01241162|Antimetabolites|antimetabolites|mesh-ancestor
153828437|NCT01241162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153828438|NCT01241162|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153828439|NCT01241162|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153828440|NCT00484133|Dobutamine|dobutamine|mesh-list
153828441|NCT00484133|Dopamine|dopamine|mesh-list
153828442|NCT00484133|Enoximone|enoximone|mesh-list
153828443|NCT00484133|Norepinephrine|norepinephrine|mesh-list
153828444|NCT00484133|Nitroglycerin|nitroglycerin|mesh-list
153828445|NCT00484133|Vasodilator Agents|vasodilator agents|mesh-ancestor
153828446|NCT00484133|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
153828447|NCT00484133|Sympathomimetics|sympathomimetics|mesh-ancestor
153828448|NCT00484133|Autonomic Agents|autonomic agents|mesh-ancestor
153368459|NCT02542761|Carbon Fiber|carbon fiber|mesh-list
153828511|NCT00484328|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153828512|NCT00484575|Propofol|propofol|mesh-list
153828513|NCT00484575|Sevoflurane|sevoflurane|mesh-list
153828514|NCT00484575|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153828515|NCT00484575|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153828516|NCT00484575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153828517|NCT00484575|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153828518|NCT00484575|Anesthetics, General|anesthetics, general|mesh-ancestor
153828519|NCT00484575|Anesthetics|anesthetics|mesh-ancestor
153828520|NCT00484575|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153368543|NCT02481297|Rituximab|rituximab|mesh-list
153368597|NCT01166126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153368598|NCT01166126|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153368599|NCT01166126|Immunologic Factors|immunologic factors|mesh-ancestor
153828633|NCT02275806|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153828634|NCT02275806|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153828635|NCT02275806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153828636|NCT02275806|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153828638|NCT01241409|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
153828639|NCT01241409|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153828640|NCT01241409|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
153828690|NCT00489437|Anticoagulants|anticoagulants|mesh-ancestor
153828691|NCT00489437|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153828692|NCT00489437|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153828693|NCT00489437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153828694|NCT00485160|Ibuprofen|ibuprofen|mesh-list
153828695|NCT00485160|Indomethacin|indomethacin|mesh-list
153828708|NCT00485160|Tocolytic Agents|tocolytic agents|mesh-ancestor
153828745|NCT00485108|Sensory System Agents|sensory system agents|mesh-ancestor
153828746|NCT00485108|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153828747|NCT00485108|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153368760|NCT05296460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153368761|NCT05296460|Leprostatic Agents|leprostatic agents|mesh-ancestor
153368762|NCT05296460|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153368763|NCT01136798|Exenatide|exenatide|mesh-list
153368764|NCT01136798|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
153368765|NCT01136798|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153368766|NCT01136798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153368769|NCT01136798|Hormones|hormones|mesh-ancestor
153368793|NCT02246816|Opium|opium|mesh-list
153828767|NCT04513509|Propranolol|propranolol|mesh-list
153828768|NCT04513509|Metoprolol|metoprolol|mesh-list
153828769|NCT04513509|Digoxin|digoxin|mesh-list
153828770|NCT04513509|Atenolol|atenolol|mesh-list
153828771|NCT04513509|Verapamil|verapamil|mesh-list
153828775|NCT04513509|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
153828776|NCT04513509|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
153828777|NCT04513509|Adrenergic Agents|adrenergic agents|mesh-ancestor
153828778|NCT04513509|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153828779|NCT04513509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153828780|NCT04513509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153368797|NCT02246816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153828823|NCT00489593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153828824|NCT00489593|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153828825|NCT00489593|Serotonin Agents|serotonin agents|mesh-ancestor
153828826|NCT00489593|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
153828827|NCT00489593|Antidepressive Agents|antidepressive agents|mesh-ancestor
153828828|NCT00489593|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
153368864|NCT01173848|Micronutrients|micronutrients|mesh-ancestor
153368865|NCT01173848|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153368866|NCT01174082|Vaccines|vaccines|mesh-list
153368867|NCT01174082|Sargramostim|sargramostim|mesh-list
153828861|NCT04697511|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153828862|NCT04697511|Anesthetics, General|anesthetics, general|mesh-ancestor
153828864|NCT04697511|GABA Modulators|gaba modulators|mesh-ancestor
153828865|NCT04697511|GABA Agents|gaba agents|mesh-ancestor
153828866|NCT04697511|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153828867|NCT04697511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153828868|NCT00485511|Hydroxyurea|hydroxyurea|mesh-list
153828869|NCT00485511|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153828870|NCT00485511|Antisickling Agents|antisickling agents|mesh-ancestor
153368935|NCT02383758|Cathartics|cathartics|mesh-ancestor
153368936|NCT02383758|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153368937|NCT02383758|Laxatives|laxatives|mesh-ancestor
153368938|NCT02492451|Progesterone|progesterone|mesh-list
153368939|NCT02492451|Progestins|progestins|mesh-ancestor
153368940|NCT02492451|Hormones|hormones|mesh-ancestor
153828900|NCT01302067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153828907|NCT00485550|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153828908|NCT00485550|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153828909|NCT00485550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153828910|NCT00485550|Dopamine Agents|dopamine agents|mesh-ancestor
153828911|NCT00485550|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153828912|NCT00485550|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
153828913|NCT00485550|Adrenergic Agents|adrenergic agents|mesh-ancestor
153828914|NCT00485628|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
153828919|NCT00485628|Adrenergic Agents|adrenergic agents|mesh-ancestor
153828945|NCT00489944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153828946|NCT00489944|Growth Inhibitors|growth inhibitors|mesh-ancestor
153828947|NCT00489944|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153828948|NCT00489944|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153368969|NCT01181258|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153368970|NCT01181258|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153368971|NCT01181258|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153368972|NCT01181258|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153368973|NCT01181258|Antiemetics|antiemetics|mesh-ancestor
153368974|NCT01181258|Autonomic Agents|autonomic agents|mesh-ancestor
153368975|NCT01181258|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153368976|NCT01181258|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153828968|NCT00489983|Pemetrexed|pemetrexed|mesh-list
153828969|NCT00489983|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153828970|NCT00489983|Antimetabolites|antimetabolites|mesh-ancestor
153828971|NCT00489983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153828972|NCT00489983|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153828973|NCT00489983|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153828974|NCT00489983|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153828975|NCT00489983|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153828976|NCT01241682|Cyclophosphamide|cyclophosphamide|mesh-list
153828977|NCT01241682|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153828978|NCT01241682|Immunologic Factors|immunologic factors|mesh-ancestor
153828979|NCT01241682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153828997|NCT00485771|Antiemetics|antiemetics|mesh-ancestor
153828998|NCT00485771|Autonomic Agents|autonomic agents|mesh-ancestor
153828999|NCT00485771|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153829000|NCT00485771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153829001|NCT00485771|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153829002|NCT00485771|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153829003|NCT00485771|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153829004|NCT00485771|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153829005|NCT00485771|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153829006|NCT00485771|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
153829011|NCT00485771|Serotonin Agents|serotonin agents|mesh-ancestor
153829024|NCT00485810|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153829025|NCT00485810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153829026|NCT00485810|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153829027|NCT00485810|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153829028|NCT00485810|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153829029|NCT00485810|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153829030|NCT00485810|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153829031|NCT00485810|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
153829032|NCT00485810|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153829033|NCT00485810|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153369059|NCT01143818|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153829040|NCT00490373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153829052|NCT00485823|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153829053|NCT00485823|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
153829054|NCT00485823|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153829055|NCT00485823|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153829056|NCT00485823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153829057|NCT00485823|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153829058|NCT00485823|Serotonin Agents|serotonin agents|mesh-ancestor
153829081|NCT00485862|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153829082|NCT00485862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153829083|NCT00485862|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153829084|NCT00485862|Serotonin Agents|serotonin agents|mesh-ancestor
153829085|NCT00485862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153829086|NCT00485862|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
153829087|NCT00485862|Adrenergic Agents|adrenergic agents|mesh-ancestor
153829088|NCT00485901|Haloperidol|haloperidol|mesh-list
153829089|NCT00485901|Olanzapine|olanzapine|mesh-list
153829090|NCT00485901|Haloperidol decanoate|haloperidol decanoate|mesh-list
153829091|NCT00485901|Antiemetics|antiemetics|mesh-ancestor
153369159|NCT00422175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153369160|NCT00422175|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153369161|NCT00422175|Immunologic Factors|immunologic factors|mesh-ancestor
153369162|NCT00422175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153369163|NCT01186250|Pioglitazone|pioglitazone|mesh-list
153369164|NCT01186250|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153369165|NCT01186250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153369166|NCT01186406|Bevacizumab|bevacizumab|mesh-list
153369167|NCT01186406|Temozolomide|temozolomide|mesh-list
153369168|NCT01186406|Carmustine|carmustine|mesh-list
153369169|NCT01186406|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153369170|NCT01186406|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153369171|NCT01186406|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153829156|NCT00486083|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
153829157|NCT00486083|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153829161|NCT00486083|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153829162|NCT00486083|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
153829163|NCT00486083|Adrenergic Agents|adrenergic agents|mesh-ancestor
153829164|NCT00490685|Sorafenib|sorafenib|mesh-list
153369205|NCT02581839|Antiemetics|antiemetics|mesh-ancestor
153369206|NCT02581839|Autonomic Agents|autonomic agents|mesh-ancestor
153369207|NCT02581839|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153369208|NCT02581839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153369209|NCT02581839|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153369210|NCT02581839|Glucocorticoids|glucocorticoids|mesh-ancestor
153369211|NCT02581839|Hormones|hormones|mesh-ancestor
153369212|NCT02581839|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153369223|NCT02504775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153369224|NCT02504775|Antipyretics|antipyretics|mesh-ancestor
153369225|NCT02504931|Sertraline|sertraline|mesh-list
153369226|NCT02504931|Antidepressive Agents|antidepressive agents|mesh-ancestor
153369227|NCT02504931|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153369228|NCT02504931|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
153829197|NCT00490880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153829198|NCT00486174|Methylene Blue|methylene blue|mesh-list
153829199|NCT00486174|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153829200|NCT00486174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153829201|NCT00490958|Telmisartan|telmisartan|mesh-list
153829202|NCT00490958|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153829203|NCT00490958|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
153829204|NCT00490958|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
153829205|NCT00490958|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153829207|NCT00486213|Vitamin B 6|vitamin b 6|mesh-list
153369241|NCT04423029|Nivolumab|nivolumab|mesh-list
153369266|NCT01187498|Urological Agents|urological agents|mesh-ancestor
153369267|NCT01148420|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
153369268|NCT01148420|Medroxyprogesterone|medroxyprogesterone|mesh-list
153369269|NCT01148420|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
153369270|NCT01148420|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
153829229|NCT00490997|Sensory System Agents|sensory system agents|mesh-ancestor
153829231|NCT00490997|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
153829232|NCT00490997|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
153829271|NCT00486668|Tubulin Modulators|tubulin modulators|mesh-ancestor
153829272|NCT00486668|Antimitotic Agents|antimitotic agents|mesh-ancestor
153829273|NCT00486668|Mitosis Modulators|mitosis modulators|mesh-ancestor
153829274|NCT00486668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153829275|NCT00486668|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153829276|NCT00486668|Immunologic Factors|immunologic factors|mesh-ancestor
153369303|NCT01189292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153369304|NCT01189292|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153369305|NCT01189292|Glucocorticoids|glucocorticoids|mesh-ancestor
153369307|NCT01189292|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153369308|NCT01189292|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153369309|NCT01189292|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153829310|NCT00486798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153829311|NCT01301833|Biguanides|biguanides|mesh-list
153829312|NCT01301833|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-list
153829313|NCT01301833|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153829314|NCT01301833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153829315|NCT01301833|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153829316|NCT01301833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153829317|NCT00486785|Alfuzosin|alfuzosin|mesh-list
153369381|NCT01191476|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153369382|NCT01191476|Anesthetics, General|anesthetics, general|mesh-ancestor
153369383|NCT01191476|Anesthetics|anesthetics|mesh-ancestor
153369384|NCT01191476|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153369385|NCT01191476|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
153369386|NCT02508207|Ivacaftor|ivacaftor|mesh-list
153369387|NCT02508207|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
153369388|NCT02508207|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153829330|NCT04324411|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153829331|NCT04324411|Antifungal Agents|antifungal agents|mesh-ancestor
153829356|NCT00491348|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153888156|NCT00601913|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153829357|NCT00491348|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153829358|NCT00491348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153829359|NCT00491348|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153369389|NCT02508207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153369390|NCT02509065|Pancrelipase|pancrelipase|mesh-list
153369391|NCT02509065|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153369392|NCT01194674|Plasminogen|plasminogen|mesh-list
153369409|NCT01154192|Dexamethasone|dexamethasone|mesh-list
153369426|NCT02511561|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153369427|NCT02511561|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153369428|NCT02511561|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153369429|NCT02511561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153369430|NCT02511561|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153369431|NCT02511561|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
153369432|NCT02511561|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153369433|NCT01195922|Sirolimus|sirolimus|mesh-list
153369434|NCT01195922|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153369435|NCT01195922|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153369436|NCT01195922|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153369437|NCT01195922|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153829406|NCT01300819|Rotigotine|rotigotine|mesh-list
153369445|NCT02512575|Hormones|hormones|mesh-ancestor
153369446|NCT02512575|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153369447|NCT02512575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153369448|NCT02512575|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153369449|NCT02512575|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153369450|NCT01199744|Zanamivir|zanamivir|mesh-list
153369451|NCT01199744|Antiviral Agents|antiviral agents|mesh-ancestor
153829472|NCT00491426|Caspofungin|caspofungin|mesh-list
153829473|NCT00491426|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
153829474|NCT00491426|Anidulafungin|anidulafungin|mesh-list
153829475|NCT00491426|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153369503|NCT01159262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153369504|NCT01159262|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153369505|NCT01159262|Narcotics|narcotics|mesh-ancestor
153369506|NCT01159262|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153369507|NCT01159262|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153829515|NCT00487110|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
153829516|NCT00487110|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153829517|NCT00487110|Serotonin Agents|serotonin agents|mesh-ancestor
153829518|NCT00487110|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153829519|NCT00487110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153829520|NCT00487136|Warfarin|warfarin|mesh-list
153369549|NCT02976441|Alkylating Agents|alkylating agents|mesh-ancestor
153369550|NCT02976441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153369551|NCT02976441|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153369552|NCT00363753|Aspirin|aspirin|mesh-list
153369553|NCT00363753|Clopidogrel|clopidogrel|mesh-list
153888168|NCT01301391|Maleic acid|maleic acid|mesh-list
153369569|NCT00363753|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
153369582|NCT01203644|Sensory System Agents|sensory system agents|mesh-ancestor
153369583|NCT01203644|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153369584|NCT00363831|Oxaliplatin|oxaliplatin|mesh-list
153369585|NCT00363831|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153369586|NCT02433834|Glycopyrrolate|glycopyrrolate|mesh-list
153369587|NCT02433834|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
153369588|NCT02433834|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153369589|NCT02433834|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
153369590|NCT02433834|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
153369591|NCT02433834|Cholinergic Agents|cholinergic agents|mesh-ancestor
153369592|NCT02433834|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153369604|NCT02433678|Dapagliflozin|dapagliflozin|mesh-list
153829560|NCT00487227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153829561|NCT00487227|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
153829562|NCT00487227|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
153829563|NCT00487227|Purinergic Agents|purinergic agents|mesh-ancestor
153829564|NCT00487227|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153829565|NCT01300351|Fulvestrant|fulvestrant|mesh-list
153829566|NCT01300351|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153829567|NCT01300351|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153829568|NCT01300351|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
153829569|NCT01300351|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
153829570|NCT01300351|Hormone Antagonists|hormone antagonists|mesh-ancestor
153829571|NCT01300351|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153369635|NCT01205828|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153369636|NCT01205828|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
153369637|NCT01205828|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153369638|NCT02515305|Clindamycin|clindamycin|mesh-list
153369640|NCT02515305|Clindamycin phosphate|clindamycin phosphate|mesh-list
153369641|NCT02515305|Benzoyl Peroxide|benzoyl peroxide|mesh-list
153829577|NCT00487253|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153829578|NCT00487253|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153829579|NCT00487253|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153829598|NCT02276196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153829600|NCT00487422|Laxatives|laxatives|mesh-ancestor
153829601|NCT00487422|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153829602|NCT00487422|Serotonin 5-HT4 Receptor Agonists|serotonin 5-ht4 receptor agonists|mesh-ancestor
153829603|NCT00487422|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
153829604|NCT00487422|Serotonin Agents|serotonin agents|mesh-ancestor
153429238|NCT00002582|Fertility Agents, Female|fertility agents, female|mesh-ancestor
153829612|NCT04697355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153829614|NCT04697355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153369643|NCT02515305|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153369645|NCT02515305|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153829615|NCT04697355|Provitamins|provitamins|mesh-ancestor
153829616|NCT04697355|Vitamins|vitamins|mesh-ancestor
153829617|NCT04697355|Micronutrients|micronutrients|mesh-ancestor
153829618|NCT04697355|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
153829619|NCT04697355|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153829620|NCT04697355|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
153829621|NCT04697355|Hormone Antagonists|hormone antagonists|mesh-ancestor
153829622|NCT04697355|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153829639|NCT00491855|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153829640|NCT00491855|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153829641|NCT00491855|Growth Substances|growth substances|mesh-ancestor
153829642|NCT00491855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153829643|NCT00491855|Growth Inhibitors|growth inhibitors|mesh-ancestor
153829644|NCT04697277|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
153829645|NCT04697277|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153829646|NCT00487448|Cytarabine|cytarabine|mesh-list
153829647|NCT00487448|Fludarabine|fludarabine|mesh-list
153829648|NCT00487448|Idarubicin|idarubicin|mesh-list
153829651|NCT00487448|Antimetabolites|antimetabolites|mesh-ancestor
153829653|NCT00487448|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153829654|NCT00487448|Immunologic Factors|immunologic factors|mesh-ancestor
153829655|NCT00487448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153829656|NCT00487448|Antiviral Agents|antiviral agents|mesh-ancestor
153829657|NCT00487448|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153829658|NCT00487448|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153829659|NCT00487448|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153829660|NCT00487448|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153829661|NCT00487448|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153829662|NCT00506259|Melatonin|melatonin|mesh-list
153829663|NCT00506259|Antioxidants|antioxidants|mesh-ancestor
153829664|NCT00506259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153829665|NCT00506259|Protective Agents|protective agents|mesh-ancestor
153829666|NCT00506259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153829667|NCT00506259|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153829668|NCT00506298|Diflunisal|diflunisal|mesh-list
153829669|NCT00506298|Bezafibrate|bezafibrate|mesh-list
153829670|NCT00506298|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153369696|NCT05859217|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153369697|NCT05858645|Deucravacitinib|deucravacitinib|mesh-list
153369698|NCT05858645|Dermatologic Agents|dermatologic agents|mesh-ancestor
153369699|NCT05858645|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153369700|NCT05858645|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153369702|NCT05858177|Temozolomide|temozolomide|mesh-list
153829693|NCT01242215|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
153829694|NCT01242215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153829695|NCT01242228|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
153829696|NCT01242228|Vildagliptin|vildagliptin|mesh-list
153829697|NCT01242228|Saxagliptin|saxagliptin|mesh-list
153829698|NCT01242228|Alogliptin|alogliptin|mesh-list
153829699|NCT01242228|Ipragliflozin|ipragliflozin|mesh-list
153829700|NCT01242228|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
153829701|NCT01242228|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153829702|NCT01242228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153829703|NCT01242228|Incretins|incretins|mesh-ancestor
153369730|NCT05836025|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153369731|NCT05836025|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153369745|NCT05785195|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153369746|NCT05785195|Autonomic Agents|autonomic agents|mesh-ancestor
153369747|NCT05785195|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153369748|NCT05785195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153369749|NCT05785195|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153369750|NCT05785195|Respiratory System Agents|respiratory system agents|mesh-ancestor
153369751|NCT05785195|Free Radical Scavengers|free radical scavengers|mesh-ancestor
153829728|NCT00492128|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
153829729|NCT00492128|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
153829730|NCT00492128|Diuretics|diuretics|mesh-ancestor
153829731|NCT00492128|Natriuretic Agents|natriuretic agents|mesh-ancestor
153829732|NCT00492128|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
153829733|NCT00487734|Methyltestosterone|methyltestosterone|mesh-list
153829734|NCT00487734|Testosterone|testosterone|mesh-list
153829735|NCT00487734|Testosterone undecanoate|testosterone undecanoate|mesh-list
153829736|NCT00487734|Testosterone enanthate|testosterone enanthate|mesh-list
153829737|NCT00487734|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
153829749|NCT01300234|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153829750|NCT01300234|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153829751|NCT01300234|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153829752|NCT01300234|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153829753|NCT01300234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153829754|NCT01300234|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153829755|NCT01300234|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153829756|NCT01242332|Pregabalin|pregabalin|mesh-list
153829757|NCT01242332|Analgesics|analgesics|mesh-ancestor
153369819|NCT05545891|Aripiprazole|aripiprazole|mesh-list
153429253|NCT02239627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153429254|NCT02239627|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153429255|NCT02239627|Sympatholytics|sympatholytics|mesh-ancestor
153429256|NCT02239627|Autonomic Agents|autonomic agents|mesh-ancestor
153429257|NCT02239627|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
153429258|NCT02239627|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153429259|NCT02239627|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153369821|NCT05545891|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153829798|NCT00487773|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153829799|NCT00487773|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153829801|NCT01299961|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153829802|NCT01299961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153829803|NCT01299961|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153829804|NCT01299961|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153829805|NCT01299961|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153829806|NCT01299961|Immunologic Factors|immunologic factors|mesh-ancestor
153829807|NCT01299961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153829808|NCT01299961|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153829809|NCT00492245|Mitomycins|mitomycins|mesh-list
153829810|NCT00492245|Mitomycin|mitomycin|mesh-list
153829811|NCT00492245|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153829838|NCT01299805|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153829839|NCT01299805|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153829840|NCT01299805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153829841|NCT01299805|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153829842|NCT01299805|Serotonin Agents|serotonin agents|mesh-ancestor
153829843|NCT01299805|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
153829844|NCT01299805|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
153829845|NCT01299805|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
153829846|NCT01299805|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153829847|NCT00487682|Valacyclovir|valacyclovir|mesh-list
153829848|NCT00487682|Antiviral Agents|antiviral agents|mesh-ancestor
153829849|NCT00487682|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153829850|NCT04512261|Pembrolizumab|pembrolizumab|mesh-list
153369882|NCT05229055|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
153369912|NCT04930536|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153829851|NCT04512261|Trastuzumab|trastuzumab|mesh-list
153829852|NCT04512261|Tucatinib|tucatinib|mesh-list
153829853|NCT04512261|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153829854|NCT04512261|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153829855|NCT04512261|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153829856|NCT04512261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153369930|NCT04893291|Antifungal Agents|antifungal agents|mesh-ancestor
153369931|NCT04803422|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
153369933|NCT04803422|Metronidazole|metronidazole|mesh-list
153369934|NCT04803422|Tazobactam|tazobactam|mesh-list
153369935|NCT04803422|Piperacillin|piperacillin|mesh-list
153369936|NCT04803422|Clavulanic Acids|clavulanic acids|mesh-list
153369937|NCT04803422|Clavulanic Acid|clavulanic acid|mesh-list
153369938|NCT04803422|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
153369939|NCT04803422|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153369940|NCT04803422|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153829912|NCT00495326|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153829913|NCT00495326|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153829914|NCT00492479|Kinetin|kinetin|mesh-list
153829915|NCT00492479|Plant Growth Regulators|plant growth regulators|mesh-ancestor
153829916|NCT00492479|Growth Substances|growth substances|mesh-ancestor
153829917|NCT00492479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153829918|NCT00495365|Epoetin Alfa|epoetin alfa|mesh-list
153829919|NCT00495365|Hematinics|hematinics|mesh-ancestor
153829920|NCT00492518|Acetylcysteine|acetylcysteine|mesh-list
153369949|NCT04731779|Cannabidiol|cannabidiol|mesh-list
153369950|NCT04731779|Anticonvulsants|anticonvulsants|mesh-ancestor
153369951|NCT04715568|Losartan|losartan|mesh-list
153829927|NCT00492518|Free Radical Scavengers|free radical scavengers|mesh-ancestor
153829929|NCT00492518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153829930|NCT00492518|Protective Agents|protective agents|mesh-ancestor
153829931|NCT00492518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153829932|NCT00492518|Antidotes|antidotes|mesh-ancestor
153829933|NCT00492518|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153829934|NCT00492518|Autonomic Agents|autonomic agents|mesh-ancestor
153829935|NCT00492518|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153829936|NCT00492518|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153829944|NCT04513860|Cenobamate|cenobamate|mesh-list
153829958|NCT00506844|Antimetabolites|antimetabolites|mesh-ancestor
153829959|NCT00506844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153829960|NCT00506844|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153829961|NCT00506844|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
153829962|NCT00506844|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153829963|NCT00506844|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153829964|NCT00506844|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153829965|NCT00506961|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
153888172|NCT04325633|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153888173|NCT04325633|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153888174|NCT04325633|Analgesics|analgesics|mesh-ancestor
153888175|NCT04325633|Sensory System Agents|sensory system agents|mesh-ancestor
153888176|NCT04325633|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153888177|NCT04325633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153829979|NCT00492635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153829980|NCT00492635|Urological Agents|urological agents|mesh-ancestor
153829981|NCT00507000|Vitamin D|vitamin d|mesh-list
153829982|NCT00507000|Cholecalciferol|cholecalciferol|mesh-list
153829983|NCT00507000|Vitamins|vitamins|mesh-ancestor
153829984|NCT00507000|Micronutrients|micronutrients|mesh-ancestor
153829985|NCT00507000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153370042|NCT04002674|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153370043|NCT04002674|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153888192|NCT05643417|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153888193|NCT05643417|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153888194|NCT05643417|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153888195|NCT05643417|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153370083|NCT03554044|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
153370084|NCT03554044|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153370085|NCT03554044|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153370086|NCT03554044|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
153370087|NCT03554044|Hormone Antagonists|hormone antagonists|mesh-ancestor
153370088|NCT03554044|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153370089|NCT03554044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153370096|NCT03524937|Melatonin|melatonin|mesh-list
153830080|NCT01298362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153830081|NCT00493415|Nitroglycerin|nitroglycerin|mesh-list
153830082|NCT00493415|Vasodilator Agents|vasodilator agents|mesh-ancestor
153370110|NCT03435458|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
153370111|NCT03435458|Abortifacient Agents|abortifacient agents|mesh-ancestor
153370112|NCT03435458|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153370113|NCT03435458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153370114|NCT03435458|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
153370115|NCT03435458|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153370116|NCT03435458|Oxytocics|oxytocics|mesh-ancestor
153370117|NCT03184194|Cyclophosphamide|cyclophosphamide|mesh-list
153370118|NCT03184194|Nivolumab|nivolumab|mesh-list
153370119|NCT03184194|Daratumumab|daratumumab|mesh-list
153370120|NCT03184194|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
153370140|NCT02889159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153370142|NCT02889159|Immunologic Factors|immunologic factors|mesh-ancestor
153370143|NCT02889159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153830083|NCT01244009|Niraparib|niraparib|mesh-list
153830084|NCT01244009|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
153830085|NCT01244009|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153830086|NCT01244009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153830088|NCT04511832|Diclofenac|diclofenac|mesh-list
153830113|NCT00496028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153830114|NCT00496028|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153830115|NCT04516278|Bevacizumab|bevacizumab|mesh-list
153830116|NCT04516278|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153370145|NCT02889159|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153370146|NCT02889159|Interferon Inducers|interferon inducers|mesh-ancestor
153370147|NCT02889159|Histamine Agonists|histamine agonists|mesh-ancestor
153370148|NCT02889159|Histamine Agents|histamine agents|mesh-ancestor
153830132|NCT04518462|Bupivacaine|bupivacaine|mesh-list
153830133|NCT04518462|Anesthetics, Local|anesthetics, local|mesh-ancestor
153830134|NCT04518462|Anesthetics|anesthetics|mesh-ancestor
153830135|NCT04518462|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153830136|NCT04518462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153830137|NCT04518462|Sensory System Agents|sensory system agents|mesh-ancestor
153830138|NCT04518462|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153830139|NCT00496184|Nifedipine|nifedipine|mesh-list
153830140|NCT00496184|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153830141|NCT00496184|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153830142|NCT00496184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153830143|NCT00496184|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153830144|NCT00496184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153830145|NCT00496184|Vasodilator Agents|vasodilator agents|mesh-ancestor
153830146|NCT00496184|Tocolytic Agents|tocolytic agents|mesh-ancestor
153370176|NCT02760329|Gasotransmitters|gasotransmitters|mesh-ancestor
153429275|NCT00002594|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153429276|NCT00002594|Alkylating Agents|alkylating agents|mesh-ancestor
153429277|NCT00002594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153370212|NCT02620865|Interleukin-2|interleukin-2|mesh-list
153370213|NCT02620865|Antibodies|antibodies|mesh-list
153370214|NCT02620865|Immunoglobulins|immunoglobulins|mesh-list
153370215|NCT02620865|Sargramostim|sargramostim|mesh-list
153830147|NCT00496184|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153830148|NCT00493610|Acetylcysteine|acetylcysteine|mesh-list
153830149|NCT00493610|N-monoacetylcystine|n-monoacetylcystine|mesh-list
153830150|NCT00493610|Antiviral Agents|antiviral agents|mesh-ancestor
153830151|NCT00493610|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153830152|NCT00493610|Expectorants|expectorants|mesh-ancestor
153830153|NCT00493610|Respiratory System Agents|respiratory system agents|mesh-ancestor
153830154|NCT00493610|Free Radical Scavengers|free radical scavengers|mesh-ancestor
153830155|NCT00493610|Antioxidants|antioxidants|mesh-ancestor
153830156|NCT00493610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153830157|NCT00493610|Protective Agents|protective agents|mesh-ancestor
153830158|NCT00493610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153830178|NCT00496223|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153830179|NCT00496223|Growth Substances|growth substances|mesh-ancestor
153830180|NCT00496223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153830181|NCT00496223|Growth Inhibitors|growth inhibitors|mesh-ancestor
153830182|NCT00496223|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153370217|NCT02620865|Levoleucovorin|levoleucovorin|mesh-list
153370218|NCT02620865|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153370219|NCT02620865|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153370237|NCT02620865|Vitamins|vitamins|mesh-ancestor
153830201|NCT00493727|Acetylcysteine|acetylcysteine|mesh-list
153888197|NCT05643417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153888198|NCT05643417|Growth Inhibitors|growth inhibitors|mesh-ancestor
153888199|NCT04303741|Apatinib|apatinib|mesh-list
153888200|NCT04303741|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153888201|NCT04303741|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153888202|NCT04303741|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153888203|NCT04303741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153830203|NCT00493727|Antiviral Agents|antiviral agents|mesh-ancestor
153830205|NCT00493727|Expectorants|expectorants|mesh-ancestor
153830209|NCT00493727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153830210|NCT00493727|Protective Agents|protective agents|mesh-ancestor
153830211|NCT00493727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153830212|NCT00493727|Antidotes|antidotes|mesh-ancestor
153830213|NCT00493766|Panobinostat|panobinostat|mesh-list
153830214|NCT00493766|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153830215|NCT00493766|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
153830216|NCT00493766|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153830217|NCT00493766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153830218|NCT05146479|Fluorides|fluorides|mesh-list
153830219|NCT05146479|Fluorides, Topical|fluorides, topical|mesh-list
153830220|NCT05146479|Cariostatic Agents|cariostatic agents|mesh-ancestor
153830221|NCT05146479|Protective Agents|protective agents|mesh-ancestor
153830222|NCT05146479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153370281|NCT01665677|Calcium|calcium|mesh-list
153370282|NCT01665677|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153370283|NCT01665677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153370284|NCT01665677|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153370285|NCT01665677|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153370286|NCT01665677|Antimetabolites|antimetabolites|mesh-ancestor
153370287|NCT01665677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153370291|NCT01530373|Clonidine|clonidine|mesh-list
153370315|NCT01499953|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
153370316|NCT01499953|Protease Inhibitors|protease inhibitors|mesh-ancestor
153370317|NCT01499953|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153370318|NCT01499953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153370319|NCT01499953|Anticoagulants|anticoagulants|mesh-ancestor
153370320|NCT01499953|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153370321|NCT01499953|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153370322|NCT01440816|Interleukin-12|interleukin-12|mesh-list
153370323|NCT01440816|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153370324|NCT01440816|Immunologic Factors|immunologic factors|mesh-ancestor
153370325|NCT01440816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153370326|NCT01440816|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153370327|NCT01440816|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153370328|NCT01440816|Growth Substances|growth substances|mesh-ancestor
153370329|NCT01440816|Growth Inhibitors|growth inhibitors|mesh-ancestor
153830282|NCT02591199|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
153830283|NCT02591199|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153830284|NCT02591199|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153830285|NCT02591199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153830286|NCT02591199|Anticoagulants|anticoagulants|mesh-ancestor
153830287|NCT02591199|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153830288|NCT02591199|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153830289|NCT00494078|Insulin Aspart|insulin aspart|mesh-list
153830290|NCT00494078|Insulin, Long-Acting|insulin, long-acting|mesh-list
153830292|NCT00494078|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153830301|NCT00494156|Clopidogrel|clopidogrel|mesh-list
153830302|NCT00494156|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153830303|NCT00494156|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153429302|NCT00002600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153830304|NCT00494156|Analgesics|analgesics|mesh-ancestor
153830305|NCT00494156|Sensory System Agents|sensory system agents|mesh-ancestor
153830306|NCT00494156|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153830307|NCT00494156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153830308|NCT00494156|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153830309|NCT00494156|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153830310|NCT00494156|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153830311|NCT00494156|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153830312|NCT00494156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153830313|NCT00494156|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153830314|NCT00494156|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153830315|NCT00494156|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153370377|NCT02431806|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153370378|NCT02431806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153370379|NCT02431806|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153370380|NCT02431806|Serotonin Agents|serotonin agents|mesh-ancestor
153370381|NCT02431806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153370382|NCT02431806|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
153370383|NCT02431806|Antidepressive Agents|antidepressive agents|mesh-ancestor
153830319|NCT00494156|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
153370399|NCT05220813|Sensory System Agents|sensory system agents|mesh-ancestor
153370400|NCT05220813|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153370401|NCT05220813|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153370402|NCT05220813|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
153370403|NCT05220813|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153370404|NCT05220813|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153370405|NCT05220813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153370406|NCT01650246|Lesinurad|lesinurad|mesh-list
153370407|NCT01650246|Gout Suppressants|gout suppressants|mesh-ancestor
153830367|NCT02596503|Cefixime|cefixime|mesh-list
153830368|NCT02596503|Irinotecan|irinotecan|mesh-list
153830369|NCT02596503|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
153830370|NCT02596503|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153830371|NCT02596503|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153830372|NCT02596503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153830373|NCT02596503|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153830374|NCT02596503|Third Generation Cephalosporins|third generation cephalosporins|mesh-ancestor
153830375|NCT02596503|Beta Lactam Antibiotics|beta lactam antibiotics|mesh-ancestor
153830376|NCT02596503|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153830433|NCT05142072|Cholecalciferol|cholecalciferol|mesh-list
153830434|NCT05142072|Vitamins|vitamins|mesh-ancestor
153830435|NCT05142072|Micronutrients|micronutrients|mesh-ancestor
153370472|NCT01286402|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153370473|NCT01286402|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153370474|NCT01286402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153370475|NCT01286402|Dopamine Agents|dopamine agents|mesh-ancestor
153370476|NCT01286402|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153830460|NCT00494663|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153830461|NCT00494663|Hormone Antagonists|hormone antagonists|mesh-ancestor
153830462|NCT00494663|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153830463|NCT00494663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153830464|NCT00494663|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
153830465|NCT05146674|Tadalafil|tadalafil|mesh-list
153830482|NCT00507195|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153830483|NCT00507195|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153830484|NCT00507195|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153830485|NCT00507195|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153830486|NCT00507195|GABA Modulators|gaba modulators|mesh-ancestor
153370627|NCT05457647|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
153830704|NCT00502970|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153830705|NCT00502970|Antimetabolites|antimetabolites|mesh-ancestor
153830706|NCT00502970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153830707|NCT00502970|Hematinics|hematinics|mesh-ancestor
153370780|NCT03009500|Lidocaine|lidocaine|mesh-list
153370831|NCT01716221|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153370832|NCT01716221|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153830769|NCT00503204|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153830770|NCT00503204|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153830771|NCT00503204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153830772|NCT00503204|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153830773|NCT00503204|Alkylating Agents|alkylating agents|mesh-ancestor
153370865|NCT01215344|Hormones|hormones|mesh-ancestor
153830800|NCT02276391|Telmisartan|telmisartan|mesh-list
153830805|NCT05145270|Sulforaphane|sulforaphane|mesh-list
153830871|NCT01245452|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153830872|NCT01245452|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153370911|NCT04514393|Temozolomide|temozolomide|mesh-list
153370912|NCT04514393|Ibrutinib|ibrutinib|mesh-list
153370913|NCT04514393|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
153370914|NCT04514393|Abortifacient Agents|abortifacient agents|mesh-ancestor
153888254|NCT05271721|Hormones|hormones|mesh-ancestor
153888255|NCT05271721|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153888256|NCT05271721|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153888257|NCT05271721|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153888258|NCT05271721|Protease Inhibitors|protease inhibitors|mesh-ancestor
153888259|NCT05271721|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153371048|NCT02597907|Autonomic Agents|autonomic agents|mesh-ancestor
153371049|NCT02597907|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153429351|NCT00002618|Antidotes|antidotes|mesh-ancestor
153429352|NCT00002618|Protective Agents|protective agents|mesh-ancestor
153429353|NCT00002618|Vitamin B Complex|vitamin b complex|mesh-ancestor
153429354|NCT00002618|Vitamins|vitamins|mesh-ancestor
153429355|NCT00002618|Micronutrients|micronutrients|mesh-ancestor
153429356|NCT00002618|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153429357|NCT00002618|Tubulin Modulators|tubulin modulators|mesh-ancestor
153429358|NCT00002618|Antimitotic Agents|antimitotic agents|mesh-ancestor
153429359|NCT00002618|Mitosis Modulators|mitosis modulators|mesh-ancestor
153429360|NCT00002618|Trace Elements|trace elements|mesh-ancestor
153831120|NCT05929664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153831121|NCT05929664|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153831122|NCT05929664|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153831123|NCT05915104|Budesonide|budesonide|mesh-list
153831124|NCT05915104|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153831125|NCT05915104|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153831126|NCT05915104|Autonomic Agents|autonomic agents|mesh-ancestor
153831128|NCT05915104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153831129|NCT05915104|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153831172|NCT05809011|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153831173|NCT05809011|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153831174|NCT05809011|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153831175|NCT05801419|Nicotine|nicotine|mesh-list
153831176|NCT05801419|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
153831177|NCT05801419|Autonomic Agents|autonomic agents|mesh-ancestor
153831178|NCT05801419|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153831180|NCT05801419|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
153831221|NCT05638633|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153831222|NCT05638633|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153831223|NCT05638633|Antiemetics|antiemetics|mesh-ancestor
153831224|NCT05638633|Autonomic Agents|autonomic agents|mesh-ancestor
153371272|NCT01243580|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
153371273|NCT01743521|Ribavirin|ribavirin|mesh-list
153371274|NCT01743521|Antimetabolites|antimetabolites|mesh-ancestor
153371275|NCT01743521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153371276|NCT01743521|Antiviral Agents|antiviral agents|mesh-ancestor
153371277|NCT01743521|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153371278|NCT00361803|Topotecan|topotecan|mesh-list
153371279|NCT00361803|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
153831254|NCT05439005|Sensory System Agents|sensory system agents|mesh-ancestor
153831255|NCT05439005|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153831256|NCT05439005|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
153831257|NCT05439005|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153831258|NCT05439005|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153831259|NCT05439005|Adrenergic Agents|adrenergic agents|mesh-ancestor
153831260|NCT05439005|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153831261|NCT05439005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153831263|NCT05429580|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
153831268|NCT05401565|Balovaptan|balovaptan|mesh-list
153831287|NCT05229042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153831288|NCT05194488|Botulinum Toxins|botulinum toxins|mesh-list
153831289|NCT05194488|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
153831290|NCT05194488|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
153831291|NCT05194488|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
153831292|NCT05194488|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153371345|NCT01307618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153371346|NCT01307618|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153371347|NCT01307618|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153371348|NCT01307618|Growth Substances|growth substances|mesh-ancestor
153371349|NCT01307618|Growth Inhibitors|growth inhibitors|mesh-ancestor
153371350|NCT01307618|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153371352|NCT01307930|Antifungal Agents|antifungal agents|mesh-ancestor
153371353|NCT01307930|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153371354|NCT05371197|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
153371355|NCT05371197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153371356|NCT05371197|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153371357|NCT05371197|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153371359|NCT01746095|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153371361|NCT05730777|Paclitaxel|paclitaxel|mesh-list
153831332|NCT05111002|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153831333|NCT05091346|Pembrolizumab|pembrolizumab|mesh-list
153831334|NCT05091346|Lenvatinib|lenvatinib|mesh-list
153831335|NCT05091346|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153831336|NCT05091346|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153831337|NCT05091346|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153831338|NCT05091346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153831339|NCT05091346|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153371394|NCT01309802|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
153371395|NCT01309802|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
153371396|NCT01309802|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153371397|NCT01309802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153371398|NCT01309802|Cholinergic Agents|cholinergic agents|mesh-ancestor
153371403|NCT00366093|Eszopiclone|eszopiclone|mesh-list
153831386|NCT05019638|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153831387|NCT05019638|Narcotics|narcotics|mesh-ancestor
153831388|NCT05019638|Analgesics|analgesics|mesh-ancestor
153371439|NCT05730621|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153371440|NCT05730621|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153371441|NCT05730621|Analgesics|analgesics|mesh-ancestor
153371442|NCT05730621|Sensory System Agents|sensory system agents|mesh-ancestor
153371443|NCT05730621|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153371444|NCT05730621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153371445|NCT05730621|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153371453|NCT05730621|Antipyretics|antipyretics|mesh-ancestor
153831423|NCT05019430|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
153831424|NCT05019430|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
153831425|NCT05019430|Serotonin Agents|serotonin agents|mesh-ancestor
153831426|NCT04949399|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
153831427|NCT04949399|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
153831428|NCT04949399|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
153831429|NCT04949399|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153831430|NCT04949399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153831431|NCT04949399|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
153831432|NCT04949399|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153831433|NCT04949399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153371493|NCT05343429|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153371494|NCT05343429|Analgesics|analgesics|mesh-ancestor
153371495|NCT05343429|Sensory System Agents|sensory system agents|mesh-ancestor
153371496|NCT05343429|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153371497|NCT05343429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153371498|NCT05343429|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153371499|NCT05343429|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153371500|NCT05343429|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153371501|NCT05343429|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153371502|NCT05343429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153371503|NCT05343429|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153371504|NCT05343429|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153371506|NCT05343429|Antipyretics|antipyretics|mesh-ancestor
153371539|NCT01349972|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153831478|NCT04692285|Zolpidem|zolpidem|mesh-list
153831584|NCT04230759|Durvalumab|durvalumab|mesh-list
153831585|NCT04230759|Mitomycins|mitomycins|mesh-list
153831586|NCT04230759|Mitomycin|mitomycin|mesh-list
153831587|NCT04230759|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
153831588|NCT04230759|Antimetabolites|antimetabolites|mesh-ancestor
153831589|NCT04230759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153371651|NCT01312844|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153371652|NCT01312844|Antiemetics|antiemetics|mesh-ancestor
153371653|NCT01312844|Autonomic Agents|autonomic agents|mesh-ancestor
153371654|NCT01312844|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153371655|NCT01312844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153371656|NCT01312844|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153371657|NCT01312844|Mydriatics|mydriatics|mesh-ancestor
153371658|NCT01312844|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
153831631|NCT04150731|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
153831632|NCT04150731|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
153831633|NCT04150731|Estradiol|estradiol|mesh-list
153831634|NCT04150731|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
153831635|NCT04150731|Estrogens|estrogens|mesh-ancestor
153831636|NCT04150731|Hormones|hormones|mesh-ancestor
153831637|NCT04150731|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153831671|NCT04083183|Antitubercular Agents|antitubercular agents|mesh-ancestor
153831672|NCT04083183|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153831673|NCT04083183|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153371834|NCT04182399|Anticonvulsants|anticonvulsants|mesh-ancestor
153371908|NCT02618343|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153371909|NCT02618343|Antipruritics|antipruritics|mesh-ancestor
153371910|NCT02618343|Dermatologic Agents|dermatologic agents|mesh-ancestor
153371911|NCT02618343|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
153371912|NCT02618343|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153371913|NCT02618343|Serotonin Agents|serotonin agents|mesh-ancestor
153371914|NCT02618343|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153371915|NCT02618343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153371916|NCT02991053|Ketamine|ketamine|mesh-list
153371917|NCT02991053|Analgesics|analgesics|mesh-ancestor
153371924|NCT02991053|Anesthetics|anesthetics|mesh-ancestor
153371957|NCT01355588|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153371958|NCT01355588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153371959|NCT01355588|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153831889|NCT02852486|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153831890|NCT02852486|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153831892|NCT02852486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153831893|NCT02852486|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153831894|NCT02721732|Pembrolizumab|pembrolizumab|mesh-list
153831960|NCT02174666|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
153831961|NCT02174666|Estrogens|estrogens|mesh-ancestor
153831962|NCT02174666|Hormones|hormones|mesh-ancestor
153831963|NCT02174666|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153831964|NCT02074631|Vitamin D|vitamin d|mesh-list
153831965|NCT02074631|Cholecalciferol|cholecalciferol|mesh-list
153831966|NCT02074631|Ergocalciferols|ergocalciferols|mesh-list
153831967|NCT02074631|Pamidronate|pamidronate|mesh-list
153831968|NCT02074631|Calcium|calcium|mesh-list
153831969|NCT02074631|Vitamins|vitamins|mesh-ancestor
153831970|NCT02074631|Micronutrients|micronutrients|mesh-ancestor
153831971|NCT02074631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153372047|NCT02253173|Hormones|hormones|mesh-ancestor
153372048|NCT02253173|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153372056|NCT03009578|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
153372057|NCT03009578|Hematinics|hematinics|mesh-ancestor
153372058|NCT01361048|Metronidazole|metronidazole|mesh-list
153372059|NCT01361048|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153372061|NCT01361048|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153372062|NCT01361048|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153831991|NCT01859858|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153831995|NCT01613118|Irbesartan|irbesartan|mesh-list
153372093|NCT01362686|Protective Agents|protective agents|mesh-ancestor
153832046|NCT00752479|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
153888275|NCT01301001|Antimanic Agents|antimanic agents|mesh-ancestor
153832047|NCT00752479|Protective Agents|protective agents|mesh-ancestor
153832048|NCT00752479|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153372102|NCT01322048|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153372103|NCT01322048|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153372104|NCT01322048|Vasodilator Agents|vasodilator agents|mesh-ancestor
153372105|NCT01322048|Analgesics|analgesics|mesh-ancestor
153372106|NCT01322048|Sensory System Agents|sensory system agents|mesh-ancestor
153372107|NCT01322048|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153372108|NCT01322048|Sympatholytics|sympatholytics|mesh-ancestor
153372109|NCT01322048|Autonomic Agents|autonomic agents|mesh-ancestor
153372110|NCT01322048|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
153372111|NCT01322048|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153372112|NCT01322048|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153372113|NCT01322360|Morphine|morphine|mesh-list
153372114|NCT01322360|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153372115|NCT01322360|Narcotics|narcotics|mesh-ancestor
153372116|NCT01322360|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153372117|NCT01322360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153372118|NCT01322360|Analgesics|analgesics|mesh-ancestor
153372119|NCT01322360|Sensory System Agents|sensory system agents|mesh-ancestor
153372120|NCT01322360|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153372121|NCT04351724|Ritonavir|ritonavir|mesh-list
153372122|NCT04351724|Lopinavir|lopinavir|mesh-list
153372124|NCT04351724|Chloroquine|chloroquine|mesh-list
153832090|NCT00499811|Vorinostat|vorinostat|mesh-list
153832091|NCT00499811|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153832092|NCT00499811|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
153888290|NCT01300455|Suvorexant|suvorexant|mesh-list
153832154|NCT00500279|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153832155|NCT00500279|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153832156|NCT00500279|Analgesics|analgesics|mesh-ancestor
153832157|NCT00500279|Sensory System Agents|sensory system agents|mesh-ancestor
153832158|NCT00500279|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153832159|NCT00500279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153832160|NCT00500279|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153832161|NCT00500279|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153372208|NCT01323140|Androgens|androgens|mesh-ancestor
153372209|NCT01323140|Hormones|hormones|mesh-ancestor
153372286|NCT01365650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153372299|NCT01324700|Citalopram|citalopram|mesh-list
153832241|NCT00507663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153832243|NCT00508287|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
153832244|NCT00508287|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153832245|NCT00508287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153832246|NCT00508287|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
153832247|NCT00508287|Incretins|incretins|mesh-ancestor
153832248|NCT00508287|Hormones|hormones|mesh-ancestor
153832250|NCT00508326|Paclitaxel|paclitaxel|mesh-list
153372307|NCT01324700|Serotonin Agents|serotonin agents|mesh-ancestor
153832339|NCT02954484|Pregabalin|pregabalin|mesh-list
153832340|NCT02954484|Morphine|morphine|mesh-list
153832341|NCT02954484|Ropivacaine|ropivacaine|mesh-list
153832342|NCT02954484|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153832343|NCT02954484|Narcotics|narcotics|mesh-ancestor
153372392|NCT01777217|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
153372393|NCT01777217|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
153372394|NCT01777217|Cholinergic Agents|cholinergic agents|mesh-ancestor
153372395|NCT01777217|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153372396|NCT01777217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153372397|NCT01777217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153832370|NCT00501098|Caspofungin|caspofungin|mesh-list
153832371|NCT00501098|Antifungal Agents|antifungal agents|mesh-ancestor
153832372|NCT00501098|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153832373|NCT00501098|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153832374|NCT00501098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153832375|NCT00501137|Vaccines|vaccines|mesh-list
153832376|NCT00501137|Immunologic Factors|immunologic factors|mesh-ancestor
153832377|NCT00501137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153832378|NCT01248260|Folic Acid|folic acid|mesh-list
153832379|NCT01248260|Hematinics|hematinics|mesh-ancestor
153372634|NCT00367263|Ciclesonide|ciclesonide|mesh-list
153429399|NCT00002642|Micronutrients|micronutrients|mesh-ancestor
153832808|NCT00502190|Silicon|silicon|mesh-list
153372978|NCT01403246|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153832972|NCT00511212|Immunologic Factors|immunologic factors|mesh-ancestor
153832973|NCT00511212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153832974|NCT00510354|Imatinib Mesylate|imatinib mesylate|mesh-list
153832975|NCT00510354|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153832976|NCT00510354|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153832977|NCT00510354|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153832978|NCT00510354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153832979|NCT00510354|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153832980|NCT01241006|Dexamethasone|dexamethasone|mesh-list
153832981|NCT01241006|Prednisone|prednisone|mesh-list
153373075|NCT05588037|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153373076|NCT05588037|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153373077|NCT05588037|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153373078|NCT05588037|Protease Inhibitors|protease inhibitors|mesh-ancestor
153373079|NCT05588037|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153373080|NCT05588037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153373081|NCT02194088|Diclofenac|diclofenac|mesh-list
153373082|NCT02194088|Atropine|atropine|mesh-list
153373083|NCT02194088|Analgesics|analgesics|mesh-list
153373084|NCT02194088|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153373085|NCT02194088|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153833025|NCT00511446|Docetaxel|docetaxel|mesh-list
153373167|NCT01817855|AZD7624|azd7624|mesh-list
153833206|NCT00513552|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153833207|NCT00513552|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153833208|NCT00513552|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
153833209|NCT00513552|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153833210|NCT00513552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153833211|NCT00513552|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
153833212|NCT00513552|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153373371|NCT02249663|Azelastine|azelastine|mesh-list
153373372|NCT02249663|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153833309|NCT01246973|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153833310|NCT01246973|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153833311|NCT01246973|Analgesics|analgesics|mesh-ancestor
153833312|NCT01246973|Sensory System Agents|sensory system agents|mesh-ancestor
153833313|NCT01246973|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153833314|NCT01246973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153833315|NCT01246973|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153833316|NCT01246973|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153833317|NCT01246973|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153833318|NCT01246973|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153833319|NCT01246973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153373419|NCT01829399|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153373420|NCT01829399|Adrenergic Agents|adrenergic agents|mesh-ancestor
153833372|NCT01245101|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153833373|NCT01245101|Antiviral Agents|antiviral agents|mesh-ancestor
153833377|NCT01245101|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153833379|NCT01245062|Trametinib|trametinib|mesh-list
153373483|NCT01833845|Hydroxychloroquine|hydroxychloroquine|mesh-list
153373484|NCT01833845|Antimetabolites|antimetabolites|mesh-ancestor
153373485|NCT01833845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153373486|NCT01833845|Antiviral Agents|antiviral agents|mesh-ancestor
153373487|NCT01833845|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153373489|NCT01833845|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153373490|NCT01833845|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153373491|NCT01833845|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153373492|NCT01833845|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153373493|NCT01416194|Raloxifene Hydrochloride|raloxifene hydrochloride|mesh-list
153373494|NCT01416194|Bazedoxifene|bazedoxifene|mesh-list
153373495|NCT01416194|Diphosphonates|diphosphonates|mesh-list
153373496|NCT01416194|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
153833449|NCT02955641|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153373515|NCT02698215|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
153833552|NCT01240811|Copper|copper|mesh-list
153373646|NCT03349281|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153373667|NCT03206151|Leucovorin|leucovorin|mesh-list
153833668|NCT04519463|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153833669|NCT04519463|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153833670|NCT04519463|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
153373711|NCT04795583|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153373712|NCT04795583|Glucocorticoids|glucocorticoids|mesh-ancestor
153373713|NCT04795583|Hormones|hormones|mesh-ancestor
153373714|NCT04795583|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153373715|NCT04795583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153373718|NCT02722239|Metformin|metformin|mesh-list
153833682|NCT01244256|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153833683|NCT01244256|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
153833684|NCT01244256|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153373783|NCT02724033|Glucocorticoids|glucocorticoids|mesh-ancestor
153373785|NCT02724033|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153373786|NCT02724033|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153373787|NCT02724033|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153373788|NCT02724033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153373789|NCT02724033|Anesthetics, Local|anesthetics, local|mesh-ancestor
153373790|NCT02724033|Anesthetics|anesthetics|mesh-ancestor
153373791|NCT02724033|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153373828|NCT04950621|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153373829|NCT04950621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153373830|NCT04950621|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153373831|NCT04950621|Anesthetics, General|anesthetics, general|mesh-ancestor
153373832|NCT04950621|Anesthetics|anesthetics|mesh-ancestor
153373833|NCT01848899|Bivalirudin|bivalirudin|mesh-list
153373834|NCT01848899|Antithrombins|antithrombins|mesh-ancestor
153373835|NCT01848899|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
153373836|NCT01848899|Protease Inhibitors|protease inhibitors|mesh-ancestor
153373837|NCT01848899|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153373839|NCT01848899|Anticoagulants|anticoagulants|mesh-ancestor
153833846|NCT01248468|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
153833847|NCT01248468|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
153833848|NCT01248468|Serotonin Agents|serotonin agents|mesh-ancestor
153833849|NCT02275299|Methotrexate|methotrexate|mesh-list
153833850|NCT02275299|Leflunomide|leflunomide|mesh-list
153833851|NCT02275299|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
153833852|NCT02275299|Abortifacient Agents|abortifacient agents|mesh-ancestor
153833855|NCT02275299|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153833857|NCT02275299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153833858|NCT02275299|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153833985|NCT00516750|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
153833986|NCT00516750|Abortifacient Agents|abortifacient agents|mesh-ancestor
153833987|NCT00516750|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153374106|NCT01422434|Betamethasone Valerate|betamethasone valerate|mesh-list
153374107|NCT01422434|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
153374108|NCT01422434|Betamethasone benzoate|betamethasone benzoate|mesh-list
153374109|NCT01422434|Calcipotriene|calcipotriene|mesh-list
153374110|NCT01422434|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
153374111|NCT01422434|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153374112|NCT01422434|Glucocorticoids|glucocorticoids|mesh-ancestor
153374113|NCT01422434|Hormones|hormones|mesh-ancestor
153374114|NCT01422434|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153374115|NCT01422434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153839520|NCT02919501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153839521|NCT02919501|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
153839522|NCT02919501|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153839523|NCT02919501|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153839524|NCT02919501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153839525|NCT02919501|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153839526|NCT02919501|Serotonin Agents|serotonin agents|mesh-ancestor
153379944|NCT03002090|Iron|iron|mesh-list
153381118|NCT02978157|Antacids|antacids|mesh-ancestor
153381175|NCT01602692|Lidocaine|lidocaine|mesh-list
153381200|NCT01602692|Mydriatics|mydriatics|mesh-ancestor
153381201|NCT01602692|Sympathomimetics|sympathomimetics|mesh-ancestor
153381202|NCT01602692|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
153381369|NCT03029273|Cyclophosphamide|cyclophosphamide|mesh-list
153381414|NCT01642238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153381415|NCT01642238|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153381416|NCT01642238|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153381417|NCT01642238|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153381418|NCT01642238|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153381420|NCT01642238|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153381489|NCT05200481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153381490|NCT05200481|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153381492|NCT01615484|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
153381529|NCT01651442|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
153381530|NCT01651442|GABA Agonists|gaba agonists|mesh-ancestor
153841711|NCT02427841|Tubulin Modulators|tubulin modulators|mesh-ancestor
153841712|NCT02427841|Antimitotic Agents|antimitotic agents|mesh-ancestor
153841995|NCT01191697|Oxaliplatin|oxaliplatin|mesh-list
153842032|NCT01044745|Immunologic Factors|immunologic factors|mesh-ancestor
153382147|NCT02196155|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
153842101|NCT02915172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153382217|NCT04499573|Alkylating Agents|alkylating agents|mesh-ancestor
153382218|NCT04499573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153842762|NCT02935647|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153842763|NCT02935647|Anesthetics, General|anesthetics, general|mesh-ancestor
153842764|NCT02935647|Anesthetics|anesthetics|mesh-ancestor
153842765|NCT02912247|Adalimumab|adalimumab|mesh-list
153842766|NCT02912247|Antibodies|antibodies|mesh-list
153842767|NCT02912247|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
153842768|NCT02912247|Immunologic Factors|immunologic factors|mesh-ancestor
153842769|NCT02912247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153842825|NCT02934464|Mitosis Modulators|mitosis modulators|mesh-ancestor
153842826|NCT02934464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153842827|NCT02934464|Antidotes|antidotes|mesh-ancestor
153842828|NCT02934464|Protective Agents|protective agents|mesh-ancestor
153842829|NCT02934464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153842830|NCT02934464|Vitamin B Complex|vitamin b complex|mesh-ancestor
153842831|NCT02934464|Vitamins|vitamins|mesh-ancestor
153842832|NCT02934464|Micronutrients|micronutrients|mesh-ancestor
153842833|NCT02934464|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153842834|NCT02934464|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153842835|NCT02934464|Growth Substances|growth substances|mesh-ancestor
153842862|NCT02934152|Rabeprazole|rabeprazole|mesh-list
153842863|NCT02934152|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153842864|NCT02934152|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153842865|NCT02934152|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
153842867|NCT02934152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153842868|NCT02934152|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
153842869|NCT02934152|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153842870|NCT02934152|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
153842871|NCT02934152|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153383031|NCT02071823|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
153842908|NCT02934945|Formoterol Fumarate|formoterol fumarate|mesh-list
153842909|NCT02934945|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153842910|NCT02934945|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153842911|NCT02934945|Autonomic Agents|autonomic agents|mesh-ancestor
153842912|NCT02934945|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153842913|NCT02934945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153842914|NCT02934945|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153842915|NCT02934945|Respiratory System Agents|respiratory system agents|mesh-ancestor
153842917|NCT02934945|Hormones|hormones|mesh-ancestor
153842966|NCT02933099|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153842967|NCT02933099|Antiemetics|antiemetics|mesh-ancestor
153842968|NCT02933099|Autonomic Agents|autonomic agents|mesh-ancestor
153842969|NCT02933099|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153842970|NCT02933099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153842971|NCT02933099|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153842972|NCT02933099|Glucocorticoids|glucocorticoids|mesh-ancestor
153842973|NCT02933099|Hormones|hormones|mesh-ancestor
153383074|NCT01721564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153383075|NCT02342561|Anti-Infective Agents|anti-infective agents|mesh-list
153383076|NCT02342561|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
153383077|NCT02343575|Valproic Acid|valproic acid|mesh-list
153383078|NCT02343575|Haloperidol|haloperidol|mesh-list
153383079|NCT02343575|Haloperidol decanoate|haloperidol decanoate|mesh-list
153383080|NCT02343575|Antiemetics|antiemetics|mesh-ancestor
153383081|NCT02343575|Autonomic Agents|autonomic agents|mesh-ancestor
153383082|NCT02343575|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153383083|NCT02343575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153383084|NCT02343575|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153383085|NCT02343575|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153383090|NCT02343575|Dopamine Agents|dopamine agents|mesh-ancestor
153383117|NCT00354965|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
153383118|NCT00354965|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153383119|NCT00354965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153383120|NCT02037425|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
153383121|NCT02037425|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
153383122|NCT02037425|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
153383123|NCT02037425|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153383124|NCT02037425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153383182|NCT02354339|Antacids|antacids|mesh-ancestor
153383185|NCT01747850|Ethanol|ethanol|mesh-list
153843156|NCT04137770|Ketorolac|ketorolac|mesh-list
153843233|NCT02933775|Immunologic Factors|immunologic factors|mesh-ancestor
153843234|NCT02933775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153843235|NCT02933775|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153843236|NCT02933775|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153843237|NCT02933775|Alkylating Agents|alkylating agents|mesh-ancestor
153843238|NCT02933775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153843239|NCT02933775|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153843284|NCT02933853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153843285|NCT00532194|Cediranib|cediranib|mesh-list
153843286|NCT00532194|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153843287|NCT00532194|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153383407|NCT01749956|Antidotes|antidotes|mesh-ancestor
153383408|NCT01749956|Protective Agents|protective agents|mesh-ancestor
153383409|NCT01749956|Vitamin B Complex|vitamin b complex|mesh-ancestor
153383410|NCT01749956|Vitamins|vitamins|mesh-ancestor
153383411|NCT01749956|Micronutrients|micronutrients|mesh-ancestor
153383412|NCT01749956|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153383413|NCT01749956|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153383414|NCT01749956|Growth Substances|growth substances|mesh-ancestor
153383750|NCT02389361|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153843765|NCT02931786|Analgesics|analgesics|mesh-ancestor
153888324|NCT02879110|Protective Agents|protective agents|mesh-ancestor
153888325|NCT02879110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153843869|NCT02919059|Immunologic Factors|immunologic factors|mesh-ancestor
153843870|NCT04727775|Remdesivir|remdesivir|mesh-list
153843871|NCT04727775|Favipiravir|favipiravir|mesh-list
153843872|NCT04727775|Antimetabolites|antimetabolites|mesh-ancestor
153843873|NCT04727775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153843874|NCT04727775|Antiviral Agents|antiviral agents|mesh-ancestor
153843875|NCT04727775|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153843876|NCT02918825|Olanzapine|olanzapine|mesh-list
153843877|NCT02918825|Paliperidone Palmitate|paliperidone palmitate|mesh-list
153843878|NCT02918825|Antiemetics|antiemetics|mesh-ancestor
153384037|NCT01736852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153384038|NCT01810952|Insulin|insulin|mesh-list
153384039|NCT01810952|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
153384040|NCT01810952|Insulin Glargine|insulin glargine|mesh-list
153384041|NCT01810952|Insulin, Isophane|insulin, isophane|mesh-list
153384042|NCT01810952|Isophane Insulin, Human|isophane insulin, human|mesh-list
153843929|NCT02918747|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153843930|NCT02918747|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153843931|NCT02918747|Tubulin Modulators|tubulin modulators|mesh-ancestor
153843971|NCT00532584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153843972|NCT00532584|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153843973|NCT00532584|Respiratory System Agents|respiratory system agents|mesh-ancestor
153843974|NCT04687332|Tryptophan|tryptophan|mesh-list
153843975|NCT04687332|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
153843976|NCT04687332|Antidepressive Agents|antidepressive agents|mesh-ancestor
153843977|NCT04687332|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153843978|NCT05467709|Midazolam|midazolam|mesh-list
153843979|NCT05467709|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153843980|NCT05467709|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153843981|NCT05467709|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153843982|NCT05467709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153844031|NCT00533676|Sympathomimetics|sympathomimetics|mesh-ancestor
153844032|NCT00533676|Autonomic Agents|autonomic agents|mesh-ancestor
153844033|NCT00533676|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153384133|NCT03974789|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153844047|NCT05466149|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153844048|NCT05466149|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153844049|NCT05466149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153844050|NCT00532701|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
153844052|NCT00532701|Ribavirin|ribavirin|mesh-list
153844080|NCT00532454|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153844081|NCT00532454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153844095|NCT01275625|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
153844097|NCT05459792|Bupivacaine|bupivacaine|mesh-list
153844098|NCT05459792|Anesthetics, Local|anesthetics, local|mesh-ancestor
153844099|NCT05459792|Anesthetics|anesthetics|mesh-ancestor
153844100|NCT05459792|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153844101|NCT05459792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153844102|NCT05459792|Sensory System Agents|sensory system agents|mesh-ancestor
153844103|NCT05459792|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153844104|NCT05459792|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153844105|NCT05459792|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
153844106|NCT05459792|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153844107|NCT05459792|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153844108|NCT05459792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153844109|NCT04686825|DA-8010|da-8010|mesh-list
153844110|NCT04686825|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
153844111|NCT04686825|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
153844112|NCT04686825|Cholinergic Agents|cholinergic agents|mesh-ancestor
153844113|NCT04686825|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153844114|NCT04686825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153844116|NCT00533988|Anti-Infective Agents|anti-infective agents|mesh-list
153384245|NCT00357461|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153384246|NCT00357461|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153384247|NCT00357461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153844177|NCT00534183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153844178|NCT00534183|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153844179|NCT00534183|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153384352|NCT03519243|Darbepoetin alfa|darbepoetin alfa|mesh-list
153384353|NCT03519243|Hematinics|hematinics|mesh-ancestor
153384354|NCT03577275|Moxifloxacin|moxifloxacin|mesh-list
153384355|NCT03577275|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153384356|NCT03577275|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153384357|NCT03577275|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153384358|NCT03577275|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153384359|NCT03577275|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153384360|NCT03577275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153384361|NCT03577275|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153384362|NCT03521505|Dexmedetomidine|dexmedetomidine|mesh-list
153384363|NCT03521505|Propofol|propofol|mesh-list
153384364|NCT03521505|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153384365|NCT03521505|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153384366|NCT03521505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153384367|NCT03521505|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153384368|NCT03521505|Analgesics|analgesics|mesh-ancestor
153384369|NCT03521505|Sensory System Agents|sensory system agents|mesh-ancestor
153384405|NCT03594045|Protease Inhibitors|protease inhibitors|mesh-ancestor
153384406|NCT03594045|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153384407|NCT03594045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153384408|NCT03594045|Anticoagulants|anticoagulants|mesh-ancestor
153384409|NCT03595449|Lidocaine|lidocaine|mesh-list
153384411|NCT03595449|Anesthetics|anesthetics|mesh-ancestor
153384412|NCT03595449|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153384413|NCT03595449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153384414|NCT03595449|Sensory System Agents|sensory system agents|mesh-ancestor
153384415|NCT03595449|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153384416|NCT03595449|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153844282|NCT05152004|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153844283|NCT05152004|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
153844284|NCT05132153|Milrinone|milrinone|mesh-list
153844285|NCT05132153|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
153844286|NCT05132153|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153844287|NCT05132153|Vasodilator Agents|vasodilator agents|mesh-ancestor
153844288|NCT05132153|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
153844289|NCT05132153|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
153844290|NCT05132153|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153844291|NCT05132153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153844292|NCT05132153|Protective Agents|protective agents|mesh-ancestor
153844293|NCT05132153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153844303|NCT00534378|Anesthetics, General|anesthetics, general|mesh-ancestor
153844304|NCT00534378|Anesthetics|anesthetics|mesh-ancestor
153844305|NCT00534378|GABA Modulators|gaba modulators|mesh-ancestor
153844306|NCT00534378|GABA Agents|gaba agents|mesh-ancestor
153844307|NCT00534378|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153844308|NCT00534378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153844309|NCT05131997|Atorvastatin|atorvastatin|mesh-list
153384425|NCT03597009|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153384426|NCT03597009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153384427|NCT03352323|Phenylephrine|phenylephrine|mesh-list
153384428|NCT03352323|Oxymetazoline|oxymetazoline|mesh-list
153384429|NCT03352323|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153384430|NCT03352323|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153384431|NCT03352323|Adrenergic Agents|adrenergic agents|mesh-ancestor
153384432|NCT03352323|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153384433|NCT03352323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153384434|NCT03352323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153844362|NCT04686890|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153844363|NCT00533039|Varespladib methyl|varespladib methyl|mesh-list
153844364|NCT00533039|Phospholipase A2 Inhibitors|phospholipase a2 inhibitors|mesh-ancestor
153844365|NCT00533039|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153844366|NCT00533039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153844367|NCT05103306|Empagliflozin|empagliflozin|mesh-list
153844368|NCT05103306|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153844369|NCT05103306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153844370|NCT05103306|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
153844372|NCT00534651|Acetaminophen|acetaminophen|mesh-list
153844425|NCT01270828|Pregabalin|pregabalin|mesh-list
153844426|NCT01270828|Analgesics|analgesics|mesh-ancestor
153844427|NCT01270828|Sensory System Agents|sensory system agents|mesh-ancestor
153844428|NCT01270828|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153844429|NCT01270828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153384527|NCT02310750|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153384528|NCT02310750|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153384529|NCT02310750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153384530|NCT03615807|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
153844439|NCT00533195|5-Methoxypsoralen|5-methoxypsoralen|mesh-list
153844440|NCT00533195|Methoxsalen|methoxsalen|mesh-list
153844441|NCT00533195|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
153844442|NCT00533195|Dermatologic Agents|dermatologic agents|mesh-ancestor
153844443|NCT00533195|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153844444|NCT03982407|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
153844489|NCT04959825|Antioxidants|antioxidants|mesh-ancestor
153844490|NCT04959825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153844491|NCT04959825|Protective Agents|protective agents|mesh-ancestor
153844492|NCT04959825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153844493|NCT04959825|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153844494|NCT05471453|Tocotrienols|tocotrienols|mesh-list
153844496|NCT05471453|Tocopherols|tocopherols|mesh-list
153844497|NCT05471453|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
153844498|NCT05471453|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153844536|NCT05471063|Antifungal Agents|antifungal agents|mesh-ancestor
153844537|NCT05471063|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153844538|NCT05471063|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
153844539|NCT05471063|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153844540|NCT05471063|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153844541|NCT05471063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153844542|NCT05471063|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153844576|NCT01268059|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153844577|NCT01268059|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153844579|NCT01268059|Antimitotic Agents|antimitotic agents|mesh-ancestor
153844580|NCT01268059|Mitosis Modulators|mitosis modulators|mesh-ancestor
153844583|NCT01267825|Anesthetics, Local|anesthetics, local|mesh-ancestor
153844641|NCT00593710|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
153844642|NCT00593710|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
153844643|NCT00593710|Adrenergic Agents|adrenergic agents|mesh-ancestor
153844644|NCT00593710|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153844646|NCT04885686|Thymol|thymol|mesh-list
153844647|NCT04885686|Dexamethasone|dexamethasone|mesh-list
153844648|NCT04885686|Hydrocortisone|hydrocortisone|mesh-list
153844649|NCT04885686|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153844650|NCT04885686|Antiemetics|antiemetics|mesh-ancestor
153844651|NCT04885686|Autonomic Agents|autonomic agents|mesh-ancestor
153384783|NCT05747768|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153844658|NCT04885686|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153844659|NCT04885686|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153844660|NCT04885686|Disinfectants|disinfectants|mesh-ancestor
153844661|NCT04885686|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153844662|NCT04885686|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
153844663|NCT04885686|Antifungal Agents|antifungal agents|mesh-ancestor
153844664|NCT00594217|Progesterone|progesterone|mesh-list
153844665|NCT00594217|Progestins|progestins|mesh-ancestor
153844666|NCT00594217|Hormones|hormones|mesh-ancestor
153384815|NCT03398421|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153384816|NCT03398421|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153384817|NCT03398421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153384818|NCT03398421|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153384819|NCT03398421|Hormone Antagonists|hormone antagonists|mesh-ancestor
153384820|NCT03398421|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153384824|NCT01839110|Ranolazine|ranolazine|mesh-list
153844700|NCT00536276|Vitamin D|vitamin d|mesh-list
153384854|NCT01841606|Serotonin Agents|serotonin agents|mesh-ancestor
153384855|NCT01841606|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153384856|NCT01841606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153384857|NCT04392141|Colchicine|colchicine|mesh-list
153384858|NCT04392141|Gout Suppressants|gout suppressants|mesh-ancestor
153384859|NCT04392141|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153844748|NCT01808820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153844749|NCT01808820|Immunomodulating Agents|immunomodulating agents|mesh-ancestor
153844750|NCT01808820|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153844751|NCT01808820|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153844752|NCT01808820|Interferon Inducers|interferon inducers|mesh-ancestor
153844753|NCT05469386|Methylphenidate|methylphenidate|mesh-list
153844754|NCT05469386|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
153844755|NCT05469386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153844759|NCT05469386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153844760|NCT05469386|Dopamine Agents|dopamine agents|mesh-ancestor
153844761|NCT05469386|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153844763|NCT01462890|Bevacizumab|bevacizumab|mesh-list
153844764|NCT01462890|Carboplatin|carboplatin|mesh-list
153844767|NCT01462890|Tubulin Modulators|tubulin modulators|mesh-ancestor
153844787|NCT01259713|Antifungal Agents|antifungal agents|mesh-ancestor
153844788|NCT05469035|Heparin|heparin|mesh-list
153844790|NCT05469035|Anticoagulants|anticoagulants|mesh-ancestor
153844791|NCT05469035|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153844792|NCT05469035|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153844793|NCT05469035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153844794|NCT05468879|Glimepiride|glimepiride|mesh-list
153844795|NCT05468879|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153844796|NCT05468879|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153844797|NCT05468879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153844798|NCT05468879|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153844799|NCT05468879|Immunologic Factors|immunologic factors|mesh-ancestor
153844800|NCT05471427|Docetaxel|docetaxel|mesh-list
153844801|NCT05471427|Taxane|taxane|mesh-list
153384938|NCT04365153|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
153384939|NCT04365153|Immunologic Factors|immunologic factors|mesh-ancestor
153384940|NCT04365153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153384941|NCT03654417|Lidocaine|lidocaine|mesh-list
153384942|NCT03654417|Anesthetics, Local|anesthetics, local|mesh-ancestor
153384943|NCT03654417|Anesthetics|anesthetics|mesh-ancestor
153844809|NCT04326985|Immunologic Factors|immunologic factors|mesh-ancestor
153844810|NCT04326985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153844811|NCT04326985|Viscosupplements|viscosupplements|mesh-ancestor
153844812|NCT04326985|Protective Agents|protective agents|mesh-ancestor
153844813|NCT00536393|Doxorubicin|doxorubicin|mesh-list
153844814|NCT00536393|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
153844815|NCT00536393|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153844816|NCT00536393|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153844817|NCT00536393|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153844818|NCT00536393|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153384963|NCT04358991|Avibactam|avibactam|mesh-list
153384964|NCT04358991|Third Generation Cephalosporins|third generation cephalosporins|mesh-ancestor
153384965|NCT04358991|Beta Lactam Antibiotics|beta lactam antibiotics|mesh-ancestor
153384966|NCT04358991|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153384967|NCT04358991|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153384968|NCT04358991|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
153384969|NCT04358991|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153384970|NCT04358991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153384972|NCT04338009|Protease Inhibitors|protease inhibitors|mesh-ancestor
153385015|NCT02265224|Respiratory System Agents|respiratory system agents|mesh-ancestor
153385016|NCT02265224|Free Radical Scavengers|free radical scavengers|mesh-ancestor
153385017|NCT02265224|Antioxidants|antioxidants|mesh-ancestor
153385018|NCT02265224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153385019|NCT02265224|Protective Agents|protective agents|mesh-ancestor
153385020|NCT02265224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153385021|NCT02265224|Antidotes|antidotes|mesh-ancestor
153844887|NCT00596050|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153844888|NCT00596050|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153844930|NCT04207957|Antifungal Agents|antifungal agents|mesh-ancestor
153844931|NCT04207957|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153844932|NCT00596557|Everolimus|everolimus|mesh-list
153844933|NCT00596557|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
153844934|NCT00596557|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153844935|NCT00596557|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153844936|NCT00596557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153844937|NCT00596557|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153844938|NCT00596557|Immunologic Factors|immunologic factors|mesh-ancestor
153845001|NCT00596986|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153845002|NCT00596986|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153845003|NCT00596986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153845004|NCT00596986|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153845005|NCT00596986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153845006|NCT00596986|Analgesics|analgesics|mesh-ancestor
153845007|NCT00596986|Sensory System Agents|sensory system agents|mesh-ancestor
153845008|NCT00596986|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153845009|NCT00596986|Antidepressive Agents|antidepressive agents|mesh-ancestor
153845010|NCT00596986|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153845011|NCT00596986|Dopamine Agents|dopamine agents|mesh-ancestor
153385129|NCT04203225|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
153385130|NCT04203225|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153385131|NCT04203225|Autonomic Agents|autonomic agents|mesh-ancestor
153385132|NCT04203225|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153385133|NCT04203225|Respiratory System Agents|respiratory system agents|mesh-ancestor
153385135|NCT04203225|Sympathomimetics|sympathomimetics|mesh-ancestor
153385136|NCT04203225|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
153385137|NCT05314257|Granisetron|granisetron|mesh-list
153385138|NCT05314257|Antiemetics|antiemetics|mesh-ancestor
153385139|NCT05314257|Autonomic Agents|autonomic agents|mesh-ancestor
153385140|NCT05314257|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153385141|NCT05314257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153385179|NCT03701061|Vaccines|vaccines|mesh-list
153845088|NCT00598156|Bevacizumab|bevacizumab|mesh-list
153845096|NCT00598156|Growth Inhibitors|growth inhibitors|mesh-ancestor
153845097|NCT00598156|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153845098|NCT00598156|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153845099|NCT00598156|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153845100|NCT00598156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153845101|NCT00598195|Ketamine|ketamine|mesh-list
153845102|NCT00598195|Analgesics|analgesics|mesh-ancestor
153845103|NCT00598195|Sensory System Agents|sensory system agents|mesh-ancestor
153845104|NCT00598195|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153845105|NCT00598195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153845106|NCT00598195|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
153845107|NCT00598195|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153845108|NCT00598195|Anesthetics, General|anesthetics, general|mesh-ancestor
153845109|NCT00598195|Anesthetics|anesthetics|mesh-ancestor
153845110|NCT00598195|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153845111|NCT00598195|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
153845112|NCT00598195|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
153845113|NCT00598195|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153845114|NCT00598195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153845115|NCT00598234|Celecoxib|celecoxib|mesh-list
153845116|NCT00598234|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153845117|NCT00598234|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153845118|NCT00598234|Analgesics|analgesics|mesh-ancestor
153385219|NCT03710187|Hydrocortisone|hydrocortisone|mesh-list
153385220|NCT03710187|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153385221|NCT04167189|Lidocaine|lidocaine|mesh-list
153385222|NCT04167189|Anesthetics, Local|anesthetics, local|mesh-ancestor
153385223|NCT04167189|Anesthetics|anesthetics|mesh-ancestor
153385224|NCT04167189|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153385225|NCT04167189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153385226|NCT04167189|Sensory System Agents|sensory system agents|mesh-ancestor
153385296|NCT03360890|Pembrolizumab|pembrolizumab|mesh-list
153385298|NCT03360890|Tubulin Modulators|tubulin modulators|mesh-ancestor
153385299|NCT03360890|Antimitotic Agents|antimitotic agents|mesh-ancestor
153385300|NCT03360890|Mitosis Modulators|mitosis modulators|mesh-ancestor
153385301|NCT03360890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153385302|NCT03360890|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153845188|NCT02909478|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
153845189|NCT02909478|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153845190|NCT02909478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153845191|NCT02909478|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
153845192|NCT02909478|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153845193|NCT02909478|Serotonin Agents|serotonin agents|mesh-ancestor
153845194|NCT00536211|Metformin|metformin|mesh-list
153385369|NCT03958071|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153385370|NCT04066647|Dexamethasone|dexamethasone|mesh-list
153385371|NCT04066647|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153385372|NCT04066647|Antiemetics|antiemetics|mesh-ancestor
153385373|NCT04066647|Autonomic Agents|autonomic agents|mesh-ancestor
153385374|NCT04066647|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153385375|NCT04066647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153385376|NCT04066647|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153385377|NCT04066647|Glucocorticoids|glucocorticoids|mesh-ancestor
153845341|NCT04319926|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
153845342|NCT04319926|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153845343|NCT04319926|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153845344|NCT04319926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153845345|NCT01313923|Sirolimus|sirolimus|mesh-list
153845346|NCT01313923|Temsirolimus|temsirolimus|mesh-list
153845347|NCT01313923|MTOR Inhibitors|mtor inhibitors|mesh-list
153845348|NCT01313923|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153845349|NCT01313923|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153385455|NCT00552578|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
153385456|NCT02301936|Sofosbuvir|sofosbuvir|mesh-list
153385457|NCT02301936|Ledipasvir, sofosbuvir drug combination|ledipasvir, sofosbuvir drug combination|mesh-list
153385458|NCT02301936|Ledipasvir|ledipasvir|mesh-list
153385459|NCT02301936|Antiviral Agents|antiviral agents|mesh-ancestor
153385460|NCT02301936|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153385461|NCT03881163|Acetylcysteine|acetylcysteine|mesh-list
153385464|NCT03881163|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153385465|NCT03881163|Expectorants|expectorants|mesh-ancestor
153385466|NCT03881163|Respiratory System Agents|respiratory system agents|mesh-ancestor
153385467|NCT03881163|Free Radical Scavengers|free radical scavengers|mesh-ancestor
153845369|NCT01313884|Alkylating Agents|alkylating agents|mesh-ancestor
153845370|NCT01313884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153845371|NCT01313884|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153845410|NCT00537836|Hormones|hormones|mesh-ancestor
153845411|NCT00537836|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153845412|NCT00537836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153845413|NCT02277171|Nitric Oxide|nitric oxide|mesh-list
153845414|NCT02277171|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153845415|NCT02277171|Autonomic Agents|autonomic agents|mesh-ancestor
153845445|NCT05056584|Glucagon|glucagon|mesh-list
153845661|NCT01256476|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153845662|NCT05507892|Canagliflozin|canagliflozin|mesh-list
153845663|NCT05507892|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
153845665|NCT05507892|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153845706|NCT01255423|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153845707|NCT01255423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153845708|NCT01255423|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153845709|NCT01255423|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153845710|NCT01255423|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153845711|NCT01255423|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153845712|NCT01255423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153845741|NCT04390698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153845742|NCT04390698|Narcotics|narcotics|mesh-ancestor
153845743|NCT04390698|Analgesics|analgesics|mesh-ancestor
153845746|NCT04673578|Celecoxib|celecoxib|mesh-list
153845794|NCT01254292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153845795|NCT01254292|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
153845796|NCT01254292|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
153845797|NCT01254292|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
153845798|NCT04683458|Paclitaxel|paclitaxel|mesh-list
153845799|NCT04683458|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
153845800|NCT04683458|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153845801|NCT04683458|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153845802|NCT04683458|Tubulin Modulators|tubulin modulators|mesh-ancestor
153845803|NCT04683458|Antimitotic Agents|antimitotic agents|mesh-ancestor
153845804|NCT04683458|Mitosis Modulators|mitosis modulators|mesh-ancestor
153845805|NCT04683458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153385916|NCT02281448|Eslicarbazepine acetate|eslicarbazepine acetate|mesh-list
153385917|NCT02281448|Contraceptive Agents|contraceptive agents|mesh-list
153385918|NCT02281448|Contraceptives, Oral|contraceptives, oral|mesh-list
153385919|NCT02281448|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-list
153385920|NCT02281448|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153385921|NCT02281448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153385922|NCT02281448|Anticonvulsants|anticonvulsants|mesh-ancestor
153385923|NCT02281448|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
153385924|NCT02281448|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153385925|NCT02281448|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153845832|NCT04515901|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
153845833|NCT04515901|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153845834|NCT04515901|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153845835|NCT04515901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153845836|NCT04320589|Dexmedetomidine|dexmedetomidine|mesh-list
153845838|NCT04320589|Anesthetics, General|anesthetics, general|mesh-list
153845839|NCT04320589|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153845840|NCT04320589|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153845841|NCT04320589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153845842|NCT04320589|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153385986|NCT02717949|Sofosbuvir|sofosbuvir|mesh-list
153845877|NCT01252186|Progestins|progestins|mesh-ancestor
153386079|NCT01379469|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153386080|NCT01379469|Analgesics|analgesics|mesh-ancestor
153386081|NCT01379469|Sensory System Agents|sensory system agents|mesh-ancestor
153386082|NCT01379469|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153386083|NCT01379469|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153845941|NCT04283513|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153845942|NCT01251367|Botulinum Toxins|botulinum toxins|mesh-list
153845953|NCT03910998|Rocuronium|rocuronium|mesh-list
153846007|NCT04320277|Ritonavir|ritonavir|mesh-list
153386266|NCT01895036|Naltrexone|naltrexone|mesh-list
153846311|NCT01266265|Epoprostenol|epoprostenol|mesh-list
153846312|NCT01266265|Sildenafil Citrate|sildenafil citrate|mesh-list
153846313|NCT01266265|Tadalafil|tadalafil|mesh-list
153846314|NCT01266265|Iloprost|iloprost|mesh-list
153846315|NCT01266265|Tezosentan|tezosentan|mesh-list
153846316|NCT01266265|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-list
153846317|NCT01266265|Vasodilator Agents|vasodilator agents|mesh-ancestor
153846318|NCT01266265|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
153846319|NCT01266265|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153846320|NCT01266265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153846321|NCT01266265|Urological Agents|urological agents|mesh-ancestor
153846322|NCT01266265|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153846323|NCT01266265|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
153846359|NCT00538317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153846360|NCT00538317|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153386474|NCT01048125|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
153386475|NCT01048125|Nasal Decongestants|nasal decongestants|mesh-ancestor
153386476|NCT01048125|Respiratory System Agents|respiratory system agents|mesh-ancestor
153386477|NCT01048125|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
153386478|NCT01048125|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153386479|NCT01048125|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153386480|NCT01048125|Adrenergic Agents|adrenergic agents|mesh-ancestor
153386481|NCT01048125|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153386482|NCT01048125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153386483|NCT01048125|Protective Agents|protective agents|mesh-ancestor
153386484|NCT01048125|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153386485|NCT01048125|Vasodilator Agents|vasodilator agents|mesh-ancestor
153386486|NCT01048125|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
153386487|NCT01901588|Dexmedetomidine|dexmedetomidine|mesh-list
153386488|NCT01901588|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153386489|NCT01901588|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153386490|NCT01901588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153386491|NCT01901588|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153386492|NCT01901588|Analgesics|analgesics|mesh-ancestor
153386493|NCT01901588|Sensory System Agents|sensory system agents|mesh-ancestor
153386494|NCT01901588|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153386495|NCT01901588|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
153386496|NCT01901588|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153386497|NCT01901588|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153386498|NCT01901588|Adrenergic Agents|adrenergic agents|mesh-ancestor
153846361|NCT01265953|Sulforaphane|sulforaphane|mesh-list
153846362|NCT01265953|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
153846366|NCT01265875|Secretin|secretin|mesh-list
153846378|NCT00538395|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153846379|NCT00538395|Alkylating Agents|alkylating agents|mesh-ancestor
153846380|NCT00538395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153846381|NCT00538395|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153846382|NCT00538395|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153846383|NCT00538395|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153846384|NCT00538395|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153386567|NCT00982995|Antiemetics|antiemetics|mesh-ancestor
153386568|NCT00982995|Autonomic Agents|autonomic agents|mesh-ancestor
153386569|NCT00982995|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153386570|NCT00982995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153386571|NCT00982995|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153386572|NCT00982995|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
153386573|NCT00982995|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153386574|NCT00982995|Serotonin Agents|serotonin agents|mesh-ancestor
153386577|NCT00965055|Atorvastatin|atorvastatin|mesh-list
153846532|NCT00539331|Cediranib|cediranib|mesh-list
153846551|NCT02236013|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153846552|NCT02236013|Immunologic Factors|immunologic factors|mesh-ancestor
153846553|NCT02236013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153846554|NCT02236013|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153846555|NCT02236013|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153846556|NCT02236013|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153846557|NCT02236013|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153846558|NCT02236013|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153846559|NCT02236013|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153846560|NCT00539409|Insulin|insulin|mesh-list
153846701|NCT00546936|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
153846702|NCT00546936|Dermatologic Agents|dermatologic agents|mesh-ancestor
153846703|NCT01263496|Alogliptin|alogliptin|mesh-list
153846704|NCT01263496|Voglibose|voglibose|mesh-list
153846705|NCT01263496|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153846706|NCT01263496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153846707|NCT01263496|Incretins|incretins|mesh-ancestor
153846708|NCT01263496|Hormones|hormones|mesh-ancestor
153846709|NCT01263496|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153846710|NCT01263496|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
153846711|NCT01263496|Protease Inhibitors|protease inhibitors|mesh-ancestor
153846712|NCT01263496|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153846718|NCT04681937|Prednisolone|prednisolone|mesh-list
153846931|NCT00548067|Valsartan|valsartan|mesh-list
153846932|NCT00548067|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
153846933|NCT00548067|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153846934|NCT00548067|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153846935|NCT00548067|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153846936|NCT00548067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153846937|NCT00548067|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153847060|NCT01262872|Vaccines|vaccines|mesh-list
153847065|NCT00548574|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153847066|NCT00548574|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153847067|NCT00548574|Analgesics|analgesics|mesh-ancestor
153847068|NCT00548574|Sensory System Agents|sensory system agents|mesh-ancestor
153847069|NCT00548574|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153847070|NCT00548574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153847072|NCT00548574|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153847103|NCT04206865|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
153847104|NCT04206865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153847105|NCT00535080|Methyl 5-aminolevulinate|methyl 5-aminolevulinate|mesh-list
153847106|NCT00535080|Aminolevulinic Acid|aminolevulinic acid|mesh-list
153847108|NCT00535080|Dermatologic Agents|dermatologic agents|mesh-ancestor
153847165|NCT04043494|Autonomic Agents|autonomic agents|mesh-ancestor
153847166|NCT04043494|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153847167|NCT04043494|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153847168|NCT04043494|Glucocorticoids|glucocorticoids|mesh-ancestor
153847169|NCT04043494|Hormones|hormones|mesh-ancestor
153847170|NCT04043494|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153847171|NCT04043494|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153847172|NCT04043494|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153847173|NCT04043494|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153387309|NCT05719961|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
153387310|NCT05719961|Insulin Aspart|insulin aspart|mesh-list
153847398|NCT02896829|Imatinib Mesylate|imatinib mesylate|mesh-list
153387564|NCT00000219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153387565|NCT00000219|Analgesics|analgesics|mesh-ancestor
153387566|NCT00000219|Sensory System Agents|sensory system agents|mesh-ancestor
153387567|NCT00000219|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153847438|NCT00551538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153847439|NCT00551577|Carboplatin|carboplatin|mesh-list
153847458|NCT03556696|Anesthetics, General|anesthetics, general|mesh-ancestor
153847459|NCT03556696|Anesthetics|anesthetics|mesh-ancestor
153847465|NCT04320706|Oxytocin|oxytocin|mesh-list
153387729|NCT00000249|Anesthetics|anesthetics|mesh-ancestor
153387730|NCT00000249|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153387731|NCT00000249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153387732|NCT00000249|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153387733|NCT00000249|Analgesics|analgesics|mesh-ancestor
153387734|NCT00000249|Sensory System Agents|sensory system agents|mesh-ancestor
153387735|NCT00000249|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153387736|NCT00000261|Nitrous Oxide|nitrous oxide|mesh-list
153387737|NCT00000261|Sevoflurane|sevoflurane|mesh-list
153387738|NCT00000261|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153387918|NCT05362487|Parasympatholytics|parasympatholytics|mesh-ancestor
153847865|NCT01099449|Calcium|calcium|mesh-list
153847916|NCT05409885|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153847917|NCT05409885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153847918|NCT00552864|Ropivacaine|ropivacaine|mesh-list
153847919|NCT00552864|Levobupivacaine|levobupivacaine|mesh-list
153847920|NCT00552864|Anesthetics, Local|anesthetics, local|mesh-ancestor
153847921|NCT00552864|Anesthetics|anesthetics|mesh-ancestor
153847922|NCT00552864|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153847923|NCT00552864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153847924|NCT00552864|Sensory System Agents|sensory system agents|mesh-ancestor
153847925|NCT00552864|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153847926|NCT01211665|Methylprednisolone|methylprednisolone|mesh-list
153848001|NCT00553137|Hormone Antagonists|hormone antagonists|mesh-ancestor
153848002|NCT00553137|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153388128|NCT00000945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153388131|NCT04344041|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153388132|NCT04344041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153388133|NCT04344041|Vitamins|vitamins|mesh-ancestor
153388134|NCT04344041|Micronutrients|micronutrients|mesh-ancestor
153388135|NCT04344041|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153429542|NCT00002696|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153429543|NCT00002696|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153429544|NCT00002702|Aldesleukin|aldesleukin|mesh-list
153429545|NCT00002702|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153429546|NCT00002702|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153429547|NCT00002702|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153429548|NCT00002702|Antiviral Agents|antiviral agents|mesh-ancestor
153429549|NCT00002702|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153429550|NCT01890577|Darbepoetin alfa|darbepoetin alfa|mesh-list
153848154|NCT03540758|Vasodilator Agents|vasodilator agents|mesh-ancestor
153848155|NCT03540758|Vitamin B Complex|vitamin b complex|mesh-ancestor
153429551|NCT01890577|Hematinics|hematinics|mesh-ancestor
153429552|NCT01315873|Bortezomib|bortezomib|mesh-list
153429553|NCT01315873|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
153848160|NCT03187379|Bupivacaine|bupivacaine|mesh-list
153848174|NCT03182231|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153848175|NCT02964884|Lovastatin|lovastatin|mesh-list
153848176|NCT02964884|L 647318|l 647318|mesh-list
153848177|NCT02964884|Dihydromevinolin|dihydromevinolin|mesh-list
153848178|NCT02964884|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153848179|NCT02964884|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153848180|NCT02964884|Antimetabolites|antimetabolites|mesh-ancestor
153848181|NCT02964884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153848182|NCT02964884|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153848183|NCT02964884|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
153848184|NCT02964884|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153848185|NCT02837042|Pembrolizumab|pembrolizumab|mesh-list
153848447|NCT04678076|Analgesics|analgesics|mesh-ancestor
153848586|NCT01209832|Anesthetics, General|anesthetics, general|mesh-ancestor
153848587|NCT01209832|Anesthetics|anesthetics|mesh-ancestor
153848588|NCT01209832|GABA Modulators|gaba modulators|mesh-ancestor
153848589|NCT01209832|GABA Agents|gaba agents|mesh-ancestor
153848590|NCT01209832|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153848591|NCT01209832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153848592|NCT04667819|Hyaluronic Acid|hyaluronic acid|mesh-list
153848593|NCT04667819|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153848594|NCT04667819|Immunologic Factors|immunologic factors|mesh-ancestor
153388736|NCT00001437|Protective Agents|protective agents|mesh-ancestor
153388737|NCT00001437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153388738|NCT00001437|Vasodilator Agents|vasodilator agents|mesh-ancestor
153388740|NCT00001437|Antioxidants|antioxidants|mesh-ancestor
153388806|NCT00381147|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
153388807|NCT00381147|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153388808|NCT00381147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153388809|NCT00381147|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
153388810|NCT00381147|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153388811|NCT05210465|Dobutamine|dobutamine|mesh-list
153388812|NCT05210465|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
153388813|NCT05210465|Sympathomimetics|sympathomimetics|mesh-ancestor
153388814|NCT05210465|Autonomic Agents|autonomic agents|mesh-ancestor
153848707|NCT04805541|Cholinergic Agents|cholinergic agents|mesh-ancestor
153848825|NCT00557102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153388993|NCT00002325|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153388994|NCT00002325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153388995|NCT00002325|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
153388996|NCT00002325|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
153388997|NCT00002331|Clarithromycin|clarithromycin|mesh-list
153388998|NCT00002331|Ethambutol|ethambutol|mesh-list
153388999|NCT00002331|Clofazimine|clofazimine|mesh-list
153389000|NCT00002331|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153389001|NCT00002331|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153389003|NCT00002331|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153389057|NCT00002343|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153389058|NCT00002343|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
153848952|NCT00539877|Irinotecan|irinotecan|mesh-list
153848953|NCT00539877|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
153848954|NCT00539877|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153848955|NCT00539877|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153848956|NCT00539877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153848957|NCT00539877|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153848958|NCT03798405|Analgesics|analgesics|mesh-list
153848959|NCT03798405|Narcotics|narcotics|mesh-list
153848960|NCT03798405|Sensory System Agents|sensory system agents|mesh-ancestor
153849005|NCT06087055|Antiviral Agents|antiviral agents|mesh-ancestor
153389207|NCT00002397|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
153389208|NCT00002397|Protease Inhibitors|protease inhibitors|mesh-ancestor
153389209|NCT00002397|Antimetabolites|antimetabolites|mesh-ancestor
153389210|NCT00002397|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
153389211|NCT00002397|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153389212|NCT00002205|Abacavir|abacavir|mesh-list
153389213|NCT00002205|Amprenavir|amprenavir|mesh-list
153389214|NCT00002205|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153389216|NCT00002205|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153849075|NCT06085417|Bupivacaine|bupivacaine|mesh-list
153849076|NCT06085417|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153849077|NCT06085417|Antiemetics|antiemetics|mesh-ancestor
153849078|NCT06085417|Autonomic Agents|autonomic agents|mesh-ancestor
153849079|NCT06085417|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153849080|NCT06085417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153849081|NCT06085417|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153849082|NCT06085417|Glucocorticoids|glucocorticoids|mesh-ancestor
153849083|NCT06085417|Hormones|hormones|mesh-ancestor
153849084|NCT06085417|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153849109|NCT06084000|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153849110|NCT06084000|Tubulin Modulators|tubulin modulators|mesh-ancestor
153849111|NCT06084000|Antimitotic Agents|antimitotic agents|mesh-ancestor
153849112|NCT06084000|Mitosis Modulators|mitosis modulators|mesh-ancestor
153849113|NCT06084000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153849114|NCT06080347|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
153849115|NCT06078969|Prednisone|prednisone|mesh-list
153849118|NCT06078969|Hormones|hormones|mesh-ancestor
153849129|NCT06078306|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153849131|NCT06078228|Fentanyl|fentanyl|mesh-list
153849132|NCT06078228|Atracurium|atracurium|mesh-list
153849133|NCT06078228|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153849134|NCT06078228|Narcotics|narcotics|mesh-ancestor
153849135|NCT06078228|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153849136|NCT06078228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153849137|NCT06078228|Analgesics|analgesics|mesh-ancestor
153849138|NCT06078228|Sensory System Agents|sensory system agents|mesh-ancestor
153849191|NCT06053983|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153849192|NCT06053983|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
153849193|NCT06053983|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153849194|NCT06053840|Chloral Hydrate|chloral hydrate|mesh-list
153849195|NCT06053840|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153849196|NCT06053840|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153849197|NCT06053840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153849198|NCT06049160|Misoprostol|misoprostol|mesh-list
153849199|NCT06049160|Oxytocin|oxytocin|mesh-list
153849200|NCT06049160|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
153849201|NCT06049160|Abortifacient Agents|abortifacient agents|mesh-ancestor
153389386|NCT00002235|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153389387|NCT00002235|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153389389|NCT00002463|Prednisone|prednisone|mesh-list
153389390|NCT00002463|Methotrexate|methotrexate|mesh-list
153389391|NCT00002463|Vincristine|vincristine|mesh-list
153849224|NCT06046937|Monolaurin|monolaurin|mesh-list
153849225|NCT06046937|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153849226|NCT06046937|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153849227|NCT06046937|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
153849228|NCT06046937|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153849229|NCT06046937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153849255|NCT05978687|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153849256|NCT05978687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153849257|NCT05978687|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153849258|NCT05978687|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153849259|NCT05978687|Adrenergic Agents|adrenergic agents|mesh-ancestor
153849260|NCT05978687|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153849261|NCT05978687|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
153389451|NCT00002475|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153389453|NCT00002481|Dexamethasone|dexamethasone|mesh-list
153389454|NCT00002481|Cyclophosphamide|cyclophosphamide|mesh-list
153389455|NCT00002481|Etoposide|etoposide|mesh-list
153389456|NCT00002481|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153389457|NCT00002481|Immunologic Factors|immunologic factors|mesh-ancestor
153389458|NCT00002481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153389459|NCT00002481|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153389460|NCT00002481|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153389461|NCT00002481|Alkylating Agents|alkylating agents|mesh-ancestor
153389479|NCT00002481|Antimetabolites|antimetabolites|mesh-ancestor
153389480|NCT00002481|Antiviral Agents|antiviral agents|mesh-ancestor
153389481|NCT00002481|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153389483|NCT00002253|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153389484|NCT00002253|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153389485|NCT00002253|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153389486|NCT00002487|Methotrexate|methotrexate|mesh-list
153849320|NCT05756673|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153849321|NCT05745935|Oxytocin|oxytocin|mesh-list
153849322|NCT05745935|Oxytocics|oxytocics|mesh-ancestor
153849323|NCT05745935|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153849324|NCT05745935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153849325|NCT05693077|Vancomycin|vancomycin|mesh-list
153849326|NCT05693077|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153849327|NCT05693077|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153849328|NCT05692271|Propranolol|propranolol|mesh-list
153849329|NCT05692271|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
153849330|NCT05692271|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
153849331|NCT05692271|Adrenergic Agents|adrenergic agents|mesh-ancestor
153849332|NCT05692271|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153849336|NCT05692271|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153849337|NCT05692271|Vasodilator Agents|vasodilator agents|mesh-ancestor
153849339|NCT05647889|Anesthetics, Local|anesthetics, local|mesh-ancestor
153849340|NCT05647889|Anesthetics|anesthetics|mesh-ancestor
153849341|NCT05647889|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153849342|NCT05647889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153849343|NCT05647889|Sensory System Agents|sensory system agents|mesh-ancestor
153849344|NCT05647889|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153849345|NCT05647889|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153849346|NCT05647889|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
153849354|NCT05526469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153849355|NCT05526469|Sensory System Agents|sensory system agents|mesh-ancestor
153849356|NCT05526469|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153849357|NCT05490511|Cannabidiol|cannabidiol|mesh-list
153849358|NCT05490511|Tacrolimus|tacrolimus|mesh-list
153849359|NCT05490511|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153849360|NCT05490511|Immunologic Factors|immunologic factors|mesh-ancestor
153849361|NCT05490511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153849362|NCT05490511|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
153849363|NCT05490511|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153849364|NCT05490511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153429591|NCT00002714|Glucocorticoids|glucocorticoids|mesh-ancestor
153389622|NCT00002277|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
153389623|NCT00002277|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153389624|NCT00002277|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153389626|NCT00002277|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153389627|NCT00002277|Hormone Antagonists|hormone antagonists|mesh-ancestor
153389628|NCT00002277|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153389629|NCT00002277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153389630|NCT00002277|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
153389631|NCT00002277|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
153389632|NCT00002277|Amebicides|amebicides|mesh-ancestor
153849456|NCT05259319|Atezolizumab|atezolizumab|mesh-list
153849479|NCT05193227|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153849480|NCT05193227|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153849481|NCT05193227|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
153849482|NCT05193227|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153849483|NCT05193227|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153849484|NCT05193227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153849485|NCT05097599|Pembrolizumab|pembrolizumab|mesh-list
153849486|NCT05097599|Trastuzumab|trastuzumab|mesh-list
153849487|NCT05097599|Axitinib|axitinib|mesh-list
153849488|NCT05097599|Talazoparib|talazoparib|mesh-list
153849489|NCT05097599|Sacituzumab govitecan|sacituzumab govitecan|mesh-list
153849490|NCT05097599|Trastuzumab deruxtecan|trastuzumab deruxtecan|mesh-list
153429612|NCT01821859|Bevacizumab|bevacizumab|mesh-list
153849494|NCT05097599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153849495|NCT05097599|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153849496|NCT05097599|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153849497|NCT05097599|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
153849498|NCT05097599|Immunoconjugates|immunoconjugates|mesh-ancestor
153849499|NCT05097599|Immunologic Factors|immunologic factors|mesh-ancestor
153849500|NCT05097599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153849501|NCT05048719|Dulaglutide|dulaglutide|mesh-list
153849502|NCT05048719|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
153849503|NCT05048719|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153849504|NCT05048719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153849505|NCT05048498|Azacitidine|azacitidine|mesh-list
153849506|NCT05048498|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153849518|NCT05009862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153849519|NCT05009862|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153849520|NCT05009862|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153849521|NCT05009862|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153849522|NCT05009862|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153849523|NCT05009862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153849524|NCT05009862|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153849525|NCT05009862|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153849526|NCT05009862|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153849527|NCT05009862|Antipyretics|antipyretics|mesh-ancestor
153849528|NCT05009862|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
153849529|NCT05009862|Antithrombins|antithrombins|mesh-ancestor
153389729|NCT04826237|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153389730|NCT04826237|Glucocorticoids|glucocorticoids|mesh-ancestor
153389731|NCT04826237|Hormones|hormones|mesh-ancestor
153389732|NCT04826237|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153389733|NCT04826237|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153389734|NCT04826237|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153849554|NCT04763564|Hormones|hormones|mesh-ancestor
153849555|NCT04763564|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153849556|NCT04743505|Osimertinib|osimertinib|mesh-list
153849557|NCT04743505|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153849558|NCT04743505|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153849559|NCT04743505|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153849561|NCT04743505|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153389752|NCT00002535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153389753|NCT00002535|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153389754|NCT00002535|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153389755|NCT00002535|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153389756|NCT00002535|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153389757|NCT00002535|Antiviral Agents|antiviral agents|mesh-ancestor
153389758|NCT00002535|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153389759|NCT00002535|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153389761|NCT00002535|Analgesics|analgesics|mesh-ancestor
153389771|NCT00002547|Cyclosporine|cyclosporine|mesh-list
153389772|NCT00002547|Cyclophosphamide|cyclophosphamide|mesh-list
153389773|NCT00002547|Busulfan|busulfan|mesh-list
153389774|NCT00002547|Methotrexate|methotrexate|mesh-list
153389775|NCT00002547|Cyclosporins|cyclosporins|mesh-list
153389776|NCT00002547|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153389777|NCT00002547|Immunologic Factors|immunologic factors|mesh-ancestor
153389778|NCT00002547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153389779|NCT00002547|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153849651|NCT04567407|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153849652|NCT04567407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153849653|NCT04567407|Sensory System Agents|sensory system agents|mesh-ancestor
153849654|NCT04567407|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153849655|NCT04465097|Exemestane|exemestane|mesh-list
153849656|NCT04465097|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153849657|NCT04465097|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
153849658|NCT04465097|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153389823|NCT00002559|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153849715|NCT04160325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153849716|NCT04160325|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153849717|NCT04154189|Etoposide|etoposide|mesh-list
153849718|NCT04154189|Lenvatinib|lenvatinib|mesh-list
153849719|NCT04154189|Ifosfamide|ifosfamide|mesh-list
153849720|NCT04154189|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153849721|NCT04154189|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153849722|NCT04154189|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153849775|NCT04032964|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153849776|NCT04032964|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153849838|NCT03795311|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153849839|NCT03795311|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153849840|NCT03795311|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153849841|NCT03795311|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153849842|NCT03795311|Growth Substances|growth substances|mesh-ancestor
153849843|NCT03795311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153849844|NCT03795311|Growth Inhibitors|growth inhibitors|mesh-ancestor
153849845|NCT03776136|Pembrolizumab|pembrolizumab|mesh-list
153849846|NCT03776136|Lenvatinib|lenvatinib|mesh-list
153849847|NCT03776136|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153849848|NCT03776136|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153849853|NCT03769181|Cemiplimab|cemiplimab|mesh-list
153849871|NCT03468985|Nivolumab|nivolumab|mesh-list
153849872|NCT03468985|Ipilimumab|ipilimumab|mesh-list
153849873|NCT03468985|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153849874|NCT03468985|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153849875|NCT03468985|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153849876|NCT03468985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153849877|NCT03434418|Osimertinib|osimertinib|mesh-list
153849878|NCT03434418|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153849879|NCT03434418|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153849880|NCT03434418|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153849881|NCT03434418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153849882|NCT03434418|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153849883|NCT03386539|Mycophenolic Acid|mycophenolic acid|mesh-list
153849884|NCT03386539|Everolimus|everolimus|mesh-list
153849885|NCT03386539|Tacrolimus|tacrolimus|mesh-list
153849932|NCT03061474|Nicotinic Acids|nicotinic acids|mesh-list
153849933|NCT03061474|Vitamin B Complex|vitamin b complex|mesh-ancestor
153390109|NCT05806307|Anesthetics|anesthetics|mesh-ancestor
153390110|NCT05806307|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153390111|NCT05806307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153390112|NCT05806307|Sensory System Agents|sensory system agents|mesh-ancestor
153390174|NCT05805553|Androgens|androgens|mesh-ancestor
153850134|NCT04659785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153850135|NCT04659785|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
153850149|NCT01207453|Levomilnacipran|levomilnacipran|mesh-list
153850299|NCT00540891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153392184|NCT01951118|Cholinergic Agents|cholinergic agents|mesh-ancestor
153392187|NCT01951118|Nootropic Agents|nootropic agents|mesh-ancestor
153392528|NCT00000723|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153393012|NCT00421967|Sympathomimetics|sympathomimetics|mesh-ancestor
153393013|NCT00421967|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
153393014|NCT03209687|Menotropins|menotropins|mesh-list
153393015|NCT03209687|Fertility Agents, Female|fertility agents, female|mesh-ancestor
153393016|NCT03209687|Fertility Agents|fertility agents|mesh-ancestor
153393017|NCT03209687|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153393018|NCT03209687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153393019|NCT04997798|Trastuzumab|trastuzumab|mesh-list
153393020|NCT04997798|Exemestane|exemestane|mesh-list
153853162|NCT05174065|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
153853163|NCT05174065|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153853164|NCT05174065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153853166|NCT05141682|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153853167|NCT05141682|Antimetabolites|antimetabolites|mesh-ancestor
153853168|NCT05141682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153853169|NCT05141682|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153393385|NCT01727791|Analgesics|analgesics|mesh-ancestor
153393386|NCT01727791|Sensory System Agents|sensory system agents|mesh-ancestor
153393464|NCT05317039|Calcium|calcium|mesh-list
153393498|NCT03990363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153393499|NCT04341857|Antibodies|antibodies|mesh-list
153393500|NCT04341857|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
153393501|NCT04341857|Immunologic Factors|immunologic factors|mesh-ancestor
153393502|NCT04341857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153393503|NCT00002913|Paclitaxel|paclitaxel|mesh-list
153393550|NCT03083405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153393552|NCT00383799|Procainamide|procainamide|mesh-list
153853319|NCT04761848|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
153853321|NCT04761848|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
153853322|NCT04761848|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
153853323|NCT04761848|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153853324|NCT04757571|Paroxetine|paroxetine|mesh-list
153853327|NCT04757571|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153393593|NCT02918955|Cisplatin|cisplatin|mesh-list
153393673|NCT00002961|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153393674|NCT00002961|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153393675|NCT00002961|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153393676|NCT00002961|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153393677|NCT00002961|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153393678|NCT00002961|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153393679|NCT00002961|Antifungal Agents|antifungal agents|mesh-ancestor
153393680|NCT00002961|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153393681|NCT00002961|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
153393682|NCT00002967|Tamoxifen|tamoxifen|mesh-list
153853471|NCT04377386|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153393743|NCT00003003|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153393744|NCT00003003|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153393745|NCT00003003|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153393746|NCT00003003|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153393747|NCT00003003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153393748|NCT00003003|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153393749|NCT00003003|Alkylating Agents|alkylating agents|mesh-ancestor
153393750|NCT00003003|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153393751|NCT00003009|Aldesleukin|aldesleukin|mesh-list
153393752|NCT00003009|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153393753|NCT00003009|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153393754|NCT00003009|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153393755|NCT00003009|Antiviral Agents|antiviral agents|mesh-ancestor
153393756|NCT00003009|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153393757|NCT00003015|Carboplatin|carboplatin|mesh-list
153393758|NCT00003015|Vincristine|vincristine|mesh-list
153393759|NCT00003015|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153393760|NCT00003015|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153393761|NCT00003015|Tubulin Modulators|tubulin modulators|mesh-ancestor
153393762|NCT00003015|Antimitotic Agents|antimitotic agents|mesh-ancestor
153393763|NCT00003015|Mitosis Modulators|mitosis modulators|mesh-ancestor
153393765|NCT04204837|Nivolumab|nivolumab|mesh-list
153393766|NCT04204837|Relatlimab|relatlimab|mesh-list
153393902|NCT00003105|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153393903|NCT00003105|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153393904|NCT00003105|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153853696|NCT03238196|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153393924|NCT00003117|Antimitotic Agents|antimitotic agents|mesh-ancestor
153393925|NCT00003117|Mitosis Modulators|mitosis modulators|mesh-ancestor
153393926|NCT00003117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153393927|NCT02240329|Capsaicin|capsaicin|mesh-list
153393928|NCT02240329|Antipruritics|antipruritics|mesh-ancestor
153853918|NCT01829568|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153853919|NCT01829568|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153853920|NCT01829568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153853921|NCT01762839|Moxifloxacin|moxifloxacin|mesh-list
153853922|NCT01762839|Oritavancin|oritavancin|mesh-list
153853923|NCT01762839|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153853924|NCT01762839|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153853925|NCT01762839|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153853926|NCT01762839|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153853927|NCT01762839|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153394228|NCT01762501|Amlodipine|amlodipine|mesh-list
153854141|NCT00558506|Abatacept|abatacept|mesh-list
153854248|NCT02905305|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153394596|NCT01790659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153394597|NCT01790659|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153394598|NCT01790659|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153394662|NCT01800877|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
153394663|NCT01800877|Protective Agents|protective agents|mesh-ancestor
153394664|NCT01800877|Hemostatics|hemostatics|mesh-ancestor
153394665|NCT01800877|Coagulants|coagulants|mesh-ancestor
153394666|NCT01800877|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
153394667|NCT01800877|Natriuretic Agents|natriuretic agents|mesh-ancestor
153394668|NCT01800877|Dopamine Agents|dopamine agents|mesh-ancestor
153394669|NCT02471651|Dexamethasone|dexamethasone|mesh-list
153394670|NCT02471651|Ranibizumab|ranibizumab|mesh-list
153394671|NCT02471651|Aflibercept|aflibercept|mesh-list
153394745|NCT02519387|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153394746|NCT02519387|Narcotics|narcotics|mesh-ancestor
153394747|NCT02519387|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153394748|NCT02519387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153394749|NCT02519387|Analgesics|analgesics|mesh-ancestor
153394750|NCT02519387|Sensory System Agents|sensory system agents|mesh-ancestor
153394751|NCT02519387|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153394752|NCT02519387|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
153854625|NCT02896803|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153854626|NCT02896803|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153854627|NCT02896803|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153394867|NCT01879735|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153394868|NCT02417831|Tamsulosin|tamsulosin|mesh-list
153394869|NCT02417831|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
153394871|NCT02417831|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
153854655|NCT01229176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153854657|NCT01228747|Anticonvulsants|anticonvulsants|mesh-ancestor
153854658|NCT01228747|Nootropic Agents|nootropic agents|mesh-ancestor
153854894|NCT00624676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153854895|NCT00624676|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153854896|NCT00624676|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153854897|NCT00624676|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153395179|NCT02430389|Remifentanil|remifentanil|mesh-list
153395180|NCT02430389|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153395181|NCT02430389|Narcotics|narcotics|mesh-ancestor
153395184|NCT02430389|Analgesics|analgesics|mesh-ancestor
153854988|NCT05427903|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
153854989|NCT05427903|Sensory System Agents|sensory system agents|mesh-ancestor
153854990|NCT05427747|Meropenem|meropenem|mesh-list
153854991|NCT05427747|Cefotaxime|cefotaxime|mesh-list
153854992|NCT05427747|Cefoxitin|cefoxitin|mesh-list
153855023|NCT02903004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153855024|NCT02903004|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153855026|NCT02903004|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153855027|NCT02903004|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153855028|NCT02903004|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153855029|NCT02903004|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153395336|NCT02437253|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153395337|NCT02437253|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153395338|NCT01829503|Cytarabine|cytarabine|mesh-list
153395339|NCT01829503|Decitabine|decitabine|mesh-list
153395340|NCT01829503|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153395341|NCT01829503|Antimetabolites|antimetabolites|mesh-ancestor
153395343|NCT01829503|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153855363|NCT00553488|Insulin|insulin|mesh-list
153855692|NCT04318444|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153855693|NCT04318444|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153855694|NCT04318444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153855695|NCT04318444|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153855696|NCT03276143|Enoxaparin|enoxaparin|mesh-list
153855697|NCT03276143|Apixaban|apixaban|mesh-list
153855698|NCT03276143|Anticoagulants|anticoagulants|mesh-ancestor
153855699|NCT03276143|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153855700|NCT03276143|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153855701|NCT03276143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153396067|NCT02605187|Gabapentin|gabapentin|mesh-list
153396179|NCT01847131|Adrenergic Agents|adrenergic agents|mesh-ancestor
153396180|NCT01847131|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153396181|NCT01847131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153396182|NCT01847131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153396184|NCT01847131|Autonomic Agents|autonomic agents|mesh-ancestor
153396185|NCT01847131|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153396186|NCT01847131|Nasal Decongestants|nasal decongestants|mesh-ancestor
153396187|NCT01847131|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
153396188|NCT01847131|Respiratory System Agents|respiratory system agents|mesh-ancestor
153396189|NCT01847131|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
153396190|NCT01847131|Mydriatics|mydriatics|mesh-ancestor
153856132|NCT03685500|Darunavir|darunavir|mesh-list
153396440|NCT04485065|Antimetabolites|antimetabolites|mesh-ancestor
153856235|NCT04680195|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153856236|NCT04680195|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153856237|NCT04680195|Growth Substances|growth substances|mesh-ancestor
153856238|NCT04680195|Growth Inhibitors|growth inhibitors|mesh-ancestor
153856239|NCT04680195|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153856240|NCT04864431|Vitamin D|vitamin d|mesh-list
153856241|NCT04864431|Cholecalciferol|cholecalciferol|mesh-list
153856242|NCT04864431|Vitamins|vitamins|mesh-ancestor
153856243|NCT04864431|Micronutrients|micronutrients|mesh-ancestor
153856321|NCT02205528|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153856322|NCT02205528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153396632|NCT02641691|Fluorouracil|fluorouracil|mesh-list
153856540|NCT04688723|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
153856541|NCT04688723|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
153856542|NCT04688723|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
153856543|NCT04688723|Purinergic Agents|purinergic agents|mesh-ancestor
153856544|NCT04688723|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153856545|NCT04688723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153856546|NCT04688723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153856547|NCT04688723|Antithrombins|antithrombins|mesh-ancestor
153396790|NCT02654483|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
153396791|NCT02654483|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153396792|NCT02654483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153396793|NCT02654483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153396794|NCT02655653|Tranexamic Acid|tranexamic acid|mesh-list
153396795|NCT02655653|Aminocaproic Acid|aminocaproic acid|mesh-list
153396864|NCT05044871|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153396865|NCT05044871|Growth Substances|growth substances|mesh-ancestor
153396866|NCT05044871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153396867|NCT05044871|Growth Inhibitors|growth inhibitors|mesh-ancestor
153396868|NCT05044871|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
153396869|NCT05044871|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153396870|NCT04931693|Acetaminophen|acetaminophen|mesh-list
153396871|NCT04931693|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153396912|NCT04651595|Analgesics|analgesics|mesh-ancestor
153396913|NCT04651595|Sensory System Agents|sensory system agents|mesh-ancestor
153396914|NCT04651595|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153396916|NCT02669615|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153396917|NCT02669615|Alkylating Agents|alkylating agents|mesh-ancestor
153396918|NCT02669615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153396919|NCT02669615|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153396920|NCT02669615|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153396921|NCT02669615|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153396922|NCT02669615|Immunologic Factors|immunologic factors|mesh-ancestor
153396923|NCT02669615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153396924|NCT02672111|Buprenorphine|buprenorphine|mesh-list
153396947|NCT02679911|Ciclopirox|ciclopirox|mesh-list
153396977|NCT02692391|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153396978|NCT02692391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153396979|NCT02692391|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153396980|NCT02692391|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153396981|NCT02692391|Gout Suppressants|gout suppressants|mesh-ancestor
153396982|NCT02692391|Tocolytic Agents|tocolytic agents|mesh-ancestor
153396983|NCT02692391|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153856728|NCT01628094|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153856729|NCT01628094|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153856798|NCT02063685|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153856799|NCT02063685|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153856800|NCT02063295|CKD732|ckd732|mesh-list
153856801|NCT02063295|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153856802|NCT02063295|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153856803|NCT02063295|Growth Substances|growth substances|mesh-ancestor
153397040|NCT02268864|Simeprevir|simeprevir|mesh-list
153397041|NCT02268864|Antiviral Agents|antiviral agents|mesh-ancestor
153397042|NCT02268864|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153397043|NCT02268864|Protease Inhibitors|protease inhibitors|mesh-ancestor
153397044|NCT02268864|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153397052|NCT02703779|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153397218|NCT00085735|Tubulin Modulators|tubulin modulators|mesh-ancestor
153397219|NCT00085735|Antimitotic Agents|antimitotic agents|mesh-ancestor
153397220|NCT00085735|Mitosis Modulators|mitosis modulators|mesh-ancestor
153397221|NCT03578783|Lidocaine, Prilocaine Drug Combination|lidocaine, prilocaine drug combination|mesh-list
153397222|NCT03578783|Anesthetics, Local|anesthetics, local|mesh-ancestor
153397223|NCT03578783|Anesthetics|anesthetics|mesh-ancestor
153397224|NCT03578783|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153397225|NCT03578783|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153397226|NCT03578783|Sensory System Agents|sensory system agents|mesh-ancestor
153856958|NCT02912234|Apixaban|apixaban|mesh-list
153397234|NCT05544786|Protease Inhibitors|protease inhibitors|mesh-ancestor
153397235|NCT05544786|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153397236|NCT05544786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153397237|NCT05544786|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153397238|NCT05544786|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153397239|NCT05544786|Antiviral Agents|antiviral agents|mesh-ancestor
153397240|NCT05544786|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153397241|NCT05544786|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
153397242|NCT05544786|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153397243|NCT02726789|Interferons|interferons|mesh-list
153397244|NCT02726789|Interferon-alpha|interferon-alpha|mesh-list
153397245|NCT02726789|Interferon alpha-2|interferon alpha-2|mesh-list
153397435|NCT05446415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153397436|NCT00370799|Betamethasone|betamethasone|mesh-list
153397437|NCT00370799|Betamethasone Valerate|betamethasone valerate|mesh-list
153397438|NCT00370799|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
153397439|NCT00370799|Betamethasone benzoate|betamethasone benzoate|mesh-list
153397440|NCT00370799|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
153397441|NCT00370799|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
153397442|NCT00370799|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153397530|NCT05431673|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153857275|NCT06219226|Dermatologic Agents|dermatologic agents|mesh-ancestor
153857276|NCT06219226|Dental Disinfectants|dental disinfectants|mesh-ancestor
153857277|NCT06208592|Sevoflurane|sevoflurane|mesh-list
153857278|NCT06208592|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153857279|NCT06208592|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
153857280|NCT06208592|Anesthetics, General|anesthetics, general|mesh-ancestor
153857281|NCT06208592|Anesthetics|anesthetics|mesh-ancestor
153857282|NCT06208592|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153857283|NCT06208592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153857331|NCT06109662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153857332|NCT06048718|Trastuzumab|trastuzumab|mesh-list
153857333|NCT06048718|Trastuzumab deruxtecan|trastuzumab deruxtecan|mesh-list
153857334|NCT06048718|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153857335|NCT06048718|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153397668|NCT01897285|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153397670|NCT00370253|Norepinephrine|norepinephrine|mesh-list
153397671|NCT00370253|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153397672|NCT00370253|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
153397673|NCT00370253|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153397674|NCT00370253|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153397675|NCT00370253|Adrenergic Agents|adrenergic agents|mesh-ancestor
153397676|NCT00370253|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153397677|NCT00370253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153397678|NCT00370253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153397679|NCT00370253|Sympathomimetics|sympathomimetics|mesh-ancestor
153397680|NCT00370253|Autonomic Agents|autonomic agents|mesh-ancestor
153397682|NCT01491815|Abatacept|abatacept|mesh-list
153397748|NCT05139095|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153397749|NCT05139095|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153397750|NCT05139095|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153397751|NCT05139095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153397752|NCT04108247|Fluzoparib|fluzoparib|mesh-list
153397753|NCT04108247|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
153397754|NCT04108247|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153397755|NCT04108247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153397756|NCT04108247|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153397757|NCT05453435|Entecavir|entecavir|mesh-list
153397758|NCT05453435|Antiviral Agents|antiviral agents|mesh-ancestor
153397760|NCT03029845|Propranolol|propranolol|mesh-list
153397806|NCT05062577|GABA Modulators|gaba modulators|mesh-ancestor
153397807|NCT05062577|GABA Agents|gaba agents|mesh-ancestor
153397808|NCT05062577|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153397809|NCT05062577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153397881|NCT01901809|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153888591|NCT01313273|Androgens|androgens|mesh-list
153888592|NCT01313273|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
153888593|NCT01313273|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
153888594|NCT01313273|Androgen Antagonists|androgen antagonists|mesh-list
153429670|NCT00002744|Prednisone|prednisone|mesh-list
153429671|NCT00002744|Hydrocortisone|hydrocortisone|mesh-list
153429676|NCT00002744|Doxorubicin|doxorubicin|mesh-list
153397917|NCT00370643|Insulin|insulin|mesh-list
153397971|NCT01909141|Progestins|progestins|mesh-ancestor
153397972|NCT01909141|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
153397973|NCT01909141|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153397974|NCT01909141|Fertility Agents, Female|fertility agents, female|mesh-ancestor
153397975|NCT01909141|Fertility Agents|fertility agents|mesh-ancestor
153397976|NCT01909141|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
153397977|NCT01909141|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
153397978|NCT04486859|Rivaroxaban|rivaroxaban|mesh-list
153397979|NCT04486859|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
153397980|NCT04486859|Antithrombins|antithrombins|mesh-ancestor
153397981|NCT04486859|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
153397982|NCT04486859|Protease Inhibitors|protease inhibitors|mesh-ancestor
153398197|NCT02833805|Mycophenolic Acid|mycophenolic acid|mesh-list
153858186|NCT00357565|Mycophenolic Acid|mycophenolic acid|mesh-list
153858187|NCT00357565|Fludarabine|fludarabine|mesh-list
153858188|NCT00357565|Fludarabine phosphate|fludarabine phosphate|mesh-list
153858189|NCT00357565|Melphalan|melphalan|mesh-list
153858190|NCT00357565|Busulfan|busulfan|mesh-list
153398579|NCT01987219|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153398580|NCT01987219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153398581|NCT01987219|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
153858392|NCT01216072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153858393|NCT01216072|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153858394|NCT01940991|Botulinum Toxins|botulinum toxins|mesh-list
153398961|NCT02004613|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
153398962|NCT02004613|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153398963|NCT02004613|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153398964|NCT02004613|Adrenergic Agents|adrenergic agents|mesh-ancestor
153398965|NCT02004613|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153398966|NCT02004613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153398968|NCT01754779|Citric Acid|citric acid|mesh-list
153398969|NCT01754779|Sodium Citrate|sodium citrate|mesh-list
153398970|NCT01754779|Anticoagulants|anticoagulants|mesh-ancestor
153858701|NCT04607252|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153858702|NCT04607252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153858703|NCT04607252|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
153858704|NCT04607252|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
153858705|NCT04607252|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
153858845|NCT04322123|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153859351|NCT04664088|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
153399764|NCT02869451|Bupropion|bupropion|mesh-list
153399844|NCT02344316|Melatonin|melatonin|mesh-list
153400104|NCT02396732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153400105|NCT02396732|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153400106|NCT02396732|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153400107|NCT02396732|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153400108|NCT02396732|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153400109|NCT02396732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153400110|NCT02396732|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153859937|NCT00554424|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
153400224|NCT02062177|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153400225|NCT02062177|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153400226|NCT02062177|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153400227|NCT02062177|GABA Modulators|gaba modulators|mesh-ancestor
153400228|NCT02062177|GABA Agents|gaba agents|mesh-ancestor
153400229|NCT02062177|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153859959|NCT00540098|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153400423|NCT02363270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153400425|NCT02042534|Rivaroxaban|rivaroxaban|mesh-list
153400426|NCT02042534|Anticoagulants|anticoagulants|mesh-ancestor
153400427|NCT02042534|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
153400428|NCT02042534|Antithrombins|antithrombins|mesh-ancestor
153400429|NCT02042534|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
153400430|NCT02042534|Protease Inhibitors|protease inhibitors|mesh-ancestor
153400431|NCT02042534|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153400432|NCT02042534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153400433|NCT02043704|Acetaminophen|acetaminophen|mesh-list
153400434|NCT02043704|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153400435|NCT02043704|Analgesics|analgesics|mesh-ancestor
153400436|NCT02043704|Sensory System Agents|sensory system agents|mesh-ancestor
153400437|NCT02043704|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153860138|NCT00541463|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153860139|NCT00541463|Antiviral Agents|antiviral agents|mesh-ancestor
153860140|NCT00541463|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153860141|NCT02324985|Ibuprofen|ibuprofen|mesh-list
153860157|NCT04659642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153860379|NCT00543413|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153860380|NCT00554658|Quetiapine Fumarate|quetiapine fumarate|mesh-list
153860381|NCT00554658|Antidepressive Agents|antidepressive agents|mesh-ancestor
153860382|NCT00554658|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153860383|NCT00554658|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153860384|NCT00554658|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153860385|NCT00554658|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153400679|NCT02371850|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
153400680|NCT02371850|Autonomic Agents|autonomic agents|mesh-ancestor
153400681|NCT02371850|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153400682|NCT02371850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153400683|NCT02371850|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
153400684|NCT02371850|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
153400685|NCT02371850|Cholinergic Agents|cholinergic agents|mesh-ancestor
153400686|NCT02371850|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153400687|NCT02371850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153860413|NCT04647669|Immunologic Factors|immunologic factors|mesh-ancestor
153860414|NCT04647669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153400701|NCT03145259|Analgesics|analgesics|mesh-ancestor
153860415|NCT04647669|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153860416|NCT04647669|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153860417|NCT04647669|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153860418|NCT04647669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153860419|NCT04647669|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153400768|NCT02996591|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153400769|NCT02996591|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153400770|NCT02996591|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153400772|NCT02996591|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153400773|NCT02996591|GABA Modulators|gaba modulators|mesh-ancestor
153400774|NCT02996591|GABA Agents|gaba agents|mesh-ancestor
153400775|NCT02996591|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153400776|NCT02996591|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
153400777|NCT02996591|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
153400778|NCT02996591|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
153400779|NCT02996591|Cholinergic Agents|cholinergic agents|mesh-ancestor
153400780|NCT03066947|Interferons|interferons|mesh-list
153860486|NCT04638582|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153860487|NCT04638582|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153860488|NCT00544193|Gemcitabine|gemcitabine|mesh-list
153860489|NCT00544193|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153860490|NCT00544193|Antimetabolites|antimetabolites|mesh-ancestor
153860491|NCT00544193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153860492|NCT00544193|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153860517|NCT00544232|Dermatologic Agents|dermatologic agents|mesh-ancestor
153860518|NCT00544232|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153860519|NCT00544232|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153860520|NCT00544232|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153860521|NCT00544232|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153400818|NCT03152591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153400819|NCT03152591|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153400820|NCT03152591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153400821|NCT02063035|Tranexamic Acid|tranexamic acid|mesh-list
153860558|NCT00544388|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
153860559|NCT00544388|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
153860560|NCT00544388|Histamine Antagonists|histamine antagonists|mesh-ancestor
153860561|NCT00544388|Histamine Agents|histamine agents|mesh-ancestor
153860562|NCT00544388|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153860563|NCT00544388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153860564|NCT00544388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153400860|NCT03068897|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153860568|NCT00544505|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153860569|NCT00544505|Immunologic Factors|immunologic factors|mesh-ancestor
153860570|NCT00544505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153860571|NCT00544505|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153860572|NCT00544505|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153860573|NCT00544505|Alkylating Agents|alkylating agents|mesh-ancestor
153860574|NCT00544505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153860575|NCT00544505|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153860576|NCT00544505|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153860577|NCT00544505|Antimetabolites|antimetabolites|mesh-ancestor
153860578|NCT00544505|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153860579|NCT00544505|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153860580|NCT00544505|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153860581|NCT00544505|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153860582|NCT00544505|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153860583|NCT00544700|Bevacizumab|bevacizumab|mesh-list
153860584|NCT00544700|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153860585|NCT00544700|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153860591|NCT05824481|Lenvatinib|lenvatinib|mesh-list
153860617|NCT05824312|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153860618|NCT05824312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153400917|NCT02044393|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153400918|NCT02044393|Hormone Antagonists|hormone antagonists|mesh-ancestor
153400919|NCT02044393|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153400920|NCT02044393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153400921|NCT02044393|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
153400922|NCT05405465|Golimumab|golimumab|mesh-list
153400923|NCT05405465|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
153400924|NCT05405465|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153400925|NCT05405465|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153860626|NCT05823883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153860633|NCT05823701|Azacitidine|azacitidine|mesh-list
153860634|NCT05823701|Mitoxantrone|mitoxantrone|mesh-list
153860635|NCT05823701|Obinutuzumab|obinutuzumab|mesh-list
153860636|NCT05823701|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153860637|NCT05823701|Antimetabolites|antimetabolites|mesh-ancestor
153860638|NCT05823701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153860639|NCT05823701|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153860640|NCT05823701|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153860641|NCT05823701|Analgesics|analgesics|mesh-ancestor
153400969|NCT03177395|Expectorants|expectorants|mesh-ancestor
153400970|NCT03177395|Respiratory System Agents|respiratory system agents|mesh-ancestor
153860674|NCT05822674|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153860680|NCT05817474|Lidocaine|lidocaine|mesh-list
153860681|NCT05817474|Tranexamic Acid|tranexamic acid|mesh-list
153860682|NCT05817474|Anesthetics, Local|anesthetics, local|mesh-ancestor
153860683|NCT05817474|Anesthetics|anesthetics|mesh-ancestor
153860684|NCT05817474|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153860685|NCT05817474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153860686|NCT05817474|Sensory System Agents|sensory system agents|mesh-ancestor
153860687|NCT05817474|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153860688|NCT05817474|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153860689|NCT05817474|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
153860690|NCT05817474|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153860691|NCT05817474|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153860692|NCT05817474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153860693|NCT05817474|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
153860694|NCT05817474|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153860695|NCT05817474|Hemostatics|hemostatics|mesh-ancestor
153400995|NCT03179345|Antimanic Agents|antimanic agents|mesh-ancestor
153401010|NCT03086213|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153401031|NCT02378714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153401032|NCT02378714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153401033|NCT03091673|Glucagon|glucagon|mesh-list
153401034|NCT03091673|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
153401035|NCT03091673|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153860717|NCT05751629|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153860718|NCT05751629|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153860719|NCT05751629|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153860720|NCT05751629|Growth Substances|growth substances|mesh-ancestor
153860748|NCT05431179|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153860749|NCT05431179|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153860750|NCT05431179|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153860751|NCT05431179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153860752|NCT05410301|Bevacizumab|bevacizumab|mesh-list
153860753|NCT05410301|Lomustine|lomustine|mesh-list
153860754|NCT05410301|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153860755|NCT05410301|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153401120|NCT02068027|Sympatholytics|sympatholytics|mesh-ancestor
153401121|NCT02068027|Autonomic Agents|autonomic agents|mesh-ancestor
153401122|NCT02068027|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
153401123|NCT02068027|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153401124|NCT02068027|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153401125|NCT02068027|Adrenergic Agents|adrenergic agents|mesh-ancestor
153401126|NCT02068027|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153401127|NCT02068027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153860845|NCT04860141|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153860846|NCT04860141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153860847|NCT04860141|Antimanic Agents|antimanic agents|mesh-ancestor
153860849|NCT04823156|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153860850|NCT04823156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153860851|NCT04813653|Cyclosporine|cyclosporine|mesh-list
153860852|NCT04813653|Dexamethasone|dexamethasone|mesh-list
153860853|NCT04813653|Cyclosporins|cyclosporins|mesh-list
153860854|NCT04813653|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153401157|NCT02392286|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153401164|NCT02393378|Folic Acid|folic acid|mesh-list
153860872|NCT04813653|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153860873|NCT04813653|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
153860874|NCT04803747|Tranexamic Acid|tranexamic acid|mesh-list
153860875|NCT04803747|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
153860876|NCT04803747|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153860877|NCT04803747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153860878|NCT04803747|Hemostatics|hemostatics|mesh-ancestor
153860879|NCT04803747|Coagulants|coagulants|mesh-ancestor
153860880|NCT04790474|Dexamethasone|dexamethasone|mesh-list
153860881|NCT04790474|Pomalidomide|pomalidomide|mesh-list
153401223|NCT02069041|Ramucirumab|ramucirumab|mesh-list
153401224|NCT02069041|Antimetabolites|antimetabolites|mesh-ancestor
153401225|NCT02069041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153401226|NCT02069041|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153401227|NCT02069041|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153401228|NCT02069041|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153401229|NCT02069041|Immunologic Factors|immunologic factors|mesh-ancestor
153401230|NCT02069041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153401231|NCT02069041|Antidotes|antidotes|mesh-ancestor
153401232|NCT02069041|Protective Agents|protective agents|mesh-ancestor
153860904|NCT04743570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153860905|NCT04743570|Sensory System Agents|sensory system agents|mesh-ancestor
153401247|NCT05423834|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153401248|NCT05423834|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153401249|NCT05423834|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153860943|NCT04562090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153860945|NCT04562090|Urological Agents|urological agents|mesh-ancestor
153860946|NCT04557189|Ondansetron|ondansetron|mesh-list
153860947|NCT04557189|Antiemetics|antiemetics|mesh-ancestor
153860948|NCT04557189|Autonomic Agents|autonomic agents|mesh-ancestor
153860949|NCT04557189|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153860950|NCT04557189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153860951|NCT04557189|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153860952|NCT04557189|Antipruritics|antipruritics|mesh-ancestor
153860953|NCT04557189|Dermatologic Agents|dermatologic agents|mesh-ancestor
153860954|NCT04557189|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
153860973|NCT04415060|Anesthetics, General|anesthetics, general|mesh-ancestor
153860974|NCT04415060|Anesthetics|anesthetics|mesh-ancestor
153860975|NCT04415060|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153860976|NCT04415060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153860977|NCT04410445|Nivolumab|nivolumab|mesh-list
153401289|NCT00355862|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153401290|NCT00355862|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153401291|NCT00355862|Antimetabolites|antimetabolites|mesh-ancestor
153401292|NCT00355862|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153401293|NCT02049151|Cyclophosphamide|cyclophosphamide|mesh-list
153401294|NCT02049151|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153401295|NCT02049151|Immunologic Factors|immunologic factors|mesh-ancestor
153401296|NCT02049151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153401297|NCT02049151|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153401298|NCT02049151|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153401299|NCT02049151|Alkylating Agents|alkylating agents|mesh-ancestor
153401300|NCT02049151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153860988|NCT04225312|Immunologic Factors|immunologic factors|mesh-ancestor
153860989|NCT04225312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153860990|NCT04209205|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
153860991|NCT04209205|Immunologic Factors|immunologic factors|mesh-ancestor
153861005|NCT04129086|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153465362|NCT00282282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153465363|NCT00282282|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153465364|NCT00282282|Immunologic Factors|immunologic factors|mesh-ancestor
153465365|NCT00282282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153465366|NCT00282282|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
153465367|NCT00282282|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153861007|NCT04000555|Vancomycin|vancomycin|mesh-list
153861156|NCT01653223|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153861157|NCT01549587|Listerine|listerine|mesh-list
153401636|NCT03326999|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153401637|NCT03326999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153401638|NCT03326999|Sensory System Agents|sensory system agents|mesh-ancestor
153401639|NCT03326999|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153401641|NCT02397265|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153401642|NCT02397265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153401643|NCT00356720|Azithromycin|azithromycin|mesh-list
153401644|NCT00356720|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153401646|NCT04121780|Hormones|hormones|mesh-list
153861439|NCT00547625|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
153861440|NCT00547625|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
153861441|NCT00547625|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153861442|NCT00547625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153861443|NCT00547625|Urological Agents|urological agents|mesh-ancestor
153861444|NCT00547664|Morphine|morphine|mesh-list
153861445|NCT00547664|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153402056|NCT05840861|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153402057|NCT05840861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153402058|NCT05840861|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153402059|NCT05840861|Serotonin Agents|serotonin agents|mesh-ancestor
153402060|NCT05840861|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
153402061|NCT05840861|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
153402062|NCT05840861|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
153402063|NCT05840861|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153402064|NCT05825625|Atezolizumab|atezolizumab|mesh-list
153402065|NCT05825625|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153402066|NCT05825625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153402067|NCT05825625|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153402068|NCT05825625|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153402074|NCT05814640|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
153402076|NCT05814640|Aripiprazole|aripiprazole|mesh-list
153402077|NCT05814640|Lithium Carbonate|lithium carbonate|mesh-list
153402078|NCT05814640|Vortioxetine|vortioxetine|mesh-list
153429725|NCT01788475|BB 1101|bb 1101|mesh-list
153402356|NCT05401227|Analgesics|analgesics|mesh-ancestor
153861991|NCT04683341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153861992|NCT04683341|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153861993|NCT04683341|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153861994|NCT04628676|Epinephrine|epinephrine|mesh-list
153861995|NCT04628676|Tranylcypromine|tranylcypromine|mesh-list
153861996|NCT04628676|Tranexamic Acid|tranexamic acid|mesh-list
153861997|NCT04628676|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
153861998|NCT04628676|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153861999|NCT04628676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153862000|NCT04628676|Hemostatics|hemostatics|mesh-ancestor
153862001|NCT04628676|Coagulants|coagulants|mesh-ancestor
153862002|NCT04628676|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153862013|NCT04628676|Mydriatics|mydriatics|mesh-ancestor
153402414|NCT05308901|Lenvatinib|lenvatinib|mesh-list
153402583|NCT05074589|Levoleucovorin|levoleucovorin|mesh-list
153862228|NCT04626765|Immunologic Factors|immunologic factors|mesh-ancestor
153862244|NCT04626726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153862253|NCT04654416|Colchicine|colchicine|mesh-list
153862254|NCT04654416|Gout Suppressants|gout suppressants|mesh-ancestor
153862255|NCT04654416|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153862256|NCT04654416|Tubulin Modulators|tubulin modulators|mesh-ancestor
153862257|NCT04654416|Antimitotic Agents|antimitotic agents|mesh-ancestor
153862258|NCT04654416|Mitosis Modulators|mitosis modulators|mesh-ancestor
153862261|NCT02906150|Cisplatin|cisplatin|mesh-list
153862366|NCT04625595|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153862367|NCT04625595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153862368|NCT04625595|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
153862369|NCT04625595|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153862370|NCT04625595|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153862371|NCT04625595|Adrenergic Agents|adrenergic agents|mesh-ancestor
153862372|NCT04625595|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153862373|NCT04625595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153862375|NCT02905058|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153862376|NCT02905058|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153862377|NCT02905058|Analgesics|analgesics|mesh-ancestor
153862378|NCT02905058|Sensory System Agents|sensory system agents|mesh-ancestor
153862379|NCT02905058|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153402843|NCT04751500|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
153402844|NCT04751500|Abortifacient Agents|abortifacient agents|mesh-ancestor
153402845|NCT04751500|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153402846|NCT04751500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153402847|NCT04751500|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
153402848|NCT04751500|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153402849|NCT04751500|Oxytocics|oxytocics|mesh-ancestor
153402850|NCT04751500|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
153402851|NCT04751500|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153402852|NCT04751500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153402853|NCT04751500|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
153402854|NCT04751500|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
153402855|NCT04751500|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
153862486|NCT00562068|Vincristine|vincristine|mesh-list
153402926|NCT04640831|Hallucinogens|hallucinogens|mesh-ancestor
153402927|NCT04640831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153402928|NCT04640831|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153402929|NCT04640831|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153402930|NCT04640831|Serotonin Agents|serotonin agents|mesh-ancestor
153862567|NCT04624893|Immunoconjugates|immunoconjugates|mesh-list
153862568|NCT04624893|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
153862569|NCT04624893|Immunologic Factors|immunologic factors|mesh-ancestor
153862570|NCT04624893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153862572|NCT02902523|Antiviral Agents|antiviral agents|mesh-ancestor
153862573|NCT02902523|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153862574|NCT02902523|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153403024|NCT04292457|Propofol|propofol|mesh-list
153403134|NCT04173780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153403135|NCT04173780|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153403136|NCT04173780|Respiratory System Agents|respiratory system agents|mesh-ancestor
153403137|NCT04173780|Mydriatics|mydriatics|mesh-ancestor
153403138|NCT04173780|Parasympatholytics|parasympatholytics|mesh-ancestor
153862750|NCT00562419|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153862751|NCT00562458|Anastrozole|anastrozole|mesh-list
153862752|NCT00562458|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153862753|NCT00562458|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153862754|NCT00562458|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
153862755|NCT00562458|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153862756|NCT00562458|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153862757|NCT00562458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153862758|NCT00562458|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
153862759|NCT00562458|Hormone Antagonists|hormone antagonists|mesh-ancestor
153862760|NCT00562458|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153862761|NCT00562458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153862762|NCT02900729|Losartan|losartan|mesh-list
153862900|NCT05424692|Irinotecan|irinotecan|mesh-list
153862901|NCT05424692|Cetuximab|cetuximab|mesh-list
153862902|NCT05424692|Antimetabolites|antimetabolites|mesh-ancestor
153862951|NCT02885740|Analgesics|analgesics|mesh-ancestor
153862967|NCT01190020|Lubiprostone|lubiprostone|mesh-list
153403394|NCT03846310|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153403395|NCT03846310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153403396|NCT03846310|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153403397|NCT03846310|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153403398|NCT03846310|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153403399|NCT03738800|Trifarotene|trifarotene|mesh-list
153403400|NCT03738800|Dermatologic Agents|dermatologic agents|mesh-ancestor
153403442|NCT03715478|Growth Substances|growth substances|mesh-ancestor
153403443|NCT03715478|Growth Inhibitors|growth inhibitors|mesh-ancestor
153403444|NCT03709043|Ethanol|ethanol|mesh-list
153403445|NCT03709043|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
153403446|NCT03709043|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153403447|NCT03709043|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153863071|NCT01165216|Tubulin Modulators|tubulin modulators|mesh-ancestor
153863072|NCT01165216|Antimitotic Agents|antimitotic agents|mesh-ancestor
153863073|NCT01165216|Mitosis Modulators|mitosis modulators|mesh-ancestor
153863074|NCT01165216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153863075|NCT01165216|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153403892|NCT02207712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153403893|NCT02207712|Growth Inhibitors|growth inhibitors|mesh-ancestor
153403894|NCT02207712|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153403895|NCT02187991|Paclitaxel|paclitaxel|mesh-list
153403896|NCT02187991|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153863496|NCT04587947|Valsartan|valsartan|mesh-list
153863497|NCT04587947|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
153863498|NCT04587947|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153863500|NCT04587947|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
153863714|NCT04631874|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153863715|NCT04631874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153863716|NCT04631874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153863717|NCT02057315|Ketoprofen|ketoprofen|mesh-list
153863718|NCT02057315|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153404100|NCT00455039|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153404101|NCT00455039|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153404102|NCT00455039|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153404103|NCT00455039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153404105|NCT00410956|Dexamethasone|dexamethasone|mesh-list
153863738|NCT02032277|Cyclophosphamide|cyclophosphamide|mesh-list
153863739|NCT02032277|Carboplatin|carboplatin|mesh-list
153863740|NCT02032277|Doxorubicin|doxorubicin|mesh-list
153863741|NCT02032277|Veliparib|veliparib|mesh-list
153863742|NCT02032277|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153863743|NCT02032277|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153863744|NCT02032277|Tubulin Modulators|tubulin modulators|mesh-ancestor
153863745|NCT02032277|Antimitotic Agents|antimitotic agents|mesh-ancestor
153863746|NCT02032277|Mitosis Modulators|mitosis modulators|mesh-ancestor
153404127|NCT00380159|Lamivudine|lamivudine|mesh-list
153404128|NCT00380159|Emtricitabine|emtricitabine|mesh-list
153404129|NCT00380159|Dexelvucitabine|dexelvucitabine|mesh-list
153404130|NCT00380159|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153404131|NCT00380159|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153404132|NCT00380159|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153404133|NCT00380159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153863747|NCT02032277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153863748|NCT02032277|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153863749|NCT02032277|Immunologic Factors|immunologic factors|mesh-ancestor
153863750|NCT02032277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153863751|NCT02032277|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153863752|NCT02032277|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153863753|NCT02032277|Alkylating Agents|alkylating agents|mesh-ancestor
153863754|NCT02032277|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153863755|NCT02032277|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153863756|NCT02032277|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153863757|NCT02032277|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153863758|NCT02032277|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153863762|NCT00560976|Hematinics|hematinics|mesh-ancestor
153863763|NCT02026349|Favipiravir|favipiravir|mesh-list
153863764|NCT02026349|Antiviral Agents|antiviral agents|mesh-ancestor
153404153|NCT00006436|Prednisone|prednisone|mesh-list
153404154|NCT00006436|Cyclophosphamide|cyclophosphamide|mesh-list
153404155|NCT00006436|Rituximab|rituximab|mesh-list
153404156|NCT00006436|Doxorubicin|doxorubicin|mesh-list
153404157|NCT00006436|Etoposide|etoposide|mesh-list
153404158|NCT00006436|Vincristine|vincristine|mesh-list
153404159|NCT00006436|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
153404160|NCT00006436|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153404161|NCT00006436|Immunologic Factors|immunologic factors|mesh-ancestor
153404162|NCT00006436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153863767|NCT04611126|Nivolumab|nivolumab|mesh-list
153888672|NCT01310777|Adrenergic Agents|adrenergic agents|mesh-ancestor
153863794|NCT02014649|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153863795|NCT02014649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153863796|NCT02014142|Latanoprost|latanoprost|mesh-list
153863797|NCT02014142|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
153863798|NCT02014142|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
153863799|NCT04631250|Aminolevulinic Acid|aminolevulinic acid|mesh-list
153863800|NCT04631250|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
153863801|NCT04631250|Dermatologic Agents|dermatologic agents|mesh-ancestor
153863802|NCT01998035|Azacitidine|azacitidine|mesh-list
153863803|NCT01998035|Romidepsin|romidepsin|mesh-list
153404189|NCT00356486|Ribavirin|ribavirin|mesh-list
153863816|NCT00564057|Lercanidipine|lercanidipine|mesh-list
153863831|NCT04677335|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153863832|NCT04677335|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153863833|NCT04677335|Antimetabolites|antimetabolites|mesh-ancestor
153863834|NCT04677335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153404219|NCT02354833|Respiratory System Agents|respiratory system agents|mesh-ancestor
153404220|NCT02354833|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
153404221|NCT02354833|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153404222|NCT02354833|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153863893|NCT01165021|Micronutrients|micronutrients|mesh-ancestor
153863894|NCT01165021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153863895|NCT01165021|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153863896|NCT01165021|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153863897|NCT01165021|Antiemetics|antiemetics|mesh-ancestor
153863898|NCT01165021|Autonomic Agents|autonomic agents|mesh-ancestor
153863899|NCT01165021|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153863900|NCT01165021|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153863901|NCT01165021|Glucocorticoids|glucocorticoids|mesh-ancestor
153863902|NCT01165021|Hormones|hormones|mesh-ancestor
153404290|NCT02802566|Micronutrients|micronutrients|mesh-ancestor
153863911|NCT00561132|Vanadyl sulfate|vanadyl sulfate|mesh-list
153404333|NCT00357188|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153404334|NCT00357188|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
153404335|NCT00357188|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
153404349|NCT01349192|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
153863945|NCT01952990|Protective Agents|protective agents|mesh-ancestor
153863946|NCT04314310|Tenoxicam|tenoxicam|mesh-list
153863947|NCT04314310|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153404415|NCT02112578|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153404416|NCT02112578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153404417|NCT02112578|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
153863997|NCT04629885|Oxytocin|oxytocin|mesh-list
153863998|NCT04629885|Oxytocics|oxytocics|mesh-ancestor
153863999|NCT04629885|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153864000|NCT04629885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153864001|NCT01163851|Bococizumab|bococizumab|mesh-list
153864002|NCT01163851|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153864003|NCT01163851|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153864035|NCT04629846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153864036|NCT04629846|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153864037|NCT01909427|Methotrexate|methotrexate|mesh-list
153864038|NCT01909427|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
153864039|NCT01909427|Abortifacient Agents|abortifacient agents|mesh-ancestor
153864040|NCT01909427|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153864041|NCT01909427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153864042|NCT01909427|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153864043|NCT01909427|Antimetabolites|antimetabolites|mesh-ancestor
153864090|NCT01163266|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
153864091|NCT01163266|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
153864092|NCT01163266|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
153864093|NCT01163266|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153864094|NCT01873703|Azacitidine|azacitidine|mesh-list
153864095|NCT01873703|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153864096|NCT01873703|Antimetabolites|antimetabolites|mesh-ancestor
153864097|NCT01873703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153404489|NCT00354757|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
153404490|NCT00354757|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153864108|NCT01870505|Hormone Antagonists|hormone antagonists|mesh-ancestor
153864109|NCT01870505|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153864110|NCT01870505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153864111|NCT04629612|Anesthetics|anesthetics|mesh-list
153864112|NCT04629612|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153864113|NCT04629612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153864114|NCT00564213|Mitomycins|mitomycins|mesh-list
153864115|NCT00564213|Mitomycin|mitomycin|mesh-list
153864116|NCT00564213|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153864117|NCT00564213|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153864118|NCT00564213|Alkylating Agents|alkylating agents|mesh-ancestor
153864119|NCT00564213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153864120|NCT00564213|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153864139|NCT04609488|Pulmonary Surfactants|pulmonary surfactants|mesh-list
153864140|NCT04609488|Respiratory System Agents|respiratory system agents|mesh-ancestor
153864149|NCT01847573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153864150|NCT01847573|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153864151|NCT01847573|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153864152|NCT01847573|Growth Substances|growth substances|mesh-ancestor
153864153|NCT01847573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153864154|NCT01847573|Growth Inhibitors|growth inhibitors|mesh-ancestor
153404549|NCT02393677|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153404550|NCT02393677|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153404551|NCT02393677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153404553|NCT02393677|Analgesics|analgesics|mesh-ancestor
153864163|NCT04609254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153864165|NCT04609254|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153864166|NCT04609254|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153864167|NCT04609254|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153864168|NCT04609254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153864169|NCT04609254|Antipyretics|antipyretics|mesh-ancestor
153864170|NCT01846481|Cocaine|cocaine|mesh-list
153864171|NCT01846481|Anesthetics, Local|anesthetics, local|mesh-ancestor
153864172|NCT01846481|Anesthetics|anesthetics|mesh-ancestor
153404566|NCT02394457|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153404567|NCT02394457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153404568|NCT00355771|Levocetirizine|levocetirizine|mesh-list
153404569|NCT00355771|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
153404596|NCT01721876|Antiviral Agents|antiviral agents|mesh-ancestor
153404614|NCT04825795|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153404615|NCT04825795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153404616|NCT04825795|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153864198|NCT01804829|Immunoglobulins|immunoglobulins|mesh-list
153864199|NCT01804829|Antibodies|antibodies|mesh-list
153864200|NCT01804829|gamma-Globulins|gamma-globulins|mesh-list
153864201|NCT01804829|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
153864202|NCT01804829|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
153864270|NCT01758458|Analgesics|analgesics|mesh-ancestor
153404661|NCT03226457|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153404662|NCT00003159|Paclitaxel|paclitaxel|mesh-list
153404663|NCT00003159|Vinorelbine|vinorelbine|mesh-list
153404664|NCT00003159|Vinblastine|vinblastine|mesh-list
153404665|NCT00003159|Docetaxel|docetaxel|mesh-list
153404666|NCT00003159|Carboplatin|carboplatin|mesh-list
153404667|NCT00003159|Gemcitabine|gemcitabine|mesh-list
153404668|NCT00003159|Ifosfamide|ifosfamide|mesh-list
153404669|NCT00003159|Mitomycins|mitomycins|mesh-list
153404670|NCT00003159|Mitomycin|mitomycin|mesh-list
153404671|NCT00003159|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153404673|NCT00003159|Tubulin Modulators|tubulin modulators|mesh-ancestor
153864307|NCT01737905|Respiratory System Agents|respiratory system agents|mesh-ancestor
153864308|NCT01737905|Mydriatics|mydriatics|mesh-ancestor
153864309|NCT01737905|Sympathomimetics|sympathomimetics|mesh-ancestor
153864310|NCT01737905|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
153864311|NCT01730027|Montelukast|montelukast|mesh-list
153864312|NCT01730027|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153864313|NCT01730027|Respiratory System Agents|respiratory system agents|mesh-ancestor
153864314|NCT01730027|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
153404708|NCT00355927|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153404709|NCT00355927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153404710|NCT00355927|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153404711|NCT00355927|Anesthetics, General|anesthetics, general|mesh-ancestor
153404713|NCT00357422|Ethanol|ethanol|mesh-list
153404714|NCT00357422|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
153404715|NCT00357422|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153404716|NCT00357422|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153404740|NCT00376337|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153864329|NCT00555230|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153864330|NCT00555230|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153864331|NCT00555230|Antimetabolites|antimetabolites|mesh-ancestor
153864332|NCT00555230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153864333|NCT00555230|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153864334|NCT00555230|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
153864335|NCT00555230|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153864336|NCT04600089|Ketamine|ketamine|mesh-list
153864337|NCT04600089|Analgesics|analgesics|mesh-ancestor
153864338|NCT04600089|Sensory System Agents|sensory system agents|mesh-ancestor
153864344|NCT04600089|Anesthetics|anesthetics|mesh-ancestor
153864357|NCT01698281|Autonomic Agents|autonomic agents|mesh-ancestor
153864358|NCT01698281|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153864361|NCT01698281|Glucocorticoids|glucocorticoids|mesh-ancestor
153404783|NCT01805271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153404784|NCT01805271|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153404785|NCT01805271|Immunologic Factors|immunologic factors|mesh-ancestor
153404786|NCT01805271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153864376|NCT01858883|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153864377|NCT01858883|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153864378|NCT01858883|Tubulin Modulators|tubulin modulators|mesh-ancestor
153864379|NCT01858883|Antimitotic Agents|antimitotic agents|mesh-ancestor
153864380|NCT01858883|Mitosis Modulators|mitosis modulators|mesh-ancestor
153864381|NCT01858883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153864382|NCT01858883|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153864383|NCT01858883|Antimetabolites|antimetabolites|mesh-ancestor
153864384|NCT01697072|Cisplatin|cisplatin|mesh-list
153864391|NCT01697072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153864392|NCT01697072|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153864394|NCT01697072|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153864395|NCT01697072|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153864396|NCT01697072|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153864398|NCT00565500|Celecoxib|celecoxib|mesh-list
153864399|NCT00565500|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153404811|NCT00003195|Busulfan|busulfan|mesh-list
153404834|NCT00356083|Sensory System Agents|sensory system agents|mesh-ancestor
153404835|NCT00356083|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153404836|NCT00356083|Antitussive Agents|antitussive agents|mesh-ancestor
153404837|NCT00356083|Respiratory System Agents|respiratory system agents|mesh-ancestor
153404838|NCT02977832|Alfuzosin|alfuzosin|mesh-list
153404839|NCT02977832|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
153404840|NCT02977832|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
153404849|NCT04344236|Povidone|povidone|mesh-list
153404878|NCT04706897|Ketamine|ketamine|mesh-list
153404879|NCT04706897|Anesthetics, Local|anesthetics, local|mesh-ancestor
153404880|NCT04706897|Anesthetics|anesthetics|mesh-ancestor
153404881|NCT04706897|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153404882|NCT04706897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153404883|NCT04706897|Sensory System Agents|sensory system agents|mesh-ancestor
153404884|NCT04706897|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153404885|NCT04706897|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153404886|NCT04706897|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
153404887|NCT04706897|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153404888|NCT04706897|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153864527|NCT00565656|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153864528|NCT00565656|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153864529|NCT00565656|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153864530|NCT00565656|Growth Substances|growth substances|mesh-ancestor
153404930|NCT01445067|Calcitonin Gene-Related Peptide|calcitonin gene-related peptide|mesh-list
153404931|NCT01445067|Katacalcin|katacalcin|mesh-list
153404932|NCT01445067|Vasodilator Agents|vasodilator agents|mesh-ancestor
153404933|NCT01445067|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153404934|NCT01445067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153404935|NCT01445067|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153404936|NCT02978066|Anesthetics|anesthetics|mesh-list
153404937|NCT02978066|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153404938|NCT02978066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153404939|NCT00003399|Dexamethasone|dexamethasone|mesh-list
153404940|NCT00003399|Paclitaxel|paclitaxel|mesh-list
153864574|NCT00555386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153864575|NCT00555386|Trace Elements|trace elements|mesh-ancestor
153864576|NCT00555386|Micronutrients|micronutrients|mesh-ancestor
153864577|NCT00565929|Smallpox and monkeypox vaccine modified vaccinia ankara-bavarian nordic|smallpox and monkeypox vaccine modified vaccinia ankara-bavarian nordic|mesh-list
153864578|NCT00565929|Antiviral Agents|antiviral agents|mesh-ancestor
153864579|NCT00565929|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153864580|NCT04676516|GSK-3326595|gsk-3326595|mesh-list
153864581|NCT04676516|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153864583|NCT04675697|Etoposide|etoposide|mesh-list
153864607|NCT04675619|Sensory System Agents|sensory system agents|mesh-ancestor
153864608|NCT04675619|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153864609|NCT04675619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153864610|NCT04675619|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153864611|NCT04675619|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153864612|NCT04675619|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153864613|NCT04675619|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153864614|NCT04675619|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153864615|NCT05305300|Vaccines|vaccines|mesh-list
153864650|NCT04606563|Angiotensin II Type 2 Receptor Blockers|angiotensin ii type 2 receptor blockers|mesh-ancestor
153864651|NCT00565968|Sorafenib|sorafenib|mesh-list
153864652|NCT00565968|Melphalan|melphalan|mesh-list
153864653|NCT00565968|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153864654|NCT00565968|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153864655|NCT00565968|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153864656|NCT00565968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153864657|NCT00565968|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153864685|NCT01162486|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153864686|NCT01162486|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153864687|NCT01162486|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
153864688|NCT01162486|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
153864689|NCT01162486|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
153864690|NCT01162486|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
153864691|NCT01162486|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
153864692|NCT01162486|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
153405100|NCT03254147|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
153405101|NCT03254147|Protease Inhibitors|protease inhibitors|mesh-ancestor
153864694|NCT01162135|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153405144|NCT01238211|Antiviral Agents|antiviral agents|mesh-ancestor
153405145|NCT01238211|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153405146|NCT01238211|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153405147|NCT01238211|Immunologic Factors|immunologic factors|mesh-ancestor
153864723|NCT04314505|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153864724|NCT04314505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153864726|NCT04314505|Sensory System Agents|sensory system agents|mesh-ancestor
153864727|NCT04314505|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153864728|NCT02885545|Anticoagulants|anticoagulants|mesh-list
153864729|NCT01161472|Alprazolam|alprazolam|mesh-list
153864801|NCT01160614|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153864802|NCT01160614|Narcotics|narcotics|mesh-ancestor
153864803|NCT01160614|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153864804|NCT01160614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153864805|NCT01160614|Analgesics|analgesics|mesh-ancestor
153864806|NCT01160614|Sensory System Agents|sensory system agents|mesh-ancestor
153864807|NCT01160614|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153864808|NCT00566124|Insulin|insulin|mesh-list
153864809|NCT00566124|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
153864810|NCT00566124|Insulin Glargine|insulin glargine|mesh-list
153864811|NCT00566124|Insulin Detemir|insulin detemir|mesh-list
153864828|NCT04606212|Losartan|losartan|mesh-list
153864830|NCT04606212|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153864831|NCT04606212|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
153864832|NCT04606212|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
153405237|NCT00003249|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
153405238|NCT00003249|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153405239|NCT00003249|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153405240|NCT00003249|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153405241|NCT00003249|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153864863|NCT00560924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153864864|NCT00560963|Everolimus|everolimus|mesh-list
153864865|NCT00560963|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
153864866|NCT00560963|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153864867|NCT00560963|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153864868|NCT00560963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153405273|NCT00003261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153405298|NCT02264574|Ibrutinib|ibrutinib|mesh-list
153864898|NCT01159171|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153864900|NCT01159171|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153864901|NCT01159171|Growth Substances|growth substances|mesh-ancestor
153864902|NCT01159171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153864903|NCT01159171|Growth Inhibitors|growth inhibitors|mesh-ancestor
153864904|NCT01159171|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153864905|NCT01159171|Antimetabolites|antimetabolites|mesh-ancestor
153864906|NCT01159171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153864907|NCT04631315|Prednisolone|prednisolone|mesh-list
153864908|NCT04631315|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
153864909|NCT04631315|Methylprednisolone|methylprednisolone|mesh-list
153405314|NCT04412863|Immunologic Factors|immunologic factors|mesh-ancestor
153405315|NCT04412863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153405316|NCT03400475|Simvastatin|simvastatin|mesh-list
153405317|NCT03400475|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153405318|NCT03400475|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153405319|NCT03400475|Antimetabolites|antimetabolites|mesh-ancestor
153405320|NCT03400475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153405321|NCT03400475|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153405322|NCT03400475|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
153864910|NCT04631315|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
153864911|NCT04631315|Prednisolone acetate|prednisolone acetate|mesh-list
153864912|NCT04631315|Phenylephrine|phenylephrine|mesh-list
153864913|NCT04631315|Oxymetazoline|oxymetazoline|mesh-list
153864914|NCT04631315|Ophthalmic Solutions|ophthalmic solutions|mesh-list
153864915|NCT04631315|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
153864918|NCT04631315|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
153864919|NCT04631315|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153864920|NCT04631315|Glucocorticoids|glucocorticoids|mesh-ancestor
153864957|NCT01158118|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153864958|NCT00566241|Mecasermin|mecasermin|mesh-list
153864959|NCT00566241|Growth Substances|growth substances|mesh-ancestor
153405364|NCT04290871|Protective Agents|protective agents|mesh-ancestor
153405365|NCT03465787|Quetiapine Fumarate|quetiapine fumarate|mesh-list
153405366|NCT03465787|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
153405367|NCT03465787|Antidepressive Agents|antidepressive agents|mesh-ancestor
153405368|NCT03465787|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153405369|NCT03465787|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153405370|NCT03465787|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153864980|NCT00561197|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
153864981|NCT00564993|Dobutamine|dobutamine|mesh-list
153864982|NCT00564993|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
153864983|NCT00564993|Sympathomimetics|sympathomimetics|mesh-ancestor
153864984|NCT00564993|Autonomic Agents|autonomic agents|mesh-ancestor
153864985|NCT00564993|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153864986|NCT00564993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153864987|NCT00564993|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
153864988|NCT00564993|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
153405393|NCT00376025|Protective Agents|protective agents|mesh-ancestor
153405395|NCT00376103|Temozolomide|temozolomide|mesh-list
153405416|NCT03403517|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153405417|NCT03403517|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153405418|NCT03403517|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153405419|NCT03403517|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
153405420|NCT03403517|Protective Agents|protective agents|mesh-ancestor
153405421|NCT02263326|Lamivudine|lamivudine|mesh-list
153405422|NCT02263326|Dolutegravir|dolutegravir|mesh-list
153405423|NCT02263326|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
153405424|NCT02263326|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153405425|NCT02263326|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153405441|NCT00356395|Protease Inhibitors|protease inhibitors|mesh-ancestor
153405442|NCT00356395|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153405443|NCT00356473|Atorvastatin|atorvastatin|mesh-list
153405444|NCT00356473|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153405445|NCT00356473|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153405446|NCT00356473|Antimetabolites|antimetabolites|mesh-ancestor
153405447|NCT00356473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153405448|NCT00356473|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153865030|NCT00566553|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153865031|NCT00566553|Antioxidants|antioxidants|mesh-ancestor
153865033|NCT00566553|Protective Agents|protective agents|mesh-ancestor
153865053|NCT01157065|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153865054|NCT01157065|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153865055|NCT01157065|Growth Substances|growth substances|mesh-ancestor
153865056|NCT01157065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153865057|NCT01157065|Growth Inhibitors|growth inhibitors|mesh-ancestor
153865058|NCT01157065|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153865060|NCT00566592|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
153865061|NCT00566592|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153405470|NCT05445440|Abortifacient Agents|abortifacient agents|mesh-ancestor
153405471|NCT05445440|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153405472|NCT05445440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153405473|NCT05445440|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153405474|NCT05445440|Antimetabolites|antimetabolites|mesh-ancestor
153405475|NCT05445440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153405476|NCT05445440|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153405477|NCT05445440|Dermatologic Agents|dermatologic agents|mesh-ancestor
153405478|NCT05445440|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153405479|NCT05445440|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153405497|NCT05041322|Buspirone|buspirone|mesh-list
153405498|NCT05041322|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153405499|NCT05041322|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153405500|NCT05041322|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153405501|NCT05041322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153405502|NCT05041322|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153405503|NCT05041322|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
153405545|NCT02259582|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153405546|NCT02259582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153405547|NCT02259582|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153405548|NCT02259582|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153405549|NCT00360386|Clopidogrel|clopidogrel|mesh-list
153405550|NCT00360386|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153405551|NCT00360386|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
153865131|NCT04628000|Vitamin D|vitamin d|mesh-list
153405581|NCT04343768|Interferon-beta|interferon-beta|mesh-list
153865144|NCT01155661|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153865145|NCT01155661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153865146|NCT01155661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153865147|NCT01155661|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153865148|NCT01155661|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153865149|NCT01155661|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
153865150|NCT01155661|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153865151|NCT01155661|Disinfectants|disinfectants|mesh-ancestor
153865152|NCT00565188|Adenosine|adenosine|mesh-list
153865153|NCT00565188|Analgesics|analgesics|mesh-ancestor
153865154|NCT00565188|Sensory System Agents|sensory system agents|mesh-ancestor
153865155|NCT00565188|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153865164|NCT04603833|Docetaxel|docetaxel|mesh-list
153865193|NCT01155583|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153865194|NCT01155583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153865195|NCT01155583|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153405607|NCT05925491|Pembrolizumab|pembrolizumab|mesh-list
153865196|NCT01155583|Glucocorticoids|glucocorticoids|mesh-ancestor
153865197|NCT01155583|Hormones|hormones|mesh-ancestor
153865198|NCT01155583|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153865199|NCT01155583|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153865207|NCT01155583|Antimetabolites|antimetabolites|mesh-ancestor
153865252|NCT01155388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153865253|NCT00565227|Docetaxel|docetaxel|mesh-list
153865254|NCT00565227|Vorinostat|vorinostat|mesh-list
153865255|NCT00565227|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153865256|NCT00565227|Tubulin Modulators|tubulin modulators|mesh-ancestor
153865257|NCT00565227|Antimitotic Agents|antimitotic agents|mesh-ancestor
153865258|NCT00565227|Mitosis Modulators|mitosis modulators|mesh-ancestor
153405668|NCT05923021|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153405669|NCT05923021|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153405670|NCT05923021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153865304|NCT01154218|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153865305|NCT01154218|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153865306|NCT01154218|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153865307|NCT01154218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153865308|NCT01154218|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153865309|NCT04601142|Methylprednisolone|methylprednisolone|mesh-list
153405781|NCT05920707|Oxytocics|oxytocics|mesh-ancestor
153405782|NCT05920707|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153405783|NCT05920707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153405784|NCT05920707|Hemostatics|hemostatics|mesh-ancestor
153405785|NCT05920707|Coagulants|coagulants|mesh-ancestor
153405786|NCT05920707|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
153405787|NCT05920707|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
153405788|NCT05920707|Natriuretic Agents|natriuretic agents|mesh-ancestor
153405789|NCT05920538|Nicardipine|nicardipine|mesh-list
153865410|NCT00567216|Adrenergic Agents|adrenergic agents|mesh-ancestor
153865411|NCT00567216|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153865412|NCT00567216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153865413|NCT00567216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153865414|NCT00567216|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153405907|NCT05832398|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153405908|NCT05832398|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153405909|NCT05832398|Antidotes|antidotes|mesh-ancestor
153405910|NCT05832398|Protective Agents|protective agents|mesh-ancestor
153405911|NCT05832398|Vitamin B Complex|vitamin b complex|mesh-ancestor
153405912|NCT05832398|Vitamins|vitamins|mesh-ancestor
153405913|NCT05832398|Micronutrients|micronutrients|mesh-ancestor
153405914|NCT05823987|Lenvatinib|lenvatinib|mesh-list
153865466|NCT00567450|Ropivacaine|ropivacaine|mesh-list
153865467|NCT00567450|Mepivacaine|mepivacaine|mesh-list
153865507|NCT04590612|Immunologic Factors|immunologic factors|mesh-ancestor
153865508|NCT04590612|Dopamine Agonists|dopamine agonists|mesh-ancestor
153865509|NCT00562250|Dapagliflozin|dapagliflozin|mesh-list
153865510|NCT00562250|Glimepiride|glimepiride|mesh-list
153865511|NCT00562250|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
153865512|NCT00562250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153405929|NCT05823467|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153405930|NCT05823467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153405934|NCT05823337|Selenium|selenium|mesh-list
153865545|NCT00562289|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
153865546|NCT00562289|Antithrombins|antithrombins|mesh-ancestor
153865547|NCT00562289|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
153865548|NCT00562289|Protease Inhibitors|protease inhibitors|mesh-ancestor
153865549|NCT00562289|Anticoagulants|anticoagulants|mesh-ancestor
153405965|NCT05730205|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
153405966|NCT05730205|Contraceptive Agents|contraceptive agents|mesh-ancestor
153405967|NCT05730205|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153405971|NCT05706233|Sensory System Agents|sensory system agents|mesh-ancestor
153405996|NCT05693454|Analgesics|analgesics|mesh-ancestor
153405997|NCT05693454|Sensory System Agents|sensory system agents|mesh-ancestor
153405998|NCT05693454|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153405999|NCT05693454|Anesthetics, Local|anesthetics, local|mesh-ancestor
153406000|NCT05693454|Anesthetics|anesthetics|mesh-ancestor
153406001|NCT05672108|Mitomycins|mitomycins|mesh-list
153406002|NCT05672108|Mitomycin|mitomycin|mesh-list
153406003|NCT05672108|Ethiodized Oil|ethiodized oil|mesh-list
153406004|NCT05672108|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153406005|NCT05672108|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153406040|NCT05601700|Antimitotic Agents|antimitotic agents|mesh-ancestor
153406041|NCT05601700|Mitosis Modulators|mitosis modulators|mesh-ancestor
153406042|NCT05601700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153406043|NCT05601700|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
153406044|NCT05601700|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153406045|NCT05601700|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153406046|NCT05601700|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
153406047|NCT05601700|Hormone Antagonists|hormone antagonists|mesh-ancestor
153865604|NCT04590183|Antiemetics|antiemetics|mesh-ancestor
153865647|NCT01153009|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
153429846|NCT01756573|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153865648|NCT01153009|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153865649|NCT01153009|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153865650|NCT01153009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153865651|NCT01153009|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153865652|NCT01153009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153865653|NCT01153009|Analgesics|analgesics|mesh-ancestor
153865654|NCT01153009|Sensory System Agents|sensory system agents|mesh-ancestor
153865655|NCT01153009|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153865656|NCT01153009|Antidepressive Agents|antidepressive agents|mesh-ancestor
153865657|NCT01153009|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153865658|NCT01153009|Dopamine Agents|dopamine agents|mesh-ancestor
153865659|NCT01153009|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153865660|NCT01153009|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153865661|NCT01153009|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153406096|NCT05353140|Clopidogrel|clopidogrel|mesh-list
153406123|NCT05351944|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
153888742|NCT01057693|Analgesics|analgesics|mesh-ancestor
153888743|NCT01057693|Sensory System Agents|sensory system agents|mesh-ancestor
153888744|NCT01057693|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153888745|NCT01057693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153888746|NCT01057693|Anticonvulsants|anticonvulsants|mesh-ancestor
153888747|NCT01057693|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153888748|NCT01057693|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153406173|NCT05216952|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
153406174|NCT05216952|Abortifacient Agents|abortifacient agents|mesh-ancestor
153406175|NCT05216952|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153406177|NCT05216952|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
153406178|NCT05216952|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153406180|NCT05216952|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
153865739|NCT04588935|Bisoprolol|bisoprolol|mesh-list
153865740|NCT04588935|Perindopril|perindopril|mesh-list
153865741|NCT04588935|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153865742|NCT04588935|Sympatholytics|sympatholytics|mesh-ancestor
153865743|NCT04588935|Autonomic Agents|autonomic agents|mesh-ancestor
153865744|NCT04588935|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153865745|NCT04588935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153865746|NCT04588935|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
153865747|NCT04588935|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
153865748|NCT04588935|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
153865749|NCT04588935|Adrenergic Agents|adrenergic agents|mesh-ancestor
153865750|NCT04588935|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153865751|NCT04588935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153865755|NCT00562523|Sorafenib|sorafenib|mesh-list
153865758|NCT00562523|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153865759|NCT00562523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153865760|NCT04649697|Clobetasol|clobetasol|mesh-list
153865761|NCT04649697|Rebamipide|rebamipide|mesh-list
153865762|NCT04649697|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153406181|NCT05216952|Contraceptive Agents|contraceptive agents|mesh-ancestor
153406182|NCT05216952|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
153406183|NCT05213676|Nitric Oxide|nitric oxide|mesh-list
153406184|NCT05213676|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153406185|NCT05213676|Autonomic Agents|autonomic agents|mesh-ancestor
153406186|NCT05213676|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153406187|NCT05213676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153406188|NCT05213676|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153406189|NCT05213676|Respiratory System Agents|respiratory system agents|mesh-ancestor
153865783|NCT00567762|Tacrolimus|tacrolimus|mesh-list
153865786|NCT00567762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153865787|NCT00567762|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
153865788|NCT00567762|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153865789|NCT00567762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153865790|NCT04620785|Methylene Blue|methylene blue|mesh-list
153406235|NCT05139238|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153406236|NCT05139238|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
153406237|NCT05139238|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
153406238|NCT05138614|Analgesics, Opioid|analgesics, opioid|mesh-list
153406240|NCT05138614|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153406241|NCT05138614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153406242|NCT05138614|Analgesics|analgesics|mesh-ancestor
153406256|NCT05093582|Autonomic Agents|autonomic agents|mesh-ancestor
153406279|NCT05045703|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
153406280|NCT05045703|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153406282|NCT04990037|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153406283|NCT04927884|Cyclophosphamide|cyclophosphamide|mesh-list
153406284|NCT04927884|Sacituzumab govitecan|sacituzumab govitecan|mesh-list
153406285|NCT04927884|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153865844|NCT04588194|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153865845|NCT04588194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153865846|NCT04588194|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153865847|NCT04588194|Glucocorticoids|glucocorticoids|mesh-ancestor
153865848|NCT04588194|Hormones|hormones|mesh-ancestor
153865849|NCT04588194|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153865850|NCT04588194|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153865851|NCT04588194|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153465368|NCT00282282|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153465369|NCT00282282|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153865852|NCT04588194|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153865853|NCT04588194|Immunologic Factors|immunologic factors|mesh-ancestor
153865854|NCT04588194|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153865855|NCT02940314|Solifenacin Succinate|solifenacin succinate|mesh-list
153865856|NCT02940314|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
153865857|NCT02940314|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
153865858|NCT02940314|Cholinergic Agents|cholinergic agents|mesh-ancestor
153865859|NCT02940314|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153406286|NCT04927884|Immunologic Factors|immunologic factors|mesh-ancestor
153865895|NCT01150357|Aliskiren|aliskiren|mesh-list
153865896|NCT01150357|Renin Inhibitors|renin inhibitors|mesh-ancestor
153865897|NCT01150357|Protease Inhibitors|protease inhibitors|mesh-ancestor
153865898|NCT01150357|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153865899|NCT01150357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153865900|NCT04619537|Docetaxel|docetaxel|mesh-list
153865901|NCT04619537|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153865902|NCT04619537|Tubulin Modulators|tubulin modulators|mesh-ancestor
153865903|NCT04619537|Antimitotic Agents|antimitotic agents|mesh-ancestor
153865904|NCT04619537|Mitosis Modulators|mitosis modulators|mesh-ancestor
153865905|NCT04619537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153865906|NCT04619381|Clopidogrel|clopidogrel|mesh-list
153865907|NCT04619381|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153406350|NCT04717089|Anesthetics|anesthetics|mesh-list
153406364|NCT04687098|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153406365|NCT04687098|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153406366|NCT04687098|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153406367|NCT04687098|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153406368|NCT04687098|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153406369|NCT04687098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153406370|NCT04683406|Oseltamivir|oseltamivir|mesh-list
153406371|NCT04683406|Antiviral Agents|antiviral agents|mesh-ancestor
153406372|NCT04683406|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153865977|NCT00568815|Rituximab|rituximab|mesh-list
153865978|NCT00568815|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153865979|NCT00568815|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153865980|NCT00568815|Immunologic Factors|immunologic factors|mesh-ancestor
153865981|NCT00568815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153865982|NCT00568815|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153865983|NCT00568893|Drotrecogin alfa activated|drotrecogin alfa activated|mesh-list
153865984|NCT00568893|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153865985|NCT00568971|Docetaxel|docetaxel|mesh-list
153406454|NCT04427293|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153406455|NCT04427293|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153406456|NCT04427293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153406459|NCT04391842|Diclofenac|diclofenac|mesh-list
153406480|NCT04383262|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153406481|NCT04360681|Lofexidine|lofexidine|mesh-list
153406482|NCT04360681|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153429851|NCT01126801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153866022|NCT04585932|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153866087|NCT00569790|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153866088|NCT00569790|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153866089|NCT00569790|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153866090|NCT00569790|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153866091|NCT00569790|Growth Substances|growth substances|mesh-ancestor
153866092|NCT00569790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153866093|NCT00569790|Growth Inhibitors|growth inhibitors|mesh-ancestor
153406521|NCT04327024|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153866094|NCT00569790|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
153866095|NCT00569790|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153866096|NCT00569790|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153866097|NCT00569790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153866098|NCT00567957|Remifentanil|remifentanil|mesh-list
153866124|NCT04617782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153866125|NCT04617782|Cholinergic Agents|cholinergic agents|mesh-ancestor
153866126|NCT04617782|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153429864|NCT00002768|Abortifacient Agents|abortifacient agents|mesh-ancestor
153429865|NCT00002768|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153429866|NCT00002768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153429868|NCT00002768|Antimetabolites|antimetabolites|mesh-ancestor
153866127|NCT04617782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153866128|NCT04617782|Nootropic Agents|nootropic agents|mesh-ancestor
153866129|NCT00569985|Cyclophosphamide|cyclophosphamide|mesh-list
153866174|NCT00570219|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153866175|NCT00570219|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153866176|NCT00570219|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153866177|NCT00570375|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
153866178|NCT00570375|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153866179|NCT00570375|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153866180|NCT00570375|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153866181|NCT00570375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153866182|NCT00570375|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153866183|NCT00568074|Repaglinide|repaglinide|mesh-list
153866184|NCT00568074|Acarbose|acarbose|mesh-list
153866185|NCT00568074|Gliquidone|gliquidone|mesh-list
153866194|NCT00568113|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153866195|NCT00568113|Expectorants|expectorants|mesh-ancestor
153866196|NCT00568113|Respiratory System Agents|respiratory system agents|mesh-ancestor
153406644|NCT04179396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153406645|NCT04179396|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153406646|NCT04158440|Paclitaxel|paclitaxel|mesh-list
153406647|NCT04158440|Docetaxel|docetaxel|mesh-list
153406648|NCT04158440|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
153406649|NCT04158440|Cisplatin|cisplatin|mesh-list
153866232|NCT04610879|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153866233|NCT04610879|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153866234|NCT04610879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153866235|NCT04610879|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
153866236|NCT04610879|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
153866237|NCT00570648|Hyaluronic Acid|hyaluronic acid|mesh-list
153866238|NCT00570648|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153866239|NCT00570648|Immunologic Factors|immunologic factors|mesh-ancestor
153866240|NCT00570648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153866241|NCT00570648|Viscosupplements|viscosupplements|mesh-ancestor
153866242|NCT00570648|Protective Agents|protective agents|mesh-ancestor
153866243|NCT00570726|Ranibizumab|ranibizumab|mesh-list
153866244|NCT00570726|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153406682|NCT03974217|Antimetabolites|antimetabolites|mesh-ancestor
153406718|NCT03916510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153406719|NCT03916510|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153406720|NCT03901482|Dihydroergotamine|dihydroergotamine|mesh-list
153406721|NCT03901482|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
153406729|NCT03901482|Sensory System Agents|sensory system agents|mesh-ancestor
153406730|NCT03901482|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153406732|NCT03853317|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153866347|NCT04613609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153866348|NCT04613609|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
153866349|NCT04613609|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
153866350|NCT04613609|Cholinergic Agents|cholinergic agents|mesh-ancestor
153866351|NCT04613609|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153866352|NCT04613609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153866354|NCT00571740|Bevacizumab|bevacizumab|mesh-list
153866355|NCT00571740|Cetuximab|cetuximab|mesh-list
153866356|NCT00571740|Fluorouracil|fluorouracil|mesh-list
153866357|NCT00571740|Oxaliplatin|oxaliplatin|mesh-list
153866422|NCT00563615|Serotonin Agents|serotonin agents|mesh-ancestor
153866423|NCT00563615|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153866427|NCT00563654|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
153866428|NCT00563654|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
153866429|NCT00563654|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
153866430|NCT00563654|Adrenergic Agents|adrenergic agents|mesh-ancestor
153866431|NCT00563654|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153866432|NCT00563654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153866433|NCT00563654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153406872|NCT03576612|Temozolomide|temozolomide|mesh-list
153406873|NCT03576612|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153406874|NCT03576612|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153406875|NCT03576612|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153406876|NCT03576612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153866462|NCT00568347|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153866463|NCT00568347|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153866464|NCT00568347|Autonomic Agents|autonomic agents|mesh-ancestor
153866465|NCT00568347|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153866466|NCT00568347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153866467|NCT00568347|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153866472|NCT00568347|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
153866473|NCT00568347|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153406912|NCT03439865|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153406913|NCT03439865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153406914|NCT03427125|Sevelamer|sevelamer|mesh-list
153866525|NCT04581876|Raltitrexed|raltitrexed|mesh-list
153866526|NCT04581876|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153866527|NCT04581876|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153866528|NCT04581876|Tubulin Modulators|tubulin modulators|mesh-ancestor
153866529|NCT04581876|Antimitotic Agents|antimitotic agents|mesh-ancestor
153866530|NCT04581876|Mitosis Modulators|mitosis modulators|mesh-ancestor
153406971|NCT03144804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153406973|NCT03144804|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153407026|NCT02956590|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153407027|NCT02956590|Antimetabolites|antimetabolites|mesh-ancestor
153407028|NCT02956590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153866577|NCT04611776|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153866578|NCT04611776|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153866579|NCT04611776|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153866580|NCT00572637|Delanzomib|delanzomib|mesh-list
153866602|NCT01149655|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
153866603|NCT00575406|Prednisolone|prednisolone|mesh-list
153866604|NCT00575406|Cyclophosphamide|cyclophosphamide|mesh-list
153866606|NCT00575406|Doxorubicin|doxorubicin|mesh-list
153866607|NCT00575406|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
153866608|NCT00575406|Vincristine|vincristine|mesh-list
153866609|NCT00575406|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153866610|NCT00575406|Immunologic Factors|immunologic factors|mesh-ancestor
153866611|NCT00575406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153866612|NCT00575406|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153866632|NCT01149538|Choline|choline|mesh-list
153866633|NCT01149538|Lipotropic Agents|lipotropic agents|mesh-ancestor
153866634|NCT01149538|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153866635|NCT01149538|Antimetabolites|antimetabolites|mesh-ancestor
153866636|NCT01149538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153866637|NCT01149538|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153407082|NCT02586038|Growth Substances|growth substances|mesh-ancestor
153407083|NCT02586038|Growth Inhibitors|growth inhibitors|mesh-ancestor
153407084|NCT02586038|Protease Inhibitors|protease inhibitors|mesh-ancestor
153407161|NCT02088632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153407162|NCT02088632|Cholinergic Agents|cholinergic agents|mesh-ancestor
153407163|NCT02088632|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153407164|NCT02031536|Everolimus|everolimus|mesh-list
153407165|NCT02031536|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
153407166|NCT02031536|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153407167|NCT02031536|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153407168|NCT02031536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153407169|NCT02031536|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153866695|NCT04579731|Lactitol|lactitol|mesh-list
153866728|NCT04600037|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153866729|NCT04600037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153866739|NCT00575796|Antimitotic Agents|antimitotic agents|mesh-ancestor
153866740|NCT00575796|Mitosis Modulators|mitosis modulators|mesh-ancestor
153866741|NCT00575796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153866743|NCT00575835|Ergocalciferols|ergocalciferols|mesh-list
153866744|NCT00575835|Cholecalciferol|cholecalciferol|mesh-list
153866745|NCT00575835|Vitamins|vitamins|mesh-list
153866746|NCT00575835|Micronutrients|micronutrients|mesh-ancestor
153866747|NCT00575835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153407191|NCT01964430|Antimitotic Agents|antimitotic agents|mesh-ancestor
153866754|NCT00575874|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153866755|NCT00575874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153866756|NCT03454217|Oxycodone|oxycodone|mesh-list
153866757|NCT03454217|Tramadol|tramadol|mesh-list
153866758|NCT03454217|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153866759|NCT03454217|Narcotics|narcotics|mesh-ancestor
153407203|NCT01579734|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153407211|NCT01566240|Carboplatin|carboplatin|mesh-list
153407254|NCT01390584|Dermatologic Agents|dermatologic agents|mesh-ancestor
153407255|NCT01374841|Cyclophosphamide|cyclophosphamide|mesh-list
153407256|NCT01374841|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153407257|NCT01374841|Immunologic Factors|immunologic factors|mesh-ancestor
153407258|NCT01374841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153407259|NCT01374841|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153407260|NCT01374841|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153866809|NCT00573417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153866810|NCT00573417|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
153866814|NCT00573495|BIRC5 protein, human|birc5 protein, human|mesh-list
153866841|NCT00573690|Pemetrexed|pemetrexed|mesh-list
153866842|NCT00573690|Sorafenib|sorafenib|mesh-list
153866843|NCT00573690|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153866844|NCT00573690|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153866845|NCT00573690|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153866846|NCT00573690|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153866847|NCT00573690|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153407313|NCT01160107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153407314|NCT01160107|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153407315|NCT01160107|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153888784|NCT01056289|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153888785|NCT01056289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153888786|NCT01056289|Antidepressive Agents|antidepressive agents|mesh-ancestor
153866905|NCT00576615|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153866906|NCT00576615|Anesthetics, General|anesthetics, general|mesh-ancestor
153866907|NCT00576615|Anesthetics|anesthetics|mesh-ancestor
153866908|NCT00574041|Interferons|interferons|mesh-list
153866909|NCT00574041|Interferon-beta|interferon-beta|mesh-list
153866910|NCT00574041|Interferon beta-1a|interferon beta-1a|mesh-list
153866911|NCT00574041|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153866912|NCT00574041|Antiviral Agents|antiviral agents|mesh-ancestor
153866913|NCT00574041|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153866914|NCT00574041|Immunologic Factors|immunologic factors|mesh-ancestor
153407369|NCT01063179|Glucocorticoids|glucocorticoids|mesh-ancestor
153407376|NCT01063179|Alkylating Agents|alkylating agents|mesh-ancestor
153407385|NCT01063179|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153866915|NCT00574041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153866916|NCT00574041|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153866917|NCT00566267|Simvastatin|simvastatin|mesh-list
153866918|NCT00566267|Ezetimibe|ezetimibe|mesh-list
153866919|NCT00566267|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153866920|NCT00566267|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153866921|NCT00566267|Antimetabolites|antimetabolites|mesh-ancestor
153866923|NCT00566267|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153407405|NCT00779194|Immunologic Factors|immunologic factors|mesh-ancestor
153407406|NCT00779194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153407407|NCT00665600|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
153407408|NCT00665600|Albuterol|albuterol|mesh-list
153407409|NCT00665600|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153407410|NCT00665600|Autonomic Agents|autonomic agents|mesh-ancestor
153407415|NCT00665600|Tocolytic Agents|tocolytic agents|mesh-ancestor
153407416|NCT00665600|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153866933|NCT04596839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153866934|NCT04596839|Antiviral Agents|antiviral agents|mesh-ancestor
153866935|NCT04596839|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153866936|NCT00574470|Infliximab|infliximab|mesh-list
153866937|NCT00574470|Daclizumab|daclizumab|mesh-list
153866938|NCT00574470|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
153866939|NCT00574470|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153866940|NCT00574470|Dermatologic Agents|dermatologic agents|mesh-ancestor
153866941|NCT00574470|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153866942|NCT00574470|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153866958|NCT00577161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153866960|NCT00577161|Antiviral Agents|antiviral agents|mesh-ancestor
153866961|NCT00577161|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153407436|NCT00551928|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153407437|NCT00551928|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153407438|NCT00551928|Immunologic Factors|immunologic factors|mesh-ancestor
153407439|NCT00551928|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153407440|NCT00551928|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153407441|NCT00551928|Growth Substances|growth substances|mesh-ancestor
153407442|NCT00551928|Growth Inhibitors|growth inhibitors|mesh-ancestor
153407443|NCT00551928|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153407444|NCT00551928|Alkylating Agents|alkylating agents|mesh-ancestor
153407445|NCT00551928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153866974|NCT04596488|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
153866975|NCT04596488|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
153866976|NCT04596488|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
153866977|NCT04596488|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
153866978|NCT04595942|Fludrocortisone|fludrocortisone|mesh-list
153866979|NCT04595942|Midodrine|midodrine|mesh-list
153866980|NCT04595942|Sympathomimetics|sympathomimetics|mesh-ancestor
153866991|NCT04595942|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153866992|NCT00566384|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
153866993|NCT00566384|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153866994|NCT00566384|Immunologic Factors|immunologic factors|mesh-ancestor
153866995|NCT00566384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153866996|NCT00574743|Mycophenolic Acid|mycophenolic acid|mesh-list
153866997|NCT00574743|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153866998|NCT00574743|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153866999|NCT00574743|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
153867000|NCT00574743|Antitubercular Agents|antitubercular agents|mesh-ancestor
153867001|NCT00574743|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153867002|NCT00574743|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153867003|NCT00574743|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153867004|NCT00574743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153867005|NCT04595318|Varenicline|varenicline|mesh-list
153867006|NCT04595318|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
153867007|NCT04595318|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
153867008|NCT04595318|Cholinergic Agents|cholinergic agents|mesh-ancestor
153867009|NCT04595318|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153867033|NCT00577668|Leprostatic Agents|leprostatic agents|mesh-ancestor
153867034|NCT00577668|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153867035|NCT00577668|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153867036|NCT00577668|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153867037|NCT00577668|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153867038|NCT00577668|Growth Substances|growth substances|mesh-ancestor
153867039|NCT00577668|Growth Inhibitors|growth inhibitors|mesh-ancestor
153867040|NCT01147744|Fluticasone|fluticasone|mesh-list
153867041|NCT01147744|Xhance|xhance|mesh-list
153867043|NCT01147744|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153867044|NCT01147744|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153867045|NCT01147744|Autonomic Agents|autonomic agents|mesh-ancestor
153867046|NCT01147744|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153867047|NCT01147744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153867048|NCT01147744|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153867049|NCT01147744|Respiratory System Agents|respiratory system agents|mesh-ancestor
153867050|NCT01147744|Dermatologic Agents|dermatologic agents|mesh-ancestor
153867051|NCT01147744|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
153867052|NCT01147744|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
153867053|NCT01147744|Hormone Antagonists|hormone antagonists|mesh-ancestor
153407523|NCT00274924|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153867060|NCT04313374|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153867061|NCT04313374|Narcotics|narcotics|mesh-ancestor
153867062|NCT04313374|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153867063|NCT04313374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153867064|NCT04313374|Analgesics|analgesics|mesh-ancestor
153867065|NCT04313374|Sensory System Agents|sensory system agents|mesh-ancestor
153867066|NCT04313374|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153867067|NCT04313374|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153867068|NCT04313374|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153867069|NCT04313374|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153867070|NCT04313374|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153867071|NCT00577980|Testosterone|testosterone|mesh-list
153867072|NCT00577980|Androgens|androgens|mesh-ancestor
153867073|NCT00577980|Hormones|hormones|mesh-ancestor
153888788|NCT02875093|Cytarabine|cytarabine|mesh-list
153867081|NCT01147393|Epratuzumab|epratuzumab|mesh-list
153867108|NCT00578370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153867109|NCT00578370|Antifungal Agents|antifungal agents|mesh-ancestor
153867110|NCT00578370|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153867111|NCT00578370|Dermatologic Agents|dermatologic agents|mesh-ancestor
153867112|NCT00578370|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153867113|NCT00578370|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
153867114|NCT00578370|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153867116|NCT00578370|Hormones|hormones|mesh-ancestor
153867117|NCT00578370|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153867118|NCT00578370|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153867120|NCT04593836|Peppermint oil|peppermint oil|mesh-list
153407601|NCT00060346|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153407602|NCT00060346|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153407603|NCT00060346|Alkylating Agents|alkylating agents|mesh-ancestor
153407604|NCT00060346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153407605|NCT00060346|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153407606|NCT00060346|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153407607|NCT00060346|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153407608|NCT00060346|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153407609|NCT00060346|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153407610|NCT00060346|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153407611|NCT00060346|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153465370|NCT00282282|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153465371|NCT00282282|Antifungal Agents|antifungal agents|mesh-ancestor
153465372|NCT00282282|Alkylating Agents|alkylating agents|mesh-ancestor
153916618|NCT00995007|Carboplatin|carboplatin|mesh-list
153916619|NCT00995007|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153867136|NCT00578526|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153867137|NCT00578526|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153867138|NCT00578526|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153867139|NCT00578526|Growth Substances|growth substances|mesh-ancestor
153867140|NCT00578526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153867141|NCT00578526|Growth Inhibitors|growth inhibitors|mesh-ancestor
153867142|NCT00578526|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153867143|NCT00578526|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153867144|NCT00578526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153867145|NCT04593446|Picosulfate sodium|picosulfate sodium|mesh-list
153867146|NCT04593446|Cathartics|cathartics|mesh-ancestor
153867147|NCT04593446|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153867148|NCT00566891|Tirofiban|tirofiban|mesh-list
153867149|NCT00566891|Clopidogrel|clopidogrel|mesh-list
153407626|NCT00057954|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
153407627|NCT00057954|Abortifacient Agents|abortifacient agents|mesh-ancestor
153407631|NCT00057954|Antimetabolites|antimetabolites|mesh-ancestor
153867179|NCT04592822|Protease Inhibitors|protease inhibitors|mesh-ancestor
153867180|NCT04592822|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153867181|NCT04592822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153867183|NCT00567047|Vildagliptin|vildagliptin|mesh-list
153867184|NCT00567047|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153867185|NCT00567047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153407647|NCT00057954|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153407648|NCT00057954|Adenosine Deaminase Inhibitors|adenosine deaminase inhibitors|mesh-ancestor
153407651|NCT00049530|Interferon alpha-2|interferon alpha-2|mesh-list
153407652|NCT00049530|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
153407653|NCT00049530|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153407694|NCT00033657|Tubulin Modulators|tubulin modulators|mesh-ancestor
153407695|NCT00033657|Antimitotic Agents|antimitotic agents|mesh-ancestor
153407696|NCT00033657|Mitosis Modulators|mitosis modulators|mesh-ancestor
153407697|NCT00033657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153407698|NCT00033657|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
153407699|NCT00033657|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153407700|NCT00033657|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153407702|NCT00003389|Cyclophosphamide|cyclophosphamide|mesh-list
153407745|NCT00002525|Tetrahydrofolates|tetrahydrofolates|mesh-list
153407746|NCT00002525|Formyltetrahydrofolates|formyltetrahydrofolates|mesh-list
153867250|NCT00580242|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153867251|NCT00580242|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153867252|NCT00580242|Growth Substances|growth substances|mesh-ancestor
153867272|NCT00580827|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
153867273|NCT00580827|Acetaldehyde Dehydrogenase Inhibitors|acetaldehyde dehydrogenase inhibitors|mesh-ancestor
153867274|NCT00580827|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153867275|NCT00580827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153867276|NCT00580905|Adenosine|adenosine|mesh-list
153867277|NCT00580905|Nitroprusside|nitroprusside|mesh-list
153867278|NCT00580905|Analgesics|analgesics|mesh-ancestor
153867279|NCT00580905|Sensory System Agents|sensory system agents|mesh-ancestor
153867318|NCT00567554|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153867319|NCT00567554|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153867320|NCT00567554|Tubulin Modulators|tubulin modulators|mesh-ancestor
153867321|NCT00567554|Antimitotic Agents|antimitotic agents|mesh-ancestor
153407790|NCT02259348|Analgesics|analgesics|mesh-ancestor
153407791|NCT02259348|Sensory System Agents|sensory system agents|mesh-ancestor
153407792|NCT02259348|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153407793|NCT02259348|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153407794|NCT02259348|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153407795|NCT00357019|Isospaglumic acid|isospaglumic acid|mesh-list
153407796|NCT00357019|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153407797|NCT00357019|Autonomic Agents|autonomic agents|mesh-ancestor
153867343|NCT04590482|Letrozole|letrozole|mesh-list
153407822|NCT03587207|Immunologic Factors|immunologic factors|mesh-ancestor
153407834|NCT03592121|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
153407835|NCT03592121|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153407836|NCT03592121|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153407837|NCT03592121|Adrenergic Agents|adrenergic agents|mesh-ancestor
153407838|NCT03592121|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153407839|NCT03592121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153407840|NCT03592121|Protective Agents|protective agents|mesh-ancestor
153407842|NCT04332809|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153867344|NCT04590482|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153867345|NCT04590482|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
153867346|NCT04590482|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153867347|NCT04590482|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153867348|NCT04590482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153867349|NCT04590482|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
153867350|NCT04590482|Hormone Antagonists|hormone antagonists|mesh-ancestor
153867351|NCT04590482|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153867352|NCT04590482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153867353|NCT00581217|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
153407850|NCT03596723|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
153407851|NCT03596723|Prednisolone acetate|prednisolone acetate|mesh-list
153407852|NCT03596723|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
153407853|NCT03596723|Prednisolone phosphate|prednisolone phosphate|mesh-list
153407854|NCT03596723|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153407855|NCT03596723|Glucocorticoids|glucocorticoids|mesh-ancestor
153407856|NCT03596723|Hormones|hormones|mesh-ancestor
153407857|NCT03596723|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153407859|NCT03596723|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153407860|NCT03596723|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153407861|NCT03596723|Antiemetics|antiemetics|mesh-ancestor
153407862|NCT03596723|Autonomic Agents|autonomic agents|mesh-ancestor
153407863|NCT03596723|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153407891|NCT03472469|Antipyretics|antipyretics|mesh-ancestor
153407892|NCT03472469|Anticonvulsants|anticonvulsants|mesh-ancestor
153407893|NCT03472469|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153407894|NCT03472469|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153407895|NCT03472469|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153407896|NCT03472469|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153407897|NCT03472469|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153429907|NCT00002780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153407915|NCT04926233|Autonomic Agents|autonomic agents|mesh-ancestor
153407916|NCT04926233|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153407917|NCT04926233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153407918|NCT04926233|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153407919|NCT04926233|Respiratory System Agents|respiratory system agents|mesh-ancestor
153892336|NCT02949284|Hormones|hormones|mesh-list
153916620|NCT00909883|Botulinum Toxins|botulinum toxins|mesh-list
153916621|NCT00909883|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
153916622|NCT00909883|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153916623|NCT00909883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153916624|NCT00909883|Cholinergic Agents|cholinergic agents|mesh-ancestor
153916625|NCT00909883|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153916626|NCT00909883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153916627|NCT00639925|Gemcitabine|gemcitabine|mesh-list
153867425|NCT04577430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153867426|NCT00567788|Bimatoprost|bimatoprost|mesh-list
153867427|NCT00567788|Latanoprost|latanoprost|mesh-list
153867428|NCT00567788|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
153867436|NCT00581685|Pregabalin|pregabalin|mesh-list
153867437|NCT00581685|Analgesics|analgesics|mesh-ancestor
153867438|NCT00581685|Sensory System Agents|sensory system agents|mesh-ancestor
153867439|NCT00581685|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153867440|NCT00581685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153867441|NCT00581685|Anticonvulsants|anticonvulsants|mesh-ancestor
153867446|NCT00581685|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153867447|NCT00581685|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153867448|NCT00581685|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153867449|NCT00581685|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153867450|NCT00581685|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153867451|NCT00581685|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153867452|NCT00581685|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153867453|NCT00581685|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153867454|NCT00581685|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
153867461|NCT04588220|Protective Agents|protective agents|mesh-ancestor
153867462|NCT04588220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153867463|NCT04588220|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153867464|NCT04588220|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153867465|NCT04588220|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153867466|NCT04586543|Docetaxel|docetaxel|mesh-list
153867467|NCT04586543|Selegiline|selegiline|mesh-list
153867468|NCT04586543|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153867469|NCT04586543|Tubulin Modulators|tubulin modulators|mesh-ancestor
153867470|NCT04586543|Antimitotic Agents|antimitotic agents|mesh-ancestor
153867471|NCT04586543|Mitosis Modulators|mitosis modulators|mesh-ancestor
153867472|NCT04586543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153867473|NCT04586543|Antidepressive Agents|antidepressive agents|mesh-ancestor
153867474|NCT04586543|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153867475|NCT04586543|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
153867491|NCT04586465|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153867492|NCT04586465|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153867493|NCT04586465|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153867494|NCT04586465|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153407970|NCT04960202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153407971|NCT04960202|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153407972|NCT04960202|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153408010|NCT04428359|Vitamin D|vitamin d|mesh-list
153408011|NCT04428359|Vitamins|vitamins|mesh-ancestor
153408012|NCT04428359|Micronutrients|micronutrients|mesh-ancestor
153408013|NCT04428359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153408014|NCT04428359|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153408019|NCT02257632|Growth Substances|growth substances|mesh-ancestor
153408020|NCT02257632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153408021|NCT02257632|Growth Inhibitors|growth inhibitors|mesh-ancestor
153408022|NCT02257632|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153408023|NCT05436054|Picosulfate sodium|picosulfate sodium|mesh-list
153867518|NCT04593108|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
153867519|NCT04593108|Abortifacient Agents|abortifacient agents|mesh-ancestor
153867520|NCT04593108|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153867521|NCT04593108|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
153867522|NCT04593108|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153867524|NCT04585412|Palonosetron|palonosetron|mesh-list
153867525|NCT04585412|Antiemetics|antiemetics|mesh-ancestor
153867526|NCT04585412|Autonomic Agents|autonomic agents|mesh-ancestor
153867527|NCT04585412|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153867566|NCT00582582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153867567|NCT00582582|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153867568|NCT00566904|Aspirin|aspirin|mesh-list
153867569|NCT00566904|Lidocaine|lidocaine|mesh-list
153867570|NCT00566904|Anesthetics, Local|anesthetics, local|mesh-list
153867571|NCT00566904|Anesthetics|anesthetics|mesh-list
153867572|NCT00566904|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153867573|NCT00566904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153408054|NCT01640184|Vitamins|vitamins|mesh-ancestor
153867594|NCT04584983|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
153867595|NCT04584983|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
153867596|NCT04584515|Itraconazole|itraconazole|mesh-list
153867597|NCT04584515|Rifampin|rifampin|mesh-list
153867598|NCT04584515|Antifungal Agents|antifungal agents|mesh-ancestor
153867599|NCT04584515|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153867600|NCT04584515|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
153867601|NCT04584515|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153867602|NCT04584515|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153867603|NCT04584515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153867604|NCT04584515|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153867605|NCT04584515|Hormone Antagonists|hormone antagonists|mesh-ancestor
153867606|NCT04584515|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153867607|NCT04584515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153867608|NCT04584515|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
153408092|NCT04439396|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153867620|NCT04584710|Dactolisib|dactolisib|mesh-list
153867656|NCT04576143|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153867657|NCT04576143|Immunologic Factors|immunologic factors|mesh-ancestor
153867658|NCT04576143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153867659|NCT04576143|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153867660|NCT04576143|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153867661|NCT04576143|Alkylating Agents|alkylating agents|mesh-ancestor
153867662|NCT04576143|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153867663|NCT04576143|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153867664|NCT04576143|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153867665|NCT04576143|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153867719|NCT00568217|Acetaminophen|acetaminophen|mesh-list
153867721|NCT00568217|Diclofenac|diclofenac|mesh-list
153408206|NCT03514277|Anesthetics, Local|anesthetics, local|mesh-ancestor
153408207|NCT03514277|Anesthetics|anesthetics|mesh-ancestor
153408208|NCT03514277|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153408209|NCT03514277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153408210|NCT03514277|Sensory System Agents|sensory system agents|mesh-ancestor
153408211|NCT03514277|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153408212|NCT05334108|Ecopipam|ecopipam|mesh-list
153408213|NCT05334108|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153408214|NCT05334108|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153408242|NCT04870866|Niacin|niacin|mesh-list
153408245|NCT04870866|Vitamins|vitamins|mesh-ancestor
153408246|NCT04870866|Micronutrients|micronutrients|mesh-ancestor
153408247|NCT04870866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153408248|NCT04870866|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153408249|NCT04870866|Antimetabolites|antimetabolites|mesh-ancestor
153408250|NCT04870866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153408251|NCT04870866|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153408252|NCT04870866|Vasodilator Agents|vasodilator agents|mesh-ancestor
153408253|NCT03657407|Glycerol|glycerol|mesh-list
153408254|NCT03657407|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
153408255|NCT03657407|Protective Agents|protective agents|mesh-ancestor
153408256|NCT03657407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153408257|NCT01639560|Varenicline|varenicline|mesh-list
153408258|NCT01639560|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
153408259|NCT01639560|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
153867753|NCT00590928|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153867754|NCT00590928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153867755|NCT01145482|Insulin|insulin|mesh-list
153867782|NCT00583518|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153867783|NCT00583518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153867784|NCT00583518|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153867785|NCT04582136|Sirolimus|sirolimus|mesh-list
153867786|NCT04582136|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153867787|NCT04582136|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153867788|NCT04582136|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153867832|NCT04575675|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
153867833|NCT04575675|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
153867834|NCT04575675|Hormone Antagonists|hormone antagonists|mesh-ancestor
153429950|NCT05531708|Fludarabine|fludarabine|mesh-list
153429951|NCT05531708|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153429952|NCT05531708|Immunologic Factors|immunologic factors|mesh-ancestor
153429953|NCT05531708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153429954|NCT05531708|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153867856|NCT00568529|Oxaliplatin|oxaliplatin|mesh-list
153867872|NCT04575558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153867873|NCT04575558|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153867874|NCT00568763|Sargramostim|sargramostim|mesh-list
153867875|NCT00568763|Immunologic Factors|immunologic factors|mesh-ancestor
153867876|NCT00568763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153867877|NCT00568841|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
153867878|NCT00568841|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153408369|NCT03667547|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
153408370|NCT03667547|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
153408396|NCT03675581|Ethinyl Estradiol-Norgestrel Combination|ethinyl estradiol-norgestrel combination|mesh-list
153408397|NCT03675581|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153408398|NCT03675581|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153408400|NCT03675581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153408401|NCT03675581|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
153408402|NCT03675581|Contraceptive Agents|contraceptive agents|mesh-ancestor
153408403|NCT03675581|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153408404|NCT03675581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153408405|NCT03675581|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
153867900|NCT00568880|Antimalarials|antimalarials|mesh-ancestor
153867901|NCT00568880|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153867902|NCT00568880|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153867903|NCT00568880|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153408437|NCT02976116|Gefitinib|gefitinib|mesh-list
153408438|NCT02976116|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153867917|NCT00569465|Antiviral Agents|antiviral agents|mesh-ancestor
153867918|NCT00569465|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153867920|NCT00569465|Respiratory System Agents|respiratory system agents|mesh-ancestor
153867921|NCT00569465|Free Radical Scavengers|free radical scavengers|mesh-ancestor
153867922|NCT00569465|Antioxidants|antioxidants|mesh-ancestor
153867923|NCT00569465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153867924|NCT00569465|Protective Agents|protective agents|mesh-ancestor
153867969|NCT00570245|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153408532|NCT00361790|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
153408533|NCT00361790|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
153408534|NCT00361790|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153408535|NCT00361790|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
153408536|NCT00361790|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
153868025|NCT00570830|Fluocinolone Acetonide|fluocinolone acetonide|mesh-list
153868026|NCT00570830|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153868027|NCT00570830|Glucocorticoids|glucocorticoids|mesh-ancestor
153868030|NCT00570830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153408607|NCT00361166|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153408608|NCT00361166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153868125|NCT00571337|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
153868126|NCT00571337|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153868127|NCT00571337|Dermatologic Agents|dermatologic agents|mesh-ancestor
153868128|NCT00571337|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153408634|NCT00377273|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153408635|NCT00377273|Immunologic Factors|immunologic factors|mesh-ancestor
153408636|NCT00377273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153408637|NCT03706313|Bupivacaine|bupivacaine|mesh-list
153408638|NCT03706313|Anesthetics, Local|anesthetics, local|mesh-ancestor
153408639|NCT03706313|Anesthetics|anesthetics|mesh-ancestor
153408640|NCT03706313|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153408648|NCT05369364|Autonomic Agents|autonomic agents|mesh-ancestor
153408707|NCT00361322|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153408708|NCT00361322|Analgesics|analgesics|mesh-ancestor
153408709|NCT00361322|Sensory System Agents|sensory system agents|mesh-ancestor
153408710|NCT00361322|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153408711|NCT00361322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153408712|NCT00361322|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153408713|NCT00361322|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153408714|NCT00361322|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153408715|NCT02974712|Fentanyl|fentanyl|mesh-list
153408716|NCT02974712|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153868190|NCT00572078|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153408739|NCT03557333|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153408740|NCT03557333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153868241|NCT00572663|Antiviral Agents|antiviral agents|mesh-ancestor
153868242|NCT00572663|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153868243|NCT00572663|Expectorants|expectorants|mesh-ancestor
153868244|NCT00572663|Respiratory System Agents|respiratory system agents|mesh-ancestor
153868245|NCT00572663|Free Radical Scavengers|free radical scavengers|mesh-ancestor
153868246|NCT00572663|Antioxidants|antioxidants|mesh-ancestor
153868248|NCT00572663|Protective Agents|protective agents|mesh-ancestor
153888842|NCT01096342|Cyclin-Dependent Kinase Inhibitor Proteins|cyclin-dependent kinase inhibitor proteins|mesh-list
153868266|NCT01140568|Nilotinib|nilotinib|mesh-list
153868267|NCT01140568|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153868268|NCT01140568|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153868269|NCT01140568|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153868270|NCT01140568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153868271|NCT00572819|Misoprostol|misoprostol|mesh-list
153868272|NCT00572819|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
153868273|NCT00572819|Abortifacient Agents|abortifacient agents|mesh-ancestor
153408773|NCT00362726|Ritonavir|ritonavir|mesh-list
153888858|NCT01096186|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
153888859|NCT01096186|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153888860|NCT01032889|Deoxycholic Acid|deoxycholic acid|mesh-list
153888861|NCT01032889|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
153888862|NCT01032889|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153868274|NCT00572819|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153868275|NCT00572819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153868276|NCT00572819|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
153868277|NCT00572819|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153868278|NCT00572819|Oxytocics|oxytocics|mesh-ancestor
153868279|NCT03451110|Fluconazole|fluconazole|mesh-list
153868280|NCT03451110|Lemborexant|lemborexant|mesh-list
153868281|NCT03451110|Famotidine|famotidine|mesh-list
153868303|NCT03451110|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153868304|NCT03451110|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153868305|NCT03451110|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
153868307|NCT03451110|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
153868308|NCT03451110|Contraceptive Agents|contraceptive agents|mesh-ancestor
153868309|NCT03451110|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153868310|NCT03451110|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
153408838|NCT04031885|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153408839|NCT04031885|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
153408840|NCT04031885|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
153408841|NCT04031885|Hormone Antagonists|hormone antagonists|mesh-ancestor
153408842|NCT04031885|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153408843|NCT04031885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153408844|NCT01638000|Solifenacin Succinate|solifenacin succinate|mesh-list
153408845|NCT01638000|Mirabegron|mirabegron|mesh-list
153408846|NCT01638000|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
153408847|NCT01638000|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
153408848|NCT01638000|Cholinergic Agents|cholinergic agents|mesh-ancestor
153408849|NCT01638000|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153408850|NCT01638000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153408851|NCT01638000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153408942|NCT05722405|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153408943|NCT02767531|Orlistat|orlistat|mesh-list
153408944|NCT02767531|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153408945|NCT02767531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153408946|NCT02767531|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
153408947|NCT02767531|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153408992|NCT03504410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153868462|NCT00573950|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153868463|NCT00573950|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153868464|NCT00573950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153868465|NCT00573950|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153868466|NCT00573950|Vasodilator Agents|vasodilator agents|mesh-ancestor
153868467|NCT00573950|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
153868468|NCT00573950|Protective Agents|protective agents|mesh-ancestor
153868469|NCT00573950|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
153868502|NCT00574769|Everolimus|everolimus|mesh-list
153868503|NCT00574769|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153868504|NCT00574769|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153868505|NCT00574769|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153868506|NCT00574769|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153868507|NCT00574769|Growth Substances|growth substances|mesh-ancestor
153868508|NCT00574769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153868509|NCT00574769|Growth Inhibitors|growth inhibitors|mesh-ancestor
153868510|NCT00574769|Tubulin Modulators|tubulin modulators|mesh-ancestor
153868511|NCT00574769|Antimitotic Agents|antimitotic agents|mesh-ancestor
153868514|NCT00574769|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
153868535|NCT00574925|Esomeprazole|esomeprazole|mesh-list
153868536|NCT00574925|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
153868555|NCT00574964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153868557|NCT01137682|Octreotide|octreotide|mesh-list
153868558|NCT01137682|Lanreotide|lanreotide|mesh-list
153868559|NCT01137682|Pasireotide|pasireotide|mesh-list
153868560|NCT01137682|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153868561|NCT01137682|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153868562|NCT01137682|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153868563|NCT01137682|Hormones|hormones|mesh-ancestor
153868564|NCT01137682|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153409069|NCT00357253|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153409070|NCT02068430|Riboflavin|riboflavin|mesh-list
153409122|NCT04344457|Indomethacin|indomethacin|mesh-list
153868587|NCT00586911|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153868588|NCT00586911|Antimetabolites|antimetabolites|mesh-ancestor
153868589|NCT00586911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153868590|NCT00586911|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153868591|NCT00575393|Gold Sodium Thiomalate|gold sodium thiomalate|mesh-list
153868592|NCT00575393|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153868593|NCT03453684|Vancomycin|vancomycin|mesh-list
153868594|NCT03453684|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153868595|NCT03453684|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153868596|NCT00575627|Interferons|interferons|mesh-list
153868597|NCT00575627|Ribavirin|ribavirin|mesh-list
153868598|NCT00575627|Interferon-alpha|interferon-alpha|mesh-list
153868599|NCT00575627|Interferon alpha-2|interferon alpha-2|mesh-list
153868600|NCT00575627|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
153868601|NCT00575627|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153868627|NCT04674176|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153868628|NCT04674527|Temozolomide|temozolomide|mesh-list
153868629|NCT04674527|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153868630|NCT04674527|Alkylating Agents|alkylating agents|mesh-ancestor
153868631|NCT04674527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153868632|NCT04674527|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153868633|NCT00199836|Monatide (IMS 3015)|monatide (ims 3015)|mesh-list
153868634|NCT00199836|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153868635|NCT00199836|Immunologic Factors|immunologic factors|mesh-ancestor
153868637|NCT00199797|Leucovorin|leucovorin|mesh-list
153409210|NCT05717257|Dapagliflozin|dapagliflozin|mesh-list
153409211|NCT05717257|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
153409212|NCT05717257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153409213|NCT05717257|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153868683|NCT05214976|Antimitotic Agents|antimitotic agents|mesh-ancestor
153868684|NCT05214976|Mitosis Modulators|mitosis modulators|mesh-ancestor
153868685|NCT05214976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153409214|NCT05717257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153409217|NCT04341818|Cholecalciferol|cholecalciferol|mesh-list
153409218|NCT04341818|Vitamins|vitamins|mesh-list
153409219|NCT04341818|Micronutrients|micronutrients|mesh-ancestor
153409220|NCT04341818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153868739|NCT00197106|Xhance|xhance|mesh-list
153868742|NCT00197106|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153868743|NCT00197106|Autonomic Agents|autonomic agents|mesh-ancestor
153868744|NCT00197106|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153868745|NCT00197106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153868746|NCT00197106|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153409256|NCT05716945|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153409320|NCT02454296|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153409321|NCT02454296|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153409322|NCT02454296|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
153888864|NCT01049503|Cariostatic Agents|cariostatic agents|mesh-ancestor
153888865|NCT01049503|Protective Agents|protective agents|mesh-ancestor
153888866|NCT01049503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153868784|NCT00637390|Alemtuzumab|alemtuzumab|mesh-list
153868787|NCT00196326|Levonorgestrel|levonorgestrel|mesh-list
153409349|NCT00358969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153409350|NCT00358969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153429987|NCT00378937|Respiratory System Agents|respiratory system agents|mesh-ancestor
153429988|NCT00002792|Cyclosporine|cyclosporine|mesh-list
153429989|NCT00002792|Cyclophosphamide|cyclophosphamide|mesh-list
153409357|NCT02896712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153409358|NCT05346601|Chiauranib|chiauranib|mesh-list
153409359|NCT05346601|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153409360|NCT05346601|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153868884|NCT00195507|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153868885|NCT00195507|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153868886|NCT00195507|Analgesics|analgesics|mesh-ancestor
153868887|NCT00195507|Sensory System Agents|sensory system agents|mesh-ancestor
153868888|NCT00195507|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153409397|NCT04450836|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153409398|NCT05679193|Propranolol|propranolol|mesh-list
153409420|NCT02977741|Olanzapine|olanzapine|mesh-list
153409453|NCT01634178|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153868926|NCT00195273|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153868927|NCT00195273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153868928|NCT00195273|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153868929|NCT00195273|Immunologic Factors|immunologic factors|mesh-ancestor
153868930|NCT00195273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153868931|NCT00195273|Antifungal Agents|antifungal agents|mesh-ancestor
153409518|NCT05648058|Promethazine|promethazine|mesh-list
153409519|NCT05648058|Nefopam|nefopam|mesh-list
153409520|NCT05648058|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
153409521|NCT05648058|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153409522|NCT05648058|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153409530|NCT05648058|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153868996|NCT00193206|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153868997|NCT00193206|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153868998|NCT00193206|Tubulin Modulators|tubulin modulators|mesh-ancestor
153409541|NCT05210101|Sotrovimab|sotrovimab|mesh-list
153869036|NCT04608734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153869037|NCT00192075|Leucovorin|leucovorin|mesh-list
153869038|NCT00192075|Folic Acid|folic acid|mesh-list
153869039|NCT00192075|Gemcitabine|gemcitabine|mesh-list
153869040|NCT00192075|Oxaliplatin|oxaliplatin|mesh-list
153869041|NCT00192075|Levoleucovorin|levoleucovorin|mesh-list
153869042|NCT00192075|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153869043|NCT00192075|Antimetabolites|antimetabolites|mesh-ancestor
153869044|NCT00192075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153869045|NCT00192075|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153869046|NCT00192075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153869047|NCT00192075|Antidotes|antidotes|mesh-ancestor
153869048|NCT00192075|Protective Agents|protective agents|mesh-ancestor
153869049|NCT00192075|Vitamin B Complex|vitamin b complex|mesh-ancestor
153869050|NCT00192075|Vitamins|vitamins|mesh-ancestor
153869051|NCT00192075|Micronutrients|micronutrients|mesh-ancestor
153869059|NCT00191724|Enoxaparin|enoxaparin|mesh-list
153869086|NCT00191334|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153869087|NCT00191334|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153869088|NCT00191334|Antimetabolites|antimetabolites|mesh-ancestor
153869089|NCT00191334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153869091|NCT00191139|Gemcitabine|gemcitabine|mesh-list
153869092|NCT00191139|Docetaxel|docetaxel|mesh-list
153869093|NCT00191139|Etoposide|etoposide|mesh-list
153869094|NCT00191139|Etoposide phosphate|etoposide phosphate|mesh-list
153869095|NCT00191139|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153869096|NCT00191139|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153869097|NCT00191139|Antimetabolites|antimetabolites|mesh-ancestor
153869098|NCT00191139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153869099|NCT00191139|Tubulin Modulators|tubulin modulators|mesh-ancestor
153869100|NCT00191139|Antimitotic Agents|antimitotic agents|mesh-ancestor
153869101|NCT00191139|Mitosis Modulators|mitosis modulators|mesh-ancestor
153869102|NCT00191139|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153869105|NCT00191139|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153869106|NCT00564512|Cyclophosphamide|cyclophosphamide|mesh-list
153869107|NCT00564512|Rituximab|rituximab|mesh-list
153869108|NCT00564512|Fludarabine|fludarabine|mesh-list
153869109|NCT00564512|Alemtuzumab|alemtuzumab|mesh-list
153869110|NCT00564512|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153869111|NCT00564512|Immunologic Factors|immunologic factors|mesh-ancestor
153869112|NCT00564512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153869113|NCT00564512|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153409655|NCT02976259|Dolutegravir|dolutegravir|mesh-list
153409656|NCT02976259|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
153409657|NCT02976259|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
153409658|NCT02976259|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153409659|NCT02976259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153409660|NCT02976259|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153409666|NCT00360295|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153869134|NCT00190749|Serotonin Agents|serotonin agents|mesh-ancestor
153869135|NCT00190749|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153869157|NCT04607447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153869158|NCT04607447|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153869159|NCT04607447|Glucocorticoids|glucocorticoids|mesh-ancestor
153869160|NCT04607447|Hormones|hormones|mesh-ancestor
153869161|NCT04607447|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153869162|NCT04607447|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153869163|NCT04607447|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153869166|NCT04607447|Antimetabolites|antimetabolites|mesh-ancestor
153869167|NCT04607447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153869168|NCT04607447|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153869169|NCT04607447|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
153869170|NCT04607447|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153869171|NCT00190671|Cyclophosphamide|cyclophosphamide|mesh-list
153869172|NCT00190671|Pemetrexed|pemetrexed|mesh-list
153869173|NCT00190671|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153869174|NCT00190671|Immunologic Factors|immunologic factors|mesh-ancestor
153869175|NCT00190671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153869176|NCT00190671|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153409690|NCT00360607|Metronidazole|metronidazole|mesh-list
153409691|NCT00360607|Amikacin|amikacin|mesh-list
153409692|NCT00360607|Ceftazidime|ceftazidime|mesh-list
153409693|NCT00360607|Sulbactam|sulbactam|mesh-list
153409694|NCT00360607|Cefoperazone|cefoperazone|mesh-list
153409695|NCT00360607|Sulperazone|sulperazone|mesh-list
153869187|NCT04607525|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153869195|NCT04607525|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153869196|NCT04607525|Adrenergic Agents|adrenergic agents|mesh-ancestor
153869197|NCT04607525|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153869198|NCT04607525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153869200|NCT00198276|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153869201|NCT00198276|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153869202|NCT04607642|Manganese|manganese|mesh-list
153869203|NCT04607642|Trace Elements|trace elements|mesh-ancestor
153869233|NCT00564668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153869234|NCT00564707|Botulinum Toxins|botulinum toxins|mesh-list
153409750|NCT04730635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153409751|NCT04730635|Nootropic Agents|nootropic agents|mesh-ancestor
153409752|NCT04676035|Vitamin K 1|vitamin k 1|mesh-list
153409753|NCT04676035|Vitamin K|vitamin k|mesh-list
153409754|NCT04676035|Midazolam|midazolam|mesh-list
153409755|NCT04676035|Omeprazole|omeprazole|mesh-list
153409756|NCT04676035|Warfarin|warfarin|mesh-list
153409757|NCT04676035|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153409758|NCT04676035|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153409785|NCT04359199|Cetuximab|cetuximab|mesh-list
153409786|NCT04359199|Durvalumab|durvalumab|mesh-list
153409787|NCT04359199|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153409788|NCT04359199|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153409789|NCT04359199|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153409791|NCT00361075|Estradiol|estradiol|mesh-list
153409866|NCT05616468|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153409867|NCT05616468|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153409868|NCT05616468|Alkylating Agents|alkylating agents|mesh-ancestor
153429997|NCT00002792|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153869385|NCT00476229|Immunologic Factors|immunologic factors|mesh-ancestor
153869456|NCT00474708|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153869514|NCT02277600|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153869571|NCT01580865|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153869572|NCT01580865|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153869573|NCT00473694|Glycopyrrolate|glycopyrrolate|mesh-list
153410118|NCT00003279|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153410119|NCT00383487|Calcitriol|calcitriol|mesh-list
153410120|NCT00383487|Dihydroxycholecalciferols|dihydroxycholecalciferols|mesh-list
153410121|NCT00383487|Naproxen|naproxen|mesh-list
153410122|NCT00383487|Naproxen-n-butyl nitrate|naproxen-n-butyl nitrate|mesh-list
153410123|NCT00383487|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153869605|NCT00473655|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
153869606|NCT00473655|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153869607|NCT00582920|Zoledronic Acid|zoledronic acid|mesh-list
153410142|NCT00383487|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
153410143|NCT00003429|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
153410144|NCT00003429|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
153410145|NCT00003429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153410146|NCT00003435|Antiviral Agents|antiviral agents|mesh-list
153410147|NCT00003435|Melphalan|melphalan|mesh-list
153410148|NCT00003435|Antilymphocyte Serum|antilymphocyte serum|mesh-list
153410149|NCT00003435|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153410150|NCT00003435|Alkylating Agents|alkylating agents|mesh-ancestor
153410151|NCT00003435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153410153|NCT00003435|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153410154|NCT00003435|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153410155|NCT00003435|Immunologic Factors|immunologic factors|mesh-ancestor
153410156|NCT00003435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153410157|NCT00003435|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153410158|NCT00003441|Irofulven|irofulven|mesh-list
153410159|NCT00003441|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153410160|NCT00003441|Alkylating Agents|alkylating agents|mesh-ancestor
153410161|NCT00003441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153410162|NCT00003441|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153410164|NCT00002805|Cytarabine|cytarabine|mesh-list
153410165|NCT00002805|Hydrocortisone|hydrocortisone|mesh-list
153410190|NCT00002805|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153410191|NCT00002805|Antiviral Agents|antiviral agents|mesh-ancestor
153410192|NCT00002805|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153410193|NCT00002805|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153410194|NCT00002805|Analgesics|analgesics|mesh-ancestor
153410195|NCT00002805|Sensory System Agents|sensory system agents|mesh-ancestor
153410196|NCT00002805|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153410197|NCT00002805|Trace Elements|trace elements|mesh-ancestor
153410198|NCT00002805|Micronutrients|micronutrients|mesh-ancestor
153410200|NCT00003297|Mitoxantrone|mitoxantrone|mesh-list
153410201|NCT00003297|Thiotepa|thiotepa|mesh-list
153410202|NCT00003297|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
153410203|NCT00003297|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153410204|NCT00003297|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153410205|NCT00003297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153410206|NCT00003297|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153410236|NCT00003315|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153410237|NCT00003315|Antifungal Agents|antifungal agents|mesh-ancestor
153410238|NCT00002817|Sargramostim|sargramostim|mesh-list
153410239|NCT00002817|Immunologic Factors|immunologic factors|mesh-ancestor
153410240|NCT00002817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153410242|NCT00003465|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153888896|NCT01023217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153869688|NCT00583271|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153869689|NCT00583349|Paclitaxel|paclitaxel|mesh-list
153869690|NCT00583349|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153869691|NCT00583349|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153869692|NCT00583349|Tubulin Modulators|tubulin modulators|mesh-ancestor
153869693|NCT00583349|Antimitotic Agents|antimitotic agents|mesh-ancestor
153869694|NCT00583349|Mitosis Modulators|mitosis modulators|mesh-ancestor
153869695|NCT00583349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153410267|NCT00361621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153410268|NCT00361621|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153410269|NCT00361621|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153410270|NCT00361621|Alkylating Agents|alkylating agents|mesh-ancestor
153410271|NCT00361621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153869719|NCT01133626|Glucocorticoids|glucocorticoids|mesh-ancestor
153869720|NCT01133626|Hormones|hormones|mesh-ancestor
153869721|NCT01133626|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153869724|NCT01133626|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153410304|NCT00003339|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153410305|NCT00002829|Interferons|interferons|mesh-list
153410306|NCT00002829|Interferon-alpha|interferon-alpha|mesh-list
153410318|NCT00002829|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153869749|NCT02882893|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153869750|NCT02210364|Capecitabine|capecitabine|mesh-list
153869751|NCT02210364|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153869752|NCT02210364|Antimetabolites|antimetabolites|mesh-ancestor
153869753|NCT02210364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153410340|NCT03596905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153410341|NCT03596905|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153410342|NCT00002835|Leucovorin|leucovorin|mesh-list
153410343|NCT00002835|Interferons|interferons|mesh-list
153410344|NCT00002835|Cytarabine|cytarabine|mesh-list
153410345|NCT00002835|Interferon-alpha|interferon-alpha|mesh-list
153410346|NCT00002835|Methylprednisolone|methylprednisolone|mesh-list
153869772|NCT00471237|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153869785|NCT04570449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153869786|NCT04570449|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
153869787|NCT04570449|Antidepressive Agents|antidepressive agents|mesh-ancestor
153869788|NCT04570449|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153869789|NCT04570449|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
153869796|NCT00470847|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153869797|NCT00470847|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153869798|NCT00470847|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153869799|NCT00470847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153869800|NCT00584090|Solifenacin Succinate|solifenacin succinate|mesh-list
153869801|NCT00584090|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
153869802|NCT00584090|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
153869803|NCT00584090|Cholinergic Agents|cholinergic agents|mesh-ancestor
153869804|NCT00584090|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153869805|NCT00584090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153869806|NCT00584090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153869807|NCT00584090|Urological Agents|urological agents|mesh-ancestor
153410365|NCT00002835|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153410366|NCT00002835|Immunologic Factors|immunologic factors|mesh-ancestor
153410367|NCT00002835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153410368|NCT00002835|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153888898|NCT01023217|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153869809|NCT00584168|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153869810|NCT00584168|Antiemetics|antiemetics|mesh-ancestor
153869811|NCT00584168|Autonomic Agents|autonomic agents|mesh-ancestor
153869812|NCT00584168|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153410375|NCT00002835|Abortifacient Agents|abortifacient agents|mesh-ancestor
153410376|NCT00002835|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153410377|NCT00002835|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153410378|NCT00002835|Antimetabolites|antimetabolites|mesh-ancestor
153410379|NCT00002835|Dermatologic Agents|dermatologic agents|mesh-ancestor
153410380|NCT00002835|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153410381|NCT00002835|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153410382|NCT00002835|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153410383|NCT00002835|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153410385|NCT00002835|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153410386|NCT00002835|Antiviral Agents|antiviral agents|mesh-ancestor
153410387|NCT00002835|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153869845|NCT00470184|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153869846|NCT04570254|Vitamins|vitamins|mesh-list
153869847|NCT04570254|Vitamin E|vitamin e|mesh-list
153869869|NCT00470067|Carboplatin|carboplatin|mesh-list
153869870|NCT00470067|Doxorubicin|doxorubicin|mesh-list
153869872|NCT00470067|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153869873|NCT00470067|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153869874|NCT00470067|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153869875|NCT00470067|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153869876|NCT00470067|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153869877|NCT00470067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153869878|NCT00584636|Budesonide|budesonide|mesh-list
153869885|NCT00584636|Respiratory System Agents|respiratory system agents|mesh-ancestor
153869886|NCT00584636|Glucocorticoids|glucocorticoids|mesh-ancestor
153869887|NCT00584636|Hormones|hormones|mesh-ancestor
153869888|NCT00584636|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153869889|NCT00479817|Paclitaxel|paclitaxel|mesh-list
153869890|NCT00479817|Trebananib|trebananib|mesh-list
153869891|NCT00479817|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153869892|NCT00479817|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153869893|NCT00479817|Tubulin Modulators|tubulin modulators|mesh-ancestor
153869894|NCT00479817|Antimitotic Agents|antimitotic agents|mesh-ancestor
153869895|NCT00479817|Mitosis Modulators|mitosis modulators|mesh-ancestor
153869896|NCT00479817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153869897|NCT00479817|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153410488|NCT00002865|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153410489|NCT00002865|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
153869919|NCT04575194|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153869920|NCT04575194|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153869921|NCT04575194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153869922|NCT04575194|Dopamine Agents|dopamine agents|mesh-ancestor
153869923|NCT04575194|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153869924|NCT04575194|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
153869925|NCT04575194|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153869926|NCT04575194|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153869927|NCT00478179|Bupivacaine|bupivacaine|mesh-list
153869928|NCT00478179|Anesthetics, Local|anesthetics, local|mesh-ancestor
153410519|NCT04154943|Cemiplimab|cemiplimab|mesh-list
153869935|NCT00585143|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153869936|NCT00585143|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153869937|NCT00585143|Antimetabolites|antimetabolites|mesh-ancestor
153869938|NCT00585143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153869939|NCT00585143|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153869940|NCT00585143|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
153869941|NCT00585143|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153869942|NCT00585260|Mannitol|mannitol|mesh-list
153869943|NCT00585260|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
153869944|NCT00585260|Diuretics|diuretics|mesh-ancestor
153869945|NCT00585260|Natriuretic Agents|natriuretic agents|mesh-ancestor
153869947|NCT00475020|Fludarabine|fludarabine|mesh-list
153869986|NCT01132807|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153410546|NCT04342273|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153410547|NCT04342273|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153410548|NCT04342273|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153410549|NCT04342273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153410550|NCT04342273|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153410552|NCT00003375|Lomustine|lomustine|mesh-list
153869987|NCT01132807|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153869988|NCT01132807|Alkylating Agents|alkylating agents|mesh-ancestor
153869989|NCT01132807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153869990|NCT01132807|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153869991|NCT01132807|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153869992|NCT01132807|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153869993|NCT01132807|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153869994|NCT01132807|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153410557|NCT00003375|Antimitotic Agents|antimitotic agents|mesh-ancestor
153410558|NCT00003375|Mitosis Modulators|mitosis modulators|mesh-ancestor
153410559|NCT00003375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153410560|NCT00003375|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153410561|NCT00003375|Alkylating Agents|alkylating agents|mesh-ancestor
153410562|NCT03498391|Ketamine|ketamine|mesh-list
153410563|NCT03498391|Propofol|propofol|mesh-list
153410564|NCT03498391|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153869995|NCT01132807|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153869996|NCT01132807|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153869997|NCT01132807|Glucocorticoids|glucocorticoids|mesh-ancestor
153869998|NCT01132807|Hormones|hormones|mesh-ancestor
153869999|NCT01132807|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153870000|NCT01132807|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153870001|NCT01132807|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153870002|NCT01132807|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
153870019|NCT01089504|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153870020|NCT01089504|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153870021|NCT01089504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153870040|NCT01088997|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153870041|NCT01088997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153870042|NCT01088997|Protective Agents|protective agents|mesh-ancestor
153870043|NCT01088997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153870044|NCT00586118|Propofol|propofol|mesh-list
153870084|NCT00586430|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153870085|NCT00586430|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153870086|NCT00586430|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153870087|NCT00586430|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153870088|NCT00586430|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153870089|NCT00586430|GABA Modulators|gaba modulators|mesh-ancestor
153870090|NCT00586430|GABA Agents|gaba agents|mesh-ancestor
153870091|NCT00586430|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153870092|NCT00586430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153870093|NCT04569279|Warfarin|warfarin|mesh-list
153870122|NCT04312282|Antitubercular Agents|antitubercular agents|mesh-ancestor
153870123|NCT04312282|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153870124|NCT04312282|Leprostatic Agents|leprostatic agents|mesh-ancestor
153870125|NCT04312282|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153870126|NCT04312282|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
153870127|NCT04312282|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
153870128|NCT04312282|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
153870146|NCT01087788|Immunologic Factors|immunologic factors|mesh-ancestor
153870147|NCT01087788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153870148|NCT01087788|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153870150|NCT00586976|Anesthetics, Local|anesthetics, local|mesh-ancestor
153870151|NCT00586976|Anesthetics|anesthetics|mesh-ancestor
153870152|NCT00586976|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153870153|NCT00586976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153870154|NCT00586976|Sensory System Agents|sensory system agents|mesh-ancestor
153870155|NCT00586976|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153870156|NCT00587015|Immunotoxin HA22|immunotoxin ha22|mesh-list
153870157|NCT00587015|Immunotoxins|immunotoxins|mesh-ancestor
153410728|NCT00003981|N-(3-chloro-7-indolyl)-1,4-benzenedisulphonamide|n-(3-chloro-7-indolyl)-1,4-benzenedisulphonamide|mesh-list
153410729|NCT00003981|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153410730|NCT00003981|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
153410731|NCT00003981|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153410732|NCT00003981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153410733|NCT00003993|Aldesleukin|aldesleukin|mesh-list
153410734|NCT00003993|Bryostatin 1|bryostatin 1|mesh-list
153410755|NCT03476239|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153410756|NCT00004863|Paclitaxel|paclitaxel|mesh-list
153410757|NCT00004863|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153410758|NCT00004863|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153410759|NCT00004863|Tubulin Modulators|tubulin modulators|mesh-ancestor
153410760|NCT00004863|Antimitotic Agents|antimitotic agents|mesh-ancestor
153410761|NCT00004863|Mitosis Modulators|mitosis modulators|mesh-ancestor
153410762|NCT00004863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153410763|NCT00004875|Heparin|heparin|mesh-list
153410764|NCT00004875|Enoxaparin|enoxaparin|mesh-list
153870181|NCT01086150|Lidocaine|lidocaine|mesh-list
153410775|NCT00003561|Immunologic Factors|immunologic factors|mesh-ancestor
153410776|NCT00003561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153410777|NCT00003567|Temozolomide|temozolomide|mesh-list
153410778|NCT00003567|Carmustine|carmustine|mesh-list
153410779|NCT00003567|O(6)-benzylguanine|o(6)-benzylguanine|mesh-list
153410780|NCT00003567|Sargramostim|sargramostim|mesh-list
153410788|NCT00003573|Cyclophosphamide|cyclophosphamide|mesh-list
153410789|NCT00003573|Cisplatin|cisplatin|mesh-list
153410790|NCT00003573|Etoposide|etoposide|mesh-list
153410791|NCT00003573|Vincristine|vincristine|mesh-list
153410792|NCT00003573|Lenograstim|lenograstim|mesh-list
153410793|NCT00003573|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153870197|NCT00587249|Antacids|antacids|mesh-ancestor
153870223|NCT01085136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153870224|NCT01085136|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153870226|NCT00587873|Methotrexate|methotrexate|mesh-list
153870227|NCT00587873|Thioguanine|thioguanine|mesh-list
153870228|NCT00587873|Calcium|calcium|mesh-list
153870229|NCT00587873|Levoleucovorin|levoleucovorin|mesh-list
153870230|NCT00587873|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153870231|NCT00587873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153870232|NCT00587873|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
153870248|NCT00587873|Vitamin B Complex|vitamin b complex|mesh-ancestor
153870249|NCT00587873|Vitamins|vitamins|mesh-ancestor
153870250|NCT00587873|Micronutrients|micronutrients|mesh-ancestor
153870251|NCT01084707|Nicotine|nicotine|mesh-list
153870252|NCT01084707|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
153870253|NCT01084707|Autonomic Agents|autonomic agents|mesh-ancestor
153870254|NCT01084707|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153870255|NCT01084707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153870256|NCT01084707|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
153870257|NCT01084707|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
153410847|NCT02975323|Vasodilator Agents|vasodilator agents|mesh-ancestor
153410851|NCT00003597|Etoposide|etoposide|mesh-list
153430032|NCT05513612|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153870285|NCT01084005|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153870286|NCT01084005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153870288|NCT01084005|Hormones|hormones|mesh-ancestor
153410863|NCT00003597|Immunologic Factors|immunologic factors|mesh-ancestor
153410864|NCT00003597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153410865|NCT00004005|Leucovorin|leucovorin|mesh-list
153410866|NCT00004005|Fluorouracil|fluorouracil|mesh-list
153410867|NCT00004005|Irinotecan|irinotecan|mesh-list
153410890|NCT00003603|Lomustine|lomustine|mesh-list
153410891|NCT00003603|Idarubicin|idarubicin|mesh-list
153410892|NCT00003603|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153410893|NCT00003603|Immunologic Factors|immunologic factors|mesh-ancestor
153410894|NCT00003603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153410895|NCT00003603|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153410896|NCT00003603|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153410897|NCT00003603|Alkylating Agents|alkylating agents|mesh-ancestor
153410898|NCT00003603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153410899|NCT00003603|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153410900|NCT00003603|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153410901|NCT00003603|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153410902|NCT00003603|Antiemetics|antiemetics|mesh-ancestor
153870341|NCT00589238|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153870342|NCT00589238|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153870343|NCT00589238|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153870344|NCT00589394|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
153870345|NCT00589394|Immunologic Factors|immunologic factors|mesh-ancestor
153870346|NCT00589394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153870347|NCT01083576|Gentamicins|gentamicins|mesh-list
153870348|NCT01083576|Paromomycin|paromomycin|mesh-list
153870349|NCT01083576|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153870350|NCT01083576|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153870351|NCT01083576|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
153870352|NCT01083576|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153410930|NCT00004887|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153410931|NCT00004893|Interleukin-12|interleukin-12|mesh-list
153410932|NCT00004893|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153410933|NCT00004893|Immunologic Factors|immunologic factors|mesh-ancestor
153410934|NCT00004893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153410935|NCT00004893|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153410960|NCT00004905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153410961|NCT00004905|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153410962|NCT00004905|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153410963|NCT00004905|Alkylating Agents|alkylating agents|mesh-ancestor
153410964|NCT00004905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153410965|NCT00004905|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153410966|NCT00004905|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153410967|NCT00004905|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153410968|NCT00004905|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153410997|NCT00421915|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153410998|NCT00421915|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153410999|NCT00421915|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153411000|NCT00421915|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153411001|NCT00421915|Immunologic Factors|immunologic factors|mesh-ancestor
153411003|NCT00362713|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153411004|NCT00362713|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153411005|NCT00362713|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153411013|NCT00003627|Fluorouracil|fluorouracil|mesh-list
153870570|NCT01081782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153870647|NCT04572542|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153870648|NCT04572542|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153870650|NCT04572620|Abatacept|abatacept|mesh-list
153411336|NCT00005031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153870801|NCT03450434|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153870802|NCT03450434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153411411|NCT00004227|Cetuximab|cetuximab|mesh-list
153411469|NCT00003723|Antimetabolites|antimetabolites|mesh-ancestor
153411542|NCT00003735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153411543|NCT00003735|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153411600|NCT00005091|Exatecan|exatecan|mesh-list
153871055|NCT00190775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153871056|NCT00198263|Bleomycin|bleomycin|mesh-list
153871057|NCT00198263|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153871173|NCT00176462|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153871244|NCT00171314|Letrozole|letrozole|mesh-list
153871245|NCT00171314|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153871246|NCT00171314|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
153871248|NCT00171314|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153411996|NCT00363584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153412085|NCT00004785|Prednisolone acetate|prednisolone acetate|mesh-list
153412089|NCT00004785|Antiemetics|antiemetics|mesh-ancestor
153871543|NCT04555707|Apremilast|apremilast|mesh-list
153412246|NCT00005631|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153412247|NCT00005631|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153412248|NCT00005631|Immunologic Factors|immunologic factors|mesh-ancestor
153412353|NCT00005799|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153412354|NCT00005799|Antifungal Agents|antifungal agents|mesh-ancestor
153412355|NCT00005799|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153871791|NCT01085201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153412484|NCT02420210|Glucocorticoids|glucocorticoids|mesh-ancestor
153412485|NCT02420210|Hormones|hormones|mesh-ancestor
153871892|NCT00179010|Analgesics|analgesics|mesh-ancestor
153412587|NCT00588523|Temozolomide|temozolomide|mesh-list
153412625|NCT00363025|Idarubicin|idarubicin|mesh-list
153412632|NCT02444143|Tacrolimus|tacrolimus|mesh-list
153412684|NCT02421211|Protease Inhibitors|protease inhibitors|mesh-ancestor
153889019|NCT01026493|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153412775|NCT02429869|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153872300|NCT00556127|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153872301|NCT00556127|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153872376|NCT00477750|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153872377|NCT00477750|Alkylating Agents|alkylating agents|mesh-ancestor
153872378|NCT00477750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153872379|NCT00477750|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153872380|NCT00477750|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153413185|NCT02536105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153413190|NCT02536105|Dopamine Agents|dopamine agents|mesh-ancestor
153872577|NCT04560101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153872578|NCT04560101|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
153413252|NCT02439164|GABA Agents|gaba agents|mesh-ancestor
153413310|NCT02511236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153413335|NCT02514044|Dextroamphetamine|dextroamphetamine|mesh-list
153413369|NCT04025060|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153889051|NCT01021813|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
153872865|NCT04539444|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153872964|NCT04545879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153872965|NCT04545879|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153873003|NCT04558424|Antioxidants|antioxidants|mesh-ancestor
153873005|NCT04558424|Protective Agents|protective agents|mesh-ancestor
153413760|NCT04741880|Sensory System Agents|sensory system agents|mesh-ancestor
153873176|NCT00625495|Esomeprazole|esomeprazole|mesh-list
153873182|NCT02882425|Selexipag|selexipag|mesh-list
153873235|NCT01121926|Antidepressive Agents|antidepressive agents|mesh-ancestor
153873332|NCT04544163|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153873433|NCT04536051|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153873435|NCT04536051|Antipyretics|antipyretics|mesh-ancestor
153414150|NCT02560051|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
153414152|NCT02560051|Alkylating Agents|alkylating agents|mesh-ancestor
153414288|NCT03551210|Nemonoxacin|nemonoxacin|mesh-list
153414289|NCT03551210|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
153873677|NCT04531332|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153873679|NCT04531332|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153873765|NCT02882113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153873766|NCT04530045|Piperacillin|piperacillin|mesh-list
153414498|NCT00422396|Antimetabolites|antimetabolites|mesh-ancestor
153873879|NCT01120600|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153414630|NCT02977286|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
153414631|NCT02977286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153414774|NCT02513719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153874048|NCT00581165|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153874181|NCT04577027|Travoprost|travoprost|mesh-list
153874294|NCT02219490|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153874297|NCT02219490|Antimetabolites|antimetabolites|mesh-ancestor
153388849|NCT00002127|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153388850|NCT00002127|Immunologic Factors|immunologic factors|mesh-ancestor
153390071|NCT05806723|Atorvastatin|atorvastatin|mesh-list
153396089|NCT02605187|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153396091|NCT05592197|Lenvatinib|lenvatinib|mesh-list
153396093|NCT05592197|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153396094|NCT05592197|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153402901|NCT04669197|Gemcitabine|gemcitabine|mesh-list
153402902|NCT04669197|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
153402903|NCT04669197|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153402904|NCT04669197|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153405616|NCT05925283|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153405617|NCT05925283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153408298|NCT03925532|Denosumab|denosumab|mesh-list
153408299|NCT03925532|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153409250|NCT02959255|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153409251|NCT02959255|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
153409252|NCT02959255|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153409253|NCT02959255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153409254|NCT05716945|Fluorometholone|fluorometholone|mesh-list
153409255|NCT05716945|Dexamethasone|dexamethasone|mesh-list
153409484|NCT00608972|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153410107|NCT04329585|Protective Agents|protective agents|mesh-ancestor
153411794|NCT00384969|Sorafenib|sorafenib|mesh-list
153412407|NCT01689987|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153412408|NCT01689987|Antifungal Agents|antifungal agents|mesh-ancestor
153412409|NCT01689987|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153413764|NCT04741880|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153413765|NCT04741880|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153414241|NCT02564497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153414242|NCT02564497|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153414243|NCT02565901|Sirolimus|sirolimus|mesh-list
153430322|NCT00379015|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153416066|NCT00367939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153417228|NCT02752256|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153417229|NCT02752256|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153417300|NCT05349032|Analgesics|analgesics|mesh-ancestor
153417532|NCT02768558|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153420191|NCT03123614|Methylprednisolone|methylprednisolone|mesh-list
153420409|NCT03091478|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153420410|NCT03091478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153423738|NCT03591068|Fluticasone|fluticasone|mesh-list
153424873|NCT02934932|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153424874|NCT02934932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153426971|NCT00001016|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153428485|NCT00002288|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153428487|NCT00002288|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153428733|NCT05701436|Oxaliplatin|oxaliplatin|mesh-list
153428734|NCT05701436|Raltitrexed|raltitrexed|mesh-list
153889298|NCT01281813|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
153432219|NCT05116293|Digoxin|digoxin|mesh-list
153433062|NCT02970318|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153433438|NCT00000865|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153433439|NCT00000865|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153433793|NCT00000997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153433794|NCT00000997|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153433795|NCT00000997|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153433796|NCT00000997|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153433803|NCT00000697|Antiviral Agents|antiviral agents|mesh-ancestor
153433804|NCT00000697|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153434120|NCT00002347|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153434121|NCT00002347|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153434532|NCT00002125|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153434534|NCT00001579|Leucovorin|leucovorin|mesh-list
153434900|NCT00003086|Cyclophosphamide|cyclophosphamide|mesh-list
153889359|NCT04306354|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153889360|NCT04306354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153435409|NCT00002263|Antiviral Agents|antiviral agents|mesh-ancestor
153435410|NCT00002263|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153435713|NCT05720767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153435831|NCT00002581|Abortifacient Agents|abortifacient agents|mesh-ancestor
153435857|NCT00002587|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
153436137|NCT00003956|Antidotes|antidotes|mesh-ancestor
153436591|NCT00004064|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153436593|NCT00382057|Anastrozole|anastrozole|mesh-list
153889434|NCT01079962|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153889435|NCT01079962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153430565|NCT04977674|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153437343|NCT00384566|Vasodilator Agents|vasodilator agents|mesh-ancestor
153437590|NCT00003728|Protective Agents|protective agents|mesh-ancestor
153437829|NCT00004346|L 647318|l 647318|mesh-list
153430605|NCT05286320|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153438249|NCT00003920|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
153889509|NCT01075984|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153889510|NCT01075984|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
153438537|NCT00004796|Lactulose|lactulose|mesh-list
153438639|NCT00005636|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153438640|NCT00005642|Semaxinib|semaxinib|mesh-list
153438995|NCT04563260|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
153438996|NCT04563260|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153438997|NCT04563260|Serotonin Agents|serotonin agents|mesh-ancestor
153438998|NCT04563260|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153439000|NCT04173793|Ezetimibe|ezetimibe|mesh-list
153439234|NCT03693781|Colchicine|colchicine|mesh-list
153439653|NCT00003541|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
153439654|NCT00003541|Etoposide|etoposide|mesh-list
153439655|NCT00003541|Vincristine|vincristine|mesh-list
153440033|NCT00003619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153440035|NCT00003619|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153440036|NCT00003619|Antimetabolites|antimetabolites|mesh-ancestor
153440834|NCT00003211|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153440835|NCT00003211|Tubulin Modulators|tubulin modulators|mesh-ancestor
153441286|NCT00004855|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
153442346|NCT02145078|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153444113|NCT00378833|Niacin|niacin|mesh-list
153446165|NCT00002003|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153446166|NCT00002003|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153446168|NCT00002003|Analgesics|analgesics|mesh-ancestor
153447005|NCT00002501|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153447006|NCT00002501|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153889605|NCT00627991|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153450892|NCT04649060|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153451557|NCT00003917|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153452484|NCT01803282|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153452834|NCT01790568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153452835|NCT01790568|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153453006|NCT01769508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153889711|NCT02871193|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153453238|NCT01762800|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
153889712|NCT02871193|Anesthetics, Local|anesthetics, local|mesh-ancestor
153453629|NCT01725126|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153453707|NCT01721772|Nivolumab|nivolumab|mesh-list
153453975|NCT01695954|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153454035|NCT01691508|Hormones|hormones|mesh-ancestor
153455477|NCT06034314|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153456516|NCT01499160|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
153456899|NCT01441596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153456902|NCT01441596|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153457994|NCT03591900|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153460766|NCT03458598|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153460768|NCT03458598|Analgesics|analgesics|mesh-ancestor
153460771|NCT03791736|Octreotide|octreotide|mesh-list
153916652|NCT00993915|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
153916653|NCT00993915|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153916654|NCT01202591|Fulvestrant|fulvestrant|mesh-list
153916655|NCT01202591|Exemestane|exemestane|mesh-list
153916656|NCT01202591|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153916657|NCT01202591|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153916658|NCT01202591|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
153916659|NCT01202591|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
153916671|NCT01202279|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153916672|NCT01202279|Autonomic Agents|autonomic agents|mesh-ancestor
153916673|NCT01202279|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153916674|NCT01202279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153916675|NCT01202279|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153916676|NCT01202279|Respiratory System Agents|respiratory system agents|mesh-ancestor
153916677|NCT01202279|Nasal Decongestants|nasal decongestants|mesh-ancestor
153916678|NCT01202279|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
153916679|NCT01202279|Sympathomimetics|sympathomimetics|mesh-ancestor
153916680|NCT01202279|Adrenergic Agents|adrenergic agents|mesh-ancestor
153916681|NCT01202279|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153916682|NCT01202279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153916683|NCT01202279|Expectorants|expectorants|mesh-ancestor
153916684|NCT01202279|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153916704|NCT02687347|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153916705|NCT02687347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153916706|NCT02687347|Analgesics|analgesics|mesh-ancestor
153916707|NCT02687347|Sensory System Agents|sensory system agents|mesh-ancestor
153916708|NCT02687347|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153815039|NCT04715165|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153916709|NCT02687347|Antitussive Agents|antitussive agents|mesh-ancestor
153916710|NCT02687347|Respiratory System Agents|respiratory system agents|mesh-ancestor
153916711|NCT02687425|Pioglitazone|pioglitazone|mesh-list
153916712|NCT02687425|Imatinib Mesylate|imatinib mesylate|mesh-list
153465416|NCT00223704|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153465419|NCT00223704|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153892621|NCT01299896|Nicotine|nicotine|mesh-list
153916714|NCT02687425|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153916715|NCT02687425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153783692|NCT00236717|GABA Agents|gaba agents|mesh-ancestor
153916716|NCT02687425|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153916717|NCT02687425|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153916718|NCT02687425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153916719|NCT02687425|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153916720|NCT02687269|Ranolazine|ranolazine|mesh-list
153916726|NCT02689297|Disinfectants|disinfectants|mesh-ancestor
153916727|NCT02689297|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153916728|NCT04185805|Fexuprazan|fexuprazan|mesh-list
153916729|NCT04185805|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153916730|NCT01201811|Azacitidine|azacitidine|mesh-list
153916731|NCT01201811|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153916732|NCT01201811|Antimetabolites|antimetabolites|mesh-ancestor
153916733|NCT01201811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153916734|NCT01201811|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153916735|NCT01201811|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153916736|NCT04186897|Salicylic Acid|salicylic acid|mesh-list
153916737|NCT04186897|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153916738|NCT04186897|Antifungal Agents|antifungal agents|mesh-ancestor
153916739|NCT04186897|Keratolytic Agents|keratolytic agents|mesh-ancestor
153916742|NCT05392127|Vitamin K 1|vitamin k 1|mesh-list
153916743|NCT05392127|Repaglinide|repaglinide|mesh-list
153916744|NCT05392127|Midazolam|midazolam|mesh-list
153916745|NCT05392127|Omeprazole|omeprazole|mesh-list
153916746|NCT05392127|Warfarin|warfarin|mesh-list
153916747|NCT05392127|Vitamins|vitamins|mesh-ancestor
153783694|NCT00236717|Antimanic Agents|antimanic agents|mesh-ancestor
153783695|NCT00236717|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153783696|NCT00236717|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153916748|NCT05392127|Micronutrients|micronutrients|mesh-ancestor
153916769|NCT05392127|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153916770|NCT05392127|Hemostatics|hemostatics|mesh-ancestor
153916771|NCT05392127|Coagulants|coagulants|mesh-ancestor
153916772|NCT05392127|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153916773|NCT02685163|Antioxidants|antioxidants|mesh-list
153916774|NCT02685163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153783698|NCT00236717|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153783699|NCT00236717|Analgesics|analgesics|mesh-ancestor
153889786|NCT01266603|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153783700|NCT00236717|Sensory System Agents|sensory system agents|mesh-ancestor
153783701|NCT00236717|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153783702|NCT00236717|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153892786|NCT01298570|Leucovorin|leucovorin|mesh-list
153916776|NCT02685163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153916777|NCT00640003|Baclofen|baclofen|mesh-list
153916778|NCT00640003|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
153465471|NCT00225498|Antiemetics|antiemetics|mesh-ancestor
153465472|NCT00225498|Autonomic Agents|autonomic agents|mesh-ancestor
153916779|NCT00640003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153916788|NCT01201343|Interferon-beta|interferon-beta|mesh-list
153916789|NCT01201343|Interferon beta-1a|interferon beta-1a|mesh-list
153916790|NCT01201343|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153916791|NCT01201343|Antiviral Agents|antiviral agents|mesh-ancestor
153916792|NCT01201343|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153916793|NCT01201343|Immunologic Factors|immunologic factors|mesh-ancestor
153783703|NCT00236717|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153783704|NCT00236717|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
153783705|NCT00236717|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
153430912|NCT00000301|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
153465527|NCT00227760|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153465529|NCT00227994|Galantamine|galantamine|mesh-list
153465530|NCT00227994|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
153465531|NCT00227994|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153465532|NCT00227994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153465533|NCT00227994|Cholinergic Agents|cholinergic agents|mesh-ancestor
153465534|NCT00227994|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153783706|NCT00236756|Topiramate|topiramate|mesh-list
153783707|NCT00236756|Anticonvulsants|anticonvulsants|mesh-ancestor
153783708|NCT00236756|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153783709|NCT00236756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153783710|NCT00269412|Rifaximin|rifaximin|mesh-list
153783711|NCT00269412|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153783712|NCT00269412|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153783713|NCT00269412|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153783714|NCT00236795|Ethinyl Estradiol|ethinyl estradiol|mesh-list
153783715|NCT00236795|Norelgestromin|norelgestromin|mesh-list
153783716|NCT00236795|Ethinyl Estradiol-Norgestrel Combination|ethinyl estradiol-norgestrel combination|mesh-list
153783717|NCT00236795|Estradiol|estradiol|mesh-list
153783718|NCT00236795|Estrogens|estrogens|mesh-ancestor
153465535|NCT00227994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153783719|NCT00236795|Hormones|hormones|mesh-ancestor
153465536|NCT00227994|Nootropic Agents|nootropic agents|mesh-ancestor
153465537|NCT00227994|Parasympathomimetics|parasympathomimetics|mesh-ancestor
153465538|NCT00227994|Autonomic Agents|autonomic agents|mesh-ancestor
153465539|NCT00227994|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153465540|NCT00114504|Simvastatin|simvastatin|mesh-list
153465541|NCT00114504|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153465542|NCT00114504|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153465543|NCT00114504|Antimetabolites|antimetabolites|mesh-ancestor
153783720|NCT00236795|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153783721|NCT00236795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153783722|NCT00236795|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
153783723|NCT00236795|Contraceptive Agents|contraceptive agents|mesh-ancestor
153783724|NCT00236795|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153783725|NCT00236795|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
153465544|NCT00114504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153465545|NCT00114504|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153465548|NCT01898676|Valproic Acid|valproic acid|mesh-list
153916794|NCT01201343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153916795|NCT01201343|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153916796|NCT04185649|Capecitabine|capecitabine|mesh-list
153916797|NCT04185649|Lapatinib|lapatinib|mesh-list
153916798|NCT04185649|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153916800|NCT04185649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153916802|NCT04185649|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153783726|NCT00236795|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
153916803|NCT04185649|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153916826|NCT00638677|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153916827|NCT01200485|Allopurinol|allopurinol|mesh-list
153916828|NCT01200485|Rasburicase|rasburicase|mesh-list
153916829|NCT01200485|Antimetabolites|antimetabolites|mesh-ancestor
153916830|NCT01200485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153916831|NCT01200485|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153916832|NCT01200485|Gout Suppressants|gout suppressants|mesh-ancestor
153916833|NCT01200485|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153916834|NCT01200485|Free Radical Scavengers|free radical scavengers|mesh-ancestor
153916835|NCT01200485|Antioxidants|antioxidants|mesh-ancestor
153916836|NCT01200485|Protective Agents|protective agents|mesh-ancestor
153916837|NCT01200485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153916838|NCT02688907|Adavosertib|adavosertib|mesh-list
153916839|NCT02688907|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153916840|NCT02688907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153916841|NCT02686645|Metronidazole|metronidazole|mesh-list
153916843|NCT02686645|Loperamide|loperamide|mesh-list
153916844|NCT02686645|Antidiarrheals|antidiarrheals|mesh-list
153916845|NCT02686645|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153916846|NCT02686645|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153916847|NCT02686645|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153916848|NCT02686645|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153916849|NCT02686645|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153916850|NCT04318067|Melatonin|melatonin|mesh-list
153465583|NCT00288600|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
153465584|NCT00288600|Immunologic Factors|immunologic factors|mesh-ancestor
153465585|NCT00288600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153465587|NCT00290472|Temsirolimus|temsirolimus|mesh-list
153465588|NCT00290472|MTOR Inhibitors|mtor inhibitors|mesh-list
153465589|NCT00290472|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153465590|NCT00290472|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153465598|NCT00290472|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153465599|NCT00290472|Antifungal Agents|antifungal agents|mesh-ancestor
153465600|NCT04752852|Dexamethasone|dexamethasone|mesh-list
153916851|NCT04318067|Antioxidants|antioxidants|mesh-ancestor
153916852|NCT04318067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153916853|NCT04318067|Protective Agents|protective agents|mesh-ancestor
153916854|NCT04318067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153916855|NCT04318067|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153916857|NCT01200407|Olmesartan|olmesartan|mesh-list
153916858|NCT01200407|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
153916859|NCT01200407|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153916860|NCT01200407|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153916861|NCT01200407|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153916862|NCT01200407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153916863|NCT01200407|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153916864|NCT01200407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153916865|NCT01200407|Vasodilator Agents|vasodilator agents|mesh-ancestor
153916866|NCT01200407|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
153916867|NCT01200407|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
153916868|NCT02685085|Misoprostol|misoprostol|mesh-list
153916869|NCT02685085|Dinoprostone|dinoprostone|mesh-list
153916870|NCT02685085|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
153916871|NCT02685085|Abortifacient Agents|abortifacient agents|mesh-ancestor
153916872|NCT02685085|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153916873|NCT02685085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153916874|NCT02685085|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
153916897|NCT01199939|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
153916898|NCT01199939|Protease Inhibitors|protease inhibitors|mesh-ancestor
153916899|NCT01199939|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153916900|NCT01199939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153916901|NCT01199939|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153916902|NCT01199939|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153916903|NCT01199939|Antiviral Agents|antiviral agents|mesh-ancestor
153916904|NCT01199939|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153783728|NCT00236795|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
153465648|NCT00118404|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
153465649|NCT00118404|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153465650|NCT00118404|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153465652|NCT00121836|Capecitabine|capecitabine|mesh-list
153465653|NCT00121836|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153465654|NCT00121836|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153783729|NCT00236795|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
153783730|NCT00236795|Contraceptives, Postcoital, Hormonal|contraceptives, postcoital, hormonal|mesh-ancestor
153465655|NCT00121836|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153465656|NCT00121836|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153465657|NCT00121836|Growth Substances|growth substances|mesh-ancestor
153465658|NCT00121836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153465659|NCT00121836|Growth Inhibitors|growth inhibitors|mesh-ancestor
153889787|NCT01266603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153430913|NCT00000301|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
153465660|NCT00121836|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153465661|NCT00121836|Antimetabolites|antimetabolites|mesh-ancestor
153465662|NCT00121836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153465664|NCT00237666|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153465665|NCT00237666|Serotonin Agents|serotonin agents|mesh-ancestor
153783731|NCT00236795|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
153430914|NCT00000301|Antiviral Agents|antiviral agents|mesh-ancestor
153465666|NCT00237666|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153465667|NCT00237666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153916907|NCT01199939|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153916908|NCT01199939|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153916909|NCT02688361|Acetylcysteine|acetylcysteine|mesh-list
153916910|NCT02688361|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
153916911|NCT02688361|N-monoacetylcystine|n-monoacetylcystine|mesh-list
153916912|NCT02688361|Antiviral Agents|antiviral agents|mesh-ancestor
153893178|NCT02888574|Oxytocin|oxytocin|mesh-list
153916913|NCT02688361|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153916914|NCT02688361|Expectorants|expectorants|mesh-ancestor
153916940|NCT00640081|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153916941|NCT00640081|Antimetabolites|antimetabolites|mesh-ancestor
153465690|NCT00296322|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
153465691|NCT00123162|Sildenafil Citrate|sildenafil citrate|mesh-list
153465692|NCT00123162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153465693|NCT00123162|Vasodilator Agents|vasodilator agents|mesh-ancestor
153465694|NCT00123162|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
153465695|NCT00123162|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
153465696|NCT00123162|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153916954|NCT01199705|gamma-Globulins|gamma-globulins|mesh-list
153916955|NCT01199705|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
153465697|NCT00123162|Urological Agents|urological agents|mesh-ancestor
153916956|NCT01199705|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
153916957|NCT01199705|Immunologic Factors|immunologic factors|mesh-ancestor
153916958|NCT01199705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153916996|NCT01179048|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153916998|NCT00603265|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
153783737|NCT00236834|Imipenem|imipenem|mesh-list
153916999|NCT00603265|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153465753|NCT00125034|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153465754|NCT00125034|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153465755|NCT02100930|Molgramostim|molgramostim|mesh-list
153465756|NCT02100930|Isotretinoin|isotretinoin|mesh-list
153465757|NCT02100930|Antibodies|antibodies|mesh-list
153465758|NCT02100930|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
153465759|NCT02100930|Sargramostim|sargramostim|mesh-list
153465760|NCT02100930|Immunologic Factors|immunologic factors|mesh-ancestor
153465761|NCT02100930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153465762|NCT02100930|Dermatologic Agents|dermatologic agents|mesh-ancestor
153465763|NCT02100930|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153783739|NCT00236834|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153783740|NCT00236834|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153465767|NCT00241176|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153465768|NCT00241176|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153465769|NCT00241176|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153465770|NCT00241176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153465771|NCT00241176|Dopamine Agonists|dopamine agonists|mesh-ancestor
153465772|NCT00241176|Dopamine Agents|dopamine agents|mesh-ancestor
153917028|NCT02686021|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153917029|NCT02686021|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153917030|NCT02686021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153917033|NCT01158534|Interferon-alpha|interferon-alpha|mesh-list
153917034|NCT01158534|Interferon alpha-2|interferon alpha-2|mesh-list
153917035|NCT01158534|Celecoxib|celecoxib|mesh-list
153917045|NCT01158534|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153917047|NCT01158534|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153917048|NCT01158534|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
153917049|NCT01158534|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153917050|NCT01158534|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153917051|NCT01158534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153917052|NCT02687971|Miltefosine|miltefosine|mesh-list
153917053|NCT02687971|Antifungal Agents|antifungal agents|mesh-ancestor
153917054|NCT02687971|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153917055|NCT02687971|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153917056|NCT02687971|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153783741|NCT00236834|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153465792|NCT02102100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153465794|NCT02102100|Dermatologic Agents|dermatologic agents|mesh-ancestor
153465795|NCT02094534|Insulin|insulin|mesh-list
153465796|NCT02094534|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153465797|NCT02094534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153465799|NCT00242502|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
153465800|NCT00242502|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153917057|NCT02687971|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153917058|NCT02683213|Fluoxetine|fluoxetine|mesh-list
153917059|NCT02683213|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
153917060|NCT02683213|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153917061|NCT02683213|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153889790|NCT01266603|Antiviral Agents|antiviral agents|mesh-ancestor
153783742|NCT00236834|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153783743|NCT00236834|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153430915|NCT00000301|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153917062|NCT02683213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153917063|NCT02683213|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153917064|NCT02683213|Serotonin Agents|serotonin agents|mesh-ancestor
153917065|NCT02683213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153917066|NCT02683213|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
153917067|NCT02683213|Antidepressive Agents|antidepressive agents|mesh-ancestor
153815040|NCT04715165|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153430916|NCT00000301|Dopamine Agents|dopamine agents|mesh-ancestor
153889791|NCT01266603|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153889792|NCT04295551|Ritonavir|ritonavir|mesh-list
153889793|NCT04295551|Lopinavir|lopinavir|mesh-list
153889794|NCT04295551|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
153917068|NCT02683213|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153917069|NCT02683213|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
153917089|NCT02684071|Cyclophosphamide|cyclophosphamide|mesh-list
153917090|NCT02684071|Methotrexate|methotrexate|mesh-list
153917091|NCT02684071|Topotecan|topotecan|mesh-list
153917092|NCT02684071|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153917093|NCT02684071|Immunologic Factors|immunologic factors|mesh-ancestor
153815041|NCT04715165|Analgesics|analgesics|mesh-ancestor
153430917|NCT00000301|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153430918|NCT00000301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153783744|NCT00236834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153917094|NCT02684071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153917095|NCT02684071|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153917096|NCT02684071|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153893857|NCT00627952|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153434974|NCT00002515|Topotecan|topotecan|mesh-list
153917097|NCT02684071|Alkylating Agents|alkylating agents|mesh-ancestor
153917098|NCT02684071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153917099|NCT02684071|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153917100|NCT02684071|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153917101|NCT02684071|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
153917102|NCT02684071|Abortifacient Agents|abortifacient agents|mesh-ancestor
153917103|NCT02684071|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153889795|NCT04295551|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
153889796|NCT04295551|Protease Inhibitors|protease inhibitors|mesh-ancestor
153889797|NCT04295551|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153430919|NCT00000301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153783745|NCT00236834|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153783746|NCT00236834|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
153917104|NCT02684071|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153917121|NCT01158222|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153917122|NCT01158222|Growth Substances|growth substances|mesh-ancestor
153783747|NCT00236834|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153783748|NCT00236873|Topiramate|topiramate|mesh-list
153783749|NCT00236873|Anticonvulsants|anticonvulsants|mesh-ancestor
153783750|NCT00236873|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153783751|NCT00236873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153783752|NCT00236912|Metronidazole|metronidazole|mesh-list
153783753|NCT00236912|Levofloxacin|levofloxacin|mesh-list
153783754|NCT00236912|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153783755|NCT00236912|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153783756|NCT00236912|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153783757|NCT00236912|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153783762|NCT00236912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153889798|NCT04295551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153783763|NCT00236912|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153783764|NCT00236912|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
153783765|NCT00236912|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153783766|NCT02215447|Paclitaxel|paclitaxel|mesh-list
153783767|NCT02215447|Carboplatin|carboplatin|mesh-list
153783768|NCT02215447|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153783769|NCT02215447|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153783770|NCT02215447|Tubulin Modulators|tubulin modulators|mesh-ancestor
153783771|NCT02215447|Antimitotic Agents|antimitotic agents|mesh-ancestor
153783772|NCT02215447|Mitosis Modulators|mitosis modulators|mesh-ancestor
153783775|NCT00236990|Anticoagulants|anticoagulants|mesh-ancestor
153889801|NCT04295551|Antiviral Agents|antiviral agents|mesh-ancestor
153783782|NCT00237068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153430922|NCT00000301|Sensory System Agents|sensory system agents|mesh-ancestor
153783783|NCT00269568|Misoprostol|misoprostol|mesh-list
153783784|NCT00269568|Mifepristone|mifepristone|mesh-list
153783785|NCT00269568|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
153889802|NCT04295551|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153430924|NCT00000307|Naltrexone|naltrexone|mesh-list
153889803|NCT04295551|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
153783786|NCT00269568|Abortifacient Agents|abortifacient agents|mesh-ancestor
153783789|NCT00269568|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
153917123|NCT01158222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153917124|NCT01158222|Growth Inhibitors|growth inhibitors|mesh-ancestor
153917125|NCT01158222|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153917126|NCT01158222|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153917134|NCT02940769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153917136|NCT02940769|Autonomic Agents|autonomic agents|mesh-ancestor
153917137|NCT02940769|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153917138|NCT02940769|Dopamine Agents|dopamine agents|mesh-ancestor
153917139|NCT02940769|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153917140|NCT02940769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153783790|NCT00269568|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153783791|NCT00269568|Oxytocics|oxytocics|mesh-ancestor
153917141|NCT02940769|Adrenergic Agents|adrenergic agents|mesh-ancestor
153917142|NCT02940769|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
153917143|NCT02940769|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153917144|NCT02940769|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153917145|NCT02940769|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
153435212|NCT00002798|Cytarabine|cytarabine|mesh-list
153917146|NCT04315584|Deoxyglucose|deoxyglucose|mesh-list
153917147|NCT04315584|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
153917148|NCT04315584|Dihydroxyphenylalanine|dihydroxyphenylalanine|mesh-list
153917149|NCT04315584|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
153889804|NCT04295551|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153889805|NCT01266291|Vigabatrin|vigabatrin|mesh-list
153415250|NCT00367393|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153889806|NCT01266291|Anticonvulsants|anticonvulsants|mesh-ancestor
153889807|NCT01266291|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153430929|NCT00000307|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153430930|NCT00000313|Fenfluramine|fenfluramine|mesh-list
153783792|NCT00269568|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
153889808|NCT01266291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153783793|NCT00269568|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
153917150|NCT04315584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153917151|NCT04315584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153917152|NCT04315584|Antimetabolites|antimetabolites|mesh-ancestor
153917153|NCT04315584|Antiviral Agents|antiviral agents|mesh-ancestor
153917154|NCT04315584|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153917155|NCT04315584|Dopamine Agents|dopamine agents|mesh-ancestor
153917156|NCT04315584|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153917157|NCT02683291|Mycophenolic Acid|mycophenolic acid|mesh-list
153917158|NCT02683291|Sirolimus|sirolimus|mesh-list
153917159|NCT02683291|Prednisone|prednisone|mesh-list
153917161|NCT02683291|Thymoglobulin|thymoglobulin|mesh-list
153917162|NCT02683291|Antilymphocyte Serum|antilymphocyte serum|mesh-list
153917163|NCT02683291|Basiliximab|basiliximab|mesh-list
153917164|NCT02683291|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153917165|NCT02683291|Glucocorticoids|glucocorticoids|mesh-ancestor
153917166|NCT02683291|Hormones|hormones|mesh-ancestor
153917167|NCT02683291|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153917168|NCT02683291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153889809|NCT01266291|GABA Agents|gaba agents|mesh-ancestor
153889810|NCT01266291|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153889811|NCT01266291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153889812|NCT01004263|Rizatriptan|rizatriptan|mesh-list
153430932|NCT00000313|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153889813|NCT01004263|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
153917169|NCT02683291|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153917179|NCT02683291|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153917180|NCT02683291|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153465922|NCT02103114|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153889814|NCT01004263|Serotonin Agents|serotonin agents|mesh-ancestor
153430933|NCT00000313|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153889815|NCT01004263|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153889816|NCT01004263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153783795|NCT00269568|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
153430934|NCT00000313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153889820|NCT01265823|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153783797|NCT00269568|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
153783799|NCT00269568|Hormone Antagonists|hormone antagonists|mesh-ancestor
153815042|NCT04715165|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
153894188|NCT04288765|Antiemetics|antiemetics|mesh-ancestor
153465923|NCT02103114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153465924|NCT02103114|Anticoagulants|anticoagulants|mesh-ancestor
153465925|NCT01790022|Methylprednisolone|methylprednisolone|mesh-list
153465926|NCT01790022|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
153465927|NCT01790022|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
153465928|NCT01790022|Prednisolone|prednisolone|mesh-list
153815043|NCT04715165|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153465929|NCT01790022|Prednisolone acetate|prednisolone acetate|mesh-list
153465930|NCT01790022|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
153465931|NCT01790022|Prednisolone phosphate|prednisolone phosphate|mesh-list
153465932|NCT01790022|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153465933|NCT01790022|Antiemetics|antiemetics|mesh-ancestor
153465934|NCT01790022|Autonomic Agents|autonomic agents|mesh-ancestor
153465935|NCT01790022|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153465936|NCT01790022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153465937|NCT01790022|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153465938|NCT01790022|Glucocorticoids|glucocorticoids|mesh-ancestor
153465940|NCT01790022|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153815044|NCT04715165|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153815045|NCT04715165|Adrenergic Agents|adrenergic agents|mesh-ancestor
153815046|NCT04715165|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153465941|NCT01790022|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
153465942|NCT01790022|Protective Agents|protective agents|mesh-ancestor
153917181|NCT02683291|Antifungal Agents|antifungal agents|mesh-ancestor
153917182|NCT02685397|Leuprolide|leuprolide|mesh-list
153917183|NCT02685397|Goserelin|goserelin|mesh-list
153917184|NCT02685397|Triptorelin Pamoate|triptorelin pamoate|mesh-list
153917185|NCT02685397|Fertility Agents, Female|fertility agents, female|mesh-ancestor
153917186|NCT02685397|Fertility Agents|fertility agents|mesh-ancestor
153917187|NCT02685397|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153917188|NCT02685397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153917189|NCT02685397|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153917190|NCT02685397|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153917191|NCT02685397|Luteolytic Agents|luteolytic agents|mesh-ancestor
153917192|NCT02685397|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
153917193|NCT02685397|Contraceptive Agents|contraceptive agents|mesh-ancestor
153917194|NCT02685397|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
153917195|NCT02683837|Remifentanil|remifentanil|mesh-list
153917196|NCT02683837|Sevoflurane|sevoflurane|mesh-list
153917201|NCT02683837|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153917202|NCT02683837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153917203|NCT02683837|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153917205|NCT02683837|Analgesics|analgesics|mesh-ancestor
153917206|NCT02683837|Sensory System Agents|sensory system agents|mesh-ancestor
153917207|NCT02683837|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153783800|NCT00269568|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153783801|NCT00269568|Luteolytic Agents|luteolytic agents|mesh-ancestor
153430937|NCT00000313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153783802|NCT00269568|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
153783803|NCT00269568|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
153783804|NCT00237146|Zoledronic Acid|zoledronic acid|mesh-list
153889823|NCT01004185|Mesalamine|mesalamine|mesh-list
153783805|NCT00237146|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153889824|NCT01004185|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153917208|NCT02680951|Cytarabine|cytarabine|mesh-list
153917209|NCT02680951|Fludarabine|fludarabine|mesh-list
153917210|NCT02680951|Dasatinib|dasatinib|mesh-list
153917211|NCT02680951|Idarubicin|idarubicin|mesh-list
153465945|NCT00140556|Bevacizumab|bevacizumab|mesh-list
153917212|NCT02680951|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153435436|NCT00002816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153435438|NCT00002816|Glucocorticoids|glucocorticoids|mesh-ancestor
153917213|NCT02680951|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153917214|NCT02680951|Antimetabolites|antimetabolites|mesh-ancestor
153783806|NCT00237146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153783807|NCT04544059|Lenalidomide|lenalidomide|mesh-list
153430939|NCT00000319|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153430940|NCT00000319|Narcotics|narcotics|mesh-ancestor
153889826|NCT01004185|Analgesics|analgesics|mesh-ancestor
153889827|NCT01004185|Sensory System Agents|sensory system agents|mesh-ancestor
153783809|NCT04544059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153783810|NCT04544059|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153430941|NCT00000319|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153783812|NCT04544059|Growth Substances|growth substances|mesh-ancestor
153783813|NCT04544059|Growth Inhibitors|growth inhibitors|mesh-ancestor
153783814|NCT04544059|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153783815|NCT00269607|Naltrexone|naltrexone|mesh-list
153783816|NCT00269607|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
153783822|NCT00237224|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153783823|NCT00237224|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
153889828|NCT01004185|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153783824|NCT00237224|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153889829|NCT01004185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153783825|NCT00237224|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153783826|NCT00237224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153430942|NCT00000319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153430943|NCT00000319|Analgesics|analgesics|mesh-ancestor
153783827|NCT00237224|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
153783828|NCT00237224|Hormone Antagonists|hormone antagonists|mesh-ancestor
153889830|NCT01004185|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153889831|NCT01004185|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153783833|NCT00262236|Protease Inhibitors|protease inhibitors|mesh-ancestor
153783834|NCT00262236|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153889832|NCT01004185|Antitubercular Agents|antitubercular agents|mesh-ancestor
153430944|NCT00000319|Sensory System Agents|sensory system agents|mesh-ancestor
153430945|NCT00000319|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153783843|NCT00262275|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153889833|NCT01004185|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153889834|NCT01004185|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153889835|NCT01265511|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
153430947|NCT00000325|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
153783846|NCT00262275|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153889836|NCT01265511|Antiviral Agents|antiviral agents|mesh-ancestor
153889837|NCT01265511|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153889838|NCT01264965|Acetaminophen|acetaminophen|mesh-list
153783847|NCT00262275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153889839|NCT01264965|Oxycodone|oxycodone|mesh-list
153917215|NCT02680951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153917216|NCT02680951|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153917217|NCT02680951|Immunologic Factors|immunologic factors|mesh-ancestor
153917218|NCT02680951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153917219|NCT02680951|Antiviral Agents|antiviral agents|mesh-ancestor
153917220|NCT02680951|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153917221|NCT02680951|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153917222|NCT02680951|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153917223|NCT02680951|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153917224|NCT02680951|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153917225|NCT02680951|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153917226|NCT02680951|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153917228|NCT02680717|Calcipotriene|calcipotriene|mesh-list
153917229|NCT02680717|Tacrolimus|tacrolimus|mesh-list
153917230|NCT02680717|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153917231|NCT02680717|Immunologic Factors|immunologic factors|mesh-ancestor
153917232|NCT02680717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153917233|NCT02680717|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
153917234|NCT02680717|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153917235|NCT02680717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153465973|NCT05201430|Capecitabine|capecitabine|mesh-list
153465974|NCT05201430|Oxaliplatin|oxaliplatin|mesh-list
153465976|NCT05201430|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153465977|NCT05201430|Antimetabolites|antimetabolites|mesh-ancestor
153783852|NCT00262275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153430949|NCT00000325|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153783853|NCT00262275|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153783854|NCT00262275|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153889840|NCT01264965|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153889841|NCT01264965|Analgesics|analgesics|mesh-ancestor
153415252|NCT00367471|Paclitaxel|paclitaxel|mesh-list
153783857|NCT00262275|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
153465978|NCT05201430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153465979|NCT05201430|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153465980|NCT05201430|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
153465981|NCT05201430|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153465982|NCT05201430|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153465983|NCT00142506|Sildenafil Citrate|sildenafil citrate|mesh-list
153465984|NCT00142506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153465985|NCT00142506|Vasodilator Agents|vasodilator agents|mesh-ancestor
153783858|NCT00262275|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
153783861|NCT00262275|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153917245|NCT02680795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153917246|NCT00640237|Calcifediol|calcifediol|mesh-list
153917247|NCT00640237|Vitamins|vitamins|mesh-ancestor
153917248|NCT00640237|Micronutrients|micronutrients|mesh-ancestor
153917249|NCT00640237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153917250|NCT00640237|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153917251|NCT02683759|Curcumin|curcumin|mesh-list
153917252|NCT02683759|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153917253|NCT02683759|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153917255|NCT02683759|Sensory System Agents|sensory system agents|mesh-ancestor
153894365|NCT01205685|Letrozole|letrozole|mesh-list
153917256|NCT02683759|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153917257|NCT02683759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153917258|NCT02683759|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153917259|NCT02683759|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153917260|NCT02683759|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153917261|NCT02683759|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153917262|NCT02683759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153465995|NCT05266794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153465996|NCT05266794|Vitamin B Complex|vitamin b complex|mesh-ancestor
153465997|NCT05266794|Vitamins|vitamins|mesh-ancestor
153917263|NCT04292691|Ropivacaine|ropivacaine|mesh-list
153917264|NCT04292691|Anesthetics, Local|anesthetics, local|mesh-ancestor
153917265|NCT04292691|Anesthetics|anesthetics|mesh-ancestor
153917266|NCT04292691|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153917267|NCT04292691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153917268|NCT04292691|Sensory System Agents|sensory system agents|mesh-ancestor
153783862|NCT02214979|Telmisartan|telmisartan|mesh-list
153360826|NCT01475513|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
153360827|NCT01407575|Buprenorphine|buprenorphine|mesh-list
153820873|NCT00465192|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153820874|NCT00465192|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
153820876|NCT00434681|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153820877|NCT00434681|Analgesics|analgesics|mesh-ancestor
153820878|NCT00434681|Sensory System Agents|sensory system agents|mesh-ancestor
153820879|NCT00434681|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153820880|NCT00434681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153361072|NCT01379183|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
153361073|NCT01379183|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153361074|NCT01379183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153361075|NCT01380197|Morphine|morphine|mesh-list
153361076|NCT01380197|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153361077|NCT01380197|Narcotics|narcotics|mesh-ancestor
153361078|NCT01380197|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153361079|NCT01380197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153361080|NCT01380197|Analgesics|analgesics|mesh-ancestor
153821168|NCT00437333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153821169|NCT00482079|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
153361159|NCT00823082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153361160|NCT00823082|Anticoagulants|anticoagulants|mesh-ancestor
153361161|NCT01382303|Pentoxifylline|pentoxifylline|mesh-list
153361162|NCT01382303|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
153361163|NCT01382303|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153361164|NCT01382303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153361165|NCT01382303|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153361179|NCT05236634|Urological Agents|urological agents|mesh-ancestor
153361180|NCT05236634|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
153361206|NCT01424033|Respiratory System Agents|respiratory system agents|mesh-ancestor
153361207|NCT01424033|Free Radical Scavengers|free radical scavengers|mesh-ancestor
153361208|NCT01424033|Antioxidants|antioxidants|mesh-ancestor
153361209|NCT01424033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153361210|NCT01424033|Protective Agents|protective agents|mesh-ancestor
153361211|NCT01424033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153361212|NCT01424033|Antidotes|antidotes|mesh-ancestor
153361213|NCT01503749|Lenograstim|lenograstim|mesh-list
153361268|NCT00870896|Respiratory System Agents|respiratory system agents|mesh-ancestor
153361269|NCT00870896|Parasympatholytics|parasympatholytics|mesh-ancestor
153361270|NCT00870896|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
153361271|NCT00870896|Cholinergic Agents|cholinergic agents|mesh-ancestor
153361272|NCT00870896|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153361273|NCT00870896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153361275|NCT00825344|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153361276|NCT00825344|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153361400|NCT01507181|Sensory System Agents|sensory system agents|mesh-ancestor
153361401|NCT01507181|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153361402|NCT01507181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153821419|NCT00438386|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153821420|NCT00438386|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153821421|NCT00438386|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153821422|NCT00438386|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153821423|NCT00438386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153821424|NCT00438386|Dopamine Agonists|dopamine agonists|mesh-ancestor
153821425|NCT00438386|Dopamine Agents|dopamine agents|mesh-ancestor
153821465|NCT00475137|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153821466|NCT00438581|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
153821467|NCT00438581|Immunologic Factors|immunologic factors|mesh-ancestor
153821468|NCT00438581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153821470|NCT00475293|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153821471|NCT00475293|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153821472|NCT00438737|Leucovorin|leucovorin|mesh-list
153821473|NCT00438737|Bevacizumab|bevacizumab|mesh-list
153821474|NCT00438737|Cetuximab|cetuximab|mesh-list
153821477|NCT00438737|Calcium|calcium|mesh-list
153821582|NCT00475800|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153821583|NCT00475800|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153821584|NCT00475800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153821585|NCT00475800|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153821586|NCT00475800|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153821588|NCT00475800|Sensory System Agents|sensory system agents|mesh-ancestor
153821589|NCT00475800|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153821590|NCT00475800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153361655|NCT01430819|Vaccines|vaccines|mesh-list
153361656|NCT01430819|Immunologic Factors|immunologic factors|mesh-ancestor
153361657|NCT01430819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153361658|NCT00828542|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
153361659|NCT00828542|Medroxyprogesterone|medroxyprogesterone|mesh-list
153361660|NCT00828542|Desogestrel|desogestrel|mesh-list
153361661|NCT00828542|Etonogestrel|etonogestrel|mesh-list
153361662|NCT00828542|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
153361663|NCT00828542|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
153361679|NCT01395329|cyclo(Trp-Asp-Pro-Val-Leu)|cyclo(trp-asp-pro-val-leu)|mesh-list
153890141|NCT04021017|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
153461759|NCT04130802|Dexamethasone|dexamethasone|mesh-list
153821766|NCT00440102|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153821767|NCT00440102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153821768|NCT00440102|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
153821769|NCT00440102|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153821770|NCT00440102|Anesthetics, General|anesthetics, general|mesh-ancestor
153361727|NCT00882206|Abortifacient Agents|abortifacient agents|mesh-ancestor
153361831|NCT00887510|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153361832|NCT00887510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153890149|NCT03764553|Oxaliplatin|oxaliplatin|mesh-list
153890150|NCT03764553|Irinotecan|irinotecan|mesh-list
153821881|NCT00440687|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153821882|NCT00440687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153821883|NCT00440687|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153821884|NCT00440687|Respiratory System Agents|respiratory system agents|mesh-ancestor
153821905|NCT00440804|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153821906|NCT00440804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153821907|NCT00440843|Olanzapine|olanzapine|mesh-list
153821908|NCT00440843|Antiemetics|antiemetics|mesh-ancestor
153821909|NCT00440843|Autonomic Agents|autonomic agents|mesh-ancestor
153821910|NCT00440843|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153821911|NCT00440843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153821912|NCT00440843|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153821935|NCT00440960|Anesthetics, Local|anesthetics, local|mesh-ancestor
153821936|NCT00440960|Anesthetics|anesthetics|mesh-ancestor
153361890|NCT01432145|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153361891|NCT04979520|Brodalumab|brodalumab|mesh-list
153361892|NCT04979520|Dermatologic Agents|dermatologic agents|mesh-ancestor
153361893|NCT01432379|Botulinum Toxins|botulinum toxins|mesh-list
153361894|NCT01432379|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
153361895|NCT01432379|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
153361896|NCT01432379|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
153821937|NCT00440960|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153821938|NCT00440960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153821939|NCT00440960|Sensory System Agents|sensory system agents|mesh-ancestor
153890151|NCT03764553|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153890152|NCT03764553|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153821955|NCT00440960|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153821956|NCT00440960|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153821957|NCT00440960|Narcotics|narcotics|mesh-ancestor
153821958|NCT00440960|Analgesics|analgesics|mesh-ancestor
153821962|NCT00438828|Autonomic Agents|autonomic agents|mesh-ancestor
153821963|NCT00438828|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153821964|NCT00438828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153821965|NCT00438828|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153821966|NCT00438828|Glucocorticoids|glucocorticoids|mesh-ancestor
153821967|NCT00438828|Hormones|hormones|mesh-ancestor
153821968|NCT00438828|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153821969|NCT00438828|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153361948|NCT05946135|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153821981|NCT00106002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153821982|NCT00106002|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153821983|NCT00106002|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153821984|NCT00476853|Nevirapine|nevirapine|mesh-list
153821985|NCT00476853|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153821986|NCT00476853|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153821987|NCT00476853|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153821988|NCT00476853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153821989|NCT00476853|Antiviral Agents|antiviral agents|mesh-ancestor
153821990|NCT00476853|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153821991|NCT00476853|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153821992|NCT00476853|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153361949|NCT05946135|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
153821993|NCT00476853|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
153821994|NCT00476853|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
153821995|NCT00438906|Secretin|secretin|mesh-list
153821996|NCT00438906|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153821997|NCT00438906|Hormones|hormones|mesh-ancestor
153821998|NCT00438906|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153821999|NCT00438906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153822000|NCT00438945|Eprosartan|eprosartan|mesh-list
153822001|NCT00438945|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153917269|NCT04292691|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153917270|NCT00990249|Busulfan|busulfan|mesh-list
153890154|NCT03764553|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153890155|NCT03764553|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153890156|NCT03764553|Immunologic Factors|immunologic factors|mesh-ancestor
153431152|NCT06316076|Immunologic Factors|immunologic factors|mesh-ancestor
153822009|NCT00441428|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153822010|NCT00441428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153822011|NCT00441428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153822012|NCT00441428|Urological Agents|urological agents|mesh-ancestor
153822013|NCT00438984|Aldesleukin|aldesleukin|mesh-list
153822014|NCT00438984|Cyclophosphamide|cyclophosphamide|mesh-list
153822015|NCT00438984|Interleukin-2|interleukin-2|mesh-list
153822016|NCT00438984|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153890158|NCT03764553|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
153890159|NCT03764553|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153822018|NCT00438984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153822019|NCT00438984|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153822020|NCT00438984|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153822021|NCT00438984|Alkylating Agents|alkylating agents|mesh-ancestor
153822022|NCT00438984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153822023|NCT00438984|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153822024|NCT00438984|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153822025|NCT00438984|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153362000|NCT05945368|Pertuzumab|pertuzumab|mesh-list
153822028|NCT00438984|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153822029|NCT00438984|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153822030|NCT00438984|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153822031|NCT00438984|Antiviral Agents|antiviral agents|mesh-ancestor
153822032|NCT00438984|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153822033|NCT00441506|Hypnotics and Sedatives|hypnotics and sedatives|mesh-list
153822034|NCT00441506|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153822035|NCT00441506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153822036|NCT00441662|Triamcinolone|triamcinolone|mesh-list
153822037|NCT00441662|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153822038|NCT00441662|Glucocorticoids|glucocorticoids|mesh-ancestor
153822039|NCT00441662|Hormones|hormones|mesh-ancestor
153890160|NCT03764553|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153822042|NCT00439062|Roxithromycin|roxithromycin|mesh-list
153362032|NCT05943080|Respiratory System Agents|respiratory system agents|mesh-ancestor
153822045|NCT02957162|Atorvastatin|atorvastatin|mesh-list
153822046|NCT02957162|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153822047|NCT02957162|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153822048|NCT02957162|Antimetabolites|antimetabolites|mesh-ancestor
153822049|NCT02957162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153822050|NCT02957162|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153822052|NCT02957162|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153822053|NCT00441740|Gemcitabine|gemcitabine|mesh-list
153890162|NCT03764553|Protective Agents|protective agents|mesh-ancestor
153822102|NCT03279341|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153822103|NCT03279341|Serotonin 5-HT4 Receptor Agonists|serotonin 5-ht4 receptor agonists|mesh-ancestor
153822104|NCT03279341|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
153822105|NCT03279341|Serotonin Agents|serotonin agents|mesh-ancestor
153822106|NCT03279341|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153822107|NCT03279341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153822108|NCT03279341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153822109|NCT03279341|Cathartics|cathartics|mesh-ancestor
153822110|NCT03279146|Tenofovir|tenofovir|mesh-list
153822111|NCT03279146|Antiviral Agents|antiviral agents|mesh-ancestor
153822112|NCT03279146|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153362069|NCT05867147|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
153431156|NCT06316076|Alkylating Agents|alkylating agents|mesh-ancestor
153822113|NCT03279146|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153822114|NCT03279146|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153822115|NCT03279146|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153822116|NCT03279146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153822117|NCT03279146|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153822118|NCT03279146|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153822119|NCT00442052|Aspirin|aspirin|mesh-list
153822120|NCT00442052|Omeprazole|omeprazole|mesh-list
153822121|NCT00442052|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153822122|NCT00442052|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153362101|NCT05687110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153362102|NCT05687110|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153362103|NCT05683392|Insulin|insulin|mesh-list
153362104|NCT05683392|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153362105|NCT05683392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153362106|NCT05674565|Magnesium Sulfate|magnesium sulfate|mesh-list
153362107|NCT05674565|Analgesics|analgesics|mesh-ancestor
153362108|NCT05674565|Sensory System Agents|sensory system agents|mesh-ancestor
153822162|NCT00477516|Dialysis Solutions|dialysis solutions|mesh-list
153822163|NCT00477516|Calcium|calcium|mesh-list
153822164|NCT00477516|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153362165|NCT05341583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153362166|NCT05160805|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
153362167|NCT05160805|Ophthalmic Solutions|ophthalmic solutions|mesh-list
153362168|NCT05155436|Amlodipine|amlodipine|mesh-list
153362169|NCT05155436|Telmisartan|telmisartan|mesh-list
153362170|NCT05155436|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153362171|NCT05155436|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153362172|NCT05155436|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153362175|NCT05155436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153431194|NCT06315790|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
153431195|NCT06315790|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
153431196|NCT06315790|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153890179|NCT03219177|Narcotics|narcotics|mesh-ancestor
153890180|NCT03219177|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153890181|NCT03219177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153890182|NCT03219177|Analgesics|analgesics|mesh-ancestor
153822228|NCT00477945|Clofarabine|clofarabine|mesh-list
153822241|NCT00477984|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153822242|NCT00477984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153822243|NCT00478101|Fentanyl|fentanyl|mesh-list
153822244|NCT00478101|Oxycodone|oxycodone|mesh-list
153890205|NCT02890602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153890206|NCT02890602|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153822245|NCT00478101|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153822249|NCT00478101|Analgesics|analgesics|mesh-ancestor
153822259|NCT00443105|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153822260|NCT00443105|Immunologic Factors|immunologic factors|mesh-ancestor
153822261|NCT00443105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153822262|NCT00443105|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
153822263|NCT00443105|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153822264|NCT00443105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153822265|NCT00443144|Hormones|hormones|mesh-list
153822266|NCT00443144|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153822267|NCT00443144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153822268|NCT00440154|Ezetimibe|ezetimibe|mesh-list
153822269|NCT00440154|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153822270|NCT00440154|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153822271|NCT00440154|Antimetabolites|antimetabolites|mesh-ancestor
153822273|NCT00440154|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153822277|NCT00478374|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153822278|NCT00478374|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153822279|NCT00478374|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153822280|NCT00478374|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153822281|NCT00478374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153822282|NCT00478374|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153822283|NCT00478452|Cyclophosphamide|cyclophosphamide|mesh-list
153822284|NCT00478452|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153822285|NCT00478452|Immunologic Factors|immunologic factors|mesh-ancestor
153822287|NCT00478452|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153822295|NCT03279549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153822296|NCT03271983|Metronidazole|metronidazole|mesh-list
153822297|NCT03271983|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153822298|NCT03271983|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153822299|NCT03271983|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153822300|NCT03271983|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153822301|NCT00443222|Infliximab|infliximab|mesh-list
153822302|NCT00443222|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
153822303|NCT00443222|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153822304|NCT00443222|Dermatologic Agents|dermatologic agents|mesh-ancestor
153822305|NCT00443222|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153822306|NCT00443222|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153822307|NCT00440349|Tamoxifen|tamoxifen|mesh-list
153822308|NCT00440349|Prednisone|prednisone|mesh-list
153822337|NCT04700228|Adrenergic Agents|adrenergic agents|mesh-ancestor
153822338|NCT04700228|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153822339|NCT04700228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153822340|NCT00440427|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
153362293|NCT03933631|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153362294|NCT03933631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153362295|NCT03933631|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153362296|NCT03933631|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153890347|NCT01298778|Analgesics|analgesics|mesh-ancestor
153362412|NCT03275857|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153362413|NCT02764762|Adalimumab|adalimumab|mesh-list
153822512|NCT00444236|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153822514|NCT00478998|Tamsulosin|tamsulosin|mesh-list
153431544|NCT06112522|Tirbanibulin|tirbanibulin|mesh-list
153362777|NCT00891878|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153362778|NCT00891878|Growth Substances|growth substances|mesh-ancestor
153822829|NCT03278808|Antimalarials|antimalarials|mesh-ancestor
153822830|NCT03278808|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153822831|NCT03278808|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153822832|NCT03278808|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153822833|NCT03278808|Analgesics|analgesics|mesh-ancestor
153822834|NCT03278808|Sensory System Agents|sensory system agents|mesh-ancestor
153362871|NCT01447511|Antifungal Agents|antifungal agents|mesh-ancestor
153362872|NCT01447511|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
153822923|NCT00455234|Haloperidol decanoate|haloperidol decanoate|mesh-list
153822924|NCT00455234|Antiemetics|antiemetics|mesh-ancestor
153822925|NCT00455234|Autonomic Agents|autonomic agents|mesh-ancestor
153822926|NCT00455234|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153822927|NCT00455234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153362873|NCT01447511|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153362874|NCT01447511|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153362964|NCT02504268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153362965|NCT02504268|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153362966|NCT02504268|Dermatologic Agents|dermatologic agents|mesh-ancestor
153362967|NCT02504268|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153362968|NCT02504268|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153822990|NCT00455585|Nevirapine|nevirapine|mesh-list
153822991|NCT00455585|Stavudine|stavudine|mesh-list
153822992|NCT00455585|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153822993|NCT00455585|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153431756|NCT05928806|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153431757|NCT05928806|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153431758|NCT05928806|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153431759|NCT05928806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153431760|NCT05904470|Ruzasvir|ruzasvir|mesh-list
153431761|NCT05904470|Antiviral Agents|antiviral agents|mesh-ancestor
153431762|NCT05904470|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153823052|NCT00480558|Vaccines|vaccines|mesh-list
153363061|NCT03214172|Antithrombins|antithrombins|mesh-ancestor
153363062|NCT03214172|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
153890863|NCT01036594|Dexamethasone acetate|dexamethasone acetate|mesh-list
153890879|NCT01036594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153890880|NCT01036594|Antifungal Agents|antifungal agents|mesh-ancestor
153890881|NCT01036594|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153890882|NCT01036594|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
153890883|NCT01036594|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153823237|NCT00457223|Hemostatics|hemostatics|mesh-ancestor
153823259|NCT03278379|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153823260|NCT03278379|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153823261|NCT02956538|Thalidomide|thalidomide|mesh-list
153823262|NCT02956538|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153823263|NCT02956538|Immunologic Factors|immunologic factors|mesh-ancestor
153823264|NCT02956538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153823265|NCT02956538|Leprostatic Agents|leprostatic agents|mesh-ancestor
153823266|NCT02956538|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153823267|NCT02956538|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153431937|NCT05600426|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153431938|NCT05600426|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
153431939|NCT05589974|Verteporfin|verteporfin|mesh-list
153431940|NCT05589974|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
153431941|NCT05589974|Dermatologic Agents|dermatologic agents|mesh-ancestor
153431942|NCT05581004|Atezolizumab|atezolizumab|mesh-list
153431947|NCT05574712|Leuprolide|leuprolide|mesh-list
153431958|NCT05574712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153431959|NCT05574712|Hormone Antagonists|hormone antagonists|mesh-ancestor
153431960|NCT05574712|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153363273|NCT01834898|Oxycodone|oxycodone|mesh-list
153363274|NCT01834898|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153363275|NCT01834898|Narcotics|narcotics|mesh-ancestor
153363276|NCT01834898|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153363277|NCT01834898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153363278|NCT01834898|Analgesics|analgesics|mesh-ancestor
153363279|NCT01834898|Sensory System Agents|sensory system agents|mesh-ancestor
153823381|NCT00444015|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153823382|NCT00444015|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153823458|NCT00459485|Astringents|astringents|mesh-ancestor
153823459|NCT00459485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153823460|NCT00459485|Dermatologic Agents|dermatologic agents|mesh-ancestor
153823461|NCT00459563|Vitamin D|vitamin d|mesh-list
153823462|NCT00459563|Calcitriol|calcitriol|mesh-list
153823463|NCT00459563|Vitamins|vitamins|mesh-ancestor
153823464|NCT00459563|Micronutrients|micronutrients|mesh-ancestor
153823465|NCT00459563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153363418|NCT01457885|Alkylating Agents|alkylating agents|mesh-ancestor
153363432|NCT01561469|Vancomycin|vancomycin|mesh-list
153823561|NCT00495339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153823562|NCT00495339|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153823575|NCT00460226|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153823576|NCT00460226|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153363533|NCT03210506|Antiviral Agents|antiviral agents|mesh-ancestor
153363534|NCT03210506|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153363535|NCT02500758|Chloroxylenol|chloroxylenol|mesh-list
153363536|NCT02500758|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
153363537|NCT02500758|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153363538|NCT02500758|Disinfectants|disinfectants|mesh-ancestor
153363539|NCT02500758|Schistosomicides|schistosomicides|mesh-ancestor
153363540|NCT02500758|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
153363541|NCT02500758|Anthelmintics|anthelmintics|mesh-ancestor
153363542|NCT02500758|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153363543|NCT01839812|Cosyntropin|cosyntropin|mesh-list
153823577|NCT00460226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153823578|NCT00460226|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153823580|NCT00460226|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153363591|NCT01464359|Busulfan|busulfan|mesh-list
153823612|NCT01242579|Maraviroc|maraviroc|mesh-list
153823798|NCT00461747|Antiemetics|antiemetics|mesh-ancestor
153823799|NCT00461747|Autonomic Agents|autonomic agents|mesh-ancestor
153823800|NCT00461747|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153823801|NCT00461747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153823802|NCT00461747|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153823803|NCT00461747|Glucocorticoids|glucocorticoids|mesh-ancestor
153823804|NCT00461747|Hormones|hormones|mesh-ancestor
153823805|NCT00461747|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153823806|NCT00461747|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153823807|NCT00461747|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153363865|NCT02497404|Fludarabine|fludarabine|mesh-list
153363866|NCT02497404|Azacitidine|azacitidine|mesh-list
153363867|NCT02497404|Melphalan|melphalan|mesh-list
153363868|NCT02497404|Alemtuzumab|alemtuzumab|mesh-list
153363869|NCT02497404|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153363870|NCT02497404|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153823907|NCT00591916|Hemostatics|hemostatics|mesh-ancestor
153823908|NCT00591916|Coagulants|coagulants|mesh-ancestor
153823909|NCT00591916|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153823910|NCT00591916|Immunologic Factors|immunologic factors|mesh-ancestor
153823911|NCT00591916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153823912|NCT00591916|Viscosupplements|viscosupplements|mesh-ancestor
153363872|NCT02497404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153363873|NCT02497404|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153363896|NCT02218307|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153363897|NCT02218307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153363898|NCT01722110|Indomethacin|indomethacin|mesh-list
153363899|NCT01722110|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153363900|NCT01722110|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153363901|NCT01722110|Analgesics|analgesics|mesh-ancestor
153363902|NCT01722110|Sensory System Agents|sensory system agents|mesh-ancestor
153363903|NCT01722110|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153363904|NCT01722110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153363937|NCT01574807|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
153363938|NCT01574807|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153363939|NCT01574807|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153363941|NCT01575275|Aminolevulinic Acid|aminolevulinic acid|mesh-list
153364183|NCT02981459|Adrenergic Agents|adrenergic agents|mesh-ancestor
153364184|NCT02981459|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153824223|NCT00466388|Autonomic Agents|autonomic agents|mesh-ancestor
153824224|NCT00466388|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153824226|NCT00466388|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
153364273|NCT01724372|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153364274|NCT01724372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153364275|NCT01724372|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
153364276|NCT01724372|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
153364277|NCT01724372|Serotonin Agents|serotonin agents|mesh-ancestor
153364278|NCT01724372|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
153364337|NCT01046396|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153364338|NCT01046396|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153364339|NCT01046396|Analgesics|analgesics|mesh-ancestor
153364341|NCT01046396|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153364342|NCT01046396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153364415|NCT03000413|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153364416|NCT03000413|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
153364417|NCT03000413|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
153364418|NCT03000413|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153364419|NCT03000413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153364420|NCT03000413|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153364421|NCT03000413|Narcotics|narcotics|mesh-ancestor
153364422|NCT03000413|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153364423|NCT01724918|Lacosamide|lacosamide|mesh-list
153364440|NCT01588457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153364442|NCT01588457|Anticonvulsants|anticonvulsants|mesh-ancestor
153364480|NCT01591733|Irinotecan|irinotecan|mesh-list
153824559|NCT00491634|Alkylating Agents|alkylating agents|mesh-ancestor
153824560|NCT00491634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153824561|NCT00491634|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153824562|NCT00491634|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153824563|NCT00491634|Immunologic Factors|immunologic factors|mesh-ancestor
153824564|NCT00491634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153364530|NCT03005483|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
153364531|NCT03005483|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153364532|NCT03005483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153824625|NCT00592111|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153364665|NCT03400592|Nimotuzumab|nimotuzumab|mesh-list
153364782|NCT03002675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153364783|NCT03002675|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
153364784|NCT03002675|Incretins|incretins|mesh-ancestor
153364785|NCT03002675|Hormones|hormones|mesh-ancestor
153364786|NCT03002675|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153364787|NCT02247557|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
153364788|NCT02247557|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
153364789|NCT02247557|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
153364790|NCT02247557|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153364791|NCT02247557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153364792|NCT02247557|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
153364793|NCT02247557|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153364795|NCT02247557|Cholinergic Agents|cholinergic agents|mesh-ancestor
153364828|NCT03401606|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153364829|NCT03401606|Narcotics|narcotics|mesh-ancestor
153364830|NCT02516592|Fluticasone|fluticasone|mesh-list
153364831|NCT02516592|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
153364832|NCT02516592|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153364833|NCT02516592|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153364834|NCT02516592|Autonomic Agents|autonomic agents|mesh-ancestor
153364835|NCT02516592|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153824862|NCT04327453|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
153824863|NCT04327453|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153824864|NCT04327453|Antitubercular Agents|antitubercular agents|mesh-ancestor
153364870|NCT03401372|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153364871|NCT03401372|Antimalarials|antimalarials|mesh-ancestor
153364872|NCT03401372|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153364873|NCT03401372|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153364874|NCT04934904|Ropivacaine|ropivacaine|mesh-list
153364875|NCT04934904|Anesthetics, Local|anesthetics, local|mesh-ancestor
153364876|NCT04934904|Anesthetics|anesthetics|mesh-ancestor
153824912|NCT00592930|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153824913|NCT00592930|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153824914|NCT00592930|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153824915|NCT00592930|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
153364879|NCT04934904|Sensory System Agents|sensory system agents|mesh-ancestor
153364880|NCT04934904|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153364984|NCT02241278|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
153364985|NCT02241278|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
153364986|NCT02241278|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153364987|NCT02241278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153364989|NCT04347512|Hydroxychloroquine|hydroxychloroquine|mesh-list
153364990|NCT04347512|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153364991|NCT04347512|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153364992|NCT04347512|Antimalarials|antimalarials|mesh-ancestor
153825021|NCT00465452|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153825024|NCT01379521|Everolimus|everolimus|mesh-list
153365084|NCT04364906|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153365085|NCT04364906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153365086|NCT02488980|Mefloquine|mefloquine|mesh-list
153365087|NCT02488980|Tafenoquine|tafenoquine|mesh-list
153365088|NCT02488980|Antimalarials|antimalarials|mesh-ancestor
153825154|NCT00473720|Tubulin Modulators|tubulin modulators|mesh-ancestor
153825155|NCT00473720|Antimitotic Agents|antimitotic agents|mesh-ancestor
153365182|NCT03207347|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153365183|NCT03207347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153365184|NCT03207347|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153365185|NCT02249039|Clonidine|clonidine|mesh-list
153365186|NCT02249039|Analgesics|analgesics|mesh-ancestor
153365187|NCT02249039|Sensory System Agents|sensory system agents|mesh-ancestor
153365188|NCT02249039|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153365189|NCT02249039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153825264|NCT00500058|Rituximab|rituximab|mesh-list
153825318|NCT00493194|Cyclosporine|cyclosporine|mesh-list
153825319|NCT00493194|Sirolimus|sirolimus|mesh-list
153825320|NCT00493194|Cyclosporins|cyclosporins|mesh-list
153825321|NCT00493194|Daclizumab|daclizumab|mesh-list
153365287|NCT02244242|Tamsulosin|tamsulosin|mesh-list
153365288|NCT02244242|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
153365289|NCT02244242|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
153365290|NCT02244242|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
153365291|NCT02244242|Adrenergic Agents|adrenergic agents|mesh-ancestor
153365292|NCT02244242|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153825379|NCT00493233|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153825380|NCT00493233|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153825381|NCT00493233|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
153825382|NCT00493233|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153825383|NCT00493233|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153825461|NCT00469430|Cefotaxime|cefotaxime|mesh-list
153825462|NCT00469430|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153365471|NCT02087111|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153365472|NCT02087111|Antiviral Agents|antiviral agents|mesh-ancestor
153365473|NCT02087111|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153365474|NCT02087111|Antimetabolites|antimetabolites|mesh-ancestor
153365540|NCT02451930|Necitumumab|necitumumab|mesh-list
153365541|NCT02451930|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153365542|NCT02451930|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153365617|NCT01598207|Sensory System Agents|sensory system agents|mesh-ancestor
153825688|NCT00501111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153825689|NCT00501111|Nootropic Agents|nootropic agents|mesh-ancestor
153825690|NCT01340209|Tiotropium Bromide|tiotropium bromide|mesh-list
153825691|NCT01340209|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153825692|NCT01340209|Autonomic Agents|autonomic agents|mesh-ancestor
153825693|NCT01340209|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153825694|NCT01340209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153825695|NCT01340209|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153825696|NCT01340209|Respiratory System Agents|respiratory system agents|mesh-ancestor
153825740|NCT00469937|Antidepressive Agents|antidepressive agents|mesh-ancestor
153825741|NCT00469937|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153825742|NCT00469937|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153825743|NCT00469937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153825805|NCT01246284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153825806|NCT01246284|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153825807|NCT01246284|Immunologic Factors|immunologic factors|mesh-ancestor
153825808|NCT01246284|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153825809|NCT01246284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153825810|NCT00599833|Cetuximab|cetuximab|mesh-list
153825811|NCT00599833|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153825839|NCT00599950|Mitomycins|mitomycins|mesh-list
153825840|NCT00599950|Mitomycin|mitomycin|mesh-list
153825841|NCT00599950|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153825842|NCT00599950|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153825843|NCT00599950|Alkylating Agents|alkylating agents|mesh-ancestor
153825844|NCT00599950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153825845|NCT00599950|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153825846|NCT00599950|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153825847|NCT00600145|Mirtazapine|mirtazapine|mesh-list
153825848|NCT00600145|Antidepressive Agents|antidepressive agents|mesh-ancestor
153365823|NCT01607645|Antimetabolites|antimetabolites|mesh-ancestor
153891056|NCT01061710|Varenicline|varenicline|mesh-list
153891057|NCT01061710|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
153891058|NCT01061710|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
153891059|NCT01061710|Cholinergic Agents|cholinergic agents|mesh-ancestor
153891060|NCT01061710|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153891061|NCT01061710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153365862|NCT01649609|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153365868|NCT01649609|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153365869|NCT01649609|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153365870|NCT01649609|Antifungal Agents|antifungal agents|mesh-ancestor
153825933|NCT00501618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153825934|NCT00501618|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153825935|NCT00501618|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153825936|NCT00501618|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153365909|NCT00942578|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153365910|NCT00942578|Immunologic Factors|immunologic factors|mesh-ancestor
153825964|NCT00623077|Thiotepa|thiotepa|mesh-list
153825965|NCT00623077|Sargramostim|sargramostim|mesh-list
153825966|NCT00623077|Mesna|mesna|mesh-list
153825967|NCT00623077|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153825968|NCT00623077|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153825969|NCT00623077|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153825970|NCT00623077|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153825971|NCT00623077|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153825972|NCT00623077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153825973|NCT00623077|Immunologic Factors|immunologic factors|mesh-ancestor
153825974|NCT00623077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153825975|NCT00623077|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153825976|NCT00623077|Alkylating Agents|alkylating agents|mesh-ancestor
153825977|NCT00623077|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153825978|NCT00623077|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153825979|NCT00623077|Protective Agents|protective agents|mesh-ancestor
153365961|NCT04355936|Telmisartan|telmisartan|mesh-list
153825989|NCT00475358|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153825990|NCT00475358|Antidepressive Agents|antidepressive agents|mesh-ancestor
153825991|NCT00475358|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153825992|NCT00475358|Dopamine Agents|dopamine agents|mesh-ancestor
153825993|NCT00623116|Testosterone|testosterone|mesh-list
153825994|NCT00623116|Estrogens|estrogens|mesh-list
153825995|NCT00623116|Androgens|androgens|mesh-ancestor
153825996|NCT00623116|Hormones|hormones|mesh-ancestor
153825997|NCT00623116|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153826031|NCT00600847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153826032|NCT00600847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153826033|NCT00600847|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
153826034|NCT00600847|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
153826035|NCT00600847|Histamine Antagonists|histamine antagonists|mesh-ancestor
153826037|NCT00600847|Antipruritics|antipruritics|mesh-ancestor
153826038|NCT00600847|Dermatologic Agents|dermatologic agents|mesh-ancestor
153826117|NCT04325893|Hydroxychloroquine|hydroxychloroquine|mesh-list
153366181|NCT04359212|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
153366182|NCT04359212|Tinzaparin|tinzaparin|mesh-list
153366183|NCT04359212|Dalteparin|dalteparin|mesh-list
153366185|NCT04359212|Fondaparinux|fondaparinux|mesh-list
153366186|NCT04359212|Anticoagulants|anticoagulants|mesh-ancestor
153826250|NCT00475553|Contraceptive Agents|contraceptive agents|mesh-ancestor
153826251|NCT00475553|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153826252|NCT00475553|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
153826253|NCT00475553|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
153826309|NCT00475826|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153826310|NCT00475826|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153826339|NCT00493545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153826340|NCT00470873|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
153826341|NCT00470873|Vasodilator Agents|vasodilator agents|mesh-ancestor
153826342|NCT00470873|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
153826343|NCT00470873|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
153826344|NCT00470873|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153826345|NCT00470873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153826346|NCT00470873|Urological Agents|urological agents|mesh-ancestor
153826347|NCT00493623|Ibandronic Acid|ibandronic acid|mesh-list
153826348|NCT00493623|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153826350|NCT00476099|Budesonide|budesonide|mesh-list
153366386|NCT03031184|Histamine Agents|histamine agents|mesh-ancestor
153366387|NCT03031184|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153366388|NCT03031184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153366389|NCT03031184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153366390|NCT03031184|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153366391|NCT03031184|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153366392|NCT03031184|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153366393|NCT03031184|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
153366402|NCT02238977|Fluoxetine|fluoxetine|mesh-list
153366434|NCT03034382|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153366435|NCT03034382|Narcotics|narcotics|mesh-ancestor
153366436|NCT03034382|Analgesics|analgesics|mesh-ancestor
153891085|NCT01028014|Nasal Decongestants|nasal decongestants|mesh-ancestor
153366437|NCT03034382|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153366438|NCT03034382|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153366439|NCT03034382|Adrenergic Agents|adrenergic agents|mesh-ancestor
153366440|NCT03034382|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153366441|NCT03034382|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
153366442|NCT03034382|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153366443|NCT03034382|Autonomic Agents|autonomic agents|mesh-ancestor
153826437|NCT00602134|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153826457|NCT00471341|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
153826458|NCT00471341|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153826459|NCT00471341|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153826460|NCT00471341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153826461|NCT01325428|Vinorelbine|vinorelbine|mesh-list
153826462|NCT01325428|Afatinib|afatinib|mesh-list
153826463|NCT01325428|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153366484|NCT01664897|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153366485|NCT03030716|Proanthocyanidin|proanthocyanidin|mesh-list
153366486|NCT03030716|Grape Seed Extract|grape seed extract|mesh-list
153366488|NCT03030716|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153366489|NCT03030716|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153826473|NCT00494247|Immunologic Factors|immunologic factors|mesh-ancestor
153826474|NCT00494247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153826475|NCT00471419|Rimexolone|rimexolone|mesh-list
153826476|NCT00471419|Glucocorticoids|glucocorticoids|mesh-ancestor
153826477|NCT00471419|Hormones|hormones|mesh-ancestor
153826481|NCT01325350|Minoxidil|minoxidil|mesh-list
153826504|NCT04325698|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153826505|NCT04325698|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153826506|NCT04325698|Tubulin Modulators|tubulin modulators|mesh-ancestor
153826507|NCT04325698|Antimitotic Agents|antimitotic agents|mesh-ancestor
153826508|NCT04325698|Mitosis Modulators|mitosis modulators|mesh-ancestor
153826509|NCT04325698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153826510|NCT04325698|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153826511|NCT04325698|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153826512|NCT04325698|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153826513|NCT04325698|Growth Substances|growth substances|mesh-ancestor
153826514|NCT04325698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153826515|NCT04325698|Growth Inhibitors|growth inhibitors|mesh-ancestor
153826516|NCT01324141|Fluorouracil|fluorouracil|mesh-list
153826517|NCT01324141|Mitomycins|mitomycins|mesh-list
153826518|NCT01324141|Mitomycin|mitomycin|mesh-list
153826519|NCT01324141|Tempol|tempol|mesh-list
153826520|NCT01324141|Antimetabolites|antimetabolites|mesh-ancestor
153826523|NCT01324141|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153826524|NCT01324141|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153826536|NCT01324024|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
153826537|NCT01324024|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
153826538|NCT01324024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153826539|NCT01324024|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
153826540|NCT01324024|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153366528|NCT02249741|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153366529|NCT02249741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153366530|NCT03033836|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
153366532|NCT03033836|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153366536|NCT03033836|Antiviral Agents|antiviral agents|mesh-ancestor
153366552|NCT03030560|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153366553|NCT03030560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153366554|NCT03033368|Rilpivirine|rilpivirine|mesh-list
153366555|NCT03033368|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153366556|NCT03033368|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153366557|NCT03033368|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153366558|NCT03033368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153366559|NCT03033368|Antiviral Agents|antiviral agents|mesh-ancestor
153366560|NCT03033368|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153366561|NCT03033368|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153366562|NCT03033368|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153366563|NCT03031262|Cytarabine|cytarabine|mesh-list
153366587|NCT03028532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153366588|NCT03028532|Fertility Agents, Female|fertility agents, female|mesh-ancestor
153366589|NCT03028532|Fertility Agents|fertility agents|mesh-ancestor
153366590|NCT03028532|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153366591|NCT03028532|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
153366592|NCT03028532|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
153366593|NCT03017768|Tryptophan|tryptophan|mesh-list
153366594|NCT03017768|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
153366622|NCT01010282|Lubricant Eye Drops|lubricant eye drops|mesh-list
153366623|NCT01010282|Glycerol|glycerol|mesh-list
153826634|NCT00471965|Immunologic Factors|immunologic factors|mesh-ancestor
153826635|NCT00471965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153826636|NCT00471965|Antidotes|antidotes|mesh-ancestor
153366624|NCT01010282|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
153366625|NCT01010282|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
153366626|NCT01010282|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
153366627|NCT01010282|Protective Agents|protective agents|mesh-ancestor
153366628|NCT01010282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153826686|NCT01246557|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153826687|NCT01246557|Growth Substances|growth substances|mesh-ancestor
153826688|NCT01246557|Growth Inhibitors|growth inhibitors|mesh-ancestor
153826689|NCT00476918|Triamcinolone|triamcinolone|mesh-list
153826690|NCT00476918|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
153826691|NCT00476918|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
153826692|NCT00476918|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
153826693|NCT00476918|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153826694|NCT00476918|Glucocorticoids|glucocorticoids|mesh-ancestor
153826695|NCT00476918|Hormones|hormones|mesh-ancestor
153826696|NCT00476918|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153826697|NCT00476918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153826698|NCT00476918|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153826699|NCT00476918|Immunologic Factors|immunologic factors|mesh-ancestor
153826700|NCT00476918|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153826701|NCT00476918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153366724|NCT01676831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153366726|NCT01680653|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
153366727|NCT01680653|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153366728|NCT01680653|Hormones|hormones|mesh-ancestor
153366729|NCT01680653|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153366730|NCT01680653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153366731|NCT01680653|Incretins|incretins|mesh-ancestor
153366732|NCT02448810|Fluorouracil|fluorouracil|mesh-list
153366733|NCT02448810|Panitumumab|panitumumab|mesh-list
153366745|NCT01680887|Cholinergic Agents|cholinergic agents|mesh-ancestor
153826756|NCT01246752|Cytarabine|cytarabine|mesh-list
153366852|NCT01685411|Alkylating Agents|alkylating agents|mesh-ancestor
153366853|NCT01685411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153366854|NCT01685411|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153366855|NCT01685411|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153366856|NCT01685411|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153366857|NCT01685411|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
153366858|NCT01685411|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153432146|NCT05255211|Propofol|propofol|mesh-list
153826882|NCT01244334|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
153826883|NCT01244334|Methylprednisolone|methylprednisolone|mesh-list
153826884|NCT01244334|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
153826885|NCT01244334|Prednisolone acetate|prednisolone acetate|mesh-list
153826886|NCT01244334|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
153826887|NCT01244334|Prednisolone phosphate|prednisolone phosphate|mesh-list
153826888|NCT01244334|Difluprednate|difluprednate|mesh-list
153826889|NCT01244334|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153826890|NCT01244334|Glucocorticoids|glucocorticoids|mesh-ancestor
153826891|NCT01244334|Hormones|hormones|mesh-ancestor
153826896|NCT01244334|Antiemetics|antiemetics|mesh-ancestor
153826918|NCT00477581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153826919|NCT00477581|Incretins|incretins|mesh-ancestor
153826920|NCT00477581|Hormones|hormones|mesh-ancestor
153826921|NCT00477581|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153826922|NCT00477581|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
153826923|NCT00477581|Protease Inhibitors|protease inhibitors|mesh-ancestor
153826924|NCT00477581|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153826925|NCT00477581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153826926|NCT00477581|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
153826927|NCT00477581|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
153826928|NCT00477737|Propofol|propofol|mesh-list
153826956|NCT00477815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153826957|NCT00477815|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153826958|NCT00477815|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153826959|NCT00477815|Alkylating Agents|alkylating agents|mesh-ancestor
153826961|NCT00477815|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153367002|NCT03018626|Alkylating Agents|alkylating agents|mesh-ancestor
153367003|NCT03018626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153367008|NCT03018626|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153367009|NCT03018626|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153367010|NCT03018626|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153367011|NCT03018626|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153367012|NCT03018626|Glucocorticoids|glucocorticoids|mesh-ancestor
153367014|NCT03018626|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153827003|NCT01248975|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
153827004|NCT01248975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153827005|NCT02955927|Atropine|atropine|mesh-list
153827006|NCT02955927|Ophthalmic Solutions|ophthalmic solutions|mesh-list
153827007|NCT02955927|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
153827008|NCT02955927|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153367064|NCT03018236|Ethanol|ethanol|mesh-list
153367065|NCT03018236|Acetylcysteine|acetylcysteine|mesh-list
153367066|NCT03018236|Cocaine|cocaine|mesh-list
153367067|NCT03018236|N-monoacetylcystine|n-monoacetylcystine|mesh-list
153367068|NCT03018236|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
153367069|NCT03018236|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153827112|NCT00478946|Antidotes|antidotes|mesh-ancestor
153827113|NCT00478946|Protective Agents|protective agents|mesh-ancestor
153827116|NCT00478946|Vitamins|vitamins|mesh-ancestor
153367175|NCT01024010|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153367176|NCT01024010|Alkylating Agents|alkylating agents|mesh-ancestor
153367177|NCT01024010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153367178|NCT01024010|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153367179|NCT01024010|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153367242|NCT04200066|Temozolomide|temozolomide|mesh-list
153367243|NCT04200066|Maprotiline|maprotiline|mesh-list
153367244|NCT04200066|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153367245|NCT04200066|Alkylating Agents|alkylating agents|mesh-ancestor
153367246|NCT04200066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153827224|NCT00478985|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153827225|NCT00478985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153827226|NCT00478985|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153827264|NCT01315249|Xhance|xhance|mesh-list
153827299|NCT04207411|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153827300|NCT04207411|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
153827301|NCT04207411|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153827302|NCT04207411|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153827303|NCT04207411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153827304|NCT00473486|Carboplatin|carboplatin|mesh-list
153827305|NCT00473486|Pemetrexed|pemetrexed|mesh-list
153827306|NCT00473486|Sorafenib|sorafenib|mesh-list
153827307|NCT00473486|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153827308|NCT00473486|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153367295|NCT00995072|Vasodilator Agents|vasodilator agents|mesh-ancestor
153367296|NCT00995072|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
153827313|NCT05644483|Propofol|propofol|mesh-list
153827325|NCT01248819|Sensory System Agents|sensory system agents|mesh-ancestor
153827327|NCT01313767|Botulinum Toxins|botulinum toxins|mesh-list
153827339|NCT01248858|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153827340|NCT01248858|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153367330|NCT01031498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153367331|NCT01031498|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153367333|NCT01031498|Dermatologic Agents|dermatologic agents|mesh-ancestor
153367334|NCT01031498|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
153367335|NCT01031498|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153367336|NCT01031498|Serotonin Agents|serotonin agents|mesh-ancestor
153367337|NCT01031498|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153367338|NCT01031498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153367339|NCT01031810|Tranylcypromine|tranylcypromine|mesh-list
153367340|NCT01031810|Antidepressive Agents|antidepressive agents|mesh-ancestor
153367341|NCT01031810|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153367342|NCT01031810|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
153367343|NCT01031810|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153367344|NCT01031810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153367345|NCT01031810|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153367346|NCT01031810|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153827364|NCT00481364|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153827365|NCT00481442|Phenylephrine|phenylephrine|mesh-list
153827366|NCT00481442|Oxymetazoline|oxymetazoline|mesh-list
153827367|NCT00481442|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
153827368|NCT00481442|Mydriatics|mydriatics|mesh-ancestor
153827369|NCT00481442|Autonomic Agents|autonomic agents|mesh-ancestor
153827370|NCT00481442|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153827371|NCT00481442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153367464|NCT02169440|Warfarin|warfarin|mesh-list
153367465|NCT02169440|Anticoagulants|anticoagulants|mesh-ancestor
153367466|NCT02169440|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
153367467|NCT02169440|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153367468|NCT02169440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153367469|NCT02169440|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
153367470|NCT02169440|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
153367471|NCT03015350|Sevoflurane|sevoflurane|mesh-list
153367472|NCT03015350|Desflurane|desflurane|mesh-list
153367473|NCT03015350|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153367505|NCT02170376|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153367506|NCT02170376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153367507|NCT02170376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153367508|NCT02170376|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
153367509|NCT02170376|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153367510|NCT02170376|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
153367511|NCT02170532|Albuterol|albuterol|mesh-list
153827491|NCT01313221|Immunologic Factors|immunologic factors|mesh-ancestor
153827521|NCT00480194|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
153827522|NCT00505089|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
153827523|NCT00505089|Immunologic Factors|immunologic factors|mesh-ancestor
153827524|NCT00505089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153827525|NCT00505167|Memantine|memantine|mesh-list
153827526|NCT00505167|Donepezil|donepezil|mesh-list
153827527|NCT00505167|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
153827528|NCT00505167|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153827548|NCT00480272|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
153827549|NCT00480272|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153827550|NCT04517058|Antidepressive Agents|antidepressive agents|mesh-list
153827551|NCT04517058|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153827552|NCT00480389|Sorafenib|sorafenib|mesh-list
153827553|NCT00480389|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153827555|NCT00480389|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153827592|NCT00482222|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153827593|NCT00482222|Immunologic Factors|immunologic factors|mesh-ancestor
153827594|NCT00482222|Antidotes|antidotes|mesh-ancestor
153827595|NCT00482222|Protective Agents|protective agents|mesh-ancestor
153827596|NCT00482222|Vitamin B Complex|vitamin b complex|mesh-ancestor
153827597|NCT00482222|Vitamins|vitamins|mesh-ancestor
153827598|NCT00482222|Micronutrients|micronutrients|mesh-ancestor
153827599|NCT00482222|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153827600|NCT01312129|Sulfasalazine|sulfasalazine|mesh-list
153827601|NCT01312129|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153827602|NCT01312129|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153827603|NCT01312129|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153827604|NCT01312129|Analgesics|analgesics|mesh-ancestor
153827605|NCT01312129|Sensory System Agents|sensory system agents|mesh-ancestor
153827606|NCT01312129|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153827607|NCT01312129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153827608|NCT01312129|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153827609|NCT01312129|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153827610|NCT01312129|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153827611|NCT04518852|Sorafenib|sorafenib|mesh-list
153367610|NCT03014804|Nivolumab|nivolumab|mesh-list
153827615|NCT04518852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153827616|NCT01311661|Olodaterol|olodaterol|mesh-list
153827617|NCT01311661|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153827618|NCT01311661|Autonomic Agents|autonomic agents|mesh-ancestor
153827619|NCT01311661|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153827620|NCT01311661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153827621|NCT01311661|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153827622|NCT01311661|Respiratory System Agents|respiratory system agents|mesh-ancestor
153827623|NCT04518735|Anticoagulants|anticoagulants|mesh-list
153827624|NCT00482261|Aspirin|aspirin|mesh-list
153827625|NCT00482261|Dexamethasone|dexamethasone|mesh-list
153827626|NCT00482261|Lenalidomide|lenalidomide|mesh-list
153827627|NCT00482261|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153827628|NCT00482261|Antiemetics|antiemetics|mesh-ancestor
153827629|NCT00482261|Autonomic Agents|autonomic agents|mesh-ancestor
153827630|NCT00482261|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153827632|NCT00482261|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153367649|NCT01071044|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153367650|NCT05150756|Lidocaine|lidocaine|mesh-list
153367651|NCT05150756|Morphine|morphine|mesh-list
153367652|NCT05150756|Anesthetics, Local|anesthetics, local|mesh-ancestor
153367653|NCT05150756|Anesthetics|anesthetics|mesh-ancestor
153367654|NCT05150756|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153367655|NCT05150756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153367656|NCT05150756|Sensory System Agents|sensory system agents|mesh-ancestor
153367657|NCT05150756|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153367658|NCT05150756|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153367659|NCT05150756|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
153367660|NCT05150756|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153827656|NCT04518618|Naloxone|naloxone|mesh-list
153827657|NCT04518618|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153827658|NCT04518618|Narcotics|narcotics|mesh-ancestor
153827661|NCT04518618|Analgesics|analgesics|mesh-ancestor
153367665|NCT05150756|Analgesics|analgesics|mesh-ancestor
153367666|NCT01072136|Azithromycin|azithromycin|mesh-list
153367667|NCT01072136|Cefixime|cefixime|mesh-list
153367668|NCT01072136|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153367669|NCT01072136|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153367670|NCT01072136|Third Generation Cephalosporins|third generation cephalosporins|mesh-ancestor
153367671|NCT01072136|Beta Lactam Antibiotics|beta lactam antibiotics|mesh-ancestor
153367672|NCT05135858|Methotrexate|methotrexate|mesh-list
153367673|NCT05135858|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
153367674|NCT05135858|Abortifacient Agents|abortifacient agents|mesh-ancestor
153367678|NCT05135858|Antimetabolites|antimetabolites|mesh-ancestor
153827724|NCT00480623|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153827726|NCT01240655|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153827727|NCT01240655|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153827728|NCT01240655|Tubulin Modulators|tubulin modulators|mesh-ancestor
153827729|NCT01240655|Antimitotic Agents|antimitotic agents|mesh-ancestor
153827730|NCT01240655|Mitosis Modulators|mitosis modulators|mesh-ancestor
153827731|NCT01240655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153827732|NCT04518189|Lidocaine|lidocaine|mesh-list
153827733|NCT04518189|Anesthetics, Local|anesthetics, local|mesh-ancestor
153827734|NCT04518189|Anesthetics|anesthetics|mesh-ancestor
153827735|NCT04518189|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153827736|NCT04518189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153827737|NCT04518189|Sensory System Agents|sensory system agents|mesh-ancestor
153827738|NCT04518189|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153827739|NCT04518189|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153827744|NCT00482378|Zoledronic Acid|zoledronic acid|mesh-list
153827766|NCT01309828|Olmesartan|olmesartan|mesh-list
153827767|NCT01309828|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
153827768|NCT01309828|Chlorthalidone|chlorthalidone|mesh-list
153827769|NCT01309828|Azilsartan medoxomil|azilsartan medoxomil|mesh-list
153827770|NCT01309828|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153827771|NCT01309828|Diuretics|diuretics|mesh-ancestor
153827772|NCT01309828|Natriuretic Agents|natriuretic agents|mesh-ancestor
153827773|NCT01309828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153827774|NCT01309828|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
153827802|NCT00482573|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153827803|NCT00482573|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153827804|NCT00482573|Adrenergic Agents|adrenergic agents|mesh-ancestor
153827805|NCT00482573|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153827806|NCT00482573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153827807|NCT00482573|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
153827808|NCT00482573|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153827809|NCT00482573|Autonomic Agents|autonomic agents|mesh-ancestor
153827827|NCT00481013|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153827829|NCT01309243|Efavirenz, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|efavirenz, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
153827830|NCT01309243|Emtricitabine, Rilpivirine, Tenofovir Drug Combination|emtricitabine, rilpivirine, tenofovir drug combination|mesh-list
153827831|NCT01309243|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153827832|NCT01309243|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153827833|NCT01309243|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153827855|NCT04517526|Growth Substances|growth substances|mesh-ancestor
153827856|NCT04517526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153827857|NCT04517526|Growth Inhibitors|growth inhibitors|mesh-ancestor
153827858|NCT04517526|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153827859|NCT04517526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153827860|NCT04517526|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153827861|NCT04517526|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153827862|NCT01309204|Brimonidine Tartrate|brimonidine tartrate|mesh-list
153827863|NCT01309204|Ophthalmic Solutions|ophthalmic solutions|mesh-list
153827864|NCT01309204|Brinzolamide|brinzolamide|mesh-list
153827865|NCT01309204|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
153827866|NCT01309204|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153827867|NCT01309204|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
153827868|NCT01309204|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153827885|NCT01240148|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153827886|NCT01240148|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153827887|NCT01240148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153827896|NCT04517292|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153827897|NCT04517292|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153827898|NCT04517292|Antimetabolites|antimetabolites|mesh-ancestor
153827899|NCT04517292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153367896|NCT01085786|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
153367897|NCT01085786|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153367898|NCT02170220|Vortioxetine|vortioxetine|mesh-list
153367899|NCT02170220|Antidepressive Agents|antidepressive agents|mesh-ancestor
153367900|NCT02170220|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153367901|NCT02170220|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153367902|NCT02170220|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153367903|NCT02170220|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153367904|NCT02170220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153367905|NCT02170220|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
153367934|NCT02386098|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
153367935|NCT02386098|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153367936|NCT02386098|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153367937|NCT02386098|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153367938|NCT02386098|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
153367939|NCT02386098|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
153367940|NCT01089062|Dihydroergotamine|dihydroergotamine|mesh-list
153367941|NCT01089062|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
153367942|NCT01089062|Dopamine Agonists|dopamine agonists|mesh-ancestor
153367943|NCT01089062|Dopamine Agents|dopamine agents|mesh-ancestor
153367944|NCT01089062|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153367946|NCT01089062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153367953|NCT02412618|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
153367954|NCT02412618|Abortifacient Agents|abortifacient agents|mesh-ancestor
153367955|NCT02412618|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153367956|NCT02412618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153367957|NCT02412618|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
153367958|NCT02412618|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153367959|NCT02412618|Oxytocics|oxytocics|mesh-ancestor
153367960|NCT02412618|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
153827973|NCT01240941|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
153827974|NCT01240941|Hormone Antagonists|hormone antagonists|mesh-ancestor
153827975|NCT01240941|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153827976|NCT01240941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153827977|NCT01240941|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153827978|NCT00482963|Efavirenz|efavirenz|mesh-list
153827979|NCT00482963|Levonorgestrel|levonorgestrel|mesh-list
153367980|NCT02179892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153367981|NCT02179892|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153367982|NCT02179892|Glucocorticoids|glucocorticoids|mesh-ancestor
153827984|NCT00482963|Antiviral Agents|antiviral agents|mesh-ancestor
153827985|NCT00482963|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153827986|NCT00482963|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
153827987|NCT00482963|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153827988|NCT00482963|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
153827989|NCT00482963|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
153827990|NCT00482963|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
153827991|NCT00482963|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
153827992|NCT00482963|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
153827993|NCT00482963|Contraceptive Agents|contraceptive agents|mesh-ancestor
153827994|NCT00482963|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153827997|NCT00482963|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
153827998|NCT00482963|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
153828000|NCT01241019|Anticonvulsants|anticonvulsants|mesh-ancestor
153828003|NCT01240928|Exemestane|exemestane|mesh-list
153828009|NCT01240928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153828010|NCT01240928|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
153828011|NCT01240928|Hormone Antagonists|hormone antagonists|mesh-ancestor
153828012|NCT01240928|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153828013|NCT01240928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153828014|NCT01240928|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153828015|NCT00481169|Bazedoxifene|bazedoxifene|mesh-list
153828016|NCT00481169|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
153828017|NCT00481169|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
153828018|NCT00481169|Hormone Antagonists|hormone antagonists|mesh-ancestor
153828019|NCT00481169|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153828022|NCT00483093|Cisplatin|cisplatin|mesh-list
153439794|NCT00002833|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153439795|NCT00002833|Antifungal Agents|antifungal agents|mesh-ancestor
153439796|NCT00002833|Dermatologic Agents|dermatologic agents|mesh-ancestor
153439797|NCT00002833|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153439798|NCT00002833|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
153439799|NCT00002833|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153439800|NCT00002833|Antiemetics|antiemetics|mesh-ancestor
153439801|NCT00002833|Autonomic Agents|autonomic agents|mesh-ancestor
153439802|NCT00002833|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153439803|NCT00002833|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153439804|NCT00002833|Glucocorticoids|glucocorticoids|mesh-ancestor
153439813|NCT00003061|Cytarabine|cytarabine|mesh-list
153898511|NCT00605995|Antimetabolites|antimetabolites|mesh-ancestor
153898512|NCT00605995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153898513|NCT00605995|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153898514|NCT00605995|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
153898515|NCT00605995|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153898516|NCT00605683|Cabergoline|cabergoline|mesh-list
153898611|NCT01263470|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153898612|NCT01263470|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
153898613|NCT01263470|Protease Inhibitors|protease inhibitors|mesh-ancestor
153898614|NCT01263470|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153898615|NCT01263470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153898616|NCT01263470|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
153898617|NCT04322786|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
153898693|NCT00939523|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153898694|NCT01260584|Clopidogrel|clopidogrel|mesh-list
153898695|NCT01260584|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
153440027|NCT00003619|Etoposide|etoposide|mesh-list
153898776|NCT05937880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153898777|NCT05937880|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153898778|NCT05937880|Immunologic Factors|immunologic factors|mesh-ancestor
153898779|NCT05937880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153898780|NCT05937841|Compound 21|compound 21|mesh-list
153898971|NCT05635110|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
153899005|NCT05246111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153899006|NCT05246111|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153440406|NCT00003691|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153440407|NCT00003691|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153440408|NCT00003139|Pilocarpine|pilocarpine|mesh-list
153440409|NCT00003139|Miotics|miotics|mesh-ancestor
153440410|NCT00003139|Autonomic Agents|autonomic agents|mesh-ancestor
153440411|NCT00003139|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153440412|NCT00003139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153440413|NCT00003139|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
153440414|NCT00003139|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
153440415|NCT00003139|Cholinergic Agents|cholinergic agents|mesh-ancestor
153440416|NCT00003139|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153440417|NCT00003139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153899103|NCT04220931|Cholinergic Agents|cholinergic agents|mesh-ancestor
153899140|NCT03690869|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153899141|NCT03690869|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153899142|NCT03637764|Atezolizumab|atezolizumab|mesh-list
153899158|NCT06268873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153899160|NCT06268769|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153899161|NCT06268769|Immunologic Factors|immunologic factors|mesh-ancestor
153899162|NCT06268769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153440487|NCT00003151|Bismuth tripotassium dicitrate|bismuth tripotassium dicitrate|mesh-list
153440489|NCT00003151|Bismuth|bismuth|mesh-list
153440490|NCT00003151|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153899197|NCT06268652|Gemcitabine|gemcitabine|mesh-list
153899198|NCT06268652|Capecitabine|capecitabine|mesh-list
153899199|NCT06268652|Vinorelbine|vinorelbine|mesh-list
153899201|NCT06268652|Antimetabolites|antimetabolites|mesh-ancestor
153899202|NCT06268652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153899203|NCT06268652|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153440532|NCT00003727|Interferons|interferons|mesh-list
153899255|NCT06268275|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
153899256|NCT06268275|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
153899257|NCT06268275|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
153899258|NCT06268275|Adrenergic Agents|adrenergic agents|mesh-ancestor
153899259|NCT06268275|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153899260|NCT06268275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153899261|NCT06268275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153899273|NCT06268210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153899274|NCT06268210|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153899277|NCT06268093|Thalidomide|thalidomide|mesh-list
153440653|NCT00004099|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153440654|NCT00004099|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153440655|NCT00004099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153899318|NCT06267794|Sensory System Agents|sensory system agents|mesh-ancestor
153899319|NCT06267794|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153899320|NCT06267794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153899321|NCT06267794|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153899547|NCT06191692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153899548|NCT06191692|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
153899549|NCT06191692|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
153899550|NCT06191692|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
153899551|NCT06191692|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
153440897|NCT00003829|Fludarabine phosphate|fludarabine phosphate|mesh-list
153440898|NCT00003829|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153440899|NCT00003829|Immunologic Factors|immunologic factors|mesh-ancestor
153440900|NCT00003829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153440901|NCT00003829|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153441014|NCT00003847|Tubulin Modulators|tubulin modulators|mesh-ancestor
153441015|NCT00003847|Antimitotic Agents|antimitotic agents|mesh-ancestor
153441016|NCT00003847|Mitosis Modulators|mitosis modulators|mesh-ancestor
153441017|NCT00004195|Eniluracil|eniluracil|mesh-list
153441018|NCT00004195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153441019|NCT00004195|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153441020|NCT00003853|Esorubicin|esorubicin|mesh-list
153441021|NCT00003853|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153441022|NCT00003853|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153441023|NCT00385021|Leucovorin|leucovorin|mesh-list
153441024|NCT00385021|Fluorouracil|fluorouracil|mesh-list
153441123|NCT00003883|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
153441124|NCT00003883|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153441125|NCT00003883|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153441126|NCT00003883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153441127|NCT00003883|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153441128|NCT00003883|Hormone Antagonists|hormone antagonists|mesh-ancestor
153899766|NCT05894564|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153899767|NCT05894564|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153899882|NCT05759949|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153899883|NCT05759949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153899884|NCT05759949|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153899885|NCT05759949|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153899886|NCT05759949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153899887|NCT05756348|Protective Agents|protective agents|mesh-list
153441251|NCT00004255|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
153441252|NCT00004255|Protective Agents|protective agents|mesh-ancestor
153441253|NCT00004261|Antibodies|antibodies|mesh-list
153441422|NCT00004891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153441424|NCT00003337|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153441425|NCT00003337|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153441426|NCT00003343|Prednisone|prednisone|mesh-list
153441427|NCT00003343|Mitoxantrone|mitoxantrone|mesh-list
153441428|NCT00003343|Prinomastat|prinomastat|mesh-list
153441429|NCT00003343|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153441430|NCT00003343|Glucocorticoids|glucocorticoids|mesh-ancestor
153441431|NCT00003343|Hormones|hormones|mesh-ancestor
153441433|NCT00003343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153441545|NCT00004981|Antimetabolites|antimetabolites|mesh-ancestor
153441547|NCT00004993|Parathyroid Hormone|parathyroid hormone|mesh-list
153441548|NCT00004993|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153900192|NCT05251909|Benralizumab|benralizumab|mesh-list
153441568|NCT00003361|Decitabine|decitabine|mesh-list
153441569|NCT00003361|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153441570|NCT00003361|Antimetabolites|antimetabolites|mesh-ancestor
153441571|NCT00003361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153441572|NCT00003361|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153900283|NCT04993677|Pembrolizumab|pembrolizumab|mesh-list
153900284|NCT04993677|Pemetrexed|pemetrexed|mesh-list
153900285|NCT04993677|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153900286|NCT04993677|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153900287|NCT04993677|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153441663|NCT00005017|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
153441664|NCT00005017|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
153441665|NCT00005017|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
153441666|NCT00005017|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
153441667|NCT00005017|Antimetabolites|antimetabolites|mesh-ancestor
153441668|NCT00005017|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
153441669|NCT00005017|Antitubercular Agents|antitubercular agents|mesh-ancestor
153441670|NCT00005017|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153441751|NCT00386269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153441752|NCT00386269|Analgesics|analgesics|mesh-ancestor
153441753|NCT00386269|Sensory System Agents|sensory system agents|mesh-ancestor
153441754|NCT00386269|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153441755|NCT00386269|Antitussive Agents|antitussive agents|mesh-ancestor
153441756|NCT00386269|Respiratory System Agents|respiratory system agents|mesh-ancestor
153441757|NCT00005581|Paclitaxel|paclitaxel|mesh-list
153441758|NCT00005581|Cyclophosphamide|cyclophosphamide|mesh-list
153441844|NCT00005089|Tubulin Modulators|tubulin modulators|mesh-ancestor
153441845|NCT00005089|Antimitotic Agents|antimitotic agents|mesh-ancestor
153441846|NCT00005089|Mitosis Modulators|mitosis modulators|mesh-ancestor
153441847|NCT00005599|Paclitaxel|paclitaxel|mesh-list
153441848|NCT00005599|Bryostatin 1|bryostatin 1|mesh-list
153441849|NCT00005599|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153441850|NCT00005599|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153441851|NCT00005599|Tubulin Modulators|tubulin modulators|mesh-ancestor
153441852|NCT00005599|Antimitotic Agents|antimitotic agents|mesh-ancestor
153441853|NCT00005599|Mitosis Modulators|mitosis modulators|mesh-ancestor
153441858|NCT00004567|Mycophenolic Acid|mycophenolic acid|mesh-list
153900603|NCT04194203|Bevacizumab|bevacizumab|mesh-list
153441986|NCT00005647|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153441987|NCT00005647|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153441988|NCT00005647|Growth Substances|growth substances|mesh-ancestor
153441989|NCT00005647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153441990|NCT00005647|Growth Inhibitors|growth inhibitors|mesh-ancestor
153441991|NCT00005647|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153441992|NCT00005647|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153441993|NCT00005665|Interferons|interferons|mesh-list
153441994|NCT00005665|Interferon-alpha|interferon-alpha|mesh-list
153441995|NCT00005665|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153441996|NCT00005665|Antiviral Agents|antiviral agents|mesh-ancestor
153441997|NCT00005665|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153441998|NCT00005665|Immunologic Factors|immunologic factors|mesh-ancestor
153441999|NCT00005665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153442000|NCT00004669|Hydrocortisone|hydrocortisone|mesh-list
153442001|NCT00004669|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153442002|NCT00385411|Valproic Acid|valproic acid|mesh-list
153442003|NCT00385411|Anticonvulsants|anticonvulsants|mesh-ancestor
153442004|NCT00385411|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153442005|NCT00385411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153900604|NCT04194203|Carboplatin|carboplatin|mesh-list
153900605|NCT04194203|Pemetrexed|pemetrexed|mesh-list
153900606|NCT04194203|Atezolizumab|atezolizumab|mesh-list
153900608|NCT04194203|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153442138|NCT00005773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153442139|NCT00005773|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153442140|NCT00005773|Respiratory System Agents|respiratory system agents|mesh-ancestor
153442141|NCT00005773|Free Radical Scavengers|free radical scavengers|mesh-ancestor
153442142|NCT00005773|Antioxidants|antioxidants|mesh-ancestor
153442143|NCT00005773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153442144|NCT00005773|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153900774|NCT03728179|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153900775|NCT03728179|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153900776|NCT03728179|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153442360|NCT02100228|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
153442361|NCT02100228|Protease Inhibitors|protease inhibitors|mesh-ancestor
153442362|NCT02100228|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153442363|NCT02100228|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
153442364|NCT02100228|Hemostatics|hemostatics|mesh-ancestor
153442365|NCT02100228|Coagulants|coagulants|mesh-ancestor
153442366|NCT02099838|Metformin|metformin|mesh-list
153442367|NCT02099838|Pioglitazone|pioglitazone|mesh-list
153442368|NCT02099838|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153901018|NCT02719574|Azacitidine|azacitidine|mesh-list
153442599|NCT02116530|Dexamethasone|dexamethasone|mesh-list
153442887|NCT02045862|Mirabegron|mirabegron|mesh-list
153442888|NCT02045862|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
153442889|NCT02045862|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
153442890|NCT02045862|Cholinergic Agents|cholinergic agents|mesh-ancestor
153442897|NCT02045862|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153442898|NCT02045862|Adrenergic Agents|adrenergic agents|mesh-ancestor
153442899|NCT04182984|Mycophenolic Acid|mycophenolic acid|mesh-list
153442900|NCT04182984|Prednisone|prednisone|mesh-list
153442901|NCT04182984|Azathioprine|azathioprine|mesh-list
153442902|NCT04182984|Bromides|bromides|mesh-list
153442931|NCT02044302|Analgesics|analgesics|mesh-list
153442932|NCT02044302|Bupivacaine|bupivacaine|mesh-list
153442933|NCT02044302|Botulinum Toxins|botulinum toxins|mesh-list
153442934|NCT02044302|Anesthetics, Local|anesthetics, local|mesh-ancestor
153442935|NCT02044302|Anesthetics|anesthetics|mesh-ancestor
153442936|NCT02044302|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153442937|NCT02044302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153442938|NCT02044302|Sensory System Agents|sensory system agents|mesh-ancestor
153443157|NCT02014584|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153443158|NCT02014584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153443159|NCT02014584|Hormone Antagonists|hormone antagonists|mesh-ancestor
153443160|NCT02014584|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153443161|NCT02014584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153443162|NCT02037984|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
153443163|NCT02037984|Immunologic Factors|immunologic factors|mesh-ancestor
153443164|NCT02037984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153443165|NCT02036580|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
153901742|NCT05881083|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
153901743|NCT05881083|Cholinergic Agents|cholinergic agents|mesh-ancestor
153443271|NCT02034162|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153443272|NCT02034162|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153443273|NCT02034162|Tubulin Modulators|tubulin modulators|mesh-ancestor
153443276|NCT02034162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153443277|NCT02034162|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153443278|NCT02034162|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153443280|NCT02034006|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153901863|NCT05433961|Xenon|xenon|mesh-list
153901875|NCT05355168|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153443451|NCT01994850|Brentuximab Vedotin|brentuximab vedotin|mesh-list
153443452|NCT01994850|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153443453|NCT01994850|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153443454|NCT01994850|Immunotoxins|immunotoxins|mesh-ancestor
153443455|NCT01994850|Immunoconjugates|immunoconjugates|mesh-ancestor
153443456|NCT01994850|Immunologic Factors|immunologic factors|mesh-ancestor
153443457|NCT01994850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153443458|NCT01994382|Rituximab|rituximab|mesh-list
153443471|NCT01994226|Analgesics|analgesics|mesh-ancestor
153443472|NCT01994226|Sensory System Agents|sensory system agents|mesh-ancestor
153443473|NCT01994226|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153443474|NCT01994226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153443485|NCT02002884|Botulinum Toxins|botulinum toxins|mesh-list
153902403|NCT00840853|Histamine Agents|histamine agents|mesh-ancestor
153443888|NCT01999218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153443889|NCT01999218|Incretins|incretins|mesh-ancestor
153443890|NCT01999218|Hormones|hormones|mesh-ancestor
153443891|NCT01999218|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153443892|NCT01999218|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
153443893|NCT01999218|Protease Inhibitors|protease inhibitors|mesh-ancestor
153443894|NCT01999218|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153443895|NCT01999218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153443896|NCT01999218|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153443897|NCT01999218|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153443898|NCT01999218|Immunologic Factors|immunologic factors|mesh-ancestor
153443899|NCT01999218|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
153443900|NCT01936974|Bevacizumab|bevacizumab|mesh-list
153443902|NCT01936974|Gemcitabine|gemcitabine|mesh-list
153443903|NCT01936974|Oxaliplatin|oxaliplatin|mesh-list
153443904|NCT01936974|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153443905|NCT01936974|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153443975|NCT01932996|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153902530|NCT00609193|Antidepressive Agents|antidepressive agents|mesh-ancestor
153443986|NCT01957644|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153443987|NCT01957644|Antimetabolites|antimetabolites|mesh-ancestor
153443988|NCT01957644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153443989|NCT01957644|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153443990|NCT01957644|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153443991|NCT01931202|Escitalopram|escitalopram|mesh-list
153443992|NCT01931202|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
153443993|NCT01931202|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153443994|NCT01931202|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153902612|NCT05052541|Dronabinol|dronabinol|mesh-list
153902613|NCT05052541|Hallucinogens|hallucinogens|mesh-ancestor
153902614|NCT05052541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153902615|NCT05052541|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153902616|NCT05052541|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153902617|NCT05052541|Analgesics|analgesics|mesh-ancestor
153902618|NCT05052541|Sensory System Agents|sensory system agents|mesh-ancestor
153902619|NCT05052541|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153902620|NCT05052541|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
153902621|NCT05052541|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
153902711|NCT00926575|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153902713|NCT00926575|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153444171|NCT02936999|Cholecalciferol|cholecalciferol|mesh-list
153444187|NCT00378443|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153444188|NCT00378443|Glucocorticoids|glucocorticoids|mesh-ancestor
153444189|NCT00378443|Hormones|hormones|mesh-ancestor
153444190|NCT00378443|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153444191|NCT00378443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153444192|NCT00378443|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153444193|NCT00378443|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153444194|NCT00378443|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153902757|NCT01217190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153444265|NCT02708849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153444266|NCT02708849|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
153444267|NCT02708849|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153444268|NCT02708849|Anesthetics, General|anesthetics, general|mesh-ancestor
153444269|NCT02708849|Anesthetics|anesthetics|mesh-ancestor
153444270|NCT02708849|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153444271|NCT02708849|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
153444272|NCT02708849|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
153444273|NCT02708849|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153444274|NCT02708849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153444276|NCT02708849|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153902882|NCT01133847|Dopamine Agents|dopamine agents|mesh-ancestor
153903119|NCT00919867|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
153903120|NCT00919867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153903121|NCT00919867|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
153903122|NCT00919867|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153444561|NCT03792191|Bupivacaine|bupivacaine|mesh-list
153444562|NCT03792191|Anesthetics, Local|anesthetics, local|mesh-ancestor
153444563|NCT03792191|Anesthetics|anesthetics|mesh-ancestor
153444564|NCT03792191|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153444583|NCT00983645|Tacrolimus|tacrolimus|mesh-list
153903278|NCT01212588|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
153903279|NCT01212588|Abortifacient Agents|abortifacient agents|mesh-ancestor
153903280|NCT01212588|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153903281|NCT01212588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153903282|NCT01212588|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
153903283|NCT01212588|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
153903284|NCT01212588|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
153907689|NCT00895453|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153468326|NCT06298071|Methotrexate|methotrexate|mesh-list
153468327|NCT06298071|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
153817580|NCT06186895|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153817608|NCT06186440|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153817609|NCT06186440|Alkylating Agents|alkylating agents|mesh-ancestor
153817610|NCT06186440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153817612|NCT06186388|Antioxidants|antioxidants|mesh-ancestor
153817668|NCT06174402|Fenofibrate|fenofibrate|mesh-list
153817669|NCT06174402|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153817670|NCT06174402|Antimetabolites|antimetabolites|mesh-ancestor
153817672|NCT06174402|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153668028|NCT00030615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153668031|NCT03857087|Edetic Acid|edetic acid|mesh-list
153668035|NCT03857087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153668036|NCT03857087|Anticoagulants|anticoagulants|mesh-ancestor
153668037|NCT03857087|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
153668038|NCT03857087|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
153668039|NCT00030654|Ketoconazole|ketoconazole|mesh-list
153668040|NCT00030654|Vinblastine|vinblastine|mesh-list
153668068|NCT00030654|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153668251|NCT00031161|Nitisinone|nitisinone|mesh-list
153668878|NCT00034086|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153668881|NCT00034125|Tamoxifen|tamoxifen|mesh-list
153669604|NCT00037518|Cinacalcet|cinacalcet|mesh-list
153670466|NCT00130325|Isoniazid|isoniazid|mesh-list
153670479|NCT00394394|Amiloride|amiloride|mesh-list
153670773|NCT05736978|Venetoclax|venetoclax|mesh-list
153670938|NCT05012189|Baloxavir|baloxavir|mesh-list
153671240|NCT03492125|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153671569|NCT05766410|Hormone Antagonists|hormone antagonists|mesh-ancestor
153673036|NCT00049179|Cytarabine|cytarabine|mesh-list
153673242|NCT00022217|Paclitaxel|paclitaxel|mesh-list
153673350|NCT00050154|Tipifarnib|tipifarnib|mesh-list
153673732|NCT00024089|Gefitinib|gefitinib|mesh-list
153674127|NCT00025142|Fluorouracil|fluorouracil|mesh-list
153511959|NCT01409694|Vitamin D|vitamin d|mesh-list
153675151|NCT00028964|Cyclophosphamide|cyclophosphamide|mesh-list
153675612|NCT00031070|Lamivudine|lamivudine|mesh-list
153675613|NCT00031070|Zidovudine|zidovudine|mesh-list
153675614|NCT00031070|Efavirenz|efavirenz|mesh-list
153675849|NCT00031733|Antacids|antacids|mesh-ancestor
153675917|NCT00059826|Interferons|interferons|mesh-list
153676115|NCT00060489|Quetiapine Fumarate|quetiapine fumarate|mesh-list
153676327|NCT00033449|Gefitinib|gefitinib|mesh-list
153676436|NCT00061503|Travoprost|travoprost|mesh-list
153676717|NCT00062205|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153676952|NCT00036101|Dopamine Agents|dopamine agents|mesh-ancestor
153677055|NCT00063687|Oxypurinol|oxypurinol|mesh-list
153677642|NCT00070278|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153677839|NCT00066846|Antidotes|antidotes|mesh-ancestor
153677914|NCT00399165|Dutasteride|dutasteride|mesh-list
153678047|NCT00067860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153678174|NCT00038519|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
153678408|NCT00203905|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153678507|NCT00204529|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153678529|NCT00072150|Bortezomib|bortezomib|mesh-list
153678643|NCT00072462|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
153678660|NCT00205738|Olanzapine|olanzapine|mesh-list
153678781|NCT00072618|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153679134|NCT00040586|Interleukin-2|interleukin-2|mesh-list
153679756|NCT00210457|Lanreotide|lanreotide|mesh-list
153680136|NCT00069459|Bupropion|bupropion|mesh-list
153680568|NCT00217243|Anesthetics|anesthetics|mesh-ancestor
153681217|NCT00397319|Hormones|hormones|mesh-list
153681251|NCT00123175|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153681552|NCT00043277|Anticoagulants|anticoagulants|mesh-ancestor
153681770|NCT00402493|Ibuprofen|ibuprofen|mesh-list
153682291|NCT00044486|Posaconazole|posaconazole|mesh-list
153683089|NCT00131053|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153683090|NCT00131053|Immunologic Factors|immunologic factors|mesh-ancestor
153683091|NCT00131053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153683092|NCT00131053|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153683093|NCT00131053|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153814318|NCT00338468|Hematinics|hematinics|mesh-ancestor
153814319|NCT00338507|Erdosteine|erdosteine|mesh-list
153814320|NCT00338507|Expectorants|expectorants|mesh-ancestor
153814321|NCT00338507|Respiratory System Agents|respiratory system agents|mesh-ancestor
153814322|NCT00445185|Vaccines|vaccines|mesh-list
153814323|NCT00445185|Immunologic Factors|immunologic factors|mesh-ancestor
153814324|NCT00445185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153814325|NCT00338546|Cocaine|cocaine|mesh-list
153814326|NCT00338546|Dexmedetomidine|dexmedetomidine|mesh-list
153814327|NCT00338546|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153814328|NCT00338546|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153814329|NCT00338546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153360773|NCT01368809|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153360774|NCT01368809|Narcotics|narcotics|mesh-ancestor
153360775|NCT01368809|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153360776|NCT01368809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153360777|NCT01368809|Analgesics|analgesics|mesh-ancestor
153360778|NCT01368809|Sensory System Agents|sensory system agents|mesh-ancestor
153360779|NCT01368809|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153360780|NCT01368809|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153360781|NCT01368809|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153360782|NCT01368809|Anesthetics, General|anesthetics, general|mesh-ancestor
153360783|NCT01368809|Anesthetics|anesthetics|mesh-ancestor
153360784|NCT01369745|Prednisone|prednisone|mesh-list
153360785|NCT01369745|Prednisolone|prednisolone|mesh-list
153437649|NCT00004274|Estrogens|estrogens|mesh-list
153814645|NCT00452907|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153814646|NCT00452907|Antiviral Agents|antiviral agents|mesh-ancestor
153896589|NCT01292837|Anticonvulsants|anticonvulsants|mesh-ancestor
153896590|NCT01292837|Nootropic Agents|nootropic agents|mesh-ancestor
153437859|NCT00384878|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153896691|NCT05569382|Verapamil|verapamil|mesh-list
153438000|NCT00005024|Cyclophosphamide|cyclophosphamide|mesh-list
153896748|NCT04319484|Lenvatinib|lenvatinib|mesh-list
153438018|NCT00005024|Antiemetics|antiemetics|mesh-ancestor
153896786|NCT01292057|Aripiprazole|aripiprazole|mesh-list
153896804|NCT01290887|Reslizumab|reslizumab|mesh-list
153438109|NCT00004442|Chenodeoxycholic Acid|chenodeoxycholic acid|mesh-list
153814683|NCT00453141|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153814684|NCT00453141|Glucocorticoids|glucocorticoids|mesh-ancestor
153814685|NCT00453141|Hormones|hormones|mesh-ancestor
153814686|NCT00453141|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153896899|NCT01287221|Riboflavin|riboflavin|mesh-list
153814687|NCT00453141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153917271|NCT00990249|Clofarabine|clofarabine|mesh-list
153917272|NCT00990249|Thymoglobulin|thymoglobulin|mesh-list
153917273|NCT00990249|Antilymphocyte Serum|antilymphocyte serum|mesh-list
153917274|NCT00990249|Alkylating Agents|alkylating agents|mesh-ancestor
153917275|NCT00990249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153917276|NCT00990249|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153917277|NCT00990249|Immunologic Factors|immunologic factors|mesh-ancestor
153917278|NCT00990249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153814693|NCT00421109|Histamine Antagonists|histamine antagonists|mesh-ancestor
153814694|NCT00421109|Histamine Agents|histamine agents|mesh-ancestor
153814695|NCT00421109|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153814696|NCT00421109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153814697|NCT00421109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153814698|NCT02273583|Cyclophosphamide|cyclophosphamide|mesh-list
153814699|NCT02273583|Methotrexate|methotrexate|mesh-list
153814700|NCT02273583|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153814701|NCT02273583|Immunologic Factors|immunologic factors|mesh-ancestor
153814702|NCT02273583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153917279|NCT00990249|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153438201|NCT00004496|Hormones|hormones|mesh-list
153814709|NCT02273583|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
153814710|NCT02273583|Abortifacient Agents|abortifacient agents|mesh-ancestor
153896971|NCT02860897|Estrogens|estrogens|mesh-ancestor
153814711|NCT02273583|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153814712|NCT02273583|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153814713|NCT02273583|Antimetabolites|antimetabolites|mesh-ancestor
153814714|NCT02273583|Dermatologic Agents|dermatologic agents|mesh-ancestor
153814715|NCT02273583|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153814716|NCT02273583|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153814717|NCT02273583|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153814718|NCT00446862|Losartan|losartan|mesh-list
153814719|NCT00446862|Enalapril|enalapril|mesh-list
153814722|NCT00446862|Enzyme Inhibitors|enzyme inhibitors|mesh-list
153814723|NCT00446862|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153814724|NCT00446862|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153814730|NCT00446901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153814731|NCT00446901|Protective Agents|protective agents|mesh-ancestor
153387547|NCT00000213|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
153897079|NCT00956293|Dermatologic Agents|dermatologic agents|mesh-ancestor
153814732|NCT00446901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153814734|NCT00446901|Micronutrients|micronutrients|mesh-ancestor
153897180|NCT02445391|Cisplatin|cisplatin|mesh-list
153438490|NCT00005576|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153438513|NCT04712929|Hormone Antagonists|hormone antagonists|mesh-ancestor
153814735|NCT00453375|Butylated Hydroxytoluene|butylated hydroxytoluene|mesh-list
153897293|NCT02857309|Diuretics|diuretics|mesh-ancestor
153917280|NCT00990249|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153917281|NCT00990249|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153917282|NCT00990249|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153917284|NCT02846545|Golimumab|golimumab|mesh-list
153466025|NCT05266716|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
153466027|NCT05266560|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153466028|NCT05266560|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153438580|NCT00004778|Antiemetics|antiemetics|mesh-ancestor
153438615|NCT00005624|Tacedinaline|tacedinaline|mesh-list
153897373|NCT02856685|Mitoxantrone|mitoxantrone|mesh-list
153814738|NCT00453375|Protective Agents|protective agents|mesh-ancestor
153814740|NCT00446940|Atorvastatin|atorvastatin|mesh-list
153814741|NCT00446940|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
153814742|NCT00446940|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153438734|NCT00005768|Estrogens|estrogens|mesh-list
153814743|NCT00446940|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153897498|NCT01232556|Alkylating Agents|alkylating agents|mesh-ancestor
153814745|NCT00446940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153438805|NCT05006677|Vitamin K|vitamin k|mesh-list
153438851|NCT04568876|Palmidrol|palmidrol|mesh-list
153897606|NCT01155063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153814746|NCT00446940|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153897670|NCT01228734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153897672|NCT01228734|Antidotes|antidotes|mesh-ancestor
153360218|NCT00802100|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
153814749|NCT00453414|Iloprost|iloprost|mesh-list
153439070|NCT04094701|Analgesics|analgesics|mesh-ancestor
153814750|NCT00453414|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153814751|NCT00453414|Vasodilator Agents|vasodilator agents|mesh-ancestor
153360220|NCT00802100|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
153814755|NCT00446979|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153814756|NCT00453453|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
153897854|NCT02860117|Anesthetics, General|anesthetics, general|mesh-ancestor
153814806|NCT00447213|Insulin Glargine|insulin glargine|mesh-list
153814807|NCT00447213|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153814808|NCT00447213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153814809|NCT00453648|Vitamin A|vitamin a|mesh-list
153814810|NCT00453648|Retinol palmitate|retinol palmitate|mesh-list
153814811|NCT00453648|Antioxidants|antioxidants|mesh-ancestor
153814812|NCT00453648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153814813|NCT00453648|Protective Agents|protective agents|mesh-ancestor
153814817|NCT00453648|Vitamins|vitamins|mesh-ancestor
153814948|NCT00344123|Antimetabolites|antimetabolites|mesh-ancestor
153814949|NCT00344123|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153814950|NCT00344123|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
153814951|NCT00344201|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
153814952|NCT00344201|Hemostatics|hemostatics|mesh-ancestor
153360225|NCT00802100|Cholinergic Agents|cholinergic agents|mesh-ancestor
153814953|NCT00344201|Coagulants|coagulants|mesh-ancestor
153814954|NCT00453960|Norethindrone|norethindrone|mesh-list
153814959|NCT00453960|Contraceptive Agents|contraceptive agents|mesh-ancestor
153466029|NCT05266560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153466030|NCT05266560|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153466031|NCT05266560|Anesthetics, General|anesthetics, general|mesh-ancestor
153466032|NCT05266560|Anesthetics|anesthetics|mesh-ancestor
153466033|NCT00147966|Rituximab|rituximab|mesh-list
153917285|NCT02846545|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
153894441|NCT01202409|Panitumumab|panitumumab|mesh-list
153917287|NCT02846545|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153917288|NCT02846545|Immunologic Factors|immunologic factors|mesh-ancestor
153814961|NCT00453960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153814962|NCT00453960|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
153814964|NCT00447681|Fezakinumab|fezakinumab|mesh-list
153814965|NCT00447681|Dermatologic Agents|dermatologic agents|mesh-ancestor
153360226|NCT00802100|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
153814969|NCT00447759|Naproxen|naproxen|mesh-list
153897971|NCT01147107|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153439274|NCT00003397|Etoposide|etoposide|mesh-list
153917289|NCT02846545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153917290|NCT04291755|Pembrolizumab|pembrolizumab|mesh-list
153917291|NCT04291755|Nivolumab|nivolumab|mesh-list
153917292|NCT04291755|Ipilimumab|ipilimumab|mesh-list
153917293|NCT04291755|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153917294|NCT04291755|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153917295|NCT04291755|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153917296|NCT04291755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153360227|NCT00809276|Cyclophosphamide|cyclophosphamide|mesh-list
153814972|NCT00447759|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153814973|NCT00447759|Analgesics|analgesics|mesh-ancestor
153814974|NCT00447759|Sensory System Agents|sensory system agents|mesh-ancestor
153814975|NCT00447759|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153814976|NCT00447759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153814977|NCT00447759|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153814978|NCT00447759|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153814979|NCT00447759|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153814980|NCT00447759|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153814981|NCT00447759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153814985|NCT00344513|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
153917297|NCT04292769|Decitabine|decitabine|mesh-list
153917298|NCT04292769|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153917299|NCT04292769|Antimetabolites|antimetabolites|mesh-ancestor
153917300|NCT04292769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153917301|NCT04292769|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153917302|NCT04292769|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153917303|NCT00640939|Diclofenac|diclofenac|mesh-list
153917304|NCT00640939|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153814986|NCT00344513|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
153814990|NCT00344513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153814992|NCT00344513|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153917305|NCT00640939|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153917306|NCT00640939|Analgesics|analgesics|mesh-ancestor
153917307|NCT00640939|Sensory System Agents|sensory system agents|mesh-ancestor
153917308|NCT00640939|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153917309|NCT00640939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153917310|NCT00640939|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153917311|NCT00640939|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153917312|NCT00640939|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153917313|NCT00640939|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153917314|NCT00640939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153917315|NCT05663749|Metformin|metformin|mesh-list
153917316|NCT05663749|Topiramate|topiramate|mesh-list
153917317|NCT05663749|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153917318|NCT05663749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153814994|NCT00344513|Protective Agents|protective agents|mesh-ancestor
153917319|NCT05663749|Anticonvulsants|anticonvulsants|mesh-ancestor
153917320|NCT02867553|Rituximab|rituximab|mesh-list
153917321|NCT02867553|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153917322|NCT02867553|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153917323|NCT02867553|Immunologic Factors|immunologic factors|mesh-ancestor
153917324|NCT02867553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153917326|NCT00909961|Zoledronic Acid|zoledronic acid|mesh-list
153814996|NCT00344513|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153439331|NCT00002989|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153815000|NCT00344513|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
153815003|NCT00344552|Paclitaxel|paclitaxel|mesh-list
153815005|NCT00344552|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153815007|NCT00344552|Antimitotic Agents|antimitotic agents|mesh-ancestor
153815010|NCT00447915|Vitamin D|vitamin d|mesh-list
153815011|NCT00447915|Cholecalciferol|cholecalciferol|mesh-list
153815012|NCT00447915|Ibandronic Acid|ibandronic acid|mesh-list
153815013|NCT00447915|Calcium|calcium|mesh-list
153815015|NCT00447915|Micronutrients|micronutrients|mesh-ancestor
153815016|NCT00447915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153815017|NCT00447915|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153815018|NCT00447915|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153815019|NCT00344669|Albendazole|albendazole|mesh-list
153815020|NCT00344669|Anthelmintics|anthelmintics|mesh-ancestor
153815021|NCT00344669|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153782028|NCT00259779|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153917327|NCT00909961|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153917328|NCT00909961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153917329|NCT00642577|Leucovorin|leucovorin|mesh-list
153917330|NCT00642577|Bevacizumab|bevacizumab|mesh-list
153917331|NCT00642577|Fluorouracil|fluorouracil|mesh-list
153917332|NCT00642577|Irinotecan|irinotecan|mesh-list
153917333|NCT00642577|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153782039|NCT00259779|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153782040|NCT00259779|Adrenergic Agents|adrenergic agents|mesh-ancestor
153782041|NCT00259779|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153917334|NCT00642577|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153917335|NCT00642577|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153917336|NCT00642577|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153917337|NCT00642577|Growth Substances|growth substances|mesh-ancestor
153917338|NCT00642577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153917339|NCT00642577|Growth Inhibitors|growth inhibitors|mesh-ancestor
153782042|NCT00259779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153360230|NCT00809276|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153782043|NCT02211079|Tolbutamide|tolbutamide|mesh-list
153782044|NCT02211079|Midazolam|midazolam|mesh-list
153782045|NCT02211079|Caffeine|caffeine|mesh-list
153782046|NCT02211079|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153360231|NCT00809276|Immunologic Factors|immunologic factors|mesh-ancestor
153782048|NCT02211079|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153782049|NCT02211079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153782050|NCT02211079|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153782051|NCT02211079|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153782052|NCT02211079|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153782053|NCT02211079|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153782054|NCT02211079|Anesthetics, General|anesthetics, general|mesh-ancestor
153782055|NCT02211079|Anesthetics|anesthetics|mesh-ancestor
153917340|NCT00642577|Antimetabolites|antimetabolites|mesh-ancestor
153435672|NCT00003416|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153917341|NCT00642577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153917342|NCT00642577|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153917343|NCT00642577|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153466085|NCT00324870|Immunologic Factors|immunologic factors|mesh-ancestor
153466086|NCT00324870|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
153466087|NCT00324870|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153466088|NCT00324870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153466093|NCT00151320|Immunologic Factors|immunologic factors|mesh-ancestor
153466094|NCT00151320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153466095|NCT00151320|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153917344|NCT00642577|Immunologic Factors|immunologic factors|mesh-ancestor
153917345|NCT00642577|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
153917346|NCT00642577|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153917347|NCT00642577|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153917348|NCT00642577|Antidotes|antidotes|mesh-ancestor
153917349|NCT00642577|Protective Agents|protective agents|mesh-ancestor
153917350|NCT00642577|Vitamin B Complex|vitamin b complex|mesh-ancestor
153917352|NCT00642577|Micronutrients|micronutrients|mesh-ancestor
153917353|NCT02682121|Metformin|metformin|mesh-list
153917354|NCT02682121|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153917355|NCT02682121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153917356|NCT02683603|Imipenem|imipenem|mesh-list
153917357|NCT02683603|Colistin|colistin|mesh-list
153917358|NCT02683603|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153782063|NCT02211079|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
153917359|NCT02683603|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153917360|NCT00641095|Cyclophosphamide|cyclophosphamide|mesh-list
153917361|NCT00641095|Rituximab|rituximab|mesh-list
153917362|NCT00641095|Fludarabine|fludarabine|mesh-list
153917363|NCT00641095|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153917364|NCT00641095|Immunologic Factors|immunologic factors|mesh-ancestor
153917365|NCT00641095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153917366|NCT00641095|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153917367|NCT00641095|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153917368|NCT00641095|Alkylating Agents|alkylating agents|mesh-ancestor
153894624|NCT01196091|Antimalarials|antimalarials|mesh-list
153782067|NCT00232622|Streptokinase|streptokinase|mesh-list
153782068|NCT00232622|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153782069|NCT00232622|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153782070|NCT00232622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153782071|NCT00232661|Tamoxifen|tamoxifen|mesh-list
153782072|NCT00232661|Anastrozole|anastrozole|mesh-list
153782073|NCT00232661|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
153815023|NCT00344669|Anticestodal Agents|anticestodal agents|mesh-ancestor
153782075|NCT00232661|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153782076|NCT00232661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153782077|NCT00232661|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153782078|NCT00232661|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153360232|NCT00809276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153815024|NCT00344669|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
153815026|NCT00344669|Tubulin Modulators|tubulin modulators|mesh-ancestor
153782079|NCT00232661|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
153815027|NCT00344669|Antimitotic Agents|antimitotic agents|mesh-ancestor
153782080|NCT00232661|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
153782081|NCT00232661|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153782082|NCT00232661|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
153782085|NCT00232661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153782086|NCT00267267|Atorvastatin|atorvastatin|mesh-list
153782087|NCT00267267|Simvastatin|simvastatin|mesh-list
153782088|NCT00267267|Ezetimibe|ezetimibe|mesh-list
153782089|NCT00267267|Ezetimibe, Simvastatin Drug Combination|ezetimibe, simvastatin drug combination|mesh-list
153782090|NCT00267267|Torcetrapib|torcetrapib|mesh-list
153782094|NCT00267267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153782095|NCT00267267|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153782096|NCT00267267|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
153782097|NCT00267267|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153782098|NCT04564690|Vitamin E|vitamin e|mesh-list
153782099|NCT04564690|Selenium|selenium|mesh-list
153782100|NCT04564690|Vitamins|vitamins|mesh-ancestor
153917369|NCT00641095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153782101|NCT04564690|Micronutrients|micronutrients|mesh-ancestor
153917370|NCT00641095|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153917371|NCT00641095|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153917372|NCT00641095|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153917373|NCT01196975|Vaccines|vaccines|mesh-list
153917374|NCT01196975|Immunologic Factors|immunologic factors|mesh-ancestor
153917375|NCT01196975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153917376|NCT00992589|Rabeprazole|rabeprazole|mesh-list
153917377|NCT00992589|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
153917378|NCT00992589|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153917379|NCT00992589|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
153917380|NCT00992589|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153917381|NCT00992589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153917382|NCT01196741|Paclitaxel|paclitaxel|mesh-list
153917383|NCT01196741|Saracatinib|saracatinib|mesh-list
153917384|NCT01196741|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153917385|NCT01196741|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153917386|NCT01196741|Tubulin Modulators|tubulin modulators|mesh-ancestor
153917387|NCT01196741|Antimitotic Agents|antimitotic agents|mesh-ancestor
153917388|NCT01196741|Mitosis Modulators|mitosis modulators|mesh-ancestor
153782102|NCT04564690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153387550|NCT00000213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153782103|NCT04564690|Antioxidants|antioxidants|mesh-ancestor
153815028|NCT00344669|Mitosis Modulators|mitosis modulators|mesh-ancestor
153387569|NCT00000225|Buprenorphine|buprenorphine|mesh-list
153782105|NCT04564690|Protective Agents|protective agents|mesh-ancestor
153782106|NCT04564690|Trace Elements|trace elements|mesh-ancestor
153387570|NCT00000225|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153782108|NCT00232700|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
153782110|NCT00232700|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153782111|NCT00232700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153782113|NCT00232700|Serotonin Agents|serotonin agents|mesh-ancestor
153782115|NCT04564456|Fluticasone|fluticasone|mesh-list
153782117|NCT04564456|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
153782118|NCT04564456|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
153782120|NCT04564456|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153782123|NCT04564456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153782124|NCT04564456|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153782125|NCT04564456|Respiratory System Agents|respiratory system agents|mesh-ancestor
153782126|NCT04564456|Dermatologic Agents|dermatologic agents|mesh-ancestor
153782127|NCT04564456|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
153439374|NCT00003001|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153439375|NCT00003001|Immunologic Factors|immunologic factors|mesh-ancestor
153917389|NCT01196741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153917390|NCT01196741|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153917391|NCT00629187|Temozolomide|temozolomide|mesh-list
153917392|NCT00629187|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153917393|NCT00629187|Alkylating Agents|alkylating agents|mesh-ancestor
153917394|NCT00629187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153917395|NCT00629187|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153466096|NCT00328770|Sirolimus|sirolimus|mesh-list
153917396|NCT04291287|Fibrinolytic Agents|fibrinolytic agents|mesh-list
153917397|NCT04291287|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153917398|NCT04291287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153917399|NCT00983385|Tapentadol|tapentadol|mesh-list
153917400|NCT00983385|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153917401|NCT00983385|Narcotics|narcotics|mesh-ancestor
153917402|NCT00983385|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153917403|NCT00983385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153917405|NCT00983385|Sensory System Agents|sensory system agents|mesh-ancestor
153782131|NCT04564456|Adrenergic Agents|adrenergic agents|mesh-ancestor
153782132|NCT04564456|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153782133|NCT04564456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153917406|NCT00983385|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153917407|NCT00983385|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
153466148|NCT00338988|Antimetabolites|antimetabolites|mesh-ancestor
153466149|NCT00338988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153466150|NCT00338988|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153917439|NCT04290819|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
153917440|NCT04290819|Purinergic Agents|purinergic agents|mesh-ancestor
153917441|NCT04290819|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153917442|NCT01196429|Sirolimus|sirolimus|mesh-list
153917443|NCT01196429|Paclitaxel|paclitaxel|mesh-list
153917444|NCT01196429|Docetaxel|docetaxel|mesh-list
153917445|NCT01196429|Carboplatin|carboplatin|mesh-list
153917446|NCT01196429|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
153917447|NCT01196429|Temsirolimus|temsirolimus|mesh-list
153917448|NCT01196429|MTOR Inhibitors|mtor inhibitors|mesh-list
153917449|NCT01196429|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153917450|NCT01196429|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153782136|NCT04564456|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153782137|NCT04564456|Sympathomimetics|sympathomimetics|mesh-ancestor
153782138|NCT04564144|Meclizine|meclizine|mesh-list
153917451|NCT01196429|Tubulin Modulators|tubulin modulators|mesh-ancestor
153917452|NCT01196429|Antimitotic Agents|antimitotic agents|mesh-ancestor
153917453|NCT01196429|Mitosis Modulators|mitosis modulators|mesh-ancestor
153917454|NCT01196429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153917455|NCT01196429|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153917456|NCT01196429|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153917457|NCT01196429|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153466219|NCT00350532|Sensory System Agents|sensory system agents|mesh-ancestor
153466220|NCT00350532|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153466221|NCT00350532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153466222|NCT00350532|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153466223|NCT00350532|Sympatholytics|sympatholytics|mesh-ancestor
153466224|NCT00350532|Autonomic Agents|autonomic agents|mesh-ancestor
153782140|NCT04564144|Autonomic Agents|autonomic agents|mesh-ancestor
153782141|NCT04564144|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153436038|NCT00003212|Doxorubicin|doxorubicin|mesh-list
153466225|NCT00350532|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
153917482|NCT01195103|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153917483|NCT01195103|Anesthetics, General|anesthetics, general|mesh-ancestor
153917485|NCT01195103|GABA Modulators|gaba modulators|mesh-ancestor
153917486|NCT01195103|GABA Agents|gaba agents|mesh-ancestor
153917487|NCT01195103|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153917488|NCT01195103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153917489|NCT01195103|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153782142|NCT04564144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153917490|NCT01195103|Narcotics|narcotics|mesh-ancestor
153917491|NCT01195103|Analgesics|analgesics|mesh-ancestor
153917492|NCT01195103|Sensory System Agents|sensory system agents|mesh-ancestor
153917493|NCT01195103|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153917494|NCT01194869|Paclitaxel|paclitaxel|mesh-list
153917495|NCT01194869|Cisplatin|cisplatin|mesh-list
153917496|NCT01194869|Sorafenib|sorafenib|mesh-list
153436096|NCT00003950|Cyclosporine|cyclosporine|mesh-list
153917509|NCT01177800|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153917510|NCT01177800|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153917511|NCT01177722|Vaccines|vaccines|mesh-list
153917512|NCT01177722|Immunologic Factors|immunologic factors|mesh-ancestor
153917513|NCT01177722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153917514|NCT02884986|Etoricoxib|etoricoxib|mesh-list
153917515|NCT02884986|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153917516|NCT02884986|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153917517|NCT02884986|Analgesics|analgesics|mesh-ancestor
153917518|NCT02884986|Sensory System Agents|sensory system agents|mesh-ancestor
153917519|NCT02884986|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153917520|NCT02884986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153917521|NCT02884986|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153917522|NCT02884986|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153466259|NCT00351936|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
153466261|NCT00352794|Prednisone|prednisone|mesh-list
153466262|NCT00352794|Lenalidomide|lenalidomide|mesh-list
153466263|NCT00352794|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153466264|NCT00352794|Glucocorticoids|glucocorticoids|mesh-ancestor
153466265|NCT00352794|Hormones|hormones|mesh-ancestor
153466266|NCT00352794|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153466267|NCT00352794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153466268|NCT00352794|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153466269|NCT00352794|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153466270|NCT00352794|Immunologic Factors|immunologic factors|mesh-ancestor
153466271|NCT00352794|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153466272|NCT00352794|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153466273|NCT00352794|Growth Substances|growth substances|mesh-ancestor
153917538|NCT01177410|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153917540|NCT01177410|Analgesics|analgesics|mesh-ancestor
153917541|NCT01177410|Sensory System Agents|sensory system agents|mesh-ancestor
153917542|NCT01177410|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153917543|NCT01177410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153917544|NCT01177410|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153895059|NCT05926895|Prilocaine|prilocaine|mesh-list
153917545|NCT01177410|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153917546|NCT02884596|Serotonin|serotonin|mesh-list
153917547|NCT02884596|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-list
153917548|NCT02884596|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
153917549|NCT02884596|Serotonin Agents|serotonin agents|mesh-ancestor
153917550|NCT02884596|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153782144|NCT04564144|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
153917551|NCT02884596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153917569|NCT04205916|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153917570|NCT04205916|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153917571|NCT04205916|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153917572|NCT04205916|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153917573|NCT04205916|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153917574|NCT04205916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153917575|NCT04205916|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153917576|NCT04205916|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153917577|NCT04205916|Analgesics|analgesics|mesh-ancestor
153917578|NCT04205916|Sensory System Agents|sensory system agents|mesh-ancestor
153917579|NCT04205916|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153466317|NCT01794078|Respiratory System Agents|respiratory system agents|mesh-ancestor
153466318|NCT01794078|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
153466319|NCT01794078|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153466320|NCT01794078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153466321|NCT01794078|Vasodilator Agents|vasodilator agents|mesh-ancestor
153466322|NCT01794078|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
153466323|NCT01794078|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
153466324|NCT01794078|Purinergic Agents|purinergic agents|mesh-ancestor
153466325|NCT01794078|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153782147|NCT04564144|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153917599|NCT02867397|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153917600|NCT02867397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153917601|NCT01175382|Tamsulosin|tamsulosin|mesh-list
153917602|NCT01175382|Tolterodine Tartrate|tolterodine tartrate|mesh-list
153917603|NCT01175382|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
153917604|NCT01175382|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
153917605|NCT01175382|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
153917606|NCT01175382|Adrenergic Agents|adrenergic agents|mesh-ancestor
153917607|NCT01175382|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153917608|NCT01175382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153917609|NCT01175382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153917610|NCT01175382|Urological Agents|urological agents|mesh-ancestor
153917611|NCT01175382|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
153917612|NCT01175382|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
153917623|NCT00979407|Immunologic Factors|immunologic factors|mesh-ancestor
153917624|NCT00979407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153917626|NCT00975975|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153917627|NCT00975975|Immunologic Factors|immunologic factors|mesh-ancestor
153917628|NCT00975975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153917629|NCT01193153|Paliperidone Palmitate|paliperidone palmitate|mesh-list
153917630|NCT01193153|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153917631|NCT01193153|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153917632|NCT01193153|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153917633|NCT01193153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153917634|NCT01193153|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153917635|NCT01193153|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
153917636|NCT01193153|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153917638|NCT01193153|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153917639|NCT01193153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153917640|NCT01193153|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
153917641|NCT01193153|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
153917642|NCT01193153|Dopamine Agents|dopamine agents|mesh-ancestor
153917643|NCT02867007|Mogamulizumab|mogamulizumab|mesh-list
153917644|NCT02867007|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153917645|NCT04289883|Calcium|calcium|mesh-list
153917646|NCT04289883|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153466383|NCT03984240|GABA Agents|gaba agents|mesh-ancestor
153466384|NCT00359736|Sildenafil Citrate|sildenafil citrate|mesh-list
153466385|NCT00359736|Vasodilator Agents|vasodilator agents|mesh-ancestor
153466386|NCT00359736|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
153466387|NCT00359736|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
153466388|NCT00359736|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153466395|NCT00360126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153466396|NCT00360126|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153466397|NCT00360126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153466398|NCT00360126|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153466399|NCT00360126|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153466400|NCT00360126|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153466401|NCT00360126|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153466402|NCT00360126|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153466403|NCT00360360|Paclitaxel|paclitaxel|mesh-list
153466404|NCT00360360|Bevacizumab|bevacizumab|mesh-list
153466405|NCT00360360|Carboplatin|carboplatin|mesh-list
153466406|NCT00360360|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
153466407|NCT00360360|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153466408|NCT00360360|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153466409|NCT00360360|Tubulin Modulators|tubulin modulators|mesh-ancestor
153466410|NCT00360360|Antimitotic Agents|antimitotic agents|mesh-ancestor
153466411|NCT00360360|Mitosis Modulators|mitosis modulators|mesh-ancestor
153466412|NCT00360360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153466413|NCT00360360|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153466414|NCT00360360|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153466415|NCT00360360|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153466417|NCT00360360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153466418|NCT00360360|Growth Inhibitors|growth inhibitors|mesh-ancestor
153917647|NCT04289883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153917648|NCT02865369|Asunaprevir|asunaprevir|mesh-list
153782148|NCT04564144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153917649|NCT02865369|Protease Inhibitors|protease inhibitors|mesh-ancestor
153917650|NCT02865369|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153917651|NCT02865369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153917652|NCT01192295|Oxycodone|oxycodone|mesh-list
153917653|NCT01192295|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153917654|NCT01192295|Narcotics|narcotics|mesh-ancestor
153436590|NCT00004064|Oregovomab|oregovomab|mesh-list
153917655|NCT01192295|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153917656|NCT01192295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153917657|NCT01192295|Analgesics|analgesics|mesh-ancestor
153917658|NCT01192295|Sensory System Agents|sensory system agents|mesh-ancestor
153917659|NCT01192295|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153917660|NCT04289103|Inolimomab|inolimomab|mesh-list
153917661|NCT04289103|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153917662|NCT04289103|Immunologic Factors|immunologic factors|mesh-ancestor
153917663|NCT04289103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153917664|NCT01154166|Ropinirole|ropinirole|mesh-list
153917670|NCT01154166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153782149|NCT04564144|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
153782150|NCT04564144|Cholinergic Agents|cholinergic agents|mesh-ancestor
153917671|NCT01154166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153917673|NCT04290195|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153917674|NCT04290195|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153917675|NCT04290195|Growth Substances|growth substances|mesh-ancestor
153917676|NCT04290195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153917677|NCT04290195|Growth Inhibitors|growth inhibitors|mesh-ancestor
153387575|NCT00000225|Sensory System Agents|sensory system agents|mesh-ancestor
153917678|NCT04290195|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153895577|NCT01908777|Cytarabine|cytarabine|mesh-list
153917679|NCT05656703|Anesthetics|anesthetics|mesh-list
153917680|NCT05656703|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153917681|NCT05656703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153917682|NCT05656079|Cyclophosphamide|cyclophosphamide|mesh-list
153917683|NCT05656079|Docetaxel|docetaxel|mesh-list
153466419|NCT00360360|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153466420|NCT00360360|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153466421|NCT00360360|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153466422|NCT01552590|Tolvaptan|tolvaptan|mesh-list
153466424|NCT01552590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153466425|NCT01552590|Natriuretic Agents|natriuretic agents|mesh-ancestor
153466426|NCT01552590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153466428|NCT00549978|Probucol|probucol|mesh-list
153466429|NCT00549978|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153466430|NCT00549978|Autonomic Agents|autonomic agents|mesh-ancestor
153466431|NCT00549978|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153466432|NCT00549978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153917684|NCT05656079|Doxorubicin|doxorubicin|mesh-list
153917685|NCT05656079|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
153917686|NCT05656079|Trastuzumab|trastuzumab|mesh-list
153917687|NCT05656079|Epirubicin|epirubicin|mesh-list
153917688|NCT05656079|Pertuzumab|pertuzumab|mesh-list
153917689|NCT05656079|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153917690|NCT05656079|Immunologic Factors|immunologic factors|mesh-ancestor
153917691|NCT05656079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153917692|NCT05656079|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153917693|NCT05656079|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153917694|NCT05656079|Alkylating Agents|alkylating agents|mesh-ancestor
153917695|NCT05656079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153387576|NCT00000225|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153917696|NCT05656079|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153917697|NCT05656079|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153917698|NCT05656079|Tubulin Modulators|tubulin modulators|mesh-ancestor
153917703|NCT05656079|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153917704|NCT05656079|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153917705|NCT05656079|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153917706|NCT01181921|Galantamine|galantamine|mesh-list
153917707|NCT01181921|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
153917708|NCT01181921|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153917709|NCT01181921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153917710|NCT01181921|Cholinergic Agents|cholinergic agents|mesh-ancestor
153917711|NCT01181921|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153782153|NCT00267306|Immunologic Factors|immunologic factors|mesh-ancestor
153917712|NCT01181921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153917713|NCT01181921|Parasympathomimetics|parasympathomimetics|mesh-ancestor
153917714|NCT01181921|Autonomic Agents|autonomic agents|mesh-ancestor
153917715|NCT01181921|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153917716|NCT01181921|Nootropic Agents|nootropic agents|mesh-ancestor
153917717|NCT00932698|Ixazomib|ixazomib|mesh-list
153917718|NCT00932698|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153917719|NCT00932698|Protease Inhibitors|protease inhibitors|mesh-ancestor
153917720|NCT00932698|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153917721|NCT00932698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153917722|NCT00978627|Insulin|insulin|mesh-list
153917723|NCT00978627|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
153917724|NCT00978627|Insulin Aspart|insulin aspart|mesh-list
153917725|NCT00978627|Insulin, Long-Acting|insulin, long-acting|mesh-list
153782154|NCT00267306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153387577|NCT00000225|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
153917726|NCT00978627|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
153917727|NCT00978627|Insulin Detemir|insulin detemir|mesh-list
153917728|NCT00978627|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153917729|NCT00978627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153917730|NCT01181609|Bevacizumab|bevacizumab|mesh-list
153917731|NCT01181609|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153917732|NCT01181609|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153782156|NCT00259896|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
153782157|NCT00259896|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153917733|NCT01181609|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153917734|NCT01181609|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153917735|NCT01181609|Growth Substances|growth substances|mesh-ancestor
153917736|NCT01181609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153917737|NCT01181609|Growth Inhibitors|growth inhibitors|mesh-ancestor
153917738|NCT04261426|Immunoglobulins|immunoglobulins|mesh-list
153917739|NCT04261426|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
153917740|NCT04261426|Antibodies|antibodies|mesh-list
153917741|NCT04261426|gamma-Globulins|gamma-globulins|mesh-list
153917742|NCT04261426|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
153917743|NCT04261426|Immunologic Factors|immunologic factors|mesh-ancestor
153917744|NCT04261426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153917745|NCT04264078|Fludarabine|fludarabine|mesh-list
153466481|NCT00361140|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153782158|NCT00259896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153782159|NCT00259896|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
153466482|NCT00361140|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153917751|NCT04264078|Immunologic Factors|immunologic factors|mesh-ancestor
153917752|NCT04264078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153917753|NCT04264078|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153917755|NCT04264078|Alkylating Agents|alkylating agents|mesh-ancestor
153917756|NCT04264078|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153917757|NCT00608218|Ciclesonide|ciclesonide|mesh-list
153466502|NCT00305682|Antilymphocyte Serum|antilymphocyte serum|mesh-list
153917778|NCT01147926|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153917779|NCT01147926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153917780|NCT01147926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153917781|NCT05115136|Diphenhydramine|diphenhydramine|mesh-list
153917782|NCT05115136|Promethazine|promethazine|mesh-list
153387578|NCT02294604|Chlorhexidine|chlorhexidine|mesh-list
153917783|NCT05115136|Doxepin|doxepin|mesh-list
153917797|NCT05115136|Histamine Agents|histamine agents|mesh-ancestor
153466533|NCT00309738|Pitavastatin|pitavastatin|mesh-list
153466534|NCT00309738|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153466535|NCT00309738|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153466536|NCT00309738|Antimetabolites|antimetabolites|mesh-ancestor
153466537|NCT00309738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153466538|NCT00309738|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153466539|NCT00309738|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
153466540|NCT00309738|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153466541|NCT00310050|Pemetrexed|pemetrexed|mesh-list
153466542|NCT00310050|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153466543|NCT00310050|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153466544|NCT00310050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153466545|NCT00310050|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153466546|NCT00310050|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153466547|NCT00363168|Ranibizumab|ranibizumab|mesh-list
153466548|NCT00363168|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153466549|NCT00363168|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153917798|NCT05115136|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153782160|NCT00259896|Incretins|incretins|mesh-ancestor
153782161|NCT00259896|Hormones|hormones|mesh-ancestor
153917799|NCT05115136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153917800|NCT05115136|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
153917801|NCT05115136|Antipruritics|antipruritics|mesh-ancestor
153917802|NCT05115136|Dermatologic Agents|dermatologic agents|mesh-ancestor
153917803|NCT05115136|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
153917804|NCT05115136|Antidepressive Agents|antidepressive agents|mesh-ancestor
153917805|NCT05115136|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153917806|NCT00608374|Fludarabine|fludarabine|mesh-list
153917815|NCT00608374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153917816|NCT00608374|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153917818|NCT00625014|Haloperidol|haloperidol|mesh-list
153917819|NCT00625014|Haloperidol decanoate|haloperidol decanoate|mesh-list
153917820|NCT00625014|Antiemetics|antiemetics|mesh-ancestor
153917821|NCT00625014|Autonomic Agents|autonomic agents|mesh-ancestor
153917822|NCT00625014|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153917823|NCT00625014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153917824|NCT00625014|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153917825|NCT00625014|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153917826|NCT00625014|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153917827|NCT00625014|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153917828|NCT00625014|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153917829|NCT00625014|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
153917830|NCT00625014|Dopamine Agents|dopamine agents|mesh-ancestor
153917831|NCT00625014|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153917832|NCT00625014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153917833|NCT00625014|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
153917834|NCT01147848|Fluticasone|fluticasone|mesh-list
153917835|NCT01147848|Xhance|xhance|mesh-list
153917836|NCT01147848|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
153917837|NCT01147848|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153917838|NCT01147848|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153917839|NCT01147848|Autonomic Agents|autonomic agents|mesh-ancestor
153917840|NCT01147848|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153782162|NCT00259896|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153782163|NCT04675021|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
153917841|NCT01147848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153917842|NCT01147848|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153917843|NCT01147848|Respiratory System Agents|respiratory system agents|mesh-ancestor
153917844|NCT01147848|Dermatologic Agents|dermatologic agents|mesh-ancestor
153917845|NCT01147848|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
153917846|NCT01147848|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
153917848|NCT01147848|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153917849|NCT01147848|Adrenergic Agents|adrenergic agents|mesh-ancestor
153917850|NCT01147848|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153917851|NCT01147848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153917852|NCT04261270|Ritonavir|ritonavir|mesh-list
153466589|NCT00311376|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153466590|NCT00311376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153782164|NCT00232817|Nicotine|nicotine|mesh-list
153466592|NCT00311376|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153917866|NCT01152996|Antidepressive Agents|antidepressive agents|mesh-ancestor
153917868|NCT01152996|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153917869|NCT01152996|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153917870|NCT01152996|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153917871|NCT01152996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153917872|NCT01152996|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
153917873|NCT01152996|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153917874|NCT01152996|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153917875|NCT01152996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153917876|NCT01152996|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153917877|NCT01152996|Serotonin Agents|serotonin agents|mesh-ancestor
153917878|NCT01152996|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
153917879|NCT01152996|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
153917880|NCT01152996|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
153917881|NCT01152996|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153917884|NCT00624936|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153917885|NCT00624936|Antimetabolites|antimetabolites|mesh-ancestor
153917886|NCT00624936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153917887|NCT00624936|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153917888|NCT00624936|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153917889|NCT00979953|Oxycodone|oxycodone|mesh-list
153917890|NCT00979953|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153917891|NCT00979953|Narcotics|narcotics|mesh-ancestor
153917892|NCT00979953|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153917893|NCT00979953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153917895|NCT00979953|Sensory System Agents|sensory system agents|mesh-ancestor
153917896|NCT00979953|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153782165|NCT00232817|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
153782166|NCT00232817|Autonomic Agents|autonomic agents|mesh-ancestor
153782167|NCT00232817|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153917897|NCT01181531|Vitamin D|vitamin d|mesh-list
153917898|NCT01181531|Cinacalcet|cinacalcet|mesh-list
153917899|NCT01181531|Vitamins|vitamins|mesh-ancestor
153917900|NCT01181531|Micronutrients|micronutrients|mesh-ancestor
153917901|NCT01181531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153917902|NCT01181531|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153917903|NCT01181531|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153917904|NCT01181531|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
153917905|NCT01181531|Hormone Antagonists|hormone antagonists|mesh-ancestor
153917906|NCT01181531|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153917907|NCT01152450|Tiotropium Bromide|tiotropium bromide|mesh-list
153917908|NCT01152450|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153917909|NCT01152450|Autonomic Agents|autonomic agents|mesh-ancestor
153917910|NCT01152450|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153917911|NCT01152450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153917912|NCT01152450|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153917913|NCT01152450|Respiratory System Agents|respiratory system agents|mesh-ancestor
153917914|NCT01152450|Parasympatholytics|parasympatholytics|mesh-ancestor
153917915|NCT01152450|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
153917916|NCT01152450|Cholinergic Agents|cholinergic agents|mesh-ancestor
153466652|NCT00321594|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153466653|NCT00321594|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
153466654|NCT00321594|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153466655|NCT00321594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153466656|NCT04751136|Cerebrolysin|cerebrolysin|mesh-list
153466657|NCT04751136|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
153466658|NCT04751136|Protective Agents|protective agents|mesh-ancestor
153782169|NCT00232817|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
153782170|NCT00232817|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
153782171|NCT00232817|Cholinergic Agents|cholinergic agents|mesh-ancestor
153466659|NCT04751136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153466660|NCT04751136|Nootropic Agents|nootropic agents|mesh-ancestor
153437506|NCT00004244|Antiviral Agents|antiviral agents|mesh-ancestor
153466661|NCT00390234|Aflibercept|aflibercept|mesh-list
153466662|NCT00390234|Endothelial Growth Factors|endothelial growth factors|mesh-list
153917924|NCT01181141|Enoxaparin|enoxaparin|mesh-list
153917925|NCT01181141|Enoxaparin sodium|enoxaparin sodium|mesh-list
153917926|NCT01181141|Edoxaban|edoxaban|mesh-list
153917927|NCT01181141|Anticoagulants|anticoagulants|mesh-ancestor
153917928|NCT01181141|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153917929|NCT01181141|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153917930|NCT01181141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153917931|NCT01181141|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
153917932|NCT01181141|Antithrombins|antithrombins|mesh-ancestor
153917933|NCT01181141|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
153917935|NCT01181141|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153917936|NCT00606814|Docetaxel|docetaxel|mesh-list
153917937|NCT00606814|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153917938|NCT00606814|Tubulin Modulators|tubulin modulators|mesh-ancestor
153917939|NCT00606814|Antimitotic Agents|antimitotic agents|mesh-ancestor
153917940|NCT00606814|Mitosis Modulators|mitosis modulators|mesh-ancestor
153917941|NCT00606814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153917942|NCT01173120|Abatacept|abatacept|mesh-list
153917943|NCT01173120|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153917944|NCT01173120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153917945|NCT01173120|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153917946|NCT01173120|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153917947|NCT01173120|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153917948|NCT01173120|Immunologic Factors|immunologic factors|mesh-ancestor
153917949|NCT01173120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153917950|NCT01173120|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153917951|NCT00977379|Capecitabine|capecitabine|mesh-list
153917971|NCT04263844|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153917972|NCT04263844|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153917973|NCT04263844|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153917974|NCT04263844|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153917975|NCT04263844|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153917976|NCT04263844|Anesthetics, General|anesthetics, general|mesh-ancestor
153782172|NCT00232817|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153466713|NCT00393978|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153466714|NCT00393978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153466715|NCT00393978|Anticonvulsants|anticonvulsants|mesh-ancestor
153466716|NCT00393978|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153466717|NCT00396006|Protease Inhibitors|protease inhibitors|mesh-list
153466718|NCT00396006|Alpha 1-Antitrypsin|alpha 1-antitrypsin|mesh-list
153918012|NCT00629343|Alkylating Agents|alkylating agents|mesh-ancestor
153918013|NCT01180049|Sirolimus|sirolimus|mesh-list
153918014|NCT01180049|Temsirolimus|temsirolimus|mesh-list
153918015|NCT01180049|MTOR Inhibitors|mtor inhibitors|mesh-list
153918016|NCT01180049|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153918017|NCT01180049|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153918018|NCT01180049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153918019|NCT01180049|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153918020|NCT01180049|Immunologic Factors|immunologic factors|mesh-ancestor
153918021|NCT01180049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153918022|NCT01180049|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153918023|NCT01180049|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153918024|NCT01180049|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153918025|NCT01180049|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153918039|NCT01147458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153918041|NCT01172808|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
153918042|NCT01172808|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153918043|NCT01172808|Autonomic Agents|autonomic agents|mesh-ancestor
153918044|NCT01172808|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153466780|NCT00401778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153466781|NCT00401778|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153466782|NCT00401778|Immunologic Factors|immunologic factors|mesh-ancestor
153466783|NCT00401778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153466784|NCT00401778|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153466785|NCT00402714|Pentostatin|pentostatin|mesh-list
153466786|NCT00402714|Methoxsalen|methoxsalen|mesh-list
153466787|NCT00402714|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153466788|NCT00402714|Adenosine Deaminase Inhibitors|adenosine deaminase inhibitors|mesh-ancestor
153466789|NCT00402714|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153466790|NCT00402714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153466791|NCT00402714|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
153466792|NCT00402714|Dermatologic Agents|dermatologic agents|mesh-ancestor
153466793|NCT00405288|Hydrocortisone|hydrocortisone|mesh-list
153918045|NCT01172808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153918046|NCT01172808|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153918062|NCT04315194|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
153918063|NCT04315194|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153918064|NCT04315194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153918065|NCT04315194|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
153918066|NCT04315194|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153918067|NCT04315194|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153918068|NCT04315194|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153918070|NCT04315194|Sensory System Agents|sensory system agents|mesh-ancestor
153918072|NCT04315194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153918073|NCT04315194|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153918074|NCT04315194|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153918075|NCT04315194|Gout Suppressants|gout suppressants|mesh-ancestor
153782173|NCT00232817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153782174|NCT00267384|Acetylcysteine|acetylcysteine|mesh-list
153918076|NCT04315194|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153918078|NCT01149486|Losartan|losartan|mesh-list
153918079|NCT01149486|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
153918089|NCT01149486|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153466794|NCT00405288|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
153918090|NCT00601705|Fluorouracil|fluorouracil|mesh-list
153918092|NCT00601705|Epirubicin|epirubicin|mesh-list
153918093|NCT00601705|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153918095|NCT00601705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153918096|NCT00601705|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153918097|NCT00601705|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153918098|NCT00601705|Immunologic Factors|immunologic factors|mesh-ancestor
153918099|NCT00601705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153918100|NCT00601705|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153918101|NCT00601705|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153466840|NCT00381810|Antipruritics|antipruritics|mesh-ancestor
153466841|NCT00381810|Dermatologic Agents|dermatologic agents|mesh-ancestor
153466842|NCT00458952|3-Iodobenzylguanidine|3-iodobenzylguanidine|mesh-list
153466843|NCT00458952|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153466844|NCT00458952|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153466845|NCT00458952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153918102|NCT00601705|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153918103|NCT00601705|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153918105|NCT01179737|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153918106|NCT01179737|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153918107|NCT01179737|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153918108|NCT01179737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153918122|NCT00641173|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153918123|NCT00929110|Glycopyrrolate|glycopyrrolate|mesh-list
153918124|NCT00929110|Bromides|bromides|mesh-list
153918125|NCT00929110|Tiotropium Bromide|tiotropium bromide|mesh-list
153918126|NCT00929110|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153918127|NCT00929110|Autonomic Agents|autonomic agents|mesh-ancestor
153918128|NCT00929110|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153918129|NCT00929110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153918130|NCT00929110|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153896717|NCT01285310|Thalidomide|thalidomide|mesh-list
153918131|NCT00929110|Respiratory System Agents|respiratory system agents|mesh-ancestor
153918132|NCT00929110|Parasympatholytics|parasympatholytics|mesh-ancestor
153918133|NCT00929110|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
153918134|NCT00929110|Cholinergic Agents|cholinergic agents|mesh-ancestor
153918135|NCT00929110|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153918136|NCT00929110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153918137|NCT00929110|Anticonvulsants|anticonvulsants|mesh-ancestor
153918138|NCT00929110|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153918139|NCT00929110|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
153918140|NCT00922519|Listerine|listerine|mesh-list
153918141|NCT00922519|Fluorides|fluorides|mesh-list
153918142|NCT00922519|Sodium Fluoride|sodium fluoride|mesh-list
153918143|NCT00922519|Cariostatic Agents|cariostatic agents|mesh-ancestor
153918144|NCT00922519|Protective Agents|protective agents|mesh-ancestor
153782175|NCT00267384|N-monoacetylcystine|n-monoacetylcystine|mesh-list
153782176|NCT00267384|Antiviral Agents|antiviral agents|mesh-ancestor
153918145|NCT00922519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153918146|NCT00922519|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
153918147|NCT00922519|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153918159|NCT02683369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153918165|NCT00640627|Celecoxib|celecoxib|mesh-list
153918166|NCT00640627|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153918167|NCT00640627|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153918168|NCT00640627|Analgesics|analgesics|mesh-ancestor
153918169|NCT00640627|Sensory System Agents|sensory system agents|mesh-ancestor
153466910|NCT00382590|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153466911|NCT00382824|Ubiquinone|ubiquinone|mesh-list
153466912|NCT00382824|Coenzyme Q10|coenzyme q10|mesh-list
153466913|NCT00382824|Micronutrients|micronutrients|mesh-ancestor
153466914|NCT00382824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153466915|NCT00382824|Vitamins|vitamins|mesh-ancestor
153466916|NCT00462072|Infliximab|infliximab|mesh-list
153466917|NCT00462072|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
153466918|NCT00462072|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153466920|NCT00462072|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153918170|NCT00640627|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153918171|NCT00640627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153918172|NCT00640627|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153918173|NCT00640627|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153918174|NCT00640627|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
153918175|NCT00640627|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153918176|NCT00640627|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153918177|NCT00640627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153918178|NCT02681887|Melatonin|melatonin|mesh-list
153918179|NCT02681887|Antioxidants|antioxidants|mesh-ancestor
153918180|NCT02681887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153918206|NCT01179347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153918207|NCT01146288|Furosemide|furosemide|mesh-list
153782179|NCT00267384|Respiratory System Agents|respiratory system agents|mesh-ancestor
153782180|NCT00267384|Free Radical Scavengers|free radical scavengers|mesh-ancestor
153918208|NCT01146288|Acetazolamide|acetazolamide|mesh-list
153918209|NCT01146288|Diuretics|diuretics|mesh-ancestor
153918214|NCT01146288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153918216|NCT01146288|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
153918217|NCT01146288|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153918221|NCT01146054|Antimetabolites|antimetabolites|mesh-ancestor
153918222|NCT01146054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153918223|NCT01146054|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153918224|NCT01146054|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
153918225|NCT00640705|Diclofenac|diclofenac|mesh-list
153918226|NCT00640705|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153918227|NCT00640705|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153918228|NCT00640705|Analgesics|analgesics|mesh-ancestor
153918229|NCT00640705|Sensory System Agents|sensory system agents|mesh-ancestor
153918230|NCT00640705|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153466974|NCT00410826|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153466976|NCT00410826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153438187|NCT00005066|Carmustine|carmustine|mesh-list
153466977|NCT00464646|Cyclophosphamide|cyclophosphamide|mesh-list
153782181|NCT00267384|Antioxidants|antioxidants|mesh-ancestor
153466978|NCT00464646|Bevacizumab|bevacizumab|mesh-list
153466979|NCT00464646|Docetaxel|docetaxel|mesh-list
153466980|NCT00464646|Trastuzumab|trastuzumab|mesh-list
153466981|NCT00464646|Epirubicin|epirubicin|mesh-list
153466982|NCT00464646|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153466983|NCT00464646|Immunologic Factors|immunologic factors|mesh-ancestor
153466984|NCT00464646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153466985|NCT00464646|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153466986|NCT00464646|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153466987|NCT00464646|Alkylating Agents|alkylating agents|mesh-ancestor
153466988|NCT00464646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153466989|NCT00464646|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153466990|NCT00464646|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153466991|NCT00464646|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153466992|NCT00464646|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153466993|NCT00464646|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153466994|NCT00464646|Growth Substances|growth substances|mesh-ancestor
153466995|NCT00464646|Growth Inhibitors|growth inhibitors|mesh-ancestor
153466996|NCT00464646|Tubulin Modulators|tubulin modulators|mesh-ancestor
153466997|NCT00464646|Antimitotic Agents|antimitotic agents|mesh-ancestor
153918231|NCT00640705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153918232|NCT00640705|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153918233|NCT00640705|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153918234|NCT00640705|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153897003|NCT04284007|Anesthetics|anesthetics|mesh-ancestor
153918235|NCT00640705|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153918236|NCT00640705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153918238|NCT01145898|Dorzolamide|dorzolamide|mesh-list
153918239|NCT01145898|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
153918240|NCT01145898|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
153918241|NCT01145898|Adrenergic Agents|adrenergic agents|mesh-ancestor
153918249|NCT02681653|Atorvastatin|atorvastatin|mesh-list
153918250|NCT02681653|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153918251|NCT02681653|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153918252|NCT02681653|Antimetabolites|antimetabolites|mesh-ancestor
153918253|NCT02681653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153918254|NCT02681653|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153466998|NCT00464646|Mitosis Modulators|mitosis modulators|mesh-ancestor
153918255|NCT02681653|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
153918256|NCT02681653|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153918257|NCT04315116|Loperamide|loperamide|mesh-list
153918258|NCT04315116|Antidiarrheals|antidiarrheals|mesh-list
153918259|NCT04315116|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153918260|NCT02883114|Itraconazole|itraconazole|mesh-list
153918261|NCT02883114|Antifungal Agents|antifungal agents|mesh-ancestor
153918262|NCT02883114|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153918269|NCT02883114|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153918270|NCT02883114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153918271|NCT02883114|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
153918272|NCT04183387|Simvastatin|simvastatin|mesh-list
153918273|NCT04183387|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153918274|NCT04183387|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153918275|NCT04183387|Antimetabolites|antimetabolites|mesh-ancestor
153918276|NCT04183387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153782182|NCT00267384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153782183|NCT00267384|Protective Agents|protective agents|mesh-ancestor
153918277|NCT04183387|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153467025|NCT00410904|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153467026|NCT00410904|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153467027|NCT00410904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153467028|NCT00410904|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153467029|NCT00410904|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153467030|NCT00410904|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153467032|NCT00385788|Methotrexate|methotrexate|mesh-list
153467033|NCT00385788|Fludarabine phosphate|fludarabine phosphate|mesh-list
153467034|NCT00385788|Fludarabine|fludarabine|mesh-list
153467035|NCT00385788|Melphalan|melphalan|mesh-list
153467036|NCT00385788|Tacrolimus|tacrolimus|mesh-list
153467037|NCT00385788|Thymoglobulin|thymoglobulin|mesh-list
153467046|NCT00385788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153918278|NCT04183387|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
153918279|NCT04183387|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153918280|NCT00625092|Leucovorin|leucovorin|mesh-list
153918281|NCT00625092|Fluorouracil|fluorouracil|mesh-list
153918282|NCT00625092|Oxaliplatin|oxaliplatin|mesh-list
153918283|NCT00625092|Calcium|calcium|mesh-list
153918284|NCT00625092|Levoleucovorin|levoleucovorin|mesh-list
153918285|NCT00625092|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153918286|NCT00625092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153918287|NCT00625092|Antimetabolites|antimetabolites|mesh-ancestor
153918288|NCT00625092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153782185|NCT00267384|Antidotes|antidotes|mesh-ancestor
153782186|NCT00259935|Topotecan|topotecan|mesh-list
153918289|NCT00625092|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153918290|NCT00625092|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153918291|NCT00625092|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153918292|NCT00625092|Immunologic Factors|immunologic factors|mesh-ancestor
153918293|NCT00625092|Antidotes|antidotes|mesh-ancestor
153918294|NCT00625092|Protective Agents|protective agents|mesh-ancestor
153918295|NCT00625092|Vitamin B Complex|vitamin b complex|mesh-ancestor
153918296|NCT00625092|Vitamins|vitamins|mesh-ancestor
153918297|NCT00625092|Micronutrients|micronutrients|mesh-ancestor
153918298|NCT00931918|Prednisone|prednisone|mesh-list
153918299|NCT00931918|Cyclophosphamide|cyclophosphamide|mesh-list
153918300|NCT00931918|Rituximab|rituximab|mesh-list
153918301|NCT00931918|Doxorubicin|doxorubicin|mesh-list
153918302|NCT00931918|Vincristine|vincristine|mesh-list
153918303|NCT00931918|Bortezomib|bortezomib|mesh-list
153918304|NCT00931918|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153467047|NCT00385788|Dermatologic Agents|dermatologic agents|mesh-ancestor
153467048|NCT00385788|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153918305|NCT00931918|Immunologic Factors|immunologic factors|mesh-ancestor
153918306|NCT00931918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153918307|NCT00931918|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153918308|NCT00931918|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153918311|NCT00931918|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153918312|NCT00931918|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153897271|NCT00955357|Lacosamide|lacosamide|mesh-list
153918314|NCT00931918|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153918315|NCT00931918|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153918316|NCT00931918|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153918317|NCT00931918|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153918318|NCT00931918|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153918319|NCT00931918|Glucocorticoids|glucocorticoids|mesh-ancestor
153782187|NCT00259935|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
153782188|NCT00259935|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153918320|NCT00931918|Hormones|hormones|mesh-ancestor
153918321|NCT00931918|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153918322|NCT00931918|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153918323|NCT00931918|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153918324|NCT00931918|Tubulin Modulators|tubulin modulators|mesh-ancestor
153438574|NCT00004826|GABA Agents|gaba agents|mesh-ancestor
153918325|NCT00931918|Antimitotic Agents|antimitotic agents|mesh-ancestor
153918328|NCT04183075|Ascorbic Acid|ascorbic acid|mesh-list
153918329|NCT04183075|Micronutrients|micronutrients|mesh-ancestor
153467078|NCT00412464|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153467079|NCT00412464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153467080|NCT00412464|Anticoagulants|anticoagulants|mesh-ancestor
153467081|NCT00412464|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153467082|NCT00412464|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153467083|NCT00466752|Sorafenib|sorafenib|mesh-list
153467084|NCT00466752|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153467085|NCT00466752|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153467086|NCT00466752|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153438613|NCT00005618|Arsenic Trioxide|arsenic trioxide|mesh-list
153467087|NCT00466752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153467088|NCT02115750|Etanercept|etanercept|mesh-list
153467089|NCT02115750|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153782191|NCT00259935|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153467090|NCT02115750|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153467091|NCT02115750|Analgesics|analgesics|mesh-ancestor
153467092|NCT02115750|Sensory System Agents|sensory system agents|mesh-ancestor
153467093|NCT02115750|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153467094|NCT02115750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153467095|NCT02115750|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153467096|NCT02115750|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153467097|NCT02115750|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153782192|NCT00232856|Sirolimus|sirolimus|mesh-list
153782193|NCT00232856|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153782194|NCT00232856|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153467098|NCT02115750|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153467099|NCT02115750|Immunologic Factors|immunologic factors|mesh-ancestor
153467100|NCT00413166|Idarubicin|idarubicin|mesh-list
153467101|NCT00413166|Tretinoin|tretinoin|mesh-list
153467102|NCT00413166|Arsenic Trioxide|arsenic trioxide|mesh-list
153467103|NCT00413166|Gemtuzumab|gemtuzumab|mesh-list
153467104|NCT00413166|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153918330|NCT04183075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153918331|NCT04183075|Antioxidants|antioxidants|mesh-ancestor
153918332|NCT04183075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153918333|NCT04183075|Protective Agents|protective agents|mesh-ancestor
153918334|NCT02679001|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-list
153918335|NCT02679001|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153918336|NCT02678221|Aspirin|aspirin|mesh-list
153918337|NCT02678221|Sildenafil Citrate|sildenafil citrate|mesh-list
153918338|NCT02678221|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153918339|NCT02678221|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153918340|NCT02678221|Analgesics|analgesics|mesh-ancestor
153918341|NCT02678221|Sensory System Agents|sensory system agents|mesh-ancestor
153918342|NCT02678221|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153918348|NCT02678221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153918349|NCT02678221|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153918350|NCT02678221|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153918351|NCT02678221|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153918352|NCT02678221|Antipyretics|antipyretics|mesh-ancestor
153918353|NCT02678221|Vasodilator Agents|vasodilator agents|mesh-ancestor
153918355|NCT02678221|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
153918356|NCT02678221|Urological Agents|urological agents|mesh-ancestor
153918358|NCT00641329|Analgesics|analgesics|mesh-ancestor
153918359|NCT00641329|Sensory System Agents|sensory system agents|mesh-ancestor
153782195|NCT00232856|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153918360|NCT00641329|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153918361|NCT00641329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153918362|NCT00641329|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153918365|NCT00641329|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
153918366|NCT00641329|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153918367|NCT00641329|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153918368|NCT00641329|Adrenergic Agents|adrenergic agents|mesh-ancestor
153918369|NCT00641329|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153918370|NCT00641329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153918371|NCT01179191|Naltrexone|naltrexone|mesh-list
153918372|NCT01179191|Morphine|morphine|mesh-list
153918373|NCT01179191|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153918374|NCT01179191|Narcotics|narcotics|mesh-ancestor
153918375|NCT01179191|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153918376|NCT01179191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153467127|NCT00413400|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153467128|NCT00413400|Immunologic Factors|immunologic factors|mesh-ancestor
153467129|NCT00413478|Azacitidine|azacitidine|mesh-list
153467130|NCT00413478|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153467131|NCT00413478|Antimetabolites|antimetabolites|mesh-ancestor
153467134|NCT00413478|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153467135|NCT00413634|Anagrelide|anagrelide|mesh-list
153467136|NCT00413634|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153467137|NCT00413634|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153467138|NCT00413634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153467139|NCT00413634|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153467140|NCT00387036|Fluticasone|fluticasone|mesh-list
153467147|NCT00387036|Respiratory System Agents|respiratory system agents|mesh-ancestor
153467149|NCT00387036|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
153467150|NCT00387660|Carboplatin|carboplatin|mesh-list
153467151|NCT00387660|Irinotecan|irinotecan|mesh-list
153467152|NCT00387660|Camptothecin|camptothecin|mesh-list
153782196|NCT00232856|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153782197|NCT00232856|Antifungal Agents|antifungal agents|mesh-ancestor
153467153|NCT00387660|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153467154|NCT00387660|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
153467155|NCT00387660|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153467156|NCT00387660|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153467157|NCT00387660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153467158|NCT00387660|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153467159|NCT00472056|Cytarabine|cytarabine|mesh-list
153467160|NCT00472056|Rituximab|rituximab|mesh-list
153467161|NCT00472056|Etoposide|etoposide|mesh-list
153918377|NCT01179191|Analgesics|analgesics|mesh-ancestor
153918378|NCT01179191|Sensory System Agents|sensory system agents|mesh-ancestor
153467162|NCT00472056|Melphalan|melphalan|mesh-list
153467163|NCT00472056|Carmustine|carmustine|mesh-list
153782198|NCT00232856|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153782199|NCT00232856|Immunologic Factors|immunologic factors|mesh-ancestor
153918379|NCT01179191|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153918380|NCT01179191|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
153918381|NCT01179191|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
153918382|NCT00642421|Octreotide|octreotide|mesh-list
153918383|NCT00642421|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153918384|NCT00642421|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153918385|NCT00642421|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153918386|NCT00642187|Budesonide|budesonide|mesh-list
153918387|NCT00642187|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153918388|NCT00642187|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153897500|NCT01232556|Immunotoxins|immunotoxins|mesh-ancestor
153918389|NCT00642187|Autonomic Agents|autonomic agents|mesh-ancestor
153918390|NCT00642187|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153918391|NCT00642187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153918392|NCT00642187|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153918408|NCT01132482|Urological Agents|urological agents|mesh-ancestor
153918409|NCT02678767|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
153467167|NCT00472056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153467168|NCT00472056|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153467169|NCT00472056|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153782200|NCT00232856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153782201|NCT00259974|Rituximab|rituximab|mesh-list
153467170|NCT00472056|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153467171|NCT00472056|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153467172|NCT00472056|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153467173|NCT00472056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153467174|NCT00472056|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153467175|NCT00472056|Antimetabolites|antimetabolites|mesh-ancestor
153467176|NCT00472056|Antiviral Agents|antiviral agents|mesh-ancestor
153467177|NCT00472056|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153467178|NCT00472056|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153467179|NCT00472056|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153467180|NCT00472056|Alkylating Agents|alkylating agents|mesh-ancestor
153467181|NCT00472056|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153918415|NCT00931762|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
153918416|NCT00931762|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153782205|NCT00259974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153918417|NCT00931762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153918419|NCT00641407|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
153438782|NCT00385970|Leucovorin|leucovorin|mesh-list
153918421|NCT00641407|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153918422|NCT00641407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153918423|NCT02677597|Paclitaxel|paclitaxel|mesh-list
153918424|NCT02677597|Cisplatin|cisplatin|mesh-list
153918425|NCT02677597|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153918426|NCT02677597|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153918427|NCT02677597|Tubulin Modulators|tubulin modulators|mesh-ancestor
153918428|NCT02677597|Antimitotic Agents|antimitotic agents|mesh-ancestor
153918429|NCT02677597|Mitosis Modulators|mitosis modulators|mesh-ancestor
153918430|NCT02677597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153918431|NCT02681263|Temocillin|temocillin|mesh-list
153918432|NCT02681263|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153918433|NCT02681263|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153918449|NCT01145508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153918450|NCT01145508|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153918451|NCT01145508|Tubulin Modulators|tubulin modulators|mesh-ancestor
153918452|NCT01145508|Antimitotic Agents|antimitotic agents|mesh-ancestor
153918453|NCT01145508|Mitosis Modulators|mitosis modulators|mesh-ancestor
153918454|NCT01145508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153918455|NCT01145508|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153918456|NCT01145508|Glucocorticoids|glucocorticoids|mesh-ancestor
153918457|NCT01145508|Hormones|hormones|mesh-ancestor
153918458|NCT01145508|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153918459|NCT01145508|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153918460|NCT01145508|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153918461|NCT01145508|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153918462|NCT01145508|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153918463|NCT01145508|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153918465|NCT00931528|Vasodilator Agents|vasodilator agents|mesh-ancestor
153782209|NCT00232895|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153918466|NCT00931528|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
153918467|NCT00931528|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
153918468|NCT00931528|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153918469|NCT00931528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153918470|NCT00931528|Urological Agents|urological agents|mesh-ancestor
153918471|NCT04312152|Vitamins|vitamins|mesh-list
153918472|NCT04312152|Vitamin E|vitamin e|mesh-list
153918473|NCT04312152|Tocopherols|tocopherols|mesh-list
153918474|NCT04312152|Folic Acid|folic acid|mesh-list
153467226|NCT00478218|Cyclophosphamide|cyclophosphamide|mesh-list
153467227|NCT00478218|Lenalidomide|lenalidomide|mesh-list
153467228|NCT00478218|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153467229|NCT00478218|Immunologic Factors|immunologic factors|mesh-ancestor
153467230|NCT00478218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153467231|NCT00478218|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153467232|NCT00478218|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153467233|NCT00478218|Alkylating Agents|alkylating agents|mesh-ancestor
153782214|NCT00232934|Thalidomide|thalidomide|mesh-list
153467234|NCT00478218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153467235|NCT00478218|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153467236|NCT00478218|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153918475|NCT04312152|Vitamin B Complex|vitamin b complex|mesh-list
153918476|NCT04312152|Micronutrients|micronutrients|mesh-ancestor
153918477|NCT04312152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153918478|NCT04312152|Antioxidants|antioxidants|mesh-ancestor
153918479|NCT04312152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153918480|NCT04312152|Protective Agents|protective agents|mesh-ancestor
153918481|NCT04312152|Hematinics|hematinics|mesh-ancestor
153918482|NCT00975195|Fluticasone|fluticasone|mesh-list
153918483|NCT00975195|Xhance|xhance|mesh-list
153918484|NCT00975195|Tiotropium Bromide|tiotropium bromide|mesh-list
153918485|NCT00975195|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
153897548|NCT01231464|Xhance|xhance|mesh-list
153918486|NCT00975195|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153918487|NCT00975195|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153918488|NCT00975195|Autonomic Agents|autonomic agents|mesh-ancestor
153918489|NCT00975195|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153918490|NCT00975195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153918491|NCT00975195|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153782221|NCT00232934|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153782222|NCT00232934|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153918492|NCT00975195|Respiratory System Agents|respiratory system agents|mesh-ancestor
153918493|NCT00975195|Dermatologic Agents|dermatologic agents|mesh-ancestor
153918494|NCT00975195|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
153918495|NCT00975195|Parasympatholytics|parasympatholytics|mesh-ancestor
153918496|NCT00975195|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
153918497|NCT00975195|Cholinergic Agents|cholinergic agents|mesh-ancestor
153918498|NCT00975195|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153918500|NCT00975195|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
153918501|NCT00975195|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
153918502|NCT00975195|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153918503|NCT00975195|Adrenergic Agents|adrenergic agents|mesh-ancestor
153918504|NCT00642499|Dronabinol|dronabinol|mesh-list
153918505|NCT00642499|Hallucinogens|hallucinogens|mesh-ancestor
153897575|NCT01155531|Telenzepine|telenzepine|mesh-list
153918506|NCT00642499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153918507|NCT00642499|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153918508|NCT00642499|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153918510|NCT00642499|Sensory System Agents|sensory system agents|mesh-ancestor
153918511|NCT00642499|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153918512|NCT00642499|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
153918513|NCT00642499|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
153918514|NCT00642499|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153918515|NCT00642499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153918516|NCT00642499|Hormones|hormones|mesh-ancestor
153918517|NCT00642499|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153918518|NCT00644215|Mitomycins|mitomycins|mesh-list
153918519|NCT00644215|Mitomycin|mitomycin|mesh-list
153918520|NCT00644215|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153918521|NCT00644215|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153918522|NCT00644215|Alkylating Agents|alkylating agents|mesh-ancestor
153918523|NCT00644215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153918524|NCT00644215|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153918525|NCT00644215|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153918526|NCT01145352|Etanercept|etanercept|mesh-list
153918527|NCT01145352|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153918528|NCT01145352|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153918529|NCT01145352|Analgesics|analgesics|mesh-ancestor
153918530|NCT01145352|Sensory System Agents|sensory system agents|mesh-ancestor
153918531|NCT01145352|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153918532|NCT01145352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153467295|NCT00425802|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
153467296|NCT00425802|Antitubercular Agents|antitubercular agents|mesh-ancestor
153467297|NCT00425802|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153467298|NCT00530634|Gemcitabine|gemcitabine|mesh-list
153467299|NCT00530634|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153467300|NCT00530634|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153467301|NCT00530634|Antimetabolites|antimetabolites|mesh-ancestor
153467302|NCT00530634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153782240|NCT04673812|Anesthetics, General|anesthetics, general|mesh-ancestor
153898090|NCT00950599|Saxagliptin|saxagliptin|mesh-list
153898091|NCT00950599|Incretins|incretins|mesh-ancestor
153782241|NCT04673812|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
153782242|NCT00260052|Epoetin Alfa|epoetin alfa|mesh-list
153782243|NCT00260052|Hematinics|hematinics|mesh-ancestor
153782244|NCT04673500|Lidocaine|lidocaine|mesh-list
153782245|NCT04673500|Propofol|propofol|mesh-list
153782246|NCT04673500|Anesthetics, Local|anesthetics, local|mesh-ancestor
153782247|NCT04673500|Anesthetics|anesthetics|mesh-ancestor
153782248|NCT04673500|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153467303|NCT00531882|Pioglitazone|pioglitazone|mesh-list
153467305|NCT00531882|Simvastatin|simvastatin|mesh-list
153918539|NCT01178099|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153918540|NCT02673463|Spironolactone|spironolactone|mesh-list
153782249|NCT04673500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153439379|NCT00003001|Vitamins|vitamins|mesh-ancestor
153918541|NCT02673463|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
153918542|NCT02673463|Hormone Antagonists|hormone antagonists|mesh-ancestor
153918543|NCT02673463|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153918544|NCT02673463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153918545|NCT02673463|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
153918546|NCT02673463|Diuretics|diuretics|mesh-ancestor
153782250|NCT04673500|Sensory System Agents|sensory system agents|mesh-ancestor
153918547|NCT02673463|Natriuretic Agents|natriuretic agents|mesh-ancestor
153918548|NCT01169532|Vorinostat|vorinostat|mesh-list
153918549|NCT01169532|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153918550|NCT01169532|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
153918551|NCT01169532|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153918552|NCT01169532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153918553|NCT02537353|Epinephrine|epinephrine|mesh-list
153918554|NCT02537353|Racepinephrine|racepinephrine|mesh-list
153782252|NCT04673500|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153918555|NCT02537353|Epinephryl borate|epinephryl borate|mesh-list
153918556|NCT02537353|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153918557|NCT02537353|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153918558|NCT02537353|Adrenergic Agents|adrenergic agents|mesh-ancestor
153918559|NCT02537353|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153918560|NCT02537353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153918561|NCT02537353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153918562|NCT02537353|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
153918563|NCT02537353|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153918564|NCT02537353|Autonomic Agents|autonomic agents|mesh-ancestor
153918565|NCT02537353|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153918566|NCT02537353|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153918567|NCT02537353|Respiratory System Agents|respiratory system agents|mesh-ancestor
153918568|NCT02537353|Mydriatics|mydriatics|mesh-ancestor
153918569|NCT02537353|Sympathomimetics|sympathomimetics|mesh-ancestor
153918570|NCT02537353|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
153918571|NCT00643357|Nitrous Oxide|nitrous oxide|mesh-list
153918572|NCT00643357|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
153918573|NCT00643357|Anesthetics, General|anesthetics, general|mesh-ancestor
153918574|NCT00643357|Anesthetics|anesthetics|mesh-ancestor
153918575|NCT00643357|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153918576|NCT00643357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153918577|NCT00643357|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153918578|NCT00643357|Analgesics|analgesics|mesh-ancestor
153918579|NCT00643357|Sensory System Agents|sensory system agents|mesh-ancestor
153918580|NCT00643357|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153918581|NCT01177943|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
153918582|NCT01177943|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
153918584|NCT01177943|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153918585|NCT01177943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153918586|NCT01177943|Adrenergic Agents|adrenergic agents|mesh-ancestor
153918587|NCT01177943|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153918588|NCT01177943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153918590|NCT04178785|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153918591|NCT04178785|Narcotics|narcotics|mesh-ancestor
153918592|NCT04178785|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153918593|NCT04178785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153918594|NCT04178785|Analgesics|analgesics|mesh-ancestor
153918595|NCT04178785|Sensory System Agents|sensory system agents|mesh-ancestor
153467348|NCT00428922|Growth Inhibitors|growth inhibitors|mesh-ancestor
153782254|NCT04673500|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153898110|NCT01143207|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
153782255|NCT04673500|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153467349|NCT00428922|Tubulin Modulators|tubulin modulators|mesh-ancestor
153467350|NCT00428922|Antimitotic Agents|antimitotic agents|mesh-ancestor
153467351|NCT00428922|Mitosis Modulators|mitosis modulators|mesh-ancestor
153467352|NCT00428922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153467353|NCT00533442|Mycophenolic Acid|mycophenolic acid|mesh-list
153467354|NCT00533442|Sirolimus|sirolimus|mesh-list
153467355|NCT00533442|Tacrolimus|tacrolimus|mesh-list
153467356|NCT00533442|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153467357|NCT00533442|Immunologic Factors|immunologic factors|mesh-ancestor
153467358|NCT00533442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153467359|NCT00533442|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
153782256|NCT04673500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153782257|NCT04673500|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153898113|NCT01143051|Epinephrine|epinephrine|mesh-list
153467360|NCT00533442|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153467361|NCT00533442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153467362|NCT00533442|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153918596|NCT04178785|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153918597|NCT00928486|Dexamethasone|dexamethasone|mesh-list
153918598|NCT00928486|Lenalidomide|lenalidomide|mesh-list
153782258|NCT04673500|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153782259|NCT04673500|Anesthetics, General|anesthetics, general|mesh-ancestor
153918599|NCT00928486|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153918600|NCT00928486|Antiemetics|antiemetics|mesh-ancestor
153918601|NCT00928486|Autonomic Agents|autonomic agents|mesh-ancestor
153918602|NCT00928486|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153918603|NCT00928486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153918604|NCT00928486|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153918605|NCT00928486|Glucocorticoids|glucocorticoids|mesh-ancestor
153918606|NCT00928486|Hormones|hormones|mesh-ancestor
153918607|NCT00928486|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153918608|NCT00928486|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153918609|NCT00928486|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153918610|NCT00928486|Immunologic Factors|immunologic factors|mesh-ancestor
153918611|NCT00928486|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153918612|NCT00928486|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153918613|NCT00928486|Growth Substances|growth substances|mesh-ancestor
153918614|NCT00928486|Growth Inhibitors|growth inhibitors|mesh-ancestor
153918615|NCT05655221|Mitogens|mitogens|mesh-list
153918617|NCT05655221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153918619|NCT00610792|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
153918620|NCT00610792|Bortezomib|bortezomib|mesh-list
153918621|NCT00610792|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153918622|NCT00610792|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153918623|NCT00610792|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153918624|NCT00610792|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153918625|NCT00610792|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153918626|NCT00610792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153918627|NCT00610870|Atorvastatin|atorvastatin|mesh-list
153918628|NCT00610870|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153918629|NCT00610870|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153918630|NCT00610870|Antimetabolites|antimetabolites|mesh-ancestor
153918631|NCT00610870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153782264|NCT00267540|Cholecalciferol|cholecalciferol|mesh-list
153782265|NCT00267540|Vitamin D|vitamin d|mesh-list
153918632|NCT00610870|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153918633|NCT00610870|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
153918634|NCT00610870|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153918635|NCT01168596|Rasagiline|rasagiline|mesh-list
153918636|NCT01168596|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
153918637|NCT01168596|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153918638|NCT01168596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153918639|NCT01168596|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
153439401|NCT00003421|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153918649|NCT02675647|Coagulants|coagulants|mesh-ancestor
153918650|NCT05370898|Calcium Carbonate|calcium carbonate|mesh-list
153918651|NCT05370898|Antacids|antacids|mesh-ancestor
153918652|NCT05370898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153467408|NCT00429702|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153467409|NCT00429702|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153467410|NCT00429702|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153467411|NCT00429702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153467412|NCT00429702|Antipruritics|antipruritics|mesh-ancestor
153467413|NCT00429702|Dermatologic Agents|dermatologic agents|mesh-ancestor
153467414|NCT00429702|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
153467415|NCT00429702|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153467416|NCT00429702|Serotonin Agents|serotonin agents|mesh-ancestor
153467417|NCT00429702|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153467418|NCT00429702|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
153467419|NCT00429702|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153467420|NCT00429702|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153467421|NCT00429702|Anesthetics, Local|anesthetics, local|mesh-ancestor
153467422|NCT00429702|Anesthetics|anesthetics|mesh-ancestor
153918655|NCT00610948|Fluorouracil|fluorouracil|mesh-list
153918656|NCT00610948|Oxaliplatin|oxaliplatin|mesh-list
153918657|NCT00610948|Everolimus|everolimus|mesh-list
153918658|NCT00610948|Panitumumab|panitumumab|mesh-list
153918659|NCT00610948|Calcium|calcium|mesh-list
153918660|NCT00610948|Levoleucovorin|levoleucovorin|mesh-list
153918661|NCT00610948|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153918662|NCT00610948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153918663|NCT00610948|Antimetabolites|antimetabolites|mesh-ancestor
153918664|NCT00610948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153918665|NCT00610948|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153782269|NCT00267540|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153782270|NCT00267540|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153918666|NCT00610948|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153918667|NCT00610948|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153918668|NCT00610948|Immunologic Factors|immunologic factors|mesh-ancestor
153918681|NCT02675413|Immunologic Factors|immunologic factors|mesh-ancestor
153918682|NCT02675413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153918683|NCT00928408|Cinacalcet|cinacalcet|mesh-list
153918684|NCT00928408|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153918685|NCT00928408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153918686|NCT00928408|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
153918687|NCT00928408|Hormone Antagonists|hormone antagonists|mesh-ancestor
153918688|NCT00928408|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153918689|NCT00928252|Fluorides|fluorides|mesh-list
153918690|NCT00928252|Cariostatic Agents|cariostatic agents|mesh-ancestor
153918691|NCT00928252|Protective Agents|protective agents|mesh-ancestor
153782271|NCT00233051|Fluticasone|fluticasone|mesh-list
153782272|NCT00233051|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
153439425|NCT00003007|Interferons|interferons|mesh-list
153918692|NCT00928252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153918693|NCT02673229|Bacitracin|bacitracin|mesh-list
153918694|NCT02673229|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
153918695|NCT02673229|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153918696|NCT02673229|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153918697|NCT00644293|Azithromycin|azithromycin|mesh-list
153918698|NCT00644293|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153918699|NCT00644293|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153918700|NCT00930982|Ciprofloxacin|ciprofloxacin|mesh-list
153918701|NCT00930982|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153918702|NCT00930982|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153918703|NCT00930982|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153918704|NCT00930982|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153918705|NCT00930982|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153918706|NCT00930982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153918707|NCT00930982|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153918708|NCT00930982|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
153918709|NCT00930982|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153918710|NCT01176773|Hyaluronic Acid|hyaluronic acid|mesh-list
153918711|NCT01176773|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153918712|NCT01176773|Immunologic Factors|immunologic factors|mesh-ancestor
153782280|NCT00233051|Dermatologic Agents|dermatologic agents|mesh-ancestor
153918713|NCT01176773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153918714|NCT01176773|Viscosupplements|viscosupplements|mesh-ancestor
153467467|NCT00431184|GABA Agents|gaba agents|mesh-ancestor
153467468|NCT00431184|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153467469|NCT00431184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153467470|NCT00431184|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153467471|NCT00431184|Narcotics|narcotics|mesh-ancestor
153467478|NCT00535938|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
153467479|NCT00535938|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
153467480|NCT00535938|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153467481|NCT00535938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153467482|NCT00535938|Cholinergic Agents|cholinergic agents|mesh-ancestor
153467483|NCT00535938|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153467484|NCT00535938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153467485|NCT00535938|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
153467486|NCT00535938|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153918716|NCT02887625|Insulin|insulin|mesh-list
153918717|NCT02887625|Insulin Glargine|insulin glargine|mesh-list
153918718|NCT02887625|Pioglitazone|pioglitazone|mesh-list
153918719|NCT02887625|Insulin Aspart|insulin aspart|mesh-list
153918720|NCT02887625|Exenatide|exenatide|mesh-list
153918721|NCT02887625|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153918722|NCT02887625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153918723|NCT02887625|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
153918724|NCT02887625|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
153918733|NCT02675335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153918735|NCT02675335|Hormones|hormones|mesh-ancestor
153918736|NCT02675335|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153918737|NCT02675335|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
153918738|NCT02675335|Protease Inhibitors|protease inhibitors|mesh-ancestor
153918739|NCT02675335|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153918740|NCT02675335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153918741|NCT02675101|Sucrose polyester|sucrose polyester|mesh-list
153918742|NCT02675101|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153918743|NCT02675101|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153918744|NCT02675101|Antimetabolites|antimetabolites|mesh-ancestor
153467488|NCT01795794|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
153918745|NCT02675101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153918746|NCT02675101|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153918747|NCT00928018|Cyclosporine|cyclosporine|mesh-list
153918748|NCT00928018|Sirolimus|sirolimus|mesh-list
153782281|NCT00233051|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
153918749|NCT00928018|Mycophenolic Acid|mycophenolic acid|mesh-list
153918750|NCT00928018|Methotrexate|methotrexate|mesh-list
153918751|NCT00928018|Tacrolimus|tacrolimus|mesh-list
153918752|NCT00928018|Cyclosporins|cyclosporins|mesh-list
153918753|NCT00928018|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
153918754|NCT00928018|Abortifacient Agents|abortifacient agents|mesh-ancestor
153918755|NCT00928018|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153918756|NCT00928018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153918757|NCT00928018|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153918758|NCT00928018|Antimetabolites|antimetabolites|mesh-ancestor
153918759|NCT00928018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153782282|NCT00233051|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
153782283|NCT00233051|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
153918760|NCT00928018|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153918761|NCT00928018|Dermatologic Agents|dermatologic agents|mesh-ancestor
153918762|NCT00928018|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153918763|NCT00928018|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153918764|NCT00928018|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153918765|NCT00928018|Immunologic Factors|immunologic factors|mesh-ancestor
153918766|NCT00928018|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153467519|NCT00492336|Protective Agents|protective agents|mesh-ancestor
153467520|NCT00492336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153467521|NCT00538434|Reslizumab|reslizumab|mesh-list
153467522|NCT00538434|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153467523|NCT00538434|Respiratory System Agents|respiratory system agents|mesh-ancestor
153467524|NCT00538824|Thalidomide|thalidomide|mesh-list
153467525|NCT00538824|Dexamethasone|dexamethasone|mesh-list
153467526|NCT00538824|Lenalidomide|lenalidomide|mesh-list
153898122|NCT01143051|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
153467527|NCT00538824|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153467528|NCT00538824|Antiemetics|antiemetics|mesh-ancestor
153918767|NCT00928018|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153918768|NCT00928018|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
153918769|NCT00928018|Antifungal Agents|antifungal agents|mesh-ancestor
153918770|NCT00928018|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153918771|NCT00928018|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153918772|NCT00928018|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
153918773|NCT00928018|Antitubercular Agents|antitubercular agents|mesh-ancestor
153918774|NCT00928018|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153918775|NCT02672839|Betadex|betadex|mesh-list
153918776|NCT02672839|Sequestering Agents|sequestering agents|mesh-ancestor
153918777|NCT02672839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153918778|NCT00910117|Nimotuzumab|nimotuzumab|mesh-list
153918779|NCT00910117|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153918780|NCT00910117|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153918781|NCT00927862|Warfarin|warfarin|mesh-list
153918782|NCT00927862|Anticoagulants|anticoagulants|mesh-ancestor
153918783|NCT02672527|Dexamethasone|dexamethasone|mesh-list
153918784|NCT02672527|Trabectedin|trabectedin|mesh-list
153918785|NCT02672527|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153918787|NCT02672527|Autonomic Agents|autonomic agents|mesh-ancestor
153918788|NCT02672527|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153918789|NCT02672527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153918790|NCT02672527|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153918791|NCT02672527|Glucocorticoids|glucocorticoids|mesh-ancestor
153918792|NCT02672527|Hormones|hormones|mesh-ancestor
153918793|NCT02672527|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153918794|NCT02672527|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153918795|NCT02672527|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153918796|NCT02672527|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153918797|NCT02672527|Alkylating Agents|alkylating agents|mesh-ancestor
153782285|NCT00233051|Adrenergic Agents|adrenergic agents|mesh-ancestor
153782286|NCT00233051|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153918798|NCT02672527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153918799|NCT00976989|Docetaxel|docetaxel|mesh-list
153918800|NCT00976989|Trastuzumab|trastuzumab|mesh-list
153918801|NCT00976989|Pertuzumab|pertuzumab|mesh-list
153918802|NCT00976989|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153918803|NCT00976989|Tubulin Modulators|tubulin modulators|mesh-ancestor
153918804|NCT00976989|Antimitotic Agents|antimitotic agents|mesh-ancestor
153918805|NCT00976989|Mitosis Modulators|mitosis modulators|mesh-ancestor
153918806|NCT00976989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153918807|NCT00976989|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153918809|NCT02675023|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
153918810|NCT02675023|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153918811|NCT02675023|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153918812|NCT00644371|Rituximab|rituximab|mesh-list
153918813|NCT00644371|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153918814|NCT00644371|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153918815|NCT00644371|Immunologic Factors|immunologic factors|mesh-ancestor
153918816|NCT00644371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153918817|NCT00644371|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153918818|NCT02864199|Ribavirin|ribavirin|mesh-list
153918819|NCT02864199|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
153918820|NCT02864199|Antimetabolites|antimetabolites|mesh-ancestor
153918821|NCT02864199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153918822|NCT02864199|Antiviral Agents|antiviral agents|mesh-ancestor
153918823|NCT02864199|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153918824|NCT05911126|Celecoxib|celecoxib|mesh-list
153918825|NCT05911126|Scopolamine|scopolamine|mesh-list
153467529|NCT00538824|Autonomic Agents|autonomic agents|mesh-ancestor
153918826|NCT05911126|Bromides|bromides|mesh-list
153918827|NCT05911126|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
153918828|NCT05911126|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153918829|NCT05911126|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153918832|NCT05911126|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153467589|NCT00439296|Immunologic Factors|immunologic factors|mesh-ancestor
153467590|NCT00439296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153467591|NCT00439296|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153467592|NCT00439296|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153467593|NCT00439296|Alkylating Agents|alkylating agents|mesh-ancestor
153467594|NCT00439296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153898144|NCT05199597|Cholinergic Agents|cholinergic agents|mesh-ancestor
153467595|NCT00439296|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153467596|NCT00439296|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153467597|NCT00439296|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153467599|NCT00439296|Autonomic Agents|autonomic agents|mesh-ancestor
153467600|NCT00439296|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153467601|NCT00439296|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153467602|NCT00439296|Glucocorticoids|glucocorticoids|mesh-ancestor
153467603|NCT00439296|Hormones|hormones|mesh-ancestor
153467604|NCT00439296|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153467605|NCT00439296|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153918833|NCT05911126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153918834|NCT05911126|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153918835|NCT05911126|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153782287|NCT00233051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153467606|NCT00439296|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153918836|NCT05911126|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
153918837|NCT05911126|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153918838|NCT05911126|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153918839|NCT05911126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153918840|NCT05911126|Anticonvulsants|anticonvulsants|mesh-ancestor
153782289|NCT04672759|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
153918841|NCT05911126|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153918842|NCT05911126|Antiemetics|antiemetics|mesh-ancestor
153918843|NCT05911126|Autonomic Agents|autonomic agents|mesh-ancestor
153918845|NCT05911126|Mydriatics|mydriatics|mesh-ancestor
153918846|NCT05911126|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
153918847|NCT05911126|Cholinergic Agents|cholinergic agents|mesh-ancestor
153439326|NCT00002989|Idarubicin|idarubicin|mesh-list
153918848|NCT05911126|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153918849|NCT05911126|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
153918850|NCT05911126|Parasympatholytics|parasympatholytics|mesh-ancestor
153918852|NCT05908513|N-monoacetylcystine|n-monoacetylcystine|mesh-list
153918853|NCT05908513|Antiviral Agents|antiviral agents|mesh-ancestor
153918854|NCT05908513|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153918855|NCT05908513|Expectorants|expectorants|mesh-ancestor
153918856|NCT05908513|Respiratory System Agents|respiratory system agents|mesh-ancestor
153918857|NCT05908513|Free Radical Scavengers|free radical scavengers|mesh-ancestor
153918858|NCT05908513|Antioxidants|antioxidants|mesh-ancestor
153918859|NCT05908513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153918860|NCT05908513|Protective Agents|protective agents|mesh-ancestor
153918861|NCT05908513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153918862|NCT05908513|Antidotes|antidotes|mesh-ancestor
153918863|NCT05908305|Epinephrine|epinephrine|mesh-list
153918864|NCT05908305|Racepinephrine|racepinephrine|mesh-list
153918865|NCT05908305|Anesthetics|anesthetics|mesh-list
153918866|NCT05908305|Mepivacaine|mepivacaine|mesh-list
153918867|NCT05908305|Carticaine|carticaine|mesh-list
153918868|NCT05908305|Epinephryl borate|epinephryl borate|mesh-list
153898151|NCT01139775|Pemetrexed|pemetrexed|mesh-list
153918869|NCT05908305|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153467607|NCT00439296|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153918870|NCT05908305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153918871|NCT05908305|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153918872|NCT05908305|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153918873|NCT05908305|Adrenergic Agents|adrenergic agents|mesh-ancestor
153918874|NCT05908305|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153918875|NCT05908305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153918876|NCT05908305|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
153782290|NCT04672759|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153918877|NCT05908305|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153918878|NCT05908305|Autonomic Agents|autonomic agents|mesh-ancestor
153918879|NCT05908305|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153918880|NCT05908305|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153918881|NCT05908305|Respiratory System Agents|respiratory system agents|mesh-ancestor
153918882|NCT05908305|Mydriatics|mydriatics|mesh-ancestor
153918883|NCT05908305|Sympathomimetics|sympathomimetics|mesh-ancestor
153918884|NCT05908305|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
153918885|NCT05908305|Anesthetics, Local|anesthetics, local|mesh-ancestor
153918886|NCT05908305|Sensory System Agents|sensory system agents|mesh-ancestor
153918887|NCT02672995|Bevacizumab|bevacizumab|mesh-list
153918888|NCT02672995|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153467644|NCT04750122|Trastuzumab|trastuzumab|mesh-list
153467645|NCT04750122|Pertuzumab|pertuzumab|mesh-list
153467646|NCT04750122|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153467647|NCT04750122|Tubulin Modulators|tubulin modulators|mesh-ancestor
153467648|NCT04750122|Antimitotic Agents|antimitotic agents|mesh-ancestor
153467649|NCT04750122|Mitosis Modulators|mitosis modulators|mesh-ancestor
153467650|NCT04750122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153467651|NCT04750122|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153467652|NCT00443352|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
153467653|NCT00443352|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
153467654|NCT00443352|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153467655|NCT00443352|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153467656|NCT00443352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153467657|NCT00443352|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153467658|NCT00443352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153467659|NCT00443352|Analgesics|analgesics|mesh-ancestor
153467660|NCT00443352|Sensory System Agents|sensory system agents|mesh-ancestor
153467661|NCT00443352|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153782291|NCT04672759|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153782292|NCT04672759|Immunologic Factors|immunologic factors|mesh-ancestor
153439448|NCT00003007|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153918889|NCT02672995|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153918890|NCT02672995|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153918891|NCT02672995|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153918892|NCT02672995|Growth Substances|growth substances|mesh-ancestor
153918893|NCT02672995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153918894|NCT02672995|Growth Inhibitors|growth inhibitors|mesh-ancestor
153918895|NCT05907902|Aspirin|aspirin|mesh-list
153918899|NCT05907902|Sensory System Agents|sensory system agents|mesh-ancestor
153918900|NCT05907902|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153918901|NCT05907902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153918902|NCT05907902|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153918903|NCT05907902|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153918904|NCT05907902|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153918905|NCT05907902|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153918906|NCT05907902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153918909|NCT05907902|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153918910|NCT05907902|Antipyretics|antipyretics|mesh-ancestor
153918911|NCT05907733|Mitogens|mitogens|mesh-list
153782293|NCT04672759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153918912|NCT05907733|Mitosis Modulators|mitosis modulators|mesh-ancestor
153918913|NCT05907733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153918914|NCT05907499|Decitabine|decitabine|mesh-list
153918915|NCT05907499|Epoetin Alfa|epoetin alfa|mesh-list
153918916|NCT05907499|Lenograstim|lenograstim|mesh-list
153918917|NCT05907499|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153918918|NCT05907499|Antimetabolites|antimetabolites|mesh-ancestor
153918919|NCT05907499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153918920|NCT05907499|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153918921|NCT05907499|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153918922|NCT05907499|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153918923|NCT05907499|Immunologic Factors|immunologic factors|mesh-ancestor
153918924|NCT05907499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153918925|NCT05907499|Hematinics|hematinics|mesh-ancestor
153918926|NCT05907486|Cytarabine|cytarabine|mesh-list
153918927|NCT05907486|Acetylcysteine|acetylcysteine|mesh-list
153918928|NCT05907486|Cyclophosphamide|cyclophosphamide|mesh-list
153918929|NCT05907486|Busulfan|busulfan|mesh-list
153918930|NCT05907486|N-monoacetylcystine|n-monoacetylcystine|mesh-list
153918931|NCT05907486|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153918932|NCT05907486|Immunologic Factors|immunologic factors|mesh-ancestor
153918933|NCT05907486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153918934|NCT05907486|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153782294|NCT00260247|Carbamazepine|carbamazepine|mesh-list
153782295|NCT00260247|Oxcarbazepine|oxcarbazepine|mesh-list
153918935|NCT05907486|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153918936|NCT05907486|Alkylating Agents|alkylating agents|mesh-ancestor
153918937|NCT05907486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153918938|NCT05907486|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153918939|NCT05907486|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153918940|NCT05907486|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153918941|NCT05907486|Antimetabolites|antimetabolites|mesh-ancestor
153918942|NCT05907486|Antiviral Agents|antiviral agents|mesh-ancestor
153918943|NCT05907486|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153782296|NCT00260247|Anticonvulsants|anticonvulsants|mesh-ancestor
153918944|NCT05907486|Expectorants|expectorants|mesh-ancestor
153467700|NCT00504660|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153467701|NCT00504660|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153467702|NCT00504660|Alkylating Agents|alkylating agents|mesh-ancestor
153467703|NCT00504660|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153467704|NCT00504660|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153467705|NCT00504660|Analgesics|analgesics|mesh-ancestor
153467706|NCT00504660|Sensory System Agents|sensory system agents|mesh-ancestor
153467707|NCT00504660|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153467708|NCT00504660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153782297|NCT00260247|Antimanic Agents|antimanic agents|mesh-ancestor
153467709|NCT00504660|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153467710|NCT00504660|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153467711|NCT00504660|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
153467712|NCT00504660|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153467713|NCT00504660|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153918945|NCT05907486|Respiratory System Agents|respiratory system agents|mesh-ancestor
153918946|NCT05907486|Free Radical Scavengers|free radical scavengers|mesh-ancestor
153918947|NCT05907486|Antioxidants|antioxidants|mesh-ancestor
153918948|NCT05907486|Protective Agents|protective agents|mesh-ancestor
153918949|NCT05907486|Antidotes|antidotes|mesh-ancestor
153918950|NCT05906992|Ocrelizumab|ocrelizumab|mesh-list
153918951|NCT05906992|Immunologic Factors|immunologic factors|mesh-ancestor
153918952|NCT05906992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153918953|NCT05906576|Infliximab|infliximab|mesh-list
153918954|NCT05906576|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
153918967|NCT05906524|Bevacizumab|bevacizumab|mesh-list
153918968|NCT05906524|Tislelizumab|tislelizumab|mesh-list
153918969|NCT05906524|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153918970|NCT05906524|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153918984|NCT05906498|Protective Agents|protective agents|mesh-ancestor
153918985|NCT05906498|Antiviral Agents|antiviral agents|mesh-ancestor
153918986|NCT05906498|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153918987|NCT05906498|Expectorants|expectorants|mesh-ancestor
153918988|NCT05906498|Respiratory System Agents|respiratory system agents|mesh-ancestor
153918989|NCT05906498|Free Radical Scavengers|free radical scavengers|mesh-ancestor
153918990|NCT05906498|Antidotes|antidotes|mesh-ancestor
153919001|NCT05892510|Tenecteplase|tenecteplase|mesh-list
153919002|NCT05892510|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153782299|NCT00260247|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153387587|NCT02294604|Blood Substitutes|blood substitutes|mesh-ancestor
153919003|NCT05892510|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153919006|NCT05760807|Oxytocics|oxytocics|mesh-ancestor
153919007|NCT05760807|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153919008|NCT05760807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153467760|NCT00546156|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153467761|NCT00546156|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153467762|NCT00546156|Alkylating Agents|alkylating agents|mesh-ancestor
153467763|NCT00546156|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153467764|NCT00546156|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153919010|NCT05746442|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
153387588|NCT01645176|Hydroxychloroquine|hydroxychloroquine|mesh-list
153919011|NCT05746442|Autonomic Agents|autonomic agents|mesh-ancestor
153919012|NCT05746442|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153919013|NCT05746442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153919014|NCT05746442|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
153919015|NCT05746442|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
153919022|NCT05736874|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153919023|NCT05736874|Autonomic Agents|autonomic agents|mesh-ancestor
153919024|NCT05736874|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153919025|NCT05736874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153919027|NCT05736874|Respiratory System Agents|respiratory system agents|mesh-ancestor
153919028|NCT05736874|Dermatologic Agents|dermatologic agents|mesh-ancestor
153919029|NCT05736874|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
153919030|NCT05699655|Oxaliplatin|oxaliplatin|mesh-list
153919031|NCT05699655|Apatinib|apatinib|mesh-list
153919032|NCT05699655|Tislelizumab|tislelizumab|mesh-list
153919033|NCT05699655|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153919034|NCT05699655|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153919035|NCT05699655|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153919036|NCT05699655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153919037|NCT05699655|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153898170|NCT01283282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153919039|NCT05687500|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153919040|NCT05687500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153919041|NCT05675163|Vitamin K|vitamin k|mesh-list
153919042|NCT05675163|Vitamin K 2|vitamin k 2|mesh-list
153919043|NCT05675163|Vitamins|vitamins|mesh-ancestor
153919044|NCT05675163|Micronutrients|micronutrients|mesh-ancestor
153919045|NCT05675163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153919046|NCT05675163|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
153919047|NCT05675163|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153919048|NCT05675163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153919049|NCT05675163|Hemostatics|hemostatics|mesh-ancestor
153919050|NCT05675163|Coagulants|coagulants|mesh-ancestor
153919051|NCT05596786|Rituximab|rituximab|mesh-list
153919052|NCT05596786|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153919053|NCT05596786|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153919054|NCT05596786|Immunologic Factors|immunologic factors|mesh-ancestor
153782300|NCT00260247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153919055|NCT05596786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153919056|NCT05596786|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153919057|NCT05582707|Pioglitazone|pioglitazone|mesh-list
153919058|NCT05582707|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153919059|NCT05582707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153919060|NCT05564611|Omalizumab|omalizumab|mesh-list
153919064|NCT05559164|Atorvastatin|atorvastatin|mesh-list
153919065|NCT05559164|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153919066|NCT05559164|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153919067|NCT05559164|Antimetabolites|antimetabolites|mesh-ancestor
153919068|NCT05559164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153919069|NCT05559164|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153919070|NCT05559164|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
153919071|NCT05559164|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153919072|NCT05553405|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
153467773|NCT00449046|Fluticasone|fluticasone|mesh-list
153919073|NCT05553405|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
153919074|NCT05553405|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
153919075|NCT05553405|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
153919076|NCT05487261|Valsartan|valsartan|mesh-list
153919077|NCT05487261|Enalapril|enalapril|mesh-list
153919078|NCT05487261|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
153467830|NCT00511992|Mitosis Modulators|mitosis modulators|mesh-ancestor
153439477|NCT00003013|Alkylating Agents|alkylating agents|mesh-ancestor
153467831|NCT00511992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153467832|NCT00511992|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153467833|NCT00511992|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153467834|NCT00511992|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153467835|NCT00511992|Growth Substances|growth substances|mesh-ancestor
153467836|NCT00511992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153467837|NCT00511992|Growth Inhibitors|growth inhibitors|mesh-ancestor
153467838|NCT00451698|Epoetin Alfa|epoetin alfa|mesh-list
153467839|NCT00451698|Hematinics|hematinics|mesh-ancestor
153467840|NCT00549042|Hydromorphone|hydromorphone|mesh-list
153467841|NCT00549042|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153467842|NCT00549042|Narcotics|narcotics|mesh-ancestor
153782301|NCT00260247|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153782302|NCT00260247|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153782303|NCT00260247|Analgesics|analgesics|mesh-ancestor
153782304|NCT00260247|Sensory System Agents|sensory system agents|mesh-ancestor
153782305|NCT00260247|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153439481|NCT00003013|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153782306|NCT00260247|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153782307|NCT00260247|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153782308|NCT00260247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153782309|NCT00260247|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
153782310|NCT00260247|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
153782311|NCT00260247|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
153467843|NCT00549042|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153898204|NCT02852239|Dabrafenib|dabrafenib|mesh-list
153467844|NCT00549042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153467846|NCT00549042|Sensory System Agents|sensory system agents|mesh-ancestor
153467847|NCT00549042|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153467848|NCT00452868|Donepezil|donepezil|mesh-list
153467849|NCT00452868|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
153467850|NCT00452868|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153467851|NCT00452868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153467852|NCT00452868|Cholinergic Agents|cholinergic agents|mesh-ancestor
153467853|NCT00452868|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153467854|NCT00452868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153467856|NCT00453336|Dihematoporphyrin Ether|dihematoporphyrin ether|mesh-list
153467857|NCT00453336|Trioxsalen|trioxsalen|mesh-list
153467858|NCT00453336|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153467859|NCT00453336|Dermatologic Agents|dermatologic agents|mesh-ancestor
153467860|NCT00453336|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
153467861|NCT00549822|Letrozole|letrozole|mesh-list
153919079|NCT05487261|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153919080|NCT05487261|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
153919081|NCT05487261|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
153919082|NCT05487261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153919083|NCT05487261|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
153919084|NCT05487261|Protease Inhibitors|protease inhibitors|mesh-ancestor
153919085|NCT05487261|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153919086|NCT05479240|Capecitabine|capecitabine|mesh-list
153467862|NCT00549822|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153919087|NCT05479240|Oxaliplatin|oxaliplatin|mesh-list
153919088|NCT05479240|Tislelizumab|tislelizumab|mesh-list
153919089|NCT05479240|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153919090|NCT05479240|Antimetabolites|antimetabolites|mesh-ancestor
153919091|NCT05479240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153919092|NCT05479240|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153919093|NCT05479240|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153782314|NCT04671589|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153782315|NCT00260325|Valdecoxib|valdecoxib|mesh-list
153919094|NCT05442684|Vaccines|vaccines|mesh-list
153919095|NCT05442684|Immunologic Factors|immunologic factors|mesh-ancestor
153919096|NCT05442684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153919097|NCT05380388|Vaccines|vaccines|mesh-list
153919098|NCT05380388|Immunologic Factors|immunologic factors|mesh-ancestor
153919099|NCT05380388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153919100|NCT05332444|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
153919101|NCT05332444|Amoxicillin|amoxicillin|mesh-list
153919102|NCT05332444|Metronidazole|metronidazole|mesh-list
153919103|NCT05332444|Clarithromycin|clarithromycin|mesh-list
153919104|NCT05332444|Levofloxacin|levofloxacin|mesh-list
153919105|NCT05332444|Tetracycline|tetracycline|mesh-list
153919106|NCT05332444|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
153919107|NCT05332444|Rabeprazole|rabeprazole|mesh-list
153919108|NCT05332444|Bismuth|bismuth|mesh-list
153919109|NCT05332444|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
153919110|NCT05332444|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153919111|NCT05332444|Antitubercular Agents|antitubercular agents|mesh-ancestor
153919112|NCT05332444|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153919113|NCT05332444|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153919114|NCT05332444|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
153919115|NCT05332444|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153919116|NCT05332444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153919117|NCT05332444|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
153919118|NCT05332444|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153919119|NCT05332444|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
153467870|NCT00549822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153467871|NCT00550290|Cefazolin|cefazolin|mesh-list
153467872|NCT00550290|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153467873|NCT00550290|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153467874|NCT01797198|Repaglinide|repaglinide|mesh-list
153467875|NCT01797198|Gemfibrozil|gemfibrozil|mesh-list
153467876|NCT01797198|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153467877|NCT01797198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153467878|NCT01797198|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153467879|NCT01797198|Antimetabolites|antimetabolites|mesh-ancestor
153467880|NCT01797198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153782327|NCT00260325|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153782328|NCT04671160|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
153782329|NCT04671160|Dalteparin|dalteparin|mesh-list
153782330|NCT04671160|Anticoagulants|anticoagulants|mesh-ancestor
153782331|NCT04671160|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153782332|NCT04671160|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153467881|NCT01797198|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153467882|NCT01797198|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
153467883|NCT01797198|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153467884|NCT01797198|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153467885|NCT00552786|Acetylcysteine|acetylcysteine|mesh-list
153467886|NCT00552786|N-monoacetylcystine|n-monoacetylcystine|mesh-list
153467887|NCT00552786|Antiviral Agents|antiviral agents|mesh-ancestor
153467888|NCT00552786|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153467889|NCT00552786|Expectorants|expectorants|mesh-ancestor
153467890|NCT00552786|Respiratory System Agents|respiratory system agents|mesh-ancestor
153467891|NCT00552786|Free Radical Scavengers|free radical scavengers|mesh-ancestor
153467892|NCT00552786|Antioxidants|antioxidants|mesh-ancestor
153467895|NCT00552786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153919126|NCT05332444|Antacids|antacids|mesh-ancestor
153919127|NCT05290740|Norepinephrine|norepinephrine|mesh-list
153919128|NCT05290740|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153919129|NCT05290740|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153919130|NCT05290740|Adrenergic Agents|adrenergic agents|mesh-ancestor
153919131|NCT05290740|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153919132|NCT05290740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153919133|NCT05290740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153919134|NCT05290740|Sympathomimetics|sympathomimetics|mesh-ancestor
153919135|NCT05290740|Autonomic Agents|autonomic agents|mesh-ancestor
153919136|NCT05290740|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153919137|NCT05290740|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
153782333|NCT04671160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153919138|NCT05234554|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
153919139|NCT05234554|Ophthalmic Solutions|ophthalmic solutions|mesh-list
153919140|NCT05212311|Chitosan|chitosan|mesh-list
153919141|NCT05212311|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153919142|NCT05212311|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153919143|NCT05212311|Antimetabolites|antimetabolites|mesh-ancestor
153919144|NCT05212311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153919145|NCT05212311|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153782334|NCT04671394|Photosensitizing Agents|photosensitizing agents|mesh-list
153782335|NCT04671394|Dermatologic Agents|dermatologic agents|mesh-ancestor
153919146|NCT05212311|Chelating Agents|chelating agents|mesh-ancestor
153919147|NCT05212311|Sequestering Agents|sequestering agents|mesh-ancestor
153919148|NCT05212311|Hemostatics|hemostatics|mesh-ancestor
153919149|NCT05212311|Coagulants|coagulants|mesh-ancestor
153919150|NCT05159752|Afamelanotide|afamelanotide|mesh-list
153919151|NCT05159752|Dermatologic Agents|dermatologic agents|mesh-ancestor
153919152|NCT05006417|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
153919153|NCT05006417|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
153467920|NCT00553098|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153467921|NCT00553098|Antimetabolites|antimetabolites|mesh-ancestor
153467922|NCT00553098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153467923|NCT00553098|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153467924|NCT00553098|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153467925|NCT00553098|Antifungal Agents|antifungal agents|mesh-ancestor
153467926|NCT00553098|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153467927|NCT00553098|Dermatologic Agents|dermatologic agents|mesh-ancestor
153467928|NCT00553098|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153782336|NCT00233558|Adalimumab|adalimumab|mesh-list
153439489|NCT00003013|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153782338|NCT00233558|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
153782339|NCT00233558|Abortifacient Agents|abortifacient agents|mesh-ancestor
153782340|NCT00233558|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153782341|NCT00233558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153782342|NCT00233558|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153782343|NCT00233558|Antimetabolites|antimetabolites|mesh-ancestor
153782345|NCT00233558|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153467929|NCT00553098|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
153467930|NCT00553098|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153467931|NCT00553098|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
153467939|NCT00553410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153919159|NCT05006417|Cholinergic Agents|cholinergic agents|mesh-ancestor
153919160|NCT05006417|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153919161|NCT05001152|Ozanimod|ozanimod|mesh-list
153919162|NCT05001152|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
153919163|NCT05001152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153919164|NCT05001152|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153919165|NCT05001152|Immunologic Factors|immunologic factors|mesh-ancestor
153439502|NCT00003445|Mitosis Modulators|mitosis modulators|mesh-ancestor
153782348|NCT00233558|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153782349|NCT00233558|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153439508|NCT00003451|Antiviral Agents|antiviral agents|mesh-ancestor
153782350|NCT00233558|Immunologic Factors|immunologic factors|mesh-ancestor
153360236|NCT00809276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153898215|NCT00602251|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153782351|NCT00233558|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153360237|NCT00809276|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153919166|NCT05001152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153919167|NCT04930653|Mogamulizumab|mogamulizumab|mesh-list
153919168|NCT04930653|Immunoglobulins|immunoglobulins|mesh-list
153919169|NCT04930653|Immunoglobulin G|immunoglobulin g|mesh-list
153919170|NCT04930653|Immunologic Factors|immunologic factors|mesh-ancestor
153919171|NCT04930653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153919172|NCT04930653|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153467941|NCT00553410|Hormone Antagonists|hormone antagonists|mesh-ancestor
153919173|NCT04889079|Contraceptive Agents|contraceptive agents|mesh-list
153898266|NCT01218516|Paclitaxel|paclitaxel|mesh-list
153919174|NCT04889079|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153919175|NCT04889079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153919176|NCT04839549|Fluorometholone|fluorometholone|mesh-list
153919177|NCT04839549|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153919178|NCT04839549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153919179|NCT04839549|Glucocorticoids|glucocorticoids|mesh-ancestor
153919181|NCT04839549|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153919182|NCT04839549|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
153919183|NCT04794569|Tinzaparin|tinzaparin|mesh-list
153919184|NCT04794569|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
153919185|NCT04794569|Dalteparin|dalteparin|mesh-list
153919186|NCT04794569|Rivaroxaban|rivaroxaban|mesh-list
153919188|NCT04794569|Antithrombins|antithrombins|mesh-ancestor
153782352|NCT00233558|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153360238|NCT00809276|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153898244|NCT00604435|Docetaxel|docetaxel|mesh-list
153919189|NCT04794569|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
153919190|NCT04794569|Protease Inhibitors|protease inhibitors|mesh-ancestor
153919191|NCT04794569|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153919192|NCT04794569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153919193|NCT04794569|Anticoagulants|anticoagulants|mesh-ancestor
153919194|NCT04794569|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153919195|NCT04794569|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153898245|NCT00604435|Epirubicin|epirubicin|mesh-list
153782353|NCT00233558|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
153919196|NCT04787042|Pembrolizumab|pembrolizumab|mesh-list
153919197|NCT04787042|Obinutuzumab|obinutuzumab|mesh-list
153919198|NCT04787042|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153919199|NCT04787042|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153919200|NCT04787042|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153919201|NCT04787042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153919202|NCT04624178|Nivolumab|nivolumab|mesh-list
153919203|NCT04624178|Rucaparib|rucaparib|mesh-list
153467957|NCT00524472|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153467958|NCT00524472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153467959|NCT00555048|Cyclophosphamide|cyclophosphamide|mesh-list
153467960|NCT00555048|Busulfan|busulfan|mesh-list
153467961|NCT00555048|Methotrexate|methotrexate|mesh-list
153467962|NCT00555048|Alemtuzumab|alemtuzumab|mesh-list
153467963|NCT00555048|Tacrolimus|tacrolimus|mesh-list
153467964|NCT00555048|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153467965|NCT00555048|Immunologic Factors|immunologic factors|mesh-ancestor
153467966|NCT00555048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153467967|NCT00555048|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153467968|NCT00555048|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153467969|NCT00555048|Alkylating Agents|alkylating agents|mesh-ancestor
153467970|NCT00555048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153467971|NCT00555048|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153467972|NCT00555048|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153467973|NCT00555048|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
153467974|NCT00555048|Abortifacient Agents|abortifacient agents|mesh-ancestor
153467975|NCT00555048|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153467976|NCT00555048|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153467977|NCT00555048|Antimetabolites|antimetabolites|mesh-ancestor
153467978|NCT00555048|Dermatologic Agents|dermatologic agents|mesh-ancestor
153919204|NCT04624178|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153919205|NCT04624178|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153919206|NCT04624178|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153919207|NCT04624178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153919208|NCT04624178|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
153919209|NCT04624178|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153919210|NCT04563338|Bevacizumab|bevacizumab|mesh-list
153919211|NCT04563338|Atezolizumab|atezolizumab|mesh-list
153919212|NCT04563338|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153919213|NCT04563338|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153919214|NCT04563338|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153782355|NCT00233636|Gefitinib|gefitinib|mesh-list
153782356|NCT00233636|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153782357|NCT00233636|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153782358|NCT00233636|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153782359|NCT00233636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153919215|NCT04563338|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153919216|NCT04563338|Growth Substances|growth substances|mesh-ancestor
153919217|NCT04563338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153919218|NCT04563338|Growth Inhibitors|growth inhibitors|mesh-ancestor
153782362|NCT00267657|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153782363|NCT00267657|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153782364|NCT00267657|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153782365|NCT00267657|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153782366|NCT00267657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153782367|NCT00267657|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153782368|NCT00267657|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
153782369|NCT00267657|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153782370|NCT00267657|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153782371|NCT00267657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153782372|NCT00267657|Adrenergic Agents|adrenergic agents|mesh-ancestor
153782373|NCT00267657|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153360240|NCT00802412|Anticonvulsants|anticonvulsants|mesh-ancestor
153919219|NCT04563338|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153919220|NCT04563338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153919221|NCT04524910|Aflibercept|aflibercept|mesh-list
153919222|NCT04524910|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153782374|NCT04670809|Clevidipine|clevidipine|mesh-list
153782375|NCT04670809|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153919223|NCT04524910|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153919224|NCT04524910|Growth Substances|growth substances|mesh-ancestor
153919225|NCT04524910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153919226|NCT04524910|Growth Inhibitors|growth inhibitors|mesh-ancestor
153919232|NCT04410653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153439548|NCT00003493|Doxorubicin|doxorubicin|mesh-list
153919233|NCT04410653|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153919235|NCT04377087|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
153919236|NCT04377087|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153919237|NCT04377087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153919238|NCT04377087|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153919239|NCT04341779|Tenofovir|tenofovir|mesh-list
153919240|NCT04341779|Antiviral Agents|antiviral agents|mesh-ancestor
153919241|NCT04341779|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153919242|NCT04341779|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153919243|NCT04341779|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153782376|NCT04670809|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153919244|NCT04341779|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153919245|NCT04341779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153919246|NCT04341779|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153898298|NCT00949117|Histamine Agents|histamine agents|mesh-ancestor
153919247|NCT04341779|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153919248|NCT04205838|Vidarabine|vidarabine|mesh-list
153919249|NCT04205838|Cyclophosphamide|cyclophosphamide|mesh-list
153919250|NCT04205838|Fludarabine|fludarabine|mesh-list
153919251|NCT04205838|Fludarabine phosphate|fludarabine phosphate|mesh-list
153919252|NCT04205838|Axicabtagene ciloleucel|axicabtagene ciloleucel|mesh-list
153468007|NCT00525876|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153468008|NCT00525876|Antimetabolites|antimetabolites|mesh-ancestor
153468009|NCT00555750|Eszopiclone|eszopiclone|mesh-list
153468010|NCT00555750|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153468011|NCT00555750|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153468012|NCT00555750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153468013|NCT00556140|Aripiprazole|aripiprazole|mesh-list
153468014|NCT00556140|Antidepressive Agents|antidepressive agents|mesh-ancestor
153468015|NCT00556140|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153468016|NCT00556140|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153468017|NCT00556140|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153468018|NCT00556140|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153468019|NCT00556140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153468020|NCT00556140|Dopamine Agonists|dopamine agonists|mesh-ancestor
153468021|NCT00556140|Dopamine Agents|dopamine agents|mesh-ancestor
153468022|NCT00556140|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153468023|NCT00556140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153468024|NCT00556140|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
153468025|NCT00556140|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
153468026|NCT00556140|Serotonin Agents|serotonin agents|mesh-ancestor
153468027|NCT00556140|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
153468028|NCT00556140|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153919253|NCT04205838|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
153919255|NCT04205838|Immunologic Factors|immunologic factors|mesh-ancestor
153919256|NCT04205838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153919257|NCT04205838|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153919258|NCT04205838|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153919259|NCT04205838|Alkylating Agents|alkylating agents|mesh-ancestor
153919260|NCT04205838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153919261|NCT04205838|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153919262|NCT04205838|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153919270|NCT04170543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153919271|NCT04170543|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153919272|NCT04170543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153919273|NCT04163016|Certolizumab Pegol|certolizumab pegol|mesh-list
153919274|NCT04163016|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
153919275|NCT04163016|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153919276|NCT04163016|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153919277|NCT04163016|Immunologic Factors|immunologic factors|mesh-ancestor
153919278|NCT04163016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153919279|NCT04163016|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153919280|NCT04147013|Celecoxib|celecoxib|mesh-list
153919281|NCT04147013|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153919282|NCT04147013|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153919284|NCT04147013|Sensory System Agents|sensory system agents|mesh-ancestor
153919285|NCT04147013|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153919286|NCT04147013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153919287|NCT04147013|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153919288|NCT04147013|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153919289|NCT04147013|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
153919290|NCT04147013|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153782377|NCT04670809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153898268|NCT01218516|Pemetrexed|pemetrexed|mesh-list
153919291|NCT04147013|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153919292|NCT04147013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153919293|NCT04084717|Crizotinib|crizotinib|mesh-list
153919294|NCT04084717|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153919295|NCT04084717|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153919296|NCT04084717|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153919297|NCT04084717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153919298|NCT04084717|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153919300|NCT03991819|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153468058|NCT00556452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153468059|NCT00556452|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153468061|NCT00556452|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153468062|NCT00556452|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153468063|NCT00556452|Antimetabolites|antimetabolites|mesh-ancestor
153468064|NCT03158376|Gabapentin|gabapentin|mesh-list
153468065|NCT03158376|Analgesics|analgesics|mesh-ancestor
153468066|NCT03158376|Sensory System Agents|sensory system agents|mesh-ancestor
153919301|NCT03991819|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153919302|NCT03991819|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153782378|NCT04670809|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153782379|NCT04670809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153919303|NCT03991819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153919304|NCT03919552|Cisplatin|cisplatin|mesh-list
153919305|NCT03919552|Carboplatin|carboplatin|mesh-list
153919306|NCT03919552|Docetaxel|docetaxel|mesh-list
153919307|NCT03919552|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153919308|NCT03919552|Tubulin Modulators|tubulin modulators|mesh-ancestor
153919309|NCT03919552|Antimitotic Agents|antimitotic agents|mesh-ancestor
153919310|NCT03919552|Mitosis Modulators|mitosis modulators|mesh-ancestor
153919311|NCT03919552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153919312|NCT03758950|Mometasone Furoate|mometasone furoate|mesh-list
153919313|NCT03758950|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153919314|NCT03758950|Dermatologic Agents|dermatologic agents|mesh-ancestor
153919315|NCT03758950|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
153919316|NCT03641456|Dexamethasone|dexamethasone|mesh-list
153919317|NCT03641456|Dexamethasone acetate|dexamethasone acetate|mesh-list
153919318|NCT03641456|Lenalidomide|lenalidomide|mesh-list
153919319|NCT03641456|Bortezomib|bortezomib|mesh-list
153919320|NCT03641456|BB 1101|bb 1101|mesh-list
153919321|NCT03641456|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153919322|NCT03641456|Antiemetics|antiemetics|mesh-ancestor
153919323|NCT03641456|Autonomic Agents|autonomic agents|mesh-ancestor
153919324|NCT03641456|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153919325|NCT03641456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153919326|NCT03641456|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153782380|NCT00233714|Sirolimus|sirolimus|mesh-list
153782381|NCT00233714|Temsirolimus|temsirolimus|mesh-list
153782382|NCT00233714|MTOR Inhibitors|mtor inhibitors|mesh-list
153919327|NCT03641456|Glucocorticoids|glucocorticoids|mesh-ancestor
153919328|NCT03641456|Hormones|hormones|mesh-ancestor
153919329|NCT03641456|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153919330|NCT03641456|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153919331|NCT03641456|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153919333|NCT03641456|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153919334|NCT03641456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153782383|NCT00233714|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153919335|NCT03641456|Immunologic Factors|immunologic factors|mesh-ancestor
153919336|NCT03641456|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153919337|NCT03641456|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153919338|NCT03641456|Growth Substances|growth substances|mesh-ancestor
153919339|NCT03641456|Growth Inhibitors|growth inhibitors|mesh-ancestor
153919340|NCT03493152|Everolimus|everolimus|mesh-list
153919341|NCT03493152|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
153919342|NCT03493152|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153919343|NCT03493152|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153919344|NCT03493152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153898295|NCT00949117|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153782384|NCT00233714|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153919345|NCT03493152|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153919346|NCT03493152|Immunologic Factors|immunologic factors|mesh-ancestor
153919347|NCT03493152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153919348|NCT03493152|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153919349|NCT03492671|Paclitaxel|paclitaxel|mesh-list
153919350|NCT03492671|Gemcitabine|gemcitabine|mesh-list
153898303|NCT00949117|Serotonin Agents|serotonin agents|mesh-ancestor
153919351|NCT03492671|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153919352|NCT03492671|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153919353|NCT03492671|Tubulin Modulators|tubulin modulators|mesh-ancestor
153919354|NCT03492671|Antimitotic Agents|antimitotic agents|mesh-ancestor
153468067|NCT03158376|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153919355|NCT03492671|Mitosis Modulators|mitosis modulators|mesh-ancestor
153919356|NCT03492671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153919357|NCT03492671|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153919358|NCT03492671|Antimetabolites|antimetabolites|mesh-ancestor
153919359|NCT03355300|Cannabidiol|cannabidiol|mesh-list
153919360|NCT03355300|Anticonvulsants|anticonvulsants|mesh-ancestor
153919361|NCT03255434|Oxaliplatin|oxaliplatin|mesh-list
153919362|NCT03255434|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153782385|NCT00233714|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153919363|NCT03087903|Grape Seed Extract|grape seed extract|mesh-list
153919364|NCT03087903|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153919365|NCT03087903|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153468122|NCT05622162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153468123|NCT00558012|Vitamin D|vitamin d|mesh-list
153468124|NCT00558012|Zoledronic Acid|zoledronic acid|mesh-list
153468125|NCT00558012|Calcium|calcium|mesh-list
153468126|NCT00558012|Vitamins|vitamins|mesh-ancestor
153468127|NCT00558012|Micronutrients|micronutrients|mesh-ancestor
153468128|NCT00558012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153468129|NCT00558012|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153468130|NCT00558012|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153468132|NCT00561834|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153468133|NCT00561834|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153468134|NCT00561834|Growth Substances|growth substances|mesh-ancestor
153919367|NCT03087903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153919368|NCT03087903|Protective Agents|protective agents|mesh-ancestor
153919369|NCT03087903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153919370|NCT03074045|Drospirenone|drospirenone|mesh-list
153919371|NCT03074045|Levonorgestrel|levonorgestrel|mesh-list
153919372|NCT03074045|Ethinyl Estradiol|ethinyl estradiol|mesh-list
153919373|NCT03074045|Estradiol|estradiol|mesh-list
153919374|NCT03074045|Estrogens|estrogens|mesh-ancestor
153919375|NCT03074045|Hormones|hormones|mesh-ancestor
153919376|NCT03074045|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153919377|NCT03074045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153919378|NCT03074045|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
153919386|NCT03074045|Hormone Antagonists|hormone antagonists|mesh-ancestor
153919387|NCT03074045|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
153782386|NCT00233714|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153919389|NCT03074045|Natriuretic Agents|natriuretic agents|mesh-ancestor
153919390|NCT02948543|Mitomycins|mitomycins|mesh-list
153919391|NCT02948543|Mitomycin|mitomycin|mesh-list
153919392|NCT02948543|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153439707|NCT00383539|Vaccines|vaccines|mesh-list
153919393|NCT02948543|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153919394|NCT02948543|Alkylating Agents|alkylating agents|mesh-ancestor
153919395|NCT02948543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153919396|NCT02948543|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153919397|NCT02948543|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153919398|NCT02901041|Zonisamide|zonisamide|mesh-list
153919399|NCT02901041|Anticonvulsants|anticonvulsants|mesh-ancestor
153919400|NCT02901041|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153919401|NCT02901041|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153919402|NCT02901041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153919403|NCT02901041|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153919404|NCT02901041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153919405|NCT02840227|Anesthetics|anesthetics|mesh-list
153919406|NCT02840227|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153919407|NCT02840227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153782388|NCT00233714|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153919408|NCT02705508|Gemcitabine|gemcitabine|mesh-list
153919409|NCT02705508|Etoposide|etoposide|mesh-list
153919410|NCT02705508|Etoposide phosphate|etoposide phosphate|mesh-list
153919411|NCT02705508|Pegaspargase|pegaspargase|mesh-list
153919412|NCT02705508|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153919413|NCT02705508|Antimetabolites|antimetabolites|mesh-ancestor
153919414|NCT02705508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153468135|NCT00561834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153919416|NCT02705508|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153919417|NCT02705508|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153919418|NCT02705508|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153919419|NCT02705508|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153919420|NCT02673398|Neratinib|neratinib|mesh-list
153919421|NCT02673398|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153919422|NCT02673398|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153919423|NCT02673398|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153919424|NCT02673398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153919425|NCT02547987|Carboplatin|carboplatin|mesh-list
153919426|NCT02547987|Docetaxel|docetaxel|mesh-list
153468185|NCT02128230|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153468186|NCT02128230|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153468187|NCT02128230|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153468188|NCT02128230|Growth Substances|growth substances|mesh-ancestor
153468189|NCT02128230|Growth Inhibitors|growth inhibitors|mesh-ancestor
153468190|NCT02128230|Leprostatic Agents|leprostatic agents|mesh-ancestor
153468191|NCT02128230|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153468192|NCT02128230|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153898338|NCT00604591|Tolcapone|tolcapone|mesh-list
153919427|NCT02547987|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153919428|NCT02547987|Tubulin Modulators|tubulin modulators|mesh-ancestor
153919429|NCT02547987|Antimitotic Agents|antimitotic agents|mesh-ancestor
153919430|NCT02547987|Mitosis Modulators|mitosis modulators|mesh-ancestor
153919431|NCT02547987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153919433|NCT02523040|Immunologic Factors|immunologic factors|mesh-ancestor
153919434|NCT02523040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153919435|NCT02523040|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153919436|NCT02523040|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153919438|NCT02523040|Growth Inhibitors|growth inhibitors|mesh-ancestor
153898345|NCT02691156|Bilirubin|bilirubin|mesh-list
153782390|NCT00233714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153919439|NCT02523040|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153919442|NCT02396043|Prednisone|prednisone|mesh-list
153919443|NCT02396043|Cyclophosphamide|cyclophosphamide|mesh-list
153919444|NCT02396043|Methotrexate|methotrexate|mesh-list
153919445|NCT02396043|Vincristine|vincristine|mesh-list
153919446|NCT02396043|Mercaptopurine|mercaptopurine|mesh-list
153919447|NCT02396043|Pegaspargase|pegaspargase|mesh-list
153919448|NCT02396043|Asparaginase|asparaginase|mesh-list
153919449|NCT02396043|Pirarubicin|pirarubicin|mesh-list
153919451|NCT02396043|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153919452|NCT02396043|Immunologic Factors|immunologic factors|mesh-ancestor
153919453|NCT02396043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153919454|NCT02396043|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153919455|NCT02396043|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153919456|NCT02396043|Alkylating Agents|alkylating agents|mesh-ancestor
153919457|NCT02396043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153919458|NCT02396043|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153919459|NCT02396043|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153919460|NCT02396043|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153919461|NCT02396043|Antiemetics|antiemetics|mesh-ancestor
153919462|NCT02396043|Autonomic Agents|autonomic agents|mesh-ancestor
153919463|NCT02396043|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153919464|NCT02396043|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153919465|NCT02396043|Glucocorticoids|glucocorticoids|mesh-ancestor
153919466|NCT02396043|Hormones|hormones|mesh-ancestor
153919467|NCT02396043|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153919468|NCT02396043|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153919469|NCT02396043|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153919470|NCT02396043|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
153919471|NCT02396043|Abortifacient Agents|abortifacient agents|mesh-ancestor
153919472|NCT02396043|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153919473|NCT02396043|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153919474|NCT02396043|Antimetabolites|antimetabolites|mesh-ancestor
153919475|NCT02396043|Dermatologic Agents|dermatologic agents|mesh-ancestor
153919476|NCT02396043|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153919477|NCT02396043|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153919478|NCT02396043|Antiviral Agents|antiviral agents|mesh-ancestor
153919479|NCT02396043|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153919480|NCT02396043|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153468194|NCT03416244|Nivolumab|nivolumab|mesh-list
153919481|NCT02396043|Tubulin Modulators|tubulin modulators|mesh-ancestor
153919482|NCT02396043|Antimitotic Agents|antimitotic agents|mesh-ancestor
153439659|NCT00003541|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153782391|NCT00233714|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153782392|NCT00233714|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153919483|NCT02396043|Mitosis Modulators|mitosis modulators|mesh-ancestor
153919484|NCT02396043|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153919485|NCT02396043|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153919486|NCT02396043|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153919487|NCT02232191|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
153919488|NCT02232191|Immunologic Factors|immunologic factors|mesh-ancestor
153919489|NCT02232191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153919490|NCT01273610|Trastuzumab|trastuzumab|mesh-list
153919491|NCT01273610|Lapatinib|lapatinib|mesh-list
153919492|NCT01273610|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153877870|NCT05293509|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153877871|NCT05293509|Glucocorticoids|glucocorticoids|mesh-ancestor
153877872|NCT05293509|Hormones|hormones|mesh-ancestor
153877873|NCT05293509|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153877874|NCT05293509|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153877875|NCT05293509|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153877892|NCT05284643|Growth Inhibitors|growth inhibitors|mesh-ancestor
153877894|NCT05256472|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153877895|NCT05256472|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153418670|NCT03032965|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153418674|NCT03032965|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
153418675|NCT03032965|Purinergic Agonists|purinergic agonists|mesh-ancestor
153418676|NCT03032965|Purinergic Agents|purinergic agents|mesh-ancestor
153418677|NCT03032965|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153418678|NCT03032965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153418679|NCT03032965|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
153418680|NCT03032965|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153418681|NCT03032965|Adrenergic Agents|adrenergic agents|mesh-ancestor
153418718|NCT03033511|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153877932|NCT05183412|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153877933|NCT05183412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153877934|NCT05183412|Adrenergic Agents|adrenergic agents|mesh-ancestor
153877935|NCT05183412|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
153877936|NCT05183412|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153877937|NCT05183412|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153877938|NCT05183412|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
153877939|NCT05147376|Curcumin|curcumin|mesh-list
153877940|NCT05147376|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153877941|NCT05147376|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153877942|NCT05147376|Analgesics|analgesics|mesh-ancestor
153418719|NCT03033511|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153418720|NCT03033511|Protease Inhibitors|protease inhibitors|mesh-ancestor
153418721|NCT03033511|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153898376|NCT02851459|Vaccines|vaccines|mesh-list
153782394|NCT04670497|Epinephrine|epinephrine|mesh-list
153782395|NCT04670497|Racepinephrine|racepinephrine|mesh-list
153418722|NCT03033511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153418723|NCT03033511|Immunologic Factors|immunologic factors|mesh-ancestor
153418724|NCT02951312|Glycopyrrolate|glycopyrrolate|mesh-list
153418725|NCT02951312|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
153418726|NCT02951312|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153418727|NCT02951312|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
153898407|NCT00606541|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153418728|NCT02951312|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
153418729|NCT02951312|Cholinergic Agents|cholinergic agents|mesh-ancestor
153418730|NCT02951312|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153418731|NCT02951312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153418732|NCT02951312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153418733|NCT03035929|Dexamethasone|dexamethasone|mesh-list
153418734|NCT03035929|Dexamethasone acetate|dexamethasone acetate|mesh-list
153877943|NCT05147376|Sensory System Agents|sensory system agents|mesh-ancestor
153877944|NCT05147376|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153877945|NCT05147376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153877946|NCT05147376|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153877947|NCT05147376|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153877948|NCT05147376|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153877949|NCT05147376|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153877950|NCT05147376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153782399|NCT04670497|Anesthetics|anesthetics|mesh-ancestor
153877952|NCT05118854|Carboplatin|carboplatin|mesh-list
153877953|NCT05118854|Pemetrexed|pemetrexed|mesh-list
153877954|NCT05118854|Sotorasib|sotorasib|mesh-list
153877955|NCT05118854|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153877956|NCT05118854|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153877957|NCT05118854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153877958|NCT05118854|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153418735|NCT03035929|BB 1101|bb 1101|mesh-list
153418736|NCT03035929|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153418737|NCT03035929|Antiemetics|antiemetics|mesh-ancestor
153418738|NCT03035929|Autonomic Agents|autonomic agents|mesh-ancestor
153418739|NCT03035929|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153418740|NCT03035929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153418741|NCT03035929|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153418742|NCT03035929|Glucocorticoids|glucocorticoids|mesh-ancestor
153418744|NCT03035929|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153418745|NCT03035929|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153418746|NCT03035929|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153418747|NCT03035929|Protease Inhibitors|protease inhibitors|mesh-ancestor
153418748|NCT03035929|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153418749|NCT03035929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153418750|NCT02951702|Vancomycin|vancomycin|mesh-list
153418751|NCT02951702|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153418757|NCT02831816|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153418758|NCT02831816|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153418759|NCT02831816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153418760|NCT02831816|Disinfectants|disinfectants|mesh-ancestor
153782400|NCT04670497|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153418761|NCT02831816|Dermatologic Agents|dermatologic agents|mesh-ancestor
153418763|NCT03036163|Antitubercular Agents|antitubercular agents|mesh-ancestor
153418764|NCT03036163|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153418765|NCT03036163|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153418766|NCT02953886|Fluorides|fluorides|mesh-list
153418767|NCT02953886|Cariostatic Agents|cariostatic agents|mesh-ancestor
153877960|NCT05118854|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153877961|NCT05118854|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153877962|NCT05116007|Carboplatin|carboplatin|mesh-list
153877963|NCT05116007|Etoposide|etoposide|mesh-list
153782402|NCT04670497|Sensory System Agents|sensory system agents|mesh-ancestor
153877980|NCT05083312|Autonomic Agents|autonomic agents|mesh-ancestor
153877981|NCT05083312|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153877982|NCT05083312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153877983|NCT05083312|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153877984|NCT05083312|Respiratory System Agents|respiratory system agents|mesh-ancestor
153877985|NCT05083312|Dermatologic Agents|dermatologic agents|mesh-ancestor
153877986|NCT05083312|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
153877987|NCT05079698|Pluvicto|pluvicto|mesh-list
153877988|NCT05079698|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
153877989|NCT05079698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153877990|NCT05078138|Epoetin Alfa|epoetin alfa|mesh-list
153877991|NCT05078138|Hematinics|hematinics|mesh-ancestor
153877992|NCT05069935|Cyclophosphamide|cyclophosphamide|mesh-list
153418771|NCT03035708|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
153418772|NCT03035708|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
153418773|NCT03035708|Cholinergic Agents|cholinergic agents|mesh-ancestor
153878010|NCT05062902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153418790|NCT02916745|Dermatologic Agents|dermatologic agents|mesh-ancestor
153878013|NCT05062902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153878014|NCT05058859|Dapagliflozin|dapagliflozin|mesh-list
153878015|NCT05058859|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
153878016|NCT05058859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153878017|NCT05058859|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153878018|NCT05058859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153878019|NCT05050500|Dapagliflozin|dapagliflozin|mesh-list
153878020|NCT05050500|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
153878021|NCT05050500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153878022|NCT05050500|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153878023|NCT05050500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153878024|NCT05043870|Infliximab|infliximab|mesh-list
153878025|NCT05043870|Immunosuppressive Agents|immunosuppressive agents|mesh-list
153782404|NCT04670497|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153878026|NCT05043870|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
153418807|NCT02954198|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153418813|NCT02954198|Antitubercular Agents|antitubercular agents|mesh-ancestor
153418814|NCT02954198|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153418815|NCT02954198|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153418816|NCT02954198|Antiemetics|antiemetics|mesh-ancestor
153418817|NCT02954198|Autonomic Agents|autonomic agents|mesh-ancestor
153418818|NCT02954198|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153418819|NCT02954198|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153418820|NCT02954198|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
153898455|NCT00605371|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153418821|NCT02954198|Protective Agents|protective agents|mesh-ancestor
153418822|NCT02956070|Dexamethasone|dexamethasone|mesh-list
153418836|NCT02956070|Protease Inhibitors|protease inhibitors|mesh-ancestor
153418837|NCT02956070|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153418838|NCT02956070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153418839|NCT02956616|Ketorolac|ketorolac|mesh-list
153418840|NCT02956616|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153418841|NCT02956616|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153418842|NCT02956616|Analgesics|analgesics|mesh-ancestor
153782405|NCT04670497|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153782406|NCT04670497|Adrenergic Agents|adrenergic agents|mesh-ancestor
153439771|NCT00002833|Cytarabine|cytarabine|mesh-list
153418843|NCT02956616|Sensory System Agents|sensory system agents|mesh-ancestor
153878069|NCT04979611|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
153878070|NCT04979611|Incretins|incretins|mesh-ancestor
153878072|NCT04979611|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153878073|NCT04971577|Simvastatin|simvastatin|mesh-list
153878074|NCT04971577|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153878075|NCT04971577|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153782407|NCT04670497|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153782408|NCT04670497|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153898477|NCT00934843|Antiemetics|antiemetics|mesh-ancestor
153878076|NCT04971577|Antimetabolites|antimetabolites|mesh-ancestor
153418858|NCT05829551|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153418859|NCT05829551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153418860|NCT05829551|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153418861|NCT05829551|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153418862|NCT05829551|Antiviral Agents|antiviral agents|mesh-ancestor
153418863|NCT05829551|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153898485|NCT00934843|Protective Agents|protective agents|mesh-ancestor
153418864|NCT05829551|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
153878079|NCT04971577|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
153878080|NCT04971577|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153878081|NCT04967248|Fulvestrant|fulvestrant|mesh-list
153878082|NCT04967248|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153878083|NCT04967248|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153878084|NCT04967248|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
153878085|NCT04967248|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
153878086|NCT04967248|Hormone Antagonists|hormone antagonists|mesh-ancestor
153878087|NCT04967248|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153878088|NCT04967248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153878089|NCT04952792|Apixaban|apixaban|mesh-list
153878090|NCT04952792|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
153878091|NCT04952792|Antithrombins|antithrombins|mesh-ancestor
153878092|NCT04952792|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
153878093|NCT04952792|Protease Inhibitors|protease inhibitors|mesh-ancestor
153878094|NCT04952792|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153475843|NCT00835224|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
153878095|NCT04952792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153878097|NCT04947631|Tadalafil|tadalafil|mesh-list
153878098|NCT04947631|Dutasteride|dutasteride|mesh-list
153878099|NCT04947631|Vasodilator Agents|vasodilator agents|mesh-ancestor
153878100|NCT04947631|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
153418877|NCT05829148|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153878109|NCT04947631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153878111|NCT04914910|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153878112|NCT04914910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153878113|NCT04913610|Ivermectin|ivermectin|mesh-list
153878114|NCT04913610|Albendazole|albendazole|mesh-list
153878115|NCT04913610|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153878116|NCT04913610|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153878117|NCT04913610|Anthelmintics|anthelmintics|mesh-ancestor
153782409|NCT04670497|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
153782410|NCT04670497|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153782411|NCT04670497|Autonomic Agents|autonomic agents|mesh-ancestor
153878118|NCT04913610|Anticestodal Agents|anticestodal agents|mesh-ancestor
153878119|NCT04913610|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
153878120|NCT04913610|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153878121|NCT04913610|Tubulin Modulators|tubulin modulators|mesh-ancestor
153878122|NCT04913610|Antimitotic Agents|antimitotic agents|mesh-ancestor
153878123|NCT04913610|Mitosis Modulators|mitosis modulators|mesh-ancestor
153878124|NCT04913610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153878125|NCT04913610|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153878126|NCT04893161|Belimumab|belimumab|mesh-list
153878127|NCT04893161|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153878128|NCT04893161|Immunologic Factors|immunologic factors|mesh-ancestor
153418910|NCT05828199|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153418912|NCT05828199|Sensory System Agents|sensory system agents|mesh-ancestor
153418914|NCT05828199|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
153418915|NCT05828199|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153418916|NCT05828199|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153418941|NCT05827770|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153418942|NCT05827770|Alkylating Agents|alkylating agents|mesh-ancestor
153418943|NCT05827770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153418944|NCT05827770|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153418945|NCT05827497|Methotrexate|methotrexate|mesh-list
153418946|NCT05827497|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
153418947|NCT05827497|Abortifacient Agents|abortifacient agents|mesh-ancestor
153418948|NCT05827497|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153418951|NCT05827497|Antimetabolites|antimetabolites|mesh-ancestor
153878158|NCT04864210|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153878159|NCT04864210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153878160|NCT04864210|Sensory System Agents|sensory system agents|mesh-ancestor
153878161|NCT04864210|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153782412|NCT04670497|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153878168|NCT04828031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153878169|NCT04828031|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153878178|NCT04825496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153878180|NCT04825496|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153878181|NCT04809220|Dulaglutide|dulaglutide|mesh-list
153418983|NCT05822934|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153418984|NCT05822934|Antimetabolites|antimetabolites|mesh-ancestor
153418985|NCT05822934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153418988|NCT05821972|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153418989|NCT05821972|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153418990|NCT05821972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153418991|NCT05821972|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153418992|NCT05821972|Analgesics|analgesics|mesh-ancestor
153418993|NCT05821972|Sensory System Agents|sensory system agents|mesh-ancestor
153418994|NCT05821972|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153418995|NCT05821972|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
153782413|NCT04670497|Respiratory System Agents|respiratory system agents|mesh-ancestor
153782414|NCT04670497|Mydriatics|mydriatics|mesh-ancestor
153418996|NCT05821972|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153418999|NCT05821972|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153878205|NCT04775550|Lenalidomide|lenalidomide|mesh-list
153878206|NCT04775550|Bortezomib|bortezomib|mesh-list
153878207|NCT04775550|Daratumumab|daratumumab|mesh-list
153878208|NCT04775550|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153878209|NCT04775550|Antiemetics|antiemetics|mesh-ancestor
153878210|NCT04775550|Autonomic Agents|autonomic agents|mesh-ancestor
153878211|NCT04775550|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153878212|NCT04775550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153878213|NCT04775550|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153878214|NCT04775550|Glucocorticoids|glucocorticoids|mesh-ancestor
153878215|NCT04775550|Hormones|hormones|mesh-ancestor
153782415|NCT04670497|Sympathomimetics|sympathomimetics|mesh-ancestor
153878217|NCT04775550|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153878218|NCT04775550|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153878238|NCT04764162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153878239|NCT04764162|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153878240|NCT04764162|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153419023|NCT05683535|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153419024|NCT05683535|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153782416|NCT04670497|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
153475846|NCT00835224|Adrenergic Agents|adrenergic agents|mesh-ancestor
153419026|NCT05683535|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153419027|NCT05683535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153419028|NCT05683535|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153419029|NCT05683535|Respiratory System Agents|respiratory system agents|mesh-ancestor
153419030|NCT05683535|Mydriatics|mydriatics|mesh-ancestor
153419031|NCT05683535|Parasympatholytics|parasympatholytics|mesh-ancestor
153419032|NCT05683535|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
153419033|NCT05683535|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
153419034|NCT05683535|Cholinergic Agents|cholinergic agents|mesh-ancestor
153419035|NCT05683535|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153419036|NCT05683535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153419037|NCT05678244|Acetaminophen|acetaminophen|mesh-list
153419038|NCT05678244|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153419039|NCT05678244|Analgesics|analgesics|mesh-ancestor
153419040|NCT05678244|Sensory System Agents|sensory system agents|mesh-ancestor
153419041|NCT05678244|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153419042|NCT05678244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153419043|NCT05678244|Antipyretics|antipyretics|mesh-ancestor
153419044|NCT05675800|Psilocybin|psilocybin|mesh-list
153419045|NCT05675800|Hallucinogens|hallucinogens|mesh-ancestor
153419046|NCT05675800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153419047|NCT05675800|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153419048|NCT05675319|Dexamethasone|dexamethasone|mesh-list
153419049|NCT05675319|Dexamethasone acetate|dexamethasone acetate|mesh-list
153419050|NCT05675319|Lenalidomide|lenalidomide|mesh-list
153419051|NCT05675319|Bortezomib|bortezomib|mesh-list
153878242|NCT04760613|Cannabidiol|cannabidiol|mesh-list
153878243|NCT04760613|Anticonvulsants|anticonvulsants|mesh-ancestor
153878244|NCT04732494|Tislelizumab|tislelizumab|mesh-list
153878245|NCT04732494|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153878246|NCT04732494|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153878247|NCT04721132|Bevacizumab|bevacizumab|mesh-list
153878251|NCT04721132|Antibodies|antibodies|mesh-list
153878252|NCT04721132|Immunoglobulins|immunoglobulins|mesh-list
153878253|NCT04721132|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
153878254|NCT04721132|Immunoglobulin G|immunoglobulin g|mesh-list
153878255|NCT04721132|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153878256|NCT04721132|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153878257|NCT04721132|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153878258|NCT04721132|Growth Substances|growth substances|mesh-ancestor
153878259|NCT04721132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153878260|NCT04721132|Growth Inhibitors|growth inhibitors|mesh-ancestor
153878261|NCT04721132|Immunologic Factors|immunologic factors|mesh-ancestor
153878262|NCT04721132|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153878263|NCT04721132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153878264|NCT04721106|Dacomitinib|dacomitinib|mesh-list
153878265|NCT04721106|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153878266|NCT04721106|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153878267|NCT04721106|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153878268|NCT04721106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153878269|NCT04701476|Pembrolizumab|pembrolizumab|mesh-list
153878270|NCT04701476|Tirapazamine|tirapazamine|mesh-list
153878271|NCT04701476|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153878272|NCT04701476|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153878273|NCT04701476|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153878274|NCT04701476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153878275|NCT04633551|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
153878276|NCT04620746|Penicillins|penicillins|mesh-list
153782417|NCT04670107|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
153878277|NCT04620746|Penicillin G|penicillin g|mesh-list
153419064|NCT05675319|Glucocorticoids|glucocorticoids|mesh-ancestor
153419066|NCT05675319|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153419067|NCT05675319|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153419068|NCT05675319|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153419069|NCT05675319|Protease Inhibitors|protease inhibitors|mesh-ancestor
153419070|NCT05675319|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153419071|NCT05675319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153878285|NCT04614909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153878286|NCT04614909|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153878287|NCT04614909|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
153878288|NCT04614909|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153878289|NCT04614636|Cyclophosphamide|cyclophosphamide|mesh-list
153878306|NCT04588246|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153475854|NCT00837252|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153360243|NCT01355705|Aspirin|aspirin|mesh-list
153878308|NCT04588246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153419096|NCT05615311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153419098|NCT05615311|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153419100|NCT05607615|Sequestering Agents|sequestering agents|mesh-ancestor
153419101|NCT05607615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153419103|NCT05593939|Niacin|niacin|mesh-list
153419104|NCT05593939|Nicotinic Acids|nicotinic acids|mesh-list
153419105|NCT05593939|Vitamin B Complex|vitamin b complex|mesh-ancestor
153419106|NCT05593939|Vitamins|vitamins|mesh-ancestor
153419107|NCT05593939|Micronutrients|micronutrients|mesh-ancestor
153878316|NCT04553666|Antioxidants|antioxidants|mesh-ancestor
153878317|NCT04553666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153878318|NCT04553666|Protective Agents|protective agents|mesh-ancestor
153878319|NCT04553666|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
153878320|NCT04553666|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
153878321|NCT04553666|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153878322|NCT04553666|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
153878323|NCT04551885|Aldesleukin|aldesleukin|mesh-list
153878324|NCT04551885|Cyclophosphamide|cyclophosphamide|mesh-list
153419114|NCT05577845|Ramosetron|ramosetron|mesh-list
153419115|NCT05577845|Antiemetics|antiemetics|mesh-ancestor
153419116|NCT05577845|Autonomic Agents|autonomic agents|mesh-ancestor
153419117|NCT05577845|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153419118|NCT05577845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153419119|NCT05577845|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153419120|NCT05577845|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153419121|NCT05577845|Serotonin Agents|serotonin agents|mesh-ancestor
153419122|NCT05577845|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153782418|NCT04670107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153419123|NCT05577845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153419124|NCT05527912|Rituximab|rituximab|mesh-list
153419125|NCT05527912|Zanubrutinib|zanubrutinib|mesh-list
153878333|NCT04551885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153878334|NCT04551885|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153878335|NCT04551885|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153878336|NCT04551885|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153878337|NCT04551885|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153419126|NCT05527912|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153419127|NCT05527912|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153419128|NCT05527912|Immunologic Factors|immunologic factors|mesh-ancestor
153419129|NCT05527912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153419130|NCT05527912|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153419131|NCT05527912|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153419132|NCT05527912|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153419133|NCT05527912|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153419134|NCT05527912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153878348|NCT04516447|Tubulin Modulators|tubulin modulators|mesh-ancestor
153878349|NCT04516447|Antimitotic Agents|antimitotic agents|mesh-ancestor
153878350|NCT04516447|Mitosis Modulators|mitosis modulators|mesh-ancestor
153878351|NCT04516447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153878352|NCT04516447|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153878353|NCT04516447|Antimetabolites|antimetabolites|mesh-ancestor
153878354|NCT04516447|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153878355|NCT04516447|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153419152|NCT05480878|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153419153|NCT05480878|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153419154|NCT05480878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153419155|NCT05480878|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153419156|NCT05480878|Serotonin Agents|serotonin agents|mesh-ancestor
153419157|NCT05480878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153419158|NCT05480878|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153419159|NCT05480878|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153419160|NCT05414331|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
153878363|NCT04485559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153878365|NCT04485559|Immunologic Factors|immunologic factors|mesh-ancestor
153878366|NCT04485559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153878367|NCT04485559|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153878368|NCT04466345|Semaglutide|semaglutide|mesh-list
153782419|NCT04670107|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153782420|NCT04670107|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153878369|NCT04466345|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
153878370|NCT04466345|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153878371|NCT04466345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153878372|NCT04466150|Ocrelizumab|ocrelizumab|mesh-list
153419162|NCT05414331|Adrenergic Agents|adrenergic agents|mesh-ancestor
153419165|NCT05414331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153419167|NCT05398367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153419168|NCT05383716|Pembrolizumab|pembrolizumab|mesh-list
153419169|NCT05383716|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153419170|NCT05383716|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153782421|NCT00260364|Bevacizumab|bevacizumab|mesh-list
153360247|NCT01355705|Amrubicin|amrubicin|mesh-list
153782422|NCT00260364|Gemcitabine|gemcitabine|mesh-list
153419171|NCT05383716|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153419172|NCT05383716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153419173|NCT05378945|Varenicline|varenicline|mesh-list
153878381|NCT04464265|Anesthetics|anesthetics|mesh-ancestor
153878382|NCT04448184|Tranexamic Acid|tranexamic acid|mesh-list
153878383|NCT04448184|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
153878384|NCT04448184|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153878385|NCT04448184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153419174|NCT05378945|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
153419175|NCT05378945|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
153782423|NCT00260364|Capecitabine|capecitabine|mesh-list
153782424|NCT00260364|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
153419176|NCT05378945|Cholinergic Agents|cholinergic agents|mesh-ancestor
153419177|NCT05378945|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153419178|NCT05378945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153419179|NCT05378945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153419180|NCT05330377|Cytarabine|cytarabine|mesh-list
153419181|NCT05330377|Mitoxantrone|mitoxantrone|mesh-list
153419182|NCT05330377|Cladribine|cladribine|mesh-list
153782426|NCT00260364|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153419183|NCT05330377|Lenograstim|lenograstim|mesh-list
153419184|NCT05330377|Gilteritinib|gilteritinib|mesh-list
153419185|NCT05330377|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153419186|NCT05330377|Antimetabolites|antimetabolites|mesh-ancestor
153419187|NCT05330377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153419188|NCT05330377|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153419189|NCT05330377|Antiviral Agents|antiviral agents|mesh-ancestor
153419190|NCT05330377|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153419191|NCT05330377|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153782428|NCT00260364|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153419192|NCT05330377|Immunologic Factors|immunologic factors|mesh-ancestor
153419193|NCT05330377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153419194|NCT05330377|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153419195|NCT05330377|Analgesics|analgesics|mesh-ancestor
153419197|NCT05330377|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153419198|NCT05330377|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153419199|NCT05330377|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153419200|NCT05330377|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153419201|NCT05330377|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153419202|NCT05330377|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153419203|NCT05323435|Vaccines|vaccines|mesh-list
153419204|NCT05323435|Immunologic Factors|immunologic factors|mesh-ancestor
153419205|NCT05323435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153419206|NCT05322252|Misoprostol|misoprostol|mesh-list
153419207|NCT05322252|Mifepristone|mifepristone|mesh-list
153878386|NCT04448184|Hemostatics|hemostatics|mesh-ancestor
153878387|NCT04448184|Coagulants|coagulants|mesh-ancestor
153878388|NCT04437888|Ketamine|ketamine|mesh-list
153878389|NCT04437888|Analgesics|analgesics|mesh-ancestor
153878390|NCT04437888|Sensory System Agents|sensory system agents|mesh-ancestor
153878391|NCT04437888|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153419208|NCT05322252|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
153878392|NCT04437888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153878393|NCT04437888|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
153782429|NCT00260364|Growth Substances|growth substances|mesh-ancestor
153878394|NCT04437888|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153878395|NCT04437888|Anesthetics, General|anesthetics, general|mesh-ancestor
153878396|NCT04437888|Anesthetics|anesthetics|mesh-ancestor
153878397|NCT04437888|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153878398|NCT04437888|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
153878399|NCT04437888|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
153878400|NCT04437888|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153878401|NCT04437888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153878402|NCT04417062|Olaparib|olaparib|mesh-list
153878403|NCT04417062|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
153878404|NCT04417062|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153878405|NCT04417062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153878406|NCT04417062|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153878407|NCT04406389|Heparin|heparin|mesh-list
153878408|NCT04406389|Calcium heparin|calcium heparin|mesh-list
153878409|NCT04406389|Enoxaparin|enoxaparin|mesh-list
153878414|NCT04406389|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153878415|NCT04406389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153878416|NCT04406389|Antithrombins|antithrombins|mesh-ancestor
153878417|NCT04406389|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
153878418|NCT04406389|Protease Inhibitors|protease inhibitors|mesh-ancestor
153878419|NCT04406389|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153878420|NCT04406389|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153878421|NCT04356729|Bevacizumab|bevacizumab|mesh-list
153878422|NCT04356729|Atezolizumab|atezolizumab|mesh-list
153878423|NCT04356729|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153878424|NCT04356729|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153419219|NCT05322252|Contraceptive Agents|contraceptive agents|mesh-ancestor
153419220|NCT05322252|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
153419221|NCT05322252|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
153419222|NCT05322252|Hormone Antagonists|hormone antagonists|mesh-ancestor
153419223|NCT05322252|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153419224|NCT05322252|Luteolytic Agents|luteolytic agents|mesh-ancestor
153419227|NCT05246943|Fibrin fragment D|fibrin fragment d|mesh-list
153419228|NCT05246943|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
153419229|NCT05246943|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153419230|NCT05246943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153419231|NCT05246943|Hemostatics|hemostatics|mesh-ancestor
153419232|NCT05246943|Coagulants|coagulants|mesh-ancestor
153419233|NCT05212454|Capecitabine|capecitabine|mesh-list
153419234|NCT05212454|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153419235|NCT05212454|Antimetabolites|antimetabolites|mesh-ancestor
153419236|NCT05212454|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153419237|NCT05212454|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153419238|NCT05096845|Vaccines|vaccines|mesh-list
153419239|NCT05096845|Immunologic Factors|immunologic factors|mesh-ancestor
153419240|NCT05096845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153419241|NCT05091866|Progesterone|progesterone|mesh-list
153878440|NCT04329650|Glucocorticoids|glucocorticoids|mesh-ancestor
153878441|NCT04329650|Hormones|hormones|mesh-ancestor
153878443|NCT04329650|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153878444|NCT04329650|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153878445|NCT04327310|Meplazumab|meplazumab|mesh-list
153878446|NCT04327310|Antiviral Agents|antiviral agents|mesh-ancestor
153878447|NCT04327310|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153878448|NCT04282187|Azacitidine|azacitidine|mesh-list
153878449|NCT04282187|Decitabine|decitabine|mesh-list
153878450|NCT04282187|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-list
153878451|NCT04282187|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153878452|NCT04282187|Antimetabolites|antimetabolites|mesh-ancestor
153419243|NCT05091866|Hormones|hormones|mesh-ancestor
153419244|NCT05091866|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153419245|NCT05091866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153419246|NCT05079828|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
153419247|NCT05079828|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
153878501|NCT04204798|Dexmedetomidine|dexmedetomidine|mesh-list
153878502|NCT04204798|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153419293|NCT04987892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153419294|NCT04987892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153419296|NCT05019222|Anesthetics|anesthetics|mesh-list
153419297|NCT05019222|Sevoflurane|sevoflurane|mesh-list
153419298|NCT05019222|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153782431|NCT00260364|Growth Inhibitors|growth inhibitors|mesh-ancestor
153419299|NCT05019222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153419300|NCT05019222|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153419301|NCT05019222|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
153419311|NCT04966663|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153419312|NCT04966663|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153878505|NCT04204798|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153878507|NCT04204798|Sensory System Agents|sensory system agents|mesh-ancestor
153782433|NCT00260364|Antimetabolites|antimetabolites|mesh-ancestor
153878508|NCT04204798|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153878509|NCT04204798|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
153878510|NCT04204798|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153878511|NCT04204798|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153878512|NCT04204798|Adrenergic Agents|adrenergic agents|mesh-ancestor
153878515|NCT04193293|Pembrolizumab|pembrolizumab|mesh-list
153878516|NCT04193293|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
153878517|NCT04193293|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153878518|NCT04193293|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153878519|NCT04193293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153878520|NCT04171843|Cyclophosphamide|cyclophosphamide|mesh-list
153419313|NCT04966663|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153419314|NCT04966663|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153419318|NCT04922593|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153419319|NCT04922593|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153419320|NCT04922593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153419321|NCT04922593|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153419322|NCT04922593|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
153419323|NCT04922593|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153419325|NCT04922593|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153878529|NCT04171843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153878530|NCT04171843|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153878531|NCT04171843|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153878532|NCT04171843|Gamma Secretase Inhibitors and Modulators|gamma secretase inhibitors and modulators|mesh-ancestor
153878533|NCT04171843|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153419326|NCT04922593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153419327|NCT04922593|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
153419328|NCT04922593|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
153419343|NCT04889118|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153419344|NCT04819971|Docetaxel|docetaxel|mesh-list
153419345|NCT04819971|Oxaliplatin|oxaliplatin|mesh-list
153419346|NCT04819971|Trastuzumab|trastuzumab|mesh-list
153419347|NCT04819971|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153419348|NCT04819971|Tubulin Modulators|tubulin modulators|mesh-ancestor
153419349|NCT04819971|Antimitotic Agents|antimitotic agents|mesh-ancestor
153419350|NCT04819971|Mitosis Modulators|mitosis modulators|mesh-ancestor
153419351|NCT04819971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153419352|NCT04819971|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153419353|NCT04724148|Fentanyl|fentanyl|mesh-list
153419354|NCT04724148|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153419355|NCT04724148|Narcotics|narcotics|mesh-ancestor
153878543|NCT04141501|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153878545|NCT04091490|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153878546|NCT04091490|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153878547|NCT04091490|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153878548|NCT04091490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153878549|NCT04082780|Rifamycins|rifamycins|mesh-list
153878550|NCT04082780|Rifamycin SV|rifamycin sv|mesh-list
153878551|NCT04082780|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153878552|NCT04082780|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153878553|NCT04082780|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153878554|NCT04080284|Niraparib|niraparib|mesh-list
153878555|NCT04080284|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
153878556|NCT04080284|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153878557|NCT04080284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153878558|NCT04080284|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153878559|NCT04067115|Alovudine|alovudine|mesh-list
153878561|NCT04067115|Trabectedin|trabectedin|mesh-list
153878564|NCT04067115|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153878565|NCT04067115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153419358|NCT04724148|Analgesics|analgesics|mesh-ancestor
153419359|NCT04724148|Sensory System Agents|sensory system agents|mesh-ancestor
153419360|NCT04724148|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153419361|NCT04724148|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153419362|NCT04724148|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153419363|NCT04724148|Anesthetics, General|anesthetics, general|mesh-ancestor
153419364|NCT04724148|Anesthetics|anesthetics|mesh-ancestor
153419365|NCT04703803|Lidocaine|lidocaine|mesh-list
153419366|NCT04703803|Anesthetics, Local|anesthetics, local|mesh-ancestor
153878569|NCT04067115|Antiviral Agents|antiviral agents|mesh-ancestor
153878570|NCT04067115|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153878571|NCT04054375|Prednisone|prednisone|mesh-list
153878572|NCT04054375|Prednisolone|prednisolone|mesh-list
153878573|NCT04054375|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153878574|NCT04054375|Glucocorticoids|glucocorticoids|mesh-ancestor
153878575|NCT04054375|Hormones|hormones|mesh-ancestor
153878576|NCT04054375|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153878578|NCT04054375|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153878579|NCT04054375|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153419373|NCT04703803|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
153419374|NCT04703803|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153419375|NCT04703803|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153419376|NCT04703803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153419378|NCT04670978|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153419379|NCT04670978|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153419380|NCT04670978|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153419381|NCT04670978|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153419384|NCT04670978|Growth Inhibitors|growth inhibitors|mesh-ancestor
153419385|NCT04639180|Apatinib|apatinib|mesh-list
153419386|NCT04639180|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153419387|NCT04639180|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153419388|NCT04639180|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153419389|NCT04639180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153419390|NCT04531943|Progesterone|progesterone|mesh-list
153419391|NCT04531943|Estrogens|estrogens|mesh-list
153419392|NCT04531943|Progestins|progestins|mesh-ancestor
153419393|NCT04531943|Hormones|hormones|mesh-ancestor
153419394|NCT04531943|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153419395|NCT04531943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153419396|NCT04516850|Steroid delta-isomerase|steroid delta-isomerase|mesh-list
153419398|NCT04516850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153419400|NCT04503460|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
153419401|NCT04503460|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
153419402|NCT04503460|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153419403|NCT04503460|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153419405|NCT04503460|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153419406|NCT04503460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153878582|NCT04028830|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153878583|NCT04028830|Antitubercular Agents|antitubercular agents|mesh-ancestor
153878585|NCT04017442|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153878587|NCT04017442|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153878588|NCT04017442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153878589|NCT04017442|Analgesics|analgesics|mesh-ancestor
153878590|NCT04017442|Sensory System Agents|sensory system agents|mesh-ancestor
153878591|NCT04017442|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153878592|NCT04015622|Docetaxel|docetaxel|mesh-list
153878593|NCT04015622|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153878594|NCT04015622|Tubulin Modulators|tubulin modulators|mesh-ancestor
153878595|NCT04015622|Antimitotic Agents|antimitotic agents|mesh-ancestor
153878596|NCT04015622|Mitosis Modulators|mitosis modulators|mesh-ancestor
153878597|NCT04015622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153878598|NCT04010578|Vitamin D|vitamin d|mesh-list
153878599|NCT04010578|Cholecalciferol|cholecalciferol|mesh-list
153878600|NCT04010578|Vitamins|vitamins|mesh-ancestor
153878601|NCT04010578|Micronutrients|micronutrients|mesh-ancestor
153878602|NCT04010578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153878603|NCT04010578|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153878604|NCT04010578|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153878605|NCT03994055|Antioxidants|antioxidants|mesh-list
153878606|NCT03994055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153878607|NCT03994055|Protective Agents|protective agents|mesh-ancestor
153878608|NCT03994055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153878609|NCT03991104|Oxaliplatin|oxaliplatin|mesh-list
153878610|NCT03991104|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153878611|NCT03968913|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
153878612|NCT03968913|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153878613|NCT03959488|Palivizumab|palivizumab|mesh-list
153419407|NCT04503460|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153419410|NCT04503460|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
153419411|NCT04503460|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
153419412|NCT04503460|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
153419413|NCT04503460|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153419414|NCT04503460|Adrenergic Agents|adrenergic agents|mesh-ancestor
153419415|NCT04503460|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153419416|NCT04503460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153419417|NCT04503460|Glucocorticoids|glucocorticoids|mesh-ancestor
153419422|NCT04395196|Lipotropic Agents|lipotropic agents|mesh-ancestor
153419423|NCT04395196|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153419424|NCT04395196|Antimetabolites|antimetabolites|mesh-ancestor
153419425|NCT04395196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153419426|NCT04395196|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153419427|NCT04395196|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153419428|NCT04395196|Nootropic Agents|nootropic agents|mesh-ancestor
153419429|NCT04233515|Anticoagulants|anticoagulants|mesh-list
153419430|NCT04169373|Upadacitinib|upadacitinib|mesh-list
153419431|NCT04169373|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
153419432|NCT04169373|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153419433|NCT04169373|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153419434|NCT04169373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153419435|NCT04169373|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153419436|NCT04150042|Vitamins|vitamins|mesh-list
153419437|NCT04150042|Ascorbic Acid|ascorbic acid|mesh-list
153878626|NCT03950817|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
153878627|NCT03950817|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
153878628|NCT03950817|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153878629|NCT03950817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153878630|NCT03936894|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
153878631|NCT03936894|Immunologic Factors|immunologic factors|mesh-ancestor
153878632|NCT03936894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153878633|NCT03913195|Ibalizumab|ibalizumab|mesh-list
153878634|NCT03913195|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153878635|NCT03913195|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153878636|NCT03913195|Antiviral Agents|antiviral agents|mesh-ancestor
153878637|NCT03913195|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153878638|NCT03907124|Psychotropic Drugs|psychotropic drugs|mesh-list
153878639|NCT03873818|Pembrolizumab|pembrolizumab|mesh-list
153878640|NCT03873818|Ipilimumab|ipilimumab|mesh-list
153878641|NCT03873818|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153878642|NCT03873818|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153878643|NCT03873818|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153419439|NCT04150042|Hydroxocobalamin|hydroxocobalamin|mesh-list
153419441|NCT04150042|Melphalan|melphalan|mesh-list
153419442|NCT04150042|Carmustine|carmustine|mesh-list
153419443|NCT04150042|Micronutrients|micronutrients|mesh-ancestor
153419444|NCT04150042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153419445|NCT04150042|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153419446|NCT04150042|Alkylating Agents|alkylating agents|mesh-ancestor
153419447|NCT04150042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153419448|NCT04150042|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153878651|NCT03843294|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153878652|NCT03843294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153878654|NCT03765541|Dexamethasone|dexamethasone|mesh-list
153878655|NCT03765541|Azacitidine|azacitidine|mesh-list
153878656|NCT03765541|Amsacrine|amsacrine|mesh-list
153878657|NCT03765541|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153878658|NCT03765541|Antiemetics|antiemetics|mesh-ancestor
153878659|NCT03765541|Autonomic Agents|autonomic agents|mesh-ancestor
153419456|NCT04150042|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153419457|NCT04150042|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153419458|NCT04150042|Hematinics|hematinics|mesh-ancestor
153419459|NCT04093024|Nintedanib|nintedanib|mesh-list
153419460|NCT04093024|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153419461|NCT04093024|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153419462|NCT04093024|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153878666|NCT03765541|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153878668|NCT03765541|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153878669|NCT03765541|Antimetabolites|antimetabolites|mesh-ancestor
153878670|NCT03765541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153878671|NCT03765541|Antiviral Agents|antiviral agents|mesh-ancestor
153878672|NCT03765541|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153878673|NCT03765541|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153878674|NCT03765541|Immunologic Factors|immunologic factors|mesh-ancestor
153878675|NCT03765541|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153419473|NCT04014790|Immunologic Factors|immunologic factors|mesh-ancestor
153419474|NCT04014790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153419475|NCT04014790|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153419476|NCT03965234|Cisplatin|cisplatin|mesh-list
153419477|NCT03965234|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153419483|NCT03827070|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153419484|NCT03827070|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153419485|NCT03827070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153419486|NCT03827070|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153419487|NCT03748303|Pregnanolone|pregnanolone|mesh-list
153419488|NCT03748303|Anesthetics|anesthetics|mesh-ancestor
153419489|NCT03748303|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153419490|NCT03748303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153419491|NCT03680053|Cetrorelix|cetrorelix|mesh-list
153419492|NCT03680053|Dydrogesterone|dydrogesterone|mesh-list
153419493|NCT03680053|Fertility Agents, Female|fertility agents, female|mesh-ancestor
153419494|NCT03680053|Fertility Agents|fertility agents|mesh-ancestor
153419495|NCT03680053|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153419496|NCT03680053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153419497|NCT03680053|Hormone Antagonists|hormone antagonists|mesh-ancestor
153419499|NCT03680053|Progestins|progestins|mesh-ancestor
153419500|NCT03680053|Hormones|hormones|mesh-ancestor
153419501|NCT03673007|Contraceptive Agents|contraceptive agents|mesh-list
153419502|NCT03673007|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153419503|NCT03673007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153419504|NCT03657602|Levonorgestrel|levonorgestrel|mesh-list
153419505|NCT03657602|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
153878685|NCT03712098|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
153878687|NCT03712098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153878688|NCT03712098|Incretins|incretins|mesh-ancestor
153919558|NCT00004223|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153919559|NCT00004223|Antimetabolites|antimetabolites|mesh-ancestor
153919560|NCT00004223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153919561|NCT00004223|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153919562|NCT00004223|Tubulin Modulators|tubulin modulators|mesh-ancestor
153919563|NCT00004223|Antimitotic Agents|antimitotic agents|mesh-ancestor
153919564|NCT00004223|Mitosis Modulators|mitosis modulators|mesh-ancestor
153919565|NCT00003764|Cyclophosphamide|cyclophosphamide|mesh-list
153919566|NCT00003764|Fludarabine|fludarabine|mesh-list
153919567|NCT00003764|Fludarabine phosphate|fludarabine phosphate|mesh-list
153919568|NCT00003764|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153878689|NCT03712098|Hormones|hormones|mesh-ancestor
153878690|NCT03712098|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153878691|NCT03704688|Trametinib|trametinib|mesh-list
153878692|NCT03704688|Ponatinib|ponatinib|mesh-list
153878693|NCT03704688|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153878694|NCT03704688|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153878695|NCT03704688|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153878696|NCT03704688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153878697|NCT03704688|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153878699|NCT03686332|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
153878700|NCT03686332|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153878705|NCT03686332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153419506|NCT03657602|Contraceptive Agents|contraceptive agents|mesh-ancestor
153419507|NCT03657602|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153419508|NCT03657602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153419519|NCT03625687|Sofosbuvir-velpatasvir drug combination|sofosbuvir-velpatasvir drug combination|mesh-list
153419520|NCT03625687|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153419522|NCT03469284|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153419526|NCT03425331|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153419527|NCT03425331|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153419528|NCT03425331|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153419529|NCT03425331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153878742|NCT03616886|Paclitaxel|paclitaxel|mesh-list
153878743|NCT03616886|Carboplatin|carboplatin|mesh-list
153878744|NCT03616886|Durvalumab|durvalumab|mesh-list
153419545|NCT03043430|Midazolam|midazolam|mesh-list
153419546|NCT03043430|Ketamine|ketamine|mesh-list
153419547|NCT03043430|Analgesics|analgesics|mesh-ancestor
153419548|NCT03043430|Sensory System Agents|sensory system agents|mesh-ancestor
153419549|NCT03043430|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153419550|NCT03043430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153419551|NCT03043430|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
153419552|NCT03043430|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153419553|NCT03043430|Anesthetics, General|anesthetics, general|mesh-ancestor
153419554|NCT03043430|Anesthetics|anesthetics|mesh-ancestor
153419555|NCT03043430|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153419556|NCT03043430|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
153419557|NCT03043430|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
153419558|NCT03043430|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153419559|NCT03043430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153419560|NCT03043430|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153419561|NCT03043430|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153419564|NCT03043430|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153419565|NCT03043430|GABA Modulators|gaba modulators|mesh-ancestor
153419566|NCT03043430|GABA Agents|gaba agents|mesh-ancestor
153878767|NCT03601897|Mitosis Modulators|mitosis modulators|mesh-ancestor
153878768|NCT03601897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153878769|NCT03601897|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153878770|NCT03601897|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153878771|NCT03562507|Nivolumab|nivolumab|mesh-list
153878772|NCT03562507|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153419574|NCT03004261|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153419575|NCT03004261|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153419576|NCT03004261|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153419577|NCT03004261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153919570|NCT00003764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153919571|NCT00003764|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153919572|NCT00003764|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153919573|NCT00003764|Alkylating Agents|alkylating agents|mesh-ancestor
153419578|NCT03004261|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153419579|NCT02856425|Pembrolizumab|pembrolizumab|mesh-list
153419580|NCT02856425|Nintedanib|nintedanib|mesh-list
153419581|NCT02856425|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153419582|NCT02856425|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153419583|NCT02856425|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153419651|NCT00255346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153419652|NCT00255346|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153419666|NCT02839772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153419667|NCT03041636|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-list
153419668|NCT03041636|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153419669|NCT03041636|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153419678|NCT03043105|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153419679|NCT03043105|Alkylating Agents|alkylating agents|mesh-ancestor
153419680|NCT03043105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153419681|NCT03043105|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153419682|NCT03043105|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153419683|NCT03043105|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153419684|NCT03043105|Glucocorticoids|glucocorticoids|mesh-ancestor
153419685|NCT03043105|Hormones|hormones|mesh-ancestor
153419686|NCT03043105|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153419687|NCT03043105|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153419688|NCT03043105|Leprostatic Agents|leprostatic agents|mesh-ancestor
153419689|NCT03043105|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153419690|NCT03043105|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153419691|NCT03043105|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153419692|NCT03043105|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153419693|NCT03043105|Growth Substances|growth substances|mesh-ancestor
153419694|NCT03043105|Growth Inhibitors|growth inhibitors|mesh-ancestor
153419702|NCT00374647|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153419703|NCT00374647|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153419704|NCT00374647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153419705|NCT00374647|Antifungal Agents|antifungal agents|mesh-ancestor
153419706|NCT00374647|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153419707|NCT00374647|Immunologic Factors|immunologic factors|mesh-ancestor
153419729|NCT02969876|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153419730|NCT02969876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153419732|NCT02969876|Serotonin Agents|serotonin agents|mesh-ancestor
153419733|NCT02969876|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
153419734|NCT02969876|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
153419735|NCT02969876|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
153419736|NCT02969876|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153419737|NCT02970032|Heparin|heparin|mesh-list
153419738|NCT02970032|Calcium heparin|calcium heparin|mesh-list
153419739|NCT02970032|Anticoagulants|anticoagulants|mesh-ancestor
153419740|NCT02970032|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153419741|NCT02970032|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153419744|NCT02813551|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153419746|NCT02813551|Natriuretic Agents|natriuretic agents|mesh-ancestor
153419747|NCT02813551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153419748|NCT02813551|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
153878921|NCT03291158|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153878922|NCT03291158|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153878923|NCT03259867|Nivolumab|nivolumab|mesh-list
153878924|NCT03259867|Tirapazamine|tirapazamine|mesh-list
153878925|NCT03259867|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153878927|NCT03259867|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153878928|NCT03259867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153878929|NCT03226691|Plerixafor|plerixafor|mesh-list
153878930|NCT03226691|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153878931|NCT03226691|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153878932|NCT03226691|Antiviral Agents|antiviral agents|mesh-ancestor
153878933|NCT03226691|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153878934|NCT03202628|Dexamethasone|dexamethasone|mesh-list
153878935|NCT03202628|Dexamethasone acetate|dexamethasone acetate|mesh-list
153878936|NCT03202628|Pomalidomide|pomalidomide|mesh-list
153878937|NCT03202628|Ixazomib|ixazomib|mesh-list
153878938|NCT03202628|Ichthammol|ichthammol|mesh-list
153878939|NCT03202628|BB 1101|bb 1101|mesh-list
153878940|NCT03202628|Glycine|glycine|mesh-list
153878941|NCT03202628|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153878942|NCT03202628|Antiemetics|antiemetics|mesh-ancestor
153878943|NCT03202628|Autonomic Agents|autonomic agents|mesh-ancestor
153878944|NCT03202628|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153878945|NCT03202628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153878946|NCT03202628|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153878947|NCT03202628|Glucocorticoids|glucocorticoids|mesh-ancestor
153419752|NCT02817763|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153419753|NCT02817763|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153419754|NCT02817763|Analgesics|analgesics|mesh-ancestor
153419755|NCT02817763|Sensory System Agents|sensory system agents|mesh-ancestor
153419756|NCT02817763|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153419757|NCT02817763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153419758|NCT02817763|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153419759|NCT02817763|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153419760|NCT02817763|Antipyretics|antipyretics|mesh-ancestor
153419761|NCT02846792|Nivolumab|nivolumab|mesh-list
153419762|NCT02846792|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153419763|NCT02846792|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153419764|NCT02846792|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153419765|NCT02846792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153419815|NCT00373789|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
153419816|NCT00373789|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
153419817|NCT00373789|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
153419818|NCT00373789|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153419832|NCT03050294|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153419833|NCT03050294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153419835|NCT02831569|Methocarbamol|methocarbamol|mesh-list
153879016|NCT03129828|Bortezomib|bortezomib|mesh-list
153879017|NCT03129828|Ibrutinib|ibrutinib|mesh-list
153879018|NCT03129828|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153879019|NCT03129828|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153879020|NCT03129828|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153879021|NCT03129828|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153879023|NCT03127631|Atorvastatin|atorvastatin|mesh-list
153879024|NCT03127631|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
153879025|NCT03127631|Simvastatin|simvastatin|mesh-list
153419838|NCT02831569|Analgesics|analgesics|mesh-ancestor
153419839|NCT02831569|Sensory System Agents|sensory system agents|mesh-ancestor
153419840|NCT02831569|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153419841|NCT02831569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153419842|NCT02831569|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153419843|NCT02831569|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153419844|NCT02831569|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
153419845|NCT02831569|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
153419846|NCT03065179|Nivolumab|nivolumab|mesh-list
153419847|NCT03065179|Ipilimumab|ipilimumab|mesh-list
153919574|NCT00003764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153919575|NCT00003764|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153919576|NCT00003764|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153919577|NCT00003764|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153919578|NCT00003764|Antimetabolites|antimetabolites|mesh-ancestor
153419848|NCT03065179|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153419854|NCT02988050|Dexmedetomidine|dexmedetomidine|mesh-list
153419855|NCT02988050|Remifentanil|remifentanil|mesh-list
153419856|NCT02988050|Bupivacaine|bupivacaine|mesh-list
153419857|NCT02988050|Propofol|propofol|mesh-list
153419858|NCT02988050|Anesthetics, Local|anesthetics, local|mesh-ancestor
153419859|NCT02988050|Anesthetics|anesthetics|mesh-ancestor
153419860|NCT02988050|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153419861|NCT02988050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153419863|NCT02988050|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153419864|NCT02988050|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153419865|NCT02988050|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
153419866|NCT02988050|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153419867|NCT02988050|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153879035|NCT03127631|Protease Inhibitors|protease inhibitors|mesh-ancestor
153879038|NCT06080854|Paclitaxel|paclitaxel|mesh-list
153879039|NCT06080854|Gemcitabine|gemcitabine|mesh-list
153879040|NCT06080854|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153879041|NCT06080854|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153879042|NCT06080854|Tubulin Modulators|tubulin modulators|mesh-ancestor
153879043|NCT06080854|Antimitotic Agents|antimitotic agents|mesh-ancestor
153879044|NCT06080854|Mitosis Modulators|mitosis modulators|mesh-ancestor
153879064|NCT06080802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153879065|NCT06080724|Dexamethasone|dexamethasone|mesh-list
153419868|NCT02988050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153419869|NCT02988050|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153419870|NCT02988050|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153419871|NCT02988050|Analgesics|analgesics|mesh-ancestor
153419872|NCT02988050|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
153419873|NCT02988050|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153419874|NCT02988050|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153419875|NCT02988050|Adrenergic Agents|adrenergic agents|mesh-ancestor
153419876|NCT02988050|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153419877|NCT02988050|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153419878|NCT02988050|Anesthetics, General|anesthetics, general|mesh-ancestor
153419879|NCT02988050|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
153419880|NCT02988050|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153419881|NCT02988050|Autonomic Agents|autonomic agents|mesh-ancestor
153419882|NCT02988050|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153419883|NCT02988050|Respiratory System Agents|respiratory system agents|mesh-ancestor
153419884|NCT02988050|Mydriatics|mydriatics|mesh-ancestor
153419885|NCT02988050|Sympathomimetics|sympathomimetics|mesh-ancestor
153419886|NCT02988050|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
153419887|NCT02988050|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153419888|NCT02988050|Narcotics|narcotics|mesh-ancestor
153419889|NCT02988986|Tamoxifen|tamoxifen|mesh-list
153419890|NCT02988986|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
153419891|NCT02988986|Hormone Antagonists|hormone antagonists|mesh-ancestor
153461753|NCT03708588|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
153419896|NCT02988986|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
153419897|NCT02988986|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
153419898|NCT02988986|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153419900|NCT02832115|Nitroglycerin|nitroglycerin|mesh-list
153419901|NCT02832115|Anesthetics, Local|anesthetics, local|mesh-list
153419902|NCT02832115|Anesthetics|anesthetics|mesh-list
153419903|NCT02832115|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153419904|NCT02832115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153419905|NCT02832115|Sensory System Agents|sensory system agents|mesh-ancestor
153419906|NCT02832115|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153419935|NCT02935699|Antipruritics|antipruritics|mesh-ancestor
153419936|NCT02935699|Dermatologic Agents|dermatologic agents|mesh-ancestor
153419937|NCT02936479|Complement C1 Inactivator Proteins|complement c1 inactivator proteins|mesh-list
153419938|NCT02936479|Complement C1 Inhibitor Protein|complement c1 inhibitor protein|mesh-list
153419939|NCT02936479|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
153419940|NCT02936479|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153419941|NCT02936479|Immunologic Factors|immunologic factors|mesh-ancestor
153879133|NCT06079606|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153879134|NCT06079333|Trametinib|trametinib|mesh-list
153879135|NCT06079333|Dabrafenib|dabrafenib|mesh-list
153879136|NCT06079333|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153879137|NCT06079333|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153879138|NCT06079333|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153419942|NCT02936479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153419943|NCT02841241|Esmolol|esmolol|mesh-list
153419944|NCT02841241|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
153419945|NCT02841241|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
153419946|NCT02841241|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
153419947|NCT02841241|Adrenergic Agents|adrenergic agents|mesh-ancestor
153419948|NCT02841241|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153419949|NCT02841241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153419950|NCT02841241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153419951|NCT00374881|Phenylephrine|phenylephrine|mesh-list
153419952|NCT00374881|Oxymetazoline|oxymetazoline|mesh-list
153419953|NCT00374881|Morphine|morphine|mesh-list
153419954|NCT00374881|Sorbitol|sorbitol|mesh-list
153419955|NCT00374881|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153419956|NCT00374881|Narcotics|narcotics|mesh-ancestor
153419957|NCT00374881|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153419970|NCT00374881|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153419971|NCT00374881|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153419972|NCT00374881|Adrenergic Agents|adrenergic agents|mesh-ancestor
153419973|NCT00374881|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153879142|NCT06078995|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153879143|NCT06078995|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153879144|NCT06078995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153879145|NCT06078982|Disitamab vedotin|disitamab vedotin|mesh-list
153879146|NCT06078982|Immunoconjugates|immunoconjugates|mesh-ancestor
153879147|NCT06078982|Immunologic Factors|immunologic factors|mesh-ancestor
153879148|NCT06078982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153879149|NCT06078891|BCG Vaccine|bcg vaccine|mesh-list
153879150|NCT06078891|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153879151|NCT06078891|Immunologic Factors|immunologic factors|mesh-ancestor
153879152|NCT06078891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153879153|NCT06078839|Nafamostat|nafamostat|mesh-list
153879154|NCT06078839|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153879155|NCT06078839|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153879156|NCT06078839|Analgesics|analgesics|mesh-ancestor
153879157|NCT06078839|Sensory System Agents|sensory system agents|mesh-ancestor
153879158|NCT06078839|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153879160|NCT06078839|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153879161|NCT06078839|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153879162|NCT06078839|Anticoagulants|anticoagulants|mesh-ancestor
153879163|NCT06078839|Protease Inhibitors|protease inhibitors|mesh-ancestor
153879164|NCT06078839|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153879165|NCT06078839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153879166|NCT06078839|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
153879168|NCT06078839|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
153879170|NCT06078839|Immunologic Factors|immunologic factors|mesh-ancestor
153879171|NCT06078787|Olaparib|olaparib|mesh-list
153879172|NCT06078787|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
153879173|NCT06078787|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153419979|NCT00374959|Third Generation Cephalosporins|third generation cephalosporins|mesh-ancestor
153419980|NCT00374959|Beta Lactam Antibiotics|beta lactam antibiotics|mesh-ancestor
153419981|NCT00374959|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153419982|NCT00374959|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153419983|NCT02846233|Metformin|metformin|mesh-list
153419984|NCT02846233|Empagliflozin|empagliflozin|mesh-list
153419985|NCT02846233|Dulaglutide|dulaglutide|mesh-list
153419986|NCT02846233|rGLP-1 protein|rglp-1 protein|mesh-list
153419987|NCT02846233|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
153419988|NCT02846233|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-list
153419989|NCT02846233|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153419990|NCT02846233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153419991|NCT02846233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153419992|NCT02865590|Cimetidine|cimetidine|mesh-list
153420010|NCT03075553|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153420011|NCT03075553|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153420012|NCT03075553|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153420013|NCT03075553|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153420014|NCT03054740|Ethyl Chloride|ethyl chloride|mesh-list
153420015|NCT03054740|Anesthetics, Local|anesthetics, local|mesh-ancestor
153420016|NCT03054740|Anesthetics|anesthetics|mesh-ancestor
153420017|NCT03054740|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153420018|NCT03054740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153420019|NCT03054740|Sensory System Agents|sensory system agents|mesh-ancestor
153420020|NCT03054740|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153879187|NCT06078696|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153879188|NCT06078696|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153879189|NCT06078696|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153879190|NCT06078696|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153879192|NCT06078696|Antifungal Agents|antifungal agents|mesh-ancestor
153879194|NCT06078670|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153879195|NCT06078670|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153879196|NCT06078670|Tubulin Modulators|tubulin modulators|mesh-ancestor
153879197|NCT06078670|Antimitotic Agents|antimitotic agents|mesh-ancestor
153879198|NCT06078670|Mitosis Modulators|mitosis modulators|mesh-ancestor
153879199|NCT06078670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153879200|NCT06078605|Niacinamide|niacinamide|mesh-list
153879202|NCT06078605|Nicotinic Acids|nicotinic acids|mesh-list
153879203|NCT06078605|Vitamin B Complex|vitamin b complex|mesh-ancestor
153879204|NCT06078605|Vitamins|vitamins|mesh-ancestor
153879205|NCT06078605|Micronutrients|micronutrients|mesh-ancestor
153879211|NCT06078605|Vasodilator Agents|vasodilator agents|mesh-ancestor
153879212|NCT06078592|Timolol|timolol|mesh-list
153879213|NCT06078592|Brimonidine Tartrate|brimonidine tartrate|mesh-list
153879214|NCT06078592|Ophthalmic Solutions|ophthalmic solutions|mesh-list
153879215|NCT06078592|Maleic acid|maleic acid|mesh-list
153420022|NCT02997722|Analgesics|analgesics|mesh-ancestor
153420023|NCT02997722|Sensory System Agents|sensory system agents|mesh-ancestor
153420024|NCT02997722|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153420025|NCT02997722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153420026|NCT02997722|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
153420027|NCT02997722|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153420028|NCT02997722|Anesthetics, General|anesthetics, general|mesh-ancestor
153420029|NCT02997722|Anesthetics|anesthetics|mesh-ancestor
153420030|NCT02997722|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153420031|NCT02997722|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
153420032|NCT02997722|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
153420033|NCT02997722|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153420034|NCT02997722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153420035|NCT03108482|Celecoxib|celecoxib|mesh-list
153420036|NCT03108482|Tramadol|tramadol|mesh-list
153420037|NCT03108482|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153420038|NCT03108482|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153420039|NCT03108482|Analgesics|analgesics|mesh-ancestor
153420040|NCT03108482|Sensory System Agents|sensory system agents|mesh-ancestor
153420041|NCT03108482|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153420042|NCT03108482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153420043|NCT03108482|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153420044|NCT03108482|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153420045|NCT03108482|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
153420046|NCT03108482|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153420047|NCT03108482|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153420048|NCT03108482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153420049|NCT03108482|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153420050|NCT03108482|Narcotics|narcotics|mesh-ancestor
153420051|NCT03108482|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153420052|NCT02850601|Dexamethasone|dexamethasone|mesh-list
153420053|NCT02850601|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153420054|NCT02850601|Antiemetics|antiemetics|mesh-ancestor
153420055|NCT02850601|Autonomic Agents|autonomic agents|mesh-ancestor
153420056|NCT02850601|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153420057|NCT02850601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153420058|NCT02850601|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153420059|NCT02850601|Glucocorticoids|glucocorticoids|mesh-ancestor
153420060|NCT02850601|Hormones|hormones|mesh-ancestor
153420061|NCT02850601|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153420062|NCT02850601|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153420063|NCT02850601|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153420064|NCT03056456|Insulin Lispro|insulin lispro|mesh-list
153420065|NCT03056456|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153420066|NCT03056456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153420067|NCT03057704|Lidocaine|lidocaine|mesh-list
153420068|NCT03057704|Anesthetics, Local|anesthetics, local|mesh-ancestor
153420069|NCT03057704|Anesthetics|anesthetics|mesh-ancestor
153420070|NCT03057704|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153420071|NCT03057704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153420072|NCT03057704|Sensory System Agents|sensory system agents|mesh-ancestor
153420073|NCT03057704|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153879233|NCT06076980|Sensory System Agents|sensory system agents|mesh-ancestor
153879234|NCT06076980|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153879235|NCT06076980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153879237|NCT06070961|Immunoglobulin G|immunoglobulin g|mesh-list
153879238|NCT06070961|Immunologic Factors|immunologic factors|mesh-ancestor
153879239|NCT06070961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153879240|NCT06070350|Tranexamic Acid|tranexamic acid|mesh-list
153879241|NCT06070350|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
153879242|NCT06070350|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153879243|NCT06070350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153879244|NCT06070350|Hemostatics|hemostatics|mesh-ancestor
153879245|NCT06070350|Coagulants|coagulants|mesh-ancestor
153879246|NCT06064448|Sildenafil Citrate|sildenafil citrate|mesh-list
153879247|NCT06064448|Vasodilator Agents|vasodilator agents|mesh-ancestor
153879248|NCT06064448|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
153879249|NCT06064448|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
153879251|NCT06064448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153879252|NCT06064448|Urological Agents|urological agents|mesh-ancestor
153879253|NCT06061250|Anesthetics|anesthetics|mesh-list
153879254|NCT06061250|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153879255|NCT06061250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153879256|NCT06026254|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
153879257|NCT06026254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153879258|NCT06026254|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153879259|NCT06026254|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153879260|NCT05988697|Trametinib|trametinib|mesh-list
153879261|NCT05988697|Dabrafenib|dabrafenib|mesh-list
153420082|NCT02874092|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
153420083|NCT02874092|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
153420084|NCT02874092|Purinergic Agents|purinergic agents|mesh-ancestor
153420085|NCT02874092|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153420086|NCT02874092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153420087|NCT02874092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153420088|NCT02876900|Asenapine|asenapine|mesh-list
153879271|NCT05975450|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153879272|NCT05975450|Immunologic Factors|immunologic factors|mesh-ancestor
153879273|NCT05975450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153879274|NCT05975450|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153879276|NCT05943821|Antimetabolites|antimetabolites|mesh-ancestor
153879277|NCT05943821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153879280|NCT05943821|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153879281|NCT05943821|Free Radical Scavengers|free radical scavengers|mesh-ancestor
153879282|NCT05943821|Antioxidants|antioxidants|mesh-ancestor
153879283|NCT05943821|Protective Agents|protective agents|mesh-ancestor
153879307|NCT05824728|Nootropic Agents|nootropic agents|mesh-ancestor
153879308|NCT05813314|Natriuretic Peptide, C-Type|natriuretic peptide, c-type|mesh-list
153879309|NCT05813314|Natriuretic Agents|natriuretic agents|mesh-ancestor
153879310|NCT05813314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153420146|NCT03118466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153420147|NCT03118466|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153420148|NCT03118466|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153420149|NCT03118466|Growth Substances|growth substances|mesh-ancestor
153879320|NCT05721755|Antimitotic Agents|antimitotic agents|mesh-ancestor
153879321|NCT05721755|Mitosis Modulators|mitosis modulators|mesh-ancestor
153879322|NCT05721755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153879323|NCT05721755|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153879324|NCT05721755|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153879325|NCT05721755|Antimetabolites|antimetabolites|mesh-ancestor
153879326|NCT05721755|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153879327|NCT05721755|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153879332|NCT05717166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153879334|NCT05689099|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
153879335|NCT05689099|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153879336|NCT05689099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153879337|NCT05684055|Antihypertensive Agents|antihypertensive agents|mesh-list
153879338|NCT05656443|Ritonavir|ritonavir|mesh-list
153420150|NCT03118466|Growth Inhibitors|growth inhibitors|mesh-ancestor
153420151|NCT03118466|Analgesics|analgesics|mesh-ancestor
153420152|NCT03118466|Sensory System Agents|sensory system agents|mesh-ancestor
153420153|NCT03118466|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153420155|NCT03068312|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
153420156|NCT03068312|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153420157|NCT03068312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153420158|NCT03119168|Simethicone|simethicone|mesh-list
153420159|NCT03119168|Antifoaming Agents|antifoaming agents|mesh-ancestor
153420160|NCT03119168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153420161|NCT03119168|Emollients|emollients|mesh-ancestor
153420162|NCT03119168|Dermatologic Agents|dermatologic agents|mesh-ancestor
153420163|NCT03070730|Atenolol|atenolol|mesh-list
153420164|NCT03070730|Droxidopa|droxidopa|mesh-list
153420165|NCT03070730|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153420166|NCT03070730|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153420167|NCT03070730|Sympatholytics|sympatholytics|mesh-ancestor
153420168|NCT03070730|Autonomic Agents|autonomic agents|mesh-ancestor
153420169|NCT03070730|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153420170|NCT03070730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153420171|NCT03070730|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
153420174|NCT03070730|Adrenergic Agents|adrenergic agents|mesh-ancestor
153420175|NCT03070730|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153879346|NCT05656443|Antiviral Agents|antiviral agents|mesh-ancestor
153879347|NCT05656443|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153420188|NCT03123614|Loteprednol Etabonate|loteprednol etabonate|mesh-list
153879348|NCT05656443|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
153879349|NCT05656443|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153879350|NCT05630755|Islatravir|islatravir|mesh-list
153879351|NCT05630755|Antiviral Agents|antiviral agents|mesh-ancestor
153879352|NCT05630755|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153879353|NCT05630755|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153879354|NCT05630755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153879355|NCT05630755|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153879356|NCT05630755|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153879358|NCT05621174|Dextroamphetamine|dextroamphetamine|mesh-list
153879359|NCT05621174|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
153879360|NCT05621174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153879361|NCT05621174|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
153879362|NCT05621174|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153879363|NCT05621174|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153879364|NCT05621174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153420214|NCT03123848|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
153420215|NCT03123848|Protease Inhibitors|protease inhibitors|mesh-ancestor
153879446|NCT05169554|Clarithromycin|clarithromycin|mesh-list
153879447|NCT05169554|Rifampin|rifampin|mesh-list
153879448|NCT05169554|Clavulanic Acid|clavulanic acid|mesh-list
153879449|NCT05169554|Clavulanic Acids|clavulanic acids|mesh-list
153879450|NCT05169554|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
153879451|NCT05169554|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153879452|NCT05169554|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153879453|NCT05169554|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
153879454|NCT05169554|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153879455|NCT05169554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153879456|NCT05169554|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
153420325|NCT02860507|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153420326|NCT02860507|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153420327|NCT02860507|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
153420328|NCT02860507|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
153879488|NCT05101356|Sargramostim|sargramostim|mesh-list
153879489|NCT05101356|Immunologic Factors|immunologic factors|mesh-ancestor
153879490|NCT05101356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153879491|NCT05101356|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153879492|NCT05101356|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153879493|NCT05101356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153879494|NCT05046431|Golimumab|golimumab|mesh-list
153879495|NCT05046431|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
153879496|NCT05046431|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153879497|NCT05046431|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153879498|NCT05046431|Immunologic Factors|immunologic factors|mesh-ancestor
153879499|NCT05046431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153879500|NCT04996433|Antidepressive Agents|antidepressive agents|mesh-list
153879501|NCT04996433|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153879502|NCT04867798|Tenofovir|tenofovir|mesh-list
153879503|NCT04867798|Lamivudine|lamivudine|mesh-list
153879504|NCT04867798|Antiviral Agents|antiviral agents|mesh-ancestor
153420334|NCT03082196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153420335|NCT02861131|Neostigmine|neostigmine|mesh-list
153420336|NCT02861131|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
153420337|NCT02861131|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153420339|NCT02861131|Cholinergic Agents|cholinergic agents|mesh-ancestor
153420340|NCT02861131|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153420341|NCT02861131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153420342|NCT02861131|Parasympathomimetics|parasympathomimetics|mesh-ancestor
153420343|NCT02861131|Autonomic Agents|autonomic agents|mesh-ancestor
153420344|NCT02861131|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153420345|NCT04707092|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
153420346|NCT04707092|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153879550|NCT04812535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153879552|NCT04730947|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
153420378|NCT03090620|Miotics|miotics|mesh-ancestor
153420379|NCT02953873|Mycophenolic Acid|mycophenolic acid|mesh-list
153420380|NCT02953873|Prednisone|prednisone|mesh-list
153420381|NCT02953873|Methylprednisolone|methylprednisolone|mesh-list
153420382|NCT02953873|Tacrolimus|tacrolimus|mesh-list
153420383|NCT02953873|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153420384|NCT02953873|Glucocorticoids|glucocorticoids|mesh-ancestor
153420385|NCT02953873|Hormones|hormones|mesh-ancestor
153420386|NCT02953873|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153420387|NCT02953873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153420388|NCT02953873|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153420389|NCT02953873|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153420390|NCT02953873|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153420391|NCT02953873|Immunologic Factors|immunologic factors|mesh-ancestor
153420392|NCT02953873|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
153420393|NCT02953873|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153420394|NCT02953873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153420395|NCT02953873|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153420396|NCT02953873|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
153420397|NCT02953873|Antitubercular Agents|antitubercular agents|mesh-ancestor
153420398|NCT02953873|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153420399|NCT02953873|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153420400|NCT02953873|Antiemetics|antiemetics|mesh-ancestor
153420401|NCT02953873|Autonomic Agents|autonomic agents|mesh-ancestor
153420402|NCT02953873|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153420403|NCT02953873|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153420404|NCT02953873|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
153420405|NCT02953873|Protective Agents|protective agents|mesh-ancestor
153420406|NCT03091478|Pembrolizumab|pembrolizumab|mesh-list
153879563|NCT04716725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153879564|NCT04660799|Diphenhydramine|diphenhydramine|mesh-list
153879565|NCT04660799|Promethazine|promethazine|mesh-list
153879566|NCT04660799|Prednisone|prednisone|mesh-list
153879567|NCT04660799|Cyclophosphamide|cyclophosphamide|mesh-list
153879568|NCT04660799|Rituximab|rituximab|mesh-list
153879569|NCT04660799|Doxorubicin|doxorubicin|mesh-list
153879570|NCT04660799|Vincristine|vincristine|mesh-list
153879571|NCT04660799|Histamine H1 Antagonists|histamine h1 antagonists|mesh-list
153879572|NCT04660799|Histamine Antagonists|histamine antagonists|mesh-list
153879577|NCT04660799|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153879578|NCT04660799|Alkylating Agents|alkylating agents|mesh-ancestor
153879579|NCT04660799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153879580|NCT04660799|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153879581|NCT04660799|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153879582|NCT04660799|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153879583|NCT04660799|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153879584|NCT04660799|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153879585|NCT04660799|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153879586|NCT04660799|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153879587|NCT04660799|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153879588|NCT04660799|Glucocorticoids|glucocorticoids|mesh-ancestor
153879589|NCT04660799|Hormones|hormones|mesh-ancestor
153879590|NCT04660799|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153879591|NCT04660799|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153879592|NCT04660799|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153879593|NCT04660799|Tubulin Modulators|tubulin modulators|mesh-ancestor
153420420|NCT00375596|Dermatologic Agents|dermatologic agents|mesh-ancestor
153420421|NCT00375596|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
153420431|NCT03093272|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153420432|NCT03093272|Tubulin Modulators|tubulin modulators|mesh-ancestor
153420433|NCT03093272|Antimitotic Agents|antimitotic agents|mesh-ancestor
153420434|NCT03093272|Mitosis Modulators|mitosis modulators|mesh-ancestor
153420435|NCT03093272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153420436|NCT03093272|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153420438|NCT03093272|Hormones|hormones|mesh-ancestor
153420439|NCT03093272|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153420440|NCT03093272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153420441|NCT03093272|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153420442|NCT03093272|Fertility Agents, Female|fertility agents, female|mesh-ancestor
153420443|NCT03093272|Fertility Agents|fertility agents|mesh-ancestor
153420444|NCT03093272|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153420445|NCT03100123|Aspirin|aspirin|mesh-list
153420448|NCT03100123|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
153420450|NCT03100123|Dalteparin|dalteparin|mesh-list
153879605|NCT04660799|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153879606|NCT04660799|Histamine Agents|histamine agents|mesh-ancestor
153879607|NCT04660799|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153879608|NCT04660799|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
153879609|NCT04660799|Antipruritics|antipruritics|mesh-ancestor
153879610|NCT04660799|Dermatologic Agents|dermatologic agents|mesh-ancestor
153879611|NCT04648033|Atovaquone|atovaquone|mesh-list
153879612|NCT04648033|Cisplatin|cisplatin|mesh-list
153879613|NCT04648033|Vinorelbine|vinorelbine|mesh-list
153879614|NCT04648033|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153879615|NCT04648033|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153879616|NCT04648033|Tubulin Modulators|tubulin modulators|mesh-ancestor
153879617|NCT04648033|Antimitotic Agents|antimitotic agents|mesh-ancestor
153879618|NCT04648033|Mitosis Modulators|mitosis modulators|mesh-ancestor
153879619|NCT04648033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153879620|NCT04648033|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153879621|NCT04648033|Antimalarials|antimalarials|mesh-ancestor
153879622|NCT04648033|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153879623|NCT04648033|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153879624|NCT04648033|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153420456|NCT03100123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153420457|NCT03100123|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153420458|NCT03100123|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153420459|NCT03100123|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153420460|NCT03100123|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153420461|NCT03100123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153420462|NCT03100123|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153420463|NCT03100123|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153420464|NCT03100123|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153420466|NCT03100123|Anticoagulants|anticoagulants|mesh-ancestor
153420528|NCT00422617|Immunologic Factors|immunologic factors|mesh-ancestor
153420529|NCT00422617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153420530|NCT03104738|Insulin|insulin|mesh-list
153420532|NCT03104738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153420533|NCT03163472|Anesthetics|anesthetics|mesh-list
153420534|NCT03163472|Anesthetics, Local|anesthetics, local|mesh-list
153420535|NCT03163472|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153420536|NCT03163472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153420538|NCT03163472|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153420539|NCT04468568|Terbutaline|terbutaline|mesh-list
153420540|NCT04468568|Atosiban|atosiban|mesh-list
153420541|NCT04468568|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153420542|NCT04468568|Autonomic Agents|autonomic agents|mesh-ancestor
153420543|NCT04468568|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153420544|NCT04468568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153420545|NCT04468568|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153420546|NCT04468568|Respiratory System Agents|respiratory system agents|mesh-ancestor
153462312|NCT01924104|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153462642|NCT05605002|Serotonin Agents|serotonin agents|mesh-ancestor
153462643|NCT05605002|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153462644|NCT05605002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153462645|NCT05605002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153462646|NCT04124016|Grape Seed Extract|grape seed extract|mesh-list
153462647|NCT04124016|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153462648|NCT04124016|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153462649|NCT04124016|Antioxidants|antioxidants|mesh-ancestor
153462650|NCT04124016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153462651|NCT04124016|Protective Agents|protective agents|mesh-ancestor
153462652|NCT04124016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153462653|NCT04124094|Fluticasone|fluticasone|mesh-list
153462815|NCT04129008|Antipyretics|antipyretics|mesh-ancestor
153463122|NCT02952222|Adrenergic Agents|adrenergic agents|mesh-ancestor
153463123|NCT02952222|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153463124|NCT02952222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153463125|NCT02952222|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153463126|NCT02952222|Anesthetics, General|anesthetics, general|mesh-ancestor
153463128|NCT03826368|Cannabidiol|cannabidiol|mesh-list
153463129|NCT03826368|Anticonvulsants|anticonvulsants|mesh-ancestor
153463130|NCT04391478|Milrinone|milrinone|mesh-list
153463131|NCT04391478|Sildenafil Citrate|sildenafil citrate|mesh-list
153463132|NCT04391478|Vasodilator Agents|vasodilator agents|mesh-ancestor
153919584|NCT00003601|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
153919585|NCT00003601|Protective Agents|protective agents|mesh-ancestor
153919586|NCT00003601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153919587|NCT00003266|Methylphenidate|methylphenidate|mesh-list
153919588|NCT00003266|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
153919589|NCT00003266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153914701|NCT00607750|Cholinergic Agents|cholinergic agents|mesh-ancestor
153914702|NCT00607750|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153914703|NCT00607750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153914705|NCT00609544|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153914706|NCT04908475|Apremilast|apremilast|mesh-list
153914771|NCT04527757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153463489|NCT01457820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153463491|NCT05020782|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153463492|NCT05020782|Immunologic Factors|immunologic factors|mesh-ancestor
153463493|NCT05020782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153463495|NCT01893294|Fluorouracil|fluorouracil|mesh-list
153463496|NCT01893294|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153463497|NCT01893294|Antimetabolites|antimetabolites|mesh-ancestor
153463498|NCT01893294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153463499|NCT01893294|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153463500|NCT01893294|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153914834|NCT01215227|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
153914835|NCT01215227|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153914846|NCT01009515|Antimitotic Agents|antimitotic agents|mesh-ancestor
153914847|NCT01009515|Mitosis Modulators|mitosis modulators|mesh-ancestor
153914848|NCT01009515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153914849|NCT01009515|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153914850|NCT01009515|Alkylating Agents|alkylating agents|mesh-ancestor
153463784|NCT01451736|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153463786|NCT01451736|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153463883|NCT01989780|Fertility Agents, Female|fertility agents, female|mesh-ancestor
153463884|NCT01989780|Fertility Agents|fertility agents|mesh-ancestor
153463885|NCT01989780|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153463887|NCT02549898|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
153463888|NCT02549898|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153463889|NCT02549898|Autonomic Agents|autonomic agents|mesh-ancestor
153463890|NCT02549898|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153463891|NCT02549898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153463892|NCT02549898|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153463894|NCT02549898|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153463895|NCT02549898|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153463896|NCT02549898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153463898|NCT02549898|Vasodilator Agents|vasodilator agents|mesh-ancestor
153915223|NCT00848731|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153915224|NCT00848731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153915370|NCT02698813|Immunologic Factors|immunologic factors|mesh-ancestor
153915371|NCT02698813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153915446|NCT04295967|Formaldehyde|formaldehyde|mesh-list
153915564|NCT03250507|Anesthetics, Local|anesthetics, local|mesh-ancestor
153464320|NCT01763580|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153464321|NCT01763580|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153464322|NCT01740492|Ketamine|ketamine|mesh-list
153464323|NCT01740492|Analgesics|analgesics|mesh-ancestor
153464324|NCT01740492|Sensory System Agents|sensory system agents|mesh-ancestor
153915640|NCT05324839|Botulinum Toxins|botulinum toxins|mesh-list
153915772|NCT05322889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153915828|NCT00997503|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153915829|NCT00997503|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153915830|NCT00997503|Analgesics|analgesics|mesh-ancestor
153915831|NCT00997503|Sensory System Agents|sensory system agents|mesh-ancestor
153915983|NCT02052193|Dabrafenib|dabrafenib|mesh-list
153916034|NCT00619333|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153917979|NCT04263844|GABA Agents|gaba agents|mesh-ancestor
153917980|NCT00610324|Chlorhexidine|chlorhexidine|mesh-list
153917981|NCT00610324|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
153917982|NCT00610324|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
153917983|NCT00610324|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153917984|NCT00610324|Disinfectants|disinfectants|mesh-ancestor
153917985|NCT00610324|Dermatologic Agents|dermatologic agents|mesh-ancestor
153917986|NCT02884128|Leucovorin|leucovorin|mesh-list
153917987|NCT02884128|Fluorouracil|fluorouracil|mesh-list
153917988|NCT02884128|Irinotecan|irinotecan|mesh-list
153917989|NCT02884128|Antimetabolites|antimetabolites|mesh-ancestor
153917990|NCT02884128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153917991|NCT02884128|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153918678|NCT02675413|Dimethyl Fumarate|dimethyl fumarate|mesh-list
153918725|NCT02887625|Incretins|incretins|mesh-ancestor
153918726|NCT02887625|Hormones|hormones|mesh-ancestor
153918727|NCT02887625|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153918728|NCT02886377|Antibodies|antibodies|mesh-list
153918729|NCT02886377|Immunologic Factors|immunologic factors|mesh-ancestor
153918730|NCT02886377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153918731|NCT02675335|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
153918732|NCT02675335|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153918734|NCT02675335|Incretins|incretins|mesh-ancestor
153918898|NCT05907902|Analgesics|analgesics|mesh-ancestor
153919603|NCT00003057|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153468836|NCT05950334|Immunologic Factors|immunologic factors|mesh-ancestor
153919604|NCT00003057|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153919605|NCT00003057|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153919606|NCT00002922|Paclitaxel|paclitaxel|mesh-list
153919607|NCT00002922|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153919608|NCT00002922|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153919609|NCT00002922|Tubulin Modulators|tubulin modulators|mesh-ancestor
153919610|NCT00002922|Antimitotic Agents|antimitotic agents|mesh-ancestor
153920876|NCT06266546|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
153920877|NCT06266546|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153920878|NCT06266546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153920879|NCT06266546|Hemostatics|hemostatics|mesh-ancestor
153920880|NCT06266546|Coagulants|coagulants|mesh-ancestor
153920905|NCT06252753|Durvalumab|durvalumab|mesh-list
153920906|NCT06252753|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
153920909|NCT06252753|Immunologic Factors|immunologic factors|mesh-ancestor
153919613|NCT00002514|Leucovorin|leucovorin|mesh-list
153919614|NCT00002514|Cytarabine|cytarabine|mesh-list
153919615|NCT00002514|Dexamethasone|dexamethasone|mesh-list
153919616|NCT00002514|Prednisone|prednisone|mesh-list
153919617|NCT00002514|Cyclophosphamide|cyclophosphamide|mesh-list
153919618|NCT00002514|Methotrexate|methotrexate|mesh-list
153919619|NCT00002514|Etoposide|etoposide|mesh-list
153919620|NCT00002514|Vincristine|vincristine|mesh-list
153468377|NCT06297811|Tubulin Modulators|tubulin modulators|mesh-ancestor
153468378|NCT06297811|Antimitotic Agents|antimitotic agents|mesh-ancestor
153468379|NCT06297811|Mitosis Modulators|mitosis modulators|mesh-ancestor
153468380|NCT06297811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153920998|NCT06191744|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153920999|NCT06191744|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153921000|NCT06191744|Glucocorticoids|glucocorticoids|mesh-ancestor
153921001|NCT06191744|Hormones|hormones|mesh-ancestor
153921002|NCT06191744|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153921003|NCT06191744|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153469762|NCT04473911|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153469763|NCT04473911|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153919654|NCT00002514|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153919655|NCT00002514|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153919656|NCT00002514|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153919657|NCT00002514|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153919658|NCT00002514|Antiviral Agents|antiviral agents|mesh-ancestor
153919659|NCT00002514|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153919660|NCT00002514|Antidotes|antidotes|mesh-ancestor
153919661|NCT00002514|Protective Agents|protective agents|mesh-ancestor
153919662|NCT00002514|Vitamin B Complex|vitamin b complex|mesh-ancestor
153919663|NCT00002514|Vitamins|vitamins|mesh-ancestor
153919664|NCT00002514|Micronutrients|micronutrients|mesh-ancestor
153919665|NCT00002514|Tubulin Modulators|tubulin modulators|mesh-ancestor
153919666|NCT00002514|Antimitotic Agents|antimitotic agents|mesh-ancestor
153919667|NCT00002514|Mitosis Modulators|mitosis modulators|mesh-ancestor
153919668|NCT00002514|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153919669|NCT00002514|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153919670|NCT00002514|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153919671|NCT00607282|Udenafil|udenafil|mesh-list
153919672|NCT00607282|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
153469820|NCT04305054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153469821|NCT04305054|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153469822|NCT04305054|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153469823|NCT04257578|Acalabrutinib|acalabrutinib|mesh-list
153921058|NCT06161025|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153921059|NCT06161025|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153921060|NCT06161025|Tubulin Modulators|tubulin modulators|mesh-ancestor
153921061|NCT06161025|Antimitotic Agents|antimitotic agents|mesh-ancestor
153921062|NCT06161025|Mitosis Modulators|mitosis modulators|mesh-ancestor
153921063|NCT06161025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153921064|NCT06161025|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153919685|NCT00642655|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153919686|NCT00642655|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153919687|NCT00642655|Immunologic Factors|immunologic factors|mesh-ancestor
153919688|NCT00642655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153468449|NCT06295562|Trazodone|trazodone|mesh-list
153919729|NCT04264858|Immunologic Factors|immunologic factors|mesh-ancestor
153919730|NCT04264858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153919731|NCT00976911|Paclitaxel|paclitaxel|mesh-list
153919732|NCT00976911|Bevacizumab|bevacizumab|mesh-list
153919733|NCT00976911|Doxorubicin|doxorubicin|mesh-list
153919734|NCT00976911|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
153919735|NCT00976911|Topotecan|topotecan|mesh-list
153919736|NCT00976911|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153919737|NCT00976911|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153919738|NCT00976911|Tubulin Modulators|tubulin modulators|mesh-ancestor
153919739|NCT00976911|Antimitotic Agents|antimitotic agents|mesh-ancestor
153921110|NCT06119529|Hormones|hormones|mesh-ancestor
153921111|NCT06119529|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153919775|NCT05336968|Analgesics|analgesics|mesh-ancestor
153919776|NCT05336968|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153919777|NCT05336968|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153919778|NCT02674555|Naquotinib|naquotinib|mesh-list
153919779|NCT02674555|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153919780|NCT02674555|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153921180|NCT06105632|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153921181|NCT06105632|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153469955|NCT03982485|Paclitaxel|paclitaxel|mesh-list
153469956|NCT03982485|Apatinib|apatinib|mesh-list
153919818|NCT04287777|Mupirocin|mupirocin|mesh-list
153919819|NCT04287777|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153919820|NCT04287777|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153919821|NCT04287777|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
153468578|NCT06277609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153468579|NCT06277609|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153468580|NCT06277609|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153919822|NCT04287777|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153919823|NCT04287777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153919824|NCT04180657|Protein C|protein c|mesh-list
153919825|NCT04180657|Anticoagulants|anticoagulants|mesh-ancestor
153919826|NCT04180657|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153919827|NCT04180657|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153919828|NCT04180657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153919829|NCT00927082|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
153919830|NCT00927082|Antiviral Agents|antiviral agents|mesh-ancestor
153919831|NCT00927082|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153919832|NCT02674243|Povidone-Iodine|povidone-iodine|mesh-list
153919860|NCT00976677|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
153919861|NCT00976677|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153919862|NCT00976677|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153919863|NCT00976677|Tubulin Modulators|tubulin modulators|mesh-ancestor
153919864|NCT00976677|Antimitotic Agents|antimitotic agents|mesh-ancestor
153919865|NCT00976677|Mitosis Modulators|mitosis modulators|mesh-ancestor
153919866|NCT00976677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153919867|NCT00976677|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153919868|NCT00976677|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153919869|NCT00976677|Growth Substances|growth substances|mesh-ancestor
153919870|NCT00976677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153919871|NCT00976677|Growth Inhibitors|growth inhibitors|mesh-ancestor
153919872|NCT00976677|Immunologic Factors|immunologic factors|mesh-ancestor
153919875|NCT00976677|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153468658|NCT06236425|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153468659|NCT06236425|Antiviral Agents|antiviral agents|mesh-ancestor
153468660|NCT06236425|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153468662|NCT06225505|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
153468663|NCT06225505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153468664|NCT06213233|Cannabidiol|cannabidiol|mesh-list
153468665|NCT06213233|Anticonvulsants|anticonvulsants|mesh-ancestor
153468666|NCT06212271|Colchicine|colchicine|mesh-list
153468667|NCT06212271|Gout Suppressants|gout suppressants|mesh-ancestor
153921346|NCT06042478|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153921347|NCT06042478|Respiratory System Agents|respiratory system agents|mesh-ancestor
153921358|NCT06022068|Sirolimus|sirolimus|mesh-list
153919932|NCT02865681|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
153919933|NCT00644137|Pregabalin|pregabalin|mesh-list
153919934|NCT00644137|Analgesics|analgesics|mesh-ancestor
153919935|NCT00644137|Sensory System Agents|sensory system agents|mesh-ancestor
153919936|NCT00644137|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153919937|NCT00644137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153919987|NCT00970281|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
153919988|NCT00970281|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153919989|NCT00970281|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153468712|NCT06172257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153468713|NCT06172257|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153919990|NCT00970281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153919991|NCT00970281|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153919992|NCT00970281|Serotonin Agents|serotonin agents|mesh-ancestor
153919993|NCT00607438|Paclitaxel|paclitaxel|mesh-list
153919994|NCT00607438|Sorafenib|sorafenib|mesh-list
153919995|NCT00607438|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
153919996|NCT00607438|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153919997|NCT00607438|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153919998|NCT00607438|Tubulin Modulators|tubulin modulators|mesh-ancestor
153919999|NCT00607438|Antimitotic Agents|antimitotic agents|mesh-ancestor
153920000|NCT00607438|Mitosis Modulators|mitosis modulators|mesh-ancestor
153920001|NCT00607438|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153920002|NCT00607438|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153920003|NCT00607438|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153920022|NCT03746301|Rivaroxaban|rivaroxaban|mesh-list
153920023|NCT03746301|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
153920024|NCT03746301|Antithrombins|antithrombins|mesh-ancestor
153920025|NCT03746301|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
153921628|NCT05738291|Digoxin|digoxin|mesh-list
153920026|NCT03746301|Protease Inhibitors|protease inhibitors|mesh-ancestor
153920027|NCT03746301|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153920028|NCT03746301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153920029|NCT03746301|Anticoagulants|anticoagulants|mesh-ancestor
153920030|NCT00925990|Ribavirin|ribavirin|mesh-list
153920031|NCT00925990|Antimetabolites|antimetabolites|mesh-ancestor
153920032|NCT00925990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153920033|NCT00925990|Antiviral Agents|antiviral agents|mesh-ancestor
153920034|NCT00925990|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153920035|NCT02670655|Lidocaine|lidocaine|mesh-list
153920036|NCT02670655|Prilocaine|prilocaine|mesh-list
153920037|NCT02670655|Lidocaine, Prilocaine Drug Combination|lidocaine, prilocaine drug combination|mesh-list
153920038|NCT02670655|Anesthetics, Local|anesthetics, local|mesh-ancestor
153920039|NCT02670655|Anesthetics|anesthetics|mesh-ancestor
153920040|NCT02670655|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153920050|NCT01131078|Bevacizumab|bevacizumab|mesh-list
153468831|NCT05950334|Cyclophosphamide|cyclophosphamide|mesh-list
153468832|NCT05950334|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
153468833|NCT05950334|Rituximab|rituximab|mesh-list
153468834|NCT05950334|Fludarabine|fludarabine|mesh-list
153468835|NCT05950334|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153468837|NCT05950334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153468838|NCT05950334|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153468839|NCT05950334|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153468840|NCT05950334|Alkylating Agents|alkylating agents|mesh-ancestor
153920105|NCT02862873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153920106|NCT03814005|Paclitaxel|paclitaxel|mesh-list
153920107|NCT03814005|Docetaxel|docetaxel|mesh-list
153920108|NCT03814005|Carboplatin|carboplatin|mesh-list
153920109|NCT03814005|Azacitidine|azacitidine|mesh-list
153920110|NCT03814005|Pevonedistat|pevonedistat|mesh-list
153920111|NCT03814005|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153920112|NCT03814005|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153920113|NCT03814005|Tubulin Modulators|tubulin modulators|mesh-ancestor
153920114|NCT03814005|Antimitotic Agents|antimitotic agents|mesh-ancestor
153920115|NCT03814005|Mitosis Modulators|mitosis modulators|mesh-ancestor
153920116|NCT03814005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153920117|NCT03814005|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153920118|NCT03814005|Antimetabolites|antimetabolites|mesh-ancestor
153920119|NCT03814005|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153920120|NCT04016233|Tenofovir|tenofovir|mesh-list
153920121|NCT04016233|Antiviral Agents|antiviral agents|mesh-ancestor
153920122|NCT04016233|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153920123|NCT04016233|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153920124|NCT04016233|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153920125|NCT04016233|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153920126|NCT04016233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153920127|NCT04016233|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153920128|NCT04016233|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153920129|NCT04033471|Midazolam|midazolam|mesh-list
153920130|NCT04033471|Morphine|morphine|mesh-list
153920131|NCT04033471|Bupivacaine|bupivacaine|mesh-list
153920132|NCT04033471|Anesthetics, Local|anesthetics, local|mesh-ancestor
153920144|NCT04033471|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153920145|NCT04033471|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153920146|NCT04033471|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153920147|NCT04033471|Anesthetics, General|anesthetics, general|mesh-ancestor
153920148|NCT04033471|GABA Modulators|gaba modulators|mesh-ancestor
153920149|NCT04033471|GABA Agents|gaba agents|mesh-ancestor
153920150|NCT04033471|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153921821|NCT05667662|Hormone Antagonists|hormone antagonists|mesh-ancestor
153921822|NCT05667662|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153921823|NCT05667662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153921824|NCT05667662|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
153920187|NCT02670109|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153920188|NCT02670109|Alkylating Agents|alkylating agents|mesh-ancestor
153920189|NCT02670109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153920190|NCT02670109|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153920191|NCT02670109|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153920192|NCT00922636|Methylphenidate|methylphenidate|mesh-list
153920193|NCT00922636|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
153920194|NCT00922636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153920195|NCT00922636|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
153468952|NCT05745038|Zaleplon|zaleplon|mesh-list
153468953|NCT05745038|Anticonvulsants|anticonvulsants|mesh-ancestor
153468954|NCT05745038|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153468955|NCT05745038|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153468956|NCT05745038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153468957|NCT05745038|GABA Modulators|gaba modulators|mesh-ancestor
153468958|NCT05745038|GABA Agents|gaba agents|mesh-ancestor
153920239|NCT04258930|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153920240|NCT04258930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153920241|NCT04258930|Chelating Agents|chelating agents|mesh-ancestor
153920242|NCT04258930|Sequestering Agents|sequestering agents|mesh-ancestor
153920243|NCT04258930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153920244|NCT04258930|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153920245|NCT04258930|Immunologic Factors|immunologic factors|mesh-ancestor
153920246|NCT01175135|Risperidone|risperidone|mesh-list
153920247|NCT01175135|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153920248|NCT01175135|Serotonin Agents|serotonin agents|mesh-ancestor
153920249|NCT01175135|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153920250|NCT01175135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153920288|NCT00973479|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153920289|NCT00973479|Immunologic Factors|immunologic factors|mesh-ancestor
153920290|NCT00973479|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153920291|NCT00973479|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153920292|NCT00973479|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
153920293|NCT00973479|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153920294|NCT04315493|Maleic acid|maleic acid|mesh-list
153920295|NCT04315493|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153920296|NCT04315493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153920298|NCT04173871|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153920341|NCT00645229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153920342|NCT00645229|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153920343|NCT00645229|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153920344|NCT00645229|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153920345|NCT00645229|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153920346|NCT00645229|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
153920347|NCT00645229|Dopamine Agents|dopamine agents|mesh-ancestor
153920348|NCT01172873|Cycloserine|cycloserine|mesh-list
153920349|NCT01172873|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
153920350|NCT01172873|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153920351|NCT01172873|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
153920352|NCT01172873|Antitubercular Agents|antitubercular agents|mesh-ancestor
153920353|NCT01172873|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153920354|NCT01172873|Antimetabolites|antimetabolites|mesh-ancestor
153920355|NCT01172873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153920356|NCT02886299|Simvastatin|simvastatin|mesh-list
153920357|NCT02886299|Fenofibrate|fenofibrate|mesh-list
153920358|NCT02886299|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153920359|NCT02886299|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153920360|NCT02886299|Antimetabolites|antimetabolites|mesh-ancestor
153920388|NCT06331845|Antimetabolites|antimetabolites|mesh-ancestor
153920389|NCT06331845|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153920390|NCT06331715|Palbociclib|palbociclib|mesh-list
153920391|NCT06331715|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153920392|NCT06331715|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153922196|NCT05159050|Tubulin Modulators|tubulin modulators|mesh-ancestor
153922197|NCT05159050|Antimitotic Agents|antimitotic agents|mesh-ancestor
153922198|NCT05159050|Mitosis Modulators|mitosis modulators|mesh-ancestor
153922199|NCT05159050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153922213|NCT05143840|Niacinamide|niacinamide|mesh-list
153922214|NCT05143840|Imatinib Mesylate|imatinib mesylate|mesh-list
153922215|NCT05143840|Dasatinib|dasatinib|mesh-list
153922216|NCT05143840|Nilotinib|nilotinib|mesh-list
153922217|NCT05143840|Asciminib|asciminib|mesh-list
153922218|NCT05143840|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153922219|NCT05143840|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153920395|NCT06331702|Vaccines|vaccines|mesh-list
153920445|NCT06331520|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153920446|NCT06331520|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153920447|NCT06331520|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153920448|NCT06331520|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
153469209|NCT05421819|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153920462|NCT06331468|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153920463|NCT06331455|Durvalumab|durvalumab|mesh-list
153920464|NCT06331455|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153920465|NCT06331455|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153920466|NCT06331442|Chlorhexidine|chlorhexidine|mesh-list
153920467|NCT06331442|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
153920468|NCT06331442|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153920469|NCT06331442|Disinfectants|disinfectants|mesh-ancestor
153920470|NCT06331390|Niacinamide|niacinamide|mesh-list
153920471|NCT06331390|Niacin|niacin|mesh-list
153920472|NCT06331390|Nicotinic Acids|nicotinic acids|mesh-list
153920473|NCT06331390|Vitamin B Complex|vitamin b complex|mesh-ancestor
153920474|NCT06331390|Vitamins|vitamins|mesh-ancestor
153920475|NCT06331390|Micronutrients|micronutrients|mesh-ancestor
153920476|NCT06331390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153920477|NCT06331390|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153920478|NCT06331390|Antimetabolites|antimetabolites|mesh-ancestor
153920482|NCT06331299|Mitomycins|mitomycins|mesh-list
153469293|NCT05285358|Paclitaxel|paclitaxel|mesh-list
153469294|NCT05285358|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
153469295|NCT05285358|Cisplatin|cisplatin|mesh-list
153469296|NCT05285358|Gemcitabine|gemcitabine|mesh-list
153469297|NCT05285358|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153469298|NCT05285358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153469299|NCT05285358|Tubulin Modulators|tubulin modulators|mesh-ancestor
153469300|NCT05285358|Antimitotic Agents|antimitotic agents|mesh-ancestor
153920523|NCT06331169|Trastuzumab|trastuzumab|mesh-list
153920524|NCT06331169|Trastuzumab deruxtecan|trastuzumab deruxtecan|mesh-list
153920525|NCT06331169|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153920526|NCT06331169|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153920527|NCT06331169|Immunoconjugates|immunoconjugates|mesh-ancestor
153920528|NCT06331169|Immunologic Factors|immunologic factors|mesh-ancestor
153920529|NCT06331169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153469335|NCT05203913|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153920568|NCT06330662|Protective Agents|protective agents|mesh-ancestor
153920569|NCT06330584|Midazolam|midazolam|mesh-list
153920570|NCT06330584|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153920571|NCT06330584|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153920572|NCT06330584|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153920573|NCT06330584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153920574|NCT06330584|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153920575|NCT06330584|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153922621|NCT04620382|Autonomic Agents|autonomic agents|mesh-ancestor
153471392|NCT05594823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153471393|NCT05581797|Psilocybin|psilocybin|mesh-list
153920680|NCT06329895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153920681|NCT06329895|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153920682|NCT06329895|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
153920683|NCT06329895|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153920684|NCT06329895|Antithrombins|antithrombins|mesh-ancestor
153920685|NCT06329895|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
153920686|NCT06329895|Protease Inhibitors|protease inhibitors|mesh-ancestor
153920773|NCT06329518|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153920774|NCT06328738|Leucovorin|leucovorin|mesh-list
153920775|NCT06328738|Paclitaxel|paclitaxel|mesh-list
153920776|NCT06328738|Capecitabine|capecitabine|mesh-list
153920777|NCT06328738|Fluorouracil|fluorouracil|mesh-list
153920778|NCT06328738|Oxaliplatin|oxaliplatin|mesh-list
153920779|NCT06328738|Trastuzumab|trastuzumab|mesh-list
153920780|NCT06328738|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153920792|NCT06328738|Antidotes|antidotes|mesh-ancestor
153920864|NCT06282458|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
153920865|NCT06282458|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153920866|NCT06282458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153920875|NCT06266546|Tranexamic Acid|tranexamic acid|mesh-list
153469633|NCT04702893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153469635|NCT04671667|Carboplatin|carboplatin|mesh-list
153469636|NCT04671667|Pembrolizumab|pembrolizumab|mesh-list
153469637|NCT04671667|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153920907|NCT06252753|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153920908|NCT06252753|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153920910|NCT06252753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153920911|NCT06245889|Paclitaxel|paclitaxel|mesh-list
153920912|NCT06245889|Cyclophosphamide|cyclophosphamide|mesh-list
153920974|NCT06196671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153920975|NCT06196671|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153920976|NCT06196671|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153920977|NCT06191744|Prednisone|prednisone|mesh-list
153920978|NCT06191744|Cyclophosphamide|cyclophosphamide|mesh-list
153920979|NCT06191744|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
153920980|NCT06191744|Rituximab|rituximab|mesh-list
153920981|NCT06191744|Doxorubicin|doxorubicin|mesh-list
153920982|NCT06191744|Vincristine|vincristine|mesh-list
153920983|NCT06191744|Lenalidomide|lenalidomide|mesh-list
153920984|NCT06191744|Obinutuzumab|obinutuzumab|mesh-list
153920985|NCT06191744|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153469767|NCT04439292|Dabrafenib|dabrafenib|mesh-list
153921068|NCT06161025|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153921069|NCT06161025|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153921070|NCT06161025|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
153921072|NCT06146101|Dronabinol|dronabinol|mesh-list
153921073|NCT06146101|Anticonvulsants|anticonvulsants|mesh-ancestor
153921074|NCT06146101|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
153921075|NCT06146101|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153921076|NCT06146101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153921077|NCT06146101|Diuretics|diuretics|mesh-ancestor
153921078|NCT06146101|Natriuretic Agents|natriuretic agents|mesh-ancestor
153921149|NCT06107413|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153921150|NCT06107413|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153921151|NCT06107413|Immunologic Factors|immunologic factors|mesh-ancestor
153921152|NCT06107413|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
153921153|NCT06107413|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153921154|NCT06107413|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153921155|NCT06107413|Antidotes|antidotes|mesh-ancestor
153921156|NCT06107413|Protective Agents|protective agents|mesh-ancestor
153921157|NCT06107413|Vitamin B Complex|vitamin b complex|mesh-ancestor
153921158|NCT06107413|Vitamins|vitamins|mesh-ancestor
153921159|NCT06107413|Micronutrients|micronutrients|mesh-ancestor
153921160|NCT06107413|Hematinics|hematinics|mesh-ancestor
153921161|NCT06106152|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
153921162|NCT06106152|Antibodies|antibodies|mesh-list
153921163|NCT06106152|Immunoglobulins|immunoglobulins|mesh-list
153921170|NCT06105632|Everolimus|everolimus|mesh-list
153921223|NCT06093893|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
153921224|NCT06093893|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
153921225|NCT06093893|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153471741|NCT02894398|Letrozole|letrozole|mesh-list
153921226|NCT06093893|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153921227|NCT06093893|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153921228|NCT06093893|Vasodilator Agents|vasodilator agents|mesh-ancestor
153469990|NCT03913104|Abortifacient Agents|abortifacient agents|mesh-ancestor
153469991|NCT03913104|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153469992|NCT03913104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153469993|NCT03913104|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
153469994|NCT03913104|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
153469995|NCT03913104|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
153469996|NCT03913104|Contraceptive Agents|contraceptive agents|mesh-ancestor
153921232|NCT06091410|Vaccines|vaccines|mesh-list
153921255|NCT06091254|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153921256|NCT06091254|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153921257|NCT06091254|Glucocorticoids|glucocorticoids|mesh-ancestor
153921258|NCT06091254|Hormones|hormones|mesh-ancestor
153921259|NCT06091254|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153921260|NCT06091254|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153921261|NCT06091254|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153921262|NCT06091254|Tubulin Modulators|tubulin modulators|mesh-ancestor
153921263|NCT06091254|Antimitotic Agents|antimitotic agents|mesh-ancestor
153921264|NCT06091254|Mitosis Modulators|mitosis modulators|mesh-ancestor
153921265|NCT06081153|Evolocumab|evolocumab|mesh-list
153921290|NCT06073470|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153921296|NCT06065059|Olaparib|olaparib|mesh-list
153921297|NCT06065059|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
153921298|NCT06065059|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153921299|NCT06065059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153470161|NCT03391466|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153470162|NCT03391466|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153470163|NCT03391466|Alkylating Agents|alkylating agents|mesh-ancestor
153470164|NCT03391466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153470165|NCT03391466|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153470166|NCT03391466|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153470167|NCT03391466|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153470169|NCT03383575|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153470170|NCT03383575|Antimetabolites|antimetabolites|mesh-ancestor
153470171|NCT03383575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153470172|NCT03383575|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153921483|NCT05893147|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153921484|NCT05893147|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153921485|NCT05891496|Semaglutide|semaglutide|mesh-list
153921486|NCT05891496|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
153921487|NCT05891496|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153921488|NCT05891496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153921489|NCT05889468|Aspirin|aspirin|mesh-list
153921490|NCT05889468|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153470372|NCT02518594|Progesterone|progesterone|mesh-list
153470373|NCT02518594|Progestins|progestins|mesh-ancestor
153470374|NCT02518594|Hormones|hormones|mesh-ancestor
153921646|NCT05738291|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153921647|NCT05738291|Antimetabolites|antimetabolites|mesh-ancestor
153921648|NCT05738291|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153921649|NCT05738291|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
153921650|NCT05738291|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153921651|NCT05738291|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153921652|NCT05738291|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
153921653|NCT05738291|Protective Agents|protective agents|mesh-ancestor
153921654|NCT05736549|Dexamethasone|dexamethasone|mesh-list
153921655|NCT05736549|Methylprednisolone|methylprednisolone|mesh-list
153470462|NCT01856478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153470463|NCT01856478|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153470464|NCT01856478|Dermatologic Agents|dermatologic agents|mesh-ancestor
153470465|NCT01856478|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153470466|NCT01856478|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153470467|NCT01856478|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153470468|NCT01856478|Immunologic Factors|immunologic factors|mesh-ancestor
153470469|NCT01856478|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153470470|NCT01856478|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153470471|NCT01856478|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153921687|NCT05725135|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153921688|NCT05725135|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153921689|NCT05725135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153921690|NCT05725135|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153921691|NCT05725135|Anesthetics, General|anesthetics, general|mesh-ancestor
153921693|NCT05724628|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
153470566|NCT00096434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153470567|NCT00565266|Beclomethasone|beclomethasone|mesh-list
153470568|NCT00565266|Bromides|bromides|mesh-list
153470569|NCT00565266|Tiotropium Bromide|tiotropium bromide|mesh-list
153470570|NCT00565266|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
153470571|NCT00565266|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153921814|NCT05667662|Antifungal Agents|antifungal agents|mesh-ancestor
153921815|NCT05667662|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153921816|NCT05667662|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
153921817|NCT05667662|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153921898|NCT05587881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153921899|NCT05582265|Paclitaxel|paclitaxel|mesh-list
153921900|NCT05582265|Cisplatin|cisplatin|mesh-list
153921901|NCT05582265|Carboplatin|carboplatin|mesh-list
153921902|NCT05582265|Tislelizumab|tislelizumab|mesh-list
153921903|NCT05582265|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153921904|NCT05582265|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153921905|NCT05582265|Tubulin Modulators|tubulin modulators|mesh-ancestor
153921906|NCT05582265|Antimitotic Agents|antimitotic agents|mesh-ancestor
153470638|NCT05362500|Dermatologic Agents|dermatologic agents|mesh-ancestor
153921907|NCT05582265|Mitosis Modulators|mitosis modulators|mesh-ancestor
153470640|NCT05362500|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153921908|NCT05582265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153921909|NCT05582265|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153470745|NCT02783430|Anesthetics|anesthetics|mesh-ancestor
153470746|NCT02783430|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153470747|NCT02783430|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
153470748|NCT02783430|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
153470749|NCT02783430|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153470750|NCT02783430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153474383|NCT00671970|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153922031|NCT05424315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153922032|NCT05424315|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153922033|NCT05424315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153922035|NCT05421065|Psilocybin|psilocybin|mesh-list
153922036|NCT05421065|Analgesics|analgesics|mesh-ancestor
153922037|NCT05421065|Sensory System Agents|sensory system agents|mesh-ancestor
153922038|NCT05421065|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153922039|NCT05421065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153470803|NCT05175768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153470804|NCT05175768|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153470806|NCT05175768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153470807|NCT05175768|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153470808|NCT05175768|Vasodilator Agents|vasodilator agents|mesh-ancestor
153470809|NCT05097846|Amoxicillin|amoxicillin|mesh-list
153470810|NCT05097846|Doxycycline|doxycycline|mesh-list
153470811|NCT05097846|Furazolidone|furazolidone|mesh-list
153470812|NCT05097846|Esomeprazole|esomeprazole|mesh-list
153470813|NCT05097846|Bismuth|bismuth|mesh-list
153470814|NCT05097846|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153470815|NCT05097846|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153922040|NCT05421065|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
153922073|NCT05353439|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153922074|NCT05353439|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153922075|NCT05333458|Atezolizumab|atezolizumab|mesh-list
153922076|NCT05333458|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
153922077|NCT05333458|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153922078|NCT05333458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153922079|NCT05333458|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153922081|NCT05333458|Immunologic Factors|immunologic factors|mesh-ancestor
153922125|NCT05283720|Lenalidomide|lenalidomide|mesh-list
153922127|NCT05283720|Ibrutinib|ibrutinib|mesh-list
153922128|NCT05283720|Polatuzumab vedotin|polatuzumab vedotin|mesh-list
153922129|NCT05283720|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153922130|NCT05283720|Immunologic Factors|immunologic factors|mesh-ancestor
153922131|NCT05283720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153922132|NCT05283720|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153922133|NCT05283720|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153922191|NCT05172245|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153922192|NCT05172245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153922193|NCT05159050|Paclitaxel|paclitaxel|mesh-list
153922194|NCT05159050|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153922195|NCT05159050|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153922222|NCT05143840|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153922223|NCT05143840|Vitamin B Complex|vitamin b complex|mesh-ancestor
153922224|NCT05143840|Vitamins|vitamins|mesh-ancestor
153922286|NCT05053971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153922287|NCT05037617|Oxytocin|oxytocin|mesh-list
153922288|NCT05037617|Oxytocics|oxytocics|mesh-ancestor
153922289|NCT05037617|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153922290|NCT05037617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153922291|NCT05029882|Trifluridine|trifluridine|mesh-list
153922292|NCT05029882|Bevacizumab|bevacizumab|mesh-list
153922293|NCT05029882|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153922329|NCT04975919|Decitabine and cedazuridine drug combination|decitabine and cedazuridine drug combination|mesh-list
153922330|NCT04975919|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153922331|NCT04975919|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153922332|NCT04975919|Antimetabolites|antimetabolites|mesh-ancestor
153922333|NCT04975919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153922334|NCT04975919|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153922335|NCT04945213|Biperiden|biperiden|mesh-list
153922336|NCT04945213|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
153922337|NCT04945213|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
153922338|NCT04945213|Parasympatholytics|parasympatholytics|mesh-ancestor
153922339|NCT04945213|Autonomic Agents|autonomic agents|mesh-ancestor
153922340|NCT04945213|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153922432|NCT04838288|Immunologic Factors|immunologic factors|mesh-ancestor
153922433|NCT04838288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153922434|NCT04838288|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
153922435|NCT04838288|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153922436|NCT04838288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153922438|NCT04799275|Cortisone|cortisone|mesh-list
153922439|NCT04799275|Cyclophosphamide|cyclophosphamide|mesh-list
153922440|NCT04799275|Rituximab|rituximab|mesh-list
153922441|NCT04799275|Doxorubicin|doxorubicin|mesh-list
153471262|NCT05765747|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153471263|NCT05765747|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153471264|NCT05765747|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
153471265|NCT05765747|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153471266|NCT05765747|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153471267|NCT05765747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153922490|NCT04786210|Antimetabolites|antimetabolites|mesh-ancestor
153922491|NCT04786210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153922494|NCT04786210|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153922495|NCT04786210|Immunologic Factors|immunologic factors|mesh-ancestor
153922499|NCT04786210|Hormones|hormones|mesh-ancestor
153471321|NCT05764746|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153471322|NCT05764746|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153471323|NCT05764746|Antiviral Agents|antiviral agents|mesh-ancestor
153922552|NCT04711252|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153922553|NCT04711252|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
153922554|NCT04711252|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153922555|NCT04711252|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
153922556|NCT04711252|Hormone Antagonists|hormone antagonists|mesh-ancestor
153922632|NCT04616560|Camptothecin|camptothecin|mesh-list
153922685|NCT04525014|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153922686|NCT04525014|Alkylating Agents|alkylating agents|mesh-ancestor
153922687|NCT04483206|Melphalan|melphalan|mesh-list
153922688|NCT04483206|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153922689|NCT04483206|Alkylating Agents|alkylating agents|mesh-ancestor
153471459|NCT05055024|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153471460|NCT05055024|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
153471461|NCT05055024|Dopamine Agents|dopamine agents|mesh-ancestor
153471469|NCT05012631|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153471473|NCT04954196|Amlodipine|amlodipine|mesh-list
153922744|NCT04438382|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153922745|NCT04438382|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153922746|NCT04438382|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
153922747|NCT04438382|Protective Agents|protective agents|mesh-ancestor
153922748|NCT04438382|Immunologic Factors|immunologic factors|mesh-ancestor
153922749|NCT04438382|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
153922750|NCT04438382|Dermatologic Agents|dermatologic agents|mesh-ancestor
153922752|NCT04406272|Bevacizumab|bevacizumab|mesh-list
153922753|NCT04406272|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153471598|NCT04247126|Fulvestrant|fulvestrant|mesh-list
153922818|NCT04301934|Estradiol|estradiol|mesh-list
153471729|NCT02983045|Ipilimumab|ipilimumab|mesh-list
153471793|NCT02126969|Docetaxel|docetaxel|mesh-list
153471794|NCT02126969|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153471799|NCT02099188|Leucovorin|leucovorin|mesh-list
153923082|NCT03819153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153923083|NCT03816163|Paclitaxel|paclitaxel|mesh-list
153923084|NCT03816163|Gemcitabine|gemcitabine|mesh-list
153923085|NCT03816163|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153923086|NCT03816163|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153923166|NCT03699956|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153923219|NCT03504774|Immunologic Factors|immunologic factors|mesh-ancestor
153923220|NCT03504774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153923222|NCT03499249|N-monoacetylcystine|n-monoacetylcystine|mesh-list
153923223|NCT03499249|Antiviral Agents|antiviral agents|mesh-ancestor
153923224|NCT03499249|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153923225|NCT03499249|Expectorants|expectorants|mesh-ancestor
153923226|NCT03499249|Respiratory System Agents|respiratory system agents|mesh-ancestor
153923227|NCT03499249|Free Radical Scavengers|free radical scavengers|mesh-ancestor
153923228|NCT03499249|Antioxidants|antioxidants|mesh-ancestor
153923229|NCT03499249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153923230|NCT03499249|Protective Agents|protective agents|mesh-ancestor
153923269|NCT03412409|Cyclophosphamide|cyclophosphamide|mesh-list
153923270|NCT03412409|Busulfan|busulfan|mesh-list
153923271|NCT03412409|Semustine|semustine|mesh-list
153923272|NCT03412409|Fludarabine|fludarabine|mesh-list
153923273|NCT03412409|Antilymphocyte Serum|antilymphocyte serum|mesh-list
153923274|NCT03412409|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153923275|NCT03412409|Immunologic Factors|immunologic factors|mesh-ancestor
153923276|NCT03412409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153923277|NCT03412409|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153923278|NCT03412409|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153923279|NCT03412409|Alkylating Agents|alkylating agents|mesh-ancestor
153923280|NCT03412409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153923281|NCT03412409|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153923282|NCT03412409|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153923283|NCT03412409|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153923284|NCT03412409|Antimetabolites|antimetabolites|mesh-ancestor
153923285|NCT03412409|Antiviral Agents|antiviral agents|mesh-ancestor
153923286|NCT03412409|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153923287|NCT03404960|Nivolumab|nivolumab|mesh-list
153923288|NCT03404960|Ipilimumab|ipilimumab|mesh-list
153923289|NCT03404960|Niraparib|niraparib|mesh-list
153923290|NCT03404960|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153923291|NCT03404960|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153923320|NCT03215511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153923321|NCT03172858|Oxytocin|oxytocin|mesh-list
153923322|NCT03172858|Oxytocics|oxytocics|mesh-ancestor
153923323|NCT03172858|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153923324|NCT03172858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153923325|NCT03125902|Paclitaxel|paclitaxel|mesh-list
153923326|NCT03125902|Atezolizumab|atezolizumab|mesh-list
153923327|NCT03125902|Antibodies|antibodies|mesh-list
153923328|NCT03125902|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
153415872|NCT05502211|Lidocaine|lidocaine|mesh-list
153923384|NCT02929589|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153472158|NCT04374006|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153472159|NCT04372836|Vasopressins|vasopressins|mesh-list
153472160|NCT04372836|Arginine Vasopressin|arginine vasopressin|mesh-list
153923385|NCT02929589|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153923386|NCT02929589|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153923387|NCT02929589|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153923388|NCT02929589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153923389|NCT02929589|Narcotics|narcotics|mesh-ancestor
153923390|NCT02929589|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153923391|NCT02897063|Midodrine|midodrine|mesh-list
153923392|NCT02897063|Droxidopa|droxidopa|mesh-list
153923393|NCT02897063|Sympathomimetics|sympathomimetics|mesh-ancestor
153923394|NCT02897063|Autonomic Agents|autonomic agents|mesh-ancestor
153923395|NCT02897063|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153923396|NCT02897063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153923397|NCT02897063|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
153923398|NCT02897063|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
153923399|NCT02897063|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153923406|NCT02870738|Triamcinolone|triamcinolone|mesh-list
153923436|NCT02725060|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153923437|NCT02725060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153923438|NCT02725060|Protective Agents|protective agents|mesh-ancestor
153923439|NCT02725060|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
153923440|NCT02725060|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153923441|NCT02725060|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153923442|NCT02673333|Pembrolizumab|pembrolizumab|mesh-list
153923443|NCT02673333|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153923444|NCT02673333|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153923453|NCT02650804|Vitamins|vitamins|mesh-ancestor
153923476|NCT02273362|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
153923477|NCT02273362|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153923478|NCT02273362|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153923479|NCT02273362|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153923480|NCT02273362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153923481|NCT02273362|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153923483|NCT02232399|Milrinone|milrinone|mesh-list
153923484|NCT02232399|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
153472247|NCT04365270|Hemostatics|hemostatics|mesh-ancestor
153923571|NCT01559935|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153923572|NCT01559935|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153923573|NCT01559935|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153923574|NCT01559935|Protease Inhibitors|protease inhibitors|mesh-ancestor
153472353|NCT04360356|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153472354|NCT04360356|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153472355|NCT04359576|Hemostatics|hemostatics|mesh-list
153472356|NCT04359576|Coagulants|coagulants|mesh-ancestor
153472357|NCT04358796|Perflubron|perflubron|mesh-list
153923575|NCT01559935|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153923634|NCT00381680|Dexamethasone|dexamethasone|mesh-list
153923635|NCT00381680|Prednisone|prednisone|mesh-list
153923636|NCT00381680|Cyclophosphamide|cyclophosphamide|mesh-list
153923637|NCT00381680|Doxorubicin|doxorubicin|mesh-list
153923638|NCT00381680|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
153923639|NCT00381680|Methotrexate|methotrexate|mesh-list
153923640|NCT00381680|Etoposide|etoposide|mesh-list
153472358|NCT04358796|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
153923641|NCT00381680|Vincristine|vincristine|mesh-list
153923642|NCT00381680|Etoposide phosphate|etoposide phosphate|mesh-list
153923643|NCT00381680|Asparaginase|asparaginase|mesh-list
153923644|NCT00381680|Mercaptopurine|mercaptopurine|mesh-list
153923645|NCT00381680|Pegaspargase|pegaspargase|mesh-list
153923646|NCT00381680|Levoleucovorin|levoleucovorin|mesh-list
153923647|NCT00381680|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153923648|NCT00381680|Immunologic Factors|immunologic factors|mesh-ancestor
153472426|NCT04355598|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153923692|NCT00018057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153923693|NCT00018057|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153923695|NCT00018057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153923696|NCT00018057|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
153923697|NCT00018057|Antidepressive Agents|antidepressive agents|mesh-ancestor
153923698|NCT00018057|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153923699|NCT00018057|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
153923700|NCT00018057|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153923701|NCT00018057|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153472494|NCT04353336|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153472495|NCT04353336|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153472496|NCT04353336|Analgesics|analgesics|mesh-ancestor
153472497|NCT04353336|Sensory System Agents|sensory system agents|mesh-ancestor
153472500|NCT04353336|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153472684|NCT04341402|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153472685|NCT04341402|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153472686|NCT04341402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153875486|NCT01201798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153472687|NCT04341402|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153472688|NCT04341402|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
153472689|NCT04341402|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
153472690|NCT04341402|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153472691|NCT04341402|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153472692|NCT04341402|Hormone Antagonists|hormone antagonists|mesh-ancestor
153472749|NCT04338906|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153472750|NCT04338906|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153472751|NCT04338906|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153472752|NCT04338906|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153472753|NCT04338906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153472946|NCT05136690|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153472947|NCT05136690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153472948|NCT05035680|Vaccines|vaccines|mesh-list
153472949|NCT05035680|Immunologic Factors|immunologic factors|mesh-ancestor
153472950|NCT05035680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153472999|NCT03033264|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153473000|NCT03033264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153473001|NCT03030768|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
153473002|NCT03030768|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153473003|NCT03030768|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153473067|NCT03018990|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
153473068|NCT03018990|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153473069|NCT03018990|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153473070|NCT03018990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153473071|NCT03018756|Fentanyl|fentanyl|mesh-list
153473072|NCT03018756|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153473073|NCT03018756|Narcotics|narcotics|mesh-ancestor
153473075|NCT03018756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153473329|NCT03005496|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153473330|NCT03005496|Vasodilator Agents|vasodilator agents|mesh-ancestor
153473331|NCT03005496|Tocolytic Agents|tocolytic agents|mesh-ancestor
153473332|NCT03005496|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153473333|NCT03005496|Antioxidants|antioxidants|mesh-ancestor
153473334|NCT03005496|Protective Agents|protective agents|mesh-ancestor
153473335|NCT03005496|Provitamins|provitamins|mesh-ancestor
153473336|NCT03005496|Iron Chelating Agents|iron chelating agents|mesh-ancestor
153473337|NCT03005496|Chelating Agents|chelating agents|mesh-ancestor
153473338|NCT03005496|Sequestering Agents|sequestering agents|mesh-ancestor
153473339|NCT03005808|Ropivacaine|ropivacaine|mesh-list
153473340|NCT03005808|Anesthetics, Local|anesthetics, local|mesh-ancestor
153473341|NCT03005808|Anesthetics|anesthetics|mesh-ancestor
153473510|NCT02987244|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153473511|NCT02987244|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153473512|NCT02987244|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153473513|NCT02987244|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153473514|NCT02987244|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153473515|NCT02987244|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153473516|NCT02987244|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153473517|NCT02987244|Tubulin Modulators|tubulin modulators|mesh-ancestor
153473518|NCT02987244|Antimitotic Agents|antimitotic agents|mesh-ancestor
153473677|NCT02641782|Interleukin-2|interleukin-2|mesh-list
153473678|NCT02641782|Tretinoin|tretinoin|mesh-list
153473679|NCT02641782|Dinutuximab|dinutuximab|mesh-list
153473682|NCT02641782|Sargramostim|sargramostim|mesh-list
153473683|NCT02641782|Immunologic Factors|immunologic factors|mesh-ancestor
153473684|NCT02641782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153473685|NCT02641782|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153473686|NCT02641782|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153473687|NCT02641782|Analgesics|analgesics|mesh-ancestor
153473688|NCT02641782|Sensory System Agents|sensory system agents|mesh-ancestor
153473689|NCT02641782|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153473692|NCT02641782|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153473719|NCT04769778|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
153473720|NCT04769778|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
153473860|NCT05139966|Cariostatic Agents|cariostatic agents|mesh-ancestor
153473861|NCT05139966|Protective Agents|protective agents|mesh-ancestor
153473862|NCT05139966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153473885|NCT00578214|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153473886|NCT00578214|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153473887|NCT00578214|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153473888|NCT00578214|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153473889|NCT00578214|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153473890|NCT00578214|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153473891|NCT00578214|Anesthetics, General|anesthetics, general|mesh-ancestor
153473892|NCT00578214|GABA Modulators|gaba modulators|mesh-ancestor
153473893|NCT00578214|GABA Agents|gaba agents|mesh-ancestor
153473894|NCT00578214|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153473895|NCT00578214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153473896|NCT00580398|Varenicline|varenicline|mesh-list
153473897|NCT00580398|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
153473898|NCT00580398|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
153473903|NCT00582660|Celecoxib|celecoxib|mesh-list
153474065|NCT00592488|Acetylcarnitine|acetylcarnitine|mesh-list
153474066|NCT00592488|Vitamin B Complex|vitamin b complex|mesh-ancestor
153474067|NCT00592488|Vitamins|vitamins|mesh-ancestor
153474068|NCT00592488|Micronutrients|micronutrients|mesh-ancestor
153474069|NCT00592488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153474070|NCT00592488|Nootropic Agents|nootropic agents|mesh-ancestor
153474071|NCT00595530|Ketamine|ketamine|mesh-list
153474072|NCT00595530|Analgesics|analgesics|mesh-ancestor
153474073|NCT00595530|Sensory System Agents|sensory system agents|mesh-ancestor
153474074|NCT00595530|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153474075|NCT00595530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153474076|NCT00595530|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
153474126|NCT00603018|Serotonin Agents|serotonin agents|mesh-ancestor
153474127|NCT00603018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153474128|NCT00603018|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
153474129|NCT00603018|Antidepressive Agents|antidepressive agents|mesh-ancestor
153474385|NCT00671970|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153474386|NCT00671970|Growth Substances|growth substances|mesh-ancestor
153474387|NCT00671970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153474447|NCT00676806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153474448|NCT00676806|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153474449|NCT00676806|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153474450|NCT00676806|Alkylating Agents|alkylating agents|mesh-ancestor
153474451|NCT00676806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153474452|NCT00676806|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153474453|NCT00676806|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153474454|NCT00678834|Tocopherols|tocopherols|mesh-list
153474462|NCT00678834|Vitamins|vitamins|mesh-ancestor
153474614|NCT00706446|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
153474615|NCT00706446|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
153474616|NCT00706446|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153474617|NCT00706446|Adrenergic Agents|adrenergic agents|mesh-ancestor
153474618|NCT00706446|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153474619|NCT00706446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153474620|NCT00706446|Parasympatholytics|parasympatholytics|mesh-ancestor
153474621|NCT00706446|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
153474622|NCT00706446|Cholinergic Agents|cholinergic agents|mesh-ancestor
153474623|NCT00706446|Anticonvulsants|anticonvulsants|mesh-ancestor
153474624|NCT00706836|Pregabalin|pregabalin|mesh-list
153474625|NCT00706836|Analgesics|analgesics|mesh-ancestor
153474626|NCT00706836|Sensory System Agents|sensory system agents|mesh-ancestor
153474627|NCT00706836|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153474628|NCT00706836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153474732|NCT00720330|Anesthetics|anesthetics|mesh-ancestor
153474733|NCT00720330|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153474734|NCT00720330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153474735|NCT00720330|Sensory System Agents|sensory system agents|mesh-ancestor
153474736|NCT00720330|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153474737|NCT00720330|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153474738|NCT00720330|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
153474739|NCT00720330|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153474740|NCT00720330|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153474741|NCT00720330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153474742|NCT00720330|Analgesics|analgesics|mesh-ancestor
153474743|NCT00720330|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
153474873|NCT00735462|Toll-Like Receptor Agonists|toll-like receptor agonists|mesh-ancestor
153474874|NCT00735462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153474875|NCT00735462|Immunomodulating Agents|immunomodulating agents|mesh-ancestor
153474876|NCT00735462|Immunologic Factors|immunologic factors|mesh-ancestor
153474877|NCT00735462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153474878|NCT00735462|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153474879|NCT00735462|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153474880|NCT00735462|Interferon Inducers|interferon inducers|mesh-ancestor
153474881|NCT00736242|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
153474990|NCT00745290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153474991|NCT00745290|Sensory System Agents|sensory system agents|mesh-ancestor
153474992|NCT00745290|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153474993|NCT00751530|Raltegravir Potassium|raltegravir potassium|mesh-list
153474994|NCT00751530|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153474995|NCT00751530|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153474996|NCT00751530|Antiviral Agents|antiviral agents|mesh-ancestor
153475131|NCT00762528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153475269|NCT00787722|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153475270|NCT00787722|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153475271|NCT00787722|Glucocorticoids|glucocorticoids|mesh-ancestor
153475272|NCT00787722|Hormones|hormones|mesh-ancestor
153475273|NCT00787722|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153475274|NCT00787722|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
153475275|NCT00787722|Protective Agents|protective agents|mesh-ancestor
153475276|NCT00787722|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153475278|NCT00788892|Daunorubicin|daunorubicin|mesh-list
153475279|NCT00788892|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153475280|NCT00788892|Antimetabolites|antimetabolites|mesh-ancestor
153475301|NCT00789672|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153475302|NCT00789750|Pioglitazone|pioglitazone|mesh-list
153475304|NCT00789750|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153475305|NCT00789750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153475306|NCT00789750|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153475307|NCT00789750|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153475357|NCT00795210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153475495|NCT00804648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153475496|NCT00804648|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
153475497|NCT00804648|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
153475498|NCT00804648|Adrenergic Agents|adrenergic agents|mesh-ancestor
153475499|NCT00804648|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153475500|NCT00804648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153475501|NCT00804648|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153475502|NCT00804648|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153475639|NCT04603248|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153475640|NCT04603248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153475642|NCT03763656|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153475643|NCT03763656|Antisickling Agents|antisickling agents|mesh-ancestor
153475644|NCT03763656|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153475647|NCT02682888|Oxytocin|oxytocin|mesh-list
153475734|NCT00825786|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153475735|NCT00825786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153475736|NCT00825786|Sensory System Agents|sensory system agents|mesh-ancestor
153475737|NCT00825786|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153475738|NCT00826800|Bevacizumab|bevacizumab|mesh-list
153475743|NCT00826800|Growth Substances|growth substances|mesh-ancestor
153475829|NCT00834678|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
153475830|NCT00834678|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153475831|NCT00834678|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153475832|NCT00834678|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153475833|NCT00834678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153874536|NCT01643889|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153874537|NCT01643889|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153874538|NCT01643889|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153874539|NCT01643889|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153874540|NCT01643889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153874541|NCT01643889|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153874542|NCT01643889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153874543|NCT01643889|Antiemetics|antiemetics|mesh-ancestor
153874544|NCT01643889|Autonomic Agents|autonomic agents|mesh-ancestor
153874545|NCT01643889|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153874546|NCT01643889|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153874547|NCT01643889|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
153874548|NCT01643889|Dopamine Agents|dopamine agents|mesh-ancestor
153874549|NCT01643889|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153874550|NCT04550078|Calcium, Dietary|calcium, dietary|mesh-list
153874551|NCT04550078|Calcium Carbonate|calcium carbonate|mesh-list
153874552|NCT04550078|Calcium|calcium|mesh-list
153415266|NCT02207244|Adalimumab|adalimumab|mesh-list
153874569|NCT04549844|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153874571|NCT04549844|Sensory System Agents|sensory system agents|mesh-ancestor
153874572|NCT04549844|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153415284|NCT02207088|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
153415285|NCT02207088|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153415286|NCT02207088|Antimetabolites|antimetabolites|mesh-ancestor
153415287|NCT02638597|Gemfibrozil|gemfibrozil|mesh-list
153415303|NCT02239926|Ranolazine|ranolazine|mesh-list
153874602|NCT04528797|Protective Agents|protective agents|mesh-ancestor
153874603|NCT04528797|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153874605|NCT00624481|Teriparatide|teriparatide|mesh-list
153874606|NCT00624481|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153874607|NCT00624481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153874608|NCT00624481|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153874609|NCT04529187|Midazolam|midazolam|mesh-list
153874610|NCT04529187|Dexmedetomidine|dexmedetomidine|mesh-list
153874611|NCT04529187|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153874612|NCT04529187|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153415328|NCT02206152|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153874655|NCT01182181|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153874656|NCT01182181|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153874657|NCT01182181|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
153874658|NCT01182181|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153874659|NCT01182181|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153874660|NCT01182181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153874661|NCT01182181|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
153415428|NCT02169336|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153415429|NCT02169336|Analgesics|analgesics|mesh-ancestor
153415430|NCT02169336|Sensory System Agents|sensory system agents|mesh-ancestor
153415431|NCT02169336|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153415432|NCT02169336|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
153415433|NCT02169336|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153415434|NCT02169336|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153415435|NCT02169336|Adrenergic Agents|adrenergic agents|mesh-ancestor
153874760|NCT04547426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153874761|NCT04547426|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
153874762|NCT04547426|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
153874763|NCT04547426|Cholinergic Agents|cholinergic agents|mesh-ancestor
153874764|NCT04547426|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153874765|NCT04547426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153874766|NCT01641666|Ribavirin|ribavirin|mesh-list
153874767|NCT01641666|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
153874768|NCT01641666|Interferon-alpha|interferon-alpha|mesh-list
153415491|NCT02201784|Ropivacaine|ropivacaine|mesh-list
153874808|NCT01641783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153874809|NCT02214602|Doxorubicin|doxorubicin|mesh-list
153874810|NCT02214602|Epirubicin|epirubicin|mesh-list
153874811|NCT02214602|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153415582|NCT02302976|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153415583|NCT02302976|Sensory System Agents|sensory system agents|mesh-ancestor
153415584|NCT02302976|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153415585|NCT02302976|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
153415586|NCT02302976|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
153415587|NCT02302976|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153415588|NCT02302976|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153415589|NCT02302976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153874901|NCT02214680|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153874902|NCT02214680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153874903|NCT02214680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153874904|NCT02214680|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153874905|NCT02214680|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153874906|NCT02214680|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
153874907|NCT02214680|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153415678|NCT04739774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153415679|NCT04739774|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153415680|NCT04739774|Hormone Antagonists|hormone antagonists|mesh-ancestor
153415681|NCT04739774|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153415682|NCT04739774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153415683|NCT04739774|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
153415684|NCT02660918|Bupivacaine|bupivacaine|mesh-list
153415685|NCT02660918|Anesthetics, Local|anesthetics, local|mesh-ancestor
153415686|NCT02660918|Anesthetics|anesthetics|mesh-ancestor
153415687|NCT02660918|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153874967|NCT04544969|Docetaxel|docetaxel|mesh-list
153415726|NCT05587621|8-hydroxy-2,2,14,14-tetramethylpentadecanedioic acid|8-hydroxy-2,2,14,14-tetramethylpentadecanedioic acid|mesh-list
153874973|NCT04544969|Tubulin Modulators|tubulin modulators|mesh-ancestor
153874974|NCT04544969|Antimitotic Agents|antimitotic agents|mesh-ancestor
153874975|NCT04544969|Mitosis Modulators|mitosis modulators|mesh-ancestor
153874976|NCT04544969|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153875029|NCT04544228|Cholinergic Agents|cholinergic agents|mesh-ancestor
153875030|NCT04544228|Parasympathomimetics|parasympathomimetics|mesh-ancestor
153875031|NCT04544228|Autonomic Agents|autonomic agents|mesh-ancestor
153875032|NCT01646736|Cyclophosphamide|cyclophosphamide|mesh-list
153875033|NCT01646736|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153875034|NCT01646736|Immunologic Factors|immunologic factors|mesh-ancestor
153875035|NCT01646736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153875036|NCT01646736|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153875037|NCT01646736|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153415800|NCT02643979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153415811|NCT02643979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153415812|NCT05587231|Fluorometholone|fluorometholone|mesh-list
153415813|NCT05587231|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153415814|NCT05587231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153415815|NCT05587231|Glucocorticoids|glucocorticoids|mesh-ancestor
153415817|NCT05587231|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153415818|NCT05587231|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
153875105|NCT04543916|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
153875106|NCT04543916|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153875107|NCT04543916|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153875108|NCT04543916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153875109|NCT04543916|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153875110|NCT04541303|Tranexamic Acid|tranexamic acid|mesh-list
153875111|NCT04541303|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
153875112|NCT04541303|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153875113|NCT04541303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153875114|NCT04541303|Hemostatics|hemostatics|mesh-ancestor
153875115|NCT04541303|Coagulants|coagulants|mesh-ancestor
153875116|NCT02214992|Telmisartan|telmisartan|mesh-list
153875155|NCT04543565|Tenofovir|tenofovir|mesh-list
153875156|NCT04543565|Pradefovir|pradefovir|mesh-list
153875157|NCT04543565|Antiviral Agents|antiviral agents|mesh-ancestor
153875158|NCT04543565|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153875159|NCT04543565|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153875160|NCT04543565|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153875161|NCT04543565|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153875162|NCT04543565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153875163|NCT04543565|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153415885|NCT05502211|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153415886|NCT05502211|Narcotics|narcotics|mesh-ancestor
153415887|NCT05502211|Analgesics|analgesics|mesh-ancestor
153415888|NCT05502211|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153415889|NCT05502211|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153415890|NCT05502211|Anesthetics, General|anesthetics, general|mesh-ancestor
153415891|NCT02674412|Buspirone|buspirone|mesh-list
153415892|NCT02674412|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153415893|NCT02674412|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153875184|NCT04543370|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153875228|NCT02215382|Parasympatholytics|parasympatholytics|mesh-ancestor
153418162|NCT02908490|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153875229|NCT02215382|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
153416014|NCT02659501|Epinephrine|epinephrine|mesh-list
153875332|NCT01180660|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153875333|NCT01180660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153875334|NCT01180660|Sensory System Agents|sensory system agents|mesh-ancestor
153875335|NCT01180660|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153418257|NCT03002012|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153418258|NCT03002012|Hormone Antagonists|hormone antagonists|mesh-ancestor
153875386|NCT01649037|Respiratory System Agents|respiratory system agents|mesh-ancestor
153875387|NCT01649037|Mydriatics|mydriatics|mesh-ancestor
153875388|NCT01649037|Sympathomimetics|sympathomimetics|mesh-ancestor
153875389|NCT01649037|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
153875390|NCT01649037|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153875391|NCT04539119|Tenofovir|tenofovir|mesh-list
153875392|NCT04539119|Entecavir|entecavir|mesh-list
153875393|NCT04539119|Antiviral Agents|antiviral agents|mesh-ancestor
153875394|NCT04539119|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153875395|NCT04539119|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153418279|NCT03001453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153875396|NCT04539119|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153875397|NCT04539119|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153875398|NCT04539119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153875399|NCT04539119|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153875400|NCT04539119|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153875401|NCT02279511|Adenosine|adenosine|mesh-list
153875402|NCT02279511|Analgesics|analgesics|mesh-ancestor
153875403|NCT02279511|Sensory System Agents|sensory system agents|mesh-ancestor
153875413|NCT02279628|Morphine|morphine|mesh-list
153875434|NCT01683006|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
153875436|NCT01683006|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153875437|NCT01683006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153875438|NCT01683162|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
153875439|NCT01683162|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
153875440|NCT01683162|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
153875441|NCT01683162|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
153875442|NCT02215733|Telmisartan|telmisartan|mesh-list
153875443|NCT02215733|Diuretics|diuretics|mesh-list
153416171|NCT02670343|Testosterone enanthate|testosterone enanthate|mesh-list
153416172|NCT02670343|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
153416173|NCT02670343|Androgens|androgens|mesh-ancestor
153416174|NCT02670343|Hormones|hormones|mesh-ancestor
153416180|NCT02730884|ON 01910|on 01910|mesh-list
153416210|NCT02732899|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153416211|NCT02732899|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153416212|NCT02732899|Antifungal Agents|antifungal agents|mesh-ancestor
153416213|NCT02732899|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153416254|NCT00368342|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153416255|NCT00368342|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
153416256|NCT00368342|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153875564|NCT01649544|Vasodilator Agents|vasodilator agents|mesh-ancestor
153875565|NCT01649544|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
153875566|NCT01649544|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153875567|NCT01649544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153875568|NCT01649544|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153875569|NCT01649544|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
153875570|NCT01649544|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153875571|NCT01649544|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153416304|NCT00369356|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153416305|NCT00369356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153416306|NCT00369356|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153416307|NCT00369356|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153416308|NCT02679469|Nalmefene|nalmefene|mesh-list
153416309|NCT02679469|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
153416310|NCT02679469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153416311|NCT02679469|Sensory System Agents|sensory system agents|mesh-ancestor
153416312|NCT02679469|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153416313|NCT02681809|Fibrinolysin|fibrinolysin|mesh-list
153416333|NCT00367627|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
153416334|NCT00367627|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153416335|NCT00367627|Tubulin Modulators|tubulin modulators|mesh-ancestor
153875590|NCT01649622|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
153875591|NCT01649622|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153875592|NCT01649622|Alkylating Agents|alkylating agents|mesh-ancestor
153875593|NCT01649622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153875594|NCT01649622|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153875595|NCT01683747|Tranexamic Acid|tranexamic acid|mesh-list
153875596|NCT01683747|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
153875597|NCT01683747|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153416385|NCT04003987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153416386|NCT04003987|Sensory System Agents|sensory system agents|mesh-ancestor
153416387|NCT04003987|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153416388|NCT05448001|Lansoprazole|lansoprazole|mesh-list
153416389|NCT05448001|Dexlansoprazole|dexlansoprazole|mesh-list
153416390|NCT05448001|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
153416391|NCT05448001|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153416392|NCT05448001|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
153416393|NCT05448001|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153416428|NCT03615547|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153416429|NCT03615547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153416430|NCT03615547|Fertility Agents, Female|fertility agents, female|mesh-ancestor
153416431|NCT03615547|Fertility Agents|fertility agents|mesh-ancestor
153416432|NCT03615547|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153416434|NCT03615547|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
153875717|NCT04315831|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153875718|NCT04315831|Narcotics|narcotics|mesh-ancestor
153875721|NCT04315831|Analgesics|analgesics|mesh-ancestor
153875760|NCT01684449|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153875761|NCT01684449|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153875762|NCT01684449|Antifungal Agents|antifungal agents|mesh-ancestor
153875763|NCT01684449|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153875764|NCT01684449|Immunologic Factors|immunologic factors|mesh-ancestor
153875765|NCT01684449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153875766|NCT01684683|Theophylline|theophylline|mesh-list
153875767|NCT01684683|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153875768|NCT01684683|Autonomic Agents|autonomic agents|mesh-ancestor
153875769|NCT01684683|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153416567|NCT04338919|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153416569|NCT04338919|Analgesics|analgesics|mesh-ancestor
153416570|NCT04338919|Sensory System Agents|sensory system agents|mesh-ancestor
153416571|NCT04338919|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153416572|NCT04338919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153416573|NCT04338919|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153416574|NCT04338919|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153875797|NCT04531163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153416575|NCT04338919|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153416602|NCT00369889|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153416603|NCT00369889|Growth Substances|growth substances|mesh-ancestor
153416604|NCT00369889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153875847|NCT01685658|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153875848|NCT01685658|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153875849|NCT01685658|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153875850|NCT01685658|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153875851|NCT01685658|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153875852|NCT01685658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153875853|NCT04530578|Heparin|heparin|mesh-list
153875854|NCT04530578|Calcium heparin|calcium heparin|mesh-list
153875855|NCT04530578|Enoxaparin|enoxaparin|mesh-list
153875857|NCT04530578|Tinzaparin|tinzaparin|mesh-list
153875866|NCT01685853|Laxatives|laxatives|mesh-ancestor
153875867|NCT04530422|Azithromycin|azithromycin|mesh-list
153875868|NCT04530422|Hydroxychloroquine|hydroxychloroquine|mesh-list
153875869|NCT04530422|Sofosbuvir|sofosbuvir|mesh-list
153875870|NCT04530422|Oseltamivir|oseltamivir|mesh-list
153875871|NCT04530422|Ledipasvir|ledipasvir|mesh-list
153875872|NCT04530422|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153875873|NCT04530422|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153875874|NCT04530422|Antimalarials|antimalarials|mesh-ancestor
153875875|NCT04530422|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153875876|NCT04530422|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153875877|NCT04530422|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153875878|NCT04530422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153875879|NCT04530422|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153875919|NCT01685931|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
153416662|NCT05451121|Dexmedetomidine|dexmedetomidine|mesh-list
153416663|NCT05451121|Propofol|propofol|mesh-list
153416664|NCT05451121|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153416665|NCT05451121|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153416666|NCT05451121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153416667|NCT05451121|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153416668|NCT05451121|Analgesics|analgesics|mesh-ancestor
153418913|NCT05828199|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153875961|NCT01686321|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153875962|NCT01686321|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153875963|NCT01686321|Immunologic Factors|immunologic factors|mesh-ancestor
153875964|NCT01686321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153875965|NCT01686321|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153875966|NCT01686321|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153875967|NCT01686321|Alkylating Agents|alkylating agents|mesh-ancestor
153416723|NCT05450497|Propofol|propofol|mesh-list
153875996|NCT02217683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153875997|NCT02217683|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153875998|NCT02217683|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
153875999|NCT02217683|Vasodilator Agents|vasodilator agents|mesh-ancestor
153876000|NCT02217683|Gasotransmitters|gasotransmitters|mesh-ancestor
153876001|NCT02217683|Protective Agents|protective agents|mesh-ancestor
153876002|NCT02217722|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
153416745|NCT05449028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153416746|NCT05449028|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153416748|NCT04845139|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153416749|NCT04845139|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153416752|NCT04738526|Lithium Carbonate|lithium carbonate|mesh-list
153876025|NCT02217956|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153876026|NCT02217956|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153876027|NCT02217956|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153876028|NCT02217956|Growth Substances|growth substances|mesh-ancestor
153876030|NCT02217956|Growth Inhibitors|growth inhibitors|mesh-ancestor
153876031|NCT01687140|Cycloserine|cycloserine|mesh-list
153876032|NCT01687140|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
153876033|NCT01687140|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153876034|NCT01687140|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
153876035|NCT01687140|Antitubercular Agents|antitubercular agents|mesh-ancestor
153416784|NCT05448937|Zinc Oxide|zinc oxide|mesh-list
153416816|NCT05448781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153416817|NCT05448781|Growth Inhibitors|growth inhibitors|mesh-ancestor
153416818|NCT00370825|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
153416819|NCT00370825|Miltefosine|miltefosine|mesh-list
153416820|NCT00370825|Antifungal Agents|antifungal agents|mesh-ancestor
153416821|NCT00370825|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153416822|NCT00370825|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153416823|NCT00370825|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153416824|NCT00370825|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153416825|NCT02535247|Pembrolizumab|pembrolizumab|mesh-list
153416826|NCT02535247|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153416872|NCT02229396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153416873|NCT02229396|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153876097|NCT02218034|Micronutrients|micronutrients|mesh-ancestor
153876098|NCT02218034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153876099|NCT01688154|Proanthocyanidin|proanthocyanidin|mesh-list
153876100|NCT01688154|Procyanidin|procyanidin|mesh-list
153876101|NCT01688154|Antioxidants|antioxidants|mesh-ancestor
153416874|NCT02229396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153876102|NCT01688154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153876103|NCT01688154|Protective Agents|protective agents|mesh-ancestor
153876104|NCT01688154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153416888|NCT00370370|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153416889|NCT00370370|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153416890|NCT00370370|Growth Substances|growth substances|mesh-ancestor
153416891|NCT00370370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153416892|NCT00370370|Growth Inhibitors|growth inhibitors|mesh-ancestor
153878307|NCT04588246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153416894|NCT00370370|Glucocorticoids|glucocorticoids|mesh-ancestor
153416895|NCT00370370|Hormones|hormones|mesh-ancestor
153416896|NCT00370370|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153416897|NCT00370370|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153876175|NCT01199068|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153876176|NCT01199068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153876177|NCT01199068|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153876178|NCT01198873|Dronedarone|dronedarone|mesh-list
153876179|NCT01198873|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153876180|NCT01198795|Escitalopram|escitalopram|mesh-list
153876181|NCT01198795|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
153876182|NCT01198795|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153876183|NCT01198795|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153876184|NCT01198795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153416932|NCT00371527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153876205|NCT02216552|Antioxidants|antioxidants|mesh-ancestor
153876206|NCT02216552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153876207|NCT02216552|Protective Agents|protective agents|mesh-ancestor
153416954|NCT04027322|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153417008|NCT03886922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153417009|NCT03886922|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153417010|NCT03886922|Respiratory System Agents|respiratory system agents|mesh-ancestor
153417011|NCT03886922|Parasympatholytics|parasympatholytics|mesh-ancestor
153417012|NCT03886922|Vasodilator Agents|vasodilator agents|mesh-ancestor
153876279|NCT01196416|2,2-dimethyl-N-(6-oxo-6,7-dihydro-5H-dibenzo(b,d)azepin-7-yl)-N'-(2,2,3,3,3-pentafluoropropyl)malonamide|2,2-dimethyl-n-(6-oxo-6,7-dihydro-5h-dibenzo(b,d)azepin-7-yl)-n'-(2,2,3,3,3-pentafluoropropyl)malonamide|mesh-list
153876281|NCT01196416|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153876282|NCT01196416|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153876283|NCT01196416|Alkylating Agents|alkylating agents|mesh-ancestor
153876284|NCT01196416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153876285|NCT01196416|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153876287|NCT01196416|Antimitotic Agents|antimitotic agents|mesh-ancestor
153876288|NCT01196416|Mitosis Modulators|mitosis modulators|mesh-ancestor
153876289|NCT01196416|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153876291|NCT01196104|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
153876292|NCT01196104|Insulin Glargine|insulin glargine|mesh-list
153876293|NCT01196104|Insulin Aspart|insulin aspart|mesh-list
153876294|NCT01196104|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153876295|NCT01196104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153417080|NCT02196714|Autonomic Agents|autonomic agents|mesh-ancestor
153417081|NCT02196714|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153417082|NCT02196714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153417083|NCT02196714|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153876311|NCT04534322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153876312|NCT04534322|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153876313|NCT04534322|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153876315|NCT02219672|Ritonavir|ritonavir|mesh-list
153876316|NCT02219672|Lopinavir|lopinavir|mesh-list
153876317|NCT02219672|Tenofovir|tenofovir|mesh-list
153876318|NCT02219672|Lamivudine|lamivudine|mesh-list
153876319|NCT02219672|Raltegravir Potassium|raltegravir potassium|mesh-list
153876320|NCT02219672|Triptolide|triptolide|mesh-list
153876348|NCT03113955|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153876349|NCT03113955|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153876350|NCT03113955|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153876351|NCT03113955|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153876352|NCT03113955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153876353|NCT02219750|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
153876354|NCT02219750|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153417156|NCT02737891|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
153417157|NCT02737891|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
153417158|NCT02737891|Adrenergic Agents|adrenergic agents|mesh-ancestor
153876388|NCT04533867|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153876389|NCT04533867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153876390|NCT04533867|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153876391|NCT04533867|Antipruritics|antipruritics|mesh-ancestor
153876392|NCT04533867|Dermatologic Agents|dermatologic agents|mesh-ancestor
153876393|NCT04533867|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
153876398|NCT02219867|Ketamine|ketamine|mesh-list
153419471|NCT04014790|KRN 7000|krn 7000|mesh-list
153417199|NCT00370669|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153417201|NCT00370669|Immunologic Factors|immunologic factors|mesh-ancestor
153417202|NCT00370669|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153417203|NCT00370669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153417204|NCT02740543|Fluticasone|fluticasone|mesh-list
153417206|NCT02740543|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153417207|NCT02740543|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153417208|NCT02740543|Autonomic Agents|autonomic agents|mesh-ancestor
153417209|NCT02740543|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153876476|NCT04532931|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
153876477|NCT04532931|Anthelmintics|anthelmintics|mesh-ancestor
153876478|NCT01195363|Quetiapine Fumarate|quetiapine fumarate|mesh-list
153876479|NCT01195363|Antidepressive Agents|antidepressive agents|mesh-ancestor
153876480|NCT01195363|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153876481|NCT01195363|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153419498|NCT03680053|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153417232|NCT02227446|Vancomycin|vancomycin|mesh-list
153876519|NCT02214563|Vitamins|vitamins|mesh-list
153876520|NCT02214563|Micronutrients|micronutrients|mesh-ancestor
153876524|NCT01194973|Eculizumab|eculizumab|mesh-list
153876569|NCT02279147|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153876570|NCT02279186|Tranexamic Acid|tranexamic acid|mesh-list
153876571|NCT02279186|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
153876572|NCT02279186|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153876573|NCT02279186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153876574|NCT02279186|Hemostatics|hemostatics|mesh-ancestor
153876575|NCT02279186|Coagulants|coagulants|mesh-ancestor
153876577|NCT01177540|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153419598|NCT02429700|Etoposide|etoposide|mesh-list
153876598|NCT01640093|Abiraterone Acetate|abiraterone acetate|mesh-list
153876599|NCT01640093|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153876653|NCT01640639|Growth Substances|growth substances|mesh-ancestor
153876654|NCT01640639|Growth Inhibitors|growth inhibitors|mesh-ancestor
153876655|NCT01640639|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153876656|NCT01642667|Saruplase|saruplase|mesh-list
153876657|NCT01642667|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153876658|NCT01642667|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153876659|NCT01642667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153876705|NCT04497519|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153876706|NCT04497519|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153876707|NCT04497519|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153876708|NCT04497519|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153876709|NCT04497519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153876710|NCT04497519|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153876711|NCT01641224|Pinaverium|pinaverium|mesh-list
153876712|NCT01641224|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153876713|NCT01641224|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153876758|NCT01643252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153876759|NCT01643252|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
153876760|NCT01643252|Dermatologic Agents|dermatologic agents|mesh-ancestor
153876761|NCT01641458|Capecitabine|capecitabine|mesh-list
153876762|NCT01641458|Fluorouracil|fluorouracil|mesh-list
153876763|NCT01641458|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153876764|NCT01641458|Antimetabolites|antimetabolites|mesh-ancestor
153876765|NCT01641458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153876766|NCT01641458|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153878961|NCT03202628|Glycine Agents|glycine agents|mesh-ancestor
153876808|NCT06032039|Triamcinolone|triamcinolone|mesh-list
153876837|NCT06048705|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153876838|NCT06048705|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153876839|NCT06048705|Alkylating Agents|alkylating agents|mesh-ancestor
153876840|NCT06048705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153876841|NCT06048705|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153876842|NCT06048705|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153876843|NCT06048692|Ampicillin|ampicillin|mesh-list
153876844|NCT06048692|Cefepime|cefepime|mesh-list
153417649|NCT04337593|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153417650|NCT04337593|Immunologic Factors|immunologic factors|mesh-ancestor
153419829|NCT03050294|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153419830|NCT03050294|Glucocorticoids|glucocorticoids|mesh-ancestor
153417661|NCT04064684|Budesonide|budesonide|mesh-list
153417662|NCT04064684|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153417663|NCT04064684|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153417664|NCT04064684|Autonomic Agents|autonomic agents|mesh-ancestor
153417665|NCT04064684|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153417666|NCT04064684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153876922|NCT06046612|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153876970|NCT06045936|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153876971|NCT06045936|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153876972|NCT06045936|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
153876973|NCT06045936|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153876974|NCT06045936|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153876975|NCT06045936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153876976|NCT06045858|Anticoagulants|anticoagulants|mesh-list
153876977|NCT06045832|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
153876978|NCT06045832|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153876979|NCT06045429|Chlorhexidine|chlorhexidine|mesh-list
153417780|NCT00372476|Mitosis Modulators|mitosis modulators|mesh-ancestor
153417782|NCT04737967|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
153417783|NCT04737967|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
153417784|NCT04737967|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
153417785|NCT04737967|Dopamine Agents|dopamine agents|mesh-ancestor
153417786|NCT04737967|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153417787|NCT04737967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153417788|NCT04737967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153417789|NCT04737967|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
153417790|NCT04737967|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
153417791|NCT04737967|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
153417792|NCT04737967|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153417793|NCT04737967|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153417794|NCT04737967|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
153877039|NCT06044675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153877040|NCT06044675|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
153877041|NCT06044675|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153877042|NCT06044675|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153877043|NCT06044675|Adrenergic Agents|adrenergic agents|mesh-ancestor
153877044|NCT06044480|Dexamethasone|dexamethasone|mesh-list
153877045|NCT06044480|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153877046|NCT06044480|Antiemetics|antiemetics|mesh-ancestor
153877047|NCT06044480|Autonomic Agents|autonomic agents|mesh-ancestor
153877048|NCT06044480|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153877050|NCT06044480|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153877094|NCT06043349|Vasodilator Agents|vasodilator agents|mesh-ancestor
153877138|NCT06042985|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
153877139|NCT06042985|Chelating Agents|chelating agents|mesh-ancestor
153877140|NCT06042985|Sequestering Agents|sequestering agents|mesh-ancestor
153877141|NCT06042985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153877142|NCT06042985|Antacids|antacids|mesh-ancestor
153877143|NCT06042985|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153877144|NCT06042816|Analgesics, Opioid|analgesics, opioid|mesh-list
153877145|NCT06042816|Anesthetics|anesthetics|mesh-list
153877146|NCT06042816|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153877147|NCT06042816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153877149|NCT06042816|Analgesics|analgesics|mesh-ancestor
153877150|NCT06042816|Sensory System Agents|sensory system agents|mesh-ancestor
153877151|NCT06042816|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153877152|NCT06037993|Palmidrol|palmidrol|mesh-list
153877153|NCT06037993|Analgesics|analgesics|mesh-ancestor
153417964|NCT00372541|Beta Lactam Antibiotics|beta lactam antibiotics|mesh-ancestor
153417965|NCT00372541|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153417966|NCT00372541|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153417967|NCT04762381|Dexamethasone|dexamethasone|mesh-list
153420202|NCT03123614|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153420203|NCT03123614|Antiemetics|antiemetics|mesh-ancestor
153877241|NCT06010810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153877242|NCT06010810|Hemostatics|hemostatics|mesh-ancestor
153877245|NCT06009653|Incretins|incretins|mesh-ancestor
153877246|NCT06009653|Hormones|hormones|mesh-ancestor
153877247|NCT06009653|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153877248|NCT06009653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153877249|NCT06007846|Memantine|memantine|mesh-list
153877250|NCT06007846|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
153877251|NCT06007846|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
153877252|NCT06007846|Dopamine Agents|dopamine agents|mesh-ancestor
153877253|NCT06007846|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153877255|NCT06007846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153418082|NCT00373165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153418084|NCT04333550|Siderophores|siderophores|mesh-ancestor
153418085|NCT04333550|Iron Chelating Agents|iron chelating agents|mesh-ancestor
153418086|NCT04333550|Chelating Agents|chelating agents|mesh-ancestor
153418171|NCT02911844|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153418192|NCT02790788|Protective Agents|protective agents|mesh-ancestor
153418193|NCT02790788|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153418194|NCT02790788|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153418195|NCT02888665|Doxorubicin|doxorubicin|mesh-list
153418196|NCT02888665|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
153418197|NCT02888665|Pembrolizumab|pembrolizumab|mesh-list
153418198|NCT02888665|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153877476|NCT05752734|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153877477|NCT05752734|Antiemetics|antiemetics|mesh-ancestor
153877478|NCT05752734|Autonomic Agents|autonomic agents|mesh-ancestor
153877479|NCT05752734|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153877480|NCT05752734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153877481|NCT05752734|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153877482|NCT05752734|Glucocorticoids|glucocorticoids|mesh-ancestor
153877483|NCT05752734|Hormones|hormones|mesh-ancestor
153418297|NCT03001843|Analgesics|analgesics|mesh-ancestor
153418298|NCT03001843|Sensory System Agents|sensory system agents|mesh-ancestor
153418299|NCT03001843|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153418300|NCT03001843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153418301|NCT03001843|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
153418302|NCT03001843|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153418303|NCT03001843|Anesthetics, General|anesthetics, general|mesh-ancestor
153420696|NCT02161146|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153877566|NCT05653401|Magnesium Sulfate|magnesium sulfate|mesh-list
153877567|NCT05653401|Anesthetics, Local|anesthetics, local|mesh-ancestor
153877568|NCT05653401|Anesthetics|anesthetics|mesh-ancestor
153877569|NCT05653401|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153877571|NCT05653401|Sensory System Agents|sensory system agents|mesh-ancestor
153877572|NCT05653401|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153877573|NCT05653401|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153877575|NCT05653401|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153877618|NCT05589220|Cholinergic Agents|cholinergic agents|mesh-ancestor
153418384|NCT02806544|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153418385|NCT00374348|Aripiprazole|aripiprazole|mesh-list
153420766|NCT03132571|Naltrexone|naltrexone|mesh-list
153418413|NCT02903407|Midazolam|midazolam|mesh-list
153418414|NCT02903407|Dexmedetomidine|dexmedetomidine|mesh-list
153418415|NCT02903407|Propofol|propofol|mesh-list
153418416|NCT02903407|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153418417|NCT02903407|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153877705|NCT05431920|Hydroxycholecalciferols|hydroxycholecalciferols|mesh-list
153877706|NCT05431920|Calcifediol|calcifediol|mesh-list
153877707|NCT05431920|Vitamins|vitamins|mesh-list
153877708|NCT05431920|Micronutrients|micronutrients|mesh-ancestor
153418480|NCT03018223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153418481|NCT03018223|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153418482|NCT03018223|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153418483|NCT03018223|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153418484|NCT03018223|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
153418485|NCT03018223|Antitubercular Agents|antitubercular agents|mesh-ancestor
153418486|NCT03018223|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153418487|NCT03018223|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153418488|NCT03018223|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153418489|NCT03018223|Antifungal Agents|antifungal agents|mesh-ancestor
153418490|NCT03018223|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153418495|NCT03018925|Immunologic Factors|immunologic factors|mesh-ancestor
153418543|NCT03025945|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153877757|NCT05403385|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153877758|NCT05403385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153877759|NCT05403385|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153877760|NCT05403385|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153877761|NCT05400863|Metformin|metformin|mesh-list
153877762|NCT05400863|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153425549|NCT00795236|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153420547|NCT04468568|Sympathomimetics|sympathomimetics|mesh-ancestor
153420548|NCT04468568|Tocolytic Agents|tocolytic agents|mesh-ancestor
153420549|NCT04468568|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153420550|NCT04468568|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
153420551|NCT04468568|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
153420552|NCT04468568|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153420553|NCT04468568|Adrenergic Agents|adrenergic agents|mesh-ancestor
153420557|NCT04468568|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153420558|NCT03168308|Glycopyrrolate|glycopyrrolate|mesh-list
153420559|NCT03168308|Neostigmine|neostigmine|mesh-list
153420560|NCT03168308|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
153420561|NCT03168308|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153420562|NCT03168308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153420563|NCT03168308|Cholinergic Agents|cholinergic agents|mesh-ancestor
153420564|NCT03168308|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153425647|NCT00691574|Melatonin|melatonin|mesh-list
153425671|NCT00681044|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153884722|NCT02270606|Protective Agents|protective agents|mesh-ancestor
153884744|NCT01606046|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153425716|NCT00639626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153420565|NCT03168308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153420566|NCT03168308|Parasympathomimetics|parasympathomimetics|mesh-ancestor
153420567|NCT03168308|Autonomic Agents|autonomic agents|mesh-ancestor
153420568|NCT03168308|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153420569|NCT03168308|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153420570|NCT03168308|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
153420571|NCT03168308|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
153420573|NCT03109015|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153420576|NCT03109015|Growth Substances|growth substances|mesh-ancestor
153879720|NCT04077684|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153879721|NCT04077684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153879722|NCT04027972|Glycopyrrolate|glycopyrrolate|mesh-list
153879723|NCT04027972|Neostigmine|neostigmine|mesh-list
153879724|NCT04027972|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
153879725|NCT04027972|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153879726|NCT04027972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153879727|NCT04027972|Cholinergic Agents|cholinergic agents|mesh-ancestor
153879728|NCT04027972|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153879729|NCT04027972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153879730|NCT04027972|Parasympathomimetics|parasympathomimetics|mesh-ancestor
153879731|NCT04027972|Autonomic Agents|autonomic agents|mesh-ancestor
153425782|NCT01705106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153425826|NCT00624650|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
153884880|NCT02271464|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153425852|NCT00610532|Uricosuric Agents|uricosuric agents|mesh-ancestor
153884924|NCT02892357|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
153884925|NCT02892357|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153425911|NCT04714099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153884969|NCT01172821|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153879732|NCT04027972|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153879733|NCT04027972|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153879734|NCT04027972|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
153879735|NCT04027972|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
153879737|NCT04026009|Immunologic Factors|immunologic factors|mesh-ancestor
153425949|NCT00589550|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153425950|NCT00589550|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153425951|NCT00589550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153425952|NCT00589550|Immunologic Factors|immunologic factors|mesh-ancestor
153425953|NCT00589550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153425954|NCT01636466|Everolimus|everolimus|mesh-list
153425955|NCT01636466|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
153425956|NCT01636466|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153425957|NCT01636466|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153884998|NCT02273102|Antidepressive Agents|antidepressive agents|mesh-ancestor
153884999|NCT02273102|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153885000|NCT02273102|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
153885001|NCT02273102|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153885002|NCT02273102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153885003|NCT02273102|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153885004|NCT02273102|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153885005|NCT02273102|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153885006|NCT02273102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153885007|NCT02272478|Decitabine|decitabine|mesh-list
153885008|NCT02272478|Gemtuzumab|gemtuzumab|mesh-list
153425958|NCT01636466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153425960|NCT01636466|Immunologic Factors|immunologic factors|mesh-ancestor
153425961|NCT01636466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153425962|NCT01636466|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153425963|NCT00568802|Hydroxyurea|hydroxyurea|mesh-list
153885014|NCT02272478|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153885015|NCT02272478|Immunotoxins|immunotoxins|mesh-ancestor
153885016|NCT02272478|Immunoconjugates|immunoconjugates|mesh-ancestor
153885017|NCT02272478|Immunologic Factors|immunologic factors|mesh-ancestor
153885018|NCT02272478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153885019|NCT02272517|Vortioxetine|vortioxetine|mesh-list
153885020|NCT02272517|Escitalopram|escitalopram|mesh-list
153425970|NCT03949621|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153425972|NCT04429880|Oxytocics|oxytocics|mesh-ancestor
153425975|NCT01692158|Heparin|heparin|mesh-list
153885021|NCT02272517|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
153885022|NCT02272517|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153885023|NCT02272517|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153885024|NCT02272517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153885025|NCT02272517|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153885026|NCT02272517|Serotonin Agents|serotonin agents|mesh-ancestor
153885027|NCT02272517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153885029|NCT02272517|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153885030|NCT02272517|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153885031|NCT02272517|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153426011|NCT03928327|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
153885036|NCT02272517|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153885037|NCT02272829|Analgesics, Opioid|analgesics, opioid|mesh-list
153885038|NCT02272829|Narcotics|narcotics|mesh-ancestor
153885039|NCT02272829|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153885040|NCT02272829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153885043|NCT02272829|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153885044|NCT00596115|Pramipexole|pramipexole|mesh-list
153885045|NCT00596115|Dexpramipexole|dexpramipexole|mesh-list
153885046|NCT00596115|Antioxidants|antioxidants|mesh-ancestor
153885047|NCT00596115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153885065|NCT02272868|Laxatives|laxatives|mesh-ancestor
153885073|NCT02273453|GABA Modulators|gaba modulators|mesh-ancestor
153885074|NCT02273453|GABA Agents|gaba agents|mesh-ancestor
153885075|NCT02273453|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153885076|NCT02273453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153885077|NCT01108510|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
153885078|NCT01108510|Atazanavir Sulfate|atazanavir sulfate|mesh-list
153885079|NCT01108510|Cobicistat|cobicistat|mesh-list
153885080|NCT01108510|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153426031|NCT01055756|Autonomic Agents|autonomic agents|mesh-ancestor
153426032|NCT01055756|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153426033|NCT01055756|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153426034|NCT01055756|Respiratory System Agents|respiratory system agents|mesh-ancestor
153426035|NCT01055756|Nasal Decongestants|nasal decongestants|mesh-ancestor
153426036|NCT01055756|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
153426038|NCT01055756|Sympathomimetics|sympathomimetics|mesh-ancestor
153885081|NCT01108510|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153885082|NCT01108510|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153885083|NCT01108510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153885084|NCT01108510|Antiviral Agents|antiviral agents|mesh-ancestor
153885085|NCT01108510|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153885086|NCT01108510|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153885087|NCT01108510|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153885093|NCT02273258|Insulin|insulin|mesh-list
153426062|NCT04333225|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153426063|NCT04333225|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153426064|NCT04333225|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153426065|NCT04333225|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153426106|NCT00521924|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153426107|NCT00521924|Analgesics|analgesics|mesh-ancestor
153885140|NCT01107925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153885141|NCT04310293|Hormones|hormones|mesh-list
153885142|NCT04310293|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153885143|NCT04310293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153885144|NCT01339559|Brivaracetam|brivaracetam|mesh-list
153885145|NCT01339559|Anticonvulsants|anticonvulsants|mesh-ancestor
153885146|NCT01588847|Sufentanil|sufentanil|mesh-list
153885154|NCT01588847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153885155|NCT01588847|Sensory System Agents|sensory system agents|mesh-ancestor
153885159|NCT01588847|Anesthetics, General|anesthetics, general|mesh-ancestor
153426128|NCT00379964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153426129|NCT01545518|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
153426130|NCT01545518|Immunologic Factors|immunologic factors|mesh-ancestor
153426131|NCT01545518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153426132|NCT01526408|Famciclovir|famciclovir|mesh-list
153426133|NCT01526408|Antiviral Agents|antiviral agents|mesh-ancestor
153426134|NCT01526408|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153426135|NCT01526408|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153426136|NCT01526408|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153426137|NCT01526408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153426138|NCT04713644|Propofol|propofol|mesh-list
153885171|NCT00107900|Antithrombins|antithrombins|mesh-ancestor
153885172|NCT00107900|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
153885173|NCT00107900|Protease Inhibitors|protease inhibitors|mesh-ancestor
153885174|NCT00107900|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153885176|NCT00107900|Anticoagulants|anticoagulants|mesh-ancestor
153426159|NCT00000734|Antimalarials|antimalarials|mesh-ancestor
153426160|NCT00000734|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153426161|NCT00000734|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153885190|NCT01335971|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
153885191|NCT01335971|Protective Agents|protective agents|mesh-ancestor
153885192|NCT01335971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153885208|NCT01335698|Atazanavir Sulfate|atazanavir sulfate|mesh-list
153885209|NCT01335698|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
153885210|NCT01335698|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
153885211|NCT01335698|Protease Inhibitors|protease inhibitors|mesh-ancestor
153885212|NCT01335698|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153885213|NCT01335698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153885214|NCT01335698|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153885215|NCT01335698|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153885216|NCT01335698|Antiviral Agents|antiviral agents|mesh-ancestor
153885222|NCT00107120|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153885223|NCT00107120|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153885224|NCT00107120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153885225|NCT00107120|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153426182|NCT00000764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153426184|NCT03909763|Danazol|danazol|mesh-list
153426185|NCT03909763|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
153426186|NCT03909763|Hormone Antagonists|hormone antagonists|mesh-ancestor
153885226|NCT00107120|Serotonin Agents|serotonin agents|mesh-ancestor
153885227|NCT00107120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153885228|NCT01335464|Nintedanib|nintedanib|mesh-list
153885229|NCT01335464|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153885230|NCT01335464|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153885231|NCT01335464|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153885232|NCT01335464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153885233|NCT00106184|Rituximab|rituximab|mesh-list
153885234|NCT00106184|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153885235|NCT00106184|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153885239|NCT00598923|Topiramate|topiramate|mesh-list
153426204|NCT00484718|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153426205|NCT00484718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153885259|NCT01334918|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
153885260|NCT01334918|Purinergic Agonists|purinergic agonists|mesh-ancestor
153885261|NCT01334918|Purinergic Agents|purinergic agents|mesh-ancestor
153885262|NCT01334918|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153885263|NCT01334918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153885275|NCT00598962|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153885276|NCT00598962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153885277|NCT00598962|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
153885278|NCT00598962|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
153885279|NCT00598962|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
153885280|NCT00598962|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
153885281|NCT00598962|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
153885282|NCT00598962|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
153885283|NCT01332968|Prednisone|prednisone|mesh-list
153885284|NCT01332968|Cyclophosphamide|cyclophosphamide|mesh-list
153885285|NCT01332968|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
153885286|NCT01332968|Rituximab|rituximab|mesh-list
153426248|NCT00000770|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
153426250|NCT00368654|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
153426251|NCT00368654|Abortifacient Agents|abortifacient agents|mesh-ancestor
153426252|NCT00368654|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153426253|NCT00368654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153426254|NCT00368654|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153426255|NCT00368654|Antimetabolites|antimetabolites|mesh-ancestor
153426257|NCT00368654|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153885288|NCT01332968|Vincristine|vincristine|mesh-list
153885289|NCT01332968|Obinutuzumab|obinutuzumab|mesh-list
153885290|NCT01332968|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153885291|NCT01332968|Immunologic Factors|immunologic factors|mesh-ancestor
153885292|NCT01332968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153885293|NCT01332968|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153885294|NCT01332968|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153885295|NCT01332968|Alkylating Agents|alkylating agents|mesh-ancestor
153426283|NCT00000776|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
153426284|NCT00000776|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153426285|NCT00000776|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153426286|NCT00000776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153426287|NCT00000776|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153426288|NCT00000776|Hormone Antagonists|hormone antagonists|mesh-ancestor
153426289|NCT00000776|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
153426290|NCT00000776|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
153885311|NCT01332968|Antimitotic Agents|antimitotic agents|mesh-ancestor
153426315|NCT00000782|Immunologic Factors|immunologic factors|mesh-ancestor
153426316|NCT00000782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153426317|NCT00000800|Zidovudine|zidovudine|mesh-list
153885330|NCT00599274|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153885331|NCT00599274|Immunologic Factors|immunologic factors|mesh-ancestor
153885332|NCT00599274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153885333|NCT00599274|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153885334|NCT01332227|Ritonavir|ritonavir|mesh-list
153885335|NCT01332227|Atazanavir Sulfate|atazanavir sulfate|mesh-list
153885336|NCT01332227|Tenofovir|tenofovir|mesh-list
153885337|NCT01332227|Emtricitabine|emtricitabine|mesh-list
153885338|NCT01332227|Raltegravir Potassium|raltegravir potassium|mesh-list
153885339|NCT01332227|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
153885340|NCT01332227|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
153885344|NCT01332227|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153885348|NCT01332227|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
153885349|NCT01332227|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153885350|NCT01332227|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153885351|NCT01332227|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153885352|NCT01332227|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
153885353|NCT01332227|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
153885354|NCT01332149|Pregabalin|pregabalin|mesh-list
153885355|NCT01332149|Analgesics|analgesics|mesh-ancestor
153426319|NCT00000800|Antimetabolites|antimetabolites|mesh-ancestor
153426320|NCT00000800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153426321|NCT00000800|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153885364|NCT01332149|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153885365|NCT01332149|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153426329|NCT00000800|Narcotics|narcotics|mesh-ancestor
153426330|NCT00000800|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153426331|NCT00000800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153426332|NCT00000800|Analgesics|analgesics|mesh-ancestor
153426333|NCT00000800|Sensory System Agents|sensory system agents|mesh-ancestor
153426334|NCT00000800|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153426335|NCT00000800|Antitussive Agents|antitussive agents|mesh-ancestor
153426336|NCT00000800|Respiratory System Agents|respiratory system agents|mesh-ancestor
153426337|NCT03679975|Riluzole|riluzole|mesh-list
153426338|NCT03679975|Anticonvulsants|anticonvulsants|mesh-ancestor
153426346|NCT03887299|Disinfectants|disinfectants|mesh-list
153885367|NCT01332149|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153885368|NCT01326702|Rituximab|rituximab|mesh-list
153885369|NCT01326702|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
153885370|NCT01326702|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
153885371|NCT01326702|Veliparib|veliparib|mesh-list
153885372|NCT01326702|Antibodies|antibodies|mesh-list
153885373|NCT01326702|Immunoglobulins|immunoglobulins|mesh-list
153885374|NCT01326702|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
153885375|NCT01326702|Immunologic Factors|immunologic factors|mesh-ancestor
153885376|NCT01326702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153885377|NCT01326702|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153885378|NCT01326702|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153885389|NCT00599625|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153885390|NCT00599625|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
153885391|NCT00599625|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153885392|NCT05649878|Methylprednisolone|methylprednisolone|mesh-list
153885393|NCT05649878|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
153885394|NCT05649878|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
153885395|NCT05649878|Prednisolone|prednisolone|mesh-list
153885396|NCT05649878|Prednisolone acetate|prednisolone acetate|mesh-list
153885404|NCT05649878|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153426368|NCT00218036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153426370|NCT00218036|Serotonin Agents|serotonin agents|mesh-ancestor
153426371|NCT00218036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153426372|NCT00218036|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
153426373|NCT00218036|Antidepressive Agents|antidepressive agents|mesh-ancestor
153426374|NCT00218036|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153885405|NCT05649878|Glucocorticoids|glucocorticoids|mesh-ancestor
153885406|NCT05649878|Hormones|hormones|mesh-ancestor
153885407|NCT05649878|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153885408|NCT05649878|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
153885409|NCT05649878|Protective Agents|protective agents|mesh-ancestor
153885410|NCT05649878|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153885411|NCT05649878|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153885412|NCT01327703|Pancreatin|pancreatin|mesh-list
153879738|NCT04026009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153879739|NCT04013854|Nivolumab|nivolumab|mesh-list
153879740|NCT04013854|Ipilimumab|ipilimumab|mesh-list
153879741|NCT04013854|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153879742|NCT04013854|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153879743|NCT04013854|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153426406|NCT00000812|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153426407|NCT00000812|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153426408|NCT00000812|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153426409|NCT00000812|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153426410|NCT00000812|Growth Substances|growth substances|mesh-ancestor
153426411|NCT00000812|Growth Inhibitors|growth inhibitors|mesh-ancestor
153426412|NCT00000812|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153426413|NCT00000818|Zidovudine|zidovudine|mesh-list
153885441|NCT01380080|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
153885442|NCT01380080|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
153885443|NCT01380080|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
153885444|NCT01380080|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153885445|NCT01380080|Antimetabolites|antimetabolites|mesh-ancestor
153885446|NCT01380080|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153885447|NCT01379573|Hydroxychloroquine|hydroxychloroquine|mesh-list
153885448|NCT01379573|Antimalarials|antimalarials|mesh-ancestor
153885449|NCT01379573|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153885458|NCT01371851|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
153885459|NCT01371851|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
153885460|NCT01371851|Adrenergic Agents|adrenergic agents|mesh-ancestor
153885461|NCT01371851|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153885462|NCT01371851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153885463|NCT01371851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153885464|NCT01371734|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
153885465|NCT01371734|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
153885466|NCT01371734|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153885467|NCT01371734|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153426435|NCT00177866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153426437|NCT00089414|Ethinyl Estradiol|ethinyl estradiol|mesh-list
153426438|NCT00089414|Drospirenone and ethinyl estradiol combination|drospirenone and ethinyl estradiol combination|mesh-list
153426439|NCT00089414|Estradiol|estradiol|mesh-list
153426440|NCT00089414|Progesterone|progesterone|mesh-list
153426441|NCT00089414|Estrogens|estrogens|mesh-ancestor
153426442|NCT00089414|Hormones|hormones|mesh-ancestor
153426443|NCT00089414|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153426444|NCT00089414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153426445|NCT00089414|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
153885473|NCT04328870|Oxytocin|oxytocin|mesh-list
153426454|NCT00089414|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
153426455|NCT00089414|Diuretics|diuretics|mesh-ancestor
153426456|NCT00089414|Natriuretic Agents|natriuretic agents|mesh-ancestor
153426457|NCT00075608|Melphalan|melphalan|mesh-list
153426458|NCT00075608|Immunologic Factors|immunologic factors|mesh-ancestor
153426459|NCT00075608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153426460|NCT00075608|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153426461|NCT00075608|Alkylating Agents|alkylating agents|mesh-ancestor
153426462|NCT00075608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153426463|NCT00075608|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153885488|NCT01357889|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
153885489|NCT01357889|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153885490|NCT01357889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153885491|NCT01357889|Incretins|incretins|mesh-ancestor
153885492|NCT01357889|Hormones|hormones|mesh-ancestor
153885493|NCT01357889|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153885494|NCT01357655|Dasatinib|dasatinib|mesh-list
153885495|NCT01357655|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153885496|NCT01357655|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153885497|NCT01357655|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153426469|NCT03704467|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153426470|NCT00000842|Mitogens|mitogens|mesh-list
153426471|NCT00000842|Mitosis Modulators|mitosis modulators|mesh-ancestor
153426472|NCT00000842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153426473|NCT02145260|Dialysis Solutions|dialysis solutions|mesh-list
153426474|NCT02145260|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
153426475|NCT00000848|Indinavir|indinavir|mesh-list
153426476|NCT00000848|Saquinavir|saquinavir|mesh-list
153426477|NCT00000848|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
153885499|NCT01357655|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153885503|NCT01357616|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
153885504|NCT01357616|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
153885505|NCT01357616|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
153885506|NCT01357616|Adrenergic Agents|adrenergic agents|mesh-ancestor
153885507|NCT01357616|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153885508|NCT01357616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153426478|NCT00000848|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
153426479|NCT00000848|Protease Inhibitors|protease inhibitors|mesh-ancestor
153426480|NCT00000848|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153885509|NCT01357616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153885510|NCT01357616|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153885511|NCT01357616|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153885512|NCT01357616|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
153885513|NCT01357616|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153885514|NCT01351025|Atorvastatin|atorvastatin|mesh-list
153885515|NCT01351025|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153885516|NCT01351025|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153426512|NCT00000854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153426513|NCT00000854|Anabolic Agents|anabolic agents|mesh-ancestor
153426514|NCT00000854|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153426515|NCT04298918|Trastuzumab|trastuzumab|mesh-list
153426516|NCT04298918|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
153426517|NCT04298918|Venetoclax|venetoclax|mesh-list
153426519|NCT04298918|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153426520|NCT04298918|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153426521|NCT04298918|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153426522|NCT04298918|Tubulin Modulators|tubulin modulators|mesh-ancestor
153426523|NCT04298918|Antimitotic Agents|antimitotic agents|mesh-ancestor
153885525|NCT01348763|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153885526|NCT01348763|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153885527|NCT01348763|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153885528|NCT01348763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153885529|NCT01348763|Antiviral Agents|antiviral agents|mesh-ancestor
153885530|NCT01348763|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153885543|NCT01346540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153885544|NCT01342913|Fluticasone|fluticasone|mesh-list
153885545|NCT01342913|Xhance|xhance|mesh-list
153885546|NCT01342913|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
153885547|NCT01342913|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153885548|NCT01342913|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153885549|NCT01342913|Autonomic Agents|autonomic agents|mesh-ancestor
153885550|NCT01342913|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153885551|NCT01342913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153426524|NCT04298918|Mitosis Modulators|mitosis modulators|mesh-ancestor
153426525|NCT04298918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153426526|NCT04298918|Immunotoxins|immunotoxins|mesh-ancestor
153426557|NCT03714919|Antitussive Agents|antitussive agents|mesh-ancestor
153426558|NCT03714919|Respiratory System Agents|respiratory system agents|mesh-ancestor
153426559|NCT03714919|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153426560|NCT03714919|Narcotics|narcotics|mesh-ancestor
153426561|NCT00000872|Lamivudine|lamivudine|mesh-list
153426562|NCT00000872|Zidovudine|zidovudine|mesh-list
153426563|NCT00000872|Nevirapine|nevirapine|mesh-list
153426564|NCT00000872|Abacavir|abacavir|mesh-list
153426565|NCT00000872|Stavudine|stavudine|mesh-list
153426566|NCT00000872|Nelfinavir|nelfinavir|mesh-list
153426567|NCT00000872|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153426568|NCT00000872|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153426569|NCT00000872|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153426570|NCT00000872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153426571|NCT00000872|Antiviral Agents|antiviral agents|mesh-ancestor
153426572|NCT00000872|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153426573|NCT00000872|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153426574|NCT00000872|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153426575|NCT00000872|Antimetabolites|antimetabolites|mesh-ancestor
153879745|NCT03927690|Ranibizumab|ranibizumab|mesh-list
153885580|NCT01342445|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
153885581|NCT01342445|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153885582|NCT01342445|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153885583|NCT01342445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153885584|NCT01342445|Dopamine Agents|dopamine agents|mesh-ancestor
153885587|NCT01342211|Bococizumab|bococizumab|mesh-list
153885598|NCT01342094|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
153885601|NCT01342094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153885602|NCT01342094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153885603|NCT01342094|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153885604|NCT01342094|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153885605|NCT01340768|Metformin|metformin|mesh-list
153885606|NCT01340768|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
153885607|NCT01340768|Glimepiride|glimepiride|mesh-list
153885608|NCT01340768|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153885609|NCT01340768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153885610|NCT01340768|Incretins|incretins|mesh-ancestor
153885611|NCT01340768|Hormones|hormones|mesh-ancestor
153885612|NCT01340768|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153885613|NCT01340768|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
153426594|NCT04204057|Phosphoinositide-3 Kinase Inhibitors|phosphoinositide-3 kinase inhibitors|mesh-ancestor
153885614|NCT01340768|Protease Inhibitors|protease inhibitors|mesh-ancestor
153885615|NCT01340768|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153885616|NCT01340768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153885617|NCT01340768|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153885618|NCT01340768|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153885619|NCT01340768|Immunologic Factors|immunologic factors|mesh-ancestor
153885620|NCT01340300|Metformin|metformin|mesh-list
153885621|NCT01340300|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153885623|NCT01107535|Palivizumab|palivizumab|mesh-list
153879746|NCT03927690|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153879747|NCT03927690|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153420581|NCT03109015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153420582|NCT03115177|Doxycycline|doxycycline|mesh-list
153420584|NCT03115177|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153420585|NCT03115177|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153420586|NCT03115177|Antimalarials|antimalarials|mesh-ancestor
153420602|NCT03115801|Immunomodulating Agents|immunomodulating agents|mesh-list
153420603|NCT03115801|Immunologic Factors|immunologic factors|mesh-list
153420604|NCT03115801|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153420605|NCT03115801|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153420606|NCT03115801|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153885631|NCT02880943|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153885632|NCT04207632|Botulinum Toxins|botulinum toxins|mesh-list
153885633|NCT04207632|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
153885634|NCT04207632|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
153885635|NCT04207632|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
153885636|NCT04207632|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153885637|NCT04207632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153885639|NCT04207632|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153885640|NCT04207632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153885641|NCT04207632|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
153885642|NCT04207632|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153885643|NCT00598338|Prucalopride|prucalopride|mesh-list
153885644|NCT00598338|Laxatives|laxatives|mesh-ancestor
153885645|NCT00598338|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153885646|NCT00598338|Serotonin 5-HT4 Receptor Agonists|serotonin 5-ht4 receptor agonists|mesh-ancestor
153885647|NCT00598338|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
153426648|NCT00000902|Nevirapine|nevirapine|mesh-list
153426649|NCT00000902|Didanosine|didanosine|mesh-list
153426650|NCT00000902|Stavudine|stavudine|mesh-list
153426651|NCT00000902|Zalcitabine|zalcitabine|mesh-list
153426652|NCT00000902|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
153426653|NCT00000902|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
153426654|NCT00000902|Protease Inhibitors|protease inhibitors|mesh-ancestor
153476374|NCT00928200|Cytarabine|cytarabine|mesh-list
153420607|NCT03115801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153420608|NCT03115801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153420609|NCT00422708|Anesthetics|anesthetics|mesh-list
153420610|NCT00422708|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153420611|NCT00422708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153420612|NCT03117517|Metformin|metformin|mesh-list
153420613|NCT03117517|Pioglitazone|pioglitazone|mesh-list
153420614|NCT03117517|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153420615|NCT03117517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153420616|NCT00375284|Pramipexole|pramipexole|mesh-list
153420617|NCT00375284|Dexpramipexole|dexpramipexole|mesh-list
153420626|NCT00375284|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153420628|NCT02966275|Pancrelipase|pancrelipase|mesh-list
153420629|NCT02966275|Pancreatin|pancreatin|mesh-list
153420630|NCT02966275|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
153420631|NCT02966275|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153420632|NCT02966275|Hormones|hormones|mesh-ancestor
153420633|NCT02966275|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153426690|NCT00000188|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
153420634|NCT02966275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153420635|NCT02966275|Incretins|incretins|mesh-ancestor
153420636|NCT03795350|Beclomethasone|beclomethasone|mesh-list
153879770|NCT03821246|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153879771|NCT03821246|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153879772|NCT03821246|Immunologic Factors|immunologic factors|mesh-ancestor
153879773|NCT03821246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153879774|NCT03806985|Psilocybin|psilocybin|mesh-list
153879775|NCT03806985|Hallucinogens|hallucinogens|mesh-ancestor
153879776|NCT03806985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153879777|NCT03806985|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153885711|NCT00623064|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153426751|NCT00001862|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153426752|NCT00001862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153426753|NCT00001862|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153420637|NCT03795350|Glycopyrrolate|glycopyrrolate|mesh-list
153420638|NCT03795350|Bromides|bromides|mesh-list
153420639|NCT03795350|Formoterol Fumarate|formoterol fumarate|mesh-list
153879778|NCT03739411|Temozolomide|temozolomide|mesh-list
153879779|NCT03739411|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153879780|NCT03739411|Alkylating Agents|alkylating agents|mesh-ancestor
153879788|NCT03721653|Irinotecan|irinotecan|mesh-list
153879789|NCT03721653|Levoleucovorin|levoleucovorin|mesh-list
153879790|NCT03721653|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153879791|NCT03721653|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153879792|NCT03721653|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153879793|NCT03721653|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153426756|NCT00001862|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153426757|NCT00001862|Immunologic Factors|immunologic factors|mesh-ancestor
153426758|NCT00000194|Cycloserine|cycloserine|mesh-list
153426759|NCT00000194|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
153426760|NCT00000194|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153426761|NCT00000194|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
153426762|NCT00000194|Antitubercular Agents|antitubercular agents|mesh-ancestor
153426763|NCT00000194|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153426766|NCT00000200|Methadone|methadone|mesh-list
153477225|NCT01045122|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153420648|NCT03795350|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153420649|NCT03795350|Adrenergic Agents|adrenergic agents|mesh-ancestor
153420650|NCT03795350|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153420651|NCT03795350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153420652|NCT03795350|Anticonvulsants|anticonvulsants|mesh-ancestor
153879881|NCT03266991|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153879882|NCT03266991|Antimetabolites|antimetabolites|mesh-ancestor
153879883|NCT03266991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153420733|NCT05347082|Cholecalciferol|cholecalciferol|mesh-list
153420758|NCT02975557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153879915|NCT02981329|Metformin|metformin|mesh-list
153879916|NCT02981329|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153885767|NCT00601692|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153885768|NCT00602004|Losartan|losartan|mesh-list
153885769|NCT00602004|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153885770|NCT00602004|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153885771|NCT00602004|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
153885772|NCT00602004|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
153885773|NCT00602004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153879917|NCT02981329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153879918|NCT02921256|Leucovorin|leucovorin|mesh-list
153879919|NCT02921256|Pembrolizumab|pembrolizumab|mesh-list
153879920|NCT02921256|Capecitabine|capecitabine|mesh-list
153879921|NCT02921256|Fluorouracil|fluorouracil|mesh-list
153879922|NCT02921256|Oxaliplatin|oxaliplatin|mesh-list
153879923|NCT02921256|Veliparib|veliparib|mesh-list
153879924|NCT02921256|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153879925|NCT02921256|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153879926|NCT02921256|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153879927|NCT02921256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153879928|NCT02921256|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153885793|NCT01171183|Antioxidants|antioxidants|mesh-ancestor
153885794|NCT01171183|Protective Agents|protective agents|mesh-ancestor
153885795|NCT01171183|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153885796|NCT01171183|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153885797|NCT01171183|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153885798|NCT01171183|Vasodilator Agents|vasodilator agents|mesh-ancestor
153885799|NCT01171183|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
153885800|NCT01171183|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
153885801|NCT01169779|Metformin|metformin|mesh-list
153885802|NCT01169779|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153477732|NCT04716296|Ketamine|ketamine|mesh-list
153420759|NCT02975557|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
153420760|NCT02975557|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
153885803|NCT01169779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153885804|NCT01169701|Mycophenolic Acid|mycophenolic acid|mesh-list
153426800|NCT00000950|Pyridoxine|pyridoxine|mesh-list
153426801|NCT00000950|Vitamin B 6|vitamin b 6|mesh-list
153426802|NCT00000950|Rifampin|rifampin|mesh-list
153426803|NCT00000950|Isoniazid|isoniazid|mesh-list
153426804|NCT00000950|Pyrazinamide|pyrazinamide|mesh-list
153426805|NCT00000950|Ethambutol|ethambutol|mesh-list
153426806|NCT00000950|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
153426807|NCT00000950|Antitubercular Agents|antitubercular agents|mesh-ancestor
153426808|NCT00000950|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153426809|NCT00000950|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153426810|NCT00000950|Leprostatic Agents|leprostatic agents|mesh-ancestor
153426811|NCT00000950|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153426812|NCT00000950|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153426813|NCT00000950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153885805|NCT01169701|Everolimus|everolimus|mesh-list
153885816|NCT01169701|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153426822|NCT00000950|Antimetabolites|antimetabolites|mesh-ancestor
153426836|NCT00000218|Analgesics|analgesics|mesh-ancestor
153426837|NCT00000218|Sensory System Agents|sensory system agents|mesh-ancestor
153885819|NCT01169701|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153885820|NCT01169701|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153420761|NCT04736810|Gemcitabine|gemcitabine|mesh-list
153420762|NCT04736810|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153420763|NCT04736810|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153420764|NCT04736810|Antimetabolites|antimetabolites|mesh-ancestor
153420765|NCT04736810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153420768|NCT03132571|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
153420769|NCT03132571|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
153420770|NCT03132571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153885821|NCT01167907|Ropivacaine|ropivacaine|mesh-list
153885822|NCT01167907|Anesthetics, Local|anesthetics, local|mesh-ancestor
153885823|NCT01167907|Anesthetics|anesthetics|mesh-ancestor
153885824|NCT01167907|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153885825|NCT01167907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153885826|NCT01167907|Sensory System Agents|sensory system agents|mesh-ancestor
153885827|NCT01167907|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153885828|NCT01115491|Bevacizumab|bevacizumab|mesh-list
153885829|NCT01115491|Temozolomide|temozolomide|mesh-list
153885830|NCT01115491|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153885834|NCT01115491|Growth Substances|growth substances|mesh-ancestor
153885835|NCT01115491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153885836|NCT01115491|Growth Inhibitors|growth inhibitors|mesh-ancestor
153885837|NCT01115491|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153885838|NCT01115491|Alkylating Agents|alkylating agents|mesh-ancestor
153885842|NCT01113931|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153885843|NCT01113931|Antimalarials|antimalarials|mesh-ancestor
153885844|NCT01113931|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153885845|NCT01113931|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153885846|NCT02881177|Oxytocin|oxytocin|mesh-list
153885847|NCT02881177|Oxytocics|oxytocics|mesh-ancestor
153885848|NCT02881177|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153885850|NCT02880787|Rocuronium|rocuronium|mesh-list
153426877|NCT00000236|Analgesics|analgesics|mesh-ancestor
153426878|NCT00000236|Sensory System Agents|sensory system agents|mesh-ancestor
153426879|NCT00000236|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153426880|NCT00000236|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
153426881|NCT00000974|Pentamidine|pentamidine|mesh-list
153420771|NCT03132571|Sensory System Agents|sensory system agents|mesh-ancestor
153420772|NCT03132571|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153420775|NCT03132571|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153420776|NCT03132571|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
153885870|NCT04309357|Plasminogen|plasminogen|mesh-list
153885871|NCT04309357|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153885872|NCT04309357|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153885873|NCT04309357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153885874|NCT04308343|Methotrexate|methotrexate|mesh-list
153885875|NCT04308343|Letrozole|letrozole|mesh-list
153885876|NCT04308343|Cetrorelix|cetrorelix|mesh-list
153885877|NCT04308343|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
153885878|NCT04308343|Abortifacient Agents|abortifacient agents|mesh-ancestor
153885879|NCT04308343|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153885880|NCT04308343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153885882|NCT04308343|Antimetabolites|antimetabolites|mesh-ancestor
153426899|NCT00000242|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153426900|NCT00000242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153426901|NCT00000242|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
153426902|NCT00000242|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
153426903|NCT00000980|Spiramycin|spiramycin|mesh-list
153426904|NCT00000980|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153426905|NCT00000980|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153426906|NCT00000980|Coccidiostats|coccidiostats|mesh-ancestor
153426907|NCT00000980|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153426908|NCT00000980|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153426909|NCT00000992|Itraconazole|itraconazole|mesh-list
153426910|NCT00000992|Antifungal Agents|antifungal agents|mesh-ancestor
153426911|NCT00000992|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153885926|NCT01103245|Natriuretic Agents|natriuretic agents|mesh-ancestor
153879931|NCT02921256|Immunologic Factors|immunologic factors|mesh-ancestor
153879932|NCT02921256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153879933|NCT02921256|Antidotes|antidotes|mesh-ancestor
153879934|NCT02921256|Protective Agents|protective agents|mesh-ancestor
153885946|NCT02878837|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153885947|NCT02878837|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
153885948|NCT02878837|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153885949|NCT02878837|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153885950|NCT02878837|Adrenergic Agents|adrenergic agents|mesh-ancestor
153885951|NCT02878837|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153885953|NCT02878837|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153480134|NCT05988671|BB 1101|bb 1101|mesh-list
153879935|NCT02921256|Vitamin B Complex|vitamin b complex|mesh-ancestor
153879936|NCT02921256|Vitamins|vitamins|mesh-ancestor
153879937|NCT02921256|Micronutrients|micronutrients|mesh-ancestor
153879938|NCT02921256|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
153879939|NCT02921256|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153879940|NCT02757885|Cyclophosphamide|cyclophosphamide|mesh-list
153885974|NCT02880085|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153885975|NCT02880085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153885976|NCT01098097|Ribavirin|ribavirin|mesh-list
153885977|NCT01098097|Antimetabolites|antimetabolites|mesh-ancestor
153885978|NCT01098097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153885979|NCT01098097|Antiviral Agents|antiviral agents|mesh-ancestor
153885980|NCT01098097|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153885981|NCT04407572|Vitamin D|vitamin d|mesh-list
153885982|NCT04407572|Vitamins|vitamins|mesh-list
153885987|NCT04407572|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153885988|NCT04407572|Vitamin B Complex|vitamin b complex|mesh-ancestor
153885989|NCT04407572|Hematinics|hematinics|mesh-ancestor
153885990|NCT04328636|Magnesium Sulfate|magnesium sulfate|mesh-list
153885991|NCT04328636|Analgesics|analgesics|mesh-ancestor
153885992|NCT04328636|Sensory System Agents|sensory system agents|mesh-ancestor
153885993|NCT04328636|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153885994|NCT04328636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153480531|NCT05525013|Calcium|calcium|mesh-list
153879941|NCT02757885|Thiotepa|thiotepa|mesh-list
153879942|NCT02757885|Fludarabine|fludarabine|mesh-list
153879943|NCT02757885|Fludarabine phosphate|fludarabine phosphate|mesh-list
153879944|NCT02757885|Hydroxyurea|hydroxyurea|mesh-list
153879945|NCT02757885|Antilymphocyte Serum|antilymphocyte serum|mesh-list
153879946|NCT02757885|Thymoglobulin|thymoglobulin|mesh-list
153879947|NCT02757885|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153879948|NCT02757885|Immunologic Factors|immunologic factors|mesh-ancestor
153420777|NCT03132571|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153420779|NCT03132571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153886011|NCT02893826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153886012|NCT02893826|Vasodilator Agents|vasodilator agents|mesh-ancestor
153886013|NCT02893280|Aspirin|aspirin|mesh-list
153886014|NCT02893280|Enoxaparin|enoxaparin|mesh-list
153886015|NCT02893280|Streptokinase|streptokinase|mesh-list
153886016|NCT02893280|Clopidogrel|clopidogrel|mesh-list
153886017|NCT02893280|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153886018|NCT02893280|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153886019|NCT02893280|Analgesics|analgesics|mesh-ancestor
153886020|NCT02893280|Sensory System Agents|sensory system agents|mesh-ancestor
153886021|NCT02893280|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153886022|NCT02893280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153886023|NCT02893280|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153886024|NCT02893280|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153886028|NCT02893280|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153886029|NCT02893280|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153886030|NCT02893280|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153886031|NCT02893280|Antipyretics|antipyretics|mesh-ancestor
153886032|NCT02893280|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
153886035|NCT02893280|Purinergic Agents|purinergic agents|mesh-ancestor
153427048|NCT03818815|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153427049|NCT03818815|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153427050|NCT03818815|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
153427051|NCT03818815|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153886038|NCT04390802|Aminolevulinic Acid|aminolevulinic acid|mesh-list
153886039|NCT04390802|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
153886040|NCT04390802|Dermatologic Agents|dermatologic agents|mesh-ancestor
153886041|NCT04328480|Colchicine|colchicine|mesh-list
153886042|NCT04328480|Gout Suppressants|gout suppressants|mesh-ancestor
153886043|NCT04328480|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153886044|NCT04328480|Tubulin Modulators|tubulin modulators|mesh-ancestor
153427068|NCT00001964|Dermatologic Agents|dermatologic agents|mesh-ancestor
153427069|NCT00001964|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153427070|NCT00001964|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
153886052|NCT02893124|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153886053|NCT02892812|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
153886054|NCT02892812|Immunologic Factors|immunologic factors|mesh-ancestor
153886055|NCT02892812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153886056|NCT00592670|Fluoxetine|fluoxetine|mesh-list
153886057|NCT00592670|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
153886058|NCT00592670|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153886059|NCT00592670|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153886060|NCT00592670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153481189|NCT04051203|Antiemetics|antiemetics|mesh-ancestor
153420780|NCT03132571|Dopamine Agents|dopamine agents|mesh-ancestor
153420781|NCT03132571|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153879957|NCT02757885|Antimetabolites|antimetabolites|mesh-ancestor
153879958|NCT02757885|Antisickling Agents|antisickling agents|mesh-ancestor
153879959|NCT02757885|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153886061|NCT00592670|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153886062|NCT00592670|Serotonin Agents|serotonin agents|mesh-ancestor
153886063|NCT00592670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153886064|NCT00592670|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
153886065|NCT00592670|Antidepressive Agents|antidepressive agents|mesh-ancestor
153886066|NCT00592670|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153886067|NCT00592670|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
153886068|NCT00592670|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153886069|NCT00592670|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153427071|NCT03801265|Ropivacaine|ropivacaine|mesh-list
153427072|NCT03801265|Anesthetics, Local|anesthetics, local|mesh-ancestor
153427073|NCT03801265|Anesthetics|anesthetics|mesh-ancestor
153481556|NCT03015129|Durvalumab|durvalumab|mesh-list
153420789|NCT02002130|gamma-Aminobutyric Acid|gamma-aminobutyric acid|mesh-list
153420790|NCT02002130|Butyric Acid|butyric acid|mesh-list
153420791|NCT02002130|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153420792|NCT02002130|Immunologic Factors|immunologic factors|mesh-ancestor
153420793|NCT02002130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153420794|NCT02002130|GABA Agents|gaba agents|mesh-ancestor
153420795|NCT02002130|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153420796|NCT02002130|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153420797|NCT02002130|Histamine Antagonists|histamine antagonists|mesh-ancestor
153886070|NCT04327232|Spironolactone|spironolactone|mesh-list
153886071|NCT04327232|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
153886072|NCT04327232|Hormone Antagonists|hormone antagonists|mesh-ancestor
153886073|NCT04327232|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153886074|NCT04327232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153886075|NCT04327232|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
153886076|NCT04327232|Diuretics|diuretics|mesh-ancestor
153886077|NCT04327232|Natriuretic Agents|natriuretic agents|mesh-ancestor
153886078|NCT00593138|Methylphenidate|methylphenidate|mesh-list
153886079|NCT00593138|Dexmethylphenidate Hydrochloride|dexmethylphenidate hydrochloride|mesh-list
153886080|NCT00593138|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
153886081|NCT00593138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153886082|NCT00593138|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
153886083|NCT00593138|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153427104|NCT00000302|Buprenorphine|buprenorphine|mesh-list
153427106|NCT00000302|Narcotics|narcotics|mesh-ancestor
153427107|NCT00000302|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153427108|NCT00000302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153427109|NCT00000302|Analgesics|analgesics|mesh-ancestor
153427110|NCT00000302|Sensory System Agents|sensory system agents|mesh-ancestor
153427111|NCT00000302|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153427112|NCT00000302|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
153427113|NCT00001052|Aluminum Hydroxide|aluminum hydroxide|mesh-list
153886090|NCT00593294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153886091|NCT00593294|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
153886092|NCT00593294|Hormone Antagonists|hormone antagonists|mesh-ancestor
153886094|NCT00593294|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
153886105|NCT00593996|Vitamin D|vitamin d|mesh-list
153886106|NCT00593996|Ergocalciferols|ergocalciferols|mesh-list
153886107|NCT00593996|Vitamins|vitamins|mesh-ancestor
153886108|NCT00593996|Micronutrients|micronutrients|mesh-ancestor
153886109|NCT00593996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153886111|NCT00593996|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153420798|NCT02002130|Histamine Agents|histamine agents|mesh-ancestor
153420799|NCT01306994|Adenosine|adenosine|mesh-list
153420803|NCT01306994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153879973|NCT02703623|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153420814|NCT02979301|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153420815|NCT02979301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153420816|NCT02979301|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153420817|NCT02979301|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153420818|NCT02979301|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
153879976|NCT02703623|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153879977|NCT02703623|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153879978|NCT02703623|Hormone Antagonists|hormone antagonists|mesh-ancestor
153879979|NCT02703623|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153879980|NCT02654119|Paclitaxel|paclitaxel|mesh-list
153879981|NCT02654119|Cyclophosphamide|cyclophosphamide|mesh-list
153879982|NCT02654119|Trastuzumab|trastuzumab|mesh-list
153879983|NCT02654119|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
153879984|NCT02654119|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
153879985|NCT02654119|Antibodies|antibodies|mesh-list
153879986|NCT02654119|Immunoglobulins|immunoglobulins|mesh-list
153886112|NCT00595322|Bevacizumab|bevacizumab|mesh-list
153886113|NCT00595322|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153886114|NCT00595322|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153886115|NCT00595322|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153886116|NCT00595322|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153886117|NCT00595322|Growth Substances|growth substances|mesh-ancestor
153886118|NCT00595322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153886119|NCT00595322|Growth Inhibitors|growth inhibitors|mesh-ancestor
153886120|NCT00596336|Imiquimod|imiquimod|mesh-list
153886121|NCT00596336|Toll-Like Receptor Agonists|toll-like receptor agonists|mesh-ancestor
153886122|NCT00596336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153886123|NCT00596336|Immunomodulating Agents|immunomodulating agents|mesh-ancestor
153886124|NCT00596336|Immunologic Factors|immunologic factors|mesh-ancestor
153427131|NCT00001058|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153427133|NCT00001058|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153427134|NCT00001058|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
153427135|NCT00001058|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153427136|NCT00001058|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153427137|NCT00001058|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
153427140|NCT00000308|Amphetamine|amphetamine|mesh-list
153427144|NCT00000308|Sympathomimetics|sympathomimetics|mesh-ancestor
153427145|NCT00000308|Autonomic Agents|autonomic agents|mesh-ancestor
153427146|NCT00000308|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153427147|NCT00000308|Dopamine Agents|dopamine agents|mesh-ancestor
153427148|NCT00000308|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153427149|NCT00000308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153427150|NCT00000308|Adrenergic Agents|adrenergic agents|mesh-ancestor
153427151|NCT00000308|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
153427152|NCT00000308|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153886139|NCT00596414|Anesthetics, General|anesthetics, general|mesh-ancestor
153886140|NCT00596414|Anesthetics|anesthetics|mesh-ancestor
153886150|NCT00596648|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
153886151|NCT00596648|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153886152|NCT00596648|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153886153|NCT00596648|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153886154|NCT00596648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153886155|NCT00596648|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153886158|NCT00622934|Epoetin Alfa|epoetin alfa|mesh-list
153886159|NCT00622934|Hematinics|hematinics|mesh-ancestor
153886160|NCT00597662|Icodextrin|icodextrin|mesh-list
153886161|NCT00597662|Dialysis Solutions|dialysis solutions|mesh-ancestor
153886162|NCT00597662|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
153886183|NCT00598676|MTOR Inhibitors|mtor inhibitors|mesh-list
153886184|NCT00598676|Temsirolimus|temsirolimus|mesh-list
153886185|NCT00598676|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153886186|NCT00598676|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153886187|NCT00598676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153886188|NCT00598676|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153886189|NCT00598676|Immunologic Factors|immunologic factors|mesh-ancestor
153886190|NCT00598676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153886191|NCT00598676|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153886198|NCT00599222|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153427207|NCT00001082|Antiviral Agents|antiviral agents|mesh-ancestor
153427208|NCT00001082|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153427209|NCT00001082|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153427210|NCT00001082|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153427211|NCT00001082|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153427212|NCT00001082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153427213|NCT00002006|Zidovudine|zidovudine|mesh-list
153886199|NCT00599222|Growth Substances|growth substances|mesh-ancestor
153886200|NCT00599222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153886201|NCT00599222|Growth Inhibitors|growth inhibitors|mesh-ancestor
153886202|NCT00599222|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153886203|NCT00599534|Montelukast|montelukast|mesh-list
153886204|NCT00599534|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153886205|NCT00599534|Respiratory System Agents|respiratory system agents|mesh-ancestor
153886206|NCT00599534|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
153886207|NCT00599534|Hormone Antagonists|hormone antagonists|mesh-ancestor
153886208|NCT00599534|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153886209|NCT00599534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153427220|NCT00002006|Antiviral Agents|antiviral agents|mesh-ancestor
153886210|NCT00599534|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
153886211|NCT00599534|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
153886212|NCT00599534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153886213|NCT00600158|Lidocaine|lidocaine|mesh-list
153886214|NCT00600158|Hydromorphone|hydromorphone|mesh-list
153886215|NCT00600158|Bupivacaine|bupivacaine|mesh-list
153886216|NCT00600158|Anesthetics, Local|anesthetics, local|mesh-ancestor
153886217|NCT00600158|Anesthetics|anesthetics|mesh-ancestor
153886218|NCT00600158|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153886219|NCT00600158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153886220|NCT00600158|Sensory System Agents|sensory system agents|mesh-ancestor
153886221|NCT00600158|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153886222|NCT00600158|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153886223|NCT00600158|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
153427233|NCT04169113|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153427234|NCT00002012|Interferons|interferons|mesh-list
153427235|NCT00002012|Interferon-alpha|interferon-alpha|mesh-list
153427243|NCT00380276|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153427246|NCT00380354|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
153427247|NCT00380354|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
153886224|NCT00600158|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153886225|NCT00600158|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153886226|NCT00600158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153886227|NCT00600158|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153886228|NCT00600158|Narcotics|narcotics|mesh-ancestor
153886229|NCT00600158|Analgesics|analgesics|mesh-ancestor
153886230|NCT04325984|Dexamethasone|dexamethasone|mesh-list
153886231|NCT04325984|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153886232|NCT04325984|Antiemetics|antiemetics|mesh-ancestor
153886233|NCT04325984|Autonomic Agents|autonomic agents|mesh-ancestor
153886234|NCT04325984|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153879987|NCT02654119|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
153420824|NCT00375440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153879992|NCT02654119|Mitosis Modulators|mitosis modulators|mesh-ancestor
153879993|NCT02654119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153879994|NCT02654119|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153427265|NCT00001088|Anesthetics, Local|anesthetics, local|mesh-ancestor
153427266|NCT00001088|Anesthetics|anesthetics|mesh-ancestor
153427267|NCT00001088|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153427268|NCT00001088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153427269|NCT00001088|Sensory System Agents|sensory system agents|mesh-ancestor
153427270|NCT00001088|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153427272|NCT00001094|Zidovudine|zidovudine|mesh-list
153427273|NCT00001094|Lamivudine, zidovudine drug combination|lamivudine, zidovudine drug combination|mesh-list
153427274|NCT00001094|Delavirdine|delavirdine|mesh-list
153427275|NCT00001094|Nelfinavir|nelfinavir|mesh-list
153886259|NCT00600626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153886260|NCT00623168|Ribavirin|ribavirin|mesh-list
153886261|NCT00623168|Antimetabolites|antimetabolites|mesh-ancestor
153886262|NCT00623168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153886263|NCT00623168|Antiviral Agents|antiviral agents|mesh-ancestor
153886264|NCT00623168|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153886265|NCT00601016|Imiquimod|imiquimod|mesh-list
153886266|NCT00601016|Toll-Like Receptor Agonists|toll-like receptor agonists|mesh-ancestor
153886267|NCT00601016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153886268|NCT00601016|Immunomodulating Agents|immunomodulating agents|mesh-ancestor
153427277|NCT00001094|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153886269|NCT00601016|Immunologic Factors|immunologic factors|mesh-ancestor
153886270|NCT00601016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153886271|NCT00601016|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153886272|NCT00601016|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153886273|NCT00601016|Interferon Inducers|interferon inducers|mesh-ancestor
153886274|NCT00601328|Calcitriol|calcitriol|mesh-list
153886275|NCT00601328|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153886276|NCT00601328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153886277|NCT00601328|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
153886278|NCT00601328|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153886279|NCT00601328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153886280|NCT00601328|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
153886281|NCT00601328|Vitamins|vitamins|mesh-ancestor
153886282|NCT00601328|Micronutrients|micronutrients|mesh-ancestor
153886283|NCT00601328|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153886284|NCT00601562|Zidovudine|zidovudine|mesh-list
153886285|NCT00601562|Antimetabolites|antimetabolites|mesh-ancestor
153427294|NCT00001100|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153427295|NCT00001100|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153427296|NCT00001100|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153427298|NCT00000332|Nimodipine|nimodipine|mesh-list
153427305|NCT00000332|Vasodilator Agents|vasodilator agents|mesh-ancestor
153427306|NCT00000338|Lisuride|lisuride|mesh-list
153427307|NCT00000338|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
153427308|NCT00000338|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
153886286|NCT00601562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153886287|NCT00601562|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153886288|NCT00601562|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153886289|NCT00601562|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153886290|NCT00601562|Antiviral Agents|antiviral agents|mesh-ancestor
153886291|NCT00601562|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153886292|NCT00601562|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153886293|NCT00601562|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153886294|NCT00601874|Pilocarpine|pilocarpine|mesh-list
153886295|NCT00601874|Miotics|miotics|mesh-ancestor
153886296|NCT00601874|Autonomic Agents|autonomic agents|mesh-ancestor
153886297|NCT00601874|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153886298|NCT00601874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153886299|NCT00601874|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
153886300|NCT00601874|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
153886301|NCT00601874|Cholinergic Agents|cholinergic agents|mesh-ancestor
153427309|NCT00000338|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
153427310|NCT00000338|Serotonin Agents|serotonin agents|mesh-ancestor
153427311|NCT00000338|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153427312|NCT00000338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153427313|NCT00000338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153427314|NCT00000338|Dopamine Agonists|dopamine agonists|mesh-ancestor
153427315|NCT00000338|Dopamine Agents|dopamine agents|mesh-ancestor
153427316|NCT04085341|Sunitinib|sunitinib|mesh-list
153427326|NCT00002018|Interferons|interferons|mesh-list
153886302|NCT00601874|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153886303|NCT00601874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153886304|NCT01326026|Insulin|insulin|mesh-list
153886309|NCT01097629|Suvorexant|suvorexant|mesh-list
153427347|NCT00001106|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153427348|NCT00001106|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153427349|NCT00001106|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153427350|NCT00000344|Buprenorphine|buprenorphine|mesh-list
153427351|NCT00000344|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
153427352|NCT00000344|Naloxone|naloxone|mesh-list
153879995|NCT02654119|Immunologic Factors|immunologic factors|mesh-ancestor
153879996|NCT02654119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153879997|NCT02654119|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153879998|NCT02654119|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153879999|NCT02654119|Alkylating Agents|alkylating agents|mesh-ancestor
153880001|NCT02635867|Calcium, Dietary|calcium, dietary|mesh-list
153880002|NCT02635867|Calcium|calcium|mesh-list
153880003|NCT02635867|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153880004|NCT02635867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153420833|NCT05113004|Antitubercular Agents|antitubercular agents|mesh-ancestor
153420834|NCT05113004|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153420835|NCT05113004|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153420836|NCT05113004|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153420837|NCT05113004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153427365|NCT04103515|Histamine Antagonists|histamine antagonists|mesh-ancestor
153427388|NCT00001112|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153886377|NCT01324310|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
153886378|NCT01324310|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153886379|NCT01324310|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153886380|NCT01324310|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
153886381|NCT01102231|Cetuximab|cetuximab|mesh-list
153886382|NCT01102231|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153886383|NCT01102231|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153886400|NCT04908865|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153886401|NCT04908865|Immunologic Factors|immunologic factors|mesh-ancestor
153886402|NCT04908865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153886403|NCT01324232|Quinidine|quinidine|mesh-list
153886404|NCT01324232|Dextromethorphan|dextromethorphan|mesh-list
153886405|NCT01324232|Antitussive Agents|antitussive agents|mesh-ancestor
153886406|NCT01324232|Respiratory System Agents|respiratory system agents|mesh-ancestor
153886407|NCT01324232|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
153886408|NCT01324232|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
153886409|NCT01324232|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153886410|NCT01324232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153886411|NCT01324232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153886412|NCT01324232|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
153886413|NCT01324232|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
153886414|NCT01324232|Adrenergic Agents|adrenergic agents|mesh-ancestor
153886416|NCT01324232|Antimalarials|antimalarials|mesh-ancestor
153420839|NCT05113004|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153420840|NCT05113004|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153880023|NCT02400242|Hormones|hormones|mesh-ancestor
153880024|NCT02400242|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153880025|NCT02400242|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153880026|NCT02400242|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153880027|NCT02400242|Immunologic Factors|immunologic factors|mesh-ancestor
153420857|NCT03143569|Heparin|heparin|mesh-list
153420858|NCT03143569|Calcium heparin|calcium heparin|mesh-list
153420859|NCT03143569|Anticoagulants|anticoagulants|mesh-ancestor
153420860|NCT03143569|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153880033|NCT02400242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153880035|NCT02338687|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153880036|NCT02338687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153880037|NCT02158091|Cyclophosphamide|cyclophosphamide|mesh-list
153880038|NCT02158091|Rituximab|rituximab|mesh-list
153880039|NCT02158091|Fludarabine|fludarabine|mesh-list
153880040|NCT02158091|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153420872|NCT02988349|Cariostatic Agents|cariostatic agents|mesh-ancestor
153420873|NCT02988349|Protective Agents|protective agents|mesh-ancestor
153420874|NCT02988349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153420875|NCT02988349|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
153886448|NCT01323920|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153886449|NCT01323920|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153886450|NCT01323920|Immunologic Factors|immunologic factors|mesh-ancestor
153886451|NCT01323920|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153886452|NCT01323920|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153886453|NCT01323920|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
153886454|NCT01093885|Ambrisentan|ambrisentan|mesh-list
153886455|NCT01093885|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153886456|NCT00597597|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
153427472|NCT00002078|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153427473|NCT00002078|Immunologic Factors|immunologic factors|mesh-ancestor
153427474|NCT00002078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153427475|NCT00000440|Naltrexone|naltrexone|mesh-list
153427476|NCT00000440|Sertraline|sertraline|mesh-list
153886457|NCT00597597|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153420876|NCT02988349|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153420877|NCT02159352|Ritonavir|ritonavir|mesh-list
153886458|NCT00597597|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153886459|NCT00597597|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153886460|NCT00597597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153886461|NCT00597597|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153886462|NCT02891967|Z 350|z 350|mesh-list
153886463|NCT02891967|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
153886464|NCT02891967|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153886465|NCT02891967|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153886466|NCT02891967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153886467|NCT02891967|Hormone Antagonists|hormone antagonists|mesh-ancestor
153886468|NCT02891967|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153886469|NCT02891967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153886470|NCT00598377|Cosyntropin|cosyntropin|mesh-list
153886471|NCT00598377|Hormones|hormones|mesh-ancestor
153427499|NCT00000446|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153427500|NCT00000446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153427501|NCT00000446|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153427503|NCT00000446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153427504|NCT04131517|Padsevonil|padsevonil|mesh-list
153427505|NCT04131517|Ethinyl estradiol, levonorgestrel drug combination|ethinyl estradiol, levonorgestrel drug combination|mesh-list
153427506|NCT04131517|Ethinyl Estradiol-Norgestrel Combination|ethinyl estradiol-norgestrel combination|mesh-list
153886477|NCT00598533|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153886478|NCT00598533|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153886479|NCT00598533|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153886480|NCT00598533|Antifungal Agents|antifungal agents|mesh-ancestor
153420878|NCT02159352|Lopinavir|lopinavir|mesh-list
153886484|NCT00598533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153886485|NCT00598533|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153886486|NCT00598533|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153886487|NCT00598533|Antimetabolites|antimetabolites|mesh-ancestor
153886488|NCT00598533|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153427531|NCT00001256|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153427532|NCT00001256|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153427533|NCT00001256|Antimetabolites|antimetabolites|mesh-ancestor
153427534|NCT00001256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153427535|NCT00001256|Dermatologic Agents|dermatologic agents|mesh-ancestor
153427536|NCT00001256|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153427537|NCT00001256|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153886492|NCT00599937|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153886493|NCT00599937|Keratolytic Agents|keratolytic agents|mesh-ancestor
153427541|NCT00001256|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153427543|NCT00000452|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
153427544|NCT00000452|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
153427545|NCT00000452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153427546|NCT00000452|Sensory System Agents|sensory system agents|mesh-ancestor
153427547|NCT00000452|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153427548|NCT00000458|Sertraline|sertraline|mesh-list
153427549|NCT00000458|Antidepressive Agents|antidepressive agents|mesh-ancestor
153427550|NCT00000458|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153886529|NCT00600405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153886530|NCT00600405|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153886531|NCT00600405|Narcotics|narcotics|mesh-ancestor
153886532|NCT00600405|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153886533|NCT00600405|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
153886534|NCT00600405|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
153886535|NCT00600405|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
153886546|NCT00600639|Albuterol|albuterol|mesh-list
153886553|NCT00600639|Hormones|hormones|mesh-ancestor
153886554|NCT00600639|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153886555|NCT00600639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153886556|NCT00600639|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153886557|NCT00600639|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153886558|NCT00600639|Antiemetics|antiemetics|mesh-ancestor
153886559|NCT00600639|Autonomic Agents|autonomic agents|mesh-ancestor
153886560|NCT00600639|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153427579|NCT00002096|Antiviral Agents|antiviral agents|mesh-ancestor
153427585|NCT00002102|Calcium|calcium|mesh-list
153427586|NCT00002102|Levoleucovorin|levoleucovorin|mesh-list
153427594|NCT00002102|Antifungal Agents|antifungal agents|mesh-ancestor
153427595|NCT00002102|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153427596|NCT00002102|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153427597|NCT00002102|Antimetabolites|antimetabolites|mesh-ancestor
153427598|NCT00002102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153427599|NCT00002102|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153427601|NCT00002102|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153427603|NCT00002108|Zidovudine|zidovudine|mesh-list
153886563|NCT00600639|Protective Agents|protective agents|mesh-ancestor
153886564|NCT00600639|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153886569|NCT00600639|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
153886570|NCT00600639|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
153886571|NCT00600639|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153886590|NCT00598611|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153886591|NCT00598611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153886592|NCT00598611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153886593|NCT00598611|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
153886594|NCT00598611|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
153886595|NCT00598611|Histamine Antagonists|histamine antagonists|mesh-ancestor
153886596|NCT00598611|Histamine Agents|histamine agents|mesh-ancestor
153886597|NCT00598611|Antipruritics|antipruritics|mesh-ancestor
153886598|NCT00598611|Dermatologic Agents|dermatologic agents|mesh-ancestor
153886599|NCT00598611|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
153886600|NCT04325724|Dermatologic Agents|dermatologic agents|mesh-list
153886613|NCT00601887|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153886614|NCT00601887|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153886615|NCT00601887|Analgesics|analgesics|mesh-ancestor
153886616|NCT00601887|Sensory System Agents|sensory system agents|mesh-ancestor
153886617|NCT00601887|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153886618|NCT00601887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153886619|NCT00601887|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153886620|NCT00601887|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153886621|NCT00601887|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
153886622|NCT00601887|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153886623|NCT00601887|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153886660|NCT01101841|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
153886661|NCT01101841|Antidepressive Agents|antidepressive agents|mesh-ancestor
153886662|NCT01101841|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153427680|NCT00000542|Vasodilator Agents|vasodilator agents|mesh-ancestor
153427681|NCT00000542|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153427682|NCT00000542|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153427684|NCT00000542|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153427685|NCT00000542|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
153427686|NCT00000542|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153427687|NCT00000542|Protease Inhibitors|protease inhibitors|mesh-ancestor
153427688|NCT00000542|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
153427689|NCT00000542|Protective Agents|protective agents|mesh-ancestor
153427700|NCT00002120|Dapsone|dapsone|mesh-list
153427701|NCT00002120|Sulfamethoxazole|sulfamethoxazole|mesh-list
153427702|NCT00002120|Trimetrexate|trimetrexate|mesh-list
153427703|NCT00002120|Calcium|calcium|mesh-list
153427705|NCT00002120|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153427726|NCT00002120|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153427727|NCT00002120|Antimetabolites|antimetabolites|mesh-ancestor
153427728|NCT00002120|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153427729|NCT00002126|Lenograstim|lenograstim|mesh-list
153427743|NCT00002132|Antifungal Agents|antifungal agents|mesh-ancestor
153427744|NCT00002132|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153427745|NCT00002132|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
153427746|NCT00002132|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153427747|NCT00002132|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153427748|NCT00002132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153427749|NCT00002132|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153427766|NCT00000578|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153427767|NCT00000578|Glucocorticoids|glucocorticoids|mesh-ancestor
153427768|NCT00000578|Hormones|hormones|mesh-ancestor
153427774|NCT00000578|Autonomic Agents|autonomic agents|mesh-ancestor
153420879|NCT02159352|Darunavir|darunavir|mesh-list
153420880|NCT02159352|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
153420881|NCT02159352|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
153420882|NCT02159352|Protease Inhibitors|protease inhibitors|mesh-ancestor
153420883|NCT02159352|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153420884|NCT02159352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153420885|NCT02159352|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153420886|NCT02159352|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153420887|NCT02159352|Antiviral Agents|antiviral agents|mesh-ancestor
153420888|NCT02159352|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153420889|NCT02159352|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
153420891|NCT02187744|Carboplatin|carboplatin|mesh-list
153420892|NCT02187744|Docetaxel|docetaxel|mesh-list
153420893|NCT02187744|Trastuzumab|trastuzumab|mesh-list
153420894|NCT02187744|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153420895|NCT02187744|Tubulin Modulators|tubulin modulators|mesh-ancestor
153420896|NCT02187744|Antimitotic Agents|antimitotic agents|mesh-ancestor
153880046|NCT02158091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153880047|NCT02158091|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153880048|NCT02158091|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153880049|NCT02158091|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153880051|NCT02054429|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
153880052|NCT02054429|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153880053|NCT02054429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153880055|NCT01460654|Methyltestosterone|methyltestosterone|mesh-list
153880056|NCT01460654|Testosterone|testosterone|mesh-list
153880057|NCT01460654|Testosterone undecanoate|testosterone undecanoate|mesh-list
153880058|NCT01460654|Testosterone enanthate|testosterone enanthate|mesh-list
153880059|NCT01460654|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
153880060|NCT01460654|Androgens|androgens|mesh-ancestor
153880061|NCT01460654|Hormones|hormones|mesh-ancestor
153880062|NCT01460654|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153880063|NCT01460654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153880064|NCT01460654|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153420897|NCT02187744|Mitosis Modulators|mitosis modulators|mesh-ancestor
153420898|NCT02187744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153488748|NCT02289222|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153420899|NCT02187744|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153420900|NCT03154333|Diacerein|diacerein|mesh-list
153420906|NCT02995915|Nicotine|nicotine|mesh-list
153420907|NCT02995915|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
153420908|NCT02995915|Autonomic Agents|autonomic agents|mesh-ancestor
153420909|NCT02995915|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153420910|NCT02995915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153420911|NCT02995915|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
153489051|NCT02413320|Antimitotic Agents|antimitotic agents|mesh-ancestor
153489052|NCT02413320|Mitosis Modulators|mitosis modulators|mesh-ancestor
153489053|NCT02413320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153489055|NCT02413320|Immunologic Factors|immunologic factors|mesh-ancestor
153489056|NCT02413320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153489057|NCT02413320|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153489065|NCT05718492|Leucovorin|leucovorin|mesh-list
153420912|NCT02995915|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
153420913|NCT02995915|Cholinergic Agents|cholinergic agents|mesh-ancestor
153420914|NCT02995915|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153420915|NCT02995915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153420916|NCT02995915|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
153420917|NCT02995915|Antidepressive Agents|antidepressive agents|mesh-ancestor
153420918|NCT02995915|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153420919|NCT02995915|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
153420920|NCT02995915|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153880069|NCT01093326|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
153880070|NCT01093326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153880071|NCT01093326|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153880072|NCT01093326|Immunologic Factors|immunologic factors|mesh-ancestor
153880073|NCT01093326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153880074|NCT03021460|Pembrolizumab|pembrolizumab|mesh-list
153880075|NCT03021460|Ibrutinib|ibrutinib|mesh-list
153880076|NCT03021460|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153880077|NCT03021460|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153880078|NCT03021460|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153880079|NCT03021460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153880080|NCT03021460|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153880081|NCT03021460|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153429133|NCT00002552|Antiviral Agents|antiviral agents|mesh-ancestor
153880082|NCT03021460|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153880083|NCT02926859|Cannabidiol|cannabidiol|mesh-list
153880084|NCT02926859|Anticonvulsants|anticonvulsants|mesh-ancestor
153880085|NCT02876107|Paclitaxel|paclitaxel|mesh-list
153880086|NCT02876107|Carboplatin|carboplatin|mesh-list
153880087|NCT02876107|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
153880088|NCT02876107|Panitumumab|panitumumab|mesh-list
153880089|NCT02876107|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
153880090|NCT02876107|Antibodies|antibodies|mesh-list
153880091|NCT02876107|Immunoglobulins|immunoglobulins|mesh-list
153880092|NCT02876107|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
153880093|NCT02876107|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153880094|NCT02876107|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153880095|NCT02876107|Tubulin Modulators|tubulin modulators|mesh-ancestor
153420927|NCT03163303|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
153420929|NCT03163303|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153420930|NCT03163303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153420931|NCT03163303|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
153420932|NCT03163303|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
153420933|NCT03163303|Cholinergic Agents|cholinergic agents|mesh-ancestor
153420934|NCT03163303|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153420935|NCT03163303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153420936|NCT03000283|Conivaptan|conivaptan|mesh-list
153420937|NCT03000283|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
153420938|NCT03000283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153420939|NCT03000283|Natriuretic Agents|natriuretic agents|mesh-ancestor
153420940|NCT03000283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153420941|NCT03168295|Dapagliflozin|dapagliflozin|mesh-list
153420942|NCT03168295|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
153429196|NCT00002576|Hormones|hormones|mesh-ancestor
153420943|NCT03168295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153420944|NCT03168295|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153880098|NCT02876107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153880099|NCT02876107|Immunologic Factors|immunologic factors|mesh-ancestor
153880100|NCT02876107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153880101|NCT02872259|Pembrolizumab|pembrolizumab|mesh-list
153880102|NCT02872259|Trametinib|trametinib|mesh-list
153880107|NCT02872259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153420947|NCT03168841|Antifungal Agents|antifungal agents|mesh-ancestor
153420948|NCT03168841|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153420949|NCT03865615|Oxytocin|oxytocin|mesh-list
153420950|NCT03865615|Oxytocics|oxytocics|mesh-ancestor
153420951|NCT03865615|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153420952|NCT03865615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153420953|NCT03185546|Nicotine|nicotine|mesh-list
153420954|NCT03185546|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
153420955|NCT03185546|Autonomic Agents|autonomic agents|mesh-ancestor
153420956|NCT03185546|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153420957|NCT03185546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153888160|NCT00601991|Aflibercept|aflibercept|mesh-list
153420958|NCT03185546|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
153420959|NCT03185546|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
153420960|NCT03185546|Cholinergic Agents|cholinergic agents|mesh-ancestor
153420961|NCT03185546|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153880120|NCT02760407|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153880121|NCT02760407|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153880122|NCT02741570|Cisplatin|cisplatin|mesh-list
153880123|NCT02741570|Carboplatin|carboplatin|mesh-list
153880124|NCT02741570|Fluorouracil|fluorouracil|mesh-list
153880125|NCT02741570|Nivolumab|nivolumab|mesh-list
153880126|NCT02741570|Cetuximab|cetuximab|mesh-list
153880127|NCT02741570|Ipilimumab|ipilimumab|mesh-list
153880128|NCT02741570|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153880129|NCT02741570|Antimetabolites|antimetabolites|mesh-ancestor
153880130|NCT02741570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153880131|NCT02741570|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153880132|NCT02741570|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153880133|NCT02741570|Immunologic Factors|immunologic factors|mesh-ancestor
153880134|NCT02741570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153880135|NCT02741570|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153420966|NCT02186652|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
153420967|NCT02186652|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153420968|NCT02186652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153420969|NCT06289335|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
153429373|NCT00002630|Melphalan|melphalan|mesh-list
153429389|NCT02047747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153429390|NCT00002642|Cobalt|cobalt|mesh-list
153429391|NCT00002642|Etoposide|etoposide|mesh-list
153429392|NCT00002642|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153429393|NCT00002642|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153429394|NCT00002642|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153429395|NCT00002642|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153429396|NCT00002642|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153420977|NCT06289257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153420978|NCT06289257|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153420979|NCT06289257|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153420982|NCT06289205|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
153420983|NCT06289205|Abortifacient Agents|abortifacient agents|mesh-ancestor
153888326|NCT02879110|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153420984|NCT06289205|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153420985|NCT06289205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153880140|NCT02730416|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153880141|NCT02730416|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153880142|NCT02730416|Tubulin Modulators|tubulin modulators|mesh-ancestor
153880143|NCT02730416|Antimitotic Agents|antimitotic agents|mesh-ancestor
153880144|NCT02730416|Mitosis Modulators|mitosis modulators|mesh-ancestor
153429517|NCT05600491|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153429518|NCT00002696|Cyclophosphamide|cyclophosphamide|mesh-list
153429519|NCT00002696|Doxorubicin|doxorubicin|mesh-list
153429520|NCT00002696|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
153429521|NCT00002696|Fluorouracil|fluorouracil|mesh-list
153429522|NCT00002696|Methotrexate|methotrexate|mesh-list
153429523|NCT00002696|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153429524|NCT00002696|Immunologic Factors|immunologic factors|mesh-ancestor
153429525|NCT00002696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153429526|NCT00002696|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153429527|NCT00002696|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153429528|NCT00002696|Alkylating Agents|alkylating agents|mesh-ancestor
153429529|NCT00002696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153429530|NCT00002696|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153888446|NCT01095094|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
153888447|NCT01095094|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153888448|NCT00623285|Pregabalin|pregabalin|mesh-list
153888449|NCT00623285|Analgesics|analgesics|mesh-ancestor
153888450|NCT00623285|Sensory System Agents|sensory system agents|mesh-ancestor
153888451|NCT00623285|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153880145|NCT02730416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153880146|NCT02730416|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153880147|NCT02730416|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153880148|NCT02723760|HYNIC-3PRGD(2)|hynic-3prgd(2)|mesh-list
153880149|NCT02723760|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
153880150|NCT02723760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153880151|NCT02703610|Acetaminophen|acetaminophen|mesh-list
153880152|NCT02703610|Ibuprofen|ibuprofen|mesh-list
153880153|NCT02703610|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
153420987|NCT06289205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153420988|NCT06289205|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153420989|NCT06289205|Dermatologic Agents|dermatologic agents|mesh-ancestor
153420990|NCT06289205|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153420991|NCT06289205|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153420992|NCT06289205|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153420993|NCT06289205|Immunologic Factors|immunologic factors|mesh-ancestor
153420994|NCT06289205|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153420995|NCT06289205|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153880159|NCT02703610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153880161|NCT02703610|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153880162|NCT02703610|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153880163|NCT02703610|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153880164|NCT02703610|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153880165|NCT02703610|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153421000|NCT06289062|Tubulin Modulators|tubulin modulators|mesh-ancestor
153421001|NCT06289062|Antimitotic Agents|antimitotic agents|mesh-ancestor
153421002|NCT06289062|Mitosis Modulators|mitosis modulators|mesh-ancestor
153421003|NCT06289062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153421004|NCT06288932|Mycophenolic Acid|mycophenolic acid|mesh-list
153421005|NCT06288932|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153421006|NCT06288932|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153421007|NCT06288932|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
153421008|NCT06288932|Antitubercular Agents|antitubercular agents|mesh-ancestor
153421009|NCT06288932|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153421010|NCT06288932|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153421011|NCT06288932|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153421012|NCT06288932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153421013|NCT06288841|Bupivacaine|bupivacaine|mesh-list
153421014|NCT06288841|Ropivacaine|ropivacaine|mesh-list
153421015|NCT06288841|Anesthetics, Local|anesthetics, local|mesh-ancestor
153421016|NCT06288841|Anesthetics|anesthetics|mesh-ancestor
153421017|NCT06288841|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153421018|NCT06288841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153880175|NCT02661035|Antilymphocyte Serum|antilymphocyte serum|mesh-list
153880176|NCT02661035|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153880177|NCT02661035|Immunologic Factors|immunologic factors|mesh-ancestor
153880178|NCT02661035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153880179|NCT02661035|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153880180|NCT02661035|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153880181|NCT02661035|Alkylating Agents|alkylating agents|mesh-ancestor
153880182|NCT02661035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153880183|NCT02661035|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153880184|NCT02661035|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153880185|NCT02661035|Antimetabolites|antimetabolites|mesh-ancestor
153880186|NCT02661035|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
153880187|NCT02661035|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153880188|NCT02661035|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153880189|NCT02661035|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
153880191|NCT02661035|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153880192|NCT02661035|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153880193|NCT02661035|Gout Suppressants|gout suppressants|mesh-ancestor
153880194|NCT02661035|Free Radical Scavengers|free radical scavengers|mesh-ancestor
153421026|NCT06288490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153421027|NCT06288490|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153421053|NCT06288334|Histamine Antagonists|histamine antagonists|mesh-ancestor
153421055|NCT06288334|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153421056|NCT06288334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153421057|NCT06288334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153880219|NCT02627846|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153880220|NCT02627846|Autonomic Agents|autonomic agents|mesh-ancestor
153880221|NCT02627846|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153880222|NCT02627846|Respiratory System Agents|respiratory system agents|mesh-ancestor
153880223|NCT02627846|Mydriatics|mydriatics|mesh-ancestor
153880224|NCT02627846|Sympathomimetics|sympathomimetics|mesh-ancestor
153880225|NCT02627846|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
153880226|NCT02627846|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
153421058|NCT06288204|Propolis|propolis|mesh-list
153421059|NCT06288204|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153421060|NCT06288152|Sodium thiosulfate|sodium thiosulfate|mesh-list
153421061|NCT06288152|Antidotes|antidotes|mesh-ancestor
153421062|NCT06288152|Protective Agents|protective agents|mesh-ancestor
153421067|NCT06288152|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153421068|NCT06288152|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153421069|NCT06288152|Chelating Agents|chelating agents|mesh-ancestor
153421070|NCT06288152|Sequestering Agents|sequestering agents|mesh-ancestor
153880246|NCT02535988|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153880247|NCT02535988|Immunologic Factors|immunologic factors|mesh-ancestor
153880248|NCT02535988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153880249|NCT02515773|Metformin|metformin|mesh-list
153880250|NCT02515773|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153880251|NCT02515773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153880252|NCT02484248|Ketotifen|ketotifen|mesh-list
153880253|NCT02484248|Antipruritics|antipruritics|mesh-ancestor
153880254|NCT02484248|Dermatologic Agents|dermatologic agents|mesh-ancestor
153880255|NCT02484248|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
153880256|NCT02484248|Histamine Antagonists|histamine antagonists|mesh-ancestor
153880257|NCT02484248|Histamine Agents|histamine agents|mesh-ancestor
153421102|NCT06287905|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153421103|NCT06287905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153421104|NCT06287905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153421105|NCT06287580|Chlorthalidone|chlorthalidone|mesh-list
153421106|NCT06287580|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153421107|NCT06287580|Diuretics|diuretics|mesh-ancestor
153421108|NCT06287580|Natriuretic Agents|natriuretic agents|mesh-ancestor
153421109|NCT06287580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153421110|NCT06287580|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
153421111|NCT06287580|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153421112|NCT06287580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153421113|NCT06287372|Cardioplegic Solutions|cardioplegic solutions|mesh-list
153421114|NCT06287372|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
153880277|NCT02456194|Calcium|calcium|mesh-list
153880278|NCT02456194|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153880279|NCT02456194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153880280|NCT02456194|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153880281|NCT02439450|Pembrolizumab|pembrolizumab|mesh-list
153880282|NCT02439450|Nivolumab|nivolumab|mesh-list
153880283|NCT02439450|Pemetrexed|pemetrexed|mesh-list
153880284|NCT02439450|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153880285|NCT02439450|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153880286|NCT02439450|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153880287|NCT02439450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153421120|NCT06287307|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153421130|NCT06287229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153421132|NCT06286059|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
153421133|NCT06286059|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
153421134|NCT06286059|Adrenergic Agents|adrenergic agents|mesh-ancestor
153888741|NCT01057693|Pregabalin|pregabalin|mesh-list
153421135|NCT06286059|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153421136|NCT06286059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153421137|NCT06286059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153421138|NCT06286059|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153421139|NCT06284317|Durvalumab|durvalumab|mesh-list
153421140|NCT06284317|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153421141|NCT06284317|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153421142|NCT06283706|Tryptophan|tryptophan|mesh-list
153421143|NCT06283706|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
153421144|NCT06283706|Antidepressive Agents|antidepressive agents|mesh-ancestor
153421145|NCT06283706|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153421146|NCT06280313|Immunomodulating Agents|immunomodulating agents|mesh-list
153421147|NCT06280313|Immunologic Factors|immunologic factors|mesh-ancestor
153880293|NCT02437136|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153880294|NCT02437136|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153880295|NCT02437136|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153880296|NCT02437136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153880297|NCT02437136|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
153880298|NCT02437136|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153880299|NCT02403778|Ipilimumab|ipilimumab|mesh-list
153880300|NCT02403778|Tretinoin|tretinoin|mesh-list
153880324|NCT02276274|Hormones|hormones|mesh-ancestor
153880325|NCT02276274|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153880326|NCT02276274|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
153880327|NCT02276274|Protease Inhibitors|protease inhibitors|mesh-ancestor
153880328|NCT02276274|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153880329|NCT02276274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153880330|NCT02199184|Prednisone|prednisone|mesh-list
153880331|NCT02199184|Cortisone|cortisone|mesh-list
153880342|NCT02199184|Antibodies|antibodies|mesh-list
153880343|NCT02199184|Immunoglobulins|immunoglobulins|mesh-list
153880344|NCT02199184|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
153880345|NCT02199184|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153880347|NCT02199184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153880348|NCT02199184|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153888847|NCT01096186|Carbidopa|carbidopa|mesh-list
153880349|NCT02199184|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153880350|NCT02199184|Alkylating Agents|alkylating agents|mesh-ancestor
153880351|NCT02199184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153880352|NCT02199184|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153421184|NCT06263491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153421185|NCT06263491|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153421186|NCT06263491|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153421187|NCT06263491|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153421188|NCT06263491|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153421189|NCT06263491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153880362|NCT02199184|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153880363|NCT02199184|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153880364|NCT02199184|Tubulin Modulators|tubulin modulators|mesh-ancestor
153880365|NCT02199184|Antimitotic Agents|antimitotic agents|mesh-ancestor
153880366|NCT02199184|Mitosis Modulators|mitosis modulators|mesh-ancestor
153880367|NCT02199184|Keratolytic Agents|keratolytic agents|mesh-ancestor
153880368|NCT02199184|Dermatologic Agents|dermatologic agents|mesh-ancestor
153421200|NCT06205485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153421201|NCT06205485|Vitamin B Complex|vitamin b complex|mesh-ancestor
153421202|NCT06205485|Vitamins|vitamins|mesh-ancestor
153421203|NCT06205485|Micronutrients|micronutrients|mesh-ancestor
153421204|NCT06205485|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153421205|NCT06205485|Immunologic Factors|immunologic factors|mesh-ancestor
153421206|NCT06175403|Niacin|niacin|mesh-list
153421207|NCT06175403|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153421209|NCT06175403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153421210|NCT06175403|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153421211|NCT06175403|Vasodilator Agents|vasodilator agents|mesh-ancestor
153421212|NCT06175403|Vitamin B Complex|vitamin b complex|mesh-ancestor
153421213|NCT06175403|Vitamins|vitamins|mesh-ancestor
153880381|NCT02164734|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153880382|NCT02164734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153880383|NCT02164734|Analgesics|analgesics|mesh-ancestor
153880384|NCT02164734|Sensory System Agents|sensory system agents|mesh-ancestor
153880385|NCT02164734|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153880387|NCT02110069|Vincristine|vincristine|mesh-list
153880388|NCT02110069|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153880389|NCT02110069|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153421223|NCT06140784|Tin Fluorides|tin fluorides|mesh-list
153421224|NCT06140784|Fluorophosphate|fluorophosphate|mesh-list
153421225|NCT06140784|Cariostatic Agents|cariostatic agents|mesh-ancestor
153421234|NCT06130423|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
153421235|NCT06130423|Cholinergic Agents|cholinergic agents|mesh-ancestor
153880392|NCT02110069|Mitosis Modulators|mitosis modulators|mesh-ancestor
153880393|NCT02110069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153880394|NCT02110069|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153880395|NCT02110069|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153880396|NCT02110069|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153880397|NCT02110069|Antifungal Agents|antifungal agents|mesh-ancestor
153880398|NCT02110069|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153880399|NCT02110069|Immunologic Factors|immunologic factors|mesh-ancestor
153880400|NCT02110069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153421243|NCT06116578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153421244|NCT06116578|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
153421245|NCT06116578|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153880409|NCT02046460|Micronutrients|micronutrients|mesh-ancestor
153880410|NCT02046460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153880411|NCT02046460|Anticoagulants|anticoagulants|mesh-ancestor
153880412|NCT02046460|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153880413|NCT02046460|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153880414|NCT02046460|Analgesics|analgesics|mesh-ancestor
153880415|NCT02046460|Sensory System Agents|sensory system agents|mesh-ancestor
153880416|NCT02046460|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153880417|NCT02046460|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153880418|NCT02046460|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153430068|NCT00379717|Docetaxel|docetaxel|mesh-list
153880419|NCT02046460|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153880420|NCT02046460|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153880421|NCT02046460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153880422|NCT02046460|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153880423|NCT02046460|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153880424|NCT02046460|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153880425|NCT02046460|Antipyretics|antipyretics|mesh-ancestor
153880430|NCT02004522|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153880431|NCT01932697|Docetaxel|docetaxel|mesh-list
153880432|NCT01932697|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153880433|NCT01932697|Tubulin Modulators|tubulin modulators|mesh-ancestor
153880446|NCT01752049|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153880447|NCT01752049|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153880448|NCT01747447|Vitamin D|vitamin d|mesh-list
153880449|NCT01747447|Ergocalciferols|ergocalciferols|mesh-list
153880450|NCT01747447|Cholecalciferol|cholecalciferol|mesh-list
153880451|NCT01747447|Vitamins|vitamins|mesh-list
153430107|NCT04403516|Hormones|hormones|mesh-ancestor
153880452|NCT01747447|Micronutrients|micronutrients|mesh-ancestor
153880453|NCT01747447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153421286|NCT06091865|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153421287|NCT06091865|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153421288|NCT06091865|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153421289|NCT06091865|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153421290|NCT06091865|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153421291|NCT06091865|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153421292|NCT06091865|Glucocorticoids|glucocorticoids|mesh-ancestor
153421293|NCT06091865|Hormones|hormones|mesh-ancestor
153880472|NCT01659658|Immunologic Factors|immunologic factors|mesh-ancestor
153880473|NCT01659658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153880474|NCT01659658|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153421307|NCT06046274|Pembrolizumab|pembrolizumab|mesh-list
153421308|NCT06046274|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153421309|NCT06046274|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153421310|NCT06046274|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153421311|NCT06046274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153421312|NCT06038682|Heparin|heparin|mesh-list
153421313|NCT06038682|Argatroban|argatroban|mesh-list
153421314|NCT06038682|Anticoagulants|anticoagulants|mesh-ancestor
153421315|NCT06038682|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153421316|NCT06038682|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153421317|NCT06038682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153421318|NCT06038682|Antithrombins|antithrombins|mesh-ancestor
153880483|NCT01659658|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153880484|NCT01659658|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153880485|NCT01659658|Glucocorticoids|glucocorticoids|mesh-ancestor
153880486|NCT01659658|Hormones|hormones|mesh-ancestor
153880487|NCT01659658|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153880488|NCT01659658|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153880489|NCT01659658|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153880490|NCT01659658|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153880491|NCT01659658|Growth Substances|growth substances|mesh-ancestor
153880492|NCT01659658|Growth Inhibitors|growth inhibitors|mesh-ancestor
153880493|NCT01659658|Leprostatic Agents|leprostatic agents|mesh-ancestor
153880494|NCT01659658|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153880497|NCT01659658|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153880498|NCT01523977|Prednisone|prednisone|mesh-list
153880499|NCT01523977|Doxorubicin|doxorubicin|mesh-list
153880500|NCT01523977|Dexrazoxane|dexrazoxane|mesh-list
153880501|NCT01523977|Vincristine|vincristine|mesh-list
153880502|NCT01523977|Everolimus|everolimus|mesh-list
153880515|NCT01523977|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153880516|NCT01523977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153880517|NCT01523977|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153880518|NCT01523977|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153880519|NCT01523977|Tubulin Modulators|tubulin modulators|mesh-ancestor
153421353|NCT05993182|Sympathomimetics|sympathomimetics|mesh-ancestor
153421354|NCT05993182|Autonomic Agents|autonomic agents|mesh-ancestor
153421355|NCT05993182|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153421356|NCT05993182|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
153421357|NCT05993182|Adrenergic Agents|adrenergic agents|mesh-ancestor
153421358|NCT05993182|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153430136|NCT04331743|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153880536|NCT01517243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153880537|NCT01517243|Growth Inhibitors|growth inhibitors|mesh-ancestor
153880538|NCT01517243|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153880539|NCT01517243|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153880540|NCT01517243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153880541|NCT01517243|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153880542|NCT01517243|Immunologic Factors|immunologic factors|mesh-ancestor
153880543|NCT01517243|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153421377|NCT05973851|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
153421378|NCT05973851|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153880553|NCT01357161|Antimitotic Agents|antimitotic agents|mesh-ancestor
153880554|NCT01357161|Mitosis Modulators|mitosis modulators|mesh-ancestor
153880555|NCT01357161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153880556|NCT01357161|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153880557|NCT01321073|Treprostinil|treprostinil|mesh-list
153880558|NCT01321073|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153880559|NCT01308203|Niacin|niacin|mesh-list
153880560|NCT01308203|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153880561|NCT01308203|Antimetabolites|antimetabolites|mesh-ancestor
153880562|NCT01308203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153880563|NCT01308203|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153880564|NCT01308203|Vasodilator Agents|vasodilator agents|mesh-ancestor
153880592|NCT01190930|Pegaspargase|pegaspargase|mesh-list
153880593|NCT01190930|Thioguanine|thioguanine|mesh-list
153880594|NCT01190930|BB 1101|bb 1101|mesh-list
153880595|NCT01190930|Calcium|calcium|mesh-list
153880596|NCT01190930|2-Aminopurine|2-aminopurine|mesh-list
153880597|NCT01190930|Levoleucovorin|levoleucovorin|mesh-list
153421426|NCT05941247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153421427|NCT05896228|Acetaminophen|acetaminophen|mesh-list
153421428|NCT05896228|Diphenhydramine|diphenhydramine|mesh-list
153421429|NCT05896228|Promethazine|promethazine|mesh-list
153421430|NCT05896228|Dexamethasone|dexamethasone|mesh-list
153421431|NCT05896228|Daratumumab|daratumumab|mesh-list
153421432|NCT05896228|Montelukast|montelukast|mesh-list
153421433|NCT05896228|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153421434|NCT05896228|Antiemetics|antiemetics|mesh-ancestor
153421435|NCT05896228|Autonomic Agents|autonomic agents|mesh-ancestor
153421436|NCT05896228|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153421437|NCT05896228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153421438|NCT05896228|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153421439|NCT05896228|Glucocorticoids|glucocorticoids|mesh-ancestor
153421440|NCT05896228|Hormones|hormones|mesh-ancestor
153421441|NCT05896228|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153421449|NCT05896228|Respiratory System Agents|respiratory system agents|mesh-ancestor
153421450|NCT05896228|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
153421451|NCT05896228|Hormone Antagonists|hormone antagonists|mesh-ancestor
153421452|NCT05896228|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
153421468|NCT05889741|Anesthetics, Local|anesthetics, local|mesh-ancestor
153421469|NCT05889741|Anesthetics|anesthetics|mesh-ancestor
153421470|NCT05889741|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153421471|NCT05889741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153421472|NCT05889741|Sensory System Agents|sensory system agents|mesh-ancestor
153880622|NCT01190930|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153880623|NCT01190930|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
153880624|NCT01190930|Abortifacient Agents|abortifacient agents|mesh-ancestor
153880625|NCT01190930|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153880626|NCT01190930|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153880627|NCT01190930|Antimetabolites|antimetabolites|mesh-ancestor
153880628|NCT01190930|Dermatologic Agents|dermatologic agents|mesh-ancestor
153880629|NCT01190930|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153880630|NCT01190930|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153880631|NCT01190930|Antiviral Agents|antiviral agents|mesh-ancestor
153880632|NCT01190930|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153880633|NCT01190930|Antidotes|antidotes|mesh-ancestor
153880634|NCT01190930|Protective Agents|protective agents|mesh-ancestor
153421492|NCT05850520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153880649|NCT01007578|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153880650|NCT01007578|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153880651|NCT01007578|Tubulin Modulators|tubulin modulators|mesh-ancestor
153880652|NCT01007578|Antimitotic Agents|antimitotic agents|mesh-ancestor
153880653|NCT01007578|Mitosis Modulators|mitosis modulators|mesh-ancestor
153880654|NCT01007578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153421512|NCT05839054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153421513|NCT05839054|Sympathomimetics|sympathomimetics|mesh-ancestor
153421514|NCT05839054|Autonomic Agents|autonomic agents|mesh-ancestor
153421515|NCT05839054|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153421516|NCT05839054|Dopamine Agents|dopamine agents|mesh-ancestor
153421517|NCT05839054|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153430343|NCT04713410|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153889230|NCT01288443|Protease Inhibitors|protease inhibitors|mesh-ancestor
153421518|NCT05839054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153421519|NCT05839054|Adrenergic Agents|adrenergic agents|mesh-ancestor
153421520|NCT05839054|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
153421521|NCT05839054|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153421522|NCT05839054|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153880671|NCT00648648|Adavosertib|adavosertib|mesh-list
153880672|NCT00648648|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153880673|NCT00648648|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153880674|NCT00648648|Antimetabolites|antimetabolites|mesh-ancestor
153880675|NCT00648648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153421532|NCT05811403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153880702|NCT00003838|Methotrexate|methotrexate|mesh-list
153880703|NCT00003838|Cyclosporins|cyclosporins|mesh-list
153880704|NCT00003838|Lenograstim|lenograstim|mesh-list
153880705|NCT00003838|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
153880706|NCT00003838|Abortifacient Agents|abortifacient agents|mesh-ancestor
153880707|NCT00003838|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153880708|NCT00003838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153421551|NCT05788393|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153421553|NCT05788393|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
153421554|NCT05788393|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153421555|NCT05788393|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153421556|NCT05788393|Adrenergic Agents|adrenergic agents|mesh-ancestor
153430401|NCT05328895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153421557|NCT05788393|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153421559|NCT05769946|Dermatologic Agents|dermatologic agents|mesh-ancestor
153421560|NCT05769946|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
153880716|NCT00003838|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153880717|NCT00003838|Immunologic Factors|immunologic factors|mesh-ancestor
153880718|NCT00003838|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153880719|NCT00003838|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153880721|NCT00003838|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153880722|NCT00003838|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
153880723|NCT00003838|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153880727|NCT06031376|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153880728|NCT06031376|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153421563|NCT05769946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153421564|NCT05769049|Vaccines|vaccines|mesh-list
153430413|NCT00879619|Hormones|hormones|mesh-ancestor
153421565|NCT05769049|Immunologic Factors|immunologic factors|mesh-ancestor
153421566|NCT05769049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153421567|NCT05765097|Pancrelipase|pancrelipase|mesh-list
153421568|NCT05765097|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153421569|NCT05754684|Aldesleukin|aldesleukin|mesh-list
153880737|NCT06031376|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153880738|NCT06031285|Bevacizumab|bevacizumab|mesh-list
153880739|NCT06031285|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153880758|NCT06031129|Respiratory System Agents|respiratory system agents|mesh-ancestor
153880759|NCT06031129|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
153880769|NCT06031090|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
153880770|NCT06031090|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153880771|NCT06031090|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153880772|NCT06031090|Adrenergic Agents|adrenergic agents|mesh-ancestor
153880773|NCT06031090|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153880774|NCT06031090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153880776|NCT06031090|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153880777|NCT06031090|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
153880778|NCT06031090|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153880779|NCT06031090|Serotonin Agents|serotonin agents|mesh-ancestor
153880780|NCT06031012|Thalidomide|thalidomide|mesh-list
153880781|NCT06031012|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153421621|NCT05676749|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153421623|NCT05668585|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153421624|NCT05668585|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153421625|NCT05668585|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153421626|NCT05668585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153421627|NCT05625399|Nivolumab|nivolumab|mesh-list
153421628|NCT05625399|Relatlimab|relatlimab|mesh-list
153421629|NCT05625399|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153421630|NCT05625399|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153421631|NCT05625399|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153421632|NCT05625399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153421633|NCT05617508|Niacinamide|niacinamide|mesh-list
153421634|NCT05617508|Niacin|niacin|mesh-list
153421635|NCT05617508|Nicotinic Acids|nicotinic acids|mesh-list
153421636|NCT05617508|Vitamin B Complex|vitamin b complex|mesh-ancestor
153421637|NCT05617508|Vitamins|vitamins|mesh-ancestor
153421638|NCT05617508|Micronutrients|micronutrients|mesh-ancestor
153421639|NCT05617508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153421640|NCT05617508|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153421641|NCT05617508|Antimetabolites|antimetabolites|mesh-ancestor
153421643|NCT05617508|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153421644|NCT05617508|Vasodilator Agents|vasodilator agents|mesh-ancestor
153880783|NCT06031012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153880784|NCT06031012|Leprostatic Agents|leprostatic agents|mesh-ancestor
153880785|NCT06031012|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153880786|NCT06031012|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153880787|NCT06031012|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153880788|NCT06031012|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153880789|NCT06031012|Growth Substances|growth substances|mesh-ancestor
153880790|NCT06031012|Growth Inhibitors|growth inhibitors|mesh-ancestor
153880791|NCT06031012|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153880792|NCT06030934|Paclitaxel|paclitaxel|mesh-list
153880793|NCT06030934|Lenvatinib|lenvatinib|mesh-list
153880794|NCT06030934|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153880795|NCT06030934|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153880796|NCT06030934|Tubulin Modulators|tubulin modulators|mesh-ancestor
153880797|NCT06030934|Antimitotic Agents|antimitotic agents|mesh-ancestor
153880798|NCT06030934|Mitosis Modulators|mitosis modulators|mesh-ancestor
153430573|NCT00402883|Pemetrexed|pemetrexed|mesh-list
153880799|NCT06030934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153880800|NCT06030934|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153880801|NCT06030934|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153880802|NCT06030557|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
153880803|NCT06030557|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153880804|NCT06030557|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153880805|NCT06030557|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153430646|NCT00703339|Treprostinil|treprostinil|mesh-list
153880806|NCT06030557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153880807|NCT06030557|Antiviral Agents|antiviral agents|mesh-ancestor
153880808|NCT06030557|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153880809|NCT06030557|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153880810|NCT06030557|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153880811|NCT06030492|Hydrogen Peroxide|hydrogen peroxide|mesh-list
153880813|NCT06030492|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153880814|NCT06030479|Epinephrine|epinephrine|mesh-list
153421660|NCT05603104|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153421661|NCT05603104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153421662|NCT05603104|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
153421663|NCT05603104|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153421668|NCT05603104|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
153421669|NCT05603104|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153461756|NCT03708588|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153880817|NCT06030479|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153880818|NCT06030479|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153880819|NCT06030479|Adrenergic Agents|adrenergic agents|mesh-ancestor
153880820|NCT06030479|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153880821|NCT06030479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153889571|NCT02871661|Amitriptyline|amitriptyline|mesh-list
153880822|NCT06030479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153880823|NCT06030479|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
153880824|NCT06030479|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153880825|NCT06030479|Autonomic Agents|autonomic agents|mesh-ancestor
153880826|NCT06030479|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153880827|NCT06030479|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153880828|NCT06030479|Respiratory System Agents|respiratory system agents|mesh-ancestor
153880829|NCT06030479|Mydriatics|mydriatics|mesh-ancestor
153430729|NCT00000217|Analgesics|analgesics|mesh-ancestor
153421670|NCT05603104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153421671|NCT05603104|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
153421672|NCT05603104|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153421673|NCT05603104|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153421674|NCT05603104|Serotonin Agents|serotonin agents|mesh-ancestor
153421675|NCT05603104|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
153421677|NCT05603104|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153421678|NCT05603104|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153421679|NCT05603104|Antimanic Agents|antimanic agents|mesh-ancestor
153880845|NCT06027099|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
153421700|NCT05556512|Incretins|incretins|mesh-ancestor
153880849|NCT06027099|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
153880851|NCT06027099|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153880852|NCT06027099|Adrenergic Agents|adrenergic agents|mesh-ancestor
153880853|NCT06027099|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153880854|NCT06027099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153880855|NCT06026358|Tirbanibulin|tirbanibulin|mesh-list
153880856|NCT06026358|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153880857|NCT06026358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153880858|NCT06014073|Cyclophosphamide|cyclophosphamide|mesh-list
153880859|NCT06014073|Fludarabine|fludarabine|mesh-list
153880860|NCT06014073|Fludarabine phosphate|fludarabine phosphate|mesh-list
153880861|NCT06014073|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153880862|NCT06014073|Immunologic Factors|immunologic factors|mesh-ancestor
153880863|NCT06014073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153889609|NCT01006291|Insulin|insulin|mesh-list
153430773|NCT00000241|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153880864|NCT06014073|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153880865|NCT06014073|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153421708|NCT05554406|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153421709|NCT05554406|Antimetabolites|antimetabolites|mesh-ancestor
153421710|NCT05554406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153421711|NCT05554406|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153421712|NCT05554406|Antiviral Agents|antiviral agents|mesh-ancestor
153421713|NCT05554406|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153421716|NCT05554406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153421718|NCT05554406|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153421719|NCT05554406|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153421720|NCT05554406|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153421722|NCT05537740|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153421723|NCT05537740|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153421724|NCT05537740|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153421725|NCT05537740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153880869|NCT06014073|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153430783|NCT00000253|Sensory System Agents|sensory system agents|mesh-ancestor
153430784|NCT00000253|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153430785|NCT00000259|Nitrous Oxide|nitrous oxide|mesh-list
153430786|NCT00000259|Sevoflurane|sevoflurane|mesh-list
153880871|NCT06014073|Antimetabolites|antimetabolites|mesh-ancestor
153880872|NCT05975060|Vaccines|vaccines|mesh-list
153880873|NCT05975060|Immunologic Factors|immunologic factors|mesh-ancestor
153880874|NCT05975060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153880875|NCT05931965|Vitamin B 12|vitamin b 12|mesh-list
153880876|NCT05931965|Hydroxocobalamin|hydroxocobalamin|mesh-list
153880877|NCT05931965|Vitamins|vitamins|mesh-ancestor
153880878|NCT05931965|Micronutrients|micronutrients|mesh-ancestor
153880879|NCT05931965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153880880|NCT05931965|Vitamin B Complex|vitamin b complex|mesh-ancestor
153880881|NCT05931965|Hematinics|hematinics|mesh-ancestor
153880882|NCT05898672|Ritonavir|ritonavir|mesh-list
153889696|NCT01311024|Vaccines|vaccines|mesh-list
153880883|NCT05898672|Nirmatrelvir|nirmatrelvir|mesh-list
153880884|NCT05898672|Nirmatrelvir and ritonavir drug combination|nirmatrelvir and ritonavir drug combination|mesh-list
153880885|NCT05898672|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
153421727|NCT05536037|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153421728|NCT05536037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153421729|NCT05526157|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
153421730|NCT05526157|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-list
153421731|NCT05526157|Glucagon|glucagon|mesh-list
153421732|NCT05526157|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
153421733|NCT05526157|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153421734|NCT05526157|Hormones|hormones|mesh-ancestor
153421735|NCT05526157|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153421736|NCT05526157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153421737|NCT05526157|Incretins|incretins|mesh-ancestor
153421738|NCT05526157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153421739|NCT05526157|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153421740|NCT05514054|Tamoxifen|tamoxifen|mesh-list
153421741|NCT05514054|Letrozole|letrozole|mesh-list
153421742|NCT05514054|Anastrozole|anastrozole|mesh-list
153421743|NCT05514054|Exemestane|exemestane|mesh-list
153421744|NCT05514054|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153421745|NCT05514054|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
153421746|NCT05514054|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153421748|NCT05514054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153421750|NCT05514054|Hormone Antagonists|hormone antagonists|mesh-ancestor
153421751|NCT05514054|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153421752|NCT05514054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153421753|NCT05514054|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153421754|NCT05514054|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
153421756|NCT05514054|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153421757|NCT05482893|Leucovorin|leucovorin|mesh-list
153421758|NCT05482893|Paclitaxel|paclitaxel|mesh-list
153421759|NCT05482893|Gemcitabine|gemcitabine|mesh-list
153421760|NCT05482893|Pembrolizumab|pembrolizumab|mesh-list
153421761|NCT05482893|Capecitabine|capecitabine|mesh-list
153880889|NCT05898672|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153880890|NCT05898672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153880891|NCT05898672|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153880892|NCT05898672|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153880893|NCT05898672|Antiviral Agents|antiviral agents|mesh-ancestor
153880894|NCT05898672|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153880895|NCT05898672|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
153880896|NCT05898672|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153880897|NCT05898672|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153880898|NCT05898672|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153880899|NCT05898672|Antimetabolites|antimetabolites|mesh-ancestor
153418610|NCT02941640|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153880900|NCT05898672|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153880901|NCT05898672|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
153880902|NCT05897554|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
153880903|NCT05897554|Plasminogen|plasminogen|mesh-list
153880905|NCT05897554|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153880906|NCT05897554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153880907|NCT05856994|Tacrolimus|tacrolimus|mesh-list
153880908|NCT05856994|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153880909|NCT05856994|Immunologic Factors|immunologic factors|mesh-ancestor
153880910|NCT05856994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153430958|NCT04181203|Fertility Agents|fertility agents|mesh-ancestor
153889844|NCT01264965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153889845|NCT01264965|Antipyretics|antipyretics|mesh-ancestor
153889846|NCT01264965|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153889847|NCT01264965|Narcotics|narcotics|mesh-ancestor
153889848|NCT01264965|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153889859|NCT01264887|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153430965|NCT04181203|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
153430966|NCT03521102|Acetaminophen|acetaminophen|mesh-list
153889873|NCT01263483|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153430972|NCT03521102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153880912|NCT05856994|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153880913|NCT05856994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153880914|NCT05846399|Amoxicillin|amoxicillin|mesh-list
153880915|NCT05846399|Ciprofloxacin|ciprofloxacin|mesh-list
153880917|NCT05846399|Clindamycin palmitate|clindamycin palmitate|mesh-list
153880918|NCT05846399|Clindamycin phosphate|clindamycin phosphate|mesh-list
153421762|NCT05482893|Fluorouracil|fluorouracil|mesh-list
153421763|NCT05482893|Oxaliplatin|oxaliplatin|mesh-list
153421764|NCT05482893|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
153421765|NCT05482893|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153430979|NCT00000763|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153889881|NCT01263483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153889882|NCT01263483|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
153889883|NCT01263483|Vitamin B Complex|vitamin b complex|mesh-ancestor
153889884|NCT01263483|Vitamins|vitamins|mesh-ancestor
153430980|NCT00000763|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153889888|NCT01011049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153421766|NCT05482893|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153421767|NCT05482893|Tubulin Modulators|tubulin modulators|mesh-ancestor
153421768|NCT05482893|Antimitotic Agents|antimitotic agents|mesh-ancestor
153421769|NCT05482893|Mitosis Modulators|mitosis modulators|mesh-ancestor
153421770|NCT05482893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153421771|NCT05482893|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153421772|NCT05482893|Antimetabolites|antimetabolites|mesh-ancestor
153421773|NCT05482893|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153421774|NCT05482893|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153421775|NCT05482893|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153421776|NCT05482893|Immunologic Factors|immunologic factors|mesh-ancestor
153421777|NCT05482893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153421778|NCT05482893|Antidotes|antidotes|mesh-ancestor
153421779|NCT05482893|Protective Agents|protective agents|mesh-ancestor
153421780|NCT05482893|Vitamin B Complex|vitamin b complex|mesh-ancestor
153421781|NCT05482893|Vitamins|vitamins|mesh-ancestor
153421782|NCT05482893|Micronutrients|micronutrients|mesh-ancestor
153880922|NCT05846399|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153889926|NCT01003639|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153889927|NCT01003639|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153889928|NCT01003639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153889929|NCT01003639|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153889932|NCT01003639|Antipyretics|antipyretics|mesh-ancestor
153889933|NCT01003639|Gout Suppressants|gout suppressants|mesh-ancestor
153889934|NCT01003639|Anticonvulsants|anticonvulsants|mesh-ancestor
153889935|NCT01003639|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
153880923|NCT05846399|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153880924|NCT05846399|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153880925|NCT05846399|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153880927|NCT05846399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153880928|NCT05846399|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153880929|NCT05846399|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
153880930|NCT05846399|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153880931|NCT05846399|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
153880932|NCT05846399|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
153880935|NCT05842759|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153880936|NCT05842759|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153880937|NCT05842759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153880938|NCT05842759|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153880939|NCT05842759|Anesthetics, General|anesthetics, general|mesh-ancestor
153461839|NCT03286842|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153461840|NCT03286842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153461841|NCT03286842|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153461842|NCT05240274|Metformin|metformin|mesh-list
153461843|NCT05240274|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153461844|NCT05240274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153461845|NCT05244018|Vitamin D|vitamin d|mesh-list
153461846|NCT05244018|Ergocalciferols|ergocalciferols|mesh-list
153462758|NCT04073784|Gemcitabine|gemcitabine|mesh-list
153463465|NCT01892748|Vitamins|vitamins|mesh-ancestor
153463466|NCT01892748|Micronutrients|micronutrients|mesh-ancestor
153463467|NCT01892748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153463468|NCT01892748|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153463469|NCT01892748|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153463470|NCT01893060|Chlorhexidine|chlorhexidine|mesh-list
153463471|NCT01893060|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
153463472|NCT01893060|Povidone-Iodine|povidone-iodine|mesh-list
153914957|NCT03369301|Immunologic Factors|immunologic factors|mesh-ancestor
153914958|NCT03369301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153914960|NCT05345119|Methylprednisolone|methylprednisolone|mesh-list
153914971|NCT05345119|Antifungal Agents|antifungal agents|mesh-ancestor
153914972|NCT05345119|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153914973|NCT05345119|Immunologic Factors|immunologic factors|mesh-ancestor
153914974|NCT05345119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153914975|NCT05345119|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153914976|NCT05345119|Antiemetics|antiemetics|mesh-ancestor
153915066|NCT00614653|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153915067|NCT00614653|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153915068|NCT03909451|(2S,3R,4R,5S,6R)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2H-pyran-3,4,5-triol|(2s,3r,4r,5s,6r)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2h-pyran-3,4,5-triol|mesh-list
153915109|NCT00614809|Gefitinib|gefitinib|mesh-list
153463910|NCT02513784|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153464212|NCT01253070|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153464214|NCT01253070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153464215|NCT01253070|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153464216|NCT01253070|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153915504|NCT04214821|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153915709|NCT02700217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153464530|NCT00056472|Serotonin Agents|serotonin agents|mesh-ancestor
153915915|NCT01204697|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153464717|NCT01897116|Vemurafenib|vemurafenib|mesh-list
153916028|NCT00996801|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153916660|NCT01202591|Hormone Antagonists|hormone antagonists|mesh-ancestor
153916661|NCT01202591|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153916662|NCT01202591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153916663|NCT01202591|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
153916664|NCT01202591|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153916665|NCT01202591|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153916666|NCT01202591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153892500|NCT00006721|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153892506|NCT00006721|Hormones|hormones|mesh-ancestor
153916856|NCT01200407|Amlodipine|amlodipine|mesh-list
153465864|NCT00250926|Autonomic Agents|autonomic agents|mesh-ancestor
153465865|NCT00250926|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153465866|NCT00250926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153465867|NCT00250926|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153465868|NCT00250926|Glucocorticoids|glucocorticoids|mesh-ancestor
153465870|NCT00250926|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153465871|NCT00250926|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153917254|NCT02683759|Analgesics|analgesics|mesh-ancestor
153917637|NCT01193153|Serotonin Agents|serotonin agents|mesh-ancestor
153917754|NCT04264078|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153466591|NCT00311376|Cholinergic Agents|cholinergic agents|mesh-ancestor
153917934|NCT01181141|Protease Inhibitors|protease inhibitors|mesh-ancestor
153918071|NCT04315194|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153918077|NCT04315194|Antiviral Agents|antiviral agents|mesh-ancestor
153466919|NCT00462072|Dermatologic Agents|dermatologic agents|mesh-ancestor
153918326|NCT00931918|Mitosis Modulators|mitosis modulators|mesh-ancestor
153918327|NCT04183075|Vitamins|vitamins|mesh-list
153467132|NCT00413478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153467133|NCT00413478|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153918583|NCT01177943|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153918653|NCT05370898|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153918654|NCT00610948|Leucovorin|leucovorin|mesh-list
153918786|NCT02672527|Antiemetics|antiemetics|mesh-ancestor
153918844|NCT05911126|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153919004|NCT05892510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153919180|NCT04839549|Hormones|hormones|mesh-ancestor
153468193|NCT02128230|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153919441|NCT02396043|Dexamethasone|dexamethasone|mesh-list
153418671|NCT03032965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153418672|NCT03032965|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153418673|NCT03032965|Vasodilator Agents|vasodilator agents|mesh-ancestor
153418752|NCT02951702|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153418753|NCT02831816|Ethanol|ethanol|mesh-list
153418754|NCT02831816|Chlorhexidine|chlorhexidine|mesh-list
153418755|NCT02831816|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
153418756|NCT02831816|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
153418762|NCT03036163|Macozinone|macozinone|mesh-list
153878162|NCT04831541|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
153878163|NCT04831541|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
153878164|NCT04831541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153878165|NCT04828031|Vitamin D|vitamin d|mesh-list
153878166|NCT04828031|Vitamins|vitamins|mesh-ancestor
153878167|NCT04828031|Micronutrients|micronutrients|mesh-ancestor
153878170|NCT04825496|Cyclophosphamide|cyclophosphamide|mesh-list
153419052|NCT05675319|Daratumumab|daratumumab|mesh-list
153419053|NCT05675319|Pomalidomide|pomalidomide|mesh-list
153419054|NCT05675319|Ixazomib|ixazomib|mesh-list
153419055|NCT05675319|Elotuzumab|elotuzumab|mesh-list
153419056|NCT05675319|BB 1101|bb 1101|mesh-list
153419057|NCT05675319|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
153419058|NCT05675319|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153419059|NCT05675319|Antiemetics|antiemetics|mesh-ancestor
153419060|NCT05675319|Autonomic Agents|autonomic agents|mesh-ancestor
153419061|NCT05675319|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153878241|NCT04764162|Nootropic Agents|nootropic agents|mesh-ancestor
153419062|NCT05675319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153419063|NCT05675319|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153419097|NCT05615311|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153419099|NCT05607615|Betadex|betadex|mesh-list
153419163|NCT05414331|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153419164|NCT05414331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153878410|NCT04406389|Enoxaparin sodium|enoxaparin sodium|mesh-list
153878411|NCT04406389|Argatroban|argatroban|mesh-list
153878412|NCT04406389|Anticoagulants|anticoagulants|mesh-ancestor
153878413|NCT04406389|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153878513|NCT04204798|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153878514|NCT04204798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153878577|NCT04054375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153419419|NCT04503460|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153419420|NCT04503460|Sympathomimetics|sympathomimetics|mesh-ancestor
153419478|NCT03921060|Denosumab|denosumab|mesh-list
153419479|NCT03921060|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153419480|NCT03921060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153419481|NCT03827070|Afatinib|afatinib|mesh-list
153419562|NCT03043430|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153419563|NCT03043430|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153878926|NCT03259867|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153879036|NCT03067571|Daratumumab|daratumumab|mesh-list
153879037|NCT03067571|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153879201|NCT06078605|Niacin|niacin|mesh-list
153879206|NCT06078605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153879250|NCT06064448|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153420172|NCT03070730|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
153420173|NCT03070730|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
153420376|NCT03090620|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153420377|NCT03090620|Cholinergic Agents|cholinergic agents|mesh-ancestor
153420446|NCT03100123|Heparin|heparin|mesh-list
153420447|NCT03100123|Enoxaparin|enoxaparin|mesh-list
153420449|NCT03100123|Tinzaparin|tinzaparin|mesh-list
153420574|NCT03109015|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153420575|NCT03109015|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153879781|NCT03739411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153879782|NCT03739411|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153879783|NCT03721653|Leucovorin|leucovorin|mesh-list
153879785|NCT03721653|Atezolizumab|atezolizumab|mesh-list
153879786|NCT03721653|Fluorouracil|fluorouracil|mesh-list
153879787|NCT03721653|Oxaliplatin|oxaliplatin|mesh-list
153420782|NCT03132571|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
153420786|NCT02374424|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153420787|NCT02374424|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153879951|NCT02757885|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153879952|NCT02757885|Alkylating Agents|alkylating agents|mesh-ancestor
153879953|NCT02757885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153879954|NCT02757885|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153879955|NCT02757885|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153879956|NCT02757885|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153420841|NCT05113004|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153420842|NCT05113004|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153880009|NCT02426658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153880010|NCT02426658|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153880020|NCT02400242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153880021|NCT02400242|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153880022|NCT02400242|Glucocorticoids|glucocorticoids|mesh-ancestor
153420901|NCT03154333|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153420902|NCT04393441|Lubricant Eye Drops|lubricant eye drops|mesh-list
153420903|NCT04393441|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
153420904|NCT04393441|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
153420905|NCT02995915|Bupropion|bupropion|mesh-list
153880103|NCT02872259|Dabrafenib|dabrafenib|mesh-list
153880104|NCT02872259|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153880105|NCT02872259|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153880106|NCT02872259|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153420997|NCT06289062|Cisplatin|cisplatin|mesh-list
153420998|NCT06289062|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153420999|NCT06289062|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153880157|NCT02703610|Sensory System Agents|sensory system agents|mesh-ancestor
153880158|NCT02703610|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153880168|NCT02703610|Narcotics|narcotics|mesh-ancestor
153421063|NCT06288152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153421064|NCT06288152|Antioxidants|antioxidants|mesh-ancestor
153421065|NCT06288152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153421066|NCT06288152|Antitubercular Agents|antitubercular agents|mesh-ancestor
153880301|NCT02403778|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153880302|NCT02403778|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153880303|NCT02403778|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153421153|NCT06275035|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
153421154|NCT06275035|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
153880322|NCT02276274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153880782|NCT06031012|Immunologic Factors|immunologic factors|mesh-ancestor
153421726|NCT05536037|Metformin|metformin|mesh-list
153880934|NCT05842759|Propofol|propofol|mesh-list
153880940|NCT05842759|Anesthetics|anesthetics|mesh-ancestor
153881189|NCT04942860|Antimetabolites|antimetabolites|mesh-ancestor
153880942|NCT05842759|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153880943|NCT05842759|Adrenergic Agents|adrenergic agents|mesh-ancestor
153421791|NCT05476939|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153422308|NCT04128956|Antipyretics|antipyretics|mesh-ancestor
153421792|NCT05476939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153422694|NCT02404870|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
153422695|NCT02404870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153422850|NCT02221674|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153881954|NCT01602588|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153881955|NCT01602588|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153421793|NCT05476939|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153421794|NCT05476939|Immunologic Factors|immunologic factors|mesh-ancestor
153882088|NCT01645826|Vasodilator Agents|vasodilator agents|mesh-ancestor
153423083|NCT03185065|Antiviral Agents|antiviral agents|mesh-ancestor
153423086|NCT03185065|Analgesics|analgesics|mesh-ancestor
153421795|NCT05476939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153421796|NCT05476939|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153421799|NCT05468489|Etoposide phosphate|etoposide phosphate|mesh-list
153421800|NCT05468489|Atezolizumab|atezolizumab|mesh-list
153421801|NCT05468489|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153421802|NCT05468489|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153421803|NCT05468489|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153880949|NCT05842759|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
153880951|NCT05779007|Nintedanib|nintedanib|mesh-list
153423274|NCT03303794|Anesthetics|anesthetics|mesh-ancestor
153882418|NCT01609101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153423303|NCT03437564|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
153423304|NCT03437564|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153423306|NCT03438266|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153423307|NCT03438266|Immunologic Factors|immunologic factors|mesh-ancestor
153423308|NCT03438266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153423309|NCT03438266|Viscosupplements|viscosupplements|mesh-ancestor
153423317|NCT03228914|Phenylephrine|phenylephrine|mesh-list
153882506|NCT01684085|Antiemetics|antiemetics|mesh-ancestor
153882507|NCT01684085|Autonomic Agents|autonomic agents|mesh-ancestor
153882508|NCT01684085|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153882509|NCT01684085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153882510|NCT01684085|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153882511|NCT01684085|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153882512|NCT01684085|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153882513|NCT01684085|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153882594|NCT01606527|Ibuprofen|ibuprofen|mesh-list
153882595|NCT01606527|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153882596|NCT01606527|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153882597|NCT01606527|Analgesics|analgesics|mesh-ancestor
153882598|NCT01606527|Sensory System Agents|sensory system agents|mesh-ancestor
153882599|NCT01606527|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153882600|NCT01606527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153882601|NCT01606527|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153423622|NCT01629966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153423623|NCT01629966|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153423625|NCT01629966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153423626|NCT01629966|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
153423630|NCT02177838|Antibodies|antibodies|mesh-list
153880952|NCT05779007|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153880953|NCT05779007|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153880954|NCT05779007|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153880955|NCT05779007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153880956|NCT05779007|Analgesics|analgesics|mesh-ancestor
153880957|NCT05779007|Sensory System Agents|sensory system agents|mesh-ancestor
153423721|NCT02176356|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
153423795|NCT03403712|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153423865|NCT03528512|Narcotics|narcotics|mesh-ancestor
153423866|NCT02133924|Prednisone|prednisone|mesh-list
153423867|NCT02133924|Methylprednisolone|methylprednisolone|mesh-list
153423868|NCT02133924|Natalizumab|natalizumab|mesh-list
153423871|NCT02133924|Hormones|hormones|mesh-ancestor
153423873|NCT02133924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153882991|NCT01687049|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153883048|NCT01687205|Antiviral Agents|antiviral agents|mesh-ancestor
153883049|NCT01687205|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153883092|NCT01689311|Misoprostol|misoprostol|mesh-list
153883093|NCT01689311|Oxytocin|oxytocin|mesh-list
153424075|NCT04338074|Tranexamic Acid|tranexamic acid|mesh-list
153424076|NCT04338074|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
153883263|NCT01683188|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153883264|NCT01683188|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153883265|NCT01683188|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153883266|NCT01683188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153883267|NCT01339923|Vaccines|vaccines|mesh-list
153883319|NCT01371747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153883320|NCT01371747|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
153883321|NCT01371747|Diuretics|diuretics|mesh-ancestor
153883322|NCT01371747|Natriuretic Agents|natriuretic agents|mesh-ancestor
153883324|NCT01335399|Dexamethasone acetate|dexamethasone acetate|mesh-list
153883325|NCT01335399|Lenalidomide|lenalidomide|mesh-list
153883326|NCT01335399|Elotuzumab|elotuzumab|mesh-list
153880958|NCT05779007|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153421804|NCT05468489|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153421805|NCT05468489|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153421806|NCT05468489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153421807|NCT05468489|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153421808|NCT05468489|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153421809|NCT05434689|Dexamethasone|dexamethasone|mesh-list
153883362|NCT01332630|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153883363|NCT01332630|Antiemetics|antiemetics|mesh-ancestor
153424353|NCT00376519|Antimetabolites|antimetabolites|mesh-ancestor
153424406|NCT04121078|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153424410|NCT04121078|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
153424412|NCT04121078|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
153424413|NCT04121078|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
153424470|NCT03857750|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153424471|NCT03857750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153424472|NCT03828422|Calcium|calcium|mesh-list
153424473|NCT03828422|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153424474|NCT03828422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153424475|NCT03852524|Methylnaltrexone|methylnaltrexone|mesh-list
153424531|NCT03831854|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153424532|NCT03831854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153424533|NCT03831854|Anticonvulsants|anticonvulsants|mesh-ancestor
153421810|NCT05434689|Daratumumab|daratumumab|mesh-list
153421811|NCT05434689|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153421812|NCT05434689|Antiemetics|antiemetics|mesh-ancestor
153421813|NCT05434689|Autonomic Agents|autonomic agents|mesh-ancestor
153421814|NCT05434689|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153883746|NCT01600742|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
153424689|NCT04005404|Anesthetics|anesthetics|mesh-ancestor
153421815|NCT05434689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153421816|NCT05434689|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153421817|NCT05434689|Glucocorticoids|glucocorticoids|mesh-ancestor
153880970|NCT05731323|Antimetabolites|antimetabolites|mesh-ancestor
153880971|NCT05731323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153880972|NCT05629260|Cyclophosphamide|cyclophosphamide|mesh-list
153880973|NCT05629260|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153883912|NCT01113541|Serotonin Agents|serotonin agents|mesh-ancestor
153883913|NCT01113541|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153883914|NCT01113541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153883925|NCT00591708|Calcium|calcium|mesh-list
153883975|NCT01607333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153424922|NCT02892500|Glucocorticoids|glucocorticoids|mesh-ancestor
153425003|NCT03723980|Propolis|propolis|mesh-list
153880974|NCT05629260|Immunologic Factors|immunologic factors|mesh-ancestor
153425112|NCT01155518|Hormones|hormones|mesh-ancestor
153880975|NCT05629260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153425395|NCT03608839|Dexamethasone|dexamethasone|mesh-list
153880976|NCT05629260|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153425676|NCT03632083|Disinfectants|disinfectants|mesh-ancestor
153425758|NCT00634322|Leucovorin|leucovorin|mesh-list
153880977|NCT05629260|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153880978|NCT05629260|Alkylating Agents|alkylating agents|mesh-ancestor
153426074|NCT00521924|Cyclosporine|cyclosporine|mesh-list
153421828|NCT05431595|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153426553|NCT03714919|Anesthetics|anesthetics|mesh-ancestor
153421829|NCT05431595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153885652|NCT00598572|Deferoxamine|deferoxamine|mesh-list
153426685|NCT04331600|Anthelmintics|anthelmintics|mesh-ancestor
153426687|NCT00000188|Antidepressive Agents|antidepressive agents|mesh-ancestor
153885868|NCT01106677|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
153426941|NCT00000260|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153885995|NCT04328636|Anesthetics|anesthetics|mesh-ancestor
153427120|NCT00001058|Ritonavir|ritonavir|mesh-list
153427333|NCT00002024|Ganciclovir|ganciclovir|mesh-list
153886353|NCT01324388|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
153427426|NCT00002042|Epoetin Alfa|epoetin alfa|mesh-list
153886716|NCT01323621|Xhance|xhance|mesh-list
153427761|NCT00002144|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153427765|NCT00000578|Theophylline|theophylline|mesh-list
153427924|NCT00000638|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
153427925|NCT00000638|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
153428074|NCT00002198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153887160|NCT01077739|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153887161|NCT01077739|Antimetabolites|antimetabolites|mesh-ancestor
153887181|NCT00626509|Growth Inhibitors|growth inhibitors|mesh-ancestor
153887315|NCT05320705|Dexmedetomidine|dexmedetomidine|mesh-list
153887598|NCT04325061|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153887599|NCT04325061|Glucocorticoids|glucocorticoids|mesh-ancestor
153887783|NCT00594737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153429063|NCT00002534|Autonomic Agents|autonomic agents|mesh-ancestor
153429131|NCT00002552|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153888096|NCT01326533|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153888140|NCT00601211|Miotics|miotics|mesh-ancestor
153888215|NCT00626977|Autonomic Agents|autonomic agents|mesh-ancestor
153429599|NCT00002714|Mitosis Modulators|mitosis modulators|mesh-ancestor
153429770|NCT00002756|Cytarabine|cytarabine|mesh-list
153429829|NCT05749016|Paclitaxel|paclitaxel|mesh-list
153430505|NCT00780481|Kininogens|kininogens|mesh-list
153430506|NCT00780481|Vasodilator Agents|vasodilator agents|mesh-ancestor
153889636|NCT01012219|Aspirin|aspirin|mesh-list
153889637|NCT01012219|Niacin|niacin|mesh-list
153889638|NCT01012219|Clopidogrel|clopidogrel|mesh-list
153889639|NCT01012219|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153889640|NCT01012219|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153889641|NCT01012219|Analgesics|analgesics|mesh-ancestor
153889642|NCT01012219|Sensory System Agents|sensory system agents|mesh-ancestor
153430799|NCT00379405|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
153430800|NCT00379405|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
153890192|NCT02866071|Anesthetics, General|anesthetics, general|mesh-ancestor
153890193|NCT02866071|Anesthetics|anesthetics|mesh-ancestor
153890196|NCT02866071|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
153431258|NCT06315478|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153431259|NCT06315478|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153431260|NCT06315478|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
153890260|NCT01300572|Antibodies|antibodies|mesh-list
153890291|NCT01258101|Immunologic Factors|immunologic factors|mesh-ancestor
153890292|NCT01258101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153431360|NCT06313008|Protease Inhibitors|protease inhibitors|mesh-ancestor
153431361|NCT06313008|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153431362|NCT06312683|Rifaximin|rifaximin|mesh-list
153431363|NCT06312683|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153431364|NCT06312683|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153431424|NCT06293963|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
153431489|NCT06273397|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153431490|NCT06273397|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
153431491|NCT06270680|Carotenoids|carotenoids|mesh-list
153431492|NCT06270680|Antioxidants|antioxidants|mesh-ancestor
153431493|NCT06270680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153431494|NCT06270680|Protective Agents|protective agents|mesh-ancestor
153431495|NCT06270680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153431496|NCT06255379|Tegafur|tegafur|mesh-list
153431497|NCT06255379|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153431498|NCT06255379|Antimetabolites|antimetabolites|mesh-ancestor
153431499|NCT06255379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153890468|NCT01077076|Omeprazole|omeprazole|mesh-list
153431514|NCT06219915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153431515|NCT06219915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153431516|NCT06219915|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
153890563|NCT00624273|Sildenafil Citrate|sildenafil citrate|mesh-list
153890564|NCT00624273|Vasodilator Agents|vasodilator agents|mesh-ancestor
153890565|NCT00624273|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
153890567|NCT00624273|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153431614|NCT06054477|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153431670|NCT06023368|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153431671|NCT06023368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153890670|NCT02875756|Ivermectin|ivermectin|mesh-list
153431727|NCT05981209|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153431728|NCT05981209|Protease Inhibitors|protease inhibitors|mesh-ancestor
153431729|NCT05981209|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153431730|NCT05981209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153890794|NCT04304560|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
153890796|NCT04304560|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153890865|NCT01036594|BB 1101|bb 1101|mesh-list
153890866|NCT01036594|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153431936|NCT05600426|Antifungal Agents|antifungal agents|mesh-ancestor
153890934|NCT02889432|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153891177|NCT01031446|Everolimus|everolimus|mesh-list
153482993|NCT05705492|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153432410|NCT04840264|Oxaliplatin|oxaliplatin|mesh-list
153891577|NCT05852769|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153432756|NCT03642626|Vidarabine|vidarabine|mesh-list
153891776|NCT05255913|Protective Agents|protective agents|mesh-ancestor
153891778|NCT05247320|Sotalol|sotalol|mesh-list
153891826|NCT05130814|Protective Agents|protective agents|mesh-ancestor
153891971|NCT04448873|Sirolimus|sirolimus|mesh-list
153892029|NCT04216017|Hormones|hormones|mesh-ancestor
153892076|NCT04002518|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
153892077|NCT04002518|Histamine Antagonists|histamine antagonists|mesh-ancestor
153892121|NCT03877549|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153433237|NCT00845650|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
153433288|NCT00000373|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153892263|NCT03245892|Nivolumab|nivolumab|mesh-list
153892314|NCT03126630|Tubulin Modulators|tubulin modulators|mesh-ancestor
153892380|NCT02652195|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153892382|NCT02350764|Nivolumab|nivolumab|mesh-list
153433535|NCT00000577|Adrenergic Agents|adrenergic agents|mesh-list
153892666|NCT04322760|Dexmedetomidine|dexmedetomidine|mesh-list
153892667|NCT04322760|Bupivacaine|bupivacaine|mesh-list
153433844|NCT00000703|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153892788|NCT01298570|Irinotecan|irinotecan|mesh-list
153421886|NCT05327127|6-((4-ethylphenyl)methyl)-3',4',5',6'-tetrahydro-6'-(hydroxymethyl)spiro(isobenzofuran-1(3H),2'-(2H)pyran)-3',4',5'-triol|6-((4-ethylphenyl)methyl)-3',4',5',6'-tetrahydro-6'-(hydroxymethyl)spiro(isobenzofuran-1(3h),2'-(2h)pyran)-3',4',5'-triol|mesh-list
153421888|NCT05327127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153421890|NCT05327127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153421891|NCT05297565|Nivolumab|nivolumab|mesh-list
153421892|NCT05297565|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153421893|NCT05297565|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153421894|NCT05297565|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153421895|NCT05297565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153421896|NCT05273554|Pembrolizumab|pembrolizumab|mesh-list
153421897|NCT05273554|Lenvatinib|lenvatinib|mesh-list
153881047|NCT05287503|Ambroxol|ambroxol|mesh-list
153881048|NCT05287503|Expectorants|expectorants|mesh-ancestor
153892924|NCT01235949|Acetaminophen|acetaminophen|mesh-list
153434138|NCT00001933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153893141|NCT01020526|Analgesics|analgesics|mesh-ancestor
153434919|NCT00003086|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153894115|NCT00628810|Vitamins|vitamins|mesh-ancestor
153894198|NCT04288765|Immunologic Factors|immunologic factors|mesh-ancestor
153435428|NCT00002816|Idarubicin|idarubicin|mesh-list
153894431|NCT01202955|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153894482|NCT01199289|Brodalumab|brodalumab|mesh-list
153436069|NCT00002611|Tubulin Modulators|tubulin modulators|mesh-ancestor
153895323|NCT03576690|Odesivimab|odesivimab|mesh-list
153895366|NCT03118674|Ledipasvir|ledipasvir|mesh-list
153436816|NCT04609423|Vitamin D|vitamin d|mesh-list
153895663|NCT00996866|Vitamin D|vitamin d|mesh-list
153895744|NCT00335140|Procarbazine|procarbazine|mesh-list
153895849|NCT02890511|Paclitaxel|paclitaxel|mesh-list
153437378|NCT00004838|Succimer|succimer|mesh-list
153437454|NCT00004868|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153437455|NCT00004868|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153437456|NCT00004868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153437457|NCT00003710|Irinotecan|irinotecan|mesh-list
153437458|NCT00003710|Mitomycins|mitomycins|mesh-list
153437459|NCT00003710|Mitomycin|mitomycin|mesh-list
153437460|NCT00003710|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
153437461|NCT00003710|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153437462|NCT00003710|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153437463|NCT00003710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153437464|NCT00003710|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153437465|NCT00003710|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153437466|NCT00003710|Alkylating Agents|alkylating agents|mesh-ancestor
153437467|NCT00003710|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153437468|NCT00004232|Cyclosporine|cyclosporine|mesh-list
153437469|NCT00004232|Prednisone|prednisone|mesh-list
153437470|NCT00004232|Methylprednisolone|methylprednisolone|mesh-list
153437471|NCT00004232|Cyclosporins|cyclosporins|mesh-list
153437472|NCT00004232|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153437489|NCT00004232|Autonomic Agents|autonomic agents|mesh-ancestor
153437490|NCT00004232|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153437491|NCT00004232|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153437492|NCT00004232|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
153437493|NCT00004232|Protective Agents|protective agents|mesh-ancestor
153437494|NCT00004874|Iodine|iodine|mesh-list
153437495|NCT00004874|Tositumomab I-131|tositumomab i-131|mesh-list
153437496|NCT00004874|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
153896521|NCT01296347|Analgesics|analgesics|mesh-ancestor
153881049|NCT05287503|Respiratory System Agents|respiratory system agents|mesh-ancestor
153881051|NCT05263908|Nirmatrelvir|nirmatrelvir|mesh-list
153881052|NCT05263908|Nirmatrelvir and ritonavir drug combination|nirmatrelvir and ritonavir drug combination|mesh-list
153881053|NCT05263908|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
153881054|NCT05263908|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
153881055|NCT05263908|Protease Inhibitors|protease inhibitors|mesh-ancestor
153881056|NCT05263908|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153421909|NCT05259527|Vitamin D|vitamin d|mesh-list
153438162|NCT00004466|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153438163|NCT00004466|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
153438164|NCT00004466|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153438165|NCT00005054|Temozolomide|temozolomide|mesh-list
153438166|NCT00005054|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153438167|NCT00005054|Alkylating Agents|alkylating agents|mesh-ancestor
153438168|NCT00005054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153438169|NCT00005054|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153421910|NCT05259527|Ergocalciferols|ergocalciferols|mesh-list
153897339|NCT01239732|Paclitaxel|paclitaxel|mesh-list
153897443|NCT01162863|Lubiprostone|lubiprostone|mesh-list
153421911|NCT05259527|Cholecalciferol|cholecalciferol|mesh-list
153897893|NCT04268563|Incretins|incretins|mesh-ancestor
153421913|NCT05259527|Micronutrients|micronutrients|mesh-ancestor
153421914|NCT05259527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153421915|NCT05259527|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153421916|NCT05259527|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153421917|NCT05256641|Acalabrutinib|acalabrutinib|mesh-list
153421918|NCT05256641|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-list
153881070|NCT05212571|Ketamine|ketamine|mesh-list
153881071|NCT05212571|Esketamine|esketamine|mesh-list
153881072|NCT05212571|Analgesics|analgesics|mesh-ancestor
153881073|NCT05212571|Sensory System Agents|sensory system agents|mesh-ancestor
153881074|NCT05212571|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153421926|NCT05203510|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153421927|NCT05196191|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
153421950|NCT05095571|Nicotinic Acids|nicotinic acids|mesh-list
153421951|NCT05095571|Vitamin B Complex|vitamin b complex|mesh-ancestor
153421952|NCT05095571|Vitamins|vitamins|mesh-ancestor
153421953|NCT05095571|Micronutrients|micronutrients|mesh-ancestor
153897991|NCT01146873|Ritonavir|ritonavir|mesh-list
153881083|NCT05212571|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153898093|NCT00950599|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153898094|NCT00950599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153898095|NCT00950599|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
153898096|NCT00950599|Protease Inhibitors|protease inhibitors|mesh-ancestor
153898097|NCT00950599|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153898098|NCT00950599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153898099|NCT00950599|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153898114|NCT01143051|Racepinephrine|racepinephrine|mesh-list
153898132|NCT05199597|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153898133|NCT05199597|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153898134|NCT05199597|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153898135|NCT05199597|Autonomic Agents|autonomic agents|mesh-ancestor
153898136|NCT05199597|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153898137|NCT05199597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153898169|NCT01283282|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153898171|NCT01283282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153898172|NCT01282814|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
153898173|NCT01282814|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
153898174|NCT01282814|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153898175|NCT01282814|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153898177|NCT01282814|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153898200|NCT00602173|Protective Agents|protective agents|mesh-ancestor
153898201|NCT00602173|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
153439529|NCT00003019|Abortifacient Agents|abortifacient agents|mesh-ancestor
153439530|NCT00003019|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153439531|NCT00003019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153439532|NCT00003019|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153439533|NCT00003019|Antimetabolites|antimetabolites|mesh-ancestor
153439569|NCT00003493|Antimitotic Agents|antimitotic agents|mesh-ancestor
153439570|NCT00003493|Mitosis Modulators|mitosis modulators|mesh-ancestor
153439571|NCT00003031|Voriconazole|voriconazole|mesh-list
153439572|NCT00003031|Amphotericin B|amphotericin b|mesh-list
153439615|NCT00002803|Cyclophosphamide|cyclophosphamide|mesh-list
153439616|NCT00002803|Doxorubicin|doxorubicin|mesh-list
153439617|NCT00002803|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
153439618|NCT00002803|Vincristine|vincristine|mesh-list
153439710|NCT00002827|Cobalt|cobalt|mesh-list
153439711|NCT00002827|Doxorubicin|doxorubicin|mesh-list
153439712|NCT00002827|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
153439770|NCT00003055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153439772|NCT00002833|Cyclosporine|cyclosporine|mesh-list
153439773|NCT00002833|Methylprednisolone|methylprednisolone|mesh-list
153439774|NCT00002833|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
153439775|NCT00002833|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
153439776|NCT00002833|Prednisolone|prednisolone|mesh-list
153439777|NCT00002833|Prednisolone acetate|prednisolone acetate|mesh-list
153439778|NCT00002833|Fludarabine|fludarabine|mesh-list
153439779|NCT00002833|Fludarabine phosphate|fludarabine phosphate|mesh-list
153439780|NCT00002833|Idarubicin|idarubicin|mesh-list
153439781|NCT00002833|Cladribine|cladribine|mesh-list
153439782|NCT00002833|Cyclosporins|cyclosporins|mesh-list
153881084|NCT05212571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153881085|NCT05212571|Antidepressive Agents|antidepressive agents|mesh-ancestor
153881132|NCT05130060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153881133|NCT05130060|Antimetabolites|antimetabolites|mesh-ancestor
153421992|NCT05038735|Fulvestrant|fulvestrant|mesh-list
153421993|NCT05038735|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153421994|NCT05038735|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153421995|NCT05038735|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
153421996|NCT05038735|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
153421997|NCT05038735|Hormone Antagonists|hormone antagonists|mesh-ancestor
153421998|NCT05038735|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153421999|NCT05038735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153422000|NCT05024318|Pembrolizumab|pembrolizumab|mesh-list
153422001|NCT05024318|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153422002|NCT05024318|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153422003|NCT05024318|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153422004|NCT05024318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153422006|NCT05006794|Sacituzumab govitecan|sacituzumab govitecan|mesh-list
153422007|NCT05006794|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153881144|NCT05114486|Cholinergic Agents|cholinergic agents|mesh-ancestor
153881145|NCT05114486|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153881146|NCT05114486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153881147|NCT05058976|Vitamin D|vitamin d|mesh-list
153881148|NCT05058976|Zoledronic Acid|zoledronic acid|mesh-list
153881149|NCT05058976|Calcium|calcium|mesh-list
153881150|NCT05058976|Vitamins|vitamins|mesh-ancestor
153881151|NCT05058976|Micronutrients|micronutrients|mesh-ancestor
153881152|NCT05058976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153881153|NCT05058976|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153881154|NCT05058976|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153881155|NCT05041647|Dronabinol|dronabinol|mesh-list
153422008|NCT05006794|Tubulin Modulators|tubulin modulators|mesh-ancestor
153422023|NCT04922333|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153422024|NCT04922333|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153422025|NCT04922333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153422026|NCT04922333|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153422027|NCT04922333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153422028|NCT04922333|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153422035|NCT04908189|Deucravacitinib|deucravacitinib|mesh-list
153422036|NCT04908189|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153422037|NCT04908189|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153422038|NCT04908189|Analgesics|analgesics|mesh-ancestor
153422039|NCT04908189|Sensory System Agents|sensory system agents|mesh-ancestor
153422040|NCT04908189|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153422041|NCT04908189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153422054|NCT04885894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153422056|NCT04885894|Immunologic Factors|immunologic factors|mesh-ancestor
153422057|NCT04885894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153881186|NCT04942860|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153881187|NCT04942860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153881188|NCT04942860|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153881190|NCT04942860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153881191|NCT04942860|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153881192|NCT04942860|Dermatologic Agents|dermatologic agents|mesh-ancestor
153881193|NCT04942860|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153881194|NCT04942860|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153881195|NCT04942860|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153881196|NCT04942860|Immunologic Factors|immunologic factors|mesh-ancestor
153881197|NCT04942860|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153422071|NCT04873596|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
153422072|NCT04873596|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153422073|NCT04873596|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153422074|NCT04873596|Adrenergic Agents|adrenergic agents|mesh-ancestor
153422075|NCT04873596|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153422076|NCT04873596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153422077|NCT04873596|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153422078|NCT04873596|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153422079|NCT04873596|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153422080|NCT04873596|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153422081|NCT04873596|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153422082|NCT04873596|Anesthetics, General|anesthetics, general|mesh-ancestor
153422083|NCT04873596|Anesthetics|anesthetics|mesh-ancestor
153422084|NCT04873596|GABA Modulators|gaba modulators|mesh-ancestor
153422085|NCT04873596|GABA Agents|gaba agents|mesh-ancestor
153881207|NCT04781673|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153881208|NCT04781673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153881209|NCT04781673|Sensory System Agents|sensory system agents|mesh-ancestor
153881210|NCT04781673|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153881220|NCT04781673|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
153881221|NCT04781673|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
153881222|NCT04781673|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153881236|NCT04620213|Adrenergic Agents|adrenergic agents|mesh-ancestor
153881237|NCT04620213|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153881238|NCT04620213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153881239|NCT04620213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153881240|NCT04620213|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153881241|NCT04608955|Bedaquiline|bedaquiline|mesh-list
153881242|NCT04608955|Antitubercular Agents|antitubercular agents|mesh-ancestor
153881244|NCT04608955|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153881245|NCT04546633|Lumefantrine|lumefantrine|mesh-list
153881246|NCT04546633|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
153881247|NCT04546633|Antimalarials|antimalarials|mesh-ancestor
153881248|NCT04546633|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153881249|NCT04546633|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153881250|NCT04546633|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153422107|NCT04824092|Immunologic Factors|immunologic factors|mesh-ancestor
153422109|NCT04824092|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153422110|NCT04824092|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153422111|NCT04824092|Alkylating Agents|alkylating agents|mesh-ancestor
153422112|NCT04824092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153422113|NCT04824092|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153422114|NCT04824092|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153422115|NCT04824092|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153422116|NCT04824092|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153422117|NCT04824092|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153422118|NCT04824092|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153422119|NCT04824092|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153422120|NCT04824092|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153422121|NCT04824092|Glucocorticoids|glucocorticoids|mesh-ancestor
153422123|NCT04824092|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153422124|NCT04824092|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153422130|NCT04824092|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153422131|NCT04824092|Growth Substances|growth substances|mesh-ancestor
153422132|NCT04824092|Growth Inhibitors|growth inhibitors|mesh-ancestor
153422133|NCT04813926|Riociguat|riociguat|mesh-list
153881306|NCT04459234|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
153422189|NCT04608409|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153422190|NCT04608409|Tubulin Modulators|tubulin modulators|mesh-ancestor
153422191|NCT04608409|Antimitotic Agents|antimitotic agents|mesh-ancestor
153422195|NCT04608409|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153422196|NCT04608409|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153422198|NCT04521803|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
153422199|NCT04521803|Antitubercular Agents|antitubercular agents|mesh-ancestor
153881324|NCT04311502|Isoniazid|isoniazid|mesh-list
153881325|NCT04311502|Pyrazinamide|pyrazinamide|mesh-list
153881326|NCT04311502|Ethambutol|ethambutol|mesh-list
153881327|NCT04311502|Vitamins|vitamins|mesh-ancestor
153881328|NCT04311502|Micronutrients|micronutrients|mesh-ancestor
153881329|NCT04311502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153881330|NCT04311502|Vitamin B Complex|vitamin b complex|mesh-ancestor
153881331|NCT04311502|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
153881332|NCT04311502|Antitubercular Agents|antitubercular agents|mesh-ancestor
153881333|NCT04311502|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153881334|NCT04311502|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153881335|NCT04311502|Leprostatic Agents|leprostatic agents|mesh-ancestor
153881336|NCT04311502|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153881337|NCT04311502|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153881338|NCT04311502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153881339|NCT04311502|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
153881340|NCT04311502|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
153881341|NCT04311502|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
153881342|NCT04311502|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
153422200|NCT04521803|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153422201|NCT04521803|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153422202|NCT04521803|Leprostatic Agents|leprostatic agents|mesh-ancestor
153422203|NCT04521803|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153422204|NCT04521803|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153422205|NCT04521803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153422206|NCT04521803|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
153422207|NCT04521803|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
153422208|NCT04521803|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
153422209|NCT04521803|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
153422210|NCT04521803|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
153422211|NCT04521803|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
153422222|NCT04499950|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
153422224|NCT04499950|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153422225|NCT04499950|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
153422226|NCT04499950|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153422227|NCT04499950|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153422228|NCT04499950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153422230|NCT04499950|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153422231|NCT04499950|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
153422232|NCT04499950|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153422233|NCT04499950|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153422234|NCT04499950|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
153422235|NCT04478279|Temozolomide|temozolomide|mesh-list
153422236|NCT04478279|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153422237|NCT04478279|Alkylating Agents|alkylating agents|mesh-ancestor
153422238|NCT04478279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153422239|NCT04478279|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153881357|NCT04283669|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153881358|NCT04283669|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153881359|NCT04283669|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153881360|NCT04283669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153881369|NCT04276883|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153881370|NCT04276883|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
153881371|NCT04276883|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153881372|NCT04276883|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153881373|NCT04276883|Adrenergic Agents|adrenergic agents|mesh-ancestor
153881374|NCT04276883|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153881375|NCT04276883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153881376|NCT04261790|Ocrelizumab|ocrelizumab|mesh-list
153881377|NCT04261790|Immunologic Factors|immunologic factors|mesh-ancestor
153881378|NCT04261790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153881379|NCT04238546|Sirolimus|sirolimus|mesh-list
153881380|NCT04238546|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153881381|NCT04238546|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153881382|NCT04238546|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153881383|NCT04238546|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153881384|NCT04238546|Antifungal Agents|antifungal agents|mesh-ancestor
153881390|NCT04212416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153881392|NCT04212416|Immunologic Factors|immunologic factors|mesh-ancestor
153881393|NCT04212416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153881394|NCT04187105|Cyclophosphamide|cyclophosphamide|mesh-list
153881395|NCT04187105|Fludarabine|fludarabine|mesh-list
153881396|NCT04187105|Tacrolimus|tacrolimus|mesh-list
153881397|NCT04187105|Complement Factor H|complement factor h|mesh-list
153881398|NCT04187105|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153881399|NCT04187105|Immunologic Factors|immunologic factors|mesh-ancestor
153881400|NCT04187105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153881401|NCT04187105|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153881402|NCT04187105|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153422259|NCT04295486|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153422260|NCT04295486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153422261|NCT04295486|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153422262|NCT04295486|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153422263|NCT04295486|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153422264|NCT04295486|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153422265|NCT04295486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153422266|NCT04295486|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153422267|NCT04295486|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153422268|NCT04295486|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153422269|NCT04295486|Antipyretics|antipyretics|mesh-ancestor
153422270|NCT04231565|Tenofovir|tenofovir|mesh-list
153422271|NCT04231565|Antiviral Agents|antiviral agents|mesh-ancestor
153422272|NCT04231565|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153422273|NCT04231565|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153422274|NCT04231565|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153422275|NCT04231565|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153422276|NCT04231565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153422277|NCT04231565|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153422278|NCT04231565|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153422279|NCT04187898|Cyclophosphamide|cyclophosphamide|mesh-list
153422280|NCT04187898|Docetaxel|docetaxel|mesh-list
153422281|NCT04187898|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153422282|NCT04187898|Immunologic Factors|immunologic factors|mesh-ancestor
153422283|NCT04187898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153422284|NCT04187898|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153422285|NCT04187898|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153422286|NCT04187898|Alkylating Agents|alkylating agents|mesh-ancestor
153422287|NCT04187898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153422288|NCT04187898|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153422289|NCT04187898|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153881404|NCT04187105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153881405|NCT04187105|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153881406|NCT04187105|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153881408|NCT04187105|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153881409|NCT04187105|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
153881410|NCT04099888|Gemcitabine|gemcitabine|mesh-list
153881423|NCT04081389|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
153881424|NCT04081389|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
153881426|NCT04081389|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153881427|NCT04081389|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153881429|NCT04081389|Antimitotic Agents|antimitotic agents|mesh-ancestor
153881430|NCT04081389|Mitosis Modulators|mitosis modulators|mesh-ancestor
153881431|NCT04081389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153881432|NCT04081389|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153881433|NCT04081389|Immunologic Factors|immunologic factors|mesh-ancestor
153881434|NCT04081389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153881435|NCT04081389|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153475877|NCT00845130|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153475878|NCT00845130|Protective Agents|protective agents|mesh-ancestor
153475879|NCT00848016|Acetic Acid|acetic acid|mesh-list
153475889|NCT00848016|Protective Agents|protective agents|mesh-ancestor
153475890|NCT00848016|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153475891|NCT00848016|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
153475892|NCT00848016|Contraceptive Agents|contraceptive agents|mesh-ancestor
153475893|NCT00848016|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153475894|NCT00848016|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153475895|NCT00848016|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
153475939|NCT00868140|Pioglitazone|pioglitazone|mesh-list
153476107|NCT00887640|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153477086|NCT01024686|Vaccines|vaccines|mesh-list
153477914|NCT03278691|Ketorolac|ketorolac|mesh-list
153881436|NCT04081389|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153422290|NCT04187898|Tubulin Modulators|tubulin modulators|mesh-ancestor
153422291|NCT04187898|Antimitotic Agents|antimitotic agents|mesh-ancestor
153481491|NCT03333616|Nivolumab|nivolumab|mesh-list
153422292|NCT04187898|Mitosis Modulators|mitosis modulators|mesh-ancestor
153422293|NCT04128956|Aspirin|aspirin|mesh-list
153483263|NCT04437485|Serotonin|serotonin|mesh-list
153484078|NCT03729258|Antiviral Agents|antiviral agents|mesh-ancestor
153484513|NCT01668030|Bacitracin|bacitracin|mesh-list
153486280|NCT02492867|Carboplatin|carboplatin|mesh-list
153488133|NCT02135094|Oxymetazoline|oxymetazoline|mesh-list
153488638|NCT02283840|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
153488682|NCT02285634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153488683|NCT02285634|Sensory System Agents|sensory system agents|mesh-ancestor
153488684|NCT02285634|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153488685|NCT02285634|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153488686|NCT02285634|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
153488687|NCT02285634|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153422294|NCT04128956|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153422295|NCT04128956|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153422296|NCT04128956|Analgesics|analgesics|mesh-ancestor
153422298|NCT04128956|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153422299|NCT04128956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153422300|NCT04128956|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153422301|NCT04128956|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153422302|NCT04128956|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153422303|NCT04128956|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153422304|NCT04128956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153422305|NCT04128956|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153422306|NCT04128956|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153422307|NCT04128956|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153422309|NCT04117087|Nivolumab|nivolumab|mesh-list
153422310|NCT04117087|Ipilimumab|ipilimumab|mesh-list
153422311|NCT04117087|Poly ICLC|poly iclc|mesh-list
153422312|NCT04117087|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153881456|NCT04032080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153881457|NCT04022005|Rituximab|rituximab|mesh-list
153422314|NCT04117087|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153422315|NCT04117087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153422316|NCT04117087|Interferon Inducers|interferon inducers|mesh-ancestor
153422317|NCT04117087|Immunologic Factors|immunologic factors|mesh-ancestor
153422318|NCT04117087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153422319|NCT04101357|Carboplatin|carboplatin|mesh-list
153422320|NCT04101357|Etoposide|etoposide|mesh-list
153422321|NCT04101357|Atezolizumab|atezolizumab|mesh-list
153422322|NCT04101357|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153422323|NCT04101357|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153422324|NCT04101357|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153422325|NCT04101357|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153422326|NCT04101357|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153422327|NCT04101357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153422328|NCT04101357|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153422329|NCT04101357|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153881483|NCT03970720|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
153881484|NCT03970720|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
153881485|NCT03970720|Dopamine Agents|dopamine agents|mesh-ancestor
153881486|NCT03970720|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153881487|NCT03970720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153422346|NCT04047862|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153422347|NCT04047862|Tubulin Modulators|tubulin modulators|mesh-ancestor
153422348|NCT04047862|Antimitotic Agents|antimitotic agents|mesh-ancestor
153422349|NCT04047862|Mitosis Modulators|mitosis modulators|mesh-ancestor
153422350|NCT04047862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153422351|NCT04047862|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153422352|NCT04047862|Antimetabolites|antimetabolites|mesh-ancestor
153422353|NCT04047862|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153422354|NCT04047862|Immunologic Factors|immunologic factors|mesh-ancestor
153422355|NCT04047862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153422356|NCT04047862|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153422357|NCT04047862|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153422358|NCT04047862|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153422359|NCT04047862|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153422360|NCT04047862|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153422361|NCT04047862|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153422362|NCT04008030|Leucovorin|leucovorin|mesh-list
153422363|NCT04008030|Bevacizumab|bevacizumab|mesh-list
153422365|NCT04008030|Cetuximab|cetuximab|mesh-list
153422366|NCT04008030|Ipilimumab|ipilimumab|mesh-list
153422367|NCT04008030|Fluorouracil|fluorouracil|mesh-list
153422368|NCT04008030|Oxaliplatin|oxaliplatin|mesh-list
153422369|NCT04008030|Irinotecan|irinotecan|mesh-list
153422370|NCT04008030|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153422371|NCT04008030|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153422372|NCT04008030|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153422373|NCT04008030|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153422374|NCT04008030|Growth Substances|growth substances|mesh-ancestor
153422375|NCT04008030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153422376|NCT04008030|Growth Inhibitors|growth inhibitors|mesh-ancestor
153422377|NCT04008030|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153422378|NCT04008030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153422379|NCT04008030|Antimetabolites|antimetabolites|mesh-ancestor
153881488|NCT03943498|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
153881489|NCT03943498|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
153881490|NCT03943498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153881491|NCT03943498|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153881492|NCT03943498|Immunologic Factors|immunologic factors|mesh-ancestor
153881493|NCT03943498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153422380|NCT04008030|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153422382|NCT04008030|Immunologic Factors|immunologic factors|mesh-ancestor
153881494|NCT03912818|Carboplatin|carboplatin|mesh-list
153881495|NCT03912818|Gemcitabine|gemcitabine|mesh-list
153881506|NCT03912818|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153881507|NCT03912818|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153881508|NCT03912818|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153881509|NCT03912818|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153881510|NCT03912818|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
153881511|NCT03912818|Abortifacient Agents|abortifacient agents|mesh-ancestor
153881512|NCT03912818|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153881513|NCT03912818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153881514|NCT03912818|Dermatologic Agents|dermatologic agents|mesh-ancestor
153881515|NCT03912818|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153881516|NCT03912818|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153881517|NCT03912818|Immunologic Factors|immunologic factors|mesh-ancestor
153881518|NCT03912818|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153881519|NCT03912818|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153881520|NCT03912818|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153881521|NCT03912818|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153881522|NCT03912818|Tubulin Modulators|tubulin modulators|mesh-ancestor
153881523|NCT03912818|Antimitotic Agents|antimitotic agents|mesh-ancestor
153881524|NCT03912818|Mitosis Modulators|mitosis modulators|mesh-ancestor
153881525|NCT03781934|Pembrolizumab|pembrolizumab|mesh-list
153881526|NCT03781934|Lenvatinib|lenvatinib|mesh-list
153422387|NCT04008030|Protective Agents|protective agents|mesh-ancestor
153422388|NCT04008030|Vitamin B Complex|vitamin b complex|mesh-ancestor
153422390|NCT04008030|Micronutrients|micronutrients|mesh-ancestor
153422391|NCT03976518|Atezolizumab|atezolizumab|mesh-list
153422392|NCT03976518|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153422393|NCT03976518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153422394|NCT03976518|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153422395|NCT03976518|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153422396|NCT03954067|Pembrolizumab|pembrolizumab|mesh-list
153422397|NCT03954067|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153422398|NCT03954067|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153422400|NCT03954067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153422401|NCT03884439|Infliximab|infliximab|mesh-list
153422402|NCT03884439|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
153422403|NCT03884439|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153422404|NCT03884439|Dermatologic Agents|dermatologic agents|mesh-ancestor
153422405|NCT03884439|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153881537|NCT03729362|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153881538|NCT03729362|Antiviral Agents|antiviral agents|mesh-ancestor
153881539|NCT03729362|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153881540|NCT03729362|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
153881541|NCT03729362|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153881542|NCT03729362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153881543|NCT03630211|Cyclophosphamide|cyclophosphamide|mesh-list
153881544|NCT03630211|Thiotepa|thiotepa|mesh-list
153881545|NCT03630211|Rituximab|rituximab|mesh-list
153422406|NCT03884439|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153422407|NCT03874936|Dexamethasone|dexamethasone|mesh-list
153422408|NCT03874936|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
153422409|NCT03874936|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153422410|NCT03874936|Antiemetics|antiemetics|mesh-ancestor
153422411|NCT03874936|Autonomic Agents|autonomic agents|mesh-ancestor
153422412|NCT03874936|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153422413|NCT03874936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153422414|NCT03874936|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153422415|NCT03874936|Glucocorticoids|glucocorticoids|mesh-ancestor
153422416|NCT03874936|Hormones|hormones|mesh-ancestor
153422417|NCT03874936|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153422418|NCT03874936|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153422419|NCT03874936|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153422420|NCT03874858|Nilotinib|nilotinib|mesh-list
153422421|NCT03874858|Asciminib|asciminib|mesh-list
153422422|NCT03874858|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153422423|NCT03874858|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153422424|NCT03874858|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153422425|NCT03874858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153422426|NCT03844061|Mycophenolic Acid|mycophenolic acid|mesh-list
153422427|NCT03844061|Rituximab|rituximab|mesh-list
153422428|NCT03844061|Belimumab|belimumab|mesh-list
153422429|NCT03844061|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153422430|NCT03844061|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153422431|NCT03844061|Immunologic Factors|immunologic factors|mesh-ancestor
153422432|NCT03844061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153422436|NCT03844061|Antitubercular Agents|antitubercular agents|mesh-ancestor
153422437|NCT03844061|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153422438|NCT03844061|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153422440|NCT03844061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153881547|NCT03630211|Thymoglobulin|thymoglobulin|mesh-list
153881548|NCT03630211|Antilymphocyte Serum|antilymphocyte serum|mesh-list
153881549|NCT03630211|Immunoglobulins|immunoglobulins|mesh-list
153881550|NCT03630211|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
153881551|NCT03630211|gamma-Globulins|gamma-globulins|mesh-list
153881552|NCT03630211|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
153881553|NCT03630211|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153881554|NCT03630211|Immunologic Factors|immunologic factors|mesh-ancestor
153881555|NCT03630211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153881556|NCT03630211|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153881557|NCT03630211|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153881558|NCT03630211|Alkylating Agents|alkylating agents|mesh-ancestor
153881559|NCT03630211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153881560|NCT03630211|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153881561|NCT03630211|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153881562|NCT03630211|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153881564|NCT03587961|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
153881565|NCT03587961|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153881566|NCT03587961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153881567|NCT03534453|Olaparib|olaparib|mesh-list
153881568|NCT03534453|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
153881569|NCT03534453|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153881570|NCT03534453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153881571|NCT03534453|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153881572|NCT03426293|Heparin|heparin|mesh-list
153881573|NCT03426293|Anticoagulants|anticoagulants|mesh-ancestor
153881574|NCT03426293|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153881575|NCT03426293|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153881576|NCT03426293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153881577|NCT03387423|Tofacitinib|tofacitinib|mesh-list
153881578|NCT03387423|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
153881579|NCT03387423|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153422441|NCT03844061|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153422442|NCT03829410|Bevacizumab|bevacizumab|mesh-list
153422443|NCT03829410|Onvansertib|onvansertib|mesh-list
153422444|NCT03829410|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153422445|NCT03829410|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153881614|NCT03190265|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153881615|NCT03190265|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153422496|NCT03594747|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
153422497|NCT03594747|Carboplatin|carboplatin|mesh-list
153422498|NCT03594747|Tislelizumab|tislelizumab|mesh-list
153422499|NCT03594747|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153422500|NCT03594747|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153422501|NCT03594747|Tubulin Modulators|tubulin modulators|mesh-ancestor
153422502|NCT03594747|Antimitotic Agents|antimitotic agents|mesh-ancestor
153422503|NCT03594747|Mitosis Modulators|mitosis modulators|mesh-ancestor
153422504|NCT03594747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153422505|NCT03594747|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153422506|NCT03500328|Interferons|interferons|mesh-list
153422507|NCT03500328|Teriflunomide|teriflunomide|mesh-list
153422508|NCT03500328|Rituximab|rituximab|mesh-list
153422509|NCT03500328|Alemtuzumab|alemtuzumab|mesh-list
153422510|NCT03500328|Ofatumumab|ofatumumab|mesh-list
153422511|NCT03500328|Cladribine|cladribine|mesh-list
153881625|NCT02615691|Coagulants|coagulants|mesh-ancestor
153881626|NCT02429570|Meclofenamic Acid|meclofenamic acid|mesh-list
153881628|NCT02429570|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153881629|NCT02429570|Analgesics|analgesics|mesh-ancestor
153881630|NCT02429570|Sensory System Agents|sensory system agents|mesh-ancestor
153881631|NCT02429570|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153881632|NCT02429570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153881634|NCT02429570|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153881635|NCT02429570|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153881636|NCT02429570|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153881637|NCT02429570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153881638|NCT01977417|Salicylsalicylic acid|salicylsalicylic acid|mesh-list
153881655|NCT01969578|Antimitotic Agents|antimitotic agents|mesh-ancestor
153422557|NCT03412877|Immunologic Factors|immunologic factors|mesh-ancestor
153422558|NCT03412877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153422559|NCT03412877|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153422560|NCT03412877|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153422561|NCT03412877|Alkylating Agents|alkylating agents|mesh-ancestor
153422562|NCT03412877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153422566|NCT03412877|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153422567|NCT03412877|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153422568|NCT03412877|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153422569|NCT03412877|Antiviral Agents|antiviral agents|mesh-ancestor
153422570|NCT03412877|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153422573|NCT03273023|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
153422574|NCT03273023|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153422575|NCT03273023|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153422576|NCT03273023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153422577|NCT03273023|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153422578|NCT03273023|Immunologic Factors|immunologic factors|mesh-ancestor
153422579|NCT03273023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153422580|NCT03273023|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153422581|NCT03273023|Trace Elements|trace elements|mesh-ancestor
153422587|NCT03237741|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153422588|NCT03237741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153881717|NCT01810588|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
153881718|NCT01810588|Antitubercular Agents|antitubercular agents|mesh-ancestor
153881719|NCT01810588|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153881720|NCT01810588|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153881721|NCT01810588|Alkylating Agents|alkylating agents|mesh-ancestor
153881725|NCT01499888|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153881726|NCT01499888|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153881727|NCT01499888|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153881728|NCT01499888|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153881729|NCT01499888|Antifungal Agents|antifungal agents|mesh-ancestor
153881730|NCT01499888|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153881731|NCT01499888|Immunologic Factors|immunologic factors|mesh-ancestor
153881732|NCT01499888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153881733|NCT01499888|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153881734|NCT00745316|Adenosine|adenosine|mesh-list
153881735|NCT00745316|Adenosine A1 Receptor Antagonists|adenosine a1 receptor antagonists|mesh-list
153881736|NCT00745316|Analgesics|analgesics|mesh-ancestor
153881737|NCT00745316|Sensory System Agents|sensory system agents|mesh-ancestor
153881738|NCT00745316|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153881739|NCT00745316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153881740|NCT00745316|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153881741|NCT00745316|Vasodilator Agents|vasodilator agents|mesh-ancestor
153881742|NCT00745316|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
153881743|NCT00745316|Purinergic Agonists|purinergic agonists|mesh-ancestor
153881744|NCT00745316|Purinergic Agents|purinergic agents|mesh-ancestor
153881745|NCT00745316|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153422655|NCT03040973|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153422656|NCT03040973|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153422657|NCT03040973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153422671|NCT02818660|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153422673|NCT02693808|Hyaluronic Acid|hyaluronic acid|mesh-list
153422674|NCT02693808|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153422675|NCT02693808|Immunologic Factors|immunologic factors|mesh-ancestor
153422676|NCT02693808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153422680|NCT02470780|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153422681|NCT02470780|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153881804|NCT01601184|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153881805|NCT01601184|Alkylating Agents|alkylating agents|mesh-ancestor
153881806|NCT01601184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153881807|NCT01601184|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153881809|NCT01643759|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153881810|NCT01643759|Narcotics|narcotics|mesh-ancestor
153422682|NCT02470780|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153422683|NCT02455557|Temozolomide|temozolomide|mesh-list
153422684|NCT02455557|Sargramostim|sargramostim|mesh-list
153422685|NCT02455557|Monatide (IMS 3015)|monatide (ims 3015)|mesh-list
153422686|NCT02455557|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153422687|NCT02455557|Alkylating Agents|alkylating agents|mesh-ancestor
153422688|NCT02455557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153422689|NCT02455557|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153422690|NCT02455557|Immunologic Factors|immunologic factors|mesh-ancestor
153422691|NCT02455557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153422692|NCT02455557|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153422693|NCT02404870|Canagliflozin|canagliflozin|mesh-list
153422696|NCT02404870|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153422697|NCT02404870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153422698|NCT02185560|Sorafenib|sorafenib|mesh-list
153422699|NCT02185560|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153422700|NCT02185560|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153422701|NCT02185560|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153422702|NCT02185560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153881827|NCT04528628|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153881828|NCT04528628|Adrenergic Agents|adrenergic agents|mesh-ancestor
153881829|NCT04528628|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153881830|NCT04528628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153422703|NCT02142803|Bevacizumab|bevacizumab|mesh-list
153422704|NCT02142803|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
153422705|NCT02142803|Endothelial Growth Factors|endothelial growth factors|mesh-list
153422706|NCT02142803|Antibodies|antibodies|mesh-list
153422707|NCT02142803|Immunoglobulins|immunoglobulins|mesh-list
153422708|NCT02142803|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
153422709|NCT02142803|Immunoglobulin G|immunoglobulin g|mesh-list
153422710|NCT02142803|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153422711|NCT02142803|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153422712|NCT02142803|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153422713|NCT02142803|Growth Substances|growth substances|mesh-ancestor
153422714|NCT02142803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153422715|NCT02142803|Growth Inhibitors|growth inhibitors|mesh-ancestor
153422716|NCT02142803|Immunologic Factors|immunologic factors|mesh-ancestor
153422717|NCT01897480|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
153422718|NCT01897480|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153422719|NCT01897480|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153422720|NCT01897480|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153422721|NCT01897480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153422722|NCT01897480|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153422723|NCT01840189|Hydrocortisone|hydrocortisone|mesh-list
153422724|NCT01840189|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
153422725|NCT01840189|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
153422726|NCT01840189|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
153881881|NCT01601730|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153422754|NCT01445509|Bevacizumab|bevacizumab|mesh-list
153422755|NCT01445509|Dasatinib|dasatinib|mesh-list
153422756|NCT01445509|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153422757|NCT01445509|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153422758|NCT01445509|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153422759|NCT01445509|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153422760|NCT01445509|Growth Substances|growth substances|mesh-ancestor
153422761|NCT01445509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153422762|NCT01445509|Growth Inhibitors|growth inhibitors|mesh-ancestor
153422763|NCT01445509|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153422764|NCT01445509|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153422765|NCT01445509|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153422766|NCT01445509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153422767|NCT01065454|Riociguat|riociguat|mesh-list
153422768|NCT01065454|Enzyme Activators|enzyme activators|mesh-ancestor
153422769|NCT01065454|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153422770|NCT00445627|Metformin|metformin|mesh-list
153422771|NCT00445627|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153422800|NCT03261193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153422801|NCT03261193|Sensory System Agents|sensory system agents|mesh-ancestor
153422812|NCT00375661|Immunologic Factors|immunologic factors|mesh-ancestor
153422813|NCT00375661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153422814|NCT04736186|Loperamide|loperamide|mesh-list
153422815|NCT04736186|Antidiarrheals|antidiarrheals|mesh-list
153422816|NCT04736186|Bentonite|bentonite|mesh-list
153422817|NCT04736186|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153422818|NCT04736186|Antidotes|antidotes|mesh-ancestor
153422819|NCT04736186|Protective Agents|protective agents|mesh-ancestor
153422820|NCT04736186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153422846|NCT02221674|Sensory System Agents|sensory system agents|mesh-ancestor
153422847|NCT02221674|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153422848|NCT02221674|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
153422849|NCT02221674|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153881956|NCT01602588|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153881957|NCT01602588|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153422873|NCT04736108|Prednisolone|prednisolone|mesh-list
153422874|NCT04736108|Goserelin|goserelin|mesh-list
153422875|NCT04736108|Abiraterone Acetate|abiraterone acetate|mesh-list
153422876|NCT04736108|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153422877|NCT04736108|Glucocorticoids|glucocorticoids|mesh-ancestor
153422878|NCT04736108|Hormones|hormones|mesh-ancestor
153422879|NCT04736108|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153422880|NCT04736108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153422881|NCT04736108|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153422882|NCT04736108|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153422885|NCT04736108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153422886|NCT04736108|Hormone Antagonists|hormone antagonists|mesh-ancestor
153422887|NCT04736108|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153422889|NCT02971033|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153422890|NCT02971033|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153422891|NCT02971033|Antimetabolites|antimetabolites|mesh-ancestor
153422892|NCT02971033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153422893|NCT02971033|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153422895|NCT05406674|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153422896|NCT05341375|Anesthetics|anesthetics|mesh-list
153422897|NCT05341375|Esketamine|esketamine|mesh-list
153422898|NCT05341375|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153422899|NCT05341375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153422900|NCT05341375|Antidepressive Agents|antidepressive agents|mesh-ancestor
153422901|NCT05341375|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153422902|NCT03200587|Avelumab|avelumab|mesh-list
153422903|NCT03200587|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153422904|NCT03200587|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153422905|NCT03198884|Dolutegravir|dolutegravir|mesh-list
153422906|NCT03198884|Darunavir|darunavir|mesh-list
153422907|NCT03198884|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
153882025|NCT01600404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153882026|NCT01600404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153422909|NCT03198884|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153422910|NCT03198884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153422911|NCT03198884|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153422912|NCT03198884|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153422913|NCT03198884|Antiviral Agents|antiviral agents|mesh-ancestor
153422914|NCT03198884|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153422915|NCT03198884|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
153422916|NCT03198884|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
153422917|NCT03198884|Protease Inhibitors|protease inhibitors|mesh-ancestor
153422918|NCT01801189|Pregabalin|pregabalin|mesh-list
153422919|NCT01801189|Analgesics|analgesics|mesh-ancestor
153422920|NCT01801189|Sensory System Agents|sensory system agents|mesh-ancestor
153422921|NCT01801189|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153422922|NCT01801189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153422923|NCT01801189|Anticonvulsants|anticonvulsants|mesh-ancestor
153422924|NCT01801189|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153422925|NCT01801189|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153422926|NCT01801189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153422938|NCT04275362|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153422973|NCT03202550|Narcotics|narcotics|mesh-ancestor
153422974|NCT03202550|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153422975|NCT03202550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153422976|NCT03202550|Analgesics|analgesics|mesh-ancestor
153422977|NCT03202550|Sensory System Agents|sensory system agents|mesh-ancestor
153422978|NCT03202550|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153422979|NCT03202550|Anticonvulsants|anticonvulsants|mesh-ancestor
153422980|NCT03202550|Antiemetics|antiemetics|mesh-ancestor
153422981|NCT03202550|Autonomic Agents|autonomic agents|mesh-ancestor
153882078|NCT02484924|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153882079|NCT02484924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153882080|NCT02484924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153882081|NCT01645826|Diltiazem|diltiazem|mesh-list
153882082|NCT01645826|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153882083|NCT01645826|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153882084|NCT01645826|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153882085|NCT01645826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153882086|NCT01645826|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153882087|NCT01645826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153882089|NCT01607034|Pramipexole|pramipexole|mesh-list
153882090|NCT01607034|Dexpramipexole|dexpramipexole|mesh-list
153882091|NCT01607034|Antioxidants|antioxidants|mesh-ancestor
153882092|NCT01607034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153882103|NCT01603251|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
153882104|NCT01603251|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153882149|NCT01681979|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
153882150|NCT01681979|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153882151|NCT01681979|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153882152|NCT01681979|Autonomic Agents|autonomic agents|mesh-ancestor
153882153|NCT01681979|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153882154|NCT01681979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153423035|NCT02076217|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153423037|NCT02076217|Hormones|hormones|mesh-ancestor
153423038|NCT02076217|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153423039|NCT03291080|Tretinoin|tretinoin|mesh-list
153423040|NCT03291080|Isotretinoin|isotretinoin|mesh-list
153423041|NCT03291080|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153423042|NCT03291080|Keratolytic Agents|keratolytic agents|mesh-ancestor
153423043|NCT03291080|Dermatologic Agents|dermatologic agents|mesh-ancestor
153423044|NCT04874545|Propofol|propofol|mesh-list
153423045|NCT04874545|Sevoflurane|sevoflurane|mesh-list
153423046|NCT04874545|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153423047|NCT04874545|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153423048|NCT04874545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153423049|NCT04874545|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153423050|NCT04874545|Anesthetics, General|anesthetics, general|mesh-ancestor
153423051|NCT04874545|Anesthetics|anesthetics|mesh-ancestor
153423052|NCT04874545|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153423053|NCT04874545|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
153423054|NCT03181009|Omalizumab|omalizumab|mesh-list
153423055|NCT03181009|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
153423056|NCT03181009|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153423057|NCT03181009|Respiratory System Agents|respiratory system agents|mesh-ancestor
153423059|NCT03296072|Fluorides|fluorides|mesh-list
153423060|NCT03296072|Sodium Fluoride|sodium fluoride|mesh-list
153423061|NCT03296072|Tin Fluorides|tin fluorides|mesh-list
153423062|NCT03296072|Cariostatic Agents|cariostatic agents|mesh-ancestor
153423063|NCT03296072|Protective Agents|protective agents|mesh-ancestor
153423064|NCT03296072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153423065|NCT03296072|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
153423066|NCT03296072|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153423067|NCT03185065|Amantadine|amantadine|mesh-list
153423068|NCT03185065|Methylphenidate|methylphenidate|mesh-list
153423069|NCT03185065|Modafinil|modafinil|mesh-list
153423070|NCT03185065|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
153882155|NCT01681979|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153882156|NCT01681979|Respiratory System Agents|respiratory system agents|mesh-ancestor
153882158|NCT01681979|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
153882159|NCT01681979|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
153882160|NCT01681979|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
153882161|NCT01681979|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153882162|NCT01681979|Adrenergic Agents|adrenergic agents|mesh-ancestor
153882163|NCT01681979|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153882164|NCT01681979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153882185|NCT01607580|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
153423071|NCT03185065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153423072|NCT03185065|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
153423073|NCT03185065|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153423074|NCT03185065|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153423075|NCT03185065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153423076|NCT03185065|Dopamine Agents|dopamine agents|mesh-ancestor
153423077|NCT03185065|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153423078|NCT03185065|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
153423079|NCT03185065|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
153423080|NCT03185065|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
153423081|NCT03185065|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
153423084|NCT03185065|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153423085|NCT03185065|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153423087|NCT03185065|Sensory System Agents|sensory system agents|mesh-ancestor
153423088|NCT03185065|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153423089|NCT02159040|Azacitidine|azacitidine|mesh-list
153423090|NCT02159040|Deferasirox|deferasirox|mesh-list
153423091|NCT02159040|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153423092|NCT02159040|Antimetabolites|antimetabolites|mesh-ancestor
153423093|NCT02159040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153882187|NCT01607580|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153882199|NCT01604187|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153882200|NCT01604187|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153882202|NCT01604187|Anesthetics|anesthetics|mesh-ancestor
153882203|NCT01604382|Remifentanil|remifentanil|mesh-list
153882204|NCT01604382|Bupivacaine|bupivacaine|mesh-list
153882205|NCT01604382|Anesthetics|anesthetics|mesh-list
153882206|NCT01604382|Propofol|propofol|mesh-list
153882207|NCT01604382|Anesthetics, Local|anesthetics, local|mesh-ancestor
153882208|NCT01604382|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153882209|NCT01604382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153882210|NCT01604382|Sensory System Agents|sensory system agents|mesh-ancestor
153423094|NCT02159040|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153423095|NCT02159040|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153423096|NCT02159040|Iron Chelating Agents|iron chelating agents|mesh-ancestor
153423097|NCT02159040|Chelating Agents|chelating agents|mesh-ancestor
153423098|NCT02159040|Sequestering Agents|sequestering agents|mesh-ancestor
153423099|NCT03189589|Nemiralisib|nemiralisib|mesh-list
153423100|NCT03189589|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153423101|NCT03189589|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153423102|NCT03189589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153423103|NCT03216902|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
153423104|NCT03216902|Latanoprost|latanoprost|mesh-list
153423105|NCT03216902|Ophthalmic Solutions|ophthalmic solutions|mesh-list
153423107|NCT03190213|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153423109|NCT03190213|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153423110|NCT03190213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153423111|NCT01632150|Thalidomide|thalidomide|mesh-list
153423112|NCT01632150|Dexamethasone|dexamethasone|mesh-list
153423113|NCT01632150|Dexamethasone acetate|dexamethasone acetate|mesh-list
153423114|NCT01632150|Cyclophosphamide|cyclophosphamide|mesh-list
153423115|NCT01632150|Elotuzumab|elotuzumab|mesh-list
153423116|NCT01632150|BB 1101|bb 1101|mesh-list
153423117|NCT01632150|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153423118|NCT01632150|Immunologic Factors|immunologic factors|mesh-ancestor
153423119|NCT01632150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153423120|NCT01632150|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153882227|NCT01682408|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
153882228|NCT01682408|Histamine Antagonists|histamine antagonists|mesh-ancestor
153882229|NCT01682408|Histamine Agents|histamine agents|mesh-ancestor
153882230|NCT01682408|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153882231|NCT01682408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153882232|NCT01607970|Oxytocin|oxytocin|mesh-list
153882234|NCT01607970|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153882235|NCT01607970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153882237|NCT01608009|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153423121|NCT01632150|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153423122|NCT01632150|Alkylating Agents|alkylating agents|mesh-ancestor
153423123|NCT01632150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153423124|NCT01632150|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153423125|NCT01632150|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153423126|NCT01632150|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153423127|NCT01632150|Antiemetics|antiemetics|mesh-ancestor
153423128|NCT01632150|Autonomic Agents|autonomic agents|mesh-ancestor
153423130|NCT01632150|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153423131|NCT01632150|Glucocorticoids|glucocorticoids|mesh-ancestor
153423132|NCT01632150|Hormones|hormones|mesh-ancestor
153423133|NCT01632150|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153423134|NCT01632150|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153423135|NCT01632150|Protease Inhibitors|protease inhibitors|mesh-ancestor
153423136|NCT01632150|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153423137|NCT01632150|Leprostatic Agents|leprostatic agents|mesh-ancestor
153423138|NCT01632150|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153423139|NCT01632150|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153423140|NCT01632150|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153423141|NCT01632150|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153423142|NCT01632150|Growth Substances|growth substances|mesh-ancestor
153882258|NCT01682564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153423144|NCT02185014|Adalimumab|adalimumab|mesh-list
153423145|NCT02185014|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
153423146|NCT02185014|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153423147|NCT02185014|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153423148|NCT03297944|Zolpidem|zolpidem|mesh-list
153423149|NCT03297944|Alprazolam|alprazolam|mesh-list
153423150|NCT03297944|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
153423151|NCT03297944|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153423152|NCT03297944|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153423153|NCT03297944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153423155|NCT03297944|GABA Agonists|gaba agonists|mesh-ancestor
153423156|NCT03297944|GABA Agents|gaba agents|mesh-ancestor
153423157|NCT03297944|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153423158|NCT03297944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153423159|NCT03297944|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153423160|NCT03297944|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153423161|NCT03297944|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153423162|NCT03297944|GABA Modulators|gaba modulators|mesh-ancestor
153423163|NCT04333004|Pembrolizumab|pembrolizumab|mesh-list
153423164|NCT04333004|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153423165|NCT04333004|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153423170|NCT03219866|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
153423171|NCT03219866|Ipratropium|ipratropium|mesh-list
153423172|NCT03219866|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153423173|NCT03219866|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153423174|NCT03219866|Autonomic Agents|autonomic agents|mesh-ancestor
153423175|NCT03219866|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153423176|NCT03219866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153423177|NCT03219866|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153423178|NCT03219866|Respiratory System Agents|respiratory system agents|mesh-ancestor
153423179|NCT03219866|Glucocorticoids|glucocorticoids|mesh-ancestor
153423180|NCT03219866|Hormones|hormones|mesh-ancestor
153423228|NCT03198871|Sensory System Agents|sensory system agents|mesh-ancestor
153423229|NCT03198871|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153423230|NCT03198871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153423231|NCT03198871|Antipyretics|antipyretics|mesh-ancestor
153423233|NCT02157948|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153423234|NCT02157948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153882322|NCT01647893|Protease Inhibitors|protease inhibitors|mesh-ancestor
153882323|NCT01647893|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153882324|NCT01647893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153882325|NCT01647893|Anticoagulants|anticoagulants|mesh-ancestor
153882327|NCT01648010|Mitomycin|mitomycin|mesh-list
153882328|NCT01648010|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153882329|NCT01648010|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153882330|NCT01648010|Alkylating Agents|alkylating agents|mesh-ancestor
153423244|NCT03220958|Sensory System Agents|sensory system agents|mesh-ancestor
153423245|NCT03220958|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153423247|NCT03220958|Autonomic Agents|autonomic agents|mesh-ancestor
153423248|NCT03220958|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153423249|NCT03220958|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
153423250|NCT03220958|Histamine Antagonists|histamine antagonists|mesh-ancestor
153423251|NCT03220958|Histamine Agents|histamine agents|mesh-ancestor
153423253|NCT03220958|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153423255|NCT03220958|Antipruritics|antipruritics|mesh-ancestor
153423256|NCT03220958|Dermatologic Agents|dermatologic agents|mesh-ancestor
153423257|NCT03220958|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
153423258|NCT03220958|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
153423260|NCT02182830|Empagliflozin|empagliflozin|mesh-list
153423261|NCT02182830|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
153423262|NCT02182830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153423263|NCT02182830|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153423264|NCT02182830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153423266|NCT03424681|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
153423267|NCT03424681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153423268|NCT03424681|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
153423269|NCT03424681|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
153423270|NCT03424681|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
153423271|NCT03424681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153423273|NCT03303794|Anesthetics, Local|anesthetics, local|mesh-ancestor
153423275|NCT03303794|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153423276|NCT03303794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153423277|NCT03303794|Sensory System Agents|sensory system agents|mesh-ancestor
153423278|NCT03303794|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153423279|NCT03305822|Insulin Lispro|insulin lispro|mesh-list
153882369|NCT04528277|Leprostatic Agents|leprostatic agents|mesh-ancestor
153882371|NCT01683656|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153882372|NCT01683656|Antimetabolites|antimetabolites|mesh-ancestor
153882373|NCT01683656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153882374|NCT01683656|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153882375|NCT01683656|Vasodilator Agents|vasodilator agents|mesh-ancestor
153882376|NCT01683656|Vitamin B Complex|vitamin b complex|mesh-ancestor
153882377|NCT01683656|Vitamins|vitamins|mesh-ancestor
153882378|NCT01683656|Micronutrients|micronutrients|mesh-ancestor
153882379|NCT01683656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153882380|NCT01605864|Ceftaroline|ceftaroline|mesh-list
153882381|NCT01605864|Beta Lactam Antibiotics|beta lactam antibiotics|mesh-ancestor
153882382|NCT01605864|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153882383|NCT01605864|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153882385|NCT01608945|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
153882386|NCT01608945|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
153882387|NCT01608945|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
153882388|NCT01608945|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153882389|NCT01608984|Sufentanil|sufentanil|mesh-list
153882390|NCT01608984|Isoflurane|isoflurane|mesh-list
153882391|NCT01608984|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153882392|NCT01608984|Narcotics|narcotics|mesh-ancestor
153882393|NCT01608984|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153882394|NCT01608984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153882395|NCT01608984|Analgesics|analgesics|mesh-ancestor
153882396|NCT01608984|Sensory System Agents|sensory system agents|mesh-ancestor
153423284|NCT03435614|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153423285|NCT03435614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153423286|NCT03435614|Sensory System Agents|sensory system agents|mesh-ancestor
153423287|NCT03435614|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153423288|NCT03437564|Vortioxetine|vortioxetine|mesh-list
153423289|NCT03437564|Antidepressive Agents|antidepressive agents|mesh-ancestor
153423290|NCT03437564|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153423291|NCT03437564|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153423292|NCT03437564|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153423293|NCT03437564|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153423294|NCT03437564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153423295|NCT03437564|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
153423296|NCT03437564|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153423297|NCT03437564|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153423298|NCT03437564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153423299|NCT03437564|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153423300|NCT03437564|Serotonin Agents|serotonin agents|mesh-ancestor
153882401|NCT01608984|Anesthetics|anesthetics|mesh-ancestor
153882402|NCT01608984|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
153882403|NCT01648517|Carboplatin|carboplatin|mesh-list
153882404|NCT01648517|Gemcitabine|gemcitabine|mesh-list
153882405|NCT01648517|Docetaxel|docetaxel|mesh-list
153882406|NCT01648517|Vinorelbine|vinorelbine|mesh-list
153882407|NCT01648517|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153882408|NCT01648517|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153882409|NCT01648517|Antimetabolites|antimetabolites|mesh-ancestor
153882410|NCT01648517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153882411|NCT01648517|Tubulin Modulators|tubulin modulators|mesh-ancestor
153882412|NCT01648517|Antimitotic Agents|antimitotic agents|mesh-ancestor
153882413|NCT01648517|Mitosis Modulators|mitosis modulators|mesh-ancestor
153882414|NCT01648517|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153882415|NCT01609101|Cobalt|cobalt|mesh-list
153882416|NCT01609101|Trace Elements|trace elements|mesh-ancestor
153882417|NCT01609101|Micronutrients|micronutrients|mesh-ancestor
153423310|NCT03438266|Protective Agents|protective agents|mesh-ancestor
153423311|NCT03315104|Immunoglobulins|immunoglobulins|mesh-list
153423313|NCT03315104|gamma-Globulins|gamma-globulins|mesh-list
153423314|NCT03315104|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
153423315|NCT03315104|Immunologic Factors|immunologic factors|mesh-ancestor
153423316|NCT03315104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153423318|NCT03228914|Epinephrine|epinephrine|mesh-list
153423319|NCT03228914|Oxymetazoline|oxymetazoline|mesh-list
153423320|NCT03228914|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153423321|NCT03228914|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153423322|NCT03228914|Adrenergic Agents|adrenergic agents|mesh-ancestor
153423323|NCT03228914|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153423324|NCT03228914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153423325|NCT03228914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153423326|NCT03228914|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
153423327|NCT03228914|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153423328|NCT03228914|Autonomic Agents|autonomic agents|mesh-ancestor
153882419|NCT01648556|Prednisone|prednisone|mesh-list
153882420|NCT01648556|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153882421|NCT01648556|Glucocorticoids|glucocorticoids|mesh-ancestor
153882422|NCT01648556|Hormones|hormones|mesh-ancestor
153882423|NCT01648556|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153882424|NCT01648556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153882425|NCT01648556|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153882426|NCT01648556|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153882427|NCT01605981|Nilotinib|nilotinib|mesh-list
153882428|NCT01605981|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153882429|NCT01605981|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153475858|NCT00837252|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153475859|NCT00837252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153475861|NCT00839982|Cytarabine|cytarabine|mesh-list
153475862|NCT00839982|Clofarabine|clofarabine|mesh-list
153475863|NCT00839982|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153475864|NCT00839982|Antimetabolites|antimetabolites|mesh-ancestor
153475865|NCT00839982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153475866|NCT00839982|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153475867|NCT00839982|Antiviral Agents|antiviral agents|mesh-ancestor
153475868|NCT00839982|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153475869|NCT00839982|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153475870|NCT00839982|Immunologic Factors|immunologic factors|mesh-ancestor
153475871|NCT00839982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153475872|NCT00845130|Vitamins|vitamins|mesh-list
153475873|NCT00845130|Ascorbic Acid|ascorbic acid|mesh-list
153475874|NCT00845130|Micronutrients|micronutrients|mesh-ancestor
153882430|NCT01605981|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153882431|NCT01605981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153882432|NCT01648595|Fentanyl|fentanyl|mesh-list
153882433|NCT01648595|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153882434|NCT01648595|Narcotics|narcotics|mesh-ancestor
153882435|NCT01648595|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153882436|NCT01648595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153882437|NCT01648595|Analgesics|analgesics|mesh-ancestor
153882438|NCT01648595|Sensory System Agents|sensory system agents|mesh-ancestor
153423331|NCT03228914|Respiratory System Agents|respiratory system agents|mesh-ancestor
153423333|NCT03228914|Sympathomimetics|sympathomimetics|mesh-ancestor
153423334|NCT03228914|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
153423335|NCT03228914|Nasal Decongestants|nasal decongestants|mesh-ancestor
153423347|NCT03234374|Anesthetics, Local|anesthetics, local|mesh-ancestor
153423348|NCT03234374|Anesthetics|anesthetics|mesh-ancestor
153423349|NCT03234374|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153423368|NCT03236168|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153423381|NCT03306589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153423382|NCT03312517|Suvorexant|suvorexant|mesh-list
153423383|NCT03312517|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
153423384|NCT03312517|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153423385|NCT03312517|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153423386|NCT03312517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153423387|NCT03312517|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
153423388|NCT03312517|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153423398|NCT03239522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153423399|NCT03239522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153423400|NCT03210337|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
153423401|NCT03242408|Methyltestosterone|methyltestosterone|mesh-list
153477553|NCT05450484|Durvalumab|durvalumab|mesh-list
153423402|NCT03242408|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
153882505|NCT01684085|Anticonvulsants|anticonvulsants|mesh-ancestor
153882514|NCT01684085|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153882515|NCT01684085|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153882516|NCT01684085|GABA Modulators|gaba modulators|mesh-ancestor
153882517|NCT01684085|GABA Agents|gaba agents|mesh-ancestor
153882518|NCT01684085|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153423403|NCT03242408|Testosterone|testosterone|mesh-list
153423404|NCT03242408|Testosterone undecanoate|testosterone undecanoate|mesh-list
153423405|NCT03242408|Testosterone enanthate|testosterone enanthate|mesh-list
153423406|NCT03242408|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153423407|NCT03242408|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153423408|NCT03242408|Anabolic Agents|anabolic agents|mesh-ancestor
153423410|NCT03242408|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153423411|NCT03242408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153423412|NCT03242408|Androgens|androgens|mesh-ancestor
153423414|NCT03459794|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153423415|NCT03459794|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153423416|NCT03211117|Docetaxel|docetaxel|mesh-list
153423417|NCT03211117|Doxorubicin|doxorubicin|mesh-list
153882534|NCT01688934|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153423420|NCT03211117|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153423421|NCT03211117|Tubulin Modulators|tubulin modulators|mesh-ancestor
153423422|NCT03211117|Antimitotic Agents|antimitotic agents|mesh-ancestor
153423423|NCT03211117|Mitosis Modulators|mitosis modulators|mesh-ancestor
153423424|NCT03211117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153423425|NCT03211117|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153423426|NCT03211117|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153423427|NCT03211117|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153423428|NCT03211117|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153423429|NCT03211117|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153423430|NCT03211117|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153480594|NCT05465330|Propofol|propofol|mesh-list
153423431|NCT00376285|Fenofibrate|fenofibrate|mesh-list
153882542|NCT02279576|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153882543|NCT02279576|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153882544|NCT02279576|Tubulin Modulators|tubulin modulators|mesh-ancestor
153882545|NCT02279576|Antimitotic Agents|antimitotic agents|mesh-ancestor
153882546|NCT02279576|Mitosis Modulators|mitosis modulators|mesh-ancestor
153882547|NCT02279576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153882548|NCT02279615|Tamsulosin|tamsulosin|mesh-list
153882549|NCT02279615|Mirabegron|mirabegron|mesh-list
153882550|NCT02279615|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
153882551|NCT02279615|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
153882552|NCT02279615|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
153882553|NCT02279615|Adrenergic Agents|adrenergic agents|mesh-ancestor
153882554|NCT02279615|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153423439|NCT03321097|Botulinum Toxins|botulinum toxins|mesh-list
153423440|NCT03321097|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
153423441|NCT03321097|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153423442|NCT03321097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153423444|NCT03321097|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153423446|NCT03245762|Oxytocin|oxytocin|mesh-list
153423447|NCT03245762|Oxytocics|oxytocics|mesh-ancestor
153423448|NCT03245762|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153423449|NCT03245762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153423450|NCT03322657|Glycopyrrolate|glycopyrrolate|mesh-list
153423451|NCT03322657|Neostigmine|neostigmine|mesh-list
153423452|NCT03322657|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
153423455|NCT03322657|Cholinergic Agents|cholinergic agents|mesh-ancestor
153423456|NCT03322657|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153423485|NCT03249272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153423486|NCT03249272|Adenosine A2 Receptor Agonists|adenosine a2 receptor agonists|mesh-ancestor
153423488|NCT03468920|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153423490|NCT03468920|Sensory System Agents|sensory system agents|mesh-ancestor
153423491|NCT03468920|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153882609|NCT01609413|Calcium Carbonate|calcium carbonate|mesh-list
153882610|NCT01609413|Antacids|antacids|mesh-ancestor
153882611|NCT01609413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153882612|NCT01609413|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153882613|NCT02279966|Vortioxetine|vortioxetine|mesh-list
153882614|NCT02279966|Paroxetine|paroxetine|mesh-list
153882615|NCT02279966|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
153882616|NCT02279966|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153882617|NCT02279966|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153882618|NCT02279966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153882619|NCT02279966|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153882620|NCT02279966|Serotonin Agents|serotonin agents|mesh-ancestor
153423506|NCT03256136|Nivolumab|nivolumab|mesh-list
153423507|NCT03256136|Pemetrexed|pemetrexed|mesh-list
153423508|NCT03256136|Ipilimumab|ipilimumab|mesh-list
153423509|NCT03256136|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153423510|NCT03256136|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153423511|NCT03256136|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153423512|NCT03256136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153423513|NCT03256136|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153423514|NCT03256136|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153423544|NCT03270332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153423547|NCT03355820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153423548|NCT03357614|Amoxicillin|amoxicillin|mesh-list
153423549|NCT03357614|Ciprofloxacin|ciprofloxacin|mesh-list
153423550|NCT03357614|Clavulanic Acid|clavulanic acid|mesh-list
153423551|NCT03357614|Clavulanic Acids|clavulanic acids|mesh-list
153423552|NCT03357614|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
153423553|NCT03357614|Ertapenem|ertapenem|mesh-list
153423554|NCT03357614|Lactams|lactams|mesh-list
153423555|NCT03357614|Probenecid|probenecid|mesh-list
153423556|NCT03357614|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153423557|NCT03357614|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153882664|NCT01649336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153882666|NCT01609491|Oxymetazoline|oxymetazoline|mesh-list
153882706|NCT01609647|Purinergic Agents|purinergic agents|mesh-ancestor
153882707|NCT01609647|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153882708|NCT01609647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153882709|NCT01609647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153882710|NCT01580202|Lamivudine|lamivudine|mesh-list
153882711|NCT01580202|Entecavir|entecavir|mesh-list
153423597|NCT02181504|Ranibizumab|ranibizumab|mesh-list
153423598|NCT02181504|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153423601|NCT02181504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153423602|NCT02181504|Growth Inhibitors|growth inhibitors|mesh-ancestor
153423603|NCT02181504|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153423605|NCT02213094|Niacinamide|niacinamide|mesh-list
153423606|NCT02213094|Niacin|niacin|mesh-list
153423607|NCT02213094|Nicotinic Acids|nicotinic acids|mesh-list
153423617|NCT01629966|Antidepressive Agents|antidepressive agents|mesh-ancestor
153423618|NCT01629966|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153423619|NCT01629966|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
153423620|NCT01629966|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153423621|NCT01629966|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153423627|NCT01629966|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
153423629|NCT02177838|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
153423631|NCT02177838|Immunoglobulins|immunoglobulins|mesh-list
153488582|NCT02274870|Anesthetics|anesthetics|mesh-ancestor
153488583|NCT02274870|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153488584|NCT02274870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153488585|NCT02274870|Sensory System Agents|sensory system agents|mesh-ancestor
153488586|NCT02274870|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153488587|NCT02281422|Eslicarbazepine acetate|eslicarbazepine acetate|mesh-list
153488588|NCT02281422|Anticonvulsants|anticonvulsants|mesh-ancestor
153488589|NCT02281422|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
153488590|NCT02281422|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153488591|NCT02281422|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153488592|NCT02281422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153488593|NCT02282514|Methylprednisolone|methylprednisolone|mesh-list
153488624|NCT02282904|Immunologic Factors|immunologic factors|mesh-ancestor
153488625|NCT02282904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153488626|NCT02282904|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153423639|NCT03283436|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153423640|NCT03283436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153423641|NCT03283436|Sensory System Agents|sensory system agents|mesh-ancestor
153423642|NCT03283436|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153423643|NCT00376064|Octreotide|octreotide|mesh-list
153423644|NCT00376064|Cabergoline|cabergoline|mesh-list
153423645|NCT00376064|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153423646|NCT00376064|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153423647|NCT00376064|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153423648|NCT00376064|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
153423649|NCT00376064|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
153423650|NCT00376064|Dopamine Agonists|dopamine agonists|mesh-ancestor
153423651|NCT00376064|Dopamine Agents|dopamine agents|mesh-ancestor
153423652|NCT00376064|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153882759|NCT01649999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153423687|NCT03383588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153423689|NCT03383588|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153423690|NCT03383588|Autonomic Agents|autonomic agents|mesh-ancestor
153423691|NCT03383588|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153423692|NCT03383588|Respiratory System Agents|respiratory system agents|mesh-ancestor
153423693|NCT03383588|Mydriatics|mydriatics|mesh-ancestor
153423694|NCT03383588|Sympathomimetics|sympathomimetics|mesh-ancestor
153423695|NCT03383588|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
153423696|NCT03388268|Vancomycin|vancomycin|mesh-list
153423697|NCT03388268|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153423698|NCT03388268|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153423699|NCT03393494|Adapalene|adapalene|mesh-list
153423700|NCT03393494|Benzoyl Peroxide|benzoyl peroxide|mesh-list
153423701|NCT03393494|Dermatologic Agents|dermatologic agents|mesh-ancestor
153423702|NCT03393494|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153423703|NCT03393494|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153423704|NCT03393494|Analgesics|analgesics|mesh-ancestor
153423705|NCT03393494|Sensory System Agents|sensory system agents|mesh-ancestor
153423706|NCT03393494|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153423707|NCT03393494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153423708|NCT03393494|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153882798|NCT02273154|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
153882799|NCT02273154|Antidepressive Agents|antidepressive agents|mesh-ancestor
153882800|NCT02273154|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153882801|NCT02273154|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
153882802|NCT02273154|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153882803|NCT02273154|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153882804|NCT02273154|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153882805|NCT02273154|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153882806|NCT02273154|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153882807|NCT02273154|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
153882808|NCT01602393|1-(3',4'-dichloro-2-fluoro(1,1'-biphenyl)-4-yl)cyclopropanecarboxylic acid|1-(3',4'-dichloro-2-fluoro(1,1'-biphenyl)-4-yl)cyclopropanecarboxylic acid|mesh-list
153882809|NCT01602393|Gamma Secretase Inhibitors and Modulators|gamma secretase inhibitors and modulators|mesh-ancestor
153882810|NCT01602393|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153423709|NCT03393494|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153423711|NCT03588806|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153423712|NCT03588806|Narcotics|narcotics|mesh-ancestor
153423713|NCT03588806|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153423714|NCT03588806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153423715|NCT03588806|Analgesics|analgesics|mesh-ancestor
153423716|NCT03588806|Sensory System Agents|sensory system agents|mesh-ancestor
153423717|NCT03588806|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153423718|NCT02176356|Bimatoprost|bimatoprost|mesh-list
153423719|NCT02176356|Ophthalmic Solutions|ophthalmic solutions|mesh-list
153423720|NCT02176356|Botulinum Toxins|botulinum toxins|mesh-list
153423722|NCT02176356|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
153423723|NCT02176356|Hyaluronic Acid|hyaluronic acid|mesh-list
153423724|NCT02176356|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
153423725|NCT02176356|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
153423726|NCT02176356|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153423727|NCT02176356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153423728|NCT02176356|Cholinergic Agents|cholinergic agents|mesh-ancestor
153423729|NCT02176356|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153882811|NCT01602393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153882812|NCT01645787|4-Aminopyridine|4-aminopyridine|mesh-list
153882813|NCT01645787|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
153882814|NCT01645787|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153882815|NCT01645787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153882816|NCT02270034|Crizotinib|crizotinib|mesh-list
153882817|NCT02270034|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153882818|NCT02270034|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153882819|NCT02270034|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153882820|NCT02270034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153882821|NCT02270034|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153882822|NCT02273271|Alovudine|alovudine|mesh-list
153882823|NCT02273271|Antiviral Agents|antiviral agents|mesh-ancestor
153882824|NCT02273271|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153882825|NCT02270307|Cyclophosphamide|cyclophosphamide|mesh-list
153882826|NCT02270307|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153882827|NCT02270307|Immunologic Factors|immunologic factors|mesh-ancestor
153882828|NCT02270307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153882829|NCT02270307|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153882830|NCT02270307|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153882831|NCT02270307|Alkylating Agents|alkylating agents|mesh-ancestor
153882832|NCT02270307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153882833|NCT02270307|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153882834|NCT02270307|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153882836|NCT02270424|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
153882837|NCT02270424|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
153882838|NCT02270424|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153882845|NCT02270424|Dermatologic Agents|dermatologic agents|mesh-ancestor
153882846|NCT02270424|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
153882847|NCT02270424|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
153882848|NCT02270424|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
153882849|NCT02270424|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153882850|NCT02270424|Adrenergic Agents|adrenergic agents|mesh-ancestor
153882851|NCT02270424|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153882852|NCT02270424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153882853|NCT02270424|Glucocorticoids|glucocorticoids|mesh-ancestor
153882854|NCT02270424|Hormones|hormones|mesh-ancestor
153423787|NCT03403712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153423788|NCT03403712|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153423789|NCT03403712|Glucocorticoids|glucocorticoids|mesh-ancestor
153423790|NCT03403712|Hormones|hormones|mesh-ancestor
153882862|NCT01686347|Sensory System Agents|sensory system agents|mesh-ancestor
153882863|NCT01686347|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153882864|NCT05140655|Fulvestrant|fulvestrant|mesh-list
153882875|NCT01688570|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153882876|NCT01688570|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153882877|NCT01688570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153882878|NCT01688570|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153882879|NCT01688570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153882880|NCT01688570|Analgesics|analgesics|mesh-ancestor
153882881|NCT01688570|Sensory System Agents|sensory system agents|mesh-ancestor
153882882|NCT01688570|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153423791|NCT03403712|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153423792|NCT03403712|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153423793|NCT03403712|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153423794|NCT03403712|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
153423796|NCT03403712|Serotonin Agents|serotonin agents|mesh-ancestor
153423797|NCT03403712|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153423798|NCT03403712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153423799|NCT03404648|Choline|choline|mesh-list
153423800|NCT03404648|Lipotropic Agents|lipotropic agents|mesh-ancestor
153423801|NCT03404648|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153423803|NCT03404648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153423804|NCT03404648|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153423805|NCT03404648|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153423806|NCT03404648|Nootropic Agents|nootropic agents|mesh-ancestor
153423807|NCT03383198|Bupivacaine|bupivacaine|mesh-list
153423808|NCT03383198|Anesthetics, Local|anesthetics, local|mesh-ancestor
153423809|NCT03383198|Anesthetics|anesthetics|mesh-ancestor
153423810|NCT03383198|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153423811|NCT03383198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153423812|NCT03383198|Sensory System Agents|sensory system agents|mesh-ancestor
153882905|NCT01686464|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153423813|NCT03383198|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153423814|NCT03413618|Rivaroxaban|rivaroxaban|mesh-list
153423815|NCT03413618|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
153423816|NCT03413618|Antithrombins|antithrombins|mesh-ancestor
153423817|NCT03413618|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
153423818|NCT03413618|Protease Inhibitors|protease inhibitors|mesh-ancestor
153423819|NCT03413618|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153423820|NCT03413618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153423821|NCT03413618|Anticoagulants|anticoagulants|mesh-ancestor
153423822|NCT03523988|Acetaminophen|acetaminophen|mesh-list
153423824|NCT03523988|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153423825|NCT03523988|Analgesics|analgesics|mesh-ancestor
153423826|NCT03523988|Sensory System Agents|sensory system agents|mesh-ancestor
153423827|NCT03523988|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153423828|NCT03523988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153423829|NCT03523988|Antipyretics|antipyretics|mesh-ancestor
153423830|NCT03523988|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153423831|NCT03523988|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153423832|NCT03523988|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153423846|NCT03528512|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153423847|NCT03528512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153882926|NCT01688648|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
153882927|NCT01688648|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153882929|NCT01688648|Adrenergic Agents|adrenergic agents|mesh-ancestor
153882930|NCT01688648|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153882931|NCT01686659|Chrysarobin|chrysarobin|mesh-list
153882932|NCT01686659|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153882933|NCT01686659|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153882934|NCT01686659|Analgesics|analgesics|mesh-ancestor
153882935|NCT01686659|Sensory System Agents|sensory system agents|mesh-ancestor
153882936|NCT01686659|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153882937|NCT01686659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153882938|NCT01686659|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153882939|NCT01686659|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153423848|NCT03528512|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
153423849|NCT03528512|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153423850|NCT03528512|Anesthetics, General|anesthetics, general|mesh-ancestor
153423851|NCT03528512|Anesthetics|anesthetics|mesh-ancestor
153423852|NCT03528512|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153423853|NCT03528512|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
153423854|NCT03528512|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
153423855|NCT03528512|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153423856|NCT03528512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153423857|NCT03528512|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153423858|NCT03528512|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153423859|NCT03528512|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153423860|NCT03528512|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153882950|NCT02271165|Antibodies|antibodies|mesh-list
153882951|NCT02271165|Immunologic Factors|immunologic factors|mesh-ancestor
153882952|NCT02271165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153882953|NCT02271204|Ibandronic Acid|ibandronic acid|mesh-list
153882954|NCT02271204|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153423861|NCT03528512|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153423862|NCT03528512|GABA Modulators|gaba modulators|mesh-ancestor
153423863|NCT03528512|GABA Agents|gaba agents|mesh-ancestor
153423864|NCT03528512|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153423872|NCT02133924|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153423874|NCT02133924|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153423875|NCT02133924|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153423876|NCT02133924|Antiemetics|antiemetics|mesh-ancestor
153423877|NCT02133924|Autonomic Agents|autonomic agents|mesh-ancestor
153423878|NCT02133924|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153882958|NCT02271282|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153882959|NCT02271282|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
153882960|NCT02271282|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
153882961|NCT02271282|Hormone Antagonists|hormone antagonists|mesh-ancestor
153882962|NCT02271282|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153882963|NCT02271282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153882964|NCT02271282|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153882966|NCT01688960|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153882967|NCT01688960|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153882968|NCT01688960|Growth Substances|growth substances|mesh-ancestor
153882969|NCT01688960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153423879|NCT02133924|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153423880|NCT02133924|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
153423881|NCT02133924|Protective Agents|protective agents|mesh-ancestor
153423882|NCT02133924|Immunologic Factors|immunologic factors|mesh-ancestor
153423884|NCT03537404|Tenofovir|tenofovir|mesh-list
153423885|NCT03537404|Raltegravir Potassium|raltegravir potassium|mesh-list
153423886|NCT03537404|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
153423887|NCT03537404|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
153423888|NCT03537404|Protease Inhibitors|protease inhibitors|mesh-ancestor
153423889|NCT03537404|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153423890|NCT03537404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153423891|NCT03537404|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153423892|NCT03537404|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153423893|NCT03537404|Antiviral Agents|antiviral agents|mesh-ancestor
153423894|NCT03537404|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153423895|NCT03537404|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
153423896|NCT03537404|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153423897|NCT03537404|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153423898|NCT03537404|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153423899|NCT03537404|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
153423900|NCT03537404|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
153423901|NCT03626714|Tacrolimus|tacrolimus|mesh-list
153423902|NCT03626714|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153423903|NCT03626714|Immunologic Factors|immunologic factors|mesh-ancestor
153423904|NCT03626714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153423905|NCT03626714|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
153423912|NCT03538808|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153882970|NCT01688960|Growth Inhibitors|growth inhibitors|mesh-ancestor
153882971|NCT01688960|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153882972|NCT02271360|Cabergoline|cabergoline|mesh-list
153882973|NCT02271360|Calcium Dobesilate|calcium dobesilate|mesh-list
153882974|NCT02271360|Calcium|calcium|mesh-list
153882975|NCT02271360|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153882976|NCT02271360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153882977|NCT02271360|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
153882978|NCT02271360|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
153882979|NCT02271360|Dopamine Agonists|dopamine agonists|mesh-ancestor
153882980|NCT02271360|Dopamine Agents|dopamine agents|mesh-ancestor
153882981|NCT02271360|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153882982|NCT02271360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153882983|NCT02271360|Hemostatics|hemostatics|mesh-ancestor
153882984|NCT02271360|Coagulants|coagulants|mesh-ancestor
153882985|NCT01687049|Red yeast rice|red yeast rice|mesh-list
153882986|NCT01687049|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
153882987|NCT01687049|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153882988|NCT01687049|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153882989|NCT01687049|Antimetabolites|antimetabolites|mesh-ancestor
153882990|NCT01687049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153882992|NCT01687049|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153882993|NCT02271399|Aspirin|aspirin|mesh-list
153882994|NCT02271399|Rivaroxaban|rivaroxaban|mesh-list
153882995|NCT02271399|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153882996|NCT02271399|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153882997|NCT02271399|Analgesics|analgesics|mesh-ancestor
153882998|NCT02271399|Sensory System Agents|sensory system agents|mesh-ancestor
153882999|NCT02271399|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153883000|NCT02271399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153883001|NCT02271399|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153883002|NCT02271399|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153423913|NCT03538808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153423914|NCT03538808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153423915|NCT00377000|Clindamycin|clindamycin|mesh-list
153423916|NCT00377000|Clindamycin palmitate|clindamycin palmitate|mesh-list
153423917|NCT00377000|Clindamycin phosphate|clindamycin phosphate|mesh-list
153423918|NCT00377000|Benzoyl Peroxide|benzoyl peroxide|mesh-list
153423919|NCT00377000|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153423920|NCT00377000|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153423921|NCT00377000|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
153423922|NCT00377000|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153423923|NCT00377000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153423924|NCT00377000|Dermatologic Agents|dermatologic agents|mesh-ancestor
153423925|NCT02173548|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
153423926|NCT02173548|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153423927|NCT04501640|Mirabegron|mirabegron|mesh-list
153423928|NCT04501640|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
153423929|NCT04501640|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
153423930|NCT04501640|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153423931|NCT04501640|Adrenergic Agents|adrenergic agents|mesh-ancestor
153423932|NCT04501640|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153883006|NCT02271399|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153883007|NCT02271399|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153883008|NCT02271399|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153883025|NCT02271438|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
153883027|NCT02271438|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153423938|NCT03633344|Micronutrients|micronutrients|mesh-ancestor
153423939|NCT03633344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153423941|NCT02171130|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
153423942|NCT02171130|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153423943|NCT02171130|Hormones|hormones|mesh-ancestor
153423944|NCT02171130|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153423945|NCT02171130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153423946|NCT02171130|Incretins|incretins|mesh-ancestor
153423947|NCT04749810|Eculizumab|eculizumab|mesh-list
153423948|NCT04749810|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
153423949|NCT04749810|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153423950|NCT04749810|Immunologic Factors|immunologic factors|mesh-ancestor
153423951|NCT04749810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153423952|NCT00377078|Lactoferrin|lactoferrin|mesh-list
153423953|NCT00377078|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153423954|NCT04495712|Spironolactone|spironolactone|mesh-list
153423955|NCT04495712|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
153423956|NCT04495712|Hormone Antagonists|hormone antagonists|mesh-ancestor
153423957|NCT04495712|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153423959|NCT04495712|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
153883031|NCT02271438|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
153883032|NCT02271438|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153883033|NCT02271438|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153883035|NCT02271555|Sevoflurane|sevoflurane|mesh-list
153883036|NCT02271555|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153883037|NCT02271555|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
153883038|NCT02271555|Anesthetics, General|anesthetics, general|mesh-ancestor
153883039|NCT02271555|Anesthetics|anesthetics|mesh-ancestor
153883040|NCT02271555|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153883041|NCT02271555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153883042|NCT02271555|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153883043|NCT02271555|Narcotics|narcotics|mesh-ancestor
153883044|NCT02271555|Analgesics|analgesics|mesh-ancestor
153883045|NCT02271555|Sensory System Agents|sensory system agents|mesh-ancestor
153883046|NCT02271555|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153883050|NCT01687205|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153883051|NCT01687205|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153883052|NCT01687205|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153883053|NCT01687205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153883054|NCT01687205|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153883055|NCT01687205|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153883056|NCT01689194|genexol-PM|genexol-pm|mesh-list
153883057|NCT01689194|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153423970|NCT04456634|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153423971|NCT04456634|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153423972|NCT00377624|Hyaluronic Acid|hyaluronic acid|mesh-list
153423973|NCT00377624|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153423974|NCT00377624|Immunologic Factors|immunologic factors|mesh-ancestor
153423975|NCT00377624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153423976|NCT00377624|Viscosupplements|viscosupplements|mesh-ancestor
153423977|NCT00377624|Protective Agents|protective agents|mesh-ancestor
153423978|NCT03562988|Vitamins|vitamins|mesh-list
153423979|NCT03562988|Ascorbic Acid|ascorbic acid|mesh-list
153423980|NCT03562988|Micronutrients|micronutrients|mesh-ancestor
153423981|NCT03562988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153423982|NCT03562988|Antioxidants|antioxidants|mesh-ancestor
153423983|NCT03562988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153423984|NCT03562988|Protective Agents|protective agents|mesh-ancestor
153423985|NCT03644108|Guaifenesin|guaifenesin|mesh-list
153423986|NCT03644108|Expectorants|expectorants|mesh-ancestor
153423987|NCT03644108|Respiratory System Agents|respiratory system agents|mesh-ancestor
153423988|NCT04713956|Cyclophosphamide|cyclophosphamide|mesh-list
153423989|NCT04713956|Busulfan|busulfan|mesh-list
153423990|NCT04713956|Fludarabine|fludarabine|mesh-list
153423991|NCT04713956|Decitabine|decitabine|mesh-list
153423992|NCT04713956|Lenograstim|lenograstim|mesh-list
153423993|NCT04713956|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153423994|NCT04713956|Immunologic Factors|immunologic factors|mesh-ancestor
153423995|NCT04713956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153423996|NCT04713956|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153423997|NCT04713956|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153423998|NCT04713956|Alkylating Agents|alkylating agents|mesh-ancestor
153883058|NCT01689194|Tubulin Modulators|tubulin modulators|mesh-ancestor
153883059|NCT01689194|Antimitotic Agents|antimitotic agents|mesh-ancestor
153883060|NCT01689194|Mitosis Modulators|mitosis modulators|mesh-ancestor
153883061|NCT01689194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153883062|NCT01687439|Vinorelbine|vinorelbine|mesh-list
153883063|NCT01687439|Endostar protein|endostar protein|mesh-list
153883064|NCT01687439|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153883065|NCT01687439|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153883066|NCT01687439|Tubulin Modulators|tubulin modulators|mesh-ancestor
153883067|NCT01687439|Antimitotic Agents|antimitotic agents|mesh-ancestor
153883068|NCT01687439|Mitosis Modulators|mitosis modulators|mesh-ancestor
153883069|NCT01687439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153883070|NCT01687439|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153883071|NCT01687439|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153883072|NCT01687439|Growth Substances|growth substances|mesh-ancestor
153883073|NCT01687439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153883074|NCT01687439|Growth Inhibitors|growth inhibitors|mesh-ancestor
153423999|NCT04713956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153424006|NCT04425746|Afamelanotide|afamelanotide|mesh-list
153883075|NCT01588704|Bevacizumab|bevacizumab|mesh-list
153883077|NCT01588704|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153883078|NCT01588704|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153883079|NCT01588704|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153883080|NCT01588704|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153883081|NCT01588704|Growth Substances|growth substances|mesh-ancestor
153883082|NCT01588704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153883083|NCT01588704|Growth Inhibitors|growth inhibitors|mesh-ancestor
153883084|NCT01588704|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153883085|NCT01588704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153883086|NCT01588704|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153883087|NCT01588704|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153883088|NCT01588743|Insulin Aspart|insulin aspart|mesh-list
153883089|NCT01588743|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153883090|NCT01588743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153883091|NCT01689311|Alprostadil|alprostadil|mesh-list
153883096|NCT01689311|Dinoprost tromethamine|dinoprost tromethamine|mesh-list
153883097|NCT01689311|Oxytocics|oxytocics|mesh-ancestor
153883098|NCT01689311|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153883099|NCT01689311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153883100|NCT01689311|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
153883101|NCT01689311|Abortifacient Agents|abortifacient agents|mesh-ancestor
153883102|NCT01689311|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
153424017|NCT04392362|Purinergic Agents|purinergic agents|mesh-ancestor
153424018|NCT04392362|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153424019|NCT04392362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153424020|NCT04734782|Antibodies|antibodies|mesh-list
153424021|NCT04734782|Immunologic Factors|immunologic factors|mesh-ancestor
153424022|NCT04734782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153424023|NCT04390022|Ivermectin|ivermectin|mesh-list
153424024|NCT04390022|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153424025|NCT04390022|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153424026|NCT04370834|Immunoglobulins|immunoglobulins|mesh-list
153424027|NCT04370834|Immunoglobulin G|immunoglobulin g|mesh-list
153424028|NCT04370834|Immunologic Factors|immunologic factors|mesh-ancestor
153424029|NCT04370834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153424030|NCT03570476|Olaparib|olaparib|mesh-list
153424031|NCT03570476|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
153424032|NCT03570476|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153883108|NCT01588782|Antifungal Agents|antifungal agents|mesh-ancestor
153883109|NCT01588782|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153883110|NCT01588782|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
153883111|NCT01588782|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153883112|NCT01588782|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153883113|NCT01588782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153883114|NCT01588782|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153883115|NCT01588782|Hormone Antagonists|hormone antagonists|mesh-ancestor
153883116|NCT01588782|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153883118|NCT01588782|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
153883119|NCT02272101|Vitamin D|vitamin d|mesh-list
153883120|NCT02272101|Vitamins|vitamins|mesh-ancestor
153883121|NCT02272101|Micronutrients|micronutrients|mesh-ancestor
153424037|NCT03571724|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
153424038|NCT03571724|Autonomic Agents|autonomic agents|mesh-ancestor
153424039|NCT03571724|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153424040|NCT03571724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153424041|NCT03571724|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
153424042|NCT03571724|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
153424043|NCT03571724|Cholinergic Agents|cholinergic agents|mesh-ancestor
153424044|NCT03571724|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153424045|NCT03571724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153424046|NCT03571724|Antipruritics|antipruritics|mesh-ancestor
153424047|NCT03571724|Dermatologic Agents|dermatologic agents|mesh-ancestor
153424048|NCT03572972|Warfarin|warfarin|mesh-list
153424049|NCT03572972|Rivaroxaban|rivaroxaban|mesh-list
153424050|NCT03572972|Dabigatran|dabigatran|mesh-list
153883134|NCT01687868|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153883135|NCT01687868|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
153883136|NCT01687868|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153883138|NCT01687868|Adrenergic Agents|adrenergic agents|mesh-ancestor
153883139|NCT01687868|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153883140|NCT01687868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153883141|NCT01688024|Mitomycins|mitomycins|mesh-list
153883142|NCT01688024|Mitomycin|mitomycin|mesh-list
153883143|NCT01688024|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153424061|NCT04352660|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153424062|NCT04352660|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153424063|NCT04352660|Alkylating Agents|alkylating agents|mesh-ancestor
153424064|NCT04352660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153424065|NCT04352660|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153424066|NCT04352660|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153424068|NCT04342130|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153424069|NCT04342130|Narcotics|narcotics|mesh-ancestor
153424070|NCT04342130|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153424071|NCT04342130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153424072|NCT04342130|Analgesics|analgesics|mesh-ancestor
153424073|NCT04342130|Sensory System Agents|sensory system agents|mesh-ancestor
153424074|NCT04342130|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153424077|NCT04338074|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153424078|NCT04338074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153424079|NCT04338074|Hemostatics|hemostatics|mesh-ancestor
153424080|NCT04338074|Coagulants|coagulants|mesh-ancestor
153424081|NCT03964220|Tiotropium Bromide|tiotropium bromide|mesh-list
153424082|NCT03964220|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153424083|NCT03964220|Autonomic Agents|autonomic agents|mesh-ancestor
153424084|NCT03964220|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153424085|NCT03964220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153424089|NCT03964220|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
153424090|NCT03964220|Cholinergic Agents|cholinergic agents|mesh-ancestor
153424091|NCT03964220|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153424093|NCT04337138|Gemtuzumab|gemtuzumab|mesh-list
153424094|NCT04337138|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153424095|NCT04337138|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153424096|NCT04337138|Immunotoxins|immunotoxins|mesh-ancestor
153424097|NCT04337138|Immunoconjugates|immunoconjugates|mesh-ancestor
153424098|NCT04337138|Immunologic Factors|immunologic factors|mesh-ancestor
153883205|NCT01689896|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153883206|NCT01689896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153883207|NCT01316094|Ipragliflozin|ipragliflozin|mesh-list
153883208|NCT01316094|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
153883209|NCT01316094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153883210|NCT01316094|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153883211|NCT01316094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153883212|NCT01689935|Aminolevulinic Acid|aminolevulinic acid|mesh-list
153883213|NCT01689935|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
153883214|NCT01689935|Dermatologic Agents|dermatologic agents|mesh-ancestor
153883215|NCT01316133|Tacrolimus|tacrolimus|mesh-list
153883216|NCT01316133|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153883217|NCT01316133|Immunologic Factors|immunologic factors|mesh-ancestor
153424139|NCT04322396|Antimalarials|antimalarials|mesh-ancestor
153424140|NCT04322396|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153424141|NCT04322396|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153424142|NCT04322396|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153424143|NCT04322396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153424144|NCT04322396|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153424146|NCT03961100|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153424147|NCT03961100|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153424148|NCT03961100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153424150|NCT03336853|Dental Disinfectants|dental disinfectants|mesh-ancestor
153424151|NCT03336853|Disinfectants|disinfectants|mesh-ancestor
153424152|NCT03336853|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153424153|NCT03225313|Bupivacaine|bupivacaine|mesh-list
153424173|NCT03445195|Sulbactam|sulbactam|mesh-list
153424174|NCT03445195|Cilastatin, Imipenem Drug Combination|cilastatin, imipenem drug combination|mesh-list
153424175|NCT03445195|Durlobactam|durlobactam|mesh-list
153424176|NCT03445195|Cilastatin|cilastatin|mesh-list
153424177|NCT03445195|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153424178|NCT03445195|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153424179|NCT03445195|Protease Inhibitors|protease inhibitors|mesh-ancestor
153424180|NCT03445195|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153424181|NCT03445195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153424182|NCT03445195|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
153424183|NCT04277936|Levetiracetam|levetiracetam|mesh-list
153424184|NCT04277936|Anticonvulsants|anticonvulsants|mesh-ancestor
153424185|NCT04277936|Nootropic Agents|nootropic agents|mesh-ancestor
153424186|NCT03670160|Clonidine|clonidine|mesh-list
153424187|NCT03670160|Phenobarbital|phenobarbital|mesh-list
153424188|NCT03670160|Analgesics|analgesics|mesh-ancestor
153424189|NCT03670160|Sensory System Agents|sensory system agents|mesh-ancestor
153424190|NCT03670160|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153424191|NCT03670160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153424192|NCT03670160|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153883255|NCT01685255|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153883256|NCT01685255|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153883257|NCT01685255|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
153883258|NCT01685255|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
153883259|NCT01685255|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153883260|NCT01680965|Ofatumumab|ofatumumab|mesh-list
153883261|NCT01680965|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153883262|NCT01683188|Vemurafenib|vemurafenib|mesh-list
153424193|NCT03670160|Sympatholytics|sympatholytics|mesh-ancestor
153424196|NCT03670160|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153883274|NCT01380093|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153883275|NCT01380093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153883276|NCT01380093|Analgesics|analgesics|mesh-ancestor
153883277|NCT01380093|Sensory System Agents|sensory system agents|mesh-ancestor
153883278|NCT01380093|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153883279|NCT01380093|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
153883280|NCT01380093|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
153883281|NCT01379937|Vaccines|vaccines|mesh-list
153883282|NCT01379937|Immunologic Factors|immunologic factors|mesh-ancestor
153424214|NCT00375895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153424215|NCT00375895|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153424216|NCT00375895|Immunologic Factors|immunologic factors|mesh-ancestor
153424217|NCT00375895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153424218|NCT00375895|Antifungal Agents|antifungal agents|mesh-ancestor
153424219|NCT00375895|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153424220|NCT00375895|Dermatologic Agents|dermatologic agents|mesh-ancestor
153424221|NCT00375895|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153424222|NCT00375895|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
153883294|NCT03558854|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153883295|NCT03558854|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153883296|NCT03558854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153883297|NCT03558854|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153883298|NCT03558854|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153424223|NCT03338803|Linagliptin|linagliptin|mesh-list
153424224|NCT03338803|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153424225|NCT03338803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153424226|NCT03338803|Incretins|incretins|mesh-ancestor
153424227|NCT03338803|Hormones|hormones|mesh-ancestor
153424228|NCT03338803|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153424229|NCT03338803|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
153424231|NCT03338803|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153424232|NCT03338803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153424233|NCT00377936|Gemcitabine|gemcitabine|mesh-list
153424234|NCT00377936|Paclitaxel|paclitaxel|mesh-list
153424235|NCT00377936|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153424236|NCT00377936|Antimetabolites|antimetabolites|mesh-ancestor
153424237|NCT00377936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153424238|NCT00377936|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153424239|NCT00377936|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153424240|NCT00377936|Tubulin Modulators|tubulin modulators|mesh-ancestor
153424241|NCT00377936|Antimitotic Agents|antimitotic agents|mesh-ancestor
153424242|NCT00377936|Mitosis Modulators|mitosis modulators|mesh-ancestor
153424243|NCT03696758|Metoprolol|metoprolol|mesh-list
153424244|NCT03696758|Sildenafil Citrate|sildenafil citrate|mesh-list
153424245|NCT03696758|Vasodilator Agents|vasodilator agents|mesh-ancestor
153883303|NCT01335477|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153883304|NCT01335477|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153883305|NCT01335477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153883306|NCT03389438|Immunomodulating Agents|immunomodulating agents|mesh-list
153883307|NCT03389438|Immunologic Factors|immunologic factors|mesh-ancestor
153883308|NCT03389438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153883310|NCT01371747|Spironolactone|spironolactone|mesh-list
153883311|NCT01371747|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153883312|NCT01371747|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153883313|NCT01371747|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
153883314|NCT01371747|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
153883315|NCT01371747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153883316|NCT01371747|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
153883317|NCT01371747|Hormone Antagonists|hormone antagonists|mesh-ancestor
153883318|NCT01371747|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153883327|NCT01335399|BB 1101|bb 1101|mesh-list
153883328|NCT01335399|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153424255|NCT03696758|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153424256|NCT03696758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153424257|NCT03696758|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
153424258|NCT03696758|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
153424259|NCT03696758|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
153424260|NCT03696758|Adrenergic Agents|adrenergic agents|mesh-ancestor
153424261|NCT03696758|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153424262|NCT03233737|Anesthetics|anesthetics|mesh-list
153424263|NCT03233737|Tetracaine|tetracaine|mesh-list
153424264|NCT03233737|Benzocaine|benzocaine|mesh-list
153424265|NCT03233737|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153424267|NCT03233737|Anesthetics, Local|anesthetics, local|mesh-ancestor
153424268|NCT03233737|Sensory System Agents|sensory system agents|mesh-ancestor
153424269|NCT03233737|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153424270|NCT03711578|Tenalisib|tenalisib|mesh-list
153424271|NCT03711578|Phosphoinositide-3 Kinase Inhibitors|phosphoinositide-3 kinase inhibitors|mesh-ancestor
153424272|NCT03711578|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153424273|NCT03711578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153424274|NCT03463915|Triamcinolone|triamcinolone|mesh-list
153424275|NCT03463915|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
153883335|NCT01335399|Hormones|hormones|mesh-ancestor
153883336|NCT01335399|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153883337|NCT01335399|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153883338|NCT01335399|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153883339|NCT01335399|Protease Inhibitors|protease inhibitors|mesh-ancestor
153883340|NCT01335399|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153883341|NCT01335399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153883342|NCT01335399|Immunologic Factors|immunologic factors|mesh-ancestor
153883343|NCT01335399|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153883344|NCT01335399|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153883345|NCT01335399|Growth Substances|growth substances|mesh-ancestor
153883346|NCT01335399|Growth Inhibitors|growth inhibitors|mesh-ancestor
153883347|NCT04825262|Tacrolimus|tacrolimus|mesh-list
153883348|NCT04825262|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153883349|NCT04825262|Immunologic Factors|immunologic factors|mesh-ancestor
153883350|NCT04825262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153424276|NCT03463915|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
153424277|NCT03463915|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
153424278|NCT03463915|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153424279|NCT03463915|Glucocorticoids|glucocorticoids|mesh-ancestor
153424280|NCT03463915|Hormones|hormones|mesh-ancestor
153424281|NCT03463915|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153424282|NCT03463915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153424283|NCT03463915|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153424284|NCT03463915|Immunologic Factors|immunologic factors|mesh-ancestor
153424285|NCT03463915|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153424286|NCT03463915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153424287|NCT03473665|Celecoxib|celecoxib|mesh-list
153424288|NCT03473665|Diclofenac|diclofenac|mesh-list
153424289|NCT03473665|Indomethacin|indomethacin|mesh-list
153424290|NCT03473665|Meloxicam|meloxicam|mesh-list
153424291|NCT03473665|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153424292|NCT03473665|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153424293|NCT03473665|Analgesics|analgesics|mesh-ancestor
153883355|NCT01335009|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
153883356|NCT01335009|Immunologic Factors|immunologic factors|mesh-ancestor
153883357|NCT01335009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153883358|NCT01332630|Diphenhydramine|diphenhydramine|mesh-list
153883359|NCT01332630|Dexamethasone|dexamethasone|mesh-list
153883360|NCT01332630|Ranitidine|ranitidine|mesh-list
153883361|NCT01332630|Ranitidine bismuth citrate|ranitidine bismuth citrate|mesh-list
153883364|NCT01332630|Autonomic Agents|autonomic agents|mesh-ancestor
153883365|NCT01332630|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153883366|NCT01332630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153883367|NCT01332630|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153883368|NCT01332630|Glucocorticoids|glucocorticoids|mesh-ancestor
153883369|NCT01332630|Hormones|hormones|mesh-ancestor
153883370|NCT01332630|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153424295|NCT03473665|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153424296|NCT03473665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153424297|NCT03473665|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153424304|NCT03473665|Tocolytic Agents|tocolytic agents|mesh-ancestor
153424305|NCT03473665|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153424306|NCT03717506|Clindamycin|clindamycin|mesh-list
153424307|NCT03717506|Clindamycin palmitate|clindamycin palmitate|mesh-list
153424308|NCT03717506|Clindamycin phosphate|clindamycin phosphate|mesh-list
153424309|NCT03717506|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153424310|NCT03717506|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153883373|NCT01332630|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
153883374|NCT01332630|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153883375|NCT01332630|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153883376|NCT01332630|Anesthetics, Local|anesthetics, local|mesh-ancestor
153883378|NCT01332630|Sensory System Agents|sensory system agents|mesh-ancestor
153883379|NCT01332630|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
153883380|NCT01332630|Histamine Antagonists|histamine antagonists|mesh-ancestor
153883381|NCT01332630|Histamine Agents|histamine agents|mesh-ancestor
153883382|NCT01332630|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153883383|NCT01332630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153883384|NCT01332630|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
153883385|NCT01332630|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
153424311|NCT03717506|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
153424312|NCT03717506|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153424321|NCT03861338|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153424322|NCT03861338|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
153424323|NCT00377780|Docetaxel|docetaxel|mesh-list
153424324|NCT00377780|Doxorubicin|doxorubicin|mesh-list
153424325|NCT00377780|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
153424326|NCT00377780|Trastuzumab|trastuzumab|mesh-list
153424327|NCT00377780|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153424328|NCT00377780|Tubulin Modulators|tubulin modulators|mesh-ancestor
153424329|NCT00377780|Antimitotic Agents|antimitotic agents|mesh-ancestor
153883393|NCT01366209|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153883394|NCT01366209|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153883396|NCT01366209|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153883398|NCT01365507|Insulin Aspart|insulin aspart|mesh-list
153883399|NCT01365507|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153883400|NCT01365507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153883401|NCT02995694|Estradiol|estradiol|mesh-list
153883402|NCT02995694|Estrogens|estrogens|mesh-ancestor
153883403|NCT02995694|Hormones|hormones|mesh-ancestor
153424330|NCT00377780|Mitosis Modulators|mitosis modulators|mesh-ancestor
153424331|NCT00377780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153424332|NCT00377780|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153424333|NCT00377780|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153424334|NCT00377780|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153424335|NCT00377780|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153424336|NCT00377780|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153424337|NCT00376519|Cyclosporine|cyclosporine|mesh-list
153883415|NCT04827836|Povidone-Iodine|povidone-iodine|mesh-list
153883416|NCT04827836|Povidone|povidone|mesh-list
153883417|NCT04827836|Ophthalmic Solutions|ophthalmic solutions|mesh-list
153883418|NCT04827836|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
153883419|NCT04827836|Plasma Substitutes|plasma substitutes|mesh-ancestor
153883420|NCT04827836|Blood Substitutes|blood substitutes|mesh-ancestor
153883421|NCT04827836|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
153883422|NCT04827836|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153424349|NCT00376519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153424350|NCT00376519|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153424351|NCT00376519|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153424352|NCT00376519|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153424354|NCT00376519|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153424355|NCT00376519|Antifungal Agents|antifungal agents|mesh-ancestor
153424356|NCT00376519|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153424357|NCT00376519|Dermatologic Agents|dermatologic agents|mesh-ancestor
153424358|NCT00376519|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
153424359|NCT00376519|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153424360|NCT00376519|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
153424361|NCT00376519|Antitubercular Agents|antitubercular agents|mesh-ancestor
153424362|NCT00376519|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153424364|NCT00422864|Fluorouracil|fluorouracil|mesh-list
153424365|NCT00422864|Oxaliplatin|oxaliplatin|mesh-list
153424366|NCT00422864|Antimetabolites|antimetabolites|mesh-ancestor
153424370|NCT00422864|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153424371|NCT00422864|Immunologic Factors|immunologic factors|mesh-ancestor
153424372|NCT00422864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153424373|NCT00422864|Antidotes|antidotes|mesh-ancestor
153424374|NCT00422864|Protective Agents|protective agents|mesh-ancestor
153424375|NCT00422864|Vitamin B Complex|vitamin b complex|mesh-ancestor
153424377|NCT00422864|Micronutrients|micronutrients|mesh-ancestor
153883423|NCT01357980|Botulinum Toxins|botulinum toxins|mesh-list
153883424|NCT01357980|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
153883425|NCT01357980|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
153883426|NCT01357980|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
153883427|NCT01357980|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153883428|NCT01357980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153883429|NCT01357980|Cholinergic Agents|cholinergic agents|mesh-ancestor
153883430|NCT01357980|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153883431|NCT01357980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153883432|NCT01357980|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
153883433|NCT01357980|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153883434|NCT01332318|Diphenhydramine|diphenhydramine|mesh-list
153883435|NCT01332318|Promethazine|promethazine|mesh-list
153883436|NCT01332318|Gabapentin|gabapentin|mesh-list
153883437|NCT01332318|Analgesics|analgesics|mesh-ancestor
153883438|NCT01332318|Sensory System Agents|sensory system agents|mesh-ancestor
153424378|NCT03373591|Bupivacaine|bupivacaine|mesh-list
153883439|NCT01332318|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153883440|NCT01332318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153883441|NCT01332318|Anticonvulsants|anticonvulsants|mesh-ancestor
153883442|NCT01332318|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153883443|NCT01332318|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153883444|NCT01332318|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153883445|NCT01332318|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153883446|NCT01332318|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
153883447|NCT01332318|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
153883448|NCT01332318|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153883449|NCT01332318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153883450|NCT01332318|Antimanic Agents|antimanic agents|mesh-ancestor
153883456|NCT01332318|Autonomic Agents|autonomic agents|mesh-ancestor
153883457|NCT01332318|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153883458|NCT01332318|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
153883459|NCT01332318|Histamine Antagonists|histamine antagonists|mesh-ancestor
153883460|NCT01332318|Histamine Agents|histamine agents|mesh-ancestor
153883461|NCT01332318|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
153883462|NCT01332318|Antipruritics|antipruritics|mesh-ancestor
153883463|NCT01332318|Dermatologic Agents|dermatologic agents|mesh-ancestor
153883465|NCT01331109|Levomilnacipran|levomilnacipran|mesh-list
153883466|NCT01331109|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
153883467|NCT01331109|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153424395|NCT03378973|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153424396|NCT03378973|Adrenergic Agents|adrenergic agents|mesh-ancestor
153424397|NCT03378973|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153424398|NCT03378973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153424399|NCT04121078|Rifampin|rifampin|mesh-list
153424400|NCT04121078|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
153424401|NCT04121078|Antitubercular Agents|antitubercular agents|mesh-ancestor
153424402|NCT04121078|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153424403|NCT04121078|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153424404|NCT04121078|Leprostatic Agents|leprostatic agents|mesh-ancestor
153424405|NCT04121078|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153424414|NCT03248947|Buprenorphine|buprenorphine|mesh-list
153424415|NCT03248947|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
153424416|NCT03248947|Naloxone|naloxone|mesh-list
153424417|NCT03248947|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153424418|NCT03248947|Narcotics|narcotics|mesh-ancestor
153424419|NCT03248947|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153424420|NCT03248947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153424421|NCT03248947|Analgesics|analgesics|mesh-ancestor
153424422|NCT03248947|Sensory System Agents|sensory system agents|mesh-ancestor
153424423|NCT03248947|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153424424|NCT03248947|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
153424425|NCT04114058|Bupivacaine|bupivacaine|mesh-list
153883488|NCT02271503|Carbidopa|carbidopa|mesh-list
153883489|NCT02271503|Levodopa|levodopa|mesh-list
153883490|NCT02271503|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153883491|NCT02271503|Immunologic Factors|immunologic factors|mesh-ancestor
153883498|NCT02271503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153883499|NCT02271503|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
153883501|NCT01350804|Abatacept|abatacept|mesh-list
153883502|NCT01350804|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153424430|NCT04114058|Sensory System Agents|sensory system agents|mesh-ancestor
153424431|NCT04114058|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153424432|NCT03862040|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
153424433|NCT03862040|Cefiderocol|cefiderocol|mesh-list
153424434|NCT03862040|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153424435|NCT03862040|Siderophores|siderophores|mesh-ancestor
153424436|NCT03862040|Iron Chelating Agents|iron chelating agents|mesh-ancestor
153424438|NCT03862040|Sequestering Agents|sequestering agents|mesh-ancestor
153424439|NCT03862040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153424440|NCT03862040|Beta Lactam Antibiotics|beta lactam antibiotics|mesh-ancestor
153424441|NCT00376831|Midazolam|midazolam|mesh-list
153424442|NCT00376831|Fentanyl|fentanyl|mesh-list
153424443|NCT00376831|Ketamine|ketamine|mesh-list
153424444|NCT00376831|Analgesics|analgesics|mesh-ancestor
153883507|NCT01350804|Immunologic Factors|immunologic factors|mesh-ancestor
153883508|NCT01350804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153883509|NCT01350804|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153883511|NCT02270957|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153883512|NCT02270957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153883513|NCT02270957|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153883514|NCT02270957|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153424445|NCT00376831|Sensory System Agents|sensory system agents|mesh-ancestor
153424446|NCT00376831|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153424447|NCT00376831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153424448|NCT00376831|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
153424449|NCT00376831|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153424450|NCT00376831|Anesthetics, General|anesthetics, general|mesh-ancestor
153424451|NCT00376831|Anesthetics|anesthetics|mesh-ancestor
153424452|NCT00376831|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153424453|NCT00376831|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
153883518|NCT02270957|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153883519|NCT01348542|Trazodone|trazodone|mesh-list
153883520|NCT01348542|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153883521|NCT01348542|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153883522|NCT01348542|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153883523|NCT01348542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153883524|NCT01348542|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153883525|NCT01348542|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
153883526|NCT01348542|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153883527|NCT01348542|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153883528|NCT01348542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153883529|NCT01348542|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153883530|NCT01348542|Serotonin Agents|serotonin agents|mesh-ancestor
153424460|NCT00376831|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153424468|NCT03857750|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
153424469|NCT03857750|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
153424476|NCT03852524|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
153424477|NCT03852524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153424478|NCT03852524|Sensory System Agents|sensory system agents|mesh-ancestor
153424479|NCT03852524|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153424480|NCT04081610|Hyaluronic Acid|hyaluronic acid|mesh-list
153424481|NCT04081610|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153424482|NCT04081610|Immunologic Factors|immunologic factors|mesh-ancestor
153883551|NCT01342887|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153883552|NCT01342887|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153883553|NCT01342887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153424483|NCT04081610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153424485|NCT04081610|Protective Agents|protective agents|mesh-ancestor
153424486|NCT03840278|Pancrelipase|pancrelipase|mesh-list
153424487|NCT03840278|Pancreatin|pancreatin|mesh-list
153424488|NCT03840278|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153424489|NCT03838874|Bupivacaine|bupivacaine|mesh-list
153424490|NCT03838874|Mepivacaine|mepivacaine|mesh-list
153424491|NCT03838874|Anesthetics, Local|anesthetics, local|mesh-ancestor
153424492|NCT03838874|Anesthetics|anesthetics|mesh-ancestor
153424493|NCT03838874|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153424494|NCT03838874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153883557|NCT01342887|Antifungal Agents|antifungal agents|mesh-ancestor
153883558|NCT01342887|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153883559|NCT01342887|Dermatologic Agents|dermatologic agents|mesh-ancestor
153883560|NCT01342887|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153883561|NCT01342887|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
153883562|NCT01342887|Analgesics|analgesics|mesh-ancestor
153883563|NCT01342887|Sensory System Agents|sensory system agents|mesh-ancestor
153883564|NCT01342887|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153424495|NCT03838874|Sensory System Agents|sensory system agents|mesh-ancestor
153424496|NCT03838874|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153424498|NCT04045964|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
153424499|NCT04045964|Autonomic Agents|autonomic agents|mesh-ancestor
153424500|NCT04045964|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153424501|NCT04045964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153424502|NCT04045964|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
153424503|NCT04045964|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
153424504|NCT04045964|Cholinergic Agents|cholinergic agents|mesh-ancestor
153424505|NCT04045964|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153424506|NCT04045964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153424507|NCT04039412|Levofloxacin|levofloxacin|mesh-list
153883571|NCT04445415|Immunologic Factors|immunologic factors|mesh-ancestor
153883572|NCT04445415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153883573|NCT01342341|Chlorzoxazone|chlorzoxazone|mesh-list
153883574|NCT01342341|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
153883575|NCT01342341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153883576|NCT01342341|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
153424508|NCT04039412|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
153424509|NCT04039412|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153424510|NCT04039412|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153424511|NCT04039412|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153424512|NCT04039412|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153424514|NCT04039412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153424515|NCT04039412|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153424516|NCT04039412|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
153424524|NCT03831854|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
153424525|NCT03831854|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153424526|NCT03831854|Anesthetics, General|anesthetics, general|mesh-ancestor
153424527|NCT03831854|Anesthetics|anesthetics|mesh-ancestor
153424528|NCT03831854|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153424529|NCT03831854|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
153424530|NCT03831854|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
153424534|NCT03831854|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153424535|NCT03831854|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153424536|NCT03831854|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153424537|NCT03831854|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153424538|NCT03831854|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153424539|NCT03831854|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153424540|NCT03831854|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153883594|NCT01340625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153883596|NCT01340625|Contraceptive Agents|contraceptive agents|mesh-ancestor
153883597|NCT01340625|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153883598|NCT01340625|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
153883599|NCT01340625|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
153883600|NCT01340625|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
153883601|NCT01340625|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
153883603|NCT04823468|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153883604|NCT01340196|Tenofovir|tenofovir|mesh-list
153883605|NCT01340196|Antiviral Agents|antiviral agents|mesh-ancestor
153883606|NCT01340196|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153883607|NCT01340196|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153883608|NCT01340196|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153883609|NCT01340196|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153883610|NCT01340196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153883611|NCT01340196|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153883612|NCT01340196|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153883613|NCT02893332|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
153883614|NCT02893332|Gefitinib|gefitinib|mesh-list
153883615|NCT02893332|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153883616|NCT02893332|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153883617|NCT02893332|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153883618|NCT02893332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153883629|NCT04328493|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153883630|NCT04328493|Analgesics|analgesics|mesh-ancestor
153883631|NCT04328493|Sensory System Agents|sensory system agents|mesh-ancestor
153883632|NCT04328493|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153883633|NCT04328493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153883634|NCT04328493|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153424566|NCT04036292|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
153424568|NCT04036292|Cholinergic Agents|cholinergic agents|mesh-ancestor
153424569|NCT04036292|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153424570|NCT04036292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153424571|NCT04036292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153424572|NCT03501043|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
153424573|NCT03501043|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
153424574|NCT03501043|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153424575|NCT03501043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153424576|NCT03501043|Cholinergic Agents|cholinergic agents|mesh-ancestor
153424577|NCT03501043|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153424578|NCT03501043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153424580|NCT00377390|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
153424581|NCT00377390|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153424582|NCT00377390|Respiratory System Agents|respiratory system agents|mesh-ancestor
153424583|NCT03820388|Propofol|propofol|mesh-list
153424584|NCT03820388|Etomidate|etomidate|mesh-list
153424585|NCT03820388|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153424586|NCT03820388|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153424587|NCT03820388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153424588|NCT03820388|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153424589|NCT03820388|Anesthetics, General|anesthetics, general|mesh-ancestor
153424590|NCT03820388|Anesthetics|anesthetics|mesh-ancestor
153424591|NCT03264157|Vaccines|vaccines|mesh-list
153424592|NCT03264157|Immunologic Factors|immunologic factors|mesh-ancestor
153424596|NCT04029584|Antitubercular Agents|antitubercular agents|mesh-ancestor
153424597|NCT04029584|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153424598|NCT04029584|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153424599|NCT04029584|Leprostatic Agents|leprostatic agents|mesh-ancestor
153424600|NCT04029584|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153424601|NCT04029584|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153883635|NCT04328493|Filaricides|filaricides|mesh-ancestor
153883636|NCT04328493|Antinematodal Agents|antinematodal agents|mesh-ancestor
153883637|NCT04328493|Anthelmintics|anthelmintics|mesh-ancestor
153883638|NCT05139524|Immunoglobulin G|immunoglobulin g|mesh-list
153883639|NCT05139524|Immunologic Factors|immunologic factors|mesh-ancestor
153883640|NCT05139524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153883641|NCT01327599|Timolol|timolol|mesh-list
153883642|NCT01327599|Travoprost|travoprost|mesh-list
153883643|NCT01327599|Ophthalmic Solutions|ophthalmic solutions|mesh-list
153883644|NCT01327599|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
153883646|NCT01327599|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
153883647|NCT01327599|Adrenergic Agents|adrenergic agents|mesh-ancestor
153883648|NCT01327599|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153883649|NCT01327599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153883650|NCT01327599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153883651|NCT01327599|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153883652|NCT01327599|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153883653|NCT04498871|Nilotinib|nilotinib|mesh-list
153883654|NCT04498871|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153883655|NCT04498871|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153883656|NCT04498871|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153883657|NCT04498871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153883658|NCT01193257|Prednisone|prednisone|mesh-list
153883659|NCT01193257|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153883660|NCT01193257|Glucocorticoids|glucocorticoids|mesh-ancestor
153883661|NCT01193257|Hormones|hormones|mesh-ancestor
153883662|NCT01193257|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153883663|NCT01193257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153883664|NCT01193257|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153883665|NCT01193257|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153883666|NCT05138978|Listerine|listerine|mesh-list
153883667|NCT05138978|Sodium Fluoride|sodium fluoride|mesh-list
153883669|NCT05138978|Protective Agents|protective agents|mesh-ancestor
153883670|NCT05138978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153424602|NCT04029584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153424603|NCT04029584|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
153424604|NCT04029584|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
153424605|NCT04029584|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
153424606|NCT04029584|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
153424607|NCT04029584|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
153424608|NCT04029584|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
153424610|NCT04028960|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
153424611|NCT04028960|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153424612|NCT04028960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153424613|NCT03502915|Nitrous Oxide|nitrous oxide|mesh-list
153424614|NCT03502915|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
153424615|NCT03502915|Anesthetics, General|anesthetics, general|mesh-ancestor
153424617|NCT03502915|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153424618|NCT03502915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153424619|NCT03502915|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153424620|NCT03502915|Analgesics|analgesics|mesh-ancestor
153424621|NCT03502915|Sensory System Agents|sensory system agents|mesh-ancestor
153424622|NCT03502915|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153424623|NCT03506347|Vancomycin|vancomycin|mesh-list
153424624|NCT03506347|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153424625|NCT03506347|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153424626|NCT03266419|Rocuronium|rocuronium|mesh-list
153424627|NCT03266419|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
153424628|NCT03266419|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
153424629|NCT03266419|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
153424630|NCT03266419|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153424631|NCT03266419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153424632|NCT00377468|Dronabinol|dronabinol|mesh-list
153883671|NCT05138978|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
153883672|NCT05138978|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153883673|NCT05138861|Ophthalmic Solutions|ophthalmic solutions|mesh-list
153883674|NCT05138861|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
153883675|NCT02893176|Macitentan|macitentan|mesh-list
153883676|NCT02893176|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
153883677|NCT02893176|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
153883678|NCT02893176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153883679|NCT02893176|Endothelin B Receptor Antagonists|endothelin b receptor antagonists|mesh-ancestor
153883680|NCT01193218|Empagliflozin|empagliflozin|mesh-list
153883681|NCT01193218|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
153883682|NCT01193218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153883683|NCT01193218|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153883684|NCT01193218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153883685|NCT01193101|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
153883686|NCT01193101|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
153883687|NCT01193101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153883688|NCT04328805|Ibuprofen|ibuprofen|mesh-list
153883689|NCT04328805|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153883690|NCT04328805|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153883691|NCT04328805|Analgesics|analgesics|mesh-ancestor
153883692|NCT04328805|Sensory System Agents|sensory system agents|mesh-ancestor
153883693|NCT04328805|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153883694|NCT04328805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153883695|NCT04328805|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153883696|NCT04328805|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153883697|NCT04328805|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153883698|NCT04328805|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153883699|NCT04328805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153883701|NCT04329000|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
153883702|NCT04329000|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153883703|NCT04329000|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
153883704|NCT04329000|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153883705|NCT04329000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153883707|NCT01192399|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
153883708|NCT01192399|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153883709|NCT01192399|Immunologic Factors|immunologic factors|mesh-ancestor
153883711|NCT01176916|Exemestane|exemestane|mesh-list
153883712|NCT01176916|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153883713|NCT01176916|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
153883714|NCT01176916|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153883715|NCT01176916|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153883716|NCT01176916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153883717|NCT01176916|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
153883718|NCT01176916|Hormone Antagonists|hormone antagonists|mesh-ancestor
153883719|NCT01176916|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153883720|NCT01176916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153883721|NCT02894268|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
153883722|NCT02894268|Doxycycline|doxycycline|mesh-list
153883723|NCT02894268|Furazolidone|furazolidone|mesh-list
153883724|NCT02894268|Bismuth tripotassium dicitrate|bismuth tripotassium dicitrate|mesh-list
153883725|NCT02894268|Esomeprazole|esomeprazole|mesh-list
153883726|NCT02894268|Bismuth|bismuth|mesh-list
153883727|NCT02894268|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153883728|NCT02894268|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
153883729|NCT02894268|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153883730|NCT02894268|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
153883731|NCT02894268|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153424665|NCT03799484|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153424666|NCT03799484|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
153424667|NCT03799484|Emollients|emollients|mesh-ancestor
153424668|NCT03799484|Dermatologic Agents|dermatologic agents|mesh-ancestor
153424669|NCT00377546|Ketorolac|ketorolac|mesh-list
153424670|NCT00377546|Nepafenac|nepafenac|mesh-list
153424671|NCT00377546|Bromfenac|bromfenac|mesh-list
153424672|NCT00377546|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153424673|NCT00377546|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153424674|NCT00377546|Analgesics|analgesics|mesh-ancestor
153424675|NCT00377546|Sensory System Agents|sensory system agents|mesh-ancestor
153424676|NCT00377546|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153424677|NCT00377546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153424678|NCT00377546|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153424679|NCT00377546|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153883738|NCT02894268|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
153883739|NCT02894268|Antitrichomonal Agents|antitrichomonal agents|mesh-ancestor
153883740|NCT02894268|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
153883741|NCT01600625|Minocycline|minocycline|mesh-list
153883742|NCT01600625|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153883743|NCT01600625|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153883744|NCT01600742|Vorinostat|vorinostat|mesh-list
153883745|NCT01600742|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153883747|NCT01600742|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153883748|NCT01600742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153883749|NCT01327482|Raltegravir Potassium|raltegravir potassium|mesh-list
153883750|NCT01327482|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153883751|NCT01327482|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153883752|NCT01327482|Antiviral Agents|antiviral agents|mesh-ancestor
153883753|NCT01327482|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153883754|NCT01327482|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
153424688|NCT04005404|Anesthetics, Local|anesthetics, local|mesh-ancestor
153424690|NCT04005404|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153424691|NCT04005404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153424692|NCT04005404|Sensory System Agents|sensory system agents|mesh-ancestor
153883755|NCT01327482|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
153883756|NCT01327482|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153883757|NCT01327482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153883758|NCT02893488|Lamivudine|lamivudine|mesh-list
153883759|NCT02893488|Dolutegravir|dolutegravir|mesh-list
153883760|NCT02893488|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153883761|NCT02893488|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153883762|NCT02893488|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153883763|NCT02893488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153883765|NCT02893488|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153883766|NCT02893488|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153883767|NCT02893488|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153883768|NCT02893488|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
153883769|NCT02893488|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
153883770|NCT04328883|Aspirin|aspirin|mesh-list
153883771|NCT04328883|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153883772|NCT04328883|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153883773|NCT04328883|Analgesics|analgesics|mesh-ancestor
153883774|NCT04328883|Sensory System Agents|sensory system agents|mesh-ancestor
153883775|NCT04328883|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153883776|NCT04328883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153883777|NCT04328883|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153883778|NCT04328883|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153883779|NCT04328883|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153883780|NCT04328883|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153883781|NCT04328883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153883782|NCT04328883|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153883783|NCT04328883|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153883784|NCT04328883|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153883786|NCT01600235|Phenylephrine|phenylephrine|mesh-list
153883787|NCT01600235|Oxymetazoline|oxymetazoline|mesh-list
153883788|NCT01600235|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
153883789|NCT01600235|Mydriatics|mydriatics|mesh-ancestor
153883790|NCT01600235|Autonomic Agents|autonomic agents|mesh-ancestor
153883791|NCT01600235|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153883792|NCT01600235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153883793|NCT01600235|Sympathomimetics|sympathomimetics|mesh-ancestor
153883794|NCT01600235|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
153883795|NCT01600235|Nasal Decongestants|nasal decongestants|mesh-ancestor
153883796|NCT01600235|Respiratory System Agents|respiratory system agents|mesh-ancestor
153883797|NCT01600235|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
153883798|NCT01600235|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153883799|NCT01600235|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153883800|NCT01600235|Adrenergic Agents|adrenergic agents|mesh-ancestor
153883801|NCT01600235|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153883802|NCT01600235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153883803|NCT01600235|Protective Agents|protective agents|mesh-ancestor
153883804|NCT02893254|Adalimumab|adalimumab|mesh-list
153883805|NCT02893254|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
153883806|NCT02893254|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153883807|NCT02893254|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153883808|NCT00592137|Calcium, Dietary|calcium, dietary|mesh-list
153883809|NCT00592137|Calcium|calcium|mesh-list
153883810|NCT00592137|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153883811|NCT00592137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153883812|NCT00592137|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153883813|NCT04455776|Propofol|propofol|mesh-list
153883814|NCT04455776|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153883815|NCT04455776|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153883816|NCT04455776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153883817|NCT04455776|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153883818|NCT04455776|Anesthetics, General|anesthetics, general|mesh-ancestor
153883819|NCT04455776|Anesthetics|anesthetics|mesh-ancestor
153883820|NCT04135092|Aldesleukin|aldesleukin|mesh-list
153883821|NCT04135092|Cyclophosphamide|cyclophosphamide|mesh-list
153883822|NCT04135092|Pembrolizumab|pembrolizumab|mesh-list
153883823|NCT04135092|Fludarabine|fludarabine|mesh-list
153883824|NCT04135092|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153424758|NCT05313386|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153424759|NCT05313386|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
153424760|NCT05313386|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153424761|NCT05313386|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153424762|NCT05313386|Adrenergic Agents|adrenergic agents|mesh-ancestor
153424763|NCT05313386|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153424764|NCT05313386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153424765|NCT04018664|Nalbuphine|nalbuphine|mesh-list
153424766|NCT04018664|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
153424767|NCT04018664|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153424768|NCT04018664|Narcotics|narcotics|mesh-ancestor
153424769|NCT04018664|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153424770|NCT04018664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153424772|NCT04018664|Sensory System Agents|sensory system agents|mesh-ancestor
153424773|NCT04018664|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153424774|NCT03031340|Pregabalin|pregabalin|mesh-list
153424775|NCT03031340|Analgesics|analgesics|mesh-ancestor
153424776|NCT03031340|Sensory System Agents|sensory system agents|mesh-ancestor
153424777|NCT03031340|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153424778|NCT03031340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153424779|NCT03031340|Anticonvulsants|anticonvulsants|mesh-ancestor
153424780|NCT03031340|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153424781|NCT03031340|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153424782|NCT03031340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153424783|NCT03031340|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153424784|NCT03031340|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153424785|NCT03031340|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153424786|NCT03031340|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153424787|NCT03031340|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153424788|NCT03405259|Fluorides|fluorides|mesh-list
153424789|NCT03405259|Fluorides, Topical|fluorides, topical|mesh-list
153424790|NCT03405259|Cariostatic Agents|cariostatic agents|mesh-ancestor
153883825|NCT04135092|Immunologic Factors|immunologic factors|mesh-ancestor
153883826|NCT04135092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153883827|NCT04135092|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153883828|NCT04135092|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153883829|NCT04135092|Alkylating Agents|alkylating agents|mesh-ancestor
153883830|NCT04135092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153883831|NCT04135092|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153883832|NCT04135092|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153883833|NCT04135092|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153883835|NCT04135092|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153883836|NCT04135092|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153883837|NCT04135092|Antiviral Agents|antiviral agents|mesh-ancestor
153883838|NCT04135092|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153883839|NCT00592215|Misoprostol|misoprostol|mesh-list
153883841|NCT00592215|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
153883842|NCT00592215|Abortifacient Agents|abortifacient agents|mesh-ancestor
153883843|NCT00592215|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153883844|NCT00592215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153883845|NCT00592215|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
153883846|NCT00592215|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153883847|NCT00592215|Oxytocics|oxytocics|mesh-ancestor
153883848|NCT00592215|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
153883849|NCT00592215|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
153883850|NCT00592215|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
153883851|NCT00592215|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
153883852|NCT00592215|Contraceptive Agents|contraceptive agents|mesh-ancestor
153883853|NCT00592215|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
153883854|NCT00592215|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
153883855|NCT00592215|Hormone Antagonists|hormone antagonists|mesh-ancestor
153883856|NCT00592215|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153883857|NCT00592215|Luteolytic Agents|luteolytic agents|mesh-ancestor
153883858|NCT00592215|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
153883859|NCT00592215|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
153883860|NCT00592332|Alprazolam|alprazolam|mesh-list
153883861|NCT00592332|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153883862|NCT00592332|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153883863|NCT00592332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153424801|NCT03513757|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153424802|NCT03513757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153424803|NCT03513757|Sensory System Agents|sensory system agents|mesh-ancestor
153424804|NCT03513757|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153424805|NCT03513757|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153424806|NCT03513757|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
153424807|NCT03513757|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153424808|NCT03513757|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153424809|NCT03513757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153424810|NCT03513757|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153424811|NCT03513757|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153424812|NCT03513757|Analgesics|analgesics|mesh-ancestor
153424813|NCT03513757|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
153424814|NCT03513757|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153424815|NCT03513757|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153424816|NCT03513757|Adrenergic Agents|adrenergic agents|mesh-ancestor
153424817|NCT03513757|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153424818|NCT03513757|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153424819|NCT03513757|Anesthetics, General|anesthetics, general|mesh-ancestor
153424821|NCT03513757|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
153883864|NCT00592332|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153883865|NCT00592332|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153883866|NCT00592332|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153883868|NCT00592332|GABA Agents|gaba agents|mesh-ancestor
153883869|NCT00592332|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153883870|NCT00592332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153883872|NCT04477382|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153883873|NCT04477382|Keratolytic Agents|keratolytic agents|mesh-ancestor
153883874|NCT04477382|Dermatologic Agents|dermatologic agents|mesh-ancestor
153883875|NCT01600274|Dienogest|dienogest|mesh-list
153883876|NCT01600274|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
153883877|NCT01600274|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
153883878|NCT01600274|Ethinyl Estradiol|ethinyl estradiol|mesh-list
153883879|NCT01600274|Estradiol|estradiol|mesh-list
153883880|NCT01600274|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
153883881|NCT01600274|Nandrolone|nandrolone|mesh-list
153883882|NCT01600274|Estrogens|estrogens|mesh-ancestor
153883883|NCT01600274|Hormones|hormones|mesh-ancestor
153883884|NCT01600274|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153883885|NCT01600274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153883886|NCT01600274|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
153883887|NCT01600274|Contraceptive Agents|contraceptive agents|mesh-ancestor
153883888|NCT01600274|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153883889|NCT01600274|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
153883890|NCT01600274|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
153883891|NCT01600274|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
153883892|NCT01600274|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
153883893|NCT01600274|Hormone Antagonists|hormone antagonists|mesh-ancestor
153883895|NCT01600274|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153883897|NCT01600274|Anabolic Agents|anabolic agents|mesh-ancestor
153883898|NCT01176565|Nicardipine|nicardipine|mesh-list
153883899|NCT01176565|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153883900|NCT01176565|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153883901|NCT01176565|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153883902|NCT01176565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153883903|NCT01176565|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153883904|NCT01176565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153883905|NCT01176565|Vasodilator Agents|vasodilator agents|mesh-ancestor
153883907|NCT04374123|Immunoglobulin M|immunoglobulin m|mesh-list
153883908|NCT04374123|Immunologic Factors|immunologic factors|mesh-ancestor
153883909|NCT04374123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153883910|NCT01113541|Ziprasidone|ziprasidone|mesh-list
153883911|NCT01113541|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153883915|NCT01113541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153883916|NCT01113541|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153424853|NCT03754556|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
153424854|NCT03754556|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
153424855|NCT03521479|Squaric acid dibutyl ester|squaric acid dibutyl ester|mesh-list
153424856|NCT03521479|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153424857|NCT03521479|Immunologic Factors|immunologic factors|mesh-ancestor
153424858|NCT03521479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153424859|NCT01495988|Bevacizumab|bevacizumab|mesh-list
153424860|NCT01495988|Vemurafenib|vemurafenib|mesh-list
153424861|NCT01495988|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153424862|NCT01495988|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153883917|NCT01113541|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153883918|NCT01113541|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153883919|NCT01113541|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153883920|NCT01113541|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
153883921|NCT01113541|Dopamine Agents|dopamine agents|mesh-ancestor
153883922|NCT00591708|Calcium, Dietary|calcium, dietary|mesh-list
153883923|NCT00591708|Citric Acid|citric acid|mesh-list
153883926|NCT00591708|Calcium citrate malate|calcium citrate malate|mesh-list
153883927|NCT00591708|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153883928|NCT00591708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153883929|NCT00591708|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153883930|NCT00591708|Anticoagulants|anticoagulants|mesh-ancestor
153883931|NCT00591708|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
153883932|NCT00591708|Chelating Agents|chelating agents|mesh-ancestor
153883933|NCT00591708|Sequestering Agents|sequestering agents|mesh-ancestor
153883934|NCT00591708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153883935|NCT01176058|Fluconazole|fluconazole|mesh-list
153883936|NCT01176058|Anidulafungin|anidulafungin|mesh-list
153883937|NCT01176058|Antifungal Agents|antifungal agents|mesh-ancestor
153883938|NCT01176058|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153883939|NCT01176058|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
153883940|NCT01176058|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153883941|NCT01176058|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153883942|NCT01176058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153883943|NCT01176058|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153883944|NCT01176058|Hormone Antagonists|hormone antagonists|mesh-ancestor
153883945|NCT01176058|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153883946|NCT01176058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153883947|NCT01176058|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
153883948|NCT01176058|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
153883949|NCT04328766|Fexuprazan|fexuprazan|mesh-list
153883950|NCT04328766|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153883951|NCT02273765|Tenofovir|tenofovir|mesh-list
153883952|NCT02273765|Lamivudine|lamivudine|mesh-list
153883953|NCT02273765|Efavirenz|efavirenz|mesh-list
153883954|NCT02273765|Raltegravir Potassium|raltegravir potassium|mesh-list
153883955|NCT02273765|Antiviral Agents|antiviral agents|mesh-ancestor
153883956|NCT02273765|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153883957|NCT02273765|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153883958|NCT02273765|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153883959|NCT02273765|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153883960|NCT02273765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153883961|NCT02273765|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153883962|NCT02273765|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153883963|NCT02273765|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
153883964|NCT02273765|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153883966|NCT02273765|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
153883967|NCT02273765|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
153883968|NCT02273765|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
153883970|NCT02273765|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
153424863|NCT01495988|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153883972|NCT01607333|Anticonvulsants|anticonvulsants|mesh-ancestor
153883973|NCT01607333|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153883974|NCT01607333|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153883976|NCT01607333|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153883977|NCT01607333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153883978|NCT01607333|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153424918|NCT02892500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153424919|NCT02892500|Sensory System Agents|sensory system agents|mesh-ancestor
153424920|NCT02892500|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153424921|NCT02892500|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153424923|NCT02892500|Hormones|hormones|mesh-ancestor
153424924|NCT02892500|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153424925|NCT02892500|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153424926|NCT02892500|Respiratory System Agents|respiratory system agents|mesh-ancestor
153883979|NCT01607333|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153883980|NCT01607333|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153883981|NCT01607333|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153883982|NCT01607333|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153883983|NCT01601093|Sulbactam|sulbactam|mesh-list
153883984|NCT01601093|Cefoperazone|cefoperazone|mesh-list
153883985|NCT01601093|Sulperazone|sulperazone|mesh-list
153883986|NCT01601093|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153883987|NCT01601093|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153883988|NCT01601093|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
153883989|NCT01601093|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153883990|NCT01601093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153883991|NCT01601093|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
153883992|NCT04366830|Remestemcel-l|remestemcel-l|mesh-list
153883993|NCT04366830|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153883994|NCT04366830|Antiviral Agents|antiviral agents|mesh-ancestor
153883995|NCT04366830|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153883996|NCT01175824|Insulin|insulin|mesh-list
153883997|NCT01175824|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
153883998|NCT01175824|Insulin Glargine|insulin glargine|mesh-list
153883999|NCT01175824|Insulin Lispro|insulin lispro|mesh-list
153884000|NCT01175824|Protamines|protamines|mesh-list
153884001|NCT01175824|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153884002|NCT01175824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153884004|NCT01175824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153884006|NCT01175707|Vancomycin|vancomycin|mesh-list
153884007|NCT01175707|Daptomycin|daptomycin|mesh-list
153884008|NCT01175707|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153884009|NCT01175707|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153884010|NCT01112059|Doxycycline|doxycycline|mesh-list
153884011|NCT01112059|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153884012|NCT01112059|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153884013|NCT01112059|Antimalarials|antimalarials|mesh-ancestor
153884014|NCT01112059|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153884015|NCT01112059|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153884016|NCT01175668|Clonidine|clonidine|mesh-list
153884017|NCT01175668|Phenobarbital|phenobarbital|mesh-list
153884018|NCT01175668|Analgesics|analgesics|mesh-ancestor
153884019|NCT01175668|Sensory System Agents|sensory system agents|mesh-ancestor
153884020|NCT01175668|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153884021|NCT01175668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153884022|NCT01175668|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153884023|NCT01175668|Sympatholytics|sympatholytics|mesh-ancestor
153884024|NCT01175668|Autonomic Agents|autonomic agents|mesh-ancestor
153884025|NCT01175668|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
153884026|NCT01175668|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153884027|NCT01175668|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153884028|NCT01175668|Adrenergic Agents|adrenergic agents|mesh-ancestor
153884029|NCT01175668|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153884030|NCT01175668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153884031|NCT01175668|Anticonvulsants|anticonvulsants|mesh-ancestor
153884033|NCT01175668|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153424927|NCT00378872|Tranexamic Acid|tranexamic acid|mesh-list
153884034|NCT01175668|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
153884035|NCT01175668|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
153884036|NCT01175668|GABA Modulators|gaba modulators|mesh-ancestor
153884037|NCT01175668|GABA Agents|gaba agents|mesh-ancestor
153884038|NCT01175668|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
153884039|NCT01175668|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
153884040|NCT01175668|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
153884041|NCT01601327|Methyltestosterone|methyltestosterone|mesh-list
153884042|NCT01601327|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
153884043|NCT01601327|Testosterone|testosterone|mesh-list
153424985|NCT00378092|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153424986|NCT00378092|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153424987|NCT00378092|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153424988|NCT00378092|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
153424989|NCT00378092|Dopamine Agents|dopamine agents|mesh-ancestor
153424991|NCT01347632|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153424992|NCT01347632|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153424993|NCT01347632|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153424994|NCT01347632|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153424995|NCT02679560|Bupivacaine|bupivacaine|mesh-list
153424996|NCT02679560|Ropivacaine|ropivacaine|mesh-list
153424997|NCT02679560|Anesthetics, Local|anesthetics, local|mesh-ancestor
153424998|NCT02679560|Anesthetics|anesthetics|mesh-ancestor
153424999|NCT02679560|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153425000|NCT02679560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153425001|NCT02679560|Sensory System Agents|sensory system agents|mesh-ancestor
153425002|NCT02679560|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153425004|NCT03723980|Calcium|calcium|mesh-list
153884046|NCT01601327|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
153884047|NCT01601327|Androgens|androgens|mesh-ancestor
153884048|NCT01601327|Hormones|hormones|mesh-ancestor
153884049|NCT01601327|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153884050|NCT01601327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153884051|NCT01601327|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153884052|NCT01601327|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153884053|NCT01601327|Anabolic Agents|anabolic agents|mesh-ancestor
153884054|NCT01601327|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153884055|NCT01601366|Contraceptive Agents|contraceptive agents|mesh-list
153884056|NCT01601366|Contraceptives, Oral|contraceptives, oral|mesh-list
153884057|NCT01601366|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-list
153884058|NCT01601366|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153884059|NCT01601366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153884060|NCT01601366|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
153884062|NCT01607762|Risperidone|risperidone|mesh-list
153884063|NCT01607762|Aripiprazole|aripiprazole|mesh-list
153884064|NCT01607762|Quetiapine Fumarate|quetiapine fumarate|mesh-list
153884066|NCT01607762|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153884067|NCT01607762|Serotonin Agents|serotonin agents|mesh-ancestor
153884068|NCT01607762|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153884069|NCT01607762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153884070|NCT01607762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153884071|NCT01607762|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153884072|NCT01607762|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153884073|NCT01607762|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153884074|NCT01607762|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153884075|NCT01607762|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
153884076|NCT01607762|Dopamine Agents|dopamine agents|mesh-ancestor
153425005|NCT03723980|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153425008|NCT01240304|Gemcitabine|gemcitabine|mesh-list
153884077|NCT01607762|Antiemetics|antiemetics|mesh-ancestor
153884078|NCT01607762|Autonomic Agents|autonomic agents|mesh-ancestor
153884079|NCT01607762|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153884080|NCT01607762|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153884081|NCT01607762|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
153884082|NCT01607762|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153884083|NCT01607762|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153884084|NCT01607762|Antidepressive Agents|antidepressive agents|mesh-ancestor
153884085|NCT01607762|Dopamine Agonists|dopamine agonists|mesh-ancestor
153884086|NCT01607762|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
153884087|NCT01607762|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
153884088|NCT01607762|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
153884089|NCT01607762|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
153884090|NCT04327947|Hyaluronic Acid|hyaluronic acid|mesh-list
153884091|NCT04327947|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153884092|NCT04327947|Immunologic Factors|immunologic factors|mesh-ancestor
153884093|NCT04327947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153884094|NCT04327947|Viscosupplements|viscosupplements|mesh-ancestor
153884095|NCT04327947|Protective Agents|protective agents|mesh-ancestor
153884096|NCT01607918|Amoxicillin|amoxicillin|mesh-list
153425037|NCT03591458|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153425038|NCT03591458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153425051|NCT03565328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153425052|NCT03565328|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153425053|NCT03565328|Antimetabolites|antimetabolites|mesh-ancestor
153425056|NCT03565328|Vasodilator Agents|vasodilator agents|mesh-ancestor
153425057|NCT01206296|Gemcitabine|gemcitabine|mesh-list
153884114|NCT01607996|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153884115|NCT01607996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153425058|NCT01206296|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153425059|NCT01206296|Antimetabolites|antimetabolites|mesh-ancestor
153425060|NCT01206296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153425061|NCT01206296|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153425062|NCT02593682|Suvorexant|suvorexant|mesh-list
153425063|NCT02593682|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
153425064|NCT02593682|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153425065|NCT02593682|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153425066|NCT02593682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153425067|NCT02593682|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
153425068|NCT02593682|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153425069|NCT02593682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153425070|NCT01200602|Megestrol|megestrol|mesh-list
153425071|NCT01200602|Megestrol Acetate|megestrol acetate|mesh-list
153425072|NCT01200602|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
153425073|NCT01200602|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
153425074|NCT01200602|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
153425075|NCT01200602|Contraceptive Agents|contraceptive agents|mesh-ancestor
153425076|NCT01200602|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153425077|NCT01200602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153425078|NCT01200602|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
153425079|NCT01200602|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
153884127|NCT01601795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153884128|NCT01601912|Dexetimide|dexetimide|mesh-list
153884129|NCT01601912|Citalopram|citalopram|mesh-list
153884130|NCT01601912|Escitalopram|escitalopram|mesh-list
153884131|NCT01601912|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
153884132|NCT01601912|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
153884133|NCT01601912|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153884134|NCT01601912|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153884135|NCT01601912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153884136|NCT01601912|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153884137|NCT01601912|Serotonin Agents|serotonin agents|mesh-ancestor
153884138|NCT01601912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153884139|NCT01601912|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
153425080|NCT01200602|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153425081|NCT01200602|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153425090|NCT01194908|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153425091|NCT01194908|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153425092|NCT01194908|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
153425093|NCT01194908|Hormone Antagonists|hormone antagonists|mesh-ancestor
153425094|NCT01194908|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153425095|NCT01194908|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153425096|NCT01194908|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153425097|NCT01194908|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
153425098|NCT01194908|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
153425099|NCT01194908|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153425100|NCT01194908|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
153425102|NCT01163084|Goserelin|goserelin|mesh-list
153425103|NCT01163084|Fertility Agents, Female|fertility agents, female|mesh-ancestor
153425104|NCT01163084|Fertility Agents|fertility agents|mesh-ancestor
153425105|NCT01163084|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153425106|NCT01163084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153425107|NCT01163084|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153425108|NCT01163084|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153425109|NCT01155518|Clomiphene|clomiphene|mesh-list
153425110|NCT01155518|Testosterone|testosterone|mesh-list
153884142|NCT01601912|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
153884143|NCT01601912|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
153884144|NCT01601912|Parasympatholytics|parasympatholytics|mesh-ancestor
153884146|NCT01601912|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153884147|NCT01601912|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
153884151|NCT01601912|Adrenergic Agents|adrenergic agents|mesh-ancestor
153884152|NCT01111825|Sirolimus|sirolimus|mesh-list
153884153|NCT01111825|Temsirolimus|temsirolimus|mesh-list
153884154|NCT01111825|MTOR Inhibitors|mtor inhibitors|mesh-list
153884155|NCT01111825|Neratinib|neratinib|mesh-list
153884156|NCT01111825|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153884157|NCT01111825|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153884158|NCT01111825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153884159|NCT01111825|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153884160|NCT01111825|Immunologic Factors|immunologic factors|mesh-ancestor
153884161|NCT01111825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153884162|NCT01111825|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153884163|NCT01111825|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153884164|NCT01111825|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153884165|NCT01111825|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153884166|NCT01111825|Antifungal Agents|antifungal agents|mesh-ancestor
153884171|NCT01175590|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153425113|NCT01155518|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153425114|NCT01155518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153425115|NCT01155518|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
153425116|NCT01155518|Hormone Antagonists|hormone antagonists|mesh-ancestor
153425117|NCT01155518|Fertility Agents, Female|fertility agents, female|mesh-ancestor
153425118|NCT01155518|Fertility Agents|fertility agents|mesh-ancestor
153425119|NCT01155518|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153425120|NCT01155518|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
153425121|NCT01155518|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
153425122|NCT03490916|Acetazolamide|acetazolamide|mesh-list
153425123|NCT03490916|Anticonvulsants|anticonvulsants|mesh-ancestor
153425124|NCT03490916|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
153425125|NCT03490916|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153425126|NCT03490916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153425127|NCT03490916|Diuretics|diuretics|mesh-ancestor
153425132|NCT03333746|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153425133|NCT03333746|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153425134|NCT03333746|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153425135|NCT03333746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153425136|NCT03333746|Immunologic Factors|immunologic factors|mesh-ancestor
153425137|NCT03333746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153425138|NCT03333746|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153425139|NCT03333746|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153425140|NCT03333746|Growth Substances|growth substances|mesh-ancestor
153425141|NCT03333746|Growth Inhibitors|growth inhibitors|mesh-ancestor
153884193|NCT01111552|Antidepressive Agents|antidepressive agents|mesh-ancestor
153884195|NCT01111552|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153884196|NCT01111552|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153884197|NCT01111552|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153884198|NCT01111552|Dopamine Agonists|dopamine agonists|mesh-ancestor
153884199|NCT01111552|Dopamine Agents|dopamine agents|mesh-ancestor
153884200|NCT01111552|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
153884201|NCT01111552|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
153884202|NCT01111552|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
153425155|NCT01139996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153425157|NCT02417870|Interleukin-2|interleukin-2|mesh-list
153425158|NCT02417870|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153425159|NCT02417870|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153884205|NCT01111552|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
153884206|NCT01602185|Levomethorphan|levomethorphan|mesh-list
153884207|NCT01602185|Memantine|memantine|mesh-list
153884208|NCT01602185|Dextromethorphan|dextromethorphan|mesh-list
153884209|NCT01602185|Antitussive Agents|antitussive agents|mesh-list
153884210|NCT01602185|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
153884211|NCT01602185|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
153884212|NCT01602185|Dopamine Agents|dopamine agents|mesh-ancestor
153884213|NCT01602185|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153884214|NCT01602185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153884215|NCT01602185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153884216|NCT01602185|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
153884217|NCT01602185|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
153425160|NCT02417870|Analgesics|analgesics|mesh-ancestor
153425161|NCT02417870|Sensory System Agents|sensory system agents|mesh-ancestor
153425162|NCT02417870|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153425163|NCT02417870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153425164|NCT02417870|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153425165|NCT02417870|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153425166|NCT02417870|Antiviral Agents|antiviral agents|mesh-ancestor
153425167|NCT02417870|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153425168|NCT01131884|Alendronate|alendronate|mesh-list
153425169|NCT01131884|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153425170|NCT01131884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153425171|NCT02389712|Lamotrigine|lamotrigine|mesh-list
153425172|NCT02389712|Fluoxetine|fluoxetine|mesh-list
153425176|NCT02389712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153425177|NCT02389712|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153884228|NCT01602302|Certolizumab Pegol|certolizumab pegol|mesh-list
153884229|NCT01602302|Etanercept|etanercept|mesh-list
153884230|NCT01602302|Abatacept|abatacept|mesh-list
153884231|NCT01602302|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
153884232|NCT01602302|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153884233|NCT01602302|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153884234|NCT01602302|Dermatologic Agents|dermatologic agents|mesh-ancestor
153884235|NCT01602302|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153884236|NCT01602302|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153884237|NCT01602302|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153884238|NCT01602302|Analgesics|analgesics|mesh-ancestor
153884239|NCT01602302|Sensory System Agents|sensory system agents|mesh-ancestor
153884240|NCT01602302|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153884241|NCT01602302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153884242|NCT01602302|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153884243|NCT01602302|Immunologic Factors|immunologic factors|mesh-ancestor
153884244|NCT01602302|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153425186|NCT02389712|Anticonvulsants|anticonvulsants|mesh-ancestor
153425187|NCT02389712|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153425189|NCT02389712|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153425190|NCT02389712|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153425191|NCT02389712|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153425192|NCT02389712|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153425193|NCT02369744|Tamsulosin|tamsulosin|mesh-list
153425194|NCT02369744|Silodosin|silodosin|mesh-list
153425195|NCT02369744|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
153425196|NCT02369744|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
153425197|NCT02369744|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
153425198|NCT02369744|Adrenergic Agents|adrenergic agents|mesh-ancestor
153425199|NCT02369744|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153425200|NCT02369744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153425202|NCT02369744|Urological Agents|urological agents|mesh-ancestor
153425204|NCT03577171|Antiviral Agents|antiviral agents|mesh-ancestor
153425227|NCT01078844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153425228|NCT01078844|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
153425229|NCT01078844|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
153425231|NCT00376051|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
153425232|NCT00376051|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153425233|NCT00376051|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153425234|NCT00376051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153425235|NCT00376051|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153425237|NCT00376051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153884283|NCT01608464|Antimetabolites|antimetabolites|mesh-ancestor
153884284|NCT01608464|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153884285|NCT01608464|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153884286|NCT01608464|Immunologic Factors|immunologic factors|mesh-ancestor
153884287|NCT01608464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153884288|NCT01608464|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
153884289|NCT01608464|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153884290|NCT01608464|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153884291|NCT01608698|Drospirenone|drospirenone|mesh-list
153884292|NCT01608698|Ethinyl Estradiol|ethinyl estradiol|mesh-list
153884293|NCT01608698|Chlormadinone Acetate|chlormadinone acetate|mesh-list
153884294|NCT01608698|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
153884295|NCT01608698|Hormone Antagonists|hormone antagonists|mesh-ancestor
153884296|NCT01608698|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153884297|NCT01608698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153884298|NCT01608698|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
153425238|NCT00376051|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
153425239|NCT00376051|Antidepressive Agents|antidepressive agents|mesh-ancestor
153425240|NCT00376051|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153425241|NCT01072526|Cyclosporine|cyclosporine|mesh-list
153425242|NCT01072526|Lubricant Eye Drops|lubricant eye drops|mesh-list
153425243|NCT01072526|Cyclosporins|cyclosporins|mesh-list
153425244|NCT01072526|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153425245|NCT01072526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153425246|NCT01072526|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153425247|NCT01072526|Immunologic Factors|immunologic factors|mesh-ancestor
153425248|NCT01072526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153425249|NCT01072526|Antifungal Agents|antifungal agents|mesh-ancestor
153425250|NCT01072526|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153425251|NCT01072526|Dermatologic Agents|dermatologic agents|mesh-ancestor
153425252|NCT01072526|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153425253|NCT01072526|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
153884305|NCT01608698|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153884306|NCT01608698|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
153884308|NCT01608698|Hormones|hormones|mesh-ancestor
153884309|NCT01608698|Androgen Antagonists|androgen antagonists|mesh-ancestor
153884310|NCT01608698|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
153884311|NCT04310254|Edetic Acid|edetic acid|mesh-list
153884312|NCT04310254|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
153884313|NCT04310254|Pentetic Acid|pentetic acid|mesh-list
153884314|NCT04310254|Anticoagulants|anticoagulants|mesh-ancestor
153884315|NCT04310254|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
153425254|NCT01072526|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
153425255|NCT01072526|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
153425256|NCT05312840|Carboplatin|carboplatin|mesh-list
153425257|NCT05312840|Gemcitabine|gemcitabine|mesh-list
153425258|NCT05312840|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153425259|NCT05312840|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153425260|NCT05312840|Antimetabolites|antimetabolites|mesh-ancestor
153425261|NCT05312840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153425263|NCT00376129|Dermatologic Agents|dermatologic agents|mesh-ancestor
153425264|NCT00376129|Immunologic Factors|immunologic factors|mesh-ancestor
153425265|NCT00376129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153425267|NCT01035944|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153425268|NCT01035944|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153425269|NCT01035944|Antimetabolites|antimetabolites|mesh-ancestor
153884321|NCT04310254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153884322|NCT04310254|Iron Chelating Agents|iron chelating agents|mesh-ancestor
153884323|NCT01603511|Charcoal|charcoal|mesh-list
153884324|NCT01603511|Antidotes|antidotes|mesh-ancestor
153884325|NCT01603511|Protective Agents|protective agents|mesh-ancestor
153884326|NCT01603511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153884327|NCT01603745|Drospirenone and ethinyl estradiol combination|drospirenone and ethinyl estradiol combination|mesh-list
153884328|NCT01603745|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153884329|NCT01603745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153884330|NCT01174186|Adalimumab|adalimumab|mesh-list
153884331|NCT01174186|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
153884332|NCT01174186|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153884333|NCT01174186|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153884334|NCT01609049|Ribavirin|ribavirin|mesh-list
153884335|NCT01609049|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
153884336|NCT01609049|Antimetabolites|antimetabolites|mesh-ancestor
153425277|NCT00378638|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153425278|NCT00378638|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153425279|NCT00378638|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153425280|NCT00378638|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153425281|NCT00378638|Growth Substances|growth substances|mesh-ancestor
153425282|NCT00378638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153425283|NCT00378638|Growth Inhibitors|growth inhibitors|mesh-ancestor
153425285|NCT03582553|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
153425286|NCT03582553|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153425287|NCT03582553|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
153884339|NCT01609049|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153884341|NCT01609088|Vasodilator Agents|vasodilator agents|mesh-ancestor
153884342|NCT01609127|Capecitabine|capecitabine|mesh-list
153884343|NCT01609127|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153884344|NCT01609127|Antimetabolites|antimetabolites|mesh-ancestor
153884345|NCT01609127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153884346|NCT01609127|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153884347|NCT01609166|Allopurinol|allopurinol|mesh-list
153884348|NCT01609166|Antimetabolites|antimetabolites|mesh-ancestor
153884349|NCT01609166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153884350|NCT01609166|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153884351|NCT01609166|Gout Suppressants|gout suppressants|mesh-ancestor
153884352|NCT01609166|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153884353|NCT01609166|Free Radical Scavengers|free radical scavengers|mesh-ancestor
153884354|NCT01609166|Antioxidants|antioxidants|mesh-ancestor
153884355|NCT01609166|Protective Agents|protective agents|mesh-ancestor
153884356|NCT01609166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153884357|NCT01609205|Adalimumab|adalimumab|mesh-list
153884358|NCT01609205|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
153884359|NCT01609205|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153884360|NCT01609205|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153425302|NCT04331834|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153425303|NCT04331834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153425304|NCT04331834|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153425305|NCT01023620|Pioglitazone|pioglitazone|mesh-list
153425306|NCT01023620|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153425307|NCT01023620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153425308|NCT03595579|Bupropion|bupropion|mesh-list
153425309|NCT03595579|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
153425310|NCT03595579|Antidepressive Agents|antidepressive agents|mesh-ancestor
153425325|NCT02200328|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153425326|NCT02200328|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153425327|NCT04327843|Haloperidol|haloperidol|mesh-list
153425328|NCT04327843|Haloperidol decanoate|haloperidol decanoate|mesh-list
153425329|NCT04327843|Antiemetics|antiemetics|mesh-ancestor
153884368|NCT00592566|Antiemetics|antiemetics|mesh-ancestor
153884369|NCT00592566|Autonomic Agents|autonomic agents|mesh-ancestor
153884370|NCT00592566|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153884371|NCT00592566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153884372|NCT00592566|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153884373|NCT00592566|Glucocorticoids|glucocorticoids|mesh-ancestor
153884374|NCT00592566|Hormones|hormones|mesh-ancestor
153884375|NCT00592566|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153884376|NCT00592566|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153884377|NCT00592566|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153884378|NCT00592566|Hemostatics|hemostatics|mesh-ancestor
153884379|NCT00592566|Coagulants|coagulants|mesh-ancestor
153884380|NCT00592566|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
153884381|NCT00592566|Natriuretic Agents|natriuretic agents|mesh-ancestor
153884382|NCT01111123|Halobetasol|halobetasol|mesh-list
153884383|NCT01111123|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
153884384|NCT01604330|Baclofen|baclofen|mesh-list
153884385|NCT01604330|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
153884386|NCT01604330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153884387|NCT01604330|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
153425349|NCT00979550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153425351|NCT00979550|Immunologic Factors|immunologic factors|mesh-ancestor
153425352|NCT00979550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153425357|NCT00966992|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153425358|NCT00966992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153425360|NCT00379730|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153425361|NCT00379730|Glucocorticoids|glucocorticoids|mesh-ancestor
153425362|NCT00379730|Hormones|hormones|mesh-ancestor
153425363|NCT00379730|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153425364|NCT00379730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153425365|NCT00379730|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153425366|NCT00379730|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153425367|NCT02074904|Topiramate|topiramate|mesh-list
153884416|NCT01609439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153884417|NCT01609439|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153884418|NCT01110382|Amoxicillin|amoxicillin|mesh-list
153884419|NCT01110382|Meropenem|meropenem|mesh-list
153884420|NCT01110382|Clavulanic Acid|clavulanic acid|mesh-list
153884421|NCT01110382|Clavulanic Acids|clavulanic acids|mesh-list
153884422|NCT01110382|Doripenem|doripenem|mesh-list
153884423|NCT01110382|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
153884424|NCT01110382|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153884425|NCT01110382|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153884426|NCT01110382|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
153425372|NCT02043860|Immunologic Factors|immunologic factors|mesh-ancestor
153425373|NCT02043860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153425386|NCT00869414|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
153425387|NCT00869414|Insulin Glargine|insulin glargine|mesh-list
153425388|NCT00869414|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153425389|NCT00869414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153884442|NCT01609517|Anesthetics|anesthetics|mesh-list
153884443|NCT01609517|Anesthetics, Local|anesthetics, local|mesh-ancestor
153884444|NCT01609517|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153884445|NCT01609517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153884446|NCT01609517|Sensory System Agents|sensory system agents|mesh-ancestor
153884447|NCT01609517|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153884448|NCT00593151|Interferons|interferons|mesh-list
153884449|NCT00593151|Interferon-alpha|interferon-alpha|mesh-list
153425390|NCT00843986|Conivaptan|conivaptan|mesh-list
153425391|NCT00843986|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
153425392|NCT00843986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153425393|NCT00843986|Natriuretic Agents|natriuretic agents|mesh-ancestor
153425394|NCT00843986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153425396|NCT03608839|Dexamethasone acetate|dexamethasone acetate|mesh-list
153425397|NCT03608839|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
153425398|NCT03608839|BB 1101|bb 1101|mesh-list
153425399|NCT03608839|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153425400|NCT03608839|Antiemetics|antiemetics|mesh-ancestor
153425401|NCT03608839|Autonomic Agents|autonomic agents|mesh-ancestor
153425402|NCT03608839|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153425403|NCT03608839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153425404|NCT03608839|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153425405|NCT03608839|Glucocorticoids|glucocorticoids|mesh-ancestor
153425406|NCT03608839|Hormones|hormones|mesh-ancestor
153425407|NCT03608839|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153425408|NCT03608839|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153425409|NCT03608839|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153425410|NCT03608839|Protease Inhibitors|protease inhibitors|mesh-ancestor
153884457|NCT01173601|Serotonin|serotonin|mesh-list
153884458|NCT01173601|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-list
153884459|NCT01173601|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
153884460|NCT01173601|Serotonin Agents|serotonin agents|mesh-ancestor
153884461|NCT01173601|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153884462|NCT01173601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153884463|NCT01173601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153884464|NCT01173601|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153884465|NCT01173601|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153884469|NCT01609673|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153425411|NCT03608839|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153425424|NCT03610633|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153425425|NCT03610633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153425426|NCT00832520|Mirtazapine|mirtazapine|mesh-list
153425427|NCT00832520|Antidepressive Agents|antidepressive agents|mesh-ancestor
153425428|NCT00832520|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153425429|NCT00832520|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
153425430|NCT00832520|Histamine Antagonists|histamine antagonists|mesh-ancestor
153425431|NCT00832520|Histamine Agents|histamine agents|mesh-ancestor
153425432|NCT00832520|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153425433|NCT00832520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153425434|NCT00832520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153425435|NCT00832520|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153884479|NCT01173055|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153884480|NCT01173055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153884481|NCT01173055|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153884482|NCT01173055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153884483|NCT01173055|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153884484|NCT01173055|Analgesics|analgesics|mesh-ancestor
153884485|NCT01173055|Sensory System Agents|sensory system agents|mesh-ancestor
153884486|NCT01173055|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153884487|NCT01173055|Antidepressive Agents|antidepressive agents|mesh-ancestor
153884488|NCT01173055|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153884489|NCT00593502|Oseltamivir|oseltamivir|mesh-list
153884492|NCT00593502|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153425437|NCT00832520|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153425438|NCT00832520|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
153425439|NCT00832520|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
153425440|NCT00832520|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
153425441|NCT00832520|Adrenergic Agents|adrenergic agents|mesh-ancestor
153425442|NCT00832520|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
153425443|NCT00832520|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153425445|NCT00832520|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
153425447|NCT03545893|Oxycodone|oxycodone|mesh-list
153425448|NCT03545893|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153425449|NCT03545893|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153425450|NCT03545893|Analgesics|analgesics|mesh-ancestor
153425451|NCT03545893|Sensory System Agents|sensory system agents|mesh-ancestor
153425452|NCT03545893|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153425453|NCT03545893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153884493|NCT00593502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153884495|NCT01609907|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
153884496|NCT01609907|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153884497|NCT01609907|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153884498|NCT01609907|Antimetabolites|antimetabolites|mesh-ancestor
153884499|NCT01609907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153884500|NCT01609907|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153884501|NCT01609907|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
153884502|NCT01609907|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153884503|NCT01609907|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153884504|NCT01609907|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
153884505|NCT01609907|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
153884506|NCT00593580|Cholecalciferol|cholecalciferol|mesh-list
153884507|NCT00593580|Vitamin D|vitamin d|mesh-list
153884508|NCT00593580|Alendronate|alendronate|mesh-list
153884509|NCT00593580|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153425454|NCT03545893|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153425455|NCT03545893|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153425456|NCT03545893|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153425457|NCT03545893|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153425458|NCT03545893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153425459|NCT03545893|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153425460|NCT03545893|Narcotics|narcotics|mesh-ancestor
153425461|NCT03545893|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153425462|NCT01877564|Metformin|metformin|mesh-list
153425463|NCT01877564|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153425464|NCT01877564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153425465|NCT00376987|Zinc Oxide|zinc oxide|mesh-list
153425466|NCT00376987|Dermatologic Agents|dermatologic agents|mesh-ancestor
153425467|NCT00376987|Sunscreening Agents|sunscreening agents|mesh-ancestor
153425468|NCT00376987|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
153884515|NCT04327011|Antifungal Agents|antifungal agents|mesh-ancestor
153884516|NCT04327011|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153884517|NCT04327011|Antimetabolites|antimetabolites|mesh-ancestor
153884518|NCT04327011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153425475|NCT01889420|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153425476|NCT01889420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153425477|NCT01889420|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153425478|NCT01889420|Immunologic Factors|immunologic factors|mesh-ancestor
153425479|NCT01889420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153425480|NCT01889420|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153425481|NCT01889420|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153425482|NCT01889420|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153425483|NCT01889420|Growth Substances|growth substances|mesh-ancestor
153425484|NCT01889420|Growth Inhibitors|growth inhibitors|mesh-ancestor
153425485|NCT00379028|Fluticasone|fluticasone|mesh-list
153425489|NCT00379028|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153425491|NCT00379028|Autonomic Agents|autonomic agents|mesh-ancestor
153425492|NCT00379028|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153425493|NCT00379028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153425494|NCT00379028|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153425495|NCT00379028|Respiratory System Agents|respiratory system agents|mesh-ancestor
153425496|NCT00379028|Dermatologic Agents|dermatologic agents|mesh-ancestor
153425497|NCT00379028|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
153425498|NCT00379028|Glucocorticoids|glucocorticoids|mesh-ancestor
153884547|NCT00593697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153884548|NCT00593697|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153884550|NCT01601522|Desloratadine|desloratadine|mesh-list
153884551|NCT01601522|Histamine Antagonists|histamine antagonists|mesh-list
153884552|NCT01601522|Histamine H1 Antagonists|histamine h1 antagonists|mesh-list
153884553|NCT01601522|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
153884554|NCT01601522|Cholinergic Agents|cholinergic agents|mesh-ancestor
153884555|NCT01601522|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153884556|NCT01601522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153425500|NCT00379028|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153425501|NCT00379028|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
153425502|NCT00379028|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
153425503|NCT00379028|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153425504|NCT00379028|Adrenergic Agents|adrenergic agents|mesh-ancestor
153425505|NCT00379028|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153425506|NCT00379028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153425507|NCT00379262|Capecitabine|capecitabine|mesh-list
153425508|NCT00379262|Fluorouracil|fluorouracil|mesh-list
153425509|NCT00379262|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153425527|NCT00793520|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153425528|NCT00793520|Antidepressive Agents|antidepressive agents|mesh-ancestor
153425529|NCT00793520|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153425530|NCT03621085|Ketamine|ketamine|mesh-list
153425531|NCT03621085|Analgesics|analgesics|mesh-ancestor
153425532|NCT03621085|Sensory System Agents|sensory system agents|mesh-ancestor
153425533|NCT03621085|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153425534|NCT03621085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153425535|NCT03621085|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
153425536|NCT03621085|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153425537|NCT03621085|Anesthetics, General|anesthetics, general|mesh-ancestor
153425538|NCT03621085|Anesthetics|anesthetics|mesh-ancestor
153425539|NCT03621085|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153884595|NCT01605344|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153884596|NCT01605344|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153425540|NCT03621085|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
153425541|NCT03621085|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
153425542|NCT03621085|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153425543|NCT03621085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153425544|NCT00795236|Melatonin|melatonin|mesh-list
153425545|NCT00795236|Antioxidants|antioxidants|mesh-ancestor
153425546|NCT00795236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153425547|NCT00795236|Protective Agents|protective agents|mesh-ancestor
153425548|NCT00795236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153425550|NCT00790478|Melatonin|melatonin|mesh-list
153425551|NCT00790478|Antioxidants|antioxidants|mesh-ancestor
153425552|NCT00790478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153884604|NCT01605344|Protective Agents|protective agents|mesh-ancestor
153884605|NCT01605344|Vitamin B Complex|vitamin b complex|mesh-ancestor
153884607|NCT01605344|Micronutrients|micronutrients|mesh-ancestor
153884608|NCT01605344|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153884609|NCT01605344|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153884610|NCT01605344|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153884611|NCT01605344|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
153425554|NCT00790478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153425555|NCT00790478|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153425556|NCT04490239|Heparin|heparin|mesh-list
153425557|NCT04490239|Calcium heparin|calcium heparin|mesh-list
153425558|NCT04490239|Anticoagulants|anticoagulants|mesh-ancestor
153425559|NCT04490239|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153425560|NCT04490239|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153425561|NCT04490239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153425562|NCT00791336|Nelfinavir|nelfinavir|mesh-list
153425563|NCT00791336|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
153425564|NCT00791336|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
153425565|NCT00791336|Protease Inhibitors|protease inhibitors|mesh-ancestor
153884612|NCT00593463|Cycloserine|cycloserine|mesh-list
153884613|NCT00593463|Verapamil|verapamil|mesh-list
153884614|NCT00593463|Diltiazem|diltiazem|mesh-list
153884615|NCT00593463|Isradipine|isradipine|mesh-list
153884616|NCT00593463|Nifedipine|nifedipine|mesh-list
153884617|NCT00593463|Gabapentin|gabapentin|mesh-list
153884618|NCT00593463|Naloxone|naloxone|mesh-list
153884619|NCT00593463|Analgesics|analgesics|mesh-ancestor
153884620|NCT00593463|Sensory System Agents|sensory system agents|mesh-ancestor
153884621|NCT00593463|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153884622|NCT00593463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153884623|NCT00593463|Anticonvulsants|anticonvulsants|mesh-ancestor
153884625|NCT00593463|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153884626|NCT00593463|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153884627|NCT00593463|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153884628|NCT00593463|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
153884629|NCT00593463|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
153884630|NCT00593463|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153884631|NCT00593463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153884632|NCT00593463|Antimanic Agents|antimanic agents|mesh-ancestor
153884633|NCT00593463|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
153884634|NCT00593463|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153884635|NCT00593463|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153884636|NCT00593463|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153884638|NCT00593463|Tocolytic Agents|tocolytic agents|mesh-ancestor
153884639|NCT00593463|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153884640|NCT00593463|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
153884641|NCT00593463|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153884642|NCT00593463|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
153884643|NCT00593463|Antitubercular Agents|antitubercular agents|mesh-ancestor
153884644|NCT00593463|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153884654|NCT04328064|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153884655|NCT04328064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153884656|NCT04328064|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153884657|NCT04328064|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153884658|NCT04328064|Antimetabolites|antimetabolites|mesh-ancestor
153884659|NCT04328064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153425566|NCT00791336|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153884660|NCT04328064|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153884661|NCT04328064|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
153884662|NCT04328064|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153884664|NCT01605734|Chlorotrianisene|chlorotrianisene|mesh-list
153884665|NCT01605734|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153884669|NCT01605734|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
153884670|NCT01605734|Estrogens|estrogens|mesh-ancestor
153884672|NCT01605734|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153884673|NCT01605734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153425615|NCT00732680|Cholinergic Agents|cholinergic agents|mesh-ancestor
153425618|NCT00732680|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
153425619|NCT00732680|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153425620|NCT04441255|Mobocertinib|mobocertinib|mesh-list
153425621|NCT04441255|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153425622|NCT04441255|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153425623|NCT04441255|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153425624|NCT04441255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153425625|NCT00726830|Morphine|morphine|mesh-list
153425626|NCT00726830|Oxycodone|oxycodone|mesh-list
153425627|NCT00726830|Methadone|methadone|mesh-list
153425628|NCT00726830|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153425629|NCT00726830|Narcotics|narcotics|mesh-ancestor
153425630|NCT00726830|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153425631|NCT00726830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153425632|NCT00726830|Analgesics|analgesics|mesh-ancestor
153425633|NCT00726830|Sensory System Agents|sensory system agents|mesh-ancestor
153425634|NCT00726830|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153425635|NCT00726830|Antitussive Agents|antitussive agents|mesh-ancestor
153425636|NCT00726830|Respiratory System Agents|respiratory system agents|mesh-ancestor
153425637|NCT00691652|Rituximab|rituximab|mesh-list
153884689|NCT00594555|Antiviral Agents|antiviral agents|mesh-ancestor
153884690|NCT00594555|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153884691|NCT00594555|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153884692|NCT00594555|Immunologic Factors|immunologic factors|mesh-ancestor
153884693|NCT00594555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153884694|NCT00594555|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153884695|NCT00594555|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153884696|NCT00594555|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153425652|NCT00691574|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153425654|NCT00685880|Betamethasone acetate phosphate|betamethasone acetate phosphate|mesh-list
153425655|NCT00685880|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153425656|NCT00685880|Glucocorticoids|glucocorticoids|mesh-ancestor
153425657|NCT00685880|Hormones|hormones|mesh-ancestor
153425658|NCT00685880|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153425659|NCT00685880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153884712|NCT02270606|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153884713|NCT02270606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153884714|NCT02270606|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153884715|NCT02270606|Antimetabolites|antimetabolites|mesh-ancestor
153884716|NCT02270606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153884717|NCT02270606|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153884718|NCT02270606|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153425660|NCT00685880|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153425661|NCT00685880|Respiratory System Agents|respiratory system agents|mesh-ancestor
153425662|NCT00685880|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153425663|NCT00685880|Autonomic Agents|autonomic agents|mesh-ancestor
153425664|NCT00685880|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153425665|NCT00681044|Melphalan|melphalan|mesh-list
153425666|NCT00681044|Immunologic Factors|immunologic factors|mesh-ancestor
153425667|NCT00681044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153425668|NCT00681044|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153425669|NCT00681044|Alkylating Agents|alkylating agents|mesh-ancestor
153425670|NCT00681044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153425672|NCT00681044|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153425673|NCT00681044|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153425674|NCT03632083|Contact Lens Solutions|contact lens solutions|mesh-list
153425675|NCT03632083|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
153425677|NCT03632083|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153425678|NCT03633487|Guaifenesin|guaifenesin|mesh-list
153884730|NCT00594633|Cholinergic Agents|cholinergic agents|mesh-ancestor
153884731|NCT00594633|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153884732|NCT00594633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153884734|NCT01605968|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
153884735|NCT01605968|Laxatives|laxatives|mesh-ancestor
153884736|NCT01605968|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153884737|NCT01606046|Anesthetics|anesthetics|mesh-list
153884738|NCT01606046|Ethyl Chloride|ethyl chloride|mesh-list
153425679|NCT03633487|Expectorants|expectorants|mesh-ancestor
153425680|NCT03633487|Respiratory System Agents|respiratory system agents|mesh-ancestor
153425681|NCT00423020|Epoetin Alfa|epoetin alfa|mesh-list
153425682|NCT00423020|Hematinics|hematinics|mesh-ancestor
153425683|NCT01756586|Dexamethasone|dexamethasone|mesh-list
153425684|NCT01756586|Bupivacaine|bupivacaine|mesh-list
153425685|NCT01756586|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153425686|NCT01756586|Antiemetics|antiemetics|mesh-ancestor
153425687|NCT01756586|Autonomic Agents|autonomic agents|mesh-ancestor
153425688|NCT01756586|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153884742|NCT01606046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153884743|NCT01606046|Sensory System Agents|sensory system agents|mesh-ancestor
153884745|NCT01606046|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
153884746|NCT02892942|Cetrorelix|cetrorelix|mesh-list
153884747|NCT02892942|Fertility Agents, Female|fertility agents, female|mesh-ancestor
153884748|NCT02892942|Fertility Agents|fertility agents|mesh-ancestor
153884749|NCT02892942|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153884750|NCT02892942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153884759|NCT00594867|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153884760|NCT00594867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153425704|NCT03636061|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153425705|NCT03636061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153425706|NCT03636061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153425714|NCT00639626|Insulin Detemir|insulin detemir|mesh-list
153425715|NCT00639626|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153425717|NCT01718444|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
153425718|NCT01718444|Clomiphene|clomiphene|mesh-list
153425719|NCT01718444|Enclomiphene|enclomiphene|mesh-list
153425720|NCT01718444|Zuclomiphene|zuclomiphene|mesh-list
153884767|NCT00594867|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153884768|NCT00594867|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153884769|NCT00594867|Antipyretics|antipyretics|mesh-ancestor
153884770|NCT01606241|Cyclophosphamide|cyclophosphamide|mesh-list
153884771|NCT01606241|Vaccines|vaccines|mesh-list
153884772|NCT01606241|Immunologic Factors|immunologic factors|mesh-ancestor
153884773|NCT01606241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153884774|NCT01606241|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153884775|NCT01606241|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153884776|NCT01606241|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153884777|NCT01606241|Alkylating Agents|alkylating agents|mesh-ancestor
153884778|NCT01606241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153884779|NCT01606241|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153425725|NCT01718444|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153425726|NCT01718444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153425727|NCT01718444|Fertility Agents, Female|fertility agents, female|mesh-ancestor
153425728|NCT01718444|Fertility Agents|fertility agents|mesh-ancestor
153884789|NCT02270996|Anti-Infective Agents|anti-infective agents|mesh-list
153884790|NCT02270996|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
153884791|NCT00595140|Octreotide|octreotide|mesh-list
153884792|NCT00595140|Dopamine|dopamine|mesh-list
153884793|NCT00595140|Cabergoline|cabergoline|mesh-list
153425735|NCT01718444|Contraceptive Agents|contraceptive agents|mesh-ancestor
153425736|NCT01718444|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
153425737|NCT01718444|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
153425738|NCT01718444|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
153425739|NCT01718444|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153425740|NCT01718444|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153425741|NCT01718444|Hormones|hormones|mesh-ancestor
153425742|NCT00638222|Carvedilol|carvedilol|mesh-list
153425743|NCT00638222|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
153425744|NCT00638222|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
153425745|NCT00638222|Adrenergic Agents|adrenergic agents|mesh-ancestor
153425746|NCT00638222|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153425747|NCT00638222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153425748|NCT00638222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153425749|NCT00638222|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153425750|NCT00638222|Antioxidants|antioxidants|mesh-ancestor
153425751|NCT00638222|Protective Agents|protective agents|mesh-ancestor
153425752|NCT00638222|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153425753|NCT00638222|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153425754|NCT00638222|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153425755|NCT00638222|Vasodilator Agents|vasodilator agents|mesh-ancestor
153425756|NCT00638222|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
153425757|NCT00638222|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
153425759|NCT00634322|Antidotes|antidotes|mesh-ancestor
153884794|NCT00595140|Somatostatin|somatostatin|mesh-list
153884795|NCT00595140|Dopamine Agonists|dopamine agonists|mesh-list
153884796|NCT00595140|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153884797|NCT00595140|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153884798|NCT00595140|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153884799|NCT00595140|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
153884802|NCT00595140|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153884803|NCT00595140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153884804|NCT00595140|Dopamine Agents|dopamine agents|mesh-ancestor
153884805|NCT00595140|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153884806|NCT00595140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153884807|NCT00595140|Protective Agents|protective agents|mesh-ancestor
153884809|NCT00595140|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153884810|NCT00595140|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
153884811|NCT00595140|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
153884812|NCT02271035|Hyaluronic Acid|hyaluronic acid|mesh-list
153884813|NCT02271035|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153884814|NCT02271035|Immunologic Factors|immunologic factors|mesh-ancestor
153884815|NCT02271035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153884816|NCT02271035|Viscosupplements|viscosupplements|mesh-ancestor
153884817|NCT02271035|Protective Agents|protective agents|mesh-ancestor
153884819|NCT01606358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153884820|NCT02271113|Enoxaparin|enoxaparin|mesh-list
153884821|NCT02271113|Enoxaparin sodium|enoxaparin sodium|mesh-list
153884822|NCT02271113|Anticoagulants|anticoagulants|mesh-ancestor
153884823|NCT02271113|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153884824|NCT02271113|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153884825|NCT02271113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153884826|NCT02271191|Nicardipine|nicardipine|mesh-list
153425769|NCT00379886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153425770|NCT00379886|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153425771|NCT00379886|Anesthetics, General|anesthetics, general|mesh-ancestor
153425772|NCT00379886|Anesthetics|anesthetics|mesh-ancestor
153425773|NCT00379886|Anticonvulsants|anticonvulsants|mesh-ancestor
153425774|NCT00379886|GABA Modulators|gaba modulators|mesh-ancestor
153425775|NCT00379886|GABA Agents|gaba agents|mesh-ancestor
153425776|NCT00379886|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153425777|NCT00379886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153425778|NCT01705106|Celecoxib|celecoxib|mesh-list
153425779|NCT01705106|Capecitabine|capecitabine|mesh-list
153425780|NCT01705106|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153425781|NCT01705106|Antimetabolites|antimetabolites|mesh-ancestor
153425801|NCT00624650|Racepinephrine|racepinephrine|mesh-list
153425802|NCT00624650|Oxymetazoline|oxymetazoline|mesh-list
153425803|NCT00624650|Norepinephrine|norepinephrine|mesh-list
153425804|NCT00624650|Vasoconstrictor Agents|vasoconstrictor agents|mesh-list
153425805|NCT00624650|Epinephryl borate|epinephryl borate|mesh-list
153425806|NCT00624650|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153425807|NCT00624650|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153425808|NCT00624650|Adrenergic Agents|adrenergic agents|mesh-ancestor
153425809|NCT00624650|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153425810|NCT00624650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153425811|NCT00624650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153884862|NCT01172938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153884863|NCT01172938|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153884865|NCT01172938|Leprostatic Agents|leprostatic agents|mesh-ancestor
153884866|NCT01172938|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153425812|NCT00624650|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
153425813|NCT00624650|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153425814|NCT00624650|Autonomic Agents|autonomic agents|mesh-ancestor
153425815|NCT00624650|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153425816|NCT00624650|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153425817|NCT00624650|Respiratory System Agents|respiratory system agents|mesh-ancestor
153425818|NCT00624650|Mydriatics|mydriatics|mesh-ancestor
153425819|NCT00624650|Sympathomimetics|sympathomimetics|mesh-ancestor
153425820|NCT00624650|Diuretics|diuretics|mesh-ancestor
153425821|NCT00624650|Natriuretic Agents|natriuretic agents|mesh-ancestor
153425822|NCT00624650|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
153425823|NCT00624650|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153425824|NCT00624650|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
153425825|NCT00624650|Nasal Decongestants|nasal decongestants|mesh-ancestor
153425827|NCT00624650|Protective Agents|protective agents|mesh-ancestor
153425828|NCT00624650|Hemostatics|hemostatics|mesh-ancestor
153425829|NCT00624650|Coagulants|coagulants|mesh-ancestor
153425830|NCT00624650|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
153425831|NCT00624650|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
153425832|NCT00377065|Raltegravir Potassium|raltegravir potassium|mesh-list
153425833|NCT00377065|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153425834|NCT00377065|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153425835|NCT00377065|Antiviral Agents|antiviral agents|mesh-ancestor
153425836|NCT00377065|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153425837|NCT00377065|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
153425838|NCT00377065|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
153425839|NCT00377065|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153884870|NCT01172938|Growth Substances|growth substances|mesh-ancestor
153884871|NCT01172938|Growth Inhibitors|growth inhibitors|mesh-ancestor
153884872|NCT01172938|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153884873|NCT02271464|Cyclophosphamide|cyclophosphamide|mesh-list
153884874|NCT02271464|Bevacizumab|bevacizumab|mesh-list
153884875|NCT02271464|Capecitabine|capecitabine|mesh-list
153884876|NCT02271464|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153884877|NCT02271464|Immunologic Factors|immunologic factors|mesh-ancestor
153884878|NCT02271464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153884879|NCT02271464|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153884881|NCT02271464|Alkylating Agents|alkylating agents|mesh-ancestor
153884882|NCT02271464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153884883|NCT02271464|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153884884|NCT02271464|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153884885|NCT02271464|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153884886|NCT02271464|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153884887|NCT02271464|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153884888|NCT02271464|Growth Substances|growth substances|mesh-ancestor
153884889|NCT02271464|Growth Inhibitors|growth inhibitors|mesh-ancestor
153884890|NCT02271464|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153884891|NCT02271464|Antimetabolites|antimetabolites|mesh-ancestor
153884903|NCT04326894|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153884904|NCT04326894|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153884905|NCT04326894|Immunologic Factors|immunologic factors|mesh-ancestor
153425853|NCT00610532|Gout Suppressants|gout suppressants|mesh-ancestor
153425854|NCT00610532|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153425855|NCT03642457|Bupivacaine|bupivacaine|mesh-list
153425856|NCT03642457|Anesthetics, Local|anesthetics, local|mesh-ancestor
153425857|NCT03642457|Anesthetics|anesthetics|mesh-ancestor
153425858|NCT03642457|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153425860|NCT03642457|Sensory System Agents|sensory system agents|mesh-ancestor
153425861|NCT03642457|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153425863|NCT00379418|Anticoagulants|anticoagulants|mesh-ancestor
153884917|NCT01109992|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
153884918|NCT01109992|Purinergic Agonists|purinergic agonists|mesh-ancestor
153884919|NCT01109992|Purinergic Agents|purinergic agents|mesh-ancestor
153884920|NCT01109992|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153425869|NCT00378716|Tegafur|tegafur|mesh-list
153425870|NCT00378716|Calcium|calcium|mesh-list
153425871|NCT00378716|Levoleucovorin|levoleucovorin|mesh-list
153425872|NCT00378716|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153425873|NCT00378716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153425874|NCT00378716|Antimetabolites|antimetabolites|mesh-ancestor
153425875|NCT00378716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153425876|NCT00378716|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153425877|NCT00378716|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153884928|NCT02892357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153884929|NCT01109524|Cetuximab|cetuximab|mesh-list
153884930|NCT01109524|Vinorelbine|vinorelbine|mesh-list
153884931|NCT01109524|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153884932|NCT01109524|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153884933|NCT01109524|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153425883|NCT00378716|Vitamins|vitamins|mesh-ancestor
153425884|NCT00378716|Micronutrients|micronutrients|mesh-ancestor
153425885|NCT03644095|Phenylpropanolamine|phenylpropanolamine|mesh-list
153425886|NCT03644095|Guaifenesin|guaifenesin|mesh-list
153425887|NCT03644095|Chlorpheniramine, phenylpropanolamine drug combination|chlorpheniramine, phenylpropanolamine drug combination|mesh-list
153425888|NCT03644095|Expectorants|expectorants|mesh-ancestor
153425889|NCT03644095|Respiratory System Agents|respiratory system agents|mesh-ancestor
153425890|NCT03644095|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153425891|NCT03644095|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153425892|NCT03644095|Adrenergic Agents|adrenergic agents|mesh-ancestor
153425893|NCT03644095|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153425894|NCT03644095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153884939|NCT01109173|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153884940|NCT01109173|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153884942|NCT01109173|Sensory System Agents|sensory system agents|mesh-ancestor
153884943|NCT01109173|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153884944|NCT01109173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153884945|NCT01109173|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153884946|NCT01109173|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153884947|NCT02271971|Vitamin D|vitamin d|mesh-list
153884948|NCT02271971|Cholecalciferol|cholecalciferol|mesh-list
153884949|NCT02271971|Vitamins|vitamins|mesh-ancestor
153884950|NCT02271971|Micronutrients|micronutrients|mesh-ancestor
153425900|NCT03644095|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153425901|NCT03644095|Nasal Decongestants|nasal decongestants|mesh-ancestor
153425902|NCT03644095|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
153425903|NCT01633814|Estradiol|estradiol|mesh-list
153425904|NCT01633814|Estrogens|estrogens|mesh-ancestor
153425905|NCT01633814|Hormones|hormones|mesh-ancestor
153425906|NCT01633814|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153425907|NCT01633814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153425908|NCT04714099|Cyclosporine|cyclosporine|mesh-list
153425909|NCT04714099|Cyclosporins|cyclosporins|mesh-list
153425910|NCT04714099|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153425912|NCT04714099|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153425913|NCT04714099|Immunologic Factors|immunologic factors|mesh-ancestor
153425919|NCT04714099|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
153425920|NCT04566770|Vaccines|vaccines|mesh-list
153425921|NCT04566770|Immunologic Factors|immunologic factors|mesh-ancestor
153425922|NCT04566770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153425923|NCT04342663|Fluvoxamine|fluvoxamine|mesh-list
153425924|NCT04342663|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153425925|NCT04342663|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153425926|NCT04342663|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153425927|NCT04342663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153425928|NCT04342663|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153425929|NCT04342663|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
153425930|NCT04342663|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153425931|NCT04342663|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153425932|NCT04342663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153425933|NCT04342663|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153884951|NCT02271971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153884954|NCT01172821|Tiotropium Bromide|tiotropium bromide|mesh-list
153884955|NCT01172821|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
153884956|NCT01172821|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153884957|NCT01172821|Autonomic Agents|autonomic agents|mesh-ancestor
153884958|NCT01172821|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153884959|NCT01172821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153884960|NCT01172821|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153884961|NCT01172821|Respiratory System Agents|respiratory system agents|mesh-ancestor
153884962|NCT01172821|Parasympatholytics|parasympatholytics|mesh-ancestor
153884963|NCT01172821|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
153884964|NCT01172821|Cholinergic Agents|cholinergic agents|mesh-ancestor
153884965|NCT01172821|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153884966|NCT01172821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153884967|NCT01172821|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
153884968|NCT01172821|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
153884970|NCT01172821|Adrenergic Agents|adrenergic agents|mesh-ancestor
153884972|NCT01172275|N-monoacetylcystine|n-monoacetylcystine|mesh-list
153884973|NCT01172275|Antiviral Agents|antiviral agents|mesh-ancestor
153884974|NCT01172275|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153884975|NCT01172275|Expectorants|expectorants|mesh-ancestor
153884976|NCT01172275|Respiratory System Agents|respiratory system agents|mesh-ancestor
153884977|NCT01172275|Free Radical Scavengers|free radical scavengers|mesh-ancestor
153884978|NCT01172275|Antioxidants|antioxidants|mesh-ancestor
153884979|NCT01172275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153884980|NCT01172275|Protective Agents|protective agents|mesh-ancestor
153884981|NCT01172275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153884982|NCT01172275|Antidotes|antidotes|mesh-ancestor
153884983|NCT05034952|Acetaminophen|acetaminophen|mesh-list
153425934|NCT04342663|Serotonin Agents|serotonin agents|mesh-ancestor
153425935|NCT04342663|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
153425936|NCT04342663|Antidepressive Agents|antidepressive agents|mesh-ancestor
153425937|NCT04342663|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
153425938|NCT04342663|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153425939|NCT04342663|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153425940|NCT04342663|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
153884994|NCT02273102|Tranylcypromine|tranylcypromine|mesh-list
153884995|NCT02273102|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153884996|NCT02273102|Keratolytic Agents|keratolytic agents|mesh-ancestor
153884997|NCT02273102|Dermatologic Agents|dermatologic agents|mesh-ancestor
153425947|NCT00589550|Antiviral Agents|antiviral agents|mesh-ancestor
153425948|NCT00589550|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153425990|NCT03928327|Itraconazole|itraconazole|mesh-list
153425991|NCT03928327|Rifampin|rifampin|mesh-list
153425992|NCT03928327|Mobocertinib|mobocertinib|mesh-list
153425993|NCT03928327|Antifungal Agents|antifungal agents|mesh-ancestor
153425994|NCT03928327|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153425995|NCT03928327|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
153885041|NCT02272829|Analgesics|analgesics|mesh-ancestor
153885042|NCT02272829|Sensory System Agents|sensory system agents|mesh-ancestor
153885048|NCT00596115|Protective Agents|protective agents|mesh-ancestor
153885049|NCT00596115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153885050|NCT00596115|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
153885052|NCT00596115|Dopamine Agonists|dopamine agonists|mesh-ancestor
153885053|NCT00596115|Dopamine Agents|dopamine agents|mesh-ancestor
153885054|NCT00596115|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153885055|NCT02272868|Rifaximin|rifaximin|mesh-list
153885056|NCT02272868|Omeprazole|omeprazole|mesh-list
153885057|NCT02272868|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
153885058|NCT02272868|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
153885059|NCT02272868|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153885060|NCT02272868|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
153885061|NCT02272868|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153426012|NCT03928327|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
153426013|NCT03928327|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
153426014|NCT03928327|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
153426015|NCT03928327|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153426016|NCT03928327|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153426017|NCT01055756|Loratadine|loratadine|mesh-list
153426018|NCT01055756|Pseudoephedrine|pseudoephedrine|mesh-list
153426019|NCT01055756|Ephedrine|ephedrine|mesh-list
153426020|NCT01055756|Antipruritics|antipruritics|mesh-ancestor
153426021|NCT01055756|Dermatologic Agents|dermatologic agents|mesh-ancestor
153426022|NCT01055756|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
153426023|NCT01055756|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
153426024|NCT01055756|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
153426025|NCT01055756|Histamine Antagonists|histamine antagonists|mesh-ancestor
153426026|NCT01055756|Histamine Agents|histamine agents|mesh-ancestor
153426027|NCT01055756|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153426028|NCT01055756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153426029|NCT01055756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153426030|NCT01055756|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153426051|NCT01550510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153426052|NCT01550510|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
153426053|NCT01550510|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153426054|NCT01550510|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153885091|NCT01108510|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
153885092|NCT01108510|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153885094|NCT02273258|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
153885095|NCT02273258|Insulin Lispro|insulin lispro|mesh-list
153885096|NCT02273258|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153885097|NCT02273258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153885098|NCT04327245|Tagatose|tagatose|mesh-list
153885099|NCT04327245|Iron Chelating Agents|iron chelating agents|mesh-ancestor
153885100|NCT04327245|Chelating Agents|chelating agents|mesh-ancestor
153885101|NCT04327245|Sequestering Agents|sequestering agents|mesh-ancestor
153885102|NCT04327245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153885103|NCT01588769|Immunomodulating Agents|immunomodulating agents|mesh-list
153885104|NCT01588769|Immunologic Factors|immunologic factors|mesh-ancestor
153885105|NCT01588769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153426058|NCT01550510|Protective Agents|protective agents|mesh-ancestor
153426059|NCT01550510|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153426060|NCT04333225|Hydroxychloroquine|hydroxychloroquine|mesh-list
153426061|NCT04333225|Antimalarials|antimalarials|mesh-ancestor
153426066|NCT04333225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153426067|NCT04333225|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153426069|NCT00556400|Contraceptives, Oral|contraceptives, oral|mesh-list
153426070|NCT00556400|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-list
153426071|NCT00556400|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153426072|NCT00556400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153426073|NCT00556400|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
153426075|NCT00521924|Chloroquine|chloroquine|mesh-list
153426076|NCT00521924|Sulfasalazine|sulfasalazine|mesh-list
153426077|NCT00521924|Infliximab|infliximab|mesh-list
153426078|NCT00521924|Methotrexate|methotrexate|mesh-list
153426079|NCT00521924|Antirheumatic Agents|antirheumatic agents|mesh-list
153426080|NCT00521924|Cyclosporins|cyclosporins|mesh-list
153426081|NCT00521924|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
153426082|NCT00521924|Abortifacient Agents|abortifacient agents|mesh-ancestor
153426083|NCT00521924|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153426084|NCT00521924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153426085|NCT00521924|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153426086|NCT00521924|Antimetabolites|antimetabolites|mesh-ancestor
153426087|NCT00521924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153426088|NCT00521924|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153426089|NCT00521924|Dermatologic Agents|dermatologic agents|mesh-ancestor
153426090|NCT00521924|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153426091|NCT00521924|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153426092|NCT00521924|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153426093|NCT00521924|Immunologic Factors|immunologic factors|mesh-ancestor
153885106|NCT04327401|Dexamethasone|dexamethasone|mesh-list
153885107|NCT04327401|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153885108|NCT04327401|Antiemetics|antiemetics|mesh-ancestor
153885109|NCT04327401|Autonomic Agents|autonomic agents|mesh-ancestor
153885110|NCT04327401|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153885111|NCT04327401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153885112|NCT04327401|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153885113|NCT04327401|Glucocorticoids|glucocorticoids|mesh-ancestor
153885114|NCT04327401|Hormones|hormones|mesh-ancestor
153885115|NCT04327401|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153885116|NCT04327401|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153885117|NCT04327401|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153885121|NCT01340027|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
153885122|NCT01340027|Cholinergic Agents|cholinergic agents|mesh-ancestor
153885123|NCT01340027|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153885124|NCT01340027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153885125|NCT01340027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153885126|NCT01340027|Urological Agents|urological agents|mesh-ancestor
153885127|NCT01340027|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
153885128|NCT01340027|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
153885129|NCT01340027|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153885130|NCT01340027|Adrenergic Agents|adrenergic agents|mesh-ancestor
153885131|NCT01107925|Clopidogrel|clopidogrel|mesh-list
153885132|NCT01107925|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
153885133|NCT01107925|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153885134|NCT01107925|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
153885135|NCT01107925|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
153885136|NCT01107925|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
153885137|NCT01107925|Purinergic Agents|purinergic agents|mesh-ancestor
153885138|NCT01107925|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153885139|NCT01107925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153426094|NCT00521924|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153426095|NCT00521924|Antifungal Agents|antifungal agents|mesh-ancestor
153426096|NCT00521924|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153426097|NCT00521924|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
153426098|NCT00521924|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
153426099|NCT00521924|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153426100|NCT00521924|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153426101|NCT00521924|Amebicides|amebicides|mesh-ancestor
153426102|NCT00521924|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153426103|NCT00521924|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153426104|NCT00521924|Antimalarials|antimalarials|mesh-ancestor
153426105|NCT00521924|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153885147|NCT01588847|Bupivacaine|bupivacaine|mesh-list
153885148|NCT01588847|Anesthetics|anesthetics|mesh-list
153885149|NCT01588847|Propofol|propofol|mesh-list
153885150|NCT01588847|Sevoflurane|sevoflurane|mesh-list
153885151|NCT01588847|Rocuronium|rocuronium|mesh-list
153885152|NCT01588847|Anesthetics, Local|anesthetics, local|mesh-ancestor
153885153|NCT01588847|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153426109|NCT00521924|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153426110|NCT03927781|Pregabalin|pregabalin|mesh-list
153426111|NCT03927781|Analgesics|analgesics|mesh-ancestor
153426112|NCT03927781|Sensory System Agents|sensory system agents|mesh-ancestor
153426113|NCT03927781|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153426114|NCT03927781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153426115|NCT03927781|Anticonvulsants|anticonvulsants|mesh-ancestor
153426116|NCT03927781|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153426117|NCT03927781|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153426118|NCT03927781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153426119|NCT03927781|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153426120|NCT03927781|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153426121|NCT03927781|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153426122|NCT03927781|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153426123|NCT03927781|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153885175|NCT00107900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153885180|NCT00107315|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153885181|NCT00107315|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153885182|NCT00107315|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153885184|NCT00107315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153885185|NCT00107315|Growth Inhibitors|growth inhibitors|mesh-ancestor
153885186|NCT00107315|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153885187|NCT00107315|Antimetabolites|antimetabolites|mesh-ancestor
153885188|NCT00107315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153885189|NCT01335971|Sulforaphane|sulforaphane|mesh-list
153426144|NCT04713644|Anesthetics|anesthetics|mesh-ancestor
153426145|NCT00000734|Zidovudine|zidovudine|mesh-list
153426146|NCT00000734|Trimethoprim|trimethoprim|mesh-list
153426147|NCT00000734|Sulfamethoxazole|sulfamethoxazole|mesh-list
153426148|NCT00000734|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
153426149|NCT00000734|Antimetabolites|antimetabolites|mesh-ancestor
153426150|NCT00000734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153426151|NCT00000734|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153426152|NCT00000734|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153426153|NCT00000734|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153426154|NCT00000734|Antiviral Agents|antiviral agents|mesh-ancestor
153426155|NCT00000734|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153426156|NCT00000734|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153426157|NCT00000734|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153426158|NCT00000734|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
153885193|NCT01335971|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153885194|NCT00107276|Cyclophosphamide|cyclophosphamide|mesh-list
153885195|NCT00107276|Capecitabine|capecitabine|mesh-list
153885196|NCT00107276|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153885197|NCT00107276|Immunologic Factors|immunologic factors|mesh-ancestor
153885198|NCT00107276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153885199|NCT00107276|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153885200|NCT00107276|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153885201|NCT00107276|Alkylating Agents|alkylating agents|mesh-ancestor
153885202|NCT00107276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153885203|NCT00107276|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153885204|NCT00107276|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153885205|NCT00107276|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153885206|NCT00107276|Antimetabolites|antimetabolites|mesh-ancestor
153885207|NCT01335698|Ritonavir|ritonavir|mesh-list
153426162|NCT00000734|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153426163|NCT00000734|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
153426164|NCT00000734|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
153426165|NCT00000734|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153426166|NCT00000734|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153426168|NCT03663283|Anesthetics, Local|anesthetics, local|mesh-ancestor
153426169|NCT03663283|Anesthetics|anesthetics|mesh-ancestor
153426170|NCT03663283|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153426171|NCT03663283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153426172|NCT03663283|Sensory System Agents|sensory system agents|mesh-ancestor
153426173|NCT03663283|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153426174|NCT00000764|Interferons|interferons|mesh-list
153426175|NCT00000764|Interferon-alpha|interferon-alpha|mesh-list
153426211|NCT00448682|Oxaliplatin|oxaliplatin|mesh-list
153426212|NCT00448682|Floxuridine|floxuridine|mesh-list
153426213|NCT00448682|Levoleucovorin|levoleucovorin|mesh-list
153426214|NCT00448682|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153426215|NCT00448682|Tubulin Modulators|tubulin modulators|mesh-ancestor
153426216|NCT00448682|Antimitotic Agents|antimitotic agents|mesh-ancestor
153426217|NCT00448682|Mitosis Modulators|mitosis modulators|mesh-ancestor
153426218|NCT00448682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153426219|NCT00448682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153426220|NCT00448682|Antidotes|antidotes|mesh-ancestor
153426221|NCT00448682|Protective Agents|protective agents|mesh-ancestor
153426222|NCT00448682|Vitamin B Complex|vitamin b complex|mesh-ancestor
153426223|NCT00448682|Vitamins|vitamins|mesh-ancestor
153426224|NCT00448682|Micronutrients|micronutrients|mesh-ancestor
153426225|NCT00448682|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153426226|NCT00448682|Antimetabolites|antimetabolites|mesh-ancestor
153426227|NCT04713488|Vaccines|vaccines|mesh-list
153426228|NCT04713488|Immunologic Factors|immunologic factors|mesh-ancestor
153426229|NCT04713488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153426230|NCT03675451|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
153426231|NCT03675451|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
153426232|NCT03675451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153885243|NCT00598923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153885244|NCT00598923|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
153885245|NCT00598923|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153885246|NCT00598923|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153885247|NCT00598923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153885248|NCT00598923|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
153885249|NCT00598923|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
153885250|NCT02892318|Atezolizumab|atezolizumab|mesh-list
153885251|NCT02892318|Guadecitabine|guadecitabine|mesh-list
153885252|NCT02892318|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153885253|NCT02892318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153885254|NCT02892318|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153885255|NCT02892318|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153885256|NCT01334918|Regadenoson|regadenoson|mesh-list
153885257|NCT01334918|Technetium Tc 99m Sestamibi|technetium tc 99m sestamibi|mesh-list
153885258|NCT01334918|Adenosine A2 Receptor Agonists|adenosine a2 receptor agonists|mesh-ancestor
153426239|NCT00000770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153426240|NCT00000770|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153426241|NCT00000770|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153426242|NCT00000770|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153426243|NCT00000770|Antiviral Agents|antiviral agents|mesh-ancestor
153426244|NCT00000770|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153426245|NCT00000770|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153426246|NCT00000770|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153426262|NCT00368654|Immunologic Factors|immunologic factors|mesh-ancestor
153426263|NCT00368654|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153426264|NCT00368654|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153426266|NCT00000776|Amphotericin B|amphotericin b|mesh-list
153426267|NCT00000776|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
153426268|NCT00000776|Flucytosine|flucytosine|mesh-list
153426269|NCT00000776|Dexamethasone|dexamethasone|mesh-list
153426270|NCT00000776|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153426271|NCT00000776|Antiemetics|antiemetics|mesh-ancestor
153426272|NCT00000776|Autonomic Agents|autonomic agents|mesh-ancestor
153426273|NCT00000776|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153885299|NCT01332968|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153885300|NCT01332968|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153885301|NCT01332968|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153885302|NCT01332968|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153885303|NCT01332968|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153885304|NCT01332968|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153885305|NCT01332968|Glucocorticoids|glucocorticoids|mesh-ancestor
153885306|NCT01332968|Hormones|hormones|mesh-ancestor
153885307|NCT01332968|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153885308|NCT01332968|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153885309|NCT01332968|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153885310|NCT01332968|Tubulin Modulators|tubulin modulators|mesh-ancestor
153426274|NCT00000776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153426275|NCT00000776|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153426276|NCT00000776|Glucocorticoids|glucocorticoids|mesh-ancestor
153426277|NCT00000776|Hormones|hormones|mesh-ancestor
153426278|NCT00000776|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153885329|NCT00599274|Antiviral Agents|antiviral agents|mesh-ancestor
153426292|NCT00000776|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153426293|NCT00000776|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153426294|NCT00000776|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153426295|NCT00000776|Antimetabolites|antimetabolites|mesh-ancestor
153426296|NCT04283773|Antibodies|antibodies|mesh-list
153426297|NCT04283773|Immunoglobulins|immunoglobulins|mesh-list
153426298|NCT04283773|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
153426299|NCT04283773|Immunologic Factors|immunologic factors|mesh-ancestor
153426300|NCT04283773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153426301|NCT00329732|Lidocaine|lidocaine|mesh-list
153426302|NCT00329732|Bupivacaine|bupivacaine|mesh-list
153426303|NCT00329732|Anesthetics, Local|anesthetics, local|mesh-ancestor
153426306|NCT00329732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153426307|NCT00329732|Sensory System Agents|sensory system agents|mesh-ancestor
153426308|NCT00329732|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153426309|NCT00329732|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153426310|NCT00329732|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
153426311|NCT00329732|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153426312|NCT00329732|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153426313|NCT00329732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153426314|NCT00000782|Vaccines|vaccines|mesh-list
153885381|NCT01326702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153885383|NCT01326702|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153885384|NCT00599625|Pravastatin|pravastatin|mesh-list
153885385|NCT00599625|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153885386|NCT00599625|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153885387|NCT00599625|Antimetabolites|antimetabolites|mesh-ancestor
153885388|NCT00599625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153426353|NCT03684265|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153426354|NCT03684265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153426355|NCT03684265|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153426356|NCT03684265|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153426357|NCT03684265|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
153426358|NCT03684265|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153426359|NCT03684265|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153426360|NCT03684265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153426362|NCT00218036|Modafinil|modafinil|mesh-list
153426363|NCT00218036|Citalopram|citalopram|mesh-list
153426364|NCT00218036|Escitalopram|escitalopram|mesh-list
153426365|NCT00218036|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
153426366|NCT00218036|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153426367|NCT00218036|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153426375|NCT00218036|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
153426376|NCT00218036|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
153426377|NCT00218036|Parasympatholytics|parasympatholytics|mesh-ancestor
153426378|NCT00218036|Autonomic Agents|autonomic agents|mesh-ancestor
153426379|NCT00218036|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153426381|NCT00218036|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
153426382|NCT00218036|Cholinergic Agents|cholinergic agents|mesh-ancestor
153426383|NCT00218036|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
153426384|NCT00218036|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
153426385|NCT00218036|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
153426386|NCT00218036|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
153426388|NCT00233090|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
153426389|NCT00233090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153426390|NCT00233090|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
153426391|NCT00233090|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
153426392|NCT00233090|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
153885413|NCT01327703|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153885414|NCT01380080|Efavirenz|efavirenz|mesh-list
153885415|NCT01380080|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
153885416|NCT01380080|Efavirenz, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|efavirenz, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
153885417|NCT01380080|Rifampin|rifampin|mesh-list
153885418|NCT01380080|Isoniazid|isoniazid|mesh-list
153885419|NCT01380080|Pyrazinamide|pyrazinamide|mesh-list
153885420|NCT01380080|Ethambutol|ethambutol|mesh-list
153885421|NCT01380080|Isoniazid, pyrazinamide, rifampin drug combination|isoniazid, pyrazinamide, rifampin drug combination|mesh-list
153885422|NCT01380080|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153885423|NCT01380080|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153885424|NCT01380080|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153885425|NCT01380080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153885426|NCT01380080|Antiviral Agents|antiviral agents|mesh-ancestor
153885427|NCT01380080|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153885428|NCT01380080|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
153885429|NCT01380080|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153426393|NCT00233090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153426395|NCT02921906|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153426397|NCT02921906|Sensory System Agents|sensory system agents|mesh-ancestor
153426398|NCT02921906|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153426399|NCT02921906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153426400|NCT02921906|Antipyretics|antipyretics|mesh-ancestor
153426401|NCT00000812|Thalidomide|thalidomide|mesh-list
153426402|NCT00000812|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153426403|NCT00000812|Immunologic Factors|immunologic factors|mesh-ancestor
153426404|NCT00000812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153426405|NCT00000812|Leprostatic Agents|leprostatic agents|mesh-ancestor
153426421|NCT00000818|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153426422|NCT00000818|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153426423|NCT00177866|Celecoxib|celecoxib|mesh-list
153426424|NCT00177866|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153426426|NCT00177866|Analgesics|analgesics|mesh-ancestor
153426427|NCT00177866|Sensory System Agents|sensory system agents|mesh-ancestor
153426428|NCT00177866|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153426429|NCT00177866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153426430|NCT00177866|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153426431|NCT00177866|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153426432|NCT00177866|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
153426433|NCT00177866|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153426434|NCT00177866|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153885517|NCT01351025|Antimetabolites|antimetabolites|mesh-ancestor
153885518|NCT01351025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153885519|NCT01351025|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153885520|NCT01351025|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
153885521|NCT01351025|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153885522|NCT01348763|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
153885523|NCT01348763|Maraviroc|maraviroc|mesh-list
153885524|NCT01348763|Darunavir|darunavir|mesh-list
153426496|NCT02212574|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153426497|NCT02212574|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153426498|NCT02212574|Alkylating Agents|alkylating agents|mesh-ancestor
153426499|NCT02212574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153426500|NCT02212574|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153426501|NCT02212574|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153426502|NCT02212574|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153426503|NCT02212574|Tubulin Modulators|tubulin modulators|mesh-ancestor
153426504|NCT02212574|Antimitotic Agents|antimitotic agents|mesh-ancestor
153426505|NCT02212574|Mitosis Modulators|mitosis modulators|mesh-ancestor
153426506|NCT00000854|Nandrolone Decanoate|nandrolone decanoate|mesh-list
153426507|NCT00000854|Nandrolone|nandrolone|mesh-list
153426508|NCT00000854|Nandrolone phenpropionate|nandrolone phenpropionate|mesh-list
153426509|NCT00000854|Androgens|androgens|mesh-ancestor
153426510|NCT00000854|Hormones|hormones|mesh-ancestor
153426511|NCT00000854|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153885531|NCT01348763|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153885532|NCT01348763|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153885533|NCT01348763|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
153885534|NCT01348763|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
153885535|NCT01348763|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
153885536|NCT01348763|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
153885537|NCT01348763|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
153885538|NCT01348763|Protease Inhibitors|protease inhibitors|mesh-ancestor
153885539|NCT01346540|Nintedanib|nintedanib|mesh-list
153885540|NCT01346540|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153885541|NCT01346540|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153885542|NCT01346540|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153426527|NCT04298918|Immunoconjugates|immunoconjugates|mesh-ancestor
153426528|NCT04298918|Immunologic Factors|immunologic factors|mesh-ancestor
153426529|NCT04298918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153426530|NCT00001676|Fludarabine|fludarabine|mesh-list
153426531|NCT00001676|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153426535|NCT03714919|Levomethorphan|levomethorphan|mesh-list
153426536|NCT03714919|Dextromethorphan|dextromethorphan|mesh-list
153426537|NCT03714919|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153426538|NCT03714919|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153426539|NCT03714919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153426540|NCT03714919|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153426542|NCT03714919|Sensory System Agents|sensory system agents|mesh-ancestor
153426543|NCT03714919|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153426544|NCT03714919|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
153426547|NCT03714919|Adrenergic Agents|adrenergic agents|mesh-ancestor
153426548|NCT03714919|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153426549|NCT03714919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153426550|NCT03714919|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
153426551|NCT03714919|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153426552|NCT03714919|Anesthetics, General|anesthetics, general|mesh-ancestor
153426554|NCT03714919|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
153426555|NCT03714919|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
153426556|NCT03714919|Antipyretics|antipyretics|mesh-ancestor
153885572|NCT01342484|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153885573|NCT01342484|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
153885574|NCT01342484|Protease Inhibitors|protease inhibitors|mesh-ancestor
153885575|NCT01342484|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153885576|NCT01342484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153885577|NCT01342445|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
153885578|NCT01342445|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
153885579|NCT01342445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153885585|NCT01342445|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153885586|NCT01342211|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-list
153885588|NCT01342211|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153885589|NCT01342211|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153885590|NCT01342211|Antimetabolites|antimetabolites|mesh-ancestor
153885591|NCT01342211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153885592|NCT01342211|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153885593|NCT01342211|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153885594|NCT01342094|Timolol|timolol|mesh-list
153885595|NCT01342094|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
153885596|NCT01342094|Ophthalmic Solutions|ophthalmic solutions|mesh-list
153885597|NCT01342094|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
153426576|NCT00000872|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
153426577|NCT00000872|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
153426578|NCT00000872|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
153426579|NCT00000872|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
153426580|NCT00000872|Protease Inhibitors|protease inhibitors|mesh-ancestor
153426583|NCT00000878|Stavudine|stavudine|mesh-list
153426587|NCT00000878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153426589|NCT00000878|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153426590|NCT00000878|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153426591|NCT00000878|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153426592|NCT00000878|Antimetabolites|antimetabolites|mesh-ancestor
153426593|NCT04204057|Tenalisib|tenalisib|mesh-list
153885622|NCT01340300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153885624|NCT01107535|Antibodies|antibodies|mesh-list
153885625|NCT01107535|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
153885626|NCT01107535|Immunologic Factors|immunologic factors|mesh-ancestor
153885627|NCT01107535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153885628|NCT01107535|Antiviral Agents|antiviral agents|mesh-ancestor
153885629|NCT01107535|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153885630|NCT02880943|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
153426611|NCT00000896|Lamivudine|lamivudine|mesh-list
153426612|NCT00000896|Zidovudine|zidovudine|mesh-list
153426613|NCT00000896|Nevirapine|nevirapine|mesh-list
153426614|NCT00000896|Stavudine|stavudine|mesh-list
153426615|NCT00000896|Lamivudine, zidovudine drug combination|lamivudine, zidovudine drug combination|mesh-list
153426616|NCT00000896|Indinavir|indinavir|mesh-list
153426617|NCT00000896|Interleukin-12|interleukin-12|mesh-list
153426618|NCT00000896|Sargramostim|sargramostim|mesh-list
153426619|NCT00000896|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153426620|NCT00000896|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153426621|NCT00000896|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153426622|NCT00000896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153426623|NCT00000896|Antiviral Agents|antiviral agents|mesh-ancestor
153426624|NCT00000896|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153426625|NCT00000896|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153426626|NCT00000896|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153426627|NCT00000896|Antimetabolites|antimetabolites|mesh-ancestor
153426628|NCT00000896|Immunologic Factors|immunologic factors|mesh-ancestor
153426629|NCT00000896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153426630|NCT00000896|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153426631|NCT00000896|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
153426632|NCT00000896|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
153426633|NCT00000896|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
153426634|NCT00000896|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
153426635|NCT00000896|Protease Inhibitors|protease inhibitors|mesh-ancestor
153426636|NCT00000896|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153426637|NCT00000896|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153426638|NCT00000896|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153885650|NCT00598338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153885653|NCT00598572|Siderophores|siderophores|mesh-ancestor
153885654|NCT00598572|Iron Chelating Agents|iron chelating agents|mesh-ancestor
153426642|NCT00001790|Antifungal Agents|antifungal agents|mesh-ancestor
153426643|NCT00001790|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153426644|NCT00000902|Ritonavir|ritonavir|mesh-list
153426645|NCT00000902|Nelfinavir|nelfinavir|mesh-list
153426646|NCT00000902|Lamivudine|lamivudine|mesh-list
153426647|NCT00000902|Zidovudine|zidovudine|mesh-list
153426655|NCT00000902|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153426656|NCT00000902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153426657|NCT00000902|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153426658|NCT00000902|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153426659|NCT00000902|Antiviral Agents|antiviral agents|mesh-ancestor
153426660|NCT00000902|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153426661|NCT00000902|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
153426662|NCT00000902|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153426663|NCT00000902|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153426664|NCT00000902|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153426665|NCT00000902|Antimetabolites|antimetabolites|mesh-ancestor
153426666|NCT00000902|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
153426667|NCT00000902|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
153426668|NCT04331600|Chloroquine|chloroquine|mesh-list
153426669|NCT04331600|Chloroquine diphosphate|chloroquine diphosphate|mesh-list
153426670|NCT04331600|Amebicides|amebicides|mesh-ancestor
153426671|NCT04331600|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153426672|NCT04331600|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153426673|NCT04331600|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153426674|NCT04331600|Antimalarials|antimalarials|mesh-ancestor
153426675|NCT04331600|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153885657|NCT00598572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153885658|NCT00599820|Bevacizumab|bevacizumab|mesh-list
153885659|NCT00599820|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153885660|NCT00599820|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153885661|NCT00599820|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153885662|NCT00599820|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153885663|NCT00599820|Growth Substances|growth substances|mesh-ancestor
153885664|NCT00599820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153885665|NCT00599820|Growth Inhibitors|growth inhibitors|mesh-ancestor
153885666|NCT00599898|Nifedipine|nifedipine|mesh-list
153885667|NCT00599898|Atosiban|atosiban|mesh-list
153885669|NCT00599898|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153885670|NCT00599898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153885671|NCT00599898|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153885672|NCT00599898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153885673|NCT00599898|Vasodilator Agents|vasodilator agents|mesh-ancestor
153885674|NCT00599898|Tocolytic Agents|tocolytic agents|mesh-ancestor
153885675|NCT00599898|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153885676|NCT00599898|Hormone Antagonists|hormone antagonists|mesh-ancestor
153885677|NCT00599898|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153885680|NCT00600054|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
153885681|NCT00600054|Immunologic Factors|immunologic factors|mesh-ancestor
153885682|NCT00600054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153885683|NCT00600054|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153885684|NCT00600054|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153885685|NCT00600210|Bevacizumab|bevacizumab|mesh-list
153885686|NCT00600210|Carboplatin|carboplatin|mesh-list
153885687|NCT00600210|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153885688|NCT00600210|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153426676|NCT04331600|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153426678|NCT04331600|Analgesics|analgesics|mesh-ancestor
153426679|NCT04331600|Sensory System Agents|sensory system agents|mesh-ancestor
153426680|NCT04331600|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153426681|NCT04331600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153426682|NCT04331600|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153426683|NCT04331600|Filaricides|filaricides|mesh-ancestor
153426684|NCT04331600|Antinematodal Agents|antinematodal agents|mesh-ancestor
153426688|NCT00000188|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153426689|NCT00000188|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
153426693|NCT00000188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153426694|NCT00000188|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
153426695|NCT00000188|Protective Agents|protective agents|mesh-ancestor
153426696|NCT00000188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153426698|NCT00000914|Nelfinavir|nelfinavir|mesh-list
153426699|NCT00000914|Indinavir|indinavir|mesh-list
153426700|NCT00000914|Efavirenz|efavirenz|mesh-list
153426701|NCT00000914|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
153426702|NCT00000914|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
153426703|NCT00000914|Protease Inhibitors|protease inhibitors|mesh-ancestor
153426704|NCT00000914|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153426705|NCT00000914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153426706|NCT00000914|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153426707|NCT00000914|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153426708|NCT00000914|Antiviral Agents|antiviral agents|mesh-ancestor
153426709|NCT00000914|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153885689|NCT00600210|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153885690|NCT00600210|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153885691|NCT00600210|Growth Substances|growth substances|mesh-ancestor
153885692|NCT00600210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153885693|NCT00600210|Growth Inhibitors|growth inhibitors|mesh-ancestor
153885694|NCT00600366|Insulin Aspart|insulin aspart|mesh-list
153885695|NCT00600366|Biphasic Insulins|biphasic insulins|mesh-list
153426710|NCT00000914|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
153885696|NCT00600366|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
153885697|NCT00600366|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153885698|NCT00600366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153885702|NCT00600600|Tigecycline|tigecycline|mesh-list
153885703|NCT00600600|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153885704|NCT00600600|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153885705|NCT00600600|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
153885706|NCT00600600|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153885707|NCT00600600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153885708|NCT00623064|Gemcitabine|gemcitabine|mesh-list
153885709|NCT00623064|Lapatinib|lapatinib|mesh-list
153885710|NCT00623064|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153885713|NCT00623064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153885714|NCT00623064|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153885715|NCT00623064|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153885716|NCT00623064|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153885717|NCT00623220|Nitrous Oxide|nitrous oxide|mesh-list
153885718|NCT00623220|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
153885719|NCT00623220|Anesthetics, General|anesthetics, general|mesh-ancestor
153885720|NCT00623220|Anesthetics|anesthetics|mesh-ancestor
153885721|NCT00623220|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153885722|NCT00623220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153885723|NCT00623220|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153885724|NCT00623220|Analgesics|analgesics|mesh-ancestor
153885725|NCT00623220|Sensory System Agents|sensory system agents|mesh-ancestor
153885726|NCT00623220|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153885727|NCT00600912|SMOFlipid|smoflipid|mesh-list
153885728|NCT00600912|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
153426718|NCT00000914|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
153426720|NCT00000920|Saquinavir|saquinavir|mesh-list
153426721|NCT00000920|Lamivudine|lamivudine|mesh-list
153426740|NCT00000938|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153426741|NCT00000938|Antimalarials|antimalarials|mesh-ancestor
153426742|NCT00000938|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153426743|NCT00000938|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153426744|NCT00000938|Third Generation Cephalosporins|third generation cephalosporins|mesh-ancestor
153426745|NCT00000938|Beta Lactam Antibiotics|beta lactam antibiotics|mesh-ancestor
153426747|NCT00001862|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153426748|NCT00001862|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153426749|NCT00001862|Analgesics|analgesics|mesh-ancestor
153426750|NCT00001862|Sensory System Agents|sensory system agents|mesh-ancestor
153885729|NCT00600912|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
153885730|NCT00600912|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
153885731|NCT00600990|Vestipitant|vestipitant|mesh-list
153885732|NCT00600990|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
153885733|NCT00600990|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153885734|NCT00600990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153885735|NCT00600990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153885737|NCT00601302|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153885738|NCT00601302|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153885739|NCT00601302|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153885740|NCT00601302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153885743|NCT00601302|Vasodilator Agents|vasodilator agents|mesh-ancestor
153885744|NCT00601536|Lithium Carbonate|lithium carbonate|mesh-list
153885745|NCT00601536|Antidepressive Agents|antidepressive agents|mesh-ancestor
153885746|NCT00601536|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153885747|NCT00601536|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153885748|NCT00601536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153885749|NCT00601536|Antimanic Agents|antimanic agents|mesh-ancestor
153885750|NCT00601536|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153885751|NCT00601536|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153885752|NCT00601536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153885753|NCT00601614|Temozolomide|temozolomide|mesh-list
153885754|NCT00601614|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153885755|NCT00601614|Alkylating Agents|alkylating agents|mesh-ancestor
153885756|NCT00601614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153885757|NCT00601614|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153885758|NCT00601692|Docetaxel|docetaxel|mesh-list
153885759|NCT00601692|Irinotecan|irinotecan|mesh-list
153885760|NCT00601692|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153885761|NCT00601692|Tubulin Modulators|tubulin modulators|mesh-ancestor
153426754|NCT00001862|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153426755|NCT00001862|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153426764|NCT00000194|Antimetabolites|antimetabolites|mesh-ancestor
153426765|NCT00000194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153426767|NCT00000200|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153426768|NCT00000200|Narcotics|narcotics|mesh-ancestor
153426769|NCT00000200|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153426770|NCT00000200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153426771|NCT00000200|Analgesics|analgesics|mesh-ancestor
153426772|NCT00000200|Sensory System Agents|sensory system agents|mesh-ancestor
153426773|NCT00000200|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153426774|NCT00000200|Antitussive Agents|antitussive agents|mesh-ancestor
153426775|NCT00000200|Respiratory System Agents|respiratory system agents|mesh-ancestor
153426776|NCT00000206|Buprenorphine|buprenorphine|mesh-list
153426777|NCT00000206|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153426778|NCT00000206|Narcotics|narcotics|mesh-ancestor
153426779|NCT00000206|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153426780|NCT00000206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153426781|NCT00000206|Analgesics|analgesics|mesh-ancestor
153426782|NCT00000206|Sensory System Agents|sensory system agents|mesh-ancestor
153426783|NCT00000206|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153426784|NCT00000206|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
153426785|NCT00000944|Lamivudine|lamivudine|mesh-list
153426786|NCT00000944|Zidovudine|zidovudine|mesh-list
153885762|NCT00601692|Antimitotic Agents|antimitotic agents|mesh-ancestor
153885763|NCT00601692|Mitosis Modulators|mitosis modulators|mesh-ancestor
153885764|NCT00601692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153885765|NCT00601692|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
153885766|NCT00601692|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153885774|NCT00602082|Capecitabine|capecitabine|mesh-list
153885775|NCT00602082|Streptozocin|streptozocin|mesh-list
153885776|NCT00602082|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153885777|NCT00602082|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153885778|NCT00602082|Antimetabolites|antimetabolites|mesh-ancestor
153885779|NCT00602082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153885780|NCT00602082|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153885781|NCT04327752|Dermatologic Agents|dermatologic agents|mesh-list
153885782|NCT01171963|Vaccines|vaccines|mesh-list
153885783|NCT01171963|Immunologic Factors|immunologic factors|mesh-ancestor
153885784|NCT01171963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153885785|NCT01171183|Carvedilol|carvedilol|mesh-list
153885786|NCT01171183|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
153885787|NCT01171183|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
153885789|NCT01171183|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153885790|NCT01171183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153885791|NCT01171183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153885792|NCT01171183|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153426788|NCT00000944|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153426789|NCT00000944|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153426790|NCT00000944|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153426791|NCT00000944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153426792|NCT00000944|Antiviral Agents|antiviral agents|mesh-ancestor
153426793|NCT00000944|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153426794|NCT00000944|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153426795|NCT00000944|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153426796|NCT00000944|Antimetabolites|antimetabolites|mesh-ancestor
153426797|NCT00000944|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
153426798|NCT00000944|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
153426799|NCT00000944|Protease Inhibitors|protease inhibitors|mesh-ancestor
153885817|NCT01169701|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
153885818|NCT01169701|Antitubercular Agents|antitubercular agents|mesh-ancestor
153426815|NCT00000950|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
153426816|NCT00000950|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
153426817|NCT00000950|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
153426818|NCT00000950|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
153426819|NCT00000950|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
153426820|NCT00000950|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
153426821|NCT00000950|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153426823|NCT00000950|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153426824|NCT00000950|Vitamin B Complex|vitamin b complex|mesh-ancestor
153426826|NCT00000950|Micronutrients|micronutrients|mesh-ancestor
153426827|NCT00000950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153426828|NCT00000218|Carbamazepine|carbamazepine|mesh-list
153426829|NCT00000218|Anticonvulsants|anticonvulsants|mesh-ancestor
153426830|NCT00000218|Antimanic Agents|antimanic agents|mesh-ancestor
153426831|NCT00000218|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153426832|NCT00000218|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153426833|NCT00000218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153426834|NCT00000218|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153426835|NCT00000218|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153885839|NCT01115491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153885840|NCT01113931|Doxycycline|doxycycline|mesh-list
153885841|NCT01113931|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153426838|NCT00000218|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153426839|NCT00000218|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153426840|NCT00000218|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153426843|NCT00000218|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
153426845|NCT00000224|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153426846|NCT00000224|Narcotics|narcotics|mesh-ancestor
153426847|NCT00000224|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153426848|NCT00000224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153426849|NCT00000224|Analgesics|analgesics|mesh-ancestor
153426850|NCT00000224|Sensory System Agents|sensory system agents|mesh-ancestor
153426851|NCT00000224|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153426852|NCT00000224|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
153426853|NCT04332991|Hydroxychloroquine|hydroxychloroquine|mesh-list
153426854|NCT04332991|Antimalarials|antimalarials|mesh-ancestor
153426855|NCT04332991|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153426856|NCT04332991|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153426857|NCT04332991|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153426858|NCT04332991|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153426859|NCT04332991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153426860|NCT04332991|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153426861|NCT00000230|Buprenorphine|buprenorphine|mesh-list
153426862|NCT00000230|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153426863|NCT00000230|Narcotics|narcotics|mesh-ancestor
153426864|NCT00000230|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153426865|NCT00000230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153426866|NCT00000230|Analgesics|analgesics|mesh-ancestor
153885854|NCT02880787|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153885855|NCT02880787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153885856|NCT01106677|Metformin|metformin|mesh-list
153885857|NCT01106677|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
153885858|NCT01106677|Canagliflozin|canagliflozin|mesh-list
153885859|NCT01106677|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153885860|NCT01106677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153885861|NCT01106677|Incretins|incretins|mesh-ancestor
153885862|NCT01106677|Hormones|hormones|mesh-ancestor
153885863|NCT01106677|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153885864|NCT01106677|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
153885865|NCT01106677|Protease Inhibitors|protease inhibitors|mesh-ancestor
153885866|NCT01106677|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153885867|NCT01106677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153885869|NCT04309357|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
153426868|NCT00000230|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153426870|NCT00000236|Buprenorphine|buprenorphine|mesh-list
153426871|NCT00000236|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
153426872|NCT00000236|Naloxone|naloxone|mesh-list
153426873|NCT00000236|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153426874|NCT00000236|Narcotics|narcotics|mesh-ancestor
153426875|NCT00000236|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153426876|NCT00000236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153426889|NCT00000242|Antimanic Agents|antimanic agents|mesh-ancestor
153426890|NCT00000242|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153426891|NCT00000242|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153426892|NCT00000242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153426893|NCT00000242|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153426894|NCT00000242|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153426895|NCT00000242|Analgesics|analgesics|mesh-ancestor
153426896|NCT00000242|Sensory System Agents|sensory system agents|mesh-ancestor
153426912|NCT00000992|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
153426913|NCT00000992|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153426914|NCT00000992|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153426915|NCT00000992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153426916|NCT00000992|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153426917|NCT00000992|Hormone Antagonists|hormone antagonists|mesh-ancestor
153426918|NCT00000992|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153426919|NCT00000992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153426920|NCT00000992|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
153426921|NCT00000254|Nitrous Oxide|nitrous oxide|mesh-list
153426922|NCT00000254|Isoflurane|isoflurane|mesh-list
153426923|NCT00000254|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
153426924|NCT00000254|Anesthetics, General|anesthetics, general|mesh-ancestor
153426925|NCT00000254|Anesthetics|anesthetics|mesh-ancestor
153426926|NCT00000254|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153885899|NCT01099579|Ritonavir|ritonavir|mesh-list
153885900|NCT01099579|Atazanavir Sulfate|atazanavir sulfate|mesh-list
153885904|NCT01099579|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153885905|NCT01099579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153885906|NCT01099579|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153885907|NCT01099579|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153885908|NCT01099579|Antiviral Agents|antiviral agents|mesh-ancestor
153885909|NCT01099579|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153885910|NCT01099579|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
153885911|NCT01099579|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153885913|NCT01103713|Chloroquine|chloroquine|mesh-list
153885914|NCT01103713|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153885915|NCT01103713|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153885916|NCT01103713|Amebicides|amebicides|mesh-ancestor
153885917|NCT01103713|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153885918|NCT01103713|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153885919|NCT01103713|Antimalarials|antimalarials|mesh-ancestor
153885920|NCT01103713|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153885921|NCT01103245|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
153885922|NCT01103245|Spironolactone|spironolactone|mesh-list
153885923|NCT01103245|Aliskiren|aliskiren|mesh-list
153885924|NCT01103245|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153885925|NCT01103245|Diuretics|diuretics|mesh-ancestor
153885927|NCT01103245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153885928|NCT01103245|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
153885929|NCT01103245|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153885930|NCT01103245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153426927|NCT00000254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153426928|NCT00000254|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153426929|NCT00000254|Analgesics|analgesics|mesh-ancestor
153426930|NCT00000254|Sensory System Agents|sensory system agents|mesh-ancestor
153426931|NCT00000254|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153426932|NCT00000260|Nitrous Oxide|nitrous oxide|mesh-list
153426933|NCT00000260|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
153426934|NCT00000260|Anesthetics, General|anesthetics, general|mesh-ancestor
153426935|NCT00000260|Anesthetics|anesthetics|mesh-ancestor
153426936|NCT00000260|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153426937|NCT00000260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153426938|NCT00000260|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153426940|NCT00000260|Sensory System Agents|sensory system agents|mesh-ancestor
153426942|NCT00000266|Flupenthixol|flupenthixol|mesh-list
153426943|NCT00000266|Flupenthixol decanoate|flupenthixol decanoate|mesh-list
153426944|NCT00000266|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153426945|NCT00000266|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153426946|NCT00000266|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153426947|NCT00000266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153426948|NCT00000266|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153426949|NCT00000266|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
153426950|NCT00000266|Dopamine Agents|dopamine agents|mesh-ancestor
153426951|NCT00000266|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153426952|NCT00000266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153426953|NCT00001016|Leucovorin|leucovorin|mesh-list
153426954|NCT00001016|Trimetrexate|trimetrexate|mesh-list
153426955|NCT00001016|Calcium|calcium|mesh-list
153426956|NCT00001016|Levoleucovorin|levoleucovorin|mesh-list
153426957|NCT00001016|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153885931|NCT01103245|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
153885932|NCT01103245|Hormone Antagonists|hormone antagonists|mesh-ancestor
153885933|NCT01103245|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153885934|NCT01103245|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
153885935|NCT01103245|Renin Inhibitors|renin inhibitors|mesh-ancestor
153885936|NCT01103245|Protease Inhibitors|protease inhibitors|mesh-ancestor
153885937|NCT01103245|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153885938|NCT02878837|Midazolam|midazolam|mesh-list
153885939|NCT02878837|Dexmedetomidine|dexmedetomidine|mesh-list
153885940|NCT02878837|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153885941|NCT02878837|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153426958|NCT00001016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153885942|NCT02878837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153885943|NCT02878837|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153885944|NCT02878837|Analgesics|analgesics|mesh-ancestor
153885945|NCT02878837|Sensory System Agents|sensory system agents|mesh-ancestor
153885952|NCT02878837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153885954|NCT02878837|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153885955|NCT02878837|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153885956|NCT02878837|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153885957|NCT02878837|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153885958|NCT02878837|Anesthetics, General|anesthetics, general|mesh-ancestor
153885959|NCT02878837|Anesthetics|anesthetics|mesh-ancestor
153885960|NCT02878837|GABA Modulators|gaba modulators|mesh-ancestor
153885961|NCT02878837|GABA Agents|gaba agents|mesh-ancestor
153885962|NCT02880007|Cisplatin|cisplatin|mesh-list
153885963|NCT02880007|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153885964|NCT02880085|Lidocaine|lidocaine|mesh-list
153885965|NCT02880085|Anesthetics, Local|anesthetics, local|mesh-list
153885966|NCT02880085|Anesthetics|anesthetics|mesh-list
153885967|NCT02880085|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153885968|NCT02880085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153426974|NCT03811951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153426975|NCT04332289|Deuterium Oxide|deuterium oxide|mesh-list
153426976|NCT04332289|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153426977|NCT04332289|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
153426978|NCT04332289|Protective Agents|protective agents|mesh-ancestor
153426979|NCT04332289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153426981|NCT00001022|Didanosine|didanosine|mesh-list
153426982|NCT00001022|Zalcitabine|zalcitabine|mesh-list
153426983|NCT00001022|Antimetabolites|antimetabolites|mesh-ancestor
153426984|NCT00001022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153426985|NCT00001022|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153426996|NCT00001934|Daclizumab|daclizumab|mesh-list
153426997|NCT00001934|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153426999|NCT00001934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153427000|NCT00000278|Disulfiram|disulfiram|mesh-list
153427001|NCT00000278|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
153427002|NCT00000278|Acetaldehyde Dehydrogenase Inhibitors|acetaldehyde dehydrogenase inhibitors|mesh-ancestor
153427003|NCT00000278|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153427004|NCT00000278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153427005|NCT00001028|Dapsone|dapsone|mesh-list
153427006|NCT00001028|Pentamidine|pentamidine|mesh-list
153427007|NCT00001028|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153427008|NCT00001028|Antimalarials|antimalarials|mesh-ancestor
153427009|NCT00001028|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153427010|NCT00001028|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153427011|NCT00001028|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153427012|NCT00001028|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153427013|NCT00001028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153885999|NCT04328636|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153886000|NCT04328636|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153886001|NCT04328636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153886002|NCT04328636|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153886003|NCT04328636|Tocolytic Agents|tocolytic agents|mesh-ancestor
153886004|NCT04328636|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153886005|NCT02893826|Nimodipine|nimodipine|mesh-list
153886006|NCT02893826|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153886007|NCT02893826|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153886008|NCT02893826|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153886009|NCT02893826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153886010|NCT02893826|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153427014|NCT00001028|Leprostatic Agents|leprostatic agents|mesh-ancestor
153427015|NCT00001028|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153427016|NCT00001028|Antifungal Agents|antifungal agents|mesh-ancestor
153427017|NCT00001028|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
153427018|NCT00001940|Voriconazole|voriconazole|mesh-list
153427019|NCT00001940|Antifungal Agents|antifungal agents|mesh-ancestor
153427020|NCT00001940|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153427021|NCT00001940|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
153427022|NCT00001940|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153427023|NCT00001940|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153427024|NCT00001940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153427025|NCT00001940|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153427026|NCT00001940|Hormone Antagonists|hormone antagonists|mesh-ancestor
153427027|NCT00001940|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153427028|NCT00001940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153427057|NCT00001958|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153427059|NCT00001964|Cyclosporine|cyclosporine|mesh-list
153427060|NCT00001964|Cyclosporins|cyclosporins|mesh-list
153427061|NCT00001964|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153427062|NCT00001964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153427063|NCT00001964|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153427064|NCT00001964|Immunologic Factors|immunologic factors|mesh-ancestor
153427065|NCT00001964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153427066|NCT00001964|Antifungal Agents|antifungal agents|mesh-ancestor
153427074|NCT03801265|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153427075|NCT03801265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153427076|NCT03801265|Sensory System Agents|sensory system agents|mesh-ancestor
153427077|NCT03801265|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153427078|NCT00000290|Cocaine|cocaine|mesh-list
153427079|NCT00000290|Anesthetics, Local|anesthetics, local|mesh-ancestor
153427080|NCT00000290|Anesthetics|anesthetics|mesh-ancestor
153427081|NCT00000290|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153427082|NCT00000290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153427083|NCT00000290|Sensory System Agents|sensory system agents|mesh-ancestor
153427084|NCT00000290|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153427085|NCT00000290|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
153427086|NCT00000290|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
153427087|NCT00000290|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153427088|NCT00000290|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153427089|NCT00000290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153427090|NCT00000290|Dopamine Agents|dopamine agents|mesh-ancestor
153427091|NCT00000290|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153427092|NCT00000212|Desipramine|desipramine|mesh-list
153886086|NCT00593138|Dopamine Agents|dopamine agents|mesh-ancestor
153886087|NCT00593138|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153886088|NCT00593294|Drospirenone|drospirenone|mesh-list
153886089|NCT00593294|Ethinyl Estradiol|ethinyl estradiol|mesh-list
153427093|NCT00000212|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
153427094|NCT00000212|Antidepressive Agents|antidepressive agents|mesh-ancestor
153427095|NCT00000212|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153427096|NCT00000212|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153427097|NCT00000212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153427098|NCT00000212|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
153427099|NCT00000212|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153427100|NCT00000212|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153427101|NCT00000212|Adrenergic Agents|adrenergic agents|mesh-ancestor
153886110|NCT00593996|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153427115|NCT00001052|Immunologic Factors|immunologic factors|mesh-ancestor
153427116|NCT00001052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153427118|NCT00001052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153427119|NCT00001052|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153427121|NCT00001058|Indinavir|indinavir|mesh-list
153427122|NCT00001058|Clarithromycin|clarithromycin|mesh-list
153427123|NCT00001058|Ethambutol|ethambutol|mesh-list
153427124|NCT00001058|Rifabutin|rifabutin|mesh-list
153427125|NCT00001058|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
153427126|NCT00001058|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
153427127|NCT00001058|Protease Inhibitors|protease inhibitors|mesh-ancestor
153427128|NCT00001058|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153427129|NCT00001058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153427130|NCT00001058|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153886128|NCT00596336|Interferon Inducers|interferon inducers|mesh-ancestor
153886129|NCT00596414|Midazolam|midazolam|mesh-list
153886130|NCT00596414|Meperidine|meperidine|mesh-list
153886131|NCT00596414|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153886132|NCT00596414|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153886133|NCT00596414|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153886134|NCT00596414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153886135|NCT00596414|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153886136|NCT00596414|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153886137|NCT00596414|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153886138|NCT00596414|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153886141|NCT00596414|GABA Modulators|gaba modulators|mesh-ancestor
153886142|NCT00596414|GABA Agents|gaba agents|mesh-ancestor
153886143|NCT00596414|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153886144|NCT00596414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153886145|NCT00596414|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153886146|NCT00596414|Narcotics|narcotics|mesh-ancestor
153886147|NCT00596414|Analgesics|analgesics|mesh-ancestor
153886148|NCT00596414|Sensory System Agents|sensory system agents|mesh-ancestor
153886149|NCT00596414|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153427155|NCT00001994|Atovaquone|atovaquone|mesh-list
153427156|NCT00001994|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153427157|NCT00001994|Antimalarials|antimalarials|mesh-ancestor
153427158|NCT00001994|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153427159|NCT00001994|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153427160|NCT00001994|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153427161|NCT00001994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153427162|NCT00000320|Buprenorphine|buprenorphine|mesh-list
153427163|NCT00000320|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153427164|NCT00000320|Narcotics|narcotics|mesh-ancestor
153427165|NCT00000320|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153427166|NCT00000320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153427167|NCT00000320|Analgesics|analgesics|mesh-ancestor
153427168|NCT00000320|Sensory System Agents|sensory system agents|mesh-ancestor
153427169|NCT00000320|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153427170|NCT00000320|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
153427172|NCT00000326|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153427173|NCT00000326|Narcotics|narcotics|mesh-ancestor
153427174|NCT00000326|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153427175|NCT00000326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153427176|NCT00000326|Analgesics|analgesics|mesh-ancestor
153427177|NCT00000326|Sensory System Agents|sensory system agents|mesh-ancestor
153427178|NCT00000326|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153427179|NCT03978403|Zolmitriptan|zolmitriptan|mesh-list
153427180|NCT03978403|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
153427181|NCT03978403|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
153427182|NCT03978403|Serotonin Agents|serotonin agents|mesh-ancestor
153427184|NCT03978403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153427185|NCT03978403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153427186|NCT00002000|Valacyclovir|valacyclovir|mesh-list
153427187|NCT00002000|Acyclovir|acyclovir|mesh-list
153427188|NCT00002000|Antiviral Agents|antiviral agents|mesh-ancestor
153427189|NCT00002000|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153886163|NCT00598052|Escitalopram|escitalopram|mesh-list
153886164|NCT00598052|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
153886165|NCT00598052|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153886166|NCT00598052|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153886167|NCT00598052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153886168|NCT00598052|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153886169|NCT00598052|Serotonin Agents|serotonin agents|mesh-ancestor
153886170|NCT00598052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153886171|NCT04326296|Lenalidomide|lenalidomide|mesh-list
153886172|NCT04326296|Antibodies|antibodies|mesh-list
153886173|NCT04326296|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
153886174|NCT04326296|Immunologic Factors|immunologic factors|mesh-ancestor
153886175|NCT04326296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153886176|NCT04326296|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153886177|NCT04326296|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153886178|NCT04326296|Growth Substances|growth substances|mesh-ancestor
153886179|NCT04326296|Growth Inhibitors|growth inhibitors|mesh-ancestor
153886180|NCT04326296|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153886181|NCT00598676|Sirolimus|sirolimus|mesh-list
153886182|NCT00598676|Everolimus|everolimus|mesh-list
153427191|NCT03979807|Tiotropium Bromide|tiotropium bromide|mesh-list
153427192|NCT03979807|Olodaterol|olodaterol|mesh-list
153427193|NCT03979807|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153427194|NCT03979807|Autonomic Agents|autonomic agents|mesh-ancestor
153427195|NCT03979807|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153427196|NCT03979807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153427197|NCT03979807|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153427198|NCT03979807|Respiratory System Agents|respiratory system agents|mesh-ancestor
153427199|NCT03979807|Parasympatholytics|parasympatholytics|mesh-ancestor
153427200|NCT03979807|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
153427201|NCT03979807|Cholinergic Agents|cholinergic agents|mesh-ancestor
153427202|NCT03979807|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153427203|NCT03979807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153427204|NCT03979807|Anticonvulsants|anticonvulsants|mesh-ancestor
153427205|NCT00001082|Adefovir|adefovir|mesh-list
153427206|NCT00001082|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
153427223|NCT00002006|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153427224|NCT00002006|Immunologic Factors|immunologic factors|mesh-ancestor
153427225|NCT00002006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153427226|NCT04169113|Opiate Alkaloids|opiate alkaloids|mesh-list
153427227|NCT04169113|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153427228|NCT04169113|Narcotics|narcotics|mesh-ancestor
153427229|NCT04169113|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153427230|NCT04169113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153427231|NCT04169113|Analgesics|analgesics|mesh-ancestor
153427232|NCT04169113|Sensory System Agents|sensory system agents|mesh-ancestor
153886235|NCT04325984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153886236|NCT04325984|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153886237|NCT04325984|Glucocorticoids|glucocorticoids|mesh-ancestor
153886238|NCT04325984|Hormones|hormones|mesh-ancestor
153886239|NCT04325984|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153886240|NCT04325984|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153427248|NCT00380354|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153427249|NCT00380354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153427250|NCT03799783|Dexmedetomidine|dexmedetomidine|mesh-list
153427251|NCT03799783|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153427252|NCT03799783|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153427253|NCT03799783|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153427254|NCT03799783|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153427255|NCT03799783|Analgesics|analgesics|mesh-ancestor
153427256|NCT03799783|Sensory System Agents|sensory system agents|mesh-ancestor
153427257|NCT03799783|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153427258|NCT03799783|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
153427259|NCT03799783|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153427260|NCT03799783|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153427261|NCT03799783|Adrenergic Agents|adrenergic agents|mesh-ancestor
153427262|NCT03799783|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153886251|NCT00600626|Insulin Aspart|insulin aspart|mesh-list
153886252|NCT00600626|Insulin, Long-Acting|insulin, long-acting|mesh-list
153886253|NCT00600626|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
153886254|NCT00600626|Biphasic Insulins|biphasic insulins|mesh-list
153886255|NCT00600626|Isophane Insulin, Human|isophane insulin, human|mesh-list
153886256|NCT00600626|Insulin, Isophane|insulin, isophane|mesh-list
153886257|NCT00600626|Isophane insulin, beef|isophane insulin, beef|mesh-list
153886258|NCT00600626|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153427284|NCT00001094|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153427285|NCT00001094|Antimetabolites|antimetabolites|mesh-ancestor
153427286|NCT00001094|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
153427287|NCT00001094|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
153427288|NCT00001094|Protease Inhibitors|protease inhibitors|mesh-ancestor
153427289|NCT00001094|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
153427290|NCT00001094|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153427291|NCT00001100|Ganciclovir|ganciclovir|mesh-list
153427292|NCT00001100|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
153427293|NCT00001100|Antiviral Agents|antiviral agents|mesh-ancestor
153427299|NCT00000332|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153427300|NCT00000332|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153427317|NCT04085341|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153427318|NCT04085341|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153427319|NCT04085341|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153427320|NCT04085341|Growth Substances|growth substances|mesh-ancestor
153427321|NCT04085341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153427322|NCT04085341|Growth Inhibitors|growth inhibitors|mesh-ancestor
153427323|NCT04085341|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153427324|NCT04085341|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153427325|NCT04085341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153427327|NCT00002018|Interferon-alpha|interferon-alpha|mesh-list
153886320|NCT04308031|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153427328|NCT00002018|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153427329|NCT00002018|Antiviral Agents|antiviral agents|mesh-ancestor
153427330|NCT00002018|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153427331|NCT00002018|Immunologic Factors|immunologic factors|mesh-ancestor
153427332|NCT00002018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153427334|NCT00002024|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
153427335|NCT00002024|Antiviral Agents|antiviral agents|mesh-ancestor
153427336|NCT00002024|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153427337|NCT00002024|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153427338|NCT00002024|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153427339|NCT00002024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153427341|NCT00001106|Antimetabolites|antimetabolites|mesh-ancestor
153427342|NCT00001106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153427343|NCT00001106|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153427344|NCT00001106|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153427345|NCT00001106|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153427346|NCT00001106|Antiviral Agents|antiviral agents|mesh-ancestor
153427353|NCT00000344|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153427354|NCT00000344|Narcotics|narcotics|mesh-ancestor
153427355|NCT00000344|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153427356|NCT00000344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153427357|NCT00000344|Analgesics|analgesics|mesh-ancestor
153427358|NCT00000344|Sensory System Agents|sensory system agents|mesh-ancestor
153427359|NCT00000344|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153427360|NCT00000344|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
153427361|NCT04103515|Cimetidine|cimetidine|mesh-list
153427362|NCT04103515|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
153886321|NCT04308031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153886322|NCT04308031|Protective Agents|protective agents|mesh-ancestor
153886325|NCT01096849|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
153886326|NCT01096849|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153886327|NCT01096849|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153886328|NCT01096849|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153886329|NCT01096849|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153886330|NCT01096849|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153886331|NCT01096849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153886332|NCT01096849|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153886333|NCT01096849|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
153886334|NCT01096849|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153886335|NCT01324388|Dulaglutide|dulaglutide|mesh-list
153886336|NCT01324388|Metoprolol|metoprolol|mesh-list
153886337|NCT01324388|Lisinopril|lisinopril|mesh-list
153886338|NCT01324388|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153886339|NCT01324388|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153886340|NCT01324388|Sympatholytics|sympatholytics|mesh-ancestor
153886341|NCT01324388|Autonomic Agents|autonomic agents|mesh-ancestor
153886342|NCT01324388|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153886343|NCT01324388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153886344|NCT01324388|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
153886345|NCT01324388|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
153886346|NCT01324388|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
153886347|NCT01324388|Adrenergic Agents|adrenergic agents|mesh-ancestor
153886348|NCT01324388|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153886349|NCT01324388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153886350|NCT01324388|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
153886351|NCT01324388|Protease Inhibitors|protease inhibitors|mesh-ancestor
153886352|NCT01324388|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153886354|NCT01324388|Protective Agents|protective agents|mesh-ancestor
153427363|NCT04103515|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153427364|NCT04103515|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
153427366|NCT04103515|Histamine Agents|histamine agents|mesh-ancestor
153427367|NCT04103515|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153427368|NCT04103515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153427369|NCT04103515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153427370|NCT04103515|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
153427371|NCT04103515|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153427372|NCT04103515|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153427373|NCT00002030|Pentamidine|pentamidine|mesh-list
153427374|NCT00002030|Antifungal Agents|antifungal agents|mesh-ancestor
153427375|NCT00002030|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153427376|NCT00002030|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153427377|NCT00002030|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153427378|NCT00002030|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
153427380|NCT00001112|Zidovudine|zidovudine|mesh-list
153427381|NCT00001112|Interferon-gamma|interferon-gamma|mesh-list
153427382|NCT00001112|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153427383|NCT00001112|Antiviral Agents|antiviral agents|mesh-ancestor
153427384|NCT00001112|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153427385|NCT00001112|Antimetabolites|antimetabolites|mesh-ancestor
153427386|NCT00001112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153886355|NCT01324388|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
153886356|NCT01324388|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153886357|NCT02878681|Ranibizumab|ranibizumab|mesh-list
153886358|NCT02878681|Aflibercept|aflibercept|mesh-list
153886359|NCT02878681|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153886360|NCT02878681|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153886361|NCT02878681|Growth Substances|growth substances|mesh-ancestor
153886362|NCT02878681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153886363|NCT02878681|Growth Inhibitors|growth inhibitors|mesh-ancestor
153886364|NCT02878681|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153886365|NCT01324310|Ketoconazole|ketoconazole|mesh-list
153886366|NCT01324310|Romidepsin|romidepsin|mesh-list
153886367|NCT01324310|Antifungal Agents|antifungal agents|mesh-ancestor
153886368|NCT01324310|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153886369|NCT01324310|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
153886370|NCT01324310|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153886371|NCT01324310|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153886372|NCT01324310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153886373|NCT01324310|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153886374|NCT01324310|Hormone Antagonists|hormone antagonists|mesh-ancestor
153886375|NCT01324310|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153886376|NCT01324310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153427387|NCT00001112|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153886388|NCT01095835|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153886389|NCT01095835|Antiviral Agents|antiviral agents|mesh-ancestor
153886390|NCT01095835|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153886391|NCT01095835|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153886392|NCT01095835|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153886393|NCT01095835|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153886394|NCT01095835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153886395|NCT01095835|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153886396|NCT01095835|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153886397|NCT01095835|Immunologic Factors|immunologic factors|mesh-ancestor
153886398|NCT01095835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153886399|NCT04908865|Belimumab|belimumab|mesh-list
153427410|NCT00000374|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153427411|NCT00000374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153427412|NCT00000374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153427413|NCT00000374|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153427414|NCT00000374|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153427415|NCT00000374|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153427416|NCT00000374|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153427417|NCT00000374|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
153427418|NCT00000374|Dopamine Agents|dopamine agents|mesh-ancestor
153427419|NCT00000374|Antiemetics|antiemetics|mesh-ancestor
153427420|NCT00000374|Autonomic Agents|autonomic agents|mesh-ancestor
153427421|NCT00000374|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153427422|NCT00000374|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153427423|NCT00000374|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
153427424|NCT00000374|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153427425|NCT00000374|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153427427|NCT00002042|Hematinics|hematinics|mesh-ancestor
153427428|NCT03789175|Niacinamide|niacinamide|mesh-list
153427429|NCT03789175|Niacin|niacin|mesh-list
153427430|NCT03789175|Nicotinic Acids|nicotinic acids|mesh-list
153427431|NCT03789175|Vitamin B Complex|vitamin b complex|mesh-ancestor
153427432|NCT03789175|Vitamins|vitamins|mesh-ancestor
153886420|NCT01324232|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153427434|NCT03789175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153427435|NCT03789175|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153427436|NCT03789175|Antimetabolites|antimetabolites|mesh-ancestor
153427437|NCT03789175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153427438|NCT03789175|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153427439|NCT03789175|Vasodilator Agents|vasodilator agents|mesh-ancestor
153427440|NCT00002048|Zidovudine|zidovudine|mesh-list
153427441|NCT00002048|Antimetabolites|antimetabolites|mesh-ancestor
153427442|NCT00002048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153427443|NCT00002048|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153427444|NCT00002048|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153427445|NCT00002048|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153427446|NCT00002048|Antiviral Agents|antiviral agents|mesh-ancestor
153427447|NCT00002048|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153427448|NCT00002048|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153427449|NCT00002048|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153427450|NCT00002054|Pentamidine|pentamidine|mesh-list
153427451|NCT00002054|Antifungal Agents|antifungal agents|mesh-ancestor
153427452|NCT00002054|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153427453|NCT00002054|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153427454|NCT00002054|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153427488|NCT00000440|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153427490|NCT00002084|Valacyclovir|valacyclovir|mesh-list
153427491|NCT00002084|Acyclovir|acyclovir|mesh-list
153427492|NCT00002084|Antiviral Agents|antiviral agents|mesh-ancestor
153427493|NCT00002084|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153886476|NCT00598533|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153427495|NCT00000446|Antidepressive Agents|antidepressive agents|mesh-ancestor
153427496|NCT00000446|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153886510|NCT00600249|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153886512|NCT00600249|Antimitotic Agents|antimitotic agents|mesh-ancestor
153886513|NCT00600249|Mitosis Modulators|mitosis modulators|mesh-ancestor
153886514|NCT00600249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153886515|NCT00600249|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153886516|NCT00600405|Ibuprofen|ibuprofen|mesh-list
153886517|NCT00600405|Oxycodone|oxycodone|mesh-list
153886518|NCT00600405|Tamsulosin|tamsulosin|mesh-list
153886519|NCT00600405|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153886520|NCT00600405|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153886521|NCT00600405|Analgesics|analgesics|mesh-ancestor
153886522|NCT00600405|Sensory System Agents|sensory system agents|mesh-ancestor
153886523|NCT00600405|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153886524|NCT00600405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153427564|NCT03782233|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
153427565|NCT03782233|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153427566|NCT03782233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153427567|NCT00002090|Azithromycin|azithromycin|mesh-list
153427568|NCT00002090|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153427569|NCT00002090|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153427570|NCT00002096|Zidovudine|zidovudine|mesh-list
153427571|NCT00002096|Didanosine|didanosine|mesh-list
153427572|NCT00002096|Ganciclovir|ganciclovir|mesh-list
153427573|NCT00002096|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
153427574|NCT00002096|Antimetabolites|antimetabolites|mesh-ancestor
153886561|NCT00600639|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153886562|NCT00600639|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
153427576|NCT00002096|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153427577|NCT00002096|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153427578|NCT00002096|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153427580|NCT00002096|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153427581|NCT00002096|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153427582|NCT00002096|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153427583|NCT00002102|Leucovorin|leucovorin|mesh-list
153427584|NCT00002102|Trimetrexate|trimetrexate|mesh-list
153886565|NCT00600639|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153886566|NCT00600639|Respiratory System Agents|respiratory system agents|mesh-ancestor
153427620|NCT00381134|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
153427621|NCT00381134|Hormone Antagonists|hormone antagonists|mesh-ancestor
153427622|NCT00381134|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153427623|NCT00381134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153427625|NCT00381134|Diuretics|diuretics|mesh-ancestor
153427626|NCT00381134|Natriuretic Agents|natriuretic agents|mesh-ancestor
153427627|NCT00000506|Phentermine|phentermine|mesh-list
153427628|NCT00000506|Fenfluramine|fenfluramine|mesh-list
153427629|NCT00000506|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
153427630|NCT00000506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153427631|NCT00000506|Appetite Depressants|appetite depressants|mesh-ancestor
153427632|NCT00000506|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
153427633|NCT00000506|Sympathomimetics|sympathomimetics|mesh-ancestor
153427634|NCT00000506|Autonomic Agents|autonomic agents|mesh-ancestor
153886639|NCT01325337|Bimatoprost|bimatoprost|mesh-list
153886640|NCT01325337|Minoxidil|minoxidil|mesh-list
153886641|NCT01325337|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
153886642|NCT01325337|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153886643|NCT01325337|Vasodilator Agents|vasodilator agents|mesh-ancestor
153886644|NCT01324947|Pomalidomide|pomalidomide|mesh-list
153886645|NCT01324947|Immunologic Factors|immunologic factors|mesh-ancestor
153886646|NCT01324947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153886647|NCT01324947|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153886669|NCT02877511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153886670|NCT02877511|Dermatologic Agents|dermatologic agents|mesh-ancestor
153886672|NCT01324323|Romidepsin|romidepsin|mesh-list
153886673|NCT01324323|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
153886674|NCT01324323|Antitubercular Agents|antitubercular agents|mesh-ancestor
153886675|NCT01324323|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153886676|NCT01324323|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153886677|NCT01324323|Leprostatic Agents|leprostatic agents|mesh-ancestor
153886678|NCT01324323|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153886679|NCT01324323|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153427696|NCT00000542|Adrenergic Agents|adrenergic agents|mesh-ancestor
153427697|NCT00000542|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153427698|NCT00002120|Leucovorin|leucovorin|mesh-list
153427699|NCT00002120|Trimethoprim|trimethoprim|mesh-list
153886684|NCT01324323|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
153886686|NCT01324323|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
153886700|NCT01323582|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
153886701|NCT01323582|Erythromycin stearate|erythromycin stearate|mesh-list
153886702|NCT01323582|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153886703|NCT01323582|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153886704|NCT01323582|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153886705|NCT01323582|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
153886706|NCT01323582|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153886707|NCT01323582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153886708|NCT05367765|Imatinib Mesylate|imatinib mesylate|mesh-list
153886709|NCT05367765|Flumatinib|flumatinib|mesh-list
153886710|NCT05367765|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153886711|NCT05367765|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153886712|NCT05367765|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153886713|NCT05367765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153886715|NCT01323621|Fluticasone|fluticasone|mesh-list
153886717|NCT01323621|Albuterol|albuterol|mesh-list
153886718|NCT01323621|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
153886723|NCT01323621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153886724|NCT01323621|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153886725|NCT01323621|Respiratory System Agents|respiratory system agents|mesh-ancestor
153886726|NCT01323621|Dermatologic Agents|dermatologic agents|mesh-ancestor
153886727|NCT01323621|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
153886728|NCT01323621|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
153886729|NCT01323621|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
153886730|NCT01323621|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153886731|NCT01323621|Adrenergic Agents|adrenergic agents|mesh-ancestor
153886732|NCT01323621|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153886733|NCT01323621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153886734|NCT01323621|Tocolytic Agents|tocolytic agents|mesh-ancestor
153886735|NCT01323621|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153886736|NCT05645289|Alendronate|alendronate|mesh-list
153886737|NCT05645289|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153886738|NCT05645289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153886739|NCT01320033|Doxycycline|doxycycline|mesh-list
153886740|NCT01320033|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153886741|NCT01320033|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153427759|NCT00002144|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153427760|NCT00002144|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153427762|NCT00002144|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153427763|NCT00002144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153427771|NCT00000578|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153886786|NCT01100437|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153427807|NCT00000584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153427808|NCT00000590|Immunoglobulins|immunoglobulins|mesh-list
153427809|NCT00000590|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
153427811|NCT00000590|Immunologic Factors|immunologic factors|mesh-ancestor
153427812|NCT00000590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153427813|NCT00000614|Warfarin|warfarin|mesh-list
153427814|NCT00000614|Anticoagulants|anticoagulants|mesh-ancestor
153427815|NCT02973464|Valganciclovir|valganciclovir|mesh-list
153427816|NCT02973464|Ganciclovir|ganciclovir|mesh-list
153427817|NCT02973464|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
153427818|NCT02973464|Antiviral Agents|antiviral agents|mesh-ancestor
153427819|NCT02973464|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153427834|NCT00000626|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153427835|NCT00000626|Alkylating Agents|alkylating agents|mesh-ancestor
153427836|NCT00000626|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153427837|NCT00000626|Tubulin Modulators|tubulin modulators|mesh-ancestor
153427838|NCT00000626|Antimitotic Agents|antimitotic agents|mesh-ancestor
153427839|NCT00000626|Mitosis Modulators|mitosis modulators|mesh-ancestor
153427841|NCT03109873|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153427842|NCT03109873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153427844|NCT04713254|Midazolam|midazolam|mesh-list
153427845|NCT04713254|Bupropion|bupropion|mesh-list
153427846|NCT04713254|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153427847|NCT04713254|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153427848|NCT04713254|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153427849|NCT04713254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153427850|NCT04713254|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153427851|NCT04713254|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153427852|NCT04713254|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153886805|NCT02891616|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
153886806|NCT02891616|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
153886807|NCT02891616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153886808|NCT01321710|Acetaminophen|acetaminophen|mesh-list
153886809|NCT01321710|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153886810|NCT01321710|Analgesics|analgesics|mesh-ancestor
153886811|NCT01321710|Sensory System Agents|sensory system agents|mesh-ancestor
153886812|NCT01321710|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153886813|NCT01321710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153886814|NCT01321710|Antipyretics|antipyretics|mesh-ancestor
153886815|NCT01321008|Prednisone|prednisone|mesh-list
153886816|NCT01321008|Cyclophosphamide|cyclophosphamide|mesh-list
153886817|NCT01321008|Doxorubicin|doxorubicin|mesh-list
153886818|NCT01321008|Vincristine|vincristine|mesh-list
153886819|NCT01321008|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153427853|NCT04713254|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153886820|NCT01321008|Immunologic Factors|immunologic factors|mesh-ancestor
153886821|NCT01321008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153886822|NCT01321008|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153886823|NCT01321008|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153886824|NCT01321008|Alkylating Agents|alkylating agents|mesh-ancestor
153886825|NCT01321008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153886826|NCT01321008|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153886827|NCT01321008|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153886828|NCT01321008|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153886829|NCT01321008|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153886830|NCT01321008|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153886831|NCT01321008|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153886878|NCT01313559|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153886880|NCT02890875|Heparin|heparin|mesh-list
153886881|NCT02890875|Anticoagulants|anticoagulants|mesh-ancestor
153886882|NCT02890875|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153886883|NCT02890875|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153886896|NCT01310127|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153886897|NCT01310127|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153886898|NCT01310127|Analgesics|analgesics|mesh-ancestor
153886899|NCT01310127|Sensory System Agents|sensory system agents|mesh-ancestor
153886900|NCT01310127|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153427923|NCT00000638|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
153427926|NCT00000638|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
153427927|NCT00000638|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
153427928|NCT00000638|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153427929|NCT00000638|Antimetabolites|antimetabolites|mesh-ancestor
153427930|NCT00000638|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153427931|NCT00000638|Vitamin B Complex|vitamin b complex|mesh-ancestor
153427932|NCT00000638|Vitamins|vitamins|mesh-ancestor
153427933|NCT00000638|Micronutrients|micronutrients|mesh-ancestor
153427934|NCT00000638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153427935|NCT00000650|Ditiocarb|ditiocarb|mesh-list
153427936|NCT00000650|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153427937|NCT00000650|Immunologic Factors|immunologic factors|mesh-ancestor
153427938|NCT00000650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153427939|NCT00000650|Antiviral Agents|antiviral agents|mesh-ancestor
153427940|NCT00000650|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153427941|NCT00000650|Chelating Agents|chelating agents|mesh-ancestor
153427942|NCT00000650|Sequestering Agents|sequestering agents|mesh-ancestor
153427943|NCT00000650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153427944|NCT00000656|Zidovudine|zidovudine|mesh-list
153427945|NCT00000656|Didanosine|didanosine|mesh-list
153427946|NCT00000656|Antimetabolites|antimetabolites|mesh-ancestor
153427947|NCT00000656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153427948|NCT00000656|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153886916|NCT01318902|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153886917|NCT01318902|Protease Inhibitors|protease inhibitors|mesh-ancestor
153886918|NCT01318902|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153886919|NCT01318902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153886921|NCT01313858|Methotrexate|methotrexate|mesh-list
153886922|NCT01313858|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
153886923|NCT01313858|Abortifacient Agents|abortifacient agents|mesh-ancestor
153886924|NCT01313858|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153886925|NCT01313858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153886926|NCT01313858|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153886927|NCT01313858|Antimetabolites|antimetabolites|mesh-ancestor
153886928|NCT01313858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153886929|NCT01313858|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153886930|NCT01313858|Dermatologic Agents|dermatologic agents|mesh-ancestor
153886931|NCT01313858|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153887000|NCT00624754|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153887001|NCT00624754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153887002|NCT00624754|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153887003|NCT00624754|Respiratory System Agents|respiratory system agents|mesh-ancestor
153887004|NCT00624754|Glucocorticoids|glucocorticoids|mesh-ancestor
153887005|NCT00624754|Hormones|hormones|mesh-ancestor
153887006|NCT00624754|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153428055|NCT00001502|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153887021|NCT01313312|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
153887022|NCT01313312|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153887023|NCT01313312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153887024|NCT01313312|Cholinergic Agents|cholinergic agents|mesh-ancestor
153887025|NCT01313312|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153887026|NCT01313312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153887027|NCT01313312|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
153887028|NCT01313312|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153887029|NCT01114672|Ergocalciferols|ergocalciferols|mesh-list
153887030|NCT01114672|Vitamin D|vitamin d|mesh-list
153887031|NCT01114672|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153887032|NCT01114672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153887033|NCT01114672|Vitamins|vitamins|mesh-ancestor
153887034|NCT01114672|Micronutrients|micronutrients|mesh-ancestor
153887035|NCT01114672|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153887036|NCT01114516|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
153887037|NCT01114516|Clindamycin|clindamycin|mesh-list
153887038|NCT01114516|Clindamycin palmitate|clindamycin palmitate|mesh-list
153428068|NCT00002192|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
153428069|NCT00002192|Leprostatic Agents|leprostatic agents|mesh-ancestor
153428070|NCT00002198|Abacavir|abacavir|mesh-list
153428071|NCT00002198|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153428072|NCT00002198|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153428073|NCT00002198|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153428075|NCT00002198|Antiviral Agents|antiviral agents|mesh-ancestor
153428076|NCT00002198|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153428077|NCT00002198|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153428078|NCT00002198|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153428088|NCT00000704|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153428089|NCT00000728|Zidovudine|zidovudine|mesh-list
153428090|NCT00000728|Aldesleukin|aldesleukin|mesh-list
153428091|NCT00000728|Antimetabolites|antimetabolites|mesh-ancestor
153428101|NCT00001520|Neostigmine|neostigmine|mesh-list
153428102|NCT00001520|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
153428103|NCT00001520|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153428104|NCT00001520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153428105|NCT00001520|Cholinergic Agents|cholinergic agents|mesh-ancestor
153428106|NCT00001520|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153887070|NCT01310036|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153887071|NCT01310036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153887072|NCT01310036|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153887073|NCT01075321|Lenalidomide|lenalidomide|mesh-list
153887075|NCT01075321|Immunologic Factors|immunologic factors|mesh-ancestor
153887076|NCT01075321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153887077|NCT01075321|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153887078|NCT01075321|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153887079|NCT01075321|Growth Substances|growth substances|mesh-ancestor
153887080|NCT01075321|Growth Inhibitors|growth inhibitors|mesh-ancestor
153887081|NCT01075321|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153887082|NCT01075321|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
153887083|NCT01075321|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153887084|NCT01075321|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153428162|NCT00002300|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
153428163|NCT00002300|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153428164|NCT00002300|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153428165|NCT00002300|Appetite Stimulants|appetite stimulants|mesh-ancestor
153428166|NCT00002300|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
153428168|NCT00002306|Antifungal Agents|antifungal agents|mesh-ancestor
153428169|NCT00002306|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153428170|NCT00002306|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
153887109|NCT01078441|Alkylating Agents|alkylating agents|mesh-ancestor
153887110|NCT01078441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153887111|NCT01078441|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153887112|NCT01078441|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153887113|NCT01078441|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153887115|NCT01078441|Autonomic Agents|autonomic agents|mesh-ancestor
153887116|NCT01078441|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153887117|NCT01078441|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153887118|NCT01078441|Glucocorticoids|glucocorticoids|mesh-ancestor
153887119|NCT01078441|Hormones|hormones|mesh-ancestor
153887120|NCT01078441|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153887121|NCT01078441|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153887122|NCT01078441|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153887123|NCT01078441|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153887124|NCT01078441|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153887125|NCT01078441|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153887126|NCT00626665|Tadalafil|tadalafil|mesh-list
153887127|NCT00626665|Vasodilator Agents|vasodilator agents|mesh-ancestor
153887128|NCT00626665|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
153887146|NCT00623402|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153887147|NCT00623402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153887149|NCT01077739|Bevacizumab|bevacizumab|mesh-list
153428179|NCT00002306|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
153428180|NCT00002210|Delavirdine|delavirdine|mesh-list
153428181|NCT00002210|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153428182|NCT00002210|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153428183|NCT00002210|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153428184|NCT00002210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153428185|NCT00002210|Antiviral Agents|antiviral agents|mesh-ancestor
153887154|NCT01077739|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153887155|NCT01077739|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153887156|NCT01077739|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153887157|NCT01077739|Growth Substances|growth substances|mesh-ancestor
153887158|NCT01077739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153887159|NCT01077739|Growth Inhibitors|growth inhibitors|mesh-ancestor
153887182|NCT00626509|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153887183|NCT00626509|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153887184|NCT00626509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153887185|NCT02877901|Tolterodine Tartrate|tolterodine tartrate|mesh-list
153887186|NCT02877901|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
153887187|NCT02877901|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
153887188|NCT02877901|Cholinergic Agents|cholinergic agents|mesh-ancestor
153887189|NCT02877901|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153887190|NCT02877901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153428222|NCT00002312|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153428223|NCT00002312|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153428224|NCT00002318|Doxorubicin|doxorubicin|mesh-list
153428225|NCT00002318|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
153428226|NCT00002318|Bleomycin|bleomycin|mesh-list
153428227|NCT00002318|Vincristine|vincristine|mesh-list
153428228|NCT00002318|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153428229|NCT00002318|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153428230|NCT00002318|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153428231|NCT00002318|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153428232|NCT00002318|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153428233|NCT00002318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153428234|NCT00002318|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153428235|NCT00002318|Tubulin Modulators|tubulin modulators|mesh-ancestor
153428236|NCT00002318|Antimitotic Agents|antimitotic agents|mesh-ancestor
153428237|NCT00002318|Mitosis Modulators|mitosis modulators|mesh-ancestor
153428238|NCT00002228|Enfuvirtide|enfuvirtide|mesh-list
153428239|NCT00002228|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
153887198|NCT01305200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153887200|NCT01304498|Immunologic Factors|immunologic factors|mesh-ancestor
153887201|NCT01304498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153887202|NCT01074931|Ritonavir|ritonavir|mesh-list
153887203|NCT01074931|Lopinavir|lopinavir|mesh-list
153887204|NCT01074931|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
153887205|NCT01074931|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
153887206|NCT01074931|Protease Inhibitors|protease inhibitors|mesh-ancestor
153887207|NCT01074931|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153887208|NCT01074931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153428264|NCT00002234|Efavirenz|efavirenz|mesh-list
153428265|NCT00002234|Didanosine|didanosine|mesh-list
153428266|NCT00002234|Adefovir|adefovir|mesh-list
153428267|NCT00002234|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
153428268|NCT00002234|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153428269|NCT00002234|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153428270|NCT00002234|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153428271|NCT00002234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153428273|NCT00002234|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153428274|NCT00002234|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153428275|NCT00002234|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153428276|NCT00002234|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
153428277|NCT00002234|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153428278|NCT00002234|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
153428292|NCT00002324|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153428293|NCT00002324|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153887231|NCT01302938|Cholinergic Agents|cholinergic agents|mesh-ancestor
153887255|NCT01074307|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153887256|NCT01074307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153887257|NCT01074307|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
153887258|NCT01074307|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
153887260|NCT01074307|Adrenergic Agents|adrenergic agents|mesh-ancestor
153428294|NCT00002324|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
153428295|NCT00002324|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
153428296|NCT00002330|Ganciclovir|ganciclovir|mesh-list
153428297|NCT00002330|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
153428298|NCT00002330|Antiviral Agents|antiviral agents|mesh-ancestor
153887309|NCT04989166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153887310|NCT04989166|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153887311|NCT04989166|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153887312|NCT04989166|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153887313|NCT04989166|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153887314|NCT04989166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153887316|NCT05320705|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153887317|NCT05320705|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153887318|NCT05320705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153887319|NCT05320705|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153887320|NCT05320705|Analgesics|analgesics|mesh-ancestor
153428352|NCT00001646|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153428353|NCT00001646|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153428354|NCT00001646|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153428355|NCT00001658|Amoxicillin|amoxicillin|mesh-list
153428356|NCT00001658|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153428357|NCT00001658|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153428359|NCT00002252|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153428395|NCT00002354|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153428396|NCT00002354|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153428397|NCT00002354|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
153428398|NCT00002354|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
153428402|NCT00002360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153428403|NCT00002360|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153428404|NCT00002360|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153428405|NCT00002360|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153428406|NCT00002360|Antiviral Agents|antiviral agents|mesh-ancestor
153887376|NCT02875873|Plasma-lyte 148|plasma-lyte 148|mesh-list
153887377|NCT02875873|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
153887378|NCT02875873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153887379|NCT02875873|Sympathomimetics|sympathomimetics|mesh-ancestor
153887380|NCT02875873|Autonomic Agents|autonomic agents|mesh-ancestor
153887381|NCT02875873|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153887382|NCT02875873|Dopamine Agents|dopamine agents|mesh-ancestor
153887383|NCT02875873|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153887384|NCT02875873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153887385|NCT02875873|Adrenergic Agents|adrenergic agents|mesh-ancestor
153428448|NCT00378547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153428450|NCT00378547|Analgesics|analgesics|mesh-ancestor
153428451|NCT00378547|Sensory System Agents|sensory system agents|mesh-ancestor
153428452|NCT00378547|Antipyretics|antipyretics|mesh-ancestor
153428453|NCT00378547|Anticonvulsants|anticonvulsants|mesh-ancestor
153428454|NCT00378547|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153428455|NCT00378547|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153428456|NCT00378547|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153428457|NCT00378547|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153428458|NCT00378547|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153428459|NCT00378547|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153428460|NCT00378547|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153428461|NCT00002282|Fluconazole|fluconazole|mesh-list
153428462|NCT00002282|Clotrimazole|clotrimazole|mesh-list
153428463|NCT00002282|Miconazole|miconazole|mesh-list
153428464|NCT00002282|Antifungal Agents|antifungal agents|mesh-ancestor
153428466|NCT00002282|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
153428467|NCT00002282|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153887425|NCT04972396|Levonorgestrel|levonorgestrel|mesh-list
153887426|NCT04972396|Ethinyl Estradiol|ethinyl estradiol|mesh-list
153887427|NCT04972396|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153887428|NCT04972396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153887429|NCT04972396|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153887430|NCT04972396|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153887431|NCT04972396|Antimetabolites|antimetabolites|mesh-ancestor
153887432|NCT04972396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153887433|NCT04972396|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153887434|NCT04972396|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
153887435|NCT04972396|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153887436|NCT04972396|Anticoagulants|anticoagulants|mesh-ancestor
153887437|NCT04972396|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
153887438|NCT04972396|Contraceptive Agents|contraceptive agents|mesh-ancestor
153887439|NCT04972396|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153887440|NCT04972396|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
153887441|NCT04972396|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
153887442|NCT04972396|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
153887443|NCT04972396|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153887444|NCT04972396|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
153887445|NCT04972396|Protective Agents|protective agents|mesh-ancestor
153887446|NCT04972396|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
153887447|NCT04972396|Estrogens|estrogens|mesh-ancestor
153887448|NCT04972396|Hormones|hormones|mesh-ancestor
153887449|NCT04972396|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153887450|NCT01089361|Ketamine|ketamine|mesh-list
153887451|NCT01089361|Analgesics|analgesics|mesh-ancestor
153887452|NCT01089361|Sensory System Agents|sensory system agents|mesh-ancestor
153428522|NCT00002372|Amprenavir|amprenavir|mesh-list
153428523|NCT00002372|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
153428524|NCT00002372|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
153428525|NCT00002372|Protease Inhibitors|protease inhibitors|mesh-ancestor
153428526|NCT00002372|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153887475|NCT01102972|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
153887477|NCT04328753|Chlorhexidine|chlorhexidine|mesh-list
153887478|NCT04328753|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
153887479|NCT04328753|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153887480|NCT04328753|Disinfectants|disinfectants|mesh-ancestor
153887481|NCT01087489|Lidocaine|lidocaine|mesh-list
153887482|NCT01087489|Anesthetics, Local|anesthetics, local|mesh-ancestor
153887483|NCT01087489|Anesthetics|anesthetics|mesh-ancestor
153887484|NCT01087489|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153887485|NCT01087489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153887486|NCT01087489|Sensory System Agents|sensory system agents|mesh-ancestor
153887487|NCT01087489|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153428528|NCT00002372|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153428529|NCT00002372|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153428530|NCT00002372|Antiviral Agents|antiviral agents|mesh-ancestor
153428531|NCT00002372|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153428532|NCT00002372|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
153428533|NCT00002372|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153428534|NCT00002372|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
153428535|NCT00002372|Antitubercular Agents|antitubercular agents|mesh-ancestor
153428536|NCT00002372|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153428537|NCT00002378|Ritonavir|ritonavir|mesh-list
153428538|NCT00002378|Nelfinavir|nelfinavir|mesh-list
153428539|NCT00002378|Saquinavir|saquinavir|mesh-list
153428540|NCT00002378|Lamivudine|lamivudine|mesh-list
153428541|NCT00002378|Zidovudine|zidovudine|mesh-list
153428542|NCT00002378|Stavudine|stavudine|mesh-list
153428543|NCT00002378|Delavirdine|delavirdine|mesh-list
153428544|NCT00002378|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
153428545|NCT00002378|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
153428546|NCT00002378|Protease Inhibitors|protease inhibitors|mesh-ancestor
153428547|NCT00002378|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153428576|NCT02589145|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153428578|NCT02589145|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153428579|NCT02589145|Immunologic Factors|immunologic factors|mesh-ancestor
153428580|NCT02589145|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153428581|NCT02589145|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153887557|NCT01101334|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153887558|NCT01327547|Maraviroc|maraviroc|mesh-list
153887559|NCT01327547|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
153887560|NCT01327547|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
153887561|NCT01327547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153887562|NCT01327547|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153887563|NCT01327547|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153887564|NCT01327547|Antiviral Agents|antiviral agents|mesh-ancestor
153887565|NCT01327547|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153887566|NCT01327547|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
153887567|NCT01308567|Prednisone|prednisone|mesh-list
153887568|NCT01308567|Docetaxel|docetaxel|mesh-list
153887569|NCT01308567|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153887570|NCT01308567|Tubulin Modulators|tubulin modulators|mesh-ancestor
153887571|NCT01308567|Antimitotic Agents|antimitotic agents|mesh-ancestor
153887572|NCT01308567|Mitosis Modulators|mitosis modulators|mesh-ancestor
153887573|NCT01308567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153887574|NCT01308567|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153887575|NCT01308567|Glucocorticoids|glucocorticoids|mesh-ancestor
153887576|NCT01308567|Hormones|hormones|mesh-ancestor
153887577|NCT01308567|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153887578|NCT01308567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153887579|NCT01308567|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153887580|NCT00592241|Insulin|insulin|mesh-list
153887581|NCT00592241|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
153887582|NCT00592241|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153887583|NCT00592241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153887584|NCT02890719|Ribavirin|ribavirin|mesh-list
153428664|NCT04024501|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153887597|NCT04325061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153887600|NCT04325061|Hormones|hormones|mesh-ancestor
153887601|NCT04325061|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153887602|NCT04325061|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153887603|NCT04325061|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153887668|NCT02875717|Heparin|heparin|mesh-list
153887669|NCT02875717|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
153887670|NCT02875717|Tinzaparin|tinzaparin|mesh-list
153887671|NCT02875717|Dalteparin|dalteparin|mesh-list
153887672|NCT02875717|Anticoagulants|anticoagulants|mesh-ancestor
153887673|NCT02875717|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153887674|NCT02875717|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153887675|NCT02875717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153887676|NCT02875717|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153887677|NCT02875717|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153887679|NCT02875717|Sensory System Agents|sensory system agents|mesh-ancestor
153887680|NCT02875717|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153887681|NCT02875717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153887682|NCT02875717|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153887683|NCT02875717|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153887684|NCT02875717|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153428771|NCT00002438|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153428772|NCT00002438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153887701|NCT00593099|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153887702|NCT00593099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153887704|NCT00593099|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153887705|NCT00593099|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153887732|NCT00594191|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153887733|NCT00594191|Antimetabolites|antimetabolites|mesh-ancestor
153887734|NCT00594191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153887735|NCT00594191|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153887736|NCT00594191|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
153887741|NCT00594269|Paroxetine|paroxetine|mesh-list
153887742|NCT00594269|Escitalopram|escitalopram|mesh-list
153887743|NCT00594269|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153887744|NCT00594269|Serotonin Agents|serotonin agents|mesh-ancestor
153887745|NCT00594269|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153887746|NCT00594269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153887747|NCT00594269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153887748|NCT00594269|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153887749|NCT00594269|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153887750|NCT00594269|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153887751|NCT00594269|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153887753|NCT00594269|Dopamine Agents|dopamine agents|mesh-ancestor
153887754|NCT00594269|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
153887755|NCT00594269|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153887756|NCT00594269|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153887757|NCT00594269|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
153887758|NCT00594269|Antidepressive Agents|antidepressive agents|mesh-ancestor
153887759|NCT00594269|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
153887760|NCT00594269|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153428804|NCT05751746|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153887766|NCT04326959|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
153887767|NCT04326959|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
153887768|NCT04326959|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
153887769|NCT04326959|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153887770|NCT04326959|Glucocorticoids|glucocorticoids|mesh-ancestor
153887771|NCT04326959|Hormones|hormones|mesh-ancestor
153887772|NCT04326959|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153887773|NCT04326959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153887774|NCT04326959|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153887775|NCT04326959|Immunologic Factors|immunologic factors|mesh-ancestor
153887776|NCT04326959|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153887777|NCT04326959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153887778|NCT00594737|Memantine|memantine|mesh-list
153887779|NCT00594737|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
153887780|NCT00594737|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
153887781|NCT00594737|Dopamine Agents|dopamine agents|mesh-ancestor
153887782|NCT00594737|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153428837|NCT00002456|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153428838|NCT00002456|Antifungal Agents|antifungal agents|mesh-ancestor
153428839|NCT00002456|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153428840|NCT00002456|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
153428842|NCT01525927|Carboplatin|carboplatin|mesh-list
153428843|NCT01525927|Etoposide|etoposide|mesh-list
153428844|NCT01525927|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153428845|NCT01525927|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153428846|NCT01525927|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153428847|NCT01525927|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153428848|NCT01525927|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153428849|NCT01525927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153428850|NCT00002474|Cyclophosphamide|cyclophosphamide|mesh-list
153428851|NCT00002474|Carboplatin|carboplatin|mesh-list
153428852|NCT00002474|Mitoxantrone|mitoxantrone|mesh-list
153428853|NCT00002474|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153428854|NCT00002474|Immunologic Factors|immunologic factors|mesh-ancestor
153428855|NCT00002474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153428856|NCT00002474|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153428857|NCT00002474|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153428859|NCT00002474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153428861|NCT00002474|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153428862|NCT00002474|Analgesics|analgesics|mesh-ancestor
153428863|NCT00002474|Sensory System Agents|sensory system agents|mesh-ancestor
153428864|NCT00002474|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153428865|NCT00002474|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153428866|NCT00002474|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153428867|NCT00002474|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153428868|NCT00002492|Doxorubicin|doxorubicin|mesh-list
153428893|NCT05751512|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153887815|NCT00596297|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153887816|NCT00596297|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153887817|NCT00596297|Growth Substances|growth substances|mesh-ancestor
153887818|NCT00596297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153887819|NCT00596297|Growth Inhibitors|growth inhibitors|mesh-ancestor
153887820|NCT00596375|Lidocaine|lidocaine|mesh-list
153887821|NCT00596375|Anesthetics, Local|anesthetics, local|mesh-ancestor
153887822|NCT00596375|Anesthetics|anesthetics|mesh-ancestor
153887823|NCT00596375|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153887828|NCT00596375|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
153887829|NCT00596375|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153887830|NCT00596375|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153887855|NCT01064401|Interferon beta-1a|interferon beta-1a|mesh-list
153887856|NCT01064401|Daclizumab|daclizumab|mesh-list
153887857|NCT01064401|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153887858|NCT01064401|Antiviral Agents|antiviral agents|mesh-ancestor
153428922|NCT00002498|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153428923|NCT00002498|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
153428925|NCT00002498|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153428926|NCT00002498|Dermatologic Agents|dermatologic agents|mesh-ancestor
153428948|NCT00002510|Cyclophosphamide|cyclophosphamide|mesh-list
153428949|NCT00002510|Etoposide|etoposide|mesh-list
153428951|NCT00002510|Immunologic Factors|immunologic factors|mesh-ancestor
153428952|NCT00002510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153428953|NCT00002510|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153428954|NCT00002510|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153428955|NCT00002510|Alkylating Agents|alkylating agents|mesh-ancestor
153428956|NCT00002510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153428957|NCT00002510|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153887869|NCT00597389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153887870|NCT00597389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153887871|NCT00597389|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153887872|NCT00597389|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153887873|NCT00597389|Vasodilator Agents|vasodilator agents|mesh-ancestor
153887874|NCT01306617|Ritonavir|ritonavir|mesh-list
153887875|NCT01306617|Ribavirin|ribavirin|mesh-list
153887876|NCT01306617|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
153887877|NCT01306617|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
153887878|NCT01306617|Protease Inhibitors|protease inhibitors|mesh-ancestor
153887879|NCT01306617|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153887880|NCT01306617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153887881|NCT01306617|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153887882|NCT01306617|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153887883|NCT01306617|Antiviral Agents|antiviral agents|mesh-ancestor
153887884|NCT01306617|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153887885|NCT01306617|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
153887886|NCT01306617|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153887887|NCT01306617|Antimetabolites|antimetabolites|mesh-ancestor
153887888|NCT00597623|Adalimumab|adalimumab|mesh-list
153887889|NCT00597623|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
153887890|NCT00597623|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153887891|NCT00597623|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153887892|NCT00597857|Hydrocortisone|hydrocortisone|mesh-list
153887893|NCT00597857|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153887894|NCT00627133|Levetiracetam|levetiracetam|mesh-list
153887895|NCT00627133|Anticonvulsants|anticonvulsants|mesh-ancestor
153887896|NCT00627133|Nootropic Agents|nootropic agents|mesh-ancestor
153887897|NCT00598013|Pioglitazone|pioglitazone|mesh-list
153887898|NCT00598013|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153887899|NCT00598013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153887900|NCT04303429|Capecitabine|capecitabine|mesh-list
153887901|NCT04303429|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153887902|NCT04303429|Antimetabolites|antimetabolites|mesh-ancestor
153887903|NCT04303429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153428959|NCT00002510|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153428960|NCT00002510|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153428961|NCT00002510|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153428962|NCT00002510|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153428963|NCT01500109|Acetaminophen|acetaminophen|mesh-list
153428964|NCT01500109|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153428965|NCT01500109|Analgesics|analgesics|mesh-ancestor
153428966|NCT01500109|Sensory System Agents|sensory system agents|mesh-ancestor
153428967|NCT01500109|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153428968|NCT01500109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153428969|NCT01500109|Antipyretics|antipyretics|mesh-ancestor
153428970|NCT00002516|Cobalt|cobalt|mesh-list
153428971|NCT00002516|Dactinomycin|dactinomycin|mesh-list
153428972|NCT00002516|Cyclophosphamide|cyclophosphamide|mesh-list
153428973|NCT00002516|Ifosfamide|ifosfamide|mesh-list
153428974|NCT00002516|Doxorubicin|doxorubicin|mesh-list
153428975|NCT00002516|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
153428976|NCT00002516|Etoposide|etoposide|mesh-list
153428977|NCT00002516|Vincristine|vincristine|mesh-list
153428979|NCT00002516|Immunologic Factors|immunologic factors|mesh-ancestor
153428980|NCT00002516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153428981|NCT00002516|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153428982|NCT00002516|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153428983|NCT00002516|Alkylating Agents|alkylating agents|mesh-ancestor
153428984|NCT00002516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153428985|NCT00002516|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153428986|NCT00002516|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153887908|NCT00598091|Antimetabolites|antimetabolites|mesh-ancestor
153887909|NCT00598091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153887910|NCT00598091|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153887911|NCT00598091|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153887912|NCT00598091|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153887913|NCT00598091|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153887914|NCT00623415|Flupirtine|flupirtine|mesh-list
153887915|NCT00623415|Analgesics|analgesics|mesh-ancestor
153887916|NCT00623415|Sensory System Agents|sensory system agents|mesh-ancestor
153887917|NCT00623415|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153887918|NCT00623415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153887919|NCT04326725|Hydroxychloroquine|hydroxychloroquine|mesh-list
153887920|NCT04326725|Antimalarials|antimalarials|mesh-ancestor
153887921|NCT04326725|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153887922|NCT04326725|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153887923|NCT04326725|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153887924|NCT04326725|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153887925|NCT04326725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153887926|NCT04326725|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153887927|NCT01038427|Mometasone Furoate|mometasone furoate|mesh-list
153428991|NCT00002516|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153428992|NCT00002516|Tubulin Modulators|tubulin modulators|mesh-ancestor
153428993|NCT00002516|Antimitotic Agents|antimitotic agents|mesh-ancestor
153428994|NCT00002516|Mitosis Modulators|mitosis modulators|mesh-ancestor
153428995|NCT00002516|Trace Elements|trace elements|mesh-ancestor
153428996|NCT00002516|Micronutrients|micronutrients|mesh-ancestor
153428997|NCT00002516|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153428998|NCT00002516|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153428999|NCT00002516|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
153429000|NCT00002516|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153429001|NCT00002522|Cyclophosphamide|cyclophosphamide|mesh-list
153429002|NCT00002522|Etoposide|etoposide|mesh-list
153429003|NCT00002522|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153429004|NCT00002522|Immunologic Factors|immunologic factors|mesh-ancestor
153429005|NCT00002522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153429006|NCT00002522|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153429007|NCT00002522|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153429008|NCT00002522|Alkylating Agents|alkylating agents|mesh-ancestor
153887952|NCT00598169|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153887953|NCT00598169|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153429009|NCT00002522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153429010|NCT00002522|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153429011|NCT00002522|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153429012|NCT00002522|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153429013|NCT00002522|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153429014|NCT00002522|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153429015|NCT00002522|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153429016|NCT00002528|Tamoxifen|tamoxifen|mesh-list
153429017|NCT00002528|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
153429018|NCT00002528|Hormone Antagonists|hormone antagonists|mesh-ancestor
153429019|NCT00002528|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153429020|NCT00002528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153429039|NCT02341495|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153429041|NCT02341495|Chelating Agents|chelating agents|mesh-ancestor
153887956|NCT00598169|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153887957|NCT00598169|Alkylating Agents|alkylating agents|mesh-ancestor
153887958|NCT00598247|Paclitaxel|paclitaxel|mesh-list
153887959|NCT00598247|Paclitaxel poliglumex|paclitaxel poliglumex|mesh-list
153887960|NCT00598247|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153887961|NCT00598247|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153887962|NCT00598247|Tubulin Modulators|tubulin modulators|mesh-ancestor
153887963|NCT00598247|Antimitotic Agents|antimitotic agents|mesh-ancestor
153887964|NCT00598247|Mitosis Modulators|mitosis modulators|mesh-ancestor
153887965|NCT00598247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153887967|NCT00598403|Cefditoren pivoxil|cefditoren pivoxil|mesh-list
153887968|NCT00598403|Cefditoren|cefditoren|mesh-list
153887969|NCT00598403|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153887970|NCT00598403|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153887971|NCT00598403|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153887972|NCT00598403|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153887973|NCT00598403|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153887974|NCT00598403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153887975|NCT00598403|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153887976|NCT00598403|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
153887977|NCT00598403|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153887978|NCT00598637|Everolimus|everolimus|mesh-list
153887979|NCT00598637|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
153887980|NCT00598637|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153887981|NCT00598637|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153887982|NCT00598637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153887983|NCT00598637|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153887984|NCT00598637|Immunologic Factors|immunologic factors|mesh-ancestor
153887985|NCT00598637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153887986|NCT00598637|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153887987|NCT00598715|Sirolimus|sirolimus|mesh-list
153887988|NCT00598715|Paclitaxel|paclitaxel|mesh-list
153887989|NCT00598715|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153887990|NCT00598715|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153887991|NCT00598715|Tubulin Modulators|tubulin modulators|mesh-ancestor
153887992|NCT00598715|Antimitotic Agents|antimitotic agents|mesh-ancestor
153887993|NCT00598715|Mitosis Modulators|mitosis modulators|mesh-ancestor
153429050|NCT00002534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153429051|NCT00002534|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153429052|NCT00002534|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153429053|NCT00002534|Alkylating Agents|alkylating agents|mesh-ancestor
153429055|NCT00002534|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153429056|NCT00002534|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153429057|NCT00002534|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153429058|NCT00002534|Antimetabolites|antimetabolites|mesh-ancestor
153429059|NCT00002534|Antiviral Agents|antiviral agents|mesh-ancestor
153429060|NCT00002534|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153429061|NCT00002534|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153429062|NCT00002534|Antiemetics|antiemetics|mesh-ancestor
153429064|NCT00002534|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153429065|NCT00002534|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153429066|NCT00002534|Glucocorticoids|glucocorticoids|mesh-ancestor
153429067|NCT00002534|Hormones|hormones|mesh-ancestor
153429068|NCT00002534|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153429069|NCT00002534|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
153429070|NCT00002534|Protective Agents|protective agents|mesh-ancestor
153429071|NCT00002546|Ifosfamide|ifosfamide|mesh-list
153429073|NCT00002546|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153887994|NCT00598715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153887995|NCT00598715|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153887996|NCT00598715|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153887997|NCT00598715|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153887998|NCT00598715|Antifungal Agents|antifungal agents|mesh-ancestor
153887999|NCT00598715|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153888000|NCT00598715|Immunologic Factors|immunologic factors|mesh-ancestor
153888001|NCT00598715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153888002|NCT00598793|Insulin|insulin|mesh-list
153888003|NCT00598793|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
153888006|NCT00598793|Pioglitazone|pioglitazone|mesh-list
153888007|NCT00598793|Insulin Aspart|insulin aspart|mesh-list
153888008|NCT00598793|Biphasic Insulins|biphasic insulins|mesh-list
153888009|NCT00598793|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153888010|NCT00598793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153888011|NCT01326845|Deferasirox|deferasirox|mesh-list
153888012|NCT01326845|Iron Chelating Agents|iron chelating agents|mesh-ancestor
153888013|NCT01326845|Chelating Agents|chelating agents|mesh-ancestor
153888014|NCT01326845|Sequestering Agents|sequestering agents|mesh-ancestor
153888015|NCT01326845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153888016|NCT01062763|Spironolactone|spironolactone|mesh-list
153888017|NCT01062763|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
153888018|NCT01062763|Hormone Antagonists|hormone antagonists|mesh-ancestor
153888028|NCT00599573|Ondansetron|ondansetron|mesh-list
153888029|NCT00599573|Antiemetics|antiemetics|mesh-ancestor
153888030|NCT00599573|Autonomic Agents|autonomic agents|mesh-ancestor
153888031|NCT00599573|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153888032|NCT00599573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153888033|NCT00599573|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153888034|NCT00599573|Antipruritics|antipruritics|mesh-ancestor
153888035|NCT00599573|Dermatologic Agents|dermatologic agents|mesh-ancestor
153888036|NCT00599573|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
153888037|NCT00599573|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153888038|NCT00599573|Serotonin Agents|serotonin agents|mesh-ancestor
153888039|NCT00599573|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153888040|NCT00599573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153888041|NCT00599651|Pulmonary Surfactants|pulmonary surfactants|mesh-list
153888042|NCT00599651|Respiratory System Agents|respiratory system agents|mesh-ancestor
153888043|NCT01048099|Trastuzumab|trastuzumab|mesh-list
153429101|NCT00002552|Cytarabine|cytarabine|mesh-list
153429102|NCT00002552|Hydrocortisone|hydrocortisone|mesh-list
153429103|NCT00002552|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
153429104|NCT00002552|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
153429106|NCT00002552|Cyclophosphamide|cyclophosphamide|mesh-list
153429107|NCT00002552|Carmustine|carmustine|mesh-list
153429108|NCT00002552|Methotrexate|methotrexate|mesh-list
153429109|NCT00002552|Etoposide|etoposide|mesh-list
153429110|NCT00002552|Sargramostim|sargramostim|mesh-list
153429111|NCT00002552|Levoleucovorin|levoleucovorin|mesh-list
153429112|NCT00002552|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153429113|NCT00002552|Immunologic Factors|immunologic factors|mesh-ancestor
153429114|NCT00002552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153429115|NCT00002552|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153429116|NCT00002552|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153429118|NCT00002552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153429119|NCT00002552|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153429120|NCT00002552|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153429121|NCT00002552|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
153429122|NCT00002552|Abortifacient Agents|abortifacient agents|mesh-ancestor
153429123|NCT00002552|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153429124|NCT00002552|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153429125|NCT00002552|Antimetabolites|antimetabolites|mesh-ancestor
153429126|NCT00002552|Dermatologic Agents|dermatologic agents|mesh-ancestor
153429127|NCT00002552|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153429128|NCT00002552|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153429129|NCT00002552|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153429130|NCT00002552|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153429132|NCT00002552|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153888046|NCT01048099|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153888047|NCT00599807|Vitamin D|vitamin d|mesh-list
153888048|NCT00599807|Cholecalciferol|cholecalciferol|mesh-list
153888049|NCT00599807|Vitamins|vitamins|mesh-ancestor
153888050|NCT00599807|Micronutrients|micronutrients|mesh-ancestor
153888051|NCT00599807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153888052|NCT00599807|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153888053|NCT00599807|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153888054|NCT00599885|Valsartan|valsartan|mesh-list
153888055|NCT00599885|Telmisartan|telmisartan|mesh-list
153888056|NCT00599885|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153888057|NCT00599885|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
153888058|NCT00599885|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
153888059|NCT00599885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153888060|NCT01303965|Sirolimus|sirolimus|mesh-list
153888061|NCT01303965|Lenalidomide|lenalidomide|mesh-list
153888062|NCT01303965|Tacrolimus|tacrolimus|mesh-list
153888063|NCT01303965|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153888064|NCT01303965|Immunologic Factors|immunologic factors|mesh-ancestor
153888065|NCT01303965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153888066|NCT01303965|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
153888067|NCT01303965|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153888068|NCT01303965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153888069|NCT01303965|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153888070|NCT01303965|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153888071|NCT01303965|Growth Substances|growth substances|mesh-ancestor
153888072|NCT01303965|Growth Inhibitors|growth inhibitors|mesh-ancestor
153888073|NCT01303965|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153888074|NCT01303965|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153888075|NCT01303965|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153888076|NCT01303965|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153429134|NCT00002552|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153429135|NCT00002552|Antidotes|antidotes|mesh-ancestor
153429136|NCT00002552|Protective Agents|protective agents|mesh-ancestor
153429137|NCT00002552|Vitamin B Complex|vitamin b complex|mesh-ancestor
153429139|NCT00002552|Micronutrients|micronutrients|mesh-ancestor
153429140|NCT00002552|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153429141|NCT00378781|Minocycline|minocycline|mesh-list
153429142|NCT00378781|Heparin|heparin|mesh-list
153429143|NCT00378781|Anticoagulants|anticoagulants|mesh-ancestor
153429144|NCT00378781|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153429146|NCT00378781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153429148|NCT00378781|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153429150|NCT00377923|Progestins|progestins|mesh-ancestor
153429151|NCT00377923|Hormones|hormones|mesh-ancestor
153429152|NCT00377923|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153429154|NCT00002570|Leucovorin|leucovorin|mesh-list
153429155|NCT00002570|Fluorouracil|fluorouracil|mesh-list
153429156|NCT00002570|Calcium|calcium|mesh-list
153429157|NCT00002570|Levoleucovorin|levoleucovorin|mesh-list
153429158|NCT00002570|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153429159|NCT00002570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153429160|NCT00002570|Antimetabolites|antimetabolites|mesh-ancestor
153429161|NCT00002570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153429162|NCT00002570|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153429163|NCT00002570|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153429164|NCT00002570|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153429166|NCT00002570|Antidotes|antidotes|mesh-ancestor
153888080|NCT00600041|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153888081|NCT00600041|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
153888082|NCT00600041|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153888083|NCT00600041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153888084|NCT01045993|Analgesics|analgesics|mesh-list
153888085|NCT01045993|Sensory System Agents|sensory system agents|mesh-ancestor
153888086|NCT01045993|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153888087|NCT01045993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153888088|NCT00600509|Levetiracetam|levetiracetam|mesh-list
153888089|NCT00600509|Anticonvulsants|anticonvulsants|mesh-ancestor
153888090|NCT00600509|Nootropic Agents|nootropic agents|mesh-ancestor
153888092|NCT01326533|Antimalarials|antimalarials|mesh-ancestor
153888093|NCT01326533|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153888094|NCT01326533|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153888095|NCT01326533|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153888097|NCT01326533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153888098|NCT01326533|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153888099|NCT00600587|Carboplatin|carboplatin|mesh-list
153888100|NCT00600587|Gemcitabine|gemcitabine|mesh-list
153888101|NCT00600587|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
153888103|NCT00600587|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153888104|NCT00600587|Antimetabolites|antimetabolites|mesh-ancestor
153888105|NCT00600587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153888106|NCT00600587|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153429219|NCT00002582|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153429220|NCT00002582|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153429221|NCT00002582|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153429222|NCT00002582|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153429224|NCT00002582|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153429225|NCT00002582|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
153429226|NCT00002582|Abortifacient Agents|abortifacient agents|mesh-ancestor
153429227|NCT00002582|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153429228|NCT00002582|Dermatologic Agents|dermatologic agents|mesh-ancestor
153429229|NCT00002582|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153429231|NCT00002582|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
153888134|NCT00600977|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153888135|NCT00600977|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153888136|NCT00600977|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153888137|NCT00600977|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153888138|NCT00600977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153888141|NCT00601211|Autonomic Agents|autonomic agents|mesh-ancestor
153888142|NCT00601211|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153888143|NCT00601211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153888144|NCT00601211|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
153888145|NCT00601211|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
153888146|NCT00601211|Cholinergic Agents|cholinergic agents|mesh-ancestor
153888147|NCT00601211|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153888148|NCT00601211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153888149|NCT00601289|Temozolomide|temozolomide|mesh-list
153888150|NCT00601289|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153888151|NCT00601289|Alkylating Agents|alkylating agents|mesh-ancestor
153888152|NCT00601289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153429233|NCT00002582|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153429234|NCT00002582|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153429235|NCT00002582|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
153429236|NCT00002582|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
153429237|NCT00002582|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153429239|NCT00002582|Fertility Agents|fertility agents|mesh-ancestor
153429240|NCT00002588|Etoposide|etoposide|mesh-list
153429241|NCT00002588|Topotecan|topotecan|mesh-list
153429242|NCT00002588|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153429243|NCT00002588|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153429244|NCT00002588|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153429245|NCT00002588|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153429246|NCT00002588|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153429247|NCT00002588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153429248|NCT00002588|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
153429249|NCT02239627|Clonidine|clonidine|mesh-list
153429250|NCT02239627|Analgesics|analgesics|mesh-ancestor
153429251|NCT02239627|Sensory System Agents|sensory system agents|mesh-ancestor
153429252|NCT02239627|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153888178|NCT04325633|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153429272|NCT00002594|Immunologic Factors|immunologic factors|mesh-ancestor
153429273|NCT00002594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153429274|NCT00002594|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153888204|NCT00626977|Clonidine|clonidine|mesh-list
153888205|NCT00626977|Ropivacaine|ropivacaine|mesh-list
153888206|NCT00626977|Anesthetics, Local|anesthetics, local|mesh-ancestor
153888208|NCT00626977|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153888209|NCT00626977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153888210|NCT00626977|Sensory System Agents|sensory system agents|mesh-ancestor
153888211|NCT00626977|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153888212|NCT00626977|Analgesics|analgesics|mesh-ancestor
153888213|NCT00626977|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153888214|NCT00626977|Sympatholytics|sympatholytics|mesh-ancestor
153888216|NCT00626977|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
153888217|NCT00626977|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153888218|NCT00626977|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153429284|NCT02234011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153429285|NCT02234011|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
153429286|NCT02234011|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153429287|NCT02234011|Anesthetics, General|anesthetics, general|mesh-ancestor
153429288|NCT02234011|Anesthetics|anesthetics|mesh-ancestor
153429289|NCT02234011|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153429319|NCT00002618|Prednisone|prednisone|mesh-list
153429320|NCT00002618|Doxorubicin|doxorubicin|mesh-list
153429321|NCT00002618|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
153429322|NCT00002618|Methotrexate|methotrexate|mesh-list
153429323|NCT00002618|Vincristine|vincristine|mesh-list
153429324|NCT00002618|Mercaptopurine|mercaptopurine|mesh-list
153429325|NCT00002618|Levoleucovorin|levoleucovorin|mesh-list
153429326|NCT00002618|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153429327|NCT00002618|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153888276|NCT01300923|Acamprosate|acamprosate|mesh-list
153888277|NCT01300923|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
153888278|NCT01300767|Contact Lens Solutions|contact lens solutions|mesh-list
153888279|NCT01300767|Disinfectants|disinfectants|mesh-ancestor
153888280|NCT01300767|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153888281|NCT02890173|Eplerenone|eplerenone|mesh-list
153888282|NCT02890173|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
153888283|NCT02890173|Hormone Antagonists|hormone antagonists|mesh-ancestor
153888284|NCT02890173|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153888285|NCT02890173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153429407|NCT03983941|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153429408|NCT04331054|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
153429409|NCT04331054|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153429410|NCT04331054|Respiratory System Agents|respiratory system agents|mesh-ancestor
153429412|NCT00002654|Trace Elements|trace elements|mesh-ancestor
153429413|NCT00002654|Micronutrients|micronutrients|mesh-ancestor
153429414|NCT00002654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153429416|NCT01426555|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153429417|NCT01426555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153429418|NCT01434745|Simvastatin|simvastatin|mesh-list
153429419|NCT01434745|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153429420|NCT01434745|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153429421|NCT01434745|Antimetabolites|antimetabolites|mesh-ancestor
153429422|NCT01434745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153429423|NCT01434745|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153429425|NCT01434745|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153888331|NCT01100944|Doxorubicin|doxorubicin|mesh-list
153888332|NCT01100944|Belinostat|belinostat|mesh-list
153888333|NCT01100944|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153888334|NCT01100944|Immunologic Factors|immunologic factors|mesh-ancestor
153888335|NCT01100944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153888336|NCT01100944|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153888337|NCT01100944|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153888338|NCT01100944|Alkylating Agents|alkylating agents|mesh-ancestor
153888339|NCT01100944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153888340|NCT01100944|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153888341|NCT01100944|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153888342|NCT01100944|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153888343|NCT01100944|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153888378|NCT00626080|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153888379|NCT00626080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153888380|NCT04309240|Rivaroxaban|rivaroxaban|mesh-list
153888381|NCT04309240|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
153429459|NCT01402531|Growth Inhibitors|growth inhibitors|mesh-ancestor
153429460|NCT00381836|Darbepoetin alfa|darbepoetin alfa|mesh-list
153429461|NCT00381836|Hematinics|hematinics|mesh-ancestor
153429462|NCT01971853|Analgesics|analgesics|mesh-list
153429463|NCT01971853|Sensory System Agents|sensory system agents|mesh-ancestor
153429464|NCT01971853|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153429465|NCT01971853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153429466|NCT00002678|Dexamethasone|dexamethasone|mesh-list
153429467|NCT00002678|Prednisone|prednisone|mesh-list
153429468|NCT00002678|Melphalan|melphalan|mesh-list
153429469|NCT00002678|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153429470|NCT00002678|Antiemetics|antiemetics|mesh-ancestor
153429471|NCT00002678|Autonomic Agents|autonomic agents|mesh-ancestor
153429472|NCT00002678|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153888389|NCT01035229|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
153888390|NCT01035229|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153888391|NCT01035229|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153888399|NCT01059799|Insulin Glargine|insulin glargine|mesh-list
153888400|NCT01059799|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153888401|NCT01059799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153888402|NCT04301869|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
153888403|NCT04301869|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153429483|NCT00002678|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153429486|NCT01397695|Bevacizumab|bevacizumab|mesh-list
153888404|NCT04301479|Hydrocortisone|hydrocortisone|mesh-list
153888405|NCT04301479|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
153888406|NCT04301479|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
153888407|NCT04301479|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
153888408|NCT04301479|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153888410|NCT01106092|Immunologic Factors|immunologic factors|mesh-ancestor
153888411|NCT01106092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153888412|NCT04307290|Dexmedetomidine|dexmedetomidine|mesh-list
153888413|NCT04307290|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153888414|NCT04307290|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153888415|NCT04307290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153888416|NCT04307290|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153888417|NCT04307290|Analgesics|analgesics|mesh-ancestor
153888418|NCT04307290|Sensory System Agents|sensory system agents|mesh-ancestor
153888419|NCT04307290|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153888420|NCT04307290|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
153888421|NCT04307290|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153888422|NCT04307290|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153888423|NCT04307290|Adrenergic Agents|adrenergic agents|mesh-ancestor
153429512|NCT02972918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153429514|NCT05600491|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153429515|NCT05600491|Alkylating Agents|alkylating agents|mesh-ancestor
153429516|NCT05600491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153888429|NCT01324349|Hemostatics|hemostatics|mesh-list
153888430|NCT01324349|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
153888431|NCT01324349|Coagulants|coagulants|mesh-ancestor
153888432|NCT01095250|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
153888433|NCT01095250|Immunologic Factors|immunologic factors|mesh-ancestor
153888434|NCT01095250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153888435|NCT01095094|Ritonavir|ritonavir|mesh-list
153888436|NCT01095094|Lopinavir|lopinavir|mesh-list
153429573|NCT01303003|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153429574|NCT01303003|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153429578|NCT00002714|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
153429579|NCT00002714|Bleomycin|bleomycin|mesh-list
153429580|NCT00002714|Etoposide|etoposide|mesh-list
153429581|NCT00002714|Vincristine|vincristine|mesh-list
153429582|NCT00002714|Vinblastine|vinblastine|mesh-list
153429583|NCT00002714|Mechlorethamine|mechlorethamine|mesh-list
153888499|NCT01320683|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153888500|NCT01320683|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153888501|NCT01320683|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
153888502|NCT01320683|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153888503|NCT01320683|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153888504|NCT01320683|Antidotes|antidotes|mesh-ancestor
153888505|NCT01320683|Protective Agents|protective agents|mesh-ancestor
153888506|NCT01320683|Vitamin B Complex|vitamin b complex|mesh-ancestor
153888507|NCT01320683|Vitamins|vitamins|mesh-ancestor
153888508|NCT01320683|Micronutrients|micronutrients|mesh-ancestor
153888509|NCT01320293|Adalimumab|adalimumab|mesh-list
153888510|NCT01320293|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
153888511|NCT01320293|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153888512|NCT01320293|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153429585|NCT00002714|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153429586|NCT00002714|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153429587|NCT00002714|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153429588|NCT00002714|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153429589|NCT00002714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153429590|NCT00002714|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153429592|NCT00002714|Hormones|hormones|mesh-ancestor
153429593|NCT00002714|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153429594|NCT00002714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153429595|NCT00002714|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153429596|NCT00002714|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153429597|NCT00002714|Tubulin Modulators|tubulin modulators|mesh-ancestor
153429598|NCT00002714|Antimitotic Agents|antimitotic agents|mesh-ancestor
153429600|NCT00002714|Alkylating Agents|alkylating agents|mesh-ancestor
153429601|NCT00002714|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153429602|NCT00002720|Tamoxifen|tamoxifen|mesh-list
153429603|NCT00002720|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
153429604|NCT00002720|Hormone Antagonists|hormone antagonists|mesh-ancestor
153888517|NCT01318811|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153888518|NCT01318811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153888519|NCT05644769|Lisinopril|lisinopril|mesh-list
153888520|NCT05644769|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
153888521|NCT05644769|Protease Inhibitors|protease inhibitors|mesh-ancestor
153888522|NCT05644769|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153888523|NCT05644769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153888524|NCT05644769|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153888525|NCT05644769|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
153888526|NCT05644769|Protective Agents|protective agents|mesh-ancestor
153888527|NCT05644769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153429674|NCT00002744|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
153429675|NCT00002744|Cyclophosphamide|cyclophosphamide|mesh-list
153429677|NCT00002744|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
153429688|NCT00002744|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153429693|NCT00002744|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153429694|NCT00002744|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153429695|NCT00002744|Antiemetics|antiemetics|mesh-ancestor
153429696|NCT00002744|Autonomic Agents|autonomic agents|mesh-ancestor
153429697|NCT00002744|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153429698|NCT00002744|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153429699|NCT00002744|Glucocorticoids|glucocorticoids|mesh-ancestor
153429700|NCT00002744|Hormones|hormones|mesh-ancestor
153888606|NCT01313273|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153888607|NCT01313273|Anabolic Agents|anabolic agents|mesh-ancestor
153888608|NCT01313273|Hormone Antagonists|hormone antagonists|mesh-ancestor
153888610|NCT01091974|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
153888611|NCT01091974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153888612|NCT01091974|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
153888613|NCT01091974|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
153888614|NCT01091974|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
153429756|NCT00423007|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153429757|NCT00423007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153429758|NCT00423007|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153429759|NCT00423007|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153888655|NCT01312961|Hormones|hormones|mesh-ancestor
153888656|NCT01312961|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153888657|NCT01312961|Sympathomimetics|sympathomimetics|mesh-ancestor
153888658|NCT00626158|Gemcitabine|gemcitabine|mesh-list
153888659|NCT00626158|Capecitabine|capecitabine|mesh-list
153888660|NCT00626158|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153888661|NCT00626158|Antimetabolites|antimetabolites|mesh-ancestor
153888662|NCT00626158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153888663|NCT00626158|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153888665|NCT01310777|Ophthalmic Solutions|ophthalmic solutions|mesh-list
153888666|NCT01310777|Brinzolamide|brinzolamide|mesh-list
153888667|NCT01310777|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
153888668|NCT01310777|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153888669|NCT01310777|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
153888670|NCT01310777|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153888671|NCT01310777|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153888673|NCT01310777|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153888674|NCT01310777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153888675|NCT01310777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153888676|NCT01310777|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
153888677|NCT01310777|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153888679|NCT01309997|Imatinib Mesylate|imatinib mesylate|mesh-list
153888680|NCT01309997|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153429761|NCT00002750|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153429762|NCT00002750|Alkylating Agents|alkylating agents|mesh-ancestor
153429763|NCT00002750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153429764|NCT00002750|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153429765|NCT00002750|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153429766|NCT00002750|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153429767|NCT00002750|Immunologic Factors|immunologic factors|mesh-ancestor
153429768|NCT00002750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153429769|NCT00002756|Leucovorin|leucovorin|mesh-list
153429771|NCT00002756|Prednisone|prednisone|mesh-list
153429772|NCT00002756|Hydrocortisone|hydrocortisone|mesh-list
153429773|NCT00002756|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
153429774|NCT00002756|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
153429775|NCT00002756|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
153888681|NCT01309997|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153888682|NCT01309997|Immunologic Factors|immunologic factors|mesh-ancestor
153888683|NCT01309997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153888684|NCT01309997|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153888685|NCT01309997|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153888686|NCT01309997|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153888687|NCT01309997|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153888688|NCT01309997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153888690|NCT01309841|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
153888691|NCT01309841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153888692|NCT01309841|Sensory System Agents|sensory system agents|mesh-ancestor
153888693|NCT01309841|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153888694|NCT01308749|Oxytocin|oxytocin|mesh-list
153888695|NCT01308749|Oxytocics|oxytocics|mesh-ancestor
153888696|NCT01308749|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153429776|NCT00002756|Cyclophosphamide|cyclophosphamide|mesh-list
153429777|NCT00002756|Methotrexate|methotrexate|mesh-list
153429778|NCT00002756|Etoposide|etoposide|mesh-list
153429780|NCT00002756|Daunorubicin|daunorubicin|mesh-list
153429781|NCT00002756|Asparaginase|asparaginase|mesh-list
153429782|NCT00002756|Mercaptopurine|mercaptopurine|mesh-list
153429783|NCT00002756|Levoleucovorin|levoleucovorin|mesh-list
153429784|NCT00002756|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153429785|NCT00002756|Immunologic Factors|immunologic factors|mesh-ancestor
153429786|NCT00002756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153429787|NCT00002756|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153429788|NCT00002756|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153429789|NCT00002756|Alkylating Agents|alkylating agents|mesh-ancestor
153429790|NCT00002756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153429791|NCT00002756|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153429792|NCT00002756|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153429793|NCT00002756|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153888701|NCT01307891|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153888703|NCT01307891|Antimitotic Agents|antimitotic agents|mesh-ancestor
153888704|NCT01307891|Mitosis Modulators|mitosis modulators|mesh-ancestor
153888705|NCT01307891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153888707|NCT05644301|Celecoxib|celecoxib|mesh-list
153888708|NCT05644301|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153888709|NCT05644301|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153888710|NCT05644301|Analgesics|analgesics|mesh-ancestor
153888711|NCT05644301|Sensory System Agents|sensory system agents|mesh-ancestor
153888712|NCT05644301|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153888713|NCT05644301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153888714|NCT05644301|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153888715|NCT05644301|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153888716|NCT05644301|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
153429797|NCT00002756|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153429798|NCT00002756|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
153429799|NCT00002756|Abortifacient Agents|abortifacient agents|mesh-ancestor
153429800|NCT00002756|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153429801|NCT00002756|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153429802|NCT00002756|Antimetabolites|antimetabolites|mesh-ancestor
153429803|NCT00002756|Dermatologic Agents|dermatologic agents|mesh-ancestor
153429804|NCT00002756|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153429805|NCT00002756|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153429807|NCT00002756|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153429808|NCT00002756|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153429809|NCT00002756|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153429810|NCT00002756|Antiviral Agents|antiviral agents|mesh-ancestor
153429811|NCT00002756|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153429812|NCT00002756|Antidotes|antidotes|mesh-ancestor
153429813|NCT00002756|Protective Agents|protective agents|mesh-ancestor
153429814|NCT00002756|Vitamin B Complex|vitamin b complex|mesh-ancestor
153429815|NCT00002756|Vitamins|vitamins|mesh-ancestor
153429816|NCT00002756|Micronutrients|micronutrients|mesh-ancestor
153429817|NCT00002756|Tubulin Modulators|tubulin modulators|mesh-ancestor
153429818|NCT00002756|Antimitotic Agents|antimitotic agents|mesh-ancestor
153429819|NCT00002756|Mitosis Modulators|mitosis modulators|mesh-ancestor
153429820|NCT00002756|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153888720|NCT05644301|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153888721|NCT05644301|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153888722|NCT02890745|Empagliflozin|empagliflozin|mesh-list
153888723|NCT02890745|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
153888724|NCT02890745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153888725|NCT02890745|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153888726|NCT02890745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153888727|NCT01307579|Fluconazole|fluconazole|mesh-list
153888728|NCT01307579|Caspofungin|caspofungin|mesh-list
153888730|NCT01307579|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153888731|NCT01307579|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
153888732|NCT01307579|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153888733|NCT01307579|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153888734|NCT01307579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153888738|NCT01307579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153888739|NCT01307579|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
153888740|NCT01307579|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
153429827|NCT01157533|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153429828|NCT01157533|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153429830|NCT05749016|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
153429831|NCT05749016|Carboplatin|carboplatin|mesh-list
153429832|NCT05749016|Pertuzumab|pertuzumab|mesh-list
153429833|NCT05749016|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153429834|NCT05749016|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153429835|NCT05749016|Tubulin Modulators|tubulin modulators|mesh-ancestor
153429836|NCT05749016|Antimitotic Agents|antimitotic agents|mesh-ancestor
153429837|NCT05749016|Mitosis Modulators|mitosis modulators|mesh-ancestor
153429838|NCT05749016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153429840|NCT01756573|Bupivacaine|bupivacaine|mesh-list
153429841|NCT01756573|Anesthetics, Local|anesthetics, local|mesh-ancestor
153429842|NCT01756573|Anesthetics|anesthetics|mesh-ancestor
153429843|NCT01756573|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153429844|NCT01756573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153429845|NCT01756573|Sensory System Agents|sensory system agents|mesh-ancestor
153888761|NCT04325009|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
153888763|NCT01034137|Methotrexate|methotrexate|mesh-list
153429850|NCT01126801|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153429852|NCT01702909|Interleukin-2|interleukin-2|mesh-list
153429853|NCT01702909|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153429854|NCT01702909|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153429855|NCT01702909|Analgesics|analgesics|mesh-ancestor
153429856|NCT01702909|Sensory System Agents|sensory system agents|mesh-ancestor
153429857|NCT01702909|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153429858|NCT01702909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153429859|NCT00002768|Cytarabine|cytarabine|mesh-list
153429860|NCT00002768|Methotrexate|methotrexate|mesh-list
153429861|NCT00002768|Etoposide|etoposide|mesh-list
153429862|NCT00002768|Busulfan|busulfan|mesh-list
153429867|NCT00002768|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153429869|NCT00002768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153429870|NCT00002768|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153888772|NCT01034137|Dermatologic Agents|dermatologic agents|mesh-ancestor
153888773|NCT01034137|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153888778|NCT01034137|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153888779|NCT01056289|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
153888780|NCT01056289|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
153888781|NCT01056289|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153888782|NCT01056289|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153888783|NCT01056289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153429874|NCT00002768|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153429875|NCT00002768|Immunologic Factors|immunologic factors|mesh-ancestor
153429876|NCT00002768|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153429877|NCT00002768|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153429878|NCT00002768|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153429879|NCT00002768|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153429880|NCT00002768|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153429881|NCT00002768|Antiviral Agents|antiviral agents|mesh-ancestor
153429882|NCT00002768|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153429883|NCT00002768|Alkylating Agents|alkylating agents|mesh-ancestor
153429884|NCT00002768|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153888787|NCT01056289|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153888789|NCT02875093|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153888790|NCT02875093|Antimetabolites|antimetabolites|mesh-ancestor
153888791|NCT02875093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153888792|NCT02875093|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153888793|NCT02875093|Antiviral Agents|antiviral agents|mesh-ancestor
153888794|NCT02875093|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153888795|NCT02875093|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153888796|NCT02875093|Immunologic Factors|immunologic factors|mesh-ancestor
153429885|NCT00002768|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153429887|NCT00002774|Fluorouracil|fluorouracil|mesh-list
153429888|NCT00002774|Tirapazamine|tirapazamine|mesh-list
153429891|NCT00002774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153429892|NCT00002774|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153429893|NCT00002774|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153429894|NCT00002774|Immunologic Factors|immunologic factors|mesh-ancestor
153429895|NCT00002774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153429896|NCT00002780|Aldesleukin|aldesleukin|mesh-list
153429897|NCT00002780|Cyclophosphamide|cyclophosphamide|mesh-list
153429899|NCT00002780|Carboplatin|carboplatin|mesh-list
153429900|NCT00002780|Sargramostim|sargramostim|mesh-list
153429901|NCT00002780|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153429902|NCT00002780|Immunologic Factors|immunologic factors|mesh-ancestor
153429903|NCT00002780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153429905|NCT00002780|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153429906|NCT00002780|Alkylating Agents|alkylating agents|mesh-ancestor
153429908|NCT00002780|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153429909|NCT00002780|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153429910|NCT00002780|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153429911|NCT00002780|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153429912|NCT00002780|Antiviral Agents|antiviral agents|mesh-ancestor
153429913|NCT00002780|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153429914|NCT01692691|Dacarbazine|dacarbazine|mesh-list
153888797|NCT02875093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153888798|NCT01033825|Ciclesonide|ciclesonide|mesh-list
153888799|NCT01033825|Dexamethasone|dexamethasone|mesh-list
153888800|NCT01033825|Dexamethasone acetate|dexamethasone acetate|mesh-list
153888801|NCT01033825|BB 1101|bb 1101|mesh-list
153888802|NCT01033825|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153888803|NCT01033825|Antiemetics|antiemetics|mesh-ancestor
153888804|NCT01033825|Autonomic Agents|autonomic agents|mesh-ancestor
153888813|NCT01033825|Protease Inhibitors|protease inhibitors|mesh-ancestor
153888814|NCT01033825|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153888815|NCT01033825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153888816|NCT01033825|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
153888817|NCT01033747|Deferasirox|deferasirox|mesh-list
153888818|NCT01033747|Iron Chelating Agents|iron chelating agents|mesh-ancestor
153888820|NCT01033747|Sequestering Agents|sequestering agents|mesh-ancestor
153888821|NCT01033747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153888822|NCT02875015|Lidocaine|lidocaine|mesh-list
153888823|NCT02875015|Bupivacaine|bupivacaine|mesh-list
153888824|NCT02875015|Anesthetics, Local|anesthetics, local|mesh-ancestor
153888825|NCT02875015|Anesthetics|anesthetics|mesh-ancestor
153888826|NCT02875015|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153888827|NCT02875015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153888829|NCT02875015|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153888830|NCT02875015|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153888831|NCT02875015|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
153888832|NCT02875015|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153888833|NCT02875015|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153888834|NCT02875015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153888836|NCT01091428|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153888837|NCT01091428|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153888838|NCT01091428|Tubulin Modulators|tubulin modulators|mesh-ancestor
153888839|NCT01091428|Antimitotic Agents|antimitotic agents|mesh-ancestor
153888840|NCT01091428|Mitosis Modulators|mitosis modulators|mesh-ancestor
153888844|NCT01096342|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153888845|NCT01096342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153888846|NCT01096186|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
153888848|NCT01096186|Levodopa|levodopa|mesh-list
153888849|NCT01096186|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153888850|NCT01096186|Immunologic Factors|immunologic factors|mesh-ancestor
153888851|NCT01096186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153888852|NCT01096186|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
153888853|NCT01096186|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
153888854|NCT01096186|Dopamine Agonists|dopamine agonists|mesh-ancestor
153888855|NCT01096186|Dopamine Agents|dopamine agents|mesh-ancestor
153888856|NCT01096186|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153888857|NCT01096186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153429955|NCT05531708|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153429957|NCT05531708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153429958|NCT05531708|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153429959|NCT05531708|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153429960|NCT01663285|Gemcitabine|gemcitabine|mesh-list
153429961|NCT01663285|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153429962|NCT01663285|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153429963|NCT01663285|Antimetabolites|antimetabolites|mesh-ancestor
153429964|NCT01663285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153429965|NCT00002786|Aldesleukin|aldesleukin|mesh-list
153429966|NCT00002786|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153888867|NCT04302649|Dialysis Solutions|dialysis solutions|mesh-list
153888868|NCT04302649|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
153888869|NCT04301557|Capecitabine|capecitabine|mesh-list
153888870|NCT04301557|Oxaliplatin|oxaliplatin|mesh-list
153888871|NCT04301557|Antibodies|antibodies|mesh-list
153888872|NCT04301557|Immunologic Factors|immunologic factors|mesh-ancestor
153888873|NCT04301557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153888874|NCT04301557|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153888875|NCT04301557|Antimetabolites|antimetabolites|mesh-ancestor
153429968|NCT00002786|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153429969|NCT00002786|Antiviral Agents|antiviral agents|mesh-ancestor
153429970|NCT00002786|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153429971|NCT00378937|Acetaminophen|acetaminophen|mesh-list
153429972|NCT00378937|Morphine|morphine|mesh-list
153429973|NCT00378937|Oxycodone|oxycodone|mesh-list
153429975|NCT00378937|Dextropropoxyphene|dextropropoxyphene|mesh-list
153429976|NCT00378937|Levopropoxyphene|levopropoxyphene|mesh-list
153429977|NCT00378937|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153429978|NCT00378937|Narcotics|narcotics|mesh-ancestor
153429979|NCT00378937|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153429980|NCT00378937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153429981|NCT00378937|Analgesics|analgesics|mesh-ancestor
153429982|NCT00378937|Sensory System Agents|sensory system agents|mesh-ancestor
153429983|NCT00378937|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153429984|NCT00378937|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153429985|NCT00378937|Antipyretics|antipyretics|mesh-ancestor
153429986|NCT00378937|Antitussive Agents|antitussive agents|mesh-ancestor
153888881|NCT01029535|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153888882|NCT01029535|Immunologic Factors|immunologic factors|mesh-ancestor
153888883|NCT01029535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153888884|NCT01029535|Viscosupplements|viscosupplements|mesh-ancestor
153888885|NCT01029535|Protective Agents|protective agents|mesh-ancestor
153888886|NCT01028053|Flutemetamol|flutemetamol|mesh-list
153888887|NCT01028053|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
153888888|NCT01028053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153888889|NCT01023217|Lamivudine|lamivudine|mesh-list
153888891|NCT01023217|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
153888892|NCT01023217|Entecavir|entecavir|mesh-list
153888894|NCT01023217|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153888895|NCT01023217|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153429992|NCT00002792|Tacrolimus|tacrolimus|mesh-list
153429993|NCT00002792|Cyclosporins|cyclosporins|mesh-list
153429994|NCT00002792|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153429995|NCT00002792|Immunologic Factors|immunologic factors|mesh-ancestor
153429998|NCT00002792|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153429999|NCT00002792|Alkylating Agents|alkylating agents|mesh-ancestor
153430000|NCT00002792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153430001|NCT00002792|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153430002|NCT00002792|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153888897|NCT01023217|Antiviral Agents|antiviral agents|mesh-ancestor
153888899|NCT01023217|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153888900|NCT01023217|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153888902|NCT01095796|Elvitegravir, Cobicistat, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|elvitegravir, cobicistat, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
153888904|NCT01095796|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153888905|NCT01095796|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153430003|NCT00002792|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
153430004|NCT00002792|Abortifacient Agents|abortifacient agents|mesh-ancestor
153430005|NCT00002792|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153430006|NCT00002792|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153430007|NCT00002792|Antimetabolites|antimetabolites|mesh-ancestor
153430008|NCT00002792|Dermatologic Agents|dermatologic agents|mesh-ancestor
153430009|NCT00002792|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153430010|NCT00002792|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153430011|NCT00002792|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153430012|NCT00002792|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
153430013|NCT00002792|Antifungal Agents|antifungal agents|mesh-ancestor
153888906|NCT01095796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153888907|NCT01095796|Antiviral Agents|antiviral agents|mesh-ancestor
153888908|NCT01095796|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153888909|NCT01095796|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153888910|NCT01095796|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153888912|NCT01023061|Leuprolide|leuprolide|mesh-list
153888913|NCT01023061|Goserelin|goserelin|mesh-list
153888914|NCT01023061|Abiraterone Acetate|abiraterone acetate|mesh-list
153888915|NCT01023061|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153888916|NCT01023061|Glucocorticoids|glucocorticoids|mesh-ancestor
153888917|NCT01023061|Hormones|hormones|mesh-ancestor
153888918|NCT01023061|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153430016|NCT01090141|Antifungal Agents|antifungal agents|mesh-ancestor
153430017|NCT01090141|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153430018|NCT01048723|Everolimus|everolimus|mesh-list
153430019|NCT01048723|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
153430020|NCT01048723|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153430021|NCT01048723|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153430022|NCT01048723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153430023|NCT01048723|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153430024|NCT01048723|Immunologic Factors|immunologic factors|mesh-ancestor
153430025|NCT01048723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153430026|NCT01048723|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153430027|NCT05513612|Cyclophosphamide|cyclophosphamide|mesh-list
153888927|NCT01023061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153888929|NCT01023061|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153430028|NCT05513612|Fludarabine|fludarabine|mesh-list
153430030|NCT05513612|Immunologic Factors|immunologic factors|mesh-ancestor
153430031|NCT05513612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153430033|NCT05513612|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153430034|NCT05513612|Alkylating Agents|alkylating agents|mesh-ancestor
153430035|NCT05513612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153430036|NCT05513612|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153430037|NCT05513612|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153430038|NCT05594407|Lidocaine|lidocaine|mesh-list
153430039|NCT05594407|Dexmedetomidine|dexmedetomidine|mesh-list
153430040|NCT05594407|Ketamine|ketamine|mesh-list
153430041|NCT05594407|Remifentanil|remifentanil|mesh-list
153430042|NCT05594407|Anesthetics, Local|anesthetics, local|mesh-ancestor
153430043|NCT05594407|Anesthetics|anesthetics|mesh-ancestor
153430044|NCT05594407|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153430045|NCT05594407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153430046|NCT05594407|Sensory System Agents|sensory system agents|mesh-ancestor
153430047|NCT05594407|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153430048|NCT05594407|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153430049|NCT05594407|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
153430050|NCT05594407|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153430051|NCT05594407|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153430052|NCT05594407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153430053|NCT05594407|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153430054|NCT05594407|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153430055|NCT05594407|Analgesics|analgesics|mesh-ancestor
153430056|NCT05594407|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
153430057|NCT05594407|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153430058|NCT05594407|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153430059|NCT05594407|Adrenergic Agents|adrenergic agents|mesh-ancestor
153430060|NCT05594407|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153430061|NCT05594407|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
153430062|NCT05594407|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153430063|NCT05594407|Anesthetics, General|anesthetics, general|mesh-ancestor
153888930|NCT01027897|Doripenem|doripenem|mesh-list
153888931|NCT01027897|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153888932|NCT01027897|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153888933|NCT01027351|Vaccines|vaccines|mesh-list
153888934|NCT01027351|Immunologic Factors|immunologic factors|mesh-ancestor
153888935|NCT01027351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153888936|NCT05661045|Anesthetics|anesthetics|mesh-list
153888937|NCT05661045|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153888938|NCT05661045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153888940|NCT01294683|Niacinamide|niacinamide|mesh-list
153888941|NCT01294683|Nicotinic Acids|nicotinic acids|mesh-list
153888942|NCT01294683|Simvastatin|simvastatin|mesh-list
153888943|NCT01294683|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153888944|NCT01294683|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153888945|NCT01294683|Antimetabolites|antimetabolites|mesh-ancestor
153888946|NCT01294683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153888947|NCT01294683|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153888948|NCT01294683|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
153888949|NCT01294683|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153888950|NCT01294683|Vasodilator Agents|vasodilator agents|mesh-ancestor
153888951|NCT01294683|Vitamin B Complex|vitamin b complex|mesh-ancestor
153888952|NCT01294683|Vitamins|vitamins|mesh-ancestor
153888953|NCT01294683|Micronutrients|micronutrients|mesh-ancestor
153888954|NCT01294683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153888955|NCT01294449|Cytarabine|cytarabine|mesh-list
153888956|NCT01294449|Dexamethasone|dexamethasone|mesh-list
153888957|NCT01294449|Methotrexate|methotrexate|mesh-list
153888958|NCT01294449|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153888959|NCT01294449|Antimetabolites|antimetabolites|mesh-ancestor
153888960|NCT01294449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153888961|NCT01294449|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153888962|NCT01294449|Antiviral Agents|antiviral agents|mesh-ancestor
153888963|NCT01294449|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153430078|NCT04706377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153430080|NCT01583647|Niacin|niacin|mesh-list
153430081|NCT01583647|Niacinamide|niacinamide|mesh-list
153430082|NCT01583647|Nicotinic Acids|nicotinic acids|mesh-list
153430083|NCT01583647|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153430084|NCT01583647|Antimetabolites|antimetabolites|mesh-ancestor
153888977|NCT01294449|Abortifacient Agents|abortifacient agents|mesh-ancestor
153888978|NCT01294449|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153888979|NCT01294449|Dermatologic Agents|dermatologic agents|mesh-ancestor
153888980|NCT01294449|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153888981|NCT01294449|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153888982|NCT01294449|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153888983|NCT01294449|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153888984|NCT01293123|Tenofovir|tenofovir|mesh-list
153430085|NCT01583647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153430086|NCT01583647|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153430087|NCT01583647|Vasodilator Agents|vasodilator agents|mesh-ancestor
153430088|NCT01583647|Vitamin B Complex|vitamin b complex|mesh-ancestor
153430089|NCT01583647|Vitamins|vitamins|mesh-ancestor
153430090|NCT01583647|Micronutrients|micronutrients|mesh-ancestor
153430091|NCT01583647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153430092|NCT04403516|Dexamethasone|dexamethasone|mesh-list
153430093|NCT04403516|Prednisolone|prednisolone|mesh-list
153430094|NCT04403516|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
153888992|NCT01293123|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153888993|NCT01293123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153888994|NCT01293123|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153888995|NCT01293123|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153430096|NCT04403516|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
153430097|NCT04403516|Prednisolone acetate|prednisolone acetate|mesh-list
153430102|NCT04403516|Autonomic Agents|autonomic agents|mesh-ancestor
153430103|NCT04403516|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153430104|NCT04403516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153430105|NCT04403516|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153430106|NCT04403516|Glucocorticoids|glucocorticoids|mesh-ancestor
153430108|NCT04403516|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153430109|NCT04403516|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153430110|NCT04403516|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153889368|NCT04306276|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
153889369|NCT04306276|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
153889370|NCT04306276|Hormone Antagonists|hormone antagonists|mesh-ancestor
153889371|NCT04306276|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153889378|NCT01086358|Sumatriptan|sumatriptan|mesh-list
153889379|NCT01086358|Naratriptan|naratriptan|mesh-list
153430490|NCT00801931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153430491|NCT00801931|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153430492|NCT00801931|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153430493|NCT00801931|Alkylating Agents|alkylating agents|mesh-ancestor
153430494|NCT00801931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153430495|NCT00801931|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153430496|NCT00801931|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153430497|NCT00801931|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153430498|NCT00801931|Anticonvulsants|anticonvulsants|mesh-ancestor
153430502|NCT00801931|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
153430503|NCT00801931|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
153430504|NCT00780481|Bradykinin|bradykinin|mesh-list
153430507|NCT00780481|Cysteine Proteinase Inhibitors|cysteine proteinase inhibitors|mesh-ancestor
153430508|NCT00780481|Protease Inhibitors|protease inhibitors|mesh-ancestor
153430509|NCT00780481|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153430510|NCT00780481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153430511|NCT00019747|Thalidomide|thalidomide|mesh-list
153430512|NCT00019747|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153430513|NCT00019747|Immunologic Factors|immunologic factors|mesh-ancestor
153430514|NCT00019747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153430525|NCT00759577|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
153430526|NCT00759577|Cholinergic Agents|cholinergic agents|mesh-ancestor
153430527|NCT00759577|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153430528|NCT00759577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153430529|NCT00759577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153430530|NCT00759577|Urological Agents|urological agents|mesh-ancestor
153430533|NCT00746239|Escitalopram|escitalopram|mesh-list
153430534|NCT00746239|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
153430535|NCT00746239|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153430536|NCT00746239|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153430537|NCT00746239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153430653|NCT04330586|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
153430654|NCT00382694|Fludarabine|fludarabine|mesh-list
153430655|NCT00382694|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153430656|NCT04508036|Fibrin fragment D|fibrin fragment d|mesh-list
153430657|NCT04508036|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
153430658|NCT04508036|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153430659|NCT04508036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153430660|NCT04508036|Hemostatics|hemostatics|mesh-ancestor
153430661|NCT04508036|Coagulants|coagulants|mesh-ancestor
153889523|NCT01024231|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153889524|NCT01024231|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153889525|NCT01024231|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153889526|NCT01024231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153889527|NCT01077544|Nilotinib|nilotinib|mesh-list
153889565|NCT01016977|Dermatologic Agents|dermatologic agents|mesh-ancestor
153889566|NCT01016977|Keratolytic Agents|keratolytic agents|mesh-ancestor
153889567|NCT01016977|Vitamin B Complex|vitamin b complex|mesh-ancestor
153889568|NCT01016977|Vitamins|vitamins|mesh-ancestor
153889569|NCT01016977|Micronutrients|micronutrients|mesh-ancestor
153430686|NCT00000199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153430687|NCT00000199|Nootropic Agents|nootropic agents|mesh-ancestor
153430688|NCT00668785|Ranibizumab|ranibizumab|mesh-list
153430689|NCT00668785|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153430690|NCT00668785|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153430760|NCT00000235|Analgesics|analgesics|mesh-ancestor
153430761|NCT00000235|Sensory System Agents|sensory system agents|mesh-ancestor
153430762|NCT00000235|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153430763|NCT00000235|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
153430764|NCT00000241|Flupenthixol|flupenthixol|mesh-list
153430765|NCT00000241|Flupenthixol decanoate|flupenthixol decanoate|mesh-list
153430766|NCT00000241|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153430767|NCT00000241|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153430768|NCT00000241|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153430769|NCT00000241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153430770|NCT00000241|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153430771|NCT00000241|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
153430772|NCT00000241|Dopamine Agents|dopamine agents|mesh-ancestor
153430774|NCT00000241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153430775|NCT00000253|Nitrous Oxide|nitrous oxide|mesh-list
153430776|NCT00000253|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
153889624|NCT02871349|Vasodilator Agents|vasodilator agents|mesh-ancestor
153889626|NCT01012609|Cetuximab|cetuximab|mesh-list
153430777|NCT00000253|Anesthetics, General|anesthetics, general|mesh-ancestor
153430778|NCT00000253|Anesthetics|anesthetics|mesh-ancestor
153889627|NCT01012609|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
153889628|NCT01012609|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153889629|NCT01012609|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153889630|NCT01012609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153889631|NCT01012609|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153889632|NCT01012609|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153889633|NCT04297501|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
153889634|NCT04297501|Antiviral Agents|antiviral agents|mesh-ancestor
153889635|NCT04297501|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153430801|NCT00379405|Protease Inhibitors|protease inhibitors|mesh-ancestor
153430802|NCT00379405|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153430803|NCT00379405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153430804|NCT00379405|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153430805|NCT00379405|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153430806|NCT00379405|Antiviral Agents|antiviral agents|mesh-ancestor
153889691|NCT01011673|Dopamine Agents|dopamine agents|mesh-ancestor
153431105|NCT06316336|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153431106|NCT06316336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153431109|NCT06316323|Listerine|listerine|mesh-list
153431110|NCT06316323|Fluorides|fluorides|mesh-list
153431111|NCT06316323|Sodium Fluoride|sodium fluoride|mesh-list
153431112|NCT06316323|Cariostatic Agents|cariostatic agents|mesh-ancestor
153431113|NCT06316323|Protective Agents|protective agents|mesh-ancestor
153431114|NCT06316323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153431115|NCT06316323|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
153890072|NCT01008553|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153890073|NCT01008553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153890074|NCT01008553|Analgesics|analgesics|mesh-ancestor
153890075|NCT01008553|Sensory System Agents|sensory system agents|mesh-ancestor
153890076|NCT01008553|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153890077|NCT01008553|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153890078|NCT01008553|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153890100|NCT04479267|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
153890101|NCT04479267|Antibodies|antibodies|mesh-list
153890102|NCT04479267|Immunoglobulins|immunoglobulins|mesh-list
153890103|NCT04479267|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
153431116|NCT06316323|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153431184|NCT06315881|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153431185|NCT06315881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153431186|NCT06315881|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
153431187|NCT06315881|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
153431188|NCT06315881|Cholinergic Agents|cholinergic agents|mesh-ancestor
153431189|NCT06315881|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153431190|NCT06315881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153431191|NCT06315881|Respiratory System Agents|respiratory system agents|mesh-ancestor
153431192|NCT06315790|Botulinum Toxins|botulinum toxins|mesh-list
153431193|NCT06315790|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
153890187|NCT02866071|Sensory System Agents|sensory system agents|mesh-ancestor
153890188|NCT02866071|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153890189|NCT02866071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153890190|NCT02866071|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
153890191|NCT02866071|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153890194|NCT02866071|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153890195|NCT02866071|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
153890197|NCT02866071|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153890198|NCT02866071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153890199|NCT02890602|Prednisolone|prednisolone|mesh-list
153890200|NCT02890602|Cyclophosphamide|cyclophosphamide|mesh-list
153890201|NCT02890602|Vincristine|vincristine|mesh-list
153890202|NCT02890602|Darbepoetin alfa|darbepoetin alfa|mesh-list
153890203|NCT02890602|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153890204|NCT02890602|Immunologic Factors|immunologic factors|mesh-ancestor
153431197|NCT06315790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153431198|NCT06315790|Cholinergic Agents|cholinergic agents|mesh-ancestor
153431199|NCT06315790|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153431200|NCT06315790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153431201|NCT06315790|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
153431202|NCT06315790|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153431203|NCT06315699|Clemastine|clemastine|mesh-list
153431204|NCT06315699|Antipruritics|antipruritics|mesh-ancestor
153431205|NCT06315699|Dermatologic Agents|dermatologic agents|mesh-ancestor
153431206|NCT06315699|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
153431207|NCT06315699|Histamine Antagonists|histamine antagonists|mesh-ancestor
153890213|NCT02890602|Tubulin Modulators|tubulin modulators|mesh-ancestor
153890214|NCT02890602|Antimitotic Agents|antimitotic agents|mesh-ancestor
153890215|NCT02890602|Mitosis Modulators|mitosis modulators|mesh-ancestor
153890216|NCT02890602|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153890217|NCT02890602|Glucocorticoids|glucocorticoids|mesh-ancestor
153431210|NCT06315699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153431211|NCT06315699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153431212|NCT06315699|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
153431214|NCT06315686|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153431215|NCT06315686|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153431216|NCT06315686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153431217|NCT06315686|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153431218|NCT06315686|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153431219|NCT06315634|Midazolam|midazolam|mesh-list
153431220|NCT06315634|Dexmedetomidine|dexmedetomidine|mesh-list
153431221|NCT06315634|Bupivacaine|bupivacaine|mesh-list
153431222|NCT06315634|Anesthetics, Local|anesthetics, local|mesh-ancestor
153431223|NCT06315634|Anesthetics|anesthetics|mesh-ancestor
153431224|NCT06315634|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153431225|NCT06315634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153431226|NCT06315634|Sensory System Agents|sensory system agents|mesh-ancestor
153431227|NCT06315634|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153431228|NCT06315634|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153431229|NCT06315634|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153431230|NCT06315634|Analgesics|analgesics|mesh-ancestor
153461761|NCT04130802|Antiemetics|antiemetics|mesh-ancestor
153431233|NCT06315634|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153431234|NCT06315634|Adrenergic Agents|adrenergic agents|mesh-ancestor
153431235|NCT06315634|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153431236|NCT06315634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153431237|NCT06315634|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153431238|NCT06315634|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153431239|NCT06315634|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153431240|NCT06315634|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153431241|NCT06315634|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153431242|NCT06315634|Anesthetics, General|anesthetics, general|mesh-ancestor
153431243|NCT06315634|GABA Modulators|gaba modulators|mesh-ancestor
153431244|NCT06315634|GABA Agents|gaba agents|mesh-ancestor
153431245|NCT06315556|Aflibercept|aflibercept|mesh-list
153431246|NCT06315556|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153431247|NCT06315556|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153431248|NCT06315556|Growth Substances|growth substances|mesh-ancestor
153431249|NCT06315556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153431250|NCT06315556|Growth Inhibitors|growth inhibitors|mesh-ancestor
153431251|NCT06315556|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153431252|NCT06315478|Amoxicillin|amoxicillin|mesh-list
153431253|NCT06315478|Metronidazole|metronidazole|mesh-list
153431254|NCT06315478|Clarithromycin|clarithromycin|mesh-list
153431256|NCT06315478|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153431257|NCT06315478|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153431261|NCT06315478|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153431262|NCT06315478|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
153890244|NCT01302054|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
153890245|NCT01302054|Cholinergic Agents|cholinergic agents|mesh-ancestor
153890246|NCT01302054|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153890247|NCT01302054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153890248|NCT01302054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153890249|NCT01302054|Urological Agents|urological agents|mesh-ancestor
153890250|NCT05642910|Nirmatrelvir and ritonavir drug combination|nirmatrelvir and ritonavir drug combination|mesh-list
153890251|NCT05642910|Antiviral Agents|antiviral agents|mesh-ancestor
153890252|NCT05642910|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153890253|NCT01300650|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
153890254|NCT01300650|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153890256|NCT01300572|Mycophenolic Acid|mycophenolic acid|mesh-list
153890257|NCT01300572|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
153890258|NCT01300572|Fludarabine|fludarabine|mesh-list
153890259|NCT01300572|Fludarabine phosphate|fludarabine phosphate|mesh-list
153890261|NCT01300572|Immunoglobulins|immunoglobulins|mesh-list
153890262|NCT01300572|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
153890263|NCT01300572|Cyclosporins|cyclosporins|mesh-list
153890264|NCT01300572|Immunologic Factors|immunologic factors|mesh-ancestor
153890265|NCT01300572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153890266|NCT01300572|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153890267|NCT01300572|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153431263|NCT06315478|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153431264|NCT06315478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153431265|NCT06315478|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
153431266|NCT06315478|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
153431267|NCT06315478|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153431268|NCT06315400|Pentanedioic acid imidazolyl ethanamide|pentanedioic acid imidazolyl ethanamide|mesh-list
153431269|NCT06315400|Antiviral Agents|antiviral agents|mesh-ancestor
153431270|NCT06315400|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153431272|NCT06315322|Anticonvulsants|anticonvulsants|mesh-ancestor
153431273|NCT06315309|Methotrexate|methotrexate|mesh-list
153431275|NCT06315309|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
153431276|NCT06315309|Abortifacient Agents|abortifacient agents|mesh-ancestor
153431277|NCT06315309|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153431278|NCT06315309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153431279|NCT06315309|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153431280|NCT06315309|Antimetabolites|antimetabolites|mesh-ancestor
153431281|NCT06315309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153431282|NCT06315309|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153431283|NCT06315309|Dermatologic Agents|dermatologic agents|mesh-ancestor
153431284|NCT06315309|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153890268|NCT01300572|Antimetabolites|antimetabolites|mesh-ancestor
153890269|NCT01300572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153890270|NCT01300572|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153890271|NCT01300572|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153890272|NCT01300572|Antifungal Agents|antifungal agents|mesh-ancestor
153890273|NCT01300572|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153890274|NCT01300572|Dermatologic Agents|dermatologic agents|mesh-ancestor
153890275|NCT01300572|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153890276|NCT01300572|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
153890277|NCT01300572|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153890278|NCT01300572|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
153890279|NCT01300572|Antitubercular Agents|antitubercular agents|mesh-ancestor
153890280|NCT01300572|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153890281|NCT01077154|Denosumab|denosumab|mesh-list
153890282|NCT01077154|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153890283|NCT01077154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153890284|NCT01258101|Ribavirin|ribavirin|mesh-list
153890285|NCT01258101|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
153890286|NCT01258101|Interferon-alpha|interferon-alpha|mesh-list
153890287|NCT01258101|Antimetabolites|antimetabolites|mesh-ancestor
153890288|NCT01258101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153890289|NCT01258101|Antiviral Agents|antiviral agents|mesh-ancestor
153890290|NCT01258101|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153890293|NCT05640804|Dasatinib|dasatinib|mesh-list
153890294|NCT05640804|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153890295|NCT05640804|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153890296|NCT05640804|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153890297|NCT05640804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153890298|NCT05640804|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153890299|NCT00623688|Imidacloprid|imidacloprid|mesh-list
153890300|NCT00623688|Cholinergic Agents|cholinergic agents|mesh-ancestor
153890301|NCT00623688|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153890302|NCT00623688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153890303|NCT00623688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153890304|NCT01300260|Dulaglutide|dulaglutide|mesh-list
153890305|NCT01300260|Glucagon|glucagon|mesh-list
153890306|NCT01300260|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
153890307|NCT01300260|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153890308|NCT01300260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153890309|NCT01300260|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153890311|NCT01300260|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153890312|NCT01300260|Incretins|incretins|mesh-ancestor
153890313|NCT01300260|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
153890314|NCT01256385|Sirolimus|sirolimus|mesh-list
153890315|NCT01256385|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
153890316|NCT01256385|Cetuximab|cetuximab|mesh-list
153890317|NCT01256385|Temsirolimus|temsirolimus|mesh-list
153890318|NCT01256385|MTOR Inhibitors|mtor inhibitors|mesh-list
153890319|NCT01256385|Antibodies|antibodies|mesh-list
153431314|NCT06314997|Panitumumab|panitumumab|mesh-list
153431315|NCT06314997|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153431316|NCT06314997|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153431317|NCT06314880|Vaccines|vaccines|mesh-list
153431318|NCT06314880|Immunologic Factors|immunologic factors|mesh-ancestor
153431319|NCT06314880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153431320|NCT06314867|Vaccines|vaccines|mesh-list
153431321|NCT06314867|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
153431322|NCT06314867|Immunologic Factors|immunologic factors|mesh-ancestor
153431323|NCT06314867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153431324|NCT06314763|Sotorasib|sotorasib|mesh-list
153431325|NCT06314763|Rivaroxaban|rivaroxaban|mesh-list
153431326|NCT06314763|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
153431327|NCT06314763|Antithrombins|antithrombins|mesh-ancestor
153431328|NCT06314763|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
153431329|NCT06314763|Protease Inhibitors|protease inhibitors|mesh-ancestor
153431330|NCT06314763|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153431331|NCT06314763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153431332|NCT06314763|Anticoagulants|anticoagulants|mesh-ancestor
153431333|NCT06314763|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153431334|NCT06314763|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153431336|NCT06314698|Denosumab|denosumab|mesh-list
153890335|NCT00637182|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153890336|NCT00637182|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
153890337|NCT00637182|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153890339|NCT00637182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153890340|NCT00637182|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
153890341|NCT00637182|Hormone Antagonists|hormone antagonists|mesh-ancestor
153890342|NCT00637182|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153890343|NCT00637182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153890344|NCT01298778|Acetaminophen|acetaminophen|mesh-list
153890345|NCT01298778|Morphine|morphine|mesh-list
153431341|NCT06314685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153431342|NCT06314659|Vaccines|vaccines|mesh-list
153431343|NCT06314659|Immunologic Factors|immunologic factors|mesh-ancestor
153431344|NCT06314659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153431351|NCT06314334|Pegaspargase|pegaspargase|mesh-list
153431352|NCT06314334|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153431353|NCT06313008|Empagliflozin|empagliflozin|mesh-list
153431354|NCT06313008|Vildagliptin|vildagliptin|mesh-list
153431355|NCT06313008|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
153431356|NCT06313008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153431357|NCT06313008|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153431358|NCT06313008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153431359|NCT06313008|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
153431365|NCT06312683|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153890360|NCT01297920|Ophthalmic Solutions|ophthalmic solutions|mesh-list
153890362|NCT01297920|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
153890363|NCT01297920|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153890364|NCT01297920|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
153890365|NCT01297920|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153890366|NCT01297920|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153890367|NCT01297920|Adrenergic Agents|adrenergic agents|mesh-ancestor
153890368|NCT01297920|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153890370|NCT01297920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153890371|NCT01297920|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
153890372|NCT01297920|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153890374|NCT01255761|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
153890375|NCT01255761|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153431379|NCT06305754|Acetaminophen|acetaminophen|mesh-list
153431380|NCT06305754|Dexamethasone|dexamethasone|mesh-list
153431381|NCT06305754|Carboplatin|carboplatin|mesh-list
153431382|NCT06305754|Pemetrexed|pemetrexed|mesh-list
153431383|NCT06305754|Histamine Antagonists|histamine antagonists|mesh-list
153431384|NCT06305754|Histamine H1 Antagonists|histamine h1 antagonists|mesh-list
153431385|NCT06305754|Histamine H2 Antagonists|histamine h2 antagonists|mesh-list
153431386|NCT06305754|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153431387|NCT06305754|Antiemetics|antiemetics|mesh-ancestor
153431388|NCT06305754|Autonomic Agents|autonomic agents|mesh-ancestor
153431389|NCT06305754|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153431390|NCT06305754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153431391|NCT06305754|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153431392|NCT06305754|Glucocorticoids|glucocorticoids|mesh-ancestor
153431393|NCT06305754|Hormones|hormones|mesh-ancestor
153431394|NCT06305754|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153431395|NCT06305754|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153431396|NCT06305754|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153431397|NCT06305754|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153431398|NCT06305754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153890393|NCT01297062|Incretins|incretins|mesh-ancestor
153890394|NCT01297062|Hormones|hormones|mesh-ancestor
153890395|NCT01297062|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153890396|NCT01296672|Finasteride|finasteride|mesh-list
153890397|NCT01296672|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
153890398|NCT01296672|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153890399|NCT01296672|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153890400|NCT01296672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153890401|NCT01296672|Hormone Antagonists|hormone antagonists|mesh-ancestor
153890402|NCT01296672|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153890403|NCT01296672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153431403|NCT06305754|Sensory System Agents|sensory system agents|mesh-ancestor
153431405|NCT06305754|Histamine Agents|histamine agents|mesh-ancestor
153431406|NCT06305754|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153431407|NCT06303284|Teriparatide|teriparatide|mesh-list
153431408|NCT06303284|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153431409|NCT06303284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153431410|NCT06303284|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153431411|NCT06293963|Methamphetamine|methamphetamine|mesh-list
153431412|NCT06293963|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
153431413|NCT06293963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153431414|NCT06293963|Sympathomimetics|sympathomimetics|mesh-ancestor
153431415|NCT06293963|Autonomic Agents|autonomic agents|mesh-ancestor
153431416|NCT06293963|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153431417|NCT06293963|Dopamine Agents|dopamine agents|mesh-ancestor
153431418|NCT06293963|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153431419|NCT06293963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153431421|NCT06293963|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
153431422|NCT06293963|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153431423|NCT06293963|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153431425|NCT06293937|Methamphetamine|methamphetamine|mesh-list
153431426|NCT06293937|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
153431427|NCT06293937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153431428|NCT06293937|Sympathomimetics|sympathomimetics|mesh-ancestor
153431429|NCT06293937|Autonomic Agents|autonomic agents|mesh-ancestor
153431430|NCT06293937|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153431431|NCT06293937|Dopamine Agents|dopamine agents|mesh-ancestor
153431432|NCT06293937|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153431433|NCT06293937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153890405|NCT01254669|Vaccines|vaccines|mesh-list
153890406|NCT01254669|Immunologic Factors|immunologic factors|mesh-ancestor
153890407|NCT01254669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153890408|NCT04324476|Bevacizumab|bevacizumab|mesh-list
153890409|NCT04324476|Capecitabine|capecitabine|mesh-list
153890410|NCT04324476|Oxaliplatin|oxaliplatin|mesh-list
153890411|NCT04324476|Irinotecan|irinotecan|mesh-list
153890412|NCT04324476|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153890413|NCT04324476|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153890414|NCT04324476|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153890415|NCT04324476|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153890416|NCT04324476|Growth Substances|growth substances|mesh-ancestor
153890417|NCT04324476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153890418|NCT04324476|Growth Inhibitors|growth inhibitors|mesh-ancestor
153890419|NCT04324476|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153890420|NCT04324476|Antimetabolites|antimetabolites|mesh-ancestor
153890421|NCT04324476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153890422|NCT04324476|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
153890423|NCT04324476|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153890424|NCT04324476|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153890425|NCT01295814|Adalimumab|adalimumab|mesh-list
153890426|NCT01295814|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
153890427|NCT01295814|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153890428|NCT01295814|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153890429|NCT01254045|Oxytocin|oxytocin|mesh-list
153890430|NCT01254045|Oxytocics|oxytocics|mesh-ancestor
153890431|NCT01254045|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153890432|NCT01254045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153890433|NCT01075282|Metformin|metformin|mesh-list
153890434|NCT01075282|Insulin Glargine|insulin glargine|mesh-list
153890435|NCT01075282|Glimepiride|glimepiride|mesh-list
153890436|NCT01075282|Dulaglutide|dulaglutide|mesh-list
153890439|NCT01075282|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153890440|NCT01075282|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153890442|NCT01075282|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
153890443|NCT04324086|Calcium, Dietary|calcium, dietary|mesh-list
153890444|NCT04324086|Calcium|calcium|mesh-list
153890445|NCT04324086|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153890446|NCT04324086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153431446|NCT06288451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153431447|NCT06288451|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153431448|NCT06288451|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153431449|NCT06288451|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
153431450|NCT06288451|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153431466|NCT06285240|Cholinergic Agents|cholinergic agents|mesh-ancestor
153431467|NCT06285240|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153431468|NCT06285240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153431469|NCT06285240|Nootropic Agents|nootropic agents|mesh-ancestor
153431471|NCT06278285|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
153431472|NCT06278285|Incretins|incretins|mesh-ancestor
153431473|NCT06278285|Hormones|hormones|mesh-ancestor
153431474|NCT06278285|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153431476|NCT06278285|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153431477|NCT06273397|Metolazone|metolazone|mesh-list
153431479|NCT06273397|Acetazolamide|acetazolamide|mesh-list
153431480|NCT06273397|Diuretics|diuretics|mesh-ancestor
153431481|NCT06273397|Natriuretic Agents|natriuretic agents|mesh-ancestor
153431482|NCT06273397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153431483|NCT06273397|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
153431484|NCT06273397|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153431485|NCT06273397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153431486|NCT06273397|Anticonvulsants|anticonvulsants|mesh-ancestor
153431487|NCT06273397|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
153431488|NCT06273397|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153431500|NCT06255379|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153890465|NCT01253421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153890466|NCT01253421|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
153890467|NCT01253421|Antidepressive Agents|antidepressive agents|mesh-ancestor
153890469|NCT01077076|Omeprazole, sodium bicarbonate drug combination|omeprazole, sodium bicarbonate drug combination|mesh-list
153890470|NCT01077076|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
153890471|NCT01077076|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153890472|NCT01077076|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
153890473|NCT01077076|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153890474|NCT01077076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153890475|NCT02876224|Bevacizumab|bevacizumab|mesh-list
153890476|NCT02876224|Atezolizumab|atezolizumab|mesh-list
153890477|NCT02876224|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153890478|NCT02876224|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153890479|NCT02876224|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153890480|NCT02876224|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153890481|NCT02876224|Growth Substances|growth substances|mesh-ancestor
153890482|NCT02876224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153890483|NCT02876224|Growth Inhibitors|growth inhibitors|mesh-ancestor
153890484|NCT02876224|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153890485|NCT02876224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153890486|NCT01294644|Deoxycholic Acid|deoxycholic acid|mesh-list
153890487|NCT01294644|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
153890488|NCT01294644|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153890489|NCT01253265|Ixekizumab|ixekizumab|mesh-list
153890490|NCT01253265|Dermatologic Agents|dermatologic agents|mesh-ancestor
153890491|NCT01293006|Suvorexant|suvorexant|mesh-list
153890492|NCT01293006|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
153890493|NCT01293006|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153890494|NCT01293006|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153890497|NCT01293006|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153890498|NCT01293006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153431501|NCT06234007|Capecitabine|capecitabine|mesh-list
153431502|NCT06234007|Oxaliplatin|oxaliplatin|mesh-list
153431503|NCT06234007|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153431504|NCT06234007|Antimetabolites|antimetabolites|mesh-ancestor
153431505|NCT06234007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153431506|NCT06234007|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153431507|NCT06219915|Levodopa|levodopa|mesh-list
153431508|NCT06219915|Carbidopa|carbidopa|mesh-list
153431509|NCT06219915|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
153431510|NCT06219915|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
153431511|NCT06219915|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
153431512|NCT06219915|Dopamine Agents|dopamine agents|mesh-ancestor
153431513|NCT06219915|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153431517|NCT06219915|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153890507|NCT01253187|Natriuretic Agents|natriuretic agents|mesh-ancestor
153890508|NCT01253187|Vitamin B Complex|vitamin b complex|mesh-ancestor
153890509|NCT01253187|Vitamins|vitamins|mesh-ancestor
153890510|NCT01253187|Micronutrients|micronutrients|mesh-ancestor
153890511|NCT01252563|Amlodipine|amlodipine|mesh-list
153890512|NCT01252563|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153890514|NCT01252563|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153890515|NCT01252563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153890516|NCT01252563|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153890517|NCT01252563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153431523|NCT06134492|Acyclovir|acyclovir|mesh-list
153431524|NCT06134492|Antiviral Agents|antiviral agents|mesh-ancestor
153431525|NCT06134492|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153431526|NCT06128044|Cyclophosphamide|cyclophosphamide|mesh-list
153431529|NCT06128044|Immunologic Factors|immunologic factors|mesh-ancestor
153431530|NCT06128044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153431531|NCT06128044|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153431532|NCT06128044|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153431533|NCT06128044|Alkylating Agents|alkylating agents|mesh-ancestor
153431534|NCT06128044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153431535|NCT06128044|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153431536|NCT06128044|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153431538|NCT06120881|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153431539|NCT06120881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153431540|NCT06115070|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
153431541|NCT06115070|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153431542|NCT06115070|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153431549|NCT06097364|Rituximab|rituximab|mesh-list
153431550|NCT06097364|Doxorubicin|doxorubicin|mesh-list
153431551|NCT06097364|Vincristine|vincristine|mesh-list
153431552|NCT06097364|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153431553|NCT06097364|Immunologic Factors|immunologic factors|mesh-ancestor
153431554|NCT06097364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153431555|NCT06097364|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153431556|NCT06097364|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153431557|NCT06097364|Alkylating Agents|alkylating agents|mesh-ancestor
153431558|NCT06097364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153431559|NCT06097364|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153431560|NCT06097364|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153431561|NCT06097364|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153431562|NCT06097364|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153431563|NCT06097364|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153431564|NCT06097364|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153431565|NCT06097364|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153431566|NCT06097364|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153431567|NCT06097364|Glucocorticoids|glucocorticoids|mesh-ancestor
153431569|NCT06097364|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153431570|NCT06097364|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153431571|NCT06097364|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153431572|NCT06097364|Tubulin Modulators|tubulin modulators|mesh-ancestor
153890549|NCT01252251|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153890550|NCT01252251|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153890551|NCT01252251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153890552|NCT01252251|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153890553|NCT01252251|Immunologic Factors|immunologic factors|mesh-ancestor
153890554|NCT01252251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153890555|NCT01252251|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153890556|NCT01252251|Hormones|hormones|mesh-ancestor
153890557|NCT01252251|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153890558|NCT02888301|Clofarabine|clofarabine|mesh-list
153890559|NCT02888301|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153890560|NCT02888301|Antimetabolites|antimetabolites|mesh-ancestor
153890561|NCT02888301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153890562|NCT02888301|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153890566|NCT00624273|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
153890568|NCT00624273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153431573|NCT06097364|Antimitotic Agents|antimitotic agents|mesh-ancestor
153431574|NCT06097364|Mitosis Modulators|mitosis modulators|mesh-ancestor
153431576|NCT06081829|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153431577|NCT06081829|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153431578|NCT06081829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153431579|NCT06067828|Budesonide|budesonide|mesh-list
153431580|NCT06067828|Glycopyrrolate|glycopyrrolate|mesh-list
153431581|NCT06067828|Formoterol Fumarate|formoterol fumarate|mesh-list
153431582|NCT06067828|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153431585|NCT06067828|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153431586|NCT06067828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153431588|NCT06067828|Respiratory System Agents|respiratory system agents|mesh-ancestor
153431589|NCT06067828|Glucocorticoids|glucocorticoids|mesh-ancestor
153431590|NCT06067828|Hormones|hormones|mesh-ancestor
153431591|NCT06067828|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153431592|NCT06067828|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
153431593|NCT06067828|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
153431594|NCT06067828|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153431595|NCT06067828|Adrenergic Agents|adrenergic agents|mesh-ancestor
153431596|NCT06067828|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153431597|NCT06067828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153431598|NCT06067828|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153431599|NCT06067828|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
153431600|NCT06067828|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
153431601|NCT06067828|Cholinergic Agents|cholinergic agents|mesh-ancestor
153890569|NCT00624273|Urological Agents|urological agents|mesh-ancestor
153890570|NCT04305964|Silicon|silicon|mesh-list
153890571|NCT04305964|Trace Elements|trace elements|mesh-ancestor
153890572|NCT04305964|Micronutrients|micronutrients|mesh-ancestor
153890573|NCT04305964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153890574|NCT04306042|Pembrolizumab|pembrolizumab|mesh-list
153890575|NCT04306042|Nivolumab|nivolumab|mesh-list
153890576|NCT04306042|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153890577|NCT04306042|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153431607|NCT06058130|Anticoagulants|anticoagulants|mesh-list
153890578|NCT04306042|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153890579|NCT04306042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153890580|NCT01074502|Apremilast|apremilast|mesh-list
153890581|NCT01074502|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153890582|NCT01074502|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153890583|NCT01074502|Analgesics|analgesics|mesh-ancestor
153890584|NCT01074502|Sensory System Agents|sensory system agents|mesh-ancestor
153890585|NCT01074502|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153890586|NCT01074502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153890587|NCT01074502|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153890588|NCT01074502|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153890589|NCT01074502|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
153890590|NCT01074502|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
153890591|NCT01074502|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153890593|NCT01289028|Nilotinib|nilotinib|mesh-list
153890594|NCT01289028|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153890595|NCT01289028|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153890596|NCT01289028|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153890597|NCT01289028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153890598|NCT04303312|Benzydamine|benzydamine|mesh-list
153890599|NCT04303312|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153890600|NCT01285908|Norepinephrine|norepinephrine|mesh-list
153890601|NCT01285908|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153890602|NCT01285908|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153890603|NCT01285908|Adrenergic Agents|adrenergic agents|mesh-ancestor
153890604|NCT01285908|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153890605|NCT01285908|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153890606|NCT01285908|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153890607|NCT01285908|Sympathomimetics|sympathomimetics|mesh-ancestor
153890608|NCT01285908|Autonomic Agents|autonomic agents|mesh-ancestor
153431615|NCT06054477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153431616|NCT06045364|Anisodamine|anisodamine|mesh-list
153431617|NCT06045364|Glycopyrrolate|glycopyrrolate|mesh-list
153431618|NCT06045364|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153431619|NCT06045364|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
153431620|NCT06045364|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
153431621|NCT06045364|Cholinergic Agents|cholinergic agents|mesh-ancestor
153431622|NCT06045364|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153431623|NCT06045364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153431624|NCT06045364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153431625|NCT06045364|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153431627|NCT06045364|Adrenergic Agents|adrenergic agents|mesh-ancestor
153431628|NCT06045364|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153431629|NCT06045364|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153431630|NCT06045364|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153431632|NCT06045364|Sensory System Agents|sensory system agents|mesh-ancestor
153431633|NCT06045364|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153431634|NCT06045364|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153431635|NCT06045364|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153431636|NCT06045364|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
153431637|NCT06045364|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153431638|NCT06045364|Parasympatholytics|parasympatholytics|mesh-ancestor
153431639|NCT06045364|Autonomic Agents|autonomic agents|mesh-ancestor
153431640|NCT06045364|Vasodilator Agents|vasodilator agents|mesh-ancestor
153431641|NCT06045364|Free Radical Scavengers|free radical scavengers|mesh-ancestor
153431642|NCT06045364|Antioxidants|antioxidants|mesh-ancestor
153431643|NCT06045364|Protective Agents|protective agents|mesh-ancestor
153431644|NCT06041646|Dexmedetomidine|dexmedetomidine|mesh-list
153431645|NCT06041646|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153431647|NCT06041646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153431648|NCT06041646|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153431649|NCT06041646|Analgesics|analgesics|mesh-ancestor
153431650|NCT06041646|Sensory System Agents|sensory system agents|mesh-ancestor
153890609|NCT01285908|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153890610|NCT01285908|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
153890612|NCT01074268|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
153890613|NCT01074268|Insulin Aspart|insulin aspart|mesh-list
153890614|NCT01074268|Insulin Detemir|insulin detemir|mesh-list
153890615|NCT01074268|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153890616|NCT01074268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153890617|NCT01074190|Fentanyl|fentanyl|mesh-list
153890618|NCT01074190|Bupivacaine|bupivacaine|mesh-list
153890619|NCT01074190|Anesthetics, Local|anesthetics, local|mesh-ancestor
153890620|NCT01074190|Anesthetics|anesthetics|mesh-ancestor
153890621|NCT01074190|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153890622|NCT01074190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153890623|NCT01074190|Sensory System Agents|sensory system agents|mesh-ancestor
153890624|NCT01074190|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153890625|NCT01074190|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153890626|NCT01074190|Narcotics|narcotics|mesh-ancestor
153890627|NCT01074190|Analgesics|analgesics|mesh-ancestor
153890628|NCT01074190|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153890629|NCT01074190|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153890630|NCT01074190|Anesthetics, General|anesthetics, general|mesh-ancestor
153890631|NCT01073566|Insulin|insulin|mesh-list
153890632|NCT01073566|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
153890633|NCT01073566|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153890634|NCT01073566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153890635|NCT01072396|Tiotropium Bromide|tiotropium bromide|mesh-list
153890636|NCT01072396|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153890637|NCT01072396|Autonomic Agents|autonomic agents|mesh-ancestor
153890638|NCT01072396|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153890639|NCT01072396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153890640|NCT01072396|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153890641|NCT01072396|Respiratory System Agents|respiratory system agents|mesh-ancestor
153890642|NCT01072396|Parasympatholytics|parasympatholytics|mesh-ancestor
153890643|NCT01072396|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
153890644|NCT01072396|Cholinergic Agents|cholinergic agents|mesh-ancestor
153890645|NCT01072396|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153431651|NCT06041646|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153431652|NCT06041646|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
153431666|NCT06029179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153431668|NCT06023368|Anesthetics, Local|anesthetics, local|mesh-ancestor
153431669|NCT06023368|Anesthetics|anesthetics|mesh-ancestor
153431672|NCT06023368|Sensory System Agents|sensory system agents|mesh-ancestor
153431673|NCT06023368|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153431674|NCT06023368|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
153890666|NCT02876146|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153890667|NCT02874586|Immunosuppressive Agents|immunosuppressive agents|mesh-list
153890668|NCT02874586|Immunologic Factors|immunologic factors|mesh-ancestor
153890669|NCT02874586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153890671|NCT02875756|Selamectin|selamectin|mesh-list
153890672|NCT02875756|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153890673|NCT02875756|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153431690|NCT06016088|Tobramycin|tobramycin|mesh-list
153431691|NCT06016088|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153431692|NCT06016088|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153431693|NCT06014983|Ferrous fumarate|ferrous fumarate|mesh-list
153431694|NCT06014983|Trace Elements|trace elements|mesh-ancestor
153431695|NCT06014983|Micronutrients|micronutrients|mesh-ancestor
153431696|NCT06014983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153431697|NCT06004336|Pembrolizumab|pembrolizumab|mesh-list
153431698|NCT06004336|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153431700|NCT06004336|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153431701|NCT06004336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153431702|NCT05992311|Montelukast|montelukast|mesh-list
153431703|NCT05992311|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153431704|NCT05992311|Respiratory System Agents|respiratory system agents|mesh-ancestor
153431705|NCT05992311|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
153890675|NCT02874820|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
153890676|NCT02874820|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
153890677|NCT02874820|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
153890678|NCT02874820|Adrenergic Agents|adrenergic agents|mesh-ancestor
153890679|NCT02874820|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153890680|NCT02874820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153890681|NCT02874820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153890682|NCT04305028|Aspirin|aspirin|mesh-list
153890683|NCT04305028|Rivaroxaban|rivaroxaban|mesh-list
153890684|NCT04305028|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153890685|NCT04305028|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153890686|NCT04305028|Analgesics|analgesics|mesh-ancestor
153890687|NCT04305028|Sensory System Agents|sensory system agents|mesh-ancestor
153890688|NCT04305028|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153890689|NCT04305028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153431706|NCT05992311|Hormone Antagonists|hormone antagonists|mesh-ancestor
153890690|NCT04305028|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153890692|NCT04305028|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153890693|NCT04305028|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153890694|NCT04305028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153890695|NCT04305028|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153890696|NCT04305028|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153890697|NCT04305028|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153890698|NCT04305028|Antipyretics|antipyretics|mesh-ancestor
153890699|NCT04305028|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
153890700|NCT04305028|Antithrombins|antithrombins|mesh-ancestor
153890701|NCT04305028|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
153890702|NCT04305028|Protease Inhibitors|protease inhibitors|mesh-ancestor
153890703|NCT04305028|Anticoagulants|anticoagulants|mesh-ancestor
153890704|NCT04304794|Antithyroid Agents|antithyroid agents|mesh-list
153890707|NCT04304794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153890708|NCT02874664|Rovalpituzumab tesirine|rovalpituzumab tesirine|mesh-list
153890709|NCT02874664|Immunoconjugates|immunoconjugates|mesh-ancestor
153890710|NCT02874664|Immunologic Factors|immunologic factors|mesh-ancestor
153890711|NCT02874664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153890712|NCT01284114|Aliskiren|aliskiren|mesh-list
153890713|NCT01284114|Renin Inhibitors|renin inhibitors|mesh-list
153890714|NCT01284114|Protease Inhibitors|protease inhibitors|mesh-ancestor
153890715|NCT01284114|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153890716|NCT01284114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153890717|NCT01283334|Carboplatin|carboplatin|mesh-list
153431723|NCT05981209|Glucocorticoids|glucocorticoids|mesh-ancestor
153431725|NCT05981209|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153431726|NCT05981209|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153431731|NCT05981209|Dermatologic Agents|dermatologic agents|mesh-ancestor
153431732|NCT05963217|Cyclophosphamide|cyclophosphamide|mesh-list
153431733|NCT05963217|Fludarabine|fludarabine|mesh-list
153431734|NCT05963217|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153431735|NCT05963217|Immunologic Factors|immunologic factors|mesh-ancestor
153431736|NCT05963217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153431737|NCT05963217|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153431738|NCT05963217|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153431739|NCT05963217|Alkylating Agents|alkylating agents|mesh-ancestor
153890733|NCT01282476|Panobinostat|panobinostat|mesh-list
153890734|NCT01282476|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153890735|NCT01282476|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153890736|NCT01282476|Immunologic Factors|immunologic factors|mesh-ancestor
153890737|NCT01282476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153890738|NCT01282476|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153890739|NCT01282476|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
153431745|NCT05943990|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153890744|NCT02889822|Vasodilator Agents|vasodilator agents|mesh-ancestor
153890745|NCT02889822|Urological Agents|urological agents|mesh-ancestor
153890746|NCT01282164|Insulin|insulin|mesh-list
153890747|NCT01282164|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
153890748|NCT01282164|Glucagon|glucagon|mesh-list
153890749|NCT01282164|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
153890750|NCT01282164|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153890751|NCT01282164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153890752|NCT01282164|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153890753|NCT01282164|Hormones|hormones|mesh-ancestor
153890754|NCT01282164|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153890755|NCT01282164|Incretins|incretins|mesh-ancestor
153890756|NCT01250379|Bevacizumab|bevacizumab|mesh-list
153890757|NCT01250379|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153890759|NCT01250379|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153890760|NCT01250379|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153890761|NCT01250379|Growth Substances|growth substances|mesh-ancestor
153890762|NCT01250379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153890763|NCT01250379|Growth Inhibitors|growth inhibitors|mesh-ancestor
153890764|NCT01072630|Modafinil|modafinil|mesh-list
153890765|NCT01072630|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
153890766|NCT01072630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153890767|NCT01072630|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
153890768|NCT01072630|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
153890769|NCT01072630|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
153890770|NCT01072630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153890771|NCT04302532|Ubiquinone|ubiquinone|mesh-list
153890772|NCT04302532|Coenzyme Q10|coenzyme q10|mesh-list
153890773|NCT04302532|Clomiphene|clomiphene|mesh-list
153890774|NCT04302532|Enclomiphene|enclomiphene|mesh-list
153431786|NCT05877547|Semaglutide|semaglutide|mesh-list
153431787|NCT05877547|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
153431788|NCT05877547|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153890778|NCT04302532|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153890779|NCT04302532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153890780|NCT04302532|Fertility Agents, Female|fertility agents, female|mesh-ancestor
153890781|NCT04302532|Fertility Agents|fertility agents|mesh-ancestor
153890782|NCT04302532|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153890783|NCT04302532|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
153890784|NCT04302532|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
153890785|NCT04302532|Micronutrients|micronutrients|mesh-ancestor
153890786|NCT04302532|Vitamins|vitamins|mesh-ancestor
153890787|NCT01281306|Valsartan|valsartan|mesh-list
153890788|NCT01281306|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
153890789|NCT01281306|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153890790|NCT01281306|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
153890791|NCT01281306|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
153890792|NCT01281306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153890793|NCT04304560|Dapagliflozin|dapagliflozin|mesh-list
153890795|NCT04304560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153431802|NCT05831124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153431804|NCT05818150|Triamcinolone|triamcinolone|mesh-list
153431805|NCT05818150|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153431806|NCT05818150|Antiemetics|antiemetics|mesh-ancestor
153431808|NCT05818150|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153431809|NCT05818150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153431810|NCT05818150|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153431813|NCT05818150|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153431814|NCT05818150|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
153431815|NCT05818150|Protective Agents|protective agents|mesh-ancestor
153431821|NCT05786443|Empagliflozin|empagliflozin|mesh-list
153431822|NCT05786443|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
153431823|NCT05786443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153431824|NCT05786443|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153431825|NCT05786443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153431826|NCT05781152|Infliximab|infliximab|mesh-list
153431827|NCT05781152|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
153431828|NCT05781152|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153431829|NCT05781152|Dermatologic Agents|dermatologic agents|mesh-ancestor
153431830|NCT05781152|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153431831|NCT05781152|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153890797|NCT04304560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153890798|NCT01250145|Teriparatide|teriparatide|mesh-list
153890799|NCT01250145|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153890800|NCT01250145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153890801|NCT01250145|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153890802|NCT01067326|Aliskiren|aliskiren|mesh-list
153890803|NCT01067326|Renin Inhibitors|renin inhibitors|mesh-ancestor
153890804|NCT01067326|Protease Inhibitors|protease inhibitors|mesh-ancestor
153890805|NCT01067326|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153890808|NCT04319601|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153890809|NCT04319601|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153890810|NCT04319601|Immunologic Factors|immunologic factors|mesh-ancestor
153890811|NCT04319601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153890812|NCT04319601|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153890813|NCT04640896|Lidocaine|lidocaine|mesh-list
153890814|NCT04640896|Bupivacaine|bupivacaine|mesh-list
153890815|NCT04640896|Anesthetics, Local|anesthetics, local|mesh-ancestor
153890816|NCT04640896|Anesthetics|anesthetics|mesh-ancestor
153890818|NCT04640896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153890819|NCT04640896|Sensory System Agents|sensory system agents|mesh-ancestor
153890820|NCT04640896|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153890821|NCT04640896|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153890822|NCT04640896|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
153890823|NCT04640896|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153890824|NCT04640896|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153890825|NCT04640896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153890827|NCT01273818|Cefazolin|cefazolin|mesh-list
153890828|NCT01273818|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153890829|NCT01273818|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153890830|NCT01273818|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
153890847|NCT01269918|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153890848|NCT01269918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153890849|NCT01269918|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153890850|NCT01269918|Analgesics|analgesics|mesh-ancestor
153890851|NCT01269918|Sensory System Agents|sensory system agents|mesh-ancestor
153890852|NCT01269918|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153890853|NCT01269918|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
153890854|NCT01269918|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153890855|NCT01269918|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153431865|NCT05709574|Tadalafil|tadalafil|mesh-list
153431866|NCT05709574|Vasodilator Agents|vasodilator agents|mesh-ancestor
153431867|NCT05709574|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
153431868|NCT05709574|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
153431869|NCT05709574|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153431870|NCT05709574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153431871|NCT05709574|Urological Agents|urological agents|mesh-ancestor
153890864|NCT01036594|Hydrocortisone|hydrocortisone|mesh-list
153890867|NCT01036594|Antiemetics|antiemetics|mesh-ancestor
153890868|NCT01036594|Autonomic Agents|autonomic agents|mesh-ancestor
153890869|NCT01036594|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153890870|NCT01036594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153890871|NCT01036594|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153890872|NCT01036594|Glucocorticoids|glucocorticoids|mesh-ancestor
153890873|NCT01036594|Hormones|hormones|mesh-ancestor
153890875|NCT01036594|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153890876|NCT01036594|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153890877|NCT01036594|Protease Inhibitors|protease inhibitors|mesh-ancestor
153890878|NCT01036594|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153431887|NCT05657613|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
153431888|NCT05657613|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
153431889|NCT05657613|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153431890|NCT05657613|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
153431891|NCT05651282|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
153431892|NCT05651282|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
153431893|NCT05651282|Contraceptive Agents|contraceptive agents|mesh-ancestor
153431894|NCT05651282|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153890889|NCT04301908|Antiviral Agents|antiviral agents|mesh-ancestor
153890890|NCT04301908|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153890891|NCT04304248|Paclitaxel|paclitaxel|mesh-list
153890892|NCT04304248|Carboplatin|carboplatin|mesh-list
153890893|NCT04304248|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
153890894|NCT04304248|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153890895|NCT04304248|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153890896|NCT04304248|Tubulin Modulators|tubulin modulators|mesh-ancestor
153431904|NCT05626439|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153431905|NCT05626439|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153431906|NCT05626439|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153431907|NCT05626439|GABA Modulators|gaba modulators|mesh-ancestor
153431908|NCT05626439|GABA Agents|gaba agents|mesh-ancestor
153431909|NCT05626439|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153431910|NCT05626439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153431911|NCT05600426|Cyclosporine|cyclosporine|mesh-list
153431912|NCT05600426|Cyclophosphamide|cyclophosphamide|mesh-list
153431913|NCT05600426|Methotrexate|methotrexate|mesh-list
153431914|NCT05600426|Fludarabine|fludarabine|mesh-list
153431915|NCT05600426|Cyclosporins|cyclosporins|mesh-list
153431916|NCT05600426|Thymoglobulin|thymoglobulin|mesh-list
153431917|NCT05600426|Antilymphocyte Serum|antilymphocyte serum|mesh-list
153431918|NCT05600426|Immunosuppressive Agents|immunosuppressive agents|mesh-list
153431919|NCT05600426|Immunologic Factors|immunologic factors|mesh-ancestor
153431920|NCT05600426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153431921|NCT05600426|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153431922|NCT05600426|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153890899|NCT04304248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153890900|NCT01268046|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
153890901|NCT01268046|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
153890903|NCT01268046|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
153890904|NCT01268046|Estrogens|estrogens|mesh-list
153890905|NCT01268046|Hormones|hormones|mesh-ancestor
153890907|NCT01268046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153890908|NCT01268046|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
153890909|NCT01268046|Contraceptive Agents|contraceptive agents|mesh-ancestor
153890910|NCT01268046|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153890911|NCT01268046|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
153890912|NCT01267266|Hydrocortisone|hydrocortisone|mesh-list
153890913|NCT01267266|Saracatinib|saracatinib|mesh-list
153890914|NCT01267266|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153890915|NCT01267266|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153890916|NCT01267266|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153890917|NCT01267266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153890918|NCT01034176|Levofloxacin|levofloxacin|mesh-list
153890919|NCT01034176|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
153890920|NCT01034176|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153890921|NCT01034176|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153890922|NCT01034176|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153890923|NCT01034176|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153431932|NCT05600426|Dermatologic Agents|dermatologic agents|mesh-ancestor
153431933|NCT05600426|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153431934|NCT05600426|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153431935|NCT05600426|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153431952|NCT05574712|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153431953|NCT05574712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153431954|NCT05574712|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153431955|NCT05574712|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153431956|NCT05574712|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153431957|NCT05574712|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153431961|NCT05574712|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153431969|NCT05548296|Gemcitabine|gemcitabine|mesh-list
153431970|NCT05548296|Prexasertib|prexasertib|mesh-list
153431971|NCT05548296|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153431972|NCT05548296|Antimetabolites|antimetabolites|mesh-ancestor
153431973|NCT05548296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153431974|NCT05548296|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153431975|NCT05548296|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153431976|NCT05548296|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153890949|NCT01062256|Respiratory System Agents|respiratory system agents|mesh-ancestor
153890950|NCT01062256|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153890951|NCT01062256|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153890952|NCT01062256|Adrenergic Agents|adrenergic agents|mesh-ancestor
153890953|NCT01062256|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153890954|NCT01062256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153890955|NCT01062256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153890956|NCT01062256|Appetite Depressants|appetite depressants|mesh-ancestor
153890957|NCT01062256|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
153890958|NCT01062256|Sympathomimetics|sympathomimetics|mesh-ancestor
153890959|NCT01062256|Autonomic Agents|autonomic agents|mesh-ancestor
153890960|NCT01062256|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153890961|NCT01062256|Nasal Decongestants|nasal decongestants|mesh-ancestor
153890962|NCT01062256|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
153890963|NCT01029886|Liraglutide|liraglutide|mesh-list
153890964|NCT01029886|Exenatide|exenatide|mesh-list
153890965|NCT01029886|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
153890966|NCT01029886|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153890967|NCT01029886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153431978|NCT05535764|Interferon-alpha|interferon-alpha|mesh-list
153431979|NCT05535764|Interferon alpha-2|interferon alpha-2|mesh-list
153431990|NCT05509777|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153431991|NCT05509777|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153431992|NCT05509777|Analgesics|analgesics|mesh-ancestor
153431993|NCT05509777|Sensory System Agents|sensory system agents|mesh-ancestor
153431994|NCT05509777|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153431995|NCT05509777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153890968|NCT01029886|Incretins|incretins|mesh-ancestor
153890969|NCT01029886|Hormones|hormones|mesh-ancestor
153890970|NCT01029886|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153890971|NCT01029886|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
153890972|NCT01244061|Varenicline|varenicline|mesh-list
153890973|NCT01244061|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
153890974|NCT01244061|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
153890975|NCT01244061|Cholinergic Agents|cholinergic agents|mesh-ancestor
153890976|NCT01244061|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153890977|NCT01244061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153890978|NCT01244061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153890980|NCT01243671|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
153890981|NCT01243671|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153890982|NCT01243671|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153890983|NCT01240785|Metformin|metformin|mesh-list
153890984|NCT01240785|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153890985|NCT01240785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153890986|NCT01266876|Alirocumab|alirocumab|mesh-list
153890987|NCT01266876|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
153890988|NCT01266876|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153890989|NCT01266876|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153890990|NCT01266876|Antimetabolites|antimetabolites|mesh-ancestor
153432056|NCT05469204|Anesthetics, General|anesthetics, general|mesh-ancestor
153432057|NCT05469204|Anesthetics|anesthetics|mesh-ancestor
153432058|NCT05469204|GABA Modulators|gaba modulators|mesh-ancestor
153432059|NCT05469204|GABA Agents|gaba agents|mesh-ancestor
153432060|NCT05469204|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153891044|NCT01265550|Adrenergic Agents|adrenergic agents|mesh-ancestor
153891045|NCT01265394|Flutemetamol|flutemetamol|mesh-list
153891046|NCT01265394|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
153891047|NCT01265394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153891048|NCT01029262|Lenalidomide|lenalidomide|mesh-list
153891049|NCT01029262|Immunologic Factors|immunologic factors|mesh-ancestor
153891050|NCT01029262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153891051|NCT01029262|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153432084|NCT05361915|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153432085|NCT05361915|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153432086|NCT05361915|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153432096|NCT05325593|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153432098|NCT05325593|Hormones|hormones|mesh-ancestor
153432099|NCT05325593|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153432100|NCT05325593|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153432101|NCT05325593|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153432102|NCT05325593|Protease Inhibitors|protease inhibitors|mesh-ancestor
153891102|NCT01264770|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153891103|NCT02873650|Dabrafenib|dabrafenib|mesh-list
153891104|NCT02873650|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153891105|NCT02873650|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153891106|NCT02873650|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153891107|NCT02873650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153891109|NCT01302080|Antidepressive Agents|antidepressive agents|mesh-ancestor
153891110|NCT01302080|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153891111|NCT01302080|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
153891112|NCT01302080|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153891113|NCT01302080|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153891114|NCT01302080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153891115|NCT01302080|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153891116|NCT01302080|Serotonin Agents|serotonin agents|mesh-ancestor
153891117|NCT01302080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153891118|NCT01032070|Etoposide|etoposide|mesh-list
153891119|NCT01032070|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
153891120|NCT01032070|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153432143|NCT05262556|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153432144|NCT05262556|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153432145|NCT05262556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153432147|NCT05255211|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153432148|NCT05255211|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153432149|NCT05255211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153432150|NCT05255211|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153432151|NCT05255211|Anesthetics, General|anesthetics, general|mesh-ancestor
153432152|NCT05255211|Anesthetics|anesthetics|mesh-ancestor
153432153|NCT05200988|Nivolumab|nivolumab|mesh-list
153432154|NCT05200988|Ipilimumab|ipilimumab|mesh-list
153432155|NCT05200988|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153432156|NCT05200988|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153432157|NCT05200988|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153891124|NCT01032070|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153891125|NCT01032070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153891126|NCT01032070|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153891127|NCT01032070|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153891129|NCT01237899|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
153891130|NCT01237899|Hormone Antagonists|hormone antagonists|mesh-ancestor
153891131|NCT01237899|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153891132|NCT01237899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153891133|NCT01237899|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
153891134|NCT01237899|Diuretics|diuretics|mesh-ancestor
153891135|NCT01237899|Natriuretic Agents|natriuretic agents|mesh-ancestor
153891136|NCT01237899|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153891137|NCT01263444|Timolol|timolol|mesh-list
153891138|NCT01263444|Bimatoprost|bimatoprost|mesh-list
153891139|NCT01263444|Travoprost|travoprost|mesh-list
153891140|NCT01263444|Latanoprost|latanoprost|mesh-list
153432209|NCT05118490|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
153432210|NCT05118490|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
153432211|NCT05118490|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
153432212|NCT05118490|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
153432213|NCT05117242|Pembrolizumab|pembrolizumab|mesh-list
153432214|NCT05117242|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153891173|NCT01031680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153891174|NCT01031680|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153891175|NCT01031680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153891176|NCT01031446|Paclitaxel|paclitaxel|mesh-list
153891178|NCT01031446|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153891179|NCT01031446|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153891180|NCT01031446|Tubulin Modulators|tubulin modulators|mesh-ancestor
153891181|NCT01031446|Antimitotic Agents|antimitotic agents|mesh-ancestor
153891182|NCT01031446|Mitosis Modulators|mitosis modulators|mesh-ancestor
153891183|NCT01031446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153891184|NCT01031446|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
153891185|NCT01031446|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153891186|NCT01031446|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153891187|NCT01031446|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153891188|NCT01031446|Immunologic Factors|immunologic factors|mesh-ancestor
153432215|NCT05117242|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153891189|NCT01031446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153891190|NCT01030900|Prednisone|prednisone|mesh-list
153891191|NCT01030900|Cyclophosphamide|cyclophosphamide|mesh-list
153891192|NCT01030900|Rituximab|rituximab|mesh-list
153891193|NCT01030900|Doxorubicin|doxorubicin|mesh-list
153891194|NCT01030900|Etoposide|etoposide|mesh-list
153891195|NCT01030900|Vincristine|vincristine|mesh-list
153891196|NCT01030900|Alemtuzumab|alemtuzumab|mesh-list
153891197|NCT01030900|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153891198|NCT01030900|Immunologic Factors|immunologic factors|mesh-ancestor
153891199|NCT01030900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153432233|NCT05116293|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153432234|NCT05116293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153432235|NCT05116293|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153432236|NCT05116293|Analgesics|analgesics|mesh-ancestor
153432237|NCT05116293|Sensory System Agents|sensory system agents|mesh-ancestor
153432238|NCT05116293|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153432239|NCT05116293|Antipyretics|antipyretics|mesh-ancestor
153432240|NCT05116293|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153432241|NCT05116293|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
153432242|NCT05116293|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153432243|NCT05116293|Protective Agents|protective agents|mesh-ancestor
153432244|NCT05113251|Paclitaxel|paclitaxel|mesh-list
153432245|NCT05113251|Cyclophosphamide|cyclophosphamide|mesh-list
153432246|NCT05113251|Doxorubicin|doxorubicin|mesh-list
153432247|NCT05113251|Trastuzumab|trastuzumab|mesh-list
153432248|NCT05113251|Pertuzumab|pertuzumab|mesh-list
153432249|NCT05113251|Trastuzumab deruxtecan|trastuzumab deruxtecan|mesh-list
153432250|NCT05113251|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153432251|NCT05113251|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153432252|NCT05113251|Tubulin Modulators|tubulin modulators|mesh-ancestor
153432253|NCT05113251|Antimitotic Agents|antimitotic agents|mesh-ancestor
153432254|NCT05113251|Mitosis Modulators|mitosis modulators|mesh-ancestor
153432255|NCT05113251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153432256|NCT05113251|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153432258|NCT05113251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153432259|NCT05113251|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153432260|NCT05113251|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153432261|NCT05113251|Alkylating Agents|alkylating agents|mesh-ancestor
153432262|NCT05113251|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153432263|NCT05113251|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153432264|NCT05113251|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153432265|NCT05113251|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153432266|NCT05113251|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153432267|NCT05113251|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153891217|NCT01030900|Tubulin Modulators|tubulin modulators|mesh-ancestor
153891218|NCT01030900|Antimitotic Agents|antimitotic agents|mesh-ancestor
153891220|NCT01030822|Vaccines|vaccines|mesh-list
153891222|NCT01030822|Immunologic Factors|immunologic factors|mesh-ancestor
153891223|NCT01030822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153891224|NCT01026454|Valacyclovir|valacyclovir|mesh-list
153891225|NCT01026454|Acyclovir|acyclovir|mesh-list
153891226|NCT01026454|Antiviral Agents|antiviral agents|mesh-ancestor
153891228|NCT01026220|Prednisone|prednisone|mesh-list
153891229|NCT01026220|Cyclophosphamide|cyclophosphamide|mesh-list
153891230|NCT01026220|Ifosfamide|ifosfamide|mesh-list
153891231|NCT01026220|Doxorubicin|doxorubicin|mesh-list
153891232|NCT01026220|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
153891233|NCT01026220|Etoposide|etoposide|mesh-list
153891234|NCT01026220|Vincristine|vincristine|mesh-list
153891235|NCT01026220|Vinorelbine|vinorelbine|mesh-list
153891236|NCT01026220|Bleomycin|bleomycin|mesh-list
153891237|NCT01026220|Etoposide phosphate|etoposide phosphate|mesh-list
153891238|NCT01026220|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153891239|NCT01026220|Immunologic Factors|immunologic factors|mesh-ancestor
153891240|NCT01026220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153891241|NCT01026220|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153891242|NCT01026220|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153891243|NCT01026220|Alkylating Agents|alkylating agents|mesh-ancestor
153891244|NCT01026220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153891245|NCT01026220|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153891246|NCT01026220|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153891247|NCT01026220|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153891248|NCT01026220|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153891249|NCT01026220|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153891250|NCT01026220|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153891251|NCT01026220|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153891252|NCT01026220|Glucocorticoids|glucocorticoids|mesh-ancestor
153891253|NCT01026220|Hormones|hormones|mesh-ancestor
153891254|NCT01026220|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153891255|NCT01026220|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153891256|NCT01026220|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153891257|NCT01026220|Tubulin Modulators|tubulin modulators|mesh-ancestor
153432276|NCT05087914|Sensory System Agents|sensory system agents|mesh-ancestor
153432277|NCT05087914|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153432278|NCT05087914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153432279|NCT05087914|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153432281|NCT05087914|Gout Suppressants|gout suppressants|mesh-ancestor
153432282|NCT05087914|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153432283|NCT05087914|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153432284|NCT05087914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153432285|NCT05087914|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
153432286|NCT05087914|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
153432288|NCT05087914|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153432289|NCT05087914|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
153432290|NCT05087914|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153432291|NCT05087914|Immunologic Factors|immunologic factors|mesh-ancestor
153432292|NCT05087914|Dopamine Agonists|dopamine agonists|mesh-ancestor
153432293|NCT05058651|Cisplatin|cisplatin|mesh-list
153891270|NCT06055348|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153891272|NCT06055348|Tubulin Modulators|tubulin modulators|mesh-ancestor
153891273|NCT06055348|Antimitotic Agents|antimitotic agents|mesh-ancestor
153891274|NCT06055348|Mitosis Modulators|mitosis modulators|mesh-ancestor
153891275|NCT06055348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153891276|NCT06055348|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153891277|NCT06055348|Antimetabolites|antimetabolites|mesh-ancestor
153891278|NCT06055335|Anesthetics|anesthetics|mesh-list
153891279|NCT06055335|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153432300|NCT05058651|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153432301|NCT05058651|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153432302|NCT05058651|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153432303|NCT05058651|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153432304|NCT05058651|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153432305|NCT05058651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153432306|NCT05058651|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153432307|NCT05058651|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153432308|NCT05058651|Immunologic Factors|immunologic factors|mesh-ancestor
153432309|NCT05058651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153432310|NCT05058651|Keratolytic Agents|keratolytic agents|mesh-ancestor
153432311|NCT05058651|Dermatologic Agents|dermatologic agents|mesh-ancestor
153432312|NCT05058651|Tubulin Modulators|tubulin modulators|mesh-ancestor
153432313|NCT05058651|Antimitotic Agents|antimitotic agents|mesh-ancestor
153432314|NCT05058651|Mitosis Modulators|mitosis modulators|mesh-ancestor
153432316|NCT05048238|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
153891293|NCT06055257|Antioxidants|antioxidants|mesh-ancestor
153891294|NCT06055257|Vitamins|vitamins|mesh-ancestor
153891301|NCT06055166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153891302|NCT06055166|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153891304|NCT06055166|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153891305|NCT06055153|Disitamab vedotin|disitamab vedotin|mesh-list
153891306|NCT06055153|Immunoconjugates|immunoconjugates|mesh-ancestor
153475860|NCT00837252|Urological Agents|urological agents|mesh-ancestor
153475934|NCT00866034|Fertility Agents|fertility agents|mesh-ancestor
153477556|NCT05398484|Niacin|niacin|mesh-list
153479255|NCT01275300|Niacin|niacin|mesh-list
153480838|NCT04905446|Niacin|niacin|mesh-list
153482959|NCT05804708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153482960|NCT05804708|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153482990|NCT05705492|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153482991|NCT05705492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153482992|NCT05705492|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153482994|NCT05705492|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153482995|NCT05705492|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153483186|NCT04597099|Flutamide|flutamide|mesh-list
153483759|NCT01537926|Antioxidants|antioxidants|mesh-ancestor
153484649|NCT01707420|Antimanic Agents|antimanic agents|mesh-ancestor
153485012|NCT01750086|Denosumab|denosumab|mesh-list
153891307|NCT06055153|Immunologic Factors|immunologic factors|mesh-ancestor
153891308|NCT06055153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153891309|NCT06055101|Dexmedetomidine|dexmedetomidine|mesh-list
153891310|NCT06055101|Bupivacaine|bupivacaine|mesh-list
153891311|NCT06055101|Neostigmine|neostigmine|mesh-list
153891312|NCT06055101|Anesthetics, Local|anesthetics, local|mesh-ancestor
153891313|NCT06055101|Anesthetics|anesthetics|mesh-ancestor
153891314|NCT06055101|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153891315|NCT06055101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153891316|NCT06055101|Sensory System Agents|sensory system agents|mesh-ancestor
153891317|NCT06055101|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153891318|NCT06055101|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153891319|NCT06055101|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153891320|NCT06055101|Analgesics|analgesics|mesh-ancestor
153891321|NCT06055101|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
153432342|NCT05039619|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153432355|NCT05039619|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153432356|NCT05039619|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153432357|NCT05039619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153432358|NCT05039619|Antiemetics|antiemetics|mesh-ancestor
153432359|NCT05039619|Autonomic Agents|autonomic agents|mesh-ancestor
153432360|NCT05039619|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153432361|NCT05039619|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
153432362|NCT05039619|Protective Agents|protective agents|mesh-ancestor
153432363|NCT05039619|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153432364|NCT05039619|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
153432365|NCT05039619|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153432366|NCT05039619|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153432367|NCT05039619|Anesthetics, Local|anesthetics, local|mesh-ancestor
153432368|NCT05039619|Anesthetics|anesthetics|mesh-ancestor
153432369|NCT05039619|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
153432370|NCT05039619|Histamine Antagonists|histamine antagonists|mesh-ancestor
153891322|NCT06055101|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153891323|NCT06055101|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153891324|NCT06055101|Adrenergic Agents|adrenergic agents|mesh-ancestor
153891325|NCT06055101|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153891326|NCT06055101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153891327|NCT06055101|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
153891329|NCT06055101|Cholinergic Agents|cholinergic agents|mesh-ancestor
153891330|NCT06055101|Parasympathomimetics|parasympathomimetics|mesh-ancestor
153891331|NCT06055101|Autonomic Agents|autonomic agents|mesh-ancestor
153891332|NCT06054919|Vitamin D|vitamin d|mesh-list
153891336|NCT06054919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153891337|NCT06054919|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153891338|NCT06054919|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153891339|NCT06054789|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
153486541|NCT01825512|Deferasirox|deferasirox|mesh-list
153891367|NCT06054321|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153891368|NCT06054321|Dopamine Agonists|dopamine agonists|mesh-ancestor
153891370|NCT06054321|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
153891371|NCT06054321|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
153891372|NCT06054321|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
153891373|NCT06054321|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153432396|NCT04862663|Fulvestrant|fulvestrant|mesh-list
153432397|NCT04862663|Palbociclib|palbociclib|mesh-list
153432398|NCT04862663|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153432399|NCT04862663|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153432400|NCT04862663|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
153432401|NCT04862663|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
153432402|NCT04862663|Hormone Antagonists|hormone antagonists|mesh-ancestor
153432403|NCT04862663|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153432404|NCT04862663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153432405|NCT04862663|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153432406|NCT04862663|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153432407|NCT04862663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153432408|NCT04840264|Docetaxel|docetaxel|mesh-list
153432409|NCT04840264|Fluorouracil|fluorouracil|mesh-list
153432411|NCT04840264|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153432412|NCT04840264|Tubulin Modulators|tubulin modulators|mesh-ancestor
153432413|NCT04840264|Antimitotic Agents|antimitotic agents|mesh-ancestor
153432414|NCT04840264|Mitosis Modulators|mitosis modulators|mesh-ancestor
153432415|NCT04840264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153432416|NCT04840264|Antimetabolites|antimetabolites|mesh-ancestor
153432417|NCT04840264|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153432418|NCT04840264|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153891388|NCT06054152|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153891389|NCT06054100|Colchicine|colchicine|mesh-list
153891390|NCT06054100|Gout Suppressants|gout suppressants|mesh-ancestor
153891391|NCT06054100|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153891392|NCT06054100|Tubulin Modulators|tubulin modulators|mesh-ancestor
153891393|NCT06054100|Antimitotic Agents|antimitotic agents|mesh-ancestor
153891394|NCT06054100|Mitosis Modulators|mitosis modulators|mesh-ancestor
153891395|NCT06054100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153432419|NCT04840264|Immunologic Factors|immunologic factors|mesh-ancestor
153432420|NCT04840264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153432421|NCT04837196|Pembrolizumab|pembrolizumab|mesh-list
153432422|NCT04837196|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153432423|NCT04837196|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153432424|NCT04837196|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153432425|NCT04837196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153432426|NCT04835441|ALPN-101|alpn-101|mesh-list
153432427|NCT04835441|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153432428|NCT04835441|Immunologic Factors|immunologic factors|mesh-ancestor
153432429|NCT04835441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153432438|NCT04803734|Respiratory System Agents|respiratory system agents|mesh-ancestor
153432439|NCT04803734|Tocolytic Agents|tocolytic agents|mesh-ancestor
153432440|NCT04803734|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153432441|NCT04803734|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
153432442|NCT04803734|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
153432443|NCT04803734|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153432444|NCT04803734|Adrenergic Agents|adrenergic agents|mesh-ancestor
153432445|NCT04803734|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153432446|NCT04803734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153432447|NCT04801797|Cytarabine|cytarabine|mesh-list
153432448|NCT04801797|Azacitidine|azacitidine|mesh-list
153432449|NCT04801797|Daunorubicin|daunorubicin|mesh-list
153432450|NCT04801797|Venetoclax|venetoclax|mesh-list
153432459|NCT04801797|Immunologic Factors|immunologic factors|mesh-ancestor
153432460|NCT04801797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153432461|NCT04801797|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153432462|NCT04801797|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153432463|NCT04801797|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153432464|NCT04801797|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153432465|NCT04790370|Heparin|heparin|mesh-list
153432466|NCT04790370|Calcium heparin|calcium heparin|mesh-list
153432467|NCT04790370|Anticoagulants|anticoagulants|mesh-ancestor
153432468|NCT04790370|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153432469|NCT04790370|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153432470|NCT04790370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153432471|NCT04785300|Dasatinib|dasatinib|mesh-list
153432472|NCT04785300|Quercetin|quercetin|mesh-list
153432473|NCT04785300|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153432474|NCT04785300|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153432475|NCT04785300|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153432478|NCT04785300|Antioxidants|antioxidants|mesh-ancestor
153432479|NCT04785300|Protective Agents|protective agents|mesh-ancestor
153432480|NCT04785300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153432481|NCT04781036|Chlorhexidine|chlorhexidine|mesh-list
153432482|NCT04781036|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
153432483|NCT04781036|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153432484|NCT04781036|Disinfectants|disinfectants|mesh-ancestor
153891436|NCT05983354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153891437|NCT05983354|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153891438|NCT05983354|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153891439|NCT05983354|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153891440|NCT05983354|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153891441|NCT05983354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153891442|NCT05983354|Antiemetics|antiemetics|mesh-ancestor
153891443|NCT05983354|Autonomic Agents|autonomic agents|mesh-ancestor
153891444|NCT05983354|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153891445|NCT05983354|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
153891446|NCT05983354|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
153891447|NCT05983354|Dopamine Agents|dopamine agents|mesh-ancestor
153891448|NCT05983354|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153891450|NCT05960708|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
153891451|NCT05960708|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153891452|NCT05960708|Respiratory System Agents|respiratory system agents|mesh-ancestor
153891453|NCT05959044|Folic Acid|folic acid|mesh-list
153891454|NCT05959044|Vitamins|vitamins|mesh-ancestor
153891455|NCT05959044|Micronutrients|micronutrients|mesh-ancestor
153891456|NCT05959044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153891457|NCT05959044|Hematinics|hematinics|mesh-ancestor
153891458|NCT05959044|Vitamin B Complex|vitamin b complex|mesh-ancestor
153891459|NCT05955924|Niacinamide|niacinamide|mesh-list
153891460|NCT05955924|Niacin|niacin|mesh-list
153891461|NCT05955924|Nicotinic Acids|nicotinic acids|mesh-list
153891462|NCT05955924|Vitamin B Complex|vitamin b complex|mesh-ancestor
153891463|NCT05955924|Vitamins|vitamins|mesh-ancestor
153891464|NCT05955924|Micronutrients|micronutrients|mesh-ancestor
153891465|NCT05955924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153891466|NCT05955924|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153891467|NCT05955924|Antimetabolites|antimetabolites|mesh-ancestor
153891468|NCT05955924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153891469|NCT05955924|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153891470|NCT05955924|Vasodilator Agents|vasodilator agents|mesh-ancestor
153891471|NCT05954962|Progesterone|progesterone|mesh-list
153891472|NCT05954962|Ganirelix|ganirelix|mesh-list
153891473|NCT05954962|Progestins|progestins|mesh-ancestor
153891474|NCT05954962|Hormones|hormones|mesh-ancestor
153432498|NCT04755283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153432499|NCT04755283|Anticoagulants|anticoagulants|mesh-ancestor
153432500|NCT04752267|Clevudine|clevudine|mesh-list
153432501|NCT04752267|Antiviral Agents|antiviral agents|mesh-ancestor
153432502|NCT04752267|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153432503|NCT04749043|Nitrous Oxide|nitrous oxide|mesh-list
153487868|NCT02024724|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153432504|NCT04749043|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
153432505|NCT04749043|Anesthetics, General|anesthetics, general|mesh-ancestor
153432506|NCT04749043|Anesthetics|anesthetics|mesh-ancestor
153432507|NCT04749043|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153432508|NCT04749043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153432509|NCT04749043|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153432532|NCT04643470|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153432533|NCT04643470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153432534|NCT04643470|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153432537|NCT04612751|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153432538|NCT04612751|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153432539|NCT04586010|Teriflunomide|teriflunomide|mesh-list
153432540|NCT04586010|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153432541|NCT04586010|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153432542|NCT04586010|Analgesics|analgesics|mesh-ancestor
153432543|NCT04586010|Sensory System Agents|sensory system agents|mesh-ancestor
153432544|NCT04586010|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153432545|NCT04586010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153432546|NCT04586010|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153432547|NCT04586010|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153891497|NCT05931575|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
153891506|NCT05931575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153891507|NCT05931575|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153891508|NCT05931575|Vasodilator Agents|vasodilator agents|mesh-ancestor
153891509|NCT05931575|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153891510|NCT05931575|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153891511|NCT05927714|Hemostatics|hemostatics|mesh-list
153891512|NCT05927714|Coagulants|coagulants|mesh-ancestor
153891513|NCT05907525|Propofol|propofol|mesh-list
153891514|NCT05907525|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153891515|NCT05907525|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153891516|NCT05907525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153891518|NCT05907525|Anesthetics, General|anesthetics, general|mesh-ancestor
153891519|NCT05907525|Anesthetics|anesthetics|mesh-ancestor
153891520|NCT05890586|Fluvoxamine|fluvoxamine|mesh-list
153891521|NCT05890586|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153914649|NCT02709031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153432548|NCT04586010|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153432549|NCT04586010|Immunologic Factors|immunologic factors|mesh-ancestor
153432551|NCT04560166|Temozolomide|temozolomide|mesh-list
153432552|NCT04560166|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
153432553|NCT04560166|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153432554|NCT04560166|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153432555|NCT04560166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153432556|NCT04560166|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153432557|NCT04560166|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153432561|NCT04538742|Durvalumab|durvalumab|mesh-list
153432562|NCT04538742|Pertuzumab|pertuzumab|mesh-list
153432563|NCT04538742|Tucatinib|tucatinib|mesh-list
153432564|NCT04538742|Trastuzumab deruxtecan|trastuzumab deruxtecan|mesh-list
153432565|NCT04538742|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153432566|NCT04538742|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153432567|NCT04538742|Tubulin Modulators|tubulin modulators|mesh-ancestor
153488263|NCT02179788|Metformin|metformin|mesh-list
153432578|NCT04472598|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153432579|NCT04431258|Folfirinox|folfirinox|mesh-list
153432580|NCT04431258|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153432581|NCT04430790|Doxapram|doxapram|mesh-list
153432582|NCT04430790|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
153432583|NCT04430790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153432584|NCT04430790|Respiratory System Agents|respiratory system agents|mesh-ancestor
153432585|NCT04382898|Cemiplimab|cemiplimab|mesh-list
153432586|NCT04382898|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153432587|NCT04382898|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153432588|NCT04260854|Bupivacaine|bupivacaine|mesh-list
153432589|NCT04260854|Anesthetics, Local|anesthetics, local|mesh-ancestor
153432590|NCT04260854|Anesthetics|anesthetics|mesh-ancestor
153432591|NCT04260854|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153432592|NCT04260854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153432593|NCT04260854|Sensory System Agents|sensory system agents|mesh-ancestor
153432594|NCT04260854|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153488575|NCT02272686|Ibrutinib|ibrutinib|mesh-list
153891556|NCT05864625|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153891557|NCT05864625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153891558|NCT05864625|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153891559|NCT05864625|Anesthetics, General|anesthetics, general|mesh-ancestor
153891560|NCT05864625|Anesthetics|anesthetics|mesh-ancestor
153891561|NCT05864625|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153891562|NCT05864625|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
153891563|NCT05852769|Flurbiprofen|flurbiprofen|mesh-list
153891564|NCT05852769|Digoxin|digoxin|mesh-list
153891565|NCT05852769|Midazolam|midazolam|mesh-list
153891566|NCT05852769|Caffeine|caffeine|mesh-list
153432595|NCT04180215|Pembrolizumab|pembrolizumab|mesh-list
153432596|NCT04180215|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153432597|NCT04180215|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153432598|NCT04180215|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153432601|NCT04103034|Hemostatics|hemostatics|mesh-ancestor
153432602|NCT04103034|Coagulants|coagulants|mesh-ancestor
153432603|NCT04103034|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
153432604|NCT04103034|Natriuretic Agents|natriuretic agents|mesh-ancestor
153432605|NCT04103034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153432606|NCT04095442|Benzocaine|benzocaine|mesh-list
153432607|NCT04095442|Anesthetics, Local|anesthetics, local|mesh-ancestor
153432608|NCT04095442|Anesthetics|anesthetics|mesh-ancestor
153432609|NCT04095442|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153432610|NCT04095442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153488691|NCT02285634|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153432612|NCT04095442|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153432613|NCT04075266|Ocrelizumab|ocrelizumab|mesh-list
153432614|NCT04075266|Immunologic Factors|immunologic factors|mesh-ancestor
153432615|NCT04075266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153432616|NCT04024462|Cyclophosphamide|cyclophosphamide|mesh-list
153432617|NCT04024462|Docetaxel|docetaxel|mesh-list
153432618|NCT04024462|Doxorubicin|doxorubicin|mesh-list
153432619|NCT04024462|Trastuzumab|trastuzumab|mesh-list
153432620|NCT04024462|Pertuzumab|pertuzumab|mesh-list
153432621|NCT04024462|Hormones|hormones|mesh-list
153432622|NCT04024462|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153432623|NCT04024462|Immunologic Factors|immunologic factors|mesh-ancestor
153432624|NCT04024462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153432625|NCT04024462|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153432626|NCT04024462|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153432627|NCT04024462|Alkylating Agents|alkylating agents|mesh-ancestor
153891567|NCT05852769|Omeprazole|omeprazole|mesh-list
153891568|NCT05852769|Pravastatin|pravastatin|mesh-list
153891569|NCT05852769|Montelukast|montelukast|mesh-list
153891570|NCT05852769|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153891572|NCT05852769|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153891573|NCT05852769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153891574|NCT05852769|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153891575|NCT05852769|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153891576|NCT05852769|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153432629|NCT04024462|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153891578|NCT05852769|Anesthetics, General|anesthetics, general|mesh-ancestor
153891579|NCT05852769|Anesthetics|anesthetics|mesh-ancestor
153891580|NCT05852769|GABA Modulators|gaba modulators|mesh-ancestor
153891581|NCT05852769|GABA Agents|gaba agents|mesh-ancestor
153891582|NCT05852769|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153891583|NCT05852769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153891584|NCT05852769|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
153488808|NCT02307318|Hemostatics|hemostatics|mesh-list
153891595|NCT05852769|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
153891596|NCT05852769|Hormone Antagonists|hormone antagonists|mesh-ancestor
153891597|NCT05852769|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153891598|NCT05852769|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
153891599|NCT05852769|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
153891600|NCT05852769|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153891601|NCT05852769|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
153891605|NCT05852769|Antimetabolites|antimetabolites|mesh-ancestor
153891606|NCT05852769|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153891607|NCT05852769|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
153432638|NCT04024462|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153432639|NCT04024462|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153432640|NCT04015869|Pregnanolone|pregnanolone|mesh-list
153432641|NCT04015869|Anesthetics|anesthetics|mesh-ancestor
153432642|NCT04015869|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153432643|NCT04015869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153432645|NCT03927105|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153432646|NCT03927105|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153432647|NCT03927105|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153432648|NCT03927105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153432649|NCT03874052|Venetoclax|venetoclax|mesh-list
153432650|NCT03874052|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-list
153488951|NCT02374398|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
153891616|NCT05809700|Hyaluronic Acid|hyaluronic acid|mesh-list
153891617|NCT05809700|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153891618|NCT05809700|Immunologic Factors|immunologic factors|mesh-ancestor
153891619|NCT05809700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153891620|NCT05809700|Viscosupplements|viscosupplements|mesh-ancestor
153432651|NCT03874052|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153432652|NCT03874052|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153432653|NCT03874052|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153432654|NCT03874052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153432655|NCT03829722|Paclitaxel|paclitaxel|mesh-list
153432656|NCT03829722|Carboplatin|carboplatin|mesh-list
153432657|NCT03829722|Nivolumab|nivolumab|mesh-list
153432658|NCT03829722|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153432664|NCT03829722|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153432665|NCT03829722|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153432667|NCT03764098|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153432668|NCT03764098|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
153432669|NCT03764098|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153432670|NCT03764098|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153432671|NCT03764098|Adrenergic Agents|adrenergic agents|mesh-ancestor
153432672|NCT03764098|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153432673|NCT03764098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153432674|NCT03764098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153891628|NCT05734443|Triptorelin Pamoate|triptorelin pamoate|mesh-list
153891629|NCT05734443|Luteolytic Agents|luteolytic agents|mesh-ancestor
153891630|NCT05734443|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
153891631|NCT05734443|Contraceptive Agents|contraceptive agents|mesh-ancestor
153891632|NCT05734443|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153891633|NCT05734443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153891634|NCT05734443|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
153891635|NCT05734443|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153891636|NCT05734443|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153891637|NCT05707455|Chrysarobin|chrysarobin|mesh-list
153432678|NCT03757585|Antiviral Agents|antiviral agents|mesh-ancestor
153432679|NCT03757585|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153432680|NCT03757585|Expectorants|expectorants|mesh-ancestor
153432681|NCT03757585|Respiratory System Agents|respiratory system agents|mesh-ancestor
153432682|NCT03757585|Free Radical Scavengers|free radical scavengers|mesh-ancestor
153432683|NCT03757585|Antioxidants|antioxidants|mesh-ancestor
153891653|NCT05613842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153891655|NCT05613842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153891656|NCT05592951|Methamphetamine|methamphetamine|mesh-list
153891657|NCT05592951|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
153432691|NCT03732677|Gemcitabine|gemcitabine|mesh-list
153432693|NCT03732677|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153432694|NCT03732677|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153432695|NCT03732677|Antimetabolites|antimetabolites|mesh-ancestor
153432696|NCT03732677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153432697|NCT03732677|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153432698|NCT03700801|Insulin|insulin|mesh-list
153432699|NCT03700801|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
153432700|NCT03700801|Metformin|metformin|mesh-list
153432701|NCT03700801|Dapagliflozin|dapagliflozin|mesh-list
153432702|NCT03700801|Insulin Aspart|insulin aspart|mesh-list
153432703|NCT03700801|Saxagliptin|saxagliptin|mesh-list
153432704|NCT03700801|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153432705|NCT03700801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153432706|NCT03700801|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
153432707|NCT03700801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153432708|NCT03700801|Incretins|incretins|mesh-ancestor
153432709|NCT03700801|Hormones|hormones|mesh-ancestor
153432710|NCT03700801|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153432711|NCT03700801|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
153432712|NCT03700801|Protease Inhibitors|protease inhibitors|mesh-ancestor
153432713|NCT03700801|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153432714|NCT03683251|Ranibizumab|ranibizumab|mesh-list
153432716|NCT03683251|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153432718|NCT03683251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153432719|NCT03683251|Growth Inhibitors|growth inhibitors|mesh-ancestor
153432720|NCT03683251|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153432721|NCT03671018|Rituximab|rituximab|mesh-list
153432722|NCT03671018|Polatuzumab vedotin|polatuzumab vedotin|mesh-list
153432723|NCT03671018|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153432724|NCT03671018|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153432725|NCT03671018|Immunologic Factors|immunologic factors|mesh-ancestor
153891661|NCT05592951|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153891663|NCT05592951|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153891669|NCT05592951|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
153891672|NCT05579119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153891674|NCT05579119|Hormones|hormones|mesh-ancestor
153891675|NCT05579119|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153891676|NCT05579119|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
153891677|NCT05579119|Protease Inhibitors|protease inhibitors|mesh-ancestor
153891678|NCT05579119|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153891679|NCT05579119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153891680|NCT05530954|Calcium|calcium|mesh-list
153891681|NCT05530954|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153891682|NCT05530954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153891683|NCT05518929|Propofol|propofol|mesh-list
153891684|NCT05518929|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153891685|NCT05518929|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153891686|NCT05518929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153891687|NCT05518929|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153432739|NCT03670966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153432740|NCT03670966|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153432741|NCT03670966|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153432742|NCT03670966|Alkylating Agents|alkylating agents|mesh-ancestor
153891700|NCT05477004|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
153891701|NCT05477004|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
153891702|NCT05477004|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153891703|NCT05477004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153432743|NCT03670966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153432744|NCT03670966|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153432745|NCT03670966|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153432746|NCT03670966|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153432747|NCT03670966|Antimetabolites|antimetabolites|mesh-ancestor
153432748|NCT03670966|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153432749|NCT03670966|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
153432751|NCT03670966|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153432752|NCT03670966|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
153432753|NCT03670966|Antitubercular Agents|antitubercular agents|mesh-ancestor
153432754|NCT03670966|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153432755|NCT03670966|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153432757|NCT03642626|Cyclophosphamide|cyclophosphamide|mesh-list
153432758|NCT03642626|Fludarabine|fludarabine|mesh-list
153432759|NCT03642626|Fludarabine phosphate|fludarabine phosphate|mesh-list
153432760|NCT03642626|Tisagenlecleucel|tisagenlecleucel|mesh-list
153432761|NCT03642626|Axicabtagene ciloleucel|axicabtagene ciloleucel|mesh-list
153432762|NCT03642626|Brexucabtagene autoleucel|brexucabtagene autoleucel|mesh-list
153432763|NCT03642626|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153432764|NCT03642626|Immunologic Factors|immunologic factors|mesh-ancestor
153432765|NCT03642626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153432766|NCT03642626|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153891711|NCT05422001|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153891716|NCT05422001|Anesthetics|anesthetics|mesh-ancestor
153891717|NCT05422001|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153891718|NCT05422001|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
153891719|NCT05422001|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
153891720|NCT05422001|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153891721|NCT05422001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153891722|NCT05363631|Selenium|selenium|mesh-list
153891723|NCT05363631|Pembrolizumab|pembrolizumab|mesh-list
153891724|NCT05363631|Axitinib|axitinib|mesh-list
153891725|NCT05363631|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153891726|NCT05363631|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153891727|NCT05363631|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153891728|NCT05363631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153432768|NCT03642626|Alkylating Agents|alkylating agents|mesh-ancestor
153432769|NCT03642626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153432770|NCT03642626|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153432786|NCT03624946|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
153432787|NCT03624946|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
153432788|NCT03624946|Immunoglobulin G|immunoglobulin g|mesh-list
153432789|NCT03624946|Immunologic Factors|immunologic factors|mesh-ancestor
153432790|NCT03624946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153432791|NCT03599245|Ocrelizumab|ocrelizumab|mesh-list
153432792|NCT03599245|Immunologic Factors|immunologic factors|mesh-ancestor
153432793|NCT03599245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153432794|NCT03596073|Calcipotriene|calcipotriene|mesh-list
153432795|NCT03596073|Petrolatum|petrolatum|mesh-list
153432796|NCT03596073|Dermatologic Agents|dermatologic agents|mesh-ancestor
153432797|NCT03596073|Emollients|emollients|mesh-ancestor
153432798|NCT03588754|Propranolol|propranolol|mesh-list
153432799|NCT03588754|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
153432800|NCT03588754|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
153432801|NCT03588754|Adrenergic Agents|adrenergic agents|mesh-ancestor
153432810|NCT03582176|Dermatologic Agents|dermatologic agents|mesh-ancestor
153432811|NCT03582176|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
153432812|NCT03582176|Histamine Antagonists|histamine antagonists|mesh-ancestor
153432813|NCT03582176|Histamine Agents|histamine agents|mesh-ancestor
153432814|NCT03582176|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153432815|NCT03582176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153432816|NCT03582176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153432817|NCT03582176|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
153432818|NCT03556332|Dexamethasone|dexamethasone|mesh-list
153432819|NCT03556332|Lenalidomide|lenalidomide|mesh-list
153891747|NCT05295589|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153891748|NCT05295589|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153891749|NCT05295589|Tubulin Modulators|tubulin modulators|mesh-ancestor
153891750|NCT05295589|Antimitotic Agents|antimitotic agents|mesh-ancestor
153891751|NCT05295589|Mitosis Modulators|mitosis modulators|mesh-ancestor
153891752|NCT05295589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153891761|NCT05294965|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153891762|NCT05294965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153891763|NCT05294965|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153891764|NCT05294965|Respiratory System Agents|respiratory system agents|mesh-ancestor
153891765|NCT05294965|Sympathomimetics|sympathomimetics|mesh-ancestor
153891766|NCT05294965|Tocolytic Agents|tocolytic agents|mesh-ancestor
153891767|NCT05294965|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153891768|NCT05294965|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
153891769|NCT05294965|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
153891770|NCT05294965|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153891771|NCT05294965|Adrenergic Agents|adrenergic agents|mesh-ancestor
153891772|NCT05294965|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153891773|NCT05294965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153891775|NCT05255913|Cariostatic Agents|cariostatic agents|mesh-ancestor
153891777|NCT05255913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153432820|NCT03556332|Daratumumab|daratumumab|mesh-list
153432821|NCT03556332|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153432822|NCT03556332|Antiemetics|antiemetics|mesh-ancestor
153432823|NCT03556332|Autonomic Agents|autonomic agents|mesh-ancestor
153432824|NCT03556332|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153432825|NCT03556332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153432826|NCT03556332|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153432827|NCT03556332|Glucocorticoids|glucocorticoids|mesh-ancestor
153432828|NCT03556332|Hormones|hormones|mesh-ancestor
153432829|NCT03556332|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153432830|NCT03556332|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153432831|NCT03556332|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153432832|NCT03556332|Immunologic Factors|immunologic factors|mesh-ancestor
153432833|NCT03556332|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153432834|NCT03556332|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153432835|NCT03556332|Growth Substances|growth substances|mesh-ancestor
153432836|NCT03556332|Growth Inhibitors|growth inhibitors|mesh-ancestor
153432837|NCT03551626|Trametinib|trametinib|mesh-list
153432838|NCT03551626|Dabrafenib|dabrafenib|mesh-list
153432839|NCT03551626|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153432840|NCT03551626|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153432841|NCT03551626|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153432842|NCT03551626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153432843|NCT03525925|Nivolumab|nivolumab|mesh-list
153891786|NCT05247320|Sympatholytics|sympatholytics|mesh-ancestor
153891787|NCT05247320|Autonomic Agents|autonomic agents|mesh-ancestor
153891788|NCT05247320|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153891789|NCT05238714|Venglustat|venglustat|mesh-list
153891790|NCT05238714|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153891791|NCT05238714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153891792|NCT05228496|Tislelizumab|tislelizumab|mesh-list
153891793|NCT05228496|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153891794|NCT05228496|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153891795|NCT05183204|Metformin|metformin|mesh-list
153891796|NCT05183204|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153891797|NCT05183204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153432852|NCT03524092|Mirikizumab|mirikizumab|mesh-list
153432853|NCT03524092|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153432854|NCT03524092|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153432855|NCT03524092|Analgesics|analgesics|mesh-ancestor
153432856|NCT03524092|Sensory System Agents|sensory system agents|mesh-ancestor
153432857|NCT03524092|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153432858|NCT03524092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153432859|NCT03524092|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153432860|NCT03524092|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153432861|NCT03524092|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
153432862|NCT03524092|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153432864|NCT03490864|Antioxidants|antioxidants|mesh-ancestor
153432866|NCT03490864|Protective Agents|protective agents|mesh-ancestor
153891803|NCT05178173|Ethanol|ethanol|mesh-list
153891804|NCT05178173|Cetylpyridinium|cetylpyridinium|mesh-list
153891805|NCT05178173|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
153891806|NCT05178173|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153891807|NCT05178173|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153891808|NCT05178173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153891809|NCT05151263|Salicylates|salicylates|mesh-list
153891810|NCT05151263|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153891811|NCT05151263|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153891812|NCT05151263|Analgesics|analgesics|mesh-ancestor
153891813|NCT05151263|Sensory System Agents|sensory system agents|mesh-ancestor
153891814|NCT05151263|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153891815|NCT05151263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153891816|NCT05151263|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153891817|NCT05151263|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153891818|NCT05151263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153891819|NCT05151263|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153891820|NCT05151263|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153891821|NCT05130814|Hyaluronic Acid|hyaluronic acid|mesh-list
153891822|NCT05130814|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153891823|NCT05130814|Immunologic Factors|immunologic factors|mesh-ancestor
153891824|NCT05130814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153891825|NCT05130814|Viscosupplements|viscosupplements|mesh-ancestor
153891827|NCT05124457|Insulin|insulin|mesh-list
153891828|NCT05124457|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
153891829|NCT05124457|Insulin Detemir|insulin detemir|mesh-list
153891830|NCT05124457|Isophane Insulin, Human|isophane insulin, human|mesh-list
153891831|NCT05124457|Insulin, Isophane|insulin, isophane|mesh-list
153891832|NCT05124457|Isophane insulin, beef|isophane insulin, beef|mesh-list
153891833|NCT05124457|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153891834|NCT05124457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153891835|NCT05096195|Calcium, Dietary|calcium, dietary|mesh-list
153891843|NCT05096195|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153891844|NCT05093959|Metformin|metformin|mesh-list
153891845|NCT05093959|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153891846|NCT05093959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153891847|NCT05044468|Lidocaine|lidocaine|mesh-list
153891848|NCT05044468|Bupivacaine|bupivacaine|mesh-list
153891849|NCT05044468|Anesthetics, Local|anesthetics, local|mesh-ancestor
153891850|NCT05044468|Anesthetics|anesthetics|mesh-ancestor
153891851|NCT05044468|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153891852|NCT05044468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153891853|NCT05044468|Sensory System Agents|sensory system agents|mesh-ancestor
153891854|NCT05044468|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153432897|NCT03418038|Cytarabine|cytarabine|mesh-list
153432898|NCT03418038|Dexamethasone|dexamethasone|mesh-list
153432899|NCT03418038|Dexamethasone acetate|dexamethasone acetate|mesh-list
153432900|NCT03418038|Cisplatin|cisplatin|mesh-list
153432901|NCT03418038|Rituximab|rituximab|mesh-list
153432902|NCT03418038|Carboplatin|carboplatin|mesh-list
153432903|NCT03418038|Gemcitabine|gemcitabine|mesh-list
153432904|NCT03418038|Oxaliplatin|oxaliplatin|mesh-list
153432905|NCT03418038|Etoposide|etoposide|mesh-list
153432906|NCT03418038|Etoposide phosphate|etoposide phosphate|mesh-list
153432907|NCT03418038|Ifosfamide|ifosfamide|mesh-list
153432908|NCT03418038|Isophosphamide mustard|isophosphamide mustard|mesh-list
153432909|NCT03418038|Podophyllotoxin|podophyllotoxin|mesh-list
153432910|NCT03418038|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
153432911|NCT03418038|Antibodies|antibodies|mesh-list
153432912|NCT03418038|Immunoglobulins|immunoglobulins|mesh-list
153432913|NCT03418038|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
153432914|NCT03418038|BB 1101|bb 1101|mesh-list
153432915|NCT03418038|Micronutrients|micronutrients|mesh-ancestor
153432916|NCT03418038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153432917|NCT03418038|Immunologic Factors|immunologic factors|mesh-ancestor
153432918|NCT03418038|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153432919|NCT03418038|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153432920|NCT03418038|Antiemetics|antiemetics|mesh-ancestor
153432921|NCT03418038|Autonomic Agents|autonomic agents|mesh-ancestor
153891858|NCT05044468|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153891859|NCT05044468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153891860|NCT04989283|Paclitaxel|paclitaxel|mesh-list
153891861|NCT04989283|Etoposide|etoposide|mesh-list
153891862|NCT04989283|Podophyllotoxin|podophyllotoxin|mesh-list
153891863|NCT04989283|Cisplatin|cisplatin|mesh-list
153891864|NCT04989283|Carboplatin|carboplatin|mesh-list
153891865|NCT04989283|Pemetrexed|pemetrexed|mesh-list
153891866|NCT04989283|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
153891867|NCT04989283|Etoposide phosphate|etoposide phosphate|mesh-list
153891868|NCT04989283|Atezolizumab|atezolizumab|mesh-list
153891869|NCT04989283|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
153891870|NCT04989283|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153891871|NCT04989283|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153891872|NCT04989283|Tubulin Modulators|tubulin modulators|mesh-ancestor
153891875|NCT04989283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153891876|NCT04989283|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153891877|NCT04989283|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153891878|NCT04989283|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153432926|NCT03418038|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153432927|NCT03418038|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153432928|NCT03418038|Protease Inhibitors|protease inhibitors|mesh-ancestor
153432929|NCT03418038|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153432930|NCT03418038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153432931|NCT03418038|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153432932|NCT03418038|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153432933|NCT03418038|Antimetabolites|antimetabolites|mesh-ancestor
153432934|NCT03418038|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153432935|NCT03418038|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153432936|NCT03418038|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153432937|NCT03418038|Antiviral Agents|antiviral agents|mesh-ancestor
153432938|NCT03418038|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153432939|NCT03418038|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153432940|NCT03418038|Antioxidants|antioxidants|mesh-ancestor
153432941|NCT03418038|Protective Agents|protective agents|mesh-ancestor
153432942|NCT03418038|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153432943|NCT03418038|Alkylating Agents|alkylating agents|mesh-ancestor
153432944|NCT03418038|Keratolytic Agents|keratolytic agents|mesh-ancestor
153432945|NCT03418038|Dermatologic Agents|dermatologic agents|mesh-ancestor
153432946|NCT03418038|Tubulin Modulators|tubulin modulators|mesh-ancestor
153432947|NCT03418038|Antimitotic Agents|antimitotic agents|mesh-ancestor
153432948|NCT03418038|Mitosis Modulators|mitosis modulators|mesh-ancestor
153432949|NCT03374800|Pantoprazole|pantoprazole|mesh-list
153432950|NCT03374800|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
153432951|NCT03374800|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153432952|NCT03374800|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
153432953|NCT03374800|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153432954|NCT03374800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153432955|NCT03291028|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
153432958|NCT03291028|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153891879|NCT04989283|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153891880|NCT04989283|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153891881|NCT04989283|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153891882|NCT04989283|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153891883|NCT04989283|Immunologic Factors|immunologic factors|mesh-ancestor
153891884|NCT04989283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153891885|NCT04989283|Keratolytic Agents|keratolytic agents|mesh-ancestor
153891886|NCT04989283|Dermatologic Agents|dermatologic agents|mesh-ancestor
153891888|NCT04988841|Ipilimumab|ipilimumab|mesh-list
153891889|NCT04988841|Laxatives|laxatives|mesh-list
153891890|NCT04988841|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
153891891|NCT04988841|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153891892|NCT04988841|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153891893|NCT04988841|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153891894|NCT04988841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153891895|NCT04988841|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153891896|NCT04977778|Fluorides|fluorides|mesh-list
153891897|NCT04977778|Tin Fluorides|tin fluorides|mesh-list
153891899|NCT04977778|Protective Agents|protective agents|mesh-ancestor
153891900|NCT04977778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153891901|NCT04973254|Rilpivirine|rilpivirine|mesh-list
153891902|NCT04973254|Cabotegravir|cabotegravir|mesh-list
153891903|NCT04973254|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153891904|NCT04973254|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153891905|NCT04973254|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153891906|NCT04973254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153891907|NCT04973254|Antiviral Agents|antiviral agents|mesh-ancestor
153891908|NCT04973254|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153891909|NCT04973254|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153891910|NCT04973254|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153891911|NCT04973254|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
153891912|NCT04973254|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
153891914|NCT04964505|Venetoclax|venetoclax|mesh-list
153891915|NCT04964505|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153891916|NCT04964505|Antimetabolites|antimetabolites|mesh-ancestor
153891917|NCT04964505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153891918|NCT04964505|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153891919|NCT04964505|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153891920|NCT04873895|Hydroxychloroquine|hydroxychloroquine|mesh-list
153891921|NCT04873895|Axitinib|axitinib|mesh-list
153432969|NCT03274492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153432970|NCT03274492|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153432971|NCT03274492|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153432972|NCT03274492|Alkylating Agents|alkylating agents|mesh-ancestor
153432973|NCT03274492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153432974|NCT03274492|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153432975|NCT03274492|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153432976|NCT03274492|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153432977|NCT03274492|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153432978|NCT03274492|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153432979|NCT03274492|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153432980|NCT03274492|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153432981|NCT03274492|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153432982|NCT03274492|Glucocorticoids|glucocorticoids|mesh-ancestor
153432983|NCT03274492|Hormones|hormones|mesh-ancestor
153432984|NCT03274492|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153432985|NCT03274492|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153432986|NCT03274492|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153432987|NCT03274492|Tubulin Modulators|tubulin modulators|mesh-ancestor
153432988|NCT03274492|Antimitotic Agents|antimitotic agents|mesh-ancestor
153432989|NCT03274492|Mitosis Modulators|mitosis modulators|mesh-ancestor
153432990|NCT03271372|Avelumab|avelumab|mesh-list
153432991|NCT03271372|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
153432992|NCT03271372|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153891932|NCT04869436|Immunologic Factors|immunologic factors|mesh-ancestor
153891933|NCT04869436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153891934|NCT04860154|Hematoporphyrins|hematoporphyrins|mesh-list
153891935|NCT04860154|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
153891936|NCT04860154|Dermatologic Agents|dermatologic agents|mesh-ancestor
153891938|NCT04615403|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153891939|NCT04577014|Gemcitabine|gemcitabine|mesh-list
153891940|NCT04577014|Docetaxel|docetaxel|mesh-list
153891941|NCT04577014|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153891942|NCT04577014|Antimetabolites|antimetabolites|mesh-ancestor
153891943|NCT04577014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153891944|NCT04577014|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153891945|NCT04577014|Tubulin Modulators|tubulin modulators|mesh-ancestor
153891946|NCT04577014|Antimitotic Agents|antimitotic agents|mesh-ancestor
153891948|NCT04567784|Cannabidiol|cannabidiol|mesh-list
153891949|NCT04567784|Anticonvulsants|anticonvulsants|mesh-ancestor
153891950|NCT04531046|Axicabtagene ciloleucel|axicabtagene ciloleucel|mesh-list
153891951|NCT04531046|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153432998|NCT03253289|Autonomic Agents|autonomic agents|mesh-ancestor
153432999|NCT03253289|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153433000|NCT03253289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153433001|NCT03253289|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153433002|NCT03253289|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
153433003|NCT03253289|Histamine Antagonists|histamine antagonists|mesh-ancestor
153433004|NCT03253289|Histamine Agents|histamine agents|mesh-ancestor
153433005|NCT03253289|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153433006|NCT03253289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153433007|NCT03253289|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
153433008|NCT03253289|Cholinergic Agents|cholinergic agents|mesh-ancestor
153433009|NCT03253289|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
153433010|NCT03241550|Isavuconazole|isavuconazole|mesh-list
153433011|NCT03241550|Antifungal Agents|antifungal agents|mesh-ancestor
153433012|NCT03241550|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153433013|NCT03170206|Palbociclib|palbociclib|mesh-list
153433014|NCT03170206|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153433015|NCT03170206|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153433016|NCT03170206|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153433017|NCT03170206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153433018|NCT03160339|Vaccines|vaccines|mesh-list
153433019|NCT03160339|Immunologic Factors|immunologic factors|mesh-ancestor
153433020|NCT03160339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153433021|NCT03126331|Nivolumab|nivolumab|mesh-list
153433022|NCT03126331|Ipilimumab|ipilimumab|mesh-list
153433023|NCT03126331|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153433024|NCT03126331|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153433025|NCT03126331|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153433026|NCT03126331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153433027|NCT03098355|Interleukin-2|interleukin-2|mesh-list
153433028|NCT03098355|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153433029|NCT03098355|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153891952|NCT04531046|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153891953|NCT04494503|Rituximab|rituximab|mesh-list
153891954|NCT04494503|Ibrutinib|ibrutinib|mesh-list
153891955|NCT04494503|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153891956|NCT04494503|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153891957|NCT04494503|Immunologic Factors|immunologic factors|mesh-ancestor
153433030|NCT03098355|Analgesics|analgesics|mesh-ancestor
153433031|NCT03098355|Sensory System Agents|sensory system agents|mesh-ancestor
153891958|NCT04494503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153891959|NCT04494503|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153891960|NCT04494503|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153891961|NCT04494503|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153891962|NCT04494503|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153891963|NCT04494503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153891964|NCT04477304|Analgesics, Opioid|analgesics, opioid|mesh-list
153891965|NCT04477304|Narcotics|narcotics|mesh-ancestor
153891966|NCT04477304|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153891967|NCT04477304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153891969|NCT04477304|Sensory System Agents|sensory system agents|mesh-ancestor
153891970|NCT04477304|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153891972|NCT04448873|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153891973|NCT04448873|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153891974|NCT04448873|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153891975|NCT04448873|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153891976|NCT04448873|Antifungal Agents|antifungal agents|mesh-ancestor
153891977|NCT04448873|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153891978|NCT04448873|Immunologic Factors|immunologic factors|mesh-ancestor
153891979|NCT04448873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153891980|NCT04368429|Vaccines|vaccines|mesh-list
153891981|NCT04368429|Immunologic Factors|immunologic factors|mesh-ancestor
153891982|NCT04368429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153891983|NCT04356326|Aspirin|aspirin|mesh-list
153891984|NCT04356326|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153891985|NCT04356326|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153891987|NCT04356326|Sensory System Agents|sensory system agents|mesh-ancestor
153891988|NCT04356326|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153891989|NCT04356326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153891990|NCT04356326|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153891991|NCT04356326|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153891992|NCT04356326|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153433040|NCT03049618|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153433041|NCT03049618|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153433042|NCT03049618|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153433043|NCT03049618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153433044|NCT03032172|Risdiplam|risdiplam|mesh-list
153433045|NCT03032172|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
153433046|NCT03032172|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153433047|NCT03032172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153433048|NCT02970318|Rituximab|rituximab|mesh-list
153433049|NCT02970318|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
153433050|NCT02970318|Acalabrutinib|acalabrutinib|mesh-list
153433051|NCT02970318|Idelalisib|idelalisib|mesh-list
153433052|NCT02970318|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153433053|NCT02970318|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153433054|NCT02970318|Immunologic Factors|immunologic factors|mesh-ancestor
153433055|NCT02970318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153433056|NCT02970318|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153433057|NCT02970318|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153433058|NCT02970318|Alkylating Agents|alkylating agents|mesh-ancestor
153433059|NCT02970318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153433060|NCT02970318|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153433061|NCT02970318|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153891993|NCT04356326|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153891994|NCT04356326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153891995|NCT04356326|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153891996|NCT04356326|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153891997|NCT04356326|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153891998|NCT04356326|Antipyretics|antipyretics|mesh-ancestor
153891999|NCT04300049|Glucagon|glucagon|mesh-list
153892000|NCT04300049|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
153892001|NCT04300049|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153892002|NCT04300049|Hormones|hormones|mesh-ancestor
153892003|NCT04300049|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153892004|NCT04300049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153892009|NCT04278729|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
153892010|NCT04278729|Protease Inhibitors|protease inhibitors|mesh-ancestor
153892011|NCT04278729|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153892012|NCT04278729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153892013|NCT04278729|Anticoagulants|anticoagulants|mesh-ancestor
153892014|NCT04216017|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
153892015|NCT04216017|Lidocaine|lidocaine|mesh-list
153892016|NCT04216017|Anesthetics, Local|anesthetics, local|mesh-ancestor
153892017|NCT04216017|Anesthetics|anesthetics|mesh-ancestor
153892018|NCT04216017|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153892019|NCT04216017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153892020|NCT04216017|Sensory System Agents|sensory system agents|mesh-ancestor
153892021|NCT04216017|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153892022|NCT04216017|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153892023|NCT04216017|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
153892024|NCT04216017|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153892025|NCT04216017|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153892026|NCT04216017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153892027|NCT04216017|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153892028|NCT04216017|Glucocorticoids|glucocorticoids|mesh-ancestor
153892030|NCT04216017|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153892031|NCT04216017|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153892032|NCT04216017|Immunologic Factors|immunologic factors|mesh-ancestor
153892033|NCT04206813|Vaccines|vaccines|mesh-list
153892034|NCT04206813|Immunologic Factors|immunologic factors|mesh-ancestor
153892035|NCT04206813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153892036|NCT04191421|Spartalizumab|spartalizumab|mesh-list
153892037|NCT04191421|Siltuximab|siltuximab|mesh-list
153892038|NCT04191421|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153892039|NCT04191421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153892040|NCT04191421|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153892042|NCT04142125|Rivaroxaban|rivaroxaban|mesh-list
153914650|NCT00612547|Artesunate|artesunate|mesh-list
153433092|NCT02411448|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153433093|NCT02411448|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153433094|NCT02411448|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153433095|NCT02411448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153433096|NCT02411448|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153433097|NCT02411448|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153433098|NCT02411448|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153433099|NCT02411448|Growth Substances|growth substances|mesh-ancestor
153433100|NCT02411448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153433101|NCT02411448|Growth Inhibitors|growth inhibitors|mesh-ancestor
153433111|NCT02339155|Diphenhydramine|diphenhydramine|mesh-list
153433114|NCT02339155|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153433115|NCT02339155|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153433116|NCT02339155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153433117|NCT02339155|Anesthetics, Local|anesthetics, local|mesh-ancestor
153433118|NCT02339155|Anesthetics|anesthetics|mesh-ancestor
153433119|NCT02339155|Sensory System Agents|sensory system agents|mesh-ancestor
153433120|NCT02339155|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153433121|NCT02339155|Antiemetics|antiemetics|mesh-ancestor
153433122|NCT02339155|Autonomic Agents|autonomic agents|mesh-ancestor
153433123|NCT02339155|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153433124|NCT02339155|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
153433125|NCT02339155|Histamine Antagonists|histamine antagonists|mesh-ancestor
153433126|NCT02339155|Histamine Agents|histamine agents|mesh-ancestor
153433127|NCT02339155|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153892043|NCT04142125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153892044|NCT04142125|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153892045|NCT04142125|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
153892046|NCT04142125|Antithrombins|antithrombins|mesh-ancestor
153892047|NCT04142125|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
153892048|NCT04142125|Protease Inhibitors|protease inhibitors|mesh-ancestor
153892049|NCT04142125|Anticoagulants|anticoagulants|mesh-ancestor
153892050|NCT04133194|Mesalamine|mesalamine|mesh-list
153892051|NCT04133194|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153892052|NCT04133194|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153892053|NCT04133194|Analgesics|analgesics|mesh-ancestor
153892054|NCT04133194|Sensory System Agents|sensory system agents|mesh-ancestor
153892055|NCT04133194|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153892056|NCT04133194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153892057|NCT04133194|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153892058|NCT04133194|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153892059|NCT04123379|Nivolumab|nivolumab|mesh-list
153892060|NCT04123379|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153892061|NCT04123379|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153892062|NCT04123379|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153892063|NCT04123379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153892064|NCT04084769|Vaccines|vaccines|mesh-list
153892065|NCT04084769|Immunologic Factors|immunologic factors|mesh-ancestor
153892066|NCT04084769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153892067|NCT04059224|Trametinib|trametinib|mesh-list
153892068|NCT04059224|Dabrafenib|dabrafenib|mesh-list
153892069|NCT04059224|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153892070|NCT04059224|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153892071|NCT04059224|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153892072|NCT04059224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153892073|NCT04002518|Cimetidine|cimetidine|mesh-list
153892074|NCT04002518|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
153892075|NCT04002518|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153892078|NCT04002518|Histamine Agents|histamine agents|mesh-ancestor
153892079|NCT04002518|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153892080|NCT04002518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153892081|NCT04002518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153892082|NCT04002518|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
153892083|NCT04002518|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153892084|NCT04002518|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153892085|NCT03918850|Buprenorphine|buprenorphine|mesh-list
153892086|NCT03918850|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153892088|NCT03918850|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153892089|NCT03918850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153433140|NCT02301286|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153433141|NCT02301286|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153433142|NCT02301286|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153433143|NCT02301286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153433144|NCT02301286|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153433145|NCT02301286|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153433146|NCT02301286|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153433147|NCT02301286|Antipyretics|antipyretics|mesh-ancestor
153433149|NCT02246621|Anastrozole|anastrozole|mesh-list
153433150|NCT02246621|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153433151|NCT02246621|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
153433152|NCT02246621|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153433153|NCT02246621|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153433154|NCT02246621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153433155|NCT02246621|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
153433156|NCT02246621|Hormone Antagonists|hormone antagonists|mesh-ancestor
153433157|NCT02246621|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153433158|NCT02246621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153433159|NCT02246621|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153433160|NCT02216838|Botulinum Toxins|botulinum toxins|mesh-list
153433161|NCT02216838|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
153433162|NCT02216838|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
153433163|NCT02216838|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
153433164|NCT02216838|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153433165|NCT02216838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153433166|NCT02216838|Cholinergic Agents|cholinergic agents|mesh-ancestor
153433167|NCT02216838|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153433168|NCT02216838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153433169|NCT02216838|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
153433172|NCT02081378|Dasatinib|dasatinib|mesh-list
153892090|NCT03918850|Analgesics|analgesics|mesh-ancestor
153892091|NCT03918850|Sensory System Agents|sensory system agents|mesh-ancestor
153892092|NCT03918850|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153892093|NCT03918850|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
153892094|NCT03914170|Cetuximab|cetuximab|mesh-list
153892095|NCT03914170|Folfirinox|folfirinox|mesh-list
153892096|NCT03914170|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153892097|NCT03914170|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153892098|NCT03911739|Buprenorphine|buprenorphine|mesh-list
153892099|NCT03911739|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153892100|NCT03911739|Narcotics|narcotics|mesh-ancestor
153892101|NCT03911739|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153892102|NCT03911739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153892103|NCT03911739|Analgesics|analgesics|mesh-ancestor
153892104|NCT03911739|Sensory System Agents|sensory system agents|mesh-ancestor
153892105|NCT03911739|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153892106|NCT03911739|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
153892107|NCT03890367|Vaccines|vaccines|mesh-list
153892108|NCT03890367|Immunologic Factors|immunologic factors|mesh-ancestor
153892109|NCT03890367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153892110|NCT03877549|Dexamethasone|dexamethasone|mesh-list
153892111|NCT03877549|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153892112|NCT03877549|Antiemetics|antiemetics|mesh-ancestor
153892113|NCT03877549|Autonomic Agents|autonomic agents|mesh-ancestor
153892114|NCT03877549|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153892115|NCT03877549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153892116|NCT03877549|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153892119|NCT03877549|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153892120|NCT03877549|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153892122|NCT03868124|Travoprost|travoprost|mesh-list
153892123|NCT03868124|Ophthalmic Solutions|ophthalmic solutions|mesh-list
153892124|NCT03868124|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
153892125|NCT03868124|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153892126|NCT03720717|Baclofen|baclofen|mesh-list
153433188|NCT01979406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153433189|NCT01770743|Vaccines|vaccines|mesh-list
153433190|NCT01770743|Immunologic Factors|immunologic factors|mesh-ancestor
153433191|NCT01770743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153433192|NCT01759771|Vitamin D|vitamin d|mesh-list
153433193|NCT01759771|Cholecalciferol|cholecalciferol|mesh-list
153433194|NCT01759771|Vitamins|vitamins|mesh-ancestor
153433195|NCT01759771|Micronutrients|micronutrients|mesh-ancestor
153433196|NCT01759771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153433197|NCT01759771|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153433198|NCT01759771|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153433199|NCT01753115|Ciprofloxacin|ciprofloxacin|mesh-list
153433200|NCT01753115|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153433201|NCT01753115|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153433202|NCT01753115|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153433203|NCT01753115|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153433204|NCT01753115|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153433205|NCT01753115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153433206|NCT01753115|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153433207|NCT01753115|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
153433208|NCT01753115|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153433209|NCT01500551|Tofacitinib|tofacitinib|mesh-list
153433210|NCT01500551|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
153433211|NCT01500551|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153892139|NCT03701321|Venetoclax|venetoclax|mesh-list
153892140|NCT03701321|Daratumumab|daratumumab|mesh-list
153892141|NCT03701321|Ichthammol|ichthammol|mesh-list
153892142|NCT03701321|BB 1101|bb 1101|mesh-list
153892143|NCT03701321|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153892144|NCT03701321|Antiemetics|antiemetics|mesh-ancestor
153892145|NCT03701321|Autonomic Agents|autonomic agents|mesh-ancestor
153892146|NCT03701321|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153892147|NCT03701321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153892148|NCT03701321|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153892149|NCT03701321|Glucocorticoids|glucocorticoids|mesh-ancestor
153892150|NCT03701321|Hormones|hormones|mesh-ancestor
153892151|NCT03701321|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153892152|NCT03701321|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153892153|NCT03701321|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153892154|NCT03701321|Protease Inhibitors|protease inhibitors|mesh-ancestor
153892155|NCT03701321|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153892156|NCT03701321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153892157|NCT03701321|Dermatologic Agents|dermatologic agents|mesh-ancestor
153892158|NCT03678129|Clobazam|clobazam|mesh-list
153892159|NCT03678129|Anticonvulsants|anticonvulsants|mesh-ancestor
153892160|NCT03678129|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153892161|NCT03678129|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153892162|NCT03678129|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153433212|NCT01500551|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153433215|NCT01263691|Immunologic Factors|immunologic factors|mesh-ancestor
153433216|NCT01263691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153433217|NCT01216293|Esomeprazole|esomeprazole|mesh-list
153433218|NCT01216293|Dexlansoprazole|dexlansoprazole|mesh-list
153433219|NCT01216293|Lansoprazole|lansoprazole|mesh-list
153433220|NCT01216293|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
153433221|NCT01216293|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153433222|NCT01216293|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
153433223|NCT01216293|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153433224|NCT01216293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153433225|NCT01199783|Vancomycin|vancomycin|mesh-list
153433226|NCT01199783|Daptomycin|daptomycin|mesh-list
153433227|NCT01199783|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153433228|NCT01199783|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153433229|NCT01006798|Vaccines|vaccines|mesh-list
153433230|NCT01006798|Immunologic Factors|immunologic factors|mesh-ancestor
153433231|NCT01006798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153433232|NCT00877656|Zanolimumab|zanolimumab|mesh-list
153433233|NCT00877656|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153433234|NCT00877656|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153433235|NCT00845650|Immunoglobulins|immunoglobulins|mesh-list
153433236|NCT00845650|gamma-Globulins|gamma-globulins|mesh-list
153433238|NCT00845650|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
153433239|NCT00845650|Immunologic Factors|immunologic factors|mesh-ancestor
153892163|NCT03678129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153892164|NCT03678129|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153892165|NCT03678129|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
153892166|NCT03678129|GABA Agonists|gaba agonists|mesh-ancestor
153892167|NCT03678129|GABA Agents|gaba agents|mesh-ancestor
153892168|NCT03678129|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153892169|NCT03678129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153892170|NCT03661684|Prednisone|prednisone|mesh-list
153892171|NCT03661684|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153892173|NCT03661684|Hormones|hormones|mesh-ancestor
153892174|NCT03661684|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153892175|NCT03661684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153892176|NCT03661684|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153892177|NCT03661684|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153892178|NCT03561376|Petrolatum|petrolatum|mesh-list
153892179|NCT03561376|Zinc Oxide|zinc oxide|mesh-list
153892180|NCT03561376|Emollients|emollients|mesh-ancestor
153433240|NCT00845650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153433241|NCT00636519|Antitoxins|antitoxins|mesh-list
153892181|NCT03561376|Dermatologic Agents|dermatologic agents|mesh-ancestor
153892182|NCT03561376|Sunscreening Agents|sunscreening agents|mesh-ancestor
153892183|NCT03561376|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
153892184|NCT03561376|Protective Agents|protective agents|mesh-ancestor
153892185|NCT03561376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153892186|NCT03469271|Calcitriol|calcitriol|mesh-list
153892187|NCT03469271|Dihydroxycholecalciferols|dihydroxycholecalciferols|mesh-list
153892190|NCT03469271|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
153892191|NCT03469271|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153892192|NCT03469271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153892193|NCT03469271|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
153892195|NCT03469271|Micronutrients|micronutrients|mesh-ancestor
153892196|NCT03469271|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153892197|NCT03458260|Rituximab|rituximab|mesh-list
153892198|NCT03458260|Etoposide|etoposide|mesh-list
153892199|NCT03458260|Ifosfamide|ifosfamide|mesh-list
153892200|NCT03458260|Pixantrone|pixantrone|mesh-list
153892201|NCT03458260|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153892202|NCT03458260|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153892203|NCT03458260|Immunologic Factors|immunologic factors|mesh-ancestor
153892204|NCT03458260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153892205|NCT03458260|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153892206|NCT03458260|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153892207|NCT03458260|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153892208|NCT03458260|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153433260|NCT00000811|Trimethoprim|trimethoprim|mesh-list
153433261|NCT00000811|Sulfamethoxazole|sulfamethoxazole|mesh-list
153433262|NCT00000811|Atovaquone|atovaquone|mesh-list
153433263|NCT00000811|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153433264|NCT00000811|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153433265|NCT00000811|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
153433266|NCT00000811|Antimalarials|antimalarials|mesh-ancestor
153433267|NCT00000811|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153433268|NCT00000811|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153433269|NCT00000811|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153433270|NCT00000811|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153433271|NCT00000811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153433272|NCT00000811|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
153433273|NCT00000811|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
153433274|NCT00000811|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153433275|NCT00000373|Olanzapine|olanzapine|mesh-list
153433276|NCT00000373|Fluoxetine|fluoxetine|mesh-list
153433277|NCT00000373|Antiemetics|antiemetics|mesh-ancestor
153433278|NCT00000373|Autonomic Agents|autonomic agents|mesh-ancestor
153433279|NCT00000373|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153433280|NCT00000373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153433281|NCT00000373|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153433282|NCT00000373|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153433283|NCT00000373|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153433284|NCT00000373|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153433285|NCT00000373|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153433286|NCT00000373|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
153433287|NCT00000373|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153433289|NCT00000373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153433290|NCT00000373|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153433291|NCT00000373|Serotonin Agents|serotonin agents|mesh-ancestor
153433292|NCT00000373|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
153433293|NCT00000373|Antidepressive Agents|antidepressive agents|mesh-ancestor
153433294|NCT00000373|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
153433295|NCT00000373|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153892209|NCT03458260|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153892210|NCT03458260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153892211|NCT03458260|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153892212|NCT03458260|Alkylating Agents|alkylating agents|mesh-ancestor
153892213|NCT03425279|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
153892229|NCT03376672|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153892230|NCT03376672|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153892231|NCT03376672|Immunologic Factors|immunologic factors|mesh-ancestor
153892232|NCT03376672|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153892233|NCT03376672|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153892234|NCT03376672|Growth Substances|growth substances|mesh-ancestor
153892235|NCT03376672|Growth Inhibitors|growth inhibitors|mesh-ancestor
153892236|NCT03376672|Protease Inhibitors|protease inhibitors|mesh-ancestor
153892237|NCT03376672|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153892238|NCT03376672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153892240|NCT03302234|Ipilimumab|ipilimumab|mesh-list
153892241|NCT03302234|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153892242|NCT03302234|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153892243|NCT03302234|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153892244|NCT03302234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153433297|NCT00000823|Zidovudine|zidovudine|mesh-list
153433298|NCT00000823|Didanosine|didanosine|mesh-list
153433299|NCT00000823|Antimetabolites|antimetabolites|mesh-ancestor
153433300|NCT00000823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153433301|NCT00000823|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153433302|NCT00000823|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153433303|NCT00000823|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153433304|NCT00000823|Antiviral Agents|antiviral agents|mesh-ancestor
153433305|NCT00000823|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153433312|NCT00000379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153433314|NCT00000379|Serotonin Agents|serotonin agents|mesh-ancestor
153433315|NCT00000379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153433316|NCT00000379|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
153433317|NCT00000379|Antidepressive Agents|antidepressive agents|mesh-ancestor
153433318|NCT00000379|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153433319|NCT00000379|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
153433320|NCT00000379|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153433321|NCT00000379|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153433322|NCT00000385|Lithium Carbonate|lithium carbonate|mesh-list
153433323|NCT00000385|Antidepressive Agents|antidepressive agents|mesh-ancestor
153433324|NCT00000385|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153433325|NCT00000385|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153433326|NCT00000385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153433327|NCT00000385|Antimanic Agents|antimanic agents|mesh-ancestor
153433328|NCT00000385|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153433331|NCT00002894|Paclitaxel|paclitaxel|mesh-list
153892245|NCT03290937|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
153892246|NCT03290937|Cetuximab|cetuximab|mesh-list
153892247|NCT03290937|Irinotecan|irinotecan|mesh-list
153892248|NCT03290937|Camptothecin|camptothecin|mesh-list
153892249|NCT03290937|Antibodies|antibodies|mesh-list
153892250|NCT03290937|Immunoglobulins|immunoglobulins|mesh-list
153892251|NCT03290937|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
153892252|NCT03290937|Immunoglobulin G|immunoglobulin g|mesh-list
153892253|NCT03290937|Immunologic Factors|immunologic factors|mesh-ancestor
153892254|NCT03290937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153892255|NCT03290937|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153892256|NCT03290937|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
153892257|NCT03290937|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153892258|NCT03290937|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153892259|NCT03290937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153892260|NCT03290937|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153892261|NCT03245892|Paclitaxel|paclitaxel|mesh-list
153892262|NCT03245892|Carboplatin|carboplatin|mesh-list
153892264|NCT03245892|Ipilimumab|ipilimumab|mesh-list
153892265|NCT03245892|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153892266|NCT03245892|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153892267|NCT03245892|Tubulin Modulators|tubulin modulators|mesh-ancestor
153892268|NCT03245892|Antimitotic Agents|antimitotic agents|mesh-ancestor
153892269|NCT03245892|Mitosis Modulators|mitosis modulators|mesh-ancestor
153892270|NCT03245892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153892271|NCT03245892|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153892272|NCT03245892|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153892273|NCT03218137|Adenosine|adenosine|mesh-list
153892274|NCT03218137|Verapamil|verapamil|mesh-list
153892275|NCT03218137|Analgesics|analgesics|mesh-ancestor
153892276|NCT03218137|Sensory System Agents|sensory system agents|mesh-ancestor
153892277|NCT03218137|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153892278|NCT03218137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153892279|NCT03218137|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153892280|NCT03218137|Vasodilator Agents|vasodilator agents|mesh-ancestor
153433336|NCT00002894|Antimitotic Agents|antimitotic agents|mesh-ancestor
153433337|NCT00002894|Mitosis Modulators|mitosis modulators|mesh-ancestor
153433338|NCT00002894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153433339|NCT00000829|Vaccines|vaccines|mesh-list
153433340|NCT00000829|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
153433341|NCT00000829|Immunologic Factors|immunologic factors|mesh-ancestor
153433342|NCT00000829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153433343|NCT03282344|Nivolumab|nivolumab|mesh-list
153433344|NCT03282344|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153433345|NCT03282344|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153433346|NCT03282344|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153433347|NCT03282344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153433348|NCT00000403|Doxycycline|doxycycline|mesh-list
153433349|NCT00000403|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153433350|NCT00000403|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153433351|NCT00000403|Antimalarials|antimalarials|mesh-ancestor
153433352|NCT00000403|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153433353|NCT00000403|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153433354|NCT00000841|Lamivudine|lamivudine|mesh-list
153433355|NCT00000841|Zidovudine|zidovudine|mesh-list
153433356|NCT00000841|Stavudine|stavudine|mesh-list
153433357|NCT00000841|Indinavir|indinavir|mesh-list
153433358|NCT00000841|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153433359|NCT00000841|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153433360|NCT00000841|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153433361|NCT00000841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153433362|NCT00000841|Antiviral Agents|antiviral agents|mesh-ancestor
153433363|NCT00000841|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153433364|NCT00000841|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153433365|NCT00000841|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153433366|NCT00000841|Antimetabolites|antimetabolites|mesh-ancestor
153433367|NCT00000841|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
153433368|NCT00000841|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
153433369|NCT00000841|Protease Inhibitors|protease inhibitors|mesh-ancestor
153892285|NCT03218137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153892286|NCT03218137|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153892287|NCT03218137|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153892288|NCT03218137|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153892289|NCT03155100|Dexamethasone|dexamethasone|mesh-list
153433370|NCT00000415|Calcium|calcium|mesh-list
153433373|NCT00000847|polysaccharide-K|polysaccharide-k|mesh-list
153892290|NCT03155100|Elotuzumab|elotuzumab|mesh-list
153892291|NCT03155100|Proteasome Inhibitors|proteasome inhibitors|mesh-list
153892292|NCT03155100|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153892293|NCT03155100|Antiemetics|antiemetics|mesh-ancestor
153892294|NCT03155100|Autonomic Agents|autonomic agents|mesh-ancestor
153892295|NCT03155100|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153892296|NCT03155100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153892297|NCT03155100|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153892298|NCT03155100|Glucocorticoids|glucocorticoids|mesh-ancestor
153892299|NCT03155100|Hormones|hormones|mesh-ancestor
153892300|NCT03155100|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153892309|NCT03126630|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153892310|NCT03126630|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153892311|NCT03126630|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153892312|NCT03126630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153892313|NCT03126630|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153892315|NCT03126630|Antimitotic Agents|antimitotic agents|mesh-ancestor
153892316|NCT03126630|Mitosis Modulators|mitosis modulators|mesh-ancestor
153892317|NCT03126630|Immunoconjugates|immunoconjugates|mesh-ancestor
153892318|NCT03126630|Immunologic Factors|immunologic factors|mesh-ancestor
153892319|NCT03126630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153892320|NCT03060473|Amoxicillin|amoxicillin|mesh-list
153892321|NCT03060473|Azithromycin|azithromycin|mesh-list
153892322|NCT03060473|Erythromycin|erythromycin|mesh-list
153892323|NCT03060473|Erythromycin Estolate|erythromycin estolate|mesh-list
153433377|NCT00000847|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153433378|NCT00000847|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153433379|NCT00000847|Antiviral Agents|antiviral agents|mesh-ancestor
153433380|NCT00000847|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153433381|NCT00000847|Interferon Inducers|interferon inducers|mesh-ancestor
153433382|NCT00000847|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
153433383|NCT00000847|Protective Agents|protective agents|mesh-ancestor
153433384|NCT00000439|Valproic Acid|valproic acid|mesh-list
153433385|NCT00000439|Anticonvulsants|anticonvulsants|mesh-ancestor
153433386|NCT00000439|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153433387|NCT00000439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153433388|NCT00000439|GABA Agents|gaba agents|mesh-ancestor
153433389|NCT00000439|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153433390|NCT00000439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153433391|NCT00000439|Antimanic Agents|antimanic agents|mesh-ancestor
153433399|NCT00002912|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153433400|NCT00002912|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153433401|NCT00002912|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153433402|NCT00002912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153433403|NCT00002912|Analgesics|analgesics|mesh-ancestor
153433404|NCT00002912|Sensory System Agents|sensory system agents|mesh-ancestor
153433405|NCT00002912|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153433406|NCT00002912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153433407|NCT00000445|Naltrexone|naltrexone|mesh-list
153433408|NCT00000445|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
153433409|NCT00000445|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
153892324|NCT03060473|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
153892325|NCT03060473|Erythromycin stearate|erythromycin stearate|mesh-list
153892326|NCT03060473|Ampicillin|ampicillin|mesh-list
153892327|NCT03060473|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153892328|NCT03060473|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153892329|NCT03060473|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153892354|NCT02891954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153433410|NCT00000445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153433411|NCT00000445|Sensory System Agents|sensory system agents|mesh-ancestor
153433412|NCT00000445|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153433413|NCT00000451|Naltrexone|naltrexone|mesh-list
153433414|NCT00000451|Sertraline|sertraline|mesh-list
153433415|NCT00000451|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
153433416|NCT00000451|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
153433417|NCT00000451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153433418|NCT00000451|Sensory System Agents|sensory system agents|mesh-ancestor
153433419|NCT00000451|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153433420|NCT00000451|Antidepressive Agents|antidepressive agents|mesh-ancestor
153433421|NCT00000451|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153433422|NCT00000451|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
153433423|NCT00000451|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153433424|NCT00000451|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153892361|NCT02754596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153892363|NCT02754596|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
153892364|NCT02754596|Adrenergic Agents|adrenergic agents|mesh-ancestor
153892365|NCT02754596|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153892366|NCT02754596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153892367|NCT02754596|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153892368|NCT02754596|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153892369|NCT02744898|Paclitaxel|paclitaxel|mesh-list
153892370|NCT02744898|Carboplatin|carboplatin|mesh-list
153892371|NCT02744898|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
153892372|NCT02744898|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153892373|NCT02744898|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153892374|NCT02744898|Tubulin Modulators|tubulin modulators|mesh-ancestor
153892375|NCT02744898|Antimitotic Agents|antimitotic agents|mesh-ancestor
153892376|NCT02744898|Mitosis Modulators|mitosis modulators|mesh-ancestor
153892377|NCT02744898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153892378|NCT02652195|Oxytocin|oxytocin|mesh-list
153892381|NCT02652195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153892383|NCT02350764|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153892384|NCT02350764|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153892385|NCT02350764|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153892386|NCT02350764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153892387|NCT02095132|Irinotecan|irinotecan|mesh-list
153892388|NCT02095132|Camptothecin|camptothecin|mesh-list
153892389|NCT02095132|Adavosertib|adavosertib|mesh-list
153892390|NCT02095132|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
153892391|NCT02095132|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153892392|NCT02095132|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153892393|NCT02095132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153892394|NCT02095132|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153892395|NCT02095132|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153892396|NCT01919086|Dexamethasone|dexamethasone|mesh-list
153892397|NCT01919086|Lenalidomide|lenalidomide|mesh-list
153892398|NCT01919086|Bortezomib|bortezomib|mesh-list
153892399|NCT01919086|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153892400|NCT01919086|Antiemetics|antiemetics|mesh-ancestor
153433492|NCT00000541|Vitamins|vitamins|mesh-list
153433493|NCT00000541|Folic Acid|folic acid|mesh-list
153433494|NCT00000541|Vitamin E|vitamin e|mesh-list
153892433|NCT01534494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153892434|NCT01534494|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153892435|NCT01273441|Amoxicillin|amoxicillin|mesh-list
153892436|NCT01273441|Metronidazole|metronidazole|mesh-list
153892437|NCT01273441|Clarithromycin|clarithromycin|mesh-list
153892438|NCT01273441|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153433495|NCT00000541|Vitamin B 12|vitamin b 12|mesh-list
153433496|NCT00000541|Vitamin B 6|vitamin b 6|mesh-list
153433497|NCT00000541|Pyridoxal|pyridoxal|mesh-list
153433498|NCT00000541|Pyridoxine|pyridoxine|mesh-list
153433499|NCT00000541|Beta Carotene|beta carotene|mesh-list
153433500|NCT00000541|Vitamin B Complex|vitamin b complex|mesh-list
153433501|NCT00000541|Carotenoids|carotenoids|mesh-list
153433502|NCT00000541|Micronutrients|micronutrients|mesh-ancestor
153433503|NCT00000541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153433504|NCT00000541|Antioxidants|antioxidants|mesh-ancestor
153433505|NCT00000541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153433506|NCT00000541|Protective Agents|protective agents|mesh-ancestor
153433507|NCT00000541|Hematinics|hematinics|mesh-ancestor
153433508|NCT00000541|Provitamins|provitamins|mesh-ancestor
153433509|NCT00000913|Ritonavir|ritonavir|mesh-list
153433516|NCT00000913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153433517|NCT00000913|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153433518|NCT00000913|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153433519|NCT00000913|Antiviral Agents|antiviral agents|mesh-ancestor
153433520|NCT00000913|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153433521|NCT00000913|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
153433522|NCT00000913|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153433523|NCT00000547|Enalapril|enalapril|mesh-list
153433524|NCT00000547|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
153433525|NCT00000547|Protease Inhibitors|protease inhibitors|mesh-ancestor
153433526|NCT00000547|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153433527|NCT00000547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153433528|NCT00000547|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153433529|NCT00002930|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
153433530|NCT00002930|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
153433531|NCT00002930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153433532|NCT00000577|Colchicine|colchicine|mesh-list
153892439|NCT01273441|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153892440|NCT01273441|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153892441|NCT01273441|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153892442|NCT01273441|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
153892443|NCT01273441|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153892444|NCT01273441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153892445|NCT01273441|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
153892446|NCT01273441|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153892447|NCT00856037|Doxorubicin|doxorubicin|mesh-list
153892448|NCT00856037|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
153892450|NCT00856037|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153892451|NCT00856037|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153892472|NCT00602797|Mitosis Modulators|mitosis modulators|mesh-ancestor
153433533|NCT00000577|Albuterol|albuterol|mesh-list
153433534|NCT00000577|Hormones|hormones|mesh-list
153433536|NCT00000577|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-list
153433538|NCT00000577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153433539|NCT00000577|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153433540|NCT00000577|Autonomic Agents|autonomic agents|mesh-ancestor
153433541|NCT00000577|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153433542|NCT00000577|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153433543|NCT00000577|Respiratory System Agents|respiratory system agents|mesh-ancestor
153433544|NCT00000577|Tocolytic Agents|tocolytic agents|mesh-ancestor
153433545|NCT00000577|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153433546|NCT00000577|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
153433547|NCT00000577|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153433548|NCT00000577|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153433549|NCT00000577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153433550|NCT00000577|Gout Suppressants|gout suppressants|mesh-ancestor
153433551|NCT00000577|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153433552|NCT00000577|Tubulin Modulators|tubulin modulators|mesh-ancestor
153433553|NCT00000577|Antimitotic Agents|antimitotic agents|mesh-ancestor
153433555|NCT00000577|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153433556|NCT03321799|Anti-Infective Agents|anti-infective agents|mesh-list
153433557|NCT03321799|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
153433559|NCT03015896|Lenalidomide|lenalidomide|mesh-list
153433560|NCT03015896|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153433561|NCT03015896|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153433562|NCT03015896|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153433563|NCT03015896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153433564|NCT03015896|Immunologic Factors|immunologic factors|mesh-ancestor
153433565|NCT03015896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153433566|NCT03015896|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153433567|NCT03015896|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153892473|NCT00602797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153892474|NCT00550615|Dasatinib|dasatinib|mesh-list
153892475|NCT00550615|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153892476|NCT00550615|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153892477|NCT00550615|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153892478|NCT00550615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153892479|NCT00550615|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153433576|NCT02994836|Dermatologic Agents|dermatologic agents|mesh-ancestor
153433577|NCT02994836|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153433602|NCT00000949|Antiviral Agents|antiviral agents|mesh-ancestor
153433603|NCT00000949|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153433604|NCT00002936|Etoposide|etoposide|mesh-list
153433605|NCT00002936|Altretamine|altretamine|mesh-list
153433606|NCT00002936|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153433607|NCT00002936|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153433608|NCT00002936|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153433610|NCT00002936|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153433611|NCT00002936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153433612|NCT00002936|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153433613|NCT00002936|Alkylating Agents|alkylating agents|mesh-ancestor
153433614|NCT00000649|Zidovudine|zidovudine|mesh-list
153433615|NCT00000649|Nevirapine|nevirapine|mesh-list
153433616|NCT00000649|Antimetabolites|antimetabolites|mesh-ancestor
153433617|NCT00000649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153433618|NCT00000649|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153433619|NCT00000649|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153433620|NCT00000649|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153892531|NCT01030666|Dermatologic Agents|dermatologic agents|mesh-ancestor
153892532|NCT01030666|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153892533|NCT01030666|Antimalarials|antimalarials|mesh-ancestor
153892534|NCT01030666|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153892535|NCT01030666|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153892536|NCT01023256|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
153892537|NCT01023256|Immunologic Factors|immunologic factors|mesh-ancestor
153892538|NCT01023256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153892539|NCT01058668|Cariprazine|cariprazine|mesh-list
153892540|NCT01058668|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153892541|NCT01058668|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153892542|NCT01058668|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153892543|NCT01058668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153892544|NCT01058668|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153892545|NCT00623558|Docetaxel|docetaxel|mesh-list
153892546|NCT00623558|Cetuximab|cetuximab|mesh-list
153892547|NCT00623558|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153892548|NCT00623558|Tubulin Modulators|tubulin modulators|mesh-ancestor
153892549|NCT00623558|Antimitotic Agents|antimitotic agents|mesh-ancestor
153892550|NCT00623558|Mitosis Modulators|mitosis modulators|mesh-ancestor
153892551|NCT00623558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153892552|NCT00623558|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153892553|NCT01301066|Pravastatin|pravastatin|mesh-list
153892554|NCT01301066|Pitavastatin|pitavastatin|mesh-list
153892555|NCT01301066|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153892556|NCT01301066|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153892557|NCT01301066|Antimetabolites|antimetabolites|mesh-ancestor
153892559|NCT01301066|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153892560|NCT01301066|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
153892561|NCT01301066|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153892562|NCT01022398|Vitamin D|vitamin d|mesh-list
153892563|NCT01022398|Cholecalciferol|cholecalciferol|mesh-list
153892564|NCT01022398|Vitamins|vitamins|mesh-ancestor
153892565|NCT01022398|Micronutrients|micronutrients|mesh-ancestor
153892566|NCT01022398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153892567|NCT01022398|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153892568|NCT01022398|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153892569|NCT05642624|Amphotericin B|amphotericin b|mesh-list
153892570|NCT05642624|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
153892571|NCT05642624|Deoxycholic Acid|deoxycholic acid|mesh-list
153892572|NCT05642624|Amebicides|amebicides|mesh-ancestor
153892573|NCT05642624|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153892574|NCT05642624|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153892575|NCT05642624|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153433637|NCT00000961|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153433638|NCT00000961|Immunologic Factors|immunologic factors|mesh-ancestor
153433639|NCT00000961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153433640|NCT04048304|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
153433641|NCT04048304|Vancomycin|vancomycin|mesh-list
153433642|NCT04048304|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153433643|NCT00000655|Trimethoprim|trimethoprim|mesh-list
153433644|NCT00000655|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
153433645|NCT00000655|Atovaquone|atovaquone|mesh-list
153433646|NCT00000655|Sulfamethoxazole|sulfamethoxazole|mesh-list
153433647|NCT00000655|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
153433648|NCT00000655|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153433649|NCT00000655|Antimalarials|antimalarials|mesh-ancestor
153433650|NCT00000655|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153433651|NCT00000655|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153433652|NCT00000655|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153433653|NCT00000655|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153433654|NCT00000655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153433655|NCT00000655|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
153433656|NCT00000655|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
153433657|NCT00000655|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153433658|NCT00000655|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153433659|NCT00002948|Topotecan|topotecan|mesh-list
153433660|NCT00002948|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
153433661|NCT00002948|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153433662|NCT00002948|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153433663|NCT00002948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153433664|NCT00002948|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153892582|NCT04324346|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153892583|NCT04324346|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153892584|NCT04324346|Tubulin Modulators|tubulin modulators|mesh-ancestor
153892585|NCT04324346|Antimitotic Agents|antimitotic agents|mesh-ancestor
153892586|NCT04324346|Mitosis Modulators|mitosis modulators|mesh-ancestor
153892587|NCT04324346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153892593|NCT02890238|Sildenafil Citrate|sildenafil citrate|mesh-list
153892594|NCT02890238|Citric Acid|citric acid|mesh-list
153892595|NCT02890238|Sodium Citrate|sodium citrate|mesh-list
153892596|NCT02890238|Clomiphene|clomiphene|mesh-list
153892597|NCT02890238|Enclomiphene|enclomiphene|mesh-list
153892598|NCT02890238|Zuclomiphene|zuclomiphene|mesh-list
153892599|NCT02890238|Anticoagulants|anticoagulants|mesh-ancestor
153892600|NCT02890238|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
153892601|NCT02890238|Chelating Agents|chelating agents|mesh-ancestor
153892602|NCT02890238|Sequestering Agents|sequestering agents|mesh-ancestor
153892603|NCT02890238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153892604|NCT02890238|Vasodilator Agents|vasodilator agents|mesh-ancestor
153892605|NCT02890238|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
153892606|NCT02890238|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
153892607|NCT02890238|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153892608|NCT02890238|Urological Agents|urological agents|mesh-ancestor
153892609|NCT02890238|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
153892610|NCT02890238|Hormone Antagonists|hormone antagonists|mesh-ancestor
153892611|NCT02890238|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153892612|NCT02890238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153892613|NCT02890238|Fertility Agents, Female|fertility agents, female|mesh-ancestor
153892614|NCT02890238|Fertility Agents|fertility agents|mesh-ancestor
153892616|NCT02890238|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
153892617|NCT02890238|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
153892619|NCT00627796|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153892620|NCT01299896|Bupropion|bupropion|mesh-list
153433680|NCT00000967|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153433681|NCT00000967|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153433682|NCT00000967|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153433683|NCT00000967|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153433684|NCT00000661|Zidovudine|zidovudine|mesh-list
153433685|NCT00000661|Oxazepam|oxazepam|mesh-list
153433686|NCT00000661|Antimetabolites|antimetabolites|mesh-ancestor
153433687|NCT00000661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153433688|NCT00000661|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153433689|NCT00000661|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153433690|NCT00000661|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153433691|NCT00000661|Antiviral Agents|antiviral agents|mesh-ancestor
153433692|NCT00000661|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153433693|NCT00000661|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153433694|NCT00000661|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153433695|NCT00000661|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153433696|NCT00000661|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153433697|NCT00000661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153433698|NCT00000661|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153433699|NCT00000661|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153892622|NCT01299896|Varenicline|varenicline|mesh-list
153892623|NCT01299896|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
153892624|NCT01299896|Autonomic Agents|autonomic agents|mesh-ancestor
153892625|NCT01299896|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153892626|NCT01299896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153892627|NCT01299896|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
153892628|NCT01299896|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
153892629|NCT01299896|Cholinergic Agents|cholinergic agents|mesh-ancestor
153892630|NCT01299896|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153892631|NCT01299896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153892632|NCT01299896|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
153892633|NCT01299896|Antidepressive Agents|antidepressive agents|mesh-ancestor
153892634|NCT01299896|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153892635|NCT01299896|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
153892636|NCT01299896|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153892637|NCT01299896|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153892638|NCT01299896|Dopamine Agents|dopamine agents|mesh-ancestor
153892639|NCT01299896|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
153892640|NCT01299896|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153892641|NCT01299896|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153892642|NCT01299584|Remifentanil|remifentanil|mesh-list
153892643|NCT01299584|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153892644|NCT01299584|Narcotics|narcotics|mesh-ancestor
153892645|NCT01299584|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153892646|NCT01299584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153892647|NCT01299584|Analgesics|analgesics|mesh-ancestor
153892648|NCT01299584|Sensory System Agents|sensory system agents|mesh-ancestor
153892649|NCT01299584|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153892650|NCT01236573|Cyclophosphamide|cyclophosphamide|mesh-list
153892651|NCT01236573|Fludarabine|fludarabine|mesh-list
153892652|NCT01236573|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153892653|NCT01236573|Immunologic Factors|immunologic factors|mesh-ancestor
153892654|NCT01236573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153892655|NCT01236573|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153433700|NCT00000661|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153892656|NCT01236573|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153892657|NCT01236573|Alkylating Agents|alkylating agents|mesh-ancestor
153892658|NCT01236573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153892660|NCT01236573|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153892661|NCT04323228|Antioxidants|antioxidants|mesh-list
153892662|NCT04323228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153892663|NCT04323228|Protective Agents|protective agents|mesh-ancestor
153892664|NCT04323228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153892665|NCT04322760|Lidocaine|lidocaine|mesh-list
153892668|NCT04322760|Anesthetics, Local|anesthetics, local|mesh-ancestor
153892669|NCT04322760|Anesthetics|anesthetics|mesh-ancestor
153892670|NCT04322760|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153892671|NCT04322760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153433748|NCT00000673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153433750|NCT00000685|Antimetabolites|antimetabolites|mesh-ancestor
153433751|NCT00000685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153433752|NCT00000685|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153433753|NCT00000685|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153433754|NCT00000685|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153433755|NCT00000685|Antiviral Agents|antiviral agents|mesh-ancestor
153433756|NCT00000685|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153433757|NCT00000685|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153433758|NCT00000685|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153433759|NCT00002972|Paclitaxel|paclitaxel|mesh-list
153433760|NCT00002972|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153433761|NCT00002972|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153433762|NCT00002972|Tubulin Modulators|tubulin modulators|mesh-ancestor
153433763|NCT00002972|Antimitotic Agents|antimitotic agents|mesh-ancestor
153433764|NCT00002972|Mitosis Modulators|mitosis modulators|mesh-ancestor
153892674|NCT04322760|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153892675|NCT04322760|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
153892676|NCT04322760|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153892677|NCT04322760|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153892678|NCT04322760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153892679|NCT04322760|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153892680|NCT04322760|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153892681|NCT04322760|Analgesics|analgesics|mesh-ancestor
153892682|NCT04322760|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
153892683|NCT04322760|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153892684|NCT04322760|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153892685|NCT04322760|Adrenergic Agents|adrenergic agents|mesh-ancestor
153892686|NCT04322760|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153892687|NCT04322214|Cobicistat|cobicistat|mesh-list
153892688|NCT04322214|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153892689|NCT04322214|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153892690|NCT04322214|Antiviral Agents|antiviral agents|mesh-ancestor
153892691|NCT04322214|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153892692|NCT04322214|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
153892693|NCT04322214|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153892694|NCT04322214|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153892695|NCT04322214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153892696|NCT01057810|Ipilimumab|ipilimumab|mesh-list
153892697|NCT01057810|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153892698|NCT01057810|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153892699|NCT01057810|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153892700|NCT01057810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153892701|NCT01262352|Ivacaftor|ivacaftor|mesh-list
153433765|NCT00002972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153433766|NCT00000691|Foscarnet|foscarnet|mesh-list
153433767|NCT00000691|Phosphonoacetic Acid|phosphonoacetic acid|mesh-list
153433768|NCT00000691|Antiviral Agents|antiviral agents|mesh-ancestor
153433769|NCT00000691|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153433770|NCT00000691|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153433776|NCT00002984|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153433777|NCT00002984|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153433778|NCT00002984|Tubulin Modulators|tubulin modulators|mesh-ancestor
153433779|NCT00002984|Antimitotic Agents|antimitotic agents|mesh-ancestor
153433780|NCT00002984|Mitosis Modulators|mitosis modulators|mesh-ancestor
153433781|NCT00002984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153433782|NCT00002984|Antimetabolites|antimetabolites|mesh-ancestor
153433783|NCT00002984|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153433784|NCT00002984|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153433785|NCT00002984|Immunologic Factors|immunologic factors|mesh-ancestor
153433786|NCT00002984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153433787|NCT00002990|BCG Vaccine|bcg vaccine|mesh-list
153433788|NCT00002990|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153433789|NCT00002990|Immunologic Factors|immunologic factors|mesh-ancestor
153433790|NCT00002990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153892702|NCT01262352|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
153892703|NCT01262352|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153892704|NCT01262352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153892705|NCT01299272|Serotonin|serotonin|mesh-list
153892706|NCT01299272|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-list
153892707|NCT01299272|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
153892708|NCT01299272|Serotonin Agents|serotonin agents|mesh-ancestor
153892709|NCT01299272|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153892710|NCT01299272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153892711|NCT01299272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153892712|NCT01299272|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153892713|NCT01299272|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153892714|NCT01299116|Contraceptive Agents|contraceptive agents|mesh-list
153892716|NCT01299116|Contraceptives, Oral|contraceptives, oral|mesh-list
153892717|NCT01299116|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153892718|NCT01299116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153892719|NCT01299116|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
153892720|NCT01299116|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
153892721|NCT04207398|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
153892722|NCT04207398|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
153433791|NCT00000997|Zalcitabine|zalcitabine|mesh-list
153892723|NCT04207398|Adrenergic Agents|adrenergic agents|mesh-ancestor
153892724|NCT04207398|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153892725|NCT04207398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153892726|NCT04207398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153892727|NCT01299038|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
153892728|NCT01299038|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153892729|NCT01299038|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153892730|NCT01299038|Antimetabolites|antimetabolites|mesh-ancestor
153892731|NCT01299038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153892732|NCT01299038|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153892733|NCT01299038|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
153892734|NCT01299038|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153892735|NCT04321278|Azithromycin|azithromycin|mesh-list
153892736|NCT04321278|Hydroxychloroquine|hydroxychloroquine|mesh-list
153892737|NCT04321278|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153892738|NCT04321278|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153892739|NCT04321278|Antimalarials|antimalarials|mesh-ancestor
153892740|NCT04321278|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153892741|NCT04321278|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153892742|NCT04321278|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153892743|NCT04321278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153892744|NCT04321278|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153892745|NCT01261338|Sucrose polyester|sucrose polyester|mesh-list
153892746|NCT01261338|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153433813|NCT00000703|Leucovorin|leucovorin|mesh-list
153433814|NCT00000703|Cytarabine|cytarabine|mesh-list
153433815|NCT00000703|Zidovudine|zidovudine|mesh-list
153433816|NCT00000703|Dexamethasone|dexamethasone|mesh-list
153433817|NCT00000703|Cyclophosphamide|cyclophosphamide|mesh-list
153433818|NCT00000703|Doxorubicin|doxorubicin|mesh-list
153433819|NCT00000703|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
153433820|NCT00000703|Methotrexate|methotrexate|mesh-list
153433821|NCT00000703|Vincristine|vincristine|mesh-list
153433822|NCT00000703|Bleomycin|bleomycin|mesh-list
153433823|NCT00000703|Allopurinol|allopurinol|mesh-list
153433824|NCT00000703|Levoleucovorin|levoleucovorin|mesh-list
153433825|NCT00000703|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153433826|NCT00000703|Immunologic Factors|immunologic factors|mesh-ancestor
153433827|NCT00000703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153433828|NCT00000703|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153433829|NCT00000703|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153433830|NCT00000703|Alkylating Agents|alkylating agents|mesh-ancestor
153433831|NCT00000703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153433832|NCT00000703|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153433833|NCT00000703|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153433834|NCT00000703|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153433835|NCT00000703|Antiemetics|antiemetics|mesh-ancestor
153433836|NCT00000703|Autonomic Agents|autonomic agents|mesh-ancestor
153433837|NCT00000703|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153433838|NCT00000703|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153433839|NCT00000703|Glucocorticoids|glucocorticoids|mesh-ancestor
153433840|NCT00000703|Hormones|hormones|mesh-ancestor
153433841|NCT00000703|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153433842|NCT00000703|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153433843|NCT00000703|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153433845|NCT00000703|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153433846|NCT00000703|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153433847|NCT00000703|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
153433848|NCT00000703|Abortifacient Agents|abortifacient agents|mesh-ancestor
153433849|NCT00000703|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153892747|NCT01261338|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153433850|NCT00000703|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153433852|NCT00000703|Dermatologic Agents|dermatologic agents|mesh-ancestor
153892748|NCT01261338|Antimetabolites|antimetabolites|mesh-ancestor
153892749|NCT01261338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153892750|NCT01261338|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153892752|NCT01260948|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
153892755|NCT01260948|Cholinergic Agents|cholinergic agents|mesh-ancestor
153892756|NCT01260948|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153892757|NCT01260948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153892758|NCT01260948|Nootropic Agents|nootropic agents|mesh-ancestor
153892759|NCT01025284|Lenograstim|lenograstim|mesh-list
153892760|NCT01025284|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153892761|NCT01025284|Immunologic Factors|immunologic factors|mesh-ancestor
153892762|NCT01025284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153892763|NCT02873026|Triamcinolone|triamcinolone|mesh-list
153892764|NCT02873026|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
153892765|NCT02873026|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
153892766|NCT02873026|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
153892767|NCT02873026|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153892768|NCT02873026|Glucocorticoids|glucocorticoids|mesh-ancestor
153892769|NCT02873026|Hormones|hormones|mesh-ancestor
153892770|NCT02873026|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153892771|NCT02873026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153892772|NCT02873026|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153892773|NCT02873026|Immunologic Factors|immunologic factors|mesh-ancestor
153892774|NCT02873026|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153892775|NCT02873026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153892776|NCT01056718|Nebivolol|nebivolol|mesh-list
153892777|NCT01056718|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153892778|NCT01056718|Vasodilator Agents|vasodilator agents|mesh-ancestor
153892779|NCT01056718|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
153892780|NCT01056718|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
153892781|NCT01056718|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153892782|NCT01056718|Adrenergic Agents|adrenergic agents|mesh-ancestor
153433854|NCT00000703|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153433855|NCT00000703|Antiviral Agents|antiviral agents|mesh-ancestor
153433856|NCT00000703|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153433857|NCT00000703|Antidotes|antidotes|mesh-ancestor
153433858|NCT00000703|Protective Agents|protective agents|mesh-ancestor
153433859|NCT00000703|Vitamin B Complex|vitamin b complex|mesh-ancestor
153433861|NCT00000703|Micronutrients|micronutrients|mesh-ancestor
153433862|NCT00000703|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153433863|NCT00000703|Tubulin Modulators|tubulin modulators|mesh-ancestor
153433864|NCT00000703|Antimitotic Agents|antimitotic agents|mesh-ancestor
153433865|NCT00000703|Mitosis Modulators|mitosis modulators|mesh-ancestor
153433866|NCT00000703|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153433867|NCT00000703|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153433868|NCT00000703|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153433869|NCT00000703|Gout Suppressants|gout suppressants|mesh-ancestor
153433870|NCT00000703|Free Radical Scavengers|free radical scavengers|mesh-ancestor
153433871|NCT00000703|Antioxidants|antioxidants|mesh-ancestor
153433872|NCT00001015|Ribavirin|ribavirin|mesh-list
153433873|NCT00001015|Antimetabolites|antimetabolites|mesh-ancestor
153433874|NCT00001015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153433875|NCT00001015|Antiviral Agents|antiviral agents|mesh-ancestor
153433876|NCT00001015|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153433877|NCT00000709|Zidovudine|zidovudine|mesh-list
153433878|NCT00000709|Antimetabolites|antimetabolites|mesh-ancestor
153433879|NCT00000709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153433880|NCT00000709|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153433881|NCT00000709|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153433882|NCT00000709|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153433883|NCT00000709|Antiviral Agents|antiviral agents|mesh-ancestor
153892783|NCT01056718|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153892784|NCT01056718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153892785|NCT01056718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153892787|NCT01298570|Fluorouracil|fluorouracil|mesh-list
153892789|NCT01298570|Levoleucovorin|levoleucovorin|mesh-list
153892791|NCT01298570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153892793|NCT01298570|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153892794|NCT01298570|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153892795|NCT01298570|Immunologic Factors|immunologic factors|mesh-ancestor
153892796|NCT01298570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153892797|NCT01298570|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
153892798|NCT01298570|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153892799|NCT01298570|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153433884|NCT00000709|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153892800|NCT01298570|Antidotes|antidotes|mesh-ancestor
153892801|NCT01298570|Protective Agents|protective agents|mesh-ancestor
153892802|NCT01298570|Vitamin B Complex|vitamin b complex|mesh-ancestor
153892803|NCT01298570|Vitamins|vitamins|mesh-ancestor
153892804|NCT01298570|Micronutrients|micronutrients|mesh-ancestor
153892805|NCT01259856|Aspirin|aspirin|mesh-list
153892806|NCT01259856|Interferons|interferons|mesh-list
153892807|NCT01259856|Interferon-alpha|interferon-alpha|mesh-list
153892808|NCT01259856|Interferon alpha-2|interferon alpha-2|mesh-list
153892809|NCT01259856|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
153892810|NCT01259856|Hydroxyurea|hydroxyurea|mesh-list
153892811|NCT01259856|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153892812|NCT01259856|Antiviral Agents|antiviral agents|mesh-ancestor
153892813|NCT01259856|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153892814|NCT01259856|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153892815|NCT01259856|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153892816|NCT01259856|Analgesics|analgesics|mesh-ancestor
153892817|NCT01259856|Sensory System Agents|sensory system agents|mesh-ancestor
153892818|NCT01259856|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153892819|NCT01259856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153892820|NCT01259856|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153892821|NCT01259856|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153892822|NCT01259856|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153892823|NCT01259856|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153892824|NCT01259856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153892825|NCT01259856|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153892826|NCT01259856|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153892827|NCT01259856|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153433901|NCT00000727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153433902|NCT00000727|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153433903|NCT00000727|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153433904|NCT00000727|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153433905|NCT00000727|Antiviral Agents|antiviral agents|mesh-ancestor
153433906|NCT00000727|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153433907|NCT00000727|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153433908|NCT00000727|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153433909|NCT00000727|Antimalarials|antimalarials|mesh-ancestor
153433910|NCT00000727|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153433911|NCT00000727|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153433912|NCT00000727|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153433914|NCT00000727|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
153433915|NCT00000727|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
153433916|NCT00000727|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153433917|NCT00000727|Antifungal Agents|antifungal agents|mesh-ancestor
153433918|NCT00000727|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
153433919|NCT00000727|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153433920|NCT00001039|Clarithromycin|clarithromycin|mesh-list
153433921|NCT00001039|Ethambutol|ethambutol|mesh-list
153433922|NCT00001039|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153433923|NCT00001039|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153433924|NCT00001039|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
153433925|NCT00001039|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153433926|NCT00001039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153433927|NCT00001039|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
153433928|NCT00001039|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153433929|NCT00001039|Antitubercular Agents|antitubercular agents|mesh-ancestor
153433930|NCT00001057|Zidovudine|zidovudine|mesh-list
153433931|NCT00001057|Didanosine|didanosine|mesh-list
153892828|NCT01259856|Antipyretics|antipyretics|mesh-ancestor
153892829|NCT01259856|Immunologic Factors|immunologic factors|mesh-ancestor
153892830|NCT01259856|Antisickling Agents|antisickling agents|mesh-ancestor
153892831|NCT01259856|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153892832|NCT00624000|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
153892833|NCT00624000|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153892834|NCT00624000|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153892835|NCT00624000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153892836|NCT01259466|Nicotine|nicotine|mesh-list
153892837|NCT01259466|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
153892838|NCT01259466|Autonomic Agents|autonomic agents|mesh-ancestor
153433932|NCT00001057|Antimetabolites|antimetabolites|mesh-ancestor
153892839|NCT01259466|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153892840|NCT01259466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153892841|NCT01259466|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
153892842|NCT01259466|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
153892843|NCT01259466|Cholinergic Agents|cholinergic agents|mesh-ancestor
153892844|NCT01259466|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153892845|NCT01259466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153892846|NCT01259388|Lithium Carbonate|lithium carbonate|mesh-list
153892847|NCT01259388|Antidepressive Agents|antidepressive agents|mesh-ancestor
153892848|NCT01259388|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153892849|NCT01259388|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153892850|NCT01259388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153892851|NCT01259388|Antimanic Agents|antimanic agents|mesh-ancestor
153892852|NCT01259388|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153892853|NCT01259388|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153892854|NCT01259388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153892855|NCT05525910|Ritonavir|ritonavir|mesh-list
153892856|NCT05525910|Nirmatrelvir|nirmatrelvir|mesh-list
153892857|NCT05525910|Nirmatrelvir and ritonavir drug combination|nirmatrelvir and ritonavir drug combination|mesh-list
153892858|NCT05525910|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
153892859|NCT05525910|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
153892860|NCT05525910|Protease Inhibitors|protease inhibitors|mesh-ancestor
153892862|NCT05525910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153892863|NCT05525910|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153892864|NCT05525910|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153892865|NCT05525910|Antiviral Agents|antiviral agents|mesh-ancestor
153892866|NCT05525910|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153892867|NCT05525910|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
153892868|NCT05525910|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153433944|NCT00002293|Antifungal Agents|antifungal agents|mesh-ancestor
153433945|NCT00002293|Ionophores|ionophores|mesh-ancestor
153433946|NCT00002293|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153433947|NCT00002293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153433948|NCT00002299|Interferons|interferons|mesh-list
153433949|NCT00002299|Interferon-beta|interferon-beta|mesh-list
153433950|NCT00002299|Ganciclovir|ganciclovir|mesh-list
153433951|NCT00002299|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
153433952|NCT00002299|Interferon beta-1b|interferon beta-1b|mesh-list
153433953|NCT00002299|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153433954|NCT00002299|Antiviral Agents|antiviral agents|mesh-ancestor
153433955|NCT00002299|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153433956|NCT00002299|Immunologic Factors|immunologic factors|mesh-ancestor
153433957|NCT00002299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153433958|NCT00002299|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153433959|NCT00002299|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153433960|NCT00002299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153433961|NCT00002299|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153433962|NCT00001063|Zidovudine|zidovudine|mesh-list
153433963|NCT00001063|Didanosine|didanosine|mesh-list
153433964|NCT00001063|Stavudine|stavudine|mesh-list
153433965|NCT00001063|Antimetabolites|antimetabolites|mesh-ancestor
153433966|NCT00001063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153433967|NCT00001063|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153433968|NCT00001063|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153433969|NCT00001063|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153433970|NCT00001063|Antiviral Agents|antiviral agents|mesh-ancestor
153433971|NCT00001063|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153433972|NCT00001063|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153433973|NCT00001063|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153433974|NCT00002305|Fluconazole|fluconazole|mesh-list
153892869|NCT00624078|Antivenins|antivenins|mesh-list
153892870|NCT00624078|Immunologic Factors|immunologic factors|mesh-ancestor
153892871|NCT00624078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153892872|NCT01297244|Tivozanib|tivozanib|mesh-list
153892873|NCT01297244|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153892874|NCT01297244|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153892875|NCT01297244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153892876|NCT04554732|Mitogens|mitogens|mesh-list
153892877|NCT04554732|Mitosis Modulators|mitosis modulators|mesh-ancestor
153892878|NCT04554732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153892879|NCT04481256|Paclitaxel|paclitaxel|mesh-list
153892880|NCT04481256|Carboplatin|carboplatin|mesh-list
153433975|NCT00002305|Amphotericin B|amphotericin b|mesh-list
153892881|NCT04481256|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153892882|NCT04481256|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153892883|NCT04481256|Tubulin Modulators|tubulin modulators|mesh-ancestor
153892884|NCT04481256|Antimitotic Agents|antimitotic agents|mesh-ancestor
153892885|NCT04481256|Mitosis Modulators|mitosis modulators|mesh-ancestor
153892886|NCT04481256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153892887|NCT04387110|Ocrelizumab|ocrelizumab|mesh-list
153892888|NCT04387110|Immunologic Factors|immunologic factors|mesh-ancestor
153892889|NCT04387110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153892890|NCT03377478|Sofosbuvir|sofosbuvir|mesh-list
153892891|NCT03377478|Sofosbuvir-velpatasvir drug combination|sofosbuvir-velpatasvir drug combination|mesh-list
153892892|NCT03377478|Velpatasvir|velpatasvir|mesh-list
153892893|NCT03377478|Antiviral Agents|antiviral agents|mesh-ancestor
153892900|NCT02888730|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153892901|NCT01598298|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
153892902|NCT01598298|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
153892903|NCT01598298|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153892904|NCT01598298|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153892905|NCT01598298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153892906|NCT01598298|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153892907|NCT01598298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153892908|NCT01598298|Analgesics|analgesics|mesh-ancestor
153892909|NCT01598298|Sensory System Agents|sensory system agents|mesh-ancestor
153892910|NCT01598298|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153892911|NCT01598298|Antidepressive Agents|antidepressive agents|mesh-ancestor
153433988|NCT00002305|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
153433989|NCT00002305|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
153433990|NCT00002305|Amebicides|amebicides|mesh-ancestor
153433991|NCT00002305|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153433992|NCT00002305|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153433993|NCT00002305|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153433994|NCT00002305|Antimetabolites|antimetabolites|mesh-ancestor
153433995|NCT00001081|Nitazoxanide|nitazoxanide|mesh-list
153433996|NCT00001081|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153433997|NCT00001081|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153433998|NCT00002311|Wobenzym|wobenzym|mesh-list
153433999|NCT00002311|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153434000|NCT00002311|Immunologic Factors|immunologic factors|mesh-ancestor
153434001|NCT00002311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153434003|NCT00002317|Trimetrexate|trimetrexate|mesh-list
153434004|NCT00002317|Calcium|calcium|mesh-list
153434005|NCT00002317|Levoleucovorin|levoleucovorin|mesh-list
153434006|NCT00002317|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153434007|NCT00002317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153434008|NCT00002317|Antidotes|antidotes|mesh-ancestor
153434009|NCT00002317|Protective Agents|protective agents|mesh-ancestor
153434010|NCT00002317|Vitamin B Complex|vitamin b complex|mesh-ancestor
153434011|NCT00002317|Vitamins|vitamins|mesh-ancestor
153434012|NCT00002317|Micronutrients|micronutrients|mesh-ancestor
153434013|NCT00002317|Antifungal Agents|antifungal agents|mesh-ancestor
153434014|NCT00002317|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153434015|NCT00002317|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153434016|NCT00002317|Antimetabolites|antimetabolites|mesh-ancestor
153892912|NCT01598298|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153892913|NCT01598298|Dopamine Agents|dopamine agents|mesh-ancestor
153892914|NCT02888652|Clopidogrel|clopidogrel|mesh-list
153892915|NCT02888652|Ticagrelor|ticagrelor|mesh-list
153892916|NCT02888652|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-list
153892917|NCT02888652|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
153892918|NCT02888652|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
153892919|NCT02888652|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
153892920|NCT02888652|Purinergic Agents|purinergic agents|mesh-ancestor
153892921|NCT02888652|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153892922|NCT02888652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153892923|NCT02888652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153892925|NCT01235949|Ibuprofen|ibuprofen|mesh-list
153892926|NCT01235949|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153892927|NCT01235949|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153892928|NCT01235949|Analgesics|analgesics|mesh-ancestor
153892948|NCT01235793|Alkylating Agents|alkylating agents|mesh-ancestor
153892949|NCT01235793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153892950|NCT01235793|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153892951|NCT05601648|Psilocybin|psilocybin|mesh-list
153892952|NCT05601648|Hallucinogens|hallucinogens|mesh-ancestor
153892953|NCT05601648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153892954|NCT05601648|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153892955|NCT01235715|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
153892956|NCT01235715|Hemostatics|hemostatics|mesh-ancestor
153892957|NCT01235715|Coagulants|coagulants|mesh-ancestor
153434037|NCT00002323|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
153434038|NCT00002323|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
153434039|NCT00380965|Nabilone|nabilone|mesh-list
153434040|NCT00380965|Antiemetics|antiemetics|mesh-ancestor
153434042|NCT00380965|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153434043|NCT00380965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153434044|NCT00380965|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153434045|NCT00380965|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153434046|NCT00380965|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153434048|NCT00380965|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153434049|NCT00001135|Nevirapine|nevirapine|mesh-list
153434050|NCT00001135|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153434051|NCT00001135|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153434052|NCT00001135|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153434053|NCT00001135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153434054|NCT00001135|Antiviral Agents|antiviral agents|mesh-ancestor
153434055|NCT00001135|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153434056|NCT00001135|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153434057|NCT00001135|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153434058|NCT00001135|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
153434059|NCT00001135|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
153434060|NCT00003002|Sargramostim|sargramostim|mesh-list
153434061|NCT00003002|Immunologic Factors|immunologic factors|mesh-ancestor
153434062|NCT00003002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153434063|NCT00001891|Dobutamine|dobutamine|mesh-list
153434064|NCT00001891|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
153434065|NCT00001891|Sympathomimetics|sympathomimetics|mesh-ancestor
153892958|NCT01235403|Lacosamide|lacosamide|mesh-list
153892959|NCT01235403|Anticonvulsants|anticonvulsants|mesh-ancestor
153892960|NCT01235403|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
153892961|NCT01235403|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153892962|NCT01235403|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153892963|NCT01235403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153892964|NCT01024036|Siltuximab|siltuximab|mesh-list
153892965|NCT01024036|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153892966|NCT01234467|Rituximab|rituximab|mesh-list
153892967|NCT01234467|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
153892968|NCT01234467|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153892969|NCT01234467|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153892970|NCT01234467|Immunologic Factors|immunologic factors|mesh-ancestor
153892971|NCT01234467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153434066|NCT00001891|Autonomic Agents|autonomic agents|mesh-ancestor
153892972|NCT01234467|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153892973|NCT01234467|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153434076|NCT00383864|Interferons|interferons|mesh-list
153892974|NCT01234467|Alkylating Agents|alkylating agents|mesh-ancestor
153892975|NCT01234467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153892976|NCT01233999|Botulinum Toxins|botulinum toxins|mesh-list
153892977|NCT01233999|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
153892978|NCT01233999|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
153892979|NCT01233999|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
153892980|NCT01233999|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153892981|NCT01233999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153892982|NCT01233999|Cholinergic Agents|cholinergic agents|mesh-ancestor
153892983|NCT01233999|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153892984|NCT01233999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153892985|NCT01233999|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
153892986|NCT01233999|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153892987|NCT01233687|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
153892988|NCT01233687|Rilotumumab|rilotumumab|mesh-list
153892989|NCT01233687|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153892990|NCT01233687|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153892991|NCT01233687|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153892992|NCT01233687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153892993|NCT01233687|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153892998|NCT01233609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153434082|NCT00383864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153434083|NCT00001903|Immunoglobulins|immunoglobulins|mesh-list
153434084|NCT00001903|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
153434085|NCT00001903|Antibodies|antibodies|mesh-list
153434086|NCT00001903|Immunologic Factors|immunologic factors|mesh-ancestor
153434087|NCT00001903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153434088|NCT00002335|Emtricitabine|emtricitabine|mesh-list
153434089|NCT00002335|Antiviral Agents|antiviral agents|mesh-ancestor
153434090|NCT00002335|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153434091|NCT00002335|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153434092|NCT00002335|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153434093|NCT00002335|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153434094|NCT00002335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153434095|NCT00002335|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153434096|NCT00002335|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153434097|NCT00002341|Itraconazole|itraconazole|mesh-list
153434098|NCT00002341|Antifungal Agents|antifungal agents|mesh-ancestor
153434099|NCT00002341|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153434100|NCT00002341|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
153434101|NCT00002341|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153434102|NCT00002341|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153434103|NCT00002341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153434104|NCT00002341|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153434105|NCT00002341|Hormone Antagonists|hormone antagonists|mesh-ancestor
153434106|NCT00002341|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153434107|NCT00002341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153434109|NCT00002347|Zidovudine|zidovudine|mesh-list
153893000|NCT01233609|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153893001|NCT01233609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153893002|NCT01233609|Antimanic Agents|antimanic agents|mesh-ancestor
153893003|NCT01233609|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153893004|NCT01233609|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153893005|NCT01233609|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153893006|NCT01232283|Apremilast|apremilast|mesh-list
153893007|NCT01232283|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153893008|NCT01232283|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153893009|NCT01232283|Analgesics|analgesics|mesh-ancestor
153893010|NCT01232283|Sensory System Agents|sensory system agents|mesh-ancestor
153893017|NCT01232283|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153893018|NCT01232283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153893019|NCT01232127|Ritonavir|ritonavir|mesh-list
153893020|NCT01232127|Atazanavir Sulfate|atazanavir sulfate|mesh-list
153893021|NCT01232127|Tenofovir|tenofovir|mesh-list
153893022|NCT01232127|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-list
153893023|NCT01232127|Famotidine|famotidine|mesh-list
153893024|NCT01232127|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
153893025|NCT01232127|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
153893040|NCT01232127|Histamine Agents|histamine agents|mesh-ancestor
153893041|NCT01232127|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153893042|NCT01232127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153893044|NCT01258608|Mapatumumab|mapatumumab|mesh-list
153893045|NCT01258608|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153434127|NCT00002347|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
153434128|NCT00002347|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153434129|NCT00001237|Molgramostim|molgramostim|mesh-list
153434130|NCT00001237|Sargramostim|sargramostim|mesh-list
153434131|NCT00001237|Immunologic Factors|immunologic factors|mesh-ancestor
153434132|NCT00001237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153434133|NCT00001237|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153434134|NCT00001933|Nefiracetam|nefiracetam|mesh-list
153434135|NCT00001933|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153434136|NCT00001933|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
153434137|NCT00001933|Protective Agents|protective agents|mesh-ancestor
153434139|NCT00001933|Nootropic Agents|nootropic agents|mesh-ancestor
153434140|NCT00001249|Antibodies|antibodies|mesh-list
153434141|NCT00001249|Immunologic Factors|immunologic factors|mesh-ancestor
153434142|NCT00001249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153434143|NCT00380575|Conivaptan|conivaptan|mesh-list
153434144|NCT00380575|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
153434145|NCT00380575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153434146|NCT00380575|Natriuretic Agents|natriuretic agents|mesh-ancestor
153893046|NCT01258608|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153893047|NCT01258608|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153893048|NCT01258608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153893063|NCT01231659|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153893064|NCT02875288|Bupivacaine|bupivacaine|mesh-list
153893065|NCT02875288|Anesthetics, Local|anesthetics, local|mesh-ancestor
153893066|NCT02875288|Anesthetics|anesthetics|mesh-ancestor
153893067|NCT02875288|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153893068|NCT02875288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153893069|NCT02875288|Sensory System Agents|sensory system agents|mesh-ancestor
153893070|NCT02875288|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153893071|NCT01054222|Fesoterodine|fesoterodine|mesh-list
153893072|NCT01054222|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
153893073|NCT01054222|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
153893074|NCT01054222|Cholinergic Agents|cholinergic agents|mesh-ancestor
153893075|NCT01054222|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153893076|NCT01054222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153893077|NCT01054222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153434148|NCT00001963|Chrysarobin|chrysarobin|mesh-list
153893078|NCT01054222|Urological Agents|urological agents|mesh-ancestor
153893079|NCT01052428|Metoprolol|metoprolol|mesh-list
153893080|NCT01052428|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153893081|NCT01052428|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153893082|NCT01052428|Sympatholytics|sympatholytics|mesh-ancestor
153893083|NCT01052428|Autonomic Agents|autonomic agents|mesh-ancestor
153893088|NCT01052428|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
153893089|NCT01052428|Adrenergic Agents|adrenergic agents|mesh-ancestor
153893090|NCT01052428|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153893091|NCT01052428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153893093|NCT01052272|Candesartan|candesartan|mesh-list
153893094|NCT01052272|Candesartan cilexetil|candesartan cilexetil|mesh-list
153893095|NCT01052272|Ramipril|ramipril|mesh-list
153893096|NCT01052272|Antimetabolites|antimetabolites|mesh-ancestor
153893097|NCT01052272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153434181|NCT00001339|Mitotane|mitotane|mesh-list
153434182|NCT00001339|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153434202|NCT00001993|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153434203|NCT00001993|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153434204|NCT00001993|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
153434205|NCT00001993|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153434206|NCT00001993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153434208|NCT00001999|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
153434209|NCT00001999|Immunoglobulins|immunoglobulins|mesh-list
153893098|NCT01052272|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153893099|NCT01052272|Gout Suppressants|gout suppressants|mesh-ancestor
153893100|NCT01052272|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153893101|NCT01052272|Free Radical Scavengers|free radical scavengers|mesh-ancestor
153893102|NCT01052272|Antioxidants|antioxidants|mesh-ancestor
153893103|NCT01052272|Protective Agents|protective agents|mesh-ancestor
153893104|NCT01052272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153893105|NCT01052272|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153893106|NCT01052272|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
153893107|NCT01052272|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
153893108|NCT01052272|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
153893109|NCT01052272|Protease Inhibitors|protease inhibitors|mesh-ancestor
153893110|NCT01257204|Interferons|interferons|mesh-list
153434210|NCT00001999|Antibodies|antibodies|mesh-list
153893129|NCT01231581|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153893130|NCT01050634|Exemestane|exemestane|mesh-list
153893131|NCT01050634|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153893132|NCT01050634|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
153893133|NCT01050634|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153893134|NCT01050634|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153893135|NCT01050634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153893136|NCT01050634|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
153893137|NCT01050634|Hormone Antagonists|hormone antagonists|mesh-ancestor
153893138|NCT01050634|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153893139|NCT01050634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153434226|NCT00002383|Antiviral Agents|antiviral agents|mesh-ancestor
153434227|NCT00002383|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153434228|NCT00002383|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
153434229|NCT00002383|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153434230|NCT00002389|Lamivudine|lamivudine|mesh-list
153434231|NCT00002389|Zidovudine|zidovudine|mesh-list
153434232|NCT00002389|Abacavir|abacavir|mesh-list
153434233|NCT00002389|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153434234|NCT00002389|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153434235|NCT00002389|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153434236|NCT00002389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153434237|NCT00002389|Antiviral Agents|antiviral agents|mesh-ancestor
153434238|NCT00002389|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153434239|NCT00002389|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153434240|NCT00002389|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153434241|NCT00002389|Antimetabolites|antimetabolites|mesh-ancestor
153434242|NCT00001357|Interleukin-2|interleukin-2|mesh-list
153434243|NCT00001357|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153434256|NCT00001381|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153434257|NCT00002011|Methoxsalen|methoxsalen|mesh-list
153434258|NCT00002011|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
153434259|NCT00002011|Dermatologic Agents|dermatologic agents|mesh-ancestor
153434260|NCT00002017|Interleukin-2|interleukin-2|mesh-list
153893142|NCT01020526|Sensory System Agents|sensory system agents|mesh-ancestor
153893143|NCT01020526|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153893144|NCT01020526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153434261|NCT00002017|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153434262|NCT00002017|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153893145|NCT01020526|Anticonvulsants|anticonvulsants|mesh-ancestor
153893146|NCT01020526|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153893147|NCT01020526|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153893148|NCT01020526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153893149|NCT01020526|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153893150|NCT01020526|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153893151|NCT01020526|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153893152|NCT01020526|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153893153|NCT01020526|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153893154|NCT01020448|Triptorelin Pamoate|triptorelin pamoate|mesh-list
153893155|NCT01020448|Luteolytic Agents|luteolytic agents|mesh-ancestor
153893156|NCT01020448|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
153893157|NCT01020448|Contraceptive Agents|contraceptive agents|mesh-ancestor
153893158|NCT01020448|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153893159|NCT01020448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153893160|NCT01020448|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
153893161|NCT01020448|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153893162|NCT01020448|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153893163|NCT04286230|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
153893164|NCT04286230|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
153893165|NCT04286230|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153893166|NCT04286230|Antitubercular Agents|antitubercular agents|mesh-ancestor
153893167|NCT01256658|Lumefantrine|lumefantrine|mesh-list
153893168|NCT01256658|Artemether|artemether|mesh-list
153893169|NCT01256658|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
153893170|NCT01256658|Antimalarials|antimalarials|mesh-ancestor
153893171|NCT01256658|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153893172|NCT01256658|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153434266|NCT00002017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153434267|NCT00002023|Zidovudine|zidovudine|mesh-list
153434268|NCT00002023|Antimetabolites|antimetabolites|mesh-ancestor
153434269|NCT00002023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153434270|NCT00002023|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153434271|NCT00002023|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153434272|NCT00002023|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153434273|NCT00002023|Antiviral Agents|antiviral agents|mesh-ancestor
153434274|NCT00002023|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153434275|NCT00002023|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153434276|NCT00002023|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153434277|NCT00002029|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
153434278|NCT00002029|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
153434279|NCT00002029|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
153434280|NCT00002029|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
153434281|NCT00002035|Zidovudine|zidovudine|mesh-list
153434282|NCT00002035|Didanosine|didanosine|mesh-list
153434283|NCT00002035|Antimetabolites|antimetabolites|mesh-ancestor
153434284|NCT00002035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153434285|NCT00002035|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153434286|NCT00002035|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153434287|NCT00002035|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153434288|NCT00002035|Antiviral Agents|antiviral agents|mesh-ancestor
153434289|NCT00002035|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153434290|NCT00002035|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153434291|NCT00002035|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153434292|NCT00002041|Amphotericin B|amphotericin b|mesh-list
153434293|NCT00002041|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
153434294|NCT00002041|Amebicides|amebicides|mesh-ancestor
153434295|NCT00002041|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153434296|NCT00002041|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153893180|NCT02888574|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153893181|NCT02888574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153893182|NCT01231503|Vaccines|vaccines|mesh-list
153893183|NCT01231503|Immunologic Factors|immunologic factors|mesh-ancestor
153893184|NCT01231503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153893185|NCT01228071|Testosterone|testosterone|mesh-list
153893186|NCT01228071|Androgens|androgens|mesh-ancestor
153893187|NCT01228071|Hormones|hormones|mesh-ancestor
153893188|NCT01228071|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153893189|NCT01228071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153893190|NCT04319289|Vitamin D|vitamin d|mesh-list
153434297|NCT00002041|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153893197|NCT04319289|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153893199|NCT01008475|Cetuximab|cetuximab|mesh-list
153893200|NCT01008475|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
153893201|NCT01008475|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153893202|NCT01008475|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153893203|NCT01008475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153893204|NCT01008475|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153893205|NCT01008475|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153893206|NCT01226745|Ceralifimod|ceralifimod|mesh-list
153893207|NCT01226745|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
153893208|NCT01226745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153893209|NCT01226745|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153893210|NCT01226745|Immunologic Factors|immunologic factors|mesh-ancestor
153893211|NCT01226745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153893212|NCT01226511|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
153893213|NCT01226511|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
153893214|NCT01226511|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153893215|NCT01226511|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153893216|NCT01226511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153893217|NCT01226511|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153893218|NCT01226511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153893219|NCT01226511|Analgesics|analgesics|mesh-ancestor
153893220|NCT01226511|Sensory System Agents|sensory system agents|mesh-ancestor
153434310|NCT00002053|Pentamidine|pentamidine|mesh-list
153434311|NCT00002053|Antifungal Agents|antifungal agents|mesh-ancestor
153434312|NCT00002053|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153434313|NCT00002053|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153434314|NCT00002053|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153434315|NCT00002053|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
153434316|NCT00002059|Inosine Pranobex|inosine pranobex|mesh-list
153434317|NCT00002059|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153434318|NCT00002059|Immunologic Factors|immunologic factors|mesh-ancestor
153434319|NCT00002059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153434320|NCT00002059|Antiviral Agents|antiviral agents|mesh-ancestor
153434321|NCT00002059|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153434337|NCT00002401|Delavirdine|delavirdine|mesh-list
153434338|NCT00002401|Indinavir|indinavir|mesh-list
153434339|NCT00002401|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153434340|NCT00002401|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153893221|NCT01226511|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153893222|NCT01226511|Antidepressive Agents|antidepressive agents|mesh-ancestor
153893223|NCT01226511|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153893224|NCT01226511|Dopamine Agents|dopamine agents|mesh-ancestor
153893225|NCT01226043|Insulin Glargine|insulin glargine|mesh-list
153893226|NCT01226043|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153893227|NCT01226043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153893228|NCT01001377|Cetuximab|cetuximab|mesh-list
153893229|NCT01001377|Panitumumab|panitumumab|mesh-list
153893230|NCT01001377|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153893231|NCT01001377|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153893232|NCT01225887|Nintedanib|nintedanib|mesh-list
153893233|NCT01225887|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-list
153434341|NCT00002401|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153434343|NCT00002401|Antiviral Agents|antiviral agents|mesh-ancestor
153893234|NCT01225887|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153893235|NCT01225887|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153893236|NCT01225887|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153893237|NCT01225887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153893238|NCT01296932|BI 836826|bi 836826|mesh-list
153893239|NCT01296932|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153893240|NCT01296932|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153893241|NCT01296698|Nicotine|nicotine|mesh-list
153893242|NCT01296698|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
153893243|NCT01296698|Autonomic Agents|autonomic agents|mesh-ancestor
153893244|NCT01296698|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153893245|NCT01296698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153893246|NCT01296698|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
153893247|NCT01296698|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
153893248|NCT01296698|Cholinergic Agents|cholinergic agents|mesh-ancestor
153893249|NCT01296698|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153893250|NCT01296698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153893251|NCT01001221|Gemcitabine|gemcitabine|mesh-list
153893252|NCT01001221|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153893253|NCT01001221|Antimetabolites|antimetabolites|mesh-ancestor
153893254|NCT01001221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153893255|NCT01001221|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153893256|NCT01296152|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
153893257|NCT01296152|Medroxyprogesterone|medroxyprogesterone|mesh-list
153893258|NCT01296152|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
153893259|NCT01296152|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
153893260|NCT01296152|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
153893261|NCT01296152|Contraceptive Agents|contraceptive agents|mesh-ancestor
153893262|NCT01296152|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153914653|NCT00612547|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153434357|NCT00002407|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153434358|NCT00002407|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153434359|NCT00002407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153434360|NCT00002407|Antiviral Agents|antiviral agents|mesh-ancestor
153434361|NCT00002407|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153434362|NCT00002407|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153434363|NCT00002407|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153434364|NCT00002407|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
153434365|NCT00002407|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
153434366|NCT00002407|Antimetabolites|antimetabolites|mesh-ancestor
153434368|NCT00002407|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
153434369|NCT00002407|Protease Inhibitors|protease inhibitors|mesh-ancestor
153434370|NCT00002413|Emivirine|emivirine|mesh-list
153434371|NCT00002413|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153434372|NCT00002413|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153434373|NCT00002413|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153434374|NCT00002413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153434375|NCT00002413|Antiviral Agents|antiviral agents|mesh-ancestor
153434376|NCT00002413|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153434377|NCT00002419|Efavirenz|efavirenz|mesh-list
153434378|NCT00002419|Abacavir|abacavir|mesh-list
153434379|NCT00002419|Adefovir|adefovir|mesh-list
153434380|NCT00002419|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
153434381|NCT00002419|Amprenavir|amprenavir|mesh-list
153434382|NCT00002419|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153434383|NCT00002419|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153434384|NCT00002419|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153434385|NCT00002419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153434386|NCT00002419|Antiviral Agents|antiviral agents|mesh-ancestor
153893263|NCT01296152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153893264|NCT01296152|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
153893265|NCT01296152|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
153893266|NCT01296152|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
153893267|NCT01296152|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153893268|NCT01296152|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153893269|NCT01002547|Vitamins|vitamins|mesh-list
153893270|NCT01002547|Vitamin E|vitamin e|mesh-list
153893271|NCT01002547|Tocopherols|tocopherols|mesh-list
153893272|NCT01002547|Tocotrienols|tocotrienols|mesh-list
153893273|NCT01002547|alpha-Tocopherol|alpha-tocopherol|mesh-list
153893274|NCT01002547|Pioglitazone|pioglitazone|mesh-list
153893275|NCT01002547|Micronutrients|micronutrients|mesh-ancestor
153893276|NCT01002547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153893277|NCT01002547|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153893278|NCT01002547|Antioxidants|antioxidants|mesh-ancestor
153893279|NCT01002547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153893280|NCT01002547|Protective Agents|protective agents|mesh-ancestor
153893281|NCT04295161|Abiraterone Acetate|abiraterone acetate|mesh-list
153893282|NCT04295161|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153893283|NCT04295161|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153893284|NCT04295161|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153893285|NCT04295161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153893288|NCT04295161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153893289|NCT04295161|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153893291|NCT01007149|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
153893292|NCT01007149|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153893293|NCT01007149|Respiratory System Agents|respiratory system agents|mesh-ancestor
153893294|NCT00998335|Insulin|insulin|mesh-list
153893295|NCT00998335|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
153893296|NCT00998335|Insulin Aspart|insulin aspart|mesh-list
153893297|NCT00998335|Insulin, Long-Acting|insulin, long-acting|mesh-list
153893298|NCT00998335|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
153893299|NCT00998335|Insulin Detemir|insulin detemir|mesh-list
153893300|NCT00998335|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153893301|NCT00998335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153893302|NCT02871505|Penicillins|penicillins|mesh-list
153893303|NCT02871505|Penicillin G|penicillin g|mesh-list
153893304|NCT02871505|Penicillin G Benzathine|penicillin g benzathine|mesh-list
153893305|NCT02871505|Penicillin G Procaine|penicillin g procaine|mesh-list
153893306|NCT02871505|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153893307|NCT02871505|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153434401|NCT00002419|Protease Inhibitors|protease inhibitors|mesh-ancestor
153434403|NCT00381511|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
153434404|NCT00381511|Tinzaparin|tinzaparin|mesh-list
153434405|NCT00381511|Dalteparin|dalteparin|mesh-list
153434406|NCT00381511|Anticoagulants|anticoagulants|mesh-ancestor
153434407|NCT00381511|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153434408|NCT00381511|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153434409|NCT00381511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153434410|NCT00002425|Saquinavir|saquinavir|mesh-list
153434411|NCT00002425|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
153434412|NCT00002425|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
153434413|NCT00002425|Protease Inhibitors|protease inhibitors|mesh-ancestor
153434414|NCT00002425|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153434415|NCT00002425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153434416|NCT00002425|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153434417|NCT00002425|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153434418|NCT00002425|Antiviral Agents|antiviral agents|mesh-ancestor
153434419|NCT00002425|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153434420|NCT00002425|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
153434421|NCT00002425|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153434422|NCT00002431|Chlorhexidine|chlorhexidine|mesh-list
153434423|NCT00002431|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
153893308|NCT01294670|Etoposide|etoposide|mesh-list
153893309|NCT01294670|Vorinostat|vorinostat|mesh-list
153893310|NCT01294670|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153893311|NCT01294670|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153893312|NCT01294670|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153893313|NCT01294670|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153893314|NCT01294670|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153893315|NCT01294670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153893316|NCT01294670|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
153893317|NCT01006603|Glimepiride|glimepiride|mesh-list
153893318|NCT01006603|Saxagliptin|saxagliptin|mesh-list
153893319|NCT01006603|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153893320|NCT01006603|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153893324|NCT01006603|Incretins|incretins|mesh-ancestor
153893325|NCT01006603|Hormones|hormones|mesh-ancestor
153893326|NCT01006603|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153893327|NCT01006603|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
153893328|NCT01006603|Protease Inhibitors|protease inhibitors|mesh-ancestor
153893329|NCT01006603|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153893330|NCT01006603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153893331|NCT00997321|Ketamine|ketamine|mesh-list
153893332|NCT00997321|Propofol|propofol|mesh-list
153893333|NCT00997321|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153893334|NCT00997321|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153893335|NCT00997321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153893336|NCT00997321|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153434425|NCT00002431|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153893337|NCT00997321|Anesthetics, General|anesthetics, general|mesh-ancestor
153893338|NCT00997321|Anesthetics|anesthetics|mesh-ancestor
153893339|NCT00997321|Analgesics|analgesics|mesh-ancestor
153893340|NCT00997321|Sensory System Agents|sensory system agents|mesh-ancestor
153893341|NCT00997321|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153893342|NCT00997321|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
153893343|NCT00997321|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
153893344|NCT00997321|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
153893345|NCT00997321|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153893346|NCT00997321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153893347|NCT01294592|Tamsulosin|tamsulosin|mesh-list
153893348|NCT01294592|Dutasteride|dutasteride|mesh-list
153893349|NCT01294592|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
153893350|NCT01294592|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
153893351|NCT01294592|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
153893352|NCT01294592|Adrenergic Agents|adrenergic agents|mesh-ancestor
153893353|NCT01294592|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153893354|NCT01294592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153893355|NCT01294592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153893356|NCT01294592|Urological Agents|urological agents|mesh-ancestor
153893357|NCT01294592|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
153434453|NCT00002101|Rifabutin|rifabutin|mesh-list
153434454|NCT00002101|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153434455|NCT00002101|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153434456|NCT00002101|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
153434457|NCT00002101|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153434458|NCT00002101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153434459|NCT00002101|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
153434460|NCT00002101|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153434461|NCT00002101|Antitubercular Agents|antitubercular agents|mesh-ancestor
153434462|NCT00002101|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
153434463|NCT02335424|Pembrolizumab|pembrolizumab|mesh-list
153434464|NCT02335424|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153434465|NCT02335424|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153434466|NCT02335424|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153434467|NCT02335424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153434468|NCT00002107|Aldesleukin|aldesleukin|mesh-list
153434469|NCT00002107|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153434470|NCT00002107|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153434471|NCT00002107|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153434472|NCT00002107|Antiviral Agents|antiviral agents|mesh-ancestor
153434474|NCT00002113|Fluconazole|fluconazole|mesh-list
153434475|NCT00002113|Flucytosine|flucytosine|mesh-list
153434476|NCT00002113|Antifungal Agents|antifungal agents|mesh-ancestor
153434477|NCT00002113|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153434478|NCT00002113|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
153434479|NCT00002113|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153434480|NCT00002113|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153434481|NCT00002113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153893358|NCT01294592|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153893359|NCT01294592|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153893360|NCT01294592|Hormone Antagonists|hormone antagonists|mesh-ancestor
153893361|NCT01294592|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153893362|NCT00997243|Azacitidine|azacitidine|mesh-list
153893363|NCT00997243|Lintuzumab|lintuzumab|mesh-list
153893364|NCT00997243|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153893365|NCT00997243|Antimetabolites|antimetabolites|mesh-ancestor
153893366|NCT00997243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153893367|NCT00997243|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153893368|NCT00997243|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153893369|NCT00997243|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153893370|NCT02869321|Fentanyl|fentanyl|mesh-list
153893371|NCT02869321|Morphine|morphine|mesh-list
153893372|NCT02869321|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153893373|NCT02869321|Narcotics|narcotics|mesh-ancestor
153893374|NCT02869321|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153893375|NCT02869321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153893377|NCT02869321|Sensory System Agents|sensory system agents|mesh-ancestor
153893378|NCT02869321|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153893379|NCT02869321|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153893380|NCT02869321|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153893381|NCT02869321|Anesthetics, General|anesthetics, general|mesh-ancestor
153893382|NCT02869321|Anesthetics|anesthetics|mesh-ancestor
153893383|NCT01294436|Dapagliflozin|dapagliflozin|mesh-list
153893384|NCT01294436|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
153893385|NCT01294436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153893386|NCT01294436|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153893387|NCT01294436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153893388|NCT01294358|Gemcitabine|gemcitabine|mesh-list
153893389|NCT01294358|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153893390|NCT01294358|Antimetabolites|antimetabolites|mesh-ancestor
153893391|NCT01294358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153893392|NCT01294358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153893393|NCT01224639|Vaccines|vaccines|mesh-list
153893394|NCT01224639|Immunologic Factors|immunologic factors|mesh-ancestor
153893395|NCT01224639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153893396|NCT01293968|Diphenhydramine|diphenhydramine|mesh-list
153893397|NCT01293968|Promethazine|promethazine|mesh-list
153893398|NCT01293968|Ibuprofen|ibuprofen|mesh-list
153893400|NCT01293968|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153893401|NCT01293968|Analgesics|analgesics|mesh-ancestor
153434496|NCT00002437|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153434497|NCT00002437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153434498|NCT00002443|Zidovudine|zidovudine|mesh-list
153434499|NCT00002443|Indinavir|indinavir|mesh-list
153434500|NCT00002443|Antimetabolites|antimetabolites|mesh-ancestor
153434501|NCT00002443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153434502|NCT00002443|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153434503|NCT00002443|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153434504|NCT00002443|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153434505|NCT00002443|Antiviral Agents|antiviral agents|mesh-ancestor
153434506|NCT00002443|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153434507|NCT00002443|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153434508|NCT00002443|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153434509|NCT00002443|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
153434510|NCT00002443|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
153434511|NCT00002443|Protease Inhibitors|protease inhibitors|mesh-ancestor
153434512|NCT00001561|Immunoglobulins|immunoglobulins|mesh-list
153434513|NCT00001561|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
153434514|NCT00001561|Antibodies|antibodies|mesh-list
153434515|NCT00001561|Immunoglobulin Idiotypes|immunoglobulin idiotypes|mesh-list
153434516|NCT00001561|Immunologic Factors|immunologic factors|mesh-ancestor
153434517|NCT00001561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153434518|NCT00002449|Aldesleukin|aldesleukin|mesh-list
153434519|NCT00002449|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153434520|NCT00002449|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153434521|NCT00002449|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153434522|NCT00002449|Antiviral Agents|antiviral agents|mesh-ancestor
153434523|NCT00002449|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153434524|NCT00003014|Carboplatin|carboplatin|mesh-list
153893402|NCT01293968|Sensory System Agents|sensory system agents|mesh-ancestor
153893403|NCT01293968|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153893404|NCT01293968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153893405|NCT01293968|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153893406|NCT01293968|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153893407|NCT01293968|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153893408|NCT01293968|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153893409|NCT01293968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153893410|NCT01293968|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
153893411|NCT01293968|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153893412|NCT01293968|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153893413|NCT01293968|Anesthetics, Local|anesthetics, local|mesh-ancestor
153893414|NCT01293968|Anesthetics|anesthetics|mesh-ancestor
153893415|NCT01293968|Antiemetics|antiemetics|mesh-ancestor
153893416|NCT01293968|Autonomic Agents|autonomic agents|mesh-ancestor
153893417|NCT01293968|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153434525|NCT00003014|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153434526|NCT00002125|Foscarnet|foscarnet|mesh-list
153893418|NCT01293968|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
153893419|NCT01293968|Histamine Antagonists|histamine antagonists|mesh-ancestor
153893420|NCT01293968|Histamine Agents|histamine agents|mesh-ancestor
153893421|NCT01293968|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153893422|NCT01293968|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
153893423|NCT01293968|Antipruritics|antipruritics|mesh-ancestor
153893424|NCT01293968|Dermatologic Agents|dermatologic agents|mesh-ancestor
153893425|NCT01293032|Tamoxifen|tamoxifen|mesh-list
153893426|NCT01293032|Aromatase Inhibitors|aromatase inhibitors|mesh-list
153893427|NCT01293032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153893428|NCT01293032|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
153893429|NCT01293032|Hormone Antagonists|hormone antagonists|mesh-ancestor
153893430|NCT01293032|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153893431|NCT01293032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153893432|NCT01293032|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153893434|NCT01293032|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
153893435|NCT01293032|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
153893436|NCT01293032|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153893437|NCT01293032|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153893438|NCT01293032|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153893439|NCT01224171|Vedolizumab|vedolizumab|mesh-list
153893440|NCT01224171|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153893441|NCT01223937|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
153893442|NCT01223937|Hemostatics|hemostatics|mesh-ancestor
153893443|NCT01223937|Coagulants|coagulants|mesh-ancestor
153893444|NCT01223937|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
153893445|NCT01223937|Natriuretic Agents|natriuretic agents|mesh-ancestor
153434543|NCT00001579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153434544|NCT00001579|Antidotes|antidotes|mesh-ancestor
153434545|NCT00001579|Protective Agents|protective agents|mesh-ancestor
153434546|NCT00001579|Vitamin B Complex|vitamin b complex|mesh-ancestor
153434547|NCT00001579|Vitamins|vitamins|mesh-ancestor
153434548|NCT00001579|Micronutrients|micronutrients|mesh-ancestor
153434549|NCT00001579|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153434550|NCT00003020|Immunotoxins|immunotoxins|mesh-list
153434551|NCT00003020|Immunoconjugates|immunoconjugates|mesh-ancestor
153434552|NCT00003020|Immunologic Factors|immunologic factors|mesh-ancestor
153434553|NCT00003020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153434554|NCT00002131|Vesnarinone|vesnarinone|mesh-list
153434555|NCT00002131|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153434556|NCT00002131|Immunologic Factors|immunologic factors|mesh-ancestor
153434557|NCT00002131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153434558|NCT00002131|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153434559|NCT00002131|Antiviral Agents|antiviral agents|mesh-ancestor
153434560|NCT00002131|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153434561|NCT00002131|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
153434562|NCT00002131|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
153434563|NCT00002131|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153434564|NCT00002131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153434565|NCT00002131|Protective Agents|protective agents|mesh-ancestor
153434566|NCT00380887|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
153434567|NCT00380887|Estrogens|estrogens|mesh-ancestor
153434568|NCT00380887|Hormones|hormones|mesh-ancestor
153434569|NCT00380887|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153434570|NCT00380887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153434571|NCT00002461|Cyclophosphamide|cyclophosphamide|mesh-list
153893446|NCT01223937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153893447|NCT01223235|Bevacizumab|bevacizumab|mesh-list
153893448|NCT01223235|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153893449|NCT01223235|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153893450|NCT01223235|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153893451|NCT01223235|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153893452|NCT01223235|Growth Substances|growth substances|mesh-ancestor
153893453|NCT01223235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153893454|NCT01223235|Growth Inhibitors|growth inhibitors|mesh-ancestor
153893455|NCT00993967|Idebenone|idebenone|mesh-list
153893456|NCT00993967|Antioxidants|antioxidants|mesh-ancestor
153893457|NCT00993967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153434572|NCT00002461|Carmustine|carmustine|mesh-list
153434573|NCT00002461|Etoposide|etoposide|mesh-list
153434574|NCT00002461|Sargramostim|sargramostim|mesh-list
153434575|NCT00002461|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153893458|NCT00993967|Protective Agents|protective agents|mesh-ancestor
153893459|NCT00993967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153893460|NCT04204603|CKD-506|ckd-506|mesh-list
153893467|NCT01222533|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153893468|NCT01222533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153893469|NCT01222533|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153893470|NCT01222533|Respiratory System Agents|respiratory system agents|mesh-ancestor
153893471|NCT01222533|Parasympatholytics|parasympatholytics|mesh-ancestor
153893472|NCT01222533|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
153893473|NCT01222533|Cholinergic Agents|cholinergic agents|mesh-ancestor
153893474|NCT01222533|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153893475|NCT01222533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153893476|NCT01221753|Carboplatin|carboplatin|mesh-list
153893477|NCT01221753|Docetaxel|docetaxel|mesh-list
153893478|NCT01221753|Fluorouracil|fluorouracil|mesh-list
153893479|NCT01221753|Cetuximab|cetuximab|mesh-list
153893480|NCT01221753|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153893481|NCT01221753|Tubulin Modulators|tubulin modulators|mesh-ancestor
153893482|NCT01221753|Antimitotic Agents|antimitotic agents|mesh-ancestor
153893483|NCT01221753|Mitosis Modulators|mitosis modulators|mesh-ancestor
153893484|NCT01221753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153893486|NCT01221753|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153893487|NCT01221753|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153893488|NCT01221753|Immunologic Factors|immunologic factors|mesh-ancestor
153434588|NCT00003026|Bicalutamide|bicalutamide|mesh-list
153434589|NCT00003026|Triptorelin Pamoate|triptorelin pamoate|mesh-list
153434590|NCT00003026|Flutamide|flutamide|mesh-list
153434591|NCT00003026|Androgen Antagonists|androgen antagonists|mesh-ancestor
153434600|NCT00003026|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
153434601|NCT00003026|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153434602|NCT00002143|Acitretin|acitretin|mesh-list
153434603|NCT00002143|Keratolytic Agents|keratolytic agents|mesh-ancestor
153434604|NCT00002143|Dermatologic Agents|dermatologic agents|mesh-ancestor
153434605|NCT00002149|Amoxicillin|amoxicillin|mesh-list
153434606|NCT00002149|Clavulanic Acid|clavulanic acid|mesh-list
153434607|NCT00002149|Clavulanic Acids|clavulanic acids|mesh-list
153434608|NCT00002149|Pseudoephedrine|pseudoephedrine|mesh-list
153434609|NCT00002149|Ephedrine|ephedrine|mesh-list
153434610|NCT00002149|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153434611|NCT00002149|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153434612|NCT00002149|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
153434613|NCT00002149|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153434614|NCT00002149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153434615|NCT00002149|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153434616|NCT00002149|Autonomic Agents|autonomic agents|mesh-ancestor
153893491|NCT02888223|Factor VIII|factor viii|mesh-list
153893492|NCT02888223|Coagulants|coagulants|mesh-ancestor
153893493|NCT01014988|Zanamivir|zanamivir|mesh-list
153893494|NCT01014988|Antiviral Agents|antiviral agents|mesh-ancestor
153893495|NCT01014988|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153893496|NCT01014988|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153893497|NCT01014988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153893498|NCT01019980|Acetaminophen|acetaminophen|mesh-list
153893499|NCT01019980|Diclofenac|diclofenac|mesh-list
153893502|NCT01019980|Sensory System Agents|sensory system agents|mesh-ancestor
153893503|NCT01019980|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153893504|NCT01019980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153893505|NCT01019980|Antipyretics|antipyretics|mesh-ancestor
153893506|NCT01019980|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153893507|NCT01019980|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153893508|NCT01019980|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153893509|NCT01019980|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153893511|NCT01019980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153893512|NCT00993499|Sirolimus|sirolimus|mesh-list
153893513|NCT00993499|Afatinib|afatinib|mesh-list
153893514|NCT00993499|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153893515|NCT00993499|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153893516|NCT00993499|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153434617|NCT00002149|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153434618|NCT00002149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153434619|NCT00002149|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153434620|NCT00002149|Respiratory System Agents|respiratory system agents|mesh-ancestor
153434621|NCT00002149|Nasal Decongestants|nasal decongestants|mesh-ancestor
153434622|NCT00002149|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
153434623|NCT00002149|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
153434624|NCT00002149|Sympathomimetics|sympathomimetics|mesh-ancestor
153434625|NCT00002149|Adrenergic Agents|adrenergic agents|mesh-ancestor
153434626|NCT00002149|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153434627|NCT03868046|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
153434629|NCT03868046|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153434630|NCT03868046|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153434631|NCT02973295|Silymarin|silymarin|mesh-list
153434632|NCT02973295|Antioxidants|antioxidants|mesh-ancestor
153434633|NCT02973295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153434634|NCT02973295|Protective Agents|protective agents|mesh-ancestor
153434635|NCT02973295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153434636|NCT00003032|Tamoxifen|tamoxifen|mesh-list
153434637|NCT00003032|Cyclophosphamide|cyclophosphamide|mesh-list
153434638|NCT00003032|Mitoxantrone|mitoxantrone|mesh-list
153434639|NCT00003032|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153434640|NCT00003032|Immunologic Factors|immunologic factors|mesh-ancestor
153434641|NCT00003032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153434642|NCT00003032|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153434643|NCT00003032|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153434644|NCT00003032|Alkylating Agents|alkylating agents|mesh-ancestor
153434645|NCT00003032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153434646|NCT00003032|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153434647|NCT00003032|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153434648|NCT00003032|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
153434649|NCT00003032|Hormone Antagonists|hormone antagonists|mesh-ancestor
153434650|NCT00003032|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153434651|NCT00003032|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153893517|NCT00993499|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153893518|NCT00993499|Antifungal Agents|antifungal agents|mesh-ancestor
153893519|NCT00993499|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153893520|NCT00993499|Immunologic Factors|immunologic factors|mesh-ancestor
153893521|NCT00993499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153893522|NCT00993499|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153893523|NCT00993499|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153893524|NCT00993499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153893525|NCT00993499|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153893526|NCT01014442|Mycophenolic Acid|mycophenolic acid|mesh-list
153893527|NCT01014442|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153893529|NCT01014442|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
153893530|NCT01014442|Antitubercular Agents|antitubercular agents|mesh-ancestor
153893531|NCT01014442|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153893532|NCT01014442|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153893534|NCT01014442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153893535|NCT00996307|MF59 oil emulsion|mf59 oil emulsion|mesh-list
153893536|NCT00996307|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153893537|NCT00996307|Immunologic Factors|immunologic factors|mesh-ancestor
153893538|NCT00996307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153893539|NCT02869165|Estrogens|estrogens|mesh-list
153893540|NCT02869165|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
153893541|NCT02869165|Hormones|hormones|mesh-ancestor
153893542|NCT02869165|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153893543|NCT02869165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153893544|NCT01219959|Icodextrin|icodextrin|mesh-list
153893545|NCT01219959|Dialysis Solutions|dialysis solutions|mesh-ancestor
153893546|NCT01219959|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
153893547|NCT00993421|Sibutramine|sibutramine|mesh-list
153893548|NCT00993421|Metoprolol|metoprolol|mesh-list
153893549|NCT00993421|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153893550|NCT00993421|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153893551|NCT00993421|Sympatholytics|sympatholytics|mesh-ancestor
153434652|NCT00003032|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
153434653|NCT00003032|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
153434654|NCT00003032|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153434655|NCT00003032|Analgesics|analgesics|mesh-ancestor
153434656|NCT00003032|Sensory System Agents|sensory system agents|mesh-ancestor
153434657|NCT00003032|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153434658|NCT00003032|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153434659|NCT00003032|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153434660|NCT00003032|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153434661|NCT00002155|Lamivudine|lamivudine|mesh-list
153434662|NCT00002155|Zidovudine|zidovudine|mesh-list
153434663|NCT00002155|Indinavir|indinavir|mesh-list
153434664|NCT00002155|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153434665|NCT00002155|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153434666|NCT00002155|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153434667|NCT00002155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153434668|NCT00002155|Antiviral Agents|antiviral agents|mesh-ancestor
153434669|NCT00002155|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153434670|NCT00002155|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153434671|NCT00002155|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153434672|NCT00002155|Antimetabolites|antimetabolites|mesh-ancestor
153893552|NCT00993421|Autonomic Agents|autonomic agents|mesh-ancestor
153893553|NCT00993421|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153893554|NCT00993421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153893555|NCT00993421|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
153893556|NCT00993421|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
153893557|NCT00993421|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
153893558|NCT00993421|Adrenergic Agents|adrenergic agents|mesh-ancestor
153893559|NCT00993421|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153893560|NCT00993421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153893561|NCT00993421|Antidepressive Agents|antidepressive agents|mesh-ancestor
153893562|NCT00993421|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153893563|NCT00993421|Appetite Depressants|appetite depressants|mesh-ancestor
153893564|NCT00993421|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
153893565|NCT01014208|Rituximab|rituximab|mesh-list
153893566|NCT01014208|Ofatumumab|ofatumumab|mesh-list
153893568|NCT01014208|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153893569|NCT01014208|Immunologic Factors|immunologic factors|mesh-ancestor
153893570|NCT01014208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153893571|NCT01014208|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153893572|NCT04205578|3-n-butylphthalide|3-n-butylphthalide|mesh-list
153893573|NCT04205578|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153893574|NCT04205578|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
153893575|NCT04205578|Protective Agents|protective agents|mesh-ancestor
153893576|NCT04205578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153893577|NCT00991939|Dexamethasone|dexamethasone|mesh-list
153893578|NCT00991939|Prednisone|prednisone|mesh-list
153893579|NCT00991939|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153893580|NCT00991939|Antiemetics|antiemetics|mesh-ancestor
153893581|NCT00991939|Autonomic Agents|autonomic agents|mesh-ancestor
153893582|NCT00991939|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153893583|NCT00991939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153893584|NCT00991939|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153893585|NCT00991939|Glucocorticoids|glucocorticoids|mesh-ancestor
153893586|NCT00991939|Hormones|hormones|mesh-ancestor
153893587|NCT00991939|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153893588|NCT00991939|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153893589|NCT00991939|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153893590|NCT02868385|Praziquantel|praziquantel|mesh-list
153893591|NCT02868385|Anthelmintics|anthelmintics|mesh-ancestor
153893592|NCT02868385|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153893593|NCT02868385|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153893595|NCT00993265|N-monoacetylcystine|n-monoacetylcystine|mesh-list
153893596|NCT00993265|Antiviral Agents|antiviral agents|mesh-ancestor
153893597|NCT00993265|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153893598|NCT00993265|Expectorants|expectorants|mesh-ancestor
153893599|NCT00993265|Respiratory System Agents|respiratory system agents|mesh-ancestor
153893600|NCT00993265|Free Radical Scavengers|free radical scavengers|mesh-ancestor
153893601|NCT00993265|Antioxidants|antioxidants|mesh-ancestor
153893602|NCT00993265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153893603|NCT00993265|Protective Agents|protective agents|mesh-ancestor
153893604|NCT00993265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153893605|NCT00993265|Antidotes|antidotes|mesh-ancestor
153893606|NCT00993031|Ritonavir|ritonavir|mesh-list
153434707|NCT03805022|Isophosphamide mustard|isophosphamide mustard|mesh-list
153434708|NCT03805022|Dacarbazine|dacarbazine|mesh-list
153434709|NCT03805022|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153434710|NCT03805022|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153434711|NCT03805022|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153434712|NCT03805022|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153434713|NCT03805022|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153434714|NCT03805022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153434715|NCT03805022|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153434716|NCT03805022|Alkylating Agents|alkylating agents|mesh-ancestor
153434717|NCT05752435|Bleomycin|bleomycin|mesh-list
153434718|NCT05752435|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153434719|NCT05752435|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153434720|NCT00003050|Tamoxifen|tamoxifen|mesh-list
153434721|NCT00003050|Paclitaxel|paclitaxel|mesh-list
153434722|NCT00003050|Cyclophosphamide|cyclophosphamide|mesh-list
153434723|NCT00003050|Doxorubicin|doxorubicin|mesh-list
153434724|NCT00003050|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
153434725|NCT00003050|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153434726|NCT00003050|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153434730|NCT00003050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153434732|NCT00003050|Immunologic Factors|immunologic factors|mesh-ancestor
153434733|NCT00003050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153434734|NCT00003050|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153434735|NCT00003050|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153434736|NCT00003050|Alkylating Agents|alkylating agents|mesh-ancestor
153434737|NCT00003050|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153434738|NCT00003050|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153434739|NCT00003050|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153434740|NCT00003050|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153434741|NCT00003050|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153434742|NCT00003050|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
153893607|NCT00993031|Lopinavir|lopinavir|mesh-list
153434743|NCT00003050|Hormone Antagonists|hormone antagonists|mesh-ancestor
153893608|NCT00993031|Lamivudine|lamivudine|mesh-list
153893609|NCT00993031|Zidovudine|zidovudine|mesh-list
153893610|NCT00993031|Efavirenz|efavirenz|mesh-list
153893611|NCT00993031|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
153893612|NCT00993031|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
153893613|NCT00993031|Protease Inhibitors|protease inhibitors|mesh-ancestor
153893615|NCT00993031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153893616|NCT00993031|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153893617|NCT00993031|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153893618|NCT00993031|Antiviral Agents|antiviral agents|mesh-ancestor
153893619|NCT00993031|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153893620|NCT00993031|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
153893621|NCT00993031|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153893622|NCT00993031|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153893623|NCT00993031|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153893624|NCT00993031|Antimetabolites|antimetabolites|mesh-ancestor
153893625|NCT00993031|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
153893626|NCT00993031|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
153893627|NCT00993031|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
153893628|NCT00993031|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
153893629|NCT00993031|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
153893630|NCT01010776|Paliperidone Palmitate|paliperidone palmitate|mesh-list
153893631|NCT01010776|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153893632|NCT01010776|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153893633|NCT01010776|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153893634|NCT01010776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153893635|NCT01010776|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153893636|NCT01010776|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
153893637|NCT01010776|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153434753|NCT00002179|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153434754|NCT00002179|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153434755|NCT00002179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153434756|NCT00002179|Antiviral Agents|antiviral agents|mesh-ancestor
153434757|NCT00002179|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153434758|NCT00002179|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153434759|NCT00002179|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153434760|NCT00002179|Antimetabolites|antimetabolites|mesh-ancestor
153434761|NCT00002179|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
153434762|NCT00002179|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
153434765|NCT00003056|Methotrexate|methotrexate|mesh-list
153434766|NCT00003056|Cyclosporins|cyclosporins|mesh-list
153434767|NCT00003056|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
153434768|NCT00003056|Abortifacient Agents|abortifacient agents|mesh-ancestor
153434769|NCT00003056|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153434770|NCT00003056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153434771|NCT00003056|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153434772|NCT00003056|Antimetabolites|antimetabolites|mesh-ancestor
153893647|NCT04291729|Antiviral Agents|antiviral agents|mesh-ancestor
153893648|NCT04291729|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153893649|NCT04291729|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
153893650|NCT04291729|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
153893651|NCT04291729|Protease Inhibitors|protease inhibitors|mesh-ancestor
153893652|NCT04291729|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153893653|NCT04291729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153893654|NCT04291729|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153893655|NCT04291729|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153893656|NCT04291729|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
153893657|NCT04291729|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153893658|NCT02868931|Insulin|insulin|mesh-list
153893659|NCT02868931|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153893660|NCT02868931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153893661|NCT01018810|Interleukin-23|interleukin-23|mesh-list
153893662|NCT01018810|Antibodies|antibodies|mesh-list
153893663|NCT01018810|Immunoglobulins|immunoglobulins|mesh-list
153893664|NCT01018810|Immunologic Factors|immunologic factors|mesh-ancestor
153893665|NCT01018810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153893666|NCT01018810|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153893667|NCT01018810|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153893668|NCT01018810|Growth Substances|growth substances|mesh-ancestor
153893669|NCT01018810|Growth Inhibitors|growth inhibitors|mesh-ancestor
153893670|NCT01018810|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153893671|NCT02867917|Psyllium|psyllium|mesh-list
153434773|NCT00003056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153434774|NCT00003056|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153434775|NCT00003056|Dermatologic Agents|dermatologic agents|mesh-ancestor
153434776|NCT00003056|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153434777|NCT00003056|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153434778|NCT00003056|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153434779|NCT00003056|Immunologic Factors|immunologic factors|mesh-ancestor
153434780|NCT00003056|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153434781|NCT00003056|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153434782|NCT00003056|Antifungal Agents|antifungal agents|mesh-ancestor
153434783|NCT00003056|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153434784|NCT00003056|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
153434785|NCT00002185|Nelfinavir|nelfinavir|mesh-list
153434786|NCT00002185|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
153434787|NCT00002185|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
153434788|NCT00002185|Protease Inhibitors|protease inhibitors|mesh-ancestor
153434789|NCT00002185|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153434790|NCT00002185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153434791|NCT00002185|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153434792|NCT00002185|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153434793|NCT00002185|Antiviral Agents|antiviral agents|mesh-ancestor
153434794|NCT00002185|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153434795|NCT00003062|Temozolomide|temozolomide|mesh-list
153434796|NCT00003062|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153434797|NCT00003062|Alkylating Agents|alkylating agents|mesh-ancestor
153434798|NCT00003062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153434799|NCT00003062|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153434800|NCT00002191|Albendazole|albendazole|mesh-list
153434803|NCT00002191|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153893672|NCT02867917|Cathartics|cathartics|mesh-ancestor
153893673|NCT02867917|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153893674|NCT01018732|Lactitol|lactitol|mesh-list
153893675|NCT01018732|Cathartics|cathartics|mesh-ancestor
153893676|NCT01018732|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153893677|NCT01218867|Aldesleukin|aldesleukin|mesh-list
153893678|NCT01218867|Cyclophosphamide|cyclophosphamide|mesh-list
153893679|NCT01218867|Fludarabine|fludarabine|mesh-list
153893680|NCT01218867|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153893681|NCT01218867|Immunologic Factors|immunologic factors|mesh-ancestor
153893682|NCT01218867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153893683|NCT01218867|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153893684|NCT01218867|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153893685|NCT01218867|Alkylating Agents|alkylating agents|mesh-ancestor
153893686|NCT01218867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153893687|NCT01218867|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153893688|NCT01218867|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153893689|NCT01218867|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153893690|NCT01218867|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153893691|NCT01218867|Antiviral Agents|antiviral agents|mesh-ancestor
153893692|NCT01218867|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153893693|NCT01018264|Solifenacin Succinate|solifenacin succinate|mesh-list
153893694|NCT01018264|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
153893695|NCT01018264|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
153893696|NCT01018264|Cholinergic Agents|cholinergic agents|mesh-ancestor
153893697|NCT01018264|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153893698|NCT01018264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153893699|NCT01018264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153893700|NCT01018264|Urological Agents|urological agents|mesh-ancestor
153893701|NCT01018186|Fluticasone|fluticasone|mesh-list
153893702|NCT01018186|Xhance|xhance|mesh-list
153893703|NCT01018186|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153893704|NCT01018186|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153893705|NCT01018186|Autonomic Agents|autonomic agents|mesh-ancestor
153893706|NCT01018186|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153893707|NCT01018186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153893708|NCT01018186|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153893709|NCT01018186|Respiratory System Agents|respiratory system agents|mesh-ancestor
153893710|NCT01018186|Dermatologic Agents|dermatologic agents|mesh-ancestor
153893711|NCT01018186|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
153893712|NCT00992407|Risperidone|risperidone|mesh-list
153893713|NCT00992407|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153893714|NCT00992407|Serotonin Agents|serotonin agents|mesh-ancestor
153893715|NCT00992407|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153914654|NCT00612547|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153434817|NCT00383396|Immunologic Factors|immunologic factors|mesh-ancestor
153434818|NCT00383396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153434820|NCT00383396|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153434821|NCT00383396|Dermatologic Agents|dermatologic agents|mesh-ancestor
153434822|NCT00383396|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153434823|NCT00383396|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
153434825|NCT00002197|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153434826|NCT00002197|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153434827|NCT00002197|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153434828|NCT00002197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153434829|NCT00002197|Antiviral Agents|antiviral agents|mesh-ancestor
153434830|NCT00002197|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153434831|NCT00002197|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153434832|NCT00002197|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153434833|NCT00003068|Cyclophosphamide|cyclophosphamide|mesh-list
153434834|NCT00003068|Thiotepa|thiotepa|mesh-list
153434835|NCT00003068|Mitoxantrone|mitoxantrone|mesh-list
153434836|NCT00003068|Amifostine|amifostine|mesh-list
153434837|NCT00003068|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153434839|NCT00003068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153434841|NCT00003068|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153434842|NCT00003068|Alkylating Agents|alkylating agents|mesh-ancestor
153434843|NCT00003068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153434844|NCT00003068|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153434845|NCT00003068|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153434846|NCT00003068|Analgesics|analgesics|mesh-ancestor
153434847|NCT00003068|Sensory System Agents|sensory system agents|mesh-ancestor
153434848|NCT00003068|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153434849|NCT00003068|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153893716|NCT00992407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153893717|NCT00992407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153893718|NCT00992407|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153893719|NCT00992407|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153893720|NCT00992407|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153893721|NCT00992407|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153893722|NCT00992407|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
153893723|NCT00992407|Dopamine Agents|dopamine agents|mesh-ancestor
153893724|NCT00986245|Ropinirole|ropinirole|mesh-list
153434854|NCT00003080|Tamoxifen|tamoxifen|mesh-list
153893725|NCT00986245|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
153893727|NCT00986245|Dopamine Agonists|dopamine agonists|mesh-ancestor
153893728|NCT00986245|Dopamine Agents|dopamine agents|mesh-ancestor
153893729|NCT00986245|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153893730|NCT00986245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153893731|NCT00986245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153893732|NCT00989833|Budesonide|budesonide|mesh-list
153893733|NCT00989833|Terbutaline|terbutaline|mesh-list
153893734|NCT00989833|Formoterol Fumarate|formoterol fumarate|mesh-list
153893735|NCT00989833|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153893736|NCT00989833|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153893737|NCT00989833|Autonomic Agents|autonomic agents|mesh-ancestor
153893738|NCT00989833|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153893739|NCT00989833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153893740|NCT00989833|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153893741|NCT00989833|Respiratory System Agents|respiratory system agents|mesh-ancestor
153893742|NCT00989833|Glucocorticoids|glucocorticoids|mesh-ancestor
153893743|NCT00989833|Hormones|hormones|mesh-ancestor
153893744|NCT00989833|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153893745|NCT00989833|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
153893746|NCT00989833|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
153893747|NCT00989833|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153893748|NCT00989833|Adrenergic Agents|adrenergic agents|mesh-ancestor
153893749|NCT00989833|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153893750|NCT00989833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153893751|NCT00989833|Sympathomimetics|sympathomimetics|mesh-ancestor
153893752|NCT00989833|Tocolytic Agents|tocolytic agents|mesh-ancestor
153893753|NCT00989833|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153893754|NCT04292119|Crizotinib|crizotinib|mesh-list
153893755|NCT04292119|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153434860|NCT00003080|Alkylating Agents|alkylating agents|mesh-ancestor
153434861|NCT00003080|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153434862|NCT00003080|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153434863|NCT00003080|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153434865|NCT00003080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153434866|NCT00003080|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
153434867|NCT00003080|Hormone Antagonists|hormone antagonists|mesh-ancestor
153434868|NCT00003080|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153434869|NCT00003080|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153434870|NCT00003080|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
153434871|NCT00003080|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
153434872|NCT00003080|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153434873|NCT00003080|Analgesics|analgesics|mesh-ancestor
153434874|NCT00003080|Sensory System Agents|sensory system agents|mesh-ancestor
153434875|NCT00003080|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153434876|NCT00003080|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153434877|NCT00003080|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153434878|NCT00003080|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153434879|NCT00002203|Lamivudine|lamivudine|mesh-list
153434880|NCT00002203|Zidovudine|zidovudine|mesh-list
153434881|NCT00002203|Lamivudine, zidovudine drug combination|lamivudine, zidovudine drug combination|mesh-list
153434882|NCT00002203|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153434883|NCT00002203|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153434884|NCT00002203|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153434885|NCT00002203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153434886|NCT00002203|Antiviral Agents|antiviral agents|mesh-ancestor
153434888|NCT00002203|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153893756|NCT04292119|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153893757|NCT04292119|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153893758|NCT04292119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153893759|NCT04292119|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153893760|NCT01218477|Dasatinib|dasatinib|mesh-list
153893761|NCT01218477|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153893762|NCT01218477|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153893763|NCT01218477|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153893764|NCT01218477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153893765|NCT01218477|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153893766|NCT01218009|Albuterol|albuterol|mesh-list
153893767|NCT01218009|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153893768|NCT01218009|Autonomic Agents|autonomic agents|mesh-ancestor
153893769|NCT01218009|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153893770|NCT01218009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153893771|NCT01218009|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153893772|NCT01218009|Respiratory System Agents|respiratory system agents|mesh-ancestor
153893773|NCT01218009|Tocolytic Agents|tocolytic agents|mesh-ancestor
153893774|NCT01218009|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153893775|NCT01218009|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
153893776|NCT01218009|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
153893777|NCT01218009|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153893778|NCT01218009|Adrenergic Agents|adrenergic agents|mesh-ancestor
153893779|NCT01218009|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153893780|NCT01218009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153893781|NCT02868151|Ascorbic Acid|ascorbic acid|mesh-list
153893782|NCT02868151|Vitamins|vitamins|mesh-ancestor
153893783|NCT02868151|Micronutrients|micronutrients|mesh-ancestor
153893784|NCT02868151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153893785|NCT02868151|Antioxidants|antioxidants|mesh-ancestor
153893786|NCT02868151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153893787|NCT02868151|Protective Agents|protective agents|mesh-ancestor
153893788|NCT01217307|Metformin|metformin|mesh-list
153893789|NCT01217307|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153893790|NCT01217307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153893791|NCT02868073|Vaccines|vaccines|mesh-list
153893792|NCT02868073|Immunologic Factors|immunologic factors|mesh-ancestor
153893793|NCT02868073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153893794|NCT01013740|Capecitabine|capecitabine|mesh-list
153893795|NCT01013740|Vinorelbine|vinorelbine|mesh-list
153893798|NCT01013740|Antimetabolites|antimetabolites|mesh-ancestor
153893799|NCT01013740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153893800|NCT01013740|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153434907|NCT00003086|Thiotepa|thiotepa|mesh-list
153434908|NCT00003086|Samarium Sm-153 lexidronam|samarium sm-153 lexidronam|mesh-list
153434909|NCT00003086|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153434910|NCT00003086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153434911|NCT00003086|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153434912|NCT00003086|Immunologic Factors|immunologic factors|mesh-ancestor
153434913|NCT00003086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153434914|NCT00003086|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153434915|NCT00003086|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153434916|NCT00003086|Alkylating Agents|alkylating agents|mesh-ancestor
153434917|NCT00003086|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153434918|NCT00003086|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153434920|NCT00003086|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153434921|NCT00003086|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153434922|NCT00003086|Antimetabolites|antimetabolites|mesh-ancestor
153434923|NCT00003086|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153434924|NCT00003086|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153434925|NCT00003086|Analgesics|analgesics|mesh-ancestor
153434926|NCT00003086|Sensory System Agents|sensory system agents|mesh-ancestor
153434927|NCT00003086|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153434928|NCT00003092|Paclitaxel|paclitaxel|mesh-list
153434929|NCT00003092|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153434930|NCT00003092|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153434931|NCT00003092|Tubulin Modulators|tubulin modulators|mesh-ancestor
153434932|NCT00003092|Antimitotic Agents|antimitotic agents|mesh-ancestor
153434933|NCT00003092|Mitosis Modulators|mitosis modulators|mesh-ancestor
153893807|NCT01013740|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153893808|NCT01217073|Metformin|metformin|mesh-list
153893809|NCT01217073|Pioglitazone|pioglitazone|mesh-list
153893810|NCT01217073|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153893811|NCT01217073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153893812|NCT00985621|Oxycodone|oxycodone|mesh-list
153893813|NCT00985621|Tanezumab|tanezumab|mesh-list
153893814|NCT00985621|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153893815|NCT00985621|Narcotics|narcotics|mesh-ancestor
153893816|NCT00985621|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153893817|NCT00985621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153893818|NCT00985621|Analgesics|analgesics|mesh-ancestor
153893819|NCT00985621|Sensory System Agents|sensory system agents|mesh-ancestor
153893820|NCT00985621|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153893821|NCT01215981|Vaccines|vaccines|mesh-list
153893822|NCT01215981|Immunologic Factors|immunologic factors|mesh-ancestor
153893823|NCT01215981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153893825|NCT01215435|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
153893826|NCT01215435|Insulin Aspart|insulin aspart|mesh-list
153893827|NCT01215435|Insulin, Long-Acting|insulin, long-acting|mesh-list
153893828|NCT01215435|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
153893829|NCT01215435|Biphasic Insulins|biphasic insulins|mesh-list
153893830|NCT01215435|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
153893831|NCT01215435|Insulin, Isophane|insulin, isophane|mesh-list
153893832|NCT01215435|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153434938|NCT00381199|Antidepressive Agents|antidepressive agents|mesh-ancestor
153434939|NCT00381199|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153434940|NCT00381199|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153434941|NCT00381199|Analgesics|analgesics|mesh-ancestor
153434942|NCT00381199|Sensory System Agents|sensory system agents|mesh-ancestor
153434943|NCT00381199|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153434944|NCT00381199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153434945|NCT00381199|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
153434947|NCT00381199|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153434948|NCT00381199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153434949|NCT00381199|Adrenergic Agents|adrenergic agents|mesh-ancestor
153434950|NCT00381199|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153434951|NCT00381199|Antiemetics|antiemetics|mesh-ancestor
153434952|NCT00381199|Autonomic Agents|autonomic agents|mesh-ancestor
153434953|NCT00381199|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153434954|NCT00381199|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153434955|NCT00381199|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153434956|NCT00381199|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153434957|NCT00002509|Cyclophosphamide|cyclophosphamide|mesh-list
153434958|NCT00002509|Carboplatin|carboplatin|mesh-list
153434959|NCT00002509|Etoposide|etoposide|mesh-list
153434960|NCT00002509|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153434967|NCT00002509|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153434968|NCT00002509|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153434969|NCT00002509|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153434970|NCT00002509|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153893833|NCT01215435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153893834|NCT01215357|Ecopipam|ecopipam|mesh-list
153893835|NCT01215357|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153893836|NCT01215357|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153893837|NCT01215357|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153893838|NCT01215357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153893839|NCT01215357|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153893840|NCT01215357|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
153893841|NCT01215357|Dopamine Agents|dopamine agents|mesh-ancestor
153893842|NCT01215357|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153893843|NCT01215357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153893844|NCT01017874|Pemetrexed|pemetrexed|mesh-list
153893845|NCT01017874|Gefitinib|gefitinib|mesh-list
153893846|NCT01017874|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153893847|NCT01017874|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153893848|NCT01017874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153893849|NCT01017874|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153893850|NCT01017874|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153893851|NCT01017874|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153893852|NCT01017874|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153893853|NCT00627952|Amlodipine|amlodipine|mesh-list
153893854|NCT00627952|Manidipine|manidipine|mesh-list
153893855|NCT00627952|Delapril|delapril|mesh-list
153893856|NCT00627952|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153893858|NCT00627952|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153893859|NCT00627952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153893860|NCT00627952|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153893861|NCT00627952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153893862|NCT00627952|Vasodilator Agents|vasodilator agents|mesh-ancestor
153893863|NCT00627952|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
153893864|NCT00627952|Protease Inhibitors|protease inhibitors|mesh-ancestor
153434971|NCT00002509|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153434972|NCT00002509|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153434973|NCT00002515|Carboplatin|carboplatin|mesh-list
153434975|NCT00002515|Thiotepa|thiotepa|mesh-list
153434976|NCT00002515|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153434977|NCT00002515|Immunologic Factors|immunologic factors|mesh-ancestor
153434978|NCT00002515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153434979|NCT00002515|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
153434982|NCT00002515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153434983|NCT00002515|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153434985|NCT00002515|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153434986|NCT00002515|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153434987|NCT00002521|Cyclophosphamide|cyclophosphamide|mesh-list
153434988|NCT00002521|Etoposide|etoposide|mesh-list
153434989|NCT00002521|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153434990|NCT00002521|Immunologic Factors|immunologic factors|mesh-ancestor
153434991|NCT00002521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153434992|NCT00002521|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153434993|NCT00002521|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153434994|NCT00002521|Alkylating Agents|alkylating agents|mesh-ancestor
153434995|NCT00002521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153434996|NCT00002521|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153434997|NCT00002521|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153893873|NCT01009840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153893874|NCT01009840|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153893875|NCT01009840|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153893876|NCT02872090|Glycopyrrolate|glycopyrrolate|mesh-list
153893877|NCT02872090|Tiotropium Bromide|tiotropium bromide|mesh-list
153893878|NCT02872090|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153893879|NCT02872090|Autonomic Agents|autonomic agents|mesh-ancestor
153893880|NCT02872090|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153893881|NCT02872090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153893882|NCT02872090|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153893883|NCT02872090|Respiratory System Agents|respiratory system agents|mesh-ancestor
153893884|NCT02872090|Parasympatholytics|parasympatholytics|mesh-ancestor
153893885|NCT02872090|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
153893886|NCT02872090|Cholinergic Agents|cholinergic agents|mesh-ancestor
153893887|NCT02872090|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153893888|NCT02872090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153893889|NCT02872090|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153893890|NCT02872090|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
153893891|NCT00982657|Sunitinib|sunitinib|mesh-list
153893892|NCT00982657|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153893893|NCT00982657|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153435000|NCT00002521|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153435001|NCT00002521|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153435002|NCT00003110|Bleomycin|bleomycin|mesh-list
153435003|NCT00003110|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153435004|NCT00003110|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153435005|NCT00002215|Nelfinavir|nelfinavir|mesh-list
153435006|NCT00002215|Emivirine|emivirine|mesh-list
153435007|NCT00002215|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
153435008|NCT00002215|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
153435009|NCT00002215|Protease Inhibitors|protease inhibitors|mesh-ancestor
153435010|NCT00002215|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153435011|NCT00002215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153435012|NCT00002215|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153435013|NCT00002215|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153435014|NCT00002215|Antiviral Agents|antiviral agents|mesh-ancestor
153435015|NCT00002215|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153435016|NCT00002215|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153435017|NCT00002215|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153435018|NCT00003116|Cyclosporine|cyclosporine|mesh-list
153435019|NCT00003116|Cyclophosphamide|cyclophosphamide|mesh-list
153435020|NCT00003116|Busulfan|busulfan|mesh-list
153435021|NCT00003116|Cyclosporins|cyclosporins|mesh-list
153435022|NCT00003116|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153435023|NCT00003116|Immunologic Factors|immunologic factors|mesh-ancestor
153435024|NCT00003116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153435025|NCT00003116|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153435026|NCT00003116|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153435027|NCT00003116|Alkylating Agents|alkylating agents|mesh-ancestor
153435028|NCT00003116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153435029|NCT00003116|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153435030|NCT00003116|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153435031|NCT00003116|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153435032|NCT00003116|Antifungal Agents|antifungal agents|mesh-ancestor
153435033|NCT00003116|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153893894|NCT00982657|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153893895|NCT00982657|Growth Substances|growth substances|mesh-ancestor
153893896|NCT00982657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153893897|NCT00982657|Growth Inhibitors|growth inhibitors|mesh-ancestor
153893898|NCT00982657|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153893899|NCT00982657|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153893900|NCT00982657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153893901|NCT02867839|Oxaliplatin|oxaliplatin|mesh-list
153435034|NCT00003116|Dermatologic Agents|dermatologic agents|mesh-ancestor
153893902|NCT02867839|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153893903|NCT02867293|Anesthetics|anesthetics|mesh-list
153893904|NCT02867293|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153893905|NCT02867293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153893906|NCT01005316|Mycophenolic Acid|mycophenolic acid|mesh-list
153893908|NCT01005316|Tacrolimus|tacrolimus|mesh-list
153893909|NCT01005316|Immunoglobulins|immunoglobulins|mesh-list
153893910|NCT01005316|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
153893911|NCT01005316|Antibodies|antibodies|mesh-list
153893912|NCT01005316|gamma-Globulins|gamma-globulins|mesh-list
153893913|NCT01005316|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
153893914|NCT01005316|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153893915|NCT01005316|Glucocorticoids|glucocorticoids|mesh-ancestor
153893916|NCT01005316|Hormones|hormones|mesh-ancestor
153893917|NCT01005316|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153893918|NCT01005316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153893919|NCT01005316|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153893920|NCT01005316|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153893921|NCT01005316|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153893922|NCT01005316|Immunologic Factors|immunologic factors|mesh-ancestor
153893923|NCT01005316|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
153893924|NCT01005316|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153893925|NCT01005316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153893926|NCT01005316|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153893927|NCT01005316|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
153893928|NCT01005316|Antitubercular Agents|antitubercular agents|mesh-ancestor
153893929|NCT01005316|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153893930|NCT01005316|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153893931|NCT00988429|Eslicarbazepine acetate|eslicarbazepine acetate|mesh-list
153893932|NCT00988429|Anticonvulsants|anticonvulsants|mesh-ancestor
153893933|NCT00988429|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
153435042|NCT00002227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153435043|NCT00002227|Antiviral Agents|antiviral agents|mesh-ancestor
153435044|NCT00002227|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153435045|NCT00002227|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153435046|NCT00002227|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153435047|NCT00002227|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
153435048|NCT00002227|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153435049|NCT00002227|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
153435050|NCT00002227|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
153435051|NCT00002227|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
153435052|NCT00002227|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
153435053|NCT00002227|Antimetabolites|antimetabolites|mesh-ancestor
153435054|NCT00002233|Lamivudine|lamivudine|mesh-list
153435055|NCT00002233|Abacavir|abacavir|mesh-list
153435056|NCT00002233|Indinavir|indinavir|mesh-list
153435057|NCT00002233|Amprenavir|amprenavir|mesh-list
153435058|NCT00002233|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153435059|NCT00002233|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153435060|NCT00002233|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153435061|NCT00002233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153435063|NCT00002233|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153435064|NCT00002233|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153435065|NCT00002233|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153435066|NCT00002233|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
153435067|NCT00002233|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
153435068|NCT00002233|Protease Inhibitors|protease inhibitors|mesh-ancestor
153435069|NCT00002233|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
153435070|NCT00002233|Antitubercular Agents|antitubercular agents|mesh-ancestor
153435071|NCT00002233|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153893934|NCT00988429|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153893935|NCT00988429|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153893936|NCT00988429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153893937|NCT01008904|Magnesium Oxide|magnesium oxide|mesh-list
153893938|NCT01008904|Antacids|antacids|mesh-ancestor
153893939|NCT01008904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153893940|NCT01008904|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153893941|NCT04290793|Cyclophosphamide|cyclophosphamide|mesh-list
153893942|NCT04290793|Trastuzumab|trastuzumab|mesh-list
153893943|NCT04290793|Epirubicin|epirubicin|mesh-list
153893944|NCT04290793|Taxane|taxane|mesh-list
153435072|NCT00002527|Aspirin|aspirin|mesh-list
153893945|NCT04290793|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153893946|NCT04290793|Immunologic Factors|immunologic factors|mesh-ancestor
153893947|NCT04290793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153893948|NCT04290793|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153893949|NCT04290793|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153893950|NCT04290793|Alkylating Agents|alkylating agents|mesh-ancestor
153893951|NCT04290793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153893952|NCT04290793|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153893953|NCT04290793|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153893954|NCT04290793|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153893955|NCT04290793|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153893956|NCT04290793|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153893957|NCT04290793|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153893958|NCT04290793|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153893959|NCT01004614|Amlodipine|amlodipine|mesh-list
153893960|NCT01004614|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153893961|NCT01004614|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153893962|NCT01004614|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153893963|NCT01004614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153893964|NCT01004614|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153893965|NCT01004614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153893966|NCT01004614|Vasodilator Agents|vasodilator agents|mesh-ancestor
153893972|NCT00981409|Heparin|heparin|mesh-list
153893973|NCT00981409|Calcium heparin|calcium heparin|mesh-list
153893974|NCT00981409|PENTA|penta|mesh-list
153893975|NCT00981409|Fondaparinux|fondaparinux|mesh-list
153435084|NCT00002527|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153435085|NCT00002527|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153435086|NCT00002527|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153435087|NCT00002527|Antipyretics|antipyretics|mesh-ancestor
153435088|NCT00002533|Fluconazole|fluconazole|mesh-list
153435089|NCT00002533|Antifungal Agents|antifungal agents|mesh-ancestor
153435090|NCT00002533|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153435091|NCT00002533|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
153435092|NCT00002533|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153435093|NCT00002533|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153435094|NCT00002533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153435095|NCT00002533|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153435096|NCT00002533|Hormone Antagonists|hormone antagonists|mesh-ancestor
153435097|NCT00002533|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153435098|NCT00002533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153435100|NCT00002533|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
153435101|NCT00002539|Doxorubicin|doxorubicin|mesh-list
153435102|NCT00002539|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
153435103|NCT00002539|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153435104|NCT00002539|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153435105|NCT00002539|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153435106|NCT00002539|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153435107|NCT00002539|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153435108|NCT00002539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153435110|NCT00381589|Ipratropium|ipratropium|mesh-list
153435111|NCT00381589|Anticonvulsants|anticonvulsants|mesh-ancestor
153435112|NCT00381589|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153435113|NCT00381589|Autonomic Agents|autonomic agents|mesh-ancestor
153435114|NCT00381589|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153893982|NCT00981409|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
153893983|NCT00981409|Protease Inhibitors|protease inhibitors|mesh-ancestor
153893984|NCT00981409|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153893985|NCT04297072|Rivaroxaban|rivaroxaban|mesh-list
153893986|NCT04297072|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
153893987|NCT04297072|Antithrombins|antithrombins|mesh-ancestor
153893988|NCT04297072|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
153893989|NCT04297072|Protease Inhibitors|protease inhibitors|mesh-ancestor
153893990|NCT04297072|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153893991|NCT04297072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153893992|NCT04297072|Anticoagulants|anticoagulants|mesh-ancestor
153893993|NCT01008748|Nicotine|nicotine|mesh-list
153893994|NCT01008748|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
153893995|NCT01008748|Autonomic Agents|autonomic agents|mesh-ancestor
153893996|NCT01008748|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153893997|NCT01008748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153893998|NCT01008748|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
153893999|NCT01008748|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
153894000|NCT01008748|Cholinergic Agents|cholinergic agents|mesh-ancestor
153894001|NCT01008748|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153894002|NCT01008748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153894003|NCT00628732|Cyclophosphamide|cyclophosphamide|mesh-list
153894004|NCT00628732|Topotecan|topotecan|mesh-list
153894005|NCT00628732|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153894006|NCT00628732|Immunologic Factors|immunologic factors|mesh-ancestor
153435115|NCT00381589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153435116|NCT00381589|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153435117|NCT00381589|Respiratory System Agents|respiratory system agents|mesh-ancestor
153435118|NCT00381589|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
153435119|NCT00381589|Cholinergic Agents|cholinergic agents|mesh-ancestor
153435120|NCT00381589|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153435121|NCT00381589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153435123|NCT00002239|Amprenavir|amprenavir|mesh-list
153435124|NCT00002239|Abacavir|abacavir|mesh-list
153435125|NCT00002239|Enfuvirtide|enfuvirtide|mesh-list
153435126|NCT00002239|Efavirenz|efavirenz|mesh-list
153435127|NCT00002239|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
153435128|NCT00002239|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
153435129|NCT00002239|Protease Inhibitors|protease inhibitors|mesh-ancestor
153435130|NCT00002239|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153435131|NCT00002239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153435132|NCT00002239|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153435133|NCT00002239|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153435134|NCT00002239|Antiviral Agents|antiviral agents|mesh-ancestor
153435135|NCT00002239|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153435136|NCT00002239|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
153435137|NCT00002239|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153435138|NCT00002239|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153435139|NCT00002239|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153894007|NCT00628732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153894008|NCT00628732|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153894009|NCT00628732|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153894010|NCT00628732|Alkylating Agents|alkylating agents|mesh-ancestor
153894011|NCT00628732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153894012|NCT00628732|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153894013|NCT00628732|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153894014|NCT00628732|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
153894015|NCT00628732|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153894016|NCT00628732|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153894017|NCT04205344|Bupivacaine|bupivacaine|mesh-list
153894018|NCT04205344|Anesthetics, Local|anesthetics, local|mesh-ancestor
153894019|NCT04205344|Anesthetics|anesthetics|mesh-ancestor
153894020|NCT04205344|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153894021|NCT04205344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153894022|NCT04205344|Sensory System Agents|sensory system agents|mesh-ancestor
153894023|NCT04205344|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153894024|NCT00629317|Aminolevulinic Acid|aminolevulinic acid|mesh-list
153894025|NCT00629317|Methyl 5-aminolevulinate|methyl 5-aminolevulinate|mesh-list
153894026|NCT00629317|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
153894027|NCT00629317|Dermatologic Agents|dermatologic agents|mesh-ancestor
153894029|NCT00978757|Analgesics|analgesics|mesh-ancestor
153894030|NCT00978757|Sensory System Agents|sensory system agents|mesh-ancestor
153894031|NCT00978757|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153894032|NCT00978757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153894033|NCT00978757|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
153894034|NCT00978757|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153894035|NCT00978757|Anesthetics, General|anesthetics, general|mesh-ancestor
153894036|NCT00978757|Anesthetics|anesthetics|mesh-ancestor
153894037|NCT00978757|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153894038|NCT00978757|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
153894039|NCT00978757|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
153894040|NCT00978757|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153894041|NCT00978757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153894042|NCT01214421|Tolvaptan|tolvaptan|mesh-list
153894043|NCT01214421|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
153894044|NCT01214421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153894045|NCT01214421|Natriuretic Agents|natriuretic agents|mesh-ancestor
153894046|NCT01214421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153894047|NCT01214187|Carbon Monoxide|carbon monoxide|mesh-list
153894048|NCT01214187|Antimetabolites|antimetabolites|mesh-ancestor
153894049|NCT01214187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153894050|NCT01214187|Gasotransmitters|gasotransmitters|mesh-ancestor
153894051|NCT01214187|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153894052|NCT01214187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153894053|NCT02866903|Bevacizumab|bevacizumab|mesh-list
153435163|NCT00002245|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153435164|NCT00002245|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
153435165|NCT00002245|Antitubercular Agents|antitubercular agents|mesh-ancestor
153435166|NCT00002245|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153435167|NCT00002245|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
153435168|NCT00002245|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
153435169|NCT00002245|Protease Inhibitors|protease inhibitors|mesh-ancestor
153435170|NCT00003128|Paclitaxel|paclitaxel|mesh-list
153435171|NCT00003128|Ifosfamide|ifosfamide|mesh-list
153435173|NCT00003128|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153435174|NCT00003128|Tubulin Modulators|tubulin modulators|mesh-ancestor
153435175|NCT00003128|Antimitotic Agents|antimitotic agents|mesh-ancestor
153435176|NCT00003128|Mitosis Modulators|mitosis modulators|mesh-ancestor
153435177|NCT00003128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153435178|NCT00003128|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153435179|NCT00003128|Alkylating Agents|alkylating agents|mesh-ancestor
153435181|NCT04331197|Clomiphene|clomiphene|mesh-list
153435182|NCT04331197|Enclomiphene|enclomiphene|mesh-list
153435183|NCT04331197|Zuclomiphene|zuclomiphene|mesh-list
153435184|NCT04331197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153435185|NCT04331197|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153435186|NCT04331197|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
153435187|NCT04331197|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153435188|NCT04331197|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153435189|NCT04331197|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
153435190|NCT04331197|Hormone Antagonists|hormone antagonists|mesh-ancestor
153435191|NCT04331197|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153435192|NCT04331197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153435193|NCT04331197|Fertility Agents, Female|fertility agents, female|mesh-ancestor
153435194|NCT04331197|Fertility Agents|fertility agents|mesh-ancestor
153435195|NCT04331197|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153435196|NCT04331197|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
153894055|NCT02866903|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153894056|NCT02866903|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153894057|NCT02866903|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153894058|NCT02866903|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153894059|NCT02866903|Growth Substances|growth substances|mesh-ancestor
153435197|NCT04331197|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
153894060|NCT02866903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153894061|NCT02866903|Growth Inhibitors|growth inhibitors|mesh-ancestor
153894062|NCT01003990|Ritonavir|ritonavir|mesh-list
153894063|NCT01003990|Lopinavir|lopinavir|mesh-list
153894064|NCT01003990|Atazanavir Sulfate|atazanavir sulfate|mesh-list
153894065|NCT01003990|Tenofovir|tenofovir|mesh-list
153894066|NCT01003990|Emtricitabine|emtricitabine|mesh-list
153894067|NCT01003990|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
153894068|NCT01003990|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
153894069|NCT01003990|Protease Inhibitors|protease inhibitors|mesh-ancestor
153894070|NCT01003990|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153894071|NCT01003990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153894072|NCT01003990|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153894073|NCT01003990|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153894074|NCT01003990|Antiviral Agents|antiviral agents|mesh-ancestor
153894075|NCT01003990|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153894076|NCT01003990|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
153894077|NCT01003990|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153894078|NCT01003990|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153894079|NCT01003990|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153894080|NCT01002820|Ganaxolone|ganaxolone|mesh-list
153894081|NCT01002820|Neurosteroids|neurosteroids|mesh-ancestor
153894082|NCT01002820|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153894083|NCT01002820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153894084|NCT01002820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153894085|NCT01002820|GABA Modulators|gaba modulators|mesh-ancestor
153894086|NCT01002820|GABA Agents|gaba agents|mesh-ancestor
153894087|NCT01012258|Cetuximab|cetuximab|mesh-list
153894088|NCT01012258|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153894089|NCT01012258|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153894090|NCT00628810|Leucovorin|leucovorin|mesh-list
153894091|NCT00628810|Bevacizumab|bevacizumab|mesh-list
153894092|NCT00628810|Fluorouracil|fluorouracil|mesh-list
153894093|NCT00628810|Irinotecan|irinotecan|mesh-list
153894094|NCT00628810|Calcium|calcium|mesh-list
153435204|NCT05751733|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153435205|NCT05751733|Growth Substances|growth substances|mesh-ancestor
153435207|NCT05751733|Growth Inhibitors|growth inhibitors|mesh-ancestor
153435208|NCT05751733|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153435209|NCT05751733|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153435210|NCT05751733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153435211|NCT05751733|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153435213|NCT00002798|Aldesleukin|aldesleukin|mesh-list
153435216|NCT00002798|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
153435217|NCT00002798|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
153435218|NCT00002798|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
153435219|NCT00002798|Cyclophosphamide|cyclophosphamide|mesh-list
153435220|NCT00002798|Busulfan|busulfan|mesh-list
153435221|NCT00002798|Methotrexate|methotrexate|mesh-list
153435222|NCT00002798|Fludarabine|fludarabine|mesh-list
153435223|NCT00002798|Fludarabine phosphate|fludarabine phosphate|mesh-list
153435224|NCT00002798|Etoposide|etoposide|mesh-list
153435225|NCT00002798|Etoposide phosphate|etoposide phosphate|mesh-list
153435226|NCT00002798|Daunorubicin|daunorubicin|mesh-list
153435227|NCT00002798|Asparaginase|asparaginase|mesh-list
153435228|NCT00002798|Interleukin-2|interleukin-2|mesh-list
153435229|NCT00002798|Idarubicin|idarubicin|mesh-list
153435230|NCT00002798|Thioguanine|thioguanine|mesh-list
153435231|NCT00002798|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153435232|NCT00002798|Immunologic Factors|immunologic factors|mesh-ancestor
153435233|NCT00002798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153435234|NCT00002798|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153435235|NCT00002798|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153894095|NCT00628810|Levoleucovorin|levoleucovorin|mesh-list
153894096|NCT00628810|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153894097|NCT00628810|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153894098|NCT00628810|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153894099|NCT00628810|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153894100|NCT00628810|Growth Substances|growth substances|mesh-ancestor
153894101|NCT00628810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153894102|NCT00628810|Growth Inhibitors|growth inhibitors|mesh-ancestor
153435236|NCT00002798|Alkylating Agents|alkylating agents|mesh-ancestor
153435237|NCT00002798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153435238|NCT00002798|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153435239|NCT00002798|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153435241|NCT00002798|Antiemetics|antiemetics|mesh-ancestor
153894103|NCT00628810|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153894104|NCT00628810|Antimetabolites|antimetabolites|mesh-ancestor
153894105|NCT00628810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153894106|NCT00628810|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153894107|NCT00628810|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153894108|NCT00628810|Immunologic Factors|immunologic factors|mesh-ancestor
153894109|NCT00628810|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
153894110|NCT00628810|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153894111|NCT00628810|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153894112|NCT00628810|Antidotes|antidotes|mesh-ancestor
153894113|NCT00628810|Protective Agents|protective agents|mesh-ancestor
153894114|NCT00628810|Vitamin B Complex|vitamin b complex|mesh-ancestor
153894116|NCT00628810|Micronutrients|micronutrients|mesh-ancestor
153894117|NCT00975481|Alprazolam|alprazolam|mesh-list
153894118|NCT00975481|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153894119|NCT00975481|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153894120|NCT00975481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153894121|NCT00975481|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153894122|NCT00975481|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153894123|NCT00975481|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153894124|NCT00975481|GABA Modulators|gaba modulators|mesh-ancestor
153894125|NCT00975481|GABA Agents|gaba agents|mesh-ancestor
153894126|NCT00975481|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153894127|NCT00975481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153894128|NCT01011868|Empagliflozin|empagliflozin|mesh-list
153894129|NCT01011868|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
153894130|NCT01011868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153894132|NCT01011868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153894133|NCT04290013|Tranexamic Acid|tranexamic acid|mesh-list
153435247|NCT00002798|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153435248|NCT00002798|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153435249|NCT00002798|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
153435250|NCT00002798|Abortifacient Agents|abortifacient agents|mesh-ancestor
153435251|NCT00002798|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153435252|NCT00002798|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153435253|NCT00002798|Antimetabolites|antimetabolites|mesh-ancestor
153435254|NCT00002798|Dermatologic Agents|dermatologic agents|mesh-ancestor
153435255|NCT00002798|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153435256|NCT00002798|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153435257|NCT00002798|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153435258|NCT00002798|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153435259|NCT00002798|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153435260|NCT00002798|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153435261|NCT00002798|Antiviral Agents|antiviral agents|mesh-ancestor
153435262|NCT00002798|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153435263|NCT00002798|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153435264|NCT00002798|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153435266|NCT00002798|Sensory System Agents|sensory system agents|mesh-ancestor
153435267|NCT00002798|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153435268|NCT00002798|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153435269|NCT00002251|Ganciclovir|ganciclovir|mesh-list
153435270|NCT00002251|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
153435271|NCT00002251|Antiviral Agents|antiviral agents|mesh-ancestor
153435272|NCT00002251|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153435273|NCT00002251|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153435274|NCT00002251|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153435275|NCT00002251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153435276|NCT00002257|Ganciclovir|ganciclovir|mesh-list
153435277|NCT00002257|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
153435278|NCT00002257|Antiviral Agents|antiviral agents|mesh-ancestor
153435283|NCT00003134|Irinotecan|irinotecan|mesh-list
153894134|NCT04290013|Norethindrone|norethindrone|mesh-list
153894135|NCT04290013|Norethindrone Acetate|norethindrone acetate|mesh-list
153894136|NCT04290013|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
153894137|NCT04290013|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153894138|NCT04290013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153894139|NCT04290013|Hemostatics|hemostatics|mesh-ancestor
153894140|NCT04290013|Coagulants|coagulants|mesh-ancestor
153894141|NCT04290013|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
153894143|NCT04290013|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
153894144|NCT04290013|Contraceptive Agents|contraceptive agents|mesh-ancestor
153894145|NCT04290013|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153894146|NCT04290013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153894147|NCT04290013|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
153894148|NCT04290013|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
153894149|NCT04288999|Capecitabine|capecitabine|mesh-list
153894150|NCT04288999|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153894151|NCT04288999|Antimetabolites|antimetabolites|mesh-ancestor
153894152|NCT04288999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153894153|NCT04288999|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153894154|NCT01213173|Metoprolol|metoprolol|mesh-list
153894155|NCT01213173|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153894156|NCT01213173|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153894157|NCT01213173|Sympatholytics|sympatholytics|mesh-ancestor
153894158|NCT01213173|Autonomic Agents|autonomic agents|mesh-ancestor
153894159|NCT01213173|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153894160|NCT01213173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153894161|NCT01213173|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
153894162|NCT01213173|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
153894163|NCT01213173|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
153894164|NCT01213173|Adrenergic Agents|adrenergic agents|mesh-ancestor
153894165|NCT01213173|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153894166|NCT01213173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153894167|NCT02866435|Potassium phosphate|potassium phosphate|mesh-list
153894168|NCT02866435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153894169|NCT02866435|Cariostatic Agents|cariostatic agents|mesh-ancestor
153894170|NCT02866435|Protective Agents|protective agents|mesh-ancestor
153894171|NCT00973765|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
153435287|NCT00003134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153435288|NCT00003134|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153435289|NCT00002545|Carmustine|carmustine|mesh-list
153435290|NCT00002545|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153435291|NCT00002545|Alkylating Agents|alkylating agents|mesh-ancestor
153435292|NCT00002545|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153435293|NCT00002545|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153435294|NCT00002804|Cobalt|cobalt|mesh-list
153435295|NCT00002804|Doxorubicin|doxorubicin|mesh-list
153435296|NCT00002804|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
153435297|NCT00002804|Vincristine|vincristine|mesh-list
153435298|NCT00002804|Ifosfamide|ifosfamide|mesh-list
153435299|NCT00002804|Lenograstim|lenograstim|mesh-list
153435300|NCT00002804|Mesna|mesna|mesh-list
153435301|NCT00002804|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153435302|NCT00002804|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153435303|NCT00002804|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153435304|NCT00002804|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153435305|NCT00002804|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153435306|NCT00002804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153435307|NCT00002804|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153435308|NCT00002804|Immunologic Factors|immunologic factors|mesh-ancestor
153435309|NCT00002804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153435310|NCT00002804|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153435311|NCT00002804|Tubulin Modulators|tubulin modulators|mesh-ancestor
153435312|NCT00002804|Antimitotic Agents|antimitotic agents|mesh-ancestor
153435313|NCT00002804|Mitosis Modulators|mitosis modulators|mesh-ancestor
153435314|NCT00002804|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153435315|NCT00002804|Alkylating Agents|alkylating agents|mesh-ancestor
153435316|NCT00002804|Protective Agents|protective agents|mesh-ancestor
153435317|NCT00002804|Trace Elements|trace elements|mesh-ancestor
153894172|NCT00973765|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
153894173|NCT00973765|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153894174|NCT00973765|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153894175|NCT00973765|Antimalarials|antimalarials|mesh-ancestor
153894176|NCT00973765|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153894177|NCT00973765|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153894178|NCT01211769|Naltrexone|naltrexone|mesh-list
153894179|NCT01211769|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
153894180|NCT01211769|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
153894181|NCT01211769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153894182|NCT01211769|Sensory System Agents|sensory system agents|mesh-ancestor
153894183|NCT01211769|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153894184|NCT04288765|Dexamethasone|dexamethasone|mesh-list
153894185|NCT04288765|Lenalidomide|lenalidomide|mesh-list
153435319|NCT00002810|Melphalan|melphalan|mesh-list
153894186|NCT04288765|Daratumumab|daratumumab|mesh-list
153894187|NCT04288765|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153894189|NCT04288765|Autonomic Agents|autonomic agents|mesh-ancestor
153894190|NCT04288765|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153894191|NCT04288765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153894192|NCT04288765|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153894193|NCT04288765|Glucocorticoids|glucocorticoids|mesh-ancestor
153894194|NCT04288765|Hormones|hormones|mesh-ancestor
153894195|NCT04288765|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153894196|NCT04288765|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153894197|NCT04288765|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153894199|NCT04288765|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153894200|NCT04288765|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153894201|NCT04288765|Growth Substances|growth substances|mesh-ancestor
153894202|NCT04288765|Growth Inhibitors|growth inhibitors|mesh-ancestor
153894203|NCT01211535|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
153894204|NCT02863861|Dexmedetomidine|dexmedetomidine|mesh-list
153894205|NCT02863861|Ketamine|ketamine|mesh-list
153894206|NCT02863861|Propofol|propofol|mesh-list
153894207|NCT02863861|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153894208|NCT02863861|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153894209|NCT02863861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153894210|NCT02863861|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153894211|NCT02863861|Analgesics|analgesics|mesh-ancestor
153894212|NCT02863861|Sensory System Agents|sensory system agents|mesh-ancestor
153894213|NCT02863861|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153894214|NCT02863861|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
153894215|NCT02863861|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153435332|NCT00003140|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153435333|NCT00003140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153435334|NCT00003140|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
153435335|NCT00003140|Hormone Antagonists|hormone antagonists|mesh-ancestor
153435336|NCT00003140|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153435337|NCT00003140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153435338|NCT00003392|Paclitaxel|paclitaxel|mesh-list
153435339|NCT00003392|Cyclophosphamide|cyclophosphamide|mesh-list
153435340|NCT00003392|Carboplatin|carboplatin|mesh-list
153435341|NCT00003392|Melphalan|melphalan|mesh-list
153435342|NCT00003392|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153435343|NCT00003392|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153435344|NCT00003392|Tubulin Modulators|tubulin modulators|mesh-ancestor
153435345|NCT00003392|Antimitotic Agents|antimitotic agents|mesh-ancestor
153435346|NCT00003392|Mitosis Modulators|mitosis modulators|mesh-ancestor
153435347|NCT00003392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153435348|NCT00003392|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153435349|NCT00003392|Immunologic Factors|immunologic factors|mesh-ancestor
153435350|NCT00003392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153435354|NCT00003392|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153435355|NCT00002551|Leucovorin|leucovorin|mesh-list
153435356|NCT00002551|Levamisole|levamisole|mesh-list
153435357|NCT00002551|Fluorouracil|fluorouracil|mesh-list
153435358|NCT00002551|Calcium|calcium|mesh-list
153435359|NCT00002551|Levoleucovorin|levoleucovorin|mesh-list
153435360|NCT00002551|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153435361|NCT00002551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153435362|NCT00002551|Antimetabolites|antimetabolites|mesh-ancestor
153435363|NCT00002551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153435364|NCT00002551|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153435365|NCT00002551|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153435366|NCT00002551|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153435367|NCT00002551|Immunologic Factors|immunologic factors|mesh-ancestor
153894216|NCT02863861|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153894217|NCT02863861|Adrenergic Agents|adrenergic agents|mesh-ancestor
153894218|NCT02863861|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153894219|NCT02863861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153894220|NCT02863861|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153894221|NCT02863861|Anesthetics, General|anesthetics, general|mesh-ancestor
153894222|NCT02863861|Anesthetics|anesthetics|mesh-ancestor
153894223|NCT02863861|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
153894224|NCT02863861|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
153894225|NCT02863861|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
153894226|NCT05406765|Bupivacaine|bupivacaine|mesh-list
153894227|NCT05406765|Anesthetics, Local|anesthetics, local|mesh-ancestor
153894228|NCT05406765|Anesthetics|anesthetics|mesh-ancestor
153894229|NCT05406765|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153894230|NCT05406765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153894231|NCT05406765|Sensory System Agents|sensory system agents|mesh-ancestor
153894232|NCT05406765|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153894233|NCT01011556|Teriparatide|teriparatide|mesh-list
153894234|NCT01011556|Hormones|hormones|mesh-list
153894235|NCT01011556|Parathyroid Hormone|parathyroid hormone|mesh-list
153894236|NCT01011556|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153894237|NCT01011556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153894238|NCT01011556|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153894239|NCT01011556|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153894240|NCT01211145|Oxazolidinones|oxazolidinones|mesh-list
153894241|NCT01211145|Zolmitriptan|zolmitriptan|mesh-list
153894242|NCT01211145|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
153894243|NCT01211145|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
153894244|NCT01211145|Serotonin Agents|serotonin agents|mesh-ancestor
153894245|NCT01211145|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153894246|NCT01211145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153894247|NCT01211145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153894248|NCT01211145|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153435370|NCT00002551|Vitamin B Complex|vitamin b complex|mesh-ancestor
153435371|NCT00002551|Vitamins|vitamins|mesh-ancestor
153435372|NCT00002551|Micronutrients|micronutrients|mesh-ancestor
153435373|NCT00002551|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153435374|NCT00002551|Antinematodal Agents|antinematodal agents|mesh-ancestor
153435375|NCT00002551|Anthelmintics|anthelmintics|mesh-ancestor
153435376|NCT00002551|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153435377|NCT00002551|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153435378|NCT00002551|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153435379|NCT00003146|Melphalan|melphalan|mesh-list
153435380|NCT00003146|Busulfan|busulfan|mesh-list
153435383|NCT00003146|Alkylating Agents|alkylating agents|mesh-ancestor
153435384|NCT00003146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153435385|NCT00003146|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153435386|NCT00003146|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153435387|NCT00003146|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153435388|NCT00003146|Immunologic Factors|immunologic factors|mesh-ancestor
153435389|NCT00003146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153435390|NCT00003398|Cyclophosphamide|cyclophosphamide|mesh-list
153435391|NCT00003398|Thiotepa|thiotepa|mesh-list
153435392|NCT00003398|Antilymphocyte Serum|antilymphocyte serum|mesh-list
153435393|NCT00003398|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153435394|NCT00003398|Immunologic Factors|immunologic factors|mesh-ancestor
153435395|NCT00003398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153435396|NCT00003398|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153435397|NCT00003398|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153894249|NCT01211145|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
153894250|NCT01211145|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153894251|NCT00977665|Rasagiline|rasagiline|mesh-list
153894252|NCT00977665|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
153894253|NCT00977665|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153894254|NCT00977665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153894255|NCT00977665|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
153894256|NCT00977665|Protective Agents|protective agents|mesh-ancestor
153894257|NCT00977665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153894258|NCT04298008|Durvalumab|durvalumab|mesh-list
153894259|NCT04298008|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153894260|NCT04298008|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153894261|NCT00628342|Esomeprazole|esomeprazole|mesh-list
153894262|NCT00628342|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
153894263|NCT00628342|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153894264|NCT00628342|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
153894265|NCT00628342|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153894266|NCT00628342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153894267|NCT01210443|Sitaxsentan|sitaxsentan|mesh-list
153894268|NCT01210443|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
153894269|NCT01210443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153894270|NCT04287361|Clonazepam|clonazepam|mesh-list
153894271|NCT04287361|Anticonvulsants|anticonvulsants|mesh-ancestor
153894272|NCT04287361|GABA Modulators|gaba modulators|mesh-ancestor
153894273|NCT04287361|GABA Agents|gaba agents|mesh-ancestor
153894288|NCT01001572|Amlodipine|amlodipine|mesh-list
153894289|NCT01001572|Valsartan|valsartan|mesh-list
153894290|NCT01001572|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153894291|NCT01001572|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153894292|NCT01001572|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153894293|NCT01001572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153435417|NCT00002816|Cytarabine|cytarabine|mesh-list
153435418|NCT00002816|Dexamethasone|dexamethasone|mesh-list
153435419|NCT00002816|Hydrocortisone|hydrocortisone|mesh-list
153435420|NCT00002816|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
153435421|NCT00002816|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
153435422|NCT00002816|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
153435423|NCT00002816|Methotrexate|methotrexate|mesh-list
153435424|NCT00002816|Etoposide|etoposide|mesh-list
153435425|NCT00002816|Vincristine|vincristine|mesh-list
153435426|NCT00002816|Asparaginase|asparaginase|mesh-list
153435427|NCT00002816|Ifosfamide|ifosfamide|mesh-list
153435429|NCT00002816|Pegaspargase|pegaspargase|mesh-list
153435430|NCT00002816|Thioguanine|thioguanine|mesh-list
153435431|NCT00002816|Levoleucovorin|levoleucovorin|mesh-list
153435432|NCT00002816|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153435433|NCT00002816|Antiemetics|antiemetics|mesh-ancestor
153435434|NCT00002816|Autonomic Agents|autonomic agents|mesh-ancestor
153435435|NCT00002816|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153435437|NCT00002816|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153435439|NCT00002816|Hormones|hormones|mesh-ancestor
153435440|NCT00002816|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153435441|NCT00002816|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153435442|NCT00002816|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153435443|NCT00002816|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
153435444|NCT00002816|Abortifacient Agents|abortifacient agents|mesh-ancestor
153435445|NCT00002816|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153894299|NCT04287205|Dydrogesterone|dydrogesterone|mesh-list
153894301|NCT04287205|Hormones|hormones|mesh-ancestor
153894302|NCT04287205|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153894303|NCT04287205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153894304|NCT00628576|Heparin|heparin|mesh-list
153894305|NCT00628576|Calcium heparin|calcium heparin|mesh-list
153894306|NCT00628576|Tinzaparin|tinzaparin|mesh-list
153894307|NCT00628576|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
153894308|NCT00628576|Dalteparin|dalteparin|mesh-list
153894309|NCT00628576|Anticoagulants|anticoagulants|mesh-ancestor
153894310|NCT00628576|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153894311|NCT00628576|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153894312|NCT00628576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153894313|NCT01208337|Alemtuzumab|alemtuzumab|mesh-list
153894314|NCT01208337|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153894315|NCT01208337|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153894316|NCT04370548|Clindamycin|clindamycin|mesh-list
153894317|NCT04370548|Clindamycin palmitate|clindamycin palmitate|mesh-list
153894318|NCT04370548|Clindamycin phosphate|clindamycin phosphate|mesh-list
153894319|NCT04370548|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153894320|NCT04370548|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153435446|NCT00002816|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153435447|NCT00002816|Antimetabolites|antimetabolites|mesh-ancestor
153435448|NCT00002816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153435449|NCT00002816|Dermatologic Agents|dermatologic agents|mesh-ancestor
153435450|NCT00002816|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153435451|NCT00002816|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153435452|NCT00002816|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153435453|NCT00002816|Immunologic Factors|immunologic factors|mesh-ancestor
153435454|NCT00002816|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153435455|NCT00002816|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153435456|NCT00002816|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153435457|NCT00002816|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153435458|NCT00002816|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153435459|NCT00002816|Antiviral Agents|antiviral agents|mesh-ancestor
153435460|NCT00002816|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153435461|NCT00002816|Antidotes|antidotes|mesh-ancestor
153435462|NCT00002816|Protective Agents|protective agents|mesh-ancestor
153435463|NCT00002816|Vitamin B Complex|vitamin b complex|mesh-ancestor
153435464|NCT00002816|Vitamins|vitamins|mesh-ancestor
153435465|NCT00002816|Micronutrients|micronutrients|mesh-ancestor
153435466|NCT00002816|Tubulin Modulators|tubulin modulators|mesh-ancestor
153435467|NCT00002816|Antimitotic Agents|antimitotic agents|mesh-ancestor
153435468|NCT00002816|Mitosis Modulators|mitosis modulators|mesh-ancestor
153435469|NCT00002816|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153435470|NCT00002816|Alkylating Agents|alkylating agents|mesh-ancestor
153435471|NCT00002816|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153435472|NCT00002816|Trace Elements|trace elements|mesh-ancestor
153435473|NCT00002269|Zidovudine|zidovudine|mesh-list
153435474|NCT00002269|poly(I).poly(c12,U)|poly(i).poly(c12,u)|mesh-list
153435475|NCT00002269|Antimetabolites|antimetabolites|mesh-ancestor
153435476|NCT00002269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153435477|NCT00002269|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153435478|NCT00002269|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153894321|NCT04370548|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
153894322|NCT04370548|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153894323|NCT04370548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153894324|NCT01208181|Etoricoxib|etoricoxib|mesh-list
153894325|NCT01208181|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153894326|NCT01208181|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153435479|NCT00002269|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153435480|NCT00002269|Antiviral Agents|antiviral agents|mesh-ancestor
153894327|NCT01208181|Analgesics|analgesics|mesh-ancestor
153894328|NCT01208181|Sensory System Agents|sensory system agents|mesh-ancestor
153894329|NCT01208181|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153894330|NCT01208181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153894331|NCT01208181|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153894332|NCT01208181|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153894333|NCT01208181|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
153894334|NCT01208181|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153894335|NCT01208181|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153894336|NCT01208181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153894340|NCT01208103|Oxaliplatin|oxaliplatin|mesh-list
153894341|NCT01208103|Endothelial Growth Factors|endothelial growth factors|mesh-list
153894342|NCT01208103|Antibodies|antibodies|mesh-list
153894343|NCT01208103|Immunoglobulins|immunoglobulins|mesh-list
153894344|NCT01208103|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
153894345|NCT01208103|Immunoglobulin G|immunoglobulin g|mesh-list
153894346|NCT01208103|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153894347|NCT01208103|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153894348|NCT01208103|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153894349|NCT01208103|Growth Substances|growth substances|mesh-ancestor
153894350|NCT01208103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153894351|NCT01208103|Growth Inhibitors|growth inhibitors|mesh-ancestor
153894352|NCT01208103|Immunologic Factors|immunologic factors|mesh-ancestor
153894353|NCT01208103|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153894354|NCT01208103|Antimetabolites|antimetabolites|mesh-ancestor
153894355|NCT01208103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153894356|NCT01206777|Rituximab|rituximab|mesh-list
153894357|NCT01206777|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153894358|NCT01206777|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153435487|NCT00002275|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
153435488|NCT00003152|Interferons|interferons|mesh-list
153435489|NCT00003152|Interferon-alpha|interferon-alpha|mesh-list
153435490|NCT00003152|Prednisone|prednisone|mesh-list
153435491|NCT00003152|Cyclophosphamide|cyclophosphamide|mesh-list
153435492|NCT00003152|Vincristine|vincristine|mesh-list
153435493|NCT00003152|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153435494|NCT00003152|Immunologic Factors|immunologic factors|mesh-ancestor
153435495|NCT00003152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153435496|NCT00003152|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153435497|NCT00003152|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153435498|NCT00003152|Alkylating Agents|alkylating agents|mesh-ancestor
153435499|NCT00003152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153435500|NCT00003152|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153435501|NCT00003152|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153435502|NCT00003152|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153435503|NCT00003152|Glucocorticoids|glucocorticoids|mesh-ancestor
153435504|NCT00003152|Hormones|hormones|mesh-ancestor
153435505|NCT00003152|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153435506|NCT00003152|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153435507|NCT00003152|Antiviral Agents|antiviral agents|mesh-ancestor
153435508|NCT00003152|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153435509|NCT00003152|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153435510|NCT00003152|Tubulin Modulators|tubulin modulators|mesh-ancestor
153435511|NCT00003152|Antimitotic Agents|antimitotic agents|mesh-ancestor
153435512|NCT00003152|Mitosis Modulators|mitosis modulators|mesh-ancestor
153435514|NCT05751421|Bupivacaine|bupivacaine|mesh-list
153894360|NCT01206777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153894361|NCT01206777|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153894362|NCT01001494|Bromides|bromides|mesh-list
153894363|NCT01001494|Anticonvulsants|anticonvulsants|mesh-ancestor
153894364|NCT01205685|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
153894366|NCT01205685|Goserelin|goserelin|mesh-list
153894367|NCT01205685|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153894368|NCT01205685|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153894369|NCT01205685|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153894370|NCT01205685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153894371|NCT01205685|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153894372|NCT01205685|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
153894373|NCT01205685|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153894374|NCT01205685|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
153894375|NCT01205685|Hormone Antagonists|hormone antagonists|mesh-ancestor
153894376|NCT01205685|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153435515|NCT05751421|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
153435516|NCT05751421|Anesthetics, Local|anesthetics, local|mesh-ancestor
153435517|NCT05751421|Anesthetics|anesthetics|mesh-ancestor
153894377|NCT01205685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153894378|NCT01205685|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153894379|NCT01205529|Procainamide|procainamide|mesh-list
153894380|NCT01205529|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153894381|NCT01205529|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
153894382|NCT01205529|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153894383|NCT01205529|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153894384|NCT01205529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153894385|NCT01205451|Botulinum Toxins|botulinum toxins|mesh-list
153894386|NCT01205451|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
153894387|NCT01205451|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
153894388|NCT01205451|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
153894389|NCT01205451|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153894390|NCT01205451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153894391|NCT01205451|Cholinergic Agents|cholinergic agents|mesh-ancestor
153894392|NCT01205451|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153894393|NCT01205451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153894394|NCT01205451|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
153894395|NCT01205451|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153894396|NCT04294732|Bupivacaine|bupivacaine|mesh-list
153894397|NCT04294732|Anesthetics, Local|anesthetics, local|mesh-ancestor
153894398|NCT04294732|Anesthetics|anesthetics|mesh-ancestor
153894399|NCT04294732|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153894400|NCT04294732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153894401|NCT04294732|Sensory System Agents|sensory system agents|mesh-ancestor
153894402|NCT04294732|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153894403|NCT02887677|Dapagliflozin|dapagliflozin|mesh-list
153435535|NCT00002822|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
153435536|NCT00002822|Etoposide|etoposide|mesh-list
153435537|NCT00002822|Vincristine|vincristine|mesh-list
153435538|NCT00002822|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153435539|NCT00002822|Immunologic Factors|immunologic factors|mesh-ancestor
153435540|NCT00002822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153435541|NCT00002822|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153435542|NCT00002822|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153435543|NCT00002822|Alkylating Agents|alkylating agents|mesh-ancestor
153435544|NCT00002822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153435545|NCT00002822|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153435546|NCT00002822|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153435547|NCT00002822|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153435548|NCT00002822|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153435549|NCT00002822|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153435550|NCT00002822|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153435551|NCT00002822|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153435552|NCT00002822|Tubulin Modulators|tubulin modulators|mesh-ancestor
153435553|NCT00002822|Antimitotic Agents|antimitotic agents|mesh-ancestor
153435554|NCT00002822|Mitosis Modulators|mitosis modulators|mesh-ancestor
153894404|NCT02887677|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
153894405|NCT02887677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153894406|NCT02887677|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153894407|NCT02887677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153894408|NCT01001104|Dulaglutide|dulaglutide|mesh-list
153894409|NCT01001104|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
153894410|NCT01001104|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153894411|NCT01001104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153894412|NCT04204954|Ciprofloxacin|ciprofloxacin|mesh-list
153894413|NCT04204954|Tea Tree Oil|tea tree oil|mesh-list
153894414|NCT04204954|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153894415|NCT04204954|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153894416|NCT04204954|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153894417|NCT04204954|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153894418|NCT04204954|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153894419|NCT04204954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153894420|NCT04204954|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153894421|NCT04204954|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
153894422|NCT04204954|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153894423|NCT04204954|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
153894424|NCT01204671|Vaccines|vaccines|mesh-list
153894425|NCT01204671|Immunologic Factors|immunologic factors|mesh-ancestor
153894426|NCT01204671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153894427|NCT01202955|Tolcapone|tolcapone|mesh-list
153894428|NCT01202955|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
153894429|NCT01202955|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
153894430|NCT01202955|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
153894432|NCT01202955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153894433|NCT01202877|Azacitidine|azacitidine|mesh-list
153894434|NCT01202877|Midostaurin|midostaurin|mesh-list
153435555|NCT00002281|Zidovudine|zidovudine|mesh-list
153894435|NCT01202877|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153435556|NCT00002281|Epoetin Alfa|epoetin alfa|mesh-list
153894436|NCT01202877|Antimetabolites|antimetabolites|mesh-ancestor
153894437|NCT01202877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153894438|NCT01202877|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153894439|NCT01202877|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153894440|NCT01202877|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153894442|NCT01202409|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153894443|NCT01202409|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153894444|NCT01202175|Nebivolol|nebivolol|mesh-list
153894445|NCT01202175|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153894446|NCT01202175|Vasodilator Agents|vasodilator agents|mesh-ancestor
153894447|NCT01202175|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
153894448|NCT01202175|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
153894449|NCT01202175|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153894450|NCT01202175|Adrenergic Agents|adrenergic agents|mesh-ancestor
153894451|NCT01202175|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153894452|NCT01202175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153894453|NCT01202175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153894454|NCT01201785|Aspirin|aspirin|mesh-list
153435589|NCT00003410|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153435590|NCT00003410|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
153435591|NCT00003410|Dermatologic Agents|dermatologic agents|mesh-ancestor
153435592|NCT00384020|Paroxetine|paroxetine|mesh-list
153435593|NCT00384020|Escitalopram|escitalopram|mesh-list
153435594|NCT00384020|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
153435595|NCT00384020|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153435596|NCT00384020|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153435597|NCT00384020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153435598|NCT00384020|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153435599|NCT00384020|Serotonin Agents|serotonin agents|mesh-ancestor
153435600|NCT00384020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153435601|NCT00384020|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
153435602|NCT00384020|Antidepressive Agents|antidepressive agents|mesh-ancestor
153435603|NCT00384020|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153435604|NCT00384020|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
153435605|NCT00384020|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153435606|NCT00384020|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153435607|NCT00002557|Leucovorin|leucovorin|mesh-list
153894464|NCT01201785|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153894465|NCT01201785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153894466|NCT01201785|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153894467|NCT01201785|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153894468|NCT01201785|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153894469|NCT01201785|Antipyretics|antipyretics|mesh-ancestor
153894471|NCT01200069|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153894472|NCT01200069|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153894473|NCT01200069|Analgesics|analgesics|mesh-ancestor
153894474|NCT01200069|Sensory System Agents|sensory system agents|mesh-ancestor
153435609|NCT00002557|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
153435610|NCT00002557|Etoposide|etoposide|mesh-list
153435611|NCT00002557|Methotrexate|methotrexate|mesh-list
153435612|NCT00002557|Calcium|calcium|mesh-list
153435613|NCT00002557|Levoleucovorin|levoleucovorin|mesh-list
153435614|NCT00002557|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153435615|NCT00002557|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153435616|NCT00002557|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153435617|NCT00002557|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153435618|NCT00002557|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153435619|NCT00002557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153435620|NCT00002557|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153435621|NCT00002557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153894475|NCT01200069|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153894476|NCT01200069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153894477|NCT01200069|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153894478|NCT01200069|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153894479|NCT01200069|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153894480|NCT01200069|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153894481|NCT01200069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153894483|NCT01199289|Dermatologic Agents|dermatologic agents|mesh-ancestor
153894485|NCT01199055|Carboplatin|carboplatin|mesh-list
153894486|NCT01199055|Efatutazone|efatutazone|mesh-list
153894487|NCT01199055|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153894488|NCT01199055|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153894489|NCT01199055|Tubulin Modulators|tubulin modulators|mesh-ancestor
153894490|NCT01199055|Antimitotic Agents|antimitotic agents|mesh-ancestor
153894491|NCT01199055|Mitosis Modulators|mitosis modulators|mesh-ancestor
153894492|NCT01199055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153894493|NCT01198587|Zinc Sulfate|zinc sulfate|mesh-list
153894494|NCT01198587|Astringents|astringents|mesh-ancestor
153894495|NCT01198587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153894496|NCT01198587|Dermatologic Agents|dermatologic agents|mesh-ancestor
153894497|NCT01198509|Vancomycin|vancomycin|mesh-list
153894498|NCT01198509|Doxycycline|doxycycline|mesh-list
153894499|NCT01198509|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153894500|NCT01198509|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153894501|NCT01198509|Antimalarials|antimalarials|mesh-ancestor
153894502|NCT01198509|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153894503|NCT01198509|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153894504|NCT01198275|Amiodarone|amiodarone|mesh-list
153894505|NCT01198275|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153894506|NCT01198275|Vasodilator Agents|vasodilator agents|mesh-ancestor
153894507|NCT01198275|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
153894508|NCT01198275|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153894509|NCT01198275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153894510|NCT01198275|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153894511|NCT01198275|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
153894512|NCT01198275|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153894513|NCT01198275|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153894514|NCT01198275|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
153894515|NCT01198275|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
153894516|NCT01198275|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
153894517|NCT01197417|Magnesium Sulfate|magnesium sulfate|mesh-list
153894518|NCT01197417|Analgesics|analgesics|mesh-ancestor
153894519|NCT01197417|Sensory System Agents|sensory system agents|mesh-ancestor
153894520|NCT01197417|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153894521|NCT01197417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153894522|NCT01197417|Anesthetics|anesthetics|mesh-ancestor
153894523|NCT01197417|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153894524|NCT01197417|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153435623|NCT00002557|Abortifacient Agents|abortifacient agents|mesh-ancestor
153894525|NCT01197417|Anticonvulsants|anticonvulsants|mesh-ancestor
153894526|NCT01197417|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153894527|NCT01197417|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153894528|NCT01197417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153894529|NCT01197417|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153894530|NCT01197417|Tocolytic Agents|tocolytic agents|mesh-ancestor
153894531|NCT01197417|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153894532|NCT00977431|Temozolomide|temozolomide|mesh-list
153894533|NCT00977431|Afatinib|afatinib|mesh-list
153894534|NCT00977431|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153894535|NCT00977431|Alkylating Agents|alkylating agents|mesh-ancestor
153435673|NCT00003416|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153435675|NCT00002569|Lomustine|lomustine|mesh-list
153435676|NCT00002569|Procarbazine|procarbazine|mesh-list
153435677|NCT00002569|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153435678|NCT00002569|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153435679|NCT00002569|Tubulin Modulators|tubulin modulators|mesh-ancestor
153435680|NCT00002569|Antimitotic Agents|antimitotic agents|mesh-ancestor
153435681|NCT00002569|Mitosis Modulators|mitosis modulators|mesh-ancestor
153435682|NCT00002569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153435683|NCT00002569|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153435684|NCT00002569|Alkylating Agents|alkylating agents|mesh-ancestor
153894536|NCT00977431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153894537|NCT00977431|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153894538|NCT00977431|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153894539|NCT00977431|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153894540|NCT00977431|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153894541|NCT04290169|Botulinum Toxins|botulinum toxins|mesh-list
153894542|NCT04290169|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
153894543|NCT04290169|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
153894544|NCT04290169|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
153894545|NCT04290169|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153894546|NCT04290169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153894547|NCT04290169|Cholinergic Agents|cholinergic agents|mesh-ancestor
153894548|NCT04290169|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153894549|NCT04290169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153894550|NCT04290169|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
153894551|NCT04290169|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153894553|NCT02864095|Tranexamic Acid|tranexamic acid|mesh-list
153894554|NCT02864095|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
153894555|NCT02864095|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153894556|NCT02864095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153894557|NCT02864095|Hemostatics|hemostatics|mesh-ancestor
153894558|NCT02864095|Coagulants|coagulants|mesh-ancestor
153894559|NCT02864095|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153894560|NCT02864095|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153894561|NCT02864095|Adrenergic Agents|adrenergic agents|mesh-ancestor
153894562|NCT02864095|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153894563|NCT02864095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153894564|NCT02864095|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
153894565|NCT02864095|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153894566|NCT02864095|Autonomic Agents|autonomic agents|mesh-ancestor
153894567|NCT02864095|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153894568|NCT02864095|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153894569|NCT02864095|Respiratory System Agents|respiratory system agents|mesh-ancestor
153894570|NCT02864095|Mydriatics|mydriatics|mesh-ancestor
153894571|NCT02864095|Sympathomimetics|sympathomimetics|mesh-ancestor
153894572|NCT02864095|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
153894574|NCT00977197|Analgesics|analgesics|mesh-ancestor
153894575|NCT00977197|Sensory System Agents|sensory system agents|mesh-ancestor
153894576|NCT00977197|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153894577|NCT00977197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153894578|NCT00977197|Anticonvulsants|anticonvulsants|mesh-ancestor
153894579|NCT00977197|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153894580|NCT00977197|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153894581|NCT00977197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153894582|NCT00977197|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153894583|NCT00977197|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153435686|NCT00002840|Lomustine|lomustine|mesh-list
153894584|NCT00977197|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153894585|NCT00977197|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153894586|NCT00977197|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153894587|NCT04288219|Nifedipine|nifedipine|mesh-list
153894588|NCT04288219|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153894589|NCT04288219|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153894590|NCT04288219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153894591|NCT04288219|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153894592|NCT04288219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153894593|NCT04288219|Vasodilator Agents|vasodilator agents|mesh-ancestor
153894594|NCT04288219|Tocolytic Agents|tocolytic agents|mesh-ancestor
153435733|NCT05751031|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153435734|NCT05751031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153435735|NCT00002852|Paclitaxel|paclitaxel|mesh-list
153435736|NCT00002852|Carboplatin|carboplatin|mesh-list
153435737|NCT00002852|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153435738|NCT00002852|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153435739|NCT00002852|Tubulin Modulators|tubulin modulators|mesh-ancestor
153435740|NCT00002852|Antimitotic Agents|antimitotic agents|mesh-ancestor
153435741|NCT00002852|Mitosis Modulators|mitosis modulators|mesh-ancestor
153435742|NCT00002852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153435743|NCT00003422|Leucovorin|leucovorin|mesh-list
153435744|NCT00003422|Fluorouracil|fluorouracil|mesh-list
153894595|NCT04288219|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153894596|NCT00974233|Rituximab|rituximab|mesh-list
153894597|NCT00974233|Lenalidomide|lenalidomide|mesh-list
153894598|NCT00974233|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
153894599|NCT00974233|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153894600|NCT00974233|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153894602|NCT00974233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153894603|NCT00974233|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153894604|NCT00974233|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153894605|NCT00974233|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153894606|NCT00974233|Growth Substances|growth substances|mesh-ancestor
153894607|NCT00974233|Growth Inhibitors|growth inhibitors|mesh-ancestor
153894608|NCT00974233|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153894609|NCT00974233|Alkylating Agents|alkylating agents|mesh-ancestor
153894610|NCT00974233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153894611|NCT00972595|Ondansetron|ondansetron|mesh-list
153894612|NCT00972595|Antiemetics|antiemetics|mesh-ancestor
153894613|NCT00972595|Autonomic Agents|autonomic agents|mesh-ancestor
153894614|NCT00972595|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153894615|NCT00972595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153894616|NCT00972595|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153894617|NCT00972595|Antipruritics|antipruritics|mesh-ancestor
153894618|NCT00972595|Dermatologic Agents|dermatologic agents|mesh-ancestor
153894619|NCT00972595|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
153894620|NCT00972595|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153894621|NCT00972595|Serotonin Agents|serotonin agents|mesh-ancestor
153894622|NCT00972595|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153894623|NCT00972595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153894625|NCT01196091|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
153894626|NCT01196091|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-list
153894627|NCT01196091|Immunosuppressive Agents|immunosuppressive agents|mesh-list
153894628|NCT01196091|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153894629|NCT01196091|Analgesics|analgesics|mesh-ancestor
153894630|NCT01196091|Sensory System Agents|sensory system agents|mesh-ancestor
153894631|NCT01196091|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153894632|NCT01196091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153894633|NCT01196091|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153894634|NCT01196091|Immunologic Factors|immunologic factors|mesh-ancestor
153894635|NCT01196091|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153894636|NCT01196091|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153894637|NCT01196091|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153894638|NCT00972283|Insulin|insulin|mesh-list
153894639|NCT00972283|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
153894640|NCT00972283|Insulin Glargine|insulin glargine|mesh-list
153894641|NCT00972283|Insulin Aspart|insulin aspart|mesh-list
153894642|NCT00972283|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153894643|NCT00972283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153894644|NCT05366049|Acetaminophen|acetaminophen|mesh-list
153894645|NCT05366049|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153894646|NCT05366049|Analgesics|analgesics|mesh-ancestor
153894647|NCT05366049|Sensory System Agents|sensory system agents|mesh-ancestor
153894648|NCT05366049|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153894649|NCT05366049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153894651|NCT00969709|Milnacipran|milnacipran|mesh-list
153894652|NCT00969709|Levomilnacipran|levomilnacipran|mesh-list
153894653|NCT00969709|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
153894654|NCT00969709|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153894655|NCT00969709|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153894656|NCT00969709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153894657|NCT00969709|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153435797|NCT00002870|Thiotepa|thiotepa|mesh-list
153435798|NCT00002870|Fluorouracil|fluorouracil|mesh-list
153435799|NCT00002870|Epirubicin|epirubicin|mesh-list
153435800|NCT00002870|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153435801|NCT00002870|Immunologic Factors|immunologic factors|mesh-ancestor
153435802|NCT00002870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153435803|NCT00002870|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153435804|NCT00002870|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153435805|NCT00002870|Alkylating Agents|alkylating agents|mesh-ancestor
153894658|NCT00969709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153894659|NCT00969709|Antidepressive Agents|antidepressive agents|mesh-ancestor
153894660|NCT00969709|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153894661|NCT00969709|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153894662|NCT00969709|Analgesics|analgesics|mesh-ancestor
153894663|NCT00969709|Sensory System Agents|sensory system agents|mesh-ancestor
153894664|NCT00969709|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153894665|NCT01193517|Capecitabine|capecitabine|mesh-list
153894666|NCT01193517|Azacitidine|azacitidine|mesh-list
153894667|NCT01193517|Decitabine|decitabine|mesh-list
153894668|NCT01193517|Oxaliplatin|oxaliplatin|mesh-list
153894669|NCT01193517|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153894670|NCT01193517|Antimetabolites|antimetabolites|mesh-ancestor
153894671|NCT01193517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153894672|NCT01193517|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153894673|NCT01193517|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153894675|NCT02863705|Brimonidine Tartrate|brimonidine tartrate|mesh-list
153894676|NCT02863705|Bimatoprost|bimatoprost|mesh-list
153894677|NCT02863705|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
153894678|NCT02863705|Ophthalmic Solutions|ophthalmic solutions|mesh-list
153894679|NCT02863705|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
153894680|NCT02863705|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
153894681|NCT02863705|Adrenergic Agents|adrenergic agents|mesh-ancestor
153894682|NCT02863705|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153894683|NCT02863705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153894684|NCT02863705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153894685|NCT02863705|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153894686|NCT02863705|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153894687|NCT02863705|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
153894688|NCT02863705|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153894689|NCT02863705|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153894690|NCT01193283|Cyclosporine|cyclosporine|mesh-list
153894691|NCT01193283|Cyclophosphamide|cyclophosphamide|mesh-list
153894692|NCT01193283|Cyclosporins|cyclosporins|mesh-list
153894693|NCT01193283|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153894694|NCT01193283|Immunologic Factors|immunologic factors|mesh-ancestor
153894695|NCT01193283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153894696|NCT01193283|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153894697|NCT01193283|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153894698|NCT01193283|Alkylating Agents|alkylating agents|mesh-ancestor
153894699|NCT01193283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153894700|NCT01193283|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153894701|NCT01193283|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153894702|NCT01193283|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153894703|NCT01193283|Antifungal Agents|antifungal agents|mesh-ancestor
153894704|NCT01193283|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153894705|NCT01193283|Dermatologic Agents|dermatologic agents|mesh-ancestor
153894706|NCT01193283|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
153894707|NCT02863471|Gemcitabine|gemcitabine|mesh-list
153894708|NCT02863471|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153894709|NCT02863471|Antimetabolites|antimetabolites|mesh-ancestor
153894710|NCT02863471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153435806|NCT00002870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153894711|NCT02863471|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153894712|NCT01193127|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
153894713|NCT01193127|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
153894714|NCT01193127|Mydriatics|mydriatics|mesh-list
153894715|NCT01193127|Autonomic Agents|autonomic agents|mesh-ancestor
153894716|NCT01193127|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153894717|NCT01193127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153894718|NCT01192815|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
153894720|NCT01192815|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153894721|NCT01192815|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153435860|NCT00002876|Etoposide|etoposide|mesh-list
153435861|NCT00002876|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153435862|NCT00002876|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153435863|NCT00002876|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153435864|NCT00002876|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153435865|NCT00002876|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153435866|NCT00002876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153435867|NCT00002593|Leucovorin|leucovorin|mesh-list
153435868|NCT00002593|Levamisole|levamisole|mesh-list
153435869|NCT00002593|Fluorouracil|fluorouracil|mesh-list
153435870|NCT00002593|Calcium|calcium|mesh-list
153435871|NCT00002593|Levoleucovorin|levoleucovorin|mesh-list
153435872|NCT00002593|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153894722|NCT01192815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153894723|NCT01192815|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153894724|NCT01192191|Fluticasone|fluticasone|mesh-list
153894726|NCT01192191|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153894727|NCT01192191|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153894728|NCT01192191|Autonomic Agents|autonomic agents|mesh-ancestor
153894729|NCT01192191|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153894730|NCT01192191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153894731|NCT01192191|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153894732|NCT01192191|Respiratory System Agents|respiratory system agents|mesh-ancestor
153894733|NCT01192191|Dermatologic Agents|dermatologic agents|mesh-ancestor
153894734|NCT01192191|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
153894735|NCT01307267|Rituximab|rituximab|mesh-list
153894736|NCT01307267|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
153894737|NCT01307267|Immunoglobulin G|immunoglobulin g|mesh-list
153894738|NCT01307267|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153894739|NCT01307267|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153894740|NCT01307267|Immunologic Factors|immunologic factors|mesh-ancestor
153894741|NCT01307267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153894742|NCT01307267|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153894743|NCT01307111|Misoprostol|misoprostol|mesh-list
153894744|NCT01307111|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
153894745|NCT01307111|Abortifacient Agents|abortifacient agents|mesh-ancestor
153894746|NCT01307111|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153894747|NCT01307111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153894748|NCT01307111|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
153894749|NCT01307111|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153894750|NCT01307111|Oxytocics|oxytocics|mesh-ancestor
153894751|NCT01191801|Cytarabine|cytarabine|mesh-list
153894752|NCT01191801|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153894753|NCT01191801|Antimetabolites|antimetabolites|mesh-ancestor
153894754|NCT01191801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153894755|NCT01191801|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153894756|NCT01191801|Antiviral Agents|antiviral agents|mesh-ancestor
153894757|NCT01191801|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153894758|NCT01191801|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153894759|NCT01191801|Immunologic Factors|immunologic factors|mesh-ancestor
153894760|NCT01191801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153894761|NCT01306643|Idelalisib|idelalisib|mesh-list
153894762|NCT01306643|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153894763|NCT01306643|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153894764|NCT01306643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153894765|NCT05656833|Cysteamine|cysteamine|mesh-list
153894766|NCT05656833|Cystine Depleting Agents|cystine depleting agents|mesh-ancestor
153894767|NCT05656833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153894768|NCT01306331|Nonoxynol|nonoxynol|mesh-list
153894769|NCT01306331|Spermatocidal Agents|spermatocidal agents|mesh-ancestor
153894770|NCT01306331|Antispermatogenic Agents|antispermatogenic agents|mesh-ancestor
153894771|NCT01306331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153894772|NCT01306331|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
153894773|NCT01306331|Contraceptive Agents|contraceptive agents|mesh-ancestor
153435873|NCT00002593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153894774|NCT01306331|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153894775|NCT01306331|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
153894776|NCT00624663|Rivastigmine|rivastigmine|mesh-list
153894777|NCT00624663|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
153894778|NCT00624663|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153894779|NCT00624663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153894780|NCT00624663|Cholinergic Agents|cholinergic agents|mesh-ancestor
153894782|NCT00624663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153435925|NCT00002882|Sensory System Agents|sensory system agents|mesh-ancestor
153435926|NCT00002882|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153435927|NCT00002882|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153435928|NCT00002882|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153435929|NCT00002882|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153435930|NCT00002882|Alkylating Agents|alkylating agents|mesh-ancestor
153435931|NCT00002882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153435932|NCT00002882|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153435933|NCT00002882|Tubulin Modulators|tubulin modulators|mesh-ancestor
153435934|NCT00002882|Antimitotic Agents|antimitotic agents|mesh-ancestor
153435935|NCT00002882|Mitosis Modulators|mitosis modulators|mesh-ancestor
153435936|NCT00002888|Paclitaxel|paclitaxel|mesh-list
153435937|NCT00002888|Fluorouracil|fluorouracil|mesh-list
153435938|NCT00002888|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153435939|NCT00002888|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153435942|NCT00002888|Mitosis Modulators|mitosis modulators|mesh-ancestor
153435943|NCT00002888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153435944|NCT00002888|Antimetabolites|antimetabolites|mesh-ancestor
153435945|NCT00002888|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153435946|NCT00002888|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153435947|NCT00002888|Immunologic Factors|immunologic factors|mesh-ancestor
153435948|NCT00002888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153435949|NCT00002599|Cobalt|cobalt|mesh-list
153435950|NCT00002599|Interferons|interferons|mesh-list
153435951|NCT00002599|Interferon-alpha|interferon-alpha|mesh-list
153435952|NCT00002599|Prednisone|prednisone|mesh-list
153435953|NCT00002599|Methylprednisolone|methylprednisolone|mesh-list
153435954|NCT00002599|Cyclophosphamide|cyclophosphamide|mesh-list
153894783|NCT00624663|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
153894784|NCT00624663|Protective Agents|protective agents|mesh-ancestor
153894785|NCT02890823|Cholecalciferol|cholecalciferol|mesh-list
153894786|NCT02890823|Vitamin D|vitamin d|mesh-list
153894787|NCT02890823|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153894788|NCT02890823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153894789|NCT02890823|Vitamins|vitamins|mesh-ancestor
153894790|NCT02890823|Micronutrients|micronutrients|mesh-ancestor
153894791|NCT02890823|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153894792|NCT02887443|Midazolam|midazolam|mesh-list
153894793|NCT02887443|Idebenone|idebenone|mesh-list
153894794|NCT02887443|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153894795|NCT02887443|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153894796|NCT02887443|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153894797|NCT02887443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153435955|NCT00002599|Melphalan|melphalan|mesh-list
153894798|NCT02887443|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153894799|NCT02887443|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153894800|NCT02887443|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153894801|NCT02887443|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153894802|NCT02887443|Anesthetics, General|anesthetics, general|mesh-ancestor
153894803|NCT02887443|Anesthetics|anesthetics|mesh-ancestor
153894804|NCT02887443|GABA Modulators|gaba modulators|mesh-ancestor
153894805|NCT02887443|GABA Agents|gaba agents|mesh-ancestor
153894806|NCT02887443|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153894807|NCT02887443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153894809|NCT02887443|Protective Agents|protective agents|mesh-ancestor
153894810|NCT05359263|Dapagliflozin|dapagliflozin|mesh-list
153894811|NCT05359263|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
153894812|NCT05359263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153894813|NCT05359263|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153894814|NCT05359263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153894815|NCT01305941|Trastuzumab|trastuzumab|mesh-list
153894816|NCT01305941|Everolimus|everolimus|mesh-list
153894817|NCT01305941|Vinorelbine|vinorelbine|mesh-list
153894818|NCT01305941|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153894819|NCT01305941|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153894820|NCT01305941|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
153894821|NCT01305941|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153894822|NCT01305941|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153894823|NCT01305941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153894824|NCT01305941|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153894825|NCT01305941|Immunologic Factors|immunologic factors|mesh-ancestor
153894826|NCT01305941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153894827|NCT01305941|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153435971|NCT00002599|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153435972|NCT00002599|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153435973|NCT00002599|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153435974|NCT00002599|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153435976|NCT00002599|Hormones|hormones|mesh-ancestor
153435977|NCT00002599|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153435978|NCT00002599|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153435979|NCT00002599|Antiviral Agents|antiviral agents|mesh-ancestor
153435980|NCT00002599|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153435981|NCT00002599|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153435982|NCT00002599|Tubulin Modulators|tubulin modulators|mesh-ancestor
153435983|NCT00002599|Antimitotic Agents|antimitotic agents|mesh-ancestor
153894828|NCT01305941|Tubulin Modulators|tubulin modulators|mesh-ancestor
153894829|NCT01305941|Antimitotic Agents|antimitotic agents|mesh-ancestor
153894830|NCT01305941|Mitosis Modulators|mitosis modulators|mesh-ancestor
153894834|NCT05658549|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153894836|NCT05658549|Respiratory System Agents|respiratory system agents|mesh-ancestor
153894837|NCT05658549|Free Radical Scavengers|free radical scavengers|mesh-ancestor
153894838|NCT05658549|Antioxidants|antioxidants|mesh-ancestor
153894839|NCT05658549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153894840|NCT05658549|Protective Agents|protective agents|mesh-ancestor
153894841|NCT05658549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153894842|NCT05658549|Antidotes|antidotes|mesh-ancestor
153894843|NCT02887365|Tegafur|tegafur|mesh-list
153894844|NCT02887365|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153894845|NCT02887365|Antimetabolites|antimetabolites|mesh-ancestor
153894846|NCT02887365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153894847|NCT02887365|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153894848|NCT05658159|Vitamin D|vitamin d|mesh-list
153894849|NCT05658159|Ergocalciferols|ergocalciferols|mesh-list
153894850|NCT05658159|Cholecalciferol|cholecalciferol|mesh-list
153894851|NCT05658159|Vitamins|vitamins|mesh-list
153894852|NCT05658159|Micronutrients|micronutrients|mesh-ancestor
153894853|NCT05658159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153894854|NCT05658159|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153894855|NCT05658159|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153894856|NCT01305239|Exemestane|exemestane|mesh-list
153894857|NCT01305239|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153894858|NCT01305239|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
153894859|NCT01305239|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153894860|NCT01305239|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153894861|NCT01305239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153894862|NCT01305239|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
153894863|NCT01305239|Hormone Antagonists|hormone antagonists|mesh-ancestor
153894864|NCT01305239|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153894865|NCT01305239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153894866|NCT04317183|Miconazole|miconazole|mesh-list
153894867|NCT04317183|Antifungal Agents|antifungal agents|mesh-ancestor
153894868|NCT04317183|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153894869|NCT04317183|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
153894870|NCT04317183|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153894871|NCT04317183|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153894872|NCT04317183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153894873|NCT04317183|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153894874|NCT04317183|Hormone Antagonists|hormone antagonists|mesh-ancestor
153894875|NCT04317183|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153894876|NCT04317183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153894877|NCT04317183|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
153894878|NCT04317183|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
153435985|NCT00002599|Antiemetics|antiemetics|mesh-ancestor
153894879|NCT01194219|Apremilast|apremilast|mesh-list
153894880|NCT01194219|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153894881|NCT01194219|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153894882|NCT01194219|Analgesics|analgesics|mesh-ancestor
153894883|NCT01194219|Sensory System Agents|sensory system agents|mesh-ancestor
153894884|NCT01194219|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153894885|NCT01194219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153894886|NCT01194219|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153436035|NCT00003938|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153436036|NCT00003938|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153436037|NCT00003938|Antifungal Agents|antifungal agents|mesh-ancestor
153436039|NCT00003212|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
153436040|NCT00003212|Ifosfamide|ifosfamide|mesh-list
153436041|NCT00003212|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153436062|NCT00002611|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153894887|NCT01194219|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153894888|NCT01194219|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
153894889|NCT01194219|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
153894890|NCT01194219|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153894891|NCT01194219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153894892|NCT01304693|Ranibizumab|ranibizumab|mesh-list
153894893|NCT01304693|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153894894|NCT01304693|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153894895|NCT01304693|Growth Substances|growth substances|mesh-ancestor
153894896|NCT01304693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153894897|NCT01304693|Growth Inhibitors|growth inhibitors|mesh-ancestor
153894898|NCT01304693|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153894899|NCT01304147|Ketamine|ketamine|mesh-list
153894900|NCT01304147|Analgesics|analgesics|mesh-ancestor
153894901|NCT01304147|Sensory System Agents|sensory system agents|mesh-ancestor
153894902|NCT01304147|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153894903|NCT01304147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153894904|NCT01304147|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
153894905|NCT01304147|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153894906|NCT01304147|Anesthetics, General|anesthetics, general|mesh-ancestor
153894907|NCT01304147|Anesthetics|anesthetics|mesh-ancestor
153894908|NCT01304147|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153894909|NCT01304147|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
153894910|NCT01304147|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
153894911|NCT01304147|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153894912|NCT01304147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153436063|NCT00002611|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153436064|NCT00002611|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153436065|NCT00002611|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153436066|NCT00002611|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153436067|NCT00002611|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153436068|NCT00002611|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153436070|NCT00002611|Antimitotic Agents|antimitotic agents|mesh-ancestor
153436071|NCT00002611|Mitosis Modulators|mitosis modulators|mesh-ancestor
153436072|NCT00002611|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153436073|NCT00002611|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153436074|NCT00002611|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
153436075|NCT00002611|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153436077|NCT00003944|Cyclophosphamide|cyclophosphamide|mesh-list
153436078|NCT00003944|Carboplatin|carboplatin|mesh-list
153436079|NCT00003944|Topotecan|topotecan|mesh-list
153436080|NCT00003944|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153436081|NCT00003944|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153436082|NCT00003944|Tubulin Modulators|tubulin modulators|mesh-ancestor
153436083|NCT00003944|Antimitotic Agents|antimitotic agents|mesh-ancestor
153436084|NCT00003944|Mitosis Modulators|mitosis modulators|mesh-ancestor
153436085|NCT00003944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153436086|NCT00003944|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153436087|NCT00003944|Immunologic Factors|immunologic factors|mesh-ancestor
153436088|NCT00003944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153436089|NCT00003944|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153436090|NCT00003944|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153436091|NCT00003944|Alkylating Agents|alkylating agents|mesh-ancestor
153436092|NCT00003944|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153436093|NCT00003944|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
153436094|NCT00003944|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153436095|NCT00003944|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153436097|NCT00003950|Irinotecan|irinotecan|mesh-list
153894913|NCT05661227|Dexmedetomidine|dexmedetomidine|mesh-list
153894914|NCT05661227|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153894915|NCT05661227|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153894916|NCT05661227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153894917|NCT05661227|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153894918|NCT05661227|Analgesics|analgesics|mesh-ancestor
153894919|NCT05661227|Sensory System Agents|sensory system agents|mesh-ancestor
153894920|NCT05661227|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153894921|NCT05661227|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
153894923|NCT05661227|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153894924|NCT05661227|Adrenergic Agents|adrenergic agents|mesh-ancestor
153894925|NCT05661227|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153894926|NCT05661227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153894927|NCT01303445|Omeprazole|omeprazole|mesh-list
153894928|NCT01303445|Aspirin, Dipyridamole Drug Combination|aspirin, dipyridamole drug combination|mesh-list
153894929|NCT01303445|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
153894930|NCT01303445|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153894931|NCT01303445|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
153894932|NCT01303445|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153894933|NCT01303445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153894934|NCT01303445|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153894935|NCT01188681|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
153894936|NCT01188681|Immunoglobulin G|immunoglobulin g|mesh-list
153894937|NCT01188681|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153894938|NCT01188681|Alkylating Agents|alkylating agents|mesh-ancestor
153894939|NCT01188681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153894940|NCT01188681|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153894941|NCT01188681|Immunologic Factors|immunologic factors|mesh-ancestor
153894942|NCT01188681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153894943|NCT01302899|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
153894944|NCT01302899|Ramipril|ramipril|mesh-list
153894945|NCT01302899|Aliskiren|aliskiren|mesh-list
153894946|NCT01302899|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153894947|NCT01302899|Diuretics|diuretics|mesh-ancestor
153894948|NCT01302899|Natriuretic Agents|natriuretic agents|mesh-ancestor
153894949|NCT01302899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153894950|NCT01302899|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
153894951|NCT01302899|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153436103|NCT00003950|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153436104|NCT00003950|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153436105|NCT00003950|Immunologic Factors|immunologic factors|mesh-ancestor
153436106|NCT00003950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153436107|NCT00003950|Antifungal Agents|antifungal agents|mesh-ancestor
153436108|NCT00003950|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153436109|NCT00003950|Dermatologic Agents|dermatologic agents|mesh-ancestor
153436110|NCT00003950|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153436111|NCT00003950|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
153436113|NCT00003464|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153436114|NCT00003464|Alkylating Agents|alkylating agents|mesh-ancestor
153436115|NCT00003464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153436116|NCT00003464|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153436117|NCT00003230|Paclitaxel|paclitaxel|mesh-list
153436118|NCT00003230|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153436119|NCT00003230|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153436120|NCT00003230|Tubulin Modulators|tubulin modulators|mesh-ancestor
153436121|NCT00003230|Antimitotic Agents|antimitotic agents|mesh-ancestor
153436122|NCT00003230|Mitosis Modulators|mitosis modulators|mesh-ancestor
153436123|NCT00003230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153436124|NCT00003956|Leucovorin|leucovorin|mesh-list
153436125|NCT00003956|Fluorouracil|fluorouracil|mesh-list
153436126|NCT00003956|Calcium|calcium|mesh-list
153436127|NCT00003956|Levoleucovorin|levoleucovorin|mesh-list
153436128|NCT00003956|Lonafarnib|lonafarnib|mesh-list
153436129|NCT00003956|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153894952|NCT01302899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153894953|NCT01302899|Renin Inhibitors|renin inhibitors|mesh-ancestor
153894954|NCT01302899|Protease Inhibitors|protease inhibitors|mesh-ancestor
153894955|NCT01302899|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153894956|NCT01302899|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
153894957|NCT01187901|Sulindac|sulindac|mesh-list
153894958|NCT01187901|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
153894959|NCT01187901|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153894960|NCT01187901|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153894961|NCT01187901|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153894962|NCT01187901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153894963|NCT01187901|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153894964|NCT01187901|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153894965|NCT01187901|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153894967|NCT01187901|Sensory System Agents|sensory system agents|mesh-ancestor
153894968|NCT01187901|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153894969|NCT01187901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153894970|NCT01187901|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153894971|NCT01187901|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153436130|NCT00003956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153436140|NCT00003956|Vitamins|vitamins|mesh-ancestor
153894972|NCT01187901|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153894973|NCT01302119|Tavaborole|tavaborole|mesh-list
153894974|NCT01302119|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
153894975|NCT01302119|Antifungal Agents|antifungal agents|mesh-ancestor
153894976|NCT01302119|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153894978|NCT05927922|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153894979|NCT05927922|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153894980|NCT05927922|Analgesics|analgesics|mesh-ancestor
153894981|NCT05927922|Sensory System Agents|sensory system agents|mesh-ancestor
153894982|NCT05927922|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153894983|NCT05927922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153894984|NCT05927922|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153894985|NCT05927922|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153894986|NCT05927922|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153894987|NCT05927922|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153894988|NCT05927922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153894989|NCT05927857|Trifluridine|trifluridine|mesh-list
153894990|NCT05927857|Ramucirumab|ramucirumab|mesh-list
153894991|NCT05927857|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153894992|NCT05927857|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153894994|NCT05927857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153436150|NCT00003962|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153436151|NCT00003968|Bryostatin 1|bryostatin 1|mesh-list
153436152|NCT00003968|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153436153|NCT00003968|Immunologic Factors|immunologic factors|mesh-ancestor
153436154|NCT00003968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153436155|NCT00003968|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153436156|NCT00003974|Cyclophosphamide|cyclophosphamide|mesh-list
153436157|NCT00003974|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153436158|NCT00003974|Immunologic Factors|immunologic factors|mesh-ancestor
153436159|NCT00003974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153436160|NCT00003974|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153436161|NCT00003974|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153436162|NCT00003974|Alkylating Agents|alkylating agents|mesh-ancestor
153436163|NCT00003974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153436164|NCT00003974|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153436165|NCT00003974|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153436166|NCT00002635|Lenograstim|lenograstim|mesh-list
153436167|NCT00002635|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153436168|NCT00002635|Immunologic Factors|immunologic factors|mesh-ancestor
153436169|NCT00002635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153436171|NCT00003242|Bryostatin 1|bryostatin 1|mesh-list
153894995|NCT05927857|Growth Inhibitors|growth inhibitors|mesh-ancestor
153894996|NCT05927857|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153894997|NCT05927857|Antimetabolites|antimetabolites|mesh-ancestor
153894998|NCT05927857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153894999|NCT05927857|Antiviral Agents|antiviral agents|mesh-ancestor
153895000|NCT05927857|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153895001|NCT05927831|Grape Seed Extract|grape seed extract|mesh-list
153895002|NCT05927831|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153895003|NCT05927831|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153895004|NCT05927831|Antioxidants|antioxidants|mesh-ancestor
153895005|NCT05927831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153895006|NCT05927831|Protective Agents|protective agents|mesh-ancestor
153895007|NCT05927831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153895008|NCT05927818|Charcoal|charcoal|mesh-list
153895009|NCT05927818|Antidotes|antidotes|mesh-ancestor
153895010|NCT05927818|Protective Agents|protective agents|mesh-ancestor
153895012|NCT05927428|Ophthalmic Solutions|ophthalmic solutions|mesh-list
153895013|NCT05927428|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
153895014|NCT05927259|Acetylcysteine|acetylcysteine|mesh-list
153895015|NCT05927259|Atropine|atropine|mesh-list
153895016|NCT05927259|N-monoacetylcystine|n-monoacetylcystine|mesh-list
153895017|NCT05927259|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153895018|NCT05927259|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153895019|NCT05927259|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153895020|NCT05927259|Autonomic Agents|autonomic agents|mesh-ancestor
153895021|NCT05927259|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153895022|NCT05927259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153895023|NCT05927259|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153895024|NCT05927259|Respiratory System Agents|respiratory system agents|mesh-ancestor
153895025|NCT05927259|Mydriatics|mydriatics|mesh-ancestor
153436173|NCT00003242|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153895026|NCT05927259|Parasympatholytics|parasympatholytics|mesh-ancestor
153895027|NCT05927259|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
153895028|NCT05927259|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
153895029|NCT05927259|Cholinergic Agents|cholinergic agents|mesh-ancestor
153895030|NCT05927259|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153895031|NCT05927259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153895032|NCT05927259|Antiviral Agents|antiviral agents|mesh-ancestor
153895033|NCT05927259|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153895035|NCT05927259|Free Radical Scavengers|free radical scavengers|mesh-ancestor
153895036|NCT05927259|Antioxidants|antioxidants|mesh-ancestor
153895037|NCT05927259|Protective Agents|protective agents|mesh-ancestor
153895038|NCT05927259|Antidotes|antidotes|mesh-ancestor
153895039|NCT05927155|Tiotropium Bromide|tiotropium bromide|mesh-list
153895040|NCT05927155|Olodaterol|olodaterol|mesh-list
153895041|NCT05927155|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153895042|NCT05927155|Autonomic Agents|autonomic agents|mesh-ancestor
153895043|NCT05927155|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153895044|NCT05927155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153895045|NCT05927155|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153895046|NCT05927155|Respiratory System Agents|respiratory system agents|mesh-ancestor
153895047|NCT05927155|Parasympatholytics|parasympatholytics|mesh-ancestor
153436202|NCT05664061|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153436203|NCT05664061|Sympathomimetics|sympathomimetics|mesh-ancestor
153436204|NCT00003248|Rituximab|rituximab|mesh-list
153436205|NCT00003248|Fludarabine|fludarabine|mesh-list
153436206|NCT00003248|Fludarabine phosphate|fludarabine phosphate|mesh-list
153436207|NCT00003248|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153436208|NCT00003248|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153436209|NCT00003248|Immunologic Factors|immunologic factors|mesh-ancestor
153436210|NCT00003248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153436211|NCT00003248|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153436215|NCT00003248|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153436217|NCT00002641|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
153436218|NCT00002641|Ifosfamide|ifosfamide|mesh-list
153436219|NCT00002641|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153436220|NCT00002641|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153436221|NCT00002641|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153436222|NCT00002641|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153436223|NCT00002641|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153436224|NCT00002641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153436225|NCT00002641|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153436226|NCT00002641|Alkylating Agents|alkylating agents|mesh-ancestor
153436227|NCT00003992|Tamoxifen|tamoxifen|mesh-list
153436228|NCT00003992|Paclitaxel|paclitaxel|mesh-list
153436229|NCT00003992|Cyclophosphamide|cyclophosphamide|mesh-list
153436230|NCT00003992|Doxorubicin|doxorubicin|mesh-list
153436231|NCT00003992|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
153436232|NCT00003992|Trastuzumab|trastuzumab|mesh-list
153436233|NCT00003992|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153436234|NCT00003992|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153436235|NCT00003992|Tubulin Modulators|tubulin modulators|mesh-ancestor
153436236|NCT00003992|Antimitotic Agents|antimitotic agents|mesh-ancestor
153436237|NCT00003992|Mitosis Modulators|mitosis modulators|mesh-ancestor
153895048|NCT05927155|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
153895049|NCT05927155|Cholinergic Agents|cholinergic agents|mesh-ancestor
153895050|NCT05927155|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153895051|NCT05927155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153895052|NCT05927129|Antidepressive Agents|antidepressive agents|mesh-list
153895053|NCT05927129|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153895054|NCT05926895|Betamethasone|betamethasone|mesh-list
153895056|NCT05926895|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
153895057|NCT05926895|Betamethasone benzoate|betamethasone benzoate|mesh-list
153895058|NCT05926895|Betamethasone dipropionate, betamethasone sodium phosphate drug combination|betamethasone dipropionate, betamethasone sodium phosphate drug combination|mesh-list
153895060|NCT05926895|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
153895061|NCT05926895|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153895062|NCT05926895|Glucocorticoids|glucocorticoids|mesh-ancestor
153895063|NCT05926895|Hormones|hormones|mesh-ancestor
153895064|NCT05926895|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153895065|NCT05926895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153895066|NCT05926895|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153895067|NCT05926895|Respiratory System Agents|respiratory system agents|mesh-ancestor
153895068|NCT05926895|Anesthetics, Local|anesthetics, local|mesh-ancestor
153895069|NCT05926895|Anesthetics|anesthetics|mesh-ancestor
153895070|NCT05926895|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153895071|NCT05926895|Sensory System Agents|sensory system agents|mesh-ancestor
153895072|NCT05926895|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153895073|NCT05926882|Apremilast|apremilast|mesh-list
153895074|NCT05926882|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153895075|NCT05926882|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153895077|NCT05926882|Sensory System Agents|sensory system agents|mesh-ancestor
153895078|NCT05926882|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153895079|NCT05926882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153895080|NCT05926882|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153436238|NCT00003992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153436239|NCT00003992|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153436240|NCT00003992|Immunologic Factors|immunologic factors|mesh-ancestor
153436241|NCT00003992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153436242|NCT00003992|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153436243|NCT00003992|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153436244|NCT00003992|Alkylating Agents|alkylating agents|mesh-ancestor
153436245|NCT00003992|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153436246|NCT00003992|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153436247|NCT00003992|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153436248|NCT00003992|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153436249|NCT00003992|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153895081|NCT05926882|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153895082|NCT05926882|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
153895083|NCT05926882|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
153895084|NCT05926882|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153895085|NCT05926882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153895086|NCT05926869|Clindamycin|clindamycin|mesh-list
153895087|NCT05926869|Clindamycin palmitate|clindamycin palmitate|mesh-list
153895088|NCT05926869|Clindamycin phosphate|clindamycin phosphate|mesh-list
153895089|NCT05926869|Dapsone|dapsone|mesh-list
153895090|NCT05926869|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153895091|NCT05926869|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153895092|NCT05926869|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
153895093|NCT05926869|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153895094|NCT05926869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153895095|NCT05926869|Antimalarials|antimalarials|mesh-ancestor
153895096|NCT05926869|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153895097|NCT05926869|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153895098|NCT05926869|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153895099|NCT05926869|Leprostatic Agents|leprostatic agents|mesh-ancestor
153895100|NCT05926271|Clopidogrel|clopidogrel|mesh-list
153895101|NCT05926271|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153895102|NCT05926271|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
153895103|NCT05926271|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
153895104|NCT05926271|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
153895105|NCT05926271|Purinergic Agents|purinergic agents|mesh-ancestor
153895106|NCT05926271|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153895107|NCT05926271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153895108|NCT05926271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153895109|NCT05926245|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
153895110|NCT05926206|Folfirinox|folfirinox|mesh-list
153895111|NCT05926206|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153895112|NCT05926128|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-list
153895113|NCT05926128|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153895114|NCT05926128|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153895115|NCT05926128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153895116|NCT05922176|Immunomodulating Agents|immunomodulating agents|mesh-list
153895117|NCT05922176|Immunologic Factors|immunologic factors|mesh-list
153895118|NCT05922176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153895119|NCT05876182|Vancomycin|vancomycin|mesh-list
153895120|NCT05876182|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153895121|NCT05876182|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153895122|NCT05690984|Dexamethasone|dexamethasone|mesh-list
153895123|NCT05690984|Lenalidomide|lenalidomide|mesh-list
153895124|NCT05690984|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153895126|NCT05690984|Autonomic Agents|autonomic agents|mesh-ancestor
153895127|NCT05690984|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153895128|NCT05690984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153895129|NCT05690984|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153895130|NCT05690984|Glucocorticoids|glucocorticoids|mesh-ancestor
153895131|NCT05690984|Hormones|hormones|mesh-ancestor
153895132|NCT05690984|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153895133|NCT05690984|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153895134|NCT05690984|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153895135|NCT05690984|Immunologic Factors|immunologic factors|mesh-ancestor
153895136|NCT05690984|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153895137|NCT05690984|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153895138|NCT05690984|Growth Substances|growth substances|mesh-ancestor
153895139|NCT05690984|Growth Inhibitors|growth inhibitors|mesh-ancestor
153895140|NCT05688332|Metformin|metformin|mesh-list
153895141|NCT05688332|Glyburide|glyburide|mesh-list
153895142|NCT05688332|Voglibose|voglibose|mesh-list
153895143|NCT05688332|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153436300|NCT00003998|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153436301|NCT00003998|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153436302|NCT00003998|Tubulin Modulators|tubulin modulators|mesh-ancestor
153436303|NCT00003998|Antimitotic Agents|antimitotic agents|mesh-ancestor
153436304|NCT00003998|Mitosis Modulators|mitosis modulators|mesh-ancestor
153436305|NCT00003998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153436306|NCT00004004|Procarbazine|procarbazine|mesh-list
153436307|NCT00004004|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153436308|NCT00003260|Leucovorin|leucovorin|mesh-list
153436309|NCT00003260|Fluorouracil|fluorouracil|mesh-list
153436310|NCT00003260|Oxaliplatin|oxaliplatin|mesh-list
153436311|NCT00003260|Irinotecan|irinotecan|mesh-list
153436312|NCT00003260|Calcium|calcium|mesh-list
153436313|NCT00003260|Levoleucovorin|levoleucovorin|mesh-list
153436314|NCT00003260|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153436315|NCT00003260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153436316|NCT00003260|Antimetabolites|antimetabolites|mesh-ancestor
153436317|NCT00003260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153895144|NCT05688332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153895145|NCT05688332|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
153895146|NCT05688332|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153895147|NCT05688332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153895148|NCT05642962|Pancrelipase|pancrelipase|mesh-list
153895149|NCT05642962|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153895150|NCT05597735|Tecovirimat|tecovirimat|mesh-list
153895151|NCT05597735|Antiviral Agents|antiviral agents|mesh-ancestor
153895152|NCT05597735|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153895153|NCT05488431|8-hydroxy-2,2,14,14-tetramethylpentadecanedioic acid|8-hydroxy-2,2,14,14-tetramethylpentadecanedioic acid|mesh-list
153895154|NCT05488431|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153895155|NCT05488431|Antimetabolites|antimetabolites|mesh-ancestor
153895156|NCT05488431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153895157|NCT05488431|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153895158|NCT05488431|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153895159|NCT05488431|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153895160|NCT05488431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153895161|NCT05354453|Phenethyl isothiocyanate|phenethyl isothiocyanate|mesh-list
153895163|NCT05354453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153895165|NCT05354453|Protective Agents|protective agents|mesh-ancestor
153895166|NCT05354453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153895167|NCT05354453|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153895168|NCT05046873|Semaglutide|semaglutide|mesh-list
153895169|NCT05046873|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
153895170|NCT05046873|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153895171|NCT05046873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153895172|NCT05038982|Abrocitinib|abrocitinib|mesh-list
153895173|NCT05038982|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153895174|NCT05038982|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153895175|NCT05038982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153895177|NCT04983966|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
153895178|NCT04983966|Anesthetics, General|anesthetics, general|mesh-ancestor
153895179|NCT04983966|Anesthetics|anesthetics|mesh-ancestor
153895180|NCT04983966|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153895181|NCT04983966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153436318|NCT00003260|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153436325|NCT00003260|Antidotes|antidotes|mesh-ancestor
153895182|NCT04972942|Daratumumab|daratumumab|mesh-list
153895183|NCT04972942|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153895184|NCT04953897|Decitabine|decitabine|mesh-list
153895185|NCT04953897|Decitabine and cedazuridine drug combination|decitabine and cedazuridine drug combination|mesh-list
153895186|NCT04953897|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153895187|NCT04953897|Antimetabolites|antimetabolites|mesh-ancestor
153895188|NCT04953897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153895189|NCT04953897|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153895190|NCT04953897|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153895191|NCT04917406|Dexamethasone|dexamethasone|mesh-list
153895192|NCT04917406|Lidocaine|lidocaine|mesh-list
153895193|NCT04917406|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153895195|NCT04917406|Autonomic Agents|autonomic agents|mesh-ancestor
153895196|NCT04917406|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153895197|NCT04917406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153436360|NCT00002665|Hormones|hormones|mesh-ancestor
153436361|NCT00002665|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153436362|NCT00002665|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153436363|NCT00002665|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153436364|NCT00002665|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153436365|NCT00002665|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153436366|NCT00002665|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153436367|NCT00002665|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
153436368|NCT00002665|Abortifacient Agents|abortifacient agents|mesh-ancestor
153436369|NCT00002665|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153436370|NCT00002665|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153436371|NCT00002665|Antimetabolites|antimetabolites|mesh-ancestor
153436372|NCT00002665|Dermatologic Agents|dermatologic agents|mesh-ancestor
153895198|NCT04917406|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153895199|NCT04917406|Glucocorticoids|glucocorticoids|mesh-ancestor
153895200|NCT04917406|Hormones|hormones|mesh-ancestor
153895201|NCT04917406|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153895202|NCT04917406|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153895203|NCT04917406|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153895204|NCT04917406|Anesthetics, Local|anesthetics, local|mesh-ancestor
153895205|NCT04917406|Anesthetics|anesthetics|mesh-ancestor
153895206|NCT04917406|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153895207|NCT04917406|Sensory System Agents|sensory system agents|mesh-ancestor
153895208|NCT04917406|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153895209|NCT04917406|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
153895210|NCT04917406|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153895211|NCT04917406|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153895212|NCT04917406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153895213|NCT04867785|Dulaglutide|dulaglutide|mesh-list
153895214|NCT04867785|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
153895215|NCT04867785|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153895216|NCT04867785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153895217|NCT04812912|Hormones|hormones|mesh-list
153895218|NCT04812912|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153895219|NCT04812912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153895220|NCT04761302|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
153895221|NCT04630158|Lubricant Eye Drops|lubricant eye drops|mesh-list
153895222|NCT04630158|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
153895223|NCT04630158|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
153895224|NCT04466917|Paclitaxel|paclitaxel|mesh-list
153895225|NCT04466917|Bevacizumab|bevacizumab|mesh-list
153895226|NCT04466917|Carboplatin|carboplatin|mesh-list
153895227|NCT04466917|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153895228|NCT04466917|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153895229|NCT04466917|Tubulin Modulators|tubulin modulators|mesh-ancestor
153895230|NCT04466917|Antimitotic Agents|antimitotic agents|mesh-ancestor
153895231|NCT04466917|Mitosis Modulators|mitosis modulators|mesh-ancestor
153895232|NCT04466917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153895233|NCT04466917|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153895234|NCT04466917|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153895235|NCT04466917|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153895236|NCT04466917|Growth Substances|growth substances|mesh-ancestor
153895237|NCT04466917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153895238|NCT04466917|Growth Inhibitors|growth inhibitors|mesh-ancestor
153895239|NCT04370483|Leflunomide|leflunomide|mesh-list
153895240|NCT04370483|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153895241|NCT04370483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153895242|NCT04370483|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153895243|NCT04370483|Immunologic Factors|immunologic factors|mesh-ancestor
153895244|NCT04370483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153895245|NCT04283656|Tenofovir|tenofovir|mesh-list
153895246|NCT04283656|Lamivudine|lamivudine|mesh-list
153895247|NCT04283656|Spironolactone|spironolactone|mesh-list
153895248|NCT04283656|Estradiol|estradiol|mesh-list
153895249|NCT04283656|Antiviral Agents|antiviral agents|mesh-ancestor
153895250|NCT04283656|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153895251|NCT04283656|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153895252|NCT04283656|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153895253|NCT04283656|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153895254|NCT04283656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153895255|NCT04283656|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153895256|NCT04283656|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153895257|NCT04283656|Estrogens|estrogens|mesh-ancestor
153436423|NCT00004010|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153436424|NCT00004010|Alkylating Agents|alkylating agents|mesh-ancestor
153436425|NCT00004010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153436426|NCT00004010|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153436427|NCT00004010|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153436428|NCT00004010|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153436429|NCT00004010|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153436430|NCT00004010|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153436431|NCT00004010|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153436432|NCT00004010|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153436433|NCT00004010|Glucocorticoids|glucocorticoids|mesh-ancestor
153436435|NCT00004010|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153436436|NCT00004010|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153436437|NCT00004010|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153436438|NCT00004010|Tubulin Modulators|tubulin modulators|mesh-ancestor
153436439|NCT00004010|Antimitotic Agents|antimitotic agents|mesh-ancestor
153436440|NCT00004010|Mitosis Modulators|mitosis modulators|mesh-ancestor
153436441|NCT00004016|Interferons|interferons|mesh-list
153436442|NCT00004016|Interferon-gamma|interferon-gamma|mesh-list
153436443|NCT00004016|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153436444|NCT00004016|Antiviral Agents|antiviral agents|mesh-ancestor
153436445|NCT00004016|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153436446|NCT00004022|Aldesleukin|aldesleukin|mesh-list
153436447|NCT00004022|Muromonab-CD3|muromonab-cd3|mesh-list
153436448|NCT00004022|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153436449|NCT00004022|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153436450|NCT00004022|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153436451|NCT00004022|Antiviral Agents|antiviral agents|mesh-ancestor
153436452|NCT00004022|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153436454|NCT00004022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153895258|NCT04283656|Hormones|hormones|mesh-ancestor
153895259|NCT04283656|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153895260|NCT04283656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153895261|NCT04283656|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
153895262|NCT04283656|Hormone Antagonists|hormone antagonists|mesh-ancestor
153895263|NCT04283656|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
153895264|NCT04283656|Diuretics|diuretics|mesh-ancestor
153895265|NCT04283656|Natriuretic Agents|natriuretic agents|mesh-ancestor
153895266|NCT04238624|Trametinib|trametinib|mesh-list
153895267|NCT04238624|Dabrafenib|dabrafenib|mesh-list
153895268|NCT04238624|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153895269|NCT04238624|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153895270|NCT04238624|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153895271|NCT04238624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153895272|NCT04106414|Nivolumab|nivolumab|mesh-list
153895273|NCT04106414|Linrodostat|linrodostat|mesh-list
153895274|NCT04106414|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153895275|NCT04106414|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153895276|NCT04106414|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153895277|NCT04106414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153895278|NCT04106414|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153895279|NCT04047914|Anti-Infective Agents|anti-infective agents|mesh-list
153895280|NCT04047914|Mupirocin|mupirocin|mesh-list
153895281|NCT04047914|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
153895282|NCT04047914|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
153895283|NCT04047914|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153895284|NCT04047914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153895285|NCT04042753|Nivolumab|nivolumab|mesh-list
153895286|NCT04042753|Ipilimumab|ipilimumab|mesh-list
153895287|NCT04042753|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153895288|NCT04042753|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153895289|NCT04042753|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153895290|NCT04042753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153895291|NCT03995355|Ophthalmic Solutions|ophthalmic solutions|mesh-list
153895292|NCT03995355|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
153895293|NCT03933397|Morphine|morphine|mesh-list
153895294|NCT03933397|Hydromorphone|hydromorphone|mesh-list
153895295|NCT03933397|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153895296|NCT03933397|Narcotics|narcotics|mesh-ancestor
153895297|NCT03933397|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153895298|NCT03933397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153895299|NCT03933397|Analgesics|analgesics|mesh-ancestor
153436467|NCT00003278|Hormones|hormones|mesh-ancestor
153436468|NCT00003278|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153436469|NCT00003278|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153436470|NCT00003278|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153436471|NCT00004028|Carmustine|carmustine|mesh-list
153436472|NCT00004028|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153436473|NCT00004028|Alkylating Agents|alkylating agents|mesh-ancestor
153436474|NCT00004028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153436475|NCT00004028|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153436476|NCT00003554|Prednisone|prednisone|mesh-list
153436477|NCT00003554|Rituximab|rituximab|mesh-list
153436478|NCT00003554|Melphalan|melphalan|mesh-list
153436479|NCT00003554|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153436480|NCT00003554|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153436481|NCT00003554|Immunologic Factors|immunologic factors|mesh-ancestor
153436482|NCT00003554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153436483|NCT00003554|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153436484|NCT00003554|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153436485|NCT00003554|Glucocorticoids|glucocorticoids|mesh-ancestor
153436486|NCT00003554|Hormones|hormones|mesh-ancestor
153436487|NCT00003554|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153895300|NCT03933397|Sensory System Agents|sensory system agents|mesh-ancestor
153895301|NCT03933397|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153895302|NCT03925090|Cisplatin|cisplatin|mesh-list
153895303|NCT03925090|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153895304|NCT03919266|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
153895305|NCT03919266|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153895306|NCT03829436|Nivolumab|nivolumab|mesh-list
153895307|NCT03829436|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153895308|NCT03829436|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153895309|NCT03829436|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153895310|NCT03829436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153895311|NCT03790488|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
153895312|NCT03790488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153895313|NCT03790488|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153895314|NCT03790488|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153895315|NCT03767257|Colesevelam Hydrochloride|colesevelam hydrochloride|mesh-list
153895316|NCT03767257|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153895317|NCT03767257|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153895318|NCT03767257|Antimetabolites|antimetabolites|mesh-ancestor
153895319|NCT03767257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153895320|NCT03767257|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153895321|NCT03576690|Atoltivimab, maftivimab, and odesivimab-ebgn drug combination|atoltivimab, maftivimab, and odesivimab-ebgn drug combination|mesh-list
153895324|NCT03576690|Maftivimab|maftivimab|mesh-list
153895325|NCT03576690|Antiviral Agents|antiviral agents|mesh-ancestor
153895326|NCT03576690|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153895327|NCT03573947|Paclitaxel|paclitaxel|mesh-list
153895328|NCT03573947|Nivolumab|nivolumab|mesh-list
153895329|NCT03573947|Ipilimumab|ipilimumab|mesh-list
153895330|NCT03573947|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153895331|NCT03573947|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153895332|NCT03573947|Tubulin Modulators|tubulin modulators|mesh-ancestor
153436494|NCT00003284|Paclitaxel|paclitaxel|mesh-list
153895333|NCT03573947|Antimitotic Agents|antimitotic agents|mesh-ancestor
153895334|NCT03573947|Mitosis Modulators|mitosis modulators|mesh-ancestor
153895335|NCT03573947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153895336|NCT03573947|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153895337|NCT03573947|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153895338|NCT03532880|Olaparib|olaparib|mesh-list
153895339|NCT03532880|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
153895340|NCT03532880|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153895341|NCT03532880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153895342|NCT03532880|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153895343|NCT03207945|Alirocumab|alirocumab|mesh-list
153895344|NCT03207945|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
153895345|NCT03207945|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153895346|NCT03207945|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153895347|NCT03207945|Antimetabolites|antimetabolites|mesh-ancestor
153895348|NCT03207945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153895349|NCT03207945|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
153895350|NCT03207945|Protease Inhibitors|protease inhibitors|mesh-ancestor
153895351|NCT03207945|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153436520|NCT00004040|Interferon-alpha|interferon-alpha|mesh-list
153436521|NCT00004040|Rituximab|rituximab|mesh-list
153436522|NCT00004040|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153436523|NCT00004040|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153436524|NCT00004040|Immunologic Factors|immunologic factors|mesh-ancestor
153436525|NCT00004040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153436526|NCT00004040|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153436528|NCT00004040|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153436529|NCT00004046|Exatecan|exatecan|mesh-list
153436530|NCT00004046|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
153436531|NCT00004046|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153436532|NCT00004046|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153436533|NCT00004046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153436534|NCT00004046|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153436535|NCT00003560|Carboplatin|carboplatin|mesh-list
153436537|NCT00003560|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153436538|NCT00003560|Tubulin Modulators|tubulin modulators|mesh-ancestor
153436539|NCT00003560|Antimitotic Agents|antimitotic agents|mesh-ancestor
153436540|NCT00003560|Mitosis Modulators|mitosis modulators|mesh-ancestor
153436541|NCT00003560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153436542|NCT00003290|Hormones|hormones|mesh-list
153436543|NCT00003290|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153436544|NCT00003290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153436545|NCT05748925|Dapagliflozin|dapagliflozin|mesh-list
153436546|NCT05748925|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
153436547|NCT05748925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153436548|NCT05748925|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153436549|NCT05748925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153895352|NCT03207945|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153895353|NCT03134703|Morphine|morphine|mesh-list
153895354|NCT03134703|Methadone|methadone|mesh-list
153895355|NCT03134703|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153895356|NCT03134703|Narcotics|narcotics|mesh-ancestor
153895357|NCT03134703|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153895358|NCT03134703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153895359|NCT03134703|Analgesics|analgesics|mesh-ancestor
153895360|NCT03134703|Sensory System Agents|sensory system agents|mesh-ancestor
153895361|NCT03134703|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153895362|NCT03134703|Antitussive Agents|antitussive agents|mesh-ancestor
153895363|NCT03134703|Respiratory System Agents|respiratory system agents|mesh-ancestor
153895364|NCT03118674|Sofosbuvir|sofosbuvir|mesh-list
153895365|NCT03118674|Ledipasvir, sofosbuvir drug combination|ledipasvir, sofosbuvir drug combination|mesh-list
153895367|NCT03118674|Antiviral Agents|antiviral agents|mesh-ancestor
153895368|NCT03118674|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153895369|NCT03085056|Paclitaxel|paclitaxel|mesh-list
153895370|NCT03085056|Trametinib|trametinib|mesh-list
153895371|NCT03085056|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153895372|NCT03085056|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153895373|NCT03085056|Tubulin Modulators|tubulin modulators|mesh-ancestor
153895374|NCT03085056|Antimitotic Agents|antimitotic agents|mesh-ancestor
153895375|NCT03085056|Mitosis Modulators|mitosis modulators|mesh-ancestor
153895376|NCT03085056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153895377|NCT03085056|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153895378|NCT03085056|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153895380|NCT03069352|Venetoclax|venetoclax|mesh-list
153895381|NCT03069352|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153895382|NCT03069352|Antimetabolites|antimetabolites|mesh-ancestor
153895383|NCT03069352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153895384|NCT03069352|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153895385|NCT03069352|Antiviral Agents|antiviral agents|mesh-ancestor
153895386|NCT03069352|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153895387|NCT03069352|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153895388|NCT03069352|Immunologic Factors|immunologic factors|mesh-ancestor
153895389|NCT03069352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153895390|NCT03037437|Hydroxychloroquine|hydroxychloroquine|mesh-list
153895391|NCT03037437|Sorafenib|sorafenib|mesh-list
153895392|NCT03037437|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153895393|NCT03037437|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153895394|NCT03037437|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153895395|NCT03037437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153895396|NCT03037437|Antimalarials|antimalarials|mesh-ancestor
153436564|NCT00002689|Dexamethasone|dexamethasone|mesh-list
153436565|NCT00002689|Fluorouracil|fluorouracil|mesh-list
153436566|NCT00002689|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153436567|NCT00002689|Antiemetics|antiemetics|mesh-ancestor
153436568|NCT00002689|Autonomic Agents|autonomic agents|mesh-ancestor
153436569|NCT00002689|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153436570|NCT00002689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153436571|NCT00002689|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153436573|NCT00002689|Hormones|hormones|mesh-ancestor
153436574|NCT00002689|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153436575|NCT00002689|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153436576|NCT00002689|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153436578|NCT00002689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153436579|NCT00002689|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153436580|NCT00002689|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153436581|NCT00002689|Immunologic Factors|immunologic factors|mesh-ancestor
153436582|NCT00003296|Doxorubicin|doxorubicin|mesh-list
153436583|NCT00003296|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
153436584|NCT00003296|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153436585|NCT00003296|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153436586|NCT00003296|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153436587|NCT00003296|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153895397|NCT03037437|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153895398|NCT03037437|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153895399|NCT03037437|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153895400|NCT03037437|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153895401|NCT03036488|Paclitaxel|paclitaxel|mesh-list
153895402|NCT03036488|Cyclophosphamide|cyclophosphamide|mesh-list
153895403|NCT03036488|Carboplatin|carboplatin|mesh-list
153895404|NCT03036488|Doxorubicin|doxorubicin|mesh-list
153895405|NCT03036488|Pembrolizumab|pembrolizumab|mesh-list
153895406|NCT03036488|Epirubicin|epirubicin|mesh-list
153895407|NCT03036488|Lenograstim|lenograstim|mesh-list
153895408|NCT03036488|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153895409|NCT03036488|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153895410|NCT03036488|Tubulin Modulators|tubulin modulators|mesh-ancestor
153895411|NCT03036488|Antimitotic Agents|antimitotic agents|mesh-ancestor
153895412|NCT03036488|Mitosis Modulators|mitosis modulators|mesh-ancestor
153895413|NCT03036488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153895414|NCT03036488|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153895415|NCT03036488|Immunologic Factors|immunologic factors|mesh-ancestor
153895416|NCT03036488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153895417|NCT03036488|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153895418|NCT03036488|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153895419|NCT03036488|Alkylating Agents|alkylating agents|mesh-ancestor
153895420|NCT03036488|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153895421|NCT03036488|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153895422|NCT03036488|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153895423|NCT03036488|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153895424|NCT03036488|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153895425|NCT03036488|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153895426|NCT03036488|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153895427|NCT03036488|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153895428|NCT02993523|Azacitidine|azacitidine|mesh-list
153895429|NCT02993523|Venetoclax|venetoclax|mesh-list
153895430|NCT02993523|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153895431|NCT02993523|Antimetabolites|antimetabolites|mesh-ancestor
153895432|NCT02993523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153895433|NCT02993523|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153895434|NCT02993523|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153895435|NCT02884219|Ibuprofen|ibuprofen|mesh-list
153895436|NCT02884219|Indomethacin|indomethacin|mesh-list
153895437|NCT02884219|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-list
153895438|NCT02884219|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153895439|NCT02884219|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153895440|NCT02884219|Analgesics|analgesics|mesh-ancestor
153895441|NCT02884219|Sensory System Agents|sensory system agents|mesh-ancestor
153895442|NCT02884219|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153895443|NCT02884219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153895444|NCT02884219|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153895445|NCT02884219|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153895446|NCT02884219|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153436614|NCT00003578|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
153436615|NCT00003578|Etoposide|etoposide|mesh-list
153436616|NCT00003578|Vincristine|vincristine|mesh-list
153436617|NCT00003578|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153436618|NCT00003578|Immunologic Factors|immunologic factors|mesh-ancestor
153436619|NCT00003578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153436620|NCT00003578|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153436621|NCT00003578|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153436622|NCT00003578|Alkylating Agents|alkylating agents|mesh-ancestor
153436623|NCT00003578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153436624|NCT00003578|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153436627|NCT00003578|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153436628|NCT00003578|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153436629|NCT00003578|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153895447|NCT02884219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153895448|NCT02884219|Gout Suppressants|gout suppressants|mesh-ancestor
153895449|NCT02884219|Tocolytic Agents|tocolytic agents|mesh-ancestor
153895450|NCT02884219|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153895452|NCT02795429|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153895453|NCT02795429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153895454|NCT02795429|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153895455|NCT02795429|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153895456|NCT02792114|Cyclophosphamide|cyclophosphamide|mesh-list
153895457|NCT02792114|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153895458|NCT02792114|Immunologic Factors|immunologic factors|mesh-ancestor
153895459|NCT02792114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153895460|NCT02792114|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153895461|NCT02792114|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153895462|NCT02792114|Alkylating Agents|alkylating agents|mesh-ancestor
153895463|NCT02792114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153895464|NCT02792114|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153895465|NCT02792114|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153895466|NCT02783625|Bortezomib|bortezomib|mesh-list
153895467|NCT02783625|Romidepsin|romidepsin|mesh-list
153895468|NCT02783625|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153895469|NCT02783625|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153895470|NCT02783625|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
153895471|NCT02783625|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153895472|NCT02783625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153895473|NCT02605486|Palbociclib|palbociclib|mesh-list
153895474|NCT02605486|Bicalutamide|bicalutamide|mesh-list
153895475|NCT02605486|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153895476|NCT02605486|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153895477|NCT02605486|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153895478|NCT02605486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153895479|NCT02605486|Androgen Antagonists|androgen antagonists|mesh-ancestor
153895480|NCT02605486|Hormone Antagonists|hormone antagonists|mesh-ancestor
153895481|NCT02605486|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153895482|NCT02605486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153895483|NCT02538198|Lenalidomide|lenalidomide|mesh-list
153895484|NCT02538198|Immunologic Factors|immunologic factors|mesh-ancestor
153895485|NCT02538198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153895486|NCT02538198|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153895494|NCT02341144|Anesthetics, Local|anesthetics, local|mesh-ancestor
153895495|NCT02341144|Anesthetics|anesthetics|mesh-ancestor
153895496|NCT02341144|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153895497|NCT02341144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153895498|NCT02341144|Sensory System Agents|sensory system agents|mesh-ancestor
153895499|NCT02341144|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153895500|NCT02213328|Tenofovir|tenofovir|mesh-list
153895501|NCT02213328|Emtricitabine|emtricitabine|mesh-list
153895502|NCT02213328|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
153895503|NCT02213328|Antiviral Agents|antiviral agents|mesh-ancestor
153436676|NCT00002701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153436677|NCT00002701|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153436678|NCT00002701|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153436679|NCT00002701|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
153436680|NCT00002701|Abortifacient Agents|abortifacient agents|mesh-ancestor
153436681|NCT00002701|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153436682|NCT00002701|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153436683|NCT00002701|Antimetabolites|antimetabolites|mesh-ancestor
153436686|NCT00002701|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153436687|NCT00002701|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153436688|NCT00002701|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153436689|NCT00002701|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153436690|NCT00002701|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153436691|NCT00002701|Antiviral Agents|antiviral agents|mesh-ancestor
153436692|NCT00002701|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153436693|NCT00002701|Analgesics|analgesics|mesh-ancestor
153436694|NCT00002701|Sensory System Agents|sensory system agents|mesh-ancestor
153436695|NCT00002701|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153436696|NCT00002701|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153436697|NCT00002701|Keratolytic Agents|keratolytic agents|mesh-ancestor
153436698|NCT00004070|Interleukin-12|interleukin-12|mesh-list
153436700|NCT00004070|Immunologic Factors|immunologic factors|mesh-ancestor
153436701|NCT00004070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153436702|NCT00004070|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153436703|NCT00004070|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153436704|NCT00004070|Growth Substances|growth substances|mesh-ancestor
153436705|NCT00004070|Growth Inhibitors|growth inhibitors|mesh-ancestor
153436706|NCT00004070|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153895505|NCT02213328|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153895506|NCT02213328|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153895507|NCT02213328|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153895508|NCT02213328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153895509|NCT02213328|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153895510|NCT02213328|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153895511|NCT02204241|Dexamethasone|dexamethasone|mesh-list
153895512|NCT02204241|Cyclophosphamide|cyclophosphamide|mesh-list
153895513|NCT02204241|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153895514|NCT02204241|Immunologic Factors|immunologic factors|mesh-ancestor
153895515|NCT02204241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153895516|NCT02204241|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153895517|NCT02204241|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153895518|NCT02204241|Alkylating Agents|alkylating agents|mesh-ancestor
153895519|NCT02204241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153895520|NCT02204241|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153895521|NCT02204241|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153895522|NCT02204241|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153895523|NCT02204241|Antiemetics|antiemetics|mesh-ancestor
153895524|NCT02204241|Autonomic Agents|autonomic agents|mesh-ancestor
153895525|NCT02204241|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153895526|NCT02204241|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153895527|NCT02204241|Glucocorticoids|glucocorticoids|mesh-ancestor
153895528|NCT02204241|Hormones|hormones|mesh-ancestor
153895529|NCT02204241|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153895530|NCT02204241|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153895531|NCT02185820|Dexamethasone|dexamethasone|mesh-list
153895532|NCT02185820|Pomalidomide|pomalidomide|mesh-list
153895533|NCT02185820|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153895534|NCT02185820|Antiemetics|antiemetics|mesh-ancestor
153895535|NCT02185820|Autonomic Agents|autonomic agents|mesh-ancestor
153436707|NCT00004082|Carboplatin|carboplatin|mesh-list
153436708|NCT00004082|Gemcitabine|gemcitabine|mesh-list
153436709|NCT00004082|Docetaxel|docetaxel|mesh-list
153436710|NCT00004082|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153436711|NCT00004082|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153436712|NCT00004082|Antimetabolites|antimetabolites|mesh-ancestor
153436713|NCT00004082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153436714|NCT00004082|Tubulin Modulators|tubulin modulators|mesh-ancestor
153436715|NCT00004082|Antimitotic Agents|antimitotic agents|mesh-ancestor
153436716|NCT00004082|Mitosis Modulators|mitosis modulators|mesh-ancestor
153436717|NCT00002707|Tamoxifen|tamoxifen|mesh-list
153436718|NCT00002707|Cyclophosphamide|cyclophosphamide|mesh-list
153436719|NCT00002707|Docetaxel|docetaxel|mesh-list
153436720|NCT00002707|Doxorubicin|doxorubicin|mesh-list
153436722|NCT00002707|Immunologic Factors|immunologic factors|mesh-ancestor
153436723|NCT00002707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153436724|NCT00002707|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153436725|NCT00002707|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153436726|NCT00002707|Alkylating Agents|alkylating agents|mesh-ancestor
153436727|NCT00002707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153436728|NCT00002707|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153436729|NCT00002707|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153436730|NCT00002707|Tubulin Modulators|tubulin modulators|mesh-ancestor
153436731|NCT00002707|Antimitotic Agents|antimitotic agents|mesh-ancestor
153436732|NCT00002707|Mitosis Modulators|mitosis modulators|mesh-ancestor
153436733|NCT00002707|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153436734|NCT00002707|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153436735|NCT00002707|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153436736|NCT00002707|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153436737|NCT00002707|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
153436738|NCT00002707|Hormone Antagonists|hormone antagonists|mesh-ancestor
153436739|NCT00002707|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153436740|NCT00002707|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153895536|NCT02185820|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153895537|NCT02185820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153895538|NCT02185820|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153895539|NCT02185820|Glucocorticoids|glucocorticoids|mesh-ancestor
153895540|NCT02185820|Hormones|hormones|mesh-ancestor
153895541|NCT02185820|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153895542|NCT02185820|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153895543|NCT02185820|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153895544|NCT02185820|Immunologic Factors|immunologic factors|mesh-ancestor
153895545|NCT02185820|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153895546|NCT02185820|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153895547|NCT02185820|Growth Substances|growth substances|mesh-ancestor
153895548|NCT02185820|Growth Inhibitors|growth inhibitors|mesh-ancestor
153895549|NCT02150967|Infigratinib|infigratinib|mesh-list
153895550|NCT02150967|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153895551|NCT02085408|Cytarabine|cytarabine|mesh-list
153895552|NCT02085408|Decitabine|decitabine|mesh-list
153895553|NCT02085408|Clofarabine|clofarabine|mesh-list
153895554|NCT02085408|Azacitidine|azacitidine|mesh-list
153895555|NCT02085408|Daunorubicin|daunorubicin|mesh-list
153895556|NCT02085408|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153895557|NCT02085408|Antimetabolites|antimetabolites|mesh-ancestor
153895558|NCT02085408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153895559|NCT02085408|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153895560|NCT02085408|Antiviral Agents|antiviral agents|mesh-ancestor
153895561|NCT02085408|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153895562|NCT02085408|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153895563|NCT02085408|Immunologic Factors|immunologic factors|mesh-ancestor
153895564|NCT02085408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153895565|NCT02085408|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153895566|NCT02085408|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153895567|NCT02085408|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153895568|NCT02085408|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153895570|NCT02004782|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153436750|NCT00003596|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153436751|NCT00003596|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153436752|NCT00003596|Immunologic Factors|immunologic factors|mesh-ancestor
153436753|NCT00003596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153436754|NCT00003596|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153436755|NCT00003596|Alkylating Agents|alkylating agents|mesh-ancestor
153436756|NCT00003596|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153436757|NCT00003596|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153436759|NCT00002719|Etoposide|etoposide|mesh-list
153436760|NCT00002719|Mitoxantrone|mitoxantrone|mesh-list
153436761|NCT00002719|Idarubicin|idarubicin|mesh-list
153436762|NCT00002719|Carmustine|carmustine|mesh-list
153436763|NCT00002719|Amsacrine|amsacrine|mesh-list
153436764|NCT00002719|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153436765|NCT00002719|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153436766|NCT00002719|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153436767|NCT00002719|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153436768|NCT00002719|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153436769|NCT00002719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153436770|NCT00002719|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153436771|NCT00002719|Antimetabolites|antimetabolites|mesh-ancestor
153436772|NCT00002719|Antiviral Agents|antiviral agents|mesh-ancestor
153436773|NCT00002719|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153436774|NCT00002719|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153436775|NCT00002719|Immunologic Factors|immunologic factors|mesh-ancestor
153436776|NCT00002719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153436777|NCT00002719|Analgesics|analgesics|mesh-ancestor
153436778|NCT00002719|Sensory System Agents|sensory system agents|mesh-ancestor
153436779|NCT00002719|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153436780|NCT00002719|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153436781|NCT00002719|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153436782|NCT00002719|Alkylating Agents|alkylating agents|mesh-ancestor
153895576|NCT02004782|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153895578|NCT01908777|Etoposide|etoposide|mesh-list
153895579|NCT01908777|Melphalan|melphalan|mesh-list
153895580|NCT01908777|Carmustine|carmustine|mesh-list
153895581|NCT01908777|Romidepsin|romidepsin|mesh-list
153895582|NCT01908777|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153895583|NCT01908777|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153895584|NCT01908777|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153895585|NCT01908777|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153895586|NCT01908777|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153895587|NCT01908777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153895588|NCT01908777|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153895589|NCT01908777|Antimetabolites|antimetabolites|mesh-ancestor
153895590|NCT01908777|Antiviral Agents|antiviral agents|mesh-ancestor
153895591|NCT01908777|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153895592|NCT01908777|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153895593|NCT01908777|Immunologic Factors|immunologic factors|mesh-ancestor
153895594|NCT01908777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153895595|NCT01908777|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153895596|NCT01908777|Alkylating Agents|alkylating agents|mesh-ancestor
153895597|NCT01908777|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153895598|NCT01908777|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153895599|NCT01908777|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
153895601|NCT01873326|Etoposide|etoposide|mesh-list
153895602|NCT01873326|Ifosfamide|ifosfamide|mesh-list
153895603|NCT01873326|Bleomycin|bleomycin|mesh-list
153895604|NCT01873326|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153895605|NCT01873326|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153895606|NCT01873326|Tubulin Modulators|tubulin modulators|mesh-ancestor
153895607|NCT01873326|Antimitotic Agents|antimitotic agents|mesh-ancestor
153895608|NCT01873326|Mitosis Modulators|mitosis modulators|mesh-ancestor
153914655|NCT00612547|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153436783|NCT00003326|Paclitaxel|paclitaxel|mesh-list
153436784|NCT00003326|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153436787|NCT00003326|Antimitotic Agents|antimitotic agents|mesh-ancestor
153436788|NCT00003326|Mitosis Modulators|mitosis modulators|mesh-ancestor
153436789|NCT00003326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153436791|NCT00002725|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153436792|NCT00002725|Immunologic Factors|immunologic factors|mesh-ancestor
153436793|NCT00002725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153436794|NCT00002725|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153436795|NCT00003602|Cytarabine|cytarabine|mesh-list
153436796|NCT00003602|Etoposide|etoposide|mesh-list
153436797|NCT00003602|Mitoxantrone|mitoxantrone|mesh-list
153436798|NCT00003602|Idarubicin|idarubicin|mesh-list
153436799|NCT00003602|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153436800|NCT00003602|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153436801|NCT00003602|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153436802|NCT00003602|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153436803|NCT00003602|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153436804|NCT00003602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153436805|NCT00003602|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153436806|NCT00003602|Antimetabolites|antimetabolites|mesh-ancestor
153436807|NCT00003602|Antiviral Agents|antiviral agents|mesh-ancestor
153436808|NCT00003602|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153436809|NCT00003602|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153436810|NCT00003602|Immunologic Factors|immunologic factors|mesh-ancestor
153436811|NCT00003602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153436813|NCT00003602|Sensory System Agents|sensory system agents|mesh-ancestor
153436814|NCT00003602|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153436815|NCT00003602|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153436817|NCT04609423|Cod Liver Oil|cod liver oil|mesh-list
153895609|NCT01873326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153895610|NCT01873326|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153895611|NCT01873326|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153895612|NCT01873326|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153436818|NCT04609423|Vitamins|vitamins|mesh-ancestor
153436822|NCT00003332|Gemcitabine|gemcitabine|mesh-list
153895613|NCT01873326|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153895614|NCT01873326|Alkylating Agents|alkylating agents|mesh-ancestor
153895615|NCT01873326|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153895616|NCT01862315|Dexamethasone|dexamethasone|mesh-list
153895617|NCT01862315|Gemcitabine|gemcitabine|mesh-list
153895618|NCT01862315|Oxaliplatin|oxaliplatin|mesh-list
153895619|NCT01862315|Floxuridine|floxuridine|mesh-list
153895620|NCT01862315|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153895621|NCT01862315|Antiemetics|antiemetics|mesh-ancestor
153895622|NCT01862315|Autonomic Agents|autonomic agents|mesh-ancestor
153895623|NCT01862315|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153895624|NCT01862315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153895625|NCT01862315|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153895626|NCT01862315|Glucocorticoids|glucocorticoids|mesh-ancestor
153895627|NCT01862315|Hormones|hormones|mesh-ancestor
153895628|NCT01862315|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153895629|NCT01862315|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153895630|NCT01862315|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153895631|NCT01862315|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153895632|NCT01862315|Antimetabolites|antimetabolites|mesh-ancestor
153895633|NCT01862315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153895634|NCT01745588|Clarithromycin|clarithromycin|mesh-list
153895635|NCT01745588|Dexamethasone|dexamethasone|mesh-list
153895636|NCT01745588|Pomalidomide|pomalidomide|mesh-list
153895637|NCT01745588|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153895638|NCT01745588|Antiemetics|antiemetics|mesh-ancestor
153895639|NCT01745588|Autonomic Agents|autonomic agents|mesh-ancestor
153895640|NCT01745588|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153895641|NCT01745588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153895642|NCT01745588|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153895644|NCT01745588|Hormones|hormones|mesh-ancestor
153895645|NCT01745588|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153895646|NCT01745588|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153436823|NCT00003332|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153436824|NCT00003332|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153436825|NCT00003332|Antimetabolites|antimetabolites|mesh-ancestor
153436826|NCT00003332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153436827|NCT00004094|Paclitaxel|paclitaxel|mesh-list
153436828|NCT00004094|Carboplatin|carboplatin|mesh-list
153436829|NCT00004094|Fluorouracil|fluorouracil|mesh-list
153436830|NCT00004094|Hydroxyurea|hydroxyurea|mesh-list
153436831|NCT00004094|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153436832|NCT00004094|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153436833|NCT00004094|Tubulin Modulators|tubulin modulators|mesh-ancestor
153436834|NCT00004094|Antimitotic Agents|antimitotic agents|mesh-ancestor
153436835|NCT00004094|Mitosis Modulators|mitosis modulators|mesh-ancestor
153436836|NCT00004094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153436837|NCT00004094|Antimetabolites|antimetabolites|mesh-ancestor
153436838|NCT00004094|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153436839|NCT00004094|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153436840|NCT00004094|Immunologic Factors|immunologic factors|mesh-ancestor
153436841|NCT00004094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153436842|NCT00004094|Antisickling Agents|antisickling agents|mesh-ancestor
153436843|NCT00004094|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153436844|NCT00004094|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153436845|NCT00004100|Gemcitabine|gemcitabine|mesh-list
153436846|NCT00004100|Vinorelbine|vinorelbine|mesh-list
153436847|NCT00004100|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153436848|NCT00004100|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153436849|NCT00004100|Antimetabolites|antimetabolites|mesh-ancestor
153436850|NCT00004100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153895649|NCT01745588|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153895650|NCT01745588|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
153895651|NCT01745588|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153895652|NCT01745588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153895653|NCT01745588|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
153895654|NCT01745588|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153895655|NCT01745588|Immunologic Factors|immunologic factors|mesh-ancestor
153895656|NCT01745588|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153895657|NCT01745588|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153895658|NCT01745588|Growth Substances|growth substances|mesh-ancestor
153895659|NCT01745588|Growth Inhibitors|growth inhibitors|mesh-ancestor
153895660|NCT01290692|Adjuvants, Immunologic|adjuvants, immunologic|mesh-list
153895661|NCT01290692|Immunologic Factors|immunologic factors|mesh-ancestor
153895662|NCT01290692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153895664|NCT00996866|Cholecalciferol|cholecalciferol|mesh-list
153895667|NCT00996866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153895668|NCT00996866|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153895669|NCT00996866|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153895670|NCT00876993|Bevacizumab|bevacizumab|mesh-list
153895671|NCT00876993|Irinotecan|irinotecan|mesh-list
153895672|NCT00876993|Temozolomide|temozolomide|mesh-list
153895673|NCT00876993|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153895674|NCT00876993|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153895675|NCT00876993|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153895676|NCT00876993|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153895677|NCT00876993|Growth Substances|growth substances|mesh-ancestor
153895678|NCT00876993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153436857|NCT00002737|Isotretinoin|isotretinoin|mesh-list
153436860|NCT00002737|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153436861|NCT00002737|Immunologic Factors|immunologic factors|mesh-ancestor
153436862|NCT00002737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153436863|NCT00002737|Dermatologic Agents|dermatologic agents|mesh-ancestor
153436865|NCT00003338|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153436866|NCT00003338|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153436867|NCT00003620|Alvocidib|alvocidib|mesh-list
153436868|NCT00003620|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153436869|NCT00003620|Growth Inhibitors|growth inhibitors|mesh-ancestor
153436870|NCT00003620|Growth Substances|growth substances|mesh-ancestor
153436871|NCT00003620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153436872|NCT00003620|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153436873|NCT00003620|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153436874|NCT00003620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153436875|NCT00003344|Irinotecan|irinotecan|mesh-list
153436876|NCT00003344|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
153436877|NCT00003344|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153436878|NCT00003344|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153436879|NCT00003344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153436881|NCT00003626|Dolastatin 10|dolastatin 10|mesh-list
153436882|NCT00003626|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153436883|NCT00003626|Tubulin Modulators|tubulin modulators|mesh-ancestor
153436884|NCT00003626|Antimitotic Agents|antimitotic agents|mesh-ancestor
153436885|NCT00003626|Mitosis Modulators|mitosis modulators|mesh-ancestor
153436886|NCT00003626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153436887|NCT00003632|Cytarabine|cytarabine|mesh-list
153895689|NCT00700882|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153895690|NCT00700882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153895691|NCT00700882|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153895692|NCT00673309|Insulin|insulin|mesh-list
153895693|NCT00673309|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
153895694|NCT00673309|Itraconazole|itraconazole|mesh-list
153895695|NCT00673309|Propranolol|propranolol|mesh-list
153895696|NCT00673309|Hormones|hormones|mesh-list
153895697|NCT00673309|Oxandrolone|oxandrolone|mesh-list
153895698|NCT00673309|Nandrolone|nandrolone|mesh-list
153895699|NCT00673309|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153895700|NCT00673309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153895701|NCT00673309|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153895702|NCT00673309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153895703|NCT00673309|Antifungal Agents|antifungal agents|mesh-ancestor
153895704|NCT00673309|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153895705|NCT00673309|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
153895706|NCT00673309|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153436888|NCT00003632|Methotrexate|methotrexate|mesh-list
153436889|NCT00003632|Etoposide|etoposide|mesh-list
153436890|NCT00003632|Melphalan|melphalan|mesh-list
153436891|NCT00003632|Carmustine|carmustine|mesh-list
153436892|NCT00003632|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
153436893|NCT00003632|Abortifacient Agents|abortifacient agents|mesh-ancestor
153436903|NCT00003632|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153436904|NCT00003632|Immunologic Factors|immunologic factors|mesh-ancestor
153436905|NCT00003632|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153436906|NCT00003632|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153436907|NCT00003632|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153436908|NCT00003632|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153436909|NCT00003632|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153436910|NCT00003632|Antiviral Agents|antiviral agents|mesh-ancestor
153436911|NCT00003632|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153436912|NCT00003632|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153436913|NCT00003632|Alkylating Agents|alkylating agents|mesh-ancestor
153436914|NCT00003632|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153436915|NCT00003350|Paclitaxel|paclitaxel|mesh-list
153895712|NCT00673309|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
153895714|NCT00673309|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153895715|NCT00673309|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153895716|NCT00673309|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153895717|NCT00673309|Vasodilator Agents|vasodilator agents|mesh-ancestor
153895718|NCT00673309|Androgens|androgens|mesh-ancestor
153895719|NCT00673309|Anabolic Agents|anabolic agents|mesh-ancestor
153895720|NCT00666835|Epoetin Alfa|epoetin alfa|mesh-list
153895721|NCT00666835|Hematinics|hematinics|mesh-ancestor
153895722|NCT00551759|Docetaxel|docetaxel|mesh-list
153895723|NCT00551759|Fluorouracil|fluorouracil|mesh-list
153895724|NCT00551759|Oxaliplatin|oxaliplatin|mesh-list
153895725|NCT00551759|Cetuximab|cetuximab|mesh-list
153895726|NCT00551759|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153895727|NCT00551759|Tubulin Modulators|tubulin modulators|mesh-ancestor
153895728|NCT00551759|Antimitotic Agents|antimitotic agents|mesh-ancestor
153895729|NCT00551759|Mitosis Modulators|mitosis modulators|mesh-ancestor
153895730|NCT00551759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153895731|NCT00551759|Antimetabolites|antimetabolites|mesh-ancestor
153895732|NCT00551759|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153895733|NCT00551759|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153895734|NCT00551759|Immunologic Factors|immunologic factors|mesh-ancestor
153436916|NCT00003350|Doxorubicin|doxorubicin|mesh-list
153436917|NCT00003350|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
153436918|NCT00003350|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153436919|NCT00003350|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153436920|NCT00003350|Tubulin Modulators|tubulin modulators|mesh-ancestor
153436921|NCT00003350|Antimitotic Agents|antimitotic agents|mesh-ancestor
153436922|NCT00003350|Mitosis Modulators|mitosis modulators|mesh-ancestor
153436923|NCT00003350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153436924|NCT00003350|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153436925|NCT00003350|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153436926|NCT00003350|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153436927|NCT00003350|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153436928|NCT00003356|Aldesleukin|aldesleukin|mesh-list
153436929|NCT00003356|Rituximab|rituximab|mesh-list
153436930|NCT00003356|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153436931|NCT00003356|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153436932|NCT00003356|Immunologic Factors|immunologic factors|mesh-ancestor
153436933|NCT00003356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153436934|NCT00003356|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153436935|NCT00003356|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153436936|NCT00003356|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153436937|NCT00003356|Antiviral Agents|antiviral agents|mesh-ancestor
153436938|NCT00003356|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153436939|NCT00003638|Cyclophosphamide|cyclophosphamide|mesh-list
153436940|NCT00003638|Keyhole-limpet hemocyanin|keyhole-limpet hemocyanin|mesh-list
153436941|NCT00003638|Detox adjuvant|detox adjuvant|mesh-list
153436942|NCT00003638|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153436943|NCT00003638|Immunologic Factors|immunologic factors|mesh-ancestor
153436944|NCT00003638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153895735|NCT00551759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153895736|NCT00551759|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153895737|NCT00335140|Leucovorin|leucovorin|mesh-list
153895738|NCT00335140|Cytarabine|cytarabine|mesh-list
153895739|NCT00335140|Dexamethasone|dexamethasone|mesh-list
153895740|NCT00335140|Dexamethasone acetate|dexamethasone acetate|mesh-list
153895741|NCT00335140|Rituximab|rituximab|mesh-list
153895742|NCT00335140|Methotrexate|methotrexate|mesh-list
153895743|NCT00335140|Vincristine|vincristine|mesh-list
153895745|NCT00335140|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
153895746|NCT00335140|BB 1101|bb 1101|mesh-list
153895747|NCT00335140|Levoleucovorin|levoleucovorin|mesh-list
153895748|NCT00335140|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153895749|NCT00335140|Antiemetics|antiemetics|mesh-ancestor
153895750|NCT00335140|Autonomic Agents|autonomic agents|mesh-ancestor
153895751|NCT00335140|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153895752|NCT00335140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153895753|NCT00335140|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153895754|NCT00335140|Glucocorticoids|glucocorticoids|mesh-ancestor
153895755|NCT00335140|Hormones|hormones|mesh-ancestor
153895756|NCT00335140|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153895757|NCT00335140|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153895758|NCT00335140|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153895759|NCT00335140|Protease Inhibitors|protease inhibitors|mesh-ancestor
153895760|NCT00335140|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153895761|NCT00335140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153895762|NCT00335140|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153895763|NCT00335140|Immunologic Factors|immunologic factors|mesh-ancestor
153895764|NCT00335140|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153895765|NCT00335140|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
153895766|NCT00335140|Abortifacient Agents|abortifacient agents|mesh-ancestor
153895767|NCT00335140|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153895768|NCT00335140|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153895769|NCT00335140|Antimetabolites|antimetabolites|mesh-ancestor
153895770|NCT00335140|Dermatologic Agents|dermatologic agents|mesh-ancestor
153895771|NCT00335140|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153895772|NCT00335140|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153895773|NCT00335140|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153895774|NCT00335140|Antiviral Agents|antiviral agents|mesh-ancestor
153895775|NCT00335140|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153895776|NCT00335140|Antidotes|antidotes|mesh-ancestor
153895777|NCT00335140|Protective Agents|protective agents|mesh-ancestor
153895778|NCT00335140|Vitamin B Complex|vitamin b complex|mesh-ancestor
153895779|NCT00335140|Vitamins|vitamins|mesh-ancestor
153895780|NCT00335140|Micronutrients|micronutrients|mesh-ancestor
153895781|NCT00335140|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153436962|NCT00002749|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153436963|NCT00003362|Sargramostim|sargramostim|mesh-list
153436964|NCT00003362|Freund's Adjuvant|freund's adjuvant|mesh-list
153436965|NCT00003362|Immunologic Factors|immunologic factors|mesh-ancestor
153436966|NCT00003362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153436967|NCT00003362|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153436969|NCT00003650|Dexamethasone|dexamethasone|mesh-list
153436970|NCT00003650|Prednisone|prednisone|mesh-list
153436971|NCT00003650|Methylprednisolone|methylprednisolone|mesh-list
153436972|NCT00003650|Cyclophosphamide|cyclophosphamide|mesh-list
153436973|NCT00003650|Methotrexate|methotrexate|mesh-list
153436974|NCT00003650|Etoposide|etoposide|mesh-list
153436975|NCT00003650|Vincristine|vincristine|mesh-list
153436976|NCT00003650|Daunorubicin|daunorubicin|mesh-list
153436977|NCT00003650|Asparaginase|asparaginase|mesh-list
153436978|NCT00003650|Mercaptopurine|mercaptopurine|mesh-list
153436979|NCT00003650|Mitoxantrone|mitoxantrone|mesh-list
153436980|NCT00003650|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153436981|NCT00003650|Immunologic Factors|immunologic factors|mesh-ancestor
153436982|NCT00003650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153436983|NCT00003650|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153436984|NCT00003650|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153436985|NCT00003650|Alkylating Agents|alkylating agents|mesh-ancestor
153436986|NCT00003650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153895782|NCT00335140|Tubulin Modulators|tubulin modulators|mesh-ancestor
153895783|NCT00335140|Antimitotic Agents|antimitotic agents|mesh-ancestor
153895784|NCT00335140|Mitosis Modulators|mitosis modulators|mesh-ancestor
153895785|NCT00304239|Methyl 5-aminolevulinate|methyl 5-aminolevulinate|mesh-list
153895786|NCT00304239|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
153895787|NCT00304239|Dermatologic Agents|dermatologic agents|mesh-ancestor
153895788|NCT00101283|Carboplatin|carboplatin|mesh-list
153895789|NCT00101283|Gemcitabine|gemcitabine|mesh-list
153895790|NCT00101283|Pemetrexed|pemetrexed|mesh-list
153895791|NCT00101283|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153895792|NCT00101283|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153895793|NCT00101283|Antimetabolites|antimetabolites|mesh-ancestor
153895796|NCT00101283|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153895797|NCT00101283|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153895798|NCT01301729|Paclitaxel|paclitaxel|mesh-list
153895799|NCT01301729|Docetaxel|docetaxel|mesh-list
153895800|NCT01301729|Trastuzumab|trastuzumab|mesh-list
153895801|NCT01301729|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153895802|NCT01301729|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153895803|NCT01301729|Tubulin Modulators|tubulin modulators|mesh-ancestor
153895804|NCT01301729|Antimitotic Agents|antimitotic agents|mesh-ancestor
153895805|NCT01301729|Mitosis Modulators|mitosis modulators|mesh-ancestor
153436987|NCT00003650|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153436988|NCT00003650|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153436989|NCT00003650|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153895806|NCT01301729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153895807|NCT01301729|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153895809|NCT05643677|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
153895810|NCT05643677|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153895811|NCT05643677|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153895812|NCT05643677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153895813|NCT05643677|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153895814|NCT02890589|Chromium|chromium|mesh-list
153895815|NCT02890589|Everolimus|everolimus|mesh-list
153895816|NCT02890589|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
153895817|NCT02890589|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153895818|NCT02890589|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153895819|NCT02890589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153895820|NCT02890589|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153895821|NCT02890589|Immunologic Factors|immunologic factors|mesh-ancestor
153895822|NCT02890589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153895823|NCT02890589|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153895824|NCT02890589|Trace Elements|trace elements|mesh-ancestor
153895825|NCT02890589|Micronutrients|micronutrients|mesh-ancestor
153895826|NCT01301027|Pioglitazone|pioglitazone|mesh-list
153895827|NCT01301027|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153895828|NCT01301027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153895829|NCT04207385|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
153895830|NCT04207385|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
153437015|NCT00003650|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
153437016|NCT00003650|Protective Agents|protective agents|mesh-ancestor
153437017|NCT00003650|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153437018|NCT00003650|Analgesics|analgesics|mesh-ancestor
153437019|NCT00003650|Sensory System Agents|sensory system agents|mesh-ancestor
153437021|NCT00002755|Cobalt|cobalt|mesh-list
153437022|NCT00002755|Cyclophosphamide|cyclophosphamide|mesh-list
153437023|NCT00002755|Thiotepa|thiotepa|mesh-list
153437024|NCT00002755|Doxorubicin|doxorubicin|mesh-list
153437025|NCT00002755|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
153437026|NCT00002755|Fluorouracil|fluorouracil|mesh-list
153437027|NCT00002755|Methotrexate|methotrexate|mesh-list
153437028|NCT00002755|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153437029|NCT00002755|Immunologic Factors|immunologic factors|mesh-ancestor
153437030|NCT00002755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153437031|NCT00002755|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153437032|NCT00002755|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153437033|NCT00002755|Alkylating Agents|alkylating agents|mesh-ancestor
153437034|NCT00002755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153437035|NCT00002755|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153437036|NCT00002755|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153437037|NCT00002755|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153437038|NCT00002755|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153437039|NCT00002755|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153437040|NCT00002755|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153437041|NCT00002755|Antimetabolites|antimetabolites|mesh-ancestor
153437042|NCT00002755|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153437043|NCT00002755|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
153437044|NCT00002755|Abortifacient Agents|abortifacient agents|mesh-ancestor
153437045|NCT00002755|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153437046|NCT00002755|Dermatologic Agents|dermatologic agents|mesh-ancestor
153437047|NCT00002755|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153895831|NCT04207385|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153895832|NCT04207385|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153895835|NCT04207385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153895836|NCT04207385|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
153895837|NCT04207385|Antidepressive Agents|antidepressive agents|mesh-ancestor
153895838|NCT04207385|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153437049|NCT00002755|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
153895839|NCT05641883|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-list
153895840|NCT02886897|Antibodies|antibodies|mesh-list
153895841|NCT02886897|Immunologic Factors|immunologic factors|mesh-ancestor
153895842|NCT02886897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153895843|NCT01184859|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
153895844|NCT01184859|Hemostatics|hemostatics|mesh-ancestor
153895845|NCT01184859|Coagulants|coagulants|mesh-ancestor
153895846|NCT01184859|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
153895847|NCT01184859|Natriuretic Agents|natriuretic agents|mesh-ancestor
153895848|NCT01184859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153895850|NCT02890511|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153895851|NCT02890511|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153895852|NCT02890511|Tubulin Modulators|tubulin modulators|mesh-ancestor
153895853|NCT02890511|Antimitotic Agents|antimitotic agents|mesh-ancestor
153895854|NCT02890511|Mitosis Modulators|mitosis modulators|mesh-ancestor
153895855|NCT02890511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153895856|NCT01184079|Vaccines|vaccines|mesh-list
153895857|NCT01184079|Immunologic Factors|immunologic factors|mesh-ancestor
153895858|NCT01184079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153895859|NCT01289990|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
153895860|NCT01289990|Empagliflozin|empagliflozin|mesh-list
153895861|NCT01289990|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153895862|NCT01289990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153895863|NCT01289990|Incretins|incretins|mesh-ancestor
153895864|NCT01289990|Hormones|hormones|mesh-ancestor
153895865|NCT01289990|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153895866|NCT01289990|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
153895867|NCT01289990|Protease Inhibitors|protease inhibitors|mesh-ancestor
153895868|NCT01289990|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153895869|NCT01289990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153437057|NCT00002755|Micronutrients|micronutrients|mesh-ancestor
153437058|NCT00002761|Interferons|interferons|mesh-list
153437059|NCT00002761|Cytarabine|cytarabine|mesh-list
153437060|NCT00002761|Interferon-gamma|interferon-gamma|mesh-list
153437061|NCT00002761|Cyclosporine|cyclosporine|mesh-list
153437062|NCT00002761|Cyclophosphamide|cyclophosphamide|mesh-list
153437063|NCT00002761|Busulfan|busulfan|mesh-list
153437064|NCT00002761|Idarubicin|idarubicin|mesh-list
153437065|NCT00002761|Cyclosporins|cyclosporins|mesh-list
153437066|NCT00002761|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153437067|NCT00002761|Immunologic Factors|immunologic factors|mesh-ancestor
153437068|NCT00002761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153437069|NCT00002761|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153437070|NCT00002761|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153437071|NCT00002761|Alkylating Agents|alkylating agents|mesh-ancestor
153437072|NCT00002761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153437073|NCT00002761|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153437074|NCT00002761|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153437075|NCT00002761|Antiviral Agents|antiviral agents|mesh-ancestor
153437076|NCT00002761|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153437077|NCT00002761|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153437078|NCT00002761|Antimetabolites|antimetabolites|mesh-ancestor
153437079|NCT00002761|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153437080|NCT00002761|Antifungal Agents|antifungal agents|mesh-ancestor
153437081|NCT00002761|Dermatologic Agents|dermatologic agents|mesh-ancestor
153437082|NCT00002761|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
153437083|NCT00002761|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153437084|NCT00002761|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153437085|NCT00002761|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153895870|NCT01289990|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
153895871|NCT01190007|Amlodipine, atorvastatin drug combination|amlodipine, atorvastatin drug combination|mesh-list
153895872|NCT01190007|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153895873|NCT01190007|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153895874|NCT01190007|Antimetabolites|antimetabolites|mesh-ancestor
153895875|NCT01190007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153895877|NCT01190007|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153895878|NCT01190007|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153895879|NCT01190007|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153895880|NCT01190007|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153895881|NCT01190007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153895882|NCT01190007|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
153895883|NCT01190007|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153437086|NCT00382135|Tadalafil|tadalafil|mesh-list
153895884|NCT01300247|Cyclophosphamide|cyclophosphamide|mesh-list
153895885|NCT01300247|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
153437087|NCT00382135|Vasodilator Agents|vasodilator agents|mesh-ancestor
153437093|NCT00003662|Cyclosporine|cyclosporine|mesh-list
153895886|NCT01300247|Fludarabine|fludarabine|mesh-list
153895887|NCT01300247|Obinutuzumab|obinutuzumab|mesh-list
153895888|NCT01300247|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153895889|NCT01300247|Immunologic Factors|immunologic factors|mesh-ancestor
153895890|NCT01300247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153895891|NCT01300247|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153895892|NCT01300247|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153895893|NCT01300247|Alkylating Agents|alkylating agents|mesh-ancestor
153895894|NCT01300247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153895895|NCT01300247|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153895896|NCT01300247|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153895897|NCT01300247|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153895898|NCT02890277|Anti-Infective Agents|anti-infective agents|mesh-list
153895899|NCT02890277|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
153895900|NCT02890277|Chitosan|chitosan|mesh-list
153895901|NCT02890277|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153895902|NCT02890277|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153895903|NCT02890277|Antimetabolites|antimetabolites|mesh-ancestor
153895904|NCT02890277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153895905|NCT02890277|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153895906|NCT02890277|Chelating Agents|chelating agents|mesh-ancestor
153895907|NCT02890277|Sequestering Agents|sequestering agents|mesh-ancestor
153895908|NCT02890277|Hemostatics|hemostatics|mesh-ancestor
153895909|NCT02890277|Coagulants|coagulants|mesh-ancestor
153895910|NCT01289678|Interleukin-2|interleukin-2|mesh-list
153895911|NCT01289678|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153437104|NCT00003662|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153437105|NCT00003662|Alkylating Agents|alkylating agents|mesh-ancestor
153437106|NCT00003662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153437107|NCT00003662|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153437108|NCT00003662|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153437109|NCT00003662|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153437110|NCT00003662|Antifungal Agents|antifungal agents|mesh-ancestor
153437111|NCT00003662|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153437112|NCT00003662|Dermatologic Agents|dermatologic agents|mesh-ancestor
153437113|NCT00003662|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
153437114|NCT00003662|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153437115|NCT00003662|Antiemetics|antiemetics|mesh-ancestor
153437116|NCT00003662|Autonomic Agents|autonomic agents|mesh-ancestor
153437117|NCT00003662|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153437118|NCT00003662|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153437119|NCT00003662|Glucocorticoids|glucocorticoids|mesh-ancestor
153437120|NCT00003662|Hormones|hormones|mesh-ancestor
153437121|NCT00003662|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153437122|NCT00003662|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
153437123|NCT00003662|Protective Agents|protective agents|mesh-ancestor
153437124|NCT00004154|Fenretinide|fenretinide|mesh-list
153437125|NCT00004154|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153437126|NCT00004154|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
153437127|NCT00004154|Protective Agents|protective agents|mesh-ancestor
153895912|NCT01289678|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153895913|NCT01289678|Analgesics|analgesics|mesh-ancestor
153895914|NCT01289678|Sensory System Agents|sensory system agents|mesh-ancestor
153895915|NCT01289678|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153895916|NCT01289678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153895917|NCT01183221|Oxytocin|oxytocin|mesh-list
153895918|NCT01183221|Oxytocics|oxytocics|mesh-ancestor
153895919|NCT01183221|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153895920|NCT01183221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153895921|NCT01183143|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
153895922|NCT01183143|Hormones|hormones|mesh-ancestor
153895923|NCT01183143|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153895926|NCT01183065|Vitamin B 12|vitamin b 12|mesh-list
153895927|NCT01183065|Hydroxocobalamin|hydroxocobalamin|mesh-list
153895928|NCT01183065|Vitamins|vitamins|mesh-ancestor
153895929|NCT01183065|Micronutrients|micronutrients|mesh-ancestor
153895930|NCT01183065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153895931|NCT01183065|Hematinics|hematinics|mesh-ancestor
153895932|NCT01183065|Vitamin B Complex|vitamin b complex|mesh-ancestor
153895933|NCT01182441|Warfarin|warfarin|mesh-list
153895934|NCT01182441|Anticoagulants|anticoagulants|mesh-ancestor
153895935|NCT01182285|Valproic Acid|valproic acid|mesh-list
153437128|NCT00004154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153895936|NCT01182285|Anticonvulsants|anticonvulsants|mesh-ancestor
153895937|NCT01182285|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153895938|NCT01182285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153895939|NCT01182285|GABA Agents|gaba agents|mesh-ancestor
153895940|NCT01182285|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153895941|NCT01182285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153895942|NCT01182285|Antimanic Agents|antimanic agents|mesh-ancestor
153895943|NCT01182285|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153895944|NCT01182285|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153895945|NCT01182285|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153895946|NCT04315935|Fentanyl|fentanyl|mesh-list
153895947|NCT04315935|Butorphanol|butorphanol|mesh-list
153895948|NCT04315935|Propofol|propofol|mesh-list
153895949|NCT04315935|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153895950|NCT04315935|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153895951|NCT04315935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153895952|NCT04315935|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153895953|NCT04315935|Anesthetics, General|anesthetics, general|mesh-ancestor
153895954|NCT04315935|Anesthetics|anesthetics|mesh-ancestor
153895955|NCT04315935|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153895956|NCT04315935|Narcotics|narcotics|mesh-ancestor
153895957|NCT04315935|Analgesics|analgesics|mesh-ancestor
153895958|NCT04315935|Sensory System Agents|sensory system agents|mesh-ancestor
153895959|NCT04315935|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153895960|NCT04315935|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153895961|NCT04315935|Antitussive Agents|antitussive agents|mesh-ancestor
153895962|NCT04315935|Respiratory System Agents|respiratory system agents|mesh-ancestor
153895963|NCT04315935|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
153437155|NCT00004160|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153437156|NCT00004160|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153437157|NCT00004160|Tubulin Modulators|tubulin modulators|mesh-ancestor
153437158|NCT00004160|Antimitotic Agents|antimitotic agents|mesh-ancestor
153437159|NCT00004160|Mitosis Modulators|mitosis modulators|mesh-ancestor
153437160|NCT00004160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153437161|NCT00004160|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153437162|NCT00004160|Antimetabolites|antimetabolites|mesh-ancestor
153437163|NCT00003368|Irinotecan|irinotecan|mesh-list
153437164|NCT00003368|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
153437165|NCT00003368|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153437166|NCT00003368|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153437167|NCT00003368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153437168|NCT00003368|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153437169|NCT00003674|Dalteparin|dalteparin|mesh-list
153437170|NCT00003674|Tinzaparin|tinzaparin|mesh-list
153437171|NCT00003674|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
153437172|NCT00003674|Anticoagulants|anticoagulants|mesh-ancestor
153437173|NCT00003674|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153437174|NCT00003674|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153437175|NCT00003674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153437176|NCT00003380|Doxorubicin|doxorubicin|mesh-list
153437177|NCT00003380|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
153437179|NCT00003380|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153437180|NCT00003380|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153437182|NCT00003380|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153437183|NCT00003380|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153437184|NCT00003380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153437185|NCT00003380|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153437186|NCT00002779|Fludarabine|fludarabine|mesh-list
153437187|NCT00002779|Fludarabine phosphate|fludarabine phosphate|mesh-list
153437188|NCT00002779|Octreotide|octreotide|mesh-list
153437189|NCT00002779|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153895964|NCT01182207|Drospirenone|drospirenone|mesh-list
153895965|NCT01182207|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
153895966|NCT01182207|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
153895967|NCT01182207|Ethinyl Estradiol|ethinyl estradiol|mesh-list
153895968|NCT01182207|Drospirenone and ethinyl estradiol combination|drospirenone and ethinyl estradiol combination|mesh-list
153895969|NCT01182207|Estradiol|estradiol|mesh-list
153895970|NCT01182207|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
153895971|NCT01182207|Estrogens|estrogens|mesh-ancestor
153895972|NCT01182207|Hormones|hormones|mesh-ancestor
153895973|NCT01182207|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153895974|NCT01182207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153895975|NCT01182207|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
153895976|NCT01182207|Contraceptive Agents|contraceptive agents|mesh-ancestor
153895977|NCT01182207|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153895978|NCT01182207|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
153895979|NCT01182207|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
153895980|NCT01182207|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
153895981|NCT01182207|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
153895982|NCT01182207|Hormone Antagonists|hormone antagonists|mesh-ancestor
153895983|NCT01182207|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
153895984|NCT01182207|Diuretics|diuretics|mesh-ancestor
153895985|NCT01182207|Natriuretic Agents|natriuretic agents|mesh-ancestor
153895986|NCT01181895|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
153895987|NCT01181895|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153895988|NCT01181895|Autonomic Agents|autonomic agents|mesh-ancestor
153895989|NCT01181895|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153895990|NCT01181895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153895991|NCT01181895|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153895992|NCT01181895|Respiratory System Agents|respiratory system agents|mesh-ancestor
153895993|NCT01181895|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
153895994|NCT01181895|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
153895995|NCT01181895|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153895996|NCT01181895|Adrenergic Agents|adrenergic agents|mesh-ancestor
153895997|NCT01181895|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153895998|NCT01181895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153896000|NCT01181271|Cyclophosphamide|cyclophosphamide|mesh-list
153896001|NCT01181271|Busulfan|busulfan|mesh-list
153896002|NCT01181271|Methotrexate|methotrexate|mesh-list
153437195|NCT00002779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153437196|NCT00002779|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153437197|NCT00002779|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153437198|NCT00003680|Tamoxifen|tamoxifen|mesh-list
153437199|NCT00003680|Cyclophosphamide|cyclophosphamide|mesh-list
153437200|NCT00003680|Thiotepa|thiotepa|mesh-list
153437201|NCT00003680|Fluorouracil|fluorouracil|mesh-list
153437202|NCT00003680|Methotrexate|methotrexate|mesh-list
153437203|NCT00003680|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153437204|NCT00003680|Immunologic Factors|immunologic factors|mesh-ancestor
153437205|NCT00003680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153437206|NCT00003680|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153437207|NCT00003680|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153437208|NCT00003680|Alkylating Agents|alkylating agents|mesh-ancestor
153437209|NCT00003680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153437210|NCT00003680|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153437211|NCT00003680|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153896003|NCT01181271|Fludarabine|fludarabine|mesh-list
153896004|NCT01181271|Etoposide|etoposide|mesh-list
153896005|NCT01181271|Tacrolimus|tacrolimus|mesh-list
153896008|NCT01181271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153896009|NCT01181271|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153896010|NCT01181271|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153896011|NCT01181271|Alkylating Agents|alkylating agents|mesh-ancestor
153896012|NCT01181271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153896013|NCT01181271|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153896014|NCT01181271|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153896015|NCT01181271|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
153896016|NCT01181271|Abortifacient Agents|abortifacient agents|mesh-ancestor
153896017|NCT01181271|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153896018|NCT01181271|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153896019|NCT01181271|Antimetabolites|antimetabolites|mesh-ancestor
153896020|NCT01181271|Dermatologic Agents|dermatologic agents|mesh-ancestor
153896021|NCT01181271|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153896022|NCT01181271|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153896023|NCT01181271|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153896024|NCT01181271|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153896025|NCT01181271|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153896026|NCT01181271|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153896027|NCT01181271|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
153896028|NCT01181271|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153896029|NCT01181271|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153896030|NCT01181271|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153896031|NCT01181271|Antifungal Agents|antifungal agents|mesh-ancestor
153896033|NCT00624741|Dopamine Agonists|dopamine agonists|mesh-ancestor
153896034|NCT00624741|Dopamine Agents|dopamine agents|mesh-ancestor
153896035|NCT00624741|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153896036|NCT00624741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153896037|NCT00624741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153896038|NCT01180647|Naltrexone|naltrexone|mesh-list
153896039|NCT01180647|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
153896040|NCT01180647|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
153896041|NCT01180647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153896042|NCT01180647|Sensory System Agents|sensory system agents|mesh-ancestor
153896043|NCT01180647|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153896044|NCT01178853|Warfarin|warfarin|mesh-list
153896045|NCT01178853|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
153437212|NCT00003680|Antimetabolites|antimetabolites|mesh-ancestor
153896046|NCT01178853|Pitavastatin|pitavastatin|mesh-list
153896047|NCT01178853|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153896048|NCT01178853|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153896049|NCT01178853|Antimetabolites|antimetabolites|mesh-ancestor
153896050|NCT01178853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153896051|NCT01178853|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153896052|NCT01178853|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
153896053|NCT01178853|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153896054|NCT01178853|Anticoagulants|anticoagulants|mesh-ancestor
153896055|NCT04286035|Bupivacaine|bupivacaine|mesh-list
153896056|NCT04286035|Anesthetics, Local|anesthetics, local|mesh-ancestor
153896057|NCT04286035|Anesthetics|anesthetics|mesh-ancestor
153896058|NCT04286035|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153896059|NCT04286035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153437255|NCT00002785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153437256|NCT00002785|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153437257|NCT00002785|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153437259|NCT00002785|Antiemetics|antiemetics|mesh-ancestor
153437260|NCT00002785|Autonomic Agents|autonomic agents|mesh-ancestor
153437261|NCT00002785|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153437262|NCT00002785|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153437263|NCT00002785|Glucocorticoids|glucocorticoids|mesh-ancestor
153437265|NCT00002785|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153437269|NCT00002785|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153437270|NCT00002785|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153437271|NCT00002785|Antimetabolites|antimetabolites|mesh-ancestor
153437272|NCT00002785|Dermatologic Agents|dermatologic agents|mesh-ancestor
153437273|NCT00002785|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153437274|NCT00002785|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153437275|NCT00002785|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153896060|NCT04286035|Sensory System Agents|sensory system agents|mesh-ancestor
153896061|NCT04286035|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153896062|NCT00629473|Dexamethasone|dexamethasone|mesh-list
153896063|NCT00629473|Proteasome Inhibitors|proteasome inhibitors|mesh-list
153896064|NCT00629473|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153896065|NCT00629473|Antiemetics|antiemetics|mesh-ancestor
153896066|NCT00629473|Autonomic Agents|autonomic agents|mesh-ancestor
153896067|NCT00629473|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153896068|NCT00629473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153896069|NCT00629473|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153896070|NCT00629473|Glucocorticoids|glucocorticoids|mesh-ancestor
153896072|NCT00629473|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153896073|NCT00629473|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153896074|NCT00629473|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153896075|NCT00629473|Protease Inhibitors|protease inhibitors|mesh-ancestor
153896076|NCT00629473|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153896077|NCT00629473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153896078|NCT04286503|Ritonavir|ritonavir|mesh-list
153896079|NCT04286503|Lopinavir|lopinavir|mesh-list
153896080|NCT04286503|Chloroquine|chloroquine|mesh-list
153896081|NCT04286503|Chloroquine diphosphate|chloroquine diphosphate|mesh-list
153896082|NCT04286503|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
153896083|NCT04286503|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
153896084|NCT04286503|Protease Inhibitors|protease inhibitors|mesh-ancestor
153896085|NCT04286503|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153896086|NCT04286503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153896087|NCT04286503|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153896088|NCT04286503|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153896089|NCT04286503|Antiviral Agents|antiviral agents|mesh-ancestor
153896090|NCT04286503|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153896091|NCT04286503|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
153896092|NCT04286503|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153896093|NCT04286503|Amebicides|amebicides|mesh-ancestor
153896094|NCT04286503|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153896095|NCT04286503|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153896096|NCT04286503|Antimalarials|antimalarials|mesh-ancestor
153896097|NCT04286503|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153896098|NCT04286503|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153896099|NCT04286503|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153896100|NCT04286503|Analgesics|analgesics|mesh-ancestor
153896101|NCT04286503|Sensory System Agents|sensory system agents|mesh-ancestor
153896102|NCT04286503|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153896103|NCT04286503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153896104|NCT04286503|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153896105|NCT04286503|Filaricides|filaricides|mesh-ancestor
153896106|NCT04286503|Antinematodal Agents|antinematodal agents|mesh-ancestor
153896107|NCT04286503|Anthelmintics|anthelmintics|mesh-ancestor
153896108|NCT00968617|Darbepoetin alfa|darbepoetin alfa|mesh-list
153896109|NCT00968617|Hematinics|hematinics|mesh-ancestor
153896110|NCT00968539|Vaccines|vaccines|mesh-list
153896111|NCT00968539|Immunologic Factors|immunologic factors|mesh-ancestor
153896112|NCT00968539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153896113|NCT00976573|Paclitaxel|paclitaxel|mesh-list
153896114|NCT00976573|Bevacizumab|bevacizumab|mesh-list
153896115|NCT00976573|Carboplatin|carboplatin|mesh-list
153437312|NCT00003386|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153437313|NCT00003386|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153437314|NCT00003386|Tubulin Modulators|tubulin modulators|mesh-ancestor
153437318|NCT00003386|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153437319|NCT00003386|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153437320|NCT00003386|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153437321|NCT00003386|Alkylating Agents|alkylating agents|mesh-ancestor
153437322|NCT00003386|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153437323|NCT00003386|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153437325|NCT00384566|Carvedilol|carvedilol|mesh-list
153437326|NCT00384566|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153437327|NCT00384566|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153437328|NCT00384566|Sympatholytics|sympatholytics|mesh-ancestor
153437329|NCT00384566|Autonomic Agents|autonomic agents|mesh-ancestor
153437330|NCT00384566|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153437331|NCT00384566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153437332|NCT00384566|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
153437333|NCT00384566|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
153437334|NCT00384566|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
153437335|NCT00384566|Adrenergic Agents|adrenergic agents|mesh-ancestor
153437336|NCT00384566|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153896116|NCT00976573|Everolimus|everolimus|mesh-list
153896117|NCT00976573|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153896118|NCT00976573|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153896119|NCT00976573|Tubulin Modulators|tubulin modulators|mesh-ancestor
153896120|NCT00976573|Antimitotic Agents|antimitotic agents|mesh-ancestor
153896121|NCT00976573|Mitosis Modulators|mitosis modulators|mesh-ancestor
153896122|NCT00976573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153896123|NCT00976573|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153896124|NCT00976573|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153896125|NCT00976573|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153896126|NCT00976573|Growth Substances|growth substances|mesh-ancestor
153896127|NCT00976573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153896128|NCT00976573|Growth Inhibitors|growth inhibitors|mesh-ancestor
153896129|NCT00976573|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
153896130|NCT00976573|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153896131|NCT00976573|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153896132|NCT00976573|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153896133|NCT00976573|Immunologic Factors|immunologic factors|mesh-ancestor
153896135|NCT00629863|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153896136|NCT00629863|Antimetabolites|antimetabolites|mesh-ancestor
153896137|NCT00629863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153437337|NCT00384566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153896138|NCT00629863|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153896139|NCT00629863|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153896140|NCT00629863|Immunologic Factors|immunologic factors|mesh-ancestor
153896141|NCT00629863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153896142|NCT02865733|Treprostinil|treprostinil|mesh-list
153896143|NCT02865733|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153896144|NCT00976495|Dapagliflozin|dapagliflozin|mesh-list
153896145|NCT00976495|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
153896146|NCT00976495|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
153896147|NCT00976495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153896148|NCT00976495|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153896149|NCT00976495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153896150|NCT00976495|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153896151|NCT00976495|Diuretics|diuretics|mesh-ancestor
153896152|NCT00976495|Natriuretic Agents|natriuretic agents|mesh-ancestor
153896154|NCT00976495|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153896155|NCT00630019|Moxifloxacin|moxifloxacin|mesh-list
153896156|NCT00630019|Levofloxacin|levofloxacin|mesh-list
153896157|NCT00630019|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
153896158|NCT00630019|Ophthalmic Solutions|ophthalmic solutions|mesh-list
153896159|NCT00630019|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
153896160|NCT00630019|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153896161|NCT00630019|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153437359|NCT00002791|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153437360|NCT00002791|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153437361|NCT00002791|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153437363|NCT00002791|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153437364|NCT00002791|Alkylating Agents|alkylating agents|mesh-ancestor
153437365|NCT00004190|Gemcitabine|gemcitabine|mesh-list
153437366|NCT00004190|Oxaliplatin|oxaliplatin|mesh-list
153437367|NCT00004190|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153437368|NCT00004190|Antimetabolites|antimetabolites|mesh-ancestor
153437369|NCT00004190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153437370|NCT00004190|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153437371|NCT00004196|Interferons|interferons|mesh-list
153437372|NCT00004196|Interferon-alpha|interferon-alpha|mesh-list
153437373|NCT00004196|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153437374|NCT00004196|Antiviral Agents|antiviral agents|mesh-ancestor
153437375|NCT00004196|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153437376|NCT00004196|Immunologic Factors|immunologic factors|mesh-ancestor
153437377|NCT00004196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153437379|NCT00004838|Antidotes|antidotes|mesh-ancestor
153437380|NCT00004838|Protective Agents|protective agents|mesh-ancestor
153437381|NCT00004838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153437382|NCT00004838|Chelating Agents|chelating agents|mesh-ancestor
153437383|NCT00004838|Sequestering Agents|sequestering agents|mesh-ancestor
153437384|NCT00004838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153437385|NCT00004202|Paclitaxel|paclitaxel|mesh-list
153437386|NCT00004202|Carboplatin|carboplatin|mesh-list
153437387|NCT00004202|Efaproxiral|efaproxiral|mesh-list
153437388|NCT00004202|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153437389|NCT00004202|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153896162|NCT00630019|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153896163|NCT00630019|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153896164|NCT00630019|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153896165|NCT00630019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153896166|NCT00630019|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153896167|NCT00630019|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
153896168|NCT00630019|Contraceptive Agents|contraceptive agents|mesh-ancestor
153896169|NCT00630019|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153896170|NCT00630019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153896171|NCT00630019|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
153896172|NCT00630019|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
153896173|NCT00630019|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
153896174|NCT00630019|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
153896175|NCT00630019|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
153896176|NCT00630019|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153896177|NCT00998296|Nintedanib|nintedanib|mesh-list
153896178|NCT00998296|Afatinib|afatinib|mesh-list
153896179|NCT00998296|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153896180|NCT00998296|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153896181|NCT00998296|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153896182|NCT00998296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153896183|NCT00998296|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153896184|NCT01178073|Ambrisentan|ambrisentan|mesh-list
153896185|NCT01178073|Tadalafil|tadalafil|mesh-list
153896186|NCT01178073|Vasodilator Agents|vasodilator agents|mesh-ancestor
153896187|NCT01178073|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
153896188|NCT01178073|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
153896189|NCT01178073|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153896190|NCT01178073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153896191|NCT01178073|Urological Agents|urological agents|mesh-ancestor
153896192|NCT01178073|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153896193|NCT00997984|Guanfacine|guanfacine|mesh-list
153896194|NCT00997984|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153896195|NCT00997984|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
153896196|NCT00997984|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153896197|NCT00997984|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153896198|NCT00997984|Adrenergic Agents|adrenergic agents|mesh-ancestor
153896199|NCT00997984|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153896200|NCT00997984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153896201|NCT00997984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153896202|NCT01177293|Amlodipine|amlodipine|mesh-list
153896203|NCT01177293|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153437404|NCT00003686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153437405|NCT05495035|Dexamethasone|dexamethasone|mesh-list
153437406|NCT05495035|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153437407|NCT05495035|Antiemetics|antiemetics|mesh-ancestor
153437408|NCT05495035|Autonomic Agents|autonomic agents|mesh-ancestor
153437409|NCT05495035|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153437410|NCT05495035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153437411|NCT05495035|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153437412|NCT05495035|Glucocorticoids|glucocorticoids|mesh-ancestor
153437414|NCT05495035|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153437415|NCT05495035|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153437416|NCT05495035|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153437417|NCT00004856|Trastuzumab|trastuzumab|mesh-list
153437418|NCT00004856|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153437419|NCT00004856|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153437420|NCT00003698|Fosbretabulin|fosbretabulin|mesh-list
153437421|NCT00003698|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153437422|NCT00003698|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153437423|NCT00004862|Cytarabine|cytarabine|mesh-list
153437424|NCT00004862|Fludarabine|fludarabine|mesh-list
153437425|NCT00004862|Fludarabine phosphate|fludarabine phosphate|mesh-list
153437426|NCT00004862|Oblimersen|oblimersen|mesh-list
153437427|NCT00004862|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153437428|NCT00004862|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153437429|NCT00004862|Antimetabolites|antimetabolites|mesh-ancestor
153437430|NCT00004862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153437431|NCT00004862|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153437432|NCT00004862|Immunologic Factors|immunologic factors|mesh-ancestor
153896204|NCT01177293|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153896205|NCT01177293|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153896206|NCT01177293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153896207|NCT01177293|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153896208|NCT01177293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153896209|NCT01177293|Vasodilator Agents|vasodilator agents|mesh-ancestor
153896210|NCT02886429|Dexmedetomidine|dexmedetomidine|mesh-list
153896211|NCT02886429|Bupivacaine|bupivacaine|mesh-list
153896212|NCT02886429|Anesthetics, Local|anesthetics, local|mesh-ancestor
153896213|NCT02886429|Anesthetics|anesthetics|mesh-ancestor
153896214|NCT02886429|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153896215|NCT02886429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153896216|NCT02886429|Sensory System Agents|sensory system agents|mesh-ancestor
153896217|NCT02886429|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153896218|NCT02886429|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153896219|NCT02886429|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153896220|NCT02886429|Analgesics|analgesics|mesh-ancestor
153896221|NCT02886429|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
153896222|NCT02886429|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153896223|NCT02886429|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153896224|NCT02886429|Adrenergic Agents|adrenergic agents|mesh-ancestor
153896225|NCT02886429|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153896226|NCT02886429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153896227|NCT01299389|Paliperidone Palmitate|paliperidone palmitate|mesh-list
153896228|NCT01299389|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153896229|NCT01299389|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153896230|NCT01299389|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153896231|NCT01299389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153896232|NCT01299389|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153896233|NCT01299389|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
153896234|NCT01299389|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153896236|NCT01299389|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153896237|NCT01299389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153896238|NCT01299389|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
153896239|NCT01299389|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
153896240|NCT01299389|Dopamine Agents|dopamine agents|mesh-ancestor
153896241|NCT02886351|Nitrous Oxide|nitrous oxide|mesh-list
153896242|NCT02886351|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
153896243|NCT02886351|Anesthetics, General|anesthetics, general|mesh-ancestor
153896244|NCT02886351|Anesthetics|anesthetics|mesh-ancestor
153896245|NCT02886351|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153896246|NCT02886351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153896247|NCT02886351|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153437450|NCT00004868|Growth Substances|growth substances|mesh-ancestor
153437451|NCT00004868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153437452|NCT00004868|Growth Inhibitors|growth inhibitors|mesh-ancestor
153437453|NCT00004868|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153437473|NCT00004232|Glucocorticoids|glucocorticoids|mesh-ancestor
153437475|NCT00004232|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153437476|NCT00004232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153896248|NCT02886351|Analgesics|analgesics|mesh-ancestor
153896249|NCT02886351|Sensory System Agents|sensory system agents|mesh-ancestor
153896250|NCT02886351|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153896251|NCT00976027|Vaccines|vaccines|mesh-list
153896252|NCT00976027|Immunologic Factors|immunologic factors|mesh-ancestor
153896253|NCT00976027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153896254|NCT01298765|Buprenorphine|buprenorphine|mesh-list
153896255|NCT01298765|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153896256|NCT01298765|Narcotics|narcotics|mesh-ancestor
153896259|NCT01298765|Analgesics|analgesics|mesh-ancestor
153896260|NCT01298765|Sensory System Agents|sensory system agents|mesh-ancestor
153896261|NCT01298765|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153896262|NCT01298765|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
153896263|NCT04296214|Azacitidine|azacitidine|mesh-list
153896264|NCT04296214|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153896265|NCT04296214|Antimetabolites|antimetabolites|mesh-ancestor
153896266|NCT04296214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153896267|NCT04296214|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153896268|NCT04296214|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153896270|NCT04296370|Fluzoparib|fluzoparib|mesh-list
153896271|NCT04296370|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153896272|NCT04296370|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153896273|NCT04296370|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153896274|NCT04296370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153437477|NCT00004232|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153437478|NCT00004232|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153437480|NCT00004232|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153437481|NCT00004232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153437482|NCT00004232|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153437483|NCT00004232|Antifungal Agents|antifungal agents|mesh-ancestor
153437484|NCT00004232|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153437485|NCT00004232|Dermatologic Agents|dermatologic agents|mesh-ancestor
153437486|NCT00004232|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153437487|NCT00004232|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
153437488|NCT00004232|Antiemetics|antiemetics|mesh-ancestor
153437497|NCT00004874|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153437498|NCT00004874|Trace Elements|trace elements|mesh-ancestor
153437499|NCT00004874|Micronutrients|micronutrients|mesh-ancestor
153437500|NCT00004874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153437501|NCT00004874|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153437502|NCT00004244|Interferons|interferons|mesh-list
153437503|NCT00004244|Interferon-alpha|interferon-alpha|mesh-list
153437504|NCT00004244|Interleukin-12|interleukin-12|mesh-list
153437505|NCT00004244|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153437507|NCT00004244|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153896275|NCT04296370|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
153896276|NCT00997438|Thioctic Acid|thioctic acid|mesh-list
153896277|NCT00997438|Antioxidants|antioxidants|mesh-ancestor
153896278|NCT00997438|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153896281|NCT00997438|Vitamin B Complex|vitamin b complex|mesh-ancestor
153896283|NCT00997438|Micronutrients|micronutrients|mesh-ancestor
153896284|NCT00997126|Alfentanil|alfentanil|mesh-list
153896285|NCT00997126|Propofol|propofol|mesh-list
153896286|NCT00997126|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153896287|NCT00997126|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153896288|NCT00997126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153896289|NCT00997126|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153896290|NCT00997126|Anesthetics, General|anesthetics, general|mesh-ancestor
153896291|NCT00997126|Anesthetics|anesthetics|mesh-ancestor
153896293|NCT00997126|Narcotics|narcotics|mesh-ancestor
153896294|NCT00997126|Analgesics|analgesics|mesh-ancestor
153896295|NCT00997126|Sensory System Agents|sensory system agents|mesh-ancestor
153896296|NCT00997126|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153896297|NCT01000636|Methyl 5-aminolevulinate|methyl 5-aminolevulinate|mesh-list
153896298|NCT01000636|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
153896299|NCT01000636|Dermatologic Agents|dermatologic agents|mesh-ancestor
153896301|NCT04433494|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
153896302|NCT04433494|Hormone Antagonists|hormone antagonists|mesh-ancestor
153896303|NCT04433494|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153896304|NCT04433494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153437508|NCT00004244|Immunologic Factors|immunologic factors|mesh-ancestor
153437509|NCT00004244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153437510|NCT00004244|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153437511|NCT00004244|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153437512|NCT00004244|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153437513|NCT00004244|Growth Substances|growth substances|mesh-ancestor
153437514|NCT00004244|Growth Inhibitors|growth inhibitors|mesh-ancestor
153437515|NCT00004880|Vaccines|vaccines|mesh-list
153437516|NCT00004880|Immunologic Factors|immunologic factors|mesh-ancestor
153437517|NCT00004880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153437518|NCT00004250|Dactinomycin|dactinomycin|mesh-list
153437519|NCT00004250|Melphalan|melphalan|mesh-list
153437520|NCT00004250|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153437521|NCT00004250|Alkylating Agents|alkylating agents|mesh-ancestor
153437522|NCT00004250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153437523|NCT00004250|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153437524|NCT00004250|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153437525|NCT00004250|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153437526|NCT00004250|Immunologic Factors|immunologic factors|mesh-ancestor
153437527|NCT00004250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153437528|NCT00004250|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153437529|NCT00004250|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153437530|NCT00004250|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153437531|NCT00004250|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
153437532|NCT00004250|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153437533|NCT00004250|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153437534|NCT00003728|Leucovorin|leucovorin|mesh-list
153437535|NCT00003728|Cytarabine|cytarabine|mesh-list
153437536|NCT00003728|Dexamethasone|dexamethasone|mesh-list
153437537|NCT00003728|Methylprednisolone|methylprednisolone|mesh-list
153896305|NCT04433494|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153896306|NCT04433494|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153896307|NCT04433494|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
153896308|NCT04433494|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
153896309|NCT04433494|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153896310|NCT01000480|Pemetrexed|pemetrexed|mesh-list
153896311|NCT01000480|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153896312|NCT01000480|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153896313|NCT01000480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153896314|NCT01000480|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153896315|NCT01000480|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153896316|NCT02862691|Acetaminophen|acetaminophen|mesh-list
153896317|NCT02862691|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
153896318|NCT02862691|Oxycodone|oxycodone|mesh-list
153896319|NCT02862691|Analgesics|analgesics|mesh-list
153896320|NCT02862691|Bupivacaine|bupivacaine|mesh-list
153896321|NCT02862691|Anesthetics, Local|anesthetics, local|mesh-list
153896322|NCT02862691|Anesthetics|anesthetics|mesh-list
153437538|NCT00003728|Prednisolone|prednisolone|mesh-list
153896323|NCT02862691|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153896324|NCT02862691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153896325|NCT02862691|Sensory System Agents|sensory system agents|mesh-ancestor
153896326|NCT02862691|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153896327|NCT02862691|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153896329|NCT02862691|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153896330|NCT02862691|Narcotics|narcotics|mesh-ancestor
153896331|NCT02862691|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153896332|NCT02862691|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153896333|NCT02862691|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153896334|NCT00965341|Methyltestosterone|methyltestosterone|mesh-list
153896335|NCT00965341|Testosterone|testosterone|mesh-list
153896337|NCT00965341|Testosterone enanthate|testosterone enanthate|mesh-list
153896338|NCT00965341|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
153896340|NCT00965341|Hormones|hormones|mesh-ancestor
153896341|NCT00965341|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153896342|NCT00965341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153896343|NCT00965341|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153896344|NCT00965341|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153896345|NCT00965341|Anabolic Agents|anabolic agents|mesh-ancestor
153896346|NCT01175811|Insulin|insulin|mesh-list
153896347|NCT01175811|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
153896348|NCT01175811|Insulin Glargine|insulin glargine|mesh-list
153896349|NCT01175811|Insulin Lispro|insulin lispro|mesh-list
153896350|NCT01175811|Insulin, Isophane|insulin, isophane|mesh-list
153437557|NCT00003728|Immunologic Factors|immunologic factors|mesh-ancestor
153437558|NCT00003728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153437559|NCT00003728|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153437560|NCT00003728|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153437561|NCT00003728|Alkylating Agents|alkylating agents|mesh-ancestor
153437562|NCT00003728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153437563|NCT00003728|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153437564|NCT00003728|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153437565|NCT00003728|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153437566|NCT00003728|Antiemetics|antiemetics|mesh-ancestor
153437567|NCT00003728|Autonomic Agents|autonomic agents|mesh-ancestor
153437568|NCT00003728|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153437569|NCT00003728|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153437570|NCT00003728|Glucocorticoids|glucocorticoids|mesh-ancestor
153437571|NCT00003728|Hormones|hormones|mesh-ancestor
153437572|NCT00003728|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153437573|NCT00003728|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153437574|NCT00003728|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153437575|NCT00003728|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153437576|NCT00003728|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153437577|NCT00003728|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153896352|NCT01175811|Isophane insulin, insulin lispro drug combination 50:50|isophane insulin, insulin lispro drug combination 50:50|mesh-list
153896353|NCT01175811|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153896354|NCT01175811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153896355|NCT00965263|Cocaine|cocaine|mesh-list
153896356|NCT00965263|Anesthetics, Local|anesthetics, local|mesh-ancestor
153896357|NCT00965263|Anesthetics|anesthetics|mesh-ancestor
153896358|NCT00965263|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153896359|NCT00965263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153896360|NCT00965263|Sensory System Agents|sensory system agents|mesh-ancestor
153896361|NCT00965263|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153896362|NCT00965263|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
153896363|NCT00965263|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
153896364|NCT00965263|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153896365|NCT00965263|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153896366|NCT00965263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153896367|NCT00965263|Dopamine Agents|dopamine agents|mesh-ancestor
153896368|NCT00965263|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153896369|NCT02886195|Pemetrexed|pemetrexed|mesh-list
153896370|NCT02886195|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
153896371|NCT02886195|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153896372|NCT02886195|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153896373|NCT02886195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153896374|NCT02886195|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153896375|NCT02886195|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153896376|NCT02886195|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153896379|NCT02862769|Anesthetics, Local|anesthetics, local|mesh-ancestor
153896380|NCT02862769|Anesthetics|anesthetics|mesh-ancestor
153896381|NCT02862769|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153896382|NCT02862769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153896383|NCT02862769|Sensory System Agents|sensory system agents|mesh-ancestor
153896384|NCT02862769|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153896385|NCT02862769|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153896386|NCT02862769|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
153896387|NCT02862769|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153896388|NCT02862769|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153896389|NCT02862769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153896390|NCT00965185|Atorvastatin|atorvastatin|mesh-list
153896391|NCT00965185|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153896392|NCT00965185|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153896393|NCT00965185|Antimetabolites|antimetabolites|mesh-ancestor
153896394|NCT00965185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153896395|NCT00965185|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153896396|NCT00965185|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
153437606|NCT00004886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153437607|NCT00003734|Triptorelin Pamoate|triptorelin pamoate|mesh-list
153437609|NCT00003734|Luteolytic Agents|luteolytic agents|mesh-ancestor
153437610|NCT00003734|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
153437611|NCT00003734|Contraceptive Agents|contraceptive agents|mesh-ancestor
153437612|NCT00003734|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153437613|NCT00003734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153437614|NCT00003734|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
153437615|NCT00003734|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153437616|NCT00003734|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153437617|NCT00003734|Androgen Antagonists|androgen antagonists|mesh-ancestor
153437618|NCT00003734|Hormone Antagonists|hormone antagonists|mesh-ancestor
153437619|NCT00003734|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153437620|NCT00003740|Trastuzumab|trastuzumab|mesh-list
153437621|NCT00003740|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153437622|NCT00003740|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153437623|NCT00004256|Sargramostim|sargramostim|mesh-list
153437624|NCT00004256|Immunologic Factors|immunologic factors|mesh-ancestor
153437625|NCT00004256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153437626|NCT00004262|Motexafin gadolinium|motexafin gadolinium|mesh-list
153437627|NCT00004262|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153437629|NCT00004262|Dermatologic Agents|dermatologic agents|mesh-ancestor
153437631|NCT00004892|O(6)-benzylguanine|o(6)-benzylguanine|mesh-list
153437632|NCT00004892|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153437633|NCT00004892|Alkylating Agents|alkylating agents|mesh-ancestor
153437634|NCT00004892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153437635|NCT00004892|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153437636|NCT00004892|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153437637|NCT00004268|Midodrine|midodrine|mesh-list
153896397|NCT00965185|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153896398|NCT01174563|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
153896399|NCT01174563|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153896400|NCT01174563|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153896401|NCT01174563|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153896402|NCT01174563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153896403|NCT01174563|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153896404|NCT01298531|Etanercept|etanercept|mesh-list
153896405|NCT01298531|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153896406|NCT01298531|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153896407|NCT01298531|Analgesics|analgesics|mesh-ancestor
153896408|NCT01298531|Sensory System Agents|sensory system agents|mesh-ancestor
153896409|NCT01298531|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153896410|NCT01298531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153896411|NCT01298531|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153896412|NCT01298531|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153896413|NCT01298531|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153896414|NCT01298531|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153896415|NCT01298531|Immunologic Factors|immunologic factors|mesh-ancestor
153896416|NCT02862145|Dexamethasone|dexamethasone|mesh-list
153896417|NCT02862145|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153896418|NCT02862145|Antiemetics|antiemetics|mesh-ancestor
153896419|NCT02862145|Autonomic Agents|autonomic agents|mesh-ancestor
153896420|NCT02862145|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153896421|NCT02862145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153896422|NCT02862145|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153896423|NCT02862145|Glucocorticoids|glucocorticoids|mesh-ancestor
153896425|NCT02862145|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153896426|NCT02862145|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153896427|NCT02862145|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153896428|NCT01174173|Ranolazine|ranolazine|mesh-list
153896429|NCT01174173|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153896430|NCT01174173|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153896431|NCT01174173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153896432|NCT00964795|Aflibercept|aflibercept|mesh-list
153896433|NCT00964795|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153896434|NCT00964795|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153896435|NCT00964795|Growth Substances|growth substances|mesh-ancestor
153896436|NCT00964795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153896437|NCT00964795|Growth Inhibitors|growth inhibitors|mesh-ancestor
153437647|NCT00004268|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153437648|NCT00004268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153437650|NCT00004274|Hormones|hormones|mesh-ancestor
153437651|NCT00004274|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153437652|NCT00004274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153437653|NCT00004904|Methylprednisolone|methylprednisolone|mesh-list
153437654|NCT00004904|Cyclophosphamide|cyclophosphamide|mesh-list
153437655|NCT00004904|Etoposide|etoposide|mesh-list
153437656|NCT00004904|Cladribine|cladribine|mesh-list
153437657|NCT00004904|Tacrolimus|tacrolimus|mesh-list
153437658|NCT00004904|Antilymphocyte Serum|antilymphocyte serum|mesh-list
153437659|NCT00004904|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153437660|NCT00004904|Immunologic Factors|immunologic factors|mesh-ancestor
153437661|NCT00004904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153437662|NCT00004904|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153437663|NCT00004904|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153437664|NCT00004904|Alkylating Agents|alkylating agents|mesh-ancestor
153437665|NCT00004904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153437667|NCT00004904|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153437668|NCT00004904|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153437669|NCT00004904|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153437674|NCT00004904|Antiemetics|antiemetics|mesh-ancestor
153896438|NCT00964795|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153896439|NCT01173471|Niacinamide|niacinamide|mesh-list
153896440|NCT01173471|Vitamin B Complex|vitamin b complex|mesh-ancestor
153896441|NCT01173471|Vitamins|vitamins|mesh-ancestor
153896442|NCT01173471|Micronutrients|micronutrients|mesh-ancestor
153896443|NCT01173471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153896444|NCT01172847|Oseltamivir|oseltamivir|mesh-list
153896445|NCT01172847|Rimantadine|rimantadine|mesh-list
153896446|NCT01172847|Antiviral Agents|antiviral agents|mesh-ancestor
153896447|NCT01172847|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153896448|NCT01172847|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153896449|NCT01172847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153896450|NCT01172847|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153896451|NCT00966355|Octreotide|octreotide|mesh-list
153896452|NCT00966355|Terlipressin|terlipressin|mesh-list
153896453|NCT00966355|Somatostatin|somatostatin|mesh-list
153896454|NCT00966355|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153896455|NCT00966355|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153896456|NCT00966355|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153896457|NCT00966355|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153896458|NCT00966355|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
153896473|NCT01172535|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
153896474|NCT01172535|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153896476|NCT05160493|Ketamine|ketamine|mesh-list
153896477|NCT05160493|Esketamine|esketamine|mesh-list
153896478|NCT05160493|Analgesics|analgesics|mesh-ancestor
153896479|NCT05160493|Sensory System Agents|sensory system agents|mesh-ancestor
153896480|NCT05160493|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153896481|NCT05160493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153896482|NCT05160493|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
153896483|NCT05160493|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153896484|NCT05160493|Anesthetics, General|anesthetics, general|mesh-ancestor
153896485|NCT05160493|Anesthetics|anesthetics|mesh-ancestor
153896486|NCT05160493|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153896487|NCT05160493|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
153896488|NCT05160493|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
153896489|NCT05160493|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153437701|NCT00003758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153437702|NCT00003758|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153437703|NCT00003758|Antiviral Agents|antiviral agents|mesh-ancestor
153437704|NCT00003758|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153437705|NCT00003758|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153437706|NCT00003758|Immunologic Factors|immunologic factors|mesh-ancestor
153437707|NCT00003758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153437708|NCT00003758|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153437709|NCT00003758|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153437711|NCT00003758|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153437712|NCT00004310|Clomipramine|clomipramine|mesh-list
153437713|NCT00004310|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
153437714|NCT00004310|Antidepressive Agents|antidepressive agents|mesh-ancestor
153437715|NCT00004310|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153437716|NCT00004310|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
153437717|NCT00004310|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153437718|NCT00004310|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153437719|NCT00004310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153437720|NCT00004310|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153437722|NCT00004310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153437724|NCT00004922|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
153437725|NCT00004922|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153437726|NCT00004922|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153437727|NCT00004922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153437728|NCT00004922|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153437729|NCT00004316|Capsaicin|capsaicin|mesh-list
153437730|NCT00004316|Antipruritics|antipruritics|mesh-ancestor
153437731|NCT00004316|Dermatologic Agents|dermatologic agents|mesh-ancestor
153437732|NCT00004316|Sensory System Agents|sensory system agents|mesh-ancestor
153437733|NCT00004316|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153896490|NCT05160493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153896491|NCT05160493|Anticonvulsants|anticonvulsants|mesh-ancestor
153896492|NCT05160493|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153896493|NCT05160493|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153896494|NCT05160493|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153896495|NCT05160493|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153896496|NCT05160493|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153896497|NCT05160493|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153896498|NCT05160493|Antidepressive Agents|antidepressive agents|mesh-ancestor
153896499|NCT00966277|Dalteparin|dalteparin|mesh-list
153896500|NCT00966277|Tinzaparin|tinzaparin|mesh-list
153896501|NCT00966277|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
153896502|NCT00966277|Anticoagulants|anticoagulants|mesh-ancestor
153896503|NCT00966277|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153896504|NCT00966277|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153896505|NCT00966277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153896506|NCT01297517|Brimonidine Tartrate|brimonidine tartrate|mesh-list
153896507|NCT01297517|Ophthalmic Solutions|ophthalmic solutions|mesh-list
153896508|NCT01297517|Brinzolamide|brinzolamide|mesh-list
153896509|NCT01297517|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
153896510|NCT01297517|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153896511|NCT01297517|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
153896512|NCT01297517|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153896513|NCT01297517|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153896514|NCT01297517|Adrenergic Agents|adrenergic agents|mesh-ancestor
153896515|NCT01297517|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153896516|NCT01297517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153896517|NCT01297517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153896518|NCT01297517|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
153896519|NCT01297517|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153896522|NCT01296347|Sensory System Agents|sensory system agents|mesh-ancestor
153896523|NCT01296347|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153896524|NCT01296347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153896525|NCT01296347|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
153896526|NCT01296347|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153896527|NCT01296347|Anesthetics, General|anesthetics, general|mesh-ancestor
153896528|NCT01296347|Anesthetics|anesthetics|mesh-ancestor
153437740|NCT00004928|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
153437741|NCT00004928|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153437742|NCT00004928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153437743|NCT00004928|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
153437744|NCT00004928|Vitamins|vitamins|mesh-ancestor
153437745|NCT00004928|Micronutrients|micronutrients|mesh-ancestor
153437746|NCT00004328|Enalapril|enalapril|mesh-list
153437747|NCT00004328|Polystyrene sulfonic acid|polystyrene sulfonic acid|mesh-list
153437748|NCT00004328|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
153437749|NCT00004328|Protease Inhibitors|protease inhibitors|mesh-ancestor
153437750|NCT00004328|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153437751|NCT00004328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153437753|NCT00004328|Chelating Agents|chelating agents|mesh-ancestor
153437754|NCT00004328|Sequestering Agents|sequestering agents|mesh-ancestor
153437756|NCT00004934|Carboplatin|carboplatin|mesh-list
153437757|NCT00004934|Epirubicin|epirubicin|mesh-list
153437758|NCT00004934|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153437759|NCT00004934|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153896529|NCT01296347|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153896530|NCT01296347|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
153896531|NCT01296347|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
153896532|NCT01296347|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153896533|NCT01296347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153896534|NCT01296035|Panitumumab|panitumumab|mesh-list
153896535|NCT01296035|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153896536|NCT01296035|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153896537|NCT01294787|Glycopyrrolate|glycopyrrolate|mesh-list
153896538|NCT01294787|Bromides|bromides|mesh-list
153896539|NCT01294787|Tiotropium Bromide|tiotropium bromide|mesh-list
153896540|NCT01294787|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153896541|NCT01294787|Autonomic Agents|autonomic agents|mesh-ancestor
153896542|NCT01294787|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153896543|NCT01294787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153896544|NCT01294787|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153896545|NCT01294787|Respiratory System Agents|respiratory system agents|mesh-ancestor
153896546|NCT01294787|Parasympatholytics|parasympatholytics|mesh-ancestor
153896547|NCT01294787|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
153896548|NCT01294787|Cholinergic Agents|cholinergic agents|mesh-ancestor
153896549|NCT01294787|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153896550|NCT01294787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153896551|NCT01294787|Anticonvulsants|anticonvulsants|mesh-ancestor
153896552|NCT01294787|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153896553|NCT01294787|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
153896554|NCT01294553|Metformin|metformin|mesh-list
153896555|NCT01294553|Rosiglitazone|rosiglitazone|mesh-list
153896556|NCT01294553|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153896557|NCT01294553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153896558|NCT04326023|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
153896559|NCT04326023|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153896560|NCT04326023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153896561|NCT04326023|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153896562|NCT01294397|Denosumab|denosumab|mesh-list
153896563|NCT01294397|Etanercept|etanercept|mesh-list
153437760|NCT00004934|Tubulin Modulators|tubulin modulators|mesh-ancestor
153896564|NCT01294397|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153896565|NCT01294397|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153896566|NCT01294397|Analgesics|analgesics|mesh-ancestor
153896567|NCT01294397|Sensory System Agents|sensory system agents|mesh-ancestor
153896568|NCT01294397|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153896569|NCT01294397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153896570|NCT01294397|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153896571|NCT01294397|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153896572|NCT01294397|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153896573|NCT01294397|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153896574|NCT01294397|Immunologic Factors|immunologic factors|mesh-ancestor
153896575|NCT01294397|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153896576|NCT01293695|Hypnotics and Sedatives|hypnotics and sedatives|mesh-list
153896577|NCT01293695|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153896578|NCT01293695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153896579|NCT01293539|Melphalan|melphalan|mesh-list
153896580|NCT01293539|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153896581|NCT01293539|Alkylating Agents|alkylating agents|mesh-ancestor
153437795|NCT00003776|Antidotes|antidotes|mesh-ancestor
153437796|NCT00003776|Protective Agents|protective agents|mesh-ancestor
153437800|NCT00003776|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153437801|NCT00003776|Alkylating Agents|alkylating agents|mesh-ancestor
153437802|NCT00003776|Antifungal Agents|antifungal agents|mesh-ancestor
153437803|NCT00003776|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153437805|NCT00003788|Lomustine|lomustine|mesh-list
153437806|NCT00003788|Procarbazine|procarbazine|mesh-list
153437807|NCT00003788|Dihematoporphyrin Ether|dihematoporphyrin ether|mesh-list
153437808|NCT00003788|Trioxsalen|trioxsalen|mesh-list
153437809|NCT00003788|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153437810|NCT00003788|Alkylating Agents|alkylating agents|mesh-ancestor
153437811|NCT00003788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153437812|NCT00003788|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153437813|NCT00003788|Dermatologic Agents|dermatologic agents|mesh-ancestor
153437814|NCT00003788|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
153437815|NCT00004340|Calcitriol|calcitriol|mesh-list
153437816|NCT00004340|Hormones|hormones|mesh-list
153437817|NCT00004340|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153437818|NCT00004340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153437819|NCT00004340|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153437820|NCT00004340|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
153437821|NCT00004340|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153437822|NCT00004340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153437823|NCT00004340|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
153437824|NCT00004340|Vitamins|vitamins|mesh-ancestor
153437825|NCT00004340|Micronutrients|micronutrients|mesh-ancestor
153437826|NCT00004340|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153437828|NCT00004346|Lovastatin|lovastatin|mesh-list
153896582|NCT01293539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153896583|NCT01293539|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153896584|NCT01293539|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153896585|NCT01293539|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153896586|NCT01293539|Immunologic Factors|immunologic factors|mesh-ancestor
153896587|NCT01293539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153896588|NCT01292837|Levetiracetam|levetiracetam|mesh-list
153896591|NCT00965731|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
153896592|NCT00965731|Crizotinib|crizotinib|mesh-list
153896593|NCT00965731|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153896594|NCT00965731|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153896595|NCT00965731|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153896596|NCT00965731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153896597|NCT00965731|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153896598|NCT00630175|Zolpidem|zolpidem|mesh-list
153896599|NCT00630175|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
153896600|NCT00630175|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153896601|NCT00630175|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153896604|NCT00630175|GABA Agonists|gaba agonists|mesh-ancestor
153896605|NCT00630175|GABA Agents|gaba agents|mesh-ancestor
153896606|NCT00630175|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153896607|NCT00630175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153896608|NCT00965575|Melatonin|melatonin|mesh-list
153896609|NCT00965575|Antioxidants|antioxidants|mesh-ancestor
153896610|NCT00965575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153896611|NCT00965575|Protective Agents|protective agents|mesh-ancestor
153896612|NCT00965575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153896613|NCT00965575|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153896614|NCT00965497|Escitalopram|escitalopram|mesh-list
153896615|NCT00965497|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
153896616|NCT00965497|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153896617|NCT00965497|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153896618|NCT00965497|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153896619|NCT00965497|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153896620|NCT00965497|Serotonin Agents|serotonin agents|mesh-ancestor
153896621|NCT00965497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153896622|NCT00963937|Sumatriptan|sumatriptan|mesh-list
153437841|NCT00384800|Tegafur|tegafur|mesh-list
153437842|NCT00384800|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153437843|NCT00384800|Immunologic Factors|immunologic factors|mesh-ancestor
153437844|NCT00384800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153437845|NCT00384800|Leprostatic Agents|leprostatic agents|mesh-ancestor
153437846|NCT00384800|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153437847|NCT00384800|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153437848|NCT00384800|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153437849|NCT00384800|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153437850|NCT00384800|Growth Substances|growth substances|mesh-ancestor
153437851|NCT00384800|Growth Inhibitors|growth inhibitors|mesh-ancestor
153437852|NCT00384800|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153437853|NCT00384800|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153437854|NCT00384800|Antimetabolites|antimetabolites|mesh-ancestor
153437855|NCT00384800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153437856|NCT00384878|Leucovorin|leucovorin|mesh-list
153437857|NCT00384878|Fluorouracil|fluorouracil|mesh-list
153437858|NCT00384878|Cetuximab|cetuximab|mesh-list
153437860|NCT00384878|Antimetabolites|antimetabolites|mesh-ancestor
153437861|NCT00384878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153437862|NCT00384878|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153437863|NCT00384878|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153437864|NCT00384878|Immunologic Factors|immunologic factors|mesh-ancestor
153437865|NCT00384878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153437866|NCT00384878|Antidotes|antidotes|mesh-ancestor
153437867|NCT00384878|Protective Agents|protective agents|mesh-ancestor
153437868|NCT00384878|Vitamin B Complex|vitamin b complex|mesh-ancestor
153437869|NCT00384878|Vitamins|vitamins|mesh-ancestor
153437870|NCT00384878|Micronutrients|micronutrients|mesh-ancestor
153437871|NCT00384878|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153437872|NCT02972762|Propofol|propofol|mesh-list
153437873|NCT02972762|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153437874|NCT02972762|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153896623|NCT00963937|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
153896624|NCT00963937|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
153896625|NCT00963937|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
153896626|NCT00963937|Serotonin Agents|serotonin agents|mesh-ancestor
153896627|NCT00963937|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153896628|NCT00963937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153896629|NCT00963937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153437875|NCT02972762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153437878|NCT02972762|Anesthetics|anesthetics|mesh-ancestor
153896630|NCT01170663|Paclitaxel|paclitaxel|mesh-list
153896631|NCT01170663|Ramucirumab|ramucirumab|mesh-list
153896632|NCT01170663|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153896633|NCT01170663|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153896634|NCT01170663|Tubulin Modulators|tubulin modulators|mesh-ancestor
153896635|NCT01170663|Antimitotic Agents|antimitotic agents|mesh-ancestor
153896636|NCT01170663|Mitosis Modulators|mitosis modulators|mesh-ancestor
153896637|NCT01170663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153896638|NCT01170663|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153896640|NCT01170663|Growth Substances|growth substances|mesh-ancestor
153896641|NCT01170663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153896642|NCT01170663|Growth Inhibitors|growth inhibitors|mesh-ancestor
153896644|NCT04315155|Ipilimumab|ipilimumab|mesh-list
153896645|NCT04315155|Belinostat|belinostat|mesh-list
153896646|NCT04315155|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153896647|NCT04315155|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153896648|NCT04315155|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153896649|NCT04315155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153896650|NCT04315155|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
153896651|NCT04315155|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153896652|NCT01170273|Vitamin D|vitamin d|mesh-list
153896653|NCT01170273|Vitamins|vitamins|mesh-ancestor
153896654|NCT01170273|Micronutrients|micronutrients|mesh-ancestor
153896655|NCT01170273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153896656|NCT01170273|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153896658|NCT01170039|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
153896659|NCT01170039|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153896660|NCT01170039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153437883|NCT00004358|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153437884|NCT00004358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153437885|NCT00004358|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153437886|NCT00004358|Vasodilator Agents|vasodilator agents|mesh-ancestor
153437887|NCT00004364|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
153437888|NCT00004364|Hemostatics|hemostatics|mesh-ancestor
153437889|NCT00004364|Coagulants|coagulants|mesh-ancestor
153437890|NCT00004364|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
153437891|NCT00004364|Natriuretic Agents|natriuretic agents|mesh-ancestor
153437892|NCT00004364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153437894|NCT00005000|Zidovudine|zidovudine|mesh-list
153437895|NCT00005000|Efavirenz|efavirenz|mesh-list
153437896|NCT00005000|Didanosine|didanosine|mesh-list
153437897|NCT00005000|Stavudine|stavudine|mesh-list
153437898|NCT00005000|Nelfinavir|nelfinavir|mesh-list
153437899|NCT00005000|Keyhole-limpet hemocyanin|keyhole-limpet hemocyanin|mesh-list
153437900|NCT00005000|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153437901|NCT00005000|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153437902|NCT00005000|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153437903|NCT00005000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153437904|NCT00005000|Antiviral Agents|antiviral agents|mesh-ancestor
153437905|NCT00005000|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153437906|NCT00005000|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153437907|NCT00005000|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153896661|NCT01286558|Amlodipine|amlodipine|mesh-list
153896662|NCT01286558|Telmisartan|telmisartan|mesh-list
153896663|NCT01286558|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153896664|NCT01286558|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153896665|NCT01286558|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153896666|NCT01286558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153896667|NCT01286558|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153896668|NCT01286558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153896669|NCT01286558|Vasodilator Agents|vasodilator agents|mesh-ancestor
153896670|NCT01286558|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
153896671|NCT01286558|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
153896672|NCT01169103|Hormones|hormones|mesh-list
153896673|NCT01169103|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153896674|NCT01169103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153896675|NCT01286168|Chlorhexidine|chlorhexidine|mesh-list
153896676|NCT01286168|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
153896677|NCT01286168|Sodium Hypochlorite|sodium hypochlorite|mesh-list
153896678|NCT01286168|Eusol|eusol|mesh-list
153896679|NCT01286168|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
153896680|NCT01286168|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
153896681|NCT01286168|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153896682|NCT01286168|Disinfectants|disinfectants|mesh-ancestor
153896683|NCT01286168|Dermatologic Agents|dermatologic agents|mesh-ancestor
153896684|NCT02889692|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
153896685|NCT02889692|Gefitinib|gefitinib|mesh-list
153437908|NCT00005000|Antimetabolites|antimetabolites|mesh-ancestor
153896686|NCT02889692|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153896687|NCT02889692|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153896688|NCT02889692|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153896689|NCT02889692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153896692|NCT05569382|Bisoprolol|bisoprolol|mesh-list
153896693|NCT05569382|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153896694|NCT05569382|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153896695|NCT05569382|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153896696|NCT05569382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153896697|NCT05569382|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153896698|NCT05569382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153896699|NCT05569382|Vasodilator Agents|vasodilator agents|mesh-ancestor
153896700|NCT05569382|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153896701|NCT05569382|Sympatholytics|sympatholytics|mesh-ancestor
153896702|NCT05569382|Autonomic Agents|autonomic agents|mesh-ancestor
153896703|NCT05569382|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153896704|NCT05569382|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
153896705|NCT05569382|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
153896706|NCT05569382|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
153896707|NCT05569382|Adrenergic Agents|adrenergic agents|mesh-ancestor
153896708|NCT05569382|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153437934|NCT00005006|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153437935|NCT00005006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153437936|NCT00005006|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153437937|NCT00005006|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153437938|NCT00004382|Tin mesoporphyrin|tin mesoporphyrin|mesh-list
153437939|NCT00004382|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153437940|NCT00004382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153437941|NCT00005012|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
153437942|NCT00005012|Antiviral Agents|antiviral agents|mesh-ancestor
153437943|NCT00005012|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153437944|NCT00004400|Testosterone|testosterone|mesh-list
153437945|NCT00004400|Androgens|androgens|mesh-ancestor
153437946|NCT00004400|Hormones|hormones|mesh-ancestor
153437947|NCT00004400|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153437948|NCT00004400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153437949|NCT00003812|Paclitaxel|paclitaxel|mesh-list
153437950|NCT00003812|Etoposide|etoposide|mesh-list
153437951|NCT00003812|Carboplatin|carboplatin|mesh-list
153437952|NCT00003812|Topotecan|topotecan|mesh-list
153437953|NCT00003812|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153437954|NCT00003812|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153437955|NCT00003812|Tubulin Modulators|tubulin modulators|mesh-ancestor
153437956|NCT00003812|Antimitotic Agents|antimitotic agents|mesh-ancestor
153437957|NCT00003812|Mitosis Modulators|mitosis modulators|mesh-ancestor
153437958|NCT00003812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153437959|NCT00003812|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153437960|NCT00003812|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153437961|NCT00003812|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153437962|NCT00003812|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
153437963|NCT00005018|Efavirenz|efavirenz|mesh-list
153437964|NCT00005018|Abacavir|abacavir|mesh-list
153437965|NCT00005018|Didanosine|didanosine|mesh-list
153437966|NCT00005018|Hydroxyurea|hydroxyurea|mesh-list
153437967|NCT00005018|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153896709|NCT00963547|Trastuzumab|trastuzumab|mesh-list
153896710|NCT00963547|Lapatinib|lapatinib|mesh-list
153896711|NCT00963547|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153896712|NCT00963547|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153896713|NCT00963547|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153896714|NCT00963547|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153437969|NCT00005018|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153896715|NCT00963547|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153896716|NCT00963547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153896718|NCT01285310|Apremilast|apremilast|mesh-list
153896719|NCT01285310|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153896722|NCT01285310|Sensory System Agents|sensory system agents|mesh-ancestor
153896723|NCT01285310|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153896724|NCT01285310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153896725|NCT01285310|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153896726|NCT01285310|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153896727|NCT01285310|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
153896728|NCT01285310|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
153896729|NCT01285310|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153896730|NCT01285310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153896731|NCT01285310|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153896732|NCT01285310|Immunologic Factors|immunologic factors|mesh-ancestor
153896733|NCT01285310|Leprostatic Agents|leprostatic agents|mesh-ancestor
153896734|NCT01285310|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153896735|NCT01285310|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153896736|NCT01285310|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153896737|NCT01285310|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153896738|NCT01285310|Growth Substances|growth substances|mesh-ancestor
153896739|NCT01285310|Growth Inhibitors|growth inhibitors|mesh-ancestor
153896740|NCT01285310|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153896741|NCT01254630|Vaccines|vaccines|mesh-list
153896742|NCT01254630|Immunologic Factors|immunologic factors|mesh-ancestor
153896743|NCT01254630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153896744|NCT01253304|Dulaglutide|dulaglutide|mesh-list
153896745|NCT01253304|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
153896746|NCT01253304|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153896747|NCT01253304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153437974|NCT00005018|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153437975|NCT00005018|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
153437976|NCT00005018|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
153437977|NCT00005018|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
153437978|NCT00005018|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
153437979|NCT00005018|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153437980|NCT00005018|Antisickling Agents|antisickling agents|mesh-ancestor
153437981|NCT00005018|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153437982|NCT00005018|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153437983|NCT00005018|Antimetabolites|antimetabolites|mesh-ancestor
153437984|NCT00003824|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
153437985|NCT00003824|Ciprofloxacin|ciprofloxacin|mesh-list
153437986|NCT00003824|Cephalexin|cephalexin|mesh-list
153437987|NCT00003824|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153437988|NCT00003824|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153437989|NCT00003824|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153437990|NCT00003824|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153437991|NCT00003824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153437992|NCT00003824|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153437993|NCT00003824|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
153437994|NCT00003824|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153437995|NCT00004406|Hormones|hormones|mesh-list
153437996|NCT00004406|Parathyroid Hormone|parathyroid hormone|mesh-list
153437997|NCT00004406|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153437998|NCT00004406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153437999|NCT00004406|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153438001|NCT00005024|Carboplatin|carboplatin|mesh-list
153438002|NCT00005024|Doxorubicin|doxorubicin|mesh-list
153438003|NCT00005024|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
153438004|NCT00005024|Granisetron|granisetron|mesh-list
153438005|NCT00005024|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153438006|NCT00005024|Immunologic Factors|immunologic factors|mesh-ancestor
153896749|NCT04319484|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153896750|NCT04319484|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153896751|NCT04319484|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153896752|NCT04319484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153896753|NCT01253226|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
153896754|NCT01253226|Immunologic Factors|immunologic factors|mesh-ancestor
153896755|NCT01253226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153896756|NCT01252134|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
153896757|NCT00624312|Epoetin Alfa|epoetin alfa|mesh-list
153896758|NCT00624312|Hematinics|hematinics|mesh-ancestor
153896759|NCT01250418|Ketamine|ketamine|mesh-list
153896760|NCT01250418|Analgesics|analgesics|mesh-ancestor
153896761|NCT01250418|Sensory System Agents|sensory system agents|mesh-ancestor
153896762|NCT01250418|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153896763|NCT01250418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153896764|NCT01250418|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
153896765|NCT01250418|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153896766|NCT01250418|Anesthetics, General|anesthetics, general|mesh-ancestor
153896767|NCT01250418|Anesthetics|anesthetics|mesh-ancestor
153896768|NCT01250418|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153896769|NCT01250418|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
153896770|NCT01250418|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
153896771|NCT01250418|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153896772|NCT01250418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153896773|NCT01292603|Cyclophosphamide|cyclophosphamide|mesh-list
153896774|NCT01292603|Rituximab|rituximab|mesh-list
153896775|NCT01292603|Fludarabine|fludarabine|mesh-list
153896776|NCT01292603|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153896777|NCT01292603|Immunologic Factors|immunologic factors|mesh-ancestor
153896778|NCT01292603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153896779|NCT01292603|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153896780|NCT01292603|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153438007|NCT00005024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153438008|NCT00005024|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153438009|NCT00005024|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153438010|NCT00005024|Alkylating Agents|alkylating agents|mesh-ancestor
153438011|NCT00005024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153438012|NCT00005024|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153438013|NCT00005024|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153438014|NCT00005024|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153438015|NCT00005024|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153438016|NCT00005024|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153438017|NCT00005024|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153438019|NCT00005024|Autonomic Agents|autonomic agents|mesh-ancestor
153438020|NCT00005024|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153438021|NCT00005024|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153438022|NCT00005024|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
153438024|NCT00005024|Serotonin Agents|serotonin agents|mesh-ancestor
153438025|NCT00005024|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153438026|NCT00005030|Lonafarnib|lonafarnib|mesh-list
153438027|NCT00005030|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153438028|NCT00005030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153438029|NCT00004424|Midazolam|midazolam|mesh-list
153438030|NCT00004424|Fentanyl|fentanyl|mesh-list
153438031|NCT00004424|Propofol|propofol|mesh-list
153438032|NCT00004424|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153438033|NCT00004424|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153438034|NCT00004424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153438035|NCT00004424|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153438036|NCT00004424|Anesthetics, General|anesthetics, general|mesh-ancestor
153438037|NCT00004424|Anesthetics|anesthetics|mesh-ancestor
153438038|NCT00004424|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153438039|NCT00004424|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153896781|NCT01292603|Alkylating Agents|alkylating agents|mesh-ancestor
153896782|NCT01292603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153896783|NCT01292603|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153896784|NCT01292603|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153896785|NCT01292603|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153896787|NCT01292057|Antidepressive Agents|antidepressive agents|mesh-ancestor
153896788|NCT01292057|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153438040|NCT00004424|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153896789|NCT01292057|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153896790|NCT01292057|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153896791|NCT01292057|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153896792|NCT01292057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153896793|NCT01292057|Dopamine Agonists|dopamine agonists|mesh-ancestor
153896794|NCT01292057|Dopamine Agents|dopamine agents|mesh-ancestor
153896795|NCT01292057|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153896796|NCT01292057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153896797|NCT01292057|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
153896798|NCT01292057|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
153896799|NCT01292057|Serotonin Agents|serotonin agents|mesh-ancestor
153896800|NCT01292057|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
153896801|NCT01292057|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153896802|NCT01292057|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
153896803|NCT01292057|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
153896805|NCT01290887|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153896806|NCT01290887|Respiratory System Agents|respiratory system agents|mesh-ancestor
153896807|NCT01290731|Interferons|interferons|mesh-list
153896808|NCT01290731|Ribavirin|ribavirin|mesh-list
153896809|NCT01290731|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
153896810|NCT01290731|Simeprevir|simeprevir|mesh-list
153896811|NCT01290731|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153896812|NCT01290731|Antiviral Agents|antiviral agents|mesh-ancestor
153896813|NCT01290731|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153896814|NCT01290731|Antimetabolites|antimetabolites|mesh-ancestor
153896815|NCT01290731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153896816|NCT01290731|Protease Inhibitors|protease inhibitors|mesh-ancestor
153896817|NCT01290731|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153896818|NCT01290341|Naftifine|naftifine|mesh-list
153896819|NCT01290341|Antifungal Agents|antifungal agents|mesh-ancestor
153896820|NCT01290341|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153896821|NCT01290263|Bevacizumab|bevacizumab|mesh-list
153896822|NCT01290263|Trebananib|trebananib|mesh-list
153438052|NCT00004430|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153438053|NCT00004430|Glucocorticoids|glucocorticoids|mesh-ancestor
153438054|NCT00004430|Hormones|hormones|mesh-ancestor
153438055|NCT00004430|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153438056|NCT00004430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153438057|NCT00004430|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153438058|NCT00004430|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153438059|NCT00003842|Interleukin-4|interleukin-4|mesh-list
153438060|NCT00003842|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153438061|NCT00003842|Immunologic Factors|immunologic factors|mesh-ancestor
153438062|NCT00003842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153438063|NCT00003842|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153438064|NCT00003842|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153438065|NCT00005036|Leucovorin|leucovorin|mesh-list
153438066|NCT00005036|Fluorouracil|fluorouracil|mesh-list
153438067|NCT00005036|Oxaliplatin|oxaliplatin|mesh-list
153438068|NCT00005036|Irinotecan|irinotecan|mesh-list
153438069|NCT00005036|Calcium|calcium|mesh-list
153438070|NCT00005036|Levoleucovorin|levoleucovorin|mesh-list
153438071|NCT00005036|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153438072|NCT00005036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153438073|NCT00005036|Antimetabolites|antimetabolites|mesh-ancestor
153438074|NCT00005036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153438075|NCT00005036|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153438076|NCT00005036|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153896823|NCT01290263|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153896824|NCT01290263|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153896826|NCT01290263|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153896827|NCT01290263|Growth Substances|growth substances|mesh-ancestor
153896828|NCT01290263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153896829|NCT01290263|Growth Inhibitors|growth inhibitors|mesh-ancestor
153896830|NCT01290029|Cinacalcet|cinacalcet|mesh-list
153896831|NCT01290029|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153896832|NCT01290029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153896833|NCT01290029|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
153896834|NCT01290029|Hormone Antagonists|hormone antagonists|mesh-ancestor
153896835|NCT01290029|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153896836|NCT02890199|Lidocaine|lidocaine|mesh-list
153896837|NCT02890199|Bupivacaine|bupivacaine|mesh-list
153896838|NCT02890199|Anesthetics, Local|anesthetics, local|mesh-ancestor
153896839|NCT02890199|Anesthetics|anesthetics|mesh-ancestor
153896840|NCT02890199|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153896841|NCT02890199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153896842|NCT02890199|Sensory System Agents|sensory system agents|mesh-ancestor
153896843|NCT02890199|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153438077|NCT00005036|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153896844|NCT02890199|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153896845|NCT02890199|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
153896846|NCT02890199|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153896847|NCT02890199|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153896848|NCT02890199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153896849|NCT01289639|Pioglitazone|pioglitazone|mesh-list
153896850|NCT01289639|Fenofibrate|fenofibrate|mesh-list
153896851|NCT01289639|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153896852|NCT01289639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153896853|NCT01289639|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153896854|NCT01289639|Antimetabolites|antimetabolites|mesh-ancestor
153896855|NCT01289639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153896856|NCT01289639|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153896857|NCT01288937|Milnacipran|milnacipran|mesh-list
153896858|NCT01288937|Levomilnacipran|levomilnacipran|mesh-list
153896859|NCT01288937|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
153896860|NCT01288937|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153896861|NCT01288937|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153896862|NCT01288937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153896863|NCT01288937|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153896864|NCT01288937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153896865|NCT01288937|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153896866|NCT01288937|Analgesics|analgesics|mesh-ancestor
153896867|NCT01288937|Sensory System Agents|sensory system agents|mesh-ancestor
153438101|NCT00005042|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153438102|NCT00005042|Growth Substances|growth substances|mesh-ancestor
153438103|NCT00005042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153438104|NCT00005042|Growth Inhibitors|growth inhibitors|mesh-ancestor
153438105|NCT00005042|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153438106|NCT00005042|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153438107|NCT00005042|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153438108|NCT00005042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153438110|NCT00004442|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
153438111|NCT00004442|Cholic Acids|cholic acids|mesh-list
153438112|NCT00004442|Cathartics|cathartics|mesh-ancestor
153438113|NCT00004442|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153438114|NCT00004442|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
153438115|NCT05444569|Liraglutide|liraglutide|mesh-list
153438116|NCT05444569|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
153438117|NCT05444569|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153438118|NCT05444569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153438119|NCT05444569|Incretins|incretins|mesh-ancestor
153438120|NCT05444569|Hormones|hormones|mesh-ancestor
153438121|NCT05444569|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153438122|NCT00004448|Prednisone|prednisone|mesh-list
153438123|NCT00004448|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153438124|NCT00004448|Glucocorticoids|glucocorticoids|mesh-ancestor
153438125|NCT00004448|Hormones|hormones|mesh-ancestor
153438126|NCT00004448|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153438127|NCT00004448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153438128|NCT00004448|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153438130|NCT00003860|Carboplatin|carboplatin|mesh-list
153438133|NCT00003860|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153438134|NCT00003860|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153896868|NCT01288937|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153896869|NCT01288937|Antidepressive Agents|antidepressive agents|mesh-ancestor
153896870|NCT01288937|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153896871|NCT01288469|Atorvastatin|atorvastatin|mesh-list
153896872|NCT01288469|Alirocumab|alirocumab|mesh-list
153896873|NCT01288469|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
153896874|NCT01288469|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153896875|NCT01288469|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153896876|NCT01288469|Antimetabolites|antimetabolites|mesh-ancestor
153896877|NCT01288469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153896878|NCT01288469|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153896879|NCT01288469|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
153896880|NCT01288469|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153896881|NCT01288469|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
153896882|NCT01288469|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
153896883|NCT01288469|Protease Inhibitors|protease inhibitors|mesh-ancestor
153896884|NCT01288469|Immunologic Factors|immunologic factors|mesh-ancestor
153896885|NCT01288469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153896886|NCT01288079|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
153896887|NCT01288079|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
153896888|NCT01288079|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153896889|NCT01288079|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153896890|NCT01288079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153896891|NCT01288079|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153896892|NCT01288079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153896893|NCT01288079|Analgesics|analgesics|mesh-ancestor
153896894|NCT01288079|Sensory System Agents|sensory system agents|mesh-ancestor
153896895|NCT01288079|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153896896|NCT01288079|Antidepressive Agents|antidepressive agents|mesh-ancestor
153896897|NCT01288079|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153896898|NCT01288079|Dopamine Agents|dopamine agents|mesh-ancestor
153896900|NCT01287221|Rifampin|rifampin|mesh-list
153896901|NCT01287221|Vitamins|vitamins|mesh-ancestor
153896902|NCT01287221|Micronutrients|micronutrients|mesh-ancestor
153896903|NCT01287221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153896904|NCT01287221|Vitamin B Complex|vitamin b complex|mesh-ancestor
153896905|NCT01287221|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
153896906|NCT01287221|Antitubercular Agents|antitubercular agents|mesh-ancestor
153896907|NCT01287221|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153438142|NCT00005048|Estramustine|estramustine|mesh-list
153438143|NCT00005048|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153438144|NCT00005048|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153438145|NCT00005048|Tubulin Modulators|tubulin modulators|mesh-ancestor
153438146|NCT00005048|Antimitotic Agents|antimitotic agents|mesh-ancestor
153438147|NCT00005048|Mitosis Modulators|mitosis modulators|mesh-ancestor
153438148|NCT00005048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153438149|NCT00005048|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153438150|NCT00005048|Alkylating Agents|alkylating agents|mesh-ancestor
153438151|NCT00005048|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153438152|NCT04756765|Talazoparib|talazoparib|mesh-list
153438153|NCT04756765|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
153438154|NCT04756765|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153438155|NCT04756765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153438156|NCT04756765|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153438159|NCT00004466|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153438160|NCT00004466|Antimetabolites|antimetabolites|mesh-ancestor
153438161|NCT00004466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153438170|NCT00004478|Droxidopa|droxidopa|mesh-list
153438171|NCT00004478|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
153438172|NCT00004478|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
153438173|NCT00003878|Carmustine|carmustine|mesh-list
153896908|NCT01287221|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153896909|NCT01287221|Leprostatic Agents|leprostatic agents|mesh-ancestor
153896910|NCT01287221|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153896911|NCT01287221|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153896912|NCT01287221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153896913|NCT01287221|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
153896914|NCT01287221|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
153896915|NCT01287221|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
153896916|NCT01287221|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
153896917|NCT01287221|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
153896918|NCT01287221|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
153896919|NCT01287221|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
153896920|NCT01287221|Dermatologic Agents|dermatologic agents|mesh-ancestor
153896921|NCT01167153|Amlodipine|amlodipine|mesh-list
153896922|NCT01167153|Valsartan|valsartan|mesh-list
153896923|NCT01167153|Nifedipine|nifedipine|mesh-list
153896924|NCT01167153|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153896925|NCT01167153|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153896926|NCT01167153|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153896927|NCT01167153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153896928|NCT01167153|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153896929|NCT01167153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153896930|NCT01167153|Vasodilator Agents|vasodilator agents|mesh-ancestor
153896931|NCT01167153|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
153896932|NCT01167153|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
153896933|NCT01167153|Tocolytic Agents|tocolytic agents|mesh-ancestor
153896934|NCT01167153|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153896935|NCT01166763|Vitamin D|vitamin d|mesh-list
153896936|NCT01166763|Cholecalciferol|cholecalciferol|mesh-list
153896937|NCT01166763|Vitamins|vitamins|mesh-ancestor
153896938|NCT01166763|Micronutrients|micronutrients|mesh-ancestor
153438174|NCT00003878|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153438175|NCT00003878|Alkylating Agents|alkylating agents|mesh-ancestor
153438176|NCT00003878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153438177|NCT00003878|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153438180|NCT00005060|Tubulin Modulators|tubulin modulators|mesh-ancestor
153438181|NCT00005060|Antimitotic Agents|antimitotic agents|mesh-ancestor
153438182|NCT00005060|Mitosis Modulators|mitosis modulators|mesh-ancestor
153438183|NCT00005060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153438184|NCT00003884|Zoledronic Acid|zoledronic acid|mesh-list
153438185|NCT00003884|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153438186|NCT00003884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153438188|NCT00005066|O(6)-benzylguanine|o(6)-benzylguanine|mesh-list
153438189|NCT00005066|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153438190|NCT00005066|Alkylating Agents|alkylating agents|mesh-ancestor
153438191|NCT00005066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153438192|NCT00005066|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153438193|NCT00005066|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153438194|NCT00005072|Interleukin-2|interleukin-2|mesh-list
153438195|NCT00005072|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153438196|NCT00005072|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153438197|NCT00005072|Analgesics|analgesics|mesh-ancestor
153438198|NCT00005072|Sensory System Agents|sensory system agents|mesh-ancestor
153438199|NCT00005072|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153438200|NCT00005072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153438202|NCT00004496|alpha-MSH|alpha-msh|mesh-list
153438203|NCT00004496|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
153438205|NCT00004496|beta-Endorphin|beta-endorphin|mesh-list
153896939|NCT01166763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153896940|NCT01166763|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153896941|NCT01166763|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153896942|NCT02885961|Dabigatran|dabigatran|mesh-list
153896943|NCT02885961|Antithrombins|antithrombins|mesh-ancestor
153896944|NCT02885961|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
153896945|NCT02885961|Protease Inhibitors|protease inhibitors|mesh-ancestor
153896946|NCT02885961|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153896947|NCT02885961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153896948|NCT02885961|Anticoagulants|anticoagulants|mesh-ancestor
153896949|NCT02885727|Durvalumab|durvalumab|mesh-list
153896950|NCT02885727|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153896951|NCT02885727|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153896952|NCT00963235|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
153896953|NCT00963235|Immunologic Factors|immunologic factors|mesh-ancestor
153896954|NCT00963235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153896955|NCT00630097|Modafinil|modafinil|mesh-list
153896956|NCT00630097|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
153896957|NCT00630097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153896958|NCT00630097|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
153896959|NCT00630097|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
153896960|NCT00630097|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
153896961|NCT00630097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153896962|NCT01165281|Oxycodone|oxycodone|mesh-list
153896963|NCT01165281|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153896964|NCT01165281|Narcotics|narcotics|mesh-ancestor
153896965|NCT01165281|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153896966|NCT01165281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153896967|NCT01165281|Analgesics|analgesics|mesh-ancestor
153896968|NCT01165281|Sensory System Agents|sensory system agents|mesh-ancestor
153896969|NCT01165281|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153896970|NCT02860897|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
153896972|NCT02860897|Hormones|hormones|mesh-ancestor
153896973|NCT02860897|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153896974|NCT02860897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153896975|NCT02860819|Carboplatin|carboplatin|mesh-list
153896976|NCT02860819|Gemcitabine|gemcitabine|mesh-list
153896977|NCT02860819|Veliparib|veliparib|mesh-list
153896978|NCT02860819|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153896979|NCT02860819|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153896980|NCT02860819|Antimetabolites|antimetabolites|mesh-ancestor
153438217|NCT00003902|Tubulin Modulators|tubulin modulators|mesh-ancestor
153438218|NCT00003902|Antimitotic Agents|antimitotic agents|mesh-ancestor
153438219|NCT00003902|Mitosis Modulators|mitosis modulators|mesh-ancestor
153438221|NCT00003908|Docetaxel|docetaxel|mesh-list
153438222|NCT00003908|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153438223|NCT00003908|Tubulin Modulators|tubulin modulators|mesh-ancestor
153438224|NCT00003908|Antimitotic Agents|antimitotic agents|mesh-ancestor
153438225|NCT00003908|Mitosis Modulators|mitosis modulators|mesh-ancestor
153438226|NCT00003908|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153438227|NCT00382837|Epratuzumab|epratuzumab|mesh-list
153438228|NCT00382837|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153438229|NCT00382837|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153438230|NCT00003914|Dolastatin 10|dolastatin 10|mesh-list
153438231|NCT00003914|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153438232|NCT00003914|Tubulin Modulators|tubulin modulators|mesh-ancestor
153438233|NCT00003914|Antimitotic Agents|antimitotic agents|mesh-ancestor
153438234|NCT00003914|Mitosis Modulators|mitosis modulators|mesh-ancestor
153438235|NCT00003914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153438236|NCT00005078|Paclitaxel|paclitaxel|mesh-list
153438237|NCT00005078|Carboplatin|carboplatin|mesh-list
153438238|NCT00005078|Tirapazamine|tirapazamine|mesh-list
153438239|NCT00005078|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153438240|NCT00005078|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153438241|NCT00005078|Tubulin Modulators|tubulin modulators|mesh-ancestor
153438242|NCT00005078|Antimitotic Agents|antimitotic agents|mesh-ancestor
153438243|NCT00005078|Mitosis Modulators|mitosis modulators|mesh-ancestor
153438244|NCT00005078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153896981|NCT02860819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153896982|NCT02860819|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
153896983|NCT02860819|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153896984|NCT04284007|Dexamethasone|dexamethasone|mesh-list
153896985|NCT04284007|Dexamethasone acetate|dexamethasone acetate|mesh-list
153896986|NCT04284007|Levobupivacaine|levobupivacaine|mesh-list
153896987|NCT04284007|BB 1101|bb 1101|mesh-list
153896988|NCT04284007|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153896989|NCT04284007|Antiemetics|antiemetics|mesh-ancestor
153896990|NCT04284007|Autonomic Agents|autonomic agents|mesh-ancestor
153896991|NCT04284007|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153896992|NCT04284007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153896993|NCT04284007|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153896994|NCT04284007|Glucocorticoids|glucocorticoids|mesh-ancestor
153896995|NCT04284007|Hormones|hormones|mesh-ancestor
153896996|NCT04284007|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153438245|NCT00003920|Cyclosporine|cyclosporine|mesh-list
153438246|NCT00003920|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
153438247|NCT00003920|Antibodies|antibodies|mesh-list
153896997|NCT04284007|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153896998|NCT04284007|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153896999|NCT04284007|Protease Inhibitors|protease inhibitors|mesh-ancestor
153897000|NCT04284007|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153897001|NCT04284007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153897002|NCT04284007|Anesthetics, Local|anesthetics, local|mesh-ancestor
153897004|NCT04284007|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153897005|NCT04284007|Sensory System Agents|sensory system agents|mesh-ancestor
153897006|NCT01165203|Vaccines|vaccines|mesh-list
153897007|NCT01165203|Immunologic Factors|immunologic factors|mesh-ancestor
153897008|NCT01165203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153897009|NCT00960661|Insulin|insulin|mesh-list
153897010|NCT00960661|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
153897011|NCT00960661|Metformin|metformin|mesh-list
153897012|NCT00960661|Exenatide|exenatide|mesh-list
153897013|NCT00960661|Insulin Lispro|insulin lispro|mesh-list
153897014|NCT00960661|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153897015|NCT00960661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153897016|NCT00960661|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
153897020|NCT00960661|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153897022|NCT00960193|Gout Suppressants|gout suppressants|mesh-ancestor
153897023|NCT00960193|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153897024|NCT00960193|Tubulin Modulators|tubulin modulators|mesh-ancestor
153897025|NCT00960193|Antimitotic Agents|antimitotic agents|mesh-ancestor
153438264|NCT00003926|Thiotepa|thiotepa|mesh-list
153438265|NCT00003926|Lenograstim|lenograstim|mesh-list
153438266|NCT00003926|Amifostine|amifostine|mesh-list
153438267|NCT00003926|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153438268|NCT00003926|Immunologic Factors|immunologic factors|mesh-ancestor
153438269|NCT00003926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153438270|NCT00003926|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153438271|NCT00003926|Alkylating Agents|alkylating agents|mesh-ancestor
153438272|NCT00003926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153438273|NCT00003926|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153438274|NCT00003926|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153438275|NCT00003926|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153438276|NCT00003926|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
153438277|NCT00003926|Protective Agents|protective agents|mesh-ancestor
153438278|NCT05122819|Anesthetics|anesthetics|mesh-list
153438279|NCT05122819|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153438280|NCT05122819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153438281|NCT00005090|Cyclophosphamide|cyclophosphamide|mesh-list
153438282|NCT00005090|Dacarbazine|dacarbazine|mesh-list
153438283|NCT00005090|Carmustine|carmustine|mesh-list
153438284|NCT00005090|Doxorubicin|doxorubicin|mesh-list
153438285|NCT00005090|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
153438286|NCT00005090|Etoposide|etoposide|mesh-list
153438287|NCT00005090|Bleomycin|bleomycin|mesh-list
153438288|NCT00005090|Vinblastine|vinblastine|mesh-list
153438289|NCT00005090|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153438290|NCT00005090|Immunologic Factors|immunologic factors|mesh-ancestor
153438291|NCT00005090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153438292|NCT00005090|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153438293|NCT00005090|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153897026|NCT00960193|Mitosis Modulators|mitosis modulators|mesh-ancestor
153897027|NCT00960193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153897028|NCT00960193|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153897029|NCT00960115|Cyclophosphamide|cyclophosphamide|mesh-list
153897030|NCT00960115|Immunologic Factors|immunologic factors|mesh-ancestor
153897031|NCT00960115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153897032|NCT00960115|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153897033|NCT00960115|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153897034|NCT00960115|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153897035|NCT00960115|Alkylating Agents|alkylating agents|mesh-ancestor
153897036|NCT00960115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153897037|NCT00960115|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153897038|NCT00960115|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153897040|NCT00959647|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153897041|NCT00959647|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153897042|NCT00959647|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153438294|NCT00005090|Alkylating Agents|alkylating agents|mesh-ancestor
153897043|NCT00959647|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153897044|NCT00959647|Growth Substances|growth substances|mesh-ancestor
153897045|NCT00959647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153897046|NCT00959647|Growth Inhibitors|growth inhibitors|mesh-ancestor
153897048|NCT00957853|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153897049|NCT00957853|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153897050|NCT02604511|Ibrutinib|ibrutinib|mesh-list
153897051|NCT02604511|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153897052|NCT02604511|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153897053|NCT02604511|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153897054|NCT02604511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153897055|NCT02859571|Oxytocin|oxytocin|mesh-list
153897056|NCT02859571|Oxytocics|oxytocics|mesh-ancestor
153897057|NCT02859571|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153897058|NCT02859571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153897059|NCT00956839|Vitamin D|vitamin d|mesh-list
153897060|NCT00956839|Ergocalciferols|ergocalciferols|mesh-list
153897061|NCT00956839|Cholecalciferol|cholecalciferol|mesh-list
153897062|NCT00956839|Vitamins|vitamins|mesh-list
153897063|NCT00956839|Micronutrients|micronutrients|mesh-ancestor
153897064|NCT00956839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153897065|NCT00956839|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153897066|NCT00956839|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153897067|NCT00956293|Cyclosporine|cyclosporine|mesh-list
153897068|NCT00956293|Mycophenolic Acid|mycophenolic acid|mesh-list
153897069|NCT00956293|Everolimus|everolimus|mesh-list
153897070|NCT00956293|Cyclosporins|cyclosporins|mesh-list
153438312|NCT00004580|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153438313|NCT00004580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153438314|NCT00004580|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153438315|NCT00004580|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153438316|NCT00004580|Antiviral Agents|antiviral agents|mesh-ancestor
153438317|NCT00004580|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153438318|NCT00004580|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
153438319|NCT00004580|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153438320|NCT00004580|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153438321|NCT00004580|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153438322|NCT00004580|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
153438323|NCT00004580|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
153438324|NCT00005096|Docetaxel|docetaxel|mesh-list
153438325|NCT00005096|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153438326|NCT00005096|Tubulin Modulators|tubulin modulators|mesh-ancestor
153438327|NCT00005096|Antimitotic Agents|antimitotic agents|mesh-ancestor
153438328|NCT00005096|Mitosis Modulators|mitosis modulators|mesh-ancestor
153438329|NCT00005096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153438330|NCT00004640|Chlorhexidine|chlorhexidine|mesh-list
153438331|NCT00004640|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
153438332|NCT00004640|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153438333|NCT00004640|Disinfectants|disinfectants|mesh-ancestor
153438334|NCT00004646|Prednisone|prednisone|mesh-list
153438335|NCT00004646|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153897071|NCT00956293|Basiliximab|basiliximab|mesh-list
153897072|NCT00956293|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153897073|NCT00956293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153897074|NCT00956293|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153897075|NCT00956293|Immunologic Factors|immunologic factors|mesh-ancestor
153897076|NCT00956293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153897077|NCT00956293|Antifungal Agents|antifungal agents|mesh-ancestor
153897078|NCT00956293|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153897080|NCT00956293|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153897081|NCT00956293|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
153897082|NCT00956293|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
153897083|NCT00956293|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153897084|NCT00956293|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153897085|NCT00956293|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153897086|NCT00956293|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
153897087|NCT00956293|Antitubercular Agents|antitubercular agents|mesh-ancestor
153897088|NCT00956293|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153897090|NCT04282291|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153897091|NCT04282291|Narcotics|narcotics|mesh-ancestor
153897092|NCT04282291|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153897093|NCT04282291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153438336|NCT00004646|Glucocorticoids|glucocorticoids|mesh-ancestor
153897094|NCT04282291|Analgesics|analgesics|mesh-ancestor
153897095|NCT04282291|Sensory System Agents|sensory system agents|mesh-ancestor
153897096|NCT04282291|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153897097|NCT00955825|Immunomodulating Agents|immunomodulating agents|mesh-list
153897098|NCT00955825|Immunologic Factors|immunologic factors|mesh-ancestor
153897099|NCT00955825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153897100|NCT02859103|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
153897101|NCT02859103|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
153897102|NCT02859103|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153897103|NCT02859103|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153897104|NCT02859103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153897105|NCT02859103|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153897106|NCT02859103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153897107|NCT02859103|Antidepressive Agents|antidepressive agents|mesh-ancestor
153897108|NCT02859103|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153897109|NCT02869009|Aspirin|aspirin|mesh-list
153897110|NCT02869009|Clopidogrel|clopidogrel|mesh-list
153897111|NCT02869009|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153897112|NCT02869009|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153897113|NCT02869009|Analgesics|analgesics|mesh-ancestor
153897114|NCT02869009|Sensory System Agents|sensory system agents|mesh-ancestor
153897115|NCT02869009|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153897116|NCT02869009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153897117|NCT02869009|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153438359|NCT00004652|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
153438360|NCT00005120|Calanolide A|calanolide a|mesh-list
153438361|NCT00005120|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153438362|NCT00005120|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153438363|NCT00005120|Antiviral Agents|antiviral agents|mesh-ancestor
153438364|NCT00005120|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153438365|NCT00004664|Megestrol|megestrol|mesh-list
153438366|NCT00004664|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
153438367|NCT00004664|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
153438368|NCT00004664|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
153438369|NCT00004664|Contraceptive Agents|contraceptive agents|mesh-ancestor
153438370|NCT00004664|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153438371|NCT00004664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153438372|NCT00004664|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
153438373|NCT00004664|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
153438374|NCT00004664|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153438375|NCT00004664|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153438376|NCT00004682|Immunoglobulins|immunoglobulins|mesh-list
153438377|NCT00004682|Antibodies|antibodies|mesh-list
153438378|NCT00004682|gamma-Globulins|gamma-globulins|mesh-list
153438379|NCT00004682|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
153438380|NCT00004682|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
153438381|NCT00004682|Immunologic Factors|immunologic factors|mesh-ancestor
153438382|NCT00004682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153438383|NCT00004688|Mercaptopurine|mercaptopurine|mesh-list
153438384|NCT00004688|Carmustine|carmustine|mesh-list
153897118|NCT02869009|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153897119|NCT02869009|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153897120|NCT02869009|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153897121|NCT02869009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153897122|NCT02869009|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153897123|NCT02869009|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153897124|NCT02869009|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153897125|NCT02869009|Antipyretics|antipyretics|mesh-ancestor
153897126|NCT02869009|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
153897127|NCT02869009|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
153897128|NCT02869009|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
153897129|NCT02869009|Purinergic Agents|purinergic agents|mesh-ancestor
153897130|NCT02869009|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153897131|NCT01164579|Methotrexate|methotrexate|mesh-list
153897132|NCT01164579|Tofacitinib|tofacitinib|mesh-list
153897133|NCT01164579|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
153897134|NCT01164579|Abortifacient Agents|abortifacient agents|mesh-ancestor
153897135|NCT01164579|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153897136|NCT01164579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153897137|NCT01164579|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153897138|NCT01164579|Antimetabolites|antimetabolites|mesh-ancestor
153897139|NCT01164579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153438385|NCT00004688|Streptozocin|streptozocin|mesh-list
153438386|NCT00004688|Antimetabolites|antimetabolites|mesh-ancestor
153897140|NCT01164579|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153897141|NCT01164579|Dermatologic Agents|dermatologic agents|mesh-ancestor
153897142|NCT01164579|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153897143|NCT01164579|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153897144|NCT01164579|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153897145|NCT01164579|Immunologic Factors|immunologic factors|mesh-ancestor
153897146|NCT01164579|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153897147|NCT01164579|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153897148|NCT01164579|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
153897149|NCT01164579|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153897150|NCT02859259|Fostemsavir|fostemsavir|mesh-list
153897151|NCT02859259|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153897152|NCT02859259|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153897153|NCT02859259|Antiviral Agents|antiviral agents|mesh-ancestor
153897154|NCT02859259|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153897155|NCT02859259|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
153897156|NCT02859259|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
153897157|NCT02859259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153897158|NCT02857777|Esketamine|esketamine|mesh-list
153897159|NCT02857777|Antidepressive Agents|antidepressive agents|mesh-ancestor
153897160|NCT02857777|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153897161|NCT00630643|Muromonab-CD3|muromonab-cd3|mesh-list
153897162|NCT00630643|Immunologic Factors|immunologic factors|mesh-ancestor
153897163|NCT00630643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153897164|NCT00630643|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153438408|NCT00004730|Sensory System Agents|sensory system agents|mesh-ancestor
153438409|NCT00004730|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153438410|NCT00004730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153438411|NCT00004730|Anesthetics|anesthetics|mesh-ancestor
153438412|NCT00004730|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153438413|NCT00004730|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153438414|NCT00004730|Anticonvulsants|anticonvulsants|mesh-ancestor
153438415|NCT00004730|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153438416|NCT00004730|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153438417|NCT00004730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153438418|NCT00004730|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153438419|NCT00004730|Tocolytic Agents|tocolytic agents|mesh-ancestor
153438420|NCT00004730|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153438421|NCT00004736|Lamivudine|lamivudine|mesh-list
153438422|NCT00004736|Zidovudine|zidovudine|mesh-list
153438423|NCT00004736|Stavudine|stavudine|mesh-list
153438424|NCT00004736|Nelfinavir|nelfinavir|mesh-list
153438425|NCT00004736|Isoniazid|isoniazid|mesh-list
153438426|NCT00004736|Pyrazinamide|pyrazinamide|mesh-list
153438427|NCT00004736|Ethambutol|ethambutol|mesh-list
153897165|NCT03202849|Vitamin D|vitamin d|mesh-list
153897166|NCT03202849|Ergocalciferols|ergocalciferols|mesh-list
153897167|NCT03202849|Cholecalciferol|cholecalciferol|mesh-list
153897168|NCT03202849|Vitamins|vitamins|mesh-list
153897169|NCT03202849|Micronutrients|micronutrients|mesh-ancestor
153897170|NCT03202849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153897171|NCT03202849|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153897172|NCT03202849|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153897173|NCT04277533|Calcium|calcium|mesh-list
153897174|NCT04277533|Bilirubin|bilirubin|mesh-list
153897175|NCT04277533|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153897176|NCT04277533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153897177|NCT04277533|Antioxidants|antioxidants|mesh-ancestor
153897178|NCT04277533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153897179|NCT04277533|Protective Agents|protective agents|mesh-ancestor
153897181|NCT02445391|Carboplatin|carboplatin|mesh-list
153897182|NCT02445391|Capecitabine|capecitabine|mesh-list
153897183|NCT02445391|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153897184|NCT02445391|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153897185|NCT02445391|Antimetabolites|antimetabolites|mesh-ancestor
153897186|NCT02445391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153897187|NCT01246986|Sorafenib|sorafenib|mesh-list
153897188|NCT01246986|Ramucirumab|ramucirumab|mesh-list
153897189|NCT01246986|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153897190|NCT01246986|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153897191|NCT01246986|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153897192|NCT01246986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153897193|NCT01246986|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153897194|NCT01246986|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153897195|NCT01246986|Growth Substances|growth substances|mesh-ancestor
153897196|NCT01246986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153897197|NCT01246986|Growth Inhibitors|growth inhibitors|mesh-ancestor
153897198|NCT01164501|Empagliflozin|empagliflozin|mesh-list
153897199|NCT01164501|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
153438428|NCT00004736|Rifabutin|rifabutin|mesh-list
153438431|NCT00004736|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153897200|NCT01164501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153897201|NCT01164501|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153897202|NCT01164501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153897203|NCT01163721|Ranolazine|ranolazine|mesh-list
153897204|NCT01163721|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153897205|NCT01163721|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153897206|NCT01163721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153897207|NCT00958243|Vaccines|vaccines|mesh-list
153897208|NCT00958243|Immunologic Factors|immunologic factors|mesh-ancestor
153897209|NCT00958243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153897210|NCT01241760|Interferons|interferons|mesh-list
153897211|NCT01241760|Ribavirin|ribavirin|mesh-list
153897212|NCT01241760|Interferon-alpha|interferon-alpha|mesh-list
153897213|NCT01241760|Interferon alpha-2|interferon alpha-2|mesh-list
153897214|NCT01241760|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
153897215|NCT01241760|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153897216|NCT01241760|Antiviral Agents|antiviral agents|mesh-ancestor
153897217|NCT01241760|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153897218|NCT01241760|Antimetabolites|antimetabolites|mesh-ancestor
153897219|NCT01241760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153897220|NCT01241760|Immunologic Factors|immunologic factors|mesh-ancestor
153438464|NCT00004748|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153438465|NCT00004748|Gout Suppressants|gout suppressants|mesh-ancestor
153438466|NCT00004748|Tubulin Modulators|tubulin modulators|mesh-ancestor
153438467|NCT00004748|Antimitotic Agents|antimitotic agents|mesh-ancestor
153438468|NCT00004748|Mitosis Modulators|mitosis modulators|mesh-ancestor
153438469|NCT00004748|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
153438470|NCT00004748|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153438471|NCT00004754|Epoprostenol|epoprostenol|mesh-list
153438472|NCT00004754|Tezosentan|tezosentan|mesh-list
153438473|NCT00004754|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153438474|NCT00004754|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153438475|NCT00004754|Vasodilator Agents|vasodilator agents|mesh-ancestor
153438476|NCT00005576|Aldesleukin|aldesleukin|mesh-list
153438477|NCT00005576|Interleukin-2|interleukin-2|mesh-list
153438478|NCT00005576|Dinutuximab|dinutuximab|mesh-list
153438479|NCT00005576|Isotretinoin|isotretinoin|mesh-list
153438480|NCT00005576|Antibodies|antibodies|mesh-list
153438481|NCT00005576|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
153438482|NCT00005576|Sargramostim|sargramostim|mesh-list
153438483|NCT00005576|Immunologic Factors|immunologic factors|mesh-ancestor
153438484|NCT00005576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153438485|NCT00005576|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153438486|NCT00005576|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153438487|NCT00005576|Analgesics|analgesics|mesh-ancestor
153438488|NCT00005576|Sensory System Agents|sensory system agents|mesh-ancestor
153438489|NCT00005576|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153438491|NCT00005576|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153897221|NCT01241760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153897222|NCT04280263|Caffeine|caffeine|mesh-list
153897223|NCT04280263|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
153897224|NCT04280263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153897225|NCT04280263|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
153897226|NCT04280263|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153897227|NCT04280263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153897228|NCT04280263|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
153897229|NCT04280263|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
153897230|NCT04280263|Purinergic Agents|purinergic agents|mesh-ancestor
153897231|NCT04280263|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153897232|NCT00953329|Alefacept|alefacept|mesh-list
153897233|NCT00953329|Dermatologic Agents|dermatologic agents|mesh-ancestor
153897234|NCT00953329|Immunologic Factors|immunologic factors|mesh-ancestor
153897235|NCT00953329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153897236|NCT02857153|Urapidil|urapidil|mesh-list
153897237|NCT02857153|Phenylephrine|phenylephrine|mesh-list
153897238|NCT02857153|Oxymetazoline|oxymetazoline|mesh-list
153438492|NCT00005576|Antiviral Agents|antiviral agents|mesh-ancestor
153438493|NCT00005576|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153438494|NCT00005576|Dermatologic Agents|dermatologic agents|mesh-ancestor
153897239|NCT02857153|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
153897240|NCT02857153|Mydriatics|mydriatics|mesh-ancestor
153897241|NCT02857153|Autonomic Agents|autonomic agents|mesh-ancestor
153897242|NCT02857153|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153897243|NCT02857153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153897244|NCT02857153|Sympathomimetics|sympathomimetics|mesh-ancestor
153897245|NCT02857153|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
153897246|NCT02857153|Nasal Decongestants|nasal decongestants|mesh-ancestor
153897247|NCT02857153|Respiratory System Agents|respiratory system agents|mesh-ancestor
153897248|NCT02857153|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
153897249|NCT02857153|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153897250|NCT02857153|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153897251|NCT02857153|Adrenergic Agents|adrenergic agents|mesh-ancestor
153897252|NCT02857153|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153897253|NCT02857153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153897254|NCT02857153|Protective Agents|protective agents|mesh-ancestor
153897255|NCT02857153|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153897256|NCT02857153|Vasodilator Agents|vasodilator agents|mesh-ancestor
153897257|NCT02857153|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
153897258|NCT02857153|Serotonin Agents|serotonin agents|mesh-ancestor
153897259|NCT02857153|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
153897260|NCT02857153|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
153897261|NCT02857153|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
153897262|NCT00953017|Bisacodyl|bisacodyl|mesh-list
153897263|NCT00953017|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
153897264|NCT00953017|Lubiprostone|lubiprostone|mesh-list
153897265|NCT00953017|Cathartics|cathartics|mesh-ancestor
153897266|NCT00953017|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153438512|NCT04712929|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153438514|NCT04712929|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153438515|NCT04712929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153438516|NCT04712929|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
153438517|NCT04712929|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
153438518|NCT00004784|Methotrexate|methotrexate|mesh-list
153438519|NCT00004784|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
153438520|NCT00004784|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
153438521|NCT00004784|Abortifacient Agents|abortifacient agents|mesh-ancestor
153438522|NCT00004784|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153438523|NCT00004784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153438524|NCT00004784|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153438525|NCT00004784|Antimetabolites|antimetabolites|mesh-ancestor
153438526|NCT00004784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153438527|NCT00004784|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153438528|NCT00004784|Dermatologic Agents|dermatologic agents|mesh-ancestor
153438529|NCT00004784|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153438530|NCT00004784|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153438531|NCT00004784|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153438532|NCT00004784|Immunologic Factors|immunologic factors|mesh-ancestor
153438533|NCT00004784|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153438535|NCT00004784|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
153897267|NCT00953017|Laxatives|laxatives|mesh-ancestor
153897268|NCT00953017|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
153897269|NCT00953017|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153897270|NCT00953017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153897272|NCT00955357|Anticonvulsants|anticonvulsants|mesh-ancestor
153897273|NCT00955357|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
153897274|NCT00955357|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153897275|NCT00955357|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153897276|NCT00955357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153897277|NCT00955279|Golimumab|golimumab|mesh-list
153897278|NCT00955279|Ustekinumab|ustekinumab|mesh-list
153897279|NCT00955279|Dermatologic Agents|dermatologic agents|mesh-ancestor
153897280|NCT00955279|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
153897281|NCT00955279|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153897282|NCT00955279|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153897283|NCT00955279|Immunologic Factors|immunologic factors|mesh-ancestor
153897284|NCT00955279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153897285|NCT02857309|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-list
153897286|NCT02857309|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-list
153897287|NCT02857309|Mineralocorticoids|mineralocorticoids|mesh-list
153897288|NCT02857309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153897289|NCT02857309|Hormone Antagonists|hormone antagonists|mesh-ancestor
153897290|NCT02857309|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153897291|NCT02857309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153897292|NCT02857309|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
153897294|NCT02857309|Natriuretic Agents|natriuretic agents|mesh-ancestor
153897295|NCT02857309|Hormones|hormones|mesh-ancestor
153897296|NCT04261231|Anesthetics|anesthetics|mesh-list
153897297|NCT04261231|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153897298|NCT04261231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153897299|NCT02857465|Dexamethasone|dexamethasone|mesh-list
153897300|NCT02857465|Dexamethasone acetate|dexamethasone acetate|mesh-list
153897301|NCT02857465|Sufentanil|sufentanil|mesh-list
153897302|NCT02857465|Dsuvia|dsuvia|mesh-list
153897303|NCT02857465|Ropivacaine|ropivacaine|mesh-list
153897304|NCT02857465|BB 1101|bb 1101|mesh-list
153897305|NCT02857465|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153897306|NCT02857465|Antiemetics|antiemetics|mesh-ancestor
153897307|NCT02857465|Autonomic Agents|autonomic agents|mesh-ancestor
153897308|NCT02857465|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153897309|NCT02857465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153897310|NCT02857465|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153897311|NCT02857465|Glucocorticoids|glucocorticoids|mesh-ancestor
153897312|NCT02857465|Hormones|hormones|mesh-ancestor
153897313|NCT02857465|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153897314|NCT02857465|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153897315|NCT02857465|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153438560|NCT00004814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153438561|NCT00004814|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153438562|NCT00004814|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153438563|NCT00004826|Clozapine|clozapine|mesh-list
153438564|NCT00004826|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153438565|NCT00004826|Serotonin Agents|serotonin agents|mesh-ancestor
153438566|NCT00004826|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153438567|NCT00004826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153438568|NCT00004826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153438569|NCT00004826|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153438570|NCT00004826|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153438571|NCT00004826|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153438572|NCT00004826|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153438573|NCT00004826|GABA Antagonists|gaba antagonists|mesh-ancestor
153438575|NCT00004778|Dexamethasone|dexamethasone|mesh-list
153438576|NCT00004778|Betamethasone|betamethasone|mesh-list
153438577|NCT00004778|Hormones|hormones|mesh-list
153438578|NCT00004778|Thyrotropin-Releasing Hormone|thyrotropin-releasing hormone|mesh-list
153438579|NCT00004778|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153438581|NCT00004778|Autonomic Agents|autonomic agents|mesh-ancestor
153438582|NCT00004778|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153438583|NCT00004778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153438584|NCT00004778|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153438585|NCT00004778|Glucocorticoids|glucocorticoids|mesh-ancestor
153438586|NCT00004778|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153438587|NCT00004778|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153438588|NCT00004778|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153438589|NCT00004778|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153438591|NCT00005612|Paclitaxel|paclitaxel|mesh-list
153897316|NCT02857465|Protease Inhibitors|protease inhibitors|mesh-ancestor
153897317|NCT02857465|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153897318|NCT02857465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153897319|NCT02857465|Anesthetics, Local|anesthetics, local|mesh-ancestor
153897320|NCT02857465|Anesthetics|anesthetics|mesh-ancestor
153897321|NCT02857465|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153897322|NCT02857465|Sensory System Agents|sensory system agents|mesh-ancestor
153897323|NCT02857465|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153897324|NCT02857465|Narcotics|narcotics|mesh-ancestor
153897325|NCT02857465|Analgesics|analgesics|mesh-ancestor
153897326|NCT02857465|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153897327|NCT02857465|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153897328|NCT02857465|Anesthetics, General|anesthetics, general|mesh-ancestor
153897329|NCT04260139|Metronidazole|metronidazole|mesh-list
153897330|NCT04260139|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153897331|NCT04260139|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153897332|NCT04260139|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153897333|NCT04260139|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153897334|NCT04206618|Denosumab|denosumab|mesh-list
153897335|NCT04206618|Teriparatide|teriparatide|mesh-list
153897336|NCT04206618|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153897337|NCT04206618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153897338|NCT04206618|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153897340|NCT01239732|Bevacizumab|bevacizumab|mesh-list
153897341|NCT01239732|Carboplatin|carboplatin|mesh-list
153897342|NCT01239732|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153897343|NCT01239732|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153897344|NCT01239732|Tubulin Modulators|tubulin modulators|mesh-ancestor
153897345|NCT01239732|Antimitotic Agents|antimitotic agents|mesh-ancestor
153897346|NCT01239732|Mitosis Modulators|mitosis modulators|mesh-ancestor
153897347|NCT01239732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153897348|NCT01239732|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153897349|NCT01239732|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153897350|NCT01239732|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153897351|NCT01239732|Growth Substances|growth substances|mesh-ancestor
153897352|NCT01239732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153897353|NCT01239732|Growth Inhibitors|growth inhibitors|mesh-ancestor
153897354|NCT02856919|Brimonidine Tartrate|brimonidine tartrate|mesh-list
153897355|NCT02856919|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153897356|NCT02856919|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
153897357|NCT02856919|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153897358|NCT02856919|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153897359|NCT02856919|Adrenergic Agents|adrenergic agents|mesh-ancestor
153438606|NCT00005612|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153438607|NCT00005612|Alkylating Agents|alkylating agents|mesh-ancestor
153438608|NCT00005612|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153438609|NCT00005612|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153438610|NCT00005612|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153438611|NCT00005612|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153438612|NCT00005612|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
153438614|NCT00005618|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153438616|NCT00005624|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-list
153438617|NCT00005624|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153438621|NCT00385502|Antifungal Agents|antifungal agents|mesh-ancestor
153438622|NCT00385502|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153897360|NCT02856919|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153897361|NCT02856919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153897362|NCT02856919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153897363|NCT00947011|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
153897364|NCT00947011|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153897365|NCT00947011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153897366|NCT00947011|Incretins|incretins|mesh-ancestor
153897367|NCT00947011|Hormones|hormones|mesh-ancestor
153897368|NCT00947011|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153897369|NCT00947011|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
153897370|NCT00947011|Protease Inhibitors|protease inhibitors|mesh-ancestor
153897371|NCT00947011|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153897372|NCT00947011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153897374|NCT02856685|Analgesics|analgesics|mesh-ancestor
153897375|NCT02856685|Sensory System Agents|sensory system agents|mesh-ancestor
153897376|NCT02856685|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153897377|NCT02856685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153897378|NCT02856685|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153897379|NCT02856685|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153897380|NCT02856685|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153897381|NCT02856685|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153897382|NCT02856685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153897383|NCT02860663|Vitamin D|vitamin d|mesh-list
153897384|NCT02860663|Ergocalciferols|ergocalciferols|mesh-list
153897385|NCT02860663|Cholecalciferol|cholecalciferol|mesh-list
153897386|NCT02860663|Vitamins|vitamins|mesh-list
153897387|NCT02860663|Micronutrients|micronutrients|mesh-ancestor
153897388|NCT02860663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153897389|NCT02860663|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153897390|NCT02860663|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153897391|NCT02854345|Parathyroid Hormone|parathyroid hormone|mesh-list
153897392|NCT02854345|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153897393|NCT02854345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153897394|NCT01239342|Everolimus|everolimus|mesh-list
153897395|NCT01239342|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
153897396|NCT01239342|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153897397|NCT01239342|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153897398|NCT01239342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153897399|NCT01239342|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153438625|NCT00385502|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153897400|NCT01239342|Immunologic Factors|immunologic factors|mesh-ancestor
153897401|NCT01239342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153897402|NCT01239342|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153897403|NCT00946309|Sulforaphane|sulforaphane|mesh-list
153897404|NCT00946309|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
153897405|NCT00946309|Protective Agents|protective agents|mesh-ancestor
153897406|NCT00946309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153897407|NCT00946309|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153897408|NCT02853799|Insulin|insulin|mesh-list
153897409|NCT02853799|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153897410|NCT02853799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153897411|NCT01236534|Lubiprostone|lubiprostone|mesh-list
153897412|NCT01236534|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
153897413|NCT01236534|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153897414|NCT01236534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153438663|NCT00005654|Hormone Antagonists|hormone antagonists|mesh-ancestor
153438664|NCT00005654|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153438665|NCT00005654|Fertility Agents, Female|fertility agents, female|mesh-ancestor
153438667|NCT00005654|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153438668|NCT00005654|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
153438669|NCT00005654|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
153438670|NCT00005684|Heparin|heparin|mesh-list
153438671|NCT00005684|Warfarin|warfarin|mesh-list
153438672|NCT00005684|Anticoagulants|anticoagulants|mesh-ancestor
153438673|NCT00005684|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153438675|NCT00005684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153438676|NCT00386282|Misoprostol|misoprostol|mesh-list
153438677|NCT00386282|Mifepristone|mifepristone|mesh-list
153438678|NCT00386282|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
153438679|NCT00386282|Abortifacient Agents|abortifacient agents|mesh-ancestor
153438680|NCT00386282|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153438681|NCT00386282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153438682|NCT00386282|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
153438683|NCT00386282|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153438684|NCT00386282|Oxytocics|oxytocics|mesh-ancestor
153438685|NCT00386282|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
153438686|NCT00386282|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
153438687|NCT00386282|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
153438688|NCT00386282|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
153438689|NCT00386282|Contraceptive Agents|contraceptive agents|mesh-ancestor
153438690|NCT00386282|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
153438692|NCT00386282|Hormone Antagonists|hormone antagonists|mesh-ancestor
153897415|NCT01235598|Certolizumab Pegol|certolizumab pegol|mesh-list
153897416|NCT01235598|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
153897417|NCT01235598|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153897418|NCT01235598|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153897419|NCT01235598|Immunologic Factors|immunologic factors|mesh-ancestor
153897420|NCT01235598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153897421|NCT01235598|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153897422|NCT01235442|Etanercept|etanercept|mesh-list
153897423|NCT01235442|Clobetasol|clobetasol|mesh-list
153897424|NCT01235442|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153897425|NCT01235442|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153897426|NCT01235442|Analgesics|analgesics|mesh-ancestor
153897427|NCT01235442|Sensory System Agents|sensory system agents|mesh-ancestor
153897428|NCT01235442|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153897429|NCT01235442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153897430|NCT01235442|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153897431|NCT01235442|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153897432|NCT01235442|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153897433|NCT01235442|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153897434|NCT01235442|Immunologic Factors|immunologic factors|mesh-ancestor
153897435|NCT01235442|Glucocorticoids|glucocorticoids|mesh-ancestor
153897436|NCT01235442|Hormones|hormones|mesh-ancestor
153897437|NCT01235442|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153897438|NCT01163253|Tofacitinib|tofacitinib|mesh-list
153897439|NCT01163253|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
153897440|NCT01163253|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153897441|NCT01163253|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153897442|NCT01163253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153897444|NCT01162863|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
153897445|NCT01162863|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153897446|NCT01162863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153897447|NCT01162473|Caseins|caseins|mesh-list
153897448|NCT01162473|Chelating Agents|chelating agents|mesh-ancestor
153897449|NCT01162473|Sequestering Agents|sequestering agents|mesh-ancestor
153897450|NCT01162473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153897451|NCT01162239|Varenicline|varenicline|mesh-list
153897452|NCT01162239|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
153897453|NCT01162239|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
153897454|NCT01162239|Cholinergic Agents|cholinergic agents|mesh-ancestor
153897455|NCT01162239|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153897456|NCT01162239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153897457|NCT01162239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153897458|NCT01161537|Ivacaftor|ivacaftor|mesh-list
153438708|NCT00005762|Nelfinavir|nelfinavir|mesh-list
153438709|NCT00005762|Indinavir|indinavir|mesh-list
153438710|NCT00005762|Saquinavir|saquinavir|mesh-list
153438711|NCT00005762|Amprenavir|amprenavir|mesh-list
153438712|NCT00005762|Efavirenz|efavirenz|mesh-list
153438713|NCT00005762|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
153438714|NCT00005762|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
153438715|NCT00005762|Protease Inhibitors|protease inhibitors|mesh-ancestor
153438716|NCT00005762|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153438717|NCT00005762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153438718|NCT00005762|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153438719|NCT00005762|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153438720|NCT00005762|Antiviral Agents|antiviral agents|mesh-ancestor
153438721|NCT00005762|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153438722|NCT00005762|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
153438723|NCT00005762|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153438724|NCT00005762|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153438725|NCT00005762|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153438726|NCT00005762|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
153438727|NCT00005762|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
153438728|NCT00005762|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
153438729|NCT00005762|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
153438730|NCT00005762|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
153438731|NCT00005762|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
153438732|NCT00005762|Antitubercular Agents|antitubercular agents|mesh-ancestor
153438733|NCT00005762|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153438735|NCT00005768|Hormones|hormones|mesh-ancestor
153438736|NCT00005768|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153897459|NCT01161537|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
153897460|NCT01161537|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153897461|NCT01161537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153897462|NCT04314297|Durvalumab|durvalumab|mesh-list
153897463|NCT04314297|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153897464|NCT04314297|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153897465|NCT04124133|Hyaluronic Acid|hyaluronic acid|mesh-list
153897466|NCT04124133|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153897467|NCT04124133|Immunologic Factors|immunologic factors|mesh-ancestor
153897468|NCT04124133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153897469|NCT04124133|Viscosupplements|viscosupplements|mesh-ancestor
153897470|NCT04124133|Protective Agents|protective agents|mesh-ancestor
153897471|NCT01233258|Factor VIII|factor viii|mesh-list
153897472|NCT01233258|Coagulants|coagulants|mesh-ancestor
153897473|NCT01232790|Acetylcysteine|acetylcysteine|mesh-list
153438737|NCT00005768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153897474|NCT01232790|N-monoacetylcystine|n-monoacetylcystine|mesh-list
153897475|NCT01232790|Antiviral Agents|antiviral agents|mesh-ancestor
153897476|NCT01232790|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153897477|NCT01232790|Expectorants|expectorants|mesh-ancestor
153897478|NCT01232790|Respiratory System Agents|respiratory system agents|mesh-ancestor
153897479|NCT01232790|Free Radical Scavengers|free radical scavengers|mesh-ancestor
153897480|NCT01232790|Antioxidants|antioxidants|mesh-ancestor
153897481|NCT01232790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153897482|NCT01232790|Protective Agents|protective agents|mesh-ancestor
153897484|NCT01232790|Antidotes|antidotes|mesh-ancestor
153897485|NCT01232556|Rituximab|rituximab|mesh-list
153897486|NCT01232556|Inotuzumab Ozogamicin|inotuzumab ozogamicin|mesh-list
153897487|NCT01232556|Gemcitabine|gemcitabine|mesh-list
153897488|NCT01232556|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
153897489|NCT01232556|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153897490|NCT01232556|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153897491|NCT01232556|Immunologic Factors|immunologic factors|mesh-ancestor
153897492|NCT01232556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153897493|NCT01232556|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153897494|NCT01232556|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153897495|NCT01232556|Antimetabolites|antimetabolites|mesh-ancestor
153897496|NCT01232556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153897497|NCT01232556|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153897499|NCT01232556|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153897501|NCT01232556|Immunoconjugates|immunoconjugates|mesh-ancestor
153897502|NCT00946153|Lenvatinib|lenvatinib|mesh-list
153897503|NCT00946153|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153897504|NCT00946153|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153438752|NCT00005792|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153438753|NCT00005792|Alkylating Agents|alkylating agents|mesh-ancestor
153438754|NCT00005792|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153438755|NCT00005792|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153438756|NCT00005792|Immunologic Factors|immunologic factors|mesh-ancestor
153438757|NCT00005792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153438758|NCT00005792|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
153438759|NCT00005798|Cyclophosphamide|cyclophosphamide|mesh-list
153438760|NCT00005798|Thiotepa|thiotepa|mesh-list
153438761|NCT00005798|Carboplatin|carboplatin|mesh-list
153438762|NCT00005798|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153438763|NCT00005798|Immunologic Factors|immunologic factors|mesh-ancestor
153438764|NCT00005798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153438765|NCT00005798|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153438766|NCT00005798|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153438767|NCT00005798|Alkylating Agents|alkylating agents|mesh-ancestor
153438768|NCT00005798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153438769|NCT00005798|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153438770|NCT00005798|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153438771|NCT00005810|Carboplatin|carboplatin|mesh-list
153438772|NCT00005810|Docetaxel|docetaxel|mesh-list
153438773|NCT00005810|Estramustine|estramustine|mesh-list
153438774|NCT00005810|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153438775|NCT00005810|Tubulin Modulators|tubulin modulators|mesh-ancestor
153438776|NCT00005810|Antimitotic Agents|antimitotic agents|mesh-ancestor
153438777|NCT00005810|Mitosis Modulators|mitosis modulators|mesh-ancestor
153438778|NCT00005810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153438779|NCT00005810|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153438780|NCT00005810|Alkylating Agents|alkylating agents|mesh-ancestor
153438781|NCT00005810|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153438783|NCT00385970|polysaccharide-K|polysaccharide-k|mesh-list
153438784|NCT00385970|Tegafur|tegafur|mesh-list
153438785|NCT00385970|Calcium|calcium|mesh-list
153438786|NCT00385970|Levoleucovorin|levoleucovorin|mesh-list
153438787|NCT00385970|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153897505|NCT00946153|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153897506|NCT00946153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153897507|NCT01914367|Vaccines|vaccines|mesh-list
153438788|NCT00385970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153897508|NCT01914367|Immunologic Factors|immunologic factors|mesh-ancestor
153897509|NCT01914367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153897510|NCT01160289|Tadalafil|tadalafil|mesh-list
153897511|NCT01160289|Vasodilator Agents|vasodilator agents|mesh-ancestor
153897512|NCT01160289|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
153897513|NCT01160289|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
153897514|NCT01160289|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153897515|NCT01160289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153897517|NCT01159665|Plasminogen|plasminogen|mesh-list
153897518|NCT01159665|Fibrinolysin|fibrinolysin|mesh-list
153897519|NCT01159665|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153897520|NCT01159665|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153897521|NCT01159665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153897522|NCT01158261|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
153897523|NCT01158261|Hemostatics|hemostatics|mesh-ancestor
153897524|NCT01158261|Coagulants|coagulants|mesh-ancestor
153897525|NCT01157169|Buprenorphine|buprenorphine|mesh-list
153897526|NCT01157169|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153897527|NCT01157169|Narcotics|narcotics|mesh-ancestor
153897528|NCT01157169|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153897529|NCT01157169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153897530|NCT01157169|Analgesics|analgesics|mesh-ancestor
153897531|NCT01157169|Sensory System Agents|sensory system agents|mesh-ancestor
153897532|NCT01157169|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153897533|NCT01157169|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
153897534|NCT04313907|Clonazepam|clonazepam|mesh-list
153897535|NCT04313907|Anticonvulsants|anticonvulsants|mesh-ancestor
153897536|NCT04313907|GABA Modulators|gaba modulators|mesh-ancestor
153897537|NCT04313907|GABA Agents|gaba agents|mesh-ancestor
153897538|NCT04313907|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153897539|NCT04313907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153897540|NCT04313907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153897541|NCT01231620|Oseltamivir|oseltamivir|mesh-list
153897542|NCT01231620|Zanamivir|zanamivir|mesh-list
153438791|NCT00385970|Vitamin B Complex|vitamin b complex|mesh-ancestor
153438793|NCT00385970|Micronutrients|micronutrients|mesh-ancestor
153438794|NCT00385970|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153438795|NCT00385970|Antimetabolites|antimetabolites|mesh-ancestor
153438796|NCT00385970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153438797|NCT00385970|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153438798|NCT00385970|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153438799|NCT00385970|Immunologic Factors|immunologic factors|mesh-ancestor
153438800|NCT00385970|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153438801|NCT00385970|Antiviral Agents|antiviral agents|mesh-ancestor
153438802|NCT00385970|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153438803|NCT00385970|Interferon Inducers|interferon inducers|mesh-ancestor
153438804|NCT00385970|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
153438806|NCT05006677|Anticoagulants|anticoagulants|mesh-list
153438807|NCT05006677|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-list
153438808|NCT05006677|Vitamins|vitamins|mesh-ancestor
153438809|NCT05006677|Micronutrients|micronutrients|mesh-ancestor
153438810|NCT05006677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153438811|NCT05006677|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
153438812|NCT05006677|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153438813|NCT05006677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153438814|NCT05006677|Hemostatics|hemostatics|mesh-ancestor
153438815|NCT05006677|Coagulants|coagulants|mesh-ancestor
153438816|NCT00386126|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
153438817|NCT00386126|Hematinics|hematinics|mesh-ancestor
153438818|NCT04569890|Hydroxychloroquine|hydroxychloroquine|mesh-list
153438819|NCT04569890|Prednisone|prednisone|mesh-list
153438820|NCT04569890|Certolizumab Pegol|certolizumab pegol|mesh-list
153438821|NCT04569890|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153438822|NCT04569890|Glucocorticoids|glucocorticoids|mesh-ancestor
153438823|NCT04569890|Hormones|hormones|mesh-ancestor
153438824|NCT04569890|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153438825|NCT04569890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153438826|NCT04569890|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153438827|NCT04569890|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153438828|NCT04569890|Antimalarials|antimalarials|mesh-ancestor
153438829|NCT04569890|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153897543|NCT01231620|Antiviral Agents|antiviral agents|mesh-ancestor
153897544|NCT01231620|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153897545|NCT01231620|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153897546|NCT01231620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153897547|NCT01231464|Fluticasone|fluticasone|mesh-list
153897549|NCT01231464|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153897550|NCT01231464|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153897551|NCT01231464|Autonomic Agents|autonomic agents|mesh-ancestor
153897552|NCT01231464|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153897553|NCT01231464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153897554|NCT01231464|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153897555|NCT01231464|Respiratory System Agents|respiratory system agents|mesh-ancestor
153897556|NCT01231464|Dermatologic Agents|dermatologic agents|mesh-ancestor
153897557|NCT01231464|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
153897558|NCT01156311|Dimethyl Fumarate|dimethyl fumarate|mesh-list
153897559|NCT01156311|Dermatologic Agents|dermatologic agents|mesh-ancestor
153897560|NCT01156311|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153897561|NCT01156311|Immunologic Factors|immunologic factors|mesh-ancestor
153897562|NCT01156311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153897563|NCT04281745|Botulinum Toxins|botulinum toxins|mesh-list
153897564|NCT04281745|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
153897565|NCT04281745|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
153897566|NCT04281745|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
153897567|NCT04281745|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153897568|NCT04281745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153897569|NCT04281745|Cholinergic Agents|cholinergic agents|mesh-ancestor
153897570|NCT04281745|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153897571|NCT04281745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153897572|NCT04281745|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
153897573|NCT04281745|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153897574|NCT01155531|Sertraline|sertraline|mesh-list
153897576|NCT01155531|Antidepressive Agents|antidepressive agents|mesh-ancestor
153897577|NCT01155531|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153897578|NCT01155531|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
153438830|NCT04569890|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153438831|NCT04569890|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153438832|NCT04569890|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153438833|NCT04569890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153438834|NCT04569890|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153438835|NCT04569890|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
153438836|NCT04569890|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153438837|NCT04569890|Immunologic Factors|immunologic factors|mesh-ancestor
153438838|NCT00423163|Voriconazole|voriconazole|mesh-list
153438840|NCT00423163|Antifungal Agents|antifungal agents|mesh-ancestor
153438841|NCT00423163|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153438842|NCT00423163|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
153438843|NCT00423163|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153438844|NCT00423163|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153438845|NCT00423163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153438846|NCT00423163|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153438847|NCT00423163|Hormone Antagonists|hormone antagonists|mesh-ancestor
153438848|NCT00423163|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153438849|NCT00423163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153438850|NCT00423163|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
153438852|NCT04568876|Analgesics|analgesics|mesh-ancestor
153438853|NCT04568876|Sensory System Agents|sensory system agents|mesh-ancestor
153438854|NCT04568876|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153897579|NCT01155531|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153897580|NCT01155531|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153897581|NCT01155531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153897582|NCT01155531|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153897583|NCT01155531|Serotonin Agents|serotonin agents|mesh-ancestor
153897584|NCT01155531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153897585|NCT01155531|Parasympatholytics|parasympatholytics|mesh-ancestor
153897586|NCT01155531|Autonomic Agents|autonomic agents|mesh-ancestor
153897587|NCT01155531|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153897588|NCT01155219|Latanoprost|latanoprost|mesh-list
153897589|NCT01155219|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
153897590|NCT01155219|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
153897591|NCT00631033|Metformin|metformin|mesh-list
153897592|NCT00631033|Diazoxide|diazoxide|mesh-list
153897593|NCT00631033|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153897594|NCT00631033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153897595|NCT00631033|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153897596|NCT00631033|Vasodilator Agents|vasodilator agents|mesh-ancestor
153897597|NCT01155063|Exemestane|exemestane|mesh-list
153897598|NCT01155063|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153897599|NCT01155063|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
153897600|NCT01155063|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153897601|NCT01155063|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153897602|NCT01155063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153897603|NCT01155063|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
153897604|NCT01155063|Hormone Antagonists|hormone antagonists|mesh-ancestor
153897605|NCT01155063|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153897607|NCT01154673|Ritonavir|ritonavir|mesh-list
153897608|NCT01154673|Lopinavir|lopinavir|mesh-list
153897609|NCT01154673|Tenofovir|tenofovir|mesh-list
153897610|NCT01154673|Emtricitabine|emtricitabine|mesh-list
153897611|NCT01154673|Raltegravir Potassium|raltegravir potassium|mesh-list
153897612|NCT01154673|Maraviroc|maraviroc|mesh-list
153897613|NCT01154673|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
153897614|NCT01154673|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
153897615|NCT01154673|Protease Inhibitors|protease inhibitors|mesh-ancestor
153897616|NCT01154673|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153897617|NCT01154673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153897618|NCT01154673|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153897619|NCT01154673|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153897620|NCT01154673|Antiviral Agents|antiviral agents|mesh-ancestor
153897621|NCT01154673|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153897622|NCT01154673|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
153438873|NCT02210702|Estradiol|estradiol|mesh-list
153438874|NCT02210702|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
153438875|NCT02210702|Estrogens|estrogens|mesh-ancestor
153438876|NCT02210702|Hormones|hormones|mesh-ancestor
153438877|NCT02210702|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153438878|NCT02210702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153438879|NCT02210702|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
153438880|NCT02210702|Contraceptive Agents|contraceptive agents|mesh-ancestor
153438881|NCT02210702|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153438882|NCT02210702|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
153438883|NCT02210702|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
153438885|NCT02210702|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
153438886|NCT04568096|Tamoxifen|tamoxifen|mesh-list
153438887|NCT04568096|Tretinoin|tretinoin|mesh-list
153438888|NCT04568096|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
153438889|NCT04568096|Hormone Antagonists|hormone antagonists|mesh-ancestor
153438890|NCT04568096|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153438891|NCT04568096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153438892|NCT04568096|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153438893|NCT04568096|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153438894|NCT04568096|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
153438895|NCT04568096|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
153438896|NCT04568096|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153438897|NCT04568096|Keratolytic Agents|keratolytic agents|mesh-ancestor
153438898|NCT04568096|Dermatologic Agents|dermatologic agents|mesh-ancestor
153438899|NCT04568018|Pulmonary Surfactants|pulmonary surfactants|mesh-list
153438900|NCT04568018|Respiratory System Agents|respiratory system agents|mesh-ancestor
153438901|NCT02278172|Vitamin D|vitamin d|mesh-list
153438902|NCT02278172|Ergocalciferols|ergocalciferols|mesh-list
153438903|NCT02278172|Cholecalciferol|cholecalciferol|mesh-list
153438904|NCT02278172|Vitamins|vitamins|mesh-list
153438905|NCT02278172|Micronutrients|micronutrients|mesh-ancestor
153438906|NCT02278172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153438907|NCT02278172|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153897623|NCT01154673|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153897624|NCT01154673|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153897625|NCT01154673|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153897626|NCT01154673|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
153897627|NCT01154673|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
153897628|NCT01154673|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
153897629|NCT01154673|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
153897630|NCT01154673|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
153897631|NCT02884713|Doxycycline|doxycycline|mesh-list
153897632|NCT02884713|Levofloxacin|levofloxacin|mesh-list
153897633|NCT02884713|Esomeprazole|esomeprazole|mesh-list
153897634|NCT02884713|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
153897635|NCT02884713|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153897636|NCT02884713|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
153897637|NCT02884713|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153897638|NCT02884713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153897639|NCT02884713|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153897640|NCT02884713|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153897641|NCT02884713|Antimalarials|antimalarials|mesh-ancestor
153897642|NCT02884713|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153897643|NCT02884713|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153897644|NCT02884713|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
153897645|NCT02884713|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153897646|NCT02884713|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153897647|NCT02884713|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153897648|NCT02884713|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
153897649|NCT02884713|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153897650|NCT01154127|Glycopyrrolate|glycopyrrolate|mesh-list
153897651|NCT01154127|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153897652|NCT01154127|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
153897653|NCT01154127|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
153897654|NCT01154127|Cholinergic Agents|cholinergic agents|mesh-ancestor
153897655|NCT01154127|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153897656|NCT01154127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153897657|NCT01154127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153897659|NCT01228734|Folic Acid|folic acid|mesh-list
153897660|NCT01228734|Fluorouracil|fluorouracil|mesh-list
153897661|NCT01228734|Oxaliplatin|oxaliplatin|mesh-list
153438913|NCT04566224|Dermatologic Agents|dermatologic agents|mesh-ancestor
153438914|NCT02210858|Tipifarnib|tipifarnib|mesh-list
153438915|NCT02210858|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153438916|NCT04565678|Mitapivat|mitapivat|mesh-list
153438917|NCT04565678|Enzyme Activators|enzyme activators|mesh-ancestor
153438918|NCT04565678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153438919|NCT04564430|Clonidine|clonidine|mesh-list
153438920|NCT04564430|Analgesics|analgesics|mesh-ancestor
153438921|NCT04564430|Sensory System Agents|sensory system agents|mesh-ancestor
153438922|NCT04564430|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153438924|NCT04564430|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153438925|NCT04564430|Sympatholytics|sympatholytics|mesh-ancestor
153438926|NCT04564430|Autonomic Agents|autonomic agents|mesh-ancestor
153438927|NCT04564430|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
153438928|NCT04564430|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153438930|NCT04564430|Adrenergic Agents|adrenergic agents|mesh-ancestor
153438931|NCT04564430|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153438932|NCT04564430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153438933|NCT04564040|Acalabrutinib|acalabrutinib|mesh-list
153438934|NCT04564040|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153438935|NCT04564040|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153438936|NCT04564040|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153438937|NCT04564040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153438938|NCT04564040|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153438939|NCT00005804|Cyclophosphamide|cyclophosphamide|mesh-list
153438940|NCT00005804|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153438941|NCT00005804|Immunologic Factors|immunologic factors|mesh-ancestor
153897662|NCT01228734|Cetuximab|cetuximab|mesh-list
153897663|NCT01228734|Levoleucovorin|levoleucovorin|mesh-list
153897664|NCT01228734|Antimetabolites|antimetabolites|mesh-ancestor
153897665|NCT01228734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153897666|NCT01228734|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153897667|NCT01228734|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153897668|NCT01228734|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153897669|NCT01228734|Immunologic Factors|immunologic factors|mesh-ancestor
153897671|NCT01228734|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153897673|NCT01228734|Protective Agents|protective agents|mesh-ancestor
153897674|NCT01228734|Vitamin B Complex|vitamin b complex|mesh-ancestor
153897675|NCT01228734|Vitamins|vitamins|mesh-ancestor
153897676|NCT01228734|Micronutrients|micronutrients|mesh-ancestor
153897677|NCT01228734|Hematinics|hematinics|mesh-ancestor
153897678|NCT01153971|Rituximab|rituximab|mesh-list
153897679|NCT01153971|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153897680|NCT01153971|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153897681|NCT01153971|Immunologic Factors|immunologic factors|mesh-ancestor
153897682|NCT01153971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153897683|NCT01153971|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153897684|NCT01153893|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
153897685|NCT01153893|Immunologic Factors|immunologic factors|mesh-ancestor
153897686|NCT01153893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153897687|NCT00951379|Pioglitazone|pioglitazone|mesh-list
153897688|NCT00951379|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153897689|NCT00951379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153897690|NCT01153815|Botulinum Toxins|botulinum toxins|mesh-list
153897691|NCT01153815|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
153897692|NCT01153815|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
153897693|NCT01153815|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
153897694|NCT01153815|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153897695|NCT01153815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153897696|NCT01153815|Cholinergic Agents|cholinergic agents|mesh-ancestor
153897697|NCT01153815|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153897698|NCT01153815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153897699|NCT01153815|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
153897700|NCT01153815|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153897701|NCT01153425|Zoledronic Acid|zoledronic acid|mesh-list
153897702|NCT01153425|Teriparatide|teriparatide|mesh-list
153897703|NCT01153425|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153897704|NCT01153425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153897705|NCT01153425|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153897706|NCT01153269|Ritonavir|ritonavir|mesh-list
153897707|NCT01153269|Lopinavir|lopinavir|mesh-list
153438959|NCT04563962|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
153438960|NCT04563962|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153438961|NCT04563962|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153438962|NCT04563962|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
153438964|NCT02211482|Dolutegravir|dolutegravir|mesh-list
153438965|NCT02211482|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153438966|NCT02211482|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153438967|NCT02211482|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153438968|NCT02211482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153438969|NCT02211482|Antiviral Agents|antiviral agents|mesh-ancestor
153438970|NCT02211482|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153438971|NCT02211482|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153438972|NCT02211482|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153438973|NCT02211482|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
153438974|NCT02211482|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
153438975|NCT04929847|Emollients|emollients|mesh-list
153438976|NCT04929847|Dermatologic Agents|dermatologic agents|mesh-ancestor
153438977|NCT04561934|Fluorides|fluorides|mesh-list
153438978|NCT04561934|Cariostatic Agents|cariostatic agents|mesh-ancestor
153438979|NCT04561934|Protective Agents|protective agents|mesh-ancestor
153897708|NCT01153269|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
153897709|NCT01153269|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
153897710|NCT01153269|Protease Inhibitors|protease inhibitors|mesh-ancestor
153897711|NCT01153269|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153897712|NCT01153269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153897713|NCT01153269|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153897714|NCT01153269|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153897715|NCT01153269|Antiviral Agents|antiviral agents|mesh-ancestor
153897716|NCT01153269|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153897717|NCT01153269|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
153897718|NCT01153269|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153897719|NCT02884635|Methotrexate|methotrexate|mesh-list
153897720|NCT02884635|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
153897721|NCT02884635|Abortifacient Agents|abortifacient agents|mesh-ancestor
153897722|NCT02884635|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153897723|NCT02884635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153897724|NCT02884635|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153897725|NCT02884635|Antimetabolites|antimetabolites|mesh-ancestor
153897726|NCT02884635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153897727|NCT02884635|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153897728|NCT02884635|Dermatologic Agents|dermatologic agents|mesh-ancestor
153897729|NCT02884635|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153897730|NCT02884635|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153897731|NCT02884635|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153897732|NCT02884635|Immunologic Factors|immunologic factors|mesh-ancestor
153897733|NCT02884635|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153897734|NCT02884635|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153897735|NCT02884479|Docetaxel|docetaxel|mesh-list
153897736|NCT02884479|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153897737|NCT02884479|Tubulin Modulators|tubulin modulators|mesh-ancestor
153897738|NCT02884479|Antimitotic Agents|antimitotic agents|mesh-ancestor
153897739|NCT02884479|Mitosis Modulators|mitosis modulators|mesh-ancestor
153897740|NCT02884479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153438980|NCT04561934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153897741|NCT01152021|Dexmedetomidine|dexmedetomidine|mesh-list
153897742|NCT01152021|Propofol|propofol|mesh-list
153897743|NCT01152021|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153897744|NCT01152021|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153897745|NCT01152021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153897746|NCT01152021|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153897747|NCT01152021|Analgesics|analgesics|mesh-ancestor
153897748|NCT01152021|Sensory System Agents|sensory system agents|mesh-ancestor
153897749|NCT01152021|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153897750|NCT01152021|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
153897751|NCT01152021|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153897752|NCT01152021|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153897753|NCT01152021|Adrenergic Agents|adrenergic agents|mesh-ancestor
153897754|NCT01152021|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153897755|NCT01152021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153897756|NCT01152021|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153897757|NCT01152021|Anesthetics, General|anesthetics, general|mesh-ancestor
153897758|NCT01152021|Anesthetics|anesthetics|mesh-ancestor
153897759|NCT01151085|Voriconazole|voriconazole|mesh-list
153439014|NCT04561856|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153439015|NCT04561856|Glucocorticoids|glucocorticoids|mesh-ancestor
153439016|NCT04561856|Hormones|hormones|mesh-ancestor
153439017|NCT04561856|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153439019|NCT04561856|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153439020|NCT04561856|Protease Inhibitors|protease inhibitors|mesh-ancestor
153439021|NCT04561856|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153439022|NCT04561856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153439023|NCT00382681|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
153439024|NCT04173403|Ezetimibe|ezetimibe|mesh-list
153439025|NCT04173403|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153439026|NCT04173403|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153439027|NCT04173403|Antimetabolites|antimetabolites|mesh-ancestor
153439028|NCT04173403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153439029|NCT04173403|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153439030|NCT03539887|Ketamine|ketamine|mesh-list
153439031|NCT03539887|Analgesics|analgesics|mesh-ancestor
153439032|NCT03539887|Sensory System Agents|sensory system agents|mesh-ancestor
153439033|NCT03539887|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153439034|NCT03539887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153439035|NCT03539887|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
153439036|NCT03539887|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153439037|NCT03539887|Anesthetics, General|anesthetics, general|mesh-ancestor
153439038|NCT03539887|Anesthetics|anesthetics|mesh-ancestor
153439039|NCT03539887|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153439040|NCT03539887|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
153439041|NCT03539887|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
153439042|NCT03539887|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153439043|NCT03539887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153439044|NCT04123717|Acetaminophen|acetaminophen|mesh-list
153439045|NCT04123717|Ibuprofen|ibuprofen|mesh-list
153439046|NCT04123717|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153897760|NCT01151085|Antifungal Agents|antifungal agents|mesh-ancestor
153897761|NCT01151085|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153897762|NCT01151085|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
153897763|NCT01151085|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153897764|NCT01151085|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153897765|NCT01151085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153897766|NCT01151085|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153897767|NCT01151085|Hormone Antagonists|hormone antagonists|mesh-ancestor
153897768|NCT01151085|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153897769|NCT01151085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153897770|NCT01151085|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
153897771|NCT01149369|Aprepitant|aprepitant|mesh-list
153897773|NCT01149369|Autonomic Agents|autonomic agents|mesh-ancestor
153897774|NCT01149369|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153897775|NCT01149369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153897776|NCT01149369|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153897777|NCT01149369|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
153897778|NCT01149369|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153897779|NCT01149369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153897780|NCT00879931|Methylprednisolone|methylprednisolone|mesh-list
153897781|NCT00879931|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
153897782|NCT00879931|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
153897783|NCT00879931|Prednisolone|prednisolone|mesh-list
153897784|NCT00879931|Prednisolone acetate|prednisolone acetate|mesh-list
153897785|NCT00879931|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
153897786|NCT00879931|Prednisolone phosphate|prednisolone phosphate|mesh-list
153897787|NCT00879931|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153897788|NCT00879931|Antiemetics|antiemetics|mesh-ancestor
153897789|NCT00879931|Autonomic Agents|autonomic agents|mesh-ancestor
153897790|NCT00879931|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153897791|NCT00879931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153897792|NCT00879931|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153897793|NCT00879931|Glucocorticoids|glucocorticoids|mesh-ancestor
153897794|NCT00879931|Hormones|hormones|mesh-ancestor
153897795|NCT00879931|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153897796|NCT00879931|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
153897797|NCT00879931|Protective Agents|protective agents|mesh-ancestor
153897798|NCT00879931|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153439055|NCT04123717|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153439056|NCT04123717|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153439057|NCT04123717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153439058|NCT03472495|Diltiazem|diltiazem|mesh-list
153439059|NCT03472495|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153439062|NCT03472495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153439063|NCT03472495|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153439064|NCT03472495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153439065|NCT03472495|Vasodilator Agents|vasodilator agents|mesh-ancestor
153439066|NCT04094701|Analgesics, Opioid|analgesics, opioid|mesh-list
153439067|NCT04094701|Narcotics|narcotics|mesh-ancestor
153439068|NCT04094701|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153439069|NCT04094701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153439071|NCT04094701|Sensory System Agents|sensory system agents|mesh-ancestor
153439072|NCT04094701|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153439073|NCT03351361|Nivolumab|nivolumab|mesh-list
153439074|NCT03351361|Ipilimumab|ipilimumab|mesh-list
153439075|NCT03351361|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153439076|NCT03351361|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153439077|NCT03351361|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153439078|NCT03351361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153439080|NCT03234907|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153439081|NCT04330027|Mitogens|mitogens|mesh-list
153439082|NCT04330027|Mitosis Modulators|mitosis modulators|mesh-ancestor
153439084|NCT00002893|Leucovorin|leucovorin|mesh-list
153897799|NCT00879931|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153897800|NCT01227564|Saponin QA-21V1|saponin qa-21v1|mesh-list
153897801|NCT01227564|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153897802|NCT01227564|Immunologic Factors|immunologic factors|mesh-ancestor
153897803|NCT01227564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153897804|NCT00739141|Cyclophosphamide|cyclophosphamide|mesh-list
153897805|NCT00739141|Thiotepa|thiotepa|mesh-list
153897806|NCT00739141|Fludarabine|fludarabine|mesh-list
153897807|NCT00739141|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153897808|NCT00739141|Immunologic Factors|immunologic factors|mesh-ancestor
153897809|NCT00739141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153897810|NCT00739141|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153897811|NCT00739141|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153897812|NCT00739141|Alkylating Agents|alkylating agents|mesh-ancestor
153897813|NCT00739141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153897814|NCT00739141|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153897815|NCT00739141|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153897816|NCT01148979|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
153897817|NCT01148979|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
153897818|NCT01148979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153897819|NCT01148979|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
153897820|NCT01148979|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153897821|NCT01148979|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153897822|NCT01148979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153897823|NCT01148979|Dopamine Agents|dopamine agents|mesh-ancestor
153897824|NCT01148979|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153897825|NCT01735825|Paclitaxel|paclitaxel|mesh-list
153897826|NCT01735825|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
153897827|NCT01735825|Everolimus|everolimus|mesh-list
153897828|NCT01735825|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153897829|NCT01735825|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153897830|NCT01735825|Tubulin Modulators|tubulin modulators|mesh-ancestor
153897831|NCT01735825|Antimitotic Agents|antimitotic agents|mesh-ancestor
153897832|NCT01735825|Mitosis Modulators|mitosis modulators|mesh-ancestor
153897833|NCT01735825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153897834|NCT01735825|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
153897835|NCT01735825|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153897836|NCT01735825|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153897837|NCT01735825|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153897838|NCT01735825|Immunologic Factors|immunologic factors|mesh-ancestor
153897839|NCT01735825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153897840|NCT01148511|Ranibizumab|ranibizumab|mesh-list
153897841|NCT01148511|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153897842|NCT01148511|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153897843|NCT01148511|Growth Substances|growth substances|mesh-ancestor
153439102|NCT00002893|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153439103|NCT00002893|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153439104|NCT03818581|Suvorexant|suvorexant|mesh-list
153439105|NCT03818581|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
153439106|NCT03818581|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153439114|NCT00002905|Cyclophosphamide|cyclophosphamide|mesh-list
153439115|NCT00002905|Prednimustine|prednimustine|mesh-list
153439116|NCT00002905|Doxorubicin|doxorubicin|mesh-list
153439117|NCT00002905|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
153439118|NCT00002905|Etoposide|etoposide|mesh-list
153439119|NCT00002905|Mitoxantrone|mitoxantrone|mesh-list
153439120|NCT00002905|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153439121|NCT00002905|Immunologic Factors|immunologic factors|mesh-ancestor
153439122|NCT00002905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153439123|NCT00002905|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153439124|NCT00002905|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153439125|NCT00002905|Alkylating Agents|alkylating agents|mesh-ancestor
153439126|NCT00002905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153439127|NCT00002905|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153439128|NCT00002905|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153439129|NCT00002905|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153897844|NCT01148511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153897845|NCT01148511|Growth Inhibitors|growth inhibitors|mesh-ancestor
153897846|NCT01148511|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153897847|NCT02860117|Ketamine|ketamine|mesh-list
153897848|NCT02860117|Analgesics|analgesics|mesh-ancestor
153897849|NCT02860117|Sensory System Agents|sensory system agents|mesh-ancestor
153897850|NCT02860117|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153897851|NCT02860117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153897852|NCT02860117|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
153897853|NCT02860117|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153897855|NCT02860117|Anesthetics|anesthetics|mesh-ancestor
153897856|NCT02860117|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153897857|NCT02860117|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
153897858|NCT02860117|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
153897859|NCT02860117|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153439130|NCT00002905|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153439131|NCT00002905|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153439144|NCT00002911|Marimastat|marimastat|mesh-list
153897860|NCT02860117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153897862|NCT02853253|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
153897863|NCT02853253|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
153897864|NCT02853253|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
153897865|NCT04269187|Theophylline|theophylline|mesh-list
153897866|NCT04269187|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153897867|NCT04269187|Autonomic Agents|autonomic agents|mesh-ancestor
153897868|NCT04269187|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153897869|NCT04269187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153897870|NCT04269187|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153897871|NCT04269187|Respiratory System Agents|respiratory system agents|mesh-ancestor
153897872|NCT04269187|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
153897873|NCT04269187|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153897874|NCT04269187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153897875|NCT04269187|Vasodilator Agents|vasodilator agents|mesh-ancestor
153897876|NCT04269187|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
153897877|NCT04269187|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
153897878|NCT04269187|Purinergic Agents|purinergic agents|mesh-ancestor
153897879|NCT04269187|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153897880|NCT04269109|Analgesics, Opioid|analgesics, opioid|mesh-list
153897881|NCT04269109|Narcotics|narcotics|mesh-ancestor
153897882|NCT04269109|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153897883|NCT04269109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153897884|NCT04269109|Analgesics|analgesics|mesh-ancestor
153897885|NCT04269109|Sensory System Agents|sensory system agents|mesh-ancestor
153897886|NCT04269109|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153439148|NCT00002917|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153439149|NCT00002917|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153439150|NCT00002917|Tubulin Modulators|tubulin modulators|mesh-ancestor
153439151|NCT00002917|Antimitotic Agents|antimitotic agents|mesh-ancestor
153439152|NCT00002917|Mitosis Modulators|mitosis modulators|mesh-ancestor
153439153|NCT00002917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153439154|NCT00383695|Capecitabine|capecitabine|mesh-list
153439155|NCT00383695|Oxaliplatin|oxaliplatin|mesh-list
153439156|NCT00383695|Cetuximab|cetuximab|mesh-list
153439157|NCT00383695|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153439158|NCT00383695|Antimetabolites|antimetabolites|mesh-ancestor
153439159|NCT00383695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153439160|NCT00383695|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153439161|NCT00383695|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153439162|NCT00383851|Temozolomide|temozolomide|mesh-list
153439163|NCT00383851|Tetrathiomolybdate|tetrathiomolybdate|mesh-list
153439164|NCT00383851|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153439165|NCT00383851|Alkylating Agents|alkylating agents|mesh-ancestor
153439166|NCT00383851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153439167|NCT00383851|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153439168|NCT00383851|Chelating Agents|chelating agents|mesh-ancestor
153439169|NCT00383851|Sequestering Agents|sequestering agents|mesh-ancestor
153439170|NCT00383851|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153439171|NCT00383851|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153439172|NCT00383851|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153897887|NCT01226472|Mogamulizumab|mogamulizumab|mesh-list
153897888|NCT01226472|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153897889|NCT04268563|Metformin|metformin|mesh-list
153897890|NCT04268563|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
153897891|NCT04268563|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153897892|NCT04268563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153897894|NCT04268563|Hormones|hormones|mesh-ancestor
153897895|NCT04268563|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153897896|NCT04268563|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
153897897|NCT04268563|Protease Inhibitors|protease inhibitors|mesh-ancestor
153897898|NCT04268563|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153897899|NCT04268563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153897900|NCT01225146|Ranibizumab|ranibizumab|mesh-list
153897901|NCT01225146|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153897902|NCT01225146|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153897903|NCT01225146|Growth Substances|growth substances|mesh-ancestor
153897904|NCT01225146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153897905|NCT01225146|Growth Inhibitors|growth inhibitors|mesh-ancestor
153897906|NCT01225146|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153897907|NCT01223196|Pioglitazone|pioglitazone|mesh-list
153897908|NCT01223196|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153439173|NCT00383851|Growth Substances|growth substances|mesh-ancestor
153897909|NCT01223196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153897910|NCT01222416|Radiopharmaceuticals|radiopharmaceuticals|mesh-list
153897911|NCT01222416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153897912|NCT00950911|Denosumab|denosumab|mesh-list
153897913|NCT00950911|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153897914|NCT00950911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153897915|NCT02855515|Anesthetics|anesthetics|mesh-list
153897916|NCT02855515|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153897917|NCT02855515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153897918|NCT04206228|Iron isomaltoside 1000|iron isomaltoside 1000|mesh-list
153897919|NCT04206228|Hematinics|hematinics|mesh-ancestor
153897920|NCT01218594|Endostatins|endostatins|mesh-list
153897921|NCT01218594|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153897922|NCT01218594|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153897923|NCT01218594|Growth Substances|growth substances|mesh-ancestor
153897924|NCT01218594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153897925|NCT01218594|Growth Inhibitors|growth inhibitors|mesh-ancestor
153897926|NCT01218594|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153897927|NCT01610557|Bevacizumab|bevacizumab|mesh-list
153897928|NCT01610557|Ranibizumab|ranibizumab|mesh-list
153897929|NCT01610557|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153897930|NCT01610557|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153897931|NCT01610557|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153897932|NCT01610557|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153897933|NCT01610557|Growth Substances|growth substances|mesh-ancestor
153897934|NCT01610557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153439197|NCT00002935|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
153439199|NCT00002941|Carmustine|carmustine|mesh-list
153439200|NCT00002941|Etoposide|etoposide|mesh-list
153439201|NCT00002941|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153439202|NCT00002941|Immunologic Factors|immunologic factors|mesh-ancestor
153439203|NCT00002941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153439204|NCT00002941|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153439205|NCT00002941|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153439206|NCT00002941|Alkylating Agents|alkylating agents|mesh-ancestor
153439207|NCT00002941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153439208|NCT00002941|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153439209|NCT00002941|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153439210|NCT00002941|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153439211|NCT00002941|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153439212|NCT00002941|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153439213|NCT00002941|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153897935|NCT01610557|Growth Inhibitors|growth inhibitors|mesh-ancestor
153897936|NCT00943735|Fesoterodine|fesoterodine|mesh-list
153897937|NCT00943735|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
153897938|NCT00943735|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
153897939|NCT00943735|Cholinergic Agents|cholinergic agents|mesh-ancestor
153897940|NCT00943735|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153897941|NCT00943735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153897942|NCT00943735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153897943|NCT00943735|Urological Agents|urological agents|mesh-ancestor
153897944|NCT00943111|Eliglustat|eliglustat|mesh-list
153897945|NCT00943111|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153897946|NCT00943111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153897947|NCT01147497|Misoprostol|misoprostol|mesh-list
153897948|NCT01147497|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
153897949|NCT01147497|Abortifacient Agents|abortifacient agents|mesh-ancestor
153897950|NCT01147497|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153897951|NCT01147497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153897952|NCT01147497|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
153897953|NCT01147497|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153897954|NCT01147497|Oxytocics|oxytocics|mesh-ancestor
153897955|NCT01147341|Certolizumab Pegol|certolizumab pegol|mesh-list
153897956|NCT01147341|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
153897957|NCT01147341|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153897958|NCT01147341|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153897959|NCT01147341|Immunologic Factors|immunologic factors|mesh-ancestor
153897960|NCT01147341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153897961|NCT01147341|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153897962|NCT00950755|Tositumomab I-131|tositumomab i-131|mesh-list
153897963|NCT00950755|Antibodies|antibodies|mesh-list
153897964|NCT00950755|Immunologic Factors|immunologic factors|mesh-ancestor
153897965|NCT00950755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153897966|NCT00950755|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153897967|NCT01147107|Efavirenz|efavirenz|mesh-list
153897968|NCT01147107|Raltegravir Potassium|raltegravir potassium|mesh-list
153897969|NCT01147107|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153897970|NCT01147107|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153897972|NCT01147107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153897973|NCT01147107|Antiviral Agents|antiviral agents|mesh-ancestor
153897974|NCT01147107|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153897975|NCT01147107|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
153897976|NCT01147107|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153897977|NCT01147107|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
153897978|NCT01147107|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
153897979|NCT01147107|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
153897980|NCT01147107|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
153897981|NCT01147107|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153897982|NCT01147107|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153897983|NCT01147107|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
153897984|NCT01147107|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
153897985|NCT01146951|Rufinamide|rufinamide|mesh-list
153897986|NCT01146951|Anticonvulsants|anticonvulsants|mesh-ancestor
153897987|NCT01146951|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
153897988|NCT01146951|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153897989|NCT01146951|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153439255|NCT00002971|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153439256|NCT00002971|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153439257|NCT00002971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153439265|NCT00002977|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153439266|NCT00002977|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153439267|NCT00002977|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153439268|NCT00003391|Antibodies|antibodies|mesh-list
153439269|NCT00003391|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
153439270|NCT00003391|Immunologic Factors|immunologic factors|mesh-ancestor
153439271|NCT00003391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153439272|NCT00003397|Dexamethasone|dexamethasone|mesh-list
153439273|NCT00003397|Paclitaxel|paclitaxel|mesh-list
153439275|NCT00003397|Cyclophosphamide|cyclophosphamide|mesh-list
153439276|NCT00003397|Rituximab|rituximab|mesh-list
153439277|NCT00003397|Gemcitabine|gemcitabine|mesh-list
153439278|NCT00003397|Melphalan|melphalan|mesh-list
153439279|NCT00003397|Carmustine|carmustine|mesh-list
153439280|NCT00003397|Sargramostim|sargramostim|mesh-list
153439281|NCT00003397|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153439282|NCT00003397|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153897990|NCT01146951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153897992|NCT01146873|Lopinavir|lopinavir|mesh-list
153897993|NCT01146873|Abacavir|abacavir|mesh-list
153897994|NCT01146873|Stavudine|stavudine|mesh-list
153897995|NCT01146873|Efavirenz|efavirenz|mesh-list
153897996|NCT01146873|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
153897997|NCT01146873|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
153897998|NCT01146873|Protease Inhibitors|protease inhibitors|mesh-ancestor
153897999|NCT01146873|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153898000|NCT01146873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153898001|NCT01146873|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153898002|NCT01146873|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153898003|NCT01146873|Antiviral Agents|antiviral agents|mesh-ancestor
153898004|NCT01146873|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153898005|NCT01146873|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
153439283|NCT00003397|Tubulin Modulators|tubulin modulators|mesh-ancestor
153439284|NCT00003397|Antimitotic Agents|antimitotic agents|mesh-ancestor
153439285|NCT00003397|Mitosis Modulators|mitosis modulators|mesh-ancestor
153439287|NCT00003397|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153898006|NCT01146873|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153898007|NCT01146873|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153898008|NCT01146873|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153898009|NCT01146873|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
153898010|NCT01146873|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
153898011|NCT01146873|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
153898012|NCT01146873|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
153898013|NCT01146873|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
153898014|NCT01146873|Antimetabolites|antimetabolites|mesh-ancestor
153898015|NCT01146795|Paclitaxel|paclitaxel|mesh-list
153898016|NCT01146795|Bevacizumab|bevacizumab|mesh-list
153898017|NCT01146795|Carboplatin|carboplatin|mesh-list
153898018|NCT01146795|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153898019|NCT01146795|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153898020|NCT01146795|Tubulin Modulators|tubulin modulators|mesh-ancestor
153898021|NCT01146795|Antimitotic Agents|antimitotic agents|mesh-ancestor
153898022|NCT01146795|Mitosis Modulators|mitosis modulators|mesh-ancestor
153898023|NCT01146795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153898024|NCT01146795|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153898025|NCT01146795|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153898026|NCT01146795|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153898027|NCT01146795|Growth Substances|growth substances|mesh-ancestor
153898028|NCT01146795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153898029|NCT01146795|Growth Inhibitors|growth inhibitors|mesh-ancestor
153898030|NCT01146561|Tanezumab|tanezumab|mesh-list
153898031|NCT01146561|Analgesics|analgesics|mesh-ancestor
153898032|NCT01146561|Sensory System Agents|sensory system agents|mesh-ancestor
153898033|NCT01146561|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153439302|NCT00003397|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153439303|NCT00003397|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153439304|NCT00003397|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153439306|NCT00003397|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153439307|NCT00003397|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153439308|NCT00003397|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153439309|NCT00003409|Motexafin gadolinium|motexafin gadolinium|mesh-list
153439310|NCT00003409|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153439311|NCT00003409|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
153439312|NCT00003409|Dermatologic Agents|dermatologic agents|mesh-ancestor
153439313|NCT00003415|Topotecan|topotecan|mesh-list
153439314|NCT00003415|Amifostine|amifostine|mesh-list
153439315|NCT00003415|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
153439316|NCT00003415|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153439317|NCT00003415|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153439318|NCT00003415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153439319|NCT00003415|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153439320|NCT00003415|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
153439321|NCT00003415|Protective Agents|protective agents|mesh-ancestor
153439322|NCT00003415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153439323|NCT00002989|Cyclophosphamide|cyclophosphamide|mesh-list
153439324|NCT00002989|Melphalan|melphalan|mesh-list
153439325|NCT00002989|Busulfan|busulfan|mesh-list
153439327|NCT00002989|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153439328|NCT00002989|Immunologic Factors|immunologic factors|mesh-ancestor
153439329|NCT00002989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153439330|NCT00002989|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153898034|NCT01146561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153898035|NCT00942175|Esomeprazole|esomeprazole|mesh-list
153898036|NCT00942175|Omeprazole|omeprazole|mesh-list
153898037|NCT00942175|Lansoprazole|lansoprazole|mesh-list
153898038|NCT00942175|Dexlansoprazole|dexlansoprazole|mesh-list
153898039|NCT00942175|Clopidogrel|clopidogrel|mesh-list
153898040|NCT00942175|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153898041|NCT00942175|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
153898042|NCT00942175|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
153898043|NCT00942175|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
153898044|NCT00942175|Purinergic Agents|purinergic agents|mesh-ancestor
153898045|NCT00942175|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153898046|NCT00942175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153898047|NCT00942175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153898048|NCT00942175|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
153898049|NCT00942175|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153439332|NCT00002989|Alkylating Agents|alkylating agents|mesh-ancestor
153898050|NCT00942175|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
153898051|NCT00942175|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153898052|NCT01145625|Minoxidil|minoxidil|mesh-list
153898053|NCT01145625|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153898054|NCT01145625|Vasodilator Agents|vasodilator agents|mesh-ancestor
153898055|NCT02852083|Pioglitazone|pioglitazone|mesh-list
153898056|NCT02852083|Clarithromycin|clarithromycin|mesh-list
153898057|NCT02852083|Nivolumab|nivolumab|mesh-list
153898058|NCT02852083|Treosulfan|treosulfan|mesh-list
153898059|NCT02852083|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153898060|NCT02852083|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153898061|NCT02852083|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153898062|NCT02852083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153898063|NCT02852083|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153898064|NCT02852083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153898065|NCT02852083|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153898066|NCT02852083|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153898067|NCT02852083|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
153898068|NCT02852083|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153898069|NCT02852083|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
153898070|NCT02852083|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153898071|NCT02852083|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153898072|NCT02852083|Alkylating Agents|alkylating agents|mesh-ancestor
153898073|NCT00602407|Cilostazol|cilostazol|mesh-list
153898074|NCT00602407|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153898075|NCT00602407|Autonomic Agents|autonomic agents|mesh-ancestor
153898076|NCT00602407|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153898077|NCT00602407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153898078|NCT00602407|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153439361|NCT00002995|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153439362|NCT00002995|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153439363|NCT00003001|Leucovorin|leucovorin|mesh-list
153439364|NCT00003001|Gemcitabine|gemcitabine|mesh-list
153439365|NCT00003001|Fluorouracil|fluorouracil|mesh-list
153439366|NCT00003001|Calcium|calcium|mesh-list
153439367|NCT00003001|Levoleucovorin|levoleucovorin|mesh-list
153439368|NCT00003001|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153439369|NCT00003001|Antimetabolites|antimetabolites|mesh-ancestor
153439370|NCT00003001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153439371|NCT00003001|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153439372|NCT00003001|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153439373|NCT00003001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153439376|NCT00003001|Antidotes|antidotes|mesh-ancestor
153439377|NCT00003001|Protective Agents|protective agents|mesh-ancestor
153439378|NCT00003001|Vitamin B Complex|vitamin b complex|mesh-ancestor
153898079|NCT00602407|Respiratory System Agents|respiratory system agents|mesh-ancestor
153898080|NCT00602407|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153898081|NCT00602407|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153898082|NCT00602407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153898083|NCT00602407|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153898084|NCT00602407|Vasodilator Agents|vasodilator agents|mesh-ancestor
153898085|NCT00602407|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
153898086|NCT00602407|Protective Agents|protective agents|mesh-ancestor
153898087|NCT00602407|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
153898088|NCT00602407|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
153898089|NCT00602407|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153898092|NCT00950599|Hormones|hormones|mesh-ancestor
153898100|NCT01143207|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
153898101|NCT01143207|Medroxyprogesterone|medroxyprogesterone|mesh-list
153898102|NCT01143207|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
153898103|NCT01143207|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
153898104|NCT01143207|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
153898105|NCT01143207|Contraceptive Agents|contraceptive agents|mesh-ancestor
153898106|NCT01143207|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153898107|NCT01143207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153898108|NCT01143207|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
153898109|NCT01143207|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
153898111|NCT01143207|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153898112|NCT01143207|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153898115|NCT01143051|Epinephryl borate|epinephryl borate|mesh-list
153898116|NCT01143051|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153898117|NCT01143051|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153898118|NCT01143051|Adrenergic Agents|adrenergic agents|mesh-ancestor
153898119|NCT01143051|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153439396|NCT00003421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153439397|NCT00003421|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153439399|NCT00003421|Antimitotic Agents|antimitotic agents|mesh-ancestor
153439400|NCT00003421|Mitosis Modulators|mitosis modulators|mesh-ancestor
153439402|NCT00003421|Glucocorticoids|glucocorticoids|mesh-ancestor
153439403|NCT00003421|Hormones|hormones|mesh-ancestor
153439404|NCT00003421|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153439405|NCT00003421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153439406|NCT00003421|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153439407|NCT00003421|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153439408|NCT00003421|Alkylating Agents|alkylating agents|mesh-ancestor
153439409|NCT00003427|Oxaliplatin|oxaliplatin|mesh-list
153439410|NCT00003427|Irinotecan|irinotecan|mesh-list
153439411|NCT00003427|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153439412|NCT00003427|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
153439413|NCT00003427|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153439414|NCT00003427|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153439415|NCT00003427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153439416|NCT00003439|Interleukin-12|interleukin-12|mesh-list
153439417|NCT00003439|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153439418|NCT00003439|Immunologic Factors|immunologic factors|mesh-ancestor
153439419|NCT00003439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153439420|NCT00003439|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153439421|NCT00003439|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153439422|NCT00003439|Growth Substances|growth substances|mesh-ancestor
153439423|NCT00003439|Growth Inhibitors|growth inhibitors|mesh-ancestor
153439424|NCT00003439|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153439426|NCT00003007|Interferon-alpha|interferon-alpha|mesh-list
153898120|NCT01143051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153898121|NCT01143051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153898123|NCT01143051|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153898124|NCT01143051|Autonomic Agents|autonomic agents|mesh-ancestor
153898125|NCT01143051|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153898126|NCT01143051|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153898127|NCT01143051|Respiratory System Agents|respiratory system agents|mesh-ancestor
153898128|NCT01143051|Mydriatics|mydriatics|mesh-ancestor
153898129|NCT01143051|Sympathomimetics|sympathomimetics|mesh-ancestor
153898130|NCT01143051|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
153898131|NCT05199597|Atropine|atropine|mesh-list
153898138|NCT05199597|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153898139|NCT05199597|Respiratory System Agents|respiratory system agents|mesh-ancestor
153898140|NCT05199597|Mydriatics|mydriatics|mesh-ancestor
153898141|NCT05199597|Parasympatholytics|parasympatholytics|mesh-ancestor
153898142|NCT05199597|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
153898143|NCT05199597|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
153898145|NCT05199597|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153898146|NCT05199597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153898147|NCT01142193|Topiramate|topiramate|mesh-list
153898148|NCT01142193|Anticonvulsants|anticonvulsants|mesh-ancestor
153898149|NCT01142193|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153898150|NCT01142193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153439427|NCT00003007|Dexamethasone|dexamethasone|mesh-list
153439428|NCT00003007|Cyclophosphamide|cyclophosphamide|mesh-list
153439429|NCT00003007|Melphalan|melphalan|mesh-list
153439430|NCT00003007|Sargramostim|sargramostim|mesh-list
153439431|NCT00003007|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153439432|NCT00003007|Immunologic Factors|immunologic factors|mesh-ancestor
153439433|NCT00003007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153439434|NCT00003007|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153439435|NCT00003007|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153439436|NCT00003007|Alkylating Agents|alkylating agents|mesh-ancestor
153439437|NCT00003007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153439438|NCT00003007|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153439439|NCT00003007|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153439440|NCT00003007|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153439441|NCT00003007|Antiemetics|antiemetics|mesh-ancestor
153439442|NCT00003007|Autonomic Agents|autonomic agents|mesh-ancestor
153439443|NCT00003007|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153439444|NCT00003007|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153439445|NCT00003007|Glucocorticoids|glucocorticoids|mesh-ancestor
153439447|NCT00003007|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153439449|NCT00003007|Antiviral Agents|antiviral agents|mesh-ancestor
153439450|NCT00003007|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153439451|NCT01478035|Phenytoin|phenytoin|mesh-list
153439452|NCT01478035|Anticonvulsants|anticonvulsants|mesh-ancestor
153439453|NCT01478035|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
153439454|NCT01478035|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153439455|NCT01478035|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153439456|NCT01478035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153439457|NCT01478035|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
153439458|NCT01478035|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
153439459|NCT00003013|Tamoxifen|tamoxifen|mesh-list
153439460|NCT00003013|Paclitaxel|paclitaxel|mesh-list
153439461|NCT00003013|Cyclophosphamide|cyclophosphamide|mesh-list
153898152|NCT01139775|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153898153|NCT01139775|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153898154|NCT01139775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153898155|NCT01139775|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153898156|NCT01139775|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153898157|NCT01283516|Ceritinib|ceritinib|mesh-list
153898158|NCT01283516|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153898159|NCT01283516|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153898160|NCT01283516|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153898161|NCT01283516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153898162|NCT01283516|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153898163|NCT01283282|Clopidogrel|clopidogrel|mesh-list
153898164|NCT01283282|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153898165|NCT01283282|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
153898166|NCT01283282|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
153898167|NCT01283282|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
153898168|NCT01283282|Purinergic Agents|purinergic agents|mesh-ancestor
153898176|NCT01282814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153898178|NCT01282814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153898179|NCT01282814|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
153898180|NCT01282814|Antidepressive Agents|antidepressive agents|mesh-ancestor
153898181|NCT01282814|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153439462|NCT00003013|Doxorubicin|doxorubicin|mesh-list
153439463|NCT00003013|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
153439464|NCT00003013|Fluorouracil|fluorouracil|mesh-list
153439465|NCT00003013|Methotrexate|methotrexate|mesh-list
153439466|NCT00003013|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153439467|NCT00003013|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153439468|NCT00003013|Tubulin Modulators|tubulin modulators|mesh-ancestor
153439469|NCT00003013|Antimitotic Agents|antimitotic agents|mesh-ancestor
153439472|NCT00003013|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153439473|NCT00003013|Immunologic Factors|immunologic factors|mesh-ancestor
153439474|NCT00003013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153439475|NCT00003013|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153439476|NCT00003013|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153439478|NCT00003013|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153439479|NCT00003013|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153439480|NCT00003013|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153439482|NCT00003013|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153439483|NCT00003013|Antimetabolites|antimetabolites|mesh-ancestor
153439484|NCT00003013|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153898182|NCT00941863|Sorafenib|sorafenib|mesh-list
153898183|NCT00941863|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153898184|NCT00941863|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153898185|NCT00941863|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153898186|NCT00941863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153898187|NCT00602173|Cilostazol|cilostazol|mesh-list
153898188|NCT00602173|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153898189|NCT00602173|Autonomic Agents|autonomic agents|mesh-ancestor
153898190|NCT00602173|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153898191|NCT00602173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153898192|NCT00602173|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153898193|NCT00602173|Respiratory System Agents|respiratory system agents|mesh-ancestor
153898194|NCT00602173|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153898195|NCT00602173|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153898196|NCT00602173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153898197|NCT00602173|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153898198|NCT00602173|Vasodilator Agents|vasodilator agents|mesh-ancestor
153898199|NCT00602173|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
153898202|NCT00602173|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
153898203|NCT00602173|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153439485|NCT00003013|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
153439486|NCT00003013|Abortifacient Agents|abortifacient agents|mesh-ancestor
153439487|NCT00003013|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153439488|NCT00003013|Dermatologic Agents|dermatologic agents|mesh-ancestor
153439490|NCT00003013|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153439491|NCT00003013|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
153439492|NCT00003013|Hormone Antagonists|hormone antagonists|mesh-ancestor
153439493|NCT00003013|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153439494|NCT00003013|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153439495|NCT00003013|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
153439497|NCT00003013|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153439498|NCT00003445|Docetaxel|docetaxel|mesh-list
153439499|NCT00003445|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153439500|NCT00003445|Tubulin Modulators|tubulin modulators|mesh-ancestor
153439501|NCT00003445|Antimitotic Agents|antimitotic agents|mesh-ancestor
153439503|NCT00003445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153439504|NCT00003451|Interferons|interferons|mesh-list
153439505|NCT00003451|Interferon-alpha|interferon-alpha|mesh-list
153439506|NCT00003451|Interleukin-12|interleukin-12|mesh-list
153439507|NCT00003451|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153439509|NCT00003451|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153439510|NCT00003451|Immunologic Factors|immunologic factors|mesh-ancestor
153439511|NCT00003451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153439512|NCT00003451|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153439513|NCT00003451|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153439514|NCT00003451|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153439515|NCT00003451|Growth Substances|growth substances|mesh-ancestor
153898205|NCT02852239|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153898206|NCT02852239|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153898207|NCT02852239|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153898208|NCT02852239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153898209|NCT01282424|Idelalisib|idelalisib|mesh-list
153898210|NCT01282424|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153898211|NCT01282424|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153898212|NCT01282424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153898213|NCT00602251|Terbinafine|terbinafine|mesh-list
153898214|NCT00602251|Antifungal Agents|antifungal agents|mesh-ancestor
153898216|NCT00602251|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153898217|NCT00602251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153898218|NCT01281956|Naluzotan|naluzotan|mesh-list
153898219|NCT01281956|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
153898220|NCT01281956|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
153898221|NCT01281956|Serotonin Agents|serotonin agents|mesh-ancestor
153898222|NCT01281956|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153898223|NCT01281956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153898224|NCT01281956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153898225|NCT00604357|Sirolimus|sirolimus|mesh-list
153898226|NCT00604357|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153898227|NCT00604357|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153898228|NCT00604357|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153898229|NCT00604357|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153898230|NCT00604357|Antifungal Agents|antifungal agents|mesh-ancestor
153898231|NCT00604357|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153898232|NCT00604357|Immunologic Factors|immunologic factors|mesh-ancestor
153898233|NCT00604357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153898234|NCT00602719|Zolpidem|zolpidem|mesh-list
153898235|NCT00602719|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
153898236|NCT00602719|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153898237|NCT00602719|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153898238|NCT00602719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153898239|NCT00602719|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
153898240|NCT00602719|GABA Agonists|gaba agonists|mesh-ancestor
153898241|NCT00602719|GABA Agents|gaba agents|mesh-ancestor
153898242|NCT00602719|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153898243|NCT00602719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153898246|NCT00604435|Endostatins|endostatins|mesh-list
153439528|NCT00003019|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
153439534|NCT00003019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153439535|NCT00003019|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153439536|NCT00003019|Dermatologic Agents|dermatologic agents|mesh-ancestor
153439537|NCT00003019|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153439538|NCT00003019|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153439539|NCT00003019|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153439540|NCT00003019|Immunologic Factors|immunologic factors|mesh-ancestor
153439541|NCT00003019|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153439542|NCT00003019|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153439543|NCT00003019|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153439544|NCT00003019|Tubulin Modulators|tubulin modulators|mesh-ancestor
153439545|NCT00003019|Antimitotic Agents|antimitotic agents|mesh-ancestor
153439546|NCT00003019|Mitosis Modulators|mitosis modulators|mesh-ancestor
153439549|NCT00003493|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
153439550|NCT00003493|Vincristine|vincristine|mesh-list
153439551|NCT00003493|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153439552|NCT00003493|Antiemetics|antiemetics|mesh-ancestor
153439553|NCT00003493|Autonomic Agents|autonomic agents|mesh-ancestor
153439554|NCT00003493|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153439555|NCT00003493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153439556|NCT00003493|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153439557|NCT00003493|Glucocorticoids|glucocorticoids|mesh-ancestor
153439558|NCT00003493|Hormones|hormones|mesh-ancestor
153439559|NCT00003493|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153439560|NCT00003493|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153439561|NCT00003493|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153439562|NCT00003493|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153439563|NCT00003493|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153898247|NCT00604435|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153898248|NCT00604435|Tubulin Modulators|tubulin modulators|mesh-ancestor
153898249|NCT00604435|Antimitotic Agents|antimitotic agents|mesh-ancestor
153898250|NCT00604435|Mitosis Modulators|mitosis modulators|mesh-ancestor
153898251|NCT00604435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153898252|NCT00604435|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153898253|NCT00604435|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153898254|NCT00604435|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153898255|NCT00604435|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153898256|NCT00604435|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153898257|NCT00604435|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153898258|NCT00604435|Growth Substances|growth substances|mesh-ancestor
153898259|NCT00604435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153898260|NCT00604435|Growth Inhibitors|growth inhibitors|mesh-ancestor
153898261|NCT01136967|Lenvatinib|lenvatinib|mesh-list
153898262|NCT01136967|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153898263|NCT01136967|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153898264|NCT01136967|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153898265|NCT01136967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153898267|NCT01218516|Carboplatin|carboplatin|mesh-list
153898269|NCT01218516|Farletuzumab|farletuzumab|mesh-list
153898270|NCT01218516|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153898271|NCT01218516|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153898272|NCT01218516|Tubulin Modulators|tubulin modulators|mesh-ancestor
153898273|NCT01218516|Antimitotic Agents|antimitotic agents|mesh-ancestor
153898274|NCT01218516|Mitosis Modulators|mitosis modulators|mesh-ancestor
153898275|NCT01218516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153898276|NCT01218516|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153898277|NCT01218516|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153898281|NCT00938431|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
153439564|NCT00003493|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153439565|NCT00003493|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153439566|NCT00003493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153439567|NCT00003493|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153439568|NCT00003493|Tubulin Modulators|tubulin modulators|mesh-ancestor
153439573|NCT00003031|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
153439574|NCT00003031|Amphotericin B, deoxycholate drug combination|amphotericin b, deoxycholate drug combination|mesh-list
153439575|NCT00003031|Deoxycholic Acid|deoxycholic acid|mesh-list
153439576|NCT00003031|Antifungal Agents|antifungal agents|mesh-ancestor
153439577|NCT00003031|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153439578|NCT00003031|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
153439579|NCT00003031|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153439580|NCT00003031|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153439581|NCT00003031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153439582|NCT00003031|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153439583|NCT00003031|Hormone Antagonists|hormone antagonists|mesh-ancestor
153439584|NCT00003031|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153439585|NCT00003031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153439586|NCT00003031|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
153439587|NCT00003031|Amebicides|amebicides|mesh-ancestor
153439588|NCT00003031|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153439589|NCT00003031|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153439590|NCT00003031|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153439593|NCT00003517|Leuprolide|leuprolide|mesh-list
153898282|NCT00938431|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153898283|NCT00938431|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153898284|NCT00938431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153898285|NCT05381389|Bupivacaine|bupivacaine|mesh-list
153898286|NCT05381389|Anesthetics, Local|anesthetics, local|mesh-ancestor
153898287|NCT05381389|Anesthetics|anesthetics|mesh-ancestor
153898288|NCT05381389|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153898289|NCT05381389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153898290|NCT05381389|Sensory System Agents|sensory system agents|mesh-ancestor
153898291|NCT05381389|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153898292|NCT00949117|Cyproheptadine|cyproheptadine|mesh-list
153898293|NCT00949117|Antipruritics|antipruritics|mesh-ancestor
153898294|NCT00949117|Dermatologic Agents|dermatologic agents|mesh-ancestor
153898296|NCT00949117|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
153898297|NCT00949117|Histamine Antagonists|histamine antagonists|mesh-ancestor
153898299|NCT00949117|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153898300|NCT00949117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153898301|NCT00949117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153898302|NCT00949117|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153898304|NCT00949117|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
153898305|NCT04312347|Tamoxifen|tamoxifen|mesh-list
153898306|NCT04312347|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
153898307|NCT04312347|Hormone Antagonists|hormone antagonists|mesh-ancestor
153898308|NCT04312347|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153898309|NCT04312347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153898310|NCT04312347|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153898311|NCT04312347|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153898312|NCT04312347|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
153898314|NCT04312347|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153898315|NCT00938041|Tositumomab I-131|tositumomab i-131|mesh-list
153898316|NCT00938041|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153898317|NCT05379283|Lidocaine|lidocaine|mesh-list
153898318|NCT05379283|Anesthetics, Local|anesthetics, local|mesh-ancestor
153898319|NCT05379283|Anesthetics|anesthetics|mesh-ancestor
153898320|NCT05379283|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153898321|NCT05379283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153898322|NCT05379283|Sensory System Agents|sensory system agents|mesh-ancestor
153898323|NCT05379283|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153898324|NCT05379283|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153898325|NCT05379283|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
153439609|NCT00003037|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153439610|NCT00003037|Antimetabolites|antimetabolites|mesh-ancestor
153439611|NCT00003037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153439612|NCT00003037|Tubulin Modulators|tubulin modulators|mesh-ancestor
153439613|NCT00003037|Antimitotic Agents|antimitotic agents|mesh-ancestor
153439614|NCT00003037|Mitosis Modulators|mitosis modulators|mesh-ancestor
153439619|NCT00002803|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153439620|NCT00002803|Immunologic Factors|immunologic factors|mesh-ancestor
153439621|NCT00002803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153439622|NCT00002803|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153439623|NCT00002803|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153439624|NCT00002803|Alkylating Agents|alkylating agents|mesh-ancestor
153439625|NCT00002803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153439626|NCT00002803|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153439627|NCT00002803|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153439628|NCT00002803|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153439629|NCT00002803|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153439630|NCT00002803|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153439631|NCT00002803|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153439632|NCT00002803|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153439633|NCT00002803|Tubulin Modulators|tubulin modulators|mesh-ancestor
153439634|NCT00002803|Antimitotic Agents|antimitotic agents|mesh-ancestor
153439635|NCT00002803|Mitosis Modulators|mitosis modulators|mesh-ancestor
153439636|NCT00383929|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
153439637|NCT00383929|Candesartan|candesartan|mesh-list
153898326|NCT05379283|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153898327|NCT05379283|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153898328|NCT05379283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153898329|NCT01218438|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
153898330|NCT01218438|Immunoglobulins|immunoglobulins|mesh-list
153898331|NCT01218438|Antibodies|antibodies|mesh-list
153898332|NCT01218438|gamma-Globulins|gamma-globulins|mesh-list
153898333|NCT01218438|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
153898334|NCT01218438|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
153898335|NCT01218438|Immunoglobulin G|immunoglobulin g|mesh-list
153898336|NCT01218438|Immunologic Factors|immunologic factors|mesh-ancestor
153898337|NCT01218438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153898339|NCT00604591|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
153898340|NCT00604591|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
153898341|NCT00604591|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
153898342|NCT00604591|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153898347|NCT02691156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153898348|NCT02691156|Gasotransmitters|gasotransmitters|mesh-ancestor
153898349|NCT02691156|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153898350|NCT02691156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153898351|NCT02691156|Antioxidants|antioxidants|mesh-ancestor
153898352|NCT02691156|Protective Agents|protective agents|mesh-ancestor
153898353|NCT00603031|Glucagon|glucagon|mesh-list
153898354|NCT00603031|Gastric Inhibitory Polypeptide|gastric inhibitory polypeptide|mesh-list
153898355|NCT00603031|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153898356|NCT00603031|Hormones|hormones|mesh-ancestor
153898357|NCT00603031|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153898358|NCT00603031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153898359|NCT00603031|Incretins|incretins|mesh-ancestor
153898360|NCT05379049|Adalimumab|adalimumab|mesh-list
153898361|NCT05379049|Infliximab|infliximab|mesh-list
153898362|NCT05379049|Etanercept|etanercept|mesh-list
153898363|NCT05379049|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
153898364|NCT05379049|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153898365|NCT05379049|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153898366|NCT05379049|Dermatologic Agents|dermatologic agents|mesh-ancestor
153898367|NCT05379049|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153898368|NCT05379049|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153898369|NCT05379049|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153898370|NCT05379049|Analgesics|analgesics|mesh-ancestor
153898371|NCT05379049|Sensory System Agents|sensory system agents|mesh-ancestor
153439656|NCT00003541|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153439657|NCT00003541|Immunologic Factors|immunologic factors|mesh-ancestor
153439658|NCT00003541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153439660|NCT00003541|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153439661|NCT00003541|Alkylating Agents|alkylating agents|mesh-ancestor
153439662|NCT00003541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153439663|NCT00003541|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153439664|NCT00003541|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153439665|NCT00003541|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153439666|NCT00003541|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153439667|NCT00003541|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153439668|NCT00003541|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153439669|NCT00003541|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153439670|NCT00003541|Glucocorticoids|glucocorticoids|mesh-ancestor
153439671|NCT00003541|Hormones|hormones|mesh-ancestor
153439672|NCT00003541|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153439673|NCT00003541|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153439674|NCT00003541|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153439675|NCT00003541|Tubulin Modulators|tubulin modulators|mesh-ancestor
153439676|NCT00003541|Antimitotic Agents|antimitotic agents|mesh-ancestor
153439677|NCT00003541|Mitosis Modulators|mitosis modulators|mesh-ancestor
153439678|NCT00002809|Cyclophosphamide|cyclophosphamide|mesh-list
153439679|NCT00002809|Methotrexate|methotrexate|mesh-list
153439680|NCT00002809|Tacrolimus|tacrolimus|mesh-list
153439681|NCT00002809|Antilymphocyte Serum|antilymphocyte serum|mesh-list
153439682|NCT00002809|Sargramostim|sargramostim|mesh-list
153439683|NCT00002809|Immunoglobulins|immunoglobulins|mesh-list
153439684|NCT00002809|Antibodies|antibodies|mesh-list
153439685|NCT00002809|gamma-Globulins|gamma-globulins|mesh-list
153439686|NCT00002809|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
153439687|NCT00002809|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
153898372|NCT05379049|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153898373|NCT05379049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153898374|NCT05379049|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153898375|NCT05379049|Immunologic Factors|immunologic factors|mesh-ancestor
153439688|NCT00002809|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153439689|NCT00002809|Immunologic Factors|immunologic factors|mesh-ancestor
153439690|NCT00002809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153898377|NCT02851459|Immunologic Factors|immunologic factors|mesh-ancestor
153898378|NCT02851459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153898379|NCT00603343|Propiverine|propiverine|mesh-list
153898380|NCT00603343|Parasympatholytics|parasympatholytics|mesh-ancestor
153898381|NCT00603343|Autonomic Agents|autonomic agents|mesh-ancestor
153898382|NCT00603343|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153898383|NCT00603343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153898384|NCT00603343|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
153898385|NCT00603343|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
153898386|NCT00603343|Cholinergic Agents|cholinergic agents|mesh-ancestor
153898387|NCT00603343|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153898388|NCT00603343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153898389|NCT00603343|Urological Agents|urological agents|mesh-ancestor
153898390|NCT01277510|Cinacalcet|cinacalcet|mesh-list
153898391|NCT01277510|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153898392|NCT01277510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153898393|NCT01277510|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
153898394|NCT01277510|Hormone Antagonists|hormone antagonists|mesh-ancestor
153898395|NCT01277510|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153898396|NCT00937495|Bortezomib|bortezomib|mesh-list
153898397|NCT00937495|Vorinostat|vorinostat|mesh-list
153898398|NCT00937495|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153898399|NCT00937495|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
153898400|NCT00937495|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153898401|NCT00937495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153898402|NCT04265833|Calcium|calcium|mesh-list
153898403|NCT04265833|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153898404|NCT04265833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153898405|NCT00606541|Quetiapine Fumarate|quetiapine fumarate|mesh-list
153898406|NCT00606541|Antidepressive Agents|antidepressive agents|mesh-ancestor
153898408|NCT00606541|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153898409|NCT00606541|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153439695|NCT00002809|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153439696|NCT00002809|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153439697|NCT00002809|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
153439698|NCT00002809|Abortifacient Agents|abortifacient agents|mesh-ancestor
153439699|NCT00002809|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153439700|NCT00002809|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153439702|NCT00002809|Dermatologic Agents|dermatologic agents|mesh-ancestor
153439703|NCT00002809|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153439704|NCT00002809|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153439705|NCT00002809|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153439706|NCT00002809|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
153439708|NCT00383539|Immunologic Factors|immunologic factors|mesh-ancestor
153439709|NCT00383539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153439713|NCT00002827|Bleomycin|bleomycin|mesh-list
153439714|NCT00002827|Etoposide|etoposide|mesh-list
153439715|NCT00002827|Dexrazoxane|dexrazoxane|mesh-list
153898410|NCT00606541|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153898411|NCT00606541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153898412|NCT00936715|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
153898413|NCT00936715|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153898414|NCT00936715|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153898415|NCT00936715|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153898416|NCT00936715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153898417|NCT00936715|Antiviral Agents|antiviral agents|mesh-ancestor
153898418|NCT00936715|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153898419|NCT00936715|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153898420|NCT00936715|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153898421|NCT05378191|Vaccines|vaccines|mesh-list
153898422|NCT05378191|Immunologic Factors|immunologic factors|mesh-ancestor
153898423|NCT05378191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153898424|NCT00605137|Insulin|insulin|mesh-list
153898425|NCT00605137|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
153898426|NCT00605137|Insulin Detemir|insulin detemir|mesh-list
153898427|NCT00605137|Isophane Insulin, Human|isophane insulin, human|mesh-list
153898428|NCT00605137|Insulin, Isophane|insulin, isophane|mesh-list
153898429|NCT00605137|Isophane insulin, beef|isophane insulin, beef|mesh-list
153898430|NCT00605137|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153898431|NCT00605137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153898434|NCT00606775|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
153898435|NCT00606775|Adrenergic Agents|adrenergic agents|mesh-ancestor
153898436|NCT00606775|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153898437|NCT00606775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153898438|NCT00606775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153898439|NCT00606775|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153898440|NCT00606775|Antioxidants|antioxidants|mesh-ancestor
153898441|NCT00606775|Protective Agents|protective agents|mesh-ancestor
153439716|NCT00002827|Vincristine|vincristine|mesh-list
153439717|NCT00002827|Razoxane|razoxane|mesh-list
153439718|NCT00002827|Lenograstim|lenograstim|mesh-list
153898442|NCT00606775|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153898443|NCT00606775|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153898444|NCT00606775|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153898445|NCT00606775|Vasodilator Agents|vasodilator agents|mesh-ancestor
153898446|NCT00606775|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
153898447|NCT00606775|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
153898448|NCT00605371|Lamotrigine|lamotrigine|mesh-list
153898449|NCT00605371|Anticonvulsants|anticonvulsants|mesh-list
153898450|NCT00605371|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153898451|NCT00605371|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153898452|NCT00605371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153898453|NCT00605371|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153898454|NCT00605371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153898456|NCT00605371|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153898457|NCT00605371|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153898458|NCT00605371|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153898459|NCT00605371|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153439751|NCT00003049|Levoleucovorin|levoleucovorin|mesh-list
153439752|NCT00003049|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153439753|NCT00003049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153439754|NCT00003049|Antimetabolites|antimetabolites|mesh-ancestor
153439755|NCT00003049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153439756|NCT00003049|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153439757|NCT00003049|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153439758|NCT00003049|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153439760|NCT00003049|Antidotes|antidotes|mesh-ancestor
153439761|NCT00003049|Protective Agents|protective agents|mesh-ancestor
153439762|NCT00003049|Vitamin B Complex|vitamin b complex|mesh-ancestor
153439764|NCT00003049|Micronutrients|micronutrients|mesh-ancestor
153439765|NCT00003055|Irinotecan|irinotecan|mesh-list
153439766|NCT00003055|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153439767|NCT00003055|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
153439768|NCT00003055|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153439769|NCT00003055|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153439784|NCT00002833|Prednisolone phosphate|prednisolone phosphate|mesh-list
153898460|NCT01267994|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
153898461|NCT01267994|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153898462|NCT02850913|Doxycycline|doxycycline|mesh-list
153898463|NCT02850913|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153898464|NCT02850913|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153898465|NCT02850913|Antimalarials|antimalarials|mesh-ancestor
153439785|NCT00002833|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153439786|NCT00002833|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153439787|NCT00002833|Antimetabolites|antimetabolites|mesh-ancestor
153439789|NCT00002833|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153898466|NCT02850913|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153898467|NCT02850913|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153898468|NCT00934843|Methylprednisolone|methylprednisolone|mesh-list
153898469|NCT00934843|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
153898470|NCT00934843|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
153898471|NCT00934843|Prednisolone|prednisolone|mesh-list
153898472|NCT00934843|Prednisolone acetate|prednisolone acetate|mesh-list
153898473|NCT00934843|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
153898474|NCT00934843|Prednisolone phosphate|prednisolone phosphate|mesh-list
153898475|NCT00934843|Glucocorticoids|glucocorticoids|mesh-list
153898476|NCT00934843|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153898478|NCT00934843|Autonomic Agents|autonomic agents|mesh-ancestor
153898479|NCT00934843|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153898480|NCT00934843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153898481|NCT00934843|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153898482|NCT00934843|Hormones|hormones|mesh-ancestor
153898483|NCT00934843|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153898484|NCT00934843|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
153898486|NCT00934843|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153898487|NCT00934843|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153898488|NCT00605605|Levomethorphan|levomethorphan|mesh-list
153898489|NCT00605605|Dextromethorphan|dextromethorphan|mesh-list
153898490|NCT00605605|Antitussive Agents|antitussive agents|mesh-ancestor
153898491|NCT00605605|Respiratory System Agents|respiratory system agents|mesh-ancestor
153898492|NCT00605605|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
153898493|NCT00605605|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
153898494|NCT00605605|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153898495|NCT00605605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153898496|NCT00605605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153898497|NCT00605605|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153898498|NCT00605605|Narcotics|narcotics|mesh-ancestor
153475896|NCT00848016|Spermatocidal Agents|spermatocidal agents|mesh-ancestor
153475897|NCT00848016|Antispermatogenic Agents|antispermatogenic agents|mesh-ancestor
153475899|NCT00849810|Nebivolol|nebivolol|mesh-list
153475900|NCT00849810|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153475901|NCT00849810|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153475902|NCT00849810|Sympatholytics|sympatholytics|mesh-ancestor
153475903|NCT00849810|Autonomic Agents|autonomic agents|mesh-ancestor
153475904|NCT00849810|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153475905|NCT00849810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153475906|NCT00849810|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
153475907|NCT00849810|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
153475908|NCT00849810|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
153475909|NCT00849810|Adrenergic Agents|adrenergic agents|mesh-ancestor
153475910|NCT00849810|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153475911|NCT00849810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153475912|NCT00849810|Vasodilator Agents|vasodilator agents|mesh-ancestor
153475913|NCT00849810|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
153475914|NCT00849810|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
153475915|NCT00849810|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153475916|NCT00856050|Letrozole|letrozole|mesh-list
153475917|NCT00856050|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153475918|NCT00856050|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
153475919|NCT00856050|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153475920|NCT00856050|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153475921|NCT00856050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153475922|NCT00856050|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
153475923|NCT00856050|Hormone Antagonists|hormone antagonists|mesh-ancestor
153475924|NCT00856050|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153475925|NCT00856050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153475926|NCT00858468|Vaccines|vaccines|mesh-list
153475927|NCT00858468|Immunologic Factors|immunologic factors|mesh-ancestor
153475928|NCT00858468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153475929|NCT00858858|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
153475930|NCT00858858|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
153475931|NCT00858858|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153475932|NCT00866034|Cetrorelix|cetrorelix|mesh-list
153475933|NCT00866034|Fertility Agents, Female|fertility agents, female|mesh-ancestor
153475935|NCT00866034|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153475936|NCT00866034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153475937|NCT00866034|Hormone Antagonists|hormone antagonists|mesh-ancestor
153475938|NCT00866034|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153475940|NCT00868140|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153475941|NCT00868140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153475942|NCT00868374|Quetiapine Fumarate|quetiapine fumarate|mesh-list
153475943|NCT00868374|Antidepressive Agents|antidepressive agents|mesh-ancestor
153475944|NCT00868374|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153475945|NCT00868374|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153475946|NCT00868374|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153475947|NCT00868374|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153475948|NCT00868374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153475964|NCT00868452|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
153475965|NCT00868452|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
153475966|NCT00868452|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
153475967|NCT00868452|Adrenergic Agents|adrenergic agents|mesh-ancestor
153475968|NCT00868452|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
153475969|NCT00868452|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153475970|NCT00868452|Serotonin Agents|serotonin agents|mesh-ancestor
153475971|NCT00868452|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
153475972|NCT00868452|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
153475973|NCT00868452|Dopamine Agents|dopamine agents|mesh-ancestor
153475975|NCT00869622|Risedronic Acid|risedronic acid|mesh-list
153475976|NCT00869622|Calcium|calcium|mesh-list
153475977|NCT00869622|Vitamins|vitamins|mesh-ancestor
153475978|NCT00869622|Micronutrients|micronutrients|mesh-ancestor
153475979|NCT00869622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153475980|NCT00869622|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153475981|NCT00869622|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153475982|NCT00869622|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153475983|NCT00869622|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153475984|NCT00869622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153475985|NCT00871260|Regadenoson|regadenoson|mesh-list
153475986|NCT00871260|Adenosine A2 Receptor Agonists|adenosine a2 receptor agonists|mesh-ancestor
153475987|NCT00871260|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
153475988|NCT00871260|Purinergic Agonists|purinergic agonists|mesh-ancestor
153475989|NCT00871260|Purinergic Agents|purinergic agents|mesh-ancestor
153475990|NCT00871260|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153475991|NCT00871260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153475992|NCT00871260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153475993|NCT00874614|3-Iodobenzylguanidine|3-iodobenzylguanidine|mesh-list
153475994|NCT00874614|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153475995|NCT00874614|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153475996|NCT00874614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153475997|NCT00874614|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
153475998|NCT00875550|Midazolam|midazolam|mesh-list
153475999|NCT00875550|Fentanyl|fentanyl|mesh-list
153476000|NCT00875550|Dexmedetomidine|dexmedetomidine|mesh-list
153476001|NCT00875550|Morphine|morphine|mesh-list
153476002|NCT00875550|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153476003|NCT00875550|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153476004|NCT00875550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153476017|NCT00875550|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153476018|NCT00875550|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153476019|NCT00875550|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153476020|NCT00875550|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153476021|NCT00875550|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153476092|NCT00887562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153476094|NCT00887640|Diphenhydramine|diphenhydramine|mesh-list
153476095|NCT00887640|Promethazine|promethazine|mesh-list
153476096|NCT00887640|Sirolimus|sirolimus|mesh-list
153476097|NCT00887640|Temsirolimus|temsirolimus|mesh-list
153476098|NCT00887640|MTOR Inhibitors|mtor inhibitors|mesh-list
153476099|NCT00887640|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153476100|NCT00887640|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153476101|NCT00887640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153476102|NCT00887640|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153476103|NCT00887640|Immunologic Factors|immunologic factors|mesh-ancestor
153476104|NCT00887640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153476105|NCT00887640|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153476106|NCT00887640|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153476108|NCT00887640|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153476109|NCT00887640|Antifungal Agents|antifungal agents|mesh-ancestor
153476110|NCT00887640|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
153476111|NCT00887640|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153476112|NCT00887640|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153476113|NCT00887640|Anesthetics, Local|anesthetics, local|mesh-ancestor
153476114|NCT00887640|Anesthetics|anesthetics|mesh-ancestor
153476115|NCT00887640|Sensory System Agents|sensory system agents|mesh-ancestor
153476116|NCT00887640|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153476119|NCT00887640|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153476120|NCT00887640|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
153476121|NCT00887640|Histamine Antagonists|histamine antagonists|mesh-ancestor
153476122|NCT00887640|Histamine Agents|histamine agents|mesh-ancestor
153476123|NCT00887640|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153476124|NCT00887640|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
153476125|NCT00887640|Antipruritics|antipruritics|mesh-ancestor
153476177|NCT00899574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153476178|NCT00899574|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153476179|NCT00899574|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153476181|NCT00900666|Botulinum Toxins|botulinum toxins|mesh-list
153476182|NCT00900666|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
153476183|NCT00900666|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
153476184|NCT00900666|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
153476185|NCT00900666|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153476186|NCT00900666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153476233|NCT00905580|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153476234|NCT00905580|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153476235|NCT00905580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153476236|NCT00905580|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153476305|NCT00923910|Sensory System Agents|sensory system agents|mesh-ancestor
153476306|NCT00923910|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153476307|NCT00923910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153476308|NCT00923910|Antipyretics|antipyretics|mesh-ancestor
153476309|NCT00923910|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
153476310|NCT00923910|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153476311|NCT00923910|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153476312|NCT00923910|Anesthetics, Local|anesthetics, local|mesh-ancestor
153476313|NCT00923910|Anesthetics|anesthetics|mesh-ancestor
153476314|NCT00923910|Antiemetics|antiemetics|mesh-ancestor
153476315|NCT00923910|Autonomic Agents|autonomic agents|mesh-ancestor
153476316|NCT00923910|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153476317|NCT00923910|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
153476318|NCT00923910|Histamine Antagonists|histamine antagonists|mesh-ancestor
153476319|NCT00923910|Histamine Agents|histamine agents|mesh-ancestor
153476320|NCT00923910|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153476321|NCT00923910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153476362|NCT00925938|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153476364|NCT00926952|Methyl 5-aminolevulinate|methyl 5-aminolevulinate|mesh-list
153476365|NCT00926952|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
153476366|NCT00926952|Dermatologic Agents|dermatologic agents|mesh-ancestor
153476367|NCT00927888|Bupivacaine|bupivacaine|mesh-list
153476368|NCT00927888|Anesthetics, Local|anesthetics, local|mesh-ancestor
153476369|NCT00927888|Anesthetics|anesthetics|mesh-ancestor
153476370|NCT00927888|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153476371|NCT00927888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153476372|NCT00927888|Sensory System Agents|sensory system agents|mesh-ancestor
153476385|NCT00928200|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153476386|NCT00928200|Antiemetics|antiemetics|mesh-ancestor
153476387|NCT00928200|Autonomic Agents|autonomic agents|mesh-ancestor
153476388|NCT00928200|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153476389|NCT00928200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153476390|NCT00928200|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153476391|NCT00928200|Glucocorticoids|glucocorticoids|mesh-ancestor
153476392|NCT00928200|Hormones|hormones|mesh-ancestor
153476393|NCT00928200|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153476394|NCT00928200|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153476395|NCT00928200|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153476396|NCT00928200|Protease Inhibitors|protease inhibitors|mesh-ancestor
153476397|NCT00928200|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153476398|NCT00928200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153476403|NCT00928200|Abortifacient Agents|abortifacient agents|mesh-ancestor
153476404|NCT00928200|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153476405|NCT00928200|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153476406|NCT00928200|Antimetabolites|antimetabolites|mesh-ancestor
153476407|NCT00928200|Dermatologic Agents|dermatologic agents|mesh-ancestor
153476408|NCT00928200|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153476409|NCT00928200|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153476410|NCT00928200|Immunologic Factors|immunologic factors|mesh-ancestor
153476411|NCT00928200|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153476412|NCT00928200|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153476414|NCT00928200|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153476416|NCT00928200|Tubulin Modulators|tubulin modulators|mesh-ancestor
153476467|NCT00935064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153476468|NCT00939120|Tolterodine Tartrate|tolterodine tartrate|mesh-list
153476469|NCT00939120|Dutasteride|dutasteride|mesh-list
153476470|NCT00939120|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
153476471|NCT00939120|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153476472|NCT00939120|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153476473|NCT00939120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153476474|NCT00939120|Hormone Antagonists|hormone antagonists|mesh-ancestor
153476475|NCT00939120|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153476476|NCT00939120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153476477|NCT00939120|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
153476478|NCT00939120|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
153476479|NCT00939120|Cholinergic Agents|cholinergic agents|mesh-ancestor
153476480|NCT00939120|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153476481|NCT00939120|Urological Agents|urological agents|mesh-ancestor
153476482|NCT00939900|Zoledronic Acid|zoledronic acid|mesh-list
153476483|NCT00939900|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153476484|NCT00939900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153476485|NCT00943098|Diclofenac|diclofenac|mesh-list
153476486|NCT00943098|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153476487|NCT00943098|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153476488|NCT00943098|Analgesics|analgesics|mesh-ancestor
153476489|NCT00943098|Sensory System Agents|sensory system agents|mesh-ancestor
153476490|NCT00943098|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153476491|NCT00943098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153476515|NCT00943800|Alkylating Agents|alkylating agents|mesh-ancestor
153476516|NCT00943800|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153476517|NCT00943878|Vaccines|vaccines|mesh-list
153476533|NCT00945750|Famotidine|famotidine|mesh-list
153476534|NCT00945750|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
153476535|NCT00945750|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153476536|NCT00945750|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
153476537|NCT00945750|Histamine Antagonists|histamine antagonists|mesh-ancestor
153476567|NCT00953862|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
153476568|NCT00953862|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
153476569|NCT00953862|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153476570|NCT00953862|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153476571|NCT00953862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153476572|NCT00953862|Adrenergic Agents|adrenergic agents|mesh-ancestor
153476573|NCT00953862|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153476574|NCT00953862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153476575|NCT00955266|Calcium|calcium|mesh-list
153476576|NCT00955266|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153476631|NCT00973752|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
153476632|NCT00973752|Abortifacient Agents|abortifacient agents|mesh-ancestor
153476633|NCT00973752|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153476704|NCT00986856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153476705|NCT00987480|Cyclosporine|cyclosporine|mesh-list
153476706|NCT00987480|Cyclophosphamide|cyclophosphamide|mesh-list
153476707|NCT00987480|Busulfan|busulfan|mesh-list
153476708|NCT00987480|Fludarabine|fludarabine|mesh-list
153476709|NCT00987480|Cyclosporins|cyclosporins|mesh-list
153476710|NCT00987480|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153476711|NCT00987480|Immunologic Factors|immunologic factors|mesh-ancestor
153476712|NCT00987480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153476713|NCT00987480|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153476714|NCT00987480|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153476770|NCT00991458|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
153476771|NCT00993798|Bupivacaine|bupivacaine|mesh-list
153476772|NCT00993798|Anesthetics, Local|anesthetics, local|mesh-ancestor
153476773|NCT00993798|Anesthetics|anesthetics|mesh-ancestor
153476774|NCT00993798|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153476775|NCT00993798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153476776|NCT00993798|Sensory System Agents|sensory system agents|mesh-ancestor
153476777|NCT00993798|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153476778|NCT00997620|Fluticasone|fluticasone|mesh-list
153476780|NCT00997620|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153476781|NCT00997620|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153476782|NCT00997620|Autonomic Agents|autonomic agents|mesh-ancestor
153476783|NCT00997620|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153476784|NCT00997620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153476785|NCT00997620|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153476838|NCT01000818|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153476839|NCT01000818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153476841|NCT01001052|Gout Suppressants|gout suppressants|mesh-ancestor
153476855|NCT01003938|Topotecan|topotecan|mesh-list
153476892|NCT01005810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153476894|NCT01005888|Complement C1s|complement c1s|mesh-list
153476895|NCT01005888|Complement C1 Inhibitor Protein|complement c1 inhibitor protein|mesh-list
153476896|NCT01005888|Complement C1 Inactivator Proteins|complement c1 inactivator proteins|mesh-list
153476897|NCT01005888|Immunologic Factors|immunologic factors|mesh-ancestor
153476898|NCT01005888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153476899|NCT01005888|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
153476900|NCT01005888|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153476901|NCT01007994|Propranolol|propranolol|mesh-list
153476902|NCT01007994|Enalapril|enalapril|mesh-list
153476903|NCT01007994|Isradipine|isradipine|mesh-list
153476904|NCT01007994|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
153476905|NCT01007994|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
153476906|NCT01007994|Adrenergic Agents|adrenergic agents|mesh-ancestor
153476907|NCT01007994|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153476908|NCT01007994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153476909|NCT01007994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153476910|NCT01007994|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153476911|NCT01007994|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153476912|NCT01007994|Vasodilator Agents|vasodilator agents|mesh-ancestor
153476913|NCT01007994|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
153476914|NCT01007994|Protease Inhibitors|protease inhibitors|mesh-ancestor
153476915|NCT01007994|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153476916|NCT01007994|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153476917|NCT01007994|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153476919|NCT01008462|Cytarabine|cytarabine|mesh-list
153476941|NCT01008462|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153476942|NCT01008462|Antimetabolites|antimetabolites|mesh-ancestor
153476943|NCT01008462|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153476944|NCT01008462|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153476945|NCT01008462|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153476946|NCT01008462|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153476947|NCT01008462|Antiviral Agents|antiviral agents|mesh-ancestor
153476948|NCT01008462|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153476949|NCT01008462|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
153476950|NCT01008462|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153476951|NCT01008462|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
153476952|NCT01008462|Antitubercular Agents|antitubercular agents|mesh-ancestor
153476953|NCT01008462|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153476954|NCT01008462|Keratolytic Agents|keratolytic agents|mesh-ancestor
153476955|NCT01008462|Dermatologic Agents|dermatologic agents|mesh-ancestor
153476956|NCT01008462|Tubulin Modulators|tubulin modulators|mesh-ancestor
153476957|NCT01008462|Antimitotic Agents|antimitotic agents|mesh-ancestor
153476998|NCT01017042|Gout Suppressants|gout suppressants|mesh-ancestor
153476999|NCT01017042|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153477002|NCT01017042|Mitosis Modulators|mitosis modulators|mesh-ancestor
153477067|NCT02406222|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153477069|NCT02406222|Growth Inhibitors|growth inhibitors|mesh-ancestor
153477070|NCT00458796|Zoledronic Acid|zoledronic acid|mesh-list
153477071|NCT00458796|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153477072|NCT00458796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153477073|NCT01022190|Etoricoxib|etoricoxib|mesh-list
153477074|NCT01022190|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153477075|NCT01022190|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153477076|NCT01022190|Analgesics|analgesics|mesh-ancestor
153477077|NCT01022190|Sensory System Agents|sensory system agents|mesh-ancestor
153477078|NCT01022190|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153477079|NCT01022190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153477080|NCT01022190|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153477081|NCT01022190|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153477082|NCT01022190|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
153477083|NCT01022190|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153477084|NCT01022190|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153477085|NCT01022190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153477087|NCT01024686|Immunologic Factors|immunologic factors|mesh-ancestor
153477088|NCT01024686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153477089|NCT01027806|Montelukast|montelukast|mesh-list
153477090|NCT01027806|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153477091|NCT01027806|Respiratory System Agents|respiratory system agents|mesh-ancestor
153477092|NCT01027806|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
153477093|NCT01027806|Hormone Antagonists|hormone antagonists|mesh-ancestor
153477094|NCT01027806|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153477095|NCT01027806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153477096|NCT01027806|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
153477097|NCT01027806|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
153477098|NCT01027806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153477099|NCT01029054|Dexamethasone|dexamethasone|mesh-list
153477101|NCT01029054|Lenalidomide|lenalidomide|mesh-list
153477154|NCT01842672|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153477155|NCT01842672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153477156|NCT01842672|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153477157|NCT01842672|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153477158|NCT01842672|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153477159|NCT01842672|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153477222|NCT01045122|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153477223|NCT01045122|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
153477349|NCT05821192|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153477350|NCT05821192|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153477351|NCT05821192|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153477417|NCT05796570|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153477418|NCT05796570|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153477419|NCT06024031|Acetylcysteine|acetylcysteine|mesh-list
153477420|NCT06024031|N-monoacetylcystine|n-monoacetylcystine|mesh-list
153477421|NCT06024031|Antiviral Agents|antiviral agents|mesh-ancestor
153477422|NCT06024031|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153477423|NCT06024031|Expectorants|expectorants|mesh-ancestor
153477424|NCT06024031|Respiratory System Agents|respiratory system agents|mesh-ancestor
153477425|NCT06024031|Free Radical Scavengers|free radical scavengers|mesh-ancestor
153477426|NCT06024031|Antioxidants|antioxidants|mesh-ancestor
153477427|NCT06024031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153477428|NCT06024031|Protective Agents|protective agents|mesh-ancestor
153477430|NCT06024031|Antidotes|antidotes|mesh-ancestor
153477527|NCT05581823|Carbamazepine|carbamazepine|mesh-list
153477528|NCT05581823|Anticonvulsants|anticonvulsants|mesh-ancestor
153477529|NCT05581823|Antimanic Agents|antimanic agents|mesh-ancestor
153477530|NCT05581823|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153477531|NCT05581823|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153477532|NCT05581823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153477533|NCT05581823|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153477534|NCT05581823|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153477535|NCT05581823|Analgesics|analgesics|mesh-ancestor
153477536|NCT05581823|Sensory System Agents|sensory system agents|mesh-ancestor
153477547|NCT05498116|Hormone Antagonists|hormone antagonists|mesh-ancestor
153477548|NCT05498116|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153477625|NCT05175547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153477626|NCT05175547|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153477627|NCT05175547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153477629|NCT04924166|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153477630|NCT04908371|Lidocaine|lidocaine|mesh-list
153477631|NCT04908371|Epinephrine|epinephrine|mesh-list
153477632|NCT04908371|Racepinephrine|racepinephrine|mesh-list
153477633|NCT04908371|Levobupivacaine|levobupivacaine|mesh-list
153477634|NCT04908371|Epinephryl borate|epinephryl borate|mesh-list
153477635|NCT04908371|Anesthetics, Local|anesthetics, local|mesh-ancestor
153477636|NCT04908371|Anesthetics|anesthetics|mesh-ancestor
153477637|NCT04908371|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153477638|NCT04908371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153477639|NCT04908371|Sensory System Agents|sensory system agents|mesh-ancestor
153477640|NCT04908371|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153477641|NCT04908371|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153477642|NCT04908371|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
153477643|NCT04908371|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153477644|NCT04908371|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153477646|NCT04908371|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153477652|NCT04908371|Autonomic Agents|autonomic agents|mesh-ancestor
153477653|NCT04908371|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153477654|NCT04908371|Respiratory System Agents|respiratory system agents|mesh-ancestor
153477656|NCT04908371|Sympathomimetics|sympathomimetics|mesh-ancestor
153477657|NCT04908371|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
153477658|NCT04838379|Dexamethasone|dexamethasone|mesh-list
153477659|NCT04838379|Dexmedetomidine|dexmedetomidine|mesh-list
153477720|NCT04761159|Sensory System Agents|sensory system agents|mesh-ancestor
153477721|NCT04761159|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153477722|NCT04761159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153477723|NCT04761159|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
153477724|NCT04761159|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153477725|NCT04761159|Anesthetics, General|anesthetics, general|mesh-ancestor
153477726|NCT04761159|Anesthetics|anesthetics|mesh-ancestor
153477727|NCT04761159|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153477777|NCT04652661|GABA Agents|gaba agents|mesh-ancestor
153477837|NCT04148105|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153477838|NCT04148105|Vasodilator Agents|vasodilator agents|mesh-ancestor
153477839|NCT04148105|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
153477840|NCT04148105|Protective Agents|protective agents|mesh-ancestor
153477841|NCT04148105|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
153477842|NCT04148105|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
153477843|NCT04148105|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153477844|NCT04067518|Pegaspargase|pegaspargase|mesh-list
153477845|NCT04067518|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153477847|NCT04033419|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
153477848|NCT04033419|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
153477901|NCT03636451|Natriuretic Agents|natriuretic agents|mesh-ancestor
153477902|NCT03576989|Mineral Oil|mineral oil|mesh-list
153477903|NCT03576989|Emollients|emollients|mesh-ancestor
153477904|NCT03576989|Dermatologic Agents|dermatologic agents|mesh-ancestor
153477915|NCT03278691|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153477916|NCT03278691|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153477917|NCT03278691|Analgesics|analgesics|mesh-ancestor
153477918|NCT03278691|Sensory System Agents|sensory system agents|mesh-ancestor
153477919|NCT03278691|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153477959|NCT01995344|Sensory System Agents|sensory system agents|mesh-ancestor
153477960|NCT01995344|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153477961|NCT01845688|Losartan|losartan|mesh-list
153477962|NCT01845688|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153477963|NCT01845688|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153477964|NCT01845688|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
153477965|NCT01845688|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
153477966|NCT01845688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153477967|NCT01591291|Ondansetron|ondansetron|mesh-list
153477968|NCT01591291|Antiemetics|antiemetics|mesh-ancestor
153477969|NCT01591291|Autonomic Agents|autonomic agents|mesh-ancestor
153477970|NCT01591291|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153477971|NCT01591291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153477972|NCT01591291|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153477973|NCT01591291|Antipruritics|antipruritics|mesh-ancestor
153477974|NCT01591291|Dermatologic Agents|dermatologic agents|mesh-ancestor
153477975|NCT01591291|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
153477976|NCT01591291|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153478016|NCT01060020|Sildenafil Citrate|sildenafil citrate|mesh-list
153478017|NCT01060020|Vasodilator Agents|vasodilator agents|mesh-ancestor
153478018|NCT01060020|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
153478019|NCT01060020|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
153478159|NCT01096680|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
153478160|NCT01096680|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153478163|NCT01096680|Dopamine Agents|dopamine agents|mesh-ancestor
153478217|NCT01100268|Dopamine Agents|dopamine agents|mesh-ancestor
153478218|NCT01100268|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153478219|NCT01101750|Vaccines|vaccines|mesh-list
153478220|NCT01101750|Immunologic Factors|immunologic factors|mesh-ancestor
153478221|NCT01101750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153478222|NCT01102218|Pentoxifylline|pentoxifylline|mesh-list
153478223|NCT01102218|Epoetin Alfa|epoetin alfa|mesh-list
153478224|NCT01102218|Hematinics|hematinics|mesh-ancestor
153478225|NCT01102218|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
153478226|NCT01102218|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153478227|NCT01102218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153478228|NCT01102218|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153478229|NCT01102218|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
153478230|NCT01102218|Protective Agents|protective agents|mesh-ancestor
153478232|NCT01102218|Vasodilator Agents|vasodilator agents|mesh-ancestor
153478281|NCT01105650|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153478282|NCT01105650|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153478283|NCT01105650|Glucocorticoids|glucocorticoids|mesh-ancestor
153478284|NCT01105650|Hormones|hormones|mesh-ancestor
153478285|NCT01105650|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153478286|NCT01105650|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
153478287|NCT01105650|Protective Agents|protective agents|mesh-ancestor
153478288|NCT01105650|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153478289|NCT01105650|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153478290|NCT01105650|Analgesics|analgesics|mesh-ancestor
153478291|NCT01105650|Sensory System Agents|sensory system agents|mesh-ancestor
153478292|NCT01110876|Temozolomide|temozolomide|mesh-list
153478293|NCT01110876|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
153478294|NCT01110876|Vorinostat|vorinostat|mesh-list
153478295|NCT01110876|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153478296|NCT01110876|Alkylating Agents|alkylating agents|mesh-ancestor
153478341|NCT01119222|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153478342|NCT01119222|Narcotics|narcotics|mesh-ancestor
153478343|NCT01119222|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153478344|NCT01119222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153478345|NCT01119222|Analgesics|analgesics|mesh-ancestor
153478346|NCT01119222|Sensory System Agents|sensory system agents|mesh-ancestor
153478370|NCT01120236|Leuprolide|leuprolide|mesh-list
153478413|NCT04974138|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153478414|NCT04974138|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153478415|NCT04974138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153478431|NCT04142892|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153478432|NCT04142892|Fertility Agents, Female|fertility agents, female|mesh-ancestor
153478433|NCT04142892|Fertility Agents|fertility agents|mesh-ancestor
153478436|NCT04142892|Hormone Antagonists|hormone antagonists|mesh-ancestor
153478467|NCT02410512|Immunoglobulins|immunoglobulins|mesh-list
153478468|NCT02410512|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
153478469|NCT02410512|Immunologic Factors|immunologic factors|mesh-ancestor
153478470|NCT02410512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153478471|NCT02410512|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153478472|NCT02410512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153478473|NCT02410512|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153478474|NCT02410512|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153478475|NCT00255138|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
153478476|NCT00255138|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
153478477|NCT00255138|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153478478|NCT00255138|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153478479|NCT00255138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153478480|NCT00255138|Adrenergic Agents|adrenergic agents|mesh-ancestor
153478481|NCT00255138|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153478483|NCT01128192|Pasireotide|pasireotide|mesh-list
153478524|NCT01130844|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153478526|NCT01134198|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
153478527|NCT01134198|Abortifacient Agents|abortifacient agents|mesh-ancestor
153478528|NCT01134198|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153478529|NCT01134198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153478530|NCT01134198|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
153478531|NCT01134198|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
153478532|NCT01134198|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
153478533|NCT01134198|Contraceptive Agents|contraceptive agents|mesh-ancestor
153478534|NCT01134198|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
153478535|NCT01134198|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
153478536|NCT01134198|Hormone Antagonists|hormone antagonists|mesh-ancestor
153478537|NCT01134198|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153478538|NCT01134198|Luteolytic Agents|luteolytic agents|mesh-ancestor
153478539|NCT01134198|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
153478540|NCT01134198|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
153478579|NCT01140360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153478580|NCT01140360|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153478581|NCT01142310|Lamotrigine|lamotrigine|mesh-list
153478582|NCT01142310|Anticonvulsants|anticonvulsants|mesh-ancestor
153478583|NCT01142310|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153478584|NCT01142310|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153478585|NCT01142310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153478650|NCT01151046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153478651|NCT01151046|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
153478709|NCT01170390|Ethinyl estradiol, levonorgestrel drug combination|ethinyl estradiol, levonorgestrel drug combination|mesh-list
153478711|NCT01170390|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
153478712|NCT01170390|Estrogens|estrogens|mesh-ancestor
153478713|NCT01170390|Hormones|hormones|mesh-ancestor
153478714|NCT01170390|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153478715|NCT01170390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153478775|NCT01177956|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153478776|NCT01183650|Tadalafil|tadalafil|mesh-list
153478777|NCT01183650|Vasodilator Agents|vasodilator agents|mesh-ancestor
153478778|NCT01183650|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
153478779|NCT01183650|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
153478780|NCT01183650|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153478781|NCT01183650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153478782|NCT01183650|Urological Agents|urological agents|mesh-ancestor
153478783|NCT01184898|Cytarabine|cytarabine|mesh-list
153478784|NCT01184898|Sirolimus|sirolimus|mesh-list
153478785|NCT01184898|Etoposide|etoposide|mesh-list
153478786|NCT01184898|Mitoxantrone|mitoxantrone|mesh-list
153478787|NCT01184898|Etoposide phosphate|etoposide phosphate|mesh-list
153478788|NCT01184898|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153478789|NCT01184898|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153478790|NCT01184898|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153478791|NCT01184898|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153478792|NCT01184898|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153478794|NCT01184898|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153478832|NCT01195116|Adrenergic Agents|adrenergic agents|mesh-ancestor
153478833|NCT01195116|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153478834|NCT01195116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153478835|NCT01197612|Budesonide|budesonide|mesh-list
153478836|NCT01197612|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153478837|NCT01197612|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153478838|NCT01197612|Autonomic Agents|autonomic agents|mesh-ancestor
153478839|NCT01197612|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153478840|NCT01197612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153478841|NCT01197612|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153478842|NCT01197612|Respiratory System Agents|respiratory system agents|mesh-ancestor
153478843|NCT01197612|Glucocorticoids|glucocorticoids|mesh-ancestor
153478844|NCT01197612|Hormones|hormones|mesh-ancestor
153478846|NCT01198158|Bevacizumab|bevacizumab|mesh-list
153478892|NCT01208922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153478893|NCT01208922|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153478894|NCT01208922|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
153478895|NCT01208922|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153478896|NCT01208922|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153478897|NCT01210170|Mometasone Furoate|mometasone furoate|mesh-list
153478898|NCT01210170|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153478899|NCT01210170|Dermatologic Agents|dermatologic agents|mesh-ancestor
153478900|NCT01210170|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
153478901|NCT01210560|Tolvaptan|tolvaptan|mesh-list
153478904|NCT01210560|Natriuretic Agents|natriuretic agents|mesh-ancestor
153478956|NCT01216410|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153478958|NCT01216410|Protective Agents|protective agents|mesh-ancestor
153478959|NCT01216410|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
153478973|NCT01218984|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153478975|NCT01218984|Narcotics|narcotics|mesh-ancestor
153478976|NCT01218984|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153478977|NCT01218984|Analgesics|analgesics|mesh-ancestor
153478978|NCT01222260|Dexamethasone|dexamethasone|mesh-list
153478979|NCT01222260|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
153478980|NCT01222260|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153478981|NCT01222260|Antiemetics|antiemetics|mesh-ancestor
153478982|NCT01222260|Autonomic Agents|autonomic agents|mesh-ancestor
153478983|NCT01222260|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153478984|NCT01222260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153478985|NCT01222260|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153478986|NCT01222260|Glucocorticoids|glucocorticoids|mesh-ancestor
153478987|NCT01222260|Hormones|hormones|mesh-ancestor
153478988|NCT01222260|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153478989|NCT01222260|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153479001|NCT01222884|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
153479002|NCT01222884|Hematinics|hematinics|mesh-ancestor
153479003|NCT01223352|Bosentan|bosentan|mesh-list
153479004|NCT01223352|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153479005|NCT01223352|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
153479006|NCT01223352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153479007|NCT01224210|Ambrisentan|ambrisentan|mesh-list
153479008|NCT01224210|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153479009|NCT01224678|Vitamin D|vitamin d|mesh-list
153479010|NCT01224678|Vitamins|vitamins|mesh-ancestor
153479011|NCT01224678|Micronutrients|micronutrients|mesh-ancestor
153479012|NCT01224678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153479013|NCT01224678|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153479064|NCT01232946|Liraglutide|liraglutide|mesh-list
153479065|NCT01232946|Insulin Detemir|insulin detemir|mesh-list
153479066|NCT01232946|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153479067|NCT01232946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153479068|NCT01232946|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
153479069|NCT01232946|Incretins|incretins|mesh-ancestor
153479070|NCT01232946|Hormones|hormones|mesh-ancestor
153479071|NCT01232946|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153479072|NCT01235910|Cyclosporine|cyclosporine|mesh-list
153479073|NCT01235910|Cyclosporins|cyclosporins|mesh-list
153479074|NCT01235910|Aliskiren|aliskiren|mesh-list
153479075|NCT01235910|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153479130|NCT01249872|Anesthetics, Local|anesthetics, local|mesh-ancestor
153479131|NCT01249872|Anesthetics|anesthetics|mesh-ancestor
153479132|NCT01250184|Lidocaine|lidocaine|mesh-list
153479133|NCT01250184|Anesthetics, Local|anesthetics, local|mesh-ancestor
153479134|NCT01250184|Anesthetics|anesthetics|mesh-ancestor
153479135|NCT01250184|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153479136|NCT01250184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153479137|NCT01250184|Sensory System Agents|sensory system agents|mesh-ancestor
153479138|NCT01250184|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153479139|NCT01250184|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153479140|NCT01250184|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
153479141|NCT01250184|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153479199|NCT01258374|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
153479200|NCT01258374|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
153479201|NCT01258374|Protease Inhibitors|protease inhibitors|mesh-ancestor
153479202|NCT01262118|Tofacitinib|tofacitinib|mesh-list
153479203|NCT01262118|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
153479204|NCT01262118|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153479250|NCT01272960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153479251|NCT01272960|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
153479252|NCT01272960|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
153479254|NCT01275300|Aspirin|aspirin|mesh-list
153479256|NCT01275300|Niacinamide|niacinamide|mesh-list
153479257|NCT01275300|Nicotinic Acids|nicotinic acids|mesh-list
153479258|NCT01275300|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153479259|NCT01275300|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153479260|NCT01275300|Analgesics|analgesics|mesh-ancestor
153479261|NCT01275300|Sensory System Agents|sensory system agents|mesh-ancestor
153479314|NCT01282242|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153479315|NCT01282242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153479317|NCT01285050|Emtricitabine|emtricitabine|mesh-list
153479385|NCT01295112|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153479386|NCT01295112|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153479387|NCT01295112|Growth Substances|growth substances|mesh-ancestor
153479389|NCT01295112|Growth Inhibitors|growth inhibitors|mesh-ancestor
153479390|NCT01295112|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153479391|NCT01295112|Antiemetics|antiemetics|mesh-ancestor
153479392|NCT01295112|Autonomic Agents|autonomic agents|mesh-ancestor
153479393|NCT01295112|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153479451|NCT01308060|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
153479452|NCT01308060|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
153479453|NCT01308060|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
153479454|NCT01308060|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153479455|NCT01308060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153479456|NCT01308060|Cholinergic Agents|cholinergic agents|mesh-ancestor
153479457|NCT01308060|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153479458|NCT01308060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153479459|NCT01308060|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
153479460|NCT01308060|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153479461|NCT01308294|Vaccines|vaccines|mesh-list
153479462|NCT01308294|Monatide (IMS 3015)|monatide (ims 3015)|mesh-list
153479463|NCT01308294|Immunologic Factors|immunologic factors|mesh-ancestor
153479464|NCT01308294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153479465|NCT01308294|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153479466|NCT01308840|Gemcitabine|gemcitabine|mesh-list
153479467|NCT01308840|Oxaliplatin|oxaliplatin|mesh-list
153479468|NCT01308840|Panitumumab|panitumumab|mesh-list
153479469|NCT01308840|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153479470|NCT01308840|Antimetabolites|antimetabolites|mesh-ancestor
153479507|NCT01312818|Hormones|hormones|mesh-ancestor
153479508|NCT01312818|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153479509|NCT01312818|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153479510|NCT01312818|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153479511|NCT01312818|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
153479512|NCT01312818|Abortifacient Agents|abortifacient agents|mesh-ancestor
153479513|NCT01312818|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153479514|NCT01312818|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153479577|NCT01318278|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153479578|NCT01318278|Dopamine Agents|dopamine agents|mesh-ancestor
153479579|NCT01318278|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153479636|NCT01328964|Glucocorticoids|glucocorticoids|mesh-ancestor
153479638|NCT01328964|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153479639|NCT01328964|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
153479640|NCT01328964|Hormone Antagonists|hormone antagonists|mesh-ancestor
153479641|NCT01328964|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
153479642|NCT01328964|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
153479643|NCT01328964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153479644|NCT01330134|Lidocaine|lidocaine|mesh-list
153479645|NCT01330134|Anesthetics, Local|anesthetics, local|mesh-ancestor
153479646|NCT01330134|Anesthetics|anesthetics|mesh-ancestor
153479647|NCT01330134|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153479648|NCT01330134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153479649|NCT01330134|Sensory System Agents|sensory system agents|mesh-ancestor
153479650|NCT01330134|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153479695|NCT01331694|Tocolytic Agents|tocolytic agents|mesh-ancestor
153479696|NCT01331694|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153479697|NCT01331694|Glucocorticoids|glucocorticoids|mesh-ancestor
153479698|NCT01331694|Hormones|hormones|mesh-ancestor
153479699|NCT01331694|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153479700|NCT01331694|Sympathomimetics|sympathomimetics|mesh-ancestor
153479701|NCT01333098|Mifepristone|mifepristone|mesh-list
153479702|NCT01333098|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
153479703|NCT01333098|Abortifacient Agents|abortifacient agents|mesh-ancestor
153479756|NCT06244667|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153479757|NCT06244667|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
153479758|NCT06244667|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153479759|NCT06244667|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153479760|NCT06244667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153479761|NCT06244498|Tranexamic Acid|tranexamic acid|mesh-list
153479762|NCT06244498|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
153479763|NCT06244498|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153479764|NCT06244498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153479765|NCT06244498|Hemostatics|hemostatics|mesh-ancestor
153479766|NCT06244498|Coagulants|coagulants|mesh-ancestor
153479767|NCT06244485|Trastuzumab deruxtecan|trastuzumab deruxtecan|mesh-list
153479770|NCT06244485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153479771|NCT06244303|Listerine|listerine|mesh-list
153479772|NCT06244303|Sodium Fluoride|sodium fluoride|mesh-list
153479773|NCT06244303|Cariostatic Agents|cariostatic agents|mesh-ancestor
153479774|NCT06244303|Protective Agents|protective agents|mesh-ancestor
153479775|NCT06244303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153479776|NCT06244303|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
153479777|NCT06244303|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153479778|NCT06244290|Listerine|listerine|mesh-list
153479779|NCT06244290|Fluorides|fluorides|mesh-list
153479866|NCT06243510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153479867|NCT06243510|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
153479868|NCT06243510|Antithrombins|antithrombins|mesh-ancestor
153479869|NCT06243510|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
153479870|NCT06243510|Protease Inhibitors|protease inhibitors|mesh-ancestor
153479871|NCT06243510|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153479872|NCT06243393|Sacituzumab govitecan|sacituzumab govitecan|mesh-list
153479873|NCT06243393|Immunoconjugates|immunoconjugates|mesh-ancestor
153479874|NCT06243393|Immunologic Factors|immunologic factors|mesh-ancestor
153479875|NCT06243393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153479876|NCT06243185|Letrozole|letrozole|mesh-list
153479877|NCT06243185|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153479926|NCT06243120|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153479927|NCT06243120|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
153479928|NCT06243120|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153479929|NCT06243120|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153479930|NCT06243120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153479931|NCT06243042|Vitamin D|vitamin d|mesh-list
153479932|NCT06243042|Vitamins|vitamins|mesh-ancestor
153479933|NCT06243042|Micronutrients|micronutrients|mesh-ancestor
153479934|NCT06243042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153479935|NCT06243042|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153479936|NCT06238778|Insulin Lispro|insulin lispro|mesh-list
153479940|NCT06235606|Bupivacaine|bupivacaine|mesh-list
153479990|NCT06189742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153479991|NCT06149793|Empagliflozin|empagliflozin|mesh-list
153479992|NCT06149793|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
153479993|NCT06149793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153479994|NCT06149793|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153479995|NCT06149793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153479996|NCT06138249|Vitamin D|vitamin d|mesh-list
153479997|NCT06138249|Vitamins|vitamins|mesh-ancestor
153479998|NCT06138249|Micronutrients|micronutrients|mesh-ancestor
153479999|NCT06138249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153480000|NCT06138249|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153480001|NCT06133075|Mirabegron|mirabegron|mesh-list
153480002|NCT06133075|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
153480050|NCT06066554|Antimetabolites|antimetabolites|mesh-ancestor
153480122|NCT05995249|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
153480123|NCT05995249|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153480124|NCT05995249|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153480125|NCT05995249|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
153480127|NCT05995249|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
153480128|NCT05995249|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153480129|NCT05995249|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153480130|NCT05995249|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
153480131|NCT05988671|Dexamethasone|dexamethasone|mesh-list
153480132|NCT05988671|Dexamethasone acetate|dexamethasone acetate|mesh-list
153480133|NCT05988671|Dexmedetomidine|dexmedetomidine|mesh-list
153480135|NCT05988671|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153480136|NCT05988671|Antiemetics|antiemetics|mesh-ancestor
153480137|NCT05988671|Autonomic Agents|autonomic agents|mesh-ancestor
153480138|NCT05988671|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153480139|NCT05988671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153480140|NCT05988671|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153480141|NCT05988671|Glucocorticoids|glucocorticoids|mesh-ancestor
153480142|NCT05988671|Hormones|hormones|mesh-ancestor
153480143|NCT05988671|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153480144|NCT05988671|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153480145|NCT05988671|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153480146|NCT05988671|Protease Inhibitors|protease inhibitors|mesh-ancestor
153480147|NCT05988671|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153480149|NCT05988671|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153480158|NCT05988671|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153480159|NCT05984420|Emollients|emollients|mesh-list
153480160|NCT05984420|Dermatologic Agents|dermatologic agents|mesh-ancestor
153480161|NCT05971355|Emollients|emollients|mesh-list
153480162|NCT05971355|Dermatologic Agents|dermatologic agents|mesh-ancestor
153480163|NCT05962034|Aspirin|aspirin|mesh-list
153480164|NCT05962034|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153480165|NCT05962034|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153480227|NCT05923086|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153480228|NCT05923086|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153480229|NCT05923086|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
153480230|NCT05923086|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153480231|NCT05923086|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153480232|NCT05923086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153480233|NCT05901545|Panitumumab|panitumumab|mesh-list
153480234|NCT05901545|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153480235|NCT05901545|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153480237|NCT05842096|Immunologic Factors|immunologic factors|mesh-ancestor
153480238|NCT05842096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153480239|NCT05839756|Budesonide|budesonide|mesh-list
153480240|NCT05839756|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153480241|NCT05839756|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153480283|NCT05785377|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153480284|NCT05785377|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
153480285|NCT05785377|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153480286|NCT05785377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153480287|NCT05785377|Cholinergic Agents|cholinergic agents|mesh-ancestor
153480288|NCT05785377|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153480346|NCT05750992|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153480347|NCT05750992|Anesthetics, General|anesthetics, general|mesh-ancestor
153480349|NCT05736341|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153480350|NCT05736341|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153480351|NCT05736341|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153480352|NCT05736341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153480353|NCT05736341|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153480354|NCT05736341|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153480355|NCT05736341|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153480356|NCT05736341|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153480357|NCT05736341|Anesthetics, General|anesthetics, general|mesh-ancestor
153480358|NCT05736341|Anesthetics|anesthetics|mesh-ancestor
153480359|NCT05736341|GABA Modulators|gaba modulators|mesh-ancestor
153480360|NCT05736341|GABA Agents|gaba agents|mesh-ancestor
153480361|NCT05736341|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153480362|NCT05736341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153480363|NCT05730751|Anesthetics|anesthetics|mesh-list
153480364|NCT05730751|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153480365|NCT05730751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153480366|NCT05709990|Vitamin D|vitamin d|mesh-list
153480403|NCT05658874|Estrogens|estrogens|mesh-list
153480404|NCT05658874|Analgesics|analgesics|mesh-ancestor
153480405|NCT05658874|Sensory System Agents|sensory system agents|mesh-ancestor
153480406|NCT05658874|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153480407|NCT05658874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153480408|NCT05658874|Anticonvulsants|anticonvulsants|mesh-ancestor
153480409|NCT05658874|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153480410|NCT05658874|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153480411|NCT05658874|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153480412|NCT05658874|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153480413|NCT05658874|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
153480414|NCT05658874|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
153480415|NCT05658874|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153480416|NCT05658874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153480417|NCT05658874|Antimanic Agents|antimanic agents|mesh-ancestor
153480418|NCT05658874|Hormones|hormones|mesh-ancestor
153480419|NCT05658874|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153480420|NCT05658874|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
153480421|NCT05658874|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
153480422|NCT05658874|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153480423|NCT05658874|Adrenergic Agents|adrenergic agents|mesh-ancestor
153480440|NCT05631899|Ipilimumab|ipilimumab|mesh-list
153480456|NCT05631899|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153480457|NCT05631899|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153480458|NCT05631899|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153480526|NCT05536856|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153480527|NCT05536856|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153480657|NCT05386472|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153480658|NCT05386472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153480659|NCT05386472|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153480660|NCT05386472|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153480661|NCT05386472|Antiviral Agents|antiviral agents|mesh-ancestor
153480662|NCT05386472|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153480663|NCT05386472|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
153480664|NCT05386472|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153480665|NCT05382442|Leucovorin|leucovorin|mesh-list
153480666|NCT05382442|Capecitabine|capecitabine|mesh-list
153480667|NCT05382442|Fluorouracil|fluorouracil|mesh-list
153480668|NCT05382442|Oxaliplatin|oxaliplatin|mesh-list
153480669|NCT05382442|Irinotecan|irinotecan|mesh-list
153480670|NCT05382442|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153480671|NCT05382442|Antimetabolites|antimetabolites|mesh-ancestor
153480715|NCT05310110|Anesthetics, General|anesthetics, general|mesh-ancestor
153480716|NCT05310110|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
153480717|NCT05310110|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
153480718|NCT05310110|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
153480719|NCT05310110|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
153480720|NCT05310110|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
153480721|NCT05310110|Cholinergic Agents|cholinergic agents|mesh-ancestor
153480722|NCT05310110|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153480724|NCT05289063|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153480725|NCT05289063|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153480778|NCT05085496|Atezolizumab|atezolizumab|mesh-list
153480779|NCT05085496|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
153480780|NCT05085496|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153480781|NCT05085496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153480782|NCT05085496|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153480783|NCT05085496|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153480784|NCT05085496|Immunologic Factors|immunologic factors|mesh-ancestor
153480785|NCT05085496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153480786|NCT05083481|Pembrolizumab|pembrolizumab|mesh-list
153480787|NCT05083481|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153480788|NCT05083481|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153480789|NCT05083481|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153480790|NCT05083481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153480791|NCT05065970|Felzartamab|felzartamab|mesh-list
153480893|NCT04848584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153480898|NCT04781088|Pembrolizumab|pembrolizumab|mesh-list
153480899|NCT04781088|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
153480900|NCT04781088|Lenvatinib|lenvatinib|mesh-list
153480901|NCT04781088|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153480902|NCT04781088|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153480903|NCT04781088|Tubulin Modulators|tubulin modulators|mesh-ancestor
153480904|NCT04781088|Antimitotic Agents|antimitotic agents|mesh-ancestor
153480954|NCT04706507|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153480955|NCT04706507|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153480956|NCT04706507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153480957|NCT04704999|Chloroquine|chloroquine|mesh-list
153480958|NCT04704999|Lumefantrine|lumefantrine|mesh-list
153480960|NCT04704999|Tafenoquine|tafenoquine|mesh-list
153480961|NCT04704999|Amebicides|amebicides|mesh-ancestor
153480962|NCT04704999|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153480963|NCT04704999|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153480964|NCT04704999|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153480965|NCT04704999|Antimalarials|antimalarials|mesh-ancestor
153480966|NCT04704999|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153480967|NCT04696185|Dapagliflozin|dapagliflozin|mesh-list
153480968|NCT04696185|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
153480969|NCT04696185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153480970|NCT04696185|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153480971|NCT04696185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153480972|NCT04676646|Spironolactone|spironolactone|mesh-list
153480973|NCT04676646|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
153480974|NCT04676646|Hormone Antagonists|hormone antagonists|mesh-ancestor
153480975|NCT04676646|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153480978|NCT04676646|Diuretics|diuretics|mesh-ancestor
153481004|NCT04546230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153481005|NCT04511234|Sirolimus|sirolimus|mesh-list
153481006|NCT04511234|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153481007|NCT04511234|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153481072|NCT04284397|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153481073|NCT04284397|Analgesics|analgesics|mesh-ancestor
153481074|NCT04284397|Sensory System Agents|sensory system agents|mesh-ancestor
153481075|NCT04284397|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153481076|NCT04284397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153481077|NCT04284397|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153481078|NCT04284397|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153481079|NCT04284397|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153481080|NCT04284397|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153481081|NCT04284397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153481082|NCT04284397|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153481083|NCT04284397|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153481084|NCT04284397|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153481085|NCT04284397|Antipyretics|antipyretics|mesh-ancestor
153481086|NCT04247542|Vancomycin|vancomycin|mesh-list
153481087|NCT04247542|Ibezapolstat|ibezapolstat|mesh-list
153481088|NCT04247542|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153481089|NCT04247542|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153481090|NCT04247542|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153481091|NCT04247542|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153481092|NCT04247542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153481093|NCT04227184|Trospium chloride|trospium chloride|mesh-list
153481094|NCT04227184|Parasympatholytics|parasympatholytics|mesh-ancestor
153481095|NCT04227184|Autonomic Agents|autonomic agents|mesh-ancestor
153481096|NCT04227184|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153481097|NCT04227184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153481104|NCT04221529|Atezolizumab|atezolizumab|mesh-list
153481112|NCT04167514|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153481113|NCT04167514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153481114|NCT04167514|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
153481115|NCT04167514|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
153481116|NCT04141696|Midazolam|midazolam|mesh-list
153481117|NCT04141696|Ketamine|ketamine|mesh-list
153481118|NCT04141696|Analgesics|analgesics|mesh-ancestor
153481119|NCT04141696|Sensory System Agents|sensory system agents|mesh-ancestor
153481120|NCT04141696|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153481121|NCT04141696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153481122|NCT04141696|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
153481124|NCT04141696|Anesthetics, General|anesthetics, general|mesh-ancestor
153481125|NCT04141696|Anesthetics|anesthetics|mesh-ancestor
153481126|NCT04141696|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153481170|NCT04051203|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
153481171|NCT04051203|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
153481172|NCT04051203|Prednisolone|prednisolone|mesh-list
153481173|NCT04051203|Prednisolone acetate|prednisolone acetate|mesh-list
153481174|NCT04051203|Lidocaine|lidocaine|mesh-list
153481175|NCT04051203|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
153481176|NCT04051203|Prednisolone phosphate|prednisolone phosphate|mesh-list
153481177|NCT04051203|Anesthetics, Local|anesthetics, local|mesh-ancestor
153481178|NCT04051203|Anesthetics|anesthetics|mesh-ancestor
153481179|NCT04051203|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153481180|NCT04051203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153481181|NCT04051203|Sensory System Agents|sensory system agents|mesh-ancestor
153481182|NCT04051203|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153481183|NCT04051203|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153481191|NCT04051203|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153481192|NCT04051203|Glucocorticoids|glucocorticoids|mesh-ancestor
153481193|NCT04051203|Hormones|hormones|mesh-ancestor
153481194|NCT04051203|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153481218|NCT04040452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153481219|NCT04024761|Cyclophosphamide|cyclophosphamide|mesh-list
153481220|NCT04024761|Fludarabine|fludarabine|mesh-list
153481221|NCT04024761|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153481222|NCT04024761|Immunologic Factors|immunologic factors|mesh-ancestor
153481223|NCT04024761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153481224|NCT04024761|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153481225|NCT04024761|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153481226|NCT04024761|Alkylating Agents|alkylating agents|mesh-ancestor
153481227|NCT04024761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153481228|NCT04024761|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153481229|NCT04024761|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153481230|NCT04013542|Nivolumab|nivolumab|mesh-list
153481231|NCT04013542|Ipilimumab|ipilimumab|mesh-list
153481232|NCT04013542|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153481233|NCT04013542|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153481234|NCT04013542|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153481236|NCT03984357|Gemcitabine|gemcitabine|mesh-list
153481274|NCT03907969|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153481275|NCT03907969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153481276|NCT03900793|Sunitinib|sunitinib|mesh-list
153481277|NCT03900793|Losartan|losartan|mesh-list
153481278|NCT03900793|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153481279|NCT03900793|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153481280|NCT03900793|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153481281|NCT03900793|Growth Substances|growth substances|mesh-ancestor
153481282|NCT03900793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153481283|NCT03900793|Growth Inhibitors|growth inhibitors|mesh-ancestor
153481284|NCT03900793|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153481285|NCT03900793|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153481339|NCT03764293|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153481340|NCT03764293|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153481342|NCT03752307|Prednisone|prednisone|mesh-list
153481412|NCT03484507|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153481413|NCT03484507|Glucocorticoids|glucocorticoids|mesh-ancestor
153481414|NCT03484507|Hormones|hormones|mesh-ancestor
153481415|NCT03484507|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153481416|NCT03484507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153481417|NCT03484507|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153481418|NCT03484507|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153481480|NCT03338205|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153481481|NCT03338205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153481482|NCT03338205|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
153481483|NCT03338205|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153481484|NCT03338205|Anesthetics, General|anesthetics, general|mesh-ancestor
153481485|NCT03338205|Anesthetics|anesthetics|mesh-ancestor
153481486|NCT03338205|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153481548|NCT03036098|Nivolumab|nivolumab|mesh-list
153481549|NCT03036098|Ipilimumab|ipilimumab|mesh-list
153481550|NCT03036098|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153481551|NCT03036098|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153481552|NCT03036098|Antimetabolites|antimetabolites|mesh-ancestor
153481553|NCT03036098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153481747|NCT00936936|Tubulin Modulators|tubulin modulators|mesh-ancestor
153481748|NCT00936936|Antimitotic Agents|antimitotic agents|mesh-ancestor
153481749|NCT00936936|Mitosis Modulators|mitosis modulators|mesh-ancestor
153481750|NCT00936936|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153481751|NCT00936936|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153481752|NCT00936936|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153481753|NCT00936936|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153481755|NCT00936936|Alkylating Agents|alkylating agents|mesh-ancestor
153481756|NCT00936936|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153481757|NCT00936936|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153481758|NCT00936936|Immunologic Factors|immunologic factors|mesh-ancestor
153481759|NCT00936936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153481809|NCT01336296|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
153481810|NCT01336296|Antitubercular Agents|antitubercular agents|mesh-ancestor
153481811|NCT01336296|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153481812|NCT01336296|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153481813|NCT01336296|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153481814|NCT01336296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153481816|NCT01337700|Levomilnacipran|levomilnacipran|mesh-list
153481817|NCT01337700|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
153481818|NCT01337700|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153481819|NCT01337700|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153481820|NCT01337700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153481821|NCT01337700|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153481822|NCT01337700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153481823|NCT01337700|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153481824|NCT01337700|Analgesics|analgesics|mesh-ancestor
153481856|NCT01342770|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153481857|NCT01342770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153481858|NCT01343004|Teriparatide|teriparatide|mesh-list
153481859|NCT01343004|Abaloparatide|abaloparatide|mesh-list
153481860|NCT01343004|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153481861|NCT01343004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153481864|NCT01347060|Xhance|xhance|mesh-list
153481918|NCT01363050|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153481919|NCT01363050|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153481920|NCT01363050|Analgesics|analgesics|mesh-ancestor
153481921|NCT01363050|Sensory System Agents|sensory system agents|mesh-ancestor
153481922|NCT01363050|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153481923|NCT01363050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153481924|NCT01363050|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153481925|NCT01363050|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153481926|NCT01363050|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153481927|NCT01363050|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153481928|NCT01363050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153481982|NCT01365624|Sensory System Agents|sensory system agents|mesh-ancestor
153481983|NCT01365624|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153481984|NCT01365624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153481985|NCT01365624|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153481986|NCT01365624|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153481987|NCT01365624|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
153481988|NCT01365624|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153481989|NCT01365624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153481990|NCT01371786|Mometasone Furoate|mometasone furoate|mesh-list
153481991|NCT01371786|Ciclesonide|ciclesonide|mesh-list
153481992|NCT01371786|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153481993|NCT01371786|Dermatologic Agents|dermatologic agents|mesh-ancestor
153481994|NCT01371786|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
153481995|NCT01371786|Glucocorticoids|glucocorticoids|mesh-ancestor
153481996|NCT01371786|Hormones|hormones|mesh-ancestor
153481997|NCT01371786|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153481998|NCT01371786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153481999|NCT01377636|Isoproterenol|isoproterenol|mesh-list
153482000|NCT01377636|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
153482001|NCT01377636|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153482002|NCT01377636|Adrenergic Agents|adrenergic agents|mesh-ancestor
153482003|NCT01377636|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153482035|NCT01387464|Sensory System Agents|sensory system agents|mesh-ancestor
153482048|NCT01390818|Sirolimus|sirolimus|mesh-list
153482049|NCT01390818|MTOR Inhibitors|mtor inhibitors|mesh-list
153482050|NCT01390818|Temsirolimus|temsirolimus|mesh-list
153482052|NCT01390818|Protease Inhibitors|protease inhibitors|mesh-ancestor
153482053|NCT01390818|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153482054|NCT01390818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153482055|NCT01390818|Vitamin B Complex|vitamin b complex|mesh-ancestor
153482056|NCT01390818|Vitamins|vitamins|mesh-ancestor
153482057|NCT01390818|Micronutrients|micronutrients|mesh-ancestor
153482093|NCT01399008|Tubulin Modulators|tubulin modulators|mesh-ancestor
153482094|NCT01399008|Antimitotic Agents|antimitotic agents|mesh-ancestor
153482096|NCT01399008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153482098|NCT01399008|Antimetabolites|antimetabolites|mesh-ancestor
153482099|NCT01399008|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153482100|NCT01399008|Free Radical Scavengers|free radical scavengers|mesh-ancestor
153482101|NCT01399008|Antioxidants|antioxidants|mesh-ancestor
153482102|NCT01399008|Protective Agents|protective agents|mesh-ancestor
153482159|NCT01410084|Cholecalciferol|cholecalciferol|mesh-list
153482160|NCT01410084|Vitamins|vitamins|mesh-list
153482161|NCT01410084|Vitamin E|vitamin e|mesh-list
153482162|NCT01410084|Micronutrients|micronutrients|mesh-ancestor
153482163|NCT01410084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153482164|NCT01410084|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153482165|NCT01410084|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153482166|NCT01410084|Antioxidants|antioxidants|mesh-ancestor
153482167|NCT01410084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153482168|NCT01410084|Protective Agents|protective agents|mesh-ancestor
153482169|NCT01413750|Paclitaxel|paclitaxel|mesh-list
153482170|NCT01413750|Carboplatin|carboplatin|mesh-list
153482171|NCT01413750|Vorinostat|vorinostat|mesh-list
153482172|NCT01413750|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153482173|NCT01413750|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153482174|NCT01413750|Tubulin Modulators|tubulin modulators|mesh-ancestor
153482175|NCT01413750|Antimitotic Agents|antimitotic agents|mesh-ancestor
153482176|NCT01413750|Mitosis Modulators|mitosis modulators|mesh-ancestor
153482177|NCT01413750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153482178|NCT01413750|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
153482179|NCT01413750|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153482180|NCT01417026|Oxytocin|oxytocin|mesh-list
153482181|NCT01417026|Oxytocics|oxytocics|mesh-ancestor
153482182|NCT01417026|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153482183|NCT01417026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153482184|NCT01420146|Trastuzumab|trastuzumab|mesh-list
153482185|NCT01420146|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153482186|NCT01420146|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153482187|NCT01421472|Paclitaxel|paclitaxel|mesh-list
153482188|NCT01421472|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153482189|NCT01421472|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153482190|NCT01421472|Tubulin Modulators|tubulin modulators|mesh-ancestor
153482191|NCT01421472|Antimitotic Agents|antimitotic agents|mesh-ancestor
153482239|NCT01432236|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153482240|NCT01432236|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153482242|NCT01434186|Saxagliptin|saxagliptin|mesh-list
153482243|NCT01434186|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153482244|NCT01434186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153482245|NCT01434186|Incretins|incretins|mesh-ancestor
153482246|NCT01434186|Hormones|hormones|mesh-ancestor
153482247|NCT01434186|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153482248|NCT01434186|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
153482249|NCT01434186|Protease Inhibitors|protease inhibitors|mesh-ancestor
153482250|NCT01434186|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153482251|NCT01434186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153482252|NCT01434342|Nicotine|nicotine|mesh-list
153482253|NCT01434342|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
153482254|NCT01434342|Autonomic Agents|autonomic agents|mesh-ancestor
153482255|NCT01434342|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153482256|NCT01434342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153482257|NCT01434342|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
153482258|NCT01434342|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
153482259|NCT01434342|Cholinergic Agents|cholinergic agents|mesh-ancestor
153482260|NCT01434342|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153482340|NCT01462812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153482341|NCT01462812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153482342|NCT01463202|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
153482344|NCT01463202|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
153482345|NCT01463202|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
153482346|NCT01463202|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
153482347|NCT01463202|Contraceptive Agents|contraceptive agents|mesh-ancestor
153482348|NCT01463202|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153482349|NCT01463202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153482350|NCT01463202|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
153482351|NCT01463202|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
153482352|NCT01463202|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
153482353|NCT01463202|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153482354|NCT01463202|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153482355|NCT01467882|Triptorelin Pamoate|triptorelin pamoate|mesh-list
153482356|NCT01467882|Luteolytic Agents|luteolytic agents|mesh-ancestor
153482357|NCT01467882|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
153482358|NCT01467882|Contraceptive Agents|contraceptive agents|mesh-ancestor
153482359|NCT01467882|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153482360|NCT01467882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153482361|NCT01467882|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
153482362|NCT01467882|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153482363|NCT01467882|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153482364|NCT01468350|4-Aminopyridine|4-aminopyridine|mesh-list
153482365|NCT01468350|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
153482366|NCT01468350|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153482367|NCT01468350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153482368|NCT01468584|Ribavirin|ribavirin|mesh-list
153482369|NCT01468584|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
153482370|NCT01468584|Antimetabolites|antimetabolites|mesh-ancestor
153482371|NCT01468584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153482372|NCT01468584|Antiviral Agents|antiviral agents|mesh-ancestor
153482382|NCT01474122|Endothelin B Receptor Antagonists|endothelin b receptor antagonists|mesh-ancestor
153482383|NCT01474590|Doxycycline|doxycycline|mesh-list
153482384|NCT01474590|Isotretinoin|isotretinoin|mesh-list
153482385|NCT01474590|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153482386|NCT01474590|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153482387|NCT01474590|Antimalarials|antimalarials|mesh-ancestor
153482388|NCT01474590|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153482389|NCT01474590|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153482390|NCT01474590|Dermatologic Agents|dermatologic agents|mesh-ancestor
153482391|NCT01477320|Pantoprazole|pantoprazole|mesh-list
153482431|NCT01479270|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
153482432|NCT01479348|Tetrahydrouridine|tetrahydrouridine|mesh-list
153482433|NCT01479348|Antimetabolites|antimetabolites|mesh-ancestor
153482434|NCT01479348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153482435|NCT01483560|Metformin|metformin|mesh-list
153482436|NCT01483560|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153482437|NCT01483560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153482438|NCT01484340|Nicotine|nicotine|mesh-list
153482439|NCT01484340|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
153482440|NCT01484340|Autonomic Agents|autonomic agents|mesh-ancestor
153482441|NCT01484340|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153482442|NCT01484340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153482443|NCT01484340|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
153482444|NCT01484340|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
153482445|NCT01484340|Cholinergic Agents|cholinergic agents|mesh-ancestor
153482446|NCT01484340|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153482447|NCT01484340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153482448|NCT01485588|hI-con1|hi-con1|mesh-list
153482449|NCT01485588|Immunoconjugates|immunoconjugates|mesh-ancestor
153482450|NCT01485588|Immunologic Factors|immunologic factors|mesh-ancestor
153482451|NCT01485588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153482452|NCT01488318|Cetuximab|cetuximab|mesh-list
153482453|NCT01488318|Dasatinib|dasatinib|mesh-list
153482454|NCT01488318|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153482455|NCT01488318|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153482456|NCT01488318|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153482457|NCT01488318|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153482479|NCT01504854|Protective Agents|protective agents|mesh-ancestor
153482480|NCT01504854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153482481|NCT01504854|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153482482|NCT01504854|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153482483|NCT01508832|Lidocaine|lidocaine|mesh-list
153482484|NCT01508832|Bupivacaine|bupivacaine|mesh-list
153482485|NCT01508832|Anesthetics, Local|anesthetics, local|mesh-ancestor
153482486|NCT01508832|Anesthetics|anesthetics|mesh-ancestor
153482487|NCT01508832|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153482488|NCT01508832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153482489|NCT01508832|Sensory System Agents|sensory system agents|mesh-ancestor
153482490|NCT01508832|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153482491|NCT01508832|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153482492|NCT01508832|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
153482493|NCT01508832|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153482494|NCT01508832|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153482495|NCT01508832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153482496|NCT01511640|Pregabalin|pregabalin|mesh-list
153482497|NCT01511640|Analgesics|analgesics|mesh-ancestor
153482498|NCT01511640|Sensory System Agents|sensory system agents|mesh-ancestor
153482506|NCT01511640|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153482507|NCT01511640|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153482508|NCT01511640|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153482509|NCT01511640|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153482520|NCT01513122|Antiviral Agents|antiviral agents|mesh-ancestor
153482521|NCT01513122|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153482522|NCT01513122|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
153482523|NCT01513122|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153482524|NCT01513122|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
153482525|NCT01513122|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
153482526|NCT01513902|Tofacitinib|tofacitinib|mesh-list
153482527|NCT01513902|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
153482528|NCT01513902|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153482529|NCT01513902|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153482530|NCT01513902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153482531|NCT01515540|Lidocaine|lidocaine|mesh-list
153482532|NCT01515540|Anesthetics, Local|anesthetics, local|mesh-ancestor
153482533|NCT01515540|Anesthetics|anesthetics|mesh-ancestor
153482534|NCT01515540|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153482535|NCT01515540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153482536|NCT01515540|Sensory System Agents|sensory system agents|mesh-ancestor
153482537|NCT01515540|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153482538|NCT01515540|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153482539|NCT01515540|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
153482540|NCT01515540|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153482543|NCT01519284|Levodopa|levodopa|mesh-list
153482572|NCT01520688|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153482573|NCT01520688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153482574|NCT01520688|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153482575|NCT01520688|Respiratory System Agents|respiratory system agents|mesh-ancestor
153482576|NCT01520688|Dermatologic Agents|dermatologic agents|mesh-ancestor
153482577|NCT01520688|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
153482578|NCT01520688|Glucocorticoids|glucocorticoids|mesh-ancestor
153482579|NCT01520688|Hormones|hormones|mesh-ancestor
153482639|NCT01535664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153482641|NCT01535976|Analgesics|analgesics|mesh-ancestor
153482642|NCT01535976|Sensory System Agents|sensory system agents|mesh-ancestor
153482643|NCT01535976|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153482644|NCT01535976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153482645|NCT01535976|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
153482646|NCT01535976|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153482647|NCT01535976|Anesthetics, General|anesthetics, general|mesh-ancestor
153482648|NCT01535976|Anesthetics|anesthetics|mesh-ancestor
153482649|NCT01535976|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153482650|NCT01535976|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
153482651|NCT01535976|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
153482652|NCT01535976|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153482653|NCT01535976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153482654|NCT01536366|Repaglinide|repaglinide|mesh-list
153482655|NCT01536366|Opicapone|opicapone|mesh-list
153482656|NCT01536366|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153482657|NCT01536366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153482658|NCT01536366|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
153482659|NCT01536366|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153482660|NCT01536366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153482661|NCT01536366|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
153482677|NCT06115005|Mitogens|mitogens|mesh-list
153482678|NCT06115005|Mitosis Modulators|mitosis modulators|mesh-ancestor
153482679|NCT06115005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153482680|NCT06114979|Silodosin|silodosin|mesh-list
153482682|NCT06114979|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
153482733|NCT06114758|Abortifacient Agents|abortifacient agents|mesh-ancestor
153482734|NCT06114758|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153482735|NCT06114758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153482736|NCT06114758|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
153482737|NCT06114758|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153482738|NCT06114758|Oxytocics|oxytocics|mesh-ancestor
153482739|NCT06114758|Antidepressive Agents|antidepressive agents|mesh-ancestor
153482740|NCT06114758|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153482741|NCT06114758|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
153482742|NCT06114758|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153482743|NCT06114758|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153482744|NCT06114758|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153482745|NCT06114758|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153482747|NCT06114641|Enoxaparin sodium|enoxaparin sodium|mesh-list
153482748|NCT06114641|Anticoagulants|anticoagulants|mesh-ancestor
153482749|NCT06114641|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153482750|NCT06114641|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153482751|NCT06114641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153482752|NCT06114576|Vitamin D|vitamin d|mesh-list
153482753|NCT06114576|Cholecalciferol|cholecalciferol|mesh-list
153482754|NCT06114576|Vitamins|vitamins|mesh-ancestor
153482755|NCT06114576|Micronutrients|micronutrients|mesh-ancestor
153482756|NCT06114576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153482757|NCT06114576|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153482758|NCT06114576|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153482759|NCT06114537|Acetazolamide|acetazolamide|mesh-list
153482760|NCT06114537|Anticonvulsants|anticonvulsants|mesh-ancestor
153482761|NCT06114537|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
153482762|NCT06114537|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153482763|NCT06114537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153482764|NCT06114537|Diuretics|diuretics|mesh-ancestor
153482765|NCT06114537|Natriuretic Agents|natriuretic agents|mesh-ancestor
153482766|NCT06114537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153482767|NCT06114381|Vitamin D|vitamin d|mesh-list
153482769|NCT06114381|Vitamins|vitamins|mesh-ancestor
153482775|NCT06114225|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153482777|NCT06114225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153482778|NCT06114225|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153482779|NCT06114173|Antibodies, Bispecific|antibodies, bispecific|mesh-list
153482780|NCT06114173|Immunologic Factors|immunologic factors|mesh-ancestor
153482781|NCT06114173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153482783|NCT06114121|Bupivacaine|bupivacaine|mesh-list
153482784|NCT06114121|Ropivacaine|ropivacaine|mesh-list
153482794|NCT06114082|Doxorubicin|doxorubicin|mesh-list
153482795|NCT06114082|Idarubicin|idarubicin|mesh-list
153482796|NCT06114082|Chlorotrianisene|chlorotrianisene|mesh-list
153482797|NCT06114082|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153482798|NCT06114082|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153482799|NCT06114082|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153482800|NCT06114082|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153482801|NCT06114082|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153482802|NCT06114082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153482803|NCT06114082|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
153482804|NCT06114082|Estrogens|estrogens|mesh-ancestor
153482805|NCT06114082|Hormones|hormones|mesh-ancestor
153482818|NCT06114004|Gemcitabine|gemcitabine|mesh-list
153482821|NCT06114004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153482822|NCT06114004|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153482823|NCT06113900|Dapagliflozin|dapagliflozin|mesh-list
153482824|NCT06113900|Empagliflozin|empagliflozin|mesh-list
153482825|NCT06113900|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
153482826|NCT06113900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153482827|NCT06113900|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153482828|NCT06113900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153482829|NCT06113367|Immunomodulating Agents|immunomodulating agents|mesh-list
153482830|NCT06113367|Immunologic Factors|immunologic factors|mesh-ancestor
153482831|NCT06113367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153482832|NCT06113289|Decitabine and cedazuridine drug combination|decitabine and cedazuridine drug combination|mesh-list
153482833|NCT06113289|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153482834|NCT06113289|Antimetabolites|antimetabolites|mesh-ancestor
153482835|NCT06113289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153482836|NCT06113289|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153482838|NCT06112938|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153482839|NCT06110130|Empagliflozin|empagliflozin|mesh-list
153482840|NCT06110130|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
153482874|NCT05997732|Phentolamine|phentolamine|mesh-list
153482875|NCT05997732|Phenylephrine|phenylephrine|mesh-list
153482876|NCT05997732|Isoproterenol|isoproterenol|mesh-list
153482877|NCT05997732|Oxymetazoline|oxymetazoline|mesh-list
153482878|NCT05997732|Norepinephrine|norepinephrine|mesh-list
153482879|NCT05997732|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
153482880|NCT05997732|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
153482881|NCT05997732|Adrenergic Agents|adrenergic agents|mesh-ancestor
153482882|NCT05997732|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153482883|NCT05997732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153482884|NCT05997732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153482885|NCT05997732|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153482938|NCT05891548|Growth Inhibitors|growth inhibitors|mesh-ancestor
153482939|NCT05891548|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153482940|NCT05891548|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153482941|NCT05891548|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153482942|NCT05891548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153482943|NCT05862792|Bupivacaine|bupivacaine|mesh-list
153482944|NCT05862792|Anesthetics, Local|anesthetics, local|mesh-ancestor
153482945|NCT05862792|Anesthetics|anesthetics|mesh-ancestor
153482946|NCT05862792|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153482947|NCT05862792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153482948|NCT05862792|Sensory System Agents|sensory system agents|mesh-ancestor
153482949|NCT05862792|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153482999|NCT05705492|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153483000|NCT05705492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153483001|NCT05705492|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153483002|NCT05705492|Serotonin Agents|serotonin agents|mesh-ancestor
153483012|NCT05557578|Gemcitabine|gemcitabine|mesh-list
153483013|NCT05557578|Oxaliplatin|oxaliplatin|mesh-list
153483014|NCT05557578|Tislelizumab|tislelizumab|mesh-list
153483015|NCT05557578|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153483016|NCT05557578|Antimetabolites|antimetabolites|mesh-ancestor
153483017|NCT05557578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153483033|NCT05482516|Growth Inhibitors|growth inhibitors|mesh-ancestor
153483034|NCT05482516|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153483035|NCT05482516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153483036|NCT05475873|Ondansetron|ondansetron|mesh-list
153483037|NCT05475873|Antiemetics|antiemetics|mesh-ancestor
153483038|NCT05475873|Autonomic Agents|autonomic agents|mesh-ancestor
153483103|NCT04982874|Furosemide|furosemide|mesh-list
153483104|NCT04982874|Diuretics|diuretics|mesh-ancestor
153483105|NCT04982874|Natriuretic Agents|natriuretic agents|mesh-ancestor
153483106|NCT04982874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153483107|NCT04982874|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
153483108|NCT04982874|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153483109|NCT04982874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153483110|NCT04966585|Posaconazole|posaconazole|mesh-list
153483111|NCT04966585|Antifungal Agents|antifungal agents|mesh-ancestor
153483112|NCT04966585|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153483113|NCT04966585|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
153483114|NCT04966585|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153483115|NCT04966585|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153483116|NCT04966585|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
153483117|NCT04966585|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153483118|NCT04966585|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153483119|NCT04966585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153483120|NCT04966585|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153483121|NCT04966585|Hormone Antagonists|hormone antagonists|mesh-ancestor
153483157|NCT04812379|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153483158|NCT04812379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153483159|NCT04812379|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
153483160|NCT04812379|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
153483161|NCT04812379|Serotonin Agents|serotonin agents|mesh-ancestor
153483162|NCT04812379|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
153483163|NCT04812379|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153483164|NCT04812379|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
153483165|NCT04812379|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
153483167|NCT04681833|Immunologic Factors|immunologic factors|mesh-ancestor
153483168|NCT04681833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153483169|NCT04629729|Cyclophosphamide|cyclophosphamide|mesh-list
153483205|NCT04582383|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
153483207|NCT04582383|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153483208|NCT04582383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153483209|NCT04582383|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
153483210|NCT04582383|Diuretics|diuretics|mesh-ancestor
153483211|NCT04582383|Natriuretic Agents|natriuretic agents|mesh-ancestor
153483212|NCT04546672|Neostigmine|neostigmine|mesh-list
153483213|NCT04546672|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
153483214|NCT04546672|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153483215|NCT04546672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153483216|NCT04546672|Cholinergic Agents|cholinergic agents|mesh-ancestor
153483217|NCT04546672|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153483218|NCT04546672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153483219|NCT04546672|Parasympathomimetics|parasympathomimetics|mesh-ancestor
153483220|NCT04546672|Autonomic Agents|autonomic agents|mesh-ancestor
153483260|NCT04437485|Norepinephrine|norepinephrine|mesh-list
153483262|NCT04437485|Antidepressive Agents|antidepressive agents|mesh-list
153483264|NCT04437485|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-list
153483265|NCT04437485|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
153483266|NCT04437485|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153483267|NCT04437485|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
153483268|NCT04437485|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153483269|NCT04437485|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153483270|NCT04437485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153483271|NCT04437485|Dopamine Agents|dopamine agents|mesh-ancestor
153483272|NCT04437485|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153483273|NCT04437485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153483274|NCT04437485|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
153483275|NCT04437485|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153483276|NCT04437485|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153483277|NCT04437485|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153483278|NCT04437485|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153483279|NCT04437485|Adrenergic Agents|adrenergic agents|mesh-ancestor
153483280|NCT04437485|Sympathomimetics|sympathomimetics|mesh-ancestor
153483281|NCT04437485|Autonomic Agents|autonomic agents|mesh-ancestor
153483282|NCT04437485|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153483380|NCT03586089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153483381|NCT03586089|GABA Modulators|gaba modulators|mesh-ancestor
153483382|NCT03586089|GABA Agents|gaba agents|mesh-ancestor
153483383|NCT03586089|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
153483384|NCT03586089|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
153483385|NCT03586089|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
153483386|NCT03586089|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153483387|NCT03586089|Antiemetics|antiemetics|mesh-ancestor
153483388|NCT03586089|Autonomic Agents|autonomic agents|mesh-ancestor
153483389|NCT03586089|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153483390|NCT03586089|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153483391|NCT03586089|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
153483392|NCT03586089|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
153483393|NCT03586089|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153483394|NCT03586089|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153483395|NCT03586089|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153483396|NCT03586089|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153483397|NCT03586089|Anesthetics, General|anesthetics, general|mesh-ancestor
153483398|NCT03586089|Anesthetics|anesthetics|mesh-ancestor
153483399|NCT03546686|Pembrolizumab|pembrolizumab|mesh-list
153483400|NCT03546686|Nivolumab|nivolumab|mesh-list
153483401|NCT03546686|Ipilimumab|ipilimumab|mesh-list
153483419|NCT03508921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153483421|NCT03508921|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153483422|NCT03508921|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
153483423|NCT03508921|Antimalarials|antimalarials|mesh-ancestor
153483424|NCT03508921|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153483425|NCT03508921|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153483426|NCT03508921|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153483427|NCT03508921|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153483485|NCT03125642|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153483486|NCT03125642|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153483487|NCT03125642|Alkylating Agents|alkylating agents|mesh-ancestor
153483488|NCT03125642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153483489|NCT03125642|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153483559|NCT01961219|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153483619|NCT00701155|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153483620|NCT00701155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153483622|NCT00687453|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153483623|NCT00687453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153483624|NCT00687063|Insulin Detemir|insulin detemir|mesh-list
153483625|NCT00687063|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153483626|NCT00687063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153483691|NCT00476437|Biphasic Insulins|biphasic insulins|mesh-list
153483692|NCT00476437|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153483693|NCT00476437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153483694|NCT00414648|Sirolimus|sirolimus|mesh-list
153483695|NCT00414648|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153483696|NCT00414648|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153483697|NCT00414648|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153483698|NCT00414648|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153483699|NCT00414648|Antifungal Agents|antifungal agents|mesh-ancestor
153483700|NCT00414648|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153483701|NCT00414648|Immunologic Factors|immunologic factors|mesh-ancestor
153483702|NCT00414648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153483703|NCT00337155|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
153483704|NCT00337155|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153483705|NCT00313742|Insulin|insulin|mesh-list
153483706|NCT00313742|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
153483707|NCT00313742|Insulin Glargine|insulin glargine|mesh-list
153483708|NCT00313742|Insulin Detemir|insulin detemir|mesh-list
153483709|NCT00313742|Isophane Insulin, Human|isophane insulin, human|mesh-list
153483752|NCT01537926|Acetylcysteine|acetylcysteine|mesh-list
153483753|NCT01537926|N-monoacetylcystine|n-monoacetylcystine|mesh-list
153483754|NCT01537926|Antiviral Agents|antiviral agents|mesh-ancestor
153483755|NCT01537926|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153483756|NCT01537926|Expectorants|expectorants|mesh-ancestor
153483757|NCT01537926|Respiratory System Agents|respiratory system agents|mesh-ancestor
153483758|NCT01537926|Free Radical Scavengers|free radical scavengers|mesh-ancestor
153483760|NCT01537926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153483819|NCT01551888|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153483820|NCT01551888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153483821|NCT01551888|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153483824|NCT01551888|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
153483888|NCT01563198|Hypnotics and Sedatives|hypnotics and sedatives|mesh-list
153483889|NCT01563198|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153483890|NCT01563198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153483891|NCT01564914|Bevacizumab|bevacizumab|mesh-list
153483892|NCT01564914|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153483893|NCT01564914|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153483894|NCT01564914|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153483895|NCT01564914|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153483896|NCT01564914|Growth Substances|growth substances|mesh-ancestor
153483897|NCT01564914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153483898|NCT01564914|Growth Inhibitors|growth inhibitors|mesh-ancestor
153483899|NCT01565538|Pemetrexed|pemetrexed|mesh-list
153483900|NCT01565538|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
153483901|NCT01565538|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153483902|NCT01565538|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153484013|NCT05564832|Ophthalmic Solutions|ophthalmic solutions|mesh-list
153484015|NCT05564832|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
153484016|NCT05564832|Miotics|miotics|mesh-ancestor
153484017|NCT05564832|Autonomic Agents|autonomic agents|mesh-ancestor
153484018|NCT05564832|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153484019|NCT05564832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153484020|NCT05564832|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
153484021|NCT05564832|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
153484022|NCT05564832|Cholinergic Agents|cholinergic agents|mesh-ancestor
153484023|NCT05564832|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153484024|NCT05564832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153484025|NCT05564442|Benzocaine|benzocaine|mesh-list
153484026|NCT05564442|Anesthetics, Local|anesthetics, local|mesh-ancestor
153484027|NCT05564442|Anesthetics|anesthetics|mesh-ancestor
153484028|NCT05564442|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153484029|NCT05564442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153484066|NCT05672394|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153484067|NCT05672394|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
153484068|NCT05672394|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153484069|NCT05672394|Autonomic Agents|autonomic agents|mesh-ancestor
153484070|NCT05672394|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153484071|NCT05672394|Respiratory System Agents|respiratory system agents|mesh-ancestor
153484073|NCT05672394|Sympathomimetics|sympathomimetics|mesh-ancestor
153484074|NCT05672394|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
153484075|NCT03729258|Amantadine|amantadine|mesh-list
153484076|NCT03729258|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
153484077|NCT03729258|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
153484079|NCT03729258|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153484080|NCT03729258|Dopamine Agents|dopamine agents|mesh-ancestor
153484081|NCT03729258|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153484082|NCT03729258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153484083|NCT03729258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153484084|NCT03729258|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153484085|NCT03729258|Analgesics|analgesics|mesh-ancestor
153484086|NCT03729258|Sensory System Agents|sensory system agents|mesh-ancestor
153484087|NCT03729258|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153484088|NCT03355170|Domperidone|domperidone|mesh-list
153484089|NCT03355170|Lansoprazole|lansoprazole|mesh-list
153484090|NCT03355170|Dexlansoprazole|dexlansoprazole|mesh-list
153484091|NCT03355170|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
153484092|NCT03355170|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153484093|NCT03355170|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
153484116|NCT05120076|Antiemetics|antiemetics|mesh-ancestor
153484117|NCT05120076|Autonomic Agents|autonomic agents|mesh-ancestor
153484118|NCT05120076|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153484119|NCT05120076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153484120|NCT05120076|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153484121|NCT05120076|Glucocorticoids|glucocorticoids|mesh-ancestor
153484122|NCT05120076|Hormones|hormones|mesh-ancestor
153484123|NCT05120076|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153484124|NCT05120076|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153484145|NCT04508166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153484146|NCT04508166|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153484147|NCT04508166|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153484149|NCT04508166|Anesthetics|anesthetics|mesh-ancestor
153484150|NCT04175964|Metformin|metformin|mesh-list
153484157|NCT03624270|Protective Agents|protective agents|mesh-ancestor
153484158|NCT03624270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153484159|NCT03624270|Vitamins|vitamins|mesh-ancestor
153484160|NCT03624270|Micronutrients|micronutrients|mesh-ancestor
153484161|NCT03624270|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153484162|NCT03455088|Fluoxetine|fluoxetine|mesh-list
153484163|NCT03455088|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
153484164|NCT03455088|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153484165|NCT03455088|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153484166|NCT03455088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153484167|NCT03455088|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153484219|NCT01610154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153484221|NCT01611948|Antiemetics|antiemetics|mesh-ancestor
153484222|NCT01611948|Autonomic Agents|autonomic agents|mesh-ancestor
153484223|NCT01611948|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153484224|NCT01611948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153484225|NCT01611948|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153484226|NCT01611948|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
153484227|NCT01611948|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153484228|NCT01611948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153484229|NCT01612884|Clopidogrel|clopidogrel|mesh-list
153484281|NCT01620216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153484282|NCT01620216|Growth Inhibitors|growth inhibitors|mesh-ancestor
153484283|NCT01620216|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153484284|NCT01621230|Fentanyl|fentanyl|mesh-list
153484285|NCT01621230|Bupivacaine|bupivacaine|mesh-list
153484286|NCT01621230|Anesthetics, Local|anesthetics, local|mesh-ancestor
153484287|NCT01621230|Anesthetics|anesthetics|mesh-ancestor
153484305|NCT01631682|Propranolol|propranolol|mesh-list
153484306|NCT01631682|Oxytocin|oxytocin|mesh-list
153484307|NCT01631682|Mifepristone|mifepristone|mesh-list
153484308|NCT01631682|Oxytocics|oxytocics|mesh-ancestor
153484309|NCT01631682|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153484310|NCT01631682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153484311|NCT01631682|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
153484312|NCT01631682|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
153484315|NCT01631682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153484316|NCT01631682|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153484317|NCT01631682|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153484323|NCT01631682|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
153484324|NCT01631682|Contraceptive Agents|contraceptive agents|mesh-ancestor
153484325|NCT01631682|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
153484326|NCT01631682|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
153484327|NCT01631682|Hormone Antagonists|hormone antagonists|mesh-ancestor
153484328|NCT01631682|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153484329|NCT01631682|Luteolytic Agents|luteolytic agents|mesh-ancestor
153484330|NCT01631682|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
153484331|NCT01631682|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
153484332|NCT01635504|Botulinum Toxins|botulinum toxins|mesh-list
153484333|NCT01635504|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
153484334|NCT01635504|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
153484335|NCT01635504|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
153484336|NCT01635504|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153484337|NCT01635504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153484338|NCT01635504|Cholinergic Agents|cholinergic agents|mesh-ancestor
153484339|NCT01635504|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153484340|NCT01635504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153484341|NCT01635504|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
153484342|NCT01635504|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153484343|NCT01636206|Lifitegrast|lifitegrast|mesh-list
153484344|NCT01636206|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
153484345|NCT01636206|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
153484346|NCT01639872|Risperidone|risperidone|mesh-list
153484347|NCT01639872|Clozapine|clozapine|mesh-list
153484348|NCT01639872|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153484349|NCT01639872|Serotonin Agents|serotonin agents|mesh-ancestor
153484350|NCT01639872|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153484374|NCT01640340|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153484375|NCT01640340|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153484376|NCT01640340|Antipruritics|antipruritics|mesh-ancestor
153484377|NCT01640340|Dermatologic Agents|dermatologic agents|mesh-ancestor
153484378|NCT01640340|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
153484379|NCT01640340|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153484380|NCT01640340|Serotonin Agents|serotonin agents|mesh-ancestor
153484381|NCT01640340|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153484382|NCT01640340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153484419|NCT01644396|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153484420|NCT01644396|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153484421|NCT01645098|Dexmedetomidine|dexmedetomidine|mesh-list
153484422|NCT01645098|Ketamine|ketamine|mesh-list
153484423|NCT01645098|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153484424|NCT01645098|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153484425|NCT01645098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153484426|NCT01645098|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153484427|NCT01645098|Analgesics|analgesics|mesh-ancestor
153484428|NCT01645098|Sensory System Agents|sensory system agents|mesh-ancestor
153484429|NCT01645098|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153484430|NCT01645098|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
153484431|NCT01645098|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153484432|NCT01645098|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153484433|NCT01645098|Adrenergic Agents|adrenergic agents|mesh-ancestor
153484434|NCT01645098|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153484435|NCT01645098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153484436|NCT01645098|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
153484437|NCT01645098|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153484438|NCT01645098|Anesthetics, General|anesthetics, general|mesh-ancestor
153484439|NCT01645098|Anesthetics|anesthetics|mesh-ancestor
153484440|NCT01645098|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
153484441|NCT01645098|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
153484442|NCT01650402|Antihypertensive Agents|antihypertensive agents|mesh-list
153484443|NCT01651806|Tranexamic Acid|tranexamic acid|mesh-list
153484444|NCT01651806|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
153484445|NCT01651806|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153484447|NCT01651806|Hemostatics|hemostatics|mesh-ancestor
153484466|NCT01652976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153484467|NCT01652976|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153484469|NCT01652976|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153484491|NCT01661088|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153484492|NCT01661946|Bevacizumab|bevacizumab|mesh-list
153484493|NCT01661946|Ranibizumab|ranibizumab|mesh-list
153484494|NCT01661946|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153484495|NCT01661946|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153484496|NCT01661946|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153484497|NCT01661946|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153484498|NCT01661946|Growth Substances|growth substances|mesh-ancestor
153484499|NCT01661946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153484507|NCT01667796|Cholecalciferol|cholecalciferol|mesh-list
153484509|NCT01667796|Micronutrients|micronutrients|mesh-ancestor
153484510|NCT01667796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153484511|NCT01667796|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153484512|NCT01667796|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153484514|NCT01668030|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
153484515|NCT01668030|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153484516|NCT01668030|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153484517|NCT01669434|Ramipril|ramipril|mesh-list
153484573|NCT01692756|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
153484574|NCT01692756|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
153484575|NCT01692756|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153484576|NCT01692756|Glucocorticoids|glucocorticoids|mesh-ancestor
153484577|NCT01692756|Hormones|hormones|mesh-ancestor
153484578|NCT01692756|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153484644|NCT01707420|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153484645|NCT01707420|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
153484646|NCT01707420|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
153484647|NCT01707420|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153484648|NCT01707420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153484650|NCT01708122|Fentanyl|fentanyl|mesh-list
153484651|NCT01708122|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153484652|NCT01708122|Narcotics|narcotics|mesh-ancestor
153484717|NCT05136066|Peppermint oil|peppermint oil|mesh-list
153484779|NCT01721226|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153484780|NCT01721460|Dexmedetomidine|dexmedetomidine|mesh-list
153484781|NCT01721460|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153484782|NCT01721460|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153484783|NCT01721460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153484784|NCT01721460|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153484786|NCT01721460|Sensory System Agents|sensory system agents|mesh-ancestor
153484787|NCT01721460|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153484788|NCT01721460|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
153484789|NCT01721460|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153484790|NCT01721460|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153484791|NCT01721460|Adrenergic Agents|adrenergic agents|mesh-ancestor
153484792|NCT01721460|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153484793|NCT01721460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153484794|NCT01722318|Plecanatide|plecanatide|mesh-list
153484795|NCT01722318|Guanylyl Cyclase C Agonists|guanylyl cyclase c agonists|mesh-ancestor
153484796|NCT01722318|Enzyme Activators|enzyme activators|mesh-ancestor
153484797|NCT01722318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153484798|NCT01722318|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153484799|NCT01723722|Methadone|methadone|mesh-list
153484800|NCT01723722|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153484801|NCT01723722|Narcotics|narcotics|mesh-ancestor
153484802|NCT01723722|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153484803|NCT01723722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153484804|NCT01723722|Analgesics|analgesics|mesh-ancestor
153484807|NCT01723722|Antitussive Agents|antitussive agents|mesh-ancestor
153484824|NCT01729338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153484825|NCT01729338|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153484826|NCT01729338|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153484827|NCT01729338|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153484828|NCT01729338|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153484829|NCT01729338|Growth Substances|growth substances|mesh-ancestor
153484894|NCT03162510|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153484895|NCT03162510|Tubulin Modulators|tubulin modulators|mesh-ancestor
153484896|NCT03162510|Antimitotic Agents|antimitotic agents|mesh-ancestor
153484897|NCT03162510|Mitosis Modulators|mitosis modulators|mesh-ancestor
153484898|NCT03162510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153484899|NCT03162510|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153484962|NCT01740414|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153484963|NCT01740414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153484964|NCT01740414|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153484965|NCT01740414|Respiratory System Agents|respiratory system agents|mesh-ancestor
153484966|NCT01740414|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
153484967|NCT01740414|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153484968|NCT01740414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153484969|NCT01740414|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153484970|NCT01740414|Vasodilator Agents|vasodilator agents|mesh-ancestor
153484971|NCT01740726|Fluoxetine|fluoxetine|mesh-list
153484972|NCT01740726|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
153484973|NCT01740726|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153484974|NCT01740726|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153484975|NCT01740726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153485016|NCT01750086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153485017|NCT01750086|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153485018|NCT01750398|Methyltestosterone|methyltestosterone|mesh-list
153485019|NCT01750398|Leuprolide|leuprolide|mesh-list
153485020|NCT01750398|Goserelin|goserelin|mesh-list
153485021|NCT01750398|Testosterone|testosterone|mesh-list
153485022|NCT01750398|Testosterone undecanoate|testosterone undecanoate|mesh-list
153485023|NCT01750398|Testosterone enanthate|testosterone enanthate|mesh-list
153485024|NCT01750398|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
153485025|NCT01750398|Androgens|androgens|mesh-ancestor
153485026|NCT01750398|Hormones|hormones|mesh-ancestor
153485027|NCT01750398|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153485028|NCT01750398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153485029|NCT01750398|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153485030|NCT01750398|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153485031|NCT01750398|Anabolic Agents|anabolic agents|mesh-ancestor
153485032|NCT01750398|Fertility Agents, Female|fertility agents, female|mesh-ancestor
153485033|NCT01750398|Fertility Agents|fertility agents|mesh-ancestor
153485034|NCT01750398|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153485035|NCT01752426|Deuterium Oxide|deuterium oxide|mesh-list
153485036|NCT01752426|Ibrutinib|ibrutinib|mesh-list
153485037|NCT01752426|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153485038|NCT01752426|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153485051|NCT01753362|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153485053|NCT01758588|Interferon-alpha|interferon-alpha|mesh-list
153485054|NCT01758588|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
153485055|NCT01758588|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153485056|NCT01758588|Antiviral Agents|antiviral agents|mesh-ancestor
153485057|NCT01758588|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153485058|NCT01758588|Immunologic Factors|immunologic factors|mesh-ancestor
153485059|NCT01758588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153485060|NCT01759602|Complement C1s|complement c1s|mesh-list
153485061|NCT01759602|Complement C1 Inhibitor Protein|complement c1 inhibitor protein|mesh-list
153485062|NCT01759602|Complement C1 Inactivator Proteins|complement c1 inactivator proteins|mesh-list
153485063|NCT01759602|Immunologic Factors|immunologic factors|mesh-ancestor
153485114|NCT01769586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153485115|NCT01769586|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
153485116|NCT01769586|Anesthetics, Local|anesthetics, local|mesh-ancestor
153485117|NCT01769586|Sensory System Agents|sensory system agents|mesh-ancestor
153485118|NCT01769586|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153485119|NCT01769586|Antiemetics|antiemetics|mesh-ancestor
153485120|NCT01769586|Autonomic Agents|autonomic agents|mesh-ancestor
153485172|NCT01785186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153485173|NCT01785186|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153485174|NCT01785186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153485175|NCT01785186|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
153485176|NCT01785186|Antitubercular Agents|antitubercular agents|mesh-ancestor
153485177|NCT01785186|Leprostatic Agents|leprostatic agents|mesh-ancestor
153485178|NCT01785186|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153485179|NCT01785186|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
153485180|NCT01785186|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
153485181|NCT01785186|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
153485182|NCT01785186|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
153485183|NCT01785186|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
153485184|NCT01785186|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
153485221|NCT01790490|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153485222|NCT01790490|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
153485223|NCT01790490|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
153485224|NCT01790490|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153485225|NCT01790490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153485226|NCT01790490|Anticonvulsants|anticonvulsants|mesh-ancestor
153485227|NCT01790490|Antiemetics|antiemetics|mesh-ancestor
153485228|NCT01790490|Autonomic Agents|autonomic agents|mesh-ancestor
153485229|NCT01790490|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153485230|NCT01790490|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153485231|NCT01790490|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153485232|NCT01790490|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153485233|NCT01790490|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153485234|NCT01790490|GABA Modulators|gaba modulators|mesh-ancestor
153485235|NCT01790490|GABA Agents|gaba agents|mesh-ancestor
153485252|NCT01794702|Decitabine|decitabine|mesh-list
153485253|NCT01794702|Clofarabine|clofarabine|mesh-list
153485254|NCT01794702|Idarubicin|idarubicin|mesh-list
153485255|NCT01794702|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153485256|NCT01794702|Antimetabolites|antimetabolites|mesh-ancestor
153485257|NCT01794702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153485258|NCT01794702|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153485259|NCT01794702|Antiviral Agents|antiviral agents|mesh-ancestor
153485325|NCT06020456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153485326|NCT06020378|Hydroxychloroquine|hydroxychloroquine|mesh-list
153485327|NCT06020378|Antimalarials|antimalarials|mesh-ancestor
153485328|NCT06020378|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153485329|NCT06020378|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153485330|NCT06020378|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153485331|NCT06020378|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153485332|NCT06020378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153485333|NCT06020378|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153485390|NCT06019130|Interferon-beta|interferon-beta|mesh-list
153485391|NCT06019130|Interferon beta-1a|interferon beta-1a|mesh-list
153485392|NCT06019130|Cisplatin|cisplatin|mesh-list
153485393|NCT06019130|Gemcitabine|gemcitabine|mesh-list
153485394|NCT06019130|Nivolumab|nivolumab|mesh-list
153485395|NCT06019130|Fluorouracil|fluorouracil|mesh-list
153485396|NCT06019130|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153485397|NCT06019130|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153485398|NCT06019130|Antimetabolites|antimetabolites|mesh-ancestor
153485399|NCT06019130|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153485400|NCT06019130|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153485401|NCT06019130|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153485402|NCT06019130|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153485403|NCT06019130|Immunologic Factors|immunologic factors|mesh-ancestor
153485404|NCT06019130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153485405|NCT06019130|Antiviral Agents|antiviral agents|mesh-ancestor
153485406|NCT06019130|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153485436|NCT06014944|Immunologic Factors|immunologic factors|mesh-ancestor
153485437|NCT06014944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153485438|NCT06014359|Dexmedetomidine|dexmedetomidine|mesh-list
153485439|NCT06014359|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153485440|NCT06014359|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153485441|NCT06014359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153485442|NCT06014359|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153485500|NCT05982990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153485501|NCT05982990|Glucocorticoids|glucocorticoids|mesh-ancestor
153485502|NCT05982990|Hormones|hormones|mesh-ancestor
153485503|NCT05982990|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153485504|NCT05982990|Sympathomimetics|sympathomimetics|mesh-ancestor
153485511|NCT05972655|Antibodies|antibodies|mesh-list
153485570|NCT05875077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153485571|NCT05875077|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153485572|NCT05875077|Anesthetics, General|anesthetics, general|mesh-ancestor
153485573|NCT05875077|Anesthetics|anesthetics|mesh-ancestor
153485574|NCT05852158|Cefazolin|cefazolin|mesh-list
153485575|NCT05852158|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153485643|NCT05633147|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153485644|NCT05633147|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153485645|NCT05633147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153485646|NCT05633147|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153485647|NCT05633147|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153485648|NCT05633147|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153485649|NCT05633147|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153485650|NCT05633147|Anesthetics, General|anesthetics, general|mesh-ancestor
153485652|NCT05633147|GABA Modulators|gaba modulators|mesh-ancestor
153485708|NCT05420948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153485709|NCT05420948|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153485710|NCT05420948|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153485711|NCT05418348|Nimodipine|nimodipine|mesh-list
153485712|NCT05418348|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153485713|NCT05418348|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153485714|NCT05418348|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153485715|NCT05418348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153485716|NCT05418348|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153485717|NCT05418348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153485718|NCT05418348|Vasodilator Agents|vasodilator agents|mesh-ancestor
153485719|NCT05416320|Calcipotriene|calcipotriene|mesh-list
153485720|NCT05416320|Dermatologic Agents|dermatologic agents|mesh-ancestor
153485721|NCT05377606|Temazepam|temazepam|mesh-list
153485722|NCT05377606|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153485763|NCT05350371|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153485842|NCT05115513|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153485843|NCT04978298|Phenelzine|phenelzine|mesh-list
153485844|NCT04978298|Ozanimod|ozanimod|mesh-list
153485854|NCT04921527|Paclitaxel|paclitaxel|mesh-list
153485890|NCT04811573|Immunologic Factors|immunologic factors|mesh-ancestor
153485891|NCT04811573|Leprostatic Agents|leprostatic agents|mesh-ancestor
153485892|NCT04811573|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153485893|NCT04811573|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153485894|NCT04811573|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153485895|NCT04811573|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153485896|NCT04811573|Growth Substances|growth substances|mesh-ancestor
153485897|NCT04811573|Growth Inhibitors|growth inhibitors|mesh-ancestor
153485898|NCT04811573|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153485899|NCT04774094|Ceftazidime|ceftazidime|mesh-list
153485956|NCT04605081|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153485957|NCT04605081|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
153485958|NCT04605081|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153485959|NCT04605081|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153485960|NCT04605081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153486023|NCT04526210|Chelating Agents|chelating agents|mesh-ancestor
153486024|NCT04526210|Sequestering Agents|sequestering agents|mesh-ancestor
153486025|NCT04526210|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153486026|NCT04526210|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153486027|NCT04526210|Growth Substances|growth substances|mesh-ancestor
153486028|NCT04526210|Growth Inhibitors|growth inhibitors|mesh-ancestor
153486029|NCT04526210|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153486030|NCT04422652|Bupropion|bupropion|mesh-list
153486031|NCT04422652|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
153486032|NCT04422652|Antidepressive Agents|antidepressive agents|mesh-ancestor
153486033|NCT04422652|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153486034|NCT04422652|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
153486035|NCT04422652|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153486082|NCT04190056|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153486083|NCT04190056|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153486084|NCT04190056|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153486085|NCT04190056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153486086|NCT04190056|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
153486087|NCT04190056|Hormone Antagonists|hormone antagonists|mesh-ancestor
153486088|NCT04190056|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153486089|NCT04190056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153486090|NCT04190056|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153486091|NCT04190056|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
153486092|NCT04190056|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
153486093|NCT04190056|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153486094|NCT04190056|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
153486095|NCT04190056|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153486097|NCT04189757|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-list
153486112|NCT04149964|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153486114|NCT04149964|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153486115|NCT04149964|Antitussive Agents|antitussive agents|mesh-ancestor
153486116|NCT04149964|Respiratory System Agents|respiratory system agents|mesh-ancestor
153486117|NCT04149964|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153486120|NCT04076579|Olaparib|olaparib|mesh-list
153486163|NCT03777813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153486164|NCT03777813|Vitamin B Complex|vitamin b complex|mesh-ancestor
153486165|NCT03777813|Vitamins|vitamins|mesh-ancestor
153486166|NCT03777813|Micronutrients|micronutrients|mesh-ancestor
153486167|NCT03777813|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153486168|NCT03754933|Fludarabine|fludarabine|mesh-list
153486169|NCT03754933|Fludarabine phosphate|fludarabine phosphate|mesh-list
153486170|NCT03754933|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153486171|NCT03754933|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153486172|NCT03754933|Antimetabolites|antimetabolites|mesh-ancestor
153486173|NCT03754933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153486174|NCT03754933|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153486230|NCT03229499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153486231|NCT03223025|Hormones|hormones|mesh-list
153486232|NCT03223025|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153486233|NCT03223025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153486234|NCT03118037|Zaleplon|zaleplon|mesh-list
153486235|NCT03118037|Anticonvulsants|anticonvulsants|mesh-ancestor
153486236|NCT03118037|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153486237|NCT03118037|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153486238|NCT03118037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153486281|NCT02492867|Durvalumab|durvalumab|mesh-list
153486282|NCT02492867|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153486283|NCT02492867|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153486284|NCT02492867|Tubulin Modulators|tubulin modulators|mesh-ancestor
153486285|NCT02492867|Antimitotic Agents|antimitotic agents|mesh-ancestor
153486286|NCT02492867|Mitosis Modulators|mitosis modulators|mesh-ancestor
153486287|NCT02492867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153486288|NCT02492867|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153486289|NCT02375204|Paclitaxel|paclitaxel|mesh-list
153486290|NCT02375204|Etoposide|etoposide|mesh-list
153486291|NCT02375204|Carboplatin|carboplatin|mesh-list
153486292|NCT02375204|Ifosfamide|ifosfamide|mesh-list
153486293|NCT02375204|Etoposide phosphate|etoposide phosphate|mesh-list
153486294|NCT02375204|Lenograstim|lenograstim|mesh-list
153486295|NCT02375204|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153486296|NCT02375204|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153486297|NCT02375204|Tubulin Modulators|tubulin modulators|mesh-ancestor
153486298|NCT02375204|Antimitotic Agents|antimitotic agents|mesh-ancestor
153486299|NCT02375204|Mitosis Modulators|mitosis modulators|mesh-ancestor
153486300|NCT02375204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153486301|NCT02375204|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153486302|NCT02375204|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153486303|NCT02375204|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153486304|NCT02375204|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153486305|NCT02375204|Immunologic Factors|immunologic factors|mesh-ancestor
153486306|NCT02375204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153486312|NCT02269319|Linezolid|linezolid|mesh-list
153486330|NCT02055456|Hormones|hormones|mesh-ancestor
153486331|NCT02055456|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153486332|NCT02055456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153486333|NCT02055456|Anabolic Agents|anabolic agents|mesh-ancestor
153486334|NCT02055456|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153486335|NCT02031250|Carboplatin|carboplatin|mesh-list
153486336|NCT02031250|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153486337|NCT01995669|Lenalidomide|lenalidomide|mesh-list
153486347|NCT01880567|Rituximab|rituximab|mesh-list
153486397|NCT01568177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153486398|NCT01503632|Mercaptopurine|mercaptopurine|mesh-list
153486399|NCT01503632|Antimetabolites|antimetabolites|mesh-ancestor
153486400|NCT01503632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153486401|NCT01503632|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153486402|NCT01503632|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153486403|NCT01503632|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153486404|NCT01503632|Immunologic Factors|immunologic factors|mesh-ancestor
153486405|NCT01503632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153486466|NCT00354393|Abortifacient Agents|abortifacient agents|mesh-ancestor
153486467|NCT00354393|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153486468|NCT00354393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153486469|NCT00354393|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153486470|NCT00354393|Antimetabolites|antimetabolites|mesh-ancestor
153486471|NCT00354393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153486472|NCT00354393|Dermatologic Agents|dermatologic agents|mesh-ancestor
153486473|NCT00354393|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153486474|NCT00354393|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153486475|NCT00354393|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153486476|NCT00354393|Immunologic Factors|immunologic factors|mesh-ancestor
153486477|NCT00354393|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153486478|NCT00354393|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153486514|NCT01821378|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
153486515|NCT01821378|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153486516|NCT01821378|Serotonin Agents|serotonin agents|mesh-ancestor
153486517|NCT01821378|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
153486518|NCT01821378|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
153486519|NCT01821378|Dopamine Agents|dopamine agents|mesh-ancestor
153486521|NCT01822548|Vildagliptin|vildagliptin|mesh-list
153486522|NCT01822548|Glyburide|glyburide|mesh-list
153486523|NCT01822548|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153486524|NCT01822548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153486525|NCT01822548|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
153486526|NCT01822548|Protease Inhibitors|protease inhibitors|mesh-ancestor
153486527|NCT01822548|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153486528|NCT01822548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153486529|NCT01825122|Nadolol|nadolol|mesh-list
153486530|NCT01825122|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
153486531|NCT01825122|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
153486532|NCT01825122|Adrenergic Agents|adrenergic agents|mesh-ancestor
153486533|NCT01825122|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153486534|NCT01825122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153486535|NCT01825122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153486536|NCT01825122|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153486537|NCT01825122|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153486538|NCT01825122|Sympatholytics|sympatholytics|mesh-ancestor
153486539|NCT01825122|Autonomic Agents|autonomic agents|mesh-ancestor
153486540|NCT01825122|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153486542|NCT01825512|Deferiprone|deferiprone|mesh-list
153486543|NCT01825512|Iron Chelating Agents|iron chelating agents|mesh-ancestor
153486544|NCT01825512|Chelating Agents|chelating agents|mesh-ancestor
153486545|NCT01825512|Sequestering Agents|sequestering agents|mesh-ancestor
153486558|NCT01828476|Antimalarials|antimalarials|mesh-ancestor
153486559|NCT01828476|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153486560|NCT01828476|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153486561|NCT01828476|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153486562|NCT01828476|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153486563|NCT01828476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153486564|NCT01828476|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153486565|NCT01828476|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153486566|NCT01828554|Capecitabine|capecitabine|mesh-list
153486567|NCT01828554|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153486568|NCT01828554|Antimetabolites|antimetabolites|mesh-ancestor
153486569|NCT01828554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153486570|NCT01828554|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153486571|NCT01834404|Topiramate|topiramate|mesh-list
153486572|NCT01834404|Phentermine|phentermine|mesh-list
153486610|NCT01766076|Antimetabolites|antimetabolites|mesh-ancestor
153486611|NCT01766076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153486612|NCT01766076|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153486613|NCT01766076|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
153486614|NCT01766076|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153486615|NCT01767792|Bevacizumab|bevacizumab|mesh-list
153486616|NCT01767792|Endothelial Growth Factors|endothelial growth factors|mesh-list
153486617|NCT01767792|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153486674|NCT01842594|Immunologic Factors|immunologic factors|mesh-ancestor
153486675|NCT01842594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153486676|NCT01842594|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153486677|NCT01842594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153486678|NCT01842594|Antimalarials|antimalarials|mesh-ancestor
153486679|NCT01842594|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153486680|NCT01842594|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153486681|NCT01842594|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153486682|NCT01843920|Trimethoprim|trimethoprim|mesh-list
153486684|NCT01843920|Polymyxin B|polymyxin b|mesh-list
153486685|NCT01843920|Prednisolone|prednisolone|mesh-list
153486686|NCT01843920|Timolol|timolol|mesh-list
153486687|NCT01843920|Dorzolamide|dorzolamide|mesh-list
153486688|NCT01843920|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153486689|NCT01843920|Glucocorticoids|glucocorticoids|mesh-ancestor
153486690|NCT01843920|Hormones|hormones|mesh-ancestor
153486691|NCT01843920|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153486693|NCT01843920|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153486694|NCT01843920|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153486695|NCT01843920|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
153486696|NCT01843920|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
153486728|NCT01845636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153486729|NCT01845636|Nootropic Agents|nootropic agents|mesh-ancestor
153486730|NCT01845636|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153486731|NCT01845636|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153486732|NCT01845636|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153486733|NCT01845636|Autonomic Agents|autonomic agents|mesh-ancestor
153486734|NCT01845636|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153486735|NCT01845636|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153486736|NCT01845636|Respiratory System Agents|respiratory system agents|mesh-ancestor
153486737|NCT01845636|Mydriatics|mydriatics|mesh-ancestor
153486738|NCT01845636|Parasympatholytics|parasympatholytics|mesh-ancestor
153486739|NCT01845636|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
153486740|NCT01845636|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
153486741|NCT01845792|Abiraterone Acetate|abiraterone acetate|mesh-list
153486742|NCT01845792|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153486743|NCT01845792|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153486744|NCT01845792|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153486745|NCT01845792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153486746|NCT01845792|Hormone Antagonists|hormone antagonists|mesh-ancestor
153486747|NCT01845792|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153486748|NCT01845792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153486749|NCT01845792|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153486751|NCT01846728|Hormones|hormones|mesh-ancestor
153486775|NCT01849692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153486776|NCT01849692|Growth Inhibitors|growth inhibitors|mesh-ancestor
153486777|NCT01849692|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153486778|NCT01849770|Mexiletine|mexiletine|mesh-list
153486779|NCT01849770|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153486780|NCT01849770|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
153486781|NCT01849770|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153486782|NCT01849770|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153486783|NCT01849770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153486784|NCT01850394|Tranexamic Acid|tranexamic acid|mesh-list
153486785|NCT01850394|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
153486827|NCT01861002|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153486828|NCT01861002|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153486829|NCT01861002|Immunologic Factors|immunologic factors|mesh-ancestor
153486830|NCT01861002|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153486831|NCT01861002|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153486832|NCT01861002|Antiviral Agents|antiviral agents|mesh-ancestor
153486833|NCT01861002|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153486834|NCT01870596|Cytarabine|cytarabine|mesh-list
153486835|NCT01870596|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153486894|NCT05327088|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153486895|NCT05327088|Adrenergic Agents|adrenergic agents|mesh-ancestor
153486896|NCT05327088|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153486897|NCT05327088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153486898|NCT05327088|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153486899|NCT05327088|Narcotics|narcotics|mesh-ancestor
153486900|NCT05290194|Capecitabine|capecitabine|mesh-list
153486901|NCT05290194|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
153486902|NCT05290194|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153486903|NCT05290194|Antimetabolites|antimetabolites|mesh-ancestor
153486904|NCT05290194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153486905|NCT05290194|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153486906|NCT05290194|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153486907|NCT04774068|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
153486908|NCT04774068|Romidepsin|romidepsin|mesh-list
153486909|NCT04774068|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153486910|NCT04774068|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153486911|NCT04774068|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153486912|NCT04774068|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
153486913|NCT04774068|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153486914|NCT04774068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153486916|NCT03776760|Antiviral Agents|antiviral agents|mesh-ancestor
153486917|NCT03776760|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153486918|NCT03191526|Mogamulizumab|mogamulizumab|mesh-list
153486941|NCT05746728|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153486942|NCT05746728|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153486943|NCT05714670|Curcumin|curcumin|mesh-list
153487016|NCT04418466|Dopamine Agents|dopamine agents|mesh-ancestor
153487017|NCT04360044|Dronabinol|dronabinol|mesh-list
153487018|NCT04360044|Cannabidiol|cannabidiol|mesh-list
153487019|NCT04360044|Anticonvulsants|anticonvulsants|mesh-ancestor
153487020|NCT04360044|Hallucinogens|hallucinogens|mesh-ancestor
153487021|NCT04360044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153487022|NCT04360044|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153487023|NCT04360044|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153487024|NCT04360044|Analgesics|analgesics|mesh-ancestor
153487068|NCT01430442|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
153487069|NCT01430442|Serotonin Agents|serotonin agents|mesh-ancestor
153487070|NCT01430442|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153487071|NCT01430442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153487072|NCT01430442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153487073|NCT01420926|Bortezomib|bortezomib|mesh-list
153487074|NCT01420926|Decitabine|decitabine|mesh-list
153487075|NCT01420926|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153487076|NCT01420926|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153487077|NCT01420926|Antimetabolites|antimetabolites|mesh-ancestor
153487132|NCT01904526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153487134|NCT01906866|Antioxidants|antioxidants|mesh-ancestor
153487135|NCT01906866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153487136|NCT01906866|Protective Agents|protective agents|mesh-ancestor
153487137|NCT01906866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153487138|NCT01906866|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153487140|NCT01907334|Xhance|xhance|mesh-list
153487141|NCT01907334|Albuterol|albuterol|mesh-list
153487142|NCT01907334|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
153487197|NCT01910064|Benzoyl Peroxide|benzoyl peroxide|mesh-list
153487198|NCT01910064|Dermatologic Agents|dermatologic agents|mesh-ancestor
153487199|NCT01910064|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153487200|NCT01910064|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153487201|NCT01910064|Analgesics|analgesics|mesh-ancestor
153487202|NCT01910064|Sensory System Agents|sensory system agents|mesh-ancestor
153487266|NCT01933464|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153487267|NCT01933464|Respiratory System Agents|respiratory system agents|mesh-ancestor
153487268|NCT01933776|Vaccines|vaccines|mesh-list
153487269|NCT01933776|Immunologic Factors|immunologic factors|mesh-ancestor
153487270|NCT01933776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153487271|NCT01936896|Alpha 1-Antitrypsin|alpha 1-antitrypsin|mesh-list
153487272|NCT01936896|Protein C Inhibitor|protein c inhibitor|mesh-list
153487273|NCT01936896|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
153487274|NCT01936896|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
153487275|NCT01936896|Protease Inhibitors|protease inhibitors|mesh-ancestor
153487276|NCT01936896|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153487329|NCT01951950|Adrenergic Agents|adrenergic agents|mesh-ancestor
153487330|NCT01951950|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153487331|NCT01951950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153487332|NCT01951950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153487333|NCT01951950|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153487334|NCT01951950|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153487335|NCT01951950|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153487385|NCT05739786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153487386|NCT05739786|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153487387|NCT05739786|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153487388|NCT05739630|Cytarabine|cytarabine|mesh-list
153487389|NCT05739630|Cyclophosphamide|cyclophosphamide|mesh-list
153487390|NCT05739630|Busulfan|busulfan|mesh-list
153487391|NCT05739630|Fludarabine|fludarabine|mesh-list
153487392|NCT05739630|Mitoxantrone|mitoxantrone|mesh-list
153487393|NCT05739630|Tacrolimus|tacrolimus|mesh-list
153487394|NCT05739630|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153487395|NCT05739630|Immunologic Factors|immunologic factors|mesh-ancestor
153487396|NCT05739630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153487397|NCT05739630|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153487398|NCT05739630|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153487399|NCT05739630|Alkylating Agents|alkylating agents|mesh-ancestor
153487400|NCT05739630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153487401|NCT05739630|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153487402|NCT05739630|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153487414|NCT05738616|Lenvatinib|lenvatinib|mesh-list
153487443|NCT05737680|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153487444|NCT05735028|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
153487445|NCT05735028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153487446|NCT05735028|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153487447|NCT05735028|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153487448|NCT05725200|Gemcitabine|gemcitabine|mesh-list
153487449|NCT05725200|Methotrexate|methotrexate|mesh-list
153487450|NCT05725200|Pembrolizumab|pembrolizumab|mesh-list
153487451|NCT05725200|Trastuzumab|trastuzumab|mesh-list
153487452|NCT05725200|Cetuximab|cetuximab|mesh-list
153487453|NCT05725200|Everolimus|everolimus|mesh-list
153487509|NCT05245734|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
153487510|NCT05245734|Antibodies|antibodies|mesh-list
153487511|NCT05245734|gamma-Globulins|gamma-globulins|mesh-list
153487512|NCT05245734|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
153487513|NCT05245734|Immunologic Factors|immunologic factors|mesh-ancestor
153487514|NCT05245734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153487515|NCT05242692|Dexmedetomidine|dexmedetomidine|mesh-list
153487516|NCT05242692|Ketamine|ketamine|mesh-list
153487517|NCT05242692|Esketamine|esketamine|mesh-list
153487518|NCT05242692|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153487576|NCT03551730|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153487577|NCT03551730|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153487578|NCT03551730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153487579|NCT03366480|Paclitaxel|paclitaxel|mesh-list
153487580|NCT03366480|Carboplatin|carboplatin|mesh-list
153487581|NCT03366480|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153487582|NCT03366480|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153487583|NCT03366480|Tubulin Modulators|tubulin modulators|mesh-ancestor
153487584|NCT03366480|Antimitotic Agents|antimitotic agents|mesh-ancestor
153487642|NCT01086540|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153487644|NCT01086540|Anesthetics|anesthetics|mesh-ancestor
153487645|NCT01086540|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
153487646|NCT01086540|Histamine Antagonists|histamine antagonists|mesh-ancestor
153487699|NCT01980654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153487701|NCT01984398|Sodium Citrate|sodium citrate|mesh-list
153487702|NCT01984398|Enclomiphene|enclomiphene|mesh-list
153487704|NCT01984398|Zuclomiphene|zuclomiphene|mesh-list
153487705|NCT01984398|Anticoagulants|anticoagulants|mesh-ancestor
153487706|NCT01984398|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
153487707|NCT01984398|Chelating Agents|chelating agents|mesh-ancestor
153487708|NCT01984398|Sequestering Agents|sequestering agents|mesh-ancestor
153487710|NCT01984398|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
153487759|NCT01994538|Nasal Decongestants|nasal decongestants|mesh-ancestor
153487760|NCT01994538|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
153487761|NCT01994538|Respiratory System Agents|respiratory system agents|mesh-ancestor
153487763|NCT01998438|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
153487764|NCT01998438|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153487765|NCT01998438|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153487766|NCT01998438|Hemostatics|hemostatics|mesh-ancestor
153487767|NCT01998438|Coagulants|coagulants|mesh-ancestor
153487768|NCT01999530|Prazosin|prazosin|mesh-list
153487769|NCT01999530|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153487770|NCT01999530|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
153487819|NCT02004366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153487820|NCT02004990|Povidone-Iodine|povidone-iodine|mesh-list
153487821|NCT02004990|Povidone|povidone|mesh-list
153487822|NCT02004990|Plasma Substitutes|plasma substitutes|mesh-ancestor
153487823|NCT02004990|Blood Substitutes|blood substitutes|mesh-ancestor
153487824|NCT02004990|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
153487825|NCT02004990|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153487826|NCT02006160|4-Aminopyridine|4-aminopyridine|mesh-list
153487827|NCT02006160|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
153487828|NCT02006160|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153487829|NCT02006160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153487830|NCT02011464|Bupivacaine|bupivacaine|mesh-list
153487831|NCT02011464|Anesthetics, Local|anesthetics, local|mesh-ancestor
153487832|NCT02011464|Anesthetics|anesthetics|mesh-ancestor
153487833|NCT02011464|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153487834|NCT02011464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153487835|NCT02011464|Sensory System Agents|sensory system agents|mesh-ancestor
153487836|NCT02011464|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153487837|NCT02058420|Tocotrienols|tocotrienols|mesh-list
153487838|NCT02058420|Vitamin E|vitamin e|mesh-list
153487839|NCT02058420|Tocopherols|tocopherols|mesh-list
153487840|NCT02058420|Antioxidants|antioxidants|mesh-ancestor
153487874|NCT02025426|Phenylephrine|phenylephrine|mesh-list
153487875|NCT02025426|Oxymetazoline|oxymetazoline|mesh-list
153487932|NCT02032758|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
153487934|NCT02032758|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153487935|NCT02032758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153487936|NCT02032758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153487937|NCT02032758|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153487938|NCT02032758|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153487939|NCT02032758|Vasodilator Agents|vasodilator agents|mesh-ancestor
153487940|NCT02036424|Dexamethasone|dexamethasone|mesh-list
153487941|NCT02036424|Bevacizumab|bevacizumab|mesh-list
153487942|NCT02036424|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153487943|NCT02036424|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153487955|NCT02036424|Hormones|hormones|mesh-ancestor
153487993|NCT02054754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153487994|NCT02054754|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
153487997|NCT02054754|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153487999|NCT02054754|Analgesics|analgesics|mesh-ancestor
153488063|NCT02062710|Dextromethorphan|dextromethorphan|mesh-list
153488064|NCT02062710|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
153488065|NCT02062710|Mydriatics|mydriatics|mesh-ancestor
153488066|NCT02062710|Autonomic Agents|autonomic agents|mesh-ancestor
153488067|NCT02062710|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153488068|NCT02062710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153488069|NCT02062710|Sympathomimetics|sympathomimetics|mesh-ancestor
153488070|NCT02062710|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
153488071|NCT02062710|Nasal Decongestants|nasal decongestants|mesh-ancestor
153488129|NCT02135016|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
153488130|NCT02135016|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153488131|NCT02135016|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153488132|NCT02135016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153488135|NCT02135094|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153488197|NCT02158572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153488198|NCT02159976|Amoxicillin|amoxicillin|mesh-list
153488199|NCT02159976|Metronidazole|metronidazole|mesh-list
153488200|NCT02159976|Clarithromycin|clarithromycin|mesh-list
153488201|NCT02159976|Tetracycline|tetracycline|mesh-list
153488202|NCT02159976|Pantoprazole|pantoprazole|mesh-list
153488204|NCT02159976|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153488205|NCT02159976|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153488206|NCT02159976|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
153488207|NCT02159976|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153488208|NCT02159976|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
153488209|NCT02159976|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153488210|NCT02159976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153488262|NCT02178696|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
153488265|NCT02179788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153488266|NCT02180100|Fluconazole|fluconazole|mesh-list
153488267|NCT02180100|Terconazole|terconazole|mesh-list
153488268|NCT02180100|Antifungal Agents|antifungal agents|mesh-ancestor
153488269|NCT02180100|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153488280|NCT02181426|Ketorolac|ketorolac|mesh-list
153488311|NCT02201394|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153488312|NCT02201394|Analgesics|analgesics|mesh-ancestor
153488313|NCT02201394|Sensory System Agents|sensory system agents|mesh-ancestor
153488314|NCT02201394|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153488315|NCT02201394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153488316|NCT02201394|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153488317|NCT02201394|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153488318|NCT02201394|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
153488319|NCT02201394|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153488375|NCT02214420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153488376|NCT02214420|Antiviral Agents|antiviral agents|mesh-ancestor
153488377|NCT02214420|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153488378|NCT02214420|Protease Inhibitors|protease inhibitors|mesh-ancestor
153488379|NCT02214420|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153488380|NCT02215200|Lenograstim|lenograstim|mesh-list
153488381|NCT02215200|Thymoglobulin|thymoglobulin|mesh-list
153488445|NCT02239380|Anticonvulsants|anticonvulsants|mesh-ancestor
153488446|NCT02239380|Antiemetics|antiemetics|mesh-ancestor
153488447|NCT02239380|Autonomic Agents|autonomic agents|mesh-ancestor
153488448|NCT02239380|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153488449|NCT02239380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153488450|NCT02239380|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153488451|NCT02239380|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153488452|NCT02239380|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153488453|NCT02239380|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
153488454|NCT02239380|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153488455|NCT02239380|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153488508|NCT02251236|Antiviral Agents|antiviral agents|mesh-ancestor
153488509|NCT02251236|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153488510|NCT02251236|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
153488511|NCT02251236|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153488512|NCT02251236|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153488513|NCT02251236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153488514|NCT02251236|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153488515|NCT02251236|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153488516|NCT02251236|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
153488572|NCT02271906|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153488574|NCT02271906|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153488576|NCT02272686|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153488628|NCT02282904|Alkylating Agents|alkylating agents|mesh-ancestor
153488629|NCT02282904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153488630|NCT02282904|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153488631|NCT02282904|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153488632|NCT02282904|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153488633|NCT02282904|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153488634|NCT02282904|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153488635|NCT02282904|Antifungal Agents|antifungal agents|mesh-ancestor
153488636|NCT02283840|Eslicarbazepine acetate|eslicarbazepine acetate|mesh-list
153488637|NCT02283840|Anticonvulsants|anticonvulsants|mesh-ancestor
153488688|NCT02285634|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153488689|NCT02285634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153488690|NCT02285634|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153488742|NCT02289222|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153488743|NCT02289222|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153488744|NCT02289222|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153488745|NCT02289222|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153488746|NCT02289222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153488747|NCT02289222|Immunologic Factors|immunologic factors|mesh-ancestor
153488813|NCT02314104|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153488869|NCT02343276|Nitroglycerin|nitroglycerin|mesh-list
153488870|NCT02343276|Vasodilator Agents|vasodilator agents|mesh-ancestor
153488871|NCT02348658|Azilsartan medoxomil|azilsartan medoxomil|mesh-list
153488872|NCT02348658|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
153488873|NCT02348658|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
153488874|NCT02348658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153488875|NCT02351700|Ibuprofen|ibuprofen|mesh-list
153488876|NCT02351700|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153488877|NCT02351700|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153488878|NCT02351700|Analgesics|analgesics|mesh-ancestor
153488879|NCT02351700|Sensory System Agents|sensory system agents|mesh-ancestor
153488880|NCT02351700|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153488930|NCT02360124|Cariostatic Agents|cariostatic agents|mesh-ancestor
153488931|NCT02360124|Protective Agents|protective agents|mesh-ancestor
153488932|NCT02360124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153488933|NCT02369172|Bupropion|bupropion|mesh-list
153488934|NCT02369172|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
153488935|NCT02369172|Antidepressive Agents|antidepressive agents|mesh-ancestor
153488936|NCT02369172|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153488937|NCT02369172|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
153488938|NCT02369172|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153488939|NCT02369172|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153488940|NCT02369172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153488941|NCT02369172|Dopamine Agents|dopamine agents|mesh-ancestor
153488942|NCT02369172|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153488943|NCT02369172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153488944|NCT02369172|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
153488945|NCT02369172|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153488946|NCT02369172|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153488947|NCT02374164|Febuxostat|febuxostat|mesh-list
153488948|NCT02374164|Gout Suppressants|gout suppressants|mesh-ancestor
153488949|NCT02374164|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153488950|NCT02374398|Tranexamic Acid|tranexamic acid|mesh-list
153488952|NCT02374398|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153488953|NCT02374398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153488954|NCT02374398|Hemostatics|hemostatics|mesh-ancestor
153488955|NCT02374398|Coagulants|coagulants|mesh-ancestor
153488979|NCT02384070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153488980|NCT02384070|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153489043|NCT02413320|Paclitaxel|paclitaxel|mesh-list
153489044|NCT02413320|Docetaxel|docetaxel|mesh-list
153489045|NCT02413320|Cyclophosphamide|cyclophosphamide|mesh-list
153489046|NCT02413320|Carboplatin|carboplatin|mesh-list
153489047|NCT02413320|Doxorubicin|doxorubicin|mesh-list
153489048|NCT02413320|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153489049|NCT02413320|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153489050|NCT02413320|Tubulin Modulators|tubulin modulators|mesh-ancestor
153475875|NCT00845130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153475876|NCT00845130|Antioxidants|antioxidants|mesh-ancestor
153475881|NCT00848016|Gossypol acetic acid|gossypol acetic acid|mesh-list
153475883|NCT00848016|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153475884|NCT00848016|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153475885|NCT00848016|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153475886|NCT00848016|Immunologic Factors|immunologic factors|mesh-ancestor
153475887|NCT00848016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153475888|NCT00848016|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
153475950|NCT00868452|Lithium Carbonate|lithium carbonate|mesh-list
153475951|NCT00868452|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
153475952|NCT00868452|Antidepressive Agents|antidepressive agents|mesh-ancestor
153475953|NCT00868452|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153475954|NCT00868452|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153475955|NCT00868452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153475956|NCT00868452|Antimanic Agents|antimanic agents|mesh-ancestor
153475957|NCT00868452|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153475958|NCT00868452|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153475959|NCT00868452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153475960|NCT00868452|Anticonvulsants|anticonvulsants|mesh-ancestor
153475961|NCT00868452|GABA Agents|gaba agents|mesh-ancestor
153475962|NCT00868452|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153475963|NCT00868452|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153476022|NCT00875550|Anesthetics, General|anesthetics, general|mesh-ancestor
153476023|NCT00875550|Anesthetics|anesthetics|mesh-ancestor
153476024|NCT00875550|GABA Modulators|gaba modulators|mesh-ancestor
153476025|NCT00875550|GABA Agents|gaba agents|mesh-ancestor
153476026|NCT00878436|Bicalutamide|bicalutamide|mesh-list
153476027|NCT00878436|Panobinostat|panobinostat|mesh-list
153476028|NCT00878436|Androgen Antagonists|androgen antagonists|mesh-ancestor
153476029|NCT00878436|Hormone Antagonists|hormone antagonists|mesh-ancestor
153476030|NCT00878436|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153476034|NCT00878436|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153476080|NCT00886626|Glucagon-Like Peptide-1 Receptor Agonists|glucagon-like peptide-1 receptor agonists|mesh-ancestor
153476081|NCT00886626|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153476082|NCT00886626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153476083|NCT00886626|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
153476084|NCT00886626|Incretins|incretins|mesh-ancestor
153476085|NCT00886626|Hormones|hormones|mesh-ancestor
153476086|NCT00886626|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153476087|NCT00887562|Ubiquinone|ubiquinone|mesh-list
153476088|NCT00887562|Idebenone|idebenone|mesh-list
153476089|NCT00887562|Antioxidants|antioxidants|mesh-ancestor
153476090|NCT00887562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153476091|NCT00887562|Protective Agents|protective agents|mesh-ancestor
153476093|NCT00887562|Micronutrients|micronutrients|mesh-ancestor
153476126|NCT00887640|Dermatologic Agents|dermatologic agents|mesh-ancestor
153476127|NCT00889200|Eszopiclone|eszopiclone|mesh-list
153476128|NCT00889200|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153476129|NCT00889200|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153476130|NCT00889200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153476131|NCT00892710|Bevacizumab|bevacizumab|mesh-list
153476132|NCT00892710|Carboplatin|carboplatin|mesh-list
153476133|NCT00892710|Pemetrexed|pemetrexed|mesh-list
153476134|NCT00892710|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153476135|NCT00892710|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153476136|NCT00892710|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153476137|NCT00892710|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153476138|NCT00892710|Growth Substances|growth substances|mesh-ancestor
153476174|NCT00899574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153476175|NCT00899574|Immunomodulating Agents|immunomodulating agents|mesh-ancestor
153476176|NCT00899574|Immunologic Factors|immunologic factors|mesh-ancestor
153476180|NCT00899574|Interferon Inducers|interferon inducers|mesh-ancestor
153476373|NCT00927888|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153476375|NCT00928200|Dexamethasone|dexamethasone|mesh-list
153476376|NCT00928200|Dexamethasone acetate|dexamethasone acetate|mesh-list
153476377|NCT00928200|Doxorubicin|doxorubicin|mesh-list
153476378|NCT00928200|Methotrexate|methotrexate|mesh-list
153476379|NCT00928200|Vincristine|vincristine|mesh-list
153476380|NCT00928200|Asparaginase|asparaginase|mesh-list
153476381|NCT00928200|Dexrazoxane|dexrazoxane|mesh-list
153476382|NCT00928200|Razoxane|razoxane|mesh-list
153476383|NCT00928200|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
153476384|NCT00928200|BB 1101|bb 1101|mesh-list
153476518|NCT00943878|Immunologic Factors|immunologic factors|mesh-ancestor
153476519|NCT00943878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153476520|NCT00945282|Ritonavir|ritonavir|mesh-list
153476521|NCT00945282|Lopinavir|lopinavir|mesh-list
153476522|NCT00945282|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
153476523|NCT00945282|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
153476524|NCT00945282|Protease Inhibitors|protease inhibitors|mesh-ancestor
153476525|NCT00945282|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153476526|NCT00945282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153476527|NCT00945282|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153476528|NCT00945282|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153476529|NCT00945282|Antiviral Agents|antiviral agents|mesh-ancestor
153476530|NCT00945282|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153476531|NCT00945282|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
153476532|NCT00945282|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153476786|NCT00997620|Respiratory System Agents|respiratory system agents|mesh-ancestor
153476787|NCT00997620|Dermatologic Agents|dermatologic agents|mesh-ancestor
153476829|NCT01000818|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153476830|NCT01000818|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153476831|NCT01000818|Antiviral Agents|antiviral agents|mesh-ancestor
153476832|NCT01000818|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153476833|NCT01000818|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
153476834|NCT01000818|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
153476835|NCT01000818|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
153476836|NCT01000818|Histamine Antagonists|histamine antagonists|mesh-ancestor
153476837|NCT01000818|Histamine Agents|histamine agents|mesh-ancestor
153476840|NCT01001052|Colchicine|colchicine|mesh-list
153477003|NCT01017042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153477004|NCT01017042|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153477006|NCT01018056|Anticonvulsants|anticonvulsants|mesh-ancestor
153477007|NCT01018056|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
153477008|NCT01018056|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
153477009|NCT01018056|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153477010|NCT01018056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153477060|NCT02406222|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153477061|NCT02406222|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153477063|NCT02406222|Hormones|hormones|mesh-ancestor
153477064|NCT02406222|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153477065|NCT02406222|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
153477066|NCT02406222|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153477068|NCT02406222|Growth Substances|growth substances|mesh-ancestor
153477224|NCT01045122|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153477226|NCT01045122|Adrenergic Agents|adrenergic agents|mesh-ancestor
153477227|NCT01045122|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153477228|NCT01045122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153477229|NCT01045122|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153477230|NCT01045122|Anesthetics, General|anesthetics, general|mesh-ancestor
153477231|NCT01045122|Anesthetics|anesthetics|mesh-ancestor
153477232|NCT01050582|Risperidone|risperidone|mesh-list
153477233|NCT01050582|Antipsychotic Agents|antipsychotic agents|mesh-list
153477234|NCT01050582|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
153477235|NCT01050582|Serotonin Agents|serotonin agents|mesh-ancestor
153477236|NCT01050582|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153477237|NCT01050582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153477238|NCT01050582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153477239|NCT01050582|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153477240|NCT01050582|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153477276|NCT01028820|Antidepressive Agents|antidepressive agents|mesh-ancestor
153477277|NCT01028820|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153477278|NCT01028820|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153477348|NCT05821192|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153477551|NCT05498116|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
153477552|NCT05498116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153477554|NCT05450484|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153477555|NCT05450484|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153477557|NCT05398484|Psilocybin|psilocybin|mesh-list
153477612|NCT05014087|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153477613|NCT05014087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153477614|NCT05014087|Protective Agents|protective agents|mesh-ancestor
153477615|NCT05014087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153477617|NCT04955678|Calcium|calcium|mesh-list
153477618|NCT04955678|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153477619|NCT04955678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153477620|NCT04955678|Cathartics|cathartics|mesh-ancestor
153477621|NCT04955678|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153477622|NCT05175547|Clevidipine|clevidipine|mesh-list
153477623|NCT05175547|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153477624|NCT05175547|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153477628|NCT04924166|Hydrocortisone|hydrocortisone|mesh-list
153477728|NCT04761159|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
153477729|NCT04761159|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
153477730|NCT04761159|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153477731|NCT04761159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153477733|NCT04716296|Analgesics|analgesics|mesh-ancestor
153477734|NCT04716296|Sensory System Agents|sensory system agents|mesh-ancestor
153477735|NCT04716296|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153477740|NCT04716296|Anesthetics|anesthetics|mesh-ancestor
153477773|NCT04652661|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153477774|NCT04652661|Anesthetics, General|anesthetics, general|mesh-ancestor
153477775|NCT04652661|Anesthetics|anesthetics|mesh-ancestor
153477776|NCT04652661|GABA Modulators|gaba modulators|mesh-ancestor
153478020|NCT01060020|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153478021|NCT01060020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153478022|NCT01060020|Urological Agents|urological agents|mesh-ancestor
153478024|NCT01060098|Etanercept|etanercept|mesh-list
153478084|NCT01083732|Antithrombins|antithrombins|mesh-ancestor
153478085|NCT01083732|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
153478086|NCT01083732|Protease Inhibitors|protease inhibitors|mesh-ancestor
153478087|NCT01083732|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153478088|NCT01083732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153478089|NCT01083732|Anticoagulants|anticoagulants|mesh-ancestor
153478154|NCT01096290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153478155|NCT01096680|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
153478156|NCT01096680|Modafinil|modafinil|mesh-list
153478157|NCT01096680|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
153478158|NCT01096680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153478416|NCT04974138|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153478417|NCT04974138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153478418|NCT04974138|Vasodilator Agents|vasodilator agents|mesh-ancestor
153478419|NCT04974138|Hematinics|hematinics|mesh-ancestor
153478420|NCT04974138|Vitamin B Complex|vitamin b complex|mesh-ancestor
153478421|NCT04974138|Vitamins|vitamins|mesh-ancestor
153478422|NCT04974138|Micronutrients|micronutrients|mesh-ancestor
153478423|NCT04973982|Tacrolimus|tacrolimus|mesh-list
153478424|NCT04973982|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153478425|NCT04973982|Immunologic Factors|immunologic factors|mesh-ancestor
153478426|NCT04973982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153478427|NCT04973982|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
153478428|NCT04973982|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153478429|NCT04973982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153478430|NCT04142892|Onapristone|onapristone|mesh-list
153478586|NCT01142310|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153478587|NCT01142310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153478643|NCT01150500|Immunologic Factors|immunologic factors|mesh-ancestor
153478644|NCT01150500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153478645|NCT01151046|Exemestane|exemestane|mesh-list
153478646|NCT01151046|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153478647|NCT01151046|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
153478648|NCT01151046|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153478649|NCT01151046|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153478710|NCT01170390|Estradiol|estradiol|mesh-list
153478960|NCT01216410|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
153478961|NCT01216410|Dopamine Agents|dopamine agents|mesh-ancestor
153478963|NCT01218048|Cetuximab|cetuximab|mesh-list
153478964|NCT01218048|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153478965|NCT01218048|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153478966|NCT01218984|Naltrexone|naltrexone|mesh-list
153478967|NCT01218984|Hydromorphone|hydromorphone|mesh-list
153478968|NCT01218984|Naloxone|naloxone|mesh-list
153478969|NCT01218984|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
153478970|NCT01218984|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
153478971|NCT01218984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153478972|NCT01218984|Sensory System Agents|sensory system agents|mesh-ancestor
153478974|NCT01218984|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153479144|NCT01250730|Crizotinib|crizotinib|mesh-list
153479190|NCT01258374|Darunavir|darunavir|mesh-list
153479191|NCT01258374|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153479192|NCT01258374|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153479193|NCT01258374|Antiviral Agents|antiviral agents|mesh-ancestor
153479194|NCT01258374|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153479195|NCT01258374|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
153479196|NCT01258374|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
153479197|NCT01258374|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153479198|NCT01258374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153479515|NCT01312818|Antimetabolites|antimetabolites|mesh-ancestor
153479516|NCT01312818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153479517|NCT01312818|Dermatologic Agents|dermatologic agents|mesh-ancestor
153479518|NCT01312818|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153479519|NCT01312818|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153479570|NCT01318278|Coagulants|coagulants|mesh-ancestor
153479571|NCT01318278|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
153479572|NCT01318278|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
153479573|NCT01318278|Natriuretic Agents|natriuretic agents|mesh-ancestor
153479574|NCT01318278|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
153479575|NCT01318278|Sympathomimetics|sympathomimetics|mesh-ancestor
153479576|NCT01318278|Autonomic Agents|autonomic agents|mesh-ancestor
153479780|NCT06244290|Sodium Fluoride|sodium fluoride|mesh-list
153479786|NCT06244277|Zolpidem|zolpidem|mesh-list
153479806|NCT06244121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153479808|NCT06243822|Propofol|propofol|mesh-list
153479809|NCT06243822|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153479810|NCT06243822|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153479811|NCT06243822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153479812|NCT06243822|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153479813|NCT06243822|Anesthetics, General|anesthetics, general|mesh-ancestor
153479814|NCT06243822|Anesthetics|anesthetics|mesh-ancestor
153479815|NCT06243822|Analgesics|analgesics|mesh-ancestor
153479816|NCT06243822|Sensory System Agents|sensory system agents|mesh-ancestor
153479817|NCT06243822|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153479818|NCT06243822|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
153479819|NCT06243822|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
153479820|NCT06243822|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
153479821|NCT06243822|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153479865|NCT06243510|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
153480051|NCT06066554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153480052|NCT06066554|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153480053|NCT06066554|Dermatologic Agents|dermatologic agents|mesh-ancestor
153480054|NCT06066554|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153480055|NCT06066554|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153480056|NCT06066554|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153480060|NCT06022003|Azacitidine|azacitidine|mesh-list
153480117|NCT05995249|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
153480118|NCT05995249|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153480119|NCT05995249|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
153480120|NCT05995249|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
153480121|NCT05995249|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
153480242|NCT05839756|Autonomic Agents|autonomic agents|mesh-ancestor
153480243|NCT05839756|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153480244|NCT05839756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153480245|NCT05839756|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153480246|NCT05839756|Respiratory System Agents|respiratory system agents|mesh-ancestor
153480247|NCT05839756|Glucocorticoids|glucocorticoids|mesh-ancestor
153480281|NCT05785377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153480282|NCT05785377|Sensory System Agents|sensory system agents|mesh-ancestor
153480529|NCT05536856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153480530|NCT05525013|Simvastatin|simvastatin|mesh-list
153480532|NCT05525013|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153480533|NCT05525013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153480534|NCT05525013|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
153480535|NCT05525013|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153480536|NCT05525013|Antimetabolites|antimetabolites|mesh-ancestor
153480587|NCT05470491|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
153480588|NCT05470491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153480589|NCT05470491|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
153480590|NCT05470491|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
153480591|NCT05470491|Antiviral Agents|antiviral agents|mesh-ancestor
153480592|NCT05470491|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153480593|NCT05470491|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
153480655|NCT05386472|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
153480656|NCT05386472|Protease Inhibitors|protease inhibitors|mesh-ancestor
153480792|NCT05065970|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153480793|NCT05065970|Immunologic Factors|immunologic factors|mesh-ancestor
153480794|NCT05065970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153480795|NCT05028751|Gilteritinib|gilteritinib|mesh-list
153480796|NCT05028751|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153480834|NCT04907370|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153480835|NCT04907370|Antimetabolites|antimetabolites|mesh-ancestor
153480836|NCT04907370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153480837|NCT04905446|Niacinamide|niacinamide|mesh-list
153480839|NCT04905446|Nicotinic Acids|nicotinic acids|mesh-list
153480840|NCT04905446|Vitamin B Complex|vitamin b complex|mesh-ancestor
153480841|NCT04905446|Vitamins|vitamins|mesh-ancestor
153480842|NCT04905446|Micronutrients|micronutrients|mesh-ancestor
153480843|NCT04905446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153480844|NCT04905446|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153480845|NCT04905446|Antimetabolites|antimetabolites|mesh-ancestor
153480846|NCT04905446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153480847|NCT04905446|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153480848|NCT04905446|Vasodilator Agents|vasodilator agents|mesh-ancestor
153480849|NCT04893109|Paclitaxel|paclitaxel|mesh-list
153481008|NCT04511234|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
153481009|NCT04511234|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153481010|NCT04511234|Antifungal Agents|antifungal agents|mesh-ancestor
153481011|NCT04511234|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153481012|NCT04511234|Immunologic Factors|immunologic factors|mesh-ancestor
153481013|NCT04511234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153481014|NCT04486716|Ofatumumab|ofatumumab|mesh-list
153481068|NCT04323436|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153481069|NCT04323436|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153481071|NCT04284397|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153481184|NCT04051203|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
153481185|NCT04051203|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
153481186|NCT04051203|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153481187|NCT04051203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153481188|NCT04051203|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153481190|NCT04051203|Autonomic Agents|autonomic agents|mesh-ancestor
153481554|NCT03036098|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153481615|NCT02765256|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
153481616|NCT02765256|Histamine Antagonists|histamine antagonists|mesh-ancestor
153481618|NCT02765256|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153481619|NCT02765256|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
153481620|NCT02765256|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
153481621|NCT02765256|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153481622|NCT02765256|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153481623|NCT02765256|Anesthetics, Local|anesthetics, local|mesh-ancestor
153481624|NCT02765256|Anesthetics|anesthetics|mesh-ancestor
153481627|NCT02765256|Antiemetics|antiemetics|mesh-ancestor
153481680|NCT01772472|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153481681|NCT01772472|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153481682|NCT01772472|Tubulin Modulators|tubulin modulators|mesh-ancestor
153481683|NCT01772472|Antimitotic Agents|antimitotic agents|mesh-ancestor
153481684|NCT01772472|Mitosis Modulators|mitosis modulators|mesh-ancestor
153481685|NCT01772472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153481686|NCT01772472|Immunotoxins|immunotoxins|mesh-ancestor
153481687|NCT01772472|Immunoconjugates|immunoconjugates|mesh-ancestor
153481688|NCT01772472|Immunologic Factors|immunologic factors|mesh-ancestor
153481689|NCT01772472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153481760|NCT00770809|Paclitaxel|paclitaxel|mesh-list
153481825|NCT01337700|Sensory System Agents|sensory system agents|mesh-ancestor
153481826|NCT01337700|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153481827|NCT01337700|Antidepressive Agents|antidepressive agents|mesh-ancestor
153481828|NCT01337700|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153481829|NCT01339260|Dexamethasone|dexamethasone|mesh-list
153481830|NCT01339260|Palonosetron|palonosetron|mesh-list
153481831|NCT01339260|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153481832|NCT01339260|Antiemetics|antiemetics|mesh-ancestor
153481833|NCT01339260|Autonomic Agents|autonomic agents|mesh-ancestor
153481834|NCT01339260|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153481835|NCT01339260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153481836|NCT01339260|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153481837|NCT01339260|Glucocorticoids|glucocorticoids|mesh-ancestor
153481853|NCT01340586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153481854|NCT01340586|Anticoagulants|anticoagulants|mesh-ancestor
153481855|NCT01342770|Pioglitazone|pioglitazone|mesh-list
153482036|NCT01387464|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153482037|NCT01387464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153482038|NCT01387464|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153482039|NCT01387464|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153482040|NCT01388946|Ropivacaine|ropivacaine|mesh-list
153482041|NCT01388946|Anesthetics, Local|anesthetics, local|mesh-ancestor
153482042|NCT01388946|Anesthetics|anesthetics|mesh-ancestor
153482043|NCT01388946|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153482044|NCT01388946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153482045|NCT01388946|Sensory System Agents|sensory system agents|mesh-ancestor
153482046|NCT01388946|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153482047|NCT01390818|Niacinamide|niacinamide|mesh-list
153482192|NCT01421472|Mitosis Modulators|mitosis modulators|mesh-ancestor
153482193|NCT01421472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153482194|NCT01428336|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
153482195|NCT01428336|Melanocyte-Stimulating Hormones|melanocyte-stimulating hormones|mesh-list
153482196|NCT01428336|Cosyntropin|cosyntropin|mesh-list
153482197|NCT01428336|beta-Endorphin|beta-endorphin|mesh-list
153482198|NCT01428336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153482199|NCT01428336|Hormones|hormones|mesh-ancestor
153482200|NCT01428336|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153482201|NCT01428336|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153482202|NCT01428336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153482203|NCT01429272|Aspirin|aspirin|mesh-list
153482204|NCT01429272|Minocycline|minocycline|mesh-list
153482205|NCT01429272|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153482206|NCT01429272|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153482207|NCT01429272|Analgesics|analgesics|mesh-ancestor
153482208|NCT01429272|Sensory System Agents|sensory system agents|mesh-ancestor
153482209|NCT01429272|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153482210|NCT01429272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153482211|NCT01429272|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153482212|NCT01429272|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153482235|NCT01432236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153482236|NCT01432236|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153482238|NCT01432236|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153482241|NCT01434186|Metformin|metformin|mesh-list
153482261|NCT01434342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153482262|NCT01435824|Amoxicillin|amoxicillin|mesh-list
153482263|NCT01435824|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153482264|NCT01435824|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153482265|NCT01436526|Rivaroxaban|rivaroxaban|mesh-list
153482266|NCT01436526|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
153482267|NCT01436526|Antithrombins|antithrombins|mesh-ancestor
153482268|NCT01436526|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
153482269|NCT01436526|Protease Inhibitors|protease inhibitors|mesh-ancestor
153482270|NCT01436526|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153482271|NCT01436526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153482272|NCT01436526|Anticoagulants|anticoagulants|mesh-ancestor
153482273|NCT01438710|Tacrolimus|tacrolimus|mesh-list
153482274|NCT01438710|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153482275|NCT01438710|Immunologic Factors|immunologic factors|mesh-ancestor
153482276|NCT01438710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153482277|NCT01438710|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
153482278|NCT01438710|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153482280|NCT01443546|Leuprolide|leuprolide|mesh-list
153482339|NCT01462812|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153482343|NCT01463202|Medroxyprogesterone|medroxyprogesterone|mesh-list
153482373|NCT01468584|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153482374|NCT01472874|Trientine|trientine|mesh-list
153482375|NCT01472874|Chelating Agents|chelating agents|mesh-ancestor
153482376|NCT01472874|Sequestering Agents|sequestering agents|mesh-ancestor
153482377|NCT01472874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153482378|NCT01474122|Macitentan|macitentan|mesh-list
153482379|NCT01474122|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
153482380|NCT01474122|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
153482381|NCT01474122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153482499|NCT01511640|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153482500|NCT01511640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153482501|NCT01511640|Anticonvulsants|anticonvulsants|mesh-ancestor
153482502|NCT01511640|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
153482503|NCT01511640|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153482504|NCT01511640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153482505|NCT01511640|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153482510|NCT01513122|Ritonavir|ritonavir|mesh-list
153482662|NCT01536366|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
153482663|NCT06115174|Pentoxifylline|pentoxifylline|mesh-list
153482665|NCT06115174|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
153482666|NCT06115174|Immunologic Factors|immunologic factors|mesh-ancestor
153482667|NCT06115174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153482668|NCT06115174|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
153482669|NCT06115174|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153482670|NCT06115174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153482671|NCT06115174|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
153482672|NCT06115174|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
153482674|NCT06115174|Vasodilator Agents|vasodilator agents|mesh-ancestor
153482675|NCT06115174|Free Radical Scavengers|free radical scavengers|mesh-ancestor
153482676|NCT06115174|Antioxidants|antioxidants|mesh-ancestor
153482785|NCT06114121|Anesthetics, Local|anesthetics, local|mesh-ancestor
153482787|NCT06114121|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153482788|NCT06114121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153482789|NCT06114121|Sensory System Agents|sensory system agents|mesh-ancestor
153482790|NCT06114121|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153482791|NCT06114121|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153482792|NCT06114121|Narcotics|narcotics|mesh-ancestor
153482793|NCT06114121|Analgesics|analgesics|mesh-ancestor
153482951|NCT05829603|Hallucinogens|hallucinogens|mesh-ancestor
153482952|NCT05829603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153482953|NCT05829603|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153482954|NCT05829603|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
153482955|NCT05829603|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153482956|NCT05829603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153482957|NCT05804708|N,N-Dimethyltryptamine|n,n-dimethyltryptamine|mesh-list
153482958|NCT05804708|Hallucinogens|hallucinogens|mesh-ancestor
153482996|NCT05705492|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153482997|NCT05705492|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
153482998|NCT05705492|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153483170|NCT04629729|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
153483171|NCT04629729|Fludarabine|fludarabine|mesh-list
153483172|NCT04629729|Interleukin-2|interleukin-2|mesh-list
153483173|NCT04629729|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153483174|NCT04629729|Immunologic Factors|immunologic factors|mesh-ancestor
153483175|NCT04629729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153483176|NCT04629729|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153483177|NCT04629729|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153483178|NCT04629729|Alkylating Agents|alkylating agents|mesh-ancestor
153483179|NCT04629729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153483180|NCT04629729|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153483181|NCT04629729|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153483182|NCT04629729|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153483183|NCT04629729|Analgesics|analgesics|mesh-ancestor
153483184|NCT04629729|Sensory System Agents|sensory system agents|mesh-ancestor
153483185|NCT04629729|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153483204|NCT04582383|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
153483206|NCT04582383|Hormone Antagonists|hormone antagonists|mesh-ancestor
153483283|NCT04437485|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
153483284|NCT04437485|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
153483285|NCT04437485|Serotonin Agents|serotonin agents|mesh-ancestor
153483286|NCT04338399|Paclitaxel|paclitaxel|mesh-list
153483287|NCT04338399|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153483293|NCT04306510|Antibodies|antibodies|mesh-list
153483307|NCT04082442|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153483317|NCT04054752|Vaccines|vaccines|mesh-list
153483318|NCT04054752|Immunologic Factors|immunologic factors|mesh-ancestor
153483319|NCT04054752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153483320|NCT04003285|Pregnanolone|pregnanolone|mesh-list
153483321|NCT04003285|Anesthetics|anesthetics|mesh-ancestor
153483322|NCT04003285|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153483373|NCT03586089|Anticonvulsants|anticonvulsants|mesh-ancestor
153483374|NCT03586089|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153483375|NCT03586089|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153483376|NCT03586089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153483377|NCT03586089|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
153483378|NCT03586089|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
153483379|NCT03586089|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153483490|NCT03125642|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
153483491|NCT03125642|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
153483492|NCT03125642|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153483553|NCT02266329|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
153483554|NCT02266329|Adrenergic Agents|adrenergic agents|mesh-ancestor
153483555|NCT02266329|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153483556|NCT02266329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153483557|NCT02266329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153483561|NCT01873131|Timolol|timolol|mesh-list
153483903|NCT01565538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153483904|NCT01565538|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
153483905|NCT01565538|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153483942|NCT01569126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153483943|NCT01569126|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153483944|NCT01569126|Serotonin Agents|serotonin agents|mesh-ancestor
153483945|NCT01569126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153484010|NCT05565924|Biguanides|biguanides|mesh-list
153484011|NCT05565924|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153484012|NCT05565924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153484014|NCT05564832|Pilocarpine|pilocarpine|mesh-list
153484125|NCT05120076|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153484126|NCT04868760|Ipilimumab|ipilimumab|mesh-list
153484127|NCT04868760|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
153484128|NCT04868760|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153484129|NCT04868760|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
153484130|NCT04868760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153484132|NCT04508166|Dexmedetomidine|dexmedetomidine|mesh-list
153484133|NCT04508166|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153484134|NCT04508166|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153484135|NCT04508166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153484136|NCT04508166|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153484137|NCT04508166|Analgesics|analgesics|mesh-ancestor
153484138|NCT04508166|Sensory System Agents|sensory system agents|mesh-ancestor
153484139|NCT04508166|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153484140|NCT04508166|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
153484141|NCT04508166|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153484142|NCT04508166|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153484143|NCT04508166|Adrenergic Agents|adrenergic agents|mesh-ancestor
153484144|NCT04508166|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153484148|NCT04508166|Anesthetics, General|anesthetics, general|mesh-ancestor
153484288|NCT01621230|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153484289|NCT01621230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153484290|NCT01621230|Sensory System Agents|sensory system agents|mesh-ancestor
153484291|NCT01621230|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153484292|NCT01621230|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153484293|NCT01621230|Narcotics|narcotics|mesh-ancestor
153484294|NCT01621230|Analgesics|analgesics|mesh-ancestor
153484295|NCT01621230|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
153484296|NCT01621230|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
153484297|NCT01621230|Anesthetics, General|anesthetics, general|mesh-ancestor
153484299|NCT01621776|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
153484300|NCT01621776|Insulin Aspart|insulin aspart|mesh-list
153484301|NCT01621776|Insulin Lispro|insulin lispro|mesh-list
153484302|NCT01621776|Insulin glulisine|insulin glulisine|mesh-list
153484303|NCT01621776|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153484304|NCT01621776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153484351|NCT01639872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153484352|NCT01639872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153484353|NCT01639872|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153484354|NCT01639872|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153484355|NCT01639872|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153484356|NCT01639872|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153484364|NCT01640340|Palonosetron|palonosetron|mesh-list
153484365|NCT01640340|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153484366|NCT01640340|Antiemetics|antiemetics|mesh-ancestor
153484367|NCT01640340|Autonomic Agents|autonomic agents|mesh-ancestor
153484368|NCT01640340|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153484369|NCT01640340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153484370|NCT01640340|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153484371|NCT01640340|Glucocorticoids|glucocorticoids|mesh-ancestor
153484372|NCT01640340|Hormones|hormones|mesh-ancestor
153484373|NCT01640340|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153484470|NCT01652976|Immunologic Factors|immunologic factors|mesh-ancestor
153484471|NCT01652976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153484472|NCT01652976|Antidotes|antidotes|mesh-ancestor
153484473|NCT01652976|Protective Agents|protective agents|mesh-ancestor
153484474|NCT01652976|Vitamin B Complex|vitamin b complex|mesh-ancestor
153484475|NCT01652976|Vitamins|vitamins|mesh-ancestor
153484476|NCT01652976|Micronutrients|micronutrients|mesh-ancestor
153484477|NCT01652976|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors|mesh-ancestor
153484478|NCT01652976|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153484479|NCT01652976|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153484480|NCT01656252|Cytarabine|cytarabine|mesh-list
153484481|NCT01656252|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
153484482|NCT01656252|Antimetabolites|antimetabolites|mesh-ancestor
153484483|NCT01656252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153484484|NCT01656252|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153484485|NCT01656252|Antiviral Agents|antiviral agents|mesh-ancestor
153484486|NCT01656252|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153484487|NCT01656252|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
153484488|NCT01656252|Immunologic Factors|immunologic factors|mesh-ancestor
153484489|NCT01656252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153484490|NCT01661088|Folfirinox|folfirinox|mesh-list
153484718|NCT05136066|Antiemetics|antiemetics|mesh-ancestor
153484719|NCT05136066|Autonomic Agents|autonomic agents|mesh-ancestor
153484720|NCT05136066|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153484721|NCT05136066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153484722|NCT05136066|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153484723|NCT05136066|Parasympatholytics|parasympatholytics|mesh-ancestor
153484724|NCT04676802|Analgesics, Opioid|analgesics, opioid|mesh-list
153484725|NCT04676802|Narcotics|narcotics|mesh-ancestor
153484726|NCT04676802|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153484785|NCT01721460|Analgesics|analgesics|mesh-ancestor
153484976|NCT01740726|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153484977|NCT01740726|Serotonin Agents|serotonin agents|mesh-ancestor
153484978|NCT01740726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153484979|NCT01740726|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
153484980|NCT01740726|Antidepressive Agents|antidepressive agents|mesh-ancestor
153484981|NCT01740726|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153484982|NCT01740726|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
153484983|NCT01740726|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153485008|NCT01749930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153485009|NCT01749930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153485010|NCT01749930|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
153485011|NCT01749930|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153485013|NCT01750086|Alendronate|alendronate|mesh-list
153485014|NCT01750086|Teriparatide|teriparatide|mesh-list
153485015|NCT01750086|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
153485121|NCT01769586|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153485122|NCT01769586|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
153485123|NCT01769586|Histamine Antagonists|histamine antagonists|mesh-ancestor
153485124|NCT01769586|Histamine Agents|histamine agents|mesh-ancestor
153485125|NCT01769586|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
153485126|NCT01769586|Antipruritics|antipruritics|mesh-ancestor
153485127|NCT01769586|Dermatologic Agents|dermatologic agents|mesh-ancestor
153485128|NCT01773954|Aflibercept|aflibercept|mesh-list
153485129|NCT01773954|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153485130|NCT01773954|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153485131|NCT01773954|Growth Substances|growth substances|mesh-ancestor
153485132|NCT01773954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153485133|NCT01773954|Growth Inhibitors|growth inhibitors|mesh-ancestor
153485134|NCT01773954|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153485135|NCT01778634|Azithromycin|azithromycin|mesh-list
153485136|NCT01778634|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153485137|NCT01778634|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153485167|NCT01785186|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153485168|NCT01785186|Anti-Infective Agents|anti-infective agents|mesh-ancestor
153485169|NCT01785186|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
153485170|NCT01785186|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
153485171|NCT01785186|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153485220|NCT01790490|Anesthetics|anesthetics|mesh-ancestor
153485236|NCT01791972|Albuterol|albuterol|mesh-list
153485237|NCT01791972|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
153485238|NCT01791972|Autonomic Agents|autonomic agents|mesh-ancestor
153485239|NCT01791972|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153485240|NCT01791972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153485241|NCT01791972|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
153485242|NCT01791972|Respiratory System Agents|respiratory system agents|mesh-ancestor
153485243|NCT01791972|Tocolytic Agents|tocolytic agents|mesh-ancestor
153485244|NCT01791972|Reproductive Control Agents|reproductive control agents|mesh-ancestor
153485245|NCT01791972|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
153485246|NCT01791972|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
153485247|NCT01791972|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153485248|NCT01791972|Adrenergic Agents|adrenergic agents|mesh-ancestor
153485249|NCT01791972|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153485250|NCT01791972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153485251|NCT01794702|Cytarabine|cytarabine|mesh-list
153485407|NCT06019130|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
153485408|NCT06018948|Dexmedetomidine|dexmedetomidine|mesh-list
153485409|NCT06018948|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
153485410|NCT06018948|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153485411|NCT06018948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153485412|NCT06018948|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153485413|NCT06018948|Analgesics|analgesics|mesh-ancestor
153485414|NCT06018948|Sensory System Agents|sensory system agents|mesh-ancestor
153485415|NCT06018948|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153485416|NCT06018948|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
153485417|NCT06018948|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
153485418|NCT06018948|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
153485419|NCT06018948|Adrenergic Agents|adrenergic agents|mesh-ancestor
153485435|NCT06014944|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
153485764|NCT05350371|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
153485765|NCT05350371|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153485767|NCT05348200|Lidocaine|lidocaine|mesh-list
153485832|NCT05115513|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153485833|NCT05115513|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153485834|NCT05115513|Analgesics|analgesics|mesh-ancestor
153485835|NCT05115513|Sensory System Agents|sensory system agents|mesh-ancestor
153485836|NCT05115513|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153485837|NCT05115513|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
153485838|NCT05115513|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
153485839|NCT05115513|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153485840|NCT05115513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153485841|NCT05115513|Hormones|hormones|mesh-ancestor
153486099|NCT04189757|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153486100|NCT04189757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153486101|NCT04189757|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153486102|NCT04149964|Acetaminophen|acetaminophen|mesh-list
153486103|NCT04149964|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
153486104|NCT04149964|Oxycodone|oxycodone|mesh-list
153486105|NCT04149964|Hydrocodone|hydrocodone|mesh-list
153486106|NCT04149964|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153486107|NCT04149964|Analgesics|analgesics|mesh-ancestor
153486108|NCT04149964|Sensory System Agents|sensory system agents|mesh-ancestor
153486109|NCT04149964|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153486110|NCT04149964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153486111|NCT04149964|Antipyretics|antipyretics|mesh-ancestor
153486113|NCT04149964|Narcotics|narcotics|mesh-ancestor
153486177|NCT03694262|Bevacizumab|bevacizumab|mesh-list
153486223|NCT03229499|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
153486224|NCT03229499|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
153486225|NCT03229499|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153486226|NCT03229499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153486227|NCT03229499|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
153486228|NCT03229499|Hormone Antagonists|hormone antagonists|mesh-ancestor
153486229|NCT03229499|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153486406|NCT01503632|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
153486407|NCT01503632|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153486408|NCT01231906|Cyclophosphamide|cyclophosphamide|mesh-list
153486461|NCT00468234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153486462|NCT00354393|Methotrexate|methotrexate|mesh-list
153486463|NCT00354393|Vinorelbine|vinorelbine|mesh-list
153486464|NCT00354393|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153486465|NCT00354393|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
153486573|NCT01834404|Anticonvulsants|anticonvulsants|mesh-ancestor
153486574|NCT01834404|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153486575|NCT01834404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153486576|NCT01834404|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
153486577|NCT01834404|Appetite Depressants|appetite depressants|mesh-ancestor
153486578|NCT01834404|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
153486579|NCT01834404|Sympathomimetics|sympathomimetics|mesh-ancestor
153486580|NCT01834404|Autonomic Agents|autonomic agents|mesh-ancestor
153486581|NCT01834404|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
153486582|NCT01834404|Adrenergic Agents|adrenergic agents|mesh-ancestor
153486609|NCT01766076|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
153486752|NCT01846728|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153486754|NCT01848054|Buprenorphine|buprenorphine|mesh-list
153486755|NCT01848054|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
153486756|NCT01848054|Naloxone|naloxone|mesh-list
153486757|NCT01848054|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
153486758|NCT01848054|Narcotics|narcotics|mesh-ancestor
153486759|NCT01848054|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153486770|NCT01849068|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
153486771|NCT01849692|Ranibizumab|ranibizumab|mesh-list
153486772|NCT01849692|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
153486773|NCT01849692|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153486774|NCT01849692|Growth Substances|growth substances|mesh-ancestor
153486944|NCT05714670|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
153486945|NCT05714670|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
153486946|NCT05714670|Analgesics|analgesics|mesh-ancestor
153486947|NCT05714670|Sensory System Agents|sensory system agents|mesh-ancestor
153487009|NCT04418466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153487010|NCT04418466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153487011|NCT04418466|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
153487012|NCT04418466|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
153487013|NCT04418466|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153487014|NCT04418466|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
153487015|NCT04418466|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
153487336|NCT01951950|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
153487337|NCT01951950|Vasodilator Agents|vasodilator agents|mesh-ancestor
153487338|NCT01953432|Doxazosin|doxazosin|mesh-list
153487339|NCT01953432|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
153487340|NCT01953432|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
153487341|NCT01953432|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
153487342|NCT01953432|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
153487343|NCT01953432|Adrenergic Agents|adrenergic agents|mesh-ancestor
153487344|NCT01953432|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153487345|NCT01953432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153487346|NCT01953432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153487648|NCT01086540|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153487649|NCT01086540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153487650|NCT01086540|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
153487651|NCT01086540|Antipruritics|antipruritics|mesh-ancestor
153487652|NCT01086540|Dermatologic Agents|dermatologic agents|mesh-ancestor
153487653|NCT01962870|Vasopressins|vasopressins|mesh-list
153487655|NCT01962870|Hemostatics|hemostatics|mesh-ancestor
153487656|NCT01962870|Coagulants|coagulants|mesh-ancestor
153487657|NCT01962870|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
153487658|NCT01962870|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
153487659|NCT01962870|Natriuretic Agents|natriuretic agents|mesh-ancestor
153487660|NCT01962870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153487661|NCT01965366|Dexamethasone|dexamethasone|mesh-list
153487662|NCT01965366|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
153487697|NCT01980654|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153487698|NCT01980654|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153487703|NCT01984398|Clomiphene|clomiphene|mesh-list
153487841|NCT02058420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153487842|NCT02058420|Protective Agents|protective agents|mesh-ancestor
153487843|NCT02058420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153487844|NCT02058420|Vitamins|vitamins|mesh-ancestor
153487845|NCT02058420|Micronutrients|micronutrients|mesh-ancestor
153487846|NCT02020278|Tolvaptan|tolvaptan|mesh-list
153487847|NCT02020278|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
153487849|NCT02020278|Natriuretic Agents|natriuretic agents|mesh-ancestor
153487866|NCT02024724|Hormones|hormones|mesh-ancestor
153487867|NCT02024724|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
153487869|NCT02024724|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
153487870|NCT02024724|Anesthetics, Local|anesthetics, local|mesh-ancestor
153487872|NCT02024724|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
153487873|NCT02024724|Sensory System Agents|sensory system agents|mesh-ancestor
153488211|NCT02159976|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
153488212|NCT02159976|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
153488213|NCT02159976|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
153488214|NCT02159976|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
153488255|NCT02178696|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
153488256|NCT02178696|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
153488257|NCT02178696|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
153488258|NCT02178696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153488259|NCT02178696|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
153488260|NCT02178696|Serotonin Agents|serotonin agents|mesh-ancestor
153488261|NCT02178696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
153488264|NCT02179788|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
153488577|NCT02272686|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
153488578|NCT02272686|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
153488579|NCT02272686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153488580|NCT02274870|Bupivacaine|bupivacaine|mesh-list
153488581|NCT02274870|Anesthetics, Local|anesthetics, local|mesh-ancestor
153488627|NCT02282904|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
153488749|NCT02289222|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
153488805|NCT02304432|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
153488806|NCT02304432|Antimetabolites|antimetabolites|mesh-ancestor
153488807|NCT02304432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
153488809|NCT02307318|Coagulants|coagulants|mesh-ancestor
153488810|NCT02314104|Ropivacaine|ropivacaine|mesh-list
153488811|NCT02314104|Anesthetics, Local|anesthetics, local|mesh-ancestor
153488812|NCT02314104|Anesthetics|anesthetics|mesh-ancestor
